PMCID: 6331660
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (neural basis: [phsu]), (adhd-asd overlap: [cgab]), (relevant eeg-imaging studies: [diap]), (seventy-five articles: [qnco]), (broad neurocognitive domains: []), (findings: [clna]), (neural overlaps: [topp]), (distinctions: []), (adhd: [mobd]), (asd: [cgab]), (single study: [fndg]), (disorders: [dsyn]),
ASD Terms: (broad neurocognitive domains, 'Cognitive Ability')(adhd, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 6314746
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (aim: [phsu]), (study: [resa]), (associations: [menp]), (maternal dietary patterns: [resa]), (autism spectrum disorders: [mobd]), (association: [menp]), (maternal supplement intake: [famg]), (asd: [cgab]), (case-control study design: [resa]), ((td) children: [aggp]), (children: [aggp]), (data: [euka]), (autism clinical: [mobd]), (environmental database (aced): [aapp,bacs]), (seventy: []), (autism: [mobd]), (age: [orga]), (td children: [aggp]), (multivariate: []), (logistic regression model: [inpr,qnco]), (maternal unbalanced dietary patterns: [resa]), (conception: [orgf]), ([95% ci: [lbpr]), (maternal supplementation: [topp]), (calcium: [bacs,elii,phsu]), (pregnancy preparation: [orgf]), (decreased asd risk: [cgab]), (preliminary evidence: []), (risk factor: [qnco]), (supplementation: [topp]), (offspring: [famg]), 
ASD Terms: (maternal supplement intake, 'Dietary Supplements')(autism spectrum disorders, 'Autism Phenotype')(autism clinical, 'Autism Phenotype')(autism, 'Autism Phenotype')(maternal supplementation, 'Dietary Supplements')(supplementation, 'Dietary Supplements')(asd in offspring, 'Perinatal History')(offspring, 'Perinatal History')

PMCID: 6307226
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (neuroglial cells: [cell]), (homeostatic support: [biof]), (form defence: []), (nervous system contribute: [acty]), (neurological disorders: [dsyn]), (major types: []), (neuroglia: [cell]), ( astrocytes: [cell]), ( oligodendrocytes: [cell]), (microglia: [cell]), (brains: [bpoc]), (animal model: [emod]), (autism spectrum disorder: [mobd]), (rats: [mamm]), (mood stabilizer drug valproic acid;: [orch,phsu]), (model: []), (clinical relevance: []), (autistic-like behaviors: [mobd]), (male rats: [mamm]), (three-chamber test: [lbpr]), (hole board test: [lbpr]), (human infancy: [humn]), ( adolescence: []), (adulthood: []), (such tasks: []), (postnatal day: []), (respectively: []), (sacrifice: []), (gene: [gngm]), (protein expression: [genf]), (specific markers: [clna]), (hippocampus: [bpoc]), ( prefrontal cortex: [bpoc]), (brain regions: [blor]), (autism spectrum disorder pathogenesis: [mobd]), (infant offspring: [aggp]), (vpa-exposed dams: [gngm]), (ultrasonic vocalizations: [npop]), (mothers: [famg]), (siblings: [famg]), (adolescence: []), (altered sociability: [socb]), (chamber test: [lbpr]), (stereotypic behavior: [mobd]), (molecular analyses: [mbrt]), (prenatal valproic acid exposure: [orch,phsu]), (types: []), (transcriptional modifications: [genf]), (prominent changes: [qnco]), (prefrontal cortex: [bpoc]), (changes: [qnco]), (infancy: []), (neuroglial pathological phenotype: [orga]), (autism spectrum disorder rat model: [mamm]), (little signs: [fndg]), (chronic neuroinflammation: []), 
ASD Terms: (neurological disorders, 'Neurologic Indications')(autism spectrum disorder, 'Autism Phenotype')(mood stabilizer drug valproic acid, 'Mood')(human infancy, 'Perinatal History')(autism spectrum disorder pathogenesis, 'Autism Phenotype')(infant offspring, 'Perinatal History')(ultrasonic vocalizations, 'Vocalizations')(stereotypic behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(prenatal valproic acid exposure, 'Exposures')(infancy, 'Perinatal History')(autism spectrum disorder rat model, 'Autism Phenotype')

PMCID: 6324819
SFARI Genes: FOXP2, FOXP2, 
Non SFARI Genes: iv, 
Named Entities: ((cntnap2) gene: [gngm]), (member: [popg]), (neurexin superfamily: []), (cntnap2: [gngm]), (cortical dysplasia-focal epilepsy (cdfe): [dsyn]), (recessive disease: [dsyn]), (intellectual disability: [mobd]), (epilepsy: [dsyn]), ( language impairments: [mobd]), (autistic features: [mobd]), (associated snps: [nusq]), (heterozygous deletions: [genf]), (autism: [mobd]), ( schizophrenia: [mobd]), (other psychiatric: [hlca]), (neurological disorders: [dsyn]), (evidence: []), (role: [socb]), (susceptibility: [clna]), (disorders: [dsyn]), (analysis: [resa]), (multiple classes: [hlca]), (genetic variation: [npop]), (large genomic datasets: [gngm]), (study: [resa]), (i) summary statistics: [inch]), (psychiatric genomics consortium (pgc) gwas: [mbrt]), (psychiatric disorders; ii): [mobd]), (structural variants: []), (patients: [podg]), (controls; iii): [sbst]), (cross-disorder analysis: [hlca]), (snps;: [nusq]), (burden tests: [lbpr]), (pathogenic rare variants: [fndg]), (data (4: [fndg]), (483 asd: [cgab]), (schizophrenia cases: [mobd]), (controls): [sbst]), (distribution: []), (cnvs: [nusq]), (psychiatric cases: [qnco]), (previous reports: [hlca]), (controls: [sbst]), (database: []), (genomic variants: [gngm]), (gene-based association: []), (common variants: [qnco]), (other psychiatric phenotypes: [orga]), (association: [menp]), (functional snps rs7794745: [nusq]), (rs2710102: []), (brain connectivity: [bpoc]), (functional snps yield: [nusq]), (significant results: [fndg]), (psychiatric disorders: [mobd]), (rare variant burden: [gngm]), (schizophrenia: [mobd]),(cnv mircroarray study: [nusq]), (extended bipolar disorder family: [famg]), (affected relatives: [famg]), (deletion: [genf]), (cntnap2 intron: [bacs,nnon]), (foxp2 transcription factor: [aapp,bacs]), (site: [blor]), (quantitative-pcr validation: [mbrt]), (segregation analysis: [socb]), (cnv: [nusq]), (imperfect segregation: [socb]), (bd: []), (large comprehensive study: [resa]), (robust risk gene: [gngm]), (psychiatric phenotypes: [orga]), 
ASD Terms: (cortical dysplasia-focal epilepsy, 'Epilepsy')(intellectual disability, 'Learning Disorders')(epilepsy, 'Epilepsy')(language impairments, 'Language Ability')(autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(neurological disorders, 'Neurologic Indications')(psychiatric disorders, 'Mental Disorders')(autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(bipolar disorder family, 'Bipolar Disorder')(extended bipolar disorder family, 'Bipolar Disorder')

PMCID: 6299922
SFARI Genes: CHD8, CHD8, CHD8, CHD8, CHD8, CHD8, CHD8, CHD8, CHD8, CHD8, CHD8, CHD8, CHD8, MAP2, CHD8, MAP2, Chd8, E16, Chd8, E16, Chd8, Chd8, CHD8, CHD8, 
Non SFARI Genes: 
Named Entities: (mutations: [genf]), (chd8: [gngm]), ( chromodomain helicase dna-binding protein: [aapp,enzy]), (common findings: [clna]), (genetic studies: [resa]), (autism spectrum disorder (asd): [mobd]), (chd8 protein: [aapp,bacs]), (transcriptional regulator: [genf]), (chromatin structure: [celc]), (histone h1: [aapp,bacs]), (genes: [gngm]), (mechanism: []), (deficiency: [dsyn]), (chd8 causes asd: [cgab]), (expression: [topp]), (mouse brains: [tisu]), (immunohistochemistry: [diap]), (rna: [nnon]), (situ hybridization: [mbrt]), (utero electroporation: [lbpr,resa]), ( neuronal culture: [lbpr]), (biochemical analysis: [resa]), (rnai: [genf]), (functional consequences: []), (chd8 deficiency: [dsyn]), (neurons: [cell]), (low levels: [qnco]), (glia cells: [cell]), (humans: [humn]), (mice: [mamm]), (specifically: []), ( chd8: [gngm]), (nucleus: [celc]), (map2: [gngm]), (parvalbumin-positive neurons: [aapp,bacs]), (developing mouse brain: [tisu]), ( expression: [topp]), (chd8 peaks: [gngm]), (e16: [gngm]), (e18: []), (p14: [gngm]), (knockdown: []), (chd8 results: [gngm]), (reduced axon: [celc]), (dendritic growth: [orgf]), ( disruption: []), (axon projections: [celc]), (contralateral cortex: [bpoc]), (delayed neuronal migration: [gngm]), (e18.5: []), (recovers: [orgf]), (p3: [gngm]), (p7: [gngm]), (findings: [clna]), (important role: [socb]), (axon development: [celf]), (neuronal migration: [gngm]), (novel insights: [menp]), (circuit mechanisms: []), (asd: [cgab]), (article: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 6293633
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (targeted sequencing: [mbrt]), (autism risk genes: [gngm]), (probands: [orga]), (autism clinical: [mobd]), (genetic: [topp]), (china (acgc) (phase i): []), (here: []), (analysis: [resa]), (cohort: [popg]), (patients: [podg]), ((acgc phase ii): []), (prevalence: [qnco]), ( inheritance: [qnco]), (genotypephenotype correlations: []), (likely gene-disrupting (lgd) mutations: [genf]), (autism candidate genes: [mobd]), (cohorts: [popg]), (european descent: [famg]), (genes: [gngm]), (single-molecule molecular inversion probes: [comd]), (inheritance: [qnco]), (pathogenic mutations: [genf]), (meta-analysis: [resa]), (phase: []), (ii data: [euka]), (results: [fndg]), (exome sequence data: [nusq]), (phenotypes: [orga]), (carrier parents: [fndg]), (multiple hits: [fndg]), (different autism risk genes: [gngm]), (recurrent: []), ( lgd: []), (mutations: [genf]), (potential novel risk gene (znf292): [gngm]), (novel gene: [gngm]), (recurrent lgd dnms (ralgapb): [gngm]), (macrocephaly (gigyf2: [cgab]), (wdfy3): [gngm]), (transmission: [patf]), (private lgd mutations: [genf]), (dnms: []), (parental carriers: [fndg]), (share: [socb]), (autism-related phenotypes: [mobd]), (candidate genes: [gngm]), (severe phenotypes: [fndg]), (new risk genes: [gngm]), (deleterious mutations: [comd]), (fact: [gngm]), (milder phenotypes: [fndg]), (multifactorial model: [fndg]), (risk: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0247-z) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism risk genes, 'Autism Phenotype')(autism clinical, 'Autism Phenotype')(autism candidate genes, 'Autism Phenotype')(different autism risk genes, 'Autism Phenotype')

PMCID: 6293525
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (animal models: [anim]), (neurodevelopmental disorders: [mobd]), (single genetic mutation: [fndg]), (fixed genetic background: [orga]), (recent human genetic studies: [humn]), (clinical diagnosis: []), (asdautism spectrum disorder (asd): [dsyn]), (multiple genetic fore-: [fndg]), (background changes: [qnco]), (translational value: [qnco]), (animal model studies: [emod]), (genetic insults: [topp]), (quantitative framework: [qnco]), (genetic backgrounds: [orga]), (collaborative cross: [socb]), (novel mouse: [mamm]), (genetic reference population: [popg]), (quantitative genetic architecture: [qnco]), (mouse: [mamm]), (behavioral phenotypes: [bhvr]), (ndd: []), (classical tests: [lbpr]), (social recognition: [menp]), (phenotypes: [orga]), (insufficient: []), (quantitative studies: [lbpr]), (genetic dilution: [lbpr]), (heritability: []), (contrast: [irda]), ( digging: [neop]), ( locomotor activity: [dora]), (exploratory patterns: []), (continuous distribution: [qnco]), (cc sample: [sbst]), (trait loci: [gngm]), (genes: [gngm]), (human populations: [popg]), (findings: [clna]), (cc: [celc]), (comparative single gene-single background designs: [fndg]), (point: [qnco]), (type: [qnco]), (effect: []), (developmental etiologies: [orgf]), (multiple genetic backgrounds: [orga]), (electronic supplementary material: []), (online version: []), (article: []), (supplementary material: []), (users: [humn]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(clinical diagnosis, 'Diagnosis')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 6288876
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (gut microbiota: [orgm]), (capacity: [qnco]), (regular function: [phsf]), (brain: [bpoc]), (turn: [fndg]), (composition: [clna]), (microbiota: [orgm]), (autism spectrum disorder (asd) patients: [mobd]), (gastrointestinal problems: []), (experience changes: [qnco]), (gut microbiota; however: [orgm]), (change: [qnco]), (asd: [cgab]), (cause: []), (consequence: []), (disease: [dsyn]), (species richness: []), (microbial composition: [clna]), (valproic acid (vpa)-induced rat model autism: [mamm]), (fecal samples: [bdsu]), (rectum: [bpoc]), (necropsy: [diap]), ( microbial total dna: [bacs,nnon]), (rrna genes: [gngm]), (illumina: []), (global microbial co-occurrence network: [orgm]), (random matrix: [resa]), (theory-based pipeline: []), (rat microbiome data: [mamm]), (available data: [euka]), (cases: [qnco]), (autism: [mobd]), (vpa administration: [topp]), (pregnancy: [orgf]), (fecal microbial richness: [bdsu]), (gut: [bdsy]), (metabolite potential: [bacs]), (fecal microbial community: [bdsu]), (pattern: []), (patients: [podg]), (however: []), (global network property: [popg]), (network composition: [popg]), (microbial co-occurrence patterns: [orgm]), (offspring: [famg]), (rats: [mamm]), (prenatal administration: [topp]), (vpa: []), (data: [euka]), (vpa rat model: [mamm]), (model: []), (addition: []), (autistic brain: [mobd]), (microbiome features: [orgm]), (best-suited rodent models: [mamm]), (study: [resa]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0251-3) contains: [acty]), (users: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')(rat model autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(offspring, 'Perinatal History')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 6280477
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (observational studies: [resa]), (prenatal phthalate exposures: [fndg]), (autism spectrum disorder (asd): [mobd]), (risk: []), (asd: [cgab]), (metabolites: [bacs]), (phthalates: [orch]), (multiple maternal urine samples: [bdsu]), (trimesters: []), (pregnancy: [orgf]), (mother-child pairs: [socb]), (marbles (markers: [inch]), (autism risk: [mobd]), (babies  learning early signs): [menp]), (high-risk asd longitudinal cohort: [cgab]), (years: []), (old: []), ( children: [aggp]), (diagnostic categories: asd (n: [cgab]), (non-typical development: [orgf]), ((non-td: []), ( n: [aapp,imft]), (typical development (td: [orgf]), (multinomial logistic regression: [resa]), (association: [menp]), (phthalate: [orch]), (metabolite concentrations: [menp]), (non-td: []), (associations: [menp]), (phthalate biomarkers: [clna]), (exception: []), (monoethyl phthalate (mep): [orch]), (non-td (per: []), (2.72-fold relative increase: [qnco]), (concentration: relative risk ratio (rrr): [qnco]), (confidence interval: [qnco]), (prenatal vitamin use: [phsu,vita]), (first month: [qnco]), (mothers: [famg]), (vitamins: [orch,phsu,vita]), ( asd risk: [cgab]), (mono-isobutyl phthalate (mibp: [orch,phsu]), ( rrr: []), (ci:: [lbpr]), (mono(3-carboxypropyl) phthalate (mcpp: [orch,phsu]), (mono-carboxyisooctyl phthalate (mcop: [dsyn]), (prenatal vitamins: [phsu,vita]), ( non-td risk: []), (mcpp (rrr: [orch,phsu]), (mcop (rrr: [dsyn]), (mono-carboxyisononyl phthalate (mcnp: [orch]), (sex: [orgf]), (boys: [aggp]), ( mep: [gngm]), ( monobenzyl phthalate: [orch]), ( mcpp: [orch,phsu]), ( mcnp: []), (sum: [qnco]), (di(2-ethylhexyl) phthalate metabolites: [gngm]), (non-td risk: []), (girls: [aggp]), ( associations: [menp]), (study: [resa]), (phthalate exposures: [phpr]), (late pregnancy: [patf]), (children: [aggp]), (high-risk asd cohort: [cgab]), (further studies: [lbpr]), (general population: [popg]), (high-risk genes: [gngm]), (findings: [clna]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s12940-018-0428-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (prenatal phthalate exposures, 'Exposures')(autism spectrum disorder, 'Autism Phenotype')(prenatal vitamin use, 'Dietary Supplements')(vitamins, 'Dietary Supplements')(prenatal vitamins, 'Dietary Supplements')(phthalate exposures, 'Exposures')

PMCID: 6258166
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (hyperserotonemia: []), (brain: [bpoc]), (endophenotype: []), (autism spectrum disorder (asd): [mobd]), (serotonin levels: [bacs,orch]), (modulation: []), (serotonin transporter function: [aapp,bacs]), (asd symptoms: [cgab]), (behavior: [inbe]), (gene expression: [genf]), (causal mechanism: []), (asd-relevant: [cgab]), (social deficits: []), (serotonin transporter (sert) knockout mice: [mamm]), (heterozygous knockout mice (hz): [mamm]), (homozygous knockout mice (ko): [mamm]), (general anxiety: [mobd]), (ko mice: [mamm]), (weeks: []), (dietary restriction: [fndg]), (serotonin precursor tryptophan: [bacs,orch]), (brain hyperserotonemia: [bpoc]), (asd-relevant social deficits: [cgab]), (sert hz: [qnco]), (expression: [topp]), (distinct sets: [menp]), (genes: [gngm]), (substantial portion: []), (tryptophan depletion: [aapp,bacs,phsu]), (alterations: []), (signal transduction pathways: [moft]), (changes: [qnco]), (extracellular serotonin: [bacs,orch]), (derivative: []), (serotonin: [bacs,orch]), (au015836 gene: [gngm]), (au015836 expression: [topp]), (dietary tryptophan restriction: [aapp,bacs,phsu]), (findings: [clna]), (sert gene: [gngm]), (dose-dependent effect: [qnco]), (related behavioral sequelae: [inbe]), (asd: [cgab]), (possible therapeutic target: [diap]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0243-3) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(improve asd symptoms, 'Complaints and Indications')(social deficits, 'Social Competence')(general anxiety, 'Anxiety Disorders')(dietary restriction, 'Dietary Restrictions')(asd-relevant social deficits in serotonin transporter hz, 'Social Competence')(asd-relevant social deficits, 'Social Competence')(dietary tryptophan restriction, 'Dietary Restrictions')

PMCID: 6249852
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (neurodevelopmental disorders: [mobd]), (core symptoms: [sosy]), (social interaction deficits: [fndg]), (cognitive inflexibility: []), (communication disorders: [mobd]), (children: [aggp]), (past several years: []), (effective treatment: []), (btbr t+tf/j (btbr) mice: [mamm]), (accepted model: []), (autistic-like behaviors: [mobd]), (asd: [cgab]), (transplantation: [topp]), (human bone marrow: [humn]), (mesenchymal stem cells: [cell]), (lateral ventricles: [bsoj]), (btbr mice results: [fndg]), (long lasting improvement: []), (autistic behavioral phenotypes: [mobd]), (recent studies: [lbpr]), (main mediators: [orch,phsu]), (therapeutic effect: [clna]), (msc: [gngm]), (here: []), (treatment: [topp]), (exosomes: [celc]), (msc (msc-exo): []), (similar beneficial effects: []), (intranasal administration: [topp]), (msc-exo: []), (male: [orga]), (social interaction: [fndg]), (reduced repetitive behaviors: [fndg]), (moreover: []), (increases: [qnco]), (ultrasonic vocalizations: [npop]), (significant improvement: [qnco]), (maternal behaviors: [socb]), (pup retrieval: [hlca]), (negative symptoms: [fndg]), (msc-exo intranasal treatments: [topp]), (btbr: [mamm]), (healthy c57bl mice: [mamm]), (marked beneficial effects: []), (btbr mice: [mamm]), (therapeutic strategy: [menp]), (symptoms: [sosy]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0240-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(social interaction deficits, 'Reciprocal Social Interaction')(cognitive inflexibility, 'Cognitive Ability')(core symptoms of asd, 'Complaints and Indications')(social interaction, 'Reciprocal Social Interaction')(reduced repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(ultrasonic vocalizations, 'Vocalizations')(symptoms of asd, 'Complaints and Indications')

PMCID: 6252219
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (red blood cells: [lbpr]), (people: [popg]), (autism spectrum disorders: [mobd]), (target: [diap]), (oxidative stress: [comd]), (electron microscopy: [lbpr]), (rbc morphology: [lbpr]), (asd children: [cgab]), (show: [anim]), (rbc: [cell]), (typical biconcave shape: []), ((mean  sd): [mamm]), ((td) controls: [sbst]), (codocytes: [lbpr]), (star-shaped cells: [cell]), (asd erythrocytes: [lbpr]), (rbc shape alterations: [cell]), (anticoagulant: [phsu]), (different handling procedures: [fndg]), (glutaraldehyde fixation: [bodm,irda,orch]), (incubation: []), (h: [gngm]), (presence: [qnco]), (antioxidants: [phsu]), (normal morphology: [fndg]), (erythrocytes: [lbpr]), (asd patients: [cgab]), (coomassie staining: [fndg]), (analysis: [resa]), (relevant proteins: [aapp,bacs]), (key role: [socb]), (membrane-cytoskeleton organization: [celc]), (differences: [qnco]), (rbc ghost composition: [celc]), (asd: [cgab]), (normal subjects: [fndg]), (phosphatidylserine (ps) exposure: [orch]), (extracellular membrane domain: [celc]), (basal: []), (erythroptosis-inducing conditions: [dsyn]), (td samples: [sbst]), (aminophospholipid translocase: [aapp,bacs]), (n-ethylmaleimide: [irda,orch]), ( upon: []), (increased amount: [qnco]), (ps: [gngm]), (outer membrane: [celc]), (complex data: [euka]), (light: [gngm]), (current understanding: [menp]), (mode: [qnco]), (erythrocyte shape: [clna]), (other pathological conditions: [patf]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(phosphatidylserine exposure, 'Exposures')

PMCID: 6220561
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (altered: []), (neuronal development: [celf]), (pathogenic mechanism: [fndg]), (autism spectrum disorders: [mobd]), (copy number variations: [nusq]), (individuals: [humn]), (asd: [cgab]), (genes: [gngm]), (region: []), ( quinolinate phosphoribosyltransferase (qprt): [aapp,enzy]), (regulation: [biof]), (neuronal differentiation: [fndg]), (sh-sy5y neuroblastoma cells: [cell]), (causal relation: [socb]), (tryptophan metabolism-related enzyme: [enzy,orch]), (effect: []), (qprt: [gngm]), (differentiation: [celf]), (sh-sy5y: []), (neuronal morphology: [fndg]), ( metabolites: [bacs]), (tryptophan pathway: [aapp,bacs,phsu]), (neurodevelopmental transcriptome: [nusq]), (gene: [gngm]), (dosage-dependent change: [qnco]), (qprt expression: [topp]), (chr16p11.2 deletion: [genf]), (lymphoblastoid cell line (lcl): [cell]), (deletion carrier: [genf]), (non-carrier parents: []), (expression: [topp]), (correlation: []), (neuromorphology: []), (sh-sy5y cells: [cell]), (qprt function: [phsf]), ((kd): [dsyn]), ( (ii) chemical mimicking: [chem]), (loss: [qnco]), ((iii): []), (complete crispr/cas9-mediated knock: [nnon]), ((ko): [bdsy]), (qprt-kd cells: [dsyn]), (underwent morphological analysis: [resa]), (qprt-ko cells: [cell]), (viability assays: [lbpr]), (additionally: []), ( qprt-ko cells: [cell]), (underwent metabolite: [bacs]), (whole transcriptome analyses: [lbpr,mbrt]), (ko: [gngm]), (enrichment: []), (biological processes: [biof]), (co-regulated gene-networks: [moft]), (human brain: [humn]), (lcl: []), (neuritic complexity: [celc]), (reduction: [npop]), (differentiated sh-sy5y cells: [celf]), (chemical inhibition: [acty]), (complete ko: [bdsy]), (induction: [topp]), (qprt-associated tryptophan pathway: [aapp,bacs,phsu]), (transcriptome level: [nusq]), ( genes: [gngm]), (neurodevelopmental processes: [phpr]), (synaptic structures: []), (asd candidates: [cgab]), (co-regulated gene networks: [moft]), (development: [orgf]), (dorsolateral prefrontal: []), (hippocampus: [bpoc]), (amygdala: [bpoc]), (study: [resa]), ( qprt: [gngm]), (vitro neuronal differentiation: [fndg]), (gene networks: [moft]), (thus: []), (data: [euka]), (important role: [socb]), (pathogenesis: [patf]), (chr16p11.2 deletion carriers: [genf]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0239-z) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(neurodevelopmental transcriptome, 'Learning Disorders')(chemical mimicking, 'Imitation')(neurodevelopmental processes, 'Learning Disorders')

PMCID: 6247386
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (group: [popg]), (early-onset neurodevelopmental conditions: [dsyn]), (alterations: []), (brain connectivity: [bpoc]), (effects: []), (neuropsychological functions: []), (framework: []), (interest: [menp]), (environmental conditions: [dsyn]), (genetic factors: [fndg]), (asd: [cgab]), (many authors: []), (changes: [qnco]), (intrauterine environment: [bsoj]), (different stages: []), (pregnancy: [orgf]), (maternal metabolic pathologies: [famg]), (long-term conditions: [dsyn]), (newborn: [aggp]), (particular: []), (number: [qnco]), (epidemiological studies: [resa]), (role: [socb]), (obesity: [dsyn]), (maternal diabetes: [patf]), (risk factor: [qnco]), (psychiatric disorders: [mobd]), (humans: [humn]), (literature: [inpr,mnob]), (specific etiopathological mechanisms: []), (body: [humn]), (evidence: []), (presence: [qnco]), (relationship: []), (maternal immune dysregulation: [fndg]), ( inflammation: [patf]), (oxidative stress: [comd]), (development: [orgf]), (offspring: [famg]), ( results: [fndg]), (high-fat diet animal models: [topp]), (neurodevelopment: [ortf]), (pathways: [moft]), (maternal metabolic conditions: [dsyn]), (aim: [phsu]), (review: []), (overview: []), (early life insults: []), (asd etiopathogenesis: [cgab]), (biological terms: [orgf]), 
ASD Terms: (early-onset neurodevelopmental conditions, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')(maternal diabetes, 'Diabetes Mellitus Type 1')(psychiatric disorders, 'Mental Disorders')(offspring, 'Perinatal History')(high-fat diet animal models, 'Dietary Restrictions')(maternal metabolic conditions, 'Metabolic Indications')

PMCID: 6193446
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract autism spectrum disorder (asd): [mobd]), (complex neurodevelopmental disorder: [mobd]), (strong genetic contributions: [acty]), (comprehensive resource: []), (genetic evidence: [topp]), (asd: [cgab]), (autism knowledgebase (autismkb): [mobd]), (version: []), (integrates: []), (multiscale genetic data: [euka]), (genes: [gngm]), (copy number variations: [nusq]), (structural variations: []), (single-nucleotide variations: [fndg]), (small insertions/deletions: [genf]), (linkage regions: [moft]), (particular: []), ( autismkb: []), (highlights: []), (snvs/indels: [genf]), (significant contribution: [acty]), (asd genetics: [cgab]), (mosaic variants: [orgm]), (contributions: [acty]), (asd pathogenesis: [cgab]), (variants: []), (clinical evidence: []), (users: [humn]), (functional consequences: []), (snvs: []), (small indels: [genf]), (comprehensive predictions: []), (pathogenicity: [orga]), (ifish: []), ( sift: []), ( polyphen etc: []), (user: [humn]), (new version: []), (multiple query methods: [topp]), (simple query: []), (query: []), (batch query: [qnco]), (analytical tools: [resa]), (downstream: []), (gene: [gngm]), (tool: []), (enrichment analysis tool: [resa]), ( kobas: [plnt]), (valuable resource: []), (researchers: []), 
ASD Terms: (complex neurodevelopmental disorder, 'Learning Disorders')(abstract autism spectrum disorder, 'Autism Phenotype')(autism knowledgebase, 'Autism Phenotype')

PMCID: 6191442
SFARI Genes: Nuak1, Nuak1, Nuak1, Nuak1, Nuak1, Nuak1, 
Non SFARI Genes: 
Named Entities: (recently: []), (numerous rare: [gngm]), (mutations: [genf]), (patients: [podg]), (autism spectrum disorders: [mobd]), (however: []), (predicted loss-of-function nature: [phsf]), (affected individuals: [humn]), (heterozygous carriers: [fndg]), (candidate genes: [gngm]), (haploinsufficient and/or lead: [comd]), (expression: [topp]), (dominant-negative forms: [comd]), (protein: [aapp,bacs]), (here: []), (hypothesis: []), (candidate asd gene nuak1: [cgab]), (role: [socb]), (development: [orgf]), (cortical connectivity: [bpoc]), (nuak1: [gngm]), (mice: [mamm]), (regard: []), (function: [phsf]), (cortical development: [ortf]), (nuak1+/ mice: [mamm]), (combination: [fndg]), (abnormal behavioral traits: [inbe]), (defective spatial memory consolidation: [menp]), ( defects: []), (social novelty (but: []), (social preference): []), (abnormal sensorimotor gating: [phsf]), (overall: []), (results: [fndg]), (nuak1 haploinsufficiency: [comd]), (defects: []), (complex array: [chvs]), (behavorial deficits: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(combination of abnormal behavioral traits, 'Personal Traits')(defective spatial memory consolidation, 'Working Memory')(abnormal behavioral traits, 'Personal Traits')

PMCID: 6197704
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (psychiatric illnesses: [mobd]), (polygenic: [genf]), (widespread alterations: []), (brain: [bpoc]), (genetic factors: [fndg]), (attempts: [evnt]), (polygenic risk scores: [qnco]), (measure: [qnco]), (overall genetic risk: [qnco]), (disorder: [dsyn]), (brain structure: [bpoc]), (univariate methods: []), (however: []), ( prs: [dsyn]), (covarying effects: []), (used multivariate machine learning: [mcha]), (proof-of-principle study: [qnco]), (associations: [menp]), (prs: [gngm]), (psychiatric disorders; attention deficit-hyperactivity disorder (adhd): [mobd]), (bipolar disorder: [mobd]), (schizophrenia: [mobd]), (sample: [sbst]), (individuals: [humn]), (patients: [podg]), (depression (69): [mobd]), (bipolar disorder (33): [mobd]), (healthy controls: []), (summary data: [euka]), (psychiatric genomics consortium: [hlca]), (t1-weighted magnetic resonance images: [orga]), (voxel-based morphometry: [lbpr]), (spm12: []), (multivariate relevance vector regression: [nnon]), (pattern recognition: [menp]), (neuroimaging toolbox (pronto): [diap]), (whole sample: [sbst]), (multivariate pattern: []), (grey matter: [tisu]), (autism (r: [mobd]), (pfdr: []), (mse: [gngm]), (schizophrenia prs: [dsyn]), (significant (mse =: [gngm]), (correlation: []), (results: [fndg]), (support: []), (hypothesis: []), (polygenic liability: [genf]), (autism: [mobd]), (widespread changes: [qnco]), (grey matter concentrations: [tisu]), (disorders: [dsyn]), (expression: [topp]), (disease: [dsyn]), (genetic risk: [qnco]), (prss: [gngm]), 
ASD Terms: (psychiatric illnesses, 'Mental Disorders')(psychiatric disorders, 'Mental Disorders')(attention deficit-hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism, 'Autism Phenotype')(bipolar disorder, 'Bipolar Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(depression, 'Depressive Disorder')(pattern recognition, 'Pattern Recognition and Rendering')(autism, 'Autism Phenotype')(schizophrenia polygenic risk, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')

PMCID: 6205438
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (significance autism spectrum disorder (asd): [mobd]), (neurodevelopmental disorder: [mobd]), (communication: [socb]), (social behavior deficits: [socb]), (repetitive behaviors: [fndg]), (medical comorbidities: [hlca]), (gastrointestinal dysfunction: [dsyn]), (pharmacologic treatments: [topp]), (ameliorate core symptoms: [sosy]), (genetic variants: [npop]), (serotonin transporter (sert): [aapp,bacs]), (asd: [cgab]), (administration: [topp]), (cns-penetrant p38 mapk antagonist: [aapp,enzy]), (behavioral perturbations reminiscent: [inbe]), (adult: [aggp]), ( sert ala56 mice: [mamm]), (conditional: []), (genetic manipulations: [mbrt]), (requirement: []), (5-ht neuron p38 mapk signaling: [bacs,orch]), (perturbations: []), (sert ala56 mice: [mamm]), (findings: [clna]), (p38 mapk: [aapp,enzy]), (potential target: [diap]), (treatment: [topp]), (adults: [aggp]), (relation: [socb]), (traits: [gngm]), (elevated sert activity: [acty]), (signaling: [celf]), 
ASD Terms: (significance autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(social behavior deficits, 'Personal Traits')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(medical comorbidities, 'Comorbidities')

PMCID: 6167902
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (histological evidence: []), (autism spectrum disorder (asd): [mobd]), (reduced integrity: [inbe]), (grey-white matter boundary: [tisu]), (structural neuroimaging study: [diap]), (vivo reporting: [hlca]), (grey-white matter tissue contrast (gwc): [dsyn]), (adult individuals: [aggp]), (years: []), (age): [orga]), (asd: [cgab]), ((td) controls: [sbst]), (however: []), (neuroanatomical differences: [qnco]), (development: [orgf]), (here: []), (differences: [qnco]), (neurodevelopmental trajectories: [ortf]), (gwc: [dsyn]), (cross-sectional sample: []), (male asd individuals: [cgab]), (childhood: []), (early adulthood: [aggp]), (years): []), (nested model comparisons: [acty]), (developmental trajectory: [orgf]), (many regions: []), (cortex: [bpoc]), (non-linear effects: []), (age: [orga]), (second: [qnco]), (asd individuals: [cgab]), (findings: [clna]), (atypical grey matter cytoarchitecture alone: [tisu]), (other aspects: [qnco]), (cortical architecture: [bpoc]), (age-dependent variability: [orga]), (myelin integrity: [tisu]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0232-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental trajectories, 'Learning Disorders')

PMCID: 6195348
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (social capacities: [qnco]), (postnatal experience: [menp]), (pathways: [moft]), (experience guides development: [orgf]), (normal development: [fndg]), (motor: []), (nonmotor capacities: [qnco]), (cerebellar activity: [bpoc]), (chemogenetic perturbation: []), (molecular layer interneurons: [cell]), (cerebellar output: [bpoc]), (mice: [mamm]), (activity: [acty]), (posterior regions: [blor]), (juvenile life modulates: [aggp]), (expression: [topp]), (eyeblink: [ortf]), ((paravermal lobule vi: [bpoc]), ( crus i): [bpoc]), ( reversal: []), ((lobule vi): [bpoc]), (persistive behavior: [inbe]), (novelty-seeking (lobule vii): [bpoc]), (social preference (crus i/ii): [inch]), (perturbation: []), (adult life: [aggp]), (subset: []), (phenotypes: [orga]), (adult: [aggp]), (juvenile disruption: [aggp]), (gait metrics: [orch,phsu]), (contributions: [acty]), (amount: [qnco]), (lobule inactivated: [bpoc]), (anterograde transsynaptic tracer: [irda]), (posterior cerebellum: [bpoc]), (strong connections: []), (prelimbic: []), ( orbitofrontal: []), (anterior cingulate cortex: [bpoc]), (findings: [clna]), (anatomical substrates: [sbst]), (clinical observation: [hlca]), (cerebellar injury: [bpoc]), (risk: []), (autism: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')

PMCID: 6164279
SFARI Genes: DBS, DBS, DBS, DBS, 
Non SFARI Genes: 
Named Entities: (deep brain stimulation (dbs): [topp]), (promising treatment: [topp]), (resistant depression: [mobd]), (serotonin (5-hydroxytryptamine: [bacs,orch]), ( 5-ht) system: [bacs,orch]), (infralimbic prefrontal cortex (ilpfc): [bpoc]), (previous study: [resa]), (dysfunction: [dsyn]), (brain: [bpoc]), (5-ht homeostasis: [bacs,orch]), (valproate (vpa)-induced rat autism spectrum disorder (asd) model: [mamm]), (whether ilpfc dbs: [gngm]), (deficits: []), (vpa-induced: []), (5-ht system: [bacs,orch]), (vpa-induced offspring: [famg]), (effect: []), (dbs: [gngm]), (autistic phenotypes: [mobd]), (underlying mechanism: []), (molecular approaches: []), (5-ht1a receptor agonist treatment: [aapp,rcpt]), (8-hydroxy-2-(di-n-propylamino)tetralin (8-oh-dpat): [orch,phsu]), (sociability deficits: [socb]), ( anxiety: [mobd]), (hyperactivity: [mobd]), (vpa-exposed offspring: [famg]), (selective 5-ht1a receptor: [genf]), (antagonist n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-n-2-pyridinylcyclohexanecarboxamide maleate: [fndg]), (terms: [orgf]), (autistic behaviors: [mobd]), (dbs treatment: [topp]), (expressions: [topp]), (nr2b subunit: [aapp]), (n-methyl-d-aspartate receptors (nmdars): [aapp,rcpt]), (3 subunit: [aapp]), (-aminobutyric acid type a receptors (gabaar): [aapp,phsu]), (pfc region: [gngm]), (results: [fndg]), (first evidence: [qnco]), (characteristic behavioral changes: [mobd]), (ilpfc: []), 
ASD Terms: (resistant depression, 'Depressive Disorder')(rat autism spectrum disorder model, 'Autism Phenotype')(vpa-induced offspring, 'Perinatal History')(anxiety, 'Anxiety Disorders')(anxiety, 'Anxiety Disorders')(hyperactivity, 'Overactivity')(vpa-exposed offspring, 'Perinatal History')

PMCID: 6139139
SFARI Genes: TSC2, FMR1, CNTNAP2, TSC2, FMR1, CNTNAP2, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (heterogeneous group: [popg]), (disorders: [dsyn]), (hundreds: []), (rare genetic mutations: [genf]), (several environmental risk factors: [qnco]), (mouse models: [mamm]), (specific risk factors: [qnco]), (molecular mechanisms: []), (factor: []), (however: []), ( comparisons: [acty]), (different models: []), (underlying common pathways: [moft]), (clusters: [qnco]), (relevant disease subtypes: []), (different methodological approaches: []), (different brain regions: [blor]), (labs: [fndg]), (model: []), (here: []), (novel proteomic technique: []), (quantitative multiplex co-immunoprecipitation: [lbpr]), (qmi: []), (series: [qnco]), (identical measurements: []), (synaptic protein interaction network: []), (different animal models: [anim]), (molecular disruptions: []), (models: []), (hippocampal: [bpoc]), (cortical samples: [bpoc]), (asd: shank3b: [cgab]), ( shank3ex4-9: []), ( ube3a2xtg: []), ( tsc2: [dsyn]), ( fmr1: [gngm]), (cntnap2 mutants: [aapp,bacs]), (e12.5 vpa (maternal valproic acid injection: [orch,phsu]), (day: []), (post-conception): [orgf]), (qmi panel: []), (network: [popg]), (interacting: []), ( asd-linked: [cgab]), (synaptic proteins: [aapp,bacs]), (potential co-associations: [menp]), (custom non-parametric statistical test: [acty]), (significant differences: [qnco]), (asd models: [cgab]), (littermate controls: [sbst]), (hierarchical clustering: [resa]), (principal components: [qnco]), (mean log2: [qnco]), (change values: []), (unique set: [menp]), (disrupted interactions: []), (interactions: []), (multiple models: [qnco]), (synaptic activity: [acty]), (potential relationships: []), (deficits: []), (akt: [gngm]), (ube3a2xtg mice: [mamm]), (phospho-western blots: [lbpr]), (data: [euka]), (great heterogeneity: [orga]), (high-dimensional measures: [qnco]), (synaptic protein network: [popg]), (differentiation: [celf]), (subtypes: []), (asd: [cgab]), (molecular pathology: [lbpr]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0229-1) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 6122816
SFARI Genes: adsl, mbd5, shank3, adsl, mbd5, shank3, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (serious neurodevelopmental disorder: [mobd]), (abnormal social interaction: [fndg]), (communication: [socb]), (repetitive behaviour: [fndg]), (asd: [cgab]), (asia: []), ( europe: []), (united states: []), (frequency: [qnco]), (year: []), (recent epidemiological studies: [resa]), (exposure: [clna]), (chemicals: [chem]), (environment: []), (air: [gngm]), (water: [sbst]), (thus: []), (toxicological studies: [resa]), (however: []), (experimental efficiency: [qnco]), (experimental models: []), (many models: []), (challenges: [hlca]), (terms: [orgf]), (animal welfare: [acty]), (alternative asd animal models: [cgab]), (this: []), (efficacy: [resa]), (zebrafish embryo/larva: [fish]), (alternative model: []), (specifically: []), (acid (0: [chem]), (m): [aapp,imft]), (chemical: [chem]), (autism-like effects: [mobd]), (subsequent developmental: [orgf]), ( behavioural: [inbe]), (transcriptomic changes: [nusq]), (m: [aapp,imft]), (m valproic acid: [orch,phsu]), (hatching rate: [qnco]), (locomotor activity: [dora]), (zebrafish embryos/larvae: [fish]), (transcriptomic analysis: [lbpr,mbrt]), (significant alterations: [qnco]), (number: [qnco]), (genes: [gngm]), (autism: [mobd]), (adsl: [gngm]), ( mbd5: [gngm]), ( shank3: [aapp]), (tsc1b: []), (changes: [qnco]), (gene ontology: []), (previous studies: [lbpr]), (findings: [clna]), (humans: [humn]), (common physiological pathways: [moft]), (animal model: [emod]), (alternative tool: []), (causes: []), (potential treatments: [topp]), (illness: [sosy]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(serious neurodevelopmental disorder, 'Learning Disorders')(abnormal social interaction, 'Reciprocal Social Interaction')(repetitive behaviour, 'Restricted and Repetitive Behavior')(exposure, 'Exposures')(autism, 'Autism Phenotype')

PMCID: 6119280
SFARI Genes: A2, A2, 
Non SFARI Genes: 
Named Entities: (abnormal: [qnco]), (phospholipid metabolism: [moft]), (major component: []), (many neurodevelopmental disorders: [mobd]), (autism: [mobd]), (oral administration: [topp]), (propionic acid: [orch]), (behavioral abnormalities: [mobd]), (biochemical features: []), (rodents: [mamm]), (model: []), (impaired brain: [bpoc]), (fatty acid metabolism: [moft]), (present study: [qnco]), (alterations: []), (brain: [bpoc]), (rodent model: [mamm]), (vitamin b12: [orch,phsu,vita]), (remedies: []), (groups: [popg]), (rats: [mamm]), (selected: group: [popg]), (control: [sbst]), (group: [popg]), (neurotoxic dose: [inpo]), (ppa: [mobd]), (vitamin b12 cobalamin (16.7 mg/kg/day): [orch,phsu,vita]), (days: []), (ppa treatment: [mobd]), (pharmaceutical grade omega-3 (200: [bacs,orch,phsu]), (free-dha/kg body: [humn]), (product: [qnco]), (madre: []), (germany: []), (combined dose: [qnco]), (-3 + vitamin b12: [orch,phsu,vita]), (same duration post-ppa treatment: [mobd]), (phospholipid levels: [bacs,orch]), (phospholipase a2: [aapp,enzy]), (brain homogenates: [bpoc]), (elisa: [lbpr]), (western blotting: [lbpr,mbrt]), (cpla2 protein level: [lbtr]), (significant decrease: [qnco]), (significant increase: [qnco]), (cpla2: [gngm]), (brain tissue: [bpoc]), (ppa-treated rats; however: [mamm]), (neurotoxic effect: [inpo]), (role: [socb]), (impaired phospholipid metabolism: [moft]), (autism; however: [mobd]), (proper clinical trials: [resa]), 
ASD Terms: (many neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(behavioral abnormalities, 'Personal Traits')(autism, 'Autism Phenotype')(vitamin b12, 'Dietary Supplements')(autism, 'Autism Phenotype')(vitamin b12 cobalamin, 'Dietary Supplements')(-3 + vitamin b12, 'Dietary Supplements')(autism, 'Autism Phenotype')(impaired phospholipid metabolism, 'Metabolic Indications')

PMCID: 6192781
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (previous studies: [lbpr]), (genetic factors: [fndg]), (predominate cause: []), (autism spectrum disorder (asd): [mobd]), (nevertheless: []), (knowledge: []), (date: []), (systematic study: [resa]), (data: [euka]), (objective: []), ( complete list: []), (genes: [gngm]), (demonstrated associations: [menp]), (asd: [cgab]), (present study: [qnco]), (literature data mining analysis: [mcha]), (>2: [qnco]), (064 articles: []), (publications: [inpr,mnob]), (january: []), (april: [gngm]), (asd target genes: [cgab]), (gene: [gngm]), (enrichment analysis (gsea): [resa]), ( sub-network enrichment analysis (snea): [qnco]), (network connectivity analysis (nca): []), (functional profile: [lbpr]), (pathogenic significance: [qnco]), (total: [qnco]), (literature metrics: [orch,phsu]), (curated asd genes: [cgab]), (specific significance: [qnco]), (approach: []), (development: [orgf]), (genetic database: []), (subsequent analysis: [resa]), (biological pathways: [moft]), (significant functional associations: [menp]), (other: []), (majority: [socb]), (asd genes: [cgab]), (significant roles: [socb]), (pathogenesis: [patf]), (other neuropsychiatric disorders: [dsyn]), (results: [fndg]), (genetic causes: [topp]), (large network: [popg]), (functionally-associated genes: [gngm]), (metric scores: [orch,phsu]), (basis: [phsu]), (future biological/genetic modeling: [resa]), (field: [irda]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 6112123
SFARI Genes: kit, kit, 
Non SFARI Genes: CD9, CD81, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (brain inflammation: [dsyn]), (activation: [acty]), (microglia: [cell]), (triggers: [clna]), (extracellular vesicles (evs): [celc]), (many cells: [cell]), (blood: [bdsu]), (other biological fluids: [tisu]), (molecules: [sbst]), (function: [phsf]), (target cells: [cell]), (evs: [qnco]), (several diseases: [dsyn]), (presence: [qnco]), (asd: [cgab]), (serum: [bdsu]), (children: [aggp]), (asd (n: [cgab]), (males: [orga]), (years: []), (unrelated age: [orga]), (sex-matched normotypic controls: [orgf]), (exoeasy qiagen kit: [aapp,imft,rcpt]), (cd9: [gngm]), (cd81: [gngm]), (membrane-associated markers: [clna]), (western blot analysis: [lbpr]), (morphology: [fndg]), (size: []), (transmission electron microscopy (tem): [lbpr]), (human: [humn]), (sv40: [virs]), (h: [gngm]), (evs (1: [fndg]), (total ev-associated protein: [neop]), (h. il-1 secretion: [elii]), (elisa: [lbpr]), (results: [fndg]), (mann-whitney u: []), (non-parametric test: []), (statistical analyses: [resa]), (graph pad prism: [topp]), (spherical structures: []), (nm): [celf]), (membrane: [celc]), ((p: [aapp,imft]), (patients: [podg]), (controls: [sbst]), (evs (5 g/ml): [qnco]), (cultured human microglia: [humn]), (pro-inflammatory cytokine: [aapp,bacs]), (interleukin il-1 (163.5: [aapp,imft]), (pg/ml): [qnco]), (control (117.7: [sbst]), (pg/ml: [qnco]), ( p: [aapp,imft]), (amount: [qnco]), (mitochondrial dna (mtdna7s): [bacs,nnon]), (normotypic controls: [sbst]), (findings: [clna]), (novel information: []), (inflammation: [patf]), (brain: [bpoc]), (novel effective treatments: [topp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 6110470
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (genetic generalized epilepsy (gge): [dsyn]), (benign epilepsy: [dsyn]), (centro-temporal spikes: []), (rolandic epilepsy (re): [dsyn]), (common forms: [qnco]), (genetic epilepsies: [dsyn]), (rare copy number variants: [nusq]), (important risk factors: [qnco]), (brain disorders: [dsyn]), (systematic survey: []), (rare deletions: [genf]), (protein-coding genes: [gngm]), (exome data: [gngm]), (patients: [podg]), (exomes: [gngm]), (european patients: [podg]), (gge: []), (re): [qnco]), (population controls: []), (low-frequency: []), (genic deletions: [genf]), ((32 gge: []), (re) patients: [podg]), (i.e: [diap,inpr]), (~19%: []), (rare genic deletions: [genf]), (particular: []), ( large deletions: [genf]), (kb) represent: [acty]), (burden: []), (re: []), (detected low-frequency deletions: [genf]), (share genes: [gngm]), (brain-expressed exons: [bacs,nnon]), (negative selection: [lbpr]), ( (2) overlap: [qnco]), (known autism: [mobd]), (epilepsy-associated candidate genes: [dsyn]), ( (3): [fndg]), (cnv: [nusq]), (intolerant genes: [gngm]), (exome aggregation consortium (exac): [gngm]), ((4) coincide: []), (mutations: [genf]), (npdenovo database: []), (several knowledge databases: [qnco]), (prominent epilepsy candidate genes: [dsyn]), (protein-protein networks: [aapp,bacs]), 
ASD Terms: (benign epilepsy, 'Epilepsy')(genetic epilepsies, 'Epilepsy')(genetic generalized epilepsy, 'Epilepsy')(rolandic epilepsy, 'Epilepsy')(genetic epilepsies, 'Epilepsy')(known autism, 'Autism Phenotype')(genetic generalized epilepsy, 'Epilepsy')(prominent epilepsy candidate genes, 'Epilepsy')

PMCID: 6106874
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (immune system: [bdsy]), (fundamental role: [socb]), (development: [orgf]), (pregnancy: [orgf]), (early life: []), (alterations: []), (neonatal immune mediators: [imft,phsu]), (pregnancy complications: [dsyn]), (susceptibility: [clna]), (neurodevelopmental conditions: [dsyn]), (life: []), (evidence: []), (adults: [aggp]), (environmental stimulation: [npop]), (strong genetic control: [genf]), (first genetic study: [resa]), (mother-infant pairs: [famg]), (circulating levels: []), (neonatal bloodspot-derived immune mediators: [imft,phsu]), (context: [fndg]), (fetal genotype: [orga]), (fetal genome-wide snp-based heritability (h2g): [nusq]), (immune molecule: [sbst]), (genome-wide association studies: [mbrt]), (specific loci: [gngm]), (individual immune mediators: [imft,phsu]), (relationship: []), (genetic immune determinants: [topp]), (asd: [cgab]), (neonatal cytokines/chemokines: [aapp,imft]), (genetic regulation: [genf]), (independent methodologies: [fndg]), (novel fetal loci: [emst]), (immune function: [ortf]), (physiological levels: []), (maternal immune mediators: [imft,phsu]), (vice versa: []), (cross-associated loci: [gngm]), (distinct genomic regions: [gngm]), (individual-specific immune mediator loci: [gngm]), (interaction: []), (il-8 levels: [aapp,imft]), (birth: [orgf]), ( autism spectrum disorder (asd) status: [mobd]), (specific maternal genotype: [orga]), (results: [fndg]), (fetal genetic variation: [npop]), (distinct mechanisms: []), (understanding: [menp]), (immune factor determinants: []), (early development: [orgf]), (light: [gngm]), (risk factors: [qnco]), (developmental disorders: [mobd]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13073-018-0576-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (pregnancy complications as well as susceptibility, 'Pregnancy Complications')(pregnancy complications, 'Pregnancy Complications')(neurodevelopmental conditions, 'Learning Disorders')(autism spectrum disorder status, 'Autism Phenotype')(autism spectrum disorder status, 'Autism Phenotype')

PMCID: 6104917
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (body: [humn]), (evidence: []), (prenatal environment: [aggp]), (autism spectrum disorder (asd) etiology: [mobd]), (study: [resa]), (placental shape features: [emst]), (siblings: [famg]), (children: [aggp]), (asd: [cgab]), (high asd risk: [cgab]), (sample: [sbst]), (low risk peers: [popg]), (digital photographs: []), (fetal placenta surface: [emst]), (sliced placental disk: [emst]), (high asd risk newborns: [cgab]), (newborns: [aggp]), (national childrens study vanguard pilot: [resa]), (comparable measures: [qnco]), (placental chorionic surface: [emst]), (shape: []), ( umbilical cord displacement: [menp]), (disk thickness: [bpoc]), (placental thickness measures: [qnco]), (asd cases: [cgab]), (placentas: [emst]), (asd-case siblings: [famg]), (perimeter: []), (general population placentas: [emst]), (stratification: [resa]), (across-group differences: [popg]), (sexes: [orgf]), (females: [orga]), (significant differences: [qnco]), (cord insertion measures: [genf]), (variations: []), (flexibility: []), (placental growth: [orgf]), (response: [fndg]), (changes: [qnco]), (intrauterine environment: [bsoj]), (placenta establishes: [emst]), (matures: []), (placental shape variability: [emst]), (high asd risk siblings: [famg]), (low-risk controls: [fndg]), (ability: [orga]), (intrauterine changes: [qnco]), 
ASD Terms: (autism spectrum disorder etiology, 'Medical History')

PMCID: 6217926
SFARI Genes: 
Non SFARI Genes: CPEB4, CPEB4, CPEB4, CPEB4, 
Named Entities: (common: [qnco]), (genetic contributions: [acty]), (spectrum disorder (asd) reside: [cgab]), (risk-gene variants: [gngm]), (minimal effect-sizes: []), (neurodevelopment-perturbing environmental factors: [ortf]), (altered regulators: []), (multiple asd-risk genes: [fndg]), (neurodevelopment: [ortf]), (cytoplasmic polyadenylation element: [moft]), (proteins: [aapp,bacs]), (1-4 (cpeb1-4) regulate translation: [moft]), (specific mrnas: [bacs,nnon]), (poly(a)-tail: [bacs,nnon]), (embryonic development: [ortf]), (synaptic plasticity: [ortf]), (cpeb4: [gngm]), (transcripts: [nnon]), (high-confidence asd genes: [cgab]), (idiopathic-asd brains: [cgab]), (cpeb4 transcript isoform imbalance: [aapp]), (decreased inclusion: [celc]), (neuronal-specific microexon: [imft]), (new molecular signature: [clna]), (global poly(a)-tail shortening: [bacs,nnon]), (high-confidence asd-risk genes: [cgab]), (concomitant reduction: [npop]), (protein levels: [lbtr]), (equivalent cpeb4 transcript isoform imbalance: [aapp]), (mice mimics: [mamm]), (mrna-polyadenylation: [genf]), (level changes: [qnco]), (asd genes: [cgab]), (induces asd-like: [cgab]), (behavioral phenotypes: [bhvr]), (data: [euka]), (novel regulator: []), (asd-risk genes: [cgab]), 
ASD Terms: (autism spectrum disorder reside, 'Autism Phenotype')

PMCID: 6126750
SFARI Genes: CHD7, CHD8, CHD7, CHD8, Chd7, Chd7, Chd7, Chd8, Chd7, Chd8, 
Non SFARI Genes: 
Named Entities: (significance oligodendrocyte precursor cells: [cell]), (main proliferative cells: [cell]), (adult brain: [bpoc]), (deregulation: [acty]), (opc proliferation-differentiation balance results: [celf]), (glioma formation: [neop]), (defective (re)myelination: [qnco]), (mutations: [genf]), (chromatin remodelers chd7: [aapp]), (chd8: [gngm]), (cause: []), (charge syndrome: [cgab,dsyn]), (autism spectrum disorders: [mobd]), (chd7: [gngm]), (opcs: []), (apoptosis: [celf]), (chromatin closing: [aapp]), (gene repression: [genf]), (p53: [gngm]), (chd7 induces: [gngm]), (gene activation: [genf]), (opc-differentiation regulators: [celf]), (chd7 is: [gngm]), ( however: []), ( dispensable: []), (oligodendrocyte stage: [cell]), (chd8 compensatory function: [phsf]), (common chromatin-binding profiles: [lbpr]), (asd-riskassociated genes: [cgab]), (results: [fndg]), (oligodendroglia: [cell]), (asd: [cgab]), (charge: [orga]), (new avenues: []), (chd7/chd8 functions: [phsf]), (pathological brain development: [ortf]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 6092396
SFARI Genes: GABRB3, GABRB3, 
Non SFARI Genes: GABRG3, GABRG3, GABRG3, GABRG3, GABRG3, 
Named Entities: (cytogenetic studies: [lbpr]), (chromosome: [celc]), (candidate region: []), (risk: []), (autism: [mobd]), (previous association studies: [menp]), (caucasian populations: [popg]), (risk variants: []), (genes: [gngm]), (region: []), (however: []), (association: [menp]), (chinese han population: [popg]), (autism trios: [aapp,enzy]), (family-based association study: [socb]), (tag: [gngm]), (polymorphisms (snps): [nusq]), (protein-coding genes: [gngm]), (autism-related genes: [gngm]), (rare variants: [gngm]), (healthy controls: []), (results: [fndg]), (c allele: [gngm]), (rs7180500: []), (gabrg3: [gngm]), (risk variant: []), (autism (p: [mobd]), (expression: [topp]), (quantitative trait loci (eqtl) analysis: [gngm]), (cerebellum (braineac: p: [bpoc]), (gtex: p: [aapp,imft]), (moreover: []), ((p.val233met): [aapp,imft]), (rs201427468 (p.pro365ser): [aapp,imft]), (gabrb3: [gngm]), (autistic patients: [mobd]), (variants: []), (autistic children: [podg]), ((pearson 2-test: [lbpr]), ( 2: [qnco]), (p: [gngm]), (functional prediction: []), (rs201602655 (p.val233met): [aapp,imft]), (thus: []), (findings: [clna]), (pathogenesis: [patf]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism trios, 'Autism Phenotype')(autism trios, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 6086890
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (identification: [menp]), (brain-targeted autoantibodies: [aapp,imft]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (possibility: []), (autoimmune: [patf]), (encephalopathy (aie): [dsyn]), (intravenous immunoglobulin (ivig): [aapp,imft,phsu]), (aie: []), (asd: [cgab]), (here: []), (case series: [resa]), (ivig: [aapp,imft,phsu]), (asd clinic: [cgab]), ((60%): [fndg]), ((38%): []), (treatment: [topp]), (care team: [grup]), (majority: [socb]), (parents (90%): [fndg]), (improvement: []), (improvements: []), (symptoms: [sosy]), (subset: []), (patients: [podg]), ( aberrant behavior checklist (abc): [inbe]), (social responsiveness scale (srs): [acty]), (ivig treatment: [aapp,imft,phsu]), (significant improvement: [qnco]), (srs: [gngm]), (abc: [dsyn]), (antidopamine d2l receptor: [aapp,rcpt]), (anti-tubulin antibody: [aapp,imft]), (ratio: [qnco]), (antidopamine d2l: []), (d1 receptor antibodies: [aapp,rcpt]), (changes: [qnco]), (cunningham panel: []), ( abc: [dsyn]), (parent-based treatment responses: [orga]), (good accuracy: []), (adverse effects: [patf]), (common (62%): [qnco]), (infusion period: [topp]), ((6%) patients: [podg]), (open-label case series: [resa]), (support: []), (uncommon: []), ( ivig treatment needs: [aapp,imft,phsu]), (cautiously: []), (immune biomarkers: []), (select ivig responders: [aapp,imft,phsu]), (cohorts: [popg]), (detail: []), (small open-label exploratory trial: [resa]), (evidence: []), (neuroimmune subgroup: [virs]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 6086213
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract mecp2 duplication syndrome: [mobd]), (x-linked form: [genf]), (syndromic autism: [mobd]), (genomic duplication: [gngm]), (region: []), (methyl-cpg-binding protein: [gngm]), ((mecp2): [aapp,bacs]), (mice: [mamm]), (mecp2 demonstrate: [aapp,bacs]), (social impairment: [patf]), ( behavioral inflexibility: [inbe]), (patterns: []), (learning: [menp]), (memory: [menp]), (previous work: []), (stability: []), (dendritic spines: [celc]), (motor training: [edac]), (apical tuft: []), (primary motor cortex (area m1): [gngm]), (corticospinal neurons: [cell]), (mecp2 duplication mouse model: [aapp,bacs]), (current study: [resa]), (structural plasticity: [npop]), (axonal boutons: [celc]), (layer: [bird]), (pyramidal neuron projections: [menp]), (area m1: [gngm]), (wild-type littermate control mice: [mamm]), (rotarod: []), (bouton formation rate changes: [celc]), (all: []), (bouton elimination rate: [celc]), (doubles: [acty]), (notably: []), (observed upregulation: [genf]), (bouton elimination: [celc]), (training: [edac]), (mecp2 duplication mice: [mamm]), (result: [fndg]), (further evidence: []), (imbalance: [sosy]), (structural stability: []), (plasticity: [npop]), (form: []), (observation: [hlca]), (axonal bouton elimination: [celc]), (wild-type animals contrasts: [irda]), (increase: []), (dendritic spine consolidation: [celc]), (same layer: [bird]), (dissociation: [mobd]), (different area m1 microcircuits: [gngm]), (different patterns: []), (structural synaptic plasticity: [ortf]), 
ASD Terms: (syndromic autism, 'Autism Phenotype')(demonstrate social impairment, 'Social Competence')(memory, 'Working Memory')(syndromic autism, 'Autism Phenotype')

PMCID: 6082846
SFARI Genes: SHANK3, SHANK3, met, met, 
Non SFARI Genes: 
Named Entities: (phelanmcdermid syndrome: [dsyn]), (deletions: [genf]), (various sizes: [phsu]), (shank3 gene: [gngm]), (neurodevelopmental disorder: [mobd]), ( behavioural symptoms: [sosy]), (autism spectrum disorder (asd): [mobd]), (half: [qnco]), (cases: [qnco]), (neurophysiological characterization: [acty]), (genotypephenotype correlation: []), (eighteen patients: [podg]), ((8 males: [orga]), ( mean age: [orga]), (years: []), ( sd: [mamm]), (determination: [lbpr]), (deletion size: [genf]), (behavioural: [inbe]), ( language: [lang]), (assessments: [hlca]), (neurophysiological indices: [lbpr]), (autism (i.e.: [mobd]), ( eye: [bpoc]), (social/non-social task: []), (auditory: []), (potential mismatch): []), (thirty-nine percent: [qnco]), (asd: [cgab]), (clinical criteria: []), (cut-off scores: [qnco]), (adi-r (autism diagnosis interview: [acty]), (period: []), (age): [orga]), (ados-2 (autism diagnosis observation schedule: [hlca]), (current period): [npop]), (patients: [podg]), (intellectual disability: [mobd]), (language disability: [mobd]), (receptive language disability: [mobd]), (assessment scores: [clna]), (developmental quotient: [orgf]), (eye tracking: [bpoc]), (pupil size: [clna]), (furthermore: []), (latency: []), (mismatch negativity response: [fndg]), (n250 pattern: []), (cognitive deficits: [mobd]), (autistic behavioural symptoms: [mobd]), (different neurophysiological networks: [phsf]), (typical autism: [mobd]), (results: [fndg]), (indication: []), (early speech therapy: [orgf]), (intensive autism programme: [mobd]), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(language disability, 'Language Ability')(receptive language disability, 'Language Ability')(eye tracking, 'Eye Contact')(cognitive deficits, 'Cognitive Ability')(autistic behavioural symptoms, 'Complaints and Indications')(typical autism, 'Autism Phenotype')(early speech therapy, 'Language Ability')(intensive autism programme, 'Autism Phenotype')

PMCID: 6091020
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (different: []), (dietary approaches: []), (gluten: [aapp,bacs]), (casein: [aapp,phsu]), (free diets: []), (use: []), (probiotics: [bact]), (prebiotics: [orch]), (autistic spectrum disorders: [mobd]), (order: [acty]), (gastrointestinal (gi) disturbances: [fndg]), (gi symptoms: [sosy]), (particular interest: [menp]), (population: [popg]), (correlation: []), (severity: []), (behavioural traits: [inbe]), (nowadays: []), (lack: []), (strong evidence: []), (effect: []), (dietary interventions: [topp]), (problems: []), (impact: [gngm]), (exclusion diets: [topp]), (6-week bimuno galactooligosaccharide (b-gos): []), (prebiotic intervention: [orch]), (autistic children: [podg]), (results: [fndg]), (children: [aggp]), (scores: [clna]), (abdominal pain: [sosy]), (bowel movement: [orgf]), (abundance: []), (bifidobacterium spp: [bact]), (veillonellaceae family: [bact]), (presence: [qnco]), (faecalibacterium prausnitzii: [bact]), (bacteroides spp: [bact]), (addition: []), ( significant correlations: [qnco]), (bacterial populations: [popg]), (faecal amino acids: [aapp,bacs,phsu]), (group: [popg]), (unrestricted diet: [hlca]), (b-gos intervention: [hlca]), (improvements: []), (anti-social behaviour: [mobd]), (significant increase: [qnco]), (lachnospiraceae family: [famg]), (significant changes: [qnco]), (urine metabolites: [bdsu]), (knowledge: []), (first study: [qnco]), (potential beneficial effects: []), (combined dietary approach: []), (gut microbiota composition: [orgm]), (metabolism: [orgf]), (multiple interventions: [hlca]), (improvement: []), (aspects: [qnco]), (psychological traits: [gngm]), (trial registration nct02720900;: [resa]), (november: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s40168-018-0523-3) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autistic spectrum disorders, 'Autistic Disorder')(free diets, 'Dietary Restrictions')(behavioural traits, 'Personal Traits')(exclusion diets, 'Dietary Restrictions')(exclusion diets, 'Dietary Restrictions')(abdominal pain, 'Pain')(bacterial populations, 'Bacterial Infections')(unrestricted diet, 'Dietary Restrictions')(exclusion diets, 'Dietary Restrictions')

PMCID: 6090838
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent literatures: []), (maternal hormone exposure: [inpo]), (risk factor: [qnco]), (autism spectrum disorder (asd): [mobd]), (prenatal progestin exposure: [horm,orch,phsu]), (neuroprotective effect: []), (estrogen: [horm,orch,phsu]), (contribute: [acty]), (asd development: [cgab]), (method: [lbpr]), (prenatal progestin exposure-induced autism-like behavior: [horm,orch,phsu]), (prenatal progestin: [horm,orch,phsu]), (exposure-induced offspring: [famg]), (resveratrol (rsv): [orch,phsu]), (postnatal exposure: [clna]), (autism-like behavior testing: [mobd]), (other biomedical analyses: [resa]), (prenatal norethindrone: [horm,orch,phsu]), (er: [gngm]), (lentivirus: [virs]), (rsv: []), (further testing: []), (pregnant dams: [fndg]), (prenatal net exposure: [aapp,bacs]), (offspring: [famg]), (kinds: []), (relevant progestins: [horm,orch,phsu]), (prenatal exposure: [fndg]), (decreased er expression: [topp]), (amygdala: [bpoc]), (autism-like behavior: [mobd]), (oral administration: [topp]), (prenatal rsv treatment: [topp]), (effect: []), (er activation: [acty]), (further investigation: [hlca]), (target genes: [gngm]), (demethylation: [npop]), (dna: [bacs,nnon]), (histone: [aapp,bacs]), (er promoter: [bacs,nnon]), (progestin-induced oxidative stress: [horm,orch,phsu]), (dysfunction: [dsyn]), (mitochondria: [celc]), (lipid metabolism: [moft]), (brain: [bpoc]), (resveratrol: [orch,phsu]), (data: [euka]), (strong risk factor: [qnco]), (many potential clinical progestin applications: [horm,orch,phsu]), (oral contraceptive pills: [phsu]), ( preterm birth drugs: [fndg]), (progestin-contaminated drinking water: [sbst]), (seafood: [anim]), (risk factors: [qnco]), (asd: [cgab]), (addition: []), ( rsv: []), (good candidate: []), (asd symptoms: [cgab]), (humans: [humn]), (high doses: [qnco]), (animals: [anim]), (potential limitation: []), (human application: [humn]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0225-5) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(maternal hormone exposure, 'Exposures')(prenatal progestin exposure, 'Exposures')(exposure-induced offspring, 'Perinatal History')(postnatal exposure, 'Exposures')(prenatal net exposure, 'Exposures')(offspring, 'Perinatal History')(prenatal exposure, 'Exposures')(asd symptoms, 'Complaints and Indications')

PMCID: 6068102
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (elevated levels: []), (prenatal testosterone: [horm,orch,phsu]), (risk: []), (autism spectrum conditions: [mobd]), (polycystic ovary syndrome (pcos): [dsyn]), (elevated prenatal testosterone: [fndg]), (precursor sex: [orgf]), (hypothesis: []), (prenatal sex steroid theory: [orgf]), (women: [popg]), (pcos: [dsyn]), (autistic traits: [mobd]), (rate: [qnco]), (autism: [mobd]), (children: [aggp]), (electronic health records: []), (clinical practice research datalink (cprd): [resa]), (uk: []), (case-control studies: [resa]), (studies: [lbpr]), (autism (n: [mobd]), (pcos (n: [dsyn]), (respectively: []), (matched controls: [resa]), (study: [resa]), (odds: []), ((or): []), (first-born children: []), (controls: [sbst]), (prevalence: [qnco]), (autism (2.3%: [mobd]), (unadjusted or:: []), (ci:: [lbpr]), (elevated rates: [qnco]), (pcos (0.17%: [dsyn]), (child: [aggp]), (adjustment: [inbe]), (maternal psychiatric diagnoses: [mobd]), (obstetric complications: [patf]), (maternal metabolic conditions: [dsyn]), (or:: []), (further evidence: []), 
ASD Terms: (autism spectrum conditions, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(obstetric complications, 'Obstetric Delivery Complications')(maternal metabolic conditions, 'Metabolic Indications')(autism spectrum conditions, 'Autism Phenotype')

PMCID: 6132446
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (children: [aggp]), (united states: []), (etiology: []), (asd: [cgab]), (environmental factors: []), (physiological abnormalities: [cgab]), (sensitive individuals: [patf]), (major physiological abnormalities: [cgab]), (mitochondrial dysfunction: [fndg]), (significant subset: [qnco]), (literature: [inpr,mnob]), (human studies: [humn]), (clinical aspects: [clna]), (unusual neurodevelopmental regression: [fndg]), (inflammatory event: [evnt]), ( gastrointestinal symptoms: [sosy]), ( seizures: [sosy]), ( motor delays: []), ( fatigue: [sosy]), (lethargy: [sosy]), (traditional biomarkers: [clna]), (mitochondrial disease: [dsyn]), (biomarkers: [clna]), (buccal cell: [gngm]), (fatty acid metabolism: [moft]), (non-mitochondrial enzyme function: [celc]), ( apoptosis markers: [bacs]), (mitochondrial antibodies: [aapp,imft]), (many genetic abnormalities: [fndg]), (chromosomal abnormalities: [comd]), ( mitochondrial dna mutations: [bacs,nnon]), (large-scale deletions: [genf]), (mutations: [genf]), (non-mitochondrial nuclear genes: [gngm]), (immune: []), (buccal cells: [cell]), ( fibroblasts: [cell]), ( muscle: [tisu]), (gastrointestinal tissue: [tisu]), (brains: [bpoc]), (individuals: [humn]), (several environmental factors: [qnco]), (toxicants: [hops]), ( microbiome metabolites: [orgm]), (oxidized microenvironment: [moft]), (mitochondrial function: [celc]), (asd tissues: [cgab]), (investigations: [hlca]), (treatments: [topp]), (preliminary: []), (however: []), (preliminary evidence: []), (mitochondria: [celc]), (fruitful target: [diap]), (treatment: [topp]), (prevention: [resa]), (further research: [resa]), (role: [socb]), (pathophysiology: [patf]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(unusual neurodevelopmental regression, 'Learning Disorders')(motor delays, 'Motor Skills')

PMCID: 6056057
SFARI Genes: 
Non SFARI Genes: ARMC8, ARMC8, 
Named Entities: (exact cause: []), (mechanisms: []), (pathobiology: []), (autism spectrum disorder (asd): [mobd]), (dysregulation: []), (long interspersed element-1 (line-1): [bacs,nnon]), (brains: [bpoc]), (asd-like: [cgab]), (mutant mice: [mamm]), (asd brain tissues: [cgab]), (however: []), (role: [socb]), (methylation: [moft]), (line-1: [fndg]), (individuals: [humn]), (asd: [cgab]), (study: [resa]), (line-1 insertion: [genf]), (genes: [gngm]), (line-1 methylation: [moft]), (degs: [gngm]), (transcriptome profiles: [qnco]), (list: []), (line-1-containing genes: [gngm]), (transpogene database: []), (ingenuity pathway analysis (ipa): []), (conducted: [inbe]), (dna methylation: [moft]), (bisulfite restriction analysis (cobra): [rept]), (lymphoblastoid cell lines: [cell]), (asd individuals: [cgab]), (unaffected individuals: [humn]), (methylation levels: [moft]), (expression levels: [qnco]), (line-1-inserted degs: [gngm]), ( c1orf27: [gngm]), (armc8: [gngm]), (ipa: [bacs,orch,phsu]), (asd-related mechanisms: [cgab]), (sex hormone receptor: [orgf]), (axon guidance signaling: [celf]), (moreover: []), (line-1 methylation level: [moft]), (severe language impairment: [mobd]), (transcript level: [phsu]), (methylation level: [moft]), (expression: [topp]), (line-1-inserted deg c1orf27: [gngm]), (severe language: [lang]), (impairment: [patf]), ( line-1 methylation: [moft]), (findings: [clna]), (association: [menp]), (asd blood samples: [cgab]), (further investigation: [hlca]), (molecular mechanisms: []), (effects: []), (asd pathobiology deserve: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(severe language impairment, 'Language Ability')(severe language impairment, 'Language Ability')

PMCID: 6116350
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (gabaergic dysfunction underlies: [dsyn]), (psychiatric disorders: [mobd]), (gabaergic: []), (several forms: [qnco]), (plasticity: [npop]), (postsynaptic levels: []), (nmda receptor: [aapp,rcpt]), ((nmdar)dependent inhibitory long-term potentiation (iltp): [aapp,rcpt]), (increase: []), (surface gabaars: []), (exocytosis;: [celf]), (regulatory mechanisms: []), (neuropathological significance: [qnco]), (autism-related protein px-rics: [mobd]), (gabaar transport driven: [menp]), (nmdardependent gabaergic iltp: []), (induced iltp: []), (rapid increase: []), (wild-type mouse: [mamm]), (hippocampal neurons: [cell]), (px-rics/ricsdeficient neurons: [cell]), (px-rics/gabarap/143-3 complex: [chvs]), (gene: [gngm]), (rescue studies: [lbpr]), (iltp: []), (camkiidependent phosphorylation: [moft]), (px-rics: [gngm]), (px-rics14-3-3 assembly: [acty]), (notably: []), ( px-rics/ricsdeficient mice: [mamm]), (impaired amygdaladependent fear learning: [menp]), (gabaergic activity: [acty]), (clonazepam: [orch,phsu]), (results: [fndg]), (px-ricsmediated gabaar trafficking: [celf]), (key target: [diap]), (gabaergic plasticity: [npop]), (dysfunction: [dsyn]), (atypical emotional processing: [menp]), (autism: [mobd]), 
ASD Terms: (psychiatric disorders, 'Mental Disorders')(impaired amygdaladependent fear learning, 'Learning Disorders')(autism, 'Autism Phenotype')

PMCID: 6051604
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (microbiome: [orgm]), (vital role: [socb]), (human health: [humn]), (disease: [dsyn]), (interaction: []), (human hosts: [humn]), (number: [qnco]), (transcriptomic regulation: [nusq]), (microrna (mirna): [bacs,nnon]), (animal models: [anim]), (circadian variations: []), (mirna: [bacs,nnon]), (microbiome elements: [orgm]), (patterns: []), (co-expression: [topp]), (potential diurnal interaction: []), (humans: [humn]), (daily oscillations: [topp]), (salivary mirna: [bacs,nnon]), (microbial rna: [bacs,nnon]), (relationships: []), (components: []), (gut-brain-axis: [bpoc]), (implications: []), (nine subjects: [humn]), (saliva samples: [bdsu]), (times: [qnco]), (days: []), (samples: [sbst]), (sets: [menp]), (exploration: [topp]), (cross-validation: [resa]), (identification: [menp]), (quantification: [qnco]), (host mirna: [bacs,nnon]), (next generation sequencing: [mbrt]), (stages: [clna]), (statistical analyses: [resa]), (circadian oscillators:: []), (two-way analysis: [resa]), (variance: [qnco]), (sample sets: [menp]), (host mirnas: [bacs,nnon]), (microbial rnas: [bacs,nnon]), (abundance: []), (collection time (but: []), (multivariate modeling: [resa]), (subsets: []), (mirnas: [bacs,nnon]), (collection time: []), (predictive ability: [orga]), (independent hold-out sample: [sbst]), (regulation: [biof]), (circadian mirnas: [bacs,nnon]), (data: [euka]), (autistic children: [podg]), (disordered sleep (n: [dsyn]), (autistic peers: [mobd]), (typical sleep (n: [orgf]), (eleven mirnas: [bacs,nnon]), (consistent diurnal oscillation: [topp]), (hold-out set: [menp]), (associations: [menp]), (circadian microbial rnas: [bacs,nnon]), (mirnas circamirs: [bacs,nnon]), (circamirs: []), (gene targets: [gngm]), (enrichment: []), (circadian gene targets: [gngm]), (metabolic signaling processes: [celf]), (expression patterns: [topp]), (children: [aggp]), (disordered sleep: [dsyn]), (thus: []), ( novel: []), (circadian oscillations: [topp]), (human mirna: [humn]), (microbial rna exist: [bacs,nnon]), (distinct implications: []), 
ASD Terms: 

PMCID: 6050725
SFARI Genes: PPP1R3F, PPP1R3F, PPP1R3F, PPP1R3F, 
Non SFARI Genes: 
Named Entities: (objective: []), (study: [resa]), (master regulators: []), (transcriptional networks: [moft]), (autism spectrum disorders: [mobd]), (sets: [menp]), (independent rna-seq data: [nusq]), (cerebellum: [bpoc]), (patients: [podg]), (asds: [cgab]), (subjects (n: [aapp,imft]), (n: [aapp,imft]), (respectively): []), (network deconvolution: [popg]), (transcriptomic data: [nusq]), (virtual protein activity analysis: [aapp,bacs]), (ppp1r3f (protein phosphatase: [aapp,enzy]), (regulatory subunit: [aapp]), (candidate master regulator: []), (large body: [humn]), (downstream genes: [gngm]), (disease phenotype: [dsyn]), (pathway analysis: []), (identified targets: [fndg]), (ppp1r3f: [gngm]), (datasets: []), (alteration: []), (endocytosis pathway: []), (limited sample: [sbst]), (first applications: [hlca]), (network deconvolution approach: [popg]), (brain: [bpoc]), (hypotheses: []), (large-scale studies: [lbpr]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13104-018-3594-0) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 6050263
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (categorical diagnoses: [fndg]), (diagnostic: [fndg]), (statistical manual: [inpr,mnob]), (mental disorders (dsm): [mobd]), (international classification: []), (diseases (icd) manuals: [inpr,mnob]), (neuroscientific evidence: []), (points towards: [qnco]), (neurobiological dysfunction: [dsyn]), (attention deficit/hyperactivity disorder: [mobd]), (autism spectrum disorder: [mobd]), (resting-state functional magnetic resonance: [npop]), (data: [euka]), ( functional connectivity: []), (default mode: [qnco]), (dorsal attention: [menp]), (salience network: [popg]), (participants: [popg]), (transdiagnostic hierarchical bayesian modeling framework: [resa]), (indian buffet processes: [phpr]), (latent dirichlet allocation: [acty]), (urgent need: [topp]), (objective brain-derived measures: [bpoc]), (brain network dysfunction: [popg]), (disorders: [dsyn]), (main variation factors: []), (patterns: []), (temporoparietal cortices: [bpoc]), (default mode network: [popg]), (brain-derived factors: [bpoc]), (underlying neural dysfunction: [dsyn]), (accurately: []), (reliable diagnoses: [fndg]), (brain-derived phenotypes: [bpoc]), (classification accuracy: []), (underlying neuropathology: [patf]), ((+/3.07): [fndg]), (new individuals: [humn]), ((+/3.97) accuracy: [fndg]), (results: [fndg]), (initial evidence: []), (neural dysfunction: [dsyn]), (adhd: [mobd]), (asd: [cgab]), (conventional brain recordings: [bpoc]), (data-led fashion: [euka]), (work: []), (translational endeavor: [genf]), (clinical decision-making: [diap]), (treatment: [topp]), (future: []), 
ASD Terms: (mental disorders, 'Mental Disorders')(attention deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism spectrum disorder, 'Autism Phenotype')(adhd, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 6047246
SFARI Genes: 
Non SFARI Genes: Bax, 
Named Entities: (aspect: [qnco]), (treatment: [topp]), (autistic behaviour: [mobd]), (valproic acid rat model: [mamm]), (pregnant female rats: [mamm]), (main groups: [popg]), (male rats/group): [mamm]), (days: []), (subgroups: [virs]), (first group: [popg]), (normal rats: [mamm]), (subgroups: (a)  control group: [grup]), ( (b): []), (camel milk: [mamm]), (ml/p.o): [qnco]), ((c): []), (g/kg i.p): [aapp,enzy]), (daily: []), (second group: [popg]), (autistic rats: [mamm]), (follows: (d): []), (positive control (autistics: [mobd]), ((e): []), (cam: [gngm]), ( (f): [inch,phsu]), (moderate dose: [qnco]), (leptin: [aapp,horm]), ((g): [qnco]), (dose: [qnco]), (autistic behaviours: [mobd]), (male: [orga]), (pulz maze tests: [topp]), (valproic: []), ((vpa)-induced autistic rats: [mamm]), (severe changes: [qnco]), (oxidative stress markers: [comd]), ( neurotransmitters: [bacs]), (inflammatory cytokines: [aapp,imft]), (genotoxic manifestation: [comd]), (expression: [topp]), (tumour necrosis factor: [aapp,imft]), ((tnf)-: [aapp,bacs]), ( bax: [aapp,bacs]), (caspase-3: [aapp,enzy]), (signs: [fndg]), (toxicity: [inpo]), (pronounced improvement: []), (control rats: [mamm]), (control itself: [sbst]), (cam treatment: [topp]), (autistic animals: [mobd]), (significant improvement: [qnco]), (parameters: [fndg]), (genetic expression values: [genf]), (improvement: []), (animals: [anim]), (results: [fndg]), (potential therapeutic candidate: [topp]), (autism: [mobd]), (regulation: [biof]), (inflammatory: []), (apoptotic pathways: [celf]), (essential role: [socb]), (alleviation: []), (antioxidant effects: [phsf]), 
ASD Terms: (autism, 'Autism Phenotype')

PMCID: 6040688
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (cerebellum: [bpoc]), (neurons: [cell]), (human brain: [humn]), (learning: [menp]), (predictive processing: [acty]), (motor: []), ( sensory: []), (cognitive domains: []), (morphological features: []), (individuals: [humn]), (unexplored in-vivo: []), (first study: [qnco]), (high-resolution: [lbpr]), (fractal analysis: [resa]), (fractal dimension: [qnco]), (measure: [qnco]), (structural complexity: [chvs]), (object: []), (left: []), (right cerebellar cortex: [bpoc]), (magnetic resonance images: [npop]), (freesurfer): []), (male children: [aggp]), (autism spectrum disorders (asd) (n: [mobd]), (years: []), (sex: [orgf]), ( age: [orga]), ( verbal-iq: []), ((td): []), ((n =: [aapp,imft]), (mean age:: [orga]), (age range: [qnco]), (late childhood period: [fndg]), (brain development: [ortf]), (mann-whitney u test: [qnco]), (significant reduction: [npop]), (fd: []), (asd: [cgab]), (td: []), ((p =: [aapp,imft]), (bonferroni-corrected): []), ( indicating flatter: []), (regular surface protrusions: [anab]), (td males: [orga]), (prediction: []), (implicit learning: [menp]), (asd boys: [cgab]), ((vs: []), (piq>viq difference: [gngm]), (higher: []), (normative complexity: [chvs]), (td children: [aggp]), (new insight: [menp]), (understanding: [menp]), (neurological basis: [phsu]), (differences: [qnco]), (performance: [inbe]), (cognitive abilities: [menp]), 
ASD Terms: (cognitive domains, 'Cognitive Ability')(autism spectrum disorders, 'Autism Phenotype')(neurological basis, 'Neurologic Indications')(cognitive abilities, 'Cognitive Ability')

PMCID: 6049608
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (visual abstract: []), 
ASD Terms: (visual abstract, 'Visual Thinking')

PMCID: 6071194
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (visual abstract: []), 
ASD Terms: (visual abstract, 'Visual Thinking')

PMCID: 6086092
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (changes: [qnco]), (efficiency: [qnco]), (protein translation: [moft]), (autism spectrum disorders: [mobd]), (hypothesis: []), (environmental factors: []), (genetic factors: [fndg]), (translation efficiency: [moft]), (small set: [menp]), (asd-associated genes: [cgab]), (asd-associated variants: [cgab]), (single nucleotide variant (snv): [fndg]), (protein: [aapp,bacs]), (region changes translation speed: [moft]), (study: [resa]), (set: [menp]), (autism quartets: [mobd]), (affected child: [aggp]), (unaffected child): [aggp]), (genome-wide variants: [gngm]), (test statistic: [lbpr]), (relevant variables: ribosome: [celc]), (data: [euka]), ( presence/absence: []), (cpg dinucleotides: [bacs,nnon]), (phylogenetic conservation: []), (inclusion: [celc]), (ribosome profiling abundances: [celc]), (results: [fndg]), (malemale sibling pairs: [famg]), (cpg information: [bacs,nnon]), (femalefemale pairs: []), (insight: [menp]), (significant gender differences: [orga]), (autism incidence: [qnco]), (single-variant test statistic: [fndg]), (variants: []), (gene: [gngm]), (single gene score: [clna]), (gene distinguishes: [gngm]), (unaffected siblings: [famg]), (statistical methods: [resa]), (gene sets: [gngm]), (power: [hcpp]), (gene variants: [gngm]), (pathway: [moft]), (enrichment analysis: [resa]), (importance: []), (wnt: []), (other pathways: [moft]), (atp binding: [moft]), (atp-ase pathways: [aapp,enzy]), (etiology: []), (asds: [cgab]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism quartets, 'Autism Phenotype')(autism incidence, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 6034210
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (inherited abnormalities: [cgab]), (perception: [menp]), ( recognition: [menp]), (attention: [menp]), (etiology: []), (autism spectrum disorders: [mobd]), (abnormal components: [qnco]), (event-related brain potentials: [ortf]), (faces: [blor]), (familial aggregation: [famg]), (face processing erp: [fndg]), (asd: [cgab]), (verbal individuals: [humn]), (unaffected siblings: [famg]), (unaffected fathers: [famg]), (unrelated controls: [sbst]), ( us: []), (uc groups: [popg]), (age: [orga]), (uf group: [popg]), (years: []), (erp: [gngm]), (images: []), (houses: []), (disparate eeg reference schemes: [diap]), (face-sensitive features: [patf]), (n170: []), (p1: [gngm]), (groups: [popg]), (differences: [qnco]), (control groups: [grup]), (eeg reference scheme: [diap]), (notably: []), (superiority: [socb]), (face: [gngm]), (object: []), (n170 latency: []), (asd subjects: [cgab]), (relatives;: [famg]), (average reference: [qnco]), (difference: [qnco]), (us groups: [popg]), (effect: []), (vertex reference: [blor]), (furthermore: []), (similar group differences: [popg]), (lack: []), (face specificity: [qnco]), (attenuation: [acty]), (n170 inversion effect: [comd]), (present findings: [clna]), (understanding: [menp]), (face processing erps: [ortf]), (data: [euka]), (modest evidence: []), (highly-selective asd-sensitive erp features: [cgab]), (sensitivity: [patf]), (biomarkers: [clna]), (erp reference scheme: [fndg]), (schemes: []), (studies: [lbpr]), (future studies: [lbpr]), (relationship: []), (erp characteristics: [fndg]), ( genotype: [orga]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0220-x) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (perception, 'Cognitive Ability')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 6028639
SFARI Genes: MECP2, MECP2, MECP2, Abat, MECP2, Abat, 
Non SFARI Genes: 
Named Entities: (unstable epigenome: [evnt]), (pathophysiology: [patf]), (neurodevelopmental disorders: [mobd]), (schizophrenia: [mobd]), (autism: [mobd]), (epigenome: []), (adult: [aggp]), (maternal immune activation (mia): [acty]), (significant global dna hypomethylation: [genf]), (hypothalamus: [bpoc]), (however: []), (genes: [gngm]), (methylation: [moft]), (functional effects: []), (gene expression: [genf]), (changes: [qnco]), (study: [resa]), (next-generation sequencing (ngs): [mbrt]), (methylome profiling: [lbpr]), (mia rodent model: [mamm]), (regions: []), (chromatin state: [aapp]), (known dnase: [aapp,enzy]), (sites (dhss): [orch,phsu]), (functional effect: []), (mia: [gngm]), (qpcr: [mbrt]), (finally: []), (methylation differences: [moft]), (post-natal dietary (omega): []), (fatty acid (pufa) supplementation: [bacs,orch]), (experiments: [resa]), (hypothalamic brain tissue: [bpoc]), (12-week-old offspring: [famg]), (mice: [mamm]), (viral analogue polyi:c: [chvs]), (gestation day: [orgf]), (pregnancy: [orgf]), (saline: [sbst]), (half: [qnco]), (animals: [anim]), (group: [popg]), (n-3 pufa: [bacs,orch,phsu]), ((mia group: [popg]), ( n: [aapp,imft]), (units: [qnco]), ( n =: [aapp,imft]), (mice; control group: [mamm]), (mice): [mamm]), (results: [fndg]), (previous finding: [sosy]), (furthermore: []), ( genes: [gngm]), (synaptic plasticity: [ortf]), (mia-induced: [gngm]), (mecp2 binding: [aapp,bacs]), (n-3 pufa intervention: [bacs,orch,phsu]), (increased expression: [topp]), (top five genes: [gngm]), (integrated analysis: [resa]), (dmrs: [gngm]), ( dhss: [orch,phsu]), (mecp2: [gngm]), (sites: []), (abat (t: [gngm]), (p <: [aapp,imft]), (gnas9 (t: [clna]), (p: [gngm]), (dietary intervention: [topp]), (thus: []), (prenatal mia exposure: [fndg]), (epigenomic regulation: [biof]), (gene pathways: [gngm]), (neurodevelopmental conditions;: [mobd]), (low-cost dietary intervention: [topp]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(fatty acid supplementation, 'Dietary Supplements')(12-week-old offspring, 'Perinatal History')(gestation day, 'Perinatal History')(gestation day, 'Perinatal History')(prenatal maternal immune activation exposure, 'Exposures')(neurodevelopmental conditions, 'Learning Disorders')

PMCID: 6026208
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (cnvs: [nusq]), (single genes: [fndg]), (extensive phenotypic heterogeneity: [fndg]), (variably-expressive cnvs: [nusq]), (disease gene discovery: [mbrt]), (functional evaluation: [diap]), (here: []), (complex interaction model: [chvs]), (pathogenicity: [orga]), (deletion: [genf]), (cnv genes interact: [gngm]), (conserved pathways: [moft]), (expression: [topp]), (phenotype: [orga]), (multiple quantitative methods: [topp]), (drosophila rnai: [euka]), (range: [qnco]), (neurodevelopmental phenotypes: [orga]), (knockdown: []), (homologs: [gngm]), (different tissues: [tisu]), (pairwise knockdowns: []), (developing eye: [bpoc]), (interactions: []), (pairs: []), (neurodevelopmental genes: [gngm]), (cell proliferation phenotypes: [celf]), (one-hit knockdowns: [dsyn]), (cell proliferation pathways: [celf]), (human brain-specific network: [humn]), (translational relevance: [genf]), (humans: [humn]), (study: [resa]), (role: [socb]), (pervasive genetic interactions: [genf]), (cnvs towards: [nusq]), (developmental phenotypes: [orga]), 
ASD Terms: (neurodevelopmental phenotypes, 'Learning Disorders')(neurodevelopmental genes, 'Learning Disorders')

PMCID: 6022498
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (several reports: [hlca]), (role: [socb]), (epigenetic mechanisms: [genf]), (asd etiology: [cgab]), (epigenome-wide association studies: [menp]), (autism spectrum disorder (asd): [mobd]), (light: [gngm]), (particular biological mechanisms: []), (however: []), ( studies: [lbpr]), (asd cases versus controls: [cgab]), (post-mortem timing: [diap]), (small sample sizes: [sbst]), (reports: [hlca]), (in-life sampling: [diap]), (blood: [bdsu]), (saliva: [bdsu]), (sample size: [qnco]), (and/or genomic coverage: [gngm]), (case-control ewas: [hlca]), (asd: [cgab]), (data: [euka]), (population-based case-control: [popg]), (case-sibling pair studies: [famg]), (dna: [bacs,nnon]), (blood samples: [bdsu]), (children: [aggp]), (study: [resa]), (early development (seed: [plnt]), (epigenome-wide array dna methylation (dnam) data: [moft]), (cpg sites: [bacs,nnon]), (cases: [qnco]), (controls: [sbst]), (illumina: []), (beadchip: []), (simons simplex collection (ssc): [bpoc]), (array dnam data: [euka]), (unaffected siblings: [famg]), (ewas meta-analysis: [resa]), (results: [fndg]), (data sets: []), (adjustment: [inbe]), (sex: [orgf]), (surrogate variables: [famg]), (major sources: [fndg]), (biological variation: []), (technical confounding: []), (cell type: [cell]), ( batch: [qnco]), (ancestry: []), (top ewas results: [fndg]), (previous brain-based analysis: [bpoc]), (enrichment: []), (asd ewas cpgs: [cgab]), (targets: [diap]), (meqtl associations: [menp]), (available snp genotype data: [nusq]), (seed sample: [plnt]), (findings: [clna]), (meta-analysis: [resa]), (blood-based dna: [bdsu]), (single cpg: [fndg]), (bonferroni discovery threshold: [acty]), (p: [gngm]), (seven cpgs: [bacs,nnon]), (differences: [qnco]), (brain-based asd associations: [cgab]), (well: []), (effect sizes: []), (modest concordance (r: [clna]), (direction: []), (effect: []), (cerebellum samples: [bpoc]), (suggestive evidence: []), (snps (meqtl targets): [nusq]), (ewas cpg hits: [bacs,nnon]), (ewas: []), (meqtl discovery p value thresholds: [qnco]), (single cpg site: [fndg]), (large enough dnam difference: [qnco]), (epigenome-wide significance: [qnco]), (disease associations: []), (blood-based samples: [bdsu]), (sites: []), (suggestive statistical significance: [qnco]), (consistent: []), (stronger: []), ( effects: []), (same sites: []), (brain samples: [bpoc]), (discovery-oriented ewas: [acty]), (samples: [sbst]), (unified genetic data: [euka]), (further understand dnam: [menp]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0224-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 6121142
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract: []), (prior diffusion tensor: [npop]), ((dti) studies: [diap]), (significant differences: [qnco]), (white matter organizations: [tisu]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (neural correlates: []), (clinical diagnosis: []), (people: [popg]), (endophenotypes: []), (dti data: [diap]), (total: [qnco]), (participants: [popg]), (conventional approach: []), (asd: [cgab]), (unaffected siblings: [famg]), (region-of-interest approach: [menp]), (differences: [qnco]), (distribution: []), ((td) siblings: [famg]), (conventional approaches: []), (bootstrapping: [qnco]), (large difference: [qnco]), (axial diffusivity: []), (left stria terminalis: [bpoc]), (td siblings (99.998 percentile): [famg]), (results: [fndg]), (multiple comparisons: [acty]), (bonferroni method: [lbpr]), (aspect: [qnco]), (tract: [bpoc]), (development: [orgf]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(clinical diagnosis, 'Diagnosis')

PMCID: 6011246
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (concomitant occurrence: []), (impaired social interaction; restricted: [mobd]), ( perseverative: [mobd]), (stereotypical behaviour;: [mobd]), (abnormal communication skills: [orga]), (recent epidemiological studies: [resa]), (dramatic increase: []), (prevalence: [qnco]), (asd: [cgab]), (children: [aggp]), (fact: [gngm]), (reversible postnatally: []), (possibility: []), (gene therapy: [topp]), (disease-modifying treatment: [dsyn]), (such therapies: [topp]), (human disease: [humn]), (monogenic disorders: [dsyn]), (metachromatic leukodystrophy: [dsyn]), ( sma type: [aapp,bacs]), (regard: []), (technical advances: []), (capacity: [qnco]), (disorder: [dsyn]), (animals: [anim]), (ability: [orga]), (genes: [gngm]), (central nervous system (cns): [bdsy]), (first preclinical studies: [resa]), (monogenic asd: [cgab]), (gene replacement: [topp]), (silencing: [mobd]), (furthermore: []), (awareness: [menp]), (understanding: [menp]), (pathways: [moft]), (gene: [gngm]), (therapys potential scope: []), (various polygenic asds: [cgab]), (review: []), (number: [qnco]), (outstanding challenges: [hlca]), ( gene therapy: [topp]), (excellent potential: []), (cognitive dysfunction: [mobd]), 
ASD Terms: (impaired social interaction, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(stereotypical behaviour, 'Stereotyped, Restricted, and Repetitive Behavior')(abnormal communication skills, 'Reciprocal Social Interaction')(cognitive dysfunction, 'Cognitive Ability')

PMCID: 6011198
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (micrornas (mirnas): [bacs,nnon]), (small: [qnco]), ( non-coding rnas: [nnon]), (gene expression: [genf]), (post-transcriptional level: [genf]), (mirnas: [bacs,nnon]), (important modulators: []), (brain development: [ortf]), (neuronal function: [phsf]), (several neurological diseases: [dsyn]), (previous studies: [lbpr]), (mir-146a upregulation: [genf]), (common mirna deregulation event: [bacs,nnon]), (neurodevelopmental disorders: [mobd]), (autism spectrum disorder (asd): [mobd]), ( epilepsy: [dsyn]), (intellectual disability (id): [mobd]), (fetal brain: [emst]), (expression: [topp]), (mir-146a: []), (temporal lobe: [bpoc]), (asd children: [cgab]), (taqman assay: [lbpr]), (role: [socb]), (early brain development: [ortf]), (h9: [gngm]), (human neural stem cell (h9 hnsc): [humn]), (various cell: [gngm]), (molecular biology techniques: [lbpr]), (childhood: []), (asd brain: [cgab]), (mir-146a overexpression enhances: [acty]), (neurite outgrowth: [celf]), (branching: []), (favors: [orch,phsu,vita]), (cells: [cell]), (expression analyses: [resa]), (transcriptome: [nusq]), (modules: []), (cell cycle control: [celf]), (neuronal differentiation: [fndg]), (targets: [diap]), (potential drivers: [popg]), (distinct transcription profiles: [genf]), (human brain development: [ortf]), (regions: []), (asd: [cgab]), (neocortex: [bpoc]), ( amygdala: [bpoc]), (hippocampus: [bpoc]), (cell type analyses: [resa]), (markers: [clna]), (pyramidal: []), (interneurons: [cell]), (deregulated gene list: [gngm]), (neuronal lineages: [imft]), (acquisition: [acty]), (neuronal identities: [menp]), (results: [fndg]), (dynamic roles: [socb]), (early neuronal development: [celf]), (new insight: [menp]), (molecular events: [evnt]), (mir-146a overexpression: [genf]), (neurodevelopment: [ortf]), (this: []), (turn: [fndg]), (new therapeutic targets: [diap]), (strategies: [menp]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0219-3) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (several neurological diseases, 'Neurologic Indications')(neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(epilepsy, 'Epilepsy')(intellectual disability, 'Learning Disorders')

PMCID: 6004695
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (essential question: []), (evolutionary biology: [genf]), (shifts: [phpr]), (set: [menp]), (polygenic behaviors share: [inbe]), (genetic basis: [phsu]), (species: []), (behavioral shift: [inbe]), (cave-dwelling mexican tetra: [fish]), ( astyanax mexicanus: [fish]), (surface-dwelling conspecifics: []), ( cavefish: []), (school (asocial): [mnob,orgt]), (sleepless: [sosy]), (particular vibration stimulus: [npop]), (attention): [menp]), (repetitively: []), (show: [anim]), (stress hormone levels: [lbtr]), (interestingly: []), (traits: [gngm]), (core symptoms: [sosy]), (human autism spectrum disorder (asd): [humn]), (possibility: []), (behavioral traits: [inbe]), (similar set: [menp]), (genes (i.e: [gngm]), (suite: []), (genes): [gngm]), (result here: [fndg]), (modification: []), (asd-risk genes underlies: [cgab]), (evolution: [genf]), (transcriptomic analyses: [lbpr,mbrt]), (cavefish orthologs: [gngm]), (asd-risk genes: [cgab]), (same direction: []), (genes: [gngm]), (postmortem brains: [diap]), (asd patients: [cgab]), (enrichment tests: [lbpr]), (asd-risk gene orthologs: [cgab]), (a. mexicanus: []), (positive selection: [lbpr]), (other genes: [gngm]), (genome: [gngm]), (notably: []), (cavefish asd-risk genes: [cgab]), (pathways: [moft]), (gut function: [phsf]), ( inflammatory diseases: [dsyn]), (lipid/energy metabolism: [moft]), (lastly: []), ( asd drugs: [cgab]), (cavefishs asd-like behaviors: [cgab]), (aspects: [qnco]), (neural processing: [acty]), (overall: []), (study: [resa]), (metabolic pathways): []), (polygenic behaviors: [inbe]), (evolutionary time: [genf]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s12862-018-1199-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (sleepless, 'Sleeping Problems')(human autism spectrum disorder, 'Autism Phenotype')(cavefishs asd-like behaviors, 'Autism Phenotype')

PMCID: 6002020
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (testosterone: [horm,orch,phsu]), (part: [qnco]), (prevalence: [qnco]), (autism spectrum disorder (asd): [mobd]), (males: [orga]), (previous studies: [lbpr]), (elevated postnatal testosterone levels: [fndg]), (children: [aggp]), (women: [popg]), (asd: [cgab]), (men: [gngm]), (levels: []), (salivary testosterone: [horm,orch,phsu]), (undergraduate males: [orga]), (yrs: [gngm]), ( sd: [mamm]), (low: [qnco]), ( mid-range: [qnco]), (high levels: [qnco]), (autistic traits: [mobd]), (autism-spectrum quotient: [qnco]), (analyses: [resa]), (significant differences: [qnco]), (testosterone concentrations: [horm,orch,phsu]), (groups: [popg]), (current data add: [euka]), (evidence: []), (lack: []), (relationship: []), (postnatal levels: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 6182718
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objective: []), (retrospective analysis: [resa]), (longitudinal millennium cohort study: [resa]), (maternal alcohol consumption: [inbe]), (pregnancy (macp): [orgf]), (development: [orgf]), (childhood autism spectrum disorders: [mobd]), (data: [euka]), (macp: []), (asd: [cgab]), (parental questionnaires: []), (singleton motherchild pairs: [fndg]), (question: []), (children: [aggp]), (years: []), (significant association: [menp]), (light (or: [npop]), (ci: [gngm]), (moderate (or: []), (heavy (or: []), (alcohol consumption: [inbe]), (pregnancy: [orgf]), (risk: []), (study cohort: [popg]), 
ASD Terms: (maternal alcohol consumption, 'Alcohol Drinking')(childhood autism spectrum disorders, 'Autism Phenotype')(alcohol consumption, 'Alcohol Drinking')(alcohol consumption, 'Alcohol Drinking')(alcohol consumption, 'Alcohol Drinking')(heavy alcohol consumption, 'Alcohol Drinking')(alcohol consumption, 'Alcohol Drinking')

PMCID: 6195236
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction nodding syndrome (ns): [dsyn]), (high anion gap: [clna]), ( biotinidase: [aapp,enzy]), (acetyl carnitine deficiency: [dsyn]), ( vitamin b6: [orch,phsu,vita]), (d deficiency: [aapp,imft]), (internal displacement: [menp]), (objective: []), (study: [resa]), (metabolic analysis: [resa]), (ns children: [aggp]), (review literature: []), (similarities: []), (asd: [cgab]), (biochemical analysis: [resa]), (blood: [bdsu]), (urine: [bdsu]), (hope: [menp]), (humans (hfh) centre: [humn]), (literature: [inpr,mnob]), (ethical approval: []), (irb: []), (data analysis: []), (stata version: []), (significant: [qnco]), (biotinidase deficiency: [cgab,dsyn]), (ns: [gngm]), (ci(1.61: [lbpr]), (p: [gngm]), (ci(16.10: [lbpr]), (17.75; p<0.001); low bmi-for-age: [orga]), (17.75; p: [aapp,imft]), (age: [orga]), (ci(0.78: [lbpr]), (4.660; p: [aapp,imft]), (idp duration: [aapp,enzy]), (ci(4.48: [lbpr]), (ci(7.03: [lbpr]), (episodes: []), ((2)=22.15: [qnco]), ( p=0.005; ns siblings: [famg]), (ns (2): []), (idps (2): [aapp,enzy]), (findings: [clna]), (biotinidase: [aapp,enzy]), ( idps: [aapp,enzy]), (environmental exposures: [inpo]), (new cases: [qnco]), (ugandan moh: [popg]), (who: []), (idp camps: [dora]), (communities: []), (own communities: []), (feed: [acty]), (own grown foods: []), (autism spectrum disorder (asd): [mobd]), (finding: [sosy]), (efforts: [orgf]), (treatment: [topp]), (rehabilitation: [topp]), 
ASD Terms: (vitamin b6, 'Dietary Supplements')(environmental exposures, 'Exposures')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5974415
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (neurodevelopmental disorders: [mobd]), (asd: [cgab]), (adhd: [mobd]), (males: [orga]), (times: [qnco]), (females: [orga]), (hemideletion: []), (copy number variation: [nusq]), (previous work: []), (lab: [gngm]), (mouse model: [emod]), (male-specific behavioral phenotypes: [orga]), (we: []), ( therefore: []), (magnetic resonance: [npop]), ((mri): [diap]), (del/+ animals: [comd]), (sex-specific neuroanatomical endophenotype: [orgf]), (allen mouse brain atlas: [bpoc]), (expression patterns: [topp]), (genes: [gngm]), (region: []), (gene expression patterns: [genf]), (brain: [bpoc]), (structural changes: [topp]), (mri: [gngm]), (ex vivo: []), (resulting images: []), (voxel-based morphometry: [lbpr]), (t1-weighted sequences: [orga]), (tract-based spatial statistics: [gngm]), (diffusion-weighted images: [orga]), (subsequent step: [qnco]), (situ hybridization (ish) maps: [mbrt]), (waxholm space: []), (clusters: [qnco]), (sex-specific group comparisons: [orgf]), (gene(s): [gngm]), (expression: [topp]), (regions: []), (sex-specific changes: [topp]), (male animals: [orga]), (increased fractional anisotropy: [npop]), (medial fiber tracts: [bpoc]), (proximate: []), (striatum: [bpoc]), (moreover: []), (male-specific structural changes: [orga]), (neurite outgrowth: [celf]), (mapk pathway: [moft]), (previous molecular studies: [lbpr]), (convergent changes: [qnco]), (sex-specific dysregulation: [orgf]), (mapk signaling: [moft]), (convergent evidence: [acty]), (idea: []), (ish maps: [aapp,bacs]), (data sets: []), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(adhd, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 5970172
SFARI Genes: Nlgn3, Nlgn3, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (pervasive neurodevelopmental syndrome: [dsyn]), (high human: [humn]), (economic burden: [qnco]), (pathophysiology: [patf]), (asd: [cgab]), (development: [orgf]), (pharmacological treatments: [topp]), (core symptoms: [sosy]), (disorder: [dsyn]), (abnormalities: [cgab]), (glutamate: [aapp,bacs]), (gaba: [aapp,bacs]), (asd symptoms: [cgab]), (therapeutic target: [diap]), (humans: [humn]), (rodent models: [mamm]), (translational proton: [elii]), (magnetic resonance spectroscopy ([1h]mrs): [diap]), (gaba levels: [aapp,bacs]), (adult humans: [aggp]), (panel: []), (diverse rodent asd models: [cgab]), (environmental etiologies: []), ([1h]mrs: [diap]), (striatum: [bpoc]), (medial prefrontal cortex: [celc]), ( mice: [mamm]), (rats: [mamm]), (order: [acty]), (direct cross-species comparisons: [acty]), (subcortical brain regions: [blor]), ( glutamate concentration: [aapp,bacs]), (severity: []), (social symptoms: [sosy]), (brain region: [blor]), (reduction: [npop]), (striatal glutamate: [bpoc]), (mice: [mamm]), (valproate: [orch,phsu]), (nlgn3 mutations: [genf]), (rodent asd models: [cgab]), (other etiologies: []), (findings: [clna]), (glutamate/gaba abnormalities: [aapp,bacs]), (corticostriatal circuitry: []), (key pathological mechanism: []), (asd;: [cgab]), (alterations: []), (neuroliginneurexin: []), (complex: [chvs]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(pervasive neurodevelopmental syndrome, 'Learning Disorders')(underlie asd symptoms, 'Complaints and Indications')

PMCID: 5946742
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (immune system: [bdsy]), (role: [socb]), (pathogenesis: [patf]), (autism spectrum disorder (asd): [mobd]), (atypical autism: [mobd]), (aim: [phsu]), (study: [resa]), (cytokine: [aapp,imft]), (growth factor panel: [aapp,bacs]), (diagnosis: [fndg]), (prognosis: [hlca]), (children: [aggp]), (asd: [cgab]), (material/: [sbst]), (asd (typical: [cgab]), (atypical): [fndg]), (siblings: [famg]), (panel: []), (ten serum cytokines: [dsyn]), (growth factors: [aapp,bacs]), (addressable laser bead: [plnt]), ((albia): []), (enzyme-linked immunosorbent assay (elisa) kits: [lbpr]), (results: [fndg]), (scores: [clna]), (childhood autism rating scale (cars): [mobd]), (autism diagnostic observation schedule (ados): [hlca]), (findings: [clna]), (significant differences: [qnco]), (serum cytokine: [aapp,imft]), (growth factor levels: [aapp,bacs]), (cars: [gngm]), (ados: [aapp,enzy]), (typical autism: [mobd]), (part: [qnco]), (asd spectrum: [cgab]), (serum levels: [bdsu]), (cytokines: [aapp,imft]), (positive correlation: [fndg]), (ados scores: [aapp,enzy]), (serum measurement: [bdsu]), (panels: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(atypical autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')(childhood autism rating scale, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(typical autism, 'Autism Phenotype')(atypical autism, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(autism diagnostic observation schedule scores, 'Autism Phenotype')(diagnosis, 'Diagnosis')

PMCID: 5919902
SFARI Genes: Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, 
Non SFARI Genes: 
Named Entities: (new line: [sbst]), (shank3 mutant mice: [mamm]), (complete loss: [qnco]), (shank3: [gngm]), (exons: [bacs,nnon]), ((e422) globally: []), (e422 mice display: [mamm]), (robust asd-like behaviors: [cgab]), (impaired social interaction: [mobd]), (communication: [socb]), (stereotypical behavior: [mobd]), (excessive grooming: [fndg]), (profound deficit: [dsyn]), (instrumental learning: [menp]), (however: []), (neural circuitry: [bpoc]), (behaviors: [inbe]), (mice: [mamm]), (forebrain: [bpoc]), ( striatum: [bpoc]), (striatal d1: [bpoc]), (d2 cells: [cell]), (circuit/brain-region: [blor]), (cell-type specific role: [socb]), (expression: [topp]), (autism-related behaviors: [mobd]), (whole-cell patch recording: [resa]), (biochemical analyses: [resa]), (synaptic function: [phsf]), (molecular changes: [qnco]), (specific brain regions: [blor]), (perseverative exploratory behaviors: [mobd]), (deletion: [genf]), (striatal inhibitory neurons: [bpoc]), (conversely: []), ( self-grooming: [inbe]), (induced lesions: [fndg]), (excitatory neurons: [cell]), ( social: []), ( communicative: [socb]), (instrumental learning behaviors: [menp]), (global e422 mice: [mamm]), (unique patterns: []), (change: [qnco]), (electrophysiological findings: [clna]), (respective brain regions: [blor]), (complex nature: [chvs]), (transcriptional regulation: [genf]), (reductions: [npop]), (homer1b/c: [gngm]), (membrane hyper-excitability: [mobd]), (striatal loss: [bpoc]), (comparison: [acty]), ( shank3 deletion: [genf]), (hippocampal neurons: [cell]), (increased nmdar-currents: [aapp,rcpt]), (glun2b-containing nmdars: [aapp,rcpt]), (results: [fndg]), (neural circuits: [bpoc]), (behavior: [inbe]), (study: [resa]), (dissociation: [mobd]), (shank3 functions: [phsf]), (striatal neurons: [bpoc]), (asd-related behaviors: [cgab]), (complexity: [chvs]), (neural circuit mechanisms: []), 
ASD Terms: (profound deficit in instrumental learning, 'Learning Disorders')(robust asd-like behaviors, 'Autism Phenotype')(impaired social interaction, 'Reciprocal Social Interaction')(stereotypical behavior, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 5974625
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recently: []), (animals: [anim]), (telomerase reverse transcriptase (tert) overexpression exhibit: [aapp,enzy]), (social interaction: [fndg]), (preference: []), (novel social interaction: [fndg]), (poor nest-building behaviors symptoms: [grpa]), (human autism spectrum disorders: [humn]), (overexpression: [genf]), (tert: [gngm]), (excitatory/inhibitory (e/i) ratio: [acty]), (medial prefrontal cortex: [celc]), (however: []), (effects: []), (tert overexpression: [aapp,enzy]), (hippocampal-dependent learning: [menp]), (synaptic efficacy: [resa]), (present study: [qnco]), (electrophysiological approaches: [diap]), (combination: [fndg]), (behavioral analysis: [hlca]), (hippocampal function: [phsf]), (transgenic (tert-tg) mice: [mamm]), (fvb controls: [mamm]), (tert overexpression results: [aapp,enzy]), (enhanced hippocampal excitation: [acty]), (changes: [qnco]), (inhibition: [acty]), (long-term synaptic plasticity: [ortf]), (interestingly: []), (expression levels: [qnco]), (creb: []), (phosphory-lated camkii: [aapp,enzy]), (expression level: [qnco]), (camkii: [aapp,enzy]), (hippocampus: [bpoc]), (tert-overexpressing mice: [mamm]), (observations: [hlca]), (importance: []), (normal synaptic function: [phsf]), (behavior: [inbe]), (additional information: []), (novel animal model: [emod]), (asd: [cgab]), 
ASD Terms: (novel social interaction, 'Reciprocal Social Interaction')(social interaction, 'Reciprocal Social Interaction')(human autism spectrum disorders, 'Autism Phenotype')

PMCID: 6071837
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background: prenatal exposure: [fndg]), ((op) pesticides: [hops]), (poorer neurodevelopment: [grpa]), (behaviors: [inbe]), (spectrum disorders: [dsyn]), (previous studies: [lbpr]), (center: [fndg]), (health assessment: [hlca]), (mothers: [famg]), (children: [aggp]), (salinas (chamacos): [euka]), (birth cohort living: [qnco]), (agricultural salinas valley: [euka]), (california: [plnt]), (objectives:: []), (association: [menp]), (prenatal exposure: [fndg]), (op pesticides: [hops]), (traits: [gngm]), (asd: [cgab]), (childhood: []), (adolescents: [aggp]), (chamacos: []), (methods:: []), (op exposure: [clna]), (pregnancy: [orgf]), (measurements: []), (dialkyl phosphates: [inch,phsu]), (metabolites: [bacs]), (residential proximity: [humn]), (op use: []), (californias pesticide use reporting (pur) data: [resa]), (associations: [menp]), (asd-related traits: [cgab]), (linear regression models: [qnco]), (parents: []), (teachers: []), (childs performance: [aggp]), (tests: [lbpr]), (ability: [orga]), (facial expressions: [fndg]), (mental state: [fndg]), (others: [fndg]), (years: []), (age: [orga]), (results: prenatal daps: [aapp]), (poorer parent: [grpa]), (teacher: [fndg]), (social behavior: [socb]), (10-fold dap increase: [aapp]), (2.7-point increase (95% confidence interval: [qnco]), (parent-reported social responsiveness scale: [acty]), ( version: []), (t-scores: [clna]), (clear evidence: [fndg]), (conclusions:: []), (findings: [clna]), (mixed evidence: [fndg]), (op pesticide exposures: [hops]), (developmental disorders: [mobd]), (subtle pesticide-related effects: [hops]), (population: [popg]), (ubiquitous exposure: [clna]), (rise: []), (cases: [qnco]), (diagnosed disorders: [dsyn]), (https://doi.org/10.1289/ehp2580: [fndg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(prenatal exposure, 'Exposures')(prenatal exposure, 'Exposures')(assessed organophosphate exposure, 'Exposures')(organophosphate exposure, 'Exposures')(years of age, 'Onset of Symptoms')(facial expressions, 'Integrated Verbal and NonVerbal Communication')(social behavior, 'Reciprocal Social Interaction')(organophosphate pesticide exposures, 'Exposures')(ubiquitous exposure, 'Exposures')

PMCID: 5915454
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (strong association: [menp]), (cannabis use: [plnt]), (schizophrenia: [mobd]), (underlying cellular links: [cell]), (neurons: [cell]), (human-induced pluripotent stem cells: [cell]), (platform: []), (baseline: [bodm]), (dynamic changes: [qnco]), (human neural cells: [lbtr]), (here: []), (hipscs: [cell]), (9-tetrahydrocannabinol (thc): [orch,phsu]), (diagnosis-specific differences: [qnco]), (vehicle-controls: [bodm]), (rna: [nnon]), (transcriptomic analyses: [lbpr,mbrt]), (thc: [gngm]), (acute: []), (chronic exposure: [clna]), (neuronal transcriptional response: [genf]), (potassium: [elii]), (chloride (kcl)-induced neuronal depolarization: [inch]), (thc-treated neurons: [orch,phsu]), (significant synaptic: [qnco]), ( mitochondrial: [celc]), (glutamate signaling alterations: [aapp,bacs]), (failure: [inbe]), (appropriately;: []), (response: [fndg]), (effects: []), (significant alteration: [qnco]), (thc-related genes: [gngm]), (autism: [mobd]), (intellectual disability: [mobd]), (molecular pathways: [moft]), (neuropsychiatric disorders: [dsyn]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(chronic exposure, 'Exposures')(autism, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')

PMCID: 5914043
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mercury (hg): [elii,hops]), (autism: [mobd]), (past: []), (suspected link: []), (vaccinations: [topp]), (thiomersal: [orch,phsu]), (review: []), (literature: [inpr,mnob]), (significant burden: [qnco]), (total quantity: [qnco]), (hg: [elii,hops]), (environment: []), (here: []), (avon longitudinal study: [resa]), (parents: []), (children (alspac): [aggp]), (prenatal exposure: [fndg]), (total maternal blood hg: [bdsu]), (first half: [fndg]), (pregnancy: [orgf]), (risk: []), (extreme levels: []), (autistic traits: [mobd]), (longitudinal study: [resa]), (date: []), (hypothesis: []), (one: [qnco]), (early pregnancy: [dsyn]), (direct comparison: [acty]), (pregnancies: [orgf]), (children: [aggp]), (diagnosed autism: [mobd]), (population: [popg]), ((2) comparison: [qnco]), (high scores: [qnco]), (risk (n~2800): [aapp,imft]), ((3) indirect measures: [qnco]), (association: [menp]), (outcomes: []), (proxies: [grup]), (hg levels: [elii,hops]), (frequency: [qnco]), (fish consumption: [fish]), (exposure: [clna]), (amalgam (n: [bodm,inch]), (logistic regression: [resa]), (social conditions: []), (maternal age: []), ( housing: []), (circumstances: []), ( maternal education: [fndg]), (parity: [fndg]), (interactions: []), (risks: []), (non-fish eaters: [fish]), (suggestion: []), (adverse effect: [patf]), (total prenatal blood hg levels: [bdsu]), (ci: [gngm]), (sd: [gngm]), (hg (p: [elii,hops]), (only indication: [qnco]), (adverse effects: [patf]), (measure: [qnco]), (poor social cognition: [grpa]), (mother ate: [dsyn]), (fish: [gngm]), (aor: [moft]), ([95% ci: [lbpr]), (offspring: [famg]), (fish-eaters (aor: [fish]), (study: [resa]), (prenatal total blood hg: [bdsu]), (mother ate fish: [dsyn]), (results: [fndg]), (other populations: [popg]), (evidence: []), (recommendation: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0215-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (vaccinations, 'Vaccination')(autism, 'Autism Phenotype')(prenatal exposure, 'Exposures')(autism, 'Autism Phenotype')(diagnosed autism, 'Autism Phenotype')(exposure, 'Exposures')(social conditions, 'Social Competence')(diagnosed autism, 'Autism Phenotype')(poor social cognition, 'Cognitive Ability')(offspring of fish-eaters (aor, 'Perinatal History')(offspring, 'Perinatal History')

PMCID: 5911435
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (cerebral palsy (cp): [dsyn]), (common motor disability: [fndg]), (childhood: []), (unchanging problems: [fndg]), (movement: [orgf]), ( posture: [orga]), (motor function: []), (heterogeneous clinical spectrum: [orga]), (frequent neurodevelopmental comorbidities: [ortf]), (aetiology: []), (cp: [gngm]), (recent reports: [hlca]), (genetic contribution: [acty]), (cases: [qnco]), (transcriptional dysregulation: [genf]), (pathways: [moft]), (patient-derived cell lines: [cell]), (unselected cohort: [popg]), (cp-affected individuals: [humn]), (differential expression analysis: [resa]), (weighted gene co-expression network analysis (wgcna): [orga]), (genes: [gngm]), (network modules: [popg]), (cp status: []), (asd: [cgab]), (transcriptome: [nusq]), (whole exome: [gngm]), ((wes) data: [euka]), (cp cohort: [popg]), (wes: [mbrt]), (collectively: []), (results: [fndg]), (convergent: [acty]), (molecular abnormality: [fndg]), 
ASD Terms: (common motor disability of childhood, 'Motor Skills')(common motor disability, 'Motor Skills')(motor function, 'Motor Skills')(frequent neurodevelopmental comorbidities, 'Learning Disorders')

PMCID: 5910592
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prevalence: [qnco]), (autism spectrum disorders: [mobd]), (recent decades: [qnco]), (efforts: [orgf]), (roles: [socb]), (environmental risk factors: []), (way: []), (widespread public health concern: [hlca]), (several epidemiological studies: [resa]), (associations: [menp]), (developmental exposure: [clna]), (traffic-related air pollution: [eehu]), (asd risk: [cgab]), (rodent models: [mamm]), (limited number: [qnco]), (studies: [lbpr]), (ultrafine particulates: [orch]), (diesel: []), (exhaust (de): [hops]), (behavioral phenotypes: [bhvr]), (mild asd: [cgab]), (series: [qnco]), (experiments: [resa]), (developmental de exposure: [clna]), (asd-related behaviors: [cgab]), (mice: [mamm]), (c57bl/6j mice: [mamm]), (embryonic day: [emst]), (postnatal day: []), (g/m3 de: [qnco]), (air (fa): [inch,phsu]), (control: [sbst]), (de: []), (deficits: []), (hallmark categories: []), (asd behavior:: [cgab]), (social interaction: [fndg]), (reciprocal interaction: []), (social preference tests: [lbpr]), (repetitive behavior: [fndg]), (t-maze: [topp]), (marble-burying test: [inch]), (altered communication: [socb]), (isolation-induced ultrasonic vocalizations: [npop]), (responses: [orga]), (social odors: [npop]), (findings: [clna]), (exposure: [clna]), (diesel-fuel combustion: [sbst]), (asd-related behavioral changes: [cgab]), (concern: []), (air pollution: [eehu]), (contributor: []), (onset: [qnco]), (asd: [cgab]), (humans: [humn]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s12989-018-0254-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(developmental exposure, 'Exposures')(developmental diesel exhaust exposure, 'Exposures')(social interaction, 'Reciprocal Social Interaction')(reciprocal interaction, 'Reciprocal Social Interaction')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(isolation-induced ultrasonic vocalizations, 'Vocalizations')(onset, 'Onset of Symptoms')(exposure, 'Exposures')

PMCID: 5902935
SFARI Genes: IL-6, IL-6, 
Non SFARI Genes: 
Named Entities: (alu elements: [bacs,nnon]), (group: [popg]), (repetitive elements: [nusq]), (gene expression: [genf]), (cpg residues: [bacs,nnon]), (transcription factor binding: [genf]), (altered gene expression: [genf]), (methylation profiles: [moft]), (various tissues: [tisu]), (cell lines: [cell]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (however: []), (role: [socb]), (asd: [cgab]), (altered gene expression profiles: [qnco]), (blood-based gene expression profiles: [qnco]), (gene expression omnibus database: [genf]), (human alu-inserted gene lists: [gngm]), (transpogene database: []), (genes: [gngm]), (study: [resa]), (human alu-inserted genes: [gngm]), (biological functions: [biof]), (networks: []), (alu-inserted degs: [gngm]), (ingenuity pathway analysis (ipa): []), (combined bisulfite restriction analysis: [inch,phsu]), (lymphoblastoid cell lines: [cell]), (age-matched unaffected individuals: [humn]), (global dna methylation levels: [moft]), (alu expression levels: [qnco]), (quantitative rt-pcr: [mbrt]), (asd blood: [cgab]), (blood-derived cells: [cell]), (alu-inserted genes: [gngm]), (biological function: [biof]), (pathway analysis: []), (neurodevelopmental disorders: [mobd]), (neurological functions: [ortf]), (asd etiology: [cgab]), (interestingly: []), ( estrogen receptor: [aapp,rcpt]), (androgen: [horm,phsu]), (pathways: [moft]), (sex bias: [socb]), (il-6 signaling: [celf]), (neuroinflammation: []), (alu methylation: [moft]), (age-matched control groups: [popg]), (alu methylation patterns: [moft]), (asd cases: [cgab]), (autism diagnostic: [mobd]), (interview-revised scores: [acty]), (matched controls: [resa]), (quantitative rt-pcr analysis: [lbpr]), (alu expression: [topp]), (significant differences: [qnco]), (asd subgroups: [cgab]), ( alu expression: [topp]), (methylation status: [moft]), (phenotypic asd subgroup: [cgab]), (expression: [topp]), (lcls: []), (findings: [clna]), (association: [menp]), (gene dysregulation: [gngm]), (asd blood samples: [cgab]), (further investigation: [hlca]), (moreover: []), (classification: []), (asd individuals: [cgab]), (subgroups: [virs]), (phenotypes: [orga]), (insights: [menp]), (unknown etiology: [fndg]), (underlying mechanisms: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0213-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(neurological functions, 'Neurologic Indications')(autism diagnostic, 'Autism Phenotype')(phenotypic asd subgroup, 'Autism Phenotype')

PMCID: 6044186
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (functional mri (fmri): [diap]), (convolution: []), (hemodynamic response function (hrf): [phsf]), (unmeasured latent neural signal: [phpr]), (however: []), ( hrf: [aapp,bacs]), (brain regions: [blor]), (subjects: [humn]), (variability: []), (non-neural factors: []), (aberrations: []), (neurochemical mechanisms: []), (control hrf shape: [aapp,bacs]), (autism spectrum disorders: [mobd]), (systematic differences: [fndg]), (hrf shape: [aapp,bacs]), (asd: [cgab]), (healthy controls: []), (corollary: []), (such alterations: []), (differences: [qnco]), (functional connectivity: []), (fmri space: [diap]), (neural space: []), (hypotheses: []), (blind deconvolution: [fndg]), (resting-state fmri time series: [diap]), (large number: [qnco]), (autism brain imaging data exchange (abide) database (n: [mobd]), (many brain regions: [blor]), (autism: [mobd]), (specifically: []), (precuneus: [bpoc]), (hrf parameters: [fndg]), (consequently: []), (precuneus-seed-based functional connectivity differences: [plnt]), (controls: [sbst]), (fmri: [diap]), (latent neural signals: [phpr]), (non-deconvolved fmri data: [diap]), (group differences: [popg]), (connectivity: []), (certain brain regions: [blor]), (deconvolved data: [euka]), (results: [fndg]), (understanding: [menp]), (neurochemical aberrations: []), (methodological implications: []), (resting-state functional connectivity studies: [lbpr]), (disorders: [dsyn]), (neurochemical alterations: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism brain imaging data exchange database, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5899373
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (eu-aims: [orgt]), (european research program: [resa]), (stratification biomarkers: [clna]), (novel interventions: [hlca]), (autism spectrum disorder (asd): [mobd]), (program: [phsu]), (longitudinal european autism project (leap): [mobd]), (rare sample: [sbst]), (dizygotic twins: [famg]), ( discordant: []), (concordant: [socb]), (asd: [cgab]), (twins: [famg]), (aim: [phsu]), (letter: [clna]), (previous descriptions: []), (leap case-control sample: [sbst]), (suitability: []), (sample: [sbst]), (twin-control analyses purposes: [famg]), (share: [socb]), (lessons: []), (diagnosis: [fndg]), (increased symptom levels: [qnco]), (adhd: [mobd]), (rates: [qnco]), (intellectual disability: [mobd]), (family income: [famg]), (future: []), (leap twin cohort: [famg]), (multiple options: [qnco]), (analyses: [resa]), (non-shared environmental factors: [socb]), (new hypotheses: []), (cohort: [popg]), (leap singletons: [fndg]), (refine evidence: [acty]), (it: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0212-x) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(longitudinal european autism project, 'Autism Phenotype')(diagnosis, 'Diagnosis')(adhd, 'Attention Deficit Disorder with Hyperactivity')(rates of intellectual disability, 'Learning Disorders')(longitudinal european autism project case-control sample, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(longitudinal european autism project, 'Autism Phenotype')

PMCID: 5911343
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (beta-synuclein (-synuclein): [aapp,bacs]), (presynaptic proteins: [aapp,bacs]), (important roles: [socb]), (neuronal plasticity: [ortf]), (synaptic vesicle regulation: [celc]), (association: [menp]), (proteins: [aapp,bacs]), (autism spectrum disorder: [mobd]), (-synuclein levels: [aapp,bacs]), (male children: [aggp]), (asd (2: [cgab]), (autism: [mobd]), ((pdd-nos)) comparing: [dsyn]), (age-matched controls: [orga]), (enzyme-linked immunosorbent assay (elisa): [lbpr]), (levels: []), (asd subgroups: [cgab]), (significant differences: [qnco]), (plasma -synuclein: [aapp,bacs]), (pdd-nos groups: [dsyn]), (thus: []), (subgroups: [virs]), (asd group: [cgab]), (interestingly: []), (mean plasma -synuclein level: [bdsu]), ((p: [aapp,imft]), (asd children: [cgab]), (ng/ml): [qnco]), (controls: [sbst]), (first study: [qnco]), (associations: [menp]), (male asd patients: [cgab]), (alterations: []), (synaptic abnormalities: [cgab]), (asd pathogenesis: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5881179
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recurrent: []), (kb: []), (microdeletion: []), (genetic etiologies: [topp]), (autism spectrum disorder: [mobd]), ( overweightness: [sosy]), (related neurodevelopmental disorders: [mobd]), (case presentation: []), (patient: [podg]), (2-year-old white girl: [popg]), (first pregnancy: [fndg]), (non-consanguineous healthy young white couple: [fndg]), (mother 29-years old): [famg]), (parents dna: [bacs,nnon]), (comparative genomic hybridization-array platform: [mbrt]), (comparative genomic hybridization-array analysis: [mbrt]), (kb deletion: [genf]), (region: []), (segregant nature: []), (mother: [famg]), (2-year-old daughter: [famg]), (fluorescence: [npop]), (situ hybridization analysis: [mbrt]), (presented clinical case: []), (note: [clna]), (observed microdeletion: []), (clinical phenotype: [orga]), (proband (female): [orga]), (poor height: [grpa]), (weight development: [orga]), (anorexia: [dsyn]), (moreover: []), (observed genomic abnormality: [gngm]), (phenotypic variability: [fndg]), (daughter: [famg]), (case: []), (phenotypical spectrum: [qnco]), (reasons: []), (presence: [qnco]), (suspected genetic pathology: [patf]), (proband: [famg]), (clinical point: [qnco]), (view: []), (clinical observation: [hlca]), (parents: []), (good family anamnesis: [ortf]), (way: []), (familial genetic pathology: [patf]), (phenotypical outcomes: []), (members: [popg]), (family: [famg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(related neurodevelopmental disorders, 'Learning Disorders')

PMCID: 5879542
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, shank3, shank3, homer1, homer1, homer1, homer1, SHANK3, SHANK3, 
Non SFARI Genes: 
Named Entities: (human: [humn]), (genomic studies: [gngm]), (strong causal role: [socb]), (shank3 deficiency: [dsyn]), (autism spectrum disorder (asd): [mobd]), (however: []), (molecular mechanism: []), (asd: [cgab]), (zebrafish: [fish]), (attractive organism: [orgm]), (high efficiency: [qnco]), (genetic manipulation: [mbrt]), (robust behavioral phenotypes: [bhvr]), (orthologous gene: [gngm]), (human shank3: [humn]), (zebrafish genome: [fish]), (homologs: [gngm]), ( shank3a: []), (shank3b: []), (previous studies: [lbpr]), (shank3 morphants: [aapp]), (morpholino method: [nnon]), (here: []), (generation: [acty]), (characterization: [acty]), (mutant zebrafish: [fish]), (larval: [euka]), (adult stages: [aggp]), (crispr/cas9 genome: [nnon]), (technique: []), (crispr/cas9: [nnon]), (shank3b loss-of-function mutation (shank3b/): [phsf]), (series: [qnco]), (morphological measurements: []), (behavioral tests: [diap]), (molecular analyses: [mbrt]), (molecular changes: [qnco]), (shank3b mutant zebrafish: [fish]), (shank3b/ zebrafish: [fish]), (abnormal morphology: [fndg]), (early development: [orgf]), (reduced locomotor activity: [hlca]), (larvae: [euka]), (adults: [aggp]), (social interaction: [fndg]), (time: []), (conspecifics: []), (significant repetitive swimming behaviors: [dora]), (levels: []), (postsynaptic homer1: [gngm]), (presynaptic synaptophysin: [aapp,bacs]), (adult brain: [bpoc]), (shank3b-deficient zebrafish: [fish]), (first inheritable shank3b: [qnco]), (mutant zebrafish model: [fish]), (crispr/cas9 gene: [nnon]), (approach: []), (robust autism-like behaviors: [mobd]), (altered levels: []), (synaptic proteins homer1: [aapp,bacs]), (synaptophysin: [aapp,bacs]), (versatility: []), (model: []), (neurodevelopment: [ortf]), (drug screening: [resa]), (significant contribution: [acty]), (future studies: [lbpr]), (human shank3 function: [aapp]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0204-x) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(exhibited abnormal morphology in early development, 'Learning Disorders')(social interaction, 'Reciprocal Social Interaction')(significant repetitive swimming behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 5872584
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (severe neurodevelopmental disorder: [mobd]), (deficits: []), (social communication: [socb]), (repetitive behaviors: [fndg]), ( interests: [menp]), (activities: [acty]), (etiology: []), (asd: [cgab]), (environmental risk factors: []), (epigenetic processes: [genf]), (mechanism: []), (non-genetic variation influence gene regulation: [genf]), (pathogenesis: [patf]), (aim: [phsu]), (study: [resa]), (dna methylation biomarkers: [moft]), (asd detectable: [cgab]), (birth: [orgf]), (neonatal methylomic variation: []), (infantsof: []), (asdusing dna: [bacs,nnon]), (blood spots: [neop]), (genotype data: [orga]), (same individuals: [humn]), (molecular consequences: []), (asd-associated: [cgab]), (genetic risk variants: [npop]), (methylomic variation: []), (elevated polygenic burden: [genf]), (addition: []), (dna methylation: [moft]), (quantitative trait loci (mqtl) mapping: [gngm]), (target genes: [gngm]), (asd gwas findings: [cgab]), (robust epigenetic signatures: [amas]), (gestational age: [orga]), (prenatal tobacco exposure: [plnt]), (utility: [orgt]), (dna methylation data: [moft]), (neonatal blood spots: [neop]), (specific loci: [gngm]), (robust differences: [qnco]), (neonatal dna methylation: [moft]), (significant association: [menp]), (polygenic burden: [genf]), (autism: [mobd]), (unit: [qnco]), (elevated asd polygenic risk score: [cgab]), (mean increase: [qnco]), (cpg sites: [bacs,nnon]), (robust gwas signal: [mbrt]), (chromosome: [celc]), (analysis: [resa]), (asd undertaken: [cgab]), (epigenetic variation: []), (polygenic risk score: [clna]), (molecular variation: []), (disease: [dsyn]), (mqtl: []), (regulatory variation: []), (asd risk variants: [cgab]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13073-018-0527-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(severe neurodevelopmental disorder, 'Learning Disorders')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(gestational age, 'Perinatal History')(prenatal tobacco exposure, 'Exposures')(autism, 'Autism Phenotype')

PMCID: 5985734
SFARI Genes: Fmr1, Fmr1, Fmr1, Fmr1, Fmr1, Fmr1, Fmr1, Fmr1, 
Non SFARI Genes: 
Named Entities: (abstract fragile x syndrome (fxs): [cgab,dsyn]), (monogenic form: []), (intellectual disability: [mobd]), (autism spectrum disorder: [mobd]), (absence: [anab]), (fragile x: [comd]), (mental retardation protein (fmrp): [aapp,bacs]), (biological models: []), (disease: [dsyn]), (upregulated mrna translation: [moft]), (consequence: []), ( deficits: []), (synaptic architecture: []), (plasticity: [npop]), (preclinical studies: [resa]), (pharmacological interventions: [hlca]), (deficits: []), (fxs cognitive: []), (behavioral symptoms: [sosy]), (here: []), (rate: [qnco]), (protein synthesis: [moft]), (patients: [podg]), (fxs: []), (relationship: []), (clinical severity: []), (fibroblasts: [cell]), (individuals: [humn]), (controls: [sbst]), (primary neurons: [cell]), (fmr1 ko mice: [mamm]), (levels: []), (however: []), (cellular phenotype: [orga]), (broad distribution: []), (proportion: [qnco]), (fragile x individuals: [humn]), (increased levels: [qnco]), (measures: [qnco]), (normal range: [qnco]), (same fmr1 ko: [bdsy]), (animal measures: [anim]), (neurons: [cell]), (validity: [qnco]), (peripheral biomarker: [clna]), (study: [resa]), (potential explanation: []), (comprehensive drug development program: [hlca]), (negative results: [fndg]), (significant proportion: [qnco]), (reduction: [npop]), (excessive levels: []), 
ASD Terms: (monogenic form of intellectual disability, 'Learning Disorders')(abstract fragile x syndrome, 'Fragile X Syndrome')(intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(fragile x, 'Fragile X Syndrome')(mental retardation protein, 'Mental Retardation')(fragile x, 'Fragile X Syndrome')(fragile x syndrome, 'Fragile X Syndrome')(fragile x, 'Fragile X Syndrome')(fragile x individuals, 'Fragile X Syndrome')(fragile x, 'Fragile X Syndrome')

PMCID: 5859484
SFARI Genes: TYR, PCCB, TYR, PCCB, CADM1, ASMT, CADM1, ASMT, 
Non SFARI Genes: GJB2, TPP1, SLC25A15, NDUFV2, PNPLA4, HBB, SOS1, SFTPC, OTC, 
Named Entities: (chromosomal microarray analysis (cma): [celc]), (first-tier clinical diagnostic test: [diap]), (individuals: [humn]), (developmental disabilities: [mobd]), (addition: []), (copy number variations: [nusq]), ( cma: [celf]), (single nucleotide polymorphism probes: [nusq]), (large homozygous regions: [orga]), (genome: [gngm]), (potential risk: []), (disorders: [dsyn]), (frequency: [qnco]), (pathogenic: [fndg]), (likely pathogenic variants: [fndg]), (regions: []), (homozygosity: [orga]), (whole exome: [gngm]), ((wes): [mbrt]), (cma: [celf]), (patients: [podg]), (clinical laboratory: [hlca]), (variety: []), (neurodevelopmental conditions: [dsyn]), (autism spectrum disorder: [mobd]), (developmental delay: [mobd]), (intellectual disability: [mobd]), (microcephaly: [cgab,dsyn]), ((6/53): []), (cases: [qnco]), (analysis: [resa]), (homozygous variants: [orga]), (gjb2: [gngm]), ( tpp1: [gngm]), ( slc25a15: [gngm]), ( tyr: [aapp,enzy]), ( pccb: [gngm]), (ndufv2: [gngm]), (diseases: [dsyn]), (evaluation: [hlca]), (heterozygous variants: [orga]), (autosomal dominant inheritance: [genf]), ( compound heterozygotes: [orga]), (variants: []), (x-linked inheritance: [genf]), (pnpla4: [gngm]), ( cadm1: [aapp,imft]), ( hbb: []), ( sos1: [gngm]), ( sftpc: [gngm]), ( otc: [phsu]), (asmt: [gngm]), ((8/53): []), (phenotypes: [orga]), (otc; gjb2: [phsu]), (asmt): [gngm]), (study: [resa]), (clinical utility: [orgt]), (wes: [mbrt]), (cma uncovers: [celf]), (phenotype: [orga]), (homozygosity levels: [orga]), (high: [qnco]), ( wes: [mbrt]), (significant number: [qnco]), (relevant variants: []), (neurodevelopmental phenotypes: [orga]), (mutations: [genf]), (appropriate: []), (test: [lbpr]), (sequencing: [mbrt]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s12881-018-0555-3) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (developmental disabilities, 'Learning Disorders')(neurodevelopmental conditions, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(developmental delay, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(neurodevelopmental phenotypes, 'Learning Disorders')

PMCID: 5857311
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (serious neurodevelopmental disorders: [mobd]), (population: [popg]), (disorders: [dsyn]), (genetics: []), (several recent linkage analyses: [lbpr]), (copy number variations: [nusq]), (autism risk: [mobd]), (microdeletion: []), (region: []), (pathogenic copy number variation: [nusq]), (developmental delays: [mobd]), (congenital heart defects: [cgab]), ( dysmorphism: [cgab]), (various psychiatric disorders: [mobd]), (cases: [qnco]), (chromosomal deletion: [comd]), (them: []), (autistic phenotype: [mobd]), (case presentation: []), (case: []), (44-month-old caucasian girl: [popg]), (global development delay: [fndg]), (associated organ anomalies: [bpoc]), (different workups: []), (atypical phenotype: [orga]), (preserved relational competency: [lbpr]), (imitation abilities: [orga]), (main contribution: [acty]), (case report: [clna]), (precise description: []), (deletion: [genf]), (atypical clinical features: [clna]), (markers: [clna]), (genetic anomaly: [fndg]), (pathophysiology: [patf]), (autism: [mobd]), (incomplete penetrance: [fndg]), (variable expressivity: [fndg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(serious neurodevelopmental disorders, 'Learning Disorders')(autism risk, 'Autism Phenotype')(developmental delays, 'Learning Disorders')(various psychiatric disorders, 'Mental Disorders')(autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(global development delay, 'Learning Disorders')(imitation abilities, 'Imitation')(autism, 'Autism Phenotype')

PMCID: 5854306
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (interactions: []), (important role: [socb]), (childrens early development: [orgf]), (young children: [aggp]), (brother: [famg]), (sister: [famg]), (autism spectrum disorder (asd): [mobd]), (study: [resa]), (naturalistic: []), ( observational method: [resa]), (18-month-old infants: [aggp]), (asd (n: [cgab]), (control group: [grup]), ((n: [aapp,imft]), (addition: []), ( role (a)symmetry: [socb]), (influence: []), (gender: [orga]), (asd-dyads: [cgab]), (levels: []), (negativity: [fndg]), ( role asymmetry: [socb]), (groups: [popg]), (child: [aggp]), (dominant position: []), (finally: []), ( siblings pairs: [famg]), (positive behaviours: [inbe]), (differences: [qnco]), (developmental trajectories: [orgf]), (early relationships: []), (account: [clna]), (future asd research: [cgab]), (interventions: [hlca]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 6071802
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background: previous studies: [lbpr]), (associations: [menp]), (perinatal exposure: [hcpp]), (air: [gngm]), (metals: [inch]), (volatile organic compounds: [orch]), (autism spectrum disorder (asd): [mobd]), (objectives:: []), (goal: []), (further explore associations: [menp]), (perinatal air toxics: [inch,phsu]), (asd: [cgab]), (quantitative traits: [gngm]), (high-risk multiplex families: [famg]), (methods:: []), (participants: [popg]), (u.s: []), (family-based study: [diap]), (autism genetic resource exchange (agre)]: [mobd]), (address information: []), (average annual concentrations: [qnco]), (birth: [orgf]), (air toxics: [inch,phsu]), (u.s. epa: []), (emissions-based national-scale air: [inch,phsu]), (assessment: [acty]), (a) asd diagnosis (1: [cgab]), (540 cases: [qnco]), (controls); b): [sbst]), (continuous measure: [qnco]), (autism-related traits: [mobd]), (social responsiveness scale (srs: [acty]), (cases: [qnco]), (controls);: [sbst]), (measure: [qnco]), (autism: [mobd]), (calibrated severity score: [qnco]), (cases): [qnco]), (addition: []), (individuals air: [inch,phsu]), (toxic level: [phsu]), (mixed models: [fndg]), (family): [famg]), (family: [famg]), ( birth year: []), (census covariates: [qnco]), (consideration: [fndg]), (false discovery rate: [qnco]), (results: asd diagnosis: [cgab]), (propionaldehyde: [hops,orch]), ( methyl tert-butyl ether (mtbe): [orch,phsu]), (1: [fndg]), (4-dioxane: [irda,orch]), ( dibenzofurans: [orch]), (glycol ethers: [orch]), (4-dichlorobenzene: [hops,orch]), ( 4: [fndg]), (4-methylene diphenyl diisocyanate (mdi): [mobd]), ( benzidine: [hops,orch]), (ethyl carbamate (urethane): [orch,phsu]), (two-pollutant models: [hops]), (autism severity: [mobd]), (carbon disulfide: [hops,inch]), (chlorobenzene: [orch,phsu]), (srs: [gngm]), (conclusions:: []), (asd risk: [cgab]), (severity: []), (traffic-related air pollutants: [hops]), (newly-reported associations: [menp]), (https://doi.org/10.1289/ehp1867: [fndg]), 
ASD Terms: (perinatal exposure, 'Perinatal Exposures')(autism spectrum disorder, 'Autism Phenotype')(perinatal air toxics, 'Perinatal Exposures')(autism, 'Autism Phenotype')(a) asd diagnosis, 'Diagnosis')(asd diagnosis, 'Diagnosis')(autism severity, 'Autism Phenotype')

PMCID: 5845860
SFARI Genes: 
Non SFARI Genes: TMEM132C, 
Named Entities: (empathy: [inbe]), (ability: [orga]), (emotional states: [menp]), (other individuals: [humn]), (important psychological process: [phpr]), (social interactions: [fndg]), (relationships: []), (several psychological studies: [lbpr]), (difficulties: [fndg]), (performance-based measures: []), (range: [qnco]), (psychiatric conditions: [mobd]), (study: [resa]), (genetic architecture: [topp]), (genome-wide association studies: [mbrt]), (results: [fndg]), (gwas: [mbrt]), (date: []), (well-validated self-report measure: [resa]), (empathy quotient (eq): [inbe]), (research participants: [resa]), (inc: []), (suggestive loci (p: [aapp,imft]), (none: []), (p <: [aapp,imft]), (multiple testing: [qnco]), (significant snp: [nusq]), (non-stratified analysis (rs4882760; p: [aapp,imft]), (intronic snp: [nusq]), (tmem132c: [gngm]), (eq: [qnco]), (significant narrow-sense heritability (0.11: [ortf]), (p: [gngm]), (predicted: [qnco]), (work: []), (significant female advantage: [orga]), (eq (p: [qnco]), (cohens d: []), (similar snp heritability: [nusq]), (high genetic correlation: [qnco]), (sexes: [orgf]), (also: []), (significant negative genetic correlation: [fndg]), (autism: [mobd]), (eq (rg = 0.27: [gngm]), (significant positive genetic correlation: [fndg]), (risk: []), (schizophrenia (rg: [mobd]), (anorexia nervosa (rg =: [mobd]), (extraversion (rg: [menp]), (first gwas: [mbrt]), (self-reported empathy: [inbe]), (genetic variations: [npop]), (role: [socb]), (psychological traits: [gngm]), 
ASD Terms: (empathy, 'Empathy')(social interactions, 'Reciprocal Social Interaction')(empathy, 'Empathy')(range of psychiatric conditions, 'Mental Disorders')(psychiatric conditions, 'Mental Disorders')(empathy, 'Empathy')(empathy, 'Empathy')(empathy quotient, 'Empathy')(autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(self-reported empathy, 'Empathy')(role in psychiatric conditions, 'Mental Disorders')

PMCID: 5840789
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (inefficient: []), (diagnostic practices: [menp]), (autism spectrum disorder (asd): [mobd]), (times: [qnco]), (access: []), (objectives: []), (canadian pediatricians: [fndg]), (determinants: []), (wait time: []), (asd diagnosis: [cgab]), (online survey: []), (canadian paediatric societys: [fndg]), (developmental pediatrics: [hlca]), ( community pediatrics: [hlca]), (mental health sections: [menp]), (participants: [popg]), (demographic information: []), (asd: [cgab]), (elements: [elii]), (diagnostic assessment: [diap]), (multiple linear regression: [qnco]), (total wait time (time: [qnco]), (communication: [socb]), (diagnosis: [fndg]), (family): [famg]), (function: [phsf]), (practice characteristics: [menp]), (conducted: [inbe]), (total: [qnco]), (survey: []), (practices: [menp]), (respondents: [popg]), (varied use: []), (multi-disciplinary teams: [hlca]), (participation: []), (team: [grup]), (composed teams: [grup]), (reported: [hlca]), (use: []), (diagnostic tools: [fndg]), (tools: []), (median: [qnco]), (total wait: [qnco]), (asd diagnosis time: [cgab]), (months: []), (months): []), (time: []), (assessment: [acty]), (only variable: [qnco]), (multiple regression (p: [aapp,imft]), (affect wait time: [menp]), (canadian asd: [cgab]), (assessments: [hlca]), (substantial7 months: []), (time spent: [qnco]), (significant determinant: [qnco]), (need: []), (efficient assessment practices: [menp]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0201-0) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(asd diagnosis, 'Diagnosis')(asd diagnosis time, 'Diagnosis')(diagnosis, 'Diagnosis')

PMCID: 5840786
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (male predominance: [fndg]), (prevalence: [qnco]), (autism spectrum disorder (asd): [mobd]), (research: [resa]), (sex differentiation: [ortf]), (asd: [cgab]), (multiple sources: [fndg]), (evidence: []), (neurophenotypic convergence: [acty]), (asd-related characteristics: [cgab]), (typical sex differences: [orga]), (competing: []), ( models: []), (predictions: []), (such neurophenotypic: []), (models: []), (neuroimaging: [diap]), (specifically: []), (extreme male brain (emb) model: [orga]), (enhanced brain maleness: [orga]), (males: [orga]), (females: [orga]), (shift-towards-maleness): [orga]), (contrast: [irda]), (gender incoherence (gi) model: [orga]), (shift-towards-maleness: [orga]), (shift-towards-femaleness: [orga]), (model applies: []), (intrinsic functional properties: []), (brain: [bpoc]), (statistical overlap: [topp]), (asd-related atypicalities: [cgab]), (resting-state fmri (r-fmri) datasets: [diap]), (main analyses: [resa]), (large-scale r-fmri samples:: [diap]), (neurotypical (nt) males: [orga]), (nt females: [diap]), (functional connectome project: [anst]), (nt males: [diap]), (autism brain imaging data exchange: [mobd]), (r-fmri metrics: [orch,phsu]), ( results: [fndg]), (default network: [popg]), (somatomotor network: [popg]), (explorations: [topp]), (associated cognitive processes: [menp]), (available cognitive ontology maps: [aapp,bacs]), (higher-order social cognitive functions: [menp]), (lower-order sensory motor processes: [blor]), (present findings: [clna]), (atypical intrinsic brain properties: [bpoc]), (mechanisms: []), (sexual differentiation: [ortf]), (model: []), (network-dependent atypical sex mosaicism: [orga]), (theories: []), (factors: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0192-x) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism brain imaging data exchange, 'Autism Phenotype')(associated cognitive processes, 'Cognitive Ability')(available cognitive ontology maps, 'Cognitive Ability')(higher-order social cognitive functions, 'Ability to Converse in Social Settings')

PMCID: 5838237
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neuropsychiatric disorder: [dsyn]), (strong evidence: []), (genetic contribution: [acty]), (research efforts: [resa]), (ever-growing list: []), (asd candidate genes: [cgab]), (however: []), (fraction: [qnco]), (hundreds: []), (nominated asd-related genes: [cgab]), (loss: [qnco]), (function (lof) mutations: [phsf]), (disorder: [dsyn]), (reason: []), (means: []), (candidate genes: [gngm]), (asd: [cgab]), (false-positive results: [fndg]), (allow researchers: [socb]), (genes: [gngm]), (machine: []), (model: []), (brain-specific functional relationship network (frn): [popg]), (genome-wide ranking: [gngm]), (asd risk genes: [cgab]), (gene: [gngm]), (results: [fndg]), (multiplex asd families: [cgab]), (finally: []), (functional enrichment analysis: [hlca]), (candidate gene: [gngm]), (small number: [qnco]), (pathways: [moft]), (early neural development: [orgf]), (further support: []), (potential role: [socb]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 6019410
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (concerns: []), (need: []), (translational aspects: [qnco]), (genetics research studies: [resa]), (community members: [popg]), (research process: [resa]), (literature: [inpr,mnob]), (patient advocates: [podg]), (addition: []), (work: []), (patient advocacy: [hlca]), (groups: [popg]), ( organizations: [orgt]), (patient-centered outcomes research institute advocate: [hlca]), (change: [qnco]), (culture: [lbpr]), (research: [resa]), (project: []), ( autism genetics: [mobd]), (outcomes (autgo): []), (phases: [euka]), (goal: []), (phase: []), (general discussion: [socb]), (main topic (i.e.: [diap,inpr]), (genetics: []), (outcomes: []), (patient-centered outcomes research institute engagement approach: [hlca]), (partnership: [orgt]), (wide range: [qnco]), (stakeholders: []), (perspective: []), (projects: []), (outcomes research data/principles;: [resa]), (identify barriers: []), ( facilitators: []), (engagement: [fndg]), (patient-centered genetics research;: [resa]), (distill: []), (describe actions: []), (utilization: []), (patient/parent perspectives: [podg]), (phase i: []), (community: []), (advisory board: [orgt]), (participants: [popg]), (clinicians: []), ( healthcare: [hlca]), (members: [popg]), (community/industry representatives: [acty]), (sessions: [evnt]), (12-month period: []), (combination: [fndg]), (online powerpoint presentations: []), ( surveys: []), (in-person group discussions: [socb]), (topics: []), (outcomes research: [resa]), (relevant materials: [sbst]), (patient stories: [podg]), ( research projects: [resa]), (resources: []), (sets: [menp]), (surveys: []), ( project evaluations: [hlca]), (session evaluations: [hlca]), (feedback: [phpr]), (content analysis strategies: [menp]), (themes: []), (subthemes: []), (herein: []), (partnership (aim: [phsu]), (barriers: []), (lessons: []), (recommendations: []), (research community: [resa]), (recommendation: []), (phase ii: []), (specific disease (i.e.: [dsyn]), (projected plan: [dsyn]), (potential significance: [qnco]), (study limitations: [resa]), ( challenges: [hlca]), (type: [qnco]), (multidisciplinary work: []), (potential ways: []), (them: []), (autgo project: []), (unique collaborative forum: [socb]), (dialogue: []), (ways: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1007/s40271-018-0302-z) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism genetics, 'Autism Phenotype')(projected plan, 'Planning')

PMCID: 5835496
SFARI Genes: NLGN3, NLGN3, PSD-95, PSD-95, 
Non SFARI Genes: 
Named Entities: (synaptic abnormalities: [cgab]), (individuals: [humn]), (autism spectrum disorders: [mobd]), (cell-adhesion molecule neuroligin-3 (nlgn3): [gngm]), (essential role: [socb]), (function: [phsf]), (maturation: [phsf]), (synapses: [bsoj]), (nlgn3 asd-associated mutations: [cgab]), (cortical function: [bpoc]), (wnt/-catenin: [aapp,bacs]), (increases nlgn3 mrna: [bacs,nnon]), (protein levels: [lbtr]), (ht22 mouse hippocampal cells: [mamm]), (primary cultures: [topp]), (rat: [mamm]), (hippocampal neurons: [cell]), (activity: [acty]), (mouse: [mamm]), (rat nlgn3 promoter constructs: [mamm]), (putative t-cell factor/lymphoid: [cell]), (factor: []), ((tcf/lef)-binding elements (tbe): [elii]), (wnt/-catenin cell reporter assays: [aapp,bacs]), (chromatin immunoprecipitation (chip) assays: [lbpr]), (site-directed mutagenesis experiments: [genf]), (endogenous -catenin binds: [aapp,bacs]), (tbe consensus sequences: [nusq]), (nlgn3 promoter: [bacs,nnon]), (moreover: []), ( activation: [acty]), (cascade: []), (nlgn3 clustering: [resa]), (co- localization: [biof]), (scaffold psd-95 protein: [aapp,bacs]), (dendritic processes: [celc]), (primary neurons: [cell]), (results: [fndg]), (transcription: [genf]), (nlgn3 gene: [gngm]), (functional role: []), (pathway: [moft]), (dysregulation: []), (excitatory/inhibitory neuronal activity: [acty]), (animal models: [anim]), (asd: [cgab]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 5934305
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent generation: [acty]), (family studies: [famg]), (autism: [mobd]), (array: []), (neurobehavioural susceptibilities: [clna]), (syndrome: [dsyn]), (partially-independent sets: [menp]), (genetic variation: [npop]), (liabilities: []), (significant share: [socb]), (heritability: []), (contribute: [acty]), (severity: []), (autism itself: [mobd]), (genetic variants: [npop]), (traits: [gngm]), (diagnosis: [fndg]), (personalized approaches: []), (intervention: [hlca]), (epiphenomenon: []), (earlier-interacting susceptibilities: [clna]), (implications: []), (neurobehavioural degeneration: [patf]), (notion: []), (critical co-aggregation: [qnco]), (earlier-interacting neuropsychiatric liabilities: []), (phenotypic expression: [orga]), (sex: [orgf]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism itself, 'Autism Phenotype')(autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')

PMCID: 5833085
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (group: [popg]), (neurodevelopmental disorders: [mobd]), (core symptoms:: [sosy]), (social interaction: [fndg]), (communication: [socb]), (repetitive behaviors: [fndg]), (interests: [menp]), (pathophysiology: [patf]), (asd: [cgab]), (plethora: [fndg]), (environmental risk factors: []), (causal: []), (recent findings: [clna]), (putative convergent pathway: [moft]), (forms: []), (downregulation: [moft]), (calcium-binding protein parvalbumin (pv): [aapp,bacs]), (pv-deficient mice (pv/: [neop]), ( pv+/): [neop]), (shank1/: [gngm]), ( shank3/: [aapp]), (vpa: []), (behavioral deficits: [inbe]), (human asd core symptoms: [humn]), (pv expression levels: [neop]), (hypothesis: []), (pv expression: [neop]), (17- estradiol (e2): [horm,orch,phsu]), ( pv+/ mice: [mamm]), (e2: [gngm]), (postnatal days: []), (asd-related behavior: [cgab]), (e2 treatment and: [topp]), ( concomitantly: []), ( sociability deficits: [socb]), (pv+/ mice: [mamm]), (direct reciprocal social interaction: [fndg]), (3-chamber social approach assay: [lbpr]), (e2 treatment: [topp]), (pv+/+ mice: [mamm]), (pv levels: [neop]), (detrimental effects: []), (sociability: [socb]), (repetitive behavior: [fndg]), (pv/ mice: [mamm]), ( e2: [moft]), (pv levels;: [neop]), (behaviors: [inbe]), (ones: [qnco]), (vehicle-treated pv/ mice: [mamm]), (results: [fndg]), (e2-linked amelioration: [moft]), (asd-like behaviors: [cgab]), (pv upregulation: [neop]), (e2-mediated rescue: [moft]), (asd-relevant behavioral impairments: [cgab]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0199-3) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(behavioral deficits, 'Personal Traits')(human asd core symptoms, 'Complaints and Indications')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(direct reciprocal social interaction, 'Reciprocal Social Interaction')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(asd-like behaviors, 'Autism Phenotype')(estradiol-mediated rescue of asd-relevant behavioral impairments, 'Personal Traits')(asd-relevant behavioral impairments, 'Personal Traits')

PMCID: 5824550
SFARI Genes: Met, Met, Met, Met, Met, Met, Met, Met, Met, Met, Met, Met, 
Non SFARI Genes: IV, 
Named Entities: (met receptor tyrosine kinase: [aapp,enzy,rcpt]), (neurogenesis: [orgf]), ( differentiation: [celf]), ( migration: [phpr]), ( connectivity: []), (synaptic plasticity: [ortf]), (human met gene: [humn]), (prominent risk factor: [qnco]), (autism spectrum disorder (asd): [mobd]), (met: [gngm]), (gene-altered mice serve: [mamm]), (useful models: []), (mechanistic studies: []), (asd: [cgab]), (inactivation: []), (excitatory cortical neurons: [bpoc]), (mice (emx1cre/met flox mice): [mamm]), (phenotype: [orga]), (gabaa: []), (receptor-mediated inhibition: [celf]), (excitation/inhibition (e/i) balance: [acty]), (excitation: [acty]), (somatosensory cortex: [bpoc]), (further: []), (wild-type mice: [mamm]), ( insulin: [aapp,horm,phsu]), (inhibition: [acty]), (mutant cortex: [bpoc]), (consequences: []), (kinase: [aapp,enzy]), (inactive met gene: [gngm]), (desensitization: [topp]), (insulin receptors: [aapp,enzy,rcpt]), (hypothesis: []), (effects: []), (insulin receptor sensitizer: [aapp,enzy,rcpt]), ( pioglitazone: [orch,phsu]), (somatosensory thalamocortical circuitry: []), (whole-cell patch clamp electrophysiology: [celf]), (analyzed excitatory: [resa]), (inhibitory responses: [acty]), (cortical layer iv excitatory cells: [bpoc]), (stimulation: [npop]), (thalamic input: [bpoc]), (thalamocortical pathway: [moft]), (intact brain slices: [sbst]), (thiazolidinedione: [orch,phsu]), ( pioglitazone (pio): [orch,phsu]), (gabaa receptors: [aapp,rcpt]), (emx1cre/met flox mice: [mamm]), (wt brain: [bpoc]), (slices: [sbst]), ( application: [qnco]), (insulin: [aapp,horm,phsu]), (pio: [orch,phsu]), (effect: []), (insulin alone: [aapp,horm,phsu]), (contrast: [irda]), ( pio application: [orch,phsu]), (met-defective cortex: [bpoc]), (thus: []), ( insulin resistance: [patf]), (receptor-mediated response: [menp]), (mutant mice: [mamm]), (desensitized insulin receptors: [aapp,enzy,rcpt]), (sporadic clinical studies: [resa]), (improved behavioral symptoms: [sosy]), (children: [aggp]), (autism: [mobd]), (pio treatment: [orch,phsu]), (normalization: [resa]), (e/i balance: [inch]), (primary somatosensory cortex: [bpoc]), (potential physiological mechanism: []), (positive effects: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5819172
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (etiology: []), (autism spectrum disorders: [mobd]), (mitochondrial dysfunction: [fndg]), (asd; however: [cgab]), (primary mitochondrial disease: [celc]), (small subset: [qnco]), (patients: [podg]), (main goal: []), (present study: [qnco]), (correlations: []), (mitochondrial dna (mtdna) changes: [bacs,nnon]), (alterations: []), (genes: [gngm]), (mtdna maintenance: [bacs,nnon]), (asd: [cgab]), (healthy individuals: [humn]), (common mtdna mutations: [cgab]), (next generation sequencing: [mbrt]), (major mtdna deletions: [comd]), (gene panels: [gngm]), (nuclear genes: [gngm]), (cohorts: [popg]), (healthy controls: []), ( asd patients: [cgab]), (mtdna alterations: [bacs,nnon]), (mitochondrial disorders: [dsyn]), (mtdna deletions: [comd]), (comparison groups: [popg]), ((10/60): [fndg]), (asd (mtdel-asd): [cgab]), (mtdel-asd children: [cgab]), (rare snvs: [gngm]), (asd-associated genes: [cgab]), (intergenomic panel: []), (cohort: [popg]), (likely pathogenic variant: [fndg]), (mitochondrial disease: [dsyn]), (pathogenic mutations: [genf]), (variants: []), (uncertain significance (vus): [fndg]), (mtdel-asd: [cgab]), (other comparison groups: [popg]), (mtdna deletion: [comd]), (vus: []), (panel: []), (control individuals: [humn]), (isolated genetic alterations: [genf]), (asd;: [cgab]), (other asd-associated genetic risk factors: [cgab]), (intergenomic communication: [socb]), (findings: [clna]), (consequence: []), (causative culprit genes: [gngm]), (autism: [mobd]), (harmful effect: []), (environmental factors: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s12993-018-0135-x) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5814017
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (complex hereditary: [chvs]), (environmental factors: []), (however: []), (mechanisms: []), (asd development: [cgab]), (purpose: []), (study: [resa]), (standard indicators: [irda]), (condition: [dsyn]), (clinical: []), ( pathophysiological: [patf]), (neurobehavioral features: []), (autism-like animal model: [emod]), (total: [qnco]), (male sprague-dawley rats: [mamm]), (control: [sbst]), (mg/kg: [qnco]), ((ppa)-treated groups: [mobd]), (rats: [mamm]), (tests: [lbpr]), ( gene expression analyses: [mbrt]), (histological analyses: [resa]), (neurobehavioral alterations: []), (exploratory activity: [acty]), (non-aggressive behavior: [mobd]), (ppa-treated rats: [mamm]), ( whereas: []), (aggressive behavior: [mobd]), (adjacent interactions: []), (day: []), (ppa administration: [mobd]), (gene expression: [genf]), (ppa: [mobd]), (hippocampal tissue: [tisu]), (reverse transcription pcr: [genf]), (glial: [cell]), (fibrillary acidic protein: [aapp,bacs]), (ppa-treated group: [mobd]), (appearance: [orga]), (asd-like behaviors: [cgab]), (administration: [topp]), (octamer-binding transcription factor: [aapp,bacs]), (expression: [topp]), (histological evaluation: [hlca]), (diameter: [qnco]), (layer thickness: [bird]), (granule cells: [cell]), (control rats: [mamm]), (abnormal neural cell: [cell]), (increased aggressive behavior: [mobd]), (passive behaviors: [inbe]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurobehavioral features, 'Central Nervous System Diseases')(neurobehavioral alterations, 'Central Nervous System Diseases')(aggressive behavior, 'Aggressive Behavior')(asd-like behaviors, 'Autism Phenotype')(increased aggressive behavior, 'Aggressive Behavior')

PMCID: 5810065
SFARI Genes: ARHGEF10, ARHGEF10, ARHGEF10, ARHGEF10, ARHGEF10, ARHGEF10, Arhgef10, Arhgef10, Arhgef10, Arhgef10, Arhgef10, Arhgef10, ARHGEF10, Arhgef10, ARHGEF10, Arhgef10, 
Non SFARI Genes: 
Named Entities: (impaired: []), (social interaction: [fndg]), (essential features: []), (autism spectrum disorder (asd): [mobd]), (previous copy number variation (cnv) study: [nusq]), (novel: []), (region: []), (asd: [cgab]), (genes: [gngm]), (deleted region: [acty]), (arhgef10: [gngm]), (missense mutation: [genf]), (factors: []), (several diseases: [dsyn]), (central nervous system: [bdsy]), (however: []), (relationship: []), (loss: [qnco]), (clinical symptoms: [sosy]), (arhgef10 knockout mice: [mamm]), (model: []), (social behavior: [socb]), (biochemical changes: [qnco]), (brains: [bpoc]), (knockout mice: [mamm]), (arhgef10-depleted mice: [mamm]), (social interaction impairment: [fndg]), ( hyperactivity: [mobd]), (depression-like: [mobd]), (anxiety-like behavior: [mobd]), (behavioral measures: [qnco]), (morris water maze: [sbst]), (arhgef10 deficiency: [dsyn]), (moreover: []), ( neurotransmitters: [bacs]), (serotonin: [bacs,orch]), ( norepinephrine: [horm,orch,phsu]), (dopamine: [bacs,orch,phsu]), (different brain regions: [blor]), (addition: []), ( monoamine: [orch]), (several brain regions: [blor]), (results: [fndg]), (candidate risk gene: [gngm]), (arhgef10 knockout model: [gngm]), (tool: []), (mechanisms: []), (neurotransmission: [celf]), (trial registration animal studies: [resa]), (institutional animal care: [anim]), (use committee: [grup]), (national taiwan university (iacuc: [mnob,orgt]), (august: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0197-5) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(clinical symptoms of asd, 'Complaints and Indications')(social behavior, 'Reciprocal Social Interaction')(social interaction impairment, 'Reciprocal Social Interaction')(hyperactivity, 'Overactivity')

PMCID: 5850384
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (long-term outcomes: []), (perinatal exposure: [hcpp]), (maternal antiretroviral therapy: [topp]), (hiv-exposed uninfected (heu) children: [virs]), (however: []), (hiv: [virs]), (antiretroviral therapy: [topp]), (autism spectrum disorder (asd): [mobd]), (mitochondrial alterations: [comd]), (leukocyte: [cell]), (mitochondrial dna (mtdna) content: [bacs,nnon]), (marker: [clna]), (mitochondrial dysfunction: [fndg]), (cross-sectional: []), ( nested case-control study: [resa]), ( heu children: [aggp]), (asd: [cgab]), (age: [orga]), ( sex: [orgf]), (ethnicity: [popg]), (heu children: [aggp]), (hiv-unexposed uninfected (huu) controls: [virs]), (huu children: [aggp]), (leukocyte mtdna content: [bacs,nnon]), (quantitative pcr: [mbrt]), (heu: []), (study: [resa]), ((4.7%): [fndg]), (general population prevalence estimates: [qnco]), (mtdna content: [bacs,nnon]), (huu controls: [sbst]), (other study groups: [popg]), (results: [fndg]), (clear association: [menp]), (asd status: [cgab]), (contributor: []), (high asd prevalence: [cgab]), (cohort: [popg]), 
ASD Terms: (perinatal exposure, 'Perinatal Exposures')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5806238
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (reported neural features: [hlca]), (autism spectrum disorder (asd): [mobd]), (alteration: []), (multiple long-range white matter fiber tracts: [tisu]), (diffusion-weighted imaging: [diap]), (reduced fractional anisotropy (fa): [npop]), (recent methodological advances: []), ( however: []), (same pattern: []), (reduced fa: []), (excessive head motion: [npop]), (poorer data quality: [grpa]), (aberrant structural connectivity: []), (children: [aggp]), (asd: [cgab]), (right inferior longitudinal fasciculus (ilf): [bpoc]), (study: [resa]), (observation: [hlca]), (right ilf: [gngm]), (group differences: [popg]), (head motion: [npop]), (data quality: []), (addition: []), (associations: [menp]), (fa: [gngm]), (quantitative asd characteristics: [cgab]), (involvement: []), (visual processing: [menp]), (global: []), (probabilistic tractography: []), (data: [euka]), (adolescent boys: [aggp]), (boys: [aggp]), (age: [orga]), ( performance iq: [orga]), ( handedness: [orga]), (tasks: []), (various aspects: [qnco]), (visual information processing: [menp]), (questionnaires: []), (asd characteristics: [cgab]), (neural data: [euka]), (findings: [clna]), (bayesian statistics: []), (evidence: []), (replication: [genf]), (statistical power: [resa]), ((partial) correlations: [qnco]), (measures: [qnco]), (asd group: [cgab]), (performance: [inbe]), (visual search task: [acty]), (studies: [lbpr]), (right ilf only: [gngm]), (altered fa: []), (left ilf: [gngm]), (indecisive: [fndg]), (visual search: [acty]), (fragmented part-oriented processing style: [fndg]), (individual differences: [menp]), (severity: []), (asd traits: [cgab]), (clinical status: []), (specific fiber tract: [bpoc]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0188-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(visual processing, 'Visual Thinking')(visual information processing, 'Visual Thinking')(visual search task, 'Visual Thinking')(visual search, 'Visual Thinking')

PMCID: 5828599
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (significance: [qnco]), (factor: []), (autism spectrum disorder (asd): [mobd]), (severe class: []), (likely gene: [gngm]), (disruptive (lgd): []), (iq: []), (phenotypic characteristic: [orga]), (asd: [cgab]), (core feature: [bdsu]), (individuals: [humn]), (asd phenotypic feature: [cgab]), (report: [hlca]), (lgd: []), (missense mutations: [genf]), (target gene vulnerability: [gngm]), (significant associations: [menp]), (diminished motor skills: [orgf]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(asd phenotypic feature, 'Autism Phenotype')

PMCID: 5804031
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (butyrate (bt): [orch]), (ubiquitous short-chain fatty acid (scfa): [bacs,orch]), (enteric microbiome: [orgm]), (bt: [gngm]), (mitochondrial function: [celc]), (oxidative phosphorylation: [moft]), (beta-oxidation: [plnt]), (neuroprotectant: [phsu]), (other scfas: []), (autism spectrum disorders: [mobd]), (condition: [dsyn]), (mitochondrial dysfunction: [fndg]), (lymphoblastoid cell line (lcl) model: [cell]), (asd: [cgab]), (subset: []), (lcls: []), (mitochondrial dysfunction (ad-a): [fndg]), (normal mitochondrial function (ad-n): [celc]), (positive modulation: [fndg]), (preferential positive effect: [fndg]), (ad-a lcls: []), (end: [gngm]), (age-matched control (cnt) lcls: [orga]), (boys: [aggp]), (h exposure: [elii]), (bt (0: [fndg]), (mm): []), (vitro increase: []), (reactive oxygen species: [bacs,elii]), (expression: [topp]), (key genes: [gngm]), (mitochondrial response: [celc]), (cnt lcls: []), ( respiratory parameters: [fndg]), (triphosphate: [inch]), ((atp) production: [aapp,enzy]), (mm bt: []), (contrast: [irda]), ( bt: []), (respiratory parameters: [fndg]), (atp production: [aapp,enzy]), (ad-n lcls: []), (context: [fndg]), (ros: [gngm]), (groups: [popg]), (individual lcl: [humn]), (mitochondrial respiration: [celc]), (common set-point: [menp]), (set-point: [menp]), (other groups: [popg]), (concentration: [menp]), (bt (1 mm): [fndg]), (genes: [gngm]), (mitochondrial fission (pink1: [celf]), ( drp1: [gngm]), ( fis1): [gngm]), (physiological stress (ucp2: [patf]), ( mtor: [aapp,enzy]), ( hif1: [aapp,bacs]), ( pgc1): [gngm]), (cognition: [menp]), (behavior (creb1: [inbe]), ( camkinase ii): []), (data: [euka]), (enteric microbiome-derived scfa bt: [orgm]), (mitochondrial activity: [celc]), (modulation dependent: []), ( microenvironment redox state: [moft]), (underlying mitochondrial function: [celc]), (cell: [gngm]), (physiological stress: [patf]), (important metabolite: [bacs]), (energy metabolism: [phsf]), (disease states: [dsyn]), (thus: []), (metabolic modulator: [celf]), (wide applications: [hlca]), (health: []), (disease: [dsyn]), (wide variety: []), (conditions: [dsyn]), (however: []), (future clinical studies: [resa]), (humans: [humn]), (practical implications: []), (physiological findings: [fndg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(h exposure, 'Exposures')(cognition, 'Cognitive Ability')

PMCID: 5985537
SFARI Genes: OTUD7A, OTUD7A, OTUD7A, OTUD7A, OTUD7A, OTUD7A, 
Non SFARI Genes: 
Named Entities: (copy-number variations (cnvs): [nusq]), (strong risk factors: [qnco]), (psychiatric disorders: [mobd]), (microdeletion: []), (syndrome region: [dsyn]), (genes: [gngm]), (numerous conditions: [dsyn]), (autism spectrum disorder (asd): [mobd]), ( epilepsy: [dsyn]), ( schizophrenia: [mobd]), (intellectual disability;: [mobd]), (mechanisms: []), (pathogenesis: [patf]), (microdeletion syndrome: [dsyn]), (whole-genome sequencing: [mbrt]), ( human brain gene expression (proteome: [humn]), (transcriptome): [nusq]), (mouse model: [emod]), (syntenic heterozygous deletion (df(h15q13)/+ mice): [mamm]), (microdeletion results: [fndg]), (abnormal development: [cgab]), (cortical dendritic spines: [bpoc]), (dendrite outgrowth: [celc]), (analysis: [resa]), (large-scale genomic: [gngm]), ( transcriptomic: [nusq]), (proteomic data: [euka]), (otud7a: [gngm]), (critical gene: [gngm]), (brain function: [ortf]), (spine compartments: [bpoc]), (cortical neurons: [bpoc]), (reduced levels: []), (df(h15q13)/+: []), (dendritic spine: [celc]), (dendrite outgrowth deficits: [celc]), (results: [fndg]), (major regulatory gene: [gngm]), (microdeletion syndrome phenotypes: [dsyn]), (disease mechanism: [dsyn]), (abnormal cortical neuron: [bpoc]), (morphological development: [orgf]), 
ASD Terms: (psychiatric disorders, 'Mental Disorders')(autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(intellectual disability, 'Learning Disorders')(microdeletion results in abnormal development, 'Learning Disorders')(abnormal development, 'Learning Disorders')

PMCID: 5814383
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (schizophrenia share: [mobd]), (genetic etiology: [topp]), (common changes: [qnco]), (brain structure: [bpoc]), (common cognitive deficits: [mobd]), (number: [qnco]), (studies: [lbpr]), (state fmri: [diap]), (machine: []), (algorithms: []), (healthy controls: []), (individuals: [humn]), (autism spectrum disorder: [mobd]), (schizophrenia: [mobd]), (however: []), (disorders: [dsyn]), (linear support vector machine: [qnco]), (features: []), (disorder: [dsyn]), (independent cohort: [popg]), (subjects: [humn]), (divergent connectivity differences: [qnco]), (default mode network: [popg]), (salience: []), (motor networks: []), (autistic subjects: [mobd]), (divergent connectivity changes: [qnco]), (framework: []), (cognitive deficits: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(schizophrenia share, 'Schizophrenia and Disorders with Psychotic Features')(common cognitive deficits, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(cognitive deficits, 'Cognitive Ability')

PMCID: 6060879
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (reduced prosocial behaviour: [inbe]), (however: []), (social interactions: [fndg]), (peers: [popg]), (course: []), (development: [orgf]), (reduction: [npop]), (asd symptoms: [cgab]), (vice versa: []), (we: []), ( therefore: []), (if: []), (adolescence: []), ( possible improvements: []), (prosocial behaviours: [inbe]), (time: []), (participants: [popg]), (adolescents: [aggp]), (tracking adolescents individual lives survey (trails) cohorts: [aggp]), (measurements: []), (place: [acty]), (waves: [gngm]), (years): []), (longitudinal associations: [menp]), (teacher-rated classroom: [fndg]), (prosocial skills: [inbe]), (parent-rated asd symptoms: [cgab]), (random: [resa]), (cross-lagged panel model: [gngm]), (addition: []), (stable: []), ( between-person: [grup]), (dynamical effects: []), (within-person level: [phsu]), (between-person level: [phsu]), (correlated: []), (unexpected positive cross-lagged effect: [fndg]), (wave: [gngm]), (literature: [inpr,mnob]), (that: []), (between-person association: [socb]), (low prosocial skills: [inbe]), (asd: [cgab]), ( within-person gains: [qnco]), (subsequent reduction: [npop]), (reductions: [npop]), (subsequent enhancement: [acty]), (therefore: []), ( conclude: [bodm,orch]), (findings: [clna]), (inverse association: []), (autistic symptoms: [mobd]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1007/s00787-018-1114-3) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social interactions, 'Reciprocal Social Interaction')(asd symptoms, 'Complaints and Indications')(parent-rated asd symptoms, 'Complaints and Indications')(asd symptoms, 'Complaints and Indications')(asd symptoms, 'Complaints and Indications')(asd symptoms, 'Complaints and Indications')(autistic symptoms, 'Complaints and Indications')

PMCID: 5791216
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (sleep difficulties: [sosy]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (temporal nature: []), (association: [menp]), (sleep problems: [dsyn]), (asd: [cgab]), (longitudinal studies: [resa]), (aim: [phsu]), (autistic traits: [mobd]), (consequence: []), (disorder: [dsyn]), (sleep measures: [orgf]), (years: []), (age: [orga]), (generation r study: [resa]), (large prospective birth cohort: [resa]), (netherlands: []), (pervasive developmental problems: [orgf]), ((pdp): [gngm]), (child behavior checklist (cbcl): [diap,inpr]), (social responsiveness scale (srs): [acty]), (cohort: [popg]), (childhood: []), (srs score: [clna]), (baseline pdp score: [bodm]), (asd diagnosis: [cgab]), (baseline sleep problems: [bodm]), (trajectory: []), (autistic behavior: [mobd]), (early childhood: []), (time: []), ( children: [aggp]), (increase: []), ( whereas: []), (decrease: [qnco]), (findings: [clna]), (part: [qnco]), (construct asd: [cgab]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0194-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(sleep difficulties, 'Sleeping Problems')(sleep problems, 'Sleeping Problems')(years of age, 'Onset of Symptoms')(pervasive developmental problems score, 'Learning Disorders')(asd diagnosis, 'Diagnosis')(baseline sleep problems, 'Sleeping Problems')(sleep problems, 'Sleeping Problems')(sleep problems, 'Sleeping Problems')

PMCID: 5790834
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (solid progress: [bodm]), (last decade: [qnco]), (understanding: [menp]), (molecular genetic basis: [phsu]), (neurodevelopmental disorders: [mobd]), (schizophrenia: [mobd]), (autism: [mobd]), (particular: []), (genetic architecture: [topp]), (disorders: [dsyn]), (imagined: []), ( many key loci: [gngm]), (vivo: []), (vitro technologies: []), (specific high-penetrant genetic loci: [gngm]), (disc1/nde1: [gngm]), (cyfip1/eif4e: [aapp,bacs]), (exemplars: []), (opportunities: []), (challenges: [hlca]), (animal models: [anim]), (human-induced pluripotent stem cell technologies: [humn]), (further understand/treat: [menp]), (consequences: []), (article: []), (part: [qnco]), (discussion meeting issue of mice: [mamm]), (mental health:: [menp]), (dialogue: []), (clinical neuroscientists: []), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(imagined, 'Imagination')

PMCID: 5785483
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (altered gut microbiota: [orgm]), (autism spectrum disorders: [mobd]), (group: [popg]), (complex: [chvs]), (difficult-to-diagnose neurodevelopmental disorders: [mobd]), (however: []), (role: [socb]), (oral microbiota: [orgm]), (asd: [cgab]), (via high-throughput sequencing: [mbrt]), (oral samples: [sbst]), (children: [aggp]), (healthy controls: []), (dental microbiota: [orgm]), (asd patients: [cgab]), (healthy individuals: [humn]), (lower: [blor]), (bacterial diversity: []), (asd children: [cgab]), (dental samples: [hlca]), (also: []), (principal coordinate analysis: [resa]), (divergences: []), (controls: [sbst]), (moreover: []), ( pathogens: [orgm]), (haemophilus: [bact]), (saliva: [bdsu]), (streptococcus: [bact]), (plaques: [acab]), (abundance: []), (whereas commensals: [euka]), (prevotella: [bact]), ( selenomonas: [bact]), ( actinomyces: [bact]), ( porphyromonas: [bact]), (fusobacterium: [bact]), (reduced: []), (specifically: []), (overt depletion: []), (prevotellaceae co-occurrence network: [popg]), (dental plaques: [dsyn]), (distinguishable bacteria: [bact]), (clinical indices: [lbpr]), (disease severity: []), (oral health status (i.e: [fndg]), (dental caries): [dsyn]), (finally: []), (diagnostic models: [fndg]), (key microbes: [orgm]), (accuracy: []), (together: []), (study: [resa]), (habitat-specific profile: [lbpr]), (novel strategies: [menp]), (diagnosis: [fndg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(difficult-to-diagnose neurodevelopmental disorders, 'Learning Disorders')(bacterial diversity, 'Bacterial Infections')(principal coordinate analysis, 'Motor Skills')(distinguishable bacteria, 'Bacterial Infections')(diagnosis, 'Diagnosis')

PMCID: 5784506
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (genetic mosaicism: [orga]), (obvious health: []), (developmental issues: [fndg]), (cases concern: [qnco]), (healthy parents: []), (mosaicism: [orga]), (targeted testing: []), (genetic defect: [cgab]), (children: [aggp]), (germline genetic defect: [cell]), (euchromatin histone methyltransferase: [celc]), ((ehmt1) gene causes kleefstra syndrome: [gngm]), (typical triad: [bodm,orch]), (distinct facial appearance: [orga]), ( (childhood) hypotonia: [fndg]), (intellectual disability: [mobd]), (high degree: [qnco]), (psychopathology: []), (syndrome: [dsyn]), (few parents: [qnco]), (mosaic ehmt1 mutation: [genf]), (child: [aggp]), (germline ehmt1 defect: [cell]), (first glance: [qnco]), ( carriers: [fndg]), (normally: []), (however: []), (recent studies: [lbpr]), (postzygotic mutations: [genf]), (important developmental genes: [gngm]), (spectrum disorder (asd): [cgab]), (ehmt1 mosaicism: [orga]), (neuropsychiatric defects: []), (this: []), (detailed investigation: [hlca]), (cognitive neuropsychiatric parameters: [fndg]), (parents: []), (adults: [aggp]), (female): [orga]), (diagnosis: [fndg]), (means: []), (battery: [inpo]), (tests: [lbpr]), (observational instruments: [resa]), (psychiatric features: [hlca]), (instruments:: []), (autism diagnostic observation schedule: [hlca]), (mini psychiatric assessment schedules: [diap]), (developmental: [orgf]), ((mini pas-add): [orch,phsu]), (vineland adaptive behavior scales (vabs): []), (cambridge neuropsychological test automated battery (cantab): [diap]), (measures: [qnco]), (data: [euka]), (kleefstra: []), (syndrome patients: [dsyn]), (confirmed (germline) ehmt1 defects: [cell]), (subjects: [humn]), (maximum total scores: [qnco]), (vabs: []), ( indicative: []), (adequate (adaptive): []), (all: []), ( scores: [clna]), (cutoff: []), (ados: [aapp,enzy]), (asd: [cgab]), (mini pas-add: [orch,phsu]), (major depressive disorder (lifetime): [mobd]), (finally: []), ( results: [fndg]), (cantab: []), (impaired cognitive flexibility: [menp]), (individuals: [humn]), (vulnerability: []), (severe psychopathology: []), (mood disorders: [mobd]), (daily functioning: []), (significant psychiatric symptoms: [sosy]), (cognitive flexibility: [menp]), (comparison: [acty]), (general population: [popg]), 
ASD Terms: (developmental issues, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(cognitive neuropsychiatric parameters, 'Cognitive Ability')(diagnosis, 'Diagnosis')(autism diagnostic observation schedule, 'Autism Phenotype')(vineland adaptive behavior scales, 'Adaptive Life Skills')(adaptive behavior scales, 'Adaptive Life Skills')(autism, 'Autism Phenotype')(major depressive disorder, 'Depressive Disorder')(impaired cognitive flexibility, 'Cognitive Ability')(mood disorders, 'Mood Disorders')(cognitive flexibility, 'Cognitive Ability')

PMCID: 5780507
SFARI Genes: NHE9, NHE9, NHE9, NHE9, NHE9, NHE9, 
Non SFARI Genes: 
Named Entities: (psychoactive compounds: [chem]), (chloroquine: [orch,phsu]), (amphetamine act: [topp]), (ph gradient: [qnco]), (intracellular membranes: [celc]), (physiological mechanisms: []), (organelle ph: [celc]), (interestingly: []), (recent human genetic studies: [humn]), (endosomal na+/h+ exchanger nhe9: [celc]), (autism spectrum disorders: [mobd]), (attention deficit hyperactivity disorder (adhd): [mobd]), (plasma membrane nhes: [aapp,bacs]), (cytosolic ph: [celc]), (role: [socb]), (intracellular isoforms: [celc]), (inactivation: []), (nhe9: [gngm]), (mice reproduces: [mamm]), (behavioral features: [inbe]), (asd: [cgab]), (impaired social interaction: [mobd]), (repetitive behaviors: [fndg]), (sensory processing: [ortf]), (physiological characterization reveals: [acty]), (cell-autonomous defect: [gngm]), (glutamate receptor expression: [aapp,rcpt]), (impaired neurotransmitter release: [celf]), (defect: []), (presynaptic ca2+ entry: [elii,phsu]), (acute inhibition: [acty]), (synaptic vesicle acidification: [celc]), (release: [hlca]), (primary defect: [topp]), (loss: [qnco]), 
ASD Terms: (amphetamine act, 'Substance Abuse')(autism spectrum disorders, 'Autism Phenotype')(attention deficit hyperactivity disorder, 'Overactivity')(impaired social interaction, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 5785951
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (environmental factors: []), (role: [socb]), (development: [orgf]), (autism spectrum disorder (asd): [mobd]), (case-control study: [resa]), (association: [menp]), (childhood asd: [cgab]), (single-nucleotide polymorphisms: [nusq]), (genes: [gngm]), (vitamin b12: [orch,phsu,vita]), (metabolism: [orgf]), (material/ genotypes: [orga]), (transcobalamin: [aapp,vita]), ((tcn2) rs1801198: [gngm]), ( methionine synthase (mtr) rs1805087: [aapp,enzy]), ( methionine synthase reductase (mtrr) rs1801394: [aapp,enzy]), (methylene tetrahydrofolate reductase (mthfr) rs1801133: [aapp,enzy]), (children: [aggp]), (asd: [cgab]), (healthy controls: []), (han chinese population: [popg]), (results: [fndg]), (snps: [nusq]), (severity: []), (none: []), (examined snps: [nusq]), (risk factor: [qnco]), (susceptibility: [clna]), (disease: [dsyn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(vitamin b12, 'Dietary Supplements')

PMCID: 5775320
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (speech: [orgf]), (motor deficits: [fndg]), (prevalent (>70%): [qnco]), (individuals: [humn]), (bp4-bp5: [aapp,bacs]), (deletion;: [genf]), (mechanisms: []), (deficits: []), (ability: [orga]), (interventions: [hlca]), (advance treatment: [topp]), (study: [resa]), (fundamental aspects: [qnco]), (speech motor control: [orgf]), (participants: [popg]), (deletion: [genf]), (capacity: [qnco]), (control: [sbst]), (voice: [orgf]), (subjects: [humn]), (pitch: [qnco]), (trial: [resa]), (transient perturbation: [popg]), (auditory feedback: [menp]), (deletion carriers: [genf]), (over-exaggerated pitch compensation response: [fndg]), (unpredictable mid-vocalization pitch perturbations: [fndg]), (sensorimotor adaptation: [orgf]), (sustained productions: []), (formants: []), ((speech spectral peak frequencies: [orgf]), (vowel identity): [menp]), (response: [fndg]), (consistent changes: [qnco]), (vowel production: []), (vowel identity changes: [qnco]), (results: [fndg]), (fundamental impairments: [patf]), (basic mechanisms: []), (impairments: [patf]), (language: [lang]), 
ASD Terms: (speech, 'Language Ability')(motor deficits, 'Motor Skills')(speech motor control, 'Language Ability')(speech, 'Language Ability')(sensorimotor adaptation, 'Adaptive Life Skills')(speech motor control, 'Language Ability')(speech, 'Language Ability')

PMCID: 6017261
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (aim: [phsu]), (review: []), (interrelationship: []), (melatonin: [horm,orch,phsu]), (autism spectrum disorder (asd): [mobd]), (fetal development: [phsf]), (asd refers: [cgab]), (diverse range: [qnco]), (neurodevelopmental disorders: [mobd]), (social deficits: []), (communication: [socb]), (repetitive behaviors: [fndg]), (pineal gland: [bpoc]), (circadian entraining effects: []), (hormone: [horm]), (placenta: [emst]), (fetal circulation: [ortf]), (photoperiodic information: []), (fetus: [tisu]), (establishment: []), (normal sleep patterns: [fndg]), (circadian rhythms: [orgf]), (normal neurodevelopment: [ortf]), (melatonin synthesis: [moft]), (patients: [podg]), (asd: [cgab]), (oxidative stress: [comd]), (central nervous system: [bdsy]), (roles: [socb]), (risk: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(social deficits, 'Social Competence')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(normal sleep patterns, 'Sleeping Problems')(circadian rhythms, 'Prosody')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 5798319
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (significance: [qnco]), (emotion-related responses: [menp]), (fear: [menp]), (anxiety: [mobd]), (important behavioral phenomena: [inbe]), (animal species: [anim]), (humans: [humn]), (however: []), (underlying mechanisms: []), (animals: [anim]), (anxiety disorders: [mobd]), (large unmet medical need: [qnco]), (human clinic: [humn]), (animal models: [anim]), (discovery: [acty]), (mechanisms: []), (human health: [humn]), (herein: []), (identification: [menp]), (chemokine-like gene family: [aapp,imft]), (samdori (sam): []), (present functional characterization: [qnco]), (sam2: []), (anxiety-related responses: [mobd]), (mouse knockout models: [mamm]), (results: [fndg]), (role: [socb]), (anxiety-like behavior: [mobd]), 
ASD Terms: (anxiety, 'Anxiety Disorders')(anxiety, 'Anxiety Disorders')(anxiety disorders, 'Anxiety Disorders')(large unmet medical need, 'Medications')

PMCID: 5767968
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (antidepressant exposure: [phsu]), (pregnancy: [orgf]), (risk: []), (autism spectrum disorder (asd): [mobd]), (attention deficit hyperactivity disorder (adhd): [mobd]), (several observational studies: [resa]), (systematic review: []), (studies: [lbpr]), (effect: []), (important methodological limitations: []), (such analyses: [resa]), (approaches: []), (conduct: [inbe]), ( reporting: [hlca]), (interpretation: [clna]), (future studies: [lbpr]), (review: []), (medline: []), (embase: []), (casecontrol: []), ( cohort: [popg]), (asd: [cgab]), (adhd: [mobd]), (antidepressant use: [phsu]), (adjustment: [inbe]), (described: []), (crude: []), (effect estimates: [qnco]), (comparisons: [acty]), (unexposed women: [popg]), (generic inverse variance method: [phsu]), (analysis: [resa]), (alternative pre-selected comparison groups: [popg]), (total: [qnco]), (outcome: []), (children: [aggp]), (cases): [qnco]), (patients: [podg]), (variation: []), (association: [menp]), (maternal antidepressant exposure: [phsu]), (random-effects risk: [resa]), (confidence interval: [qnco]), (similar significant associations: [menp]), (pre-pregnancy maternal antidepressant exposure: [phsu]), (ci: [gngm]), (paternal antidepressant exposure: [phsu]), (analyses: [resa]), (women: [popg]), (history: [orga]), (affective disorder: [mobd]), (associations: [menp]), (exposure were: rarr: [clna]), (pregnancy): [orgf]), ( rarr: []), (pre-pregnancy): []), ((paternal exposure): [inpo]), ((women: [popg]), (affective disorder): [mobd]), (rarr: []), (studies): [lbpr]), (observational studies: [resa]), (design: [acty]), (classical comparisons: [acty]), (high risk: [fndg]), (residual confounding: []), (alternative comparisons: [acty]), (designs: [acty]), (causality: []), (utility: [orgt]), (potential limitations: []), (meta-analyses: [resa]), (such data: [euka]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s12916-017-0993-3) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (antidepressant exposure, 'Exposures')(autism spectrum disorder, 'Autism Phenotype')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(antidepressant exposure, 'Exposures')(maternal antidepressant exposure, 'Exposures')(paternal antidepressant exposure, 'Exposures')(pre-pregnancy maternal antidepressant exposure, 'Exposures')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(exposure, 'Exposures')(exposure were, 'Exposures')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(antidepressant exposure, 'Exposures')

PMCID: 5943853
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract: []), (association: [menp]), (maternal diabetes: [patf]), (autism spectrum disorders: [mobd]), (provide inconsistent findings;: [acty]), (comprehensive literature review: []), (meta-analysis: [resa]), (order: [acty]), (available evidences: []), (databases: []), (inclusion criteria: []), (eligible studies: [lbpr]), (estimated effects: [qnco]), (dependent: []), (presence: [qnco]), (absence: [anab]), (heterogeneity: [orga]), (twelve: [qnco]), (studies: [lbpr]), (significant association: [menp]), (asds: [cgab]), (children: [aggp]), ((relative risk [rr]: [qnco]), (however: []), (high heterogeneity: [orga]), (publication bias: []), (terms: [orgf]), (analyses: [resa]), (reliable evidences: []), (case-control studies: [resa]), ( heterogeneity: [orga]), (publication bias disappeared: []), (risk: []), (diabetic mothers: [famg]), (non-diabetic mothers: [famg]), (gestational diabetes: [patf]), (limited number: [qnco]), (large-scale population-based prospective studies: [resa]), (firm conclusions: []), 
ASD Terms: (maternal diabetes, 'Diabetes Mellitus Type 1')(autism spectrum disorders, 'Autism Phenotype')(maternal diabetes, 'Diabetes Mellitus Type 1')(autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(diabetic mothers, 'Diabetes Mellitus Type 1')(gestational diabetes, 'Perinatal History')

PMCID: 5766538
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (retroelements: [bacs,nnon]), (human endogenous retroviruses (hervs): [virs]), (many complex diseases: [dsyn]), (neuropsychiatric disorders: [dsyn]), (previously: []), (distinctive expression profile: [lbpr]), (specific herv families: [virs]), (peripheral blood: [bdsu]), (mononuclear cells: [cell]), (autistic spectrum disorders (asd) patients: [podg]), (involvement: []), (asd: [cgab]), (distinct asd mouse models:: [cgab]), (btbr t+tf/j mice: [aapp,imft]), (cd-1: [mamm]), (mice: [mamm]), (acid: [chem]), (whole embryos: [emst]), ( blood: [bdsu]), (brain samples: [bpoc]), (different ages: [bacs,orch]), (expression: [topp]), (several erv families: [virs]), (etnii-: []), ( etnii-: []), ( musd: []), (iap): [gngm]), (proinflammatory cytokines: [aapp,imft]), ((il-1: [aapp,imft]), ( il-6: [aapp,imft]), (tnf-): [aapp,bacs]), (toll-like receptors (tlr3: [aapp,rcpt]), (tlr4): [gngm]), (distinct mouse models: [mamm]), (transcriptional activity: [genf]), (erv families: [virs]), (comparison: [acty]), (controls: [sbst]), (expression levels: [qnco]), (tlrs: []), (current results: [npop]), (agreement: [socb]), (previous findings: [clna]), (asd children: [cgab]), (hypothesis: []), (ervs: [virs]), (biomarkers: [clna]), (atypical brain development: [ortf]), (moreover: []), (changes: [qnco]), (proinflammatory cytokines expression: [aapp,imft]), (autistic-like traits acquisition: [mobd]), (mouse models: [mamm]), 
ASD Terms: (autistic spectrum disorders, 'Autistic Disorder')(biomarkers of atypical brain development, 'Learning Disorders')(atypical brain development, 'Learning Disorders')

PMCID: 5766530
SFARI Genes: FOXP1, FOXP1, FOXP1, FOXP1, FOXP1, FOXP1, FOXP1, FOXP1, 
Non SFARI Genes: 
Named Entities: (de: []), (foxp1 mutations: [genf]), (intellectual disability (id): [mobd]), ( motor delay: [dsyn]), (autistic features: [mobd]), (wide spectrum: [qnco]), (speech difficulties: [fndg]), (c syndrome (opitz c trigonocephaly syndrome): [dsyn]), (heterogeneous condition: [fndg]), (trigonocephaly: [cgab]), ( craniofacial anomalies: [cgab]), (id: [lbpr]), (several different chromosome deletions: [comd]), (point mutations: [comd]), (distinct genes: [gngm]), (disease: [dsyn]), (patients: [podg]), (opitz c: []), (whole exome sequencing: [mbrt]), (mutation: [genf]), (foxp1: [gngm]), (patient: [podg]), (c syndrome: [dsyn]), (syndromic intellectual disability: [mobd]), (mutation (c.1428: [genf]), (g > a): [qnco]), (skipping: [fndg]), (frameshift: [comd]), (premature stop codon (p.ala450glyfs*13): [nusq]), (minigene strategy: [menp]), (shares: [socb]), (difficulties: [fndg]), ( intellectual disability: [mobd]), (other foxp1 syndrome patients: [dsyn]), (diagnosis: [fndg]), (changed: [qnco]), (finally: []), (foxp1 mutation: [genf]), 
ASD Terms: (speech difficulties, 'Language Ability')(intellectual disability, 'Learning Disorders')(motor delay, 'Motor Skills')(syndromic intellectual disability with trigonocephaly, 'Learning Disorders')(syndromic intellectual disability, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(diagnosis, 'Diagnosis')

PMCID: 5766517
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (great advances: [qnco]), (neuroscience: []), (genetic studies: [resa]), (understanding: [menp]), (neurodevelopmental disorders: [mobd]), (important reason: []), (objective psychiatric clinical tests: [lbpr]), (quantitative neurodevelopment assessment: [qnco]), (natural movement outputs: [orgf]), (movement: [orgf]), (complex coordination: [phsf]), (temporal alterations: []), (precise dynamic controls: [sbst]), (continuous movement output data: [euka]), (high definition: [qnco]), (electromagnetic sensors: [npop]), (millisecond time scales: [bpoc]), (new metrics: [orch,phsu]), (physiological information: []), (traditional motion assessments: [npop]), (naked eye observations: [fndg]), (putative biomarker: [clna]), (individualized classifications: []), (clear differences: [qnco]), (autism spectrum disorder (asd): [mobd]), (mature: []), ((td) individuals: [humn]), (asd: [cgab]), (complementary quantitative classification: [qnco]), (clinicaly: []), (functioning levels: []), (spectrum: [qnco]), (td: []), (potential age-related neurodevelopmental trajectories: [orga]), (movement biomarker: [orgf]), (parents: []), (asd individuals: [cgab]), (cohort: [popg]), (novel potential familial signature asd tie: [cgab]), (paper: []), (putative behavioral biomarker: [clna]), (level: [phsu]), (neurodevelopment: [ortf]), (power: [hcpp]), (asd subjects: [cgab]), (example: []), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(complex coordination, 'Motor Skills')(autism spectrum disorder subjects, 'Autism Phenotype')(potential age-related neurodevelopmental trajectories, 'Learning Disorders')

PMCID: 5821970
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (environmental factors: []), (etiology: []), (autism spectrum disorder (asd): [mobd]), (case-control study: [resa]), (association: [menp]), (single-nucleotide polymorphisms: [nusq]), (rs731276 (taqi): [fndg]), ( rs1568820 (cdx2): []), ( rs1544410 (bsmi): []), (rs2228570 (foki): []), (vitamin d receptor (vdr) gene: [gngm]), (susceptibility: [clna]), (childhood asd: [cgab]), (severity: []), (disease: [dsyn]), (total: [qnco]), (children: [aggp]), (asd: [cgab]), (healthy controls: []), (han: [lang]), (chinese population: [popg]), (recruited: []), (snp genotyping: [mbrt]), (taqman: []), (probe-based real-time pcr: [mbrt]), (genomic dna: [nnon]), (blood cells: [cell]), (snps: [nusq]), (ct genotype (odds: [orga]), ((or) =: []), (confidence interval (ci): [qnco]), (p: [gngm]), (c allele (or: [gngm]), (ci: [gngm]), (rs731276: []), (increased risks: [qnco]), (none: []), (results: [fndg]), (certain polymorphisms: [genf]), (vdr gene: [gngm]), (risk factor: [qnco]), (han chinese population: [popg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(vitamin d receptor gene, 'Dietary Supplements')

PMCID: 5802583
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (children: [aggp]), (us: []), (disease control: [topp]), (prevention (cdc): [hcro]), (impairments: [patf]), (social interactions: [fndg]), (repetitive patterns: []), (behaviors: [inbe]), (interests: [menp]), (complexity: [chvs]), (limited number: [qnco]), (treatment options: [topp]), (debilitating symptoms: [sosy]), (studies: [lbpr]), (genetic link: [topp]), (environmental factors: []), (medications: [clna]), ( toxins: [bacs,hops]), (maternal infection: [fndg]), (pregnancy: [orgf]), (birth complications: [fndg]), (role: [socb]), (set: [menp]), (candidate genes: [gngm]), (different dna methylation profiles: [moft]), (asd: [cgab]), (healthy individuals: [humn]), (epigenetic alterations: []), (geneenvironment gap: []), (neurobiology: []), (autism: [mobd]), (however: []), (epigenome-wide association studies: [menp]), (postmortem brain samples: [bpoc]), (hence: []), (cellular models: [cell]), (brain development: [ortf]), (vitro: []), (great importance: [qnco]), (critical epigenetic alterations: []), (review: []), (overview: []), (state: []), (art: [gngm]), (knowledge: []), (epigenetic changes: [qnco]), (new: []), ( cutting edge expertise: [topp]), (three-dimensional (3d) stem cell technology models: [cell]), (multiple aspects: [qnco]), (disease mechanisms: [dsyn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(social interactions, 'Reciprocal Social Interaction')(repetitive patterns of behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(medications, 'Medications')(birth complications, 'Obstetric Delivery Complications')(autism, 'Autism Phenotype')(mimicking brain development in vitro, 'Imitation')

PMCID: 5802496
SFARI Genes: GRIN1, GRIN2A, GRIN1, GRIN2A, 
Non SFARI Genes: GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRIN2C, GRIN2D, GRIN2D, GRIN2C, GRIN2D, 
Named Entities: (schizophrenia (scz): [mobd]), (autism spectrum disorder: [mobd]), (dysregulation: []), (glutamate transmission: [aapp,bacs]), (n-methyl-d-aspartate receptors (nmdars): [aapp,rcpt]), (potential etiological mechanism: []), (previous studies: [lbpr]), (evidence: []), (nmdar-encoding genes' role: [aapp,rcpt]), (etiology: []), (scz: []), (asd: [cgab]), (screening study: [resa]), (exonic regions: [bacs,nnon]), (grin1: [gngm]), ( grin2a: [gngm]), ( grin2c: [gngm]), ( grin2d: [gngm]), ( grin3a: [gngm]), (grin3b: [gngm]), (nmdar subunits: [aapp,rcpt]), (participates: []), ((370 scz: []), (asd): [cgab]), (forty: [qnco]), (rare variants: [gngm]), (frameshift mutation: [comd]), (grin2c: [gngm]), (splice site mutation: [genf]), (grin2d: [gngm]), (silico analysis: [resa]), (variants: []), (missense variants: [fndg]), (deleterious prediction: []), (de: []), (analysis: [resa]), (pedigree samples: [sbst]), (intron retention: [bacs,nnon]), (minigene assay: [lbpr]), (independent sample: [sbst]), (comprising: [acty]), (asd cases: [cgab]), (controls: [sbst]), (study: [resa]), (support: []), (view: []), (ultra-rare variants: [gngm]), (loss: [qnco]), (function (frameshift: [comd]), ( nonsense: [comd]), (splice site): [blor]), (nmdars genes: [aapp,rcpt]), (possible risk: []), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5802446
SFARI Genes: CHD8, EHMT1, SATB2, CHD8, EHMT1, SATB2, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (affected neural circuits: [bpoc]), (cell types: [cell]), (different developmental stages: []), (multiple sets: [menp]), (human single cell: [humn]), (transcriptome profiles: [qnco]), (asd candidates: [cgab]), (enriched gene expression: [genf]), (inhibitory neurons: [acty]), (hubs: [gngm]), (co-expression gene module: [moft]), (inhibitory: [acty]), (feature: []), (excitatory neurons: [cell]), (addition: []), (upregulated genes: [gngm]), (multiple asd cortex samples: [bpoc]), (genes: [gngm]), (potential increase: []), (imbalance: [sosy]), (ratio: [qnco]), (excitatory: []), (asd brains: [cgab]), (downstream targets: [diap]), (several asd candidates: [cgab]), (chd8: [gngm]), ( ehmt1: [gngm]), (satb2: [gngm]), (enriched expression: [topp]), (analyses: [resa]), (single cell: [fndg]), (transcriptomic data suggest: [nusq]), (major neuron subtype: [cell]), (disruption: []), (asd gene: [cgab]), (functional evidence: []), (excitatory/inhibitory (e/i) imbalance hypothesis: [acty]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(different developmental stages, 'Learning Disorders')

PMCID: 5759870
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder: [mobd]), (epilepsy: [dsyn]), (extent: []), (association: [menp]), (autism symptoms: [mobd]), (aetiology: []), (direct effects: []), (seizures: [sosy]), (topic: []), (debate: [acty]), (angelman syndrome (as): [dsyn]), (suitable disease model: [emod]), (data: [euka]), (medical records: [clna]), (questionnaires: []), (age: [orga]), (onset: [qnco]), ( autism: [mobd]), (symptoms: [sosy]), ( genetic aberration: [topp]), (communication level: [socb]), (forty-eight participants: [popg]), ((median age: [orga]), (years; range: [qnco]), (years): []), (measure: [qnco]), (social communication questionnaire; scq): [socb]), (individuals: [humn]), (years: []), (genetic cause: [topp]), (deletion: [genf]), (other genetic aberrations: [topp]), (15q11-q13 area: [celc]), (number: [qnco]), (signs: [fndg]), (sign: [fndg]), (signs): [fndg]), (nonverbal communication: [menp]), (mean age: [orga]), (epilepsy onset: [qnco]), (months7.8 years): []), (mean scq score: [clna]), ((sd: [mamm]), (p: [gngm]), (age differences: [aggp]), (groups: [popg]), (presence: [qnco]), ( level: [phsu]), (type: [qnco]), (genetic aberration: [topp]), (scq scores: [clna]), (p =: [aapp,imft]), (group: [popg]), ((19.4: []), (scq (r =: [clna]), (multiple regression: []), (seizure onset: [qnco]), (scq score ( =: [clna]), (genetic abnormality: [fndg]), ((r2 =: [neop]), (f: [inch,phsu]), (study: [resa]), (support: []), (notion: []), (underlying genetic pathology alone: [fndg]), (rare genetic syndrome: [dsyn]), (angelman syndrome: [dsyn]), (relation: [socb]), (autism symptomatology: [mobd]), 
ASD Terms: (autism symptoms, 'Complaints and Indications')(autism spectrum disorder, 'Autism Phenotype')(epilepsy, 'Epilepsy')(medical records, 'Medications')(onset, 'Onset of Symptoms')(autism, 'Autism Phenotype')(autism symptoms, 'Complaints and Indications')(nonverbal communication, 'Non-Verbal Communication')(epilepsy onset, 'Onset of Symptoms')(epilepsy, 'Epilepsy')(epilepsy onset, 'Onset of Symptoms')(seizure onset, 'Onset of Symptoms')(epilepsy, 'Epilepsy')(autism symptomatology, 'Autism Phenotype')

PMCID: 5759230
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (substantial amount: [qnco]), (research: [resa]), (rate: [qnco]), (autistic type: [mobd]), (problems: []), (males: [orga]), (male: [orga]), (ratio: [qnco]), (consistent findings: []), (autism spectrum disorder (asd): [mobd]), (interest: [menp]), (asd: [cgab]), (genetic disorders: [dsyn]), (increased: [qnco]), (prevalence: [qnco]), (general population: [popg]), (smith-magenis syndrome (sms): [dsyn]), (complex genetic syndrome: [dsyn]), (interstitial deletion: [genf]), (chromosome: [celc]), (mutation: [genf]), (retinoic acid: [orch,phsu,vita]), (gene: [gngm]), (disorder: [dsyn]), (intellectual disability: [mobd]), (multiple congenital anomalies: [cgab]), (neurobehavioural abnormalities: [cgab]), (disrupted circadian sleep-wake pattern: [fndg]), (parents: []), (persons: [popg]), (sms: [gngm]), (years: []), (study: [resa]), (total: [qnco]), (age: [orga]), (time: []), (sweden: []), (norway: []), (information: []), (number: [qnco]), (autism spectrum symptoms: [sosy]), (social communication questionnaire (scq): [socb]), (social responsiveness scale (srs): [acty]), (adaptive behaviour: [inbe]), (vineland adaptive behavior scale ii: []), (level: [phsu]), (review: []), (medical chart: [hlca]), (significant gender differences: [orga]), (asd symptomatology: [cgab]), (scq: []), (srs questionnaires: []), (females: [orga]), (scq cutoff: []), (same differences: [qnco]), (intellectual level: [phsu]), (emotional problems: [mobd]), (gender: [orga]), (independent contribution: [acty]), (regression model: [menp]), (total scq score: [clna]), (developmental behaviour checklist: [inbe]), (scq scores: [clna]), (gender difference: [orga]), (search: [acty]), (female protective factors: [inbe]), (male bias: [orga]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(autism spectrum symptoms, 'Complaints and Indications')(social communication questionnaire, 'Reciprocal Social Interaction')(adaptive behaviour, 'Adaptive Life Skills')(vineland adaptive behavior scale ii, 'Adaptive Life Skills')(level of intellectual disability, 'Learning Disorders')(medical chart, 'Medications')(social communication questionnaire cutoff, 'Reciprocal Social Interaction')(total social communication questionnaire score, 'Reciprocal Social Interaction')(social communication questionnaire scores, 'Reciprocal Social Interaction')

PMCID: 6061181
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (impairments: [patf]), (language: [lang]), (communication: [socb]), (social behavior: [socb]), (occurrence: []), (stereotypic patterns: [menp]), (behavior: [inbe]), (interests: [menp]), (substantial speculation: []), (causes: []), (asd: [cgab]), (exact etiology: []), (recent studies: [lbpr]), (link: []), (immune dysfunction: [dsyn]), (behavioral traits: [inbe]), (various immune anomalies: [phsu]), (cellular immunity: [orgf]), (abnormalities: [cgab]), (molecular level: [phsu]), (evidence: []), (altered immune function: [ortf]), (cerebrospinal fluid: [bdsu]), (peripheral blood: [bdsu]), (several studies: [lbpr]), (role: [socb]), (neuroinflammation: []), (brain tissue: [bpoc]), (cerebrospinal fluid analysis: [bdsu]), (microglial activation: [celf]), (immune abnormalities: [cgab]), (substantial number: [qnco]), (individuals: [humn]), (subgroups: [virs]), (immune system dysregulation: [fndg]), (specific cellular immunophenotypes: [lbpr]), (different symptoms: [sosy]), (group: [popg]), (patients: [podg]), (major etiology: []), (behavioral symptoms: [sosy]), (determinations: []), (opportunity: []), (causative treatments: [topp]), (defined patient group: [popg]), (approach: []), (review: []), (recent insights: [menp]), (immune system dysfunction: [bdsy]), (potential implications: []), (future therapies: [topp]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1007/s12035-017-0822-x) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (impairments in language, 'Language Ability')(stereotypic patterns, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorders, 'Autism Phenotype')(social behavior, 'Reciprocal Social Interaction')(cerebrospinal fluid, 'Hydrocephalus')(cerebrospinal fluid analysis, 'Hydrocephalus')

PMCID: 5753567
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disease: [mobd]), (deficit: [dsyn]), (social interactions: [fndg]), (communication: [socb]), (restrictive behavior: [mobd]), (altered cells: [cell]), (metabolic enzymes: [enzy,orch]), (dysregulation: []), (canonical wnt/-catenin pathway: [moft]), (asd: [cgab]), (review: []), (hypothesis: []), (warburg effect: [comd]), (overexpression: [genf]), (upregulation: [genf]), (wnt/-catenin pathway induces: [moft]), (aerobic glycolysis: [moft]), (warburg: []), (activation: [acty]), (glucose transporter (glut): [aapp,bacs]), ( pyruvate kinase m2 (pkm2): [aapp,enzy]), ( pyruvate dehydrogenase: [aapp,enzy]), (monocarboxylate lactate transporter: [aapp,bacs]), ((mct-1): [aapp,bacs]), ( lactate dehydrogenase: [aapp,enzy]), (inactivation: []), (pyruvate dehydrogenase: [aapp,enzy]), (complex (pdh): [dsyn]), (supply: [qnco]), (large part: [qnco]), (glucose: [bacs,orch,phsu]), (lactate regardless: [orch,phsu]), (oxygen: [elii,phsu]), (terms: [orgf]), (atp production: [aapp,enzy]), (oxidative phosphorylation: [moft]), (shunt: [fndg]), (tca cycle: [moft]), (energetic metabolism: [orgf]), (cell deregulation: [acty]), (progression: [patf]), (warburg effect regulation: [biof]), (attractive target: [diap]), (therapeutic interventions: [topp]), 
ASD Terms: (social interactions, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disease, 'Learning Disorders')(restrictive behavior, 'Restricted and Repetitive Behavior')(energetic metabolism, 'Abnormal Activity or Energy Level')

PMCID: 6014693
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background: emerging work: []), (neurodevelopmental outcomes: [ortf]), (prenatal exposure: [fndg]), (per-: []), (polyfluoroalkyl substances: [sbst]), (few studies: [lbpr]), (associations: [menp]), (autism spectrum disorder (asd): [mobd]), (objectives:: []), (objective: []), (maternal prenatal pfas concentrations: [menp]), (asd: [cgab]), (intellectual disability (id): [mobd]), (children: [aggp]), (methods: participants: [popg]), (population-based nested casecontrol study: [resa]), (southern california: [plnt]), (asd (n=553): [cgab]), ( id: [lbpr]), (autism (n=189): [mobd]), (general population (gp): [popg]), ((n=433): [aapp,imft]), (concentrations: [menp]), (pfas: [gngm]), (maternal sera: [bdsu]), (wk gestational age: [orga]), (study groups: [popg]), (logistic regression: [resa]), (adjusted odds ratios: [qnco]), (association: [menp]), (prenatal pfas concentrations: [menp]), (quartiles): []), (asd versus gp controls: [cgab]), (id versus gp controls: [lbpr]), (results: geometric: [fndg]), (mean concentrations: [menp]), (id groups: [popg]), (gp controls: [gngm]), (prenatal concentrations: [menp]), (significant inverse associations: [qnco]), (perfluorooctanoate (pfoa): [orch,phsu]), (perfluorooctane sulfonate (pfos): [orch,phsu]), (ors: [inch,phsu]), (vs: []), (quartiles: []), ((95% ci:: [lbpr]), (respectively]: []), (results: [fndg]), (id: [lbpr]), (similar: []), (conclusions: results: [fndg]), (large casecontrol study: [resa]), (prenatal measurements: [aggp]), (hypothesis: []), (https://doi.org/10.1289/ehp1830: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental outcomes, 'Learning Disorders')(prenatal exposure, 'Exposures')(intellectual disability in children, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(autism, 'Autism Phenotype')(wk gestational age, 'Perinatal History')(intellectual disability versus general population controls, 'Learning Disorders')(intellectual disability groups, 'Learning Disorders')(results for intellectual disability, 'Learning Disorders')(prenatal exposure, 'Exposures')

PMCID: 6055932
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (strong role: [socb]), (genetics: []), (phenotypic manifestation: [orga]), (autism spectrum disorder: [mobd]), (specific genes: [gngm]), (variable forms: []), (asd: [cgab]), (combinatorial genetic model: []), (epistatic interactions: [fndg]), (many small effect mutations: [genf]), (coalitional: [socb]), (cooperative game theory: [orgt]), (technique: []), (studies: [lbpr]), (combined effects: []), (groups: [popg]), (players: []), (coalitions: [socb]), (performance--the relationship: [inbe]), (specific disease: [dsyn]), (coalition: [socb]), (method: [lbpr]), (informative signal: [phpr]), (gene expression data: [genf]), (to-date: [aapp,enzy]), (search: [acty]), (cooperative mutations: [genf]), (putative asd genes: [cgab]), (approach: []), (genes: [gngm]), (coalitional game theory: [socb]), (alteration data: [euka]), (genomes: [gngm]), (multiplex families: [famg]), (alterations: []), (binary matrices: []), (asd (case): [cgab]), (unaffected (control) samples: [sbst]), (likely gene-disrupting: [gngm]), ( inherited mutations: [genf]), (altered genes: [gngm]), (individual gene contributions: [gngm]), (asd phenotype: [cgab]), (player metric: [orch,phsu]), (shapley value: [qnco]), (gene: [gngm]), (case: []), (control cohorts: [popg]), (sixty: [qnco]), (player scores: [clna]), (likely represent: [acty]), (significant contributors: [qnco]), (genetic coordination: [phsf]), (network: [popg]), (cross-study analysis: [resa]), (biological pathways: [moft]), (autism cases: [mobd]), (subset: []), (several genes: [famg]), (strong associations: [menp]), (findings: [clna]), (large-scale genomic data: [gngm]), (influential players: []), (complex polygenic disorders: [dsyn]), (autism: [mobd]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(informative signal in gene expression data, 'Ability to Convey Information')(asd phenotype, 'Autism Phenotype')(genetic coordination, 'Motor Skills')(autism cases, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5758853
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (effects: []), (age: [orga]), (genotype: [orga]), (regard: []), (severity: []), (aberrant: []), ( autistic: [mobd]), (food-related behaviors: [inbe]), (prader-willi syndrome (pws): [cgab]), (emphasis: []), (contrast: [irda]), (adolescents: [aggp]), (young adults: [aggp]), (aberrant behavior checklist: [inbe]), (japanese version: [popg]), (food related problem questionnaire (frpq): [imft,phsu]), (pervasive developmental disorders autism society japan rating scale (pars): [aapp,enzy]), (pws patients: [cgab]), (significant differences: [qnco]), (u tests): [lbpr]), (abc-j (p: [dsyn]), (pars (p: [aapp,enzy]), (scores: [clna]), (del subgroups: [comd]), (age groups: [aggp]), (mupd subgroups: [virs]), (significant difference: [qnco]), (terms: [orgf]), (frpq (p: [aapp,imft]), (results: [fndg]), (autistic behaviors: [mobd]), (trend: []), (other hand: [bpoc]), ( food-related behaviors: [inbe]), (sign: [fndg]), (change: [qnco]), (transitory stage: [clna]), (mupd: []), (aberrant behaviors: [inbe]), 
ASD Terms: (prader-willi syndrome, 'Prader-Willi Syndrome')(pervasive developmental disorders autism society japan rating scale, 'Autism Phenotype')(prader-willi syndrome patients, 'Prader-Willi Syndrome')

PMCID: 5741226
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (brain connectivity: [bpoc]), (autism spectrum disorders: [mobd]), (heterogeneous nature: [orga]), (spectrum: [qnco]), (connectivity: []), (brain: [bpoc]), (complex: [chvs]), ( multilevel: []), (multi-temporal manner: [qnco]), (fluctuations: [sosy]), (local oxygen demand: [biof]), (different time scales: [bpoc]), (study: [resa]), (model-free complexity analysis: []), (fractal dimension: [qnco]), (rs-bold signal: [phpr]), (magnetic resonance imaging: [diap]), (measure: [qnco]), (signal complexity: [chvs]), (previous studies: [lbpr]), (reduction: [npop]), (disease: [dsyn]), (detectable difference: [qnco]), (rs-bold signal complexity: [chvs]), (asd patients: [cgab]), (controls: [sbst]), (methods: []), (findings anatomical: [clna]), (functional data: [euka]), (fifty-five subjects: [humn]), (asd (12.7: [cgab]), (y/o): []), (age-matched (14.1: [orga]), (healthy controls: []), (nitrc database: []), (abide project: []), (subjects: [humn]), (ge signa mri: [diap]), (32-channel rf-coil: [npop]), (axial fspgr-3d images: [diap]), (rs-bold (te/tr =: [elii,hops]), (time points: []), (motion correction: [npop]), (functional images: []), (n27 standard brain atlas: [bpoc]), (fractal analysis: [resa]), (grey matter mask: [tisu]), (hurst exponent: [qnco]), (frequency domain: [qnco]), (power: [hcpp]), (spectral density approach: [qnco]), (estimation: [qnco]), (time domain: []), (de-trended fluctuation analysis: [resa]), (signal summation conversion methods: [phpr]), (voxel-wise: [gngm]), (fractal dimension (fd): [qnco]), (subject: [humn]), (control group: [grup]), (asd group: [cgab]), (roi-based z-scores: [qnco]), (voxel-wise validation: [resa]), (fd normality: [qnco]), (non-gaussian voxels: [qnco]), (subsequent analysis: [resa]), (confidence level: [menp]), (z-score values: [qnco]), (standard deviations: [qnco]), (mean (i.e: [qnco]), (|z|: []), (analysis: [resa]), (main regions: []), (amygdala (p =: [bpoc]), (vermis (p: [bpoc]), (basal: []), ((p =: [aapp,imft]), (hippocampus (p: [bpoc]), (regions: []), (significant increase: [qnco]), (findings: [clna]), (adir: [gngm]), (ados assessment tools: [aapp,enzy]), (correlation: []), (ados metrics: [orch,phsu]), (complex system: [chvs]), (complexity: [chvs]), (brain oxygen demand: [biof]), (utilization: []), (important information: []), (connectivity issues: [phpr]), (asd: [cgab]), (moreover: []), (technique: []), (characterization: [acty]), (single subject: [fndg]), (respect: [socb]), (need: []), (group analysis: [popg]), (novel approach: []), (ideal avenue: []), (personalized diagnostics: [fndg]), (unique patient specific assessment: [hlca]), (treatments: [topp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 5902398
SFARI Genes: PTEN, MECP2, PTEN, MECP2, KIRREL3, KIRREL3, KIRREL3, KIRREL3, TSC2, TSC2, TSC2, TSC2, KIRREL3, KIRREL3, 
Non SFARI Genes: 
Named Entities: (abstract genetic testing: [lbpr]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (clinical setting: []), (american college: [popg]), (medical genetics: []), (genomics (acmgg) guidelines: []), (microarray: []), (fragile x: [comd]), (boys: [aggp]), (additional gene sequencing: [lbpr]), (pten: [gngm]), (mecp2: [gngm]), (appropriate patients: [podg]), (increasingly: []), (utilizing high throughput: [qnco]), (gene panels: [gngm]), (whole exome sequencing: [mbrt]), (well: []), ( fragile x testing: [comd]), (gene panel: [gngm]), (genes: [gngm]), (asd risk: [cgab]), (clinical population: [popg]), (characterized children: [aggp]), (asd: [cgab]), (frequency: [qnco]), (rare variants: [gngm]), (individual genes: [gngm]), (exome aggregation consortium (exac) database: [gngm]), (conditions: [dsyn]), (complete penetrance: [qnco]), (asd; however: [cgab]), ( copy number variants: [nusq]), (likely pathogenic variants: [fndg]), ( yet: []), (careful analysis: [resa]), ( none: []), (likely causative: []), (disease: [dsyn]), (kirrel3 variants: [gngm]), (exac: []), (potential role: [socb]), (minor facial dysmorphism: [fndg]), (intellectual disability: [mobd]), (increase: []), (tsc2: [gngm]), (however: []), ( analysis: [resa]), (variant data: [euka]), (simons simplex collection: [bpoc]), (specific racial/ethnic groups: [popg]), (population: [popg]), (exac database: []), (yield: []), ( fragile x (boys): [aggp]), (diagnostic yield;: [fndg]), (kirrel3: [gngm]), (findings: [clna]), (need: []), (racial/ethnic diversity: [popg]), (largescale genomic databases: []), (variants: []), (risk: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(medical genetics, 'Medications')(fragile x, 'Fragile X Syndrome')(fragile x testing, 'Fragile X Syndrome')(intellectual disability, 'Learning Disorders')(fragile x, 'Fragile X Syndrome')

PMCID: 5738835
SFARI Genes: PTEN, PTEN, PTEN, MTOR, PPP2R5D, PTEN, MTOR, PPP2R5D, PTEN, PTEN, 
Non SFARI Genes: PIK3CA, PIK3CA, rest, 
Named Entities: (macrocephaly: [cgab]), (head circumference: [clna]), (standard deviations: [qnco]), (feature: []), (children: [aggp]), (developmental delay and/or autism spectrum disorder: [mobd]), (pten: [gngm]), (well-known gene: [gngm]), (patients: [podg]), (syndromic presentation: [dsyn]), (other genes: [gngm]), (pi3k-akt-mtor: [aapp,enzy]), (pathway: [moft]), (important roles: [socb]), (aim: [phsu]), (study: [resa]), (mutation spectrum: [genf]), (group: [popg]), (whole-exome sequencing: [mbrt]), (developmental delay/autism spectrum disorder: [mobd]), (sources: [fndg]), (genomic dna: [nnon]), (blood: [bdsu]), ( buccal mucosa: [bpoc]), (saliva: [bdsu]), (germline mutations: [genf]), (sanger sequencing: [mbrt]), ( whereas: []), (somatic mutations: [comd]), (droplet: []), (digital pcr: [mbrt]), (pathogenic mutations: [genf]), (pten (n: [aapp,enzy]), (pik3ca (n: [aapp,enzy]), (mtor (n =: [aapp,enzy]), (ppp2r5d (n: [aapp,bacs]), (additional pten mutation: [aapp,enzy]), (variant: []), (unknown significance: [fndg]), (patient: [podg]), (pathogenic pten mutation: [aapp,enzy]), (harbour bi-allelic germline pten mutations: [gngm]), (somatic pik3ca mutations: [aapp,enzy]), (level: [phsu]), (somatic mosaicism: [fndg]), (blood dna: [bdsu]), (mutations: [genf]), (pi3k-akt-mtor pathway: [aapp,enzy]), (developmental quotient: [orgf]), (rest: [gngm]), (cohort (dq: [popg]), (vs: []), (p: [gngm]), (dysmorphic features: [cgab]), (ten patients: [dsyn]), (identified mutations: [genf]), ( brain: [bpoc]), (magnetic resonance imaging: [diap]), (megalencephaly: [cgab]), (half: [qnco]), (subtle dysmorphic features: [cgab]), (mild developmental issues: [fndg]), (clinically: []), ( patients: [podg]), (therefore: []), ( sequencing: [mbrt]), (saliva dna: [bacs,nnon]), (high diagnostic yield: [fndg]), (management implications: [hlca]), (comprehensive genetic testing: [lbpr]), (clinical evaluation: [hlca]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-017-0182-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (developmental delay and/or autism spectrum disorder, 'Autism Phenotype')(buccal mucosa, 'Ulcerative Colitis')(mild developmental issues, 'Learning Disorders')

PMCID: 5853625
SFARI Genes: GTF2I, GTF2I, GTF2I, GTF2I, Gtf2i, Gtf2i, Gtf2i, Gtf2i, Gtf2i, Gtf2i, Gtf2i, Gtf2i, Gtf2i, Gtf2i, GTF2i, GTF2i, GTF2i, GTF2i, 
Non SFARI Genes: 
Named Entities: (abstract introduction williamsbeuren syndrome (wbs): [dsyn]), (developmental disorder: [mobd]), (hemizygous deletion: [genf]), (human chromosome: [celc]), (hypersocial behavior: [inbe]), (symptom: [clna]), (wbs: [gngm]), (contrasts: [irda]), (hyposociality: []), (autism spectrum disorder (asd): [mobd]), (interestingly: []), ( duplications: []), (asd: [cgab]), (social phenotype: [orga]), (gtf2i: [gngm]), (general transcription factor iii (tfiii): [gngm]), (duplication: [comd]), (deletion (gtf2i +/): [genf]), (duplication (gtf2i +/dup): [comd]), ((gtf2i +/+) littermate controls: [gngm]), (series: [qnco]), (behavioral tasks: [inbe]), (openfield activity monitoring: [topp]), ( olfactory: [orgf]), (social choice: [inbe]), (social transmission: [patf]), (food preference: []), ( habituationdishabituation: []), (operant social motivation paradigms: [menp]), (openfield observations: [hlca]), ( gtf2i +/: [gngm]), (gtf2i +/dup: [gngm]), (normal activity: [acty]), (thigmotaxis: [orgf]), (strain: [menp]), (significant preference: [qnco]), (stimulus mouse: [mamm]), (gtf2i +/+ siblings: [famg]), (gtf2i +/: [gngm]), (normal olfaction: [orgf]), (food probes: [chvf]), (gtf2i +/ mice: [mamm]), (time: []), (urine scent versus water: [sbst]), (other strains: [inpo]), (nosetonose contact: [acty]), (openfield encounter: [bhvr]), (food preference task: []), (operant tasks: []), (social motivation: [menp]), ( gtf2i +/ mice: [mamm]), (presses: []), (social rewards: [menp]), (difference: [qnco]), (gtf2i +/dup mice: [mamm]), (discussion results: [socb]), (paradigms: [resa]), (role: [socb]), (hypersocial phenotype: [orga]), (regulation: [biof]), (social behavior: [socb]), (support: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social behavior, 'Reciprocal Social Interaction')

PMCID: 5735531
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder: [mobd]), (diagnosis: [fndg]), (part: [qnco]), (time: []), (administration: [topp]), (standard exams: [hlca]), (autism diagnostic observation schedule (ados): [hlca]), (shorter: [qnco]), (mobilized approaches: [fndg]), (bottlenecks: []), (healthcare system: [hcro]), (previous work: []), (machine learning: [mcha]), (subset: []), (behaviors: [inbe]), (ados: [aapp,enzy]), (acceptable levels: []), (accuracy: []), (initial work: []), (sparse models: []), (clinical population: [popg]), (collection: []), (score sheets: [clna]), (children: [aggp]), (phrased speech (module: [orgf]), (asd: [cgab]), (controls): [sbst]), (verbal fluency (module: []), (sparsity/parsimony: []), (regularization techniques: []), (nested cross validation: [resa]), (grid search: [gngm]), (features: []), (unique: []), (models: []), (values: []), (additional indicator features: [irda]), (feature: []), (gender: [orga]), (age: [orga]), (interpretable classifiers: []), (robust detection: [topp]), (methods: []), (classification families: [famg]), (sparse use: []), (standard error: [qnco]), (optimal model: []), (reduced sets: [menp]), (majority: [socb]), (performance: [inbe]), (logistic regression: [resa]), (l2 regularization: [blor]), (linear svm: []), (l1 regularization: [gngm]), (area: []), (roc curve: [qnco]), (ados module: [aapp,enzy]), (resulting models: []), (stability: []), (previous machine: []), (efforts: [orgf]), (time complexity: [chvs]), (autism detection: [mobd]), (regularization: []), (small parameter space: [qnco]), (robustness techniques: []), (classifiers: []), (alternative modes: [qnco]), (autism: [mobd]), (screening: [diap]), ( diagnosis: [fndg]), (monitoring: [resa]), (analysis: [resa]), (short home videos: [qnco]), 
ASD Terms: (autism spectrum disorder diagnosis, 'Diagnosis')(autism diagnostic observation schedule, 'Autism Phenotype')(phrased speech, 'Language Ability')(autism diagnostic observation schedule module, 'Autism Phenotype')(autism detection, 'Autism Phenotype')(autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')

PMCID: 5732476
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (instruments: []), (neurodevelopmental disorders: [mobd]), (conditions: [dsyn]), (autismtics: []), ( ad/hd: []), (other comorbidities inventory (a-tac): [diap]), (good excellent validity: [qnco]), (several disorders: [dsyn]), (article: []), (findings: [clna]), (sample: [sbst]), (swedish national patient register (npr): [popg]), (parents: []), (9-year-old swedish twins: [famg]), (telephone interview: [resa]), (child: [aggp]), (adolescent twin study: [resa]), (sweden: []), ( catss: []), (catss: []), (npr: [gngm]), (data: [euka]), (outpatient care: [hlca]), (diagnoses: [fndg]), ((previous validity): [qnco]), ((predictive validity): []), (interview: [acty]), (sensitivity: [patf]), (specificity: [qnco]), (a-tac scores: [clna]), (clinical diagnoses: []), (values: []), (area: []), (curve: []), (clinical diagnosis: []), (autism spectrum disorder (asd): [mobd]), (.98: []), ( attention deficit hyperactivity disorder (adhd) .93: [mobd]), (disorder (ld) .92: [dsyn]), (oppositional defiant disorder (odd) .99: [mobd]), (small differences: [qnco]), (terms: [orgf]), (predictive analyses: [resa]), (a-tac: [phsu]), (little validity: [qnco]), (disorders: [dsyn]), (result support: [fndg]), (previous claims: a-tac: [phsu]), (broad screening instrument: [diap]), (particular strength: [qnco]), (asd: [cgab]), ( adhd: [mobd]), ( ld: [bpoc]), (odd: [gngm]), (ages: [bacs,orch]), (phenotypic information: [orga]), (other child: [aggp]), (psychiatric disorders: [mobd]), (electronic supplementary material: []), (online version: []), ((10.1186/s12888-017-1563-0) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(other comorbidities inventory, 'Comorbidities')(neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')(clinical diagnosis, 'Diagnosis')(attention deficit hyperactivity disorder .93, 'Attention Deficit Disorder with Hyperactivity')(other comorbidities inventory scores, 'Comorbidities')(attention deficit hyperactivity disorder .93, 'Overactivity')(attention deficit hyperactivity disorder, 'Overactivity')(psychiatric disorders, 'Mental Disorders')

PMCID: 6101561
SFARI Genes: 
Non SFARI Genes: SETD1A, 
Named Entities: (abstract common: [qnco]), (genetic variants: [npop]), (gene: [gngm]), (transcription factor: [aapp,bacs]), ((tcf4): [aapp,bacs]), (risk: []), (schizophrenia: [mobd]), (conversely: []), (tcf4 mutations: [aapp,bacs]), (individuals: [humn]), (intellectual disability (id): [mobd]), (autism spectrum disorder (asd): [mobd]), (chromatin immunoprecipitation: [lbpr]), (next generation: [acty]), (genomic targets: [gngm]), (tcf4: [gngm]), (data: [euka]), (disease gene sets: [menp]), (range: [qnco]), (computational tools: [acty]), (sites: []), (genome: [gngm]), (genes: [gngm]), (de: []), (enrichment: []), (e-box (5-catctg): [qnco]), (h3k27ac histone modification: [moft]), (active enhancers: [nnon]), (enrichment analysis: [resa]), (set: [menp]), (tcf4 targets: [aapp,bacs]), (significant functional clusters: [qnco]), (pathways: [moft]), (nervous system: [bdsy]), (development: [orgf]), ( ion transport: [celf]), (signal transduction: [celf]), (co-expression modules: [topp]), (synaptic function: [phsf]), (brain development: [ortf]), (importantly: []), (novo mutations: [genf]), (schizophrenia (p: [mobd]), (asd (p: [cgab]), (id (p: [lbpr]), (other schizophrenia risk loci: [mobd]), (nicotinic acetylcholine receptor cluster: [aapp,rcpt]), ( chrna5/chrna3/chrnb4: [gngm]), (setd1a: [gngm]), (data demonstrate: [euka]), (large number: [qnco]), (neuronal genes: [gngm]), (many genetic risk factors: []), (common neurodevelopmental disorders: [mobd]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(individuals with intellectual disability, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(other schizophrenia risk loci, 'Schizophrenia and Disorders with Psychotic Features')(common neurodevelopmental disorders, 'Learning Disorders')

PMCID: 5721546
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (white matter: [tisu]), (astrocytic abnormalities: [cgab]), (autism: [mobd]), (detailed investigation: [hlca]), (astrocytes: [cell]), (conducted: [inbe]), (investigation: [hlca]), (role: [socb]), (neuroinflammation: []), (autism pathogenesis: [mobd]), (key players: []), (process: [phpr]), (first study: [qnco]), (astrocyte density: [cell]), (morphology: [fndg]), (dorsolateral prefrontal cortex (dlpfc): [bpoc]), (individuals: [humn]), (dlpfc: []), (formalin-fixed sections: [hops,orch,phsu]), (autism (n: [mobd]), (age: [orga]), (years): []), (age-matched controls: [orga]), (glial fibrillary acidic protein (gfap): [aapp,bacs]), (density: [qnco]), (other glia: [cell]), (optical fractionator: [orgf]), ( astrocyte: [cell]), (somal size: [cell]), (nucleator: []), (astrocyte process length: [qnco]), (spaceballs: []), (alteration: []), (autism versus: [mobd]), (differences: [qnco]), (astrocyte somal size: [cell]), (process length: [qnco]), (results: [fndg]), (astrocyte abnormalities: [cell]), (however: []), (astrocytic dysregulation: [blor]), (absence: [anab]), (gross morphological changes: [clna]), (lack: []), (extent: []), (small sample size: [qnco]), (wide age range: [qnco]), (pathological features: []), (early stages: [clna]), (nonetheless: []), (future investigations: [hlca]), (functional markers: [clna]), (light: [gngm]), (pathophysiology: [patf]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-017-0181-5) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')(autism pathogenesis, 'Autism Phenotype')(autism versus, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5719902
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (fastest-growing developmental disorders: [fndg]), (united states: []), (variations: []), (placental chorionic surface: [emst]), (vascular network: [anst]), ((pcsvn) structure: []), (overall effects: []), (regulated variations: []), (morphogenesis: [orgf]), (conceptus: [emst]), (fetus vital organs: [emst]), (paper: []), (sound evidences: [npop]), (study: [resa]), (asd risks: [cgab]), (pcsvn: []), (combination: [fndg]), (feature-selection: [genf]), (classification algorithms: []), (twenty: [aggp]), (arterial: [bpoc]), (shape-based pcsvn: []), (high-risk asd cohort: [cgab]), (placentas: [emst]), (population-based cohort: [popg]), (ranked relevance: []), (modified version: []), (random: [resa]), (algorithm: [lbpr]), (boruta method: [lbpr]), (principal component analysis (pca): [qnco]), (principal effects: []), (arterial growth: [orgf]), (fetal surface: [emst]), (placenta: [emst]), (linear discriminant analysis (lda): [resa]), (10-fold cross validation: [resa]), (error statistics: []), (arterial attributes: [bpoc]), (relevant: []), (difference: [qnco]), (low asd risk: [cgab]), (arterial features: [clna]), (principal features: []), (pca: [gngm]), (data variability: [euka]), (pcsvns: []), (high-risk asd pregnancies: [patf]), (branch points: [bpoc]), ( thicker: []), (tortuous arteries: [bpoc]), (extension: []), (surface boundary: []), (branch angles: [bpoc]), (population-based counterparts: [popg]), (set: [menp]), (methods: []), (major pcsvn differences: [fndg]), (high risk asd pregnancies: [patf]), (general population: [popg]), (research paradigm: [resa]), (connections: []), (pcsvn features: []), (fetal outcomes: [emst]), (gestational diabetes: [patf]), (hypertension: [dsyn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(gestational diabetes, 'Perinatal History')

PMCID: 5751211
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (systematic review: []), (studies: [lbpr]), (effects: []), (-3 polyunsaturated fatty acids (pufas): [bacs,orch]), (major: []), (somehow: []), (related: [fndg]), ( developmental psychiatric disorders: autism: [mobd]), ( attention deficit: [mobd]), (hyperactivity disorder: [mobd]), (psychosis: [mobd]), (impact: [gngm]), (-3 pufas: [bacs,orch]), (clinical symptoms: [sosy]), (possible: []), ( brain trajectory: [bpoc]), (children: [aggp]), (adolescents: [aggp]), (illnesses: [sosy]), (biological plausibility: []), (omega-3 fatty acids: [bacs,orch,phsu]), (potential perspectives: []), (field: [irda]), (heterogeneity: [orga]), (study designs: [resa]), (light: [gngm]), (differences: [qnco]), (results: [fndg]), (interpretation: [clna]), 
ASD Terms: (developmental psychiatric disorders, 'Mental Disorders')(autism, 'Autism Phenotype')(hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 5712192
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (complex: [chvs]), ( pervasive: []), (heterogeneous neurodevelopmental conditions: [orga]), (trajectories: []), (significant male bias: [orga]), (unknown etiology: [fndg]), (however: []), (understanding: [menp]), (biological mechanisms: []), (pathophysiology: [patf]), (immune system aberrations: [bdsy]), (cytokine profiles: [aapp,imft]), (role: [socb]), (asd: [cgab]), (altered cytokine levels: [aapp,imft]), (identification: [menp]), (asd subtypes: [cgab]), (provide biological markers: [clna]), (response: [fndg]), (effective treatments: []), (research: [resa]), (relationship: []), (asd symptoms: [cgab]), (infancy: []), (objective: []), (study: [resa]), (relationships: []), (cytokine levels: [aapp,imft]), (severity: []), (other clinical traits: [gngm]), (multiplex: []), (techniques: []), (measure levels: [qnco]), (cytokines: [aapp,imft]), (plasma samples: [bdsu]), (cohort: [popg]), (children: [aggp]), (overall: []), ( results: [fndg]), (significant negative association: [menp]), (platelet-derived growth factor: [aapp,bacs]), (furthermore: []), (significant interaction: [qnco]), (sex: [orgf]), (different immune profile: [lbpr]), (females: [orga]), (asd symptom severity: [cgab]), (levels: []), ( il-1: [aapp,imft]), ( il-8: [aapp,imft]), ( mip-1: [aapp,imft]), (vegf: [gngm]), (males: [orga]), (results: [fndg]), (present study: [qnco]), (altered cytokine response: [aapp,imft]), (profile: [lbpr]), (asd-related symptoms: [cgab]), (potential modifier: [chvf]), (further research: [resa]), (populations: [popg]), (importance: []), (sex comparisons: [orgf]), (longitudinal assessments: [hlca]), (immune system: [bdsy]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-017-0176-2) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(heterogeneous neurodevelopmental conditions, 'Learning Disorders')(asd symptoms, 'Complaints and Indications')(infancy, 'Perinatal History')(asd symptoms, 'Complaints and Indications')(asd symptom severity, 'Complaints and Indications')

PMCID: 5789217
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (significant progress: [qnco]), (study: [resa]), (epidemiology: [hlca]), (genetics: []), (autism: [mobd]), (etiology: []), (patho-physiology: [phsf]), (condition: [dsyn]), (curative treatment: [fndg]), (solid scientific research continues: [resa]), (attempt: [evnt]), (explanations: []), (number: [qnco]), (pure myths: [moft]), (myths: []), (vaccines: [imft,phsu]), (mercury: [elii,hops]), (misguided scientists; frustrated: [menp]), (effective parent groups;: [popg]), (politicians: []), (protection: [fndg]), (vaccination: [topp]), (administration: [topp]), (mercury-chelating agents: [irda,phsu]), (real damage: [inpo]), (autistic individuals: [mobd]), (innocent bystanders: []), (result: [fndg]), (diseases: [dsyn]), (such myths: []), (consequence: []), (authority: [socb]), (scientific evidence: []), (scientific methodology: []), (ground: [topp]), (truths: []), (alternative science: []), (article: []), (origin: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(vaccines, 'Vaccination')(vaccination, 'Vaccination')(autism, 'Autism Phenotype')

PMCID: 5789216
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (impairment: [patf]), (social communication: [socb]), (patterns: []), (behavior: [inbe]), (pharmacological treatment: [topp]), (us food: [imft,phsu]), (drug administration (fda): [hcro]), (core symptoms: [sosy]), (asd: [cgab]), (support: []), (literature: [inpr,mnob]), (management: [hlca]), (behavioral symptoms: [sosy]), (developmental disorder: [mobd]), (particular: []), ( irritability: [fndg]), (hyperactivity: [mobd]), (aripiprazole: [orch,phsu]), (risperidone: [orch,phsu]), (fda: [hcro]), (treatment: [topp]), (irritability: [fndg]), (youth: [aggp]), (fda-approved: [hcro]), ( methylphenidate: [orch,phsu]), (guanfacine: [orch,phsu]), (children: [aggp]), (selective serotonin reuptake inhibitors: [phsu]), (clinical practice: [menp]), (anxiety: [mobd]), (compulsions; however: [mobd]), (little evidence: [fndg]), (use: []), (population: [popg]), (great need: [qnco]), (further research: [resa]), (safety: [hcpp]), (efficacy: [resa]), (psychotropic medications: [phsu]), (development: [orgf]), (new treatment modalities: [topp]), (core: [bdsu]), (associated behavioral symptoms: [sosy]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(restricted patterns of behavior, 'Restricted and Repetitive Behavior')(autism spectrum disorder, 'Autism Phenotype')(core symptoms of asd, 'Complaints and Indications')(hyperactivity, 'Overactivity')(hyperactivity, 'Overactivity')(target anxiety, 'Anxiety Disorders')(compulsions, 'Obsessive-Compulsive Disorder')(psychotropic medications, 'Medications')

PMCID: 5789213
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (group: [popg]), (neurodevelopmental conditions: [dsyn]), (basis: [phsu]), (behavioral assessments: [hlca]), (social deficits: []), (progress: []), (genetic underpinnings: [topp]), (asd-associated genetic variants: [cgab]), (copy number variants: [nusq]), (mutations: [genf]), (asd-risk genes: [cgab]), ( account: [clna]), (%: []), (asd cases: [cgab]), (high level: [qnco]), (genetic heterogeneity: [orga]), (challenges: [hlca]), (genetic testing: [lbpr]), (clinical settings: []), (traditional definition: []), (syndromic asd: [cgab]), (disorder: [dsyn]), (defined pattern: []), (somatic abnormalities: [cell]), (neurobehavioral phenotype: [orga]), (asd: [cgab]), (genetic cause: [topp]), (examples: []), (fragile x syndrome: [cgab,dsyn]), (tuberous sclerosis complex: [neop]), (syndromic autism: [mobd]), (groups: (i): [inch]), (context: [fndg]), (disorders: [dsyn]), (familiarity: [menp]), (clinician: []), (features: []), (syndrome: [dsyn]), (diagnosis: [fndg]), ((eg: []), ( mutation screening: [genf]), (fmr1); (ii) asd: [cgab]), (feature: []), (patients: [podg]), ( asd-associated variants: [cgab]), (genome-wide testing: [gngm]), (microarray: []), ( whole exome sequencing): [mbrt]), (asd groups: [cgab]), (variant: []), (variable somatic abnormalities (dysmorphism: [cell]), (birth defects): [cgab]), (article: []), (common diagnoses: [fndg]), (above categories: []), (testing strategy: [menp]), (individual: [humn]), (complex asd; patients: [cgab]), (latter group: [popg]), (morphologic anomalies: [anab]), (physical examination: [hlca]), (syndromic versus: [dsyn]), (nonsyndromic designation: [fndg]), (classification: []), (genetic etiology: [topp]), (associated spectrum: [qnco]), (penetrance: [qnco]), (somatic manifestations: [sosy]), 
ASD Terms: (neurodevelopmental conditions, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(social deficits, 'Social Competence')(neurobehavioral phenotype, 'Central Nervous System Diseases')(fragile x syndrome, 'Fragile X Syndrome')(tuberous sclerosis complex, 'Tuberous Sclerosis')(syndromic autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')

PMCID: 5789211
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (complex neurodevelopmental disorder: [mobd]), (social deficits: []), (repetitive/restrictive interests: [menp]), (asd: [cgab]), (multiple comorbidities: [qnco]), (intellectual disability: [mobd]), ( anxiety: [mobd]), (epilepsy: [dsyn]), (evidence: []), (major efforts: [orgf]), (genetics: []), (possible contributions: [acty]), (hundreds: []), (genes: [gngm]), (common variation: [qnco]), (copy-number changes: [qnco]), (perspective: []), (overview: []), (current state: [clna]), (asd genetics: [cgab]), (genetic research: [resa]), (development: [orgf]), (vivo: []), (vitro models: []), (animals: [anim]), (patient cells: [podg]), (impact: [gngm]), (genetic mutations: [genf]), (cellular function: [celf]), (efforts: [orgf]), (findings: [clna]), (successful therapies: [topp]), (fruit: []), (valuable insight: [menp]), (disorder: [dsyn]), (new models: []), (future clinical trials: [resa]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(complex neurodevelopmental disorder, 'Learning Disorders')(social deficits, 'Social Competence')(multiple comorbidities, 'Comorbidities')(intellectual disability, 'Learning Disorders')(anxiety, 'Anxiety Disorders')(epilepsy, 'Epilepsy')

PMCID: 5727786
SFARI Genes: A2, RTT, A2, RTT, A2, RTT, A2, RTT, A2, RTT, A2, RTT, A2, A2, 
Non SFARI Genes: 
Named Entities: (rett syndrome (rtt): [dsyn]), (autism spectrum disorders: [mobd]), (expression: [topp]), (brain dysfunction: [dsyn]), (perturbation: []), (physiological/metabolic homeostasis: [biof]), (accordingly: []), (disorders: [dsyn]), (increased vulnerability: [qnco]), (toxicants: [hops]), (redox imbalance: [moft]), ( inflammation: [patf]), (pollution: [eehu]), (impairment: [patf]), (systemic-detoxifying agents: [orgf]), (role: [socb]), (exacerbation: []), (detrimental processes: [phpr]), (hypothesis: []), (activities: [acty]), (related blood-based enzymes: [bdsu]), (paraoxonase-1 (arylesterase: [aapp,enzy]), ( paraoxonase: [aapp,enzy]), (lactonase): [aapp,enzy]), (lipoprotein-associated phospholipase a2 (lp-pla2): [aapp,enzy]), (serum: [bdsu]), (asd: [cgab]), (rtt patients: [dsyn]), (controls: [sbst]), (lactonase: [aapp,enzy]), (lp-pla2: [aapp,enzy]), (similar trend: []), (levels: []), (rtt (p: [dsyn]), (pairwise comparisons): [acty]), (noteworthy: []), (operator curve (roc) analysis: [qnco]), (and: []), ( mostly: [qnco]), ( lp-pla2: [aapp,enzy]), ((lactonase: area: [aapp,enzy]), (curve: []), ( auc: [qnco]), ( auc =: [qnco]), (females: [orga]), (rtt (lactonase: [dsyn]), (results: [fndg]), ( especially: []), ( lp-pla2 activities: [moft]), (novel candidate biomarkers: [clna]), 
ASD Terms: (rett syndrome, 'Rett Syndrome')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 5702092
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (micrornas (mirnas): [bacs,nnon]), (major role: [socb]), (immune responses: [ortf]), (post-transcriptional levels: [genf]), (previously: []), (fluctuating interlukine-1 (il-1)/il-10 ratios: [aapp,imft]), (peripheral blood monocytes: [cell]), (patients: [podg]), (autism spectrum disorders: [mobd]), (study: [resa]), (changes: [qnco]), (mirna expression: [bacs,nnon]), (pbmo: []), (il-1/il-10 ratios: [aapp,imft]), (such changes: [qnco]), (asd: [cgab]), (clinical features: [clna]), (purified pbmo: []), (asd subjects (n: [cgab]), (non-asd controls: [cgab]), (high-throughput sequencing: [mbrt]), (cytokine production: [orgf]), (responses: [orga]), (stimuli: [phpr]), (innate immunity: [orga]), (behavioral symptoms: [sosy]), (aberrant behavioral checklist (abc)]: [inbe]), (same time: []), (sample obtainment: [sbst]), (whole: [qnco]), (difference: [qnco]), (non-asd pbmo: [cgab]), (however: []), (asd cells: [cgab]), (groups: [popg]), (high: [qnco]), ( normal: [fndg]), (low il-1/il-10 ratios: [aapp,imft]), (results section: [qnco]), (comparison: [acty]), (data: [euka]), (namely: []), (3-fold changes: [qnco]), (expression: [topp]), (mir-181a: []), ( mir-93: []), ( mir-223: [gngm]), ( mir-342: []), (mir-1248: []), (asd pbmo: [cgab]), (normal ratios: [qnco]), (mirnas: [bacs,nnon]), (regulation: [biof]), (pathways: [moft]), (production: []), (cytokines: [aapp,imft]), ((il-6: [aapp,imft]), ( tnf-: [aapp,bacs]), (tgf-): [aapp,bacs]), (association: [menp]), (cytokine levels: [aapp,imft]), (high/low il-1/il-10 ratios: [aapp,imft]), (non-ige-mediated food allergy: [patf]), (frequency: [qnco]), (asd subjects: [cgab]), (cytokine profiles: [aapp,imft]), (inflammatory responses: [patf]), (biomarkers: [clna]), (immune-mediated inflammation: [patf]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s12974-017-1003-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(non-ige-mediated food allergy, 'Allergies')

PMCID: 5701449
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prospective studies: [resa]), (infants: [aggp]), (familial risk: [famg]), (autism spectrum disorder (asd): [mobd]), (insights: [menp]), (signs: [fndg]), (disorder: [dsyn]), (heterogeneous samples: [orga]), (unclear aetiology: []), (approach: []), (cohorts: [popg]), (monogenic syndromes: [dsyn]), (high rates: [qnco]), (asd: [cgab]), (opportunity: []), (factors: []), (first report: [qnco]), (prospective study: [resa]), (ten 10-month-old infants: [dsyn]), (neurofibromatosis type: [gngm]), ((nf1): [gngm]), (monogenic disorder: [dsyn]), (high prevalence: [qnco]), (asd symptomatology: [cgab]), (data: [euka]), (nf1: [gngm]), (large cohort: [popg]), (outcome: []), (age: [orga]), (asd (n: [cgab]), (atypical development (n: [aapp,imft]), (typical development (n =: [aapp,imft]), (low-risk controls: [fndg]), (domains: []), (months: []), (parent report: [hlca]), (examiner observation: [hlca]), (adaptive function: [phsf]), (sensory processing: [ortf]), ( social engagement: [fndg]), (temperament: [menp]), (striking impairments: [patf]), (motor: []), (low-risk infants;: [aggp]), (pattern: []), (later asd: [cgab]), (familial cohort (hr-asd): [cgab]), (hr-asd group: [cgab]), (communication delays: [socb]), (low-risk infants: [aggp]), (ten-month-old infants: [dsyn]), (range: [qnco]), (developmental difficulties: [fndg]), (communication domains: [socb]), (hr-asd: [cgab]), (social skills: [socb]), (first information: [qnco]), (early neurodevelopment: [ortf]), (strong inferences: [menp]), (sample size: [qnco]), (findings: [clna]), (implications: []), (early comparative developmental science: [orgf]), (highlight motor functioning: []), (important domain: []), (development: [orgf]), (relevant animal models: [anim]), (clinical implications: []), (important focus: []), (early surveillance: [hlca]), (remediation: []), (genetic disorder: [dsyn]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-017-0178-0) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(atypical development, 'Learning Disorders')(adaptive function, 'Adaptive Life Skills')(social engagement, 'Engaging in Social Conversation')(showed striking impairments in motor, 'Motor Skills')(range of developmental difficulties, 'Learning Disorders')(developmental difficulties, 'Learning Disorders')(social skills, 'Ability to Converse in Social Settings')(highlight motor functioning, 'Motor Skills')

PMCID: 5708064
SFARI Genes: 
Non SFARI Genes: MBP, 
Named Entities: (environmental exposure: [inpo]), (organic endocrine: [bdsy]), (chemicals: [chem]), (dioxins: [hops,orch]), ( dibenzofurans: [orch]), (a (bpa): [gngm]), (phthalates: [orch]), (neurodevelopmental disorders: [mobd]), (autism spectrum disorder (asd): [mobd]), (pilot monitoring study: [resa]), (asd cases: [cgab]), ((td) controls: [sbst]), (years: []), (communities: []), (gulf: []), (mexico: []), (alabama: [euka]), (houses: []), (superfund sites: []), (concentrations: [menp]), (dibenzofurans: [orch]), (serum: [bdsu]), (bpa: [gngm]), (ester metabolites: [orch]), (general linear models: [qnco]), (creatinine-adjusted geometric mean concentrations: [bacs,orch]), (aforementioned chemicals: [chem]), (asd case: [cgab]), (td control groups: [grup]), (findings: [clna]), (means: []), (national health: [popg]), (nutrition examination survey: [resa]), ( survey years: []), (td: []), (study: [resa]), (bpa (59%): [gngm]), (mehhp (26%) concentrations: [menp]), (mbp (50%) concentration: [menp]), (comparable (<20% difference) mep: [gngm]), ( mbzp: []), ( meohp: []), (mcpp concentrations: [orch,phsu]), (preliminary investigation: [hlca]), (dietary exposures: [phpr]), (consumption: [acty]), (certain types: []), (fish: [gngm]), (ocdd concentrations: [menp]), (soft drinks: []), (juices: []), (meohp: []), (respectively: []), 
ASD Terms: (environmental exposure, 'Exposures')(neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(dietary exposures, 'Exposures')

PMCID: 5702026
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (incidence: [qnco]), (prevalence: [qnco]), (autism spectrum disorder (asd): [mobd]), (decades: [qnco]), (considerable efforts: [orgf]), (aetiological factors: []), (association: [menp]), (month: []), (birth: [orgf]), (asd incidence: [qnco]), (retrospective cohort: [resa]), (male children: [aggp]), (january: []), (december: []), (large health organisation: [hcro]), (israel (maccabi healthcare services): [hlca]), ( asd: [cgab]), (boys: [aggp]), (cases: [qnco]), (asd: [cgab]), (rates: [qnco]), (male: [orga]), (live births): []), (children: [aggp]), (may: []), (august: []), ( respectively: []), (february (7.6: []), (socioeconomic status households: [famg]), (ci: [gngm]), (other months: []), (line: [sbst]), (several previous studies: [lbpr]), (likelihood: [qnco]), (autism occurrence: [mobd]), (socioeconomic levels: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism occurrence, 'Autism Phenotype')

PMCID: 5691387
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (complex neurodevelopmental disorders: [mobd]), (individual studies: [humn]), (gene expression: [genf]), (asd cannot: [cgab]), (clear consensus conclusions: [socb]), (systematic review: []), (current findings: [clna]), (brain tissues: [tisu]), (search tool: []), (share: [socb]), (meta-analysis results: [resa]), (here: []), (meta-analysis: [resa]), (brain gene expression profiles: [qnco]), (human asd expression datasets: [humn]), (frozen male cortex: [bpoc]), (female cortex: [bpoc]), (cerebellum samples: [bpoc]), (formalin: [hops,orch,phsu]), (knock-out mouse asd model expression datasets: [cgab]), (collective brain samples): [bpoc]), (r language software: [lang]), (updated database (dbmdega): []), (results: [fndg]), (data: [euka]), (asd studies: [cgab]), (genes: [gngm]), (brain: [bpoc]), (database: []), ( dbmdega (https://dbmdega.shinyapps.io/dbmdega/): [euka]), (manual annotation: [inpr,mnob]), (visualization: [menp]), (degs: [gngm]), (meta-analysis values: [resa]), (plots: []), (gene entries: [gngm]), (meta-values: [euka]), ( statistical values: []), (brain samples: [bpoc]), (searchable meta-analysis results: [resa]), (brain gene: [gngm]), (expression datasets: [topp]), (asd: [cgab]), (candidate genes: [gngm]), (disorder: [dsyn]), (new analytical tool: [resa]), (valuable assistance: [socb]), (discovery: [acty]), (elucidation: []), (molecular pathogenicity: [orga]), (database model: []), (other disorders: [dsyn]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s12859-017-1915-2) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(complex neurodevelopmental disorders, 'Learning Disorders')(visualization, 'Visual Thinking')

PMCID: 5770771
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (human: [humn]), (microdeletion: []), (common gene copy number variations: [nusq]), (risk: []), (intellectual disability (id): [mobd]), (autism spectrum disorder (asd): [mobd]), (people: [popg]), (single copy deletion: [fndg]), (~27: []), (microdeletion syndrome: [dsyn]), (id: [lbpr]), (language: [lang]), ( communication: [socb]), (socialization skills: [edac]), (asd: [cgab]), (studies: [lbpr]), (animal models: [anim]), (single copy: [fndg]), (region: []), (morphological: []), ( behavioral: [inbe]), (electrophysiological abnormalities: [cgab]), (previous studies: [lbpr]), (possibility: []), (overlap: [topp]), (mechanisms: []), (pathophysiology: [patf]), (fragile x syndrome: [cgab,dsyn]), (improvements: []), (fragile x phenotypes: [orga]), (chronic treatment: [topp]), (r-baclofen: [orch,phsu]), (selective agonist: [genf]), (gabab receptors: [aapp,rcpt]), (effects: []), (chronic oral r-baclofen administration: [topp]), (mouse models: [mamm]), (independent laboratories: [mnob,orgt]), (chronic activation: [acty]), (performance: [inbe]), (series: [qnco]), (social tasks: []), (deletion mouse models: [mamm]), (findings: [clna]), (clinical utility: [orgt]), (core symptoms: [sosy]), 
ASD Terms: (confer risk for intellectual disability, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(socialization skills, 'Ability to Converse in Social Settings')(fragile x syndrome, 'Fragile X Syndrome')(fragile x phenotypes, 'Fragile X Syndrome')

PMCID: 5688748
SFARI Genes: MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, AR, MECP2, AR, MECP2, MECP2, MECP2, 
Non SFARI Genes: 
Named Entities: (chromosomal duplication: [comd]), (xq28 region: [celc]), (mecp2 gene: [gngm]), ( share: [socb]), (consistent clinical phenotypes: [orga]), (distinct facial phenotype: [blor]), (mecp2 duplication syndrome: [mobd]), (typical clinical features: [clna]), (infantile hypotonia: [cgab]), ( mild: []), (broad range: [qnco]), (neurodevelopmental disorders: [mobd]), ( recurrent infections: [fndg]), (progressive spasticity: [fndg]), (chinese mecp2 duplication: [aapp,bacs]), (family: [famg]), (patients: [podg]), ((five males: [orga]), (female): [orga]), (asymptomatic female carriers: [fndg]), (kinds: []), (chips: []), (cnv + snp chip: [nusq]), (custom: [acty]), (cnv chip: [nusq]), (mecp2 duplication: [aapp,bacs]), (fluorescent: [irda,orch]), (situ hybridization (fish) analysis: [mbrt]), (exact copy number: [qnco]), (mecp2: [gngm]), (x-chromosome inactivation (xci) analysis: [genf]), (ar gene: [gngm]), (female family members: [orga]), (microsatellite analysis: [mbrt]), (recombination event: [genf]), (mecp2 region: [aapp,bacs]), (affected male subjects: [orga]), (neurodevelopmental symptoms: [sosy]), (intellectual disability: [mobd]), (developmental delay: [mobd]), ( seizure: [sosy]), ( language deficit: [lang]), (autism spectrum disorder): [mobd]), (facial dysmorphism: [cgab]), (other symptoms: [sosy]), (western patients: [podg]), (previous reported: [hlca]), (seizure: [sosy]), (chinese patients: [podg]), (first time: [qnco]), (addition: []), (recombination events: [genf]), (mecp2-duplication allele: [gngm]), (maternal transmission: [patf]), (x: [gngm]), (homologous recombination: [genf]), (chinese pedigree: [lang]), (detailed clinical description: []), (molecular genetic characterization: [acty]), (affected family members: [famg]), (typical phenotype: [orga]), (genomic disorder: [dsyn]), (chinese population: [popg]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s12881-017-0486-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(neurodevelopmental symptoms, 'Learning Disorders')

PMCID: 5684358
SFARI Genes: MEF2C, MEF2C, MEF2C, MEF2C, Mef2c, Mef2c, MEF2C, MEF2C, 
Non SFARI Genes: 
Named Entities: (transcription factor mef2c: [aapp,bacs]), (multiple genes: [fndg]), (spectrum disorder (asd): [cgab]), (human mef2c haploinsufficiency results: [humn]), (asd: [cgab]), (intellectual disability: [mobd]), (epilepsy: [dsyn]), (however: []), (molecular mechanisms: []), (mef2c haploinsufficiency syndrome: [comd]), (mef2c: [gngm]), (+/(mef2c-het) mice exhibit: [mamm]), (behavioral deficits: [inbe]), (human patients: [humn]), (gene expression analyses: [mbrt]), (brains: [bpoc]), (mice: [mamm]), (changes: [qnco]), (genes: [gngm]), (neurogenesis: [orgf]), ( synapse formation: [ortf]), (neuronal cell death: [celf]), (accordingly: []), ( mef2c-het mice exhibit: [mamm]), (neuronal apoptosis: [celf]), (ratio: [qnco]), (excitatory: []), ((e/i) neurotransmission: [celf]), (importantly: []), (neurobehavioral deficits: []), ( e/i imbalance: [inch]), (histological damage: [inpo]), (treatment: [topp]), (nitrosynapsin: []), (new dual-action compound: [chem]), (fda-approved drug memantine: [hcro]), (uncompetitive/fast off-rate antagonist: [fndg]), (nmda-type glutamate receptors: [aapp,rcpt]), (results: [fndg]), (mef2c haploinsufficiency: [comd]), (brain development: [ortf]), (neurobehavioral dysfunction: [dsyn]), (pharmacological intervention: [hlca]), 
ASD Terms: (intellectual disability, 'Learning Disorders')(epilepsy, 'Epilepsy')(behavioral deficits, 'Personal Traits')(neurobehavioral deficits, 'Central Nervous System Diseases')(neurobehavioral dysfunction, 'Central Nervous System Diseases')

PMCID: 5681818
SFARI Genes: SHANK3, SHANK3, met, met, met, met, met, met, 
Non SFARI Genes: 
Named Entities: (limited behavioural phenotype literature: [inpr,mnob]), (phelanmcdermid: []), (syndrome (pms): [dsyn]), (high levels: [qnco]), (activity: [acty]), ( impulsivity: [inbe]), (autism spectrum disorder (asd) behaviours: [mobd]), (divergent profiles: [lbpr]), (asd: [cgab]), (pms: [gngm]), (studies: [lbpr]), (similarities: []), (others: [fndg]), (uneven profile: [lbpr]), (communication impairments: [mobd]), (repetitive behaviours: [inbe]), (evaluation: [hlca]), (behavioural phenotype: [bhvr]), (prevalence: [qnco]), (phenomenology: []), (causal involvement: []), (shank3 gene: [gngm]), (aetiology: []), (carers: []), (individuals: [humn]), (pms (n: [dsyn]), (mean age: [orga]), (sd: [gngm]), (questionnaires: []), (overactivity: [fndg]), ( mood: [menp]), ( interest: [menp]), (pleasure: [menp]), ( repetitive behaviour: [fndg]), (asd phenomenology: [cgab]), (data: [euka]), (matched samples: [sbst]), (fragile x: [comd]), (down syndromes: [dsyn]), (idiopathic asd: [cgab]), (order: [acty]), (profile: [lbpr]), (comparisons: [acty]), (made: first: [qnco]), (total sample: [sbst]), (threshold indicative: []), (autism: [mobd]), (asd screening measure: [cgab]), (results: [fndg]), (mood: [menp]), (differences: [qnco]), (impulsivity: [inbe]), (routine-driven repetitive behaviours: [menp]), (pms;: [dsyn]), (motor-based stereotyped behaviours: [dora]), (common: [qnco]), (sample: [sbst]), (cutoff score: [clna]), (cutoff: []), (impairments: [patf]), (communication: [socb]), (social interaction: [fndg]), (repetitive behaviour: [fndg]), (however: []), (threshold: []), (atypical profile: [lbpr]), (relation: [socb]), (wider: []), (evidence: []), (autism endophenotype: [mobd]), 
ASD Terms: (high levels of activity, 'Abnormal Activity or Energy Level')(autism spectrum disorder behaviours, 'Autism Phenotype')(repetitive behaviours, 'Restricted and Repetitive Behavior')(overactivity, 'Overactivity')(mood, 'Mood')(repetitive behaviour, 'Restricted and Repetitive Behavior')(fragile x, 'Fragile X Syndrome')(down syndromes, 'Down Syndrome')(autism, 'Autism Phenotype')(mood, 'Mood')(routine-driven repetitive behaviours, 'Restricted and Repetitive Behavior')(motor-based stereotyped behaviours, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism endophenotype, 'Autism Phenotype')

PMCID: 5680830
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (symptoms: [sosy]), (attention-deficit/hyperactivity disorder (adhd): [mobd]), (previous findings: [clna]), (children: [aggp]), (asd: [cgab]), (impairment: [patf]), (executive function (ef) abilities: [orga]), (however: []), ( studies: [lbpr]), (association: [menp]), (single framework: [fndg]), (other related factors: [fndg]), (theory: []), (mind (tom) abilities: [orga]), (asd symptoms: [cgab]), (structural equation: []), (relations: [socb]), (ef: []), ( tom: [gngm]), (adhd: [mobd]), (data: [euka]), (population-based sample: [popg]), (adolescents: [aggp]), (full-scale iq: [acty]), ((the special needs: []), (autism project (snap) cohort): [mobd]), (study: [resa]), (multi-informant approach: [qnco]), (performance: [inbe]), (inhibition: [acty]), ( planning: [menp]), ( switching: []), (memory tasks: [menp]), (indexed ef: []), (tasks: []), (indexed tom: [gngm]), (measures: [qnco]), (adhd symptoms: [mobd]), (parent: []), (teacher reports: [fndg]), (direct observation: [hlca]), (shared source: [fndg]), (symptom reporting: [hlca]), (parental rating: [acty]), (latent factor: []), (symptom measures: [qnco]), (parents: []), (impairments: [patf]), (ef abilities: [orga]), (impaired tom: [gngm]), (accounting: []), (associations: [menp]), (cognitive domain: []), (other factors: []), (symptom latent factors: [clna]), (source: [fndg]), (model: []), (correlated pathway: [moft]), (tom factors: [gngm]), (specific relations: [socb]), (cognitive domains: []), (behavioral symptoms: [sosy]), (iq: []), (asd sample: [cgab]), ( symptoms: [sosy]), (separate cognitive domains: []), (tom impairments: [patf]), (likely partial explanation: [qnco]), (co-occurrence: []), (role: [socb]), (reporting effects: [hlca]), (inclusion: [celc]), (independent informants: [grup]), (objective measures: [qnco]), (future research: [resa]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-017-0177-1) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(executive function abilities, 'Executive Function')(asd symptoms, 'Complaints and Indications')(executive function, 'Executive Function')(symptoms of asd, 'Complaints and Indications')(planning, 'Planning')(performance on tasks, 'Task Performance')(planning, 'Planning')(memory tasks, 'Working Memory')(indexed executive function, 'Executive Function')(attention-deficit/hyperactivity disorder symptoms, 'Attention Deficit Disorder with Hyperactivity')(executive function abilities, 'Executive Function')(attention-deficit/hyperactivity disorder symptoms, 'Attention Deficit Disorder with Hyperactivity')(cognitive domain, 'Cognitive Ability')(executive function, 'Executive Function')(attention-deficit/hyperactivity disorder symptom, 'Attention Deficit Disorder with Hyperactivity')(cognitive domains, 'Cognitive Ability')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(separate cognitive domains, 'Cognitive Ability')(executive function, 'Executive Function')(attention-deficit/hyperactivity disorder symptoms, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 5679329
SFARI Genes: RAB39B, RAB39B, RAB39B, RAB39B, RAB39B, RAB39B, RAB39B, RAB39B, 
Non SFARI Genes: impact, 
Named Entities: (autism spectrum disorder: [mobd]), (developmental disorder: [mobd]), (early childhood onset: [fndg]), (males: [orga]), (times: [qnco]), (females: [orga]), (role: [socb]), (sex chromosomes: [celc]), (study: [resa]), (family: [famg]), (asd: [cgab]), (pathogenic nonsense mutation: [comd]), (x-chromosome gene rab39b: [gngm]), (asd phenotype: [cgab]), (clinical phenotyping: [lbpr]), ( microarray: []), (whole genome: [gngm]), ((wgs): [mbrt]), (members: [popg]), (maternal: [famg]), (x inactivation ratio: [genf]), (phase: []), (mutant-induced pluripotent stem cells: [cell]), (nonsense mutation: [comd]), (cortical neurons: [bpoc]), (expression: [topp]), (pathway analyses: []), (inherited rab39b mutation: [genf]), (macrocephaly: [cgab]), ( intellectual disability (id): [mobd]), (female sibling: [famg]), (same mutation: [genf]), (id: [lbpr]), (broad autism phenotype: [mobd]), (transmitting mother: [famg]), (neurodevelopmental diagnosis: [fndg]), (investigation: [hlca]), (maternal preferential inactivation: [famg]), (allele: [gngm]), (such bias: [bird]), (explanation: []), (bias: [bird]), (x inactivation: [genf]), (absence: [anab]), (neurocognitive phenotype: [orga]), (mother: [famg]), (cellular knockout model: [cell]), (rab39b: [gngm]), (impact: [gngm]), (differentiated neurons: [celf]), (several genes: [famg]), (brain development: [ortf]), (function: [phsf]), (pathway enrichment analysis: []), (penetrance: [qnco]), (rab39b mutations: [genf]), (critical role: [socb]), (gene: [gngm]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-017-0175-3) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (early childhood onset, 'Onset of Symptoms')(autism spectrum disorder, 'Autism Phenotype')(asd phenotype, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(broad autism phenotype, 'Autism Phenotype')(neurodevelopmental diagnosis, 'Diagnosis')(neurocognitive phenotype, 'Cognitive Ability')

PMCID: 5726525
SFARI Genes: Arid1b, Arid1b, Arid1b, Arid1b, Arid1b, Arid1b, Arid1b, Pvalb, Arid1b, Pvalb, Arid1b, Arid1b, Arid1b, Arid1b, 
Non SFARI Genes: 
Named Entities: (haploinsufficiency: [comd]), (at-rich: []), (interactive domain: []), ((arid1b) gene causes: [gngm]), (spectrum disorder (asd): [cgab]), (intellectual disability: [mobd]), (neurobiological basis: [phsu]), (here: []), (arid1b knockout mice: [mamm]), (heterozygotes: [orga]), (human patients: [humn]), (arid1b: [gngm]), (heterozygous mice: [mamm]), (decreased number: [qnco]), (cortical gabaergic interneurons: [bpoc]), (reduced proliferation: [patf]), (interneuron progenitors: [cell]), (ganglionic eminence: [bpoc]), (arid1b haploinsufficiency: [comd]), (imbalance: [sosy]), (excitatory: []), (inhibitory synapses: [celc]), (cerebral cortex: [bpoc]), (histone h3: [aapp,bacs]), (acetylation (h3k9ac) overall: [moft]), (h3k9ac: []), (pvalb promoter: [bacs,nnon]), (transcription: [genf]), (abnormal cognitive: [qnco]), (social behavior: [socb]), (treatment: [topp]), (positive allosteric gabaa receptor modulator: [aapp,rcpt]), (results: [fndg]), (critical role: [socb]), (arid1b gene: [gngm]), (interneuron development: [cell]), (behavior: [inbe]), (insight: [menp]), (pathogenesis: [patf]), (asd: [cgab]), 
ASD Terms: (intellectual disability, 'Learning Disorders')(abnormal cognitive, 'Cognitive Ability')(social behavior, 'Reciprocal Social Interaction')

PMCID: 5667738
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (work: []), ( gene expression: [genf]), (autism spectrum disorder (asd): [mobd]), (goal: []), (attributed genes: [gngm]), (classification: []), (objective: []), (combination: [fndg]), (various statistical filters: [phsu]), (wrapper-based geometric binary particle swarm optimization-support vector machine: [qnco]), ((gbpso-svm) algorithm: [lbpr]), (utilization: []), (different filters: []), (mean: [qnco]), (median ratio criterion: [qnco]), (similar genes: [gngm]), (results: [fndg]), (discriminative genes: [gngm]), (last selection steps: [genf]), (presence: [qnco]), (repetitive gene (caps2): [dsyn]), (gene: [gngm]), (asd risk: [cgab]), (gene subset: [gngm]), (gbpso-svm algorithm: [lbpr]), (classification accuracy: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5701309
SFARI Genes: EBF3, EBF3, EBF3, EBF3, 
Non SFARI Genes: 
Named Entities: (whole-exome sequencing: [mbrt]), (unrelated individuals: [fndg]), (global developmental delay: [fndg]), ( hypotonia: [fndg]), (dysmorphic facial features: [fndg]), (increased frequency: [qnco]), (short stature: [cgab,dsyn]), ( ataxia: [sosy]), (autism: [mobd]), (heterozygous frameshift: [comd]), ( nonsense: [comd]), ( splice: []), (missense variants: [fndg]), (early b-cell transcription factor family member: [genf]), ((ebf3) gene: [gngm]), (ebf3: [gngm]), (member: [popg]), (collier/olfactory-1/early b-cell factor (coe) family: [orgf]), (proteins: [aapp,bacs]), (central nervous system (cns) development: [ortf]), (coe proteins: [aapp,bacs]), (regulate neuronal specification: [imft]), ( migration: [phpr]), ( axon guidance: [celf]), (dendritogenesis: []), (development: [orgf]), (neuronal identity: [menp]), (adult neurons: [aggp]), (haploinsufficiency: [comd]), (brain development: [ortf]), (function: [phsf]), (developmental delay: [mobd]), (intellectual disability: [mobd]), (behavioral differences: [inbe]), (individuals: [humn]), (deleterious variant: []), 
ASD Terms: (unrelated individuals with global developmental delay, 'Learning Disorders')(global developmental delay, 'Learning Disorders')(autism, 'Autism Phenotype')(developmental delay, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(behavioral differences, 'Personal Traits')

PMCID: 5701304
SFARI Genes: NR2F1, NR2F1, NR2F1, NR2F1, NR2F1, NR2F1, 
Non SFARI Genes: 
Named Entities: (boschboonstraschaaf: []), (optic atrophy syndrome (bbsoas): [dsyn]), (autosomal dominant disorder: [dsyn]), (mutations: [genf]), (nr2f1 gene: [gngm]), (cases: [qnco]), (bbsoas: [dsyn]), (literature: [inpr,mnob]), (common features: [qnco]), (developmental delay: [mobd]), ( intellectual disability: [mobd]), ( hypotonia: [fndg]), (optic nerve atrophy: [dsyn]), ( attention deficit: [mobd]), (disorder: [dsyn]), ( autism spectrum disorder: [mobd]), ( seizures: [sosy]), (defects: []), ( spasticity: [sosy]), (thinning: []), (corpus callosum: [bpoc]), (unrelated probands: [orga]), (missense variants: [fndg]), (nr2f1: [gngm]), (14-yr-old male patient: [orga]), (hypotonia: [fndg]), (optic nerve hypoplasia: [cgab]), (bone age: [fndg]), (short stature: [cgab,dsyn]), (neurotransmitter levels: [bacs]), (cerebrospinal fluid testing: [bdsu]), (5-yr-old female: [orga]), (severe developmental delay: [fndg]), ( motor: []), (speech delay: [mobd]), (repetitive motion behavior: [npop]), (whole-exome sequencing: [mbrt]), (novel missense nr2f1 variant: [fndg]), (case: []), ( cys86phe: []), (dna-binding domain: [amas]), (leu372pro: []), (ligand-binding domain: [amas]), (presence: [qnco]), (clinical findings: [sosy]), (structural analysis: [topp]), (atomic resolution: [qnco]), (homology-based molecular modeling: [mbrt]), (molecular dynamic simulations: [mcha]), ( support: []), (pathogenicity: [orga]), (variants: []), (abnormal cns neurotransmitters: [bacs]), (macrocephaly: [cgab]), (syndrome: [dsyn]), (phenotypic expansion: [orga]), (review: []), (new evidence: []), (report support genotypephenotype correlations: [hlca]), 
ASD Terms: (developmental delay, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(cerebrospinal fluid, 'Hydrocephalus')(intellectual disability, 'Learning Disorders')(cerebrospinal fluid testing, 'Hydrocephalus')(5-yr-old female with severe developmental delay, 'Learning Disorders')(severe developmental delay, 'Learning Disorders')(speech delay, 'Idiosyncratic and Routinized Speech')(repetitive motion behavior, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 5658953
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (previous studies: [lbpr]), (clear critical region: [fndg]), (medical comorbidities: [hlca]), (children: [aggp]), (deletions: [genf]), (duplications: []), (purpose: []), (study: [resa]), (individuals: [humn]), (small nested deletions: [genf]), (lcr-a: [orch,phsu]), (b region: []), (show: [anim]), (elevated rate: [qnco]), (autism spectrum disorder (asd): [mobd]), (region: []), (patients: [podg]), (nested deletions: [genf]), (b (n: []), (c (n: [aapp,imft]), (d (n: [aapp,imft]), (n dup: [aapp,imft]), (nested regions: []), (parent questionnaire: []), ( record review: [fndg]), ( and: []), (subset: []), ( in-person evaluation: [hlca]), (asd: [cgab]), (diagnostic classification: []), (rates: [qnco]), (involvement: []), (lcr-b: [orch,phsu]), (lcr-d: [orch,phsu]), (fishers: [mamm]), (exact test: []), (sample: [sbst]), (psychiatric diagnoses: [mobd]), (questionnaires: []), (chart review: [hlca]), (group: [popg]), (mean differences: [qnco]), (psychiatric questionnaires: [hlca]), (b: []), (rate: [qnco]), (similar rates: [qnco]), (d: [aapp,imft]), (consistent: []), (prior studies: [lbpr]), (risk: []), (autism spectrum disorder: [mobd]), (replication: [genf]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-017-0171-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (medical comorbidities, 'Comorbidities')(autism spectrum disorder, 'Autism Phenotype')(medical comorbidities, 'Comorbidities')(mean differences on psychiatric questionnaires, 'Mental Disorders')(medical comorbidities, 'Comorbidities')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5656305
SFARI Genes: KMT2C, KMT2C, KMT2C, KMT2C, KMT2C, KMT2C, 
Non SFARI Genes: Arc, 
Named Entities: (kleefstra syndrome: [dsyn]), (haploinsufficiency: [comd]), (euchromatin histone methyltransferase: [celc]), ((ehmt1): [gngm]), (intellectual disability (id): [mobd]), ( autism spectrum disorder (asd): [mobd]), (characteristic facial dysmorphisms: [cgab]), (other variable clinical features: [fndg]), (addition: []), (ehmt1: [gngm]), (variants: []), (additional genes: [gngm]), (smarcb1: [gngm]), ( nr1i3: [gngm]), (kmt2c): [aapp,enzy]), (single individuals: [popg]), (clinical characteristics: [clna]), (here: []), (novel cohort: [popg]), (patients: [podg]), (loss: [qnco]), (function mutations: [phsf]), (histone methyltransferase kmt2c: [aapp,enzy]), (clinical data: []), (kmt2c phenotypic spectrum: [aapp,enzy]), (phenotypic overlap: [orga]), (other related id disorders: [dsyn]), (common molecular basis: [qnco]), (neuropathology: [patf]), (mutations: [genf]), (kmt2c: [gngm]), (role: [socb]), (drosophila kmt2c: [euka]), (related (trr): [fndg]), (nervous system: [bdsy]), (drosophila ehmt1: [euka]), (g9a: [gngm]), ( trr: [gngm]), (mushroom body: [bpoc]), (short term memory: [menp]), (trr chip-seq: [mbrt]), (sites: []), (promoter: [bacs,nnon]), (genes: [gngm]), (neuronal processes: [celc]), (transcriptional profiling: [genf]), (pan-neuronal trr knockdown: [dsyn]), (g9a null mutant fly heads: [euka]), ( respectively: []), (gene: [gngm]), (significant overlap: [topp]), (identical gene ontology enrichments: []), (majority: [socb]), (observed biological convergence: [acty]), (indirect target genes: [gngm]), (however: []), (common direct targets: [qnco]), (drosophila ortholog: [euka]), (arc (arc1): []), (key regulator: []), (synaptic plasticity: [ortf]), (data: [euka]), (molecular convergence: [acty]), (kmt2: []), (ehmt: []), (families: [famg]), (molecular network: [popg]), (group: [popg]), (id/asd-related disorders: [cgab]), 
ASD Terms: (intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(other related intellectual disability disorders, 'Learning Disorders')(short term memory, 'Working Memory')(intellectual disability/asd-related disorders, 'Learning Disorders')

PMCID: 5655952
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autistic personality traits (apt): [mobd]), (schizotypal personality traits: [fndg]), (depression: [mobd]), (however: []), (factors: []), (relationships: []), (focus: []), (current study: [resa]), (effects: []), (childhood neglect: [fndg]), (relationship: []), (apt/spt: [orch,phsu]), (cross-sectional study: [resa]), (first-year students: [popg]), (hunan university: [mnob,orgt]), (chinese medicine: []), (hengyang normal college (changsha: [fndg]), ( china): []), (participants: [popg]), (surveys: []), (apt: [gngm]), ( spt: []), ( childhood neglect: [fndg]), ( abuse: [mobd]), (correlational analyses: [inpr,resa]), ( apt: [orch,phsu]), (spt traits: [gngm]), (depression (p: [mobd]), (hierarchical regression analysis: []), (types: []), (childhood: []), (emotional neglect (: [menp]), (p <: [aapp,imft]), (physical neglect (: [hlca]), (predictors: []), (further analysis: [resa]), (spt: [gngm]), (childhood maltreatment: []), ( neglect: [fndg]), (predicting factor: []), (neglect: [fndg]), (strong mediating factor: [socb]), 
ASD Terms: (autistic personality traits, 'Personal Traits')(schizotypal personality traits, 'Personal Traits')(depression, 'Depressive Disorder')(traits/schizotypal personality traits, 'Personal Traits')(autistic personality traits, 'Personal Traits')(schizotypal personality traits traits, 'Personal Traits')(depression, 'Depressive Disorder')(schizotypal personality traits, 'Personal Traits')(depression, 'Depressive Disorder')(schizotypal personality traits, 'Personal Traits')

PMCID: 5655854
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (haploinsufficiency: [comd]), (forkhead-box protein p1 (foxp1) gene: [gngm]), (neurodevelopmental disorder: [mobd]), (foxp1 syndrome: [dsyn]), (previous studies: [lbpr]), (individuals: [humn]), (foxp1 mutations: [genf]), (deletions: [genf]), (presence: [qnco]), (autism spectrum disorder (asd): [mobd]), (intellectual disability: [mobd]), ( language impairment: [mobd]), (psychiatric features: [hlca]), (goal: []), (present study: [qnco]), (clinical spectrum: [qnco]), (first study: [qnco]), (genotype-phenotype relationship: [orga]), (multiple individuals: [humn]), (battery: [inpo]), (standardized clinical assessments: [hlca]), (genetic: [topp]), (clinical data: []), (children: [aggp]), (adolescents: [aggp]), (ages: [bacs,orch]), (mutations: [genf]), (foxp1: [gngm]), (phenotypic characterization: [orga]), (gold standard asd testing: [cgab]), (norm-referenced measures: [qnco]), (cognition: [menp]), (adaptive behavior: [inbe]), ( language: [lang]), ( motor: []), (visual-motor integration skills: [orgf]), (addition: []), ( psychiatric: [hlca]), ( medical: [hlca]), ( neurological: [clna]), (dysmorphology examinations: [hlca]), (multidisciplinary team: [hlca]), (clinicians: []), (comprehensive review: []), (reported cases: [qnco]), (missense: [fndg]), (in-frame mutations: [genf]), (three-dimensional structure: []), (dna-bound foxp1: [bacs,nnon]), (nonsense: [comd]), (mutation: [genf]), (essential splice site: [blor]), (frameshift: [comd]), (insertion: [genf]), (premature stop codon: [nusq]), (in-frame deletion: [genf]), (prior literature: [inpr,mnob]), (instances: []), (recurrent mutations: [genf]), (private mutations: [genf]), (majority: [socb]), (pathogenic missense: [fndg]), (missense mutations: [genf]), (cohort: [popg]), ( lie: []), (dna-binding domain: [amas]), (amino acids: [aapp,bacs,phsu]), (dna: [bacs,nnon]), (domain: []), (foxp1 dimerization: [npop]), (delays: []), (early motor: []), (language milestones: [lang]), (impairment (expressive language >: [lang]), (receptive language): [lang]), ( asd: [cgab]), (visual-motor integration deficits: [fndg]), (complex psychiatric presentations: [hlca]), (anxiety: [mobd]), ( obsessive-compulsive traits: [fndg]), ( attention deficits: [mobd]), (symptoms: [sosy]), (medical features: [hlca]), (non-specific structural brain abnormalities: [fndg]), (dysmorphic features: [cgab]), ( endocrine: [bdsy]), (gastrointestinal problems: []), ( sleep disturbances: [dsyn]), (sinopulmonary infections: [patf]), (study: [resa]), (novel foxp1 mutations: [comd]), ( identifies: []), (significant clustering: [resa]), (clinical findings: [sosy]), (role foxp1: [socb]), (development: [orgf]), (multiple domains: [qnco]), (functioning: []), (genetic findings: [lbtr]), (clinical genetics practice: [menp]), (accurate genetic diagnosis: [fndg]), (monitoring: [resa]), (treatment: [topp]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-017-0172-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(autism spectrum disorder traits, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(language impairment, 'Language Ability')(cognition, 'Cognitive Ability')(adaptive behavior, 'Adaptive Life Skills')(medical, 'Medications')(neurological, 'Neurologic Indications')(delays in early motor, 'Motor Skills')(language impairment, 'Language Ability')(anxiety, 'Anxiety Disorders')(medical features, 'Medications')(sleep disturbances, 'Sleeping Problems')(genetic diagnosis, 'Diagnosis')(accurate genetic diagnosis, 'Diagnosis')

PMCID: 5654961
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (integration: [genf]), (epigenetic information: []), (autism spectrum disorder (asd): [mobd]), (genetic results: [clna]), (functional insights: [menp]), (type: [qnco]), (information: []), (isolation: [topp]), (genotype: [orga]), (dna methylation (dnam) data: [moft]), (cord blood: [tisu]), (peripheral blood: [bdsu]), (snps: [nusq]), (dna methylation (meqtl lists): [moft]), (available fetal brain: [emst]), (lung meqtl lists: [bpoc]), (enrichment: []), (asd gwas results: [cgab]), (tissue-specific meqtls: [bdsu]), (asd-associated snps: [cgab]), (fetal brain (or: [emst]), (p: [gngm]), (peripheral blood meqtls (or: [bdsu]), (cpg targets: [bacs,nnon]), (asd: [cgab]), (cord: [gngm]), ( blood: [bdsu]), (brain tissues: [tisu]), (immune-related pathways: [moft]), ( consistent: []), (other expression: [topp]), (dnam results: [fndg]), (pathways: [moft]), (genetic findings: [lbtr]), (joint analysis: [bsoj]), (dnam: []), (potential: []), (brain: [bpoc]), (blood-based dnam: [bdsu]), (insights: [menp]), (psychiatric phenotypes: [orga]), (broadly: []), 
ASD Terms: (autism spectrum, 'Autism Phenotype')

PMCID: 5908763
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (challenges: [hlca]), (families: [famg]), (health providers: []), (genetic testing: [lbpr]), (autism spectrum disorder (asd): [mobd]), (qualitative study: [resa]), (parents: []), (unstandardized three-step process: [phpr]), (asd: [cgab]), (step: [gngm]), (clinical diagnosis: []), (providers: []), (team: [grup]), (offer: []), (etiology: []), (testing: []), ( step: [qnco]), (parents decision: [menp]), (professional guidelines: []), (recommendations: []), ( interviews: [acty]), (considerable variability: []), (approaches: []), (lack: []), (consensus: [socb]), (questions: []), (clinical utility: [orgt]), (many families: [famg]), (option: []), (genetic testing;: [lbpr]), (decisions: [menp]), (provider recommendations: [hlca]), (insurance coverage: []), (consideration: [fndg]), (account: [clna]), (different views: []), (variability: []), (ideally: []), ( policy makers: []), (range: [qnco]), (clinical specialties: []), (asd care: [cgab]), (policies: []), (purpose: []), (appropriate use: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(clinical diagnosis, 'Diagnosis')

PMCID: 5680520
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (glyoxalase pathway functions: [aapp,enzy]), (reactive dicarbonyl compounds: [chem]), (glyoxalase pathway: [aapp,enzy]), (antioxidant defense mechanism: [phsu]), (neuroprotection: [celf]), (excessive concentrations: [menp]), (methylglyoxal: [irda,orch]), (deleterious effects: []), (cells: [cell]), (levels: []), (inflammation: [patf]), (oxidative stress: [comd]), (neurodegenerative diseases: [dsyn]), (alzheimer's: []), ( parkinson's: [plnt]), ( aging: [orgf]), (autism spectrum disorder: [mobd]), (accumulation: [fndg]), (antioxidant: [phsu]), (possess several distinct mechanisms: [mobd]), (function: [phsf]), (neuroprotectants: [phsu]), (flavonoids: [orch]), (well-researched secondary plant metabolites: [neop]), (neural cells: [cell]), (novel flavonoids: [orch]), 
ASD Terms: (neurodegenerative diseases, 'Neurodegenerative Diseases')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5640251
SFARI Genes: 
Non SFARI Genes: IV, IV, 
Named Entities: (gastrointestinal (gi) symptoms: [sosy]), (autism spectrum disorder (asd): [mobd]), (pathophysiology: [patf]), (imbalances: [sosy]), (enteric microbiome: [orgm]), (asd: [cgab]), (gi dysfunction: [dsyn]), (disruption: []), (mitochondrial function: [celc]), (microbiome metabolites: [orgm]), (mitochondrial dysfunction: [fndg]), (gi symptoms: [sosy]), (study: [resa]), (cecum biopsies: [diap]), (assumption: []), (certain microbiome metabolites: [orgm]), (butyrate: [orch]), (propionic acid: [orch]), (cecum: [bpoc]), (rectum: [bpoc]), (cecum mucosal biopsies: [bpoc]), (elective diagnostic colonoscopy: [topp]), (single-blind case-control design: [resa]), ( complex: [chvs]), (iv: [gngm]), (synthase activities: [moft]), (complex i-v protein quantity: [inch]), (children: [aggp]), (crohns disease: [dsyn]), (neurotypical children: [aggp]), (nonspecific gi complaints: [fndg]), (measured: [diap]), (protein: [aapp,bacs]), (complex ii: [aapp,enzy]), (asd samples: [cgab]), (other groups: [popg]), ( asd samples: [cgab]), (complex iv: [aapp,enzy]), (synthase: [aapp,enzy]), (gut mucosa: [tisu]), (similar gi symptomatology: [gngm]), (unique pathophysiology: [patf]), (abnormalities: [cgab]), (role: [socb]), (microbiome: [orgm]), (production: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(crohns disease, 'Crohn Disease')(gut mucosa, 'Ulcerative Colitis')

PMCID: 5638204
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (genetic mechanisms: [topp]), (complex diseases: [dsyn]), (hard problem: [fndg]), (methods: []), (power: [hcpp]), (set: [menp]), (responsible genes: [gngm]), (protein-protein interaction networks: []), (gene-disease associations: [gngm]), (bayesian framework: []), ( conflux: []), (disease: [dsyn]), (genes: [gngm]), (data: [euka]), (networks: []), (prior: [evnt]), (main advantages: []), (probabilistic graphical model: [inpr,qnco]), (first: [qnco]), ( networks: []), (substantial impediment: []), (gene discovery: [mbrt]), (structure: []), (probabilistic models: []), (gene inference: [gngm]), (impact: [gngm]), (solution: [bodm]), (noisy network structure directly: [popg]), (second: [qnco]), (track: []), (uncertainty: [fndg]), (gene: [gngm]), (phenotype: [orga]), (fixed list: [phpr]), (gene detection: [gngm]), (individual gene testing: [lbpr]), (performance: [inbe]), (conflux: []), (state-of-the-art diffusion: [npop]), (network-based method hotnet2: [popg]), (variety: []), (other network: [popg]), (variant aggregation methods: [qnco]), (literature-reported gene sets: [gngm]), (hotnet2: []), (several network configurations: [popg]), (biases: []), (patterns: []), (false positives: [lbtr]), (false negatives: [lbtr]), (case: []), (experiments: [resa]), (novel bayesian framework conflux: []), (advantages: []), (current state-of-the-art methods: [clna]), (flexibility: []), (improved power: [hcpp]), (many gene-disease association scenarios: [gngm]), 
ASD Terms: 

PMCID: 5636137
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (altered processing: [acty]), (emotions: [menp]), (ability: [orga]), (social interaction: [fndg]), (communication: [socb]), (autism spectrum disorder: [mobd]), ( asd: [cgab]), (face-emotion recognition: [menp]), (asd: [cgab]), (adolescent age groups: [aggp]), (fifty adolescents: [aggp]), ((age: [orga]), (years): []), (asd diagnosis: [cgab]), (parent-rated social communication questionnaire: [socb]), (cued go/ nogo task: [gngm]), (pictures: []), (facial expressions: [fndg]), (reaction: []), (intra-individual variability: [humn]), (reaction time: []), (omissions/commissions: [fndg]), (social responsiveness scale: [acty]), (measure: [qnco]), (social function: [socb]), (analyses: [resa]), (whole group: [popg]), (old (: []), (years) age groups: [aggp]), (significant differences: [qnco]), (task measures: [qnco]), (significant correlations: [qnco]), (however: []), (non-significant tendency: [qnco]), (young group: [popg]), (asd (p: [cgab]), (reaction time (r: [clna]), (p =: [aapp,imft]), (p: [gngm]), (contrast: [irda]), (old group (r = -0.23: [popg]), ( p: [aapp,imft]), (r = -0.38: [fndg]), (respectively): []), (significant age group interactions: [aggp]), (reaction time (p =: [aapp,imft]), (reaction time (p: [aapp,imft]), (findings: [clna]), (age-dependent association: [menp]), (emotion recognition: [menp]), (severity: []), (social problems: [fndg]), (delayed development: [mobd]), (emotional understanding: [menp]), (towards alterations: []), (top-down attention control: [menp]), (asd group: [cgab]), (novel disease-related features: [patf]), (details: []), (experimental settings: [qnco]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(asd diagnosis, 'Diagnosis')(parent-rated social communication questionnaire, 'Reciprocal Social Interaction')(facial expressions, 'Integrated Verbal and NonVerbal Communication')(social function, 'Social Competence')(emotion recognition, 'Empathy')(severity of social problems, 'Social Competence')(delayed development of emotional understanding, 'Learning Disorders')(social problems, 'Social Competence')(delayed development, 'Learning Disorders')

PMCID: 5682605
SFARI Genes: Ambra1, Ambra1, Ambra1, Ambra1, Ambra1, Ambra1, AMBRA1, AMBRA1, AMBRA1, AMBRA1, Ambra1, Ambra1, 
Non SFARI Genes: 
Named Entities: (ambra1: [gngm]), (heterozygous ambra1 deficiency induces: [dsyn]), (autism-like behavior: [mobd]), (dimorphic manner: []), (extraordinarily: []), (autistic features: [mobd]), (female mice only: [mamm]), (ambra1 protein reduction: [aapp,bacs]), (brain: [bpoc]), (however: []), ( significance: [qnco]), (autistic phenotypes: [mobd]), (humans: [humn]), (behavior: [inbe]), (other autism-typical features: [fndg]), (early brain enlargement: [patf]), (increased seizure propensity: [sosy]), (independent human samples: [humn]), (single normal ambra1: [fndg]), (intronic snp rs3802890-aa: [plnt]), (women: [popg]), (mrna expression: [genf]), (peripheral blood mononuclear cells: [cell]), (gg carriers: [fndg]), (non-coding rna: [nnon]), (likely relevant: []), (mrna: [bacs,nnon]), (protein interaction: [moft]), ( rs3802890 (a versus g allele): [gngm]), (stability: []), (modification: []), (folding: [topp]), (silico analysis: [resa]), (further autism-relevant characteristics: [mobd]), (ambra1+/ mice: [mamm]), (reduced interest: [fndg]), (male mutants: [orga]), (pheromone signals: [bacs]), (respective other gender: [orga]), (social intellicage: []), (moreover: []), (pentylentetrazol-induced seizure: [sosy]), (vivo readout: []), (neuronal excitationinhibition dysbalance: [imft]), (female mutants: [orga]), (magnetic resonance imaging reveals: [diap]), (prepubertal brain enlargement: [patf]), (genders: [orga]), ( uncoupling: []), (brain dimensions: [bpoc]), (female expression: [orga]), (other autistic phenotypes: [mobd]), (here: []), (data support: [euka]), (role: [socb]), (ambra1/ambra1: [gngm]), (partial loss-of-function genotypes: [phsf]), (female autistic traits: [mobd]), (heterozygous mice: [mamm]), (novel: []), (construct-valid genetic mouse model: [mamm]), (female autism: [mobd]), 
ASD Terms: (female autism, 'Autism Phenotype')

PMCID: 5675000
SFARI Genes: 
Non SFARI Genes: GDF1, MYH6, FLT4, 
Named Entities: (congenital heart disease (chd): [cgab,dsyn]), (cause: []), (mortality: [qnco]), (birth defects: [cgab]), (exome sequencing: [mbrt]), (single cohort: [fndg]), (chd probands: [orga]), (parent-offspring trios: [aapp,enzy]), (rare inherited mutations: [genf]), (recessive founder mutation: [comd]), (gdf1 accounting: [gngm]), (~5%: [qnco]), (severe chd: [aapp,enzy]), (ashkenazim: [popg]), (recessive genotypes: [orga]), (myh6 accounting: [gngm]), (~11%: []), (shone complex: [cgab,dsyn]), (dominant flt4 mutations: [aapp,enzy,rcpt]), (tetralogy: []), (fallot: []), (de: []), (mutations: [genf]), (cases: [qnco]), (~3%: [fndg]), (isolated chd patients: [topp]), (~28%: []), (extra-cardiac congenital anomalies: [cgab]), (seven genes: [gngm]), (thresholds: []), (genome-wide significance: [gngm]), (genes: [gngm]), (chd: [aapp,enzy]), (probability: [qnco]), (disease-related; dnms: [dsyn]), (~440 genes: [gngm]), (overlap: [topp]), (dnms: []), (probands: [orga]), 
ASD Terms: (congenital heart disease, 'Congenital Abnormalities')(congenital heart disease, 'Cardiovascular Diseases')(severe congenital heart disease, 'Cardiovascular Diseases')(isolated congenital heart disease patients, 'Cardiovascular Diseases')(autism, 'Autism Phenotype')

PMCID: 5629761
SFARI Genes: DYRK1A, DYRK1A, DYRK1A, DYRK1A, DYRK1A, DYRK1A, DYRK1A, CHD8, DYRK1A, CHD8, DYRK1A, DYRK1A, DYRK1A, DYRK1A, DYRK1A, DYRK1A, DYRK1A, CHD8, DYRK1A, CHD8, DYRK1A, DYRK1A, DYRK1A, CHD8, DYRK1A, CHD8, DYRK1A, DYRK1A, 
Non SFARI Genes: 
Named Entities: (dyrk1a: [gngm]), (gene: [gngm]), (asd population: [cgab]), (number: [qnco]), (case reports: []), (dyrk1a haploinsufficiency exhibit: [comd]), (common phenotypic features: [orga]), (microcephaly: [cgab,dsyn]), ( intellectual disability: [mobd]), ( speech delay: [mobd]), (facial dysmorphisms: [cgab]), (phenotypic information: [orga]), (dyrk1a cases (n: [aapp,imft]), (participants: [popg]), (ongoing study: [resa]), (university: [mnob,orgt]), (washington (uw: []), (compiled: []), (frequencies: []), (recurrent phenotypic features: [orga]), (population: [popg]), (features: []), (large sample: [sbst]), (idiopathic asd: [cgab]), (simons simplex collection (n: [aapp,imft]), (uw dyrk1a cases: [qnco]), (set: [menp]), (idiopathic asd cases: [cgab]), (age: [orga]), (gender (n: [orga]), (cases: [qnco]), (asd-associated disruptive mutation: [cgab]), (chd8 (n: [gngm]), (contribution: [acty]), (familial genetic background: [famg]), (clinical heterogeneity: [fndg]), (head circumference: [clna]), ( iq: []), (asd-related symptoms: [cgab]), (unaffected parents: []), (dyrk1a haploinsufficiency results: [comd]), (common phenotypic profile: [orga]), (intellectual disability: [mobd]), ( speech: [orgf]), (motor difficulties: [fndg]), ( microcephaly: [cgab,dsyn]), (difficulties: [fndg]), (vision abnormalities: [orgf]), (eighty-nine percent: [qnco]), (dyrk1a cases: [qnco]), (asd: [cgab]), (constellation: []), (symptoms: [sosy]), (iq: []), (adaptive functioning: []), (head size: [fndg]), (chd8 cases: [qnco]), (phenotypic variability: [fndg]), (parental head circumference: [clna]), (observed variability: []), (affected child phenotype: [aggp]), (results: [fndg]), (core: [bdsu]), (clinical phenotype: [orga]), (dyrk1a disruptions: [gngm]), (combination: [fndg]), (dyrk1a mutations: [genf]), (disruptive mutations: [genf]), (chd8: [gngm]), (measurable: []), (quantitative characterization: [acty]), (dyrk1a haploinsufficiency: [comd]), (clinical variability: [fndg]), (part: [qnco]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-017-0173-5) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (intellectual disability, 'Learning Disorders')(speech delay, 'Idiosyncratic and Routinized Speech')(speech, 'Language Ability')(motor difficulties, 'Motor Skills')(adaptive functioning, 'Adaptive Life Skills')

PMCID: 6168830
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract objective: []), (nutritional supplementation: [topp]), (pregnancy: [orgf]), (reduced risk: []), (autism spectrum disorder (asd): [mobd]), (intellectual disability: [mobd]), (offspring: [famg]), (design observational: [resa]), (prospective cohort study: [resa]), (multivariable logistic regression: [resa]), (controls: [sbst]), (propensity score matching: [qnco]), (stockholm county: []), ( sweden: []), (participants: [popg]), (mother-child pairs: [socb]), (population registers: [popg]), (study sample: [sbst]), (children: [aggp]), (years: []), (end: [gngm]), (follow-up: [hlca]), (december: []), (exposures multivitamin: [orch,phsu,vita]), ( iron: [inch]), (folic acid supplement use: [orch,phsu,vita]), (first antenatal visit: [fndg]), (main: []), (outcome measure diagnosis: [qnco]), (asd: [cgab]), (register data: [euka]), (prevalence: [qnco]), ((158 cases: [qnco]), (maternal multivitamin use group: [popg]), ((430 cases: [qnco]), (nutritional supplementation use group: [popg]), (maternal multivitamin use: [famg]), (additional iron: [inch]), (folic acid: [orch,phsu,vita]), (odds: []), (child: [aggp]), (mothers: [famg]), (multivitamins: [phsu,vita]), (folic acid (odds: [orch,phsu,vita]), (confidence interval: [qnco]), (similar estimates: [qnco]), (propensity score: [qnco]), (control: [sbst]), (latter association: [menp]), (consistent evidence: []), (iron: [inch]), (folic acid use: [orch,phsu,vita]), (asd prevalence: [qnco]), (maternal multivitamin supplementation: [topp]), (scrutiny: []), (maternal nutrition: [orgf]), (role: [socb]), (cause: []), (autism: [mobd]), 
ASD Terms: (nutritional supplementation, 'Dietary Supplements')(autism spectrum disorder, 'Autism Phenotype')(intellectual disability in offspring, 'Perinatal History')(intellectual disability, 'Learning Disorders')(offspring, 'Perinatal History')(exposures multivitamin, 'Exposures')(folic acid supplement use, 'Dietary Supplements')(outcome measure diagnosis, 'Diagnosis')(intellectual disability in children, 'Learning Disorders')(nutritional supplementation use group, 'Dietary Supplements')(maternal multivitamin supplementation, 'Dietary Supplements')(asd with intellectual disability, 'Learning Disorders')(autism, 'Autism Phenotype')

PMCID: 5627471
SFARI Genes: app, app, app, app, App, App, 
Non SFARI Genes: 
Named Entities: (mobile: [hcro,mnob]), (touchscreen devices: []), (speech-generating devices (sgds): []), (communication: [socb]), (skills: [inbe]), (children: [aggp]), (autism spectrum disorders: [mobd]), (language: [lang]), (however: []), (alternative communication (aac) mobile app: [socb]), (chinese language: [lang]), (mainland china: []), (aac mobile app: []), (knowledge: []), (yuudee: []), ((chinese name  (xiaoyudi)): [lang]), (objective-c: []), (java programming languages: []), (five-phase training protocol: [fndg]), (requests: []), (picture exchange communication system: [clna]), (verbal children: [aggp]), (asd: [cgab]), (effectiveness: []), (training: [edac]), (built-in library: [gngm,nnon]), (pictures: []), (spoken phrases: [fndg]), (categories: []), (simple requests: []), (emotions: [menp]), (additional important feature: []), (customization functions: [phsf]), (parent: []), (trainer: []), (phrases: []), (new pictures: []), (layouts: []), (orders: [acty]), (personal needs: [orga]), (child: [aggp]), (ios version: [diap]), (itunes app store: []), (android version: [horm,orch,phsu]), (google play (https://play.google.com/store/apps/details?id=com.supersuperstar.yuudee.vue): [dora]), (domestic chinese android app stores: [horm,orch,phsu]), (consecutive unprompted successful responses: [orga]), (initial training success: [socb]), (phases: [euka]), (evaluated children: [hlca]), (accuracy rate: [qnco]), (phase: []), (seven children: [aggp]), (accuracy: []), (trained: [orgt]), (data: [euka]), (useful tool: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-017-0165-5) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 5627457
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (biological mechanisms: []), (social behavior: [socb]), (animal models: [anim]), (standard behavioral paradigms: [inbe]), (laboratory-independent manner: [mnob,orgt]), (past decade: [qnco]), (three-chamber test: [lbpr]), (standard paradigm: [resa]), (social preference (sociability): [socb]), (social novelty preference: []), (mice: [mamm]), (test: [lbpr]), (several caveats: [qnco]), (reliance: [bodm]), (spatial navigation skills: [menp]), (negligence: []), (behavioral dynamics: [inbe]), (here: []), (novel experimental apparatus: [anst]), (analysis system: []), (alternative: []), (aforementioned caveats: []), (custom-made apparatus: [anst]), (production: []), (open-source software: [inpr,mnob]), (free use: []), (system: []), (dynamics: [npop]), (social preference: []), (social novelty preference tests: [lbpr]), (male: [orga]), (female c57bl/6j mice: [mamm]), (tests: [lbpr]), ( male mice: [mamm]), (preference: []), (stimuli: [phpr]), (periods: []), (females: [orga]), (several new parameters: [fndg]), (social behavioral dynamics: [inbe]), (social preference behavior: [socb]), (time: []), (distinct phases: [euka]), (early exploration phase: [topp]), (high rate: [qnco]), (transitions: [acty]), (short bouts: [qnco]), (stimulus investigation: [hlca]), (interaction phase: []), (low transition rate: [qnco]), (interactions: []), (preferred stimulus: [phpr]), (finally: []), (c57bl/6j: [mamm]), (btbr male: [orga]), (latter: []), (asocial strain serving: [qnco]), (model: []), (autism spectrum disorder: [mobd]), (btbr mice (n: [aapp,imft]), (specific deficit: [dsyn]), (transition: [acty]), (exploration phase: [topp]), (social preference test: [lbpr]), (reduced tendency towards: []), (social interaction: [fndg]), (new experimental system: []), (strain-specific differences: [qnco]), (detailed analysis: [resa]), (small rodent models: [mamm]), (comparison: [acty]), (strains: [menp]), (treatments: [topp]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-017-0169-1) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (social behavior, 'Reciprocal Social Interaction')(social behavior, 'Reciprocal Social Interaction')(social behavioral dynamics, 'Reciprocal Social Interaction')(social preference behavior, 'Reciprocal Social Interaction')(social behavior, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(social behavior, 'Reciprocal Social Interaction')(social behavior, 'Reciprocal Social Interaction')

PMCID: 5626391
SFARI Genes: TrkB, TrkB, 
Non SFARI Genes: 
Named Entities: (kang: []), (al: [lbpr]), (vaccinia-related kinase: [virs]), ((vrk3) expression: [topp]), (synaptic structure: []), (function: [phsf]), (results: [fndg]), (cognitive dysfunction: [mobd]), (autism-like behaviors: [mobd]), (mice: [mamm]), (trkb stimulation: [aapp,rcpt]), (altered synaptic properties: []), (vrk3-deficient mice: [mamm]), 
ASD Terms: (cognitive dysfunction, 'Cognitive Ability')

PMCID: 5625821
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (previous reviews: []), (association: [menp]), (maternal use: [famg]), (folic acid supplements: [orch,phsu,vita]), (pregnancy: [orgf]), (risk: []), (autism spectrum disorders: [mobd]), (children: [aggp]), (definitive conclusion: []), (comprehensive meta-analysis: [resa]), (relationship: []), (folic acid: [orch,phsu,vita]), (asd: [cgab]), (electronic databases pubmed: [fndg]), ( web: []), (knowledge: []), (wanfang data: [euka]), (eligible studies: [lbpr]), (march: []), (random effects model: [resa]), (relative risk (rr): [qnco]), (confidence intervals: [qnco]), (sensitivity analysis: [patf]), (publication bias: []), (conducted: [inbe]), (total: [qnco]), (articles: []), (studies: [lbpr]), (asd cases: [cgab]), (report: [hlca]), (supplementation: [topp]), (asd [rr: [cgab]), (ci: [gngm]), (p heterogeneity: [orga]), (women: [popg]), (folic acid supplementation: [topp]), (associations: [menp]), (asian: [popg]), ( european: [popg]), (american populations: [popg]), (summary: []), (ethnicity: [popg]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-017-0170-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (folic acid supplements, 'Dietary Supplements')(autism spectrum disorders, 'Autism Phenotype')(supplementation, 'Dietary Supplements')(folic acid supplementation, 'Dietary Supplements')(folic acid supplements, 'Dietary Supplements')

PMCID: 5622473
SFARI Genes: DYRK1A, DYRK1A, Dyrk1a, Dyrk1a, Dyrk1a, Dyrk1a, DYRK1A, DYRK1A, DYRK1A, DYRK1A, DYRK1A, DYRK1A, 
Non SFARI Genes: crh, crh, crh, 
Named Entities: (dyrk1a maps: [aapp,bacs]), (down syndrome: [cgab,dsyn]), (critical region: []), (mutations: [genf]), (kinase-encoding gene: [gngm]), (microcephaly: [cgab,dsyn]), (intellectual disability: [mobd]), (autism: [mobd]), (humans: [humn]), (murine model: [mamm]), (dyrk1a: [gngm]), (down syndrome phenotypes: [cgab,dsyn]), (however: []), (embryonic lethality: [emst]), (homozygous knockout (ko): [orga]), (murine model studies: [mamm]), (sufficient evidence: []), (dyrk1a dysfunction: [dsyn]), (molecular mechanisms: []), (autism spectrum disorders: [mobd]), (vivo dyrk1aa ko model: [bdsy]), (zebrafish: [fish]), (patient: [podg]), (mutation: [genf]), (dyrk1a gene: [gngm]), (microarray analysis: [lbpr]), (barrier: []), (dyrk1aa ko zebrafish: [fish]), (transcription: [genf]), (activator-like effector: []), (nuclease (talen)-mediated genome editing: [gngm]), (social behavioral tests: [diap]), (social interaction: [fndg]), (assay: [lbpr]), (group behavior assay: [lbpr]), (molecular analysis: [mbrt]), (neuronal activity: [acty]), (specific brain regions: [blor]), (situ hybridization: [mbrt]), (various probes: [phsu]), (c-fos: [gngm]), (crh: [gngm]), (molecular markers: [clna]), (stress response: [phsf]), (microarray: []), (intragenic microdeletion: []), (individual: [humn]), (behavioral tests: [diap]), (group behavior: [socb]), ( dyrk1aa ko zebrafish: [fish]), (social impairments: [patf]), (human phenotypes: [humn]), (vertebrate animal model: [emod]), (social impairment: [patf]), (crh expression: [topp]), (transcriptional expression: [genf]), (wild type fish: [fish]), (specific hypothalamic regions: [bpoc]), (ko fish brains: [fish]), (social context: []), (study: [resa]), (zebrafish model: [fish]), (candidate gene: [gngm]), (vertebrate animal: [vtbt]), (results: [fndg]), (functional deficiency: [dsyn]), (underlying disease mechanism: [dsyn]), (simple social behavioral assays: [lbpr]), (tool: []), (autism candidate genes: [mobd]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-017-0168-2) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (down syndrome, 'Down Syndrome')(autism, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(down syndrome phenotypes, 'Down Syndrome')(autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(social behavioral tests, 'Reciprocal Social Interaction')(social interaction, 'Reciprocal Social Interaction')(social interaction, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(social impairments, 'Social Competence')(social impairment in dyrk1aa knockout zebrafish, 'Social Competence')(social impairment, 'Social Competence')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism candidate genes, 'Autism Phenotype')(simple social behavioral assays, 'Reciprocal Social Interaction')

PMCID: 6346295
SFARI Genes: ABAT, ABAT, 
Non SFARI Genes: GABBR1, 
Named Entities: (abstract autism spectrum disorder (asd): [mobd]), (complex neuropsychiatric syndrome: [dsyn]), (etiology: []), (environmental components: []), (epigenetic marks: []), (environmental insult: []), (development: [orgf]), (asd: [cgab]), (initial brain studies: [bpoc]), (dysregulation: []), (however: []), (cellular heterogeneity: [orga]), (brain: [bpoc]), (studies: [lbpr]), (true change: [qnco]), (neuronal epigenetic signature: [amas]), (here: []), (genome-wide methylation study: [moft]), (fluorescence-activated cell: [npop]), (sorting-sorted neuronal nuclei: [acty]), (frontal cortex: [bpoc]), (male asd: [cgab]), (male control subjects: [orga]), (k beadarray: [qnco]), (regions: []), (loci: [gngm]), (gabaergic system: []), (abat: [gngm]), (gabbr1: [gngm]), (brain-specific micrornas: [bacs,nnon]), (dmrs: [gngm]), (targeted next generation bisulfite sequencing: [mbrt]), (gene correlation network analysis: [popg]), (co-methylation modules: [moft]), (genomic regions: [gngm]), (neuronal: [imft]), ( gabaergic: []), (immune system genes: [gngm]), (overlap: [topp]), (asd-related dmrs: [cgab]), (neurodevelopment: [ortf]), (investigation: [hlca]), (alterations: []), (dna methylation pattern: [moft]), (cortical neurons: [bpoc]), (further evidence: []), (epigenetic alterations: []), (disorder-relevant tissues: [dsyn]), (biology: []), 
ASD Terms: (abstract autism spectrum disorder, 'Autism Phenotype')

PMCID: 5650680
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (interval: []), (ability: [orga]), (duration: [phsu]), (short events: [evnt]), (autism spectrum disorders: [mobd]), (timing abilities: [orga]), (underlie behaviours: [inbe]), (sensory integration: [orgf]), ( motor coordination: [ortf]), (communication: [socb]), (atypical temporal processing: [acty]), (asd: [cgab]), (disorder's symptoms: [dsyn]), (particular motor clumsiness: [fndg]), (difficulties: [fndg]), (social interaction: [fndg]), (recent behavioural investigations: [hlca]), (interval timing: []), (intact sensitivity: [patf]), (reduced precision: []), (duration judgements: [menp]), (study: [resa]), (processing: [acty]), (group: [popg]), (high-functioning individuals: [humn]), (magnetoencephalography (meg): [diap]), (adolescents: [aggp]), (adults: [aggp]), (iq-matched typically-developing control (tdc) individuals: [resa]), (consecutive tones: [phsu]), (pitch: [qnco]), (separate experimental blocks: [sbst]), (analysis: [resa]), (identical stimuli: [phpr]), (hz tones: [phsu]), (ms): [aapp,enzy]), (standard: []), (probe: [chvf]), (pitch task respectively: [qnco]), (results: [fndg]), (tdc individuals: [humn]), ( individuals: [humn]), (standard tone accurately: [phsu]), (sensitivity: [patf]), (comparison process: [phpr]), (resources: []), (different times: [qnco]), (nature: []), (task (pitch: [qnco]), (duration discrimination): [socb]), (duration task: [phsu]), (pitch task regardless: [qnco]), (context: [fndg]), (individuals: [humn]), (top-down adaptation: [orgf]), (task: [gngm]), (neuronal strategy: [menp]), (bias: [bird]), (readiness: [fndg]), (different types: []), (tasks: []), (diminished allocation: [acty]), (duration processing: [acty]), (effect: []), (learning: [menp]), (development: [orgf]), (other cognitive functions: [menp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(motor coordination, 'Motor Skills')(social interaction, 'Reciprocal Social Interaction')(perform different types of tasks, 'Task Performance')(other cognitive functions, 'Cognitive Ability')(top-down adaptation, 'Adaptive Life Skills')

PMCID: 5610466
SFARI Genes: CD38, CD38, CD38, CD38, CD38, CD38, 
Non SFARI Genes: 
Named Entities: (dysbiosis: [patf]), (gut microbiota: [orgm]), (autism spectrum disorder (asd): [mobd]), (behavioral impairment: [inbe]), (vitamin a (va): [orch,phsu,vita]), (role: [socb]), (regulation: [biof]), (study: [resa]), (va: [hcro,mnob]), (changes: [qnco]), (autism functions: [mobd]), (children: [aggp]), (asd: [cgab]), (sixty: [qnco]), (years: []), (old children: []), (6-month follow-up study: [resa]), (va intervention: [hlca]), (high-performance liquid chromatography: [lbpr]), (plasma retinol levels: [bdsu]), (autism behaviour checklist (abc): [mobd]), ( childhood autism rating scale (cars): [mobd]), (social responsiveness scale (srs): [acty]), (autism symptoms: [mobd]), (cd38: [gngm]), (acid-related orphan receptor alpha (rora) mrna levels: [bacs,nnon]), (autism-related biochemical indicators changes: [irda]), (evaluations: [hlca]), (plasma retinol: [orch,phsu,vita]), ( abc: [dsyn]), ( cars: [aapp,enzy]), ( srs: []), ( cd38: [lbpr]), (rora mrna levels: [bacs,nnon]), (months: []), (intervention: [hlca]), (illumina miseq: []), (rrna genes: [gngm]), (differences: [qnco]), (treatment: [topp]), (subset: []), ( plasma retinol: [orch,phsu,vita]), ((all p <: [aapp,imft]), (scores: [clna]), (abc: [dsyn]), (srs scales: [bpoc]), (significant differences: [qnco]), (p: [gngm]), (meanwhile: []), (proportion: [qnco]), (bacteroidetes/bacteroidales: [bact]), (bifidobacterium: [bact]), (subgroup: [virs]), ((all: []), (false discovery rate (fdr) q: [qnco]), (key taxa: []), (moreover: []), ( va: [hcro,mnob]), (autism biomarkers: [mobd]), (va concentration: [menp]), (trial registration: [resa]), (study protocol: []), (institutional review board: []), (childrens hospital: [hcro,mnob]), ( chongqing medical university: [mnob,orgt]), (chinese clinical trial registry (chictr): [resa]), (november: []), ((trn: chictr-roc-14005442): [gngm]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s12866-017-1096-1) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(behavioral impairment, 'Personal Traits')(vitamin a, 'Dietary Supplements')(role of vitamin a, 'Dietary Supplements')(autism functions, 'Autism Phenotype')(6-month follow-up study with vitamin a intervention, 'Dietary Supplements')(vitamin a intervention, 'Dietary Supplements')(autism behaviour checklist, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(assess autism symptoms, 'Complaints and Indications')(autism, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(autism behaviour checklist, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(autism behaviour checklist, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(autism biomarkers, 'Autism Phenotype')(vitamin a, 'Dietary Supplements')(vitamin a concentration, 'Dietary Supplements')(autism symptoms, 'Complaints and Indications')(childrens hospital, 'Hospitalizations')(medical university, 'Medications')(chongqing medical university, 'Medications')

PMCID: 5610446
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prospective studies: [resa]), (infants: [aggp]), (high familial risk: [famg]), (autism spectrum disorder (asd): [mobd]), (number: [qnco]), (putative early markers: [clna]), (asd outcome: [cgab]), (years: []), (age: [orga]), (however: []), (diagnostic changes: [qnco]), (toddlerhood: []), (mid-childhood: []), (question: []), (infant markers: [aggp]), (diagnosis: [fndg]), (first: [qnco]), (infant neurocognitive markers: [aggp]), ((7-month neural response: [fndg]), (eye gaze shifts: [bpoc]), (14-month visual disengagement latencies): []), (observational marker: [resa]), (asd: [cgab]), ((the autism observation scale: [hlca]), (infants; aosi): [aggp]), (high-risk (hr) 7-year-olds: [fndg]), (asd diagnosis (hr-asd: [cgab]), (hr-no asd): [cgab]), (low risk (lr) controls: [fndg]), (second: [qnco]), (neurocognitive markers: [clna]), (predictive power: [hcpp]), (aosi: []), (children: [aggp]), (asd diagnosis: [cgab]), (hr-no asd: [cgab]), (lr groups: [popg]), (exploratory analysis: [resa]), (stable versus: []), (lost/late diagnosis: [fndg]), (year period: []), (samples: [sbst]), (months: []), (neurocognitive marker: [clna]), (model fit: [sosy]), (aosi alone: [fndg]), (infant: [aggp]), (early observational marker: [resa]), (findings: [clna]), (implications: []), (neurodevelopmental mechanisms: [ortf]), (risk: []), (identification: [menp]), (potential targets: [diap]), (pre-emptive intervention: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-017-0167-3) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(diagnosis, 'Diagnosis')(infant neurocognitive markers, 'Cognitive Ability')(asd behaviours, 'Autism Phenotype')(asd diagnosis, 'Diagnosis')(neurocognitive markers, 'Cognitive Ability')(asd diagnosis, 'Diagnosis')(lost/late diagnosis, 'Diagnosis')(neurocognitive marker, 'Cognitive Ability')(neurodevelopmental mechanisms, 'Learning Disorders')

PMCID: 5609014
SFARI Genes: 
Non SFARI Genes: Mb, STS, 
Named Entities: (x-linked ichthyosis: [dsyn]), (dermatological condition: [dsyn]), (deficiency: [dsyn]), (enzyme steroid sulfatase: [aapp,enzy]), (previously: []), (x-linked ichthyosis/steroid sulfatase deficiency: [dsyn]), (neurological phenotypes: [orga]), (first time: [qnco]), (additional psychiatric phenotype (psychosis): [mobd]), (case presentation: []), (case: []), (11-year-old saudi arabian boy: [aggp]), (psychosis: [mobd]), ( mental retardation: [mobd]), ( autism spectrum disorder: [mobd]), (inattentive attention deficit hyperactivity disorder: [mobd]), (epilepsy: [dsyn]), (genetic analysis: [lbpr]), (mb deletion: [genf]), (sts: [gngm]), (cells: [cell]), (biochemical analysis: [resa]), (low steroid sulfatase activity consistent: [moft]), (diagnosis: [fndg]), (psychotic symptoms: [sosy]), (administration: [topp]), (atypical antipsychotic: [phsu]), (report: [hlca]), (comorbid: []), (psychosis (most: [mobd]), (early-onset schizophrenia): [mobd]), (steroid sulfatase: [aapp,enzy]), (contiguous genes: [gngm]), (vulnerability: []), (other psychological disorders: [mobd]), 
ASD Terms: (dermatological condition, 'Skin Indications')(neurological phenotypes, 'Neurologic Indications')(mental retardation, 'Mental Retardation')(autism spectrum disorder, 'Autism Phenotype')(inattentive attention deficit hyperactivity disorder, 'Overactivity')(epilepsy, 'Epilepsy')(diagnosis, 'Diagnosis')(comorbid, 'Comorbidities')

PMCID: 5652137
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (prevalent neurodevelopmental conditions: [qnco]), (awareness: [menp]), (asd: [cgab]), (gastrointestinal distress: [sosy]), (intestinal microbiome: [orgm]), (host-microbiome interactions: [orgm]), (disease symptoms: [dsyn]), (however: []), (paucity: []), (knowledge: []), (gut-brain axis: [bpoc]), (autism constitutes: [mobd]), (obstacle: []), (development: [orgf]), (precision: []), (microbiota-based therapeutics: [orgm]), (end: [gngm]), (interactions: []), (intestinal microbiota: [orgm]), ( gut physiology: [phsf]), (social behavior: [socb]), (btbr t+itpr3tf/j mouse model: [mamm]), (reduction: [npop]), (relative abundance: [qnco]), (particular bacterial taxa: []), (btbr gut: [bdsy]), (bile-metabolizing bifidobacterium: [bact]), (blautia: [bact]), (deficient bile acid: [bacs,orch]), (tryptophan metabolism: [moft]), (intestine: [bpoc]), (gastrointestinal dysfunction: [dsyn]), (social interactions: [fndg]), (btbr mice: [mamm]), (data support: [euka]), (concept: []), (targeted manipulation: [topp]), (gut microbiota: [orgm]), (behavioral symptomatology: [inbe]), (specific plausible targets: [diap]), (endeavor: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(prevalent neurodevelopmental conditions, 'Learning Disorders')(autism constitutes, 'Autism Phenotype')(social behavior, 'Reciprocal Social Interaction')(impaired social interactions, 'Reciprocal Social Interaction')(particular bacterial taxa, 'Bacterial Infections')(social interactions, 'Reciprocal Social Interaction')

PMCID: 5607486
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (complex neurodevelopmental disorder: [mobd]), (impaired social communication: [socb]), (repetitive behaviours: [inbe]), (features: []), (intellectual disability: [mobd]), (impaired sensorimotor function: [phsf]), (interest: [menp]), (devastating disorder: [dsyn]), (families: [famg]), (young parents: [fndg]), (certainties: []), (regards: []), (aetiology: []), (significant genetic background: [orga]), (little information: [fndg]), (social adaptation: [socb]), (quality: []), (life: []), (patients: [podg]), (autism spectrum disorder: [mobd]), (long-term outcome: []), (sample: [sbst]), (children: [aggp]), ( adolescent: [aggp]), (young adults: [aggp]), (case study: []), (subjects: [humn]), (asd: [cgab]), (clinics: [hcro,mnob]), (rehabilitation centers: [hcro,mnob]), (campania region: []), (south: []), (italy: []), (study sample: [sbst]), (females): [orga]), (years: []), (sd: [gngm]), (follow-up interview: [acty]), (means: []), (questionnaire: []), (parents/caregivers: []), (mean age: [orga]), (son/daughter: [famg]), (years; range: [qnco]), (reports: [hlca]), (parents: []), (caregivers: []), (overall improvement: []), (regard: []), (adaptive abilities: [orga]), (group: [popg]), (teen-agers: [aapp,rcpt]), (major concerns: []), (significant quality: [qnco]), (life parameters: [fndg]), (independent living: [dora]), ( work: []), (experiences: [menp]), ( friendships: [socb]), (relationships: []), ( accommodation: [clna]), (recreational activities: [dora]), (personal autonomy: [inbe]), (persisting: []), (present study: [qnco]), (large number: [qnco]), (considerable problems: []), (employment opportunities: []), (social relationships: []), (continuous support: []), (facilities: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(complex neurodevelopmental disorder, 'Learning Disorders')(impaired social communication, 'Reciprocal Social Interaction')(repetitive behaviours, 'Restricted and Repetitive Behavior')(intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(social adaptation, 'Adaptive Life Skills')(adaptive abilities, 'Adaptive Life Skills')(recreational activities, 'Use of Free Time')

PMCID: 5724703
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract diffuse: []), (white matter injury (wmi): [fndg]), (serious problem: [fndg]), (preterm infants: [aggp]), (adverse neurodevelopmental outcome: [ortf]), (cognitive impairments: [mobd]), (risk: []), (autismspectrum disorders: [dsyn]), (important risk factors: [qnco]), (perinatal inflammatory insults: []), (cerebral oxygenation: [celf]), (however: []), (exact mechanisms: []), (diffuse wmi: []), (treatment options: [topp]), (use: []), (relevant animal models: [anim]), (knowledge: []), (pathophysiology: [patf]), (definition: []), (novel therapeutic targets: [diap]), (present study: [qnco]), (multiplehit: []), (animal model: [emod]), (fetal inflammation: [patf]), (postnatal hypoxia: [patf]), (rats: [mamm]), (effects: []), (white matter development: [tisu]), (functional outcome: []), (immunohistochemistry: [diap]), ( mri: [diap]), (behavioral paradigms: [inbe]), (delayed cortical myelination: [bpoc]), ( microglia activation: [celf]), (astrogliosis: [patf]), (p18: [gngm]), (longterm changes: [qnco]), (oligodendrocyte maturation: [celf]), (week: []), (old animals: [anim]), (furthermore: []), ( rats: [mamm]), (wmi: []), (impaired motor performance: [orgf]), (anxiety: [mobd]), (signs: [fndg]), (autismlike behavior: [inbe]), ( i.e: [diap,inpr]), (social play behavior: [dora]), (repetitive grooming: [inbe]), (conclusion: []), (combination: [fndg]), (pattern: []), (brain injury: [inpo]), (functional impairments: [patf]), (clinical situation: []), (opportunity: []), (pathophysiological mechanisms: [patf]), (novel treatment options: [topp]), 
ASD Terms: (adverse neurodevelopmental outcome, 'Learning Disorders')(cognitive impairments, 'Cognitive Ability')(perinatal inflammatory insults, 'Perinatal Exposures')(impaired motor performance, 'Motor Skills')(anxiety, 'Anxiety Disorders')(social play behavior, 'Reciprocal Social Interaction')(brain injury, 'Head Injury')

PMCID: 5605987
SFARI Genes: Nf1, Nf1, 
Non SFARI Genes: 
Named Entities: (excitation/inhibition (e/i) imbalance: [acty]), (hypothesis: []), (autism spectrum disorders: [mobd]), (presence: [qnco]), (imbalance: [sosy]), (therapeutic target: [diap]), (treatment: [topp]), (cognitive disabilities: [fndg]), (pathology: [patf]), (consequently: []), (study: [resa]), (monogenic disorders: [dsyn]), (neurofibromatosis type: [gngm]), ((nf1): [gngm]), (promising approach: []), (mechanisms: []), (asd-related cognitive disabilities: [cgab]), (however: []), (nf1 mouse model: [gngm]), (-aminobutyric acid (gaba): [aapp,bacs]), (human disease: [humn]), (reduced cortical gaba levels: [bpoc]), (e/i imbalance hypothesis: [inch]), (true: []), (e/i: [inch]), (postsynaptic push-pull mechanisms: [fndg]), (current study: [resa]), (critical components: []), (concentration: [menp]), (neurotransmitters: [bacs]), (levels: []), (gaba(a) receptors: [aapp,rcpt]), (measurements: []), (hippocampi: [bpoc]), ( striatum: [bpoc]), (prefrontal cortices: [bpoc]), (vivo magnetic resonance spectroscopy (mrs): [diap]), (molecular approaches: []), (asd-related animal: [cgab]), (nf1 +/ mouse: [mamm]), (striatal gaba/glutamate ratios: [bpoc]), (postsynaptic level: [phsu]), (high receptor gaba(a) receptor expression: [aapp,bacs]), (hippocampus: [bpoc]), (small reduction: [npop]), (gaba levels: [aapp,bacs]), (gabaergic tone (either: [fndg]), (receptor levels: [aapp,rcpt]), (gaba/glutamate ratios): [aapp,bacs]), (regions: []), (different mechanism: []), (data: [euka]), (support: []), (e/i imbalance: [inch]), (nf1: [gngm]), (postsynaptic changes: [qnco]), (findings: [clna]), (previous physiological evidence: []), (increased inhibitory tone: [fndg]), (such heterogeneity: [orga]), (therapeutic approaches: [topp]), (neurochemical imbalance: [sosy]), (asd: [cgab]), (targets: [diap]), (convergent physiological mechanisms: [acty]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(cognitive disabilities, 'Cognitive Ability')(asd-related cognitive disabilities, 'Cognitive Ability')

PMCID: 5605661
SFARI Genes: Trio, Rac1, Trio, Rac1, Rac1, Rac1, Trio, Rac1, Trio, Rac1, Trio, Trio, Trio, Trio, 
Non SFARI Genes: Rho, 
Named Entities: (rho guanine: [nnon]), (exchange factor (rhogef) trio: [aapp,enzy]), (actin polymerization: [celf]), (small gtpase rac1: [aapp,enzy]), (recent studies: [lbpr]), (autism: [mobd]), (spectrum disorder: [dsyn]), ((asd)-related behavioral phenotypes: [cgab]), (animal models: [anim]), (asd: [cgab]), (dysregulation: []), (rac1s control: [sbst]), (glutamatergic synapses: [bsoj]), (here: []), (humans: [humn]), (large cluster: [qnco]), (asd-related: [cgab]), (mutations: [genf]), (trios rac1: [aapp,enzy]), (domain: []), ( gef1: [gngm]), (study reveals: [resa]), (hyperfunctional forms: [patf]), (trio: [gngm]), (rodent neurons: [mamm]), (vitro: []), (accordance: []), (pathological increases: [qnco]), (decreases: [qnco]), (glutamatergic neurotransmission: [celf]), (synaptic ampa receptor expression: [aapp,rcpt]), (glutamatergic synaptogenesis: [ortf]), (together: []), (findings: [clna]), (reduced trio activity: [aapp,enzy]), (synaptic dysfunction: [dsyn]), (asd-related pathogenesis: [cgab]), (point: [qnco]), (trio-rac1 pathway: [aapp,enzy]), (possible key point: [qnco]), (convergence: [acty]), (many asd-related genes: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5763335
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract mutations: [genf]), (kinesin family member: [aapp,enzy]), ((kif1a) gene: [gngm]), (wide range: [qnco]), (phenotypes: [orga]), (recessive mutations: [genf]), (hereditary sensory: []), (hereditary spastic paraplegia: [dsyn]), (dominant mutations: [genf]), (complex neurological disorder: [dsyn]), (peripheral nervous system: [bdsy]), (dominant missense variant: [fndg]), ( (c.38g>a: []), ( p.r13h): [aapp,imft]), (atp: [aapp,enzy]), (site: [blor]), (kinesin motor domain: [aapp,enzy]), (patient: [podg]), (complex phenotype: [orga]), (autism spectrum disorder (asd): [mobd]), (spastic paraplegia: [dsyn]), (axonal neuropathy: [dsyn]), (presence: [qnco]), (asd: [cgab]), (case: []), (patients: [podg]), (kif1a: [gngm]), 
ASD Terms: (complex neurological disorder, 'Neurologic Indications')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5915192
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background: maternal: [famg]), (folic acid (fa) protects: [orch,phsu,vita]), (developmental toxicity: [inpo]), (certain environmental chemicals: [chem]), (combined exposures: [phpr]), (maternal fa: [famg]), (pesticides: [hops]), (relation: [socb]), (spectrum disorder (asd): [cgab]), (methods: participants: [popg]), (california children: [aggp]), (childhood autism risks: [mobd]), (genetics: []), (environment (charge) casecontrol study: [resa]), (age: [orga]), (y: []), (asd (n=296): [cgab]), (typical development (n=220): [aapp,imft]), (information: []), (maternal supplemental fa: [famg]), (pesticide exposures: [hops]), (maternal: [famg]), (supplemental fa: []), (household pesticide product use: [hops]), (telephone interviews: [resa]), (low daily fa intake: [qnco]), ((median): [qnco]), (mothers addresses: [famg]), (statewide database: []), (commercial applications: [hlca]), (agricultural pesticide exposure: [hops]), (results: high fa: [fndg]), ((800g): []), (first pregnancy month: [fndg]), (pesticide exposure: [hops]), (reference group: [popg]), (analyses: [resa]), (group: [popg]), ( asd: [cgab]), (association: [menp]), (<800g fa: []), (indoor pesticide exposure: [hops]), (odds: []), ([or]=2.5 [95% confidence interval: [qnco]), (low fa [or=1.2 (95% ci:: [fndg]), (indoor pesticides: [hops]), ((95% ci:: [lbpr]), (alone: [fndg]), (ors: [inch,phsu]), (combination: [fndg]), (low fa: [qnco]), (regular pregnancy exposure (6 mo): [orgf]), (sprays: [bodm]), (foggers: []), (respectively: []), (low maternal fa: [qnco]), (mo: []), (conception: [orgf]), (chlorpyrifos: [hops,orch]), (pyrethroids: [hops,orch,phsu]), (carbamates: [orch]), (times: [qnco]), (exposure: [clna]), (expected ors: [inch,phsu]), (multiplicative: [qnco]), (additive models: [sbst]), (conclusions:: []), (study: [resa]), (associations: [menp]), (asd: [cgab]), (high versus: [qnco]), (low fa intake: [qnco]), (first month: [qnco]), (pregnancy: [orgf]), (confirmatory: []), (mechanistic studies: []), (https://doi.org/10.1289/ehp604: [fndg]), 
ASD Terms: (combined exposures, 'Exposures')(childhood autism risks, 'Autism Phenotype')(maternal supplemental folic acid, 'Dietary Supplements')(pesticide exposures, 'Exposures')(supplemental folic acid, 'Dietary Supplements')(agricultural pesticide exposure, 'Exposures')(pesticide exposure, 'Exposures')(indoor pesticide exposure, 'Exposures')(regular pregnancy exposure, 'Exposures')(combined exposures, 'Exposures')(exposure, 'Exposures')(pesticide exposures, 'Exposures')

PMCID: 5618565
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (group: [popg]), (neurodevelopmental disorders: [mobd]), (symptoms: [sosy]), (impaired communication: [socb]), (social interaction: [fndg]), (repetitive motor movements: [fndg]), (general cognitive deficits: [mobd]), (severe chronic childhood disorders: [dsyn]), (terms: [orgf]), (prevalence: [qnco]), ( morbidity: [qnco]), (impact: [gngm]), (society: [orgt]), (effective treatment: []), (asd: [cgab]), (neurobiological basis: [phsu]), (understood hence: [menp]), (specific drugs: [topp]), (developed: []), (endocannabinoid (ec) system: [bacs,orch]), (major neuromodulatory system: []), (regulation: [biof]), (emotional responses: [menp]), (behavioral reactivity: [inbe]), (ec system: []), (conditions: [dsyn]), (subsets: []), (patients: [podg]), (intellectual disabilities: [mobd]), (sleep pattern disturbances: [fndg]), (indirect evidence suggestive: []), (involvement: []), (few studies: [lbpr]), (role: [socb]), (context: [fndg]), (review: []), (available data: [euka]), (investigation: [hlca]), (presence: [qnco]), (alterations: []), (effects: []), (pharmacological manipulations: [topp]), (animal models: [anim]), (asd-like behaviors: [cgab]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(repetitive motor movements, 'Stereotyped, Restricted, and Repetitive Behavior')(general cognitive deficits, 'Cognitive Ability')(emotional responses, 'Empathy')(intellectual disabilities, 'Learning Disorders')(sleep pattern disturbances, 'Sleeping Problems')(asd-like behaviors, 'Autism Phenotype')

PMCID: 5584030
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (recent years: []), ( evidence: []), (link: []), (inflammation: [patf]), (neuropsychiatric disorders: [dsyn]), (mounting: []), (autism spectrum disorders: [mobd]), (share: [socb]), (clinical similarities: []), (same biological basis: [phsu]), ( namely: []), (terms: [orgf]), (however: []), (diagnosis: [fndg]), (asd: [cgab]), (schizophrenia relies: [mobd]), (clinical symptoms: [sosy]), (useful biomarker: [clna]), (course: []), (such illnesses: [sosy]), (focus: []), (review: []), (central role: [socb]), (inflammation plays: [dora]), (schizophrenia: [mobd]), (pre-clinical animal models: [anim]), (clinical research: [resa]), (vitro studies: [lbpr]), (major areas: []), (covered: (1): [fndg]), (inflammatory brain resident myeloid cells: [bpoc]), ( (2) biomarkers: [clna]), (cytokines: [aapp,imft]), ( oxidative stress markers: [comd]), (microrna players: [bacs,nnon]), (cellular processes: [celf]), (brain: [bpoc]), (immune levels: []), ( (3) effect: [fndg]), (anti-psychotics: [mobd]), (biomarkers: [clna]), (other predictors: []), (response: [fndg]), ((4) impact: [gngm]), (gender: [orga]), (activation: [acty]), ( biomarkers: [clna]), (anti-psychotic treatments: [topp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(schizophrenia share, 'Schizophrenia and Disorders with Psychotic Features')(diagnosis, 'Diagnosis')(schizophrenia relies, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 5578492
SFARI Genes: PAX6, PAX6, Robo1, Robo1, 
Non SFARI Genes: WT1, PRRG4, PRRG4, PRRG4, PRRG4, PRRG4, PRRG4, 
Named Entities: (wagr syndrome: [dsyn]), (wilms tumor: [neop]), ( aniridia: [cgab]), (genitourinary abnormalities: [cgab]), (intellectual disabilities: [mobd]), (wagr: [gngm]), (chromosomal deletion: [comd]), (pax6: [gngm]), ( wt1: [neop]), (prrg4 genes: [gngm]), (prrg4: [gngm]), (autistic symptoms: [mobd]), (molecular function: [moft]), (drosophila commissureless (comm) gene: [euka]), (short transmembrane protein: [aapp]), (py motifs: [amas]), ( features: []), (prrg4 protein: [aapp,bacs]), (comm: []), (robo axon guidance receptor: [aapp,rcpt]), (er/golgi: [celc]), (targets robo: [diap]), (degradation: [orgf]), (commissural axons: [celc]), (cns midline: [bdsy]), (expression: [topp]), (human robo1: [humn]), (fly cns: [euka]), (midline crossing: [celc]), (co-expression: [topp]), (cyyr: []), ( shisa: []), (yeast rcr genes: [fngs]), (cell culture: [lbpr]), (hrobo1: []), (cell surface: [celc]), (functional homologue: [gngm]), (axon guidance: [celf]), (synapse formation: [ortf]), (fly: [euka]), (processes: [phpr]), (human brain: [humn]), 
ASD Terms: (genitourinary abnormalities, 'Urogenital Diseases')(intellectual disabilities, 'Learning Disorders')(autistic symptoms, 'Complaints and Indications')(autistic symptoms, 'Complaints and Indications')

PMCID: 5783661
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background: prior studies: [lbpr]), (neurodevelopmental impacts: [gngm]), (polybrominated diphenyl ethers: [orch]), (developmental disorders: [mobd]), (objectives:: []), (aim: [phsu]), (prenatal exposure: [fndg]), (flame retardants: [chvf]), (autism spectrum disorder (asd): [mobd]), (intellectual disability: [mobd]), (autism (id): [mobd]), (methods:: []), (population-based casecontrol study: [resa]), (children: [aggp]), (asd (n=545): [cgab]), (id (n=181): [lbpr]), (california department: [orgt]), (developmental: [orgf]), (general population (gp): [popg]), (state birth certificates: []), (asd cases: [cgab]), (controls: [sbst]), (sex: [orgf]), ( birth month: []), (birth year: []), (concentrations: [menp]), (bfrs: [dsyn]), (maternal second trimester serum samples: [bdsu]), (routine screening: [diap]), (logistic regression: [resa]), (crude: []), (odds ratios: [qnco]), (associations: [menp]), (asd: [cgab]), (id: [lbpr]), (gp controls: [gngm]), (quartiles: []), (analyte concentrations: [menp]), (primary analyses: [resa]), (results: geometric: [fndg]), (mean concentrations: [menp]), (congeners: [chvs]), (55%: []), (samples: [sbst]), (limit: []), (detection: [topp]), (mothers: [famg]), (analyses: [resa]), (inverse associations: []), (several congeners: [chvs]), (asd relative: [cgab]), (gp (e.g.: [gngm]), (vs: []), (bde-153: aor=0.56: [orch]), (ci:: [lbpr]), (child sex: [orgf]), (females: [orga]), (gp): [gngm]), ( estimates: [qnco]), (overall analyses: [resa]), (boys: [aggp]), (opposite direction: []), (bde-28: [orch]), (-47 (aor=2.58: [moft]), (aor=2.64: [moft]), (respectively): []), (similar patterns: []), (conclusions: contrary: []), (pbde concentrations: [orch]), (decreased odds: [qnco]), (girls: [aggp]), (findings: [clna]), (confirmation: []), (potential sexual dimorphism: [ortf]), (https://doi.org/10.1289/ehp1079: [fndg]), 
ASD Terms: (neurodevelopmental impacts, 'Learning Disorders')(autism, 'Autism Phenotype')(prenatal exposure, 'Exposures')(flame retardants, 'Mental Retardation')(autism spectrum disorder, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(brominated flame retardants, 'Mental Retardation')

PMCID: 5618521
SFARI Genes: Arid1b, Arid1b, Arid1b, Arid1b, Arid1b, Arid1b, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disorder: [mobd]), (core symptoms: [sosy]), (poor social communication: [fndg]), (interests: [menp]), (repetitive behaviors: [fndg]), (several asd mouse models: [mamm]), (impaired social interaction: [mobd]), (anxiety-like behavior: [mobd]), (perseveration: [mobd]), (large-scale whole exome: [gngm]), (studies: [lbpr]), (many genes: [gngm]), (asd: [cgab]), (chromodomain helicase dna binding protein: [aapp,enzy]), (gene: [gngm]), (individuals: [humn]), (candidate gene at-rich interaction domain: [gngm]), ((arid1b): [gngm]), (chromatin: [aapp]), (factor: []), (arid1b: [gngm]), (heterozygous knockout (hko) mice: [mamm]), (asd-like traits: [cgab]), (social behavior: [socb]), ( anxiety: [mobd]), (addition: []), (features: []), (cases: [qnco]), (reduced weight: [orga]), (motor coordination: [ortf]), (hydrocephalus: [dsyn]), (hko: []), (wild-type littermates: [gngm]), (genome-wide gene expression patterns: [genf]), (arid1b hko mice: [mamm]), (asd patients: [cgab]), (chd8-haploinsufficient: [comd]), (asd model: [cgab]), (changes: [qnco]), (gene expression: [genf]), (fast-spiking cells: [fndg]), (mouse brain: [tisu]), (results: [fndg]), (arid1b haploinsufficiency: [comd]), (asd-like phenotypes: [cgab]), (mice: [mamm]), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(poor social communication, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(impaired social interaction, 'Reciprocal Social Interaction')(perseveration, 'Involuntary Behaviors')(perseveration, 'Involuntary Behaviors')(social behavior, 'Reciprocal Social Interaction')(anxiety, 'Anxiety Disorders')(motor coordination, 'Motor Skills')(hydrocephalus, 'Hydrocephalus')

PMCID: 5575292
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (variants: []), (loss: [qnco]), (function: [phsf]), (human genes: [gngm]), (interest: [menp]), (clinical impact: [gngm]), (surprising prevalence: [qnco]), (healthy individuals: [humn]), (here: []), (aloft (annotation: []), (loss-of-function transcripts): [phsf]), (method: [lbpr]), (disease-causing potential: []), (loss-of-function variants: [phsf]), (data: [euka]), (mendelian disease-gene discovery: [mbrt]), (aloft: []), (heterozygotes: [orga]), (disease: [dsyn]), (homozygous state: [orga]), (investigation: [hlca]), (healthy populations: [popg]), (heterozygous premature stop alleles: [gngm]), (homozygotes: [orga]), (putative loss-of-function variants: [phsf]), (autism-affected families: [famg]), ( aloft distinguishes: []), (deleterious variants: []), (patients: [podg]), (benign variants: []), (unaffected siblings: [famg]), (finally: []), ( analysis: [resa]), (somatic variants: [cell]), (>6500 cancer: [euka]), (driver genes: [gngm]), 
ASD Terms: 

PMCID: 5571902
SFARI Genes: NLGN4, NLGN4, NLGN, NLGN, 
Non SFARI Genes: 
Named Entities: (genetic mutations: [genf]), (etiology: []), (autism spectrum disorder: [mobd]), (common: [qnco]), (heterogeneous neurodevelopmental disorder: [orga]), (impairments: [patf]), (social interaction: [fndg]), ( communication: [socb]), (restricted patterns: []), (behavior: [inbe]), (cell adhesion molecule: [aapp,bacs]), (neuronal synapse: [bsoj]), (risk gene: [gngm]), (asd: [cgab]), (several additional variants: [qnco]), (nlgn3: [gngm]), (nlgn4: [gngm]), (asd patients: [cgab]), (moreover: []), ( synaptopathies: []), (several neuropsychiatric disorders: [dsyn]), (humans: [humn]), ( nlgns consist: [gngm]), (family members: [famg]), (neuroligin1 (nlgn1): [aapp,rcpt]), (major component: []), (complex: [chvs]), (excitatory glutamatergic synapses: [celc]), (however: []), (significance: [qnco]), (nlgn1: [gngm]), (neuropsychiatric disorders: [dsyn]), (here: []), (missense variants: [fndg]), (cellular alterations: [comd]), (variants: []), (novel nlgn1 pro89leu (p89l) missense variant: [fndg]), (asd siblings: [famg]), (changes: [qnco]), (cellular localization: [celf]), ( protein degradation: [moft]), (impairment: [patf]), (spine formation: [bpoc]), (furthermore: []), (knock-in p89l mice: [mamm]), (p89l heterozygote mice display: [mamm]), (abnormal social behavior: [patf]), (core feature: [bdsu]), (results: [fndg]), (first time: [qnco]), ( implicate: []), (rare variants: [gngm]), (support: []), (nlgn: [gngm]), (synaptic pathway: [moft]), (importance: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(restricted patterns of behavior, 'Restricted and Repetitive Behavior')(heterogeneous neurodevelopmental disorder, 'Learning Disorders')(abnormal social behavior, 'Personal Traits')

PMCID: 5611737
SFARI Genes: 
Non SFARI Genes: rho, 
Named Entities: (reticulon: []), (receptor (rtn4r): [gngm]), (essential role: [socb]), (axonal regeneration: [fndg]), (plasticity: [npop]), (central nervous system: [bdsy]), (activation: [acty]), (rho kinase: [aapp,enzy]), (chromosome: [celc]), (region: []), (hotspot: [nusq]), (schizophrenia (scz): [mobd]), (autism spectrum disorder (asd): [mobd]), (recently: []), (rare variants: [gngm]), (copy-number variants: [nusq]), (single-nucleotide variants: [fndg]), (focus: []), (research: [resa]), (large effect size: [qnco]), (increased susceptibility: [clna]), (scz: []), (asd: [cgab]), (possibility: []), (pathophysiology: [patf]), (mental disorder: [mobd]), (functional analysis: [hlca]), (role: [socb]), (etiopathophysiology: []), (rtn4r coding exons: [bacs,nnon]), (sample: [sbst]), (asd patients: [cgab]), (association analysis: [menp]), (large number: [qnco]), (unrelated individuals: [fndg]), (controls): [sbst]), (mutation screening: [genf]), (rare (minor allele frequency <1%) missense mutations: [genf]), (d259n: []), ( r292h: []), (v363m): []), (rtn4r: [gngm]), (rare mutations: [genf]), (scz (p=0.048): [fndg]), (furthermore: []), (vitro: []), (functional assays: [lbpr]), (r292h mutation: [genf]), (formation: [biof]), (growth cones: [celc]), (study: [resa]), (evidence: []), (association: [menp]), (light: [gngm]), (molecular mechanisms: []), (neurodevelopmental disorder: [mobd]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorder, 'Autism Phenotype')(mental disorder, 'Mental Disorders')(neurodevelopmental disorder, 'Learning Disorders')

PMCID: 5561609
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (impairments: [patf]), (social communication: [socb]), (repetitive behaviors: [fndg]), (interests: [menp]), (asd: [cgab]), (children: [aggp]), (towards males: [orga]), (ratio: [qnco]), (many possible explanations: []), (potential causative factors: []), (reported: [hlca]), (genetics: []), ( sex: [orgf]), (environmental factors: []), (detailed mechanisms: []), (dams: [gngm]), (oral contraceptives: [phsu]), (vehicle control (veh): [bodm]), (levonorgestrel (lng) alone: [horm,orch,phsu]), ( ethinyl estradiol (ee) alone: [horm,orch,phsu]), (combination: [fndg]), (lng/ee: []), (days: []), (pregnancy: [orgf]), (subsequent 10-week-old offspring: [famg]), (autism-like behavior testing: [mobd]), (limbic tissues: [tisu]), (analysis: [resa]), (experimental group: [popg]), (8-week-old male: [orga]), (infusion: [topp]), (er: [gngm]), (overexpression/knockdown lentivirus: [virs]), (amygdala: [bpoc]), (offspring: [famg]), (weeks: []), (prenatal exposure: [fndg]), (lng: []), (lng/ee combination: [fndg]), (ee: []), (alone: [fndg]), ( results: [fndg]), (suppression: [qnco]), (er (estrogen receptor ): [aapp,rcpt]), (target genes: [gngm]), (autism-like behavior: [mobd]), (male offspring: [aggp]), (effect: []), (female offspring: [aggp]), (however: []), (hippocampus: [bpoc]), (hypothalamus: [bpoc]), (further investigation: [hlca]), (er suppression: [qnco]), (lng-mediated altered methylation: [moft]), (er promoter: [bacs,nnon]), (results: [fndg]), (tissue damage: [inpo]), (oxidative stress: [comd]), (dysfunction: [dsyn]), (mitochondria: [celc]), (fatty acid metabolism: [moft]), (overexpression: [genf]), (lng-induced er suppression: [qnco]), (autism-like behaviors: [mobd]), (mimics: [hops,orch]), (er expression: [topp]), (important role: [socb]), (autism-like behavior development: [mobd]), (prenatal levonorgestrel exposure: [horm,orch,phsu]), (knowledge: []), (first time: [qnco]), (potential effect: []), (contribution: [acty]), (discovered: [acty]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0159-3) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(subsequent 10-week-old offspring, 'Perinatal History')(offspring, 'Perinatal History')(female offspring, 'Perinatal History')(prenatal exposure, 'Exposures')(male offspring, 'Perinatal History')(autism-like behaviors in offspring, 'Perinatal History')(prenatal levonorgestrel exposure, 'Exposures')

PMCID: 5574313
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (formation: [biof]), (complex cerebellar cortical circuits: [bpoc]), (different phases: [euka]), (initial synaptogenesis: [ortf]), (subsequent processes: [phpr]), (refinement: []), (variety: []), (mechanisms: []), (regularity: []), (synaptic organization: [orgt]), (cerebellar cortex: [bpoc]), (detailed studies: [lbpr]), (structural plasticity mechanisms: [npop]), (new synapses: [bsoj]), (retraction: [topp]), (redundant ones: [qnco]), (attainment: []), (monoinnervation: []), (purkinje cell: [cell]), (single climbing: [fndg]), (fiber: [anim]), ( several signals: [phpr]), (electrical activity: [ortf]), ( contact: [acty]), (heterosynaptic interaction: []), ( calcium transients: [bacs,elii,phsu]), (postsynaptic receptors: [aapp,rcpt]), (transduction pathways: [moft]), (important role: [socb]), (developmental program: [hlca]), (serotonergic projections: [menp]), ( induce: []), (phases: [euka]), (synaptic formation: [biof]), (maturation: [phsf]), (adult: [aggp]), (many developmental mechanisms persist: [orgf]), (different roles: [socb]), (synaptic plasticity: [ortf]), (learning: [menp]), (cerebellar memory traces: [bpoc]), (dysfunction: [dsyn]), (stage: [clna]), (process: [phpr]), (disorders: [dsyn]), (cerebellar origin: [bpoc]), (autism spectrum disorders: [mobd]), (deficits: []), (recent evidence: []), (animal models: [anim]), (impairment: [patf]), (purkinje cell function: [cell]), (autism-like symptoms: [mobd]), (sociability deficits: [socb]), (movements: [orgf]), (interspecific communication: [socb]), (vocalization: [fndg]), 
ASD Terms: (cerebellar memory traces, 'Working Memory')(autism spectrum disorders, 'Autism Phenotype')(motor deficits, 'Motor Skills')(vocalization, 'Vocalizations')

PMCID: 5557355
SFARI Genes: En2, En2, En2, En2, En2, En2, En2, En2, En2, En2, En2, En2, En2, En2, En2, En2, En2, En2, 
Non SFARI Genes: 
Named Entities: ((en1): [gngm]), ((en2) code: [gngm]), (related homeoproteins: [aapp,bacs]), (transcription factors: [aapp,bacs]), (molecules: [sbst]), (patterning: []), (development: [orgf]), (maintenance: [acty]), (monoaminergic pathways: [moft]), (wiring: [topp]), (en2: [gngm]), (autism susceptibility gene: [mobd]), (individuals: [humn]), (autism: [mobd]), (overexpression: [genf]), (homeogene: []), (mechanisms: []), (present study: [qnco]), (effect: []), (morphology: [fndg]), (hippocampal cells: [cell]), (low levels: [qnco]), (engrailed proteins: [aapp,bacs]), (means: []), (rt-qpcr: [mbrt]), (en1: [gngm]), (hippocampus: [bpoc]), (hippocampal neurons: [cell]), (pronounced decrease: [qnco]), (en2 expression: [topp]), (birth: [orgf]), (first postnatal week: [qnco]), (period: []), (intense synaptogenesis: [ortf]), (putative effect: []), (engrailed: []), (dendritogenesis: []), (synaptogenesis: [ortf]), (recombinant en1: [gngm]), (cell cultures: [lbpr]), (en2 treatment: [topp]), (complexity: [chvs]), (dendritic tree: [celc]), (glutamatergic neurons: [cell]), (gabaergic cells: [cell]), (density: [qnco]), (dendritic spines: [celc]), (vitro: []), (vivo: []), (pronounced effect: []), (spine density: [bpoc]), (number: [qnco]), (mature synapses: [bsoj]), (en1 treatment: [topp]), (area: []), (post-synaptic densities: [celc]), (finally: []), (mtorc1 activity: [celc]), (protein synthesis: [moft]), (effects: []), (mrna translation: [moft]), (results: [fndg]), (proteins: [aapp,bacs]), (low concentrations: [menp]), (active role: [socb]), (morphogenesis: [orgf]), (further: []), (over-regulation: [biof]), (gaba cell morphology: [aapp,bacs]), (vulnerability: []), (excitatory synapses: [celc]), (pathological context: [fndg]), (en2 overexpression: [genf]), 
ASD Terms: (autism, 'Autism Phenotype')(autism susceptibility gene, 'Autism Phenotype')

PMCID: 5607556
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract introduction neuroligins: [moft]), (postsynaptic cell adhesion: [celf]), (interact: []), (neurexins: []), (fine balance: [fndg]), (excitation: [acty]), (inhibition: [acty]), (synapses: [bsoj]), (recently: []), (evidence: []), (mutation: [genf]), (cellular assays: [resa]), (mouse models: [mamm]), (neuroligin (nlgn) mutations: [genf]), (synapse maturation: [ortf]), (function: [phsf]), (previously: []), (missense variations: [fndg]), ((nlgn3): [gngm]), ( p.g84r (nlgn4x): [gngm]), ( p.q162k (nlgn4x): [gngm]), (p.a283t (nlgn4x)]: [gngm]), (different unrelated patients: [podg]), (pcr: [mbrt]), (direct sequencing: [mbrt]), (study: [resa]), (functional effect: []), (vitro experiment: [resa]), (stable hek293 cells: [cell]), (wildtype: [gngm]), (mutant neuroligin: [moft]), (mutations: [genf]), (expression: [topp]), (neurexin: []), (interaction: []), (variants: []), (modest role: [socb]), (pathogenesis: [patf]), (autism: [mobd]), (unreported infrequent polymorphisms: [genf]), (data: [euka]), (neuroligin mutations: [genf]), (primary risk factors: [qnco]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5550983
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (arginine vasopressin: [aapp,horm,phsu]), (emotional behaviors: [inbe]), (arginine vasopressin receptor (avpr1a): [aapp,rcpt]), (genetic polymorphisms: [genf]), (avpr1a promoter region: [bacs,nnon]), (susceptibility: [clna]), (social deficits: []), (autism spectrum disorder (asd): [mobd]), (alleles: [gngm]), (polymorphisms: [genf]), (promoter region: [bacs,nnon]), (avpr1a: [gngm]), (certain transcriptional factors: [aapp,bacs]), (turn: [fndg]), (affect quantitative traits: [menp]), (sociality: []), (children: [aggp]), (autism: [mobd]), (association study: [menp]), (asd: [cgab]), (korean population: [popg]), (family-based association test (fbat): [socb]), (correlation: []), (genotypes: [orga]), (quantitative traits: [gngm]), (promoter assay: [lbpr]), (t98g cells: [cell]), (binding affinities: [npop]), (transcription factors: [aapp,bacs]), (rs7294536: []), (polymorphismsrs1: []), ( rs3: []), ( rs7294536: []), (analyzed: [resa]), (dominant model: []), ( rs1310: []), (shorter allele: [gngm]), (fbat: []), (rs7294536 a allele: [gngm]), (bi-allelic mode: [gngm]), (rs10877969: []), (genotype models: [orga]), (modes: [qnco]), (luciferase: [aapp,enzy,irda]), (electrophoretic mobility-shift assays: [lbpr]), (rs7294536 a/g allele results: [gngm]), (nf-b binding site: [rcpt]), (affinities: [npop]), (allele: [gngm]), (results: [fndg]), (pathophysiology: [patf]), (functional regulation: [biof]), (expression: [topp]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0161-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social deficits, 'Social Competence')(autism, 'Autism Phenotype')

PMCID: 5633642
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (number: [qnco]), (autistic traits: [mobd]), (other mental health problems: [fndg]), ( research: [resa]), (association: [menp]), (preschool children: [aggp]), (emotional/behavioral outcomes: [inbe]), (data: [euka]), (japanese community-based children: [aggp]), (study: [resa]), (age: [orga]), (results: [fndg]), (prior autistic traits: [mobd]), (emotional/behavioral domains: [menp]), (baseline emotional/behavioral scores: [bodm]), (emotional symptoms: [menp]), (problems: []), (addition: []), (clinical asd: [cgab]), (subthreshold autistic traits: [mobd]), (subsequent emotional/behavioral outcomes: [inbe]), 
ASD Terms: (other mental health problems, 'Mental Retardation')

PMCID: 5543534
SFARI Genes: MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, RTT, RTT, MECP2, MECP2, MECP2, RTT, MECP2, RTT, MECP2, MECP2, 
Non SFARI Genes: 
Named Entities: (methyl-cpg-binding protein-2 (mecp2): [aapp,bacs]), (critical regulator: []), (neural development: [orgf]), (gain-of-function leads: [elii,hops]), (neurodevelopmental disorders: [mobd]), (rett: []), ((rtt): [dsyn]), (autism spectrum disorder (asd): [mobd]), (mecp2 mutations: [aapp,bacs]), (patients: [podg]), (asd: [cgab]), (autism-related mutations: [mobd]), (proper function: [phsf]), (mecp2: [gngm]), (whole-exome sequencing: [mbrt]), (other asd candidate genes: [cgab]), (parents: []), (mecp2 mutation: [aapp,bacs]), (further sanger sequencing: [mbrt]), (patient: [podg]), (case report form: []), (general information: [hlca]), (clinical scales: [bpoc]), (clinical features: [clna]), (mouse: [mamm]), (cortical neurons: [bpoc]), (hek-293 cells: [cell]), (wild-type (wt): [gngm]), (mutant: [comd]), (function: [phsf]), (autism-associated mecp2 mutants: [aapp,bacs]), (expression: [topp]), (mutant constructs: [comd]), (western blot: [lbpr]), (neurites: [celc]), (axon outgrowth: [celc]), (immunofluorescence experiments: [lbpr]), (missense mutations: [genf]), (autism patients: [mobd]), (whole-exome sequencing: p.p152l (c.455c>t): [clna]), ( p.p376s (c.1162c>t): [clna]), (p.r294x (c.880c>t): [clna]), (mutations: [genf]), ( p.p152l: [aapp,imft]), (p.r294x: [aapp,imft]), (p.p376s: [aapp,imft]), (maternally: []), (diagnosis: [fndg]), (rtt: [gngm]), (abnormalities: [cgab]), (axonal growth: [ortf]), (autism-related mecp2 mutants: [aapp,bacs]), (cortical neurons;: [bpoc]), (autism-related mecp2 mutations: [aapp,bacs]), (proper development: [orgf]), (neurons: [cell]), (study: [resa]), (genetic mutations: [genf]), (mecp2 gene: [gngm]), (finding: [sosy]), (loss-of-function mutations: [phsf]), (spectrum disorders: [dsyn]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0157-5) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(rett syndrome, 'Rett Syndrome')(autism spectrum disorder, 'Autism Phenotype')(autism patients, 'Autism Phenotype')(diagnosis, 'Diagnosis')(autism patients, 'Autism Phenotype')

PMCID: 5541734
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (adenylosuccinate lyase (adsl) deficiency: [dsyn]), (defect: []), (purine metabolism: [moft]), (purinosome assembly: [acty]), (metabolite fluxes: [npop]), (purine: [orch]), (synthesis: [biof]), (pathways: [moft]), (disorder: [dsyn]), (wide spectrum: [qnco]), (symptoms: [sosy]), (forms: []), (severe form: []), (neonatal encephalopathy: [dsyn]), ( absence: [anab]), (spontaneous movement: [orgf]), (respiratory failure: [dsyn]), ( intractable seizures: [fndg]), (early death: [fndg]), (first weeks: [qnco]), (life: []), (commonly: []), ( adsl presents: [gngm]), (neurologic clinical picture: []), (severe psychomotor retardation: [fndg]), (early onset: [fndg]), (seizures: [sosy]), (autistic features: [mobd]), (i): [inch]), (form: []), (later onset: []), (major features: []), (psychomotor retardation: [fndg]), (transient contact disturbances: [acty]), (ii): []), (diagnostic markers: [clna]), (presence: [qnco]), (succinylaminoimidazole carboxamide riboside (saicar): [nnon]), (succinyladenosine (sado): [nnon]), (extracellular fluids: [bdsu]), (adsl: [gngm]), (rare disorder: [dsyn]), (prevalence: [qnco]), (wide range: [qnco]), (nonspecific manifestations: []), (lack: []), (awareness: [menp]), (condition: [dsyn]), (prevent diagnosis: [fndg]), (case presentation: []), (case: []), (mild: []), ( late onset adsl: [gngm]), (whole exome sequencing (wes): [mbrt]), (valuable diagnostic value: [qnco]), (wes: [mbrt]), (report: [hlca]), (new data: [euka]), (wide clinical manifestation: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13052-017-0383-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (early onset, 'Onset of Symptoms')(later onset, 'Onset of Symptoms')(neurologic clinical picture, 'Neurologic Indications')(severe psychomotor retardation, 'Mental Retardation')(moderate psychomotor retardation, 'Mental Retardation')(prevent diagnosis, 'Diagnosis')(late onset adenylosuccinate lyase, 'Onset of Symptoms')

PMCID: 5611740
SFARI Genes: CX3CR1, CX3CR1, CX3CR1, CX3CR1, CX3CR1, CX3CR1, CX3CR1, CX3CR1, CX3CR1, CX3CR1, CX3CR1, CX3CR1, 
Non SFARI Genes: impact, 
Named Entities: (g: [qnco]), (protein-coupled receptor: [aapp,rcpt]), (microglia: [cell]), (brain: [bpoc]), (neurodevelopmental disorders: [mobd]), (schizophrenia (scz): [mobd]), (autism spectrum disorders: [mobd]), (animal studies: [anim]), (genetic studies: [resa]), (impacts: [gngm]), (variants: []), (cx3cr1: [gngm]), (exon-targeted resequencing: [bacs,nnon]), (japanese scz: [popg]), (asd patients: [cgab]), (next-generation sequencing technology: [mbrt]), (genetic association study: [mbrt]), (sample: [sbst]), (unrelated individuals: [fndg]), (scz: []), (asd: [cgab]), (controls): [sbst]), (silico three-dimensional (3d) structural modeling: [resa]), (vivo disruption: []), (akt phosphorylation: [aapp,enzy]), (impact: [gngm]), (detected variant: [fndg]), (cx3cr1-dependent signal transduction: [celf]), (significant association: [menp]), (variant ala55thr: []), (asd phenotypes: [cgab]), (ratio=8.3: [qnco]), ( p=0.020): [fndg]), (structural model: []), (ala55thr: []), (conformation: []), (cx3cr1 helix: [euka]), (interaction: []), (heterotrimeric g protein: [aapp,enzy]), (vitro functional analysis: [hlca]), (cx3cr1-ala55thr mutation: [genf]), (cell: [gngm]), (ligand: [chem]), (data: [euka]), (disruption: []), (cx3cr1 signaling: [celf]), (results: [fndg]), (association: [menp]), (microglia-specific genes: [gngm]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorders, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(asd phenotypes, 'Autism Phenotype')

PMCID: 5569583
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (highlights: []), (children: [aggp]), (asd: [cgab]), (adhd: [mobd]), (heterogeneous executive function (ef) profiles: [menp]), (typical: []), (ef: []), (individuals: [humn]), (callous-unemotional (cu) traits: [tisu]), (effect: []), (cu traits: [gngm]), (event-related potential (erp) responses: [ortf]), (cued continuous performance test (cpt-ox): [gngm]), ( adhd: [mobd]), (co-occurring asd + adhd: [cgab]), (high cu traits: [gngm]), (conflict monitoring: [inbe]), (low cu traits: [gngm]), (cognitive strengths: []), 
ASD Terms: (adhd, 'Attention Deficit Disorder with Hyperactivity')(heterogeneous executive function profiles, 'Executive Function')(executive function, 'Executive Function')(adhd, 'Attention Deficit Disorder with Hyperactivity')(co-occurring asd + adhd, 'Attention Deficit Disorder with Hyperactivity')(cognitive strengths, 'Cognitive Ability')

PMCID: 5539636
SFARI Genes: 
Non SFARI Genes: Rho, 
Named Entities: (amygdala: [bpoc]), (socioemotional behavior: [inbe]), (etiology: []), (autism spectrum disorder (asd): [mobd]), (precocious amygdala development: [ortf]), (asd youth: [cgab]), (degree: [qnco]), (overgrowth: [fndg]), (severity: []), (asd symptoms: [cgab]), (prenatal exposure: [fndg]), (vpa: []), (asd phenotype: [cgab]), (humans: [humn]), (rats: [mamm]), (used tool: [fndg]), (complexity: [chvs]), (laboratory: [mnob,orgt]), (here: []), (abnormalities: [cgab]), (gene expression: [genf]), (development: [orgf]), (valproic acid (vpa): [orch,phsu]), (model: []), (asd: [cgab]), (rat: [mamm]), (oral gavage: []), (vpa (500 mg/kg): [qnco]), (e11: []), (sexes: [orgf]), (rna sequencing: [nusq]), (proteomics: []), (amygdala samples: [bpoc]), (male rats: [mamm]), (effects: []), (time: []), (social proximity: []), (anxiety-like behavior: [mobd]), (sex dependent: [orgf]), (social abnormalities: [cgab]), (males: [orga]), (anxiety: [mobd]), (females: [orga]), (time vpa: []), (cellular death: [celf]), (disorder: [dsyn]), ( pathways: [moft]), (amygdala relative: [bpoc]), (controls: [sbst]), (postnatal day: []), (gene pathways: [gngm]), (nervous system: [bdsy]), (cellular development: [celf]), (activations: [acty]), (vpa amygdala samples: [bpoc]), (juvenile age: [orga]), ( however: []), (proteomic pathways: [moft]), (reductions: [npop]), (cellular growth: [celf]), (neural development: [orgf]), (alterations: []), (immune pathways: [moft]), ( calcium signaling: [celf]), ( rho gtpases: [aapp,enzy]), (a signaling: [celf]), (behavioral: [inbe]), ( developmental: [orgf]), (genomic alterations: [gngm]), (results: [fndg]), (support: []), (exposure: [clna]), (useful tool: []), (developmental insults: [orgf]), (molecular pathways: [moft]), (rise: []), (asd-related syndromes: [cgab]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0160-x) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(asd symptoms, 'Complaints and Indications')(asd symptoms, 'Complaints and Indications')(prenatal exposure, 'Exposures')(asd phenotype, 'Autism Phenotype')(with social abnormalities, 'Social Competence')(anxiety, 'Anxiety Disorders')(social abnormalities, 'Social Competence')

PMCID: 5578055
SFARI Genes: GATM, SLC6A8, GATM, SLC6A8, GATM, SLC6A8, GATM, SLC6A8, GATM, GATM, SLC6A8, SLC6A8, GATM, GATM, 
Non SFARI Genes: GAMT, GAMT, 
Named Entities: (creatine deficiency syndrome (cds) comprises: [dsyn]), (separate enzyme deficiencies: [dsyn]), (clinical presentations: arginine:glycine amidinotransferase (gatm gene: [aapp,bacs,phsu]), ( glycine amidinotransferase): [aapp,enzy]), ( guanidinoacetate methyltransferase (gamt gene): [aapp,enzy]), (creatine transporter deficiency (slc6a8 gene: [dsyn]), ( solute carrier family: [aapp]), (member: [popg]), (cds presents: [dsyn]), (developmental delays/regression: [dsyn]), (intellectual disability: [mobd]), ( speech: [orgf]), (language: [lang]), (impairment: [patf]), ( autistic behaviour: [mobd]), (epileptic seizures: [dsyn]), (treatment-refractory epilepsy: [dsyn]), (extrapyramidal movement disorders; symptoms: [sosy]), (children: [aggp]), (autism: [mobd]), (objective: []), (study: [resa]), (hypothesis: []), (genetic variability: [topp]), (creatine metabolism genes: [gngm]), (gatm: [gngm]), ( gamt: [gngm]), (slc6a8 genes: [gngm]), (patients: [podg]), (sequence: [nusq]), ( introns: [bacs,nnon]), (adjacent untranslated regions): [nnon]), (total: [qnco]), (variants: []), (gene: [gngm]), ( respectively: []), (slc6a8 (not present: [qnco]), (genomes: [gngm]), ( exome sequencing project (esp): [mbrt]), (exome aggregation consortium (exac) databases): [gngm]), (single variant: [fndg]), (minor allele frequency (maf): [qnco]), (autism population: [mobd]), (east: []), (asian population (fishers exact test): [popg]), (mafs: []), (european population: [popg]), (summary: []), (apparent associations: [menp]), (gamt: [gngm]), (data implying: [euka]), (association: [menp]), (specific gatm gene variants: [gngm]), (observation: [hlca]), (group: [popg]), (autism patients: [mobd]), (sub-populations: [popg]), (asian ethnicities: [popg]), (overall: []), (findings: [clna]), (creatine synthesis/transport: [celf]), (part: [qnco]), (pathogenesis: [patf]), (autism spectrum disorder (asd): [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(speech, 'Language Ability')(epileptic seizures, 'Epilepsy')(treatment-refractory epilepsy, 'Epilepsy')(autism population, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism patients, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5621737
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (studies: [lbpr]), (infant siblings: [famg]), (autistic probands: [mobd]), (elevated risk: []), (autism: [mobd]), (features: []), (first year: [qnco]), (life: []), (emerge: []), (second year: [qnco]), (recent longitudinal neuroimaging study: [resa]), (high-risk siblings: [famg]), (specific pattern: []), (brain development: [ortf]), (infants: [aggp]), (cortical surface area hyper-expansion: [bpoc]), (brain volume overgrowth: [fndg]), (emergence: []), (autistic social deficits: [mobd]), (new observations: [hlca]), (autism risk alleles: [gngm]), (rodent model: [mamm]), (findings: [clna]), (conceptual framework: []), (early: []), ( post-natal development: [orgf]), (framework: []), (increase: []), (proliferation: [patf]), (neural progenitor cells: [cell]), (hyper-expansion: [mobd]), (cortical surface area: [bpoc]), (pre-symptomatic period: [mamm]), (disrupted sensorimotor: []), (attentional experience: [menp]), (experience-dependent neuronal development: [celf]), (decreased elimination: [fndg]), (neuronal processes: [celc]), (process: [phpr]), (disruption: []), (refinement: []), (neural circuit connections: []), (understanding: [menp]), (timing: []), (developmental brain: [emst]), (behavior mechanisms: [resa]), (infancy: []), (period: []), (disorder: [dsyn]), (important implications: []), (rational approaches: []), (early intervention: [hlca]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(emergence of autistic social deficits, 'Social Competence')(autistic social deficits, 'Social Competence')(autism, 'Autism Phenotype')(autism risk alleles, 'Autism Phenotype')(emergence of autistic social deficits, 'Social Competence')(autism, 'Autism Phenotype')(infancy, 'Perinatal History')

PMCID: 5538124
SFARI Genes: EHMT1, EHMT1, EHMT1, EHMT1, 
Non SFARI Genes: 
Named Entities: (aim: [phsu]), (present study: [qnco]), (vitro kleefstra syndrome (ks) disease model: [dsyn]), (human induced pluripotent stem cell (hipsc) technology: [humn]), (previously: []), (autism spectrum disorder (asd) patient: [mobd]), (kleefstra: []), (deleterious premature termination codon mutation: [nusq]), (ehmt1 gene: [gngm]), (patient: [podg]), (specific hipscs: [cell]), (peripheral blood: [bdsu]), (mononuclear cells: [cell]), (ks-asd patient: [cgab]), (post-mitotic cortical neurons: [bpoc]), (levels: []), (ehmt1 mrna: [bacs,nnon]), (protein expression: [genf]), (cells: [cell]), (morphological analysis: [resa]), (neuronal cells: [cell]), (ks-asd: [cgab]), (patient-derived hipsc clones: [cell]), (neurites: [celc]), (reduced arborization: []), (healthy controls: []), (moreover: []), ( density: [qnco]), (dendritic protrusions: [celc]), (ks-asd hipscs: [cgab]), (control cells: [cell]), (synaptic connections: [bsoj]), (spontaneous neuronal activity: [acty]), (live cell calcium imaging: [bacs,elii,phsu]), (weeks: []), (differentiation: [celf]), (ks-asd cells: [cgab]), (sensitivity: [patf]), (calcium responses: [bacs,elii,phsu]), (stimulation: [npop]), (nicotinic cholinergic tone: [hops,orch,phsu]), (baseline condition: [bodm]), (addition: []), ( gene expression profiling: [lbpr,mbrt]), (differentiated neuronal cells: [celf]), (expression: [topp]), (proliferation-related genes: [gngm]), (mrna levels: [bacs,nnon]), (genes: [gngm]), (neuronal maturation: [celf]), (migration: [phpr]), (data: [euka]), (functional activity: [acty]), (gene expression: [genf]), (patient-specific hipsc-derived neuronal cultures: [cell]), (vitro system: []), (understanding: [menp]), (ks: [gngm]), (other neurodevelopmental disorders: [mobd]), (asd: [cgab]), 
ASD Terms: (autism spectrum disorder patient, 'Autism Phenotype')(other neurodevelopmental disorders, 'Learning Disorders')

PMCID: 5526322
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (presence: [qnco]), (attention-deficit/hyperactive disorder (adhd) symptoms: [mobd]), (impaired attention performance: [menp]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (however: []), (attention performance: [menp]), (unaffected siblings: [famg]), (study: [resa]), (adhd-related traits: [mobd]), (probands: [orga]), (autism: [mobd]), (asperger: []), ((as): []), (clinical correlates: []), (intention: [menp]), ( hyperactivity-impulsivity: [mobd]), (oppositional symptoms: [sosy]), (attention profiles: [menp]), (diagnosis: [fndg]), (asd (122: [cgab]), (as): []), (controls: [sbst]), (parents reports: [hlca]), (adhd-related symptoms: [mobd]), (connors' continuous performance test (ccpt): [diap]), ( respectively: []), (td: []), (asd probands: [cgab]), (as probands: [orga]), (ccpt: []), (as: []), (intermediate levels: [lbtr]), (performance: [inbe]), (focused attention: [menp]), (sustained attention: [menp]), (contrast: [irda]), (autism probands: [mobd]), (ccpt performance: [inbe]), (addition: []), (behaviors: [inbe]), (groups: [popg]), (distinctive patterns: []), (other correlates: []), (sibling groups: [famg]), (work: []), (hyperactive/impulsive traits: [mobd]), (trend: []), (pervasive attention deficits: [mobd]), (potential endophenotypes: []), (genetic studies: [resa]), (trial registration clinicaltrials.gov: [resa]), ( nct01582256 electronic: []), (supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0153-9) contains: [acty]), (users: [humn]), 
ASD Terms: (attention-deficit/hyperactive disorder symptoms, 'Attention Deficit Disorder with Hyperactivity')(autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(asperger syndrome, 'Asperger Syndrome')(asperger, 'Asperger Syndrome')(diagnosis, 'Diagnosis')(asperger syndromed, 'Asperger Syndrome')(asperger, 'Asperger Syndrome')(asperger syndrome, 'Asperger Syndrome')(asperger syndrome, 'Asperger Syndrome')(autism probands, 'Autism Phenotype')(asperger syndrome, 'Asperger Syndrome')

PMCID: 5537407
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (schizophrenia: [mobd]), (multi-dimensional spectrum disorders: [dsyn]), (substantial phenotypic overlap: [orga]), (overlap: [topp]), (non-clinical population: [popg]), (social disorganisation (sd): [socb]), (study: [resa]), (balance: [fndg]), (excitatory glutamate: [aapp,bacs]), (inhibitory -aminobutyric acid (gaba) concentrations: [aapp,bacs]), (non-clinical sample: [sbst]), (low trait sd: [mamm]), (glutamate: [aapp,bacs]), (gaba abnormalities: [aapp,bacs]), (schizophrenia spectrum disorders: [mobd]), (participants: [popg]), (low (10 females): [orga]), (high (9 females) sd scorers: [orga]), (years: []), (gaba+macromolecule (gaba+) concentrations: [aapp,bacs]), (right: []), (superior temporal (st) voxels: []), (gaba+ concentration (p: [aapp,bacs]), (glutamate/gaba+ ratio (p: [aapp,bacs]), (right st voxel: []), (high sd group: [popg]), (gaba+ concentration: [aapp,bacs]), (left: []), (st: []), ((p: [aapp,imft]), (bilateral glutamate concentration: [aapp,bacs]), (high sd group (p: [popg]), (group interaction (p: [popg]), (results: [fndg]), (expression: [topp]), (sd phenotype: [orga]), (increased glutamate/gaba+ ratio: [aapp,bacs]), (right st region: []), (speech prosody processing: [orgf]), (lead behavioural characteristics: [elii,hops]), (schizotypal spectra: [qnco]), 
ASD Terms: (autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia spectrum disorders, 'Schizophrenia and Disorders with Psychotic Features')(affect speech prosody processing, 'Prosody')

PMCID: 5672813
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (post-zygotic mutations: [emst]), (whole-exome sequences: [nusq]), (collection: []), (trios: [aapp,enzy]), (autism spectrum disorder (asd): [mobd]), (unpublished trios: [aapp,enzy]), (re-sequencing: [mbrt]), (multiple independent technologies: [fndg]), (mutations: [genf]), (pzms: []), (previous studies: [lbpr]), (damaging: [inpo]), (non-synonymous pzms: []), (critical exons: [bacs,nnon]), (prenatally-expressed genes: [gngm]), (asd probands: [cgab]), (controls: [sbst]), (genes: [gngm]), (expression: [topp]), (amygdala (p=5.410-3): [bpoc]), (genes (klf16: [gngm]), (msantd2): [gngm]), (pzms genome-wide: [gngm]), (other pzms: []), (genes (scn2a: [gngm]), ( hnrnpu: [gngm]), ( smarca4): [aapp,bacs]), (asd: [cgab]), (other neurodevelopmental disorders: [mobd]), (significant proportion: [qnco]), (asd risk: [cgab]), 
ASD Terms: (autism spectrum disorder available, 'Autism Phenotype')(other neurodevelopmental disorders, 'Learning Disorders')

PMCID: 5842695
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (infants: [aggp]), (crawl: [fndg]), (walk: [dora]), (world: [popg]), (looking:: [orga]), (preferential attention: [menp]), (social stimuli: [phpr]), (faces2: []), ( face-like stimuli3: [blor]), (biological motion4: []), (capacitysocial visual engagementshapes: []), (typical infant development: [phsf]), (birth5: []), (children: [aggp]), (autism6: []), (variation: []), (viewing: []), (social scenesincluding levels: []), (timing: []), ( direction: []), (targeting: []), (individual eye movementsis: [bpoc]), (genetic factors: [fndg]), (effects: []), (social information7: []), (series: [qnco]), (eye-tracking experiments: [bpoc]), (epidemiologically-ascertained twins: [famg]), (non-twins: [famg]), (autism: [mobd]), (singleton controlswe: [fndg]), (high monozygotic twin-twin concordance (0.91): [famg]), (low dizygotic concordance (0.35): [fndg]), (moreover: []), (measures: [qnco]), (heritable: []), ( preferential attention: [menp]), (eye: [bpoc]), (mouth regions: [blor]), (face: [gngm]), (autism (2=64.03: [mobd]), ( p<0.0001): [fndg]), (social visual engagement: [fndg]), (neurodevelopmental endophenotypenot: [ortf]), (population-wide variation: [qnco]), (social-information-seeking8reveal: []), (means: []), (human biological niche construction: [humn]), (phenotypic differences: [orga]), (interaction: []), (individual genotypes: [orga]), (early life experience7: []), 
ASD Terms: (capacitysocial visual engagementshapes, 'Visual Thinking')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(neurodevelopmental endophenotypenot, 'Learning Disorders')(social visual engagement, 'Visual Thinking')

PMCID: 5518846
SFARI Genes: 
Non SFARI Genes: PRKAG2, PRKAG2, PRKAG2, PRKAG2, 
Named Entities: (case series patient:  final diagnosis: prkag2: [podg]), (symptoms: palpitation  dyspnea: [sosy]), (fatigue  syncope medication:  clinical procedure: radiofrequency catheter ablation  pacemaker implantion: [sosy]), (antiarrhythmic drugs specialty: cardiology objective: rare disease background: prkag2: [phsu]), (syndrome diagnosis: [dsyn]), (wolff-parkinson-white syndrome (wpw): [dsyn]), ( ventricular hypertrophy (vh): [dsyn]), (accumulation: [fndg]), (conduction system disease (csd): [patf]), (rarity: [gngm]), (lack: []), (literature: [inpr,mnob]), (treatment: [topp]), (present study: [qnco]), (appropriate strategies: [menp]), (affected family members: [famg]), (prkag2 syndrome: [dsyn]), (long follow-up period: [hlca]), (case report:: [clna]), (individuals: [humn]), (family members: [famg]), ((mean age: [orga]), (years): []), (patients: [podg]), (wpw: [dsyn]), (vh: [gngm]), (group: [popg]), ((61.1%): []), ((33.3%): []), ((5.6%): [fndg]), (palpitations: [fndg]), (pain: [sosy]), ( dizziness: [sosy]), ((72.2%): []), ((83.3%): []), (dyspnea: [sosy]), ((72%): []), (sudden cardiac death (scd): [patf]), ((11.1%): []), (cardiac arrest (ca): [dsyn]), (pre-excited atrial flutter-fibrillation (afl: [dsyn]), (af): [lbtr]), (documented mechanism: [hlca]), (transient ischemic attack (tia): [dsyn]), (learning/language disabilities: [mobd]), (delayed development: [mobd]), (observed: []), (genetic analysis: [lbpr]), (new missense: [fndg]), (pathogenic variant (p.k290i): [aapp,imft]), (prkag2 gene: [gngm]), (cardiac histopathology: [bpoc]), (predominance: []), (vacuoles: [celc]), (glycogen: [bacs,orch]), (fibrosis: [patf]), (hypertension: [dsyn]), (mellitus (dm): [dsyn]), (antiarrhythmic drugs: [phsu]), (anticoagulation: [fndg]), (radiofrequency catheter ablation (rca): [topp]), ((33.3%) underwent pacemaker implantation (pm): [orgf]), (conclusions:: []), (clinical treatment: [topp]), (rare cardiac syndrome: [dsyn]), (prkag2 mutation: [genf]), 
ASD Terms: (final diagnosis, 'Diagnosis')(fatigue  syncope medication, 'Medications')(syndrome diagnosis, 'Diagnosis')(pain, 'Pain')(learning/language disabilities with delayed development, 'Learning Disorders')(delayed development, 'Learning Disorders')

PMCID: 5504648
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (group: [popg]), (complex neurodevelopmental disorders: [mobd]), (diverse clinical manifestations: []), (symptoms: [sosy]), (years: []), (significant advances: [qnco]), (genetic basis: [phsu]), (asd: [cgab]), (establishment: []), (asd bio-collections: [cgab]), (application: [qnco]), (research: [resa]), (here: []), (selection: [genf]), (major asd bio-collections: [cgab]), (findings: [clna]), (collectively: []), (asd candidate genes: [cgab]), (nature: []), (frequency: [qnco]), (gene mutations: [genf]), (association: [menp]), (clinical subgroups: [virs]), ( insights: [menp]), (related molecular pathways: [moft]), (synapses: [bsoj]), ( chromatin remodelling: [genf]), ( transcription: [genf]), (asd-related brain regions: [cgab]), (studies: [lbpr]), (use: []), (induced pluripotent stem cells: [cell]), (culture: [lbpr]), (insight: [menp]), (asd progression: [cgab]), (development: [orgf]), (human cell models: [lbtr]), (drug screening: [resa]), (finally: []), (perspectives: []), (utilities: [orgt]), (limitations: []), (highlight considerations: [fndg]), (new bio-collection: [fndg]), (asd research: [cgab]), 
ASD Terms: (complex neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5799342
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (sleep problems: [dsyn]), (adhd: [mobd]), (autism spectrum disorder (asd): [mobd]), (better insight: [menp]), (etiology: []), (clinical importance: []), (intervention: [hlca]), (prevention strategies: []), (mechanisms: []), (association: [menp]), (patterns: []), (sleep hygiene: [orgf]), ((behavioral/environmental practices: [inbe]), (sleep quality: [fndg]), ( e.g: []), (caffeine: [orch,phsu]), (use): []), ( access: []), (electronic media: [tisu]), ( chronotype: []), (anxiety/depression: [mobd]), (children: [aggp]), (years: []), ( asd: [cgab]), (typical development (td): [orgf]), (parental questionnaires: []), (anova: [gngm]), (linear regression analyses: []), (age: [orga]), (sex: [orgf]), (asd: [cgab]), (vs: []), (td): []), (sleep duration: [fndg]), (controls: [sbst]), (differences: [qnco]), (td: []), (significant association: [menp]), (access: []), (chronotype: []), (groups: [popg]), (types: []), (associations: [menp]), (td;: []), (effects: []), (hygiene: []), ( sleep problems: [dsyn]), (factors: []), (clinical implications: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s00787-017-1025-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (sleep problems, 'Sleeping Problems')(adhd, 'Attention Deficit Disorder with Hyperactivity')(autism spectrum disorder, 'Autism Phenotype')(sleep problems, 'Sleeping Problems')(sleep problems, 'Sleeping Problems')(sleep patterns, 'Sleeping Problems')(sleep hygiene, 'Hygiene')(adhd, 'Attention Deficit Disorder with Hyperactivity')(adhd, 'Attention Deficit Disorder with Hyperactivity')(adhd, 'Attention Deficit Disorder with Hyperactivity')(sleep problems, 'Sleeping Problems')(adhd, 'Attention Deficit Disorder with Hyperactivity')(sleep problems, 'Sleeping Problems')(sleep problems, 'Sleeping Problems')

PMCID: 5886277
SFARI Genes: 
Non SFARI Genes: doc2a, doc2a, 
Named Entities: (abstract deletion: [genf]), (cnv affects: [nusq]), (core genes: [gngm]), (multiple symptoms: [sosy]), (brain: [bpoc]), (body: [humn]), (seizures: [sosy]), ( hyperactivity: [mobd]), ( macrocephaly: [cgab]), (obesity: [dsyn]), (available data: [euka]), (symptoms: [sosy]), (haploinsufficiency: [comd]), (genes: [gngm]), (pairwise partial loss: [fndg]), (function antisense screen: [phsf]), (embryonic brain morphology: [fndg]), (accessible zebrafish model: [fish]), (fam57ba: []), (ceramide synthase: [aapp,enzy]), (doc2a gene: [gngm]), (calcium-sensitive exocytosis: [bacs,elii,phsu]), (genetic interaction: [genf]), (genetic mutants: [gngm]), (doc2a+/ fam57ba+/: [gngm]), (hyperactivity: [mobd]), (increased seizure susceptibility: [sosy]), (wild-type: [gngm]), (single doc2a/: [fndg]), (fam57ba/ mutants: [comd]), (additionally: []), ( doc2a+/ fam57ba+/: [gngm]), (double heterozygotes: []), (body length: [orga]), (head size: [fndg]), (single doc2a+/: [fndg]), (fam57ba+/ heterozygotes: [orga]), (body size: [orga]), (increase; however: []), (homozygous mutants: [orga]), (contribution: [acty]), (haploinsufficient interaction: [comd]), (doc2a: [gngm]), (doc2a+/ fam57ba+/ interaction: [gngm]), (gene: [gngm]), (findings: [clna]), (pair: []), (homologs: [gngm]), (body phenotypes: [humn]), (people: [popg]), (deletion: [genf]), (together: []), (dysregulation: []), (ceramide pathways: [bacs,orch]), (calcium: [bacs,elii,phsu]), (sensitive exocytosis underlies seizures: [sosy]), (large body size: [orga]), (zebrafish: [fish]), (data inform consideration: [aapp,imft,phsu]), (mechanisms: []), (deletion symptoms: [genf]), 
ASD Terms: (hyperactivity, 'Overactivity')

PMCID: 5501949
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (disagreements: [socb]), (genetic signatures: []), (disease: [dsyn]), (field: [irda]), (psychiatric genetics: [hlca]), (sharp divide: [gngm]), (disease burdens: [dsyn]), (rare variation: [gngm]), (study designs: [resa]), (each: []), (meta-analysis: [resa]), (raw data: [diap]), (summary statistics: []), (results: [fndg]), (however: []), ( tests: [lbpr]), (functional convergence: [acty]), (study: [resa]), (candidate gene sets: [menp]), (overlaps: [topp]), (properties: []), (possible avenue: []), (data: [euka]), (functional conclusions: []), (work: []), (autism spectrum disorder (asd): [mobd]), (different study types: [resa]), (degree: [qnco]), (gene: [gngm]), (autism: [mobd]), (different study designs: [resa]), (differences: [qnco]), (effect size: [qnco]), (unified means: []), (impact: [gngm]), (study design: [resa]), (analysis: [resa]), (convergence: [acty]), (significant positive trends: [fndg]), (significant properties: [qnco]), ((false discovery rate <0.01): [qnco]), (areas researchers: []), (different reasoning: [menp]), (fragile x: [comd]), (mental retardation protein (fmrp) interactor enrichment: [aapp,bacs]), ((false discovery rate: [qnco]), (novel technical effects: []), (network enrichment: [popg]), (proteinprotein interaction data: [euka]), (control data: [euka]), (convergent functional signal: [phpr]), (subset: []), (novel functions: []), (asd: [cgab]), (sources: [fndg]), (genetic variation: [npop]), (meta-analytic approaches: [euka]), (other diseases: [dsyn]), (novel functional associations: [menp]), (statistical power: [resa]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13073-017-0455-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(fragile x, 'Fragile X Syndrome')(mental retardation protein interactor enrichment, 'Mental Retardation')

PMCID: 5602032
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (genetic evaluation: [hlca]), (etiology: []), (individuals: [humn]), (autism spectrum: [mobd]), (several studies: [lbpr]), (underuse: []), (genetic services: [hlca]), (affected families: [famg]), (access: []), (perception: [menp]), (genetics: []), (recurrence risk: [qnco]), (parents: []), (autistic children: [podg]), (spain: []), (high interest: [menp]), (results: [fndg]), (remarkable underutilization: []), (families: [famg]), (genetic service: [hlca]), (patients: [podg]), (genetic test: [lbpr]), (poor service provision: [grpa]), (recurrence risk perception: [phpr]), (great impact: [gngm]), (family planning: [hlca]), (national health system: [popg]), (informed decisions: [menp]), (precise information: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-017-3203-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum, 'Autism Phenotype')(perception, 'Cognitive Ability')(family planning, 'Planning')(recurrence risk perception, 'Cognitive Ability')

PMCID: 5535916
SFARI Genes: CB2, CB2, 
Non SFARI Genes: 
Named Entities: (several studies: [lbpr]), (key involvement: []), (endocannabinoid (ec) system: [bacs,orch]), (autism pathophysiology: [mobd]), (ec system: []), (complex network: [popg]), (pathways: [moft]), (arachidonic acid-derived compounds: [orch]), ((anandamide: [bacs,orch]), ( aea): []), (2-arachidonoyl glycerol: [orch,phsu]), (g-protein-coupled receptors: [aapp,rcpt]), (receptors cb1: [gngm]), (cb2): [gngm]), (enzymes: [enzy,orch]), (addition: []), (several other psychiatric disorders: [mobd]), (anxiety: [mobd]), ( major depression: [mobd]), (bipolar disorder: [mobd]), (schizophrenia): [mobd]), (system: []), (key regulator: []), (metabolic: [celf]), (cellular pathways: [moft]), (autism: [mobd]), (food intake: [orgf]), ( energy metabolism: [phsf]), (immune system control: [bdsy]), (early studies: [lbpr]), (autism animal models: [mobd]), (alterations: []), (brains ec system: [bpoc]), (immune system dysregulation: [fndg]), (alteration: []), (differential monocyte: [cell]), (macrophage responses: [cell]), (abnormal cytokine: [aapp,imft]), (t cell levels: [cell]), (ec system dysfunction: [dsyn]), (monocyte: [cell]), (macrophagic cellular model: [cell]), (mrna: [bacs,nnon]), (protein: [aapp,bacs]), (cb2 receptor: [aapp,rcpt]), (ec enzymes: [enzy,orch]), (involvement: []), (autism-associated immunological disruptions: [mobd]), (together: []), (new findings: [fndg]), (novel perspective: []), (autism research: [mobd]), (indicate: []), (novel target option: [diap]), (autism pharmacotherapy: [mobd]), 
ASD Terms: (autism pathophysiology, 'Autism Phenotype')(several other psychiatric disorders, 'Mental Disorders')(autism, 'Autism Phenotype')(autism animal models, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism research, 'Autism Phenotype')(autism pharmacotherapy, 'Autism Phenotype')

PMCID: 5493637
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mitoplasticity: []), (mitochondria: [celc]), (stressors: []), (subset: []), (lymphoblastoid cell lines: [cell]), (children: [aggp]), (autistic disorder (ad) show mitoplasticity: [mobd]), (previous environmental exposures;: [inpo]), (ad lcls: []), (normal mitochondrial activity (ad-n): [celc]), (understand mitoplasticity: [menp]), (ad-a lcls: []), (changes: [qnco]), (mitochondrial function: [celc]), (seahorse xf96 analyzer: [fish]), (ad: []), (control lcls: [sbst]), (exposure: [clna]), (hydrate (tcah): [orch,phsu]), (vivo metabolite: [bacs]), (environmental toxicant: [hops]), (common environmental pollutant trichloroethylene: [orch,phsu]), (role: [socb]), (reactive oxygen species: [bacs,elii]), ( tcah exposure: [clna]), (acute exposure: [clna]), ((dmnq): [irda,orch]), (agent: [chvf]), (ros: [gngm]), (tcah exposure: [clna]), (decline: []), (mitochondrial respiration: [celc]), (lcl groups: [popg]), (effect: []), (tcah: []), (acute dmnq exposure: [irda,orch]), (dmnq: [irda,orch]), (ad-n lcls: []), (detrimental effect: []), (increase: []), (data: [euka]), (acute increases: [qnco]), (mitochondrial protective pathways: [celc]), (protective pathways: [moft]), 
ASD Terms: (autistic disorder show mitoplasticity, 'Autistic Disorder')(autistic disorder lymphoblastoid cell lines, 'Autistic Disorder')(previous environmental exposures, 'Exposures')(autistic disorder, 'Autistic Disorder')(exposure, 'Exposures')(trichloroacetaldehyde hydrate exposure, 'Exposures')(acute exposure, 'Exposures')(acute dmnq exposure, 'Exposures')

PMCID: 5489536
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (exposure: [clna]), (developmental periods: [orgf]), (brain development: [ortf]), ( studies: [lbpr]), (association: [menp]), (maternal smoking: [inbe]), (autism spectrum disorder (asd): [mobd]), (findings: [clna]), (prior meta-analyses: [resa]), (significant association: [menp]), (meta-analysis: [resa]), (novel approach: []), (population-level smoking metrics: [orch,phsu]), (moderators: []), (main meta-analysis: [resa]), (observational studies: [resa]), (cases: [qnco]), (control participants: [popg]), (random-effects model: [resa]), (pregnancy: [orgf]), (asd: [cgab]), ((pooled odds: [sbst]), ((or) =: []), (ci:: [lbpr]), (however: []), ( meta-regression analyses: [resa]), (pooled ors: [inch,phsu]), (adult male smoking prevalence (z: [qnco]), (p: [gngm]), (country: []), (world health organization data: [hcro]), (study: [resa]), (population-level smoking metrics uncovers: [orch,phsu]), (significant relationships: [qnco]), (asd risk: [cgab]), (correlational analyses: [inpr,resa]), (male smoking prevalence approximates: [qnco]), (smoke exposure: [hops]), (possibility: []), (role: [socb]), (postnatal nicotine exposure: [fndg]), (utero nicotine exposure: [bpoc]), (importance: []), (secondhand smoking: [eehu]), (addition: []), 
ASD Terms: (maternal smoking, 'Smoking')(exposure, 'Exposures')(autism spectrum disorder, 'Autism Phenotype')(population-level smoking metrics, 'Smoking')(maternal smoking, 'Smoking')(adult male smoking prevalence, 'Smoking')(maternal smoking, 'Smoking')(population-level smoking metrics uncovers, 'Smoking')(male smoking prevalence approximates, 'Smoking')(smoke exposure, 'Exposures')(secondhand smoking, 'Smoking')(maternal smoking, 'Smoking')(postnatal nicotine exposure, 'Exposures')(utero nicotine exposure, 'Exposures')

PMCID: 5485587
SFARI Genes: DPP10, DPP10, DPP10, DPP10, 
Non SFARI Genes: 
Named Entities: (array: []), (comparative genomic hybridization (acgh): [mbrt]), (first-tier genetic test: [lbpr]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (however: []), ( interpretation: [clna]), (results: [fndg]), (fact: [gngm]), (copy number variants: [nusq]), (non-european asd patients: [cgab]), (literature: [inpr,mnob]), (cnv findings: [nusq]), (cohort: [popg]), (chinese children: [aggp]), (asd: [cgab]), (dna samples: [bacs,nnon]), (chinese asd patients: [cgab]), (child assessment center: [aggp]), (january: []), (august: []), (acgh: []), (guidelines: []), (pathogenic cnvs: [nusq]), (likely pathogenic cnv: [nusq]), (patients: [podg]), (overall diagnostic yield: [fndg]), (kb duplication: [comd]), (exons: [bacs,nnon]), (dpp10 (arr[grch37]: [gngm]), (patient (0.39%): [podg]), (same cnv: [nusq]), (variant: []), (uncertain significance (vus): [fndg]), (decipher database: []), (multiple individuals: [humn]), (typical development: [orgf]), (similar duplication: [comd]), (ancestry-matched control: [resa]), (frequency: [qnco]), ((0.92%): [fndg]), (genomic databases: []), (dpp10 duplication: [comd]), (benign cnv polymorphism: [nusq]), (southern chinese: [lang]), (population frequency: [qnco]), (~1%: [fndg]), (importance: []), (ancestry-matched controls: [resa]), (interpretation: [clna]), (acgh findings: [clna]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0136-x) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5619996
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (purpose: []), (study: [resa]), (somatosensory responses: [orga]), (group: [popg]), (children: [aggp]), (epilepsy: [dsyn]), (autism spectrum disorder (asd): [mobd]), (age: [orga]), (td controls: [sbst]), (magnitude: [qnco]), (tactile p50m somatosensory response: [fndg]), (patient groups: [popg]), (gabaergic: []), (variety: []), (previous animal models: [anim]), (vivo human mrs studies: [humn]), (decreases: [qnco]), (tactile p50m dipole moment values: [qnco]), (source: [fndg]), (tactile p50m response: [fndg]), (asd: [cgab]), (latency: []), (tactile p50m peak: [qnco]), (td: []), (asd groups: [cgab]), (data support: [euka]), (hypothesis: []), (impaired gabaergic signaling: [celf]), (further work: []), (findings: [clna]), (vivo measures: [qnco]), (gaba: [aapp,bacs]), (e.g: []), (magnetic resonance spectroscopy: [diap]), (psychophysical assessments: [hlca]), (somatosensory function: [phsf]), (behavioral indices: [inbe]), 
ASD Terms: (epilepsy, 'Epilepsy')(autism spectrum disorder, 'Autism Phenotype')(epilepsy, 'Epilepsy')(epilepsy, 'Epilepsy')

PMCID: 5482876
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (functions: [phsf]), (human brains: [humn]), (precise temporal regulation: [biof]), (gene expression: [genf]), (temporal brain transcriptome profile: [qnco]), (lifespan: [grpa]), (substantial transcriptome alteration: [nusq]), (neural disorders: [mobd]), (autism: [mobd]), (pathology: [patf]), (cell type composition: [clna]), (brains: [bpoc]), (pathological transcriptome changes: [nusq]), (here: []), (transcriptome deconvolution procedure: [nusq]), (age series rna-seq dataset: [nusq]), (autism samples: [mobd]), (contribution: [acty]), (pathological transcriptome: [nusq]), (composition change: [qnco]), (primary factor: [topp]), (types: []), (transcriptome changes: [nusq]), (other hand: [bpoc]), ( genes: [gngm]), (substantial composition-independent expression changes: [qnco]), (cases: [qnco]), (autism pathological composition-independent changes: [mobd]), (synaptic functions: []), (important intracellular regulatory changes: [celc]), (processes: [phpr]), 
ASD Terms: (autism, 'Autism Phenotype')(autism samples, 'Autism Phenotype')(autism pathological composition-independent changes, 'Autism Phenotype')

PMCID: 5481972
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (eu-aims longitudinal european autism project (leap): [orgt]), (date: []), (multi-centre: []), ( multi-disciplinary observational study: [resa]), (biomarkers: [clna]), (autism spectrum disorder (asd): [mobd]), (current paper: [npop]), (clinical characteristics: [clna]), (leap cohort: [popg]), (examines: []), (sex: [orgf]), (iq differences: [qnco]), (asd core symptoms: [cgab]), (common co-occurring psychiatric symptoms: [qnco]), (companion paper: [anim]), (overall design: [acty]), (experimental protocol: [fndg]), (strategy: [menp]), (stratification biomarkers: [clna]), (research centres: [resa]), (european countries: []), (children: [aggp]), (adults: [aggp]), (asd: [cgab]), (controls: [sbst]), (ages: [bacs,orch]), (years: []), (iqs: []), (in-depth clinical characterisation: [acty]), (wide range: [qnco]), (observational: [resa]), ( interview: [acty]), (questionnaire measures: [qnco]), (asd phenotype: [cgab]), (co-occurring psychiatric symptoms: [sosy]), (cohort: [popg]), (heterogeneity: [orga]), (asd symptom presentation: [cgab]), (site differences: [qnco]), (core: [bdsu]), (cognitive measures: [qnco]), (parent-report interview: [acty]), ( asd symptom severity: [cgab]), (adolescents: [aggp]), (precise pattern: []), (differences: [qnco]), (measures: [qnco]), (evidence: []), (social symptoms: [sosy]), (repetitive behaviour severity: [fndg]), (males: [orga]), (asd symptom scores: [cgab]), (females: [orga]), (parent interview: [acty]), (diagnostic measures: [qnco]), (parent-reported dimensional measures: [qnco]), (asd symptoms: [cgab]), (contrast: [irda]), ( self-reported asd symptom severity: [cgab]), (adult females: [popg]), (scores: [clna]), (asd symptom measures: [cgab]), (iq: []), (hyperactive/impulsive adhd symptoms: [mobd]), (levels: []), (phenotypic heterogeneity: [fndg]), (variation: []), (core asd symptom severity: [cgab]), ( age: [orga]), (pattern: []), (asd symptom differences: [cgab]), (age: [orga]), (clinician ratings: [acty]), (parent-: []), (important implications: []), (potential use: []), (outcome measures: [qnco]), (clinical trials: [resa]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0145-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (eu-aims longitudinal european autism project, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(asd core symptoms, 'Complaints and Indications')(longitudinal european autism project cohort, 'Autism Phenotype')(asd phenotype, 'Autism Phenotype')(asd symptom presentation, 'Complaints and Indications')(cognitive measures, 'Cognitive Ability')(asd symptom severity, 'Complaints and Indications')(repetitive behaviour severity, 'Restricted and Repetitive Behavior')(asd symptom scores, 'Complaints and Indications')(asd symptoms, 'Complaints and Indications')(self-reported asd symptom severity, 'Complaints and Indications')(asd symptom measures, 'Complaints and Indications')(hyperactive/impulsive adhd symptoms, 'Attention Deficit Disorder with Hyperactivity')(established phenotypic heterogeneity in asd, 'Autism Phenotype')(core asd symptom severity, 'Complaints and Indications')(asd symptom differences, 'Complaints and Indications')

PMCID: 5481887
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (aetiological diversity: []), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (major obstacle: []), (development: [orgf]), (new treatments: [topp]), (particular subgroups: [virs]), (precision medicine approaches: [topp]), (challenge: [hlca]), (treatments: [topp]), (stratification biomarkers: [clna]), (treatment: [topp]), (particular individuals: [humn]), (however: []), (stratification biomarker: [clna]), (asd: [cgab]), (fact: [gngm]), (research studies: [resa]), (identification: [menp]), (mean case-control differences: [qnco]), (within-group variability: [popg]), (small samples: [sbst]), (stratification approaches: [resa]), (eu-aims longitudinal european autism project (leap): [orgt]), (date: []), (multi-centre: []), ( multi-disciplinary observational study: [resa]), (leap: []), (children: [aggp]), (adults: [aggp]), (typical development: [orgf]), (mild intellectual disability: [mobd]), (accelerated longitudinal design: [acty]), (participant: [popg]), (terms: [orgf]), (clinical symptoms: [sosy]), ( comorbidities: []), (functional outcomes: []), (neurocognitive profile: [lbpr]), ( brain structure: [bpoc]), (function: [phsf]), ( biochemical markers: []), (genomics: []), (twin-pairs (of: [famg]), (asd): [cgab]), (environmental factors: []), (phenotypic variability: [fndg]), (here: []), (demographic characteristics: [grpa]), (cohort: [popg]), (analytic stratification approaches: [resa]), ( criteria: []), (steps: [qnco]), (candidate stratification: [resa]), (pre-registration procedures: [topp]), (transparency: []), ( standardisation: [resa]), (data robustness: [euka]), (analyses: [resa]), (share: [socb]), (lessons: []), (clinical characterisation: [acty]), (companion paper (charman: [anim]), (al.: [lbpr]), ( accepted): []), (reject: [acty]), (current hypotheses: [npop]), (neurocognitive/neurobiological abnormalities: [cgab]), (meaningful asd subgroups: [cgab]), (phenotypic heterogeneity: [fndg]), (different aetiologies: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0146-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(eu-aims longitudinal european autism project, 'Autism Phenotype')(longitudinal european autism project, 'Autism Phenotype')(mild intellectual disability, 'Learning Disorders')(comorbidities, 'Comorbidities')(comorbidities, 'Comorbidities')(neurocognitive profile, 'Cognitive Ability')

PMCID: 5480153
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (complex: [chvs]), (functional genomics work: []), (diverse array: []), (dysregulated transcriptomic programs: [nusq]), (synaptic: []), ( immune: []), ( cell cycle: [celf]), ( dna damage: [comd]), ( wnt: []), (cortical patterning: [bpoc]), (differentiation): [celf]), (asd brain abnormalities: [cgab]), (childhood: []), (adulthood: []), (however: []), (pathways: [moft]), (coordinated hierarchical systems-level pathology: [patf]), (asd: [cgab]), (cortical transcriptome datasets: [bpoc]), (consensus: [socb]), (gene co-expression network analysis (wgcna): [popg]), (common co-expression modules: [qnco]), (datasets: []), (linear mixed-effect models: [qnco]), (bayesian replication statistics: [genf]), (modules: []), (eigengene network analysis: []), (between-group differences: [popg]), (co-expression modules interact: [topp]), (cluster: [qnco]), (hierarchical meta-modular organization: [orgt]), (protein-protein interaction analyses: [resa]), (dysregulated co-expression modules: [topp]), (enhanced interactions: [acty]), (replicable evidence: []), (gene co-expression modules: [moft]), (asd cortex: [bpoc]), (independent non-interacting sources: [fndg]), (pathology: [patf]), (co-expression modules: [topp]), (synergy: []), (protein level: [lbtr]), (systems-level transcriptional signals: [genf]), (downregulation: [moft]), (synaptic processes: [phpr]), (upregulation: [genf]), (immune/inflammation: [patf]), ( response: [fndg]), (other organism: [orgm]), ( catabolism: [orgf]), ( viral processes: [biof]), ( translation: [moft]), ( protein: [aapp,bacs]), (localization: [biof]), ( cell proliferation: [celf]), (vasculature development: [ortf]), (hierarchical organization: [orgt]), (meta-modules (clusters: [qnco]), (modules): []), (findings: [clna]), (dysregulation: []), (cortical transcriptome: [bpoc]), (multiple coordinated transcriptional programs: [genf]), (synergistic systems-level effects: [phsu]), (cannot: []), (individual component: [humn]), (biological processes: [biof]), (isolation: [topp]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0147-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(coordinated hierarchical systems-level pathology, 'Motor Skills')(multiple coordinated transcriptional programs, 'Motor Skills')

PMCID: 5486135
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (fragile x syndrome (fxs): [cgab,dsyn]), (common monogenic form: [qnco]), (autism spectrum disorder (asd): [mobd]), (fxs: []), (asd results: [cgab]), (loss: [qnco]), (fragile x: [comd]), (mental retardation (fmr) gene products: [mobd]), (mental retardation protein (fmrp): [aapp,bacs]), (variety: []), (behavioral abnormalities: [mobd]), (disorder: [dsyn]), (clock components: [gngm]), (behavioral circadian rhythms and: [orgf]), (mutation: [genf]), (fmr gene: [gngm]), (disturbed sleep patterns: [fndg]), (circadian rhythms: [orgf]), (result: [fndg]), ( fxs: []), (asd individuals: [cgab]), (dysregulation: []), (melatonin synthesis: [moft]), (alterations: []), (melatonin-dependent signaling pathways: [horm,orch,phsu]), (vigilance: [menp]), ( learning: [menp]), (memory abilities: [orga]), (autistic behaviors: [mobd]), (abnormal anxiety responses: [mobd]), (wide variety: []), (possible causes: []), ( symptoms: [sosy]), (clinical features: [clna]), (asd: [cgab]), (correlation: []), (altered circadian rhythms: [orgf]), (recent studies: [lbpr]), (impact: [gngm]), (melatonin: [horm,orch,phsu]), (nervous: [sosy]), ( immune: []), (metabolic systems: [celf]), (utilization: []), (sleep dysfunctions: [sosy]), (clinical research: [resa]), (future studies: [lbpr]), (neuroprotective role: [socb]), (developmental period: [orgf]), (individuals: [humn]), (present review: [qnco]), (regulatory circuits: [phsf]), (disruptions: []), (circadian system: []), (neuroprotective effects: []), (melatonin intervention: [horm,orch,phsu]), (improvements: []), (neuroplasticity: [ortf]), (physical capabilities: [hlca]), (molecular mechanisms: []), (reviewed: []), (authors: []), (useful treatment: [topp]), (terms: [orgf]), (adverse effects: [patf]), (variations: []), (circadian rhythm: [orgf]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(fragile x syndrome, 'Fragile X Syndrome')(fragile x syndrome with asd results, 'Fragile X Syndrome')(fragile x, 'Fragile X Syndrome')(mental retardation gene products, 'Mental Retardation')(mental retardation protein, 'Mental Retardation')(behavioral abnormalities, 'Personal Traits')(behavioral circadian rhythms and, 'Prosody')(mental retardation gene, 'Mental Retardation')(disturbed sleep patterns, 'Sleeping Problems')(circadian rhythms, 'Prosody')(fragile x syndrome with asd individuals, 'Fragile X Syndrome')(fragile x syndrome, 'Fragile X Syndrome')(memory abilities, 'Working Memory')(abnormal anxiety responses, 'Anxiety Disorders')(altered circadian rhythms, 'Prosody')(fragile x syndrome with asd, 'Fragile X Syndrome')(sleep dysfunctions in asd, 'Sleeping Problems')(sleep dysfunctions, 'Sleeping Problems')(fragile x syndrome with asd, 'Fragile X Syndrome')(useful treatment for fragile x syndrome, 'Fragile X Syndrome')(circadian rhythm, 'Prosody')

PMCID: 5539915
SFARI Genes: GRIA1, GRIA1, Grid2, Grid2, GRIA1, GRIA1, 
Non SFARI Genes: 
Named Entities: (missense mutations: [genf]), (cases: [qnco]), (autism: [mobd]), (gene-truncating mutations: [genf]), (research: [resa]), (latter: []), (properties: []), (patients: [podg]), (neurodevelopmental disorders: [mobd]), (genes: [gngm]), (excess missense mutations: [genf]), (amino acid sites: [aapp,bacs,phsu]), (sequencing: [mbrt]), (sites: []), (ndd patients: [podg]), (new patients: [podg]), (identical missense mutations: [genf]), (recurrent site: [blor]), (glutamate receptor subunit: [aapp,rcpt]), ( gria1: [gngm]), (same amino acid substitution: [genf]), (distinct mouse glutamate receptor subunit grid2: [mamm]), (lurcher ataxia: [sosy]), (phenotypic follow-up: [orga]), (individuals: [humn]), (gria1 mutations: [genf]), (evidence: []), (disabilities: [fndg]), (significant clustering: [resa]), (mutations: [genf]), (specific functional domains: []), (synaptic candidate genes: [gngm]), (ndd pathology: [patf]), 
ASD Terms: (autism, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 5472997
SFARI Genes: SHANK3, SHANK3, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (heterogeneous condition: [fndg]), (social: []), ( repetitive: []), (sensory behavioral abnormalities: [mobd]), (treatments: [topp]), (core: [bdsu]), (diagnostic symptoms: [sosy]), (asd: [cgab]), (stages: [clna]), (therapeutic discovery: [acty]), (development: [orgf]), ( robust: []), (reproducible behavioral phenotypes: [bhvr]), (biological markers: [clna]), (preclinical animal models: [anim]), (goal: []), (study: [resa]), (electroencephalographic (eeg): [diap]), (behavioral phenotypes: [bhvr]), (independent cohorts: [popg]), (mouse model: [emod]), (strategy: [menp]), (preclinical biomedical asd research field: [cgab]), (reproducible behavioral: [inbe]), (physiological phenotypes: [orga]), (animal models: [anim]), (characterization: [acty]), (mechanistic underpinnings: []), (asd-relevant phenotypes: [cgab]), (reliability: [qnco]), (discovery: [acty]), (novel therapeutics: [orch,phsu]), (genetic disruption: [topp]), (shank3: [gngm]), (scaffolding protein: [aapp,bacs]), (stability: []), (postsynaptic density: [celc]), (excitatory synapses: [celc]), (large number: [qnco]), (cases: [qnco]), (therefore: []), (robustness: []), (asd-relevant behavioral phenotypes: [cgab]), (cohorts: [popg]), (first time: [qnco]), (translational eeg activity: [diap]), (shank3b null mutant mice: [mamm]), (vivo physiology: [phsf]), (behavioral assays: [lbpr]), (full cohorts: [popg]), (shank3b: []), (mutant (shank3b ko): [bdsy]), (wildtype littermate control (wt) mice: [mamm]), (eeg: [diap]), (wireless: []), (telemeters: [diap]), (days: []), (baseline: [bodm]), (min: [neop]), (pentylenetetrazol (ptz) challenge: [orch,phsu]), (behaviors: [inbe]), (associated symptoms: [sosy]), (battery: [inpo]), (behavioral tests: [diap]), (assays: [lbpr]), (original behavioral characterization: [inbe]), (shank3b ko mice: [mamm]), (corroborative tests: [lbpr]), (behavioral domain: []), ( cognitive: []), (anxiety-related: [mobd]), ( sensory: []), (motor categories: []), (wt mice: [mamm]), ( shank3b ko mice: [mamm]), (dramatic resistance: [menp]), (ptz seizure induction: [sosy]), (enhancement: [acty]), (gamma band: [npop]), (oscillatory eeg activity indicative: [diap]), (enhanced inhibitory tone: [acty]), (findings: [clna]), (separate cohorts: [popg]), (behaviorally: []), (repetitive grooming: [inbe]), ( deficits: []), (aspects: [qnco]), (reciprocal social interactions: [fndg]), (vocalizations: [fndg]), (reduced open field activity: [acty]), (variable deficits: []), (sensory responses: [orga]), ( anxiety-related behaviors: [mobd]), ( learning: [menp]), (memory: [menp]), (robust animal models: [anim]), (quantitative: [qnco]), (replicable biomarkers: [clna]), (neural dysfunction: [dsyn]), (risk: []), (enable successful drug discovery: [resa]), (other neurodevelopmental disorders: [mobd]), (complementary: []), (replicated behavioral phenotypes: [bhvr]), (shank3b mutant mouse: [mamm]), (new identification: [menp]), (robust: []), ( translational: [genf]), (vivo neurophysiological phenotype: [orga]), (strong evidence: []), (replicability: []), (key translational phenotypes: [orga]), (mutant mice: [mamm]), (usefulness: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0142-z) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(sensory behavioral abnormalities, 'Reaction to Sensory Stimuli')(diagnostic symptoms of asd, 'Complaints and Indications')(associated symptoms of asd, 'Complaints and Indications')(cognitive, 'Cognitive Ability')(reciprocal social interactions, 'Reciprocal Social Interaction')(vocalizations, 'Vocalizations')(sensory responses, 'Reaction to Sensory Stimuli')(memory, 'Working Memory')(other neurodevelopmental disorders, 'Learning Disorders')

PMCID: 5903412
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract: []), (autism: [mobd]), (attention-deficit/hyperactivity disorder (adhd): [mobd]), (distinct conditions: [dsyn]), (diagnostic perspective: [fndg]), (share: [socb]), (phenotypic features: [orga]), (high comorbidity: [qnco]), (regardless: []), (studies: [lbpr]), (condition: [dsyn]), (considerable heterogeneity: [orga]), (results: [fndg]), (dual-condition approach: [dsyn]), (distinct neural characteristics: []), (graph theory: []), (topological properties: []), (structural covariance networks: []), (conditions: [dsyn]), (neurotypical (nt; n =: [diap]), (group: [popg]), (data: [euka]), (abide (autism;: [mobd]), (adhd-200 datasets (adhd;: [mobd]), (regional cortical thickness: [bpoc]), (theoretical framework: []), (potential differences: [qnco]), (short-range connectivity: [qnco]), (specific focus: []), (relation: [socb]), (central graph measures: [qnco]), (cortical thickness: [bpoc]), (convergence: [acty]), (adhd: [mobd]), (overall decrease: [qnco]), (ct covariance: [aapp]), (increased euclidean distance: [resa]), (centroids: []), (nt population: [diap]), (divergence: []), (namely: []), (modular overlap: [topp]), (nt group: [diap]), (adhd group: [mobd]), (reduced cortical thickness: [bpoc]), (degree: [qnco]), (hub regions: [gngm]), (autism group: [mobd]), (lastly: []), (reduced wiring costs: [qnco]), (autism groups: [mobd]), (need: []), (approach: []), (comorbid conditions: [fndg]), (furthermore: []), ( autism: [mobd]), (alterations: []), (inter-regional covariance: []), (centroid distance: [qnco]), (groups: [popg]), (steeper decline: []), (covariance: []), (function: [phsf]), (distance: [qnco]), (modular organization: [orgt]), ( cortical thickness: [bpoc]), (cost: [qnco]), (covariance network: [popg]), (thus: []), (network: [popg]), (others: [fndg]), 
ASD Terms: (autism, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(high comorbidity, 'Comorbidities')(specific focus on relation, 'Attention and Focus')(autism, 'Autism Phenotype')(attention-deficit/hyperactivity disorder group, 'Attention Deficit Disorder with Hyperactivity')(autism group, 'Autism Phenotype')(autism groups, 'Autism Phenotype')(comorbid conditions, 'Comorbidities')(autism, 'Autism Phenotype')

PMCID: 5537637
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (share: [socb]), (core set: [menp]), (nosological features: []), (substantial genetic heterogeneity: [orga]), (parsimonious hypothesis posits: []), (epigenetic mechanisms: [genf]), (common pathways: [moft]), (etiology: []), (asds: [cgab]), (hypothesis: []), (novel mouse model: [emod]), (brain-specific deletion: [genf]), ((chd5): []), (chromatin: [aapp]), (protein: [aapp,bacs]), (neuronal differentiation: [fndg]), (member: [popg]), (gene family: [gngm]), (rna sequencing: [nusq]), (chd5/ mouse forebrain tissue: [mamm]), (preponderance: []), (changes: [qnco]), (expression: [topp]), (genes: [gngm]), (cellular development: [celf]), (signaling: [celf]), ( sociocommunicative behavior: [inbe]), (pyramidal neurons: [cell]), (chd5/ cortex: [bpoc]), (alterations: []), (dendritic morphology: [celc]), (asd: [cgab]), (nosology: []), ( chd5/ mice: [mamm]), (abnormal sociocommunicative behavior: [mobd]), (strong preference: []), (familiarity: [menp]), (chd5/ mice: [mamm]), (deficits: []), (distress: [menp]), (conspecific: []), (mouse homolog: [mamm]), (empathy: [inbe]), (thus: []), (pattern: []), (behavioral effects: [inbe]), (presentation: []), 
ASD Terms: (autism spectrum disorders share, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(abnormal sociocommunicative behavior, 'Personal Traits')(empathy, 'Empathy')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 5474730
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (persistence: [menp]), (common: [qnco]), (heritable psychiatric disorders: [mobd]), (reproductive fitness: [genf]), (evolutionary paradox: [genf]), (here: []), (selection pressures: [genf]), (sequence variants: [npop]), (autism: [mobd]), ( bipolar disorder: [mobd]), (major depression: [mobd]), (attention deficit hyperactivity disorder (adhd): [mobd]), (genomic data: [gngm]), (icelanders: [popg]), (psychiatric diseases: [mobd]), (polygenic risk: [genf]), (adhd: [mobd]), (number: [qnco]), (children: [aggp]), (age: [orga]), (first child: [aggp]), (evidence: []), (selective advantage: [genf]), (high polygenic risk: [fndg]), (schizophrenia: [mobd]), (bipolar disorder: [mobd]), (rare copy-number variants: [nusq]), (high risk: [fndg]), (psychiatric illness: [mobd]), (negative selection pressure: [phpr]), (common sequence variants: [npop]), 
ASD Terms: (heritable psychiatric disorders, 'Mental Disorders')(autism, 'Autism Phenotype')(bipolar disorder, 'Bipolar Disorder')(major depression, 'Depressive Disorder')(attention deficit hyperactivity disorder, 'Overactivity')(psychiatric diseases, 'Mental Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(psychiatric illness, 'Mental Disorders')

PMCID: 5469475
SFARI Genes: 
Non SFARI Genes: CA1, CA1, 
Named Entities: (autism spectrum disorder (hereafter: [mobd]), (asd): [cgab]), (heterogeneous neurodevelopmental condition: [orga]), (impaired social communication: [socb]), (interactions: []), (repetitive activities: [acty]), (interests: [menp]), (alterations: []), (network connectivity: [popg]), (memory function: [menp]), (autism patients: [mobd]), (hippocampus: [bpoc]), (however: []), (specific changes: [qnco]), (early brain development: [ortf]), (remain: []), (here: []), (development: [orgf]), (dendritic arbor: [celc]), (hippocampal ca1 pyramidal neurons: [cell]), (btbr t+tf/j (btbr) mouse model: [aapp,imft]), (autism: [mobd]), (btbr mice: [mamm]), (behavioural features: [inbe]), (exhibit: []), (impaired learning: [menp]), (memory: [menp]), (c57bl/6j (b6): [mamm]), (lengths: [qnco]), (basal dendrites: [celc]), (neonatal btbr animals: [anim]), (further: []), ( basal: []), (branching complexity: [chvs]), (contrast: [irda]), ( cross-sectional area: []), (soma: [orch,phsu]), (addition: []), (similar density: [qnco]), (ca1: [gngm]), (pyramidal neurons: [cell]), (thickness: []), (neuronal layer: [bird]), (strains: [menp]), (thus: []), (specific: []), ( compartmentalized overgrowth: [fndg]), (dendrites: [celc]), (early development: [orgf]), (btbr animals: [anim]), (biochemical analysis: [resa]), (extracellular signal-regulated kinases: [aapp,enzy]), (pathway: [moft]), (dendritic structure: [celc]), (information integration: [genf]), (data: [euka]), (impaired hippocampal function: [phsf]), (behavior: [inbe]), (btbr model: [mamm]), (activation: [acty]), (erk pathway: [moft]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(heterogeneous neurodevelopmental condition, 'Learning Disorders')(impaired social communication, 'Reciprocal Social Interaction')(memory function, 'Working Memory')(autism patients, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(impaired learning, 'Learning Disorders')(memory, 'Working Memory')

PMCID: 5596045
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent reports: [hlca]), (worldwide incidence: [qnco]), (autism spectrum disorder (asd): [mobd]), (asd etiology: [cgab]), (pathogenesis: [patf]), (dietary-derived essential compounds: [chem]), (amino acid tryptophan: [aapp,bacs,phsu]), (patients: [podg]), (asd: [cgab]), (tryptophan (trp): [aapp,bacs,phsu]), (significant role: [socb]), (human organism: [humn]), (precursor: []), (wide range: [qnco]), (bioactive compounds: [chem]), (major neurotransmitters: [bacs]), (research: [resa]), (tryptophan: [aapp,bacs,phsu]), (subjects: [humn]), (deficiency: [dsyn]), (tryptophan level: [aapp,bacs,phsu]), (trp levels: [aapp,bacs]), (major metabolite kynurenine: [aapp,bacs]), (purpose: []), (present study: [qnco]), (tryptophan content: [aapp,bacs,phsu]), (urine samples: [bdsu]), (asd patients: [cgab]), (supplemented dietary panel: []), (b vitamins: [orch,vita]), (magnesium: [elii]), (diet regimen): [topp]), (samples: [sbst]), (gas chromatography-mass spectrometry: [lbpr]), (correlation: []), (body mass index (bmi): [diap]), (level: [phsu]), (amino acid: [aapp,bacs,phsu]), (urine: [bdsu]), (basic parameters: [fndg]), (statistical evaluations: [hlca]), (concentration: [menp]), (different severity: []), (symptoms: [sosy]), (significant difference: [qnco]), (tryptophan levels: [aapp,bacs,phsu]), (groups: [popg]), (supplementation: [topp]), (influence: []), (trp concentration: [menp]), (furthermore: []), (bmi: []), (found: [qnco]), (results: [fndg]), (trp level: [aapp,bacs]), (asd subjects: [cgab]), (intake: []), (metabolic homeostasis: [biof]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(b vitamins, 'Dietary Supplements')(supplemented dietary panel, 'Dietary Supplements')(b vitamins, 'Dietary Supplements')(supplementation, 'Dietary Supplements')(b vitamins, 'Dietary Supplements')

PMCID: 5472790
SFARI Genes: LRFN2, LRFN2, Lrfn2, Lrfn2, PSD-95, GluA1, PSD-95, GluA1, Lrfn2, PSD-95, Lrfn2, PSD-95, LRFN2, LRFN2, 
Non SFARI Genes: 
Named Entities: (lrfn2/salm1: [gngm]), (psd-95-interacting synapse adhesion molecule: [bsoj]), (human lrfn2: [humn]), (disabilities: [fndg]), (role: [socb]), (brain function: [ortf]), (underlying mechanisms: []), (lrfn2 knockout mice exhibit: [mamm]), (autism-like behavioural abnormalities: [mobd]), (social withdrawal: [fndg]), (vocal communications: [socb]), (stereotyped activities: [menp]), (prepulse inhibition deficits: [phsf]), (enhanced learning: [menp]), (memory: [menp]), (hippocampus: [bpoc]), (levels: []), (synaptic psd-95: [gngm]), (glua1: [gngm]), (synapses: [bsoj]), (immature: []), (postsynaptic densities: [celc]), (ampa/nmda ratio: [aapp,bacs,phsu]), (ltp: [ortf]), (vitro experiments: [resa]), (synaptic surface expression: [topp]), (ampar: []), (direct interaction: []), (lrfn2: [gngm]), (psd-95: [gngm]), (furthermore: []), (defective lrfn2 missense mutations: [genf]), (autism: [mobd]), (schizophrenia patients: [mobd]), (together: []), (findings: [clna]), (lrfn2/lrfn2: [gngm]), (core components: [bdsu]), (excitatory synapse maturation: [ortf]), (maintenance: [acty]), (dysfunction: [dsyn]), (immature/silent synapses: [bsoj]), (pathophysiological state: [patf]), 
ASD Terms: (autism-like behavioural abnormalities, 'Personal Traits')(vocal communications, 'Vocalizations')(stereotyped activities, 'Stereotyped, Restricted, and Repetitive Behavior')(memory, 'Working Memory')(autism, 'Autism Phenotype')(schizophrenia patients, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 5468250
SFARI Genes: GABRB3, GABRA5, GABRB3, GABRA5, GABRB3, GABRA5, GABRB3, GABRA5, GABRB3, GABRA5, GABRB3, GABRA5, GABRB3, GABRB3, 
Non SFARI Genes: GABRG3, GABRG3, GABRG3, 
Named Entities: (gabaa receptor subunit genes gabrb3: [aapp,rcpt]), ( gabra5: [gngm]), (gabrg3: [gngm]), (chromosome 15q11-q13: [celc]), (etiology: []), (autistic spectrum disorders: [mobd]), (study: [resa]), (possible role: [socb]), (single-nucleotide polymorphisms: [nusq]), (gabrb3 (rs2081648: [gngm]), (gabra5 (rs35586628): [gngm]), (gabrg3 (rs208129) genes: [gngm]), (asd susceptibility: [cgab]), (developmental phenotypes: [orga]), (asd: [cgab]), (chinese han children: [aggp]), (adolescents: [aggp]), (asd patients: [cgab]), ((td) controls: [sbst]), (taqman: []), (assay: [lbpr]), (symptom-based phenotypes: [orga]), (childhood autism rating scale (cars): [mobd]), (autism behavior checklist (abc): [mobd]), (early childhood development questionnaire (ecdq): [phpr]), (haplotypes: [orga]), (global: []), (test: [lbpr]), (snps: [nusq]), (significant associations: [menp]), (td groups: [popg]), (besides: []), ( gabrb3 rs2081648: [gngm]), ( gabra5 rs35586628: [gngm]), (polymorphisms: [genf]), (symptom-based deficits: [fndg]), (social interaction: [fndg]), ( sensorimotor: []), (somatosensory coordination: [phsf]), (visual response: [fndg]), ( imitation: [socb]), ( activity: [acty]), (level: [phsu]), ( language expression: [lang]), (adaptability: [menp]), (developmental abnormalities: [cgab]), (late emergences: []), (fine motor: []), (gabrb3 rs2081648 polymorphism: [genf]), (overall results: [fndg]), (gene synergy: [gngm]), (asd pathogenesis: [cgab]), (gabaa receptor gene polymorphisms: [aapp,rcpt]), (developmental deficits: [orgf]), (asd individuals: [cgab]), 
ASD Terms: (autistic spectrum disorders, 'Autistic Disorder')(developmental phenotypes of asd, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(autism behavior checklist, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(somatosensory coordination, 'Motor Skills')(visual response, 'Visual Thinking')(imitation, 'Imitation')(language expression, 'Expressive Language')(adaptability, 'Adaptive Life Skills')(developmental abnormalities in late emergences, 'Learning Disorders')(developmental abnormalities, 'Learning Disorders')(developmental deficits in asd individuals, 'Learning Disorders')(developmental deficits, 'Learning Disorders')

PMCID: 5466314
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (autism spectrum disorders (asd) orient: [mobd]), (salient stimuli: [phpr]), (dynamic social images: []), (turn: [fndg]), (lack: []), (social orienting: []), (affected individuals socio communicative development: [socb]), (here: []), (relationship: []), (time: []), (asd: [cgab]), (joint attention: [menp]), (communication: [socb]), (preschoolers: [aggp]), (autism spectrum: [mobd]), (study: [resa]), ( social orienting: []), (eye-tracking: [bpoc]), (task: [gngm]), (side-by-side presentations: []), (dynamic geometric images: []), (side: []), (screen: [hlca]), (type: [qnco]), (video: []), (items: []), (visual perseveration: [mobd]), (location: [blor]), (participants: [popg]), (visual exploration patterns: [topp]), ((td) children: [aggp]), (joint attention behaviors: [menp]), (parent reports: [hlca]), (social images: []), (td children: [aggp]), (also: []), ( asd participants: [cgab]), (first fixations: [topp]), (however: []), (great heterogeneity: [orga]), (asd group: [cgab]), (asd preschoolers: [cgab]), (pronounced visual engagement: [fndg]), (mean fixation duration: [phsu]), (saccades: [ortf]), (second): [qnco]), (moreover: []), (increased frequency: [qnco]), (improved communication skills: [orga]), (results: [fndg]), (further: []), (social world: [popg]), (young children: [aggp]), (communicative deficits: [socb]), (therefore: []), (focus: []), (intervention programs: [hlca]), (possible: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(affected individuals socio communicative development, 'Reciprocal Social Interaction')(joint attention, 'Joint Attention')(autism spectrum, 'Autism Phenotype')(visual perseveration, 'Involuntary Behaviors')(visual exploration patterns, 'Visual Thinking')(joint attention behaviors, 'Joint Attention')(pronounced visual engagement, 'Visual Thinking')(joint attention behaviors, 'Joint Attention')(improved communication skills, 'Reciprocal Social Interaction')

PMCID: 5457729
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (children: [aggp]), (usa: []), (asd blood biomarker: [cgab]), (early diagnosis: [diap]), (and/or identification: [menp]), (new therapeutic targets: [diap]), (serum samples: [bdsu]), (asd: [cgab]), ((td): []), ((n: [aapp,imft]), (differences: [qnco]), (proteins: [aapp,bacs]), (multiplex immunoassay: [lbpr]), (modest accuracy: []), (multiple training: [edac]), (test sets: [menp]), (different detection platform: [topp]), (sample: [sbst]), (td boys: [aggp]), (hormone (tsh): [horm]), (interleukin-8 (il-8): [aapp,imft]), (putative biomarkers: [clna]), (tsh levels: [lbpr]), (asd boys: [cgab]), (il-8 levels: [aapp,imft]), (diagnostic accuracy: []), (tsh: []), (addition: []), ( tsh levels: [lbpr]), (autism diagnostic observation schedule subdomain scores: [hlca]), (data: [euka]), (panel: []), (putative blood biomarker: [bdsu]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(early diagnosis, 'Diagnosis')(autism diagnostic observation schedule subdomain scores, 'Autism Phenotype')

PMCID: 5455122
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (severe: []), (lifelong neurodevelopmental disorder: [mobd]), (early onset: [fndg]), (heavy burden: []), (affected individuals: [humn]), (families: [famg]), (need: []), (health: []), (vocational services: []), ( asd: [cgab]), (cost-intensive disorder: [dsyn]), (strain: [menp]), (health care systems: [hcro]), (age: [orga]), (affected individual: [humn]), (asd-net: [cgab]), (germanys: []), (cohort: [popg]), (patients: [podg]), (asd: [cgab]), (lifespan: [grpa]), (methodological expertise: []), (levels: []), (clinical research: [resa]), (translational approach: [genf]), (neurobiological pathways: [moft]), (different phenotypes: [orga]), (appropriate identification: [menp]), (treatment: [topp]), (work: []), (clusters: [qnco]), (diagnostics: [fndg]), ( therapy: [topp]), (health economics: []), (diagnostic cluster: [qnco]), ( data: [euka]), (large: [gngm]), ( well-characterized sample (n =: [aapp,imft]), (efficiency: [qnco]), (diagnostic procedures: [diap]), (pattern classification methods: []), (learning): [menp]), (algorithms: []), (purposes: []), (second step: [qnco]), (algorithm: [lbpr]), (independent sample: [sbst]), (therapy cluster: [qnco]), (asd-specific social skills: [cgab]), (concomitant oxytocin administration: [aapp,horm,phsu]), (behavior: [inbe]), (first time: [qnco]), (long-term effects: [phpr]), (social skills: [socb]), (oxytocin treatment: [aapp,horm,phsu]), (neurobiological phenotypes: [orga]), (acute effects: []), (oxytocin: [aapp,horm,phsu]), (specific effects: []), (additional oxytocin treatment: [aapp,horm,phsu]), (order: [acty]), (plausible models: []), (symptoms: [sosy]), (successful therapeutic interventions: [clna]), (finally: []), (service utilization: []), (asd-related costs: [cgab]), (potential needs: []), (cost savings: [qnco]), (part: [qnco]), (german research network: [popg]), (mental disorders: [mobd]), (bmbf (german federal ministry: [popg]), (education: [fndg]), (research): [resa]), (discussion: [socb]), (integrated structure: [genf]), (asd-net guarantees: [cgab]), (collaboration: [socb]), (clinicians: []), (researchers: []), (individual distress: [menp]), ( harm: []), (social disability: [fndg]), (costs: [qnco]), (german health care system: [hcro]), (trial registration: [resa]), (clinical trials: [resa]), (german clinical trials register: drks00008952: [resa]), (august: []), (drks00010053: []), (april: [gngm]), 
ASD Terms: (early onset, 'Onset of Symptoms')(lifelong neurodevelopmental disorder, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(asd-specific social skills, 'Ability to Converse in Social Settings')(social skills, 'Ability to Converse in Social Settings')(mental disorders, 'Mental Disorders')(social disability of patients, 'Social Competence')(social disability, 'Social Competence')

PMCID: 5461492
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (environmental factors: []), (etiologies: []), (autism spectrum disorder (asd): [mobd]), (evidence: []), (specific environmental exposures: [inpo]), (susceptibility windows: [clna]), (dizygotic twins: [famg]), (asd: [cgab]), (fetal: [emst]), (postnatal metal dysregulation increases asd risk: [cgab]), (tooth-matrix biomarkers: [clna]), (post-natal exposure profiles: [lbpr]), (toxic elements: [elii]), (significant divergences: [qnco]), (metal uptake: [inch]), (asd cases: [cgab]), (control siblings: [famg]), (discrete developmental periods: [orgf]), (cases: [qnco]), (uptake: [celf]), (essential elements: [elii]), (zinc: [elii,phsu]), (neurotoxin lead: [elii,hops]), (lead: [elii,hops]), (asd severity: [cgab]), (autistic traits: [mobd]), (study: [resa]), (metal: [inch]), (toxicant uptake: [celf]), (essential element deficiency: [dsyn]), (specific developmental windows: [orgf]), (asd risk: [cgab]), (severity: []), (hypothesis: []), (systemic elemental dysregulation: [elii]), (independent replication: [genf]), (population-based studies: [resa]), (findings: [clna]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(specific environmental exposures, 'Exposures')(post-natal exposure profiles, 'Exposures')

PMCID: 5451068
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (genetic studies: [resa]), (many risk loci: [gngm]), (autism spectrum disorder (asd): [mobd]), (causal factors: []), (majority: [socb]), (cases: [qnco]), (currently: []), (asd risk genes: [cgab]), (protein-coding genes;: [gngm]), (vast majority: [socb]), (transcripts: [nnon]), (humans: [humn]), (non-coding rnas (ncrnas): [nnon]), (proteins: [aapp,bacs]), (recently: []), (non-coding rnas (lncrnas): [nnon]), (human brain: [humn]), (normal brain development: [bpoc]), (computational pipeline: [acty]), (integration: [genf]), (various genomic datasets: [gngm]), (lncrnas: [nnon]), (asd: [cgab]), (pipeline: []), (differential gene expression patterns: [genf]), (affected tissues: [tisu]), (conjunction: []), (gene co-expression networks: [moft]), (tissue-matched non-affected samples: [tisu]), (rna-seq data: [nusq]), (cortical brain tissues: [bpoc]), (asd cases: [cgab]), (controls: [sbst]), (gene co-expression network: [moft]), (independent human brain: [humn]), (developmental transcriptome: [nusq]), (convergence: [acty]), (specific co-expression modules: [topp]), (co-expression network analysis: [topp]), (discovery: [acty]), (associations: [menp]), (molecular pathways: [moft]), (at-risk developmental time points: [orgf]), (addition: []), (high degree: [qnco]), (overlap: [topp]), (major cnvs: [nusq]), (integrative approach: [genf]), (differential expression analysis: [resa]), (connectivity metrics: [orch,phsu]), (developmental co-expression network: [popg]), (set: [menp]), (candidate asd-associated lncrnas: [cgab]), (identification: [menp]), (novel asd susceptibility genes: [cgab]), (genetic pathogenesis: [patf]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5518181
SFARI Genes: 
Non SFARI Genes: MAF, MAF, 
Named Entities: (roles: [socb]), (characteristics: []), (postzygotic singlenucleotide mosaicisms: [orga]), (autism spectrum disorders: [mobd]), (study: [resa]), (whole exomes: [gngm]), (families: [famg]), (simons simplex collection: [bpoc]), (putative psnms: []), (children: [aggp]), (snps: [nusq]), (detectable parental mosaicism: [orga]), (ultradeep amplicon: []), (validation rate: [qnco]), (analyses: [resa]), (validated psnms: []), (missense/lossoffunction (lof) psnms: [fndg]), (high mutant: [comd]), (allele fraction: [gngm]), (asd: [cgab]), ((p =: [aapp,imft]), (odds: []), (whereas missense/lof psnms: [fndg]), (low maf (maf<0.2): [fndg]), (autistic traits: [mobd]), (male nonasd siblings: [famg]), (lof psnms: []), (parents: []), (neutral psnms (p: [aapp,imft]), (missense/lof psnms: [fndg]), (low maf: [qnco]), (probands: [orga]), (or: []), (psnms: []), (novo mutations: [genf]), (parental psnms: []), (risk: []), (transmission: [patf]), (association test model: [diap]), (new asd risk genes: [cgab]), (results: [fndg]), (repertoire: []), (genes: [gngm]), (new light: [npop]), (contribution: [acty]), (genomic mosaicisms: [orga]), (asd diagnoses: [cgab]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 5467355
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder: [mobd]), (developmental disability: [mobd]), (united states: []), (group: [popg]), (neurodevelopmental disorders: [mobd]), (impaired social interaction: [mobd]), (communication: [socb]), (repetitive behavior: [fndg]), (underlying cause: []), (autism: [mobd]), (therapy: [topp]), (behavioral abnormalities: [mobd]), (studies: [lbpr]), (link: []), (mitochondrial dysfunction: [fndg]), (asd: [cgab]), (here: []), (evidence: []), (potential connection: []), (biochemical links: []), ( genetic-based associations: []), (related mechanisms: [fndg]), (novel therapeutic strategies: [menp]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(developmental disability, 'Learning Disorders')(impaired social interaction, 'Reciprocal Social Interaction')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')(behavioral abnormalities, 'Personal Traits')

PMCID: 5907836
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract neuroligins (nlgs): [moft]), (transmembrane cell adhesion molecules: [aapp,bacs]), (essential roles: [socb]), (synapse development: [ortf]), (function: [phsf]), (genetic mutations: [genf]), (neuroligin genes: [gngm]), (neurodevelopmental disorders: [mobd]), (autism: [mobd]), (nlgs: [orch]), (endoplasmic reticulum (er): [celc]), (however: []), (mechanisms underlying normal nlg maturation: [fndg]), (trafficking: [celf]), (here: []), (drosophila: [euka]), ((dnlg2) undergoes: []), (proteolytic cleavage: [celf]), (er: [gngm]), (variety: []), (drosophila tissues: [euka]), (developmental stages: []), (region: []), (y642t698: []), (process: [phpr]), (immature: []), (non-cleavable dnlg2: []), (c-terminal fragment: [amas]), (dnlg2: []), (neuromuscular junction defects: [celc]), (gluriib reduction: [npop]), (dnlg2 deletion: [genf]), (autism-associated r598c mutation: [mobd]), (similar marked defects: []), (proteolytic process: [moft]), (potential role: [socb]), (improper nlg cleavage: [celf]), (autism pathogenesis: [mobd]), (collectively: []), (findings: [clna]), (specific mechanism: []), (dnlg2 maturation: [phsf]), ( suggesting: []), (perturbed proteolytic cleavage: [celf]), (likely contributes: [acty]), (disorder: [dsyn]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')(autism pathogenesis, 'Autism Phenotype')(autism disorder, 'Autism Phenotype')

PMCID: 5534939
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (currently: []), (effective pharmacologic treatments: []), (core symptoms: [sosy]), (autism spectrum disorder (asd): [mobd]), (is: []), ( nevertheless: []), ( potential: []), (progress: []), (example: []), ( recent evidence: []), (excitatory (e) glutamate: [aapp,bacs]), (inhibitory (i) gaba systems: [aapp,bacs]), (asd: [cgab]), (however: []), (prior studies: [lbpr]), (responsivity: [menp]), (ei system: [qnco]), (challenge;: [hlca]), (ei modulation alters abnormalities: [cgab]), (functional connectivity: []), (brain regions: [blor]), (disorder: [dsyn]), (therefore: []), (magnetic resonance spectroscopy ([1h]mrs): [diap]), (prefrontal ei flux: [npop]), (response: [fndg]), (glutamate: [aapp,bacs]), (gaba: [aapp,bacs]), (drug riluzole: [orch,phsu]), (adult men: [aggp]), (change: [qnco]), (prefrontal inhibitory indexthe gaba fraction: [aapp,bacs]), (pool: [clna]), (riluzole challenge;: [orch,phsu]), (impact: [gngm]), (riluzole: [orch,phsu]), (differences: [qnco]), (resting-state functional connectivity: [fndg]), (baseline differences: [bodm]), (ei balance: [fndg]), (significant group difference: [popg]), (challenge: [hlca]), (prefrontal cortex inhibitory index: [bpoc]), (controls: [sbst]), (prefrontal functional connectivity: []), (baseline: [bodm]), (asd group: [cgab]), (results: [fndg]), (first time: [qnco]), (ei: [gngm]), (pharmacologic challenge: [hlca]), (further: []), (initial evidence: []), (abnormalities: [cgab]), (adults: [aggp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5442155
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (multiple: [qnco]), (epidermal growth factor-like-domains: [aapp,horm,phsu]), (critical member: [popg]), (apoptotic engulfment pathway: [celf]), (synapse elimination: [bsoj]), (brain development: [ortf]), (previous studies: [lbpr]), (synaptic pruning deficit: [ortf]), (autism-related phenotypes: [mobd]), (however: []), (relationship: []), (megf10: [gngm]), (autism: [mobd]), (disease-associated variants: [dsyn]), (transcription: [genf]), (regulatory regions: [bacs,nnon]), (transcription start site (tss): [bacs,nnon]), (cis-regulatory elements: [bacs,nnon]), (role: [socb]), (megf10 variants: [gngm]), (putative transcription: [genf]), (regulatory function: [phsf]), (etiology: []), (family-based association study: [socb]), (chinese han trios: [aapp,enzy]), (results: [fndg]), (polymorphisms (snps): [nusq]), ( rs4836316: []), ( rs2194079: []), (rs4836317: []), (tss: [dsyn]), (bonferroni correction (p: [aapp,imft]), (p =: [aapp,imft]), (respectively): []), (haplotype t-a-g (rs4836316-rs2194079-rs4836317): [orga]), (parents: []), ((p permutation: [aapp,imft]), (consistently: []), (functional exploration: [topp]), (risk allele: [gngm]), (haplotype: [orga]), (binding: [moft]), (transcription factors: [aapp,bacs]), (decreased transcriptional activity: [sosy]), (findings: [clna]), (risk alleles: [gngm]), (megf10 tss: [dsyn]), (transcriptional activity: [genf]), (susceptibility: [clna]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(affected offspring, 'Perinatal History')

PMCID: 5441062
SFARI Genes: FOXP1, ATP2B2, FOXP1, ATP2B2, EXT1, ASTN2, MACROD2, HDAC4, EXT1, ASTN2, MACROD2, HDAC4, 
Non SFARI Genes: PITX3, CUEDC2, 
Named Entities: (past decade genome-wide association studies: [mbrt]), (aid: [gngm]), (understanding: [menp]), (biology: []), (traits: [gngm]), (success: [socb]), (approach: []), (underlying effect sizes: []), (true risk variants: []), (corresponding statistical power: [resa]), (such effects: []), (study design: [resa]), (sample size: [qnco]), (investigation: [hlca]), (previous asd gwas: [cgab]), (genome-wide significant (gws) risk: [gngm]), (studies: [lbpr]), (low statistical power: [resa]), (gws loci: [gngm]), (effect: []), ((odds ratio: [qnco]), (<1.15): [fndg]), (large-scale coordinated international collaboration: [socb]), (data: [euka]), (statistical power: [resa]), (robust discovery: [acty]), (study: [resa]), (discovery sample (7387 asd cases: [cgab]), (controls): [sbst]), (meta-analysis: [resa]), (summary statistics: []), (replication sets: [genf]), (asd cases: [cgab]), (controls;: [sbst]), (gws locus: [gngm]), (overlaps: [topp]), (several genes: [famg]), (pitx3: [gngm]), (transcription factor: [aapp,bacs]), (role: [socb]), (neuronal differentiation: [fndg]), (cuedc2: [gngm]), (social skills: [socb]), (independent population cohort: [popg]), (overlap: [topp]), (regions: []), (schizophrenia: [mobd]), (strong genetic correlation: [topp]), (disorders: [dsyn]), (p: [gngm]), (psychiatric: [hlca]), (consortium (pgc) asd gwas data: [cgab]), (recent pgc schizophrenia gwas: [mbrt]), (additional regions: []), (common neurodevelopmental phenotype: [orga]), (novel gws loci: [gngm]), (loci: [gngm]), (asd: [cgab]), (foxp1: [gngm]), (atp2b2: [gngm]), (neurodevelopmental hub: [gngm]), (chromosome: [celc]), (important step: [qnco]), (ongoing endeavour: []), (common variant signal: [phpr]), (addition: []), (significant genetic correlation: [qnco]), (association: [menp]), (several neurodevelopmental-related genes: [famg]), (ext1: [gngm]), ( astn2: [gngm]), ( macrod2: [gngm]), (hdac4: [gngm]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0137-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (large-scale coordinated international collaboration, 'Motor Skills')(social skills, 'Ability to Converse in Social Settings')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(common neurodevelopmental phenotype, 'Learning Disorders')(neurodevelopmental hub, 'Learning Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 5455002
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (globally: []), (women: [popg]), (reproductive age: [orgf]), (children: [aggp]), (obese mothers: [dsyn]), (risk: []), (obesity: [dsyn]), ( coronary heart disease: [dsyn]), ( diabetes: [dsyn]), ( stroke: [dsyn]), (asthma: [dsyn]), (adulthood: []), (experimental evidence: []), (maternal obesity: [fndg]), (health: []), (function: [phsf]), (brain: [bpoc]), (lifespan: [grpa]), (review: []), (current findings: [clna]), (animal studies: [anim]), (impact: [gngm]), (aspects: [qnco]), (learning: [menp]), ( memory: [menp]), (affective disorders: [mobd]), (attention-deficit hyperactivity disorder: [mobd]), ( autism spectrum disorders: [mobd]), (neurodegeneration: [comd]), (offspring: [famg]), (epigenetic mechanisms: [genf]), (motherchild interaction: []), 
ASD Terms: (asthma, 'Asthma')(coronary heart disease, 'Cardiovascular Diseases')(diabetes, 'Diabetes Mellitus Type 1')(memory, 'Working Memory')(memory, 'Working Memory')(attention-deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism spectrum disorders, 'Autism Phenotype')(offspring, 'Perinatal History')

PMCID: 5454987
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: ((cgt): [gngm]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (negative effects: [fndg]), (knowledge: []), (parents attitudes: []), (good involvement: []), (caregivers: []), (accurate diagnosis: [fndg]), (effective clinical management: [hlca]), (study: [resa]), (cgt: [gngm]), (asd: [cgab]), (parent members: [popg]), (norwegian autism society: [mobd]), (untested questionnaire: []), (answered: []), (linear regression analyses: []), (contribution: [acty]), (parent: []), (child characteristics: [aggp]), (statements: []), (casual explanation: []), (childs asd: [cgab]), (possibilities: []), (early interventions: [hlca]), (negative impact: [gngm]), (health insurance: [hlca]), (concern: []), (childs future: [aggp]), (family conflicts: [famg]), (parents: []), (cgt (9%): [gngm]), (positive effects: [fndg]), (negative impacts: [gngm]), (severity: []), (childrens asd diagnosis: [cgab]), (weak positive association: [menp]), (parents positive attitudes: [menp]), ((p-values: [qnco]), (<0.001: [fndg]), (child: [aggp]), (asd (65%): [cgab]), (childs development: [orgf]), (normal (48%): [fndg]), (pregnancy (36%): [orgf]), (majority: [socb]), (etiological explanation: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(accurate diagnosis, 'Diagnosis')(norwegian autism society, 'Autism Phenotype')(childrens asd diagnosis, 'Diagnosis')

PMCID: 5454981
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (deletion syndrome (22q11.2ds): [genf]), (genomic disorder: [dsyn]), (autism spectrum disorders: [mobd]), (cases; however: [qnco]), ( others: [fndg]), (individuals: [humn]), (present psychiatric: [qnco]), (behavioral features: [inbe]), (asds: [cgab]), (full criteria: []), (asd diagnoses: [cgab]), (such wide variability: []), (findings: [clna]), (part: [qnco]), (methodological differences: [qnco]), (studies: [lbpr]), (study: [resa]), (meet: [phpr]), (strict asd: [cgab]), (diagnostic criteria: []), (research-based guidelines: [orgt]), (collaborative programs: [socb]), (excellence: []), (autism (cpea): [mobd]), (gathering: []), (information: []), (autism diagnostic: [mobd]), (autism diagnostic observational schedule (ados): [mobd]), (clinicians best-estimate diagnosis: [fndg]), (cohort: [popg]), (children: [aggp]), ( adolescents: [aggp]), (young adults: [aggp]), (developmental concerns: [orgf]), ((n: [aapp,imft]), (participants: [popg]), (cpea criteria: []), (asd diagnosis: [cgab]), (majority: [socb]), (level: [phsu]), (social-communication impairment: [mobd]), (presence: [qnco]), (repetitive behaviors: [fndg]), (substantial proportion: [qnco]), (early childhood: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism diagnostic, 'Autism Phenotype')(autism diagnostic observational schedule, 'Autism Phenotype')(clinicians best-estimate diagnosis, 'Diagnosis')(autism criteria, 'Autism Phenotype')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(asd diagnosis, 'Diagnosis')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 5437096
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (clinical heterogeneity: [fndg]), (however: []), (biochemical impairments: [patf]), (melatonin (crucial: [horm,orch,phsu]), (circadian regulation): [biof]), (elevated platelet n-acetylserotonin (the precursor: [cell]), (melatonin): [horm,orch,phsu]), (frequent features: []), (individuals: [humn]), (asd: [cgab]), (mechanisms: []), (dysfunctions: [dsyn]), (melatonin synthesis: [moft]), (post-mortem pineal: [bpoc]), (main source: [fndg]), (melatonin (9 patients: [horm,orch,phsu]), (controls): [sbst]), (samples: [sbst]), (serotonin (11 patients: [bacs,orch]), (blood platelets: [cell]), (first-degree relatives: [qnco]), (controls: [sbst]), (results: [fndg]), (enzymatic mechanism: [moft]), (melatonin deficit: [horm,orch,phsu]), (reduction: [npop]), (enzyme activities: [moft]), (synthesis (aanat: [biof]), (asmt): [gngm]), (pineal gland: [bpoc]), (gut: [bdsy]), (platelets: [cell]), (patients: [podg]), (further investigations: [hlca]), (new: []), ( post-translational (reduced levels: [genf]), (14-3-3 proteins: [aapp,bacs]), (aanat: [gngm]), (asmt activities): [acty]), (post-transcriptional (increased levels: [genf]), (14-3-3) mechanisms: [aapp,bacs]), (impairments: [patf]), (study: [resa]), (insights: [menp]), (pathophysiological pathways: [moft]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 5436821
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (body: [humn]), (evidence: []), (significant comorbidity: [qnco]), (psychotic disorders: [mobd]), (schizophrenia: [mobd]), (attention-deficit/hyperactivity disorder: [mobd]), (autism-spectrum disorders: [mobd]), (recently: []), ( research: [resa]), (psychosis-proneness: [mobd]), (healthy individuals: [humn]), (promising way: []), (mechanisms: []), (psychosis: [mobd]), (adhd: [mobd]), (asd symptoms: [cgab]), (normal distribution: [qnco]), (general population: [popg]), (such trait comorbidity: [orga]), (studies: [lbpr]), (thus: []), (extent: []), (psychosis-proneness relates: [orch]), (healthy subjects: [popg]), (psychosis-prone populations: [popg]), (present paper: [qnco]), (robustness: []), (overlap: [topp]), (adhd/asd symptoms: [cgab]), (correlations: []), (scores: [clna]), (commonly-used questionnaires: [fndg]), (delusion-proneness (peters delusion inventory): [mobd]), ( adhd tendencies: [mobd]), (adhd self-report scale): [resa]), (asd tendencies (autism quotient): [cgab]), (large sample: [sbst]), (raw scores: [diap]), ( prototypical questions: []), (factor analysis: [qnco]), (results: [fndg]), (positive correlations: [fndg]), (adhd-: [mobd]), (asd-symptoms: [cgab]), (effect: []), (asd: [cgab]), (findings: [clna]), (idea: []), (asd-tendencies: [cgab]), (account: [clna]), (order: [acty]), (study: [resa]), (observed trait correlations: [orga]), (common pathway: [moft]), (underlying information processing: [menp]), (states: []), 
ASD Terms: (significant comorbidity, 'Comorbidities')(psychotic disorders, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(asd symptoms, 'Complaints and Indications')(such trait comorbidity, 'Comorbidities')(asd symptoms, 'Complaints and Indications')(attention-deficit/hyperactivity disorder tendencies, 'Attention Deficit Disorder with Hyperactivity')(underlying information processing, 'Ability to Convey Information')

PMCID: 5552240
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd) risk: [mobd]), (variation: []), (influence: []), (polygenic risk: [genf]), (asds: [cgab]), (subgroups: [virs]), (asd cases: [cgab]), (variants: []), (novel approach: []), (polygenic transmission disequilibrium test: [dsyn]), (data: [euka]), (families: [famg]), (child: [aggp]), (asd: [cgab]), ( schizophrenia: [mobd]), (educational attainment: [fndg]), (children: [aggp]), (findings: [clna]), (proband iq: [famg]), (polygenic variation: [genf]), (strong acting: []), (variant: []), (elements: [elii]), (relationship: []), (phenotype: [orga]), (results: [fndg]), (genetic influences: [topp]), (risk: []), (distinct etiologic pathways: [moft]), 
ASD Terms: (autism spectrum disorder risk, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 5534955
SFARI Genes: 
Non SFARI Genes: HNMT, HRH1, HRH2, HRH3, 
Named Entities: (histaminergic system (hs): []), (critical role: [socb]), (cognition: [menp]), ( sleep: [orgf]), (other behaviors: [inbe]), (autism spectrum disorder: [mobd]), (hs: [gngm]), (many neurological disorders: [dsyn]), (share comorbidity: [socb]), (asd: [cgab]), (tourette syndrome (ts): [dsyn]), (preliminary studies: [lbpr]), (antagonism: [socb]), (histamine receptors: [aapp,rcpt]), (reduces symptoms: [sosy]), (specific behaviors: [inbe]), (asd patients: [cgab]), (relevant animal models: [anim]), (hs mediates: [socb]), (together: []), (rna: [nnon]), (genome-wide expression: [gngm]), (focused gene: [gngm]), (analysis: [resa]), (key hs genes (hdc: [gngm]), ( hnmt: [gngm]), ( hrh1: [gngm]), ( hrh2: [gngm]), ( hrh3: [gngm]), (hrh4): [gngm]), (postmortem dorsolateral prefrontal cortex (dlpfc): [bpoc]), (subjects: [humn]), (controls: [sbst]), (genome level: [gngm]), (transcripts: [nnon]), ((false discovery rate <0.05): [qnco]), (small nucleolar rnas (snornas): [bacs,nnon]), (significant diagnosis effect: [fndg]), (individual hs genes: [gngm]), (expression: [topp]), (gene set: [gngm]), (hnmt: [gngm]), (hrh3: [gngm]), (hs gene sets: [gngm]), (differential expression analysis: [resa]), (gene sets: [gngm]), (independent rna-seq asd data set: [cgab]), (dlpfc: []), (additional subjects: [humn]), (findings: [clna]), (physiological relevance: []), (altered hs: []), (new therapeutic options: [topp]), (treatment: [topp]), 
ASD Terms: (cognition, 'Cognitive Ability')(share comorbidity, 'Comorbidities')(autism spectrum disorder, 'Autism Phenotype')(many neurological disorders, 'Neurologic Indications')(tourette syndrome, 'Tourette Syndrome')(significant diagnosis effect, 'Diagnosis')

PMCID: 5431663
SFARI Genes: ADSL, ADSL, 
Non SFARI Genes: 
Named Entities: (next-generation sequencing (ngs): [mbrt]), (powerful tool: []), (exonic variants: [bacs,nnon]), (causality: []), (sequence variants: [npop]), (human disease: [humn]), (important part: [qnco]), (ngs: []), (research: [resa]), (clinical applications: [hlca]), (recently: []), (important guidelines: []), (study: [resa]), (chinese families: [famg]), (clinical diagnosis: []), (epilepsy: [dsyn]), (seizures: [sosy]), ( psychomotor retardation: [fndg]), ( hypotonia: [fndg]), (etc: []), (features: []), (trio-wes: [aapp,enzy]), (proband: [famg]), (unaffected parents): []), (standard interpretation: [clna]), (identified variants: [fndg]), (guidelines: []), (novel mutations: [comd]), (c > t: []), (c.1387-1389delgag: []), ( p.e463-; c.134 g > a: [qnco]), ( p.w45*; nm_000026): [celf]), (adsl: [gngm]), (causal variants: []), (disease-adenylosuccinate lyase deficiency: [dsyn]), (specific therapy: [topp]), (patients: [podg]), (refined molecular diagnosis: [lbpr]), (effect: []), (limited success: [socb]), (power: [hcpp]), (advantages: []), (wes: [mbrt]), (etiology: []), (wes study: [resa]), (necessary strategy: [menp]), (molecular diagnosis: [lbpr]), (individualized treatment: [topp]), 
ASD Terms: (clinical diagnosis, 'Diagnosis')(epilepsy, 'Epilepsy')(psychomotor retardation, 'Mental Retardation')(refined molecular diagnosis, 'Diagnosis')(molecular diagnosis, 'Diagnosis')

PMCID: 5423032
SFARI Genes: 
Non SFARI Genes: APOD, 
Named Entities: (pathophysiology: [patf]), (autistic spectrum disorder (asd): [mobd]), (predictive biomarkers: [clna]), (glycosylation: [moft]), (human proteins: [aapp,bacs]), (various pathological changes: [qnco]), (however: []), (alterations: []), (glycoproteins: [aapp,bacs]), (asd: [cgab]), (study: [resa]), ( serum glycopattern: [bdsu]), (maackia amurensis: [plnt]), (lectin-ii binding glycoproteins: [aapp,bacs]), (children: [aggp]), ((td) children: [aggp]), (lectin microarrays: [aapp,bacs]), (lectin-magnetic particle: [aapp,bacs]), (conjugate-assisted lc-ms/ms analyses: [resa]), (expression: [topp]), (sia2-3 gal/galnac: [imft,orch]), (pooled (fold change: [qnco]), (p <: [aapp,imft]), (individual (p =: [humn]), (serum samples: [bdsu]), (asd versus td children: [cgab]), (total: [qnco]), (mgbs: [lbpr]), (td: []), (respectively: []), (proteins: [aapp,bacs]), (bioinformatic analysis: [resa]), (abnormal complement cascade: [moft]), (aberrant regulation: [biof]), (response-to-stimulus: [menp]), (novel makers: []), (markers: [clna]), (moreover: []), ( increase: []), (apod: [gngm]), (2-3 sialoglycosylation: [resa]), (distinguish asd samples: [cgab]), (td samples (auc: [qnco]), (conclusion: []), ( alteration: []), (mbgs expression: [topp]), (sialoglycosylation: []), (potential biomarkers: [clna]), (diagnosis: [fndg]), (useful information: []), (investigations: [hlca]), (pathogenesis: [patf]), 
ASD Terms: (autistic spectrum disorder, 'Autistic Disorder')(diagnosis, 'Diagnosis')

PMCID: 5419910
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract background:: []), (aim: [phsu]), (meta-analysis: [resa]), (prenatal: [aggp]), ( perinatal: []), (postnatal risk factors: [qnco]), (children: [aggp]), (methods: pubmed: []), ( embase: []), ( web: []), (science: []), (studies: [lbpr]), (fixed-effects model: [phpr]), (random-effects model: [resa]), (overall effect estimates: [qnco]), (results: data: [euka]), (autistic children: [podg]), (nonautistic children: [aggp]), (collated: []), (prenatal period: [aggp]), (factors: []), (autism risk: [mobd]), (paternal age35 years: [famg]), ( mother's: [famg]), (father's race: white: [famg]), (asian: [popg]), (gestational hypertension: [patf]), (gestational diabetes: [patf]), ( maternal: [famg]), (paternal education college graduate+: [edac]), (abortion: [topp]), (antepartum hemorrhage: [patf]), (caesarian delivery: [topp]), ( gestational age36 weeks: [hlca]), (spontaneous labor: [orgf]), (labor: [orgf]), ( breech presentation: [patf]), ( preeclampsia: [patf]), (fetal distress: [dsyn]), (postnatal period: []), (low birth weight: [fndg]), ( postpartum hemorrhage: [patf]), ( male gender: [orga]), (brain anomaly: [dsyn]), (parity4: []), (decreased risk: [qnco]), (autism: [mobd]), (addition: []), ( exposure: [clna]), (smoking: [inbe]), ( urinary infection: [dsyn]), (father's race: black: [famg]), (hispanic: [popg]), ( mother's country: [famg]), (birth: [orgf]), (europe: []), (north america: []), (umbilical cord: [emst]), (neck: [blor]), ( premature membrane: [fndg]), (5-minutes apgar score<7: [clna]), (respiratory infection: [dsyn]), (increased risk: [qnco]), (conclusion:: []), (present meta-analysis: [resa]), (relation: [socb]), (postnatal factors: []), (causal: []), (secondary role: [socb]), (development: [orgf]), (further studies: [lbpr]), (findings: [clna]), (effects: []), (multiple factors: [qnco]), (single factor: [fndg]), 
ASD Terms: (perinatal, 'Perinatal Exposures')(perinatal, 'Perinatal Exposures')(autism risk, 'Autism Phenotype')(gestational hypertension, 'Perinatal History')(gestational diabetes, 'Perinatal History')(caesarian delivery, 'Perinatal History')(gestational age36 weeks, 'Perinatal History')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(exposure, 'Exposures')(smoking, 'Smoking')(5-minutes apgar score<7, 'Apgar Score')(respiratory infection, 'Respiratory Indications')(autism, 'Autism Phenotype')(perinatal, 'Perinatal Exposures')(autism, 'Autism Phenotype')

PMCID: 5886262
SFARI Genes: CACNA1D, Cav1.3, CACNA1D, Cav1.3, Cav1.3, CACNA1D, Cav1.3, CACNA1D, CACNA1D, CACNA1D, Cav1.3, Cav1.3, Cav1.3, Cav1.3, CACNA1D, CACNA1D, Cav1.3, Cav1.3, 
Non SFARI Genes: 
Named Entities: (abstract cacna1d: [gngm]), (pore-forming 1-subunit: [aapp]), (cav1.3: [gngm]), (l-type voltage-gated ca2+-channel: [phsf]), (recent discovery: [acty]), (gain-of-function mutations: [phsf]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (intellectual disability cacna1d: [mobd]), (prominent asd-risk gene: [cgab]), (large scale genetic analyses: [lbpr]), (such studies: [lbpr]), (likely-disruptive genetic variants: [npop]), (discovery: [acty]), (characterization: [acty]), (missense mutation: [genf]), (cacna1d (v401l): [gngm]), (patient: [podg]), (asd: [cgab]), (functional characterization: [acty]), (mutation v401l: [genf]), (major c-terminal long: [amas]), (short cav1.3 splice variants: [gngm]), (wild-type: [gngm]), (mutant channel complexes: [chvs]), (tsa-201 cells: [cell]), (whole-cell patch-clamp recordings: [resa]), (channels activation gate: [acty]), (current densities: [qnco]), (voltage dependence: [menp]), (activation: [acty]), (inactivation: []), (negative voltages: [qnco]), (reduced channel inactivation: []), (cav1.3 splice variants: [gngm]), (altogether: []), (gating changes: [qnco]), (enhanced ca2+-influx: [elii,phsu]), (channel: []), (strong gain-of-function phenotype: [phsf]), (additionally: []), (mutant channels: [comd]), (full sensitivity: [patf]), (available ca2+ -channel blocker isradipine: [orch,phsu]), (findings: [clna]), (evidence: []), (cacna1d: [gngm]), (novel candidate autism risk gene: [mobd]), (experimental therapy: [topp]), (available channel-blockers: [phsu]), (mutation: [genf]), (additional presence: [qnco]), (seizures: [sosy]), (neurological abnormalities: [cgab,dsyn]), (patient define: [podg]), (novel phenotype: [orga]), (symptoms: [sosy]), (pasna (congenital: [gngm]), (primary aldosteronism: [dsyn]), ( seizures: [sosy]), (neurological abnormalities): [cgab,dsyn]), (similar cav1.3 gain-of-function mutations: [phsf]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(intellectual disability cacna1d, 'Learning Disorders')(novel candidate autism risk gene, 'Autism Phenotype')(neurological abnormalities, 'Neurologic Indications')

PMCID: 5534947
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prenatal infection: [dsyn]), (environmental risk factor: []), (various brain disorders: [dsyn]), (neurodevelopmental components: [ortf]), (autism spectrum disorder: [mobd]), (schizophrenia: [mobd]), (association: [menp]), (animals shows: [anim]), (maternal immune activation: [acty]), (fetal brain development: [phsf]), (emergence: []), (behavioral disturbances: [mobd]), (life: []), (recent discoveries: [acty]), (preclinical models: []), (epigenetic modifications: [genf]), (critical molecular mechanism: []), (prenatal immune activation: [acty]), (changes: [qnco]), (brain development: [ortf]), (functions: [phsf]), (generations: []), (review: []), (potential epigenetic mechanisms: [genf]), (effects: []), (prenatal infections: [patf]), (infection-mediated epigenetic reprogramming: [dsyn]), (transgenerational transmission: [patf]), (pathological traits: [gngm]), (identification: [menp]), (transgenerational mechanisms: []), (infection-mediated neurodevelopmental disorders: [dsyn]), (brain disorders: [dsyn]), (diagnostic classifications: []), (complex patterns: [chvs]), (transgenerational disease transmission: [patf]), (genetic inheritance: []), (consideration: [fndg]), (ancestral infectious histories: [dsyn]), (great clinical interest: [menp]), (new preventive treatment strategies: []), 
ASD Terms: (neurodevelopmental components, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(emergence of behavioral disturbances, 'Personal Traits')(behavioral disturbances, 'Personal Traits')(infection-mediated neurodevelopmental disorders, 'Learning Disorders')(infection-mediated neurodevelopmental disorders, 'Learning Disorders')

PMCID: 5414283
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (daily risk: []), (exposure: [clna]), (insecticides: [hops]), (chlorpyrifos (cpf): [hops,orch]), (pregnant women: [popg]), (cpf: [gngm]), (decreased birth weight: [fndg]), (abnormal reflexes: [sosy]), ( reduction: [npop]), (iq: []), (maternal reports: [hlca]), (signs: [fndg]), (pervasive developmental disorder: [mobd]), (aim: [phsu]), (current study: [resa]), (long term effects: [phpr]), (prenatal exposure: [fndg]), (c57bl/6 j (b6) mice: [mamm]), (specific focus: []), (repetitive behavior: [fndg]), (b6: [mamm]), (female mice: [mamm]), (mg/kg cpf: [gngm]), (mg/kg: [qnco]), (gestational days: []), (oral gavage: []), (postnatal days: []), (early development: [orgf]), (neuromotor ability: [orga]), (neonatal reflexes: [ortf]), (offspring: [famg]), (adulthood: []), ( pnd: [gngm]), (social behavior: [socb]), (social preference: []), (social novelty: []), (social conditioned place preference tasks: [menp]), (object recognition: [menp]), (interest: [menp]), (repetitive novel: []), (object contact task (rnoc): [acty]), (pn d: [aapp,bacs]), (order: [acty]), (possibility: []), (cpf administration: [topp]), (alterations: []), (maternal care: [hlca]), (dams behavior: [inbe]), (maternal retrieval task: [famg]), (cpf treatment: [topp]), (delayed development: [mobd]), (pnds: [dsyn]), (pnd: [gngm]), (mice: [mamm]), (mg/kg dose: [qnco]), (reduced preference towards: []), (unfamiliar conspecific: []), (social preference test: [lbpr]), (social conditioned place preference: [menp]), (rnoc task: []), ( mice: [mamm]), (restricted interest: [menp]), (memory: [menp]), (recognition deficit: [menp]), (object recognition task: [menp]), (data: [euka]), (gestational exposure: [clna]), (long-term deleterious effects: [phpr]), (limits exploration: [topp]), (novel objects: []), 
ASD Terms: (exposure, 'Exposures')(exposure, 'Exposures')(prenatal exposure, 'Exposures')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(gestational days, 'Perinatal History')(offspring, 'Perinatal History')(social behavior, 'Reciprocal Social Interaction')(social conditioned place preference tasks, 'Social Competence')(delayed development of neonatal reflexes, 'Learning Disorders')(delayed development, 'Learning Disorders')(social conditioned place preference, 'Social Competence')(restricted interest, 'Restricted Range of Interests')(cause memory, 'Working Memory')(social behavior, 'Reciprocal Social Interaction')(gestational exposure, 'Perinatal History')

PMCID: 5637135
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (aims: [phsu]), (objectives:: []), (primary aim: [phsu]), (evaluation: [hlca]), (pattern: []), (gross congenital malformations: [cgab]), (rat model: [mamm]), (autism spectrum disorder (asd): [mobd]), (secondary aim: [neop]), (characterization: [acty]), (common gross malformation observed: [cgab]), (materials and methods:: [sbst]), (late pro-oestrous phase: [aapp,bacs]), (vaginal smear cytology: [diap]), (then: []), (ratio (male: female): [orga]), (pregnancy: [orgf]), (presence: [qnco]), (sperm plug: [cell]), (vagina: [bpoc]), (sperm: [cell]), (vaginal smear: [diap]), (asd group: [cgab]), ( asd: [cgab]), (valproic acid: [orch,phsu]), (mg/kg (i.p.): [inch]), (female rats: [mamm]), (day: []), ((single injection): [fndg]), (vehicle: [bodm]), ((normal saline): [inch,phsu]), (control group (n: [grup]), (delivery: [topp]), ( pups: []), (congenital malformations: [cgab]), (time: []), (sacrifice (3 months): []), (different types: []), (malformations: [cgab]), (frequency: [qnco]), (results:: [fndg]), (congenital malformation: [cgab]), (pups: []), ( whereas: []), (control: [sbst]), (male pups: [orga]), ((90%: [fndg]), (males: [orga]), (female pups): [orga]), (tail deformity: [cgab]), (common malformation: [cgab]), (other malformations: [cgab]), (dental malformation (3.82%): [fndg]), (genital malformation (3.28%): [cgab]), (paw malformation (1.1%): [cgab]), (hind limb paralysis: [dsyn]), (pup: []), (tail anomalies: [bpoc]), (gross appearance: [orga]), (location: [blor]), (malformation: [cgab]), (conclusion:: []), (well-validated rat model: [mamm]), (asd: [cgab]), (integral part: [qnco]), (management: [hlca]), (case: []), (vice versa: []), ( i.e.: [diap,inpr]), (baby: [aggp]), (congenital deformity: [cgab]), 
ASD Terms: (pattern of gross congenital malformations, 'Congenital Abnormalities')(autism spectrum disorder, 'Autism Phenotype')(gross congenital malformations, 'Congenital Abnormalities')(delivery, 'Perinatal History')(congenital malformations, 'Congenital Abnormalities')(congenital malformation, 'Congenital Abnormalities')(genital malformation, 'Urogenital Diseases')

PMCID: 5409803
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objective advanced: []), (paternal age (apa): [gngm]), (conception: [orgf]), (autism: [mobd]), (schizophrenia: [mobd]), (offspring: [famg]), ( neurodevelopmental disorders: [mobd]), (social functioning: [socb]), (current study: [resa]), (effects: []), (paternal age: []), (social development: [socb]), (general population: [popg]), (multilevel growth: [orgf]), (apa effects: [gngm]), (socioemotional development: [orgf]), (early childhood: []), (strengths: []), (difficulties questionnaire (sdq): [fndg]), (twins early development study (teds) sample: [resa]), (environmental underpinnings: []), (paternal age effects: [fndg]), (development: [orgf]), (additive genetics: [sbst]), ( common environment: [qnco]), (unique environment (ace): [aapp,bacs]), (geneenvironment (gxe) models: []), (advanced paternal ages: [popg]), (altered trajectory: []), (social development (intercept: p = .01;: [socb]), (p = .03): [aapp,imft]), (other behavioral domain: []), (advanced age: [popg]), (specificity: [qnco]), (importance: []), (genetic factors: [fndg]), (young fathers: [famg]), (distinct underpinnings: []), (extremes: []), (findings: [clna]), (apa-related deficits: [gngm]), (population: [popg]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')(offspring, 'Perinatal History')(neurodevelopmental disorders, 'Learning Disorders')(social functioning, 'Ability to Converse in Social Settings')(social development, 'Ability to Converse in Social Settings')(altered trajectory of social development, 'Ability to Converse in Social Settings')

PMCID: 5454854
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (phenylketonuria (pku): [dsyn]), (common genetic metabolic disease: [dsyn]), (well-documented association: [menp]), (autism spectrum disorders: [mobd]), (deficiency: [dsyn]), (phenylalanine hydroxylase activity: [moft]), (plasmatic hyperphenylalaninemia: [dsyn]), (cognitive impairments: [mobd]), (potential pathophysiological mechanisms: [patf]), (excitation/inhibition (e/i) imbalance: [acty]), (alterations: []), (excitatory/inhibitory synapse development: [acty]), (synaptic transmission: [celf]), (plasticity: [npop]), ( downstream: []), (pathways: [moft]), (intrinsic neuronal excitability: [sosy]), (here: []), (molecular alterations: []), (prefrontal cortex (pfc): [bpoc]), (btbr-pahenu2 (enu2): [mamm]), (animal model: [emod]), (pku: [dsyn]), (data show: [euka]), (frequency: [qnco]), (inhibitory transmissions: [acty]), (significant reduced frequency: [qnco]), (excitatory transmissions: [patf]), (pku-affected mice: [mamm]), (comparison: [acty]), (type: [qnco]), (moreover: []), (pfc: [gngm]), (enu2 mice: [mamm]), (levels: []), (post-synaptic cell-adhesion proteins: [gngm]), (altogether: []), (data point: [euka]), (imbalance: [sosy]), (e/i neurotransmission: [celf]), (inhibition: [acty]), (molecular components: []), (organization: [orgt]), (cortical synapse: [bpoc]), (addition: []), (first evidence: [qnco]), (e/i imbalance: [inch]), (cortical areas: [bpoc]), (mouse model: [emod]), (study: [resa]), (further evidence: []), (animal models: [anim]), (pathology: [patf]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(phenylketonuria, 'Phenylketonurias')(common genetic metabolic disease, 'Metabolic Indications')(phenylalanine hydroxylase activity, 'Phenylketonurias')(cognitive impairments, 'Cognitive Ability')(pku, 'Phenylketonurias')(pku, 'Phenylketonurias')

PMCID: 5454851
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (circadian: []), (network: [popg]), (peripheral oscillators) controls: [sbst]), (circadian rhythms: [orgf]), (expression: [topp]), (range: [qnco]), (downstream genes: [gngm]), (organism: [orgm]), (environmental changes: [qnco]), (role: [socb]), (several studies: [lbpr]), (circadian clock genes: [orgf]), (widespread physiological effect: []), (cognition: [menp]), ( mood: [menp]), (reward-related behaviors: [menp]), (furthermore: []), (core: [bdsu]), (psychiatric disorders: [mobd]), (autism spectrum disorder: [mobd]), ( schizophrenia: [mobd]), ( anxiety disorders: [mobd]), (major depressive disorder: [mobd]), (bipolar disorder: [mobd]), (attention deficit hyperactivity disorder): [mobd]), (however: []), (underlying mechanisms: []), (associations: [menp]), (causeeffect relationships: []), (objective: []), (article: []), (clock genes: [gngm]), (sleepwake rhythms: [fndg]), (development: [orgf]), (problems: []), (early onset: [fndg]), (psychiatric disorders): [mobd]), (molecular mechanisms: []), (described: []), (relationships: []), (further research: [resa]), (perspectives: []), (promising avenues: []), (early detection: [diap]), (therapeutic intervention: [topp]), 
ASD Terms: (circadian rhythms, 'Prosody')(circadian rhythms, 'Prosody')(cognition, 'Cognitive Ability')(mood, 'Mood')(mood, 'Mood')(psychiatric disorders, 'Mental Disorders')(sleepwake rhythms, 'Prosody')(circadian rhythms, 'Prosody')

PMCID: 5407180
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (considerable research: [resa]), (genetic background: [orga]), (autism spectrum: [mobd]), (disorders: [dsyn]), ( environmental factors: []), (variation: []), (prevalence: [qnco]), (time: []), (rodent experiments: [mamm]), (environmental exposures: [inpo]), (effects: []), (subsequent generations: []), (human studies: [humn]), (parental prenatal exposures: [fndg]), (part: [qnco]), (developmental variation: [cgab]), (avon longitudinal study: [resa]), (parents: []), (children (alspac): [aggp]), (hypothesis: []), (mother: [famg]), (father (f1): [famg]), (own mothers (f0) smoking: [famg]), (pregnancy: [orgf]), (offspring (f2): [gngm]), (increased risk: [qnco]), (autism: [mobd]), (association: [menp]), (maternal grandmother smoking: [inbe]), (grand daughters: [famg]), (adverse scores: [qnco]), (social communication: [socb]), (repetitive behaviour measures: [qnco]), (diagnosed autism: [mobd]), (line: [sbst]), (this: []), (actual diagnosis: [fndg]), (grandchildren: [famg]), (paternal grandmothers: [famg]), (associations: [menp]), 
ASD Terms: (autism spectrum, 'Autism Phenotype')(environmental exposures, 'Exposures')(parental prenatal exposures, 'Exposures')(own mothers smoking during pregnancy, 'Smoking')(autism, 'Autism Phenotype')(own mothers smoking, 'Smoking')(offspring, 'Perinatal History')(maternal grandmother smoking, 'Smoking')(social communication, 'Reciprocal Social Interaction')(repetitive behaviour measures, 'Restricted and Repetitive Behavior')(diagnosed autism, 'Autism Phenotype')(actual diagnosis, 'Diagnosis')

PMCID: 5805137
SFARI Genes: CaV1.2, CaV1.2, 
Non SFARI Genes: 
Named Entities: (development: [orgf]), (nervous system: [bdsy]), (coordinated succession: [fndg]), (events: [evnt]), (migration: [phpr]), (gabaergic neurons: [cell]), (forebrain: [bpoc]), (integration: [genf]), (cortical circuits: [bpoc]), (however: []), (interregional interactions: []), (human cells: [lbtr]), (here: []), (human pluripotent cells: [lbtr]), (three-dimensional spheroids: [fndg]), (dorsal: []), (ventral forebrain: [bpoc]), (cortical glutamatergic: [bpoc]), (subdomain-specific forebrain spheroids: [bpoc]), (saltatory migration: [phpr]), (interneurons: [cell]), (fetal forebrain: [bpoc]), (system: []), (timothy: [plnt]), (neurodevelopmental disorder: [mobd]), (mutations: [genf]), (cav1.2 calcium channel: [aapp,bacs]), ( interneurons: [cell]), (abnormal migratory saltations: [qnco]), (glutamatergic neurons: [cell]), (microphysiological system: []), (approach: []), (disease: [dsyn]), (spheroids: [fndg]), (resemble other brain regions: [blor]), (assemble circuits: [acty]), (vitro: []), 
ASD Terms: (coordinated succession of events, 'Motor Skills')(coordinated succession, 'Motor Skills')(neurodevelopmental disorder, 'Learning Disorders')

PMCID: 5487758
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (diagnostic criterion: [fndg]), (impaired emotion regulation: [menp]), (autism: [mobd]), (present study: [qnco]), (self-reported use: [resa]), (emotion regulation strategies: [menp]), (individuals: [humn]), (autistic traits: [mobd]), (late positive potential: [fndg]), (emotional arousal: [menp]), (effect: []), (strategy: [menp]), ( reappraisal: []), (adaptive emotion regulation strategies: [menp]), (attenuation: [acty]), (downregulation: [moft]), (unpleasant pictures: []), (used valence-changing reappraisal operationalisation: [qnco]), (hence: []), (self-report: [resa]), (electrophysiological findings: [clna]), (this: []), 
ASD Terms: (impaired emotion regulation, 'Emotional Regulation and Control')(autism, 'Autism Phenotype')(emotion regulation strategies, 'Emotional Regulation and Control')(adaptive emotion regulation strategies, 'Emotional Regulation and Control')(impaired emotion regulation, 'Emotional Regulation and Control')

PMCID: 5964452
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (obsessive-compulsive disorder (ocd) share abnormalities: [mobd]), (hot executive functions: [npop]), (reward-based decision-making: [menp]), (temporal discounting task (td): [menp]), (studies: [lbpr]), ( however: []), (disorders: [dsyn]), (common/distinct neural profiles: [lbpr]), (such abnormalities: [cgab]), (transdiagnostic feature: []), (similar neurofunctional substrates: [sbst]), (shared phenotype: [orga]), (disorder-differential neurofunctional underpinnings: [dsyn]), (age: [orga]), (iq-matched boys: [aggp]), (asd (n: [cgab]), (ocd (n =: [mobd]), (healthy controls: []), (individually-adjusted functional magnetic resonance: [npop]), ((fmri) td task: [diap]), (brain activation: [bpoc]), (performance: [inbe]), (groups: [popg]), (boys: [aggp]), (asd: [cgab]), (choice-impulsivity: [inbe]), (ocd: [mobd]), (whole-brain between-group comparison: [popg]), (reductions: [npop]), (delayed-immediate choices: [inbe]), (right ventromedial/lateral orbitofrontal cortex: [bpoc]), (medial/inferior prefrontal cortex: [bpoc]), (cerebellum: [bpoc]), ( posterior cingulate: [bpoc]), (precuneus: [bpoc]), (immediate-delayed choices: [inbe]), ( patients: [podg]), (controls: [sbst]), (reduced activation: [acty]), (anterior cingulate/ventromedial prefrontal cortex: [bpoc]), (caudate: []), ( which: []), (trend level: [phsu]), (ocd patients: [mobd]), (inferior parietal regions: [bpoc]), (first fmri comparison: [diap]), (youth: [aggp]), (reward-based decision-making task: [menp]), (neurofunctional abnormalities: [cgab]), (td: []), (cerebellar regions: [bpoc]), (temporal foresight: []), (reward processing: [menp]), (trans-diagnostic neurofunctional deficits: [fndg]), 
ASD Terms: (obsessive-compulsive disorder share abnormalities, 'Obsessive-Compulsive Disorder')(hot executive functions, 'Executive Function')(autism spectrum disorder, 'Autism Phenotype')(obsessive-compulsive disorder, 'Obsessive-Compulsive Disorder')(obsessive-compulsive disorder, 'Obsessive-Compulsive Disorder')(obsessive-compulsive disorder relative, 'Obsessive-Compulsive Disorder')(obsessive-compulsive disorder patients, 'Obsessive-Compulsive Disorder')

PMCID: 5487747
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (medical conditions: [dsyn]), (diagnosis: [fndg]), (autism spectrum disorder (asd): [mobd]), (matched case control design: [acty]), (asd cases: [cgab]), (controls: [sbst]), (increased asd risk: [cgab]), (developmental delay: [mobd]), ( mental health: [menp]), (neurology conditions: [dsyn]), (associations: [menp]), (strong associations: [menp]), (nutrition: [fndg]), ( genetic: [topp]), (sleep conditions: [orgf]), (machine: []), (methods: []), (children: [aggp]), (asd diagnosis: [cgab]), (asd risk stratification: [cgab]), (findings: [clna]), (new evidence indicating: []), (asd: [cgab]), (disproportionate burden: []), (certain medical conditions: [dsyn]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-017-3130-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(diagnosis, 'Diagnosis')(medical conditions, 'Medications')(developmental delay, 'Learning Disorders')(neurology conditions, 'Neurologic Indications')(sleep conditions, 'Sleeping Problems')(asd diagnosis, 'Diagnosis')(certain medical conditions, 'Medications')

PMCID: 5487748
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (implicit responses: [orga]), (emotional cues: [menp]), (autism spectrum disorder (asd): [mobd]), (emotional understanding: [menp]), (temporal bisection task: [topp]), (responsiveness: []), (face: [gngm]), (wildlife images: [anim]), (emotional salience: [menp]), (significant differences: [qnco]), (adult asd: [cgab]), (comparison group: [popg]), (implicit overestimation: []), (emotional stimuli: [menp]), (further: []), (correlation: []), (overestimation: []), (autistic traits: [mobd]), (undergraduate students: [popg]), (data: [euka]), (fundamental insensitivity: [fndg]), (content: [menp]), (emotional images: [menp]), (asd: [cgab]), (individuals: [humn]), (high degree: [qnco]), (findings: [clna]), (implications: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(showing implicit overestimation of emotional stimuli, 'Showing Emotion')

PMCID: 5399393
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (numerous studies: [lbpr]), (elevated degree: [qnco]), (comorbidity: []), (autism spectrum disorder (asd): [mobd]), (comorbid conditions: [fndg]), (further impairments: [patf]), (individuals: [humn]), (autism: [mobd]), (neurotypical populations: [popg]), (high rates: [qnco]), (account: [clna]), (overlap: [topp]), (symptoms: [sosy]), (asd shares: [cgab]), (other pathologies: []), (research perspective: [resa]), (common molecular mechanisms: [qnco]), (conditions: [dsyn]), (therefore: []), (crucial genes: [gngm]), (asd: [cgab]), (comorbid disorders: [fndg]), (common biological processes: [biof]), (light: [gngm]), (understanding: [menp]), (autism etiology: [mobd]), (work: []), (two-fold systems: [phpr]), (approach: []), (biological processes: [biof]), (gene networks: [moft]), (comparative analysis: [resa]), (order: [acty]), (multi-disorder subcomponent: [dsyn]), (new genes: [gngm]), (potential relevance: []), (asd etiology: [cgab]), (predictions: []), (significance: [qnco]), (candidate genes: [gngm]), (high throughput: [qnco]), (transcriptome expression: [nusq]), (studies: [lbpr]), (prior knowledge: [evnt]), (disease-related biological processes: [dsyn]), (interaction networks: []), (disorders: [dsyn]), (set: [menp]), (genes: [gngm]), (potential etiologic relevance: []), (enriched roles: [socb]), (neurological processes: [phpr]), (optimal brain development: [ortf]), (function: [phsf]), ( learning: [menp]), (memory: [menp]), ( cognition: [menp]), (social behavior: [socb]), (novel perspective: []), (point: [qnco]), (view: []), (related comorbid disorders: [fndg]), (model: []), (genome-wide search: [gngm]), (autism candidate genes: [mobd]), (genetic heterogeneity: [orga]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s12864-017-3667-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (comorbidity, 'Comorbidities')(autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(comorbid conditions, 'Comorbidities')(comorbidity, 'Comorbidities')(autism etiology, 'Medical History')(comorbid disorders, 'Comorbidities')(autism, 'Autism Phenotype')(comorbid disorders, 'Comorbidities')(autism, 'Autism Phenotype')(neurological processes, 'Neurologic Indications')(memory, 'Working Memory')(cognition, 'Cognitive Ability')(social behavior, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(autism candidate genes, 'Autism Phenotype')(related comorbid disorders, 'Comorbidities')

PMCID: 5399341
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (range: [qnco]), (neurodevelopmental conditions: [dsyn]), (prevalence worldwide: [qnco]), (intriguingly: []), ( asd: [cgab]), (array: []), (systemic aberrations: []), ((1): [fndg]), (serotonin: [bacs,orch]), ( (2): [qnco]), (various modes: [qnco]), (gastrointestinal disorders: [dsyn]), ((3) inflammatory bowel disease (ibd): [dsyn]), (underlying cause: []), (such comorbidities: []), (also: []), (number: [qnco]), (studies: [lbpr]), (gut microbial composition: [bdsy]), (children: [aggp]), (asd: [cgab]), (patients: [podg]), (ibd: []), (surprisingly: []), (gut microbiota: [orgm]), (poly i:c: [nnon,phsu]), (vpa-induced mouse models: [mamm]), (distinct pattern: []), (microbial dysbiosis: [patf]), (clinical cases: [qnco]), (moreover: []), (such microbial dysbiosis: [patf]), (notable perturbations: []), (microbial metabolic pathways: [orgm]), (host: [orgm]), (regards: []), (pathogenesis: [patf]), (lastly: []), (serum level: [bdsu]), (vpa mice: [mamm]), (increases: [qnco]), (bacterial genus: []), (metabolic pathway: []), (stimulation: [npop]), (host serotonin production: [phsf]), (results: [fndg]), (animal model identify: [emod]), (prenatal environmental risk factors: [fndg]), (autism: [mobd]), (possible causative agents: [fndg]), (ibd-related gut: [bdsy]), (multifaceted role: [socb]), (systemic pathogenesis: [patf]), (hyperserotonemia: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13041-017-0292-0) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (neurodevelopmental conditions, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(such comorbidities, 'Comorbidities')(gastrointestinal disorders, 'Gastrointestinal Diseases')(inflammatory bowel disease, 'Inflammatory Bowel Diseases')(inflammatory bowel disease, 'Inflammatory Bowel Diseases')(bacterial genus, 'Bacterial Infections')(autism, 'Autism Phenotype')(inflammatory bowel, 'Inflammatory Bowel Diseases')

PMCID: 5573912
SFARI Genes: 
Non SFARI Genes: NDUFS4, 
Named Entities: (autism: [mobd]), (complex genetic disorder: [dsyn]), (denovo: []), (inherited genetics factors: [genf]), (role: [socb]), (next generation: [acty]), (approaches: []), (rare variants: [gngm]), (such studies: [lbpr]), (nuclear genome;: [gngm]), (mitochondrial dna (mtdna) variation: [bacs,nnon]), (autism unexplored: [mobd]), (recently: []), (analytical tools: [resa]), (mtdna: [bacs,nnon]), (wholeexome data: [euka]), (mtdna sequence: [nusq]), (wholeexome sequencing: [mbrt]), (multiplex families: [famg]), (families: [famg]), (variants: []), (interest: [menp]), (mtnd5 gene: [gngm]), (mitochondrial function: [celc]), (addition: []), (second family: [famg]), (vois; mtdna variant: [bacs,nnon]), (mtatp6: [gngm]), (nuclear dna variant: [bacs,nnon]), (ndufs4: [gngm]), (vois: []), (mitochondrial respiratory chain complex: [celc]), (findings: [clna]), (further support: []), (mitochondria: [celc]), (asd: [cgab]), (analysis: [resa]), (stage: [clna]), (further comprehensive genetic investigations: [hlca]), (autism res: [mobd]), (international society: [orgt]), (autism research: [mobd]), ( wiley periodicals: []), ( inc: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism unexplored, 'Autism Phenotype')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 5412412
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent decades: [qnco]), (autism spectrum disorder (asd): [mobd]), (diverse: []), (heterogeneous genetic etiology: [orga]), (aberrations: []), (hundreds: []), (genes: [gngm]), (asd: [cgab]), (common variations: [qnco]), (specific common molecular pathways: [moft]), (development: [orgf]), (core asd: [cgab]), (task: [gngm]), (common molecular pathways: [moft]), (several studies: [lbpr]), (genetic analysis: [lbpr]), (bioinformatical techniques: []), (molecular mechanisms: []), (autism-associated genetic aberrations: [mobd]), (recently: []), (several analysis: [resa]), (mechanisms: []), (wnt: []), (ca2+/calmodulin-signaling pathways: [aapp,bacs]), (autism-associated mutations: [mobd]), (review: []), (specific molecular pathways: [moft]), (in-depth: [gngm]), (biological roles: [socb]), (pathways: [moft]), (specific pharmacological intervention: [hlca]), (important therapeutic targets: [diap]), (treatment: [topp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5485071
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (relevant research literature: [inpr,mnob]), (hypothesis: []), (link: []), (cholesterol: [bacs,orch]), ( vitamin d: [orch,phsu,vita]), (steroid hormones: [horm,orch]), (development: [orgf]), (autisms [coleman: [mobd]), (gillberg]: []), (peer: [popg]), (literature: [inpr,mnob]), ( posits: []), (links: []), (cholesterol metabolism: [moft]), (steroid metabolism: [moft]), (findings: [clna]), (steroid abnormalities: [cgab]), (various kinds: [phsu]), (testosterone: [horm,orch,phsu]), ( estrogens: [horm,orch,phsu]), ( progesterone: [horm,orch,phsu]), ( vitamin d): [orch,phsu,vita]), (autism spectrum disorder (asd): [mobd]), (further research: [resa]), (potential links: []), (understanding: [menp]), (biological mechanisms: []), (asd: [cgab]), (autism res: [mobd]), (autism research: [mobd]), (wiley periodicals: []), ( inc: []), (behalf: []), (international society: [orgt]), ( wiley periodicals: []), 
ASD Terms: (vitamin d, 'Dietary Supplements')(vitamin d, 'Dietary Supplements')(autisms, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 5409610
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (altered immune functioning: [ortf]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (current study: [resa]), (relationship: []), (immune functioning: [ortf]), (asd traits: [cgab]), (healthy young adults: [aggp]), (n: [aapp,imft]), (students: [popg]), (utrecht university: [mnob,orgt]), (survey: []), (autistic traits: [mobd]), (addition: []), (rating: [acty]), (immune function questionnaire (ifq): [ortf]), (dutch translation: [moft]), (autism-spectrum quotient (aq): [qnco]), (variation: []), (domains: []), (social insights: [menp]), (behavior: [inbe]), ( difficulties: [fndg]), (change: [qnco]), ( communication: [socb]), ( phantasy: [menp]), (imagination: [menp]), (detail orientation: [menp]), (1-item perceived immune: [menp]), (score: [clna]), (total aq score: [clna]), (however: []), (significant negative correlation: [fndg]), (aq subscale difficulties: [fndg]), (change (r = 0.119: [qnco]), ( p: [aapp,imft]), (aq subscales difficulties: [fndg]), (change (r = 0.149: [qnco]), (communication (r = 0.145: [socb]), (men: [gngm]), ( none: []), (aq: []), (conclusion: []), (modest relationship: []), (several autistic traits: [mobd]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(imagination, 'Imagination')

PMCID: 5416715
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (spectrum conditions: [dsyn]), (males: [orga]), (females: [orga]), (biological basis: [phsu]), (difference: [qnco]), (primary causes: [topp]), (asc: [gngm]), (partial disconnection: [phpr]), (frontal lobe: [bpoc]), (association areas: [menp]), (development (that: [orgf]), (frontal disconnection syndrome'): [dsyn]), (therefore: []), (current study: [resa]), (frontal connectivity differs: []), (adults: [aggp]), (confirmed high-functioning asc diagnosis (61 males:: [orga]), (years;: []), (females:: [orga]), (years): []), (neurotypical controls: [sbst]), (males:: [orga]), (current asc symptoms: [sosy]), (autism diagnostic observation schedule (ados): [hlca]), (diffusion tensor imaging: [diap]), (fractional anisotropy (fa) maps: [aapp,bacs]), (created: [acty]), (mean fa values: [qnco]), (frontal fiber bundles: [anim]), (non-frontal fiber tracts: [bpoc]), (between-group differences: [popg]), (mean tract fa: [qnco]), (sex-by-diagnosis interactions: [orgf]), (additional analyses: [resa]), (ados scores: [aapp,enzy]), (influence: []), (current asc symptom severity: [fndg]), (frontal connectivity: []), (scores: [clna]), (current symptom severity: [fndg]), (tract: [bpoc]), (differences: [qnco]), (significant sex-by-diagnosis effects: [orgf]), (frontal tracts: [bpoc]), (account: [clna]), (findings: [clna]), (observed power: [hcpp]), (analyses: [resa]), (frontal connectivity abnormalities: [cgab]), (sex differences: [orga]), (behavioral phenotype: [bhvr]), 
ASD Terms: (autism spectrum conditions, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(confirmed high-functioning autism spectrum conditions diagnosis, 'Diagnosis')(current autism spectrum conditions symptoms, 'Complaints and Indications')(autism diagnostic observation schedule, 'Autism Phenotype')(current autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')

PMCID: 5387247
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (chromosome: [celc]), (syndrome: [dsyn]), (rare chromosomal disorder: [celc]), (early onset refractory: [fndg]), (epilepsy: [dsyn]), ( intellectual disability: [mobd]), ( autism spectrum disorder: [mobd]), (number: [qnco]), (diverse health issues: [fndg]), (aim: [phsu]), (work: []), (recommendations: []), (diagnosis: [fndg]), (management: [hlca]), (persons: [popg]), (evidence: []), (literature: [inpr,mnob]), (experience: [menp]), (health professionals: []), (different medical backgrounds: [hlca]), (several years subjects: [humn]), (literature search: [inpr,mnob]), (original papers: []), (meta-analyses: [resa]), ( reviews: []), ( books: []), (guidelines: []), (final recommendations: []), (consensus: [socb]), (conventional cytogenetics: []), (primary tool: [topp]), (ring chromosome: [celc]), (children: [aggp]), (terminal deletion: [genf]), ((cgh/snp array): [dsyn]), (presence: [qnco]), (early diagnosis: [diap]), (order: [acty]), (social assistance: [socb]), (multidisciplinary team: [hlca]), (clinical investigations: [resa]), (neurophysiology: [phsf]), ( patients: [podg]), (relatives/caregivers: [famg]), (regular care: [acty]), (health: []), (social issues: [socb]), (onset: [qnco]), (anticonvulsive therapy: [topp]), (likewise: []), (difficulties: [fndg]), (need: []), (nutritional assessment: [diap]), (patients: [podg]), (nutritional support: [topp]), (malnourishment: [dsyn]), (cases: [qnco]), (autistic traits: [mobd]), (many patients: [podg]), (ability: [orga]), (effort: [orgf]), (autonomy: []), 
ASD Terms: (rare chromosomal disorder, 'Down Syndrome')(early onset refractory, 'Onset of Symptoms')(epilepsy, 'Epilepsy')(intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(diagnosis, 'Diagnosis')(different medical backgrounds, 'Medications')(early diagnosis, 'Diagnosis')(epilepsy, 'Epilepsy')(social issues, 'Social Competence')(onset with anticonvulsive therapy, 'Onset of Symptoms')(onset, 'Onset of Symptoms')

PMCID: 5384197
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (association: [menp]), (use: []), (assisted reproductive technology (art): [topp]), (autism spectrum disorder (asd) risk: [mobd]), (several studies: [lbpr]), (result: [fndg]), (risk: []), (asd: [cgab]), (relation: [socb]), (art: [gngm]), (meta-analysis: [resa]), (literature search: [inpr,mnob]), (pubmed: []), ( embase: []), (web: []), (knowledge databases: []), (april: [gngm]), (relevant records: []), (risk ratios (rrs): [qnco]), (confidence intervals: [qnco]), (strength: [qnco]), (random-effect models: [resa]), (heterogeneity test: [orga]), (subgroup analyses: [resa]), (analysis: [resa]), (records: [qnco]), ((3 cohort studies: [qnco]), (case-control studies): [resa]), (percentage: [qnco]), (asd (rr: [cgab]), (ci:: [lbpr]), (p: [gngm]), (addition: []), ( subgroup analyses: [resa]), (study design: [resa]), ( study location: [blor]), (study quality: [resa]), (conducted: [inbe]), (subgroups: [virs]), (significant association: [menp]), (study: [resa]), (offspring: [famg]), (however: []), (high-quality studies: [lbpr]), 
ASD Terms: (autism spectrum disorder risk, 'Autism Phenotype')(offspring, 'Perinatal History')

PMCID: 5384041
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (human studies: [humn]), (sleep impairment: [orgf]), (concurrent comorbidity: []), (autism spectrum disorders: [mobd]), (etiology: []), (prominent theories: []), (asd: [cgab]), (imbalance: [sosy]), (synaptic excitation/inhibition: [acty]), (various aspects: [qnco]), (sleep impairments: [orgf]), (identification: [menp]), (nlgn3r451c mutation: [genf]), (patients: [podg]), (effects: []), (synaptic transmission: [celf]), (social behaviours: [socb]), (mouse model: [emod]), (however: []), (contributory role: [socb]), (mutation: [genf]), (impairments: [patf]), (study: [resa]), (nlgn3r451c knock-in mice: [mamm]), (genetic model: []), (normal duration: [phsu]), (distribution: []), (sleep/wake states: [orgf]), (electroencephalography (eeg) power: [diap]), (spectral profiles: [lbpr]), (wake: [phsf]), (sleep: [orgf]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(concurrent comorbidity, 'Comorbidities')(sleep impairment, 'Sleeping Problems')(sleep impairments, 'Sleeping Problems')(social behaviours, 'Reciprocal Social Interaction')(sleep impairments in asd, 'Sleeping Problems')

PMCID: 5416693
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mental disorders: [mobd]), (intellectual disability (id): [mobd]), ( autism spectrum disorders: [mobd]), (strong genetic component: [gngm]), (recently: []), (many gene mutations: [genf]), (id: [lbpr]), ( asd: [cgab]), (schizophrenia: [mobd]), (high-throughput sequencing: [mbrt]), (substantial fraction: [qnco]), (mutations: [genf]), (genes: [gngm]), (transcriptional regulators: [genf]), (different mds: [gngm]), (same gene: [gngm]), (regulatory network: [popg]), (information: []), (molecular relation: [socb]), (mds: [gngm]), (physical interaction: [moft]), (strong predictor: []), (cooperation: [socb]), (gene regulation: [genf]), (here: []), (neural stem cells: [cell]), (interaction partners: [popg]), (mass spectrometry: [lbpr]), (protein interaction network: []), (proteins: [aapp,bacs]), (md patients: [podg]), (variation: []), (humans: [humn]), (network: [popg]), (molecular connections: []), (md proteins: [aapp,bacs]), (discovery tool: [acty]), (novel md genes: [gngm]), (genome: [gngm]), (cooperate: []), (disease-relevant gene regulation: [genf]), (results: [fndg]), (observed transcriptional regulators: [genf]), (part: [qnco]), (transcriptional network: [moft]), (severe mutations: [genf]), (network proteins: [popg]), (intelligence quotient (iq): [orga]), (level: [phsu]), (disruption: []), (transcriptional network correlates: [moft]), (cognitive dysfunction: [mobd]), 
ASD Terms: (mental disorders, 'Mental Disorders')(intellectual disability, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(different mental disorders, 'Mental Retardation')(cognitive dysfunction, 'Cognitive Ability')(intelligence quotient, 'IQ')

PMCID: 5379648
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (shared: [socb]), (genetic influences: [topp]), (attention-deficit/hyperactivity disorder (adhd) symptoms: [mobd]), (autism spectrum disorder (asd) symptoms: [mobd]), (cross-trait: [orga]), (genetic relationships: [topp]), (however: []), ( subject: [humn]), (dynamic changes: [qnco]), (development: [orgf]), (continuity: []), (genetic overlap: [topp]), (asd: [cgab]), (adhd symptoms: [mobd]), (general population sample: [popg]), (childhood: []), (adolescence: []), (cross-dimensional trait-disorder links: [dsyn]), (respect: [socb]), (genetic adhd: [mobd]), (asd risk: [cgab]), (social-communication difficulties: [socb]), (social: []), (communication disorders checklist: [mobd]), ( scdc): []), (hyperactive-impulsive/inattentive adhd symptoms (n: [mobd]), (strengths: []), (difficulties questionnaire: [fndg]), ( sdq-adhd): [mobd]), (uk birth cohort (alspac: [qnco]), ( age: [orga]), (years): []), (genome-wide summary statistics: [gngm]), (clinical asd (5305 cases;: [cgab]), (pseudo-controls): [sbst]), (adhd (4163: [mobd]), (controls/pseudo-controls): [sbst]), (psychiatric genomics consortium: [hlca]), (genetic trait variances: [npop]), (phenotypes: [orga]), (genome-wide data: [gngm]), (general population: [popg]), (scdc: []), (sdq-adhd scores: [mobd]), (genetic correlations: [topp]), (traits: [gngm]), (similar strength: [qnco]), (magnitude: [qnco]), ((cross-trait r g: [qnco]), (p min: [neop]), (measures: [qnco]), (same trait: [orga]), ((within-trait r g: [qnco]), (later adolescence: []), (variants: []), (k-ras signalling: [gngm]), (upregulated genes: [gngm]), (population-based trait: [popg]), (behavioural continuum: risk-increasing alleles: [gngm]), (clinical adhd: [mobd]), ((marginal regression r: [menp]), (age-specific genetic overlap: [topp]), (clinical asd: [cgab]), (previous reports: [hlca]), (cross-dimensionally: []), ( however: []), (genetic risk: [qnco]), (disorder: [dsyn]), (genetic aetiologies: [topp]), (child: [aggp]), (adolescent development: [fndg]), (similar biological pathways: [moft]), (adhd: [mobd]), (population-based traits: [popg]), (clinical disorder: [dsyn]), (clinical discovery samples: [sbst]), (detect cross-dimensional trait-disorder relationships: [fndg]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0131-2) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (attention-deficit/hyperactivity disorder symptoms, 'Attention Deficit Disorder with Hyperactivity')(autism spectrum disorder symptoms, 'Complaints and Indications')(genetic attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(hyperactive-impulsive/inattentive attention-deficit/hyperactivity disorder symptoms, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(clinical attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder dimension, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 5379515
SFARI Genes: 
Non SFARI Genes: TRRAP, ZNF236, 
Named Entities: (childhood: []), (disintegrative disorder (cdd): [dsyn]), (rare form: [gngm]), (autism spectrum disorder (asd): [mobd]), (unknown etiology: [fndg]), (late-onset regression: [menp]), (significant intellectual disability (id): [mobd]), (severe autism: [fndg]), (phenotypic differences: [orga]), (cdd: [gngm]), (other forms: []), (asd: [cgab]), (neurobiological differences: [qnco]), (multidisciplinary study: [resa]), (cdd (n =: [aapp,imft]), (comparison: [acty]), (low-functioning asd (n: [cgab]), (high-functioning asd (n =: [cgab]), ((n: [aapp,imft]), (individuals: [humn]), (whole-exome sequencing (wes): [mbrt]), (number: [qnco]), (variant (cnv): [nusq]), (gene expression analyses: [mbrt]), (cdd and: [gngm]), (subsets: []), (cohort: [popg]), (non-sedated functional magnetic resonance: [npop]), ((fmri): [diap]), (socioemotional (faces): [blor]), (non-socioemotional (houses) stimuli: [phpr]), (eye: [bpoc]), (emotional faces: [blor]), (potential differences: [qnco]), (wes: [mbrt]), (cnv analyses: [nusq]), (homozygous: [orga]), (hemizygous (mother-to-son transmission: [patf]), (chrx) variants: []), (probands: [orga]), (unaffected sibling controls: [famg]), (deleterious variants: []), (recurrent candidate genes: [gngm]), (candidate genes: [gngm]), (variant position: []), (variation: []), (trrap: [gngm]), ( znf236: [gngm]), (kiaa2018: [gngm]), (role: [socb]), (transcription: [genf]), (human brainspan transcriptome dataset: [humn]), ( cdd candidate genes: [gngm]), (non-neocortical regions: []), (neocortical regions: []), (expression profile: [lbpr]), (independent cohort: [popg]), (asd probands: [cgab]), (regression: [menp]), (fmri: [diap]), (response: [fndg]), (faces: [blor]), (thalamus: [bpoc]), ( cerebellum: [bpoc]), ( caudate: []), (hippocampus: [bpoc]), (eye-tracking analysis: [bpoc]), (that: []), ( subjects: [humn]), (eyes: [bpoc]), (pictures: []), (cohort sizes: [popg]), (rarity: [gngm]), (challenges: [hlca]), (non-sedated fmri: [diap]), (eye tracking: [bpoc]), (subjects: [humn]), (significant id: [lbpr]), (exploratory study: [resa]), (neurobiological features: []), (addition: []), (first multimodal analysis: [diap]), (combination: [fndg]), (eye-tracking analyses: [bpoc]), (first time: [qnco]), (low-functioning individuals: [humn]), (results: [fndg]), (differences: [qnco]), (clinical level: [phsu]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0133-0) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')(significant intellectual disability, 'Learning Disorders')(severe autism, 'Autism Phenotype')(eye tracking in subjects, 'Eye Contact')(eye tracking, 'Eye Contact')

PMCID: 5609623
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract autism spectrum disorder: [mobd]), (heterogeneous disorder: [fndg]), (identification: [menp]), (etiological factors: []), (patient and: [podg]), (genetic counseling: [topp]), (families: [famg]), (risk: []), (however: []), (last decades: [qnco]), (remarkable advances: []), (knowledge: []), (genetic aspects: []), (autism: [mobd]), (molecular research: [resa]), (development: [orgf]), (new molecular diagnostic tools: [lbpr]), (scenario: []), (nowadays: []), (available molecular tests: [lbpr]), (potential underlying genetic cause: [topp]), (cases: [qnco]), (clinical assessment: [hlca]), (prenatal history evaluation: [hlca]), (investigation: [hlca]), (etiological explanation: []), (disease: [dsyn]), (patients: [podg]), (therefore: []), (view: []), (current knowledge: [npop]), (genetic architecture: [topp]), (autism spectrum disorder: [mobd]), (precise genetic counseling: [topp]), (potential benefits: [qnco]), (etiological investigation: [hlca]), ( molecular genetic investigation: [hlca]), (here: []), (current view: [npop]), (list: []), (key aspects: [qnco]), 
ASD Terms: (abstract autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5496724
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract objective:: []), (perinatal features: []), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (methods: retrospective review: [resa]), (medical records: [clna]), (asd: [cgab]), (january: []), (inclusion criteria: []), (diagnosis: [fndg]), (dsm-5 criteria: []), (informed consent form: []), (person: [grup]), (exclusion criterion: [acty]), (medical record: []), (variables: []), (maternal age: []), ( prematurity: [dsyn]), ((gestational age: [orga]), (weeks): []), (low birth weight (<2: [fndg]), (500 g): [qnco]), (perinatal asphyxia (5th minute apgar score <7): [orga]), (data: [euka]), (difference: [qnco]), (proportions: [qnco]), (significant p<0.05: [fndg]), (results:: [fndg]), (seventy-five patients: [podg]), (years: []), (years): []), (premature birth: [fndg]), ((18.7%) patients: [podg]), (perinatal asphyxia: [patf]), ((8.0%): [fndg]), (low birth weight: [fndg]), ((42.6%) patients: [podg]), (prevalence: [qnco]), (prematurity: [dsyn]), (study: [resa]), (general prevalence: [qnco]), (conditions: [dsyn]), (live births: []), (country: []), ( region: []), (state: []), (respectively: []), (brazil;: []), (southern brazil;: []), (paran: []), (conclusions:: []), (findings: [clna]), (limitations: []), (retrospective study design: [resa]), (small sample size: [qnco]), (large prospective studies: [resa]), (possible association: [menp]), (perinatal complications: [patf]), 
ASD Terms: (analyze perinatal features, 'Perinatal Exposures')(perinatal features, 'Perinatal Exposures')(autism spectrum disorder, 'Autism Phenotype')(medical records, 'Medications')(diagnosis, 'Diagnosis')(medical record, 'Medications')(perinatal asphyxia, 'Perinatal Exposures')(perinatal asphyxia, 'Perinatal Exposures')(perinatal asphyxia, 'Perinatal Exposures')(perinatal complications, 'Perinatal Exposures')

PMCID: 5374665
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (environmental exposures: [inpo]), (immune conditions: [dsyn]), (pregnancy: [orgf]), (development: [orgf]), (autism spectrum disorder (asd): [mobd]), (offspring: [famg]), (however: []), (few studies: [lbpr]), (immune-triggering exposures: [clna]), (relation: [socb]), (association: [menp]), (parental workplace exposures: [phpr]), (factors: []), (asthma (asthmagens): [dsyn]), (asd: [cgab]), (population-based case-control study: [resa]), (danish population: [popg]), (linkage: [moft]), (study population: [popg]), (asd cases: [cgab]), (controls: [sbst]), (cases: [qnco]), (icd-10 codes: []), (danish psychiatric central register: [lbpr]), (parental danish international standard classification: []), (occupations: []), ((disco-88) job codes: [mcha]), (parental occupational asthmagen exposure: [inpo]), (disco-88 codes: []), (asthma-specific job-exposure matrix: [dsyn]), (maternal analyses: [resa]), (case mothers: [famg]), (control mothers: [famg]), (pregnancy period: [fndg]), (weak inverse association: [sosy]), (maternal occupational asthmagen exposure: [inpo]), (sociodemographic covariates: []), (or:: []), (ci:: [lbpr]), (analyses: [resa]), (employed fathers: [famg]), ( paternal occupational asthmagen exposure: [inpo]), (null association: [menp]), (paternal occupational exposure: [inpo]), (estimate: [qnco]), (unmeasured confounding: []), (effect: []), (null: [qnco]), (overall: []), (results: [fndg]), (positive association: [menp]), (parental asthmagen exposure: [clna]), (children: [aggp]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s12940-017-0230-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (immune conditions during pregnancy, 'Pregnancy Complications')(autism spectrum disorder, 'Autism Phenotype')(environmental exposures, 'Exposures')(offspring, 'Perinatal History')(immune-triggering exposures, 'Exposures')(parental workplace exposures, 'Exposures')(asthma, 'Asthma')(occupations job codes, 'Job Performance')(occupations codes, 'Job Performance')(parental occupational asthmagen exposure, 'Exposures')(maternal occupational asthmagen exposure, 'Exposures')(paternal occupational asthmagen exposure, 'Exposures')(paternal occupational asthmagen exposure, 'Exposures')(maternal occupational asthmagen exposure, 'Exposures')(paternal occupational exposure, 'Exposures')(parental asthmagen exposure, 'Exposures')

PMCID: 5372175
SFARI Genes: CNTNAP2, CNTNAP2, DPP4, DPP4, CNTNAP2, CNTNAP2, CNTNAP2, CNTNAP2, 
Non SFARI Genes: TRHR, MLF1, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (ritualistic-repetitive behaviors: []), (impaired verbal/non-verbal communication: [fndg]), (many asd susceptibility genes: [cgab]), (neuronal pathways/brain development: [ortf]), (lebanese population: [popg]), (recessive genes: [gngm]), (shared ancestry: [socb]), (high rate: [qnco]), (consanguineous marriages: [fndg]), (aims: [phsu]), (asd genes: [cgab]), (uncover novel: []), (asd susceptibility genes: [cgab]), (lebanese: [popg]), (asd families: [cgab]), (unaffected parents:: []), (unaffected siblings:: [famg]), (unaffected lebanese controls: [sbst]), (cytogenetics: []), (m microarrays/cytoscan hd: [aapp,imft]), (mapping: [acty]), (homozygous regions: [orga]), (genome: [gngm]), (cntnap2 gene: [gngm]), (sanger sequencing: [mbrt]), (homozygosity mapping: [orga]), (dpp4: [gngm]), ( trhr: [gngm]), (mlf1: [gngm]), (novel candidate susceptibility genes: [clna]), (asd: [cgab]), (hot spot exons: [bacs,nnon]), (cntnap2: [gngm]), (discovery: [acty]), (bp insertion: [genf]), (asd patients: [cgab]), (mutation: [genf]), (unaffected family members: [famg]), (slight increase: []), (number: [qnco]), (family members: [famg]), (significant differences: [qnco]), (allele frequencies: [qnco]), (affecteds: []), (controls: [sbst]), (2 value: [qnco]), (p: [gngm]), (cntnap2 polymorphism: [aapp,bacs]), (population: [popg]), ( hence: []), (asd phenotype: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(asd phenotype, 'Autism Phenotype')

PMCID: 5368984
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (alterations: []), (microbiota-gut-brain axis: [orgm]), (pathogenesis: [patf]), (autism spectrum disorders: [mobd]), (mouse models: [mamm]), (excellent tool: []), (gut dysbiosis: [patf]), (related alterations: [fndg]), (autistic phenotype: [mobd]), (study: [resa]), (gut microbiota (gm): [orgm]), (behavioral characteristics: [inbe]), (intestinal integrity: [bpoc]), (immunological features: []), (colon tissues: [bpoc]), (btbr t + tf/j (btbr): [aapp,imft]), (animal model: [emod]), (asd: [cgab]), (sex: [orgf]), (date: []), (animal models: [anim]), (results: [fndg]), (btbr mice: [mamm]), (sexes: [orgf]), (marked intestinal dysbiosis: [patf]), ( alterations: []), (behavior: [inbe]), ( gut permeability: [npop]), (immunological state: []), (respect: [socb]), (prosocial c57bl/6j (c57) strain: [mamm]), (noticeably: []), (sex-related differences: [orga]), (bacteroides: [bact]), ( parabacteroides: [bact]), ( sutterella: [bact]), ( dehalobacterium: [bact]), (oscillospira genera: [bact]), (key drivers: [popg]), (sex-specific gut microbiota profiles: [orgm]), (pathological traits: [gngm]), (findings: [clna]), (alteration: []), (gm: [gngm]), (btbr mice shows: [anim]), (sex-associated differences: [orga]), (use: []), (btbr mouse model: [mamm]), (autism: [mobd]), (microbiota-gut-brain axis alteration: [orgm]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(dissect autism, 'Autism Phenotype')

PMCID: 5363048
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (large controversy: [socb]), (potential existence: []), (clinical significance: [fndg]), (brain volumes: [qnco]), (toddlers: [aggp]), (autism: [mobd]), (relationship: []), (clinical utility: [orgt]), (early head circumference: [clna]), ((hc) measures: [horm,orch,phsu]), (validity: [qnco]), (early overgrowth hypothesis: [fndg]), (brain development: [ortf]), (hallmark: []), (disorder: [dsyn]), (retrospective comparison: [resa]), (hc: [gngm]), ( height: [orga]), (weight measurements: [qnco]), (controls: [sbst]), (unbiased regional sample: [sbst]), (single health service provider: [fndg]), (southern district: []), (israel: []), (average: [qnco]), (measurements: []), (birth: [orgf]), (age: [orga]), (two: [qnco]), (individual hc: [horm,orch,phsu]), (weight development: [orga]), (high precision: [qnco]), (negative exponential growth model: [orgf]), (data: [euka]), (toddler: [gngm]), (exceptional accuracy: []), (analyses: [resa]), (hc sizes: [horm,orch,phsu]), (growth rates: []), (autism group: [mobd]), (verbal capabilities: []), (time: []), (diagnosis: [fndg]), (addition: []), (significant correlations: [qnco]), (ados scores: [aapp,enzy]), (time-point: []), (years: []), (life: []), (negative results: [fndg]), (evidence: []), (brain volume: [qnco]), (results: [fndg]), (other studies: [lbpr]), (small sample sizes: [sbst]), ( use: []), (population norms: [popg]), ( changes: [qnco]), (clinical definition: []), ( and/or inclusion: [celc]), (individuals: [humn]), (syndromic autism: [mobd]), (large brains: [bpoc]), (mri scans: [qnco]), (common etiology: [qnco]), (entire autism population: [mobd]), (early hc measures: [horm,orch,phsu]), ( therefore: []), (limited clinical utility: [orgt]), (assessment: [acty]), (autism risk: [mobd]), (general population: [popg]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0129-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')(autism group, 'Autism Phenotype')(diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')(syndromic autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(entire autism population, 'Autism Phenotype')(autism risk, 'Autism Phenotype')

PMCID: 5491690
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (parvalbumin: [aapp,bacs]), (inhibitory interneurons: [cell]), (proper excitatory/inhibitory balance: [acty]), (high-frequency neuronal synchronization: [imft]), (activity: [acty]), (critical developmental trajectories: [orgf]), ( sensory: []), (cognitive processing: [menp]), (social behavior: [socb]), (heterogeneity: [orga]), (etiology: []), (schizophrenia: [mobd]), (autism spectrum disorder: [mobd]), ( pvi circuits: [topp]), (psychiatric disorders: [mobd]), (mechanism(s): []), (pvi deficits: [topp]), (treatments: [topp]), (particular cognition: [menp]), (basis: [phsu]), (new data: [euka]), (oxidative stress: [comd]), (common pathological mechanism: [qnco]), (pvi impairment: [patf]), (forms: []), (autism: [mobd]), (series: [qnco]), (animal models: [anim]), (genetic and/or: [topp]), (environmental risks: []), (etiological aspects: []), (disorders: [dsyn]), (anterior cingulate cortex: [bpoc]), (specifically: []), (integrity: [inbe]), (pvis: [topp]), (extracellular perineuronal net: [celc]), (interneurons: [cell]), (dysregulation: []), (systems: []), (glutamatergic: []), ( dopaminergic: [bacs,orch,phsu]), ( immune: []), (antioxidant signaling: [phsu]), (convergent end point: [qnco]), ( redox dysregulation: [moft]), (antioxidants/redox regulators: [phsu]), (several animal models: [anim]), (new perspectives: []), (use: []), (antioxidant treatments: [phsu]), (at-risk individuals: [humn]), (close temporal proximity: [fndg]), (environmental impacts: [phpr]), 
ASD Terms: (cognitive processing, 'Cognitive Ability')(social behavior, 'Reciprocal Social Interaction')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorder, 'Autism Phenotype')(psychiatric disorders, 'Mental Disorders')(particular cognition, 'Cognitive Ability')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')

PMCID: 5416665
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (altered sensory processing: [ortf]), (many children: [aggp]), (autism spectrum disorder (asd): [mobd]), (evidence: []), (impairments: [patf]), (integration: [genf]), (information: []), (different senses: [ortf]), (multisensory function): [phsf]), (serotonin system: [bacs,orch]), (important role: [socb]), (sensory development: [orgf]), (function: [phsf]), (alterations: []), (role: [socb]), (asd: [cgab]), (gain-of-function: [phsf]), (variant: []), (serotonin transporter (sert): [aapp,bacs]), (sensory aversion: [orch,phsu]), (humans: [humn]), (mice produces traits: [mamm]), (disruptions: []), (communicative function: [phsf]), (repetitive behaviors: [fndg]), (current study: [resa]), (mice: [mamm]), (changes: [qnco]), (multisensory function: [phsf]), (wild-type (wt) animals: [anim]), (same genetic background: [orga]), (visual stimuli: [ortf]), (visual: []), ( auditory: []), (audiovisual (multisensory) conditions: [dsyn]), (wt mice: [mamm]), (significant gains: [qnco]), (response accuracy: [fndg]), (audiovisual conditions: [dsyn]), (contrast: [irda]), (sert mutant animals: [anim]), (auditory: []), (visual tasks: []), (wt littermates: [fish]), (behavioral gains: [inbe]), (multisensory conditions: [dsyn]), (results: [fndg]), (first behavioral evidence: [inbe]), (multisensory deficits: []), (genetic mouse model: [mamm]), (multisensory processing: [acty]), (multisensory changes: [qnco]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(communicative function, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(visual stimuli, 'Visual Thinking')(visual, 'Visual Thinking')(show behavioral gains under multisensory conditions, 'Personal Traits')(visual tasks, 'Visual Thinking')(first behavioral evidence of multisensory deficits, 'Personal Traits')

PMCID: 5361831
SFARI Genes: USP15, USP15, FMRP, FMRP, USP15, USP15, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (heritable neuropsychiatric disorders: [dsyn]), (molecular mechanisms: []), (extreme locus heterogeneity: []), (meaningful endophenotypes: []), (biomarkers: [clna]), (effective strategy: [menp]), (heterogeneity: [orga]), (novel asd genes: [cgab]), (numerous lines: [qnco]), (evidence: []), (link: []), (hyperserotonemia: []), ( i.e.: [diap,inpr]), (whole blood: [bdsu]), (asd: [cgab]), (however: []), (genetic determinants: [topp]), (blood: [bdsu]), (5-ht level: [bacs,orch]), (relationship: []), (study: [resa]), (hypothesis: []), (variants: []), (rare risk alleles: [gngm]), (recessive mode: [qnco]), (important role: [socb]), (predisposition: [clna]), (people: [popg]), (whole exome: [gngm]), ((wes): [mbrt]), (asd parent-proband trios: [cgab]), ((107) probands: [orga]), (5-ht measurements: [bacs,orch]), (asd dnvs: [cgab]), (usp15: [gngm]), (recurrent: []), (loss: [qnco]), (function mutations: [phsf]), (genes: [gngm]), (recurrent dnvs (foxp1: [gngm]), (kdm5b): [gngm]), (functional dnvs: []), (functional/disease gene sets: [gngm]), (fmrp targets: [aapp,bacs]), (synaptic formation: [biof]), (transcriptional regulation genes: [gngm]), (probands: [orga]), (high-5ht: [bacs,orch]), (normal-5ht groups: [bacs,orch]), (normalized serotonin levels: [bacs,orch]), (network-based gene: [gngm]), (enrichment analysis (ngsea): [resa]), (novel hyperserotonemia-related asd genes: [cgab]), (lof: []), (missense dnvs: [fndg]), (enrichment: []), (high-5ht group: [bacs,orch]), (gene network: [moft]), (points: [qnco]), (tgf- pathway: [aapp,bacs]), (cell junction processes: [celc]), (analysis: [resa]), (rare compound: [chem]), (loci: [gngm]), (asd-associated gene set: [cgab]), (rare variant group-wise transmission disequilibrium tests: [dsyn]), (significant association: [menp]), (rare variants: [gngm]), (subset: []), (serotonin pathway: [bacs,orch]), (novel gene: [gngm]), (recurrent dnvs: []), (potential value: [qnco]), (effective endophenotype: []), (gene discovery: [mbrt]), (effectiveness: []), (strategy: [menp]), (studies: [lbpr]), (sample sizes: [sbst]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0130-3) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5370427
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (purpose: []), (study: [resa]), (values: []), (mean platelet volume (mpv): [lbpr]), (children: [aggp]), (attention deficit hyperactivity disorder (adhd): [mobd]), (autism spectrum disorders: [mobd]), (risk: []), (cardiovascular disease: [dsyn]), (disorder groups: [dsyn]), (material/: [sbst]), (total: [qnco]), (patients: [podg]), (adhd: [mobd]), (asds: [cgab]), (controls: [sbst]), (van region: []), (turkey: [bird]), (control group: [grup]), (subjects: [humn]), (age: [orga]), (sex: [orgf]), ( asds: [cgab]), (chronic disease: [dsyn]), (vitamins: [orch,phsu,vita]), (hematological parameters: [fndg]), (mpv: [lbpr]), ( vitamin b12: [orch,phsu,vita]), (vitamin d: [orch,phsu,vita]), (assessed: [acty]), (adolescents: [aggp]), (years: []), ((32 females: [orga]), (males): [orga]), (adhd group: [mobd]), (asds group: [cgab]), (significant difference: [qnco]), (groups: [popg]), (significant differences: [qnco]), (terms: [orgf]), (vitamin b12: [orch,phsu,vita]), (patient groups: [popg]), (levels: []), (negative correlation: [fndg]), (mpv (p<0.05): [lbpr]), (partial correlation analysis: [inpr,resa]), (particular: []), (d: [aapp,imft]), (b12 (p:: [gngm]), (presence: [qnco]), (d deficiency: [aapp,imft]), (own characteristics: []), (therefore: []), (disorders: [dsyn]), 
ASD Terms: (cardiovascular disease, 'Cardiovascular Diseases')(attention deficit hyperactivity disorder, 'Overactivity')(autism spectrum disorders, 'Autism Phenotype')(attention deficit hyperactivity, 'Overactivity')(vitamins, 'Dietary Supplements')(vitamin b12, 'Dietary Supplements')(vitamin d, 'Dietary Supplements')(attention deficit hyperactivity disorder group, 'Overactivity')(vitamin b12, 'Dietary Supplements')(cardiovascular disease, 'Cardiovascular Diseases')(vitamin b12, 'Dietary Supplements')

PMCID: 5357816
SFARI Genes: CHD8, CHD8, CHD8, CHD8, TCF4, CHD8, TCF4, CHD8, CHD8, CHD8, TCF4, TCF4, CHD8, CHD8, DLX1, DLX1, 
Non SFARI Genes: DLX6-AS1, 
Named Entities: (chd8 (chromodomain: [gngm]), (dna-binding protein: [aapp,bacs]), (codes: []), (member: [popg]), (chd family: [famg]), (atp-dependent chromatin-remodeling factors: [aapp]), (genes: [gngm]), (autism spectrum disorders: [mobd]), (exome-sequencing studies: [lbpr]), (loss: [qnco]), (function mutations: [phsf]), (gene: [gngm]), (schizophrenia (sz): [mobd]), (intellectual disabilities: [mobd]), (influence cancer cell proliferation: [celf]), (rna-seq analysis: [nusq]), (neural progenitor cells: [cell]), (monolayer neurons: [cell]), (induced pluripotent stem (ips) cells: [cell]), (chd8 knockout (ko) alleles: [gngm]), (crispr-cas9 gene editing: [nnon]), (significant number: [qnco]), (asd: [cgab]), (sz: [sosy]), (comparison: [acty]), (heterozygous ko lines (chd8 +/) vs isogenic controls: [orga]), (bipolar disorder (bd) candidate gene tcf4: [aapp,bacs]), (chd8 +/: [gngm]), (neuronal cells: [cell]), (current study: [resa]), ( rna-seq: [nusq]), (isogenic control (chd8 +/+): [gngm]), (cerebral organoids: [tisu]), (3-dimensional structures: []), (ips cells: [cell]), (human telencephalon: [humn]), (tcf4 expression was: [aapp,bacs]), (pathway analysis: []), (genes (degs): [gngm]), (enrichment: []), (neurogenesis: [orgf]), ( neuronal differentiation: [fndg]), ( forebrain: [bpoc]), (development: [orgf]), ( wnt/-catenin signaling: [celf]), (axonal guidance: [celf]), (previous study: [resa]), (npcs: []), (significant overlap: [topp]), (chd8 +/ degs: [gngm]), (transcriptome analysis: [lbpr,mbrt]), (group: [popg]), (family: [famg]), (idiopathic asd: [cgab]), (top deg: [qnco]), (respective studies: [lbpr]), (non-coding rna dlx6-as1: [nnon]), (studies; dlx6-as1: [gngm]), (expression: [topp]), (members: [popg]), (dlx: []), ((distal-less homeobox) gene family: [gngm]), (dlx1: [gngm]), (studies: [lbpr]), (dlx genes code: [gngm]), (transcription factors: [aapp,bacs]), (key role: [socb]), (gabaergic interneuron differentiation: [celf]), (transcriptome study: [nusq]), (ips cell-derived neurons: [cell]), (patients: [podg]), (bd: []), (condition: [dsyn]), (dysregulated wnt/-catenin signaling: [celf]), (subgroup: [virs]), (affected individuals: [humn]), (findings: [clna]), (distinct asd: [cgab]), ( sz: [sosy]), (genes converge: [gngm]), (common molecular targetsan: [qnco]), (important consideration: [fndg]), (novel therapeutics: [orch,phsu]), (heterogeneous complex traits: [orga]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0124-1) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (chd family, 'Congenital Heart Defects')(autism spectrum disorders, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(intellectual disabilities, 'Learning Disorders')(schizophrenia candidate genes, 'Schizophrenia and Disorders with Psychotic Features')(bipolar disorder candidate gene tcf4, 'Bipolar Disorder')(bipolar disorder, 'Bipolar Disorder')(bipolar disorder candidate genes converge, 'Bipolar Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 5372671
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (heterogeneity: [orga]), (genetics: []), (clinical presentation: []), ( dysfunction: [dsyn]), (mechanistic target: [diap]), (rapamycin: [antb,orch]), ((mtorc1): [celc]), (pathway: [moft]), (molecular feature: []), (several well-characterized syndromes: [dsyn]), (high prevalence: [qnco]), (asd: [cgab]), (additionally: []), (recent findings: [clna]), (mtorc1: [celc]), (abnormalities: [cgab]), (subset: []), (nonsyndromic asd: [cgab]), (defective mtorc1 pathway: [celc]), (potential converging mechanism: [acty]), (asd pathology: [cgab]), (different etiologies: []), (however: []), (mechanistic evidence: []), (causal link: []), (pathway activity: [acty]), (neurobehavioral features varies: []), (asd form involved: [cgab]), (review: []), (monogenic asd-related syndromes: [cgab]), (novel mtoropathies: []), (contribution: [acty]), (understanding: [menp]), (neurobiological mechanisms: []), (evidence: []), (aberrant mtorc1: [celc]), (role: [socb]), 
ASD Terms: (autism spectrum disorder exhibits, 'Autism Phenotype')(neurobehavioral features varies, 'Central Nervous System Diseases')

PMCID: 5356236
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (variance: [qnco]), (autism spectrum disorder (asd) liability: [mobd]), (environmental factors: []), (present paper: [qnco]), (review: []), (systematic reviews: []), (meta-analyses: [resa]), (environmental risk factors: []), (asd: [cgab]), (quality: []), (evidence: []), (brief overview: []), (putative mechanisms: []), (findings current evidence: [npop]), (several environmental factors: [qnco]), (vaccination: [topp]), ( maternal smoking: [inbe]), ( thimerosal exposure: [orch,phsu]), (likely assisted reproductive technologies: [topp]), (risk: []), (contrary: []), (parental age: [grpa]), (birth complications: [fndg]), (trauma: [inpo]), (ischemia: [patf]), (hypoxia: [patf]), (strong links: []), (other pregnancy-related factors: [dsyn]), (maternal diabetes: [patf]), (caesarian section: [topp]), (strong (but significant) association: [menp]), (reviews: []), (nutritional elements: []), (detrimental effects: []), (deficiency: [dsyn]), (folic acid: [orch,phsu,vita]), (vitamin d: [orch,phsu,vita]), (patients: [podg]), (studies: [lbpr]), (toxic elements: [elii]), (design: [acty]), (enough evidence: []), (association: [menp]), (heavy metals: [elii]), (important inorganic mercury: [elii,hops]), (lead): [elii,hops]), (warrants: []), (further investigation: [hlca]), (mechanisms: []), (non-causative association: [menp]), (confounding): []), ( gene-related effect: [gngm]), (oxidative stress: [comd]), ( inflammation: [patf]), ( hypoxia/ischemia: [patf]), ( endocrine disruption: [bdsy]), ( neurotransmitter alterations: [bacs]), (interference: []), (pathways: [moft]), (genetic studies: [resa]), ( studies: [lbpr]), (infancy: []), (significant methodological limitations: [qnco]), (future studies: [lbpr]), (asd risk factors: [qnco]), (developmental psychopathology approach: [orgf]), (prospective design: [resa]), ( precise exposure measurement: [clna]), (reliable timing: []), (exposure: [clna]), (relation: [socb]), (critical developmental periods: [orgf]), (account: [clna]), (dynamic interplay: []), (gene: [gngm]), (environment: []), (designs: [acty]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0121-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder liability, 'Autism Phenotype')(vaccination, 'Vaccination')(maternal smoking, 'Smoking')(thimerosal exposure, 'Exposures')(birth complications, 'Obstetric Delivery Complications')(trauma, 'Post-Traumatic Stress Disorders')(maternal diabetes, 'Diabetes Mellitus Type 1')(vitamin d, 'Dietary Supplements')(infancy, 'Perinatal History')(exposure, 'Exposures')(precise exposure measurement, 'Exposures')

PMCID: 5432605
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (further insight: [menp]), (psychosexual functioning: []), (interpersonal aspects: [qnco]), (adolescents: [aggp]), (autism spectrum disorder (asd): [mobd]), (multi-informant measures: [qnco]), (study: [resa]), (development: [orgf]), (new measure: [qnco]), (self-reports: [resa]), ((teen transition inventory; tti): [diap]), (domains: []), (psychosexual functioning (i.e: [diap,inpr]), (psychosexual socialization: [edac]), (psychosexual selfhood: []), (sexual/intimate behavior): [bhvr]), (initial testing: []), (instrument: []), (asd (n: [cgab]), (self-report): [resa]), (typically developing (td) adolescents: [aggp]), (account gender: [orga]), (covariate: []), (results: [fndg]), (informants: [grup]), (difficulties: [fndg]), (asd group: [cgab]), (regard: []), (behavior: [inbe]), (parents: []), (problems: []), (asd: [cgab]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-017-3071-y) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5354243
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (number: [qnco]), (diagnosed cases: [qnco]), (autism spectrum disorders (asd): [mobd]), (decades; however: [qnco]), (considerable debate: [acty]), (pathophysiology: [patf]), (asd: [cgab]), (lack: []), (biological knowledge: []), (behavioral observations: [topp]), (psychometric tools: [diap]), (however: []), (physiological measurements: [diap]), (behavioral diagnoses: [inbe]), (future: []), (order: [acty]), (accurate diagnoses: [fndg]), (towards: []), (goal: []), (biochemical data: [euka]), (asd diagnosis: [cgab]), (paper: []), (measurements: []), (metabolite concentrations: [menp]), (folate-dependent one-carbon metabolism: [orch,phsu,vita]), (transulfuration pathways: [moft]), (blood samples: [bdsu]), (participants: [popg]), (age-matched neurotypical peers: [popg]), (fisher discriminant analysis: [resa]), (multivariate classification: []), (spectrum: [qnco]), (results: [fndg]), (neurotypical participants: [popg]), (asd cohort: [cgab]), (furthermore: []), ( kernel: []), (squares: []), (adaptive behavior: [inbe]), (vineland adaptive behavior composite score: [inbe]), (measurement: []), (metabolites: [bacs]), (pathways: [moft]), (vineland score: [clna]), (r2: [gngm]), (cross-validation: [resa]), (level: [phsu]), (accuracy: []), (classification: []), (severity prediction: []), (other approach: []), (field: [irda]), (strong indicator: [irda]), (consideration: [fndg]), (statistical analysis: [resa]), (tremendous potential: []), (important information: []), (complex biochemical data sets: [chvs]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(asd diagnosis, 'Diagnosis')(adaptive behavior, 'Adaptive Life Skills')(vineland adaptive behavior composite score, 'Adaptive Life Skills')

PMCID: 5364052
SFARI Genes: UBE3A, UBE3A, UBE3A, UBE3A, Cbln1, UBE3A, Cbln1, UBE3A, Cbln1, Cbln1, Cbln1, Ube3a, Cbln1, Ube3a, Cbln1, Cbln1, 
Non SFARI Genes: 
Named Entities: (summary maternally: []), (15q11-13 chromosomal triplications: [dsyn]), (penetrant autism: [mobd]), (gene dosages: [qnco]), (ube3a: [gngm]), (transcriptional co-regulatory functions: [genf]), (here: []), (vivo mouse genetics: [mamm]), (nucleus down-regulates: [celc]), (glutamatergic synapse organizer: [bsoj]), (cerebellin-1 (cbln1): [aapp,bacs]), (sociability: [socb]), (mice: [mamm]), (epileptic seizures: [dsyn]), (cbln1: [gngm]), (sociability impairments: [patf]), (asymptomatic increases: [qnco]), (ube3a-seizure synergy maps: [aapp,bacs]), (neurons: [cell]), (midbrain: [bpoc]), (ventral tegmental area (vta): [bpoc]), (cbln1 deletions: [genf]), (weaken glutamatergic transmission: [patf]), (preclinical evidence: []), (viral-vector-based chemogenetic activations: [biof]), (cbln1 restorations: [gngm]), (vta: [bpoc]), (glutamatergic neurons: [cell]), (sociability deficits: [socb]), (ube3a and/or seizures: [sosy]), (results: [fndg]), (gene: [gngm]), (seizure interaction: [sosy]), (key node: [bpoc]), (protein interaction network: []), (autism genes: [gngm]), 
ASD Terms: (penetrant autism, 'Autism Phenotype')(epileptic seizures, 'Epilepsy')(autism genes, 'Autism Phenotype')

PMCID: 5349246
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (second iteration: [fndg]), (autism brain imaging data exchange (abide ii): [mobd]), (scope: []), (brain connectomics research: [resa]), (autism spectrum disorder (asd): [mobd]), (initial abide effort (abide i): [inch]), (datasets: []), (new multisite open-data resource: [euka]), (aggregate: []), (state: []), (functional magnetic resonance imaging (mri): [diap]), (corresponding structural mri: [diap]), (phenotypic datasets: [orga]), (abide ii: []), (individuals: [humn]), (asd: [cgab]), (controls: [sbst]), (international institutions: []), (combination: [fndg]), (abide: []), (investigators: []), (unique cross-sectional datasets: []), (selection: [genf]), (samples: [sbst]), (discovery and/or replication: [genf]), (sample size: [qnco]), (identification: [menp]), (neurobiological subgroups: [virs]), (preliminary examinations: [hlca]), (sex differences: [orga]), (additionally: []), ( abide ii: []), (range: [qnco]), (psychiatric variables: [hlca]), (understanding: [menp]), (neural correlates: []), (co-occurring psychopathology;: [acty]), (diffusion: [npop]), (enhancements: [acty]), (key sources: [fndg]), (asd heterogeneity: [cgab]), 
ASD Terms: (autism brain imaging data exchange aims, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5372633
SFARI Genes: th, th, th, th, th, th, 
Non SFARI Genes: cs, sts, 
Named Entities: (progress: []), (epidemiological: []), ( molecular: []), (clinical genetics: []), (development: [orgf]), (new techniques: []), (knowledge: []), (genetic syndromes: [dsyn]), (autism spectrum disorder (asd): [mobd]), (objective: []), (article: []), (diversity: []), (genetic disorders: [dsyn]), (asd: [cgab]), (extensive review: []), (single-gene disorders: [fndg]), ( copy number variants: [nusq]), (other chromosomal disorders): [cgab,dsyn]), (hierarchical diagnostic strategy: [menp]), (stepwise evaluation: [hlca]), (general practitioners/pediatricians: []), (child psychiatrists: []), (geneticists: []), (neuropediatricians: []), (order: [acty]), (first step: [qnco]), (clinical investigation involving:: [hlca]), (child: [aggp]), (psychological evaluation: [hlca]), (autism diagnosis: [mobd]), (different observational sources: [resa]), (autism severity;: [mobd]), (neuropediatric evaluation: [hlca]), (neurological symptoms: [sosy]), (developmental milestones;: []), (genetic evaluation: [hlca]), (dysmorphic features: [cgab]), (malformations: [cgab]), (second step: [qnco]), (laboratory: [mnob,orgt]), (necessary neuroimaging: [diap]), (eeg studies: [diap]), (clinical results: [fndg]), (neuropediatric examinations: [hlca]), (identification: [menp]), (practical implications: []), (diagnostic strategies: [menp]), (early detection: [diap]), (prevention: [resa]), (co-morbidity: []), ( specific treatment: [topp]), (up: []), (genetic counseling: [topp]), 
ASD Terms: 

PMCID: 5360855
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (effective biomarkers: [clna]), (challenging tasks: [hlca]), (research field: [resa]), (autism spectrum disorder (asd): [mobd]), (magnetic resonance: [npop]), ((mri): [diap]), (powerful tool: []), (changes: [qnco]), (structure: []), ( function: [phsf]), ( maturation: [phsf]), ( connectivity: []), (metabolism: [orgf]), (brain: [bpoc]), (children: [aggp]), (asd: [cgab]), (here: []), (recent mri studies: [diap]), (young children: [aggp]), (candidate biomarkers: [clna]), (diagnosis: [fndg]), (childhood asd: [cgab]), (review: []), (methods: []), ( diffusion tensor: [npop]), (imaging: [diap]), ( resting-state functional mri: [diap]), (magnetic resonance spectroscopy: [diap]), (future advances: []), (techniques: []), (cross-disciplinary studies: [lbpr]), (large-scale collaborations: [socb]), (integrated approach: [genf]), (neuroimaging: [diap]), ( genetics: []), (phenotypic data: [orga]), (discovery: [acty]), (new: []), ( effective biomarkers: [clna]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(diagnosis, 'Diagnosis')

PMCID: 5360847
SFARI Genes: OXT, AVP, OXT, AVP, OXT, AVP, OXT, AVP, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (heritable neurodevelopmental disorders: [mobd]), (impaired social interactions: [mobd]), ( communication deficits: [socb]), (repetitive behavior: [fndg]), (mechanisms: []), (etiology: []), (manifestations: []), (understood: [menp]), ( several lines: [qnco]), (evidence: []), (rodent: [mamm]), (human studies: [humn]), (involvement: []), (evolutionarily highly-conserved oxytocin (oxt): [aapp,horm,phsu]), (arginine-vasopressin (avp): [aapp,horm,phsu]), (neuropeptides: [aapp,bacs]), (various aspects: [qnco]), (mammalian social behavior: [mamm]), (comprehensive review: []), (roles: [socb]), (oxt: [gngm]), (avp systems: [gngm]), (development: [orgf]), (asd: [cgab]), (genetic aspect: [qnco]), (review: []), (current knowledge: [npop]), (associations: [menp]), (single-nucleotide variants: [fndg]), (human oxt-avp pathway genes oxt: [humn]), ( avp: [gngm]), ( avp receptor: [aapp,rcpt]), ((avpr1a): [aapp]), ( oxt receptor: [aapp,rcpt]), (oxytocinase/vasopressinase (lnpep): [aapp,enzy]), (adp-ribosyl cyclase (cd38): [aapp,enzy]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(heritable neurodevelopmental disorders, 'Learning Disorders')(impaired social interactions, 'Reciprocal Social Interaction')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(mammalian social behavior, 'Reciprocal Social Interaction')

PMCID: 5345089
SFARI Genes: 
Non SFARI Genes: Mb, STAM, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (group: [popg]), (neurodevelopmental disorders: [mobd]), (high heritability: [qnco]), (underlying genetic determinants: [topp]), (asds: [cgab]), (large-scale whole-genome studies: [gngm]), (copy number variation: [nusq]), (han chinese samples: [sbst]), (genome-wide copy number variation analysis: [nusq]), (asd: [cgab]), (patients: [podg]), (sporadic cases: [qnco]), (controls: [sbst]), (chinese population: [popg]), (illumina: []), (platforms: []), (cnvs: [nusq]), (genes: [gngm]), (asd risk: [cgab]), (rare cnvs: [nusq]), (mb: [gngm]), (asd patients: [cgab]), (global burden: []), (rare: [gngm]), ( large cnvs: [nusq]), (recurrent: []), (case-private cnvs: [nusq]), (15q11-13: []), ( xp22.3: [celc]), (duplication: [comd]), (european ancestry: [popg]), (several genes: [famg]), (gramd2: [gngm]), (stam: [gngm]), (novel asd risk genes: [cgab]), (whole-genome cnvs: [nusq]), (whole-exome sequencing data: [euka]), (several cnvs: [nusq]), (asd genes (shank3: [cgab]), ( cdh10: [gngm]), ( csmd1): [gngm]), (nervous system development (nyap2: [gngm]), ( st6gal2: [gngm]), ( grm6): [aapp,rcpt]), (besides: []), (study: [resa]), (contactins-nyaps-wave1 pathway: [aapp,bacs]), (asd pathogenesis: [cgab]), (findings: [clna]), (asd-related cnvs: [cgab]), (related pathway: [moft]), (further study: [resa]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5341363
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (tuberous sclerosis: [neop]), (complex (tsc): [chvs]), (autosomal dominant condition: [dsyn]), (mutations: [genf]), (tsc1: [gngm]), (tsc2 gene: [gngm]), (widespread systemic manifestations: []), (significant neurological morbidity: [dsyn]), (addition: []), (seizures: [sosy]), (cerebral pathology: [patf]), (cortical tubers: [fndg]), (subependymal nodules: [fndg]), ( subependymal giant cell astrocytoma: [neop]), (abnormal white matter: [tisu]), (recognised neuropsychiatric difficulties: [fndg]), (intellectual disability: [mobd]), ( autism spectrum disorder (asd): [mobd]), (range: [qnco]), (learning: [menp]), (behaviour problems: [mobd]), (tuberous sclerosis-associated neuropsychiatric disorders: [neop]), (tand: []), (asd: [cgab]), (tsc: [gngm]), (particular importance: []), ((1): [fndg]), (people: [popg]), (source: [fndg]), (considerable difficulty: [fndg]), (families: [famg]), (model: []), (neurobiological pathways: [moft]), (multiple factors: [qnco]), (development: [orgf]), ((1) seizures: [sosy]), (related electrophysiological factors: [fndg]), ( (2): [qnco]), ( (3) genotype: [orga]), ((4): []), (characteristics: []), (however: []), (neurobiological pathway: [moft]), (systematic review: []), (evidence: []), (role: [socb]), (risk: []), (combination: [fndg]), (review: []), (studies: [lbpr]), (predefined risk factors: [qnco]), (children: [aggp]), (databases: medline: []), ( embase: []), ( pubmed: []), (cochrane library: [gngm,nnon]), (web: []), (science (conference proceedings citation index): [qnco]), (authors: []), (titles: []), (abstracts: []), (full text: []), (appropriate papers: []), ((3) assess: [fndg]), (bias: [bird]), (newcastle-ottawa scale: [acty]), (guidelines: []), (meta-analysis: [resa]), (systematic reviews: []), (observational: [resa]), ((moose guidelines): [mamm]), (robins-i: [inch]), (discussion: [socb]), (knowledge: []), (first systematic review: [qnco]), (multiple risk factors: [qnco]), (area: []), (researchers: []), (field: [irda]), (clinicians: []), (prognostic information: []), (systematic review registration prospero crd42016042841 electronic: [mcha]), (supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13643-017-0448-0) contains: [acty]), (users: [humn]), 
ASD Terms: (tuberous sclerosis complex, 'Tuberous Sclerosis')(tuberous sclerosis complex1, 'Tuberous Sclerosis')(tuberous sclerosis complex2 gene, 'Tuberous Sclerosis')(significant neurological morbidity, 'Neurologic Indications')(cortical tubers, 'Tuberous Sclerosis')(intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(behaviour problems, 'Personal Traits')(tuberous sclerosis-associated neuropsychiatric disorders, 'Tuberous Sclerosis')(tuberous sclerosis complex, 'Tuberous Sclerosis')(tuberous sclerosis complex, 'Tuberous Sclerosis')(tuberous sclerosis complex, 'Tuberous Sclerosis')(tuberous sclerosis complex, 'Tuberous Sclerosis')

PMCID: 5360850
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (transgenic mice: [mamm]), (mutations: [genf]), (autism spectrum disorders (asds): [mobd]), (molecular underpinnings: []), (disorders: [dsyn]), (recently: []), ( researchers: []), (advantage: []), (such models: []), (cre-loxp: [gngm]), (similar systems: []), (gene expression: [genf]), (space: []), (time: []), (clearer picture: [fndg]), (cell types: [cell]), ( circuits: []), ( brain regions: [blor]), (developmental time periods: [orgf]), (asds: [cgab]), (asd-causing mutations: [cgab]), (excitatory: []), (inhibitory neurons: [acty]), ( different neurotransmitter systems: [bacs]), (cells: [cell]), (forebrain: [bpoc]), (cerebellum: [bpoc]), (addition: []), ( mutations: [genf]), (adult mice: [mamm]), (evidence: []), (plasticity: [npop]), (reversibility: []), (core asd symptoms: [cgab]), (limited availability: [fndg]), (cre lines: [gngm]), (certain cell types: [cell]), (time periods: []), (challenge: [hlca]), (circuitry bases: [inch]), (autism: [mobd]), (other technological advances: []), (obstacle: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(core asd symptoms, 'Complaints and Indications')(autism, 'Autism Phenotype')

PMCID: 5351053
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disease: [mobd]), (difficulties: [fndg]), (social communication: [socb]), (restricted: []), ( repetitive behavior: [fndg]), (interests: [menp]), (specific abnormalities: [cgab]), (language: [lang]), (perception: [menp]), (precise etiology: []), (asd: [cgab]), (subgroup: [virs]), (patients: [podg]), (toxic environmental exposure: [inpo]), (imbalance: [sosy]), (oxidative stress: [comd]), (anti-oxidant systems: [chvf]), (previous serum: [bdsu]), (postmortem studies: [diap]), (levels: []), (glutathione: [aapp,bacs]), (main cellular free radical scavenger: [chvf]), (brain: [bpoc]), (hypothesis: []), (compound: [chem]), (role: [socb]), (pathophysiology: [patf]), (autism: [mobd]), (method: [lbpr]), (single-voxel proton: [fndg]), (magnetic resonance spectroscopy: [diap]), (gsh signal: [dsyn]), (dorsal: []), (anterior cingulate cortex (dacc): [bpoc]), (dorsolateral prefrontal cortex (dlpfc): [bpoc]), (asd patients: [cgab]), (above average iqs: [qnco]), (control subjects: [sbst]), (decreased gsh concentrations: [dsyn]), (regions: []), (overall group differences: [popg]), (neurometabolites: []), (gsh: [dsyn]), (dorsal acc (wilks: [cgab]), (test; p: [lbpr]), (dlpfc (p: [aapp,imft]), (dacc: []), (trend: []), (decreased gsh signals: [dsyn]), (gsh concentrations: [dsyn]), (asd group: [cgab]), (further studies: [lbpr]), (mrs: [gngm]), ( serum: [bdsu]), (cerebrospinal fluid measurements: [bdsu]), (gsh metabolism: [dsyn]), (other regions: []), (interest: [menp]), (whole brain spectroscopy: [lbpr]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(specific abnormalities in language, 'Language Ability')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disease, 'Learning Disorders')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(perception, 'Cognitive Ability')(toxic environmental exposure, 'Exposures')(autism, 'Autism Phenotype')(cerebrospinal fluid measurements, 'Hydrocephalus')(including other regions of interest, 'Sharing in Interests of Others')

PMCID: 5338261
SFARI Genes: NR1D1, NR1D1, NR1D1, NR1D1, Nr1d1, Nr1d1, Nr1d1, Nr1d1, Nr1d1, Nr1d1, Nr1d1, Nr1d1, Nr1d1, Nr1d1, NR1D1, NR1D1, 
Non SFARI Genes: 
Named Entities: (previous study: [resa]), (autism spectrum disorder (asd) patients: [mobd]), (sleep disorders: [dsyn]), (mutations: [genf]), (coding regions: [gngm]), (circadian-relevant genes: [gngm]), (detected mutations: [genf]), (several clock genes: [gngm]), (nr1d1: [gngm]), (here: []), (asd patients: [cgab]), (nr1d1 mutations: [genf]), (novel mutations: [comd]), (c.1499 g: [qnco]), ((p.r500h): [aapp,imft]), (role: [socb]), (development: [orgf]), (cerebral cortex: [bpoc]), (mice: [mamm]), (acute knockdown: []), (mouse nr1d1: [mamm]), (utero electroporation: [lbpr,resa]), (abnormal positioning: []), (cortical neurons: [bpoc]), (corticogenesis: []), (aberrant phenotype: [orga]), (wild type nr1d1: [gngm]), (mutant: [comd]), (time-lapse imaging: [diap]), (characteristic abnormal migration phenotypes: [orga]), (nr1d1-deficient: [qnco]), (down: []), ( axon extension: [ortf]), (dendritic arbor formation: [celc]), (proliferation: [patf]), (neuronal progenitors: [famg]), (stem cells: [cell]), (ventricular zone: [bpoc]), (together: []), ( nr1d1: [gngm]), (pivotal role: [socb]), (regulation: [biof]), (excitatory neuron migration: [celf]), (synaptic network formation: [popg]), (results: [fndg]), (functional defects: []), (asd etiology: [cgab]), (pathophysiology: [patf]), 
ASD Terms: (autism spectrum disorder patients, 'Autism Phenotype')

PMCID: 5338099
SFARI Genes: 
Non SFARI Genes: Mb, 
Named Entities: (structural variation (sv): []), (genome organization: [gngm]), (contributes: [acty]), (human disease: [humn]), (however: []), (complete mutational spectrum: [genf]), (sv: [qnco]), (disease association studies: [lbpr]), (participants: [popg]), (autism spectrum disorder (asd): [mobd]), (other developmental abnormalities: [cgab]), (genome-wide map: [resa]), (large sv: [qnco]), (long-insert jumping libraries: [mnob,orgt]), (mean physical coverage: [hlca]), (linked-read whole-genome sequencing: [dora]), (genomics: []), (major sv classes: [hlca]), (~5: [qnco]), (sv resolution: [qnco]), (results: [fndg]), (distinct large sv: [qnco]), (recurrent subclasses: []), (complex sv (cxsv): [qnco]), (that: (1) cxsv: [fndg]), (canonical sv; (2): [qnco]), (genome harbors: [gngm]), (large cxsv: [qnco]), (average;: [qnco]), (large cxsvs: [qnco]), (inversion;: [comd]), (large cxsv (93.8%): [qnco]), (previous studies: [lbpr]), (rare svs: [qnco]), (coding: []), (regulatory non-coding loci: [gngm]), (disease-associated genes: [gngm]), (multiple cases: [qnco]), (catastrophic chromosomal rearrangements: [comd]), (chromoanagenesis: []), (somatic chromoanasynthesis: [cell]), (extreme: []), (germline chromothripsis events: [cell]), (breakpoints: []), (mb: [gngm]), (chromosomes: [celc]), (rare categories: [gngm]), (extreme cxsv: []), (data: [euka]), (foundational map: [orgt]), (morbid: [qnco]), (human genome: [gngm]), (underappreciated abundance: []), (diversity: []), (cxsv: []), (genomic studies: [gngm]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13059-017-1158-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(other developmental abnormalities, 'Learning Disorders')

PMCID: 5360848
SFARI Genes: MECP2, MECP2, MECP2, MECP2, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (complex set: [menp]), (developmental neurological disorders: [mobd]), (deficits: []), (social communication: [socb]), (excessive repetitive behaviors: [fndg]), (recent years: []), ( asd: [cgab]), (disease: [dsyn]), (synapse: [bsoj]), (main type: [qnco]), (genetic aberration: [topp]), (asd: [cgab]), (gene duplication: [genf]), (several mouse models: [mamm]), (mutations: [genf]), (here: []), (effects: []), (mecp2 duplication: [aapp,bacs]), (human chromosome: [celc]), (15q11-13 duplication: [comd]), (synaptic development: [ortf]), (neural circuit wiring: [topp]), (mouse sensory cortices: [mamm]), (mice: [mamm]), (specific defects: []), (spine pruning: [bpoc]), (15q11-13 duplication mouse model: [emod]), (spine formation: [bpoc]), (results: [fndg]), (spine pathology: [bpoc]), (autism models: [mobd]), (distinct aspects: [qnco]), (neural circuit development: [orgf]), (different asd mutations: [cgab]), (importance: []), (gene dosage: [qnco]), (normal development: [fndg]), (function: [phsf]), (brain: [bpoc]), 
ASD Terms: (developmental neurological disorders, 'Neurologic Indications')(social communication, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(excessive repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism models, 'Autism Phenotype')

PMCID: 5432632
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (attention-deficit/hyperactivity disorder (adhd): [mobd]), (purpose: []), (study: [resa]), (relationships: []), (asd: [cgab]), (adhd symptoms: [mobd]), (causal modeling: [resa]), (large phenotypic data set: [orga]), (children: [aggp]), (adhd: [mobd]), (unaffected siblings: [famg]), (controls: [sbst]), (structural equation model: [resa]), (causal discovery algorithm: [lbpr]), (distinct pathways: [moft]), (identified: (1): [fndg]), (impulsivity: [inbe]), (difficulties: [fndg]), (understanding social information: [menp]), ( (2): [qnco]), (hyperactivity: [mobd]), (repetitive behavior: [fndg]), (pairwise pathway: [moft]), (inattention: [mobd]), ( difficulties: [fndg]), (verbal iq: []), (findings: [clna]), (future studies: [lbpr]), (pathophysiological mechanisms: [patf]), (overlap: [topp]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-017-3083-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder symptoms, 'Attention Deficit Disorder with Hyperactivity')(difficulties with understanding social information, 'Ability to Converse in Social Settings')(inattention, 'Attention Deficit Disorder with Hyperactivity')(understanding social information, 'Ability to Converse in Social Settings')(hyperactivity, 'Overactivity')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 5385202
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (neurobiological basis: [phsu]), (comorbidity: []), (autism spectrum disorder (asd): [mobd]), (attention deficit/hyperactivity disorder (adhd): [mobd]), (children: [aggp]), (asd: [cgab]), ( adhd: [mobd]), (adhd+asd: [cgab]), (controls: [sbst]), (electrophysiological correlates: [diap]), (gaze cue: [fndg]), (face processing: [emst]), (effects: []), (interaction: []), (edan: [orch,phsu]), (erp marker: [clna]), (visual attention: [menp]), (location: [blor]), (n170: []), (right-hemisphere lateralised erp: [fndg]), (processing: [acty]), (atypical gaze cue: [fndg]), (adhd: [mobd]), (ctrl groups: [popg]), (findings: [clna]), (presence: [qnco]), (comorbid asd symptoms: [cgab]), (research: [resa]), (samples: [sbst]), 
ASD Terms: (comorbidity, 'Comorbidities')(autism spectrum disorder, 'Autism Phenotype')(attention deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(face processing, 'Integrated Verbal and NonVerbal Communication')(visual attention, 'Visual Thinking')(face processing, 'Integrated Verbal and NonVerbal Communication')(comorbid asd symptoms, 'Comorbidities')

PMCID: 5794881
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (attention-deficit/hyperactivity disorder (adhd): [mobd]), (presence: [qnco]), (genetic link: [topp]), (asd: [cgab]), (adhd symptoms: [mobd]), (twin studies: [famg]), (genetic overlap: [topp]), (adhd: [mobd]), (adhd co-aggregate: [mobd]), (individuals: [humn]), (families: [famg]), (genetic liability: [topp]), (potential differences: [qnco]), (high-functioning asd: [cgab]), (link: []), (sweden: []), (logistic regression: [resa]), (association: [menp]), (estimates: [qnco]), ((low-functioning): [qnco]), ((high-functioning) intellectual disability: [mobd]), (risk: []), (asd (odds ratio: [cgab]), (confidence interval: [qnco]), (high-functioning: [qnco]), (low-functioning asd: [cgab]), (relatives: [famg]), (monozygotic twins: [famg]), (ci:: [lbpr]), (dizygotic twins: [famg]), (full siblings: [famg]), (increased risk: [qnco]), (pattern: []), (different types: []), (existence: []), (genomic studies: [gngm]), (overlap: [topp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder symptoms, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder co-aggregate, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(intellectual disability, 'Learning Disorders')

PMCID: 5372543
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (bipolar disorder (bpd): [mobd]), (schizophrenia (sch) show: [mobd]), (similar neuropsychiatric behavioral disturbances: [mobd]), (impaired social interaction: [mobd]), (communication: [socb]), (autism spectrum disorder (asd): [mobd]), (environmental influences: []), (risk: []), (course: []), (illness: [sosy]), (geneanalytics software: [inpr,mnob]), (pathway analysis: []), (genetic profiling: [lbpr]), (common susceptibility genes: [gngm]), (lists: []), (asd (792 genes): [cgab]), ( bpd (290 genes): [gngm]), (sch (560 genes): [gngm]), (rank scores: [clna]), (number: [qnco]), (nature: []), (genes: [gngm]), ( gene-disease association: [gngm]), ( tissue specificity: [ortf]), (gene functions: [gngm]), (categories (e.g.: []), ( diseases: [dsyn]), ( tissues: [tisu]), (functional pathways): [moft]), (twenty-three genes: [gngm]), (disorders: [dsyn]), (biological superpathways: []), (circadian entrainment (10 genes: [gngm]), ( score: [clna]), (amphetamine addiction (five genes: [gngm]), (sudden: []), (death syndrome (six genes: [gngm]), (brain tissues: [tisu]), (medulla oblongata (11 genes: [bpoc]), (thalamus (10 genes: [bpoc]), (hypothalamus (nine genes: [bpoc]), (common genes: [gngm]), (drd2: [gngm]), ( chrna7: [gngm]), ( htr2a: [gngm]), ( slc6a3: [aapp,bacs]), (tph2): []), (dopamine: [bacs,orch,phsu]), (serotonin homeostasis: [bacs,orch]), (signal transduction pathways: [moft]), (mood: [menp]), ( behavior: [inbe]), (physical activity level: [dora]), (effects: []), (pathways: [moft]), (circadian rhythms support: [orgf]), (core: [bdsu]), (etiological relationship: []), (neuropsychiatric illnesses: [sosy]), (sleep disruption: [orgf]), (hypoxia: [patf]), (central brain stem dysfunction: [patf]), 
ASD Terms: (bipolar disorder, 'Bipolar Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(similar neuropsychiatric behavioral disturbances, 'Personal Traits')(impaired social interaction, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(amphetamine addiction, 'Substance Abuse')(mood, 'Mood')(physical activity level, 'Abnormal Activity or Energy Level')(circadian rhythms support, 'Prosody')

PMCID: 5372533
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prader-willi syndrome: [cgab]), (rare genetic disorder: [dsyn]), (lack: []), (expression: [topp]), (paternal genes: [gngm]), (chromosome: [celc]), (autism spectrum disorder (asd) symptomatology: [mobd]), (various studies: [lbpr]), (however: []), (previous findings: [clna]), (studies: [lbpr]), (asd symptomatology: [cgab]), (pws: [cgab]), (children: [aggp]), (social communication functioning: [socb]), (other asd-related symptoms: [cgab]), (agreement: [socb]), (measures: [qnco]), (rates: [qnco]), (asd diagnosis: [cgab]), (autism diagnostic observation schedule-2: [hlca]), (social communication questionnaire (scq): [socb]), ( social responsiveness scale-2: [acty]), ((srs-2): []), ( social skills improvement: [socb]), (system-rating scales (ssis-rs): [inpr,qnco]), (vineland adaptive behavioral scales-ii (vabs-ii): [inbe]), (general adaptive: [hlca]), (intellectual skills: [inbe]), (estimate (cbe) diagnosis: [topp]), (experienced developmental pediatrician: [orgf]), (history: [orga]), (review: []), (available study measures: [qnco]), (account: [clna]), (overall developmental level: [orgf]), (participants: [popg]), (years: []), (genetic subtypes: [topp]), (deletion (del): [genf]), (uniparental disomy (upd): [comd]), (total: [qnco]), (female upd cases): [aapp,enzy]), (cut-offs: [phpr]), (asd assessments: [cgab]), ( agreement: [socb]), (parent questionnaires: []), (srs-2: []), ( ssis-rs): [dsyn]), (observational assessment (ados-2): [aapp,enzy]), (none: []), (cbe diagnosis: [fndg]), (asd: [cgab]), (caveat: []), (risk: []), (predominance: []), (girls: [aggp]), (sample: [sbst]), (assessments: [hlca]), (complexity: [chvs]), (asd symptom measures: [cgab]), 
ASD Terms: (autism spectrum disorder symptomatology, 'Autism Phenotype')(prader-willi syndrome, 'Prader-Willi Syndrome')(prader-willi syndrome, 'Prader-Willi Syndrome')(asd diagnosis, 'Diagnosis')(social communication functioning, 'Reciprocal Social Interaction')(autism diagnostic observation schedule-2, 'Autism Phenotype')(social communication questionnaire, 'Reciprocal Social Interaction')(social skills improvement system-rating scales social skills improvement system-rating scales), 'Ability to Converse in Social Settings')(vineland adaptive behavioral scales-ii, 'Adaptive Life Skills')(general adaptive, 'Adaptive Life Skills')(estimate diagnosis, 'Diagnosis')(prader-willi syndrome, 'Prader-Willi Syndrome')(agreement between parent questionnaires social skills improvement system-rating scales), 'Ability to Converse in Social Settings')(parent questionnaires social skills improvement system-rating scales), 'Ability to Converse in Social Settings')(estimate diagnosis, 'Diagnosis')(clinical best estimate diagnosis, 'Diagnosis')(asd symptom measures, 'Complaints and Indications')

PMCID: 5360853
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (purpose: []), (study: [resa]), (psychometric properties: [diap]), (chinese version: [lang]), (autism spectrum rating scale (asrs): [inpr,qnco]), (community-based children: [aggp]), (autism spectrum disorder (asd) cases: [mobd]), (sites: []), (parents: []), (participants: [popg]), (asrs: []), (squares: []), (variance: [qnco]), (estimator: []), (exploratory factor analysis: [qnco]), (3-factor structure: [fndg]), (items: []), (current sample: [sbst]), (item reliability: [qnco]), (asrs (mc-asrs): []), (moreover: []), (cut-off point: [qnco]), ( receiver: []), (characteristic analysis: [resa]), (mc-asrs: []), (excellent discriminate validity: [qnco]), (unmodified chinese version (uc-asrs): [lang]), (area: []), (curve values: []), ((95% ci:: [lbpr]), (respectively: []), (meanwhile: []), (confirm factor analysis: [qnco]), (construct validity: []), (uc-asrs: []), (above factor solution: [bodm]), (children: [aggp]), (mc-asrs shows: [anim]), (efficacy: [resa]), (epidemiological screening: [diap]), (asd: [cgab]), (chinese children: [aggp]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s12264-017-0104-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum rating scale, 'Autism Phenotype')(autism spectrum disorder cases, 'Autism Phenotype')

PMCID: 5386877
SFARI Genes: 
Non SFARI Genes: CYP2B6, SH3GL2, LOXHD1, PTPRD, 
Named Entities: (maternal exposure: [inpo]), (environmental pollutants: [hops]), (fetal brain development: [phsf]), (autism: [mobd]), (spectrum disorder (asd) risk: [cgab]), (conjunction: []), (differential genetic susceptibility: [orga]), (organohalogen congeners: [chvs]), (maternal midpregnancy blood samples: [bdsu]), (significant: [qnco]), (negative associations: [menp]), (asd outcome: [cgab]), (first large-scale maternal: [famg]), (fetal genetic study: [emst]), (midpregnancy serum levels: [bdsu]), (set: [menp]), (organohalogens: []), (subset: []), (genotyped women: [popg]), (children: [aggp]), (california: [plnt]), (early markers: [clna]), (autism (ema) project: [mobd]), (levels: []), (pcb: [gngm]), (biphenyl): [hops,orch]), (pbde: [orch]), (diphenyl ether) congeners: [orch]), (high maternal: [famg]), (snp-based heritability (h2g) accounting: [nusq]), (total variance: [qnco]), (genome-wide association analyses: [mbrt]), (significant maternal loci: [gngm]), (p: [gngm]), (p-dde (p =: [hops,orch]), (cyp2b6 gene: [gngm]), (bde-28 (p =: [orch]), (sh3gl2 gene: [gngm]), (lipid metabolism: [moft]), (fetal: [emst]), (genetic loci: [gngm]), (bde-100 (p =: [orch]), (pcb187 (p: [aapp,imft]), (potential metabolic genes loxhd1: [gngm]), (ptprd: [gngm]), (neurodevelopment: [ortf]), (bde-100: [orch]), ( bde153: []), (sum: [qnco]), (pbdes: [orch]), (asd: [cgab]), (genome-wide additive genetic effects: [gngm]), (pbde levels: [orch]), (results: [fndg]), (genetic control: [genf]), (midgestational biomarkers: [clna]), (environmental exposures: [inpo]), (fetal genetic determinants: [emst]), (future studies: [lbpr]), (environmental risk factors: []), (genetic variation: [npop]), (consideration: [fndg]), (independent influence: [fndg]), (fetal genetics: [emst]), (previous hypotheses: []), (fetal genotypes: [orga]), (placenta: [emst]), (maternal physiology: []), (transplacental transfer: [menp]), 
ASD Terms: (maternal exposure, 'Exposures')(increase autism, 'Autism Phenotype')(autism project, 'Autism Phenotype')(environmental exposures, 'Exposures')

PMCID: 5360852
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (norms: [fndg]), (chinese version: [lang]), (autism spectrum rating scale (asrs): [inpr,qnco]), (participants: [popg]), (shanghai: []), ( harbin: []), ( guangzhou: []), (changsha: []), ( china: []), (parents: []), (teachers: []), (chinese parent version: [lang]), (teacher version: [fndg]), (asrs: []), (versions: []), ( boys: [aggp]), (sub-scale scores: [clna]), (total score: [qnco]), (points: [qnco]), (girls: [aggp]), (p: [gngm]), (age: [orga]), (weak correlations: [sosy]), (sub-scores: [qnco]), (t-score (r: [clna]), (0.1859: [fndg]), (significance (p: [aapp,imft]), (correlations: []), (females: [orga]), (t-score: [qnco]), (chinese norms: [fndg]), (score: [clna]), (united: []), (boys: [aggp]), (children: [aggp]), (years: []), (individuals: [humn]), (autism spectrum disorders: [mobd]), (general population: [popg]), 
ASD Terms: (autism spectrum rating scale, 'Autism Phenotype')(autism spectrum rating scale, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 5320696
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (neurodevelopmental conditions: [dsyn]), (behavioural impairments: [inbe]), (addition: []), (neurological symptoms: [sosy]), ( asd: [cgab]), (gastrointestinal abnormalities: [cgab]), (role: [socb]), (gut microbiota: [orgm]), (asd: [cgab]), (gastrointestinal pathophysiology: [dsyn]), (here: []), (fungal gut microbiota: [orgm]), (cohort: [popg]), (autistic individuals: [mobd]), (presence: [qnco]), (altered microbial community structure: [orgm]), (fraction: [qnco]), (autistic subjects: [mobd]), (severe asds: [cgab]), (significant increase: [qnco]), (firmicutes/bacteroidetes ratio: [bact]), (reduction: [npop]), (bacteroidetes: [bact]), (relative abundance: [qnco]), (genus level: [phsu]), (decrease: [qnco]), (alistipes: [bact]), ( bilophila: [bact]), ( dialister: [bact]), ( parabacteroides: [bact]), (veillonella: [bact]), (asd cohort: [cgab]), (collinsella: [bact]), ( corynebacterium: [bact]), ( dorea: [bact]), (lactobacillus: [bact]), (constipation: [sosy]), (different bacterial patterns: []), (neurotypical subjects: [humn]), (constipated autistic individuals: [mobd]), (high levels: [qnco]), (bacterial taxa: []), (escherichia/shigella: [bact]), (clostridium cluster xviii: [bact]), (fungal genus candida: [fngs]), (dispersion: []), (values: []), (difference: [qnco]), (finding that: [sosy]), (bacterial gut microbiota: [orgm]), (gut mycobiota: [bdsy]), (alteration: []), (intestinal microbial community structure: [bpoc]), (asds: [cgab]), (possibility: []), (new potential intervention strategies: [topp]), (relief: [fndg]), (gastrointestinal symptoms: [sosy]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s40168-017-0242-1) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(neurodevelopmental conditions, 'Learning Disorders')(behavioural impairments, 'Personal Traits')(neurological symptoms, 'Neurologic Indications')(severe autism spectrum disorders, 'Autism Phenotype')(bacterial taxa, 'Bacterial Infections')(different bacterial patterns, 'Bacterial Infections')(autism spectrum disorders, 'Autism Phenotype')(bacterial gut microbiota, 'Bacterial Infections')

PMCID: 5438031
SFARI Genes: Adnp, Adnp, Adnp, Adnp, Adnp, Adnp, 
Non SFARI Genes: sacs, AKAP6, 
Named Entities: (major flaw: []), (autism spectrum disorder (asd) management: [mobd]), (late diagnosis: []), (activity-dependent neuroprotective protein (adnp): [celf]), (asd-related gene: [cgab]), (functionally: []), ( adnp: [gngm]), (nerve cells: [cell]), (electrical blockade: [npop]), (mice: [mamm]), ( complete adnp deficiency results: [dsyn]), (dysregulation: []), (genes: [gngm]), (failure: [inbe]), (brain: [bpoc]), (adnp haploinsufficiency results: [comd]), (social deficiencies: [dsyn]), (age-dependent deficits: [orga]), (key microtubule: [celc]), (ion channel pathways: [aapp,bacs]), (here: []), (parents/caregivers: []), (premature tooth eruption: [cgab]), (potential early diagnostic biomarker: [clna]), (adnp mutation: [genf]), (parents: []), (adnp-mutated children: [aggp]), (dentition: [bpoc]), (year: []), (age: [orga]), (molars: [bpoc]), (children: [aggp]), (teeth: [bpoc]), (normal developmental time range: [fndg]), (adnp-deficient mice: [mamm]), (computed tomography: [diap]), (dental sacs: [bpoc]), (tooth buds: [tisu]), (days: []), (deficient mice: [mamm]), (controls: [sbst]), (age-dependent dysregulation: [orga]), (allen atlas analysis: [bpoc]), (adnp expression: [topp]), (jaw area: [bpoc]), (rna: [nnon]), ((rnaseq): []), (gene: [gngm]), (array analysis: [resa]), (human adnp-mutated lymphoblastoids: [humn]), ( whole-mouse embryos: [mamm]), (mouse brains: [tisu]), (bone/nervous system-controlling genes: [gngm]), (adnp mutation/deficiency (for example: [dsyn]), ( bmp1: [gngm]), (bmp4): [aapp,bacs]), (akap6: [gngm]), (major gene: [gngm]), (adnp: [gngm]), (cognition: [menp]), (bone maintenance: [tisu]), (knowledge: []), (first time: [qnco]), (early primary (deciduous) teething: [fndg]), (adnp syndrome: [dsyn]), (early/simple diagnosis: [diap]), (path: [lbpr]), (early intervention/specialized treatment plan: [hlca]), 
ASD Terms: (autism spectrum disorder management, 'Autism Phenotype')(late diagnosis, 'Diagnosis')(cognition, 'Cognitive Ability')(early/simple diagnosis, 'Diagnosis')(early intervention/specialized treatment plan, 'Planning')

PMCID: 5340405
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (disruption: []), (synapses underlies: [bsoj]), (plethora: [fndg]), (neurodegenerative disease: [dsyn]), (presynaptic specialization: []), (active zone: []), (critical role: [socb]), (communication: [socb]), (postsynaptic neuron: [cell]), (role: [socb]), (many proteins: [aapp,bacs]), (active zones: []), (synaptic communication: [socb]), (proteins: [aapp,bacs]), (synapses: [bsoj]), (example: []), (distinct mechanisms: []), (transport: [celf]), (active zone components: []), (same transport vesicle?: [celc]), (active zone protein transport regulated?: [phsf]), (report: [hlca]), (overexpression: [genf]), (par-1/mark: [gngm]), (protein: [aapp,bacs]), (misregulation: []), (autism spectrum disorders: [mobd]), (neurodegenerative disorders: [dsyn]), ( lead: [elii,hops]), (specific block: [qnco]), (active zone protein: [aapp,bacs]), (component- bruchpilot: []), (drosophila: [euka]), (neuromuscular junctions: [celc]), (block: [qnco]), (axonal transport: [celf]), (decrease: [qnco]), (number: [qnco]), (reduced neurotransmission: [celf]), (flies: [euka]), (par-1 kinase: [aapp,enzy]), (interestingly: []), (par-1: [gngm]), (tau-one: [qnco]), (studied substrates: [sbst]), (presynaptic function: [phsf]), (tau: [gngm]), (thus: []), (study: [resa]), (components: []), 
ASD Terms: (neurodegenerative disease, 'Neurodegenerative Diseases')(autism spectrum disorders, 'Autism Phenotype')(neurodegenerative disorders, 'Neurodegenerative Diseases')

PMCID: 5321753
SFARI Genes: FMRP, FMRP, FMRP, FMRP, Fmr1, Fmr1, Fmr1, Fmr1, Fmr1, Fmr1, 
Non SFARI Genes: ADCY1, ADCY1, 
Named Entities: (fragile x syndrome (fxs): [cgab,dsyn]), (loss: [qnco]), (functional fmrp: [aapp,bacs]), (cause: []), (autism: [mobd]), (neurons: [cell]), (fmrp show: [aapp,bacs]), (aberrant mrna translation: [moft]), (intracellular signalling: [moft]), (here: []), (fmr1 knockout neurons: [cell]), ( type: [qnco]), (adenylyl cyclase (adcy1) mrna translation: [aapp,enzy]), (excessive production: []), (adcy1 protein: [aapp,bacs]), (insensitivity: [fndg]), (neuronal stimulation: [npop]), (genetic reduction: [npop]), (adcy1: [gngm]), (pi3k-mediated signalling: [aapp,enzy]), ( attenuates: [acty]), (excessive protein synthesis: [moft]), (corrects: []), (dendritic spine abnormality: [celc]), (fmr1 knockout mice: [mamm]), (autism-related symptoms: [mobd]), (repetitive behaviour: [fndg]), (defective social interaction: [fndg]), (audiogenic seizures: [dsyn]), (moreover: []), (peripheral administration: [topp]), (nb001: [orch,phsu]), (experimental compound: [chem]), (adcy1 activity: [acty]), (other adcy subtypes: []), (behavioural abnormalities: [mobd]), (results: [fndg]), (connection: []), (elevated adcy1 translation: [moft]), (abnormal erk1/2 signalling: [aapp,enzy]), (behavioural symptoms: [sosy]), (fxs: []), 
ASD Terms: (autism, 'Autism Phenotype')(fragile x syndrome, 'Fragile X Syndrome')(repetitive behaviour, 'Restricted and Repetitive Behavior')(defective social interaction, 'Reciprocal Social Interaction')(behavioural abnormalities in fmr1 knockout mice, 'Personal Traits')(behavioural abnormalities, 'Personal Traits')(fragile x syndrome, 'Fragile X Syndrome')

PMCID: 5331586
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (omega-3: [bacs,orch,phsu]), (chain: []), (fatty acid supplementation: [orch]), ((n-3 lcpufa): [aapp,imft]), (treatment: [topp]), (autism spectrum disorder (asd): [mobd]), (results: [fndg]), (previous systematic reviews: []), (meta-analyses: [resa]), (n-3 lcpufa supplementation: [topp]), (asd outcomes: [cgab]), (conducted; meta-analysis: [resa]), (blood levels: [bdsu]), (lcpufa: []), (ratios: [qnco]), (arachidonic acid (ara): [orch]), (acid (dha): [chem]), ( ara: [gngm]), (acid (epa): [chem]), (total n-3 lcpufa: [qnco]), (asd: [cgab]), (individuals: [humn]), (neurodevelopmental disorders): [mobd]), (meta-analysis: [resa]), (effects: []), (symptoms: [sosy]), (case-control studies: [resa]), (trials: [resa]), (electronic databases: [fndg]), (may: []), (mean differences: [qnco]), (inverse variance models: [qnco]), (heterogeneity: [orga]), (i2 statistic: [qnco]), (fifteen case-control studies: [resa]), (reviewed: []), (developed: []), ( asd populations: [cgab]), (dha (2.14 [95% ci 3.22: [orch]), (i2: []), (epa (0.72 [95% ci 1.25: [fndg]), (ara (0.83 [95% ci: [gngm]), ( 1.48: [fndg]), (total n-6 lcpufa: [qnco]), (n-3 lcpufa ratio (0.42 [95% ci: [fndg]), (p: [gngm]), (rcts: []), ((n: [aapp,imft]), (placebo: [topp]), ( n-3 lcpufa: [aapp,imft]), (social interaction (1.96 [95% ci 3.5: [fndg]), (restricted interests: [menp]), (behaviours: [inbe]), ([95% ci 2.17: [aapp,phsu]), (populations: [popg]), (n-3 lcpufa status: [aapp,imft]), (asd symptoms: [cgab]), (further research: [resa]), (large sample size: [qnco]), (adequate study duration: []), (efficacy: [resa]), (n-3 lcpufa: [aapp,imft]), 
ASD Terms: (fatty acid supplementation, 'Dietary Supplements')(autism spectrum disorder, 'Autism Phenotype')(n-3 lcpufa supplementation, 'Dietary Supplements')(n-3 lcpufa supplementation, 'Dietary Supplements')(symptoms of asd, 'Complaints and Indications')(social interaction (1.96, 'Reciprocal Social Interaction')(restricted interests, 'Restricted Range of Interests')(asd symptoms, 'Complaints and Indications')

PMCID: 5360849
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (documented observations: [hlca]), (kanner: []), (great debate: [acty]), (diagnoses: [fndg]), (sub-types: [qnco]), (diagnostic threshold: [fndg]), (autism spectrum disorder (asd): [mobd]), (history: [orga]), (continual refinement: []), (dsm-iii: []), (infantile autism: [mobd]), (current dsm-v diagnosis: [fndg]), (disorder: [dsyn]), (complex: [chvs]), ( pervasive: []), (heterogeneous condition: [fndg]), (multiple etiologies: []), ( sub-types: [qnco]), (developmental trajectories: [orgf]), (diagnosis: [fndg]), (observation: [hlca]), (atypical behaviors: [inbe]), (criteria: []), (persistent deficits: []), (social communication: [socb]), (repetitive patterns: []), (behavior: [inbe]), (review: []), (broad overview: []), ( prevalence: [qnco]), (etiology: []), ( clinical presentation: []), (heterogeneity: [orga]), (asd: [cgab]), (factors: []), (genetic variability: [topp]), ( comorbidity: []), (gender: [orga]), (reviewed: []), (current evidence-based pharmacological: [npop]), (behavioral treatments: [topp]), (complexities: [chvs]), (clinical trials: [resa]), (therapeutic efficacy: []), (asd populations: [cgab]), (potential: []), (new wave: [gngm]), (research: [resa]), (objective biomarkers: [clna]), (evaluation: [hlca]), (sub-typing: [qnco]), ( diagnosis: [fndg]), (treatment response: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(infantile autism, 'Autism Phenotype')(current dsm-v diagnosis, 'Diagnosis')(atypical behaviors, 'Restricted and Repetitive Behavior')(repetitive patterns of behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(diagnosis, 'Diagnosis')(social communication, 'Reciprocal Social Interaction')(comorbidity, 'Comorbidities')(diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')

PMCID: 5351204
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (etiology: []), (autism: [mobd]), (complex: [chvs]), ( heritable: []), (neurodevelopmental disorder: [mobd]), (unexplained risk: []), (recent evidence: []), (role: [socb]), (epigenetic mechanisms: [genf]), (development: [orgf]), (cpg: [bacs,nnon]), (cph (h = a: [aapp,enzy]), ( c: []), (t) methylation: [moft]), (autism-affected cortical brain tissue: [bpoc]), (representation bisulfite: [inch,phsu]), ((rrbs): []), (analysis: [resa]), (post-mortem cortical brain samples: [bpoc]), (area: []), (control individuals: [humn]), (analyses: [resa]), (single sites: [fndg]), (global methylation alterations: [moft]), (cph: [aapp,enzy]), (genome: [gngm]), (out: []), (individual site: [blor]), (region: []), (methylation: [moft]), (multi-test correction: [lbpr]), (cph dinucleotides: [aapp,enzy]), (autism-affected brains: [mobd]), ((~2-fold enrichment: [qnco]), (p: [gngm]), (cutoff: []), ( p: [aapp,imft]), (results: [fndg]), (implicate epigenetic alterations: []), (pathobiological mechanisms: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0119-y) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5351180
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (lifelong conditions: [dsyn]), (this: []), (twin studies: [famg]), (childhood: []), (twin study: [resa]), (stability: []), (autistic traits: [mobd]), (early adulthood: [aggp]), (degree: [qnco]), (environmental factors: []), (parents: []), (twin pairs: [famg]), (questionnaires: []), (twins: [famg]), (years: []), (bivariate twin analysis: [famg]), (phenotypic: [orga]), (etiological stability: []), (period: []), (genetic overlap: [topp]), (development: [orgf]), (individuals: [humn]), (broad asd phenotype: [cgab]), (scoring: [qnco]), (sample: [sbst]), (moderate phenotypic stability (r = .39): [orga]), (heritability: []), (adulthood: []), (moderate degree: [qnco]), (genetic influences: [topp]), ((genetic correlation = .49): [topp]), (majority (85%): [socb]), (genetic factors: [fndg]), (extremes: []), ((genetic correlation = .64): [topp]), (broad: []), (moderate phenotypic: [orga]), (etiological instability: [fndg]), (thus: []), (combination: [fndg]), (unique genetic factors: [fndg]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0120-5) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(broad asd phenotype, 'Autism Phenotype')

PMCID: 5339506
SFARI Genes: 
Non SFARI Genes: Cdk2, Cdk2, 
Named Entities: (proper: []), (synaptic function: [phsf]), (neural circuits: [bpoc]), (precise pairings: []), (post-synaptic partners: [famg]), (errors: []), (process: [phpr]), (development: [orgf]), (neuropsychiatric disorders: [dsyn]), (autism spectrum disorder (asd): [mobd]), (asd: [cgab]), (genetic factors: [fndg]), (copy number variations: [nusq]), (study: [resa]), (cnv occurring: [nusq]), (locus: [gngm]), (human genome: [gngm]), (investigated potential defects: []), (synaptic connectivity: [bsoj]), (reduced activities: [acty]), (genes: [gngm]), (region: []), (drosophila larval: [euka]), (neuromuscular junctions: [celc]), (well-established model synapse: [bsoj]), (stereotypic synaptic structures: [menp]), (mutation: [genf]), (rolled: [fndg]), (drosophila homolog: [euka]), (human mitogen-activated protein: [humn]), ((mapk3): [aapp,enzy]), (ectopic innervation: [ortf]), (axonal branches: [celc]), (abnormal defasciculation: [qnco]), (specificity: [qnco]), (phenotypes: [orga]), (expression: [topp]), (mutant background: [comd]), (albeit: []), (extent: []), (ectopic innervation patterns: [tisu]), (mutants: [comd]), (cdk2: [gngm]), ( gq: []), (gp93: []), (rolled mapk3: [aapp,enzy]), (further genetic analysis: [lbpr]), (double heterozygous combinations: [orga]), (synergistic interaction: []), (addition: []), ( results: [fndg]), (rt-qpcr analyses: [mbrt]), (mrna levels: [bacs,nnon]), (gp93 mutants: [comd]), (data: [euka]), (central role: [socb]), (mapk3: [gngm]), (precise targeting: []), (presynaptic axons: [celc]), (postsynaptic targets: [diap]), (critical step: [qnco]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(stereotypic synaptic structures, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 5336143
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (summary brain enlargement: [patf]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (timing: []), (phenomenon: [phpr]), (relationship: []), (appearance: [orga]), (behavioral symptoms: [sosy]), (retrospective head circumference: [resa]), (longitudinal brain volume studies: [lbpr]), (year olds: []), (age: [orga]), (years: []), (evidence: []), (brain volume: [qnco]), (development.1: [orgf]), (infants: [aggp]), (high familial risk: [famg]), (autism: [mobd]), (early development: [orgf]), (characteristic social deficits: []), (asd emerge: [cgab]), (latter part: [qnco]), (second year: [qnco]), (life3: []), (4: [fndg]), (observations: [hlca]), (prospective brain: [resa]), (studies: [lbpr]), (asd: [cgab]), (early post-natal changes: [qnco]), (emergence: []), (asd diagnosis: [cgab]), (prospective neuroimaging study: [resa]), (low-risk infants: [aggp]), (cortical surface area hyper-expansion: [bpoc]), (6-12 months: [fndg]), (age precedes brain volume overgrowth: [orga]), (12-24 months: []), (high-risk infants: [fndg]), (months: []), (brain volume overgrowth: [fndg]), (severity: []), (autistic social deficits: [mobd]), (deep learning algorithm: [menp]), (surface area information: []), (brain mri: [diap]), (diagnosis: [fndg]), (individual high-risk children: [aggp]), (positive predictive value: [qnco]), (sensitivity: [patf]), (findings: [clna]), (brain changes: [bpoc]), (period: []), (autistic behaviors: [mobd]), (first emerging: [qnco]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(characteristic social deficits in asd emerge, 'Social Competence')(characteristic social deficits, 'Social Competence')(asd diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')(severity of autistic social deficits, 'Social Competence')(autistic social deficits, 'Social Competence')(autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')

PMCID: 5496244
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent research: [resa]), (significant role: [socb]), (variation: []), (neurodevelopmental disorders: [mobd]), (data: [euka]), (families: [famg]), (autism spectrum: [mobd]), (intellectual disability: [mobd]), (developmental delay: [mobd]), (variants: []), (exome aggregation consortiums cohort: [gngm]), (adults: [aggp]), (neurodevelopmental risk: [ortf]), (loss-of-function (lof)-intolerance metric: [orch,phsu]), ( pli: [gngm]), (subset: []), (lof-intolerant genes: [gngm]), (observed signal: [phpr]), (protein: [aapp,bacs]), (modest excess: []), (inherited ptvs;: [qnco]), (genes: [gngm]), (excess: []), (inherited risk resides: [acty]), (lower-penetrant genes: [gngm]), (findings: [clna]), (importance: []), (population-based reference cohorts: [popg]), (interpretation: [clna]), (candidate pathogenic variants: [fndg]), (analyses: [resa]), (complex diseases: [dsyn]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(developmental delay, 'Learning Disorders')(neurodevelopmental risk, 'Learning Disorders')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 5374041
SFARI Genes: NAA15, KMT5B, ASH1L, NAA15, KMT5B, ASH1L, 
Non SFARI Genes: 
Named Entities: (gene-disruptive mutations: [genf]), (biology: []), (neurodevelopmental disorders: [mobd]), (pathogenic genes: [gngm]), (candidate genes: [gngm]), (>11: []), (730 patients: [podg]), (>2: [qnco]), (867 controls: [sbst]), (genes: [gngm]), (excess: []), (mutations: [genf]), (private disruptive mutations: [genf]), (patients: [podg]), (novel ndd genes: [gngm]), (drosophila: [euka]), (functional assays: [lbpr]), (subset bolster: []), (involvement: []), (ndds: []), (bias: [bird]), (autism versus: [mobd]), (intellectual disability: [mobd]), (network: [popg]), (high-functioning autism (fsiq>100): [qnco]), (clinical follow-up: [hlca]), (naa15: [gngm]), ( kmt5b: [gngm]), (ash1l reveals: [gngm]), (non-syndromic forms: [dsyn]), (disease: [dsyn]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(neurodevelopmental disorders, 'Learning Disorders')(autism versus, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(high-functioning autism, 'Autism Phenotype')

PMCID: 5328751
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (major psychiatric disorders: [mobd]), (attention deficit hyperactivity disorder (adhd): [mobd]), ( autism (aut): [mobd]), (bipolar disorder (bd): [mobd]), (major depressive disorder (mdd): [mobd]), (schizophrenia (sz): [mobd]), (polygenic: [genf]), (evidence: []), (disorders: [dsyn]), (distinct genetic risks: [qnco]), (neural connectivity abnormalities: [cgab]), (aggregate genetic risks: [qnco]), (polygenic risk score (pgrs): [clna]), (computed: [acty]), (independent general populations: [popg]), (n: [aapp,imft]), (cross-disorder pgrs: [dsyn]), (pgrs: []), (specific disorder: [dsyn]), (individual variability: [humn]), (functional connectivity: []), (bilateral insula:: [bpoc]), (left supplementary motor area: [blor]), (left superior temporal gyrus: [bpoc]), (left insula: [bpoc]), (right middle: []), (superior temporal lobe: [bpoc]), (autism: [mobd]), (bilateral midbrain: [bpoc]), (posterior cingulate: [bpoc]), ( cuneus: [bpoc]), (precuneus: [bpoc]), (bd: []), (left: []), (angular gyrus: [bpoc]), (left dorsolateral prefrontal cortex: [bpoc]), (schizophrenia: [mobd]), (significant functional connectivity: [qnco]), (adhd: [mobd]), (mdd: [mobd]), (findings: [clna]), (genetic effects: [topp]), (cross-disorder: [dsyn]), (disorder-specific neural connectivity: [dsyn]), (common genetic risk loci: [gngm]), (general population: [popg]), (polygenic risk contributes: [acty]), (main neurobiological phenotypes: [orga]), (psychiatric disorders: [mobd]), (specific functional connectivity: []), (polygenic risks: [genf]), (neural pathways: [bpoc]), 
ASD Terms: (major psychiatric disorders, 'Mental Disorders')(attention deficit hyperactivity disorder, 'Overactivity')(autism, 'Autism Phenotype')(bipolar disorder, 'Bipolar Disorder')(major depressive disorder, 'Depressive Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(bipolar disorder, 'Bipolar Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(psychiatric disorders, 'Mental Disorders')

PMCID: 5591346
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (nutrition: [fndg]), (important role: [socb]), (neurodevelopment: [ortf]), (insight: [menp]), (research: [resa]), (efficacy: [resa]), (nutrition-related interventions: [topp]), (neurodevelopmental disorders: [mobd]), (review: []), (elimination diet: [topp]), (treatment: [topp]), (attention deficit hyperactivity disorder: [mobd]), (autism spectrum disorder: [mobd]), (focus: []), (food: [imft,phsu]), (exclusion diet: [topp]), (gluten-free/casein-free diet: [hlca]), (oligoantigenic diet: [hlca]), (potential mechanisms: []), (elimination diets effects: [topp]), (main candidate mechanism: []), (microbiomegutbrain axis: [bpoc]), (complex interactions: [chvs]), (multiple systems: [qnco]), (metabolic: [celf]), ( immune: []), ( endocrine: [bdsy]), (neural system: [bdsy]), (practical implications: []), (future directions: []), (investigation: [hlca]), (elimination diets efficacy: [resa]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(elimination diet, 'Dietary Restrictions')(autism spectrum disorder, 'Autism Phenotype')(exclusion diet, 'Dietary Restrictions')(gluten-free/casein-free diet, 'Dietary Restrictions')(oligoantigenic diet, 'Dietary Restrictions')(elimination diets effects, 'Dietary Restrictions')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(elimination diets efficacy, 'Dietary Restrictions')

PMCID: 5328401
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (human brain: [humn]), (outcome: []), (innumerable evolutionary processes;: [genf]), (systems genetics: []), (psychiatric disorders: [mobd]), (signatures: [amas]), (basis: [phsu]), ( attention deficit hyperactivity: [fndg]), (autism spectrum disorder (asd): [mobd]), ( bipolar disorder: [mobd]), (major depressive disorder: [mobd]), (schizophrenia: [mobd]), (gwas: [mbrt]), (summary statistics: []), (psychiatric genomics consortium: [hlca]), (machine learning-derived scores: [mcha]), (natural-selection scenarios:: [npop]), (complete selection (loci: [genf]), (allele: [gngm]), (fixation): [topp]), (incomplete selection (loci: [genf]), (asd gwas results: [cgab]), (incomplete-selection (p: [genf]), (variants: []), (asd gwas p<0.1: [cgab]), (19%-increased probability: [qnco]), (top-5%: []), (incomplete-selection score (or: [genf]), (p: [gngm]), (effect directions: []), (minor alleles: [gngm]), (enrichment: []), (positive associations: [menp]), (snps: [nusq]), (top-5% incomplete-selection score (permutation p<104): [genf]), (set: [menp]), (asd-positive-associated variants: [cgab]), (gene-expression enrichments: [genf]), (brain: [bpoc]), (pituitary tissues: [bpoc]), (respectively): []), (gene ontology (go) enrichments: []), (nervous system development (go:0007399: [gngm]), ( p: [aapp,imft]), (synapse organization (go:0050808: [gngm]), (axon guidance (go:0007411: [celf]), (previous genetic studies: [resa]), (asd: [cgab]), (childhood intelligence: [menp]), ( college completion: [fndg]), (years: []), (schooling: [fndg]), (certain asd risk alleles: [gngm]), (positive selection: [lbpr]), (human evolution: [humn]), (involvement: []), (neurogenesis: [orgf]), (cognitive ability: [menp]), 
ASD Terms: (psychiatric disorders, 'Mental Disorders')(attention deficit hyperactivity, 'Overactivity')(autism spectrum disorder, 'Autism Phenotype')(bipolar disorder, 'Bipolar Disorder')(major depressive disorder, 'Depressive Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(cognitive ability, 'Cognitive Ability')

PMCID: 5680363
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (referred children: [aggp]), (anxiety disorders: [mobd]), (children: [aggp]), (autism spectrum disorder (asd;: [mobd]), (adhd: [mobd]), ((adhd-c; n =: [mobd]), (adhd predominantly inattentive: [mobd]), ((adhd-i; n: [inch]), (children (n: [aggp]), (child quality: [aggp]), (life (qol): [sosy]), ( paternal: [famg]), (maternal psychopathology: [famg]), (parental stress: [fndg]), (diagnoses: [fndg]), (dsm-iv-tr criteria: [gngm]), (multilevel: []), (qol: [sosy]), (ad: []), (school: [mnob,orgt]), (social functioning: [socb]), (asd: [cgab]), (normal controls: []), (domains: []), (fathers: [famg]), (ad children: [aggp]), (mothers: [famg]), (also: []), ( ad: []), (parental psychopathology: []), (other child psychopathology: []), (therefore: []), (parental factors: []), (treatment: [topp]), (adhd/asd: [cgab]), 
ASD Terms: (anxiety disorders, 'Anxiety Disorders')(autism spectrum disorder, 'Autism Phenotype')(adhd combined, 'Attention Deficit Disorder with Hyperactivity')(adhd predominantly inattentive, 'Attention Deficit Disorder with Hyperactivity')(social functioning, 'Ability to Converse in Social Settings')(adhd, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 5294827
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (brain structure: [bpoc]), ( genetics: []), (behaviors: [inbe]), (studies: [lbpr]), (brain: [bpoc]), (age: [orga]), (population: [popg]), (factor: []), (study outcome: [resa]), (sex: [orgf]), (issue: [fndg]), (microarray analyses: [lbpr]), (expression: [topp]), (rnas (sncrnas): [nnon]), (micrornas (mirnas): [bacs,nnon]), (asd: [cgab]), (control temporal cortex: [bpoc]), (males: [orga]), (females: [orga]), (mirna targets: [bacs,nnon]), (pathways: [moft]), (findings: [clna]), ( sexual dimorphism: [ortf]), (asd sncrna expression: [cgab]), (temporal cortex: [bpoc]), (patterning: []), (regions: []), (dimorphic mirnas: [bacs,nnon]), (oligodendrocyte differentiation: [celf]), ( mir-125: []), (neuronal differentiation: [fndg]), (mir-488: []), (anxiety: [mobd]), (putative mirna targets: [bacs,nnon]), (nervous system pathways: [moft]), (sexes: [orgf]), ( consistent: []), (previous mrna: [bacs,nnon]), (common pathways: [moft]), (specific target mrnas: [bacs,nnon]), (male: [orga]), (female target genes: [orga]), (axonal guidance signaling pathway: [celf]), (targets: [diap]), (sexual dimorphism: [ortf]), (sncrna levels: [nnon]), (importance: []), (addition: []), (molecular findings: [clna]), (asd brain: [cgab]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0117-0) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(anxiety, 'Anxiety Disorders')

PMCID: 5286408
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (heterogeneous group: [popg]), (neurodevelopmental disorders: [mobd]), (defined uniting pathophysiology: [bodm]), (ca2+ signaling: [celf]), (potential node: [bpoc]), (genetic architecture: [topp]), (disorder: [dsyn]), (decreased inositol trisphosphate: [orch,phsu,vita]), ((ip3)-mediated ca2+ release: [bacs,orch]), (endoplasmic reticulum: [celc]), (several rare monogenic syndromes: [dsyn]), (autism  fragile x: [mobd]), (tuberous sclerosis types: [neop]), (syndromes: [dsyn]), (findings: [clna]), (cohort: [popg]), (subjects: [humn]), (sporadic asd: [cgab]), (mutations: [genf]), (high throughput fluorometric imaging plate reader (flipr): [lbpr]), (agonist-evoked ca2+ signals: [phpr]), (human primary skin fibroblasts: [cell]), (results: [fndg]), (ip3: [bacs,orch]), (ca2+ release: [hlca]), (response: [fndg]), (activation: [acty]), (purinergic receptors: [aapp,rcpt]), (rare syndromic forms: [dsyn]), (asd: [cgab]), (deficits: []), (ip3-mediated ca2+: [bacs,orch]), (represent: [acty]), (convergent hub function: [phsf]), (spectrum: [qnco]), (autistic disorders: [mobd]), (penetrant mutations: [genf]), (sporadic forms: [fndg]), (biomarker: [clna]), (diagnosis: [fndg]), (novel drug discovery: [resa]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(autism  fragile x, 'Fragile X Syndrome')(tuberous sclerosis types, 'Tuberous Sclerosis')(autistic disorders, 'Autistic Disorder')(diagnosis, 'Diagnosis')

PMCID: 5307131
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disorder: [mobd]), (impaired social communication: [socb]), (repetitive behaviors: [fndg]), (mice serve: [mamm]), (ideal candidate organism: [orgm]), (neural mechanisms: []), (symptoms: [sosy]), (neuroligin-3 (nl3) mouse: [mamm]), (r451c mutation: [genf]), (swedish brothers: [famg]), (asd: [cgab]), ( exhibits: []), (social interactions: [fndg]), (aggressive behavior towards male mice: [mamm]), (female mice: [mamm]), (present study: [qnco]), (male nl3r451c: [orga]), (wt mice: [mamm]), (mice: [mamm]), (isolation conditions: [dsyn]), (isolation-induced increases: [qnco]), (social interaction: [fndg]), (tests: [lbpr]), (potential differences: [qnco]), (interaction: []), (nave: []), (interest: [menp]), (atypical aggressive behavior: [mobd]), (nl3r451c mice: [mamm]), (nl3r451c: []), (normal social interaction: [fndg]), (wt females: [orga]), (abnormal aggressive behavior towards females: [mobd]), (altered motivation: [inbe]), (social isolation: [socb]), (social behavior: [socb]), (isolation housing: [topp]), (response: [fndg]), (female pheromones: [orga]), (study: [resa]), (altered mating behavior: [inbe]), (nl3r451c mouse: [mamm]), (new insights: [menp]), (aggressive phenotype: [mobd]), (model: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(impaired social communication, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(social interactions, 'Reciprocal Social Interaction')(aggressive behavior towards male mice, 'Aggressive Behavior')(social interactions, 'Reciprocal Social Interaction')(social interaction, 'Reciprocal Social Interaction')(atypical aggressive behavior, 'Restricted and Repetitive Behavior')(normal social interaction, 'Reciprocal Social Interaction')(abnormal aggressive behavior towards females, 'Personal Traits')(social behavior, 'Reciprocal Social Interaction')(aggressive phenotype, 'Aggressive Behavior')

PMCID: 5299396
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (multiple: [qnco]), (epidemiological studies: [resa]), (relationship: []), (advanced paternal age (apa): [popg]), (conception: [orgf]), (adverse neurodevelopmental outcomes: [ortf]), (regard: []), (risk: []), (autism: [mobd]), (schizophrenia: [mobd]), (conclusive evidence: []), (age-related changes: [aggp]), (paternal gametes: [cell]), (age-independent behavioral traits: [inbe]), (neural development: [orgf]), (recent evidence: []), (origins: []), (apa effects: [gngm]), (predisposition: [clna]), (events: [evnt]), (review: []), (molecular findings: [clna]), (latter: []), (evidence: []), (epigenetic mechanisms: [genf]), (association: [menp]), (late fatherhood: [socb]), (disorder: [dsyn]), (offspring: [famg]), (limitations: []), (apa literature: [inpr,mnob]), (different hypotheses: []), (instead: []), ( multiple mechanisms: [qnco]), (likely contribute: [acty]), (etiological complexity: [chvs]), (neurodevelopmental disorders: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(adverse neurodevelopmental outcomes, 'Learning Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(disorder in offspring, 'Perinatal History')(offspring, 'Perinatal History')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 5299390
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (environmental contributions: [acty]), (spectrum disorder (asd): [cgab]), (informative content: [menp]), (condition: [dsyn]), (objective: []), (study: [resa]), (associations: [menp]), (medical events: [evnt]), (asd: [cgab]), (autistic traits: [mobd]), (twins: [famg]), (hypothesis: []), (cumulative environmental effect: [npop]), (asd risk: [cgab]), (total: [qnco]), (monozygotic (mz) twin pairs: [famg]), (rare sample: [sbst]), (twin pairs discordant: [famg]), (clinical asd): [cgab]), (dizygotic (dz) twin pairs: [famg]), (intra-pair differences: [qnco]), (early medical events: [evnt]), ((for example: []), ( obstetric: []), (neonatal factors: []), (first year infections): [patf]), (first: [qnco]), ( differences: [qnco]), (multisource: []), (medical records: [clna]), (pairs: []), (significant intra-pair differences: [qnco]), (relation: [socb]), (sample: [sbst]), (generalized estimating equations: [qnco]), (significant association: [menp]), (mz pairs: [phpr]), (cumulative load: [acty]), (clinical asd (z=2.85: [cgab]), ( p=0.004): [fndg]), (p=0.002): [fndg]), (infant dysregulation (feeding: [aggp]), (excessive crying: [fndg]), (worriedness): []), (intelligence quotient: [orga]), (attention deficit hyperactivity disorder comorbidity: [mobd]), (general: [hlca]), (infant dysregulation: [aggp]), (particular: []), (index children: [aggp]), (risk: []), (non-shared environmental contributions: [acty]), (clinical practice: [menp]), (findings: [clna]), (screening: [diap]), (early detection: [diap]), 
ASD Terms: (medical events, 'Medications')(early medical events, 'Medications')(early medical events, 'Medications')(medical records, 'Medications')(early medical events, 'Medications')(intelligence quotient, 'IQ')(attention deficit hyperactivity disorder comorbidity, 'Comorbidities')(early medical events, 'Medications')

PMCID: 5282903
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (sex chromosome aneuploidies: [comd]), (live births: []), (frequent abnormalities: [cgab]), ((turner: []), ((triple x): [qnco]), ((klinefelter syndrome): [cgab,dsyn]), (prevalence: [qnco]), (males: [orga]), (extra sex chromosome (e.g: [celc]), (however: []), (literature: [inpr,mnob]), (little information: [fndg]), (cognitive: []), (behavioural phenotype: [bhvr]), (natural history: []), (disease: [dsyn]), (clinical: []), (neurocognitive: []), ( social cognitive: [socb]), (psychiatric characterization: [acty]), (patient: [podg]), (syndrome: [dsyn]), (case presentation: []), (complex phenotype: [orga]), (particular cognitive profile: [lbpr]), (intellectual deficiency: [mobd]), (autism spectrum disorder (asd): [mobd]), (limited interests: [menp]), (moreover: []), (social anxiety disorder: [mobd]), (selective mutism: [mobd]), (separation anxiety disorder: [mobd]), ((dsm-5 criteria: []), ( mini assessment): [acty]), (unique medical: [hlca]), (behavioural characteristics: [inbe]), (interestingly: []), ( asd: [cgab]), (groups: [popg]), (y chromosome aneuploidy: [comd]), (clinical report: []), (social functioning: [socb]), (patients: [podg]), (new insights: [menp]), (possible therapeutic strategies: [menp]), (cognitive remediation: []), (social cognitive training: [edac]), 
ASD Terms: (extra sex chromosome, 'Down Syndrome')(cognitive, 'Cognitive Ability')(neurocognitive, 'Cognitive Ability')(social cognitive, 'Cognitive Ability')(particular cognitive profile, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(social anxiety disorder, 'Anxiety Disorders')(separation anxiety disorder, 'Anxiety Disorders')(unique medical, 'Medications')(social functioning, 'Ability to Converse in Social Settings')(cognitive remediation, 'Cognitive Ability')(social cognitive training, 'Cognitive Ability')

PMCID: 5282802
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (children: [aggp]), (usa: []), (male-to-female prevalence ratio: [qnco]), (asd: [cgab]), (understood phenomenon: [menp]), (explicit focus: []), (potential etiologic pathways: [moft]), (sex difference: [orga]), (prenatal androgen exposure: [horm,phsu]), (causes: []), (multi-threshold liability model: [qnco]), (genetic mechanisms: [topp]), (females: [orga]), (asd risk: [cgab]), (families: [famg]), (female asd: [cgab]), (pedigree: []), (umbilical cord blood: [tisu]), (early autism risk longitudinal investigation (earli) cohort: [hlca]), (earli: []), (asd-enriched risk cohort: [cgab]), (sibling: [famg]), (fetal testosterone (t): [horm,orch,phsu]), ( androstenedione (a4): [horm,orch,phsu]), (dehyroepiandrosterone (dhea) levels: []), (cord blood: [tisu]), (liquid chromatography-tandem mass spectrometry (lc-ms/ms): [lbpr]), (robust linear regression models: [qnco]), (associations: [menp]), (cord blood androgen levels: [tisu]), (12-month autism observation scales: [hlca]), (infants (aosi) scores: [aggp]), (36-month social responsiveness scale (srs): [acty]), (potential confounders: []), (androgens: [horm,phsu]), (12-month aosi score: [clna]), (36-month total srs score: [clna]), (boys: [aggp]), (girls: [aggp]), (however: []), (association: [menp]), (t: [clna]), (autistic traits: [mobd]), (subjects: [humn]), (female older: [orga]), (months: []), (interaction: []), ( p: [aapp,imft]), (deficits: []), (reciprocal social behavior: [socb]), (male: [orga]), (prenatal testosterone levels: [lbtr]), (findings: [clna]), (positive association: [menp]), (infants: [aggp]), (asd-affected siblings: [famg]), (female suggests: [orga]), (androgen-related mechanism: [horm,phsu]), (dependent on: []), (to: []), ( genetic liability factors: [fndg]), (female asd cases: [cgab]), (initial finding: [sosy]), (small subgroup: [virs]), (sample: [sbst]), (considerable caution: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0118-z) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(explicit focus on potential etiologic pathways, 'Attention and Focus')(prenatal androgen exposure, 'Exposures')(early autism risk longitudinal investigation cohort, 'Autism Phenotype')(early autism risk longitudinal investigation, 'Autism Phenotype')(12-month autism observation scales, 'Autism Phenotype')(reciprocal social behavior, 'Reciprocal Social Interaction')

PMCID: 5261619
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (copy number variations: [nusq]), (increased risk: [qnco]), (autism spectrum disorder (asd) and: [mobd]), (conjunction: []), (other genetic changes: [resa]), ( contribute: [acty]), (heterogeneity: [orga]), (asd phenotypes: [cgab]), (array: []), (comparative genomic hybridization (acgh): [mbrt]), (exome sequencing: [mbrt]), (systems genetics: []), (network analyses: []), (tools: []), (study: [resa]), (complex disorders: [dsyn]), (unknown etiology: [fndg]), (phenotypic heterogeneity: [fndg]), (therefore: []), (complex genotype-phenotype relationship: [orga]), (exomes: [gngm]), (affected siblings: [famg]), (asd: [cgab]), (dysmorphic features: [cgab]), (intellectual disability: [mobd]), (cnvs: [nusq]), (novo: []), (point variationssingle: [qnco]), (variants: []), (small insertions: [hlca]), (deletions: [genf]), (probable functional impacts: [qnco]), (acgh: []), (duplication: [comd]), (region: []), (deletion: [genf]), (paternal balanced translocation: [comd]), ( t(4: []), ((p16; p23): [gngm]), (exome variant analysis: [gngm]), (total: [qnco]), (male: [orga]), (exome data: [gngm]), (female exome data: [gngm]), (integrative network analysis: [genf]), (siblings: [famg]), (translocation: [comd]), (similar syndromic phenotype: [dsyn]), (overgrowth: [fndg]), ( macrocephaly: [cgab]), (however: []), (data: [euka]), (genes: [gngm]), (robustness: []), (network: [popg]), (contribute: [acty]), (understanding: [menp]), (spectrum: [qnco]), (psychiatric symptoms: [sosy]), (importance: []), (integrative approach: [genf]), (genotype-phenotype variability: [orga]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(asd phenotypes, 'Autism Phenotype')(autism spectrum disorder and, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')

PMCID: 5676835
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (anxiety: [mobd]), (threat bias: [bird]), (6-8-year-old children: []), (familial-risk: [famg]), (autism spectrum disorder (asd): [mobd]), (low-risk (lr: [fndg]), ( n: [aapp,imft]), (controls: [sbst]), (high-risk (hr) group: [popg]), (diagnostic criteria: []), (asd: [cgab]), ((hr-asd: [cgab]), ((hr-non asd: [cgab]), (=: []), (hr-asd group: [cgab]), (levels: []), (parent-reported anxiety: [mobd]), (hr-non asd group: [cgab]), (spatial-cueing task: [gngm]), (anxiety symptoms: [fndg]), (asd severity: [cgab]), (findings: [clna]), (mechanisms: []), (hr siblings: [famg]), (non-asd populations: [cgab]), (however: []), (children: [aggp]), ( hypersensitivity: [patf]), (threat: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-016-3012-1) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (anxiety, 'Anxiety Disorders')(autism spectrum disorder, 'Autism Phenotype')(parent-reported anxiety, 'Anxiety Disorders')(anxiety symptoms, 'Anxiety Disorders')(anxiety, 'Anxiety Disorders')(underlie anxiety symptoms, 'Anxiety Disorders')

PMCID: 5264285
SFARI Genes: 
Non SFARI Genes: impact, impact, 
Named Entities: (autism spectrum disorders: [mobd]), (complex neurobiological disorders: [dsyn]), (social interactions: [fndg]), (communication: [socb]), (lead: [elii,hops]), (repetitive: []), (patterns: []), (behavior: [inbe]), ( interests: [menp]), (activities: [acty]), (causes: []), (disorders: [dsyn]), (gut microbiota: [orgm]), (bacteria: [bact]), (human intestines: [humn]), (children: [aggp]), (asd: [cgab]), (gastrointestinal (gi) problems: []), (asd severity: [cgab]), (several previous studies: [lbpr]), (abnormal gut bacteria: [bdsy]), (gut microbiome-asd connection: [orgm]), (mouse model: [emod]), (microbiome: [orgm]), (metabolites: [bacs]), (similarly: []), (study: [resa]), (oral non-absorbable antibiotic treatment: [antb]), (gi: [gngm]), (temporarily: []), (here: []), (small open-label clinical trial: [resa]), (impact: [gngm]), (microbiota transfer therapy (mtt): [orgm]), (gut microbiota composition: [orgm]), (asd symptoms: [cgab]), (asd-diagnosed children: [cgab]), (mtt: [orch]), (2-week antibiotic treatment: [topp]), (bowel cleanse: [bpoc]), (extended fecal microbiota transplant (fmt): [orgm]), (high initial dose: [qnco]), (maintenance doses: [qnco]), (weeks: []), (gastrointestinal symptom rating scale: [sosy]), (reduction: [npop]), (gi symptoms: [sosy]), (end: [gngm]), (treatment: [topp]), (significant improvements: [qnco]), (symptoms: [sosy]), (constipation: [sosy]), ( diarrhea: [sosy]), ( indigestion: [sosy]), (abdominal pain: [sosy]), (improvements: []), (clinical assessments: [resa]), (behavioral asd symptoms: [cgab]), (treatment ended: [topp]), (bacterial: []), (phagedeep sequencing analyses: [lbpr,mbrt]), (successful partial engraftment: [phsf]), (donor microbiota: [orgm]), (beneficial changes: [qnco]), (gut environment: [bdsy]), (specifically: []), (overall bacterial diversity: []), (abundance: []), (bifidobacterium: [bact]), ( prevotella: [bact]), (desulfovibrio: [bact]), (other taxa: []), (changes: [qnco]), (weeks): []), (exploratory: []), ( extended-duration treatment protocol: [topp]), (promising approach: []), (gut microbiome: [orgm]), (virome: []), (behavioral symptoms: [sosy]), ( asd symptoms: [cgab]), (long-term impact: [gngm]), (trial registration: [resa]), (trial: [resa]), (clinicaltrials.gov: [gngm]), (registration number nct02504554 electronic: [qnco]), (supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s40168-016-0225-7) contains: [acty]), (users: [humn]), 
ASD Terms: (stereotyped patterns of behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorders, 'Autism Phenotype')(social interactions, 'Reciprocal Social Interaction')(bacteria, 'Bacterial Infections')(abnormal gut bacteria, 'Bacterial Infections')(asd symptoms, 'Complaints and Indications')(abdominal pain, 'Pain')(behavioral asd symptoms, 'Complaints and Indications')(bacterial, 'Bacterial Infections')(overall bacterial diversity, 'Bacterial Infections')(behavioral symptoms of asd, 'Complaints and Indications')(asd symptoms, 'Complaints and Indications')(asd symptoms, 'Complaints and Indications')

PMCID: 5226683
SFARI Genes: 
Non SFARI Genes: GPR141, 
Named Entities: (gene-gene interaction: [genf]), (epistasis: [fndg]), (large role: [socb]), (complex traits: [gngm]), (model: []), (genome-wide searches: [gngm]), (two-way interaction: [qnco]), (power: [hcpp]), (human studies: [humn]), (knowledge: []), (biological pathway: [moft]), (order: [acty]), (contribution: [acty]), (spectrum disorders: [dsyn]), (humans: [humn]), (reverse-pathway genetic approach: [moft]), (previous observation: [hlca]), (increased asd symptoms: [cgab]), (mendelian disorders: [dsyn]), (ras/mapk pathway (rasopathies): [gngm]), (common snps: [nusq]), (rasopathy genes: [gngm]), (enrichment: []), (association signal: [menp]), (gwas (p: [mbrt]), (genome-wide: [gngm]), (interactors: []), (rasopathy gene snps: [gngm]), (strong enrichment: []), (asd-affected individuals: [cgab]), (number: [qnco]), (pairwise interactions: []), (genome-wide criteria: [gngm]), (significance: [qnco]), (quantitative measures: [qnco]), (asd symptoms: [cgab]), (rasopathy-affected individuals: [humn]), (gwas: [mbrt]), (top region: []), (independent approaches: [fndg]), (dysregulation: []), (gene: [gngm]), (region: []), ( gpr141: [gngm]), (rasopathy: []), (neural cell line: [cell]), (orthogonal approaches: []), (strong evidence: []), (asds: [cgab]), (role: [socb]), (ras/mapk pathway: [gngm]), (idiopathic asds: [cgab]), (convergent candidate gene: [gngm]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(increased asd symptoms, 'Complaints and Indications')(asd symptoms, 'Complaints and Indications')(idiopathic autism spectrum disorders, 'Autism Phenotype')

PMCID: 5545734
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (attention-deficit/hyperactivity disorder (adhd): [mobd]), (autism spectrum disorders: [mobd]), (heritable; however: []), (genetic risk variants: [npop]), (glutamate: [aapp,bacs]), (gaba: [aapp,bacs]), (main excitatory: []), (inhibitory neurotransmitters: [bacs]), (brain;: [bpoc]), (balance: [fndg]), (proper brain development: [ortf]), (functioning: []), (study: [resa]), (role: [socb]), (gaba genetics: [aapp,bacs]), (adhd: [mobd]), (autism symptom severity: [mobd]), (inhibitory performance: [acty]), (gene: [gngm]), (approach: []), (multiple genetic variants simultaneously: [npop]), (common variants: [qnco]), (glutamatergic: []), (gabaergic genes: [gngm]), (magma software: [inpr,mnob]), (case-only sample (n=931): [aapp,imft]), (asd symptoms: [cgab]), (response inhibition: [acty]), (stop task: [acty]), (analysis: [resa]), (adhd symptom severity: [mobd]), (inattention: [mobd]), (hyperactivity/impulsivity: [mobd]), (autism: [mobd]), (symptom severity: [fndg]), (inhibition: [acty]), (principal component regression analyses: [qnco]), (subsequently: []), (gene-wide association analyses: [lbpr]), (performed: []), (glutamate gene: [gngm]), (association: [menp]), (severity: []), (hyperactivity/impulsivity (p=0.009): [mobd]), (genome-wide association levels: [menp]), (gaba gene set: [aapp,bacs]), (significant association: [menp]), (inhibition (p=0.04): [acty]), (survive correction: [phsu]), (multiple comparisons: [acty]), (none: []), (single gene: [fndg]), (single variant associations: [fndg]), (own: []), (multiple genetic variants: [npop]), (candidate gene sets: [menp]), (genetic associations: []), (involvement: []), (excitatory: []), (inhibitory neurotransmitter systems: [acty]), (asd: [cgab]), 
ASD Terms: (attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism spectrum disorders, 'Autism Phenotype')(attention-deficit/hyperactivity disorder severity, 'Attention Deficit Disorder with Hyperactivity')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(asd symptoms, 'Complaints and Indications')(response inhibition, 'Response Inhibition')(attention-deficit/hyperactivity disorder symptom severity, 'Attention Deficit Disorder with Hyperactivity')(inattention, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 5352796
SFARI Genes: mark, mark, 
Non SFARI Genes: 
Named Entities: (genetic liability: [topp]), (spectrum disorder (asd): [cgab]), (unaffected relatives: [famg]), (subclinical: []), (meaningful traits: [gngm]), (endophenotypes: []), (study: [resa]), (developmental endophenotypes: [orgf]), (parents: []), (individuals: [humn]), (asd: [cgab]), (parents childhood: []), (academic development: [orgf]), (school-age period: [mnob,orgt]), (cohort: [popg]), (children: [aggp]), (controls: [sbst]), (parents childhood records: [qnco]), (domains: []), (language: [lang]), ( reading: [dora]), (math: []), (grades k-12: [fndg]), (results: [fndg]), (performance: [inbe]), (development: [orgf]), (skills: [inbe]), ((particularly language: [lang]), (skills): [inbe]), (uneven rate: [qnco]), (asd endophenotypes: [cgab]), (adulthood: []), (severity: []), (clinical symptoms: [sosy]), (findings: [clna]), (childhood indicators: [irda]), (understanding: [menp]), (subclinical expression: [topp]), 
ASD Terms: (academic development, 'Performance in School')

PMCID: 5222512
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction: [hlca]), (number: [qnco]), (previous studies: [lbpr]), (possible association: [menp]), (toxic metals: [inpo]), (autism: [mobd]), (half: [qnco]), (studies: [lbpr]), (toxic metal levels: [inpo]), (individuals: [humn]), (autism spectrum disorders: [mobd]), (additionally: []), (several studies: [lbpr]), (levels: []), (severity: []), (asd: [cgab]), (order: [acty]), (paper: []), (detailed statistical analysis: [resa]), (date: []), (data set: []), (field: [irda]), (morning: []), (urine samples: [bdsu]), (children: [aggp]), (adults: [aggp]), (neurotypical controls: [sbst]), (similar age: [orga]), (gender: [orga]), (samples: [sbst]), (urinary toxic metals: [inpo]), (autism-related symptoms: [mobd]), (eleven behavioral measures: [qnco]), (statistical analysis: [resa]), (participants: [popg]), (asd spectrum: [cgab]), (neurotypical participants: [popg]), (utm data alone: [fndg]), (analysis: [resa]), (association: [menp]), (autism severity: [mobd]), (toxic metal excretion data: [inpo]), (nonlinear analysis: [resa]), (leave-one-out cross-validation: [resa]), (statistical independence: []), (results: [fndg]), (discussion average excretion levels: [qnco]), (several toxic metals: [inpo]), (tin: [elii]), ( thallium: [elii]), ( antimony): [elii]), (asd group: [cgab]), (however: []), ( asd classification: [cgab]), (univariate statistics: [resa]), (large variability: [qnco]), (nonlinear multivariate statistical analysis: [resa]), (asd classification: [cgab]), (type i/ii errors: [inch]), (respectively: []), (urinary toxic metal excretion profiles: [inpo]), (similarly: []), (nonlinear methods: []), (behavioral measures: [qnco]), (toxic metal excretion: [inpo]), (aberrant behavior checklist: [inbe]), (subscales: []), (irritability: [fndg]), ( stereotypy: [mobd]), ( hyperactivity: [mobd]), (inappropriate speech): [orgf]), (significant associations: [menp]), (utm: []), (autism-related assessments: [mobd]), (cross-validation r2: [neop]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism severity, 'Autism Phenotype')

PMCID: 5257193
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (complexity: [chvs]), (heterogeneity: [orga]), (findings: [clna]), (individuals: [humn]), (autism spectrum disorder: [mobd]), (underlying alterations: []), (many brain regions: [blor]), (networks: []), (ability: [orga]), (multivariate brain features: [bpoc]), (neuroimaging measures: [diap]), (individual variation: [humn]), (neurobiological mechanisms: []), (autism: [mobd]), (present study: [qnco]), (mahalanobis: []), (multidimensional counterpart: []), (euclidean distance: [resa]), (informative index: [qnco]), (individual brain variation: [bpoc]), (deviation: [fndg]), (longitudinal diffusion tensor: [npop]), (data: [euka]), (participants: [popg]), (controls): [sbst]), (years: []), (age: [orga]), (10-year period: [fndg]), (mahalanobis distance: [qnco]), (regional measures: [qnco]), (white matter microstructure: [tisu]), (mahalanobis distances: [qnco]), (autistic individuals: [mobd]), (increased atypicalities: [qnco]), (variation: []), (group: [popg]), (distributions: []), (multivariate measures: [qnco]), (discrimination: [socb]), (sensitive delineation: [patf]), (conventional univariate measures: [qnco]), (observed traits: [gngm]), (autism group: [mobd]), (results: [fndg]), (heterogeneous neurodevelopmental disorder: [orga]), (measures: [qnco]), (multiple brain regions: [blor]), (improved insight: [menp]), (diversity: []), (brain measures: [bpoc]), (same regions: []), (multidimensional brain relationships: [bpoc]), (neuroimaging-based phenotypes: [diap]), (help: []), (underlying neural mechanisms: []), (brain variation: [bpoc]), (autism spectrum disorders: [mobd]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(years of age, 'Onset of Symptoms')(autism group, 'Autism Phenotype')(substantiate autism, 'Autism Phenotype')(heterogeneous neurodevelopmental disorder, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 6093436
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract atypical: [fndg]), (cortical organization: [bpoc]), (reduced integrity: [inbe]), (graywhite matter boundary: []), (postmortem studies: [diap]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (however: []), (vivo studies: [lbpr]), (particular features: []), (asd: [cgab]), (hence: []), (structural magnetic resonance imaging: [diap]), (differences: [qnco]), (tissue contrast: [irda]), (white matter: [tisu]), (adults: [aggp]), (controls: [sbst]), (hypothesis: []), (specifically: []), (contrast: [irda]), (percentage: [qnco]), (gray: [qnco]), (white matter tissue: [tisu]), (signal intensities: [qnco]), (different cortical layers: [bpoc]), (gwpc: []), (several clusters: [qnco]), (cortex (cluster: [bpoc]), ( p: [aapp,imft]), (reductions: [npop]), (tissue intensities: [tisu]), (matter interface: []), (distinct graywhite matter boundary: []), (vivo findings: [clna]), (reduced gwpc: []), (prior postmortem findings: [diap]), (well-defined graywhite matter boundary: []), (results: [fndg]), (vivo: []), (proxy measure: [grup]), (atypical cortical microstructural organization: [bpoc]), (future studies: [lbpr]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5339767
SFARI Genes: mark, mark, mark, mark, 
Non SFARI Genes: 
Named Entities: (kleefstra syndrome (ks): [dsyn]), ((mendelian inheritance: [genf]), (man (mim) no: [humn]), (deletion syndrome: [genf]), (autosomal dominant disorder: [dsyn]), (haploinsufficiency: [comd]), (euchromatic histone methyltransferase-1 (ehmt1): [gngm]), (clinical phenotype: [orga]), (ks: [gngm]), (intellectual disability: [mobd]), (absent speech: [fndg]), ( hypotonia: [fndg]), ( brachycephaly: [cgab,dsyn]), (congenital heart defects: [cgab]), (dysmorphic facial features: [fndg]), (hypertelorism: [cgab]), ( synophrys: [cgab]), ( macroglossia: [cgab]), (tongue: [bpoc]), (prognathism: [cgab]), (few cases: [qnco]), (missense mutations: [genf]), (ehmt1: [gngm]), (rise: []), (however: []), (ehmt1 variants: [gngm]), (individuals: [humn]), (autism spectrum disorder: [mobd]), (mild intellectual disability: [mobd]), (phenotypic spectrum: [orga]), (ehmt1 alterations: [gngm]), (report: [hlca]), (unrelated patients: [podg]), (complex medical histories: [fndg]), (next generation: [acty]), (same novel c.2426c>t (p.p809l) missense variant: [fndg]), (functional significance: [qnco]), (novel variant: []), (molecular dynamics simulations: [mcha]), (wild type: [gngm]), (p.p809l variant: [aapp,imft]), (latter: []), (propensity: []), (histone mark binding: [amas]), (recombinant ehmt1 p.p809l: [gngm]), (uv: [npop]), (circular dichroism spectroscopy: [npop]), (intrinsic protein fluorescence: [npop]), (functional studies: [lbpr]), (model-based hypotheses: []), (evidence: []), (protein misfolding: [aapp,bacs]), (aberrant target recognition: [menp]), (pathogenic mechanism: [fndg]), (novel ks-associated variant: [qnco]), (first report: [qnco]), (missense variants: [fndg]), (misfolding: []), 
ASD Terms: (absent speech, 'Language Ability')(intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(mild intellectual disability, 'Learning Disorders')(complex medical histories, 'Medications')

PMCID: 5217649
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (causes: []), (autism: [mobd]), (environmental factors: []), (neurobiological changes: [qnco]), (behavioral features: [inbe]), (disorder: [dsyn]), (immune factors: [imft]), (inflammation: [patf]), (pathogenic influences: [fndg]), (cohort: [popg]), (participants: [popg]), (assessment: [acty]), (immune mediators: [imft,phsu]), (cytokines: [aapp,imft]), ( chemokines: [aapp,imft]), (growth factors: [aapp,bacs]), (serum: [bdsu]), (cerebrospinal fluid (n: [bdsu]), (potential influences: []), (such mediators: [orch,phsu]), (controls: [sbst]), (evidence: []), (differences: [qnco]), (blood profile: [bdsu]), (active systemic inflammation mechanisms: [fndg]), (modulators: []), (immune function (e.g.: [ortf]), ( egf: []), (soluble cd40 ligand): [aapp,imft]), (autism group; however: [mobd]), (group differences: [popg]), (traditional markers: [clna]), (active inflammation: [fndg]), (il-6: [gngm]), ( tnf: [aapp,bacs]), ( il-1): [aapp,imft]), (further: []), (within-subject stability: [humn]), (intraclass correlations): []), (analytes: [sbst]), (low: [qnco]), ( indicating: []), (single measurement: [fndg]), (reliable prospective indicator: [resa]), (concentration: [menp]), (additionally: []), (little correspondence: [fndg]), (blood: [bdsu]), (csf profiles: [lbpr]), (growth: [orgf]), (peripheral markers: [clna]), (immune status: [phsf]), (central nervous system: [bdsy]), (high fraction: [qnco]), (intrathecal production: [bsoj]), (chemokines: [aapp,imft]), (monocyte/microglia function: [cell]), (possible relationship: []), (homeostatic role: [socb]), (microglia: [cell]), ( control data: [euka]), (further interpretation: [clna]), (relevance: []), (longitudinal observations: [hlca]), (support: []), (hypothesized role: [socb]), (disturbances: []), (expression: [topp]), (indicator: [irda]), (systemic inflammation: [patf]), (clinicaltrials.gov: [gngm]), ( nct00298246: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-016-0115-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')(cerebrospinal fluid, 'Hydrocephalus')(autism group, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5409128
SFARI Genes: DYRK1A, DYRK1A, DYRK1A, DYRK1A, DYRK1A, DYRK1A, 
Non SFARI Genes: 
Named Entities: (abstract haploinsufficiency: [comd]), (dyrk1a: [gngm]), (recognizable developmental syndrome: [dsyn]), (mechanism: []), (action: [acty]), (pathogenic missense mutations: [genf]), (novo mutations: [genf]), (gene: [gngm]), (missense mutations: [genf]), (deciphering developmental disorder study: [mobd]), (protein: [aapp,bacs]), (structural analysis reveals: [topp]), (atp: [aapp,enzy]), (binding-sites: [rcpt]), (kinase domain: [aapp,enzy]), (protein stability: []), (loss: [qnco]), (proteins function mechanism: [phsf]), (furthermore: []), (correlation: []), (magnitude: [qnco]), (change: [qnco]), (severity: []), (resultant phenotype: [orga]), (comparison: [acty]), (distribution: []), (pathogenic mutations: [genf]), (length: [qnco]), (natural variants: []), (exac database: []), (mutations: [genf]), (n-terminal end: []), (protein function: [moft]), (particular: []), (proximity: []), (substrate peptide: [aapp]), (dominant mutations: [genf]), (dyrk1a account: [clna]), (severe developmental disorders: [mobd]), (kinase function: [phsf]), 
ASD Terms: 

PMCID: 5382976
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (difficulties: [fndg]), (social communication: [socb]), (part: [qnco]), (phenotypic overlap: [orga]), (autism spectrum disorders: [mobd]), (conditions: [dsyn]), (however: []), ( distinct developmental patterns: [orgf]), (symptoms: [sosy]), (asd: [cgab]), (early childhood: []), (schizophrenia: [mobd]), (early adulthood: [aggp]), (overlap: [topp]), (common genetic influences: [qnco]), (clinical conditions: [dsyn]), (impairments: [patf]), (developmental stage: []), (assessed trait: [orga]), (social communication difficulties: [socb]), (typically-developing youth (avon longitudinal study: [resa]), (parents: []), (children: [aggp]), ( n5553: []), (longitudinal assessments: [hlca]), (years): []), (social communication disorder checklist: [mobd]), (data: [euka]), (clinical asd: [cgab]), (cases: [qnco]), (controls): [sbst]), (controls: [sbst]), (trios): [aapp,enzy]), (psychiatric genomics consortium (pgc): [hlca]), (danish ipsych project: []), (genetic influences: [topp]), (development: [orgf]), (pgc-asd: [cgab]), (ipsych-asd sample: [cgab]), (genetic overlap: [topp]), (contrast: [irda]), (independent pgc-scz2 subsamples: [fndg]), (increase: []), (magnitude: [qnco]), (traits: [gngm]), (schizophrenia-related polygenic effects: [mobd]), (changes: [qnco]), (trait-disorder links: [dsyn]), (heterogeneity: [orga]), (genetic factors: [fndg]), (childhood versus: []), (thus: []), (schizophrenia share: [mobd]), (reveal distinct developmental profiles: [lbpr]), (genetic links: [topp]), ( consistent: []), (onset: [qnco]), (clinical symptoms: [sosy]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(autism spectrum disorders, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(symptoms of asd, 'Complaints and Indications')(social communication, 'Reciprocal Social Interaction')(social communication difficulties, 'Reciprocal Social Interaction')(social communication disorder checklist, 'Reciprocal Social Interaction')(social communication difficulties, 'Reciprocal Social Interaction')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(social communication difficulties, 'Reciprocal Social Interaction')(social communication difficulties, 'Reciprocal Social Interaction')(onset, 'Onset of Symptoms')(schizophrenia share, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 5389537
SFARI Genes: FMRP, FMRP, FMRP, FMRP, 
Non SFARI Genes: 
Named Entities: (abstract human cells: [lbtr]), (topoisomerases: [aapp,enzy]), (nucleus: [celc]), (cytoplasm: [celc]), (major topoisomerase: [aapp,enzy]), (mrnas: [bacs,nnon]), (top3: [gngm]), (only known topoisomerase: [aapp,enzy]), (rna topoisomerase activity: [nnon]), (mrna translation machinery: [moft]), (interacts: []), (rna-binding protein: [aapp,bacs]), ( fmrp: [aapp,bacs]), (synapse formation;: [ortf]), (top3 gene deletion: [genf]), (abundant mrna-binding topoisomerase: [aapp,enzy]), (cells: [cell]), (other topoisomerases: [aapp,enzy]), (distinctive rna-binding domain;: [aapp,bacs]), (deletion: [genf]), (domain: []), (amount: [qnco]), (rna binding domain: [aapp,bacs]), (moreover: []), ( top3 mutants: [comd]), (rna-binding domain: [aapp,bacs]), (catalytic residue fail: [npop]), (synapse formation: [ortf]), (mrna-binding: [genf]), (catalytic activity: [qnco]), (neurodevelopment: [ortf]), (notably: []), ( top3: [gngm]), (point mutations: [comd]), (schizophrenia: [mobd]), (autism individuals: [mobd]), (association: [menp]), (fmrp;: [aapp,bacs]), (mutants: [comd]), (rna topoisomerase reaction: [nnon]), (data: [euka]), (rna binding: [genf]), (prevent mental dysfunction: [mobd]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism individuals, 'Autism Phenotype')(prevent mental dysfunction, 'Mental Retardation')

PMCID: 5201278
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (developmental disorders: [mobd]), (autism spectrum disorder (asd): [mobd]), (intellectual disability (id): [mobd]), (common group: [popg]), (clinical manifestations: []), (variety: []), (genetic abnormalities: [fndg]), (genetic testing: [lbpr]), (chromosomal microarray (cma): [celc]), (important role: [socb]), (conditions: [dsyn]), (cma: [celf]), (incomplete coverage: [qnco]), (lack: []), (guidance: [hlca]), (physicians: []), (longitudinal: []), (trial: [resa]), (impact: [gngm]), (resolution: [qnco]), ((mm) probe-cma test: [lbpr]), (quality: []), (care: [acty]), (general pediatricians: [hlca]), (specialists: []), (twin problems: [famg]), (adequate sample size: [qnco]), (multiple rare conditions: [dsyn]), (under/incorrect diagnoses: [fndg]), (simulated patients: [edac]), (cpvs: [orch,phsu]), (control: [sbst]), (intervention groups: [popg]), (cpv: [orch,phsu]), (pediatric patients: [podg]), (dd/asd/id: [cgab]), (care responses: [orga]), (evidence-based criteria: []), (round one: [qnco]), ( participants: [popg]), (order: [acty]), (diagnostic tests: [diap]), (cma tests: [lbpr]), (round two: [qnco]), ( intervention physicians: [hlca]), (probe-cma test: [lbpr]), (outcome measures: [qnco]), (overall quality: []), (diagnosis: [fndg]), (treatment plan: []), ((p<0.001): [fndg]), (overall quality scores: [clna]), (intervention physicians: [hlca]), (use: []), ((p<0.001) improvement: [fndg]), (treatment score: [clna]), (introduction: [hlca]), (significant improvements: [qnco]), (condition-specific interventions: [dsyn]), ((p: [aapp,imft]), (improvement: []), (evaluation: [hlca]), (therapy: [topp]), (gross motor delays: []), (hunter: []), (increase: []), (early cognitive intervention: [hlca]), (foxg1-related disorder: [dsyn]), (referrals: [hlca]), (neurology: []), (dravet syndrome: [dsyn]), (physician use: [clna]), (treatment quality: [topp]), (simulated cases: [bodm]), (pediatric dd/asd/id patients: [cgab]), (delivers: [phsu]), (additional clinical utility: [orgt]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(diagnosis, 'Diagnosis')(treatment plan, 'Planning')(therapy for gross motor delays, 'Motor Skills')(early cognitive intervention, 'Cognitive Ability')(child neurology, 'Neurologic Indications')(gross motor delays, 'Motor Skills')(diagnosis, 'Diagnosis')

PMCID: 5379861
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (healthy individuals: [humn]), (anterior cingulate gyrus signals: [phpr]), (social prediction errors: discrepancies: [fndg]), (actual outcome: []), (perceived expectations: [menp]), (person: [grup]), (balsters: []), (al: [lbpr]), (demonstrate: []), (crucial social signal: [phpr]), (individuals: [humn]), (autism: [mobd]), (variability: []), (social prediction error: []), (indexes: [qnco]), (social symptom severity: [fndg]), 
ASD Terms: (autism, 'Autism Phenotype')

PMCID: 5318360
SFARI Genes: 
Non SFARI Genes: rest, 
Named Entities: (abstract introduction: [hlca]), (adaptive interactions: []), (environment: []), (individual representation: [acty]), (physical world: [hlca]), (sensation: [ortf]), (evaluation: [hlca]), (available information: []), (prior knowledge: [evnt]), (sensory evidence: []), (higherlevel expectations: []), (central nervous system (cns): [bdsy]), ((td) individuals relies: [humn]), (part: [qnco]), (interacting cortical regions: [bpoc]), (neuronal signals: [phpr]), (brain: [bpoc]), (evidence: []), (balance: [fndg]), (levels: []), (signal: [phpr]), (noise: [phpr]), (information processing: [menp]), (individuals: [humn]), (autism spectrum disorders: [mobd]), (participants: [popg]), (asd: [cgab]), (visuospatial interference task: []), (functional magnetic resonance imaging (fmri): [diap]), (parameters: [fndg]), (participants latencies: [popg]), (subtle fluctuations: [sosy]), (accumulation): [fndg]), (scan: [diap]), (hemodynamic activation: [ortf]), (analyses: [resa]), (dysfunction: [dsyn]), (interferencespecific connectivity: []), (subset: []), (asd participants: [cgab]), (td participants: [popg]), (age: [orga]), ( maletofemale ratio: [qnco]), (magnitude: [qnco]), (movement: [orgf]), (stochastic patterns: []), (response fluctuations: [sosy]), (noisetosignal levels: []), (noisy structure: [phpr]), (asd versus td participants: [cgab]), (particular asd adults: [cgab]), (clinical autistic deficits: [mobd]), (modulation: []), (interferencespecific functional connectivity: []), (td individuals: [humn]), (seeds: [plnt]), (anterior cingulate cortex (acc): [bpoc]), (inferior parietal sulcus (ips): [bsoj]), (rest: [gngm]), (uncertainty: [fndg]), (task: [gngm]), (interferencespecific: []), (bilateral anterior insula: [bpoc]), (prefrontal cortex: [bpoc]), (subtle: [clna]), (informative differences: [fndg]), (structure: []), (information exist: []), (findings: [clna]), (atypical capacity: [qnco]), (information: []), (manner: []), (adaptive functioning: []), (suboptimal messagepassing: []), (cns: [bdsy]), 
ASD Terms: (adaptive interactions, 'Adaptive Life Skills')(information processing, 'Ability to Convey Information')(autism spectrum disorders, 'Autism Phenotype')(adaptive functioning, 'Adaptive Life Skills')

PMCID: 5285408
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (distinct developmental asdadhd subtypes: [orgf]), (distinct time: []), (onset: [qnco]), (symptoms: [sosy]), ( progression: [patf]), (combination: [fndg]), (aim: [phsu]), (present narrative review: [qnco]), (structural brain: [bpoc]), (studies: [lbpr]), (light: [gngm]), (key brain areas: [bpoc]), (asd: [cgab]), (adhd symptoms: [mobd]), (undergo significant changes: [qnco]), (development: [orgf]), (findings: [clna]), (brain mechanisms: [bpoc]), (differential developmental asdadhd subtypes: [orgf]), (end: [gngm]), (literature: [inpr,mnob]), (adhd: [mobd]), (structural brain imaging symptoms: [bpoc]), (adolescent years: [aggp]), (beyond: []), (vast majority: [socb]), (mri studies: [diap]), (children: [aggp]), (include adolescents: [aggp]), (well: []), (age group: [aggp]), (age effects: [orga]), (adults: [aggp]), (asd and/or adhd: [cgab]), (age: [orga]), (linear effects: []), (data: [euka]), (various studies: [lbpr]), (crucial distinctive feature: []), (different developmental asdadhd subtypes: [orgf]), (differential developmental: [orgf]), (patterns: []), (anterior cingulate cortex: [bpoc]), (related connections: [fndg]), (other prefrontal regions: []), (regions: []), (cognitive/effortful control: [sbst]), (socio-emotional functioning: [menp]), (impairments: [patf]), (features: []), 
ASD Terms: (onset, 'Onset of Symptoms')(adhd symptoms, 'Attention Deficit Disorder with Hyperactivity')(adhd, 'Attention Deficit Disorder with Hyperactivity')(asd and/or adhd, 'Attention Deficit Disorder with Hyperactivity')(different developmental asdadhd subtypes, 'Learning Disorders')

PMCID: 5175196
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (severe neurodevelopmental disease: [mobd]), (high incidence: [qnco]), (effective biomarkers: [clna]), (diagnosis: [fndg]), (few previous studies: [lbpr]), (detection: [topp]), (mirna biomarkers: [bacs,nnon]), (autism diagnosis: [mobd]), (bioinformatics approaches: []), (study: [resa]), (knowledge-guided bioinformatics model: []), (autism mirna biomarkers: [bacs,nnon]), (gene expression microarray data: [genf]), (geo database: []), (genes: [gngm]), (expression levels: [qnco]), (asd: [cgab]), (controls: [sbst]), (autism-specific mirnamrna network: [popg]), (inferred candidate autism biomarker mirnas: [bacs,nnon]), (regulatory modes: [qnco]), (functions: [phsf]), (novel parameter: [qnco]), (autism gene percentage: [gngm]), (autism-specific knowledge: [mobd]), (identification: [menp]), (autism-specific biomarker mirnas: [bacs,nnon]), (finally: []), (mirnas: [bacs,nnon]), (putative autism biomarkers: [mobd]), (mirnas (72.7%): [bacs,nnon]), (asd samples: [cgab]), (previous reports: [hlca]), (functional enrichment results: [fndg]), (targets: [diap]), (autism-associated pathways: [mobd]), (wnt: []), ((in kegg: []), (ipa): [bacs,orch,phsu]), (cycle (in kegg): []), (glioblastoma multiforme: [neop]), ((in ipa): [bacs,orch,phsu]), (predictive power: [hcpp]), (model: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(severe neurodevelopmental disease, 'Learning Disorders')(diagnosis, 'Diagnosis')(autism diagnosis, 'Diagnosis')(autism mirna biomarkers, 'Autism Phenotype')(inferred candidate autism biomarker mirnas, 'Autism Phenotype')(autism gene percentage, 'Autism Phenotype')(putative autism biomarkers, 'Autism Phenotype')

PMCID: 5354807
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (excesses: []), (sex chromosome abnormalities: [cgab,dsyn]), (patients: [podg]), (psychiatric diseases: [mobd]), (sex differences: [orga]), (studies: [lbpr]), (evidence: []), (susceptibility loci: [clna]), (many sex: [orgf]), (chromosomal regions: [cell]), (various mental diseases: [mobd]), ( others: [fndg]), (sex chromosome aneuploidies: [comd]), (key: []), (pathogenesis: [patf]), (psychiatric disease: [mobd]), (review: []), (current evidence: [npop]), (interaction: []), (schizophrenia: [mobd]), ( autism: [mobd]), ( adhd: [mobd]), (mood disorders: [mobd]), 
ASD Terms: (psychiatric diseases, 'Mental Disorders')(various mental diseases, 'Mental Disorders')(psychiatric disease, 'Mental Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(adhd, 'Attention Deficit Disorder with Hyperactivity')(mood disorders, 'Mood Disorders')

PMCID: 5198096
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (pediatric: []), (traumatic brain injury (tbi): [inpo]), (autism spectrum disorder (asd): [mobd]), (serious conditions: [dsyn]), (youth: [aggp]), (recent data: [euka]), (clinical: []), ( show: [anim]), (pediatric tbi: [inpo]), (asd share: [cgab]), (similar symptoms: [sosy]), (same biologic mechanisms: [bacs]), (symptoms: [sosy]), (prominent symptoms: [sosy]), (disorders: [dsyn]), (gastrointestinal problems: []), (difficulties: [fndg]), ( seizures: [sosy]), (sensory processing disruption: [ortf]), (review: []), (mechanisms: []), (order: [acty]), (potential treatment options: [topp]), (condition: [dsyn]), (pharmacologic options: []), (potential novel drug targets: [diap]), (advances: []), (understanding: [menp]), (brain circuitry: [bpoc]), (improved imaging modalities: []), (forward: []), (imaging: [diap]), (diagnosis: [fndg]), (treatment planning strategies: [menp]), (pediatric patients: [podg]), (lessons: []), (field: [irda]), (rigorous trials: [resa]), (guidelines: []), (tbi: [inpo]), (asd: [cgab]), 
ASD Terms: (traumatic brain injury, 'Post-Traumatic Stress Disorders')(autism spectrum disorder, 'Autism Phenotype')(pediatric traumatic brain injury, 'Post-Traumatic Stress Disorders')(treatment planning strategies, 'Planning')(diagnosis, 'Diagnosis')

PMCID: 5159983
SFARI Genes: 
Non SFARI Genes: DLL1, 
Named Entities: (autism spectrum disorders: [mobd]), (prevalent neurodevelopmental disorders: [qnco]), (early childhood: []), (asd cases: [cgab]), (likely arise: []), (complex mixture: [sbst]), (environmental factors: []), (interface: []), (epigenetic marks: []), (dna methylation: [moft]), (risk biomarkers: []), (placenta: [emst]), (useful surrogate tissue: [tisu]), (methylation pattern: [moft]), (domains: []), (methylated domains: [phsu]), (reflective: [menp]), (methylation patterns: [moft]), (early embryo: [emst]), (study: [resa]), (human term placentas: [humn]), (marbles (markers: [inch]), (autism risk: [mobd]), (babies: learning early signs): [menp]), (prospective study: [resa]), (whole genome bisulfite sequencing: [inch,phsu]), (utility: [orgt]), (pmd/hmds: [dsyn]), (methylation differences: [moft]), (asd diagnosis: [cgab]), (age three: [orga]), (human placental methylomes: [humn]), (reproducible pmd: [dsyn]), (hmd locations: [horm,orch,phsu]), (variation: []), (individuals: [humn]), (methylation levels: [moft]), (pmds: [anab]), (hmds: [horm,orch,phsu]), (individual variability: [humn]), (comparison: [acty]), (placental samples: [emst]), (asd: [cgab]), ((td) children: [aggp]), (hmd: [horm,orch,phsu]), (putative fetal brain enhancer: [nnon]), (dll1: [gngm]), (genome-wide significance: [gngm]), (methylation: [moft]), (pyrosequencing: [lbpr]), (results: [fndg]), (informative surrogate tissue: [tisu]), (predictive asd biomarkers: [cgab]), (high-risk families: [famg]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-016-0114-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(prevalent neurodevelopmental disorders, 'Learning Disorders')(asd diagnosis, 'Diagnosis')

PMCID: 5157977
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (duplications: []), (15q11.2-q13.1 (dup15q syndrome): [dsyn]), (autism spectrum disorder (asd): [mobd]), (distinct electrophysiological (eeg) pattern: [diap]), (excessive activity: [clna]), (beta band: [celc]), (clinical reports: []), (eeg power: [diap]), (other frequency bands: [qnco]), (children: [aggp]), (dup15q syndrome: [dsyn]), (non-syndromic asd: [cgab]), (clinical correlates: []), (electrophysiological biomarker: [clna]), (first study: [qnco]), (spontaneous eeg: [diap]), (dup15q: []), ((n: [aapp,imft]), (age-and-iq-matched children: [aggp]), (asd (n =: [cgab]), ((td) children: [aggp]), (relative power: [hcpp]), (frequency bands: [qnco]), (regions: []), (interest (rois): [menp]), (group comparisons: [popg]), (repeated measures analysis: [qnco]), (variance: [qnco]), (second study: [resa]), (cohort: [popg]), (individuals: [humn]), ((n =: [aapp,imft]), (sites: []), (age: [orga]), ( epilepsy: [dsyn]), (duplication type: [qnco]), (predictors: []), (beta power: [hcpp]), (simple linear regressions: [qnco]), (spontaneous beta1 (1220 hz): [qnco]), ((2030 hz) power: [hcpp]), (comparison groups: [popg]), (delta (14 hz): [qnco]), (effect sizes: []), (large (|d|: [qnco]), (beta2 power: [hcpp]), (diagnosis: [fndg]), (here: []), (clinical stratification: [resa]), ( treatment monitoring: [resa]), (measurement: []), (target engagement: [fndg]), (future clinical trials: [resa]), (future work: []), (neural underpinnings: []), (electrophysiological signature: [amas]), (functional consequences: []), (excessive beta oscillations: [topp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(epilepsy, 'Epilepsy')(epilepsy diagnosis, 'Diagnosis')

PMCID: 5468514
SFARI Genes: NaV1.7, SCN9A, NaV1.7, SCN9A, NaV1.7, NaV1.7, SCN1A, SCN2A, NaV1.1, NaV1.2, SCN9A, NaV1.7, SCN1A, SCN2A, NaV1.1, NaV1.2, SCN9A, NaV1.7, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (complex neurodevelopmental disorder: [mobd]), (intellectual disability: [mobd]), ( language impairment: [mobd]), (medical co-morbidities: [hlca]), (heritability: []), (autism: [mobd]), (multiple genes: [fndg]), (causal: []), (however: []), (genes: [gngm]), (cases: [qnco]), (understanding: [menp]), (familial autism: [mobd]), (whole-exome sequencing: [mbrt]), (families: [famg]), (third-degree relatives: [humn]), (novel: []), (protein-altering variants: [aapp,bacs]), (small set: [menp]), (candidate genes: [gngm]), (novel private missense c1143f variant: [fndg]), (second intracellular loop: [celc]), (voltage-gated sodium channel nav1.7: [bacs,elii]), (scn9a gene: [gngm]), (family: [famg]), (electrophysiological analysis: [resa]), (nav1.7c1143f: [gngm]), (partial loss-of-function effects: [phsf]), (recovery: [acty]), (inactivation: []), (decreased excitability: [sosy]), (cultured cortical neurons: [bpoc]), (furthermore: []), (same intracellular loop: [celc]), (nav1.7: [gngm]), (excess: []), (rare variants: [gngm]), (casecontrol: []), (variant-burden study: [resa]), (functional analysis: [hlca]), (variants: []), ( m932l/v991l: []), (reduced firing: []), (cortical neurons: [bpoc]), (variant: []), (caucasians: [popg]), (latino population: [popg]), (genetic background: [orga]), (effects: []), (phenotype: [orga]), (involvement: []), (scn1a: [gngm]), (scn2a genes: [gngm]), (nav1.1: [gngm]), (nav1.2 channels: [gngm]), (asd: [cgab]), (study: [resa]), (inherited scn9a variants: [gngm]), (partial loss-of-function: [phsf]), (nav1.7 channels: [gngm]), (etiology: []), (rare familial asd: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(complex neurodevelopmental disorder, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(language impairment, 'Language Ability')(medical co-morbidities, 'Medications')(autism, 'Autism Phenotype')(familial autism, 'Autism Phenotype')

PMCID: 5187870
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (copy number variants: [nusq]), (chromosomal microarray analysis (cma): [celc]), (etiology: []), (autism spectrum disorder (asd): [mobd]), (other related conditions: [dsyn]), (recognition: [menp]), (value: [qnco]), (cma: [celf]), (impact: [gngm]), (medical management: [hlca]), ( cma: [celf]), (medical guidelines: [hlca]), (first-tier test: [lbpr]), (evaluation: [hlca]), (children: [aggp]), (disorders: [dsyn]), (routine care: [acty]), (patients: [podg]), (clinical findings: [sosy]), (study: [resa]), (results: [fndg]), (years: []), (clia-certified clinical testing laboratory: [hlca]), (probe microarray: [chvf]), (detection: [topp]), (cnvs: [nusq]), (neurodevelopmental disorders: [mobd]), (overall cnv detection rate: [nusq]), (consecutive patients: [podg]), (cases: [qnco]), (asd: [cgab]), (only developmental delay/intellectual disability (dd/id): [mobd]), (multiple congenital anomalies: [cgab]), (overall detection rate: [topp]), (individuals: [humn]), (detection rate: [topp]), (pathogenic yield: [fndg]), (indications: []), (testing: []), ( age: [orga]), (gender: [orga]), (specialty: []), (ordering doctor: [acty]), (discrete differences: [qnco]), (common recurrent cnvs: [nusq]), (diagnosis: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(medical management, 'Medications')(medical guidelines, 'Medications')(neurodevelopmental disorders, 'Learning Disorders')(only developmental delay/intellectual disability and/or, 'Learning Disorders')(diagnosis, 'Diagnosis')

PMCID: 5157792
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disorder: [mobd]), (changes: [qnco]), (cortical volume: [bpoc]), (constituents: [sbst]), (cortical thickness: [bpoc]), (surface area: []), (separable developmental trajectories: [orgf]), (different neurobiological processes: [phpr]), (however: []), (developmental trajectories: [orgf]), (asd: [cgab]), (magnetic resonance: [npop]), ((mri) study: [diap]), (accelerated longitudinal design: [acty]), (cortical development: [ortf]), (individuals: [humn]), (controls: [sbst]), (years: []), (cortical measures: [bpoc]), (freesurfer software package: []), (linear mixed model analyses: [qnco]), (cortical measure: [bpoc]), (primary finding: [sosy]), (development: [orgf]), (linear trajectory: []), (differs: []), (typical development: [orgf]), (decline: []), (cortical surface area: [bpoc]), (ages: [bacs,orch]), (pattern: []), (regions: []), (groups: [popg]), (stringent correction: []), (interdependency: [socb]), (measures: [qnco]), (account: [clna]), (effect: []), (significance: [qnco]), (left banks: []), (superior temporal sulcus: [bsoj]), (postcentral area: []), (right supramarginal area: []), (areas: []), (interpretation: [clna]), (processing: [acty]), (audiovisual social stimuli: [phpr]), (distinction: []), (self: []), (others: [fndg]), (differences: [qnco]), (thickness: []), (found: [qnco]), ( none: []), (multiple testing: [qnco]), (study: [resa]), (importance: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')

PMCID: 5142147
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (illumina: []), (array: []), (epigenetic association studies: [menp]), (current quality-control (qc) pipelines: [npop]), (certain sets: [menp]), (probes: [chvf]), (snp: [nusq]), (multiple mapping locations: [acty]), (additional set: [menp]), (problematic probes: []), (dna methylation distributions: [moft]), (distinct clusters: [qnco]), (gaps: []), (data-driven identification: [menp]), (such probes: [chvf]), (additional insights: [menp]), (downstream analyses: [resa]), (procedure: [topp]), (gap hunting: []), (: []), (distributions: []), (peripheral blood samples: [bdsu]), (study: [resa]), (early development: [orgf]), (gap: [gngm]), (vast majority (9199): [socb]), (underlying snp(s): [nusq]), (other variant: []), (probe: [chvf]), (snp-affected probes: [mbrt]), (gap signals: [phpr]), (specific factors: []), (snps lead: [elii,hops]), (type: [qnco]), (nucleotide change: [nnon]), ( probe type: [qnco]), ( dna strand: [bacs,nnon]), (overall methylation state: [moft]), (effects: []), (paired genotype: [orga]), (data: [euka]), (same samples: [sbst]), (gap probes: [chvf]), (surrogate: [famg]), (local genetic sequence: [nusq]), (haplotype scale: [orga]), (population stratification: [popg]), (characteristics: []), (informative biology: []), (qc pipelines: [aapp,enzy]), (efficient data-driven approach: [menp]), (flags gap probes: [chvf]), (careful interpretation: [clna]), (downstream association analyses: [menp]), (results: [fndg]), (illumina epic array: [lbpr]), (similar chemistry: [lbpr]), (content design: [acty]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13072-016-0107-z) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: 

PMCID: 5554617
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (intense interest: [menp]), (modifiable risk factors: [qnco]), (autism-spectrum disorders: [mobd]), (autism-related traits: [mobd]), (continuous fashion: []), ( share risk factors: [qnco]), (asd: [cgab]), (informative phenotypes: [orga]), (population-based cohort studies: [resa]), (body: [humn]), (research: [resa]), (gestational vitamin d deficiency: [dsyn]), (altered brain development: [ortf]), (common exposure: [clna]), (candidate: []), (modifiable risk factor: [qnco]), (association: [menp]), (continuous measure: [qnco]), (years: []), ((social responsiveness scale; srs): [acty]), (large population-based cohort: [popg]), (mothers: [famg]), (children: [aggp]), (25-hydroxyvitamin d (25ohd): [horm,orch,phsu]), (maternal mid-gestation sera: [orgf]), (neonatal sera: [bdsu]), (cord blood): [tisu]), (vitamin d deficiency: [dsyn]), (concentrations: [menp]), (nmol l1: [gngm]), (sufficient group (25ohd>50: [popg]), (deficient: [qnco]), ((more: []), (abnormal) srs: [qnco]), ((mid-gestation n=2866: [orgf]), ( =0.06: [fndg]), ( p<0.001; cord blood: [tisu]), (n=1712: [aapp,imft]), ( =0.03: [fndg]), ( p=0.01): [fndg]), (findings: [clna]), (models: []), (european ancestry: [popg]), ( (b): []), (sample structure: [sbst]), (genetic data: [euka]), ((d): []), (effect: []), (season: []), (blood sampling: [diap]), (large population-based sample: [sbst]), (safe: []), ( cheap: []), (accessible supplements: []), (candidate risk factor warrants: [qnco]), (scrutiny: []), 
ASD Terms: (intense interest, 'Intense Interests')(gestational vitamin d deficiency, 'Perinatal History')(common exposure, 'Exposures')(gestational vitamin d deficiency, 'Perinatal History')(vitamin d deficiency, 'Dietary Supplements')(accessible supplements, 'Dietary Supplements')

PMCID: 5129651
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (complex conditions: [dsyn]), (pathogenesis: [patf]), (interactions: []), (definitive mechanisms: []), (environmental triggers: [clna]), (asd: [cgab]), (involvement: []), (inflammation: [patf]), (immunity: [phsf]), (inappropriate antigen: [imft]), (impaired intestinal barrier: [bpoc]), (passage: []), (antigens: [imft]), (immune-activated complexes: [aapp,imft]), (permissive bloodbrain: [inbe]), ((bbb): [bpoc]), (part: [qnco]), (chain: []), (events: [evnt]), (disorders: [dsyn]), (goal: []), (altered bbb: [bpoc]), (gut permeability: [npop]), (pathophysiology: [patf]), (postmortem: [diap]), (cerebral cortex: [bpoc]), (cerebellum tissues: [bpoc]), ( schizophrenia (scz): [mobd]), (healthy subjects: [popg]), (duodenal biopsies: [diap]), (hc: [gngm]), (gene: [gngm]), (protein expression profiles: [lbtr]), (tight junctions: [bsoj]), (other key molecules: [sbst]), (neurovascular unit integrity: [inbe]), (function: [phsf]), (neuroinflammation: []), (claudin: []), (asd cortex: [bpoc]), (cerebellum: [bpoc]), (cldn-3: []), ( tricellulin: [aapp,bacs]), (mmp-9: [aapp,enzy]), (il-8: [gngm]), ( tpa: [aapp,enzy,phsu]), (iba-1: []), (scz: []), (il-1b: [gngm]), (scz cerebellum: [bpoc]), (differences: [qnco]), (genes: [gngm]), (brain areas: [bpoc]), (cldn-5 protein: [aapp,bacs]), (cldn-12: []), (scz cortexes: [bpoc]), (asd samples: [cgab]), (expression: [topp]), (barrier-forming tj components: []), ((cldn-1: []), ( ocln: [gngm]), ( tric): [gngm]), (pore-forming cldns: [celc]), ((cldn-2: []), ( -10: [fndg]), ( -15): []), (asd brain: [cgab]), (altered expression: [topp]), (bbb integrity: [bpoc]), (increased neuroinflammation: [qnco]), (gut: [bdsy]), (integrity: [inbe]), (findings: [clna]), (possibility: []), (distinct scz subgroups: [virs]), (additional studies: [lbpr]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(inappropriate antigen, 'Allergies')(antigens, 'Allergies')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 5126876
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (heterogeneous disorder: [fndg]), (deficits: []), (communication: [socb]), (social interactions: [fndg]), (high rate: [qnco]), (co-occurring disorders: [dsyn]), (metabolic abnormalities: [cgab]), ( gastrointestinal: []), (sleep disorders: [dsyn]), (seizures: [sosy]), (present: [qnco]), (cognitive development: [menp]), (mortality rate: [qnco]), (asd population: [cgab]), (relative prevalence: [qnco]), (non-febrile seizures: [dsyn]), (children: [aggp]), (idiopathic asd: [cgab]), (multiplex: []), (simplex families: [famg]), (unaffected siblings: [famg]), (cohort: [popg]), (autism genetic resource exchange: [mobd]), (secondary analysis: [neop]), (life-time prevalence: [qnco]), (statistical models: [inpr,qnco]), (non-independence: []), (data: [euka]), (multiplex families: [famg]), (potential confounding effects: []), (age: [orga]), ( gender: [orga]), (history: [orga]), (febrile seizures: [dsyn]), (odds: []), (asd: [cgab]), (logistic regression analysis: [resa]), (familial clustering: [resa]), ( children: [aggp]), (times: [qnco]), (comparison: [acty]), (presence: [qnco]), (gastrointestinal dysfunction: [dsyn]), (prevalence: [qnco]), (further studies: [lbpr]), (modifiable risk factors: [qnco]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social interactions, 'Reciprocal Social Interaction')(metabolic abnormalities, 'Metabolic Indications')(cognitive development, 'Cognitive Ability')(autism genetic resource exchange, 'Autism Phenotype')

PMCID: 5125044
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (half: [qnco]), (genome: [gngm]), (parents: []), (small number: [qnco]), (novel mutations: [comd]), (gametogenesis: [ortf]), (postzygotically: []), (recent genome: [gngm]), (studies: [lbpr]), (trios: [aapp,enzy]), (first insights: [menp]), (number: [qnco]), (distribution: []), (mutations: [genf]), (health: []), (disease: [dsyn]), (factors: []), (offspring: [famg]), (de: []), (major cause: []), (severe early-onset genetic disorders: [dsyn]), (intellectual disability: [mobd]), ( autism spectrum disorder: [mobd]), (other developmental diseases: [mobd]), (occurrence: []), (generation: [acty]), (lethal disorders: [dsyn]), (population: [popg]), (recent studies: [lbpr]), (paternal origin: [famg]), (number increases: [qnco]), (advanced paternal age: [popg]), (here: []), (recent literature: [inpr,mnob]), (detection: [topp]), (biological characterization: [acty]), (medical impact: [gngm]), 
ASD Terms: (offspring, 'Perinatal History')(intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(medical impact, 'Medications')

PMCID: 5121959
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (behavioral observation: [topp]), (lack: []), (laboratory biomarkers: []), (clinicians: []), (reliable diagnoses: [fndg]), (metabolomics: []), (human biofluids: [humn]), (sensitive tool: [patf]), (metabolite profiles: [lbpr]), (biomarkers: [clna]), (asd: [cgab]), (initial metabolomic studies: [lbpr]), (urines: [bdsu]), (plasma: [bdsu]), (individuals: [humn]), (autistic patients: [mobd]), (share: [socb]), (metabolic abnormalities: [cgab]), (several inconsistencies: [qnco]), (differences: [qnco]), (technology: []), ( ethnicity: [popg]), ( age range: [qnco]), (definition: []), (control status: [sbst]), (asd-specific urinary metabolomic patterns: [cgab]), (early age: [orga]), (asd children: [cgab]), (controls: [sbst]), (m:f: [inch,phsu]), (hydrophilic interaction chromatography: [lbpr]), (mass: [dsyn]), (sensitive: [patf]), ( accurate: []), (unbiased approach: []), (metabolites: [bacs]), (statistical analysis: [resa]), (metabolic pathway: []), (urinary metabolites: [bpoc]), (young asd: [cgab]), (children: [aggp]), (tryptophan: [aapp,bacs,phsu]), (metabolic pathways: []), (also: []), ( vitamin b6: [orch,phsu,vita]), (phenylalanine-tyrosine-tryptophan biosynthesis: [moft]), ( pantothenate: [aapp,phsu,vita]), (coa: []), (pyrimidine metabolism: [moft]), (significantly: []), (xanthurenic acid: [bacs,orch]), (quinolinic acid (two catabolites: [bacs,orch]), (kynurenine pathway): [aapp,bacs]), (expense: [qnco]), (kynurenic acid: [orch,phsu]), (melatonin: [horm,orch,phsu]), (gut microbiome contributes: [orgm]), (tryptophan metabolism: [moft]), (increased levels: [qnco]), (indolyl 3-acetic acid: [horm,orch]), (indolyl lactate: [orch,phsu]), (young italian autistic children: [podg]), (rodent models: [mamm]), (maternal immune activation: [acty]), (genetic manipulations: [mbrt]), (results: [fndg]), (proposal: []), (purine-driven cell danger response: [orch]), (overproduction: []), (excitotoxic quinolinic acid: [bacs,orch]), (large reductions: [npop]), (melatonin synthesis: [moft]), (gut dysbiosis: [patf]), (several comorbidities: [qnco]), (seizures: [sosy]), ( sleep disorders: [dsyn]), (gastrointestinal symptoms: [sosy]), (severity: []), (diagnostic sensitivity: [qnco]), ( disease-specificity: [qnco]), (interethnic variability: [popg]), (investigation: [hlca]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-016-0109-5) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(metabolic abnormalities, 'Metabolic Indications')(vitamin b6, 'Dietary Supplements')(several comorbidities, 'Comorbidities')(autism severity, 'Autism Phenotype')

PMCID: 5128902
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction longitudinal studies: [resa]), (evolution: [genf]), (autism spectrum disorder (asd) symptoms: [mobd]), (measurements: []), (several months: [qnco]), (however: []), ( measurements: []), (changes: [qnco]), (everyday life: []), (real life: []), (patient: [podg]), (family: [famg]), (child's asd symptoms: [cgab]), (effect: []), (quality: []), (life: []), ( psychological status: [mobd]), (anxiety: [mobd]), (child's parents: [famg]), (6-month period: []), (smartautism: []), (smartphone application: [qnco]), (method: [lbpr]), (analysis: [resa]), (prospective: [resa]), ( longitudinal: []), ( exploratory: []), (open study: [resa]), (6-month follow-up period: [hlca]), (data: [euka]), (multiple weeks: [qnco]), (natural conditions: [dsyn]), (factors: []), (parents: []), (children: [aggp]), (asd: [cgab]), (children's functional symptoms: [aggp]), (feasibility: []), (asd patients: [cgab]), (primary objective:: [topp]), (child's behaviour: [inbe]), (months: []), (social) effects: []), (secondary objective: assess: [neop]), (application: [qnco]), (filling rate: [qnco]), (application usage: [qnco]), (families: [famg]), (child: [aggp]), (baseline: [bodm]), ( sociodemographic: []), ( psychiatric: [hlca]), (medical data: [euka]), (correlations: []), (general epidemiological variables: [hlca]), ((primary outcome measure): []), (multivariate analysis: [qnco]), (rate (relative: [qnco]), (ideal: []), (rate): [qnco]), ((secondary outcome measure): []), (ethics: []), (dissemination: []), (smartautism study: [resa]), (approval: []), (local ethics committee: []), (data security: []), (use: []), (encryption: []), (secure: [bodm]), (medical server: [popg]), (autism resource centres: [mobd]), (france: []), 
ASD Terms: (autism spectrum disorder symptoms, 'Complaints and Indications')(child's asd symptoms, 'Complaints and Indications')(anxiety, 'Anxiety Disorders')(anxiety, 'Anxiety Disorders')(medical data, 'Medications')(medical server, 'Medications')(autism resource centres, 'Autism Phenotype')

PMCID: 5119728
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (folic acid supplementation: [topp]), (early pregnancy (up: [dsyn]), (weeks: []), (gestation): [orgf]), (neural tube defects: [fndg]), (folate effects: [orch,phsu,vita]), (neuro-structural defects: []), (alterations: []), (emotional skills: [menp]), (autism spectrum disorders: [mobd]), (other developmental disorders: [mobd]), (objective: []), (review: []), (evidence: []), (impact: [gngm]), (folic acid: [orch,phsu,vita]), (neurodevelopment: [ortf]), (ntds: [fndg]), (online search: []), (relevant literature: [inpr,mnob]), (national library: [gngm,nnon]), (medicine: [phsu]), (medline: []), (embase: []), (dec: [fndg]), (http://www.ncbi.nlm.nih.gov/entrez/query/fcgi: [hcro]), (http://www.elsevier.com/online-tools/embase): []), (files: []), (english literature): [inpr,mnob]), (following key: []), (folate: [orch,phsu,vita]), (folic acid (171322 papers: [orch,phsu,vita]), (search);: [acty]), (maternal: [famg]), (pregnancy: [orgf]), (gestation: [orgf]), (periconception: []), (periconceptional (1349219 papers: []), (autism: [mobd]), (developmental delay: [mobd]), (development: [orgf]), (mental: [menp]), (cognitive: []), (language: [lang]), (gross motor: []), (fine motor: []), (behaviour: [inbe]), (intelligence: [menp]), (bayley scale (8268145 papers: [acty]), (search): [acty]), (papers: []), (issues: [fndg]), (total: [qnco]), (original papers: []), (association: [menp]), (human pregnancy: [humn]), (neurodevelopment/autism: [mobd]), (screening: [diap]), (studies: [lbpr]), (beneficial effect: []), (significant difference: [qnco]), (study: [resa]), (harmful effect: []), (mg: [elii,phsu]), (folic acid supplementation/day: [topp]), (folic: []), (supplementation: [topp]), (beneficial effects: []), (children: [aggp]), (proven effect: []), 
ASD Terms: (folic acid supplementation, 'Dietary Supplements')(autism spectrum disorders, 'Autism Phenotype')(gestation, 'Perinatal History')(autism, 'Autism Phenotype')(developmental delay, 'Learning Disorders')(cognitive, 'Cognitive Ability')(supplementation, 'Dietary Supplements')(folic acid supplementation, 'Dietary Supplements')(supplementation, 'Dietary Supplements')

PMCID: 5354548
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (physiological abnormalities: [cgab]), (abnormal redox: [moft]), (mitochondrial metabolism: [celc]), (lymphoblastoid cell lines: [cell]), (children: [aggp]), (asd exhibit: [cgab]), (oxidative stress: [comd]), (glutathione redox capacity: [aapp,bacs]), (active mitochondria: [celc]), (increased vulnerability: [qnco]), (oxygen species: [elii,phsu]), (unaffected siblings (sibs): [famg]), (individuals: [humn]), (asd share: [cgab]), (redox: [moft]), (lcls: []), (sibs share asd-associated mitochondrial abnormalities: [famg]), (mitochondrial bioenergetics: [celc]), (sets: [menp]), (asd: [cgab]), ( sibs: [famg]), (unrelated/unaffected controls: [sbst]), (acute increases: [qnco]), (ros: [gngm]), (additionally: []), (intracellular glutathione: [aapp,bacs]), (uncoupling protein: [aapp,bacs]), ((ucp2) gene expressions: [genf]), (sib lcls: [famg]), ( asd lcls: [cgab]), (atp-linked respiration: [phsf]), (maximal: [qnco]), (respiratory capacity: [qnco]), (glycolysis: [moft]), (glycolytic reserve: [moft]), (asd lcls: [cgab]), (change: [qnco]), (parameters: [fndg]), (sib: [famg]), (con lcls: []), (con: []), (proton: [elii]), (respiration: [phsf]), (this: []), ( intracellular glutathione redox capacity: [aapp,bacs]), (ucp2 gene expression: [genf]), (data: [euka]), (mitochondrial respiratory function: [celc]), (abnormal redox homeostasis: [moft]), ( distinguishes: []), (unaffected lcls.rose: [plnt]), ( s.: []), ( bennuri: []), ( s. c.: [clna]), ( wynne: []), ( r.: [clna]), ( melnyk: []), ( james: []), ( s. j.: [clna]), ( frye: []), ( r. e. mitochondrial: [celc]), (redox abnormalities: [moft]), (autism: [mobd]), (lymphoblastoid cells:: [cell]), (control study: [resa]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5155555
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract children: [aggp]), (autism spectrum disorders: [mobd]), (gastrointestinal problems: []), (imbalances: [sosy]), (gut microbial population: [popg]), (treatment: [topp]), (antibiotics: [antb]), (pro/prebiotics: [orch]), (microbiota: [orgm]), (gut symptoms: [sosy]), (lack: []), (evidence: []), (such approaches: []), (prebiotics: [orch]), (study: [resa]), (influence: []), (prebiotic galactooligosaccharide (b-gos): [orch]), (gut microbial ecology: [bdsy]), (metabolic function: [phsf]), (faecal samples: [bdsu]), (non-autistic children: [podg]), (vitro gut model system: [bdsy]), (bacteriology: []), (flow cytometry: [lbpr]), (fluorescence: [npop]), (situ hybridization: [mbrt]), (metabolic activity: [acty]), (hplc: [lbpr]), (children: [aggp]), (asd: [cgab]), (number: [qnco]), (clostridium spp: [bact]), (bifidobacteria: [bact]), (b-gos administration: [topp]), (bifidobacterial populations: [bact]), (compartment: []), (models: []), (non-autistic-derived samples: [mobd]), (lactobacilli: [bact]), (final vessel: [bpoc]), (non-autistic models: [mobd]), (addition: []), ( changes: [qnco]), (other bacterial population: [popg]), (clostridium: [bact]), ( rosburia: []), ( bacteroides: [bact]), ( atopobium: [bact]), ( faecalibacterium prausnitzii: [bact]), ( sutterella spp: [gngm]), (veillonellaceae: [bact]), (b-gos: []), (short-chain fatty acid production: [bacs,orch]), (increased ethanol: [orch,phsu]), (lactate: [orch,phsu]), (autistic children: [podg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(other bacterial population, 'Bacterial Infections')

PMCID: 5128689
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (copy number variants: [nusq]), (chromosomal microarray analysis (cma): [celc]), (etiology: []), (neurodevelopmental disorders: [mobd]), (developmental delay (dd): [mobd]), (intellectual disability (id): [mobd]), (autism spectrum disorder (asd): [mobd]), (study: [resa]), (results: [fndg]), (years: []), (cma: [celf]), (laboratory: [mnob,orgt]), (patients: [podg]), (neurodevelopmental conditions: [dsyn]), (rare copy number variants: [nusq]), (2.8-million probe custom cma: [celf]), (detection: [topp]), (cnvs: [nusq]), (overall detection rate: [topp]), (neurodevelopmental cohort: [popg]), (cases: [qnco]), (dd/id and/or mca: [bpoc]), (detection rate: [topp]), (asd cohort: [cgab]), (pathogenic yield: [fndg]), (primary indications: []), (testing: []), (age: [orga]), (individuals tested: [humn]), (specialty: []), (ordering doctor: [acty]), (significant difference: [qnco]), (ultrahigh resolution: [qnco]), (array: []), (comparison: [acty]), (increase: []), (efficient: []), (effective medical management: [hlca]), (clinic: [hcro,mnob]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(developmental delay, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental conditions, 'Learning Disorders')(cases with developmental delay/intellectual disability and/or mca, 'Learning Disorders')(neurodevelopmental cohort, 'Learning Disorders')(developmental delay/intellectual disability and/or mca, 'Learning Disorders')(neurodevelopmental conditions, 'Learning Disorders')(effective medical management, 'Medications')

PMCID: 5147776
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (sexual dimorphism: [ortf]), (common disease: [dsyn]), (dramatic male preponderance: [orga]), (autism spectrum disorders: [mobd]), (potential: []), (genetic explanations: [topp]), (liability threshold model: []), (polymorphism risk: [genf]), (females: [orga]), ( sex-limited x-chromosome contribution: [celc]), (gene-environment interaction: [genf]), (differences: [qnco]), (hormonal milieu: []), ( risk: []), (genes: [gngm]), (early brain development: [ortf]), (contribution: [acty]), (general mechanisms: [hlca]), (secondary sex characteristics: [neop]), (large single nucleotide polymorphism (snp) dataset: [nusq]), (distinct sex-specific genome-wide significant loci: [orgf]), (genetic hypotheses: [topp]), (evidence: []), (genetic risk load: [qnco]), (sex heterogeneity: [orgf]), (x chromosome: [celc]), (sex-heterogeneous snps: [orgf]), (anthropometric traits: [resa]), (asd risk: [cgab]), (thus: []), (results: [fndg]), (pleiotropy: []), (secondary sex: [orgf]), (characteristic determination: [lbpr]), (asds: [cgab]), (biological basis: [phsu]), (sex differences: [orga]), (non brain-limited mechanisms: [bpoc]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(differences in hormonal milieu, 'Endocrine System Diseases')

PMCID: 5116076
SFARI Genes: mTOR, mTOR, mTOR, Pten, mTOR, Pten, mTOR, mTOR, 
Non SFARI Genes: 
Named Entities: (multiple autism risk genes: [fndg]), (regulation: [biof]), (mtor signalling: [aapp,enzy]), (key effector: []), (neuronal growth: [orgf]), (connectivity: []), (early postnatal development: [orgf]), (cerebral cortex: [bpoc]), (germ-line heterozygous pten: [aapp,enzy]), (mutant mice (pten+/): [mamm]), (macrocephaly/autism syndrome: [dsyn]), (basolateral amygdala (bla): [bpoc]), (input: []), (subcortical-projecting neurons: [cell]), (medial prefrontal cortex (mpfc): [celc]), (analysis: [resa]), (mpfc: []), (bla: []), (axonal projections reveals: [celc]), (pten+/ mice exhibit: [mamm]), (axonal branching: [celf]), (increased activity: [fndg]), (response: [fndg]), (social stimuli: [phpr]), (social behavioural deficits: [socb]), (phenotypes: [orga]), (pharmacological inhibition: [acty]), (s6k1: [gngm]), (early postnatal life: []), (activity: [acty]), (mpfcbla circuitry: []), (adulthood: []), (findings: [clna]), (mechanism: []), (altered connectivity: []), (potential relevance: []), (pathophysiology: [patf]), (autism spectrum disorders: [mobd]), (dysregulated mtor signalling: [aapp,enzy]), 
ASD Terms: (multiple autism risk genes, 'Autism Phenotype')(social behavioural deficits, 'Personal Traits')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 5109935
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (oxytocin (ot): [aapp,horm,phsu]), (focus: []), (investigations: [hlca]), (autism spectrum disorder (asd): [mobd]), (social deficits: []), (asd: [cgab]), (connectivity: []), (brain sites: [bpoc]), (mesolimbic reward pathway (nucleus accumbens; amygdala): [bpoc]), (ot projections: [menp]), (social motivation: [menp]), (cortical sites: [bpoc]), (social perception: [menp]), (functional magnetic resonance imaging: [diap]), (randomized: [resa]), (double blind: [resa]), ( placebo-controlled crossover design: [resa]), (ot administration: [hlca]), (asd increases activity: [cgab]), (brain regions: [blor]), (social-emotional information: [menp]), (further: []), ( ot: [hlca]), (nodes: [bpoc]), (brains reward: [menp]), (socioemotional processing systems: [acty]), (social (versus nonsocial) stimuli: [phpr]), (effect: []), (coherent versus: [fndg]), (biological motion: [npop]), (happy versus: [menp]), (angry voices: [menp]), (findings: [clna]), (mechanism: []), (intranasal ot: [hlca]), (social motivationone: []), (could: []), (future: []), (behavioral treatments: [topp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social deficits, 'Social Competence')(social perception, 'Cognitive Ability')

PMCID: 5108086
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (common neurodevelopmental disorder: [mobd]), (other diseases: [dsyn]), (asthma: [dsyn]), ( inflammatory bowel disease: [dsyn]), (infections: [patf]), ( cerebral palsy: [dsyn]), (cardiomyopathy: [dsyn]), ( muscular dystrophy: [cgab,dsyn]), (schizophrenia: [mobd]), (however: []), (molecular basis: []), (co-occurrence: []), (component: []), (pathophysiology: [patf]), (environmental triggering: [clna]), (illness: [sosy]), (this: []), (three-tiered transcriptomic meta-analysis: [lbpr,mbrt]), (functions: [phsf]), (gene: [gngm]), ( pathway: [moft]), (disease levels: [dsyn]), (asd: [cgab]), (co-morbidities: []), (analysis: [resa]), (novel: []), (innate: []), (immune component: []), (examined: [fndg]), (particular: []), (toll-like receptor signaling: [aapp,rcpt]), (chemokine: [aapp,imft]), (pathways: [moft]), (key pathways: [moft]), (innate immune response: [orga]), (shared statistical significance: [qnco]), (moreover: []), (disease genes: [gngm]), (immunity pathways: [phsf]), (cases: [qnco]), (co-morbidities vs. controls: [sbst]), (% accuracy: []), (finding: [sosy]), (neuropsychiatric condition: [dsyn]), (majority: [socb]), (non-brain-related co-morbidities share: [bpoc]), (dysregulated signal: [phpr]), (common genetic basis: [phsu]), (diseases: [dsyn]), (link: []), (environmental triggers: [clna]), (possibility: []), (treatment and/or prophylaxis: [topp]), (disorders: [dsyn]), (innate immunity: [orga]), (asd patients: [cgab]), (immune-related phenotypes: [orga]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13059-016-1084-z) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(common neurodevelopmental disorder, 'Learning Disorders')(asthma, 'Asthma')(inflammatory bowel disease, 'Inflammatory Bowel Diseases')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(asd patients with immune-related phenotypes, 'Autism Phenotype')

PMCID: 5135580
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (core symptoms: [sosy]), (autism spectrum disorder: [mobd]), (current medications: [fndg]), (symptoms: [sosy]), (diagnosis: [fndg]), (epilepsy: [dsyn]), (vice versa: []), (medically-supervised ketogenic diets: [fndg]), (effective nonpharmacological treatments: []), (drug-refractory cases: [qnco]), (evidence: []), (efficacy: [resa]), (ketogenic diets: [fndg]), (autism spectrum disorders: [mobd]), (animal models: [anim]), (limited reports: [fndg]), (benefits: [qnco]), (patients: [podg]), (study: [resa]), (behavioral effects: [inbe]), (ketogenic diet feeding: [fndg]), (el: [aapp,enzy]), (model: []), (behavioral characteristics: [inbe]), (comorbid epilepsy: [dsyn]), (male: [orga]), (female el mice: [mamm]), (control diet: [hlca]), (ketogenic diet formulas ad libitum: [fndg]), (weeks: []), (age: [orga]), ( diet protocols: []), (performance: [inbe]), (group: [popg]), (tests: [lbpr]), (sociability: [socb]), (repetitive behavior: [fndg]), (ketogenic diet: [fndg]), (test-specific manner;: [lbpr]), (relevant behaviors: [inbe]), (ketogenic: [moft]), (improved multiple measures: [qnco]), (reduced repetitive behavior: [fndg]), (female mice: [mamm]), (limited effects: [fndg]), (males: [orga]), (additional experiments: [resa]), (clinically-relevant diet formula: [hlca]), (results: [fndg]), (number: [qnco]), (studies: [lbpr]), (related diets: [fndg]), (significant relief: [fndg]), (cases: [qnco]), (females: [orga]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(current medications, 'Medications')(autism spectrum disorder, 'Autism Phenotype')(diagnosis, 'Diagnosis')(epilepsy, 'Epilepsy')(medically-supervised ketogenic diets, 'Dietary Restrictions')(ketogenic diets, 'Dietary Restrictions')(autism spectrum disorders, 'Autism Phenotype')(ketogenic diet feeding, 'Dietary Restrictions')(comorbid epilepsy, 'Epilepsy')(control diet, 'Dietary Restrictions')(ketogenic diet formulas ad libitum, 'Dietary Restrictions')(diet protocols, 'Dietary Restrictions')(diet protocols, 'Dietary Restrictions')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorder, 'Autism Phenotype')(ketogenic diet, 'Dietary Restrictions')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(reduced repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(clinically-relevant diet formula, 'Dietary Restrictions')(autism spectrum disorder, 'Autism Phenotype')(related diets, 'Dietary Restrictions')

PMCID: 5102445
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (auditory-motor mapping training: [edac]), (intonation-based treatment: [topp]), (spoken language: [fndg]), (verbal children: [aggp]), (autism spectrum disorder (asd): [mobd]), (control treatment: [topp]), ( speech repetition therapy (srt): [hlca]), (asd (20 male: [cgab]), ( mean age: [orga]), (sessions: [evnt]), (ammt: []), (seven: [qnco]), (age: [orga]), (verbal ability: [menp]), (participants: [popg]), ((five male): [orga]), (srt: [clna]), (outcome measures: [qnco]), (percent syllables approximated: [qnco]), ( percent consonants correct (of: [qnco]), (percent vowels correct (of: [qnco]), (sets: [menp]), (bisyllabic stimuli: [phpr]), (subjects: [humn]), (measures: [qnco]), (several times: [qnco]), (baseline: [bodm]), (post-25 session assessment timepoint: [evnt]), (best baseline performance: [bodm]), (overall: []), ( ammt participants: [popg]), (syllables approximated: []), (consonants correct: []), ( and19.1% vowels correct: []), (best baseline: [bodm]), (matched ammt-srt group: [grup]), (vowels correct: []), (chi-square tests: []), (srt participants: [popg]), (groups: [popg]), (number: [qnco]), (stimulus: [phpr]), (pre-treatment ability: [orga]), (phonemes: []), (chronological age: [orga]), (baseline performance: [bodm]), (amount: [qnco]), (improvement: []), (intonation-based therapy: [topp]), (promising new interventional approach: []), (asd: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(speech repetition therapy, 'Language Ability')(speech repetition therapy participants, 'Language Ability')(imitate phonemes, 'Imitation')

PMCID: 5129305
SFARI Genes: 
Non SFARI Genes: GSTP1, GSTP1, 
Named Entities: (aluminum: [elii]), (neurotoxic metal: [inpo]), (health effects: []), (animals: [anim]), (humans: [humn]), (glutathione-s-transferase (gst) genes: [gngm]), (enzymes: [enzy,orch]), (major role: [socb]), (detoxification: [orgf]), (several heavy metals: [elii]), (direct relationship: []), (oxidative stress; aluminum: [elii]), (gst enzyme activities: [moft]), (data: [euka]), (jamaican children; age: [aggp]), (years;: []), (autism spectrum disorder (asd): [mobd]), ((td) children;: [aggp]), (association: [menp]), (polymorphisms: [genf]), (gst genes (gstp1; gstm1;: [aapp,enzy]), (gstt1): [gngm]), (mean blood aluminum concentrations: [elii]), (children: [aggp]), (asd: [cgab]), (log-transformed blood aluminum concentration: [elii]), (dependent variable: []), (linear regression model;: [qnco]), (interactive effects: []), (asd status: [cgab]), (gst genes: [gngm]), (relation: [socb]), (aluminum concentrations: [elii]), (none: []), (additive effects: [sbst]), (significant (all p: [aapp,imft]), (significant interaction: [qnco]), (gstp1 ile105val (rs1695): [aapp,enzy]), (asd status (p: [cgab]), (parental education level: [fndg]), (consumption: [acty]), (avocado; root vegetables;: [plnt]), (tuna: [gngm]), (fish): [fish]), (findings: [clna]), ((p: [aapp,imft]), (geometric mean blood aluminum concentration: [elii]), (td children: [aggp]), (val/val genotype (14.57 g/l);: [aapp]), (ile/ile: [aapp,bacs,phsu]), (ile/val genotypes: [aapp]), (geometric mean: [qnco]), (g/l: [qnco]), (however;: []), (difference: [qnco]), (asd cases (p: [cgab]), (potential effect modifier: []), (gstp1 rs1695: [aapp,enzy]), (blood aluminum concentrations: [elii]), (jamaican children: [aggp]), (replication: [genf]), (other populations: [popg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5105161
SFARI Genes: SCN2A, CHD8, DSCAM, MECP2, POGZ, WDFY3, ASH1L, SCN2A, CHD8, DSCAM, MECP2, POGZ, WDFY3, ASH1L, 
Non SFARI Genes: 
Named Entities: (recurrent: []), ((dn): [dsyn]), (likely gene-disruptive (lgd) mutations: [genf]), (spectrum disorders: [dsyn]), (european cohorts: [popg]), (here: []), (risk genes: [gngm]), (chinese asd probands: [cgab]), (trios): [aapp,enzy]), (11-fold increase: [phpr]), (odds: []), (dn lgd mutations: [genf]), (expectation: []), (exome-wide neutral model: [gngm]), (mutation: [genf]), (aggregate: []), ( 4%: [fndg]), (asd patients: [cgab]), (dn mutation: [genf]), (autism risk genes: [gngm]), (prevalent gene: [qnco]), (recurrent dn mutations: [genf]), (scn2a (1.1%: [gngm]), (patients): [podg]), (chd8: [gngm]), ( dscam: [gngm]), ( mecp2: [aapp,bacs]), ( pogz: [gngm]), ( wdfy3: [gngm]), (ash1l: [gngm]), (novel dn lgd: [dsyn]), ((gigyf2: [gngm]), ( myt1l: [gngm]), ( cul3: [gngm]), ( dock8: [gngm]), (znf292): [gngm]), (dn mutations: [genf]), (previous asd candidates: [cgab]), (ncor1: [gngm]), ( phip: [hops,orch]), ( stxbp1: [gngm]), ( cdkl5: [gngm]), (shank1): [gngm]), (phenotypic: [orga]), (follow-up confirms: [hlca]), (potential subtypes: []), (large global cohorts: [popg]), (pathogenic significance: [qnco]), (rare mutations: [genf]), 
ASD Terms: (autism risk genes, 'Autism Phenotype')

PMCID: 5119539
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (sex differences: [orga]), (brain development: [ortf]), (risk factors: [qnco]), (outcomes: []), (brain disorders: [dsyn]), (sex: [orgf]), (other: []), (brain: [bpoc]), (techniques: []), (recent years: []), (functional maps: []), (living brain: [bpoc]), (so: []), ( studies: [lbpr]), (sample size: [qnco]), (inconsistent findings: [clna]), (example: []), (findings: [clna]), (size: []), (corpus callosum: [bpoc]), (consortia: []), (enhancing neuro imaging genetics: [diap]), (meta analysis consortium: [resa]), (expertise: []), ( data: [euka]), (resources: []), (hundreds: []), (institutions: []), (world: [popg]), (adequate power: [hcpp]), (reproducibility: []), (initiatives: [menp]), (brain structure: [bpoc]), (development: [orgf]), ( disease: [dsyn]), (potential modulators: []), (effects: []), (review: []), (life span: [grpa]), (pitfalls: []), (health: []), (disease: [dsyn]), (sexrelated findings: [clna]), (enigma consortium: [gngm]), (efforts: [orgf]), (brain circuitry: [bpoc]), (authors: []), (journal: [inpr,mnob]), (neuroscience research: [resa]), (wiley periodicals: []), ( inc: []), 
ASD Terms: (sex differences in brain development, 'Learning Disorders')

PMCID: 5098241
SFARI Genes: 
Non SFARI Genes: F2, F2, F3, F3, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (pervasive developmental disorder: [mobd]), (environmental factors: []), (development: [orgf]), (recently: []), ( epigenetics: [genf]), (novel concept: []), (asd aetiology: [cgab]), (proposition: []), (epigenetic marks: []), (assumption: []), (epigenetics: [genf]), (transgenerational inheritance: [qnco]), (asd-like behaviours: [cgab]), (related synaptic changes: [qnco]), (vpa: []), (animal model: [emod]), (asd: [cgab]), (first generation (f1): [acty]), (vpa-exposed offspring: [famg]), (autistic-like impaired sociability: [mobd]), (marble burying: [inch]), (increased seizure susceptibility: [sosy]), ( hyperactivity: [mobd]), (anxiety: [mobd]), (vpa-exposed f1 male: [orga]), (nave females: [orga]), (second generation (f2): [gngm]), (f2: [gngm]), (third generation (f3): [aapp,imft]), (autism-like behavioural phenotypes: [mobd]), (f1: []), (f3: [gngm]), (frontal cortices: [bpoc]), (imbalanced expressions: [topp]), (excitatory/inhibitory synaptic markers: [acty]), (transgenerational epigenetic inheritance: [qnco]), (results: [fndg]), (idea: []), (e/i imbalance: [inch]), (asd-like behavioural changes: [cgab]), (environmental insults: []), (mice: [mamm]), (least: [qnco]), (third generation: [acty]), (study: [resa]), (unprecedented increase: []), (asd prevalence: [qnco]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(vpa-exposed offspring, 'Perinatal History')(hyperactivity, 'Overactivity')(anxiety, 'Anxiety Disorders')

PMCID: 5313513
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (human neurodevelopment: [humn]), (organization: [orgt]), (neural elements: [elii]), (functional networks: []), (connectome: [anst]), (data: [euka]), (prenatal exposure: [fndg]), (maternal stress: [menp]), (role: [socb]), (wiring: [topp]), (miswiring: []), (developing connectome: [anst]), (stress-related symptoms: [sosy]), (women: [popg]), (pregnancy: [orgf]), (risk factors: [qnco]), (neurobehavioral disorders: [dsyn]), (autism spectrum disorder: [mobd]), ( attention deficit hyperactivity disorder: [mobd]), (addiction: [mobd]), (major depression: [mobd]), (schizophrenia: [mobd]), (review: []), (functional connectivity: []), (impact: [gngm]), (changes: [qnco]), (women's stress-based physiology: [phsf]), (dynamic development: [orgf]), (human connectome: [anst]), (fetal brain: [emst]), 
ASD Terms: (prenatal exposure, 'Exposures')(neurobehavioral disorders, 'Central Nervous System Diseases')(autism spectrum disorder, 'Autism Phenotype')(attention deficit hyperactivity disorder, 'Overactivity')(major depression, 'Depressive Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 5098909
SFARI Genes: NLGN2, NLGN3, NLGN2, NLGN3, NLGN3, NLGN2, NLGN3, NLGN2, NLGN, NLGN, NLGN, NLGN, 
Non SFARI Genes: CA1, 
Named Entities: (neuroligins (nlgns): [moft]), (postsynaptic cell adhesion: [celf]), (neurexins: []), (synapse development: [ortf]), (function: [phsf]), (nlgn2: [gngm]), (inhibitory synapses: [celc]), (nlgn3: [gngm]), (excitatory: []), (nlgn3 function: [phsf]), (rat ca1: [mamm]), (presence: [qnco]), (domain: []), (extracellular region: [celc]), (functional difference: [qnco]), (cytoplasmic tail (c-tail): [celc]), (domains: []), (c-tail: [bpoc]), (nlgn function: [phsf]), (gephyrin-dependent mechanism: [aapp,bacs]), (autism-associated mutation: [mobd]), (r705: []), (gephyrin-independent mechanism reliant: [bodm]), (putative phosphorylation site: [amas]), (s714: []), (work highlights: []), (separate roles: [socb]), (intracellular regions: [celc]), (nlgn function respectively: [phsf]), (doi: http://dx.doi.org/10.7554/elife.19236.001: [fndg]), 
ASD Terms: 

PMCID: 5091763
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd) symptoms: [mobd]), (individuals: [humn]), (attention-deficit/hyperactivity disorder (adhd): [mobd]), (evidence: []), (adhd: [mobd]), (asd: [cgab]), (differential structural brain correlates: [bpoc]), ( knowledge: []), (structural brain profile: [bpoc]), (asd symptoms: [cgab]), (presence: [qnco]), (asd-like symptoms: [cgab]), (children's social behavior questionnaire (csbq): [socb]), (sample: [sbst]), (controls (n: [aapp,imft]), (participants: [popg]), (adhd (n =: [mobd]), (unaffected siblings: [famg]), (ages: [bacs,orch]), (structural: []), (magnetic resonance: [npop]), ((mri) correlates: [diap]), (asd ratings: [cgab]), (relationship: []), (grey matter volumes: [tisu]), (mixed effects models: [fndg]), (adhd symptom count: [mobd]), (total brain volume: [bpoc]), (adhd relative: [mobd]), (controls: [sbst]), (entire group (participants: [popg]), (td: []), (mixed effect models: [fndg]), (left caudate nucleus volume: [qnco]), (asd ratings (t: [cgab]), (p: [gngm]), (current findings: [clna]), (role: [socb]), (caudate nucleus: [bpoc]), (executive function: [menp]), (selection: [genf]), (goals: []), (evaluation: [hlca]), (action outcomes: [acty]), (use: []), (social reward: [menp]), (reward representations: [menp]), (specific volumetric profile: [lbpr]), (subclinical asd-like symptoms: [cgab]), (globus pallidus: [bpoc]), (critical importance: []), (level: [phsu]), (groups: [popg]), 
ASD Terms: (attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism spectrum disorder symptoms, 'Complaints and Indications')(asd symptoms, 'Complaints and Indications')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(children's social behavior questionnaire, 'Reciprocal Social Interaction')(attention-deficit/hyperactivity disorder symptom count, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder relative, 'Attention Deficit Disorder with Hyperactivity')(executive function, 'Executive Function')

PMCID: 5115650
SFARI Genes: KMO, KMO, meCP2, meCP2, 
Non SFARI Genes: 
Named Entities: (full range: [qnco]), (tryptophan metabolites: [aapp,bacs,phsu]), (kynurenine: [aapp,bacs]), (liquid chromatography  tandem mass spectrometry method: [lbpr]), (brain extracts: [bpoc]), (rodents: [mamm]), (kynurenine-3-mono-oxygenase (kmo) inhibitor ro61-8048: [aapp,enzy]), (pregnancy: [orgf]), (significant increases: [qnco]), (levels: []), (kynurenic acid: [orch,phsu]), (anthranilic acid: [orch,phsu]), (3-hydroxy-kynurenine (3-hk): [aapp,bacs]), (maternal brain: [bpoc]), (h: [gngm]), (embryos: [emst]), (high levels: [qnco]), (h post-treatment: [elii]), (strong trend: []), (increase: []), (quinolinic acid levels: [bacs,orch]), (significant changes: [qnco]), (other kynurenine metabolites: [aapp,bacs]), (results: [fndg]), (marked increase: []), (accumulation: [fndg]), (neuroactive kynurenines: [aapp,bacs]), (kmo: [gngm]), (potential importance: []), (changes: [qnco]), (prolonged duration: [phsu]), (metabolite accumulation: [fndg]), (embryo: [emst]), (trapping: []), (compounds: [chem]), (embryonic cns: [bdsy]), (maternal levels: [famg]), (brains: [bpoc]), (young mice: [mamm]), (mecp2 gene: [gngm]), (potential model: []), (rett syndrome: [dsyn]), (differences: [qnco]), (control mice: [mamm]), (roles: [socb]), (kynurenines: [aapp,bacs]), (autism spectrum disorder: [mobd]), (recognition: [menp]), (distinct: []), ( independent: [fndg]), ( condition: [dsyn]), 
ASD Terms: (rett syndrome, 'Rett Syndrome')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5075143
SFARI Genes: 
Non SFARI Genes: BSCL2, 
Named Entities: (background: progressive encephalopathy: [fndg]), (lipodystrophy: [dsyn]), (rare autosomal recessive childhood-onset seipin-associated neurodegenerative syndrome: [dsyn]), (developmental regression: [dsyn]), (motor: []), (cognitive skills: [inbe]), (study: [resa]), (patient: [podg]), (autism: [mobd]), (causative mutation: [genf]), (exome sequencing: [mbrt]), (methods:: []), (proband: [famg]), (hypertonia: [fndg]), (regression: [menp]), (developmental milestones: []), (advantages: []), (next-generation: [acty]), ((ngs): []), ( whole exome: [gngm]), ((wes): [mbrt]), (requested: []), (functional significance: [qnco]), (variants: []), (ngs-specific prediction servers: [popg]), (sanger sequencing: [mbrt]), (segregation analysis: [socb]), (family: [famg]), (results:: [fndg]), (specific sign: [fndg]), (paraclinical investigations: [hlca]), (conclusive clinical diagnosis: []), (wes: [mbrt]), (homozygous nonsense mutation: [orga]), (bscl2 (nm_001122955.3:c: [gngm]), (p.arg329*): [aapp,imft]), (variant: []), (pedigree: []), (autosomal recessive pattern: [genf]), (conclusion: exome sequencing: [mbrt]), (robust method: [lbpr]), (candidate gene variants: [gngm]), (mendelian traits: [gngm]), 
ASD Terms: (rare autosomal recessive childhood-onset seipin-associated neurodegenerative syndrome, 'Neurodegenerative Diseases')(cognitive skills, 'Cognitive Ability')(autism, 'Autism Phenotype')(conclusive clinical diagnosis, 'Diagnosis')

PMCID: 5102276
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract:: []), (progress: []), (biology: []), (autism spectrum disorder (asd): [mobd]), (effective biological interventions: [hlca]), (core symptoms: [sosy]), (etiological heterogeneity: [orga]), (asd: [cgab]), ( identification: [menp]), (one-size-fits-all treatment approach: [sosy]), (meeting: [acty]), (university: [mnob,orgt]), (missouri: []), (thompson center: [fndg]), (strategies: [menp]), (patients: [podg]), (purpose: []), (precision medicine: [topp]), (white paper: [popg]), (challenges: [hlca]), (suggestions: []), (future solutions: [sbst]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5085253
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (biochemical evidence implicate: []), (mitochondrial dysfunction: [fndg]), (pathophysiology: [patf]), (autism spectrum disorder (asd): [mobd]), (biological basis: [phsu]), (connection: []), (possible cause: []), (asd: [cgab]), (genetic variation: [npop]), (mitochondrial dna (mtdna) sequence: [bacs,nnon]), (large genomic studies: [gngm]), (mtdna variation: [bacs,nnon]), (mixture: [sbst]), (different mtdna molecules: [bacs,nnon]), (same individual (i.e.: [diap,inpr]), ( heteroplasmy): [fndg]), (data: [euka]), (mother-proband-sibling trios: [famg]), (simplex families: [famg]), (child: [aggp]), (heteroplasmic mutations: [genf]), (autistic probands: [mobd]), (non-polymorphic mtdna sites: [bacs,nnon]), (deleterious effects: []), (heteroplasmies: [fndg]), (polymorphic mtdna sites: [bacs,nnon]), (~1.5-fold enrichment: [qnco]), (nonsynonymous mutations: [genf]), (~2.2-fold enrichment: [qnco]), (predicted pathogenic mutations: [genf]), (non-autistic siblings: [famg]), (pathogenic mutations: [genf]), (probands: [orga]), (risk: []), (asd (odds ratio: [cgab]), ( or[95% ci] =: [lbpr]), (respectively): []), (influence: []), (families: [famg]), (diminished iq and/or: [qnco]), (social behavior: [socb]), (genetic transmission pattern: [patf]), (mtdna heteroplasmies: [bacs,nnon]), (high pathogenic potential: [qnco]), (mother-autistic proband pairs: [famg]), (mother-sibling pairs: [famg]), (utero contributions: [bpoc]), (genetic findings substantiate: [lbtr]), (pathogenic mtdna mutations: [cgab]), (potential cause: []), (recent work: []), (attention: [menp]), (unique metabolic phenotypes: [orga]), (diagnosis: [fndg]), (treatment: [topp]), (children: [aggp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social behavior, 'Reciprocal Social Interaction')(diagnosis, 'Diagnosis')

PMCID: 5080712
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (compulsivity: [mobd]), (trait impulsivity: [inbe]), (addictive behaviour: [mobd]), (several neurodevelopmental disorders: [mobd]), (attention-deficit/hyperactivity disorder (adhd): [mobd]), ( autism spectrum disorder (asd): [mobd]), (obsessive compulsive disorder (ocd): [mobd]), (disorders: [dsyn]), (impaired fronto-striatal functioning: [bpoc]), (glutamatergic signalling: [biof]), (genetic factors: [fndg]), (important role: [socb]), (aetiology: []), (compulsivity-related disorders: [mobd]), (compuls study: [resa]), (multi-center study: [resa]), (relationship: []), (traits: [gngm]), (impulsivity: [inbe]), ( and: []), (extent: []), ( addictive behaviour: [mobd]), (neurodevelopmental disorders adhd: [mobd]), ( asd: [cgab]), (ocd: [mobd]), (phenotypic: [orga]), ( cognitive: []), ( neural: []), (genetic level: [phsu]), (participants: [popg]), (part: [qnco]), (compuls: []), (different sites: []), (europe: []), (data collection: [resa]), (diagnostic interviews: [acty]), ( behavioural questionnaires: [inbe]), (cognitive measures: [qnco]), (spectral neuroimaging: [diap]), (genome-wide genetic information: [gngm]), (discussion: [socb]), (unique opportunity: []), (several key aspects: [qnco]), (large cohort: [popg]), (adhd: [mobd]), (ocd patients: [mobd]), 
ASD Terms: (compulsivity, 'Obsessive-Compulsive Disorder')(several neurodevelopmental disorders, 'Learning Disorders')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism spectrum disorder, 'Autism Phenotype')(obsessive compulsive disorder, 'Obsessive-Compulsive Disorder')(neurodevelopmental disorders, 'Learning Disorders')(cognitive, 'Cognitive Ability')(cognitive measures, 'Cognitive Ability')(compulsivity, 'Obsessive-Compulsive Disorder')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(obsessive compulsive disorder patients, 'Obsessive-Compulsive Disorder')

PMCID: 5290345
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (propionic acid (ppa): [orch]), (ubiquitous short-chain fatty acid: [bacs,orch]), (major fermentation product: [moft]), (enteric microbiome: [orgm]), (ppa: [mobd]), (normal intermediate: [lbtr]), (metabolism: [orgf]), (foods: []), (preservative: [bodm]), (derivatives: [chvs]), (health: []), (disease: [dsyn]), (whereas ppa: [mobd]), (energy substrate: [sbst]), (beneficial effects: []), (human disorders: [humn]), (mitochondrial dysfunction: [fndg]), (propionic acidemia: [dsyn]), (autism spectrum disorders: [mobd]), (dichotomy: []), (disease effects: [dsyn]), (mitochondrial function: [celc]), (asd: [cgab]), (gender-matched control lymphoblastoid cell lines: [orga]), (incubation: []), (several concentrations: [menp]), (durations: []), (vitro increase: []), (reactive oxygen species: [bacs,elii]), (particular exposure durations: []), (concentrations: [menp]), (asd lcls: [cgab]), (enhancement: [acty]), (contrast: [irda]), (ros: [gngm]), (positive ppa effect: [mobd]), (detriment: []), (data demonstrate: [euka]), (enteric microbiome metabolites: [orgm]), (toxic effects: [inpo]), (concentration: [menp]), ( exposure duration: []), (microenvironment redox state: [moft]), (effects: []), (lcls: []), (individuals: [humn]), (enteric bacteria: [bact]), (wide variety: []), (diseases: [dsyn]), ( diabetes: [dsyn]), ( obesity: [dsyn]), (inflammatory diseases: [dsyn]), ( insight: [menp]), (metabolic modulator: [celf]), (host microbiome: [orgm]), (wide applications: [hlca]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(particular exposure durations, 'Exposures')(exposure duration, 'Exposures')(enteric bacteria, 'Bacterial Infections')(diabetes, 'Diabetes Mellitus Type 1')

PMCID: 5094851
SFARI Genes: MEF2C, MEF2C, MEF2C, MEF2C, Mef2c, Mef2c, MEF2C, MEF2C, Mef2c, MEF2C, Mef2c, MEF2C, 
Non SFARI Genes: 
Named Entities: (numerous genetic variants: [npop]), (mef2c: [gngm]), (intellectual disability (id): [mobd]), (schizophrenia (scz): [mobd]), (heterogeneous collection: [orga]), (neurodevelopmental disorders: [mobd]), (unclear pathophysiology: [patf]), (cortical excitatory neurons: [bpoc]), (role: [socb]), (development: [orgf]), (conditional embryonic deletion: [genf]), (hippocampal excitatory neurons: [cell]), (dramatic reduction: [npop]), (cortical network activity: [bpoc]), (vivo: []), (part: [qnco]), (dramatic increase: []), (inhibitory: [acty]), (decrease: [qnco]), (excitatory synaptic transmission: [ortf]), (addition: []), (e/i synapse density: [bsoj]), (cell-autonomous: [gngm]), ( transcriptional repressor: [aapp,bacs]), (analysis: [resa]), (differential gene expression: [genf]), (mutant cortex: [bpoc]), (significant overlap: [topp]), (autism-linked genes: [mobd]), (mutant mice: [mamm]), (numerous behaviors reminiscent: [inbe]), (autism: [mobd]), ( id: [lbpr]), (scz: []), (mef2c function: [phsf]), (neocortex: [bpoc]), (id-like behaviors: [inbe]), (mice: [mamm]), (doi: http://dx.doi.org/10.7554/elife.20059.001: [fndg]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(intellectual disability, 'Learning Disorders')

PMCID: 5389513
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract gene set analysis: [gngm]), (gene lists: [gngm]), (enriched functions: [phsf]), (common bioinformatic methods: [topp]), (results: [fndg]), (face value: [blor]), (agreement: [socb]), (algorithms themselves: []), (them: []), (paper: []), (robustness: []), (uniqueness: []), (enrichment results: [fndg]), (means: []), (methods: []), (correctness: []), ((multifunctional) genes: [gngm]), (genomics: []), (study results: [fndg]), (generation: [acty]), (non-specific enrichment results: [fndg]), (fragile significances: [qnco]), (enrichment analyses: [resa]), (non-robust findings: [clna]), (use: []), (significant progress: [qnco]), (recent bias correction methods: [bird]), (enrichment: []), (own software implementation: [inpr,mnob]), (approach: []), (pre-existing package: [qnco]), 
ASD Terms: 

PMCID: 5324567
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract neuroimaging studies: [diap]), (physiological differences: [qnco]), (causes: []), (development: [orgf]), (autism spectrum disorder (asd): [mobd]), (multisite: []), (recruitment: [acty]), (samples: [sbst]), (statistical power: [resa]), (however: []), (recent largescale studies: [lbpr]), (findings: [clna]), (results: [fndg]), (database used: [fndg]), (substantial heterogeneity: [orga]), (category: []), (major source: [fndg]), (variance: [qnco]), (acquisition: [acty]), (data: [euka]), (multiple centres: [qnco]), (work: []), (differences: [qnco]), ( multimodal: [diap]), (database: []), (uk medical research council autism imaging multicentre study (mrc aims): [diap]), (terms: [orgf]), (diagnosis: [fndg]), (acquisition sites: [acty]), (dissimilarities: []), (sites: []), (diagnostic groups: [popg]), (technique: []), (significance: [qnco]), (principal component analysis (swpca): [qnco]), (undesired intensity variance: [qnco]), (acquisition site: [blor]), (group differences: [popg]), (significant group differences: [popg]), (broca's area: [bpoc]), (temporoparietal junction: []), (discriminative power: [socb]), (accuracies results: [fndg]), (recent claims: []), (asd: [cgab]), (heterogeneous condition: [fndg]), (neuroimaging: [diap]), (different (and: []), (homogenous) subgroups: [orga]), (understanding: [menp]), (hum brain mapp: [bpoc]), (wiley periodicals: []), ( inc: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(uk medical research council autism, 'Medications')(uk medical research council autism imaging multicentre study, 'Medications')(diagnosis, 'Diagnosis')

PMCID: 5412832
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (hypotheses: []), (association: [menp]), (paternal age: []), (childhood: []), (psychiatric disorders: [mobd]), (spectrum: [qnco]), (attention: [menp]), (deficit/hyperactive disorder): [mobd]), (adult disorders: [dsyn]), (bipolar: []), ( obsessivecompulsive: []), (major depressive disorder): [mobd]), (epidemiological studies: [resa]), (several hypotheses: [qnco]), (paternal age effect: [fndg]), (mainnot: []), (mutation: [genf]), (hypothesis: []), (selection: [genf]), (late fatherhood hypothesis: [socb]), (environmental resource hypothesis: []), (advanced: []), (relation: [socb]), (spectrum disorders: [dsyn]), (schizophrenia: [mobd]), (robust epidemiological evidence: []), (studies: [lbpr]), (monotonic risk increase: []), (others: [fndg]), (marked increase: []), (age threshold: [orga]), (evidence: []), (mutation hypothesis: [genf]), (late fatherhood: [socb]), (mechanism(s): []), (advanced paternal age: [popg]), (psychiatric illness: [mobd]), (remains: []), (further clarified: [acty]), (authors: []), (american journal: [inpr,mnob]), (medical genetics part b: neuropsychiatric genetics: [qnco]), (wiley periodicals: []), ( inc: []), 
ASD Terms: (psychiatric disorders, 'Mental Disorders')(autism spectrum disorders, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(psychiatric illness, 'Mental Disorders')(medical genetics part b, 'Medications')

PMCID: 5222916
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (sotos syndrome: [cgab,dsyn]), (congenital overgrowth disorder: [dsyn]), (incidence: [qnco]), (study: [resa]), (behavioural characteristics: [inbe]), (asd: [cgab]), (large cohort: [popg]), (individuals: [humn]), (sotos: [gngm]), ((n: [aapp,imft]), (social responsiveness scale: [acty]), (second edition: []), (participants: [popg]), ((83.33 %): []), (clinical cut-off (t-score 60): [qnco]), (significant gender difference: [orga]), (symptom severity: [fndg]), (significant effect: [qnco]), (age: [orga]), (scores: [clna]), (early childhood: []), (adulthood: []), (furthermore: []), ( individuals: [humn]), (trait profile: [lbpr]), (findings: [clna]), (majority: [socb]), (display: []), (significant behavioural symptomatology: [inbe]), 
ASD Terms: (congenital overgrowth disorder, 'Congenital Abnormalities')(investigated behavioural characteristics of asd, 'Autism Phenotype')

PMCID: 5085789
SFARI Genes: NLGN3, NLGN4X, NLGN3, NLGN4X, NLGN4X, NLGN4X, NLGN4X, NLGN4X, 
Non SFARI Genes: 
Named Entities: (synaptic transmission: [celf]), (x-chromosome: [celc]), ( neuroligins: [moft]), (good positional: [fndg]), (functional candidate genes: [gngm]), (autism spectrum disorder pathogenesis: [mobd]), (contradictory results: [fndg]), (here: []), (case-control study: [resa]), (association: [menp]), (genetic variants: [npop]), (nlgn3: [gngm]), (nlgn4x genes: [gngm]), (autism: [mobd]), (italian cohort: [popg]), (autistic children: [podg]), (high-resolution melting: [npop]), (results: [fndg]), (data: [euka]), (european healthy controls: [popg]), (genomes project): [gngm]), (italian controls: [lang]), (illumina: []), (polymorphism: [genf]), ((snp) array: [nusq]), (statistical evaluations: [hlca]), (plink v1.07: [bpoc]), (omnibus multiple loci approach: [gngm]), (european: [popg]), (italian control: [sbst]), (6-marker haplotype: [orga]), (nlgn4x (rs6638575(g): [qnco]), ( rs3810688(t): [clna]), ( rs3810687(g): [qnco]), ( rs3810686(c): []), ( rs5916269(g): [qnco]), ( rs1882260(t)): [clna]), (autism (odd ratio: [qnco]), (p-value =: [qnco]), (european controls; odds: [sbst]), (italian controls): [sbst]), (furthermore: []), (several haplotype blocks: [orga]), (snps: [nusq]), ( respectively: []), (similar association: [menp]), (evidence: []), (polymorphisms: [genf]), (nlgn4x: [gngm]), (key role: [socb]), (autism pathophysiology: [mobd]), (male prevalence: [qnco]), 
ASD Terms: (autism spectrum disorder pathogenesis, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism pathophysiology, 'Autism Phenotype')

PMCID: 5075177
SFARI Genes: SHANK3, CHD8, ADNP, SHANK3, CHD8, ADNP, 
Non SFARI Genes: 
Named Entities: (search: [acty]), (genetic factors: [fndg]), (autism spectrum disorders: [mobd]), (identification: [menp]), (hundreds: []), (genes: [gngm]), (thousands: [qnco]), (variants: []), (mode: [qnco]), (inheritance: [qnco]), ( effect size: [qnco]), ( frequency: [qnco]), (function: [phsf]), (major challenge: [hlca]), (collective evidence: [orgt]), (unbiased: []), ( systematic manner: []), (functional relevance: []), (here: []), (scoring algorithm: [lbpr]), (prioritization: []), (candidate genes: [gngm]), (cumulative strength: [qnco]), (evidence: []), (asd-associated variant: [cgab]), (autdb (also: []), (sfari gene): [gngm]), (data: [euka]), (publications: [inpr,mnob]), (dataset: []), (common variants: [qnco]), (asd: [cgab]), (individual variant: [humn]), (multiple attributes: [qnco]), (original report: []), (score assignment: [clna]), (set: [menp]), (standardized parameters: [fndg]), (single score: [fndg]), (gene: [gngm]), (wide variation: []), (scores; shank3: [aapp]), ( chd8: [gngm]), (adnp: [gngm]), (scores: [clna]), (other genes: [gngm]), (gene scores: [gngm]), (rankings: []), (asd genes (r spearman: [cgab]), (p<: [aapp,imft]), (support: []), (new resource: []), (first time aggregates: [qnco]), (one-platform variants: [qnco]), (various study types: [resa]), (multiplex: []), ( multigenerational: []), (consanguineous families): [fndg]), (rare variants: [gngm]), (putative functional consequences: []), (scheme: []), (work: []), (major step: [qnco]), (autism variants: [mobd]), (data-driven approaches: [menp]), (significance: [qnco]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-016-0103-y) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism variants, 'Autism Phenotype')

PMCID: 5073317
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (gastrointestinal symptoms: [sosy]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (significant proportion: [qnco]), (asd: [cgab]), (histologic evidence: []), (ileocolitis (inflammation: [patf]), (terminal ileum and/or colon): [bpoc]), (molecular characterization: [acty]), (gastrointestinal biopsy tissue: [diap]), (asd children: [cgab]), (ileocolitis (asdic+): [dsyn]), (tissue: [tisu]), (inflammatory bowel disease (ibd; i.e: [dsyn]), (crohns disease: [dsyn]), (ulcerative colitis): [dsyn]), (evidence: []), (gastrointestinal mucosal inflammation (tdic): [dsyn]), (asdic+ children: [aggp]), (gene expression: [genf]), (that: []), (ibd: []), (distinctive differences: [qnco]), (present study: [qnco]), (findings: [clna]), (second cohort: [popg]), (cases (asdic+): [qnco]), (controls: [sbst]), (mucosal-based cohorts: [tisu]), (overlap: [topp]), (transcripts: [nnon]), (ileocolonic tissue: [tisu]), (symptomatic asdic+ children: [aggp]), (peripheral blood: [bdsu]), (set: [menp]), (putative blood-based biomarker: [bdsu]), (asd-associated: [cgab]), (ileocolonic inflammation: [patf]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(inflammatory bowel disease, 'Inflammatory Bowel Diseases')(gastrointestinal mucosal inflammation, 'Inflammatory Bowel Diseases')

PMCID: 5093279
SFARI Genes: 
Non SFARI Genes: impact, impact, 
Named Entities: (several genetic causes: [famg]), (autism spectrum disorder (asd): [mobd]), (however: []), (recent work: []), (certain environmental exposures: [inpo]), (life: []), (cases: [qnco]), (autism: [mobd]), (environmental insults: []), (pregnancy: [orgf]), (infection: [dsyn]), (malnutrition: [dsyn]), (brain development: [ortf]), (maternal viral: [famg]), (bacterial infections: [dsyn]), (disruptors: []), (brain shaping: [orga]), (underlying mechanisms: []), (poor: [grpa]), (nutritional diversity: [clna]), (nutrient deficiency: [dsyn]), (neurodevelopmental disorders: [mobd]), (children: [aggp]), (instance: []), (imbalanced levels: []), (essential fatty acids: [orch]), (polyunsaturated fatty acids (pufas): [bacs,orch]), (patients: [podg]), (asd: [cgab]), (other neurodevelopmental disorders: [mobd]), (attention deficit hyperactivity disorder (adhd): [mobd]), (schizophrenia): [mobd]), (interestingly: []), ( pufas: [bacs,orch]), (n-3 pufas: [bacs,orch,phsu]), (powerful immunomodulators: [imft,phsu]), (exert anti-inflammatory properties: [phsu]), (prenatal dietary: [aggp]), (immunologic factors: [imft]), (fetal brain: [emst]), (microbiota: [orgm]), (link: []), (prenatal life: [aggp]), (future neurodevelopmental disorders: [mobd]), (nutrition: [fndg]), (inflammation: [patf]), (crosstalk: [moft]), (actors: []), (promising framework: []), (asd etiology: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(certain environmental exposures, 'Exposures')(autism, 'Autism Phenotype')(bacterial infections, 'Bacterial Infections')(neurodevelopmental disorders, 'Learning Disorders')(other neurodevelopmental disorders, 'Learning Disorders')(future neurodevelopmental disorders, 'Learning Disorders')

PMCID: 5390696
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract oxytocin: [aapp,horm,phsu]), (autism spectrum disorder (asd): [mobd]), (single-nucleotide polymorphisms: [nusq]), (oxytocin receptor (oxtr): [aapp,rcpt]), (however: []), (biological functions: [biof]), (oxtr snps: [nusq]), (asd: [cgab]), (critical oxtr snps: [nusq]), (determine oxytocins effects: []), (here: []), (machine-learning algorithm: [mcha]), (collective effects: [orgt]), (multiple snps: [nusq]), (informative snps: [nusq]), (relationships: []), (representative oxtr snps: [nusq]), (types: []), (behavioral/neural response: [inbe]), (asd individuals: [cgab]), (oxytocin effects: [aapp,horm,phsu]), (previous placebo-controlled within-participant clinical trial: [resa]), (single-dose intranasal oxytocin: [fndg]), (high-functioning adult: [aggp]), (japanese asd males: [cgab]), (consequently: []), (different snp sets: [menp]), (different oxytocin efficacies: [aapp,horm,phsu]), (robustness: []), (snp selections: [nusq]), (variations: []), (datasets: []), (analysis parameters: [fndg]), (moreover: []), (major alleles: [gngm]), (several prominent oxtr snpsincluding rs53576: [qnco]), (dissociable effects: []), (oxytocin efficacies: [aapp,horm,phsu]), (findings: [clna]), (oxtr snp variants: [nusq]), (autistic oxytocin responses: [aapp,horm,phsu]), (clinical oxytocin efficacy: [aapp,horm,phsu]), (actual administration: [topp]), (future precision medicines: [topp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5125235
SFARI Genes: GRIN2B, GluN2B, GRIN2B, GluN2B, GRIN2B, GRIN2B, GRIN2B, GRIN2B, GRIN2B, GRIN2B, 
Non SFARI Genes: 
Named Entities: (development: [orgf]), (whole exome/genome sequencing technologies: [gngm]), (rise: []), (unprecedented volume: [qnco]), (data: [euka]), (patient genomic variability: [gngm]), (brain disorder phenotypes: [dsyn]), (surprising number: [qnco]), (variants: []), (n-methyl-d-aspartate receptor (nmdar) gene family: [aapp,rcpt]), (grin2b gene: [gngm]), (glun2b subunit: [aapp]), (many cases: [qnco]), (neurodevelopmental disorders: [mobd]), (psychiatric conditions: [mobd]), (childhood: []), (language: [lang]), ( motor: []), (disorders: [dsyn]), ( autism spectrum disorder (asd): [mobd]), ( attention deficit hyperactivity disorder (adhd): [mobd]), ( developmental delay: [mobd]), ( epilepsy: [dsyn]), (schizophrenia: [mobd]), (crucial role: [socb]), (normal neuronal development: [fndg]), (memory: [menp]), (mutations: [genf]), (human grin2b: [humn]), (entire gene: [gngm]), (number: [qnco]), (patients: [podg]), (developmental disorders: [mobd]), (studies: [lbpr]), (functional analysis: [hlca]), (current analysis: [resa]), (disease cases: [dsyn]), (intellectual disability: [mobd]), (developmental delay: [mobd]), ( asd: [cgab]), (epileptic encephalopathies: [dsyn]), (nmdar function: [aapp,rcpt]), (here: []), (current reports: [npop]), (disease-associated variants: [dsyn]), (grin2b: [gngm]), (multiple neurodevelopmental disorders: [mobd]), (implications: []), (importance: []), (precision medicine therapies: [topp]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(psychiatric conditions, 'Mental Disorders')(autism spectrum disorder, 'Autism Phenotype')(attention deficit hyperactivity disorder, 'Overactivity')(developmental delay, 'Learning Disorders')(epilepsy, 'Epilepsy')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(memory, 'Working Memory')(intellectual disability, 'Learning Disorders')(epileptic encephalopathies, 'Epilepsy')(multiple neurodevelopmental disorders, 'Learning Disorders')

PMCID: 5794882
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (high-dose folinic acid: [orch,phsu,vita]), (verbal communication: [socb]), (children: [aggp]), (non-syndromic autism spectrum disorder (asd): [mobd]), (language impairment: [mobd]), (double-blind placebo control setting: [resa]), (forty-eight children: [aggp]), ((mean age: [orga]), (years: []), (male): [orga]), (asd: [cgab]), (weeks: []), (high-dose folinic acid (2 mg kg1: [orch,phsu,vita]), (day: []), ( maximum: [qnco]), (mg: [elii,phsu]), (day; n=23): [qnco]), (placebo (n=25): [topp]), (glutathione: [aapp,bacs]), (receptor- autoantibody (fraa) status: [aapp,imft]), (improvement: []), (ability-appropriate standardized instrument: [orga]), (participants: [popg]), (folinic acid: [orch,phsu,vita]), (effect: []), ((1.0: [fndg]), (10.4): [fndg]), (points: [qnco]), (medium-to-large effect size (cohens d=0.70): [qnco]), (fraa status: []), (response: [fndg]), (fraa-positive participants: [popg]), ( improvement: []), ((1.4: [fndg]), (13.2): []), (large effect size (cohens d=0.91): [qnco]), (folinic acid treatment: [topp]), (fraa positive: [fndg]), (improvements: []), (subscales: []), (vineland adaptive behavior scale: []), (aberrant behavior checklist: [inbe]), (autism symptom questionnaire: [mobd]), (behavioral assessment system: [hlca]), (folinic acid group: [orch,phsu,vita]), (placebo group: [popg]), (significant difference: [qnco]), (adverse effects: [patf]), (treatment groups: [popg]), (thus: []), (small trial: [resa]), (non-syndromic asd: [cgab]), ( treatment: [topp]), (placebo: [topp]), (fraas: []), 
ASD Terms: (non-syndromic autism spectrum disorder, 'Autism Phenotype')(language impairment, 'Language Ability')(vineland adaptive behavior scale, 'Adaptive Life Skills')(autism symptom questionnaire, 'Complaints and Indications')(language impairment, 'Language Ability')

PMCID: 5222910
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (sex differences: [orga]), (typical development: [orgf]), (context: [fndg]), (asd: [cgab]), (baron-cohen: [hcro]), (cogn sci: []), (extreme expression: [topp]), (normal male: [orga]), (phenotypic profiles: [orga]), (paper: []), ( sex-specific m-chat scores: [aapp,enzy]), (n: [aapp,imft]), (18-month-old toddlers: [aggp]), ((32 females): [orga]), (results: [fndg]), (nuanced view: [gngm]), (extreme male brain theory: [bpoc]), (autism: [mobd]), (item: []), (male: [orga]), (female disadvantage: [orga]), (population: [popg]), (m-chat vulnerabilities: [aapp,enzy]), (however: []), (total m-chat failures: [aapp,enzy]), (male disadvantage: [orga]), (asd-associated features: [cgab]), ( females: [orga]), (relative strengths: [qnco]), (joint attention: [menp]), (impairments: [patf]), (imitation: [socb]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-016-2945-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (sex differences in typical development, 'Learning Disorders')(autism, 'Autism Phenotype')(joint attention, 'Joint Attention')(imitation, 'Imitation')

PMCID: 5067562
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (individuals: [humn]), (autism spectrum conditions: [mobd]), (heterogeneous: [orga]), (novel approaches: []), (heterogeneity: [orga]), (precision: []), (translational research: [resa]), (clustering approach: [resa]), (genomics: []), (systems: []), (large independent cognitive datasets: [fndg]), (adults: [aggp]), (asc (n: [aapp,imft]), (replicable evidence: []), (discrete asc subgroups: [virs]), (item-level performance: [inbe]), (explicit mentalizing task: []), (ability: [orga]), (complex emotion: [menp]), (mental states: [fndg]), (eye region: [blor]), (face: [gngm]), (mind: [menp]), (eyes test; rmet): [bpoc]), (subgroups: [virs]), (asc adults: [aggp]), (evidence: []), (large impairments: [patf]), (d = 1.03: [fndg]), (other subgroups: [virs]), (findings: [clna]), (robust natural subdivisions: [fndg]), (asc population: [popg]), (individualized inferences: [menp]), (research towards precision medicine goals: [topp]), 
ASD Terms: (autism spectrum conditions, 'Autism Phenotype')(large independent cognitive datasets, 'Cognitive Ability')(discrete autism spectrum conditions, 'Autism Phenotype')

PMCID: 5324163
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction autism spectrum disorders: [mobd]), (neurodevelopmental disorder: [mobd]), (sub-saharan africa: []), (proportion: [qnco]), (children: [aggp]), (present features: [qnco]), (asd: [cgab]), (democratic republic: []), (congo (drc): []), (co-morbidities: []), (upfront symptoms: [sosy]), (management difficult: [hlca]), (prognosis: [hlca]), (present study: [qnco]), (clinical profile: [lbpr]), (autism spectrum disorder (asd): [mobd]), (associated morbidities: [qnco]), (adolescents: [aggp]), (outpatient clinics: [hcro,mnob]), (kinshasa: []), (congo: []), (cross sectional study: [resa]), (outpatients centers: [podg]), (patients: [podg]), (neurodevelopmental disorders: [mobd]), ( drc: []), (june: []), (total: [qnco]), (subjects: [humn]), (years: []), (study: [resa]), (clinical diagnosis: []), (dsm-iv-r: [clna]), (adir: [gngm]), (dsm-iv-r criteria: [clna]), (extensive clinical interview: [hlca]), (observation: [hlca]), (intellectual quotient evaluation: [hlca]), (electroencephalogram reporting: [lbtr]), ((29.3%): [fndg]), (diagnosis: [fndg]), (boys: [aggp]), (girls: [aggp]), (mean age: [orga]), ((p<: [aapp,imft]), (intellectual disability (75.83 %): [mobd]), (epilepsy (72.50%): [dsyn]), (main co-morbidities: []), (autism: [mobd]), (iq<70 (p=0.05): [fndg]), (males: [orga]), (female: [orga]), (intellectual disabilities: [mobd]), (findings: [clna]), (survey: []), (various structures: [phsu]), (rejected children: [aggp]), (society: [orgt]), (kinshasa drc: []), (early stage: [clna]), 
ASD Terms: (introduction autism spectrum disorders, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(clinical diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')(intellectual disability, 'Learning Disorders')(epilepsy, 'Epilepsy')(autism, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(intellectual disabilities, 'Learning Disorders')

PMCID: 5066262
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract autism spectrum disorder (asd): [mobd]), (cognitive deficits: [mobd]), (excessive anxiety: [mobd]), (studies: [lbpr]), (atypical structure: [fndg]), (neural connectivity: []), (hippocampus: [bpoc]), (medial prefrontal cortex (mpfc): [celc]), (striatum: [bpoc]), ( regions: []), (cognitive function: [menp]), (anxiety regulation: [mobd]), (adult: [aggp]), (hippocampal neurogenesis: [orgf]), (many behaviors: [inbe]), (asd: [cgab]), (cognition: [menp]), ( anxiety: [mobd]), (social behaviors: [socb]), (additionally: []), (glial cells: [cell]), (astrocytes: [cell]), (microglia: [cell]), (development: [orgf]), (glial dysfunction: [cell]), (key contributor: []), (cells: [cell]), (astroglial characteristics: [cell]), (progenitor cells: [cell]), (developing: []), (adult brain: [bpoc]), (here: []), (neurogenesis: [orgf]), (astroglia: [cell]), ( mpfc: []), (models: []), (autism-like phenotypes: [mobd]), ( cntnap2/: [aapp,bacs]), (shank3+/c: [aapp]), (transgenic mice: [mamm]), (substantial decrease: [qnco]), (number: [qnco]), (immature neurons: [cell]), (radial glial progenitor cells: [cell]), (ventral hippocampus: [bpoc]), (transgenic models: [emod]), (wild-type controls: [gngm]), (consistent differences: [qnco]), (size: []), (other brain region examined: [blor]), (future work: []), (functional contribution: [acty]), (adult neurogenesis: [orgf]), (autism-related behaviors: [mobd]), (glial plasticity: [cell]), 
ASD Terms: (abstract autism spectrum disorder, 'Autism Phenotype')(cognitive deficits, 'Cognitive Ability')(excessive anxiety, 'Anxiety Disorders')(cognitive function, 'Cognitive Ability')(anxiety regulation, 'Anxiety Disorders')(cognition, 'Cognitive Ability')(anxiety, 'Anxiety Disorders')(social behaviors, 'Reciprocal Social Interaction')

PMCID: 5222913
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (ambiguous empirical data: [euka]), ( substance: [sbst]), (use-related problems: [mobd]), (patients: [podg]), (autism spectrum disorders: [mobd]), (swedish population-based registers: [inpr,qnco]), (individuals: [humn]), (asd: [cgab]), (non-asd relatives: [cgab]), (diagnosed comorbidity: [fndg]), (attention deficit hyperactivity disorder (adhd): [mobd]), (intellectual disability: [mobd]), (doubled risk: []), (substance: [sbst]), (risk: []), (adhd: [mobd]), (further: []), ( risks: []), (full siblings: [famg]), (half-siblings: [famg]), (parents: []), (risk factor: [qnco]), (elevated risks: []), (relatives: [famg]), (probands: [orga]), (familial (genetic and/or: [famg]), (environmental) liability: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-016-2914-2) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(comorbidity, 'Comorbidities')(diagnosed comorbidity, 'Comorbidities')(attention deficit hyperactivity disorder, 'Overactivity')(intellectual disability, 'Learning Disorders')

PMCID: 5085743
SFARI Genes: kit, kit, 
Non SFARI Genes: ACTB, GAPDH, YWHAZ, 
Named Entities: (childhood autism: [mobd]), (severe form: []), (set: [menp]), (neurodevelopmental diseases: [mobd]), (autism spectrum disorders: [mobd]), (reverse transcriptase: [aapp,enzy]), (quantitative real-time pcr (rt-qpcr): [mbrt]), (sensitive technique: [patf]), (transcriptome analysis: [lbpr,mbrt]), (asd gene expression studies: [cgab]), (however: []), ( normalization: [resa]), (reference gene(s): [gngm]), (alteration: []), (mrna level: [bacs,nnon]), (target genes: [gngm]), (main goal: []), (present study: [qnco]), (stable reference genes: [gngm]), (salivary transcriptome: [nusq]), (rt-qpcr analysis: [mbrt]), (non-syndromic male childhood autism: [mobd]), (saliva samples: [bdsu]), (drug: [phsu]), (non-syndromic male children: [dsyn]), (autism: [mobd]), (location-matched healthy controls: [blor]), (rna-stabilizer kit: [nnon]), (dna genotek: [bacs,nnon]), (systematic two-phased measurement: [qnco]), (whole saliva mrna levels: [bacs,nnon]), (genes (hkgs): [gngm]), (rt-qpcr: [mbrt]), (stability: []), (expression: [topp]), (candidate gene: [gngm]), (specialized algorithms: []), ( genorm: []), (normfinder: []), (parallel: [resa]), (analysis: [resa]), (hkg actb: [gngm]), (suitable reference: []), (combination: [fndg]), (gapdh: [gngm]), (ywhaz: [gngm]), (normalization: [resa]), (non-syndromic autistic male children: [dsyn]), 
ASD Terms: (neurodevelopmental diseases, 'Learning Disorders')(childhood autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(non-syndromic male childhood autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5056722
SFARI Genes: iNOS, iNOS, 
Non SFARI Genes: 
Named Entities: (perinatal infection: [dsyn]), (well-identified risk factor: [qnco]), (number: [qnco]), (neurodevelopmental disorders: [mobd]), (brain: [bpoc]), (white matter injury (wmi): [fndg]), (autism spectrum disorders: [mobd]), (mechanisms: []), (early life: []), (inflammatory events cause: [evnt]), (aberrant neural: []), ( cytoarchitectural: []), (network: [popg]), (study: [resa]), (systemic lipopolysaccharide (lps)-induced neuroinflammation affects: [orch]), (phenotypes: [orga]), (early neural developmental events: [orgf]), (rats: [mamm]), (lps exposure: [orch]), (early postnatal day: []), (robust microglia activation: [celf]), (mixed microglial proinflammatory (m1): [gngm]), (anti-inflammatory (m2) phenotypes: [phsu]), (specifically: []), (microglial m1 markers: [clna]), (mhc-ii: [aapp,imft]), (low levels: [qnco]), (manner: []), ( whereas m2 markers cd206: [clna]), (tgf: [aapp,bacs]), (sub-set: [menp]), (activated microglia: [cell]), (gray matter structures: [tisu]), (unique microglial response: [fndg]), (marked decrease: [qnco]), (increase: []), (cell proliferation: [celf]), (subventricular zone (svz): [bpoc]), (dentate gyrus (dg): [bpoc]), (hippocampus: [bpoc]), (significant increase: [qnco]), (oligodendrocyte lineage population: [popg]), (discernible hypermyelination: []), (moreover: []), (lps-exposed rats: [mamm]), (significant impairments: [patf]), (cognitive functions: [menp]), (findings: [clna]), (possible role: [socb]), (m2-like: [qnco]), (microglial activation: [celf]), (abnormal neural development: [orgf]), (asd-like: [cgab]), (behavioral impairments: [inbe]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(perinatal infection, 'Perinatal Exposures')(autism spectrum disorders, 'Autism Phenotype')(lps exposure, 'Exposures')(cognitive functions, 'Cognitive Ability')(microglial activation in abnormal neural development, 'Learning Disorders')(abnormal neural development, 'Learning Disorders')(behavioral impairments, 'Personal Traits')

PMCID: 5055293
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objective: []), (critical need: []), (biomarkers: [clna]), (objective outcome measures: [qnco]), (underlying neural mechanisms: []), (autism spectrum disorder (asd): [mobd]), (potentials (veps): []), (noninvasive technique: []), (functional integrity: [inbe]), (neural mechanisms: []), (visual pathways: [bpoc]), (disease pathophysiology: [dsyn]), (transient veps (tveps): [popg]), (unmedicated children: [aggp]), (children: [aggp]), (asd: [cgab]), ((td) children: [aggp]), (unaffected siblings: [famg]), (conventional contrast-reversing checkerboard condition: [irda]), (novel short-duration condition: [dsyn]), (objective data collection: [resa]), (affected populations: [popg]), (studies: [lbpr]), (amplitudes: []), (td children: [aggp]), (critical vep components: []), ( p60-n75: [aapp,bacs]), (n75-p100: [aapp,bacs]), (sibs: [famg]), (intermediate responses: [orga]), (td groups: [popg]), (group: [popg]), (response latency: []), (frequency band analyses: [resa]), (responses: [orga]), (asd group: [cgab]), (bands: []), (gamma-wave activity: [npop]), (ninety-two percent: [qnco]), (short-duration condition: [dsyn]), (standard condition: [dsyn]), (current study: [resa]), (utility: [orgt]), (short-duration tvep test: [lbpr]), (use: []), (levels: []), (functioning: []), (describes neural abnormalities: [cgab]), (idiopathic asd: [cgab]), (implications: []), (excitatory/inhibitory balance: [acty]), (potential application: [qnco]), (vep: []), (clinical trials: [resa]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(visual pathways, 'Visual Thinking')(transient visual, 'Visual Thinking')

PMCID: 5053497
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (x-linked ichthyosis (xli): [dsyn]), (rare dermatological condition: [dsyn]), (deficiency: [dsyn]), (enzyme: [enzy,orch]), (steroid sulfatase (sts): [aapp,enzy]), (preliminary evidence: []), (boys: [aggp]), (xli: [dsyn]), (animal model studies: [emod]), (individuals: [humn]), (sts: [gngm]), (increased risk: [qnco]), (developmental disorders: [mobd]), (traits: [gngm]), (however: []), (behavioural profile: [inbe]), (children: [aggp]), (adults: [aggp]), (all: []), (materials: [sbst]), (online survey: []), (worldwide: []), (parent-reported information: []), (behaviour: [inbe]), (adult (n =: [aggp]), ((18yrs: []), (males: [orga]), (comparison: [acty]), (data: [euka]), (non-affected brothers: [famg]), (age/gender-matched previously-published normative data: [orga]), (survey: []), (background information: []), (prior clinical diagnoses): []), (validated questionnaires: []), (phenotypes: [orga]), (particular interest (adult adhd self-report scale v1.1: [resa]), ( barrett impulsiveness scale-11: [mobd]), ( adult: [aggp]), (adolescent autism quotient: [mobd]), ( kessler psychological distress scales: [bpoc]), (disruptive behaviour disorder rating scale): [mobd]), (normal sensory function: [fndg]), (risk: []), (developmental disorder: [mobd]), ( whilst adults: [aggp]), (condition: [dsyn]), (mood disorders: [mobd]), (adult: [aggp]), (xli groups: [dsyn]), (male general population norms: [orga]), (measures: [qnco]), (inattention: [mobd]), ( impulsivity: [inbe]), ( autism-related traits: [mobd]), (psychological distress: [mobd]), (disruptive behavioural traits: [fndg]), (findings: [clna]), (xli exhibit personality profiles: [dsyn]), (general population: [popg]), (psychopathology: []), (notion: []), (ongoing brain function: [ortf]), (previous work: []), (high rates: [qnco]), (results: [fndg]), (medical care: [fndg]), (multidisciplinary teams: [hlca]), (genetic counselling: [topp]), 
ASD Terms: (rare dermatological condition, 'Skin Indications')(mood disorders, 'Mood Disorders')(inattention, 'Attention Deficit Disorder with Hyperactivity')(disruptive behavioural traits, 'Personal Traits')(medical care, 'Medications')

PMCID: 5052801
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (insular cortex: [bpoc]), (different patterns: []), (connectivity: []), (other brain regions: [blor]), (such diverse connectivity patterns: []), (wide range: [qnco]), (insular functions: [bpoc]), (cognitive: []), ( affective: []), (sensorimotor: []), (autism spectrum disorder (asd): [mobd]), (past neuroimaging studies: [diap]), (asd: [cgab]), (functional abnormalities: [cgab]), (insula: [bpoc]), (possible alterations: []), (sub-regional organization: [orgt]), (functional characteristics: []), (sub-region: [qnco]), (asd brain: [cgab]), (resting-state functional magnetic resonance: [npop]), ((rs-fmri) data: [diap]), (adult males: [aggp]), (developed (td) controls: [sbst]), (data-driven clustering analysis: [resa]), (rs-fmri data: [diap]), (voxels: []), (left: []), (right insula: [bpoc]), (group voxels: [popg]), (similar intrinsic connectivity pattern: []), (cluster: [qnco]), (optimal number: [qnco]), (clusters: [qnco]), (information: []), (theoretic measures: [qnco]), (variation: []), (mutual information: []), (functional parcellation patterns: []), (td: []), (asd groups: [cgab]), (furthermore: []), (functional profiles: [lbpr]), (neurosynth: []), (groups: [popg]), (notable alterations: []), (anterior sector: []), (left insula: [bpoc]), (middle ventral sub-region: [qnco]), (meta-analytic decoding: [menp]), (sub-regions: [qnco]), ( sensorimotor: []), (emotional/affective functions: [menp]), (td brain: [bpoc]), (single functional cluster: [fndg]), (sensorimotor functions: [phsf]), (auditory-related functions: [phsf]), (significant volumetric increase: [qnco]), (results: [fndg]), (altered organization: [orgt]), (specific parts: [qnco]), (alterations: []), (neural substrates: [sbst]), (abnormalities: [cgab]), (sensory functions: [ortf]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-016-0106-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (cognitive, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(cognitive, 'Cognitive Ability')

PMCID: 5067329
SFARI Genes: Shank, Shank, SHANK, SHANK2, SHANK3, SHANK, SHANK2, SHANK3, Shank3, Shank3, Shank3, Rac1, Shank3, Rac1, Shank, Shank3, Shank, Shank3, Shank, Shank, 
Non SFARI Genes: Cdc42, 
Named Entities: (shank: [gngm]), ((shank1: [gngm]), ( shank2: [gngm]), (shank3) act: [topp]), (molecules: [sbst]), (postsynaptic density: [celc]), (many excitatory neurons: [cell]), (mutations: [genf]), (shank genes: [gngm]), (particular shank2: [gngm]), (shank3: [gngm]), (spectrum disorders: [dsyn]), (mouse models: [mamm]), (shank3 proteins: [aapp,bacs]), (several domainsthe shank/prosap: [qnco]), (n-terminal (spn) domain: [neop]), ( ankyrin repeats: [aapp,bacs]), ( sh3 domain: [amas]), ( pdz: []), (proline-rich region: [amas]), (sterile alpha motif (sam) domain: [amas]), (via: []), (partners: [popg]), (domains: []), ( shank3: [aapp]), (wide range: [qnco]), (proteins: [aapp,bacs]), (modulators: []), (small gtpases: [aapp,enzy]), (rich2: [gngm]), (rhogap protein: [aapp,bacs]), (rhogef protein: [gngm]), (rac1: [gngm]), (cdc42: [gngm]), (actin modulators: [aapp,bacs]), (dysregulation: []), (isoforms: [aapp]), (shank proteins: [aapp,bacs]), (alterations: []), (spine morphogenesis: [orgf]), ( shape: []), (activity: [acty]), (synapse: [bsoj]), (actin dynamics: [aapp,bacs]), (therefore: []), ( here: []), (role: [socb]), (small gtpases and: [aapp,enzy]), ( ultimately: []), ( actin dynamics: [aapp,bacs]), (vitro: []), (vivo models: []), (failure: [inbe]), (regulatory role: [socb]), (mechanism: []), (pathophysiology: [patf]), (autism-associated mutations: [mobd]), (synaptic signaling: [celf]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 5386887
SFARI Genes: CHD8, CHD8, Chd8, Chd8, Chd8, Chd8, Chd8, Chd8, Chd8, Chd8, Chd8, Chd8, 
Non SFARI Genes: 
Named Entities: (de: []), (mutations: [genf]), (chd8: [gngm]), (autism spectrum disorder (asd): [mobd]), (basic biology: []), (poor understood: [grpa]), (chd8 knockdown: [gngm]), (cortical development results: [fndg]), (defective neural progenitor proliferation: [patf]), (differentiation: [celf]), (abnormal neuronal morphology: [anab]), (behaviors: [inbe]), (adult mice: [mamm]), (transcriptome analysis: [lbpr,mbrt]), (transcription: [genf]), (cell cycle genes: [gngm]), (induction: [topp]), (neural specific genes: [gngm]), (expression: [topp]), (prc2: []), (complex components: [chvs]), (furthermore: []), ( knockdown: []), (key transducers: []), (wnt signaling: [celf]), (wnt: []), (behavioral deficits: [inbe]), (roles: [socb]), (dynamics: [npop]), (chd8 expression: [topp]), (development help: [orgf]), (fine balance: [fndg]), (neural progenitor proliferation: [patf]), (together: []), (observations: [hlca]), (new insights: [menp]), (neurodevelopmental role: [socb]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(behavioral deficits, 'Personal Traits')(neurodevelopmental role, 'Learning Disorders')

PMCID: 5045145
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent developments: [orgf]), (methods: []), (bioinformatics analysis tools: [resa]), (culture-independent analysis: [resa]), (complex microbial communities: [chvs]), (environmental samples: [sbst]), ( plants: [plnt]), (animals: [anim]), (spectacular increase: [bpoc]), (number: [qnco]), (studies: [lbpr]), (membership: [inbe]), (functionalities: []), (hitherto: []), (invisible worlds: [popg]), (human microbiome: [gngm]), (wide variety: []), (available microbiome tools: [orgm]), (platforms: []), (sound conclusions: [npop]), (scientific research: [resa]), (here: []), (analytic hoops: []), (good microbiome study: [orgm]), (dna extraction: [mbrt]), (choice: [inbe]), (bioinformatics: []), (hopes: [menp]), (field: [irda]), (diseases: [dsyn]), (autism: [mobd]), (inflammatory bowel diseases: [dsyn]), (hypes: [gngm]), (correlation: []), (causation: []), (recent pseudoscientific commercialization: []), (microbiome research: [orgm]), 
ASD Terms: (autism, 'Autism Phenotype')(inflammatory bowel diseases, 'Inflammatory Bowel Diseases')

PMCID: 5083212
SFARI Genes: TSHZ3, TSHZ3, TSHZ3, TSHZ3, Tshz3, Tshz3, Tshz3, Tshz3, Tshz3, TSHZ3, Tshz3, TSHZ3, 
Non SFARI Genes: 
Named Entities: (tshz3: [gngm]), (zinc-finger transcription factor: [amas]), (hub gene: [gngm]), (module: []), (genes: [gngm]), (expression: [topp]), (human neocortex: [humn]), (functions: [phsf]), (here: []), (critical region: []), (syndrome: [dsyn]), (heterozygous deletions: [genf]), (autism spectrum disorder (asd): [mobd]), (null mice: [mamm]), (layer-specific markers: [clna]), (cerebral cortical projection neurons: [menp]), (human orthologues: [humn]), (asd: [cgab]), (furthermore: []), (tshz3 deletion show: [genf]), (functional changes: [topp]), (synapses: [bsoj]), (cpns: [gngm]), (exhibit core asd-like: [cgab]), (behavioral abnormalities: [mobd]), (findings: [clna]), (essential roles: [socb]), (cpn development: [orgf]), (function: [phsf]), (alterations: []), (newly-defined tshz3 deletion syndrome: [genf]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(behavioral abnormalities, 'Personal Traits')

PMCID: 5418740
SFARI Genes: 
Non SFARI Genes: impact, FOXK1, KCNA7, FOXK1, FOXK1, FOXK1, FOXK1, FOXK1, 
Named Entities: (abstract children: [aggp]), (fathers: [famg]), (risk: []), (autism: [mobd]), (other disorders: [dsyn]), (underlying mechanisms: []), (correlation: []), (sperm dna methylation: [moft]), (paternal age: []), (impact: [gngm]), (epigenome: []), (offspring: [famg]), (methylation levels: [moft]), (candidate genes: [gngm]), (line-1 repeats: [fndg]), (bisulfite pyrosequencing: [inch,phsu]), (sperm dna: [cell]), (donors: [popg]), (cord blood samples: [bdsu]), (children: [aggp]), (ivf/icsi: [topp]), (same sperm samples): [cell]), (genes: [gngm]), (significant negative correlation: [fndg]), (sperm methylation: [moft]), (foxk1: [gngm]), (kcna7: [gngm]), (age effect: [orga]), (sperm epigenome: [cell]), (independent cohort: [popg]), (sperm samples: [cell]), (foetal cord blood (fcb) methylation: [moft]), (deep bisulfite sequencing: [mbrt]), (allele-specific pyrosequencing: [gngm]), (paternal alleles: [gngm]), (fcb samples: [sbst]), (informative snp: [nusq]), (fcb methylation: [moft]), (paternal foxk1 allele: [gngm]), (maternal allele: [gngm]), (maternal age: []), (foxk1 duplication: [comd]), (blood foxk1 methylation: [moft]), (age-matched controls: [orga]), (foxk1 promoter: [bacs,nnon]), (trend: []), (accelerated demethylation: [npop]), (autism group: [mobd]), (dual luciferase reporter: [aapp,enzy,irda]), (foxk1 methylation influences gene: [gngm]), (collectively: []), (study: [resa]), (age-related dna methylation changes: [moft]), (sperm: [cell]), (next generation: [acty]), (disease risk: [fndg]), 
ASD Terms: (autism, 'Autism Phenotype')(offspring, 'Perinatal History')(autism group, 'Autism Phenotype')

PMCID: 5159755
SFARI Genes: NRXN1, GRIN2B, NRXN1, GRIN2B, 
Non SFARI Genes: 
Named Entities: (chromosomal copy-number variations (cnvs): [celc]), (class: []), (genetic variants: [npop]), (aetiology: []), (neurodevelopmental disorders: [mobd]), (intellectual disabilities: [mobd]), (schizophrenia: [mobd]), (autism spectrum disorders: [mobd]), (majority: [socb]), (adults: [aggp]), (idiopathic id presenting: [lbpr]), (services: []), (cnvs: [nusq]), (genome-wide chromosomal microarray analysis (cma): [celc]), (idiopathic id: [lbpr]), (community: []), (in-patient id psychiatry services: [podg]), (england: []), (cnv pathogenicity: [nusq]), (standard clinical diagnostic methods: [diap]), (participants: [popg]), (psychiatric phenotyping: [lbpr]), (yield: []), (likely pathogenic cnvs (22/202): [nusq]), (recurrent loci: [gngm]), (16p11.2-p13.11 regions: [celc]), (increased frequency: [qnco]), (duplications: []), (single-disorder cohorts: [fndg]), (genes: [gngm]), (effect neurodevelopment: [ortf]), (nrxn1: [gngm]), (grin2b: [gngm]), (deletions: [genf]), (routine cma: [celf]), (id psychiatry: [lbpr]), (~11%: []), (new genetic diagnoses: [diap]), (potential implications: []), (patient management: [hlca]), (consideration: [fndg]), (cma: [celf]), (assessment: [acty]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(intellectual disabilities, 'Learning Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorders, 'Autism Phenotype')(idiopathic intellectual disabilities, 'Learning Disorders')(in-patient intellectual disabilities psychiatry services across england, 'Learning Disorders')(in-patient intellectual disabilities psychiatry services, 'Learning Disorders')(routine chromosomal microarray analysis in intellectual disabilities psychiatry, 'Learning Disorders')(intellectual disabilities psychiatry, 'Learning Disorders')

PMCID: 5048213
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (cognitive abilities: [menp]), (children: [aggp]), (primary reasons: lack: []), (engagement: [fndg]), (sensitivity: [patf]), (inherent performance variability: [inbe]), (engaging: [fndg]), ( adaptive digital cognitive platform: []), (video game: []), (measure: [qnco]), (attention-based abilities: [orga]), (neurodevelopmental disabilities: []), (genetic condition: [dsyn]), (deletion: [genf]), (genetic variation: [npop]), (attention deficit/hyperactivity disorder: [mobd]), (autism: [mobd]), (siblings: [famg]), (neurotypical age-matched children: [aggp]), (deletion carriers: [genf]), (response times: []), (response variability: []), (comparison: [acty]), ( traditional non-adaptive selective attention assessments: [hlca]), (group differences: [popg]), (phenotypic characterization: [orga]), (potential power: [hcpp]), (administering tools: [topp]), (adaptive psychophysical mechanics: [npop]), (video-game-style mechanics: [npop]), (robust: []), (reliable measurements: []), 
ASD Terms: (cognitive abilities, 'Cognitive Ability')(adaptive digital cognitive platform, 'Cognitive Ability')(neurodevelopmental disabilities, 'Learning Disorders')(autism, 'Autism Phenotype')(attention deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(adaptive psychophysical mechanics, 'Adaptive Life Skills')

PMCID: 5046013
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (randomized clinical trials: [inpr,resa]), (environmental enrichment: []), (symptoms: [sosy]), (autism spectrum disorder (asd): [mobd]), (present study: [qnco]), (therapy: [topp]), (real-world circumstances: [popg]), (children: [aggp]), (daily sensory enrichment therapy: [topp]), (parents: []), (personalized therapy instructions: [clna]), (internet: []), (child: [aggp]), (weeks: []), (months: []), (intention-to-treat analysis: [menp]), (significant overall gains: [qnco]), (wide range: [qnco]), (learning: [menp]), ( memory: [menp]), ( anxiety: [mobd]), ( attention span: [menp]), ( motor skills: [orgf]), ( eating: [orgf]), (sleeping: [orgf]), ( sensory processing: [ortf]), (self-awareness: [menp]), ( communication: [socb]), (social skills: [socb]), (mood/autism behaviors: [mobd]), (compliant caregivers: [inbe]), (significant improvement: [qnco]), (treatment: [topp]), (wide age range: [qnco]), (equal progress: []), (males: [orga]), (females: [orga]), (usa: []), (international subjects: [humn]), (individuals: [humn]), (levels: []), (initial symptom severity: [fndg]), (online system: [inpr,mnob]), (effective: []), ( low-cost means: [qnco]), (asd: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(memory, 'Working Memory')(anxiety, 'Anxiety Disorders')(attention span, 'Attention and Focus')(social skills, 'Ability to Converse in Social Settings')(symptoms of asd, 'Complaints and Indications')

PMCID: 5024993
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (de: []), (mutation: [genf]), (autism spectrum disorder (asd): [mobd]), (however: []), (contribution: [acty]), (post-zygotic mutation: [emst]), (asd: [cgab]), (exome sequencing: [mbrt]), (paired samples: [sbst]), (analysis: [resa]), (variants: []), (whole-exome sequencing: [mbrt]), (families: [famg]), (little evidence: [fndg]), (tissue-specific mosaic mutation: [genf]), ( multi-tissue post-zygotic mutation (i.e: [emst]), (mosaicism): [orga]), (detectable mosaic variation: [clna]), (mutations: [genf]), (mosaic missense: [fndg]), (likely-gene disrupting mutations: [genf]), (genes: [gngm]), (asd (kmt2c: [cgab]), ( nckap1: [gngm]), (myh10): [gngm]), (probands: [orga]), (none: []), (siblings: [famg]), (strong ascertainment bias: [bird]), (mosaic mutations: [genf]), (unaffected siblings: [famg]), (model: []), (variation: []), (mosaic variants: [orgm]), (errors: []), (classification: []), (mosaic status: [orgm]), (simplex asd: [cgab]), ((95%: []), (credible interval: []), (results: [fndg]), (contributory role: [socb]), (multi-tissue mosaic mutation: [genf]), (individuals: [humn]), (asd diagnosis: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(asd diagnosis, 'Diagnosis')

PMCID: 5022064
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (fine particulate matter (pm2.5): [sbst]), (risk factor: [qnco]), (neurodevelopmental disorders: [mobd]), (autism: [mobd]), (children: [aggp]), (however: []), (underlying biological mechanism: []), (dna methylation: [moft]), (fundamental mechanism: []), (neuronal responses: [orga]), (environmental cues: []), (whole particle: [chvs]), (pm2.5 (pm2.5): []), (water-soluble extracts: [sbst]), (organic extracts: [sbst]), (carbon core component (pc): [dsyn]), (chemical constitutes: [chem]), (pm2.5: []), (significant redox imbalance: [moft]), (levels: []), (intercellular methyl: []), (donor s-adenosylmethionine: [aapp,bacs,phsu]), (global dna hypomethylation: [genf]), (furthermore: []), ( pm2.5 exposure: [clna]), (gene-specific promoter dna hypo-: [bacs,nnon]), (hypermethylation: [genf]), (abnormal mrna expression: [genf]), (autism candidate genes: [mobd]), (pm2.5-induced dna hypermethylation: [genf]), (promoter regions: [bacs,nnon]), (synapse: [bsoj]), (genes: [gngm]), (decreases: [qnco]), (mrna: [bacs,nnon]), (protein expression: [genf]), (inhibiting effects: [acty]), (antioxidative reagents: [phsu]), (methylation-supporting agent: [moft]), (dna methyltransferase inhibitor: [phsu]), (involvement: []), (redox/methylation mechanism: [moft]), (pm2.5-induced: []), (abnormal dna methylation patterns: [moft]), (synaptic protein expression: [genf]), (biological effects: []), (sequence: [nusq]), (pm2.5  pwo > po > pw > pc: [dsyn]), (results: [fndg]), (novel epigenetic mechanism: [genf]), (neurodevelopmental toxicity: [inpo]), (particulate air pollution: [eehu]), (chemical components: [elii]), (neurotoxicity: [inpo]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')(autism candidate genes, 'Autism Phenotype')(pm2.5 exposure, 'Exposures')(neurodevelopmental toxicity, 'Learning Disorders')

PMCID: 5192959
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract autism spectrum disorders (asds): [mobd]), (heterogeneous group: [popg]), (neurodevelopmental disorders: [mobd]), (basis: [phsu]), (behaviour: [inbe]), (large body: [humn]), (work: []), (neuroanatomical differences: [qnco]), (individuals: [humn]), (asd: [cgab]), (neurotypical controls: [sbst]), (genetic heterogeneity: [orga]), (anatomical features: []), (cases: [qnco]), (presence: [qnco]), (number: [qnco]), (studies: [lbpr]), (such finding: [sosy]), (tendency: []), (overgrowth: [fndg]), (frontal cortex: [bpoc]), (early postnatal period: []), (reports: [hlca]), (presumed pathological anatomy: [anst]), (important insights: [menp]), (normal brain anatomy: [bpoc]), (new ideas: [menp]), (hypotheses: []), (normal trajectory: [fndg]), (brain development: [ortf]), (function: [phsf]), (specific anatomical brain structures: [bpoc]), (use: []), (model systems: []), (genetic model organisms: [orgm]), (mouse: [mamm]), (recently: []), ( human: [humn]), (pluripotent stem: [plnt]), (brain organoids: [bpoc]), (pathological human cortical development: [humn]), (informative: []), (neuroanatomical alterations: []), (autism: [mobd]), (particular focus: []), (wellvalidated findings: [clna]), (recent advances: []), (field: [irda]), (observations: [hlca]), (abnormal brain development: [bpoc]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(abstract autism spectrum disorders, 'Autism Phenotype')(particular focus on wellvalidated findings, 'Attention and Focus')(autism, 'Autism Phenotype')(abnormal brain development, 'Learning Disorders')

PMCID: 5018849
SFARI Genes: GRIN2B, GRIN2B, GRIN2B, GRIN2B, GRIN2B, GRIN2B, 
Non SFARI Genes: 
Named Entities: (n-methyl-d-aspartate receptors: [aapp,rcpt]), (critical role: [socb]), (excitatory synaptic transmission: [ortf]), (plasticity: [npop]), (central nervous systems: [bdsy]), (recent genetics studies: [lbpr]), (schizophrenia (scz) show: [mobd]), (scz: []), (nmdars: [aapp,rcpt]), (nmdar signaling complex: [aapp,rcpt]), (autism spectrum disorder (asd): [mobd]), (several studies: [lbpr]), (dysregulation: []), (risk factor: [qnco]), (asd: [cgab]), (association: [menp]), (scz/asd development: [cgab]), (mutation: [genf]), (study: [resa]), (grin2b: [gngm]), (nr2b subunit: [aapp]), (rare mutations: [genf]), (diseases: [dsyn]), (asd patients: [cgab]), (respectively): []), (association study: [menp]), (large sample set: [menp]), ( asd: [cgab]), (normal healthy controls: []), (rare missense mutations: [genf]), (mutation screening: [genf]), (significant association: [menp]), (single mutation: [fndg]), (variant: []), ( k1292r: []), (patient group: [popg]), (mutations: [genf]), (scz/asd: [cgab]), (sample size: [qnco]), (functional experiments: [resa]), 
ASD Terms: (schizophrenia show, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5016529
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (healthcare pathways: [hlca]), (patients: [podg]), (neurodevelopmental disorders: [mobd]), (autism spectrum disorder: [mobd]), (attention-deficit hyperactivity disorder: [mobd]), (study: [resa]), (main concerns: []), (healthcare professionals: []), (nd care pathways: [moft]), (concerns: []), (theory (glaser): []), (efforts: [orgf]), (nd care pathway: [moft]), (children: [aggp]), (youth: [aggp]), (swedish region: [popg]), (period: []), (years: []), (data: [euka]), (individual interviews: [acty]), (range: [qnco]), (nd: []), (group interviews: [acty]), (healthcare teams: [hlca]), ( participant: [popg]), (2-day dialogue conference: [hcpp]), ( focus group: [grup]), (regional media coverage: []), (reports: [hlca]), (other swedish regional nd projects: [popg]), (analysed: []), (main concern: []), (participants: [popg]), (overwhelming nd complexity: [chvs]), (control: [sbst]), (strategies: [menp]), (patients status: [fndg]), (needs: []), (professionals strivings: []), (constructive life space: [topp]), (health care: [hlca]), (available care goals: [hlca]), (professional ideologies: []), (workplace integrity: [inbe]), (control-seeking behaviour: [topp]), (relation: [socb]), (nd unpacking: []), (integration: [genf]), (unpacking control theory: [sbst]), (central aspects: [qnco]), (professions theory: []), (nd care development: [orgf]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(attention-deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(neurodevelopmental disorders, 'Learning Disorders')(other swedish regional neurodevelopmental disorders projects, 'Learning Disorders')(control over strategies, 'Problem Solving Ability')(overwhelming neurodevelopmental disorders complexity, 'Learning Disorders')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 5013609
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent studies: [lbpr]), (quantitative autistic traits (qats): [mobd]), (parents: []), (inherited liabilities: []), (index: [qnco]), (genetic risk: [qnco]), (clinical autism spectrum disorder (asd): [mobd]), (offspring: [famg]), (moreover: []), (preferential mating: [celf]), (qats: []), (potential factor: []), (autistic liabilities: [mobd]), (families: [famg]), (generations: []), (heretofore: []), (intergenerational studies: [lbpr]), (caucasian populationsthe present study: [popg]), (phenomena: [phpr]), (well-characterized hispanic population: [popg]), (present study: [qnco]), (qat scores: [plnt]), (siblings: [famg]), (hispanic probands: [popg]), (research: [resa]), (diagnostic criteria: []), (asd: [cgab]), (non-asd controls: [cgab]), (social responsiveness scale-2 (srs-2): [acty]), (ancestry: []), (probands: [orga]), (genotype: [orga]), (information: []), (polymorphic markers: [clna]), (hispanic children: [popg]), (pattern: []), (quantitative trait correlations: [qnco]), (asd-affected children: [cgab]), (first-degree relatives: [qnco]), (order: [acty]), (unaffected first-degree relatives: [qnco]), (asd-affected families: [cgab]), (icc =: [neop]), (sibling/father icc: [famg]), (spouses (mother/father icc: [famg]), (influence: []), (background: []), (strong preferential mating: [celf]), (variation: []), (quantitative autistic trait burden: [mobd]), (results: [fndg]), (analysis: [resa]), (ancestry-informative genetic markers: [topp]), (sample: [sbst]), (other hispanic populations: [popg]), (quantitative autistic traits: [mobd]), (measurable indices: [lbpr]), (inherited liability: []), (hispanic families: [famg]), (accumulation: [fndg]), (autistic traits occurs: [mobd]), (spouses: [famg]), (occurrence: []), (qatsthe magnitude: [qnco]), (culturesconstitutes: []), (mechanism: []), (genetic liability: [topp]), (family: [famg]), (successive generations: []), 
ASD Terms: (clinical autism spectrum disorder, 'Autism Phenotype')(offspring, 'Perinatal History')

PMCID: 5083203
SFARI Genes: Foxp2, Mef2C, Foxp2, Mef2C, Mef2C, Foxp2, Mef2C, Foxp2, Mef2C, Foxp2, Mef2C, Foxp2, Foxp2, Mef2C, Foxp2, Mef2C, 
Non SFARI Genes: 
Named Entities: (cortico-basal ganglia circuits: [bpoc]), (speech: [orgf]), (language: [lang]), (autism spectrum disorder (asd): [mobd]), (language function: [lang]), (striatum: [bpoc]), (gene: [gngm]), ( foxp2: [gngm]), (synapse suppressor: [bsoj]), ( mef2c: [gngm]), (causal evidence: []), (mef2c inhibition: [acty]), (foxp2: [gngm]), (neonatal mouse striatum: [tisu]), (synaptogenesis: [ortf]), (corticostriatal inputs: []), (vocalization: [fndg]), (neonates: [aggp]), (mef2c: [gngm]), (corticostriatal synapse formation: [ortf]), (striatal spinogenesis: [bpoc]), (can: []), ( itself: []), (direct dna binding: [genf]), (foxp2 deletion de-represses mef2c: [genf]), (global decrease: [qnco]), (mef2c rescue vocalization: [fndg]), (striatal spinogenesis defects: [bpoc]), (foxp2-deletion mutants: [genf]), (findings: [clna]), (foxp2-mef2c signaling: [celf]), (circuit formation: [biof]), (humans: [humn]), (such signaling defects: [celf]), (range: [qnco]), (neuropsychiatric disorders: [dsyn]), 
ASD Terms: (speech, 'Language Ability')(autism spectrum disorder, 'Autism Phenotype')(language function, 'Development or Regression of Language Skills')(vocalization, 'Vocalizations')(mef2c rescue vocalization, 'Vocalizations')

PMCID: 5035833
SFARI Genes: theta, theta, theta, theta, theta, theta, theta, theta, theta, theta, 
Non SFARI Genes: 
Named Entities: (abstract objective:: []), (casecontrol study: [resa]), (use: []), (low-intensity repetitive transcranial magnetic stimulation (rtms) protocol: [topp]), (motor cortex (m1) plasticity: [blor]), (youth: [aggp]), (autism spectrum disorder (asd): [mobd]), (children (tdc): [aggp]), (impairments: [patf]), (long-term potentiation-like properties: [ortf]), (neurophysiological biomarker: [clna]), (abnormal cortical function: [bpoc]), (asd: [cgab]), (methods:: []), (years: []), (controls (tdc): [sbst]), (intermittent theta burst stimulation (itbs): [gngm]), (dominant m1: [gngm]), (intensity: []), (motor threshold: []), (suprathreshold single-pulse tms: [fndg]), (amplitudes: []), (motor-evoked potentials: [ortf]), (surface electromyography electrodes: [diap]), (target muscle: [tisu]), ((20 pulses): [hlca]), ((10 pulses/time point) itbs: [hlca]), (predefined timepoints: []), (minutes): [qnco]), (potentiation effects: [topp]), (linear mixed model: [qnco]), (group differences: [popg]), (mep amplitudes: [gngm]), (time: []), (itbs: []), (results: nine youth: [aggp]), (asd (mean age: [cgab]), (males;: [orga]), (right-hand dominant): [bpoc]), (tdc: []), ((mean age: [orga]), (right-hand dominant) participated: [bpoc]), (subjects: [humn]), (procedure well: [topp]), (groups: [popg]), (mean increase: [qnco]), (excitability: [sosy]), (minutes;: [qnco]), (time course: []), (excitability changes: [qnco]), ((f9: [gngm]), (144 =: []), (p: [gngm]), (significant decrease: [qnco]), (amplitude: []), (asd group: [cgab]), (minutes: [qnco]), (multiple comparisons: [acty]), (conclusion:: []), (study: [resa]), (early evidence: []), (potential physiological biomarker: [clna]), (cortical plasticity: [bpoc]), (rapid low-intensity rtms protocol: [fndg]), (discriminate measure: [qnco]), (stimulation: [npop]), (procedure: [topp]), (participants: [popg]), (future work: []), (modification: []), (protocol: [fndg]), (ability: [orga]), (subtypes: []), (cognitive testing: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(cognitive testing, 'Cognitive Ability')

PMCID: 5025785
SFARI Genes: SHANK2, SHANK2, Shank2, Shank2, Shank2, Shank2, Shank2, Shank2, Shank2, Shank2, 
Non SFARI Genes: PC, PC, 
Named Entities: (loss-of-function mutations: [phsf]), (gene: [gngm]), (postsynaptic scaffolding protein shank2: [gngm]), (penetrant cause: []), (autism spectrum disorders: [mobd]), (cerebellum-related motor problems: [bpoc]), (recent studies: [lbpr]), (cerebellar pathology: [bpoc]), (aetiology: []), (asd: [cgab]), (possibility: []), (cerebellar purkinje cells (pcs): [cell]), (critical locus: [gngm]), (asd-like pathophysiology: [cgab]), (mice lacking shank2: [mamm]), (absence: [anab]), (shank2: [gngm]), (pc: [gngm]), (intrinsic plasticity: [npop]), (induction: [topp]), (long-term potentiation: [ortf]), (parallel fibre: [celc]), (synapse: [bsoj]), (moreover: []), ( inhibitory input: [acty]), (pcs: [lbpr]), (posterior lobe: [gngm]), (simple spike (ss) regularity: []), (pc-specific shank2 knockouts: [dsyn]), (alterations: []), (ss regularity: [mamm]), (vivo: []), (cerebellar dependence: [bpoc]), (asd-like: [cgab]), (behavioural phenotypes: [bhvr]), (motor learning: [menp]), (social interaction: [fndg]), (data: [euka]), (importance: []), (pc function: [dsyn]), (model: []), (certain forms: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(cerebellum-related motor problems, 'Motor Skills')(social interaction, 'Reciprocal Social Interaction')

PMCID: 5009541
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (gastrointestinal dysfunction: [dsyn]), (gut microbial composition disturbances: [bdsy]), (autism spectrum disorder (asd): [mobd]), (study: [resa]), (gut microbiome disturbances: [orgm]), (btbrt + tf/j (btbr) mouse model: [aapp,imft]), (asd: [cgab]), (ketogenic diet: [fndg]), (therapeutic benefit: [qnco]), (mouse model: [emod]), (profile: [lbpr]), (findings juvenile male c57bl/6 (b6): [orga]), (btbr mice: [mamm]), (standard chow: [mamm]), (%: []), (kcal fat): [gngm]), (days: []), (cecal samples: [bpoc]), (analysis: [resa]), (main findings: [clna]), (follows: (1) gut microbiota compositions: [orgm]), (fecal samples: [bdsu]), (btbr: [mamm]), (model: []), (utility: [orgt]), (gut-brain interactions: [bpoc]), (asd; (2) kd consumption: [cgab]), (anti-microbial-like effect: [orgm]), (total host: [orgm]), (bacterial abundance: []), (fecal matter; (3) specific: [bdsu]), (kd: [dsyn]), (common asd phenotype: [cgab]), (low firmicutes: [bact]), (bacteroidetes ratio: [bact]), (sample types;: []), (akkermansia: [bact]), (content: [menp]), (fecal matter: [bdsu]), (btbr animals: [anim]), (results: [fndg]), (consumption: [acty]), (likely triggers reductions: [clna]), (total gut microbial counts: [bdsy]), (compositional remodeling: [clna]), (btbr mouse: [mamm]), (findings: [clna]), (part: [qnco]), (ability: [orga]), (neurological symptoms: [sosy]), (animal model: [emod]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-016-0099-3) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(ketogenic diet, 'Dietary Restrictions')(ketogenic diet, 'Dietary Restrictions')(understanding gut-brain interactions in asd, 'Conversational Skills')(bacterial abundance, 'Bacterial Infections')(common asd phenotype, 'Autism Phenotype')(neurological symptoms, 'Neurologic Indications')

PMCID: 5007452
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent studies: [lbpr]), (neuropsychiatric disorders: [dsyn]), (symptomatology: []), (genetic aetiology: [topp]), (aims: [phsu]), (genomics: []), (childhood: []), (adult: [aggp]), (attention-deficit hyperactivity disorder (adhd): [mobd]), ( autism spectrum disorder (asd): [mobd]), (major depressive disorder (mdd): [mobd]), (analysis: [resa]), (whole-genome blood gene expression: [genf]), (genetic risk scores: [clna]), (individuals: [humn]), (participants: [popg]), (adult adhd (n: [mobd]), (childhood adhd (n: [mobd]), (mdd (n: [mobd]), (asd (n: [cgab]), (dual diagnosis: [fndg]), (adhdasd (n =: [aapp,imft]), (healthy controls: []), (gene co-expression analysis results: [fndg]), (disorder-specific signatures: [amas]), (childhood adhd: [mobd]), (mdd: [mobd]), (immune-related gene co-expression modules: [moft]), (adult adhd disease status: [mobd]), (significant relationship: [qnco]), (polygenic risk scores: [qnco]), (gene expression signatures: [qnco]), (results: [fndg]), (disorder overlap: [dsyn]), (specificity: [qnco]), (gene expression level: [gngm]), (new pathways: [moft]), (pathophysiology: [patf]), (psychiatric disorders: [mobd]), (light: [gngm]), (genomic risk factors: [qnco]), 
ASD Terms: (attention-deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism spectrum disorder, 'Autism Phenotype')(major depressive disorder, 'Depressive Disorder')(dual diagnosis, 'Diagnosis')(adult attention-deficit hyperactivity disorderasd, 'Overactivity')(attention-deficit hyperactivity disorder disease status, 'Attention Deficit Disorder with Hyperactivity')(psychiatric disorders, 'Mental Disorders')

PMCID: 5580495
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (fragile x syndrome (fxs): [cgab,dsyn]), (common form: [qnco]), (inherited intellectual disability: [mobd]), (autism cases: [mobd]), (several promising drugs: [topp]), (preclinical testing: [resa]), (fxs;: []), (bench-to-bedside plans: [dsyn]), (clinic: [hcro,mnob]), (validated biomarkers: [clna]), (outcome measures: [qnco]), (work: []), (laboratories: [mnob,orgt]), (altered levels: []), (amyloid-beta (a) protein precursor (app): [aapp,bacs]), (metabolites: [bacs]), (fxs: []), (idiopathic autism: [mobd]), (westmark: []), (colleagues: []), (-secretase (amyloidogenic) processing: [aapp,enzy]), (accumulation: [fndg]), (a peptides: [aapp]), (adult fxs models: [aggp]), (lahiri: []), (sokol: []), (-secretase (nonamyloidogenic: [aapp,enzy]), (anabolic) processing: [orch,phsu]), (sapp: []), (a: []), (pediatric autism: [mobd]), (thus: []), (groups: [popg]), (pivotal role: [socb]), (alzheimers disease: [dsyn]), ((ad)-related proteins: [aapp,bacs]), (neurodevelopmental disorders: [mobd]), (review: []), (contribution: [acty]), (app metabolites: [bacs]), (autism pathogenesis: [mobd]), (potential use: []), (blood-based biomarkers: [bdsu]), (therapeutic targets: [diap]), (future focus: []), (key underlying mechanisms: []), (app: [gngm]), (autism condition-to-disease pathology: [mobd]), (positive outcomes: [fndg]), (utilizing app metabolites: [bacs]), (clinical trials: [resa]), (drugs: [topp]), (app processing: [acty]), (potential disease therapeutics: [dsyn]), (studies: [lbpr]), (role: [socb]), (developmental conditions: [mobd]), (autism: [mobd]), (quantum leap: [phsu]), (neuroscience field: [irda]), (ad: []), 
ASD Terms: (common form of inherited intellectual disability, 'Learning Disorders')(fragile x syndrome, 'Fragile X Syndrome')(inherited intellectual disability, 'Learning Disorders')(autism cases, 'Autism Phenotype')(fragile x, 'Fragile X Syndrome')(bench-to-bedside plans, 'Planning')(fragile x syndrome, 'Fragile X Syndrome')(idiopathic autism, 'Autism Phenotype')(pediatric autism, 'Autism Phenotype')(adult fragile x, 'Fragile X Syndrome')(fragile x syndrome, 'Fragile X Syndrome')(neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')(autism pathogenesis, 'Autism Phenotype')(autism condition-to-disease pathology, 'Autism Phenotype')(developmental conditions, 'Learning Disorders')

PMCID: 5841760
SFARI Genes: 
Non SFARI Genes: EGFR, 
Named Entities: (genetic variants: [npop]), (risk: []), (autism spectrum disorder (asd): [mobd]), (role: [socb]), (post-transcriptional mechanisms: [genf]), (asd: [cgab]), (genome-wide microrna (mirna) expression: [bacs,nnon]), (post-mortem brains: [diap]), (asd patients: [cgab]), (controls: [sbst]), (mirnas: [bacs,nnon]), (co-regulated modules: []), (putative targets: [diap]), (asd-affected mirnas: [bacs,nnon]), (genes: [gngm]), (asd risk: [cgab]), (causal regulatory relationships: []), (several mirnas: [bacs,nnon]), (putative target mrnas: [bacs,nnon]), (primary human neural progenitors: [humn]), (hsa-mir-21-3p: [nusq]), (unknown cns function: [ortf]), (neuronal genes: [gngm]), (novel: []), ( primate-specific mirna: [bacs,nnon]), ( hsa_can_1002-m: [aapp,imft]), (egfr: [gngm]), (fgfr: [aapp,rcpt]), (pathways: [moft]), (neural development: [orgf]), (immune function: [ortf]), (findings: [clna]), (mirna dysregulation: [bacs,nnon]), (asd pathophysiology: [cgab]), (rich dataset: []), (framework: []), (future analyses: [resa]), (neuropsychiatric diseases: [dsyn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5099374
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, shank3, shank3, shank3, shank3, shank3, shank3, shank3, shank3, shank3, shank3, 
Non SFARI Genes: 
Named Entities: (shank3: [gngm]), (protein: [aapp,bacs]), (various synaptic proteins: [aapp,bacs]), (postsynaptic density (psd): [celc]), (excitatory glutamatergic synapses: [celc]), (autism spectrum disorders: [mobd]), (critical role: [socb]), (human phelan-mcdermid syndrome (22q13.3 deletion syndrome): [humn]), (accumulated: []), (experimental evidence: []), (zebrafish model system: [fish]), (functions: [phsf]), (asd-related gene: [cgab]), (early development: [orgf]), (however: []), (many basic features: []), (shank3 transcript expression: [topp]), (poorly understood: [menp]), (here: []), (temporal: []), ( spatial: [gngm]), (isoform-specific expression patterns: [aapp]), (zebrafish development: [fish]), (basis: [phsu]), (previous researches: [resa]), (differential effects: []), (exposure: [clna]), ((vpa): []), (asd-associated drug: [cgab]), (first: [qnco]), (shank3a: []), (shank3b: []), (early ages: [bacs,orch]), (h post-fertilization (hpf)): [elii]), (expression levels: [qnco]), (nervous system: [bdsy]), (hpf: [qnco]), (secondly: [qnco]), (shank3 transcripts: [nnon]), (subsequently: []), (peak: [qnco]), (month post-fertilization (mpf): [orgf]), (adulthood: []), (thirdly: [qnco]), ( vpa treatment: [topp]), (isoform-specific expression: [aapp]), (zebrafish shank3: [fish]), (mrna expression levels: [genf]), (isoforms: [aapp]), (sam domain: [amas]), (mrna expression level: [bacs,nnon]), (ank domain: [moft]), (findings: [clna]), (molecular diversity: []), (molecular framework: []), (isoform-specific function: [phsf]), (zebrafish: [fish]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s00427-016-0561-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(exposure, 'Exposures')

PMCID: 5000439
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neuropathological hallmark: [patf]), (brain: [bpoc]), (autistic individuals: [mobd]), (lesions: [fndg]), (however: []), (previous investigations: [hlca]), (cortical heterotopias: [dsyn]), (local distortion: [anab]), (cytoarchitecture: []), (neocortex: [bpoc]), (cases: [qnco]), (case presentation: []), (patient: [podg]), (40-year-old white woman: [popg]), (early age: [orga]), (mental retardation: [mobd]), (pencil fibers: [tisu]), (prefrontal cortex (brodmann area: [bpoc]), (composition: [clna]), (underlying white matter region: [tisu]), (extent: []), (cortical grey matter: [bpoc]), (oligodendrocytes: [cell]), ( astrocytes: [cell]), (microglial cells: [cell]), (neurons: [cell]), (new cytoarchitectural abnormality: [fndg]), (future pathological examinations: []), (mind: [menp]), (potential presence: [qnco]), (prefrontal cortex: [bpoc]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(mental retardation, 'Mental Retardation')

PMCID: 4999236
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (electrocortical activity: [acty]), (auditory sensory perception: [menp]), (lexical-semantic processing: [acty]), (nonverbal (nv): [fndg]), (minimally-verbal (mv) children: [aggp]), (autism spectrum disorder (asd): [mobd]), (currently: []), (agreement: [socb]), (children: [aggp]), (linguistic information: []), (perception: [menp]), (event-related potentials: [ortf]), (nv/mv children: [virs]), (asd: [cgab]), (neurotypical children: [aggp]), (picture-word matching paradigm: [resa]), (atypical erp responses: [orga]), (levels: []), (processing: [acty]), (basic perceptual processing: [acty]), (auditory domains: []), (amplitude: []), (typically-developing children: [aggp]), (however: []), (significant differences: [qnco]), (groups: [popg]), (lexical-semantic level: [phsu]), (atypical higher-order processes: [phpr]), (results: [fndg]), (basic perception: [menp]), (lexical- semantic functions: []), (use: []), (passive erp paradigms: [resa]), (active participant response: [fndg]), (significant potential: [qnco]), (assessment: [acty]), (non-compliant populations: [popg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(auditory sensory perception, 'Form Perception')(perception, 'Cognitive Ability')(basic perception, 'Cognitive Ability')

PMCID: 4997702
SFARI Genes: MYO1E, KCND3, PDCD1, MYO1E, KCND3, PDCD1, 
Non SFARI Genes: DLX3, TSPAN4, 
Named Entities: (patients: [podg]), (certain genetic diseases: [fndg]), (autism spectrum disorder: [mobd]), (rates: [qnco]), (mutations: [genf]), (protein-coding genes: [gngm]), (variant prioritization sum: [qnco]), (software package: []), (functional variant prioritization information: []), (power: [hcpp]), (disease risk: [fndg]), (varprism: []), (consequence: []), (exonic mutation: [bacs,nnon]), (protein sequence: [amas]), (likelihood: [qnco]), (mutation: [genf]), (likelihood ratio test: [qnco]), (gene level: [gngm]), (simons simplex collection: [bpoc]), (parent-offspring autism trios: [aapp,enzy]), (genes: [gngm]), (autism susceptibility: [clna]), (additional candidate genes: [gngm]), (myo1e: [gngm]), ( kcnd3: [gngm]), ( pdcd1: [gngm]), ( dlx3: [gngm]), (tspan4 (false discovery rate: [qnco]), (functional predictions: []), ( varprism: []), (statistical power: [resa]), (disease risks: [dsyn]), (http://www.hufflab.org/software/varprism: [inpr,mnob]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13073-016-0341-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(parent-offspring autism trios, 'Autism Phenotype')(autism susceptibility, 'Autism Phenotype')

PMCID: 4995518
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (developmental disorder evident: [mobd]), (infancy: []), (clinical identification: [menp]), (expert diagnostic training: [edac]), (new evidence: []), (disruption: []), (timing: []), (integration: [genf]), (disorder: [dsyn]), (potential new computational marker: [clna]), (early identification: [topp]), (study: [resa]), (smart tablet computers: []), (touch-sensitive screens: [ortf]), (inertial movement sensors: [orgf]), (movement kinematics: [orgf]), (gesture forces: [socb]), (children: [aggp]), (years: []), (gender-matched children: [orga]), (typically: []), (machine: []), (analysis: [resa]), (childrens motor patterns: []), (accuracy: []), (patterns: []), (forces: [phpr]), (contact: [acty]), (different distribution: []), (gesture: [socb]), (gesture kinematics: [socb]), (distal use: []), (space: []), (data support: [euka]), (notion disruption: []), (movement: [orgf]), (core feature: [bdsu]), (fun: []), ( smart device gameplay: []), 
ASD Terms: (infancy, 'Perinatal History')(autism, 'Autism Phenotype')(gesture forces, 'Integrated Verbal and NonVerbal Communication')(gesture, 'Integrated Verbal and NonVerbal Communication')(gesture kinematics, 'Integrated Verbal and NonVerbal Communication')(autism, 'Autism Phenotype')(demonstrate autism, 'Autism Phenotype')

PMCID: 5332182
SFARI Genes: 
Non SFARI Genes: GC, 
Named Entities: (background: polychlorinated biphenyls (pcbs): [hops,orch]), (organochlorine pesticides: [hops,orch]), (neurodevelopmental toxicants: [hops]), (few studies: [lbpr]), (associations: [menp]), (autism spectrum disorder (asd): [mobd]), (prenatal exposure: [fndg]), (pcbs: [orch,phsu]), (ocps influences: [dsyn]), (risk: []), (asd: [cgab]), (intellectual disability: [mobd]), (autism (id): [mobd]), (methods:: []), (population-based casecontrol study: [resa]), (southern california births: [orgf]), (children: [aggp]), (asd (n: [cgab]), (meeting diagnostic: [fndg]), (statistical manual: [inpr,mnob]), (mental disorders: [mobd]), (edition: []), ((dsm-iv-tr) criteria: [gngm]), (id (n: [lbpr]), (general population (gp): [popg]), ((n =: [aapp,imft]), (concentrations: [menp]), (pcb congeners: [orch,phsu]), (ocps: [dsyn]), (banked second-trimester serum samples: [bdsu]), (diagnostic groups: [popg]), (logistic regression: [resa]), (crude: []), (odds ratios: [qnco]), (id: [lbpr]), (gp controls: [gngm]), (quartiles: []), (analyte concentrations: [menp]), (primary analyses: [resa]), (results: geometric mean levels: [fndg]), (several pcb congeners: [orch,phsu]), (asd group: [cgab]), (gp groups: [popg]), (asd risk: [cgab]), (number: [qnco]), (pcb: [gngm]), (vs: []), (quartile: []), (pcb138/158 (aor: [moft]), (ci:: [lbpr]), (pcb153 (aor: [moft]), (deciles: []), (other congeners: [chvs]), (secondary analyses: [neop]), (pcb138/158: []), (increased id (aor: [moft]), (trend: []), (increased risk: [qnco]), ( whereas: []), (nonmonotonic increases: [qnco]), (conclusions:: []), (results: [fndg]), (levels: []), (organochlorine compounds: [orch]), (pregnancy: [orgf]), (citation: lyall k: [qnco]), ( croen la: [elii]), ( sjdin a: []), ( yoshida ck: [aapp,enzy]), ( zerbo o: []), ( kharrazi m: [aapp,imft]), ( windham gc: [gngm]), (biphenyl: [hops,orch]), (organochlorine pesticide concentrations: [menp]), (maternal mid-pregnancy serum samples: association: [orgf]), (autism spectrum disorder: [mobd]), (environ health perspect: [orch]), (http://dx.doi.org/10.1289/ehp277: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental toxicants, 'Learning Disorders')(offspring risk of asd, 'Perinatal History')(autism, 'Autism Phenotype')(prenatal exposure, 'Exposures')(intellectual disability, 'Learning Disorders')(mental disorders, 'Mental Disorders')

PMCID: 5022092
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent studies: [lbpr]), (long-term oxytocin administration: [aapp,horm,phsu]), (symptoms: [sosy]), (autism spectrum disorder (asd); however: [mobd]), ( factors: []), (efficacy: [resa]), (single-center phase: [fndg]), (pilot: [gngm]), (randomized: [resa]), ( double-blind: [resa]), ( placebo-controlled: [resa]), ( parallel-group: [popg]), ( clinical trial: [resa]), (young adults: [aggp]), (high-functioning asd: [cgab]), (oxytocin dosage: [aapp,horm,phsu]), (genetic background: [orga]), (oxytocin receptor affects: [aapp,rcpt]), (trial: [resa]), (double-blind (12: [resa]), (open-label (12 weeks): [resa]), (follow-up phases: [euka]), (weeks): []), (dose dependency: [qnco]), (participants: [popg]), (high-dose (32 iu: [nnon]), (day): []), (low-dose intranasal: [qnco]), ((16 iu: [nnon]), (placebo groups: [popg]), (double-blind phase: [resa]), (next: []), (single-nucleotide polymorphisms: [nusq]), (oxytocin receptor gene (oxtr): [aapp,rcpt]), (intention-to-treat population: [popg]), (outcomes: []), (oxytocin administration: [aapp,horm,phsu]), (however: []), (male: [orga]), ( clinical global: []), (impression-improvement (cgi-i) scores: [inch]), (high-dose group: [popg]), (low-dose group: [popg]), (placebo group: [popg]), (oxytocin efficacy: [aapp,horm,phsu]), (cgi-i scores: [inch]), (daily dosage: [qnco]), (oxtr polymorphisms: [genf]), (male participants: [orga]), (>21 iu: [nnon]), (day oxytocin: [aapp,horm,phsu]), (21 iu: [nnon]), (day: []), (snp: [nusq]), (oxtr (rs6791619): [gngm]), (treatment: [topp]), (severe adverse events: [fndg]), (results: [fndg]), (young men: [popg]), (oxytocin receptor: [aapp,rcpt]), (effectiveness: []), (oxytocin treatment: [aapp,horm,phsu]), (asd: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5167061
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (motivation: analyzing genome: [menp]), (wide association data: [menp]), (context: [fndg]), (biological pathways: [moft]), (genetic variation influences phenotype: [orga]), (power: [hcpp]), (associations: [menp]), (however: []), (utility: [orgt]), (pathway-based analysis tools: []), (undercuration: []), (reliance: [bodm]), (distribution: []), (genes: [gngm]), (pathway: [moft]), (methods: []), (wide association results: [menp]), (genetic networks: [moft]), (key phenotype-modulating subnetworks: [orga]), (issues: [fndg]), (network definitions: [popg]), (yes/no labels: []), (gene-gene interactions: [genf]), (recent method (ew_dmgwas): [lbpr]), (biological network: [popg]), (weighted edge probability: [orga]), (secondary phenotype-specific expression dataset: [neop]), (article: []), (algorithm: [lbpr]), (weighted-edge module searching: [orga]), (probabilistic interaction network: [popg]), (order: [acty]), (method: [lbpr]), ( stams: [gngm]), (modules: []), (strong associations: [menp]), (phenotype: [orga]), (probable biologic coherence: [qnco]), (method builds: [lbpr]), (ew_dmgwas: []), (secondary expression dataset: [neop]), (performs: [phsu]), (test cases: [qnco]), (standard gene-based analysis: [lbpr]), (precision: []), (recall: [menp]), (wellcome trust rheumatoid arthritis: [dsyn]), (stams-identified modules: [fndg]), (ew_dmgwas (stams p-value: [qnco]), (ew_dmgwas- p-value =: [qnco]), (area: []), (precision-recall curve: [menp]), (times: [qnco]), (stams: [gngm]), (wellcome trust type: [inbe]), (diabetes data: [dsyn]), (availability: []), (implementation: stams: [acty]), (r package: [qnco]), (https://simtk.org/projects/stams: [gngm]), (contact: rbaltman@stanford.edu supplementary information: supplementary data: [orch,phsu]), (bioinformatics online: []), 
ASD Terms: (diabetes data, 'Diabetes Mellitus Type 1')

PMCID: 5352777
SFARI Genes: 
Non SFARI Genes: SPX, 
Named Entities: (recent studies: [lbpr]), (sensory processing atypicalities: [ortf]), (share: [socb]), (genetic influences: [topp]), (autism spectrum disorder (asd): [mobd]), (further investigate: []), (adolescent/adult sensory profile (aasp) questionnaire: []), (parents: []), (children: [aggp]), (simplex asd families (spx): [cgab]), (multiplex asd families: [cgab]), (gender: [orga]), (presence: [qnco]), (mental disorders: [mobd]), ( results: [fndg]), (mpx parents: []), (p-td parents: [aapp,imft]), (subscales: []), (aasp: []), (differences: [qnco]), (spx: [gngm]), (significance: [qnco]), (sensory sensitivity subscale: [patf]), (subsequent modality-specific analyses: [resa]), (auditory: []), (visual domains: []), (high genetic liability: [qnco]), (asd (i.e.: [cgab]), ( mpx): []), (spx): [gngm]), ((i.e.: [diap,inpr]), ( p-td) asd: [cgab]), (genetic liability: [topp]), (genetic susceptibility: [orga]), (asd: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(sensory processing atypicalities, 'Reaction to Sensory Stimuli')(mental disorders, 'Mental Disorders')(visual domains, 'Visual Thinking')(sensory processing atypicalities than parents, 'Reaction to Sensory Stimuli')

PMCID: 4988023
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (cognitive deficits: [mobd]), (social impairments: [patf]), (sensory dysfunction: [dsyn]), (body: [humn]), (evidence: []), (oxidative stress: [comd]), (inflammation: [patf]), (pathophysiology: [patf]), (biomarkers: [clna]), (measure: [qnco]), (severity: []), (autistic features: [mobd]), (study: [resa]), (plasma levels: [bdsu]), (8-isoprostane: [irda,orch]), (cysteinyl leukotrienes (cyslts): [orch,phsu]), (autistic children: [podg]), (healthy controls: []), (recruited autistic patients: [mobd]), (behavior: [inbe]), ( cognitive: []), (sensory deficits: [dsyn]), (different autism severity rating scales: [mobd]), (childhood autism rating scales (cars): [mobd]), ( social responsiveness scale (srs): [acty]), (short sensory profile (ssp): [qnco]), (analysis (roc): [resa]), (data: [euka]), (predictive value: []), (oxidative stress-: [comd]), (related parameters: [fndg]), (pearsons correlations: []), (measured parameters: [fndg]), (concentrations: [menp]), (cyslts: []), (autistic patients: [mobd]), (controls: [sbst]), (significant differences: [qnco]), (ssp results: [fndg]), (levels: []), (however: []), (improvements: []), (oxidative stress status (as: [comd]), (8-isoprostane levels): [irda,orch]), (ages: [bacs,orch]), (markers: [clna]), (early recognition: [menp]), (sensory deficits phenotypes: [orga]), (early intervention: [hlca]), 
ASD Terms: (autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(cognitive deficits, 'Cognitive Ability')(social impairments, 'Social Competence')(sensory dysfunction, 'Reaction to Sensory Stimuli')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(cognitive, 'Cognitive Ability')(sensory deficits, 'Reaction to Sensory Stimuli')(different autism severity rating scales, 'Autism Phenotype')(childhood autism rating scales, 'Autism Phenotype')(sensory deficits phenotypes, 'Reaction to Sensory Stimuli')

PMCID: 5324550
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (aberrant connectivity: []), (pathophysiology: [patf]), (autism spectrum disorder (asd): [mobd]), (studies: [lbpr]), (such impairments: [patf]), (patients: [podg]), (asd: [cgab]), (alterations: []), (sensory systems: [bdsy]), (however: []), (cellular substrates: [sbst]), (molecular underpinnings: []), (disrupted connectivity: []), (eyespecific segregation: [socb]), (dorsal lateral geniculate nucleus (dlgn): [bpoc]), (model system: []), (formation: [biof]), (refinement: []), (precise patterning: []), (synaptic connections: [bsoj]), (btbr t + tf/j (btbr) mouse model: [aapp,imft]), (neonatal stage: []), (shape: []), (dlgn: []), (retinal afferents: [bpoc]), (btbr group: [popg]), (c57bl/6j (b6) animals: [mamm]), (notably: []), (degree: [qnco]), (overlap: [topp]), (ipsi: []), (contralateral afferents: []), (btbr mice: [mamm]), (moreover: []), (abnormalities: [cgab]), (mature stage: []), (btbr animals: [anim]), (persistent deficits: []), (delayed maturation: [mobd]), (axonal refinement: [celc]), (together: []), (results: [fndg]), (connectivity: []), (synaptic patterning level: [phsu]), (general: [hlca]), (neural circuitry: [bpoc]), (autistic behaviours: [mobd]), (animal model: [emod]), (data: [euka]), (notion: []), (lowerlevel: []), ( primary processing mechanisms: [topp]), (visual perception: [orgf]), (autism res: [mobd]), (autism research: [mobd]), (wiley periodicals: []), ( inc: []), (behalf: []), (international society: [orgt]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(visual perception, 'Visual Thinking')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 4988886
SFARI Genes: 
Non SFARI Genes: BOLA2, BOLA2, BOLA2, BOLA2, 
Named Entities: (genetic differences: [comd]), (unique aspects: [qnco]), (human evolution: [humn]), (comparative analyses: [resa]), (genomes: [gngm]), (humans: [humn]), (related primates1: [fndg]), (archaic hominins2: []), (3: [fndg]), (regions: []), (genome: [gngm]), ( however: []), (such study: [resa]), (recurrent copy number variation (cnv): [nusq]), (chromosome: [celc]), (accounts: [clna]), (~1%: [fndg]), (autism cases4: [mobd]), (5: [qnco]), (complex set: [menp]), (evolutionary history: [genf]), (locus: [gngm]), (bola2 (bola family member: [gngm]), (gene: [gngm]), (homo sapiens: [humn]), (kbp segment: [aapp,enzy,rcpt]), (bola2: [gngm]), (critical region ~282: []), (years: []), (series: [qnco]), (genomic changes: [gngm]), (hominid evolution: [mamm]), (copies: []), (duplication: [comd]), (human lineagea pattern: [humn]), (absence: [anab]), (selection (p: [genf]), (novel: []), ( human-specific in-frame fusion transcript: [humn]), (number correlates: [qnco]), (rna expression (r: [genf]), (level (r: [phsu]), (expression difference: [qnco]), (chimpanzee: [mamm]), (derived stem cells: [cell]), (analyses: [resa]), (patients: [podg]), (rearrangement: [genf]), (>96%: []), (breakpoints: []), (homo: [fndg]), (sapiens-specific duplication: [comd]), (duplicative transposition: [cgab]), (root: [bpoc]), (sapiens lineage ~282: []), (copy number: [qnco]), (iron homeostasis: [celf]), (species: []), (rearrangements: [genf]), (disease: [dsyn]), 
ASD Terms: (autism cases4, 'Autism Phenotype')

PMCID: 5073112
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (maternal immune activity: [acty]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (maternal occupational exposure: [inpo]), (asthma-causing agents: [dsyn]), (pregnancy: [orgf]), (relation: [socb]), (asd risk: [cgab]), (sample: [sbst]), (asd cases: [cgab]), (general population controls: [hlca]), (study: [resa]), (early development: [orgf]), (mothers: [famg]), (job: [mcha]), (asthmagen exposure: [clna]), (job-exposure matrix: [phsu]), (odds ratio: [qnco]), (asd: [cgab]), ((95 % ci: [lbpr]), (maternal workplace asthmagen exposure: [inpo]), (result: [fndg]), (involvement: []), (maternal exposure: [inpo]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-016-2882-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(maternal occupational exposure, 'Exposures')(asthmagen exposure, 'Exposures')(maternal exposure, 'Exposures')(maternal workplace asthmagen exposure, 'Exposures')

PMCID: 4979025
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (brain-derived neurotrophic factor (bdnf): [aapp,bacs]), (neuronal survival: [celf]), (growth: [orgf]), (synaptic plasticity: [ortf]), (recently: []), ( researchers: []), (relationship: []), (peripheral bdnf levels: [aapp,bacs,phsu]), (autism spectrum disorder (asd): [mobd]), (findings: [clna]), (first systematic review: [qnco]), (meta-analysis: [resa]), (studies: [lbpr]), (asd: [cgab]), (healthy controls: []), (pubmed: []), ( embase: []), (cochrane library databases: [gngm,nnon]), (february: []), (fourteen studies: [qnco]), (participants: [popg]), (incident cases: [qnco]), (evidence: []), (controls: [sbst]), (mean difference (smd): [dsyn]), (confidence interval (95% ci): [qnco]), (p: [gngm]), (subgroup: [virs]), (bdnf levels: [aapp,bacs,phsu]), (serum [smd =: [bdsu]), (ci: [gngm]), ([smd =: [dsyn]), (childhood: []), (similar cumulative effect size [smd: [dsyn]), (adulthood [smd: [dsyn]), (ci = 1.721.80; p: [lbpr]), (potential biomarker: [clna]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 4979185
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (genome-wide association studies: [mbrt]), (hundreds: []), (genetic variants: [npop]), (complex traits: [gngm]), (diseases: [dsyn]), (however: []), (causal genes: [gngm]), (gwas hits: [mbrt]), (summary data-based mendelian randomization (smr) method: [resa]), (gwas: [mbrt]), (summary datasets: []), (genes: [gngm]), (expression levels: [qnco]), (traits: [gngm]), ((the expression level: [qnco]), (gene: [gngm]), (trait: [orga]), (same causal variant: []), (locus): [gngm]), (novel associations: [menp]), (mb distance: [qnco]), (genes): [gngm]), (results: [fndg]), (online database (http://www.cnsgenomics/shiny/smrdb/): [fndg]), (important resources: []), (further follow-up: [hlca]), (example: []), (functional studies: [lbpr]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13073-016-0338-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: 

PMCID: 4977510
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (genetic heterogeneity: [orga]), ( identification: [menp]), (causal genetic determinants: [topp]), (autism spectrum disorder (asd): [mobd]), (whereas: []), (several dozen rare: [gngm]), (genetic variants: [npop]), (asd susceptibility: [cgab]), (identified: [fndg]), ( studies: [lbpr]), (common variants: [qnco]), (subtle effects: [clna]), (recent application: [qnco]), (genome-wide association studies: [mbrt]), (asd: [cgab]), (significant associations: [menp]), (single nucleotide polymorphisms: [nusq]), (chromosome: [celc]), (non-coding region: [gngm]), (cadherin10 (cdh10): []), (cadherin9 (cdh9): []), (vivo bacterial artificial chromosome (bac): []), (enhancer-trapping strategy: [menp]), (mice: [mamm]), (gene desert: [gngm]), (spatiotemporal cis-regulatory activities: [acty]), (results: [fndg]), (asd-associated interval: [cgab]), (cortical area: [bpoc]), ( striatum: [bpoc]), (cerebellum: [bpoc]), (specific enhancers: [nnon]), (long non-coding rna: [nnon]), ( moesin pseudogene1 antisense (msnp1as): [aapp]), (brain: [bpoc]), (stages: [clna]), (mouse moesin protein levels: [aapp,bacs]), (human antisense rnas: [humn]), (transgenic brains: [anim]), (difficulty: [fndg]), (effects: []), (vivo evidence: []), (spatiotemporal transcription: [genf]), (msnp1as: []), (further support: []), (intergenic variant: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(vivo bacterial artificial chromosome, 'Bacterial Infections')

PMCID: 4977499
SFARI Genes: CACNA1C, CACNA1C, CACNA1C, CACNA1C, CACNA1C, CACNA1C, 
Non SFARI Genes: 
Named Entities: (mutations: [genf]), (cacna1c gene: [gngm]), (ventricular tachycardia (vt): [dsyn]), (cacna1c mutations: [genf]), (patients: [podg]), (cardiac arrhythmias: [fndg]), ( mechanisms: []), (such genetic mutation conditions: [dsyn]), (study: [resa]), (novel mechanism: []), (vt: []), (repolarization dispersion: []), (key factor: []), (arrhythmias: [fndg]), (cacna1c g1911r mutation: [genf]), (multi-scale computational models: [acty]), (human ventricle: [humn]), (increased calcium influx: [fndg]), (mutation: [genf]), (action: [acty]), (potential duration (apd): [orch,phsu]), (potential duration restitution (apdr): [phsu]), (membrane: [celc]), (potential differences: [qnco]), (different cell types: [cell]), (repolarization: []), (transmural dispersion: []), (repolarization (dor): [aapp,rcpt]), (temporal heterogeneity: [orga]), (cardiac electrical activities: [ortf]), (consequentially: []), (vulnerability: []), (unidirectional conduction block: [dsyn]), (response: [fndg]), (premature stimulus: [fndg]), (tissue level: [tisu]), (g1911r mutation: [genf]), (functional repolarization dispersion: []), (reentrant excitation waves: [acty]), (tissue: [tisu]), (organ models: [bpoc]), (initiation: [menp]), (maintenance: [acty]), (rotor tip: [gngm]), (primary factor: [topp]), (genesis: [gngm]), (timothy syndrome: [dsyn]), 
ASD Terms: 

PMCID: 5226686
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background:: []), (united: []), (exposure: [clna]), (air pollution: [eehu]), (early life: []), (autism spectrum disorders: [mobd]), (children: [aggp]), (evidence: []), (european data: [euka]), (association: [menp]), (road traffic: [fndg]), (risk: []), (asd: [cgab]), (careful adjustment: [inbe]), (other confounders: []), (method: children born: [orgf]), (residing: [acty]), (stockholm: []), ( sweden: []), (asd diagnosis: [cgab]), (multiple health registers: [qnco]), (cases: [qnco]), (sample: [sbst]), (same study base: [inch]), (controls: [sbst]), (levels: []), (nitrogen oxides: [inch]), (matter: []), (diameter: [qnco]), (m (pm10): [aapp,imft]), (residential addresses: [humn]), (mothers pregnancy: [famg]), (childs: [aggp]), (first year: [qnco]), (life: []), (dispersion models: []), (odds ratios (or): [qnco]), (confidence intervals: [qnco]), (intellectual disability (id): [mobd]), (logistic regression models: [inpr,qnco]), (municipality: []), (calendar year: []), (birth: [orgf]), (adjustment: [inbe]), (potential confounders: []), (result: air pollution exposure: [eehu]), (prenatal period: [aggp]), (overall (or: []), (ci:: [lbpr]), (10-g/m3 increase: [qnco]), (pm10: []), (or: []), (20-g/m3 increase: [qnco]), (nox: []), (mothers pregnancy): [famg]), (similar results: [fndg]), (combination: [fndg]), (id: [lbpr]), (inverse association: []), (air pollution exposure: [eehu]), (asd risk: [cgab]), (mothers: [famg]), (new residence: []), (pregnancy: [orgf]), (conclusion:: []), (early-life exposure: [clna]), (low levels: [qnco]), (citation: gong t: []), ( dalman c: []), ( wicks s: [clna]), ( dal h: [elii]), ( magnusson c: []), ( lundholm c: []), ( almqvist c: []), ( pershagen g: [qnco]), (perinatal exposure: [hcpp]), (traffic-related air pollution: [eehu]), (environ health perspect: [orch]), (http://dx.doi.org/10.1289/ehp118: [fndg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(exposure, 'Exposures')(exposure, 'Exposures')(asd diagnosis, 'Diagnosis')(intellectual disability, 'Learning Disorders')(air pollution exposure, 'Exposures')(air pollution exposure, 'Exposures')(early-life exposure, 'Exposures')(perinatal exposure, 'Perinatal Exposures')

PMCID: 5215415
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract dynamic changes: [qnco]), (synaptic strength: [qnco]), (protein synthesis: [moft]), (protein degradation: [moft]), (ubiquitin proteasome system (ups): [aapp,enzy]), (disruption: []), (cellular processes: [celf]), (significant impairments: [patf]), (synaptic plasticity: [ortf]), (memory formation: [menp]), (mutations: [genf]), (several genes: [famg]), (regulators: []), (mrna translation: [moft]), (members: [popg]), (ups: [gngm]), (risk: []), (development: [orgf]), (autism spectrum disorders: [mobd]), (similar imbalance: [sosy]), (protein homeostasis (proteostasis): [biof]), (synapse: [bsoj]), (review: []), (recent work: []), (role: [socb]), (glutamatergic synapses: [bsoj]), (dysfunctional proteostasis: [dsyn]), (common consequence: [qnco]), (several genetic mutations: [genf]), (spectrum disorders: [dsyn]), (dynamic changes: [qnco]), (mrna translation (i.e: [moft]), (fmr1): [gngm]), (protein degradation (i.e: [moft]), (ube3a): [gngm]), (intellectual disability (asd/id): [cgab]), (compensatory changes: [qnco]), (rate: [qnco]), (proteostasis: []), (neurological symptoms: [sosy]), (asd/id: [cgab]), (asd: [cgab]), (article: []), (part: [qnco]), (mini review: [orga]), (synaptic function: [phsf]), (dysfunction: [dsyn]), (brain diseases: [dsyn]), 
ASD Terms: (memory formation, 'Working Memory')(autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')(neurological symptoms, 'Neurologic Indications')(brain diseases, 'Central Nervous System Diseases')

PMCID: 5022076
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (genes: [gngm]), (autism spectrum disorders: [mobd]), (fragile x syndrome (fxs): [cgab,dsyn]), (intellectual disabilities: [mobd]), (neuronal function: [phsf]), (differentiation: [celf]), (sh-sy5y neuroblastoma cell: [cell]), (used system: [fndg]), (applicability: []), (cortical development: [ortf]), (optimal neuronal differentiation protocol: [fndg]), (system: []), (evaluated neurodevelopment: [hlca]), (transcriptomic level: [nusq]), (context: [fndg]), (machine-learning algorithm: [mcha]), (human post-mortem brain data: [diap]), (developmental stage: []), (regional identity: [menp]), (transcriptomic signatures: [amas]), (improved model: []), (contrast: [irda]), (sh-sy5y models: []), (early neurodevelopmental processes: [phpr]), (high fidelity: [qnco]), (regression modelling: [menp]), (dynamic time: []), (analysis: [resa]), ( parallel independent component analysis: [resa]), (weighted gene co-expression network analysis: [orga]), (activated gene sets: [gngm]), (networks: []), (finally: []), (sets: [menp]), (enrichment: []), (risk genes: [gngm]), (neuropsychiatric disorders: [dsyn]), (significant overlap: [topp]), (asd: [cgab]), (fxs: []), ( id: [lbpr]), (scz: []), (however: []), ( counterintuitive: []), (observation: [hlca]), (pathways: [moft]), (disorder: [dsyn]), (early neurodevelopment: [ortf]), ( fxs: []), (positive regulators: [fndg]), (id-implicated genes: [gngm]), (negative regulators: [fndg]), (neuronal differentiation: [fndg]), (id genes: [gngm]), (dendritic branching modules: [celc]), (asd risk genes: [cgab]), (histone modification: [moft]), (axonal guidance: [celf]), (cell cycle modules: [celf]), (underlying signatures: [amas]), (genetic architecture results: [fndg]), (disorders: [dsyn]), (id: [lbpr]), (thus: []), (developmental network context: [popg]), (genetic analyses: [lbpr]), (pathophysiology: [patf]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(fragile x syndrome, 'Fragile X Syndrome')(intellectual disabilities, 'Learning Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(early neurodevelopmental processes, 'Learning Disorders')(fragile x, 'Fragile X Syndrome')(intellectual disabilities genes, 'Learning Disorders')(intellectual disabilities in asd, 'Learning Disorders')

PMCID: 4969621
SFARI Genes: RBFOX1, RBFOX1, RBFOX1, RBFOX1, 
Non SFARI Genes: 
Named Entities: (gene abnormalities: [comd]), (rbfox1: [gngm]), (mrna-splicing factor: [genf]), (autism spectrum disorder: [mobd]), (other neurodevelopmental disorders: [mobd]), (pathophysiological significance: [qnco]), (dominant nuclear isoform: [aapp]), (neurons: [cell]), ( rbfox1-isoform1 (iso1): [gngm]), (comprehensive analyses: [resa]), (rbfox1-iso1: [gngm]), (mouse corticogenesis: [mamm]), (knockdown: []), (utero electroporation: [lbpr,resa]), (abnormal neuronal positioning: [imft]), (corticogenesis: []), (migration: [phpr]), (defects: []), (radial migration: [phpr]), (terminal translocation: [comd]), (impaired nucleokinesis: []), (axon extension: [ortf]), (dendritic arborization: [ortf]), (vivo: []), (rbfox1-iso1-deficient: [qnco]), (cortical neurons: [bpoc]), (addition: []), ( electrophysiology experiments: [resa]), (significant defects: [qnco]), (membrane: [celc]), (synaptic properties: []), (deficient neurons: [cell]), (aberrant morphology: [fndg]), (vitro analyses; rbfox1-iso1-konckdown: [resa]), (hippocampal neurons: [cell]), (reduction: [npop]), (primary axon: [celc]), (total length: [qnco]), (dendrites: [celc]), ( spine density: [bpoc]), (mature spine number: [bpoc]), (together: []), (study: [resa]), (important role: [socb]), (neuronal migration: [gngm]), (synapse network formation: [popg]), (critical processes: [phpr]), (functional defects: []), (pathophysiology: [patf]), (neurodevelopmental disorders: [mobd]), (rbfox1 abnormalities: [cgab]), 
ASD Terms: (cause autism spectrum disorder, 'Autism Phenotype')(other neurodevelopmental disorders, 'Learning Disorders')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 5000625
SFARI Genes: 
Non SFARI Genes: IRS1, IRS1, 
Named Entities: (insulin-like growth factor (igf) pathway: [aapp,horm]), (important role: [socb]), (brain development: [ortf]), (altered levels: []), (igfs: [aapp,horm]), (signaling regulators: [celf]), (autism spectrum disorder (asd) patients: [mobd]), (study: [resa]), (region: []), (single-nucleotide polymorphisms (csnps): [nusq]), (insulin receptor: [aapp,enzy,rcpt]), ((irs1: [gngm]), (irs2): [aapp,bacs]), (key mediators: [orch,phsu]), (igf pathway: [aapp,horm]), (asd: [cgab]), (korean males: [orga]), (csnps (rs1801123: [nusq]), (irs1: [gngm]), (rs4773092: []), (direct sequencing: [mbrt]), (male asd patients: [cgab]), (male control subjects: [orga]), (significant association: [menp]), (rs1801123: []), (additive (p =: [aapp,imft]), (odds: []), ((or) =: []), (confidence interval (ci): [qnco]), (dominant models: []), (or: []), (ci: [gngm]), (allele frequency analysis: [qnco]), (association: [menp]), (asd (p: [cgab]), (results: [fndg]), (susceptibility: [clna]), 
ASD Terms: (autism spectrum disorder patients, 'Autism Phenotype')

PMCID: 4966969
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objective cohort selection: [genf]), (large-scale electronic health record (ehr) analyses: [resa]), (international classification: []), (diseases: [dsyn]), (edition: []), ((icd-9) diagnostic codes: [fndg]), (unreliable disease predictors: [qnco]), (objective: []), (evaluate: [hlca]), (automated algorithm: [lbpr]), (autism spectrum disorder (asd): [mobd]), (patient cohort: [podg]), (ehr: []), (utility: [orgt]), (investigation: [hlca]), (date: []), (co-occurrence patterns: []), (medical comorbidities: [hlca]), (asd: [cgab]), (icd-9 codes: []), (concepts: []), (clinical notes: []), (gold standard patient set: [menp]), (clinicians: []), (boston childrens hospital (bch) (n =: [hcro,mnob]), (cincinnati childrens hospital: [hcro,mnob]), (medical center (cchmc) (n: [hcro,mnob]), (algorithms: []), (asd criteria: [cgab]), (diagnostic: [fndg]), (statistical manual: [inpr,mnob]), (mental diseases: [mobd]), ( (2) predictive classifier: [qnco]), (positive predictive values: [qnco]), (icd-9 code baseline: [bodm]), (patients: [podg]), (grouped icd-9 codes: []), (subgroups: [virs]), (rule-based algorithm: [lbpr]), (ppv: (a) bch:: [dsyn]), ((baseline); (b) cchmc:: [bodm]), ((baseline); (c): [bodm]), (vs: []), ((baseline): [bodm]), (validation: [resa]), (childrens hospital: [hcro,mnob]), (philadelphia: []), ((ppv): [qnco]), (analyses: [resa]), (comorbidities: []), (three-site large cohort (n: [aapp,imft]), (asd patients): [cgab]), (psychiatric: [hlca]), ( developmental: [orgf]), (seizure disorder clusters: [dsyn]), (large cross-institutional cohort: [hcro,mnob]), ( co-occurrence patterns: []), (asds: [cgab]), (further hypothetical evidence: []), (distinct courses: []), (cohort selection: [genf]), (open avenues: []), (other large-scale ehr studies: [lbpr]), (individualized treatment: [topp]), 
ASD Terms: (autism spectrum disorder patient cohort, 'Autism Phenotype')(medical comorbidities, 'Comorbidities')(boston childrens hospital, 'Hospitalizations')(cincinnati childrens hospital, 'Hospitalizations')(medical center, 'Medications')(mental diseases, 'Mental Disorders')(boston childrens hospital, 'Hospitalizations')(childrens hospital, 'Hospitalizations')(childrens hospital, 'Hospitalizations')(comorbidities, 'Comorbidities')(comorbidities, 'Comorbidities')

PMCID: 5132150
SFARI Genes: RTs, RTs, 
Non SFARI Genes: 
Named Entities: (attention deficit hyperactivity disorder (adhd): [mobd]), (autism spectrum disorder (asd) show: [mobd]), (genetic overlap: [topp]), (adhd: [mobd]), (asd: [cgab]), (poor performance: [grpa]), (range: [qnco]), (cognitive tasks: []), (particular: []), (response time variability (rtv): []), (promising indicator: [irda]), (risk: []), (however: []), (different indices: [lbpr]), (rtv: [orch,phsu]), (changes: [qnco]), (task conditions: [dsyn]), (disorders: [dsyn]), (children: [aggp]), (asd (n: [cgab]), (adhd (n: [mobd]), (asd + adhd (n =: [cgab]), (controls (tdc;: [sbst]), (fourchoice rt task: [bpoc]), (slowbaseline: []), (fastincentive conditions: [dsyn]), (performance: [inbe]), (mean rt (mrt): [bpoc]), (standard deviation: [qnco]), (rt (sdrt): [bpoc]), ( coefficient: [qnco]), (variation (cv): []), (exgaussian distribution measures: [qnco]), (mu: [gngm]), ( sigma: []), (tau: [gngm]), (slowbaseline condition: [dsyn]), (categorical diagnoses: [fndg]), (trait measures: [qnco]), (adhdonly: []), (asd + adhd: [cgab]), (mrt: [blor]), ( sdrt: []), ( cv: []), (tdc: []), (asdonly: []), (importantly: []), (improvement: []), (conditions: [dsyn]), (variable rts: []), (markers: [clna]), (controls: [sbst]), (energetic factors: [fndg]), (rewards: [menp]), (task performance: [topp]), (extent: []), (findings: [clna]), ( adhd: [mobd]), (indices: [lbpr]), (variability: []), (further work: []), (neural processes: [phpr]), (increased rtv: [orch,phsu]), (order: [acty]), (disorderspecific: []), (disorderconvergent aetiological pathways: [moft]), 
ASD Terms: (attention deficit hyperactivity disorder, 'Overactivity')(autism spectrum disorder show, 'Autism Phenotype')(cognitive tasks, 'Cognitive Ability')(asd + attention deficit hyperactivity disorder, 'Overactivity')(attention deficit hyperactivity, 'Overactivity')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(energetic factors, 'Abnormal Activity or Energy Level')(improve task performance, 'Task Performance')(attention deficit hyperactivity disorder, 'Overactivity')

PMCID: 5545711
SFARI Genes: FAN1, TRPM1, OTUD7A, CHRNA7, FAN1, TRPM1, OTUD7A, CHRNA7, 
Non SFARI Genes: MTMR10, KLF13, 
Named Entities: (microdeletion syndrome: [dsyn]), (1.5-mb hemizygous microdeletion: [qnco]), (genes: fan1; mtmr10; trpm1;: [gngm]), (mir-211; klf13; otud7a;: [gngm]), (chrna7: [gngm]), (microdeletion: []), (risk: []), (intellectual disability: [mobd]), ( epilepsy: [dsyn]), ( autism spectrum disorder: [mobd]), (schizophrenia: [mobd]), (clinical profile varies: [lbpr]), (mouse models: [mamm]), (syndrome: [dsyn]), (hemizygous deletion: [genf]), (orthologous region: []), (murine genome: [mamm]), (number: [qnco]), (physiological deficits: []), (human condition: [humn]), (still: []), (underlying biological mechanisms: []), (human cases: [humn]), (homozygous deletion: [genf]), (region: []), (physiological impairments: [patf]), (homozygous knockout: [orga]), (pronounced behavioral: [inbe]), (mice: [mamm]), (characterization: [acty]), (knockout mouse: [mamm]), (marked deficits: []), (altered seizure: [sosy]), (susceptibility: [clna]), ( autistic behavior-related phenotypes: [orga]), (auditory sensory processing: [ortf]), (deficits: []), (hemizygous littermates: []), (gene-dosage dependency: [menp]), (findings: [clna]), (studies: [lbpr]), (hemi-: []), (mouse strains: [mamm]), (understanding: [menp]), (biological mechanisms: []), (severe mental disorders: [mobd]), 
ASD Terms: (risk of intellectual disability, 'Learning Disorders')(epilepsy, 'Epilepsy')(autism spectrum disorder, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(epilepsy, 'Epilepsy')(autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(severe mental disorders, 'Mental Disorders')

PMCID: 5325728
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (transcriptional underpinnings: [genf]), (brain development: [ortf]), (humans: [humn]), (related non-human primates: [humn]), (high resolution: [lbpr]), (transcriptional atlas: [bpoc]), (rhesus monkey brain development: [mamm]), (combines: []), (dense temporal sampling: [diap]), (prenatal: [aggp]), (postnatal periods: []), (fine anatomical parcellation: []), (subcortical regions: [blor]), (human neuropsychiatric disease: [humn]), (gene expression changes: [genf]), (birth: [orgf]), (progenitor cells: [cell]), (neurons: [cell]), (cortical layers: [bpoc]), (areas: []), (adult-like molecular profiles: [aggp]), (late postnatally: []), (disparate cell populations: [popg]), (distinct developmental timing: [orgf]), (unexpected synchrony: []), (processes: [phpr]), (neural circuit construction: [topp]), (cell projection: [celc]), (adhesion: [patf]), (candidate risk genes: [gngm]), (neurodevelopmental disorders: [mobd]), (primary microcephaly: [cgab,dsyn]), ( autism spectrum: [mobd]), (intellectual disability: [mobd]), (schizophrenia: [mobd]), (disease-specific spatiotemporal enrichment: [dsyn]), (human: [humn]), (developmental expression trajectories: [orgf]), (rodent: [mamm]), (genes: [gngm]), (human-specific regulation: [humn]), (evidence: []), (prolonged maturation: [phsf]), (neoteny: [orgf]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 4963856
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evaluation: [hlca]), (environmental risk factors: []), (development: [orgf]), (autism spectrum disorder (asd): [mobd]), (complete understanding: [menp]), (disease etiology: []), (approaches: []), (prevention: [resa]), ( diagnosis: [fndg]), (treatment: [topp]), (pilot experiment: [resa]), (children: [aggp]), (asd: [cgab]), (controls;: [sbst]), (years): []), (urinary mycotoxins: [hops,orch]), (liquid chromatography-tandem mass spectrometry: [lbpr]), (current exposure: [clna]), ((20%) samples: [fndg]), (limit: []), (detection: [topp]), (mycotoxin/group: [popg]), (mycotoxins: [hops,orch]), (asd-diagnosed children: [cgab]), (potential correlates: []), (mycotoxin presence: [hops,orch]), (urine: [bdsu]), (subjects: [humn]), (urinary mycotoxin: [hops,orch]), (participants: [popg]), (difference: [qnco]), (presence: [qnco]), (absence: [anab]), (mycotoxin: [hops,orch]), (age: [orga]), ((t-test; p: [aapp,imft]), (gender (fishers: [orga]), (exact test; p: [aapp,imft]), (exposure: [clna]), (serotonin reuptake inhibitors: [phsu]), (other medications: [clna]), (positive association: [menp]), (sophisticated sample preparation techniques: [fndg]), (instrumentation: [qnco]), (selectivity: [genf]), (group: [popg]), (sensitivity: [patf]), (further: []), (utero (mothers): [famg]), (newborn-toddler years: [aggp]), (additional exposure windows: [clna]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')(current exposure, 'Exposures')(exposure, 'Exposures')(other medications, 'Medications')(additional exposure windows, 'Exposures')

PMCID: 4949425
SFARI Genes: SmN, SmN, 
Non SFARI Genes: Nr4a1, Nr4a1, Nr4a1, Nr4a1, 
Named Entities: (small nuclear ribonucleoprotein: [aapp,bacs]), (n (snrpn) gene: [gngm]), (rna-associated smn protein: [nnon]), ( duplications: []), (deletions: [genf]), (neurodevelopmental disabilities: []), (snrpn-coding protein: [aapp,bacs]), (brain: [bpoc]), (however: []), (role: [socb]), (snrpn protein: [aapp,bacs]), (neural development: [orgf]), (expression: [topp]), (snrpn: [gngm]), (postnatal brain development: [bpoc]), (overexpression: [genf]), (knockdown: []), (cortical neurons: [bpoc]), (neurite outgrowth: [celf]), ( neuron migration: [celf]), (distribution: []), (dendritic spines: [celc]), (expression level: [qnco]), (nr4a1: [gngm]), (critical nuclear receptor: [aapp,rcpt]), (cultured primary cortical neurons: [bpoc]), (abnormal spine development: [bpoc]), (snrpn overexpression: [genf]), (nr4a1 co-expression: [aapp,rcpt]), (importantly: []), (3- diindolylmethane (dim): [orch,phsu]), (nr4a1 antagonist: [aapp,rcpt]), (effects: []), (snrpn knockdown: [gngm]), (embryonic cortical neurons: [bpoc]), (potential therapeutic methods: [topp]), (snrpn deletion disorders: [genf]), (proper level: [phsu]), (cortical neurodevelopment: [bpoc]), (finally: []), ( nr4a1: [aapp,rcpt]), (potential drug target: []), (snrpn-related neurodevelopmental disabilities: [fndg]), (prader-willi syndrome (pws): [cgab]), (autism spectrum disorders: [mobd]), 
ASD Terms: (neurodevelopmental disabilities, 'Learning Disorders')(abnormal spine development, 'Learning Disorders')(prader-willi syndrome, 'Prader-Willi Syndrome')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 4962257
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (well-trained staff: [orgt]), (good quality autism services: [mobd]), (people: [popg]), (autism: [mobd]), (support needs: []), (other populations: [popg]), (terms: [orgf]), (daily living: []), (mental: [menp]), (physical health: [orga]), (poorly-trained staff: [orgt]), (detrimental effects: []), (service provision: []), (staff morale: [inbe]), (staff burn-out: [fndg]), (service user anxiety: [mobd]), (stress: [fndg]), (paper: []), (survey: []), (health: []), ( social care: [hlca]), (education staff: [fndg]), (statutory autism services sector: [mobd]), (uk: []), (knowledge: []), (training: [edac]), (regards: []), (interview data: [acty]), (staff: []), (service users: [humn]), (qualitative illustrations: []), (survey findings: [clna]), (findings: [clna]), (acute lack: []), (autism-specific training: [mobd]), (detrimental impacts: [gngm]), (brief: []), (basic awareness: [menp]), (in-depth understanding: [menp]), (issues: [fndg]), (skills: [inbe]), (evidence-based practice: []), (effects: []), (lack: []), (staff training: [edac]), (services: []), (discussion: [socb]), (policy routes: []), (quality staff training: [edac]), (practice: [menp]), (focus: []), (quality: []), (life: []), (mental health: [menp]), (services users: [humn]), (significant cost-savings: [qnco]), (governments: [orgt]), 
ASD Terms: (good quality autism services, 'Autism Phenotype')(autism, 'Autism Phenotype')(service user anxiety, 'Anxiety Disorders')(statutory autism services sector, 'Autism Phenotype')

PMCID: 4945013
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (burden: []), (comorbidity: []), (autism spectrum disorder (asd): [mobd]), (symptoms: [sosy]), (autism: [mobd]), (many other human conditions: [humn]), (common molecular pathologies: [qnco]), (cross-disorder analysis: [hlca]), (autism gene candidates: [gngm]), (genes: [gngm]), (intersection: []), (related conditions: [dsyn]), (nonspecific indicators: [irda]), (dysregulation: []), (causal role: [socb]), (thorough literature review: []), (icd-9 codes comorbid: []), (asd: [cgab]), (specific human disorders: [humn]), (present work: [qnco]), (automated extraction: [lbpr]), (comorbid disorders: [fndg]), (asd only: [cgab]), (comorbid disorder: [fndg]), (pathway analysis: []), (pathways: [moft]), (other comorbid disorders: [fndg]), (basal: []), (cellular functions: [celf]), (comorbid conditions: [fndg]), (neural function: [phsf]), (sequence: [nusq]), (differential evolutionary constraints: [genf]), (long term constraints: []), (genomic evolutionary rate profiling: [genf]), (several comorbid disorders: [fndg]), (purifying selection: [genf]), (result: [fndg]), (dn/ds ratio: [qnco]), (compare: [acty]), (short-term evolutionary constraints: [genf]), (same trend: []), (pn/ps ratio: [aapp,bacs]), (evolutionary constraint: [genf]), (other disorders: [dsyn]), 
ASD Terms: (comorbidity, 'Comorbidities')(autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(help prioritize autism gene candidates, 'Autism Phenotype')(autism, 'Autism Phenotype')(icd-9 codes comorbid, 'Comorbidities')(comorbid disorders, 'Comorbidities')(comorbid disorder, 'Comorbidities')(other comorbid disorders, 'Comorbidities')(comorbid conditions, 'Comorbidities')(several comorbid disorders, 'Comorbidities')

PMCID: 5658669
SFARI Genes: atg7, atg7, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (neurodevelopmental disorders: [mobd]), (environmental factors: []), (synaptic abnormalities: [cgab]), (asd development: [cgab]), (microglia: [cell]), (role: [socb]), (synaptic refinement: []), (development: [orgf]), (autophagy: [celf]), (pathways: [moft]), (asds: [cgab]), (however: []), (precise roles: [socb]), (microglial autophagy: [celf]), (synapses: [bsoj]), (neurobehavior regulation: [biof]), (deletion: [genf]), (atg7: [gngm]), (myeloid cell-specific lysozyme m-cre mice: [mamm]), (social behavioral defects: [inbe]), (repetitive behaviors: [fndg]), (characteristic features: []), (mice: [mamm]), (increases: [qnco]), (dendritic spines: [celc]), (synaptic markers: [clna]), (connectivity: []), (brain regions: [blor]), (defects: []), (synaptosome degradation: [celc]), (atg7-deficient microglia: [cell]), (immature: []), (dendritic filopodia: [celc]), (neurons: [cell]), (knowledge: []), (results: [fndg]), (regulation: [biof]), (synapse: [bsoj]), (neurobehaviors: [fndg]), (starting point: [qnco]), (comprehensive studies: [lbpr]), (putative therapeutics: [orch,phsu]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(neurobehavior regulation, 'Central Nervous System Diseases')(autism spectrum disorders, 'Autism Phenotype')(social behavioral defects, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(neurobehaviors, 'Central Nervous System Diseases')

PMCID: 5545709
SFARI Genes: ERMN, ERMN, ERMN, ERMN, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (complex conditions: [dsyn]), (penetrant mutations: [genf]), (multiple genes: [fndg]), (etiology: []), (<1/3: [fndg]), (cases: [qnco]), (strong evidence: []), (environmental contribution: [acty]), (asd: [cgab]), (epigenetic modifications: [genf]), (methylation changes: [moft]), (blood dna: [bdsu]), (male asd patients: [cgab]), (healthy controls: []), (methylomic array (450k illumina): []), (variants: []), (transcriptional alterations: [genf]), (blood rnaseq data: [bdsu]), (casecontrol association study: [menp]), (relevant findings: [clna]), (cohort (394 cases: [popg]), (controls): [sbst]), (cpgs: [bacs,nnon]), (asd group: [cgab]), (cis-acting expression changes: [topp]), (locations: []), ((1) hypomethylation: [fndg]), (rare genetic variants: [npop]), (loci (ermn: [gngm]), ( usp24: [gngm]), ( mettl21c: [gngm]), ( pde10a: [gngm]), ( stx16: [gngm]), (dbt): [gngm]), ((q-value <0.05);: [fndg]), ((2): [qnco]), (epimutations: []), (transcriptional changes: [genf]), (single-asd patients: [fndg]), (mesnvs: []), (clustered epimutations: [qnco]), (unaffected parents: []), (top candidate genes: [gngm]), (significant load: [acty]), (deleterious mutations: [comd]), (ermn: [gngm]), (controls: [sbst]), (data: [euka]), (inherited methylation alterations: [moft]), (epigenetic defects: []), (gene expression: [genf]), (contribute: [acty]), (asd susceptibility: [cgab]), (additive manner: [sbst]), (novel asd gene: [cgab]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 4936315
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism-spectrum quotient (aq): [qnco]), (autistic traits: [mobd]), (parents: []), (individuals: [humn]), (autism spectrum disorders: [mobd]), (general population: [popg]), (papers objective: []), (aq's: []), (psychometric properties: [diap]), (chinese version: [lang]), (mainland china: []), (pattern: []), (sex differences: [orga]), (quantity: [qnco]), (usefulness: []), (aq: []), (asd: [cgab]), ( schizophrenia (sch): [mobd]), (obsessive-compulsive disorder (ocd): [mobd]), (healthy controls: []), (study: [resa]), (children: [aggp]), (children (tdc): [aggp]), (participants: [popg]), (patients: [podg]), (sch: [gngm]), (ocd patients: [mobd]), (age: [orga]), ( gender: [orga]), (iq): []), (internal consistency: [qnco]), (test-retest reliability: [resa]), (aq subscales: []), (acceptable range: [qnco]), (asd children: [cgab]), (total aq: [qnco]), (tdc parents: []), (items: []), (fathers: [famg]), (mothers: [famg]), (subscales: []), (sole exception: [blor]), (subscale attention: [menp]), (total aq score: [clna]), (asd group: [cgab]), ( ocd: [mobd]), (hc groups: [horm,orch,phsu]), (hc group: [horm,orch,phsu]), (ocd groups: [mobd]), (differences: [qnco]), (mandarin aq: []), (reliable instrument: []), (non-clinical samples: [sbst]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(obsessive-compulsive disorder, 'Obsessive-Compulsive Disorder')(obsessive-compulsive disorder patients, 'Obsessive-Compulsive Disorder')(obsessive-compulsive disorder, 'Obsessive-Compulsive Disorder')(obsessive-compulsive disorder groups, 'Obsessive-Compulsive Disorder')

PMCID: 4935837
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (forkhead-box domain (fox): [mamm]), (family members: [famg]), (role: [socb]), (neocorticogenesis: []), (disorders: [dsyn]), (autism spectrum: [mobd]), (single rna-binding protein: [fndg]), ( hu antigen r (hur): [aapp,bacs]), (translation specificity: [qnco]), (bound mrnas: [bacs,nnon]), (distinct foxp-characterized subpopulations: [popg]), (neocortical projection neurons: [cell]), (furthermore: []), (distinct phosphorylation states: [moft]), (hur: [gngm]), (translation: [moft]), (foxp mrnas: [bacs,nnon]), (vitro: []), (importance: []), (rna: [nnon]), (proteins: [aapp,bacs]), (framework: []), (brain: [bpoc]), (mrna translation: [moft]), (autism pathogenesis: [mobd]), 
ASD Terms: (autism spectrum, 'Autism Phenotype')(hu antigen r, 'Allergies')(hu antigen r, 'Allergies')(autism pathogenesis, 'Autism Phenotype')

PMCID: 5215991
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (heterogeneous neurodevelopmental disorders: [orga]), (molecular mechanisms: []), (asd pathogenesis: [cgab]), (genetic studies: [resa]), ( brain pathology: [patf]), (imaging: [diap]), (major impediment: []), (asd hypotheses: [cgab]), (lack: []), (human cell models: [lbtr]), (here: []), (fibroblasts: [cell]), (induced pluripotent stem cells: [cell]), ((ipscs): []), ( neural progenitor cells: [cell]), (neurons: [cell]), (asd individuals: [cgab]), (early brain overgrowth: [bpoc]), (non-asd controls: [cgab]), (normal brain size: [bpoc]), (asd-derived npcs display: [cgab]), (cell proliferation: [celf]), (dysregulation: []), (-catenin/brn2 transcriptional cascade: [aapp,bacs]), (asd-derived neurons: [cgab]), (abnormal neurogenesis: [orgf]), (reduced synaptogenesis: [ortf]), (functional defects: []), (neuronal networks: [imft]), (interestingly: []), ( defects: []), (igf-1: [aapp,bacs]), (drug: [phsu]), (clinical trials: [resa]), (asd: [cgab]), (work: []), (selection: [genf]), (asd subjects: [cgab]), (endophenotypes: []), (relevant pathway disruption: [moft]), (potential cellular mechanism: [cell]), (therapeutic effect: [clna]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(heterogeneous neurodevelopmental disorders, 'Learning Disorders')

PMCID: 4988267
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (many adults: [aggp]), (autism spectrum disorder (asd): [mobd]), (specialist assessment clinics: [hcro,mnob]), (detection: [topp]), (cases: [qnco]), (such services: []), (unnecessary referrals: [hlca]), (services: []), (individuals: [humn]), (autism-spectrum quotient: [qnco]), (self-report questionnaire measure: [resa]), (autistic traits: [mobd]), (however: []), (ability: [orga]), (aq: []), (diagnosis: [fndg]), (asd: [cgab]), (adults: [aggp]), (national asd: [cgab]), (diagnostic referral service: [hlca]), (suspected asd: [cgab]), (aq scores: [clna]), (predictors: []), (asd diagnosis: [cgab]), (expert clinicians: []), (international classification: []), (diseases: [dsyn]), ((icd)-10 criteria: []), (autism diagnostic observation schedule-generic (ados-g): [hlca]), (autism diagnostic: [mobd]), (interview-revised (adi-r) assessments: [acty]), (participants: [popg]), (clinical diagnosis: []), (self-report aq scores: [resa]), (receipt: []), (high sensitivity: [lbpr]), ([95% confidence interval: [qnco]), (positive predictive value: [qnco]), ((95% ci: [lbpr]), (specificity: [qnco]), (negative predictive value: [qnco]), (low: [qnco]), (thus: []), (aq cut-off: []), (false negatives: [lbtr]), (fact: [gngm]), (co-morbidity data: [euka]), (generalized anxiety disorder: [mobd]), (false positives: [lbtr]), (aq's utility: [orgt]), (referrals: [hlca]), (sample: [sbst]), (recommendations: []), (aq's role: [socb]), (assessment: [acty]), (adult asd: [cgab]), ( e.g: []), (uk nice guidelines: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(diagnosis, 'Diagnosis')(asd diagnosis, 'Diagnosis')(autism diagnostic observation schedule-generic, 'Autism Phenotype')(autism diagnostic, 'Autism Phenotype')(clinical diagnosis, 'Diagnosis')(generalized anxiety disorder, 'Anxiety Disorders')

PMCID: 4943479
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (number: [qnco]), (researchers: []), (neurological disorders: [dsyn]), (interaction: []), (common susceptibility genes: [gngm]), (stochastic factors: []), (genetic factors: [fndg]), (mutations: [genf]), ( insertions: [hlca]), ( deletions: [genf]), (copy number variations: [nusq]), (small subset: [qnco]), (cases: [qnco]), (unknown environmental contaminants: [sbst]), (role: [socb]), (idiopathic autism: [mobd]), (psychoactive pharmaceuticals: [phsu]), (potential environmental contaminants: [sbst]), (drinking water: [sbst]), (low concentrations: [menp]), (preliminary studies: [lbpr]), (laboratory: [mnob,orgt]), (gene sets: [gngm]), (neuronal systems: [imft]), (human neurological disorders: [humn]), (fish brains: [fish]), (environmental concentrations: [menp]), (gene expression inductions: [genf]), (changes: [qnco]), (fish behavior: [fish]), (here: []), (hypothesis: []), (similar treatments: [topp]), (vitro gene expression: [genf]), (autism): [mobd]), (human neuronal cells: [lbtr]), (human sk-n-sh neuroblastoma cells: [neop]), (mixture (fluoxetine: [orch,phsu]), ( carbamazepine: [orch,phsu]), (venlafaxine): [orch,phsu]), (valproate: [orch,phsu]), (positive control: []), (autism-associated profiles): [mobd]), (transcriptome analysis: [lbpr,mbrt]), (rna-seq approach: [nusq]), (neuronal gene sets: [gngm]), (autism-associated sets): [menp]), (moreover: []), (altered expression profiles: [lbpr]), (human cells: [lbtr]), (gene expression: [genf]), (vitro gene expression profiles: [qnco]), (neuronal growth: [orgf]), ( development: [orgf]), (regulation: [biof]), (expression patterns: [topp]), (potential neurological disorders: [dsyn]), (autism: [mobd]), (aggravate: [fndg]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s12864-016-2784-1) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (neurological disorders, 'Neurologic Indications')(idiopathic autism, 'Autism Phenotype')(neurological disorders, 'Neurologic Indications')(human neurological disorders, 'Neurologic Indications')(neurological disorders, 'Neurologic Indications')(potential neurological disorders, 'Neurologic Indications')(autism, 'Autism Phenotype')

PMCID: 4926223
SFARI Genes: BDNF, BDNF, BDNF, BDNF, BDNF, BDNF, 
Non SFARI Genes: 
Named Entities: (role: [socb]), (synaptic zinc: [elii,phsu]), (asd pathogenesis: [cgab]), (zinc transporter: [aapp,bacs]), ((znt3) null mice: [mamm]), (weeks: []), (age: [orga]), ( male: [orga]), (female znt3 null mice: [mamm]), (autistic-like behaviors: [mobd]), (cortical volume: [bpoc]), (neurite density: [celc]), (male znt3 null mice: [mamm]), (wt mice: [mamm]), (level: [phsu]), (bdnf: [gngm]), (activity: [acty]), (mmp-9: [aapp,enzy]), (known roles: [socb]), (mmps: [aapp,enzy]), (upregulation: [genf]), ( 2.5-week treatment: [topp]), (mmp inhibitor: [phsu]), (bdnf levels: [aapp,bacs,phsu]), (megalencephaly: [cgab]), (znt3 null state: [qnco]), (free zinc: [elii,phsu]), (cytosol: [celc]), (brain cells: [cell]), (mmp-9 activity: [moft]), (present results: [fndg]), (zinc dyshomeostasis: [elii,phsu]), (critical period: []), (brain development: [ortf]), (possible contributing mechanism: [acty]), (asd: [cgab]), 
ASD Terms: 

PMCID: 4931610
SFARI Genes: IL-6, IL-6, IL-6, IL-6, IL-6, IL-17, IL-6, IL-17, IL-6, IL-6, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (children: [aggp]), (deficits: []), (sociability: [socb]), (communication: [socb]), (stereotypic movements: [fndg]), (many children: [aggp]), (severe anxiety: [mobd]), (lack: []), (distinct pathogenesis: [patf]), (reliable biomarkers: [clna]), (development: [orgf]), (effective treatments: []), (result: [fndg]), (asd: [cgab]), (psychopharmacologic agents: [phsu]), (core symptoms: [sosy]), (autoantibodies: [aapp,imft]), (brain epitopes: [imft]), (mothers: [famg]), (many such children: [aggp]), (allergic symptoms: [sosy]), (aberrant immune response: [ortf]), (disruption: []), (bloodbrain barrier (bbb): [bpoc]), (recent epidemiological studies: [resa]), (strong statistical correlation: [inpr,resa]), (risk: []), (infantile atopic diseases: [dsyn]), (asthma: [dsyn]), ( eczema: [dsyn]), ( food allergies: [patf]), (food: [imft,phsu]), (activation: [acty]), (mast cells: [cell]), (unique tissue immune cells: [cell]), (tissues: [tisu]), (thalamus: [bpoc]), (hypothalamus: [bpoc]), (emotions: [menp]), (mc-derived inflammatory: []), (vasoactive mediators: [orch,phsu]), (bbb permeability: [bpoc]), (expression: [topp]), (inflammatory molecules: [sbst]), (tumor necrosis factor (tnf): [aapp,imft]), (brain: [bpoc]), ( cerebrospinal fluid: [bdsu]), (serum: [bdsu]), (patients: [podg]), (nf-kb: [aapp,imft]), (brain samples: [bpoc]), (peripheral blood: [bdsu]), (immune cells: [cell]), (other patients; however: [podg]), (molecules: [sbst]), (peptide neurotensin: [aapp,horm]), (corticotropin-releasing hormone: [aapp,horm,phsu]), (stress: [fndg]), (peptides: [aapp]), (mc: []), (il-6: [gngm]), (tnf: [gngm]), (turn: [fndg]), ( stimulate microglia proliferation: [celf]), (neuronal connectivity: [imft]), (mc-derived il-6: [aapp,imft]), (tgf: [aapp,bacs]), (maturation: [phsf]), (th17 cells: [cell]), (mcs: [gngm]), (il-17: [gngm]), (serum il-6: [aapp,imft]), (asd subgroup: [cgab]), (benefits: [qnco]), (treatment: [topp]), (natural flavonoid luteolin: [orch,phsu]), (atopic diseases: [dsyn]), (phenotype: [orga]), (formulations: [resa]), (focal inflammation: [fndg]), (great promise: [qnco]), 
ASD Terms: (stereotypic movements, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorders, 'Autism Phenotype')(severe anxiety, 'Anxiety Disorders')(core symptoms of asd, 'Complaints and Indications')(allergic symptoms, 'Allergies')(asthma, 'Asthma')(eczema, 'Skin Indications')(food allergies, 'Allergies')(cerebrospinal fluid, 'Hydrocephalus')

PMCID: 4931605
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (youth: [aggp]), (autism spectrum disorder (asd): [mobd]), (anxiety: [mobd]), (comorbidity: []), (significant functional impairment: [patf]), (however: []), (mechanisms: []), (overlap: [topp]), (interplay: []), (asd traits: [cgab]), (reward processing: [menp]), (asd: [cgab]), (community sample: [sbst]), (adolescents: [aggp]), ((mean age=14.4 years): [orga]), (modified monetary incentive delay task: []), (part: [qnco]), (imagen project: []), (blood-oxygen-level dependent (bold) responses: [orga]), (anticipation: [menp]), (feedback: [phpr]), (analysis: [resa]), (variance test (asd traits: low/high; anxiety symptoms: low/high): [cgab]), (plausible covariates: []), (addition: []), (longitudinal design: [acty]), (neural responses: [orga]), (2-year follow-up: [hlca]), (high asd traits: [cgab]), (reduced bold responses: [orga]), (dorsal prefrontal regions: [blor]), (reward anticipation: [menp]), (negative feedback: [phpr]), (participants: [popg]), (high anxiety symptoms: [fndg]), (increased lateral prefrontal responses: [orga]), (decreased responses: [orga]), (interaction effects: []), (combined asd traits: [cgab]), ( relative: [qnco]), (other youth: [aggp]), (activation: [acty]), (reward: [menp]), (low right-sided caudate: [qnco]), ( putamen: [bpoc]), ( medial: []), (lateral prefrontal activations: [acty]), (negative feedback (all clusters: [phpr]), (bold activation patterns: [acty]), (right dorsal cingulate: []), (right medial frontal gyrus: [bpoc]), (new-onset anxiety: [mobd]), (low asd traits: [cgab]), (results: [fndg]), (distinct neural correlates: []), (specific neural responses: [orga]), (risk factor: [qnco]), (asd youth: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(anxiety, 'Anxiety Disorders')(comorbidity, 'Comorbidities')(anxiety, 'Anxiety Disorders')(anxiety, 'Anxiety Disorders')(high anxiety symptoms, 'Anxiety Disorders')(new-onset anxiety, 'Anxiety Disorders')(comorbidity, 'Comorbidities')(anxiety, 'Anxiety Disorders')

PMCID: 4924796
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (laboratory rat: [mamm]), (attractive preclinical animal model: [anim]), (autism spectrum disorder (asd): [mobd]), (investigators: []), (pharmacological manipulations: [topp]), (species: []), (complex: [chvs]), ( reciprocal social behavior: [socb]), (present study: [qnco]), (strains: [menp]), (laboratory: [mnob,orgt]), (rats: [mamm]), ( sprague-dawley (sd): [mamm]), (long-evans (le): [mamm]), (ages: [bacs,orch]), (postnatal day: []), (high-throughput behavioral phenotyping tools: [bhvr]), (mouse models: [mamm]), (asd: [cgab]), (use: []), (few differences: [qnco]), (young sd: [mamm]), (le strains: [menp]), (standard assays: [lbpr]), (exploration: [topp]), ( sensorimotor gating: [phsf]), (repetitive behaviors: [fndg]), (learning: [menp]), (sd: [gngm]), (sociability: [socb]), (3-chamber social approach test: [lbpr]), (time: []), (social chamber: [bpoc]), (constrained age/strain/sex: [orgf]), (novel partner: [popg]), (identical chamber: [bpoc]), (partner: [popg]), (pronounced differences: [qnco]), (social dyad paradigm: [resa]), (sd rats: [mamm]), (paradigm: [resa]), (play: [dora]), (durations: []), (le rats: [mamm]), (juvenile: [aggp]), (young adult: [aggp]), (developmental time points: [orgf]), (results: [fndg]), (study: [resa]), (preclinical asd models: [cgab]), (threefold: (i): [inch]), (strains exhibit: [inpo]), (unique patterns: []), (social interactions: [fndg]), (strain-specific play behaviors: [dora]), (environment: []), (expression: [topp]), (strain-specific social behavior: [socb]), ((iii): []), (measures: [qnco]), (complexities: [chvs]), (rat: [mamm]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(reciprocal social behavior, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(social interactions, 'Reciprocal Social Interaction')(strain-specific social behavior, 'Reciprocal Social Interaction')

PMCID: 4923867
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (tendency: []), (judgements: [menp]), (quantities (lengths: [qnco]), ( durations: []), (towards: []), (mean: [qnco]), (robust perceptual effects: []), (bayesian account: [clna]), (central tendency: [lbpr]), (integration: [genf]), (noisy sensory estimates: [phpr]), (prior knowledge representations: [menp]), (mean stimulus: [phpr]), (performance: [inbe]), (process: [phpr]), (prior knowledge: [evnt]), (sensory estimates: [qnco]), (noise: [phpr]), (study: [resa]), (autism: [mobd]), (recent theoretical hypothesis: []), (autistic perception relies: [mobd]), (typical perception: [menp]), (autistic children: [podg]), (reduced central tendency: [lbpr]), (temporal resolution: [lbtr]), (ability-matched typical children: [orga]), (child-friendly tasks:: [aggp]), (time: []), (interval reproduction task: [orgf]), (temporal domain;: []), (time discrimination: [socb]), (age: [orga]), (typical development: [orgf]), (temporal resolution improved: [lbtr]), (temporal discrimination: [socb]), (matched controls: [resa]), (computational simulations: [resa]), (theoretical modelling: [resa]), (poor temporal resolution: [grpa]), 
ASD Terms: (autism, 'Autism Phenotype')(autistic perception relies, 'Cognitive Ability')(typical perception, 'Cognitive Ability')

PMCID: 4925020
SFARI Genes: AT-1, AT-1, 
Non SFARI Genes: 
Named Entities: (expression: [topp]), (er membrane: [celc]), (acetyl-coa transporter at-1: [gngm]), (autism-like phenotype: [mobd]), (mice: [mamm]), 
ASD Terms: 

PMCID: 4917935
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (strong mechanistic evidence: []), (vitamin d: [orch,phsu,vita]), (chain: []), (fatty acids: [orch]), ((n-3 lcpufas): [aapp,imft]), (acid (dha): [chem]), (potential: []), (symptoms: [sosy]), (autism spectrum disorder (asd): [mobd]), (however: []), (trials: [resa]), (effect: []), (n-3 lcpufa supplementation: [topp]), (autism severity symptoms: [mobd]), (objective: []), (factorial trial: [resa]), (n-3 lcpufas: [aapp,imft]), (combination: [fndg]), (core symptoms: [sosy]), (asd: [cgab]), (methods/design children: [aggp]), (new zealand (n: [mamm]), (children): [aggp]), (treatments: [topp]), (daily: vitamin d (2000 iu): [orch,phsu,vita]), (n-3 lcpufas (722 mg dha): [orch,phsu]), ( vitamin d (2000 iu) +: [orch,phsu,vita]), (placebo: [topp]), (months: []), (researchers: []), ( participants: [popg]), (caregivers: []), (data analysis: []), (randomisation: [resa]), (active/placebo capsules: [bodm]), (allocation: [acty]), (parties: []), (primary outcome measures: [qnco]), (change: [qnco]), (social-communicative functioning: [socb]), ( sensory processing issues: [fndg]), (problem behaviours: [mobd]), (baseline: [bodm]), (secondary outcome measure: []), (gastrointestinal symptoms: [sosy]), (baseline data: [bodm]), (basic nutritional deficiencies: [dsyn]), (treatment allocation: [acty]), (safety measures: [hcpp]), (25-hydroxyvitamin d: [horm,orch,phsu]), (calcium: [bacs,elii,phsu]), (weekly compliance: [inbe]), (gastrointestinal symptom diaries: [sosy]), (study period: [resa]), (discussion: [socb]), (knowledge: []), (effects: []), (dha supplementation: [topp]), ( dha: [orch,phsu]), (trial: [resa]), (non-invasive approach: []), (asd symptoms: [cgab]), (trial registration: [resa]), (australian new zealand clinical trial registry: [mamm]), ( actrn12615000144516: []), (february: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13063-016-1428-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(vitamin d, 'Dietary Supplements')(autism severity symptoms, 'Complaints and Indications')(n-3 lcpufa supplementation, 'Dietary Supplements')(vitamin d, 'Dietary Supplements')(core symptoms of asd, 'Complaints and Indications')(vitamin d, 'Dietary Supplements')(vitamin d +, 'Dietary Supplements')(sensory processing issues, 'Reaction to Sensory Stimuli')(problem behaviours between baseline, 'Personal Traits')(sensory processing issues, 'Reaction to Sensory Stimuli')(problem behaviours, 'Personal Traits')(acid supplementation, 'Dietary Supplements')(docosahexaenoic acid supplementation, 'Dietary Supplements')(asd symptoms, 'Complaints and Indications')

PMCID: 5324635
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (distribution: []), (autistic traits: [mobd]), (autismspectrum quotient (aq): [qnco]), (siblings: [famg]), (individuals: [humn]), (autism spectrum conditions: [mobd]), (total aq scores: [clna]), (aq subscales: []), (child: [aggp]), ( adolescent: [aggp]), (adult controls: [aggp]), ( siblings: [famg]), (volunteers: []), (asc: [gngm]), (ageappropriate versions: []), (instrument:: []), (aq (adult: [aggp]), (aqadolescent: []), (aqchild (both parentreports): []), (effect: []), (group (case: [popg]), ( sibling: [famg]), (control): [sbst]), (aq version (adult: [aggp]), (adult): [aggp]), (subscale scores: [clna]), (addition: []), (sex differences: [orga]), (groups: [popg]), (versions: []), (male: [orga]), (female adults: [aggp]), ( aq: []), (cases: [qnco]), (controls (cases: [qnco]), (controls): [sbst]), (children: [aggp]), (adolescents: [aggp]), ( female siblings: [famg]), (control females: [orga]), (female siblings: [famg]), (female controls): [orga]), (difference: [qnco]), (male siblings: [famg]), (controls: [sbst]), ((male cases: [orga]), (male controls): [orga]), (investigation: [hlca]), (communication: [socb]), (subscale (male cases: [orga]), (subscales: []), (imagination (female cases >: [menp]), (autism phenotype: [mobd]), (reveals: []), (sex: [orgf]), (aq version: []), (autism res: [mobd]), (autism research: [mobd]), (wiley periodicals: []), ( inc: []), (behalf: []), (international society: [orgt]), 
ASD Terms: (autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(imagination, 'Imagination')(autism phenotype, 'Autism Phenotype')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 4908699
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (autism spectrum disorders: [mobd]), (multifactorial disorders: [dsyn]), (complex interactions: [chvs]), (defective genes: [gngm]), (early exposure: [clna]), (environmental stressors: [fndg]), (correct neurodevelopment: [ortf]), (brain processes: [bpoc]), (organophosphate insecticides: [hops,orch]), (chlorpyrifos (cpf): [hops,orch]), (environmental toxicants: [hops]), (neurobehavioral deficits: []), (risk: []), (asd occurrence: [cgab]), (children: [aggp]), (oxidative stress: [comd]), (immune responses: [ortf]), (organophosphate neurodevelopmental effects: [orch]), (asd: [cgab]), (btbr t+tf/j: [aapp,imft]), (well-studied model: [resa]), (idiopathic autism: [mobd]), (immunological alterations: []), (asd children: [cgab]), (cpf: [gngm]), (gestational exposure: [clna]), (autistic-like traits: [mobd]), (present study: [qnco]), (behavioral effects: [inbe]), (gestational cpf administration: [topp]), (brain: [bpoc]), (lipid mediator profile: [lbpr]), (brain levels: [bpoc]), (f2-isoprostanes (15-f2t-isop): [bacs,orch]), (index: [qnco]), (vivo oxidative stress: [comd]), (prostaglandin e2: [horm,orch,phsu]), (major arachidonic acid metabolite: [orch]), (immune cells: [cell]), (specific glutamatergic neuron populations: [popg]), (cortex: [bpoc]), (hippocampus: [bpoc]), (specific enzyme-immuno assays: [lbpr]), (brain homogenates: [bpoc]), (c57bl6/j mice: [mamm]), (gestation: [orgf]), (vehicle: [bodm]), (measures: [qnco]), (mice: [mamm]), (sexes: [orgf]), (different postnatal stages: []), (birth: [orgf]), ( btbr t+tf/j: [aapp,imft]), (baseline 15-f2t-isop levels: [orch]), ( suggestive: []), (oxidative stress processes: [comd]), (gestational treatment: [topp]), (cpf-enhanced: [acty]), (pge2 levels: [horm,orch,phsu]), (age-dependent manner: [orga]), (btbr t+tf/j mice: [aapp,imft]), (pnds: [dsyn]), (pge2: [horm,orch,phsu]), (pnd: [gngm]), (cpf effects: [gngm]), (increase: []), (metabolites: [bacs]), (male mice: [mamm]), (cpf treatment: [topp]), (reduction: [npop]), (somatic growth: [orgf]), (statistical significance: [qnco]), (findings: [clna]), (autistic-like btbr t+tf/j strain: [aapp,imft]), (gestational period: [fndg]), (results: [fndg]), (further support: []), (hypothesis: []), (link: []), (environmental neurotoxicants: []), (increased levels: [qnco]), (early postnatal life: []), (long-lasting alterations: []), (specific pathways: [moft]), (important one: [qnco]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(early exposure, 'Exposures')(neurobehavioral deficits, 'Central Nervous System Diseases')(organophosphate neurodevelopmental effects, 'Learning Disorders')(idiopathic autism, 'Autism Phenotype')(gestational exposure, 'Perinatal History')(gestational cpf administration, 'Perinatal History')(gestation, 'Perinatal History')(gestational treatment, 'Perinatal History')(gestational period, 'Perinatal History')

PMCID: 4929695
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mutations: [genf]), (cell division: [celf]), (somatic lineages: [cell]), (neurogenesis persists: [orgf]), (human life: [humn]), ( somatic mutations: [comd]), (brain arise: [bpoc]), (development: [orgf]), (accumulate: []), (process: [phpr]), (human brain consists: [humn]), (neurons: [cell]), (intricate network: [popg]), (connections: []), (level: [phsu]), (cognitive functions: [menp]), (network: [popg]), (neuronal functions: [imft]), (focal area; instead: []), (neuronal network: [popg]), (areas: []), (somatic diversity: [cell]), (evident feature: []), (brain: [bpoc]), (extent: []), (somatic mutations: [comd]), (neuronal structure: [celc]), (function: [phsf]), (contribution: [acty]), (neurological disorders: [dsyn]), (disrupted brain connectivity: [bpoc]), (notably: []), (recent reports: [hlca]), (critical role: [socb]), (functional abnormalities: [cgab]), (several neurodevelopmental disorders: [mobd]), (here: []), (significance: [qnco]), (perspective: []), (potential molecular lesions: [fndg]), (common conditions: [dsyn]), (brain connectivity: [bpoc]), (moreover: []), (technical platforms: []), (detection: [topp]), (low-frequency: []), (biological functions: [biof]), (identified mutations: [genf]), (context: [fndg]), 
ASD Terms: (cognitive functions, 'Cognitive Ability')(neurological disorders, 'Neurologic Indications')(several neurodevelopmental disorders, 'Learning Disorders')

PMCID: 5026732
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (common neurodevelopmental disorder: [mobd]), (cognitive: []), ( motor: []), (emotional symptoms: [menp]), (thalamus: [bpoc]), (basal ganglia: [bpoc]), (circuits: []), (cortex: [bpoc]), (behavioral domains: []), (abnormalities: [cgab]), (structure: []), (subcortical regions: [blor]), (atypical development: [orgf]), (networks: []), (implications: []), (neural basis: [phsu]), (asd symptoms: [cgab]), (findings: [clna]), (previous volumetric studies: [lbpr]), (here: []), (advanced surface-based methodology: []), (localized differences: [qnco]), (shape: []), (surface area: []), (asd: [cgab]), (t1-weighted anatomical images: [orga]), (autism brain imaging data exchange (373 male participants: [mobd]), (years: []), (effects: []), (diagnosis: [fndg]), ( age: [orga]), (interaction: []), (volume: [qnco]), ( shape: []), (participants: [popg]), (right posterior thalamus: [bpoc]), (pulvinar nucleus: [bpoc]), (concave shape: []), (left mediodorsal nucleus: [celc]), (caudal putamen: [bpoc]), (pallidum: [bpoc]), (steeper increase: []), (concavity: []), (age: [orga]), (asd participants: [cgab]), ( restricted: []), (repetitive behaviors: [fndg]), (bilateral globus pallidus: [bpoc]), (differences: [qnco]), (overall volume: [qnco]), (surface-based approaches: []), (sensitivity: [patf]), (subcortical structure: [blor]), (work: []), (body: [humn]), (literature: [inpr,mnob]), (corticobasal ganglia-thalamic circuits: [bpoc]), (pathophysiology: [patf]), (range: [qnco]), ( emotional: [menp]), (motor functions: []), (broad role: [socb]), (complex symptom profile: [lbpr]), 
ASD Terms: (common neurodevelopmental disorder, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(cognitive, 'Cognitive Ability')(asd symptoms, 'Complaints and Indications')(atypical development, 'Learning Disorders')(autism brain imaging data exchange, 'Autism Phenotype')(diagnosis, 'Diagnosis')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(cognitive, 'Cognitive Ability')(complex symptom profile in asd, 'Complaints and Indications')(motor functions, 'Motor Skills')

PMCID: 4924178
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (major public health issue: [fndg]), (here: []), (effects: []), (folic acid intervention: [orch,phsu,vita]), (methylation cycles: [moft]), (oxidative stress: [comd]), (autistic children: [podg]), (structured teaching: [edac]), (sixty-six: [qnco]), (open-label trial: [resa]), (months: []), (forty-four children: [aggp]), (g: [qnco]), ((two times/daily): [qnco]), (period: []), (structured teaching (intervention group): [edac]), (children: [aggp]), (supplement: []), (duration: [phsu]), (study (control group): [grup]), (autism treatment evaluation checklist (atec): [mobd]), (psychoeducational profile-third edition (pep-3): [aapp,enzy]), (beginning: []), (end: [gngm]), (treatment period: [topp]), (folic: []), (homocysteine: [aapp,bacs]), (glutathione metabolism: [moft]), (plasma: [bdsu]), (treatment: [topp]), (intervention group: [popg]), (age-matched unaffected children: [aggp]), ((typical developmental group): [popg]), (results: [fndg]), (autism symptoms towards: [mobd]), (cognitive verbal/preverbal: []), (receptive language: [lang]), (affective expression: [topp]), (communication: [socb]), (furthermore: []), (concentrations: [menp]), (folic acid: [orch,phsu,vita]), ( homocysteine: [aapp,bacs]), (normalized glutathione redox metabolism: [moft]), (supplementation: [topp]), (certain role: [socb]), (autism: [mobd]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(supplement, 'Dietary Supplements')(autism treatment evaluation checklist, 'Autism Phenotype')(autism symptoms towards, 'Complaints and Indications')(cognitive verbal/preverbal, 'Cognitive Ability')(receptive language, 'Receptive Language')(supplementation, 'Dietary Supplements')(autism, 'Autism Phenotype')

PMCID: 4895433
SFARI Genes: PSD-95, PSD-95, DLG1, DLG4, DLGAP1, DLGAP2, SynGAP, DLG1, DLG4, DLGAP1, DLGAP2, SynGAP, DLG1, DLG4, DLGAP2, DLG1, DLG4, DLGAP2, 
Non SFARI Genes: PSD, DLG2, PSD, 
Named Entities: (psd-95: [gngm]), (psd proteins: [aapp,bacs]), (critical role: [socb]), (density: [qnco]), (activity: [acty]), (glutamate receptors: [aapp,rcpt]), (numerous previous studies: [lbpr]), (association: [menp]), (genes: [gngm]), (proteins: [aapp,bacs]), (schizophrenia (sz): [mobd]), (autism spectrum disorders: [mobd]), (share: [socb]), (substantial portion: []), (genetic risks: [qnco]), (protein-encoding regions: [amas]), (dlg1: [gngm]), ( dlg2: []), ( dlg4: []), ( dlgap1: [gngm]), ( dlgap2: [gngm]), (syngap: [gngm]), (cases: [qnco]), ((370 sz: [sosy]), (asd patients): [cgab]), (ion pgm platform: [elii]), (rare (minor allele frequency <1%): [qnco]), (non-synonymous mutations: [genf]), (silico functional analysis: [hlca]), (pedigree analysis: [lbpr]), (possible: []), (variants: []), ( g344r: []), ( g241s: []), (dlg4: [gngm]), (r604c: []), (dlgap2: [gngm]), (association analysis: [menp]), (independent sample set: [menp]), (sz: [sosy]), (asd patients: [cgab]), (healthy controls: []), (dlgap2-r604c: [gngm]), (samples: [sbst]), (case: []), (control: [sbst]), (additional sz patient: [sosy]), (dlg1-g344r: [gngm]), (results: [fndg]), (rare missense mutations: [genf]), (candidate psd genes: [gngm]), (susceptibility: [clna]), (sz and/or asd: [cgab]), (findings: [clna]), (theory: []), (non-synonymous variants: []), (substantial genetic risks: [qnco]), (disorders: [dsyn]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorders, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(additional schizophrenia patient, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia and/or asd, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 4948673
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, Shank3, Shank3, 
Non SFARI Genes: 
Named Entities: (summary haploinsufficiency: [comd]), (shank3: [gngm]), (synapse: [bsoj]), (protein shank3: [aapp,bacs]), (penetrant form: []), (autism spectrum disorder (asd): [mobd]), (shank3 insufficiency affects: [menp]), (specific neural circuits: [bpoc]), (specific asd symptoms: [cgab]), (shrna: [nnon]), (shank3 insufficiency: [aapp]), (ventral tegmental area (vta): [bpoc]), (mice: [mamm]), (dopamine (da): [bacs,orch,phsu]), (gaba cell-type: [aapp,bacs]), (specific changes: [qnco]), (excitatory synapse transmission: [patf]), (converge: [acty]), (da neuron activity: [cell]), (behavioral deficits: [inbe]), (impaired social preference: []), (administration: [topp]), (positive allosteric modulator: [fndg]), (type: [qnco]), (metabotropic glutamate receptors: [aapp,rcpt]), (first postnatal week: [qnco]), (da neuron excitatory synapse transmission: [celf]), (social preference defects: []), (optogenetic da neuron stimulation: [mbrt]), (social preference: []), (collectively: []), (data: [euka]), (contribution: [acty]), (impaired vta function: [bpoc]), (social behaviors: [socb]), (mglur1 modulation: [aapp,rcpt]), (postnatal development: [orgf]), (potential treatment strategy: [menp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(specific asd symptoms, 'Complaints and Indications')(behavioral deficits, 'Personal Traits')(impaired social preference, 'Social Competence')(social behaviors, 'Reciprocal Social Interaction')

PMCID: 4891671
SFARI Genes: CaV1.3, CaV1.3, CaV1.3, CaV1.3, CaV1.3, CaV1.3, CaV1.3, CaV1.3, 
Non SFARI Genes: 
Named Entities: (cav1.3 channels: [gngm]), (major class: []), (l-type ca2+ channels: [elii,phsu]), (rhythmicity: []), (heart: [bpoc]), (brain: [bpoc]), (channels: []), (excitation-transcription coupling: [genf]), (synaptic plasticity: [ortf]), (neuronal firing: [imft]), (moreover: []), ( disruption: []), (cav1.3 function: [phsf]), (several neurological disorders: [dsyn]), (here: []), (mutation a760g: [genf]), (spectrum disorder (asd): [cgab]), (role: [socb]), (mutation: [genf]), (asd pathogenesis: [cgab]), (effects: []), (a760g: []), (cav1.3 channel gating: [gngm]), (regulation: [biof]), (introduction: [hlca]), (ca2+-dependent inactivation (cdi): [elii,phsu]), (cav1.3: [gngm]), (important feedback system: [phpr]), (ca2+ homeostasis: [biof]), (reduction: [npop]), (cdi: [dsyn]), (major channel splice: []), (different extents: []), (allosteric model: []), (channel gating: []), (mechanism: []), (cdi reduction: [dsyn]), (enhanced channel opening: [acty]), (ca2+-inactivated mode: [qnco]), (a760g mutation: [genf]), (opposite increase: []), (voltage-dependent inactivation (vdi): [qnco]), (multifaceted mechanism: []), (asd: [cgab]), (combined: []), (regulatory deficits: []), (intracellular ca2+ concentration: [menp]), (neuronal development: [celf]), (synapse formation: [ortf]), 
ASD Terms: (several neurological disorders, 'Neurologic Indications')

PMCID: 5080861
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (administration: [topp]), (oxytocin: [aapp,horm,phsu]), (treatment: [topp]), (core symptoms: [sosy]), (autism spectrum disorder (asd): [mobd]), (social-communicative deficit: [dsyn]), (previous clinical trials: [resa]), (efficacy: [resa]), (safety: [hcpp]), (long-term administration: [hlca]), (individuals: [humn]), (asd: [cgab]), (studies: [lbpr]), (severe adverse events: [fndg]), (however: []), (long-term oxytocin administration: [aapp,horm,phsu]), (significant improvement: [qnco]), (long-term oxytocin: [aapp,horm,phsu]), (other studies: [lbpr]), (such improvement: []), (factors: []), (oxytocin administration: [aapp,horm,phsu]), (effects: []), (administration schedules: [topp]), (dosage: [qnco]), (amount: [qnco]), ( frequency: [qnco]), (day): []), (participant characteristics: [popg]), (age: [orga]), ( sex: [orgf]), ( intellectual ability): [fndg]), (addition: []), (particular methods: []), ( questions: []), (mechanism: []), (action: [acty]), (intranasal oxytocin: [aapp,horm,phsu]), (central nervous system: [bdsy]), (examination: []), (changes: [qnco]), (neural underpinnings: []), (social behavior: [socb]), (simultaneous oxytocin levels: [aapp,horm,phsu]), (blood: [bdsu]), (cerebrospinal fluid: [bdsu]), (pharmacokinetics: [phsf]), (intranasal: []), (optimal oxytocin treatments: [aapp,horm,phsu]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(core symptoms of asd, 'Complaints and Indications')(social behavior, 'Reciprocal Social Interaction')(cerebrospinal fluid, 'Hydrocephalus')

PMCID: 5070418
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mammalian target: [mamm]), (rapamycin (mtor): [aapp,enzy]), (key regulator: []), (various cellular processes: [celf]), (cell growth: [celf]), ( gene expression: [genf]), (synaptic functions: []), (autism spectrum disorder (asd): [mobd]), (monogenic disorders: [dsyn]), (tuberous sclerosis complex: [neop]), ( phosphatase: [aapp,enzy]), (tensin homolog tumor hamartoma: [aapp,bacs]), (fragile x syndrome: [cgab,dsyn]), (mtor: [gngm]), (mutations: [genf]), (genes: [gngm]), (pathway: [moft]), (cases: [qnco]), (syndromic asd: [cgab]), (evidences: []), (pathogenic role: [socb]), (hyperactive mtor-mediated signaling: [mobd]), (asd: [cgab]), (mtor inhibitors: [moft]), (potential pharmacotherapy: [topp]), (abnormal: [qnco]), (synaptic transmission: [celf]), (metabotropic glutamate receptor: [aapp,rcpt]), (part: [qnco]), (relationship: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(tuberous sclerosis complex, 'Tuberous Sclerosis')(fragile x syndrome, 'Fragile X Syndrome')(hyperactive mammalian target, 'Overactivity')(hyperactive mammalian target, 'Overactivity')

PMCID: 4926390
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (schizophrenia: [mobd]), (autism spectrum disorder (asd): [mobd]), (multi-symptomatic psychiatric disorders: [mobd]), (population worldwide: [popg]), (impairments: [patf]), (cognitive functions: [menp]), ( emotions: [menp]), (behaviour: [inbe]), (basic human processes: [humn]), (perception: [menp]), (judgment: [menp]), (decades: [qnco]), (extensive research: [resa]), (aetiologies: []), (asd: [cgab]), (significant challenge: [hlca]), (clinicians: []), (scientists: []), (unsatisfactory situation: []), ( patients: [podg]), (variety: []), (systemic disturbances: []), (prominent example: []), (cancer: [euka]), (direct (but: []), (inverse) comorbidity: []), (people: [popg]), (disease: [dsyn]), (uncontrolled proliferation: [patf]), (cells: [cell]), (molecular origin: []), (mutations: [genf]), (cells dna sequence: [nusq]), (such mutations: [genf]), (repair: [orgf]), (dna: [bacs,nnon]), ( cells: [cell]), (intricate dna repair pathways: []), (oxidative stress: [comd]), (oxidative dna damage: [comd]), (deficient repair: [orgf]), (oxidative dna lesions repair: [orgf]), (development: [orgf]), (article: []), (current evidence: [npop]), (cancer comorbidity: [euka]), (brain disorders: [dsyn]), (putative roles: [socb]), ( dna damage: [comd]), (dna repair: [genf]), (aetiopathology: []), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorder, 'Autism Phenotype')(multi-symptomatic psychiatric disorders, 'Mental Disorders')(cognitive functions, 'Cognitive Ability')(perception, 'Cognitive Ability')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(direct comorbidity, 'Comorbidities')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(cancer comorbidity, 'Comorbidities')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 5508252
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (copy number variants: [nusq]), (major contributors: []), (imbalance disorders: [dsyn]), (unrelated deletion: [genf]), (reciprocal duplication carriers: [fndg]), (kb bp2-bp3 interval: [gngm]), (rearrangements: [genf]), (autism spectrum disorders: [mobd]), (mirror phenotypes: [orga]), (obesity/underweight: [dsyn]), (macrocephaly/microcephaly: [cgab,dsyn]), (such phenotypes: [orga]), (kb bp4-bp5 interval: [aapp,bacs]), (cnv-prone regions: [nusq]), (complex chromatin looping: [celc]), (4c-seq: [nusq]), ( fluorescence: [npop]), (situ hybridization: [mbrt]), (hi-c: [cgab,dsyn]), (expression: [topp]), (regulation: [biof]), (encompassed genes: [gngm]), (genes: [gngm]), (bp4-bp5 cnv carriers: [nusq]), (chromatin interactions: [aapp]), (disruption: []), (chromatin interplays: [aapp]), (observed phenotypes: [orga]), (trans-acting chromatin contacts: [aapp]), (other genomic regions: [gngm]), (analogous phenotypes: [orga]), (example: []), (individuals: [humn]), (reciprocal rearrangements: [genf]), (locus: [gngm]), (head circumference: [clna]), (weight: [orga]), (results: [fndg]), (chromosomal contacts maps: [celc]), (related genes: [gngm]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 4995546
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (major programs: []), (psychiatric genetics: [hlca]), (>150 risk loci: [gngm]), (psychiatric disorders: [mobd]), (loci converge: [acty]), (small number: [qnco]), (functional pathways: [moft]), (conventional diagnostic criteria: []), (common biology: [qnco]), (schizophrenia: [mobd]), ( autism: [mobd]), (other psychiatric disorders: [mobd]), (nevertheless: []), (cellular phenotypes: [orga]), (fundamental features: []), (determined: [lbpr]), (recent advances: []), (genetics: []), (stem cell biology: [plnt]), (new prospects: [resa]), (cell-based modeling: [resa]), (advent: []), (cell reprogramming: [celf]), (induced pluripotent stem cells (ipsc): [cell]), (opportunity: []), (genetic findings: [lbtr]), (vitro models: []), (ipsc technology: []), (decade: [qnco]), (great promise: [qnco]), (gaps: []), (patients: [podg]), ( genetics: []), (biology: []), (many obvious advantages: []), ( ipsc studies: [lbpr]), (present multiple challenges: [qnco]), (expert review: []), (challenges: [hlca]), (modeling: [resa]), ( potential solutions: [sbst]), (analytical framework: [resa]), (evaluation: [hlca]), (therapeutic manipulation: [topp]), (fundamental disease processes: [dsyn]), 
ASD Terms: (psychiatric disorders, 'Mental Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(other psychiatric disorders, 'Mental Disorders')

PMCID: 4972535
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (millions: [qnco]), (individuals worldwide: [humn]), (heterogeneity: [orga]), (therapeutic intervention: [topp]), (versatile: []), (relevant model: []), (hundreds: []), (therapeutic options: [topp]), (clinical practice: [menp]), (neurons: [cell]), (pluripotent stem cells: [cell]), (tool: []), (shank3 haploinsufficiency: [comd]), (proof: [qnco]), (principle: []), (library: [gngm,nnon]), (compounds: [chem]), (shank3: [gngm]), (content: [menp]), (control: [sbst]), (human embryonic stem cells: [cell]), (induced pluripotent stem cell: [cell]), (active compounds: [chem]), (efficacy: [resa]), (dysfunctional networks: [dsyn]), (individuals: [humn]), (deleterious point mutations: [comd]), (tested: []), ( lithium: [elii,phsu]), (valproic acid: [orch,phsu]), (phenotypes: [orga]), (cellulo: []), (lithium pharmacotherapy: [elii,phsu]), (patient and: [podg]), (year: []), (encouraging decrease: [qnco]), (autism severity: [mobd]), (pluripotent stem: [plnt]), (cell-derived neurons: [cell]), (novel cellular paradigm exploitable: [resa]), (search: [acty]), (specific disease-modifying treatments: [dsyn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism severity, 'Autism Phenotype')

PMCID: 4883772
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (children: [aggp]), (attention deficit hyperactivity disorder (adhd): [mobd]), (autistic spectrum disorder (asd): [mobd]), (omega-3: [bacs,orch,phsu]), (fatty acid (n-3 pufa) levels: [bacs,orch,phsu]), (controls: [sbst]), (omega-6 (n-6) pufa levels: [bacs,orch]), (study: [resa]), (erythrocyte n-3 pufas eicosapentaenoic acid (epa): [bacs,orch,phsu]), (docosahexaenoic acid (dha): [bacs,orch,phsu]), (n-6 pufa: [bacs,orch]), (arachidonic acid (aa): [orch]), (adhd: [mobd]), ( asd: [cgab]), (n-3: [aapp,imft]), (n-6 pufas: [bacs,orch]), (poorer scores: [grpa]), (australian twin behaviour rating scale (atbrs; adhd symptoms): [mobd]), (test: [lbpr]), (variable attention (tova): [menp]), (childhood autism rating scale (cars): [mobd]), (asd: [cgab]), (assessments: [hlca]), (blood samples: [bdsu]), (years: []), (adhd (n: [mobd]), (asd (n: [cgab]), (analysed: []), (one-way anovas: [qnco]), (tukeys: []), (post-hoc analysis: [resa]), (differences: [qnco]), (pufa levels: [bacs,orch]), (groups: [popg]), (pearsons correlations: []), (correlations: []), (atbrs: []), ( tova: []), (cars: [gngm]), (dha: [orch,phsu]), ( epa: []), (aa: [gngm]), (aa/epa ratio: [qnco]), (n-3/n-6: [aapp,imft]), (p =: [aapp,imft]), (adhd (p<0.001: [mobd]), (comparisons): [acty]), (atbrs scores: [clna]), (epa (r = -.294: [clna]), ( p<0.001): [fndg]), ( dha (r = -.424: [orch,phsu]), (n-3/n-6 (r = -.477: [clna]), (aa/epa (r = .222: [clna]), ( p <.01): [aapp,imft]), (tova scores: [clna]), (dha (r = .610: [orch,phsu]), ( epa (r = .418: [clna]), ( p<0.001) aa (r = .199: [plnt]), (n-3/n-6 (r = .509: [clna]), (aa/epa (r = -.243: [clna]), (cars scores: [clna]), (dha (r = .328: [orch,phsu]), ( p: [aapp,imft]), (epa (r = -.225: [irda,orch]), ( p =: [aapp,imft]), (aa (r = .251: [plnt]), (low levels: [qnco]), (epa: []), ( dha: [orch,phsu]), (high ratio: [qnco]), (n-6/n-3 pufas: [bacs,orch]), (symptoms: [sosy]), (future research: [resa]), (abnormal fatty acid metabolism: [moft]), (disorders: [dsyn]), 
ASD Terms: (attention deficit hyperactivity disorder, 'Overactivity')(autistic spectrum disorder, 'Autistic Disorder')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(childhood autism rating scale, 'Autism Phenotype')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(childhood autism rating scale scores, 'Autism Phenotype')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(abnormal fatty acid metabolism, 'Metabolic Indications')

PMCID: 5122473
SFARI Genes: IL-6, IL-6, 
Non SFARI Genes: 
Named Entities: (immune abnormalities: [cgab]), (individuals: [humn]), (autism spectrum disorders: [mobd]), (family members: [famg]), (however: []), (few studies: [lbpr]), (role: [socb]), (prenatal cytokine: [aapp,imft]), (chemokine profiles: [aapp,imft]), (neurodevelopmental outcomes: [ortf]), (humans: [humn]), (current study: [resa]), (mid-gestational serum profiles: [bdsu]), (cytokines: [aapp,imft]), (chemokines: [aapp,imft]), (mothers: [famg]), (children: [aggp]), (asd (n=415): [cgab]), (developmental delay: [mobd]), (asd (dd) (n=188): [cgab]), (general population (gp): [popg]), ((n=428): [aapp,imft]), (bead-based multiplex technology: []), (asd group: [cgab]), (intellectual disabilities: [mobd]), ((asd+id: [cgab]), ( n=184): [aapp,imft]), ((dq70) (asd-noid: [cgab]), ( n=201): [aapp,imft]), (levels: []), (groups: [popg]), (multivariate logistic regression analyses: [resa]), (maternal age: []), ( ethnicity: [popg]), ( birth country: [fndg]), (weight: [orga]), (infant gender: [orga]), ( birth year: []), (birth month: []), (asd+id: [cgab]), (mid-gestational levels: []), (numerous cytokines: [aapp,imft]), (gm-csf: [gngm]), ( ifn-: []), ( il-1: [aapp,imft]), (il-6: [gngm]), (asd-noid: [cgab]), (dd: [gngm]), (gp controls: [gngm]), (conversely: []), ( mothers: [famg]), (chemokines il-8: [aapp,imft]), (mcp-1: [gngm]), (immunologic distinction: []), (intellectual disability (id): [mobd]), (asd: [cgab]), (findings: [clna]), (ongoing efforts: [orgf]), (identification: [menp]), (early biological markers: [clna]), (sub-phenotypes: [orga]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(neurodevelopmental outcomes, 'Learning Disorders')(developmental delay without asd, 'Learning Disorders')(developmental delay, 'Learning Disorders')(intellectual disabilities, 'Learning Disorders')(intellectual disability, 'Learning Disorders')

PMCID: 5070061
SFARI Genes: 
Non SFARI Genes: IQSEC3, COPS7A, 
Named Entities: (autism (aut): [mobd]), ( schizophrenia (scz): [mobd]), (bipolar disorder (bpd): [mobd]), (heritable neuropsychiatric conditions: [dsyn]), (clinical similarities: []), (genetic overlap: [topp]), (disorders: [dsyn]), (reported; however: [hlca]), (causes: []), (downstream effects: []), (overlap: [topp]), (transcriptomic rna-sequencing data: [nusq]), (post-mortem cortical brain tissues: [bpoc]), (aut: []), ( scz: []), ( bpd: []), (subjects: [humn]), (extent: []), (gene expression: [genf]), (scz transcriptomes: [nusq]), ((p<0.001): [fndg]), (cross-disorder comparisons (autbpd: [dsyn]), (sczbpd): []), (scz: []), (genes: [gngm]), (neurotransmission: [celf]), (synapse regulation: [bsoj]), (lack: []), (global transcriptomic overlap: [nusq]), ( iqsec3: [gngm]), (cops7a: [gngm]), (controls: [sbst]), (etiology: []), (compensatory changes: [qnco]), (neuropsychiatric conditions: [dsyn]), (finally: []), (enrichment: []), (genetic association signals: [phpr]), (bpd: []), (signal: [phpr]), (genome-wide association study (gwas): [mbrt]), (together: []), (studies: [lbpr]), (importance: []), (primary tissue: [tisu]), (neuropsychiatric conditionsthe: []), (cortical brain: [bpoc]), (shared role: [socb]), (altered neurotransmission: [celf]), (addition: []), 
ASD Terms: (autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(bipolar disorder, 'Bipolar Disorder')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4879740
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (asymmetry: []), (fusiform gyrus (ffg): [bsoj]), (structural studies: [lbpr]), (controls (tdc): [sbst]), (few studies: [lbpr]), (ffg asymmetry: []), (autism spectrum disorder (asd) subjects: [mobd]), (studies: [lbpr]), (small sample sizes: [sbst]), (cognitive ability: [menp]), (handedness: [orga]), (previous work: []), (ffg: []), (surface area: []), (cortical thickness asymmetry: [bpoc]), (asd;: [cgab]), (trajectory: []), (time: []), (ffg structural asymmetry: []), (asd symptom severity: [cgab]), (study: [resa]), (cross-sectional trajectories: []), (large sample: [sbst]), (right-handed males: [orga]), (years: []), (asd: [cgab]), (tdc subjects: [humn]), (general linear models: [qnco]), (addition: []), (relationship: []), (asd severity: [cgab]), (autism diagnostic observation schedule (ados): [hlca]), (gotham autism severity scores: [mobd]), (findings: [clna]), (group differences: [popg]), (mean leftward asymmetry: [qnco]), (symmetry: [phpr]), (tdc volume: [qnco]), (surface: []), (groups: [popg]), (spectrum: [qnco]), (leftward: []), (rightward asymmetry: []), (asd subjects: [cgab]), ( volume asymmetry: [qnco]), (ados: [aapp,enzy]), (autism severity score symptom measures: [mobd]), (subset: []), (rightward asymmetric patients: [podg]), (differential trajectory: []), (change: [qnco]), (leftward asymmetry: []), (age: [orga]), (whereas tdcs: [topp]), (reverse trend: []), (leftward symmetry: [phpr]), (observed age range: [qnco]), (abnormalities: [cgab]), (structural asymmetry: []), (severity: []), (differential developmental trajectory: [orgf]), (results: [fndg]), (important implications: []), (role: [socb]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-016-0089-5) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder subjects, 'Autism Phenotype')(cognitive ability, 'Cognitive Ability')(asd symptom severity, 'Complaints and Indications')(autism diagnostic observation schedule, 'Autism Phenotype')(gotham autism severity scores, 'Autism Phenotype')(autism severity score symptom measures, 'Complaints and Indications')(symptom severity in asd, 'Complaints and Indications')

PMCID: 4878062
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (tuberous sclerosis: [neop]), (complex (tsc): [chvs]), (neurocutaneous disorder: [dsyn]), (multiple symptoms: [sosy]), (neuropsychological deficits: []), (seizures: [sosy]), ( intellectual disability: [mobd]), (autism: [mobd]), (tsc: [gngm]), (autosomal dominant pattern: [genf]), (mutations: [genf]), (tsc1: [gngm]), (tsc2 genes: [gngm]), (enhance activation: [acty]), (mammalian target: [mamm]), (rapamycin (mtor): [aapp,enzy]), (pathway: [moft]), (recent studies: [lbpr]), (mtor inhibitors: [moft]), (rapamycin: [antb,orch]), (tsc-associated deficits: []), (rodent models: [mamm]), (addition: []), ( clinical trials: [resa]), (efficacy: [resa]), (psychiatric symptoms: [sosy]), (here: []), (case study: []), (korean patient: [podg]), (frequent seizures: [fndg]), (intellectual disability: [mobd]), ( language delays: [lang]), (social problems: [fndg]), (whole exome sequencing: [mbrt]), (novel small deletion mutation: [genf]), (tsc2: [gngm]), (novel deletion mutant: [genf]), (hek293t cells: [cell]), (mtor pathway activation: [aapp,enzy]), (furthermore: []), ( everolimus treatment: [orch,phsu]), (reduction: [npop]), (sega size: [neop]), (improved behavioral deficits: [inbe]), (related behaviors: [inbe]), (patient: [podg]), (summary: []), (severe tsc: []), (korean family: [famg]), (activation: [acty]), (mtor: [gngm]), (vitro: []), (everolimus treatment: [orch,phsu]), (behavioral deficits: [inbe]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13041-016-0222-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (tuberous sclerosis complex, 'Tuberous Sclerosis')(intellectual disability, 'Learning Disorders')(autism, 'Autism Phenotype')(tuberous sclerosis complex1, 'Tuberous Sclerosis')(tuberous sclerosis complex2 genes, 'Tuberous Sclerosis')(tuberous sclerosis, 'Tuberous Sclerosis')(tuberous sclerosis complex, 'Tuberous Sclerosis')(language delays, 'Language Ability')(social problems, 'Social Competence')(tuberous sclerosis complex2, 'Tuberous Sclerosis')(improved behavioral deficits, 'Personal Traits')(tuberous sclerosis complex2, 'Tuberous Sclerosis')(severe tuberous sclerosis complex, 'Tuberous Sclerosis')(behavioral deficits, 'Personal Traits')

PMCID: 4876513
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (fragile x syndrome (fxs): [cgab,dsyn]), (developmental disorders: [mobd]), (validated blood-based biomarkers: [bdsu]), (either: [fndg]), (bench-to-bedside approaches: []), (amyloid- (a) precursor protein (app): [aapp,imft]), (metabolites: [bacs]), (alzheimers disease (ad): [dsyn]), (app cleavage: [celf]), (-secretase produces: [aapp,enzy]), (app (sapp): []), (p3 peptide fragment: [aapp]), (-site app: [blor]), (enzyme (bace1) cleavage: [celf]), (intact a: [fndg]), (excess a: []), (brain regions: [blor]), (amygdala: [bpoc]), (ad: []), (contrast: [irda]), ( amygdala: [bpoc]), (asd: [cgab]), (fxs: []), (elevated levels: []), (sapp: []), (controls: [sbst]), (plasma a: [bdsu]), (total app levels: [qnco]), ( plasma: [bdsu]), (brain sapp: [bpoc]), (a: []), (asd vs. controls: [cgab]), (fxs plasma: [bdsu]), (age-dependent increase: [orga]), (-secretase: [aapp,enzy]), (asd brains: [cgab]), (novel mechanistic difference: [qnco]), (app pathways: [moft]), (asd (processing): [cgab]), (fxs (expression): [topp]), (app: [gngm]), (metabolite profiles: [lbpr]), (disorders: [dsyn]), (novel: []), ( distinctive biochemical differences: [qnco]), (way: []), (blood-based biomarkers: [bdsu]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(fragile x syndrome, 'Fragile X Syndrome')(fragile x syndrome, 'Fragile X Syndrome')(fragile x, 'Fragile X Syndrome')

PMCID: 5116288
SFARI Genes: MAGEL2, MAGEL2, MAGEL2, MAGEL2, MAGEL2, MAGEL2, MAGEL2, MAGEL2, MAGEL2, MAGEL2, 
Non SFARI Genes: 
Named Entities: (purpose truncating mutations: [genf]), (gene magel2: [gngm]), (prader-willi: []), (critical region 15q11-13: []), (schaaf-yang: []), (prader-willi-like disease: [dsyn]), (developmental delay/intellectual disability: [mobd]), ( hypotonia: [fndg]), (difficulties: [fndg]), (autism spectrum disorder: [mobd]), (causality: []), (reported variants: [hlca]), (context: [fndg]), (patients phenotypes: [orga]), (magel2: [gngm]), (whole gene deletions: [genf]), (clinical phenotype: [orga]), (total: [qnco]), (new individuals: [humn]), (schaaf-yang syndrome: [dsyn]), (families: [famg]), (family: [famg]), (individuals: [humn]), (variant: []), (molecularly: []), (presymptomatic fetal: [emst]), (pathogenic magel2 variant: [gngm]), (cases: [qnco]), (mutations: [genf]), (nucleotides: [nnon]), (c.1990-1996 arise: []), (mutational hotspot: [genf]), (fetus: [tisu]), (c.1996dupc: []), ((p.q666fs) mutation: [genf]), (fetuses: [emst]), (c.1996delc (p.q666fs): [aapp,imft]), (phenotypic spectrum: [orga]), (syndrome ranges: [dsyn]), (fetal akinesia: [cgab,dsyn]), (neurobehavioral disease: [dsyn]), (contractures: [acab]), (small finger joints: [bsoj]), (study: [resa]), (strong evidence: []), (pathogenicity: [orga]), (paternal allele: [gngm]), (associated clinical phenotypes: [orga]), (highlights implications: []), (genetic counseling: [topp]), (affected families: [famg]), 
ASD Terms: (prader-willi, 'Prader-Willi Syndrome')(developmental delay/intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(neurobehavioral disease, 'Central Nervous System Diseases')

PMCID: 4881591
SFARI Genes: 
Non SFARI Genes: SLC19A1, SLC19A1, SLC19A1, SLC19A1, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (group: [popg]), (neurodevelopmental disorders: [mobd]), (complex genetic etiology: [chvs]), (recent studies: [lbpr]), (children: [aggp]), (asd: [cgab]), (folate: [orch,phsu,vita]), (methionine metabolism: [moft]), (folatemethionine cycle: []), (key role: [socb]), (etiology: []), (slc19a1: [gngm]), (reduced folate carrier: [aapp,bacs]), ((rfc1): [gngm]), (member: [popg]), (solute carrier group: [aapp]), (transporters: [aapp,bacs]), (key enzymes: [enzy,orch]), (folate metabolism pathway: [moft]), (findings: [clna]), (multiple genomic screens: [gngm]), (presence: [qnco]), (autism susceptibility locus: [mobd]), (chromosome: [celc]), (therefore: []), (case-control study: [resa]), (japanese population: [popg]), (study: [resa]), ( dna samples: [bacs,nnon]), (asd patients: [cgab]), (kanazawa university hospital: [hcro,mnob]), (japan: []), (unrelated healthy japanese volunteers: [popg]), (sequence-specific primer-polymerase chain reaction method: [nnon]), (fluorescence correlation spectroscopy: [lbpr]), (p: [gngm]), (significant outcome: [qnco]), (polymorphisms (snps): [nusq]), (significant p-value: [qnco]), (aa genotype: [orga]), (snp (rs1023159: [nusq]), ( or: []), (ci: [gngm]), (fishers: [mamm]), (exact test): []), (role: [socb]), (polymorphism rs1023159: [genf]), (slc19a1 gene: [gngm]), (combination: [fndg]), (risk factor: [qnco]), (however: []), (corrections: []), (conclusion: []), (results: [fndg]), (significant risk factor: [qnco]), (asd samples: [cgab]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(autism susceptibility locus, 'Autism Phenotype')(kanazawa university hospital, 'Hospitalizations')

PMCID: 4867541
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (many children: [aggp]), (juveniles: [aggp]), (pathogenesis: [patf]), (asd: [cgab]), (environmental factors: []), (important roles: [socb]), (development: [orgf]), (possible relationship: []), (inflammatory pain: [sosy]), (neonates: [aggp]), (acute inflammation pain: [sosy]), (% formalin (5 l/day): [hops,orch,phsu]), (subcutaneous injection: []), (hindpaws: [blor]), (postnatal day: []), ((p3p5): []), (pups: []), (western blot: [lbpr]), ( immunohistochemical: [lbpr]), (behavioral examinations: [hlca]), (different time points: []), (insult: []), (formalin injection: [hops,orch,phsu]), (chronic inflammatory responses: [patf]), (transient local edema: [sosy]), (levels: []), (inflammatory cytokines: [aapp,imft]), ( tnf-: [aapp,bacs]), (il-1: [aapp,imft]), (blood: [bdsu]), (brain: [bpoc]), (microglia: [cell]), (day: []), (pain insult: [sosy]), (significant cell death: [celf]), (cortex: [bpoc]), (hippocampus: [bpoc]), (weeks: []), (hindpaw local reaction subsided: [sosy]), (axonal growth: [ortf]), (demyelization: []), (p21 juvenile rats: [mamm]), (number: [qnco]), (bromodeoxyuridine (brdu): [nnon,phsu]), (doublecortin: [gngm]), ((dcx) double-positive cells: [gngm]), (hippocampal dentate gyrus: [bpoc]), (p21 rats: [mamm]), (controls: [sbst]), ( indicating: []), (neurogenesis: [orgf]), (p21 rats brain: [bpoc]), (formalin: [hops,orch,phsu]), (expression: [topp]), (autism-related gene neurexin: [gngm]), ((nrxn1): [gngm]), ( fragile x: [comd]), (mental retardation: [mobd]), ((fmr1): [gngm]), (oxytocin: [aapp,horm,phsu]), (downregulated: []), ( consistent: []), (gene alteration: [genf]), (juvenile rats: [mamm]), (formalin group: [hops,orch,phsu]), (hyperalgesia: [sosy]), ( repetitive behaviors: [fndg]), (abnormal locomotion: [orgf]), ( sleep disorder: [dsyn]), (distinct deficits: []), (social memory: [menp]), (social activities: [socb]), (alterations: []), (neuroinflammatory reactions: []), ( gene expression: [genf]), (behaviors: [inbe]), (male: [orga]), (female rats: [mamm]), (importantly: []), (anti-inflammation treatment: [patf]), (indomethacin (10 mg/kg: [orch,phsu]), ( i.p.): [inch]), (time: []), (formalin injections: [hops,orch,phsu]), (inflammatory responses: [patf]), (neuronal cell death: [celf]), (prevented alterations: [phsu]), (asd-related genes: [cgab]), (abnormal behaviors: [mobd]), (novel observations: [hlca]), (severe inflammatory pain: [fndg]), (persistent inflammatory reactions: [patf]), (premature infants: [dsyn]), (development delays: [orgf]), (psychiatric disorders: [mobd]), (prevention: [resa]), (pain stimuli: [sosy]), (prompt treatments: [topp]), (inflammation: [patf]), (possible evolution: [genf]), (asd syndromes: [cgab]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s12974-016-0575-x) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(inflammatory pain, 'Pain')(acute inflammation pain, 'Pain')(pain insult, 'Pain')(fragile x, 'Fragile X Syndrome')(mental retardation, 'Mental Retardation')(social memory, 'Working Memory')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(social activities, 'Engagement in Social Activities')(development of abnormal behaviors, 'Personal Traits')(abnormal behaviors, 'Personal Traits')(severe inflammatory pain, 'Pain')(development delays, 'Learning Disorders')(psychiatric disorders, 'Mental Disorders')(pain stimuli, 'Pain')

PMCID: 4881129
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (environmental factors: []), (genetic factors: [fndg]), (pathogenesis: [patf]), (autism spectrum disorders: [mobd]), (epigenetics: [genf]), (essential mechanism: []), (gene regulation: [genf]), (chemical modifications: [chvs]), (dna: [bacs,nnon]), (histone proteins: [aapp,bacs]), (congenital asds: [cgab]), (endocrine disrupting chemicals: [hops]), (mental stress: [mobd]), (early life: []), (epigenetic status: []), (gene expression: [genf]), (asds: [cgab]), (moreover: []), (epigenetic changes: [qnco]), (gametogenesis: [ortf]), (generations: []), (changes: [qnco]), (behavior phenotypes: [bhvr]), (however: []), ( epigenetics: [genf]), (reversible nature: []), (addition: []), (removal: [topp]), (chemical residues: [evnt]), (original epigenetic status: []), (indeed: []), (several antidepressants: [phsu]), (anticonvulsants: [phsu]), (mental disorders: [mobd]), (epigenetic state: []), (therefore: []), (epigenetic understanding: [menp]), (development: [orgf]), (new drugs: [phsu]), (advantages: []), (epigenetic reversibility: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(congenital autism spectrum disorders, 'Congenital Abnormalities')(cause autism spectrum disorders, 'Autism Phenotype')(mental disorders, 'Mental Disorders')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 4938851
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (brain anatomy: [bpoc]), (children: [aggp]), (adolescents: [aggp]), (autism spectrum disorder (asd): [mobd]), (different developmental pattern: [orgf]), (typical age-matched peers: [popg]), (paucity: []), (studies: [lbpr]), (gray matter: [tisu]), (mid: []), (late adulthood: []), (asd: [cgab]), (cross-sectional neuroimaging study: [resa]), ( we: []), (vertex-wise whole-brain: [bpoc]), (region-of-interest analyses: [clna]), (cortical volume: [bpoc]), ( thickness: []), ( surface area: []), (gyrification index: [qnco]), (adults: [aggp]), (years: []), (significant age-related volume loss: [qnco]), (cortical thinning: [fndg]), (group: [popg]), (lack: []), (significant anatomical differences: [qnco]), (intellectual able individuals: [humn]), (gray matter morphology: [tisu]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-016-2810-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(different developmental pattern, 'Learning Disorders')

PMCID: 4936607
SFARI Genes: TOP1, TOP1, TOP1, TOP1, TOP1, TOP1, TOP1, TOP1, TOP1, TOP1, TOP1, TOP1, TOP1, TOP1, TOP1, TOP1, 
Non SFARI Genes: impact, 
Named Entities: (mammalian topoisomerase: [mamm]), ((top1): [aapp,enzy]), (essential enzyme: [enzy,orch]), (normal development: [fndg]), (top1 relaxes: [aapp,enzy]), (dna: [bacs,nnon]), (helical constraints: [euka]), (hinder dna replication: [genf]), (transcription: [genf]), (block cell growth: [celf]), (exact activity: [acty]), (top1: [gngm]), (death: [orgf]), (precursor: []), (tumorigenesis: [neop]), (cells: [cell]), (proper balance: [fndg]), (utilization: []), (catalytic activity: [qnco]), (dna topology: [bacs,nnon]), (risk: []), (toxic dna damages: [comd]), (prevents: [phsu]), (normal cell growth: [celf]), (apparent contradiction: []), (negative attribute: [fndg]), (top1 activity: [aapp,enzy]), (detrimental effect: []), (top1-induced dna lesions: [aapp,enzy]), (cell survival: [celf]), (prime target: [diap]), (cancer therapies: [topp]), (fast-growing cancer cells: [fndg]), (addition: []), ( cumulative evidence: []), (direct role: [socb]), (transcriptional progression: [patf]), (topoisomerase activity: [genf]), (involvement: []), (transcriptional regulation: [genf]), (focus: []), (potential new treatments: [topp]), (subtype: []), (autism spectrum disorders: [mobd]), (impact: [gngm]), (human health: [humn]), (review: []), (current understandings: [menp]), (human diseases: [humn]), (activity: [acty]), (disease treatments: [dsyn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 5378808
SFARI Genes: CNTN5, CNTN6, CNTN5, CNTN6, CNTN5, CNTN6, CNTN5, CNTN6, CNTN5, CNTN6, CNTN5, CNTN6, CNTN5, CNTN5, CNTN6, CNTN6, CNTN6, CNTN6, CNTN5, CNTN6, CNTN5, CNTN6, 
Non SFARI Genes: impact, 
Named Entities: (contactin genes cntn5: [aapp,bacs]), (cntn6 code: [gngm]), (neuronal cell adhesion: [celf]), (promote: [acty]), (neurite outgrowth: [celf]), (sensory-motor neuronal pathways: [cell]), (mutations: [genf]), (cntn5: [gngm]), (cntn6: [gngm]), (individuals: [humn]), (autism spectrum disorders: [mobd]), (prevalence: [qnco]), (clinical impact: [gngm]), (study: [resa]), (deleterious variants: []), (asd: [cgab]), (carriers: [fndg]), (girl: [aggp]), (attention-deficit/hyperactivity disorder: [mobd]), (copies: []), (deletions: [genf]), (controls; p=0.00006): [sbst]), (private coding sequence variants: [gngm]), (controls; p=0.0005): [sbst]), (rare cntn6 variants: [gngm]), (fathers: [famg]), (stop mutation cntn6w923x: [genf]), (mother: [famg]), (sons: [famg]), (variant cntn6p770l: []), (boy: [aggp]), (clinical investigations: [resa]), (patients: [podg]), (cntn6 variants: [gngm]), ((a condition: [dsyn]), (hyperacusis): [sosy]), (displayed changes: [qnco]), (wave latency: [gngm]), (auditory pathway: [bpoc]), (results: [fndg]), (hypothesis: []), (abnormal neuronal connectivity: [qnco]), (pathophysiology: [patf]), (new light: [npop]), (genes: [gngm]), (risk: []), (abnormal sensory perception: [dsyn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(abnormal sensory perception, 'Form Perception')

PMCID: 4866051
SFARI Genes: Shank3, Shank3, mGluR5, mGluR5, Shank3, Shank3, 
Non SFARI Genes: 
Named Entities: (human: [humn]), (studies: [lbpr]), (aberrant neural connectivity underlies: []), (behavioural deficits: [inbe]), (autism spectrum disorders: [mobd]), (neural circuit mechanisms: []), (asds: [cgab]), (here: []), (complete knockout mouse model: [mamm]), (autism-associated shank3 gene: [mobd]), (deletion: [genf]), (exons: [bacs,nnon]), ((e422): []), (mglur5-homer scaffolds: [aapp,rcpt]), (mglur5-mediated signalling: [aapp,rcpt]), (striatal neurons: [bpoc]), (changes: [qnco]), (perturbed function: [phsf]), (striatal synapses: [bpoc]), (abnormal brain morphology: [fndg]), (aberrant structural connectivity: []), (asd-like behaviour: [cgab]), (vivo recording reveals: []), (cortico-striatal-thalamic circuit: [bpoc]), (mutants: [comd]), (social behaviour: [socb]), (manipulation: [topp]), (mglur5 activity: [aapp,rcpt]), (excessive grooming: [fndg]), (instrumental learning differentially: [menp]), (rescues: []), (striatal synaptic plasticity: [bpoc]), (e422/ mice: [mamm]), (findings: [clna]), (deficiency: [dsyn]), (shank3: [gngm]), (mglur5-homer scaffolding: [aapp,rcpt]), (cortico-striatal circuit abnormalities: [bpoc]), (deficits: []), (asd-like behaviours: [cgab]), (data: [euka]), (causal links: []), (genetic: [topp]), ( molecular: []), (circuit mechanisms: []), (pathophysiology: [patf]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(behavioural deficits, 'Personal Traits')(social behaviour, 'Reciprocal Social Interaction')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 4861960
SFARI Genes: PTEN, PTEN, Pten, Pten, Pten, Pten, Pten, KATNAL2, Pten, KATNAL2, Katnal2, Katnal2, 
Non SFARI Genes: 
Named Entities: (retroviruses: [virs]), (fluorescent protein: [aapp,bacs]), ( cas9: []), (small guide rna: [bacs,nnon]), (nonsense pten mutations: [aapp,enzy]), (autism patients: [mobd]), (mouse neurons: [mamm]), (cellular phenotype: [orga]), (crispr-cas9: [nnon]), (shrna: [nnon]), (cre/lox technologies: [aapp,enzy]), (knockdown: []), (knockout (ko): [emod]), (corresponding moderate: []), (severe neuronal hypertrophy: [patf]), (cells: [cell]), (contrast: [irda]), (cas9 approach: []), (mix: [gngm]), (ko-equivalent: [qnco]), (wild type-like phenotypes: [orga]), (importantly: []), (neuronal hypertrophy: [patf]), (pten loss: [comd]), (average: [qnco]), (population: [popg]), (pten ko phenotype: [aapp,enzy]), (crispr-cas9 system: [nnon]), (viruses: [virs]), (gene: [gngm]), (autism: [mobd]), ( katnal2: [gngm]), (katnal2 deletion: [genf]), (mouse results: [mamm]), (decreased dendritic arborization: [ortf]), (retroviral implementation: [virs]), (efficient system: []), (cellular phenotype discovery: [acty]), (wild-type animals: [anim]), 
ASD Terms: (autism patients, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4859984
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (widespread use: []), (microarray technology: [lbpr]), (identification: [menp]), (duplication syndrome: [dsyn]), (reciprocal syndrome: [dsyn]), (deletion syndrome (22q11.2ds): [genf]), (individuals: [humn]), (rates: [qnco]), (community diagnoses: [fndg]), (autism spectrum disorder (asd): [mobd]), ( schizophrenia: [mobd]), (range: [qnco]), (medical problems: [clna]), (birth defects: [cgab]), (extensive medical screening: [hlca]), (case reports: []), (include patients: [podg]), (asd: [cgab]), (schizophrenia;: [mobd]), (prospective cohort study: [resa]), (reported: [hlca]), (goals: []), (study: [resa]), (neuropsychiatric functioning: []), (cohort: [popg]), (comparison: [acty]), (large samples: [sbst]), (controls (tdcs): [topp]), ( asd: [cgab]), ((2) estimate: [qnco]), (prevalence: [qnco]), ((3) determine: [fndg]), (indications: []), (genetic testing: [lbpr]), (differ: []), ((4): []), (comprehensive medical screening: [hlca]), (medical characterization: [acty]), (parental questionnaire: []), (medical chart review: [hlca]), ((n: [aapp,imft]), (neuropsychiatric characterization: [acty]), (children: [aggp]), (tdcs: [topp]), (parent-report questionnaires;: []), (addition: []), (groups: [popg]), (autism diagnostic: [mobd]), (autism diagnostic observation schedule: [hlca]), (social interaction: [fndg]), (adaptive behavior skills: [inbe]), (%: []), ((1425 %): []), (basis: [phsu]), (clinical judgment: [menp]), (adi-r: [clna]), (ados data: [aapp,enzy]), (deletions: [genf]), (duplications: []), (developmental delay: [mobd]), (however: []), (screening protocol: [fndg]), (sample: [sbst]), ( several medical problems: [clna]), (significant risk: [qnco]), (undetected: []), (high rate: [qnco]), (genetic disorder: [dsyn]), (prospective: [resa]), (medical screening: [hlca]), (patients: [podg]), (developmental delays: [mobd]), (asd alone: [cgab]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-016-0090-z) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (medical problems, 'Medications')(autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(extensive medical screening, 'Medications')(comprehensive medical screening, 'Medications')(medical chart review, 'Medications')(medical characterization, 'Medications')(autism diagnostic, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(adaptive behavior skills, 'Adaptive Life Skills')(duplications because of developmental delay, 'Learning Disorders')(developmental delay, 'Learning Disorders')(several medical problems, 'Medications')(medical screening, 'Medications')(developmental delays, 'Learning Disorders')

PMCID: 4859958
SFARI Genes: 
Non SFARI Genes: BACE1, 
Named Entities: (effect: []), (liver x receptor  (lxr): [aapp,rcpt]), (-amyloid (a) peptide generation: [aapp,imft]), (autism behaviors: [mobd]), (animal experiment: [resa]), (autistic mice: [mamm]), (lxr: []), (t0901317: [orch,phsu]), ( enzyme: [enzy,orch]), (immunosorbent assay: [irda]), (a: []), (brain tissue homogenates: [bpoc]), (western blot: [lbpr]), (a precursors: []), ( a degradation: [orgf]), (secretase enzymes: [aapp,enzy]), (expression: [topp]), (autophagy-related proteins: [celf]), (ras/raf/erkl/2: [gngm]), (proteins: [aapp,bacs]), (brain tissue: [bpoc]), (changes: [qnco]), (autism spectrum disorder syndromes: [dsyn]), (btbr mice: [mamm]), (t0901317 treatment: [orch,phsu]), (control: [sbst]), (lxr agonist t0901317: [orch,phsu]), (a level: [phsu]), (brain tissue (p: [bpoc]), (a degradation enzyme (nep: [enzy,orch]), ( ide proteins) levels: [aapp,bacs]), (p <: [aapp,imft]), (a secretase enzyme bace1 protein level (p: [aapp,enzy]), (ras: [gngm]), (p-c-raf: [gngm]), ( c-raf: [aapp,enzy]), ( p-mekl/2: [orch,phsu]), ( p-erkl/2 protein levels: [aapp,enzy]), (p: [gngm]), (improvements: []), (time: []), ( self-combing time: [bpoc]), (center: [fndg]), (platform quadrant: []), (platform: []), ((all p: [aapp,imft]), (brain a generation: [bpoc]), (a production: []), (a degradation: [orgf]), 
ASD Terms: (autism behaviors, 'Autism Phenotype')(autism spectrum disorder syndromes, 'Autism Phenotype')

PMCID: 4859484
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (duplications: []), (prader-willi/angelman syndrome (pws/as) region: [cgab]), (developmental delay: [mobd]), (autism spectrum disorder (asd): [mobd]), (schizophrenia (sz): [mobd]), (presence: [qnco]), (imprinted genes: [gngm]), (region: []), (parental origin: []), (pathogenicity: [orga]), (maternal origin: [famg]), (disease: [dsyn]), (paternal ones: [qnco]), (role: [socb]), (paternal duplications: [famg]), (detailed study: [resa]), (date: []), (15q11.2-q13.3 interstitial duplications: [celc]), (dd: [gngm]), ( asd: [cgab]), (sz cohorts: [sosy]), (first time: [qnco]), (risk: []), (dd/asd/multiple congenital anomalies: [cgab]), (sz: [sosy]), (importance: []), (epigenetic status: []), (15q11.2-q13.3 duplications: [celc]), (analysis: [resa]), (number: [qnco]), (families: [famg]), (duplication: [comd]), (mother: [famg]), (offspring: [famg]), (psychotic illness: [fndg]), (interestingly: []), (consistent clinical characteristics: [clna]), (sz patients: [sosy]), (developmental problems: [orgf]), (carriers: [fndg]), (general population: [popg]), (general population prevalence: [qnco]), (maternal duplications: [famg]), (fecundity: [orgf]), (male carriers: [fndg]), (differential survival: [acty]), (embryos: [emst]), ( something echoed: [topp]), (findings: [clna]), (types: []), (cases: [qnco]), (isodicentric chromosome: [comd]), ((idic15): []), (interstitial triplications: [blor]), (controls: [sbst]), (study: [resa]), (distinct roles: [socb]), (paternal interstitial duplications: [famg]), (critical importance: []), (genes: [gngm]), (contribution: [acty]), (copy number variants: [nusq]), (interval: []), (incidence: [qnco]), (work: []), (tangible benefits: [qnco]), (patients: [podg]), (genetic counseling: [topp]), 
ASD Terms: (developmental delay, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(15q11.2-q13.3 interstitial duplications in developmental delay, 'Learning Disorders')(schizophrenia cohorts, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(offspring, 'Perinatal History')(schizophrenia patients, 'Schizophrenia and Disorders with Psychotic Features')(developmental problems, 'Learning Disorders')

PMCID: 4881499
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mammalian chromosomes: [celc]), (complex chromatin architecture: [aapp]), (specific assembly: [acty]), (configuration: []), (chromosome: [celc]), (gene expression: [genf]), (function: [phsf]), (ways: []), (degrees: [qnco]), (heterochromatinization: []), (result: [fndg]), (giemsa (g): [irda,orch]), (negative euchromatic (light) bands: [npop]), (g-positive heterochromatic (dark) bands: [qnco]), (morphometric measurements: [lbpr]), (high-resolution chromosome ideograms: [celc]), (first time: [qnco]), (heterochromatic chromosome band: [lbpr,mbrt]), (distribution: []), (localization: [biof]), (known protein-coding genes: [gngm]), (autism spectrum disorder (asd) genes: [gngm]), (obesity genes: [dsyn]), (individual lengths: [qnco]), (g-negative euchromatin: [celc]), (g-positive heterochromatin chromosome bands: [celc]), (millimeters: [qnco]), (digital images: []), (850-band high-resolution ideograms: [lbpr]), (international society: [orgt]), (chromosome nomenclature: [celc]), (overall measurements: []), (patterns: []), (chromosome size: [celc]), (g-negative euchromatic band regions: [celc]), (protein-coding genes: [gngm]), (heterochromatic dark band sub-types: [qnco]), (asd genes: [cgab]), (darker: []), (heterochromatic sub-bands: [qnco]), (obesity gene distribution pattern: [dsyn]), (study: [resa]), (recent trends: []), (genes: [gngm]), (heterochromatin regions: [celc]), (role: [socb]), (biological processes: [biof]), (neurodevelopment: [ortf]), (asd: [cgab]), 
ASD Terms: (autism spectrum disorder genes, 'Autism Phenotype')

PMCID: 4864276
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract introduction: [hlca]), (goal: []), (project: []), (gray matter brain pathways: [tisu]), (young children: [aggp]), (autism spectrum disorder (asd): [mobd]), (asd: [cgab]), (children: [aggp]), (same age: [orga]), (high angular resolution resolution diffusion: [npop]), (tractography: []), (diffusion tensor: [npop]), (brains: [bpoc]), (controls: [sbst]), (callosal: []), (corticopontine pathways: [moft]), (terminal areas: []), (cortical gray matter: [bpoc]), (asd brains: [cgab]), (shortrange ufibers: []), (frontal lobe: [bpoc]), (control brains: [bpoc]), (gray matter pathways: [tisu]), (coherency: [fndg]), (asd brain: [cgab]), (lateral aspects: [qnco]), (middle part: []), (brain: [bpoc]), (motor areas: [blor]), (lateral surfaces: []), (anterior frontal brain regions: [bpoc]), (findings: [clna]), (tractography technique: []), (differences: [qnco]), (brain pathways: [bpoc]), (groups: [popg]), (challenging: [hlca]), ( postmortem scanning: [diap]), (valuable insights: [menp]), (connectivity: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 4870371
SFARI Genes: Oprm1, Oprm1, Oprm1, Oprm1, 
Non SFARI Genes: 
Named Entities: (environmental enrichment: []), (positive effects: [fndg]), (physiological phenotypes: [orga]), (rodent models: [mamm]), (neurodevelopmental disorders: [mobd]), (study: [resa]), (-opioid receptor gene (oprm1 /): [hops,orch,phsu]), (deficits: []), (social competence: [socb]), (communication: [socb]), (hypothesis: []), (early enrichment: []), (sociability: [socb]), (development: [orgf]), (adulthood: []), (immaturity: []), (sensory-motor capabilities: []), (young pups: []), (environmental stimulation: [npop]), (second lactating female: [orga]), (extra maternal care: [hlca]), (stimulation: [npop]), (birth: [orgf]), (results: [fndg]), (abnormal response: [fndg]), (maternal separation: [patf]), (oprm1 / pups: [gngm]), (social motivation: [menp]), (juveniles: [aggp]), (adult knockout mice: [mamm]), (oprm1 / mice act: [mamm]), (attractive social partners: [famg]), (wild types: [gngm]), (stimulus employed: [fndg]), (experiment: [resa]), (previous findings: [clna]), (early social environmental stimulation: [npop]), (long-term beneficial effects: [phpr]), (use: []), (nonpharmacological interventions: [hlca]), (treatment: [topp]), (social defects: []), (neurodevelopmental diseases: [mobd]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(social competence, 'Social Competence')(neurodevelopmental diseases, 'Learning Disorders')

PMCID: 5322585
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (considerable variation: []), (profiles: [lbpr]), (children: [aggp]), (language impairment (li): [mobd]), (challenges: [hlca]), (diagnosis: [fndg]), ( treatment: [topp]), (prevention: [resa]), (language difficulties: [fndg]), (li: [gngm]), (substantial issues: [fndg]), (investment: []), (public health resources: [hlca]), (review: []), (environmental factors: []), (developmental course: [orgf]), (review paper: []), (deficits: []), (risk factors: [qnco]), (strengths: []), (protective factors: [inbe]), (child: [aggp]), (scaffold: []), (positive development: [orgf]), (outcomes: []), 
ASD Terms: (prevention of language difficulties, 'Language Ability')(language impairment, 'Language Ability')(diagnosis, 'Diagnosis')(language difficulties, 'Language Ability')(language impairment, 'Language Ability')

PMCID: 5181638
SFARI Genes: CTNNB1, CTNNB1, CTNNB1, CTNNB1, CTNNB1, CTNNB1, CTNNB1, CTNNB1, CTNNB1, CTNNB1, CTNNB1, CTNNB1, CTNNB1, CTNNB1, CTNNB1, CTNNB1, CTNNB1, CTNNB1, CTNNB1, CTNNB1, 
Non SFARI Genes: 
Named Entities: (mutations: [genf]), (-catenin (ctnnb1): [aapp,bacs]), (cancer: [euka]), (mental disorders: [mobd]), (recently: []), (loss-of-function mutations: [phsf]), (ctnnb1: [gngm]), (intellectual disability (id): [mobd]), (rare mutations: [genf]), (patients: [podg]), (autism spectrum disorder (asd): [mobd]), (key regulator: []), (canonical wnt pathway: [moft]), ( ctnnb1: [aapp,bacs]), (essential role: [socb]), (neurodevelopment: [ortf]), (however: []), (function: [phsf]), (specific neuronal subtypes: [imft]), (ctnnb1 deficiency contributes: [aapp,bacs]), (asd: [cgab]), (conditional knockout (cko) mice: [mamm]), (parvalbumin interneurons: [aapp,bacs]), (cko mice: [mamm]), (overall change: [qnco]), (motor function: []), (interestingly: []), ( ctnnb1 cko: [aapp,bacs]), (pv-interneurons: [neop]), (object recognition: [menp]), (social interactions: [fndg]), (repetitive behaviors: [fndg]), (core symptoms: [sosy]), (surprisingly: []), (parvalbumin-interneurons: [aapp,bacs]), (enhanced spatial memory: [menp]), (effect: []), (ctnnb1 ko: [aapp,bacs]), (overall neuronal activity: [acty]), (c-fos: [gngm]), (cortex: [bpoc]), (dentate gyrus: [bpoc]), (amygdala: [bpoc]), (findings: [clna]), (cell: [gngm]), (type-specific role: [socb]), (ctnnb1 gene: [gngm]), (regulation: [biof]), (autistic-like behaviors: [mobd]), (thus: []), (study: [resa]), (important implications: []), (development: [orgf]), (therapies: [topp]), (asds: [cgab]), (ctnnb1 mutation: [comd]), (other asds: [cgab]), (wnt pathway: [moft]), (understanding: [menp]), (inhibitory circuitry: [acty]), 
ASD Terms: (mental disorders, 'Mental Disorders')(autism spectrum disorder, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(motor function, 'Motor Skills')(social interactions, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(enhanced spatial memory, 'Working Memory')

PMCID: 4898679
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (complex neurodevelopmental condition: [mobd]), (differences: [qnco]), (gray matter neuroanatomy: [tisu]), (white matter connectivity: [tisu]), (however: []), (reflect independent aetiologies: [menp]), (multimodal: [diap]), (male adults: [aggp]), (asd: [cgab]), (neurotypical controls: [sbst]), (relationship: []), (gray matter: [tisu]), (local gyrification (lgi): []), (white matter diffusivity: [tisu]), (associated fiber tracts: [bpoc]), (first: [qnco]), ( asd individuals: [cgab]), (significant increase: [qnco]), (gyrification: []), (post-central gyrus: [bpoc]), (second: [qnco]), (white matter fiber tracts: [tisu]), (and/or terminating: [ortf]), (cluster: [qnco]), (increased lgi: [qnco]), (axial diffusivity: []), (increase: []), (diffusivity: []), (tracts: [bpoc]), (close proximity: [fndg]), (cortical sheet: [bpoc]), (last: []), (lgi: []), (increased diffusivity: [qnco]), (short tracts: [bpoc]), (main effect: []), (group (i.e.: [popg]), ( asd): [cgab]), (gray matter gyrification: [tisu]), (findings: [clna]), (distinct aetiological pathways: [moft]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(complex neurodevelopmental condition, 'Learning Disorders')

PMCID: 5382808
SFARI Genes: SETDB1, SETDB1, SETDB1, SETDB1, 
Non SFARI Genes: 
Named Entities: (pathogenicity: [orga]), (copy number variations: [nusq]), (neurodevelopmental disorders: [mobd]), (research literature: [inpr,mnob]), (however: []), (few studies: [lbpr]), (utility: [orgt]), (challenges: [hlca]), (cnv analysis: [nusq]), (clinic: [hcro,mnob]), (findings: [clna]), (cnv studies: [nusq]), (cohort: [popg]), (clinical genetics evaluation: [hlca]), (autism spectrum disorders: [mobd]), (developmental disability (dd): [mobd]), (intellectual disability (id): [mobd]), (twenty-two cnv: [nusq]), (probands: [orga]), (pathogenic (18.3%): [fndg]), (cnv: [nusq]), (variants: []), (unknown significance (vus): [fndg]), (cases: [qnco]), (complex rearrangement: [genf]), (phelan-mcdermid syndrome region: [dsyn]), (deletion: [genf]), (setdb1: [gngm]), (gene: [gngm]), (methylates: [phsu]), (h3: [gngm]), (lysine-9 (h3k9) methyltransferase: [aapp,enzy]), (case: []), (typical asd: [cgab]), (id: [lbpr]), (evidence: []), (value: [qnco]), (etiological evaluation: [hlca]), ( interpretation: [clna]), (clinical significance: [fndg]), (counseling families: [topp]), (variable penetrance: [fndg]), (pleotropic expressivity: [topp]), (cnvs: [nusq]), (identification: [menp]), (further support: []), (role: [socb]), (chromatin modifiers: []), (etiology: []), (asd: [cgab]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')(developmental disability, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 4842259
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (postnatal exposure: [clna]), (certain chemicals: [chem]), (risk: []), (autism spectrum disorder: [mobd]), (propionic acid (pa): [orch]), (metabolic product: [qnco]), (food additive: []), (effects: []), (autism: [mobd]), (results: [fndg]), (animal studies: [anim]), (environmental neurotoxic agents: [hops]), (drugs: [topp]), (neurotoxicity: [inpo]), (aid: [gngm]), (treatment: [topp]), (present study: [qnco]), (ameliorative effects: []), (natural bee pollen: [orch,phsu]), (acute: []), (sub-acute brain intoxication: [bpoc]), ((pa): []), (rats: [mamm]), (twenty-four young male: [orga]), (western albino ratswere: [cgab]), (equal groups: [popg]), ( eachwith6 rats: [mamm]), (control group: [grup]), (pa-treated groups (ii: [popg]), (iii): []), (neurotoxic dose: [inpo]), (mg/kg body weight: [qnco]), (dose: [qnco]), (mg/kg body: [humn]), (asthe acute group: [popg]), (equal dose: [qnco]), (mg/kg body weight/day: [qnco]), (sub-acute group: [popg]), (fourth group: [popg]), (mg: [elii,phsu]), (bee pollen: [orch,phsu]), (days: []), (pa-acute intoxication: [inpo]), (data: [euka]), (pa-treated groups: [popg]), (multiple signs: [fndg]), (brain toxicity: [bpoc]), (depletion: []), (serotonin (5ht): [bacs,orch]), ( dopamine: [bacs,orch,phsu]), (withan increase: []), (ifn-: []), (neurotoxic effect: [inpo]), (pa. all: []), (parameters: [fndg]), (minimal alteration: []), (comparison: [acty]), (thecontrol animal: [anim]), (sub-acute pa-treated animals: [anim]), (conclusion: []), ( bee pollen: [orch,phsu]), (anti-apoptotic effects: [celf]), (impaired neurochemistry: [ortf]), (pa-intoxicated rats: [mamm]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(postnatal exposure, 'Exposures')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4841962
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (common neurodevelopmental disorder: [mobd]), (adequate screening tools: [diap]), (diagnosis: [fndg]), (therapeutic interventions: [topp]), (substantial genetic component: [gngm]), (single gene: [fndg]), (variant accounts: [clna]), (>1 %: [fndg]), (asd incidence: [qnco]), (epigenetic mechanisms: [genf]), (micrornas (mirnas): [bacs,nnon]), (asd phenotype: [cgab]), (networks: []), (neurodevelopmental genes: [gngm]), (extracellular availability: [celc]), (mirnas allows: [bacs,nnon]), (painless: []), ( noninvasive collection: []), (biofluids: []), (study: [resa]), (saliva-based mirnas: [bacs,nnon]), (diagnostic screening tools: [fndg]), (potential functional importance: []), (salivary mirna: [bacs,nnon]), (asd subjects: [cgab]), (gender-matched control subjects: [orga]), (asd group: [cgab]), (individuals: [humn]), (mild asd (dsm-5 criteria: [cgab]), (autism diagnostic observation schedule): [hlca]), (history: [orga]), (neurologic disorder: [dsyn]), ( pre-term birth: [orgf]), (chromosomal abnormality: [comd]), (subjects: [humn]), (thorough neurodevelopmental assessment: [acty]), (vineland adaptive behavior scales: []), (time: []), (saliva collection: [bdsu]), (total: [qnco]), (mirnas: [bacs,nnon]), (samples: [sbst]), (rna-seq: [nusq]), (between-group comparisons: [popg]), (non-parametric testing: [fndg]), ( multivariate: []), (logistic regression: [resa]), (classification analyses: [resa]), (monte-carlo cross-validation (mccv): [qnco]), (top mirnas: [bacs,nnon]), (correlations: []), (measures: [qnco]), (adaptive behavior: [inbe]), (functional enrichment analysis: [hlca]), (confidence: [menp]), (mrna targets: [bacs,nnon]), (database: []), (annotation: []), ( visualization: [menp]), (integrated discovery (david): [dsyn]), (simons foundation autism database (autdb): [mobd]), (asd candidate genes: [cgab]), (fourteen mirnas: [bacs,nnon]), (controls (p <0.05; fdr <0.15): [fndg]), (% accuracy: []), (subject groups: [popg]), (best-fit logistic regression model: [inpr,qnco]), (mccv: []), (average roc-auc value: [qnco]), (simulations: [resa]), (robustness: []), (findings: [clna]), (significant correlations: [qnco]), (vineland: [hcro]), (neurodevelopmental scores: [clna]), (significant over-representation: [acty]), (target gene clusters: [gngm]), (transcriptional activation: [genf]), ( neuronal development: [celf]), (autdb genes: [gngm]), (measurement: []), (pilot study: [resa]), (mild asd: [cgab]), (differential expression: [topp]), (brain: [bpoc]), ( impact mrnas: [bacs,nnon]), (brain development: [ortf]), (correlate: []), (neurodevelopmental measures: [qnco]), (high specificity: [qnco]), (cross-validated utility: [orgt]), (potential screening tool: [diap]), (asd: [cgab]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s12887-016-0586-x) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(common neurodevelopmental disorder, 'Learning Disorders')(diagnosis, 'Diagnosis')(neurodevelopmental genes, 'Learning Disorders')(asd phenotype, 'Autism Phenotype')(neurologic disorder, 'Neurologic Indications')(thorough neurodevelopmental assessment, 'Learning Disorders')(vineland adaptive behavior scales, 'Adaptive Life Skills')(adaptive behavior, 'Adaptive Life Skills')(visualization, 'Visual Thinking')(autism database, 'Autism Phenotype')(visualization, 'Visual Thinking')(simons foundation autism database, 'Autism Phenotype')(neurodevelopmental scores, 'Learning Disorders')(autism database genes, 'Autism Phenotype')(neurodevelopmental measures, 'Learning Disorders')

PMCID: 4848704
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (low vitamin d status: [orch,phsu,vita]), (early development: [orgf]), (environmental risk factor: []), (autism spectrum disorder (asd): [mobd]), (concurrent increase: []), (prevalence: [qnco]), (conditions: [dsyn]), (association: [menp]), (vitamin d: [orch,phsu,vita]), (many asd-associated: [cgab]), (medical conditions: [dsyn]), (identification: [menp]), (vitamin d-asd factors: [cgab]), (indications: []), (secondary prevention interventions: [topp]), (literature: [inpr,mnob]), (studies: [lbpr]), (vitamin d-asd relationship: [cgab]), (potential mechanistic pathways: [moft]), (specific areas: []), ( including: latitude: [qnco]), ( season: []), (conception/birth: [orgf]), ( maternal migration/ethnicity: [popg]), ( vitamin d status: [orch,phsu,vita]), (mothers: [famg]), (asd patients: [cgab]), (vitamin d intervention: [orch,phsu,vita]), (asd: [cgab]), (differences: [qnco]), (methodological procedures: [topp]), (inconsistent results: [fndg]), (conclusions: []), (areas: []), (direct measure: [qnco]), (level: [phsu]), (pregnancy: [orgf]), (childhoodwe: []), (evidence: []), (relationship: []), (findings: [clna]), (experimental studies: [resa]), (mechanistic pathways: [moft]), (however: []), (secondary prevention intervention: [topp]), (relationship cannot: []), (placebo-controlled trials: [resa]), (disease-modifying measure: [dsyn]), 
ASD Terms: (low vitamin d status, 'Dietary Supplements')(autism spectrum disorder, 'Autism Phenotype')(vitamin d, 'Dietary Supplements')(medical conditions, 'Medications')(vitamin d-asd factors, 'Dietary Supplements')(vitamin d-asd relationship, 'Dietary Supplements')(vitamin d status, 'Dietary Supplements')(vitamin d status, 'Dietary Supplements')(vitamin d intervention, 'Dietary Supplements')(vitamin d, 'Dietary Supplements')(vitamin d, 'Dietary Supplements')(vitamin d, 'Dietary Supplements')

PMCID: 4839099
SFARI Genes: 
Non SFARI Genes: impact, impact, 
Named Entities: (social impairment: [patf]), (defining feature: []), (autism spectrum disorder (asd): [mobd]), (demonstrated effective pharmacologic treatments: []), (goal: []), (study: [resa]), (efficacy: [resa]), ( safety: [hcpp]), (tolerability: [resa]), (oral n-acetylcysteine (nac): [aapp,phsu]), (function: [phsf]), (proposed mechanisms: []), (asd: [cgab]), (core: [bdsu]), (youth: [aggp]), (12-week randomized: [resa]), ( double-blind: [resa]), ( placebo-controlled trial: [resa]), (oral nac: [gngm]), (study participants: [humn]), (healthy youth age: [aggp]), (years: []), (15 kg: [qnco]), (clinical global impressions severity scale: [fndg]), (participants: [popg]), (computer: []), (active drug: [phsu]), (placebo: [topp]), (ratio: [qnco]), (target dose: [qnco]), (nac: [gngm]), (mg/kg/day: [qnco]), (doses: [qnco]), (primary outcome measure: []), (clinical global impressions improvement: [fndg]), ((cgi-i) scale: [inch]), (impact: [gngm]), (oxidative stress markers: [comd]), (peripheral blood: [bdsu]), (venous blood samples: [bdsu]), (screen: [hlca]), (week: []), (patients: [podg]), (follow-up: [hlca]), (trial: [resa]), (effects: []), (average daily dose: [qnco]), (mg/kg (sd: [mamm]), (mg/kg: [qnco]), (frequency: [qnco]), (adverse events: [patf]), (comparisons: [acty]), (groups: [popg]), (conducted: [inbe]), (significant difference: [qnco]), (placebo groups: [popg]), (cgi-i (p: [inch]), (glutathione (gsh) level: [aapp,bacs]), (blood: [bdsu]), (nac group (p: [popg]), (oxidative glutathione disulfide (gssg) level: [aapp,phsu]), (nac group: [popg]), (trend level: [phsu]), (significance (p: [aapp,imft]), (gsh/gssg ratio: [aapp,phsu]), ( dna strand break: [bacs,nnon]), (oxidative damage: [inpo]), (blood homocysteine levels: [bdsu]), ((ps: [gngm]), (results: [fndg]), (trial indicate: [resa]), (nac treatment: [topp]), (expected effect: []), (gsh production: [dsyn]), (significant impact: [gngm]), (trial registration clinicaltrails.gov nct00453180: [resa]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social impairment, 'Social Competence')(social impairment in youth, 'Social Competence')(significant impact on social impairment, 'Social Competence')

PMCID: 4872404
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (maternal pregnancy levels: [orgf]), (inflammatory marker: [clna]), (c-reactive protein (crp): [aapp,imft]), (autism spectrum disorder (asd): [mobd]), (offspring: [famg]), (population-based nested casecontrol study: [resa]), (children: [aggp]), (asd: [cgab]), (developmental delay (dd): [mobd]), (general population (gp) controls: [hlca]), (elevated crp: [fndg]), (pregnancy: [orgf]), (risk: []), (maternal crp concentration: [menp]), (archived serum: [bdsu]), (weeks: []), (genome-wide single-nucleotide polymorphism (snp) data: [nusq]), (generated: [acty]), (levels: []), (crp: [gngm]), (asd vs gp: [cgab]), (dd: [gngm]), (gp: [gngm]), (genetic associations: []), (linear regression: [qnco]), (maternal crp levels: [aapp,imft]), (mid-pregnancy: [orgf]), (mothers: [famg]), (controls: [sbst]), (fourth quartiles: [qnco]), ( respectively: []), (snps: [nusq]), (crp locus: [gngm]), (strong association: [menp]), (crp levels: [aapp,imft]), (difference: [qnco]), (reasons: []), (certainty: []), (alterations: []), (immune response: [ortf]), (infectious agents: [orgm]), (biological mechanisms: []), (association remain: [menp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(offspring, 'Perinatal History')(developmental delay, 'Learning Disorders')(developmental delay vs, 'Learning Disorders')(maternal c-reactive protein levels of developmental delay, 'Learning Disorders')

PMCID: 4836088
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (common developmental cause: [orgf]), (disability: [fndg]), (united states: []), (asds: [cgab]), (emotional cost: [menp]), (brains: [bpoc]), (asd patients: [cgab]), (structural abnormalities: [fndg]), (form: []), (dendritic spines: [celc]), (long distance connections: [qnco]), (structural differences: [qnco]), (deficiencies: [dsyn]), (heparin sulfate: [inch]), (variety: []), (neurodevelopmental processes: [phpr]), (particular interest: [menp]), (role: [socb]), (slit/robo pathway: [moft]), (regulation: [biof]), (axonal guidance: [celf]), (dendritic spine formation: [celc]), (hs: [gngm]), (slit/robo interaction;: [topp]), (presence slits: [qnco]), (repulsive activity: [acty]), (slit/robo: [topp]), (interaction: []), (srgaps (slit-robo gtpase activating proteins): [aapp,bacs]), (signaling: [celf]), (cytoskeleton depolymerization: [celc]), (dendritic spine collapse: [celc]), (interference: []), (pathway: [moft]), ( hs deficiency: [dsyn]), (excess spine formation: [bpoc]), 
ASD Terms: (common developmental cause of disability, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')(neurodevelopmental processes, 'Learning Disorders')

PMCID: 4833406
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (disease: [dsyn]), (complex nature: [chvs]), (significant genetic component: [gngm]), (importance: []), (renin-angiotensin system: [bdsy]), ((ras) elements: [gngm]), (cognition: [menp]), (behavior: [inbe]), (interaction: []), (angiotensin ii (ang ii): [aapp,bacs,phsu]), (main product: [qnco]), (angiotensin-converting enzyme (ace): [aapp,enzy,imft]), (neurotransmitters: [bacs]), (cns: [bdsy]), (involvement: []), (ras: [gngm]), (genetic architecture: [topp]), (genetic variations: [npop]), (relation: [socb]), (polymorphisms: [genf]), (ace (i/d: [aapp,bacs]), ( rs4343: []), (rs4291): []), (level: [phsu]), (ace activity: [aapp,bacs]), (association: [menp]), (case-control study: [resa]), (genotype: [orga]), (allele frequencies: [qnco]), (dnas: [bacs,nnon]), (venous blood: [tisu]), (autistic patients: [mobd]), (age: [orga]), (sex-matched healthy controls: [orgf]), (polymerase chain reaction (pcr): [mbrt]), (pcrrestriction fragment length polymorphism (pcrrflp) methods: [genf]), (strong associations: [menp]), (dd genotype: [orga]), (ace i/d: [aapp,bacs]), (d allele: [gngm]), (autism (p: [mobd]), (or: []), (ci: [gngm]), (p =: [aapp,imft]), (respectively): []), (furthermore: []), (significant association: [menp]), (g allele: [gngm]), (rs4343: []), (=: []), (moreover: []), ( haplotype analysis: [orga]), (dtg haplotype: [orch,phsu]), (data: [euka]), (genetic diversity: [npop]), (risk: []), 
ASD Terms: (autism, 'Autism Phenotype')(cognition, 'Cognitive Ability')(autism, 'Autism Phenotype')(level of angiotensin-converting enzyme activity, 'Abnormal Activity or Energy Level')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4878876
SFARI Genes: GABRB3, GABRB3, Gabrb3, Gabrb3, 
Non SFARI Genes: 
Named Entities: (neurons: [cell]), (cerebellar nuclei (cbn) transmit cerebellar signals: [bpoc]), (areas: []), (cerebellum: [bpoc]), (several autism-linked genes: [mobd]), (gabrb3: [gngm]), (gabaa receptor 3 subunits: [aapp,rcpt]), (maternal alleles: [gngm]), (angelman syndrome: [dsyn]), (m-/p+ mutation affects cbn physiology: [orch,phsu]), (mice: [mamm]), (responses: [orga]), (males: [orga]), (females: [orga]), (wild-type mice: [mamm]), (sex differences: [orga]), (synaptic excitation: [acty]), ( inhibition: [acty]), (intrinsic properties: []), (cbn cells: [orch,phsu]), (mglur1/5-dependent currents: [aapp,rcpt]), (purkinje-mediated ipscs: [socb]), (rates: [qnco]), (rotarod performances: [inbe]), (mutant cbn cells: [orch,phsu]), ( ipsc kinetics: [npop]), (mutant males: [orga]), (enlarged mglur1/5 responses: [aapp,rcpt]), (spontaneous firing: []), (changes: [qnco]), (compensatory: []), (wild-type siblings: [famg]), (rotarod task: []), (thus: []), ( sex differences: [orga]), (cerebellar physiology: [dsyn]), (similar behavioral output: [inbe]), (distinct baselines: [bodm]), (doi: http://dx.doi.org/10.7554/elife.07596.001: [fndg]), 
ASD Terms: 

PMCID: 4834637
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (serious lifelong condition: [dsyn]), (underlying neural mechanism: []), (recently: []), (neuroimaging-based classifiers: [diap]), (asd: [cgab]), (developed (td) individuals: [humn]), (abnormality: [fndg]), (functional connections: []), (interferential effects: []), (measurement conditions: [dsyn]), (demographic distributions: []), (classifiers: []), (independent cohorts: [popg]), (difficulties: [fndg]), (novel machine-learning algorithm: [mcha]), (small number: [qnco]), (fcs: [irda]), (asd versus td: [cgab]), (classifier: []), (high accuracy: [qnco]), (japanese discovery cohort: [popg]), (remarkable degree: [qnco]), (generalization: [menp]), (independent validation cohorts: [popg]), (usa: []), (japan: []), (developed asd classifier: [cgab]), (distinguish individuals: [humn]), (major depressive disorder: [mobd]), (attention-deficit hyperactivity disorder: [mobd]), (controls: [sbst]), (patients: [podg]), (schizophrenia: [mobd]), (results: [fndg]), (viable possibility: []), (neuroimaging-based dimensions: [diap]), (multiple-disorder spectrum: [qnco]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(major depressive disorder, 'Depressive Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(attention-deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 4830019
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (array-cgh (acgh): [dsyn]), (routine clinical practice: [menp]), (diagnosis: [fndg]), (patients: [podg]), (intellectual disability (id): [mobd]), (multiple congenital anomalies: [cgab]), (spectrum disorder (asd): [cgab]), (acgh: []), (small chromosomal imbalances: [celc]), ( copy number variations: [nusq]), (size: []), (gene content: [gngm]), (pathogenic imbalances: [sosy]), (%: []), (id: [lbpr]), (aims: [phsu]), (study: [resa]), (clinical clues: []), (pathogenic cnvs: [nusq]), (cytogenetic indicators: [irda]), (pathogenicity: [orga]), (variants: []), (uncertain significance (vous): [fndg]), (large cohort: [popg]), (paediatric patients: [podg]), (either: id: [fndg]), ( and/or asd: [cgab]), (mca: [bpoc]), (genetic services: [hlca]), (federico ii university: [mnob,orgt]), (naples: []), ( department: [orgt]), (translational medicine: [resa]), (patient: [podg]), (data: [euka]), (first-tier test: [lbpr]), (part: [qnco]), (wider: []), (diagnostic work-up: [diap]), (pathologic data: [euka]), (individuals: [humn]), ((30 %): [fndg]), (cnvs: [nusq]), (syndrome: [dsyn]), (pathological cnvs: [nusq]), (deletions: [genf]), (gene-dosage content: [qnco]), (positive family history: [fndg]), (id/asd/mca: [cgab]), (asd: [cgab]), (good indicators: [irda]), (pathological chromosomal rearrangements: [comd]), (other clinical features: [clna]), (eyes: [bpoc]), (loss: [qnco]), ( neurological signs: [fndg]), (cutaneous dyscromia: []), (endocrinological problems: [dsyn]), (potential predictors: []), (vous: []), (genetic features: [gngm]), ( presence: [qnco]), (deletion: [genf]), (duplication: [comd]), (genic density: [gngm]), (multiple cnvs: [nusq]), (clinical features: [clna]), (gene density: [gngm]), (result: [fndg]), (chances: []), (pathogenic gene: [gngm]), (use: []), (neurdevelopmental phenotypes: [orga]), (inferred results: [fndg]), (flow-chart: []), (children: [aggp]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13052-016-0246-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (diagnosis, 'Diagnosis')(patients with intellectual disability, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(patients with intellectual disability, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(neurological signs, 'Neurologic Indications')(children with intellectual disability, 'Learning Disorders')

PMCID: 4829151
SFARI Genes: 
Non SFARI Genes: CA1, 
Named Entities: (exposure: [clna]), (acid (vpa): [chem]), (pregnancy: [orgf]), (increased incidence: [qnco]), (autism: [mobd]), (useful autism mouse model: [mobd]), (early behavioral: [inbe]), (anatomical changes: [qnco]), (molecular changes: [qnco]), (mice: [mamm]), (vpa (vpa mice): [mamm]), (study: [resa]), (vpa mice: [mamm]), (developmental delays: [mobd]), (self-righting: []), ( eye opening tests: [bpoc]), (impaired social recognition: [menp]), (addition: []), (first evidence: [qnco]), (neurons: [cell]), (vpa-treated embryos: [emst]), (increase: []), (dendritic spines: [celc]), (control mice: [mamm]), (mutations: [genf]), (phosphatase: [aapp,enzy]), (tensin homolog (pten) gene: [gngm]), (pten: [gngm]), (show: [anim]), (autistic characteristics: [mobd]), (protein expression: [genf]), (ratio: [qnco]), (p-akt/akt: [aapp,enzy]), (cerebral cortex: [bpoc]), (hippocampus: [bpoc]), (distinctive anatomical change: [qnco]), (ca1 region: []), (prenatal exposure: [fndg]), (vpa induces: []), (neuroanatomical changes: [qnco]), (reduction: [npop]), (pten level: [aapp,enzy]), (changes: [qnco]), (early days: []), (life: []), 
ASD Terms: (autism, 'Autism Phenotype')(exposure, 'Exposures')(useful autism mouse model, 'Autism Phenotype')(developmental delays, 'Learning Disorders')(impaired social recognition, 'Social Competence')(prenatal exposure, 'Exposures')

PMCID: 4827874
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (low success (<60%): [fndg]), (autism spectrum disorder (asd) classification: [mobd]), (brain morphometry: [bpoc]), (large multi-site abide dataset: [blor]), (inconsistent findings: [clna]), (brain: [bpoc]), (morphometric abnormalities: [cgab]), (asd: [cgab]), (asd heterogeneity: [cgab]), (study: [resa]), (asd brain morphometry: [cgab]), (demonstrate: []), (heterogeneity: [orga]), (classification: []), (autism severity (as): [mobd]), (verbal iq (viq): []), (age: [orga]), (morphometric features: [lbpr]), (structural mris (smris): [diap]), (males: [orga]), (abide: []), (freesurfer: []), (random forest: [npop]), (auc: [qnco]), (achieved: []), (viq: []), (features: []), ( auc: [qnco]), (subjects: [humn]), (as: []), ( viq: []), (moderate-as sub-group (as: [popg]), (age and/or viq: [orga]), (sub-group: [popg]), (sub-group (as: [popg]), (mid-age sub-group (1318 years): [aggp]), (important features: []), (frontal: []), ( temporal: []), ( ventricular: [bpoc]), ( right hippocampal: [bpoc]), (regions: []), (however: []), (curvature: []), (index features: [qnco]), (insular regions: [bpoc]), (importance: []), (early detection: [diap]), (experiments: [resa]), (gradient boosting: [qnco]), (similar results: [fndg]), (findings: [clna]), (brain biomarkers: [bpoc]), (sub-groups: [popg]), (insightful results: [fndg]), (whole spectrum: [qnco]), (identification: [menp]), (sub-group specific brain biomarkers: [bpoc]), (monitoring: [resa]), (utility: [orgt]), (smri: []), (important tool: []), 
ASD Terms: (autism spectrum disorder classification, 'Autism Phenotype')(autism severityd, 'Autism Phenotype')(autism severityd heterogeneity, 'Autism Phenotype')(autism severityd brain morphometry, 'Autism Phenotype')(autism severity, 'Autism Phenotype')(autism severity, 'Autism Phenotype')(low autism severity sub-group, 'Autism Phenotype')

PMCID: 4825995
SFARI Genes: PCDH15, PCDH15, PCDH15, PCDH15, PCDH15, PCDH15, PCDH15, PCDH15, 
Non SFARI Genes: 
Named Entities: (schizophrenia (scz): [mobd]), (autism spectrum disorders: [mobd]), (neuropsychiatric disorders: [dsyn]), (genetic etiology: [topp]), (protocadherin: []), ((pcdh15): [gngm]), (member: [popg]), (cadherin: [gngm]), (family: [famg]), (neural development: [orgf]), (function: [phsf]), (risk gene: [gngm]), (recently: []), (rare variants: [gngm]), (large effect: [qnco]), (attention: [menp]), (etiopathology: []), (complex disorders: [dsyn]), (impacts: [gngm]), (rare: [gngm]), ( single-nucleotide variants: [fndg]), (pcdh15: [gngm]), (scz: []), (asd: [cgab]), (exon-targeted resequencing: [bacs,nnon]), (technology: []), (japanese patients: [podg]), ((370 scz: []), (asd): [cgab]), (heterozygous snvs: [orga]), (association analyses: [menp]), (cases: [qnco]), ((1: [fndg]), (714 scz: []), (controls: [sbst]), (novel variants: []), (snvs: []), (variants: []), ((p.r219k: [aapp,imft]), ( p.t281a: [aapp,imft]), (ultra-rare variants: [gngm]), ((minor allele frequency: [qnco]), (disease susceptibility: [clna]), (finally: []), (significant association: [menp]), (heterozygous pcdh15 point variants: [orga]), (results: [fndg]), (sample size: [qnco]), (subjects: [humn]), (associations: [menp]), (rare pcdh15 variants: [gngm]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 4824422
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (databases: []), (standard ways: []), (gene: [gngm]), (ontologies: []), ( pathways: [moft]), (functional linkages: [moft]), (large set: [menp]), (genes: [gngm]), (autism spectrum disorders: [mobd]), (conditions: [dsyn]), (clear pathognomonic biological markers: [clna]), (great heterogeneity: [orga]), (multiple levels: [qnco]), (brain characteristics: [bpoc]), (nuances: [gngm]), (behavioral manifestations)and: [inbe]), (everyone: []), (diagnosis: [fndg]), (behavioral criteria: [inbe]), (human gene list: [gngm]), (simons foundation autism research initiative: [mobd]), (enrichment analysis: [resa]), (kyoto encyclopedia: []), (genomes (kegg) pathway database: [gngm]), (pathway network: [popg]), (pathway-pathway functional interactions: []), (reference: []), (go (gene ontology) groups: [popg]), (sfari genes: [gngm]), (coherence: [fndg]), (pathways: [moft]), (go groups: [popg]), (relative strengths: [qnco]), (representation: [acty]), (pathway network components: [popg]), (function-associated pathways: [phsf]), (calcium: [bacs,elii,phsu]), (pathway: [moft]), (neuroactive ligand-receptor interaction: []), (significant pathways: [moft]), (mapk: []), (interactive hubs: [gngm]), (other pathways: [moft]), (present biological processes: [biof]), (convergent indications: [acty]), (process: [phpr]), (calcium-prc (protein kinase c)-ras-raf-mapk/erk: [gngm]), (major contributor: []), (asd pathophysiology: [cgab]), (perturbations: []), (keggs category: []), (environmental information processing: [menp]), (common: [qnco]), (findings: [clna]), (idea: []), (asd-associated genes: [cgab]), (features: []), (asd: [cgab]), (vulnerability: []), (systemic problems: [fndg]), (cancer: [euka]), ( metabolic conditions: [dsyn]), (heart diseases: [dsyn]), (asds: [cgab]), (vulnerabilities: []), (important molecular mechanisms: []), ( vulnerability: []), (environmental input: []), (multiple systemic co-morbidities: [qnco]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(diagnosis, 'Diagnosis')(autism research initiative, 'Autism Phenotype')(pathway network from pathway-pathway functional interactions, 'Conversational Skills')(simons foundation autism research initiative, 'Autism Phenotype')(pathway-pathway functional interactions, 'Conversational Skills')(environmental information processing, 'Ability to Convey Information')(simons foundation autism research initiative genes, 'Autism Phenotype')(metabolic conditions, 'Metabolic Indications')(heart diseases, 'Cardiovascular Diseases')

PMCID: 4818409
SFARI Genes: PARK2, PARK2, PARK2, PARK2, PARK2, PARK2, PARK2, PARK2, PARK2, PARK2, PARK2, PARK2, 
Non SFARI Genes: impact, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (early-onset neurodevelopmental disorder: [dsyn]), (complex genetic underpinning: [chvs]), (etiology: []), (copy number variations: [nusq]), (genetic factors: [fndg]), (asd: [cgab]), (recent genome-wide association studies: [mbrt]), (however: []), (significance: [qnco]), (cnv: [nusq]), (non-caucasian asd population: [cgab]), (pathogenic cnvs: [nusq]), (han chinese: [popg]), (segment-based gwas: [mbrt]), (asd cases: [cgab]), (healthy controls: []), (affymetrix: []), (polymorphism: [genf]), ((snp) array: [nusq]), (case-specific cnvs: [nusq]), (park2: [gngm]), (important genes: [gngm]), (several case-specific regions: [qnco]), (it: []), (findings: [clna]), (initial screen sample set: [menp]), (sample: [sbst]), (real-time quantitative pcr (qpcr): [mbrt]), (total: [qnco]), (cnvs: [nusq]), (different exons: [bacs,nnon]), (park2 expression level: [qnco]), (exon-dependent manner: [bacs,nnon]), (cases: [qnco]), (deletion: [genf]), (duplication: [comd]), (result: [fndg]), (gene function: [genf]), (exonic deletion: [bacs,nnon]), (asd case: [cgab]), (exonic duplication: [bacs,nnon]), (severe interference: []), (park2 expression: [topp]), (clinical feature: [clna]), (ones: [qnco]), (exons: [bacs,nnon]), (park2 gene: [gngm]), (evidence: []), (park2 function: [phsf]), (genetic etiology: [topp]), (proportion: [qnco]), (intriguing results: [fndg]), (work warrant: []), (study: [resa]), (functional impact: [gngm]), (various exonic cnvs: [bacs,nnon]), (trial registration clinicaltrials.gov nct00494754 electronic: [resa]), (supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-016-0087-7) contains: [acty]), (users: [humn]), 
ASD Terms: (early-onset neurodevelopmental disorder, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 4821887
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (environmental factors: []), (pesticides: [hops]), (autism: [mobd]), (neurodegeneration risk: [comd]), (retrospective epidemiological studies: [resa]), (chemicals: [chem]), (share: [socb]), (transcriptomic signatures: [amas]), (neurological disorders: [dsyn]), (cortical neuron-enriched cultures: [bpoc]), (hundreds: []), (environment: []), (food: [imft,phsu]), (pesticide: [hops]), (parkinson's disease risk: [dsyn]), (certain fungicides: [hops]), (pyraclostrobin: [orch]), ( trifloxystrobin: [orch]), ( famoxadone: [orch,phsu]), (fenamidone: [orch]), (transcriptional changes: [genf]), (vitro: []), (brain samples: [bpoc]), (humans: [humn]), (advanced age: [popg]), (neurodegeneration (alzheimer's disease: [dsyn]), (huntington's disease): [dsyn]), (free radical production: [bacs,chvs]), (disrupt microtubules: [celc]), (neurons: [cell]), ( effects: []), (microtubule stabilizer: [celc]), (antioxidant: [phsu]), (sulforaphane: [orch,phsu]), (study: [resa]), (approach: []), (environmental chemicals: [chem]), (other brain disorders: [dsyn]), 
ASD Terms: (autism, 'Autism Phenotype')(neurological disorders, 'Neurologic Indications')

PMCID: 4818446
SFARI Genes: Astn2, Astn2, 
Non SFARI Genes: Astn1, 
Named Entities: (bmp/ra-inducible neural-specific protein: [aapp,bacs]), ((brinp1): [gngm]), (vertebrates: [vtbt]), (neocortex: [bpoc]), ( hippocampus: [bpoc]), ( olfactory bulb: [bpoc]), (cerebellum: [bpoc]), (mid-embryonic development: [ortf]), (brinp1 knock-out (brinp1/) mice: [mamm]), (cre-recombinase-mediated removal: [aapp,enzy]), (third exon: [bacs,nnon]), (brinp1: [gngm]), (knock-out mice: [mamm]), (behavioural phenotyping: [bhvr]), ( immunohistochemistry: [diap]), (expression analysis: [resa]), (developing: []), (adult brain: [bpoc]), (absence: [anab]), (development results: [orgf]), (behavioural phenotype: [bhvr]), (autism spectrum disorder (asd): [mobd]), (knock-out mice show: [mamm]), (sociability: [socb]), (changes: [qnco]), (vocalisation capacity: [qnco]), (addition: []), ( brinp1/ mice exhibit hyper-locomotor activity: [mamm]), (short-term memory: [menp]), (exhibit: []), (poor reproductive success: [grpa]), (brinp1/ mice show: [mamm]), (density: [qnco]), (parvalbumin-expressing interneurons: [aapp,bacs]), (adult mouse brain: [aggp]), (brinp1/ mice: [mamm]), (signs: [fndg]), (altered neural precursor proliferation: [patf]), (increased apoptosis: [celf]), (late embryonic brain development: [ortf]), (expression: [topp]), (related neuronal migration genes astn1: [gngm]), (astn2: [gngm]), (brains: [bpoc]), (effects: []), (brinp1 loss: [qnco]), (important role: [socb]), (normal brain development: [bpoc]), (function: [phsf]), (neuronal distribution: [imft]), (cortex: [bpoc]), (increased cortical pv-positive interneuron density: [bpoc]), (behaviour: [inbe]), (resemble features: []), (subset: []), (human neurological disorders;: [humn]), (autism: [mobd]), (spectrum disorder (asd): [cgab]), (hyperactivity aspect: [mobd]), (attention deficit hyperactivity disorder (adhd): [mobd]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-016-0079-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(short-term memory, 'Working Memory')(human neurological disorders, 'Neurologic Indications')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(hyperactivity aspect, 'Overactivity')(autism, 'Autism Phenotype')

PMCID: 4847050
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (number: [qnco]), (children: [aggp]), (autism spectrum disorders (asd): [mobd]), (studies: [lbpr]), (risk factors: [qnco]), (development: [orgf]), (asd: [cgab]), (etiology: []), (environmental: []), ( factors: []), (heavy metals: [elii]), ( pesticides): [hops]), (key role: [socb]), (disease: [dsyn]), (control (ctr): [sbst]), (years: []), (compared: [acty]), (gas chromatography: [lbpr]), (trap mass detector: [dsyn]), (level: [phsu]), (main pyrethroid metabolite: [hops,orch,phsu]), (urine: [bdsu]), (group: [popg]), (asd patients: [cgab]), (optical emission spectrometry analysis: [lbpr]), (metals: [inch]), (microelements: []), (hair: [bpoc]), (different group: [lbpr]), (asd children: [cgab]), (presence: [qnco]), (age: [orga]), (positive correlation: [fndg]), (control group: [grup]), (same age range: [qnco]), (urine concentration: [ortf]), (values: []), (significant (p: [aapp,imft]), (mg results: [fndg]), (respect: [socb]), (v: []), ( s: [clna]), ( zn: []), (ca/mg: [bpoc]), (statistical significance: [qnco]), (results: [fndg]), (principal component (pc) analysis: [qnco]), (health status: []), (mg: [elii,phsu]), (ones: [qnco]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 4815081
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prevalence: [qnco]), (autism spectrum disorder (asd): [mobd]), (males: [orga]), (females: [orga]), (little understanding: [menp]), (underlying mechanisms: []), (developmental time course: [orgf]), (sex-specific protective: [orgf]), (risk factors: [qnco]), (differences: [qnco]), (such factors: []), (developmental approach: [orgf]), (prospective sample: [resa]), (infants: [aggp]), (low familial risk: [famg]), (asd: [cgab]), (sex differences: [orga]), (infant markers: [aggp]), (autism symptoms: [mobd]), (markers: [clna]), (autistic social-communication: [mobd]), (autism observation scale: [hlca]), (infants (aosi): [aggp]), (total score: [qnco]), ( attention disengagement speed: [menp]), (gaze: [fndg]), (behaviour: [inbe]), (aim: [phsu]), (year: []), (age: [orga]), (sex-specific mechanisms: [orgf]), (risk: []), (protection: [fndg]), (relationship: []), (3-year autism: [mobd]), (autism: [mobd]), (boys: [aggp]), (early autism markers: [mobd]), (later autism symptoms: [mobd]), (additional moderating risk: []), (protective factors: [inbe]), (findings: [clna]), (important implications: []), (prospective studies: [resa]), (terms: [orgf]), (effect: []), (sex: [orgf]), (autistic traits: [mobd]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-016-0081-0) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism symptoms, 'Complaints and Indications')(autism observation scale, 'Autism Phenotype')(3-year autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism symptoms, 'Complaints and Indications')(early autism markers, 'Autism Phenotype')(later autism symptoms, 'Complaints and Indications')

PMCID: 5014121
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, Shank3, Shank3, Shank3, mGlu5, Shank3, mGlu5, mGlu5, SHANK3, mGlu5, SHANK3, 
Non SFARI Genes: 
Named Entities: (shank3 (also: [aapp]), (prosap2): [aapp]), (genetic haploinsufficiency: [comd]), (major cause: []), (neuropsychiatric symptoms: [sosy]), (phelan-mcdermid syndrome (pms): [dsyn]), (pms: [gngm]), (rare genetic disorder: [dsyn]), (severe form: []), (intellectual disability (id): [mobd]), (expressive language delays: [lang]), (other autistic features: [mobd]), (furthermore: []), (significant number: [qnco]), (shank3 mutations: [genf]), (patients: [podg]), (autism spectrum disorders asd: [mobd]), (shank3 truncating mutations: [genf]), (id: [lbpr]), (shank3 protein: [aapp,bacs]), (scaffold protein: [aapp,bacs]), (postsynaptic density (psd): [celc]), (excitatory synapses: [celc]), (synapse development: [ortf]), (plasticity: [npop]), (study: [resa]), (molecular mechanisms: []), (asd-like behaviors: [cgab]), (shank311-/- mice: [mamm]), (deleted: [acty]), (results: [fndg]), (shank3: [gngm]), (mglu5 receptor: [gngm]), (homer1b/c: [gngm]), (psd: [gngm]), (striatum: [bpoc]), (cortex: [bpoc]), (moreover: []), (mglu5 receptor activity: [moft]), (3-cyano-n-(1: [fndg]), (3-diphenyl-1h-pyrazol-5-yl)benzamide (cdppb): [orch]), (behavioral defects: [inbe]), (pharmaceutical treatments: [topp]), (mglu5 activity: [acty]), (new approach: []), 
ASD Terms: (severe form of intellectual disability, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(expressive language delays, 'Expressive Language')(autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorders asd, 'Autism Phenotype')(asd-like behaviors, 'Autism Phenotype')

PMCID: 4807783
SFARI Genes: CD38, CD38, 
Non SFARI Genes: 
Named Entities: (event-related potentials: [ortf]), (n170: []), (reaction: []), (healthy population: [popg]), ( face-inversion: [comd]), (negative amplitudes: [fndg]), (prolonged latencies: []), ( effects: []), (patients: [podg]), (autism-spectrum-disorder (asd): [mobd]), (asd: [cgab]), (differences: [qnco]), (oxytocinergic neurotransmission: [celf]), (erp-study: [resa]), (face-inversion effect: [comd]), (association: [menp]), (oxytocinergic candidate genes: [gngm]), (risk-allele-carriers: [gngm]), (oxytocin-receptor-gene-polymorphism (rs53576): [aapp,rcpt]), (cd38 (rs379863): [lbpr]), (persons: [popg]), (additionally: []), ( reactions: []), (different facial emotional expressions: [fndg]), (difficulties: [fndg]), (replications: [genf]), (molecular genetic association studies: [menp]), (findings: [clna]), (second study: [resa]), (seventy-two male subjects: [orga]), (seventy-eight young male subjects: [orga]), (replication-study: [resa]), (eeg: [diap]), (dna: [bacs,nnon]), (buccal cells: [cell]), (results: [fndg]), (n170-amplitudes: []), (latencies: []), (comparison: [acty]), (upright ones: [qnco]), (furthermore: []), (emotion: [menp]), (effects: []), (molecular-genetic associations: [menp]), (oxytocinergic polymorphisms: [genf]), (first study: [qnco]), (replication sample: [genf]), (theoretical understanding: [menp]), (research-field: [resa]), (order: [acty]), (possible explanations: []), ( support: []), (hypotheses: []), (success: [socb]), (reproducibility: []), (strength: [qnco]), (original p-values: [qnco]), (effect: []), (original study: [resa]), 
ASD Terms: (different facial emotional expressions, 'Integrated Verbal and NonVerbal Communication')

PMCID: 4986048
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (genetic risk factors: []), (autism spectrum disorders: [mobd]), (general population: [popg]), (effects: []), (risk: []), (people: [popg]), (neuropsychiatric symptoms: [sosy]), (several large asd consortia: [cgab]), (population: [popg]), (resources: []), (genomewide genetic links: [topp]), (asds: [cgab]), (typical variation: []), (social behavior: [socb]), (adaptive functioning: []), (finding: [sosy]), (ld score correlation: [clna]), (variant analysis: [resa]), (multiple types: [qnco]), (genetic risk: [qnco]), (asds influence: [cgab]), (continuum: []), (developmental traits: [gngm]), (severe tail: [bpoc]), (asd: [cgab]), (other neuropsychiatric disorder diagnosis: [dsyn]), (continuum model: []), (design: [acty]), (interpretation: [clna]), (studies: [lbpr]), (neuropsychiatric disease biology: [dsyn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(social behavior, 'Reciprocal Social Interaction')(adaptive functioning, 'Adaptive Life Skills')(other neuropsychiatric disorder diagnosis, 'Diagnosis')

PMCID: 4801420
SFARI Genes: NBEA, NBEA, NBEA, NBEA, NBEA, NBEA, NBEA, NBEA, NBEA, NBEA, NBEA, NBEA, NBEA, NBEA, NBEA, NBEA, NBEA, NBEA, 
Non SFARI Genes: Notch1, NOTCH1, 
Named Entities: (neurobeachin (nbea): [gngm]), (autism spectrum disorders: [mobd]), (candidate gene: [gngm]), (nbea deficiency affects: [menp]), (secretion: [biof]), ( receptor trafficking: [aapp,rcpt]), (synaptic architecture: []), (protein: [aapp,bacs]), ((pka)-mediated phosphorylation: [moft]), (nbea: [gngm]), (large multidomain: [qnco]), (n-: [aapp,imft]), (c-terminus: []), ( nbea: [gngm]), (concanavalin a-like lectin domain: [aapp,bacs]), (armadillo repeats: [mamm]), (a-kinase anchoring protein: [aapp,bacs]), (domain: []), (unknown function (duf1088): [phsf]), (beach domain: []), (pleckstrin homology-like domain: [aapp,bacs]), (wd40 repeats: []), (domains: []), (protein-protein interactions: [moft]), (interaction screen: [hlca]), (performed: []), (two-hybrid screens: [mbrt]), (aca: [aapp,imft]), (pbw: []), (modules: []), (list: []), (interaction partners: [popg]), (gene ontology (go) enrichment: []), (neuro-2a cells: [cell]), (confocal microscopy: [lbpr]), (nuclear extraction analysis: [resa]), (notch-mediated transcription: [genf]), (luciferase reporter assays: [aapp,enzy,irda]), (qrt-pcr: [mbrt]), (nbea knockdown: [gngm]), (overexpression: [genf]), (domain modules: []), (go enrichment: [gngm]), (nucleus: [celc]), (transcription regulators: [genf]), (number: [qnco]), (pka substrates: [sbst]), (cytoplasm: [celc]), (nuclear localization signal: [amas]), (duf1088 domain: []), (nuclear localization: [biof]), (egfp-dpbw fusion protein: [aapp,bacs]), (notch1: [gngm]), (intracellular domain: [celc]), (physical interactor: [hlca]), (pbw domain: []), (role: [socb]), (negative regulator: [fndg]), (novel interaction partners: [popg]), (conserved nbea domain modules: [gngm]), (transcriptional regulator: [genf]), (physical interaction: [moft]), (asd pathogenesis: [cgab]), (notch signaling: [celf]), (neural development: [orgf]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 4794817
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (compulsivity: [mobd]), (cross-disorder trait: [dsyn]), (distinct psychiatric disorders: [mobd]), (childhood: []), (adolescence: []), (effectiveness: []), (serotonergic compounds: [chem]), (treatment: [topp]), (obsessive-compulsive disorder: [mobd]), ( treatment-resistant symptoms: [sosy]), (%: []), (patients: [podg]), (clinical problem: [fndg]), (medications: [clna]), (core impairments: [patf]), (autism spectrum disorder: [mobd]), (urgent need: [topp]), (development: [orgf]), (novel pharmacological strategies: [menp]), (agents: [chvf]), (glutamate neurotransmission: [celf]), (memantine: [orch,phsu]), ( represent promising candidates: [acty]), (proof-of-concept clinical study: [resa]), (pilot-testing: [gngm]), (clinical effectiveness: []), (tolerability/safety: [hcpp]), (n-methyl-d-aspartate receptor antagonist: [aapp,rcpt]), (alzheimers dementia: [dsyn]), (number: [qnco]), (countries: []), (methods/design: [acty]), (12-week study: [resa]), (add-on: []), ( randomised: []), (double-blind: [resa]), ( placebo-controlled design: [acty]), (up-titration phase: [lbpr]), (flexible dose design: [acty]), (mg/day): [qnco]), (years: []), (months: []), (obsessive-compulsive disorder (n: [mobd]), (autism: [mobd]), (spectrum disorder (n: [dsyn]), (centres: []), (european countries: []), (ratio: [qnco]), (primary objectives: [topp]), (investigation: [hlca]), (paediatric patients: [podg]), (symptoms: [sosy]), ((primary outcome measure:: []), (total score: [qnco]), (childrens: []), (yale-brown obsessive-compulsive scale): [npop]), (tolerability: [resa]), (safety: [hcpp]), (secondary objectives: [neop]), (effects: []), (level: [phsu]), (structure: []), ( function: [phsf]), (biochemistry: []), (fronto-striatal circuits: [bpoc]), (blood: [bdsu]), (genetic analyses: [lbpr]), (biomarkers: [clna]), (tertiary objectives: [qnco]), (role: [socb]), (new candidate genes: [gngm]), (pathways: [moft]), (genes: [gngm]), (clinical phenotypes: [orga]), ( response: [fndg]), (neurocognitive test performance: [diap]), (functional neuroimaging measures: [diap,resa]), (biomarkers/proteomics: [clna]), (compulsivity traits: [mobd]), (discussion: [socb]), (study: [resa]), (part: [qnco]), (large: [gngm]), ( translational project tactics (http://www.tactics-project.eu/): [orgt]), (european union: [orgt]), (molecular factors: []), (pathogenesis: [patf]), (results: [fndg]), (relevant solid information: [bodm]), (potential new mechanisms: []), (medication treatment: [hlca]), (autism spectrum disorders: [mobd]), (trial registration eudract number:: [resa]), (2014-003080-38: []), ( date: []), (registration:: [mcha]), (july: []), 
ASD Terms: (compulsivity, 'Obsessive-Compulsive Disorder')(distinct psychiatric disorders, 'Mental Disorders')(obsessive-compulsive disorder, 'Obsessive-Compulsive Disorder')(autism spectrum disorder, 'Autism Phenotype')(medications, 'Medications')(obsessive-compulsive disorder, 'Obsessive-Compulsive Disorder')(obsessive-compulsive disorder, 'Obsessive-Compulsive Disorder')(autism, 'Autism Phenotype')(compulsivity, 'Obsessive-Compulsive Disorder')(compulsivity, 'Obsessive-Compulsive Disorder')(compulsivity traits, 'Obsessive-Compulsive Disorder')(neurocognitive test performance, 'Cognitive Ability')(compulsivity, 'Obsessive-Compulsive Disorder')(relevant solid information, 'Ability to Convey Correct Information')(medication treatment, 'Medications')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 4799364
SFARI Genes: 
Non SFARI Genes: GABARAP, 
Named Entities: (jacobsen syndrome (jbs): [dsyn]), (rare congenital disorder: [dsyn]), (terminal deletion: [genf]), (long arm: [fndg]), (chromosome: [celc]), (subset: []), (patients: [podg]), (social behavioural problems: [mobd]), (diagnostic criteria: []), (autism spectrum disorder (asd);: [mobd]), (molecular pathogenesis: [patf]), (px-rics: [gngm]), (chromosomal region: [cell]), (jbs patients: [dsyn]), (autistic-like behaviour: [mobd]), (px-rics-deficient mice exhibit: [mamm]), (asd-like social behaviours: [cgab]), (asd-related comorbidities: [cgab]), (px-rics-deficient neurons: [cell]), (reduced surface: []), (-aminobutyric acid type a receptor (gabaar) levels: [aapp,phsu]), (impaired gabaar-mediated: [socb]), (synaptic transmission: [celf]), ( gabarap: [gngm]), (14-3-3/ form: [aapp,bacs]), (adaptor complex: [chvs]), (gabaar: []), (gabaar surface expression: [topp]), (asd-like behavioural abnormalities: [cgab]), (px-rics-deficient mice: [mamm]), (inhibitory synaptic transmission: [celf]), (gabaar agonist: [phsu]), (findings: [clna]), (critical role: [socb]), (cognition: [menp]), (causal link: []), (px-rics deletion: [genf]), (asd-like behaviour: [cgab]), 
ASD Terms: (rare congenital disorder, 'Congenital Abnormalities')(autism spectrum disorder, 'Autism Phenotype')(social behavioural problems, 'Personal Traits')(asd-like social behaviours, 'Reciprocal Social Interaction')(asd-related comorbidities, 'Comorbidities')(asd-like behavioural abnormalities in px-rics-deficient mice, 'Personal Traits')(asd-like behavioural abnormalities, 'Personal Traits')(cognition, 'Cognitive Ability')

PMCID: 4793536
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (intellectual disability (id): [mobd]), ( autism: [mobd]), (epilepsy share: [dsyn]), (variable comorbidities: []), (another: []), (order: [acty]), (potential genetic divergence: [genf]), (variable risk: []), (genes: [gngm]), (monogenic ids: [comd]), (autism: [mobd]), (epilepsy comorbidities: [dsyn]), (different forms: []), (id: [lbpr]), (molecular origins: []), (available genetic databases: []), (conjunction: []), (gene ontology (go): []), (genetics: []), (id diverge: [lbpr]), (comorbidities: []), (epilepsy: [dsyn]), (distinctive features: []), (apparent risk: []), (terms: [orgf]), (nervous system-specific processes: [ortf]), (structural morphogenesis: [orgf]), (contrast: [irda]), (comorbid epilepsy (hce): [hops,orch]), (lipid metabolic processes: [moft]), (epilepsy comorbidity (id only): [dsyn]), (golgi membrane: [celc]), (highly: []), (autism (hca) genes: [gngm]), (other hand: [bpoc]), (nucleus: [celc]), (regulation: [biof]), (gene: [gngm]), (expression: [topp]), ( and: []), (ids: [gngm]), (variable autism: [mobd]), ( share: [socb]), (strong ties: []), (core: [bdsu]), (protein-protein interaction (ppi) network: []), (basic patterning: []), (cns: [bdsy]), (go: [gngm]), (autism-related gene products: [mobd]), (neural development: [orgf]), (firm conclusions: []), (majority: [socb]), (hca genes: [gngm]), (general dysregulation: [hlca]), (gene expression: [genf]), (chronology: []), (neural maturation: [orgf]), (patterning: []), (susceptibility: [clna]), (spectrum conditions: [dsyn]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-016-0082-z) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (variable comorbidities, 'Comorbidities')(intellectual disability, 'Learning Disorders')(autism, 'Autism Phenotype')(epilepsy share, 'Epilepsy')(monogenic intellectual disabilitys, 'Learning Disorders')(epilepsy comorbidities, 'Epilepsy')(different forms of intellectual disability, 'Learning Disorders')(autism, 'Autism Phenotype')(comorbidities, 'Comorbidities')(intellectual disability diverge, 'Learning Disorders')(epilepsy, 'Epilepsy')(genetics of intellectual disability, 'Learning Disorders')(lipid metabolic processes while intellectual disability, 'Learning Disorders')(comorbid epilepsy, 'Epilepsy')(epilepsy comorbidity, 'Epilepsy')(along with intellectual disabilitys, 'Learning Disorders')(autism genes, 'Autism Phenotype')(intellectual disabilitys, 'Learning Disorders')(variable autism, 'Autism Phenotype')(comorbid autism genes, 'Comorbidities')(autism spectrum conditions, 'Autism Phenotype')

PMCID: 4777504
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (aim: [phsu]), (current study: [resa]), (role: [socb]), (aromatic amino acids: [aapp]), (blood: [bdsu]), (relation: [socb]), (attention-deficit/hyperactivity disorder (adhd): [mobd]), (impact: [gngm]), (synthesis: [biof]), (serotonin: [bacs,orch]), (dopamine: [bacs,orch,phsu]), (decreased concentrations: [sosy]), (aaas tryptophan: [aapp,bacs,phsu]), ( tyrosine: [aapp,bacs,phsu]), (phenylalanine: [aapp,bacs,phsu]), (expression: [topp]), (adhd symptoms: [mobd]), (aaa blood concentrations: [lbtr]), (turn: [fndg]), (dietary protein: [aapp]), (aaa catabolism: [orgf]), (increased urinary aaa concentrations: [ortf]), (eighty-three children: [aggp]), (adhd (75% males): [mobd]), ((td) children: [aggp]), (males): [orga]), (years: []), (study: [resa]), (aaa concentrations: [menp]), (blood spots: [neop]), (18-hour urinary sample: [bdsu]), (nutritional diary: [clna]), (parents: []), (dietary protein intake: [fndg]), (parent: []), (teacher questionnaires: [fndg]), (symptoms: [sosy]), (adhd: [mobd]), (oppositional defiant disorder: [mobd]), ( conduct disorder: [mobd]), (autism spectrum disorder: [mobd]), (children: [aggp]), (normal aaa concentrations: [fndg]), (normal protein: [fndg]), (associations: [menp]), (psychiatric disorders: [mobd]), (aaa metabolism: [orgf]), (large sample: [sbst]), (aaa deficiencies: [dsyn]), (results: [fndg]), (treatment: [topp]), (aaa supplements: []), (future studies: [lbpr]), (cause: []), (dopamine alterations: [bacs,orch,phsu]), (other explanations: []), (effects: []), (altered transport: [celf]), (aaas: [gngm]), 
ASD Terms: (attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder symptoms, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism spectrum disorder, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(comorbid, 'Comorbidities')(psychiatric disorders, 'Mental Disorders')(aaa supplements, 'Dietary Supplements')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 4774994
SFARI Genes: 
Non SFARI Genes: ZEB2, HTR2C, 
Named Entities: (copy number variants: [nusq]), (probands: [orga]), (autism: [mobd]), (intellectual disability: [mobd]), (self-injurious behavior (sib): [inbe]), (tissue damage: [inpo]), (proband: [famg]), (clinical history: [orga]), (detailed behavioral descriptions: [inbe]), (genetic anomalies: [fndg]), (likely clinical significance: [fndg]), (cases: [qnco]), (novel: []), (variants: []), (functional significance: [qnco]), (segmental trisomy: [dsyn]), (segmental monosomy: [cgab]), (function: [phsf]), (zeb2: [gngm]), (transcription factor): [aapp,bacs]), (htr2c: [gngm]), (serotonin receptor): [aapp,rcpt]), (results: [fndg]), (regions: []), (suggest candidate genes: [gngm]), (etiology: []), (sib: [famg]), 
ASD Terms: (autism, 'Autism Phenotype')(self-injurious behavior, 'Self-Injurious Behavior')(intellectual disability, 'Learning Disorders')(self-injurious behavior, 'Self-Injurious Behavior')

PMCID: 4774916
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (phenotypic aspect: [orga]), (many monogenic: []), (hereditary cancer syndromes: [neop]), (pleiotropic effects: []), (cancer genes: [gngm]), (autism phenotype: [mobd]), (oncology medications: [phsu]), (prevalent neurodevelopmental condition: [qnco]), (treatment: [topp]), (hypothesis: []), (autistic patients: [mobd]), (rare coding: [gngm]), ( single-nucleotide variants: [fndg]), (tumor suppressor: [gngm]), (oncogenes: [gngm]), (neoplasms: [neop]), (exome-sequencing data: [euka]), (arra autism sequencing collaboration: [socb]), (control cohort: [popg]), (exome variant server database: [gngm]), (rare: [gngm]), (variants: []), (arra asd cohort (p<1.0x10-8): [cgab]), (contrast: [irda]), ( variants: []), (tumor suppressor genes: [gngm]), (phenotypically: []), ( children: [aggp]), (adults: [aggp]), (asd: [cgab]), (protective effect: []), (cancer: [euka]), (frequency: [qnco]), ((p<0.001): [fndg]), (age: [orga]), (odds ratio: [qnco]), (neoplasm: [neop]), (asd relative: [cgab]), (controls: [sbst]), ((95% ci:: [lbpr]), (p<0.0001): [fndg]), (age group;: [aggp]), (p: [gngm]), (males: [orga]), (females: [orga]), (findings: [clna]), (defects: []), (cellular proliferation: [celf]), (autism: [mobd]), (drugs: [topp]), (oncogenic pathways: [gngm]), (therapeutic value: [qnco]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism phenotype, 'Autism Phenotype')(oncology medications, 'Medications')(prevalent neurodevelopmental condition, 'Learning Disorders')(arra autism sequencing collaboration, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4774106
SFARI Genes: 
Non SFARI Genes: STMN4, PTK2B, STMN4, 
Named Entities: (repetitive behaviors: [fndg]), (core symptom categories: [bdsu]), (autism spectrum disorders (asd): [mobd]), (heterogeneous groups: [popg]), (behaviors: [inbe]), (previous research: [resa]), (factors: []), (rrb domain: []), (effort: [orgf]), (common variants: [qnco]), (rrb: []), (genome-wide association study (gwas): [mbrt]), (autism genetic resource exchange (agre): [mobd]), ((n =: [aapp,imft]), (asd probands: [cgab]), (european ancestry): [popg]), (rrb subcategory: []), (comparisons: [acty]), (polymorphisms (snps): [nusq]), (associated snps: [nusq]), (same set: [menp]), (probands: [orga]), (rrb subcategories: []), (phenotypes: [orga]), (multivariate: []), (linear mixed model: [qnco]), (top ranked snps: [nusq]), (independent dataset: [fndg]), (principal component analysis: [qnco]), (item scores: [clna]), (autism diagnostic: [mobd]), (distinct subcategories: []), (restricted: []), (identified: repetitive sensory motor (rsm): [fndg]), (insistence: []), (sameness (is): []), (quantitative rsm: [qnco]), (is scores: [clna]), (gwas: [mbrt]), (agre asd cohort: [cgab]), (genome-wide significance (p <: [gngm]), (rsm: []), (is: []), (snps: [nusq]), (genome-wide significance: [gngm]), (multivariate association analysis: [qnco]), (top is-associated snp: [nusq]), ((p-value =: [qnco]), (chromosome: [celc]), (locus: [gngm]), (notably: []), (close proximity: [fndg]), (stmn4: [gngm]), (ptk2b: [gngm]), ( genes: [gngm]), (function: [phsf]), (neuron development: [celf]), (top-ranked snps: [nusq]), (correlations: []), (stmn4 mrna expression: [genf]), (adult ceu: [aggp]), (european descent): [famg]), (human prefrontal cortex: [bpoc]), (however: []), (association signals: [menp]), (independent sample: [sbst]), (asd: [cgab]), (insufficient sample size: [qnco]), (between-study heterogeneity: [orga]), (possible explanations: []), (analysis: [resa]), (distinct subcategories: rsm: []), (subsequent univariate: []), (genome-wide association studies: [mbrt]), (detection: [topp]), (results: [fndg]), (independent asd dataset: [cgab]), (genomic features: [gngm]), (region: []), (pathway analysis: []), (together: []), (observations: [hlca]), (future studies: [lbpr]), (possible contributions: [acty]), (etiology: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s12864-016-2475-y) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism genetic resource exchange dataset, 'Autism Phenotype')(autism diagnostic, 'Autism Phenotype')(autism genetic resource exchange asd cohort, 'Autism Phenotype')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 4846490
SFARI Genes: SHANK3, SPN, SHANK3, SPN, 
Non SFARI Genes: 
Named Entities: (autistic individuals: [mobd]), (abnormal development: [cgab]), (caudate nucleus: [bpoc]), (associative cortical areas: [bpoc]), (potential dysfunction: [dsyn]), (cortico-basal ganglia: [bpoc]), (circuits: []), (electrophysiological approaches: [diap]), (mice: [mamm]), (narrow postnatal period: [qnco]), (extensive glutamatergic synaptogenesis: [ortf]), (striatal spiny projection neurons: [bpoc]), (concomitant increase: []), (corticostriatal circuit activity: [acty]), (spns: [neop]), (development: [orgf]), (high intrinsic excitability: [sosy]), (respond: []), (cortical afferents: [bpoc]), (sparse excitatory inputs: []), (result: [fndg]), ( striatum: [bpoc]), (corticostriatal connectivity: []), (chronic changes: [qnco]), (cortical activity: [bpoc]), (early imbalances: [sosy]), (cortical function alter bg development: [bpoc]), (indeed: []), (mouse model: [emod]), (autism: [mobd]), (deletions: [genf]), (shank3 (shank3b/): [aapp]), (cortical hyperactivity: [bpoc]), (triggers: [clna]), (spn excitatory synapse: [neop]), (corticostriatal hyper-connectivity: [mobd]), (results: [fndg]), (tight functional coupling: []), (cortex: [bpoc]), (striatum: [bpoc]), (early postnatal development: [orgf]), (potential common circuit dysfunction: [phpr]), 
ASD Terms: (abnormal development, 'Learning Disorders')(autism, 'Autism Phenotype')(cortical hyperactivity, 'Overactivity')

PMCID: 4770673
SFARI Genes: Shank3, Homer1, Shank3, Homer1, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (heterogeneous group: [popg]), (disorders: [dsyn]), (wide range: [qnco]), (behavioral impairments: [inbe]), (communication deficits: [socb]), (core: [bdsu]), (significant number: [qnco]), (asd individuals: [cgab]), (levels: []), (anxiety: [mobd]), (studies: [lbpr]), (subset: []), (ability: [orga]), (fear conditioned: [menp]), (molecular basis: []), (asd: [cgab]), (poorly understood: [menp]), (study: [resa]), (autism-like impairments: [mobd]), (animal model: [emod]), (pregnant rats: [mamm]), (teratogen: [hops]), ( valproic acid (vpa): [orch,phsu]), (day: []), (gestation: [orgf]), (subsequent progeny exhibit: [famg]), (asd-like symptoms: [cgab]), (analysis: [resa]), (basal: []), (lateral nucleus: [celc]), (amygdala: [bpoc]), (region: []), (brain: [bpoc]), (asd pathology: [cgab]), (whole genome gene expression analysis: [gngm]), (bla: []), (dna microarrays: []), (differences: [qnco]), (gene expression: [genf]), (vpa-exposed animals: [anim]), (vpa-dysregulated candidate gene (homer1a): [gngm]), (quantitative pcr (qrt-pcr): [mbrt]), (western blot: [lbpr]), (homer1a: [gngm]), (lateral amygdala: [bpoc]), (nave animals: [anim]), (adeno-associated viruses: [virs]), (animals: [anim]), (battery: [inpo]), (behavioral tests: [diap]), (auditory fear: [menp]), (social interaction: [fndg]), (open field: [irda]), (microarray data: [euka]), (genes: [gngm]), (significant upregulation: [genf]), (increase: []), (homer1a messenger rna (mrna): [bacs,nnon]), (protein: [aapp,bacs]), (multiple cohorts: [popg]), (dysregulation: []), (homer1a levels: [gngm]), (symptoms: [sosy]), (hypothesis: []), (bla neurons: [cell]), (viral-mediated approach: [socb]), (overexpression: [genf]), (auditory fear conditioning: [menp]), (reduced social interaction: [clna]), (influence: []), (open-field behavior: [bhvr]), (amygdala homer1a: [bpoc]), (autism-like symptoms: [mobd]), (vpa exposure: [clna]), (findings: [clna]), (part: [qnco]), (functioning: []), (shank3: [gngm]), ( metabotropic glutamate receptors: [aapp,rcpt]), (homer1: [gngm]), (proteins: [aapp,bacs]), (models: []), (similar molecular basis: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-016-0077-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (wide range of behavioral impairments, 'Personal Traits')(autism spectrum disorders, 'Autism Phenotype')(behavioral impairments, 'Personal Traits')(anxiety, 'Anxiety Disorders')(gestation, 'Perinatal History')(social interaction, 'Reciprocal Social Interaction')(reduced social interaction, 'Reciprocal Social Interaction')(valproic acid exposure, 'Exposures')

PMCID: 4824117
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (methods: []), (protein variation focus: [aapp,bacs]), (mutation pathogenicity: [genf]), (detailed interpretation: [clna]), (variant deleteriousness: []), (structure-based information: []), (computational framework: [acty]), (sequence analysis: [lbpr,mbrt]), (structural modelling: [resa]), (rosetta protein: [aapp,bacs]), (suite): []), (deleterious protein: [aapp,bacs]), (vipur: []), (protein variants: [aapp,bacs]), (known effects: []), (protein function: [moft]), (multiple organisms: [orgm]), (curated structural models: [acty]), (variant: []), (crystal structures: [chvs]), (homology models: [gngm]), (mutations: [genf]), (organism's proteome: [aapp,bacs]), (improved generalized accuracy (auroc .83): []), (interpretability (aupr .87): []), (other methods: []), (vipur's predictions: []), (deleteriousness: []), (biological phenotypes: [orga]), (clinvar: []), (clear ranking: [fndg]), (prediction confidence: [menp]), (inflammation: [patf]), (diabetes: [dsyn]), (structural diversity: []), (disrupted functional sites: []), (improved interpretation: [clna]), (human diseases: [humn]), (lastly: []), (vipur's ability: [orga]), (candidate variants: []), (variants: []), (autism spectrum disorders: [mobd]), 
ASD Terms: (diabetes, 'Diabetes Mellitus Type 1')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 4765851
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction autism spectrum disorders: [mobd]), (hyperactivity symptoms: [mobd]), (incidence: [qnco]), (androgen activity: [horm,phsu]), (plausible biological risk factor: [qnco]), (disorders: [dsyn]), (however: []), (insufficient information: []), (association: [menp]), (children: [aggp]), (asd: [cgab]), (present study: [qnco]), (relationship: []), (parameters: [fndg]), (androgenicity: [horm,phsu]), ((plasmatic testosterone levels: [lbpr]), (androgen receptor sensitivity): [horm,phsu]), (hyperactivity: [mobd]), (boys: [aggp]), (documented differences: [qnco]), (parent: []), (trained examiners ratings: [acty]), (symptom severity: [fndg]), (standardized parent`s questionnaire (nisonger child behavior rating form): [inbe]), (direct examiner`s rating (autism: [mobd]), (diagnostic observation schedule): [hlca]), (assessment: [acty]), (significant association: [menp]), (actual plasmatic testosterone levels: [lbpr]), (number: [qnco]), (cag triplets: [famg]), (p: [gngm]), (sample: [sbst]), ( indicating: []), (androgen receptor sensitivity: [horm,phsu]), (examiners assessment: [acty]), (relevant method: [lbpr]), (behavioral problems: [mobd]), (investigation: [hlca]), (biological underpinnings: []), (problems: []), (study: [resa]), (potential asd subtype: [cgab]), (increased rates: [qnco]), (distinct etiopathogenesis: []), (specific behavioral: [inbe]), (pharmacological approach: []), (increase: []), (biomarker: [clna]), (specific asd subtype: [cgab]), (findings: [clna]), (terms: [orgf]), (implications: []), (practice: [menp]), (future research: [resa]), 
ASD Terms: (introduction autism spectrum disorders, 'Autism Phenotype')(hyperactivity symptoms, 'Overactivity')(hyperactivity symptoms, 'Overactivity')(hyperactivity, 'Overactivity')(behavioral problems, 'Personal Traits')(hyperactivity symptoms, 'Overactivity')

PMCID: 4762891
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (males: [orga]), (mechanisms: []), (sex-differential risk: [orgf]), (competing: []), (exclusive: []), ( hypotheses: []), (asd risk genes: [cgab]), (dimorphic pathways: [moft]), (dimorphic gene expression: [genf]), (multiple data sets: [qnco]), (neurotypical adult: [aggp]), (prenatal human neocortical tissue: [tisu]), (evidence: []), (sex-biased expression: [socb]), (systematic sex-differential expression: [orgf]), (instead: []), (genes: [gngm]), (levels: []), (post-mortem autistic brain: [diap]), (astrocyte: [cell]), (microglia markers: [cell]), (sex-differential regulation: [orgf]), (dimorphic processes: [phpr]), (neuronglial interactions: []), (impact: [gngm]), (risk variants: []), (contribute: [acty]), (sex-skewed prevalence: [qnco]), (asd: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 4898763
SFARI Genes: Shank3, Shank3, SHANK3, SHANK3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, 
Non SFARI Genes: impact, 
Named Entities: (asd: [cgab]), (neurodevelopmental disorder: [mobd]), (patients: [podg]), (symptoms: [sosy]), (age: [orga]), (key questions: []), (autism research: [mobd]), (pathology: [patf]), (adults: [aggp]), (developmental requirement: [orgf]), (shank3: [gngm]), (prominent monogenic asd genes: [cgab]), (asd cases26: [cgab]), (postsynaptic scaffold protein: [aapp,bacs]), (synaptic development: [ortf]), ( function: [phsf]), (plasticity: [npop]), (assembly: [acty]), (postsynaptic density (psd) macromolecular: [celc]), (complex79: []), (disruptions: []), (shank3 gene: [gngm]), (mouse models: [mamm]), (synaptic defects: []), (autistic-like behaviors: [mobd]), (anxiety: [mobd]), ( social interaction deficits: [fndg]), (repetitive behavior1013: []), (novel shank3: [aapp]), (conditional knock-in mouse model: [emod]), (re-expression: [topp]), (adult: [aggp]), (improvements: []), (synaptic protein composition: [aapp,bacs]), ( spine density: [bpoc]), (neural function: [phsf]), (striatum: [bpoc]), (behavioral evidence: [inbe]), (certain behavioral abnormalities: [mobd]), (social interaction deficit: [dsyn]), (repetitive grooming behavior: [inbe]), (motor coordination deficit: [fndg]), (adulthood: []), (together: []), (results: [fndg]), (profound impact: [gngm]), (post-developmental activation: [acty]), (shank3 expression: [topp]), (demonstrate: []), (certain degree: [qnco]), (continued plasticity: [npop]), (brain: [bpoc]), 
ASD Terms: (autism research, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(anxiety, 'Anxiety Disorders')(social interaction deficits, 'Reciprocal Social Interaction')(certain behavioral abnormalities, 'Personal Traits')(social interaction deficit, 'Reciprocal Social Interaction')(repetitive grooming behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(motor coordination deficit, 'Motor Skills')

PMCID: 4755663
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (limited capacity: [qnco]), (human brain: [humn]), (full extent: []), (visual information: []), (visual cortex: [bpoc]), (recruitment: [acty]), (mechanisms: []), (information selection: [genf]), (attention: [menp]), (neurofibromatosis: [gngm]), (type-1 (nf1): [gngm]), (neurodevelopmental disease: [mobd]), (attentional deficits: [mobd]), (disabilities: [fndg]), (similar impairments: [patf]), (other neurodevelopmental disorders: [mobd]), (autism: [mobd]), (previous study: [resa]), (patients: [podg]), (nf1: [gngm]), (targets: [diap]), (overt attention conditions: [menp]), (finding: [sosy]), (result: [fndg]), (occipito-parietal alpha oscillations: [topp]), (present study: [qnco]), (electroencephalography (eeg): [diap]), (alpha power modulations: [hcpp]), (performance: [inbe]), (covert attention task: [menp]), (covert attention: [menp]), (order: [acty]), (changes (target offset): [qnco]), (stimulus: [phpr]), (interestingly: []), (alpha oscillations: [topp]), (desynchronization: []), (task: [gngm]), (nf1 group: [gngm]), (control subjects: [sbst]), (similar pattern: []), (beta frequencies: [plnt]), (changes: [qnco]), (gamma oscillations: [npop]), (results: [fndg]), (notion: []), (different attentional states: [menp]), (task demands: [topp]), (different patterns: []), (abnormal modulation: [qnco]), (alpha oscillatory processes: [phpr]), (covert attention conditions: [menp]), (target offset: [qnco]), (high accuracy: [qnco]), (correct responses): [orga]), (excessive desynchronization: []), (findings: [clna]), (oscillatory activity: [acty]), (attentional processes: [menp]), (known role: [socb]), (alpha: []), (alpha patterns: []), (abnormal increases: [qnco]), (decreases: [qnco]), (performance dependent: [inbe]), (way: []), (compensatory mechanism: []), (normal levels: [fndg]), (dysregulation: []), (terms: [orgf]), (excessive: []), (activation patterns: [acty]), 
ASD Terms: (visual information, 'Visual Thinking')(visual cortex, 'Visual Thinking')(neurodevelopmental disease, 'Learning Disorders')(other neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')

PMCID: 4811712
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (rate: [qnco]), (single nucleotide polymorphism varies: [nusq]), (human genome: [gngm]), (influences evolution: [genf]), (incidence: [qnco]), (genetic disease: [dsyn]), (previous studies: [lbpr]), (immediate flanking nucleotides: [nnon]), (polymorphic site the sites trinucleotide sequence context: [nusq]), (polymorph levels: [cell]), (genome: [gngm]), (moreover: []), (impact: [gngm]), (sequence contexts: [nusq]), (rates: [qnco]), (polymorphism: [genf]), (new statistical framework: []), (data: [euka]), (genomes project: [gngm]), (heptanucleotide context: [fndg]), (variability: []), (substitution probabilities: [qnco]), (new mutation-promoting motifs: [amas]), (apt dinucleotide: [orch,phsu]), ( caat: []), (tacg sequences: [nusq]), (approach: []), (undocumented variability: []), (c-to-t substitutions: [acty]), (cpg sites: [bacs,nnon]), (differential methylation intensity: [moft]), (model: []), (informative substitution intolerance scores: [clna]), (genes: [gngm]), (new intolerance score: [clna]), (amino acids: [aapp,bacs,phsu]), (clinical use: []), (neuropsychiatric diseases: [dsyn]), 
ASD Terms: 

PMCID: 4749962
SFARI Genes: RNG105, RNG105, Rng105, RNG105, Rng105, RNG105, RNG105, RNG105, cage, cage, RNG105, RNG105, 
Non SFARI Genes: 
Named Entities: (rng105 (also: [gngm]), (caprin1): [gngm]), (major rna-binding protein: [aapp,bacs]), (neuronal rna granules: [celc]), (mrna transport: [celf]), (dendrites: [celc]), (neuronal network formation: [popg]), (recent study: [resa]), (heterozygous mutation: [genf]), (rng105 gene: [gngm]), (autism spectrum disorder (asd) patient: [mobd]), (causal relation: [socb]), (rng105 deficiency: [dsyn]), (asd: [cgab]), (here: []), (rng105+/ mice: [mamm]), (comprehensive behavioral test battery: [diap]), (influence: []), (mouse behavior: [mamm]), (reduced sociality: []), (home cage: []), (weak preference: [sosy]), (social novelty: []), (consistently: []), (novel objects: []), (novel place patterns: [acty]), (furthermore: []), (normal memory: [menp]), (relative difficulty: [fndg]), (reversal learning: [resa]), (spatial reference tasks: [gngm]), (findings: [clna]), (rng105: [gngm]), (heterozygous knockout: [orga]), (reduction: [npop]), (sociality: []), ( response: [fndg]), (novelty: []), (flexibility: []), (learning: [menp]), (asd-like behavior: [cgab]), 
ASD Terms: (autism spectrum disorder patient, 'Autism Phenotype')(have relative difficulty in reversal learning, 'Learning Disorders')(normal memory, 'Working Memory')(asd-like behavior, 'Autism Phenotype')

PMCID: 4747159
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (expression: [topp]), (autism-related mutant r451c neuroligin3: [mobd]), (branches: [bpoc]), (unfolded protein response: [celf]), (neuronal-like pc12 cells: [cell]), (up-regulation: [genf]), (response target genes bip: [aapp,bacs]), (chop: [gngm]), 
ASD Terms: 

PMCID: 4740767
SFARI Genes: MeCP2, MeCP2, PTEN, PTEN, MeCP2, PTEN, MeCP2, PTEN, MeCP2, PTEN, MeCP2, PTEN, MeCP2, PTEN, MeCP2, PTEN, PTEN, PTEN, MeCP2, MeCP2, MeCP2, PTEN, MeCP2, PTEN, 
Non SFARI Genes: 
Named Entities: (mecp2: [gngm]), (methyl-cpg-binding protein: [gngm]), (critical role: [socb]), (gene: [gngm]), (expression: [topp]), ( mutations: [genf]), (rett syndrome: [dsyn]), (autism: [mobd]), (pten: [gngm]), (critical tumor suppressor gene: [gngm]), (human cancers: [humn]), (autism spectrum disorders: [mobd]), (various studies: [lbpr]), (important roles: [socb]), (brain development: [ortf]), (micrornas: [bacs,nnon]), (knockdown: []), (upregulation: [genf]), (microrna-137: [gngm]), (turn represses expression: [fndg]), (deletion: [genf]), (phosphorylation: [moft]), (serine: [aapp,bacs,phsu]), (creb: []), (microrna-132: [gngm]), (mecp2 mrna: [aapp,bacs]), (work: []), (critical disorders-related gene mecp2: [aapp,bacs]), (distinct mechanisms: []), (rare mutations: [genf]), (various disorders: [dsyn]), (dysregulation: []), (other critical genes: [gngm]), (yield: []), (unexpected consequences: []), 
ASD Terms: (rett syndrome, 'Rett Syndrome')(autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 4739328
SFARI Genes: CNTNAP2, CNTNAP2, CNTNAP2, CNTNAP2, CNTNAP2, CASPR2, CNTNAP2, CASPR2, CNTNAP2, CNTNAP2, CASPR2, CASPR2, CNTNAP2, CNTNAP2, 
Non SFARI Genes: 
Named Entities: (heterozygous mutations: [genf]), (cntnap2: [gngm]), (patients: [podg]), (range: [qnco]), (complex phenotypes: [orga]), (intellectual disability: [mobd]), ( autism: [mobd]), (schizophrenia: [mobd]), (heterozygous cntnap2 mutations: [aapp,bacs]), (normal population: [popg]), (conversely: []), (homozygous mutations: [genf]), (patient populations: [popg]), (unaffected individuals: [humn]), (case presentation: []), (consanguineous family: [fndg]), (deletion: [genf]), (function: [phsf]), (protein product: [aapp,bacs]), ( caspr2: [gngm]), (homozygous family members: [orga]), (epilepsy: [dsyn]), ( facial dysmorphisms: [cgab]), (severe intellectual disability: [mobd]), (impaired language: [lang]), (individuals: [humn]), (recognisable phenotype: [orga]), (caspr2 loss: [qnco]), (early-onset refractory epilepsy: [dsyn]), ( language impairment: [mobd]), (autistic features: [mobd]), (caspr2 deficiency disorder: [dsyn]), (homozygous patients: [orga]), (criteria: []), (detailed phenotypic: [orga]), (molecular investigations: [hlca]), (contribution: [acty]), (development: [orgf]), 
ASD Terms: (intellectual disability, 'Learning Disorders')(autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(epilepsy, 'Epilepsy')(severe intellectual disability, 'Learning Disorders')(impaired language, 'Language Ability')(early-onset refractory epilepsy, 'Epilepsy')(language impairment, 'Language Ability')

PMCID: 4903018
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recurrent: []), (reciprocal genomic disorders: [dsyn]), (non-allelic homologous recombination (nahr): [gngm]), (near-identical segmental duplications (sds): [nnon]), (major cause: []), (human disease: [humn]), (distinct syndromes: [dsyn]), (genomic architecture: [gngm]), (sds: [gngm]), (significant challenge: [hlca]), (syndromes; however: [dsyn]), (capability: []), (reciprocal copy number variants: [nusq]), (mimic nahr: []), (invaluable modeling tool: [resa]), (crispr/cas9 genome engineering method: [nnon]), ( single-guide-crispr/cas-targeting-of-repetitive-elements (score): [nnon]), (capabilities: []), (reciprocal cnvs: [nusq]), (alteration: []), (copy-equivalent: [qnco]), (nahr: []), (vivo: []), (method: [lbpr]), (rnaseq: []), (transcriptional signatures: [amas]), (human subjects: [humn]), (vivo cnv: [nusq]), (corresponding: []), (vitro models: []), (new approach: []), (broad applicability: []), (study: [resa]), (genomic disorders: [dsyn]), (further development: [orgf]), (efficient correction: []), (defects: []), 
ASD Terms: 

PMCID: 4783914
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (early presumptions: []), (autism spectrum disorder (asd): [mobd]), (rearing: []), (children: [aggp]), (emotionally-distant mothers: [famg]), (advances: []), (1960s: []), (biologic basis: [phsu]), (autism: [mobd]), (high heritability: [qnco]), (recent advances: []), (specific etiologic factors: []), (autism spectrum disorders: [mobd]), (cases: [qnco]), (early reports: [hlca]), (genomic technologies: [gngm]), (diagnostic yield: [fndg]), (date: []), (investigations: [hlca]), (etiologic factors: []), (undiagnosed causes: [fndg]), (asds: [cgab]), (causes: []), (complex: [chvs]), (epigenetic: []), (multiple interacting loci: [gngm]), (dimensional causes: [qnco]), (timing: []), (variable): []), (unidentifiable cases: [qnco]), (why: []), (ever: []), (asds help: [cgab]), (families: [famg]), (important issues: [fndg]), (recurrence risk: [qnco]), (prognosis: [hlca]), ( natural history: []), (co-morbid medical conditions: [fndg]), (current era: [dsyn]), (efforts: [orgf]), (personalized medicine: [topp]), (etiology: []), (endo-phenotypic groups: [dsyn]), (individual variations: [humn]), (tailored treatment: [topp]), (persons: [popg]), (asd: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(co-morbid medical conditions, 'Medications')

PMCID: 4740114
SFARI Genes: CaV1.2, CaV1.2, 
Non SFARI Genes: 
Named Entities: (timothy syndrome (ts): [dsyn]), (multisystem disorder: [dsyn]), (cardiac action: [fndg]), (potential prolongation: []), (paroxysms: []), (life-threatening arrhythmias: [fndg]), (underlying defect: []), (missense mutation: [genf]), (cav1.2 channels: [gngm]), (g406r: []), (g402s: []), (notably: []), (mutations: [genf]), (comparable defects: []), (voltage-dependent inactivation: [qnco]), (similar manifestations: []), (patients: [podg]), (effects: []), (calcium-dependent inactivation (cdi): [bacs,elii,phsu]), (here: []), (significant defect: [qnco]), (cdi: [dsyn]), (ts channels: []), (remarkable divergence: []), (underlying mechanism: []), (g406r versus g402s variants: []), (moreover: []), ( expression: [topp]), (cultured adult guinea pig myocytes: [mamm]), (quantitative ventricular myocyte model: [cell]), (threshold behaviour: [inbe]), (induction: [topp]), (arrhythmias: [fndg]), (ts channel expression: [topp]), (important therapeutic principle:: [topp]), (small shift: [phpr]), (complement: [aapp,imft]), (mutant versus: [comd]), (wild-type channels: [gngm]), (significant clinical improvement: [qnco]), 
ASD Terms: 

PMCID: 4734032
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (previous studies: [lbpr]), (neuropsychological functioning: []), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (certain abilities: [orga]), (executive functions: [menp]), (language: [lang]), (comprehensive assessment: [acty]), (neuropsychological profile: [lbpr]), (asd: [cgab]), (focus: []), (recent research: [resa]), (evidence originates: []), (single centres: [fndg]), (studies: [lbpr]), (differences: [qnco]), (neuropsychological features: []), (countries: []), (different phenotypes: [orga]), (such studies: [lbpr]), (conducted: [inbe]), (goal: []), (neuropsychological abilities: [orga]), (northern finland: []), (egypt: []), (effect: []), (age: [orga]), (intelligence quotient (iq): [orga]), (abilities: [orga]), (design selected verbal: [acty]), (non-verbal subtests: [fndg]), (neuropsychological assessment nepsy: [diap]), (northern finland (n=54: [aapp,imft]), ( age m=11.2: [aapp,imft]), ( iq m=117.1): [aapp,imft]), (egypt (n=34: [aapp,imft]), ( age m=8.4: [aapp,imft]), ( iq m=96.6): [aapp,imft]), (finnish asd children: [cgab]), (egyptian counterparts: [lang]), (verbal nepsy: []), (comprehension: [menp]), (instructions (p<0.001): [clna]), ( comprehension: [menp]), (sentence structure (p<0.01): [fndg]), ( narrative memory (p<0.001): [socb]), (verbal fluency (p<0.05): [fndg]), (non-verbal nepsy: [fndg]), (design fluency (p<0.01): [fndg]), (egyptian asd children: [cgab]), (subtests memory: [menp]), (faces: [blor]), ( object recognition: [menp]), (object memory: [menp]), (addition: []), (verbal iq: []), (significant influence: [qnco]), (neuropsychological performance: [inbe]), (results: [fndg]), (possible cultural impact: [gngm]), (visuomotor fluency: []), (however: []), (ability: [orga]), (objects: []), (disability: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(executive functions, 'Executive Function')(identifying different phenotypes of asd, 'Autism Phenotype')(intelligence quotient, 'IQ')(narrative memory, 'Working Memory')(subtests memory, 'Working Memory')(object memory, 'Working Memory')(verbal intelligence quotient, 'IQ')

PMCID: 4732982
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (dioxin concentrations: [hops,orch]), (environment: []), (humans: [humn]), (former us air force bases: [inch]), (south vietnam: []), (previous epidemiological studies: [resa]), (adverse effects: [patf]), (dioxin exposure: [hops,orch]), (neurodevelopment: [ortf]), (years: []), (life: []), (subsequently: []), (follow-up period: [hlca]), (influence: []), (perinatal dioxin exposure: [hops,orch]), (motor coordination: [ortf]), (cognitive ability: [menp]), (preschool children: [aggp]), (presently: []), (children: [aggp]), (hot spot: [nusq]), (dioxin contamination: [hops,orch]), (birth: [orgf]), (perinatal dioxin exposure levels: [hops,orch]), (dioxin levels: [hops,orch]), (maternal breast milk: [bdsu]), (dioxin toxicity: [hops,orch]), (indices; toxic equivalent (teq)-polychlorinated dibenzo-p-dioxins/furans (pcdds/fs): [orch]), (concentration: [menp]), (2: [qnco]), (3: [fndg]), (7: []), (8-tetrachlorodibenzo-p-dioxin (tcdd): [hops,orch]), (movements: [orgf]), (manual dexterity: [inpr,mnob]), ( aiming: [phsu]), (catching: [sosy]), (balance: [fndg]), (movement assessment battery: [orgf]), ( second edition: []), (abc-2): [dsyn]), (nonverbal index (nvi): [qnco]), (kaufman assessment battery: [acty]), ( second edition (kabc-ii): []), (boys: [aggp]), ( total test: [lbpr]), (balance scores: [clna]), (movement abc-2: [dsyn]), (high teq- pcdds/fs group: [orch,phsu]), (low exposure groups: [popg]), (nvi scores: [clna]), (pattern: []), (subscale: []), (kabc-ii indicating planning ability: [orga]), (high tcdd exposure group: [hops,orch]), (low exposure group: [popg]), (however: []), (girls: [aggp]), (significant differences: [qnco]), (kabc-ii scores: [clna]), (different teq-pcdds/fs: [orch,phsu]), (tcdd exposure groups: [hops,orch]), (furthermore: []), (high risk: [fndg]), (girl: [aggp]), (teq-pcdds/fs: [orch,phsu]), (tcdd: [hops,orch]), (risk: []), (difficulties: [fndg]), (neurodevelopmental skills: [inbe]), (results: [fndg]), (differential impacts: [gngm]), (tcdd exposure: [hops,orch]), ( respectively: []), (moreover: []), (high teq-pcdds/fs exposure: [orch,phsu]), (high tcdd exposure: [hops,orch]), (autistic traits: [mobd]), (developmental coordination disorder: [mobd]), 
ASD Terms: (dioxin exposure, 'Exposures')(perinatal dioxin exposure, 'Perinatal Exposures')(cognitive ability, 'Cognitive Ability')(motor coordination, 'Motor Skills')(perinatal dioxin exposure levels, 'Perinatal Exposures')(manual dexterity, 'Functional Laterality')(low exposure groups, 'Exposures')(low exposure group, 'Exposures')(high tcdd exposure group, 'Exposures')(tcdd exposure groups, 'Exposures')(neurodevelopmental skills, 'Learning Disorders')(tcdd exposure, 'Exposures')(motor coordination, 'Motor Skills')(high teq-pcdds/fs exposure, 'Exposures')(high tcdd exposure, 'Exposures')(developmental coordination disorder, 'Motor Skills')

PMCID: 4731780
SFARI Genes: 
Non SFARI Genes: IV, IV, IV, IV, 
Named Entities: (phelan-mcdermid syndrome (pms): [dsyn]), (deletion: [genf]), (demonstrates: [acty]), (significant phenotypic variation: [fndg]), (mitochondrial genes: [gngm]), (iv: [gngm]), (mitochondrial complex activity abnormalities: [anab]), (phenotypic variation: [fndg]), (pms symptoms: [dsyn]), (complex i: [aapp,enzy]), ( ii: []), ( ii + iii: []), (iv activity: [acty]), (pms participants: [dsyn]), (caretakers: []), (questionnaires: []), (genetic information: [topp]), (pms foundation registry: [orgt]), (complex activity: [acty]), (abnormalities: [cgab]), (complex ii + iii: [aapp,enzy]), (ii: [gngm]), (disruption: []), (genes: [gngm]), (region: []), (however: []), (complex activity abnormalities: [cgab]), (specific gene deletions: [genf]), (effect: []), (regional deletions: [genf]), (adjacent gene expression: [genf]), (specific combination: [fndg]), (symptoms (autism: [mobd]), (disorder: [dsyn]), ( developmental regression: [dsyn]), (failure-to-thrive: [dsyn]), ( exercise intolerance/fatigue): [sosy]), (individuals: [humn]), (pattern: []), (symptoms: [sosy]), (data: [euka]), (mitochondrial abnormalities: [anab]), (pms individuals: [dsyn]), (results: [fndg]), (pathophysiology mechanisms: [patf]), (treatment targets: [topp]), (pms patients: [dsyn]), 
ASD Terms: 

PMCID: 4729132
SFARI Genes: Shank, SHANK, Shank, SHANK, Pvalb, Pvalb, Pvalb, Pvalb, Pvalb, Pvalb, Pvalb, Pvalb, Pvalb, Pvalb, Pvalb, Pvalb, Pvalb, Pvalb, Pvalb, Pvalb, 
Non SFARI Genes: 
Named Entities: (reduction: [npop]), (number: [qnco]), (parvalbumin (pv)-immunoreactive (pv+) gabaergic interneurons: [aapp,bacs]), (decrease: [qnco]), (pv immunoreactivity: [neop]), (several mouse models: [mamm]), (autism spectrum disorders: [mobd]), (shank: [gngm]), (mutant mice: [mamm]), (important gene families: [gngm]), (human asd: [humn]), (similar findings: [clna]), (heterozygous (pv+/-) mice: [mamm]), (pvalb gene: [gngm]), (robust asd-like phenotype: [cgab]), (here: []), (question: []), (observed reduction: [npop]), (result: [fndg]), (pv expression levels: [neop]), (loss: [qnco]), (pv-expressing gaba interneuron subpopulation hereafter: [aapp,bacs]), (neurons: [cell]), (alternatives: []), (important implications: []), (effects: []), (excitation/inhibition balance: [acty]), (decreased pv expression: [neop]), (enhanced inhibition: [acty]), (pvalb neuron subpopulation: [popg]), (reduced inhibition: [acty]), (stereology: []), (pvalb neurons: [cell]), (asd-associated brain regions: [cgab]), (medial prefrontal cortex: [celc]), ( somatosensory cortex: [bpoc]), (striatum: [bpoc]), (pv-/-: [neop]), ( pv+/-: [neop]), ( shank1-/-: [gngm]), (shank3b-/- mice: [mamm]), (second marker: [clna]), (identification: [menp]), (pvalb: [gngm]), (vicia villosa agglutinin: [aapp,bacs]), (lectin: [aapp,bacs]), (specific extracellular matrix: [tisu]), (pv protein: [neop]), (pvalb mrna levels: [bacs,nnon]), (western blot analyses: [lbpr]), (qrt-pcr: [mbrt]), ( respectively: []), (analyses: [resa]), (total cell numbers: [lbpr]), (different brain regions: [blor]), (pv+ neurons: [neop]), (cases: [qnco]), ( i.e.: [diap,inpr]), (pv+/-: [neop]), (pvalb mrna: [bacs,nnon]), (pv: [neop]), (indication: []), (neuronal cell decrease/loss: [fndg]), (unaltered numbers: [qnco]), (vva+ neurons: [cell]), (findings: [clna]), (pv system: [neop]), (convergent downstream endpoint: [qnco]), (forms: []), (asd: [cgab]), (towards: []), (inhibition: [acty]), (down-regulation: [moft]), (promising target: [diap]), (future pharmacological interventions: [hlca]), (approaches: []), (normal pv protein expression levels: [neop]), (pvalb neuron function: [phsf]), (asd-relevant phenotypes: [cgab]), (mice: [mamm]), (way: []), (novel therapeutic treatment strategies: [menp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 5310553
SFARI Genes: 
Non SFARI Genes: PC, 
Named Entities: (bergmann glia: [cell]), (specific type: [qnco]), (radial astrocytes: [cell]), (cerebellum: [bpoc]), (variety: []), (vital functions: []), (development: [orgf]), (structure: []), (however: []), (possible role: [socb]), (bg: [gngm]), (abnormalities: [cgab]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (consistent findings: []), (asd patients: [cgab]), (loss: [qnco]), (purkinje cells: [cell]), (defect: []), (dysregulation: []), (glutamate homeostasis: [orgf]), (moreover: []), (glial cells: [cell]), (long-term depression: [ortf]), (form: []), (plasticity: [npop]), (neuroprotective functions: [celf]), (aim: [phsu]), (review: []), (current knowledge: [npop]), (interactions: []), (pc: [gngm]), (special emphasis: []), (survival: [acty]), (proper functioning: []), (cerebellar neurons: [cell]), 
ASD Terms: (development of abnormalities, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(long-term depression, 'Depressive Disorder')

PMCID: 5363500
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (sex: [orgf]), (diagnostic evaluation: [diap]), (autism spectrum disorder: [mobd]), (male: [orga]), (female adults: [aggp]), (spectrum: [qnco]), (different symptom profiles: [lbpr]), (study: [resa]), (sex differences: [orga]), (clinical outcomes: []), (adults: [aggp]), ((935 males: [orga]), (females): [orga]), (autism spectrum disorder assessment: [mobd]), (significantly: []), (males: [orga]), (females (66%): [orga]), (subtype (x2: []), (p: [gngm]), (high-functioning autism spectrum disorder adults: [mobd]), (n: [aapp,imft]), (significant sex differences: [orga]), (severity: []), (socio-communicative domain symptoms: [socb]), (interests: [menp]), (females: [orga]), (d: [aapp,imft]), (multivariate analysis: [qnco]), (variance: [qnco]), (significant interaction: [qnco]), ((full-autism spectrum disorder/partial-autism spectrum disorder): [mobd]), (sex:: [orgf]), (full-autism spectrum disorder: [mobd]), ( males: [orga]), (severe socio-communicative symptoms: [socb]), (females;: [orga]), (partial-autism spectrum: [mobd]), (reverse: []), (prevalence: [qnco]), (co-morbid psychopathologies: []), (clinical sample: [sbst]), (suspected autism spectrum disorder: [mobd]), (sexes: [orgf]), (different manifestations: []), (autism spectrum disorder phenotype: [mobd]), (differences: [qnco]), (diagnostic subtype: [fndg]), (awareness: [menp]), (adult female repetitive: [popg]), (warrant attention: [menp]), (sex-specific diagnostic assessment tools: [orgf]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorder assessment, 'Autism Phenotype')(high-functioning autism spectrum disorder adults, 'Autism Phenotype')(autism spectrum disorder subtype, 'Autism Phenotype')(suspected autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorder phenotype, 'Autism Phenotype')

PMCID: 4723262
SFARI Genes: 
Non SFARI Genes: Cbl, Cbl, Cbl, 
Named Entities: (many studies: [lbpr]), (crucial role: [socb]), (vitamin b12: [orch,phsu,vita]), (folate-dependent enzyme methionine synthase (ms): [aapp,enzy]), (brain development: [ortf]), (function: [phsf]), (vitamin b12 status: [orch,phsu,vita]), (brain: [bpoc]), (lifespan: [grpa]), (vitamin b12 (cobalamin: [orch,phsu,vita]), ( cbl): []), (multiple forms: [qnco]), (methylcobalamin (mecbl): [orch,phsu,vita]), (adenosylcobalamin: [orch,phsu,vita]), (cofactors: [bacs]), (ms: [gngm]), (mutase: [aapp,enzy]), ( respectively: []), (levels: []), (cbl species: []), (postmortem: [diap]), (human frontal cortex: [humn]), (control subjects: [sbst]), (weeks: []), (fetal development: [phsf]), (years: []), (age: [orga]), (schizophrenic subjects: [humn]), (total cbl: [qnco]), (control: [sbst]), (yrs: [gngm]), (>10-fold age-dependent decline: [fndg]), (level: [phsu]), (mecbl: []), (inactive cyanocobalamin (cncbl): [orch,phsu,vita]), (fetal brain samples: [sbst]), (schizophrenic subjects mecbl: [humn]), (adocbl levels: [orch,phsu,vita]), (age-matched controls: [orga]), (autistic subjects: [mobd]), (decreased ms activity: [aapp,enzy]), (elevated levels: []), (substrate homocysteine (hcy): [aapp,bacs]), (low levels: [qnco]), (antioxidant glutathione (gsh): [aapp,bacs]), (autism: [mobd]), (schizophrenia: [mobd]), (mecbl levels: []), (glutamate-cysteine ligase modulatory subunit: [aapp,enzy]), ((gclm-ko) mice: [mamm]), (low gsh levels: [dsyn]), (findings: [clna]), (unrecognized decrease: [qnco]), (brain vitamin b12 status: [orch,phsu,vita]), (adaptation: [orgf]), (antioxidant demand: [phsu]), (deficits: []), (gsh deficiency: [dsyn]), (neuropsychiatric disorders: [dsyn]), 
ASD Terms: (vitamin b12, 'Dietary Supplements')(vitamin b12 status, 'Dietary Supplements')(years of age, 'Onset of Symptoms')(schizophrenic subjects, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenic subjects mecbl, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(brain vitamin b12 status, 'Dietary Supplements')(adaptation, 'Adaptive Life Skills')

PMCID: 4719705
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd) refers: [mobd]), (broad spectrum: [qnco]), (neurodevelopmental disorders: [mobd]), (central behavioral symptoms:: [sosy]), (social interaction: [fndg]), (social communication: [socb]), (repetitive behaviors: [fndg]), (however: []), (symptoms: [sosy]), (patients: [podg]), (number: [qnco]), (asd mouse models: [mamm]), (mutations: [genf]), (human patients: [humn]), (asd: [cgab]), (mouse model: [emod]), (unique set: [menp]), (review: []), (variations: []), (neural mechanisms: []), (electrophysiological features: [diap]), (potential neuronal mechanisms: [imft]), (role: [socb]), (cortico-basal ganglia-thalamic circuits: [bpoc]), (brain regions: [blor]), (understanding: [menp]), (circuitry mechanisms: []), (development: [orgf]), (effective treatments: []), (disorders: [dsyn]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder refers, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(social communication, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 4719563
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (evidence points: [qnco]), (critical role: [socb]), (early (prenatal): [aggp]), (atypical neurodevelopmental processes: [phpr]), (aetiology: []), (autism: [mobd]), (spectrum condition (asc): [dsyn]), (such process: [phpr]), (early neural development: [orgf]), (evidence: []), (atypical expression: [topp]), (molecular markers: [clna]), (amniotic fluid: [bdsu]), (cerebrospinal fluid (csf): [bdsu]), (brain parenchyma: [bpoc]), (role: [socb]), (inflammation: [patf]), (emergence: []), (asc: [gngm]), (number: [qnco]), (neuropathological studies: [lbpr]), (microglial activation: [celf]), (implications: []), (treatment: [topp]), (discussed: [socb]), 
ASD Terms: (early atypical neurodevelopmental processes, 'Learning Disorders')(autism, 'Autism Phenotype')(autism spectrum condition, 'Autism Phenotype')(cerebrospinal fluid, 'Hydrocephalus')

PMCID: 4726076
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (impaired: []), (social interaction: [fndg]), (defining feature: []), (autism spectrum: [mobd]), (neurodevelopmental disorder: [mobd]), (strong male preponderance: [orga]), (prevalence: [qnco]), (studies: [lbpr]), (neural circuits: [bpoc]), ( neuromodulators: [bacs]), (genetic factors: [fndg]), (social behaviors: [socb]), (mechanistic understanding: [menp]), (gender-specific social deficits: [orga]), (deletion: [genf]), (caspase-3 gene: [gngm]), (protease: [aapp,enzy,phsu]), (functions: [phsf]), (apoptosis: [celf]), (neural plasticity: [ortf]), ( alters: []), (specific social behaviors: [socb]), (male mice: [mamm]), (females: [orga]), (casp3/ mice: [mamm]), (normal behavioral responses: [inbe]), (cues: []), (food: [imft,phsu]), ( neutral chemical: [chem]), (biological sources: [fndg]), (casp3/ males: [aapp,enzy]), (robust social exploration: [topp]), (sociability: [socb]), ( recognition: [menp]), (preference: []), (enclosed novel mouse: [mamm]), (three-chamber test: [lbpr]), (however: []), ( casp3/ males: [aapp,enzy]), (social interaction behaviors: [socb]), (novel mouse: [mamm]), (interaction time: []), (mounting: []), (caspase-3: [aapp,enzy]), (subset: []), (similar hyper-locomotion: [mobd]), (male casp3/ mice: [mamm]), (social interaction deficits: [fndg]), (male bias: [orga]), (autism: [mobd]), 
ASD Terms: (autism spectrum, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(neurodevelopmental disorder, 'Learning Disorders')(mechanistic understanding of gender-specific social deficits, 'Ability to Converse in Social Settings')(social behaviors, 'Reciprocal Social Interaction')(gender-specific social deficits, 'Social Competence')(specific social behaviors, 'Reciprocal Social Interaction')(social interaction behaviors, 'Reciprocal Social Interaction')(social behaviors, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(social interaction deficits, 'Reciprocal Social Interaction')

PMCID: 4726047
SFARI Genes: 
Non SFARI Genes: RANBP1, RANBP1, 
Named Entities: (abnormal signaling: [celf]), (metabotropic glutamate receptor: [aapp,rcpt]), ((mglur5): [aapp,rcpt]), (pathophysiology: [patf]), (autism spectrum disorder (asd): [mobd]), ( fragile x syndrome: [cgab,dsyn]), (tuberous sclerosis: [neop]), (role: [socb]), (other mglurs: []), (network genes: [gngm]), (syndromic asd: [cgab]), (study: [resa]), (mglur copy number variants (cnvs): [nusq]), (children: [aggp]), (mglur second hit confers: [dsyn]), (additional risk: []), (asd: [cgab]), (deletion syndrome (22q11ds): [genf]), (mglur network cnvs: [nusq]), (microarrays: []), (asd (n: [cgab]), (patient categorization (syndromic vs nonsyndromic): [dsyn]), (blinded medical chart review: [hlca]), (mglur: []), (negative cases: [qnco]), (cnvs: [nusq]), (controls (p: [aapp,imft]), (mglur cnvs (74%: [nusq]), (p: [gngm]), (comparison cohort: [popg]), ((n: [aapp,imft]), (asd): [cgab]), (haploinsufficient: [comd]), (mglur network gene ranbp1: [gngm]), (second mglur hits: [fndg]), (+ asd: [cgab]), (hits: [gngm]), (mglur network genes: [gngm]), (22q11.2ds-asd (p: [cgab]), (ranbp1 expression: [topp]), (mechanistic link: []), (environmental forms: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(fragile x syndrome, 'Fragile X Syndrome')(tuberous sclerosis, 'Tuberous Sclerosis')(blinded medical chart review, 'Medications')

PMCID: 4719693
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (attention-deficit/hyperactivity disorder (adhd): [mobd]), (neurodevelopmental disorders: [mobd]), (environmental causes: []), (exposure: [clna]), (levels: []), (prenatal testosterone: [horm,orch,phsu]), (elevated traits: [gngm]), (asd: [cgab]), (adhd: [mobd]), (testosterone levels: [lbtr]), (dizygotic male twin fetus: [famg]), (testosterone exposure: [horm,orch,phsu]), (co-twins: [famg]), (prenatal testosterone hypothesis: [horm,orch,phsu]), (opposite-sex dizygotic twins: [orgf]), (respect: [socb]), (neurodevelopmental symptoms: [sosy]), (neuropsychiatric traits: [gngm]), (population-based twin cohort: [popg]), (child: [aggp]), (adolescent twin study: [resa]), (sweden (catss): []), (parental interviews: [acty]), (dizygotic twins: [famg]), (years: []), (autismtics: []), ( adhd: [mobd]), (other comorbidities inventory (a-tac): [diap]), (girls: [aggp]), (female co-twin: [famg]), (risk: []), (cut-off score: [clna]), (male co-twin: [famg]), (boys: [aggp]), (number: [qnco]), (traits: [gngm]), (attention deficit: [mobd]), (behaviors: [inbe]), (male twin: [famg]), (social interaction: [fndg]), (combined measures: [qnco]), ( however: []), (small effect sizes: [qnco]), (results: [fndg]), (previous study: [resa]), (adhd traits: [mobd]), (protective effect: []), (twin brother: [famg]), (effect: []), (parent report bias: [bird]), (unexpected effect: []), (intrauterine environment: [bsoj]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(neurodevelopmental disorders, 'Learning Disorders')(exposure, 'Exposures')(enhanced testosterone exposure, 'Exposures')(neurodevelopmental symptoms, 'Learning Disorders')(other comorbidities inventory, 'Comorbidities')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(social interaction, 'Reciprocal Social Interaction')(attention-deficit/hyperactivity disorder traits, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 4725892
SFARI Genes: 
Non SFARI Genes: ASD1, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disorder: [mobd]), (impairments: [patf]), (social interaction: [fndg]), (communication: [socb]), (repetitive patterns: []), (behavior: [inbe]), (order: [acty]), (individuals: [humn]), (asd: [cgab]), (initiate interventions: [hlca]), (possible age: [orga]), ( biomarkers: [clna]), (disorder: [dsyn]), (desirable: []), (research findings: [resa]), (widespread changes: [qnco]), (immune system: [bdsy]), (children: [aggp]), (autism: [mobd]), (cellular levels: [cell]), (attempt: [evnt]), (candidate antibody biomarkers: [aapp,imft]), (complex libraries: [mnob,orgt]), (peptoids: [aapp]), ((oligo-n-substituted glycines): [nnon,phsu]), (compounds: [chem]), (igg: []), (boys: [aggp]), ((td) boys: [aggp]), (unexpectedly: []), (many peptoids: [aapp]), (td boys: [aggp]), (levels: []), (igg1 subtype: [lbpr]), (serum: [bdsu]), (td: []), ((n =: [aapp,imft]), (adult males: [aggp]), (data: [euka]), (asd boys: [cgab]), (levels (>50%): [fndg]), (igg1 antibody: [celc]), (level: [phsu]), (advanced age: [popg]), (discovery: [acty]), (asd1 peptoid: [dsyn]), (accurate: []), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(repetitive patterns of behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')

PMCID: 4712554
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (dysfunctions: [dsyn]), (pi3k/mtor pathway: [aapp,enzy]), (lot: []), (attention: [menp]), (autism research: [mobd]), (discovery: [acty]), (several monogenic autism spectrum disorders: [mobd]), (mutations: [genf]), (defects: []), (pi3k/mtor: [aapp,enzy]), (components: []), (recent genetic studies: [resa]), (defective pi3k/mtor signaling: [aapp,enzy]), (shared pathomechanism: [socb]), (autism disorders: [mobd]), (unknown etiology: [fndg]), (functional molecular analyses: [hlca]), (human cells: [lbtr]), (goals: []), (study: [resa]), (functional screen: [hlca]), (cell lines: [cell]), (patients: [podg]), (idiopathic autism: [mobd]), (pi3k/mtor signaling: [aapp,enzy]), (further functional analyses: [hlca]), (molecular mechanisms: []), (approach: []), (biomarker tool: [clna]), (therapeutic targets: [diap]), (s6-specific elisa experiments: [lbpr]), (lymphoblastoid cell lines: [cell]), (agre collection: []), (simons simplex collection: [bpoc]), (healthy siblings: [famg]), (individual: [humn]), (increased s6 phosphorylation: [moft]), (multiplex family: [famg]), (further detail: []), (upstream defects: []), (pi3k: [gngm]), (autism diagnosis: [mobd]), (s6 phosphorylation: [moft]), (agre: []), (healthy control: []), (healthy sibling: [famg]), (further analysis: [resa]), (cells: [cell]), (elevated s6 phosphorylation: [moft]), (increased expression: [topp]), (catalytic subunit p110: [amas]), (lymphoblastoid cells: [cell]), (other autistic siblings: [famg]), (unaffected members: [popg]), (p110-selective inhibitor ic87114: [nnon]), (protein synthesis: [moft]), (cell line: [cell]), (results: [fndg]), (functional analysis: [hlca]), (disease-associated molecular defects: [dsyn]), (autism: [mobd]), (impaired signaling: [celf]), (molecular defect: []), (potential treatment target: [diap]), (select autism spectrum disorders: [mobd]), (p110 activity: [acty]), (schizophrenia: [mobd]), (p110: [gngm]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-015-0066-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism research, 'Autism Phenotype')(several monogenic autism spectrum disorders, 'Autism Phenotype')(autism disorders, 'Autism Phenotype')(idiopathic autism, 'Autism Phenotype')(autism diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')(select autism spectrum disorders, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 4745388
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (decades: [qnco]), (research: [resa]), (rapid alterations: []), (protein abundance: [aapp,bacs]), (synaptic plasticity: [ortf]), (cellular correlate: [cell]), (memory: [menp]), (control: [sbst]), (proteostasis: []), (complex neuronal morphology: [fndg]), (tortuous axon: [celc]), (extensive dendritic arbor: [celc]), (thousands: [qnco]), (individual synaptic compartments: [npop]), (spatiotemporal synthesis: [biof]), (proteins: [aapp,bacs]), ( neurons: [cell]), (transport: [celf]), (metabolism: [orgf]), (mrnas: [bacs,nnon]), (multiple levels: [qnco]), (regulation: [biof]), (rna: [nnon]), (control proteostasis: [sbst]), (translation: [moft]), (response: [fndg]), (synaptic activity: [acty]), (addition: []), (protein degradation: [moft]), (optimal proteostasis: []), (deviations: [fndg]), (excess: []), (insufficient abundance: []), (key synaptic factors: []), (pathologies: []), (such: []), ( mutations: [genf]), (components: []), (proteasomal: [aapp,enzy]), (translational machinery: [inpo]), (rbps: [gngm]), (pathogenesis: [patf]), (neurological disorders: [dsyn]), (fragile x syndrome (fxs): [cgab,dsyn]), ( fragile x tremor ataxia syndrome (fxtas): [dsyn]), (autism spectrum disorders: [mobd]), (review: []), (recent scientific findings: [clna]), (ongoing questions: []), (link: []), (basic molecular mechanisms: []), (common neuropsychiatric disorders: [dsyn]), 
ASD Terms: (memory, 'Working Memory')(neurological disorders, 'Neurologic Indications')(fragile x syndrome, 'Fragile X Syndrome')(fragile x tremor ataxia syndrome, 'Fragile X Syndrome')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 4707541
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (pathway: [moft]), (gene: [gngm]), (over-representation analysis (ora): [euka]), (routine task: []), (functional genomics: []), (however: []), (ora tools: [euka]), (statistical methods: [resa]), (fishers: [mamm]), (exact test: []), (list: []), (genes: [gngm]), (constitutive functional non-equivalent roles: [qnco]), (complex gene-gene interactions: [genf]), (here: []), (novel method: [lbpr]), (lego: []), ((functional link enrichment: []), (gene ontology: []), (consideration: [fndg]), (types: []), (information: []), (network-based gene weights: [orga]), (ora analysis: [resa]), (benchmarks: [qnco]), ( lego: []), (performance: [inbe]), (fisher: [mamm]), (other network-based methods: [popg]), (legos: []), (topology-based methods: []), (benchmark: [qnco]), (disease gene expression datasets: [genf]), (recent publication: [inpr,mnob]), (show: [anim]), (top-ranked methods: []), (terms: [orgf]), (sensitivity: [patf]), (prioritization: []), (target kegg pathways: [moft]), (addition: []), (cluster-and-filter approach: [qnco]), (redundancy: []), (enriched gene sets: [gngm]), (results: [fndg]), (lists: []), (autism genes: [gngm]), (relevant gene sets: [gngm]), 
ASD Terms: (autism genes, 'Autism Phenotype')

PMCID: 4736967
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (hundreds: []), (genes: [gngm]), (autism spectrum disorders: [mobd]), (interaction: []), (variants: []), (distinct autistic phenotypes: [mobd]), (spectrum.: [qnco]), (convergence: [acty]), (networks: []), (synaptic function warrants: [phsf]), (study: [resa]), (cell: [gngm]), (pathways: [moft]), (regulation: [biof]), (synapse: [bsoj]), (wnt/-catenin: [aapp,bacs]), (pathway: [moft]), (central role: [socb]), (development: [orgf]), (central nervous system: [bdsy]), (several genes: [famg]), (cascade: []), (asds: [cgab]), (present paper: [qnco]), (basic information: []), (role: [socb]), (excitatory/inhibitory balance (e/i balance): [inch]), (pre-: [mamm]), (postsynaptic compartments: [npop]), (information: []), (glycogen synthase: [aapp,enzy]), ((gsk3): [aapp,enzy]), (onset/development: [qnco]), (direct modulation: []), (wnt/-catenin signaling: [celf]), (finally: []), (gsk3 activity: [aapp,enzy]), (key modulator: []), (synaptic plasticity: [ortf]), (potential: []), (kinase: [aapp,enzy]), (therapeutic target: [diap]), (asd: [cgab]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 4705753
SFARI Genes: 
Non SFARI Genes: impact, impact, 
Named Entities: (autism spectrum disorders: [mobd]), (group: [popg]), (neurodevelopmental disorders: [mobd]), (interaction: []), (genetic vulnerability: [topp]), (environmental factors: []), (micrornas (mirnas): [bacs,nnon]), (key posttranscriptional regulators: []), (multiple aspects: [qnco]), (brain development: [ortf]), (function: [phsf]), (previous studies: [lbpr]), (mirnas expression: [bacs,nnon]), (asd: [cgab]), (non-neural cells: [cell]), (lymphoblastoid cell lines: [cell]), (postmortem tissues: [tisu]), (however: []), (relevance: []), (lcls: []), (context: [fndg]), (neurodevelopmental disorder: [mobd]), (impact: [gngm]), (cause: []), (death: [orgf]), (and/or post-death handling: [fndg]), (tissue: [tisu]), (variations: []), (studies: [lbpr]), (brain samples: [bpoc]), (mirna: [bacs,nnon]), (tlda: []), (high-throughput real-time qpcr: [mbrt]), (mirnas: [bacs,nnon]), (olfactory mucosal stem cells: [tisu]), (patients: [podg]), (controls: [sbst]), (neural stem cells: [cell]), (living patients: [podg]), (purpose before: []), (real-time pcr: [mbrt]), (set: [menp]), (bioinformatics analysis: [resa]), (common pathways: [moft]), (gene targets: [gngm]), (luciferase assays: [aapp,enzy,irda]), (real-time pcr analysis: [mbrt]), (effect: []), (mirnas misregulation: [bacs,nnon]), (expression: [topp]), (translation: [moft]), (several autism-related transcripts: [mobd]), (viral vector-mediated expression: [topp]), (mirnas deregulation: [bacs,nnon]), (glial cells: [cell]), (signature: [amas]), (mirnas (mir-146a: [bacs,nnon]), ( mir-221: [gngm]), ( mir-654-5p: [nusq]), (mir-656): []), (primary skin fibroblasts: [cell]), (intellectual disability samples: [mobd]), (putative target genes: [gngm]), (pathways: [moft]), (levels: []), (neuronal transcripts: [nnon]), (patients cells: [podg]), (mouse: [mamm]), (mir-221 display: [gngm]), (strong neuronal expression: [topp]), (regions: []), (high cognitive functions: [menp]), (abnormal mir-146a expression: [topp]), (mouse primary cell: [mamm]), (neuronal dendritic arborization: [ortf]), (astrocyte glutamate uptake capacities: [aapp,bacs]), (independent replication experiments: [genf]), (early biomarkers: [clna]), (findings: [clna]), (important diagnostic implications: [fndg]), (mechanistic connection: []), (mirna dysregulation: [bacs,nnon]), (asd pathophysiology: [cgab]), (new opportunities: []), (therapeutic: [topp]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-015-0064-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(intellectual disability samples, 'Learning Disorders')(high cognitive functions, 'Cognitive Ability')

PMCID: 4705475
SFARI Genes: 
Non SFARI Genes: RYR2, PTDSS1, AREG, 
Named Entities: (autism spectrum disorders (asds): [mobd]), (group: [popg]), (neurodevelopmental disorders: [mobd]), (ritualistic-repetitive behaviors: []), (non-verbal communication: [menp]), (objectives: []), (contribution: [acty]), (genetic variation: [npop]), (asds: [cgab]), (lebanese: [popg]), (affymetrix cytogenetics: []), (m: [aapp,imft]), (cytoscan hd arrays: []), (cnvs: [nusq]), (lebanese autistic children: [podg]), (disabled patients: [podg]), (normal participants: [popg]), (controls: [sbst]), (inherited cnvs: [nusq]), (duplications: []), (deletions: [genf]), (duplication: [comd]), (likely pathogenic encompasses ryr2: [aapp,rcpt]), (potential asd candidate gene: [cgab]), (cnv: [nusq]), (pathogenic: [fndg]), ( and: []), (uncertain significance: [fndg]), (unknown significance: [fndg]), (modulator: []), (phenotypic disease expression: [dsyn]), (rett syndrome: [dsyn]), (novel potential autism susceptibility genes ptdss1: [mobd]), (areg: [gngm]), (functional analyses: [hlca]), (novel genetic targets: [diap]), (asd: [cgab]), (lebanese families: [famg]), (autism: [mobd]), (findings: [clna]), (improved diagnosis: [fndg]), (genetic counseling: [topp]), (untapped therapeutic targets: [diap]), (non-lebanese patients: [clna]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')(rett syndrome, 'Rett Syndrome')(novel potential autism susceptibility genes ptdss1, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(diagnosis, 'Diagnosis')(improved diagnosis, 'Diagnosis')

PMCID: 4849199
SFARI Genes: 
Non SFARI Genes: Mb, 
Named Entities: (deletion syndrome: [genf]), (recurrent: []), (mb deletion: [genf]), (incidence: [qnco]), (deletion: [genf]), (rare (1: [fndg]), (phenotype: [orga]), (range: [qnco]), (phenotypic manifestations: [orga]), (online registry (3q29deletion.org): []), (ascertainment: []), (study subjects: [humn]), (phenotypic data collection: [resa]), (survey instruments: []), (data: [euka]), (months: []), (registry operation: [acty]), (patients: [podg]), (cohort: [popg]), (deletion carriers: [genf]), (systematic way: []), (data reveal: [euka]), (registry participants report: [hlca]), (neuropsychiatric phenotypes: [orga]), (anxiety disorder: [mobd]), (panic attacks: [mobd]), ( depression: [mobd]), (bipolar disorder: [mobd]), (schizophrenia: [mobd]), (other novel findings: [clna]), (high prevalence (64%): [qnco]), (problems: []), (infancy: []), (reduced weight: [orga]), (birth: [orgf]), (reduction: [npop]), (oz (394 g): [qnco]), (gestational age: [orga]), (sex: [orgf]), ( p: [aapp,imft]), (report: [hlca]), (frequency: [qnco]), (heart defects: [cgab]), (autism: [mobd]), ( recurrent ear: [bpoc]), (infections: [patf]), ( gastrointestinal phenotypes: [orga]), (dental phenotypes: [hlca]), (others: [fndg]), (expected timing: []), (delayed developmental milestones: [fndg]), (comprehensive description: []), (deletion phenotype: [genf]), (results: [fndg]), (patient care: [hlca]), (expectations: []), (physicians: []), (parents: []), (value: [qnco]), (patientreported outcomes: []), (full phenotypic spectrum: [orga]), (rare genomic disorders: [dsyn]), (authors: []), (american journal: [inpr,mnob]), (medical genetics part a: [qnco]), (wiley periodicals: []), ( inc: []), 
ASD Terms: (anxiety disorder, 'Anxiety Disorders')(panic attacks, 'Anxiety')(depression, 'Depressive Disorder')(bipolar disorder, 'Bipolar Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(infancy, 'Perinatal History')(gestational age, 'Perinatal History')(autism, 'Autism Phenotype')(expected timing of delayed developmental milestones, 'Learning Disorders')(delayed developmental milestones, 'Learning Disorders')(medical genetics part, 'Medications')(medical genetics part a, 'Medications')

PMCID: 5068870
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (multiple studies: [lbpr]), (risk: []), (prenatal antidepressant exposure: [phsu]), (autism spectrum disorder (asd): [mobd]), (attention-deficit hyperactivity disorder (adhd): [mobd]), (inconsistent results: [fndg]), (such risk: []), (any: []), (great importance: [qnco]), (light: [gngm]), (need: []), (benefit: [qnco]), (depression: [mobd]), (anxiety treatment: [fndg]), (method: [lbpr]), (data: [euka]), (multiple new england health systems: [qnco]), (maternal health data: [qnco]), (electronic health records: []), (diagnoses: [fndg]), (medication exposure: [fndg]), (children: [aggp]), (asd: [cgab]), (adhd: [mobd]), (neurodevelopmental disorders: [mobd]), (association: [menp]), (maternal antidepressant exposure: [phsu]), (adhd liability: [mobd]), (logistic regression: [resa]), (psychiatric confounding variables: [hlca]), (new cohorts: [popg]), (asd cases: [cgab]), (adhd cases: [mobd]), (socioeconomic status: []), (controls: [sbst]), (disorder: [dsyn]), (crude: []), (models: []), (odds: []), (confidence interval: [qnco]), (asd;: [cgab]), (adhd): [mobd]), (pre-pregnancy antidepressant exposure: [phsu]), (disorders: [dsyn]), (results: [fndg]), (prior reports: [hlca]), (neurodevelopmental disease: [mobd]), (false-positive finding: [lbtr]), (part: [qnco]), (confounding: []), (indication: []), (potential: []), (electronic health records studies: [lbpr]), (multiple health systems: [qnco]), (efficient pharmacovigilance investigation: [hlca]), 
ASD Terms: (prenatal antidepressant exposure, 'Exposures')(autism spectrum disorder, 'Autism Phenotype')(attention-deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(depression, 'Depressive Disorder')(anxiety treatment, 'Anxiety Disorders')(medication exposure, 'Medications')(neurodevelopmental disorders, 'Learning Disorders')(maternal antidepressant exposure, 'Exposures')(attention-deficit hyperactivity disorder liability, 'Attention Deficit Disorder with Hyperactivity')(prenatal antidepressant exposure, 'Exposures')(attention-deficit hyperactivity disorder cases, 'Attention Deficit Disorder with Hyperactivity')(pre-pregnancy antidepressant exposure, 'Exposures')(neurodevelopmental disease, 'Learning Disorders')

PMCID: 5068868
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (several gene expression experiments: [genf]), (autism spectrum disorders: [mobd]), (blood: [bdsu]), (brain tissue: [bpoc]), (individually: []), (studies: [lbpr]), (understanding: [menp]), (molecular systems: []), (molecular pathology: [lbpr]), (autism: [mobd]), (bases: [inch]), (work: []), (autism biomarkers: [mobd]), (study: [resa]), (integrated systems: [genf]), (biology analysis: [resa]), (independent gene expression experiments: [genf]), (mental retardation: [mobd]), (developmental delay: [mobd]), (control samples: []), (common signature exists: [amas]), (regulatory patterns: []), (brain relevant: [bpoc]), (matrix: [phsu]), (genes: [gngm]), (experiments: [resa]), (jaccard coefficient: [qnco]), (gene-based phylogeny: [gngm]), (bootstrap: []), (expected: []), ( experiments: [resa]), (tissue types: [lbpr]), (high statistical confidence: [qnco]), (however: []), (significant subgrouping: [qnco]), (brain data sets: [bpoc]), (different experiments: [resa]), (correlated regulatory pattern: []), (root: [bpoc]), (potential etiologic relevance: []), (enriched roles: [socb]), (neurological processes: [phpr]), (normal brain growth: [orgf]), (learning: [menp]), (memory: [menp]), (social behavior: [socb]), (cognition: [menp]), (results: [fndg]), (detectable autism signature: [amas]), (molecular echo: [topp]), (autism-related dysregulation: [mobd]), (brain: [bpoc]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(build autism biomarkers, 'Autism Phenotype')(mental retardation, 'Mental Retardation')(developmental delay, 'Learning Disorders')(neurological processes, 'Neurologic Indications')(memory, 'Working Memory')(social behavior, 'Reciprocal Social Interaction')(cognition, 'Cognitive Ability')(detectable autism signature, 'Autism Phenotype')

PMCID: 4914424
SFARI Genes: MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, 
Non SFARI Genes: Cdc42, 
Named Entities: (human met gene: [humn]), (replicated risk: []), (autism spectrum disorder (asd): [mobd]), (functional integrity: [inbe]), (brain: [bpoc]), (met: [gngm]), (receptor tyrosine kinase: [aapp,enzy,rcpt]), ( met: [dsyn]), (pleiotropic role: [socb]), (embryogenesis: [ortf]), (large number: [qnco]), (neurodevelopmental events: [evnt]), (known: []), ( however: []), (engages: []), (distinct cellular events: [evnt]), (brain development: [ortf]), (asd-relevant disease domains: [cgab]), (met protein expression: [aapp,rcpt]), (neurons: [cell]), (neuronal growth cones: [orgf]), (early developmental stages: []), (activation: [acty]), (small gtpase cdc42: [aapp,enzy]), (neuronal growth: [orgf]), (dendritic arborization: [ortf]), (spine formation: [bpoc]), (genetic ablation: [topp]), (mouse dorsal pallium: [mamm]), (neuronal morphology indicative: [fndg]), (early functional maturation: [aggp]), (contrast: [irda]), (prolonged activation: [acty]), (formation: [biof]), (functional maturation: [phsf]), (glutamatergic synapses: [bsoj]), (moreover: []), (met signaling levels: [celf]), (vivo: []), (developing prefrontal projection neurons: [cell]), (local circuit connectivity: []), (therefore: []), (normal time-delimited met signaling: [celf]), (timing: []), ( glutamatergic synapse maturation: [ortf]), (cortical circuit function: [bpoc]), (pathological changes: [qnco]), (forebrain maturation: [ortf]), (connectivity: []), (contribute: [acty]), (emergence: []), (neurological symptoms: [sosy]), (asd: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental events, 'Learning Disorders')(neurological symptoms, 'Neurologic Indications')

PMCID: 4701386
SFARI Genes: CBP, p300, CBP, p300, CBP, CBP, CBP, CBP, CBP, CBP, CBP, p300, CBP, p300, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (group: [popg]), (neurodevelopmental afflictions: [ortf]), (repetitive behaviors: [fndg]), ( deficits: []), (social interaction: [fndg]), (impaired communication skills: [orga]), (asd: [cgab]), (underlying causes: []), (genetic mutations: [genf]), (percent: [qnco]), (asd cases: [cgab]), (mutations: [genf]), (epigenetic regulators: []), (chromatin: [aapp]), (dna function: [phsf]), (critical component: []), (histone acetyltransferase creb binding protein (cbp: [aapp]), ( crebbp): []), (rubinstein-taybi syndrome: [cgab,dsyn]), (developmental disorder: [mobd]), (asd-like symptoms: [cgab]), (recently: []), (genomic studies: [gngm]), (large numbers: [qnco]), (asd patient families: [cgab]), (cbp: [gngm]), (paralog p300 (ep300): [aapp,bacs]), (critical hubs: [gngm]), (asd-associated protein: [cgab]), (gene interaction networks: [moft]), (missense mutations: [genf]), (conserved residues: [evnt]), (cbp acetyltransferase: [aapp,enzy]), (ch1 domains: [gngm]), (animal model evidence: [emod]), (notion: []), (ch1 domain: [gngm]), (mice: [mamm]), (deletion mutation: [genf]), (cbp ch1 (taz1) domain (cbpch1/ch1): [gngm]), (rts-like phenotype: [orga]), (asd-relevant repetitive behaviors: [cgab]), ( hyperactivity: [mobd]), (social interaction deficits: [fndg]), ( motor dysfunction: [fndg]), (impaired recognition memory: [menp]), (abnormal synaptic plasticity: [ortf]), (results: [fndg]), (loss: [qnco]), (cbp ch1 domain function: [phsf]), (rts: [gngm]), (domain: []), (essential role: [socb]), (normal motor: [fndg]), (function: [phsf]), ( cognition: [menp]), (social behavior: [socb]), (key physiological functions: []), (asd-associated mutation: [cgab]), (findings: [clna]), (theoretical models: []), (p300: [gngm]), (causative role: [socb]), (asd-associated cbp mutations: [cgab]), 
ASD Terms: (neurodevelopmental afflictions, 'Learning Disorders')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(social interaction, 'Reciprocal Social Interaction')(autism spectrum disorders, 'Autism Phenotype')(impaired communication skills, 'Reciprocal Social Interaction')(asd-relevant repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(hyperactivity, 'Overactivity')(social interaction deficits, 'Reciprocal Social Interaction')(motor dysfunction, 'Motor Skills')(impaired recognition memory, 'Working Memory')(cognition, 'Cognitive Ability')(social behavior, 'Reciprocal Social Interaction')

PMCID: 4700739
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disease: [mobd]), (children: [aggp]), (etiology: []), (neuroinflammation: []), (disease development: [dsyn]), (great attention: [menp]), (pro-inflammatory cytokines: [aapp,bacs]), (several studies: [lbpr]), (dysfunction unbalance: [dsyn]), (serum: [bdsu]), (brain: [bpoc]), (present work: [qnco]), (putative dysregulation: []), (pro-inflammatory cytokine: [aapp,bacs]), (il-1 family: [aapp,imft]), (sera: [gngm]), (patients: [podg]), (asd: [cgab]), (different grades: []), (healthy controls: []), (postmortem brain samples: [bpoc]), (tuberous sclerosis: [neop]), (acute inflammatory diseases: [dsyn]), (moreover: []), (quantitative analysis: [resa]), (il-18: [gngm]), (reeler: []), (experimental model: []), (autism: [mobd]), (serum il-18 levels: [aapp,imft]), (elisa: [lbpr]), (immunohistochemical analysis: [resa]), (brain sections: [bpoc]), (encephalitis patients: [dsyn]), (age-matched controls: [orga]), (wild-type mice: [mamm]), (western blots: [lbpr]), (homogenates: []), (wild-type mice brains: [bpoc]), (il-18 binding protein (il-18bp): [aapp,bacs]), (wild-type mice plasma: [bdsu]), (brains (sections: [bpoc]), (homogenates): []), (il-18 content: [aapp,imft]), (healthy subjects: [popg]), (reeler sera: [bdsu]), (wild-type controls: [gngm]), (glial cells: [cell]), (neurons: [cell]), (subjects: [humn]), (encephalitis whereas: [dsyn]), (weak il-18 positivity: [aapp,imft]), (level: [phsu]), (western blot: [lbpr]), (amounts: [qnco]), (reeler brain homogenates: [bpoc]), (wild-type littermates: [gngm]), (il-18bp: [aapp,bacs]), (reeler brain: [bpoc]), (significant difference: [qnco]), (il-18bp plasma levels: [bdsu]), (asd patients: [cgab]), (further studies: [lbpr]), (molecular details: []), (il-18 increase: [aapp,imft]), (il-18 decrease: [aapp,imft]), (increase: []), (size: []), (patient cohort: [podg]), (decreased il-18 content: [aapp,imft]), (predictive biomarker: [clna]), (measure: [qnco]), (combination: [fndg]), (other markers: [clna]), (increased levels: [qnco]), (brain-derived neurotrophic factor (bdnf)): [aapp,bacs]), (diagnostic panel: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disease, 'Learning Disorders')(tuberous sclerosis, 'Tuberous Sclerosis')(autism, 'Autism Phenotype')

PMCID: 4864049
SFARI Genes: 
Non SFARI Genes: impact, impact, impact, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (complex neurodevelopmental disorder: [mobd]), (wide range: [qnco]), (behavioral abnormalities: [mobd]), (genetic research: [resa]), (large numbers: [qnco]), (genes: [gngm]), (asd phenotypes: [cgab]), (evidence: []), (environmental factors: []), (asd: [cgab]), (influences: []), (brain: [bpoc]), (epigenetic mechanisms: [genf]), (genetic mutations: [genf]), (epigenetic influences: []), (gene expression: [genf]), (different cell types: [cell]), (mutations: [genf]), (expression: [topp]), (downstream consequences: []), (specific pathways: [moft]), (mutation: [genf]), (sets: [menp]), (methylation/hydroxymethylation: [moft]), (local histone modification patterns: [aapp,bacs]), (chromatin remodeling: [genf]), (herein: []), (recent developments: [orgf]), (research: [resa]), (focus: []), (epigenetic pathways: [moft]), (complement: [aapp,imft]), (current genetic screening: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(complex neurodevelopmental disorder, 'Learning Disorders')(behavioral abnormalities, 'Personal Traits')(asd phenotypes, 'Autism Phenotype')(focus on epigenetic pathways, 'Attention and Focus')

PMCID: 4724675
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objectives:: []), (possible association: [menp]), (oxytocin: [aapp,horm,phsu]), (melatonin levels: [horm,orch,phsu]), (severity: []), (cognitive dysfunctions: [mobd]), (correlation: []), (parameters: [fndg]), (children: [aggp]), (autism: [mobd]), (methods:: []), (case-control study: [resa]), (department: [orgt]), (chemistry: [lbpr]), (biochemistry: []), ( college: []), (medicine: [phsu]), ( al-nahrain university: [mnob,orgt]), ( baghdad: []), ( iraq: []), (study: [resa]), (male autistic patients: [mobd]), (pediatric department: [hcro]), (al-sader general hospital: [hcro,mnob]), (november: []), (april: [gngm]), (levels: []), (melatonin: [horm,orch,phsu]), (serum: [bdsu]), (autistic male patients: [mobd]), (mild: []), ( moderate: []), (severe (20 patients: [podg]), (gender-matched control subjects: [orga]), (data: [euka]), (oxytocin (44.72: [aapp,horm,phsu]), (iu/ml): [qnco]), (patients: [podg]), (pg/ml): [qnco]), ((p<0.05): [fndg]), (age-matched (102.1: [orga]), (gender-matched controls: [orga]), (disease: [dsyn]), (significant decrease: [qnco]), (oxytocin (47: [aapp,horm,phsu]), (moderate (20: [fndg]), (severe oxytocin (27.92: [aapp,horm,phsu]), (severe melatonin (21.69: [horm,orch,phsu]), (mild autistic patients: [mobd]), (oxytocin (59.22: [aapp,horm,phsu]), (melatonin (27.55: [horm,orch,phsu]), (significant positive correlation: [fndg]), (moderate (r=0.513; p=0.021): [fndg]), (severe patients: [podg]), (p=0.005): [fndg]), (conclusion: receiver: []), (characteristic analysis: [resa]), (good diagnostic marker: [clna]), (severe autistic patients: [mobd]), (autistic subgroups: [mobd]), (possibility: []), (diagnosis: [fndg]), (markers: [clna]), (autism severity: [mobd]), 
ASD Terms: (cognitive dysfunctions, 'Cognitive Ability')(autism, 'Autism Phenotype')(al-sader general hospital, 'Hospitalizations')(autism severity, 'Autism Phenotype')(diagnosis, 'Diagnosis')

PMCID: 4996332
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (etiology: []), (autism spectrum disorder (asd): [mobd]), (findings: [clna]), (importance: []), (environmental influences: []), (however: []), (recent twin studies: [famg]), (strong genetic effects: [topp]), (liability: []), (finding consistent: [sosy]), (previous reports: [hlca]), (study: [resa]), (systematic review: []), (metaanalysis: [resa]), (twin studies: [famg]), (asd: [cgab]), (date: []), (continuum: []), (quantitative measure: [qnco]), (pubmed central: [lbpr]), ( science direct: []), ( google scholar: []), ( web: []), (knowledge: []), (search: [acty]), (online: []), (thirteen: [qnco]), (primary twin studies: [famg]), (systematic recruitment criterion; correction: [acty]), (selection: [genf]), (ascertainment strategies: [menp]), (applied prevalences: [qnco]), (studies: [lbpr]), (quantile df: [qnco]), (analysis: [resa]), (childhood autism spectrum test scores: [clna]), (population sample: [popg]), (twin pairs: [famg]), (twins: [famg]), (metaanalysis correlations: [resa]), (monozygotic twins: [famg]), (.98 (95% confidence interval: [qnco]), ( .96.99): []), (dizygotic (dz) correlation: []), ( however: []), (.53 (95% ci .44.60): [fndg]), (asd prevalence rate: [qnco]), ((in line: [gngm]), (broad phenotype: [orga]), (asd): [cgab]), ((95% ci .61.72): [lbpr]), (prevalence rate: [qnco]), (metaanalytic heritability estimates: [resa]), (environmental effects: [npop]), (df: [gngm]), (departure: [acty]), (linearity: []), (heritability: []), (that: (a) asd: [cgab]), (strong genetic effects; (b): [topp]), (function: [phsf]), (prevalence rate; (c): [qnco]), (statistical artefact: [hcpp]), (overinclusion: [mobd]), (concordant dz twins: [famg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(childhood autism spectrum test scores, 'Autism Phenotype')

PMCID: 4706891
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (severe neurodevelopmental disorder: [mobd]), (many susceptible causative genes: [gngm]), (previous reports: [hlca]), (relationship: []), (human leukocyte antigen (hla) gene: [gngm]), (etiology: []), (order: [acty]), (hla-b alleles: [gngm]), (thai population: [popg]), (frequency: [qnco]), (hla-b allele: [gngm]), (autistic subjects: [mobd]), (normal subjects: [fndg]), (two-stage sequence-specific oligonucleotide probe system: [topp]), ((pcr-ssop) method: [mbrt]), (flow-cytometry technology: [lbpr]), (hla-b: [gngm]), ((p: [aapp,imft]), (or: []), (alleles: [gngm]), (moreover: []), (normal controls: []), (protective role: [socb]), (disease development: [dsyn]), (hla-b genotypes: [lbtr]), (autistic patients: [mobd]), (significant relationship: [qnco]), (control groups: [grup]), (first report: [qnco]), (thai autism: [mobd]), (marker: [clna]), (genetic susceptibility: [orga]), 
ASD Terms: (autism, 'Autism Phenotype')(severe neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(human leukocyte antigen gene, 'Allergies')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(thai autism, 'Autism Phenotype')

PMCID: 5660893
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (klinefelter syndrome (47: [cgab,dsyn]), (xxy): []), (physical: [hlca]), ( behavioral: [inbe]), (cognitive consequences: []), (deviations: [fndg]), (brain structure: [bpoc]), (function: [phsf]), (structural characteristics: []), (white matter: [tisu]), (exploratory diffusion tensor: [npop]), (study: [resa]), (white matter microstructure: [tisu]), (boys: [aggp]), (non-clinical: []), ( male controls: [orga]), (additionally: []), (similarities: []), (differences: [qnco]), (autism spectrum disorders: [mobd]), (cognition: [menp]), ( behavior: [inbe]), (neural architecture: []), (brain-behavior pathways: [inbe]), (asd: [cgab]), (fractional anisotropy (fa): [npop]), (radial diffusivity (dr): [bodm]), (axial diffusivity (da): [anab]), (mean diffusivity (md): [qnco]), (asd (n =: [cgab]), (controls (n: [aapp,imft]), (tract-based spatial statistics: [gngm]), (controls: [sbst]), ( boys: [aggp]), (fa: [gngm]), (reduced da: [anab]), (corpus callosum: [bpoc]), (dr: [bodm]), (left: []), (anterior corona radiata: [bpoc]), (sagittal striatum: [bpoc]), (show: [anim]), (da: [anab]), (right inferior fronto-occipital fasciculus: [bpoc]), (small sample size: [qnco]), (white matter integrity: [tisu]), (contributing factor: [acty]), (cognitive: []), (behavioral problems: [mobd]), (understanding: [menp]), (mechanisms: []), (behavioral outcome: [inbe]), (social dysfunction: [dsyn]), (intervention: [hlca]), 
ASD Terms: (cognitive consequences, 'Cognitive Ability')(autism spectrum disorders, 'Autism Phenotype')(cognition, 'Cognitive Ability')(cognitive, 'Cognitive Ability')(behavioral problems, 'Personal Traits')(behavioral outcome in social dysfunction, 'Personal Traits')(social dysfunction, 'Social Competence')

PMCID: 5068589
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (copy number: [qnco]), (duf1220: []), (protein domain: [amas]), (human brain evolution: [humn]), (autism severity: [mobd]), (possibility: []), (autism: [mobd]), (schizophrenia: [mobd]), (present study: [qnco]), (duf1220 copy number variation: [nusq]), (schizophrenia severity: [mobd]), (notable similarities: []), (autism symptoms: [mobd]), (schizophrenia negative symptoms: [mobd]), (divergence: []), (positive symptoms: [sosy]), (duf1220 copy number: [qnco]), (schizophrenia subgroups: [mobd]), (positive symptom features: [clna]), (autistic individuals: [mobd]), (controls: [sbst]), (schizophrenic population (n=609): [popg]), (positive symptom severity (con1 p=0.013: [fndg]), ( hls1 p=0.0227): [dsyn]), (association: [menp]), (adult-onset schizophrenia (con1 p=0.00155: [mobd]), ( hls1 p=0.00361): [dsyn]), (schizophrenic males: [orga]), ( duf1220 con1 subtype copy number increase: [qnco]), (increased negative symptom severity: [fndg]), (finding: [sosy]), (autistic populations: [mobd]), (subgroup: [virs]), (schizophrenic individuals: [humn]), (reduced con1 copy number: [qnco]), (negative symptoms: [fndg]), (findings: [clna]), (view: []), (schizophrenia exhibit: [mobd]), (phenotypes: [orga]), (disease continuum: [dsyn]), ( (2) variation: [qnco]), (duf1220 copy number contributes: [acty]), (disease risk: [fndg]), (severity: []), (disorders: [dsyn]), ((3) schizophrenia: [mobd]), (part: [qnco]), (harmful by-product: [qnco]), (extreme evolutionary increase: [genf]), (human species: [humn]), 
ASD Terms: (autism severity, 'Autism Phenotype')(autism, 'Autism Phenotype')(schizophrenia severity, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism symptoms, 'Complaints and Indications')(autism symptoms, 'Complaints and Indications')(schizophrenia negative symptoms, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia subgroups, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenic population, 'Schizophrenia and Disorders with Psychotic Features')(adult-onset schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenic males, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenic individuals, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(schizophrenia exhibit, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia disease risk, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 4909589
SFARI Genes: Tbx1, Tbx1, 
Non SFARI Genes: 
Named Entities: (critical step: [qnco]), (autism: [mobd]), (spectrum disorder (asd): [cgab]), (environmental risk factors: []), (number: [qnco]), (rare copy number variants: [nusq]), (robust genetic risk factors: []), (asd: [cgab]), (cnv carriers: [nusq]), (severity: []), (asd symptoms varies: [cgab]), (evidence exists: []), (various environmental factors: [phsu]), (symptomatic severity: []), (precise mechanisms: []), (factors: []), (ultimate severity: []), (here: []), (mouse: [mamm]), (tbx1 (a gene: [gngm]), (cnv): [nusq]), (genetically-triggered neonatal phenotype: [clna]), (vocalization: [fndg]), (negative environmental loop: [fndg]), (pup-mother social communication: [famg]), (wild-type pups: [gngm]), (diverse sequences: [nusq]), (call types: [menp]), (heterozygous pups: [orga]), (invariable call sequences: [nusq]), (back: [blor]), (representative wild-type call sequences: [nusq]), (maternal approach: [famg]), (heterozygous call sequences: [nusq]), (randomized: [resa]), (vigorous maternal approach behavior: [socb]), (data demonstrate: [euka]), (asd risk gene alters: [cgab]), (neonatal call sequence: [nusq]), (carriers: [fndg]), (pup phenotype: [orga]), (turn diminishes: [qnco]), (maternal care: [hlca]), (atypical social communication: [socb]), (thus: []), (asd risk gene: [cgab]), (atypical neonatal call sequences: [nusq]), (optimal maternal care: [hlca]), (negative neonatal environmental factor: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(asd symptoms varies, 'Complaints and Indications')(vocalization, 'Vocalizations')(pup-mother social communication, 'Reciprocal Social Interaction')(atypical social communication, 'Reciprocal Social Interaction')

PMCID: 4690969
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mothers: [famg]), (autism spectrum disorders (asd): [mobd]), (mild forms: []), (childrens cognitive characteristics: []), (prenatal brain exposure: [bpoc]), (sensitivity: [patf]), ((t): [clna]), (indeed: []), (cognition: [menp]), (hyper-systemizing: [mobd]), ( outperforming: []), (tests: [lbpr]), (cognitive domains: []), (selective attention: [menp]), (fine motor: []), (visuospatial skills: [inbe]), (general population: [popg]), (mid-forties: [qnco]), (study: [resa]), (middle-aged women: [aggp]), (biological mothers: [famg]), (individuals: [humn]), (asd: [cgab]), (performance: [inbe]), (aforementioned cognitive skills: [inbe]), (normative children: [aggp]), (groups: [popg]), (mean age: [orga]), (standardized stroop: []), (mirror-drawing tests: [lbpr]), (role: [socb]), (t: [clna]), (aforementioned tests: [lbpr]), (asd mothers: [famg]), (controls: [sbst]), (correct answers: []), (mistakes: []), (addition: []), (t levels: []), (cognitive performance: [inbe]), (cognitive decline: [mobd]), (specific skills: [inbe]), (cognitive endophenotype: []), ( t: [clna]), (important role: [socb]), (process: [phpr]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(childrens cognitive characteristics, 'Cognitive Ability')(prenatal brain exposure, 'Exposures')(cognition, 'Cognitive Ability')(cognitive domains, 'Cognitive Ability')(cognitive skills, 'Cognitive Ability')(aforementioned cognitive skills, 'Cognitive Ability')(cognitive performance, 'Cognitive Ability')(cognitive decline, 'Cognitive Ability')(cognitive endophenotype, 'Cognitive Ability')

PMCID: 4681135
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (biomarkers: [clna]), (autism: [mobd]), (outcomes: []), (diverse stakeholders: []), (research process: [resa]), (community-based participatory research (cbpr): [resa]), (biomarker discovery: [resa]), (clinical applications: [hlca]), (however: []), (limited examples: [fndg]), (stakeholder involvement: []), (autism research: [mobd]), (practical concerns: []), (applicability: []), (cbpr principles: []), (discovery: [acty]), (empirical studies: [resa]), (principles: []), (review methodology: []), (studies: [lbpr]), (results: [fndg]), (conclusions: []), (limited number: [qnco]), (methodological limitations: []), (such applications: [hlca]), (challenging: [hlca]), (cbpr themes: community: []), (global priorities: []), (collaboration: [socb]), (research design: [resa]), (further research: [resa]), (participatory principles: []), (pace: [gngm]), (development: [orgf]), (meaningful biomarkers: [clna]), (goal: []), (increased attention: [menp]), (methodological challenges: [hlca]), (participatory approaches: []), (health research: [resa]), (scientific rigor: [sosy]), (long-term partnerships: [orgt]), (stakeholders: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism research, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4678489
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (individuals: [humn]), (autism: [mobd]), (heavy demand: [topp]), (medical services: [hlca]), (prevalence estimates: [qnco]), (planning: [menp]), (such services: []), (children: [aggp]), (important implications: []), (policy makers: []), (study: [resa]), (prevalence: [qnco]), (suspected autism: [fndg]), (longhua district: []), ( shenzhen: []), (risk factors: [qnco]), (cross-sectional study: [resa]), (october: []), (total: [qnco]), (kindergartens: [fndg]), (current study: [resa]), (inclusion criteria: []), (autism behavior checklist (abc): [mobd]), (survey: []), (final analysis: [resa]), (%: []), (% ci: [lbpr]), (2.3-2.9) respondents: [popg]), (high probability: [qnco]), (3.7-4.3) respondents: [popg]), (questionable autism: [mobd]), (male children: [aggp]), (female counterparts: [orga]), (mothers: [famg]), (education level: [fndg]), (age: [orga]), (autism (p: [mobd]), (high prevalence rate: [qnco]), (urgent need: [topp]), (early detection: [diap]), (abc: [dsyn]), (shenzhen city: [clna]), (china: []), (further studies: [lbpr]), (diagnostic procedure: [diap]), (maternal age: []), (gender: [orga]), (possible factors: []), 
ASD Terms: (autism, 'Autism Phenotype')(medical services, 'Medications')(planning, 'Planning')(autism, 'Autism Phenotype')(suspected autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism behavior checklist, 'Autism Phenotype')(autism, 'Autism Phenotype')(questionable autism, 'Autism Phenotype')(develop autism, 'Autism Phenotype')(suspected autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4704485
SFARI Genes: CHD8, CHD8, 
Non SFARI Genes: 
Named Entities: (abstract genetic mechanisms: [topp]), (abnormal early neural development: [orgf]), (toddlers: [aggp]), (autism spectrum disorder (asd): [mobd]), (impossibility: []), (direct brain gene expression measurement: [gngm]), (critical periods: []), (early development: [orgf]), (recent findings: [clna]), (multitissue study: [resa]), (high expression: [topp]), (same gene networks: [moft]), (blood: [bdsu]), (brain tissues: [tisu]), (cell cycle functions: [phsf]), (relationships: []), (blood gene expression: [bdsu]), (total brain volume (tbv): [bpoc]), (asd: [cgab]), (male toddlers: [orga]), (control toddlers: [aggp]), ( tbv variation: []), (cell cycle: [celf]), (protein: [aapp,bacs]), (gene: [gngm]), (neuron number: [cell]), (synapse development: [ortf]), (correlations: []), (brain size: [qnco]), (result: [fndg]), (considerable changes: [qnco]), (network organization: [popg]), (cell adhesion gene networks: [moft]), (tbv variation: []), (cell cycle networks: [celf]), (human brain: [humn]), (prenatal states: [fndg]), (development: [orgf]), (overall: []), ( alterations: []), (brains: [bpoc]), (candidate genes: [gngm]), (brain maldevelopment: [bpoc]), (genes: [gngm]), (integrated network: [popg]), (leukocyte and/or postmortem brain tissue: [diap]), (asd subjects: [cgab]), (belong: []), (pathways: [moft]), (cell cycle g1/s: [qnco]), (g2/m phase transition: [moft]), (finally: []), ( analyses: [resa]), (chd8 subnetwork: [gngm]), (transcript levels: [nnon]), (independent study: [edac]), (chd8 suppression: [qnco]), (central role: [socb]), (neurogenesis: [orgf]), (cell adhesion: [celf]), (asd brain maldevelopment: [cgab]), 
ASD Terms: (underlying abnormal early neural development in toddlers, 'Learning Disorders')(abnormal early neural development, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 4682829
SFARI Genes: CLN8, CLN8, CLN8, CLN8, CLN8, CLN8, 
Non SFARI Genes: 
Named Entities: (rare variations: [gngm]), (spectrum disorder (asd) liability: [cgab]), (whole-exome sequencing: [mbrt]), (families: [famg]), (affected siblings: [famg]), (follow-up study: [resa]), (ceroid-lipofuscinosis: [dsyn]), ((epilepsy: [dsyn]), ( progressive: []), (mental retardation) (cln8): [mobd]), (potential genetic risk factor: [qnco]), (asd: [cgab]), (role: [socb]), (cln8: [gngm]), (genetic etiology: [topp]), (association analysis: [menp]), (japanese population: [popg]), (region: []), (asd patients: [cgab]), (rare missense variations: g.1719291g>a (r24h): [qnco]), ( rs201670636 (f39l): []), ( rs116605307 (r97h): []), ( rs143701028 (t108m): []), (rs138581191 (n152s): []), (variations: []), (patients: [podg]), (patients): [podg]), (controls: [sbst]), (however: []), (significant association: [menp]), (study: [resa]), (contribution: [acty]), (rare missense cln8 variations: [dsyn]), (asd susceptibility: [cgab]), 
ASD Terms: 

PMCID: 5030459
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (many studies: [lbpr]), (interplay: []), (environmental factors: []), (etiology: []), (autism spectrum disorder (asd): [mobd]), (limited understanding: [menp]), (underlying mechanisms hampers: []), (development: [orgf]), (effective ways: []), (detecting: [fndg]), (disorder: [dsyn]), (recent studies: [lbpr]), (hypothesis: []), (prenatal androgen exposure: [horm,phsu]), (asd: [cgab]), (maternal polycystic ovary syndrome: [dsyn]), (condition: [dsyn]), (excess androgens: [fndg]), (risk: []), (offspring: [famg]), (casecontrol study: [resa]), (total population: [qnco]), (sweden (children: [aggp]), (sweden: []), (sample: [sbst]), (asd cases: [cgab]), (controls: [sbst]), (birth month: []), (sex: [orgf]), (region: []), (birth: [orgf]), (pcos: [dsyn]), (icd codes: [mobd]), (linkage: [moft]), (health-care registers: [hlca]), (maternal pcos: [dsyn]), (odds: []), (adjustment: [inbe]), (confounders: []), (ratio: [qnco]), (confidence interval: [qnco]), (mothers: [famg]), (severe hyperandrogenemia: [fndg]), (ci: [gngm]), (risk estimates: [qnco]), (sexes: [orgf]), (conclusion: []), ( children: [aggp]), (women: [popg]), (awaits confirmation: []), (exploration: [topp]), (underlying mechanisms: []), (role: [socb]), (sex steroids: [orgf]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(prenatal androgen exposure, 'Exposures')(offspring, 'Perinatal History')

PMCID: 4668631
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (neuropsychiatric disorders: [dsyn]), (%: []), (patients: [podg]), (tuberous sclerosis complex (tsc): [neop]), (important issue: [fndg]), (families: [famg]), (autism spectrum disorder (asd): [mobd]), (common neurobehavioral disease: [dsyn]), (aims: [phsu]), (study: [resa]), (prevalence: [qnco]), (asd: [cgab]), (tsc population;: [popg]), (severity: []), (asd;: [cgab]), (potential risk factors: [qnco]), (development: [orgf]), (tsc patients: [podg]), (individuals: [humn]), (age: [orga]), (years: []), (definite diagnosis: [fndg]), (tsc: [gngm]), (tsc clinic: [hcro,mnob]), (northern italy: []), (genetic data: [euka]), (cognitive level: [phsu]), (them: []), (social communication questionnaire (scq): [socb]), (reliable screening tool: [diap]), (comparisons: [acty]), (average scores: [clna]), (genetic feature: [gngm]), (seventeen: [qnco]), ((40.5 %): [qnco]), (score: [clna]), (scq suggestive: []), (asd (15 points): [cgab]), (average scq score: [clna]), (number: [qnco]), (pathological scq scores: [clna]), (worsening: [fndg]), (intellectual disability: [mobd]), (respect: [socb]), (scores: [clna]), (degree: [qnco]), (large variability: [qnco]), (average scq: [qnco]), (clinical features: [clna]), (significant correlations: [qnco]), (epilepsy: [dsyn]), ( seizure: [sosy]), (year: []), ( spasms: [sosy]), ( mutations: [genf]), (tsc2: [gngm]), ( sleep disorders: [dsyn]), (other psychiatric problems: [mobd]), (seizure frequency: [fndg]), ( tubers localization: [plnt]), (gender: [orga]), (risk: []), (disorder: [dsyn]), (however: []), (notable variability: []), (risk factors: [qnco]), ( infantile spams: []), (mutations: [genf]), 
ASD Terms: (tuberous sclerosis complex, 'Tuberous Sclerosis')(autism spectrum disorder, 'Autism Phenotype')(common neurobehavioral disease, 'Central Nervous System Diseases')(tuberous sclerosis complex patients, 'Tuberous Sclerosis')(definite diagnosis, 'Diagnosis')(tuberous sclerosis complex, 'Tuberous Sclerosis')(tuberous sclerosis, 'Tuberous Sclerosis')(tuberous sclerosis complex clinic, 'Tuberous Sclerosis')(cognitive level, 'Cognitive Ability')(social communication questionnaire, 'Reciprocal Social Interaction')(social communication, 'Reciprocal Social Interaction')(social communication questionnaire suggestive, 'Reciprocal Social Interaction')(pathological social communication questionnaire scores, 'Reciprocal Social Interaction')(worsening of intellectual disability, 'Learning Disorders')(average social communication questionnaire score, 'Reciprocal Social Interaction')(intellectual disability, 'Learning Disorders')(epilepsy, 'Epilepsy')(spasms, 'Tourette Syndrome')(tuberous sclerosis complex2, 'Tuberous Sclerosis')(average social communication questionnaire, 'Reciprocal Social Interaction')(spasms, 'Tourette Syndrome')(other psychiatric problems, 'Mental Disorders')(tubers localization, 'Tuberous Sclerosis')(tuberous sclerosis complex patients, 'Tuberous Sclerosis')(tuberous sclerosis complex2, 'Tuberous Sclerosis')

PMCID: 4759619
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (developmental disorder: [mobd]), (nervous system: [bdsy]), (impaired social communication: [socb]), (interactions: []), (excessive repetitive behaviors: [fndg]), (drug: [phsu]), (pathology: [patf]), (disease: [dsyn]), (retinoic acid receptor-related orphan receptor  (ror): [aapp,rcpt]), (nuclear receptor: [aapp,rcpt]), (expression: [topp]), (many individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (several genes: [famg]), (individuals: [humn]), (asd: [cgab]), (putative ror target genes: [gngm]), (synthetic ror/ agonist: [phsu]), ( sr1078: [orch,phsu]), (previously: []), (treatment: [topp]), (btbr mice (a model: [mamm]), (autism): [mobd]), (sr1078 results: [orch,phsu]), (reduced repetitive behavior: [fndg]), (furthermore: []), (mice display: [mamm]), (asd-associated ror target genes: [cgab]), (brains: [bpoc]), (btbr mice: [mamm]), (human neuroblastoma cell line: [neop]), (sr1078: [orch,phsu]), (data: [euka]), (pharmacological activation: [acty]), (ror: [gngm]), (method: [lbpr]), 
ASD Terms: (autism, 'Autism Phenotype')(impaired social communication, 'Reciprocal Social Interaction')(excessive repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorder, 'Autism Phenotype')(reduced repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 4759317
SFARI Genes: SHANK3, SHANK3, SHANK3, GluR1, SHANK3, GluR1, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, Shank3, SHANK3, Shank3, 
Non SFARI Genes: 
Named Entities: (shank3: [gngm]), (synaptic scaffolding protein: [aapp,bacs]), (important role: [socb]), (neuronal development: [celf]), (various synaptic molecules: [sbst]), (post-synaptic density-95 (psd-95): [celc]), ( homer: [gngm]), (glur1 ampa receptor: [aapp,rcpt]), (shank3 gene: [gngm]), (causable gene: [gngm]), (phelan- mcdermid syndrome (also: [dsyn]), (deletion syndrome): [genf]), (manifestation: []), (global developmental delay: [fndg]), (autistic behavior: [mobd]), (severe speech: [orgf]), (language deficit: [lang]), (cumulative gene analysis: [resa]), (autistic subjects: [mobd]), (several mutations: [genf]), (deletion: [genf]), (duplication: [comd]), (particular region: []), ( abnormality: [fndg]), (neuropathology: [patf]), (autism spectrum disorder (asd): [mobd]), (recent findings: [clna]), (regard: []), (roles: [socb]), (brain: [bpoc]), (functions: [phsf]), ( molecular-biologic studies: [lbpr]), (complex expression: [topp]), (shank3 transcripts: [nnon]), (production: []), (shank3 isoforms: [aapp]), (behavioral studies: [inbe]), (shank3-mutant mice: [mamm]), (novel therapeutic approach: [topp]), (asd: [cgab]), 
ASD Terms: (global developmental delay, 'Learning Disorders')(severe speech, 'Language Ability')(language deficit, 'Language Ability')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 4734884
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (neuropeptide oxytocin (oxt): [aapp,horm,phsu]), (evolution: [genf]), (important modulator: []), (emotional processes: [menp]), (many species: []), (last decade: [qnco]), (large body: [humn]), (literature: [inpr,mnob]), (effects: []), (different aspects: [qnco]), (social behavior: [socb]), (social stress: [mobd]), (anxiety: [mobd]), ( social memory: [menp]), ( affiliation: []), (bonding: [menp]), ( emotion recognition: [menp]), ( mentalizing: []), ( empathy: [inbe]), (interpersonal trust: [inbe]), (addition: []), (impairments: [patf]), (social domains: []), (number: [qnco]), (neuropsychiatric disorders: [dsyn]), (autism: [mobd]), ( social anxiety disorder: [mobd]), ( depression: [mobd]), ( schizophrenia: [mobd]), (borderline personality: [mobd]), (role: [socb]), (oxt: [gngm]), (mental disorders: [mobd]), (treatment: [topp]), (present paper: [qnco]), (short overview: [qnco]), (lines: []), (research: [resa]), (promising target: [diap]), (novel treatment approaches: [topp]), (social impairments: [patf]), 
ASD Terms: (social behavior, 'Reciprocal Social Interaction')(anxiety, 'Anxiety Disorders')(social memory, 'Working Memory')(emotion recognition, 'Empathy')(empathy, 'Empathy')(autism, 'Autism Phenotype')(social anxiety disorder, 'Anxiety Disorders')(depression, 'Depressive Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(mental disorders, 'Mental Disorders')(social impairments, 'Social Competence')

PMCID: 4655861
SFARI Genes: NRXN1, NRXN2, NRXN1, NRXN2, NRXN1, NRXN2, NRXN1, NRXN2, NRXN1, NRXN2, NRXN1, NRXN2, NRXN1, NRXN2, NRXN1, NRXN2, NRXN1, NRXN2, NRXN1, NRXN2, 
Non SFARI Genes: 
Named Entities: (neurexins: []), (family: [famg]), (presynaptic cell adhesion molecules: [aapp,bacs]), (human: [humn]), (genetic studies: [resa]), (heterozygous deletions: [genf]), (nrxn1: [gngm]), (nrxn2: [gngm]), (-neurexin: []), (-neurexin ii (nrxn2): [aapp]), (individuals: [humn]), (autism spectrum disorders: [mobd]), (schizophrenia: [mobd]), (however: []), (link: []), (-neurexin deficiency: [dsyn]), (manifestation: []), (psychiatric disorders: [mobd]), (heterozygous loss: [genf]), (neurexins results: [fndg]), (behaviors: [inbe]), (used mice: [mamm]), (heterozygous (het) deletion: [genf]), (test: [lbpr]), (social approach: []), ( nrxn1 het mice: [mamm]), (social memory: [menp]), (familiar versus novel conspecifics: []), (passive avoidance test: [lbpr]), (female nrxn1 het mice cross: [mamm]), (chamber: [bpoc]), (nrxn2 het mice: [mamm]), (lack: []), (long-term object discrimination: [socb]), (deficit: [dsyn]), (cognition: [menp]), (observed nrxn1: [gngm]), (nrxn2 genotypic effects: [orga]), (het deletion: [genf]), (effects: []), (wide range: [qnco]), (other behavioral measures: [qnco]), (several measures: [qnco]), (anxiety: [mobd]), (findings: [clna]), (-neurexin ii: [aapp]), (mice: [mamm]), (autism: [mobd]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(psychiatric disorders, 'Mental Disorders')(social memory, 'Working Memory')(cognition, 'Cognitive Ability')(anxiety, 'Anxiety Disorders')(autism, 'Autism Phenotype')

PMCID: 4647182
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (small noncoding rnas: [nnon]), (critical role: [socb]), (messenger rna: [bacs,nnon]), (brain development: [ortf]), (effects: []), (disorders: [dsyn]), (autism spectrum disorders: [mobd]), (microrna: [bacs,nnon]), (small nucleolar rna: [bacs,nnon]), (superior temporal sulcus association cortex: [bpoc]), (primary auditory cortex: [blor]), (asd brains: [cgab]), (childhood: []), (rna expression profiles: [genf]), (asd: [cgab]), (regions: []), (changes: [qnco]), (age: [orga]), (typical micro-rna coexpression associations: [bacs,nnon]), (mir-132: []), ( mir-103: []), (mir-320 micro-rnas: [bacs,nnon]), (region-: []), (age-related micro-rna expression profiles: [genf]), (line: [sbst]), (findings: [clna]), (attenuated messenger rna: [bacs,nnon]), (noncoding rna: [nnon]), (asd brain: [cgab]), (study: [resa]), (alterations: []), (superior temporal sulcus: [bsoj]), (region: []), (social impairment: [patf]), (molecular alterations: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(social impairment, 'Social Competence')

PMCID: 4693501
SFARI Genes: FMR2, FMR2, FMR2, FMR2, 
Non SFARI Genes: 
Named Entities: (abstract fragile x syndrome (fxs): [cgab,dsyn]), (cgg triplet expansion: [dsyn]), (fragile x: [comd]), (mental retardation: [mobd]), (gene (fmr1): [gngm]), (affected males: [orga]), (criteria: []), (autism spectrum disorder (asd): [mobd]), (fxs: []), (frequent monogenetic cause: []), (syndromic asd: [cgab]), (normal variants (independent: [fndg]), (mutations): [genf]), (fragile x gene family (fmr1: [gngm]), ( fxr1: [gngm]), ( fxr2): [gngm]), (fmr2 modulate: [gngm]), (autistic features: [mobd]), (here: []), (accumulation model: [fndg]), (snps: [nusq]), (genes: [gngm]), (autistic traits: [mobd]), (discovery sample: [sbst]), (male patients: [orga]), (schizophrenia (n =: [mobd]), (independent replicate samples: patients: [podg]), (patients: [podg]), (other psychiatric diagnoses: [mobd]), (general population sample (n: [popg]), (first mechanistic insight: [menp]), (microrna expression: [bacs,nnon]), (peripheral blood: [bdsu]), (mononuclear cells: [cell]), (extreme group: [popg]), (high versus: [qnco]), (lowrisk constellation: []), (brainexpressed mir181 species: [nnon]), (potential umbrella regulator: []), (several seed matches: [plnt]), (fragile x gene family: [gngm]), (fmr2: [gngm]), (normal variation: [fndg]), (genes contributes: [gngm]), (continuum: []), (autistic phenotypes: [mobd]), 
ASD Terms: (abstract fragile x syndrome, 'Fragile X Syndrome')(fragile x, 'Fragile X Syndrome')(mental retardation, 'Mental Retardation')(autism spectrum disorder, 'Autism Phenotype')(fragile x gene family, 'Fragile X Syndrome')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 4657159
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (heritability: []), (genome wide association: [menp]), (failure: [inbe]), (considerable fraction: [qnco]), (variants detected: [fndg]), (current puzzle: [npop]), (human genetics: []), (puzzle: []), (involvement: []), (genetic variants: [npop]), (rare single nucleotide polymorphisms (snps): [nusq]), (copy number variations: [nusq]), (proposed: []), (many papers: []), (sets: [menp]), (polymorphisms: [genf]), ( however: []), (paper: []), (estimation: [qnco]), (single polymorphism: [fndg]), (rational method: [lbpr]), (individual polymorphism: [genf]), ( hp2: [dsyn]), (method: [lbpr]), (trial calculation: [resa]), (hp2: [dsyn]), (cnvs: [nusq]), (snps: [nusq]), (data: [euka]), (noteworthy examples: []), (type: [qnco]), (diabetes: [dsyn]), (schizophrenia: [mobd]), (cnv: [nusq]), ( respectively: []), (results: [fndg]), (large part: [qnco]), (novel cnvs: [nusq]), (large hp2: [dsyn]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(diabetes, 'Diabetes Mellitus Type 1')

PMCID: 4819764
SFARI Genes: POGZ, POGZ, 
Non SFARI Genes: PLEKHA4, PRKD2, HERC1, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (complex group: [popg]), (heterogeneous neurodevelopmental disorders: [orga]), (unclear etiology: []), (pathogenesis: [patf]), (genetic studies: [resa]), (numerous candidate: [qnco]), (genetic variants: [npop]), (asd-associated genes;: [cgab]), (function: [phsf]), (genes: [gngm]), (extensive bioinformatics: []), (priorities: []), (numerous candidate asd-associated genes: [cgab]), (further biological analysis: [resa]), (convenient system: []), (experimental evidence-based annotation: []), (candidate asd-associated genes: [cgab]), (trio-based whole-exome sequencing: [aapp,enzy]), (sporadic cases: [qnco]), (asd: [cgab]), (single-nucleotide variations: [fndg]), ( pogz: [gngm]), ( plekha4: [gngm]), ( pcnx: [gngm]), ( prkd2: [gngm]), (herc1: [gngm]), (snvs: []), (asd;: [cgab]), (consultation: [hlca]), (silico databases: []), (neural function: [phsf]), (gene products: [aapp,bacs]), (neural functions: [phsf]), (small hairpin: [qnco]), (rna-based assays: [nnon]), (cell lines: [cell]), (neurite development: [celf]), (knockdown: []), (one-way analysis: [resa]), (variance): [qnco]), (number: [qnco]), (gene ontology databases: []), (fisher's: [mamm]), (exact test): []), (system: []), (further analysis: [resa]), (substantial portion: []), (roles: [socb]), (neuronal systems: [imft]), (further detailed analysis: [resa]), (false positive genes: [gngm]), (candidate asd genes: [cgab]), 
ASD Terms: (heterogeneous neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 4661679
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (potential effects: []), (power: [hcpp]), (false positive rate (fpr): [qnco]), (bias: [bird]), (associations: [menp]), (hypothetical environmental exposures: [inpo]), (dichotomous autism spectrum disorders: [mobd]), (status: []), (simulated birth cohorts: [bodm]), (asd outcome: [cgab]), (uncertainty: [fndg]), (created: [acty]), (impact: [gngm]), (analysis: [resa]), (logistic regression): [resa]), (true associations: [menp]), (exposure (x1): [clna]), (fpr: [gngm]), (non-causal correlate: []), (exposure (x2: [clna]), ( r: [clna]), (dichotomized asd measure: [cgab]), (pool size: [clna]), ( sample: [sbst]), (degree: [qnco]), (measurement error variance: [qnco]), (exposure: [clna]), ( strength: [qnco]), (true association: [menp]), (shape: []), (exposure-response curve varied: [fndg]), (minimal change (bias): [bird]), (measures: [qnco]), (association: [menp]), (main effect (x1): []), (loss: [qnco]), (chance: []), (false positive result: [lbtr]), (individual level models: [phsu]), (number: [qnco]), (pools: [clna]), (effect: []), (overall sample size: [sbst]), (study: [resa]), (use: []), (laboratory costs: [mnob,orgt]), (statistical efficiency: [qnco]), (scenarios: []), (simulated prospective risk-enriched asd cohort: [resa]), 
ASD Terms: (hypothetical environmental exposures, 'Exposures')(dichotomous autism spectrum disorders, 'Autism Phenotype')(exposure, 'Exposures')(exposure, 'Exposures')

PMCID: 4820035
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (strong motivation: [menp]), (psychiatric gene discovery studies: [mbrt]), (novel insights: [menp]), (unknown biology: []), (attention-deficit hyperactivity disorder (adhd): [mobd]), (large: [gngm]), ( rare copy number variants: [nusq]), (contribute: [acty]), (pathogenesis: [patf]), (misunderstood: []), (adhd: [mobd]), (cnv data sets: [nusq]), (united kingdom: []), ( ireland: []), ( united: []), (america: []), ( northern europe: []), (canada: []), (aim: [phsu]), (enrichment: []), (neurodevelopmental gene sets: [gngm]), (recent exome-sequencing studies: [lbpr]), ((a) schizophrenia: [mobd]), ((b) autism: [mobd]), (means: []), (hypothesis: []), (common pathogenic mechanisms: [qnco]), (underlie adhd: [mobd]), (other neurodevelopmental disorders: [mobd]), (hypothesis-free testing: [resa]), (biological pathways: [moft]), (significant enrichment: [qnco]), (individual genes: [gngm]), (schizophrenia: [mobd]), (novo non-synonymous single-nucleotide variants: [fndg]), ((snvs; p=5.4: [aapp,imft]), (targets: [diap]), (fragile x: [comd]), (mental retardation protein (p=0.0018): [mobd]), (activity-regulated cytoskeleton-associated protein: [gngm]), (n-methyl-d-aspartate receptor: [aapp,rcpt]), (post-synaptic signalling gene sets: [gngm]), (adhd cnv hits: [nusq]), (genes: [gngm]), (autism: [mobd]), (snvs (p=0.019: [fndg]), (non-synonymous snv genes): [gngm]), (survive bonferroni correction: [phsu]), (ion channel pathways: [aapp,bacs]), (enrichment findings: [clna]), (corrections: []), (sensitivity analyses: [patf]), (significant sample: [sbst]), (findings: [clna]), (cnvs: [nusq]), (adhd converge: [mobd]), (meaningful gene clusters: [gngm]), (ones: [qnco]), (risk: []), 
ASD Terms: (attention-deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(neurodevelopmental gene sets, 'Learning Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(other neurodevelopmental disorders, 'Learning Disorders')(harbour schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(fragile x, 'Fragile X Syndrome')(mental retardation protein, 'Mental Retardation')(attention-deficit hyperactivity disorder cnv, 'Overactivity')(attention-deficit hyperactivity disorder converge, 'Overactivity')(other neurodevelopmental disorders, 'Learning Disorders')

PMCID: 4683429
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (multivariate pattern analysis (mvpa): [qnco]), (resting-based fmri recordings: [diap]), (neural markers: [clna]), (distinguish individuals: [humn]), (autistic spectrum disorders: [mobd]), (controls: [sbst]), (studies: [lbpr]), (brain connectivity: [bpoc]), (state episodes: []), (regions: []), (interest approaches: [menp]), (wealth: []), (task-based fmri datasets: [diap]), (populations: [popg]), (last decade: [qnco]), (techniques: []), (information: []), (single dataset: [fndg]), (datasets: []), (share: [socb]), (common features: [qnco]), (biomarkers: [clna]), (data-driven (voxel-based) approach: [menp]), (different fmri experiments: [diap]), (social stimuli (faces: [blor]), (bodies): [humn]), (method: [lbpr]), (support vector: [nnon]), ((svms): []), (recursive feature elimination (rfe): [phsf]), (experiment: [resa]), (output: []), (final classification output: []), (second: [qnco]), (rfe output: []), (voxels: []), (classification: []), (maps: [aapp,bacs]), (significant discriminative activity: [socb]), (finally: []), (clinical validity: [qnco]), (approach: []), (phenotypic information: [orga]), (classifier scores: [clna]), (results: [fndg]), (good classification accuracy (range: [qnco]), (moreover: []), (discriminative activity patterns: [socb]), (social brain: [bpoc]), (priori roi definitions: [clna]), (social motivation: [menp]), (only dimension: [qnco]), (main dimension: [qnco]), (classifiers: []), (present rfe method: [lbpr]), (relevant biomarkers: [clna]), (advantage: []), (psychiatric populations: [popg]), 
ASD Terms: (autistic spectrum disorders, 'Autistic Disorder')(different fmri experiments with social stimuli, 'Social Competence')

PMCID: 4642926
SFARI Genes: CASK, CASK, 
Non SFARI Genes: 
Named Entities: (receptor abundance: [aapp,rcpt]), (synapses: [bsoj]), (important mechanism: []), (synaptic strength: [qnco]), (pools: [clna]), (receptors: [aapp,rcpt]), (post-synaptic elements: [elii]), (immobile: [phpr]), (gabaa receptors: [aapp,rcpt]), (distinct synaptic scaffolds: []), (c: []), (neuromuscular junctions: [celc]), (frm-3/epb4.1: []), (lin-2a/cask: [gngm]), (synaptic adhesion molecules neurexin: [gngm]), (neuroligin: [moft]), (inhibitory post-synaptic currents: [acty]), (double mutants: [comd]), (scaffolds: []), (neurexin: []), ( neuroligin: [moft]), (cask mutations: [genf]), (autism spectrum disorders: [mobd]), (results: [fndg]), (mutations: [genf]), (inhibitory transmission: [acty]), (developmental: [orgf]), (cognitive deficits: [mobd]), (asd: [cgab]), (doi: http://dx.doi.org/10.7554/elife.09648.001: [fndg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(cognitive deficits, 'Cognitive Ability')

PMCID: 4643966
SFARI Genes: CACNA1A, CACNA1A, CACNA1A, CACNA1A, CACNA1A, CACNA1A, CACNA1A, CACNA1A, CACNA1A, CACNA1A, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (group: [popg]), (neurodevelopmental disorders: [mobd]), (recent studies: [lbpr]), (calcium channel genes: [aapp,bacs]), (genetic etiology: [topp]), (asd: [cgab]), (cacna1a: [gngm]), (alpha-1 subunit: [aapp,horm,phsu]), (voltage-gated calcium channel: [aapp,bacs]), (important role: [socb]), (neural development: [orgf]), (previous study: [resa]), (single nucleotide polymorphism (snp): [nusq]), (cacna1a confers: [gngm]), (central european population: [popg]), (however: []), (genetic relationship: [topp]), (autism: [mobd]), (chinese han population: [popg]), (association: [menp]), (family-based association study: [socb]), (family-based association test: [socb]), (twelve: [qnco]), (snps: [nusq]), (trios: [aapp,enzy]), (sample size: [qnco]), (additional trios: [aapp,enzy]), (total: [qnco]), (rs7249246: []), (rs12609735: []), (bonferroni correction: []), (findings: [clna]), (role: [socb]), (etiology: []), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4650984
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (purpose: []), (review: []), (recent explosion: [inpo]), (genetic findings: [lbtr]), (autism spectrum disorder (asd) research: [mobd]), (knowledge: []), (disorder's: [dsyn]), (biology: []), (etiologic architecture: []), (concepts: []), (results: [fndg]), (recent genetic studies: [resa]), (manner: []), (findings: [clna]), (trajectory: []), (asd research: [cgab]), (recent findings large consortium studies: [lbpr]), (asds: [cgab]), (many types: []), (genetic risk factors: []), (common polygenic risk: [qnco]), (single nucleotide variants: [fndg]), ( copy number variants: [nusq]), (variants: []), (heterogeneity: [orga]), (complexity: [chvs]), (rare variant findings: [clna]), (particular point: [qnco]), (genes: [gngm]), (pathways: [moft]), (gap: [gngm]), (behavior: [inbe]), (summary genetic studies: [resa]), (biological underpinnings: []), (other neuropsychiatric disorders: [dsyn]), (data: [euka]), (disease pathways: []), (pathogenesis: [patf]), (asd heterogeneity and: [cgab]), (future: []), (research studies: [resa]), (treatment trials: [resa]), 
ASD Terms: (autism spectrum disorder research, 'Autism Phenotype')

PMCID: 4641696
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (substantial similarities: []), (overlaps: [topp]), (pathophysiology: [patf]), (obsessive-compulsive disorders: [mobd]), (autism spectrum disorders: [mobd]), (etiologic cohesion: [npop]), (disorders: [dsyn]), (patterns: []), (comorbidity: []), ( longitudinal risks: []), (familial risks: [famg]), (prospective study design: [resa]), (effect: []), (prior diagnosis: []), (ocd: [mobd]), (patients: [podg]), (parents: []), (susceptibility: [clna]), (spectrum disorders: [dsyn]), (vice versa: []), (analyses: [resa]), (sex: [orgf]), ( age: [orga]), ( calendar year: []), (parental age: [grpa]), (place: [acty]), (residence: []), (time: []), (birth: [orgf]), (measures: [qnco]), (relative risk incidence rate ratios (irr): [qnco]), (confidence intervals: [qnco]), (employed: [fndg]), (risk: []), (comorbid diagnosis: [fndg]), (individuals: [humn]), (autism spectrum disorder: [mobd]), (aggregation: [qnco]), (later diagnosis: []), (ocd (irr: [mobd]), (ci: [gngm]), (whereas individuals: [humn]), (life: []), (observed associations: [menp]), (severe types: []), (mental disabilities: [mobd]), (high comorbidity: [qnco]), (sequential risk: []), (etiological mechanisms: []), (results: [fndg]), (implications: []), (current gene-searching efforts: [gngm]), (clinical practice: [menp]), 
ASD Terms: (obsessive-compulsive disorders, 'Obsessive-Compulsive Disorder')(autism spectrum disorders, 'Autism Phenotype')(comorbidity, 'Comorbidities')(prior diagnosis, 'Diagnosis')(obsessive-compulsive disorders, 'Obsessive-Compulsive Disorder')(comorbid diagnosis, 'Comorbidities')(obsessive-compulsive disorders, 'Obsessive-Compulsive Disorder')(autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(obsessive-compulsive disorders, 'Obsessive-Compulsive Disorder')(diagnosis, 'Diagnosis')(obsessive-compulsive disorders, 'Obsessive-Compulsive Disorder')(autism spectrum disorders, 'Autism Phenotype')(later diagnosis, 'Diagnosis')(autism spectrum disorders, 'Autism Phenotype')(comorbid diagnosis, 'Comorbidities')(mental disabilities, 'Mental Retardation')(obsessive-compulsive disorders, 'Obsessive-Compulsive Disorder')(high comorbidity, 'Comorbidities')

PMCID: 4637822
SFARI Genes: 
Non SFARI Genes: bEnd3, 
Named Entities: (solute carrier: [fndg]), ((slc27a) gene family: [gngm]), (acid transport proteins: [aapp,bacs]), (members: [popg]), (postnatal periods: []), (development: [orgf]), (brain: [bpoc]), (reliable supply: [qnco]), (fatty acids: [orch]), (autism spectrum disorders: [mobd]), (disorders: [dsyn]), (impaired early brain development: [bpoc]), (functional abnormalities: [cgab]), (slc27a genes: [gngm]), (pathogenesis: [patf]), (asd: [cgab]), (here: []), (expression: [topp]), (slc27a3: [gngm]), (slc27a4: [gngm]), (human neural stem cells: [humn]), (human: [humn]), (pluripotent stem cells: [cell]), (involvement: []), (developmental stage: []), (central nervous system: [bdsy]), (slc27a4 genes: [gngm]), (asd patient: [cgab]), (control samples: []), ((44 novel: []), (nonsynonymous): []), ((17 novel: []), (nonsynonymous) variants: []), (multiple rare variants: [qnco]), (slc27a4 ser209 allele: [gngm]), (asd samples: [cgab]), (slc27a4 ser209 mutant: [comd]), (fluorescently-labeled fatty acid uptake: [orch]), (bend3: [gngm]), (mouse brain: [tisu]), (capillary-derived endothelial cell line: [cell]), (slc27a4 gly209: [aapp,enzy]), (functional change: [topp]), (asd pathophysiology: [cgab]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(impaired early brain development, 'Learning Disorders')

PMCID: 4655021
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders (asd): [mobd]), (heterogeneous group: [popg]), (neurodevelopmental disorders: [mobd]), (causes: []), (asd: [cgab]), (genetic factors: [fndg]), (toxic: [inpo]), (environmental factors: []), (combination: [fndg]), (these: []), (available tests: [lbpr]), (genetic abnormalities: [fndg]), (asd children: [cgab]), (diagnosis: [fndg]), (behavioral signs: [inbe]), (symptoms: [sosy]), (young children: [aggp]), (pedagogic interventions: [hlca]), (possible: []), ( early diagnosis: [diap]), (lack: []), (nongenetic specific biological markers: [clna]), (past ten: [dsyn]), (scientific literature: []), (dozens: []), (biochemical alterations: []), (asd children;: [cgab]), (real biomarker: [clna]), (such literature: [inpr,mnob]), (light: [gngm]), (receiver operating characteristic (roc): [qnco]), (valuable statistical tool: []), (sensitivity: [patf]), (specificity: [qnco]), (biomarkers: [clna]), (diagnostic decision making: [menp]), (roc analysis: [qnco]), (data: [euka]), (diagnostic value: [qnco]), (variables: []), (roc curve analysis: [qnco]), (use: []), (tool: []), (understanding: [menp]), (nonsyndromic asd: [cgab]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')(diagnosis, 'Diagnosis')(early diagnosis, 'Diagnosis')(diagnostic decision making, 'Decision Making Ability')

PMCID: 4703709
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (altered brain connectivity: [bpoc]), (autism: [mobd]), (degree: [qnco]), (direction: []), (alterations: []), (connectivity: []), (uniqueness: []), (aim: [phsu]), (present study: [qnco]), (children: [aggp]), (controls: [sbst]), (developmental delay: [mobd]), (eeg: [diap]), (spectral power: [hcpp]), ( coherence: [fndg]), ( phase lag: [gngm]), ( pearson: []), (partial correlations: [qnco]), (epileptiform activity: [acty]), (awake: [fndg]), ( slow wave sleep: [phsf]), (rem: [gngm]), (states: []), (years: []), (autism (n: [mobd]), (typical development (n: [aapp,imft]), (findings: [clna]), (brain connectivity: [bpoc]), (coherence: [fndg]), (pearson: []), (general: [hlca]), ( children: [aggp]), (slow wave sleep: [phsf]), (interpretation functional connectivity: [clna]), (samples: [sbst]), (typical development: [orgf]), (differences: [qnco]), (state: []), (region related: [fndg]), (study: [resa]), (pattern: []), (altered connectivity: []), 
ASD Terms: (autism, 'Autism Phenotype')(children with developmental delay, 'Learning Disorders')(developmental delay, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4635597
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (humans: [humn]), ( mammalian target: [mamm]), (rapamycin (mtor): [aapp,enzy]), (kda serine/ threonine protein kinase: [aapp,enzy]), (high levels: [qnco]), (brain: [bpoc]), (mtor functions: [aapp,enzy]), (integrator: [aapp,phsu,vita]), (multiple cellular processes: [celf]), (phosphorylation: [moft]), (proteins: [aapp,bacs]), (somatic mtor mutations: [aapp,enzy]), (tumors: [neop]), (many years: []), (hemimegalencephaly: [dsyn]), ( germline mtor mutations: [genf]), (described: []), (case presentation: []), (successful application: [qnco]), (family-trio diagnostic exome sequencing (des): [famg]), (molecular etiology: []), (brothers: [famg]), (developmental lesions: [fndg]), (affected brothers: [famg]), (years: []), (age: [orga]), (time: []), (des: [gngm]), (symptoms: [sosy]), (autism spectrum disorder (asd): [mobd]), ( megalencephaly: [cgab]), (gross motor skill: [ortf]), (cryptorchidism: [cgab]), (bilateral iris coloboma: [anab]), (importantly: []), (brother: [famg]), (mtor missense alteration p.e1799k (c.5395g>a): [aapp,enzy]), (exact variant: []), (multiple independent human somatic cancer samples: [humn]), (increased mtor activation: [aapp,enzy]), (further: []), (recent independent reports: [hlca]), (unrelated families: [famg]), (megalencephaly: [cgab]), (intellectual disability (id);: [mobd]), (cases: [qnco]), ( p.e1799k: [aapp,imft]), (mosaicism: [orga]), (case: []), (family: [famg]), (absence: [anab]), (p.e1799k: [aapp,imft]), (genomic dna: [nnon]), (blood: [bdsu]), (parent: []), (alteration: []), (p.e1799k variant: [aapp,imft]), (effect: []), (gain-of-function (gof): [phsf]), (autosomal dominant mechanism: [genf]), (herein: []), (use: []), (activating mtor missense alteration: [aapp,enzy]), (gonadal mosaic origin: [bpoc]), (causative mutation: [genf]), (developmental abnormalities: [cgab]), (report: [hlca]), (total number: [qnco]), (families: [famg]), (mtor p.e1799k: [aapp,enzy]), (association: [menp]), (id: [lbpr]), ( evidence: []), (p.e1799k arose: [aapp,imft]), (affected individuals: [humn]), (thus: []), ( mtor p.e1799k: [aapp,enzy]), (pathogenic gof mutation: [genf]), (cognitive impairment: [mobd]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s12881-015-0240-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (years of age, 'Onset of Symptoms')(mild autism spectrum disorder, 'Autism Phenotype')(gross motor skill, 'Gross Motor Skills')(intellectual disability, 'Learning Disorders')(developmental abnormalities, 'Learning Disorders')(cognitive impairment, 'Cognitive Ability')

PMCID: 4660377
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (malformations: [cgab]), (cortical development: [ortf]), (rates: [qnco]), (autism spectrum disorder (asd): [mobd]), (healthy controls: []), (postmortem: [diap]), (neuropathological evaluation: [hlca]), (visual review: []), (in-vivo mri brain scans: [diap]), (elusive nature: []), (many malformations: [cgab]), (mri: [gngm]), (here: []), (quantitative approach: [resa]), (volumetric measure: [qnco]), (heterotopic: []), (gray matter: [tisu]), (white matter: [tisu]), (people: [popg]), (asd: [cgab]), (controls (tdc): [sbst]), (data: [euka]), (primary sample: [sbst]), (children/young adults: [aggp]), (gender-matched tdcs: [orga]), (autism brain imaging data exchange (abide): [mobd]), (open-access database: []), (groups: [popg]), ((1): [fndg]), (review: []), (high-resolution t1-weighted research sequences;: [orga]), ((2): [qnco]), (quantitative measurement: [qnco]), (white matter hypointensity (wmh) volume: [tisu]), (same t1-weighted scans: [orga]), (groupwise wmh volume comparisons: [acty]), (independent: [fndg]), ( multi-site sample (80 asd/80 tdc): [cgab]), (abide: []), (equivalent proportions: [qnco]), (abnormalities: [cgab]), (tdc group: [popg]), (however: []), (quantitative analysis: [resa]), (elevated periventricular: []), (deep subcortical wmh volumes: [qnco]), (finding: [sosy]), ( multi-site sample: [sbst]), (periventricular wmh volume: [qnco]), (age: [orga]), (repetitive behaviors: [fndg]), (clinician-rated assessment inventories: [diap]), (thus: []), ( findings: [clna]), (degree: [qnco]), (interests: [menp]), (etiology: []), (focal wmh clusters: [qnco]), (absence: [anab]), (age effects: [orga]), (static anomaly: [fndg]), 
ASD Terms: (malformations of cortical development, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(visual review, 'Visual Thinking')(autism brain imaging data exchange, 'Autism Phenotype')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 4930130
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (transcription: [genf]), (inherited dna sequence: [nusq]), (copies: []), (messenger rna: [bacs,nnon]), (fundamental process: [phpr]), (genome functions: [phsf]), (development: [orgf]), (sequence information: [nusq]), (epigenetic marks: []), (environmental influences: []), (converge: [acty]), (level: [phsu]), (mrna gene expression: [gngm]), (cell-type-specific: [cell]), ( tissue-specific: [bdsu]), ( spatial: [gngm]), (temporal patterns: [orga]), (expression: [topp]), (transcriptome: [nusq]), (complex interplay: [chvs]), (genomic structure: [gngm]), ( dynamic experiential demands: [topp]), (external signals: [phpr]), (property: []), (transcriptome studies: [nusq]), (complex geneticepigeneticenvironmental processes: [phpr]), (human brain development: [ortf]), (disorders: [dsyn]), (non-mendelian genetic etiologies: [topp]), (autism spectrum disorders: [mobd]), (review: []), (recent studies: [lbpr]), (unique functional genomics profile: [lbpr]), (human brain: [humn]), (neurodevelopment: [ortf]), (areas: []), (research: [resa]), (understanding: [menp]), (functional neurogenomicsnon-coding rna expression: [genf]), (gene interaction networks: [moft]), (finally: []), (previous functional genomics studies: [lbpr]), (autism spectrum disorder: [mobd]), (context: [fndg]), (investigations: [hlca]), (functional genomics: []), (convergent molecular mechanisms: [acty]), (heterogeneous disorder: [fndg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 4637446
SFARI Genes: Chd7, Chd7, 
Non SFARI Genes: 
Named Entities: (hypothesis: []), (utero exposure: [bpoc]), (heavy metals: [elii]), (autism-like behavioral phenotypes: [mobd]), (adult animals: [anim]), (induces: []), (epigenetic changes: [qnco]), (genes: [gngm]), (roles: [socb]), (etiology: []), (autism: [mobd]), (mouse dams: [mamm]), (cadmium: [elii,hops]), ( lead: [elii,hops]), ( arsenate: [inch,phsu]), ( manganese: [elii]), (mercury: [elii,hops]), (drinking water: [sbst]), (gestational days: []), (valproic acid (vpa): [orch,phsu]), ((e): []), (positive control: []), (young male: [orga]), (behavioral deficits: [inbe]), (standardized behavioral assays: [lbpr]), (study: [resa]), (multiple behavioral abnormalities: [mobd]), (adulthood: []), (vpa: []), (manganese induced changes: [elii]), (perseverative/impulsive behavior: [mobd]), (social dominance behavior: [socb]), ( arsenic: [elii,hops]), (changes: [qnco]), (lead: [elii,hops]), (induced abnormalities: [cgab]), (social interaction: [fndg]), (comparison: [acty]), (control animals: [anim]), (brain samples: [bpoc]), (mn: [gngm]), ( pb: [gngm]), (cpg island methylation: [bacs,nnon]), (promoter regions: [bacs,nnon]), (gene expression: [genf]), (chd7 gene: [gngm]), ( essential: []), (neural crest cell migration: [celf]), (patterning: []), (experimental animal: [anim]), (water-treated controls: [sbst]), (furthermore: []), (distinct patterns: []), (novel candidate genes: [gngm]), (further investigation: [hlca]), 
ASD Terms: (utero exposure, 'Exposures')(autism, 'Autism Phenotype')(gestational days, 'Perinatal History')(behavioral deficits, 'Personal Traits')(utero exposure, 'Exposures')(multiple behavioral abnormalities, 'Personal Traits')(social interaction, 'Reciprocal Social Interaction')(social dominance behavior, 'Reciprocal Social Interaction')

PMCID: 4913747
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract: []), (language: [lang]), (fine motor skills: [ortf]), (lefthemisphere specialization: []), ( whereas: []), (visuospatial skills: [inbe]), (righthemisphere specialization: []), (individuals: [humn]), (autism spectrum conditions: [mobd]), (profile: [lbpr]), (deficits: []), (strengths: []), (lateralized cognitive functions: [menp]), (hypothesis: []), (regions: []), (functions: [phsf]), (asc: [gngm]), (such atypicality: []), (functional performance: [fndg]), (participants: [popg]), (male: [orga]), (adults: [aggp]), (age: [orga]), (iqmatched: []), (neurotypical males: [orga]), (group differences: [popg]), (structural asymmetries: []), (cortical regions: [bpoc]), (interest: [menp]), (voxelbased analysis: [resa]), (grey matter volumes: [tisu]), (correlational analyses: [inpr,resa]), (measures: [qnco]), ( motor: []), (rightward lateralization: []), (inferior parietal lobule: [bpoc]), (reduced leftward lateralization: []), (auditory cortex: [bpoc]), (planum temporale: [orch,phsu]), ( heschl's gyrus: [bpoc]), (posterior supramarginal gyrus: [bpoc]), (parietal operculum: [bpoc]), (asc individuals: [humn]), (delayed language: [fndg]), (without: []), (leftward asymmetry: []), (auditory region: []), (childhood social reciprocity difficulties: [fndg]), (atypical cerebral structural asymmetry: [fndg]), (potential candidate neurophenotype: []), (hum brain mapp: [bpoc]), (human brain mapping: [diap]), (wiley periodicals: []), ( inc: []), 
ASD Terms: (fine motor skills, 'Fine Motor Skills')(autism spectrum conditions, 'Autism Phenotype')(lateralized cognitive functions, 'Functional Laterality')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions individuals, 'Autism Phenotype')(delayed language, 'Language Ability')(autism spectrum conditions, 'Autism Phenotype')(childhood social reciprocity difficulties, 'Social Competence')(autism spectrum conditions, 'Autism Phenotype')

PMCID: 4619748
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (sex ratios: [qnco]), (indirect test: [lbpr]), (association: [menp]), (prenatal testosterone levels: [lbtr]), (risk: []), (autism: [mobd]), (developmental disorder: [mobd]), (males: [orga]), (differences: [qnco]), (evidence: []), (risk factor: [qnco]), (sex: [orgf]), (conclusions: []), (prenatal testosterone: [horm,orch,phsu]), ( however: []), (additional assumptions: []), (here: []), (acyclic graphs (dags): [bacs,orch,phsu]), (elements: [elii]), (valid test: [lbpr]), (hypothesis: []), (children: [aggp]), (test: [lbpr]), (large: [gngm]), ( population-based sample: [popg]), (subjects: [humn]), (california: [plnt]), (birth records: []), (autism diagnosis: [mobd]), (administrative database: [fndg]), (california department: [orgt]), (developmental services: [orgf]), (subsequent sibling: [famg]), (generalized estimating equations: [qnco]), (sources: [fndg]), (potential bias: [bird]), (dags: [bacs,orch,phsu]), (addressed: []), (male children: [aggp]), (next-born siblings: [famg]), (brothers: [famg]), ( versus: []), (unaffected males: [orga]), (females: [orga]), (siblings: [famg]), (control females: [orga]), (relative risk: [qnco]), (subsequent male: [orga]), ((95% confidence: [menp]), (excess: []), (several threats: [qnco]), (test cannot rule: [lbpr]), (role: [socb]), (exposure: [clna]), (sex ratio: [qnco]), (common cause: [qnco]), (both: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(exposure, 'Exposures')

PMCID: 4619566
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (autism-spectrum quotient (aq): [qnco]), (big data sample: [sbst]), (uk channel: []), (television website: []), (broadcasting: []), (medical education program: [edac]), (correlations: []), (aq: []), (age: [orga]), ( sex: [orgf]), ( occupation: []), (uk: []), (geographic region: []), (individuals: [humn]), (geography: []), (sex: [orgf]), (occupation: []), (correlation: []), (mean aq: [qnco]), (total sample score: [clna]), (previous systematic review: []), (non-clinical sample (mean: [qnco]), (means: []), (big-data sample: [sbst]), (autism: [mobd]), (systematic review: []), ((mean: [qnco]), (predicted: [qnco]), (occupation differences: [qnco]), (average: [qnco]), ( males: [orga]), (sd: [gngm]), (females: [orga]), (stem career (m: [plnt]), (non-stem careers: [plnt]), ( age: [orga]), (results: [fndg]), (previous findings: [clna]), (stem careers: [plnt]), (set: [menp]), (aq scores: [clna]), (useful self-report measure: [resa]), (autistic traits: [mobd]), 
ASD Terms: (medical education program, 'Medications')(occupation, 'Job Performance')(autism, 'Autism Phenotype')(occupation differences, 'Job Performance')

PMCID: 4618364
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, 
Non SFARI Genes: 
Named Entities: (deletions: [genf]), (mutations: [genf]), (shank3 gene lead: [elii,hops]), (nonspecific clinical presentation: []), (intellectual disability: [mobd]), (absent speech: [fndg]), (autism spectrum disorders: [mobd]), (better knowledge: []), (clinical spectrum: [qnco]), (shank3 haploinsufficiency: [comd]), (clinical care monitoring: [resa]), (molecular diagnosis: [lbpr]), (genetic counselling: [topp]), (case presentation here: []), (detailed clinical description: []), (10-year-old girl: [aggp]), (deletion: [genf]), (exons: [bacs,nnon]), (shank3: [gngm]), (clinical features: [clna]), (girl: [aggp]), (diagnosis: [fndg]), (dementia infantilis: [mobd]), (heller: []), (childhood disintegrative disorder: [mobd]), (present case: [qnco]), (several observations: [hlca]), (regression: [menp]), (part: [qnco]), (clinical phenotype: [orga]), (gene shank3: [gngm]), (patients: [podg]), (childhood: []), (disintegrative disorder: [dsyn]), (developmental disorder: [mobd]), (regressive pattern: []), (communicative skills: [orga]), (instinctual functions: [phsf]), (onset: [qnco]), (years: []), 
ASD Terms: (intellectual disability, 'Learning Disorders')(absent speech, 'Language Ability')(autism spectrum disorders, 'Autism Phenotype')(molecular diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')(onset, 'Onset of Symptoms')(communicative skills, 'Reciprocal Social Interaction')

PMCID: 4930123
SFARI Genes: SHANK2, BDNF, SHANK2, BDNF, 
Non SFARI Genes: BDNF-AS, 
Named Entities: (genome-wide differential expression: [gngm]), (rnas (lncrnas): [nnon]), (blood specimens: [bdsu]), (autism spectrum disorder (asd): [mobd]), (total: [qnco]), (lncrnas: [nnon]), (asd: [cgab]), (peripheral leukocytes: [cell]), (downregulated: []), (messenger rnas (mrnas): [bacs,nnon]), (asd leukocytes: [cgab]), (functional pathway analysis: [hlca]), (neurological pathways: [moft]), (synaptic vesicle cycling: [celc]), (long-term depression: [ortf]), (long-term potentiation: [ortf]), (thirteen: [qnco]), (synaptic lncrnas: [nnon]), (synaptic mrnas: [bacs,nnon]), (identification: [menp]), (differential expression: [topp]), (mrnas: [bacs,nnon]), (synaptic vesicle transportation: [celc]), (cycling: []), (delivery: [topp]), (synaptosomal protein(s): [aapp,enzy]), (postsynaptic membranes: [celc]), (finding: [sosy]), (intergenic: []), (hox genes: [gngm]), (role: [socb]), (development: [orgf]), (discovery: [acty]), (shank2-as: [gngm]), (bdnf-as: [gngm]), (natural antisense: [topp]), (genes shank2: [gngm]), (bdnf: [gngm]), (addition: []), (gene: [gngm]), (mutations: [genf]), ( deregulation: [acty]), (asd-causing gene loci: [cgab]), (new approach: []), (possible epigenetic mechanisms: [genf]), (study: [resa]), (new avenue: []), (use: []), (lncrna(s): [nnon]), (biomarker(s): [clna]), (early detection: [diap]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurological pathways, 'Neurologic Indications')(long-term depression, 'Depressive Disorder')(delivery, 'Perinatal History')

PMCID: 4612093
SFARI Genes: BET, BET, BET, BET, 
Non SFARI Genes: 
Named Entities: (sullivan: []), (al: [lbpr]), (pharmacological suppression: [qnco]), (bet proteins: [inbe]), (selective brain-permeable inhibitor: [bpoc]), ( results: [fndg]), (suppression: [qnco]), (genes: [gngm]), (spectrum disorders: [dsyn]), (humans: [humn]), (bet inhibitor treatment: [inbe]), (young mice: [mamm]), (induction: [topp]), (autism-like syndrome: [mobd]), (alterations: []), (social behaviors: [socb]), (findings: [clna]), (key role: [socb]), (bet-controlled gene networks: [moft]), (development: [orgf]), (asd: [cgab]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(social behaviors, 'Reciprocal Social Interaction')

PMCID: 4607423
SFARI Genes: Nlgn3, Nlgn3, CB1, CB1, 
Non SFARI Genes: 
Named Entities: (single: [fndg]), (inherited: []), ( x-linked point mutation: [comd]), (arginine: [aapp,bacs,phsu]), (substitution: [acty]), (amino: []), ((r451c): []), (neuroligin: [moft]), ((nlgn3r451c): []), (likely cause: []), (autism: [mobd]), (brothers: [famg]), (knockin mice: [mamm]), (nlgn3r451c mutation: [genf]), (place: [acty]), (wild-type nlgn3 demonstrate: [gngm]), (inhibitory synaptic strength: [acty]), (somatosensory cortex: [bpoc]), (excitatory/inhibitory (e/i) imbalance: [acty]), (autism-associated behavioral deficits characteristic: [mobd]), (mice: [mamm]), (increase: []), (evoked inhibitory postsynaptic currents: [ortf]), (layer ii/iii: [bird]), (cortical pyramidal neurons: [bpoc]), (frequency: [qnco]), (spontaneous mipscs: []), (nlgn3r451c mice: [mamm]), (absence: [anab]), (action: [acty]), (potential-driven transmission: [patf]), (e/i imbalance: [inch]), (changes: [qnco]), (synapse level: [bsoj]), (network level: [popg]), (next: []), (paired whole-cell recordings: [resa]), (attempt: [evnt]), (specific interneuron subtypes: [cell]), (curiously: []), (change: [qnco]), (amplitude: []), (cell-to-cell: [gngm]), ( unitary ipscs (uipscs): [qnco]), (parvalbumin-positive (pv): [aapp,bacs]), (somatostatin-positive (som) interneurons: [aapp,horm,phsu]), (pyramidal neurons: [cell]), (number: [qnco]), (density: [qnco]), (pv: [neop]), (som interneurons: [cell]), (lii/iii: []), (rules: []), (role: [socb]), (particular interneurons: [cell]), (increased inhibitory: [acty]), (synaptic transmission: [celf]), (interneuron subtypes: [cell]), (lastly: []), (endocannabinoid signaling: [moft]), (hippocampal synaptic dysfunction: [dsyn]), (cortical synapses: [bpoc]), (bath application: [topp]), (cb1 antagonist: [ortf]), ( am: []), (wt mice: [mamm]), (nlgn3r451c increase: []), (eipsc amplitude: []), (mipsc frequency: [qnco]), (inhibitory transmission: [acty]), (mutant mice: [mamm]), (part: [qnco]), (loss: [qnco]), (cb1 receptors: [aapp,rcpt]), (interneurons: [cell]), (som: [gngm]), 
ASD Terms: (autism, 'Autism Phenotype')(autism-associated behavioral deficits characteristic, 'Personal Traits')

PMCID: 4893356
SFARI Genes: 
Non SFARI Genes: SPX, SPX, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (attention-deficit/hyperactivity disorder (adhd): [mobd]), (genetic factors: [fndg]), ( pre-: [mamm]), (perinatal risk factors: [qnco]), (asd: [cgab]), ( adhd: [mobd]), (combination: [fndg]), (disorders: [dsyn]), (manifest: []), (study: [resa]), (unique involvement: []), (ppfs: []), (adhd: [mobd]), (approach: []), (sample: [sbst]), (affected/unaffected offspring: [famg]), (single-incidence (spx): [qnco]), (multi-incidence (mpx) families: [qnco]), (pre- perinatal data: [euka]), (retrospective parent-report: [resa]), (children: [aggp]), (% males): [orga]), (spx: [gngm]), (mpx asd: [cgab]), (mpx adhd families: [famg]), (control children: [aggp]), (large family size: [grpa]), (firstborns: []), (shared pffs: [socb]), (asd (maternal infections: [cgab]), (suboptimal condition: [dsyn]), (birth): [orgf]), (unaffected siblings: [famg]), (adhd (low: [mobd]), (parental age: [grpa]), ( maternal diseases: [dsyn]), ( smoking: [inbe]), (stress): [fndg]), (firstborn-ship: []), (mpx asd probands: [cgab]), (results: [fndg]), (co-morbidity: []), (instead: []), ( ppfs: []), (crucial role: [socb]), (developmental pathways: [moft]), (disorder: [dsyn]), (index: [qnco]), (risk: []), ( whereas: []), (asd ppfs: [cgab]), (determining role: [socb]), (spx-mpx stratification: [resa]), (possible etiological differences: [qnco]), (asd families: [cgab]), (deeper insight: [menp]), (role: [socb]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10802-015-0081-0) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(perinatal risk factors, 'Perinatal Exposures')(perinatal risk factors, 'Perinatal Exposures')(affected/unaffected offspring, 'Perinatal History')(pre- perinatal data, 'Perinatal Exposures')(attention-deficit/hyperactivity disorder families, 'Attention Deficit Disorder with Hyperactivity')(perinatal risk factors, 'Perinatal Exposures')

PMCID: 4603300
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction autism: [mobd]), (genomic developmental disorders: [mobd]), (overlap: [topp]), (high-risk genes: [gngm]), (loci: [gngm]), (underlie intellectual disability (id): [mobd]), (aim: [phsu]), (stereological study: [resa]), (neuronal soma volume: [qnco]), (brain structures: [bpoc]), (subdivisions: [fndg]), (individuals: [humn]), (years: []), (age: [orga]), (chromosome: [celc]), (15q11.2-13.1 duplication syndrome [dup(15)]: [dsyn]), ( autism: [mobd]), ( id: [lbpr]), (age-matched subjects: [humn]), (autism: [mobd]), (unknown etiology: [fndg]), ((idiopathic autism): [mobd]), (control individuals: [humn]), (defects: []), (neuronal soma growth: [orgf]), (common denominator: [qnco]), (developmental pathology: [patf]), (syndromic autism: [mobd]), (genetic modifications: [resa]), (trajectory: []), (dup(15) autism: [mobd]), (application: [qnco]), (nucleator software: [inpr,mnob]), (neuronal size: [imft]), (significant neuronal soma volume deficits: [qnco]), (structures: []), (subregions: []), (%): []), (subjects: [humn]), (consistent neuronal soma volume deficits: [qnco]), (limbic system (sectors ca2: [bdsy]), (ammons: []), (third layers: [bpoc]), (entorhinal cortex: [bpoc]), (amygdala): [bpoc]), (thalamus: [bpoc]), (nucleus accumbens: [bpoc]), ( external globus pallidus: [bpoc]), (ch3 nucleus: [celc]), (magnocellular basal complex: [chvs]), (inferior olive: [bpoc]), (brainstem: [bpoc]), (second feature: [qnco]), (persistent neuronal soma deficits: [celc]), (adolescents: [aggp]), (young adults: [aggp]), ( whereas: []), (idiopathic autism: [mobd]), ( neuronal volume deficit: [dsyn]), (8-year-old children: []), (few brain regions: [blor]), (study: [resa]), (alterations: []), (neuronal growth: [orgf]), (lifespan: [grpa]), (core: [bdsu]), (pathological features: []), (however: []), ( dup(15): []), (persistent neuronal volume deficits: [qnco]), (adolescence: []), (adulthood: []), (prominent neuronal growth deficits: [orgf]), (major compartments: [npop]), (limbic system: [bdsy]), (cytoplasic volume deficits: [qnco]), (severe focal developmental defects: [acab]), (dup(15): []), (cohort: [popg]), (high prevalence: [qnco]), (early onset: [fndg]), (intractable epilepsy: [dsyn]), (sudden unexpected death: [patf]), (epilepsy: [dsyn]), 
ASD Terms: (loci that underlie intellectual disability, 'Learning Disorders')(introduction autism, 'Autism Phenotype')(underlie intellectual disability, 'Learning Disorders')(epilepsy, 'Epilepsy')(years of age, 'Onset of Symptoms')(autism, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(syndromic autism, 'Autism Phenotype')(dup autism, 'Autism Phenotype')(idiopathic autism, 'Autism Phenotype')(syndromic autism, 'Autism Phenotype')(early onset, 'Onset of Symptoms')(epilepsy, 'Epilepsy')(intractable epilepsy, 'Epilepsy')

PMCID: 5862414
SFARI Genes: 
Non SFARI Genes: CA3, 
Named Entities: (summary loss-of-function mutations: [phsf]), (synaptic adhesion: [patf]), (neuroligin-4: [aapp,bacs]), (common genetic abnormalities: [fndg]), (autism spectrum disorders: [mobd]), (function: [phsf]), (consequences: []), (loss: [qnco]), (network characteristics: [popg]), (neuroligin-4 knockout mice: [mamm]), (hippocampus: [bpoc]), (model brain region: [blor]), (critical role: [socb]), (cognition: [menp]), (memory: [menp]), (neuroligin-4 deletion: [genf]), (subtle defects: [clna]), (protein composition: [aapp,bacs]), (gabaergic synapses: [bsoj]), (hippocampal ca3 region: [bpoc]), (interestingly: []), (subtle synaptic changes: [qnco]), (pronounced perturbations: []), (-oscillatory network activity: [popg]), (cognitive function: [menp]), (neurodevelopmental disorders: [mobd]), (data: [euka]), (important insights: [menp]), (mechanisms: []), (neuroligin-4-dependent gabaergic synapses: [bsoj]), (phenotypes: [orga]), (new strategies: [menp]), (therapeutic approaches: [topp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(cognition, 'Cognitive Ability')(memory, 'Working Memory')(cognitive function, 'Cognitive Ability')(neurodevelopmental disorders, 'Learning Disorders')(autism phenotypes, 'Autism Phenotype')

PMCID: 4596821
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (intelligence: [menp]), (individuals: [humn]), (autism spectrum disorder (asd) varies: [mobd]), (pattern: []), (cognitive deficits: [mobd]), (asd: [cgab]), (absolute: []), (relative severity: [qnco]), (participants: [popg]), (relation: [socb]), (total: [qnco]), (children: [aggp]), ((m age: [orga]), (boys) participated:: [aggp]), (controls: [sbst]), (below average intelligence quotient (iq) group: [popg]), (average iq group (85<iq<115): [popg]), (above average iq group (iq>115): [popg]), (age: [orga]), ( sex: [orgf]), ( full scale iq (fsiq): [acty]), ( verbal iq (viq): []), ( performance iq (piq): [orga]), (viq-piq difference: [qnco]), (speed: [qnco]), (accuracy: []), (social cognition: [socb]), ( executive: []), (visual pattern recognition: [menp]), (basic processing speed: [qnco]), (domain: []), (composite score: [qnco]), (trend: []), (significant iq: [qnco]), (asd interaction (significant: [cgab]), (average iq group): [popg]), (absolute terms: [orgf]), ( participants: [popg]), (below average iqs: [qnco]), ((regardless: []), (diagnosis): [fndg]), (however: []), (relative terms: [orgf]), (average intelligent participants: [popg]), (substantial cognitive problems: [fndg]), (verbal working memory): [menp]), (group: [popg]), (iq-matched control group (p < .001): [grup]), (case: []), (below-average intelligence participants: [popg]), (asd (p = .57): [cgab]), (above average iqs: [qnco]), (below average iq patients: [podg]), (high iq asd individuals: [cgab]), (certain protection: [fndg]), (iq: []), (cognitive impairments: [mobd]), (clinical assessment: [hlca]), (treatment: [topp]), (conversely: []), (patients: [podg]), (asd patients: [cgab]), (above average: [qnco]), (differences: [qnco]), (cognitive functioning: [menp]), (end: [gngm]), (iq spectrum: [qnco]), (cognitive assessment: [diap]), (training: [edac]), (cognitive skills: [inbe]), (below average intelligent children: [aggp]), (fruitful endeavour: []), (findings: [clna]), (moderator: []), (cognitive presentation: []), (different cognitive processes: [menp]), (low end: [qnco]), 
ASD Terms: (autism spectrum disorder varies, 'Autism Phenotype')(cognitive deficits, 'Cognitive Ability')(cognitive deficits, 'Cognitive Ability')(intelligence quotient, 'IQ')(below average intelligence quotient group, 'IQ')(average intelligence quotient group, 'IQ')(above average intelligence quotient group, 'IQ')(full scale intelligence quotient, 'IQ')(verbal intelligence quotient, 'IQ')(performance intelligence quotient, 'IQ')(social cognition, 'Cognitive Ability')(visual pattern recognition, 'Visual Thinking')(significant intelligence quotient, 'IQ')(below average intelligence quotients, 'IQ')(substantial cognitive problems, 'Cognitive Ability')(average intelligence quotient patients, 'IQ')(above average intelligence quotients, 'IQ')(below average intelligence quotient patients, 'IQ')(high intelligence quotient asd individuals, 'IQ')(cognitive impairments, 'Cognitive Ability')(below average intelligence quotients, 'IQ')(cognitive functioning, 'Cognitive Ability')(intelligence quotient spectrum, 'IQ')(cognitive skills, 'Cognitive Ability')(cognitive assessment, 'Cognitive Ability')(cognitive presentation, 'Cognitive Ability')(different cognitive processes, 'Cognitive Ability')

PMCID: 4596286
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (autism spectrum disorders: [mobd]), (major public health problem: [fndg]), (children: [aggp]), (little understanding: [menp]), (causes: []), (asd: [cgab]), (serious social impact: []), (air pollution: [eehu]), (many toxicants: [hops]), (adverse effects: [patf]), (fetus: [tisu]), (population: [popg]), (casecontrol study: [resa]), (southwestern pennsylvania: []), (association: [menp]), (us epa: [orgt]), (nata (national air: [inch,phsu]), (assessment) levels: [acty]), (neurotoxicants: []), (total: [qnco]), (asd cases: [cgab]), (local asd diagnostic: [cgab]), (treatment centers: [topp]), (different control groups:: [grup]), (interviewed controls: [acty]), (frequency: [qnco]), (childs year: [aggp]), (birth: [orgf]), ( sex: [orgf]), (race: [gngm]), (complete residential histories: [humn]), (childs second birthday: [aggp]), (controls: [sbst]), (random sample: [resa]), (birth certificates: []), (controls): [sbst]), (residence: []), (logistic regression analysis: [resa]), (first quartile: [qnco]), (exposure: [clna]), (odds ratios (ors): [qnco]), (% confidence intervals: [qnco]), (mothers age: []), ( education: [fndg]), ( race: [gngm]), (status: []), (sex: [orgf]), (exposures: [phpr]), (adjusted or: []), (styrene: [hops,orch]), ((95 % ci =: [lbpr]), (p: [gngm]), (interviewed casecontrol analysis: [acty]), (% ci =: [lbpr]), (1.08-2.40: [fndg]), ( p: [aapp,imft]), (bc analysis: [resa]), (bc comparison: [acty]), ( chromium: [elii,hops]), (elevated or: []), (1.08-2.38: [fndg]), ( p =: [aapp,imft]), (interviewed analysis (or: [acty]), (% ci: [lbpr]), (borderline significant ors: [inch,phsu]), (methylene chloride (or: [hops,orch,phsu]), (p =: [aapp,imft]), (pahs (or: [orch]), (areas: []), (levels: []), (chromium: [elii,hops]), (pregnancy: [orgf]), (increased risk: [qnco]), (borderline effects: []), (pahs: [orch]), (methylene chloride: [hops,orch,phsu]), (results: [fndg]), (other studies: [lbpr]), (unclear: []), ( however: []), (chemicals: [chem]), (risk factors: [qnco]), (effect: []), (mixture: [sbst]), (pollutants: [hops]), (future work: []), (improved spatiotemporal estimates: [qnco]), (air: [gngm]), (account: [clna]), (dynamic movement: [orgf]), (individuals: [humn]), (daily life: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s12940-015-0064-1) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(exposure, 'Exposures')(quartile exposures, 'Exposures')(exposure, 'Exposures')

PMCID: 5304941
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (motor impairments: [patf]), (autism spectrum disorders: [mobd]), (research attention: [menp]), (social-communication: [socb]), (cognitive features: []), (yet: []), ( behavioral: [inbe]), ( neurophysiological: [phsf]), ( neuroimaging: [diap]), (histopathological studies: []), (abnormal motor system development: [cgab]), (majority: [socb]), (individuals: [humn]), (asd: [cgab]), (deficits: []), (disorder: [dsyn]), (several unique advantages: [qnco]), (motor development: [orgf]), (neurophysiological substrates: [sbst]), (motor skills: [orgf]), (animal: [anim]), (human lesion studies: [humn]), (second: [qnco]), (single-gene disorders: [fndg]), (motor dysfunctions: [fndg]), (third: [qnco]), (recent evidence: []), (onset: [qnco]), (emergence: []), (communication deficits: [socb]), (first year: [qnco]), (life: []), (motor deficits: [fndg]), (disruptions: []), (cortex: [bpoc]), (cerebellum: [bpoc]), (brainstem: [bpoc]), (questions: []), (timing: []), (development: [orgf]), (motor system alterations: []), (association: [menp]), (clinical features: [clna]), (heterogeneity: [orga]), (translational research: [resa]), (great promise: [qnco]), (gene-brain pathways: [gngm]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(motor impairments, 'Motor Skills')(cognitive features, 'Cognitive Ability')(abnormal motor system development, 'Learning Disorders')(motor dysfunctions, 'Motor Skills')(onset, 'Onset of Symptoms')(motor deficits, 'Motor Skills')

PMCID: 4591364
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (order: [acty]), (potential associations: [menp]), (autism spectrum disorder (asd): [mobd]), (functional gi disorders: [patf]), (fecal microbiota: [orgm]), (simplex families: [famg]), (single asd proband: [fndg]), (neurotypical (nt) siblings: [famg]), (simons simplex community: [bpoc]), (interactive autism network (ssc@ian): [popg]), (fecal samples: [bdsu]), (metadata: []), (diet: [hlca]), (asd probands: [cgab]), (nt siblings: [famg]), (asd: [cgab]), (functional: []), (gastrointestinal disorders: [dsyn]), (parent-completed rome iii questionnaire: []), (pediatric fgids: []), (problem behaviors: [mobd]), (child behavior check list (cbcl): [diap,inpr]), (quantitative polymerase chain reaction (qpcr) assays: [lbpr]), (taxa: []), (sutterella spp.: [gngm]), ( bacteroidetes spp: [bact]), (prevotella spp: [bact]), (illumina sequencing: [mbrt]), (v1v2: []), (v1v3 regions: []), (rrna genes: [gngm]), (fecal dna: [bacs,nnon]), (average depth: [qnco]), (high-quality reads: [dora]), (asd children: [cgab]), (rome iii criteria: []), (fgid: []), (functional constipation: [dsyn]), (asd (17: [cgab]), (nt siblings (6: [famg]), (p: [gngm]), (mean cbcl scores: [clna]), ( asd children: [cgab]), ((5862: []), (nt children: [diap]), (significant difference: [qnco]), (macronutrient intake: []), (asd severity scores: [cgab]), (diversity: []), (overall microbial composition: [clna]), (exploratory analysis: [resa]), (rrna: [bacs,nnon]), (data: [euka]), ( however: []), (several low abundance taxa: [qnco]), (genus level: [phsu]), (first order asd*fgid interactions: [cgab]), (<0.1): [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(interactive autism network, 'Autism Phenotype')(diet, 'Dietary Restrictions')(gastrointestinal disorders, 'Gastrointestinal Diseases')(problem behaviors, 'Personal Traits')(functional gastrointestinal disorders, 'Gastrointestinal Diseases')(first order asd*functional gastrointestinal disorders interactions, 'Gastrointestinal Diseases')

PMCID: 4589208
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (complex neurodevelopmental disorder: [mobd]), (deficits: []), (social cognition: [socb]), ( language development: [menp]), (behaviors: [inbe]), (complexity: [chvs]), (heterogeneity: [orga]), (asd: [cgab]), (lack: []), (proper human cellular model: [lbtr]), (pathophysiological mechanism: [patf]), (developmental process: [ortf]), (however: []), (recent progress: []), (induced pluripotent stem cell (ipsc) technology: [cell]), (vitro neural differentiation techniques: [lbpr,resa]), (neurons: [cell]), (analyze cortical development: [ortf]), (neural differentiation: [orgf]), (technical advances: []), (understanding: [menp]), (pathogenic mechanisms: [fndg]), (heterogeneous asd: [cgab]), (molecular biomarkers: [clna]), (patient stratification: [podg]), (medicine: [phsu]), (review: []), (current knowledge: [npop]), (ipsc generation: [acty]), ( differentiation: [celf]), (specific neuronal subtypes: [imft]), (ipscs: []), (phenotypic characterizations: [orga]), (human asd: [humn]), (patient-derived ipsc models: [podg]), (current limitations: [npop]), (ipsc technology: []), (future directions: []), (asd pathophysiology studies: [cgab]), 
ASD Terms: (social cognition, 'Cognitive Ability')(language development, 'Language Development')(autism spectrum disorder, 'Autism Phenotype')(complex neurodevelopmental disorder, 'Learning Disorders')(language development, 'Language Development')(phenotypic characterizations of human asd patient-derived, 'Autism Phenotype')

PMCID: 5545641
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (brain inflammation: [dsyn]), (microglia: [cell]), (brain expression: [bpoc]), (plasma levels: [bdsu]), (tumor necrosis factor (tnf): [aapp,imft]), (serum levels: [bdsu]), (il-6: [gngm]), (tnf: [gngm]), ((61.9594.76 pg ml1: [gngm]), (pg ml1: [gngm]), ( respectively): []), (same cohort: [popg]), (patients: [podg]), (elevated serum levels: [bdsu]), (corticotropin-releasing hormone (crh): [aapp,horm,phsu]), (neurotensin (nt): [aapp,horm]), (il-9: [gngm]), ( il-31: [aapp,bacs]), (il-33: [aapp]), (controls: [sbst]), (elevated crh: []), (nt levels: [diap]), (treatment: [topp]), (luteolin-containing dietary formulation: [orch,phsu]), (however: []), (mean serum il-6: [aapp,imft]), (tnf levels: [aapp,bacs]), (p=0.015: [fndg]), (end: [gngm]), (treatment period (26 weeks): [topp]), (levels: []), (beginning;: []), (decreases: [qnco]), (children: [aggp]), (behavior: [inbe]), (luteolin formulation treatment: [orch,phsu]), (results: [fndg]), (distinct subgroups: [virs]), (asds: [cgab]), (cytokines: [aapp,imft]), (distinct prognostic markers: []), (beneficial effect: []), (luteolin formulation: [orch,phsu]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 4614053
SFARI Genes: FMRP, FMRP, FMRP, FMRP, FMRP, FMRP, Fmr1, Fmr1, Fmr1, Fmr1, Fmr1, Fmr1, Fmr1, Fmr1, Fmr1, Fmr1, Fmr1, Fmr1, 
Non SFARI Genes: GFAP, 
Named Entities: (abstract fragile x syndrome: [cgab,dsyn]), (common single gene cause: [fndg]), (autism: [mobd]), ( results: [fndg]), (loss: [qnco]), (rnabinding protein fmrp: [aapp,bacs]), (fmrp: [gngm]), (neurons: [cell]), (glia: [cell]), (absence: [anab]), (abnormal function: [phsf]), (nonneuronal cells: [cell]), (pathogenesis: [patf]), (disorder: [dsyn]), (reduced numbers: [qnco]), (oligodendrocyte precursor cells: [cell]), (delayed myelination: [fndg]), (cerebellum: [bpoc]), (fragile x (fmr1) knockout mice: [mamm]), (quantitative western blotting: [lbpr,mbrt]), (immunocytochemistry: [lbpr]), (status: []), (astrocytes: [cell]), (microglia: [cell]), (fmr1 mice: [mamm]), (development: [orgf]), (adulthood: []), (expression: [topp]), (astrocyte marker gfap: [aapp,bacs]), (second postnatal week: [qnco]), (persisting: []), (weeks: []), (postnatal: []), ( expression: [topp]), (tumor necrosis factor receptor: [aapp,rcpt]), ((tnfr2): [aapp,rcpt]), (leukemia inhibitory factor (lif): [aapp,imft]), (fmr1 ko cerebellum: [bpoc]), (adults: [aggp]), (tnfr2: [gngm]), (glial marker s100: [clna]), (fmr1 knockouts: [emod]), (lif expression: [topp]), (wildtype mice: [mamm]), (evidence: []), (microglial activation: [celf]), (neuroinflammation: []), (age examined: [orga]), (findings: [clna]), (atypical pattern: [fndg]), (astrogliosis: [patf]), (fmr1 knockout mouse cerebellum: [mamm]), (enhanced tnfr2: [aapp,rcpt]), (young mice: [mamm]), (changes: [qnco]), (astrocytic proteins: [aapp,bacs]), (attempt: [evnt]), 
ASD Terms: (autism, 'Autism Phenotype')(abstract fragile x syndrome, 'Fragile X Syndrome')(fragile x knockout mice, 'Fragile X Syndrome')

PMCID: 4867450
SFARI Genes: SEMA5A, SEMA5A, SEMA5A, SEMA5A, SEMA5A, SEMA5A, SEMA5A, SEMA5A, SEMA5A, SEMA5A, 
Non SFARI Genes: 
Named Entities: (semaphorins: [aapp,bacs]), (large family: [famg]), (membrane-associated proteins: [aapp,bacs]), (wiring: [topp]), (brain: [bpoc]), (semaphorin: [aapp,bacs]), ((sema5a) acts: [topp]), (bifunctional guidance cue: [hlca]), (inhibitory effects: [acty]), (axons: [celc]), (previous studies: [lbpr]), (sema5a: [gngm]), (susceptibility gene: [gngm]), (autism spectrum disorders: [mobd]), (translocation t(5;22)(p15.3;q11.21): [comd]), (patient: [podg]), (asd: [cgab]), (intellectual disability (id): [mobd]), (translocation breakpoint: [nusq]), (chromosome: [celc]), (861-kb deletion: [genf]), (end: [gngm]), (sema5a gene: [gngm]), (breakpoint: []), (ngs: []), (gene: [gngm]), (sanger: []), (deleterious variants: []), (patients: [podg]), (independent heterozygous variants: [orga]), (conserved functional domain: []), (protein: [aapp,bacs]), (variants: []), (deleterious: []), (genetic screens: [diap]), (first case: [qnco]), (sema5a microdeletion: [gngm]), (id: [lbpr]), (study: [resa]), (associate sema5a: [gngm]), (susceptibility: [clna]), (additional evidence: []), (semaphorin dysfunction: [aapp,bacs]), (further studies: [lbpr]), (role: [socb]), (family: [famg]), (genes: [gngm]), (neurodevelopmental disorders: [mobd]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 4644211
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental syndrome: [dsyn]), (complex genetic etiology: [chvs]), (hundreds: []), (diverse genes: [gngm]), (asd;: [cgab]), (disparate function: [phsf]), (single clinical phenotype: [fndg]), (functional relationships: []), (autism candidate genes: [mobd]), (normal human brain development: [bpoc]), (convergent: [acty]), (mechanistic insight: [menp]), (genetic heterogeneity: [orga]), (asd: [cgab]), (co-expression relationships: [topp]), (genes: [gngm]), (autism: [mobd]), (brainspan: []), (human transcriptome database: [humn]), (anatomical brain regions: [blor]), (prenatal life: [aggp]), (adulthood: []), (modules: []), (asd candidate genes: [cgab]), (relevant temporal co-expression dynamics: [npop]), (functional ontologies: []), (gaba-ergic neurons: [cell]), (furthermore: []), (co-expression networks: [topp]), (entire transcriptome: [nusq]), (mitochondrial function: [celc]), ( protein translation: [moft]), (ubiquitination: [moft]), (hub genes: [gngm]), (asd-enriched modules: [cgab]), (further identified: [fndg]), (functions: [phsf]), (ontological findings: [clna]), (multi-dimensional co-expression analysis: [resa]), (human brain: [humn]), (heterogeneous set: [menp]), (asd candidates share: [cgab]), (transcriptional networks: [moft]), (formation: [biof]), (elimination: [phsf]), ( protein turnover: [moft]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s12031-015-0641-3) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental syndrome, 'Learning Disorders')(autism candidate genes, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4580585
SFARI Genes: OR2M4, MNT, OR2M4, MNT, GLIS1, NAALADL2, GLIS1, NAALADL2, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disorder: [mobd]), (strong genetic components: [gngm]), (several recent genome-wide association (gwa) studies: [mbrt]), (caucasian samples: [popg]), (number: [qnco]), (gene regions: [blor]), (loci: [gngm]), (risk: []), (asdalbeit: []), (little consensus: [socb]), (studies: [lbpr]), (two-stage gwa study: [mbrt]), (common genetic variants: [npop]), (asd: [cgab]), (taiwanese han population: [popg]), (discovery stage: [clna]), (patients: [podg]), (healthy controls: []), (affymetrix snp: [nusq]), (platform: []), (genotyping: [lbpr]), (several gene regions: [famg]), (top markers: [clna]), (extended samples: [sbst]), (single marker: [fndg]), ( haplotype: [orga]), ( gene-based: [gngm]), (pathway analyses: []), (associations: [menp]), (seven snps: [nusq]), (p-values: [qnco]), (none: []), (genome-wide significant level: [gngm]), (genes (or2m4: [gngm]), ( styk1: [gngm]), (mnt): [gngm]), (significant empirical gene-based p-values: [gngm]), (or2m4 (p =: [gngm]), (mnt (p: [gngm]), (results: [fndg]), (fine-mapping study: [acty]), (single-marker associations: [fndg]), (glis1 (rs12082358: [gngm]), (rs12080993): []), (naaladl2 (rs3914502: [gngm]), (genes: [gngm]), (gene-based associations: []), (or2m3-or2t5 (olfactory receptor genes: [aapp,rcpt]), ( p: [aapp,imft]), (glipr1/krr1 gene regions: [gngm]), (pathway: [moft]), (important pathways: [moft]), (olfactory: [orgf]), (g: [qnco]), (receptors: [aapp,rcpt]), (pathways: [moft]), (taiwanese han: [lang]), (specific susceptibility genes: [gngm]), (variants: []), (however: []), (further replication: [genf]), (other asian populations: [popg]), (findings: [clna]), (investigation: [hlca]), (biological functions: [biof]), (genetic variants: [npop]), (understanding: [menp]), (underlying pathogenesis: [patf]), (autism: [mobd]), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5068815
SFARI Genes: TSC1, TSC2, TSC1, TSC2, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (children: [aggp]), (communication skills: [orga]), (repetitive: []), ( stereotypic behavior: [mobd]), (pathophysiology: [patf]), (asd: [cgab]), (environmental heterogeneity: [orga]), (development: [orgf]), (therapies: [topp]), (diagnosis challenging: [hlca]), (genetic evidence: [topp]), (role: [socb]), (ca2+: [elii,phsu]), (here: []), (patient-derived fibroblasts: [cell]), (monogenic models: []), (asdfragile x: []), (tuberous sclerosis tsc1: [neop]), (tsc2: [gngm]), (ca2+ release: [hlca]), (inositol trisphosphate receptors: [orch,phsu,vita]), (ca2+ signals: [elii,phsu]), (g: [qnco]), (protein-coupled receptors: [aapp,rcpt]), (photoreleased ip3: [bacs,orch]), (levels: []), (local elementary ca2+ events: [elii]), (fundamental defects: []), (ip3r channel activity: [aapp,rcpt]), (ubiquitous involvement: []), (ip3r-mediated ca2+: [aapp,rcpt]), (neuronal excitability: [sosy]), (synaptic plasticity: [ortf]), ( gene expression: [genf]), (neurodevelopment: [ortf]), (dysregulated ip3r signaling: [celf]), (nexus: [bsoj]), (genes: [gngm]), (asd converge: [cgab]), (deleterious effect: []), (findings: [clna]), (potential pharmaceutical targets: [diap]), (skin fibroblasts: [cell]), (promising technique: []), (early detection: [diap]), (individuals: [humn]), 
ASD Terms: (communication skills together with repetitive, 'Reciprocal Social Interaction')(stereotypic behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorder, 'Autism Phenotype')(communication skills, 'Reciprocal Social Interaction')(stereotypic behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(diagnosis challenging, 'Diagnosis')(depressed ca2+ release through inositol trisphosphate receptors, 'Depressive Disorder')(tuberous sclerosis tsc1, 'Tuberous Sclerosis')

PMCID: 4574168
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (neurodevelopmental brain disorders: [bpoc]), (schizophrenia: [mobd]), ( autism: [mobd]), (attention deficit hyperactivity disorder: [mobd]), (complex disorders: [dsyn]), (heterogeneous etiologies: [orga]), (autism: [mobd]), (major individual suffering: [mobd]), (limited understanding: [menp]), (disease biology: [dsyn]), (understanding: [menp]), (biological pathogenesis needs: [patf]), (development: [orgf]), (targeted treatment options: [topp]), (improved efficacy: [resa]), (insights: [menp]), (pre-morbid disease: [qnco]), (morbid condition: [qnco]), (underlying biological disease mechanisms: [dsyn]), (studies: [lbpr]), (subjects: [humn]), (homogenous etiologies: [orga]), (breakthroughs: []), (psychiatric genetics: [hlca]), (several genetic anomalies: [fndg]), (danish research initiative: [resa]), (common microdeletion: [qnco]), (chromosome: [celc]), (genetic anomalies: [fndg]), (high risk: [fndg]), (methods/design: [acty]), (study: [resa]), (cause-to-outcome strategy: [menp]), (pre-morbid pathogenesis: [qnco]), (psychosis: [mobd]), (population: [popg]), (epidemiological design: [acty]), (disease prevalence: [qnco]), (environmental risk factors: []), (familial disposition: [famg]), (mental health disorders: [mobd]), (case control study design: [resa]), (functional effects: []), (neurophysiological traits: [gngm]), (deletion: [genf]), (recruited sample: [sbst]), (danish individuals: [humn]), (discussion identification: [menp]), (predictive pre-morbid clinical: [qnco]), ( cognitive: []), (structural brain alterations: [bpoc]), (deletion carriers: [genf]), (current clinical practice: [menp]), (symptomatic therapy: [topp]), (mental illness: [mobd]), (early intervention strategies: [hlca]), (risk subjects: [humn]), (etiology: []), (hopefully: []), (new insights: [menp]), (biological disease mechanisms: [dsyn]), (novel drug developments: []), (outcome: []), (pharmacological interventions: [hlca]), (psychiatry: []), 
ASD Terms: (neurodevelopmental brain disorders, 'Learning Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(attention deficit hyperactivity disorder, 'Overactivity')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(mental health disorders, 'Mental Disorders')(cognitive, 'Cognitive Ability')(cognitive, 'Cognitive Ability')(mental illness, 'Mental Disorders')

PMCID: 4564239
SFARI Genes: 
Non SFARI Genes: CLEC7A, CLEC7A, CLEC7A, CLEC7A, CLEC7A, CLEC7A, 
Named Entities: (introduction: [hlca]), (autism spectrum disorders: [mobd]), (complex gene-environment interactions: [genf]), (onset: [qnco]), (progress: []), (gastro-intestinal dysfunctions: [dsyn]), (asd: [cgab]), (involvement: []), (microbial dysbiosis: [patf]), (case-control design: [acty]), (influence: []), (dna polymorphisms: [genf]), (clec7a gene: [gngm]), (pivotal fungal sensor: [fngs]), ( dectin-1: [aapp,bacs]), (material: [sbst]), (methods dnas: [bacs,nnon]), (asd patients: [cgab]), (healthy controls: []), (clec7a rs16910631g/a: [gngm]), (rs2078178 a/g: [qnco]), ((snps): [nusq]), (differences: [qnco]), (distribution: []), (allele: [gngm]), ( genotype: [orga]), (haplotype: [orga]), (chi-square testing: [qnco]), (nonparametric analysis: [resa]), (kruskal-wallis/mannwhitney tests: [lbpr]), (appropriate: []), (performed: []), (free statistical package r.2.13 software: [inpr,mnob]), (statistical analysis: [resa]), (clec7a rs2078178 g allele: [gngm]), (gg genotype: [orga]), (hc: [gngm]), (statistical significance: [qnco]), (latter (pc =: [dsyn]), (respectively): []), (however: []), (phenotype-based stratification: [orga]), (asperger group: [popg]), (other asd subsets (pc: [dsyn]), (finding: [sosy]), (haplotype analysis (rs2078178/rs16910631 g-g/g-g) (pc: [dsyn]), (further: []), (intellectual quotient: [qnco]), ((iq)-based stratification: [resa]), (iq: []), (clec7a rs2078178 aa: [plnt]), ( ag: []), (gg genotypes (p: [orga]), (recessive manner (gg: []), (aa+ag p: [plnt]), (haplotype distribution: [orga]), (rs2078178-16910631; a-g/a-g: [qnco]), ( a-g/g-g: [qnco]), (g-g/g-g: [qnco]), ( p: [aapp,imft]), (g-g/g-g vs. others: [fndg]), (data: [euka]), (genetic diversity: [npop]), (asd phenotype: [cgab]), (disease specifier: [dsyn]), (imply: []), (genetic control: [genf]), (innate immune response: [orga]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(disease onset, 'Onset of Symptoms')(asperger group, 'Asperger Syndrome')(asd phenotype, 'Autism Phenotype')

PMCID: 4564166
SFARI Genes: ALDH1A3, ALDH1A3, Aldh1a3, Aldh1a3, ALDH1A3, Aldh1a3, ALDH1A3, Aldh1a3, Aldh1a3, Aldh1a3, ALDH1A3, ALDH1A3, 
Non SFARI Genes: FOXN1, Foxn1, FOXN1, Foxn1, Foxn1, FOXN1, 
Named Entities: (autism spectrum disorders: [mobd]), (range: [qnco]), (complex neurodevelopmental conditions: [mobd]), (dysfunctions: [dsyn]), (mental development: [menp]), (previous studies: [lbpr]), (genes: [gngm]), (asd: [cgab]), (brain: [bpoc]), (them: []), (whole exome sequencing: [mbrt]), (colombiansouth american trios: [aapp,enzy]), (missense novel snvs: [fndg]), (same child: aldh1a3 (refseq nm_000693: c.1514t>c (p.i505t)): [aggp]), (foxn1 (refseq nm_003593: c.146c>t (p.s49l)): [gngm]), (gene expression studies: [genf]), (aldh1a3: [gngm]), (foxn1: [gngm]), (~e13.5 mouse: [mamm]), (embryonic brain: [bpoc]), (adult piriform cortex (pc; ~p30): [bpoc]), (conserved retinoic acid response elements (rares) upstream: [gngm]), (human aldh1a3: [humn]), (mouse aldh1a3: [mamm]), (foxn1 genes: [gngm]), (bioinformatic approximation: []), (chromatin immunoprecipitation (chip): [lbpr]), (retinoid acid receptor b (rarb): [aapp,rcpt]), (immunoprecipitation target: [lbpr]), (ra regulation: [biof]), (mice: [mamm]), (results: [fndg]), (possible link: []), (asd etiology: [cgab]), (feasible non-additive effect: [sbst]), (unrelated variants: [fndg]), (result: [fndg]), (next generation sequencing: [mbrt]), (incidental finding: [fndg]), 
ASD Terms: (complex neurodevelopmental conditions, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 4724369
SFARI Genes: 
Non SFARI Genes: SPX, 
Named Entities: (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (unaffected siblings: [famg]), (individual: [humn]), (family affected): [famg]), (individuals: [humn]), (families: [famg]), (controls: [sbst]), (intelligence: [menp]), ( social cognition: [socb]), (executive functions: [menp]), (spx: [gngm]), (mpx asd: [cgab]), (displayed similar cognitive profiles: [lbpr]), (within-family contrasts: [irda]), (spx families: [famg]), (spx-mpx stratification: [resa]), (etiological heterogeneity: [orga]), (asd: [cgab]), (siblings: [famg]), ((regardless spx: [gngm]), (mpx): []), (cognitive problems: [fndg]), (part: [qnco]), (features: []), (endophenotypic trait: [orga]), (affective prosody: [fndg]), (sensitive cognitive marker: [clna]), (familial risk: [famg]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-015-2572-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social cognition, 'Cognitive Ability')(executive functions, 'Executive Function')(displayed similar cognitive profiles, 'Cognitive Ability')(cognitive problems, 'Cognitive Ability')(affective prosody, 'Prosody')(sensitive cognitive marker, 'Cognitive Ability')

PMCID: 4915503
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism phenotype (bap): [mobd]), (siblings: [famg]), (individuals: [humn]), (autism spectrum conditions: [mobd]), (autistic traits: [mobd]), (typical controls: []), (volunteers: []), (asc (n: [aapp,imft]), (autismspectrum quotient (aq): [qnco]), (selfreport: [resa]), (parentreport versions: []), (cluster analysis: [resa]), (aq: []), (subscale scores: [clna]), (subgroups: [virs]), (males: [orga]), (cluster: [qnco]), (lowscorers: []), (highscorers: []), (results: [fndg]), (while siblings: [famg]), (group: [popg]), (intermediate levels: [lbtr]), (participants: [popg]), (asc: [gngm]), (clinical group: [popg]), (further investigation: [hlca]), (epigenetic characteristics: []), (general population: [popg]), (relation: [socb]), (clinical diagnosis: []), (autism res: [mobd]), (autism research: [mobd]), (wiley periodicals: []), ( inc: []), (behalf: []), (international society: [orgt]), 
ASD Terms: (autism phenotype, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(clinical diagnosis, 'Diagnosis')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 4568303
SFARI Genes: 
Non SFARI Genes: NLRP5, NLRP7, NLRP2, NLRP5, NLRP5, 
Named Entities: (human-imprinting disorders: [humn]), (congenital disorders: [cgab,dsyn]), (growth: [orgf]), ( development: [orgf]), (metabolism: [orgf]), (disturbance: []), (parent: []), (origin-specific dna methylation: [moft]), (imprinted loci: [menp]), (genome: [gngm]), (imprinting disorders: [menp]), (prevalence: [qnco]), (monozygotic twinning: [orgf]), (assisted reproductive technology: [topp]), (multiple imprinted loci: [menp]), (few causative trans-acting mutations: [topp]), (mutations: [genf]), (nlrp5: [gngm]), (mothers: [famg]), (individuals: [humn]), (multilocus: []), (maternal-effect mutations: [genf]), (other human nlrp genes: [gngm]), ( nlrp7: [gngm]), (nlrp2: [gngm]), (familial biparental hydatidiform mole: [neop]), ( respectively: []), (offspring: [famg]), (nlrp5 mutations: [genf]), (epigenetic features: []), (cases: [qnco]), (discordant monozygotic twin pair: [famg]), ( individuals: [humn]), (idiopathic developmental delay: [mobd]), (autism: [mobd]), (families: [famg]), (infertility: [patf]), (reproductive wastage: [orgf]), (connections: []), (maternal reproductive fitness: [genf]), (zygotic development: [emst]), (genomic imprinting: [genf]), 
ASD Terms: (congenital disorders, 'Congenital Abnormalities')(offspring, 'Perinatal History')(individuals with idiopathic developmental delay, 'Learning Disorders')(idiopathic developmental delay, 'Learning Disorders')(autism, 'Autism Phenotype')

PMCID: 4556482
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (difficulties: [fndg]), (appropriate social interaction: [fndg]), (children: [aggp]), (autism spectrum disorders: [mobd]), (callous-unemotional traits (who: [tisu]), (risk: []), (psychopathy): [mobd]), (extant experimental studies: [resa]), (nature: []), (atypical social cognition: [socb]), (profiles: [lbpr]), (however: []), ( empathizing difficulties: [fndg]), (groups: [popg]), ( raising questions: []), (degree: [qnco]), (aetiological separation: [patf]), (social impairments: [patf]), (disorder: [dsyn]), (study: [resa]), (relative contribution: [acty]), (aetiological influences: []), (communication impairments: [mobd]), (autistic traits: [mobd]), (callous-unemotional traits: [tisu]), (parent-report: []), (population-based cohort: [popg]), (twins: [famg]), (participants: [popg]), (twin pairs: [famg]), (uk cohort (the twins early development study; teds): [resa]), (years: []), (multivariate model-fitting: [sosy]), (genetic/environmental influences: [topp]), (traits: [gngm]), (environmental influences: []), (individual differences: [menp]), (domain: []), (extant evidence: []), (neuro-imaging studies: [diap]), (social difficulties: [fndg]), (current study: [resa]), (considerable aetiological independence: []), (social interaction difficulties: [fndg]), 
ASD Terms: (appropriate social interaction, 'Reciprocal Social Interaction')(autism spectrum disorders, 'Autism Phenotype')(atypical social cognition, 'Cognitive Ability')(social impairments, 'Social Competence')(autism spectrum disorders, 'Autism Phenotype')(social difficulties, 'Social Competence')(autism spectrum disorders, 'Autism Phenotype')(social interaction difficulties, 'Reciprocal Social Interaction')

PMCID: 4653240
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (research: [resa]), (results: [fndg]), (first phase: []), (study: [resa]), (prevalence: [qnco]), (pupils: [bpoc]), (autism spectrum disorder (asd): [mobd]), (regular education: [fndg]), (quito: []), ( ecuador: []), (regular schools: [mnob,orgt]), (total: [qnco]), (asd: [cgab]), (interview: [acty]), (rector: []), (school: [mnob,orgt]), (delegate: [humn]), (low prevalence: [qnco]), (%: []), (asd diagnosis;: [cgab]), (diagnosis: [fndg]), (children: [aggp]), (adolescents: [aggp]), (light: [gngm]), (low diagnostic identification: [menp]), (low inclusion tolerance: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(asd diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')

PMCID: 4552377
SFARI Genes: EMB, EMB, 
Non SFARI Genes: EMB, 
Named Entities: (mind: [menp]), (eyes test (eyes test): [bpoc]), (advanced test: [lbpr]), (theory: []), (typical sex difference: [orga]), ((i.e.: [diap,inpr]), ( female advantage): [orga]), (individuals: [humn]), (autism show: [mobd]), (difficulty: [fndg]), (sex: [orgf]), (females: [orga]), (autism: [mobd]), (large: [gngm]), ( non-male-biased sample: [orga]), (effects: []), ( diagnosis: [fndg]), (interaction: []), (eyes test: [bpoc]), (version): []), (online: []), (adults: [aggp]), (autism (178: [mobd]), (females): [orga]), (control adults: [aggp]), (two-way anova: [qnco]), (significant sex-by-diagnosis interaction: [orgf]), (total correct score (f(1: [inch,phsu]), (711): []), (p: [gngm]), (significant sex difference: [orga]), (control males: [orga]), (cohens d: []), (absence: [anab]), (sex difference: [orga]), (males: [orga]), (autism (p: [mobd]), (d: [aapp,imft]), (significant case-control differences: [qnco]), (sexes: [orgf]), (effect sizes: []), (group-difference patterns fit: [sosy]), (extreme-male-brain (emb) theory predictions: [bpoc]), (eyes: [bpoc]), (test-empathy quotient: [inbe]), (eyes test-autism spectrum quotient correlations: [bpoc]), (autism (r: [mobd]), (r = -0.32: [fndg]), ( respectively): []), (groups: [popg]), (support vector machine (svm) classification: [qnco]), (response pattern: [fndg]), (items: []), (autism diagnosis: [mobd]), (accuracy: []), (nevertheless: []), (svm model: []), (other sex: [orgf]), (performance: [inbe]), (sex-independent phenotypic characteristic: [orgf]), (sex-common social difficulties: [orgf]), (support: []), (emb theory predictions: [gngm]), (same-sex controls: [orgf]), (coherence: [fndg]), (self-reported dispositional traits: [gngm]), (eyes test performance: [bpoc]), (other groups: [popg]), 
ASD Terms: (autism show, 'Autism Phenotype')(autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism diagnosis, 'Diagnosis')(sex-common social difficulties, 'Social Competence')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4549933
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, met, met, SHANK3, SHANK3, SHANK3, SHANK3, 
Non SFARI Genes: 
Named Entities: (phelan-mcdermid syndrome (pms): [dsyn]), (neurodevelopmental disorder: [mobd]), (terminal deletion: [genf]), (chromosome: [celc]), ((22q13): [celc]), (results: [fndg]), (loss: [qnco]), (function: [phsf]), (shank3 gene: [gngm]), (shank3: [gngm]), (gene-linkage studies: [moft]), (autism spectrum disorder (asd): [mobd]), (diagnosis: [fndg]), (asd: [cgab]), (individuals: [humn]), (pms: [gngm]), (presence: [qnco]), (global developmental delay/intellectual disability: [mobd]), (neurological symptoms: [sosy]), (current study: [resa]), (symptoms: [sosy]), (patients: [podg]), (preliminary exploration: [topp]), (genotype-asd phenotype correlations: [cgab]), (standardized interview: [acty]), (parents/guardians: [famg]), (children: [aggp]), (analyses: [resa]), (relationship: []), (disruption: []), (adjacent genes: [gngm]), (specific characteristic symptoms: [sosy]), (small subset: [qnco]), (sample: [sbst]), (majority: [socb]), (pms participants: [dsyn]), (persistent deficits: []), (social communication: [socb]), (half: [qnco]), (diagnostic criteria: []), (restricted: []), (repetitive patterns: []), (behavior: [inbe]), ( interests: [menp]), (activities: [acty]), (furthermore: []), (logistic regressions: [resa]), (general developmental delay: [mobd]), (asd diagnosis: [cgab]), (pms genotype: [dsyn]), (behavioral phenotype: [bhvr]), (additional complex relationships: [chvs]), (contributions: [acty]), (genes: [gngm]), (shank3 regions: [aapp]), (asd phenotype: [cgab]), (other neurobehavioral impairments: [patf]), (unique behavioral phenotype: [bhvr]), (better characterization: [acty]), (additional standardized assessments: [hlca]), (further analyses: [resa]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13023-015-0323-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(diagnosis, 'Diagnosis')(global developmental delay/intellectual disability, 'Learning Disorders')(neurological symptoms, 'Neurologic Indications')(symptoms of asd, 'Complaints and Indications')(social communication, 'Reciprocal Social Interaction')(repetitive patterns of behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(general developmental delay, 'Learning Disorders')(asd diagnosis, 'Diagnosis')(asd phenotype, 'Autism Phenotype')(other neurobehavioral impairments, 'Central Nervous System Diseases')

PMCID: 4550361
SFARI Genes: 
Non SFARI Genes: nodal, 
Named Entities: (introduction: [hlca]), (human functional connectome: [anst]), (graphical representation: [acty]), (nodes: [bpoc]), (edges: []), (inter-relationships: []), (blood: [bdsu]), (oxygenation-level dependent (bold) time-series: [celf]), (mri: [gngm]), (regions: []), (cerebral cortices: [bpoc]), (cerebellum: [bpoc]), (semi-metric analysis: [orch,phsu]), (weighted: [orga]), (connectome distinguishes: [anst]), (edge: []), (direct (metric): [orch,phsu]), (alternative path: [lbpr]), (alternative paths: [lbpr]), (strength: [qnco]), (direct edge: []), (sensitivity: [patf]), (specificity: [qnco]), (method: [lbpr]), (analysis: [resa]), (case-control analyses: [resa]), (independent: [fndg]), (groups: [popg]), (adolescents: [aggp]), (autism spectrum conditions: [mobd]), (major depressive disorder (mdd): [mobd]), (significance differences: [qnco]), (global percentage: [qnco]), (semi-metric edges: [orch,phsu]), (increases: [qnco]), (asc: [gngm]), (decreases: [qnco]), (mdd: [mobd]), (furthermore: []), ( mdd: [mobd]), (regional differences: [fndg]), (left frontal: []), (temporal lobes: [bpoc]), (right limbic system: [bdsy]), (contrast: [irda]), ( asc: []), (increased percentage: [qnco]), (generalised distribution: []), (effects: []), (areas: []), (reduction: [npop]), (summary: []), (localised: []), ( large reductions: [npop]), (percentage: [qnco]), ( whilst asc: []), (generalised: []), ( subtle increases: [qnco]), (differences: [qnco]), (detail: []), (inspection: []), (semi-metric backbone: [orch,phsu]), (group;: [popg]), (sub-graph: [qnco]), (>90%: [fndg]), (participants: [popg]), (nodal degree differences: [qnco]), (semi-metric connectome: [anst]), (encouraging results: [fndg]), (first application: [qnco]), (data: [euka]), ( raise confidence: [menp]), (methodology: []), (detection: [topp]), (characterisation: [acty]), (range: [qnco]), (psychiatric disorders: [mobd]), 
ASD Terms: (autism spectrum conditions, 'Autism Phenotype')(major depressive disorder, 'Depressive Disorder')(major depressive disorder relative, 'Depressive Disorder')(autism spectrum conditions, 'Autism Phenotype')(whilst autism, 'Autism Phenotype')(major depressive disorder, 'Depressive Disorder')(whilst autism, 'Autism Phenotype')(psychiatric disorders, 'Mental Disorders')

PMCID: 4550720
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (second-to-fourth digit: [bpoc]), (measure: [qnco]), (proxy: [grup]), (fetal testosterone exposure: [horm,orch,phsu]), (autism spectrum disorders: [mobd]), (extreme male brain theory: [bpoc]), (autism: [mobd]), (design: [acty]), (birth cohort study: [qnco]), (avon longitudinal study: [resa]), (parents: []), (children: [aggp]), (participants: [popg]), (alspac children: [aggp]), (data: [euka]), (digit ratio: [qnco]), (outcome measure: [qnco]), (information: []), (potential confounding variables: []), ((parental occupational class: []), (maternal education: [fndg]), (age: [orga]), (digit ratio measurement): [lbpr]), (photocopy: [mcha]), (calliper method: [lbpr]), (outcomes asd diagnosis (cases: [cgab]), (record linkage: [moft]), (maternal report): [hlca]), (measures: [qnco]), (alspac: []), (asd:: [cgab]), (children's communication checklist (coherence: [aggp]), (social: []), (communication disorders checklist: [mobd]), (repetitive behaviour measure: [qnco]), (emotionality: [fndg]), ( activity: [acty]), (sociability: [socb]), ((sociability subscale): [socb]), (risk group: [popg]), (logistic regression: [resa]), (association: [menp]), (asds: [cgab]), (dichotomised asd traits: [cgab]), (covariates: []), (occupational class: []), ( maternal education: [fndg]), (measurement: []), (males: [orga]), (or: []), (sd increase: [mamm]), ((95% ci: [lbpr]), (p=0.435): [fndg]), (females: [orga]), (or=1.36 (95% ci: [fndg]), (p=0.245): [fndg]), (similar results: [fndg]), (adjustment: [inbe]), (iq: []), (weak association: [menp]), (coherence: [fndg]), (opposite direction: []), (or=1.15 (95% ci: [fndg]), (p=0.023): [fndg]), (multiple comparisons: [acty]), (chance: []), (population-based study: [resa]), (strong evidence: []), (asd diagnosis: [cgab]), (traits: [gngm]), (cis: [gngm]), (wide: []), (results: [fndg]), 
ASD Terms: (fetal testosterone exposure, 'Exposures')(autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(outcomes asd diagnosis, 'Diagnosis')(repetitive behaviour measure, 'Restricted and Repetitive Behavior')(occupational class, 'Job Performance')(autism spectrum disorders, 'Autism Phenotype')(asd diagnosis, 'Diagnosis')

PMCID: 4627571
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (last decades: [qnco]), ( prevalence: [qnco]), (autism spectrum disorder (asd): [mobd]), (rise: []), (however: []), (clear aetiology: [fndg]), (improvements: []), (early diagnosis: [diap]), (possible biomarkers: [clna]), (asd: [cgab]), (two-dimensional polyacrylamide gel electrophoresis: [lbpr]), (nanoliquid chromatography-tandem mass spectrometry: [mbrt]), (salivary proteome profiling: [lbpr]), (children: [aggp]), (controls: [sbst]), (total: [qnco]), (spots: [sosy]), (fold change 1.7: [qnco]), (p-value <0.05: [qnco]), (fold change: [qnco]), (3.0: [fndg]), (asd cases: [cgab]), (alpha-amylase: [aapp,enzy,phsu]), ( creb-binding protein: [aapp]), ( p532: [gngm]), ( transferrin: [aapp,bacs]), ( zn: []), (glycoprotein: [aapp,bacs]), ( zymogen granule: [celc]), (cystatin d: [gngm]), (plasminogen: [aapp,bacs,phsu]), (expression: [topp]), (proto-oncogene frequently: [gngm]), (advanced t-cell lymphomas: [neop]), ((frat1): []), ( kinesin family member: [aapp,enzy]), (integrin alpha6 subunit: [aapp,bacs]), ( growth hormone: [aapp,horm]), (tbc: [gngm]), (parotid secretory protein: [aapp]), (prolactin-inducible protein: [aapp,bacs]), (mucin-16: [gngm]), ( ca: [bpoc]), (protein migration: [aapp,bacs]), (inhibitory factor-related protein: [acty]), ((mrp14): [aapp,imft]), (individuals: [humn]), (identified proteins: [aapp,bacs]), (risk factors: [qnco]), (genetic level: [phsu]), (others: [fndg]), (pathological pathways: [moft]), (asd causality: [cgab]), (oxidative stress: [comd]), ( lipid: [orch]), (cholesterol metabolism: [moft]), ( immune system disturbances: [bdsy]), (inflammation: [patf]), (data: [euka]), (signatures: [amas]), (asd presence: [cgab]), ( risk: []), (subtypes: []), (advance understanding: [menp]), (asd cause: [cgab]), (provide: [acty]), (treatment targets: [topp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(early diagnosis, 'Diagnosis')

PMCID: 4537259
SFARI Genes: Cntnap2, Cntnap2, Cntnap2, Cntnap2, Cntnap2, Cntnap2, Cntnap2, Cntnap2, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder: [mobd]), (several neurodevelopmental conditions: [mobd]), (symptoms: [sosy]), (social communication: [socb]), (repetitive behaviors: [fndg]), (major roadblock: []), (drug development: []), (autism: [mobd]), (lack: []), (robust behavioral signatures: [amas]), (clinical efficacy: []), (issue: [fndg]), (characterized: [acty]), (rigorous way: [sosy]), ( mouse models: [mamm]), (interest: [menp]), (construct validity: []), (wide availability: []), (scientific community: []), (broad behavioral battery: [inbe]), (autism domains: [mobd]), (goal: []), (robust: []), (reliable phenotypes: [orga]), (further testing: []), (comprehensive findings: [clna]), (mouse models: [mamm]), (different developmental stages: []), (systematic behavioral test battery: [diap]), (standard tests: [lbpr]), (computer-vision: [orgf]), (systems: []), (first mouse model: [emod]), (deletion: [genf]), (human chromosome: [celc]), (individuals: [humn]), (second mouse model harbors: [emod]), (homozygous null mutations: [genf]), (cntnap2: [gngm]), (pitt-hopkins-like syndrome: [dsyn]), (previous results: [fndg]), (heterozygous null mice: [mamm]), (del(7slx1b-sept1)4aam: [comd]), (wild type: [gngm]), (hyperactivity: [mobd]), (social deficits: []), (homozygous null mice: [mamm]), (testing: []), (mild gait phenotype: [fndg]), (deficits: []), (three-chamber social preference: [bpoc]), (open field test: [irda]), (exposure: [clna]), (estrous female: [orgf]), (cntnap2 null mice: [mamm]), (vocalizations: [fndg]), (addition: []), ( cntnap2 null mice: [mamm]), (cognitive procedural learning test: [menp]), (finding: [sosy]), (robust behavioral phenotypes: [bhvr]), (animal models: [anim]), (task: [gngm]), (such functional readouts: []), (development: [orgf]), (therapeutics: [orch,phsu]), (negative findings: [fndg]), (resource: []), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(several neurodevelopmental conditions, 'Learning Disorders')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(core autism domains, 'Autism Phenotype')(autism, 'Autism Phenotype')(different developmental stages, 'Learning Disorders')(autism, 'Autism Phenotype')(hyperactivity, 'Overactivity')(social deficits, 'Social Competence')(exposure, 'Exposures')(vocalizations, 'Vocalizations')(cognitive procedural learning test, 'Cognitive Ability')

PMCID: 4534101
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objective: []), (parents: []), (professionals: []), (causes: []), (treatment: [topp]), (autism spectrum disorders (asd): [mobd]), (kenyan coast: [popg]), (in-depth interviews: [acty]), (group discussions: [socb]), (questions: []), (data collection: [resa]), (participants: [popg]), (children: [aggp]), (asd: [cgab]), (special needs: []), (teachers: []), ( clinicians: []), (social workers: []), (diverse cultural background: []), (study: [resa]), (interviews: [acty]), (groups: [popg]), (recorded: [qnco]), ( transcribed verbatim: []), (themes: []), (content analysis: [resa]), (preternatural causes: []), (evil spirits: [bodm]), ( witchcraft: []), (curses: []), (biomedical causes: []), (infections: [patf]), ( drug abuse: [mobd]), ( birth complications: [fndg]), ( malnutrition: [dsyn]), (problems: []), (spiritual healing: [topp]), (health facilities: [hcro,mnob]), (consultations: [hlca]), (traditional healers: []), ( offering prayers: []), (god: []), (visits: [hlca]), (results: [fndg]), (regardless: []), (cultural backgrounds: []), ( people: [popg]), (similar views: []), (perceived causes: [menp]), (findings: [clna]), (valuable conceptual understanding: [menp]), (planning: [menp]), (community: []), (rehabilitation interventions: [topp]), (local context: [fndg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(drug abuse, 'Drug Abuse')(birth complications, 'Obstetric Delivery Complications')(planning, 'Planning')

PMCID: 4556734
SFARI Genes: 
Non SFARI Genes: rest, 
Named Entities: (endophenotypes: []), (quantifiable markers: [clna]), (identification: [menp]), (complex genetic underpinnings: [chvs]), (psychiatric conditions: [mobd]), (global hypoconnectivity: []), (endophenotype: []), (autism spectrum conditions: [mobd]), (well-matched groups: [grup]), (adolescent males: [aggp]), (autism: [mobd]), ( genetically-related siblings: [famg]), (individuals: [humn]), (typically-developing control participants: [popg]), (brain: [bpoc]), (regions: []), (complex-network analysis: [chvs]), (robust hypoconnectivity endophenotype: []), (participant group: [popg]), (whole-brain functional connectivity: [bpoc]), (controls: [sbst]), ( intermediate: [lbtr]), (siblings: [famg]), (asc: [gngm]), (task: [gngm]), (rest conditions: [dora]), (additional: []), ( local endophenotype effects: []), (specific networks: []), (visual processing: [menp]), (default mode networks: [qnco]), (analyses: [resa]), (whole-brain functional hypoconnectivity: [bpoc]), (adolescence: []), (heritable similarities: []), (adolescents: [aggp]), (relatives: [famg]), 
ASD Terms: (complex genetic underpinnings of psychiatric conditions, 'Mental Disorders')(psychiatric conditions, 'Mental Disorders')(autism spectrum conditions, 'Autism Phenotype')(autism, 'Autism Phenotype')(visual processing, 'Visual Thinking')(autism, 'Autism Phenotype')

PMCID: 4995547
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (onset: [qnco]), (age: [orga]), (years: []), ( autism spectrum disorders: [mobd]), (diseases: [dsyn]), (pre- and/or: [mamm]), (early postnatal brain: [bpoc]), (developmental anomalies: [cgab]), (early brain insults: [bpoc]), (molecular mechanisms: []), (place: [acty]), (misshaping: []), (brain: [bpoc]), (cells: [cell]), (early stages: [clna]), (ontogenesis: [orgf]), (stem cells: [cell]), (molybdenum cofactor sulfurase (mocos): [gngm]), (enzyme: [enzy,orch]), (purine metabolism: [moft]), (player: []), (asd: [cgab]), (adult: [aggp]), (nasal olfactory stem cells: [orgf]), (adults: [aggp]), (mocos: [gngm]), (gender-matched control adults: [orga]), (neuropsychiatric disorders: [dsyn]), (genetic approaches: [topp]), (vivo: []), (vitro: []), (models: []), (altered expression: [topp]), (mocos results: [fndg]), (neurotransmission: [celf]), (synaptic defects: []), (mocos misexpression induces: [gngm]), (oxidative-stress sensitivity: [comd]), (results: [fndg]), (mocos expression: [topp]), (impact: [gngm]), (neurodevelopment: [ortf]), (comorbid conditions: [fndg]), (gastrointestinal disorders: [dsyn]), (discovery: [acty]), (fresh starting point: [qnco]), (study: [resa]), (roles: [socb]), (brain development: [ortf]), (functional implications: []), (clinical symptoms: [sosy]), (moreover: []), (possible development: [orgf]), (new diagnostic tests: [diap]), (way: []), (drug: [phsu]), (novel treatments: [topp]), 
ASD Terms: (age of 3 years, 'Onset of Symptoms')(autism spectrum disorders, 'Autism Phenotype')(onset, 'Onset of Symptoms')(autism spectrum disorders, 'Autism Phenotype')(explain comorbid conditions, 'Comorbidities')(gastrointestinal disorders, 'Gastrointestinal Diseases')

PMCID: 4990618
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (klinefelter syndrome (47: [cgab,dsyn]), ( xxy): []), (several physical: [hlca]), ( cognitive: []), (behavioral consequences: [inbe]), (terms: [orgf]), (social development: [socb]), (increased risk: [qnco]), (autism symptomatology: [mobd]), (however: []), (social deficits: []), (abnormal brain development: [bpoc]), (mechanisms: []), (social dysfunction: [dsyn]), (xxy: []), (similar to: []), (different from: []), (idiopathic autism (asd): [cgab]), (study: [resa]), (neural architecture: []), (brain structures: [bpoc]), (social information processing: [menp]), (boys: [aggp]), (comparison: [acty]), (idiopathic asd: [cgab]), (mri scans: [qnco]), (asd: [cgab]), (nonclinical: []), ( male controls: [orga]), (voxel-based morphometry (vbm): [lbpr]), (region: []), (interest mask: [gngm]), (superior temporal cortex: [bpoc]), ( amygdala: [bpoc]), (orbitofrontal cortex (ofc): [blor]), (insular cortex: [bpoc]), (medial frontal cortex: [bpoc]), (social responsiveness scale (srs): [acty]), (degree: [qnco]), (autism spectrum symptoms: [sosy]), (xxy group: [popg]), (asd group: [cgab]), (mean srs scores: [clna]), (scores: [clna]), (controls: [sbst]), (vbm: [topp]), (significant gray matter volume reductions: [tisu]), (left: []), (right insula: [bpoc]), (left ofc: [dsyn]), (additionally: []), (gray matter: [tisu]), (right superior temporal gyrus: [bpoc]), (results: [fndg]), (social challenges: [hlca]), (neural anatomy: [anst]), (autism symptoms: [mobd]), (etiologies: []), 
ASD Terms: (cognitive, 'Cognitive Ability')(terms of social development, 'Ability to Converse in Social Settings')(autism symptomatology, 'Autism Phenotype')(social development, 'Ability to Converse in Social Settings')(degree underlying mechanisms of social dysfunction, 'Social Competence')(social deficits, 'Social Competence')(abnormal brain development, 'Learning Disorders')(social dysfunction, 'Social Competence')(idiopathic autism, 'Autism Phenotype')(social information processing, 'Ability to Convey Information')(autism spectrum symptoms, 'Complaints and Indications')(autism symptoms, 'Complaints and Indications')(social challenges, 'Social Competence')

PMCID: 4543079
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (copy number variations: [nusq]), (chromosome: [celc]), (contribute: [acty]), (neurodevelopmental disorders: [mobd]), (autism spectrum disorder (asd): [mobd]), (study: [resa]), (understanding: [menp]), (biological basis: [phsu]), (behavioral phenotypes: [bhvr]), (asd: [cgab]), (prevalent disruption: [qnco]), (spoken language: [fndg]), (children: [aggp]), (bp4bp5 deletion: [genf]), (auditory: []), (language: [lang]), (white matter pathways: [tisu]), (diffusion mri: [diap]), (cohort: [popg]), (pediatric deletion carriers: [genf]), (age-matched controls: [orga]), (diffusion mr tractography: [diap,resa]), (auditory radiations: [bpoc]), (arcuate fasciculus: [bpoc]), (tract: [bpoc]), (specific measures: [qnco]), (white matter microstructure: [tisu]), (tracts: [bpoc]), ( deletion carriers: [genf]), (diffusivity: []), (controls: [sbst]), (cross-sectional diffusion parameters: [npop]), (age: [orga]), (group difference: [popg]), (rate: [qnco]), (maturation: [phsf]), (deletion: [genf]), (left-hemisphere arcuate: []), (fasciculus mean: [qnco]), (radial diffusivities: []), (clinical language ability: [menp]), (non-verbal cognitive ability: [menp]), (diffusion metrics: [orch,phsu]), (right-hemisphere arcuate fasciculus: [bpoc]), (language ability: [menp]), (results: [fndg]), (link: []), (abnormal auditory: [qnco]), (specific behavioral deficits: [inbe]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(clinical language ability, 'Development or Regression of Language Skills')(non-verbal cognitive ability, 'Cognitive Ability')(language ability, 'Development or Regression of Language Skills')(specific behavioral deficits, 'Personal Traits')

PMCID: 4633447
SFARI Genes: CAT-3, SLC7A3, CAT-3, SLC7A3, SLC7A3, SLC7A3, SLC7A3, CAT-3, SLC7A3, CAT-3, SLC7A3, SLC7A3, CAT-3, CAT-3, SLC7A3, SLC7A3, SLC7A3, SLC7A3, 
Non SFARI Genes: impact, 
Named Entities: (cationic amino acid transporters: [aapp,bacs]), (entry: []), (l-type: [qnco]), (cationic amino acids: [chvs]), (ornithine: [aapp,bacs,phsu]), (lysine): [aapp,bacs,phsu]), (cells: [cell]), (neurons: [cell]), (cat-3: [gngm]), (slc7a3 gene: [gngm]), (chromosome x: [celc]), (cats present: [mamm]), (human genome: [gngm]), (selective expression: [genf]), (brain: [bpoc]), (slc7a3: [gngm]), (variation: []), (humans: [humn]), (low frequency: []), (deleterious variants: []), (available databases: []), (impact: [gngm]), (variants: []), (gene: [gngm]), (humans remains: [humn]), (study: [resa]), (missense variant: [fndg]), (cat-3 cationic amino: [chvs]), (transporter: [aapp,bacs]), (exome sequencing: [mbrt]), (brothers: [famg]), (autism spectrum disorder (asd): [mobd]), (sequence: [nusq]), (male patients: [orga]), (asd: [cgab]), (additional rare missense variants: [fndg]), (unrelated patients: [podg]), (functional analyses: [hlca]), (mutant transporters: [aapp,bacs]), (moderate loss: [qnco]), (cat-3 function: [phsf]), (altered protein stability: []), (abnormal trafficking: [qnco]), (plasma membrane: [celc]), (patient: [podg]), (deleterious slc7a3 variant: [gngm]), (high-functioning autism: [mobd]), (epilepsy: [dsyn]), (duplication: [comd]), (phenotype: [orga]), (rare hypomorphic variants: [gngm]), (male individuals: [orga]), (slc7a3 variants: [gngm]), (etiology: []), (male subjects: [orga]), (association: [menp]), (other genetic factors: [fndg]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s00726-015-2057-3) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(high-functioning autism, 'Autism Phenotype')(epilepsy, 'Epilepsy')

PMCID: 4512676
SFARI Genes: CACNA1C, CACNA1C, CACNA1C, CACNA1C, CACNA1C, CACNA1C, CACNA1C, CACNA1C, CACNA1C, CACNA1C, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (group: [popg]), (neurodevelopmental disorders: [mobd]), (strong genetic component: [gngm]), (many lines: []), (evidence: []), (asd shares: [cgab]), (common genetic variants: [npop]), (other psychiatric disorders: [mobd]), (example: []), ( schizophrenia): [mobd]), (previous studies: [lbpr]), (calcium channels: [aapp,bacs]), (etiology: []), (many psychiatric disorders: [mobd]), (schizophrenia: [mobd]), (autism: [mobd]), (significant association: [menp]), (cacna1c (calcium: [bacs,elii,phsu]), (voltage-dependent: [qnco]), ( l type: [qnco]), (subunit): [aapp]), (furthermore: []), (rare mutation: [genf]), (cacna1c: [gngm]), (timothy: [plnt]), (multisystem disorder: [dsyn]), (autism-associated phenotype: [mobd]), (however: []), (association: [menp]), (chinese han population: [popg]), (single nucleotide polymorphisms (snp): [nusq]), (family-based association study: [socb]), (eighteen snps: [nusq]), (trios: [aapp,enzy]), (snps: [nusq]), (sequenom: []), (platform: []), (snps (rs1006737: [nusq]), (rs4765905): []), (trend: []), (sample size: [qnco]), (haplotype: [orga]), (family-based association test (fbat): [socb]), (haploview: []), (permutation tests: [lbpr]), (corrections: []), (significance level: [resa]), (statistical tests: []), (two-tailed (p<0.05): [bpoc]), (results: [fndg]), (g allele: [gngm]), (rs1006737: []), (rs4765905: []), (preferential transmission: [patf]), (affected offspring: [famg]), (haplotype analyses: [orga]), (haplotypes: [orga]), (respectively; global p=0.046): [fndg]), (permutation correction (n=10: [fndg]), (000: []), ( p=0.027): [fndg]), (research: [resa]), (role: [socb]), (genetic etiology: [topp]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(other psychiatric disorders, 'Mental Disorders')(many psychiatric disorders, 'Mental Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(affected offspring, 'Perinatal History')(autism, 'Autism Phenotype')

PMCID: 4511534
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (parents: []), (children: [aggp]), (autism: [mobd]), (rates: [qnco]), (broad autism phenotype (bap) features: [mobd]), (children (tdc): [aggp]), (western countries: []), (study: [resa]), (rate: [qnco]), (bap features: [aapp,enzy]), (relationship: []), (parental bap: [aapp,enzy]), (social impairment: [patf]), (chinese sample: [sbst]), (total: [qnco]), (families: [famg]), (autistic children: [podg]), (tdc: []), (broad autism phenotype questionnaire (bapq): [mobd]), (best-estimate versions: [lbpr]), (chinese version: [lang]), (social responsiveness scale (srs): [acty]), (tdc; mothers: [famg]), (fathers: [famg]), (various bap features: [aapp,enzy]), (total scores: [qnco]), (best-estimate bapq versions: [lbpr]), (childrens srs: []), (autism group: [mobd]), (bapq versions: []), (mothers: [famg]), (tdc group: [popg]), (total srs scores: [clna]), (bap present parents: [aapp,enzy]), (absent parents: [fndg]), (bap: [gngm]), (sample: [sbst]), (chinese parents: [lang]), (childrens social functioning: [socb]), (autism families: [famg]), (tdc families: [famg]), (patterns: []), (associations: [menp]), 
ASD Terms: (broad autism phenotype features, 'Autism Phenotype')(autism, 'Autism Phenotype')(broad autism phenotype features, 'Autism Phenotype')(parental broad autism phenotype, 'Autism Phenotype')(social impairment, 'Social Competence')(broad autism phenotype questionnaire, 'Autism Phenotype')(various broad autism phenotype features, 'Autism Phenotype')(broad autism phenotypeq versions, 'Autism Phenotype')(broad autism phenotypeq versions, 'Autism Phenotype')(autism group, 'Autism Phenotype')(broad autism phenotype present parents, 'Autism Phenotype')(autism phenotype absent parents, 'Autism Phenotype')(broad autism phenotype, 'Autism Phenotype')(broad autism phenotype features, 'Autism Phenotype')(childrens social functioning, 'Ability to Converse in Social Settings')(autism families, 'Autism Phenotype')

PMCID: 4511766
SFARI Genes: 
Non SFARI Genes: Mb, 
Named Entities: (deletion syndrome (22q11ds): [genf]), (genetic risk factors: []), (development: [orgf]), (psychotic illness: [fndg]), (high rates: [qnco]), (autistic spectrum disorders: [mobd]), (childhood: []), (integrated genomic analyses: [gngm]), (genes: [gngm]), (pathways: [moft]), (specific phenotypes: [orga]), (high-resolution acgh array: [lbpr]), (deletion breakpoints: [genf]), (peripheral blood: [bdsu]), (differential expression (de): [topp]), (networks: []), (co-expressed genes: [gngm]), (variation: []), (patients: [podg]), (whole-genome transcriptional profiling: [genf]), (illumina human ht-12 microarrays: [humn]), (data mining techniques: [mcha]), (results: [fndg]), (independent samples: [sbst]), (brain tissue: [bpoc]), (idiopathic psychosis: [mobd]), (asd cases: [cgab]), (eighty-five percent: [qnco]), (individuals: [humn]), (mb deletion: [genf]), (significant variability: [qnco]), (deletion characteristics: [genf]), (remainder: []), (sample (n: [aapp,imft]), (de analysis: [resa]), (weighted gene co-expression network analysis (wgcna): [orga]), (expression changes: [qnco]), (psychotic symptoms: [sosy]), (module: []), (psychosis: [mobd]), (transcriptional regulation: [genf]), (brain-expressed genes: [gngm]), (antipsychotic medication use: [phsu]), (transcriptional changes: [genf]), (idiopathic schizophrenia: [mobd]), (de: []), (wgcna analyses: [resa]), (dysregulation: []), (immune response pathways: [moft]), (asd-associated module: [cgab]), (significant overlap: [topp]), (idiopathic asd: [cgab]), (findings: [clna]), (use: []), (peripheral tissue: [tisu]), (study: [resa]), (major mutational models: [genf]), (diseases: [dsyn]), (brain: [bpoc]), (point towards: [qnco]), (specific pathways: [moft]), (carriers: [fndg]), (asd: [cgab]), 
ASD Terms: (autistic spectrum disorders, 'Autistic Disorder')(idiopathic schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(antipsychotic medication use, 'Medications')

PMCID: 4508765
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (methylmercury (mehg): [hops,orch]), (century: [phsu,vita]), (neurotoxin: [hops]), (adults: [aggp]), (potential detrimental effects: []), (early brain development: [ortf]), (several studies: [lbpr]), (mercury: [elii,hops]), (single biomarker: [fndg]), (limitations: []), (goal: []), (paper: []), (toxicokinetic model: []), (biomarker: [clna]), (questionnaire data: [euka]), (cumulative exposure: [phpr]), (mehg: []), (seafood consumption: [acty]), (data: [euka]), (childhood autism risks: [mobd]), (genetics: []), (environment (charge) study: [orga]), (discrete-time model: []), (blood mehg concentration: [lbtr]), (piecewise-constant ingestion rate: [biof]), (single-compartment pharmacokinetics: [fndg]), (newborn bloodspot hg concentrations: [aggp]), (information: []), (maternal fish consumption: [fish]), (questionnaire: []), (mehg concentration estimates: [menp]), (cumulative mehg exposure: [phpr]), (children: [aggp]), (autism: [mobd]), ( children: [aggp]), (developmental delay: [mobd]), (cumulative mehg: []), (diagnostic groups: [popg]), (kruskal-wallis test: []), (multinomial: []), (logistic regression models: [inpr,qnco]), (association: [menp]), (cumulative mehg concentration: [menp]), (risk: []), (developmental delay (vs: [mobd]), (typical development): [orgf]), (estimated average mehg concentration: [qnco]), (fish species: [fish]), (mothers: [famg]), (ppb: [gngm]), (median cumulative mehg: [qnco]), (gestation: [orgf]), (diagnostic groups (p-values: [popg]), (potential confounding: []), (autism (or: [mobd]), (% ci:: [lbpr]), (developmental delay (or: [mobd]), (fish mehg concentration estimates: [fish]), (levels: []), (overall: []), (regression standard error: [menp]), (asd: [cgab]), (td: []), (statistical significance: [qnco]), (adjusted odds ratio: [qnco]), (method: [lbpr]), (other epidemiologic studies: [resa]), (biomarker measurement: [clna]), (exposure: [clna]), 
ASD Terms: (childhood autism risks, 'Autism Phenotype')(cumulative exposure, 'Exposures')(autism, 'Autism Phenotype')(cumulative mehg exposure, 'Exposures')(developmental delay, 'Learning Disorders')(autism, 'Autism Phenotype')(gestation, 'Perinatal History')(cumulative mehg exposure, 'Exposures')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(exposure, 'Exposures')

PMCID: 4761009
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (regulation: [biof]), (chromatin: [aapp]), (epigenetic mechanisms: [genf]), (central role: [socb]), (gene expression: [genf]), (development: [orgf]), (maintenance: [acty]), (cell identity: [menp]), (function: [phsf]), (aberrant chromatin regulation: [aapp]), (many diseases: [dsyn]), (defects: []), (epigenetic gene regulation: [genf]), (pathological gene expression programmes: [genf]), (mutations: [genf]), (genes: [gngm]), (enzymes: [enzy,orch]), (deposit: []), (dna: [bacs,nnon]), (histone modifications: [amas]), (shape chromatin architecture: [aapp]), (chromatin deregulation: [aapp]), (results: [fndg]), (neurodevelopmental disorders: [mobd]), (intellectual disabilities: [mobd]), (developmental abnormalities: [cgab]), (neurodegenerative diseases: [dsyn]), ( immunodeficiency: [dsyn]), (muscle wasting syndromes: [patf]), (epigenetic diseases: [dsyn]), (monogenic origin: []), (complex multifactorial diseases: [dsyn]), (congenital heart disease: [cgab,dsyn]), ( autism spectrum disorders: [mobd]), (cancer: [euka]), (chromatin regulators: [aapp]), (factors: []), (environment: []), (epigenome: []), (changes: [qnco]), (diseases: [dsyn]), (risk factors: [qnco]), (stress: [fndg]), ( malnutrition: [dsyn]), (exposure: [clna]), (chemicals: [chem]), (plasticity: [npop]), (chromatin regulation: [aapp]), (enzymatic machinery: [enzy,orch]), (attractive strategy: [menp]), (therapeutic intervention: [topp]), (number: [qnco]), (small molecule inhibitors: [chvf]), (variety: []), (epigenetic regulators: []), (clinical use: []), (review: []), (overview: []), (molecular lesions: [fndg]), (impact: [gngm]), (prospects: []), (epigenetic therapies: [topp]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(intellectual disabilities, 'Learning Disorders')(developmental abnormalities, 'Learning Disorders')(neurodegenerative diseases, 'Neurodegenerative Diseases')(congenital heart disease, 'Congenital Abnormalities')(autism spectrum disorders, 'Autism Phenotype')(exposure, 'Exposures')

PMCID: 4823641
SFARI Genes: JMJD1C, JMJD1C, Med, Med, JMJD1C, JMJD1C, Med, Med, JMJD1C, JMJD1C, JMJD1C, JMJD1C, JMJD1C, MECP2, JMJD1C, MECP2, JMJD1C, JMJD1C, Med, Med, JMJD1C, JMJD1C, Med, Med, 
Non SFARI Genes: MDC1, 
Named Entities: (purpose: autism spectrum disorders: [mobd]), (defects: []), (social response: [fndg]), (communication: [socb]), (context: [fndg]), (intellectual disability: [mobd]), (rett syndrome: [dsyn]), (example: []), (motor impairment: [patf]), (motor disturbance: []), (mutations: [genf]), (histone demethylases: [aapp,enzy]), (syndromes: [dsyn]), (herein: []), (candidate histone demethylase jmjd1c (jumonji domain: [aapp,bacs]), (disorders: [dsyn]), (genet med: [mamm]), (methods:: []), (functional analysis: [hlca]), (jmjd1c: [gngm]), (cases: [qnco]), (autism spectrum: [mobd]), (rett: []), (genetic defect: [cgab]), (results:: [fndg]), (jmjd1c variants: [gngm]), (control sample (~: []), (amino acid change: [fndg]), (different functional group: [chvf]), (jmjd1c germline mutations: [genf]), (case: []), (patient: [podg]), (functional study: [resa]), (mutant rett syndrome patient: [dsyn]), (altered protein: [aapp,bacs]), (abnormal subcellular localization: [biof]), (activity: [acty]), (dna: [bacs,nnon]), (damage-response protein mdc1: [aapp,bacs]), (mecp2: [gngm]), (jmjd1c protein: [aapp,bacs]), (brain regions: [blor]), (depletion compromises: [fndg]), (dendritic activity: [celc]), (conclusions:: []), (findings: [clna]), (jmjd1c contribute: [acty]), (development: [orgf]), 
ASD Terms: (context of intellectual disability, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(rett syndrome, 'Rett Syndrome')(motor impairment, 'Motor Skills')(motor disturbance, 'Motor Skills')(autism spectrum, 'Autism Phenotype')(rett, 'Rett Syndrome')(rett syndrome, 'Rett Syndrome')(patient with intellectual disability, 'Learning Disorders')(mutant rett syndrome patient, 'Rett Syndrome')(rett syndrome, 'Rett Syndrome')

PMCID: 4510504
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (world: [popg]), (chromosomal microarray (cma): [celc]), (first tier: [qnco]), (diagnostic assay: [lbpr]), (genetic testing: [lbpr]), (developmental delay (dd): [mobd]), (mental retardation (mr): [mobd]), (autism spectrum disorder (asd): [mobd]), (unknown etiology: [fndg]), (average diagnostic yield: [qnco]), (cma test: [lbpr]), (conventional g-banding karyotype: [resa]), (study: [resa]), (usefulness: []), (cma: [celf]), (purpose: []), (clinical diagnostic testing: [resa]), (korean population: [popg]), (multiplex ligation-dependent probe amplification (mlpa) tests: [mbrt]), (patients: [podg]), (normal karyotype: [fndg]), (unexplained dd: [gngm]), ( mr: [gngm]), (asd: [cgab]), (array (affymetrix: []), ( usa): []), (average resolution: [qnco]), (kb: []), (pathogenic copy number variations: [nusq]), (mlpa: [mbrt]), (known microdeletion: []), ((prader-willi/angelman syndrome: [cgab]), ( digeorge: []), (miller-dieker syndrome: [dsyn]), (williams: []), (national health insurance system: [hlca]), (korea: []), (diagnostic yield: [fndg]), (respectively: []), (thirteen (13.5%) patients: [podg]), (cases: [qnco]), (pathogenic cnvs): [nusq]), (variants: []), (uncertain clinical significance: [fndg]), (patient: [podg]), (17.1-megabase (mb) region: [qnco]), (homozygosity: [orga]), (chromosome: [celc]), (findings: [clna]), (necessity: []), (routine diagnostic test: [diap]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(developmental delay, 'Learning Disorders')(mental retardation, 'Mental Retardation')(unexplained developmental delay, 'Learning Disorders')(routine diagnostic test for unexplained developmental delay, 'Learning Disorders')

PMCID: 4504226
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (synapsins: [aapp,bacs]), (key components: []), (presynaptic neurotransmitter release machinery: [inpo]), (main role: [socb]), (synaptic vesicles: [celc]), (actin cytoskeleton: [celc]), (reserve vesicle pool: [patf]), (response: [fndg]), (membrane depolarization: [celf]), (sumoylation: [moft]), (synapsin ia (synia): [aapp,bacs]), (k687: []), (synia function: [phsf]), (replacement: [topp]), (endogenous synia: []), (non-sumoylatable mutant: [comd]), (size: []), (releasable vesicle pool: [patf]), (impairs: []), (sv exocytosis: [celf]), (sumoylation enhances synia association: [moft]), (svs: [qnco]), (efficient reclustering: []), (synia: []), (neuronal stimulation: [npop]), (presynaptic localization: [biof]), (a548t mutation: [genf]), (autism: [mobd]), (epilepsy: [dsyn]), (synia sumoylation: [moft]), (results: [fndg]), (fundamental regulator: []), (novel link: []), (neurological disorders: [dsyn]), 
ASD Terms: (autism, 'Autism Phenotype')(epilepsy, 'Epilepsy')(neurological disorders, 'Neurologic Indications')

PMCID: 4503355
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (asperger syndrome (as): [mobd]), (neurodevelopmental condition: [mobd]), (impairments: [patf]), (social interaction: [fndg]), (communication: [socb]), (presence: [qnco]), (interests: [menp]), (behaviour: [inbe]), (individuals: [humn]), (as: []), (delay: []), (language development: [menp]), (subset: []), (autism spectrum conditions (asc): [mobd]), (population prevalence: [qnco]), (few studies: [lbpr]), (genetic basis: [phsu]), (gap: [gngm]), (literature: [inpr,mnob]), (genome-wide pooled dna association study: [mbrt]), (candidate loci: [gngm]), ((294 cases: [qnco]), (controls): [sbst]), (caucasian ancestry: [popg]), (affymetrix genechip human mapping version: [humn]), (array: []), (snps: [nusq]), (same sample: [sbst]), (snps (rs1268055: [nusq]), ( rs7785891: []), (rs2782448): []), (none: []), (bonferroni correction: []), (snps (rs7785891: [nusq]), (lie: []), (loci: [gngm]), (asc: [gngm]), (however: []), ( investigation: [hlca]), (genome-wide association dataset: [menp]), (psychiatric genomics consortium: [hlca]), (effect: []), (variants: []), (modest: []), ( indicating: []), (study: [resa]), (causal variants: []), (precision: []), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(asperger syndrome, 'Asperger Syndrome')(neurodevelopmental condition, 'Learning Disorders')(asperger syndrome, 'Asperger Syndrome')(language development, 'Language Development')(autism spectrum conditions, 'Autism Phenotype')(asperger syndrome, 'Asperger Syndrome')(asperger syndromec, 'Asperger Syndrome')

PMCID: 4512177
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (sensory integration difficulties: [fndg]), (autism: [mobd]), (underlying brain-circuit mechanisms: [bpoc]), (autism-related mouse models: [mamm]), ( shank3+/c: [aapp]), ( mecp2r308/y: []), ( cntnap2/: [aapp,bacs]), ( l7-tsc1 (l7/pcp2cre::tsc1flox/+): [aapp,imft]), (specific perturbations: []), (delay: []), (form: []), (associative sensory: [menp]), (cerebellar plasticity: [bpoc]), (perturbations: []), (probability: [qnco]), (characteristics: []), (learned responses: [menp]), (cntnap2/: [aapp,bacs]), ( patdp(15q11-13)/+: []), (l7/pcp2cre::tsc1flox/+: [gngm]), (purkinje-cell/deep-nuclear gene expression: [cell]), (shank3+/c: [aapp]), (amplitudes: []), (mecp2r308/y: []), (granule cell: [cell]), (aberrant response timing: [fndg]), (reduced purkinje-cell: [cell]), (dendritic spine density: [celc]), (overall: []), (observations: [hlca]), (defects: []), (instructed learning: [menp]), (olivocerebellar loop: []), (response representation: [acty]), (granule cell pathway: [moft]), (findings: [clna]), (associative temporal binding: [menp]), (sensory events: [evnt]), (autism mouse models: [mamm]), (doi: http://dx.doi.org/10.7554/elife.06085.001: [fndg]), 
ASD Terms: (sensory integration difficulties, 'Reaction to Sensory Stimuli')(autism, 'Autism Phenotype')(autism mouse models, 'Autism Phenotype')

PMCID: 4820471
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (attention-deficit/hyperactivity disorder (adhd): [mobd]), (motor timing difficulties: [fndg]), (study: [resa]), (affected motor: []), (accuracy: []), (variability: []), (adhd: [mobd]), (comorbidity: []), (autism spectrum disorders: [mobd]), (contributes: [acty]), (80-trial motor: [resa]), (task: [gngm]), (accuracy (): []), ( variability (): []), (infrequent long response times: []), (1-s interval: [fndg]), (adolescents: [aggp]), (years): []), (clinic: [hcro,mnob]), (population: [popg]), (sample: [sbst]), (latent classes: [hlca]), (scq: []), (cprs-r:l data: [topp]), (classes: [hlca]), (behavioral problems: [mobd]), (normal-class (n: [aapp,imft]), (adhd-class (n =: [mobd]), (asd: [cgab]), (adhd(+asd)-class (n: [cgab]), (asd(+adhd)-class (n: [cgab]), (pure adhd-class: [mobd]), (normal class: [fndg]), (motor timing measures: [qnco]), ((mean rts: [qnco]), (ms: [gngm]), ( respectively): []), (comorbid adhd(+asd): [cgab]), (asd(+adhd) classes: [cgab]), (accurate (more time: []), (normal class (mean rts: [fndg]), (motor timing: []), (adhd(+asd) class: [cgab]), (tendency: []), (tedious task: []), (patients: [podg]), (severe behavioral symptoms: [sosy]), (motor timing deficiencies: [dsyn]), (cannot: []), (high adhd severity: [mobd]), (role: [socb]), (severity: []), (asd(+adhd) class: [cgab]), (former class: []), (motor: []), (deficits: []), 
ASD Terms: (attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(motor timing difficulties, 'Motor Skills')(autism spectrum disorders, 'Autism Phenotype')(comorbidity, 'Comorbidities')(behavioral problems, 'Personal Traits')(only attention-deficit/hyperactivity disorder symptoms, 'Attention Deficit Disorder with Hyperactivity')(comorbid attention-deficit/hyperactivity disorder, 'Comorbidities')(attention-deficit/hyperactivity disorder class, 'Attention Deficit Disorder with Hyperactivity')(high attention-deficit/hyperactivity disorder severity, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder symptom severity, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 4502951
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (summary: []), (addition: []), (symptoms: [sosy]), (i.e.: [diap,inpr]), ( social interaction: [fndg]), (communication difficulties: [socb]), (repetitive behaviors: [fndg]), ( autism: [mobd]), (aspects: [qnco]), (superior perception [1]: [menp]), (well-replicated finding: [sosy]), (superior performance: [inbe]), (visual search tasks: [diap]), (participants: [popg]), (presence: [qnco]), (odd-one-out element: [elii]), (number: [qnco]), (foils: []), (superior perception contribute: [menp]), (emergence: []), (core autism symptoms: [mobd]), (perceptual: []), (social interaction atypicalities: [fndg]), (independent pathologies: [fndg]), (fractionable phenotype model: [orga]), (autism [7]: [mobd]), (developmental test: [lbpr]), (hypothesis: []), (longitudinal cohorts: [popg]), (infants: [aggp]), (high risk: [fndg]), (siblings: [famg]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (autism: [mobd]), (levels: []), (autism symptoms: [mobd]), (eye: [bpoc]), (letter targets: [clna]), (s: [clna]), ( v: []), (+): []), (distractors: []), (letter x; figure: [clna]), (months: []), (autism observation scale: [hlca]), (infants (aosi; [10]): [aggp]), (years: []), (age: [orga]), (autism diagnostic observation schedule (ados; [11]): [hlca]), (enhanced: [acty]), (visual search performance: [inbe]), (level: [phsu]), (infant: [aggp]), (perceptual atypicalities: []), (autism phenotype: [mobd]), 
ASD Terms: (superior perception, 'Cognitive Ability')(social interaction, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')(visual search tasks, 'Visual Thinking')(superior perception contribute, 'Cognitive Ability')(core autism symptoms, 'Complaints and Indications')(autism, 'Autism Phenotype')(social interaction atypicalities, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(autism symptoms, 'Complaints and Indications')(autism observation scale, 'Autism Phenotype')(years of age, 'Onset of Symptoms')(autism diagnostic observation schedule (ados, 'Autism Phenotype')(visual search performance, 'Visual Thinking')(autism symptoms, 'Complaints and Indications')(autism phenotype, 'Autism Phenotype')

PMCID: 4507319
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (phthalates: [orch]), (endocrine-disrupting chemicals: [hops]), (thyroid hormones: [aapp,horm]), (sex: [orgf]), (brain development: [ortf]), (phthalate concentrations: [menp]), (house dust: [sbst]), (relation: [socb]), (risks: []), (autism spectrum disorder (asd): [mobd]), (developmental delay (dd): [mobd]), (participants: [popg]), (subset: []), (children: [aggp]), (charge (childhood autism risks: [mobd]), (genetics: []), (environment) casecontrol study: [resa]), (asd: [cgab]), (dd cases: [qnco]), (california department: [orgt]), (developmental: [orgf]), (system: []), (general population controls: [hlca]), (state birth files: [orgf]), (age: [orga]), ( sex: [orgf]), (broad geographic region: []), (asd cases: [cgab]), (dd: [gngm]), ((td)): []), (mullen scales: [plnt]), (early learning: [menp]), ( vineland adaptive behavior scales (vabs): []), (aberrant behavior checklist: [inbe]), (dust: [sbst]), (childs home: [aggp]), (high volume: [qnco]), (small surface sampler: [qnco]), (none: []), (adjustment: [inbe]), (di(2-ethylhexyl) phthalate (dehp): [bodm,hops,orch]), (butylbenzyl phthalate (bbzp) concentrations: [orch,phsu]), (indoor dust: [sbst]), (homes: []), (dd children: odds ratios: [qnco]), (% confidence interval: [qnco]), (% ci;: [lbpr]), (one-unit increase: [qnco]), (ln-transformed dehp: [bodm,hops,orch]), (bbzp: []), (respectively: []), (td children: [aggp]), ( vabs: []), (daily living: []), (adaptive composite standard scores: [clna]), (association: [menp]), (increased diethyl phthalate (dep) concentrations: [orch]), (dibutyl phthalate (dbp) concentrations: [orch,phsu]), (performance: [inbe]), (subscales: []), (indoor: []), (dust concentrations: [sbst]), (dep: [orch,phsu]), (dbp: [gngm]), (hyperactivity-impulsivity: [mobd]), (inattention: [mobd]), (discussion: [socb]), (conclusion house dust levels: [sbst]), (inability: []), (past: []), (recent exposures: [phpr]), (fact: [gngm]), (exposure: [clna]), (sources: [fndg]), ( limit: []), (interpretation: [clna]), (null findings: [clna]), (further work: []), (however: []), (associations: [menp]), (impairments: [patf]), (several adaptive functions: [qnco]), (hyperactivity: [mobd]), (evidence: []), (risk: []), (dd raise concerns: [gngm]), (chemicals: [chem]), (neurodevelopment: [ortf]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s12940-015-0024-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(developmental delay, 'Learning Disorders')(developmental delay cases, 'Learning Disorders')(adaptive behavior scales, 'Adaptive Life Skills')(vineland adaptive behavior scales, 'Adaptive Life Skills')(homes of developmental delay children, 'Learning Disorders')(developmental delay children, 'Learning Disorders')(vineland adaptive behavior scales, 'Adaptive Life Skills')(adaptive composite standard scores, 'Adaptive Life Skills')(developmental delay boys, 'Learning Disorders')(inattention, 'Attention Deficit Disorder with Hyperactivity')(recent exposures, 'Exposures')(capture exposure, 'Exposures')(hyperactivity, 'Overactivity')(increased risk of developmental delay raise concerns, 'Learning Disorders')(several adaptive functions, 'Adaptive Life Skills')(developmental delay raise concerns, 'Learning Disorders')

PMCID: 4631108
SFARI Genes: VPS13B, VPS13B, VPS13B, VPS13B, COH1, COH1, COH1, COH1, COH1, COH1, 
Non SFARI Genes: 
Named Entities: (cohen syndrome (coh1): [cgab]), (rare autosomal recessive disorder: [dsyn]), (muscular deficits: [tisu]), (large consanguineous pakistani families: [fndg]), (intellectual disability: [mobd]), (cases: [qnco]), (autistic traits: [mobd]), (clinical assessments: [resa]), (order: [acty]), (comparison: [acty]), (clinical features: [clna]), (other vps13b mutations: [genf]), (homozygosity mapping: [orga]), (whole exome sequencing: [mbrt]), (sanger: []), (strategies: [menp]), (disease-related mutations: [genf]), (novel homozygous deletion mutations: [genf]), (vps13b: [gngm]), (bp deletion: [genf]), ( nm_017890.4:c.6879delt; p.phe2293leufs*24: [celf]), (deletion: [genf]), (exons: [bacs,nnon]), (co-segregate: []), (affected status: []), (addition: []), (coh1-related traits: [cgab]), (autistic features: [mobd]), (number: [qnco]), (family members: [famg]), (friendly demeanour: [inbe]), (coh1: [gngm]), (c.6879delt mutation: [genf]), (families: [famg]), (different regions: []), (country: []), (baloch: []), (sub-ethnic group: [popg]), (haplotype: [orga]), (founder effect: [phpr]), (baloch population: [popg]), (common cause: [qnco]), (similar phenotypes: [orga]), (additionally: []), (individuals: [humn]), (traits: [gngm]), (variant: []), (distinct autistic-like coh1 subgroup: [mobd]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s12881-015-0183-0) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (large consanguineous pakistani families with intellectual disability, 'Learning Disorders')(intellectual disability, 'Learning Disorders')

PMCID: 4468215
SFARI Genes: PTEN, PTEN, 
Non SFARI Genes: AKAP8, AKAP8L, AKAP8, AKAP8L, TPTE, 
Named Entities: (microcephaly: [cgab,dsyn]), (macrocephaly: [cgab]), (individuals: [humn]), (autism: [mobd]), (disease-related risk factors: [fndg]), (analysis: [resa]), (dna microarray results: [mbrt]), (family: [famg]), (low functioning: [qnco]), (autistic child: [mobd]), (proband: [famg]), (additional unaffected family members: [famg]), (kb duplication: [comd]), (unknown clinical significance: [fndg]), (consideration: [fndg]), (deletion: [genf]), (duplication events: [evnt]), (literature: [inpr,mnob]), (support: []), (strong relationship: []), (gene dosage: [qnco]), (locus: [gngm]), (head size: [fndg]), (losses: [qnco]), (gains: [qnco]), (macrocephaly (p=2.47x10-11): [cgab]), ( respectively: []), (data support a kinase anchor protein: [aapp,enzy]), (8-like (akap8: [gngm]), (akap8l): [gngm]), (candidate genes: [gngm]), (regulation: [biof]), (head: [blor]), (interesting finding: [sosy]), (previous work: []), (akap gene family: [aapp,bacs]), (determination: [lbpr]), (akap8: [gngm]), (akap8l: [gngm]), (modulation: []), (risk: []), (disease: [dsyn]), (exome sequencing data: [euka]), (autism families: [famg]), (individuals): [humn]), (head circumference data: [euka]), (predicted loss: [qnco]), (function variants: [phsf]), (insights: [menp]), (relationship: []), (size: []), (strong evolutionary conservation: [genf]), (together: []), ( findings: [clna]), (idea: []), (particular: []), (important role: [socb]), (exome sequencing: [mbrt]), (variant: []), (splicing: [genf]), (tpte / pten2: [gngm]), (pten homologue: [aapp,enzy]), (contribute: [acty]), (autism risk: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism families, 'Autism Phenotype')(autism risk, 'Autism Phenotype')

PMCID: 4710593
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prenatal exposure: [fndg]), (air pollutants: [hops]), (possible etiologic factor: []), (occurrence: []), (autism spectrum disorder: [mobd]), (prenatal air pollution exposure: [eehu]), (childhood: []), (autistic traits: [mobd]), (general population: [popg]), (ours: []), (collaborative study: [resa]), (european population-based birth/child cohortscatss (sweden): [popg]), ( generation r (the netherlands): [acty]), ( gaspii (italy): []), (inma (spain): []), (nitrogen: [elii]), ((no2: []), ( nox): []), (particulate matter (pm): [sbst]), (diameters: [qnco]), (m (pm2.5): [aapp,imft]), (m (pm10): [aapp,imft]), (m (pmcoarse): [aapp,imft]), (pm2.5 absorbance: [phpr]), (birth addresses: [orgf]), (land-use regression models: [menp]), (monitoring campaigns: [resa]), (levels: []), (time: []), (pregnancy periods: [fndg]), (child: [aggp]), (years: []), (age: [orga]), (children: [aggp]), (borderline/clinical range: [qnco]), (clinical range: [qnco]), (cut-offs: [phpr]), (cohort-specific effect estimates: [qnco]), (random-effects meta-analysis: [resa]), (total: [qnco]), (borderline/clinical range (odds: [qnco]), (ci:: [lbpr]), (10-g/m3 increase: [qnco]), (no2 pregnancy levels): [orgf]), (similar results: [fndg]), (different cohorts: [popg]), (other pollutants: [hops]), (assessments: [hlca]), (quantitative score: [clna]), (no2: []), (pm: [gngm]), (european population-based birth/child cohort studies: [aggp]), (citation guxens m: [aapp,imft]), ( ghassabian a: []), ( gong t: []), ( garcia-esteban r: [clna]), ( porta d: [blor]), ( giorgis-allemand l: []), ( almqvist c: []), ( aranbarri a: []), ( beelen r: [clna]), ( badaloni c: []), ( cesaroni g: [qnco]), (nazelle a: []), ( estarlich m: [aapp,imft]), ( forastiere f: [inch,phsu]), ( forns j: []), ( gehring u: []), ( ibarluzea j: []), ( jaddoe vw: [imft]), ( korek m: [aapp,imft]), ( lichtenstein p: []), ( nieuwenhuijsen mj: []), ( rebagliato m: [aapp,imft]), ( slama r: [clna]), ( tiemeier h: [elii]), ( verhulst fc: [acty]), ( volk he: []), ( pershagen g: [qnco]), ( brunekreef b: []), ( sunyer j: []), (air pollution exposure: [eehu]), (pregnancy: [orgf]), (european population-based cohort: [popg]), (escape project: [menp]), (environ health perspect: [orch]), (http://dx.doi.org/10.1289/ehp.1408483: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(prenatal exposure, 'Exposures')(prenatal air pollution exposure, 'Exposures')(years of age, 'Onset of Symptoms')(years of age, 'Onset of Symptoms')(air pollution exposure, 'Exposures')

PMCID: 4466566
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (dibenzo-p-dioxins: [orch]), (dibenzofurans: [orch]), (biphenyls (pcbs): [orch,phsu]), (endocrine disruptor chemicals: [hops]), (prenatal exposure: [fndg]), (pollutants: [hops]), (fetal steroid hormone levels: [emst]), (sex-typical development: [orgf]), (autistic traits: [mobd]), (associations: [menp]), (prenatal levels: [aggp]), (pcdd/fs: [orch,phsu]), (pcbs: [orch,phsu]), (autism traits: [mobd]), (sex-typical behaviour: [bhvr]), (childhood: []), (levels: []), (maternal blood samples: [bdsu]), (pregnancy: [orgf]), (gas chromatography/high-resolution mass spectrometry: [lbpr]), (years: []), (age (n: [orga]), (age: [orga]), (social responsiveness scale (srs;: [acty]), (multiple regression analyses: [qnco]), (outcome variables: []), (blood concentrations: [lbtr]), (pg/g: [qnco]), (lipid base: [inch]), ((median =: [qnco]), (lipid base): [inch]), (concentrations: [menp]), (range: [qnco]), (pg/g lipid base): [inch]), (german background exposure: [clna]), (significant negative associations: [menp]), (pcdd/f levels: [inch,phsu]), (maternal blood: [bdsu]), (srs scores: [clna]), (whole group ( = -6.66: [popg]), ( p < .05): [aapp,imft]), (girls ( = -10.98: [aggp]), ( p < .05) and: [aapp,imft]), (srs subscale: []), (boys: [aggp]), (( = -6.86: []), (pcb: [gngm]), ( associations: [menp]), (whole study group: [popg]), (subscales: []), (girls: [aggp]), (significant associations: [menp]), (pcdd/f: [inch,phsu]), (pcb levels: [orch,phsu]), (sex: [orgf]), (part: [qnco]), (study: [resa]), ( prenatal exposure: [fndg]), (testosterone levels: [lbtr]), (findings: [clna]), (idea: []), (spectrum conditions: [dsyn]), (fetal androgen levels: [emst]), (several possible mechanisms: [qnco]), (autistic behaviour: [mobd]), (discussed: [socb]), 
ASD Terms: (prenatal exposure, 'Exposures')(autism traits, 'Autism Phenotype')(years of age, 'Onset of Symptoms')(prenatal exposure, 'Exposures')(german background exposure, 'Exposures')(prenatal exposure, 'Exposures')

PMCID: 4466563
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction males: [orga]), (females: [orga]), (general population differ: [popg]), (average: [qnco]), (drive: [menp]), ((higher: []), (females): [orga]), (males): [orga]), (people: [popg]), (autism spectrum disorder (asd): [mobd]), (empathizing: []), ( irrespective: []), (sex: [orgf]), (conceptualisation: [menp]), (asd: [cgab]), (extreme: []), (typical male brain: [bpoc]), (opposite cognitive profile: [lbpr]), (typical female brain: [bpoc]), (conditions: [dsyn]), (psychosis: [mobd]), (mania/hypomania: [fndg]), (empathizing-over-systemizing bias (for: [bird]), (bias): [bird]), (individuals: [humn]), (psychotic illness (n: [aapp,imft]), ((n =: [aapp,imft]), (overall differences: [qnco]), (distribution: []), (cognitive style: [menp]), (adults: [aggp]), (bias: [bird]), (history: [orga]), (iq: []), (group-difference: [popg]), (above-average iq: [qnco]), (women: [popg]), (link: []), (empathizing bias: [bird]), (men: [gngm]), (systemizing: []), (presence: [qnco]), (further research: [resa]), (variety: []), (clinical populations: [popg]), (role: [socb]), (development: [orgf]), (manifestation: []), (mental illness: [mobd]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(opposite cognitive profile, 'Cognitive Ability')(cognitive style, 'Cognitive Ability')(mental illness, 'Mental Disorders')

PMCID: 4490493
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (pronounced: []), ( social: []), ( cognitive: []), (personality characteristics: [fndg]), (autism spectrum disorders: [mobd]), (people: [popg]), (asd: [cgab]), (diagnostic criteria: []), (first-degree relatives: [qnco]), (individuals: [humn]), (research: [resa]), (characteristics: []), (autism phenotype (bap): [mobd]), (valuable data: [euka]), (potential expressions: [topp]), (autism-specific deficits: [mobd]), (context: [fndg]), (family relations: [socb]), (paper: []), (review: []), (bap: [gngm]), (siblings: [famg]), (reports: [hlca]), (social: []), ( communication: [socb]), (cognitive deficits: [mobd]), (studies: [lbpr]), (groups: [popg]), (participants age: papers: [orga]), (preschool: [fndg]), (asd;: [cgab]), (publications: [inpr,mnob]), (infants: [aggp]), (risk: []), (basis: [phsu]), ( suggestions: []), (further research: [resa]), (significance: [qnco]), (understanding: [menp]), (genetic determinants: [topp]), (autism: [mobd]), 
ASD Terms: (cognitive, 'Cognitive Ability')(personality characteristics, 'Personal Traits')(autism spectrum disorders, 'Autism Phenotype')(family relations, 'Interactions with Friends and Family')(autism phenotype, 'Autism Phenotype')(autism phenotype, 'Autism Phenotype')(cognitive deficits, 'Cognitive Ability')(autism, 'Autism Phenotype')

PMCID: 4462583
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (group: [popg]), (neurodevelopmental disorders: [mobd]), (deficits: []), (communication capacities: [socb]), (repetitive behaviors: [fndg]), (neuroscientific evidence: []), (neuropathology: [patf]), (asd: [cgab]), (epigenetic regulation: [biof]), (brain: [bpoc]), (mirnas: [bacs,nnon]), (peripheral blood: [bdsu]), (autism patients: [mobd]), (high-throughput mirna microarray analyses: [bacs,nnon]), (quantitative reverse transcription-polymerase chain reaction: [mbrt]), ((qrt-pcr) analysis: [resa]), (search: [acty]), (candidate target genes: [gngm]), (kyoto encyclopedia: []), (genes: [gngm]), (genomes (kegg): [gngm]), (biological pathways: [moft]), (gene ontology: []), (enrichment analysis: [resa]), (gene function: [genf]), (gene: [gngm]), (regulatory networks: []), (knowledge: []), (study: [resa]), (first global mirna expression profile: [bacs,nnon]), (china: []), (mir-34b: []), (percentage: [qnco]), (male asd patients: [cgab]), (mir-103a-3p: [nusq]), (abnormal ubiquitin-mediated proteolysis: [moft]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder comprise, 'Autism Phenotype')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism patients, 'Autism Phenotype')

PMCID: 4458007
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (people: [popg]), (autistic spectrum disorder (asd): [mobd]), (variety: []), (characteristic behavioral traits: [inbe]), (impaired social interaction: [mobd]), ( communication difficulties: [socb]), (repetitive behavior: [fndg]), (complex neurodevelopment disorder: [mobd]), (combination: [fndg]), (environmental factors: []), (neurexins: []), (neuroligins: [moft]), (key role: [socb]), (synaptogenesis: [ortf]), (neurexin-neuroligin adhesion: [patf]), (several processes: [phpr]), (autism spectrum disorders: [mobd]), (report: [hlca]), (manual annotation: [inpr,mnob]), (selection: [genf]), (gene products: [aapp,bacs]), (autism: [mobd]), (neurexin-neuroligin-shank complex: [chvs]), (focused annotation approach: []), (creation: [acty]), (descriptive gene ontology (go) terms: [orgf]), (increase: []), (number: [qnco]), (gene product annotations: [mbrt]), (granularity: [sbst]), (data: [euka]), (go database: [gngm]), (manual annotations: [inpr,mnob]), (functional analysis: [hlca]), (future autism-relevant datasets: [mobd]), (comprehensive gene annotation: [mbrt]), (essential aspect: [qnco]), (proteomic studies: [lbpr]), (quality: []), (gene annotations: [mbrt]), (statistical analysis tools: [resa]), (effective interpretation: [clna]), (genome wide association: [menp]), (next generation sequencing: [mbrt]), (transcriptomic datasets: [nusq]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s12859-015-0622-0) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autistic spectrum disorder display, 'Autistic Disorder')(impaired social interaction, 'Reciprocal Social Interaction')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4521130
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background: prenatal: [aggp]), (environmental factors: []), (maternal adiposity: [fndg]), (risk: []), (autism spectrum disorders: [mobd]), (current evidence: [npop]), (objective: []), (study: [resa]), (relationship: []), (parental bmi: []), (gestational weight gain (gwg): [fndg]), (asd: [cgab]), (population-based cohort study: [resa]), (family-based study designs: [diap]), (methods:: []), (cohort: [popg]), (stockholm county: []), ( sweden: []), (individuals: [humn]), (maternal body mass index (bmi): [diap]), (first antenatal visit: [fndg]), ( gwg: []), (paternal bmi: [famg]), (time: []), (conscription: []), (exposures: [phpr]), (equation (gee) models: []), (logit link: []), (results:: [fndg]), (population: [popg]), (maternal overweight/obesity: [sosy]), (increased risk: [qnco]), (asd [odds ratio (or)25  bmi: [cgab]), (confidence interval: [qnco]), (orbmi: []), (paternal underweight (orbmi <: [fndg]), (obesity (orbmi: [dsyn]), (models: []), (however: []), (matched sibling: [famg]), (maternal bmi: [famg]), (asd risk: [cgab]), (gwg: []), (u-shaped association: [menp]), (population level: [popg]), (analyses: [resa]), (elevated risk: []), (excessive gwg: []), (conclusions: whereas: []), (population-level results: [popg]), (paternal bmi analyses: [resa]), (proxy marker: [grup]), (other familial risk factors: []), (evidence: []), (direct link: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(gestational weight gain, 'Perinatal History')(exposures, 'Exposures')(excessive gestational weight gain, 'Perinatal History')(gestational weight gain, 'Perinatal History')

PMCID: 4729813
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (attention-deficit/hyperactivity disorder (adhd): [mobd]), (autism spectrum disorders: [mobd]), (however: []), (previous exclusionary diagnostic criteria: [fndg]), (underlying causes: []), (covariation: []), (twin studies: [famg]), (adhd symptoms: [mobd]), (autistic-like traits: [mobd]), (substantial genetic overlap: [topp]), (account: [clna]), (genetic heterogeneity: [orga]), (symptom subscales: [clna]), (study: [resa]), (phenotypic: [orga]), (genetic relations: [socb]), (adhd: [mobd]), (asd: [cgab]), (disorders: [dsyn]), (moreover: []), (adhd-related cognitive impairments: [mobd]), (relationship: []), (alt symptom subscales;: [neop]), (cognitive impairments: [mobd]), (genetic risk: [qnco]), (alt symptoms: [neop]), (multivariate: []), (structural equation modelling: [resa]), (population-based sample: [popg]), (twins: [famg]), (social-communication alts: [aapp,enzy]), (adhd symptom: [mobd]), ((phenotypic correlations: [orga]), (inattention: [mobd]), (hyperactivity-impulsivity: [mobd]), ((genetic correlation: [topp]), (respectively): []), (addition: []), (associations: [menp]), (reaction time variability (rtv): []), (significant phenotypic (0.18): [orga]), (genetic (0.32) association: [menp]), (rtv: [orch,phsu]), (significant proportion (24 %): [qnco]), (genetic influences: [topp]), (findings: [clna]), (genetic covariation: [topp]), (alts: [aapp,enzy]), (can: []), (part: [qnco]), ( contribute: [acty]), (explanation: []), (co-occurrence: []), 
ASD Terms: (attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism spectrum disorders, 'Autism Phenotype')(attention-deficit/hyperactivity disorder symptoms, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(disorder-related cognitive impairments, 'Cognitive Ability')(cognitive impairments, 'Cognitive Ability')(attention-deficit/hyperactivity disorder symptom domains, 'Attention Deficit Disorder with Hyperactivity')(inattention, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder traits, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 4736680
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (multiple medical conditions: [dsyn]), (addition: []), (asd symptoms: [cgab]), (study: [resa]), (predictive patterns: []), (medical conditions: [dsyn]), (asd: [cgab]), (medical evaluation: [hlca]), (treatment: [topp]), (meaningful subgroups: [virs]), (medical history data: [euka]), (multiplex family autism genetic resource exchange (agre): [mobd]), (fourteen: [qnco]), (replication: [genf]), (simons simplex collection (ssc): [bpoc]), (available medical condition data: [dsyn]), (gastrointestinal disturbances: [fndg]), (sleep problems: [dsyn]), ( allergy: [patf]), (epilepsy: [dsyn]), (agre cohort: [popg]), (discrete clusters: [qnco]), (gid: [dsyn]), (seizures: [sosy]), (unaffected family members: [famg]), (agre: []), (ssc: [qnco]), (further analysis: [resa]), (predictive cooccurring patterns: []), (samples: [sbst]), (child: [aggp]), (presence: [qnco]), (vice versa: []), (odds ratio: [qnco]), (direction: []), (risk patterns: []), (ssc sample: [sbst]), (risk: []), (problems: []), (cohorts: [popg]), ( seizure: [sosy]), (other conditions: [dsyn]), (behavioral impairments: [inbe]), (number: [qnco]), (medical symptoms increased: [qnco]), (findings: [clna]), (interdisciplinary clinical care: [acty]), (evaluation: [hlca]), (specific patterns: []), (affected child: [aggp]), (family members: [famg]), (autism res: [mobd]), (autism research: [mobd]), (wiley periodicals: []), ( inc: []), (behalf: []), (international society: [orgt]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(multiple medical conditions, 'Medications')(asd symptoms, 'Complaints and Indications')(medical conditions, 'Medications')(medical evaluation, 'Medications')(medical history data, 'Medications')(multiplex family autism genetic resource exchange, 'Autism Phenotype')(available medical condition data, 'Medications')(sleep problems, 'Sleeping Problems')(allergy, 'Allergies')(epilepsy, 'Epilepsy')(autism genetic resource exchange cohort, 'Autism Phenotype')(autism genetic resource exchange, 'Autism Phenotype')(behavioral impairments, 'Personal Traits')(medical symptoms increased, 'Medications')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 4438718
SFARI Genes: ERK, ERK, 
Non SFARI Genes: 
Named Entities: (critical period: []), (distinct time-window: []), (neonatal stage: []), (animals: [anim]), (sensitivity: [patf]), (certain environmental stimuli: [npop]), (particular experiences: [menp]), (long-lasting effects: []), (behaviors: [inbe]), (evidence: []), (disruption: []), (neuronal activity: [acty]), (critical period contributes: [acty]), (autistic phenotype: [mobd]), (pathogenic mechanism: [fndg]), (herein: []), (extracellular signal-regulated protein kinases: [aapp,enzy]), (play: [dora]), (important roles: [socb]), (proper formation: [biof]), (neural circuits: [bpoc]), (transient blockade: [phsu]), (erks phosphorylation: [moft]), (postnatal day: []), ((p6): []), (intraperitoneal injection: [topp]), (blood-brain barrier-penetrating mek inhibitor: [bpoc]), (-[amino[(4-aminophenyl)thio]methylene]-2-(trifluoromethyl)benzeneacetonitrile (sl327): [orch,phsu]), (significant increase: [qnco]), (apoptosis: [celf]), (forebrain: [bpoc]), (furthermore: []), (induced long-term deleterious effects: [phpr]), (brain functioning: [ortf]), (adulthood: []), (social deficits: []), (impaired memory: [mobd]), (reduced long-term potentiation (ltp): [ortf]), (conversely: []), ( blockade: [phsu]), (erk phosphorylation: [moft]), (p14: [gngm]), (induced apoptosis: [celf]), (behavioral deficits: [inbe]), (ltp: [ortf]), (thus: []), (effects: []), (erks: [aapp,enzy]), (age-dependent: [orga]), ( indicating: []), (phosphorylation: [moft]), (proper development: [orgf]), (study: [resa]), (novel insight: [menp]), (mechanistic basis: [phsu]), (neurodevelopment disorders:: [mobd]), (various neurodevelopment disorders: [mobd]), (defects: []), 
ASD Terms: (social deficits, 'Social Competence')(impaired memory, 'Working Memory')(behavioral deficits, 'Personal Traits')

PMCID: 4471293
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (chromodomain: []), (dna-binding protein: [aapp,bacs]), ((chd8): [gngm]), (autism: [mobd]), (spectrum disorder (asd) candidate gene: [cgab]), (whole-exome sequencing: [mbrt]), (subsequent targeted-sequencing studies: [lbpr]), (de: []), (loss-of-function mutations: [phsf]), (individuals: [humn]), (asd: [cgab]), (controls: [sbst]), ( accounting: []), (significant association: [menp]), (rna-mediated knockdown: [nnon]), (chd8: [gngm]), (human neural progenitor cells: [humn]), (rna: [nnon]), (chd8 insufficiency results: [fndg]), (altered expression: [topp]), (genes: [gngm]), (noncoding rnas: [nnon]), ((40%): [qnco]), (rnas: [nnon]), (transcriptional changes: [genf]), (protein-coding genes: [gngm]), (interconnected network: [popg]), (neuronal development: [celf]), (asd candidate genes: [cgab]), (results: [fndg]), (chd8 insufficiency: [gngm]), (central hub: [gngm]), (asd risk: [cgab]), 
ASD Terms: (autism, 'Autism Phenotype')

PMCID: 4479043
SFARI Genes: Shank2, Shank2, Tbr1, Tbr1, 
Non SFARI Genes: Src, Src, 
Named Entities: (genetic aspects: []), (autism spectrum disorders: [mobd]), (environmental influences: []), (asds: [cgab]), (zinc (zn): [elii,phsu]), (nutritional factor: [clna]), (evidence: []), (strong association: [menp]), (mechanism: []), (trans-synaptic zn mobilization: [topp]), (social interaction: [fndg]), (independent mouse models: [mamm]), (asd: [cgab]), (mice: [mamm]), (shank2: [gngm]), (excitatory postsynaptic scaffolding protein: [aapp,bacs]), (postsynaptic zn elevation: [topp]), (clioquinol (a zn chelator: [orch,phsu]), (ionophore) improves: [phsu]), (postsynaptic zn: []), (presynaptic pools: []), (activates nmda receptors: [aapp,rcpt]), (postsynaptic activation: [acty]), (tyrosine kinase src: [aapp,enzy]), (clioquinol: [orch,phsu]), (mice haploinsufficient: [mamm]), (transcription factor tbr1: [aapp,bacs]), (nmdar activation: [aapp,rcpt]), (amygdala: [bpoc]), (results: [fndg]), (clioquinol rescues: [orch,phsu]), (social deficits: []), (mouse models: [mamm]), (postsynaptic src: [aapp,enzy]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(social interaction, 'Reciprocal Social Interaction')(social deficits in mouse models, 'Social Competence')(social deficits, 'Social Competence')

PMCID: 4433014
SFARI Genes: 
Non SFARI Genes: MACROD2-AS1, 
Named Entities: (genome-wide association studies: [mbrt]), (common approach: [qnco]), (single nucleotide polymorphisms (snps): [nusq]), (complex diseases: [dsyn]), (joint effects: [bsoj]), (multiple genes: [fndg]), (effect: []), (individual gene: [gngm]), (snp: [nusq]), (method: [lbpr]), (multiple snps: [nusq]), (individual snps: [nusq]), (multi-snp analysis aims: [nusq]), (association: [menp]), (snp set: [menp]), (biological knowledge: []), (gene: [gngm]), (pathway: [moft]), (portion: []), (snps: [nusq]), (effects: []), (disease: [dsyn]), (challenge: [hlca]), (multi-snp analysis: [nusq]), (subset: []), (promising association signals: [menp]), (optimal p-value threshold pedigree disequilibrium test (optpdt): [dsyn]), (optpdt: []), (general nuclear families: [famg]), (variable p-value threshold algorithm: [lbpr]), (optimal p-value threshold: [qnco]), (permutation procedure: [topp]), (significance: [qnco]), (test: [lbpr]), (simulations: [resa]), (correct type: [qnco]), (rates: [qnco]), (power studies: [hcpp]), (set-based test: [menp]), (plink: []), (multi-snp fbat test: [nusq]), (test gates: [lbpr]), (family-based autism gwas dataset: [mbrt]), (gene-based association analysis: [lbpr]), (macrod2-as1: [gngm]), (genome-wide significance: [gngm]), (simulation results: [fndg]), (powerful test: [resa]), (pathway association analysis: [menp]), (secondary analysis: [neop]), (gwas datasets: [mbrt]), (set: [menp]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s12864-015-1620-3) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (family-based autism genome-wide association studies, 'Autism Phenotype')

PMCID: 4449286
SFARI Genes: CHD8, CHD8, 
Non SFARI Genes: impact, 
Named Entities: (relative impact: [gngm]), (variants: []), (autism risk: [mobd]), (comprehensive set: [menp]), (exonic single nucleotide variants: [fndg]), (number variants: [qnco]), (autism families: [famg]), (private: [orgt]), (snvs: []), (genes: [gngm]), (probands: [orga]), ((odds ratio=1.14: [qnco]), ( p=0.0002): [fndg]), (effect: []), (significant maternal transmission bias: [bird]), (bias: [bird]), (inherited cnvs: [nusq]), (small (<100 kbp): [aapp,enzy,rcpt]), (events: [evnt]), (chd8 target genes: [gngm]), (logistic regression: [resa]), (private truncating snvs: [orgt]), (rare: [gngm]), (cnvs: [nusq]), (independent autism risk factors: [qnco]), (odds ratios: [qnco]), ((p=0.0002): [fndg]), ((p=0.01): [fndg]), ( respectively: []), (analysis: [resa]), (second class: [qnco]), (candidate genes (e.g.: [gngm]), ( rims1: [gngm]), ( cul7: [gngm]), (lztr1): [gngm]), (mutations: [genf]), (sensitized background: [orgf]), 
ASD Terms: (autism risk, 'Autism Phenotype')(autism families, 'Autism Phenotype')(independent autism risk factors, 'Autism Phenotype')

PMCID: 4690162
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (clinical genetic studies: [resa]), (autism phenotype (bap): [mobd]), (relatives: [famg]), (individuals: [humn]), (autism: [mobd]), (few standardized assessment measures: [qnco]), (bap measures: [qnco]), ((informant interview: [acty]), ( self-report interview: [resa]), (impression: [fndg]), (interviewee observational scale): [resa]), (development strategy: [menp]), (findings: [clna]), (interviews: [acty]), (international molecular genetic study: [resa]), (autism consortium data: [mobd]), (families: [famg]), (comparison: [acty]), (self-report interviews: [resa]), (samples: [sbst]), (different researchers: []), (site: [blor]), (uk: []), (netherlands): []), (researchers: []), (vignettes: []), (others: [fndg]), (retest reliability: [qnco]), (participants: [popg]), (agreement: [socb]), (live scoring: [qnco]), (vignette ratings: [acty]), (retest stability: []), (high: [qnco]), (factor analysis: [qnco]), (first factor: [qnco]), (social-communication items: [socb]), (rigidity (but: [sosy]), (other repetitive domain items): []), (second factor: [qnco]), (reading: [dora]), (impairments: [patf]), (whole scale cronbach's alphas: [acty]), (correlation: []), (factor: []), (moderate (adult items: [aggp]), (childhood items: []), (kappa values: []), (between-interview agreement: [acty]), (individual items: [humn]), (correlations: []), (total score: [qnco]), (moderate: []), (inclusion: [celc]), (several factor: [qnco]), (items: []), (overall cronbach's alpha: []), (total set: [menp]), (interview measures: [acty]), (good reliability: [qnco]), (substantial stability: []), (time: []), (scores: [clna]), (bap: [gngm]), (autism res: [mobd]), (international society: [orgt]), (autism research: [mobd]), ( wiley periodicals: []), ( inc: []), 
ASD Terms: (autism phenotype, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism phenotype measures, 'Autism Phenotype')(development strategy, 'Problem Solving Ability')(autism consortium data, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 4492396
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (developmental changes: [orgf]), (spatial regulation: [biof]), (gene expression: [genf]), (emergence: []), (normal mature brain function: [ortf]), (disruptions: []), (processes: [phpr]), (many neurodevelopmental abnormalities: [cgab]), (foundational knowledge: [orgt]), (such changes: [qnco]), (primate brain: [mamm]), (extended period: []), (postnatal maturation: [orgf]), (human: [humn]), (whole-genome transcriptional profiles: [genf]), (rhesus monkey brains: [mamm]), (birth: [orgf]), (gene expression dynamics: [genf]), (infancy: []), (gene expression profiles transition: [qnco]), (stable state: []), (young adulthood: [aggp]), (biological pathway: [moft]), (enrichment analysis: [resa]), (genes: [gngm]), (cell adhesion: [celf]), (neuron differentiation: [orgf]), (juveniles: [aggp]), (adults: [aggp]), (cell death: [celf]), (neocortex: [bpoc]), (differential expression: [topp]), (time: []), (subcortical structures: [blor]), (trend: []), (protracted postnatal development: [orgf]), (cortex: [bpoc]), (network analysis: []), (co-expression modules: [topp]), (expression patterns: [topp]), (specific brain regions: [blor]), ( ages: [bacs,orch]), (both: []), (module: []), (high expression: [topp]), (neonatal cortex: [bpoc]), (striatum: [bpoc]), (juvenile development: [orgf]), (autism: [mobd]), (spectrum disorder: [dsyn]), ((asd)-related genes: [cgab]), (network: [popg]), (axon guidance: [celf]), (interneuron differentiation: [celf]), ( consistent: []), (disruption: []), (formation: [biof]), (functional cortical circuitry: [bpoc]), (asd: [cgab]), 
ASD Terms: (many neurodevelopmental abnormalities, 'Learning Disorders')(infancy, 'Perinatal History')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 4463632
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (omega-3 (n-3): [bacs,orch,phsu]), (fatty acids (pufa): [bacs,orch]), (essential nutrients: [chvf]), (brain development: [ortf]), (function: [phsf]), (however: []), (levels: []), (fatty acids: [orch]), (individuals: [humn]), (autism: [mobd]), (study: [resa]), (fatty acid contents: [orch]), (autistic patients: [mobd]), (controls: [sbst]), (analysis: [resa]), (fatty acid composition: [orch]), (red blood cell (rbc) membrane phospholipids: [celc]), (percentage: [qnco]), (total pufa: [bacs,orch]), (controls; levels: [sbst]), (n-6 arachidonic acid (aa): [orch]), (n-3 docosahexaenoic acid (dha): [bacs,orch,phsu]), ((p: [aapp,imft]), (addition: []), ( plasma levels: [bdsu]), (pro-inflammatory aa metabolite prostaglandin e2 (pge2): [horm,orch,phsu]), (subset: []), (autistic participants: [mobd]), (alteration: []), (pufa profile: [bacs,orch]), (increased production: [qnco]), (pufa-derived metabolite: [bacs,orch]), (hypothesis: []), (abnormal lipid metabolism: [moft]), 
ASD Terms: (autism, 'Autism Phenotype')(abnormal lipid metabolism, 'Metabolic Indications')

PMCID: 4485698
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disease: [mobd]), (years: []), (age: [orga]), (genetic and/or: [topp]), (environmental etiology: []), (comorbid situations: []), (gastrointestinal (gi) disorders: [dsyn]), (goal: []), (conditions: [dsyn]), (compounds: [chem]), (first years: [qnco]), ( and: []), ( primarily: []), (males: [orga]), (females: [orga]), (articles: []), (effects: []), (animal models: [anim]), (pubmed: []), (toxicology: []), (discussion: [socb]), (hypothesis: []), (first year: [qnco]), (life: []), (decreasing: []), (maternal immune protection: [fndg]), (immune-system immaturity: [bdsy]), (immune vulnerability: []), (infection diseases: [dsyn]), (antibiotics: [antb]), (dysbiosis: [patf]), (gi disorders: [dsyn]), (condition: [dsyn]), (vicious circle: [popg]), (immune system impairment: [bdsy]), (gut: [bdsy]), (neurochemical compounds: [chem]), (neurotoxic xenobiotics production: [inpo]), (absorption: [npop]), (alteration: []), (gut-brain axis communication: [bpoc]), (central nervous system: [bdsy]), (immune system: [bdsy]), (thus: []), (metabolic pathways: []), (autistic children: [podg]), (genetic alterations: [genf]), (environmentxenobiotics interference: []), (addition: []), (many xenobiotics: [bacs,hops]), (neurotoxicity: [inpo]), (sex-dependent manner: [orgf]), (multi-disciplinary information: [qnco]), (unique hypothesis: []), (possible environmental origin: [fndg]), (imbalance: [sosy]), (male:female distribution: [orga]), (idea: []), (exogenous factors: []), (recent rise: []), (disease: [dsyn]), 
ASD Terms: (years of age, 'Onset of Symptoms')(autism, 'Autism Phenotype')(neurodevelopmental disease, 'Learning Disorders')(comorbid situations, 'Comorbidities')(gastrointestinal disorders, 'Gastrointestinal Diseases')(first years of age, 'Onset of Symptoms')(autism, 'Autism Phenotype')

PMCID: 4474177
SFARI Genes: 
Non SFARI Genes: pole, 
Named Entities: (resting-state functional magnetic resonance: [npop]), ((rsfmri) studies: [lbpr]), (complex pattern: [chvs]), (hypo-connectivity: []), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (whereas rsfmri findings: [clna]), (default mode network: [popg]), (subcortical areas: [blor]), (asd: [cgab]), ( task fmri: [diap]), (behavioral experiments point: [inbe]), (social dysfunction: [dsyn]), (unifying impairment: [patf]), (disorder: [dsyn]), (here: []), (novel bayesian framework: []), (whole-brain functional connectomics: [bpoc]), (population differences: [popg]), (connectivity: []), (subset: []), (foci: []), (approach: []), (spatial constraints: [gngm]), (region foci: []), (trajectory: []), (altered functional pathways: [moft]), (method: [lbpr]), (data: [euka]), (autism brain imaging data exchange (abide): [mobd]), (pinpoint: [fndg]), (intrinsic functional networks: []), (distinguish asd patients: [cgab]), (controls: [sbst]), (network: [popg]), (right temporal pole: [bpoc]), (posterior cingulate cortex: [bpoc]), (supramarginal gyrus: [bpoc]), (middle temporal gyrus: [bpoc]), (automated decoding: [menp]), (neurosynth: []), (meta-analytic database: [euka]), (high-level concepts: [qnco]), (language: [lang]), (comprehension: [menp]), (likely functional correlates: []), (second network: [popg]), (left banks: []), (superior temporal sulcus: [bsoj]), (posterior superior temporal sulcus: [bsoj]), (temporo-parietal junction: []), (right middle temporal gyrus: [bpoc]), (associated functionality: []), (regions: []), (social: []), (person: [grup]), (abnormal pathways: [moft]), (above foci: []), (asd patients: [cgab]), (reduced long-range: [qnco]), (inter-hemispheric connectivity: []), (short-range: [qnco]), (intra-hemispheric connectivity: []), (findings: [clna]), (new insights: [menp]), (possible neural mechanisms: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social dysfunction, 'Social Competence')(autism brain imaging data exchange, 'Autism Phenotype')

PMCID: 4401440
SFARI Genes: Cav1.3, Cav1.3, Cav1.3, Cav1.3, Cav1.3, Cav1.3, Cav1.3, Cav1.3, 
Non SFARI Genes: 
Named Entities: (cav1.3: [gngm]), (voltage-gated l-type calcium channels (ltccs): [aapp,bacs]), (part: [qnco]), (postsynaptic neuronal signaling networks: [celf]), (key role: [socb]), (brain function: [ortf]), (fear memory: [menp]), (drug-taking behaviors: [inbe]), (whole-exome sequencing study: [resa]), (p.a749g: [aapp,imft]), (cav1.3 1-subunits: [aapp]), (second main ltcc: [qnco]), (brain: [bpoc]), (mutations: [genf]), (cohort: [popg]), (patients: [podg]), (autism: [mobd]), (intellectual disability: [mobd]), (genetic information: [topp]), (studies: [lbpr]), (cacna1d mutation: [genf]), ( p.g407r: [aapp,imft]), (probands: [orga]), (unaffected parents: []), (siblings: [famg]), (tsa-201 cells: [cell]), (functional consequences: []), (whole-cell patch-clamp: [resa]), (mutations p.a749g: [genf]), (p.g407r: [aapp,imft]), (dramatic changes: [qnco]), (channel gating: []), ((~15: []), (voltage dependence: [menp]), (steady-state activation: [acty]), (inactivation: []), (negative voltages: [qnco]), (pronounced slowing: []), (current inactivation: [npop]), (stimuli (p.g407r): [phpr]), (changes: [qnco]), (gain-of-function phenotype: [phsf]), (data: [euka]), (discovery: [acty]), (cav1.3 gain-of-function causes: [phsf]), (primary aldosteronism: [dsyn]), (seizures: [sosy]), ( neurologic abnormalities: [cgab,dsyn]), (cav1.3 gain-of-function mutations: [phsf]), (major part: [qnco]), (risk: []), (disease: [dsyn]), (findings: [clna]), (immediate clinical relevance: []), (blockers: []), (ltccs: []), (therapeutic attempts: [evnt]), (affected individuals: [humn]), (other symptoms: [sosy]), (cav1.3 hyperactivity: [mobd]), (particular: []), ( primary aldosteronism: [dsyn]), 
ASD Terms: (fear memory, 'Working Memory')(autism, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(neurologic abnormalities, 'Neurologic Indications')(autism, 'Autism Phenotype')(neurologic abnormalities, 'Neurologic Indications')(cav1.3 hyperactivity, 'Overactivity')

PMCID: 4413835
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objective: []), (annual prevalence: [qnco]), (autism symptom phenotype: [mobd]), (registered diagnoses: [fndg]), (autism spectrum disorder: [mobd]), (year period: []), (children: [aggp]), (design population: [popg]), (study: [resa]), (child: [aggp]), (adolescent twin study: [resa]), (national patient register: [popg]), ( sweden: []), (participants: [popg]), (twins: [famg]), (autism spectrum disorder): [mobd]), (sweden: []), (main outcome measures annual prevalence: [qnco]), (symptoms: [sosy]), (diagnostic criteria: []), (validated parental telephone interview: [resa]), (autism-tics: [mobd]), ( adhd: [mobd]), (other comorbidities inventory): [diap]), (reported diagnoses: [fndg]), (year period (p=0.87: [fndg]), (linear time trend): []), (contrast: [irda]), (monotonic significant increase: [qnco]), (prevalence: [qnco]), (national patient register (p<0.001: [fndg]), (linear trend): []), (conclusions: []), (official prevalence: [qnco]), (registered: [hlca]), (diagnosed: [fndg]), ( autism spectrum disorder: [mobd]), (substantially: []), (administrative changes: [qnco]), (registered prevalence: [qnco]), (secular factors: []), (pathogenesis: [patf]), (increase: []), (reported prevalence: [qnco]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism symptom phenotype, 'Complaints and Indications')(autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 4423768
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (cases: [qnco]), (idiopathic autism spectrum disorder (asd): [mobd]), (result: [fndg]), (unknown environmental triggers: [clna]), (susceptible individuals: [humn]), (triggers: [clna]), (maternal exposure: [inpo]), (fetus: [tisu]), (concentrations: [menp]), (pharmaceuticals: [phsu]), (carbamazepine (cbz): [orch,phsu]), ( venlafaxine (vnx): [orch,phsu]), (fluoxetine (flx): [orch,phsu]), (drinking water: [sbst]), (variety: []), (routes: []), (sewage: [eehu]), (previous studies: [lbpr]), (laboratory: [mnob,orgt]), (extent: []), (gene sets: [gngm]), (minnow brains: [fish]), (here: []), (hypothesis: []), (genes: [gngm]), (fish brains: [fish]), (human cell cultures: [humn]), (distinct characteristics: []), (asd-associated protein interaction network: [cgab]), (groups: [popg]), (network indices: [popg]), (network: [popg]), (proteins: [aapp,bacs]), (interactions: []), (generated: [acty]), (network characteristics: [popg]), (enriched gene sets: [gngm]), (particular pharmaceuticals: [phsu]), (other: []), (non-enriched asd gene sets: [cgab]), (particular: []), ( genes: [gngm]), (cbz: []), (vnx: []), (network importance: [popg]), (overall network: [popg]), (flx: []), (non-enriched asd genes: [cgab]), (multivariate network space: [popg]), (similarly: []), (pharmaceutical mixtures: [sbst]), (environmental concentrations): [menp]), (valproate (at: [orch,phsu]), (clinical dosages): [qnco]), (similar network signatures: [amas]), (overall asd network: [cgab]), (results: [fndg]), (important gene sets: [gngm]), (asd network: [cgab]), (perturbation: []), (environmental concentrations: [menp]), 
ASD Terms: (idiopathic autism spectrum, 'Autism Phenotype')(maternal exposure, 'Exposures')

PMCID: 4422995
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (global prevalence: [qnco]), (recognition: [menp]), (autistic spectrum disorder (asd): [mobd]), (arab world: []), (israel: []), (prevalence: [qnco]), (asd: [cgab]), (previous national survey: [resa]), (patients: [podg]), (jewish ancestry: [popg]), (disproportional low number: [qnco]), (arab children: [popg]), (awareness: [menp]), (cultural bias: [socb]), (present study: [qnco]), (demographic characteristics: [grpa]), (children: [aggp]), (arab: [popg]), (jewish sectors: [popg]), (child development centers: [orgf]), (incidence: [qnco]), (medical comorbidity: [hlca]), (autism: [mobd]), (ethnics: [fndg]), (psychiatric comorbidity profile: [lbpr]), (worldwide: []), (studies: [lbpr]), (arab sector: [popg]), (jewish sector: [popg]), (arab patients: [popg]), (severe autistic manifestations: [mobd]), (mental retardation: [mobd]), ( familial members: [famg]), (consanguinity (p: [fndg]), (jewish sector milder forms: [popg]), (asperger syndrome: [mobd]), (pdd-nos): [dsyn]), (discrepancy: [fndg]), (cultural factors: []), 
ASD Terms: (autistic spectrum disorder, 'Autistic Disorder')(autism, 'Autism Phenotype')(medical comorbidity, 'Comorbidities')(psychiatric comorbidity profile, 'Comorbidities')(autism, 'Autism Phenotype')(mental retardation, 'Mental Retardation')

PMCID: 4425117
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (group: [popg]), (mental illnesses: [mobd]), (gastrointestinal dysfunction: [dsyn]), (recent studies: [lbpr]), (microbial fingerprints: [orgm]), (terms: [orgf]), (composition: [clna]), (individuals: [humn]), (autism: [mobd]), (diagnostic purposes: [fndg]), (paper: []), (computational approach: [acty]), (metagenomes: [gngm]), (healthy: []), (autistic individuals: [mobd]), (genomic information: [gngm]), (enzymes: [enzy,orch]), (within: []), (detail: []), (text mining application: [mcha]), (custom-designed online application: [qnco]), (comparative metabolomics study: [resa]), (enzyme-catalyzing reactions: [moft]), (amino acid glutamate: [aapp,bacs]), (autism microbiome: [orgm]), (organism: [orgm]), (control microbiome: [orgm]), (interestingly: []), (leading hypothesis: []), (glutamate: [aapp,bacs]), (neurological excitation/inhibition imbalance;: [acty]), (association: [menp]), (study: [resa]), (results: [fndg]), (data: [euka]), (transsulfuration: [moft]), (transmethylation pathways: [moft]), (oxidative stress: [comd]), (importance: []), (alignment: [qnco]), (leading hypotheses: []), (field: [irda]), (silico nature: []), (present study: [qnco]), (new insight: [menp]), (complex metabolic interactions: [celf]), (novel methodology: []), (new hypotheses: []), (however: []), ( limitations: []), (sparse genome data availability: [gngm]), (conflicting literature: [inpr,mnob]), (experimental data: [euka]), (software tool: []), (methodology: []), (potential: []), (great utility: [orgt]), (available: []), ( comprehensive: []), (reliable: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(mental illnesses, 'Mental Disorders')(autism, 'Autism Phenotype')(autism microbiome, 'Autism Phenotype')(neurological excitation/inhibition imbalance, 'Neurologic Indications')

PMCID: 4406691
SFARI Genes: KIRREL3, KIRREL3, KIRREL3, MYO16, KIRREL3, MYO16, KIRREL3, KIRREL3, KIRREL3, CASK, KIRREL3, CASK, MYO16, MYO16, MYO16, MYO16, KIRREL3, KIRREL3, KIRREL3, KIRREL3, 
Non SFARI Genes: MAP1B, ATP1B1, UFC1, SHMT2, MAP1B, MAP1B, 
Named Entities: (cell-adhesion molecules: [aapp,bacs]), (immunoglobulin: [aapp,imft,phsu]), (critical roles: [socb]), (brain development: [ortf]), (synaptic plasticity: [ortf]), (dysfunction: [dsyn]), (cognitive impairment: [mobd]), (kirrel3: [gngm]), (synaptic molecule: [sbst]), (immunoglobulin superfamily: [aapp,imft,phsu]), (several neurodevelopmental conditions: [mobd]), (intellectual disability: [mobd]), ( autism spectrum disorder: [mobd]), (neurocognitive delay: []), (jacobsen syndrome: [dsyn]), (however: []), (molecular mechanisms: []), (physiological actions: [phsf]), (yeast two-hybrid screen: [fngs]), (extracellular domain interacts: []), (brain: [bpoc]), (proteins map1b: [aapp]), (myo16: [gngm]), (intracellular domain: [celc]), (atp1b1: [gngm]), ( ufc1: [gngm]), (shmt2: [gngm]), (interactions: []), (co-immunoprecipitation: [lbpr]), (colocalization analyses: [resa]), (proteins: [aapp,bacs]), (human embryonic kidney cells: [cell]), (neuronal cells: [cell]), (rat: [mamm]), (primary neuronal cells: [cell]), (kirrel3 colocalization: [gngm]), (marker: [clna]), (golgi apparatus: [celc]), (synaptic vesicles: [celc]), (previously: []), (x-linked intellectual disability: [mobd]), (synaptic scaffolding protein cask: [gngm]), (cytoplasmic domain: [celc]), (addition: []), (genomic deletion: [genf]), (map1b: [gngm]), (patient: [podg]), ( microcephaly: [cgab,dsyn]), (seizures: [sosy]), (deletions: [genf]), (unrelated patients: [podg]), ( autism: [mobd]), (microcephaly: [cgab,dsyn]), (synaptogenesis: [ortf]), (development: [orgf]), (actin-based membrane skeleton: [aapp,bacs]), (hippocampal neurons: [cell]), (actin cytoskeleton: [celc]), (interaction: []), (wave1 complex: [chvs]), (kirrel3 interacting proteins: [aapp,bacs]), (potential candidates: []), (autism spectrum disorder: [mobd]), (moreover: []), (findings: [clna]), (further insight: [menp]), (physiological action: [phsf]), (role: [socb]), (neurodevelopment: [ortf]), 
ASD Terms: (cognitive impairment, 'Cognitive Ability')(several neurodevelopmental conditions, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(neurocognitive delay, 'Cognitive Ability')(x-linked intellectual disability, 'Learning Disorders')(autism, 'Autism Phenotype')(potential candidates for intellectual disability, 'Learning Disorders')

PMCID: 4425104
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (diverse: []), (environmental factors: []), (development: [orgf]), (autism spectrum disorders: [mobd]), (genetic factors: [fndg]), (differential vulnerability: []), (environmental risk factors: []), (susceptible individuals: [humn]), (way: []), (incidence: [qnco]), (asd: [cgab]), (understanding: [menp]), (metabolic: [celf]), ( cellular: [cell]), (biochemical events: [evnt]), (gene x environment interactions: [genf]), (important implications: []), (prevention: [resa]), (possible treatment: [topp]), (disorder: [dsyn]), (review: []), (alternative processes: [phpr]), (genome: [gngm]), (epigenome: []), (genetically-susceptible individuals: [orga]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 4393085
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (temperament: [menp]), (development: [orgf]), (social behaviours: [socb]), (interpersonal relations: [socb]), (possible links: []), (autistic traits: [mobd]), (particular interest: [menp]), (purpose: []), (study: [resa]), (relationships: []), (temperamental characteristics: [fndg]), (framework: []), (regulative temperament theory: [menp]), (strelau: []), (emotionality: [fndg]), ( activity: [acty]), (sociability theory: [socb]), (buss: []), (plomin: []), (particular emphasis: []), (gender differences: [orga]), (autism spectrum quotient (aq): [qnco]), ( formal characteristics: []), (behaviour  temperament inventory: [diap]), (temperament survey: [menp]), (adults: [aggp]), (administered: []), (participants: [popg]), (university students: []), (females: [orga]), (males: [orga]), (results: [fndg]), (positive correlations: [fndg]), (emotional reactivity: [fndg]), ( perseveration: [mobd]), ( distress: [menp]), ( fear: [menp]), (anger: [menp]), (negative correlations: [fndg]), (activity: [acty]), ( briskness: []), ( endurance: [fndg]), (sociability: [socb]), (multiple regression: []), (autism spectrum quotient score: [clna]), (dependent measure: [qnco]), (exploratory pca analysis: [resa]), (aq: []), (factor (with aq: []), (others): [fndg]), (high aq scorers: [qnco]), (briskness: []), (norms: [fndg]), (general population: [popg]), (temperament measures: [menp]), (items: []), (parts: [qnco]), (other items: []), (obverse: []), (genders: [orga]), (regard: []), (autism phenotype: [mobd]), ( temperaments: [menp]), (healthy control samples: []), 
ASD Terms: (social behaviours, 'Reciprocal Social Interaction')(autism spectrum quotient, 'Autism Phenotype')(perseveration, 'Involuntary Behaviors')(autism spectrum quotient score, 'Autism Phenotype')(perseveration, 'Involuntary Behaviors')(autism phenotype, 'Autism Phenotype')

PMCID: 4553146
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (autistic-related traits: [mobd]), (general population lie: [popg]), (continuum: []), (autism spectrum disorders: [mobd]), (extreme end: []), (distribution: []), (here: []), (hypothesis: []), (possible relationship: []), (autistic traits: [mobd]), (brain morphometry: [bpoc]), (general population: [popg]), (participants: [popg]), (acquired: []), (associations: [menp]), (gray matter: [tisu]), (white matter microstructural-integrity: [tisu]), (exploration-group (n =: [popg]), (males: [orga]), ( m-age =: [orga]), (validation-group (n =: [popg]), (significant associations: [menp]), (aq-scores: [clna]), (exploration-group: [popg]), (data: [euka]), (questions: []), (assumption: []), (morphological associations: [menp]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-015-2441-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 4425039
SFARI Genes: MBD5, MBD5, MBD5, UBE3A, TCF4, MEF2C, EHMT1, RAI1, MBD5, UBE3A, TCF4, MEF2C, EHMT1, RAI1, MBD5, RAI1, MBD5, RAI1, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (well-established genetic cause: [topp]), (genes: [gngm]), (cellular mechanisms: [cell]), (asd: [cgab]), (deletion syndrome: [genf]), ((causative gene: [gngm]), ( mbd5): [gngm]), (genetic neurodevelopmental disorder: [mobd]), (mutations: [genf]), (mbd5: [gngm]), (asd cohorts: [cgab]), (study: [resa]), (phenotypic update: [orga]), (prevalent features: [qnco]), (severe intellectual disability: [mobd]), ( seizures: [sosy]), (significant speech impairment: [dsyn]), (sleep disturbance: [dsyn]), (autistic-like behavioral problems: [mobd]), (next: []), (phenotypic: [orga]), ( molecular: []), (relationships: []), (neurodevelopmental disorders: [mobd]), (asd:: [cgab]), (deletion rett: [genf]), ( angelman: []), ( pitt-hopkins: []), (duplication: [comd]), (deletion: [genf]), ( kleefstra: []), ( kabuki make-up: []), (smith-magenis syndromes: [dsyn]), (phenotypic overlaps: [orga]), (intellectual disability: [mobd]), ( speech delay: [mobd]), (seizures: [sosy]), ( sleep disturbance: [dsyn]), ( hypotonia: [fndg]), (autistic-like behaviors: [mobd]), (molecularly: []), ( mbd5: [gngm]), (expression: [topp]), (ube3a: [gngm]), ( tcf4: [aapp,bacs]), ( mef2c: [gngm]), ( ehmt1: [gngm]), (rai1: [gngm]), (network analysis reveals: []), (indirect protein interactions: [moft]), (implicating function: [phsf]), (common pathways: [moft]), (several common pathways: [moft]), (behavioral development: [orgf]), (findings support: [clna]), (further investigations: [hlca]), (pathway relationships: [moft]), (common points: [qnco]), (regulation: [biof]), (therapeutic intervention: [topp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(genetic neurodevelopmental disorder, 'Learning Disorders')(severe intellectual disability, 'Learning Disorders')(significant speech impairment, 'Idiosyncratic and Routinized Speech')(sleep disturbance, 'Sleeping Problems')(autistic-like behavioral problems, 'Personal Traits')(neurodevelopmental disorders, 'Learning Disorders')(deletion rett, 'Rett Syndrome')(intellectual disability, 'Learning Disorders')(speech delay, 'Idiosyncratic and Routinized Speech')(sleep disturbance, 'Sleeping Problems')

PMCID: 4412039
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (group: [popg]), (understood behavioural disorders: [mobd]), (prevalence: [qnco]), (decades: [qnco]), (animal models: [anim]), (opportunity: []), (biological basis: [phsu]), (disorders: [dsyn]), (studies: [lbpr]), (different mouse strains: [mamm]), (inbred btbr t + tf/j (btbr) strain: [aapp,imft]), (mouse model: [emod]), (asd: [cgab]), (repetitive behaviours: [inbe]), (adult btbr mice: [aggp]), (complete agenesis: [cgab]), (corpus callosum: [bpoc]), (cortical thickness: [bpoc]), (changes: [qnco]), (early neurogenesis: [orgf]), (however: []), (development: [orgf]), (ultimate organisation: [orgt]), (cortical areas: [bpoc]), (specific sensory: []), (motor functions: []), (mice: [mamm]), (behavioural phenotype: [bhvr]), (study: [resa]), (diffusion tensor imaging: [diap]), (histological analyses: [resa]), (emergence: []), (functional areas: []), (cerebral cortex: [bpoc]), (connections: []), (btbr mice: [mamm]), (age-matched c57bl/6 control mice: [mamm]), (evidence: []), (anterior commissure: [bsoj]), (hippocampal commissure compensate: [bsoj]), (loss: [qnco]), (callosal connections: []), (interhemispheric neocortical connectivity: []), (somatosensory cortical areas: [bpoc]), (controls: [sbst]), (interhemispheric connectivity: []), (cortical area formation: [ortf]), (region-specific manner: []), (behavioural deficits: [inbe]), (strain: [menp]), (developmental patterns: [orgf]), (change: [qnco]), (human asd patients: [humn]), (aetiology: []), (cortical changes: [bpoc]), (help: []), (understanding: [menp]), (disorder: [dsyn]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13064-015-0033-y) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(repetitive behaviours, 'Restricted and Repetitive Behavior')(motor functions, 'Motor Skills')(behavioural deficits, 'Personal Traits')

PMCID: 4382850
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mitochondrial dysfunction: [fndg]), (defects: []), (oxidative metabolism: [celf]), (characteristic feature: []), (many chronic illnesses: [dsyn]), (mitochondrial diseases: [dsyn]), (examples: []), (such illnesses: [sosy]), (bipolar disorder: [mobd]), (multiple sclerosis: [dsyn]), ( parkinsons disease: [dsyn]), ( schizophrenia: [mobd]), ( depression: [mobd]), ( autism: [mobd]), (chronic fatigue syndrome: [dsyn]), (discussion: [socb]), (majority: [socb]), (patients: [podg]), (widespread mitochondrial dysfunction: [fndg]), (impaired atp: [aapp,enzy]), (findings: [clna]), (parkinsons disease: [dsyn]), (bipolar disorder schizophrenia: [mobd]), (fact: [gngm]), (diagnoses: [fndg]), (disease: [dsyn]), (unitary pathogenesis: [patf]), (pathophysiology: [patf]), (however: []), ( investigations: [hlca]), (presence: [qnco]), (chronic oxidative stress: [comd]), (invariant finding: [sosy]), (study cohorts: [popg]), (diagnosis: [fndg]), (state: []), (elevated reactive oxygen: [elii,phsu]), (nitrogen species: [elii]), (reduced levels: []), (glutathione: [aapp,bacs]), (hand: [bpoc]), (chronic systemic inflammation: [patf]), (elevated levels: []), (pro-inflammatory cytokines: [aapp,bacs]), (summary: []), (paper details mechanisms: []), (reactive oxygen: [elii,phsu]), (elevated pro-inflammatory cytokines: [aapp,bacs]), (major road: []), (development: [orgf]), (impaired oxidative metabolism: [celf]), (many patients: [podg]), (disorders: [dsyn]), 
ASD Terms: (bipolar disorder, 'Bipolar Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(depression, 'Depressive Disorder')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(depression, 'Depressive Disorder')(bipolar disorder schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(diagnosis, 'Diagnosis')(development of mitochondrial dysfunction, 'Learning Disorders')(impaired oxidative metabolism, 'Metabolic Indications')

PMCID: 4376901
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (deficits: []), (social interaction: [fndg]), (communication: [socb]), (repetitive behaviours: [inbe]), (number: [qnco]), (penetrant asd gene variants: [cgab]), (evidence: []), (causal role: [socb]), (combinatorial effects: []), (contributions: [acty]), (multiple loci: [gngm]), (circadian neurological phenotypes: [orga]), (dosage variants: [qnco]), (unique human:fly orthologues: [humn]), (drosophila: [euka]), (numerous synergistic interactions: [biof]), (pairs: []), (informatically-identified candidate genes: [gngm]), (orthologues: []), (copy number variants: [nusq]), (cnvs: [nusq]), (genomes: [gngm]), (individuals: [humn]), (autism: [mobd]), (patient: [podg]), (deletion: [genf]), (dosage alterations: [qnco]), (unique drosophila orthologues: [euka]), (candidate genes: [gngm]), (single candidate gene: [fndg]), (neurological defects: [clna]), (drosophila models: [euka]), (asd-associated variants: [cgab]), (pairwise dosage changes: [qnco]), (set: [menp]), (same single human: [humn]), (cnv: [nusq]), (complete orthologous relationships: []), (significant synergistic effects: [qnco]), (simultaneous dosage change: [qnco]), (gene pairs: [gngm]), (single cnv: [fndg]), (phenotypic variation: [fndg]), (drosophila synapse: [euka]), (results: [fndg]), (genetic variants: [npop]), (concordant phenotypic outcome: [orga]), (direction: []), (human gene copy number change: [humn]), (specificity: [qnco]), (transitivity: []), (cnv candidate gene sets: [nusq]), (distinct genetic aetiologies: [topp]), (different interactions: []), (divergent synaptic processes: [phpr]), (distinct molecular aetiologies: []), (study: [resa]), (mechanisms: []), (synergistic effects: []), (large structural variation: [qnco]), (human disease: [humn]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(autism spectrum disorders, 'Autism Phenotype')(repetitive behaviours, 'Restricted and Repetitive Behavior')(circadian neurological phenotypes, 'Neurologic Indications')(autism, 'Autism Phenotype')(neurological defects, 'Neurologic Indications')

PMCID: 4383723
SFARI Genes: Ctnnd2, Ctnnd2, 
Non SFARI Genes: 
Named Entities: (summary autism: [mobd]), (multifactorial neurodevelopmental disorder: [mobd]), (males: [orga]), (females; consequently: [orga]), (multifactorial genetic hypothesis: [fndg]), ( females: [orga]), (biological threshold: []), (deleterious variants: []), (residues: [evnt]), (affected patients: []), (femfs: []), ((female-enriched multiplex families): [famg]), (severe disease: [fndg]), (detection: [topp]), (key autism genes: [gngm]), (modest numbers: [qnco]), (cases: [qnco]), (utility: [orgt]), (strategy: [menp]), (missense: [fndg]), (dosage sequence variants: [npop]), (gene: [gngm]), (adhesive junction-associated delta catenin protein (ctnnd2): [celc]), (loss-of-function effect: [phsf]), (functional analyses: [hlca]), (zebrafish embryos: [fish]), (hippocampal neurons: [cell]), (wildtype: [gngm]), (ctnnd2: [gngm]), (mouse embryos: [mamm]), (finally: []), (gene expression: [genf]), (network analyses: []), (critical role: [socb]), (neuronal development: [celf]), (intimate connection: [socb]), (biology: []), (data contribute: [acty]), (understanding: [menp]), (genetic architecture: [topp]), (autism: [mobd]), (genetic analyses: [lbpr]), (phenotypic extremes: [orga]), (innate value: [qnco]), (multifactorial disorders: [dsyn]), 
ASD Terms: (summary autism, 'Autism Phenotype')(multifactorial neurodevelopmental disorder, 'Learning Disorders')(key autism genes, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4373693
SFARI Genes: CLN8, CLN8, CLN8, CLN8, CLN8, CLN8, 
Non SFARI Genes: 
Named Entities: (rare: [gngm]), (inherited variations: []), (multiplex families: [famg]), (autism spectrum disorder (asd): [mobd]), (major role: [socb]), (genetic etiology: [topp]), (asd: [cgab]), (role: [socb]), (rare inherited variations: [gngm]), (whole-exome sequencing (wes): [mbrt]), (families: [famg]), (siblings: [famg]), (two-stage follow-up case-control study: [resa]), (japanese population: [popg]), (wes: [mbrt]), (affected siblings: [famg]), (novel rare missense variations: [fndg]), (variations: []), ( cln8 r24h: [dsyn]), (family: [famg]), (affected father: [famg]), (first stage: []), (follow-up study: [resa]), (novel: []), (rare missense variations: [fndg]), (patients: [podg]), (controls: [sbst]), ((the niigata sample): [sbst]), (cln8 r24h: [dsyn]), (mutant allele frequencies: [qnco]), (second stage: []), (variation: []), (further genotyped: [orga]), (sample: [sbst]), ((the nagoya sample): [sbst]), (combined niigata: []), (nagoya: []), (significant association (odds: [menp]), (confidence interval: [qnco]), (results: [fndg]), (subset: []), (asd patients: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 4372449
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (communicative skills: [orga]), (repetitive behaviors: [fndg]), (evidence: []), (hypothesis: []), (neurodevelopmental disorders: [mobd]), (combination: [fndg]), (genetic susceptibility: [orga]), (exposure: [clna]), (environmental toxins: [hops]), (early developmental phases: [orgf]), (study: [resa]), (effects: []), (prenatal exposure: [fndg]), (organophosphate insecticide: [hops,orch]), (developmental neurotoxicity: [inpo]), (sub-toxic doses: [qnco]), (btbr t+tf/j mouse: [aapp,imft]), (validated model: []), (idiopathic autism: [mobd]), (several behavioral traits: [inbe]), (autism spectrum: [mobd]), (aim: [phsu]), (pregnant btbr mice: [fndg]), (gestational day: []), (vehicle: [bodm]), (cpf: [gngm]), (dose: [qnco]), (mg/kg/bw: [orga]), (oral gavages: []), (offspring: [famg]), (sexes underwent assessment: [orgf]), (early developmental milestones: []), (somatic growth: [orgf]), ( motor behavior: [dora]), (ultrasound vocalization: [npop]), (potential long-term effects: [phpr]), (different social behavior patterns: [socb]), (btbr strain (free: [menp]), (social interaction: [fndg]), (same-sex companion: [anim]), (females: [orga]), (interaction: []), (receptive female: [orga]), (males): [orga]), (sexes: [orgf]), (adulthood: []), (findings: [clna]), (significant effects: [qnco]), (neonatal motor patterns: []), (pups: []), (reduced weight gain: [fndg]), (motor maturation (i.e.: [diap,inpr]), ( persistency: []), (immature patterns: []), (expenses: [qnco]), (coordinated locomotion): [orgf]), (trend: []), ( cpf: [gngm]), (alterations: []), (males: [orga]), (altered pattern: []), (investigation: [hlca]), (sexual partner: [popg]), (btbr mice: [mamm]), (cpf males: [orga]), (ultrasonic vocalization rate: [npop]), (need: []), (future studies: [lbpr]), (role: [socb]), (environmental chemicals: [chem]), (etiology: []), (neurodevelopment disorders: [mobd]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(communicative skills, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(neurodevelopmental disorders, 'Learning Disorders')(exposure, 'Exposures')(prenatal exposure, 'Exposures')(idiopathic autism, 'Autism Phenotype')(autism spectrum, 'Autism Phenotype')(gestational day, 'Perinatal History')(offspring, 'Perinatal History')(ultrasound vocalization, 'Vocalizations')(different social behavior patterns, 'Personal Traits')(ultrasonic vocalization rate, 'Vocalizations')

PMCID: 4372342
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (cognitive deficits: [mobd]), (negative symptoms: [fndg]), (important therapeutic targets: [diap]), (schizophrenia: [mobd]), (autism disorders: [mobd]), (reduction: [npop]), (phase-locked gamma oscillation: [npop]), (result: [fndg]), (reduced parvalbumin-immunoreactive (putatively: [aapp,bacs]), ( gabaergic): []), (direct correlations: []), (disorders: [dsyn]), (present study: [qnco]), (such relationships: []), (pharmacological treatment: [topp]), (drug: [phsu]), ( t-817ma: [orch,phsu]), (neurotrophic effects: []), (study: [resa]), (platelet-derived growth factor: [aapp,bacs]), (receptor- gene: [gngm]), ((pdgfr- ko) mice: [mamm]), (animal model: [emod]), (autism: [mobd]), (mutant mice: [mamm]), (social behaviors; deficits: [socb]), (prepulse inhibition (ppi);: [phsf]), (levels: []), (parvalbumin-immunoreactive neurons: [aapp,bacs]), (medical prefrontal cortex: [bpoc]), ( hippocampus: [bpoc]), ( amygdala: [bpoc]), (superior colliculus;: [bpoc]), (deficit: [dsyn]), (auditory phase-locked gamma oscillations: [npop]), (oral administration: [topp]), (t-817ma: [orch,phsu]), (symptoms: [sosy]), (pdgfr- ko mice: [mamm]), (furthermore: []), (phase-locked gamma oscillations: [npop]), (density: [qnco]), (was: []), (turn: [fndg]), (ppi: [phsu]), (behavioral parameters: [inbe]), (findings: [clna]), (recovery: [acty]), (pharmacological intervention: [hlca]), (consequently: []), (social behavioral deficits: [inbe]), (thus: []), (useful physiological biomarker: [clna]), (abnormality: [fndg]), (effective pharmacological interventions: [hlca]), (humans: [humn]), (experimental animals: [anim]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(cognitive deficits, 'Cognitive Ability')(autism disorders, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(social behaviors, 'Reciprocal Social Interaction')(medical prefrontal cortex, 'Medications')(social behavioral deficits, 'Personal Traits')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')

PMCID: 4394543
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recently: []), (autism-related research: [mobd]), (identification: [menp]), (various genes: [gngm]), (pathways: [moft]), (heterogeneous group: [popg]), (autism spectrum disorders: [mobd]), (list: []), (autism-related genes: [gngm]), (awareness: [menp]), (advances: []), (genetic technology: [mbrt]), (searchable genomic databases: []), (master list: []), (relevant autism spectrum disorder genes: [gngm]), (evidence: []), (peer-reviewed medical literature sources: [hlca]), (key words: []), (autism: [mobd]), (genetics: []), (authoritative autism-related public access websites: [mobd]), (simons foundation autism research institute autism: [mobd]), (genomic database: []), (gene discovery: [mbrt]), (characterization: [acty]), (genes: [gngm]), (alphabetical order: [acty]), (tabular form: []), (gene symbols: []), (high-resolution: [lbpr]), (human chromosome ideograms: [celc]), (laboratory geneticists: [mnob,orgt]), (genetic counsellors: []), (access: []), (convenient visual images: []), (location: [blor]), (distribution: []), (asd genes: [cgab]), (meaningful correlations: []), (observed phenotype: [orga]), (patients: [podg]), (suspected/confirmed asd gene(s): [cgab]), (chromosome region: [cell]), (breakpoint band site: [blor]), (diagnosis: [fndg]), (care: [acty]), (genetic counselling: [topp]), (families: [famg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(peer-reviewed medical literature sources, 'Medications')(relevant autism spectrum disorder genes, 'Autism Phenotype')(autism, 'Autism Phenotype')(simons foundation autism research institute autism, 'Autism Phenotype')(convenient visual images, 'Visual Thinking')(inform diagnosis, 'Diagnosis')

PMCID: 4375929
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (pathogenic mechanism: [fndg]), (formation: [biof]), (antigen-antibody complexes: [aapp,imft]), (inflammatory response: [patf]), (infiltration: [patf]), (neutrophils: [cell]), (epithelial cell-derived neutrophil-activating peptide-78 (ena-78): [aapp,imft]), (chemokine: [aapp,imft]), (recruits: []), (activates: [acty]), (pathogenic role: [socb]), (inflammation: [patf]), (autoimmune disorders: [dsyn]), (autistic children: [podg]), (levels: []), (brain: [bpoc]), (serum expression: [bdsu]), (ena-78: [gngm]), (relation: [socb]), (antineuronal auto-antibodies: [aapp,imft]), (serum ena-78: [bdsu]), (elisa test: [lbpr]), (years: []), (health-matched controls: [resa]), (serum levels: [bdsu]), (healthy controls: []), (autistic patients: [mobd]), (addition: []), ( autistic children: [podg]), (percent positivity: [qnco]), (serum antineuronal auto-antibodies (64.5%): [aapp,imft]), ((6.45%): [fndg]), ( p: [aapp,imft]), (significant positive association: [menp]), (positivity: [fndg]), (serum antineuronal auto-antibodies: [aapp,imft]), (elevated levels: []), (serum ena-78 (p: [bdsu]), (increased levels: [qnco]), (however: []), (data: [euka]), (caution: []), (further research: [resa]), (autism: [mobd]), (specific auto-antibodies: [aapp,imft]), (possible therapeutic role: [socb]), (ena-78 antagonist: [ortf]), 
ASD Terms: (autoimmune disorders, 'Autoimmune Diseases')(autism, 'Autism Phenotype')

PMCID: 4573762
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (neuroligins: [moft]), (postsynaptic cell-adhesion molecules: [aapp,bacs]), (presynaptic neurexins: []), (general synaptic role: [socb]), (specific functions: []), (synapse: [bsoj]), (moreover: []), (gene mutations: [genf]), (autism: [mobd]), (pathophysiological relevance: [patf]), (mutations: [genf]), (mechanisms: []), (action uninvestigated: [acty]), (here: []), (synaptic effects: []), (autism-associated neuroligin-4 substitution: [aapp,bacs]), (r704c): []), (cytoplasmic arginine residue: [aapp,bacs,phsu]), (r704c mutation: [genf]), (neuroligin-3: [aapp,rcpt]), ( enhances: [acty]), (interaction: []), (ampa-receptors: [aapp,rcpt]), ( increases ampa-receptor internalization: [aapp,rcpt]), (postsynaptic ampa-receptor levels: [aapp,rcpt]), (neuroligin-4: [aapp,bacs]), ( conversely: []), (ampa-receptor: [aapp,rcpt]), (synaptic responses: [orga]), (results: [fndg]), (general functional link: [hlca]), ( indicate: []), (-4 act: [topp]), (excitatory synapses: [celc]), (distinct functions: []), (demonstrate: []), (normal function: [phsf]), ( thereby: []), (pathogenicity: [orga]), 
ASD Terms: (autism, 'Autism Phenotype')

PMCID: 4367837
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (several lines: [qnco]), (evidence: []), (mitochondrial impairment: [celc]), (pathophysiology: [patf]), (autism: [mobd]), (common biomarkers: [clna]), (mitochondrial dysfunction: [fndg]), (mitochondrial dna (mtdna) copy number: [bacs,nnon]), (relationship: []), (mtdna copy number: [bacs,nnon]), (study: [resa]), (casecontrol study: [resa]), (peripheral blood cells: [cell]), (patients: [podg]), (relative mtdna copy number: [bacs,nnon]), (real-time polymerase chain reaction method: [mbrt]), (participants: [popg]), (childhood autism: [mobd]), (children: [aggp]), (healthy controls: []), (= 0.173: [fndg]), ( p: [aapp,imft]), (however: []), (significant correlations: [qnco]), (clinical features: [clna]), ((paternal age: []), ( maternal age: []), ( age: [orga]), (onset: [qnco]), ( illness: [sosy]), (duration: [phsu]), ( cars score: [clna]), (abc score): [dsyn]), (peripheral blood: [bdsu]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(childhood autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(childhood autism, 'Autism Phenotype')

PMCID: 4354353
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (adolescence: []), ( white matter microstructure: [tisu]), (important stage: [clna]), (development: [orgf]), (alterations: []), (brain connectivity: [bpoc]), (key role: [socb]), (autism spectrum conditions: [mobd]), (white matter microstructure: [tisu]), (interaction: []), (phenotype: [orga]), (autism: [mobd]), (siblings: [famg]), (individuals: [humn]), (asc: [gngm]), (times: [qnco]), (certain forms: []), (diffusion tensor: [npop]), (white matter microstructure measurements: [tisu]), (age: [orga]), (correlation differs: []), (n=43 adolescents: [aggp]), (n=38 siblings: [famg]), (correlations: []), (developmental changes: [orgf]), (previous longitudinal studies: [resa]), (comparison: [acty]), ( individuals: [humn]), (asc display weaker: [sosy]), (negative correlation: [fndg]), (mean diffusivity: [qnco]), (broad area: []), (right superior longitudinal fasciculus: [bpoc]), (differences: [qnco]), (increased heterogeneity: [orga]), (temporal alterations: []), (group's developmental pattern: [popg]), (diminished negative correlation: [qnco]), (component: []), (mean diffusivitysecond diffusion: [npop]), (observed differences match: [resa]), (location: [blor]), (correlation directionality: []), (part: [qnco]), (endophenotype: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4359103
SFARI Genes: 
Non SFARI Genes: LIF, 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (impairments: [patf]), (social interaction: [fndg]), (non-verbal communication skills: [menp]), (interests: [menp]), (repetitive behavior: [fndg]), (brain environment: [bpoc]), (imbalance: [sosy]), (neurotrophic support: []), (early development contributes: [acty]), (pathophysiology: [patf]), (sera: [gngm]), (children: [aggp]), (abnormal levels: [qnco]), (various neurotrophic factors: [aapp,bacs]), (cell death: [celf]), (oxidative stress: [comd]), (mouse primary: [mamm]), (cortical neurons: [bpoc]), (effects: []), (autistic children: [podg]), (pre-treatment: []), (ciliary neurotrophic factor (cntf): [aapp,bacs]), (small peptide mimetic: [aapp]), ( peptide: [aapp]), ((p6): []), (neuroprotective effect: []), (cntf/jak/stat pathway: [aapp,bacs]), (lif signaling: [celf]), (brain: [bpoc]), (neurotrophic factor (bdnf) expression: [aapp,bacs]), (similar neurotoxic effects: [inpo]), (neuroinflammation: []), (young wistar rats: [mamm]), (autism sera: [bdsu]), (hours: []), (birth: [orgf]), (rats: [mamm]), (developmental delay: [mobd]), (deficits: []), (social communication: [socb]), ( interaction: []), (novelty: []), (neurobiological changes: [qnco]), (behavioral autistic phenotype: [mobd]), (p6 treatment: [topp]), (findings: [clna]), (involvement: []), (neurotrophic imbalance: [sosy]), (early brain development: [ortf]), (proof: [qnco]), (principle: []), (p6: [gngm]), (potential therapeutic strategy: [menp]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(non-verbal communication skills, 'Reciprocal Social Interaction')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')(autism sera, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')(developmental delay, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4446412
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (isogenic pluripotent stem cells: [cell]), (critical tools: []), (human neurological diseases: [humn]), (effects: []), (mutation: [genf]), (fixed genetic background: [orga]), (particular interest: [menp]), (spectrum: [qnco]), (autism: [mobd]), (timothy: [plnt]), ((ts); others: [fndg]), (microdeletion: []), (microduplication syndromes: [dsyn]), (chromosomal locus: [celc]), (here: []), (human embryonic stem cell (hesc) lines: [cell]), (disorders: [dsyn]), (locus-specific endonucleases: [aapp,enzy]), (efficiency: [qnco]), (homology-directed repair (hdr): [orgf]), (system: []), (to: (1): [aapp,enzy]), (unique transcription: [genf]), (activator-like effector nuclease (talen) binding sites: [rcpt]), (genome: [gngm]), (new software program: [inpr,mnob]), ( talenseek: []), ( (2): [qnco]), (talen genes: [gngm]), (golden gate: []), (modified constructs: []), (flash protocol: [fndg]), ((3) test: [fndg]), (talen pairs: []), (amplification-based hdr assay: [lbpr]), (typical non-homologous end joining assay: [genf]), (methods: []), (construct: []), (test talens: [lbpr]), (hdr donors: [popg]), (hescs: [cell]), (isogenic ts cell line: [cell]), (scarless manner: []), (copy number disorder: [dsyn]), (genomic loci: [gngm]), (high sequence similarity: [qnco]), 
ASD Terms: (human neurological diseases, 'Neurologic Indications')(autism, 'Autism Phenotype')

PMCID: 4394500
SFARI Genes: CREBBP, CREBBP, CREBBP, CREBBP, 
Non SFARI Genes: TNC, IGFALS, TNC, IGFALS, TNC, IGFALS, 
Named Entities: (rubinstein-taybi syndrome (rsts): [cgab,dsyn]), (rare condition: [dsyn]), (prevalence: [qnco]), (births: [orgf]), (clinical features: [clna]), (facial: [blor]), ( dental: [hlca]), (limb dysmorphology: [bpoc]), (growth retardation: [patf]), (cases: [qnco]), (rsts: [gngm]), (mutations: [genf]), (molecular abnormalities: [fndg]), (rsts cases: [qnco]), (previous genetic studies: [resa]), (inconsistent results: [fndg]), (variety: []), (methods: []), (genetic analysis: [lbpr]), (purpose: []), (study: [resa]), (whole exome: [gngm]), ((wes): [mbrt]), (genetic causes: [topp]), (young girl: [aggp]), (autism phenotype: [mobd]), (autism: [mobd]), (diagnostic observation schedule (ados): [hlca]), (diagnostic interview: [acty]), (diagnosis: [fndg]), (various questionnaires: [phsu]), (other psychiatric features: [hlca]), (wes: [mbrt]), (dna sequences: [nusq]), (patient: [podg]), (parents: []), (variants: []), (typical features: []), ( wes: [mbrt]), (frameshift mutation: [comd]), (crebbp: [gngm]), (sequence variants: [npop]), (tnc: [gngm]), (igfals genes: [gngm]), (crebbp gene: [gngm]), (potential missense mutations: [genf]), (central nervous system development: [ortf]), (growth: [orgf]), (patients: [podg]), (phenotypes: [orga]), 
ASD Terms: (growth retardation, 'Mental Retardation')(autism phenotype, 'Autism Phenotype')(autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')

PMCID: 4759203
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (cognitive impairment: [mobd]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (attention-deficit hyperactivity disorder (adhd): [mobd]), (aspects: [qnco]), (intelligence: [menp]), (people: [popg]), (asd: [cgab]), (controls: [sbst]), (consistent evidence: []), (few studies: [lbpr]), (genetic overlap: [topp]), (cognitive ability: [menp]), (asd/adhd: [cgab]), (aim: [phsu]), (study: [resa]), (polygenic overlap: [topp]), (general population: [popg]), (polygenic risk: [genf]), (adhd: [mobd]), (genome-wide association studies: [mbrt]), (psychiatric genetics consortium: [hlca]), (risk scores: [qnco]), (independent cohorts: generation scotland scottish family health study (gs:sfhs): [fndg]), (lothian birth cohorts: [qnco]), ((n=1522): [aapp,imft]), (brisbane adolescent twin sample (bats) (n=921): [aggp]), (general cognitive ability (beta=0.07: [plnt]), ( p=6: [aapp,imft]), (r2=0.003): [neop]), ( logical memory: [menp]), (verbal intelligence: [menp]), (gs:sfhs: []), (bats: [mamm]), (positive association: [menp]), (full-scale intelligent quotient (iq) (beta=0.07: [plnt]), ( p=0.03: [fndg]), ( r2=0.005): [neop]), (cognitive function;: [menp]), (negative correlation: [fndg]), (iq: []), (age: [orga]), (years: []), ((beta=0.08: [plnt]), ( z=3.3: [fndg]), ( p=0.001): [fndg]), (findings: [clna]), (relationship: []), (genetic risk: [qnco]), (clinical state: []), (data: [euka]), (common genetic variation relevant: [npop]), (general cognitive ability: [fndg]), 
ASD Terms: (cognitive impairment, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(attention-deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(cognitive ability, 'Cognitive Ability')(cognitive ability, 'Cognitive Ability')(general cognitive ability, 'Cognitive Ability')(logical memory, 'Working Memory')(full-scale intelligent quotient, 'IQ')(intelligent quotient, 'IQ')(cognitive function, 'Cognitive Ability')

PMCID: 4565786
SFARI Genes: PTEN, Pten, PTEN, Pten, PTEN, Pten, PTEN, Pten, Pten, Pten, Pten, Pten, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental condition: [mobd]), (clear: [fndg]), (heterogeneous: [orga]), ( genetic component: [gngm]), (germline mutations: [genf]), (tumor suppressor pten: [gngm]), (well-established risk factor: [qnco]), (asd: [cgab]), (macrocephaly: [cgab]), (conditional pten mouse models: [mamm]), (social behavior: [socb]), (brain development: [ortf]), (mutations: [genf]), (patients: [podg]), (nuclear-cytoplasmic localization: [celc]), (pten protein: [aapp,enzy]), (ptenm3m4 model: []), (effects: []), (cytoplasm-predominant pten: [aapp,enzy]), (model: []), (germline mislocalization: [cell]), (pten: [gngm]), (inappropriate social behavior: [socb]), (profile reminiscent: [lbpr]), (high-functioning asd: [cgab]), (animals: [anim]), (histological evidence: []), (neuroinflammation: []), (expansion: []), (glial populations: [popg]), (six-weeks: [qnco]), (age: [orga]), (neural transcriptome: [nusq]), (manner: []), (human idiopathic asd: [humn]), (constitutional condition: [dsyn]), (progressive disruption: []), (neural gene expression: [genf]), (ptenm3m4 mice: [mamm]), (synaptic pathways: [moft]), (alterations: []), (downregulation: [moft]), (co-expressed human-asd-susceptibility genes: [humn]), (comparison: [acty]), (human cortical development coexpression network: [humn]), (genes: [gngm]), (same areas: []), (human asd: [humn]), (pten-related asd: [cgab]), (observations: [hlca]), (multiple molecular features: [qnco]), (human-asd: [humn]), (common pathways: [moft]), (asd pathogenesis: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental condition, 'Learning Disorders')(social behavior, 'Reciprocal Social Interaction')(inappropriate social behavior, 'Reciprocal Social Interaction')

PMCID: 4355952
SFARI Genes: CHD8, CHD8, CHD8, CHD8, CHD8, CHD8, CHD8, CHD8, 
Non SFARI Genes: 
Named Entities: (recent studies: [lbpr]), (chromatin modifiers: []), (autism spectrum disorder (asd): [mobd]), (identification: [menp]), (recurrent: []), (loss: [qnco]), (function mutations: [phsf]), (affected individuals: [humn]), (asd risk genes: [cgab]), (human midfetal cortex: [humn]), (asd risk genes converge: [cgab]), (specific regulatory networks: []), (neurodevelopment: [ortf]), (genes: [gngm]), (chd8: [gngm]), (chromodomain helicase: [aapp,enzy]), (asd: [cgab]), (human midfetal brain: [humn]), (human neural stem cells: [humn]), (embryonic mouse cortex: [tisu]), (chd8 targets: [gngm]), (other asd risk genes: [cgab]), (mouse neurodevelopment: [mamm]), (converge: [acty]), (asd-associated co-expression networks: [cgab]), (chd8 knockdown: [gngm]), (hnscs results: [fndg]), (dysregulation: []), (integration: [genf]), (chd8-binding data: [moft]), (asd risk models: [cgab]), (detection: [topp]), (risk genes: [gngm]), (results: [fndg]), (chd8 contributes: [gngm]), (ancient gene: [gngm]), (regulatory network: [popg]), (human brain development: [ortf]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 4354349
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (gene mutations: [genf]), (gene: [gngm]), (number variants: [qnco]), (autism spectrum disorders: [mobd]), (gene products: [aapp,bacs]), (part: [qnco]), (networks: []), (synapse formation and/or function: [phsf]), (alterations: []), (excitation/inhibition (e/i) balance: [acty]), (network: [popg]), (parvalbumin: [aapp,bacs]), ((pv)-expressing interneurons: [neop]), (particular attention: [menp]), (asd: [cgab]), (pv's: [neop]), (putative role: [socb]), (respect: [socb]), (genetic mouse models: [mamm]), (powerful translational tools: [genf]), (role: [socb]), (neurobiological factors: []), (here: []), (pv knockout mice (pv/): [neop]), (behavioral phenotypes: [bhvr]), (relevance: []), (core symptoms: [sosy]), (human asd patients:: [humn]), (abnormal reciprocal social interactions: [patf]), ( impairments: [patf]), (communication: [socb]), (patterns: []), (behavior: [inbe]), (pv-depleted mice: [mamm]), (several signs: [fndg]), (asd-associated comorbidities: [cgab]), (reduced pain sensitivity: [fndg]), (startle responses: [orgf]), (seizure susceptibility: [sosy]), (evidence: []), (depression: [mobd]), (schizophrenia: [mobd]), (social interactions: [fndg]), (heterozygous (pv+/) mice: [mamm]), (pv expression levels: [neop]), (decrease: [qnco]), (pv levels: [neop]), (core asd-like deficits: [cgab]), (structural: []), (magnetic resonance imaging measurements: [lbpr]), (pv/: [neop]), (pv+/ mice: [mamm]), (asd-associated developmental neuroanatomical changes: [cgab]), (transient cortical hypertrophy: [bpoc]), (cerebellar hypoplasia: [cgab]), (electrophysiological experiments: [resa]), (e/i balance: [inch]), (mice: [mamm]), (modification: []), (inhibitory: [acty]), (excitatory synaptic transmission: [ortf]), (basis: [phsu]), (changes: [qnco]), (pv expression patterns: [neop]), (several: [qnco]), (genetic rodent models: [mamm]), (models downregulation: [moft]), (pv: [neop]), (points: [qnco]), (convergence: [acty]), (common link: [qnco]), (unrelated asd-associated synapse structure/function phenotypes: [bsoj]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(abnormal reciprocal social interactions, 'Reciprocal Social Interaction')(stereotyped patterns of behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(asd-associated comorbidities, 'Comorbidities')(reduced pain sensitivity, 'Pain')(anxiety, 'Anxiety Disorders')(depression, 'Depressive Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(social interactions, 'Reciprocal Social Interaction')

PMCID: 4345539
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (children: [aggp]), (fastest-growing serious developmental disability: [fndg]), (united states: []), (medical cure: [hlca]), (diagnostic test: [diap]), (asd: [cgab]), (furthermore: []), (u.s. food: [imft,phsu]), (drug administration: [hlca]), (single drug: [fndg]), (treatment: [topp]), (autisms core symptoms: [mobd]), (numerous genome studies: [gngm]), (identification: [menp]), (hundreds: []), (genes: [gngm]), (pathways: [moft]), (pathogenesis: [patf]), (idiopathic asd: [cgab]), (post-mortem brain: [diap]), (offer: []), (little insight: [menp]), (disorder: [dsyn]), (course: []), (development: [orgf]), ( asd: [cgab]), (complex: [chvs]), ( human-specific behaviors: [inbe]), (animals: [anim]), (stem cell models: [cell]), (skin biopsies: [diap]), (asd patients: [cgab]), (fibroblasts: [cell]), (human-induced pluripotent stem cells: [cell]), (ipscs: []), (resemble embryonic stem cells: [cell]), (unique genetic signature: []), (asd patient: [cgab]), (differentiation: [celf]), (neurons: [cell]), (neuronal development: [celf]), (dish: [dsyn]), (patient-specific model: [podg]), (current understanding: [menp]), (neurobiology: []), (use: []), (stem cells: [cell]), (understanding: [menp]), (new therapeutic avenues: [topp]), 
ASD Terms: (autism spectrum disorder affects, 'Autism Phenotype')(fastest-growing serious developmental disability, 'Learning Disorders')(medical cure, 'Medications')(autisms core symptoms, 'Complaints and Indications')

PMCID: 4445756
SFARI Genes: 
Non SFARI Genes: ran, 
Named Entities: (prevalence: [qnco]), (autism spectrum disorder (asd): [mobd]), (last few years: [qnco]), (average age: [orga]), (diagnosis: [fndg]), (united: []), (developmental window: [orgf]), (early intervention: [hlca]), (gains: [qnco]), (importance: []), (accurate methods: []), (risk: []), (current standards: [npop]), (care: [acty]), (present study: [qnco]), (machine: []), (used instruments: [fndg]), (clinical assessment: [hlca]), (asd: [cgab]), (autism diagnostic observation schedule (ados): [hlca]), (subset: []), (behaviors: [inbe]), (children: [aggp]), (autism spectrum: [mobd]), (ados relies: [aapp,enzy]), (behavioral observation: [topp]), (clinical setting: []), (consists: []), (modules: []), (module: []), (individuals: [humn]), (levels: []), (cognitive functioning: [menp]), (stepwise backward feature selection: [genf]), (score sheets: [clna]), (items: []), (asd risk: [cgab]), (accuracy: []), ( respectively: []), (reduction: [npop]), (number: [qnco]), (behaviorals: []), (negligible loss: [qnco]), (role: [socb]), (statistical methods: [resa]), (asd risk detection: [cgab]), (screening: [diap]), (results: [fndg]), (development: [orgf]), (parent-directed methods: []), (preliminary risk evaluation: [hlca]), (clinical triage: [topp]), (percentage: [qnco]), (population: [popg]), (help: []), (detection: [topp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(diagnosis, 'Diagnosis')(autism diagnostic observation schedule, 'Autism Phenotype')(autism spectrum, 'Autism Phenotype')(autism, 'Autism Phenotype')(cognitive functioning, 'Cognitive Ability')(autism diagnostic observation schedule relies, 'Autism Phenotype')

PMCID: 4471388
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (population-based register study: [resa]), (association: [menp]), (child: [aggp]), (autism spectrum disorder (asd): [mobd]), (parental sick leave: []), (work participation: []), (parents: []), (children: [aggp]), (asd: [cgab]), (stockholm: []), ( sweden: []), (sick leave: []), (labor force: [orgf]), (low income: [grpa]), (results: [fndg]), (familial socioeconomic factors: [grpa]), (parental psychiatric care: [topp]), (sick: [sosy]), (intellectual disability (id): [mobd]), (id: [lbpr]), (sweden: []), (policies: []), (families: [famg]), (study: [resa]), (unmet needs: [acty]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(asd with intellectual disability, 'Learning Disorders')(intellectual disability, 'Learning Disorders')

PMCID: 4336464
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (difficulties: [fndg]), (communication: [socb]), (social interaction: [fndg]), (cognitive information processing: [menp]), (accumulation: [fndg]), (anxiety: [mobd]), (stressful situations: []), (early stage: [clna]), (problematic behaviour: [inbe]), (occurring: [acty]), (self-injurious behaviour: [inbe]), (activation: [acty]), (autonomous nervous system (ans): [bdsy]), (response: [fndg]), (heart rate variability: [clna]), (skin conductance: [ortf]), (use: []), (thus: []), (innovative analysis: [resa]), (signal perception: [menp]), (reaction: []), (non-communicative individuals: [socb]), (autism: [mobd]), (methods: []), (analysis: [resa]), (protocol: [fndg]), (place: [acty]), (real life (home: []), (social environments): []), (modifications: []), (ans: [bdsy]), (external events: [evnt]), (synchronous manner: []), (specific design: [acty]), ((spy glasses: [dsyn]), (video/audio recording): [inpr,mnob]), (phases: [euka]), (asd participants: [cgab]), (aged-matched controls: (1): [popg]), (baseline: [bodm]), (pre-experiment (physical activity: [dora]), ( sleep): [orgf]), (h: [gngm]), (real life: []), (min: [neop]), (quiet environment: []), (few seconds: []), (stressful sound: [npop]), (interview: [acty]), (feelings: [menp]), (events: [evnt]), (asd: [cgab]), (control participants: [popg]), (different physiological responses: [orga]), (same situations: []), (problematic events: [evnt]), (novelty: []), (time-series analyses: [resa]), (several nobel prizes: [qnco]), (quantitative finance): [qnco]), (ans series (heart: [bdsy]), ( skin conductance): [ortf]), (wrist motion: [blor]), (ethics: []), (dissemination ethical approval: []), (ethics committee: []), (clermont-ferrand: []), ((south-east i): [inch]), ( france (2014-a0061146): []), (trial findings: [resa]), (open-access peer-reviewed publications: [hlca]), ( conferences: [hcpp]), (clinical networks: []), ( public lectures: []), (websites: []), (trial registration number clinicaltrials identifier nct02275455: [resa]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(anxiety, 'Anxiety Disorders')(social interaction, 'Reciprocal Social Interaction')(cognitive information processing, 'Cognitive Ability')(self-injurious behaviour, 'Self-Injurious Behavior')(signal perception, 'Cognitive Ability')(autism, 'Autism Phenotype')

PMCID: 4499106
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (microorganisms: [orgm]), (inhabit humans: [humn]), (different body sites: [blor]), (tracts: [bpoc]), (specific niche: []), (unique composition: [clna]), (balanced human physiology: []), (microbial cells: [cell]), (human cells: [lbtr]), (tenfold: []), (invisible organ: [bpoc]), (microbiome: [orgm]), (excessive use: []), (antibiotics: [antb]), (unhealthy diets: []), (serious danger: []), (composition: [clna]), (imbalance: [sosy]), (microbial community: [orgm]), (pathological conditions: [patf]), (digestive system: [bdsy]), (obesity: [dsyn]), ( cancer: [euka]), (inflammatory bowel disease;: [dsyn]), (skin: [bdsy]), (atopic dermatitis: [dsyn]), ( psoriasis: [dsyn]), (acne: [dsyn]), (cardiovascular system: [irda]), (atherosclerosis: [dsyn]), (unbalanced microbiome: [orgm]), (neurodevelopmental disorders: [mobd]), (autism: [mobd]), (multiple sclerosis: [dsyn]), (strong impact: [gngm]), (development: [orgf]), (host immune system: [bdsy]), (cause: []), (certain autoimmune diseases: [dsyn]), (diabetes: [dsyn]), (arthritis: [dsyn]), (enormous progress: []), (field: [irda]), (interactions: []), (human body: [humn]), (characterization: [acty]), (understanding: [menp]), (human disease states: [humn]), (help: []), (possible association: [menp]), (certain pathologies: []), (review: []), (general findings: [sosy]), (area: []), (detailed information: []), (case: []), (study: [resa]), (aim: [phsu]), (initial insight: [menp]), (studies: [lbpr]), (connection: []), (human health: [humn]), 
ASD Terms: (unhealthy diets, 'Dietary Restrictions')(inflammatory bowel disease, 'Inflammatory Bowel Diseases')(cardiovascular system, 'Cardiovascular Diseases')(neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')(certain autoimmune diseases, 'Autoimmune Diseases')(diabetes, 'Diabetes Mellitus Type 1')

PMCID: 4471312
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (current study: [resa]), (autism diagnostic: [mobd]), (interview-revised (adi-r) algorithms: [acty]), (toddlers: [aggp]), (young preschoolers: [aggp]), (lord: [gngm]), ( j autism dev disord: [mobd]), (non-us sample: [sbst]), (ten sites: [dsyn]), (countries: []), (construct validity: []), (good fit: [sosy]), (algorithms: []), (diagnostic validity: [qnco]), (high specificities: [qnco]), (moderate sensitivities: [fndg]), (young children: [aggp]), (clinical asd: [cgab]), (language ability: [menp]), (mild-to-moderate: []), (moderate-to-severe concern ranges: [aapp,enzy]), (adi-r: [clna]), (half: [qnco]), (speech asd-group: [cgab]), (little-to-no concern range: [fndg]), (findings: [clna]), (toddler algorithms: [gngm]), (further work: []), (different properties: []), (different samples: [sbst]), (further inform research: [aapp,imft,phsu]), (clinical use: []), 
ASD Terms: (autism diagnostic, 'Autism Phenotype')(language ability, 'Development or Regression of Language Skills')(autism diagnostic interview-revised, 'Autism Phenotype')(speech asd-group, 'Language Ability')

PMCID: 4346944
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (patients: [podg]), (bp1bp2 microdeletion: []), (language: [lang]), (delay: []), ( neurobehavioral disturbances: []), (psychiatric problems: [mobd]), (autism: [mobd]), ( seizures: [sosy]), ( schizophrenia: [mobd]), (mild dysmorphic features: [fndg]), (genes (i.e.: [gngm]), ( tubgcp5: [gngm]), ( cyfip1: [gngm]), ( nipa1: [gngm]), ( nipa2): [gngm]), (syndrome: [dsyn]), (prevalence: [qnco]), (microarray analysis: [lbpr]), (fold increase: [phpr]), (controls: [sbst]), (review: []), (clinical features: [clna]), (individuals: [humn]), (categories: []), (developmental (73%): [orgf]), (speech (67%) delays;: [orgf]), (dysmorphic ears: [fndg]), (palatal anomalies: [bpoc]), ((60%): [fndg]), (reading (57%): [dora]), (difficulties: [fndg]), ( memory problems: [mobd]), (verbal iq scores 75 (50%);: [fndg]), (general behavioral problems: [mobd]), (unspecified (55%): [fndg]), (abnormal brain imaging (43%): [diap]), (other clinical features: [clna]), (seizures/epilepsy (26%): [dsyn]), ( autism spectrum disorder (27%): [mobd]), ( attention deficit disorder (add)/attention deficit hyperactivity disorder (adhd) (35%): [mobd]), (schizophrenia/paranoid psychosis (20%): [mobd]), (motor delay (42%): [dsyn]), (deletion: [genf]), (collection: []), (findings: [clna]), (share: [socb]), (biological pathways: [moft]), (genetic mechanisms: [topp]), (neuropsychiatric: []), (behavior disturbances: [mobd]), (genomic imbalances: [gngm]), (bp1bp2 region: []), (microdeletions: []), (apparent incomplete penetrance: [fndg]), (variable expressivity: [fndg]), 
ASD Terms: (neurobehavioral disturbances, 'Central Nervous System Diseases')(psychiatric problems, 'Mental Disorders')(autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(speech delays, 'Idiosyncratic and Routinized Speech')(memory problems, 'Working Memory')(general behavioral problems, 'Personal Traits')(autism spectrum disorder, 'Autism Phenotype')(attention deficit disorder /attention deficit hyperactivity disorder, 'Overactivity')(motor delay, 'Motor Skills')(behavior disturbances, 'Personal Traits')

PMCID: 4332725
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (gastrointestinal (gi) manifestations: []), (autistic children: [podg]), (fatty acids (pufas): [bacs,orch]), (carnitine: [aapp,phsu]), (anti-inflammatory molecules: [phsu]), (deficiency: [dsyn]), (gi inflammation: [patf]), (relationship: []), (increased frequency: [qnco]), (gi manifestations: [gngm]), (reduced levels: []), (pufas: [bacs,orch]), (autistic patients: [mobd]), (study: [resa]), (plasma levels: [bdsu]), (serum carnitine: [aapp,phsu]), (relation: [socb]), (linoleic: []), ( alphalinolenic: []), (arachidonic aa: [plnt]), (docosahexaenoic dha acids): [bacs,orch,phsu]), (healthy-matched children: [fndg]), (levels: []), (plasma dha: [bdsu]), ( aa: [plnt]), ( linolenic: []), (linoleic acids: [orch]), (6/3 ratio: [qnco]), (gi manifestations (48%): [gngm]), (patients: [podg]), (such manifestations: []), (addition: []), ( autistic patients: [mobd]), (percentage: [qnco]), (reduced serum carnitine (91.7%): [aapp,phsu]), (plasma dha levels (87.5%): [bdsu]), (such manifestations (42.3%: []), (respectively): []), ( (p: [aapp,imft]), (p <: [aapp,imft]), (serum carnitine levels: [aapp,phsu]), (gi problems: []), (however: []), (initial report: [hlca]), ( studies: [lbpr]), (dha: [orch,phsu]), (mere association: [menp]), (pathogenic role: [socb]), 
ASD Terms: (gastrointestinal inflammation, 'Inflammatory Bowel Diseases')

PMCID: 4319152
SFARI Genes: GRIN2B, GRIN2B, GRIN2B, GRIN2B, 
Non SFARI Genes: 
Named Entities: (autism (mim: [mobd]), (complex neurodevelopmental disorder: [mobd]), (social communication impairments: [mobd]), (repetitive behaviors: [fndg]), (high heritability: [qnco]), (much remains: [qnco]), (genetic variants: [npop]), (grin2b: [gngm]), (autism etiology: [mobd]), (system association study: [menp]), (rare variants: [gngm]), (autism: [mobd]), (cohorts: [popg]), (chinese population: [popg]), (total sample: [sbst]), (subjects: [humn]), (meta-analysis: [resa]), (triad family cohort: [famg]), (case-control cohort: [popg]), (significant associations: [menp]), (multiple common variants: [qnco]), (autism risk (pmin =: [mobd]), (significantly: []), (haplotype: [orga]), (top common variants: [qnco]), (significant association (p =: [menp]), (sanger sequencing: [mbrt]), (probands: [orga]), (triad cohort: [bodm,orch]), (several variants: [qnco]), (regions: []), (common variants: [qnco]), (common coding variants: [qnco]), (autism-related linkage disequilibrium (ld) block: [mobd]), (autism (p: [mobd]), (independent control cohort: [popg]), (burden analysis: [resa]), (case-only analysis: [resa]), (variants: []), (sanger: []), (association: [menp]), (study: [resa]), (first time reveals: [qnco]), (related haplotypes: [orga]), (autism risk: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(complex neurodevelopmental disorder, 'Learning Disorders')(social communication impairments, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')(autism etiology, 'Medical History')(autism risk, 'Autism Phenotype')

PMCID: 4445743
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (activity-dependent neuroprotective protein (adnp): [celf]), (frequent autism: [mobd]), (spectrum disorder: [dsyn]), ((asd)-associated gene: [cgab]), (only protein: [aapp,bacs]), (serum: [bdsu]), (alzheimer's disease (ad) patients: [dsyn]), (adnp: [gngm]), (asd: [cgab]), (boys: [aggp]), (ad: []), (prevalent: [qnco]), (women?: [popg]), (results: [fndg]), (sex-related learning/memory differences: [menp]), (mice: [mamm]), (hippocampal expression changes: [qnco]), (adnp-controlled ad/asd risk genes: [cgab]), (hippocampal adnp transcript content: [menp]), (male vs female mice: [mamm]), (females: [orga]), (equal expression: [topp]), (adnp haploinsufficient (adnp+/) males: [comd]), (significant genotype-associated reduction: [orga]), (male adnp expression: [orga]), (human postmortem: [humn]), (hippocampal samples: [sbst]), (hippocampal transcript: [nnon]), (apolipoprotein e (the: [aapp,bacs]), (major risk gene: [gngm]), (ad): []), (female mice: [mamm]), (males: [orga]), (adnp+/ females: [orga]), (decrease: [qnco]), (adnp+/ males: [orga]), (previously: []), ( overexpression: [genf]), (eukaryotic translation initiation factor: [aapp,bacs]), ((eif4e): [aapp,bacs]), (asd-like phenotype: [cgab]), (here: []), (sites: []), (eif4e: [gngm]), (co-immunoprecipitation: [lbpr]), (furthermore: []), (hippocampal eif4e expression: [aapp,bacs]), (young adnp+/ male mice: [mamm]), (behaviorally: []), ( adnp+/ male mice: [mamm]), (deficiencies: [dsyn]), (object recognition: [menp]), (social memory: [menp]), (adnp+/+ mice: [mamm]), (novel: []), (familiar mice: [mamm]), ( adnp+/+ females: [orga]), (preference: []), (object: []), (adnp expression: [topp]), (master regulator: []), (key asd: [cgab]), (ad risk genes: [gngm]), (novel concept: []), (hippocampal gene-regulated sexual dimorphism: [gngm]), (adnp+/ animal model: [emod]), (translational psychiatry: [genf]), 
ASD Terms: (frequent autism spectrum disorder, 'Autism Phenotype')(social memory, 'Working Memory')

PMCID: 4315573
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, 
Non SFARI Genes: 
Named Entities: (introduction clinical genomics promise: [hlca]), (study: [resa]), (heterogeneous conditions: [fndg]), (autism spectrum disorder (asd): [mobd]), (siblings: [famg]), (asd: [cgab]), (usefulness: []), (whole genome sequencing (wgs): [mbrt]), (diagnostic approach: [fndg]), (family: [famg]), (unidentified cause: []), (wgs: [mbrt]), (probands: [orga]), (state-of-the-art comprehensive bioinformatic analysis pipeline: [gngm]), (identified variants: [fndg]), (genes: [gngm]), (finding: [sosy]), (sanger: []), (parents: []), (male siblings: [famg]), (severe intellectual disability: [mobd]), ( absence: [anab]), (language: [lang]), ( autism spectrum symptoms: [sosy]), (epilepsy: [dsyn]), (negative family history: [fndg]), (mental retardation: [mobd]), ( language disorders: [mobd]), ( asd: [cgab]), (other psychiatric disorders: [mobd]), (germline mosaicism: [orga]), (heterozygous deletion: [genf]), (cytosine: [bacs,orch]), (shank3 gene: [gngm]), (missense sequence: [nusq]), (codons: [nusq]), (premature stop codon (nm_033517:c.3259_3259delc: [nusq]), ( p.ser1088profs*6): [aapp,imft]), (infrequent form: []), (familial asd: [cgab]), (clinic: [hcro,mnob]), (mutation: [genf]), (shank3: [gngm]), (relevance: []), (autism spectrum disorder: [mobd]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(severe intellectual disability, 'Learning Disorders')(autism spectrum symptoms, 'Complaints and Indications')(epilepsy, 'Epilepsy')(autism spectrum symptoms, 'Complaints and Indications')(mental retardation, 'Mental Retardation')(other psychiatric disorders, 'Mental Disorders')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 4396692
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (genetic aetiology: [topp]), (major psychiatric disorders: [mobd]), (additive effects: [sbst]), (many common variants: [qnco]), (joint effects: [bsoj]), (brain function: [ortf]), (common neural risk mechanisms: [qnco]), (effects: []), (cross-disorder polygenic risk score (pgrs): [fndg]), (genetic susceptibility: [orga]), (brain activation: [bpoc]), (performance: [inbe]), (language-based executive task: [lang]), (relationship: []), (healthy individuals: [humn]), ((n =: [aapp,imft]), (family history: [fndg]), (bipolar disorder: [mobd]), (effect: []), (interactive dependent: []), (presence: [qnco]), (significant interaction: [qnco]), (group: [popg]), (left lateral frontal cortex (ba9: [bpoc]), ( ba6): []), (further examination: []), (significant positive correlation: [fndg]), (family history (i.e: [fndg]), (healthy unrelated volunteers): [popg]), (significant relationships: [qnco]), (familial group: [famg]), (individual diagnoses: [fndg]), (pgrs: []), (disorder-specificity: [qnco]), (significant association: [menp]), (schizophrenia: [mobd]), (polygenic score only: [clna]), (other significant relationships: [qnco]), (findings: [clna]), (differences: [qnco]), (left lateral frontal brain activation: [bpoc]), (association: [menp]), (increased cross-disorder pgrs: [dsyn]), (individuals: [humn]), (psychiatric illness: [mobd]), (lack: []), (epistatic effects: [fndg]), (environmental influences: []), (specific relationship: []), (frontal cortical inefficiency: [bpoc]), (circumscribed phenotype: [orga]), (psychotic disorders: [mobd]), 
ASD Terms: (major psychiatric disorders, 'Mental Disorders')(bipolar disorder, 'Bipolar Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(psychiatric illness, 'Mental Disorders')(psychotic disorders, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 4333561
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (disorder: [dsyn]), (neurobiological origin: []), (problems: []), (communication: [socb]), (social skills: [socb]), (repetitive behavior: [fndg]), (decades: [qnco]), (research: [resa]), (etiology: []), (biomarkers: [clna]), (number: [qnco]), (studies: [lbpr]), (cytokine levels: [aapp,imft]), (blood: [bdsu]), ( brain: [bpoc]), (cerebrospinal fluid (csf): [bdsu]), (autistic subjects: [mobd]), (healthy individuals;: [humn]), (example: []), (series: [qnco]), (interleukin-6 (il-6): [aapp,imft]), ( tumor: [neop]), (interferon- (ifn-): [aapp,imft,phsu]), (different tissues: [tisu]), (however: []), (expression: [topp]), (cytokines: [aapp,imft]), (il-1: [aapp,imft]), ( il-2: [aapp,imft]), (growth: [orgf]), (granulocyte-macrophage colony-stimulating factor (gm-csf): [aapp,imft]), (different studies: [lbpr]), (various results: [fndg]), (review: []), (several types: [qnco]), (proinflammatory: []), (anti-inflammatory cytokines: [aapp,imft]), (different cell signal pathways: [moft]), (role: [socb]), (pathophysiological mechanism: [patf]), (autistic spectrum disorders: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(social skills, 'Ability to Converse in Social Settings')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')(cerebrospinal fluid, 'Hydrocephalus')(autistic spectrum disorders, 'Autistic Disorder')

PMCID: 4346882
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (brain-enriched multi-domain: [bpoc]), (protein: [aapp,bacs]), ( neurobeachin: [gngm]), (candidate gene: [gngm]), (autism patients: [mobd]), (mutations: [genf]), (synaptic adhesion protein cell adhesion molecule: [aapp,imft]), ((cadm1): [aapp,imft]), (autism spectrum: [mobd]), (neurodevelopmental disorder: [mobd]), (uncertain molecular origin: [fndg]), (potential roles: [socb]), (cadm1: [gngm]), (function: [phsf]), (vesicle transport: [celf]), (endosomal trafficking: [celc]), (protein kinase b (akt): [aapp,enzy]), (cyclic adenosine monophosphate: [bacs,nnon,phsu]), ((camp)-dependent protein: [nnon,phsu]), (a (pka): []), (key roles: [socb]), (neuron membrane: [celc]), (pathogenesis: [patf]), (autism: [mobd]), (attention deficit hyperactivity disorder (adhd): [mobd]), (insufficiencies: []), (synaptic dysfunction: [dsyn]), (dopamine transporter (dat): [aapp,bacs]), (akt: [gngm]), (dat cell-surface redistribution: [celc]), (present paper: [qnco]), (importance: []), (several protein kinases: [aapp,enzy]), (membrane: [celc]), (adhd: [mobd]), (new targets: [diap]), (therapeutic intervention: [topp]), 
ASD Terms: (autism patients, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(autism spectrum, 'Autism Phenotype')(autism, 'Autism Phenotype')(attention deficit hyperactivity disorder, 'Overactivity')(attention deficit hyperactivity, 'Overactivity')

PMCID: 4671264
SFARI Genes: 
Non SFARI Genes: impact, impact, impact, 
Named Entities: ((as): []), (important mechanism: []), (transcriptomic: [nusq]), (proteomic diversity: []), (finite genome: [gngm]), (human gene transcripts: [nnon]), (protein isoforms: [aapp]), (divergent: []), (antagonistic properties: [ortf]), (cell functions: [celf]), (events: [evnt]), (tissue-specific manner: [bdsu]), (different developmental stages: []), (rna-binding proteins: [aapp,bacs]), (tissue-specific splicing factors: [genf]), (past few years: []), (technological advances: []), (genome-wide programs: [gngm]), (as: []), (numbers: [qnco]), (factors: []), (regulatory networks: []), (consist: []), (transcripts: [nnon]), (function: [phsf]), (related processes: [phpr]), (development: [orgf]), (phenotypes: [orga]), (different cell types: [cell]), (such: []), (disruption: []), (normal programs: [fndg]), (human diseases: [humn]), (examples: []), (diseases: [dsyn]), (altered expression: [topp]), (regulatory proteins: [aapp,bacs]), (human disease pathophysiology: [humn]), (role: [socb]), (human disease: [humn]), (disease risk: [fndg]), (further investigations: [hlca]), (functions: [phsf]), (targets: [diap]), (novel therapies: [topp]), (specific as events: [evnt]), (biological pathways: [moft]), (wires rna: [nnon]), (doi:: []), (further resources: []), (article: []), ( please: []), (http://wires.wiley.com/remdoi.cgi?doi=10.1002/wrna.1276wires website: [fndg]), (conflict: [inbe]), (interest:: [menp]), (authors: []), (conflicts: [inbe]), (interest: [menp]), 
ASD Terms: (different developmental stages, 'Learning Disorders')

PMCID: 4312830
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (synaptosomal-associated protein: [celc]), (kda (snap-25): [qnco]), (different neuropsychiatric disorders: [dsyn]), (schizophrenia: [mobd]), (attention-deficit/hyperactivity disorder: [mobd]), (consistently: []), ( snap-25 polymorphisms: [genf]), (humans: [humn]), (hyperactivity and/or: [mobd]), (low cognitive scores: [qnco]), (snap-25 gene polymorphisms: [genf]), (rs363039: []), ( rs363043: []), ( rs3746544: []), (rs1051312): []), (autistic children: [podg]), (childhood autism rating scale: [mobd]), (electroencephalogram (eeg) abnormalities: [fndg]), (functional effects: []), (rs363050 single-nucleotide polymorphism (snp): [nusq]), (gene: [gngm]), (transcriptional activity: [genf]), (means: []), (luciferase reporter gene: [gngm]), (functional consequences: []), (snap-25 reduction: [npop]), (children: [aggp]), (behaviour: [inbe]), (eeg: [diap]), (snap-25+/: [moft]), (adolescent mice (snap-25+/+): [mamm]), (significant association: [menp]), (snap-25 polymorphism: [genf]), (cognitive scores: [qnco]), (analysis: [resa]), (snp: [nusq]), (regulatory element: [bacs,nnon]), (expression decrease: [qnco]), (reduction: [npop]), (snap-25 levels: [moft]), (adolescent mice: [mamm]), (hyperactivity: [mobd]), ( cognitive: []), (social impairment: [patf]), (abnormal eeg: [fndg]), (occurrence: []), (frequent spikes: []), (eeg abnormalities: [fndg]), (behavioural deficits: [inbe]), (repeated exposure: [clna]), (days: []), (salt valproate (vlp): [orch,phsu]), (partial recovery: [acty]), (snap-25 expression content: [menp]), (snap-25+/ hippocampi: [bpoc]), (western blotting: [lbpr,mbrt]), (reduced expression: [topp]), (snap-25: [gngm]), (cognitive deficits: [mobd]), (autism spectrum disorders: [mobd]), (presence: [qnco]), (rs363050(g) allele: [gngm]), (eeg alterations: [diap]), (vlp treatment: [topp]), (novel therapeutic strategies: [menp]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(hyperactivity, 'Overactivity')(low cognitive scores, 'Cognitive Ability')(hyperactivity and/or, 'Overactivity')(childhood autism rating scale, 'Autism Phenotype')(cognitive scores, 'Cognitive Ability')(cognitive, 'Cognitive Ability')(social impairment, 'Social Competence')(exposure, 'Exposures')(behavioural deficits, 'Personal Traits')(repeated exposure, 'Exposures')(cognitive deficits, 'Cognitive Ability')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 4306541
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (contactins: [aapp,bacs]), (contactin-associated proteins: [aapp,rcpt]), (contactin-associated protein-like: [aapp,rcpt]), ((cntnap2): [aapp,bacs]), (particular: []), (autism risk genes: [gngm]), (findings: [clna]), (homozygosity mapping: [orga]), (molecular cytogenetics: []), ( copy number variation analyses: [nusq]), (rare single nucleotide association studies: [fndg]), (however: []), ( data: [euka]), (regard: []), (contribution: [acty]), (heterozygous single nucleotide variants: [fndg]), (effort: [orgf]), (role: [socb]), (rare point mutations: [comd]), (cntnap2: [gngm]), (gene families: [gngm]), (next-generation sequencing: [mbrt]), (sequence data: [nusq]), (cohorts: [popg]), (cases: [qnco]), (controls: [sbst]), (evidence: []), (significant association: [menp]), (rare heterozygous mutations: [genf]), (cntn: []), (cntnap: [gngm]), ( placing: []), (limits: []), (scale: [acty]), (plausible contribution: [acty]), 
ASD Terms: (autism risk genes, 'Autism Phenotype')(related gene families, 'Interactions with Friends and Family')

PMCID: 4654237
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent studies: [lbpr]), (traits: [gngm]), (autism spectrum disorders: [mobd]), (attention-deficit/hyperactivity disorder (adhd): [mobd]), (existence: []), (combined phenotype: [orga]), (aim: [phsu]), (study: [resa]), (distinctive clinical features: [clna]), (asd: [cgab]), (adhd: [mobd]), (order: [acty]), (possible different phenotypes: [orga]), (clinical value: [qnco]), (subjects: [humn]), (diagnostic groups: adhd group: [popg]), ( asd group: [cgab]), ( asd+adhd group (that: [cgab]), (diagnostic criteria: []), (adhd): [mobd]), (group: [popg]), (intelligent quotient (iq): [orga]), (behavior problems: [mobd]), ( adhd symptoms: [mobd]), ( asd symptoms: [cgab]), (adaptive behaviors: [inbe]), (following test: wechsler intelligence scale: [lbpr]), (children: [aggp]), ( wechsler preschool: [fndg]), (primary scale: [acty]), (intelligence: [menp]), (leiter international performances scale revised: [topp]), ( child behavior checklist: [diap,inpr]), ( conners': []), (scales-revised: [topp]), ( snap-iv rating scale: [inpr,qnco]), (social communication questionnaire: [socb]), ( vineland adaptive behavior scales: []), (asd+adhd group differs: [cgab]), (domains: []), (iq: []), (mean level: [phsu]), (autistic symptoms severity: [mobd]), (however: []), (asd+adhd group shares inattention: [cgab]), (hyperactivity deficit: [mobd]), (adhd group: [mobd]), (shares: [socb]), (adaptive behavior impairment: [inbe]), (asd group: [cgab]), (findings: [clna]), (new understanding: [menp]), (clinical manifestation: []), (asd+adhd: [cgab]), (novel treatment target: [diap]), (autism res: [mobd]), (international society: [orgt]), (autism research: [mobd]), ( wiley periodicals: []), ( inc: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder group, 'Attention Deficit Disorder with Hyperactivity')(asd+and attention-deficit/hyperactivity disorder group, 'Attention Deficit Disorder with Hyperactivity')(intelligent quotient, 'IQ')(behavior problems, 'Personal Traits')(attention-deficit/hyperactivity disorder symptoms, 'Attention Deficit Disorder with Hyperactivity')(asd symptoms, 'Complaints and Indications')(adaptive behaviors, 'Adaptive Life Skills')(social communication questionnaire, 'Reciprocal Social Interaction')(vineland adaptive behavior scales, 'Adaptive Life Skills')(asd+and attention-deficit/hyperactivity disorder group differs, 'Attention Deficit Disorder with Hyperactivity')(autistic symptoms severity, 'Complaints and Indications')(adaptive behavior impairment, 'Adaptive Life Skills')(asd+and attention-deficit/hyperactivity disorder group shares inattention, 'Attention Deficit Disorder with Hyperactivity')(hyperactivity deficit, 'Overactivity')(asd+and attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 4554745
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (spectrum conditions: [dsyn]), (attention-deficit/hyperactivity disorder: [mobd]), (twin studies: [famg]), (conditions: [dsyn]), (genetic causes: [topp]), (less: [qnco]), (degree: [qnco]), (specific autistic traits: [mobd]), (specific behaviours: [inbe]), (adhd: [mobd]), (classical twin design: [famg]), (specific dimensional autistic traits: [mobd]), (social difficulties: [fndg]), ( communication atypicalities: [socb]), (repetitive behaviours: [inbe]), (differential degrees: [qnco]), (aetiological overlap: [topp]), (specific traits: [gngm]), (hyperactivity/impulsivity: [mobd]), (inattention: [mobd]), (parents: []), (pairs: []), (12-year-old twins: [famg]), (childhood autism spectrum test: [lbpr]), (conners parent rating scale: []), (measures: [qnco]), (subscales: []), (different types: []), (adhd behaviours: [mobd]), (twin model: [famg]), (genetic overlap: [topp]), (communication difficulties: [socb]), (traits: [gngm]), ((genetic correlations: [topp]), (.47.51): []), (moderate (genetic correlations: [topp]), (modest (.05.11): []), (genetic overlap respectively: [topp]), (environmental overlap: [topp]), (subscales (correlations: []), (.01.23): [qnco]), (patterns: []), (extremes: []), (general population: [popg]), (findings: [clna]), (molecular genetic studies: [lbpr]), (genetic basis: [phsu]), (asc: [gngm]), (symptom-specific approach: [clna]), (furthermore: []), (studies: [lbpr]), (communication abilities: [fndg]), (individuals: [humn]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s00787-014-0666-0) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(social difficulties, 'Social Competence')(repetitive behaviours, 'Restricted and Repetitive Behavior')(inattention, 'Attention Deficit Disorder with Hyperactivity')(childhood autism spectrum test, 'Autism Phenotype')(attention-deficit/hyperactivity disorder behaviours, 'Attention Deficit Disorder with Hyperactivity')(autism, 'Autism Phenotype')(communication abilities of individuals, 'Reciprocal Social Interaction')(communication abilities, 'Reciprocal Social Interaction')(autism spectrum conditions, 'Autism Phenotype')

PMCID: 4307681
SFARI Genes: mTOR, mTOR, mTOR, mTOR, PSD-95, PSD-95, mTOR, PSD-95, mTOR, PSD-95, mTOR, mTOR, eIF4E, eIF4E, 
Non SFARI Genes: eIF4B, 
Named Entities: (molecular mechanisms: []), (autistic behaviors: [mobd]), (mutations: [genf]), (genes: [gngm]), (affect molecules: [menp]), (dendritic spine formation: [celc]), ( function: [phsf]), (plasticity: [npop]), (increase: []), (mammalian target: [mamm]), (rapamycin: [antb,orch]), (regulator: []), (protein synthesis: [moft]), (spines: [bpoc]), (here: []), (akt/mtor pathway: [aapp,enzy]), (idiopathic autism: [mobd]), (rats: [mamm]), (animal model: [emod]), (autistic-like behavior: [mobd]), (components: []), (mtor pathway: [aapp,enzy]), (western blotting: [lbpr,mbrt]), (postmortem fusiform gyrus samples: [sbst]), (subjects: [humn]), (controls: [sbst]), (valproic acid versus: [orch,phsu]), (saline-exposed rat neocortex: [mamm]), (additionally: []), ( protein levels: [lbtr]), (brain-derived neurotrophic factor receptor (trkb) isoforms: [aapp,enzy,rcpt]), (postsynaptic organizing molecule psd-95: [gngm]), (autistic versus control subjects: [mobd]), (full-length trkb: [aapp,rcpt]), ( pi3k: [aapp,enzy]), ( akt: [aapp,enzy]), (total mtor: [aapp,enzy]), ( p70s6 kinase: [aapp,enzy]), ( eif4b: [aapp]), (psd-95: [gngm]), (autistic versus control fusiform gyrus: [mobd]), (similarly: []), (total akt: [aapp,enzy]), ( mtor: [aapp,enzy]), (phosphorylated s6 protein: [aapp,bacs]), (valproic acid- versus: [orch,phsu]), (saline-exposed rats: [mamm]), (however: []), (changes: [qnco]), (autistic brains: [mobd]), (contrast: [irda]), (monogenic disorders: [dsyn]), (high rates: [qnco]), (data: [euka]), (down-regulation: [moft]), (p70s6k/eif4b: [aapp,enzy]), (findings: [clna]), (disruption: []), (pathway: [moft]), (direction: []), (autism: [mobd]), (adverse consequences: []), (synaptic function: [phsf]), (use: []), (valproic: []), (histone deacetylase inhibitor: [aapp,enzy,phsu]), (epigenetic mechanism: [genf]), 
ASD Terms: (idiopathic autism, 'Autism Phenotype')(idiopathic autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4302585
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction characterization: [acty]), (type: [qnco]), (topography: []), (structural changes: [topp]), (alterations: []), (lifespan: [grpa]), (individuals: [humn]), (autism: [mobd]), (mechanisms: []), (autistic phenotype: [mobd]), (aim: [phsu]), (stereological study: [resa]), (neurons: [cell]), (brain structures: [bpoc]), (control subjects: [sbst]), (years: []), (age: [orga]), (course: []), (cytoplasmic volume changes: [celc]), (data: [euka]), (deficit: [dsyn]), (neuronal soma volume: [qnco]), (children: [aggp]), (deficits: []), (volume: [qnco]), (neuronal nucleus: [celc]), (cytoplasm: [celc]), (significant deficits: [qnco]), (cytoplasmic volumes: [celc]), (examined subcortical structures: [blor]), ( archicortex: [bpoc]), ( cerebellum: [bpoc]), (brainstem: [bpoc]), (8-year-old autistic children: [podg]), (global nature: []), (brain: [bpoc]), (developmental abnormalities: [cgab]), (region-specific differences: [fndg]), (severity: []), (neuronal pathology: [patf]), (observed increase: []), (nuclear volumes: [qnco]), (structures: []), (autistic teenagers/young adults: [aggp]), (decrease: [qnco]), (regions: []), (age-matched control: [orga]), (reveal opposite trajectories: []), (neuronal nuclear volumes: [qnco]), (neuronal cytoplasmic volumes: [celc]), (range: [qnco]), (interindividual differences: [qnco]), (cytoplasmic volume deficits: [celc]), (partial distinction: [qnco]), (cytoplasmic pathology: [celc]), (severe deficit: [dsyn]), (cytoplasm volume: [celc]), (4-to 8-year-old autistic children: [fndg]), (reflection: [menp]), (early developmental alterations: [orgf]), (major contribution: [acty]), (broad range: [qnco]), (functions: [phsf]), (affected structures implies: []), (age-associated abnormalities: [cgab]), (diagnostic features: [fndg]), (broad spectrum: [qnco]), (clinical alterations: []), (lack: []), (clinical improvement: []), (autistic teenagers: [mobd]), (adults: [aggp]), (neuron nucleus: [celc]), (level: [phsu]), (brain function: [ortf]), 
ASD Terms: (autism, 'Autism Phenotype')(years of age, 'Onset of Symptoms')(autism, 'Autism Phenotype')(developmental abnormalities, 'Learning Disorders')(autism, 'Autism Phenotype')

PMCID: 4407288
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction: [hlca]), (drug treatment: [hlca]), (autism spectrum disorders: [mobd]), (associated conditions: [dsyn]), (inattention: [mobd]), (irritability): [fndg]), (limited benefit: [qnco]), (core: [bdsu]), (social deficits: []), (here: []), (novel use: []), (low dose: [qnco]), (anti-epileptic phenytoin: [orch,phsu]), (social functioning: [socb]), (patient: [podg]), (autism spectrum disorder: [mobd]), (case presentation: []), (case: []), (19-year-old caucasian man: [humn]), (stimulant medication: [phsu]), (early childhood: []), (long-standing difficulties: [sosy]), (relationships: []), (social cues: []), (minutes: [qnco]), (single sublingual low dose: [fndg]), (phenytoin: [orch,phsu]), (immediate observable improvement: []), (eye contact: [socb]), (integration: [genf]), (non-verbal communication: [menp]), (adherence: []), (low-dose phenytoin therapy: [orch,phsu]), (months: []), (follow-up: [hlca]), (clinical observations: [hlca]), (ratings: [acty]), (autism-spectrum quotient: [qnco]), (depression: [mobd]), ( anxiety: [mobd]), (stress scales: [bpoc]), (pre-treatment: []), (case report: [clna]), (first potential evidence: [qnco]), (tolerated anti-epileptic medication: [phsu]), (social cognitive deficits: [mobd]), (single case: [fndg]), (lack: []), (availability: []), (effective treatments: []), (important core deficits: [bdsu]), (case noteworthy: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(social deficits, 'Social Competence')(social functioning, 'Ability to Converse in Social Settings')(autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(stimulant medication, 'Medications')(social cues, 'Awareness of Social Cues')(eye contact, 'Eye Contact')(depression, 'Depressive Disorder')(anxiety, 'Anxiety Disorders')(tolerated anti-epileptic medication, 'Medications')(social cognitive deficits, 'Social Competence')

PMCID: 4315323
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (substantial proportion: [qnco]), (autism spectrum disorder (asd) risk resides: [mobd]), (germline: [cell]), (genetic variation: [npop]), (particular: []), (rare copy number variation (cnv): [nusq]), (asd risk: [cgab]), (asd subjects: [cgab]), (striking degree: [qnco]), (genetic heterogeneity: [orga]), ( case-control studies: [resa]), (specific burden: []), (rare disruptive cnv: [nusq]), (neurodevelopmental pathways: [moft]), (here: []), (machine: []), (methods: []), (controls: [sbst]), (rare cnv data: [nusq]), (comprehensive gene annotations: [mbrt]), (performance: [inbe]), (different methods: []), (percentage: [qnco]), (presumed etiologic cnv: [nusq]), (caucasian asd subjects: [cgab]), (rare cnvs (frequency: [nusq]), (illumina: []), (1m-duo beadchips: [qnco]), (conditional inference forest (cf): [npop]), (other classification methods: []), (maximum auc (area: [qnco]), (roc curve): [qnco]), (rare genic cnvs: [nusq]), ( corresponding: []), (classified controls; performance: [inbe]), (pathogenic cnvs: [nusq]), (rare losses: [qnco]), (gains: [qnco]), (neurally-relevant annotations: []), (expression: [topp]), ( synaptic components: [celc]), (neurodevelopmental phenotypes) outperform gene ontology: [orga]), (pathway-based annotations: [moft]), (cf: [gngm]), (optimal classification approach: []), (case-control: [hlca]), (subjects: [humn]), (variants: []), (study: [resa]), (cnv: [nusq]), (case-control data-sets: [hlca]), (other neuropsychiatric disorders: [dsyn]), 
ASD Terms: (autism spectrum disorder risk resides, 'Autism Phenotype')(neurodevelopmental pathways, 'Learning Disorders')

PMCID: 4323380
SFARI Genes: mGluR5, mGluR5, 
Non SFARI Genes: 
Named Entities: (human: [humn]), (microdeletion: []), (common gene copy number variation: [nusq]), (autism: [mobd]), (synaptic pathophysiology: [patf]), (mutation: [genf]), (mouse: [mamm]), (same genetic deficiency: [dsyn]), (glutamate receptor: [aapp,rcpt]), (5-(mglur5-) dependent synaptic plasticity: [aapp,rcpt]), (protein synthesis: [moft]), (hippocampus: [bpoc]), (hippocampus-dependent memory: [bpoc]), (remarkably: []), (chronic treatment: [topp]), (negative allosteric modulator: [fndg]), (mglur5: [gngm]), (cognitive deficit: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(hippocampus-dependent memory, 'Working Memory')(cognitive deficit, 'Cognitive Ability')

PMCID: 4307305
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (classical autism: [mobd]), (autistic disorder belongs: [mobd]), (group: [popg]), (heterogeneous conditions: [fndg]), (autism spectrum disorders: [mobd]), (heritability: []), (asd: [cgab]), (compilation: []), (relevant candidate: []), (genes: [gngm]), (descriptive next generation: [acty]), (whole exome: [gngm]), (case study: []), (well-characterized caucasian females: [popg]), (autism (average: [mobd]), (years; age: [orga]), (years): []), (multiplex families: [famg]), (genomic dna: [nnon]), (paired-end next generation: [acty]), (approach: []), (x chromosome inactivation status: [genf]), (list: []), (putative disease: [dsyn]), (primary selection criteria: [topp]), (machine: []), (learning-derived classification score: [menp]), (other predictive parameters: [fndg]), (polyphen2: []), (sift): []), (variant list: []), (biological significance: [qnco]), (neural development: [orgf]), ( function: [phsf]), (neurological disorders: [dsyn]), (seventy-eight genes: [gngm]), (selection criteria: []), (filtered variants: []), (female: [orga]), (females: [orga]), (functional variants: []), (x-linked genes: [gngm]), (pir: [gngm]), ( gabrq: [gngm]), ( gprasp2: [gngm]), ( sytl4): [gngm]), (cadherin: [gngm]), ( protocadherin: []), (ankyrin repeat gene families: [moft]), ((e.g.: []), ( cdh6: [gngm]), ( fat2: [gngm]), ( pcdh8: [gngm]), ( ctnna3: [gngm]), ( ankrd11): [gngm]), (other genes: [gngm]), (neurogenesis: [orgf]), (neuronal migration (e.g.: [gngm]), ( sema3f: [gngm]), ( midn): [gngm]), 
ASD Terms: (classical autism, 'Autism Phenotype')(autistic disorder belongs, 'Autistic Disorder')(autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(neurological disorders, 'Neurologic Indications')

PMCID: 4284309
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (relationship: []), (sex/gender differences: [orga]), (autism: [mobd]), (variety: []), (research: [resa]), (male bias: [orga]), (autism prevalence: [qnco]), (findings: [clna]), (straightforward manner: []), (distinct: []), (interlinked questions: []), (implications: []), (future studies: [lbpr]), (4-level conceptual framework: [fndg]), (embedded themes: [lbpr]), (pubmed: []), (publications: [inpr,mnob]), (september: []), (search terms: [orgf]), (or gender or females and: [orga]), (a total: [qnco]), (articles: []), (relevance: []), (additional literature reviews: []), (reviewed: []), (level: [phsu]), (diagnostic challenges: [hlca]), (: []), (question: []), ( how: []), (males: [orga]), (females? level: [orga]), (sex/gender-dependent characteristics: [orga]), (similarities: []), (differences: [qnco]), (females: [orga]), (autism? level: [mobd]), (general models: [hlca]), (etiology: liability: []), (threshold: []), (liability: []), (specific: []), (etiologicaldevelopmental mechanisms: []), (sex/gender and/or sexual/gender differentiation?: [orga]), (conceptual framework: []), ( findings: [clna]), (summarized: []), (links: []), (different levels: []), (clearer: [fndg]), (4-level framework: [fndg]), (future research directions: [resa]), ( methodology: []), (specific topics: []), 
ASD Terms: (autism prevalence, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4300495
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (complex disease: [dsyn]), (etiology: []), (data: [euka]), (systems framework: []), (interactome: []), ( gene expression: [genf]), (genome sequencing: [mbrt]), (protein interaction module: [moft]), (members: [popg]), (autism candidate genes: [mobd]), (patients: [podg]), (involvement: []), (module: []), (independent cohort: [popg]), (expression: [topp]), (subcomponent: []), (corpus callosum: [bpoc]), (identified mutations: [genf]), (network center: [popg]), (rna-sequencing: [nusq]), (extensive gene mis-expression: [genf]), (immunochemical analysis: [resa]), (human corpus callosum: [humn]), (oligodendrocyte cells: [cell]), (analysis: [resa]), (functional genomic data: [euka]), (significant involvement: [qnco]), (development: [orgf]), (mouse brain: [tisu]), (natural network: [popg]), (novel candidate genes: [gngm]), (disease: [dsyn]), (understanding: [menp]), (molecular pathology: [lbpr]), 
ASD Terms: (autism, 'Autism Phenotype')(autism candidate genes, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4432080
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (rationale attention deficit hyperactivity disorder (adhd): [mobd]), (autism spectrum disorder (asd): [mobd]), (performance: [inbe]), (brain dysfunctions: [dsyn]), (motor response inhibition: [acty]), (serotonin: [bacs,orch]), (positive behavioural effects: [inbe]), (disorders: [dsyn]), (used functional magnetic resonance: [npop]), ((fmri): [diap]), (disorder-specific inhibitory brain dysfunctions: [acty]), (effects: []), (single dose: [fndg]), (selective serotonin reuptake inhibitor fluoxetine: [phsu]), (age-matched boys: [aggp]), (adhd (18): [mobd]), ( asd (19): [cgab]), (healthy controls: []), (fmri: [diap]), (stop task: [acty]), (motor inhibition: [acty]), (patients: [podg]), (twice: [qnco]), (acute dose: [qnco]), (fluoxetine: [orch,phsu]), (placebo: [topp]), (design: [acty]), (measures analyses: [qnco]), (assessed drug effects: [acty]), (potential normalisation effects: [resa]), ( patients: [podg]), (drug condition: [dsyn]), (asd boys: [cgab]), (overactivation: []), (left: []), (right inferior frontal cortex (ifc): [bpoc]), (adhd: [mobd]), (disorder-specific underactivation: [dsyn]), (orbitofrontal cortex (ofc): [blor]), (basal ganglia: [bpoc]), (prefrontal dysfunctions: [dsyn]), (inverse effects: []), (activations: fluoxetine: [orch,phsu]), (ifc: []), (ofc activation: [dsyn]), (asd: [cgab]), (findings: [clna]), (fluoxetine normalises: [orch,phsu]), (frontal lobe dysfunctions: [bpoc]), (frontal activation: [acty]), (inverse baseline serotonin levels: [bacs,orch]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s00213-014-3837-2) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (motor response inhibition, 'Response Inhibition')(rationale attention deficit hyperactivity disorder, 'Overactivity')(autism spectrum disorder, 'Autism Phenotype')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention deficit hyperactivity disorder boys, 'Overactivity')(attention deficit hyperactivity, 'Overactivity')

PMCID: 4316932
SFARI Genes: PTEN, PTEN, PTEN, PTEN, PTEN, PTEN, PTEN, PTEN, PTEN, PTEN, 
Non SFARI Genes: 
Named Entities: (germline mutations: [genf]), (phosphatase pten: [aapp,enzy]), (diverse human pathologies: []), (tumour susceptibility: [clna]), (developmental abnormalities: [cgab]), (autism: [mobd]), (genotype-phenotype relationships: [orga]), (functional consequences: []), (pten mutations: [aapp,enzy]), (patients: [podg]), (macrocephaly: [cgab]), (mutations: [genf]), (severe tumour: [neop]), (sufferers: []), (pten: [gngm]), (tumour syndrome (phts): [neop]), (autism-associated pten mutants: [mobd]), (ability: [orga]), (cellular akt signalling: [aapp,enzy]), (effects: []), (akt: [gngm]), (soma size: [orch,phsu]), (length: [qnco]), (density: [qnco]), (dendritic spines: [celc]), (primary neurons: [cell]), (conversely: []), (severe cases: [qnco]), (phts: [neop]), (akt signalling: [aapp,enzy]), (work implies: []), (incomplete loss: [fndg]), (pten function: [aapp,enzy]), (phts cases: [neop]), 
ASD Terms: (developmental abnormalities, 'Learning Disorders')(autism, 'Autism Phenotype')

PMCID: 4424375
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (peer behaviour: [inbe]), (important role: [socb]), (development: [orgf]), (social adjustment: [socb]), (genetic architecture: [topp]), (twin study: [resa]), (genome-wide complex trait analysis (gcta): [gngm]), (genome-wide screen: [gngm]), (genetic influences: [topp]), (problematic peer behaviour: [inbe]), (childhood: []), (adolescence: []), (series: [qnco]), (longitudinal measures: [qnco]), ((parent-reported strengths-and-difficulties questionnaire): [fndg]), (uk population-based birth-cohort (alspac: [popg]), (years): []), (uk twin sample: [famg]), (longitudinal twin analysis (teds; n: [famg]), (twin pairs): [famg]), (peer problems: [fndg]), (heritable (411 years: []), (< twin-h2: [famg]), (age: [orga]), (twin-rg =: [famg]), (gcta (alspac: n: [aapp,imft]), (teds: n: [aapp,imft]), (little support: [fndg]), (contribution: [acty]), (measured common genetic variants: [npop]), (childhood (412: []), (< gcta-h2(meta): [euka]), (influences: []), (adolescence (1317: []), (< gcta-h2(alspac): [gngm]), (subsequent cross-sectional genome-wide screen: [gngm]), (alspac (n: [aapp,imft]), (gcta-heritability (10: [fndg]), (years: []), (< gcta-p: []), (single variant signals: [fndg]), (teds (n: [aapp,imft]), (years) and: []), (search: [acty]), (autism: [mobd]), (quantitative trait loci: [gngm]), (autism samples: [mobd]), (npedigrees: []), (acc: ncases =: [cgab]), (however: []), (evidence: []), (association: [menp]), (teds: [gngm]), (little evidence: [fndg]), (overlap: [topp]), (autistic continuum: [mobd]), (findings: [clna]), (problematic peer relationships: [popg]), (increase: []), (common measurable genetic variation: [npop]), 
ASD Terms: (development of social adjustment, 'Ability to Converse in Social Settings')(autism, 'Autism Phenotype')(autism samples, 'Autism Phenotype')

PMCID: 4263785
SFARI Genes: VPS13B, VPS13B, 
Non SFARI Genes: 
Named Entities: (small number: [qnco]), (causal variants: []), (genetic variation: [npop]), (difficult challenge: [hlca]), (crucial one: [qnco]), (precise molecular mechanisms: []), (disease: [dsyn]), (follow-up functional studies: [resa]), (complementary statistical approaches: []), (identification: [menp]), (rare causal variants: [gngm]), (backward elimination procedure: [topp]), (groupwise association tests: [diap]), (hierarchical approach: []), (data: [euka]), (evolutionary conservation annotations: [genf]), (individual variants: [humn]), (simulations: [resa]), (incorporation: []), (multiple bioinformatic predictors: [qnco]), (deleteriousness: []), (polyphen-2: []), ( sift: []), (gerp++ scores: [clna]), (power: [hcpp]), (proof: [qnco]), (principle: []), (methods: []), (gene: [gngm]), (rare neurodevelopmental disorder: [mobd]), (cohen syndrome: [cgab]), (recessive variants: []), (autism: [mobd]), (small set: [menp]), (promising candidates: []), (causal: []), (loss-of-function variants: [phsf]), (rare: [gngm]), ( homozygous probably-damaging variant: [orga]), (risk: []), 
ASD Terms: (autism, 'Autism Phenotype')(rare neurodevelopmental disorder, 'Learning Disorders')(autism risk, 'Autism Phenotype')

PMCID: 4251975
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (psychiatric/neurological condition: [mobd]), (alterations: []), (social interaction: [fndg]), (other symptoms): [sosy]), (behavioral psychiatric methods: [inbe]), (main goal: []), (study: [resa]), (neural representations: [acty]), (meanings: []), (social concepts: []), (second goal: [qnco]), (neurocognitive markers: [clna]), (approach: []), (previous advances: []), (fmri analysis methods: [diap]), (identification: [menp]), (concept: []), (thought: [menp]), (physical object: []), (fmri pattern: [diap]), (ability: [orga]), (semantic content: [menp]), (factor analysis: [qnco]), (machine learning methods: [mcha]), (fmri activation patterns: [diap]), (adults: [aggp]), (high-functioning autism: [mobd]), (controls: [sbst]), (social interactions: [fndg]), (prominent neural representation factor: [acty]), (posterior midline regions): [blor]), (factor: []), (control participants: [popg]), (autism group: [mobd]), (moreover: []), ( machine: []), (algorithms classified individuals: [humn]), (control: [sbst]), (accuracy: []), (fmri neurocognitive markers: [diap]), (findings: [clna]), (psychiatric alterations: [hlca]), (form: []), (content: [menp]), (altered thoughts: [menp]), (brain activation patterns: [bpoc]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(neurocognitive markers, 'Cognitive Ability')(high-functioning autism, 'Autism Phenotype')(social interactions, 'Reciprocal Social Interaction')(autism group, 'Autism Phenotype')(fmri neurocognitive markers, 'Cognitive Ability')

PMCID: 4538199
SFARI Genes: ANKRD11, ANKRD11, ANKRD11, ANKRD11, ANKRD11, ANKRD11, ANKRD11, ANKRD11, 
Non SFARI Genes: 
Named Entities: (loss-of-function variants: [phsf]), (ankrd11: [gngm]), (cause: []), (kbg: []), (autosomal dominant syndrome: [dsyn]), (specific dental: [hlca]), (neurobehavioural: []), ( craniofacial: [bpoc]), (skeletal anomalies: [anab]), (cohort: [popg]), (syndrome cases: [dsyn]), (ankrd11 variants: [gngm]), (far: []), ( consisting: []), (patients: [podg]), (families: [famg]), (sixteen patients: [podg]), (sanger sequencing: [mbrt]), (familial case: [famg]), (sporadic patients: [podg]), (whole-exome sequencing: [mbrt]), (patient: [podg]), (genomewide array analysis: [resa]), (clinical geneticist: []), (orofacial phenotyping: [lbpr]), (orthodontic evaluation: [hlca]), ( intra-oral photographs: [diap]), (orthopantomograms: []), (hallmark feature: []), (macrodontia: [cgab]), (central upper incisors: [bpoc]), (several additional dental anomalies: [fndg]), (oligodontia: [cgab]), ( talon cusps: [cgab]), (other teeth: [bpoc]), (three-dimensional (3d) stereophotogrammetry: [diap]), (analysis: [resa]), (controls: [sbst]), (consistent facial dysmorphisms: [cgab]), (bulbous nasal tip: [fndg]), (broad base: [inch]), (round: []), (triangular face: [fndg]), (many patients: [podg]), (neurobehavioural problems: [mobd]), (autism spectrum disorder: [mobd]), (hyperactivity: [mobd]), (one-third: [qnco]), ((conductive) hearing loss: [dsyn]), (congenital heart defects: [cgab]), ( velopharyngeal insufficiency: [dsyn]), (hip anomalies: [bpoc]), (basis: [phsu]), (observations: [hlca]), (cardiac assessment: [hlca]), (children: [aggp]), (regular hearing tests: [diap]), (individuals: [humn]), (molecular diagnosis: [lbpr]), (kbg syndrome: [dsyn]), (common gene: [gngm]), (sequence variants: [npop]), (neurodevelopmental disorders: [mobd]), (important contributor: []), (aetiology: []), (familial cases: [famg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(hyperactivity, 'Overactivity')(hearing loss, 'Hearing Loss')(molecular diagnosis, 'Diagnosis')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 4294557
SFARI Genes: Fmr1, Fmr1, Fmr1, cap, Fmr1, cap, Fmr1, Fmr1, 
Non SFARI Genes: Mmp9, 
Named Entities: (summary fragile x syndrome (fxs): [cgab,dsyn]), (genetic cause: [topp]), (autism: [mobd]), (mutations: [genf]), (fmr1 (fragile x: [gngm]), (mental retardation: [mobd]), (gene) engender: [gngm]), (translation: [moft]), (dendritic spine dysmorphogenesis: [celc]), (synaptic plasticity alterations: [ortf]), (behavioral deficits: [inbe]), (mice: [mamm]), (reminiscent: [menp]), (fxs pheno-types: [orch,phsu]), (postmortem brains: [diap]), (fxs patients: [podg]), (fmr1 knockout mice (fmr1: [mamm]), (phosphorylation: [moft]), (mrna: [bacs,nnon]), (cap: [gngm]), (protein: [aapp,bacs]), ( eukaryotic initiation factor: [aapp,bacs]), ((eif4e): [aapp,bacs]), (increased expression: [topp]), (matrix metalloproteinase: [aapp,enzy]), ((mmp-9) protein: [aapp,enzy]), (genetic: [topp]), (pharmacological reduction: [npop]), (eif4e phosphorylation: [aapp,bacs]), (dendritic spine morphology defects: [celc]), (exaggerated translation: [moft]), (mmp9 mrna: [aapp,enzy]), (fmr1 /y: [gngm]), (whereas mmp-9 overexpression: [aapp,enzy]), (several fxs-like phenotypes: [orga]), (results: [fndg]), (mechanism: []), (regulation: [biof]), (synaptic function: [phsf]), (translational control: [genf]), (mmp-9: [aapp,enzy]), (fxs: []), (possibility: []), (new treatment avenues: [topp]), (psychiatric aspects: []), 
ASD Terms: (autism, 'Autism Phenotype')(summary fragile x syndrome, 'Fragile X Syndrome')(behavioral deficits in mice, 'Personal Traits')(fragile x, 'Fragile X Syndrome')(behavioral deficits, 'Personal Traits')(fragile x syndrome patients, 'Fragile X Syndrome')(several fragile x, 'Fragile X Syndrome')(fragile x syndrome, 'Fragile X Syndrome')(fragile x syndrome, 'Fragile X Syndrome')

PMCID: 4759095
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (significant evidence exists: [qnco]), (association: [menp]), (copy number variants: [nusq]), (autism spectrum disorder (asd);: [mobd]), (work: []), (diagnosis: [fndg]), (asd: [cgab]), (limited understanding: [menp]), (impact: [gngm]), (cnvs: [nusq]), (sub-phenotypes': [orga]), (objective: []), (paper: []), (associations: [menp]), (brain: [bpoc]), ((dbe) genes: [gngm]), (genes: [gngm]), (asd/intellectual disability (asd/id): [cgab]), (specific sub-phenotypes: [orga]), (sample: [sbst]), (cases: [qnco]), (european ancestry: [popg]), (autism genome project (agp): [mobd]), (rare cnv: [nusq]), (gene: [gngm]), (core set: [menp]), (phenotypic measures: [qnco]), (symptom severity: [fndg]), ( language impairments: [mobd]), (seizures: [sosy]), ( gait disturbances: [fndg]), ( intelligence quotient (iq): [orga]), (adaptive function: [phsf]), (maternal age: []), (classification: []), (non-parametric recursive partitioning method (random forests): [npop]), (sets: [menp]), (phenotypic characteristics: [orga]), (cnv-defined groups: [nusq]), (substantial variation: []), (classification accuracy: []), (variables: []), (verbal iq: []), (asd/id genes: [cgab]), (paternal age: []), (birth: [orgf]), (dbe genes: [gngm]), (asd/id list: [cgab]), (communication: [socb]), (language domains: [lang]), ( whereas cnvs: [nusq]), (manifestations: []), (knowledge: []), (first study: [qnco]), (sub-phenotypes: [orga]), (cnvs genome-wide: [nusq]), (importance: []), (diverse sub-phenotypic manifestations: [orga]), (specific features: []), ( comorbid conditions: [fndg]), (clinical correlates: []), (characteristics: []), (disorder: [dsyn]), 
ASD Terms: (diagnosis, 'Diagnosis')(autism spectrum disorder, 'Autism Phenotype')(autism genome project, 'Autism Phenotype')(language impairments, 'Language Ability')(intelligence quotient, 'IQ')(adaptive function, 'Adaptive Life Skills')(verbal intelligence quotient, 'IQ')(adaptive function, 'Adaptive Life Skills')(comorbid conditions, 'Comorbidities')

PMCID: 4320286
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (anatomical structures: [anst]), (mechanisms: []), (genes: [gngm]), (neuropsychiatric disorders: [dsyn]), (reciprocal copy number variants: [nusq]), (bp4-bp5 locus: [gngm]), (unique opportunity: []), (intermediate phenotypes: [orga]), (carriers: [fndg]), (high risk: [fndg]), (autism spectrum disorder (asd): [mobd]), (schizophrenia (sz): [mobd]), (variation: []), (brain anatomy: [bpoc]), (deletion: [genf]), (duplication carriers: [fndg]), (beyond gene dosage effects: [genf]), (global brain metrics: [orch,phsu]), (number: [qnco]), (genomic copies: [gngm]), (gray matter volume: [tisu]), (white matter tissue properties: [tisu]), (cortico-subcortical regions: [blor]), (reward: [menp]), ( language: [lang]), (social cognition: [socb]), (near absence: [anab]), (asd: [cgab]), (sz: [sosy]), (cohort: [popg]), (pattern: []), (brain anatomy changes: [bpoc]), (well-established structural abnormalities: [fndg]), (measures: [qnco]), (peripheral mrna: [bacs,nnon]), (genomic copy number findings: [gngm]), (molecular: []), ( neuroimaging: [diap]), (clinical approach: []), (datasets: []), (relative contributions: [acty]), (neuropsychiatric conditions: [dsyn]), (effect: []), (local brain anatomy: [bpoc]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(social cognition, 'Cognitive Ability')(schizophrenia diagnoses, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 4259993
SFARI Genes: NRXN2, NRXN2, Munc18-1, Stxbp1, Munc18-1, Stxbp1, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (strong genetic basis: [phsu]), (human: [humn]), (genetic studies: [resa]), (mutations: [genf]), (exons: [bacs,nnon]), (nrxn2 gene: [gngm]), (synaptic adhesion: [patf]), (-neurexin ii (nrxn2): [aapp]), (unrelated individuals: [fndg]), (causal link: []), (nrxn2: [gngm]), (disorder: [dsyn]), (hypothesis: []), (nrxn2 deficiency: [dsyn]), (symptoms: [sosy]), (nrxn2 knockout (ko) mice: [mamm]), (vivo: []), (nrxn2 ko mice: [mamm]), (deficits: []), (sociability: [socb]), (social memory: [menp]), (conspecifics: []), (tests: [lbpr]), (exploratory activity: [acty]), ( nrxn2 ko mice: [mamm]), (anxiety-like phenotype: [mobd]), (comparison: [acty]), (wild-type littermates: [gngm]), (thigmotaxis: [orgf]), (open field: [irda]), (time: []), (open arms: [neop]), (enclosure: []), (emergence test: [lbpr]), (novel objects: []), (however: []), (obvious changes: [qnco]), (prepulse inhibition: [phsf]), (passive avoidance learning: [menp]), (real-time pcr analysis: [mbrt]), (frontal cortex: [bpoc]), (hippocampus: [bpoc]), (significant decreases: [qnco]), (mrna levels: [bacs,nnon]), (genes: [gngm]), (proteins: [aapp,bacs]), (excitatory: []), (inhibitory transmission: [acty]), (quantification: [qnco]), (protein expression: [genf]), (munc18-1: [gngm]), (stxbp1: [gngm]), (deficiencies: [dsyn]), (presynaptic vesicular release: [hlca]), (findings: [clna]), (causal role: [socb]), (loss: [qnco]), (genesis: [gngm]), (autism-related behaviors: [mobd]), (mice: [mamm]), 
ASD Terms: (autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(social memory, 'Working Memory')

PMCID: 4244134
SFARI Genes: Tet2, Tet2, 
Non SFARI Genes: OGG1, 
Named Entities: (molecular pathogenesis: [patf]), (autism: [mobd]), (numerous genomic: [gngm]), (proteomic: []), ( metabolic: [celf]), (physiological alterations: []), (molecular processes: [phpr]), (pathogenesis: [patf]), (effective clinical management: [hlca]), (prevention: [resa]), (disorder: [dsyn]), (goal: []), (study: [resa]), (key molecular alterations: []), (role: [socb]), (pathophysiology: [patf]), (dna: [bacs,nnon]), (cerebellum: [bpoc]), (btbr t+tf/j: [aapp,imft]), (relevant mouse model: [emod]), (human post-mortem cerebellum: [humn]), (individuals: [humn]), (increased levels: [qnco]), (8-oxo-7-hydrodeoxyguanosine (8-oxodg): [bacs,nnon]), ( 5-methylcytosine (5mc): [bacs,nnon]), (5-hydroxymethylcytosine (5hmc): [orch]), (increase: []), (content: [menp]), (reduced expression: [topp]), (8-oxoguanine dna-glycosylase: [aapp,enzy]), ((ogg1): [aapp,enzy]), (expression: [topp]), ((dnmt3a: [aapp,enzy]), (dnmt3b): [gngm]), (interestingly: []), (rise: []), (level: [phsu]), (changes: [qnco]), (ten-eleven translocation expression: [comd]), ((tet1): [gngm]), (tet2 genes: [gngm]), (presence: [qnco]), (finding: [sosy]), (similar elevation: [topp]), (btbr t+tf/j mouse model: [aapp,imft]), (warrant future large-scale studies: [lbpr]), (ogg1 alterations: [aapp,enzy]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4249945
SFARI Genes: CHD2, SYNGAP1, TRIP12, PAX5, CHD2, SYNGAP1, TRIP12, PAX5, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (complex genetic component: [gngm]), (resequencing: [mbrt]), (candidate: []), (neurodevelopmental disorder risk genes: [gngm]), (probands: [orga]), (unaffected siblings: [famg]), (strong burden: []), (point mutations: [comd]), (genes: [gngm]), (chd2: [gngm]), (syngap1: [gngm]), ( genes: [gngm]), (related disorders: [dsyn]), (novel genes trip12: [gngm]), (pax5: [gngm]), (mutation carriers: [humn]), (iqs: []), (enrichment: []), (seizures: [sosy]), (data: [euka]), (distinct subtypes: []), (autism: [mobd]), (etiological classification: []), (future therapeutics: [orch,phsu]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder risk genes, 'Learning Disorders')(autism, 'Autism Phenotype')

PMCID: 4243533
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (common feature: [qnco]), (autism spectrum disorder (asd): [mobd]), (impairment: [patf]), (motor control: [sbst]), (learning: [menp]), (majority: [socb]), (children: [aggp]), (perturbation: []), (cerebellar function: [dsyn]), (alterations: []), (motor behavior: [dora]), (cerebellar synaptic plasticity: [bpoc]), (mouse model (patdp/+): [emod]), (human 15q11-13 duplication: [humn]), (genetic aberrations: [topp]), (autism: [mobd]), (mice: [mamm]), (asd-resembling social behavior deficits: [cgab]), (patdp/+ mice delay: [mamm]), (conditioninga form: []), (cerebellum-dependent motor learningis impaired: [bpoc]), (observe deregulation: [acty]), (putative cellular mechanism: [cell]), (motor: []), ( long-term depression (ltd): [ortf]), (parallel fiber-purkinje cell synapses: [cell]), (moreover: []), (developmental elimination: [phsf]), (surplus: []), (fibersa model: []), (activity-dependent synaptic pruningis impaired: [acty]), (findings point: [qnco]), (deficits: []), (synaptic plasticity: [ortf]), (pruning: []), (potential causes: []), (motor problems: []), (abnormal circuit development: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(impairment of motor control, 'Motor Skills')(autism, 'Autism Phenotype')(asd-resembling social behavior deficits, 'Personal Traits')(conditioninga form of cerebellum-dependent motor learningis impaired, 'Motor Skills')(long-term depression, 'Depressive Disorder')(cerebellum-dependent motor learningis impaired, 'Motor Skills')(long-term depression, 'Depressive Disorder')(autism, 'Autism Phenotype')(motor problems, 'Motor Skills')(abnormal circuit development, 'Learning Disorders')

PMCID: 4243332
SFARI Genes: IL-6, IL-6, IL-6, IL-6, 
Non SFARI Genes: IFI16, IFI16, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (core: [bdsu]), (behavioral domains:: []), (social deficits: []), (communication: [socb]), (repetitive behaviors: [fndg]), (glutamatergic/gabaergic imbalance: [sosy]), (various preclinical models: [phsu]), (asd: [cgab]), (additionally: []), ( autoimmunity immune dysfunction: [patf]), (neuroinflammation: []), (etiological mechanisms: []), (disorder: [dsyn]), (study: [resa]), (relationship: []), (glutamatergic/ gabaergic imbalance: [sosy]), (recently-discovered autism-related etiological mechanisms: [mobd]), (twenty: [aggp]), (autistic patients: [mobd]), (years: []), (gender-matched healthy controls: [orga]), (plasma levels: [bdsu]), (glutamate: [aapp,bacs]), ( gaba: [aapp,bacs]), (ratio: [qnco]), (markers: [clna]), (excitotoxicity: []), (tnf-: [aapp,bacs]), ( il-6: [aapp,imft]), ( ifn-: []), (ifi16: [gngm]), (groups: [popg]), (glutamate excitotoxicity: [aapp,bacs]), (glutamate concentration: [aapp,bacs]), (control subjects: [sbst]), (gaba: [aapp,bacs]), (glutamate/gaba levels: [aapp,bacs]), (subjects: [humn]), (il-6: [gngm]), (ifn-: []), (multiple regression analysis: [resa]), (associations: [menp]), (level: [phsu]), ( neuroinflammation: []), (autism: [mobd]), (developmental synaptic disorder: [mobd]), (imbalance: [sosy]), (gabaergic: []), (glutamatergic synapses: [bsoj]), (consequence: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social deficits, 'Social Competence')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')

PMCID: 4237351
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (genome-wide association studies: [mbrt]), (autism spectrum disorder (asd): [mobd]), (limited success: [socb]), (identification: [menp]), (common risk variants: [qnco]), ( consistent: []), (notion: []), (variants: []), (small individual effects: [humn]), (single snp analysis: [fndg]), (further capture disease risk gene information: [gngm]), (asd association studies: [cgab]), (network-based strategy: [popg]), (autism genome project (agp): [mobd]), (autism genetics resource exchange gwas: [mbrt]), (family-based association data: [socb]), (human protein-protein interaction (ppi) data: [inpr,resa]), (analysis: [resa]), (autism-associated proteins: [mobd]), (conventional levels: []), (significance (p<0.1): [qnco]), (random expectation: [resa]), (limited number: [qnco]), (interconnected biological processes: [biof]), (coherent networks: [fndg]), (approach: []), (asd-relevant disease biology: [cgab]), (improved positive predictive value: [qnco]), (sensitivity: [patf]), (asd candidate genes: [cgab]), (genes: [gngm]), (gwas: [mbrt]), (gene: [gngm]), (asd datasets: [cgab]), (intersection: []), (networks: []), (asd gwas: [cgab]), (unrelated disease datasets: [dsyn]), (fourteen genes: [gngm]), (asd networks: [cgab]), (novel genes: [gngm]), (abnormal nervous system phenotypes: [orga]), (animal models: [anim]), (fundamental biological processes: [biof]), (asd: [cgab]), (axon guidance: [celf]), ( cell adhesion: [celf]), (cytoskeleton organization: [celf]), (overall: []), (results: [fndg]), (novel susceptibility genes: [gngm]), (statistical noise: [phpr]), (further analysis: [resa]), (causal variants: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism genome project, 'Autism Phenotype')(autism genetics resource exchange genome-wide association studies, 'Autism Phenotype')(abnormal nervous system phenotypes in animal models, 'Nervous System Diseases')(abnormal nervous system phenotypes, 'Nervous System Diseases')

PMCID: 4233346
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (telomeres: [celc]), (protective chromosomal structures: [celc]), (key role: [socb]), (genomic stability: [genf]), (epidemiologic studies: [resa]), (abnormal: [qnco]), (telomere length: [celc]), (leukocytes: [cell]), (mental disorders: [mobd]), (age-related diseases: [dsyn]), (however: []), (association: [menp]), (leukocyte: [cell]), (length: [qnco]), (autism: [mobd]), (possible association: [menp]), (length (rtl): [qnco]), (peripheral blood leukocytes: [cell]), (childhood autism: [mobd]), (real-time polymerase chain reaction method: [mbrt]), (rtl: []), (patients: [podg]), (controls (p: [aapp,imft]), (individuals: [humn]), (presence: [qnco]), (long rtl: []), (family training interventions: [topp]), (significant effect: [qnco]), (telomere length (p: [celc]), (correlations: []), (clinical features: [clna]), ((paternal age: []), ( maternal age: []), ( age: [orga]), (onset: [qnco]), ( illness: [sosy]), (duration: [phsu]), ( cars score: [clna]), (abc score): [dsyn]), (study: [resa]), (results: [fndg]), (first evidence: [qnco]), (molecular mechanism: []), (development: [orgf]), 
ASD Terms: (mental disorders, 'Mental Disorders')(autism, 'Autism Phenotype')(childhood autism, 'Autism Phenotype')(childhood autism, 'Autism Phenotype')(childhood autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4427554
SFARI Genes: TRPC6, TRPC6, TRPC6, TRPC6, TRPC6, TRPC6, MeCP2, TRPC6, MeCP2, TRPC6, MeCP2, MeCP2, TRPC6, TRPC6, TRPC6, TRPC6, 
Non SFARI Genes: IGF1, 
Named Entities: (number: [qnco]), (genetic variants: [npop]), (autism spectrum disorders: [mobd]), (functional study: [resa]), (such variants: []), (elucidation: []), (autism pathophysiology: [mobd]), (here: []), (translocation disruption: [comd]), (trpc6: [gngm]), (cation channel: [chvs]), (non-syndromic autistic individual: [mobd]), (multiple models: [qnco]), (dental pulp cells: [cell]), (ipsc-derived neuronal cells: [cell]), (mouse models: [mamm]), (trpc6 reduction: [npop]), (haploinsufficiency leads: [comd]), (neuronal development: [celf]), ( morphology: [fndg]), (function: [phsf]), (observed neuronal phenotypes: [orga]), (trpc6 complementation: [gngm]), (treatment: [topp]), (igf1: [gngm]), (trpc6-specific agonist: [phsu]), (asd individuals: [cgab]), (alterations: []), (pathway: [moft]), (drugs: [topp]), (mecp2 levels: [aapp,bacs]), (trpc6 expression: [topp]), (mutations: [genf]), (mecp2 cause rett syndrome: [dsyn]), (common pathways: [moft]), (asds: [cgab]), (genetic sequencing: [lbpr]), (controls: [sbst]), (nonsynonymous mutations: [genf]), (asd population: [cgab]), (loss-of-function mutations: [phsf]), (incomplete penetrance: [fndg]), (patients: [podg]), (together: []), (findings: [clna]), (novel predisposing gene: [gngm]), (asd: [cgab]), (multiple-hit model: [dsyn]), (first study: [qnco]), (ipsc-derived human neurons: [humn]), (non-syndromic asd: [cgab]), (potential: []), (complex sporadic diseases: [dsyn]), (such cells: [cell]), 
ASD Terms: (autism pathophysiology, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(mutations in mecp2 cause rett syndrome, 'Rett Syndrome')(mecp2 cause rett syndrome, 'Rett Syndrome')

PMCID: 4224480
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (diagnosis: [fndg]), (autism spectrum disorder (asd): [mobd]), (age: [orga]), (effective intervention: [hlca]), (united: []), (average age: [orga]), (years: []), (metabolic biomarker signatures: [amas]), (asd: [cgab]), (blood samples: [bdsu]), (opportunity: []), (development: [orgf]), (diagnostic tests: [diap]), (detection: [topp]), (early age: [orga]), (metabolic features: [clna]), (plasma samples: [bdsu]), (children: [aggp]), (ultimate goal: []), (blood-based asd biomarkers: [cgab]), (clinical trials: [resa]), (individualized therapy: [topp]), (treatment: [topp]), (blood plasma: [bdsu]), (age-matched td children: [aggp]), (samples: [sbst]), (mass: [dsyn]), (spectrometry-based methods: [lbpr]), (broad range: [qnco]), (metabolites: [bacs]), (univariate: []), ( multivariate: []), (machine learning methods: [mcha]), (models: []), (importance: []), (features: []), (td: []), (set: [menp]), (significant features: [qnco]), (univariate analysis: [resa]), (multivariate modeling: [resa]), (subsets: []), (td samples: [sbst]), (61-sample training: [edac]), (average accuracies: [qnco]), (maximum accuracy: [qnco]), (independent 21-sample validation set: [menp]), (analysis: [resa]), (blood plasma metabolites: [bdsu]), (discovery: [acty]), (biomarkers: [clna]), (young children: [aggp]), (results: [fndg]), (basis: [phsu]), (additional discovery: [acty]), (validation research: [resa]), (patient: [podg]), (new insight: [menp]), (biochemical mechanisms: [moft]), (various subtypes: [phsu]), (biomolecular targets: [diap]), (new modes: [qnco]), (therapy: [topp]), (individualized treatment recommendations: [topp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')

PMCID: 4726659
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (highlights: []), (role: [socb]), (neuromodulation: []), (interoception: [menp]), (emotional inference: [menp]), (known neuromodulatory roles: [socb]), (oxytocin pertinent: [aapp,horm,phsu]), (model: []), (impaired interoception: [menp]), (rise: []), (autistic phenotype: [mobd]), (findings: [clna]), (autistic literature support: [mobd]), (analysis: [resa]), (therapeutic strategies: [menp]), 
ASD Terms: 

PMCID: 4230001
SFARI Genes: 
Non SFARI Genes: F3, 
Named Entities: (aim: [phsu]), (study: [resa]), (childhood autism rating scale (cars): [mobd]), ( autism treatment evaluation checklist (atec): [mobd]), (children's global assessment scale (cgas): []), (anodal transcranial direct current stimulation (tdcs): [topp]), (individuals: [humn]), (autism: [mobd]), (patients: [podg]), (consecutive days: []), (sham: [topp]), (active tdcs stimulation (1 ma): [topp]), (randomized double-blind crossover trial: [resa]), (left dorsolateral prefrontal cortex (f3): [bpoc]), (minutes: [qnco]), (different orders: []), (measures: [qnco]), (cars: [gngm]), ( atec: []), (cgas: [gngm]), (treatment: [topp]), (days posttreatment: []), (result: [fndg]), (statistical decrease: [qnco]), ((p <: [aapp,imft]), (atec total: [qnco]), ((p: [aapp,imft]), (days: []), (posttreatment (p: [aapp,imft]), (anodal tdcs: [topp]), (f3: [gngm]), (useful clinical tool: []), 
ASD Terms: (autism, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(autism treatment evaluation checklist, 'Autism Phenotype')(autism, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(autism treatment evaluation checklist, 'Autism Phenotype')(autism treatment evaluation checklist, 'Autism Phenotype')(childhood autism rating scale score, 'Autism Phenotype')(autism treatment evaluation checklist total, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4230722
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (exposure: [clna]), (environmental agents: []), (critical area: []), (intervention: [hlca]), (prenatal: [aggp]), (postnatal exposure: [clna]), (certain chemicals: [chem]), (risk: []), (autism spectrum disorder: [mobd]), (propionic acid (pa): [orch]), (foods: []), (metabolic product: [qnco]), (gut microbiota: [orgm]), (effects: []), (autism: [mobd]), (results: [fndg]), (animal studies: [anim]), (environmental contaminants: [sbst]), (drugs: [topp]), (neurotoxicity: [inpo]), (aid: [gngm]), (treatment: [topp]), (neurodevelopmental disorders: [mobd]), (present study: [qnco]), (protective and/or: []), (therapeutic effects: [clna]), (vitamin d: [orch,phsu,vita]), (brain intoxication: [bpoc]), (propionic acid (ppa): [orch]), (rats: [mamm]), (twenty-eight young male: [orga]), (western albino rats: [mamm]), (equal groups: [popg]), (control group: [grup]), (ppa-treated group: [mobd]), (neurotoxic dose: [inpo]), (mg/kg body weight/day: [qnco]), (days;: []), (vitamin d-protected group: [lbpr]), (iu/kg/day: [nnon]), (alpha: []), ( 25-dihydroxyvitamin d (3) (1: [orch,vita]), (weeks: []), (ppa: [mobd]), (days: []), (fourth group: [popg]), (d: [aapp,imft]), (therapeutic effect): [clna]), (calcium: [bacs,elii,phsu]), (plasma: [bdsu]), (groups: [popg]), (serotonin: [bacs,orch]), ( interferon gamma: [aapp,imft,phsu]), ((ifn-): []), ( glutathione-s-transferase activity: [moft]), (dna: [bacs,nnon]), (double helix breaks: [euka]), (brain tissue: [bpoc]), (data: [euka]), (d levels: [aapp,imft]), (control: [sbst]), (multiple signs: [fndg]), (brain toxicity: [bpoc]), (depletion: []), (serotonin (5ht): [bacs,orch]), (increase: []), (ifn-: []), (inhibition: [acty]), (glutathione-s-transferase activity: [moft]), (biomarkers: [clna]), (brain dysfunction: [dsyn]), (additionally: []), ( comet dna: [mbrt]), (tail length: [bpoc]), (dna % damage: [comd]), (tail moment: [bpoc]), (neurotoxic effect: [inpo]), (therapeutic effect: [clna]), (ppa-induced neurotoxicity: [mobd]), (remarkable amelioration: []), (parameters: [fndg]), (neurochemical: []), ( inflammation: [patf]), (detoxification processes: [orgf]), 
ASD Terms: (exposure, 'Exposures')(autism spectrum disorder, 'Autism Phenotype')(postnatal exposure, 'Exposures')(autism, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(vitamin d, 'Dietary Supplements')(vitamin d-protected group, 'Dietary Supplements')(plasma vitamin d levels, 'Dietary Supplements')

PMCID: 4198124
SFARI Genes: fat, fat, 
Non SFARI Genes: 
Named Entities: (knockout mouse models: [mamm]), (autism candidate gene neurobeachin (nbea): [mobd]), (independently: []), (models: []), (similar phenotypes: [orga]), (striking difference: [qnco]), (dwarf phenotype: [cgab,dsyn]), (heterozygous configuration: [orga]), (gh240b model: []), (serendipitous insertion: [genf]), (promoterless human growth hormone (hgh): [aapp,horm]), (genomic fragment: [gngm]), (nbea gene: [gngm]), (order: [acty]), (dwarfism present: [cgab,dsyn]), (nbea mouse model: [emod]), (detail: []), (growth deficiency: [patf]), (nbea +/ mice: [mamm]), (increased percentage: [qnco]), (fat mass: [dsyn]), (decrease: [qnco]), (bone mineral density: [clna]), (detectable levels: [clna]), (hgh: [aapp,horm]), (hypothalamus: [bpoc]), (liver: [bpoc]), ( hippocampus: [bpoc]), (serum: [bdsu]), (consequence: []), ( several members: [popg]), (mouse growth hormone (mgh): [mamm]), (cascade: []), (altered mrna: [bacs,nnon]), (reduction: [npop]), (growth: [orgf]), (hormone-releasing hormone mrna: [bacs,nnon]), (moreover: []), ( somatotrope cells: [cell]), (pituitary: [bpoc]), (reduced levels: []), (insulin-like growth factor: [aapp,horm]), (findings: [clna]), (random integration: [resa]), (hgh transgene: [aapp,horm]), (mouse model: [emod]), (inactivated nbea: [gngm]), (tissue-specific expression: [topp]), (negative feedback loop: [phpr]), ( mgh hyposecretion: []), (dwarfism: [cgab,dsyn]), 
ASD Terms: (autism candidate gene neurobeachin, 'Autism Phenotype')(bone mineral density, 'Dietary Supplements')

PMCID: 4350523
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence associates dysfunction: [dsyn]), (dopamine (da) transporter (dat): [aapp,bacs]), (pathophysiology: [patf]), (autism spectrum disorder (asd): [mobd]), (human dat (hdat; slc6a3): [humn]), (rare variant: [gngm]), (ala: [euka]), (val substitution: [aapp,bacs,phsu]), (amino: []), ((hdat a559v): []), (individuals: [humn]), (bipolar disorder: [mobd]), (attention-deficit hyperactivity disorder (adhd): [mobd]), (variant: []), ((n)-terminal serine (ser) residues: [aapp,bacs,phsu]), (anomalous da efflux phenotype: [orga]), (here: []), (novel identification: [menp]), (hdat a559v: []), (unrelated asd subjects: [cgab]), (first mechanistic description: [qnco]), (impaired trafficking phenotype: [orga]), (dat surface expression: [topp]), (dat substrates: [sbst]), (psychostimulant amphetamine (amph): [bacs,orch,phsu]), (hdat: []), (plasma membrane: [celc]), (integrity: [inbe]), (dat: [gngm]), (da transport capacity: [celf]), (dopaminergic neurotransmission: [ortf]), (amph-induced cell surface redistribution: [celc]), (unique trafficking phenotype: [orga]), (altered protein: [aapp,bacs]), (c  (pkc) activity: [acty]), (cells: [cell]), (hdat a559v exhibit: []), (pkc: [gngm]), (activity: [acty]), ( inhibition: [acty]), (amph-induced hdat a559v membrane redistribution: [celc]), (mechanistically: []), (inability: []), (traffic: [fndg]), (response: [fndg]), (amph: [gngm]), (phosphorylation: [moft]), (distal dat n-terminal ser: [lbpr]), (mutation: [genf]), (n-terminal ser: [lbpr]), (amph-induced trafficking: [gngm]), (furthermore: []), ( hdat a559v: []), (ability: [orga]), (lacks amph-induced da efflux: [gngm]), (pharmacological inhibition: [acty]), (ser: [lbpr]), (ala substitution: [acty]), (hdat a559v background: []), (amph-induced da efflux: [gngm]), (intracellular amph accumulation: [celc]), (multiple probands: [orga]), (neuropsychiatric disorders: [dsyn]), (imbalances: [sosy]), (da neurotransmission: [celf]), (adhd: [mobd]), (asd: [cgab]), (findings: [clna]), (valuable insight: [menp]), (new cellular phenotype: [orga]), (hdat trafficking): [celf]), (da function: [phsf]), (disorders: [dsyn]), (novel potential target (pkc): [gngm]), (therapeutic interventions: [topp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(bipolar disorder, 'Bipolar Disorder')(attention-deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(psychostimulant amphetamine, 'Substance Abuse')(transport amphetamine, 'Substance Abuse')(intracellular amphetamine accumulation, 'Substance Abuse')

PMCID: 4235743
SFARI Genes: PTEN, PTEN, 
Non SFARI Genes: 
Named Entities: (summary a period: []), (mild brain overgrowth: [bpoc]), (unknown etiology: [fndg]), (common phenotypes: [orga]), (autism: [mobd]), (here: []), (hypothesis: []), (maternal inflammation: [patf]), (critical periods: []), (embryonic development: [ortf]), (brain overgrowth: [bpoc]), (autism-associated behaviors: [mobd]), (result: [fndg]), (altered neural stem cell function: [phsf]), (pregnant mice: [mamm]), (low-dose lipopolysaccharide: [orch]), (embryonic day: [emst]), (pronounced effect: []), (pten heterozygotes: [aapp,enzy]), (exposure: [clna]), (nadph: [bacs,nnon]), ((nox)-pi3k pathway signaling: [aapp,enzy]), (hyperproliferation: []), (neural stem: [plnt]), (progenitor cells: [cell]), (forebrain microglia: [bpoc]), (abnormal autism-associated behaviors: [mobd]), (affected pups: []), (evidence: []), (idea: []), (prenatal neuroinflammatory dysregulation: [aggp]), (neural stem cell: [cell]), (concert: []), (underlying genetic susceptibilities: [orga]), (cellular responses: [orga]), (cellular levels: [cell]), (reactive oxygen species: [bacs,elii]), 
ASD Terms: (autism, 'Autism Phenotype')(produced abnormal autism-associated behaviors in affected pups, 'Personal Traits')(exposure, 'Exposures')(abnormal autism-associated behaviors, 'Personal Traits')

PMCID: 4193852
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (substantial increase: []), (research activity: [resa]), (autism: [mobd]), (past decade: [qnco]), (research: [resa]), (effective ways: []), (immediate needs: []), (autistic people: [mobd]), (efforts: [orgf]), (basic science research: [resa]), (service provision: []), (involving community members: [popg]), (potential way: []), (gap: [gngm]), (study: [resa]), (views: []), (community involvement: [acty]), (autism research: [mobd]), (perspectives: []), (autism researchers: [mobd]), (community members: [popg]), (autistic adults: [mobd]), ( family members: [famg]), (practitioners: []), (results: [fndg]), (large-scale questionnaire study (n =: [aapp,imft]), (researchers: []), (autism community: [mobd]), (community: []), (families: [famg]), (share: [socb]), (view: []), (focus groups/interviews: [grup]), (participants: [popg]), (potential benefits: [qnco]), (challenges: [hlca]), (distinct perspectives: []), (different stakeholders: []), (possibilities: []), (community engagement: [fndg]), (research process: [resa]), (lack: []), (approach: []), (uk autism research: [mobd]), (key roadblock: []), (endeavors: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism researchers, 'Autism Phenotype')(autism research, 'Autism Phenotype')(autism community, 'Autism Phenotype')(uk autism research, 'Autism Phenotype')

PMCID: 4192590
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (heterogeneous set: [menp]), (neurodevelopmental disorders: [mobd]), (neuroligin-3 (nl-3): [aapp,rcpt]), (cell adhesion protein: [aapp,bacs]), (synapse development: [ortf]), (asd: [cgab]), (ex-vivo high resolution: [lbpr]), (magnetic resonance: [npop]), (diffusion tensor: [npop]), ((dti): [diap]), (behavioral (social approach: [inbe]), (maze) tests: [topp]), (different time points: []), (days-of-age): [orga]), (nl-3: [qnco]), (wild-type littermates: [gngm]), (developmental brain abnormalities: [cgab]), (nl-3 mice: [mamm]), (mri data: [diap]), (different gray: [qnco]), (white matter regions: [tisu]), (volumetric measurements: []), (dti indices: [diap]), (regions: []), (age: [orga]), (nl-3 knock-in animals: [anim]), (sociability: [socb]), (anxiety-related behavior: [mobd]), (comparison: [acty]), (wild type littermates: [gngm]), (volume: [qnco]), (gray matter regions: [tisu]), (nl-3 knock-in mice: [mamm]), ( gender: [orga]), (time point: []), (covariates: []), (findings: [clna]), (structural changes: [topp]), (brain: [bpoc]), (mutation: [genf]), (nl-3 gene: [gngm]), (significant differences: [qnco]), (nl-3 mutation: [genf]), (profound effect: []), (water diffusion: [sbst]), (dti: [diap]), (volumetric: []), (dti studies: [diap]), (biology: []), (function: [phsf]), (asd risk model: [cgab]), (development: [orgf]), (biomarkers: [clna]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')(behavioral tests at 3 different time points, 'Personal Traits')(neurodevelopmental disorders, 'Learning Disorders')(developmental brain abnormalities, 'Learning Disorders')(neurodevelopmental disorders neuroligin-3 mice, 'Learning Disorders')(neurodevelopmental disorders, 'Learning Disorders')(neurodevelopmental disorders neuroligin-3 gene, 'Learning Disorders')

PMCID: 4530629
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (trichothiodystrophy (ttd): [dsyn]), (rare multisystem disorder: [dsyn]), (sulfur deficient hair: [elii,phsu]), (dark: []), (light tiger tail: [mamm]), (polarized light microscopy: [lbpr]), (ttd: [gngm]), (mutations: [genf]), (dna repair/transcription genes xpd: [cgab,dsyn]), ( xpb: [cgab,dsyn]), (ttda: [gngm]), (ttdn1: [gngm]), (gene: [gngm]), (unknown function: [phsf]), (ttd patients: [orch,phsu]), (photosensitive: [dsyn]), ( patients: [podg]), (ttdn1 mutations: [dsyn]), (cohort: [popg]), (patients: [podg]), (families: [famg]), (defects: []), (ttdn1 gene:: [gngm]), (photosensitivity: [fndg]), (patient: [podg]), (cutaneous burning: [sosy]), (deep phenotyping: [lbpr]), (differences: [qnco]), (delayed bone age: [fndg]), (seizure disorders: [dsyn]), (ttdn1 group (p=0.009: [dsyn]), (p=0.024: [fndg]), ( respectively): []), (characteristic ttd clinical: [orch,phsu]), ( laboratory: [mnob,orgt]), (imaging findings: [diap]), (ttdn1 patients: [dsyn]), (autistic behaviors: [mobd]), (contrast: [irda]), (characteristic friendly: []), (interactive personality: [mobd]), (other patients: [podg]), (dna: [bacs,nnon]), (revealed deletion mutations: [genf]), (size: []), (single base pair: [fndg]), (data: [euka]), (distinct phenotype relationship: [orga]), (different mechanism: []), (disease: [dsyn]), 
ASD Terms: 

PMCID: 4388743
SFARI Genes: PTEN, PTEN, PTEN, PTEN, PTEN, PTEN, Pten, Pten, PTEN, PTEN, PTEN, PTEN, PTEN, PTEN, 
Non SFARI Genes: 
Named Entities: (pten: [gngm]), (tumor suppressor: [gngm]), (inherited cancer syndrome: [neop]), (important regulator: []), (neural connectivity: []), (plasticity: [npop]), (present study: [qnco]), (phenotypic characteristics: [orga]), (individuals: [humn]), (germline: [cell]), (heterozygous pten mutations: [aapp,enzy]), (asd (pten-asd): [cgab]), (aim: [phsu]), (pathophysiologic markers: [clna]), (pten-asd: [cgab]), (targets: [diap]), (future treatment trials: [resa]), (pten-asd patients: [cgab]), ((non-pten) asd patients: [cgab]), ((macro-asd: [cgab]), ( n=16): [aapp,imft]), (macrocephaly (normo-asd: [cgab]), ( n=38): [aapp,imft]), (healthy controls: []), (group differences: [popg]), (expression levels: [qnco]), (regional structural brain volumes: [qnco]), (cortical thickness measures: [bpoc]), ( neurocognition: []), (adaptive behavior: [inbe]), (rna expression patterns: [genf]), (brain characteristics: [bpoc]), (murine model: [mamm]), (pten mislocalization: [aapp,enzy]), (further evaluate abnormalities: [hlca]), (human pten-asd patients: [humn]), (high proportion: [qnco]), (missense mutations: [genf]), (pten protein levels: [aapp,enzy]), (other groups: [popg]), ( prominent white matter: [tisu]), (cognitive abnormalities: [mobd]), (strong reductions: [sosy]), (speed: [qnco]), (memory: [menp]), (white matter abnormalities: [patf]), (relationship: []), (reductions: [npop]), (reduced cognitive ability: [menp]), (ptenm3m4 murine model: [mamm]), (differential expression: [topp]), (genes: [gngm]), (myelination: [celf]), (corpus callosum: [bpoc]), (memory deficits: [mobd]), (useful features: []), (clinicians: []), (genetics professionals: []), (gene: [gngm]), (testing: []), ( genetic counseling: [topp]), (cancer risk management;: [hlca]), (treatment targets: [topp]), (trials: [resa]), (treatments: [topp]), 
ASD Terms: (neurocognition, 'Cognitive Ability')(adaptive behavior, 'Adaptive Life Skills')(cognitive abnormalities, 'Cognitive Ability')(memory, 'Working Memory')(reduced cognitive ability, 'Cognitive Ability')(memory deficits, 'Working Memory')

PMCID: 4350522
SFARI Genes: DNMT3A, DNMT3A, MeCP2, MeCP2, 
Non SFARI Genes: DNMT3B, TET1, TET3, 
Named Entities: (epigenetic mechanisms regulate: [genf]), (gene expression: [genf]), (prenatal neurogenesis: [orgf]), (serve: []), (mediator: [aapp,bacs]), (genetics: []), (environment: []), (postnatal life: []), (recent discovery: [acty]), (concentration: [menp]), (brain: [bpoc]), (new dimension: [qnco]), (epigenetic regulation: [biof]), (neurogenesis: [orgf]), (development: [orgf]), (complex behavior disorders: [mobd]), (here: []), (candidate gene approach: [gngm]), (role: [socb]), (engrailed-2: [gngm]), ((en-2) gene expression: [genf]), (autism cerebellum: [bpoc]), (en-2 homeobox transcription: [gngm]), (autism: [mobd]), (normal cerebellar patterning: [bpoc]), (en-2 overexpression: [genf]), (promoter dna hypermethylation: [genf]), (traditional dna methylation methodology: [moft]), (cannot distinguish 5-methylcytosine (5-mc): [bacs,nnon]), (investigation: [hlca]), (globally: []), (increases: [qnco]), (expression: [topp]), (methyltransferases dnmt3a: [aapp,enzy]), (dnmt3b: [gngm]), (ten-eleven translocase genes tet1: [gngm]), (tet3: [gngm]), (8-oxo-deoxyguanosine (8-oxo-dg) content: [nnon]), (marker: [clna]), (oxidative dna damage: [comd]), (en-2 promoter: [bacs,nnon]), (significant positive correlation: [fndg]), (5-hmc content: [menp]), (en-2 gene expression: [genf]), (reports: [hlca]), (reduced mecp2 affinity: [aapp,bacs]), (5-hmc: [qnco]), ( mecp2 binding studies: [aapp,bacs]), (significant decrease: [qnco]), (repressive mecp2 binding: [aapp,bacs]), (aberrant overexpression: [genf]), (en-2: [gngm]), (normal cerebellar development: [bpoc]), (perinatal en-2 downregulation: [moft]), (sustained postnatal overexpression: [genf]), (critical window: []), (cerebellar development: [ortf]), (individuals: [humn]), (downstream developmental consequences: [orgf]), (programmed on-off switches: []), (occur: [acty]), (birth: [orgf]), (early brain development warrants: [ortf]), (further investigation: [hlca]), 
ASD Terms: (complex behavior disorders, 'Executive Function')(autism cerebellum, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(perinatal engrailed-2 downregulation, 'Perinatal Exposures')

PMCID: 4230972
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (rise: []), (measured prevalence: [qnco]), (autism: [mobd]), (much new research: [resa]), (research investment internationally: [resa]), (study: [resa]), (pattern: []), (current uk autism research funding maps: [aapp,bacs]), (concerns: []), (autism community: [mobd]), (interviews: [acty]), (groups: [popg]), (autistic adults: [mobd]), ( family members: [famg]), ( practitioners: []), (researchers: []), (priorities: []), (research: [resa]), (views: []), (large number: [qnco]), (stakeholders: []), (online survey: []), (clear disparity: [fndg]), (united kingdoms pattern: []), (funding: [qnco]), (autism research: [mobd]), (majority: [socb]), (participants: [popg]), (general consensus: [socb]), (future priorities: []), (areas: []), (difference: [qnco]), (day-to-day lives: [fndg]), (involvement: []), (priority setting: [qnco]), (resources: []), 
ASD Terms: (autism, 'Autism Phenotype')(current uk autism research funding maps, 'Autism Phenotype')(autism community, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 4419151
SFARI Genes: FOXP1, FOXP1, Foxp1, Foxp1, Foxp1, Foxp1, 
Non SFARI Genes: CA1, 
Named Entities: (neurodevelopmental disorders: [mobd]), (intellectual disability: [mobd]), ( autism spectrum disorder: [mobd]), (language impairment: [mobd]), (mutations: [genf]), (forkhead box foxp1 gene: [gngm]), (disorders: [dsyn]), (central role: [socb]), (social processes: [phpr]), (role: [socb]), (foxp1: [gngm]), (context: [fndg]), (alterations: []), (cognition: [menp]), (behaviour: [inbe]), (mice: [mamm]), (brain-specific foxp1 deletion (nestin-crefoxp1/mice): [mamm]), (mutant mice: [mamm]), (first time: [qnco]), (analysis: [resa]), (pre-: [mamm]), (postnatal neurodevelopmental phenotypes: [orga]), (pronounced disruption: []), (striatum: [bpoc]), (subtle alterations: [clna]), (hippocampus: [bpoc]), (detailed analysis: [resa]), (ca1 region: []), (abnormal neuronal morphogenesis: [orgf]), (reduced excitability: [sosy]), (imbalance: [sosy]), (excitatory: []), (input: []), (ca1: [gngm]), (hippocampal neurons: [cell]), (nestin-crefoxp1/ mice: [mamm]), (foxp1 ablation: [topp]), (social deficits: []), (new insights: [menp]), (behavioural importance: [inbe]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(language impairment, 'Language Ability')(cognition, 'Cognitive Ability')(postnatal neurodevelopmental phenotypes, 'Learning Disorders')(social deficits, 'Social Competence')

PMCID: 4177256
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction: [hlca]), (total: [qnco]), (brain: [bpoc]), (cytoarchitectonic subdivisions: [fndg]), (cortical structures: [bpoc]), ( cerebellum: [bpoc]), (brainstem: [bpoc]), (60-year-old subjects: [humn]), (autism: [mobd]), (control subjects: [sbst]), (global pattern: []), (developmental abnormalities: [cgab]), ((b): []), (function: [phsf]), (structures: []), (behavioral alterations: [inbe]), (volume: [qnco]), ( neuronal numerical density: [qnco]), (total number: [qnco]), (neurons: [cell]), (region: []), (interest: [menp]), (subjects: [humn]), (age-matched controls: [orga]), (unbiased stereological methods: []), (study: [resa]), (significant differences: [qnco]), (group: [popg]), (control groups: [grup]), (few brain regions: [blor]), (cerebellum: [bpoc]), (striatum: [bpoc]), (amygdala subdivisions: [bpoc]), (individuals: [humn]), (numerical density: [qnco]), (purkinje cells: [cell]), (respectively: []), (amygdala: [bpoc]), (significant reduction: [npop]), (neuronal density: [qnco]), (lateral nucleus: [celc]), (sign: [fndg]), (topographic selectivity: [genf]), (developmental alterations: [orgf]), (increase: []), (volumes: [qnco]), (caudate nucleus: [bpoc]), (nucleus accumbens: [bpoc]), (reduced numerical density: [fndg]), (putamen: [bpoc]), (observed pattern: []), ( amygdala: [bpoc]), (results: [fndg]), (magnetic resonance imaging studies: [diap]), (clinical correlations: []), (morphometric studies: [lbpr]), (detected abnormalities: [cgab]), (communication deficits: [socb]), (stereotypical behaviors: [mobd]), 
ASD Terms: (global pattern of developmental abnormalities, 'Learning Disorders')(autism, 'Autism Phenotype')(developmental abnormalities, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(stereotypical behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 4413819
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background: []), (attention deficit hyperactivity disorder (adhd): [mobd]), (autism spectrum disorder (asd): [mobd]), (common childhood disorders: [dsyn]), (behavioural overlap: [inbe]), (abnormalities: [cgab]), (similar brain systems: [bpoc]), (cerebellar regions: [bpoc]), (study: [resa]), (neurodevelopmental disorders: [mobd]), (disorder-specific structural brain abnormalities: [dsyn]), (method: [lbpr]), (medication-nave male adolescents: [aggp]), (adhd: [mobd]), (asd: [cgab]), (age-matched healthy male controls: [orga]), (high-resolution t1-weighted volumetric imaging: [orga]), (3-t magnetic resonance: [npop]), ((mri) scanner: [diap]), (voxel-based morphometry (vbm): [lbpr]), (group-level differences: [popg]), (structural grey matter (gm): [tisu]), (white matter (wm) volumes: [tisu]), (results: [fndg]), (significant group difference: [popg]), (gm: [gngm]), (right posterior cerebellum: [bpoc]), (middle/superior temporal gyrus (mtg/stg): [bpoc]), (post-hoc analyses: [resa]), (right posterior: []), (cerebellar gm volume: [bpoc]), (healthy controls: []), (asd boys: [cgab]), (other: []), (left mtg/stg gm volume relative: [antb,orch]), (adhd boys: [mobd]), (conclusions: []), (first time: [qnco]), (gm reduction: [antb,orch]), (cerebellum: [bpoc]), (asd whereas gm enlargement: [cgab]), (mtg/stg: [gngm]), (first step towards: [qnco]), (disorder-specific structural biomarkers: [dsyn]), (childhood disorders: [dsyn]), 
ASD Terms: (attention deficit hyperactivity disorder, 'Overactivity')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(attention deficit hyperactivity, 'Overactivity')(attention deficit hyperactivity disorder boys, 'Overactivity')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 4175587
SFARI Genes: ROBO2, ROBO2, 
Non SFARI Genes: 
Named Entities: (twin studies: [famg]), (expressive vocabulary: [topp]), (~24 months: []), (however: []), (genes: [gngm]), (early linguistic phenotype: [orga]), (genome-wide screen: [gngm]), (follow-up study: [resa]), (toddlers: [aggp]), (european descent: [famg]), (studies: [lbpr]), (lifecourse epidemiology consortium: [hlca]), (early (1518 months: []), (one-word stage: [clna]), ( ntotal=8: []), (889): []), (later (2430: []), (two-word stage: [clna]), ( ntotal=10: [fndg]), (819) phase: []), (language acquisition: [menp]), (early phase: []), (single-nucleotide polymorphism (rs7642482): [nusq]), (robo2: [gngm]), (conserved axon-binding receptor: [celc]), (genome-wide significance level (p=1.3: [gngm]), (combined sample: [sbst]), (association: [menp]), (language-related common genetic variation: [lang]), (general population: [popg]), (potential autism susceptibility locus: [mobd]), (linkage region: [moft]), (dyslexia: [mobd]), ( speech-sound disorder: [mobd]), (reading: [dora]), (contribution: [acty]), (common genetic influences: [qnco]), (modest: []), (genome-wide complex trait analysis: [gngm]), ((meta-gcta h21518-months=0.13: [fndg]), ( meta-gcta h22430-months=0.14): [fndg]), (concordance: [socb]), (additional twin analysis (5: [famg]), (733 pairs: []), ( h224-months=0.20): [fndg]), 
ASD Terms: (potential autism susceptibility locus, 'Autism Phenotype')

PMCID: 4177294
SFARI Genes: SETBP1, ZMYND11, SETBP1, ZMYND11, 
Non SFARI Genes: 
Named Entities: (copy number variants: [nusq]), (many neurocognitive disorders; however: [mobd]), (events: [evnt]), (underlying causative gene: [gngm]), (cnv morbidity map: [qnco]), (children: [aggp]), (developmental delay versus: [mobd]), (healthy controls: []), (significant cnvs: [nusq]), (candidate genes: [gngm]), (additional cases: [qnco]), (developmental delay: [mobd]), (autism: [mobd]), (controls: [sbst]), (integrated analysis: [resa]), (cnv: [nusq]), (single-nucleotide variant (snv) data: [fndg]), (ten genes: [gngm]), (putative loss: [qnco]), (function: [phsf]), (patient follow-up: [podg]), (subset: []), (new clinical subtypes: []), (pediatric disease: [dsyn]), (genes: [gngm]), (disease-associated cnvs: [nusq]), (haploinsufficiency: [comd]), (setbp1: [gngm]), (intellectual disability: [mobd]), (loss: [qnco]), (expressive language: [lang]), (truncations: [comd]), (zmynd11: [gngm]), (patients: [podg]), ( aggression: [mobd]), (complex neuropsychiatric features: [chvs]), (snv approach: []), (rapid discovery: [acty]), (new syndromes: [dsyn]), (neuropsychiatric disease genes: [gngm]), (extensive genetic heterogeneity: [orga]), 
ASD Terms: (many neurocognitive disorders, 'Cognitive Ability')(developmental delay versus, 'Learning Disorders')(developmental delay, 'Learning Disorders')(autism, 'Autism Phenotype')(expressive language, 'Expressive Language')(autism, 'Autism Phenotype')(aggression, 'Aggressive Behavior')(intellectual disability, 'Learning Disorders')(aggression, 'Aggressive Behavior')

PMCID: 4177682
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prevalence: [qnco]), (diagnosed autism: [mobd]), (last several decades: [qnco]), (u.s. children: [aggp]), (environmental factors: []), (increase: []), (list: []), (top ten: [dsyn]), (environmental toxins: [hops]), (recently: []), (temporal trends: []), (autism: [mobd]), (birth years: []), (combination: [fndg]), (data: [euka]), (california department: [orgt]), (developmental: [orgf]), ((cdds): [gngm]), (united: []), (individuals: [humn]), (disabilities education act: [topp]), (suspected toxins: [bacs,hops]), (extensive literature survey: []), (toxin: [bacs,hops]), (autism trends: [mobd]), (visual inspection: [hlca]), (computed correlation coefficients: [qnco]), (idea data: [euka]), ( autism prevalence: [qnco]), (birth year trends: []), (snapshots: []), (recent annual report: [inpr,mnob]), (constant age: [orga]), (many years: []), (reports: [hlca]), (ratio: [qnco]), (trend slopes: [qnco]), ("real" fraction: [qnco]), (cdds: [gngm]), (idea data sets: []), (strong increase: []), (autism prevalence: [qnco]), (recent decades: [qnco]), (quantitative comparison: [acty]), (idea snapshot: []), (constant-age: [orga]), (~75-80%: [fndg]), (tracked increase: []), (actual increase: []), (disorder: [dsyn]), (diagnostic criteria: []), (suspected environmental toxins: [hops]), (rise: []), (some: []), (lead: [elii,hops]), ( organochlorine pesticides: [hops,orch]), (vehicular emissions: [hops]), (trends: []), (diphenyl ethers: [orch]), ( aluminum adjuvants: [imft,phsu]), (herbicide glyphosate: [hops]), (u.s: []), (trend: []), (birth year: []), (late 1980s: []), (contrast: [irda]), ( childrens exposure: [clna]), (top ten toxic: [dsyn]), (same time frame: []), (hypotheses: []), (drivers: [popg]), (merit: []), (investigation: [hlca]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/1476-069x-13-73) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (diagnosed autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism trends, 'Autism Phenotype')(visual inspection, 'Visual Thinking')(constant age over many years, 'Onset of Symptoms')(autism prevalence, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism prevalence, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(childrens exposure, 'Exposures')(autism, 'Autism Phenotype')

PMCID: 4153713
SFARI Genes: CACNA1C, CaV1.2, CACNA1C, CaV1.2, CACNA1C, CaV1.2, CACNA1C, CaV1.2, CACNA1C, CaV1.2, CACNA1C, CaV1.2, CaV1.2, CaV1.2, CaV1.2, CaV1.2, CACNA1C, CaV1.2, CACNA1C, CaV1.2, 
Non SFARI Genes: ms, 
Named Entities: (mutations: [genf]), (cacna1c: [gngm]), (increase: []), (cav1.2 l-type ca2+ channel underlie: [gngm]), (rare forms: [gngm]), (long qt syndrome (lqts): [dsyn]), (timothy: [plnt]), ((ts): []), (variant: []), (male child: [aggp]), (filipino descent: [famg]), (arrhythmias: [fndg]), (extracardiac features: []), (candidate gene sequencing: [lbpr]), (functional expression studies: [lbpr]), (effects: []), (cav1.2 channels: [gngm]), (baby: [aggp]), (subject: [humn]), (seizures: [sosy]), (displayed developmental delays: [mobd]), (months: []), (age: [orga]), (years: []), (qtc: []), (ms: [gngm]), (experienced recurrent vt: []), (physical exam: [hlca]), (microcephaly: [cgab,dsyn]), (short stature: [cgab,dsyn]), (extremity weakness: [fndg]), (atrophy: [patf]), (hyperreflexia: [fndg]), ( spastic diplegia: [dsyn]), (multiple dental caries: [fndg]), (episodes: []), (rhabdomyolysis: [patf]), (candidate gene: [gngm]), (g>c transversion: [comd]), (position: []), (cacna1c (rs374528680): [gngm]), (glycine>arginine substitution: [aapp,bacs,phsu]), ((p.g1911r): [aapp,imft]), (cav1.2: [gngm]), (allele frequency: [qnco]), (malays: [popg]), (absent: [fndg]), (caucasian alleles: [gngm]), (genomes: [gngm]), (electrophysiological analyses: [resa]), (voltage-dependent inactivation: [qnco]), (gain: [qnco]), (function: [phsf]), (negative shift: [phpr]), (v1/2: [bpoc]), (activation: [acty]), (positive shift: [phpr]), (channel inactivation: []), (window current: [npop]), (together: []), (gain-of-function effect: [phsf]), (susceptibility: [clna]), (certain clinical settings: []), (p.g1911r variant: [aapp,imft]), (case: []), (sudden unexplained infant death (suid): [dsyn]), (number: [qnco]), (clinical observations: [hlca]), (arrhythmogenic mutations: [genf]), (cardiac ion channels: [elii]), (combined effects: []), (cacna1c variant: [gngm]), (window: []), (appreciation: []), (mechanisms: []), (qt prolongation: [fndg]), 
ASD Terms: (displayed developmental delays at 30 months, 'Learning Disorders')(displayed developmental delays, 'Learning Disorders')

PMCID: 4176835
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (fatty acids: [orch]), (essential dietary nutrients: [chvf]), (important roles: [socb]), (fatty acids (pufas): [bacs,orch]), (growth: [orgf]), (function: [phsf]), (nervous tissue: [tisu]), (short chain: [qnco]), (fatty acids (scfas): [orch]), (group: [popg]), (compounds: [chem]), (host microbiome: [orgm]), (effects: []), (gut: [bdsy]), (brain: [bpoc]), (behavior: [inbe]), (neurodevelopmental disorders: [mobd]), (autism: [mobd]), (levels: []), (pufas: [bacs,orch]), (impairments: [patf]), (behavioral performance: [inbe]), (brain development: [ortf]), (recent studies: [lbpr]), (omega -3: [bacs,orch,phsu]), (eicosapentaenoic acid (epa): [bacs,orch,phsu]), (docosahexaenoic acid (dha): [bacs,orch,phsu]), (neurogenesis: [orgf]), ( neurotransmission: [celf]), (protection: [fndg]), (oxidative stress: [comd]), (omega-3 pufas mediate: [bacs,orch,phsu]), (omega-6 pufa (arachidonic: [bacs,orch]), (aa)-induced proinflammatory prostaglandin e2; (pge2) formation: [horm,orch,phsu]), (work: []), (absolute: []), (relative concentrations: [menp]), (propionic (ppa): [mobd]), ( butyric: []), (acetic acids: [orch]), (precursors: []), (brain tissue: [bpoc]), (ppa-neurointoxicated rat pups: [mobd]), (mg ppa/kg body: [mobd]), (consecutive days): []), (rodent model: [mamm]), (persistent autistic features: [mobd]), (healthy controls: []), (data: [euka]), (omega6/omega3: [bacs,orch,phsu]), ( -linolenic/linoleic: []), ( -linolenic/epa: []), ( -linolenic/dha: [orch,phsu]), ( epa/dha: [orch,phsu]), (aa/linoleic: [plnt]), (ratios: [qnco]), (ppa-intoxicated rats: [mamm]), (role: [socb]), (impaired ratios: [qnco]), (relation: [socb]), (activity: [acty]), (desaturases: [aapp,enzy]), (elongases: []), (enzymatic groups: [popg]), (synthesis: [biof]), (relationship: []), (abnormal relative concentrations: [menp]), (studied fatty acids: [orch]), (neuroinflammation: []), (detail: []), (study: [resa]), (fatty acid ratios: [orch]), (mechanism: []), (ppa neurotoxicity: [mobd]), (therefore: []), (predictions: []), (patients: [podg]), (disorder: [dsyn]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4427538
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (previous studies: [lbpr]), (risk: []), (autism spectrum disorder (asd): [mobd]), (children: [aggp]), (antidepressants: [phsu]), (prenatal period: [aggp]), (disease-specificity: [qnco]), (possibility: []), (asd: [cgab]), (attention deficit-hyperactivity disorder (adhd): [mobd]), (large new england health care system: [hcro]), (electronic health records: []), (diagnostic group: [popg]), (adhd: [mobd]), (maternal health data: [qnco]), (birth certificates: []), (prenatal medication exposures: [fndg]), (multiple: [qnco]), (logistic regression: [resa]), (association: [menp]), (prenatal antidepressant exposures: [phsu]), (adhd risk: [mobd]), (total: [qnco]), (healthy controls: []), (models: []), (sociodemographic features: []), ( antidepressant exposure: [phsu]), (pregnancy: [orgf]), (asd risk: [cgab]), (exposure: [clna]), (maternal major depression: [mobd]), ((0.701.70)]: [fndg]), (conversely: []), (antidepressant exposure: [phsu]), (adjustment: [inbe]), (maternal depression: [mobd]), ((1.222.70)]: [fndg]), (results: [fndg]), (autism: [mobd]), (prenatal antidepressant exposure: [phsu]), (severity: []), (maternal illness: [sosy]), (further indicate: []), (such exposure: [clna]), (absolute terms: [orgf]), (result: [fndg]), (residual confounding: []), (substantial consequences: []), (untreated maternal depression: [mobd]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(attention deficit-hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(prenatal medication exposures, 'Medications')(prenatal antidepressant exposures, 'Exposures')(attention deficit-hyperactivity disorder risk, 'Attention Deficit Disorder with Hyperactivity')(exposure, 'Exposures')(antidepressant exposure, 'Exposures')(maternal major depression, 'Depressive Disorder')(maternal depression, 'Depressive Disorder')(autism, 'Autism Phenotype')(such exposure, 'Exposures')(prenatal antidepressant exposure, 'Exposures')(untreated maternal depression, 'Depressive Disorder')

PMCID: 4370361
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (phd candidate: []), (thesis: []), (oak ridge national laboratory: [plnt]), ( biology division: [orgt]), (dr. charles congdon: [bodm]), (introduction: [hlca]), (immune response: [ortf]), (graft: [tisu]), (host: [orgm]), ((gvh) disease: [dsyn]), (consequence: []), (bone marrow transplantation: [topp]), (mice: [mamm]), (sequalae: []), (gvh: [dsyn]), (potential: []), (negative clinical consequences: [fndg]), (immune system: [bdsy]), (idea: []), (immunological phenomena: [phpr]), (cancer therapy: [topp]), (late 1960s: []), (problem: [fndg]), (time t-cells: [cell]), (component: []), (soluble antigen stimulation: [npop]), (post antigen stimulation changes: [imft]), (lymphatic tissue: [tisu]), (germinal centers: [tisu]), (h: [gngm]), (induction: [topp]), (humoral immune response: [orgf]), (extracellular localization: [biof]), (soluble antigens: [imft]), (surface: []), (dendritic reticular cells: [cell]), (stroma: [bpoc]), (response: [fndg]), (b-cells: [cell]), (antibody: [aapp,imft]), (reaction: []), (rapid proliferation: [patf]), (plasma cells: [cell]), 
ASD Terms: (soluble antigen stimulation, 'Allergies')(post antigen stimulation changes, 'Allergies')(soluble antigens, 'Allergies')

PMCID: 4139321
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (field: [irda]), (autism research: [mobd]), (recent work: []), (neural markers: [clna]), (early identification: [topp]), (autism spectrum disorder (asd): [mobd]), (studies: [lbpr]), (infants: [aggp]), (significant family history: [fndg]), (autism spectrum disorder: [mobd]), (prevalence: [qnco]), (such infants: [aggp]), (present study: [qnco]), (asd: [cgab]), (sibling: [famg]), (disorder: [dsyn]), (not): []), (intrahemispheric linear coherence: [fndg]), (posterior sites: []), (measure: [qnco]), (neural functional connectivity: []), (electroencephalography: [diap]), (sounds: [npop]), (12-months-of-age infants: [aggp]), (risk: []), (reduced functional connectivity: []), (low risk infants: [aggp]), (low risk: [fndg]), (high risk: [fndg]), (significant differences: [qnco]), (functional connectivity: []), (low-risk infants: [aggp]), (high-risk infants: [fndg]), (develop asd: [cgab]), (results: [fndg]), (genetic vulnerability: [topp]), (moreover: []), (further evidence: []), (differences: [qnco]), (neural integration: [genf]), (emerge: []), (first year: [qnco]), (life: []), 
ASD Terms: (autism research, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(speech sounds, 'Vocalizations')

PMCID: 4135348
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent studies: [lbpr]), (mutations: [genf]), (pathogenesis: [patf]), (autism: [mobd]), (attention-deficit/hyperactivity disorder (adhd): [mobd]), (evidence: []), (excessive alcohol consumption: [fndg]), (increased rate: [qnco]), (germ cells (sperms: [cell]), (eggs): []), (risks: []), (adhd: [mobd]), (individuals: [humn]), (family history: [fndg]), (alcohol use disorders: [mobd]), (standardized incidence ratios: [qnco]), (biological parental history: [orga]), (auds: []), ((95% ci: [lbpr]), (respectively: []), (affected parent: []), (parents: []), (birth: [orgf]), (corresponding risks: []), (study: [resa]), (extra surveillance: [hlca]), (children: [aggp]), (further studies: [lbpr]), (underlying mechanisms: []), (doi: http://dx.doi.org/10.7554/elife.02917.001: [fndg]), 
ASD Terms: (autism, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(excessive alcohol consumption, 'Alcohol Drinking')(autism, 'Autism Phenotype')(alcohol use disorders, 'Alcohol Drinking')(autism, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(alcohol use disorders, 'Alcohol Drinking')(alcohol use disorders, 'Alcohol Drinking')

PMCID: 4136791
SFARI Genes: AChE, AChE, AChE, AChE, AChE, AChE, AChE, AChE, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (group: [popg]), (pervasive developmental disorders: [mobd]), (core symptoms: [sosy]), (sociability deficit: [dsyn]), ( language impairment: [mobd]), (behaviors: [inbe]), (worldwide prevalence: [qnco]), (asd: [cgab]), (therapeutic agents: [phsu]), (social deficits: []), (study: [resa]), (therapeutic potential: [topp]), (donepezil: [orch,phsu]), (valproic acid-induced autistic animal model (vpa animal model): [emod]), (prenatal exposure: [fndg]), (valproic acid (vpa): [orch,phsu]), (induced dysregulation: []), (cholinergic neuronal development: [cell]), (up-regulation: [genf]), (acetylcholinesterase (ache): [aapp,enzy]), (prefrontal cortex: [bpoc]), (affected rat: [mamm]), (mouse offspring: [mamm]), (similarly: []), (cortical neural progenitor cell: [bpoc]), (culture: [lbpr]), (vpa: []), (increased expression: [topp]), (ache: [gngm]), (vitro: []), (chromatin precipitation experiments: [aapp]), (acetylation: [moft]), (histone h3 bound: [aapp,bacs]), (ache promoter region: [bacs,nnon]), (addition: []), (other histone: [aapp,bacs]), (deacetyalse inhibitors: [chvf]), (trichostatin a: [antb,orch]), (sodium butyrate: [orch,phsu]), (expression: [topp]), (neural progenitor cells: [cell]), (essential role: [socb]), (hdacis: []), (regulation: [biof]), (ache expression: [sosy]), (behavioral analysis: [hlca]), (pbs: [dsyn]), ((0.3 mg/kg): [qnco]), (vpa mice: [mamm]), (postnatal day: []), (experiment: [resa]), (subchronic treatment: [topp]), (sociability: [socb]), (repetitive behavior: [fndg]), (hyperactivity: [mobd]), (vpa-treated mice offspring: [mamm]), (results: [fndg]), (evidence: []), (dysregulation: []), (ach system: []), (effective pharmacological therapeutic target: [diap]), (autistic behaviors: [mobd]), (animal model: [emod]), (further investigation: [hlca]), (clinical relevance: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(language impairment, 'Language Ability')(social deficits, 'Social Competence')(prenatal exposure, 'Exposures')(mouse offspring, 'Perinatal History')(hyperactivity, 'Overactivity')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(valproic acid-treated mice offspring, 'Perinatal History')

PMCID: 4341013
SFARI Genes: ADSL, ADSL, ADSL, ADSL, ADSL, ADSL, ADSL, ADSL, ADSL, ADSL, 
Non SFARI Genes: 
Named Entities: (adenylosuccinate lyase adsl) deficiency: [aapp,enzy]), (defect: []), (purine metabolism: [moft]), (purinosome assembly: [acty]), (metabolite fluxes: [npop]), (purine: [orch]), (synthesis: [biof]), (pathways: [moft]), (presence: [qnco]), (biologic fluids: [tisu]), (dephosphorylated substrates: [sbst]), (adsl: [gngm]), (succinylaminoimidazole carboxamide riboside (saicar): [nnon]), ((s-ado): [aapp,enzy]), (individuals: [humn]), (adsl deficiency: [dsyn]), (incidence: [qnco]), (disease: [dsyn]), (disorder: [dsyn]), (wide spectrum: [qnco]), (symptoms: [sosy]), (forms: []), (fatal neonatal form: [fndg]), (birth: [orgf]), (presents: [qnco]), (fatal neonatal encephalopathy: [fndg]), (lack: []), (spontaneous movement: [orgf]), (respiratory failure: [dsyn]), (intractable seizures: [fndg]), (early death: [fndg]), (first weeks: [qnco]), (life: []), (patients: [podg]), (type: [qnco]), (form) present: [qnco]), (neurologic clinical picture: []), (severe psychomotor retardation: [fndg]), (early onset: [fndg]), (seizures: [sosy]), (autistic features: [mobd]), (form: []), ((type ii: []), ( moderate: []), (mild form): []), (first years: [qnco]), ( slight: []), (psychomotor retardation: [fndg]), (transient contact disturbances: [acty]), (diagnosis: [fndg]), (demonstration: []), (saicar: [nnon]), (s-ado: [aapp,enzy]), (extracellular fluids: [bdsu]), (plasma: [bdsu]), ( cerebrospinal fluid and/or: [bdsu]), (genomic and/or cdna sequencing: [nnon]), (characterization: [acty]), (mutant proteins: [aapp]), (adsl mutations: [genf]), (effects: []), (protein: [aapp,bacs]), (biogenesis: [npop]), ( structural stability: []), (activity: [acty]), (characterized: [acty]), (date: []), (effective therapy: [topp]), 
ASD Terms: (early onset, 'Onset of Symptoms')(neurologic clinical picture, 'Neurologic Indications')(severe psychomotor retardation, 'Mental Retardation')(moderate psychomotor retardation, 'Mental Retardation')(diagnosis, 'Diagnosis')(cerebrospinal fluid and/or, 'Hydrocephalus')

PMCID: 4130524
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autistic perception: [mobd]), (sometimes exceptional performance: [inbe]), (several low- (e.g.: [qnco]), ( discrimination): [socb]), (mid-level (e.g.: [phsu]), ( pattern matching) tasks: [resa]), (auditory domains: []), (factor: []), (perceptive abilities: [orga]), (autistic individuals: [mobd]), (autism-specific association: [menp]), (perceptual tasks: []), (first purpose: [qnco]), (study: [resa]), (perceptual performances: [inbe]), (processing levels: [acty]), (modalities: []), (second purpose: [qnco]), (major factor: []), (covariation: []), (task performances: [topp]), (non-autistic individuals: [mobd]), (perceptual abilities: [orga]), (controls: [sbst]), (tasks: []), (auditory processing: [acty]), (intelligence: [menp]), (wechsler's intelligence scale (fsiq): []), (raven progressive matrices (rpm): []), (linear regression models: [qnco]), (groups: [popg]), (patterns: []), (addition: []), (wechsler's fsiq: []), (rpm: [qnco]), (regression models: [menp]), (effects: []), (wechsler fsiq: []), (residual covariation: []), (unimodal tasks: []), ( i.e: [diap,inpr]), (modality-specific factor: [diap]), (autistic group: [mobd]), (presence: [qnco]), (plurimodal factor: []), (exceptional performance: [inbe]), (here: []), (existence: []), (specific: []), ( plurimodal covariation: []), (general intelligence (or g factor): [menp]), (instead: []), (common perceptual process (or p: [aapp,imft]), 
ASD Terms: (autistic perception, 'Cognitive Ability')(perceptive abilities, 'Cognitive Ability')(task performances, 'Task Performance')(compare task performances, 'Task Performance')

PMCID: 4419741
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (language difficulties: [fndg]), (spectrum conditions: [dsyn]), (molecular genetic studies: [lbpr]), (asc: [gngm]), (genetic bases: [chvf]), (extent: []), (genetic: [topp]), (overlap: [topp]), (language is: [lang]), ( however: []), ( unclear: []), (twin study: [resa]), (concurrent association: [menp]), (autistic traits: [mobd]), (receptive language abilities: [menp]), (internet-based language tests: [diap]), (~3: [fndg]), (000 pairs: []), (twins: [famg]), (parent ratings: [acty]), (twin model fitting: [sosy]), (association: [menp]), (measures: [qnco]), (full sample: [sbst]), (defries-fulker analysis: [resa]), (associations: [menp]), (extremes: []), (sample: [sbst]), (phenotypic associations: [menp]), (language ability: [menp]), (degree: [qnco]), (genetic overlap: [topp]), (genetic influences: [topp]), (language scores: [lang]), (full sample (mean: [qnco]), (genetic correlation = 0.13): [fndg]), (sample (mean genetic correlation =: [qnco]), (indicating: []), (extreme autistic traits: [mobd]), (variation: []), (different nonshared environmental influences: []), (language: [lang]), (distinct etiological factors: []), (implications: []), (etiology: []), (additionally: []), (findings: [clna]), (support: []), (dsm-5 changes: [qnco]), (diagnostic criteria: []), (core asc communication symptoms: [socb]), (clinical specifier: []), 
ASD Terms: (language difficulties, 'Language Ability')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(receptive language abilities, 'Development or Regression of Language Skills')(phenotypic associations between language ability, 'Development or Regression of Language Skills')(language ability, 'Development or Regression of Language Skills')(variation in language ability, 'Development or Regression of Language Skills')(autism spectrum conditions, 'Autism Phenotype')(see language difficulties, 'Language Ability')(core autism, 'Autism Phenotype')

PMCID: 4378254
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (neuropeptide oxytocin: [aapp,horm,phsu]), (effective therapeutic strategy: [menp]), (communication deficits: [socb]), (autism: [mobd]), (recent paper: []), (oxytocin: [aapp,horm,phsu]), (autistic behavioral deficits: [mobd]), (restoration: []), (activity: [acty]), (ventromedial prefrontal cortex (vmpfc): [bpoc]), (functional magnetic resonance: [npop]), ((fmri): [diap]), (socio-communication task: [socb]), (however: []), (effects: []), (neuronal level: [phsu]), (specific task examined: [fndg]), (same randomized: [resa]), ( double-blind: [resa]), ( placebo-controlled: [resa]), ( within-subject cross-over clinical trial: [resa]), (single dose: [fndg]), (intranasal oxytocin (24 iu): [aapp,horm,phsu]), (men: [gngm]), (high-functioning autism spectrum disorder: [mobd]), (n-acetylaspartate (naa): [aapp,bacs]), (marker: [clna]), (neuronal energy demand: [topp]), (vmpfc: []), (1h-magnetic resonance spectroscopy (1h-mrs): [diap]), (differences: [qnco]), (naa levels: [aapp,bacs]), (placebo sessions: [topp]), (oxytocin-induced fmri signal changes: [aapp,horm,phsu]), (oxytocin-induced increases: [aapp,horm,phsu]), (fmri signal: [diap]), (naa differences: [aapp,bacs]), (effect: []), (variability: []), (time: []), (fmri: [diap]), (1h-mrs scans: [diap]), (order: [acty]), (administration: [topp]), (placebo (p=0.001): [topp]), (furthermore: []), ( path analysis: [resa]), (increases: [qnco]), (task-dependent fmri signals: [diap]), (improvements: []), (socio-communication difficulties: [socb]), (present study: [qnco]), (beneficial effects: []), (autistic behavior: [mobd]), (psychological task: [mobd]), (other autistic behavioral problems: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(autistic behavioral deficits, 'Personal Traits')(high-functioning autism spectrum disorder, 'Autism Phenotype')(other autistic behavioral problems, 'Personal Traits')

PMCID: 4119222
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (p75: [gngm]), (neurotrophin receptor (p75ntr): [aapp,rcpt]), (cerebellar purkinje cells: [cell]), (lifespan: [grpa]), (children: [aggp]), (autism spectrum: [mobd]), (behavior exhibit: [inbe]), (apparent cerebellar purkinje cell loss: [cell]), (cerebellar transcriptome changes: [bpoc]), (murine: [mamm]), (prenatal valproate exposure model: [orch,phsu]), (autism: [mobd]), (proteins: [aapp,bacs]), (p75ntr interactome: [aapp,rcpt]), (p75ntr: [gngm]), (modulator: []), (mitochondrial redox potential: [celc]), (others: [fndg]), (aberrant response: [fndg]), (oxidant stress: [chvf]), (major role: [socb]), (pathogenesis: [patf]), (purkinje: []), (cell-selective p75ntr knockout mice: [mamm]), (progeny: [famg]), (hemizygous cre-purkinje cell: [cell]), (c57bl mice: [mamm]), (floxed c57bl mice: [mamm]), (cre-loxp mice exhibit: [mamm]), (complete knockout: [emod]), (~50%: [fndg]), (cre-only mice: [mamm]), (wild-type c57bl mice: [mamm]), (results: [fndg]), (behavioral phenotype: [bhvr]), (allogrooming: []), ((p<0.05; one-way analysis: [fndg]), (variance): [qnco]), (socialization: [edac]), ((each p<0.05): [fndg]), (other mice;: [mamm]), ((1.2-fold) non-ambulatory exploration: [topp]), (environment: []), (wild-type (p<0.01): [gngm]), (cre: [gngm]), (mice;: [mamm]), (stereotyped jumping behavior: [menp]), (wild-type (p<0.05): [gngm]), (cre (p<0.02) mice: [mamm]), (same strain: [menp]), (wild-type mice: [mamm]), (complex dendritic arborization: [ortf]), (cre-loxp mice: [mamm]), (neurites: [celc]), (unit area (p<0.025: [fndg]), ( student's t-test): [popg]), (perpendicular branches: [bpoc]), (unit area (p<0.025): [fndg]), (short branches/long: [qnco]), (neurite (p<0.0005): [celc]), (aberrant: []), (developmental regulation: [biof]), (expression: [topp]), 
ASD Terms: (autism spectrum, 'Autism Phenotype')(autism, 'Autism Phenotype')(prenatal valproate exposure model, 'Exposures')(autism, 'Autism Phenotype')(stereotyped jumping behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')

PMCID: 4132649
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (stereotyped: [menp]), (repetitive behaviours: [inbe]), (autism: [mobd]), (deficits: []), (serotonin-modulated inhibitory control: [bacs,orch]), (daly: []), (al: [lbpr]), (use fmri: [diap]), (effects: []), (acute tryptophan depletion: [aapp,bacs,phsu]), (adult males: [aggp]), (controls: [sbst]), (go/no-go task: [gngm]), (opposite effects: []), (groups: [popg]), ( consistent: []), (altered inhibition: [acty]), 
ASD Terms: (autism, 'Autism Phenotype')(repetitive behaviours, 'Restricted and Repetitive Behavior')(stereotyped, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')

PMCID: 4137411
SFARI Genes: 
Non SFARI Genes: impact, impact, 
Named Entities: (key component: []), (genetic architecture: [topp]), (allelic spectrum: [gngm]), (trait variability: [orga]), (autism spectrum disorder (henceforth: [mobd]), (nature: []), (individual risk genes: [gngm]), (rare variation: [gngm]), (mutations18: []), (evidence: []), (recent studies: [lbpr]), (small effect: [qnco]), (substantial impact: [gngm]), (masse9: []), (10: [fndg]), (issue: [fndg]), (impact: [gngm]), (variation: []), (unique epidemiological sample: [sbst]), (sweden: []), ( novel methods: []), (distinguish total narrow-sense heritability: [ortf]), (common variation: [qnco]), (results: [fndg]), (other studies: [lbpr]), (several conclusions: [qnco]), (autisms genetic architecture:: [mobd]), (narrow-sense heritability: [ortf]), (traces: [qnco]), (common variation;: [qnco]), (mutations: [genf]), (liability;: []), (contribution: [acty]), (variance: [qnco]), 
ASD Terms: (autism spectrum, 'Autism Phenotype')(autisms genetic architecture, 'Autism Phenotype')

PMCID: 4100876
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (sex differences: [orga]), (autistic traits: [mobd]), ((male advantage): [orga]), ((female advantage): [orga]), (individuals: [humn]), (cognitive-behavioural profiles correspond: [lbpr]), (predictions: []), (extreme male brain (emb) theory: [bpoc]), (autism: [mobd]), ((extreme scores: [qnco]), (systemizing: []), (average: [qnco]), (empathizing): []), ( however: []), (adults: [aggp]), ((454 females): [orga]), (age-matched typical control adults: [aggp]), (females): [orga]), (empathy quotient: [inbe]), (autism spectrum quotient: [qnco]), (typical females: [orga]), (eq: [qnco]), (typical males: [orga]), (sq-r: [clna]), (aq: []), (males: [orga]), (females: [orga]), (shift: [phpr]), (extreme: []), (male profile: [orga]), (measures: [qnco]), (distribution: []), (brain: [bpoc]), ((the discrepancy: [fndg]), (sq-r scores): [qnco]), (further: []), (normative sex differences: [orga]), (findings: [clna]), (strong support: []), (emb theory: [gngm]), (highlight differences: [qnco]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(empathy quotient, 'Empathy')(autism spectrum quotient, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4099083
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (dramatic increase: []), (prevalence: [qnco]), (autism: [mobd]), (autistic spectrum disorders (asd): [mobd]), (decades: [qnco]), (usa: []), ( europe: []), (asia: []), (data: [euka]), (possible role: [socb]), (translation: [moft]), (etiology: []), (asd: [cgab]), (potential effects: []), (rare synonymous substitutions: [acty]), (mrna stability: []), (enhancers: [nnon]), (silencers: []), (codon usage: [nusq]), (presentation: []), (hypothesis: []), (subtle impairment: [patf]), (dosage imbalance: [sosy]), (neuron-specific proteins: [cell]), ( contributes: [acty]), (environmental neurotoxins: [hops]), (hypothesis a: []), (significant shift: [phpr]), (suboptimal codons: [nusq]), (effect: []), (other analyzed characteristics: [resa]), (transcripts: [nnon]), (result: [fndg]), (impact: [gngm]), (rare codons: [nusq]), (genes: [gngm]), (neuron development: [celf]), (magnitude: [qnco]), (pathogenesis: [patf]), (presence: [qnco]), (aggressive chemical background: [mobd]), (further analysis: [resa]), (asd-associated mutations: [cgab]), (direct biochemical characterization: [acty]), (effects: []), (assessment: [acty]), (vivo effects: []), (animal models: [anim]), (implications: []), (synergistic action: [acty]), (environmental hazards: [fndg]), (genetic variations: [npop]), (deleterious effects: []), (environmental factors: []), (general principle: [hlca]), (increase: []), (asd prevalence: [qnco]), (reviewers: [popg]), (article: []), (andrey rzhetsky: []), ( neil r. smalheiser: [clna]), (shamil r. sunyaev: [clna]), 
ASD Terms: (autism, 'Autism Phenotype')(autistic spectrum disorders, 'Autistic Disorder')(aggressive chemical background, 'Aggressive Behavior')

PMCID: 4091790
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (recent evidence: []), (role: [socb]), (disease susceptibility: [clna]), (various neuropsychiatric disorders: [dsyn]), (autism: [mobd]), ( etc: []), (): []), ( trinucleotide expansion: []), ((myotonic dystrophy: [dsyn]), ( huntington's: []), ( etc.): []), (forms: []), (cancer: [euka]), (incidence: [qnco]), (offspring: [famg]), (fathers: [famg]), (strong epidemiological evidence: []), (alterations: []), (cases: [qnco]), (mechanisms: []), (processes: [phpr]), (however: []), (epigenetics: [genf]), (dna methylation alterations: [moft]), (likely play: [dora]), (study: [resa]), (impact: [gngm]), (dna methylation: [moft]), (mature: []), (human sperm: [humn]), (methylation array approach: [moft]), (changes: [qnco]), (dna methylation patterns: [moft]), (fertile donors: [orgf]), (sperm methylome: [cell]), (samples: [sbst]), (years: []), (design: [acty]), (regions: []), (age: [orga]), (representative subset: [acty]), (independent cohort: [popg]), (total: [qnco]), (genes: [gngm]), (methylation alterations: [moft]), (gene body): [humn]), (intriguingly: []), (portion: []), (age-related changes: [aggp]), (sperm dna methylation: [moft]), (schizophrenia: [mobd]), (bipolar disorder: [mobd]), (data: [euka]), (causative relationship: []), (possibility: []), (age-associated methylation: [moft]), (candidate genes: [gngm]), (sperm: [cell]), (other disorders: [dsyn]), (males: [orga]), (whether: []), (causative relationship exists: []), 
ASD Terms: (offspring, 'Perinatal History')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(bipolar disorder, 'Bipolar Disorder')

PMCID: 4067505
SFARI Genes: SLC6A4, SLC6A4, 
Non SFARI Genes: 
Named Entities: (serotonin reuptake inhibitors: [phsu]), (off-label: []), (children: [aggp]), (autism: [mobd]), (clinical trials: [resa]), (use: []), (ssris: [phsu]), (small sample sizes: [sbst]), (inconclusive results: [fndg]), (efficacy: [resa]), (safety: [hcpp]), (autistic behaviors: [mobd]), (evidence: []), (current clinical practice: [menp]), (aim: [phsu]), (fluoxetine: [orch,phsu]), (autistic behaviors (fab) study: [mobd]), (low dose fluoxetine: [orch,phsu]), (placebo: [topp]), (frequency: [qnco]), (severity: []), (repetitive stereotypic behaviors: [mobd]), (adolescents: [aggp]), (autism spectrum disorder (asd): [mobd]), (relationship: []), (effectiveness: []), (fluoxetine treatment: [orch,phsu]), (serotonin transporter genotype: [aapp,bacs]), (methods/design: [acty]), (fab study: [resa]), (trial: [resa]), (australian governments national health: [orgt]), (medical research council (nhmrc) grant: [qnco]), (participants: [popg]), (years: []), (confirmed diagnosis: [fndg]), (asd: [cgab]), (eligible participants: [popg]), (16-week period: []), (medication: [phsu]), (weeks: []), (reponses: []), (clinical global impressions scale (cgi): [acty]), (primary outcome measure: []), (childrens yale-brown obsessive compulsive scale-modified: []), (pervasive developmental disorders: [mobd]), (baseline: [bodm]), (secondary outcome measures: [neop]), (aberrant behaviour scale: [inbe]), (spence childrens anxiety scale parent report (scas-p): [dsyn]), (repetitive behaviors scale (rbs-r): [acty]), (slc6a4 allele variants: [gngm]), (cheek swab: [lbpr]), (continuous outcomes: []), (primary outcome: [topp]), (placebo groups: [popg]), (unadjusted linear regression: [qnco]), (binary outcomes: []), (unadjusted logistic regression: [resa]), (discussion: [socb]), (large clinical trial: [resa]), (restricted: []), ( repetitive: []), (behaviors: [inbe]), (outcomes: []), (study: [resa]), (evidence-based interventions: [hlca]), (clinical practice: [menp]), (trial registration australian: [resa]), (new zealand clinical trials registry actrn12608000173392;: [mamm]), 
ASD Terms: (autism, 'Autism Phenotype')(repetitive stereotypic behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorder, 'Autism Phenotype')(medical research council, 'Medications')(diagnosis, 'Diagnosis')(confirmed diagnosis, 'Diagnosis')(medication, 'Medications')(childrens yale-brown obsessive compulsive scale-modified for pervasive developmental disorders, 'Obsessive-Compulsive Disorder')(childrens yale-brown obsessive compulsive scale-modified, 'Obsessive-Compulsive Disorder')(spence childrens anxiety scale parent report, 'Anxiety Disorders')(repetitive behaviors scale, 'Stereotyped, Restricted, and Repetitive Behavior')(stereotyped behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 4221602
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (vitamin d deficiency: [dsyn]), (possible risk factor: [qnco]), (autism spectrum disorder (asd): [mobd]), (25-hydroxyvitamin d3 (25(oh)d3) levels: [horm,orch,phsu]), (cross-sectional population-based study: [resa]), (faroe islands: []), (case group: [popg]), (total population cohort: [popg]), (individuals: [humn]), (asd: [cgab]), (years): []), (typically-developing siblings: [famg]), (parents: []), (healthy age: [orga]), (gender: [orga]), (comparisons: [acty]), (trend: []), (males: [orga]), (females: [orga]), (effects: []), (age: [orga]), ( month/season: []), (birth: [orgf]), ( iq: []), (various subcategories: [phsu]), (autism diagnostic observation schedule score: [hlca]), (investigated: []), ( however: []), (association: [menp]), (asd group: [cgab]), (pathogenic mechanism: [fndg]), 
ASD Terms: (vitamin d deficiency, 'Dietary Supplements')(autism spectrum disorder, 'Autism Phenotype')(autism diagnostic observation schedule score, 'Autism Phenotype')

PMCID: 4059929
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (multiple reports: [hlca]), (defective genetic networks: [moft]), (aetiology: []), (autism: [mobd]), (pharmacotherapeutic opportunities: []), (drugs: [topp]), (endogenous small molecules: [orch]), (protein: [aapp,bacs]), (many successful drugs: [topp]), (large gene families: [gngm]), (multiple drug binding sites: [celc]), (defective gene family interaction networks: [moft]), (patients: [podg]), (asds relative: [cgab]), (normal controls: []), (druggable genetic targets: [diap]), (significant enrichment: [qnco]), (structural defects: []), (1.8-fold enrichment): [fndg]), (metabotropic glutamate receptor (grm) gfin: [aapp,rcpt]), (attention deficit hyperactivity disorder (adhd): [mobd]), (schizophrenia: [mobd]), (mxd-myc-max network: [popg]), (genes: [gngm]), (cancer: [euka]), ((p3.83e23: [gngm]), ( 2.5-fold enrichment): [qnco]), (calmodulin: [aapp,bacs]), ((calm1) gene interaction network (p4.16e04: [moft]), (enrichment): []), (voltage-independent calcium-activated action potentials: [celf]), (neuronal synapse: [bsoj]), (multiple defective gene family interactions: [famg]), (new translational opportunities: [genf]), (therapeutic interventions: [topp]), 
ASD Terms: (autism, 'Autism Phenotype')(defective gene family interaction networks, 'Interactions with Friends and Family')(impact attention deficit hyperactivity disorder, 'Overactivity')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(multiple defective gene family interactions, 'Interactions with Friends and Family')

PMCID: 4489335
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (basis: [phsu]), (behavioral symptoms: [sosy]), (cognitive abilities: [menp]), (individuals: [humn]), (asd: [cgab]), (seventy-eight high-functioning male: [orga]), (half: [qnco]), (half without: [qnco]), (tasks: []), (iq: []), (broad range: [qnco]), (cognitive skills: [inbe]), (comorbid symptomatology: []), (aims: [phsu]), (study: [resa]), (first: [qnco]), (significant differences: [qnco]), (cases: [qnco]), (controls: [sbst]), (cognitive tasks: []), (cognitive profiles: [lbpr]), (multivariate classification method: [lbpr]), (data: [euka]), (multiple cognitive tasks: [qnco]), (groups: [popg]), (second: [qnco]), (cognitive skill level: [phsu]), (degree: [qnco]), (autistic symptom severity: [mobd]), (third: [qnco]), (comorbid psychopathology: []), (fourth: [qnco]), (cognitive characteristics: []), (asperger syndrome (as): [mobd]), (high-functioning autism (hfa): [mobd]), (compared: [acty]), ( asd: [cgab]), (control groups: [grup]), (social cognition: [socb]), ( motor performance: [orgf]), (executive function (p's: [menp]), (variables: []), (support vector machine (svm): [qnco]), (good classification accuracy (81%): []), (level: [phsu]), (chance (p: [aapp,imft]), (multiple correlations: [qnco]), (significant associations: [menp]), (cognitive performance: [inbe]), (severity: []), (as: []), (hfa groups: [dsyn]), (cognitive classification models: []), (useful aid: [gngm]), (diagnostic process: [phpr]), (conjunction: []), (other data: [euka]), (clinical history: [orga]), (autism res: [mobd]), (international society: [orgt]), (autism research: [mobd]), ( wiley periodicals: []), ( inc: []), 
ASD Terms: (asperger, 'Asperger Syndrome')(autism spectrum disorder, 'Autism Phenotype')(cognitive abilities, 'Cognitive Ability')(asperger syndromed, 'Asperger Syndrome')(cognitive skills, 'Cognitive Ability')(comorbid symptomatology, 'Comorbidities')(cognitive tasks, 'Cognitive Ability')(cognitive profiles, 'Cognitive Ability')(multiple cognitive tasks, 'Cognitive Ability')(autistic symptom severity, 'Complaints and Indications')(cognitive skill level, 'Cognitive Ability')(comorbid psychopathology, 'Comorbidities')(cognitive characteristics, 'Cognitive Ability')(asperger syndrome, 'Asperger Syndrome')(high-functioning autism, 'Autism Phenotype')(social cognition, 'Cognitive Ability')(asperger syndromed, 'Asperger Syndrome')(executive function, 'Executive Function')(cognitive performance, 'Cognitive Ability')(asperger syndrome, 'Asperger Syndrome')(high-functioning autism groups, 'Autism Phenotype')(cognitive classification models, 'Cognitive Ability')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 4184868
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (males: [orga]), (rise: []), (idea: []), (influence: []), (steroid hormones: [horm,orch]), (early fetal brain development: [phsf]), (important early biological risk factor: [qnco]), (danish historic birth cohort: [qnco]), (danish psychiatric central register: [lbpr]), (amniotic fluid samples: [bdsu]), (icd-10: []), ((international classification: []), (diseases: [dsyn]), (revision) diagnoses: [fndg]), ( asperger syndrome: [mobd]), (pdd-nos: [dsyn]), ((pervasive developmental disorder: [mobd]), (specified) (n=128): [aapp,imft]), (controls: [sbst]), (concentration levels: [menp]), (4 sex steroids: [orgf]), (17-hydroxy-progesterone: [horm,orch,phsu]), ( androstenedione: [horm,orch,phsu]), (testosterone): [horm,orch,phsu]), (cortisol: [horm,orch,phsu]), (liquid chromatography tandem mass spectrometry: [lbpr]), (hormones: [horm]), (principal component analysis: [qnco]), (latent: []), (steroidogenic factor: [moft]), (variation: []), (data: [euka]), (autism group: [mobd]), (elevations: []), (steroidogenic factor (cohen's d=0.37: [fndg]), ( p=0.0009): [fndg]), (elevation: [topp]), (diagnostic label: [fndg]), (results: [fndg]), (first direct evidence: [qnco]), (elevated fetal steroidogenic activity: [orgf]), (such elevations: []), (epigenetic fetal programming mechanisms: [biof]), (other important pathophysiological factors: [patf]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(asperger syndrome, 'Asperger Syndrome')(asperger syndrome, 'Asperger Syndrome')(autism group, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4047885
SFARI Genes: GRIN1, ERK, GRIN1, ERK, APBB1, APBB1, ERK, ERK, 
Non SFARI Genes: MAP3K1, PSEN2, 
Named Entities: (autism: [mobd]), (alzheimer's disease (ad): [dsyn]), (degenerative diseases: [dsyn]), (epidemiological burden: []), (ad-associated amyloid- precursor protein-: [aapp]), (severe autism: [fndg]), (anabolic hypothesis': [orch,phsu]), (etiology: []), (focused microarray analysis: [lbpr]), (genes: [gngm]), (notch: [bsoj]), (wnt: []), (cascades: []), (ad: []), (apoptosis pathways: [celf]), (cerebellar samples: [bpoc]), (autistic individuals: [mobd]), (further evidence: []), (pathological relevance: []), (limma package: [qnco]), (r: [clna]), (false discovery rate: [qnco]), (pathways: [moft]), (significant changes: [qnco]), (expression: [topp]), (p-values <0.05): [qnco]), (mitochondria-related genes: [gngm]), (upregulation: [genf]), (grin1: [gngm]), (channel-forming subunit: [aapp]), (nmda glutamate receptors: [aapp,rcpt]), (map3k1: [gngm]), ( known activator: []), (jnk: [gngm]), (erk pathways: [moft]), (anti-apoptotic effect: [celf]), (psen2 (presinilin: [gngm]), (apbb1 (or f65): [gngm]), (control samples: []), (results: [fndg]), (model: []), (nmda: [aapp,bacs,phsu]), (receptor-mediated erk activation: [aapp,enzy]), (-secretase activity: [aapp,enzy]), (mitochondrial adaptation: [celc]), (early brain overgrowth: [bpoc]), (disruption: []), (synaptic plasticity: [ortf]), (connectome: [anst]), (finally: []), ( systems pharmacology analyses: []), (highlighted magnesium (mg2+): [elii]), (rapamycin: [antb,orch]), (efficient drugs: [topp]), (network model: [popg]), (silico: []), (potential therapeutic application: [qnco]), (context: [fndg]), 
ASD Terms: (autism, 'Autism Phenotype')(severe autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(mitochondrial adaptation, 'Adaptive Life Skills')(autism, 'Autism Phenotype')

PMCID: 4022403
SFARI Genes: 
Non SFARI Genes: IV, Star, 
Named Entities: (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (regressive autism: [mobd]), ((r-asd).they show: [cgab]), (normal early development: [fndg]), (loss: [qnco]), (language: [lang]), (social skills: [socb]), (absent evidence-based therapies: [topp]), (anecdotal evidence: []), (improvement: []), (use: []), (corticosteroids: [horm,orch,phsu]), (study: [resa]), (effects: []), (r-asd children: [cgab]), (hz frequency: [qnco]), (evoked response (fmaer): [fndg]), (language cortex: [bpoc]), (superior temporal gyrus (stg): [bpoc]), (eeg background activity: [diap]), ( language: [lang]), (behavior: [inbe]), (untreated clinical convenience sample: [resa]), (asd children: [cgab]), (control sample: [sbst]), (steroid-treated r-asd (star): [cgab]), (not-treated asd patients: [cgab]), (years: []), (large database: [qnco]), (study participants: [humn]), (sequential fmaer: []), (eeg: [diap]), (studies;landau-kleffner syndrome diagnosis: [mobd]), (subjects records: [qnco]), (clinical receptive: [ortf]), (expressive language ratings: [lang]), (priori: []), (metrics: [orch,phsu]), (star group: [popg]), (symptom severity: [fndg]), (diagnostic: [fndg]), (statistical manual iv: [inpr,mnob]), ((dsm-iv) asd criteria list: [cgab]), (eegs: [diap]), (abnormalities: [cgab]), (fmaer responses: [orga]), (spectral analysis: [resa]), (untreated group: [popg]), (standard deviations: [qnco]), (fmaer: []), ( eeg: [diap]), (fishers: [mamm]), (tests: [lbpr]), (significant increase: [qnco]), (hz fmaer: [qnco]), (spectral response: [fndg]), (significant reduction: [npop]), (response distortion: [anab]), (nsa group: [popg]), (language ratings: [lang]), (star: [gngm]), (significant language improvement: [lang]), (star group children: [aggp]), (significant behavioral improvement: [inbe]), (treatment: [topp]), (star group language: [lang]), (behavior improvement: [inbe]), (year: []), (groups: [popg]), (terms: [orgf]), (minor eeg abnormalities: [popg]), (steroid treatment: [topp]), (lasting morbidity: [qnco]), (fmaer response magnitude: [qnco]), ( reduction: [npop]), (fmaer response distortion: [anab]), (behavior scores: [inbe]), (non-treated group: [popg]), (pilot findings: [clna]), (validation trial: [resa]), (r-asd: [cgab]), (utilizing fmaer: []), (asd: [cgab]), (behavior measures: [inbe]), (follow-up period: [hlca]), (please: []), (related article http://www.biomedcentral.com/1741-7015/12/79: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(regressive autism .they, 'Autism Phenotype')(social skills, 'Ability to Converse in Social Settings')(landau-kleffner syndrome diagnosis, 'Diagnosis')(expressive language ratings, 'Expressive Language')(significant language improvement, 'Language Development')(improvement in language, 'Language Development')

PMCID: 4011843
SFARI Genes: 
Non SFARI Genes: LSG1, FAM43A, 
Named Entities: (mathematical ability: [menp]), (few studies: [lbpr]), (molecular genetic basis: [phsu]), (specific genetic contributions: [acty]), (variation: []), (genome wide association: [menp]), (pooled dna: [bacs,nnon]), (groups: [popg]), (u.k. samples: [sbst]), (end: [gngm]), (secondary/high school: [neop]), (national academic exam: [hlca]), (high (n =: [qnco]), (versus: []), (low (n =: [qnco]), (verbal ability: [menp]), (significant differences: [qnco]), (allele frequencies: [qnco]), (snps: [nusq]), (affymetrix genechip human mapping version: [humn]), (array: []), (threshold: []), (p<1.5105: [aapp,imft]), (association analysis: [menp]), (participants: [popg]), (initial associations: [menp]), (106): []), (snps (rs789859): [nusq]), (significant association: [menp]), (bonferroni correction: []), ((rs10873824: []), ( rs4144887: []), ( rs12130910 rs2809115): []), (interest: [menp]), (within: []), (genes (fam43a: [gngm]), ( sft2d1: [gngm]), ( c14orf64): []), (snp: [nusq]), (association: [menp]), ( rs789859: []), (region: []), (chromosome: [celc]), (difficulties: [fndg]), (autism: [mobd]), (rs789859: []), (kbp downstream: [aapp,enzy,rcpt]), (lsg1: [gngm]), (bp upstream: [gngm]), (fam43a: [gngm]), (potential promoter/regulatory region: [bacs,nnon]), (latter: []), (knowledge: []), (second study: [resa]), (genetic variants: [npop]), (number: [qnco]), (interesting markers: [clna]), (future study: [resa]), 
ASD Terms: (mathematical ability, 'Numeracy')(variation in mathematical ability, 'Numeracy')(low mathematical ability, 'Numeracy')(autism, 'Autism Phenotype')

PMCID: 4140467
SFARI Genes: Kir2.1, Kir2.1, KCNJ2, Kir2.1, KCNJ2, Kir2.1, Kir2.1, Kir2.1, 
Non SFARI Genes: 
Named Entities: (short qt3 syndrome (sqt3s): [dsyn]), (cardiac disorder: [dsyn]), (high risk: [fndg]), (mortality: [qnco]), (mutations: [genf]), (kir2.1 (kcnj2) channels: [gngm]), (molecular mechanisms: []), (dysfunction: [dsyn]), ( cardiac rhythm disturbances: [fndg]), (neurodevelopmental disorders: [mobd]), (sqt3s: [dsyn]), (here: []), (monozygotic twins: [famg]), (short qt interval: [fndg]), (electrocardiogram recordings: [fndg]), (autismepilepsy phenotype: [orga]), (genetic screening: [fndg]), (novel kcnj2 variant: [gngm]), (kir2.1: [gngm]), ((i): [inch]), (channel's surface expression: [topp]), (stability: []), (plasma membrane: [celc]), ( (ii): []), (protein ubiquitylation: [moft]), (degradation: [orgf]), ( (iii): []), (protein compartmentalization: [aapp,bacs]), (lipid rafts: [orch]), (channels: []), (cholesterol-poor domains: [bacs,orch]), ((iv): []), (interactions: []), (caveolin: [aapp,bacs]), (importantly: []), (study reveals: [resa]), (physiological mechanisms: []), (wild-type kir2.1 channel processing: [aapp,bacs]), (cell: [gngm]), (binding: [moft]), (protein degradation: [moft]), (ubiquitinproteasome pathway;: [moft]), (addition: []), (potential multifunctional site: [blor]), (kir2.1 surface expression: [topp]), (rafts: []), (mechanisms: []), (crucial: []), (proper astrocyte function: [phsf]), (need: []), (neuropsychiatric evaluation: [hlca]), (patients: [podg]), (new opportunities: []), (disease management: [hlca]), 
ASD Terms: (cardiac rhythm disturbances, 'Cardiovascular Diseases')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 4038115
SFARI Genes: CACNA1C, CACNA1C, 
Non SFARI Genes: 
Named Entities: (long-qt syndrome (lqts): [dsyn]), (prolongation: []), (qt-interval: [clna]), (ecg: [diap]), (life: []), (tachyarrhythmia: [fndg]), (ventricular fibrillation: [dsyn]), (atypical form: [fndg]), (lqts: []), ( timothy syndrome (ts): [dsyn]), (syndactyly: [cgab]), ( immune deficiency: [dsyn]), ( cognitive: []), (neurological abnormalities: [cgab,dsyn]), (distinct cranio-facial abnormalities: [cgab]), (case presentation: []), (family: [famg]), (children: [aggp]), (clinical lqts: []), (whole exome: [gngm]), (causative mutations: [genf]), (targeted candidate gene panel screen: [hlca]), (long-qt syndrome target genes: [dsyn]), (underlying genetic defect: [cgab]), (exome sequencing: [mbrt]), (affected children: [aggp]), (p.402g > s mutation: [genf]), (cacna1c: [gngm]), (voltage-dependent ca2+ channel: [elii,phsu]), (mutation: [genf]), (father: [famg]), (mosaic mutation carrier: [humn]), (molecular finding: [sosy]), (careful clinical examination: [hlca]), (diagnosis: [fndg]), (timothy: [plnt]), (syndrome (ts2): [dsyn]), (thereby: []), (new therapeutic approaches: [topp]), (study: [resa]), (difficulties: [fndg]), (accurate diagnosis: [fndg]), (patients: [podg]), (rare diseases: [dsyn]), (atypical clinical manifestation: [fndg]), (such challenge: [hlca]), (help: []), (unbiased mutation screening: [genf]), 
ASD Terms: (neurological abnormalities, 'Neurologic Indications')(cognitive, 'Cognitive Ability')(diagnosis, 'Diagnosis')(accurate diagnosis, 'Diagnosis')

PMCID: 4031262
SFARI Genes: CHD8, MECP2, HUWE1, CHD8, MECP2, HUWE1, 
Non SFARI Genes: 
Named Entities: (schizophrenia: [mobd]), (serious psychiatric disorder: [fndg]), (undiscovered genetic etiology: [topp]), (recent studies: [lbpr]), (mutations: [genf]), (autism: [mobd]), (hypothesis: []), (rare genetic variation contributes: [npop]), (trios: [aapp,enzy]), (familial schizophrenia: [famg]), (sporadic trios: [aapp,enzy]), (~3.5-fold increase: [qnco]), (proportion: [qnco]), (nonsense: [comd]), ((0.101: [fndg]), (empirical p=0.01: [fndg]), ( bh-corrected p=0.044): [fndg]), (genes: [gngm]), (ranked probabilities: [qnco]), (haploinsufficiency (p=0.0029: [comd]), (p=0.006): [fndg]), (dnms: []), (potential functional consequence: []), (variation (p=2.01105: [orch,phsu]), (p =2.1103): [orch,phsu]), (autism (e.g: [mobd]), (auts2: [gngm]), ( cdh8: [gngm]), ( mecp2): [aapp,bacs]), (intellectual disability (id) (e.g: [mobd]), (huwe1: [gngm]), (trappc9): [gngm]), (genetic etiology: [topp]), (disorders: [dsyn]), (chd8: [gngm]), ( mecp2: [aapp,bacs]), (huwe1 converge: [acty]), (epigenetic regulation: [biof]), (transcription: [genf]), (important risk mechanism: []), (results: [fndg]), (analysis: [resa]), (additional exome: [gngm]), (studies: [lbpr]), (other neurodevelopmental disorders: [mobd]), (findings: [clna]), (perturbations: []), (function: [phsf]), (brain development: [ortf]), (cognition: [menp]), (central role: [socb]), (susceptibility to: [clna]), ( pathogenesis: [patf]), (treatment: [topp]), (mental disorders: [mobd]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(serious psychiatric disorder, 'Mental Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(familial schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(intellectual disability, 'Learning Disorders')(other neurodevelopmental disorders, 'Learning Disorders')(cognition, 'Cognitive Ability')(mental disorders, 'Mental Disorders')

PMCID: 4411356
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd) refers: [mobd]), (group: [popg]), (childhood: []), (neurodevelopmental disorders: [mobd]), (polygenic etiology: [genf]), (expression: [topp]), (many genes: [gngm]), (asd: [cgab]), (various factors: [phsu]), (micrornas: [bacs,nnon]), (class: []), (rnas 22 nucleotides: [nnon]), (length: [qnco]), (function: [phsf]), (translation: [moft]), (mirna recognition elements (mres) present: [bacs,nnon]), (region (3utr): []), (target mrnas: [bacs,nnon]), (role: [socb]), (mirnas: [bacs,nnon]), (neurogenesis: [orgf]), ( brain development: [ortf]), (differentiation: [celf]), (perturbations: []), (regulatory mechanism: []), (processes: [phpr]), (well: []), (recently: []), ((snps) present: [nusq]), (mrnas: [bacs,nnon]), (mres: []), (new mres: []), (snps: [nusq]), (mirna-mediated gene regulation: [bacs,nnon]), (aberrant expression: [topp]), (autism-implicated genes: [gngm]), (disease predisposition: [clna]), (pathogenesis: [patf]), (subpopulation: [popg]), (asd individuals: [cgab]), (systematic computational pipeline: [acty]), (data: [euka]), (well-established databases: []), (stringent selection criterion: [genf]), (mre-modulating snps: [nusq]), (mre-creating snps: [nusq]), (high-confidence candidate snps: [nusq]), (roles: [socb]), (further functional validation: [resa]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder refers, 'Autism Phenotype')

PMCID: 4134484
SFARI Genes: 
Non SFARI Genes: ENO2, ENO2, ENO2, ENO2, ENO2, ENO2, 
Named Entities: (dysregulation: []), (brain-expressed genes: [gngm]), (mechanism: []), (autism: [mobd]), (differential methylation: [moft]), (cpg sites: [bacs,nnon]), (gene promoters: [gngm]), (candidate biomarkers: [clna]), (early clinical screening: [diap]), (total: [qnco]), (pairs: []), (control subjects: [sbst]), (study: [resa]), (peripheral blood cells: [cell]), (array-based genome-wide methylation studies: [moft]), (neuron-specific gene: [gngm]), ( eno2: [gngm]), (autistic samples: [mobd]), (difference: [qnco]), (pcr (bsp): [irda,orch,phsu]), (differential expression: [topp]), (eno2 gene: [gngm]), (rt-qpcr: [mbrt]), (elisa: [lbpr]), (hypermethylation: [genf]), (eno2: [gngm]), (promoter region: [bacs,nnon]), (bsp: [gngm]), (% (19/131): []), (mean eno2 rna level: [nnon]), (%: []), (controls: [sbst]), (average level: [phsu]), (eno2 protein expression: [genf]), (g/l): [qnco]), (half: [qnco]), (controls (33.86: [sbst]), (conclusion:: []), (findings: [clna]), (eno2 expression: [topp]), (biomarker: [clna]), (subset: []), (autistic children: [podg]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s00431-014-2311-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3996516
SFARI Genes: 
Non SFARI Genes: Gc, Gc, Gc, Gc, Gc, 
Named Entities: (immune system dysregulation: [fndg]), (autism: [mobd]), (part: [qnco]), (etiology: []), (disorder: [dsyn]), (endocannabinoid system: [bacs,orch]), (key regulator: []), (immune system: [bdsy]), (cannabinoid receptor type: [aapp,rcpt]), ((cb2r): []), (macrophages: [cell]), (microglial cells: [cell]), (significant differences: [qnco]), (peripheral blood mononuclear cell cb2r gene expression: [genf]), (autism population: [mobd]), (use: []), (gc: [gngm]), (protein-derived macrophage activating factor: [imft,orch]), (endogenous glycosylated vitamin d: [orch,phsu,vita]), (protein: [aapp,bacs]), (macrophage cell activation: [celf]), (positive effects: [fndg]), (treatment: [topp]), (autistic children: [podg]), (current study: [resa]), (vitro effects: []), (gcmaf treatment: [aapp,phsu]), (endocannabinoid system gene expression: [genf]), (cellular activation: [celf]), (blood: [bdsu]), (monocyte-derived macrophages: [cell]), (autistic patients: [mobd]), (controls: [sbst]), (goals: []), (immunocytochemical methods: []), (observed differences: [qnco]), (dysregulated gene expression: [genf]), (autism group: [mobd]), (gcmaf: [aapp,phsu]), (over-activation: [acty]), (bmdms: []), (study: [resa]), (first observations: [hlca]), (gcmaf effects: [aapp,phsu]), (transcriptionomics: []), (expression: [topp]), (cb2r protein: [aapp,bacs]), (data point: [euka]), (potential nexus: [bsoj]), (endocannabinoids: [bacs,orch]), ( vitamin d: [orch,phsu,vita]), (transporter proteins: [aapp,bacs]), (immune dysregulations: [fndg]), 
ASD Terms: (autism, 'Autism Phenotype')(autism population, 'Autism Phenotype')(endogenous glycosylated vitamin d, 'Dietary Supplements')(autism group, 'Autism Phenotype')(vitamin d, 'Dietary Supplements')(vitamin d, 'Dietary Supplements')

PMCID: 3988108
SFARI Genes: SMARCA2, DPP10, ARNT2, AHI1, ZNF804A, SMARCA2, DPP10, ARNT2, AHI1, ZNF804A, SMARCA2, ARNT2, SMARCA2, ARNT2, 
Non SFARI Genes: NGFR, impact, 
Named Entities: (schizophrenia (sz): [mobd]), (autism spectrum disorders: [mobd]), (heritable neuropsychiatric disorders: [dsyn]), (environmental factors: []), (maternal immune activation (mia): [acty]), (role: [socb]), (well: []), (cytokines: [aapp,imft]), (effects: []), (mia: [gngm]), (neurogenesis: [orgf]), (behavior: [inbe]), (animal models: [anim]), (however: []), ( mia stimulators: [gngm]), (febrile reaction: [patf]), (independent effects: [fndg]), (heat shock: [phsf]), ((hs)-regulated cellular stress pathways: [moft]), (fever: [fndg]), (model: []), (human brain development: [ortf]), (pluripotent stem cells: [cell]), ((ipscs) differentiate: []), (3-dimensional neuronal aggregates: [imft]), (first trimester telencephalon: [bpoc]), (rna-seq: [nusq]), (aggregates: []), (heat: [npop]), (hours: []), (control partners: [popg]), (genes: [gngm]), (significant differences: [qnco]), (expression: [topp]), (hs (p<0.05): [fndg]), (hs-inducible genes: [gngm]), (expected: []), (ngfr: [gngm]), (number: [qnco]), (sz: [sosy]), (asd: [cgab]), (smarca2: [gngm]), ( dpp10: [gngm]), ( arnt2: []), ( ahi1: [gngm]), (znf804a: [gngm]), (degree: [qnco]), (genes decrease: [gngm]), (increase: []), (hs: [gngm]), (copy loss: [qnco]), (copy gain copy number variants: [nusq]), (dramatic effect: []), (asd genes places hs: [cgab]), (other cellular stressors: [cell]), (common conceptual framework: [qnco]), (disease-causing genetic variants: [npop]), (findings: [clna]), (candidate genes: [gngm]), (limited impact: [gngm]), (asd pathogenesis: [cgab]), (small number: [qnco]), (positive genetic findings: [fndg]), (arnt2: [gngm]), (fact: [gngm]), (substantial role: [socb]), (disorders: [dsyn]), (targets: [diap]), (common environmental stressors: [fndg]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorders, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 3996537
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (risk: []), (autism spectrum disorders: [mobd]), (hundreds: []), (genetic loci: [gngm]), (convergence: [acty]), (asd variants: [cgab]), (protein interactions: [moft]), (literature: [inpr,mnob]), (however: []), (datasets: []), (incomplete: [qnco]), ( carry biases: [acty]), (interactions: []), (single splicing isoform: [fndg]), (disease-relevant tissue: [dsyn]), (new interactome mapping approach: [acty]), (spliced variants: []), (asd risk factors: [qnco]), (autism spliceform interaction network reveals: [popg]), (half: [qnco]), (detected interactions: [fndg]), (partners: [popg]), (represent contribution: [acty]), (variants: []), (importance: []), (isoform networks: [aapp]), (isoform interactions: [aapp]), (direct physical connections: [hlca]), (proteins: [aapp,bacs]), (autism cnvs: [nusq]), (findings: [clna]), (critical role: [socb]), (spliceform networks: []), (genetic knowledge: [topp]), (understanding: [menp]), (human diseases: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism spliceform interaction network reveals, 'Autism Phenotype')(autism cnvs, 'Autism Phenotype')

PMCID: 3979738
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent functional magnetic resonance: [npop]), ((fmri) studies: [diap]), (autism: [mobd]), (spectrum condition (asc): [dsyn]), (dysfunctions: [dsyn]), (specific brain networks: [bpoc]), (non-social cognition: [socb]), (persist: []), (adulthood: []), (numbers: [qnco]), (fmri studies: [diap]), (atypical functional connectivity: [fndg]), (adult asc brain: [bpoc]), (such functional alterations: []), (network level: [popg]), (graph-theoretical framework: []), (here: []), (graph-theoretical analysis: [resa]), (resting-state fmri data: [diap]), (adults: [aggp]), (asc: [gngm]), (gender-matched controls: [orga]), (topological properties: []), (organization: [orgt]), (autistic brain network: [popg]), (analyses: [resa]), (global metrics: [orch,phsu]), (controls: [sbst]), ( participants: [popg]), (significant decreases: [qnco]), (coefficient: [qnco]), (characteristic path length: [qnco]), (shift towards: [phpr]), (furthermore: []), ( analyses: [resa]), (local metrics: [orch,phsu]), (hub nodes: [bpoc]), (hub disruption indices: [lbpr]), (multiple local metrics: [orch,phsu]), (loss: [qnco]), (hubness: []), (several nodes: [fndg]), (bilateral superior temporal sulcus: [bsoj]), (dorsolateral prefrontal cortex: [bpoc]), (precuneus): [bpoc]), (non-social cognitive functions: [menp]), (particular: []), ( local metrics: [orch,phsu]), (anterior cingulate cortex: [bpoc]), (significant negative correlations: [fndg]), (autism-spectrum quotient score: [clna]), (results: [fndg]), (altered patterns: []), (local topological properties: []), 
ASD Terms: (autism spectrum condition, 'Autism Phenotype')(non-social cognition, 'Cognitive Ability')(adult autism, 'Autism Phenotype')(autism spectrum condition, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism spectrum condition, 'Autism Phenotype')(non-social cognitive functions, 'Cognitive Ability')(autism spectrum condition, 'Autism Phenotype')(non-social cognition, 'Cognitive Ability')

PMCID: 4025040
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objective:: []), (association: [menp]), (kawasaki disease: [dsyn]), (autism: [mobd]), (asian populations: [popg]), (nationwide taiwanese population-based claims: [popg]), (hypothesis: []), (risk: []), (taiwan: []), (materials: [sbst]), (methods:: []), (study cohort: [popg]), (patients: [podg]), (diagnosis: [fndg]), (kawasaki: []), ((n: [aapp,imft]), (comparison cohort: [popg]), (gender-matched control patients: [orga]), (patient: [podg]), (subjects: [humn]), (years: []), (date: []), (cohort entry: [popg]), ((icd-9-cm code: []), (not: []), (cox: [gngm]), (proportional hazard regressions: [menp]), (5-year autism-free survival rates: [qnco]), (results:: [fndg]), (main finding: [sosy]), (study: [resa]), (increased risk: [qnco]), (5-year follow-up period: [hlca]), (kawasaki disease patients: [dsyn]), (adjusted hazard ratios: [qnco]), (confidence interval:: [qnco]), (p: [gngm]), (statistical significance: [qnco]), (kawasaki disease group: [dsyn]), (control group: [grup]), (5-year follow-up: [hlca]), (conclusion:: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')

PMCID: 3977681
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (autoimmune phenomena: [phpr]), (individuals: [humn]), (autism: [mobd]), (presence: [qnco]), (inappropriate immune responses: [ortf]), (disorder: [dsyn]), (role: [socb]), (nucleosome: [aapp,bacs]), (induction: [topp]), (antibody response: [biof]), (autoimmune-mediated tissue damage: [inpo]), (novel targets: [diap]), (treatment: [topp]), (paucity: []), (studies: [lbpr]), (frequency: [qnco]), (systemic auto-antibodies: [aapp,imft]), (antinucleosome-specific antibodies: [lbpr]), (group: [popg]), (autistic children: [podg]), (serum: [bdsu]), (elisa: [lbpr]), (ages: [bacs,orch]), (years: []), (comparison: [acty]), (healthy children: [fndg]), (autistic severity: [mobd]), (childhood autism rating scale (cars): [mobd]), (serum antinucleosome-specific antibodies: [bdsu]), (<0.001): [fndg]), (seropositivity: []), (family history: [fndg]), (autoimmunity (40%): [patf]), (patients: [podg]), (history (22.2%: [orga]), ( p <0.001): [fndg]), (serum levels: [bdsu]), (however: []), (data: [euka]), (caution: []), (further investigations: [hlca]), (subject population: [popg]), (antibodies: [aapp,imft]), (autoimmunity: [patf]), (subgroup: [virs]), (immunotherapy: [topp]), (children: [aggp]), 
ASD Terms: (autism, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3972136
SFARI Genes: Kit, Kit, ATRX, ATRX, 
Non SFARI Genes: L1CAM, USP9X, 
Named Entities: (developmental delay: [mobd]), (intellectual disability (dd/id): [mobd]), (children: [aggp]), (half: [qnco]), (genetic etiology: [topp]), (recent studies: [lbpr]), (targeted gene panel: [gngm]), (diagnostic testing: [diap]), (heterogeneous conditions: [fndg]), (experiences: [menp]), (parallel sequencing: [mbrt]), (genes: [gngm]), (patients: [podg]), (wide range: [qnco]), (phenotypes: [orga]), (dd/id: [lbpr]), (congenital anomalies: [cgab]), (autism spectrum disorder: [mobd]), (sequence enrichment: [nusq]), (agilent sureselect target enrichment kit: [aapp,imft,rcpt]), (illumina hiseq2000: []), (paired-end reads: [dora]), (targeted regions: []), (read depths: [dora]), (average read depths: [dora]), (targets: [diap]), (causative variants: []), (patients:: [podg]), (nonsense mutation: [comd]), (atrx gene: [gngm]), (canonical splice site mutation: [genf]), (l1cam gene: [gngm]), (third patient: [podg]), (canonical splice site variant: [blor]), (usp9x gene: [gngm]), (clinical phenotypes: [orga]), (results: [fndg]), (value: [qnco]), (targeted mps: []), (diagnostic purposes: [fndg]), (however: []), (gene mps: [gngm]), (genetic diagnosis: [fndg]), (phenotype: [orga]), (autism: [mobd]), 
ASD Terms: (developmental delay, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(developmental delay and/or, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(intellectual disability in children, 'Learning Disorders')(genetic diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')

PMCID: 3965395
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders (asds): [mobd]), (childhood neurodevelopmental disorders: [mobd]), (complex genetic origins: [chvs]), (previous studies: [lbpr]), (role: [socb]), (copy number variants (cnvs): [nusq]), (micrornas: [bacs,nnon]), (distinct etiological factors: []), (asd: [cgab]), (novel computational procedure: [topp]), (potential pathogenic role: [socb]), (microrna genes: [gngm]), (cnvs: [nusq]), (asd patients: [cgab]), (chromosomes: [celc]), (actual number: [qnco]), (mirna loci: [bacs,nnon]), (patients: [podg]), (monte carlo simulation: [qnco]), (random cnv events: [nusq]), (mirna genes: [bacs,nnon]), (hsa-mir-4436b-2: [gngm]), (non-autistic subjects: [mobd]), (database: []), (genomic variants: [gngm]), (results: [fndg]), (study: [resa]), (first step towards: [qnco]), (full understanding: [menp]), (dysregulated expression: [topp]), (mirnas genes: [bacs,nnon]), (neurodevelopment: [ortf]), (autism: [mobd]), (procedure: [topp]), (cnvs/mirna genes association data: [bacs,nnon]), (other genomic disorders: [dsyn]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')(childhood neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')(copy number variants/mirna genes association data in other genomic disorders, 'Imitation')

PMCID: 3961203
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (copy number variations: [nusq]), (autism spectrum disorder (asd): [mobd]), (duplication: [comd]), (sequences: [nusq]), (duf1220 protein: [aapp,bacs]), (dosage: [qnco]), (increased human brain size: [qnco]), (further: []), ( individuals: [humn]), (asd: [cgab]), (brain growth: [orgf]), (brain size: [qnco]), (increased symptom severity: [fndg]), (relationship: []), (duf1220: []), (number: [qnco]), (asd severity: [cgab]), (individuals: [humn]), (asd (n: [cgab]), (copy number (dosage): [qnco]), (duf1220 subtype con1: [gngm]), (copies: []), (gaussian distribution: [qnco]), (remarkably: []), (asd con1 copy number: [cgab]), (linearly associated: []), (dose-response manner: [resa]), (increased severity: [qnco]), (primary symptoms: [sosy]), (asd:: [cgab]), (social deficits: []), (communicative impairments: [mobd]), (repetitive behaviors: [fndg]), (data: [euka]), (domain (con1) dosage: [qnco]), (asd-wide effect and: [cgab]), (such: []), (key component: []), (major pathway: [moft]), (finally: []), (findings: [clna]), (unexamined: []), ( copy number: [qnco]), (brain: [bpoc]), (evolution-related gene: [gngm]), (sequence: [nusq]), (important new direction: []), (further research: [resa]), (genetic factors: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(primary symptoms of asd, 'Complaints and Indications')(social deficits, 'Social Competence')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 3961190
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (exome sequencing: [mbrt]), (pathogenic nonsynonymous single nucleotide variants: [fndg]), (diseases: [dsyn]), (however: []), (traditional statistical genetics methods: [resa]), (exome sequencing data: [euka]), (such facts: []), (large number: [qnco]), (presence: [qnco]), (non-negligible fraction: [qnco]), (pathogenic rare variants: [fndg]), (novo mutations: [genf]), (limited size: [fndg]), (normal populations: [popg]), (indeed: []), ( prevalent applications: [qnco]), (effective computational method: [resa]), (causative nonsynonymous snvs: []), (sequenced variants: [npop]), (here: []), (bioinformatics approach: []), (spring (snv prioritization: []), (integration: [genf]), (genomic data): [gngm]), (pathogenic nonsynonymous snvs: [fndg]), (query disease: [dsyn]), (functional effect scores: [clna]), (methods (sift: []), ( polyphen2: []), ( lrt: [blor]), ( mutationtaster: []), ( gerp: [gngm]), (phylop): []), (association scores: [menp]), (variety: []), (genomic data sources (gene: [gngm]), (protein-protein interactions: [moft]), ( protein: [aapp,bacs]), (domain annotations: []), (gene: [gngm]), (annotations): []), ( spring: []), (statistical significance: [qnco]), (snv: []), (hence: []), (means: []), (candidate snvs: []), (series: [qnco]), (comprehensive validation: [resa]), (spring: [gngm]), (genetic bases: [chvf]), (inheritance styles: [qnco]), (applications: [hlca]), (method: [lbpr]), (real exome sequencing data sets: [mbrt]), (capability: []), (mutations: [genf]), (autism: [mobd]), ( epileptic encephalopathies: [dsyn]), (intellectual disability: [mobd]), (online: []), (standalone software: [inpr,mnob]), (genome-wide predictions: [gngm]), (causative snvs: []), (http://bioinfo.au.tsinghua.edu.cn/spring: [dsyn]), 
ASD Terms: (autism, 'Autism Phenotype')(epileptic encephalopathies, 'Epilepsy')(epileptic encephalopathies, 'Epilepsy')(intellectual disability, 'Learning Disorders')

PMCID: 3952819
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (many factors: []), (risks: []), (neurodevelopmental maladies: [ortf]), (autism spectrum disorders: [mobd]), (intellectual disability (id): [mobd]), (state-policy factors: []), (unified geospatial framework: []), (spatial incidence patterns: [qnco]), (asd: [cgab]), (id: [lbpr]), (insurance claims: []), (third: [qnco]), (us population: [popg]), (epidemiologic evidence: []), (rate: [qnco]), (congenital malformations: [cgab]), (reproductive system: [bdsy]), (surrogate: [famg]), (environmental exposure: [inpo]), (parents: []), (unmeasured developmental risk factors: [qnco]), (toxins: [bacs,hops]), (gender: [orga]), ( ethnic: [popg]), ( socioeconomic: []), (geopolitical factors: []), (asd incidence rates: [cgab]), (population-normalized rates: [popg]), (males: [orga]), ((an increase: []), (asd incidence: [qnco]), (percent increase: [qnco]), (incidence: [qnco]), (ci:: [lbpr]), (p<6105): [aapp,imft]), (such congenital malformations: [cgab]), (id (94%: [lbpr]), (p: [gngm]), (other congenital malformations: [cgab]), (reproductive system): [bdsy]), (asd rate increase (ci:: [cgab]), (id rate increase (ci:: [lbpr]), (state-mandated rigor: [sosy]), (diagnosis: [fndg]), (pediatrician: []), (clinician: []), (consideration: [fndg]), (special education system: [edac]), (considerable decrease: [qnco]), (id incidence rates: [qnco]), (ci: [28%: [lbpr]), (p =: [aapp,imft]), (respectively): []), (observed spatial variability: [gngm]), (asd rates: [cgab]), (state-level regulatory factors;: []), (magnitude: [qnco]), (influence: []), (compound: [chem]), (environmental predictors: []), (times: [qnco]), (state-level incentives: []), (county-level random effects: [resa]), (marked spatial clustering: [resa]), (existence: []), (unidentified localized factors: []), (apparent disease incidence: [qnco]), (rates: [qnco]), (county level: [phsu]), ((pearson product-moment correlation: [qnco]), (females: [orga]), (correlation: []), ((0.197: [fndg]), ( p<2.261016): [orch,phsu]), 
ASD Terms: (neurodevelopmental maladies, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(rate of congenital malformations, 'Congenital Abnormalities')(environmental exposure, 'Exposures')(congenital malformations, 'Congenital Abnormalities')(population-normalized rates of congenital malformations, 'Congenital Abnormalities')(such congenital malformations, 'Congenital Abnormalities')(intellectual disability (94%, 'Learning Disorders')(other congenital malformations in males, 'Congenital Abnormalities')(other congenital malformations, 'Congenital Abnormalities')(intellectual disability rate increase (ci, 'Learning Disorders')(diagnosis, 'Diagnosis')(intellectual disability incidence rates, 'Learning Disorders')

PMCID: 3951190
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (seizures: [sosy]), (common phenotype: [orga]), (many neurodevelopmental disorders: [mobd]), (fragile x: [comd]), (down syndrome: [cgab,dsyn]), (autism: [mobd]), (phytoestrogens: [horm,orch,phsu]), (soy-based infant formula: [fndg]), (seizure threshold: [fndg]), (disorders: [dsyn]), (herein: []), (dependence: [menp]), (seizure incidence: [qnco]), (infant formula: [fndg]), (population: [popg]), (autistic children: [podg]), (medical record data: [euka]), (sfari simplex collection: [bpoc]), (autism diagnosis: [mobd]), (scores: [clna]), (adi-r: [clna]), (ados: [aapp,enzy]), (database: []), (data: [euka]), (use: []), ( seizure: [sosy]), (specific type: [qnco]), (seizure: [sosy]), (iq: []), (soy-based formula: [aapp,phsu]), (study population: [popg]), (females: [orga]), (subjects: [humn]), (rate: [qnco]), (febrile seizures: [dsyn]), (or: []), (ci: [gngm]), (epilepsy comorbidity [3.6% versus: [dsyn]), (simple partial seizures: [dsyn]), (significant associations: [menp]), (other outcomes: []), ( age: [orga]), (seizure onset: [qnco]), (infantile spasms: [dsyn]), (tonic clonic: [phsu]), ( absence: [anab]), (complex partial seizures: [dsyn]), (limitations: []), (study included: infant formula: [fndg]), (seizure data: [sosy]), (parental recall: [menp]), (female subjects: [orga]), (lack: []), (critical confounders: []), (reasons: []), (soy formula: [aapp,phsu]), (formula: []), (length: [qnco]), (time: []), (results: [fndg]), (genders: [orga]), (diagnosis: [fndg]), (epilepsy: [dsyn]), (males: [orga]), (retrospective nature: [resa]), (study: [resa]), (prospective study: [resa]), (association: [menp]), 
ASD Terms: (many neurodevelopmental disorders, 'Learning Disorders')(fragile x, 'Fragile X Syndrome')(down syndrome, 'Down Syndrome')(autism, 'Autism Phenotype')(medical record data, 'Medications')(autism diagnosis, 'Diagnosis')(epilepsy comorbidity, 'Epilepsy')(seizure onset, 'Onset of Symptoms')(infantile spasms, 'Tourette Syndrome')(diagnosis, 'Diagnosis')(epilepsy, 'Epilepsy')

PMCID: 4007529
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (several morphometric studies: [lbpr]), (normal neurons: [cell]), (neocortex: [bpoc]), (autistic subjects: [mobd]), (hypothesis: []), (abnormal neuronal growth: [orgf]), (marker: [clna]), (autism-associated global encephalopathy: [mobd]), (neuronal volumes: [qnco]), (brain regions: [blor]), (various subcortical structures: [blor]), ( ammons horn: [bpoc]), ( archicortex: [bpoc]), ( cerebellum: [bpoc]), (brainstem: [bpoc]), (brains: [bpoc]), (individuals: [humn]), (autism: [mobd]), (years: []), (age: [orga]), (age-matched control brains: [bpoc]), (stereological study: [resa]), (volume: [qnco]), (neuronal soma: [celc]), (regions: []), (8-year-old autistic brains: [mobd]), (controls: [sbst]), (arbitrary classification: [qnco]), (severe neuronal volume deficit: [dsyn]), (structures: []), ( severe: []), (moderate: []), (pattern: []), (neuronal growth: [orgf]), (interacting neuronal networks: [imft]), (autistic phenotype: [mobd]), (comparative study: [resa]), (control: [sbst]), (subject brains: [bpoc]), (number: [qnco]), (significant volume deficit: [dsyn]), (8-year-old autistic subjects: [mobd]), (adults: [aggp]), (neuronal volume: [qnco]), (age-matched controls: [orga]), (defects: []), (early childhood: []), (up-regulation: [genf]), (adolescence: []), (adulthood: []), (neuron soma volume deficit: [orch,phsu]), (majority: [socb]), (examined regions: [fndg]), (however: []), (significant correction: [qnco]), (neuron size: [cell]), (limited clinical improvements: [fndg]), (delayed correction: []), (functional deficits: []), 
ASD Terms: (autism, 'Autism Phenotype')(years of age, 'Onset of Symptoms')(autism, 'Autism Phenotype')

PMCID: 3941568
SFARI Genes: GLIALCAM, PTEN, GLIALCAM, PTEN, GLIALCAM, PTEN, GLIALCAM, PTEN, GLIALCAM, GLIALCAM, PTEN, PTEN, PTEN, PTEN, 
Non SFARI Genes: 
Named Entities: (genetic heterogeneity: [orga]), ( autism spectrum disorders: [mobd]), (account: [clna]), (specific endophenotypes: []), (comorbidity: []), (asd: [cgab]), (epilepsy (or paroxysmal eeg): [dsyn]), (strong genetic background: [orga]), (macrocephaly: [cgab]), (well-known endophenotype: []), (subgroups: [virs]), (asd individuals: [cgab]), (pathogenic mechanisms: [fndg]), (brain growth: [orgf]), (early development: [orgf]), (predisposing: []), (disorder: [dsyn]), (association: [menp]), (gene variants: [gngm]), (neurodevelopmental disorders: [mobd]), (patients: [podg]), (autism-epilepsy phenotype (aep): [mobd]), (cranial overgrowth: [bpoc]), (genes: [gngm]), (autism: [mobd]), (coding sequences: [bacs,nnon]), (exon-intron boundaries: [bacs,nnon]), (glialcam: [gngm]), (igg-like cell adhesion protein: [aapp,bacs]), (individuals: [humn]), (autism spectrum disorders: [mobd]), (comorbid epilepsy: [dsyn]), (paroxysmal eeg and/or macrocephaly: [cgab]), (pten gene: [gngm]), (subsample: []), (concurrent macrocephaly: [cgab]), (head circumference: [clna]), ( moreover: []), (percentile (extreme macrocephaly): [cgab]), ((19%) patients: [podg]), (several single nucleotide variants: [fndg]), (clear pathogenic effects: [fndg]), (novel pten: [aapp,enzy]), (heterozygous frameshift mutation: [comd]), (case: []), (extreme: []), (intellectual disability: [mobd]), (seizures: [sosy]), (clear association: [menp]), (glialcam mutations: [genf]), (aep-macrocephaly comorbidity: [cgab]), (identification: [menp]), (novel frameshift variant: [comd]), (pten: [gngm]), (patient: [podg]), ( confirms: []), (gene: [gngm]), (major candidate: []), (asd-macrocephaly endophenotype: [cgab]), (concurrence: []), (epilepsy: [dsyn]), (same patient: [podg]), (downstream: []), (pathway: [moft]), (autism-epilepsy comorbidity: [mobd]), (clinical endophenotypes: []), (help: []), (genetic studies: [resa]), (actual causative correlations: []), (autism-epilepsy: [dsyn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(comorbidity, 'Comorbidities')(epilepsy, 'Epilepsy')(neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')(comorbid epilepsy, 'Epilepsy')(intellectual disability, 'Learning Disorders')(autism-epilepsy phenotype-macrocephaly comorbidity, 'Comorbidities')(epilepsy, 'Epilepsy')(autism-epilepsy comorbidity, 'Comorbidities')

PMCID: 4116759
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (enhanced plasticity: [npop]), (role: [socb]), (various microstructural alterations: [phsu]), (regional cortical reallocations: [bpoc]), (autism: [mobd]), (multiple indications: [qnco]), (enhanced perceptual functioning: [acty]), (indications: []), (atypical motor functioning: [fndg]), (plasticity: [npop]), (superior variability: []), (functional cortical allocation: [bpoc]), ( predominant: []), (motor regions: []), (prediction: []), (autistics: [mobd]), (typical participants: [popg]), (age: [orga]), ( fsiq: []), ( raven percentile scores: [bird]), (handedness: [orga]), (visuo-motor imitation task: [socb]), (participant: [popg]), (coordinates: [fndg]), (task-related activation peak: [qnco]), (primary (brodmann area: [blor]), (supplementary (ba: []), (motor: []), (visuomotor: []), (superior parietal cortex: [bpoc]), (primary (ba: [topp]), (associative (bas: [menp]), (+: []), (visual areas: []), (mean signal changes: [qnco]), (roi: [clna]), (hemispheres: []), (number: [qnco]), (voxels: []), (activation cluster: [qnco]), (intensity: []), (size: []), (signal: [phpr]), (groups: [popg]), (hemisphere: []), (distance: [qnco]), (respective group average: [popg]), (variable: []), (interest: [menp]), (group differences: [popg]), (localization variability: [biof]), (measures anovas: [qnco]), (between-group comparison: [popg]), (whole-brain activation: [acty]), (mean variability: [qnco]), (localization: [biof]), (activations: [acty]), (associative areas: [menp]), (motor areas: [blor]), (however: []), (increased variability: [qnco]), (associative cortices: [bpoc]), (direct between-group comparison: [popg]), (individual variability: [humn]), (activation: [acty]), (variability: []), (autistic group: [mobd]), (typical group: [popg]), (left visuo-motor: []), (left associative visual areas: [menp]), (different: []), (unique strategies: [menp]), (autistic individual: [mobd]), (regions: []), (non-autistics raises: [mobd]), (possibility: []), (enhancement and/or: [acty]), (alteration: []), (typical plasticity mechanisms: [npop]), (current study: [resa]), (necessity: []), (fmri studies: [diap]), (autistic people: [mobd]), (hypoactivation: []), (group level: [popg]), (task: [gngm]), (unique brain allocation: [bpoc]), (comparison: [acty]), (own group: [popg]), 
ASD Terms: (autism, 'Autism Phenotype')(atypical motor functioning, 'Motor Skills')(visuo-motor imitation task, 'Imitation')(coordinates, 'Motor Skills')(associative visual areas, 'Visual Thinking')(left associative visual areas, 'Visual Thinking')(autism, 'Autism Phenotype')

PMCID: 3996043
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (exposures: [phpr]), (environmental toxins: [hops]), (development: [orgf]), (autism spectrum disorder: [mobd]), (propionic acid (pa): [orch]), (metabolic product: [qnco]), (gut bacteria: [bdsy]), (neurotoxic effects: [inpo]), (autism: [mobd]), (results: [fndg]), (animal studies: [anim]), (investigations: [hlca]), (human populations: [popg]), (environmental contaminants: [sbst]), (drugs: [topp]), (neurotoxicity: [inpo]), (forty-eight young male: [orga]), (western albino rats: [mamm]), (present study: [qnco]), (equal groups: [popg]), (rats: [mamm]), (first group: [popg]), (neurotoxic dose: [inpo]), (buffered pa (250 mg/kg body weight/day: [irda,phsu]), (consecutive days): []), (second group: [popg]), (saline (control group): [sbst]), (fourth groups: [popg]), (pa: [gngm]), (treatment: [topp]), (coenzyme q (4.5 mg/kg body: [humn]), (melatonin (10 mg/kg body weight): [horm,orch,phsu]), (week: []), (groups): [popg]), (fifth: [qnco]), (sixth groups: [popg]), (compounds: [chem]), (pa (protected groups): []), (heat shock protein70 (hsp70): [phsf]), ( gamma: [npop]), (amino-butyric acid (gaba): [aapp,bacs]), ( serotonin: [bacs,orch]), ( dopamine: [bacs,orch,phsu]), ( oxytocin: [aapp,horm,phsu]), (-inducible protein: [aapp,enzy]), (comet dna: [mbrt]), (brain tissues: [tisu]), (groups: [popg]), (data: [euka]), (multiple signs: [fndg]), (brain toxicity: [bpoc]), (depletion: []), (gaba: [aapp,bacs]), (dopamine: [bacs,orch,phsu]), (important neurotransmitters: [bacs]), (brain: [bpoc]), (function: [phsf]), ( interferon: [aapp,imft,phsu]), (high significant increase: [qnco]), (tail length: [bpoc]), ( tail dna% damage: [comd]), (tail moment: [bpoc]), (genotoxic effect: [comd]), (pa. administration: [topp]), (melatonin: [horm,orch,phsu]), (coenzyme q: [bacs,orch,phsu]), (therapeutic effects: [clna]), (patreated rats: [mamm]), (remarkable amelioration: []), (parameters: [fndg]), (conclusion: []), ( melatonin: [horm,orch,phsu]), (potential protective: []), (restorative effects: []), (pa-induced brain injury: [inpo]), (improvement: []), (biochemical markers: []), (dna: [bacs,nnon]), (double strand breaks: [moft]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(exposures, 'Exposures')(gut bacteria, 'Bacterial Infections')(autism, 'Autism Phenotype')(acid-induced brain injury, 'Head Injury')

PMCID: 4000264
SFARI Genes: 
Non SFARI Genes: CA3, CA1, CA2, CA3, CA1, CA2, CA2, CA2, 
Named Entities: (summary: []), (hippocampus: [bpoc]), (repository: []), (knowledge: []), (who: []), ( what: []), ( where: []), (when1: []), (mnemonic information: [menp]), (several parallel routes: [resa]), (distinct subregions: []), (classic trisynaptic pathway: [moft]), ( information proceeds: []), (entorhinal cortex (ec): [bpoc]), (gyrus (dg): [qnco]), (ca3: [gngm]), (main hippocampal output2: [bpoc]), (genetic lesions: [fndg]), (ec3: []), (hippocampal dg4: [bpoc]), ( ca35: []), (ca16 regions: []), (distinct functions: []), (learning: [menp]), (memory: [menp]), (role: [socb]), (ca2: [gngm]), (small area: [qnco]), (ca1: [gngm]), (nexus: [bsoj]), (powerful disynaptic circuit: [hcpp]), (ec input: []), (ca1 output7: []), (here: []), (novel transgenic mouse line: [mamm]), (synaptic connections: [bsoj]), (behavioral role: [socb]), (ca2 region: [elii,phsu]), (adult mice: [mamm]), (inactivation: []), (pyramidal neurons: [cell]), (pronounced loss: [qnco]), (social memory: [menp]), (ability: [orga]), (animal: [anim]), (conspecific: []), (change: [qnco]), (sociability: [socb]), (several other hippocampal-dependent behaviors: [inbe]), (contextual memory: [menp]), (anatomical results: [fndg]), (critical hub: [gngm]), (sociocognitive memory processing: [menp]), 
ASD Terms: (memory, 'Working Memory')(social memory, 'Working Memory')(contextual memory, 'Working Memory')(sociocognitive memory processing, 'Working Memory')

PMCID: 3919719
SFARI Genes: 
Non SFARI Genes: CNPY1, CNPY1, 
Named Entities: (previous genetic studies: [resa]), (association: [menp]), (transcription factor engrailed2 (en2): [aapp,bacs]), (autism spectrum disorder (asd): [mobd]), (subsequent molecular analysis: [mbrt]), (en2: [gngm]), (asd-associated haplotype (rs1861972-rs1861973 a-c) functions: [cgab]), (transcriptional activator: [aapp,bacs]), (gene expression: [genf]), (genes: [gngm]), ( serotonin receptor5a (htr5a): [bacs,orch]), ( insulin induced gene1 (insig1): [aapp,horm,phsu]), ( canopy1 homolog (cnpy1): [gngm]), ( rna binding motif protein33 (rbm33): [nusq]), (sonic hedgehog (shh): [gngm]), (development: [orgf]), (coordinate: [fndg]), (similar developmental processes: [ortf]), (mrna levels: [bacs,nnon]), (individuals: [humn]), (autism: [mobd]), ( post-mortem analysis: [diap]), (flanking genes: [gngm]), (post-mortem cerebellar samples: [bpoc]), (affection status: [menp]), (rs1861972-rs1861973 genotype: [orga]), (molecular analysis: [mbrt]), (en2 levels: [gngm]), (affected a-c/g-t individuals: [humn]), (.0077): []), (affected individuals: [humn]), (significant increase: [qnco]), (shh: [gngm]), (decrease: [qnco]), (insig1 levels: [gngm]), (significant increases: [qnco]), (cnpy1: [gngm]), ((g-t/g-t) levels: []), (human cell line over-expression: [topp]), (knock-down: [bpoc]), (mouse knock-out analysis: [mamm]), (possible mechanism: []), (increased shh post-mortem levels: [diap]), (a-c/g-t genotype: [orga]), (asd susceptibility gene: [cgab]), ( cnpy1: [gngm]), (likely contribute: [acty]), (shh expression: [aapp,bacs]), (post-mortem samples: [sbst]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(coordinate, 'Motor Skills')(autism, 'Autism Phenotype')

PMCID: 3915307
SFARI Genes: 
Non SFARI Genes: MIR137, MIR137, MIR137, MIR137, 
Named Entities: (retinoic: []), (acid-related orphan receptor: [chem]), (alpha gene (rora): [gngm]), (microrna mir137: [bacs,nnon]), (novel candidate genes: [gngm]), (neuropsychiatric disorders: [dsyn]), (rora: [gngm]), (ligand-dependent orphan nuclear receptor: [chem]), (transcriptional regulator: [genf]), (mir-137: [gngm]), (brain: [bpoc]), (small non-coding rna: [nnon]), (gene transcripts: [gngm]), (protein levels: [lbtr]), (evidence: []), (autism spectrum disorders: [mobd]), (mir137: [gngm]), (schizophrenia: [mobd]), (asd: [cgab]), (functional biological relationship: []), (genes: [gngm]), (herein: []), (mir-137 targets: [gngm]), (site: [blor]), (specific manner: []), (further support: []), (autism candidate: [mobd]), (large number: [qnco]), (autism genes: [gngm]), (work: []), (role: [socb]), (asd candidate: [cgab]), (direct biological link: []), (unrelated autism candidate genes: [mobd]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism candidate, 'Autism Phenotype')(autism genes, 'Autism Phenotype')(unrelated autism candidate genes, 'Autism Phenotype')

PMCID: 3969297
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (highlights: []), (prospective studies: [resa]), (infants: [aggp]), (familial risk: [famg]), (developmental pathways: [moft]), (children: [aggp]), (asd: [cgab]), (communication difficulties: [socb]), (second year: [qnco]), (life: []), (early neurocognitive markers: [clna]), (atypical neural response: [fndg]), (disengagement: []), (mapping: [acty]), (birth: [orgf]), (early identification: [topp]), (intervention: [hlca]), 
ASD Terms: (early neurocognitive markers, 'Cognitive Ability')

PMCID: 3930113
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (development: [orgf]), (language: [lang]), ( social interaction: [fndg]), (communicative skills: [orga]), (child: [aggp]), (autism spectrum disorder (asd): [mobd]), (atypical brain connectivity: [bpoc]), (patient population: [popg]), (however: []), (neural correlates: []), (language development: [menp]), (functioning: []), (state fmri: [diap]), (functional connectivity properties: []), (language network: [popg]), (group: [popg]), (asd patients: [cgab]), (clear comorbid language: [lang]), (impairment (asd-li; n =: [cgab]), (connectivity properties: []), (children: [aggp]), (verb generation task: [acty]), (language components: [lang]), (groups: [popg]), (joint language components: [lang]), (seeds: [plnt]), (resting state analysis: [resa]), (interestingly: []), (interregional: []), (seed-based whole brain connectivity analysis: [plnt]), (preserved connectivity: [lbpr]), (classical intrahemispheric language centers: [lang]), ( wernicke's: [dsyn]), (broca's areas: [bpoc]), (contrast however: [irda]), (marked loss: [qnco]), (functional connectivity: []), (right cerebellar region: [bpoc]), (supratentorial regulatory language areas: [lang]), (connectivity: []), (interhemispheric broca regions: [bpoc]), (modulatory control: [sbst]), (dorsolateral prefrontal region: []), (disruption: []), (normal modulatory control: []), (automation function: [phsf]), (cerebellum: [bpoc]), (abnormal language function: [lang]), (asd-li: [cgab]), 
ASD Terms: (development of language, 'Language Development')(social interaction, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(communicative skills, 'Reciprocal Social Interaction')(language development, 'Language Development')(clear comorbid language impairment, 'Comorbidities')(abnormal language function in children, 'Development or Regression of Language Skills')(abnormal language function, 'Development or Regression of Language Skills')

PMCID: 3907307
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (duplications: []), (common type: [qnco]), (copy number variation (cnv): [nusq]), (germline: [cell]), (somatic genomes: [gngm]), (large duplications: [qnco]), (many genes: [gngm]), (neurodevelopmental phenotypes: [orga]), (children: [aggp]), (gene amplifications: [genf]), (tumors: [neop]), (several models: [qnco]), (inverted duplication: [comd]), (dicentric chromosome intermediate: [lbtr]), (breakage-fusion-bridge (bfb) cycles: [topp]), (mechanisms: []), (rise: []), (dicentric chromosome: [comd]), (inverted duplications: []), (high-resolution array cgh: [dsyn]), ( custom sequence: [nusq]), (next-generation sequencing: [mbrt]), (long-range pcr: [mbrt]), (breakpoints: []), (nonrecurrent: []), (patients: [podg]), (intellectual disability: [mobd]), ( autism: [mobd]), (congenital anomalies: [cgab]), (half: [qnco]), (rearrangements: [genf]), (study: [resa]), (breakpoint junction: []), (sequence analysis: [lbpr,mbrt]), (breakpoint junctions: []), (normal-copy disomic spacer: [fndg]), (non-inverted copies: []), (duplication: [comd]), (further: []), (sequences: [nusq]), (boundary: []), (disomic spacer: []), (data support: [euka]), (mechanism: []), (inverted duplication formation: [biof]), (chromosome: [celc]), (double-strand break intrastrand pairs: [phpr]), (fold-back intermediate that: [blor]), (dna replication: [genf]), (dicentric: [comd]), (site: [blor]), (fold-back loop: [blor]), (process: [phpr]), (deletions: [genf]), (inverted duplication ring chromosomes: [celc]), 
ASD Terms: (neurodevelopmental phenotypes, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(autism, 'Autism Phenotype')

PMCID: 4459282
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (attention deficit hyperactivity disorder (adhd): [mobd]), (autism spectrum disorder (asd) share brain function abnormalities: [mobd]), (cognitive flexibility: [menp]), (serotonin: [bacs,orch]), (disorders: [dsyn]), (selective serotonin reuptake inhibitors: [phsu]), (behavior: [inbe]), (thus: []), (study: [resa]), (disorder-specific brain dysfunctions: [dsyn]), (reward reversal: [menp]), (acute effects: []), (ssri: [phsu]), (these: []), (age-matched boys: [aggp]), (adhd (15): [mobd]), ( asd (18): [cgab]), (controls: [sbst]), (functional magnetic resonance: [npop]), ((fmri): [diap]), (reversal task: []), (patients: [podg]), (twice: [qnco]), (acute dose: [qnco]), (fluoxetine: [orch,phsu]), (placebo: [topp]), (design: [acty]), (repeated-measures analyses: [qnco]), (assessed drug effects: [acty]), (drug condition: [dsyn]), (normalization effects: [resa]), (fmri data: [diap]), ( asd: [cgab]), (underactivated medial prefrontal cortex (mpfc): [celc]), (control: [sbst]), (adhd boys: [mobd]), (patient groups: [popg]), (decreased precuneus activation: [acty]), (activation: [acty]), (asd boys: [cgab]), (concomitant: []), (task performance: [topp]), (adhd: [mobd]), (fluoxetine therefore: [orch,phsu]), (inverse effects: []), (mpfc activation: [acty]), (asd: [cgab]), (reversal: []), (dissociated underlying serotonin abnormalities: [bacs,orch]), 
ASD Terms: (autism spectrum disorder share brain function abnormalities, 'Autism Phenotype')(cognitive flexibility, 'Cognitive Ability')(attention deficit hyperactivity disorder, 'Overactivity')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention deficit hyperactivity disorder boys, 'Overactivity')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(task performance, 'Task Performance')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 3885720
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recognition: [menp]), (mitochondrial dysfunction: [fndg]), (autism spectrum disorders: [mobd]), (however: []), (little attention: [menp]), (etiology: []), (mitochondrial abnormalities: [anab]), (other physiological disturbances: []), (autism: [mobd]), (oxidative stress: [comd]), (current study: [resa]), (respirometry: []), (reserve capacity: [qnco]), (measure: [qnco]), (mitochondrial ability: [celc]), (physiological stress: [patf]), (lymphoblastoid cell lines: [cell]), (children: [aggp]), (autistic disorder (ad): [mobd]), (age: [orga]), (gender-matched control lcls: [orga]), (first time: [qnco]), (lcls: []), (ad: []), (abnormal mitochondrial reserve capacity: [celc]), (exposure: [clna]), (concentrations: [menp]), ((dmnq): [irda,orch]), (agent: [chvf]), (intracellular reactive oxygen species: [celc]), (specifically: []), (ad lcls: []), (baseline: [bodm]), (depletion: []), (ros exposure: [clna]), (investigation: [hlca]), (reserve capacity abnormalities: [cgab]), (result: [fndg]), (atp-linked respiration: [phsf]), (maximal respiratory capacity: [qnco]), (marked increase: []), (proton leak respiration: [elii]), (ros: [gngm]), (capacity abnormalities: [cgab]), (subgroup: [virs]), ((32%): []), (additional investigation: [hlca]), (reliance: [bodm]), (glycolysis: [moft]), (protein: [aapp,bacs]), (inner mitochondria membrane: [celc]), (study: [resa]), (significant subgroup: [virs]), (ad children: [aggp]), (alterations: []), (mitochondrial function: [celc]), (pro-oxidant microenvironment: [bacs,elii]), (extrinsic sources: [fndg]), (immune activation: [acty]), (pro-oxidant environmental toxicants: [bacs,elii]), (findings: [clna]), (notion: []), (combination: [fndg]), (environmental factors: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(autistic disorder, 'Autistic Disorder')(autistic disorder, 'Autistic Disorder')(exposure, 'Exposures')(autistic disorder lymphoblastoid cell lines, 'Autistic Disorder')(reactive oxygen species exposure, 'Exposures')(autistic disorder lymphoblastoid cell lines, 'Autistic Disorder')(autistic disorder children, 'Autistic Disorder')(autistic disorder, 'Autistic Disorder')

PMCID: 3874034
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (random: [resa]), (stochastic monoallelic: []), (genes (stma genes) represent: [gngm]), (unique form: []), (monoallelic expression: [topp]), (allelic choice: [gngm]), (development: [orgf]), (consequential clonal diversity: [tisu]), (opportunity: []), (functional heterozygosity: [orga]), (tissues: [tisu]), (brain: [bpoc]), (disease: [dsyn]), (relationship: []), (stma: []), (genes: [gngm]), (clonal neural stem cells: [cell]), (neurodevelopmental disorders autism: [mobd]), (schizophrenia: [mobd]), (stma genes: [gngm]), (overrepresentation: []), (schizophrenia risk candidates: [mobd]), (genome wide association studies: [mbrt]), (genetic association database: [menp]), (similar suggestive enrichment: []), (nhgri: [hcro]), (genome-wide association study catalog: [mbrt]), (psychiatric genetics consortium schizophrenia: [mobd]), (robust gene lists: [gngm]), (statistical significance: [qnco]), (multiple sources: [fndg]), (copy number variation (cnv) datasets: [nusq]), (autism: [mobd]), (schizophrenia cohorts: [mobd]), (account: [clna]), (total gene numbers: [gngm]), (cnv: [nusq]), (cnvs: [nusq]), (enrichment: []), (control cnv datasets: [nusq]), (neural stem cells: [cell]), ( bias: [bird]), (neural transcriptome: [nusq]), (this: []), (neural stem cell: [cell]), (tests: [lbpr]), (significant number: [qnco]), (iterations: [fndg]), ( neural stem cell: [cell]), (schizophrenia cnv datasets: [nusq]), (therefore: []), ( irrespective: []), (transcriptome: [nusq]), ( stma genes: [gngm]), (association: [menp]), (regulation (or dysregulation): [biof]), (form: []), (allelic expression status: [gngm]), (contributory risk factor: [qnco]), (neurodevelopmental disorders: [mobd]), (disease discordance: [dsyn]), (monozygotic twins: [famg]), 
ASD Terms: (neurodevelopmental disorders autism, 'Learning Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia risk candidates, 'Schizophrenia and Disorders with Psychotic Features')(psychiatric genetics consortium schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(schizophrenia cohorts, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(schizophrenia copy number variation datasets, 'Schizophrenia and Disorders with Psychotic Features')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 3885205
SFARI Genes: MAOA, MAOB, DRD2, MAOA, MAOB, DRD2, MAOA, MAOB, DRD2, MAOA, MAOB, DRD2, MAOA, MAOA, MAOB, MAOB, DRD2, DRD2, MAOB, MAOB, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (indisputable evidence: []), (genetic component: [gngm]), (work: []), (association: [menp]), (genetic variations: [npop]), (neurotransmitter-related genes: [gngm]), (maoa: [gngm]), (uvntr: []), ( maob rs1799836: [aapp,enzy]), (drd2 taqi a: [aapp,rcpt]), (autistic patients: [mobd]), (healthy individuals: [humn]), (study: [resa]), (sequence variations: [npop]), (maoa uvntr: [orch,phsu]), (pcr: [mbrt]), ( maob: [aapp,enzy]), (drd2 polymorphisms: [aapp,rcpt]), (pcr-based rflp: [comd]), (allele: [gngm]), (female patients: [orga]), (controls (or: [sbst]), (maob g: [aapp,enzy]), (allele frequency: [qnco]), (controls (p: [aapp,imft]), (males: [orga]), (females): [orga]), (drd2 a1+ genotype: [aapp,rcpt]), (autism risk (or: [mobd]), (severity: []), (autism tends: [mobd]), (maoa/b genotype: [orch,phsu]), (plasma maob activity: [aapp,enzy]), (g: [qnco]), (a allele: [gngm]), (significant difference: [qnco]), (patients: [podg]), (maternal plasma maoa/b activity: [orch,phsu]), (mutations: [genf]), (snps: [nusq]), (studied patients: [podg]), (light: [gngm]), (potential role: [socb]), (autism pathogenesis: [mobd]), (warrants: []), (further studies: [lbpr]), (much consideration: [fndg]), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism risk, 'Autism Phenotype')(autism tends, 'Autism Phenotype')(autism pathogenesis, 'Autism Phenotype')

PMCID: 3881151
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (electrophysiological findings: [clna]), (site-specific impairment: [patf]), (nucleus tractus solitarius (nts): [bpoc]), (autism: [mobd]), (hypothetical consideration: [fndg]), (large role: [socb]), (small brainstem structure: [bpoc]), (basis: [phsu]), (somatic features: [cell]), (nts: [gngm]), (brains point: [bpoc]), (entry: []), (visceral afference: [bpoc]), (relay: []), (vagal reflexes: [orgf]), (integration center: [fndg]), (autonomic control: [bdsy]), (circulatory: [phsf]), ( immunological: []), ( gastrointestinal: []), (laryngeal function: [phsf]), (normal cerebrovascular perfusion: [topp]), (seminal point: [qnco]), (noradrenergic system: [moft]), (many complex behaviors: [inbe]), (microvascular configuration: []), (focal hypoxia: [patf]), (subregionthe pntspermits exposure: [clna]), (blood-brain barrier: [bpoc]), (impairment: [patf]), (acetylcholinesterase (mercury: [aapp,enzy]), (cadmium cations: [elii,phsu]), (nitrates/nitrites: [chvs]), ( organophosphates: [orch]), ( monosodium glutamate): [aapp,phsu]), ( competition: [socb]), (hemoglobin (carbon monoxide: [aapp,bacs]), ( nitrates/nitrites): [chvs]), (blood viscosity (net: [phsf]), (systemic oxidative stress): [comd]), (microcirculatory insufficiency: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(many complex behaviors, 'Executive Function')(exposure, 'Exposures')

PMCID: 3965040
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (lynx (http://lynx.ci.uchicago.edu)a: [mamm]), (web-based database: []), (knowledge extraction: [lbpr]), (annotation: []), (analysis: [resa]), (experimental data: [euka]), (generation: [acty]), (weighted hypotheses: [orga]), (molecular mechanisms: []), (human phenotypes: [humn]), (disorders: [dsyn]), (interest: [menp]), (underlying knowledge base (lynxkb): []), (various classes: [hlca]), (information: []), (>35: []), (public databases: []), (private collections: [orgt]), (data: [euka]), (group: [popg]), (collaborators: [pros]), (lynx: [mamm]), (advanced search capabilities: [acty]), (variety: []), (algorithms: []), (enrichment analysis: [resa]), (network-based gene prioritization: [gngm]), (user: [humn]), (meaningful knowledge: []), (lynxkb: []), (service-oriented architecture: [fndg]), (public access: []), (analytical tools: [resa]), (user-friendly web services: [mcha]), (interfaces: []), 
ASD Terms: 

PMCID: 3840590
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent study: [resa]), (lateral septum (ls): [celc]), (large number: [qnco]), (autism-related genes: [gngm]), (altered expression: [topp]), (postpartum state: []), (however: []), (findings: [clna]), (enrichment: []), (autism-associated genes: [gngm]), (software: [inpr,mnob]), (many gene-disease association databases: []), (popular: [socb]), ( full-featured enrichment tools: []), (use: []), (custom gene lists: [gngm]), (programs: [phsu]), (simple alternative: []), (modular single-set enrichment test: [fndg]), (minimal tool: []), (expression data: [euka]), (conceivable gene list: [gngm]), (interest: [menp]), (mset approach: []), (available expression data sets: [topp]), (areas: []), (autism: [mobd]), ( attention deficit hyperactivity disorder (adhd): [mobd]), (arthritis: [dsyn]), (independent: [fndg]), ( unique autism gene lists: [gngm]), (association databases: [menp]), (recent publications: [inpr,mnob]), (striking consensus: [socb]), (gene expression changes: [genf]), (ls: []), (postpartum mice: [mamm]), (network: [popg]), (developmental processes: [ortf]), (synaptic plasticity: [ortf]), (neuronal morphogenesis: [orgf]), (differentiation: [celf]), (additionally: []), (maternal ls: [famg]), (genes: [gngm]), (bipolar disorder: [mobd]), ( schizophrenia: [mobd]), ( adhd: [mobd]), (depression: [mobd]), (transition: [acty]), (motherhood: [orga]), (event: [evnt]), (mammals: [mamm]), (features: []), (changes: [qnco]), (sociability: [socb]), (individuals: [humn]), (other mental health disorders: [mobd]), (impaired social traits: [inbe]), (deficits: []), (elevated sociability: [socb]), (maternal brain: [bpoc]), (first study: [qnco]), (significant: [qnco]), ( quantitative link: [qnco]), (mental health disorders: [mobd]), (large scale gene expression data: [genf]), (postpartum brain: [bpoc]), (novel: []), (promising platform: []), (complex genetics: [chvs]), (improved sociability: [socb]), (direct relevance: []), (multiple psychiatric illnesses: [mobd]), (study: [resa]), (important new tool: []), (critical analysis gap: [resa]), (evaluation: [hlca]), (database: []), (emphasis: []), (ease: [menp]), (methodological transparency: []), 
ASD Terms: (autism, 'Autism Phenotype')(attention deficit hyperactivity disorder, 'Overactivity')(unique autism gene lists, 'Autism Phenotype')(bipolar disorder, 'Bipolar Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(attention deficit hyperactivity disorder, 'Overactivity')(depression, 'Depressive Disorder')(autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(other mental health disorders, 'Mental Disorders')(impaired social traits, 'Social Competence')(mental health disorders, 'Mental Disorders')(multiple psychiatric illnesses, 'Mental Disorders')

PMCID: 3827143
SFARI Genes: AUTS2, AUTS2, 
Non SFARI Genes: 
Named Entities: (copy number variants: [nusq]), ((cnvs) influence: [nusq]), (expression: [topp]), (genes: [gngm]), (rearrangement: [genf]), (flanks: [blor]), (possible mechanism(s): []), (effect: []), (intrachromosomal interactions: []), (histone modifications: [amas]), (cell lines: [cell]), (patients: [podg]), (genomic disorders: [dsyn]), (control individuals: [humn]), (chromosome conformation capture: [celc]), (set: [menp]), (williams-beuren syndrome: [cgab,dsyn]), (critical region (wbscr): []), (together: []), (auts2: [gngm]), ( mutations: [genf]), (autism: [mobd]), (intellectual disabilities: [mobd]), (deletion: [genf]), (wbscr: []), (group: [popg]), (long-range interactions: [qnco]), (interval: []), (concomitant changes: [qnco]), (samples: [sbst]), (large genomic rearrangements: [gngm]), (conformation changes: [qnco]), (structural variant: []), ( thereby: []), (phenotype: [orga]), (geo series accession: [acty]), (gse33784: []), ( gse33867: []), 
ASD Terms: (autism, 'Autism Phenotype')(intellectual disabilities, 'Learning Disorders')

PMCID: 4226210
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (clinicians: []), (researchers: []), (field: [irda]), (autism: [mobd]), (philosophical categories: []), (kinds: []), (model: []), (nature: []), (research: [resa]), (clinical practice: [menp]), (contemporary research: [resa]), (depiction: []), (scientific object: []), (systematic neuroscientific investigation: [hlca]), (image: []), (permissive account: [inbe]), (mechanistic property cluster (mpc) account: [clna]), (natural kinds: []), (psychiatric disorders: [mobd]), (heterogeneity: [orga]), ( multicausality: []), (fuzzy boundaries: [fndg]), ((mpc kinds): [cell]), (prescriptive guidance: [hlca]), (investigation: [hlca]), (objective causal mechanisms: []), (nosologists: []), (attempt: [evnt]), (autisms boundaries: [mobd]), (natural joints: [bsoj]), (however: []), (essay: []), (mechanistic model: []), (way: []), (kind: []), (behavior: [inbe]), (historical studies: [lbpr]), (definitions: []), (show: [anim]), ( normative issues: [fndg]), (disability: [fndg]), ( impairment: [patf]), (societal needs: []), (current search: [acty]), (autisms unity: [mobd]), (neurobiological mechanisms: []), (values: []), ( social norms: []), (various perspectives: [phsu]), (mental pathology: [patf]), (significant role: [socb]), ('the thing: []), (autism research: [mobd]), (issues: [fndg]), (order: [acty]), (success: [socb]), (effort: [orgf]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(psychiatric disorders, 'Mental Disorders')(autisms boundaries, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autisms unity, 'Autism Phenotype')(social norms, 'Recognition of Social Norms')(autism research, 'Autism Phenotype')

PMCID: 4035120
SFARI Genes: mark, mark, 
Non SFARI Genes: 
Named Entities: (deficits: []), (eye contact: [socb]), (hallmark: []), (autism1: []), (2: [qnco]), (conditions: [dsyn]), (initial description3: []), (diagnostic feature4: [fndg]), (figure: []), (clinical instruments5;: []), (early onset: [fndg]), (prospective longitudinal study: [resa]), (autism spectrum disorders: [mobd]), (exhibit: []), (mean decline: [qnco]), (eye fixation: [ortf]), (months: []), (life: []), (pattern: []), (infants: [aggp]), (asd: [cgab]), (observations: [hlca]), (known indicators: [irda]), (social disability: [fndg]), (infancy: []), (prior hypothesis:: [evnt]), (first months: [qnco]), (basic mechanism: []), (social adaptive actioneye: [socb]), (asd; instead: [cgab]), ( eye: [bpoc]), (normative levels: []), (timing: []), (decline highlights: []), (narrow developmental window: [qnco]), (early derailment: []), (processes: [phpr]), (key role: [socb]), (typical social development: [socb]), (observation: [hlca]), (decline: []), (eye fixationrather: [bpoc]), (outright absenceoffers: []), (promising opportunity: []), (early intervention: [hlca]), ( one: [qnco]), (apparent preservation: [lbpr]), (mechanisms: []), (reflexive initial orientation: [menp]), (eyes: [bpoc]), 
ASD Terms: (eye contact, 'Eye Contact')(early onset, 'Onset of Symptoms')(autism spectrum disorders, 'Autism Phenotype')(known indicators of social disability, 'Social Competence')(social adaptive actioneye, 'Adaptive Life Skills')(social disability, 'Social Competence')(infancy, 'Perinatal History')(typical social development, 'Ability to Converse in Social Settings')

PMCID: 3811986
SFARI Genes: PCDH9, FOXP1, GABRB3, NRXN1, RELN, MACROD2, FHIT, RORA, CNTN4, CNTNAP2, FAM135B, LAMA1, NFIA, NLGN4X, RAPGEF4, SDK1, PCDH9, FOXP1, GABRB3, NRXN1, RELN, MACROD2, FHIT, RORA, CNTN4, CNTNAP2, FAM135B, LAMA1, NFIA, NLGN4X, RAPGEF4, SDK1, 
Non SFARI Genes: 
Named Entities: (effects: []), (parental genotype: [orga]), (parent-offspring genetic interaction: [socb]), (model organisms: [orgm]), (variety: []), (traits: [gngm]), (however: []), (transgenerational genetic models: []), (humans: [humn]), (autism case-control study: [resa]), (mother-child pairs: [socb]), (genome-wide screening: [topp]), (maternal genetic effects: [famg]), (maternal-offspring genetic interaction: [socb]), (simple models: []), (single locus: [fndg]), (parent-child interaction: [socb]), (suggestive results: [fndg]), (cannot: []), (main effects: []), (genome-wide significant signals: [gngm]), (maternal-child associations: [socb]), (candidate genes: [gngm]), (pcdh9: [gngm]), ( foxp1: [gngm]), ( gabrb3: [gngm]), ( nrxn1: [gngm]), ( reln: [gngm]), ( macrod2: [gngm]), ( fhit: [gngm]), ( rora: []), ( cntn4: [gngm]), ( cntnap2: [aapp,bacs]), ( fam135b: [gngm]), ( lama1: [gngm]), ( nfia: []), ( nlgn4x: [gngm]), ( rapgef4: [gngm]), (sdk1: [gngm]), (validation: [resa]), (potential autism association: [menp]), (maternal-specific models: [famg]), (maternal-paternal comparison: [acty]), (family-based gwas datasets: [mbrt]), (results: [fndg]), (further study: [resa]), (parental genetic effects: [topp]), (autism: [mobd]), 
ASD Terms: (autism case-control study, 'Autism Phenotype')(autism candidate genes, 'Autism Phenotype')(potential autism association, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3818007
SFARI Genes: MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, RTT, MET, RTT, MET, MET, MET, MET, MET, RTT, MET, RTT, 
Non SFARI Genes: 
Named Entities: (single: [fndg]), (nucleotide variants: [nnon]), (gene: [gngm]), (met receptor tyrosine kinase: [aapp,enzy,rcpt]), (risk: []), (autism spectrum disorders: [mobd]), (met promoter snv rs1858830 c low activity' allele: [gngm]), (asd: [cgab]), (reduced protein expression: [genf]), (structural circuit connectivity: []), (humans: [humn]), (insight: [menp]), (transcriptional regulation: [genf]), (met: [gngm]), (asd-risk etiology: [cgab]), (interaction: []), (methyl cpg-binding protein: [gngm]), ((mecp2): [aapp,bacs]), (promoter region: [bacs,nnon]), (mutations: [genf]), (mecp2 cause rett syndrome: [dsyn]), (female neurodevelopmental disorder: [orga]), (clinical symptoms: [sosy]), (mecp2: [gngm]), (region: []), (met promoter: [bacs,nnon]), (asd-risk snv: [cgab]), (displays: []), (genotype-specific binding: [orga]), (human neural progenitor cells: [humn]), (olfactory neuroepithelium: [orgf]), (enhances met expression: [acty]), (presence: [qnco]), (rs1858830 c allele: [gngm]), (met transcription: [genf]), (rtt-specific mutations: [dsyn]), (postmortem: [diap]), (temporal cortex: [bpoc]), ( gene expression: [genf]), (females: [orga]), (rtt: [gngm]), (enrichment: []), (rs1858830 c low activity' allele: [gngm]), (sex-based reduction: [orgf]), (met expression: [topp]), (male asd cases: [cgab]), (female asd cases: [cgab]), (sex-matched controls: [orgf]), (experimental data: [euka]), (prominent allele-specific regulation: [gngm]), (mechanisms: []), (pronounced reduction: [npop]), (factors: []), (disorder: [dsyn]), (noted sex bias: [socb]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(cause rett syndrome, 'Rett Syndrome')(female neurodevelopmental disorder, 'Learning Disorders')

PMCID: 4015907
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (second-generation immigrants: [popg]), (environmental risk factors: []), (childhood autism: [mobd]), (previous studies: [lbpr]), (maternal region: [famg]), (birth: [orgf]), (inconsistent results: [fndg]), (previous study: [resa]), (finland: []), (study: [resa]), (nested casecontrol study: [resa]), (national birth cohort: [qnco]), (children: [aggp]), (year: []), (finnish hospital discharge register: [hlca]), (controls: [sbst]), (finnish medical birth register: [popg]), (information: []), (maternal: [famg]), (paternal country: [famg]), (mother tongue: [fndg]), (finnish central population register: [inpr,qnco]), (cases: [qnco]), (statistical test: []), (conditional logistic regression analysis: [resa]), (risk: []), (parents: []), (immigrants: [popg]), (odds: []), (confidence interval: [qnco]), (immigrant mother: [famg]), (ci: [gngm]), (immigrant father: [famg]), (mother: [famg]), (former soviet union: []), (yugoslavia: []), (father: [famg]), (asia: []), (specific parental countries: []), (former yugoslavia: []), (vietnam: []), ( children: [aggp]), (mothers: [famg]), (immigrant partner: [popg]), (risk varies: []), (immigrant parents region: [popg]), (findings: [clna]), (possible risk factors: [qnco]), (future studies: [lbpr]), 
ASD Terms: (childhood autism, 'Autism Phenotype')(finnish hospital discharge register, 'Hospitalizations')(finnish medical birth register, 'Medications')(childhood autism, 'Autism Phenotype')(childhood autism, 'Autism Phenotype')

PMCID: 3798378
SFARI Genes: CNTNAP2, CNTNAP2, CNTNAP2, CNTNAP2, CNTNAP2, CNTNAP2, CNTNAP2, CNTNAP2, 
Non SFARI Genes: impact, Mb, 
Named Entities: (multiple lines: [qnco]), (genetic evidence: [topp]), (role: [socb]), (cntnap2: [gngm]), (autism: [mobd]), (population impact: [popg]), (common single nucleotide polymorphisms (snps): [nusq]), (transmission disequilibrium test (tdt): [dsyn]), (entire ~3.3 mb cntnap2 locus: [aapp,bacs]), ((408 trios) multiplex: [aapp,enzy]), (simplex families: [famg]), (autistic spectrum disorder (asd): [mobd]), (analysis: [resa]), (snps: [nusq]), (nominal statistical significance (rs17170073: [qnco]), ( p: [aapp,imft]), (x 10-4; rs2215798: [fndg]), (survive multiple: [qnco]), (combined analysis: [resa]), ((r: [clna]), (=: []), (intron: [bacs,nnon]), (significant association: [menp]), (autism (rs2710093: [mobd]), (x 10-6; rs2253031: [qnco]), (findings: [clna]), (associations: [menp]), (previous autism studies: [mobd]), (rs2710102: []), (rs17236239): []), (additional families: [famg]), (multiplex: []), (simplex): [bpoc]), (none: []), (variants: []), (asd: [cgab]), (corrections: []), (multiple testing: [qnco]), (mendelian errors: []), (family: [famg]), (segregating deletions: [genf]), (nevertheless: []), (study: [resa]), (cntnap2 gene expression: [aapp,bacs]), (brains: [bpoc]), (autistic patients: [mobd]), (normal controls: []), (altered expression: [topp]), (subset: []), (patients: [podg]), (consequently: []), (cntnap2 dysregulation: [aapp,bacs]), (cases: [qnco]), (population contribution: [popg]), (autism susceptibility: [clna]), 
ASD Terms: (autism, 'Autism Phenotype')(autistic spectrum disorder, 'Autistic Disorder')(autism, 'Autism Phenotype')(previous autism studies, 'Autism Phenotype')(autism susceptibility, 'Autism Phenotype')

PMCID: 3793965
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (fecal microbiota: [orgm]), (metabolome: [npop]), (children: [aggp]), (pervasive developmental disorder: [mobd]), ((pdd-nos): [dsyn]), (autism: [mobd]), (comparison: [acty]), (healthy children: [fndg]), (bacterial tag-encoded flx-titanium amplicon: [elii]), ((btefap): []), (rdna: [gngm]), (rrna analyses: [bacs,nnon]), (total bacteria: [bact]), (rdna): [gngm]), (active bacteria: [bact]), (rrna): [bacs,nnon]), ( respectively: []), (main bacterial phyla (firmicutes: [bact]), ( bacteroidetes: [bact]), ( fusobacteria: [bact]), (verrucomicrobia): [bact]), (groups: [popg]), (rarefaction: [fndg]), ( chao: [euka]), (shannon diversity: []), (microbial diversity: [orgm]), (ad children: [aggp]), (culture-dependent data: [euka]), ( faecalibacterium: [bact]), (ruminococcus: [bact]), (level: [phsu]), (fecal samples: [bdsu]), (pdd-nos: [dsyn]), (hc children: [horm,orch,phsu]), (caloramator: [bact]), ( sarcina: [bact]), (clostridium genera: [bact]), (composition: [clna]), (lachnospiraceae family: [famg]), (pdd-nos and: [dsyn]), ( especially: []), ( ad children: [aggp]), (eubacterium: [bact]), (eubacteriaceae: [bact]), (bacteroidetes genera: [bact]), (alistipes: [bact]), (akkermansia species: [bact]), (sutterellaceae: [bact]), (enterobacteriaceae: [bact]), (ad: []), ( bifidobacterium species: [bact]), (canonical discriminant analysis: [resa]), (principal coordinates: [fndg]), (levels: []), (free amino acids: [aapp,bacs,phsu]), (volatile organic compounds: [orch]), (gut microbiota differences: [orgm]), (concomitant causes: []), (consequence: []), (implications: []), (specific diagnostic test: [diap]), ( and/or: []), (treatment: [topp]), (prevention: [resa]), 
ASD Terms: (autism, 'Autism Phenotype')(bacterial tag-encoded flx-titanium amplicon pyrosequencing, 'Bacterial Infections')(total bacteria, 'Bacterial Infections')(active bacteria, 'Bacterial Infections')(main bacterial phyla, 'Bacterial Infections')(autism children, 'Autism Phenotype')(principal coordinates, 'Motor Skills')(autism, 'Autism Phenotype')

PMCID: 3792997
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (social character: [menp]), ( zebrafish: [fish]), (promising model system: []), (study: [resa]), (neurochemical basis: [phsu]), (social engagement: [fndg]), (autism: [mobd]), (schizophrenia: [mobd]), (traditional shoaling paradigm: [resa]), (social cohesion: [socb]), (homogeneous groups: [popg]), (zebrafish: [fish]), (however: []), (social dynamics: [npop]), (mixed groups: [popg]), (interest: [menp]), (therapeutic point: [qnco]), (view: []), (warrants: []), (animal modeling: [anim]), (furthermore: []), (mutant zebrafish: [fish]), (large numbers: [qnco]), (therefore: []), (new paradigm: [resa]), (heterogeneous groups: [popg]), (effects: []), (mk-801: [orch,phsu]), (non-competitive antagonist: [ortf]), (glutamate n-methyl-d-aspartate (nmda) receptor: [aapp,rcpt]), (paradigm: [resa]), (drug: [phsu]), (aspects: [qnco]), (results: [fndg]), (single mk-801-treated zebrafish: [fish]), (entire shoal drastically: [qnco]), (preliminary observations: [hlca]), (shoal: []), (whole: [qnco]), 
ASD Terms: (social engagement, 'Engaging in Social Conversation')(autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')

PMCID: 3989023
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (highlights: []), (neurovascular coupling: [ortf]), (energy use: [qnco]), (autism: [mobd]), (relationship: []), (neural activity: [acty]), (bold signal: [phpr]), (simply: []), (control: [sbst]), (autistic people: [mobd]), (meaningful: []), (techniques: []), (interpretation: [clna]), (group differences: [popg]), 
ASD Terms: (autism, 'Autism Phenotype')

PMCID: 4056431
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (neurexin family: [famg]), (cell adhesion: [celf]), (consists: []), (members: [popg]), (vertebrates: [vtbt]), (several invertebrate species: [euka]), (neurexin gene: [gngm]), (-neurexin: []), (extracellular portion: [celc]), (result: [fndg]), (alternative splicing: [genf]), (major isoforms: [aapp]), (many variants: []), (structural domains: []), (variability: []), (neurexins act: [topp]), (presynaptic terminal: [celc]), (neurons: [cell]), (essential roles: [socb]), (neurotransmission: [celf]), (differentiation: [celf]), (synapses: [bsoj]), (functions: [phsf]), (formation: [biof]), (trans-synaptic complexes: [chvs]), (postsynaptic proteins: [aapp,bacs]), (neuroligins: [moft]), ( lrrtm proteins: [aapp,bacs]), (cerebellin: [aapp,bacs]), (addition: []), ( rare mutations: [genf]), (copy-number variations: [nusq]), (human neurexin genes: [gngm]), (autism: [mobd]), (schizophrenia: [mobd]), ( indicating: []), (impairments: [patf]), (synaptic function: [phsf]), (neurexins: []), (binding partners: [moft]), (pathomechanism: []), (diseases: [dsyn]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')

PMCID: 3850030
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (toxicology studies: [resa]), (potential adverse effects: [patf]), (environmental exposures: [inpo]), (various forms: [phsu]), (life: []), (clinical toxicology: []), (human health: [humn]), (new term: [orgf]), ("translational toxicology": [genf]), (discussion: [socb]), (assertion: []), (core concept: [bdsu]), (translational toxicology: [genf]), (principles: []), (toxicology: []), (epidemiology: [hlca]), (aim: [phsu]), (effective interventions: [hlca]), (simple reduction: [npop]), (avoidance: [menp]), (exposure: [clna]), (mitigate: [phpr]), (adverse human health effects: [humn]), (exposures: [phpr]), (field: [irda]), (point: [qnco]), (advances: []), (multiple areas: [qnco]), (biomedical research: [resa]), (information technologies: []), (fundamental transitions: [acty]), (action elements: []), (assessing: [acty]), (human exposures: [humn]), (critical windows: []), (lifespan: [grpa]), (defining modes: [qnco]), (action: [acty]), (relevance: []), (data: [euka]), (animal models: [anim]), (use: []), (mathematical models: []), (plausible predictions: []), (basis: [phsu]), (protective: []), (restorative human health interventions: [humn]), (critical window: []), (in-utero development: [orgf]), (summary exposure assessment: [acty]), (basic toxicology: []), (development: [orgf]), (certain categories: []), (new areas: []), (research;: [resa]), (order: [acty]), (assess: [acty]), (validate: []), (adverse effects: [patf]), (novel opportunity: []), (portfolio: []), (interventional options: [resa]), (specific preventative/restorative/mitigative therapeutics: [orch,phsu]), 
ASD Terms: (environmental exposures, 'Exposures')(exposure, 'Exposures')(exposures, 'Exposures')(human exposures, 'Exposures')(environmental exposures, 'Exposures')(summary exposure assessment, 'Exposures')

PMCID: 3819162
SFARI Genes: MAGEL2, MAGEL2, MAGEL2, MAGEL2, 
Non SFARI Genes: 
Named Entities: (prader-willi syndrome (pws): [cgab]), (absence: [anab]), (genes: [gngm]), (individuals: [humn]), (mutations: [genf]), (paternal allele: [gngm]), (magel2: [gngm]), (gene: [gngm]), (pws domain: [cgab]), (first subject: [qnco]), (whole genome sequencing analysis: [resa]), (pws features: [cgab]), (additional subjects: [humn]), (results: [fndg]), (exome sequencing: [mbrt]), (cases: [qnco]), (clinical laboratory: [hlca]), (subjects: [humn]), (autism spectrum disorder (asd): [mobd]), (intellectual disability (id): [mobd]), (varying degree: [qnco]), (behavioral features: [inbe]), (pws: [cgab]), (findings: [clna]), (novel gene: [gngm]), (complex asds: [cgab]), (magel2loss: []), (function: [phsf]), (several aspects: [qnco]), (pws phenotype: [cgab]), 
ASD Terms: (prader-willi syndrome, 'Prader-Willi Syndrome')(prader-willi syndrome domain, 'Prader-Willi Syndrome')(prader-willi syndrome features, 'Prader-Willi Syndrome')(prader-willi syndrome, 'Prader-Willi Syndrome')(autism spectrum disorder, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(prader-willi syndrome phenotype, 'Prader-Willi Syndrome')

PMCID: 3783493
SFARI Genes: OXT, AVP, OXT, AVP, OXT, AVP, OXT, AVP, OXT, AVP, OXT, AVP, OXT, AVP, OXT, AVP, 
Non SFARI Genes: impact, 
Named Entities: (autism: [mobd]), (pervasive neurodevelopmental disorder: [mobd]), (thought: [menp]), (combination: [fndg]), (genetic heritability: [topp]), (environmental risk factors: []), (autistic-like traits: [mobd]), (mothers: [famg]), (autistic children: [podg]), (dysregulation: []), (oxytocin (oxt): [aapp,horm,phsu]), ( arg-vasopressin (avp): [aapp,horm,phsu]), (sex hormones: [horm,phsu]), (plasma levels: [bdsu]), (oxt (40: [qnco]), (control group): [grup]), ( avp (40: [qnco]), (sex hormones (61: [horm,phsu]), (normal children: [aggp]), (enzyme immunoassay: [lbpr]), (relationships: []), (childrens: []), (autistic behavior scores: [clna]), (autism rating scale (cars): [mobd]), (autism behavior checklist (abc)): [mobd]), (plasma concentrations: [qnco]), (oxt (p<0.001): [fndg]), (avp (p<0.001): [gngm]), (level: [phsu]), (plasma testosterone (p<0.05): [horm,orch,phsu]), (control: [sbst]), (maternal plasma levels: [bdsu]), (oxt: [gngm]), (avp: [gngm]), (results: [fndg]), ( avp: [gngm]), (testosterone systems: [horm,orch,phsu]), (childrens susceptibility: [clna]), 
ASD Terms: (autism, 'Autism Phenotype')(pervasive neurodevelopmental disorder, 'Learning Disorders')(autism behavior checklist ), 'Autism Phenotype')

PMCID: 3779159
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (interplay: []), (workflow: []), (clinical tasks: []), (research data collection: [resa]), (questions/purposes: []), (knowledge: []), (previous studies: [lbpr]), (standards: []), (comparison: [acty]), (workflow models: []), (research tasks: [resa]), (improvement: []), (data collection: [resa]), (study: [resa]), (term dissonance: [orgf]), (occurrences: []), (discord: [socb]), (research workflows: [resa]), (translational research study: [resa]), (psychiatry: []), (clinic: [hcro,mnob]), (out: []), (points: [qnco]), (dissonance: []), (research models: [resa]), (corresponding classification system: []), (data collection workflow: [resa]), (number: [qnco]), (patients: [podg]), (enrollment: [hlca]), (indicators: [irda]), (efficiency: [qnco]), (research workflow: [resa]), (dissonances: []), (workflow modification: []), (episodes: []), (dissonance categories: actor: []), ( communication: [socb]), ( information: []), ( artifact: [hcpp]), ( time: []), (space: []), (research study: [resa]), (classification: []), (identification: [menp]), (reveal modifications: []), (clinical setting: []), (methodology: []), (researchers: []), (data collection process: [resa]), 
ASD Terms: 

PMCID: 3793312
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (maternal: [famg]), (immune activation (mia): [gngm]), (potential risk factor: [qnco]), (autism spectrum disorder (asd): [mobd]), (schizophrenia (sz): [mobd]), (rodents: [mamm]), ( mia results: [fndg]), (changes: [qnco]), (cytokine profiles: [aapp,imft]), (abnormal behaviors: [mobd]), (offspring: [famg]), (neuropsychiatric conditions: [dsyn]), (central role: [socb]), (mitochondria: [celc]), (immunity: [phsf]), (other metabolic pathways: []), (mia: [gngm]), (fetal imprinting: [menp]), (deficits: []), (bioenergetics: [orgf]), (immune cells: [cell]), (end: [gngm]), (adult: [aggp]), (viral mimic poly(i:c): [nnon,phsu]), (mitochondrial outcomes: [celc]), (significant decrease: [qnco]), (mitochondrial atp production: [celc]), (poly(i:c)-treated mice (45%: [mamm]), (controls): [sbst]), (differences: [qnco]), (groups: [popg]), (coupling: []), (electron transport: [moft]), (atp synthesis: [moft]), (oxygen uptake: [fndg]), (conditions: [dsyn]), (concanavalin a- (cona-): [aapp,bacs]), (splenocytes: [cell]), (poly(i:c) animals: [nnon,phsu]), (significant changes: [qnco]), (cytokine levels: [aapp,imft]), (present study reports: [hlca]), (first time: [qnco]), (mia activation: [acty]), (poly(i:c): [nnon,phsu]), (early gestation: [dsyn]), (behavioral impairments: [inbe]), (sz: [sosy]), (asd: [cgab]), (long-lasting effects: []), (adult offspring: [famg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(abnormal behaviors, 'Personal Traits')(offspring, 'Perinatal History')(early gestation, 'Perinatal History')(behavioral impairments, 'Personal Traits')(adult offspring, 'Perinatal History')

PMCID: 3776732
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (head circumference (hc): [clna]), (typical developing peers: [popg]), (biologic: [bacs]), (overly rapid brain growth: [orgf]), (core symptoms: [sosy]), (asd: [cgab]), (connectivity: []), (literature: [inpr,mnob]), (deleterious: []), ( protective: []), (null associations: [menp]), (hc: [gngm]), (asd symptoms: [cgab]), (autism genetic resource exchange: [mobd]), (associations: [menp]), (symptoms: [sosy]), (mixed models: [fndg]), (sex: [orgf]), ( age: [orga]), ( race/ethnicity: [popg]), (simplex/multiplex status: [bpoc]), (accounting: []), (correlations: []), (siblings: [famg]), (interactions: []), (simplex/multiplex: [bpoc]), (adjustments: [topp]), (height: [orga]), (sub-population: [popg]), (available data: [euka]), (well: []), (significant interaction term (p: [orgf]), (effect: []), (individual: [humn]), (multiplex: []), (simplex individuals: [humn]), (mean age: [orga]), (cm increase: []), (head circumference: [clna]), (increase: []), (odds: []), (high social diagnostic score: [clna]), (autism diagnostic interview: [acty]), ((odds: []), (p: [gngm]), (association: [menp]), (multiplex individuals: [humn]), (additionally: []), ( individuals: [humn]), (non-verbal iq <70: [fndg]), (simplex: [bpoc]), (head circumference (0.7 cm p: [clna]), (relative: [qnco]), (mid-range non-verbal iq group: [popg]), (interestingly: []), ( children: [aggp]), (>110 non-verbal iq: [fndg]), (hc (0.4 cm p: [horm,orch,phsu]), (hc effects: [horm,orch,phsu]), ( however: []), (samples: [sbst]), (height information: [orga]), (potential link: []), (brain growth: [orgf]), (autism: [mobd]), (specific etiologies: []), (further investigations: [hlca]), (likely mode: [qnco]), (inheritance: [qnco]), (asd subtype: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(core symptoms of asd, 'Complaints and Indications')(asd symptoms, 'Complaints and Indications')(autism, 'Autism Phenotype')(asd like symptoms, 'Complaints and Indications')(autism genetic resource exchange, 'Autism Phenotype')(autism diagnostic interview, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4042015
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (basis: [phsu]), (behavioral manifestations: [inbe]), (biomarkers: [clna]), (strong gender bias: [socb]), (autism (it: [mobd]), (times: [qnco]), (males) suggests involvement: [orga]), (steroid hormones: [horm,orch]), (autism pathobiology: [mobd]), (order: [acty]), (potential roles: [socb]), (such hormones: [horm]), (salivary levels: []), (steroids: [orch]), (prepubertal autistic male: [mobd]), (female children: [aggp]), (age groups (34: [aggp]), (years: []), (healthy controls: []), (gas chromatographymass spectrometry: [lbpr]), (radioimmunoassay: [lbpr]), (statistical analysis (anova): [resa]), (autistic children: [podg]), (salivary concentrations: [menp]), (many steroid hormones: [horm,orch]), (c21: [gngm]), (c19): []), (control children: [aggp]), (anomalies: []), (boys: [aggp]), (levels: []), (androgens (androstenediol: [horm,orch,phsu]), (androsterone: [horm,orch]), (polar conjugates): [imft]), (increased: [qnco]), ( indicative: []), (precocious adrenarche: [bacs]), (predictive: []), (early puberty: [dsyn]), (concentrations: [menp]), (steroid precursor: [orch]), ( pregnenolone: [horm,orch,phsu]), (several pregnanolones: [bacs,orch,phsu]), (healthy children: [fndg]), (cortisol levels: [lbtr]), (autism (allopregnanolone: [mobd]), ( androsterone: [horm,orch]), ( dehydroepiandrosterone: [horm,orch,phsu]), (sulfate conjugates): [inch]), (modulate gaba: [aapp,bacs]), ( glutamate: [aapp,bacs]), (opioid neurotransmission: [hops,orch,phsu]), (brain development: [ortf]), (functioning: []), (pathobiology: []), (symptoms: [sosy]), (elevated anxiety: [mobd]), ( sleep disturbances: [dsyn]), (sensory deficits: [dsyn]), (stereotypies: [mobd]), (others: [fndg]), (autism pathology: [mobd]), (progress: []), (therapy: [topp]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s00787-013-0472-0) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')(autism pathobiology, 'Autism Phenotype')(elevated anxiety, 'Anxiety Disorders')(sleep disturbances, 'Sleeping Problems')(sensory deficits, 'Reaction to Sensory Stimuli')(autism pathology, 'Autism Phenotype')

PMCID: 3893450
SFARI Genes: APP, APP, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (unknown etiopathogenesis: []), (functional abnormalities: [cgab]), (neurons: [cell]), (formation: [biof]), (reactive oxygen species: [bacs,elii]), (previous study: [resa]), (enhanced accumulation: [fndg]), (amyloid- (a): [aapp,imft]), (brain neurons: [bpoc]), (glia: [cell]), (children: [aggp]), (adults: [aggp]), (verification: [resa]), (hypothesis: []), (intraneuronal a: []), (oxidative stress: [comd]), (aim: [phsu]), (study: [resa]), (relationships: []), (neuronal a: [imft]), (markers4-hydroxy-2-nonenal (hne): [inch]), (malondialdehyde: [bacs,orch]), (frontal cortex: [bpoc]), (individuals: [humn]), (years: []), (idiopathic autism: [mobd]), (chromosome 15q11.2-q13 duplications: [comd]), (age-matched controls: [orga]), (quantification: [qnco]), (confocal microscopy images: [lbpr]), (levels: []), (neuronal n-truncated a: [imft]), (hne: [gngm]), (mda: [orch,phsu]), (dup(15)/autism: [mobd]), (controls: [sbst]), (lipid peroxidation products: [moft]), (mitochondria: [celc]), (lipofuscin deposits: [bacs,orch]), (numerous autophagic vacuoles: [fndg]), (lysosomes: [celc]), (synapses: [bsoj]), (a levels: []), (results: [fndg]), (self-enhancing pathological process: [patf]), (intraneuronal deposition: []), (n-truncated a: [aapp,imft]), (childhood: []), (cascade: []), (events: [evnt]), (altered app metabolism: [moft]), (abnormal intracellular accumulation: [celc]), (n-terminally: [aapp,imft]), (a: []), (source: [fndg]), (turn increase: [fndg]), (latter enhance a deposition: [acty]), (changes: [qnco]), (functional impairments: [patf]), (unknown etiology: [fndg]), (chromosome: [celc]), (duplication: [comd]), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(idiopathic autism, 'Autism Phenotype')(idiopathic autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3844687
SFARI Genes: MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, MeCP2, MECP2, MeCP2, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, 
Non SFARI Genes: 
Named Entities: (mecp2 gene codes: [gngm]), (methyl cpg binding protein: [gngm]), (activities: [acty]), (other genes: [gngm]), (early development: [orgf]), (brain: [bpoc]), (mutations: [genf]), (gene: [gngm]), (rett: []), (form: []), (autism: [mobd]), (purpose: []), (study: [resa]), (role: [socb]), (cis-elements: [elii]), (post-transcriptional expression: [genf]), (mecp2 gene: [gngm]), (possible correlations: []), (mutation: [genf]), (mental retardation: [mobd]), (bioinformatics approach: []), (cis-regulatory elements: [bacs,nnon]), (transcribed regions: []), (human mecp2 gene: [humn]), (mammalian orthologs: [mamm]), (cis-regulatory motifs: [amas]), (g-quadruplexes: [nusq]), ( microrna target sites: [bacs,nnon]), (au-rich elements: [bacs,nnon]), (significant importance: [qnco]), (key biological processes: [biof]), (therapeutic targets: [diap]), (5-utr (untranslated region): [bacs,nnon]), (mecp2: [gngm]), (g-quadruplex: [nusq]), (deletion: [genf]), (rett syndrome patients: [dsyn]), (decreased levels: [qnco]), (mecp2 protein: [aapp,bacs]), (5-utr g-quadruplex: [bacs,nnon]), (mecp2 translation: [moft]), (key sections: [qnco]), (untranslated regions: [nnon]), (studies: [lbpr]), (regulation: [biof]), (translation: [moft]), ( mrna turnover: [qnco]), (development-related alternative mecp2 polyadenylation: [moft]), (interactions: []), (conserved cis-regulatory elements: [bacs,nnon]), (respective trans factors: []), (complex interactions: [chvs]), (trans factors: []), (g-quadruplex motifs: [amas]), (alternative splice sites: [bacs,nusq]), (constitutive sites: []), (pair: []), (splice site: [blor]), (alternative splicing: [genf]), (positive way: [fndg]), (mecp2 pre-mrnas: [aapp,bacs]), (syndrome mutation: [dsyn]), (decreased protein expression: [genf]), (conserved g-quadruplex: [nusq]), (post-transcriptional gene expression: [genf]), (phylogenetic analysis: [resa]), (valuable insights: [menp]), 
ASD Terms: (autism, 'Autism Phenotype')(rett, 'Rett Syndrome')(mental retardation, 'Mental Retardation')(rett syndrome patients, 'Rett Syndrome')

PMCID: 4091761
SFARI Genes: 5-HT1b, 5-HT1b, 
Non SFARI Genes: 
Named Entities: (social behaviors: [socb]), (species: []), (honey bees: [euka]), (humans: [humn]), (group survival: [popg]), (cost: [qnco]), (individual: [humn]), (reinforcement: [menp]), (adaptive social interactions: [fndg]), (evolutionary persistence: [genf]), (neural mechanisms: []), (social reward: [menp]), (brain: [bpoc]), (mice oxytocin: [mamm]), ((ot) acts: [topp]), (social reinforcement signal: [socb]), (nucleus accumbens: [bpoc]), (core: [bdsu]), (long-term depression: [ortf]), (excitatory synaptic transmission: [ortf]), (medium spiny neurons: [bpoc]), (nac: [gngm]), (ot receptor-containing inputs: [hlca]), (several brain: [bpoc]), (regions: []), ( genetic deletion: [genf]), (receptors: [aapp,rcpt]), (dorsal raphe nucleus: [bpoc]), (serotonergic (5-ht) innervation: [bacs,orch]), (properties: []), (social interaction: [fndg]), (furthermore: []), ( ot-induced: [hlca]), (synaptic plasticity: [ortf]), (activation: [acty]), (5-ht1b receptors: [aapp,rcpt]), (blockade: [phsu]), (results: [fndg]), (mice: [mamm]), (coordinated activity: [acty]), (ot: [gngm]), (mechanistic insight: [menp]), (implications: []), (pathogenesis: [patf]), (social dysfunction: [dsyn]), (neuropsychiatric disorders: [dsyn]), (autism: [mobd]), 
ASD Terms: (social behaviors, 'Reciprocal Social Interaction')(adaptive social interactions, 'Reciprocal Social Interaction')(long-term depression, 'Depressive Disorder')(social interaction, 'Reciprocal Social Interaction')(social interaction, 'Reciprocal Social Interaction')(coordinated activity of oxytocin, 'Motor Skills')(pathogenesis of social dysfunction, 'Social Competence')(coordinated activity, 'Motor Skills')(social dysfunction, 'Social Competence')(autism, 'Autism Phenotype')

PMCID: 3784762
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (social deficits: []), (behavioral abnormalities: [mobd]), (recent evidence: []), (mitochondrial dysfunction: [fndg]), (oxidative stress: [comd]), (etiology: []), (first study: [qnco]), (activities: [acty]), (mitochondrial electron transport chain (etc) complexes (iv): [celc]), (dehydrogenase (pdh): [dsyn]), (mitochondrial dna (mtdna) copy number: [bacs,nnon]), (frontal cortex tissues: [bpoc]), (age-matched control subjects: [humn]), (complexes i: [aapp,enzy]), ( v: []), (pdh: [gngm]), (autism (n=14): [mobd]), (respectively: []), (confidence: [menp]), (interval (ci): [lbpr]), (control group: [grup]), (reference range: [qnco]), (impaired activities: [acty]), ( iii: []), (v: []), (autistic subjects: [mobd]), ( respectively: []), (reduced activities: [acty]), (etc complexes: [chvs]), (autistic cases: [mobd]), (multiple complexes: [chvs]), (results: [fndg]), (defects: []), (complexes: [chvs]), (iii (sites: []), (mitochondrial free radical generation): [celc]), (complex v (adenosine triphosphate synthase): [bacs,nnon,phsu]), (pdh activity: [dsyn]), (ratios: [qnco]), (mtdna: [bacs,nnon]), (mitochondrial genes nd1: [dsyn]), ( nd4: [gngm]), (cyt b (that encode: [orch,phsu]), (subunits: [aapp]), (iii): []), (nuclear dna: [bacs,nnon]), (mtdna copy number: [bacs,nnon]), (ci: [gngm]), (control: [sbst]), (autistic children: [podg]), (copy numbers: [qnco]), (mitochondrial genes: [gngm]), (furthermore: []), (cyt b deletions: [orch,phsu]), (study: [resa]), (brain: [bpoc]), 
ASD Terms: (autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(social deficits, 'Social Competence')(behavioral abnormalities, 'Personal Traits')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3767287
SFARI Genes: Top1, Top1, TOP1, TOP1, 
Non SFARI Genes: Top2b, 
Named Entities: (topoisomerases: [aapp,enzy]), (developing: []), (adult brain: [bpoc]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (however: []), (asd: [cgab]), (topoisomerase: [aapp,enzy]), ((top1): [aapp,enzy]), (expression: [topp]), (long genes: [gngm]), (mouse: [mamm]), (human neurons: [humn]), (genes: [gngm]), (kb: []), (knockdown: []), (top1: [gngm]), (top2b: [gngm]), (neurons: [cell]), ( highlighting: []), (enzyme: [enzy,orch]), (full expression: [topp]), (rna polymerase ii density genome-wide: [aapp,enzy]), (length-dependent effect: [qnco]), (gene expression: [genf]), (impaired transcription elongation: [genf]), (interestingly: []), (many high confidence asd candidate genes: [cgab]), (top1 inhibition: [acty]), (findings: [clna]), (chemicals: [chem]), (genetic mutations: [genf]), (other neurodevelopmental disorders: [mobd]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(other neurodevelopmental disorders, 'Learning Disorders')

PMCID: 4151967
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (timothy syndrome (ts): [dsyn]), (rare exonic mutations: [bacs,nnon]), (cacna1c gene: [gngm]), (inactivation: []), (cav1.2voltage-gated calcium channels: [aapp,bacs]), (cellular action potentials: [celf]), (influx: []), (calcium: [bacs,elii,phsu]), (activated cells: [cell]), (major clinical feature: [clna]), (syndrome: [dsyn]), (long qt interval: [fndg]), (results: [fndg]), (cardiac arrhythmias: [fndg]), (however: []), ( ts: []), (cognitive impairment: [mobd]), ( autism: [mobd]), (major developmental delays: [fndg]), (patients: [podg]), (appearance: [orga]), (bipolar disorder (bd): [mobd]), (patient: [podg]), (case: []), (ts: [gngm]), (few patients: [podg]), (childhood: []), (common snp: [nusq]), (bd: []), (cis-expression quantitative trait locus (eqtl): [gngm]), (cacna1c: [gngm]), (human cerebellum: [humn]), (risk allele (a): [gngm]), (decreased expression: [topp]), (cacna1c perturbations: [gngm]), (presence: [qnco]), (common cacna1c snp risk allele: [gngm]), (increase: []), (decrease: [qnco]), (calcium influx: [bacs,elii,phsu]), (excitable cells: [cell]), (treatment: [topp]), (calcium channel: [aapp,bacs]), (drugs: [topp]), (response: [fndg]), (risk allele: [gngm]), (cacna1c expression: [topp]), 
ASD Terms: (cognitive impairment, 'Cognitive Ability')(autism, 'Autism Phenotype')(major developmental delays, 'Learning Disorders')(bipolar disorder, 'Bipolar Disorder')(bipolar disorder, 'Bipolar Disorder')(bipolar disorder, 'Bipolar Disorder')

PMCID: 3756296
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (cortical neurons: [bpoc]), (superficial layers: [bpoc]), ((ii-iv) represent: [acty]), (pivotal neuronal population: [popg]), (cognitive functions: [menp]), (psychiatric diseases: [mobd]), (developmental manifestations: [orgf]), (schizophrenia: [mobd]), (autism: [mobd]), (differentiation protocols: [celf]), (human pluripotent stem cells: [humn]), (way: []), (vitro modeling: [resa]), (neuropsychiatric diseases: [dsyn]), (however: []), (protocols: []), (asynchronous production: []), (neurons: [cell]), (different layers: [bpoc]), (cortex: [bpoc]), (extended period: []), (culture: [lbpr]), (analysis: [resa]), (specific subtypes: []), (standardized manner: []), (issue: [fndg]), (stable population: [qnco]), (self-renewing late cortical progenitors: [bpoc]), (glutamatergic cortical neurons: [bpoc]), (upper layers: [bpoc]), (short time course: [qnco]), (differentiation: [celf]), (progenitors: [famg]), (high-throughput assays: [diap]), (capability: []), (lcps: []), (post: []), (mitotic neurons: [cell]), (neurites: [celc]), (response: [fndg]), (collection: []), (bioactive molecules: [sbst]), (patient-derived-induced psc: [podg]), ( indicating: []), (system: []), (functional studies: [lbpr]), (individual-specific cortical neurons: [bpoc]), (vivo: []), (disease modeling: [dsyn]), (therapeutic purposes: [topp]), 
ASD Terms: (cognitive functions, 'Cognitive Ability')(psychiatric diseases, 'Mental Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')

PMCID: 3745408
SFARI Genes: 
Non SFARI Genes: NPAT, ATM, CUL5, 
Named Entities: (runs: [dora]), (homozygosity (roh): [orga]), (role: [socb]), (complex diseases: [dsyn]), (current study: [resa]), (rohs: []), (risk: []), (autism: [mobd]), (related language impairment: [mobd]), (snps: [nusq]), (han chinese: [popg]), (controls: [sbst]), (roh: []), (extended homozygous haplotype: [orga]), (kb: []), (relative: [qnco]), (haplotype homozygosity (rehh): [orga]), (trait-associated roh region: [orga]), (signature: [amas]), (selection sweeps: [genf]), (roh regions: []), (roh region: []), (speech delay: [mobd]), (p =: [aapp,imft]), (region: []), (npat: [gngm]), (atm genes: [gngm]), (ataxia telangiectasia: [dsyn]), (language impairment;: [mobd]), (cul5 (culin: [gngm]), (gene: [gngm]), (same region: []), (neuronal migration process: [phpr]), (language functions: [lang]), (genes: [gngm]), (cerebellum: [bpoc]), (evidence: []), (recent positive selection: [lbpr]), (core: [bdsu]), (same roh region: []), (independent sample (p: [aapp,imft]), (combinatorial analysis stouffers z trend: [resa]), (findings: [clna]), (recessive loci: [gngm]), (language impairment: [mobd]), (research: [resa]), (genes influence speech pathology: [gngm]), (cerebellar functions: [dsyn]), 
ASD Terms: (autism, 'Autism Phenotype')(related language impairment, 'Language Ability')(speech delay, 'Idiosyncratic and Routinized Speech')(language impairment, 'Language Ability')(language functions, 'Development or Regression of Language Skills')(language impairment, 'Language Ability')(genes influence speech pathology, 'Language Ability')

PMCID: 3730181
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (highlights: []), (deletion: [genf]), (syn isoforms: [aapp]), (social behavior: [socb]), (synii/ mice display: [mamm]), (social interaction: [fndg]), ( novelty: []), (recognition: [menp]), (syni/: []), (synii/ mice: [mamm]), (social dominance: [socb]), (young: []), (adult syni/: [aggp]), (syniii/ mice exhibit deficits: [mamm]), (social transmission: [patf]), (food preference: []), (social deficits: []), (synii/: [gngm]), (onset: [qnco]), (epilepsy: [dsyn]), 
ASD Terms: (social behavior, 'Reciprocal Social Interaction')(social interaction, 'Reciprocal Social Interaction')(syniii/ mice exhibit deficits in social transmission, 'Social Competence')(social deficits in syni/, 'Social Competence')(onset, 'Onset of Symptoms')(epilepsy, 'Epilepsy')(social deficits, 'Social Competence')

PMCID: 3730054
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (highlights: []), (infants: [aggp]), (relevant information: []), (faces: [blor]), (autism: [mobd]), (tendency: []), (attention: [menp]), (strong face: [blor]), (response: [fndg]), (influence: []), (attentional brain systems: [menp]), 
ASD Terms: (relevant information, 'Ability to Convey Correct Information')(autism, 'Autism Phenotype')

PMCID: 3754459
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), ( heterogeneity: [orga]), (rule: []), (exception: []), (obvious source: [fndg]), (heterogeneity: [orga]), (biological sex: [orgf]), (first recognized: [qnco]), ( males: [orga]), (research: [resa]), (females: [orga]), (same underlying neurobiology: []), (males: [orga]), (evidence: []), ( however: []), (oversimplification: []), (biological base: [inch]), (study: [resa]), (questions: []), (level: [phsu]), (brain: (i): [inch]), (neuroanatomy: []), (females?: [orga]), ((ii): []), (fit predictions: [sosy]), (extreme male brain theory: [bpoc]), (neuroanatomical features: []), (voxel-based morphometry: [lbpr]), (sample: [sbst]), (equal-sized high-functioning male: [orga]), (female adults: [aggp]), (autism (n: [mobd]), (first question: [qnco]), (factorial design: [resa]), (spatial overlap analyses: [resa]), (second question: [qnco]), (specific patterns: []), (adult males: [aggp]), (minimal spatial overlap (not: [topp]), (random condition): [resa]), (grey: [qnco]), (white matter: [tisu]), (large white matter regions: [tisu]), (significant sex: [orgf]), (diagnosis interactions: [fndg]), (autism manifests: [mobd]), (furthermore: []), (atypical brain areas: [bpoc]), (non-randomly (p <: [aapp,imft]), (areas: []), (neurotypical controls: [sbst]), (neural masculinization: [patf]), (differences: [qnco]), (neuroanatomy relate: [orch]), (similarities: []), (cognition: [menp]), (future research: [resa]), (insight: [menp]), (neurobiology: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(diagnosis interactions, 'Diagnosis')(autism manifests, 'Autism Phenotype')(autism, 'Autism Phenotype')(cognition, 'Cognitive Ability')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3715700
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (characteristics: []), (visual orienting: []), (wide range: [qnco]), (atypical developmental outcomes: [orgf]), (current study: [resa]), (development: [orgf]), (visual disengagement: []), (infants: [aggp]), (risk: []), (autism: [mobd]), (efficiency: [qnco]), (central visual stimulus: [ortf]), (cohort: [popg]), (familial risk: [famg]), (virtue: []), (sibling: [famg]), (months: []), (age: [orga]), ( disengagement: []), (diagnostic outcomes: [fndg]), (however: []), (latencies: []), (subset: []), (risk group: [popg]), (other infants: [aggp]), (low-risk control group: [grup]), (moreover: []), ( infants: [aggp]), (consistent increases: [qnco]), (speed: [qnco]), (flexibility: []), (latter developmental effect: [orgf]), (form: []), (developmental concerns: [orgf]), (criteria: []), (autism): [mobd]), (other developmental concerns: [orgf]), (atypicality: []), (visual attention skills: [inbe]), (first year: [qnco]), (life: []), 
ASD Terms: (visual orienting, 'Visual Thinking')(atypical developmental outcomes, 'Learning Disorders')(visual disengagement, 'Visual Thinking')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(central visual stimulus, 'Visual Thinking')(autism, 'Autism Phenotype')(visual orienting, 'Visual Thinking')(visual attention skills, 'Visual Thinking')(other developmental concerns, 'Empathy')

PMCID: 3690523
SFARI Genes: ASMT, ASMT, 
Non SFARI Genes: STS, 
Named Entities: (summary chromosomal deletions: [comd]), (xp22.3: [celc]), (vulnerability: []), (neurodevelopmental disorders attention deficit hyperactivity disorder (adhd): [mobd]), (autism: [mobd]), (mice: [mamm]), (murine orthologue: [mamm]), (xp22.3 adhd candidate gene sts: [orch,phsu]), (steroid sulfatase): [aapp,enzy]), ( exhibit: []), (behavioural phenotypes: [bhvr]), (such disorders: [dsyn]), (hyperactivity): [mobd]), (hippocampal serotonin (5-ht) levels: [bacs,orch]), (reduced serum levels: [bdsu]), (dehydroepiandrosterone (dhea): [horm,orch,phsu]), (recently-characterised murine orthologue: [mamm]), (xp22.3 autism candidate gene asmt: [mobd]), (subsequently: []), (potential behavioural correlates: [inbe]), (genetic lesion: [fndg]), (mf1 mice: [mamm]), (behavioural tasks: [inbe]), (hippocampal and/or 5-ht function (a foraging: [bacs,orch]), (object-location task: [blor]), (1-choice serial reaction time task: [inbe]), (impulsivity): [inbe]), (sts/asmt deficiency: [dsyn]), (behaviour: [inbe]), ( reactivity: []), (familiar objects: []), (novel locations: []), (ability: [orga]), (response rates;: []), (rates: [qnco]), (hippocampal 5-ht levels: [dsyn]), (index: [qnco]), (behavioural perseveration: [inbe]), (frequent feature: []), (neurodevelopmental disorders: [mobd]), (whilst: []), (systematic relationship: []), (serum dhea levels: [lbpr]), (significant inverse: [qnco]), (linear correlation: []), (activity: [acty]), (data: [euka]), (deficiency: [dsyn]), (genes: [gngm]), (behavioural features: [inbe]), (dissociable effects: []), (hippocampal neurochemistry: [ortf]), (hormone levels: [lbtr]), (neurobiological mechanisms: []), (model: []), 
ASD Terms: (neurodevelopmental disorders attention deficit hyperactivity disorder, 'Overactivity')(autism, 'Autism Phenotype')(xp22.3 attention deficit hyperactivity disorder candidate gene sts, 'Overactivity')(xp22.3 autism candidate gene asmt, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(behavioural perseveration, 'Involuntary Behaviors')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 3723491
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (heritable neurodevelopmental disorders: [mobd]), (humans: [humn]), (significant evidence: [qnco]), (onset: [qnco]), (severity: []), (asd: [cgab]), (part: [qnco]), (complex genetic mechanisms: [chvs]), (normal development: [fndg]), (brain: [bpoc]), (number: [qnco]), (genes: [gngm]), (however: []), (spatial co-expression: [topp]), (issue: [fndg]), (co-expression network: [popg]), (autism genes: [gngm]), (autdb (http://mindspec.org/autdb.html): []), (framework: []), (expression energies: [npop]), (correlation: []), (sagittal images: [blor]), (allen mouse brain atlas: [bpoc]), (data: [euka]), (situ hybridization experiments: [mbrt]), (male: [orga]), ( 56-day old c57bl/6j mice: [mamm]), (allen reference atlas: [bpoc]), (normalized co-expression matrix: [phsu]), (cosine similarity: [qnco]), (expression vectors: [nnon]), (database: []), (network: [popg]), (autism-associated genes: [gngm]), (degree: [qnco]), (co-expression connectivity: [topp]), (other genes: [gngm]), (dataset (kolmogorovsmirnov p: []), (monte carlo simulations: [qnco]), (cliques: [popg]), (co-expressed genes: [gngm]), (autism genes (a bonferroni: [gngm]), (p<0.05): [fndg]), (cerebellar cortex (p: [bpoc]), (possible implication: []), (brain region: [blor]), (autism: [mobd]), (study: [resa]), (detailed profiling: [lbpr]), (co-expression patterns: [topp]), (mouse brain: [tisu]), (specific brain regions: [blor]), (new candidate genes: [gngm]), (autism etiology: [mobd]), 
ASD Terms: (heritable neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(onset, 'Onset of Symptoms')(autism genes, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism etiology, 'Medical History')

PMCID: 3731793
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (disordered emotion: [mobd]), (and: []), (particular: []), (deficits: []), (emotional reciprocity: [menp]), (impaired emotion recognition: [menp]), (empathy: [inbe]), (however: []), (close examination: [fndg]), (literature reveals: [inpr,mnob]), (wide heterogeneity: [orga]), (autistic population: [mobd]), (respect: [socb]), (emotional competence: [menp]), (observed: []), ( emotional impairments: [menp]), (condition: [dsyn]), (feature: []), (se: [gngm]), (alexithymia: [sosy]), (reduced ability: [orga]), (one's own emotion: [menp]), (results: [fndg]), (reduced empathy: [inbe]), (impaired ability: [orga]), (emotions: [menp]), (others: [fndg]), (review studies: [lbpr]), (emotion processing: [menp]), (recent series: [qnco]), (studies: [lbpr]), (alexithymia hypothesis': [sosy]), (alexithymia hypothesis: [sosy]), (wide-reaching implications: [orgf]), (study: [resa]), (support subgroups: [virs]), (autistic individuals with: [mobd]), (without: []), (presence: [qnco]), (elevated rates: [qnco]), (inconsistent reports: [hlca]), (emotional impairments: [menp]), (disorders: [dsyn]), ( schizophrenia: [mobd]), ( substance abuse: [mobd]), ( parkinson's disease: [dsyn]), (multiple sclerosis: [dsyn]), (anxiety disorders: [mobd]), (contribution: [acty]), (emotional symptoms: [menp]), (fruit: []), (same way: []), 
ASD Terms: (autism, 'Autism Phenotype')(impaired emotion recognition, 'Empathy')(empathy, 'Empathy')(autism, 'Autism Phenotype')(reduced empathy, 'Empathy')(autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(substance abuse, 'Substance Abuse')(anxiety disorders, 'Anxiety Disorders')

PMCID: 3729742
SFARI Genes: APP, APP, IL-6, IL-6, IL-6, IL-6, 
Non SFARI Genes: Notch1, 
Named Entities: (autistic individuals: [mobd]), (social interactions: [fndg]), (language: [lang]), (restricted: []), (behaviors: [inbe]), (elevated levels: []), (amyloid precursor: [aapp,bacs]), (product: [qnco]), (-secretase cleavage: [aapp,enzy]), (app: [gngm]), (plasma: [bdsu]), (individuals: [humn]), (autism: [mobd]), (sapp protein: [aapp,bacs]), (correlation: []), (glial differentiation: [fndg]), (human neural stem cells: [humn]), (il-6 pathway: [aapp,imft]), (evidence: []), (gliosis: [patf]), (postmortem: [diap]), (autistic brains: [mobd]), (subsets: []), (patients: [podg]), (elevations: []), (cns sapp: [bdsy]), (mice: [mamm]), (observation: [hlca]), (markers: [clna]), (autism-like behavior: [mobd]), (sapp levels: []), (brains: [bpoc]), (autistic patients: [mobd]), (transgenic mice: [mamm]), (human sapp (tgsapp mice): [mamm]), (hypoactivity: [sosy]), (impaired sociability: [socb]), (brain: [bpoc]), (glial fibrillary acidic protein (gfap) expression: [aapp,bacs]), (notch1: [gngm]), (il-6 levels: [aapp,imft]), (tgsapp mice: [mamm]), (wild-type mice: [mamm]), (sapp: []), ( displayed: []), (-tubulin iii: [aapp,bacs]), (gfap expression: [aapp,bacs]), (results: [fndg]), (brain sapp levels: [bpoc]), (tgsapp mice display signs suggestive: [mamm]), (behavioral impairment: [inbe]), 
ASD Terms: (social interactions, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(behavioral impairment, 'Personal Traits')

PMCID: 3731785
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (dysfunctional glutamatergic neurotransmission: [celf]), (autism spectrum disorder (asd): [mobd]), (however: []), (few studies: [lbpr]), (brain glutamate: [aapp,bacs]), (asd adults: [cgab]), (variation: []), (glutamate: [aapp,bacs]), (clinical phenotype: [orga]), (brain glutamate levels: [aapp,bacs]), (adults: [aggp]), (asd: [cgab]), (healthy controls: []), (results: [fndg]), (individuals: [humn]), (different points: [qnco]), (spectrum: [qnco]), (symptom severity: [fndg]), (narrowly': []), (criteria: []), (typical autism: [mobd]), ( whereas: []), (broader phenotype': [orga]), (concentration: [menp]), (combined glutamate: [aapp,bacs]), (glutamine signal (glx): [aapp,bacs,phsu]), (other important metabolites: [bacs]), (proton: [elii]), (magnetic resonance spectroscopy: [diap]), (brain regions: [blor]), (asdthe basal ganglia: [bpoc]), (head: [blor]), (caudate: []), (anterior putamen): [bpoc]), (dorsolateral prefrontal cortexas: []), (parietal cortex control' region: [bpoc]), (significant decrease (p<0.001): [qnco]), (glx: []), (basal ganglia: [bpoc]), (narrow': [qnco]), (broader' phenotype: [orga]), (also: []), (asd sample: [cgab]), (basal ganglia glx: [bpoc]), (increased impairment: [patf]), (social communication (p=0.013): [socb]), (addition: []), (significant reduction: [npop]), (other metabolites: [bacs]), (choline: [bacs,orch,phsu]), ( creatine (cr): [aapp,bacs]), (n-acetylaspartate (naa): [aapp,bacs]), (dorsolateral prefrontal cortex: [bpoc]), ( cr: [gngm]), (naa: [aapp,bacs]), ((p<0.05): [fndg]), (detectable differences: [qnco]), (other metabolite: [bacs]), (parietal lobe control region: [bpoc]), (significant between-group differences: [qnco]), (age: [orga]), ( gender: [orga]), ( iq: []), ( voxel composition: [clna]), (data quality: []), (conclusion: []), ( individuals: [humn]), (specific abnormalities: [cgab]), (subcortical glutamatergic neurotransmission: [celf]), (social development: [socb]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(typical autism, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')(variation in social development, 'Ability to Converse in Social Settings')(social development, 'Ability to Converse in Social Settings')

PMCID: 3731784
SFARI Genes: 
Non SFARI Genes: CRMP1, 
Named Entities: (autism spectrum disorders: [mobd]), (origin: []), (children: [aggp]), (united states: []), (asd-specific maternal autoantibodies: [aapp,imft]), (fetal brain antigens: [imft]), (herein: []), (lactate dehydrogenase a: [aapp,enzy]), (b (ldh): [aapp,enzy]), (stress-induced phosphoprotein: [aapp,bacs]), ((stip1): [gngm]), ( collapsin response mediator: [aapp,bacs]), ((crmp1: [aapp]), ( crmp2): [gngm]), (y-box-binding protein: [aapp,bacs]), (primary antigens: [imft]), (maternal autoantibody-related (mar) autism: [aapp,imft]), (exclusive reactivity: []), (specific antigen combinations: [phsu]), (mothers: [famg]), (asd children: [cgab]), (controls: [sbst]), (specific reactivity: []), (ldh: [aapp,enzy]), ( stip1: [gngm]), (crmp1: [gngm]), (cypin (7%: [gngm]), (controls; p<0.0002;: [sbst]), (ratios: [qnco]), ((95% confidence interval:: [qnco]), (stereotypical behaviors: [mobd]), (antibodies: [aapp,imft]), (first panel: [qnco]), (significant biomarkers: [clna]), (specificity: [qnco]), (autism risk: [mobd]), (understanding: [menp]), (etiologic mechanisms: []), (therapeutic possibilities: [topp]), (mar autism: [mobd]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(fetal brain antigens, 'Allergies')(maternal autoantibody-related autism, 'Autism Phenotype')(primary antigens, 'Allergies')(specific antigen combinations, 'Allergies')(stereotypical behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(maternal autoantibody-related autism, 'Autism Phenotype')(autism risk, 'Autism Phenotype')

PMCID: 3700858
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (high proportions: [qnco]), (autistic children: [podg]), (gastrointestinal (gi) disorders: [dsyn]), (link: []), (autism: [mobd]), (abnormalities: [cgab]), (gut microbial functions: [bdsy]), (evidence: []), (recent high-throughput sequencing analyses: [diap]), (disturbances: []), (composition: [clna]), (diversity: []), (gut microbiome: [orgm]), (various disease conditions: [dsyn]), (however: []), (microbiome-level studies: [orgm]), (pathogenic bacteria: [bact]), (therefore: []), (systemic changes: [qnco]), (autism-related gi problems: [mobd]), (survey: []), (autistic severity: [mobd]), (gi symptoms: [sosy]), (v2/v3 regions: [bpoc]), (rdna: [gngm]), (fecal dna samples: [bacs,nnon]), (gut microbiomes: [orgm]), (gi: [gngm]), (symptom-free neurotypical children: [aggp]), (presence: [qnco]), (autistic symptoms: [mobd]), (severity: []), (diverse gut microbiomes: [orgm]), (further: []), (rigorous statistical tests: [sosy]), (corrections: []), (abundances: []), (genera prevotella: [bact]), ( coprococcus: [bact]), (unclassified veillonellaceae: [bact]), (autistic samples: [mobd]), (versatile carbohydrate-degrading and/or: [orch]), (bacteria: [bact]), (potential influence: []), (unusual diet patterns: [resa]), ( multivariate analyses: [qnco]), (autism-related changes: [mobd]), (overall diversity: []), (individual genus abundances: [humn]), (diet patterns: [resa]), (together: []), ( autism: [mobd]), (diverse gut: [bdsy]), (microbial compositions: [clna]), (levels: []), (prevotella: [bact]), 
ASD Terms: (autism, 'Autism Phenotype')(gastrointestinal disorders, 'Gastrointestinal Diseases')(autism, 'Autism Phenotype')(pathogenic bacteria, 'Bacterial Infections')(autistic symptoms, 'Complaints and Indications')(unusual diet patterns, 'Dietary Restrictions')(bacteria, 'Bacterial Infections')(autistic symptoms, 'Complaints and Indications')(diet patterns, 'Dietary Restrictions')(autism, 'Autism Phenotype')

PMCID: 3696010
SFARI Genes: C3ORF58, C3ORF58, C3ORF58, C3ORF58, 
Non SFARI Genes: 
Named Entities: (catalogues: []), (protein: [aapp,bacs]), (essential effectors: []), (cellular signaling: [celf]), (metazoan genomes: [gngm]), (decade now: [qnco]), (yet: []), ( surprisingly: []), (bioinformatics: []), (protein kinase structure: [aapp,enzy]), (proteins: [aapp,bacs]), (related human genes: [gngm]), (metazoan: [euka]), (fam69 family: [famg]), (analysis: [resa]), (three-dimensional structure models: []), (conservation: []), (classic catalytic motifs: [amas]), (protein kinases: [aapp,enzy]), (human fam69 proteins: [aapp,bacs]), (catalytic phosphotransferase activity: [npop]), (ef-hand ca2+-binding domain: [moft]), (fam69a: [gngm]), (fam69b proteins: [aapp,bacs]), (structure: []), (kinase domain: [aapp,enzy]), (ca2+-dependent kinases: [aapp,enzy]), (fam69 genes: [gngm]), ( fam69a: [gngm]), ( fam69b: [gngm]), ( fam69c: [gngm]), ( c3orf58 (dia1): [gngm]), (cxorf36 (dia1r): [gngm]), (large uncharacterised molecularly: [qnco]), (several neurological disorders: [dsyn]), (genetics: []), (c3orf58 gene: [gngm]), (autism: [mobd]), (resides: [acty]), (golgi: [celc]), (high cysteine content: [aapp,bacs]), (presence: [qnco]), (signal peptides: [amas]), (family members: [famg]), (fam69 proteins: [aapp,bacs]), (phosphorylation: [moft]), (secretory pathway and/or: [celf]), (extracellular proteins: [aapp,bacs]), 
ASD Terms: (several neurological disorders, 'Neurologic Indications')(autism, 'Autism Phenotype')




PMCID: 3686873
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (oxidative stress: [comd]), (role: [socb]), (pathogenesis: [patf]), (autism spectrum disorders (asd): [mobd]), (literature: [inpr,mnob]), (contradictory results: [fndg]), (issue: [fndg]), (high number: [qnco]), (peripheral oxidative stress parameters: [comd]), (related issues: [fndg]), (erythrocyte membrane: [celc]), (functional features: []), (lipid composition: [clna]), (autistic children: [podg]), (years: []), (children (td): [aggp]), (erythrocyte: [cell]), (reactive substances: [sbst]), (urinary isoprostane: [bacs,orch]), (hexanoyl-lysine adduct levels: [aapp,bacs,phsu]), (au: [gngm]), (occurrence: []), (imbalance: [sosy]), (redox status: [moft]), (other oxidative stress markers: [comd]), (parameters: [fndg]), ((urinary 8-oxo-dg: [bacs,nnon]), ( plasma: [bdsu]), (radical absorbance capacity: [qnco]), (carbonyl groups: [popg]), ( erythrocyte superoxide dismutase: [aapp,enzy,phsu]), (catalase activities): [moft]), (significant reduction: [npop]), (na+/k+-atpase activity (66%: [moft]), (reduction: [npop]), (erythrocyte membrane fluidity: [celc]), (alteration: []), (erythrocyte fatty acid membrane profile (increase: [celc]), (monounsaturated fatty acids: [bacs,orch]), ( decrease: [qnco]), (epa: []), (dha-3: [orch,phsu]), (consequent increase: [fndg]), (6/3 ratio): [qnco]), (change: [qnco]), (membrane: [celc]), (sialic acid content: [bacs,orch]), (clinical features: [clna]), (findings;: [clna]), (particular: []), ( hyperactivity score: [mobd]), (lipidomic profile: [lbpr]), (membrane fluidity: [moft]), (erythrocyte membrane alterations: [celc]), (asd: [cgab]), (development: [orgf]), (palliative therapeutic protocols: [hcro]), (moreover: []), (marked decrease: [qnco]), (nka: [gngm]), (peripheral biomarker: [clna]), 
ASD Terms: (autistic childrentism spectrum disorders, 'Autistic Disorder')(hyperactivity score, 'Overactivity')(hyperactivity score, 'Overactivity')

PMCID: 3688993
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (brain tissue changes: [bpoc]), (autism spectrum disorders: [mobd]), (multimodal: [diap]), ( whole brain imaging technique: [diap]), (appropriate approach: []), (alterations: []), (gray matter integrity relate: [orch]), (consistent changes: [qnco]), (functional resting state connectivity: [fndg]), (individuals: [humn]), (autism (hfa): [mobd]), (diffusion tensor: [npop]), ((dti): [diap]), ( voxel-based morphometry (vbm): [lbpr]), (state: []), (functional connectivity: []), (magnetic resonance: [npop]), ((fcmri): [diap]), (differences: [qnco]), (brain structure: [bpoc]), (function: [phsf]), (hfa (mean age: [dsyn]), (sd: [gngm]), (male): [orga]), (healthy controls: []), ((mean age: [orga]), (psychological measures: [qnco]), (empathy: [inbe]), (emotionality: [fndg]), (significant dti: [diap]), ( vbm: [topp]), (fcmri findings: [clna]), (regions: []), (functional differences: [qnco]), (hfa participants: [dsyn]), (controls: [sbst]), (right temporo-parietal junction area: [blor]), (left frontal lobe: [bpoc]), (decreased fractional anisotropy (fa) values: [npop]), (decreased functional connectivity: [qnco]), (trend towards: []), (gray matter volume: [tisu]), (bilateral superior temporal gyrus: [bpoc]), (trend: []), (gray matter volume decrease: [tisu]), (temporal lobe: [bpoc]), (hfa individuals: [dsyn]), (fa decrease: [qnco]), (right temporo-parietal region: [blor]), (psychological measurements: [mobd]), (decreased emotionality: [fndg]), (results: [fndg]), (common sites: [qnco]), (functional alterations: []), (order association cortex areas: [bpoc]), (support: []), (long-standing hypothesis: [phsf]), (autism: [mobd]), (disorder: [dsyn]), (impaired higher-order multisensory integration: [genf]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(empathy, 'Empathy')(autism participants, 'Autism Phenotype')(autism individuals, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3688962
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (copy number variants: [nusq]), (important role: [socb]), (predisposition: [clna]), (spectrum disorder (asd): [cgab]), (however: []), (low frequency: []), (widespread genomic distribution: [gngm]), (accurate characterization: [acty]), (utilization: []), (clinical genetics: []), (comprehensive analysis: [resa]), (multi-study: [qnco]), ( genome-wide cnv data: [nusq]), (autdb: []), (genetic database: []), (detailed annotations: []), (scientific reports: [hlca]), (cnvs: [nusq]), (asd individuals: [cgab]), (asd subjects: [cgab]), (2.12109 bp: [gngm]), (genomic data: [gngm]), (remarkable variation: []), (cnv size: [nusq]), (duplications: []), (deletions: [genf]), ( (p: [aapp,imft]), (wilcoxon rank sum test): [qnco]), (examination: []), (cnv burden: [nusq]), (genome: [gngm]), (loci: [gngm]), (significant excess: [qnco]), (altogether: []), (kb: []), (genes: [gngm]), (locus size (20: [fndg]), (kb): []), (gene content: [gngm]), (multigenic (3 genes): [gngm]), (monogenic loci: [gngm]), (cnv data: [nusq]), (control populations: []), (boundaries: []), (asd susceptibility loci: [cgab]), (interestingly: []), (analysis: [resa]), (genomic region prone: [gngm]), (chromosomal rearrangements: [comd]), (various sizes: [phsu]), ( contains: [acty]), (distinct asd susceptibility cnv: [cgab]), (vary: []), (genomic boundaries: [gngm]), ( cnv types: [nusq]), ( inheritance patterns: [genf]), (overlap: [topp]), (autdb cnv data: [nusq]), (valuable insights: [menp]), (genomic characteristics: [gngm]), (asd susceptibility cnv loci: [cgab]), (various clinical settings: [phsu]), (facilitate future genetic research: [resa]), (disorder: [dsyn]), 
ASD Terms: 

PMCID: 3688832
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objective gastrointestinal symptoms: [sosy]), (common feature: [qnco]), (children: [aggp]), (autism: [mobd]), (attention: [menp]), (potential association: [menp]), (celiac disease: [dsyn]), (sensitivity: [patf]), (however: []), ( studies: [lbpr]), (date: []), (immune response: [ortf]), (association: [menp]), (aim: [phsu]), (study: [resa]), (immune reactivity: []), (pediatric patients: [podg]), (strict criteria: []), (potential link: []), (study participants: [humn]), (children (with: [aggp]), (gastrointestinal symptoms): [sosy]), (autism diagnostic observation schedule (ados): [hlca]), (autism diagnostic interview: [acty]), ((adi-r) (n =: []), (unaffected siblings: [famg]), (age-matched healthy controls: [orga]), (serum specimens: [bdsu]), (antibodies: [aapp,imft]), (native gliadin: [aapp,bacs]), (gliadin: [aapp,bacs]), (transglutaminase: [aapp,enzy]), ((tg2): []), (affected children: [aggp]), (hla-dq2: [aapp,imft]), (-dq8 alleles: [gngm]), (levels: []), (igg antibody: [celc]), (unrelated healthy controls: [fndg]), (igg levels: []), (statistical significance: [qnco]), (igg: []), (anti-gliadin antibody response: [lbpr]), (autistic children: [podg]), (gastrointestinal symptoms: [sosy]), (comparison: [acty]), (difference: [qnco]), (iga response: [fndg]), (groups: [popg]), (celiac disease-specific serologic markers: [dsyn]), ( i.e.: [diap,inpr]), ( antibodies: [aapp,imft]), (tg2: []), (patients: [podg]), (controls: [sbst]), (anti-gliadin antibody: [aapp,imft]), (presence: [qnco]), (hla-dq2 and/or -dq8: [aapp,imft]), (subset: []), (autism displays: [mobd]), (mechanism: []), (gi symptoms points: [qnco]), (potential mechanism: []), (immunologic and/or intestinal permeability abnormalities: [bpoc]), 
ASD Terms: (celiac disease, 'Celiac Disease')(autism, 'Autism Phenotype')(celiac disease, 'Celiac Disease')(autism, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(autism diagnostic interview, 'Autism Phenotype')(autism, 'Autism Phenotype')(autistic children with gastrointestinal symptoms, 'Complaints and Indications')(celiac disease-specific serologic markers, 'Celiac Disease')(autism displays, 'Autism Phenotype')

PMCID: 3681934
SFARI Genes: 
Non SFARI Genes: Rho, Mcf2l, RhoA, Mcf2l, 
Named Entities: (interleukin-1 receptor accessory: [aapp,imft,rcpt]), ((il1rapl1): [aapp,rcpt]), (x-linked mental retardation: [dsyn]), (autism spectrum disorder: [mobd]), (il1rapl1: [gngm]), (synapse formation: [ortf]), (cortical neurons: [bpoc]), (il1rapl1-interacting proteins: [aapp,rcpt]), (affinity chromatography: [lbpr]), (mass spectroscopy: [lbpr]), (mcf2-like (mcf2l): [aapp,bacs]), (rho guanine: [nnon]), (exchange factor: [aapp,enzy]), (cytoplasmic toll/il-1 receptor domain: [aapp,imft]), (knockdown: []), (endogenous mcf2l: [gngm]), (treatment: [topp]), (inhibitor: []), (rho-associated protein kinase: [aapp,enzy]), (downstream kinase: [aapp,enzy]), (rhoa: [gngm]), (il1rapl1-induced excitatory synapse formation: [aapp,rcpt]), (expression: [topp]), (turnover: [qnco]), (ampa receptor subunits: [aapp,rcpt]), (insertion: [genf]), (glua1-containing ampa receptors: [aapp,rcpt]), (cell surface: [celc]), (ampa receptors: [aapp,rcpt]), (glua2/3: [gngm]), (mcf2l knockdown: [gngm]), (rock inhibitor treatment: [topp]), (il1rapl1-induced changes: [aapp,rcpt]), (ampa receptor subunit insertions: [aapp,rcpt]), (results: [fndg]), (mcf2l-rhoa-rock: [aapp,enzy]), (il1rapl1-dependent formation: [aapp,rcpt]), (stabilization: [topp]), (glutamatergic synapses: [bsoj]), 
ASD Terms: (x-linked mental retardation, 'Mental Retardation')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 3898364
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (attention-deficit hyperactivity disorder (adhd): [mobd]), (autism spectrum disorder (asd): [mobd]), (factor analyses: [qnco]), (asd traits: [cgab]), (children: [aggp]), (asd: [cgab]), (presence: [qnco]), (restrictiverepetitive behaviour (rrb) factors: [inbe]), (study: [resa]), (exploratory factor analyses: [qnco]), (structure: []), (social communication questionnaire): [socb]), (adhd: [mobd]), (distinct factors: []), (social: []), (rigidity: [sosy]), (previous factor analyses: [qnco]), (clinical asd: [cgab]), (population samples: [popg]), (split: [phpr]), (rrb dimensions: [qnco]), (moreover: []), (hyperactive-impulsive symptoms: [mobd]), (rrb traits: [gngm]), (investigation: [hlca]), 
ASD Terms: (attention-deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism spectrum disorder, 'Autism Phenotype')(attention-deficit hyperactivity disorder, 'Overactivity')(attention-deficit hyperactivity disorder, 'Overactivity')(restrictiverepetitive behaviour traits, 'Personal Traits')

PMCID: 3661504
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (symptoms: [sosy]), (attention-deficit/hyperactivity disorder (adhd): [mobd]), (children: [aggp]), (autism spectrum disorders: [mobd]), (objective: []), (current study: [resa]), (memory: [menp]), ( acquisition: [acty]), (recall: [menp]), (high-functioning autism (hfa): [mobd]), (adhd: [mobd]), (children (tdc): [aggp]), (thirty-eight children: [aggp]), (hfa: [dsyn]), (tdc (age: [orga]), (letter/number: [qnco]), (task: [gngm]), (verbal list-learning task: [menp]), (possible influence: []), (attention problems: []), (hfa group: [dsyn]), ((hfa+): [dsyn]), ((hfa) attention problems: [dsyn]), (child behaviour checklist: [diap,inpr]), (hfa+: [dsyn]), (significant impairment: [patf]), (neurocognitive measures: [qnco]), (tdc: []), (working memory: [menp]), (acquisition measures: [qnco]), (hfa+ group: [dsyn]), (adhd group: [mobd]), (verbal working memory: [menp]), (recall measures: [menp]), (results: [fndg]), (proposition: []), ( hfa: [dsyn]), (clinical level: [phsu]), (neurocognitive level: [phsu]), (implications: []), (treatment: [topp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(memory, 'Working Memory')(high-functioning autism, 'Autism Phenotype')(high-functioning autism, 'Autism Phenotype')(high-functioning autism, 'Autism Phenotype')(high-functioning autism group, 'Autism Phenotype')(high-functioning autism, 'Autism Phenotype')(neurocognitive measures, 'Cognitive Ability')(working memory, 'Working Memory')(attention-deficit/hyperactivity disorder group, 'Attention Deficit Disorder with Hyperactivity')(verbal working memory, 'Working Memory')(high-functioning autism, 'Autism Phenotype')(attention-deficit/hyperactivity disorder differ, 'Attention Deficit Disorder with Hyperactivity')(neurocognitive level, 'Cognitive Ability')

PMCID: 3655150
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum conditions: [mobd]), (spectrum conditions: [dsyn]), (communicative functioning: [socb]), (features: []), (different etiological factors: []), (hypotheses: []), (independent: [fndg]), (diametric): []), (possible relationship: []), (ascs: []), (sscs: [qnco]), (predictions: []), (relationships: []), (schizotypal phenotypes: [orga]), (autism spectrum quotient: [qnco]), (schizotypal personality questionnaire-brief: [mobd]), (large non-clinical sample: [sbst]), (undergraduate students: [popg]), (previous research: [resa]), (autistic features: [mobd]), (several schizotypal features: [qnco]), (interpersonal schizotypy: []), (communication phenotypes: [socb]), (first component: [qnco]), (principal components analysis (pca): [qnco]), (subscale scores: [clna]), (positive correlations: [fndg]), (presence: [qnco]), (axis (pc1): [bpoc]), (general social interest: [menp]), (aptitude: [menp]), (second principal component (pc2): [gngm]), (pattern: []), (negative loadings indicative: [acty]), (axis: [bpoc]), (autism: [mobd]), (positive schizotypy: [fndg]), (positive schizotypal features: [fndg]), (opposite direction: []), (overall pca patterns: []), (second data set: [qnco]), (japanese population: [popg]), (validity: [qnco]), (interpretation: [clna]), (pca results: [fndg]), (handedness: [orga]), (mental rotation ability: [orga]), (correlates: []), ( respectively: []), (pc2 scores: [clna]), (hand preference: [fndg]), (schizotypal scores: [clna]), (reduced strength: [sosy]), (pc1 scores: [clna]), (performance: [inbe]), (mental rotation: [menp]), (trade-offs: []), (social skills: [socb]), (visual-spatial ability: [menp]), (results: [fndg]), (novel evidence: []), (autism-positive schizotypy axis: [bpoc]), (importance: []), (psychological variation: [mobd]), (social interest: [menp]), (functioning: []), (diverse causes: []), 
ASD Terms: (autism spectrum conditions, 'Autism Phenotype')(schizophrenia spectrum conditions, 'Schizophrenia and Disorders with Psychotic Features')(communicative functioning, 'Reciprocal Social Interaction')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum quotient, 'Autism Phenotype')(general social interest, 'Social Interest')(autism, 'Autism Phenotype')(schizophrenia spectrum conditions, 'Schizophrenia and Disorders with Psychotic Features')(suggesting trade-offs between social skills, 'Ability to Converse in Social Settings')(social skills, 'Ability to Converse in Social Settings')(social interest, 'Social Interest')

PMCID: 3652084
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (severe neurodevelopmental disorder: [mobd]), (diverse pathophysiological processes: [phpr]), (recent gene expression data: [genf]), (control: [sbst]), (normal differential gene expression: [genf]), (temporal cortex: [bpoc]), (autistic brains: [mobd]), (regional de-differentiation occurs: [celf]), (autistic brain: [mobd]), (high resolution: [lbpr]), (genome-wide rna expression microarrays: [genf]), (brain specimens: [bpoc]), (stringent selection criteria: []), (gene expression data: [genf]), (other regions: brodmann area: [blor]), ((occipital cortex): [bpoc]), (cerebellar cortex: [bpoc]), (contrast: [irda]), (frontal/temporal cortical data: [euka]), (data: [euka]), (attenuation: [acty]), (regional specialization: []), (cerebellar cortical regions: [bpoc]), 
ASD Terms: (autism, 'Autism Phenotype')(severe neurodevelopmental disorder, 'Learning Disorders')

PMCID: 3651174
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (complex developmental disability: [mobd]), (deficits: []), (social interaction: [fndg]), ( language: [lang]), (repetitive stereotyped behaviors: [mobd]), (interests: [menp]), (great heterogeneity: [orga]), (previous findings: [clna]), (atypical brain connectivity patterns: [bpoc]), (small-world network properties: [popg]), (however: []), (organizational alterations: [orgt]), (autistic brain network: [popg]), (possible organizational alterations: [orgt]), (autistic children: [podg]), (brain network metrics: [orch,phsu]), (cortical thickness correlations: [bpoc]), (modules: []), (controls: [sbst]), (cortical regions: [bpoc]), (brain functions: [ortf]), (executive strategic: [menp]), ( spatial/auditory/visual: [gngm]), (self-reference/episodic memory: [menp]), (similar patterns: []), ( autism: [mobd]), (gross network modularity: [popg]), (number: [qnco]), (inter-module connections: []), (autistic brain network demonstrates: [popg]), (inter-module connectivity: []), (brain regions: [blor]), (middle frontal gyrus: [bpoc]), (inferior parietal gyrus: [bpoc]), (cingulate: []), (underlying compensatory mechanism: []), (self-reference: []), (episodic memory: [menp]), (results: [fndg]), (correlation strength: [qnco]), (regions: []), (frontal lobe: [bpoc]), (impaired correlation strength: [qnco]), (frontoparietal regions: []), (alteration: []), (organization alteration: [orgt]), (network structures: [popg]), (autistic brains: [mobd]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(complex developmental disability, 'Learning Disorders')(repetitive stereotyped behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(brain functions of executive strategic, 'Executive Function')(self-reference/episodic memory, 'Working Memory')(autism, 'Autism Phenotype')(episodic memory, 'Working Memory')

PMCID: 3619456
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (hope: [menp]), (early markers: [clna]), (autism: [mobd]), ( attention: [menp]), (study: [resa]), (infants: [aggp]), (risk: []), (siblings: [famg]), (children: [aggp]), (condition: [dsyn]), (heritable: []), ( later-born siblings: [famg]), (diagnosed children: [aggp]), (autism phenotype: [mobd]), (general population: [popg]), (currently: []), (strong predictors: []), (early infancy: []), (diagnosis: [fndg]), (years: []), (age: [orga]), (indicators: [irda]), (brain functioning: [ortf]), (sensitive predictors: [patf]), (atypical social interactions: [fndg]), (syndrome: [dsyn]), (temporal lobe specialization: [bpoc]), (auditory social stimuli: [phsf]), (infancy differs: []), (functional near-infrared spectroscopy study: [lbpr]), ( infants: [aggp]), (months: []), (selective neural responses: [genf]), (social stimuli (auditory: [phpr]), (visual): []), (low-risk controls: [fndg]), (group differences: [popg]), (overall levels: []), (attention: [menp]), ( developmental stage: []), (chronological age: [orga]), (results: [fndg]), (first demonstration: [qnco]), (specific differences: [qnco]), (localizable brain function: [ortf]), (life: []), (group: [popg]), (further: []), (differences: [qnco]), (patterns: []), (neural atypicality: []), (adults: [aggp]), (future work: []), (infant neural responses: [aggp]), (social stimuli: [phpr]), (unaffected family members: [famg]), 
ASD Terms: (autism, 'Autism Phenotype')(autism phenotype, 'Autism Phenotype')(autism, 'Autism Phenotype')(years of age, 'Onset of Symptoms')(early infancy, 'Perinatal History')(diagnosis, 'Diagnosis')(infancy differs, 'Perinatal History')(atypical social interactions, 'Reciprocal Social Interaction')(social stimuli than low-risk controls, 'Ability to Converse in Social Settings')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3653096
SFARI Genes: SCN5A, SCN5A, CACNA1C, CACNA1C, 
Non SFARI Genes: KCNQ1, KCNH2, KCNE1, 
Named Entities: (timothy syndrome: [dsyn]), (qt syndrome type: [dsyn]), (ventricular tachyarrhythmia: [dsyn]), (30-month-old boy: [aggp]), (sudden cardiac arrest: [patf]), (anesthesia induction: [topp]), (plastic surgery: [topp]), (bilateral cutaneous syndactyly: [fndg]), (successful resuscitation: [topp]), (qt: [qnco]), (interval (qtc: []), ( 0.58-0.60 sec): [fndg]), (t-wave alternans: [fndg]), (electrocardiogram: [fndg]), (-blocker: []), (further tachycardia: [patf]), (collapse event: [patf]), (arrhythmic events: [evnt]), (genes kcnq1: [gngm]), ( kcnh2: [gngm]), ( kcne1: [gngm]), (scn5a: [gngm]), (long qt syndrome: [dsyn]), (mutation p.gly406arg: [genf]), (cacna1c: [gngm]), (l-type calcium channel depolarization: [aapp,bacs]), (heart: [bpoc]), (other systems: []), 
ASD Terms: 

PMCID: 3649927
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (disorder: [dsyn]), (disease: [dsyn]), (abnormal neurodevelopment: [ortf]), (present work: [qnco]), (hypothesis: []), (suite: []), (core: [bdsu]), (autism-related traits: [mobd]), (simple delays: []), (non-completion: []), (typical childhood: []), (developmental trajectories: [orgf]), (discussion: [socb]), (comprehensive review: []), (literature: [inpr,mnob]), (regard: []), (phenotypes: [orga]), ((1): [fndg]), (interests: [menp]), (repetitive behavior: [fndg]), ( (2) short-range: [qnco]), (functional brain connectivity: [bpoc]), ( (3): [fndg]), (local visual perception: [orgf]), (processing: [acty]), (presence: [qnco]), (differences: [qnco]), (autistic individuals: [mobd]), (individuals: [humn]), (children: [aggp]), (summary: []), (results: [fndg]), (study: [resa]), (model: []), (developmental heterochrony: [orgf]), (evolutionary extension: [genf]), (child development: [orgf]), (human lineage: [humn]), (genetic risk: [qnco]), (expression: [topp]), (autistic perception: [mobd]), ( cognition: [menp]), (behavior: [inbe]), 
ASD Terms: (autism, 'Autism Phenotype')(restricted interests, 'Restricted Range of Interests')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(local visual perception, 'Visual Thinking')(autism, 'Autism Phenotype')(autistic perception, 'Cognitive Ability')(cognition, 'Cognitive Ability')(cognition, 'Cognitive Ability')

PMCID: 3636468
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (psychiatric disorders: [mobd]), (diverse set: [menp]), (diseases: [dsyn]), (aspects: [qnco]), (mental function: [menp]), (social interaction: [fndg]), ( thinking: [menp]), ( feeling: [menp]), (mood: [menp]), (large economic burden: [qnco]), (drugs: [topp]), (variable efficacy: [resa]), (intolerable side-effects: [patf]), (development: [orgf]), (novel drugs: [topp]), (lack: []), (knowledge: []), (etiology: []), (further investigate psychiatric disorders: [mobd]), (combination: [fndg]), (human molecular genetics: [humn]), (gene-by-environment studies: [gngm]), (biochemistry: []), (animal models: [anim]), (investigation: [hlca]), (non-biological basis: [phsu]), (environmental effects: [npop]), (many psychiatric disorders: [mobd]), (autism spectrum: [mobd]), (attention-deficit/hyperactivity disorder: [mobd]), (mental retardation: [mobd]), (schizophrenia: [mobd]), (alterations: []), (neural development: [orgf]), (zebrafish: [fish]), (popular model: [socb]), (developmental biology: []), (human disease: [humn]), (recent work: []), (approach: []), (well: []), (however: []), (complex mental functions: [menp]), (human specific: [humn]), (fish: [gngm]), (review: []), (suitability: []), (developmental studies: [orgf]), (genetic tools: [topp]), (them: []), (powerful model: [hcpp]), (roles: [socb]), (genes: [gngm]), (relative speed: [qnco]), (ease: [menp]), (experiments: [resa]), (areas: []), (contribution: [acty]), (environmental factors: []), (onset: [qnco]), (screening: [diap]), (novel therapeutic compounds: [chem]), 
ASD Terms: (mental function, 'Cognitive Ability')(psychiatric disorders, 'Mental Disorders')(social interaction, 'Reciprocal Social Interaction')(mood, 'Mood')(further investigate psychiatric disorders, 'Mental Disorders')(many psychiatric disorders, 'Mental Disorders')(autism spectrum, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(mental retardation, 'Mental Retardation')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(complex mental functions, 'Cognitive Ability')(disease onset, 'Onset of Symptoms')

PMCID: 3899449
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (traits: [gngm]), (autistic spectrum disorders: [mobd]), (attention deficit hyperactivity disorder (adhd): [mobd]), (significance: [qnco]), (presence: [qnco]), (terms: [orgf]), (phenotype: [orga]), (underlying neurobiology: []), (analysis: [resa]), (levels: []), (autistic traits: [mobd]), (social communication questionnaire (scq): [socb]), ( index: [qnco]), (severe presentation: []), (large: [gngm]), (sample: [sbst]), (children: [aggp]), (adhd (n: [mobd]), (regression analyses: []), (association: [menp]), (scq scores: [clna]), (core adhd: [mobd]), (clinical comorbidities: []), (developmental features: [orgf]), (adjustment: [inbe]), (putative confounders: []), (outcomes: []), (total scq score: [clna]), (secondary analyses: [neop]), (differential association: [menp]), (asd sub-domains: [cgab]), (results: [fndg]), (asd symptomatology: [cgab]), (adhd: [mobd]), (severe phenotype: [fndg]), (oppositional: [menp]), ( conduct: [inbe]), (anxiety symptoms: [fndg]), (full-scale iq: [acty]), (memory deficits: [mobd]), (general motor problems: [hlca]), (associations: [menp]), (adhd severity: [mobd]), (autistic symptomatology: [mobd]), (severity: []), (comorbid impairments: [patf]), (context: [fndg]), (sub-domain scores: [clna]), (unique contributions: [acty]), (social deficits: []), (oppositional symptoms: [sosy]), (repetitive behaviours: [inbe]), (hyperactive-impulsive symptoms: [mobd]), (motor problems: []), (clinicians: []), (repetitive traits: [gngm]), (diagnostic criteria: []), (asd: [cgab]), (index: [qnco]), (phenotypic complexity: [orga]), (implications: []), (efficacy: [resa]), (interventions: [hlca]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s00787-013-0398-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autistic spectrum disorders, 'Autistic Disorder')(attention deficit hyperactivity disorder, 'Overactivity')(social communication questionnaire, 'Reciprocal Social Interaction')(social communication questionnaire, 'Reciprocal Social Interaction')(core attention deficit hyperactivity disorder, 'Overactivity')(clinical comorbidities, 'Comorbidities')(total social communication questionnaire, 'Reciprocal Social Interaction')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(anxiety symptoms, 'Anxiety Disorders')(memory deficits, 'Working Memory')(general motor problems, 'Motor Skills')(comorbid impairments, 'Comorbidities')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention deficit hyperactivity disorder severity, 'Overactivity')(social deficits, 'Social Competence')(repetitive behaviours, 'Restricted and Repetitive Behavior')(motor problems, 'Motor Skills')

PMCID: 3631200
SFARI Genes: ATP2B2, ATP2B2, ATP2B2, ATP2B2, ATP2B2, ATP2B2, ATP2B2, ATP2B2, ATP2B2, ATP2B2, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (heritability: []), (atp2b2: [gngm]), (human chromosome: [celc]), (plasma membrane: [celc]), (calcium-transporting atpase: [aapp,enzy]), (extrudes ca2+: [orch]), (cytosol: [celc]), (extracellular space: [bsoj]), (recent studies: [lbpr]), (association: [menp]), (samples: [sbst]), (autism genetic resource exchange (agre): [mobd]), (italy: []), (study: [resa]), (atp2b2 polymorphisms: [genf]), (chinese han population: [popg]), (family: [famg]), (association study: [menp]), (snps (rs35678: [nusq]), (exon: [bacs,nnon]), ( rs241509: []), ( rs3774180: []), ( rs3774179: []), (rs2278556: []), (introns): [bacs,nnon]), (autism trios: [aapp,enzy]), (han chinese descent: [famg]), (snps: [nusq]), (sequenom genotyping platform: [lbpr]), (family-based association test (fbat) program: [socb]), (association test: [diap]), (haplotype analyses: [orga]), (preferential transmission: [patf]), (t allele: [gngm]), (rs3774179: []), (affected offsprings: [famg]), (additive model (t>c: [clna]), ( z: []), (p: [gngm]), (c allele: [gngm]), (undertransmission: []), (parents: []), (affected children: [aggp]), (dominant model: []), ((z = 2.482: [qnco]), ( p: [aapp,imft]), (z = 2.591: [qnco]), (haplotype: [orga]), (haplotypes: [orga]), (haplotype c-c (rs3774180rs3774179): [orga]), (significant undertransmission: [qnco]), (specific: []), (global haplotype fbat (z = 2.037: [orga]), (global p: []), (c-a: []), (protective haplotype (z = 2.206: [orga]), (t-a: [topp]), (excess transmission: [patf]), (results: [fndg]), (permutation method: [lbpr]), (empirical p values: [qnco]), (research: [resa]), (role: [socb]), (etiology: []), 
ASD Terms: (autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism genetic resource exchange, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism trios, 'Autism Phenotype')(affected offsprings, 'Perinatal History')(autism, 'Autism Phenotype')

PMCID: 3626795
SFARI Genes: 
Non SFARI Genes: F2, 
Named Entities: (autism: [mobd]), (agenesis: [cgab]), (corpus callosum (agcc): [bpoc]), (anatomic phenotypes: [orga]), (genetic etiologies: [topp]), (btbr t+ tf/j (btbr) strain: [aapp,imft]), (penetrant agcc: []), (diminished hippocampal commissure: [bsoj]), (abnormal behaviors: [mobd]), (face validity: []), (genetic basis: [phsu]), (disorders: [dsyn]), (progeny: [famg]), (f2 intercross: [gngm]), (btbr: [mamm]), (c57bl/6j strains: [mamm]), (social behaviors: [socb]), (juveniles: [aggp]), (adults): [aggp]), (commisural morphology: [fndg]), (markers: [clna]), (quantitative trait loci (qtl): [gngm]), (genome scans;: [mbrt]), (significant loci: [gngm]), (btbr genome: [gngm]), (candidate genes: [gngm]), (six qtl: [gngm]), (genome-wide significance: [gngm]), (autism-relevant behaviors: [mobd]), (chromosomes: [celc]), (novel qtl: [gngm]), (commissural morphology: [fndg]), (significant qtl (lod: [qnco]), (callosal morphology: [fndg]), (distal end: []), (chromosome: [celc]), (several qtl: [gngm]), (autism-relevant traits: [mobd]), (btbr mouse: [mamm]), (twenty-nine candidate genes: [gngm]), (synaptic activity: [acty]), ( axon guidance: [celf]), (neural development: [orgf]), (role: [socb]), (processes: [phpr]), (white matter tract development: [tisu]), (aspects: [qnco]), (findings: [clna]), (mouse model: [emod]), (preclinical studies: [resa]), (agcc: []), 
ASD Terms: (autism, 'Autism Phenotype')(abnormal behaviors, 'Personal Traits')(social behaviors, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')

PMCID: 3626551
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (brain inflammation: [dsyn]), (pathogenesis: [patf]), (neuropsychiatric diseases: [dsyn]), (autism spectrum disorders: [mobd]), (learning disabilities: [mobd]), (children: [aggp]), (usa: []), (definitive pathogenesis: [patf]), (reliable biomarkers: [clna]), (asd: [cgab]), (development: [orgf]), (effective therapies: [topp]), (many children: [aggp]), (asd regress: [cgab]), (age: [orga]), (years: []), (specific event: [evnt]), (reaction: []), (infection: [dsyn]), ( stress: [fndg]), (trauma: [inpo]), (epigenetic triggers: [clna]), (distinct phenotype: [orga]), (asd children: [cgab]), (food: [imft,phsu]), (skin allergies: [dsyn]), (hormone (crh): [horm]), (stress: [fndg]), (neurotensin (nt): [aapp,horm]), (mast cells: [cell]), (microglia: [cell]), (focal brain inflammation: [dsyn]), (neurotoxicity: [inpo]), (nt: [diap]), (serum: [bdsu]), (mitochondrial dna (mtdna): [bacs,nnon]), (cell secretion: [celf]), (mtdna: [bacs,nnon]), (innate pathogen: [orgm]), (auto-inflammatory response: [patf]), (phosphatase: [aapp,enzy]), (tensin homolog (pten) gene mutation: [aapp,enzy]), (risk: []), (hyper-active mammalian target: [mobd]), (rapamycin (mtor) signalling: [aapp,enzy]), (cellular homeostasis: [celf]), (crh: [gngm]), ( nt: [diap]), (environmental triggers: [clna]), (activated mtor: [aapp,enzy]), (stimulate mast cell: [cell]), (microglia activation: [celf]), (proliferation: [patf]), (natural flavonoid luteolin inhibits: [orch,phsu]), (significant benefit: [qnco]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(learning disabilities, 'Learning Disorders')(trauma, 'Post-Traumatic Stress Disorders')(skin allergies, 'Allergies')

PMCID: 3610904
SFARI Genes: 
Non SFARI Genes: Atxn1L, Atxn1L, 
Named Entities: (hematopoietic stem cells (hscs): [cell]), (rare quiescent cells: [cell]), (cellular components: [celc]), (peripheral blood: [bdsu]), (ataxia-associated gene ataxin-1-like (atxn1l): [sosy]), (hscs: [cell]), (role: [socb]), (hsc function: [phsf]), (vitro: []), (vivo assays: [lbpr]), (mice: [mamm]), (atxn1l: [gngm]), (numbers: [qnco]), (blood: [bdsu]), (wild-type counterparts: [gngm]), (molecular analyses: [mbrt]), (null hscs: [cell]), (gene expression changes: [genf]), (program consistent: [phsu]), (level: [phsu]), (proliferation: [patf]), (novel regulator: []), (hsc quiescence: [cell]), (additional brain-associated genes: [gngm]), (candidates: []), (hematologic regulation: [biof]), (genes: [gngm]), (proteins: [aapp,bacs]), (ataxia-associated proteinprotein interaction networks: [sosy]), (representation: [acty]), (hematopoietic cell populations: [popg]), (interactomes: []), (progeny: [famg]), (data: [euka]), (heretofore: []), (unappreciated similarity: []), (regulatory modules: []), (brain: [bpoc]), (new strategy: [menp]), (novel gene discovery: [mbrt]), (systems: []), 
ASD Terms: 

PMCID: 3690969
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (children: [aggp]), (autism: [mobd]), (elevated frequency: [qnco]), (large: [gngm]), (rare copy number variants: [nusq]), (however: []), (global load: [acty]), (deletions: [genf]), (se: [gngm]), (size: []), ( location: [blor]), (relationship: []), (clinical manifestations: []), (cnv data: [nusq]), (individuals: [humn]), (typical development: [orgf]), (population-based childhood autism risks: [mobd]), (genetics: []), (environment (charge) study: [orga]), (regions: []), (segmental duplications: [nnon]), (hotspots): [nusq]), (events: [evnt]), (>50 kbp: [aapp,enzy,rcpt]), (entire genomic backbone: [gngm]), (variants: []), (custom: [acty]), (dna microarray: [mbrt]), (analysis: [resa]), (separate study: [resa]), (dynamic hotspots: [nusq]), (developmental delay syndromes: [dsyn]), (tiled array platform (>1 kbp): [aapp,enzy,rcpt]), (gender: [orga]), (ethnicity: [popg]), (significant increase: [qnco]), (number: [qnco]), (base pairs: [moft]), (duplication: [comd]), (levels: []), (cnv load: [nusq]), (removal: [topp]), (rare: [gngm]), (likely pathogenic events: [evnt]), (entire cnv load: [nusq]), (tiled array: []), (common variants: [qnco]), (impact: [gngm]), (variation: []), (correlation: []), (clinical outcomes: []), (level: [phsu]), (social skills: [socb]), (vineland adaptive behavior scales: []), ((spearman's r = 0.13: [fndg]), ( p: [aapp,imft]), (duplication cnv load: [nusq]), (affected children;: [aggp]), (association: [menp]), (communication (p: [socb]), (socialization (p: [edac]), (scores: [clna]), (cnv: [nusq]), (genomic base pairs: [moft]), ( predisposes: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(population-based childhood autism risks, 'Autism Phenotype')(developmental delay syndromes, 'Learning Disorders')(social skills, 'Ability to Converse in Social Settings')(vineland adaptive behavior scales, 'Adaptive Life Skills')

PMCID: 3680076
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (investigation: [hlca]), (environmental contribution: [acty]), (developmental neurotoxicity: [inpo]), (many environmental chemical exposures: [inpo]), (development: [orgf]), (neurological disorders: [dsyn]), (children: [aggp]), (results: [fndg]), (animal studies: [anim]), (investigations: [hlca]), (human populations: [popg]), (environmental toxicants: [hops]), (drugs: [topp]), (neurotoxicity: [inpo]), (treatment: [topp]), (neurodevelopmental disorders: [mobd]), (objective: []), (protective: []), (therapeutic effects: [clna]), (n-acetyl cysteine: [aapp,phsu]), (brain intoxication: [bpoc]), (propionic acid (ppa): [orch]), (rats: [mamm]), (twenty-eight young male: [orga]), (western albino rats: [mamm]), (present study: [qnco]), (equal groups: [popg]), (animals: [anim]), (group: [popg]), (control group: [grup]), (saline; group: [sbst]), (ppa-treated group: [mobd]), (neurotoxic dose: [inpo]), (ppa: [mobd]), (mg/kg body weight/day: [qnco]), (days; group: [popg]), (protective group: [popg]), (dose: [qnco]), (mg/kg body: [humn]), (weight/day n-acetyl-cysteine: [orga]), (week: []), (similar dose: [qnco]), (days;: []), (therapeutic group: [topp]), (same dose: [qnco]), (toxic dose: [qnco]), (serotonin: [bacs,orch]), ( interferon gamma: [aapp,imft,phsu]), (glutathione-s-transferase activity: [moft]), (comet dna: [mbrt]), (brain tissue: [bpoc]), (different groups: [lbpr]), (data: [euka]), (multiple signs: [fndg]), (brain toxicity: [bpoc]), (depletion: []), ((5ht): [bacs,orch]), ( increase: []), (ifn-: []), (inhibition: [acty]), (biomarkers: [clna]), (brain dysfunction: [dsyn]), (tail length: [bpoc]), (dna % damage: [comd]), (tail moment: [bpoc]), (n-acetyl-cysteine: [aapp,phsu]), (neurotoxic effects: [inpo]), (low dose: [qnco]), (short duration: []), (n-acetyl-cysteine treatment: [aapp,phsu]), (ppa-induced neurotoxicity: [mobd]), (remarkable amelioration: []), (impaired biochemical parameters: [fndg]), (neurochemical: []), ( inflammatory: []), ( detoxification: [orgf]), (dna damage processes: [comd]), 
ASD Terms: (neurological disorders, 'Neurologic Indications')(many environmental chemical exposures, 'Exposures')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 3884762
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (chromosomal copy number variants: [celc]), (common genetic lesion: [fndg]), (autism: [mobd]), (many autism-associated cnvs: [nusq]), (duplications: []), (chromosome: [celc]), (cases: [qnco]), (interstitial (int) dup(15): [blor]), (unaffected paternal duplications: [famg]), (phenotype/genotype analysis: [orga]), (individuals: [humn]), (understanding: [menp]), (syndrome: [dsyn]), (contribution: [acty]), (duplication: [comd]), (autism risk: [mobd]), (subjects: [humn]), (basis: [phsu]), (interstitial duplication: [comd]), (status: []), (comparative array: []), (genome hybridization: [npop]), (duplication size: [comd]), (boundaries: []), (methylation status: [moft]), (small nuclear ribonucleoprotein: [aapp,bacs]), (n gene: [gngm]), (parent: []), (origin: []), (parental origin: []), (int dup(15): [orch]), (paternal cases: [qnco]), (majority: [socb]), (int dup(15) cases: [orch]), (maternal duplication: [comd]), (autism spectrum disorder: [mobd]), (size: []), (severity: []), (phenotype: [orga]), (autism diagnostic observation scale: [hlca]), (severity score: [qnco]), (phenotypes: [orga]), (cohort: [popg]), (mild facial dysmorphism: [fndg]), ( sleep problems: [dsyn]), (unusual electroencephalogram variant: [lbtr]), (results: [fndg]), (hypothesis: []), (ubiquitin protein ligase e3a gene: [lbpr]), (autism phenotype: [mobd]), (maternal cases: [qnco]), (autism spectrum: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(autism risk, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism diagnostic observation scale, 'Autism Phenotype')(sleep problems, 'Sleeping Problems')(autism phenotype, 'Autism Phenotype')(autism spectrum, 'Autism Phenotype')

PMCID: 3596371
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (environmental factors: []), (mitochondria act: [topp]), (genes: [gngm]), (environment: []), (gene-encoded metabolic networks: [moft]), (changes: [qnco]), (chemistry: [lbpr]), (cell: [gngm]), (mitochondrial atp: [celc]), (other metabolites: [bacs]), (molecules: [sbst]), (undergo: []), (release: [hlca]), (cells: [cell]), (cellular health: [cell]), (danger: [gngm]), (purinergic signaling: [celf]), (role: [socb]), (objectives: []), (maternal immune activation (mia) mouse model: [emod]), (gestational poly(ic) exposure: [nnon,phsu]), (treatment: [topp]), (non-selective purinergic antagonist suramin: [orch,phsu]), (c57bl/6j mice: [mamm]), (antipurinergic therapy (apt): [topp]), (multisystem abnormalities: [cgab]), (asd-like phenotype: [cgab]), (model: []), (correction: []), (core: [bdsu]), (social deficits: []), (sensorimotor coordination: [phsf]), (prevention: [resa]), (cerebellar purkinje cell: [cell]), (ultrastructural synaptic dysmorphology: []), (hypothermia: [fndg]), ( metabolic: [celf]), ( mitochondrial: [celc]), ( p2y2: [aapp,rcpt]), (p2x7: [gngm]), (receptor expression: [genf]), (erk1/2: [aapp,enzy]), (camkii: [aapp,enzy]), (signal transduction abnormalities: [celf]), (hyperpurinergia: []), (treatable feature: []), (poly(ic) mouse model: [nnon,phsu]), (antipurinergic therapy: [topp]), (new tool: []), (current concepts: [npop]), (pathogenesis: [patf]), (autism: [mobd]), (related spectrum disorders: [dsyn]), (fresh path forward: [lbpr]), (new drug development: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(gestational poly exposure, 'Perinatal History')(sensorimotor coordination abnormalities, 'Motor Skills')(social deficits, 'Social Competence')(sensorimotor coordination, 'Motor Skills')(autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3637561
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (fragile x syndrome (fxs): [cgab,dsyn]), (associated disorders: []), (expansion: []), (cgg repeat: [dsyn]), (untranslated region: [nnon]), (fragile x: [comd]), (mental retardation: [mobd]), ((fmr1) gene: [gngm]), (disease classification: []), (number: [qnco]), (cgg repeats: [dsyn]), (mechanisms: []), (repeat expansion: []), (presence: [qnco]), (cis elements: [elii]), (absence: [anab]), (trans factors: []), (contribute: [acty]), (instability: [fndg]), (expansions: []), (haploinsuffient: []), (reduced expression: [topp]), (several dna repair/metabolizing proteins: [aapp,bacs]), (reduction: [npop]), (expression: [topp]), (animal models: [anim]), (substantial examination: []), (expansion mechanisms: []), (humans: [humn]), (pathways: [moft]), (trinucleotide repeat expansion: [comd]), (microarray datasets: []), (transcript expression: [topp]), (patients: [podg]), (fxs: []), (controls: [sbst]), (regulation: [biof]), (dna damage/repair pathway transcripts: [nnon]), (observation: [hlca]), (datasets: []), (different populations: [popg]), ( several transcripts: [nnon]), (direction: []), (association: [menp]), (fold change: [qnco]), (further characterization: [acty]), (genes: [gngm]), (role: [socb]), (trinucleotide repeat instability: [bacs,nnon]), 
ASD Terms: (fragile x syndrome, 'Fragile X Syndrome')(fragile x, 'Fragile X Syndrome')(mental retardation, 'Mental Retardation')

PMCID: 3628102
SFARI Genes: LIS1, LIS1, LIS1, LIS1, LIS1, LIS1, LIS1, LIS1, LIS1, LIS1, Lis1, Lis1, LIS1, LIS1, 
Non SFARI Genes: RhoA, 
Named Entities: (lis1 (pafah1b1) mutation: [cgab,dsyn]), (neuronal migration: [gngm]), (lissencephaly: [cgab]), (humans: [humn]), (lis1 loss: [cgab,dsyn]), (dynein protein motor dysfunction: [aapp,enzy]), (actin cytoskeleton: [celc]), (rhogtpases: []), (recently: []), ( lis1: [cgab,dsyn]), (important protein-network interaction node: [popg]), (high-risk autism spectrum disorder genes: [gngm]), (synapse: [bsoj]), (lis1: [gngm]), (disorder: [dsyn]), (role: [socb]), (synaptogenesis: [ortf]), (post-migrational neurons: [cell]), (social behaviour: [socb]), (mice: [mamm]), (two-photon imaging: [sbst]), (actin-rich dendritic filopodia: [aapp,bacs]), (spines: [bpoc]), (vivo: []), (significant reductions: [npop]), (elimination: [phsf]), (turnover rates: [qnco]), (dendritic protrusions: [celc]), (layer v pyramidal neurons: [cell]), (adolescent lis1+/ mice: [mamm]), (lis1+/ filopodia: [cgab,dsyn]), (immature: []), (hippocampal neurons: [cell]), (vitro: []), (density: [qnco]), ( length: [qnco]), (rhoa dependent: [aapp,enzy]), (dynamics: [npop]), (moreover: []), ( lis1+/: [cgab,dsyn]), (adolescent mice: [mamm]), (deficits: []), (social interaction: [fndg]), (lis1 inactivation: [cgab,dsyn]), (postnatal hippocampus: [bpoc]), (similar deficits: []), (dendritic protrusion density: [celc]), (social interactions: [fndg]), (thus: []), (dendritic filopodia dynamics: [npop]), (turnover: [qnco]), (dendritic spine plasticity: [celc]), (autistic-like behaviour: [mobd]), 
ASD Terms: (dynein protein motor dysfunction, 'Motor Skills')(high-risk autism spectrum disorder genes, 'Autism Phenotype')(social behaviour, 'Reciprocal Social Interaction')(social interaction, 'Reciprocal Social Interaction')(social interactions, 'Reciprocal Social Interaction')

PMCID: 3581547
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (autism spectrum disorder: [mobd]), (complex neurodevelopmental disorder: [mobd]), (years: []), (infancy: []), (persons life: [popg]), (large category: [qnco]), (genomic structural variants: [genf]), (copy number variants: [nusq]), (major contributor: []), (pathophysiology: [patf]), (autism: [mobd]), (date: []), (studies: [lbpr]), (genes present: [gngm]), (cnv loci: [nusq]), (impact: [gngm]), (non-coding regulatory micrornas (mirnas) present: [bacs,nnon]), (regions: []), (hence: []), (functional significance: [qnco]), (mirnas present: [bacs,nnon]), (autism-associated cnv loci: [nusq]), (target genes: [gngm]), (series: [qnco]), (computational tools: [acty]), (cnv loci harbor mirnas: [bacs,nnon]), (mirnas: [bacs,nnon]), (systematic analysis: []), (cnv-mirnas: [bacs,nnon]), (interactions: []), (identification: [menp]), (hsa-mir-590-3p: [bacs,nnon]), ( hsa-mir-944: [nnon]), ( hsa-mir-570: [bacs,nnon]), ( hsa-mir-34a: [gngm]), ( hsa-mir-124: [nnon]), ( hsa-mir-548f: []), ( hsa-mir-429: [bacs,nnon]), ( hsa-mir-200b: [gngm]), ( hsa-mir-195: [nnon]), (hsa-mir-497: [gngm]), (hub molecules: [sbst]), (regulatory loop: [phsf]), (transcription factors: [aapp,bacs]), (downstream target genes: [gngm]), (annotation: []), (functional involvement: []), (neurodevelopment: [ortf]), (synapse: [bsoj]), (moreover: []), (duplicated cnv loci: [nusq]), (difference: [qnco]), (dosage: [qnco]), (crucial genes: [gngm]), (them: []), (global processing: [acty]), (biogenesis: [npop]), (key molecules: [sbst]), (mirna pathway: [bacs,nnon]), (knowledge: []), (first report: [qnco]), (significance: [qnco]), (cnv-micrornas: [bacs,nnon]), (genetic heterogeneity: [orga]), (phenotypic variability: [fndg]), 
ASD Terms: (infancy, 'Perinatal History')(autism spectrum disorder, 'Autism Phenotype')(complex neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3577685
SFARI Genes: cap, cap, 
Non SFARI Genes: impact, 
Named Entities: (folate: [orch,phsu,vita]), (vitamin b12-dependent enzyme methionine synthase (ms): [aapp,enzy]), (cellular oxidative status: [cell]), (ms activity: [aapp,enzy]), (production: []), (antioxidant glutathione: [phsu]), (methylation reactions: [moft]), (metabolic activity: [acty]), (ms mrna levels: [aapp,enzy]), (postmortem: [diap]), (human cortex: [humn]), (subjects: [humn]), (lifespan: [grpa]), (dramatic progressive: []), (biphasic decrease: [qnco]), (weeks: []), (gestation: [orgf]), (years: []), (further analysis: [resa]), (alternative splicing: [genf]), (ms: [gngm]), (deletion: [genf]), (folate-binding domain exons: [bacs,nnon]), (age-dependent deletion: [genf]), (exons: [bacs,nnon]), (cap domain: []), (vitamin b12 (cobalamin): [orch,phsu,vita]), (oxidation: [moft]), (species: []), (protein: [aapp,bacs]), (full-length: [qnco]), (mrna: [bacs,nnon]), (mrna levels: [bacs,nnon]), (significant changes: [qnco]), (ms protein: [aapp,enzy]), (methionine levels: [lbpr]), (autistic subjects: [mobd]), (ages: [bacs,orch]), (decrease: [qnco]), (cultured human neuronal cells: [humn]), (treatment: [topp]), (tnf-: [aapp,bacs]), (csf levels: [topp]), (autism: [mobd]), (novel findings: [clna]), (housekeeping enzyme: [enzy,orch]), ( ms: [aapp,enzy]), (dynamic role: [socb]), (metabolism: [orgf]), (brain: [bpoc]), (development: [orgf]), (aging: [orgf]), (factors: []), (oxidative stress: [comd]), (source: [fndg]), (risk: []), (neurological disorders: [dsyn]), (impact: [gngm]), (epigenetic regulation: [biof]), (gene expression: [genf]), 
ASD Terms: (vitamin b12-dependent enzyme methionine synthase, 'Dietary Supplements')(gestation, 'Perinatal History')(vitamin b12, 'Dietary Supplements')(autism, 'Autism Phenotype')(neurological disorders, 'Neurologic Indications')

PMCID: 3590998
SFARI Genes: mark, mark, 
Non SFARI Genes: 
Named Entities: (elucidation: []), (epigenetic alterations: []), (autism brain: [mobd]), (new insights: [menp]), (molecular mechanisms: []), (abnormal gene expression: [genf]), (disorder: [dsyn]), (strong evidence: []), (engrailed-2 (en-2): [gngm]), (gene relevant: [gngm]), (abnormalities: [cgab]), (epigenetic evaluation: [hlca]), (candidate gene: [gngm]), (case: []), (post-mortem cerebellar samples: [bpoc]), (assessments: [hlca]), (global dna: [bacs,nnon]), (en-2 promoter methylation: [moft]), ( en-2 gene expression: [genf]), (en-2 protein levels: [aapp,bacs]), (chromatin immunoprecipitation: [lbpr]), (trimethylation status: []), (histone h3: [aapp,bacs]), ((h3k27): [aapp]), (gene downregulation: [gngm]), ((h3k4): [aapp]), (gene activation: [genf]), (results: [fndg]), (unusual pattern: []), (en-2 promoter region dna hypermethylation: [bacs,nnon]), (significant increases: [qnco]), (en-2 gene expression: [genf]), (protein levels: [lbtr]), (en-2 overexpression: [genf]), ( histone h3k27 trimethylation mark: [amas]), (en-2 promoter: [bacs,nnon]), (autism: [mobd]), (controls: [sbst]), (link: []), (histone h3k27 trimethylation: [aapp,bacs]), (en-2 gene: [gngm]), (mean level: [phsu]), (histone h3k4 trimethylation: [moft]), (cerebellar samples: [bpoc]), (together: []), (normal en-2 downregulation: [moft]), (signals purkinje cell maturation: [cell]), (early-postnatal development: [orgf]), (individuals: [humn]), (postnatal persistence: [menp]), (cerebellar abnormalities: [fndg]), 
ASD Terms: (autism brain, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3586480
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (childhood autism: [mobd]), (autism: [mobd]), (spectrum disorder (asd): [cgab]), (stable diagnostic categories: [fndg]), (young children: [aggp]), (psychiatric/developmental disorders: [mobd]), (stability: []), (time: []), (diagnosis: [fndg]), (asd: [cgab]), (clinical reasons: []), (diagnostic stability: [fndg]), (childhood: []), (early adulthood: [aggp]), (faroe islands:: []), (total school age population: [popg]), ((817-year-olds): []), (ad: []), (paper: []), (independent clinical diagnosis: [fndg]), (diagnostic interview: [acty]), (social: []), (communication disorders (disco): [mobd]), (algorithm diagnosis: [fndg]), (time points: []), (years: []), (clinical asd diagnosis: [cgab]), (perfect: []), (asperger syndrome (as): [mobd]), (disco algorithm subcategory diagnoses: [fndg]), (systems: []), (excellent stability: []), (seven-year period: [qnco]), (any asd diagnosis: [cgab]), (number: [qnco]), (clear cases: [qnco]), (original screening: [diap]), (findings: [clna]), (notion: []), (subcategories: []), (diagnostic entity: [fndg]), (other non-autism variables: [mobd]), (iq: []), (language levels: [lang]), (overall adaptive functioning: []), 
ASD Terms: (childhood autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(asperger, 'Asperger Syndrome')(diagnosis, 'Diagnosis')(asperger syndromed, 'Asperger Syndrome')(asperger, 'Asperger Syndrome')(algorithm diagnosis, 'Diagnosis')(independent clinical diagnosis, 'Diagnosis')(clinical asperger, 'Asperger Syndrome')(diagnosis, 'Diagnosis')(asperger syndrome, 'Asperger Syndrome')(clinical asperger syndromed diagnosis, 'Diagnosis')(asperger, 'Asperger Syndrome')(diagnosis, 'Diagnosis')(any asperger syndromed diagnosis, 'Diagnosis')(overall adaptive functioning, 'Adaptive Life Skills')

PMCID: 3570468
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (advent: []), (high-throughput technologies: []), (concurrent: []), (information sciences: []), (explosion: [inpo]), (size: []), (complexity: [chvs]), (data sets: []), (biological sciences: []), (challenge today: [antb,orch]), (wealth: []), (information: []), (conceptual framework: []), (biological functions: [biof]), (complex collection: [chvs]), (data: [euka]), (data cloud: [euka]), (multi-scale characteristics: [qnco]), (geometry: []), (foundation: [orgt]), (knowledge: []), (new methodology: []), (challenge: [hlca]), (new procedure: [topp]), (main features: []), (keys: []), (success: [socb]), (empirical similarity: []), (hierarchy: []), (configurations: []), (geometric structure: []), (ultrametric space: []), (ultrametric tree: [plnt]), (parisi matrix: [phsu]), (secondly: [qnco]), (built-in mechanism: []), (membership: [inbe]), (different tree levels: [plnt]), (trees: [plnt]), (new algorithm: [lbpr]), (standard hierarchical clustering method: [lbpr]), (real data clouds: [euka]), (fmri brain connectivity studies: [diap]), ( cancer genomics: [euka]), (social networks: [popg]), (lewis carroll's doublets: [mamm]), (cases: [qnco]), (dcg trees: [plnt]), (errors: []), (quantification: [qnco]), (multi-scale geometric structures: [bpoc]), (such: []), ( dcg-tree: [plnt]), (effective tool: []), (complex biological data sets: [chvs]), 
ASD Terms: 

PMCID: 3563690
SFARI Genes: 
Non SFARI Genes: MDGA1, 
Named Entities: (selective suppression: [genf]), (inhibitory synapseswith: [acty]), (effect: []), (excitatory synapsesresults: []), (interaction: []), (schizophrenia-associated proteins mdga1: [mobd]), (effects: []), (neuroliginneurexin pathway: [moft]), 
ASD Terms: 

PMCID: 3563033
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (clarification: [acty]), (pathogenesis: [patf]), (treatment: [topp]), (autism spectrum disorders: [mobd]), (challenges: [hlca]), (study: [resa]), (scalp hair concentrations: [menp]), (trace elements: [bacs,elii]), (children: [aggp]), (autistic disorders: [mobd]), (males: [orga]), (females): [orga]), (eighty-four (29.7%): [fndg]), ((17.6%): []), ((5.8%) subjects: [humn]), (deficient: [qnco]), (zinc: [elii,phsu]), ( magnesium: [elii]), (calcium: [bacs,elii,phsu]), ( respectively: []), (other essential metals: [inch]), (incidence rate: [qnco]), (mineral deficiency: [dsyn]), (infants: [aggp]), ((8.5%): []), ((4.8%) individuals: [humn]), (high burden: [qnco]), (aluminium: [elii]), ( cadmium: [elii,hops]), (lead: [elii,hops]), (mercury: [elii,hops]), (arsenic burden: [elii,hops]), (findings: [clna]), (magnesium-deficiency and/or toxic metal burdens: [dsyn]), (principal roles: [socb]), (environmental factors: []), (metallomics: []), (early screening: [diap]), (prevention: [resa]), (neurodevelopment disorders: [mobd]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autistic disorders, 'Autistic Disorder')(mineral deficiency, 'Dietary Supplements')

PMCID: 3583392
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (circadian rhythm alteration: [orgf]), (cortisol excretion: [horm,orch,phsu]), (level: [phsu]), (corticosteroids: [horm,orch,phsu]), (children: [aggp]), (different grades: []), (autism severity: [mobd]), (study: [resa]), (autism severity (low [lfa]: [mobd]), ( medium [mfa]: [qnco]), (high functioning autism: [mobd]), (group: [popg]), (age/sex-matched children: [orgf]), (typical development: [orgf]), (urinary levels: []), (free cortisol (at: [lbpr]), (phases: [euka]), (24-hour cycle): [qnco]), ( corticosteroids: [horm,orch,phsu]), (vanilylmandelic acid: [chem]), (5-hydroxyindole acetic acid: [hops,orch]), (determined: [lbpr]), (alteration: []), (pattern: []), (cortisol excretion (phases i: [horm,orch,phsu]), ( ii: []), (iii): []), (lfa (phase i:: []), (vs: []), (p: [gngm]), (phase ii:: []), (phase iii:: []), (mfa (phase i:: []), (control group: [grup]), (corticosteroids excretion levels: [horm,orch,phsu]), (groups: [popg]), (autism: [mobd]), (lfa (8.21.48: []), (mfa (8.21.48: []), (hfa: [dsyn]), (changes: [qnco]), (degrees: [qnco]), (severity: []), (disorder: [dsyn]), (data: [euka]), (cortisol excretion pattern: [horm,orch,phsu]), (high level: [qnco]), (urine: [bdsu]), (consequence: []), (altered hypothalamic-pituitary-adrenal axis function: [phsf]), (pathogenesis: [patf]), 
ASD Terms: (circadian rhythm alteration, 'Prosody')(autism severity, 'Autism Phenotype')(autism severity (low, 'Autism Phenotype')(high functioning autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3558482
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (amygdala: [bpoc]), (important structure: []), (socio-emotional behavior: [inbe]), (however: []), (role: [socb]), (autism: [mobd]), (study: [resa]), (days: []), ((vpa)-induced rat model: [mamm]), (autistic phenotypes: [mobd]), (synaptic characteristics: []), (lateral nucleus (la): [celc]), (vpa-treated offspring: [famg]), (social interaction: [fndg]), (fear learning: [menp]), (impaired fear memory extinction: [menp]), (slice preparation: [acty]), (electrophysiological recordings: [diap]), (long-term potentiation (ltp): [ortf]), (thalamic-amygdala pathway: [bpoc]), (la: [gngm]), (pair: []), (pulse facilitation (ppf): [clna]), (60-ms intervals: [aapp,enzy]), (significantly: []), (whole-cell recordings: [resa]), (la pyramidal neurons: [elii]), (increased miniature excitatory: [qnco]), (postsynaptic current (epsc) frequency: [ortf]), (amplitude: []), (relative contributions: [acty]), (ampa receptor: [aapp,rcpt]), (nmda receptor: [aapp,rcpt]), (epscs: []), (groups: [popg]), (results: [fndg]), (enhancement: [acty]), (presynaptic efficiency: [qnco]), (excitatory synaptic transmission: [ortf]), (hyperexcitibility: []), (ltp: [ortf]), (neurons: [cell]), (disruption: []), (synaptic excitatory/inhibitory: [acty]), ((e/i) balance: [inch]), (vpa-treated rats: [mamm]), (certain roles: [socb]), (development: [orgf]), (behaviors: [inbe]), (rat: [mamm]), (further experiments: [resa]), (direct link: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(vpa-treated offspring, 'Perinatal History')(social interaction, 'Reciprocal Social Interaction')(impaired fear memory extinction, 'Working Memory')

PMCID: 3633612
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (complex neuropsychiatric syndrome: [dsyn]), (unknown etiology: [fndg]), (inflammation: [patf]), (pregnancy: [orgf]), (common pathway: [moft]), (infections: [patf]), (other insults increase risk: []), (disorder: [dsyn]), (hence: []), (association: [menp]), (early gestational c-reactive protein: [aapp,imft]), (inflammatory biomarker: [clna]), (maternal sera: [bdsu]), (childhood autism: [mobd]), (large national birth cohort: [qnco]), (extensive serum biobank: [bdsu]), (other strengths: []), (cohort: [popg]), (complete ascertainment: []), (pregnancies: [orgf]), (finland (n=1.2 million): [aapp,imft]), (study period: [resa]), (national psychiatric registries: [popg]), (autism cases: [mobd]), (population: [popg]), (maternal crp levels: [aapp,imft]), (continuous variable: []), (offspring: [famg]), (quintile: [clna]), (risk: []), (finding: [sosy]), (maternal inflammation: [patf]), (significant role: [socb]), (possible implications: []), (preventive strategies: [menp]), (pathogenic mechanisms: [fndg]), (other neurodevelopmental disorders: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(early gestational c-reactive protein, 'Perinatal History')(childhood autism, 'Autism Phenotype')(autism cases, 'Autism Phenotype')(autism, 'Autism Phenotype')(offspring, 'Perinatal History')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(other neurodevelopmental disorders, 'Learning Disorders')

PMCID: 3547942
SFARI Genes: ASMT, ASMT, ASMT, ASMT, ASMT, ASMT, ASMT, ASMT, ASMT, ASMT, 
Non SFARI Genes: impact, 
Named Entities: (melatonin: [horm,orch,phsu]), (regulation: [biof]), (seasonal rhythms: [fndg]), (immune function: [ortf]), (prior research: [resa]), (low melatonin levels: [horm,orch,phsu]), (autism spectrum disorders: [mobd]), (asmt: [gngm]), (pseudo-autosomal region: [celc]), (last enzyme: [enzy,orch]), (melatonin biosynthesis pathway: [moft]), (previous study: [resa]), (association: [menp]), (asd: [cgab]), (single nucleotide polymorphisms: [nusq]), (rs4446909: []), (rs5989681: []), (promoter: [bacs,nnon]), (furthermore: []), (deleterious mutations: [comd]), (subset: []), (patients: [podg]), (asmt exons: [bacs,nnon]), (neighboring region: []), (chinese han individuals: [popg]), (autism: [mobd]), (healthy controls: []), (study: [resa]), (significant differences: [qnco]), (genotypic distribution: [orga]), (allele frequencies: [qnco]), (common snps: [nusq]), (mutations: [genf]), (rare variants: [gngm]), (stop mutation (p.r115w: [genf]), ( p.v166i: [aapp,imft]), ( p.v179g: [aapp,imft]), (p.w257x): [aapp,imft]), (coding variants: []), ((1.51%) patients: [podg]), (none: []), (controls: [sbst]), ((chi-square test: []), ( continuity correction: []), (two-sided): [qnco]), (functional prediction: []), (impact: [gngm]), (amino acid: [aapp,bacs,phsu]), (p.r115w: [aapp,imft]), (protein function: [moft]), (results: [fndg]), (susceptibility gene: [gngm]), (further studies: [lbpr]), (samples: [sbst]), (degree: [qnco]), (variation: []), (gene: [gngm]), (biochemical: []), (clinical impacts: [gngm]), (asmt/melatonin deficiency: [horm,orch,phsu]), 
ASD Terms: (seasonal rhythms, 'Prosody')(autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3547868
SFARI Genes: AUTS2, AUTS2, AUTS2, AUTS2, auts2, auts2, AUTS2, AUTS2, AUTS2, AUTS2, 
Non SFARI Genes: 
Named Entities: (nucleotide changes: [nnon]), (auts2: [gngm]), (noncoding regions: []), (autism: [mobd]), (other neurological disorders: [dsyn]), (attention deficit hyperactivity disorder: [mobd]), ( epilepsy: [dsyn]), ( dyslexia: [mobd]), ( motor: []), (delay: []), ( language delay: [fndg]), (visual impairment: [fndg]), ( microcephaly: [cgab,dsyn]), (alcohol consumption: [inbe]), (addition: []), ( auts2: [gngm]), (genomic region: [gngm]), (humans: [humn]), (neanderthals: [mamm]), (variants: []), (however: []), (function: [phsf]), (regulation: [biof]), (gene: [gngm]), (auts2 function: [phsf]), (zebrafish: [fish]), (head: [blor]), (neuronal reduction: [npop]), (mobility: [fndg]), (regulatory elements: [bacs,nnon]), (sequences: [nusq]), (enhancer activity: [acty]), (mice: [mamm]), (functional zebrafish: [fish]), (brain: [bpoc]), (mouse enhancer assays: [lbpr]), (mouse brain enhancers: [nnon]), (asdassociated deletion: [genf]), (mouse enhancers: [mamm]), (regions: []), (combined: []), (results: [fndg]), (expose candidate enhancer sequences: [nusq]), (nucleotide variation: [nnon]), (neurological disease: [dsyn]), (human-specific traits: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')(other neurological disorders, 'Neurologic Indications')(attention deficit hyperactivity disorder, 'Overactivity')(epilepsy, 'Epilepsy')(language delay, 'Language Ability')(visual impairment, 'Visual Thinking')(alcohol consumption, 'Alcohol Drinking')(neurological disease, 'Neurologic Indications')

PMCID: 3544904
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (structural variation: []), (major etiological role: [socb]), (development: [orgf]), (autism spectrum disorders: [mobd]), (numerous studies: [lbpr]), (relevance: []), (copy number variants: [nusq]), (asd: [cgab]), (large asd families: [cgab]), (high-impact cnvs: [nusq]), (impact: [gngm]), (general asd population: [cgab]), (affymetrix: []), (genome-wide human snp array: [gngm]), (putative autism-specific cnvs present: [nusq]), (individuals: [humn]), (multiplex asd pedigrees: [cgab]), (actual prevalence: [qnco]), (cnvs: [nusq]), (studies: [lbpr]), (custom illumina array: [acty]), (asd cases: [cgab]), (controls: [sbst]), (additional: []), (single nucleotide variants: [fndg]), (array: []), (family studies: [famg]), (standard snp array resolution: [qnco]), (results: [fndg]), (high-risk asd families: [cgab]), (odds ratios: [qnco]), (support: []), (asd risk variants: [cgab]), (addition: []), (snv probes: [chvf]), (custom array: [acty]), (eighteen: [qnco]), (validated cnvs: [nusq]), (once: []), (association: [menp]), (asd-associated cnvs: [cgab]), (dataset: []), (clinical relevance: []), (evaluation: [hlca]), (children: [aggp]), (asds: [cgab]), (data: [euka]), (strong support: []), (existence: []), (application: [qnco]), (clinical genetic evaluation: [hlca]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 3568452
SFARI Genes: CaV1.2, CaV1.2, CaV1.2, CaV1.2, 
Non SFARI Genes: RhoA, Gem, RhoA, 
Named Entities: (l-type voltage: [qnco]), (calcium channels: [aapp,bacs]), (important role: [socb]), (neuronal development: [celf]), (dendritic growth: [orgf]), (arborization13: []), (point mutation: [comd]), (cav1.2: [gngm]), (timothy syndrome: [dsyn]), (neurodevelopmental disorder: [mobd]), (autism spectrum disorders: [mobd]), (channels: []), (ts mutation cause: [genf]), (activity-dependent dendrite retraction: [celc]), (rodent neurons: [mamm]), (induced pluripotent stem cell (ipscs): [cell]), (neurons: [cell]), (individuals: [humn]), (ts: [gngm]), (dendrite retraction: [celc]), (calcium permeation: [bacs,elii,phsu]), (mutant channel: [comd]), (ectopic activation: [acty]), (rhoa: [gngm]), (over-expression: [topp]), (channel: []), (gtpase gem: [aapp,enzy]), (results: [fndg]), (ca2+: [elii,phsu]), (novel insights: [menp]), (cellular basis: [phsu]), (other asds: [cgab]), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 3669501
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (currently: []), ( autism cannot: [mobd]), (age: [orga]), (years: []), (longitudinal studies: [resa]), (high-risk populations: [popg]), (unique knowledge: []), (development: [orgf]), (autism: [mobd]), (infancy: []), (toddlerhood: []), (onset: [qnco]), (early autism research: [mobd]), (field: [irda]), (child psychiatric science: [aggp]), (key objectives: []), (fine mapping: [acty]), (neurodevelopmental trajectories: [ortf]), (biomarkers: [clna]), (risk: []), (diagnosis: [fndg]), (treatment: [topp]), (essea: []), (scientific study: [lbpr]), (early autism): [mobd]), (cost (european cooperation: [qnco]), (science: []), (technology) action: [acty]), (european collaboration: [socb]), (progress: []), (discovery: [acty]), (signs: [fndg]), (european practice guidelines: [popg]), (early identification: [topp]), (intervention: [hlca]), (european expertise: [popg]), (cognitive neuroscience: []), (clinical sciences: []), (objective: []), (article: []), (state: []), (current european research: [resa]), (at-risk autism research: [mobd]), (understanding: [menp]), (different contexts: [fndg]), (research: [resa]), (conducted: [inbe]), (essea survey data: [euka]), (ongoing european high-risk asd studies: [cgab]), (challenges: [hlca]), (opportunities: []), (high-risk autism research: [mobd]), (europe: []), (several challenges: [hlca]), (existence: []), (several key factors: [qnco]), (new and/or large-scale autism: [mobd]), (grants: [qnco]), ( availability: []), (new technologies: []), (involvement: []), (experienced research groups): [popg]), (clinical developments: [orgf]), (next few years: []), 
ASD Terms: (age of 2 years, 'Onset of Symptoms')(autism, 'Autism Phenotype')(autism cannot, 'Autism Phenotype')(infancy, 'Perinatal History')(symptom onset, 'Onset of Symptoms')(early autism research, 'Autism Phenotype')(neurodevelopmental trajectories, 'Learning Disorders')(diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')(cognitive neuroscience, 'Cognitive Ability')(understanding of different contexts, 'Understanding Context')(at-risk autism research, 'Autism Phenotype')(high-risk autism research, 'Autism Phenotype')

PMCID: 3815575
SFARI Genes: NHE9, NHE9, NHE9, NHE9, NHE9, NHE9, NHE9, NHE9, 
Non SFARI Genes: 
Named Entities: (summary nhe9 (slc9a9): [gngm]), (endosomal cation/proton antiporter: [aapp,bacs]), (orthologs: [gngm]), (yeast: [fngs]), (bacteria: [bact]), (rare: [gngm]), ( missense substitutions: [acty]), (nhe9: [gngm]), (autism: [mobd]), (evolutionary conservation analysis: [genf]), (model-structure: []), (crystal structure: [chvs]), (bacterial nhaa: []), (autism-associated variants: [mobd]), (human population: [popg]), (phenotype complementation: [orga]), (functional analysis: [hlca]), (primary cortical astrocytes: [bpoc]), (mouse: [mamm]), (nhe9-gfp localizes: [aapp,irda]), (endosomes: [celc]), (luminal ph: [qnco]), ( elevates: []), (transferrin: [aapp,bacs]), (neurotransmitter glutamate: [aapp,bacs]), (stabilizes surface expression: [topp]), (transferrin receptor: [aapp,rcpt]), (glast transporter: [aapp,bacs]), (contrast: [irda]), ( autism: [mobd]), (variants l236s: []), ( s438p: []), (v176i: []), (function: [phsf]), (astrocytes: [cell]), (thus: []), (neurobiological cell model: [gngm]), (candidate gene: [gngm]), (loss: [qnco]), (function mutations: [phsf]), (autistic phenotype: [mobd]), (synaptic membrane protein expression: [celc]), (neurotransmitter clearance: [bacs]), 
ASD Terms: (bacteria, 'Bacterial Infections')(autism, 'Autism Phenotype')(bacterial nhaa, 'Bacterial Infections')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3738022
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (attention deficit hyperactivity disorder (adhd) symptoms: [mobd]), (autistic traits: [mobd]), (together: []), (pattern: []), (etiology: []), (co-occurrence: []), (adults: [aggp]), (study: [resa]), (traits: [gngm]), (detail: []), (independent adult population samples: [aggp]), (data: [euka]), (adhd traits (inattention: [mobd]), (hyperactivity/impulsivity): [mobd]), (population sample (s1: [popg]), (unrelated individuals: [fndg]), (attention problems (ap): []), (population-based family sample: [famg]), (twins: [famg]), (siblings (s2: [famg]), (samples: [sbst]), (dimensions: [qnco]), ((social skills: [socb]), (attentional switching: [menp]), ( imagination: [menp]), ( patterns): []), (hyperactive traits: [mobd]), (autistic trait dimensions: [mobd]), (inattention (s1): [mobd]), (ap: []), (correlations: []), (prominent correlation: []), (attentional switching scale (0.47: [menp]), (respectively): []), (analyses: [resa]), (informative s2: [gngm]), (association: [menp]), (genetic factor: [topp]), (findings: [clna]), (adhd traits: [mobd]), (problems: []), (hyperactivity: [mobd]), ( social skills: [socb]), (routine preferences: []), (instead: []), (attention-related problems (inattention: [mobd]), (attentional switching capacity): [menp]), (genetic: [topp]), ( biological pathways: [moft]), (attentional control: [menp]), (promising focus: []), (future studies: [lbpr]), (genetic causes: [topp]), (disorders: [dsyn]), 
ASD Terms: (attention deficit hyperactivity disorder symptoms, 'Overactivity')(attention deficit hyperactivity disorder traits, 'Attention Deficit Disorder with Hyperactivity')(hyperactive traits, 'Overactivity')(inattention, 'Attention Deficit Disorder with Hyperactivity')(attention deficit hyperactivity disorder traits, 'Attention Deficit Disorder with Hyperactivity')(hyperactivity, 'Overactivity')(social skills, 'Ability to Converse in Social Settings')(imagination, 'Imagination')(social skills, 'Ability to Converse in Social Settings')(imagination, 'Imagination')

PMCID: 3621187
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prevalence: [qnco]), (autistic disorder: [mobd]), (serious developmental condition: [mobd]), (decades: [qnco]), (high-quality population-based research: [popg]), (etiology: []), (influence: []), (exposures: [phpr]), (traffic-related air pollution: [eehu]), (pregnancy: [orgf]), (development: [orgf]), (autism: [mobd]), (data: [euka]), (air monitoring stations: []), (land use regression (lur) model: [menp]), (methods: children: [aggp]), (mothers: [famg]), (birth: [orgf]), (los angeles: []), ( california: [plnt]), (primary ad diagnosis: [clna]), (years: []), (age: [orga]), (california department: [orgt]), (developmental: [orgf]), (california birth certificates: [plnt]), (children: [aggp]), (controls: [sbst]), (case: []), (sex: [orgf]), ( birth year: []), (minimum gestational age: [orga]), ( birth addresses: [orgf]), (air: [gngm]), (station: []), (lur model: []), (conditional logistic regression: [resa]), (perinatal characteristics: []), (indicators: [irda]), (ses: []), (results: per interquartile range (iqr) increase: [fndg]), (relative increase: [qnco]), (odds: []), (ozone [odds: [chem]), ((or) =: []), (ci:: [lbpr]), (11.54-ppb increase]: [gngm]), (particulate matter: [sbst]), (m (or: [aapp,imft]), (4.68-g/m3 increase): [qnco]), (pollutants: [hops]), (furthermore: []), (relative increases: [qnco]), (iqr increase: []), (lur-based nitric oxide: [bacs,inch,phsu]), (nitrogen dioxide exposure estimates: [qnco]), (lur-based associations: [menp]), (high school education: []), (conclusion: measured: [diap]), (ambient pollutant monitors: [hops]), (associations: [menp]), (prenatal air pollution: [eehu]), (traffic sources: [fndg]), 
ASD Terms: (autistic disorder, 'Autistic Disorder')(serious developmental condition, 'Learning Disorders')(exposures, 'Exposures')(autism, 'Autism Phenotype')(estimate exposures, 'Exposures')(primary autistic disorder diagnosis, 'Autistic Disorder')(autism, 'Autism Phenotype')(minimum gestational age, 'Perinatal History')(perinatal characteristics, 'Perinatal Exposures')(autism, 'Autism Phenotype')(nitrogen dioxide exposure estimates, 'Exposures')(exposures, 'Exposures')(autism, 'Autism Phenotype')

PMCID: 3524021
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (epistatic interactions: [fndg]), (significant role: [socb]), (pathogenesis: [patf]), ( prevention: [resa]), ( diagnosis: [fndg]), (treatment: [topp]), (complex human diseases: [humn]), (machine learning: [mcha]), (statistical methods: [resa]), (epistatic interaction detection: [topp]), (common problems: [qnco]), (limited number: [qnco]), (samples: [sbst]), (high search: [acty]), (large number: [qnco]), (false positives: [lbtr]), (ways: []), (association: [menp]), (disease markers: []), (phenotype: [orga]), (problems: []), (computational methods: [resa]), (score-based bayesian network structure: [popg]), (method: [lbpr]), ( epibn: []), (datasets: []), (real disease datasets: [dsyn]), (experimental results: [fndg]), (simulation data: [euka]), (other commonly-used methods: [fndg]), (terms: [orgf]), (power: [hcpp]), (sample-efficiency: [qnco]), (marginal effects: [fndg]), (furthermore: []), (real disease data: [dsyn]), (bayesian network-based method: [qnco]), (epibn: []), (new scoring function: [phsf]), (higher-order epistatic interactions: [acty]), (model complexity: [chvs]), (data: [euka]), (fast branch-and-bound algorithm: [fndg]), (structure: []), (two-layer bayesian network: [popg]), (target node: [diap]), (real data: [euka]), (use: []), (markov chain monte carlo (mcmc) method: [qnco]), (screening process: [phpr]), (applications: [hlca]), (real gwas (genome-wide association studies) datasets: [mbrt]), (helpful insights: [menp]), (genetic basis: [phsu]), (age-related macular degeneration: [dsyn]), (late-onset alzheimer's disease: [mobd]), (autism: [mobd]), 
ASD Terms: (diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')

PMCID: 3520798
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (sex: [orgf]), (important factor: []), (prevalence: [qnco]), ( incidence: [qnco]), ( progression: [patf]), (response: [fndg]), (treatment: [topp]), (many medical conditions: [dsyn]), (autoimmune: [patf]), (cardiovascular diseases: [dsyn]), (psychiatric conditions: [mobd]), (identification: [menp]), (molecular differences: [qnco]), (typical males: [orga]), (females: [orga]), (valuable basis: [phsu]), (conditions: [dsyn]), (methodology/principal findings using: [clna]), (multiplexed immunoassays: [lbpr]), (serum molecules: [bdsu]), (independent cohorts: [popg]), (typical individuals: [humn]), (males: [orga]), (sex differences: [orga]), (analyte levels: [sbst]), (meta-analysis approach: [resa]), (biological context: [fndg]), (k-means: [qnco]), (clusters: [qnco]), (analytes: [sbst]), (distinct biological functions: [biof]), (natural sex differences: [orga]), (analyte groups: [popg]), (dimorphic analyte expression: [topp]), (cohort: [popg]), (asperger syndrome: [mobd]), (reproducible sex differences: [orga]), (levels: []), (serum: [bdsu]), (typical controls: []), (comprised clusters: [qnco]), (molecules: [sbst]), (fatty acid oxidation/hormone regulation: [orgf]), ( immune cell growth: [celf]), (activation: [acty]), (cell death: [celf]), (immune cell chemotaxis: [celf]), (other indistinct functions: []), (comparison: [acty]), (people: [popg]), (asperger: []), (cluster: [qnco]), (functions: [phsf]), (occurrence: []), (condition: [dsyn]), (conclusions/significance sex-specific: [orgf]), (study: [resa]), (current knowledge: [npop]), (biological functions: [biof]), (metabolism: [orgf]), (immune function: [ortf]), (deviations: [fndg]), (typical sex differences: [orga]), (findings: [clna]), (importance: []), (influence: []), (medical conditions: [dsyn]), 
ASD Terms: (many medical conditions, 'Medications')(cardiovascular diseases, 'Cardiovascular Diseases')(psychiatric conditions, 'Mental Disorders')(asperger syndrome, 'Asperger Syndrome')(asperger, 'Asperger Syndrome')(medical conditions, 'Medications')

PMCID: 3565189
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (gamma: [npop]), ((gaba)-mediated synapses: [aapp,bacs]), (oscillations: [topp]), (autism: [mobd]), (gaba-acting benzodiazepines exert: [aapp,bacs]), (patients: [podg]), (paradoxical effects: []), (possibility: []), (epilepsies: [dsyn]), ( gaba: [aapp,bacs]), (neurons: [cell]), (elevated intracellular concentrations: [celc]), (chloride: [inch]), (successful pilot study: [resa]), (1: [fndg]), (double-blind clinical trial: [resa]), (diuretic: [phsu]), ( chloride-importer antagonist: [inch]), (intracellular chloride: [inch]), (gabaergic inhibition: [acty]), (sixty children: [aggp]), (asperger: []), (years: []), (months placebo: [topp]), ((1 mg daily): [elii,phsu]), (1-month wash out: [acty]), (determination: [lbpr]), (severity: []), (video films: [sbst]), (day: []), ((d0): []), (d90: []), (blind: [fndg]), ( independent evaluators: []), (bumetanide: [orch,phsu]), (childhood autism rating scale (cars) (d90d0; p<0.004: [mobd]), (vs placebo): [topp]), ( clinical global impressions (p<0.017: [fndg]), (autism diagnostic observation schedule values: [hlca]), (severe cases: [qnco]), (values: []), (means.d: []), (n=9): [aapp,imft]), ((wilcoxon test: p-value=0.031; student's: [popg]), (t-test: p-value=0.017): [qnco]), (side effects: [patf]), (occasional mild hypokalaemia (3.03.5 mm l1 k+): [fndg]), (supplemental potassium: [inch,phsu]), (companion study: [anim]), (chronic bumetanide treatment: [orch,phsu]), (accuracy: []), (facial emotional labelling: [blor]), (brain activation: [bpoc]), (areas: []), (emotional perception (hadjikhani: [menp]), (al.: [lbpr]), ( submitted): []), (therefore: []), ( bumetanide: [orch,phsu]), (promising novel: []), (therapeutic agent: [phsu]), (trials: [resa]), (population: [popg]), (treatment: [topp]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(epilepsies, 'Epilepsy')(autism, 'Autism Phenotype')(asperger, 'Asperger Syndrome')(1-month wash out, 'Performance of Chores')(autism, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(autism diagnostic observation schedule values, 'Autism Phenotype')(supplemental potassium, 'Dietary Supplements')(emotional perception, 'Visual Perception')(treat autism, 'Autism Phenotype')

PMCID: 3537519
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (adhd: [mobd]), (common childhood: [qnco]), (mental health disorder: [mobd]), (adulthood: []), (two-thirds: [qnco]), (cases: [qnco]), (comorbidities: []), (adults: [aggp]), (substance use disorders: [mobd]), (rates: [qnco]), (patients: [podg]), (substance abuse disorders: [mobd]), (impairment: [patf]), (co-morbid group: [popg]), (research: [resa]), (diagnostic interview: [acty]), (people: [popg]), (in-patient drug: [podg]), (alcohol detoxification units: [orgf]), (prevalence: [qnco]), (undiagnosed adhd: [mobd]), (substance use disorder in-patients: [podg]), (south london: []), (individuals: [humn]), (self-rated impairments: [patf]), (several domains: [qnco]), (daily life;: []), (substance abuse: [mobd]), (alcohol consumption: [inbe]), ( suicide attempts: [fndg]), (depression: [mobd]), (case records: []), (study: [resa]), (high rates: [qnco]), (untreated adhd: [mobd]), (substance use disorder populations: [popg]), (association: [menp]), (such patients: [podg]), (levels: []), (source: [fndg]), (additional impairment: [patf]), (burden: []), (clinical services: [hlca]), 
ASD Terms: (adhd, 'Attention Deficit Disorder with Hyperactivity')(mental health disorder, 'Mental Disorders')(adhd, 'Attention Deficit Disorder with Hyperactivity')(comorbidities, 'Comorbidities')(adhd, 'Attention Deficit Disorder with Hyperactivity')(substance abuse disorders, 'Substance Abuse')(alcohol detoxification units, 'Alcohol Drinking')(undiagnosed adhd, 'Attention Deficit Disorder with Hyperactivity')(substance abuse, 'Substance Abuse')(alcohol consumption, 'Alcohol Drinking')(suicide attempts, 'Depressive Disorder')(depression, 'Depressive Disorder')(untreated adhd, 'Attention Deficit Disorder with Hyperactivity')(adhd, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 3533944
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (genetic etiology: [topp]), (autism: [mobd]), (multiple disorders share genotypic: [orga]), (phenotypic traits: [orga]), (network: [popg]), (cross-disorder analysis: [hlca]), (understanding: [menp]), (characterization: [acty]), (molecular pathology: [lbpr]), (few tools: [qnco]), (results: [fndg]), (description: []), (autworks: []), (web portal: [blor]), (gene interaction: [genf]), (gene-disease association data: [gngm]), (network construction: [popg]), ( visualization: [menp]), ( network comparisons: [popg]), (numerous other related neurological conditions: [qnco]), (disorders: [dsyn]), (users: [humn]), (structure: []), (gene interactions: [genf]), (set: [menp]), (disorder-associated genes: [gngm]), ( compare networks: [acty]), (disorder/disease genes: [dsyn]), (other disorders/diseases: [dsyn]), (own sets: [menp]), (comparative analysis: [resa]), (web application: [qnco]), (easy-to-use resource: []), (researchers: []), (varied backgrounds: []), (autism gene network structure: [moft]), (availability: http://autworks.hms.harvard.edu/: [orch,phsu]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(visualization, 'Visual Thinking')(numerous other related neurological conditions, 'Neurologic Indications')(visualization, 'Visual Thinking')(autism gene network structure, 'Autism Phenotype')

PMCID: 3708282
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (rightward: []), (cerebral lateralization: [ortf]), (neuropathology: [patf]), (autism spectrum conditions: [mobd]), (neuroanatomical asymmetry: []), (terms: [orgf]), (handedness: [orga]), (corpus callosum measurements: [bpoc]), (male adolescents: [aggp]), (unaffected siblings: [famg]), (controls: [sbst]), (associations: [menp]), (executive dysfunction: [mobd]), (symptom severity: [fndg]), (adolescents: [aggp]), (autism: [mobd]), (functional asymmetry: []), (expected pattern: []), (rightward lateralization: []), (posterior: []), (anterior midbody: [blor]), (hand-preference: [fndg]), (measures: [qnco]), (asymmetry: []), (subregions: []), (posterior midbody: [blor]), (rostral body): [humn]), (opposite pattern: []), (isthmus: []), (rostrum: []), (cognitive: []), (severe clinical scores: [qnco]), 
ASD Terms: (autism spectrum conditions, 'Autism Phenotype')(autism, 'Autism Phenotype')(cognitive, 'Cognitive Ability')

PMCID: 3604131
SFARI Genes: 
Non SFARI Genes: rest, 
Named Entities: (objective recent epidemiologic studies: [resa]), (rise: []), (prevalence rates: [qnco]), (autism spectrum disorders: [mobd]), (broadening: []), (diagnostic criteria: []), (asd: [cgab]), (major contributor: []), (prevalence: [qnco]), (continuous distribution: [qnco]), (autistic traits: [mobd]), (study: [resa]), (nature: []), (population distribution: [qnco]), (quantitative trait measure: [qnco]), (large national population sample: [sbst]), (children: [aggp]), (japanese version: [popg]), (social responsiveness scale (srs): [acty]), (parents: []), (representative sample: [sbst]), ( age: [orga]), (social responsiveness scale scores: [clna]), (skewed normal distribution: [qnco]), (japanese population: [popg]), (single-factor structure: [fndg]), (significant relation: [socb]), (iq: []), (normal intellectual range: [qnco]), (evidence: []), (natural cutoff: []), (populations: [popg]), (affected children: [aggp]), (unaffected children: [aggp]), (continuous nature: []), (autistic symptoms: [mobd]), (srs: [gngm]), (validated quantitative trait measure: [qnco]), (findings: [clna]), (paradigms: [resa]), (diagnosis: [fndg]), (categorical cutoffs: []), (substantial variation: []), (prevalence estimation: [qnco]), (measurements: []), (case assignment: []), (population: [popg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autistic symptoms, 'Complaints and Indications')(diagnosis, 'Diagnosis')

PMCID: 3504046
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (complex neurological condition: [dsyn]), (childhood onset: [fndg]), (dysfunction: [dsyn]), (multiple cognitive domains: [qnco]), (socio-emotional function: [phsf]), ( speech: [orgf]), (language: [lang]), (processing: [acty]), (stimuli: [phpr]), (gross brain: [bpoc]), (anatomic differences: [qnco]), (established: []), ( recent studies: [lbpr]), (regional differences: [fndg]), (brain structure: [bpoc]), (function: [phsf]), (divergent: []), (contradictory results: [fndg]), (regional abnormalities: [cgab]), (autistic phenotype: [mobd]), (autism exhibits: [mobd]), (distinct perturbations: []), (network-level brain architecture: [popg]), (cognitive dysfunction: [mobd]), (abnormal network structure: [popg]), (network-level anatomic abnormalities: [popg]), (structural covariance mri: [diap]), (network-level differences: [popg]), (gray matter structure: [tisu]), (large-scale networks: [qnco]), (salience network: [popg]), (default mode network: [popg]), (autistic subjects: [mobd]), (age-: [orga]), ( gender-: [orga]), (iq-matched controls: [resa]), (specific perturbations: []), (brain network architecture: [popg]), (salience: []), (default-mode networks: [qnco]), (clinical manifestations: []), (extent: []), (distribution: []), (social-emotional regulation: [menp]), (environmental stimuli: [npop]), (contrast: [irda]), ( posterior elements: [elii]), (spatial distribution: []), (posteriorization: [biof]), (network: [popg]), (findings: [clna]), (network-based model: [popg]), (unifying interpretation: [clna]), (previous work: []), (moreover: []), (evidence: []), (specific abnormalities: [cgab]), (standard clinical mri: [diap]), 
ASD Terms: (childhood onset, 'Onset of Symptoms')(autism, 'Autism Phenotype')(complex neurological condition, 'Neurologic Indications')(multiple cognitive domains, 'Cognitive Ability')(speech, 'Language Ability')(autism, 'Autism Phenotype')(autism exhibits, 'Autism Phenotype')(cognitive dysfunction, 'Cognitive Ability')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 6345368
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (empathy: [inbe]), (lens: [bpoc]), (others emotion expressions: [menp]), (respond: []), (study: [resa]), ( empathy: [inbe]), (facial emotion recognition: [menp]), (adults: [aggp]), (autism spectrum conditions: [mobd]), (n=314): [aapp,imft]), ( parents: []), (child: [aggp]), (asc (n=297): [aapp,imft]), (iq-matched controls: [resa]), (participants: [popg]), (self-report measure: [resa]), (empathy (the empathy quotient [eq]): [inbe]), (modified version: []), (karolinska directed emotional faces task (kdef): [blor]), (online test interface: [lbpr]), (results: [fndg]), (mean scores: [qnco]), (eq: [qnco]), (fathers: [famg]), (mothers: [famg]), (children: [aggp]), (asc: [gngm]), (males: [orga]), (females: [orga]), (eq scores (p: [aapp,imft]), (controls: [sbst]), (kdef: []), (statistical analyses: [resa]), (overall performance: [inbe]), (asc (p: [aapp,imft]), (control group: [grup]), (distinct basic emotions: [menp]), (asc group: [popg]), (impaired performance: [inbe]), (expressions: [topp]), (sad: [menp]), ( angry: [menp]), ( afraid: [menp]), (disgusted): [menp]), (parents: []), (basic emotions: [menp]), (age: [orga]), (non-verbal iq (all: [fndg]), (finally: []), ( results: [fndg]), (significant differences: [qnco]), (emotion recognition performance (p: [menp]), (self-reported empathy (p: [inbe]), (findings: [clna]), (self-reported empathy deficits: [inbe]), (autistic probands: [mobd]), (part: [qnco]), (broader autism phenotype: [mobd]), (new findings: [fndg]), (sex differences: [orga]), (people: [popg]), (emotion recognition: [menp]), (previous work: []), (empathy difficulties: [inbe]), (use: []), (empathy measures: [inbe]), (quantitative endophenotypes: [qnco]), 
ASD Terms: (empathy, 'Empathy')(autism spectrum conditions, 'Autism Phenotype')(empathy, 'Empathy')(facial emotion recognition, 'Empathy')(empathy (the empathy quotient, 'Empathy')(karolinska directed emotional faces task, 'Emotional Regulation and Control')(directed emotional faces task, 'Emotional Regulation and Control')(emotion recognition performance, 'Empathy')(self-reported empathy, 'Empathy')(self-reported empathy deficits, 'Empathy')(broader autism phenotype, 'Autism Phenotype')(empathy difficulties, 'Empathy')(emotion recognition, 'Empathy')(empathy measures, 'Empathy')

PMCID: 3490915
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (complex neurodevelopmental disorder: [mobd]), (impaired reciprocal social interaction: [mobd]), ( communication deficits: [socb]), (repetitive behaviors: [fndg]), (large number: [qnco]), (genes: [gngm]), (encode proteins: [aapp,bacs]), (development: [orgf]), (function: [phsf]), (synaptic circuitry: []), (however: []), (manner: []), (factor: []), (broad influence: []), (brain development: [ortf]), (network formation: [popg]), (neurotransmitter serotonin: [bacs,orch]), (unfortunately: []), (alterations: []), (serotonin neuronal function: [bacs,orch]), (hypothesis: []), (dysfunction: [dsyn]), (core symptoms: [sosy]), (brain serotonin: [bacs,orch]), (null mutation: [genf]), (gene: [gngm]), (tryptophan hydroxylase: [aapp,enzy]), ((tph2)): []), (behaviors: [inbe]), (disorder: [dsyn]), (mice: [mamm]), (brain serotonin (tph2/): [bacs,orch]), (substantial deficits: []), (numerous validated tests: [lbpr]), (social interaction: [fndg]), (communication: [socb]), (compulsive behaviors: [mobd]), (newborn tph2/: [aggp]), (mutant mice show: [mamm]), (expression: [topp]), (key developmental milestones: []), (diminished preference: [qnco]), (maternal scents: [bacs]), (scent: [bacs]), (unrelated female: [orga]), (forerunner: []), (severe socialization deficits: [edac]), (weanlings: []), (persist: []), (adulthood: []), (results: [fndg]), (hypo-serotonin condition: [fndg]), (behavioral traits: [inbe]), (findings: [clna]), (new studies: [lbpr]), (brain hyposerotonemia: [bpoc]), (critical neurodevelopmental periods: [ortf]), (maturation: [phsf]), (synaptic circuits: []), (prevention: [resa]), (such deficits: []), 
ASD Terms: (autism, 'Autism Phenotype')(complex neurodevelopmental disorder, 'Learning Disorders')(impaired reciprocal social interaction, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(cause autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(compulsive behaviors, 'Obsessive-Compulsive Disorder')(severe socialization deficits, 'Social Competence')(critical neurodevelopmental periods, 'Learning Disorders')

PMCID: 3474800
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (male bias: [orga]), (autism spectrum conditions: [mobd]), (females: [orga]), (asc: [gngm]), (lack: []), (attention: [menp]), (variability: []), (heterogeneity: [orga]), (study: [resa]), (key cognitive domains: []), (emotion perception: [menp]), ( executive: []), (perceptual attention: [menp]), (function): [phsf]), (similarities: []), (differences: [qnco]), (males: [orga]), (asc (n: [aapp,imft]), (adults; n: [aggp]), (group): [popg]), (mentalizing: []), (facial emotion perception domain: [blor]), ( males: [orga]), (similar deficits: []), (neurotypical controls: [sbst]), (however: []), (dexterity: [fndg]), (executive function: [menp]), (performance relative: [qnco]), (neurotypical males: [orga]), ( females: [orga]), (neurotypical females: [orga]), (performance: [inbe]), (social-cognitive domain: []), (male: [orga]), (female adults: [aggp]), (specific non-social cognitive domains: []), ( performance: [inbe]), (sex: [orgf]), (specific domains: []), (cognitive profiles: [lbpr]), 
ASD Terms: (autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(key cognitive domains, 'Cognitive Ability')(autism spectrum conditions, 'Autism Phenotype')(facial emotion perception domain, 'Visual Perception')(executive function, 'Executive Function')(autism spectrum conditions, 'Autism Phenotype')(dexterity, 'Functional Laterality')(autism spectrum conditions, 'Autism Phenotype')(specific non-social cognitive domains, 'Cognitive Ability')(autism, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(cognitive profiles, 'Cognitive Ability')

PMCID: 3501969
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (atypical activation: [acty]), (embedded figures task: [lbpr]), (autism: [mobd]), (siblings: [famg]), (measures: [qnco]), (clinical severity: []), (participants: [popg]), (unaffected siblings: [famg]), (control subjects: [sbst]), (number: [qnco]), (frontal brain regions: [bpoc]), (groups: [popg]), ( however: []), (terms: [orgf]), (activation: [acty]), (task: [gngm]), (pattern: []), (functional endophenotype: []), (familial risk: [famg]), (condition: [dsyn]), (individuals: [humn]), (reduced activation: [acty]), (subjects: [humn]), (regions: []), (face processing areas: [emst]), (impairments: [patf]), (reciprocal social interaction: [fndg]), (behavioural performance: [inbe]), (sibling groups: [famg]), (results: [fndg]), (atypical information processing styles: [menp]), (increased activation: [acty]), (frontal regions: [bpoc]), (phenotype: [orga]), (aspects: [qnco]), (markers: [clna]), (findings: [clna]), (new insight: [menp]), (factors: []), (expression: [topp]), (families: [famg]), (children: [aggp]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(face processing areas, 'Integrated Verbal and NonVerbal Communication')(reciprocal social interaction, 'Reciprocal Social Interaction')(atypical information processing styles, 'Ability to Convey Information')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3720840
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (copy number variants: [nusq]), (major role: [socb]), (etiology: []), (autism spectrum disorders: [mobd]), (statistical significance: [qnco]), (casecontrol analyses: [resa]), (nevertheless: []), (current asd cohorts: [cgab]), (rare cnvs: [nusq]), (risk alleles): [gngm]), (here: []), (tiered approach: []), (significant cnvs: [nusq]), (large clinical cohorts: [popg]), (neurodevelopmental disorders: [mobd]), (asd): [cgab]), (cnvs: [nusq]), (well-characterized asd cohorts: [cgab]), (initial analysis: [resa]), (recurrent cnvs: [nusq]), ((segmental duplication-mediated hotspots'): [nnon]), (loci: [gngm]), (clinical cases: [qnco]), (controls: [sbst]), (total: [qnco]), (deletion cnvs: [nusq]), (duplication cnvs: [nusq]), (overlap: [topp]), (combined sample: [sbst]), (well-characterized asd cases: [cgab]), (studies: [lbpr]), (deleterious recurrent cnvs: [nusq]), (deletions: [genf]), (duplications: []), (frequency: [qnco]), (asd cohorts: [cgab]), ((24 deletions: [genf]), (loci): [gngm]), (conclusion: []), (large asd research: [cgab]), (enough power: [hcpp]), (rare causative: [gngm]), (contributory cnvs: [nusq]), ( data: [euka]), (clinical cohorts: [popg]), (likely clinical significance: [fndg]), (asd: [cgab]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 3495055
SFARI Genes: PAFAH1B1, YWHAE, PAFAH1B1, YWHAE, PAFAH1B1, YWHAE, PAFAH1B1, YWHAE, PAFAH1B1, YWHAE, PAFAH1B1, YWHAE, PAFAH1B1, YWHAE, PAFAH1B1, YWHAE, YWHAE, PAFAH1B1, YWHAE, PAFAH1B1, YWHAE, YWHAE, YWHAE, YWHAE, 
Non SFARI Genes: BHLHA9, CRK, BHLHA9, CRK, 
Named Entities: (deletions: [genf]), (duplications: []), (pafah1b1: [gngm]), (ywhae genes: [gngm]), (different clinical phenotypes: [orga]), (particular: []), ( deletion: [genf]), (pafah1b1 causes: [gngm]), (ywhae: [gngm]), (miller-dieker syndrome: [dsyn]), (isolated duplications: []), (mild developmental delay: [fndg]), (hypotonia: [fndg]), (autism: [mobd]), ( different dysmorphic features: [cgab]), (ywhae duplication: [comd]), (need: []), (patient clinical features: [podg]), (groups: [popg]), (gene: [gngm]), (chromosomal duplication: [comd]), (proband: [famg]), (family: [famg]), (array-cgh analyses: [dsyn]), (putative rearrangement: [genf]), (fluorescence: [npop]), (situ hybridization: [mbrt]), (duplication: [comd]), (kilobases: [qnco]), (fish: [gngm]), (ywhae gene: [gngm]), (mild dysmorphic phenotype: [orga]), (associated autism: [mobd]), (mental retardation: [mobd]), (bhlha9: [gngm]), ( ywhae: [gngm]), (crk genes: [gngm]), (phenotype: [orga]), (patient: [podg]), (small chromosomal duplication: [comd]), (mother: [famg]), (bipolar: []), (borderline disorder: [dsyn]), (addicted: [podg]), (additional familial case: [famg]), (observation: [hlca]), (further cases: [qnco]), (similar microduplications: []), (clinical spectrum: [qnco]), (phenotypes: [orga]), (microduplications: []), 
ASD Terms: (mild developmental delay, 'Learning Disorders')(autism, 'Autism Phenotype')(associated autism, 'Autism Phenotype')(mental retardation, 'Mental Retardation')(bipolar, 'Bipolar Disorder')

PMCID: 3460929
SFARI Genes: 
Non SFARI Genes: Npas4, Npas4, Npas4, CA1, CA3, Npas4, 
Named Entities: (npas4: [gngm]), (transcription factor: [aapp,bacs]), (brain: [bpoc]), (formation: [biof]), (maintenance: [acty]), (inhibitory synapses: [celc]), (response: [fndg]), (synaptic activity: [acty]), (deregulation: [acty]), (inhibitory-excitatory balance: [acty]), (variety: []), (human developmental disorders: [humn]), (schizophrenia: [mobd]), (autism: [mobd]), (however: []), (role: [socb]), (inhibitory pathways: [acty]), (development: [orgf]), (nervous system disorders: [dsyn]), (alterations: []), (absence: [anab]), (major role: [socb]), (expression: [topp]), (symptoms: [sosy]), (psychiatric disorders: [mobd]), (hypothesis: []), (knock-out mice (npas4-ko)): [mamm]), (battery: [inpo]), (behavioral assays: [lbpr]), (general activity: [acty]), (social behaviors: [socb]), (cognitive functions: [menp]), (npas4-ko mice: [mamm]), (novel environment: []), ( spend: [qnco]), (time: []), (unfamiliar ovariectomized female: [fndg]), (unfamiliar male: [orga]), (first encounter: [bhvr]), ( show: [anim]), (social dominance: [socb]), (wt littermates: [fish]), (pre-pulse inhibition: [phsf]), (memory: [menp]), ( long-term memory: [menp]), (cognitive flexibility deficits: [mobd]), (behavioral deficits: [inbe]), (schizophrenia-related symptomatology: [podg]), (social anxiety: [mobd]), ( hyperactivity: [mobd]), (sensorimotor gating deficits: [phsf]), (immunohistochemistry analyses: [diap]), (npas4 expression: [topp]), (hippocampus: [bpoc]), (social encounter: [bhvr]), (c-fos: [gngm]), (ca1: [gngm]), (ca3 regions: []), (cognitive task: []), (results: [fndg]), (regulation: [biof]), (social functions: [socb]), (possible implications: []), (developmental disorders: [mobd]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(nervous system disorders, 'Nervous System Diseases')(psychiatric disorders, 'Mental Disorders')(social behaviors, 'Reciprocal Social Interaction')(cognitive functions, 'Cognitive Ability')(memory, 'Working Memory')(long-term memory, 'Working Memory')(cognitive flexibility deficits, 'Cognitive Ability')(behavioral deficits, 'Personal Traits')(social anxiety, 'Anxiety Disorders')(hyperactivity, 'Overactivity')(cognitive task, 'Cognitive Ability')(social functions, 'Ability to Converse in Social Settings')

PMCID: 3544729
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (impairments: [patf]), (social interaction: [fndg]), (verbal communication: [socb]), (repetitive behaviors: [fndg]), (date: []), (etiology: []), (disorder: [dsyn]), (studies: [lbpr]), (critical roles: [socb]), (neural plasticity: [ortf]), (neuronal activity: [acty]), (neuronal networks: [imft]), (number: [qnco]), (abnormal function: [phsf]), (glia/astrocytes: [cell]), (development: [orgf]), (however: []), (direct evidence: []), (astrocytes: [cell]), (brain: [bpoc]), (autistic individuals: [mobd]), (study subjects: [humn]), (brain tissue: [bpoc]), (autistic subjects: [mobd]), ( btbr t + tfj (btbr): [mamm]), (neuroligin: [moft]), ((nl)-3 knock-down mice: [mamm]), (western blot analysis: [lbpr]), ( immunohistochemistry: [diap]), (confocal microscopy studies: [lbpr]), (density: [qnco]), (morphology: [fndg]), (wnt: []), (-catenin protein expression: [aapp,bacs]), (study: [resa]), (autisitc subjects: [humn]), (processes: [phpr]), (total branching length: [qnco]), (cell body sizes: [celc]), (astrocytosis: [patf]), (frontal cortex: [bpoc]), (addition: []), (nl3 knockdown mouse: [mamm]), (similar alterations: []), (autistic brain: [mobd]), (-catenin proteins: [aapp,bacs]), (wnt/-catenin pathway: [moft]), (regulation: [biof]), (astrocyte development: [celf]), (findings: [clna]), (neuronal plasticity: [ortf]), (autistic-like behaviors: [mobd]), (humans: [humn]), (mice: [mamm]), (alteration: []), (changes: [qnco]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')

PMCID: 3440365
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (common neurodevelopmental syndrome: [dsyn]), (numerous rare genetic etiologies: [famg]), (cases: [qnco]), (methodology/principal findings: [clna]), (important gene dysregulation: [gngm]), (ba19 (occipital) brain tissues: [blor]), (high resolution: [lbpr]), (whole genome gene expression: [genf]), (whole genome dna methylation microarrays: [moft]), (changes: [qnco]), (dna methylation: [moft]), (autistic brain: [mobd]), (gene expression abnormalities: [genf]), (areas: []), (metabolism: [orgf]), (apparent: down-regulation: [moft]), (genes: [gngm]), (mitochondrial oxidative phosphorylation: [celc]), (protein translation: [moft]), (associations: [menp]), (specific behavioral domains: []), (specific brain gene expression modules: [moft]), (inflammation/immune response: [patf]), (purinergic signaling: [celf]), (conclusions/significance: [qnco]), (work: []), (unrecognized molecular pathophysiological themes: [patf]), (molecular bases: []), (behavioral endophenotypes: [inbe]), 
ASD Terms: (autism, 'Autism Phenotype')(common neurodevelopmental syndrome, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3566384
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (significant hereditary component: [qnco]), (implicated genetic loci: [gngm]), (complex: [chvs]), (consequently: []), (gap: [gngm]), (diverse genomic aberrations: [gngm]), (result: [fndg]), (clinical asd phenotype: [cgab]), (gene expression studies: [genf]), (autism brain tissue: [mobd]), (protein-coding genes: [gngm]), (common molecular pathways: [moft]), (strong heritability: []), (clinical phenotypes: [orga]), (genomic heterogeneity: [orga]), (disorder: [dsyn]), (however: []), (regulation: [biof]), (gene expression: [genf]), (many mechanisms: []), (rnas: [nnon]), (study: [resa]), (asd brain tissue: [cgab]), (changes: [qnco]), (regulatory long noncoding rnas (lncrnas): [bacs,nnon]), (large proportion: [qnco]), (human transcriptome: [humn]), (modulate mrna: [bacs,nnon]), (aberrant expression: [topp]), (lncrnas: [nnon]), (role: [socb]), (molecular pathogenesis: [patf]), (asd: [cgab]), (annotated lncrnas: [nnon]), (mrna transcripts: [bacs,nnon]), (postmortem brain tissue: [diap]), (prefrontal cortex: [bpoc]), (cerebellum: [bpoc]), (microarray: []), (genomic regions: [gngm]), (genes: [gngm]), (psychiatric disease: [mobd]), (additionally: []), ( comparison: [acty]), (differences: [qnco]), (expression: [topp]), (mrnas: [bacs,nnon]), (individual donors: [popg]), (asd brains: [cgab]), (transcriptional homogeneity: [genf]), (moreover: []), (lncrna transcriptome: [nusq]), (results: [fndg]), (further investigation: [hlca]), (lncrna expression: [nnon]), (autistic brain: [mobd]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s12031-012-9880-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(clinical asd phenotype, 'Autism Phenotype')(autism brain tissue, 'Autism Phenotype')(psychiatric disease, 'Mental Disorders')

PMCID: 3565204
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (tourette syndrome (ts): [dsyn]), (heritable neuropsychiatric disorder: [dsyn]), (motor: []), (vocal tics: [sosy]), (decades: [qnco]), (research: [resa]), (aetiology: []), (ts: [gngm]), (elusive: []), (recent successes: [socb]), (gene discovery: [mbrt]), (genomic technologies: [gngm]), (new insights: [menp]), (genetic basis: [phsu]), (disorder: [dsyn]), (collection: []), (disparate findings: [clna]), (confusion: [mobd]), (complexity: [chvs]), (attempts: [evnt]), (findings: [clna]), (neurobiological mechanisms: []), (symptom genesis: [gngm]), (review: []), (unrecognised genetic link: [topp]), (series: [qnco]), (trans-synaptic complexes: [chvs]), ((nrxns): []), ( neuroligins: [moft]), (leucine-rich repeat transmembrane proteins: [aapp,bacs]), (leucine rich repeat neuronals: [amas]), (precursor: []), ((cbln2)): [gngm]), (autism spectrum disorder: [mobd]), (neurodevelopmental pathways: [moft]), (emergent neuropathogenetic model: []), (genes: [gngm]), (single pathogenetic chain: [fndg]), (events: [evnt]), (context: [fndg]), (research implications: [resa]), 
ASD Terms: (tourette syndrome, 'Tourette Syndrome')(vocal tics, 'Tourette Syndrome')(tourette syndrome, 'Tourette Syndrome')(tourette syndrome, 'Tourette Syndrome')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental pathways, 'Learning Disorders')(tourette, 'Tourette Syndrome')

PMCID: 3513683
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (diagnosis: [fndg]), (behavioral criteria:: [inbe]), (unusual reciprocal social interactions: [fndg]), ( deficits: []), (communication: [socb]), (repetitive behaviors: [fndg]), (restricted interests: [menp]), (large number: [qnco]), (single gene mutations: [fndg]), (chromosomal deletions: [comd]), (autism spectrum disorders: [mobd]), (strong genetic evidence: [topp]), ( mice: [mamm]), (targeted mutations: [genf]), (homologous genes: [gngm]), (translational research tools: [resa]), (mouse models: [mamm]), (biological outcomes: []), (mutations: [genf]), (risk genes: [gngm]), (field: [irda]), (robust phenotypes: [orga]), (replicable mouse models: [mamm]), (preclinical screening: [diap]), (novel therapeutics: [orch,phsu]), 
ASD Terms: (unusual reciprocal social interactions, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(restricted interests, 'Restricted Range of Interests')(autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(diagnosis, 'Diagnosis')(autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3513682
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (aim: [phsu]), (review: []), (key findings: [clna]), (epidemiological research: [resa]), (autism: [mobd]), (complex disorder: [dsyn]), (combination: [fndg]), (environmental factors: []), (remarkable advances: []), (knowledge: []), (genetic causes: [topp]), (great efforts: [orgf]), (field: [irda]), (genetics: []), (identification: [menp]), (specific alleles: [gngm]), (autism spectrum: [mobd]), (important pieces: [qnco]), (autism puzzle: [mobd]), (however: []), (many questions: []), (new questions: []), (recent results: [fndg]), (moreover: []), (amount: [qnco]), (evidence: []), (significant contribution: [acty]), (search: [acty]), (aspect: [qnco]), (study: [resa]), (interactions: []), (genes: [gngm]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum, 'Autism Phenotype')(autism puzzle, 'Autism Phenotype')

PMCID: 3513680
SFARI Genes: RTT, RTT, RTT, RTT, MeCP2, MeCP2, RTT, MeCP2, RTT, MeCP2, RTT, RTT, 
Non SFARI Genes: 
Named Entities: (rett: []), ((rtt: [dsyn]), ( mim#312750): [gngm]), (neurodevelopmental disorder: [mobd]), (autism spectrum disorder: [mobd]), (clinically: []), ( rtt: [dsyn]), (psychomotor regression: [fndg]), (loss: [qnco]), (volitional hand use: [bpoc]), (spoken language: [fndg]), (development: [orgf]), (repetitive hand stereotypies: [bpoc]), (gait impairment: [fndg]), (majority: [socb]), (people: [popg]), (rtt: [gngm]), (mutations: [genf]), (methyl-cpg-binding protein: [gngm]), (transcriptional regulator: [genf]), (interestingly: []), ( alterations: []), (function: [phsf]), (protein product: [aapp,bacs]), (mecp2: [gngm]), ( mecp2: [aapp,bacs]), (number: [qnco]), (other clinical conditions: [dsyn]), (many clinical features: [clna]), (various clinical problems: [phsu]), (alteration: []), (mecp2 function: [aapp,bacs]), (belief: []), (other neurological disorders: [dsyn]), (excitingly: []), (mouse model: [emod]), (inspiration: [orgf]), (hope: [menp]), (goal: []), (many neurodevelopmental disorders: [mobd]), 
ASD Terms: (rett syndrome, 'Rett Syndrome')(neurodevelopmental disorder, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(volitional hand use, 'Fine Motor Skills')(other neurological disorders, 'Neurologic Indications')(many neurodevelopmental disorders, 'Learning Disorders')

PMCID: 3513679
SFARI Genes: sms, th, sms, th, sms, sms, sms, sms, sms, sms, 
Non SFARI Genes: 
Named Entities: (review: []), (critical molecular processes: [phpr]), (discovery: [acty]), (genetic mutations: [genf]), (autism: [mobd]), (mechanisms: []), (neurodevelopment step(s): [qnco]), (cause: []), (molecular mechanisms: []), ((i) regulation: [inch]), (gene: [gngm]), (expression; (ii) pre-mrna splicing; (iii) protein localization: [topp]), ( translation: [moft]), (turnover; (iv): [qnco]), (synaptic transmission; (v) cell signaling;: [celf]), (functions: [phsf]), (cytoskeletal: [celc]), (proteins;: [aapp,bacs]), (function: [phsf]), (neuronal cell adhesion molecules: [aapp,bacs]), (few steps: [qnco]), (neurodevelopment: [ortf]), (structure: []), ( function: [phsf]), (and/or plasticity: [npop]), (neuronal circuitry: [bpoc]), (many genetic mutations: [genf]), (novel treatments: [topp]), (few developmental mechanisms: [orgf]), 
ASD Terms: 

PMCID: 3513678
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (kanner's: []), (classic description: []), (syndrome: [dsyn]), (early infantile autism: [mobd]), (conceptions: [orgf]), (disorder: [dsyn]), (important continuity: []), (kanner: []), (hallmarks: []), (conditionsocial impairment (autism): [mobd]), (difficulties: [fndg]), (change: [qnco]), (nonsocial world (insistence: [popg]), (sameness): []), (paper: []), (history: [orga]), (evolution: [genf]), (important potential advantages: []), (disadvantages: []), (changes: [qnco]), (dsm-5: []), (convergence: [acty]), (diagnostic approach: [fndg]), (dsm-iv: []), (icd-10: []), (shared system: [socb]), (tremendous body: [humn]), (research: [resa]), (research comparability: [resa]), (service eligibility: [hlca]), 
ASD Terms: (early infantile autism, 'Autism Phenotype')

PMCID: 3464360
SFARI Genes: ARID1B, ARID1B, ARID1B, ARID1B, ARID1B, ARID1B, ARID1B, ARID1B, 
Non SFARI Genes: 
Named Entities: (corpus callosum abnormalities: [fndg]), (common brain malformations: [cgab]), (wide clinical spectrum: [qnco]), (severe intellectual disability: [mobd]), (normal cognitive function: [menp]), (etiology: []), (cases: [qnco]), (underlying genetic cause: [topp]), (majority: [socb]), (next-generation mate-pair sequencing: [mbrt]), (chromosomal breakpoints: [nnon]), (patient: [podg]), (t(1;6)(p31;q25): [gngm]), ( agenesis: [cgab]), (corpus callosum (cc): [bpoc]), (intellectual disability: [mobd]), (severe speech impairment: [fndg]), (autism: [mobd]), (chromosome: [celc]), (breakpoint: []), (arid1b: [gngm]), (translocation patient: [comd]), (similar phenotype: [orga]), (quantitative polymerase chain reaction (q-pcr) data: [euka]), (primer: [nnon]), (proximal: []), (translocation: [comd]), (increased expression: [topp]), (whereas primer sets: [nnon]), (decreased expression: [topp]), (patient relative: [podg]), (non-related control set: [menp]), (phenotypegenotype comparison: [acty]), (unpublished patients: [podg]), (various sized deletions: [genf]), (arid1b confirms: [gngm]), (haploinsufficiency: [comd]), (cc: [celc]), (findings: [clna]), (human brain development: [ortf]), (function: [phsf]), (general: [hlca]), (development: [orgf]), (speech development: [orgf]), (particular: []), 
ASD Terms: (severe intellectual disability, 'Learning Disorders')(normal cognitive function, 'Cognitive Ability')(intellectual disability, 'Learning Disorders')(severe speech impairment, 'Idiosyncratic and Routinized Speech')(autism, 'Autism Phenotype')(speech development, 'Language Ability')

PMCID: 3432855
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (unknown etiology: [fndg]), (cases: [qnco]), (children regress: [aggp]), (clinical symptoms: [sosy]), (condition: [dsyn]), (regressive autism: [mobd]), (protein kinases: [aapp,enzy]), (g-protein-coupled receptor-mediated signal transduction: [moft]), (neuronal functions: [imft]), ( gene: [gngm]), (expression: [topp]), ( memory: [menp]), (cell differentiation: [celf]), (recently: []), (decreased activity: [sosy]), (protein: [aapp,bacs]), (a (pka): []), (frontal cortex: [bpoc]), (subjects: [humn]), (present study: [qnco]), (activity: [acty]), (protein kinase c (pkc): [aapp,enzy]), (cerebellum: [bpoc]), (different regions: []), (cerebral cortex: [bpoc]), (autistic subjects: [mobd]), (clinical history: [orga]), (regression: [menp]), (age-matched control subjects: [humn]), ( pkc activity: [moft]), (age-matched control: [orga]), ((p =: [aapp,imft]), (non-regressed autistic subjects: [mobd]), (pkc activity: [moft]), (temporal: []), ( parietal: []), (occipital cortices: [bpoc]), (autism groups: [mobd]), ( i.e.: [diap,inpr]), (non-regressed autism: [mobd]), (results: [fndg]), (brain: [bpoc]), (region-specific alteration: []), (further studies: [lbpr]), (negative correlation: [fndg]), (restrictive: []), ( repetitive: []), (pattern: []), (behavior (r= -0.084: [inbe]), ( p: [aapp,imft]), (autistic individuals: [mobd]), (involvement: []), (pkc: [gngm]), (behavioral abnormalities: [mobd]), (findings: [clna]), (part: [qnco]), (alterations: []), (pka: []), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(developing children regress into clinical symptoms, 'Childhood Disintegrative Disorder')(regressive autism, 'Autism Phenotype')(memory, 'Working Memory')(regressive autism, 'Autism Phenotype')(autism groups, 'Autism Phenotype')(non-regressed autism, 'Autism Phenotype')(stereotyped pattern, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')(behavioral abnormalities, 'Personal Traits')(autism, 'Autism Phenotype')

PMCID: 3427326
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (fast-spiking (fs) interneurons: [fndg]), (multiple neuropsychiatric disorders: [dsyn]), (autism: [mobd]), ( schizophrenia: [mobd]), (bipolar disorder: [mobd]), (fs cells: [cell]), (primary source: [fndg]), (synaptic inhibition: [acty]), (brain activity: [phsf]), (brain maturation: [ortf]), (critical developmental periods: [orgf]), (multiple cortical systems: [bpoc]), (expression: [topp]), (parvalbumin: [aapp,bacs]), (marker: [clna]), (mature fs cells: [cell]), (individuals: [humn]), (schizophrenia: [mobd]), (mouse models: [mamm]), (results: [fndg]), (immature: []), (neuropsychiatric disease: [dsyn]), (possibility: []), (study: [resa]), (time-course global expression data: [euka]), (maturation index: [qnco]), (developmental age: [orga]), (purified cortical fs cells: [bpoc]), (fs cell maturation index: [celf]), (global gene expression data: [genf]), (human cortex: [humn]), (maturity: []), (fs cell: [gngm]), (developmental program: [hlca]), (context: [fndg]), (various disease states: [dsyn]), (specificity: [qnco]), (index: [qnco]), (significant correlation: [qnco]), (maturation index measurements: [qnco]), (parvalbumin expression levels: [aapp,bacs]), (correction: []), (multiple covariates: [qnco]), (developmental gene expression program: [hlca]), (current study: [resa]), (cell-type specific maturation indices: [celf]), (developmental programs: [hlca]), (data: [euka]), (mixed cell types: [cell]), (brain homogenates: [bpoc]), 
ASD Terms: (autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(bipolar disorder, 'Bipolar Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 3548427
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mutations: [genf]), (sequence diversity: [nusq]), (substrate: [sbst]), (selection: [genf]), (rate: [qnco]), (major importance: []), (study: [resa]), (genomewide mutation rate: []), (entire genomes: [gngm]), (icelandic: [lang]), (parent-offspring trios: [aapp,enzy]), (high coverage: [qnco]), (samples: [sbst]), (average fathers age: [famg]), (average: [qnco]), (novo mutation rate: []), (nucleotide: [nnon]), (generation: [acty]), (diversity: []), (mutation rate: []), (single-nucleotide polymorphism (snp): [nusq]), (age: [orga]), (father: [famg]), (conception: [orgf]), (child: [aggp]), (effect: []), (increase: []), (year: []), (random poisson variation: [resa]), ( fathers age: [famg]), (variation: []), (mutation counts: [genf]), (observations: [hlca]), (light: [gngm]), (importance: []), (fathers age: [famg]), (risk: []), (diseases: [dsyn]), (schizophrenia: [mobd]), (autism: [mobd]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')

PMCID: 3448848
SFARI Genes: SCN1A, NaV1.1, SCN1A, NaV1.1, Scn1a, Scn1a, NaV1.1, NaV1.1, NaV1.1, NaV1.1, 
Non SFARI Genes: 
Named Entities: (haploinsufficiency: [comd]), (scn1a gene: [gngm]), (voltage-gated sodium channel nav1.1: [bacs,elii]), (dravet syndrome: [dsyn]), (childhood: []), (neuropsychiatric disorder: [dsyn]), (recurrent: []), (intractable seizures: [fndg]), ( cognitive deficit: [mobd]), (autism-spectrum behaviors: [inbe]), (neural mechanisms: []), (cognitive deficit: [mobd]), (ds: [gngm]), (mice: [mamm]), (scn1a haploinsufficiency display hyperactivity: [comd]), (behaviors: [inbe]), ( social interaction deficits: [fndg]), (impaired context-dependent spatial memory: [menp]), (olfactory sensitivity: [orgf]), (novel food odors: [npop]), (social odors: [npop]), (scn1a+/ mice: [mamm]), (gabaergic neurotransmission: [celf]), (mutation: [genf]), (selective deletion: [genf]), (nav1.1 channels: [gngm]), (forebrain interneurons: [bpoc]), (cognitive impairments: [mobd]), (remarkably: []), ( treatment: [topp]), (low-dose clonazepam: [orch,phsu]), (positive allosteric modulator: [fndg]), (gabaa receptors: [aapp,rcpt]), (abnormal social behaviors: [patf]), (deficits: []), (fear memory: [menp]), (ds mice: [mamm]), (impaired gabaergic neurotransmission: [celf]), (neuronal damage: [inpo]), (recurrent seizures: [dsyn]), (results: [fndg]), (critical role: [socb]), (neuropsychiatric functions: [phsf]), (potential therapeutic strategy: [menp]), 
ASD Terms: (cognitive deficit, 'Cognitive Ability')(scn1a haploinsufficiency display hyperactivity, 'Overactivity')(social interaction deficits, 'Reciprocal Social Interaction')(impaired context-dependent spatial memory, 'Working Memory')(cognitive impairments, 'Cognitive Ability')(fear memory, 'Working Memory')(abnormal social behaviors, 'Personal Traits')(cognitive deficit, 'Cognitive Ability')

PMCID: 3506511
SFARI Genes: MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, 
Non SFARI Genes: Mb, 
Named Entities: (autistic spectrum disorders: [mobd]), (family: [famg]), (neurodevelopmental disorders: [mobd]), (strong genetic components: [gngm]), (recent studies: [lbpr]), (copy number variations: [nusq]), (dosage: [qnco]), (sensitive genes: [gngm]), (disorders: [dsyn]), (such gene: [gngm]), (transcription factor mecp2: [aapp,bacs]), (loss: [qnco]), (function: [phsf]), (females results: [orga]), (rett syndrome: [dsyn]), (duplication: [comd]), (males results: [orga]), (developmental delay: [mobd]), (autism: [mobd]), (case presentation here: []), (chinese family: [famg]), (brothers: [famg]), (mb mecp2-containing duplication (151: [aapp,bacs]), (369: []), (305: []), (mother: [famg]), (kb duplication: [comd]), (chromosome: [celc]), (father: [famg]), (brother: [famg]), (kb deletion: [genf]), (literature: [inpr,mnob]), ( mecp2: [aapp,bacs]), (autism-associated gene: [gngm]), (cnvs: [nusq]), (boys: [aggp]), (clinical features: [clna]), (other patients: [podg]), (mecp2 duplications: [aapp,bacs]), (intellectual disability: [mobd]), ( lack: []), (speech: [orgf]), (slight hypotonia: [fndg]), (unsteadiness: [fndg]), (movement: [orgf]), (slight dysmorphic features: [cgab]), (depressed nose bridge: [fndg]), (large ears: [fndg]), (midface hypoplasia: [fndg]), (interestingly: []), (other clinical features: [clna]), (american-european patients: [podg]), (mecp2 duplication: [aapp,bacs]), (recurrent respiratory infections: [fndg]), (epilepsy: [dsyn]), (knowledge: []), (first identification: [menp]), (characterization: [acty]), (chinese han patients: [podg]), (mecp2-containing duplications: [aapp,bacs]), (further cases: [qnco]), (above: []), (clinical differences: [qnco]), (individual variations: [humn]), (genetic background: [orga]), (patients: [podg]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autistic spectrum disorders, 'Autistic Disorder')(rett syndrome, 'Rett Syndrome')(developmental delay, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(speech, 'Language Ability')(intellectual disability, 'Learning Disorders')(depressed nose bridge, 'Depressive Disorder')(recurrent respiratory infections, 'Respiratory Indications')(epilepsy, 'Epilepsy')

PMCID: 3494744
SFARI Genes: ADARB1, ADARB1, 
Non SFARI Genes: 
Named Entities: (adenosine-to-inosine (a-to-i) rna editing: [genf]), (neurodevelopmentally-regulated epigenetic modification: [genf]), (complex behavior: [inbe]), (animals: [anim]), (human a-to-i editing: [humn]), (many molecular mechanisms: []), (environmental stimuli: [npop]), (behavioral outputs: [inbe]), (thus: []), (comprehensive exploration: [topp]), (a-to-i rna: [aapp,enzy]), (human brains: [humn]), (light: [gngm]), (gene-environment interactions: [genf]), (health: []), (disease: [dsyn]), (synaptic function: [phsf]), (main target: [diap]), (a-to-i editing: [inch]), (key amino acids: [aapp,bacs,phsu]), (synaptic genes: [gngm]), (synaptic strength: [qnco]), (duration: [phsu]), (response: [fndg]), (environmental signals: [phpr]), (high-resolution survey: [lbpr]), (synaptic a-to-i rna: [aapp,enzy]), (human population: [popg]), (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (synaptic abnormalities: [cgab]), (common finding: [sosy]), (ultra-deep (>1000) sequencing: [mbrt]), (levels: []), (postmortem cerebella: [diap]), (autistic individuals: [mobd]), (high dynamic range: [qnco]), (individuals: [humn]), (sites: []), (detection limits: [topp]), (extreme ends: []), (population: [popg]), (distributions: []), (editing: []), (isoform: [aapp]), (usage: []), ( clusters: [qnco]), (differential editing patterns: []), (finally: []), (dysfunctional form: [dsyn]), (enzyme adarb1: [enzy,orch]), (results: [fndg]), (population-level: [popg]), ( high-resolution view: [lbpr]), (human cerebella: [humn]), (epigenetic risk: []), 
ASD Terms: (complex behavior, 'Executive Function')(complex behavior, 'Executive Function')(autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3400671
SFARI Genes: EN2, EN2, 
Non SFARI Genes: 
Named Entities: (homeobox transcription: [gngm]), (factor: []), ( functions: [phsf]), (gene: [gngm]), (early development: [orgf]), (connectivity: []), (rodent hindbrain: [mamm]), (cerebellum: [bpoc]), (neurogenesis: [orgf]), (development: [orgf]), (monoaminergic pathways: [moft]), (neurobiological functions: [phsf]), (en2: [gngm]), (neuroanatomical expression profiling: [mbrt]), (en2 wildtype mice: [mamm]), (rtqpcr assays: [lbpr]), (adult brain structures: [bpoc]), (somatosensory cortex: [bpoc]), ( hippocampus: [bpoc]), ( striatum: [bpoc]), ( thalamus: [bpoc]), ( hypothalamus: [bpoc]), (brainstem: [bpoc]), (human: [humn]), (genetic studies: [resa]), (autism: [mobd]), (consequences: []), (en2 mutations: [genf]), (mouse behaviors: [mamm]), (outcomes: []), (comprehensive phenotyping: [lbpr]), (social: []), ( communication: [socb]), ( repetitive: []), (cognitive behaviors: [inbe]), (null mutants: [comd]), (robust deficits: []), (reciprocal social interactions: [fndg]), (juveniles: [aggp]), (adults: [aggp]), (absence: [anab]), (sociability: [socb]), (independent cohorts: [popg]), (fear conditioning: [menp]), (water maze: [sbst]), (en2 null mutants: [comd]), (high immobility: [fndg]), (forced swim test: [dora]), (prepulse inhibition: [phsf]), (mild motor coordination impairments: [sosy]), (reduced grip strength: [sosy]), (genotype differences: [orga]), (measures: [qnco]), (ultrasonic vocalizations: [npop]), (social contexts: [hcpp]), (repetitive behaviors: [fndg]), (developmental: [orgf]), (general health: [clna]), ( olfactory: [orgf]), (abilities: [orga]), ( exploratory locomotor: []), (anxiety-like behaviors: [mobd]), (pain responses: [fndg]), (genotypes: [orga]), ( indicating: []), (behavioral abnormalities: [mobd]), (procedural confounds: [topp]), (findings: [clna]), (new insight: [menp]), (role: [socb]), (complex behaviors: [inbe]), (disturbances: []), (en2 signaling: [celf]), (neuropsychiatric disorders: [dsyn]), (cognitive deficits: [mobd]), (autism spectrum disorders: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(conducted comprehensive phenotyping of social, 'Ability to Converse in Social Settings')(cognitive behaviors, 'Cognitive Ability')(reciprocal social interactions, 'Reciprocal Social Interaction')(mild motor coordination impairments, 'Motor Skills')(ultrasonic vocalizations, 'Vocalizations')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(pain responses, 'Pain')(behavioral abnormalities, 'Personal Traits')(complex behaviors, 'Executive Function')(cognitive deficits, 'Cognitive Ability')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 3410621
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (n-methyl-d-aspartate-receptor (nmdar) signaling: [aapp,rcpt]), (schizophrenia: [mobd]), ( autism: [mobd]), (intellectual disability: [mobd]), (nmdar-hypofunction: [aapp,rcpt]), (gamma (3080 hz) oscillatory abnormalities: [npop]), (disorders: [dsyn]), (however: []), (circuit-level mechanisms: [phsu]), (such deficits: []), (study: [resa]), (relationship: []), (gamma synchrony: [npop]), ( excitatoryinhibitory (e/i) signaling: [celf]), (behavioral phenotypes: [bhvr]), (nmda-nr1neo/ mice: [mamm]), (expression: [topp]), (obligate nr1 subunit: [aapp]), (disrupted developmental nmdar function: [aapp,rcpt]), (constitutive nmdar-hypofunction: [aapp,rcpt]), (loss: [qnco]), (e/i balance: [inch]), (increase: []), (intrinsic pyramidal cell excitability: [cell]), (selective disruption: [genf]), (parvalbumin-expressing interneurons: [aapp,bacs]), (e/i coupling: [inch]), (deficits: []), (auditory-evoked gamma signal-to-noise ratio (snr): [qnco]), (gamma-band abnormalities: [npop]), (spatial working memory: [menp]), (social preference: []), (cellular changes: [qnco]), (e/i: [inch]), (behaviors: [inbe]), (gabab-receptor agonist baclofen: [aapp,phsu]), (gamma-snr: [qnco]), (behavioral deficits: [inbe]), (data: [euka]), (translatable neural-activity-based biomarker: [clna]), (preclinical screening: [diap]), (therapeutic development: [orgf]), (broad range: [qnco]), (share: [socb]), (common endophenotypes: [qnco]), (nmda-receptor signaling: [aapp,rcpt]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(spatial working memory, 'Working Memory')(behavioral deficits, 'Personal Traits')

PMCID: 3410618
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (oxidative stress: [comd]), (pathophysiology: [patf]), (autism: [mobd]), (studies: [lbpr]), (biomarkers: [clna]), (specific brain regions: [blor]), (functional consequences: []), (frozen samples: []), (cerebellum: [bpoc]), (temporal cortex (brodmann area: [bpoc]), ((ba22)): []), (individuals: [humn]), (unaffected controls: [sbst]), (group: [popg]), ( respectively): []), (glutathione (gsh): [aapp,bacs]), (glutathione (gssg): [aapp,phsu]), (glutathione redox/antioxidant capacity (gsh/gssg): [aapp,bacs]), (measured: [diap]), (oxidative protein damage: [aapp,bacs]), (oxidative dna damage: [comd]), (functional indicators: [irda]), (relative levels: [qnco]), (biomarker: [clna]), (chronic inflammatory response: [patf]), (aconitase: [aapp,enzy]), (mitochondrial superoxide production: [celc]), (previous studies: [lbpr]), (plasma: [bdsu]), (immune cells: [cell]), ( gsh: [dsyn]), (gsh/gssg: [aapp,phsu]), (autism cerebellum (p<0.01): [bpoc]), (ba22 (p<0.01): [fndg]), (significant increase: [qnco]), (autism cerebellum: [bpoc]), (similarly: []), (ba22 (p<0.01: [fndg]), (p=0.01: [fndg]), (cerebellum (p<0.01): [bpoc]), (3-ct levels: [aapp]), (brain regions: [blor]), (whereas aconitase activity: [moft]), (gsh/gssg (p=0.01): [aapp,phsu]), (together: []), (results: [fndg]), (redox/antioxidant capacity: [phsu]), (autism brain: [mobd]), (functional consequence: []), (terms: [orgf]), (oxidative protein: [aapp,bacs]), (dna damage: [comd]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism cerebellum, 'Autism Phenotype')(autism brain, 'Autism Phenotype')

PMCID: 3392732
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (lives: [fndg]), (family: [famg]), (child: [aggp]), (condition: [dsyn]), (different ways: []), (forces family members: [famg]), (daily lives: [fndg]), (reality: []), (knowledge: []), (previous research: [resa]), (concern: []), (considerations: [fndg]), (parents/caregivers: []), (children: [aggp]), (qatar: []), (arabic speaking middle eastern region: [popg]), (caregivers: []), (age: [orga]), (to17 years: []), (time: []), (study: [resa]), (asd (autistic group: [cgab]), (ag): []), (main developmental pediatric: [orgf]), (children rehabilitation clinics: [aggp]), (control group (non-autism group: [grup]), (nag): [gngm]), (non-autistic child: [mobd]), (years: []), (family clinic: [famg]), (primary health care facility: [hcro,mnob]), (routine medical check-up: [fndg]), (data: [euka]), (groups: [popg]), (child (e.g: [aggp]), (childs date: [aggp]), (birth: [orgf]), (relation: [socb]), (caregiver: []), ( number: [qnco]), (siblings: [famg]), (hours: []), (sleep: [orgf]), (day: []), (television: []), (indoors: []), (absenteeism: [inbe]), (school: [mnob,orgt]), (use: []), (nanny: []), (child): [aggp]), (caregiver (education level: [fndg]), (level: [phsu]), (consanguinity: [fndg]), (phylogram method): [lbpr]), (addition: []), (questions: []), ( caregivers: []), (ag: []), (specific questions: []), (maternal concern: [fndg]), (respect: [socb]), (future: []), (services: []), (autism group: [mobd]), (non-autism group: [mobd]), (parent: []), (s/he: []), (number: [qnco]), (specialized rehabilitation services; others: [fndg]), (needs: []), (comments: []), (long time: []), (religious faith: [fndg]), (general: [hlca]), (health-related quality: [fndg]), (life: []), (mental health: [menp]), (attention: [menp]), (concerns: []), (families: [famg]), (expectations: []), (findings: [clna]), (policy makers: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(age of 3 to17 years, 'Onset of Symptoms')(routine medical check-up, 'Medications')(autism group, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism group, 'Autism Phenotype')

PMCID: 3496584
SFARI Genes: 
Non SFARI Genes: TNF, 
Named Entities: (autism spectrum disorders (asd): [mobd]), (neurodevelopmental disorders: [mobd]), (deficits: []), (social interactions: [fndg]), ( communication: [socb]), (learning: [menp]), (stereotypic behaviors: [mobd]), (significant increase: [qnco]), (asd: [cgab]), (clues: []), (pathogenesis: [patf]), (early detection: [diap]), (treatment: [topp]), (premature babies: [dsyn]), (infections: [patf]), (inflammation: [patf]), (neurodevelopmental problems: [ortf]), (risk: []), (many autism susceptibility genes: [mobd]), (environmental factors: []), (significant role: [socb]), (evidence: []), (different asd endophenotypes: [cgab]), (discussion: [socb]), (relevant literature: [inpr,mnob]), (utero inflammation: [patf]), (labor: [orgf]), (insufficient development: [fndg]), (gut-bloodbrain barriers: [bpoc]), (exposure: [clna]), (potential neurotoxins: [hops]), (parents: []), (allergic: []), (problems: []), (gestation: [orgf]), (presence: [qnco]), (auto-antibodies: [aapp,imft]), (fetal brain proteins: [aapp,bacs]), (mothers: [famg]), (autism: [mobd]), (disruption: []), (bloodbrain-barrier (bbb): [bpoc]), (number: [qnco]), (papers: []), (increased brain expression: [bpoc]), (cerebrospinal fluid (csf) levels: [bdsu]), (pro-inflammatory cytokines: [aapp,bacs]), (tnf: [gngm]), (mast cells: [cell]), (recent evidence: []), (serum levels: [bdsu]), (pro-inflammatory mast cell trigger neurotensin (nt): [aapp,horm]), (extracellular mitochondrial dna (mtdna): [bacs,nnon]), (gene mutations: [genf]), (phosphatase: [aapp,enzy]), (tensin homolog: [aapp,bacs]), (negative regulator: [fndg]), (mammalian target: [mamm]), (rapamycin (mtor): [aapp,enzy]), (proliferation: [patf]), (function: [phsf]), (summary premature birth: [fndg]), (susceptibility genes: [gngm]), (infants: [aggp]), (environmental: []), ( infectious: [dsyn]), (stress-related triggers: [clna]), (mast cell release: [hlca]), (pro-inflammatory: [aapp,bacs]), (neurotoxic molecules: [inpo]), (brain inflammation: [dsyn]), (endophenotype: []), (asd patients: [cgab]), 
ASD Terms: (social interactions, 'Reciprocal Social Interaction')(stereotypic behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorders, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(neurodevelopmental problems, 'Learning Disorders')(many autism susceptibility genes, 'Autism Phenotype')(permit exposure, 'Exposures')(allergic, 'Allergies')(gestation, 'Perinatal History')(autism, 'Autism Phenotype')(cerebrospinal fluid levels, 'Hydrocephalus')(autism, 'Autism Phenotype')

PMCID: 3410815
SFARI Genes: IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, 
Non SFARI Genes: 
Named Entities: (t-helper (th)1/th2 dichotomy: []), (field: [irda]), (immune regulation: [biof]), (interleukin (il)-17-expressing t cells (th17): [cell]), (third lineage: [qnco]), (helper t: []), (key players: []), (pathogenesis: [patf]), (autoimmune disorders: [dsyn]), (autoimmunity: [patf]), (brain tissue: [bpoc]), (pathogenic role: [socb]), (autism: [mobd]), (il-17a: [gngm]), (pro-inflammatory cytokine: [aapp,bacs]), (important role: [socb]), (various autoimmune neuroinflammatory diseases: [dsyn]), (aim: [phsu]), (study: [resa]), (serum levels: [bdsu]), (relation: [socb]), (degree: [qnco]), (severity: []), (serum il-17a levels: [aapp,rcpt]), (elisa: [lbpr]), (children: [aggp]), (healthy controls: []), (increased serum levels: [bdsu]), (autism group: [mobd]), (patients: [podg]), (severe autism: [fndg]), (autism (p: [mobd]), (il-17a levels: [aapp,rcpt]), (severe autism (67.9%): [fndg]), (autism (17.6%): [mobd]), ( p: [aapp,imft]), (group: [popg]), (levels: []), (first study: [qnco]), (measure levels: [qnco]), (knowledge: []), (research: [resa]), (subject population: [popg]), (increase: []), (serum il-17a levels plasma: [aapp,rcpt]), (anti- il-17a therapy: [aapp,rcpt]), 
ASD Terms: (autoimmune disorders, 'Autoimmune Diseases')(autism, 'Autism Phenotype')(various autoimmune neuroinflammatory diseases, 'Autoimmune Diseases')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism group, 'Autism Phenotype')(severe autism, 'Autism Phenotype')(severe autism, 'Autism Phenotype')(moderate autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3391175
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism rate: [mobd]), (children: [aggp]), (genetic studies: [resa]), (understood complexity: [menp]), (environmental factors: []), (role: [socb]), (magnetic resonance: [npop]), ((mri) studies: [diap]), (brain sizes: [qnco]), (connectivity: []), (electroencephalogram (eeg) coherence studies: [lbtr]), (connectivity changes: [qnco]), (however: []), (genetic-: [topp]), ( mri- and/or: [diap]), (eeg-based diagnostic tests: [diap]), (varied study results: [fndg]), (population: [popg]), (small samples: [sbst]), (eeg: [diap]), ( lack: []), (attention: [menp]), (group-specific artifact: [popg]), (subjects: [humn]), (study: [resa]), (ages: [bacs,orch]), (years: []), (comparable eeg studies: [diap]), (autism spectrum disorder: [mobd]), (neuro-typical controls: []), (artifact management: [hlca]), (principal components analysis: [qnco]), (spectral coherence factors: [qnco]), (patterns: []), (12-year-old subsample: []), (c-group subjects: [humn]), (discriminant function analysis (dfa): [resa]), (spectral coherence factors' discrimination success: [socb]), (groups: [popg]), (dfa-selected coherence factors: [acty]), (asd-specific coherence differences: [cgab]), (total sample pca: [qnco]), (coherence data: [euka]), (factors: []), (total population variance: [qnco]), (significant group differences: [popg]), (split half replications: [genf]), (high-average classification success: [socb]), (asd: [cgab]), (success: [socb]), (restricted age sub-samples: [qnco]), (jackknifing: []), (coherence loadings: [acty]), (reduced short-distance: [qnco]), (reduced: []), (increased: [qnco]), ( long-distance coherences: [fndg]), (asd-groups: [cgab]), (controls: [sbst]), (factor: []), (wide (10.1 hz): [qnco]), (classification success: [socb]), (stable coherence: [fndg]), (pattern: []), (coherence-based phenotype: [orga]), (childhood autism: [mobd]), (short-distance coherences: [fndg]), (poor local network function: [grpa]), (long-distance coherences: [fndg]), (compensatory processes: [phpr]), (reduced neural pruning: []), (wide average spectral range: [qnco]), (factor loadings: [acty]), (over-damped neural networks: [aapp,bacs]), 
ASD Terms: (autism rate, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(childhood autism, 'Autism Phenotype')

PMCID: 3383751
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (epac2 disruption impairs basal: [gngm]), (apical) dendrite complexity: [celc]), (cortical neurons: [bpoc]), (autism-associated mutation: [mobd]), (epac2: [gngm]), (ras/epac2: [gngm]), (active maintenance: [acty]), (basal: []), (dendritic arbors: [celc]), 
ASD Terms: 

PMCID: 3371866
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (motivation:: [menp]), (understanding: [menp]), (genetic determinants: [topp]), (complex disease: [dsyn]), (paradigm shift: [phpr]), (genetic heterogeneity: [orga]), (rare mutations: [genf]), (deleterious effects: []), (major component: []), (disease: [dsyn]), (autism: [mobd]), (excellent example: []), (research: [resa]), (matches: [resa]), (phenotypic: [orga]), (genomic heterogeneities: [orga]), (considerable portion: []), (copy number variation: [nusq]), (single nucleotide polymorphism: [nusq]), ((snp) array: [nusq]), (sequencing technologies: [mbrt]), (small deletions: [genf]), (major unresolved computational problem: [acty]), (inability: []), (algorithms: []), (them: []), (results:: [fndg]), (article: []), (algorithmic framework: [fndg]), (term delishus: [orgf]), (implements: []), (exact algorithms: []), (regions: []), (hemizygosity: []), (genomic deletions: [genf]), (sizes: []), (frequencies: []), (snp genotype data: [nusq]), (efficient backtracking algorithmthat: []), (entry: []), (genome-wide association study snp matrix: [mbrt]), (few minutesto compute: []), (inherited deletions: [genf]), (dataset: []), (model: []), (efficient algorithm: [lbpr]), (deletions: [genf]), (finally: []), (set: [menp]), (polynomial time algorithm: [lbpr]), (critical regions: []), (recurrent deletions: [genf]), (delishus: []), (false-positive rates: [qnco]), (power: [hcpp]), (individuals: [humn]), (sample simultaneously: [sbst]), (snp array: [mbrt]), (data: [euka]), (deletion spectrum: [genf]), (family-based association studies: [socb]), (availability: delishus: []), (http://www.brown.edu/research/istrail_lab/: [orch,phsu]), (contact: eric_morrow@brown.edu: [orch,phsu]), (sorin_istrail@brown.edu supplementary information: supplementary data: [orch,phsu]), (bioinformatics online: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3536966
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (predictive power: [hcpp]), (morphological features: []), (autistic patients: [mobd]), (matched-pairs controls: [resa]), (relationship: []), (autism: [mobd]), (receiver operator: [humn]), ((roc): [qnco]), (addition: []), (recursive partitioning (rp): []), (specific pattern: []), (abnormalities: [cgab]), (difference: [qnco]), (autistic children: [podg]), (controls: [sbst]), (present findings: [clna]), (patients: [podg]), (roc: [qnco]), (rp: [gngm]), (morphological measures: [qnco]), (strong predictive accuracy: []), (facial asymmetry: [anab]), (multiple hair whorls: [bpoc]), (prominent forehead: [fndg]), (future research: [resa]), (multivariable risk prediction models: []), (use: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-012-1554-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3368908
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (idiopathic autism: [mobd]), (genetic susceptibility: [orga]), (unknown environmental triggers: [clna]), (years: []), (environmental triggers: [clna]), (understood pathophysiology: [menp]), (subjective definitions: []), (autism: [mobd]), (use: []), (antidepressants: [phsu]), (pregnant women: [popg]), (other unmetabolized psychoactive pharmaceuticals: [phsu]), (drinking water: [sbst]), (surface sources: [fndg]), (possible exposure route: []), (questions: []), (human health consequences: [humn]), (here: []), (gene expression patterns: [genf]), (fathead minnows: [fish]), (mixture: [sbst]), (psychoactive pharmaceuticals: [phsu]), (venlafaxine: [orch,phsu]), (carbamazepine): [orch,phsu]), (dosages: [qnco]), (observed conservative estimates: [qnco]), (environmental concentrations: [menp]), (microarray experiments: [resa]), (brain tissue: [bpoc]), (fish: [gngm]), (individual pharmaceuticals: [phsu]), (three: [qnco]), (gene-class analysis: [lbpr]), (enrichment: []), (gene sets: [gngm]), (ten human neurological disorders: [humn]), (sets: [menp]), (upps: []), (autism-like gene expression patterns: [mobd]), (findings: [clna]), (new potential trigger: [clna]), (susceptible individuals: [humn]), (overlooked source: [fndg]), (environmental contamination: [eehu]), 
ASD Terms: (idiopathic autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(possible exposure route, 'Exposures')(ten human neurological disorders, 'Neurologic Indications')(idiopathic autism, 'Autism Phenotype')

PMCID: 3823072
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract: []), (biomarkers: [clna]), (illness: [sosy]), (strategy: [menp]), (popularity: [socb]), (relevance: []), (clinical use: []), (biological measurement: []), (psychiatric disorder: [mobd]), (course: []), (medical problem: [clna]), (aid: [gngm]), (several studies: [lbpr]), (candidate: []), (psychiatric biomarkers: [clna]), (proteomic techniques: []), ( cholesterol: [bacs,orch]), (proteins: [aapp,bacs]), ((apos): []), (interest: [menp]), (cholesterol: [bacs,orch]), (brain development: [ortf]), (synthesis: [biof]), (rate: [qnco]), (adult brain: [bpoc]), (apos: []), (protein component: [aapp,bacs]), (lipoproteins: [aapp,bacs]), (lipid transport: [celf]), (extensive evidence: []), (levels: []), (psychiatric disorders: [mobd]), (autistic spectrum disorders: [mobd]), (here: []), (putative serum biomarkers: []), (role: [socb]), (central nervous system (cns) disorders: [dsyn]), 
ASD Terms: (psychiatric disorder, 'Mental Disorders')(medical problem, 'Medications')(psychiatric disorders, 'Mental Disorders')(autistic spectrum disorders, 'Autistic Disorder')(central nervous system disorders, 'Nervous System Diseases')

PMCID: 3352915
SFARI Genes: 
Non SFARI Genes: fuse, 
Named Entities: (language difficulties: [fndg]), (individuals: [humn]), (autism: [mobd]), (inability: []), (audiovisual information: []), (skill: [inbe]), (language development: [menp]), (9-month-old siblings: [famg]), (children: [aggp]), (risk: []), (audiovisual speech cues: [orgf]), (eye-tracker: [bpoc]), (infants: [aggp]), (screen: [hlca]), (same model: []), (face: [gngm]), (other/ga/: []), (face congruent: [blor]), (syllable sound: [npop]), (other face incongruent: [blor]), (method: [lbpr]), (low risk: [fndg]), (audiovisual speech:: [orgf]), (same amount: [qnco]), (time: []), (mouths: [bsoj]), (fusible visual/ga/: []), (congruent visual/ba/ audio/ba/displays: [inpr,mnob]), (auditory: []), (visual streams fuse: [npop]), (mcgurk-type: [qnco]), (syllabic percept: []), (incongruent condition: [dsyn]), (low-risk infants: [aggp]), (mismatch: []), (visual cues:: []), (mouth: [bsoj]), (mismatched: []), ( non-fusible visual/ba/ audio/ga/display: [inpr,mnob]), (congruent visual/ga/ audio/ga/display: [inpr,mnob]), (uncommon: []), (interesting: [menp]), ( speech-like percept: [orgf]), (incongruent mouth: [bsoj]), (anova: displays x fusion/mismatch conditions: [dsyn]), (f(1: [inch,phsu]), (16) =: []), (p: [gngm]), (behaviour: [inbe]), (high-risk infants: [fndg]), (type: [qnco]), (display: []), (difficulties: [fndg]), (visual information: []), (anova: [gngm]), ( displays: []), (conditions: [dsyn]), (25) =: []), (contrast: [irda]), (anova: displays: []), (low/high-risk groups: [popg]), (41) =: []), (cases: [qnco]), (ability: [orga]), (poor communication skills: [grpa]), 
ASD Terms: (autism, 'Autism Phenotype')(language difficulties, 'Language Ability')(language development, 'Language Development')(autism, 'Autism Phenotype')(audiovisual speech cues, 'Language Ability')(syllabic percept, 'Cognitive Ability')(audiovisual speech, 'Language Ability')(visual streams fuse, 'Visual Thinking')(visual cues, 'Visual Thinking')(speech-like percept, 'Cognitive Ability')(visual information, 'Visual Thinking')(poor communication skills, 'Reciprocal Social Interaction')

PMCID: 3352866
SFARI Genes: Fmr1, Fmr1, 
Non SFARI Genes: 
Named Entities: (pathogenic mechanisms: [fndg]), (autism: [mobd]), (evidence: []), (metabotropic: []), (ionotropic glutamate receptors: [aapp,rcpt]), (gabaergic system: []), (memantine: [orch,phsu]), (uncompetitive antagonist: [ortf]), (nmda receptors: [aapp,rcpt]), (treatment: [topp]), (alzheimer's disease treatment: [topp]), (recently: []), (language: [lang]), (function: [phsf]), ( social behavior: [socb]), (self-stimulatory behaviors: [inbe]), (autistic subjects: [mobd]), (mechanism: []), (effect: []), (study: [resa]), (cerebellar granule cells: [bpoc]), (fmr1 knockout (ko): [emod]), (mouse model: [emod]), (fragile x syndrome (fxs): [cgab,dsyn]), (syndromic autism: [mobd]), (effects: []), (dendritic spine development: [celf]), (synapse formation: [ortf]), (results: [fndg]), (maturation: [phsf]), (dendritic spines: [celc]), (fmr1-ko cgcs: [dsyn]), (reduced excitatory synapse formation: [biof]), (memantine treatment: [orch,phsu]), (cell adhesion properties: [celf]), (development: [orgf]), (mushroom-shaped mature: [fngs]), (dendritic spine: [celc]), (normal levels: [fndg]), (excitatory: []), (normal range: [qnco]), (findings: [clna]), (therapeutic capacity: [qnco]), (stimulatory effect: []), (dendritic spine maturation: [celf]), (excitatory synapse formation: [biof]), (adhesion: [patf]), (cgcs: [dsyn]), 
ASD Terms: (autism, 'Autism Phenotype')(improve language, 'Language Development')(social behavior, 'Reciprocal Social Interaction')(mouse model for fragile x syndrome, 'Fragile X Syndrome')(fragile x syndrome, 'Fragile X Syndrome')(syndromic autism, 'Autism Phenotype')

PMCID: 3399634
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background: triple x: [qnco]), (syndrome (47: [dsyn]), (xxx: [lbpr]), (trisomy x): [dsyn]), (frequent cytogenetic condition: [dsyn]), (large variety: [qnco]), (behavioural phenotypes: [bhvr]), (method:: [lbpr]), (adult patients: [aggp]), (triple x karyotype: [resa]), (described: []), (results: their karyotype: [resa]), (years: []), (patients: [podg]), (autism: [mobd]), (psychotic illness: [fndg]), (behaviour: [inbe]), ( suicidality: [clna]), (decline: []), (occupational capacity: [qnco]), (discussion:: [socb]), (gene-environment interactions: [genf]), (variety: []), (psychiatric phenotypes: [orga]), (triple x syndrome: [dsyn]), (atypical development: [orgf]), (adults: [aggp]), (conclusions:: []), (account: [clna]), (research: [resa]), (psychiatric phenotype: [orga]), (developmental disorders: [mobd]), 
ASD Terms: (occupational capacity, 'Job Performance')(autism, 'Autism Phenotype')(suicidality, 'Depressive Disorder')(ongoing atypical development in adults, 'Learning Disorders')(atypical development, 'Learning Disorders')(ongoing atypical development in adults, 'Learning Disorders')

PMCID: 3342283
SFARI Genes: ß, ß, ß, ß, ß, ß, ß, ß, ß, ß, ß, ß, ß, ß, 
Non SFARI Genes: 
Named Entities: (amyloid: [aapp,bacs]), (product: [qnco]), (proteolytic cleavage: [celf]), (amyloid  precursor protein (app): [aapp]), (neuronal cytoplasm: [celc]), (non-affected individuals: [humn]), (cell typespecific amount: [qnco]), (methodology/principal findings: [clna]), (present study: [qnco]), (percentage: [qnco]), (amyloid-positive neurons increases: [aapp,bacs]), (subjects: [humn]), (idiopathic autism: [mobd]), (duplication: [comd]), (15q11.2-q13 (dup15): [celc]), (autism spectrum disorder (asd): [mobd]), (spite: []), (interindividual differences: [qnco]), (group: [popg]), ( levels: []), (intraneuronal a load: [acty]), (dup(15) autism group: [mobd]), (control: [sbst]), (idiopathic autism group: [mobd]), (examined regions: [fndg]), (comparisons; kruskall-wallis test): [acty]), (regions: []), (control groups: [grup]), (intraneuronal a: []), (n-terminally truncated: [aapp,imft]), (intraneuronal accumulation: [fndg]), (a1740/42: []), (children: [aggp]), (adults: [aggp]), (life-long enhancement: [acty]), (app: [gngm]), (-secretase: [aapp,enzy]), (autistic subjects: [mobd]), (a accumulation: [fndg]), (neuronal endosomes: [celc]), (autophagic vacuoles: [fndg]), ( lamp1-positive lysosomes: [celc]), (lipofuscin: [bacs,orch]), (confocal microscopy: [lbpr]), (products: []), (enhanced -secretase processing accumulate: [aapp,enzy]), (organelles: [celc]), (proteolysis: [moft]), (storage: [celc]), (metabolic remnants: [emst]), (diffuse: []), (a140/42: []), (asd: [cgab]), (years: []), (age: [orga]), (age-associated risk: [orga]), (alterations: []), (short form: []), (a: []), (extracellular deposition: [celc]), (full-length a: [qnco]), (nonfibrillar plaques: [acab]), (prevalence: [qnco]), (excessive a accumulation: [fndg]), (neurons: [cell]), (individuals: [humn]), (early onset: [fndg]), (intractable seizures: [fndg]), (high risk: [fndg]), (sudden unexpected death: [patf]), (epilepsy: [dsyn]), (dup(15): []), (idiopathic asd: [cgab]), (concept: []), (functional links: []), (autism: [mobd]), ( epilepsy: [dsyn]), (astrocytic a accumulation: [fndg]), (diffuse plaque formation: [comd]), 
ASD Terms: (idiopathic autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(dup autism group, 'Autism Phenotype')(idiopathic autism group, 'Autism Phenotype')(years of age, 'Onset of Symptoms')(early onset, 'Onset of Symptoms')(epilepsy, 'Epilepsy')(autism, 'Autism Phenotype')(epilepsy, 'Epilepsy')(epilepsy, 'Epilepsy')

PMCID: 3338262
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (heterozygous parent: [orga]), (allele: [gngm]), (equal probability: [qnco]), (exceptions: []), (however: []), (meiotic drive: [phsu]), ( competition: [socb]), (gametes: [cell]), (viability selection: [genf]), (term transmission distortion (td): [orgf]), (several well-characterized examples: [acty]), (existence: []), (humans remains: [humn]), (genome-wide scan: [mbrt]), (td: []), (transmission disequilibrium test: [dsyn]), (genome-wide: [gngm]), (large sets: [menp]), (human pedigrees: [humn]), (european descent:: [famg]), (framingham heart study: [diap]), (founder population: [popg]), (european origin (hutt): [fndg]), (subset: []), (autism genetic resource exchange (agre): [mobd]), (error: []), (important confounder: []), (type: [qnco]), (analysis: [resa]), (fhs: [dsyn]), (hutt: []), (extensive quality control: []), (sufficient evidence: []), (signals: [phpr]), (agre: []), (many signals: [phpr]), (multiple snps: [nusq]), (pattern: []), (several candidate regions: [qnco]), (data set: []), (locus: [gngm]), (genome-wide significant tdt: [gngm]), (combined female: [orga]), (male transmissions: [patf]), (signature: [amas]), (recent positive selection: [lbpr]), (paternal td signal: [phpr]), (same region: []), (significant td signal: [phpr]), (european males: [orga]), (region: []), ( however: []), (paternal signal: [phpr]), (sperm competition assays: [lbpr]), (allelic imbalance: [comd]), (sperm: [cell]), (maternal transmissions: [patf]), (strong signals: [phpr]), (centromeres: [celc]), (regions: []), (female-specific meiotic drive: [menp]), (significant enrichment: [qnco]), (top signals: [phpr]), (genes: [gngm]), (cell junctions: [bsoj]), (results: [fndg]), (potential benefits: [qnco]), (challenges: [hlca]), (tdt: [gngm]), (transmission distortion: [patf]), (candidates: []), (investigation: [hlca]), (future studies: [lbpr]), 
ASD Terms: (autism genetic resource exchange, 'Autism Phenotype')

PMCID: 3338748
SFARI Genes: TSC1, TSC2, SHANK3, TSC1, TSC2, SHANK3, HOMER1, Shank3, HOMER1, Shank3, HOMER1, HOMER1, 
Non SFARI Genes: 
Named Entities: (identification: [menp]), (common molecular pathways: [moft]), (genetic variation: [npop]), (autism: [mobd]), (disease pathogenesis: [dsyn]), (effective therapies: [topp]), (here: []), (hypothesis: []), (rare genetic variation: [npop]), (metabotropic glutamate-receptor (mglur): [aapp,rcpt]), (contributes: [acty]), (susceptibility: [clna]), (single-nucleotide variants: [fndg]), (genes: [gngm]), (components: []), (mglur: []), (pathway: [moft]), (high-throughput multiplex sequencing: [mbrt]), (pooled samples: [sbst]), (non-syndromic autism cases: [mobd]), (controls: [sbst]), (independent next-generation platforms: [acty]), (analysis: [resa]), (significant enrichment: [qnco]), (rare functional variants: [gngm]), (mglur pathway: [moft]), (autism cases: [mobd]), (burdens: []), (rare: [gngm]), (deleterious variants: []), (pathway genes: [gngm]), (syndromic autism spectrum disorder: [mobd]), ( tsc1: [aapp,imft]), ( tsc2: [dsyn]), (shank3: [gngm]), (non-syndromic autism: [mobd]), (homer1: [gngm]), (postsynaptic density-localized scaffolding protein: [moft]), (mglur activity: [acty]), (novel autism-risk gene: [gngm]), (deleterious homer1 variants: [gngm]), (autism population: [mobd]), (important protein regions: [amas]), (regulatory sequences: [nusq]), (children: [aggp]), (affected families: [famg]), (rare asd-associated coding variants: [cgab]), (damaging effects: []), (ras/mapk cascade: [gngm]), (collectively: []), (findings: [clna]), (downstream: []), (mglurs contributes: [acty]), (pathogenesis: [patf]), 
ASD Terms: (autism, 'Autism Phenotype')(autism susceptibility, 'Autism Phenotype')(non-syndromic autism cases, 'Autism Phenotype')(autism cases, 'Autism Phenotype')(autism cases, 'Autism Phenotype')(syndromic autism spectrum disorder, 'Autism Phenotype')(non-syndromic autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism population, 'Autism Phenotype')(non-syndromic autism, 'Autism Phenotype')

PMCID: 3404662
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background: autism spectrum disorders: [mobd]), (many parts: [qnco]), (world: [popg]), (portion: []), (cases: [qnco]), (environmental exposures: [inpo]), (conclusive: []), (findings: [clna]), (specific exposure; however: [clna]), (evidence: []), (gestational pesticides exposures: [hops]), (strong candidates: []), (multiple developmental processes: [ortf]), (asds: [cgab]), (gestation: [orgf]), (early life: []), (biological plausibility: []), (agents: [chvf]), (core: [bdsu]), (pathophysiological features: [patf]), (objectives:: []), (objectives: []), (mechanisms: []), (autism pathophysiology: [mobd]), (effects: []), (pesticide exposures: [hops]), (neuroexcitability: []), ( oxidative stress: [comd]), (immune functions: [ortf]), (biological correlates: []), (pesticide exposure: [hops]), (autism risk: [mobd]), (methods:: []), (previous research: [resa]), (risk: []), ( developmental effects: [orgf]), (early pesticide exposure: [hops]), (basic biological mechanisms: []), (pesticides: [hops]), (autism: [mobd]), (discussion:: [socb]), (basis: [phsu]), (observational research: [resa]), (certain pesticides: [hops]), (core features: [bdsu]), (timing: []), (dose: [qnco]), (various mechanisms: [phsu]), (condition: [dsyn]), (conclusions:: []), (animal studies: [anim]), (research: [resa]), (gene  environment interactions: [genf]), (experimental exposure: [clna]), (mixtures: [sbst]), (compounds: [chem]), (similarly: []), (epidemiologic studies: [resa]), (humans: [humn]), (high exposures: [phpr]), (pesticide classes: [hops]), (concern: []), (studies: [lbpr]), (gene  environment: [gngm]), (susceptible subpopulations: [popg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(environmental exposures, 'Exposures')(specific exposure, 'Exposures')(gestational pesticides exposures, 'Perinatal History')(autism spectrum disorders, 'Autism Phenotype')(gestation, 'Perinatal History')(autism pathophysiology, 'Autism Phenotype')(pesticide exposures, 'Exposures')(pesticide exposure, 'Exposures')(autism risk, 'Autism Phenotype')(autism risk, 'Autism Phenotype')(early pesticide exposure, 'Exposures')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(experimental exposure, 'Exposures')(pesticide exposures, 'Exposures')(high exposures, 'Exposures')

PMCID: 3425128
SFARI Genes: IL-6, IL-6, 
Non SFARI Genes: 
Named Entities: (recent clinical observations: [hlca]), (certain gut: [bdsy]), (dietary factors: []), (symptoms: [sosy]), (autism: [mobd]), (propionic acid (pa): [orch]), (short chain: [qnco]), (fatty acid: [orch]), (important intermediate: [lbtr]), (cellular metabolism: [celf]), (pa: [gngm]), (several beneficial biological effects: [qnco]), (accumulation: [fndg]), (groups: [popg]), (young western albino male rats: [orga]), (grams: [qnco]), (days: []), (present study: [qnco]), (first group: [popg]), (pa-treated rats: [mamm]), (neurotoxic dose: [inpo]), (mg/kg body weight/day: [qnco]), (=: []), (second group: [popg]), (rats: [mamm]), (saline: [sbst]), (control: [sbst]), (biochemical parameters: [fndg]), (oxidative stress: [comd]), ( energy metabolism: [phsf]), (neuroinflammation: []), ( neurotransmission: [celf]), (apoptosis: [celf]), (brain homogenates: [bpoc]), (biochemical analyses: [resa]), (increase: []), (oxidative stress markers: [comd]), (example: []), ( lipid peroxidation): [moft]), (decrease: [qnco]), (glutathione (gsh): [aapp,bacs]), (glutathione peroxidase (gpx): [aapp,enzy]), (catalase activities: [moft]), (impaired energy metabolism: [phsf]), (lactate dehydrogenase: [aapp,enzy]), (activation: [acty]), (creatine kinase (ck): [aapp,enzy]), (il-6: [gngm]), ( tnf: [aapp,bacs]), ( ifn: []), (heat shock: [phsf]), ((hsp70): [aapp,bacs]), (neuroinflammatory effect: []), (moreover: []), ( elevation: [topp]), (caspase3: [aapp,enzy]), (dna fragmentation: [moft]), (neurotoxic effect: [inpo]), (pups: []), (results: [fndg]), (animal models: [anim]), (clinical data: []), (biochemical profile: [lbpr]), (autistic patients: [mobd]), (study: [resa]), (neurotoxicity: [inpo]), (environmental factor: []), (central role: [socb]), (etiology: []), (autistic biochemical features: [fndg]), 
ASD Terms: (autism, 'Autism Phenotype')(impaired energy metabolism, 'Metabolic Indications')(autism, 'Autism Phenotype')

PMCID: 3386011
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (diathesis-stress model: [clna]), (psychiatric conditions: [mobd]), (view: []), ('differential susceptibility': [clna]), (genes: [gngm]), (individual vulnerability: [humn]), (same allelic variation: [gngm]), (psychiatric disorder: [mobd]), (early) environmental adversity: []), (better-than-average functional outcome: [qnco]), (same domain: []), ((or favourable): []), (environmental conditions: [dsyn]), (studies: [lbpr]), (polymorphic variations: []), (serotonin transporter: [aapp,bacs]), (monoamino-oxidase-inhibitor a coding gene: [gngm]), (dopamine d4 receptor gene: [aapp,rcpt]), (early environment: []), (crucial role: [socb]), (development: [orgf]), (favourable versus: []), (unfavourable outcomes: []), (current evidence: [npop]), (limited: [fndg]), ( however: []), (link: []), (genetic variation: [npop]), (behavioural phenotypes: [bhvr]), (plasticity: [npop]), (neuroanatomical level: [phsu]), ('hard-wired' correlate: []), (observable behaviour: [inbe]), (present review article: [qnco]), (argument: [socb]), (favour: [orch,phsu,vita]), (differential susceptibility theory: [clna]), (findings: [clna]), (neuroanatomical studies: [lbpr]), (relation: [socb]), (oxytocin receptor gene: [aapp,rcpt]), (polymorphic variation: []), (oxytocin receptor gene (rs2254298): [aapp,rcpt]), (sociability: [socb]), ( amygdala volume: [bpoc]), (differential risk: []), (autism: [mobd]), ( depression: [mobd]), (anxiety disorder: [mobd]), (quality: []), (early environmental experiences: [menp]), (core: [bdsu]), (developmental plasticity: [npop]), (contrast: [irda]), (diathesis-stress perspective: [clna]), (evolution: [genf]), (natural selection: [npop]), (such 'risk' alleles: [gngm]), (gene pool: []), (population: [popg]), (please: []), (related manuscript: http://www.biomedcentral.com/1741-7015/10/37: [inpr,mnob]), 
ASD Terms: (diathesis-stress model of psychiatric conditions, 'Mental Disorders')(psychiatric conditions, 'Mental Disorders')(psychiatric disorder, 'Mental Disorders')(differential risk for psychiatric conditions, 'Mental Disorders')(autism, 'Autism Phenotype')(depression, 'Depressive Disorder')(anxiety disorder, 'Anxiety Disorders')

PMCID: 3325173
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (clear genetic component: [fndg]), (high genetic heterogeneity: [orga]), (disorder: [dsyn]), (challenge: [hlca]), (identification: [menp]), (causative genes: [gngm]), (homozygosity analysis: [orga]), (probands: [orga]), (nonconsanguineous families: [famg]), (evidence: []), (ancestry: []), (recessive mutations: [genf]), (whole-exome sequencing: [mbrt]), (validated homozygous: [orga]), (pathogenic recessive mutations: [genf]), (disease: [dsyn]), (families: [famg]), (candidate genes (ube3b: [gngm]), ( cltcl1: [gngm]), ( nckap5l: [gngm]), ( znf18) encode proteins: [aapp,bacs]), (proteolysis: [moft]), ( gtpase-mediated signaling: [aapp,enzy]), ( cytoskeletal organization: [celf]), (other pathways: [moft]), (furthermore: []), (neuronal depolarization: [imft]), (transcription: [genf]), (genes: [gngm]), (potential activity-dependent roles: [socb]), (neurons: [cell]), (multidimensional strategy: [menp]), (whole-exome sequence data: [nusq]), (candidate recessive mutations: [genf]), (applicability: []), (other complex: [chvs]), (heterogeneous disorders: [fndg]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3763210
SFARI Genes: 
Non SFARI Genes: impact, impact, 
Named Entities: (systematic review: []), (epidemiological surveys: []), (autistic disorder: [mobd]), (pervasive developmental disorders: [mobd]), (worldwide: []), (secondary aim: [neop]), (possible impact: [gngm]), (geographic: []), ( cultural/ethnic: [popg]), (socioeconomic factors: [grpa]), (prevalence estimates: [qnco]), (clinical presentation: []), (pdd: [dsyn]), (evidence: []), (median: [qnco]), (autism spectrum disorders: [mobd]), (estimates: [qnco]), (differences: [qnco]), (pdd prevalence: [qnco]), (geographic region: []), (strong impact: [gngm]), (however: []), ( power: [hcpp]), (such effects: []), (data sets: []), (low-income countries: [grpa]), (time: []), (different neighboring: []), (distant regions: []), (findings: [clna]), (likely represent broadening: [acty]), (diagnostic concets: [fndg]), (diagnostic switching: [fndg]), (other developmental disabilities: [mobd]), ( service availability: []), (awareness: [menp]), (autistic spectrum disorders: [mobd]), (lay: []), (professional public: []), (lack: []), (majority: [socb]), (world's population: [popg]), (critical need: []), (further research: [resa]), (capacity building: [hlca]), (middle-income countries: [qnco]), (autism res: [mobd]), (international society: [orgt]), (autism research: [mobd]), ( wiley periodicals: []), ( inc: []), 
ASD Terms: (autistic disorder, 'Autistic Disorder')(autism spectrum disorders, 'Autism Phenotype')(diagnostic switching from other developmental disabilities, 'Learning Disorders')(autistic spectrum disorders, 'Autistic Disorder')(other developmental disabilities, 'Learning Disorders')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 3613847
SFARI Genes: CHD8, KATNAL2, CHD8, KATNAL2, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (environmental origins: [fndg]), (modest fraction: [qnco]), (individuals: [humn]), (causes: []), (genetic risk factors: []), (role: [socb]), (mutations: [genf]), (asd: [cgab]), (exomes: [gngm]), (asd cases: [cgab]), (parents: []), (trios): [aapp,enzy]), (half: [qnco]), (cases: [qnco]), (missense: [fndg]), (nonsense: [comd]), (variant: []), (overall rate: [qnco]), (mutation: [genf]), (expected rate: [qnco]), (contrast: [irda]), (connectivity: []), (proteins: [aapp,bacs]), (genes: [gngm]), (nonsense mutations: [comd]), (excess connectivity: []), (asd genes: [cgab]), (major effect: []), (subset: []), (observed events: [evnt]), (asd risk: [cgab]), (small increase: [qnco]), (rate: [qnco]), (events: [evnt]), (connections: []), (limited role: [socb]), (point mutations: [comd]), (copy number variants: [nusq]), (genetic models: []), (data: [euka]), (majority: [socb]), (risk: []), (many genes: [gngm]), (penetrant (i.e.: [diap,inpr]), (results: [fndg]), (polygenic models: [genf]), (large number: [qnco]), (genes increases risk: [gngm]), (challenge: [hlca]), (such models: []), ( results: [fndg]), (novo events: [evnt]), (large parallel case-control study: [resa]), (strong evidence: []), (favor: [orch,phsu,vita]), (chd8: [gngm]), (katnal2: [gngm]), (genuine autism risk factors: [qnco]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(genuine autism risk factors, 'Autism Phenotype')

PMCID: 3350576
SFARI Genes: CHD8, NTNG1, CHD8, NTNG1, GRIN2B, LAMC3, SCN1A, GRIN2B, LAMC3, SCN1A, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (strong genetic component: [gngm]), (however: []), (cases: [qnco]), (underlying genetic cause: [topp]), (hypothesis: []), (mutations: [genf]), (substantial fraction: [qnco]), (risk: []), (asd: [cgab]), (families: [famg]), (previous history: [orga]), (phenotypesso-called sporadic: [fndg]), (simplex families2: [bpoc]), (3: [fndg]), (regions: []), (genome: [gngm]), ( i.e: [diap,inpr]), (exome: [gngm]), (parent-child trios: [aapp,enzy]), (sporadic asd: [cgab]), (new trios: [aapp,enzy]), (reported4: []), (additionally: []), (exomes: [gngm]), (unaffected siblings: [famg]), (new (n: [aapp,imft]), (trios (n: [aapp,enzy]), (total: [qnco]), (point mutations: [comd]), (origin (4:1 bias): [bird]), (paternal age: []), (children: [aggp]), (fathers: [famg]), (asd5: [cgab,dsyn]), (moreover: []), ((49/126): []), (interconnected beta-catenin/chromatin: [aapp]), (protein network: [popg]), (autism candidate genes: [mobd]), (proband: [famg]), ( recurrent protein-altering mutations: [genf]), (genes: [gngm]), ( chd8: [gngm]), (ntng1: [gngm]), (mutation screening: [genf]), (candidate genes: [gngm]), (asd probands: [cgab]), (protein-altering mutations: [genf]), (grin2b: [gngm]), ( lamc3: [gngm]), (scn1a: [gngm]), (copy number: [qnco]), (variant (cnv) data: [nusq]), (results: [fndg]), (extreme locus heterogeneity: []), (target: [diap]), (future discovery: [acty]), ( diagnostics: [fndg]), (therapeutics: [orch,phsu]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism candidate genes, 'Autism Phenotype')

PMCID: 3337277
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mental: [menp]), (behavioral disorders: [mobd]), (adults: [aggp]), (usher syndrome: [cgab,dsyn]), (case studies: []), (research: [resa]), (children: [aggp]), (article: []), (prevalence: [qnco]), (characteristics: []), (years: []), (age: [orga]), (behavioral disorder (1: [fndg]), (schizophrenia: [mobd]), (mild mental retardation: [mobd]), (atypical autism: [mobd]), (severe mental retardation: [mobd]), (conduct disorder): [mobd]), (behavioral disorder: [mobd]), (childhood: []), (vision impairment: [fndg]), (first manifests: [qnco]), (late childhood: []), (aetiology: []), (treatment: [topp]), (discussed: [socb]), (parents: []), (clinical support: []), (development: [orgf]), 
ASD Terms: (years of age, 'Onset of Symptoms')

PMCID: 3310790
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (heritable neurodevelopmental disorder: [mobd]), (genetic underpinnings: [topp]), (disorder: [dsyn]), (aberrant brain overgrowth: [bpoc]), (well-replicated observation: [hlca]), (autism literature;: [mobd]), (association: [menp]), ( linkage: [moft]), (expression studies: [topp]), (genetic factors: [fndg]), (trajectory: []), (few studies: [lbpr]), (sufficient statistical power: [resa]), (whole-genome gene expression: [genf]), (genotypic variation: [orga]), (autistic brain: [mobd]), (regions: []), (growth abnormality: [fndg]), (previous functional genomic studies: [lbpr]), (possible alterations: []), (transcript levels: [nnon]), (genes: [gngm]), (immune function: [ortf]), (thus: []), (need: []), (genetic studies: [resa]), (key brain regions: [blor]), (findings: [clna]), (role: [socb]), (particular functional pathways: [moft]), (autism pathogenesis: [mobd]), (abnormal brain gene expression patterns: [genf]), (whole-genome analysis: [gngm]), (mrna levels: [bacs,nnon]), (copy number variations: [nusq]), (control postmortem brain samples: [diap]), (prefrontal cortex tissue: [bpoc]), (excess neuron numbers: [cell]), (cortical overgrowth: [bpoc]), (majority: [socb]), (autism cases: [mobd]), (evidence: []), (dysregulation: []), (pathways: [moft]), (cell: [gngm]), (cortical patterning: [bpoc]), (differentiation: [celf]), (young autistic prefrontal cortex: [bpoc]), (contrast: [irda]), ( adult: [aggp]), (autistic prefrontal cortex: [bpoc]), (repair pathways: [orgf]), (cell cycle: [celf]), (autism-specific cnvs: [nusq]), (dna: [bacs,nnon]), (prefrontal cortex: [bpoc]), (genome-wide association study datasets: [mbrt]), (results: [fndg]), (cnvs: [nusq]), (age-dependent gene expression changes: [genf]), (distinct pathological processes: [patf]), (mature: []), (hypothesis: []), (genetic dysregulation: [topp]), (developing brain: [bpoc]), (abnormal regional patterning: [qnco]), (excess prefrontal neurons: [cell]), ( cortical overgrowth: [bpoc]), (neural dysfunction: [dsyn]), 
ASD Terms: (autism, 'Autism Phenotype')(heritable neurodevelopmental disorder, 'Learning Disorders')(autism literature, 'Autism Phenotype')(autism pathogenesis, 'Autism Phenotype')(autism cases, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3309999
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (cognitive functions: [menp]), (accurate sequencing: [mbrt]), (events: [evnt]), (action planning: [menp]), (execution: [acty]), ( verbal: []), (nonverbal communication: [menp]), (social interaction: [fndg]), (well-tuned coding: []), (temporal event-structure: [evnt]), (visual temporal event-structure coding: [anst]), (high-functioning adolescents: [aggp]), (adults: [aggp]), (autism spectrum disorder (asd): [mobd]), (typically-developing (td) individuals: [humn]), (perceptual simultaneity paradigm: [resa]), (visual simultaneity thresholds: [ortf]), (individuals: [humn]), (asd: [cgab]), (td individuals: [humn]), (autism: [mobd]), (increased parsing: [qnco]), (decreased capability: [qnco]), (integration: [genf]), (time: []), (perceptual simultaneity thresholds: []), (developmental communication difficulties: [socb]), (results: [fndg]), (local processing bias: [bird]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(cognitive functions, 'Cognitive Ability')(action planning, 'Planning')(nonverbal communication, 'Non-Verbal Communication')(autism spectrum disorder, 'Autism Phenotype')(visual temporal event-structure coding, 'Visual Thinking')(visual simultaneity thresholds, 'Visual Thinking')(autism, 'Autism Phenotype')(developmental communication difficulties, 'Learning Disorders')

PMCID: 3309533
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (neurological developmental disorders: [mobd]), (several studies: [lbpr]), (candidate biomarker: [clna]), (development: [orgf]), (disorders: [dsyn]), (date: []), (reliable biomarker: [clna]), (mass spectrometry techniques: [lbpr]), (protein profiling: [lbpr]), (blood plasma: [bdsu]), (children: [aggp]), (such disorders: [dsyn]), (order: [acty]), (proteins/peptides: [aapp]), (biomarkers: [clna]), (detection: [topp]), (peptides: [aapp]), (masscharge (m/z) values: [phpr]), (da: [anab]), (heparin plasma: [bdsu]), (asd: [cgab]), (peptide pattern: [aapp]), (non-asd control group: [cgab]), (here: []), (novel set: [menp]), (biomarkers allows: [clna]), (reliable blood-based diagnostic tool: [bdsu]), (diagnosis: [fndg]), (potentially: []), (prognosis: [hlca]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(neurological developmental disorders, 'Neurologic Indications')(diagnosis, 'Diagnosis')

PMCID: 3295800
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (williams-beuren syndrome: [cgab,dsyn]), (rare developmental disorder: [dsyn]), (deletion: [genf]), (contiguous genes: [gngm]), (strengths: []), (socialization (overfriendliness): [edac]), (communication: [socb]), ((excessive talkativeness): [mobd]), (wbs: [gngm]), (polar opposite behavioral phenotype: [bhvr]), (objective: []), (range: [qnco]), (phenotypic expression: [orga]), (relationship: []), (autistic disorder: [mobd]), (methodology: []), (study: [resa]), (french individuals: [humn]), (years: []), (behavioral assessments: [hlca]), (autism diagnostic: [mobd]), (interview-revised (adi-r): [acty]), (autism diagnostic observation schedule (ados) scales: [hlca]), (molecular characterization: [acty]), (critical region: []), (fish: [gngm]), (findings fish analysis: [fish]), (patients: [podg]), (common wbs deletion: [genf]), (adi-r: [clna]), (ados: [aapp,enzy]), (diagnostic criteria: []), (autism: [mobd]), (stereotypies: [mobd]), (severe impairments: [patf]), (social interaction: [fndg]), (absence: [anab]), (expressive language): [lang]), (additionally: []), ( patients: [podg]), (improvement: []), (social communication: [socb]), (time: []), (results: [fndg]), (comorbid autism: [mobd]), (continuum: []), (social communication impairment: [mobd]), (excessive talkativeness: [mobd]), (overfriendliness: [mobd]), (verbal language: [lang]), (poor social relationships: [grpa]), (appreciation: []), (possible co-occurrence: []), (common view: [qnco]), (opposite behavioral phenotype: [bhvr]), (improved recognition: [menp]), (individuals: [humn]), 
ASD Terms: (autistic disorder, 'Autistic Disorder')(autism diagnostic, 'Autism Phenotype')(autism diagnostic observation schedule scales, 'Autism Phenotype')(autism, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(autism diagnostic observation schedule, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')(social communication impairment, 'Reciprocal Social Interaction')(comorbid autism, 'Comorbidities')(autism, 'Autism Phenotype')

PMCID: 3280447
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract autism: [mobd]), (heterogeneous group: [popg]), (complex developmental disabilities: [mobd]), (number: [qnco]), (possible etiologies: []), (well-known number: [qnco]), (comorbidities: []), (autism spectrum disorders: [mobd]), (including: []), ( commonly: []), ( gastrointestinal (gi) pathology: [patf]), (variable combinations: [phsu]), (constipation: [sosy]), (diarrhea: [sosy]), ( abdominal pain: [sosy]), ( gastroesophageal reflux: [dsyn]), (vomiting: [sosy]), (american academy: [orgt]), (pediatrics consensus panel: [socb]), (prospective studies: [resa]), (prevalence: [qnco]), (gi disorders: [dsyn]), (asd: [cgab]), (pathophysiologic basis: [phsu]), (recent article: []), ( williams: []), (al: [lbpr]), ([b. l. williams: []), ( m. hornig: [aapp,imft]), ( t. parekh: [clna]), (w. i. lipkin: [inch]), (such study: [resa]), (autism: [mobd]), (gi comorbidities: [gngm]), (evidence: []), (sutterella species: [bact]), (ileal mucosal biopsy specimens: [tisu]), (patients: [podg]), (control children: [aggp]), (gi symptoms: [sosy]), (specific role: [socb]), (sutterella: [bact]), (sutterella sequences: [nusq]), (~1: [fndg]), (total bacterial sequences: [nusq]), (large effect size: [qnco]), (ileal: [bpoc]), (mucosal composition: [tisu]), (autism phenotype: [mobd]), (effect size: [qnco]), (ileal crohns disease phenotype: [dsyn]), (study: [resa]), (new field: [irda]), (investigation: [hlca]), (etiology: []), (consequences: []), 
ASD Terms: (heterogeneous group of complex developmental disabilities, 'Learning Disorders')(abstract autism, 'Autism Phenotype')(complex developmental disabilities, 'Learning Disorders')(comorbidities, 'Comorbidities')(autism spectrum disorders, 'Autism Phenotype')(abdominal pain, 'Pain')(gastroesophageal reflux, 'Gastroesophageal Reflux')(gastrointestinal disorders, 'Gastrointestinal Diseases')(autism, 'Autism Phenotype')(gastrointestinal comorbidities, 'Comorbidities')(total bacterial sequences, 'Bacterial Infections')(autism phenotype, 'Autism Phenotype')(ileal crohns disease phenotype, 'Crohn Disease')(gastrointestinal comorbidities, 'Comorbidities')

PMCID: 3554878
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (attention deficit hyperactivity disorder (adhd): [mobd]), (autism spectrum disorder (asd): [mobd]), (share: [socb]), (behavioural-cognitive abnormalities: [mobd]), (sustained attention: [menp]), (key question: []), (cognitive phenotype: [orga]), (different underlying pathophysiologies: [patf]), (question: []), (boys: [aggp]), (adhd: [mobd]), (age: [orga]), (iq: []), (asd: [cgab]), (healthy boys: [aggp]), (functional magnetic resonance: [npop]), ((fmri): [diap]), (vigilance task: [menp]), (load: [acty]), (asd boys: [cgab]), (activation relative: [qnco]), (controls: [sbst]), (bilateral striatothalamic regions: []), (dorsolateral prefrontal cortex (dlpfc): [bpoc]), (superior parietal cortex: [bpoc]), (groups: [popg]), (precuneus activation relative: [qnco]), (precuneus: [bpoc]), (dlpfc activation: [acty]), (attention load: [menp]), (problems: []), (deactivation: []), (task-related default mode network: [popg]), (disorders: [dsyn]), (however: []), (dlpfc underactivation: []), (furthermore: []), (sustained performance measures: [qnco]), (adhd patients: [mobd]), (other hand: [bpoc]), (disorder-specific: [dsyn]), (cerebellar activation relative: [bpoc]), (compensation: [menp]), (findings: [clna]), (disorder-specific abnormalities: [dsyn]), (brain function: [ortf]), (deficits: []), (frontostriatoparietal activation: [acty]), (default mode suppression: [qnco]), (differences: [qnco]), (severe dlpfc dysfunction: [fndg]), (disorder-specific frontostriatocerebellar dysregulation: [dsyn]), 
ASD Terms: (attention deficit hyperactivity disorder, 'Overactivity')(autism spectrum disorder, 'Autism Phenotype')(cognitive phenotype, 'Cognitive Ability')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention deficit hyperactivity disorder relative, 'Overactivity')(attention deficit hyperactivity disorder patients, 'Overactivity')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 3398286
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (plasma concentrations: [qnco]), (amyloid beta (a): [aapp]), (protein derivatives: [aapp,bacs]), (central role: [socb]), (etiology: []), (autistic features: [mobd]), (design: [acty]), (concentrations: [menp]), (human a: [humn]), ((1-42): [fndg]), ( a (1-40): [qnco]), (a (40/42): [qnco]), (plasma: [bdsu]), (autistic children: [podg]), (3-16 years): [fndg]), (age-matched control subjects: [humn]), (elisa technique: [lbpr]), (compared: [acty]), (subjects: [humn]), ( autistic children: [podg]), (a (1-40): [qnco]), (a (1-42): []), (a (40/42) concentration ratio: [menp]), (characteristics: []), ((roc) analysis: [qnco]), (measurements: []), (a peptides: [aapp]), (high specificity: [qnco]), (sensitivity: [patf]), (control subjects: [sbst]), (loss: [qnco]), (a equilibrium: [orgf]), (brain: [bpoc]), (imbalance: [sosy]), (a: []), (and/or impairment: [patf]), (- secretase's concentration: [aapp,enzy]), (kinetics: [npop]), (enzymes: [enzy,orch]), (a production: []), 
ASD Terms: 

PMCID: 3252763
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract gastrointestinal disturbances: [fndg]), (children: [aggp]), (autism: [mobd]), (compositional changes: [qnco]), (intestinal bacteria: [bact]), (previous report: [hlca]), (intestinal microbiota: [orgm]), (ileal: [bpoc]), (cecal biopsy samples: [tisu]), (gastrointestinal dysfunction (aut-gi): [dsyn]), (only gastrointestinal dysfunction (control-gi): [dsyn]), (results: [fndg]), (presence: [qnco]), (members: [popg]), (family alcaligenaceae: [bact]), (aut-gi children: [aggp]), (control-gi children: [aggp]), (alcaligenaceae sequences: [bact]), (levels: []), (alcaligenaceae: [bact]), (intestinal biopsy samples: [bpoc]), (aut-gi children result: [aggp]), (high levels: [qnco]), (genus sutterella: [bact]), (first sutterella-specific pcr assays: [mbrt]), (detecting: [fndg]), ( quantitating: []), (sutterella species: [bact]), (environmental samples: [sbst]), (sutterella: [bact]), (rrna gene sequences: [gngm]), (none: []), (phylogenetic analysis: [resa]), (predominance: []), (sutterella wadsworthensis: [bact]), (sutterella stercoricanis: [bact]), (individual sutterella-positive aut-gi patients;: [podg]), (aut-gi patient: [podg]), ( sutterella sequences: [nusq]), (species-level classification: [phsu]), (sutterella isolates: [phsu]), (western immunoblots: [lbpr]), (plasma igg: [bdsu]), (igm antibody reactivity: [celc]), (sutterella wadsworthensis antigens: [imft]), (aut-gi patients: [podg]), (pcr positive: [mbrt]), (immune response: [ortf]), 
ASD Terms: (autism, 'Autism Phenotype')(intestinal bacteria, 'Bacterial Infections')(sutterella wadsworthensis antigens in 11 aut-gi patients, 'Allergies')(sutterella wadsworthensis antigens, 'Allergies')

PMCID: 3269681
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (establishment: []), (efficient approaches: []), (developmental neurotoxicity: [inpo]), ((dnt): [hops,orch]), (issue: [fndg]), (childrens environmental health: [hlca]), (systematic approach: []), (dnt: [hops,orch]), (neuronal differentiation: [fndg]), (mouse: [mamm]), (embryonic stem cells: [cell]), (model: []), (fetal programming: [biof]), (embryoid body (eb) formation: [cell]), ( mescs: [cell]), (chemicals: [chem]), (h: [gngm]), (global gene expression profiling: [lbpr,mbrt]), (whole genome microarray analysis: [lbpr]), (gene expression signatures: [qnco]), (kinds: []), (gene sets: [gngm]), (neuronal development: [celf]), (neuronal diseases: [dsyn]), (further analysis: [resa]), (later stages: [clna]), (neuronal cell differentiation: [fndg]), (ebs: []), (neuronal phenotypic parameters: [orga]), (high-content image analyzer: [menp]), (bayesian network analysis: [qnco]), (global gene expression: [genf]), (neuronal phenotypic data: [orga]), (comprehensive networks: []), (linkage: [moft]), (early events: [evnt]), (probability distribution values: [qnco]), (strength: [qnco]), (parameters: [fndg]), (network: [popg]), (principal component analysis: [qnco]), (characterization: [acty]), (neurotoxic potential reveals: [inpo]), (multi-parametric analysis: [resa]), (phenotype: [orga]), (gene expression: [genf]), (mescs: [cell]), (useful tool: []), (neurotoxic compounds: [inpo]), 
ASD Terms: 

PMCID: 3261830
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (neurogenic inflammation: [inpo]), (large number: [qnco]), (neuropeptides: [aapp,bacs]), (tachykinins: [aapp,horm]), (p: [gngm]), (a: []), (neurokinin b): [aapp,bacs]), (pro-inflammatory neuropeptides: [aapp,bacs]), (important role: [socb]), (autoimmune neuroinflammatory diseases: [dsyn]), (autoimmunity: [patf]), (role: [socb]), (pathogenesis: [patf]), (autism: [mobd]), (patients: [podg]), (levels: []), (autistic children: [podg]), (relationship: []), (serum levels: [bdsu]), (neurokinin: [aapp,bacs]), (anti-ribosomal p protein antibodies: [lbpr]), (serum: [bdsu]), (comparison: [acty]), (healthy-matched children: [fndg]), (a levels: []), (healthy controls: []), (children: [aggp]), (severe autism: [fndg]), (autism (p: [mobd]), (significant positive correlations: [fndg]), (severity: []), (however: []), (initial report: [hlca]), (warrants: []), (further research: [resa]), (pathogenic role: [socb]), (possible link: []), (therapeutic role: [socb]), (tachykinin receptor: [aapp,rcpt]), (potential new class: []), (anti-inflammatory medications: [phsu]), 
ASD Terms: (autoimmune neuroinflammatory diseases, 'Autoimmune Diseases')(autism, 'Autism Phenotype')(severe autism, 'Autism Phenotype')(moderate autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(anti-inflammatory medications, 'Medications')

PMCID: 3235126
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (molecular underpinnings: []), (complex psychiatric disorders: [mobd]), (autism spectrum disorders: [mobd]), (increasingly: []), (structural variations: []), (discrete chromosomal loci: [celc]), (asd: [cgab]), (search space: [acty]), (disease etiology: []), (high genetic heterogeneity: [orga]), (predictive map: [lbpr]), (candidate genes: [gngm]), (integrated bioinformatics: [genf]), (reference set: [menp]), (rare: [gngm]), (syndromic candidate asd genes: [cgab]), (composite reference profile: [lbpr]), (expression analyses: [resa]), (first: [qnco]), (functional profile: [lbpr]), (autref84: []), (gene ontology (go) enrichment analysis: [resa]), (cell adhesion: [celf]), (ion channel activity: [moft]), (second: [qnco]), (expression profile: [lbpr]), (david analysis: [resa]), (enrichment: []), (brain regions: [blor]), (sensory information: []), ((olfactory bulb: [bpoc]), (occipital lobe): [bpoc]), ( executive function: [menp]), ((prefrontal cortex): [bpoc]), (hormone secretion (pituitary): [bpoc]), (disease specificity: [qnco]), (dual autref84 profile: [lbpr]), (comparative analysis: [resa]), (control: [sbst]), ( diabetes: [dsyn]), (non-specific gene sets: [gngm]), (human genome: [gngm]), (set: [menp]), (potential asd candidate genes: [cgab]), (importantly: []), (power: [hcpp]), (predictive gene map: [lbpr,mbrt]), (asd-associated genes: [cgab]), (part: [qnco]), (autref84 input dataset: []), (genes: [gngm]), (novel putative asd risk genes: [cgab]), (together: []), (composite asd reference profile: [cgab]), (novel asd candidate genes: [cgab]), (future research: [resa]), 
ASD Terms: (complex psychiatric disorders, 'Mental Disorders')(autism spectrum disorders, 'Autism Phenotype')(sensory information processing, 'Ability to Convey Information')(executive function, 'Executive Function')(diabetes, 'Diabetes Mellitus Type 1')(diabetes, 'Diabetes Mellitus Type 1')

PMCID: 3245106
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (heterogeneous neurodevelopmental disorder: [orga]), (prevalence: [qnco]), (twin studies: [famg]), (heritability: []), (strong genetic contributions: [acty]), (many genes: [gngm]), (asd: [cgab]), (evidence is: []), (comprehensive review: []), (analysis: [resa]), (literature: [inpr,mnob]), (data: [euka]), (clearer: [fndg]), (big picture: [qnco]), (autism genetics: [mobd]), (genes: [gngm]), (snps/vntrs: [bacs,nnon]), (copy number variations: [nusq]), (linkage regions: [moft]), (gwas: [mbrt]), (genome-wide cnv studies: [nusq]), ( linkage: [moft]), (low-scale genetic association studies: [lbpr]), ( expression profiling: [mbrt]), (other low-scale experimental studies: [resa]), (evidence: []), (metadata: []), (study: [resa]), (demographic features: []), (experimental design: [resa]), (statistical significance: [qnco]), (scoring: [qnco]), (approach: []), (core data set: [bdsu]), (high-confidence genes: [gngm]), (neuroactive ligandreceptor interaction: []), ( synapse transmission: [bsoj]), (axon guidance: [celf]), (databases: []), (extensive data: [euka]), (expression patterns: [topp]), ( protein: [aapp,bacs]), (animal models: [anim]), (pharmacogenetics: []), (mysql-based online database: []), (share: [socb]), (autism research community: [mobd]), (http://autismkb.cbi.pku.edu.cn: [dsyn]), (sophisticated browsing: []), (functionalities: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(heterogeneous neurodevelopmental disorder, 'Learning Disorders')(autism genetics, 'Autism Phenotype')(autism research community, 'Autism Phenotype')

PMCID: 3517299
SFARI Genes: Cav1.2, Cav1.2, Cav1.2, Cav1.2, 
Non SFARI Genes: 
Named Entities: (monogenic: []), (neurodevelopmental disorders: [mobd]), (key insights: [menp]), (pathogenesis: [patf]), (disease: [dsyn]), (specific genes: [gngm]), (development: [orgf]), (human brain: [humn]), (timothy syndrome: [dsyn]), (missense mutation: [genf]), (l-type calcium channel cav1.2: [aapp,bacs]), (developmental delay: [mobd]), (autism: [mobd]), (cortical neuronal precursor cells: [bpoc]), (neurons: [cell]), (induced pluripotent stem cells: [cell]), (individuals: [humn]), (cells: [cell]), (defects: []), (calcium (ca2+): [bacs,elii,phsu]), (activity-dependent gene expression: [genf]), (abnormalities: [cgab]), (differentiation: [celf]), (decreased expression: [topp]), (genes: [gngm]), (cortical layers: [bpoc]), (callosal projection neurons: [cell]), (addition: []), ( neurons: [cell]), (timothy: [plnt]), (show: [anim]), (abnormal expression: [topp]), (tyrosine hydroxylase: [aapp,enzy]), (increased production: [qnco]), (norepinephrine: [horm,orch,phsu]), (dopamine: [bacs,orch,phsu]), (phenotype: [orga]), (treatment: [topp]), (roscovitine: [orch,phsu]), (cyclin-dependent kinase inhibitor: [aapp,bacs]), (atypical l-typechannel blocker: [fndg]), (findings: [clna]), (strong evidence: []), (cav1.2: [gngm]), (cortical neurons: [bpoc]), (humans: [humn]), (new insights: [menp]), (causes: []), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(developmental delay, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3228874
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (summary tuberous sclerosis complex: [neop]), (fragile x syndrome: [cgab,dsyn]), (genetic diseases: [fndg]), (intellectual disability: [mobd]), (autism: [mobd]), (syndromes: [dsyn]), (mutations: [genf]), (genes: [gngm]), (protein synthesis: [moft]), (neurons: [cell]), (excessive protein synthesis: [moft]), (core: [bdsu]), (pathophysiological mechanism: [patf]), (biochemical assays: [lbpr]), (neuronal protein synthesis: [moft]), (hippocampus: [bpoc]), (tsc2+/: [dsyn]), (fmr1/y: [gngm]), (synaptic dysfunction: [dsyn]), (opposite ends: []), (physiological spectrum: [qnco]), (synaptic: []), (cognitive defects: [mobd]), (mutants: [comd]), (treatments: [topp]), (metabotropic: []), (receptor: [aapp,rcpt]), (opposite directions: []), (deficits: []), (mice: [mamm]), (thus: []), (normal synaptic plasticity: [ortf]), (cognition occur: [menp]), (optimal range: [qnco]), (metabotropic glutamate: [aapp,bacs]), (receptor-mediated protein synthesis: [moft]), (deviations: [fndg]), (direction: []), (behavioral impairments: [inbe]), 
ASD Terms: (summary tuberous sclerosis complex, 'Tuberous Sclerosis')(fragile x syndrome, 'Fragile X Syndrome')(intellectual disability, 'Learning Disorders')(autism, 'Autism Phenotype')(pathophysiological mechanism of intellectual disability, 'Learning Disorders')(cognitive defects, 'Cognitive Ability')(cognition occur, 'Cognitive Ability')(behavioral impairments, 'Personal Traits')

PMCID: 3270696
SFARI Genes: TBX1, TBX1, GNB1L, GNB1L, GNB1L, GNB1L, GNB1L, GNB1L, GNB1L, GNB1L, 
Non SFARI Genes: Mb, 
Named Entities: (structural variations: []), (chromosome: [celc]), (region: []), (nonallelic homologous recombination result: [genf]), (deletion (del22q11.2): [genf]), (duplication (dup22q11.2) syndromes: [dsyn]), (majority: [socb]), (del22q11.2 cases: [qnco]), (cardiac malformations: [cgab]), ( immunologic impairments: [patf]), (specific cognitive profile: [lbpr]), (risk: []), (schizophrenia: [mobd]), (autism spectrum disorders: [mobd]), (phenotype: [orga]), (dup22q11.2: []), (physical features: [hlca]), (spectrum: [qnco]), (neurocognitive abnormalities: [cgab]), (substantial evidence: []), (haploinsufficiency: [comd]), (tbx1: [gngm]), (role: [socb]), (del22q11.2: []), (gene(s): [gngm]), (mb region: []), (observed spectrum: [qnco]), (behavioral phenotypes: [bhvr]), (individual: [humn]), (balanced translocation: [comd]), (behavioral phenotype: [bhvr]), (cognitive impairment: [mobd]), ( autism: [mobd]), (absence: [anab]), (congenital malformations: [cgab]), (somatic cell hybrids: [cell]), (comparative genomic hybridization: [mbrt]), (chromosome-22 breakpoint: [nnon]), (gnb1l gene: [gngm]), (copy number evaluations: [hlca]), (direct dna sequencing: [nusq]), (gnb1l: [gngm]), (autism cases: [mobd]), (families: [famg]), (autism: [mobd]), (private gnb1l missense variants: [gngm]), (conserved residues: [evnt]), (identified missense variants: [fndg]), (residues: [evnt]), (wd40 repeat domains: [amas]), (deleterious effects: []), (protein: [aapp,bacs]), (prior studies: [lbpr]), (evidence: []), (findings support involvement: [clna]), (asds: [cgab]), (well: []), (wiley periodicals: []), ( inc: []), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(cardiac malformations, 'Cardiovascular Diseases')(specific cognitive profile, 'Cognitive Ability')(autism spectrum disorders, 'Autism Phenotype')(neurocognitive abnormalities, 'Cognitive Ability')(absence of congenital malformations, 'Congenital Abnormalities')(cognitive impairment, 'Cognitive Ability')(autism, 'Autism Phenotype')(congenital malformations, 'Congenital Abnormalities')(autism cases, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 3213131
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (numerous studies: [lbpr]), (copy number variants: [nusq]), (range: [qnco]), (neurological phenotypes: [orga]), (impact: [gngm]), (severity: []), (small sample: [sbst]), (sizes: []), ( lack: []), (phenotypic details: [orga]), (heterogeneity: [orga]), (platforms: []), (discovery: [acty]), (customized microarray: [acty]), (genomic hotspots: [gngm]), (large cnvs: [nusq]), (individuals: [humn]), (various neurological deficits: [fndg]), (dyslexia (376): [mobd]), (sporadic autism (350): [mobd]), (intellectual disability (id) (501): [mobd]), (controls: [sbst]), (frequency: [qnco]), (large cnvs (>1 mbp): [nusq]), (idassociated phenotypes: [orga]), ((p =: [aapp,imft]), (odds: []), (dyslexia (p: [mobd]), (striking difference: [qnco]), (rare cnvs (>50 kbp): [aapp,enzy,rcpt]), (autism (10%: [mobd]), ( p: [aapp,imft]), (id (16%: [lbpr]), ((2%): [qnco]), (difference: [qnco]), (large cnv burden: [nusq]), (dyslexia patients: [mobd]), (rare cnvs: [nusq]), (id: [lbpr]), ((40%): [qnco]), ((0%): [fndg]), (multiple congenital anomalies: [cgab]), (data: [euka]), (childhood disability: id: [lbpr]), (mca: [bpoc]), (dyslexics: [podg]), (autism: [mobd]), (increase: []), (cnv burden: [nusq]), (controls (p: [aapp,imft]), 
ASD Terms: (neurological phenotypes, 'Neurologic Indications')(various neurological deficits, 'Neurologic Indications')(sporadic autism, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(autism, 'Autism Phenotype')(intellectual disability with multiple congenital anomalies, 'Congenital Abnormalities')(autism, 'Autism Phenotype')

PMCID: 3225379
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (biomedical events: [evnt]), (text-mining applications; however: [mcha]), (such events: [evnt]), (scientific significance: [qnco]), (development: [orgf]), (biont: []), (database: []), (negated sentences: []), (such negated events: [evnt]), (description currently biont: []), (biomedical sentences: []), (resources:: []), (full-text biomedical articles: []), (elsevier: []), (pubmed central: [lbpr]), (20: [fndg]), (abstracts: []), (pubmed: []), (important genetic disorders: autism: [mobd]), ( alzheimer's disease: [dsyn]), (parkinson's disease: [dsyn]), (negated events: [evnt]), (experts: []), (biont database: []), (useful resource: []), (biomedical researchers: []), (http://bionot.askhermes.org/: []), (future work: []), (semantic web: []), (related technologies: [fndg]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3199189
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (problems: []), (communication: [socb]), ( social skills: [socb]), (repetitive behavior: [fndg]), (recent studies: [lbpr]), (inflammatory mechanisms: []), (pathogenesis: [patf]), (disorder: [dsyn]), (nuclear factor-b (nf-b): [aapp,imft]), (important gene: [gngm]), (transcriptional factor: [aapp,bacs]), (mediation: [socb]), (inflammation: [patf]), (apoptosis: [celf]), (study: [resa]), (activities: [acty]), (nf-b: []), (pathway: [moft]), (brain: [bpoc]), (autistic subjects: [mobd]), (age-matched controls: [orga]), (nf-b activation: [acty]), (btbr mice: [mamm]), (promising animal model: [emod]), (pathogenic mechanisms: [fndg]), (results: [fndg]), (level: [phsu]), (ikk kinase: [aapp,enzy]), (inhibitory subunit ib: [aapp,enzy]), (cerebellum: [bpoc]), (however: []), (expression: [topp]), (phosphorylation: [moft]), (ib: [aapp,enzy]), (nf-b (p65): [aapp,enzy]), (phosphorylation/activation: [moft]), (ser536: []), (cortex: [bpoc]), (findings: [clna]), (processes: [phpr]), (abnormal inflammatory responses: [anab]), (autistic brain: [mobd]), 
ASD Terms: (social skills, 'Ability to Converse in Social Settings')(autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(social skills, 'Ability to Converse in Social Settings')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(inhibitory subunit ib, 'Irritable Bowel Syndrome')(ib, 'Irritable Bowel Syndrome')

PMCID: 3198479
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (complex genetic disorder: [dsyn]), (multiple etiologies: []), (molecular genetic basis: [phsu]), (number: [qnco]), (rare mutations: [genf]), (dosage abnormalities: [cgab]), (cases: [qnco]), (high heritability: [qnco]), (low recurrence risk: [phpr]), (multifactorial inheritance: [genf]), (numerous loci: [gngm]), (other factors: []), (risk: []), (study: [resa]), (effect: []), (birth rank: [orgf]), (disease risk: [fndg]), (hereditary genetic models: []), (data: [euka]), (available autism family collections: [mobd]), (usa: []), (potential birth order effects: [qnco]), (statistical properties: []), (tests: [lbpr]), (adequate power: [hcpp]), (effects: []), (varying: []), ( patterns: []), (birth order effects: [qnco]), (collections: []), (multiplex families: [famg]), (v-shaped effects: []), (middle births: [orgf]), (high risk;: [fndg]), (simplex families: [famg]), (linear effects: []), (risk increases: [qnco]), (additional birth: [orgf]), (moreover: []), (birth order effect: [qnco]), (simplex collection: [bpoc]), (patterns: []), (ascertainment biases: []), (biological factors: [bacs]), (nevertheless: []), (further investigation: [hlca]), (parental age-dependent risks yields patterns: [grpa]), (part: [qnco]), (search: [acty]), (genes: [gngm]), (statistical power: [resa]), (uncover novel: []), (molecular etiologies: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(available autism family collections, 'Autism Phenotype')

PMCID: 3309488
SFARI Genes: MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, 
Non SFARI Genes: 
Named Entities: (contribution: [acty]), (peripheral immunity: [phsf]), (spectrum disorders: [dsyn]), (risk: []), (mothers: [famg]), (children: [aggp]), (asd: [cgab]), (autoantibodies: [aapp,imft]), (brain proteins: [bpoc]), (possibility: []), (subset: []), (asd cases: [cgab]), (maternal antibody response: [biof]), (gestation: [orgf]), (mechanism: []), (maternal immune system breaks tolerance: [fndg]), (decreased expression: [topp]), (met receptor tyrosine: [aapp,bacs,phsu]), (asd risk gene: [cgab]), (key negative regulator: [fndg]), (immune responsiveness: []), (sample: [sbst]), (functional met promoter variant rs1858830 c allele: [gngm]), (presence: [qnco]), (asd-specific 37+73-kda band pattern: [cgab]), (maternal autoantibodies: [aapp,imft]), (fetal brain proteins: [aapp,bacs]), (genetic association: []), (met protein: [aapp,rcpt]), (cytokine production: [orgf]), (prepared peripheral blood: [bdsu]), (mononuclear cells: [cell]), (met rs1858830 c allele: [gngm]), (met protein expression (p=0.025): [aapp,rcpt]), (moreover: []), (expression: [topp]), (regulatory cytokine il-10: [aapp,imft]), (met gene c: [gngm]), ((p=0.001): [fndg]), (reduced met protein levels: [aapp,rcpt]), (results: [fndg]), (genetic distinction: [topp]), (asd-associated antibodies: [aapp,imft]), (potential mechanism: []), (decrease: [qnco]), (met protein production: [aapp,rcpt]), (reduction: [npop]), (immune regulation: [biof]), 
ASD Terms: (autism spectrum disorders risk, 'Autism Phenotype')(gestation, 'Perinatal History')

PMCID: 3213048
SFARI Genes: IL6, IL6, IL6, IL6, IL6, IL6, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (developmental disorder: [mobd]), (emotional deficits: [menp]), ( language impairments: [mobd]), (behaviors: [inbe]), (early postnatal life: []), (study: [resa]), (relationship: []), (amongst absolute: []), (relative concentrations: [menp]), (k+: [qnco]), ( na+: [elii]), ( ca2+: [elii,phsu]), ( mg2+: [gngm]), (proinflammatory: []), (proapoptotic biomarkers: [clna]), (materials: [sbst]), (methods na+: [elii]), ( k+: [qnco]), ( na+/k+: [qnco]), ( ca2+/mg2+: [gngm]), (il6: [gngm]), ( tnf: [aapp,bacs]), (proinflammatory cytokines: [aapp,imft]), (caspase3: [aapp,enzy]), (proapoptotic biomarker: [clna]), (plasma: [bdsu]), (saudi: []), (autistic male patients: [mobd]), (age: [orga]), (control samples: []), (data: [euka]), (autistic patients: [mobd]), (plasma caspase3: [aapp,enzy]), ( il6: [aapp,imft]), (gender matching controls: [orga]), (other hand: [bpoc]), (mg2+: [gngm]), (na+: [elii]), (pearson correlations: []), (plasma concentrations: [qnco]), (cytokines: [aapp,imft]), (caspase-3: [aapp,enzy]), (ca2+: [elii,phsu]), (ca2+/k+ ratio: [qnco]), (characteristics: []), ((roc) analysis: [qnco]), (measured parameters: [fndg]), (satisfactory levels: []), (specificity: [qnco]), (sensitivity: [patf]), (alteration: []), (measured ions confirms: [elii]), (stress: [fndg]), (defective mitochondrial energy production: [celc]), (pathogenesis: [patf]), (moreover: []), (ions: [elii]), (set: [menp]), (pathways: [moft]), (role: [socb]), (prevalent disorder: [qnco]), (possible proinflammation: []), (proapoptic mechanisms: []), (autistics' brains: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(language impairments, 'Language Ability')(autism, 'Autism Phenotype')

PMCID: 3264868
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (etiology: []), (autism spectrum disorders: [mobd]), (oxidative stress: [comd]), (pathological role: [socb]), (serum levels: [bdsu]), (sonic hedgehog (shh) protein: [aapp,bacs]), (brain-derived neurotrophic factor (bdnf): [aapp,bacs]), (asd: [cgab]), (whole blood: [bdsu]), (polymorphonuclear leukocytes: [cell]), (autistic children: [podg]), (level: [phsu]), (oxygen: [elii,phsu]), (free radicals: [bacs,chvs]), (addition: []), (levels: []), (serum shh protein: [aapp,bacs]), (children: [aggp]), (mild: []), (severe form: []), (autism: [mobd]), (serum level: [bdsu]), (bdnf: [gngm]), (mild form: []), (disorder: [dsyn]), (findings: [clna]), (correlation: []), (shh: [gngm]), ( bdnf: [aapp,bacs,phsu]), (ofr: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 3183050
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (autism: [mobd]), (few interventions: [hlca]), (significant improvements: [qnco]), (speech output: [orgf]), (novel intervention: [hlca]), (auditory-motor mapping training (ammt): [edac]), (speech production: [orgf]), (association: [menp]), (sounds: [npop]), (articulatory actions: []), (intonation: []), (bimanual motor activities: [dora]), (ammt: []), (inherent musical strengths: []), (activities: [acty]), (network: [popg]), (brain regions: [blor]), (here: []), (initial efficacy study: [resa]), (concept: []), (non-verbal children: [aggp]), (autism participated: [mobd]), (intelligible words: []), (individual sessions: [evnt]), (times: [qnco]), (week: []), (8-week period: []), (probe assessments: [hlca]), (baseline: [bodm]), ( therapy: [topp]), (follow-up sessions: [evnt]), (therapy: [topp]), (ability: [orga]), (words: []), (phrases: []), (generalization: [menp]), (items: []), (therapy sessions: [evnt]), (minimal vocal output: []), (acquisition: [acty]), (speech sounds: [hcpp]), (word approximations: []), (critical step: [qnco]), (expressive language development: [menp]), 
ASD Terms: (autism, 'Autism Phenotype')(speech output, 'Language Ability')(promote speech production, 'Language Ability')(intonation, 'Prosody')(autism, 'Autism Phenotype')(autism participated, 'Autism Phenotype')(speech sounds, 'Vocalizations')(expressive language development, 'Language Development')(autism, 'Autism Phenotype')(minimal vocal output, 'Vocalizations')

PMCID: 3174969
SFARI Genes: 
Non SFARI Genes: CDX2, 
Named Entities: (gastrointestinal disturbances: [fndg]), (children: [aggp]), (autism: [mobd]), ( complicate: []), (clinical management: [hlca]), (behavioral impairment: [inbe]), (reports: [hlca]), (deficiencies: [dsyn]), (disaccharidase enzymatic activity: [aapp,enzy]), (beneficial responses: [orga]), (dietary therapies: [topp]), (survey gene expression: [genf]), (mucoepithelial microbiota: [orgm]), (intestinal biopsies: [diap]), (gastrointestinal disease: [dsyn]), (gastrointestinal disease alone: [dsyn]), (ileal transcripts: [bpoc]), (disaccharidases: [aapp,enzy]), (hexose transporters: [aapp,bacs]), (impairment: [patf]), (primary pathway: [moft]), (carbohydrate digestion: [orgf]), (transport: [celf]), (enterocytes: [cell]), (deficient expression: [topp]), (enzymes: [enzy,orch]), (transporters: [aapp,bacs]), (expression: [topp]), (intestinal transcription factor: [aapp,bacs]), ( cdx2: []), (metagenomic analysis: [resa]), (intestinal bacteria: [bact]), (compositional dysbiosis manifest: [patf]), (decreases: [qnco]), (bacteroidetes: [bact]), ( increases: [qnco]), (ratio: [qnco]), (firmicutes: [bact]), (increases: [qnco]), (betaproteobacteria: [bact]), (expression levels: [qnco]), (abundance: []), (affected bacterial phylotypes: []), (results: [fndg]), (relationship: []), (human intestinal gene expression: [humn]), (bacterial community structure: [anst]), (insights: [menp]), (pathophysiology: [patf]), 
ASD Terms: (autism, 'Autism Phenotype')(behavioral impairment, 'Personal Traits')(autism, 'Autism Phenotype')(gastrointestinal disease, 'Gastrointestinal Diseases')(gastrointestinal disease alone, 'Gastrointestinal Diseases')(autism, 'Autism Phenotype')(intestinal bacteria, 'Bacterial Infections')(affected bacterial phylotypes, 'Bacterial Infections')(autism, 'Autism Phenotype')(bacterial community structure, 'Bacterial Infections')

PMCID: 3174190
SFARI Genes: MECP2, MECP2, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (severe neuropsychiatric disorder: [fndg]), (complex pathobiology: [chvs]), (profound influences: []), (genetic factors: [fndg]), (development: [orgf]), (numerous autism: [mobd]), (susceptible genes: [gngm]), (etiology: []), (autism: [mobd]), (dna microarray: [mbrt]), (gene expression: [genf]), (peripheral blood: [bdsu]), (individuals: [humn]), (groups;: [popg]), (young adults: [aggp]), (asd: [cgab]), (gender-matched healthy subjects: [orga]), ((asd control): [cgab]), (healthy mothers: [famg]), (children: [aggp]), (asd (asdmo): [cgab]), (asdmo control: [sbst]), (blood relationship: [bdsu]), (asd group: [cgab]), (control: [sbst]), (genes: [gngm]), (cell morphology: [clna]), (cellular assembly: [celf]), (organization: [orgt]), (nerve system development: [ortf]), (function: [phsf]), (asdmo group: [popg]), (unique gene expression signature: [qnco]), (significant alterations: [qnco]), (protein synthesis: [moft]), (nonautistic diagnostic status: [fndg]), (moreover: []), (asd-associated gene expression signature: [cgab]), (unique gene expression: [genf]), (peripheral leukocytes: [cell]), (affected subjects: [humn]), (unaffected mothers: [famg]), (asd children: [cgab]), (genetic predisposition: [orga]), (peripheral cells: [cell]), (altered expression: [topp]), (several autism candidate genes: [mobd]), (fmr-1: [gngm]), (mecp2: [gngm]), (leukocytes: [cell]), (together: []), (findings: [clna]), (asd-associated genes: [cgab]), (genetic: [topp]), ( epigenetic: []), (environmental background: []), (potential tools: []), (crucial factors: []), (clinical onset: [qnco]), (disorder: [dsyn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(numerous autism, 'Autism Phenotype')(several autism candidate genes, 'Autism Phenotype')(clinical onset, 'Onset of Symptoms')

PMCID: 3179967
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (gene expression assays: [genf]), (high quality: [qnco]), (genome-wide data: [gngm]), (rna samples: [nnon]), (however: []), (methods: []), (human brain: [humn]), (poor rna quality: [grpa]), (other technical limitations: []), (many assays: [lbpr]), (cdna-mediated annealing: [nnon]), ( selection: [genf]), (ligation (dasl)-: [topp]), (vitro transcription: [genf]), ((ivt)-based genome-wide expression: [gngm]), (assays: [lbpr]), (reference pools: [clna]), (frozen brain tissue: [npop]), (formalin-fixed brain tissue: [hops,orch,phsu]), (dasl-based platform: []), (expression results: [fndg]), (reliability: [qnco]), (ivt-based platform: []), (reference brain rna: [nnon]), (rna: [nnon]), (frozen tissue-based samples: [npop]), (data: [euka]), (small sample: [sbst]), (formalin-fixed rna samples: [hops,orch,phsu]), (subset: []), (probes: [chvf]), (samples: [sbst]), (results: [fndg]), (dasl-based gene: [gngm]), (expression-profiling platform: [mbrt]), (advantages: []), (mrna assays: [bacs,nnon]), (brain: [bpoc]), (traditional ivt-based methods: []), (implications: []), (investigations: [hlca]), (neuropsychiatric disorders: [dsyn]), 
ASD Terms: 

PMCID: 3166116
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (severe neurodevelopmental disorder: [mobd]), (impaired language: [lang]), ( communication: [socb]), (social skills: [socb]), (regressive autism: [mobd]), (children: [aggp]), (first show signs: [qnco]), (language development: [menp]), (skills: [inbe]), (autistic behavior: [mobd]), (protein kinases: [aapp,enzy]), (g-protein-coupled: [aapp,enzy]), (receptor-mediated signal transduction: [moft]), (neuronal functions: [imft]), ( gene: [gngm]), (expression: [topp]), ( memory: [menp]), (cell differentiation: [celf]), (activity: [acty]), (protein: [aapp,bacs]), (a (pka): []), (cyclic ampdependent protein kinase: [aapp,enzy]), (postmortem brain tissue samples: [bpoc]), (frontal: []), ( temporal: []), ( parietal: []), (occipital cortices: [bpoc]), (cerebellum: [bpoc]), (individuals: [humn]), (regressive autism;: [mobd]), (autistic subjects: [mobd]), (clinical history: [orga]), (regression;: [menp]), (normal control subjects: [humn]), (pka: []), (catalytic subunit: [amas]), (frontal cortex: [bpoc]), (subjects: [humn]), (non-regressive autism: [mobd]), (such changes: [qnco]), (cortices: [bpoc]), (temporal: []), (occipital regions: [bpoc]), (brain: [bpoc]), (addition: []), (significant difference: [qnco]), (pka activity: [acty]), (control groups: [grup]), (results: [fndg]), (regression: [menp]), (part: [qnco]), (decreased pka-mediated phosphorylation: [moft]), (proteins: [aapp,bacs]), (abnormalities: [cgab]), (cellular signaling: [celf]), 
ASD Terms: (autism, 'Autism Phenotype')(severe neurodevelopmental disorder, 'Learning Disorders')(impaired language, 'Language Ability')(social skills, 'Ability to Converse in Social Settings')(regressive autism, 'Autism Phenotype')(language development, 'Language Development')(memory, 'Working Memory')(non-regressive autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3309504
SFARI Genes: Auts2, Auts2, 
Non SFARI Genes: 
Named Entities: (offspring: [famg]), (fathers: [famg]), (risk: []), (neurodevelopmental disorders: [mobd]), (schizophrenia: [mobd]), (autism: [mobd]), (light: [gngm]), (evidence: []), (copy number variants: [nusq]), (mouse model: [emod]), (hypothesis: []), (males: [orga]), (cnvs: [nusq]), (c57bl/6j sires: [mamm]), (3-month-old dams: [gngm]), (control: [sbst]), (old sires: []), ( respectively: []), (genome-wide microarray: [gngm]), (distinct cnvs: [nusq]), (set: [menp]), (parents: []), (competitive quantitative pcr: [mbrt]), (original set: [menp]), (frequency: [qnco]), (independent set: [menp]), (basis: [phsu]), (combined samples: [sbst]), (sires: []), (none: []), (control group: [grup]), (behavioral and/or neuroanatomical phenotypic features: [inbe]), (auts2 (autism susceptibility candidate: [mobd]), (other cnvs: [nusq]), (genes: [gngm]), (brain development: [ortf]), (first experimental demonstration: [qnco]), (results: [fndg]), (generation: [acty]), (male germline: [cell]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(offspring, 'Perinatal History')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(other copy number variants, 'Imitation')(autism, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')

PMCID: 3162001
SFARI Genes: LMX1B, LMX1B, LMX1B, LMX1B, LMX1B, LMX1B, LMX1B, LMX1B, LMX1B, LMX1B, LMX1B, LMX1B, 
Non SFARI Genes: 
Named Entities: (multiple lines: [qnco]), (evidence: []), (serotoninergic dysfunction: [dsyn]), (autism: [mobd]), (role: [socb]), (lmx1b: [gngm]), (development: [orgf]), (maintenance: [acty]), (serotoninergic neurons: [cell]), (order: [acty]), (any: []), (trio-based snp association study: [menp]), (family samples: [famg]), (agre: []), (performed: []), (method: [lbpr]), (snps: [nusq]), (hapmap data: [orga]), (location: [blor]), (minor allele frequency: [qnco]), (snps (rs10732392: [nusq]), (rs12336217): []), (moderate association: [menp]), (p values: [qnco]), (transmission disequilibrium test: [dsyn]), (haplotype agcgtg: [orga]), (significant association (p: [menp]), (further: []), ( lmx1b mrna expressions: [genf]), (postmortem brain tissues: [diap]), (autism subjects: [mobd]), (healthy controls: []), (lmx1b transcripts: [nnon]), (anterior cingulate gyrus region: [blor]), (autism patients: [mobd]), (controls: [sbst]), (study: [resa]), (possible role: [socb]), (pathophysiology: [patf]), (previous reports: [hlca]), (seretoninergic mechanism: []), (first report: [qnco]), (association: [menp]), (caution: []), (modest associations: [menp]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism subjects, 'Autism Phenotype')(autism patients, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3159129
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (dysfunction: [dsyn]), (limbic gabaergic circuits: []), (neurodevelopmental disorders: [mobd]), (humans: [humn]), (schizophrenia: [mobd]), ( autism: [mobd]), (epilepsy: [dsyn]), (current paper: [npop]), (characteristics: []), (great diversity: [qnco]), (cortical gabaergic interneurons: [bpoc]), (multiple roles: [socb]), (cells: [cell]), (mature circuits: []), (aforementioned disorders: [dsyn]), (furthermore: []), (genetic cascades: [topp]), (fate: [gngm]), (cortical interneurons: [bpoc]), (genes: [gngm]), (generation: [acty]), ( specification: []), ( maturation: [phsf]), (function: [phsf]), (disorders: [dsyn]), 
ASD Terms: (multiple neurodevelopmental disorders, 'Learning Disorders')(neurodevelopmental disorders, 'Learning Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(epilepsy, 'Epilepsy')

PMCID: 3215885
SFARI Genes: CNTN5, CNTN5, 
Non SFARI Genes: 
Named Entities: (recent array-based studies: [lbpr]), (wealth: []), (copy number variations: [nusq]), (patients: [podg]), (autism spectrum disorders: [mobd]), (cnvs: [nusq]), (contributions: [acty]), (patients phenotype: [orga]), (cohort: [popg]), (children: [aggp]), (symptoms: [sosy]), (asd: [cgab]), ( diagnosis: [fndg]), (index patient: [podg]), (ados-g: [aapp,enzy]), (adi-r: [clna]), (performed: []), (social responsiveness scale (srs): [acty]), (index: [qnco]), (parents: []), (available siblings: [famg]), (snp arrays: [mbrt]), (fish: [gngm]), (array cgh: [dsyn]), (clinical significance: [fndg]), (families: [famg]), (multiple affected children (multiplex): [aggp]), (single affected child (simplex): [fndg]), (child: [aggp]), (cnv: [nusq]), (brain-transcribed gene: [gngm]), (genes: [gngm]), (pathways: [moft]), (phosphoinositol: []), ((pik3ca: [aapp,enzy]), ( girdin): [gngm]), (contactin-based networks: [aapp,bacs]), (cell communication (cntn6): [celf]), (microcephalin (mcph1): [aapp,bacs]), (co-segregate: []), (asd phenotypes: [cgab]), (family: [famg]), (loss: [qnco]), (cntn5: [gngm]), (disease: [dsyn]), (phenotype: [orga]), (epistatic interactions: [fndg]), (inherited (transmitted) mutations: [genf]), (non-genetic factors: [fndg]), (study: [resa]), (scope: []), (genome-wide cnv: [nusq]), (sporadic patients: [podg]), (heritability: []), (genome-wide screening studies: [topp]), (complex psychiatric disorders: [mobd]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(symptoms of asd, 'Complaints and Indications')(diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')(asd phenotypes, 'Autism Phenotype')(complex psychiatric disorders, 'Mental Disorders')

PMCID: 3150391
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (autistic traits: [mobd]), (continuum: []), (general population: [popg]), (clinical autism: [mobd]), (extreme end: []), (quantitative distribution: [qnco]), (nature: []), (severity: []), (symptoms: [sosy]), (study: [resa]), (long-term stability: []), (at: []), (toddlers: [aggp]), (current investigation: [hlca]), (males: [orga]), (decades: [qnco]), (pervasive developmental disorder subscale: [mobd]), (child behavior checklist: [diap,inpr]), (childhood (m: [aapp,imft]), (years; sd: [mamm]), (autism-spectrum quotient: [qnco]), (adulthood (m: [aapp,imft]), (items: []), (scale: [acty]), (social (difficulties: [fndg]), (social interaction: [fndg]), (communication): [socb]), (repetitive behaviours: [inbe]), (interests) at: [menp]), (association: [menp]), (child: [aggp]), (adult measurements: [aggp]), (influence: []), (obstetric variables: []), (pearson's correlations: []), (linear regression: [qnco]), ( total at: [qnco]), (childhood: []), (total at (r = .16: [clna]), ( p = .002): [aapp,imft]), (social at (r = .16: [clna]), (adulthood: []), (positive correlation: [fndg]), (social at: []), (early childhood: []), (total (r = .17: [qnco]), ( p = .001): [aapp,imft]), (correlations: []), (non-social at: []), (significance: [qnco]), (furthermore: []), (significant longitudinal association: [menp]), (females: [orga]), (constraints: []), (different measures: [qnco]), (different raters: []), (ages: [bacs,orch]), (modest developmental stability: [orgf]), (boys: [aggp]), 
ASD Terms: (clinical autism, 'Autism Phenotype')

PMCID: 3150222
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (cortical circuits: [bpoc]), (brain: [bpoc]), (experience: [menp]), (critical periods: []), (postnatal life: []), (balance: [fndg]), (excitatory: []), (inhibitory: [acty]), ((e/i) neurotransmission: [celf]), (development: [orgf]), (evidence: []), (e/i imbalance: [inch]), (autism: [mobd]), (complex genetic neurodevelopmental disorder: [mobd]), (abnormal socialization: [edac]), (communication: [socb]), (repetitive behaviors: [fndg]), (interests: [menp]), (underlying cause: []), (effective treatment: []), (cure: []), (alteration: []), (expression: [topp]), (timing: []), (critical period circuit refinement: []), (primary sensory brain areas: [bpoc]), (autistic phenotypes: [mobd]), (behavioral impairments: [inbe]), (dissection: [topp]), (molecular mechanisms: []), (well-established critical periods: []), (powerful tool: []), (new potential therapeutic targets: [diap]), (normal plasticity: [npop]), (function: [phsf]), (affected neuronal circuits: [imft]), 
ASD Terms: (autism, 'Autism Phenotype')(complex genetic neurodevelopmental disorder, 'Learning Disorders')(abnormal socialization, 'Social Competence')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(behavioral impairments, 'Personal Traits')

PMCID: 3144901
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (account interaction synchrony: [clna]), (autism (ad): [mobd]), (intellectual disability (id): [mobd]), (typical development (td): [orgf]), (family home movies: [famg]), (infants: [aggp]), (months: []), (computational methods: [resa]), (methodology: []), (principal findings first: [clna]), (interactive sequences: [nusq]), (home movies: []), (children: [aggp]), (ad (n =: [aapp,imft]), (id (n: [lbpr]), (td (n: [aapp,imft]), (infant: [aggp]), (caregiver behavior scale (icbs): [acty]), (second: [qnco]), (discrete behaviors: [inbe]), (baby (bb): [aggp]), (care giver (cg) co-occurring: [acty]), (seconds: []), (single interactive patterns: [fndg]), (dyadic events): [evnt]), (analysis: [resa]), (directions: []), (interaction (cgbb: []), (bbcg): []), (group: [popg]), (semester: []), (so: []), (markov assumption: []), (generalized linear mixed model: [qnco]), (negative matrix factorization: [phsu]), (td children: [aggp]), ( bbs: []), (ad exhibit: []), (deviant development: [cgab]), (interactive patterns whereas: []), (id: [lbpr]), (initial delay: []), (development: [orgf]), (parents: []), (ad: []), (td: []), (child: [aggp]), (however: []), (interaction: []), ( parents: []), (regulation: [biof]), (behaviors: [inbe]), (first semester: [qnco]), (interactive patterns: []), (deviant autistic behaviors: [mobd]), (lack: []), (interactive initiative: [menp]), (responsiveness: []), (babies: [aggp]), (credence: []), (intuition: [menp]), (pathological process: [patf]), (interactive pattern: []), 
ASD Terms: (differentiate autism, 'Autism Phenotype')(typical development in family home movies, 'Home Life Skills')(better differentiate autism, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(autism, 'Autism Phenotype')(growing deviant development of interactive patterns whereas, 'Conversational Skills')(initial delay of development, 'Learning Disorders')(autism exhibit, 'Autism Phenotype')(autism, 'Autism Phenotype')(interactive initiative, 'Initiating Social Interaction')

PMCID: 3309518
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (siblings: [famg]), (individuals: [humn]), (autism: [mobd]), (times: [qnco]), (population risk: [popg]), (evidence: []), (comparable: []), (marked: []), ( cognitive: []), (social communication deficits: [socb]), (role: [socb]), (traits: [gngm]), (search: [acty]), (biomarkers: [clna]), (familial risk: [famg]), (however: []), (first time: [qnco]), (neural response: [fndg]), (facial expression: [fndg]), (emotion differs: [menp]), (unaffected siblings: [famg]), (healthy controls: []), (family history: [fndg]), (strikingly: []), (functional magnetic resonance: [npop]), ((fmri) response: [diap]), (happy versus: [menp]), (controls: [sbst]), (number: [qnco]), (brain areas: [bpoc]), (empathy: [inbe]), (face processing: [emst]), (response: [fndg]), (furthermore: []), ( investigation: [hlca]), (versus fixation crosses: [topp]), (that: []), (context: [fndg]), (study: [resa]), (atypical response: [fndg]), (happy faces: [blor]), (general: [hlca]), ( accounts: [clna]), (observed sibling versus: [famg]), (difference: [qnco]), (clear biomarker: [clna]), (findings: [clna]), (atypical implicit response: [fndg]), (emotion: [menp]), (basis: [phsu]), (impaired emotional reactivity: [fndg]), (autism phenotype: [mobd]), (relatives: [famg]), (results: [fndg]), (fmri response: [diap]), (candidate neuroimaging endophenotype: [diap]), (far-reaching insights: [menp]), (etiology: []), 
ASD Terms: (autism, 'Autism Phenotype')(social communication deficits, 'Reciprocal Social Interaction')(cognitive, 'Cognitive Ability')(facial expression, 'Integrated Verbal and NonVerbal Communication')(autism, 'Autism Phenotype')(empathy, 'Empathy')(face processing, 'Integrated Verbal and NonVerbal Communication')(autism, 'Autism Phenotype')(facial expression, 'Integrated Verbal and NonVerbal Communication')(autism phenotype, 'Autism Phenotype')(facial expression, 'Integrated Verbal and NonVerbal Communication')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3134991
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (major goal: []), (neuroscience: []), (development: [orgf]), (strategies: [menp]), (neural plasticity: [ortf]), (adult central nervous system: [aggp]), (functional recovery: [sosy]), (brain disease: [dsyn]), (injury: [inpo]), (new evidence: []), (pivotal role: [socb]), (cortical inhibitory circuitries: [bpoc]), (plasticity: [npop]), (adulthood: []), (paper: []), (recent findings: [clna]), (inhibition-excitation balance controls: [celf]), (brain plasticity: [bpoc]), (core: [bdsu]), (pathogenesis: [patf]), (neurodevelopmental disorders: [mobd]), (down syndrome: [cgab,dsyn]), (rett syndrome: [dsyn]), 
ASD Terms: (development of strategies, 'Problem Solving Ability')(brain disease, 'Central Nervous System Diseases')(neurodevelopmental disorders, 'Learning Disorders')(down syndrome, 'Down Syndrome')(rett syndrome, 'Rett Syndrome')

PMCID: 3142225
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (consistent biological findings: []), (autism: [mobd]), (elevated blood serotonin levels: [lbpr]), (immune abnormalities: [cgab]), (autoimmunity: [patf]), (production: []), (brain: [bpoc]), (specific auto-antibodies: [aapp,imft]), (disorder: [dsyn]), (hyperserotonemia: []), (factors: []), (patients: [podg]), (reduction: [npop]), (t-helper (th): []), (cytokines: [aapp,imft]), (possible role: [socb]), (induction: [topp]), (serum anti-myelin-basic protein: [aapp,bacs]), ((anti-mbp) auto-antibodies: [aapp,imft]), (serum levels: [bdsu]), (serotonin: [bacs,orch]), (anti-mbp auto-antibodies: [aapp,imft]), (elisa: [lbpr]), (autistic patients: [mobd]), (years: []), (healthy-matched children: [fndg]), (autistic children: [podg]), (healthy children: [fndg]), (p <: [aapp,imft]), (respectively): []), (severe autism: [fndg]), (serum serotonin levels: [bacs,orch]), (children: [aggp]), (mild: []), (autism (p: [mobd]), (significant correlations: [qnco]), (increased frequency: [qnco]), (serum anti-mbp auto-antibodies: [aapp,imft]), (data: [euka]), (caution: []), (further investigations: [hlca]), (however: []), ( inclusion: [celc]), (correlate: []), (other future immune studies: [lbpr]), (long-standing mystery: [phsf]), (pathophysiology: [patf]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(severe autism, 'Autism Phenotype')(moderate autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3120811
SFARI Genes: APP, APP, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (deficits: []), (verbal communication: [socb]), (social interactions: [fndg]), (presence: [qnco]), (repetitive: []), (compulsive behaviors: [mobd]), (excessive early brain growth: [bpoc]), (patients: [podg]), (phenotype: [orga]), (reports: [hlca]), (increased levels: [qnco]), (brain-derived neurotrophic factor (bdnf): [aapp,bacs]), (other neurotrophic-like factors: []), (autistic neonates: [aggp]), (anabolic activity: [acty]), (cns: [bdsy]), (overgrowth effect: [fndg]), (subset: []), (severe autism: [fndg]), (aggression: [mobd]), ( plasma levels: [bdsu]), (secreted amyloid- (a) precursor: [aapp,imft]), (protein-alpha form (sapp): [aapp,bacs]), (relative: [qnco]), (controls: [sbst]), (mild-to-moderate autism: [mobd]), (hypothesis: []), (levels: []), (sapp: []), (sapp (proteolytic cleavage products: [celf]), (app: [gngm]), (-secretase: [aapp,enzy]), ( respectively): []), (anabolic environment: [orch,phsu]), (brain overgrowth: [bpoc]), (plasma levels: [bdsu]), ( sapp: []), ( a peptides: [aapp]), (bdnf: [gngm]), (elisa: [lbpr]), (set: [menp]), (subjects: [humn]), (analysis: [resa]), (control: [sbst]), (mild-to-moderate: []), (autistic patient plasma samples: [mobd]), (sapp levels: []), (bdnf levels: [aapp,bacs,phsu]), (plasma: [bdsu]), (a1-40: [qnco]), ( a1-42: []), (findings: [clna]), (biochemical correlate: []), (phenotypic severity: [orga]), (together: []), (study: [resa]), (evidence: []), (aberrant non-amyloidogenic processing: [acty]), 
ASD Terms: (autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(social interactions, 'Reciprocal Social Interaction')(compulsive behaviors, 'Obsessive-Compulsive Disorder')(mild-to-moderate autism, 'Autism Phenotype')(severe autism, 'Autism Phenotype')(aggression, 'Aggressive Behavior')(mild-to-moderate autism, 'Autism Phenotype')

PMCID: 3173108
SFARI Genes: CaV1.2, CaV1.2, CaV1.2, CaV1.2, CaV1.2, CaV1.2, 
Non SFARI Genes: IV, 
Named Entities: (timothy syndrome mutations g402s: [dsyn]), (g406r: []), (abolish inactivation: []), (cav1.2: [gngm]), (multiorgan dysfunction: [dsyn]), (lethal arrhythmias: [fndg]), (insights: [menp]), (consequences: []), (g402s mutation: [genf]), (structure: []), (function: [phsf]), (channel: []), (corresponding gly-432: [aapp,bacs,phsu]), (rabbit channel: [mamm]), (applied homology modeling: [mbrt]), (mutations: [genf]), (gly-432 (g432a/m/n/v/w): [aapp,bacs,phsu]), (channel inactivation: []), (homology: [gngm]), (gly-432 forms part: [aapp,bacs,phsu]), (conserved structure motif (g/a/g/a): [amas]), (small residues: [evnt]), (homologous positions: [gngm]), (domains: []), ((gly-432 (is6): [aapp,bacs,phsu]), ( ala-780 (iis6): [euka]), ( gly-1193 (iiis6): [aapp,bacs,phsu]), ( ala-1503 (ivs6)): [euka]), (domains ii: []), ( iii: []), (iv induced: []), (contrast: [irda]), (parallel shifts: [resa]), (activation: [acty]), (inactivation curves: []), (preserved coupling: [lbpr]), (processes: [phpr]), (disruption: []), (inactivation: []), (gly-432: [aapp,bacs,phsu]), (domain i. mutations: [inch]), (inactivation irrespective: []), (changes: [qnco]), (domains residues g/a/g/a: [aapp,bacs]), (close contact: [fndg]), (bulky amino acids: [aapp,bacs,phsu]), (s6 helices: [euka]), (interactions: []), (adhesion points: [patf]), (activation gate: [acty]), (closed state: []), (structural hypothesis: []), (activation gating: [acty]), (g/a/g/a residues: [evnt]), (structural implications: []), (cav1.2 activation: [acty]), (inactivation gating: []), (discussed: [socb]), 
ASD Terms: 

PMCID: 3197027
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (several lines: [qnco]), (evidence: []), (role: [socb]), (mutations: [genf]), (mechanism: []), (common disorders: [dsyn]), (autism: [mobd]), (schizophrenia: [mobd]), (mutation rate: []), (humans: [humn]), (new mutations: [comd]), (high frequency: []), (population: [popg]), (however: []), (common diseases: [dsyn]), (genes: [gngm]), (diseases: [dsyn]), (strong negative selection: [lbpr]), (phenotype: [orga]), (lethality: []), (embryonic stages: []), (reduced reproductive fitness: [genf]), (family members: [famg]), (linkage gene mapping: [lbpr,mbrt]), (association studies: [menp]), (observation: [hlca]), (high concordance: [socb]), (monozygotic twins: [famg]), (low concordance: [socb]), (dizygotic twins: [famg]), (hypothesis: []), (significant fraction: [qnco]), (cases: [qnco]), (case: []), (second: [qnco]), (reduced reproductive fitness1: [orgf]), (incidence: [qnco]), (constant rate: [qnco]), (worldwide: []), (mutational load: [genf]), (balance: [fndg]), (selection: [genf]), (deleterious mutation: [comd]), (production: []), (mutation: [genf]), (rates: [qnco]), (reproduction: [orgf]), (negative selection factor: [lbpr]), (number: [qnco]), (mutant alleles: [gngm]), (decreased disease prevalence: [qnco]), (selective pressures: [phpr]), (different intensity: []), (different environments: []), (nonetheless: []), (severe mental disorders: [mobd]), (high prevalence: [qnco]), (worldwide population: [popg]), (wide range: [qnco]), (cultures: [lbpr]), (countries: []), (them2: [gngm]), (high new mutation rate: [comd]), (effects: []), (paternal age:: []), (risk: []), (disease: [dsyn]), (paternal age: []), (age: [orga]), (related increase: [fndg]), (schizophrenia3: []), (male-to-female ratio: [orga]), (germ-cell divisions: [celf]), (males: [orga]), (therefore: []), (males4: []), (high rate: [qnco]), (part: [qnco]), (genetic studies: [resa]), (many genes: [gngm]), (human genome: [gngm]), (identification: [menp]), (cause: []), (targeted molecular approach: []), (parents: []), (subjects: [humn]), (process: [phpr]), (genetic basis: [phsu]), (molecular approach: []), (link: []), (examples: []), 
ASD Terms: (autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(severe mental disorders, 'Mental Disorders')(autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 3324676
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (sensory hypersensitivity: [patf]), (recent study: [resa]), (visual acuity (va): [clna]), (asd: [cgab]), (region: []), (birds: [bird]), (prey: [gngm]), (validity: [qnco]), (results: [fndg]), (study: [resa]), (va: [hcro,mnob]), (individuals: [humn]), (schizophrenia (sch): [mobd]), ((typ): [gngm]), (participants: [popg]), (sch: [gngm]), (typ: [gngm]), (substantial correlations: []), (clinical severity: []), (eagle-eyed acuity hypothesis: [bird]), (evidence: []), (connection: []), (clinical phenotypes: [orga]), (research: [resa]), (origins: []), (circumstances: []), (altered sensory: [sosy]), (perceptual processing: [acty]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(visual acuity, 'Visual Thinking')(visual acuity, 'Visual Thinking')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(visual acuity, 'Visual Thinking')(visual acuity, 'Visual Thinking')

PMCID: 3110727
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mpas (minor: [popg]), (physical anomalies): [hlca]), (neurodevelopmental disorders: [mobd]), (face: [gngm]), (brain: [bpoc]), (neuroectoderm: [emst]), (first trimester: []), (conventionally: []), ( mpas: []), (evaluation: [hlca]), (external appearance: [orga]), (mri: [gngm]), (inherent observer bias: []), (multi-centre data acquisition: [acty]), (mpas: []), (brain dysmorphology: [bpoc]), (same individual: [humn]), (optical mpas exhibit: [orgf]), (trajectory: []), (fetal: [emst]), ( postnatal: []), (adult life: [aggp]), (head size enlarges: [fndg]), (age: [orga]), ( inter-orbital distance increases: [qnco]), (years: []), (optical mpas: [orgf]), (retrospective window: [resa]), (early neurodevelopment; specifically: [ortf]), (inter-orbital distance increase: [qnco]), (biomarker: [clna]), (early brain dysmaturation: [bpoc]), (autism: [mobd]), (children: [aggp]), (autism spectrum disorder: [mobd]), (controls: [sbst]), (normal iq: [fndg]), (inter-orbital distance: [qnco]), (t1-weighted mri scans: [orga]), (value: [qnco]), (voxel-by-voxel linear regression analysis: [qnco]), (grey matter: [tisu]), (bimodal mri data-set: [diap]), (total brain tissue volume: [qnco]), (covariates: []), (intra-class coefficient: [qnco]), (measurement: []), (autism group (p: [mobd]), (autism group: [mobd]), (significant relationship: [qnco]), (grey matter volume: [tisu]), (bilateral amygdalae: [bpoc]), (unci: [bpoc]), (inferior temporal poles: [blor]), (greater: [qnco]), (healthy controls: []), (infant head size expansion: [aggp]), (volume: [qnco]), (medial temporal lobe structures: [bpoc]), (link: []), (social brain dysmorphology: [bpoc]), (data: [euka]), (role: [socb]), (fossil record: [sbst]), (early aberrant neurodevelopment: [ortf]), (potential biomarker: [clna]), (brain dysmaturation: [bpoc]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism group, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3170664
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (human: [humn]), (neural progenitors: [famg]), (variety: []), (sources: [fndg]), (present new opportunities: [qnco]), (aspects: [qnco]), (human neuropsychiatric disease: [humn]), (vitro: []), (vitro models: []), (advantages: []), (human genetic background: [humn]), (easy manipulation: [topp]), (useful adjuncts: []), (models: []), (here: []), (human neuronal culture system: [humn]), (transcriptional program: [genf]), (human neural differentiation: [humn]), (molecular features: []), (neurodevelopmental disorder: [mobd]), (autism: [mobd]), (primary: [topp]), (normal human neuronal progenitors: [humn]), (post-mitotic neuronal state: [imft]), (addition: []), (specific growth factors: [aapp,bacs]), (whole-genome gene expression: [genf]), (time course: []), (neuronal differentiation: [fndg]), (weeks: []), (differentiation: [celf]), (significant number: [qnco]), (genes: [gngm]), (autism spectrum disorders: [mobd]), (asd susceptibility gene neurexin: [cgab]), (distinct pattern: []), (vivo: []), (fetal human brain: [emst]), (weighted gene co-expression network analysis (wgcna): [orga]), (network structure: [popg]), (transcriptional regulation: [genf]), (unbiased analysis: [resa]), (asd candidate genes: [cgab]), (differentiation process: [celf]), (nhnps: []), (effects: []), (mutations: [genf]), (multiple asd candidate genes: [cgab]), (gene expression: [genf]), (combination: [fndg]), (potential therapeutic molecules: [sbst]), (data: [euka]), (step: [gngm]), (understanding: [menp]), (pathways: [moft]), (asd: [cgab]), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 3130139
SFARI Genes: CNTNAP2, CNTNAP2, CNTNAP2, CNTNAP2, CNTNAP2, CNTNAP2, CNTNAP2, CNTNAP2, 
Non SFARI Genes: 
Named Entities: (early language development: [menp]), (genetic influence: [topp]), (genes: [gngm]), (normal variation: [fndg]), (general population: [popg]), (recent studies: [lbpr]), (disorder: [dsyn]), (variants: []), (cntnap2 gene: [gngm]), (language deficits: [lang]), (specific language: [lang]), (impairment (sli): [aapp,bacs]), (language delays: [lang]), (autism: [mobd]), (hypothesis: []), (cntnap2 variants: [aapp,bacs]), (communicative behavior: [socb]), (years: []), (age: [orga]), (large epidemiological sample: [sbst]), (western australian pregnancy cohort (raine) study: [orgf]), (singlepoint analyses: [resa]), (children: [aggp]), ((606 males: [orga]), (females): [orga]), (patterns: []), (association: [menp]), (previous investigations: [hlca]), (impaired language: [lang]), (same genetic markers: [genf]), (consistent direction: []), (effect (rs2710102: []), ( p: [aapp,imft]), (rs759178: []), (basis: [phsu]), (findings: [clna]), (analyses: [resa]), (four-marker haplotypes: [orga]), (rs2710102rs759178rs17236239rs2538976: []), (significant association (haplotype ttaa: [menp]), (haplotype gcag: [orga]), ( p = .0014): [aapp,imft]), (study: [resa]), (common variants: [qnco]), (exon: [bacs,nnon]), (region: []), (cntnap2 influence: [aapp,bacs]), (early language acquisition: [menp]), (susceptibility: [clna]), (sli: [gngm]), (other risk factors: [qnco]), 
ASD Terms: (early language development, 'Language Development')(specific language impairment, 'Language Ability')(autism, 'Autism Phenotype')(language deficits, 'Language Ability')(language delays, 'Language Ability')(years of age, 'Onset of Symptoms')(impaired language, 'Language Ability')

PMCID: 3130692
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (several statistical tests: [qnco]), (genome-wide association data: [menp]), (gene: [gngm]), (pathway information: [moft]), (terms: [orgf]), (gene sets: [gngm]), (methods: []), ( hundreds: []), (tested gene sets: [gngm]), (probability: [qnco]), (false positives: [lbtr]), (results: [fndg]), (many gene sets: [gngm]), (statistical significance: [qnco]), (flexible statistical framework: []), (problems: []), (spatial scan statistics: [diap]), (clustering: [resa]), (disease occurrence: [dsyn]), (field: [irda]), (epidemiology: [hlca]), (scan statistic: [diap]), (disease-associated gene clusters: [qnco]), (whole gene pathway: [gngm]), (few significant gene clusters: [gngm]), (global pathway: [moft]), (overall false positive probability: [qnco]), (increased statistical power: [resa]), (interpretation: [clna]), (test results: [fndg]), (present study: [qnco]), (method: [lbpr]), (rare copy-number variations: [nusq]), (common diseases: [dsyn]), (application: [qnco]), (simulated dataset: [bodm]), (high accuracy: [qnco]), (scan statistic approach: [diap]), (high level: [qnco]), (accuracy: []), (gene clusters: [gngm]), (study: [resa]), (sound statistical framework: [npop]), (genome-wide rare cnv data: [nusq]), (topological information: []), (gene pathway: [gngm]), 
ASD Terms: 

PMCID: 3607626
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (heritable neuro-developmental condition: [mobd]), (marked genetic heterogeneity13: [topp]), (fundamental question: []), (autism: [mobd]), (heterogeneous disorder: [fndg]), (myriad: []), (environmental risk factors: []), (common underlying molecular pathways: [moft]), (brain4: []), (here: []), (consistent differences: [qnco]), (transcriptome organization: [nusq]), (normal brain: [bpoc]), (gene co-expression network analysis: [popg]), (remarkably: []), (regional patterns: []), (gene expression: [genf]), (distinguish frontal: []), (temporal cortex: [bpoc]), (asd brain: [cgab]), (abnormalities: [cgab]), (cortical patterning: [bpoc]), (discrete modules: []), (co-expressed genes: [gngm]), (autism:: [mobd]), (neuronal module: [imft]), (autism susceptibility genes: [mobd]), (factor a2bp1/fox1: [gngm]), (module: []), (immune genes: [gngm]), (glial markers: [clna]), (dysregulated splicing: [genf]), (a2bp1-dependent: [gngm]), (alternative exons: [bacs,nnon]), (moreover: []), (autism gwas dataset: [mbrt]), (variants: []), (independent support: [fndg]), (causal involvement: []), (genes: [gngm]), (immune-glial module: [cell]), (enrichment: []), (autism gwas signals: [mbrt]), (non-genetic etiology: [topp]), (process: [phpr]), (collectively: []), (results: [fndg]), (strong evidence: []), (convergent: [acty]), (molecular abnormalities: [fndg]), (asd: [cgab]), (implicate transcriptional: [genf]), (dysregulation: []), (underlying mechanisms: []), (neuronal dysfunction: [dsyn]), (disorder: [dsyn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism susceptibility genes, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism gwas dataset, 'Autism Phenotype')(autism gwas signals, 'Autism Phenotype')

PMCID: 3252613
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, SHANK3, SHANK3, 
Non SFARI Genes: 
Named Entities: (genetic mutations: [genf]), (shank3: [gngm]), (patients: [podg]), (intellectual disability: [mobd]), ( autism spectrum disorder (asd): [mobd]), (schizophrenia: [mobd]), (synapse: [bsoj]), ( shank3/prosap2: [aapp]), (protein: [aapp,bacs]), (glutamate receptors: [aapp,rcpt]), (actin cytoskeleton: [celc]), (chain: []), (intermediary elements: [elii]), (genetic studies: [resa]), (association: [menp]), (shank3 mutations: [genf]), (susceptibility: [clna]), (neuronal consequences: [imft]), (mutations: [genf]), (here: []), (functional effects: []), (q321r): []), (inherited variations: []), (r300c): []), (asd: [cgab]), (tip: [gngm]), (actin filaments: [celc]), (polymerization: [phpr]), (growth cone motility: [celc]), (neurons: [cell]), (mutation (stop): [genf]), (development: [orgf]), (morphology: [fndg]), (dendritic spines: [celc]), ( reduces: []), (synaptic transmission: [celf]), (mature neurons: [cell]), (effect: []), (mutation: [genf]), (ankyrin domain: [aapp,bacs]), (roles: [socb]), (spine induction: [bpoc]), (actin accumulation: [aapp,bacs]), (spines: [bpoc]), (affects growth: [orgf]), (motility: [orgf]), (inherited mutations: [genf]), (intermediate effects: [lbtr]), (spine density: [bpoc]), (therefore: []), (healthy parents: []), (risk factors: [qnco]), (data: [euka]), (new insights: [menp]), (synaptic alterations: []), (humans: [humn]), (robust cellular readout: [cell]), (knowledge-based therapies: [topp]), 
ASD Terms: (patients with intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 3114764
SFARI Genes: IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, 
Non SFARI Genes: 
Named Entities: (cellular mechanisms: [cell]), (pathogenesis: [patf]), (autism: [mobd]), (number: [qnco]), (studies: [lbpr]), (localized inflammation: [fndg]), (central nervous system (cns): [bdsy]), (development: [orgf]), (recent evidence shows: [anim]), (il-6: [gngm]), (crucial role: [socb]), (plasticity: [npop]), (cns: [bdsy]), (immunohistochemistry studies: [diap]), (il-6 expression: [aapp,imft]), (cerebellum: [bpoc]), (study subjects: [humn]), (vitro adenoviral gene delivery approach: [virs]), (over-express il-6: [aapp,imft]), (cultured cerebellar granule cells: [celc]), (cell adhesion: [celf]), (migration assays: [lbpr]), ( dii: []), (to-pro-3 staining: [orch,phsu]), (immunofluorescence: [lbpr]), (migration: [phpr]), (dendritic spine morphology: [celc]), ( cell apoptosis: [celf]), (synaptic protein expression respectively: [genf]), (study: [resa]), (autistic subjects: [mobd]), (neural cell development: [celf]), (function: [phsf]), (cerebellar granule cells: [bpoc]), (il-6 viral expression vector: [aapp,imft]), (il-6 over-expression: [aapp,imft]), (granule cells: [cell]), (impairments: [patf]), (granule cell adhesion: [celc]), (little effect: [fndg]), (formation: [biof]), (dendritic spines: [celc]), (granule cell apoptosis: [celf]), (however: []), ( il-6 over-expression: [aapp,imft]), (granule cell excitatory synapses: [celc]), (inhibitory synapses: [celc]), (results: [fndg]), (further evidence: []), (aberrant il-6: [aapp,imft]), (elevated il-6: [fndg]), (autistic brain: [mobd]), (neural cell: [cell]), (adhesion: [patf]), ( migration: [phpr]), (imbalance: [sosy]), (excitatory: []), (inhibitory circuits: [acty]), (thus: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(vitro adenoviral gene delivery approach, 'Perinatal History')(autism, 'Autism Phenotype')

PMCID: 3113723
SFARI Genes: DISC1, DISC1, DISC1, DISC1, DISC1, DISC1, DISC1, DISC1, DISC1, DISC1, DISC1, DISC1, 
Non SFARI Genes: 
Named Entities: (disrupted-in-schizophrenia: [mobd]), ((disc1) gene: [gngm]), (promising candidate genes: [gngm]), (major mental disorders: [mobd]), (previous study: [resa]), (finnish group: [popg]), (disc1 polymorphisms: [genf]), (autism: [mobd]), (asperger: []), (however: []), (results: [fndg]), (korean population: [popg]), (disc1: [gngm]), (chinese han population: [popg]), (family-based association study: [socb]), (tag: [gngm]), (polymorphisms (snps): [nusq]), (kb: []), (autism trios (singleton: [aapp,enzy]), (biological parents): [famg]), (individuals: [humn]), (single snp association: [fndg]), (haplotype association analysis: [menp]), (family-based association test (fbat): [socb]), (haploview: []), (snps: [nusq]), (significant associations: [menp]), (autism (rs4366301: g > c: [mobd]), ( z: []), (p: [gngm]), (rs11585959: t > c: [clna]), (rs6668845: a > g: [qnco]), (bonferroni correction: []), ( snp rs4366301: [nusq]), (first intron: [bacs,nnon]), (haplotype: [orga]), (haplotypes: [orga]), (significant association: [menp]), (permutation method: [lbpr]), (empirical p values: [qnco]), (study: [resa]), (evidence: []), (susceptibility gene: [gngm]), (role: [socb]), (pathogenesis: [patf]), 
ASD Terms: (major mental disorders, 'Mental Disorders')(autism, 'Autism Phenotype')(asperger, 'Asperger Syndrome')(autism, 'Autism Phenotype')(autism trios, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3090385
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (several children: [aggp]), (autism show regression: [mobd]), (language: [lang]), (social development: [socb]), (normal motor milestones: [fndg]), (clear period: [fndg]), (normal development: [fndg]), (regression: [menp]), (subsequent improvement: []), (multifactorial etiology: []), (role: [socb]), (inflammation: [patf]), (autism: [mobd]), (major area: []), (study: [resa]), (viral: []), (bacterial infections: [dsyn]), ( hypoxia: [patf]), (medication: [phsu]), (foetus: [tisu]), (infant: [aggp]), (stressors: []), (transcription factors: [aapp,bacs]), (nuclear factor kappa b (nf-b): [aapp,imft]), (master switch: []), (many genes: [gngm]), (tumor necrosis factor (tnf): [aapp,imft]), (hypothesis: []), (nf-b: []), (children: [aggp]), (peripheral blood samples: [bdsu]), (control children: [aggp]), (electrophoretic mobility shift: [lbpr]), ((emsa): [lbpr]), (phosphor imaging technique: [diap]), (values: []), (fold increase: [phpr]), (control sample: [sbst]), (statistical analysis: [resa]), (spss: [gngm]), (significant increase: [qnco]), (nf-b dna: [bacs,nnon]), (activity: [acty]), (cases: [qnco]), (controls (n: [aapp,imft]), (significant difference (3.14: [fndg]), (respectively; p<0.02): [fndg]), (finding: [sosy]), (value: [qnco]), (known biochemical changes: [qnco]), (response: [fndg]), (several kinds: [qnco]), ( autism: [mobd]), (part: [qnco]), (nf-b pathway: [moft]), 
ASD Terms: (autism show regression, 'Autism Phenotype')(social development, 'Ability to Converse in Social Settings')(autism, 'Autism Phenotype')(bacterial infections, 'Bacterial Infections')(medication, 'Medications')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3087757
SFARI Genes: CD26, CD38, CD26, CD38, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (impairments: [patf]), (social behavior: [socb]), ( communication difficulties: [socb]), (occurrence: []), (repetitive: []), (behaviors: [inbe]), (substantial evidence: []), (dysregulation: []), (immune system: [bdsy]), (differences: [qnco]), (number: [qnco]), (phenotype: [orga]), (blood cells: [cell]), (young children: [aggp]), (autism (n: [mobd]), (age-matched controls: [orga]), (children: [aggp]), (confirmed diagnosis: [fndg]), (years: []), (age): [orga]), (low (iq<68: [qnco]), ( n: [aapp,imft]), (high functioning (iq68: [qnco]), (groups: [popg]), (control group: [grup]), (primary: [topp]), (secondary variables: [neop]), (cell counts: [lbpr]), (abundance: []), (cell surface antigens: [imft]), (microvolume laser: [plnt]), (cytometry: [lbpr]), (multiple differences: [qnco]), (immune cell populations: [popg]), (control groups: [grup]), (absolute number: [qnco]), (b cells: [cell]), (volume: [qnco]), (blood: [bdsu]), (nk cells: [cell]), (higher: []), (variables: []), (significant difference: [qnco]), (high functioning autism groups: [popg]), (t cells: [cell]), (cellular activation markers: [clna]), (hla-dr: [aapp,imft]), (cd26: [gngm]), (cd38: [gngm]), (autism group: [mobd]), (results: [fndg]), (previous findings: [clna]), (immune dysfunction: [dsyn]), (further evaluation: [hlca]), (nature: []), (dysfunction: [dsyn]), (role: [socb]), (etiology: []), (facets: [blor]), (autism neuropathology: [mobd]), (behavior: [inbe]), 
ASD Terms: (social behavior, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')(confirmed diagnosis, 'Diagnosis')(cell surface antigens, 'Allergies')(autism, 'Autism Phenotype')(high functioning autism groups, 'Autism Phenotype')(autism group, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism neuropathology, 'Autism Phenotype')

PMCID: 4234331
SFARI Genes: Met, Met, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (lifelong neurodevelopmental disorder: [mobd]), (aims: [phsu]), (study: [resa]), (children: [aggp]), (caries: [dsyn]), (periodontal problems: []), (treatment needs: [topp]), (control group: [grup]), (non-autistic patients: [mobd]), (baseline data: [bodm]), (comparison: [acty]), (future planning: [menp]), (dental services: [topp]), (autistic children: [podg]), (material: [sbst]), (patients: [podg]), (years: []), ((45 males: [orga]), (females): [orga]), (dubai: []), (sharjah autism: [mobd]), (relatives: [famg]), (friends: [popg]), (autistic patients: [mobd]), (attempt: [evnt]), (age: [orga]), ( sex: [orgf]), (socioeconomic status: []), (patient: [podg]), (periodontal examination: []), ( assessment: [acty]), (caries prevalence: [qnco]), (other conditions: [dsyn]), (dental plaque: [dsyn]), ( gingivitis: [dsyn]), ( restorations: []), (chi-square: [qnco]), (fisher's: [mamm]), (exact test: []), (significance: [qnco]), (groups: [popg]), (autism group: [mobd]), (male-tofemale ratio: [orga]), (decayed: [acab]), (teeth: [bpoc]), (unaffected patients: [podg]), (restorative dental treatment: [topp]), (restorative index (ri): [qnco]), (met need index (mni): [qnco]), (respectively: []), (majority: [socb]), ((36/61): []), ((23/61) oral hygiene: [inbe]), (healthy control subjects: [humn]), (likewise: []), ((59/61): []), (gingivitis: [dsyn]), (poor oral hygiene: [fndg]), (extensive unmet needs: [acty]), (dental treatment: [topp]), (non-autistic healthy control group: [grup]), (oral health program: [hlca]), (prevention: [resa]), (particular importance: []), (young people: [popg]), 
ASD Terms: (autism, 'Autism Phenotype')(lifelong neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(future planning, 'Planning')(autism, 'Autism Phenotype')(sharjah autism, 'Autism Phenotype')(autism group, 'Autism Phenotype')(autism, 'Autism Phenotype')(oral hygiene, 'Hygiene')(autism, 'Autism Phenotype')(poor oral hygiene, 'Hygiene')(autism, 'Autism Phenotype')

PMCID: 3083416
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (heterogeneity: [orga]), (symptoms: [sosy]), (autism spectrum disorders: [mobd]), (significant challenge: [hlca]), (genetic analyses: [lbpr]), (associations: [menp]), (genetic variants: [npop]), (specific trait: [orga]), (characteristic: []), (autism: [mobd]), (here: []), (quantitative trait analyses: [resa]), (asd symptoms: [cgab]), (case-control association analyses: [menp]), (distinct asd subphenotypes: [cgab]), (basis: [phsu]), (symptomatic profiles: [lbpr]), (identification: [menp]), (significant associations: [menp]), (novel single nucleotide polymorphisms: [nusq]), (symptom categories: [clna]), (deficits: []), (language: [lang]), (usage: []), ( non-verbal communication: [menp]), (social development: [socb]), (skills: [inbe]), (insistence: []), (sameness: []), (ritualistic behaviors: []), (trait-associated snps: [nusq]), (quantitative trait loci (qtl): [gngm]), (subtype: []), (partial replication: [genf]), (identified qtl: [gngm]), (notably: []), ( none: []), (novel snps: [nusq]), (exonic region: [bacs,nnon]), (hereditary components: []), (asds: [cgab]), (gene: [gngm]), (regulatory processes: [biof]), (gene expression): [genf]), (functional changes: [topp]), (gene products: [aapp,bacs]), (qtl reside: [gngm]), (intergenic chromosomal regions: [celc]), (rare copy number variants: [nusq]), (autistic samples: [mobd]), (pathway analyses: []), (genes: [gngm]), (qtl: [gngm]), (study: [resa]), (neurological functions: [ortf]), (disorders: [dsyn]), (autism pathophysiology: [mobd]), (advantage: []), (quantitative traits: [gngm]), (subphenotypes: []), (large-scale genome-wide analyses: [gngm]), (complex disorders: [dsyn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(asd symptoms, 'Complaints and Indications')(included deficits in language, 'Language Ability')(social development, 'Ability to Converse in Social Settings')(autism spectrum disorders, 'Autism Phenotype')(neurological functions, 'Neurologic Indications')(autism pathophysiology, 'Autism Phenotype')

PMCID: 3104945
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autoimmunity: [patf]), (central nervous system (cns): [bdsy]), (pathogenic role: [socb]), (subgroup: [virs]), (patients: [podg]), (autism: [mobd]), (study: [resa]), (frequency: [qnco]), (serum anti-ganglioside m1 auto-antibodies: [aapp,imft]), (indicators: [irda]), (presence: [qnco]), (cns: [bdsy]), (group: [popg]), (autistic children: [podg]), (relationship: []), (antibodies: [aapp,imft]), (degree: [qnco]), (severity: []), (serum: [bdsu]), (anti-ganglioside m1 antibodies: [aapp,imft]), (elisa: [lbpr]), (years: []), (comparison: [acty]), (healthy-matched children: [fndg]), (autistic severity: [mobd]), (childhood autism rating scale (cars): [mobd]), (serum levels: [bdsu]), (healthy children: [fndg]), (seropositivity: []), ((40/54): [qnco]), (severe autism (63%): [fndg]), (autism (37%): [mobd]), ( p: [aapp,imft]), (moreover: []), (significant positive correlations: [fndg]), (cars (p: [aapp,enzy]), (many autistic children: [podg]), (also: []), (levels: []), (thus: []), ( autism: [mobd]), (pediatric autoimmune: [patf]), (neuropsychiatric disorders: [dsyn]), (wide-scale studies: [lbpr]), (light: [gngm]), (possible etiopathogenic role: [socb]), (anti-ganglioside m1 auto-antibodies: [aapp,imft]), (role: [socb]), (immunotherapy: [topp]), (autistic patients: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(severe autism, 'Autism Phenotype')(moderate autism, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3107800
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (backgrounds autism: [mobd]), (family: [famg]), (developmental disorders: [mobd]), (unknown origin: []), (disorder: [dsyn]), (behavioral: [inbe]), ( developmental: [orgf]), (sensory abnormalities: [cgab]), (ages: [bacs,orch]), (peak prevalence rates: [qnco]), (children: [aggp]), (5-8 years: [qnco]), (recently: []), (interest: [menp]), (role: [socb]), (plasma free fatty acids (fa): [bdsu]), (pathology: [patf]), (neurological disorders: [dsyn]), (aim: [phsu]), (study: [resa]), (plasma fatty acid profiles: [bdsu]), (saudi: []), (autistic patients: [mobd]), (age-matching control: [sbst]), (attempt: [evnt]), (fa: [gngm]), (etiology: []), (autism: [mobd]), (26-age-matching controls: [sbst]), (present study: [qnco]), (methyl esters: [orch]), (hexane: [hops,orch]), (fatty acid composition: [orch]), (extract: [sbst]), (gas chromatography: [lbpr]), (data: [euka]), (fatty acids: [orch]), (plasma: [bdsu]), (increase: []), (saturated fatty acids: [food,orch]), (propionic acid: [orch]), (decrease: [qnco]), (polyunsaturated fatty acids: [bacs,orch]), (altered fatty acid profile: [orch]), (relation: [socb]), (stress: [fndg]), ( mitochondrial dysfunction: [fndg]), (high lead (pb) concentration: [menp]), (statistical analysis: [resa]), (data shows: [euka]), (age: [orga]), (controls: [sbst]), (operating characteristic (roc) curve analysis: [qnco]), (satisfactory values: []), (area: []), (curve (auc): [qnco]), (high degree: [qnco]), (specificity: [qnco]), (sensitivity: [patf]), (altered fatty acids: [orch]), (biomarkers: [clna]), (saudi arabia: []), 
ASD Terms: (backgrounds autism, 'Autism Phenotype')(sensory abnormalities, 'Reaction to Sensory Stimuli')(neurological disorders, 'Neurologic Indications')(autism, 'Autism Phenotype')

PMCID: 3090611
SFARI Genes: Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (range: [qnco]), (disorders: [dsyn]), (share: [socb]), (core: [bdsu]), (neurobehavioural deficits: []), (widespread abnormalities: [cgab]), (social interactions: [fndg]), ( deficits: []), (communication: [socb]), (interests: [menp]), (repetitive behaviours: [inbe]), (neurological basis: [phsu]), (circuitry mechanisms: []), (abnormal behaviours: [mobd]), (shank3: [gngm]), (postsynaptic protein: [aapp,bacs]), (disruption: []), (genetic level: [phsu]), (development: [orgf]), (deletion: [genf]), ((phelan-mcdermid syndrome): [dsyn]), (other non-syndromic asds: [cgab]), (mice: [mamm]), (shank3 gene deletions: [genf]), (self-injurious repetitive grooming: [inbe]), (deficits: []), (social interaction: [fndg]), (cellular: [cell]), (biochemical analyses: [resa]), (uncovered defects: []), (striatal synapses: [bpoc]), (cortico-striatal circuits: [bpoc]), (shank3 mutant mice: [mamm]), (findings: [clna]), (critical role: [socb]), (normal development: [fndg]), (neuronal connectivity: [imft]), (causality: []), (shank3 gene: [gngm]), (genesis: [gngm]), (autistic like-behaviours: [mobd]), 
ASD Terms: (social interactions, 'Reciprocal Social Interaction')(autism spectrum disorders, 'Autism Phenotype')(repetitive behaviours, 'Restricted and Repetitive Behavior')(neurological basis, 'Neurologic Indications')(abnormal behaviours, 'Personal Traits')(other non-syndromic autism spectrum disorders, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(self-injurious repetitive grooming, 'Self-Injurious Behavior')

PMCID: 3043069
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autistic spectrum disorder (asd): [mobd]), (impaired language: [lang]), ( communication: [socb]), (social skills: [socb]), (repetitive: []), (stereotypic patterns: [menp]), (behavior: [inbe]), (many autistic subjects: [mobd]), (dysregulation: []), (immune system: [bdsy]), (unresolved viral infection: [dsyn]), (prenatal onset: [fndg]), (vertical viral transmission: [patf]), (xenotropic murine leukemia: [mamm]), (virus-related virus (xmrv): [virs]), (chronic fatigue syndrome (cfs): [dsyn]), (prostate cancer: [neop]), (several: [qnco]), (studies: [lbpr]), (methodology/principal findings: [clna]), (xmrv: [virs]), (other murine leukemia: [mamm]), ((mlv)-related viruses: [virs]), (autistic disorder: [mobd]), (pcr: [mbrt]), (genomic sequences: [nusq]), (dna samples: [bacs,nnon]), ((i) peripheral blood: [inch]), (asd patients: [cgab]), (controls: [sbst]), ((ii) post-mortem brain samples: [bpoc]), (age-matched controls: [orga]), ( (iii) semen samples: [bdsu]), (fathers: [famg]), (asd: [cgab]), (infertile individuals: [patf]), (fertile controls: [topp]), (xmrv gag dna sequences: [nusq]), (detected: [fndg]), ( whereas peripheral blood samples: [bdsu]), ((3.1%) controls: [sbst]), (mlv: [virs]), (conclusions|significance: [qnco]), (mlv-related virus: [virs]), (blood: [bdsu]), ( brain: [bpoc]), (semen samples: [bdsu]), (hence infection: [dsyn]), (other mlv-related viruses: [virs]), (pathogenesis: [patf]), 
ASD Terms: (social skills, 'Ability to Converse in Social Settings')(stereotypic patterns, 'Stereotyped, Restricted, and Repetitive Behavior')(autistic spectrum disorder, 'Autistic Disorder')(impaired language, 'Language Ability')(prenatal onset, 'Onset of Symptoms')(unresolved viral infection, 'Virus Diseases')(virus-related virus, 'Virus Diseases')(other murine leukemia virus, 'Virus Diseases')(autistic disorder, 'Autistic Disorder')(virus-related virus gag dna sequences, 'Virus Diseases')(mlv-related virus, 'Virus Diseases')(autism pathogenesis, 'Autism Phenotype')

PMCID: 3043074
SFARI Genes: Fmr1, Fmr1, Fmr1, Fmr1, 
Non SFARI Genes: 
Named Entities: (animal models: [anim]), (autism spectrum disorders: [mobd]), (good construct validity: []), (genetic models: []), (pathologies: []), (asd-like deficits: [cgab]), (known causes: []), (promising strategy: [menp]), (fmr1-ko mouse: [mamm]), (example: []), (approach: []), (fragile x: [comd]), (well-known genetic disorder: [dsyn]), (asd symptoms: [cgab]), (fmr1-ko: [bdsy]), (different genetic backgrounds: [orga]), (versus c57bl/6): [mamm]), (conflicting results: [inbe]), (mutants: [comd]), (fmr1 ko: [bdsy]), (wild-type littermates: [gngm]), (fvb: [mamm]), (c57bl/6: [mamm]), (genetic backgrounds: [orga]), (battery: [inpo]), (tests: [lbpr]), (clinical symptoms: [sosy]), (asd: [cgab]), (triad: [bodm,orch]), (core symptoms (alterations: [sosy]), (social interaction: [fndg]), (communication: [socb]), ( presence: [qnco]), (repetitive behaviors): [fndg]), (secondary symptoms (disturbances: [neop]), (sensori-motor reactivity: []), (circadian patterns: []), (activity: [acty]), ( epileptic events): [dsyn]), (fmr1-ko mice: [mamm]), (autistic-like core symptoms: [mobd]), (altered social interaction: [fndg]), (occurrence: []), (repetitive behaviors: [fndg]), (additional hyperactivity: [mobd]), (genetic background: [orga]), (effects: []), (fmr1 deletion: [genf]), (c57bl/6 background: [mamm]), (further research: [resa]), (core autistic-like symptoms: [mobd]), (fmr1-mouse line: [mamm]), (main core: [bdsu]), (secondary asd symptoms: [cgab]), (neurobiological mechanisms: []), (specific asd-like endophenotypes: [cgab]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(fragile x, 'Fragile X Syndrome')(asd symptoms, 'Complaints and Indications')(clinical symptoms of asd, 'Complaints and Indications')(altered social interaction, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(additional hyperactivity, 'Overactivity')(secondary asd symptoms, 'Complaints and Indications')

PMCID: 3041792
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (many previous studies: [lbpr]), (variants: []), (guilt-by-association: [menp]), ( gene function predictions: [genf]), (high statistical confidence: [qnco]), (studies: [lbpr]), (associations: [menp]), (data (e.g.: [euka]), ( protein interaction partners): [famg]), (gene: [gngm]), (guilt: [menp]), (paper: []), (multifunctionality: []), (association: [menp]), (primary driver: [popg]), (gene function prediction: [genf]), (knowledge: []), (degree: [qnco]), (strong performance: [inbe]), (predictor: []), (gene function: [genf]), (gene interaction data: [euka]), (protein interactions: [moft]), (coexpression networks): []), (gene function prediction algorithms: [genf]), (high-quality gene function predictions: [genf]), (data: [euka]), (information: []), (gene interacts: [gngm]), (which: []), (wide range: [qnco]), (networks: []), (yeast: [fngs]), (multiple prediction methods: [topp]), (evaluation metrics: [orch,phsu]), (evidence: []), (problem: [fndg]), (failings: []), (particular algorithm: [lbpr]), (data type: []), (computational controls: [sbst]), (meaningful control: [sbst]), (gene function prediction performance: [gngm]), (source: [fndg]), (bias: [bird]), (for: []), (widespread implications: []), (interpretation: [clna]), (genomics: []), 
ASD Terms: (computational controls, 'Isolated Cognitive Skills')

PMCID: 3040743
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (causal role: [socb]), (mutations: [genf]), (multiple general transcription factors: [aapp,bacs]), (neurodevelopmental disorders: [mobd]), (autism: [mobd]), (alterations: []), (global levels: []), (gene expression regulation: [genf]), (risk: []), (sporadic cases: [qnco]), (premise: []), (changes: [qnco]), (overall distribution: []), (gene expression levels: [genf]), (instance: []), (mice: [mamm]), ( variability: []), (hippocampal-dependent behaviors: [inbe]), (variability: []), (pattern: []), (variance: [qnco]), (distribution: []), (hippocampus: [bpoc]), (similar change: [qnco]), (children: [aggp]), (gene expression microarrays: [mbrt]), (unique rna transcripts: [nnon]), (rna: [nnon]), (peripheral blood lymphocytes: [cell]), (autism (n: [mobd]), (controls (n: [aapp,imft]), (microarray: []), (groups: [popg]), (risk factor: [qnco]), (paternal age: []), (decrease: [qnco]), (pbl: [cell]), (diagnosis: [fndg]), (traditional approaches: []), (analysis: [resa]), (gene expression: [genf]), (possible mechanism: []), (decreased variance: [qnco]), (gene expression pathways: [genf]), (transcriptional regulation: [genf]), (blood: [bdsu]), (fathers: [famg]), (thus: []), ( results: [fndg]), (gene: [gngm]), (specific approaches: []), (microarray data: [euka]), (hypothesis: []), (global level: [phsu]), (global regulation: [biof]), (transcription: [genf]), ( thus: []), (possible point: [qnco]), (convergence: [acty]), (multiple etiologies: []), (other neurodevelopmental disorders: [mobd]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(other neurodevelopmental disorders, 'Learning Disorders')

PMCID: 3040206
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (pervasive neurodevelopmental disorder: [mobd]), (deficits: []), (social behavior: [socb]), (interpersonal communication: [socb]), (stereotyped: [menp]), ( repetitive behaviors: [fndg]), (towards males: [orga]), (ratio: [qnco]), (41: []), (clear understanding: [menp]), (sex hormones: [horm,phsu]), (role: [socb]), (autism susceptibility: [clna]), (male: [orga]), (female hormones: [lbtr]), (expression: [topp]), (novel autism candidate gene: [mobd]), (acid-related orphan receptor-alpha (rora): [chem]), (neuronal cell: [gngm]), (sh-sy5y: []), (addition: []), (rora: [gngm]), (enzyme: [enzy,orch]), (testosterone: [horm,orch,phsu]), (aromatase protein: [aapp,enzy]), (frontal cortex: [bpoc]), (autistic subjects: [mobd]), (age-matched controls: [orga]), (rora protein levels: [lbtr]), (brain: [bpoc]), (results: [fndg]), (positive feedback regulation: [phpr]), ( respectively: []), (transcriptional targets: [genf]), ( aromatase: [aapp,enzy]), (mechanism: []), (sex bias: [socb]), (autism: [mobd]), 
ASD Terms: (social behavior, 'Reciprocal Social Interaction')(autism susceptibility, 'Autism Phenotype')(pervasive neurodevelopmental disorder, 'Learning Disorders')(stereotyped, 'Stereotyped, Restricted, and Repetitive Behavior')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(novel autism candidate gene, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3077925
SFARI Genes: CaV1.2, CaV1.2, 
Non SFARI Genes: 
Named Entities: (individuals: [humn]), (congenital: []), (prolongation: []), (qt interval: [clna]), (long qt syndrome (lqts): [dsyn]), (risk: []), (life: []), (ventricular arrhythmia: [patf]), (lqts: []), (origin: []), (environmental factors1: []), (missense mutation: [genf]), (l-type calcium channel cav1.2: [aapp,bacs]), (patients: [podg]), (timothy: [plnt]), (effect: []), (ts mutation: [genf]), (electrical activity: [ortf]), (contraction: [patf]), (human cardiomyocytes: [humn]), (human skin cells: [bdsy]), (ts patients: [podg]), (induced pluripotent stem cells: [cell]), (cells: [cell]), (cms: [gngm]), (electrophysiological recording: [diap]), (calcium (ca2+): [bacs,elii,phsu]), (studies: [lbpr]), (irregular contraction: [patf]), (excess ca2+ influx: [elii,phsu]), (action potentials: [celf]), (irregular electrical activity: [ortf]), (abnormal calcium transients: [fndg]), (ventricular-like cells: [bpoc]), (roscovitine: [orch,phsu]), (compound: [chem]), (voltage-dependent inactivation (vdi): [qnco]), (cav1.268: [aapp,bacs]), (ca2+: [elii,phsu]), (properties: []), (study: [resa]), (new avenues: []), (cellular mechanisms: [cell]), (cardiac arrhythmias: [fndg]), (humans: [humn]), (robust assay: [lbpr]), (new drugs: [phsu]), (diseases: [dsyn]), 
ASD Terms: 

PMCID: 3060452
SFARI Genes: CaV1.2, CaV1.2, CaV1.2, CaV1.2, 
Non SFARI Genes: 
Named Entities: (cav1.2 calcium channels: [aapp,bacs]), (roles: [socb]), (diverse cellular processes: [celf]), (gene: [gngm]), (muscle contraction: [phsf]), (membrane excitation: [celc]), (activity: [acty]), (extensive alternative splicing: [genf]), (cav1.2 mrna: [bacs,nnon]), (exclusive exons: [bacs,nnon]), (encode alternate forms: [acty]), (transmembrane segment: [celc]), ((is6): []), (channel domain: []), (human genetic disorder timothy syndrome: [humn]), (mutations: [genf]), (cav1.2: [gngm]), (ca2+ homeostasis: [biof]), (severe pleiotropic disease phenotypes: [orga]), (tissue-specific pattern: [bdsu]), (leads: [elii,hops]), (differences: [qnco]), (symptoms: [sosy]), (patients: [podg]), (mechanisms: []), (exon: [bacs,nnon]), (splicing choice: [inbe]), (spectrum: [qnco]), (defects: []), (disease: [dsyn]), (polypyrimidine tract-binding protein (ptb): [aapp,bacs]), (switch: []), (splicing: [genf]), (ptb: [gngm]), (neuronal homolog: [gngm]), ( nptb: [gngm]), (regulators: []), (large sets: [menp]), (alternative exons: [bacs,nnon]), (neuronal development: [celf]), ( ptb expression: [topp]), (concurrent increase: []), (nptb expression: [topp]), (embryonic mouse brain: [tisu]), (neuronal differentiation: [fndg]), (repression: [menp]), (direct binding: [moft]), (elements: [elii]), (nptb protein: [aapp,bacs]), (repressor: [aapp,bacs]), (shift: [phpr]), (exon choice: [bacs,nnon]), (nptb replaces ptb: [gngm]), (cells: [cell]), (results: [fndg]), (mechanistic understanding: [menp]), (human disease: [humn]), (controlled: [fndg]), 
ASD Terms: 

PMCID: 3042898
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (post-genomic era: [gngm]), ( multi-faceted research: [resa]), (complex disorders: [dsyn]), (autism: [mobd]), (diverse types: []), (molecular information: []), (pathogenesis: [patf]), (rapid accumulation: [fndg]), (putative candidate genes/loci: [gngm]), (autism spectrum disorders (asd): [mobd]), (asd-related: [cgab]), (animal models: [anim]), (major challenge: [hlca]), (systematic analysis: []), (content: [menp]), (autism database (autdb): [mobd]), (available web portal: [blor]), (collection: []), (manual annotation: [inpr,mnob]), (visualization: [menp]), (genes: [gngm]), (asd: [cgab]), (here: []), (design: [acty]), ( development: [orgf]), (integration: [genf]), (new module: []), (autdb: []), (comprehensive cataloguing: []), (asd-related animal models: [cgab]), (description: []), (original autdb: []), (data: [euka]), (published: []), ( peer-reviewed scientific literature: [hlca]), (new standardized vocabulary: []), (phenotypic terms: [orgf]), (researchers: []), (diverse clinical manifestations: []), (new animal model module: [emod]), (dissemination: []), (diverse information: []), (animal model entries: [emod]), (candidate genes: [gngm]), (original "human gene" module: [humn]), (resource: []), (cross-modal navigation: [acty]), (gene models: [gngm]), (human gene studies: [gngm]), (current release: [hlca]), (animal model module: [emod]), (models: []), (expandable framework: []), (additional species: []), (non-genetic etiological models: []), (future: []), (importantly: []), (modular asd database: [cgab]), (platform: []), (data mining: [mcha]), (and/or computational biology strategies: [menp]), (predictive disease models: [dsyn]), (further insights: [menp]), (molecular underpinnings: []), (disorder: [dsyn]), (general model: [hlca]), (disease-driven databases: [dsyn]), (phenotypic characteristics: [orga]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(visualization, 'Visual Thinking')(autism database, 'Autism Phenotype')(autism database, 'Autism Phenotype')(original autism database, 'Autism Phenotype')(autism database, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3023760
SFARI Genes: c3orf58, c3orf58, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (group: [popg]), (occurring: [acty]), ( highly-heritable developmental disabilities: [mobd]), (human genes c3orf58: [gngm]), (autism-1 (dia1): [mobd]), (cxorf36: [gngm]), (autism-1 related (dia1r): [mobd]), (asd: [cgab]), (mental retardation: [mobd]), (gene products: [aapp,bacs]), (signal peptides: [amas]), (secretory pathway: [celf]), (evolutionary medicine: [genf]), (key tool: []), (numbers: [qnco]), (human diseases: [humn]), (evolutionary approach: [genf]), (dia1: [gngm]), (dia1r: [gngm]), (cnidarians: [euka]), (dia1 evolution: [genf]), (development: [orgf]), (first primitive synapses: [bsoj]), (nematodes: [euka]), (dia1 homologue: [gngm]), (caenorhabditis elegans: [euka]), (aspects: [qnco]), (zebrafish encode: [fish]), (dia1 paralogues: []), (contrast: [irda]), ( dia1r: [gngm]), (vertebrates: [vtbt]), (origin: []), (whole-genome duplication events: [gngm]), (vertebrate lineage: [vtbt]), (evolution: [genf]), (complex vertebrate: [vtbt]), (nervous system: [bdsy]), (strikingly: []), (fish: [gngm]), (solitary lifestyle: [socb]), (additional dia1-related gene: [gngm]), (dia1-like (dia1l): []), (signal peptide: [amas]), (genomes: [gngm]), (echinoderm strongylocentrotus purpuratus: [euka]), (cephalochordate branchiostoma floridae: [euka]), (evidence: []), (remarkable dia1l gene expansion: [gngm]), (b. floridae: []), (amino: []), (acid alignments: [chem]), (dia1 family gene products: [famg]), (potential golgi-retention motif: [celc]), (number: [qnco]), (conserved motifs: [amas]), (unknown function: [phsf]), (furthermore: []), (glycine: [aapp,bacs,phsu]), (cysteine residues: [aapp,bacs]), (dia1-family proteins: [famg]), (critical role: [socb]), (protein structure: [aapp]), (function: [phsf]), (new metazoan protein: [aapp,bacs]), (dia1-family: [famg]), (biological roles: [socb]), (dia1-family members: [famg]), (implications: []), (understanding: [menp]), (autism: [mobd]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(highly-heritable developmental disabilities, 'Learning Disorders')(mental retardation, 'Mental Retardation')(autism, 'Autism Phenotype')

PMCID: 3029221
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (diphenyl ethers: [orch]), (flame retardants: [chvf]), (amounts: [qnco]), (u.s: []), (last few decades: [qnco]), (pbdes: [orch]), (metabolites: [bacs]), (placenta: [emst]), (studies: [lbpr]), (rodents: [mamm]), (demonstrate neurodevelopmental toxicity: [inpo]), (prenatal exposures: [fndg]), (pbde: [orch]), (breastfeeding: [orgf]), (hand-to-mouth activities: [bpoc]), (small children: [aggp]), (participants: [popg]), (children: [aggp]), (charge (childhood autism risk: [mobd]), (genetics: []), (environment) study: [resa]), (case-control epidemiologic investigation: [hlca]), (autism/autism spectrum disorder: [mobd]), (developmental delay: [mobd]), (general population: [popg]), (diagnoses: [fndg]), (autism: [mobd]), (autism diagnostic observation schedule: [hlca]), (autism diagnostic inventory-revised: [mobd]), (mullen's scales: [plnt]), (early learning: [menp]), (vineland adaptive behavior scales: []), (controls: [sbst]), (evidence: []), (delay: []), ( autism: [mobd]), (autism spectrum disorder: [mobd]), (pbde congeners: [orch]), (gas chromatography/mass spectrometry: [lbpr]), (serum specimens: [bdsu]), (assessed: [acty]), (logistic regression: [resa]), (association: [menp]), (plasma pbdes: [orch]), (levels: []), (groups: [popg]), (plasma samples: [bdsu]), (post-diagnosis: [fndg]), (study: [resa]), (early life exposures: [phpr]), (changes: [qnco]), (introduction: [hlca]), (new household products: [famg]), (direct measurements: []), (prenatal: [aggp]), (infant exposures: [aggp]), (possible causal role: [socb]), (compounds: [chem]), (autism spectrum disorders: [mobd]), 
ASD Terms: (flame retardants, 'Mental Retardation')(prenatal exposures, 'Exposures')(neurodevelopmental toxicity, 'Learning Disorders')(demonstrate neurodevelopmental toxicity, 'Learning Disorders')(with developmental delay, 'Learning Disorders')(developmental delay, 'Learning Disorders')(autism, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(autism diagnostic inventory-revised, 'Autism Phenotype')(vineland adaptive behavior scales, 'Adaptive Life Skills')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(early life exposures, 'Exposures')(autism spectrum disorders, 'Autism Phenotype')(infant exposures, 'Exposures')

PMCID: 3006426
SFARI Genes: Pax6, Pax6, Pax6, Pax6, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (variable brain: [bpoc]), (developmental disorder: [mobd]), (strong genetic basis: [phsu]), (pax6: [gngm]), (pivotal player: []), (brain development: [ortf]), (maintenance: [acty]), (adult neural stem cells: [cell]), (astrocytes: [cell]), (entire central nervous system: [bdsy]), (neurons: [cell]), (olfactory bulb: [bpoc]), ( amygdala: [bpoc]), ( thalamus: [bpoc]), (cerebellum: [bpoc]), ( functioning: []), (context-dependent manners: [fndg]), (heterozygous mutant (rsey2/+) rats: [mamm]), (spontaneous mutation: [genf]), (pax6 gene: [gngm]), ( show: [anim]), (prepulse inhibition (ppi): [phsf]), (present study: [qnco]), (examined behaviors: [inbe]), (rsey2/+ rats: [mamm]), (abnormality: [fndg]), (social interaction: [fndg]), (aggression: [mobd]), (withdrawal): [acty]), (addition: []), (activity: [acty]), (fear-conditioned memory: [menp]), (ultrasonic vocalization (usv): [npop]), (rsey2+ rat pups: [mamm]), (male: [orga]), (female: [orga]), (moreover: []), ( treatment: [topp]), (clozapine: [orch,phsu]), (defects: []), (sensorimotor: []), (function: [phsf]), (prior human genetic data: [inpr,resa]), (results: [fndg]), (other literatures: []), ( rsey2/+ rats: [mamm]), (phenotypic components: [orga]), 
ASD Terms: (autism, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(fear-conditioned memory, 'Working Memory')(ultrasonic vocalization, 'Vocalizations')(autism, 'Autism Phenotype')

PMCID: 3114825
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (environmental causes: []), (factors: []), (autism: [mobd]), (basic science: [resa]), (epidemiologic research: [resa]), (oxidative stress: [comd]), (inflammation: [patf]), (role: [socb]), (disease development: [dsyn]), (traffic-related air: [inch,phsu]), (common exposure: [clna]), (effects: []), (pathways: [moft]), (substances: [sbst]), (adverse prenatal effects: [patf]), (association: [menp]), (proximity: []), (residence: []), (freeways: []), (major roadways: []), (pregnancy: [orgf]), (time: []), (delivery: [topp]), (surrogate: [famg]), (air pollution exposure: [eehu]), (data: [euka]), (autism cases: [mobd]), (controls: [sbst]), (childhood autism risks: [mobd]), (genetics: []), (environment (charge) study: [orga]), (mothers address: [famg]), (birth certificate: [clna]), (trimester-specific addresses: []), (residential history: [orga]), (questionnaire: []), (measures: [qnco]), (distance: [qnco]), (major roads: []), (arcgis software: [inpr,mnob]), (logistic regression models: [inpr,qnco]), (residential proximity: [humn]), (sociodemographic factors: []), (maternal smoking: [inbe]), (maternal residence: [famg]), (freeway: []), (m): [aapp,imft]), (cases: [qnco]), (controls [odds: [sbst]), ((or) =: []), (confidence interval: [qnco]), (third trimester (or: []), (ci: [gngm]), (adjustment: [inbe]), (sociodemographic characteristics: []), (associations: [menp]), (other major roads: []), (birth: [orgf]), (examination: []), (measured air pollutants: [hops]), 
ASD Terms: (autism, 'Autism Phenotype')(common exposure, 'Exposures')(autism, 'Autism Phenotype')(delivery, 'Perinatal History')(air pollution exposure, 'Exposures')(childhood autism risks, 'Autism Phenotype')(autism cases, 'Autism Phenotype')(autism cases, 'Autism Phenotype')(delivery, 'Perinatal History')(maternal smoking, 'Smoking')

PMCID: 3116738
SFARI Genes: Met, Met, MET, MET, Met, Met, MET, MET, MET, MET, 
Non SFARI Genes: 
Named Entities: (met receptor tyrosine kinase: [aapp,enzy,rcpt]), (growth: [orgf]), (development: [orgf]), (axons: [celc]), (wiring: [topp]), (limbic circuits: []), (rodent forebrain: [mamm]), (orthologous met receptor functions: [phsf]), (primate forebrain: [mamm]), (considerable interest: [menp]), (association: [menp]), (variant met alleles: [gngm]), (communication phenotypes: [socb]), (autism: [mobd]), (question: []), (met/met protein expression: [aapp,rcpt]), (developing mouse: [mamm]), (rhesus macaque forebrain: [mamm]), (strong temporal conservation: []), (expression: [topp]), (time: []), (rapid axon development: [celf]), (onset: [qnco]), (robust synapse formation: [ortf]), (expression patterns: [topp]), (met/met: [dsyn]), (limbic-related structures: [fndg]), (species: []), (marked contrast: [irda]), (divergent expression: [topp]), (neocortex: [bpoc]), (mouse: [mamm]), ( met: [dsyn]), (macaque: [mamm]), (robust met expression: [topp]), (posterior cingulate: [bpoc]), (inferior temporal: [socb]), (posterior parietal: []), (visual cortices: [bpoc]), (face processing regions: [blor]), (pattern: []), (importance: []), (vision: [orgf]), (social repertoire: []), (primate: [mamm]), (collectively: []), (data: [euka]), (conserved developmental function: [phsf]), (met receptor: [aapp,rcpt]), (neocortical circuits: []), (species-appropriate responses: [orga]), (social behavior: [socb]), 
ASD Terms: (autism, 'Autism Phenotype')(onset, 'Onset of Symptoms')(visual cortices, 'Visual Thinking')(face processing regions, 'Integrated Verbal and NonVerbal Communication')(social behavior, 'Reciprocal Social Interaction')

PMCID: 3001695
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (neurodevelopmental disorders: [mobd]), (difficulties: [fndg]), (communication: [socb]), ( cognitive: []), (deficits: []), (stereotypic behaviors: [mobd]), (majority: [socb]), (cases: [qnco]), (reliable biomarkers: [clna]), (distinct pathogenesis: [patf]), (however: []), (evidence indicates asd: [cgab]), (immune dysregulation: [fndg]), (neuroimmune component: []), (peptide neurotensin (nt): [aapp,horm]), (autistic children: [podg]), (nt: [diap]), (release: [hlca]), (extracellular mitochondrial dna (mtdna): [bacs,nnon]), ("autoimmune" trigger: [clna]), (serum: [bdsu]), (young autistic patients: [mobd]), (mtdna (n =: [bacs,nnon]), (cytochrome b: [aapp,enzy]), ( p: [aapp,imft]), (p =: [aapp,imft]), (anti-mitochondrial antibody type: [aapp,imft]), ((n: [aapp,imft]), (p: [gngm]), (unrelated controls: [sbst]), (extracellular blood mtdna: [bacs,nnon]), (other components: []), (autistic endophenotype: [mobd]), (pathogenesis: [patf]), (autoimmune responses: [patf]), 
ASD Terms: (cognitive, 'Cognitive Ability')(learning deficits, 'Learning Disorders')(stereotypic behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorders, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(cognitive, 'Cognitive Ability')

PMCID: 3057962
SFARI Genes: MECP2, MECP2, RTT, RTT, Mecp2, RTT, Mecp2, RTT, RTT, RTT, 
Non SFARI Genes: 
Named Entities: (summary mutations: [genf]), (x-linked mecp2: [aapp,bacs]), (transcriptional regulator: [genf]), (methyl-cpg-binding protein: [gngm]), ((mecp2) cause rett syndrome (rtt): [dsyn]), (several neurodevelopmental disorders: [mobd]), (cognitive disorders: [mobd]), (juvenile-onset schizophrenia: [mobd]), (encephalopathy: [dsyn]), (early lethality: [fndg]), (rtt: [gngm]), (normal early development: [fndg]), (regression: [menp]), ( motor abnormalities: [fndg]), ( seizures: [sosy]), (features: []), (autism: [mobd]), (behaviors: [inbe]), (mechanisms: []), (striking features: []), (mice: [mamm]), (mecp2: [gngm]), (-amino-butyric-acid-(gaba)-ergic neurons: [cell]), (numerous rtt: [dsyn]), (autistic features: [mobd]), (repetitive behaviors: [fndg]), (loss: [qnco]), (subset: []), (forebrain gabaergic neurons: [bpoc]), (many features: []), (mecp2-deficient gabaergic neurons: [aapp,bacs]), (reduced inhibitory quantal size consistent: [acty]), (presynaptic reduction: [npop]), (glutamic acid decarboxylase-1: [lbpr]), (-2 levels: []), (gaba immunoreactivity: [aapp,bacs]), (data demonstrate: [euka]), (normal gabaergic: [fndg]), (neuronal function: [phsf]), (subtle dysfunction: [dsyn]), (gabaergic neurons: [cell]), (numerous neuropsychiatric phenotypes: [orga]), 
ASD Terms: (cognitive disorders, 'Cognitive Ability')(autism, 'Autism Phenotype')(juvenile-onset schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(cause rett syndrome, 'Rett Syndrome')(several neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')(motor abnormalities, 'Motor Skills')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 2987909
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (disorder: [dsyn]), (early childhood: []), (social impairment: [patf]), ( communication abnormalities: [socb]), (behaviors: [inbe]), (hypothalamic-pituitary-adrenocortical (hpa) axis: [bdsy]), (special attention: [menp]), (basis: [phsu]), (emotions: [menp]), (social interactions: [fndg]), (basal: []), (plasma cortisol: [lbpr]), (adrenocorticotropic hormone (acth) levels: [lbpr]), (autistic children: [podg]), (relationship: []), (characteristics: []), (fifty: [qnco]), (comparison: [acty]), (healthy age-: [orga]), ( sex-: [orgf]), (pubertal stage-: [fndg]), (children: [aggp]), (subjects: [humn]), (clinical evaluation: [hlca]), (measurement: []), (plasma cortisol (basal: [lbpr]), (stimulated): [npop]), (acth: [gngm]), (addition: []), ( electroencephalography (eeg): [diap]), (intelligence quotient: [orga]), ((iq) assessment: [acty]), (sixteen%: [qnco]), (autistic patients: [mobd]), (high acth: [horm,phsu]), (low basal cortisol: [fndg]), (adequate cortisol response: [horm,orch,phsu]), (acth stimulation: [npop]), (basal (p: [aapp,imft]), (cortisol (p: [horm,orch,phsu]), (acth (p: [horm,phsu]), (controls: [sbst]), (childhood autism rating scale (cars) score: [mobd]), (acth (r: [horm,phsu]), (p =: [aapp,imft]), (basal (r = -0.64: [fndg]), ( p: [aapp,imft]), (cortisol (r = -0.88: [horm,orch,phsu]), (hormonal profile: [lbpr]), (relation: [socb]), (eeg abnormalities: [fndg]), ( iq: []), (self- aggressive symptoms: [mobd]), (observed hormonal changes: [fndg]), (dysfunction: [dsyn]), (hpa axis: [bpoc]), (autistic individuals: [mobd]), (further studies: [lbpr]), (role: [socb]), (hpa: [gngm]), (axis dysfunction: [bpoc]), (pathogenesis: [patf]), 
ASD Terms: (autism, 'Autism Phenotype')(social impairment, 'Social Competence')(social interactions, 'Reciprocal Social Interaction')(childhood autism rating scale score, 'Autism Phenotype')(intelligence quotient, 'IQ')(self- aggressive symptoms, 'Aggressive Behavior')(autism, 'Autism Phenotype')

PMCID: 3003876
SFARI Genes: CDH8, CDH8, CDH8, CDH8, CDH8, CDH8, CDH8, CDH8, 
Non SFARI Genes: PPL, Mb, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (impairments: [patf]), (social communication: [socb]), (pattern: []), (repetitive behaviours: [inbe]), (disability (ld): [fndg]), (cases: [qnco]), (recent study: [resa]), (ppl: [gngm]), (statistical framework: []), (novel region: []), (genetic linkage: [moft]), (chromosome: [celc]), (asd families: [cgab]), (ld: [gngm]), (study: [resa]), (families: [famg]), (autism and/or ld: [mobd]), (rare >1.6 mb microdeletions: [gngm]), (linkage region: [moft]), (deletion breakpoints: [genf]), (base-pair resolution: [moft]), (segregation analysis: [socb]), (combination: [fndg]), (polymorphism (snp) technology: [nusq]), ( array: []), (comparative genomic hybridisation: [mbrt]), (long-range pcr: [mbrt]), (sanger: []), (frequency: [qnco]), (similar genomic variants: [gngm]), (control subjects: [sbst]), (analysis: [resa]), (snp array data: [euka]), (expression: [topp]), (cdh8: [gngm]), (only gene: [gngm]), (microdeletions: []), (reverse transcriptase pcr: [mbrt]), (situ hybridisation analysis: [mbrt]), (week: []), (human embryos: [emst]), (deletion: [genf]), (chr16:: []), (boys: [aggp]), (autism: [mobd]), (none: []), (unaffected siblings: [famg]), (unaffected mother: [famg]), (second family: [famg]), (individual: [humn]), (severe ld: [bpoc]), (father: [famg]), (moderate ld: [bpoc]), (copy number variations: [nusq]), (controls: [sbst]), (expression analysis: [resa]), (cdh8 isoforms: [aapp]), (human cortex: [humn]), (rare: [gngm]), (expression analysis implicate cdh8: [gngm]), (susceptibility: [clna]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(repetitive behaviours, 'Restricted and Repetitive Behavior')(autism spectrum disorder, 'Autism Phenotype')(autism and/or, 'Autism Phenotype')(autism, 'Autism Phenotype')(learning disability, 'Learning Disorders')(father with moderate learning disability, 'Learning Disorders')(moderate learning disability, 'Learning Disorders')

PMCID: 2965350
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (summary large: [qnco]), ( rare: [gngm]), (chromosomal deletions: [comd]), (duplications: []), (copy number variants: [nusq]), (neurodevelopmental disorders: [mobd]), (attention-deficit hyperactivity disorder (adhd): [mobd]), (burden: []), (cnvs: [nusq]), (adhd: [mobd]), (identified cnvs: [nusq]), (loci: [gngm]), (autism: [mobd]), (schizophrenia: [mobd]), (genome-wide analysis: [gngm]), (children: [aggp]), (controls: [sbst]), (british birth cohort: [qnco]), (white uk origin: [popg]), (years: []), (diagnostic criteria: []), (hyperkinetic disorder: [mobd]), (community child psychiatry: [aggp]), (paediatric outpatient clinics: [hcro,mnob]), (single: [fndg]), ((snps): [nusq]), (groups: [popg]), (arrays; cnv analysis: [nusq]), (snps: [nusq]), (arrays: []), (samples: [sbst]), (high-quality data: [qnco]), (adhd group: [mobd]), (comparative genomic hybridisation: [mbrt]), (genome-wide burden: [gngm]), (large (>500 kb): [qnco]), (rare (<1% population frequency) cnvs: [nusq]), (average number: [qnco]), (sample: [sbst]), (significance: [qnco]), (permutation: []), (locus-specific tests: [lbpr]), (association: [menp]), (test regions: [lbpr]), (findings: [clna]), (icelandic patients: [podg]), (icelandic controls: [lang]), (findings data: [euka]), (full analyses: [resa]), (large: [gngm]), ( rare cnvs: [nusq]), (rate: [qnco]), (adhd (0156: [mobd]), (p=89105): [aapp,imft]), (intellectual disability (0424;: [mobd]), (significant excess: [qnco]), (cases: [qnco]), (such disability (0125: [fndg]), ( p=00077): [aapp,imft]), (excess: []), (chromosome: [celc]), (adhd group (p=00008: [mobd]), (correction: []), (multiple testing): [qnco]), (finding: [sosy]), (icelandic sample (p=0031): [aapp,imft]), (adhd cohort: [mobd]), (autism (p=00095): [mobd]), (schizophrenia (p=0010): [mobd]), (interpretation: [clna]), (genetic evidence: [topp]), (increased rate: [qnco]), (large cnvs: [nusq]), (individuals: [humn]), (social construct: []), (action research; baily thomas charitable trust; wellcome trust; uk medical research council; european union: [inbe]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(attention-deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(attention-deficit hyperactivity disorder, 'Overactivity')(attention-deficit hyperactivity disorder, 'Overactivity')(attention-deficit hyperactivity disorder group, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit hyperactivity disorder, 'Overactivity')(attention-deficit hyperactivity disorder, 'Overactivity')(attention-deficit hyperactivity disorder, 'Overactivity')(intellectual disability, 'Learning Disorders')(attention-deficit hyperactivity disorder cohort, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit hyperactivity disorder, 'Overactivity')(uk medical research council, 'Medications')

PMCID: 2953007
SFARI Genes: 
Non SFARI Genes: TLR3, 
Named Entities: (maternal infection: [fndg]), (pregnancy: [orgf]), (wide range: [qnco]), (rna: [nnon]), (dna viruses: [virs]), (risk: []), (schizophrenia: [mobd]), (autism: [mobd]), (offspring: [famg]), (common feature: [qnco]), (exposures: [phpr]), (virus replication induces: [celf]), (immunity: [phsf]), (interaction: []), (toll-like receptors: [aapp,rcpt]), (mouse model wherein: [emod]), (pregnant mice: [mamm]), (polyinosinic-polycytidylic acid [poly(i  c)]: [nnon,phsu]), (synthetic: [acty]), ( double-stranded rna: [bacs,nnon]), (molecular mimic: []), (virus: [virs]), (poly(i  c): [nnon,phsu]), (embryonic neuronal stem cell replication: [celf]), (population: [popg]), (superficial layers: [bpoc]), (neocortex: [bpoc]), (neurons: [cell]), (impaired neonatal locomotor development: [fndg]), (abnormal sensorimotor: [qnco]), (responses: [orga]), (adult offspring: [famg]), (toll-like receptor: [aapp,rcpt]), ((tlr3)-deficient mice: [mamm]), (effects: []), (tlr3: [gngm]), (inhibition: [acty]), (stem cell proliferation: [celf]), (pretreatment: [acty]), (nonsteroidal anti-inflammatory drug (nsaid): [phsu]), (cyclooxygenase (cox) inhibitor: [phsu]), (findings: [clna]), (insights: [menp]), (mechanisms: []), (subtle neuropathology: [patf]), (behavioral dysfunction: [inbe]), (strategies: [menp]), (neuropsychiatric disorders: [dsyn]), (prenatal exposures: [fndg]), (pathogens: [orgm]), (other triggers: [clna]), (innate immunity: [orga]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(offspring, 'Perinatal History')(exposures, 'Exposures')(virus replication induces, 'Virus Diseases')(virus, 'Virus Diseases')(adult offspring, 'Perinatal History')(impaired neonatal locomotor development, 'Learning Disorders')(behavioral dysfunction, 'Personal Traits')(prenatal exposures, 'Exposures')

PMCID: 2946294
SFARI Genes: 
Non SFARI Genes: Mb, 
Named Entities: (previous studies: [lbpr]), (candidate genes: [gngm]), (chromosomal regions: [cell]), (several copy number variations: [nusq]), (increased risk: [qnco]), (autism: [mobd]), (autism spectrum disorders: [mobd]), (17-year-old girl: [aggp]), (severe mental retardation: [mobd]), ( epilepsy: [dsyn]), (duplication syndrome features: [dsyn]), (gtg-banded chromosome analysis: [lbpr,mbrt]), (female karyotype: [resa]), (marker chromosome: [comd]), (metaphases: [celf]), (array cgh analysis: [dsyn]), (gain: [qnco]), (mb: [gngm]), (duplication: [comd]), (proband: [famg]), (parents: []), (unaffected siblings: [famg]), (ethnic controls: [popg]), (other copy number variations: [nusq]), (patient: [podg]), (family: [famg]), (detailed analysis: [resa]), (duplicated region revealed:: []), (area: []), (critical region: []), (duplication syndrome;: [dsyn]), (region: []), (normal individual;: [humn]), (potential asd locus: [cgab]), (asd candidate locus: [cgab]), (genes: [gngm]), (autistic features: [mobd]), (potential asd locus (9p24.3: [cgab]), (gene(s): [gngm]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(severe mental retardation, 'Mental Retardation')(epilepsy, 'Epilepsy')(other copy number variations, 'Imitation')

PMCID: 3094531
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (siblings: [famg]), (probands: [orga]), (autism spectrum disorders: [mobd]), (risk: []), (broad autism phenotype (bap): [mobd]), (linguistic abilities: [orga]), (pragmatic language: [lang]), ( school achievements: [inbe]), (underling reading processes): [dora]), (school-age siblings: [famg]), (children: [aggp]), (autism: [mobd]), (typical development: [orgf]), (results: [fndg]), (pragmatic abilities: [orga]), (subgroup: [virs]), (sibs-a: [famg]), (bap: [gngm]), (related difficulties: [fndg]), ((sibs-a-bap) whereas school achievements: [famg]), (processes: [phpr]), (furthermore: []), (sibs-a-bap: [famg]), (significant negative correlations: [fndg]), (severity: []), (autism diagnostic observation schedule: [hlca]), (verbal iq scores: [clna]), (context: [fndg]), (developmental trajectories: [orgf]), (relation: [socb]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(broad autism phenotype, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism-broad autism phenotype, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2935882
SFARI Genes: CNTNAP2, CNTNAP2, 
Non SFARI Genes: 
Named Entities: (traits: [gngm]), (autism: [mobd]), (spectrum: [qnco]), (clear boundary: [fndg]), (atypical behaviour: [inbe]), (dimensional traits: [gngm]), (autism phenotype: [mobd]), (methods: []), (principal findings ninety-three: [qnco]), (individual measures: [qnco]), (components: []), (social: []), ( communication: [socb]), (repetitive behaviours: [inbe]), (autistic spectrum disorder (asd): [mobd]), (ages: [bacs,orch]), (months: []), (years: []), (alspac database: []), (value imputation: [qnco]), ( data: [euka]), (children: [aggp]), (analysed: []), (factor analysis: [qnco]), (existence: []), (factors: []), (variance: [qnco]), (labelled: verbal ability: [menp]), ( language: [lang]), (acquisition: [acty]), ( social understanding: [menp]), ( semantic-pragmatic skills: [inbe]), (repetitive-stereotyped behaviour: [mobd]), ( articulation: [bsoj]), (social inhibition: [acty]), (phenotype: [orga]), (other co-morbid conditions: [dsyn]), (other factors: []), (difficulties: [fndg]), (specific language impairment: [dsyn]), (nevertheless: []), (explanation: []), (asd (p<0.001): [cgab]), (exploration: [topp]), (putative genetic causal factors: [fndg]), (variants: []), (cntnap2 gene: [gngm]), (pattern: []), (associations: [menp]), (alternative predictive model: []), (asd: [cgab]), (coherence subscale: [fndg]), (children's communication checklist: [aggp]), (communication disorders checklist (91: [mobd]), (repetitive behaviour (69 m): [fndg]), (sociability subscale: [socb]), (emotionality activity: [acty]), (sociability measure (38 m): [qnco]), (combined explanations: []), (similar (r2 =: [neop]), (conclusions: []), (significance: [qnco]), (results: [fndg]), (fractional nature: [qnco]), (different aetiological origins: []), (pleiotropic genetic effects: [gngm]), (observed: []), 
ASD Terms: (autism, 'Autism Phenotype')(atypical behaviour, 'Personal Traits')(autism phenotype, 'Autism Phenotype')(repetitive behaviours, 'Restricted and Repetitive Behavior')(autistic spectrum disorder, 'Autistic Disorder')(social understanding, 'Ability to Converse in Social Settings')(specific language impairment, 'Language Ability')(repetitive behaviour, 'Restricted and Repetitive Behavior')

PMCID: 2932694
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (common heritable neurodevelopmental disorder: [mobd]), (complex etiology: [chvs]), (several genome-wide linkage: [gngm]), (association scans: [menp]), (regions: []), (genes: [gngm]), (autism spectrum disorders: [mobd]), (mixed results: [fndg]), (overlap: [topp]), (autism features: [mobd]), (genetic abnormalities: [fndg]), (possible reason: []), (lack: []), (consistency: [qnco]), (influence: []), (parent-of-origin effects: []), (ability: [orga]), (linkage: [moft]), (association: [menp]), (methods: []), (findings: [clna]), (genome-wide linkage: [gngm]), (accounts: [clna]), (potential parent-of-origin effects: []), (snps: [nusq]), (families: [famg]), (autism genetic resource exchange (agre): [mobd]), (national institute: [orgt]), (mental health (nimh) autism repository: [hcro]), (parametric (gh: [aapp,horm]), ( genehunter): []), (allele-sharing linkage (aspex) results: [gngm]), (broad spectrum disorder case definition: [qnco]), (significant linkage: [moft]), (chromosomes: [celc]), ((lodgh: []), (empirical p<0.005: [fndg]), (lodaspex =: []), (p: [gngm]), (empirical p: []), (sites: []), (development: [orgf]), (offer: []), (fruitful domains: []), (molecular investigation: [hlca]), (role: [socb]), (epigenetic mechanisms: [genf]), 
ASD Terms: (common heritable neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(autism features, 'Autism Phenotype')(mental health autism repository, 'Autism Phenotype')(autism genetic resource exchange, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2923607
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (environmental risk factors: []), (autistic spectrum disorders: [mobd]), (social interaction: [fndg]), ( communication: [socb]), ( emotion processing: [menp]), ( sensorimotor gating: [phsf]), (executive function: [menp]), (both: []), (stimulating debate: [npop]), (conditions: [dsyn]), (brain imaging studies: [bpoc]), (resource: []), (brain: [bpoc]), (structural phenotype: [orga]), (disorders: [dsyn]), (datasets: []), (asd: [cgab]), (schizophrenia: [mobd]), (common framework: [qnco]), (structural similarities: []), (novel modification: []), (anatomical likelihood estimation: [qnco]), (foci: []), (voxel-based studies: [lbpr]), (participants: [popg]), ((308 asd: [cgab]), (first-episode schizophrenia): [mobd]), (controls: [sbst]), (results: [fndg]), (grey matter volumes: [tisu]), (limbic-striato-thalamic circuitry: [bpoc]), (unique features: []), (disorder: [dsyn]), (grey matter volume: [tisu]), (amygdala: [bpoc]), ( caudate: []), ( frontal: []), (medial gyrus: []), (putamen: [bpoc]), (autism: [mobd]), (thus: []), (terms: [orgf]), (brain volumetrics: [bpoc]), ( asd: [cgab]), (clear degree: [qnco]), (overlap: [topp]), (etiological mechanisms: []), (however: []), (distinctive neuroanatomy: []), (condition: [dsyn]), (question: []), (context: [fndg]), (common etiological pressures: [phpr]), 
ASD Terms: (autistic spectrum disorders, 'Autistic Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(social interaction, 'Reciprocal Social Interaction')(executive function, 'Executive Function')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')

PMCID: 2947401
SFARI Genes: MACROD2, MACROD2, ST8SIA2, TAF1C, ST8SIA2, TAF1C, 
Non SFARI Genes: PLD5, POU6F2, 
Named Entities: (autism spectrum disorders: [mobd]), (substantial genetic basis: [phsu]), (genetic risk: [qnco]), (variants: []), (copy number variants: [nusq]), (common risk: [qnco]), (autism genome project (agp) consortium: [mobd]), (asd families: [cgab]), (single-nucleotide polymorphisms (snps): [nusq]), (snp genotypes: [nusq]), (association: [menp]), (asd: [cgab]), (primary association: [menp]), (association signal: [menp]), (marker rs4141463: [clna]), (macrod2: [gngm]), (genome-wide association significance threshold: [menp]), (p <: [aapp,imft]), (replication sample: [genf]), (risk allele: [gngm]), (rs4141463: []), (over-transmitted; yet: [patf]), ( consistent: []), (winner's: []), (effect size: [qnco]), (much smaller; and: [qnco]), (combined samples: [sbst]), (threshold: []), (exploratory analyses: [resa]), (phenotypic subtypes: [orga]), (significant associations: [menp]), (correction: []), (multiple testing: [qnco]), (however: []), ( yield: []), (strong signals: [phpr]), (several genes: [famg]), ( kiaa0564: []), ( pld5: [gngm]), ( pou6f2: [gngm]), ( st8sia2: [aapp,enzy]), (taf1c: [gngm]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism genome project consortium, 'Autism Phenotype')

PMCID: 2921070
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (traditionally: []), (autistic spectrum disorder (asd): [mobd]), (specific language impairment (sli): [dsyn]), (distinct conditions: [dsyn]), (separate etiologies: []), (disorders: [dsyn]), (chance levels: []), (etiology: []), (simulations: [resa]), ( however: []), ( show: [anim]), (additive pleiotropic genes: [gngm]), (account: [clna]), (observed rates: [qnco]), (language impairment: [mobd]), (relatives: [famg]), (probands: [orga]), (sli: [gngm]), (asd + language impairment: [mobd]), (alternative account: [clna]), (terms: [orgf]), (phenomimicry: []), (i.e.: [diap,inpr]), ( language impairment: [mobd]), (comorbid cases: [qnco]), (consequence: []), (asd risk factors: [qnco]), (however: []), (cannot: []), (molecular genetic studies: [lbpr]), (common risk genotype: [orga]), (asd: [cgab]), (paper: []), (nonadditive genetic influences: [topp]), (family: [famg]), (molecular findings: [clna]), (modified simulation: [resa]), (g  g interactions: [qnco]), (levels: []), (comorbidity: []), (rates: [qnco]), (impairment: [patf]), (observed values: []), (shape: []), (distributions: []), (phenotypic trait scores: [orga]), (different genotypes: [orga]), (evidence: []), (gene: [gngm]), (epistasis: [fndg]), 
ASD Terms: (autistic spectrum disorder, 'Autistic Disorder')(specific language impairment, 'Language Ability')(language impairment, 'Language Ability')(specific language impairment, 'Language Ability')(asd + language impairment, 'Language Ability')(comorbid cases, 'Comorbidities')(language impairment, 'Language Ability')(language impairment, 'Language Ability')(comorbidity, 'Comorbidities')

PMCID: 2892398
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prevalence: [qnco]), (autism spectrum disorders (asd): [mobd]), (years: []), (whether asd: [cgab]), (burden: []), (human: [humn]), (economic terms: [orgf]), (autism: [mobd]), (mental disorders: [mobd]), (pathogenesis: [patf]), (environmental factors: []), (proposed; however: []), ( none: []), (furthermore: []), (biomarkers: [clna]), (asd: [cgab]), (risk: []), (autism birth cohort (abc): [mobd]), (gene  environment  timing interactions: [genf]), (early diagnosis: [diap]), (large: [gngm]), (unselected birth cohort wherein cases: [qnco]), (population screening: [popg]), (samples: [sbst]), (pregnancy: [orgf]), (childhood: []), (parental blood: [bdsu]), ( maternal urine: [bdsu]), ( cord blood: [tisu]), ( milk teeth: [bpoc]), (rectal swabs: [bdsu]), (children: [aggp]), (national registry: [popg]), (cases: [qnco]), (control group: [grup]), (same cohort: [popg]), (nested case-control design: [acty]), (early screening: [diap]), (diagnostic assessments: [diap]), (re-assessments: [hlca]), (rich view: []), (longitudinal trajectory: []), (genetic: [topp]), ( proteomic: []), ( immunologic: []), ( metagenomic: []), (microbiological tools: []), (unique biological samples: []), (abc: [dsyn]), (paradigm: [resa]), (role: [socb]), (complex disorders: [dsyn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(mental disorders, 'Mental Disorders')(autism birth cohort, 'Autism Phenotype')(early diagnosis, 'Diagnosis')

PMCID: 3005119
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (morphological features: []), (large group: [grpa]), (children: [aggp]), (autism spectrum disorder: [mobd]), (normal controls: []), (patients: [podg]), (controls: [sbst]), (pairs: []), (created: [acty]), (prevalence rates: [qnco]), (odds ratios: [qnco]), (conditional regression analysis: []), ( mcnemar test: [lbpr]), (t-test matched pairs: [resa]), (morphological abnormalities: [anab]), (autism: [mobd]), (normal control group: [grup]), (findings: [clna]), (potential underlying genetic mechanisms: [topp]), (association: [menp]), (understanding: [menp]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-010-1018-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder versus, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2866544
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (neuronal calcium: [bacs,elii,phsu]), (sensor-1 (ncs-1): [gngm]), (ca2+ sensor protein: [aapp,bacs]), (regulation: [biof]), (various aspects: [qnco]), (neuronal development: [celf]), (neurotransmission: [celf]), (effects: []), (interactions: []), (range: [qnco]), (target: [diap]), (interleukin receptor: [aapp,imft,rcpt]), (accessory protein like-1 (il1rapl1) protein: [aapp,rcpt]), (mutations: [genf]), (il1rapl1: [gngm]), (autism spectrum disorders: [mobd]), (missense mutation (r102q): [genf]), (ncs-1: [gngm]), (individual: [humn]), (autism: [mobd]), (effect: []), (mutation: [genf]), (structure: []), (function: [phsf]), (use: []), (nmr: [gngm]), (r102q: []), (protein: [aapp,bacs]), (increase: []), (extent: []), (conformational exchange: [clna]), (c-terminus: []), (change ncs-1(r102q): [gngm]), (changes: [qnco]), (affinity: [npop]), (ca2+: [elii,phsu]), (intracellular localisation: [celf]), (assessment: [acty]), (ncs-1 dynamics: [npop]), (cycle: []), (membrane pools: [celc]), (cycling: []), (plasma membrane: [celc]), (ncs-1(r102q): [gngm]), (loss: [qnco]), (ca2+ -dependent component: [elii,phsu]), (data: [euka]), (impairment: [patf]), (normal cycling: [fndg]), (r102q mutation: [genf]), (subtle effects: [clna]), (neuronal signalling: [biof]), (physiology: [phsf]), (developing: []), (adult brain: [bpoc]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 2898030
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (aim: [phsu]), (pilot study: [resa]), (autistic children: [podg]), ( siblings: [famg]), (parents: []), (biometric device: [resa]), (gas discharge visualization (gdv) technique: [hlca]), (order: [acty]), (physiological functional state: []), (activity: [acty]), (autonomic nervous system: [bdsy]), (hypothesis:: []), (biometric assessment: [resa]), (gdv: []), (us: (1): [fndg]), (specific features: []), (autism spectrum disorder (asd): [mobd]), (siblings: [famg]), ((2): [qnco]), (differences: [qnco]), (individual values: [humn]), (normal children: [aggp]), (results: out: [fndg]), (total: [qnco]), (acupuncture points: [topp]), (ten fingertips: [dsyn]), (hands: [bpoc]), (systems: []), ( autistic children: [podg]), (controls (p: [aapp,imft]), ((images: []), (filter): []), ((p: [aapp,imft]), ( fathers: [famg]), (controls: [sbst]), (mothers: [famg]), (filter) acupuncture points: [topp]), (conclusions: all: []), (groups: [popg]), (significant difference: [qnco]), (psycho-emotional (images: [menp]), (physiological (images: []), (filter) levels: []), (however: []), (psycho-emotional level: [menp]), (other groups: [popg]), (sympathetic autonomic: [bdsy]), (nervous system: [bdsy]), (children: [aggp]), (autism: [mobd]), (biometric method: [resa]), (promising step: [qnco]), (autism research: [mobd]), (towards: []), (disease profile: [dsyn]), (unique signature/biomarker: [amas]), (further work: []), (participants: [popg]), (findings: [clna]), 
ASD Terms: (gas discharge visualization technique, 'Visual Thinking')(gas discharge visualization, 'Visual Thinking')(autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism research, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3001124
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (research: [resa]), (mutations: [genf]), (gene: [gngm]), (neurexin-1 (nrxn1): [gngm]), (variety: []), (conditions: [dsyn]), (autism: [mobd]), ( schizophrenia: [mobd]), (nicotine dependence: [mobd]), (knowledge: []), (reports: [hlca]), (breadth: []), (phenotype: [orga]), (nrxn1: [gngm]), (medical record review: [hlca]), (subjects: [humn]), (deletions: [genf]), (exonic sequences: [bacs,nnon]), (cases: [qnco]), (individuals: [humn]), (comparative genomic hybridization: [mbrt]), (march: []), (january: []), (twelve subjects: [humn]), (exonic deletions: [bacs,nnon]), (nrxn1 deletion: [genf]), (autism spectrum disorders: [mobd]), (mental retardation: [mobd]), ( language delays: [lang]), (hypotonia: [fndg]), (significant increase: [qnco]), (clinical sample: [sbst]), (populations: [popg]), (literature (p: [inpr,mnob]), (additional subjects: [humn]), (nrxn1 deletions: [genf]), (homozygosity mapping collaborative: [socb]), (deletion: [genf]), (study: [resa]), (wide spectrum: [qnco]), (developmental disorders: [mobd]), (wiley-liss: [lbpr]), ( inc: []), 
ASD Terms: (autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(medical record review, 'Medications')(autism spectrum disorders, 'Autism Phenotype')(mental retardation, 'Mental Retardation')(language delays, 'Language Ability')(autism, 'Autism Phenotype')

PMCID: 2974190
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (casecontrol study: [resa]), (han children: [aggp]), (autism: [mobd]), (perinatal risk factors: [qnco]), (china: []), (cases: [qnco]), (public special education schools: [edac]), (controls: [sbst]), (regular public schools: [mnob,orgt]), (same region (tianjin): []), (frequency: [qnco]), (sex: [orgf]), (birth year: []), (analyses: [resa]), (adjusted analysis: [resa]), (risk factors: [qnco]), (significant association: [menp]), (autism: maternal second-hand smoke: [eehu]), (maternal chronic: [famg]), (medical conditions: [dsyn]), (maternal unhappy emotional state: [clna]), (gestational complications: [dsyn]), ( edema: [fndg]), (abnormal gestational age (<35: [orga]), (weeks): []), ( nuchal cord: [fndg]), ( gravidity >1: [fndg]), (paternal age: []), (delivery: [topp]), (year-old): []), 
ASD Terms: (autism, 'Autism Phenotype')(perinatal risk factors, 'Perinatal Exposures')(autism, 'Autism Phenotype')(maternal second-hand smoke, 'Smoking')(delivery, 'Perinatal History')(maternal second-hand smoke, 'Smoking')(medical conditions, 'Medications')(maternal unhappy emotional state, 'Depression')(gestational complications, 'Perinatal History')(abnormal gestational age, 'Perinatal History')

PMCID: 2848579
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (number: [qnco]), (studies: [lbpr]), (ages: [bacs,orch]), (parents: []), (children: [aggp]), (autistic spectrum disorders: [mobd]), (paternal age effects: [fndg]), (relationships: []), (grandparental ages: [famg]), (methods: []), (findings: [clna]), (parental: []), (population-based avon longitudinal study: [resa]), (children (alspac): [aggp]), (scores: [clna]), (regard: []), (autistic trait measures: [mobd]), (diagnosis: [fndg]), (asd: [cgab]), (mean maternal: [famg]), (paternal ages: []), (asd cases: [cgab]), (maternal grandmother age effect (p: [aapp,imft]), (or: []), (10-year increase: [fndg]), (grandmother's age: [famg]), (birth: [orgf]), (mother: [famg]), (trait measures: [qnco]), (association: [menp]), (maternal grandmother's age: [orga]), (major autistic traitthe coherence scale (regression coefficient b: [mobd]), ([95%ci: [lbpr]), (=: []), (confounders: []), (effect size: [qnco]), (year increase: []), (age: [orga]), (relationship: []), (major autistic trait: [mobd]), (biological plausibility: []), (maternal side: [famg]), (least: [qnco]), (timing: []), (female meiosis: [celf]), (direct effects: []), (grandchild's genome: [gngm]), (grandmother's pregnancy: [orgf]), (alternative explanation: []), (meiotic mismatch methylation (3 m) hypothesis: [phsu]), (first time: [qnco]), (hypothesis: []), (corroborative results: [fndg]), (other studies: [lbpr]), 
ASD Terms: (autistic spectrum disorders, 'Autistic Disorder')(diagnosis, 'Diagnosis')(year increase in age, 'Onset of Symptoms')

PMCID: 2847695
SFARI Genes: MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, 
Non SFARI Genes: 
Named Entities: (methyl cpg: [bacs,nnon]), (protein-2 (mecp2): [aapp,bacs]), (essential epigenetic regulator: []), (human brain development: [ortf]), (rett: []), (primary disorder: [dsyn]), (mutations: [genf]), (x-linked mecp2 gene: [gngm]), (period: []), (cognitive decline: [mobd]), (development: [orgf]), (hand stereotypies: [bpoc]), (seizures: [sosy]), (normal early infancy: [fndg]), (addition: []), ( mecp2 mutations: [aapp,bacs]), (duplications: []), (spectrum: [qnco]), (neurodevelopmental disorders: [mobd]), (severe neonatal encephalopathy: [dsyn]), ( x-linked mental retardation: [dsyn]), (autism: [mobd]), (mecp2: [gngm]), (essential regulator: []), (postnatal brain development: [bpoc]), (review: []), (mutation types: [genf]), (inheritance patterns: [genf]), (human disorders: [humn]), (current understanding: [menp]), (central epigenetic regulator: [lbpr]), (activity-dependent synaptic maturation: [ortf]), (central role: [socb]), (pathogenesis: [patf]), (multiple neurodevelopmental disorders: [mobd]), (investigation: [hlca]), (mecp2 function: [aapp,bacs]), (regulatory pathways: []), (promise: []), (broad-spectrum therapies: [topp]), 
ASD Terms: (cognitive decline, 'Cognitive Ability')(rett, 'Rett Syndrome')(normal early infancy, 'Perinatal History')(neurodevelopmental disorders, 'Learning Disorders')(x-linked mental retardation, 'Mental Retardation')(autism, 'Autism Phenotype')(multiple neurodevelopmental disorders, 'Learning Disorders')

PMCID: 2838793
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (united: []), (autism spectrum disorders: [mobd]), (causes: []), (treatments: [topp]), (mice: [mamm]), (deletion: [genf]), (fragile x: [comd]), (mental retardation: [mobd]), ((fmr1) gene: [gngm]), (autism: [mobd]), (loss: [qnco]), (fmr1 gene function causes fragile x syndrome (fxs): [cgab,dsyn]), (many people: [popg]), (fxs exhibit: []), (autistic-like behaviors: [mobd]), (glycogen: [bacs,orch]), (kinase-3 (gsk3): [aapp,enzy]), (brains: [bpoc]), (fmr1 knockout mice: [mamm]), (inhibition: [acty]), (gsk3: [aapp,enzy]), (lithium administration: [elii,phsu]), (behavioral impairment: [inbe]), (studies: [lbpr]), (association: [menp]), (behaviors: [inbe]), (mouse models: [mamm]), (disrupted regulation: [biof]), ( fmr1 knockout mice: [mamm]), (gsk3 knockin mice: [mamm]), (inhibitory serines: [aapp,bacs,phsu]), (isoforms: [aapp]), ( gsk3: [aapp,enzy]), (methodology/principal findings: [clna]), (sociability: [socb]), ( test mice: [mamm]), (restrained stimulus mouse (s1): [mamm]), (min: [neop]), (introduction: [hlca]), (second restrained stimulus mouse (s2): [mamm]), (social preference: []), (fmr1 knockout: [emod]), (deficit: [dsyn]), (s1 mouse: [mamm]), (wild-type mice: [mamm]), (novel s2 mouse: [mamm]), (anxiety-related behaviors: [mobd]), (social interaction (grooming: [inbe]), ( rearing: []), (digging): [neop]), (chronic lithium treatment: [elii,phsu]), (conclusions/significance: [qnco]), (results: [fndg]), (impaired inhibitory regulation: [acty]), (fmr1: [gngm]), (socialization deficits: [edac]), (lithium treatment: [elii,phsu]), (certain socialization impairments: [edac]), (present work: [qnco]), (role: [socb]), (social behaviors: [socb]), (implicate inhibition: [acty]), (potential therapeutic: [topp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(model autism, 'Autism Phenotype')(fragile x syndrome exhibit, 'Fragile X Syndrome')(fragile x, 'Fragile X Syndrome')(mental retardation, 'Mental Retardation')(gene function causes fragile x syndrome, 'Fragile X Syndrome')(mental retardation, 'Mental Retardation')(behavioral impairment, 'Personal Traits')(socialization behaviors, 'Reciprocal Social Interaction')(mental retardation, 'Mental Retardation')(social interaction, 'Reciprocal Social Interaction')(socialization deficits, 'Social Competence')(certain socialization impairments, 'Social Competence')(social behaviors, 'Reciprocal Social Interaction')

PMCID: 2869041
SFARI Genes: cut, cut, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (broad spectrum: [qnco]), (clinical manifestations: []), (qualitative impairments: [patf]), (social interactions: [fndg]), (communication: [socb]), (patterns: []), (behavior: [inbe]), (abnormal acceleration: [phpr]), (brain growth: [orgf]), (early childhood: []), ( signs: [fndg]), (growth: [orgf]), (neurons: [cell]), (minicolumn: []), (developmental abnormalities: [cgab]), (multiregional alterations: []), (aim: [phsu]), (study: [resa]), (focal qualitative developmental defects: [acab]), (brain regions: [blor]), (developmental alterations: [orgf]), (formalin-fixed brain hemispheres: [hops,orch,phsu]), (years: []), (age): [orga]), (age-matched control subjects: [humn]), (celloidin: [bodm,phsu]), (200-m-thick coronal sections: [qnco]), (cresyl violet: [irda,orch]), (neuropathological evaluation: [hlca]), (thickening: [fndg]), (subependymal cell layer: [bird]), (brains: [bpoc]), (subependymal nodular dysplasia: [patf]), (brain: [bpoc]), (active neurogenesis: [orgf]), (autistic children: [podg]), (subcortical: [blor]), ( periventricular: []), ( hippocampal: [bpoc]), (cerebellar heterotopias: [fndg]), (autistic subjects: [mobd]), (abnormal neuronal migration: [cgab,dsyn]), (multifocal cerebral dysplasia: [comd]), (local distortion: [anab]), (cytoarchitecture: []), (neocortex: [bpoc]), (entorhinal cortex: [bpoc]), (cornu ammonis: [bpoc]), (dentate gyrus: [bpoc]), (cerebellar flocculonodular dysplasia: [fndg]), (subjects: [humn]), ((46%): []), ( focal dysplasia: [comd]), (vermis: [bpoc]), (case: []), (hypoplasia: [patf]), (local failure: [inbe]), (cerebellar development: [ortf]), (detection: [topp]), (flocculonodular dysplasia: [patf]), (control: [sbst]), (focal qualitative neuropathological developmental changes: [orgf]), (examined brains: [bpoc]), (multiregional dysregulation: []), (neurogenesis: [orgf]), ( neuronal migration: [gngm]), (maturation: [phsf]), (heterogeneity: [orga]), (clinical phenotype: [orga]), 
ASD Terms: (social interactions, 'Reciprocal Social Interaction')(stereotyped patterns of behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')(developmental abnormalities, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2826417
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (high rates: [qnco]), (genomic aberrations: [gngm]), (chromosomal rearrangements: [comd]), (copy-number variations: [nusq]), (observations: [hlca]), (cancer: [euka]), (disease: [dsyn]), (genomic rearrangements: [gngm]), (role: [socb]), (correlative epidemiological study: [resa]), (possibility: []), (risk factors: [qnco]), (specific types: []), (methodology/principal findings: [clna]), (significant correlations: [qnco]), (prevalence: [qnco]), (incidence: [qnco]), (state-wide data: [euka]), (age: [orga]), (gender: [orga]), (united states: []), (autism data: [mobd]), (u.s. department: [orgt]), (education: [fndg]), (individuals: [humn]), (disabilities education act (idea) (20002007: [topp]), (age group): [aggp]), (cancer incidence data: [qnco]), (disease control: [topp]), (prevention (cdc) (19992005): [hcro]), (idea data: [euka]), (method: [lbpr]), (autism (dsm iv: [mobd]), (code: []), (federal regulations: []), (criteria): []), (spearman rank correlations: []), (possible pairwise combinations: [phsu]), (annual autism rates: [mobd]), (specific cancers: [euka]), (this: []), ( bonferroni's correction: []), (values: []), (independent methods: [fndg]), (p-value: [qnco]), (dependent correlations: []), (set: [menp]), (calculations: [acty]), (high correlations: [qnco]), (autism rates: [mobd]), (situ breast cancer (p1010: [neop]), (inverse chi square: [qnco]), (data: [euka]), (states: []), (contrast: [irda]), ( few significant correlations: [qnco]), (autism prevalence: [qnco]), (other female: [orga]), (male cancers: [orga]), (findings: [clna]), (association: [menp]), (specific forms: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism data, 'Autism Phenotype')(diagnose autism, 'Autism Phenotype')(annual autism rates, 'Autism Phenotype')(autism rates, 'Autism Phenotype')(autism prevalence, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2839489
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (attention-deficit/hyperactivity disorder (adhd): [mobd]), (autism spectrum disorder (asd): [mobd]), (heritable neurodevelopmental disorders: [mobd]), (evidence: []), (disorders: [dsyn]), (high frequency: []), (children: [aggp]), (adhd meeting criteria: [mobd]), (asd: [cgab]), (asd children: [cgab]), (criteria: []), (adhd: [mobd]), (review: []), (overview: []), (available studies: [lbpr]), (twin: [famg]), ( candidate gene: [gngm]), ( linkage: [moft]), (wide association (gwa) studies]: [mbrt]), (light: [gngm]), (role: [socb]), (genetic underpinnings: [topp]), (family: [famg]), (twin studies: [famg]), (support: []), (hypothesis: []), (similar familial/genetic factors: [fndg]), (few candidate gene: [gngm]), (studies: [lbpr]), ( linkage studies: [moft]), (gwa studies: [mbrt]), (co-occurrence: []), ( pinpointing: [fndg]), (promising pleiotropic genes: [gngm]), ( loci: [gngm]), (single nucleotide polymorphisms (snps): [nusq]), (research field: [resa]), (urgent need: [topp]), (complex issue: [fndg]), (future studies: [lbpr]), (familial etiological factors: [famg]), (family-based design: [famg]), (same phenotypic (adhd: [mobd]), (asd): [cgab]), (endophenotypic: []), (environmental measurements: []), (family members: [famg]), (multivariate multi-level models: [phsu]), (statistical analysis: [resa]), 
ASD Terms: (attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism spectrum disorder, 'Autism Phenotype')(heritable neurodevelopmental disorders, 'Learning Disorders')(attention-deficit/hyperactivity disorder meeting criteria, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 2815936
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent genetic studies: [resa]), (view: []), (current approaches: [npop]), (diagnosis: [fndg]), (classification: []), (major psychiatric illness: [mobd]), (findings: [clna]), (distinction: []), (schizophrenia: [mobd]), (bipolar disorder: [mobd]), (attention: [menp]), (relationship: []), (functional psychoses: [mobd]), (neurodevelopmental disorders: [mobd]), (autism: [mobd]), (transitional period: []), (several years: [qnco]), (psychiatry: []), (traditional descriptive diagnoses: [fndg]), (clinical entities: []), (dimensions): [qnco]), (underlying workings: []), (brain: [bpoc]), 
ASD Terms: (diagnosis, 'Diagnosis')(major psychiatric illness, 'Mental Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(bipolar disorder, 'Bipolar Disorder')(neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')

PMCID: 2797846
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (separate genome-wide association studies: [mbrt]), (single nucleotide polymorphisms (snps): [nusq]), (nonsocial autistic-like traits: [mobd]), (snps: [nusq]), (non-social autistic-like traits: [mobd]), (different snps: [nusq]), (stage: [clna]), (study: [resa]), (allele frequency differences: [qnco]), (autosomal snps: [nusq]), (dna: [bacs,nnon]), (microarrays: []), (high-scoring versus: [qnco]), (low-scoring boys: [aggp]), (general population sample (n = ~400/group): [popg]), (non-social studies: []), ( respectively: []), (qtl association: [gngm]), (independent community sample: [sbst]), (boys: [aggp]), (snp (rs11894053): [nusq]), ((p < .05: [aapp,imft]), (multiple testing): [qnco]), (social autistic-like traits: [mobd]), (sample: [sbst]), (additional snps: [nusq]), (significant (p < .05): [qnco]), ( however: []), (significant association: [menp]), (transmission disequilibrium analyses: [dsyn]), (diagnosed asd families: [cgab]), 
ASD Terms: 

PMCID: 3428055
SFARI Genes: GABRB3, GABRB3, 
Non SFARI Genes: 
Named Entities: (maternal 15q11-q13 duplication: [comd]), (common copy number variant: [nusq]), (autism: [mobd]), ( accounting: []), (1-3%: [fndg]), (cases: [qnco]), (15q11-q13 region: [celc]), (epigenetic regulation: [biof]), (genomic copy number losses: [gngm]), (gains: [qnco]), (genomic disorders: [dsyn]), (parent-of-origin-specific manner: []), (15q11-q13 locus: [gngm]), (gabaa receptor 3 subunit gene (gabrb3): [aapp,rcpt]), (several studies: [lbpr]), (absence epilepsy: [dsyn]), (co-morbidity: []), (epilepsy: [dsyn]), (maternal transmission: [patf]), (gabrb3: [gngm]), (signal peptide variant (p11s): [amas]), (childhood absence epilepsy: [dsyn]), (analysis: [resa]), (mutant 3 subunit-containing 132 gabaa receptors: [aapp,rcpt]), (reduced whole cell: [cell]), (decreased 3 subunit protein: [aapp]), (cell surface: [celc]), (impaired intracellular 3 subunit processing: [celc]), (first evidence: [qnco]), (association: [menp]), (specific gabaa receptor defect: [aapp,rcpt]), (direct evidence: []), (synaptic dysfunction: [dsyn]), (first maternal risk effect: [qnco]), (15q11-q13 autism duplication region: [mobd]), (coding variant: []), 
ASD Terms: (autism, 'Autism Phenotype')(epilepsy, 'Epilepsy')(absence epilepsy, 'Epilepsy')(childhood absence epilepsy, 'Epilepsy')(15q11-q13 autism duplication region, 'Autism Phenotype')

PMCID: 3006666
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (gene expression: [genf]), (blood: [bdsu]), (mercury levels: [lbtr]), (5-year-old boys: [aggp]), (autism (au): [mobd]), ((td) control boys: [aggp]), (possibility: []), (groups: [popg]), (toxicants: [hops]), (mercury: [elii,hops]), (rna: [nnon]), (whole genome affymetrix human u133 expression microarrays: [gngm]), (plasma mass spectrometer: [bdsu]), (analysis: [resa]), (covariance (ancova): [qnco]), (partial correlations: [qnco]), (age: [orga]), (batch effects: [qnco]), (false positives: [lbtr]), (genes: [gngm]), (ancova models: [qnco]), (au: [gngm]), (td: []), (expression: [topp]), (large number: [qnco]), (genes (n: [gngm]), (au boys (p: [aapp,imft]), (represented biological functions: [biof]), (cell death: [celf]), (cell morphology: [clna]), (td boys (p: [aapp,imft]), ( amino acid metabolism: [moft]), (antigen presentation: [celf]), (data: [euka]), (companion study: [anim]), (correlation: []), (lead levels: [lbtr]), (td children: [aggp]), (different correlations: []), (transcript levels: [nnon]), (low levels: [qnco]), (lead: [elii,hops]), (findings: [clna]), (different genetic transcriptional programs: [genf]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s12640-009-9137-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')(autism boys, 'Autism Phenotype')(autism, 'Autism Phenotype')(antigen presentation, 'Allergies')(autism, 'Autism Phenotype')

PMCID: 3006638
SFARI Genes: 
Non SFARI Genes: CD74, 
Named Entities: (objective: []), (study: [resa]), (correlation: []), (gene expression: [genf]), (lead (pb) levels: [elii,hops]), (blood: [bdsu]), (children: [aggp]), (autism (au: [mobd]), (controls (td: [sbst]), (lead levels: [lbtr]), (groups: [popg]), ( au children: [aggp]), (lead: [elii,hops]), (td children: [aggp]), (rna: [nnon]), (affymetrix microarrays: []), (separate analyses: [resa]), (covariance (ancova): [qnco]), (age: [orga]), (gender: [orga]), (td: []), ( au: []), (subjects: [humn]), (td): []), (false positives: [lbtr]), (genes: [gngm]), (ancovas: []), (considered: []), (probe sets: [menp]), (au: [gngm]), (td subjects: [humn]), (log2 pb): [gngm]), (inflammatory processes: [phpr]), (mhc class ii family members: [gngm]), (cd74: [gngm]), (large number (n =: [aapp,imft]), ((p: [aapp,imft]), (au subjects;: [humn]), (many probe sets: [menp]), (similar manner: []), (td groups: [popg]), (data: [euka]), (different associations: [menp]), (transcript levels: [nnon]), (low levels: [qnco]), (underlying genetic differences: [comd]), (other explanations: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s12640-009-9126-x) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')

PMCID: 2774338
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (spectrum: [qnco]), (cognitive disturbances: [fndg]), (childhood development: [orgf]), (numerous approaches: [qnco]), (genes: [gngm]), (development: [orgf]), (autism cases: [mobd]), (single gene disorders: [fndg]), (use: []), (high-resolution: [lbpr]), (genome-wide tilepath microarrays: [gngm]), (comparative genomic hybridization: [mbrt]), (copy number variants: [nusq]), (probands: [orga]), (multiplex autism families: [famg]), (dna methylation analysis: [mbrt]), (bisulfite sequencing: [mbrt]), (proband: [famg]), (family: [famg]), (analysis: [resa]), (methylation analysis: [moft]), (peripheral blood: [bdsu]), (temporal cortex dna: [bpoc]), (controls: [sbst]), (independent datasets: [fndg]), (oxytocin receptor (oxtr) gene expression: [aapp,rcpt]), (temporal cortex tissue: [bpoc]), (quantitative real-time polymerase chain reaction (pcr): [mbrt]), (genomic deletion: [genf]), (oxytocin receptor gene: [aapp,rcpt]), ( oxtr (mim accession no: [gngm]), (autism proband: [mobd]), (mother: [famg]), (symptoms: [sosy]), (obsessive-compulsive disorder: [mobd]), (proband's: [famg]), (deletion: [genf]), (epigenetic misregulation: []), (gene: [gngm]), (aberrant gene silencing: [genf]), (dna methylation: [moft]), (cpg island: [bacs,nnon]), (oxtr expression: [topp]), (several cpg dinucleotides: [bacs,nnon]), (significant increases: [qnco]), (dna methylation status: [moft]), (peripheral blood cells: [cell]), (temporal cortex: [bpoc]), (individuals: [humn]), (samples: [sbst]), (increase: []), (methylation: [moft]), (cpg dinucleotides: [bacs,nnon]), (oxtr mrna: [bacs,nnon]), (decreased expression: [topp]), (age: [orga]), (sex: [orgf]), (data: [euka]), (further evidence: []), (role: [socb]), (oxtr: [gngm]), (oxytocin: [aapp,horm,phsu]), (pathway: [moft]), (etiology: []), (autism and: [mobd]), (first time: [qnco]), (epigenetic regulation: [biof]), (disorder: [dsyn]), (related commentary: [fndg]), (gurrieri: []), (neri:: []), 
ASD Terms: (cognitive disturbances, 'Cognitive Ability')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism cases, 'Autism Phenotype')(multiplex autism families, 'Autism Phenotype')(autism cases, 'Autism Phenotype')(obsessive-compulsive disorder, 'Obsessive-Compulsive Disorder')(autism proband, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism cases, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism and, 'Autism Phenotype')

PMCID: 2770459
SFARI Genes: OXTR, OXTR, OXTR, OXTR, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (group: [popg]), (conditions: [dsyn]), (neurobehavioral impairment: [patf]), (children: [aggp]), (clinical presentation: []), (etiology: []), (major role: [socb]), (genetic factors: [fndg]), (number: [qnco]), (genetic studies: [resa]), (identification: [menp]), (genes and/or: [gngm]), (number variants: [qnco]), (alterations: []), (autism: [mobd]), (specific factor: []), (substantial proportion: [qnco]), (cases: [qnco]), (epigenetic modifications: [genf]), (role: [socb]), (occurrence: []), (genetic conditions: [dsyn]), (mutations: [genf]), (imprinted genes: [gngm]), (regions: []), (article: []), (gregory: []), (al: [lbpr]), (month: []), (bmc medicine: [hops,orch,phsu]), ( reports: [hlca]), (epigenetic alterations: []), (oxtr: [gngm]), (gene: [gngm]), (receptor: [aapp,rcpt]), (oxytocin: [aapp,horm,phsu]), (involvement: []), (deletion: [genf]), (autistic patient: [mobd]), (subsequent analysis: [resa]), (unrelated autistic subjects: [mobd]), (oxtr deletion: [genf]), (hypermethylation: [genf]), (gene promoter: [bacs,nnon]), (reduced mrna expression: [genf]), (findings: [clna]), (major points: [qnco]), (current debate: [acty]), (pathogenesis: [patf]), (human behavior: [inbe]), (possible involvement: []), (epigenetic mechanisms: [genf]), (nature: []), (epigenetic dysregulation: []), (unknown but: []), (failure: [inbe]), (sequence alterations: [genf]), (host: [orgm]), (candidate genes: [gngm]), (practical implications: []), (extension: []), (validation: [resa]), (scale: [acty]), (value: [qnco]), (research paper: [resa]), (al:: [lbpr]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(neurobehavioral impairment, 'Central Nervous System Diseases')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2831962
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (authors: []), (blood mercury (hg) levels: [elii,hops]), (persons: [popg]), (unaffected controls: [sbst]), (blood: [bdsu]), (total hg concentrations: [elii,hops]), (children: [aggp]), (autism: [mobd]), (spectrum disorder (au/asd): [cgab]), ((td) controls: [sbst]), (population-based samples: [popg]), (role: [socb]), (fish consumption: [fish]), (differences: [qnco]), (childhood autism risk: [mobd]), (genetics: []), (environment (charge) study: [orga]), (years: []), (age: [orga]), (diagnostic evaluation: [diap]), (groups: au/asd: [cgab]), ( non-au/asd: [cgab]), (developmental delay (dd): [mobd]), (population-based td controls: [popg]), (mothers: [famg]), (household: [famg]), ( medical: [hlca]), (dietary exposures: [phpr]), (blood hg: [bdsu]), (plasma mass spectrometry: [bdsu]), (multiple linear regression analysis: [qnco]), ((n: [aapp,imft]), (diagnostic status: [fndg]), (hg sources: [elii,hops]), (total hg concentration: [menp]), (au/asd children: [cgab]), (adjustment: [inbe]), (fish: [gngm]), (other hg sources: [elii,hops]), ( blood hg levels: [bdsu]), (td children: [aggp]), (non-fish eaters: [fish]), (direct effect: []), (au/asd diagnosis: [cgab]), (indirect pathway: [moft]), (altered fish consumption: [fish]), (reduction: [npop]), (dd children: [aggp]), (blood hg concentrations: [elii,hops]), (analyses: [resa]), (dental amalgams: [bodm,inch]), (gum-chewing: [bodm]), (teeth-grinding habits: [inbe]), (levels: []), (other differences: [qnco]), (hg: [elii,hops]), (total hg: [elii,hops]), (charge study preschoolers: [aggp]), (au/asd: [cgab]), (representative samples: [sbst]), 
ASD Terms: (autism, 'Autism Phenotype')(childhood autism risk, 'Autism Phenotype')(years of age, 'Onset of Symptoms')(spectrum disorder with developmental delay, 'Learning Disorders')(autism, 'Autism Phenotype')(developmental delay, 'Learning Disorders')(medical, 'Medications')(dietary exposures, 'Exposures')(autism spectrum disorder children, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(spectrum disorder diagnosis, 'Diagnosis')(developmental delay children, 'Learning Disorders')(autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 2772655
SFARI Genes: met, met, SEMA5A, SEMA5A, 
Non SFARI Genes: 
Named Entities: (summary: []), (autism: [mobd]), (heritable neurodevelopmental disorder: [mobd]), ( attempts: [evnt]), (specific susceptibility genes: [gngm]), (limited success: [socb]), (genome-wide association studies: [mbrt]), (markers: [clna]), (large sample sizes: [sbst]), (meta-analysis: [resa]), (great success: [socb]), (genes: [gngm]), (other complex genetic traits (http://www.genome.gov/26525384): [gngm]), (consequently: []), (linkage: [moft]), (association mapping study: [menp]), (genome-wide snps: [nusq]), (common set: [menp]), (multiplex autism families: [famg]), (affected offspring): [famg]), (regions: []), (significant linkage: [moft]), (chromosomes: [celc]), (respectively: []), (initial analysis: [resa]), (genome-wide significant associations; however: [menp]), ( genotyping: [lbpr]), (top hits: [fndg]), (additional families: [famg]), (snp: [nusq]), (chromosome: [celc]), ((between sema5a: [gngm]), (tas2r1): [gngm]), (autism (p: [mobd]), (expression: [topp]), (sema5a: [gngm]), (brains: [bpoc]), (autistic patients: [mobd]), (autism susceptibility gene: [mobd]), (linkage regions: [moft]), (provide targets: [acty]), (rare variation: [gngm]), (discovery: [acty]), (single novel association: [fndg]), (action: [acty]), (common variants: [qnco]), 
ASD Terms: (autism, 'Autism Phenotype')(heritable neurodevelopmental disorder, 'Learning Disorders')(multiplex autism families, 'Autism Phenotype')(autism susceptibility gene, 'Autism Phenotype')

PMCID: 2761880
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (heritable complex neurodevelopmental disorder: [mobd]), (genetic basis: [phsu]), (challenging: [hlca]), (numerous susceptibility genes: [gngm]), (chromosomal abnormalities: [comd]), (association: [menp]), (discoveries: [acty]), (account: [clna]), (small effect: [qnco]), (thus: []), (cases: [qnco]), (causative genetic mechanisms: [topp]), (present work: [qnco]), (autism genetic database (agd): [mobd]), (literature-driven: [inpr,mnob]), ( web-based: []), (access database: []), (aim: [phsu]), (comprehensive repository: []), (genes: [gngm]), (genomic copy number variations: [nusq]), (order: [acty]), (assessment: [acty]), (autism susceptibility: [clna]), (genetic factors: [fndg]), (description agd: []), (relational database: [socb]), (data: [euka]), (exhaustive literature searches: [inpr,mnob]), (susceptibility genes: [gngm]), (cnvs: [nusq]), (furthermore: []), (genomic information: [gngm]), (human fragile sites: [humn]), (rnas: [nnon]), (mirbase: []), ( snorna-lbme-db: [bacs,nnon]), ( pirnabank: []), (mit/icbp sirna database: [bacs,nnon]), (web client genome browser: [gngm]), (features: []), (web client query tool: [grup]), (access: []), (specific information: []), (applicable: []), ( links: []), (external databases: []), (genbank: []), ( pubmed: []), (snorna-lbme-db: [bacs,nnon]), (mit sirna database: [bacs,nnon]), (provided: [acty]), (agd: []), (comprehensive list: []), (copy number variations: [nusq]), (to-date: [aapp,enzy]), (rna genes: [gngm]), (fragile sites: [nusq]), (inclusive autism: [mobd]), (genetic database: []), (evaluation: [hlca]), (autism susceptibility factors: [mobd]), (relation: [socb]), (human diseases: [humn]), (result: [fndg]), (new autism database: [mobd]), (valuable tool: []), (research community: [resa]), (genetic findings: [lbtr]), (complex multifactorial disorder: [dsyn]), (integrated format: [genf]), (genome browser: [gngm]), (web: []), (query client: [grup]), (interest: [menp]), 
ASD Terms: (autism, 'Autism Phenotype')(heritable complex neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism genetic database, 'Autism Phenotype')(autism susceptibility, 'Autism Phenotype')(description autism genetic database, 'Autism Phenotype')(autism susceptibility factors, 'Autism Phenotype')(inclusive autism, 'Autism Phenotype')(new autism database, 'Autism Phenotype')

PMCID: 2730532
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (number: [qnco]), (recombination events: [genf]), (meiosis varies: [celf]), (recombination phenotype differs: [genf]), (male: [orga]), (individuals: [humn]), (gender: [orga]), (study: [resa]), (high-density snp genotypes: [nusq]), (offspring: [famg]), (datasets: []), (recombination landscape: [genf]), (genetic variants: [npop]), (variation: []), (recombination phenotypes: [genf]), (genetic loci: [gngm]), ((rnf212: [gngm]), (inversion: [comd]), (chromosome: [celc]), (icelandic population: [popg]), (first replication: [genf]), (other population: [popg]), (loci (kiaa1462: [gngm]), ( pdzk1: [gngm]), ( ugcg: [gngm]), ( nub1): [gngm]), ( results: [fndg]), (expression studies: [topp]), (support: []), (roles: [socb]), (meiosis: [celf]), (variants: []), (small fraction: [qnco]), (individual variation: [humn]), (recombination: [genf]), (notably: []), (different sequence variants: [npop]), (male recombination phenotypes: [genf]), (different genes: [gngm]), (characterization: [acty]), (natural variation: []), (meiotic recombination: [celf]), (understanding: [menp]), (normal meiotic events: [phsu]), (primary cause: [topp]), (pregnancy loss: [patf]), 
ASD Terms: (offspring in two datasets, 'Perinatal History')(offspring, 'Perinatal History')

PMCID: 2731203
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (dysfunctions: [dsyn]), (prefrontal cortex: [bpoc]), (individuals: [humn]), (autism spectrum disorders: [mobd]), (previous studies: [lbpr]), (first-degree relatives: [qnco]), (asd: [cgab]), (atypical brain activity: [phsf]), (tasks: []), (social function: [socb]), (however: []), (developmental changes: [orgf]), (prefrontal dysfunction: [dsyn]), (genetic influences: [topp]), (phenomena: [phpr]), (present study: [qnco]), (change: [qnco]), (hemoglobin concentration: [lbpr]), (near-infrared spectroscopy: [lbpr]), (children: [aggp]), (adults: [aggp]), (letter fluency test: [lbpr]), (moreover: []), (unaffected siblings: [famg]), (asd participants: [cgab]), (methodology/principal findings study participants: [humn]), (high-functioning asd: [cgab]), ( age-: [orga]), (healthy non-affected siblings: [famg]), (unrelated healthy controls: [fndg]), (years: []), (relative concentration: [menp]), (hemoglobin ([hb]): [aapp,bacs]), (letter fluency task: [clna]), ([oxy-hb] change: [aapp,bacs]), (task: [gngm]), (task performances: [topp]), (groups: [popg]), ([oxy-hb] increases: [aapp,bacs]), (bilateral prefrontal cortex: [bpoc]), (control subjects: [sbst]), (adult: [aggp]), (controls: [sbst]), (asds: [cgab]), (conclusion/significance: [qnco]), (cross-sectional design: [acty]), (results: [fndg]), (study: [resa]), (age-related change: [aggp]), (prefrontal activity: [acty]), (executive processing: [acty]), (first near-infrared spectroscopy study: [lbpr]), (alteration: []), (age-related changes: [aggp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(social function, 'Ability to Converse in Social Settings')(developmental changes in prefrontal dysfunction, 'Learning Disorders')(task performances, 'Task Performance')(task performances, 'Task Performance')

PMCID: 2721832
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, 
Non SFARI Genes: 
Named Entities: (heterogeneous disease: [fndg]), (genetic psychiatry disorder: [dsyn]), (recently: []), ( abnormalities: [cgab]), (synapse: [bsoj]), (etiology: []), (autism.shank3 (sh3: [mobd]), (multiple ankyrin repeat: [moft]), (protein) gene: [gngm]), (master: []), (synaptic scaffolding protein: [aapp,bacs]), (postsynaptic density (psd): [celc]), (excitatory synapse: [celc]), (rare mutations: [genf]), (copy number variation (cnv) evidence: [nusq]), (shank3: [gngm]), (strong candidate gene: [gngm]), (pathogenesis: [patf]), (autism: [mobd]), (association study: [menp]), (shank3 gene polymorphisms: [genf]), (chinese han population: [popg]), (association: [menp]), (single nucleotide: [fndg]), ((snps): [nusq]), (shank3 gene: [gngm]), (chinese han trios: [aapp,enzy]), (family: [famg]), (association test (fbat): [diap]), (linkage disequilibrium (ld) analysis: [dsyn]), (presence: [qnco]), (ld: [gngm]), (pairwise markers: [clna]), (locus: [gngm]), (mutation screening: [genf]), (mutations: [genf]), (previously: []), (significant evidence: [qnco]), (snps: [nusq]), (cohort: [popg]), (major susceptibility gene: [gngm]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3710970
SFARI Genes: 6.3, 6.3, 
Non SFARI Genes: Mb, 
Named Entities: (summary substantial evidence: []), (chromosomal abnormalities: [comd]), (risk: []), (autism: [mobd]), (duplication: [comd]), (human chromosome: [celc]), (frequent cytogenetic abnormality: [comd]), (genetic change: [comd]), (mice: [mamm]), (chromosome engineering: [celc]), (mb duplication: [comd]), (conserved linkage group: [popg]), (mouse chromosome: [mamm]), (paternal duplication display: [comd]), (poor social interaction: [mobd]), (behavioral inflexibility: [inbe]), (abnormal ultrasonic vocalizations: [npop]), (correlates: []), (anxiety: [mobd]), (mbii52 snorna: [bacs,nnon]), (duplicated region: []), (serotonin: [bacs,orch]), (receptor: [aapp,rcpt]), ((5-ht2cr): [qnco]), ( correlates: []), (altered intracellular ca2+ responses: [celc]), (5-ht2cr agonist: [phsu]), (neurons: [cell]), (paternal duplication: [comd]), (chromosome-engineered mouse model: [celc]), (various aspects: [qnco]), (human autistic phenotypes: [humn]), (relevance: []), (human chromosome abnormality: [humn]), (model: []), (forward genetics: []), (developmental brain disorders: [mobd]), (invaluable tool: []), (therapeutic development: [orgf]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(anxiety, 'Anxiety Disorders')(poor social interaction, 'Reciprocal Social Interaction')(abnormal ultrasonic vocalizations, 'Vocalizations')(autism, 'Autism Phenotype')

PMCID: 2695001
SFARI Genes: NRXN1, UBE3A, NRXN1, UBE3A, BZRAP1, BZRAP1, MDGA2, MDGA2, 
Non SFARI Genes: 
Named Entities: (genetics: []), (autism spectrum disorders: [mobd]), (poorly understood: [menp]), (previous work: []), (important role: [socb]), (structural variation: []), (subset: []), (cases: [qnco]), (resolution: [qnco]), (detection: [topp]), (large regions: [qnco]), (potential interest: [menp]), (identification: [menp]), (individual genes: [gngm]), (genes: [gngm]), (asd etiology: [cgab]), (high density: [qnco]), (multiplex families: [famg]), (autism genetics resource exchange (agre) collection: [mobd]), (results: [fndg]), (healthy controls: []), (prioritization: []), (exonic deletions: [bacs,nnon]), (exonic duplications: [bacs,nnon]), (whole gene duplication events: [genf]), (rare variants: [gngm]), (multiple unrelated probands: [orga]), (controls: [sbst]), (importantly: []), (examination: []), (independent replication cohort: [genf]), (loci: [gngm]), (nrxn1: [gngm]), (whole gene duplications: [genf]), (ube3a: [gngm]), (several other genes: [gngm]), (region: []), (course: []), (analyses: [resa]), (strong support: []), (bzrap1: [gngm]), (adaptor molecule: [sbst]), (synaptic transmission: [celf]), (edels: []), (edups: []), (twelve: [qnco]), (unrelated cases: [qnco]), (less: [qnco]), (mdga2: [gngm]), (case-specific (p: [aapp,imft]), (encoded protein: [aapp,bacs]), (high similarity: [qnco]), (contactin: [aapp,bacs]), ((blast e-value =: [qnco]), (hundreds: []), (distinct rare variants: [gngm]), (further highlights complexity: [chvs]), (asds: [cgab]), (points: [qnco]), (need: []), (cohorts: [popg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism genetics resource exchange collection, 'Autism Phenotype')

PMCID: 2921284
SFARI Genes: 
Non SFARI Genes: Mb, Mb, 
Named Entities: (child: [aggp]), (autism: [mobd]), (mild microcephaly: [fndg]), (mb microdeletion: []), (chromosome: [celc]), (hypothesis: []), (microdeletion: []), (genes: [gngm]), (autism phenotype: [mobd]), (other children: [aggp]), (autism spectrum disorders: [mobd]), (submicroscopic: []), (chromosomal rearrangements: [comd]), ( array: []), (comparative genomic hybridisation (acgh): [mbrt]), (k: [qnco]), (whole genome: [gngm]), (human bacterial artificial chromosome (bac) array: [humn]), (illumina: []), (610-quad beadchip microarray: [phsu]), (ingenuity pathway analysis (ipa): []), (functional biological networks: []), (candidate autism genes: [mobd]), (putative functional variants: []), (candidate genes: [gngm]), ( mutation screening: [genf]), (polymerase chain reaction (pcr): [mbrt]), (sanger: []), (unrelated autism patients: [mobd]), (control subjects: [sbst]), (mb deletion: [genf]), (43 genes: [gngm]), (fluorescence: [npop]), (situ hybridization (fish): [mbrt]), (literature review: []), (bioinformatics analyses: [resa]), (regulating synaptic membrane exocytosis: [celc]), ((rims3): [gngm]), (promising autism candidate gene: [mobd]), (mutation screening: [genf]), (gene: [gngm]), (autism patients: [mobd]), (variants: []), ((p.e177a): [aapp,imft]), (sibship: []), (controls: [sbst]), (case report: [clna]), (mutation: [genf]), (data: [euka]), (rims3: [gngm]), (autism causative: [mobd]), (contributory gene: [gngm]), (functional studies: [lbpr]), (rims3 variants: [gngm]), (p.e177a: [aapp,imft]), (additional insight: [menp]), (role: [socb]), (synaptic proteins: [aapp,bacs]), (pathophysiology: [patf]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(autism phenotype, 'Autism Phenotype')(human bacterial artificial chromosome array, 'Bacterial Infections')(candidate autism genes, 'Autism Phenotype')(unrelated autism patients, 'Autism Phenotype')(promising autism candidate gene, 'Autism Phenotype')(autism patients, 'Autism Phenotype')(autism causative, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2705351
SFARI Genes: NOS, NOS, 
Non SFARI Genes: 
Named Entities: (individuals: [humn]), (autism spectrum disorders: [mobd]), (symptoms: [sosy]), (other diagnostic categories: [fndg]), (studies: [lbpr]), (psychosocial outcome: [fndg]), (adult patients: [aggp]), (asds: [cgab]), (concomitant intellectual disability: [mobd]), (objective: []), (paper: []), (clinical psychiatric presentation: [hlca]), (important outcome measures: [qnco]), (large group: [grpa]), (normal-intelligence adult patients: [aggp]), (autistic symptomatology: [mobd]), (dsm-iv-criteria: []), (gillberg: []), (gillberg research criteria: [resa]), ( patterns: []), (comorbid psychopathology: []), (adults: [aggp]), (normal intelligence asds: [cgab]), (subjects: [humn]), (patients: [podg]), (autistic disorder: [mobd]), (asperger's disorder (as): [mobd]), (pervasive developmental disorder: [mobd]), ((pdd nos): [dsyn]), (study group: [popg]), (similar protocols: []), (outpatient basis: [podg]), (clinicians: []), (core: [bdsu]), (autistic symptoms: [mobd]), (asd subgroups: [cgab]), (ad subjects: [humn]), (pervasive problems: []), ( restrictions: []), (non-verbal communication: [menp]), (subgroups: [virs]), (current dsm criteria: [npop]), (verbal communication deficits: [socb]), (lifetime: []), (psychiatric axis: [bpoc]), (comorbidity: []), (mood: [menp]), (anxiety disorders: [mobd]), (adhd: [mobd]), (psychotic disorders: [mobd]), (frequency: [qnco]), (diagnoses: [fndg]), (males: [orga]), (females: [orga]), (antisocial personality disorder: [mobd]), (substance abuse: [mobd]), (pdd nos group: [dsyn]), (independent life: [fndg]), (long-term relationship: []), (female subjects: [orga]), (school: [mnob,orgt]), (male subjects: [orga]), (clinical syndromes: []), (impaired social interaction: [mobd]), (adulthood: []), (childhood: []), (high risk: [fndg]), (co-existing mental health problems: [fndg]), (broad spectrum: [qnco]), (disorders: [dsyn]), (unfavourable psychosocial life circumstances: [phpr]), (next revision: [topp]), (dsm: []), (findings: [clna]), (importance: []), (careful examination: [acty]), (exclusion criterion: [acty]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(concomitant intellectual disability, 'Learning Disorders')(comorbid psychopathology, 'Comorbidities')(normal intelligence autism spectrum disorders, 'Autism Phenotype')(autistic disorder, 'Autistic Disorder')(autistic symptoms, 'Complaints and Indications')(autistic disorder subjects, 'Autistic Disorder')(comorbidity, 'Comorbidities')(mood, 'Mood')(anxiety disorders, 'Anxiety Disorders')(psychotic disorders, 'Schizophrenia and Disorders with Psychotic Features')(substance abuse, 'Substance Abuse')(impaired social interaction, 'Reciprocal Social Interaction')(high risk for co-existing mental health problems, 'Mental Retardation')(co-existing mental health problems, 'Mental Retardation')

PMCID: 2685981
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (identification: [menp]), (numerous autism susceptibility: [clna]), (pathobiology: []), (autism: [mobd]), (present case-control study: [resa]), (global approach: []), (molecular basis: []), (autism spectrum disorders: [mobd]), (large-scale gene expression profiling: [lbpr,mbrt]), (dna microarray analyses: [mbrt]), (lymphoblastoid cell lines: [cell]), (sib pairs: [famg]), (sibling: [famg]), (diagnosis: [fndg]), (order: [acty]), (pathways: [moft]), (cells: [cell]), (nonautistic siblings: [famg]), (bioinformatics: []), (gene: [gngm]), (ontological analyses: [resa]), (data implicate genes: [gngm]), (nervous system: [bdsy]), (development: [orgf]), ( inflammation: [patf]), (cytoskeletal organization: [celf]), (addition: []), (genes: [gngm]), (other physiological symptoms: [sosy]), (moreover: []), (data: [euka]), (processes: [phpr]), (cholesterol/steroid metabolism: [bacs,orch]), (level: [phsu]), (androgenic hormones: [horm,phsu]), (elevation: [topp]), (male hormones: [horm]), (turn: [fndg]), (possible factor: []), (susceptibility: [clna]), (4 times: [qnco]), (many males: [orga]), (females: [orga]), (preliminary metabolic profiling: []), (steroid hormones: [horm,orch]), (several pairs: [qnco]), (siblings reveals: [famg]), (levels: []), (testosterone: [horm,orch,phsu]), (autistic sibling: [famg]), (increased expression: [topp]), (steroidogenesis pathway: [moft]), (global gene expression profiling: [lbpr,mbrt]), (cultured cells: [cell]), (asd: [cgab]), (serves: []), (window: []), (deficits: []), 
ASD Terms: (numerous autism susceptibility, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')

PMCID: 2705502
SFARI Genes: BDNF, BDNF, BDNF, BDNF, 
Non SFARI Genes: 
Named Entities: (single: [fndg]), ((snps): [nusq]), (important markers: [clna]), (association studies: [menp]), (susceptible genes: [gngm]), (complex diseases: [dsyn]), (high-throughput methods: [qnco]), (snp: [nusq]), (large number: [qnco]), (samples: [sbst]), (study: [resa]), (polyacrylamide gel-based microarray: [bodm,phsu]), (dual-color hybridization: [genf]), (association study: [menp]), (bdnf polymorphisms: [aapp,bacs,phsu]), (autism: [mobd]), (snps: [nusq]), (patients: [podg]), (controls: [sbst]), (c270t polymorphism: [genf]), (significant differences: [qnco]), (frequency: [qnco]), (allele (2 =: [gngm]), (p =: [aapp,imft]), (genotype (2 =: [orga]), (p: [gngm]), (haplotype association: [menp]), (significant difference: [qnco]), (global haplotype distribution: [orga]), (groups: [popg]), (bdnf: [gngm]), (possible role: [socb]), (pathogenesis: [patf]), (rapid: []), ( simple: []), (high-throughput method: [lbpr]), (snps genotyping: [mbrt]), (susceptible gene: [gngm]), (disorders: [dsyn]), (large samples: [sbst]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2683930
SFARI Genes: RAI1, RAI1, 
Non SFARI Genes: BRD1, 
Named Entities: (recent identification: [menp]), (copy-number variation: [nusq]), (human genome: [gngm]), (new avenues: []), (discovery: [acty]), (positional candidate genes: [gngm]), (complex genetic disorders: [dsyn]), (field: [irda]), (psychiatric disease: [mobd]), (major challenge: [hlca]), (susceptibility genes: [gngm]), (multitude: []), (disease-associated loci: [dsyn]), (challenge: [hlca]), (reconstruction: [topp]), (functional gene-networks: [moft]), (genes: [gngm]), (loci: [gngm]), (approach: []), (spectrum disorder (asd): [cgab]), (copy-number changes: [qnco]), (dna: [bacs,nnon]), (asd patients: [cgab]), (healthy individuals: [humn]), (illumina humanhap300 beadchips: []), (subsequently: []), (gene-network: [moft]), ( prioritizer: []), (candidate genes: [gngm]), (segmental gains: [qnco]), (losses: [qnco]), (autism cohort: [mobd]), (analysis: [resa]), (several candidate genes: [gngm]), (neuropsychiatric disorders: [dsyn]), (rai1: [gngm]), ( brd1: [gngm]), (large: [gngm]), (large gene: [gngm]), (part: [qnco]), (sub-network: [popg]), (glycobiology: []), ( present: [qnco]), (autism patients: [mobd]), (limited co-morbidity: [fndg]), (de novo: []), (patients: [podg]), (complex phenotype: [orga]), (healthy controls: []), (such sub-network: [popg]), (independent systematic analysis: [fndg]), (published autism susceptibility loci: [mobd]), (involvement: []), (similar genes: [gngm]), (findings: [clna]), (occurrence: []), (genomic gains: [gngm]), (important contributors: []), (development: [orgf]), (asd: [cgab]), 
ASD Terms: (psychiatric disease, 'Mental Disorders')(autism cohort, 'Autism Phenotype')(autism patients, 'Autism Phenotype')(published autism susceptibility loci, 'Autism Phenotype')

PMCID: 2682483
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (researchers: []), (theory: []), (cause autism: [mobd]), (many parents: []), (them: []), (scientists: []), (gap: [gngm]), (evidence: []), (doubt?: [menp]), 
ASD Terms: (cause autism, 'Autism Phenotype')

PMCID: 4023913
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (genetic studies: [resa]), (autism: [mobd]), (past decade: [qnco]), (complex landscape: [chvs]), (multiple genes: [fndg]), (face: [gngm]), (heterogeneity: [orga]), ( studies: [lbpr]), (large extended pedigrees: [qnco]), (valuable insight: [menp]), (few susceptibility genes: [gngm]), (single large families: [fndg]), (genome-wide screen: [gngm]), (families: [famg]), (pedigrees: []), (moderate-sized families: [famg]), (generations: []), (center: [fndg]), (inherited disease research (cidr): [resa]), (illumina linkage panel: [moft]), (polymorphism (snp) platform: [nusq]), (results: [fndg]), (subjects: [humn]), (autism spectrum disorder (asd): [mobd]), (relatives: [famg]), (genome-wide significance: [gngm]), (chromosome: [celc]), (distinct peaks:: [qnco]), (15q13.1-q14 (hlod=4.09: [fndg]), (15q14-q21.1 (hlod=3.59: [fndg]), (15q21.1-q22.2 (hlod=5.31: [celc]), (peaks: [qnco]), (previous findings: [clna]), (additional suggestive results: [fndg]), (chromosomes: [celc]), (2p25.3-p24.1 (hlod=1.87): [celc]), ( 7q31.31-q32.3 (hlod=1.97): [celc]), (13q12.11-q12.3 (hlod=1.93): [celc]), (affected subjects: [humn]), (linkage peaks: [moft]), (study: [resa]), (strong evidence: []), (distinct phenotypic subgroups: [orga]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 2889141
SFARI Genes: CACNA1G, CACNA1G, CACNA1G, CACNA1G, 
Non SFARI Genes: 
Named Entities: (chromosome: [celc]), (region: []), (genome: [gngm]), (susceptibility: [clna]), ((mim[209850]): [gngm]), (prior evidence: [evnt]), (linkage: [moft]), (disorder: [dsyn]), (pedigrees: []), (male probands: [orga]), (autism genetic resource exchange (agre): [mobd]), (previously: []), ( stone: [bdsu]), (high-density snp association study: [menp]), (interval: []), (common variant association: [menp]), (linkage signal: [moft]), (snp-based association study: [menp]), (coverage: []), (lod support interval: [qnco]), (linkage peak: [moft]), (majority: [socb]), (common alleles: [gngm]), (mo trios: [aapp,enzy]), (conclusions markers: [clna]), (gene cacna1g: [gngm]), (autism spectrum disorder: [mobd]), (significant level (p: [aapp,imft]), (cacna1g: [gngm]), (novel candidate: []), (autism: [mobd]), (alleles: [gngm]), (sufficient genetic effect: [topp]), (observed linkage: [moft]), (substantial genetic heterogeneity: [orga]), (clear linkage signal: [moft]), (likely harbors: []), (combination: [fndg]), (rare alleles: [gngm]), (genetic risk: [qnco]), (data: [euka]), (previous studies: [lbpr]), (chromosomes: [celc]), (major common risk alleles: [gngm]), (asd risk: [cgab]), (major linkage peaks: [moft]), (agre sample: [sbst]), (important evidence: []), (strategies: [menp]), (asd genes: [cgab]), (rare variants: [gngm]), (common variants: [qnco]), (small effect: [qnco]), 
ASD Terms: (autism (mim), 'Autism Phenotype')(autism genetic resource exchange, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism genetic resource exchange sample, 'Autism Phenotype')

PMCID: 2727366
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (ados algorithms: [aapp,enzy]), (gotham: []), (al: [lbpr]), ((j autism dev disord: [mobd]), (independent sample: [sbst]), (dutch children: [aggp]), (algorithms: []), (sensitivity: [patf]), (specificity: [qnco]), (modules: []), (efficiency: [qnco]), (classification: []), (restricted repetitive behaviour domain: [fndg]), (algorithm: [lbpr]), (clinical asd classification: [cgab]), (module: []), (results: [fndg]), (improvement: []), (low-functioning population: [popg]), (advantages: []), (strength: [qnco]), (original algorithm: [lbpr]), 
ASD Terms: (restricted repetitive behaviour domain, 'Restricted and Repetitive Behavior')

PMCID: 2758571
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (typically-developing human infants: [humn]), (biological motion: [npop]), (first days: [qnco]), (life1: []), (ability: [orga]), (species2: []), (3: [fndg]), (filial attachment: [acty]), (detection: [topp]), (predators4: []), (neural underpinnings: []), (biological motion perception: [menp]), (brain regions: [blor]), (perception: [menp]), (basic social signals: [phpr]), (facial expression: [fndg]), (gaze direction5: [fndg]), (preferential attention: [menp]), (precursor: []), (capacity: [qnco]), (intentions: [menp]), (however: []), (serendipitous observation7: []), (infant: [aggp]), (autism: [mobd]), (point-light displays: [npop]), (presence: [qnco]), (non-social: []), ( physical contingency: [hlca]), (stimuli: [phpr]), (chance: []), (observation: [hlca]), (hypothesis: []), (children: [aggp]), (early age: [orga]), (consequences: []), (social development: [socb]), (lifelong impairments: [patf]), (social interaction: [fndg]), (hallmark: []), (autism spectrum disorders8: [mobd]), (two-year-olds: [qnco]), (towards: []), (viewing behavior: [inbe]), (response: [fndg]), ( physical contingencies: [hlca]), (physical contingencies: [hlca]), (control children: [aggp]), (far-reaching implications: [orgf]), (altered neurodevelopmental trajectory: [ortf]), (brain specialization: [bpoc]), (autism9: []), 
ASD Terms: (biological motion perception, 'Cognitive Ability')(perception, 'Cognitive Ability')(facial expression, 'Integrated Verbal and NonVerbal Communication')(autism, 'Autism Phenotype')(perception, 'Cognitive Ability')(autism, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(autism spectrum disorders8, 'Autism Phenotype')(social development, 'Ability to Converse in Social Settings')(autism, 'Autism Phenotype')(neurodevelopmental trajectory, 'Learning Disorders')(altered neurodevelopmental trajectory, 'Learning Disorders')

PMCID: 2678711
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (association: [menp]), (gamma-aminobutyric acid-a (gaba-a) receptor subunit 3 (gabrb3) gene: [aapp,rcpt]), (autism spectrum disorders: [mobd]), (korea: []), (fifty-eight children: [aggp]), (asd [47: [cgab]), (years: []), (family trios: [aapp,enzy]), (healthy control: []), ([71 males: [orga]), (recruited: []), (transmission disequilibrium test: [dsyn]), (bp: [gngm]), (gabrb3 gene: [gngm]), (families: [famg]), (asd (p: [cgab]), (population-based case-control study: [resa]), ( however: []), (asd: [cgab]), (gabrb3: [gngm]), (polymorphism: [genf]), (data: [euka]), (preliminary evidence: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 2934739
SFARI Genes: IMMP2L, DOCK4, IMMP2L, DOCK4, DOCK4, DOCK4, 
Non SFARI Genes: AUTS1, AUTS1, AUTS1, 
Named Entities: (autism spectrum disorders: [mobd]), (group: [popg]), (heritable neurodevelopmental disorders: [mobd]), (complex genetic etiology: [chvs]), (international molecular genetic study: [resa]), (autism consortium: [mobd]), (linkage loci: [moft]), (chromosomes: [celc]), (auts1: [gngm]), (auts5: [dsyn]), ( respectively: []), (study: [resa]), (high-density association analysis: [menp]), (polymorphisms (snps): [nusq]), (genes: [gngm]), (region: []), (snps: [nusq]), (sequences: [nusq]), (snp genotype data: [nusq]), (copy number variation: [nusq]), (regions: []), (study sample: [sbst]), (families: [famg]), (linkage: [moft]), (respectively: []), (gender-matched controls: [orga]), (further investigation: [hlca]), (association results: [menp]), (independent european family: [famg]), (affected individuals: [humn]), (association: [menp]), (number: [qnco]), (variant analysis: [resa]), (several genes: [famg]), (immp2l: [gngm]), (dock4: [gngm]), (chromosome: [celc]), (evidence: []), (involvement: []), (autism susceptibility: [clna]), (independent replication: [genf]), (rs2217262: []), (finding: [sosy]), (deletion segregating: [genf]), (sib-pair family: [famg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(heritable neurodevelopmental disorders, 'Learning Disorders')(autism consortium, 'Autism Phenotype')(autism susceptibility, 'Autism Phenotype')

PMCID: 2752466
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, 
Non SFARI Genes: 
Named Entities: (shank3: [gngm]), (chromosome: [celc]), (scaffold protein: [aapp,bacs]), (excitatory synapses: [celc]), (pre-synaptic active zone: [celc]), (binding partner: [moft]), (genes: [gngm]), (mutations: [genf]), (small subset: [qnco]), (individuals: [humn]), (autism: [mobd]), (autism spectrum disorders: [mobd]), (several studies: [lbpr]), (deletions: [genf]), (hundreds: []), (kilobases: [qnco]), (asds: [cgab]), (chromosomal aberrations: [comd]), (involvement: []), (asd: [cgab]), (international molecular genetic study: [resa]), (autism consortium (imgsac) multiplex family: [famg]), (families: [famg]), (snp association: [menp]), (copy number variants: [nusq]), (collection: []), (imgsac: []), (italian probands: [orga]), (singleton families: [famg]), (multiplex ligation-dependent probe amplification: [mbrt]), (cnvs: [nusq]), (snp associations: [menp]), (sample set: [menp]), (sequencing: [mbrt]), (gene: [gngm]), (data: [euka]), (shank3 deletions: [genf]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(autism consortium, 'Autism Phenotype')(autism consortium multiplex family, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2663032
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (normal behavioural development: [inbe]), (interplay: []), (environmental influences: []), (case: []), (psychiatric disorders: [mobd]), (emphasis: []), (past decades: [qnco]), (biological determinism: []), (thus: []), (previous studies: [lbpr]), (autistic spectrum disorders (asd): [mobd]), (parental style: []), (however: []), (animal research: [resa]), (different behavioural traits: [gngm]), (genetic/environmental factors: [topp]), (methodology/ principal findings: [clna]), (present study: [qnco]), (asd: [cgab]), ( language disorders: [mobd]), (social factors: [grpa]), (language: [lang]), (social act: [topp]), (social influences: []), (autism diagnostic interview-revised: [acty]), (early characteristics: []), (sensori-motor: []), (language development: [menp]), (large sample: [sbst]), (children: [aggp]), (asd (n: [cgab]), (parents: []), (different levels: []), (education: [fndg]), (results: [fndg]), (high level: [qnco]), (moreover: []), (first words: [qnco]), (phrases: []), (mother: [famg]), (additional gender effect: [orga]), (conclusions/significance: [qnco]), (knowledge: []), (study: [resa]), (important new lines: []), (thought: [menp]), (help: []), (biological perspectives: []), (new hopes: [menp]), (therapies: [topp]), 
ASD Terms: (psychiatric disorders, 'Mental Disorders')(different behavioural traits, 'Personal Traits')(autism diagnostic interview-revised, 'Autism Phenotype')(language development, 'Language Development')

PMCID: 2708322
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (comorbid problems: []), ((oppositional defiant behaviors: [inbe]), ( anxiety: [mobd]), (autistic traits: [mobd]), ( motor coordination problems: [sosy]), (reading problems): [fndg]), (attention-deficit/hyperactivity disorder (adhd);: [mobd]), (executive: []), (motor problems: []), (endophenotype level: [phsu]), (adhd;: [mobd]), ((ef)and motor-endophenotypes: []), (hypothesis: []), (adhd: [mobd]), (different phenotype: [orga]), (efand: []), (neuropsychological tasks: []), (children: [aggp]), (adhdand control-families: [famg]), (additional data: [euka]), (questionnaires: []), (results: [fndg]), (oppositional defiant behaviors: [inbe]), (important comorbid problems: []), (motor coordination problems: [sosy]), (reading problems: [fndg]), (efand motor-endophenotype: []), (siblings: [famg]), (problems: []), (share: [socb]), (familial/genetic ef: [famg]), (motor deficits: [fndg]), (such results: [fndg]), (anxiety: [mobd]), (users: [humn]), 
ASD Terms: (adhd, 'Attention Deficit Disorder with Hyperactivity')(adhd, 'Attention Deficit Disorder with Hyperactivity')(comorbid problems, 'Comorbidities')(adhd, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(motor problems, 'Motor Skills')(comorbid problems, 'Comorbidities')(adhd, 'Attention Deficit Disorder with Hyperactivity')(important comorbid problems, 'Comorbidities')(motor coordination problems, 'Motor Skills')(anxiety, 'Anxiety Disorders')(motor coordination problems, 'Motor Skills')(motor deficits, 'Motor Skills')(adhd, 'Attention Deficit Disorder with Hyperactivity')(adhd, 'Attention Deficit Disorder with Hyperactivity')




PMCID: 3686873
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (oxidative stress: [comd]), (role: [socb]), (pathogenesis: [patf]), (autism spectrum disorders (asd): [mobd]), (literature: [inpr,mnob]), (contradictory results: [fndg]), (issue: [fndg]), (high number: [qnco]), (peripheral oxidative stress parameters: [comd]), (related issues: [fndg]), (erythrocyte membrane: [celc]), (functional features: []), (lipid composition: [clna]), (autistic children: [podg]), (years: []), (children (td): [aggp]), (erythrocyte: [cell]), (reactive substances: [sbst]), (urinary isoprostane: [bacs,orch]), (hexanoyl-lysine adduct levels: [aapp,bacs,phsu]), (au: [gngm]), (occurrence: []), (imbalance: [sosy]), (redox status: [moft]), (other oxidative stress markers: [comd]), (parameters: [fndg]), ((urinary 8-oxo-dg: [bacs,nnon]), ( plasma: [bdsu]), (radical absorbance capacity: [qnco]), (carbonyl groups: [popg]), ( erythrocyte superoxide dismutase: [aapp,enzy,phsu]), (catalase activities): [moft]), (significant reduction: [npop]), (na+/k+-atpase activity (66%: [moft]), (reduction: [npop]), (erythrocyte membrane fluidity: [celc]), (alteration: []), (erythrocyte fatty acid membrane profile (increase: [celc]), (monounsaturated fatty acids: [bacs,orch]), ( decrease: [qnco]), (epa: []), (dha-3: [orch,phsu]), (consequent increase: [fndg]), (6/3 ratio): [qnco]), (change: [qnco]), (membrane: [celc]), (sialic acid content: [bacs,orch]), (clinical features: [clna]), (findings;: [clna]), (particular: []), ( hyperactivity score: [mobd]), (lipidomic profile: [lbpr]), (membrane fluidity: [moft]), (erythrocyte membrane alterations: [celc]), (asd: [cgab]), (development: [orgf]), (palliative therapeutic protocols: [hcro]), (moreover: []), (marked decrease: [qnco]), (nka: [gngm]), (peripheral biomarker: [clna]), 
ASD Terms: (autistic childrentism spectrum disorders, 'Autistic Disorder')(hyperactivity score, 'Overactivity')(hyperactivity score, 'Overactivity')

PMCID: 3688993
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (brain tissue changes: [bpoc]), (autism spectrum disorders: [mobd]), (multimodal: [diap]), ( whole brain imaging technique: [diap]), (appropriate approach: []), (alterations: []), (gray matter integrity relate: [orch]), (consistent changes: [qnco]), (functional resting state connectivity: [fndg]), (individuals: [humn]), (autism (hfa): [mobd]), (diffusion tensor: [npop]), ((dti): [diap]), ( voxel-based morphometry (vbm): [lbpr]), (state: []), (functional connectivity: []), (magnetic resonance: [npop]), ((fcmri): [diap]), (differences: [qnco]), (brain structure: [bpoc]), (function: [phsf]), (hfa (mean age: [dsyn]), (sd: [gngm]), (male): [orga]), (healthy controls: []), ((mean age: [orga]), (psychological measures: [qnco]), (empathy: [inbe]), (emotionality: [fndg]), (significant dti: [diap]), ( vbm: [topp]), (fcmri findings: [clna]), (regions: []), (functional differences: [qnco]), (hfa participants: [dsyn]), (controls: [sbst]), (right temporo-parietal junction area: [blor]), (left frontal lobe: [bpoc]), (decreased fractional anisotropy (fa) values: [npop]), (decreased functional connectivity: [qnco]), (trend towards: []), (gray matter volume: [tisu]), (bilateral superior temporal gyrus: [bpoc]), (trend: []), (gray matter volume decrease: [tisu]), (temporal lobe: [bpoc]), (hfa individuals: [dsyn]), (fa decrease: [qnco]), (right temporo-parietal region: [blor]), (psychological measurements: [mobd]), (decreased emotionality: [fndg]), (results: [fndg]), (common sites: [qnco]), (functional alterations: []), (order association cortex areas: [bpoc]), (support: []), (long-standing hypothesis: [phsf]), (autism: [mobd]), (disorder: [dsyn]), (impaired higher-order multisensory integration: [genf]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(empathy, 'Empathy')(autism participants, 'Autism Phenotype')(autism individuals, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3688962
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (copy number variants: [nusq]), (important role: [socb]), (predisposition: [clna]), (spectrum disorder (asd): [cgab]), (however: []), (low frequency: []), (widespread genomic distribution: [gngm]), (accurate characterization: [acty]), (utilization: []), (clinical genetics: []), (comprehensive analysis: [resa]), (multi-study: [qnco]), ( genome-wide cnv data: [nusq]), (autdb: []), (genetic database: []), (detailed annotations: []), (scientific reports: [hlca]), (cnvs: [nusq]), (asd individuals: [cgab]), (asd subjects: [cgab]), (2.12109 bp: [gngm]), (genomic data: [gngm]), (remarkable variation: []), (cnv size: [nusq]), (duplications: []), (deletions: [genf]), ( (p: [aapp,imft]), (wilcoxon rank sum test): [qnco]), (examination: []), (cnv burden: [nusq]), (genome: [gngm]), (loci: [gngm]), (significant excess: [qnco]), (altogether: []), (kb: []), (genes: [gngm]), (locus size (20: [fndg]), (kb): []), (gene content: [gngm]), (multigenic (3 genes): [gngm]), (monogenic loci: [gngm]), (cnv data: [nusq]), (control populations: []), (boundaries: []), (asd susceptibility loci: [cgab]), (interestingly: []), (analysis: [resa]), (genomic region prone: [gngm]), (chromosomal rearrangements: [comd]), (various sizes: [phsu]), ( contains: [acty]), (distinct asd susceptibility cnv: [cgab]), (vary: []), (genomic boundaries: [gngm]), ( cnv types: [nusq]), ( inheritance patterns: [genf]), (overlap: [topp]), (autdb cnv data: [nusq]), (valuable insights: [menp]), (genomic characteristics: [gngm]), (asd susceptibility cnv loci: [cgab]), (various clinical settings: [phsu]), (facilitate future genetic research: [resa]), (disorder: [dsyn]), 
ASD Terms: 

PMCID: 3688832
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objective gastrointestinal symptoms: [sosy]), (common feature: [qnco]), (children: [aggp]), (autism: [mobd]), (attention: [menp]), (potential association: [menp]), (celiac disease: [dsyn]), (sensitivity: [patf]), (however: []), ( studies: [lbpr]), (date: []), (immune response: [ortf]), (association: [menp]), (aim: [phsu]), (study: [resa]), (immune reactivity: []), (pediatric patients: [podg]), (strict criteria: []), (potential link: []), (study participants: [humn]), (children (with: [aggp]), (gastrointestinal symptoms): [sosy]), (autism diagnostic observation schedule (ados): [hlca]), (autism diagnostic interview: [acty]), ((adi-r) (n =: []), (unaffected siblings: [famg]), (age-matched healthy controls: [orga]), (serum specimens: [bdsu]), (antibodies: [aapp,imft]), (native gliadin: [aapp,bacs]), (gliadin: [aapp,bacs]), (transglutaminase: [aapp,enzy]), ((tg2): []), (affected children: [aggp]), (hla-dq2: [aapp,imft]), (-dq8 alleles: [gngm]), (levels: []), (igg antibody: [celc]), (unrelated healthy controls: [fndg]), (igg levels: []), (statistical significance: [qnco]), (igg: []), (anti-gliadin antibody response: [lbpr]), (autistic children: [podg]), (gastrointestinal symptoms: [sosy]), (comparison: [acty]), (difference: [qnco]), (iga response: [fndg]), (groups: [popg]), (celiac disease-specific serologic markers: [dsyn]), ( i.e.: [diap,inpr]), ( antibodies: [aapp,imft]), (tg2: []), (patients: [podg]), (controls: [sbst]), (anti-gliadin antibody: [aapp,imft]), (presence: [qnco]), (hla-dq2 and/or -dq8: [aapp,imft]), (subset: []), (autism displays: [mobd]), (mechanism: []), (gi symptoms points: [qnco]), (potential mechanism: []), (immunologic and/or intestinal permeability abnormalities: [bpoc]), 
ASD Terms: (celiac disease, 'Celiac Disease')(autism, 'Autism Phenotype')(celiac disease, 'Celiac Disease')(autism, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(autism diagnostic interview, 'Autism Phenotype')(autism, 'Autism Phenotype')(autistic children with gastrointestinal symptoms, 'Complaints and Indications')(celiac disease-specific serologic markers, 'Celiac Disease')(autism displays, 'Autism Phenotype')

PMCID: 3681934
SFARI Genes: 
Non SFARI Genes: Rho, Mcf2l, RhoA, Mcf2l, 
Named Entities: (interleukin-1 receptor accessory: [aapp,imft,rcpt]), ((il1rapl1): [aapp,rcpt]), (x-linked mental retardation: [dsyn]), (autism spectrum disorder: [mobd]), (il1rapl1: [gngm]), (synapse formation: [ortf]), (cortical neurons: [bpoc]), (il1rapl1-interacting proteins: [aapp,rcpt]), (affinity chromatography: [lbpr]), (mass spectroscopy: [lbpr]), (mcf2-like (mcf2l): [aapp,bacs]), (rho guanine: [nnon]), (exchange factor: [aapp,enzy]), (cytoplasmic toll/il-1 receptor domain: [aapp,imft]), (knockdown: []), (endogenous mcf2l: [gngm]), (treatment: [topp]), (inhibitor: []), (rho-associated protein kinase: [aapp,enzy]), (downstream kinase: [aapp,enzy]), (rhoa: [gngm]), (il1rapl1-induced excitatory synapse formation: [aapp,rcpt]), (expression: [topp]), (turnover: [qnco]), (ampa receptor subunits: [aapp,rcpt]), (insertion: [genf]), (glua1-containing ampa receptors: [aapp,rcpt]), (cell surface: [celc]), (ampa receptors: [aapp,rcpt]), (glua2/3: [gngm]), (mcf2l knockdown: [gngm]), (rock inhibitor treatment: [topp]), (il1rapl1-induced changes: [aapp,rcpt]), (ampa receptor subunit insertions: [aapp,rcpt]), (results: [fndg]), (mcf2l-rhoa-rock: [aapp,enzy]), (il1rapl1-dependent formation: [aapp,rcpt]), (stabilization: [topp]), (glutamatergic synapses: [bsoj]), 
ASD Terms: (x-linked mental retardation, 'Mental Retardation')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 3898364
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (attention-deficit hyperactivity disorder (adhd): [mobd]), (autism spectrum disorder (asd): [mobd]), (factor analyses: [qnco]), (asd traits: [cgab]), (children: [aggp]), (asd: [cgab]), (presence: [qnco]), (restrictiverepetitive behaviour (rrb) factors: [inbe]), (study: [resa]), (exploratory factor analyses: [qnco]), (structure: []), (social communication questionnaire): [socb]), (adhd: [mobd]), (distinct factors: []), (social: []), (rigidity: [sosy]), (previous factor analyses: [qnco]), (clinical asd: [cgab]), (population samples: [popg]), (split: [phpr]), (rrb dimensions: [qnco]), (moreover: []), (hyperactive-impulsive symptoms: [mobd]), (rrb traits: [gngm]), (investigation: [hlca]), 
ASD Terms: (attention-deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism spectrum disorder, 'Autism Phenotype')(attention-deficit hyperactivity disorder, 'Overactivity')(attention-deficit hyperactivity disorder, 'Overactivity')(restrictiverepetitive behaviour traits, 'Personal Traits')

PMCID: 3661504
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (symptoms: [sosy]), (attention-deficit/hyperactivity disorder (adhd): [mobd]), (children: [aggp]), (autism spectrum disorders: [mobd]), (objective: []), (current study: [resa]), (memory: [menp]), ( acquisition: [acty]), (recall: [menp]), (high-functioning autism (hfa): [mobd]), (adhd: [mobd]), (children (tdc): [aggp]), (thirty-eight children: [aggp]), (hfa: [dsyn]), (tdc (age: [orga]), (letter/number: [qnco]), (task: [gngm]), (verbal list-learning task: [menp]), (possible influence: []), (attention problems: []), (hfa group: [dsyn]), ((hfa+): [dsyn]), ((hfa) attention problems: [dsyn]), (child behaviour checklist: [diap,inpr]), (hfa+: [dsyn]), (significant impairment: [patf]), (neurocognitive measures: [qnco]), (tdc: []), (working memory: [menp]), (acquisition measures: [qnco]), (hfa+ group: [dsyn]), (adhd group: [mobd]), (verbal working memory: [menp]), (recall measures: [menp]), (results: [fndg]), (proposition: []), ( hfa: [dsyn]), (clinical level: [phsu]), (neurocognitive level: [phsu]), (implications: []), (treatment: [topp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(memory, 'Working Memory')(high-functioning autism, 'Autism Phenotype')(high-functioning autism, 'Autism Phenotype')(high-functioning autism, 'Autism Phenotype')(high-functioning autism group, 'Autism Phenotype')(high-functioning autism, 'Autism Phenotype')(neurocognitive measures, 'Cognitive Ability')(working memory, 'Working Memory')(attention-deficit/hyperactivity disorder group, 'Attention Deficit Disorder with Hyperactivity')(verbal working memory, 'Working Memory')(high-functioning autism, 'Autism Phenotype')(attention-deficit/hyperactivity disorder differ, 'Attention Deficit Disorder with Hyperactivity')(neurocognitive level, 'Cognitive Ability')

PMCID: 3655150
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum conditions: [mobd]), (spectrum conditions: [dsyn]), (communicative functioning: [socb]), (features: []), (different etiological factors: []), (hypotheses: []), (independent: [fndg]), (diametric): []), (possible relationship: []), (ascs: []), (sscs: [qnco]), (predictions: []), (relationships: []), (schizotypal phenotypes: [orga]), (autism spectrum quotient: [qnco]), (schizotypal personality questionnaire-brief: [mobd]), (large non-clinical sample: [sbst]), (undergraduate students: [popg]), (previous research: [resa]), (autistic features: [mobd]), (several schizotypal features: [qnco]), (interpersonal schizotypy: []), (communication phenotypes: [socb]), (first component: [qnco]), (principal components analysis (pca): [qnco]), (subscale scores: [clna]), (positive correlations: [fndg]), (presence: [qnco]), (axis (pc1): [bpoc]), (general social interest: [menp]), (aptitude: [menp]), (second principal component (pc2): [gngm]), (pattern: []), (negative loadings indicative: [acty]), (axis: [bpoc]), (autism: [mobd]), (positive schizotypy: [fndg]), (positive schizotypal features: [fndg]), (opposite direction: []), (overall pca patterns: []), (second data set: [qnco]), (japanese population: [popg]), (validity: [qnco]), (interpretation: [clna]), (pca results: [fndg]), (handedness: [orga]), (mental rotation ability: [orga]), (correlates: []), ( respectively: []), (pc2 scores: [clna]), (hand preference: [fndg]), (schizotypal scores: [clna]), (reduced strength: [sosy]), (pc1 scores: [clna]), (performance: [inbe]), (mental rotation: [menp]), (trade-offs: []), (social skills: [socb]), (visual-spatial ability: [menp]), (results: [fndg]), (novel evidence: []), (autism-positive schizotypy axis: [bpoc]), (importance: []), (psychological variation: [mobd]), (social interest: [menp]), (functioning: []), (diverse causes: []), 
ASD Terms: (autism spectrum conditions, 'Autism Phenotype')(schizophrenia spectrum conditions, 'Schizophrenia and Disorders with Psychotic Features')(communicative functioning, 'Reciprocal Social Interaction')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum quotient, 'Autism Phenotype')(general social interest, 'Social Interest')(autism, 'Autism Phenotype')(schizophrenia spectrum conditions, 'Schizophrenia and Disorders with Psychotic Features')(suggesting trade-offs between social skills, 'Ability to Converse in Social Settings')(social skills, 'Ability to Converse in Social Settings')(social interest, 'Social Interest')

PMCID: 3652084
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (severe neurodevelopmental disorder: [mobd]), (diverse pathophysiological processes: [phpr]), (recent gene expression data: [genf]), (control: [sbst]), (normal differential gene expression: [genf]), (temporal cortex: [bpoc]), (autistic brains: [mobd]), (regional de-differentiation occurs: [celf]), (autistic brain: [mobd]), (high resolution: [lbpr]), (genome-wide rna expression microarrays: [genf]), (brain specimens: [bpoc]), (stringent selection criteria: []), (gene expression data: [genf]), (other regions: brodmann area: [blor]), ((occipital cortex): [bpoc]), (cerebellar cortex: [bpoc]), (contrast: [irda]), (frontal/temporal cortical data: [euka]), (data: [euka]), (attenuation: [acty]), (regional specialization: []), (cerebellar cortical regions: [bpoc]), 
ASD Terms: (autism, 'Autism Phenotype')(severe neurodevelopmental disorder, 'Learning Disorders')

PMCID: 3651174
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (complex developmental disability: [mobd]), (deficits: []), (social interaction: [fndg]), ( language: [lang]), (repetitive stereotyped behaviors: [mobd]), (interests: [menp]), (great heterogeneity: [orga]), (previous findings: [clna]), (atypical brain connectivity patterns: [bpoc]), (small-world network properties: [popg]), (however: []), (organizational alterations: [orgt]), (autistic brain network: [popg]), (possible organizational alterations: [orgt]), (autistic children: [podg]), (brain network metrics: [orch,phsu]), (cortical thickness correlations: [bpoc]), (modules: []), (controls: [sbst]), (cortical regions: [bpoc]), (brain functions: [ortf]), (executive strategic: [menp]), ( spatial/auditory/visual: [gngm]), (self-reference/episodic memory: [menp]), (similar patterns: []), ( autism: [mobd]), (gross network modularity: [popg]), (number: [qnco]), (inter-module connections: []), (autistic brain network demonstrates: [popg]), (inter-module connectivity: []), (brain regions: [blor]), (middle frontal gyrus: [bpoc]), (inferior parietal gyrus: [bpoc]), (cingulate: []), (underlying compensatory mechanism: []), (self-reference: []), (episodic memory: [menp]), (results: [fndg]), (correlation strength: [qnco]), (regions: []), (frontal lobe: [bpoc]), (impaired correlation strength: [qnco]), (frontoparietal regions: []), (alteration: []), (organization alteration: [orgt]), (network structures: [popg]), (autistic brains: [mobd]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(complex developmental disability, 'Learning Disorders')(repetitive stereotyped behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(brain functions of executive strategic, 'Executive Function')(self-reference/episodic memory, 'Working Memory')(autism, 'Autism Phenotype')(episodic memory, 'Working Memory')

PMCID: 3619456
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (hope: [menp]), (early markers: [clna]), (autism: [mobd]), ( attention: [menp]), (study: [resa]), (infants: [aggp]), (risk: []), (siblings: [famg]), (children: [aggp]), (condition: [dsyn]), (heritable: []), ( later-born siblings: [famg]), (diagnosed children: [aggp]), (autism phenotype: [mobd]), (general population: [popg]), (currently: []), (strong predictors: []), (early infancy: []), (diagnosis: [fndg]), (years: []), (age: [orga]), (indicators: [irda]), (brain functioning: [ortf]), (sensitive predictors: [patf]), (atypical social interactions: [fndg]), (syndrome: [dsyn]), (temporal lobe specialization: [bpoc]), (auditory social stimuli: [phsf]), (infancy differs: []), (functional near-infrared spectroscopy study: [lbpr]), ( infants: [aggp]), (months: []), (selective neural responses: [genf]), (social stimuli (auditory: [phpr]), (visual): []), (low-risk controls: [fndg]), (group differences: [popg]), (overall levels: []), (attention: [menp]), ( developmental stage: []), (chronological age: [orga]), (results: [fndg]), (first demonstration: [qnco]), (specific differences: [qnco]), (localizable brain function: [ortf]), (life: []), (group: [popg]), (further: []), (differences: [qnco]), (patterns: []), (neural atypicality: []), (adults: [aggp]), (future work: []), (infant neural responses: [aggp]), (social stimuli: [phpr]), (unaffected family members: [famg]), 
ASD Terms: (autism, 'Autism Phenotype')(autism phenotype, 'Autism Phenotype')(autism, 'Autism Phenotype')(years of age, 'Onset of Symptoms')(early infancy, 'Perinatal History')(diagnosis, 'Diagnosis')(infancy differs, 'Perinatal History')(atypical social interactions, 'Reciprocal Social Interaction')(social stimuli than low-risk controls, 'Ability to Converse in Social Settings')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3653096
SFARI Genes: SCN5A, SCN5A, CACNA1C, CACNA1C, 
Non SFARI Genes: KCNQ1, KCNH2, KCNE1, 
Named Entities: (timothy syndrome: [dsyn]), (qt syndrome type: [dsyn]), (ventricular tachyarrhythmia: [dsyn]), (30-month-old boy: [aggp]), (sudden cardiac arrest: [patf]), (anesthesia induction: [topp]), (plastic surgery: [topp]), (bilateral cutaneous syndactyly: [fndg]), (successful resuscitation: [topp]), (qt: [qnco]), (interval (qtc: []), ( 0.58-0.60 sec): [fndg]), (t-wave alternans: [fndg]), (electrocardiogram: [fndg]), (-blocker: []), (further tachycardia: [patf]), (collapse event: [patf]), (arrhythmic events: [evnt]), (genes kcnq1: [gngm]), ( kcnh2: [gngm]), ( kcne1: [gngm]), (scn5a: [gngm]), (long qt syndrome: [dsyn]), (mutation p.gly406arg: [genf]), (cacna1c: [gngm]), (l-type calcium channel depolarization: [aapp,bacs]), (heart: [bpoc]), (other systems: []), 
ASD Terms: 

PMCID: 3649927
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (disorder: [dsyn]), (disease: [dsyn]), (abnormal neurodevelopment: [ortf]), (present work: [qnco]), (hypothesis: []), (suite: []), (core: [bdsu]), (autism-related traits: [mobd]), (simple delays: []), (non-completion: []), (typical childhood: []), (developmental trajectories: [orgf]), (discussion: [socb]), (comprehensive review: []), (literature: [inpr,mnob]), (regard: []), (phenotypes: [orga]), ((1): [fndg]), (interests: [menp]), (repetitive behavior: [fndg]), ( (2) short-range: [qnco]), (functional brain connectivity: [bpoc]), ( (3): [fndg]), (local visual perception: [orgf]), (processing: [acty]), (presence: [qnco]), (differences: [qnco]), (autistic individuals: [mobd]), (individuals: [humn]), (children: [aggp]), (summary: []), (results: [fndg]), (study: [resa]), (model: []), (developmental heterochrony: [orgf]), (evolutionary extension: [genf]), (child development: [orgf]), (human lineage: [humn]), (genetic risk: [qnco]), (expression: [topp]), (autistic perception: [mobd]), ( cognition: [menp]), (behavior: [inbe]), 
ASD Terms: (autism, 'Autism Phenotype')(restricted interests, 'Restricted Range of Interests')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(local visual perception, 'Visual Thinking')(autism, 'Autism Phenotype')(autistic perception, 'Cognitive Ability')(cognition, 'Cognitive Ability')(cognition, 'Cognitive Ability')

PMCID: 3636468
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (psychiatric disorders: [mobd]), (diverse set: [menp]), (diseases: [dsyn]), (aspects: [qnco]), (mental function: [menp]), (social interaction: [fndg]), ( thinking: [menp]), ( feeling: [menp]), (mood: [menp]), (large economic burden: [qnco]), (drugs: [topp]), (variable efficacy: [resa]), (intolerable side-effects: [patf]), (development: [orgf]), (novel drugs: [topp]), (lack: []), (knowledge: []), (etiology: []), (further investigate psychiatric disorders: [mobd]), (combination: [fndg]), (human molecular genetics: [humn]), (gene-by-environment studies: [gngm]), (biochemistry: []), (animal models: [anim]), (investigation: [hlca]), (non-biological basis: [phsu]), (environmental effects: [npop]), (many psychiatric disorders: [mobd]), (autism spectrum: [mobd]), (attention-deficit/hyperactivity disorder: [mobd]), (mental retardation: [mobd]), (schizophrenia: [mobd]), (alterations: []), (neural development: [orgf]), (zebrafish: [fish]), (popular model: [socb]), (developmental biology: []), (human disease: [humn]), (recent work: []), (approach: []), (well: []), (however: []), (complex mental functions: [menp]), (human specific: [humn]), (fish: [gngm]), (review: []), (suitability: []), (developmental studies: [orgf]), (genetic tools: [topp]), (them: []), (powerful model: [hcpp]), (roles: [socb]), (genes: [gngm]), (relative speed: [qnco]), (ease: [menp]), (experiments: [resa]), (areas: []), (contribution: [acty]), (environmental factors: []), (onset: [qnco]), (screening: [diap]), (novel therapeutic compounds: [chem]), 
ASD Terms: (mental function, 'Cognitive Ability')(psychiatric disorders, 'Mental Disorders')(social interaction, 'Reciprocal Social Interaction')(mood, 'Mood')(further investigate psychiatric disorders, 'Mental Disorders')(many psychiatric disorders, 'Mental Disorders')(autism spectrum, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(mental retardation, 'Mental Retardation')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(complex mental functions, 'Cognitive Ability')(disease onset, 'Onset of Symptoms')

PMCID: 3899449
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (traits: [gngm]), (autistic spectrum disorders: [mobd]), (attention deficit hyperactivity disorder (adhd): [mobd]), (significance: [qnco]), (presence: [qnco]), (terms: [orgf]), (phenotype: [orga]), (underlying neurobiology: []), (analysis: [resa]), (levels: []), (autistic traits: [mobd]), (social communication questionnaire (scq): [socb]), ( index: [qnco]), (severe presentation: []), (large: [gngm]), (sample: [sbst]), (children: [aggp]), (adhd (n: [mobd]), (regression analyses: []), (association: [menp]), (scq scores: [clna]), (core adhd: [mobd]), (clinical comorbidities: []), (developmental features: [orgf]), (adjustment: [inbe]), (putative confounders: []), (outcomes: []), (total scq score: [clna]), (secondary analyses: [neop]), (differential association: [menp]), (asd sub-domains: [cgab]), (results: [fndg]), (asd symptomatology: [cgab]), (adhd: [mobd]), (severe phenotype: [fndg]), (oppositional: [menp]), ( conduct: [inbe]), (anxiety symptoms: [fndg]), (full-scale iq: [acty]), (memory deficits: [mobd]), (general motor problems: [hlca]), (associations: [menp]), (adhd severity: [mobd]), (autistic symptomatology: [mobd]), (severity: []), (comorbid impairments: [patf]), (context: [fndg]), (sub-domain scores: [clna]), (unique contributions: [acty]), (social deficits: []), (oppositional symptoms: [sosy]), (repetitive behaviours: [inbe]), (hyperactive-impulsive symptoms: [mobd]), (motor problems: []), (clinicians: []), (repetitive traits: [gngm]), (diagnostic criteria: []), (asd: [cgab]), (index: [qnco]), (phenotypic complexity: [orga]), (implications: []), (efficacy: [resa]), (interventions: [hlca]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s00787-013-0398-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autistic spectrum disorders, 'Autistic Disorder')(attention deficit hyperactivity disorder, 'Overactivity')(social communication questionnaire, 'Reciprocal Social Interaction')(social communication questionnaire, 'Reciprocal Social Interaction')(core attention deficit hyperactivity disorder, 'Overactivity')(clinical comorbidities, 'Comorbidities')(total social communication questionnaire, 'Reciprocal Social Interaction')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(anxiety symptoms, 'Anxiety Disorders')(memory deficits, 'Working Memory')(general motor problems, 'Motor Skills')(comorbid impairments, 'Comorbidities')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention deficit hyperactivity disorder severity, 'Overactivity')(social deficits, 'Social Competence')(repetitive behaviours, 'Restricted and Repetitive Behavior')(motor problems, 'Motor Skills')

PMCID: 3631200
SFARI Genes: ATP2B2, ATP2B2, ATP2B2, ATP2B2, ATP2B2, ATP2B2, ATP2B2, ATP2B2, ATP2B2, ATP2B2, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (heritability: []), (atp2b2: [gngm]), (human chromosome: [celc]), (plasma membrane: [celc]), (calcium-transporting atpase: [aapp,enzy]), (extrudes ca2+: [orch]), (cytosol: [celc]), (extracellular space: [bsoj]), (recent studies: [lbpr]), (association: [menp]), (samples: [sbst]), (autism genetic resource exchange (agre): [mobd]), (italy: []), (study: [resa]), (atp2b2 polymorphisms: [genf]), (chinese han population: [popg]), (family: [famg]), (association study: [menp]), (snps (rs35678: [nusq]), (exon: [bacs,nnon]), ( rs241509: []), ( rs3774180: []), ( rs3774179: []), (rs2278556: []), (introns): [bacs,nnon]), (autism trios: [aapp,enzy]), (han chinese descent: [famg]), (snps: [nusq]), (sequenom genotyping platform: [lbpr]), (family-based association test (fbat) program: [socb]), (association test: [diap]), (haplotype analyses: [orga]), (preferential transmission: [patf]), (t allele: [gngm]), (rs3774179: []), (affected offsprings: [famg]), (additive model (t>c: [clna]), ( z: []), (p: [gngm]), (c allele: [gngm]), (undertransmission: []), (parents: []), (affected children: [aggp]), (dominant model: []), ((z = 2.482: [qnco]), ( p: [aapp,imft]), (z = 2.591: [qnco]), (haplotype: [orga]), (haplotypes: [orga]), (haplotype c-c (rs3774180rs3774179): [orga]), (significant undertransmission: [qnco]), (specific: []), (global haplotype fbat (z = 2.037: [orga]), (global p: []), (c-a: []), (protective haplotype (z = 2.206: [orga]), (t-a: [topp]), (excess transmission: [patf]), (results: [fndg]), (permutation method: [lbpr]), (empirical p values: [qnco]), (research: [resa]), (role: [socb]), (etiology: []), 
ASD Terms: (autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism genetic resource exchange, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism trios, 'Autism Phenotype')(affected offsprings, 'Perinatal History')(autism, 'Autism Phenotype')

PMCID: 3626795
SFARI Genes: 
Non SFARI Genes: F2, 
Named Entities: (autism: [mobd]), (agenesis: [cgab]), (corpus callosum (agcc): [bpoc]), (anatomic phenotypes: [orga]), (genetic etiologies: [topp]), (btbr t+ tf/j (btbr) strain: [aapp,imft]), (penetrant agcc: []), (diminished hippocampal commissure: [bsoj]), (abnormal behaviors: [mobd]), (face validity: []), (genetic basis: [phsu]), (disorders: [dsyn]), (progeny: [famg]), (f2 intercross: [gngm]), (btbr: [mamm]), (c57bl/6j strains: [mamm]), (social behaviors: [socb]), (juveniles: [aggp]), (adults): [aggp]), (commisural morphology: [fndg]), (markers: [clna]), (quantitative trait loci (qtl): [gngm]), (genome scans;: [mbrt]), (significant loci: [gngm]), (btbr genome: [gngm]), (candidate genes: [gngm]), (six qtl: [gngm]), (genome-wide significance: [gngm]), (autism-relevant behaviors: [mobd]), (chromosomes: [celc]), (novel qtl: [gngm]), (commissural morphology: [fndg]), (significant qtl (lod: [qnco]), (callosal morphology: [fndg]), (distal end: []), (chromosome: [celc]), (several qtl: [gngm]), (autism-relevant traits: [mobd]), (btbr mouse: [mamm]), (twenty-nine candidate genes: [gngm]), (synaptic activity: [acty]), ( axon guidance: [celf]), (neural development: [orgf]), (role: [socb]), (processes: [phpr]), (white matter tract development: [tisu]), (aspects: [qnco]), (findings: [clna]), (mouse model: [emod]), (preclinical studies: [resa]), (agcc: []), 
ASD Terms: (autism, 'Autism Phenotype')(abnormal behaviors, 'Personal Traits')(social behaviors, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')

PMCID: 3626551
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (brain inflammation: [dsyn]), (pathogenesis: [patf]), (neuropsychiatric diseases: [dsyn]), (autism spectrum disorders: [mobd]), (learning disabilities: [mobd]), (children: [aggp]), (usa: []), (definitive pathogenesis: [patf]), (reliable biomarkers: [clna]), (asd: [cgab]), (development: [orgf]), (effective therapies: [topp]), (many children: [aggp]), (asd regress: [cgab]), (age: [orga]), (years: []), (specific event: [evnt]), (reaction: []), (infection: [dsyn]), ( stress: [fndg]), (trauma: [inpo]), (epigenetic triggers: [clna]), (distinct phenotype: [orga]), (asd children: [cgab]), (food: [imft,phsu]), (skin allergies: [dsyn]), (hormone (crh): [horm]), (stress: [fndg]), (neurotensin (nt): [aapp,horm]), (mast cells: [cell]), (microglia: [cell]), (focal brain inflammation: [dsyn]), (neurotoxicity: [inpo]), (nt: [diap]), (serum: [bdsu]), (mitochondrial dna (mtdna): [bacs,nnon]), (cell secretion: [celf]), (mtdna: [bacs,nnon]), (innate pathogen: [orgm]), (auto-inflammatory response: [patf]), (phosphatase: [aapp,enzy]), (tensin homolog (pten) gene mutation: [aapp,enzy]), (risk: []), (hyper-active mammalian target: [mobd]), (rapamycin (mtor) signalling: [aapp,enzy]), (cellular homeostasis: [celf]), (crh: [gngm]), ( nt: [diap]), (environmental triggers: [clna]), (activated mtor: [aapp,enzy]), (stimulate mast cell: [cell]), (microglia activation: [celf]), (proliferation: [patf]), (natural flavonoid luteolin inhibits: [orch,phsu]), (significant benefit: [qnco]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(learning disabilities, 'Learning Disorders')(trauma, 'Post-Traumatic Stress Disorders')(skin allergies, 'Allergies')

PMCID: 3610904
SFARI Genes: 
Non SFARI Genes: Atxn1L, Atxn1L, 
Named Entities: (hematopoietic stem cells (hscs): [cell]), (rare quiescent cells: [cell]), (cellular components: [celc]), (peripheral blood: [bdsu]), (ataxia-associated gene ataxin-1-like (atxn1l): [sosy]), (hscs: [cell]), (role: [socb]), (hsc function: [phsf]), (vitro: []), (vivo assays: [lbpr]), (mice: [mamm]), (atxn1l: [gngm]), (numbers: [qnco]), (blood: [bdsu]), (wild-type counterparts: [gngm]), (molecular analyses: [mbrt]), (null hscs: [cell]), (gene expression changes: [genf]), (program consistent: [phsu]), (level: [phsu]), (proliferation: [patf]), (novel regulator: []), (hsc quiescence: [cell]), (additional brain-associated genes: [gngm]), (candidates: []), (hematologic regulation: [biof]), (genes: [gngm]), (proteins: [aapp,bacs]), (ataxia-associated proteinprotein interaction networks: [sosy]), (representation: [acty]), (hematopoietic cell populations: [popg]), (interactomes: []), (progeny: [famg]), (data: [euka]), (heretofore: []), (unappreciated similarity: []), (regulatory modules: []), (brain: [bpoc]), (new strategy: [menp]), (novel gene discovery: [mbrt]), (systems: []), 
ASD Terms: 

PMCID: 3690969
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (children: [aggp]), (autism: [mobd]), (elevated frequency: [qnco]), (large: [gngm]), (rare copy number variants: [nusq]), (however: []), (global load: [acty]), (deletions: [genf]), (se: [gngm]), (size: []), ( location: [blor]), (relationship: []), (clinical manifestations: []), (cnv data: [nusq]), (individuals: [humn]), (typical development: [orgf]), (population-based childhood autism risks: [mobd]), (genetics: []), (environment (charge) study: [orga]), (regions: []), (segmental duplications: [nnon]), (hotspots): [nusq]), (events: [evnt]), (>50 kbp: [aapp,enzy,rcpt]), (entire genomic backbone: [gngm]), (variants: []), (custom: [acty]), (dna microarray: [mbrt]), (analysis: [resa]), (separate study: [resa]), (dynamic hotspots: [nusq]), (developmental delay syndromes: [dsyn]), (tiled array platform (>1 kbp): [aapp,enzy,rcpt]), (gender: [orga]), (ethnicity: [popg]), (significant increase: [qnco]), (number: [qnco]), (base pairs: [moft]), (duplication: [comd]), (levels: []), (cnv load: [nusq]), (removal: [topp]), (rare: [gngm]), (likely pathogenic events: [evnt]), (entire cnv load: [nusq]), (tiled array: []), (common variants: [qnco]), (impact: [gngm]), (variation: []), (correlation: []), (clinical outcomes: []), (level: [phsu]), (social skills: [socb]), (vineland adaptive behavior scales: []), ((spearman's r = 0.13: [fndg]), ( p: [aapp,imft]), (duplication cnv load: [nusq]), (affected children;: [aggp]), (association: [menp]), (communication (p: [socb]), (socialization (p: [edac]), (scores: [clna]), (cnv: [nusq]), (genomic base pairs: [moft]), ( predisposes: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(population-based childhood autism risks, 'Autism Phenotype')(developmental delay syndromes, 'Learning Disorders')(social skills, 'Ability to Converse in Social Settings')(vineland adaptive behavior scales, 'Adaptive Life Skills')

PMCID: 3680076
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (investigation: [hlca]), (environmental contribution: [acty]), (developmental neurotoxicity: [inpo]), (many environmental chemical exposures: [inpo]), (development: [orgf]), (neurological disorders: [dsyn]), (children: [aggp]), (results: [fndg]), (animal studies: [anim]), (investigations: [hlca]), (human populations: [popg]), (environmental toxicants: [hops]), (drugs: [topp]), (neurotoxicity: [inpo]), (treatment: [topp]), (neurodevelopmental disorders: [mobd]), (objective: []), (protective: []), (therapeutic effects: [clna]), (n-acetyl cysteine: [aapp,phsu]), (brain intoxication: [bpoc]), (propionic acid (ppa): [orch]), (rats: [mamm]), (twenty-eight young male: [orga]), (western albino rats: [mamm]), (present study: [qnco]), (equal groups: [popg]), (animals: [anim]), (group: [popg]), (control group: [grup]), (saline; group: [sbst]), (ppa-treated group: [mobd]), (neurotoxic dose: [inpo]), (ppa: [mobd]), (mg/kg body weight/day: [qnco]), (days; group: [popg]), (protective group: [popg]), (dose: [qnco]), (mg/kg body: [humn]), (weight/day n-acetyl-cysteine: [orga]), (week: []), (similar dose: [qnco]), (days;: []), (therapeutic group: [topp]), (same dose: [qnco]), (toxic dose: [qnco]), (serotonin: [bacs,orch]), ( interferon gamma: [aapp,imft,phsu]), (glutathione-s-transferase activity: [moft]), (comet dna: [mbrt]), (brain tissue: [bpoc]), (different groups: [lbpr]), (data: [euka]), (multiple signs: [fndg]), (brain toxicity: [bpoc]), (depletion: []), ((5ht): [bacs,orch]), ( increase: []), (ifn-: []), (inhibition: [acty]), (biomarkers: [clna]), (brain dysfunction: [dsyn]), (tail length: [bpoc]), (dna % damage: [comd]), (tail moment: [bpoc]), (n-acetyl-cysteine: [aapp,phsu]), (neurotoxic effects: [inpo]), (low dose: [qnco]), (short duration: []), (n-acetyl-cysteine treatment: [aapp,phsu]), (ppa-induced neurotoxicity: [mobd]), (remarkable amelioration: []), (impaired biochemical parameters: [fndg]), (neurochemical: []), ( inflammatory: []), ( detoxification: [orgf]), (dna damage processes: [comd]), 
ASD Terms: (neurological disorders, 'Neurologic Indications')(many environmental chemical exposures, 'Exposures')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 3884762
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (chromosomal copy number variants: [celc]), (common genetic lesion: [fndg]), (autism: [mobd]), (many autism-associated cnvs: [nusq]), (duplications: []), (chromosome: [celc]), (cases: [qnco]), (interstitial (int) dup(15): [blor]), (unaffected paternal duplications: [famg]), (phenotype/genotype analysis: [orga]), (individuals: [humn]), (understanding: [menp]), (syndrome: [dsyn]), (contribution: [acty]), (duplication: [comd]), (autism risk: [mobd]), (subjects: [humn]), (basis: [phsu]), (interstitial duplication: [comd]), (status: []), (comparative array: []), (genome hybridization: [npop]), (duplication size: [comd]), (boundaries: []), (methylation status: [moft]), (small nuclear ribonucleoprotein: [aapp,bacs]), (n gene: [gngm]), (parent: []), (origin: []), (parental origin: []), (int dup(15): [orch]), (paternal cases: [qnco]), (majority: [socb]), (int dup(15) cases: [orch]), (maternal duplication: [comd]), (autism spectrum disorder: [mobd]), (size: []), (severity: []), (phenotype: [orga]), (autism diagnostic observation scale: [hlca]), (severity score: [qnco]), (phenotypes: [orga]), (cohort: [popg]), (mild facial dysmorphism: [fndg]), ( sleep problems: [dsyn]), (unusual electroencephalogram variant: [lbtr]), (results: [fndg]), (hypothesis: []), (ubiquitin protein ligase e3a gene: [lbpr]), (autism phenotype: [mobd]), (maternal cases: [qnco]), (autism spectrum: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(autism risk, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism diagnostic observation scale, 'Autism Phenotype')(sleep problems, 'Sleeping Problems')(autism phenotype, 'Autism Phenotype')(autism spectrum, 'Autism Phenotype')

PMCID: 3596371
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (environmental factors: []), (mitochondria act: [topp]), (genes: [gngm]), (environment: []), (gene-encoded metabolic networks: [moft]), (changes: [qnco]), (chemistry: [lbpr]), (cell: [gngm]), (mitochondrial atp: [celc]), (other metabolites: [bacs]), (molecules: [sbst]), (undergo: []), (release: [hlca]), (cells: [cell]), (cellular health: [cell]), (danger: [gngm]), (purinergic signaling: [celf]), (role: [socb]), (objectives: []), (maternal immune activation (mia) mouse model: [emod]), (gestational poly(ic) exposure: [nnon,phsu]), (treatment: [topp]), (non-selective purinergic antagonist suramin: [orch,phsu]), (c57bl/6j mice: [mamm]), (antipurinergic therapy (apt): [topp]), (multisystem abnormalities: [cgab]), (asd-like phenotype: [cgab]), (model: []), (correction: []), (core: [bdsu]), (social deficits: []), (sensorimotor coordination: [phsf]), (prevention: [resa]), (cerebellar purkinje cell: [cell]), (ultrastructural synaptic dysmorphology: []), (hypothermia: [fndg]), ( metabolic: [celf]), ( mitochondrial: [celc]), ( p2y2: [aapp,rcpt]), (p2x7: [gngm]), (receptor expression: [genf]), (erk1/2: [aapp,enzy]), (camkii: [aapp,enzy]), (signal transduction abnormalities: [celf]), (hyperpurinergia: []), (treatable feature: []), (poly(ic) mouse model: [nnon,phsu]), (antipurinergic therapy: [topp]), (new tool: []), (current concepts: [npop]), (pathogenesis: [patf]), (autism: [mobd]), (related spectrum disorders: [dsyn]), (fresh path forward: [lbpr]), (new drug development: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(gestational poly exposure, 'Perinatal History')(sensorimotor coordination abnormalities, 'Motor Skills')(social deficits, 'Social Competence')(sensorimotor coordination, 'Motor Skills')(autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3637561
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (fragile x syndrome (fxs): [cgab,dsyn]), (associated disorders: []), (expansion: []), (cgg repeat: [dsyn]), (untranslated region: [nnon]), (fragile x: [comd]), (mental retardation: [mobd]), ((fmr1) gene: [gngm]), (disease classification: []), (number: [qnco]), (cgg repeats: [dsyn]), (mechanisms: []), (repeat expansion: []), (presence: [qnco]), (cis elements: [elii]), (absence: [anab]), (trans factors: []), (contribute: [acty]), (instability: [fndg]), (expansions: []), (haploinsuffient: []), (reduced expression: [topp]), (several dna repair/metabolizing proteins: [aapp,bacs]), (reduction: [npop]), (expression: [topp]), (animal models: [anim]), (substantial examination: []), (expansion mechanisms: []), (humans: [humn]), (pathways: [moft]), (trinucleotide repeat expansion: [comd]), (microarray datasets: []), (transcript expression: [topp]), (patients: [podg]), (fxs: []), (controls: [sbst]), (regulation: [biof]), (dna damage/repair pathway transcripts: [nnon]), (observation: [hlca]), (datasets: []), (different populations: [popg]), ( several transcripts: [nnon]), (direction: []), (association: [menp]), (fold change: [qnco]), (further characterization: [acty]), (genes: [gngm]), (role: [socb]), (trinucleotide repeat instability: [bacs,nnon]), 
ASD Terms: (fragile x syndrome, 'Fragile X Syndrome')(fragile x, 'Fragile X Syndrome')(mental retardation, 'Mental Retardation')

PMCID: 3628102
SFARI Genes: LIS1, LIS1, LIS1, LIS1, LIS1, LIS1, LIS1, LIS1, LIS1, LIS1, Lis1, Lis1, LIS1, LIS1, 
Non SFARI Genes: RhoA, 
Named Entities: (lis1 (pafah1b1) mutation: [cgab,dsyn]), (neuronal migration: [gngm]), (lissencephaly: [cgab]), (humans: [humn]), (lis1 loss: [cgab,dsyn]), (dynein protein motor dysfunction: [aapp,enzy]), (actin cytoskeleton: [celc]), (rhogtpases: []), (recently: []), ( lis1: [cgab,dsyn]), (important protein-network interaction node: [popg]), (high-risk autism spectrum disorder genes: [gngm]), (synapse: [bsoj]), (lis1: [gngm]), (disorder: [dsyn]), (role: [socb]), (synaptogenesis: [ortf]), (post-migrational neurons: [cell]), (social behaviour: [socb]), (mice: [mamm]), (two-photon imaging: [sbst]), (actin-rich dendritic filopodia: [aapp,bacs]), (spines: [bpoc]), (vivo: []), (significant reductions: [npop]), (elimination: [phsf]), (turnover rates: [qnco]), (dendritic protrusions: [celc]), (layer v pyramidal neurons: [cell]), (adolescent lis1+/ mice: [mamm]), (lis1+/ filopodia: [cgab,dsyn]), (immature: []), (hippocampal neurons: [cell]), (vitro: []), (density: [qnco]), ( length: [qnco]), (rhoa dependent: [aapp,enzy]), (dynamics: [npop]), (moreover: []), ( lis1+/: [cgab,dsyn]), (adolescent mice: [mamm]), (deficits: []), (social interaction: [fndg]), (lis1 inactivation: [cgab,dsyn]), (postnatal hippocampus: [bpoc]), (similar deficits: []), (dendritic protrusion density: [celc]), (social interactions: [fndg]), (thus: []), (dendritic filopodia dynamics: [npop]), (turnover: [qnco]), (dendritic spine plasticity: [celc]), (autistic-like behaviour: [mobd]), 
ASD Terms: (dynein protein motor dysfunction, 'Motor Skills')(high-risk autism spectrum disorder genes, 'Autism Phenotype')(social behaviour, 'Reciprocal Social Interaction')(social interaction, 'Reciprocal Social Interaction')(social interactions, 'Reciprocal Social Interaction')

PMCID: 3581547
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (autism spectrum disorder: [mobd]), (complex neurodevelopmental disorder: [mobd]), (years: []), (infancy: []), (persons life: [popg]), (large category: [qnco]), (genomic structural variants: [genf]), (copy number variants: [nusq]), (major contributor: []), (pathophysiology: [patf]), (autism: [mobd]), (date: []), (studies: [lbpr]), (genes present: [gngm]), (cnv loci: [nusq]), (impact: [gngm]), (non-coding regulatory micrornas (mirnas) present: [bacs,nnon]), (regions: []), (hence: []), (functional significance: [qnco]), (mirnas present: [bacs,nnon]), (autism-associated cnv loci: [nusq]), (target genes: [gngm]), (series: [qnco]), (computational tools: [acty]), (cnv loci harbor mirnas: [bacs,nnon]), (mirnas: [bacs,nnon]), (systematic analysis: []), (cnv-mirnas: [bacs,nnon]), (interactions: []), (identification: [menp]), (hsa-mir-590-3p: [bacs,nnon]), ( hsa-mir-944: [nnon]), ( hsa-mir-570: [bacs,nnon]), ( hsa-mir-34a: [gngm]), ( hsa-mir-124: [nnon]), ( hsa-mir-548f: []), ( hsa-mir-429: [bacs,nnon]), ( hsa-mir-200b: [gngm]), ( hsa-mir-195: [nnon]), (hsa-mir-497: [gngm]), (hub molecules: [sbst]), (regulatory loop: [phsf]), (transcription factors: [aapp,bacs]), (downstream target genes: [gngm]), (annotation: []), (functional involvement: []), (neurodevelopment: [ortf]), (synapse: [bsoj]), (moreover: []), (duplicated cnv loci: [nusq]), (difference: [qnco]), (dosage: [qnco]), (crucial genes: [gngm]), (them: []), (global processing: [acty]), (biogenesis: [npop]), (key molecules: [sbst]), (mirna pathway: [bacs,nnon]), (knowledge: []), (first report: [qnco]), (significance: [qnco]), (cnv-micrornas: [bacs,nnon]), (genetic heterogeneity: [orga]), (phenotypic variability: [fndg]), 
ASD Terms: (infancy, 'Perinatal History')(autism spectrum disorder, 'Autism Phenotype')(complex neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3577685
SFARI Genes: cap, cap, 
Non SFARI Genes: impact, 
Named Entities: (folate: [orch,phsu,vita]), (vitamin b12-dependent enzyme methionine synthase (ms): [aapp,enzy]), (cellular oxidative status: [cell]), (ms activity: [aapp,enzy]), (production: []), (antioxidant glutathione: [phsu]), (methylation reactions: [moft]), (metabolic activity: [acty]), (ms mrna levels: [aapp,enzy]), (postmortem: [diap]), (human cortex: [humn]), (subjects: [humn]), (lifespan: [grpa]), (dramatic progressive: []), (biphasic decrease: [qnco]), (weeks: []), (gestation: [orgf]), (years: []), (further analysis: [resa]), (alternative splicing: [genf]), (ms: [gngm]), (deletion: [genf]), (folate-binding domain exons: [bacs,nnon]), (age-dependent deletion: [genf]), (exons: [bacs,nnon]), (cap domain: []), (vitamin b12 (cobalamin): [orch,phsu,vita]), (oxidation: [moft]), (species: []), (protein: [aapp,bacs]), (full-length: [qnco]), (mrna: [bacs,nnon]), (mrna levels: [bacs,nnon]), (significant changes: [qnco]), (ms protein: [aapp,enzy]), (methionine levels: [lbpr]), (autistic subjects: [mobd]), (ages: [bacs,orch]), (decrease: [qnco]), (cultured human neuronal cells: [humn]), (treatment: [topp]), (tnf-: [aapp,bacs]), (csf levels: [topp]), (autism: [mobd]), (novel findings: [clna]), (housekeeping enzyme: [enzy,orch]), ( ms: [aapp,enzy]), (dynamic role: [socb]), (metabolism: [orgf]), (brain: [bpoc]), (development: [orgf]), (aging: [orgf]), (factors: []), (oxidative stress: [comd]), (source: [fndg]), (risk: []), (neurological disorders: [dsyn]), (impact: [gngm]), (epigenetic regulation: [biof]), (gene expression: [genf]), 
ASD Terms: (vitamin b12-dependent enzyme methionine synthase, 'Dietary Supplements')(gestation, 'Perinatal History')(vitamin b12, 'Dietary Supplements')(autism, 'Autism Phenotype')(neurological disorders, 'Neurologic Indications')

PMCID: 3590998
SFARI Genes: mark, mark, 
Non SFARI Genes: 
Named Entities: (elucidation: []), (epigenetic alterations: []), (autism brain: [mobd]), (new insights: [menp]), (molecular mechanisms: []), (abnormal gene expression: [genf]), (disorder: [dsyn]), (strong evidence: []), (engrailed-2 (en-2): [gngm]), (gene relevant: [gngm]), (abnormalities: [cgab]), (epigenetic evaluation: [hlca]), (candidate gene: [gngm]), (case: []), (post-mortem cerebellar samples: [bpoc]), (assessments: [hlca]), (global dna: [bacs,nnon]), (en-2 promoter methylation: [moft]), ( en-2 gene expression: [genf]), (en-2 protein levels: [aapp,bacs]), (chromatin immunoprecipitation: [lbpr]), (trimethylation status: []), (histone h3: [aapp,bacs]), ((h3k27): [aapp]), (gene downregulation: [gngm]), ((h3k4): [aapp]), (gene activation: [genf]), (results: [fndg]), (unusual pattern: []), (en-2 promoter region dna hypermethylation: [bacs,nnon]), (significant increases: [qnco]), (en-2 gene expression: [genf]), (protein levels: [lbtr]), (en-2 overexpression: [genf]), ( histone h3k27 trimethylation mark: [amas]), (en-2 promoter: [bacs,nnon]), (autism: [mobd]), (controls: [sbst]), (link: []), (histone h3k27 trimethylation: [aapp,bacs]), (en-2 gene: [gngm]), (mean level: [phsu]), (histone h3k4 trimethylation: [moft]), (cerebellar samples: [bpoc]), (together: []), (normal en-2 downregulation: [moft]), (signals purkinje cell maturation: [cell]), (early-postnatal development: [orgf]), (individuals: [humn]), (postnatal persistence: [menp]), (cerebellar abnormalities: [fndg]), 
ASD Terms: (autism brain, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3586480
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (childhood autism: [mobd]), (autism: [mobd]), (spectrum disorder (asd): [cgab]), (stable diagnostic categories: [fndg]), (young children: [aggp]), (psychiatric/developmental disorders: [mobd]), (stability: []), (time: []), (diagnosis: [fndg]), (asd: [cgab]), (clinical reasons: []), (diagnostic stability: [fndg]), (childhood: []), (early adulthood: [aggp]), (faroe islands:: []), (total school age population: [popg]), ((817-year-olds): []), (ad: []), (paper: []), (independent clinical diagnosis: [fndg]), (diagnostic interview: [acty]), (social: []), (communication disorders (disco): [mobd]), (algorithm diagnosis: [fndg]), (time points: []), (years: []), (clinical asd diagnosis: [cgab]), (perfect: []), (asperger syndrome (as): [mobd]), (disco algorithm subcategory diagnoses: [fndg]), (systems: []), (excellent stability: []), (seven-year period: [qnco]), (any asd diagnosis: [cgab]), (number: [qnco]), (clear cases: [qnco]), (original screening: [diap]), (findings: [clna]), (notion: []), (subcategories: []), (diagnostic entity: [fndg]), (other non-autism variables: [mobd]), (iq: []), (language levels: [lang]), (overall adaptive functioning: []), 
ASD Terms: (childhood autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(asperger, 'Asperger Syndrome')(diagnosis, 'Diagnosis')(asperger syndromed, 'Asperger Syndrome')(asperger, 'Asperger Syndrome')(algorithm diagnosis, 'Diagnosis')(independent clinical diagnosis, 'Diagnosis')(clinical asperger, 'Asperger Syndrome')(diagnosis, 'Diagnosis')(asperger syndrome, 'Asperger Syndrome')(clinical asperger syndromed diagnosis, 'Diagnosis')(asperger, 'Asperger Syndrome')(diagnosis, 'Diagnosis')(any asperger syndromed diagnosis, 'Diagnosis')(overall adaptive functioning, 'Adaptive Life Skills')

PMCID: 3570468
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (advent: []), (high-throughput technologies: []), (concurrent: []), (information sciences: []), (explosion: [inpo]), (size: []), (complexity: [chvs]), (data sets: []), (biological sciences: []), (challenge today: [antb,orch]), (wealth: []), (information: []), (conceptual framework: []), (biological functions: [biof]), (complex collection: [chvs]), (data: [euka]), (data cloud: [euka]), (multi-scale characteristics: [qnco]), (geometry: []), (foundation: [orgt]), (knowledge: []), (new methodology: []), (challenge: [hlca]), (new procedure: [topp]), (main features: []), (keys: []), (success: [socb]), (empirical similarity: []), (hierarchy: []), (configurations: []), (geometric structure: []), (ultrametric space: []), (ultrametric tree: [plnt]), (parisi matrix: [phsu]), (secondly: [qnco]), (built-in mechanism: []), (membership: [inbe]), (different tree levels: [plnt]), (trees: [plnt]), (new algorithm: [lbpr]), (standard hierarchical clustering method: [lbpr]), (real data clouds: [euka]), (fmri brain connectivity studies: [diap]), ( cancer genomics: [euka]), (social networks: [popg]), (lewis carroll's doublets: [mamm]), (cases: [qnco]), (dcg trees: [plnt]), (errors: []), (quantification: [qnco]), (multi-scale geometric structures: [bpoc]), (such: []), ( dcg-tree: [plnt]), (effective tool: []), (complex biological data sets: [chvs]), 
ASD Terms: 

PMCID: 3563690
SFARI Genes: 
Non SFARI Genes: MDGA1, 
Named Entities: (selective suppression: [genf]), (inhibitory synapseswith: [acty]), (effect: []), (excitatory synapsesresults: []), (interaction: []), (schizophrenia-associated proteins mdga1: [mobd]), (effects: []), (neuroliginneurexin pathway: [moft]), 
ASD Terms: 

PMCID: 3563033
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (clarification: [acty]), (pathogenesis: [patf]), (treatment: [topp]), (autism spectrum disorders: [mobd]), (challenges: [hlca]), (study: [resa]), (scalp hair concentrations: [menp]), (trace elements: [bacs,elii]), (children: [aggp]), (autistic disorders: [mobd]), (males: [orga]), (females): [orga]), (eighty-four (29.7%): [fndg]), ((17.6%): []), ((5.8%) subjects: [humn]), (deficient: [qnco]), (zinc: [elii,phsu]), ( magnesium: [elii]), (calcium: [bacs,elii,phsu]), ( respectively: []), (other essential metals: [inch]), (incidence rate: [qnco]), (mineral deficiency: [dsyn]), (infants: [aggp]), ((8.5%): []), ((4.8%) individuals: [humn]), (high burden: [qnco]), (aluminium: [elii]), ( cadmium: [elii,hops]), (lead: [elii,hops]), (mercury: [elii,hops]), (arsenic burden: [elii,hops]), (findings: [clna]), (magnesium-deficiency and/or toxic metal burdens: [dsyn]), (principal roles: [socb]), (environmental factors: []), (metallomics: []), (early screening: [diap]), (prevention: [resa]), (neurodevelopment disorders: [mobd]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autistic disorders, 'Autistic Disorder')(mineral deficiency, 'Dietary Supplements')

PMCID: 3583392
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (circadian rhythm alteration: [orgf]), (cortisol excretion: [horm,orch,phsu]), (level: [phsu]), (corticosteroids: [horm,orch,phsu]), (children: [aggp]), (different grades: []), (autism severity: [mobd]), (study: [resa]), (autism severity (low [lfa]: [mobd]), ( medium [mfa]: [qnco]), (high functioning autism: [mobd]), (group: [popg]), (age/sex-matched children: [orgf]), (typical development: [orgf]), (urinary levels: []), (free cortisol (at: [lbpr]), (phases: [euka]), (24-hour cycle): [qnco]), ( corticosteroids: [horm,orch,phsu]), (vanilylmandelic acid: [chem]), (5-hydroxyindole acetic acid: [hops,orch]), (determined: [lbpr]), (alteration: []), (pattern: []), (cortisol excretion (phases i: [horm,orch,phsu]), ( ii: []), (iii): []), (lfa (phase i:: []), (vs: []), (p: [gngm]), (phase ii:: []), (phase iii:: []), (mfa (phase i:: []), (control group: [grup]), (corticosteroids excretion levels: [horm,orch,phsu]), (groups: [popg]), (autism: [mobd]), (lfa (8.21.48: []), (mfa (8.21.48: []), (hfa: [dsyn]), (changes: [qnco]), (degrees: [qnco]), (severity: []), (disorder: [dsyn]), (data: [euka]), (cortisol excretion pattern: [horm,orch,phsu]), (high level: [qnco]), (urine: [bdsu]), (consequence: []), (altered hypothalamic-pituitary-adrenal axis function: [phsf]), (pathogenesis: [patf]), 
ASD Terms: (circadian rhythm alteration, 'Prosody')(autism severity, 'Autism Phenotype')(autism severity (low, 'Autism Phenotype')(high functioning autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3558482
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (amygdala: [bpoc]), (important structure: []), (socio-emotional behavior: [inbe]), (however: []), (role: [socb]), (autism: [mobd]), (study: [resa]), (days: []), ((vpa)-induced rat model: [mamm]), (autistic phenotypes: [mobd]), (synaptic characteristics: []), (lateral nucleus (la): [celc]), (vpa-treated offspring: [famg]), (social interaction: [fndg]), (fear learning: [menp]), (impaired fear memory extinction: [menp]), (slice preparation: [acty]), (electrophysiological recordings: [diap]), (long-term potentiation (ltp): [ortf]), (thalamic-amygdala pathway: [bpoc]), (la: [gngm]), (pair: []), (pulse facilitation (ppf): [clna]), (60-ms intervals: [aapp,enzy]), (significantly: []), (whole-cell recordings: [resa]), (la pyramidal neurons: [elii]), (increased miniature excitatory: [qnco]), (postsynaptic current (epsc) frequency: [ortf]), (amplitude: []), (relative contributions: [acty]), (ampa receptor: [aapp,rcpt]), (nmda receptor: [aapp,rcpt]), (epscs: []), (groups: [popg]), (results: [fndg]), (enhancement: [acty]), (presynaptic efficiency: [qnco]), (excitatory synaptic transmission: [ortf]), (hyperexcitibility: []), (ltp: [ortf]), (neurons: [cell]), (disruption: []), (synaptic excitatory/inhibitory: [acty]), ((e/i) balance: [inch]), (vpa-treated rats: [mamm]), (certain roles: [socb]), (development: [orgf]), (behaviors: [inbe]), (rat: [mamm]), (further experiments: [resa]), (direct link: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(vpa-treated offspring, 'Perinatal History')(social interaction, 'Reciprocal Social Interaction')(impaired fear memory extinction, 'Working Memory')

PMCID: 3633612
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (complex neuropsychiatric syndrome: [dsyn]), (unknown etiology: [fndg]), (inflammation: [patf]), (pregnancy: [orgf]), (common pathway: [moft]), (infections: [patf]), (other insults increase risk: []), (disorder: [dsyn]), (hence: []), (association: [menp]), (early gestational c-reactive protein: [aapp,imft]), (inflammatory biomarker: [clna]), (maternal sera: [bdsu]), (childhood autism: [mobd]), (large national birth cohort: [qnco]), (extensive serum biobank: [bdsu]), (other strengths: []), (cohort: [popg]), (complete ascertainment: []), (pregnancies: [orgf]), (finland (n=1.2 million): [aapp,imft]), (study period: [resa]), (national psychiatric registries: [popg]), (autism cases: [mobd]), (population: [popg]), (maternal crp levels: [aapp,imft]), (continuous variable: []), (offspring: [famg]), (quintile: [clna]), (risk: []), (finding: [sosy]), (maternal inflammation: [patf]), (significant role: [socb]), (possible implications: []), (preventive strategies: [menp]), (pathogenic mechanisms: [fndg]), (other neurodevelopmental disorders: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(early gestational c-reactive protein, 'Perinatal History')(childhood autism, 'Autism Phenotype')(autism cases, 'Autism Phenotype')(autism, 'Autism Phenotype')(offspring, 'Perinatal History')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(other neurodevelopmental disorders, 'Learning Disorders')

PMCID: 3547942
SFARI Genes: ASMT, ASMT, ASMT, ASMT, ASMT, ASMT, ASMT, ASMT, ASMT, ASMT, 
Non SFARI Genes: impact, 
Named Entities: (melatonin: [horm,orch,phsu]), (regulation: [biof]), (seasonal rhythms: [fndg]), (immune function: [ortf]), (prior research: [resa]), (low melatonin levels: [horm,orch,phsu]), (autism spectrum disorders: [mobd]), (asmt: [gngm]), (pseudo-autosomal region: [celc]), (last enzyme: [enzy,orch]), (melatonin biosynthesis pathway: [moft]), (previous study: [resa]), (association: [menp]), (asd: [cgab]), (single nucleotide polymorphisms: [nusq]), (rs4446909: []), (rs5989681: []), (promoter: [bacs,nnon]), (furthermore: []), (deleterious mutations: [comd]), (subset: []), (patients: [podg]), (asmt exons: [bacs,nnon]), (neighboring region: []), (chinese han individuals: [popg]), (autism: [mobd]), (healthy controls: []), (study: [resa]), (significant differences: [qnco]), (genotypic distribution: [orga]), (allele frequencies: [qnco]), (common snps: [nusq]), (mutations: [genf]), (rare variants: [gngm]), (stop mutation (p.r115w: [genf]), ( p.v166i: [aapp,imft]), ( p.v179g: [aapp,imft]), (p.w257x): [aapp,imft]), (coding variants: []), ((1.51%) patients: [podg]), (none: []), (controls: [sbst]), ((chi-square test: []), ( continuity correction: []), (two-sided): [qnco]), (functional prediction: []), (impact: [gngm]), (amino acid: [aapp,bacs,phsu]), (p.r115w: [aapp,imft]), (protein function: [moft]), (results: [fndg]), (susceptibility gene: [gngm]), (further studies: [lbpr]), (samples: [sbst]), (degree: [qnco]), (variation: []), (gene: [gngm]), (biochemical: []), (clinical impacts: [gngm]), (asmt/melatonin deficiency: [horm,orch,phsu]), 
ASD Terms: (seasonal rhythms, 'Prosody')(autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3547868
SFARI Genes: AUTS2, AUTS2, AUTS2, AUTS2, auts2, auts2, AUTS2, AUTS2, AUTS2, AUTS2, 
Non SFARI Genes: 
Named Entities: (nucleotide changes: [nnon]), (auts2: [gngm]), (noncoding regions: []), (autism: [mobd]), (other neurological disorders: [dsyn]), (attention deficit hyperactivity disorder: [mobd]), ( epilepsy: [dsyn]), ( dyslexia: [mobd]), ( motor: []), (delay: []), ( language delay: [fndg]), (visual impairment: [fndg]), ( microcephaly: [cgab,dsyn]), (alcohol consumption: [inbe]), (addition: []), ( auts2: [gngm]), (genomic region: [gngm]), (humans: [humn]), (neanderthals: [mamm]), (variants: []), (however: []), (function: [phsf]), (regulation: [biof]), (gene: [gngm]), (auts2 function: [phsf]), (zebrafish: [fish]), (head: [blor]), (neuronal reduction: [npop]), (mobility: [fndg]), (regulatory elements: [bacs,nnon]), (sequences: [nusq]), (enhancer activity: [acty]), (mice: [mamm]), (functional zebrafish: [fish]), (brain: [bpoc]), (mouse enhancer assays: [lbpr]), (mouse brain enhancers: [nnon]), (asdassociated deletion: [genf]), (mouse enhancers: [mamm]), (regions: []), (combined: []), (results: [fndg]), (expose candidate enhancer sequences: [nusq]), (nucleotide variation: [nnon]), (neurological disease: [dsyn]), (human-specific traits: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')(other neurological disorders, 'Neurologic Indications')(attention deficit hyperactivity disorder, 'Overactivity')(epilepsy, 'Epilepsy')(language delay, 'Language Ability')(visual impairment, 'Visual Thinking')(alcohol consumption, 'Alcohol Drinking')(neurological disease, 'Neurologic Indications')

PMCID: 3544904
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (structural variation: []), (major etiological role: [socb]), (development: [orgf]), (autism spectrum disorders: [mobd]), (numerous studies: [lbpr]), (relevance: []), (copy number variants: [nusq]), (asd: [cgab]), (large asd families: [cgab]), (high-impact cnvs: [nusq]), (impact: [gngm]), (general asd population: [cgab]), (affymetrix: []), (genome-wide human snp array: [gngm]), (putative autism-specific cnvs present: [nusq]), (individuals: [humn]), (multiplex asd pedigrees: [cgab]), (actual prevalence: [qnco]), (cnvs: [nusq]), (studies: [lbpr]), (custom illumina array: [acty]), (asd cases: [cgab]), (controls: [sbst]), (additional: []), (single nucleotide variants: [fndg]), (array: []), (family studies: [famg]), (standard snp array resolution: [qnco]), (results: [fndg]), (high-risk asd families: [cgab]), (odds ratios: [qnco]), (support: []), (asd risk variants: [cgab]), (addition: []), (snv probes: [chvf]), (custom array: [acty]), (eighteen: [qnco]), (validated cnvs: [nusq]), (once: []), (association: [menp]), (asd-associated cnvs: [cgab]), (dataset: []), (clinical relevance: []), (evaluation: [hlca]), (children: [aggp]), (asds: [cgab]), (data: [euka]), (strong support: []), (existence: []), (application: [qnco]), (clinical genetic evaluation: [hlca]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 3568452
SFARI Genes: CaV1.2, CaV1.2, CaV1.2, CaV1.2, 
Non SFARI Genes: RhoA, Gem, RhoA, 
Named Entities: (l-type voltage: [qnco]), (calcium channels: [aapp,bacs]), (important role: [socb]), (neuronal development: [celf]), (dendritic growth: [orgf]), (arborization13: []), (point mutation: [comd]), (cav1.2: [gngm]), (timothy syndrome: [dsyn]), (neurodevelopmental disorder: [mobd]), (autism spectrum disorders: [mobd]), (channels: []), (ts mutation cause: [genf]), (activity-dependent dendrite retraction: [celc]), (rodent neurons: [mamm]), (induced pluripotent stem cell (ipscs): [cell]), (neurons: [cell]), (individuals: [humn]), (ts: [gngm]), (dendrite retraction: [celc]), (calcium permeation: [bacs,elii,phsu]), (mutant channel: [comd]), (ectopic activation: [acty]), (rhoa: [gngm]), (over-expression: [topp]), (channel: []), (gtpase gem: [aapp,enzy]), (results: [fndg]), (ca2+: [elii,phsu]), (novel insights: [menp]), (cellular basis: [phsu]), (other asds: [cgab]), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 3669501
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (currently: []), ( autism cannot: [mobd]), (age: [orga]), (years: []), (longitudinal studies: [resa]), (high-risk populations: [popg]), (unique knowledge: []), (development: [orgf]), (autism: [mobd]), (infancy: []), (toddlerhood: []), (onset: [qnco]), (early autism research: [mobd]), (field: [irda]), (child psychiatric science: [aggp]), (key objectives: []), (fine mapping: [acty]), (neurodevelopmental trajectories: [ortf]), (biomarkers: [clna]), (risk: []), (diagnosis: [fndg]), (treatment: [topp]), (essea: []), (scientific study: [lbpr]), (early autism): [mobd]), (cost (european cooperation: [qnco]), (science: []), (technology) action: [acty]), (european collaboration: [socb]), (progress: []), (discovery: [acty]), (signs: [fndg]), (european practice guidelines: [popg]), (early identification: [topp]), (intervention: [hlca]), (european expertise: [popg]), (cognitive neuroscience: []), (clinical sciences: []), (objective: []), (article: []), (state: []), (current european research: [resa]), (at-risk autism research: [mobd]), (understanding: [menp]), (different contexts: [fndg]), (research: [resa]), (conducted: [inbe]), (essea survey data: [euka]), (ongoing european high-risk asd studies: [cgab]), (challenges: [hlca]), (opportunities: []), (high-risk autism research: [mobd]), (europe: []), (several challenges: [hlca]), (existence: []), (several key factors: [qnco]), (new and/or large-scale autism: [mobd]), (grants: [qnco]), ( availability: []), (new technologies: []), (involvement: []), (experienced research groups): [popg]), (clinical developments: [orgf]), (next few years: []), 
ASD Terms: (age of 2 years, 'Onset of Symptoms')(autism, 'Autism Phenotype')(autism cannot, 'Autism Phenotype')(infancy, 'Perinatal History')(symptom onset, 'Onset of Symptoms')(early autism research, 'Autism Phenotype')(neurodevelopmental trajectories, 'Learning Disorders')(diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')(cognitive neuroscience, 'Cognitive Ability')(understanding of different contexts, 'Understanding Context')(at-risk autism research, 'Autism Phenotype')(high-risk autism research, 'Autism Phenotype')

PMCID: 3815575
SFARI Genes: NHE9, NHE9, NHE9, NHE9, NHE9, NHE9, NHE9, NHE9, 
Non SFARI Genes: 
Named Entities: (summary nhe9 (slc9a9): [gngm]), (endosomal cation/proton antiporter: [aapp,bacs]), (orthologs: [gngm]), (yeast: [fngs]), (bacteria: [bact]), (rare: [gngm]), ( missense substitutions: [acty]), (nhe9: [gngm]), (autism: [mobd]), (evolutionary conservation analysis: [genf]), (model-structure: []), (crystal structure: [chvs]), (bacterial nhaa: []), (autism-associated variants: [mobd]), (human population: [popg]), (phenotype complementation: [orga]), (functional analysis: [hlca]), (primary cortical astrocytes: [bpoc]), (mouse: [mamm]), (nhe9-gfp localizes: [aapp,irda]), (endosomes: [celc]), (luminal ph: [qnco]), ( elevates: []), (transferrin: [aapp,bacs]), (neurotransmitter glutamate: [aapp,bacs]), (stabilizes surface expression: [topp]), (transferrin receptor: [aapp,rcpt]), (glast transporter: [aapp,bacs]), (contrast: [irda]), ( autism: [mobd]), (variants l236s: []), ( s438p: []), (v176i: []), (function: [phsf]), (astrocytes: [cell]), (thus: []), (neurobiological cell model: [gngm]), (candidate gene: [gngm]), (loss: [qnco]), (function mutations: [phsf]), (autistic phenotype: [mobd]), (synaptic membrane protein expression: [celc]), (neurotransmitter clearance: [bacs]), 
ASD Terms: (bacteria, 'Bacterial Infections')(autism, 'Autism Phenotype')(bacterial nhaa, 'Bacterial Infections')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3738022
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (attention deficit hyperactivity disorder (adhd) symptoms: [mobd]), (autistic traits: [mobd]), (together: []), (pattern: []), (etiology: []), (co-occurrence: []), (adults: [aggp]), (study: [resa]), (traits: [gngm]), (detail: []), (independent adult population samples: [aggp]), (data: [euka]), (adhd traits (inattention: [mobd]), (hyperactivity/impulsivity): [mobd]), (population sample (s1: [popg]), (unrelated individuals: [fndg]), (attention problems (ap): []), (population-based family sample: [famg]), (twins: [famg]), (siblings (s2: [famg]), (samples: [sbst]), (dimensions: [qnco]), ((social skills: [socb]), (attentional switching: [menp]), ( imagination: [menp]), ( patterns): []), (hyperactive traits: [mobd]), (autistic trait dimensions: [mobd]), (inattention (s1): [mobd]), (ap: []), (correlations: []), (prominent correlation: []), (attentional switching scale (0.47: [menp]), (respectively): []), (analyses: [resa]), (informative s2: [gngm]), (association: [menp]), (genetic factor: [topp]), (findings: [clna]), (adhd traits: [mobd]), (problems: []), (hyperactivity: [mobd]), ( social skills: [socb]), (routine preferences: []), (instead: []), (attention-related problems (inattention: [mobd]), (attentional switching capacity): [menp]), (genetic: [topp]), ( biological pathways: [moft]), (attentional control: [menp]), (promising focus: []), (future studies: [lbpr]), (genetic causes: [topp]), (disorders: [dsyn]), 
ASD Terms: (attention deficit hyperactivity disorder symptoms, 'Overactivity')(attention deficit hyperactivity disorder traits, 'Attention Deficit Disorder with Hyperactivity')(hyperactive traits, 'Overactivity')(inattention, 'Attention Deficit Disorder with Hyperactivity')(attention deficit hyperactivity disorder traits, 'Attention Deficit Disorder with Hyperactivity')(hyperactivity, 'Overactivity')(social skills, 'Ability to Converse in Social Settings')(imagination, 'Imagination')(social skills, 'Ability to Converse in Social Settings')(imagination, 'Imagination')

PMCID: 3621187
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prevalence: [qnco]), (autistic disorder: [mobd]), (serious developmental condition: [mobd]), (decades: [qnco]), (high-quality population-based research: [popg]), (etiology: []), (influence: []), (exposures: [phpr]), (traffic-related air pollution: [eehu]), (pregnancy: [orgf]), (development: [orgf]), (autism: [mobd]), (data: [euka]), (air monitoring stations: []), (land use regression (lur) model: [menp]), (methods: children: [aggp]), (mothers: [famg]), (birth: [orgf]), (los angeles: []), ( california: [plnt]), (primary ad diagnosis: [clna]), (years: []), (age: [orga]), (california department: [orgt]), (developmental: [orgf]), (california birth certificates: [plnt]), (children: [aggp]), (controls: [sbst]), (case: []), (sex: [orgf]), ( birth year: []), (minimum gestational age: [orga]), ( birth addresses: [orgf]), (air: [gngm]), (station: []), (lur model: []), (conditional logistic regression: [resa]), (perinatal characteristics: []), (indicators: [irda]), (ses: []), (results: per interquartile range (iqr) increase: [fndg]), (relative increase: [qnco]), (odds: []), (ozone [odds: [chem]), ((or) =: []), (ci:: [lbpr]), (11.54-ppb increase]: [gngm]), (particulate matter: [sbst]), (m (or: [aapp,imft]), (4.68-g/m3 increase): [qnco]), (pollutants: [hops]), (furthermore: []), (relative increases: [qnco]), (iqr increase: []), (lur-based nitric oxide: [bacs,inch,phsu]), (nitrogen dioxide exposure estimates: [qnco]), (lur-based associations: [menp]), (high school education: []), (conclusion: measured: [diap]), (ambient pollutant monitors: [hops]), (associations: [menp]), (prenatal air pollution: [eehu]), (traffic sources: [fndg]), 
ASD Terms: (autistic disorder, 'Autistic Disorder')(serious developmental condition, 'Learning Disorders')(exposures, 'Exposures')(autism, 'Autism Phenotype')(estimate exposures, 'Exposures')(primary autistic disorder diagnosis, 'Autistic Disorder')(autism, 'Autism Phenotype')(minimum gestational age, 'Perinatal History')(perinatal characteristics, 'Perinatal Exposures')(autism, 'Autism Phenotype')(nitrogen dioxide exposure estimates, 'Exposures')(exposures, 'Exposures')(autism, 'Autism Phenotype')

PMCID: 3524021
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (epistatic interactions: [fndg]), (significant role: [socb]), (pathogenesis: [patf]), ( prevention: [resa]), ( diagnosis: [fndg]), (treatment: [topp]), (complex human diseases: [humn]), (machine learning: [mcha]), (statistical methods: [resa]), (epistatic interaction detection: [topp]), (common problems: [qnco]), (limited number: [qnco]), (samples: [sbst]), (high search: [acty]), (large number: [qnco]), (false positives: [lbtr]), (ways: []), (association: [menp]), (disease markers: []), (phenotype: [orga]), (problems: []), (computational methods: [resa]), (score-based bayesian network structure: [popg]), (method: [lbpr]), ( epibn: []), (datasets: []), (real disease datasets: [dsyn]), (experimental results: [fndg]), (simulation data: [euka]), (other commonly-used methods: [fndg]), (terms: [orgf]), (power: [hcpp]), (sample-efficiency: [qnco]), (marginal effects: [fndg]), (furthermore: []), (real disease data: [dsyn]), (bayesian network-based method: [qnco]), (epibn: []), (new scoring function: [phsf]), (higher-order epistatic interactions: [acty]), (model complexity: [chvs]), (data: [euka]), (fast branch-and-bound algorithm: [fndg]), (structure: []), (two-layer bayesian network: [popg]), (target node: [diap]), (real data: [euka]), (use: []), (markov chain monte carlo (mcmc) method: [qnco]), (screening process: [phpr]), (applications: [hlca]), (real gwas (genome-wide association studies) datasets: [mbrt]), (helpful insights: [menp]), (genetic basis: [phsu]), (age-related macular degeneration: [dsyn]), (late-onset alzheimer's disease: [mobd]), (autism: [mobd]), 
ASD Terms: (diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')

PMCID: 3520798
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (sex: [orgf]), (important factor: []), (prevalence: [qnco]), ( incidence: [qnco]), ( progression: [patf]), (response: [fndg]), (treatment: [topp]), (many medical conditions: [dsyn]), (autoimmune: [patf]), (cardiovascular diseases: [dsyn]), (psychiatric conditions: [mobd]), (identification: [menp]), (molecular differences: [qnco]), (typical males: [orga]), (females: [orga]), (valuable basis: [phsu]), (conditions: [dsyn]), (methodology/principal findings using: [clna]), (multiplexed immunoassays: [lbpr]), (serum molecules: [bdsu]), (independent cohorts: [popg]), (typical individuals: [humn]), (males: [orga]), (sex differences: [orga]), (analyte levels: [sbst]), (meta-analysis approach: [resa]), (biological context: [fndg]), (k-means: [qnco]), (clusters: [qnco]), (analytes: [sbst]), (distinct biological functions: [biof]), (natural sex differences: [orga]), (analyte groups: [popg]), (dimorphic analyte expression: [topp]), (cohort: [popg]), (asperger syndrome: [mobd]), (reproducible sex differences: [orga]), (levels: []), (serum: [bdsu]), (typical controls: []), (comprised clusters: [qnco]), (molecules: [sbst]), (fatty acid oxidation/hormone regulation: [orgf]), ( immune cell growth: [celf]), (activation: [acty]), (cell death: [celf]), (immune cell chemotaxis: [celf]), (other indistinct functions: []), (comparison: [acty]), (people: [popg]), (asperger: []), (cluster: [qnco]), (functions: [phsf]), (occurrence: []), (condition: [dsyn]), (conclusions/significance sex-specific: [orgf]), (study: [resa]), (current knowledge: [npop]), (biological functions: [biof]), (metabolism: [orgf]), (immune function: [ortf]), (deviations: [fndg]), (typical sex differences: [orga]), (findings: [clna]), (importance: []), (influence: []), (medical conditions: [dsyn]), 
ASD Terms: (many medical conditions, 'Medications')(cardiovascular diseases, 'Cardiovascular Diseases')(psychiatric conditions, 'Mental Disorders')(asperger syndrome, 'Asperger Syndrome')(asperger, 'Asperger Syndrome')(medical conditions, 'Medications')

PMCID: 3565189
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (gamma: [npop]), ((gaba)-mediated synapses: [aapp,bacs]), (oscillations: [topp]), (autism: [mobd]), (gaba-acting benzodiazepines exert: [aapp,bacs]), (patients: [podg]), (paradoxical effects: []), (possibility: []), (epilepsies: [dsyn]), ( gaba: [aapp,bacs]), (neurons: [cell]), (elevated intracellular concentrations: [celc]), (chloride: [inch]), (successful pilot study: [resa]), (1: [fndg]), (double-blind clinical trial: [resa]), (diuretic: [phsu]), ( chloride-importer antagonist: [inch]), (intracellular chloride: [inch]), (gabaergic inhibition: [acty]), (sixty children: [aggp]), (asperger: []), (years: []), (months placebo: [topp]), ((1 mg daily): [elii,phsu]), (1-month wash out: [acty]), (determination: [lbpr]), (severity: []), (video films: [sbst]), (day: []), ((d0): []), (d90: []), (blind: [fndg]), ( independent evaluators: []), (bumetanide: [orch,phsu]), (childhood autism rating scale (cars) (d90d0; p<0.004: [mobd]), (vs placebo): [topp]), ( clinical global impressions (p<0.017: [fndg]), (autism diagnostic observation schedule values: [hlca]), (severe cases: [qnco]), (values: []), (means.d: []), (n=9): [aapp,imft]), ((wilcoxon test: p-value=0.031; student's: [popg]), (t-test: p-value=0.017): [qnco]), (side effects: [patf]), (occasional mild hypokalaemia (3.03.5 mm l1 k+): [fndg]), (supplemental potassium: [inch,phsu]), (companion study: [anim]), (chronic bumetanide treatment: [orch,phsu]), (accuracy: []), (facial emotional labelling: [blor]), (brain activation: [bpoc]), (areas: []), (emotional perception (hadjikhani: [menp]), (al.: [lbpr]), ( submitted): []), (therefore: []), ( bumetanide: [orch,phsu]), (promising novel: []), (therapeutic agent: [phsu]), (trials: [resa]), (population: [popg]), (treatment: [topp]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(epilepsies, 'Epilepsy')(autism, 'Autism Phenotype')(asperger, 'Asperger Syndrome')(1-month wash out, 'Performance of Chores')(autism, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(autism diagnostic observation schedule values, 'Autism Phenotype')(supplemental potassium, 'Dietary Supplements')(emotional perception, 'Visual Perception')(treat autism, 'Autism Phenotype')

PMCID: 3537519
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (adhd: [mobd]), (common childhood: [qnco]), (mental health disorder: [mobd]), (adulthood: []), (two-thirds: [qnco]), (cases: [qnco]), (comorbidities: []), (adults: [aggp]), (substance use disorders: [mobd]), (rates: [qnco]), (patients: [podg]), (substance abuse disorders: [mobd]), (impairment: [patf]), (co-morbid group: [popg]), (research: [resa]), (diagnostic interview: [acty]), (people: [popg]), (in-patient drug: [podg]), (alcohol detoxification units: [orgf]), (prevalence: [qnco]), (undiagnosed adhd: [mobd]), (substance use disorder in-patients: [podg]), (south london: []), (individuals: [humn]), (self-rated impairments: [patf]), (several domains: [qnco]), (daily life;: []), (substance abuse: [mobd]), (alcohol consumption: [inbe]), ( suicide attempts: [fndg]), (depression: [mobd]), (case records: []), (study: [resa]), (high rates: [qnco]), (untreated adhd: [mobd]), (substance use disorder populations: [popg]), (association: [menp]), (such patients: [podg]), (levels: []), (source: [fndg]), (additional impairment: [patf]), (burden: []), (clinical services: [hlca]), 
ASD Terms: (adhd, 'Attention Deficit Disorder with Hyperactivity')(mental health disorder, 'Mental Disorders')(adhd, 'Attention Deficit Disorder with Hyperactivity')(comorbidities, 'Comorbidities')(adhd, 'Attention Deficit Disorder with Hyperactivity')(substance abuse disorders, 'Substance Abuse')(alcohol detoxification units, 'Alcohol Drinking')(undiagnosed adhd, 'Attention Deficit Disorder with Hyperactivity')(substance abuse, 'Substance Abuse')(alcohol consumption, 'Alcohol Drinking')(suicide attempts, 'Depressive Disorder')(depression, 'Depressive Disorder')(untreated adhd, 'Attention Deficit Disorder with Hyperactivity')(adhd, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 3533944
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (genetic etiology: [topp]), (autism: [mobd]), (multiple disorders share genotypic: [orga]), (phenotypic traits: [orga]), (network: [popg]), (cross-disorder analysis: [hlca]), (understanding: [menp]), (characterization: [acty]), (molecular pathology: [lbpr]), (few tools: [qnco]), (results: [fndg]), (description: []), (autworks: []), (web portal: [blor]), (gene interaction: [genf]), (gene-disease association data: [gngm]), (network construction: [popg]), ( visualization: [menp]), ( network comparisons: [popg]), (numerous other related neurological conditions: [qnco]), (disorders: [dsyn]), (users: [humn]), (structure: []), (gene interactions: [genf]), (set: [menp]), (disorder-associated genes: [gngm]), ( compare networks: [acty]), (disorder/disease genes: [dsyn]), (other disorders/diseases: [dsyn]), (own sets: [menp]), (comparative analysis: [resa]), (web application: [qnco]), (easy-to-use resource: []), (researchers: []), (varied backgrounds: []), (autism gene network structure: [moft]), (availability: http://autworks.hms.harvard.edu/: [orch,phsu]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(visualization, 'Visual Thinking')(numerous other related neurological conditions, 'Neurologic Indications')(visualization, 'Visual Thinking')(autism gene network structure, 'Autism Phenotype')

PMCID: 3708282
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (rightward: []), (cerebral lateralization: [ortf]), (neuropathology: [patf]), (autism spectrum conditions: [mobd]), (neuroanatomical asymmetry: []), (terms: [orgf]), (handedness: [orga]), (corpus callosum measurements: [bpoc]), (male adolescents: [aggp]), (unaffected siblings: [famg]), (controls: [sbst]), (associations: [menp]), (executive dysfunction: [mobd]), (symptom severity: [fndg]), (adolescents: [aggp]), (autism: [mobd]), (functional asymmetry: []), (expected pattern: []), (rightward lateralization: []), (posterior: []), (anterior midbody: [blor]), (hand-preference: [fndg]), (measures: [qnco]), (asymmetry: []), (subregions: []), (posterior midbody: [blor]), (rostral body): [humn]), (opposite pattern: []), (isthmus: []), (rostrum: []), (cognitive: []), (severe clinical scores: [qnco]), 
ASD Terms: (autism spectrum conditions, 'Autism Phenotype')(autism, 'Autism Phenotype')(cognitive, 'Cognitive Ability')

PMCID: 3604131
SFARI Genes: 
Non SFARI Genes: rest, 
Named Entities: (objective recent epidemiologic studies: [resa]), (rise: []), (prevalence rates: [qnco]), (autism spectrum disorders: [mobd]), (broadening: []), (diagnostic criteria: []), (asd: [cgab]), (major contributor: []), (prevalence: [qnco]), (continuous distribution: [qnco]), (autistic traits: [mobd]), (study: [resa]), (nature: []), (population distribution: [qnco]), (quantitative trait measure: [qnco]), (large national population sample: [sbst]), (children: [aggp]), (japanese version: [popg]), (social responsiveness scale (srs): [acty]), (parents: []), (representative sample: [sbst]), ( age: [orga]), (social responsiveness scale scores: [clna]), (skewed normal distribution: [qnco]), (japanese population: [popg]), (single-factor structure: [fndg]), (significant relation: [socb]), (iq: []), (normal intellectual range: [qnco]), (evidence: []), (natural cutoff: []), (populations: [popg]), (affected children: [aggp]), (unaffected children: [aggp]), (continuous nature: []), (autistic symptoms: [mobd]), (srs: [gngm]), (validated quantitative trait measure: [qnco]), (findings: [clna]), (paradigms: [resa]), (diagnosis: [fndg]), (categorical cutoffs: []), (substantial variation: []), (prevalence estimation: [qnco]), (measurements: []), (case assignment: []), (population: [popg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autistic symptoms, 'Complaints and Indications')(diagnosis, 'Diagnosis')

PMCID: 3504046
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (complex neurological condition: [dsyn]), (childhood onset: [fndg]), (dysfunction: [dsyn]), (multiple cognitive domains: [qnco]), (socio-emotional function: [phsf]), ( speech: [orgf]), (language: [lang]), (processing: [acty]), (stimuli: [phpr]), (gross brain: [bpoc]), (anatomic differences: [qnco]), (established: []), ( recent studies: [lbpr]), (regional differences: [fndg]), (brain structure: [bpoc]), (function: [phsf]), (divergent: []), (contradictory results: [fndg]), (regional abnormalities: [cgab]), (autistic phenotype: [mobd]), (autism exhibits: [mobd]), (distinct perturbations: []), (network-level brain architecture: [popg]), (cognitive dysfunction: [mobd]), (abnormal network structure: [popg]), (network-level anatomic abnormalities: [popg]), (structural covariance mri: [diap]), (network-level differences: [popg]), (gray matter structure: [tisu]), (large-scale networks: [qnco]), (salience network: [popg]), (default mode network: [popg]), (autistic subjects: [mobd]), (age-: [orga]), ( gender-: [orga]), (iq-matched controls: [resa]), (specific perturbations: []), (brain network architecture: [popg]), (salience: []), (default-mode networks: [qnco]), (clinical manifestations: []), (extent: []), (distribution: []), (social-emotional regulation: [menp]), (environmental stimuli: [npop]), (contrast: [irda]), ( posterior elements: [elii]), (spatial distribution: []), (posteriorization: [biof]), (network: [popg]), (findings: [clna]), (network-based model: [popg]), (unifying interpretation: [clna]), (previous work: []), (moreover: []), (evidence: []), (specific abnormalities: [cgab]), (standard clinical mri: [diap]), 
ASD Terms: (childhood onset, 'Onset of Symptoms')(autism, 'Autism Phenotype')(complex neurological condition, 'Neurologic Indications')(multiple cognitive domains, 'Cognitive Ability')(speech, 'Language Ability')(autism, 'Autism Phenotype')(autism exhibits, 'Autism Phenotype')(cognitive dysfunction, 'Cognitive Ability')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 6345368
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (empathy: [inbe]), (lens: [bpoc]), (others emotion expressions: [menp]), (respond: []), (study: [resa]), ( empathy: [inbe]), (facial emotion recognition: [menp]), (adults: [aggp]), (autism spectrum conditions: [mobd]), (n=314): [aapp,imft]), ( parents: []), (child: [aggp]), (asc (n=297): [aapp,imft]), (iq-matched controls: [resa]), (participants: [popg]), (self-report measure: [resa]), (empathy (the empathy quotient [eq]): [inbe]), (modified version: []), (karolinska directed emotional faces task (kdef): [blor]), (online test interface: [lbpr]), (results: [fndg]), (mean scores: [qnco]), (eq: [qnco]), (fathers: [famg]), (mothers: [famg]), (children: [aggp]), (asc: [gngm]), (males: [orga]), (females: [orga]), (eq scores (p: [aapp,imft]), (controls: [sbst]), (kdef: []), (statistical analyses: [resa]), (overall performance: [inbe]), (asc (p: [aapp,imft]), (control group: [grup]), (distinct basic emotions: [menp]), (asc group: [popg]), (impaired performance: [inbe]), (expressions: [topp]), (sad: [menp]), ( angry: [menp]), ( afraid: [menp]), (disgusted): [menp]), (parents: []), (basic emotions: [menp]), (age: [orga]), (non-verbal iq (all: [fndg]), (finally: []), ( results: [fndg]), (significant differences: [qnco]), (emotion recognition performance (p: [menp]), (self-reported empathy (p: [inbe]), (findings: [clna]), (self-reported empathy deficits: [inbe]), (autistic probands: [mobd]), (part: [qnco]), (broader autism phenotype: [mobd]), (new findings: [fndg]), (sex differences: [orga]), (people: [popg]), (emotion recognition: [menp]), (previous work: []), (empathy difficulties: [inbe]), (use: []), (empathy measures: [inbe]), (quantitative endophenotypes: [qnco]), 
ASD Terms: (empathy, 'Empathy')(autism spectrum conditions, 'Autism Phenotype')(empathy, 'Empathy')(facial emotion recognition, 'Empathy')(empathy (the empathy quotient, 'Empathy')(karolinska directed emotional faces task, 'Emotional Regulation and Control')(directed emotional faces task, 'Emotional Regulation and Control')(emotion recognition performance, 'Empathy')(self-reported empathy, 'Empathy')(self-reported empathy deficits, 'Empathy')(broader autism phenotype, 'Autism Phenotype')(empathy difficulties, 'Empathy')(emotion recognition, 'Empathy')(empathy measures, 'Empathy')

PMCID: 3490915
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (complex neurodevelopmental disorder: [mobd]), (impaired reciprocal social interaction: [mobd]), ( communication deficits: [socb]), (repetitive behaviors: [fndg]), (large number: [qnco]), (genes: [gngm]), (encode proteins: [aapp,bacs]), (development: [orgf]), (function: [phsf]), (synaptic circuitry: []), (however: []), (manner: []), (factor: []), (broad influence: []), (brain development: [ortf]), (network formation: [popg]), (neurotransmitter serotonin: [bacs,orch]), (unfortunately: []), (alterations: []), (serotonin neuronal function: [bacs,orch]), (hypothesis: []), (dysfunction: [dsyn]), (core symptoms: [sosy]), (brain serotonin: [bacs,orch]), (null mutation: [genf]), (gene: [gngm]), (tryptophan hydroxylase: [aapp,enzy]), ((tph2)): []), (behaviors: [inbe]), (disorder: [dsyn]), (mice: [mamm]), (brain serotonin (tph2/): [bacs,orch]), (substantial deficits: []), (numerous validated tests: [lbpr]), (social interaction: [fndg]), (communication: [socb]), (compulsive behaviors: [mobd]), (newborn tph2/: [aggp]), (mutant mice show: [mamm]), (expression: [topp]), (key developmental milestones: []), (diminished preference: [qnco]), (maternal scents: [bacs]), (scent: [bacs]), (unrelated female: [orga]), (forerunner: []), (severe socialization deficits: [edac]), (weanlings: []), (persist: []), (adulthood: []), (results: [fndg]), (hypo-serotonin condition: [fndg]), (behavioral traits: [inbe]), (findings: [clna]), (new studies: [lbpr]), (brain hyposerotonemia: [bpoc]), (critical neurodevelopmental periods: [ortf]), (maturation: [phsf]), (synaptic circuits: []), (prevention: [resa]), (such deficits: []), 
ASD Terms: (autism, 'Autism Phenotype')(complex neurodevelopmental disorder, 'Learning Disorders')(impaired reciprocal social interaction, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(cause autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(compulsive behaviors, 'Obsessive-Compulsive Disorder')(severe socialization deficits, 'Social Competence')(critical neurodevelopmental periods, 'Learning Disorders')

PMCID: 3474800
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (male bias: [orga]), (autism spectrum conditions: [mobd]), (females: [orga]), (asc: [gngm]), (lack: []), (attention: [menp]), (variability: []), (heterogeneity: [orga]), (study: [resa]), (key cognitive domains: []), (emotion perception: [menp]), ( executive: []), (perceptual attention: [menp]), (function): [phsf]), (similarities: []), (differences: [qnco]), (males: [orga]), (asc (n: [aapp,imft]), (adults; n: [aggp]), (group): [popg]), (mentalizing: []), (facial emotion perception domain: [blor]), ( males: [orga]), (similar deficits: []), (neurotypical controls: [sbst]), (however: []), (dexterity: [fndg]), (executive function: [menp]), (performance relative: [qnco]), (neurotypical males: [orga]), ( females: [orga]), (neurotypical females: [orga]), (performance: [inbe]), (social-cognitive domain: []), (male: [orga]), (female adults: [aggp]), (specific non-social cognitive domains: []), ( performance: [inbe]), (sex: [orgf]), (specific domains: []), (cognitive profiles: [lbpr]), 
ASD Terms: (autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(key cognitive domains, 'Cognitive Ability')(autism spectrum conditions, 'Autism Phenotype')(facial emotion perception domain, 'Visual Perception')(executive function, 'Executive Function')(autism spectrum conditions, 'Autism Phenotype')(dexterity, 'Functional Laterality')(autism spectrum conditions, 'Autism Phenotype')(specific non-social cognitive domains, 'Cognitive Ability')(autism, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(cognitive profiles, 'Cognitive Ability')

PMCID: 3501969
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (atypical activation: [acty]), (embedded figures task: [lbpr]), (autism: [mobd]), (siblings: [famg]), (measures: [qnco]), (clinical severity: []), (participants: [popg]), (unaffected siblings: [famg]), (control subjects: [sbst]), (number: [qnco]), (frontal brain regions: [bpoc]), (groups: [popg]), ( however: []), (terms: [orgf]), (activation: [acty]), (task: [gngm]), (pattern: []), (functional endophenotype: []), (familial risk: [famg]), (condition: [dsyn]), (individuals: [humn]), (reduced activation: [acty]), (subjects: [humn]), (regions: []), (face processing areas: [emst]), (impairments: [patf]), (reciprocal social interaction: [fndg]), (behavioural performance: [inbe]), (sibling groups: [famg]), (results: [fndg]), (atypical information processing styles: [menp]), (increased activation: [acty]), (frontal regions: [bpoc]), (phenotype: [orga]), (aspects: [qnco]), (markers: [clna]), (findings: [clna]), (new insight: [menp]), (factors: []), (expression: [topp]), (families: [famg]), (children: [aggp]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(face processing areas, 'Integrated Verbal and NonVerbal Communication')(reciprocal social interaction, 'Reciprocal Social Interaction')(atypical information processing styles, 'Ability to Convey Information')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3720840
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (copy number variants: [nusq]), (major role: [socb]), (etiology: []), (autism spectrum disorders: [mobd]), (statistical significance: [qnco]), (casecontrol analyses: [resa]), (nevertheless: []), (current asd cohorts: [cgab]), (rare cnvs: [nusq]), (risk alleles): [gngm]), (here: []), (tiered approach: []), (significant cnvs: [nusq]), (large clinical cohorts: [popg]), (neurodevelopmental disorders: [mobd]), (asd): [cgab]), (cnvs: [nusq]), (well-characterized asd cohorts: [cgab]), (initial analysis: [resa]), (recurrent cnvs: [nusq]), ((segmental duplication-mediated hotspots'): [nnon]), (loci: [gngm]), (clinical cases: [qnco]), (controls: [sbst]), (total: [qnco]), (deletion cnvs: [nusq]), (duplication cnvs: [nusq]), (overlap: [topp]), (combined sample: [sbst]), (well-characterized asd cases: [cgab]), (studies: [lbpr]), (deleterious recurrent cnvs: [nusq]), (deletions: [genf]), (duplications: []), (frequency: [qnco]), (asd cohorts: [cgab]), ((24 deletions: [genf]), (loci): [gngm]), (conclusion: []), (large asd research: [cgab]), (enough power: [hcpp]), (rare causative: [gngm]), (contributory cnvs: [nusq]), ( data: [euka]), (clinical cohorts: [popg]), (likely clinical significance: [fndg]), (asd: [cgab]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 3495055
SFARI Genes: PAFAH1B1, YWHAE, PAFAH1B1, YWHAE, PAFAH1B1, YWHAE, PAFAH1B1, YWHAE, PAFAH1B1, YWHAE, PAFAH1B1, YWHAE, PAFAH1B1, YWHAE, PAFAH1B1, YWHAE, YWHAE, PAFAH1B1, YWHAE, PAFAH1B1, YWHAE, YWHAE, YWHAE, YWHAE, 
Non SFARI Genes: BHLHA9, CRK, BHLHA9, CRK, 
Named Entities: (deletions: [genf]), (duplications: []), (pafah1b1: [gngm]), (ywhae genes: [gngm]), (different clinical phenotypes: [orga]), (particular: []), ( deletion: [genf]), (pafah1b1 causes: [gngm]), (ywhae: [gngm]), (miller-dieker syndrome: [dsyn]), (isolated duplications: []), (mild developmental delay: [fndg]), (hypotonia: [fndg]), (autism: [mobd]), ( different dysmorphic features: [cgab]), (ywhae duplication: [comd]), (need: []), (patient clinical features: [podg]), (groups: [popg]), (gene: [gngm]), (chromosomal duplication: [comd]), (proband: [famg]), (family: [famg]), (array-cgh analyses: [dsyn]), (putative rearrangement: [genf]), (fluorescence: [npop]), (situ hybridization: [mbrt]), (duplication: [comd]), (kilobases: [qnco]), (fish: [gngm]), (ywhae gene: [gngm]), (mild dysmorphic phenotype: [orga]), (associated autism: [mobd]), (mental retardation: [mobd]), (bhlha9: [gngm]), ( ywhae: [gngm]), (crk genes: [gngm]), (phenotype: [orga]), (patient: [podg]), (small chromosomal duplication: [comd]), (mother: [famg]), (bipolar: []), (borderline disorder: [dsyn]), (addicted: [podg]), (additional familial case: [famg]), (observation: [hlca]), (further cases: [qnco]), (similar microduplications: []), (clinical spectrum: [qnco]), (phenotypes: [orga]), (microduplications: []), 
ASD Terms: (mild developmental delay, 'Learning Disorders')(autism, 'Autism Phenotype')(associated autism, 'Autism Phenotype')(mental retardation, 'Mental Retardation')(bipolar, 'Bipolar Disorder')

PMCID: 3460929
SFARI Genes: 
Non SFARI Genes: Npas4, Npas4, Npas4, CA1, CA3, Npas4, 
Named Entities: (npas4: [gngm]), (transcription factor: [aapp,bacs]), (brain: [bpoc]), (formation: [biof]), (maintenance: [acty]), (inhibitory synapses: [celc]), (response: [fndg]), (synaptic activity: [acty]), (deregulation: [acty]), (inhibitory-excitatory balance: [acty]), (variety: []), (human developmental disorders: [humn]), (schizophrenia: [mobd]), (autism: [mobd]), (however: []), (role: [socb]), (inhibitory pathways: [acty]), (development: [orgf]), (nervous system disorders: [dsyn]), (alterations: []), (absence: [anab]), (major role: [socb]), (expression: [topp]), (symptoms: [sosy]), (psychiatric disorders: [mobd]), (hypothesis: []), (knock-out mice (npas4-ko)): [mamm]), (battery: [inpo]), (behavioral assays: [lbpr]), (general activity: [acty]), (social behaviors: [socb]), (cognitive functions: [menp]), (npas4-ko mice: [mamm]), (novel environment: []), ( spend: [qnco]), (time: []), (unfamiliar ovariectomized female: [fndg]), (unfamiliar male: [orga]), (first encounter: [bhvr]), ( show: [anim]), (social dominance: [socb]), (wt littermates: [fish]), (pre-pulse inhibition: [phsf]), (memory: [menp]), ( long-term memory: [menp]), (cognitive flexibility deficits: [mobd]), (behavioral deficits: [inbe]), (schizophrenia-related symptomatology: [podg]), (social anxiety: [mobd]), ( hyperactivity: [mobd]), (sensorimotor gating deficits: [phsf]), (immunohistochemistry analyses: [diap]), (npas4 expression: [topp]), (hippocampus: [bpoc]), (social encounter: [bhvr]), (c-fos: [gngm]), (ca1: [gngm]), (ca3 regions: []), (cognitive task: []), (results: [fndg]), (regulation: [biof]), (social functions: [socb]), (possible implications: []), (developmental disorders: [mobd]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(nervous system disorders, 'Nervous System Diseases')(psychiatric disorders, 'Mental Disorders')(social behaviors, 'Reciprocal Social Interaction')(cognitive functions, 'Cognitive Ability')(memory, 'Working Memory')(long-term memory, 'Working Memory')(cognitive flexibility deficits, 'Cognitive Ability')(behavioral deficits, 'Personal Traits')(social anxiety, 'Anxiety Disorders')(hyperactivity, 'Overactivity')(cognitive task, 'Cognitive Ability')(social functions, 'Ability to Converse in Social Settings')

PMCID: 3544729
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (impairments: [patf]), (social interaction: [fndg]), (verbal communication: [socb]), (repetitive behaviors: [fndg]), (date: []), (etiology: []), (disorder: [dsyn]), (studies: [lbpr]), (critical roles: [socb]), (neural plasticity: [ortf]), (neuronal activity: [acty]), (neuronal networks: [imft]), (number: [qnco]), (abnormal function: [phsf]), (glia/astrocytes: [cell]), (development: [orgf]), (however: []), (direct evidence: []), (astrocytes: [cell]), (brain: [bpoc]), (autistic individuals: [mobd]), (study subjects: [humn]), (brain tissue: [bpoc]), (autistic subjects: [mobd]), ( btbr t + tfj (btbr): [mamm]), (neuroligin: [moft]), ((nl)-3 knock-down mice: [mamm]), (western blot analysis: [lbpr]), ( immunohistochemistry: [diap]), (confocal microscopy studies: [lbpr]), (density: [qnco]), (morphology: [fndg]), (wnt: []), (-catenin protein expression: [aapp,bacs]), (study: [resa]), (autisitc subjects: [humn]), (processes: [phpr]), (total branching length: [qnco]), (cell body sizes: [celc]), (astrocytosis: [patf]), (frontal cortex: [bpoc]), (addition: []), (nl3 knockdown mouse: [mamm]), (similar alterations: []), (autistic brain: [mobd]), (-catenin proteins: [aapp,bacs]), (wnt/-catenin pathway: [moft]), (regulation: [biof]), (astrocyte development: [celf]), (findings: [clna]), (neuronal plasticity: [ortf]), (autistic-like behaviors: [mobd]), (humans: [humn]), (mice: [mamm]), (alteration: []), (changes: [qnco]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')

PMCID: 3440365
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (common neurodevelopmental syndrome: [dsyn]), (numerous rare genetic etiologies: [famg]), (cases: [qnco]), (methodology/principal findings: [clna]), (important gene dysregulation: [gngm]), (ba19 (occipital) brain tissues: [blor]), (high resolution: [lbpr]), (whole genome gene expression: [genf]), (whole genome dna methylation microarrays: [moft]), (changes: [qnco]), (dna methylation: [moft]), (autistic brain: [mobd]), (gene expression abnormalities: [genf]), (areas: []), (metabolism: [orgf]), (apparent: down-regulation: [moft]), (genes: [gngm]), (mitochondrial oxidative phosphorylation: [celc]), (protein translation: [moft]), (associations: [menp]), (specific behavioral domains: []), (specific brain gene expression modules: [moft]), (inflammation/immune response: [patf]), (purinergic signaling: [celf]), (conclusions/significance: [qnco]), (work: []), (unrecognized molecular pathophysiological themes: [patf]), (molecular bases: []), (behavioral endophenotypes: [inbe]), 
ASD Terms: (autism, 'Autism Phenotype')(common neurodevelopmental syndrome, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3566384
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (significant hereditary component: [qnco]), (implicated genetic loci: [gngm]), (complex: [chvs]), (consequently: []), (gap: [gngm]), (diverse genomic aberrations: [gngm]), (result: [fndg]), (clinical asd phenotype: [cgab]), (gene expression studies: [genf]), (autism brain tissue: [mobd]), (protein-coding genes: [gngm]), (common molecular pathways: [moft]), (strong heritability: []), (clinical phenotypes: [orga]), (genomic heterogeneity: [orga]), (disorder: [dsyn]), (however: []), (regulation: [biof]), (gene expression: [genf]), (many mechanisms: []), (rnas: [nnon]), (study: [resa]), (asd brain tissue: [cgab]), (changes: [qnco]), (regulatory long noncoding rnas (lncrnas): [bacs,nnon]), (large proportion: [qnco]), (human transcriptome: [humn]), (modulate mrna: [bacs,nnon]), (aberrant expression: [topp]), (lncrnas: [nnon]), (role: [socb]), (molecular pathogenesis: [patf]), (asd: [cgab]), (annotated lncrnas: [nnon]), (mrna transcripts: [bacs,nnon]), (postmortem brain tissue: [diap]), (prefrontal cortex: [bpoc]), (cerebellum: [bpoc]), (microarray: []), (genomic regions: [gngm]), (genes: [gngm]), (psychiatric disease: [mobd]), (additionally: []), ( comparison: [acty]), (differences: [qnco]), (expression: [topp]), (mrnas: [bacs,nnon]), (individual donors: [popg]), (asd brains: [cgab]), (transcriptional homogeneity: [genf]), (moreover: []), (lncrna transcriptome: [nusq]), (results: [fndg]), (further investigation: [hlca]), (lncrna expression: [nnon]), (autistic brain: [mobd]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s12031-012-9880-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(clinical asd phenotype, 'Autism Phenotype')(autism brain tissue, 'Autism Phenotype')(psychiatric disease, 'Mental Disorders')

PMCID: 3565204
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (tourette syndrome (ts): [dsyn]), (heritable neuropsychiatric disorder: [dsyn]), (motor: []), (vocal tics: [sosy]), (decades: [qnco]), (research: [resa]), (aetiology: []), (ts: [gngm]), (elusive: []), (recent successes: [socb]), (gene discovery: [mbrt]), (genomic technologies: [gngm]), (new insights: [menp]), (genetic basis: [phsu]), (disorder: [dsyn]), (collection: []), (disparate findings: [clna]), (confusion: [mobd]), (complexity: [chvs]), (attempts: [evnt]), (findings: [clna]), (neurobiological mechanisms: []), (symptom genesis: [gngm]), (review: []), (unrecognised genetic link: [topp]), (series: [qnco]), (trans-synaptic complexes: [chvs]), ((nrxns): []), ( neuroligins: [moft]), (leucine-rich repeat transmembrane proteins: [aapp,bacs]), (leucine rich repeat neuronals: [amas]), (precursor: []), ((cbln2)): [gngm]), (autism spectrum disorder: [mobd]), (neurodevelopmental pathways: [moft]), (emergent neuropathogenetic model: []), (genes: [gngm]), (single pathogenetic chain: [fndg]), (events: [evnt]), (context: [fndg]), (research implications: [resa]), 
ASD Terms: (tourette syndrome, 'Tourette Syndrome')(vocal tics, 'Tourette Syndrome')(tourette syndrome, 'Tourette Syndrome')(tourette syndrome, 'Tourette Syndrome')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental pathways, 'Learning Disorders')(tourette, 'Tourette Syndrome')

PMCID: 3513683
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (diagnosis: [fndg]), (behavioral criteria:: [inbe]), (unusual reciprocal social interactions: [fndg]), ( deficits: []), (communication: [socb]), (repetitive behaviors: [fndg]), (restricted interests: [menp]), (large number: [qnco]), (single gene mutations: [fndg]), (chromosomal deletions: [comd]), (autism spectrum disorders: [mobd]), (strong genetic evidence: [topp]), ( mice: [mamm]), (targeted mutations: [genf]), (homologous genes: [gngm]), (translational research tools: [resa]), (mouse models: [mamm]), (biological outcomes: []), (mutations: [genf]), (risk genes: [gngm]), (field: [irda]), (robust phenotypes: [orga]), (replicable mouse models: [mamm]), (preclinical screening: [diap]), (novel therapeutics: [orch,phsu]), 
ASD Terms: (unusual reciprocal social interactions, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(restricted interests, 'Restricted Range of Interests')(autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(diagnosis, 'Diagnosis')(autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3513682
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (aim: [phsu]), (review: []), (key findings: [clna]), (epidemiological research: [resa]), (autism: [mobd]), (complex disorder: [dsyn]), (combination: [fndg]), (environmental factors: []), (remarkable advances: []), (knowledge: []), (genetic causes: [topp]), (great efforts: [orgf]), (field: [irda]), (genetics: []), (identification: [menp]), (specific alleles: [gngm]), (autism spectrum: [mobd]), (important pieces: [qnco]), (autism puzzle: [mobd]), (however: []), (many questions: []), (new questions: []), (recent results: [fndg]), (moreover: []), (amount: [qnco]), (evidence: []), (significant contribution: [acty]), (search: [acty]), (aspect: [qnco]), (study: [resa]), (interactions: []), (genes: [gngm]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum, 'Autism Phenotype')(autism puzzle, 'Autism Phenotype')

PMCID: 3513680
SFARI Genes: RTT, RTT, RTT, RTT, MeCP2, MeCP2, RTT, MeCP2, RTT, MeCP2, RTT, RTT, 
Non SFARI Genes: 
Named Entities: (rett: []), ((rtt: [dsyn]), ( mim#312750): [gngm]), (neurodevelopmental disorder: [mobd]), (autism spectrum disorder: [mobd]), (clinically: []), ( rtt: [dsyn]), (psychomotor regression: [fndg]), (loss: [qnco]), (volitional hand use: [bpoc]), (spoken language: [fndg]), (development: [orgf]), (repetitive hand stereotypies: [bpoc]), (gait impairment: [fndg]), (majority: [socb]), (people: [popg]), (rtt: [gngm]), (mutations: [genf]), (methyl-cpg-binding protein: [gngm]), (transcriptional regulator: [genf]), (interestingly: []), ( alterations: []), (function: [phsf]), (protein product: [aapp,bacs]), (mecp2: [gngm]), ( mecp2: [aapp,bacs]), (number: [qnco]), (other clinical conditions: [dsyn]), (many clinical features: [clna]), (various clinical problems: [phsu]), (alteration: []), (mecp2 function: [aapp,bacs]), (belief: []), (other neurological disorders: [dsyn]), (excitingly: []), (mouse model: [emod]), (inspiration: [orgf]), (hope: [menp]), (goal: []), (many neurodevelopmental disorders: [mobd]), 
ASD Terms: (rett syndrome, 'Rett Syndrome')(neurodevelopmental disorder, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(volitional hand use, 'Fine Motor Skills')(other neurological disorders, 'Neurologic Indications')(many neurodevelopmental disorders, 'Learning Disorders')

PMCID: 3513679
SFARI Genes: sms, th, sms, th, sms, sms, sms, sms, sms, sms, 
Non SFARI Genes: 
Named Entities: (review: []), (critical molecular processes: [phpr]), (discovery: [acty]), (genetic mutations: [genf]), (autism: [mobd]), (mechanisms: []), (neurodevelopment step(s): [qnco]), (cause: []), (molecular mechanisms: []), ((i) regulation: [inch]), (gene: [gngm]), (expression; (ii) pre-mrna splicing; (iii) protein localization: [topp]), ( translation: [moft]), (turnover; (iv): [qnco]), (synaptic transmission; (v) cell signaling;: [celf]), (functions: [phsf]), (cytoskeletal: [celc]), (proteins;: [aapp,bacs]), (function: [phsf]), (neuronal cell adhesion molecules: [aapp,bacs]), (few steps: [qnco]), (neurodevelopment: [ortf]), (structure: []), ( function: [phsf]), (and/or plasticity: [npop]), (neuronal circuitry: [bpoc]), (many genetic mutations: [genf]), (novel treatments: [topp]), (few developmental mechanisms: [orgf]), 
ASD Terms: 

PMCID: 3513678
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (kanner's: []), (classic description: []), (syndrome: [dsyn]), (early infantile autism: [mobd]), (conceptions: [orgf]), (disorder: [dsyn]), (important continuity: []), (kanner: []), (hallmarks: []), (conditionsocial impairment (autism): [mobd]), (difficulties: [fndg]), (change: [qnco]), (nonsocial world (insistence: [popg]), (sameness): []), (paper: []), (history: [orga]), (evolution: [genf]), (important potential advantages: []), (disadvantages: []), (changes: [qnco]), (dsm-5: []), (convergence: [acty]), (diagnostic approach: [fndg]), (dsm-iv: []), (icd-10: []), (shared system: [socb]), (tremendous body: [humn]), (research: [resa]), (research comparability: [resa]), (service eligibility: [hlca]), 
ASD Terms: (early infantile autism, 'Autism Phenotype')

PMCID: 3464360
SFARI Genes: ARID1B, ARID1B, ARID1B, ARID1B, ARID1B, ARID1B, ARID1B, ARID1B, 
Non SFARI Genes: 
Named Entities: (corpus callosum abnormalities: [fndg]), (common brain malformations: [cgab]), (wide clinical spectrum: [qnco]), (severe intellectual disability: [mobd]), (normal cognitive function: [menp]), (etiology: []), (cases: [qnco]), (underlying genetic cause: [topp]), (majority: [socb]), (next-generation mate-pair sequencing: [mbrt]), (chromosomal breakpoints: [nnon]), (patient: [podg]), (t(1;6)(p31;q25): [gngm]), ( agenesis: [cgab]), (corpus callosum (cc): [bpoc]), (intellectual disability: [mobd]), (severe speech impairment: [fndg]), (autism: [mobd]), (chromosome: [celc]), (breakpoint: []), (arid1b: [gngm]), (translocation patient: [comd]), (similar phenotype: [orga]), (quantitative polymerase chain reaction (q-pcr) data: [euka]), (primer: [nnon]), (proximal: []), (translocation: [comd]), (increased expression: [topp]), (whereas primer sets: [nnon]), (decreased expression: [topp]), (patient relative: [podg]), (non-related control set: [menp]), (phenotypegenotype comparison: [acty]), (unpublished patients: [podg]), (various sized deletions: [genf]), (arid1b confirms: [gngm]), (haploinsufficiency: [comd]), (cc: [celc]), (findings: [clna]), (human brain development: [ortf]), (function: [phsf]), (general: [hlca]), (development: [orgf]), (speech development: [orgf]), (particular: []), 
ASD Terms: (severe intellectual disability, 'Learning Disorders')(normal cognitive function, 'Cognitive Ability')(intellectual disability, 'Learning Disorders')(severe speech impairment, 'Idiosyncratic and Routinized Speech')(autism, 'Autism Phenotype')(speech development, 'Language Ability')

PMCID: 3432855
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (unknown etiology: [fndg]), (cases: [qnco]), (children regress: [aggp]), (clinical symptoms: [sosy]), (condition: [dsyn]), (regressive autism: [mobd]), (protein kinases: [aapp,enzy]), (g-protein-coupled receptor-mediated signal transduction: [moft]), (neuronal functions: [imft]), ( gene: [gngm]), (expression: [topp]), ( memory: [menp]), (cell differentiation: [celf]), (recently: []), (decreased activity: [sosy]), (protein: [aapp,bacs]), (a (pka): []), (frontal cortex: [bpoc]), (subjects: [humn]), (present study: [qnco]), (activity: [acty]), (protein kinase c (pkc): [aapp,enzy]), (cerebellum: [bpoc]), (different regions: []), (cerebral cortex: [bpoc]), (autistic subjects: [mobd]), (clinical history: [orga]), (regression: [menp]), (age-matched control subjects: [humn]), ( pkc activity: [moft]), (age-matched control: [orga]), ((p =: [aapp,imft]), (non-regressed autistic subjects: [mobd]), (pkc activity: [moft]), (temporal: []), ( parietal: []), (occipital cortices: [bpoc]), (autism groups: [mobd]), ( i.e.: [diap,inpr]), (non-regressed autism: [mobd]), (results: [fndg]), (brain: [bpoc]), (region-specific alteration: []), (further studies: [lbpr]), (negative correlation: [fndg]), (restrictive: []), ( repetitive: []), (pattern: []), (behavior (r= -0.084: [inbe]), ( p: [aapp,imft]), (autistic individuals: [mobd]), (involvement: []), (pkc: [gngm]), (behavioral abnormalities: [mobd]), (findings: [clna]), (part: [qnco]), (alterations: []), (pka: []), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(developing children regress into clinical symptoms, 'Childhood Disintegrative Disorder')(regressive autism, 'Autism Phenotype')(memory, 'Working Memory')(regressive autism, 'Autism Phenotype')(autism groups, 'Autism Phenotype')(non-regressed autism, 'Autism Phenotype')(stereotyped pattern, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')(behavioral abnormalities, 'Personal Traits')(autism, 'Autism Phenotype')

PMCID: 3427326
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (fast-spiking (fs) interneurons: [fndg]), (multiple neuropsychiatric disorders: [dsyn]), (autism: [mobd]), ( schizophrenia: [mobd]), (bipolar disorder: [mobd]), (fs cells: [cell]), (primary source: [fndg]), (synaptic inhibition: [acty]), (brain activity: [phsf]), (brain maturation: [ortf]), (critical developmental periods: [orgf]), (multiple cortical systems: [bpoc]), (expression: [topp]), (parvalbumin: [aapp,bacs]), (marker: [clna]), (mature fs cells: [cell]), (individuals: [humn]), (schizophrenia: [mobd]), (mouse models: [mamm]), (results: [fndg]), (immature: []), (neuropsychiatric disease: [dsyn]), (possibility: []), (study: [resa]), (time-course global expression data: [euka]), (maturation index: [qnco]), (developmental age: [orga]), (purified cortical fs cells: [bpoc]), (fs cell maturation index: [celf]), (global gene expression data: [genf]), (human cortex: [humn]), (maturity: []), (fs cell: [gngm]), (developmental program: [hlca]), (context: [fndg]), (various disease states: [dsyn]), (specificity: [qnco]), (index: [qnco]), (significant correlation: [qnco]), (maturation index measurements: [qnco]), (parvalbumin expression levels: [aapp,bacs]), (correction: []), (multiple covariates: [qnco]), (developmental gene expression program: [hlca]), (current study: [resa]), (cell-type specific maturation indices: [celf]), (developmental programs: [hlca]), (data: [euka]), (mixed cell types: [cell]), (brain homogenates: [bpoc]), 
ASD Terms: (autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(bipolar disorder, 'Bipolar Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 3548427
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mutations: [genf]), (sequence diversity: [nusq]), (substrate: [sbst]), (selection: [genf]), (rate: [qnco]), (major importance: []), (study: [resa]), (genomewide mutation rate: []), (entire genomes: [gngm]), (icelandic: [lang]), (parent-offspring trios: [aapp,enzy]), (high coverage: [qnco]), (samples: [sbst]), (average fathers age: [famg]), (average: [qnco]), (novo mutation rate: []), (nucleotide: [nnon]), (generation: [acty]), (diversity: []), (mutation rate: []), (single-nucleotide polymorphism (snp): [nusq]), (age: [orga]), (father: [famg]), (conception: [orgf]), (child: [aggp]), (effect: []), (increase: []), (year: []), (random poisson variation: [resa]), ( fathers age: [famg]), (variation: []), (mutation counts: [genf]), (observations: [hlca]), (light: [gngm]), (importance: []), (fathers age: [famg]), (risk: []), (diseases: [dsyn]), (schizophrenia: [mobd]), (autism: [mobd]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')

PMCID: 3448848
SFARI Genes: SCN1A, NaV1.1, SCN1A, NaV1.1, Scn1a, Scn1a, NaV1.1, NaV1.1, NaV1.1, NaV1.1, 
Non SFARI Genes: 
Named Entities: (haploinsufficiency: [comd]), (scn1a gene: [gngm]), (voltage-gated sodium channel nav1.1: [bacs,elii]), (dravet syndrome: [dsyn]), (childhood: []), (neuropsychiatric disorder: [dsyn]), (recurrent: []), (intractable seizures: [fndg]), ( cognitive deficit: [mobd]), (autism-spectrum behaviors: [inbe]), (neural mechanisms: []), (cognitive deficit: [mobd]), (ds: [gngm]), (mice: [mamm]), (scn1a haploinsufficiency display hyperactivity: [comd]), (behaviors: [inbe]), ( social interaction deficits: [fndg]), (impaired context-dependent spatial memory: [menp]), (olfactory sensitivity: [orgf]), (novel food odors: [npop]), (social odors: [npop]), (scn1a+/ mice: [mamm]), (gabaergic neurotransmission: [celf]), (mutation: [genf]), (selective deletion: [genf]), (nav1.1 channels: [gngm]), (forebrain interneurons: [bpoc]), (cognitive impairments: [mobd]), (remarkably: []), ( treatment: [topp]), (low-dose clonazepam: [orch,phsu]), (positive allosteric modulator: [fndg]), (gabaa receptors: [aapp,rcpt]), (abnormal social behaviors: [patf]), (deficits: []), (fear memory: [menp]), (ds mice: [mamm]), (impaired gabaergic neurotransmission: [celf]), (neuronal damage: [inpo]), (recurrent seizures: [dsyn]), (results: [fndg]), (critical role: [socb]), (neuropsychiatric functions: [phsf]), (potential therapeutic strategy: [menp]), 
ASD Terms: (cognitive deficit, 'Cognitive Ability')(scn1a haploinsufficiency display hyperactivity, 'Overactivity')(social interaction deficits, 'Reciprocal Social Interaction')(impaired context-dependent spatial memory, 'Working Memory')(cognitive impairments, 'Cognitive Ability')(fear memory, 'Working Memory')(abnormal social behaviors, 'Personal Traits')(cognitive deficit, 'Cognitive Ability')

PMCID: 3506511
SFARI Genes: MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, 
Non SFARI Genes: Mb, 
Named Entities: (autistic spectrum disorders: [mobd]), (family: [famg]), (neurodevelopmental disorders: [mobd]), (strong genetic components: [gngm]), (recent studies: [lbpr]), (copy number variations: [nusq]), (dosage: [qnco]), (sensitive genes: [gngm]), (disorders: [dsyn]), (such gene: [gngm]), (transcription factor mecp2: [aapp,bacs]), (loss: [qnco]), (function: [phsf]), (females results: [orga]), (rett syndrome: [dsyn]), (duplication: [comd]), (males results: [orga]), (developmental delay: [mobd]), (autism: [mobd]), (case presentation here: []), (chinese family: [famg]), (brothers: [famg]), (mb mecp2-containing duplication (151: [aapp,bacs]), (369: []), (305: []), (mother: [famg]), (kb duplication: [comd]), (chromosome: [celc]), (father: [famg]), (brother: [famg]), (kb deletion: [genf]), (literature: [inpr,mnob]), ( mecp2: [aapp,bacs]), (autism-associated gene: [gngm]), (cnvs: [nusq]), (boys: [aggp]), (clinical features: [clna]), (other patients: [podg]), (mecp2 duplications: [aapp,bacs]), (intellectual disability: [mobd]), ( lack: []), (speech: [orgf]), (slight hypotonia: [fndg]), (unsteadiness: [fndg]), (movement: [orgf]), (slight dysmorphic features: [cgab]), (depressed nose bridge: [fndg]), (large ears: [fndg]), (midface hypoplasia: [fndg]), (interestingly: []), (other clinical features: [clna]), (american-european patients: [podg]), (mecp2 duplication: [aapp,bacs]), (recurrent respiratory infections: [fndg]), (epilepsy: [dsyn]), (knowledge: []), (first identification: [menp]), (characterization: [acty]), (chinese han patients: [podg]), (mecp2-containing duplications: [aapp,bacs]), (further cases: [qnco]), (above: []), (clinical differences: [qnco]), (individual variations: [humn]), (genetic background: [orga]), (patients: [podg]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autistic spectrum disorders, 'Autistic Disorder')(rett syndrome, 'Rett Syndrome')(developmental delay, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(speech, 'Language Ability')(intellectual disability, 'Learning Disorders')(depressed nose bridge, 'Depressive Disorder')(recurrent respiratory infections, 'Respiratory Indications')(epilepsy, 'Epilepsy')

PMCID: 3494744
SFARI Genes: ADARB1, ADARB1, 
Non SFARI Genes: 
Named Entities: (adenosine-to-inosine (a-to-i) rna editing: [genf]), (neurodevelopmentally-regulated epigenetic modification: [genf]), (complex behavior: [inbe]), (animals: [anim]), (human a-to-i editing: [humn]), (many molecular mechanisms: []), (environmental stimuli: [npop]), (behavioral outputs: [inbe]), (thus: []), (comprehensive exploration: [topp]), (a-to-i rna: [aapp,enzy]), (human brains: [humn]), (light: [gngm]), (gene-environment interactions: [genf]), (health: []), (disease: [dsyn]), (synaptic function: [phsf]), (main target: [diap]), (a-to-i editing: [inch]), (key amino acids: [aapp,bacs,phsu]), (synaptic genes: [gngm]), (synaptic strength: [qnco]), (duration: [phsu]), (response: [fndg]), (environmental signals: [phpr]), (high-resolution survey: [lbpr]), (synaptic a-to-i rna: [aapp,enzy]), (human population: [popg]), (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (synaptic abnormalities: [cgab]), (common finding: [sosy]), (ultra-deep (>1000) sequencing: [mbrt]), (levels: []), (postmortem cerebella: [diap]), (autistic individuals: [mobd]), (high dynamic range: [qnco]), (individuals: [humn]), (sites: []), (detection limits: [topp]), (extreme ends: []), (population: [popg]), (distributions: []), (editing: []), (isoform: [aapp]), (usage: []), ( clusters: [qnco]), (differential editing patterns: []), (finally: []), (dysfunctional form: [dsyn]), (enzyme adarb1: [enzy,orch]), (results: [fndg]), (population-level: [popg]), ( high-resolution view: [lbpr]), (human cerebella: [humn]), (epigenetic risk: []), 
ASD Terms: (complex behavior, 'Executive Function')(complex behavior, 'Executive Function')(autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3400671
SFARI Genes: EN2, EN2, 
Non SFARI Genes: 
Named Entities: (homeobox transcription: [gngm]), (factor: []), ( functions: [phsf]), (gene: [gngm]), (early development: [orgf]), (connectivity: []), (rodent hindbrain: [mamm]), (cerebellum: [bpoc]), (neurogenesis: [orgf]), (development: [orgf]), (monoaminergic pathways: [moft]), (neurobiological functions: [phsf]), (en2: [gngm]), (neuroanatomical expression profiling: [mbrt]), (en2 wildtype mice: [mamm]), (rtqpcr assays: [lbpr]), (adult brain structures: [bpoc]), (somatosensory cortex: [bpoc]), ( hippocampus: [bpoc]), ( striatum: [bpoc]), ( thalamus: [bpoc]), ( hypothalamus: [bpoc]), (brainstem: [bpoc]), (human: [humn]), (genetic studies: [resa]), (autism: [mobd]), (consequences: []), (en2 mutations: [genf]), (mouse behaviors: [mamm]), (outcomes: []), (comprehensive phenotyping: [lbpr]), (social: []), ( communication: [socb]), ( repetitive: []), (cognitive behaviors: [inbe]), (null mutants: [comd]), (robust deficits: []), (reciprocal social interactions: [fndg]), (juveniles: [aggp]), (adults: [aggp]), (absence: [anab]), (sociability: [socb]), (independent cohorts: [popg]), (fear conditioning: [menp]), (water maze: [sbst]), (en2 null mutants: [comd]), (high immobility: [fndg]), (forced swim test: [dora]), (prepulse inhibition: [phsf]), (mild motor coordination impairments: [sosy]), (reduced grip strength: [sosy]), (genotype differences: [orga]), (measures: [qnco]), (ultrasonic vocalizations: [npop]), (social contexts: [hcpp]), (repetitive behaviors: [fndg]), (developmental: [orgf]), (general health: [clna]), ( olfactory: [orgf]), (abilities: [orga]), ( exploratory locomotor: []), (anxiety-like behaviors: [mobd]), (pain responses: [fndg]), (genotypes: [orga]), ( indicating: []), (behavioral abnormalities: [mobd]), (procedural confounds: [topp]), (findings: [clna]), (new insight: [menp]), (role: [socb]), (complex behaviors: [inbe]), (disturbances: []), (en2 signaling: [celf]), (neuropsychiatric disorders: [dsyn]), (cognitive deficits: [mobd]), (autism spectrum disorders: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(conducted comprehensive phenotyping of social, 'Ability to Converse in Social Settings')(cognitive behaviors, 'Cognitive Ability')(reciprocal social interactions, 'Reciprocal Social Interaction')(mild motor coordination impairments, 'Motor Skills')(ultrasonic vocalizations, 'Vocalizations')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(pain responses, 'Pain')(behavioral abnormalities, 'Personal Traits')(complex behaviors, 'Executive Function')(cognitive deficits, 'Cognitive Ability')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 3410621
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (n-methyl-d-aspartate-receptor (nmdar) signaling: [aapp,rcpt]), (schizophrenia: [mobd]), ( autism: [mobd]), (intellectual disability: [mobd]), (nmdar-hypofunction: [aapp,rcpt]), (gamma (3080 hz) oscillatory abnormalities: [npop]), (disorders: [dsyn]), (however: []), (circuit-level mechanisms: [phsu]), (such deficits: []), (study: [resa]), (relationship: []), (gamma synchrony: [npop]), ( excitatoryinhibitory (e/i) signaling: [celf]), (behavioral phenotypes: [bhvr]), (nmda-nr1neo/ mice: [mamm]), (expression: [topp]), (obligate nr1 subunit: [aapp]), (disrupted developmental nmdar function: [aapp,rcpt]), (constitutive nmdar-hypofunction: [aapp,rcpt]), (loss: [qnco]), (e/i balance: [inch]), (increase: []), (intrinsic pyramidal cell excitability: [cell]), (selective disruption: [genf]), (parvalbumin-expressing interneurons: [aapp,bacs]), (e/i coupling: [inch]), (deficits: []), (auditory-evoked gamma signal-to-noise ratio (snr): [qnco]), (gamma-band abnormalities: [npop]), (spatial working memory: [menp]), (social preference: []), (cellular changes: [qnco]), (e/i: [inch]), (behaviors: [inbe]), (gabab-receptor agonist baclofen: [aapp,phsu]), (gamma-snr: [qnco]), (behavioral deficits: [inbe]), (data: [euka]), (translatable neural-activity-based biomarker: [clna]), (preclinical screening: [diap]), (therapeutic development: [orgf]), (broad range: [qnco]), (share: [socb]), (common endophenotypes: [qnco]), (nmda-receptor signaling: [aapp,rcpt]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(spatial working memory, 'Working Memory')(behavioral deficits, 'Personal Traits')

PMCID: 3410618
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (oxidative stress: [comd]), (pathophysiology: [patf]), (autism: [mobd]), (studies: [lbpr]), (biomarkers: [clna]), (specific brain regions: [blor]), (functional consequences: []), (frozen samples: []), (cerebellum: [bpoc]), (temporal cortex (brodmann area: [bpoc]), ((ba22)): []), (individuals: [humn]), (unaffected controls: [sbst]), (group: [popg]), ( respectively): []), (glutathione (gsh): [aapp,bacs]), (glutathione (gssg): [aapp,phsu]), (glutathione redox/antioxidant capacity (gsh/gssg): [aapp,bacs]), (measured: [diap]), (oxidative protein damage: [aapp,bacs]), (oxidative dna damage: [comd]), (functional indicators: [irda]), (relative levels: [qnco]), (biomarker: [clna]), (chronic inflammatory response: [patf]), (aconitase: [aapp,enzy]), (mitochondrial superoxide production: [celc]), (previous studies: [lbpr]), (plasma: [bdsu]), (immune cells: [cell]), ( gsh: [dsyn]), (gsh/gssg: [aapp,phsu]), (autism cerebellum (p<0.01): [bpoc]), (ba22 (p<0.01): [fndg]), (significant increase: [qnco]), (autism cerebellum: [bpoc]), (similarly: []), (ba22 (p<0.01: [fndg]), (p=0.01: [fndg]), (cerebellum (p<0.01): [bpoc]), (3-ct levels: [aapp]), (brain regions: [blor]), (whereas aconitase activity: [moft]), (gsh/gssg (p=0.01): [aapp,phsu]), (together: []), (results: [fndg]), (redox/antioxidant capacity: [phsu]), (autism brain: [mobd]), (functional consequence: []), (terms: [orgf]), (oxidative protein: [aapp,bacs]), (dna damage: [comd]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism cerebellum, 'Autism Phenotype')(autism brain, 'Autism Phenotype')

PMCID: 3392732
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (lives: [fndg]), (family: [famg]), (child: [aggp]), (condition: [dsyn]), (different ways: []), (forces family members: [famg]), (daily lives: [fndg]), (reality: []), (knowledge: []), (previous research: [resa]), (concern: []), (considerations: [fndg]), (parents/caregivers: []), (children: [aggp]), (qatar: []), (arabic speaking middle eastern region: [popg]), (caregivers: []), (age: [orga]), (to17 years: []), (time: []), (study: [resa]), (asd (autistic group: [cgab]), (ag): []), (main developmental pediatric: [orgf]), (children rehabilitation clinics: [aggp]), (control group (non-autism group: [grup]), (nag): [gngm]), (non-autistic child: [mobd]), (years: []), (family clinic: [famg]), (primary health care facility: [hcro,mnob]), (routine medical check-up: [fndg]), (data: [euka]), (groups: [popg]), (child (e.g: [aggp]), (childs date: [aggp]), (birth: [orgf]), (relation: [socb]), (caregiver: []), ( number: [qnco]), (siblings: [famg]), (hours: []), (sleep: [orgf]), (day: []), (television: []), (indoors: []), (absenteeism: [inbe]), (school: [mnob,orgt]), (use: []), (nanny: []), (child): [aggp]), (caregiver (education level: [fndg]), (level: [phsu]), (consanguinity: [fndg]), (phylogram method): [lbpr]), (addition: []), (questions: []), ( caregivers: []), (ag: []), (specific questions: []), (maternal concern: [fndg]), (respect: [socb]), (future: []), (services: []), (autism group: [mobd]), (non-autism group: [mobd]), (parent: []), (s/he: []), (number: [qnco]), (specialized rehabilitation services; others: [fndg]), (needs: []), (comments: []), (long time: []), (religious faith: [fndg]), (general: [hlca]), (health-related quality: [fndg]), (life: []), (mental health: [menp]), (attention: [menp]), (concerns: []), (families: [famg]), (expectations: []), (findings: [clna]), (policy makers: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(age of 3 to17 years, 'Onset of Symptoms')(routine medical check-up, 'Medications')(autism group, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism group, 'Autism Phenotype')

PMCID: 3496584
SFARI Genes: 
Non SFARI Genes: TNF, 
Named Entities: (autism spectrum disorders (asd): [mobd]), (neurodevelopmental disorders: [mobd]), (deficits: []), (social interactions: [fndg]), ( communication: [socb]), (learning: [menp]), (stereotypic behaviors: [mobd]), (significant increase: [qnco]), (asd: [cgab]), (clues: []), (pathogenesis: [patf]), (early detection: [diap]), (treatment: [topp]), (premature babies: [dsyn]), (infections: [patf]), (inflammation: [patf]), (neurodevelopmental problems: [ortf]), (risk: []), (many autism susceptibility genes: [mobd]), (environmental factors: []), (significant role: [socb]), (evidence: []), (different asd endophenotypes: [cgab]), (discussion: [socb]), (relevant literature: [inpr,mnob]), (utero inflammation: [patf]), (labor: [orgf]), (insufficient development: [fndg]), (gut-bloodbrain barriers: [bpoc]), (exposure: [clna]), (potential neurotoxins: [hops]), (parents: []), (allergic: []), (problems: []), (gestation: [orgf]), (presence: [qnco]), (auto-antibodies: [aapp,imft]), (fetal brain proteins: [aapp,bacs]), (mothers: [famg]), (autism: [mobd]), (disruption: []), (bloodbrain-barrier (bbb): [bpoc]), (number: [qnco]), (papers: []), (increased brain expression: [bpoc]), (cerebrospinal fluid (csf) levels: [bdsu]), (pro-inflammatory cytokines: [aapp,bacs]), (tnf: [gngm]), (mast cells: [cell]), (recent evidence: []), (serum levels: [bdsu]), (pro-inflammatory mast cell trigger neurotensin (nt): [aapp,horm]), (extracellular mitochondrial dna (mtdna): [bacs,nnon]), (gene mutations: [genf]), (phosphatase: [aapp,enzy]), (tensin homolog: [aapp,bacs]), (negative regulator: [fndg]), (mammalian target: [mamm]), (rapamycin (mtor): [aapp,enzy]), (proliferation: [patf]), (function: [phsf]), (summary premature birth: [fndg]), (susceptibility genes: [gngm]), (infants: [aggp]), (environmental: []), ( infectious: [dsyn]), (stress-related triggers: [clna]), (mast cell release: [hlca]), (pro-inflammatory: [aapp,bacs]), (neurotoxic molecules: [inpo]), (brain inflammation: [dsyn]), (endophenotype: []), (asd patients: [cgab]), 
ASD Terms: (social interactions, 'Reciprocal Social Interaction')(stereotypic behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorders, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(neurodevelopmental problems, 'Learning Disorders')(many autism susceptibility genes, 'Autism Phenotype')(permit exposure, 'Exposures')(allergic, 'Allergies')(gestation, 'Perinatal History')(autism, 'Autism Phenotype')(cerebrospinal fluid levels, 'Hydrocephalus')(autism, 'Autism Phenotype')

PMCID: 3410815
SFARI Genes: IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, IL-17A, 
Non SFARI Genes: 
Named Entities: (t-helper (th)1/th2 dichotomy: []), (field: [irda]), (immune regulation: [biof]), (interleukin (il)-17-expressing t cells (th17): [cell]), (third lineage: [qnco]), (helper t: []), (key players: []), (pathogenesis: [patf]), (autoimmune disorders: [dsyn]), (autoimmunity: [patf]), (brain tissue: [bpoc]), (pathogenic role: [socb]), (autism: [mobd]), (il-17a: [gngm]), (pro-inflammatory cytokine: [aapp,bacs]), (important role: [socb]), (various autoimmune neuroinflammatory diseases: [dsyn]), (aim: [phsu]), (study: [resa]), (serum levels: [bdsu]), (relation: [socb]), (degree: [qnco]), (severity: []), (serum il-17a levels: [aapp,rcpt]), (elisa: [lbpr]), (children: [aggp]), (healthy controls: []), (increased serum levels: [bdsu]), (autism group: [mobd]), (patients: [podg]), (severe autism: [fndg]), (autism (p: [mobd]), (il-17a levels: [aapp,rcpt]), (severe autism (67.9%): [fndg]), (autism (17.6%): [mobd]), ( p: [aapp,imft]), (group: [popg]), (levels: []), (first study: [qnco]), (measure levels: [qnco]), (knowledge: []), (research: [resa]), (subject population: [popg]), (increase: []), (serum il-17a levels plasma: [aapp,rcpt]), (anti- il-17a therapy: [aapp,rcpt]), 
ASD Terms: (autoimmune disorders, 'Autoimmune Diseases')(autism, 'Autism Phenotype')(various autoimmune neuroinflammatory diseases, 'Autoimmune Diseases')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism group, 'Autism Phenotype')(severe autism, 'Autism Phenotype')(severe autism, 'Autism Phenotype')(moderate autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3391175
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism rate: [mobd]), (children: [aggp]), (genetic studies: [resa]), (understood complexity: [menp]), (environmental factors: []), (role: [socb]), (magnetic resonance: [npop]), ((mri) studies: [diap]), (brain sizes: [qnco]), (connectivity: []), (electroencephalogram (eeg) coherence studies: [lbtr]), (connectivity changes: [qnco]), (however: []), (genetic-: [topp]), ( mri- and/or: [diap]), (eeg-based diagnostic tests: [diap]), (varied study results: [fndg]), (population: [popg]), (small samples: [sbst]), (eeg: [diap]), ( lack: []), (attention: [menp]), (group-specific artifact: [popg]), (subjects: [humn]), (study: [resa]), (ages: [bacs,orch]), (years: []), (comparable eeg studies: [diap]), (autism spectrum disorder: [mobd]), (neuro-typical controls: []), (artifact management: [hlca]), (principal components analysis: [qnco]), (spectral coherence factors: [qnco]), (patterns: []), (12-year-old subsample: []), (c-group subjects: [humn]), (discriminant function analysis (dfa): [resa]), (spectral coherence factors' discrimination success: [socb]), (groups: [popg]), (dfa-selected coherence factors: [acty]), (asd-specific coherence differences: [cgab]), (total sample pca: [qnco]), (coherence data: [euka]), (factors: []), (total population variance: [qnco]), (significant group differences: [popg]), (split half replications: [genf]), (high-average classification success: [socb]), (asd: [cgab]), (success: [socb]), (restricted age sub-samples: [qnco]), (jackknifing: []), (coherence loadings: [acty]), (reduced short-distance: [qnco]), (reduced: []), (increased: [qnco]), ( long-distance coherences: [fndg]), (asd-groups: [cgab]), (controls: [sbst]), (factor: []), (wide (10.1 hz): [qnco]), (classification success: [socb]), (stable coherence: [fndg]), (pattern: []), (coherence-based phenotype: [orga]), (childhood autism: [mobd]), (short-distance coherences: [fndg]), (poor local network function: [grpa]), (long-distance coherences: [fndg]), (compensatory processes: [phpr]), (reduced neural pruning: []), (wide average spectral range: [qnco]), (factor loadings: [acty]), (over-damped neural networks: [aapp,bacs]), 
ASD Terms: (autism rate, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(childhood autism, 'Autism Phenotype')

PMCID: 3383751
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (epac2 disruption impairs basal: [gngm]), (apical) dendrite complexity: [celc]), (cortical neurons: [bpoc]), (autism-associated mutation: [mobd]), (epac2: [gngm]), (ras/epac2: [gngm]), (active maintenance: [acty]), (basal: []), (dendritic arbors: [celc]), 
ASD Terms: 

PMCID: 3371866
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (motivation:: [menp]), (understanding: [menp]), (genetic determinants: [topp]), (complex disease: [dsyn]), (paradigm shift: [phpr]), (genetic heterogeneity: [orga]), (rare mutations: [genf]), (deleterious effects: []), (major component: []), (disease: [dsyn]), (autism: [mobd]), (excellent example: []), (research: [resa]), (matches: [resa]), (phenotypic: [orga]), (genomic heterogeneities: [orga]), (considerable portion: []), (copy number variation: [nusq]), (single nucleotide polymorphism: [nusq]), ((snp) array: [nusq]), (sequencing technologies: [mbrt]), (small deletions: [genf]), (major unresolved computational problem: [acty]), (inability: []), (algorithms: []), (them: []), (results:: [fndg]), (article: []), (algorithmic framework: [fndg]), (term delishus: [orgf]), (implements: []), (exact algorithms: []), (regions: []), (hemizygosity: []), (genomic deletions: [genf]), (sizes: []), (frequencies: []), (snp genotype data: [nusq]), (efficient backtracking algorithmthat: []), (entry: []), (genome-wide association study snp matrix: [mbrt]), (few minutesto compute: []), (inherited deletions: [genf]), (dataset: []), (model: []), (efficient algorithm: [lbpr]), (deletions: [genf]), (finally: []), (set: [menp]), (polynomial time algorithm: [lbpr]), (critical regions: []), (recurrent deletions: [genf]), (delishus: []), (false-positive rates: [qnco]), (power: [hcpp]), (individuals: [humn]), (sample simultaneously: [sbst]), (snp array: [mbrt]), (data: [euka]), (deletion spectrum: [genf]), (family-based association studies: [socb]), (availability: delishus: []), (http://www.brown.edu/research/istrail_lab/: [orch,phsu]), (contact: eric_morrow@brown.edu: [orch,phsu]), (sorin_istrail@brown.edu supplementary information: supplementary data: [orch,phsu]), (bioinformatics online: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3536966
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (predictive power: [hcpp]), (morphological features: []), (autistic patients: [mobd]), (matched-pairs controls: [resa]), (relationship: []), (autism: [mobd]), (receiver operator: [humn]), ((roc): [qnco]), (addition: []), (recursive partitioning (rp): []), (specific pattern: []), (abnormalities: [cgab]), (difference: [qnco]), (autistic children: [podg]), (controls: [sbst]), (present findings: [clna]), (patients: [podg]), (roc: [qnco]), (rp: [gngm]), (morphological measures: [qnco]), (strong predictive accuracy: []), (facial asymmetry: [anab]), (multiple hair whorls: [bpoc]), (prominent forehead: [fndg]), (future research: [resa]), (multivariable risk prediction models: []), (use: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-012-1554-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3368908
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (idiopathic autism: [mobd]), (genetic susceptibility: [orga]), (unknown environmental triggers: [clna]), (years: []), (environmental triggers: [clna]), (understood pathophysiology: [menp]), (subjective definitions: []), (autism: [mobd]), (use: []), (antidepressants: [phsu]), (pregnant women: [popg]), (other unmetabolized psychoactive pharmaceuticals: [phsu]), (drinking water: [sbst]), (surface sources: [fndg]), (possible exposure route: []), (questions: []), (human health consequences: [humn]), (here: []), (gene expression patterns: [genf]), (fathead minnows: [fish]), (mixture: [sbst]), (psychoactive pharmaceuticals: [phsu]), (venlafaxine: [orch,phsu]), (carbamazepine): [orch,phsu]), (dosages: [qnco]), (observed conservative estimates: [qnco]), (environmental concentrations: [menp]), (microarray experiments: [resa]), (brain tissue: [bpoc]), (fish: [gngm]), (individual pharmaceuticals: [phsu]), (three: [qnco]), (gene-class analysis: [lbpr]), (enrichment: []), (gene sets: [gngm]), (ten human neurological disorders: [humn]), (sets: [menp]), (upps: []), (autism-like gene expression patterns: [mobd]), (findings: [clna]), (new potential trigger: [clna]), (susceptible individuals: [humn]), (overlooked source: [fndg]), (environmental contamination: [eehu]), 
ASD Terms: (idiopathic autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(possible exposure route, 'Exposures')(ten human neurological disorders, 'Neurologic Indications')(idiopathic autism, 'Autism Phenotype')

PMCID: 3823072
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract: []), (biomarkers: [clna]), (illness: [sosy]), (strategy: [menp]), (popularity: [socb]), (relevance: []), (clinical use: []), (biological measurement: []), (psychiatric disorder: [mobd]), (course: []), (medical problem: [clna]), (aid: [gngm]), (several studies: [lbpr]), (candidate: []), (psychiatric biomarkers: [clna]), (proteomic techniques: []), ( cholesterol: [bacs,orch]), (proteins: [aapp,bacs]), ((apos): []), (interest: [menp]), (cholesterol: [bacs,orch]), (brain development: [ortf]), (synthesis: [biof]), (rate: [qnco]), (adult brain: [bpoc]), (apos: []), (protein component: [aapp,bacs]), (lipoproteins: [aapp,bacs]), (lipid transport: [celf]), (extensive evidence: []), (levels: []), (psychiatric disorders: [mobd]), (autistic spectrum disorders: [mobd]), (here: []), (putative serum biomarkers: []), (role: [socb]), (central nervous system (cns) disorders: [dsyn]), 
ASD Terms: (psychiatric disorder, 'Mental Disorders')(medical problem, 'Medications')(psychiatric disorders, 'Mental Disorders')(autistic spectrum disorders, 'Autistic Disorder')(central nervous system disorders, 'Nervous System Diseases')

PMCID: 3352915
SFARI Genes: 
Non SFARI Genes: fuse, 
Named Entities: (language difficulties: [fndg]), (individuals: [humn]), (autism: [mobd]), (inability: []), (audiovisual information: []), (skill: [inbe]), (language development: [menp]), (9-month-old siblings: [famg]), (children: [aggp]), (risk: []), (audiovisual speech cues: [orgf]), (eye-tracker: [bpoc]), (infants: [aggp]), (screen: [hlca]), (same model: []), (face: [gngm]), (other/ga/: []), (face congruent: [blor]), (syllable sound: [npop]), (other face incongruent: [blor]), (method: [lbpr]), (low risk: [fndg]), (audiovisual speech:: [orgf]), (same amount: [qnco]), (time: []), (mouths: [bsoj]), (fusible visual/ga/: []), (congruent visual/ba/ audio/ba/displays: [inpr,mnob]), (auditory: []), (visual streams fuse: [npop]), (mcgurk-type: [qnco]), (syllabic percept: []), (incongruent condition: [dsyn]), (low-risk infants: [aggp]), (mismatch: []), (visual cues:: []), (mouth: [bsoj]), (mismatched: []), ( non-fusible visual/ba/ audio/ga/display: [inpr,mnob]), (congruent visual/ga/ audio/ga/display: [inpr,mnob]), (uncommon: []), (interesting: [menp]), ( speech-like percept: [orgf]), (incongruent mouth: [bsoj]), (anova: displays x fusion/mismatch conditions: [dsyn]), (f(1: [inch,phsu]), (16) =: []), (p: [gngm]), (behaviour: [inbe]), (high-risk infants: [fndg]), (type: [qnco]), (display: []), (difficulties: [fndg]), (visual information: []), (anova: [gngm]), ( displays: []), (conditions: [dsyn]), (25) =: []), (contrast: [irda]), (anova: displays: []), (low/high-risk groups: [popg]), (41) =: []), (cases: [qnco]), (ability: [orga]), (poor communication skills: [grpa]), 
ASD Terms: (autism, 'Autism Phenotype')(language difficulties, 'Language Ability')(language development, 'Language Development')(autism, 'Autism Phenotype')(audiovisual speech cues, 'Language Ability')(syllabic percept, 'Cognitive Ability')(audiovisual speech, 'Language Ability')(visual streams fuse, 'Visual Thinking')(visual cues, 'Visual Thinking')(speech-like percept, 'Cognitive Ability')(visual information, 'Visual Thinking')(poor communication skills, 'Reciprocal Social Interaction')

PMCID: 3352866
SFARI Genes: Fmr1, Fmr1, 
Non SFARI Genes: 
Named Entities: (pathogenic mechanisms: [fndg]), (autism: [mobd]), (evidence: []), (metabotropic: []), (ionotropic glutamate receptors: [aapp,rcpt]), (gabaergic system: []), (memantine: [orch,phsu]), (uncompetitive antagonist: [ortf]), (nmda receptors: [aapp,rcpt]), (treatment: [topp]), (alzheimer's disease treatment: [topp]), (recently: []), (language: [lang]), (function: [phsf]), ( social behavior: [socb]), (self-stimulatory behaviors: [inbe]), (autistic subjects: [mobd]), (mechanism: []), (effect: []), (study: [resa]), (cerebellar granule cells: [bpoc]), (fmr1 knockout (ko): [emod]), (mouse model: [emod]), (fragile x syndrome (fxs): [cgab,dsyn]), (syndromic autism: [mobd]), (effects: []), (dendritic spine development: [celf]), (synapse formation: [ortf]), (results: [fndg]), (maturation: [phsf]), (dendritic spines: [celc]), (fmr1-ko cgcs: [dsyn]), (reduced excitatory synapse formation: [biof]), (memantine treatment: [orch,phsu]), (cell adhesion properties: [celf]), (development: [orgf]), (mushroom-shaped mature: [fngs]), (dendritic spine: [celc]), (normal levels: [fndg]), (excitatory: []), (normal range: [qnco]), (findings: [clna]), (therapeutic capacity: [qnco]), (stimulatory effect: []), (dendritic spine maturation: [celf]), (excitatory synapse formation: [biof]), (adhesion: [patf]), (cgcs: [dsyn]), 
ASD Terms: (autism, 'Autism Phenotype')(improve language, 'Language Development')(social behavior, 'Reciprocal Social Interaction')(mouse model for fragile x syndrome, 'Fragile X Syndrome')(fragile x syndrome, 'Fragile X Syndrome')(syndromic autism, 'Autism Phenotype')

PMCID: 3399634
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background: triple x: [qnco]), (syndrome (47: [dsyn]), (xxx: [lbpr]), (trisomy x): [dsyn]), (frequent cytogenetic condition: [dsyn]), (large variety: [qnco]), (behavioural phenotypes: [bhvr]), (method:: [lbpr]), (adult patients: [aggp]), (triple x karyotype: [resa]), (described: []), (results: their karyotype: [resa]), (years: []), (patients: [podg]), (autism: [mobd]), (psychotic illness: [fndg]), (behaviour: [inbe]), ( suicidality: [clna]), (decline: []), (occupational capacity: [qnco]), (discussion:: [socb]), (gene-environment interactions: [genf]), (variety: []), (psychiatric phenotypes: [orga]), (triple x syndrome: [dsyn]), (atypical development: [orgf]), (adults: [aggp]), (conclusions:: []), (account: [clna]), (research: [resa]), (psychiatric phenotype: [orga]), (developmental disorders: [mobd]), 
ASD Terms: (occupational capacity, 'Job Performance')(autism, 'Autism Phenotype')(suicidality, 'Depressive Disorder')(ongoing atypical development in adults, 'Learning Disorders')(atypical development, 'Learning Disorders')(ongoing atypical development in adults, 'Learning Disorders')

PMCID: 3342283
SFARI Genes: ß, ß, ß, ß, ß, ß, ß, ß, ß, ß, ß, ß, ß, ß, 
Non SFARI Genes: 
Named Entities: (amyloid: [aapp,bacs]), (product: [qnco]), (proteolytic cleavage: [celf]), (amyloid  precursor protein (app): [aapp]), (neuronal cytoplasm: [celc]), (non-affected individuals: [humn]), (cell typespecific amount: [qnco]), (methodology/principal findings: [clna]), (present study: [qnco]), (percentage: [qnco]), (amyloid-positive neurons increases: [aapp,bacs]), (subjects: [humn]), (idiopathic autism: [mobd]), (duplication: [comd]), (15q11.2-q13 (dup15): [celc]), (autism spectrum disorder (asd): [mobd]), (spite: []), (interindividual differences: [qnco]), (group: [popg]), ( levels: []), (intraneuronal a load: [acty]), (dup(15) autism group: [mobd]), (control: [sbst]), (idiopathic autism group: [mobd]), (examined regions: [fndg]), (comparisons; kruskall-wallis test): [acty]), (regions: []), (control groups: [grup]), (intraneuronal a: []), (n-terminally truncated: [aapp,imft]), (intraneuronal accumulation: [fndg]), (a1740/42: []), (children: [aggp]), (adults: [aggp]), (life-long enhancement: [acty]), (app: [gngm]), (-secretase: [aapp,enzy]), (autistic subjects: [mobd]), (a accumulation: [fndg]), (neuronal endosomes: [celc]), (autophagic vacuoles: [fndg]), ( lamp1-positive lysosomes: [celc]), (lipofuscin: [bacs,orch]), (confocal microscopy: [lbpr]), (products: []), (enhanced -secretase processing accumulate: [aapp,enzy]), (organelles: [celc]), (proteolysis: [moft]), (storage: [celc]), (metabolic remnants: [emst]), (diffuse: []), (a140/42: []), (asd: [cgab]), (years: []), (age: [orga]), (age-associated risk: [orga]), (alterations: []), (short form: []), (a: []), (extracellular deposition: [celc]), (full-length a: [qnco]), (nonfibrillar plaques: [acab]), (prevalence: [qnco]), (excessive a accumulation: [fndg]), (neurons: [cell]), (individuals: [humn]), (early onset: [fndg]), (intractable seizures: [fndg]), (high risk: [fndg]), (sudden unexpected death: [patf]), (epilepsy: [dsyn]), (dup(15): []), (idiopathic asd: [cgab]), (concept: []), (functional links: []), (autism: [mobd]), ( epilepsy: [dsyn]), (astrocytic a accumulation: [fndg]), (diffuse plaque formation: [comd]), 
ASD Terms: (idiopathic autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(dup autism group, 'Autism Phenotype')(idiopathic autism group, 'Autism Phenotype')(years of age, 'Onset of Symptoms')(early onset, 'Onset of Symptoms')(epilepsy, 'Epilepsy')(autism, 'Autism Phenotype')(epilepsy, 'Epilepsy')(epilepsy, 'Epilepsy')

PMCID: 3338262
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (heterozygous parent: [orga]), (allele: [gngm]), (equal probability: [qnco]), (exceptions: []), (however: []), (meiotic drive: [phsu]), ( competition: [socb]), (gametes: [cell]), (viability selection: [genf]), (term transmission distortion (td): [orgf]), (several well-characterized examples: [acty]), (existence: []), (humans remains: [humn]), (genome-wide scan: [mbrt]), (td: []), (transmission disequilibrium test: [dsyn]), (genome-wide: [gngm]), (large sets: [menp]), (human pedigrees: [humn]), (european descent:: [famg]), (framingham heart study: [diap]), (founder population: [popg]), (european origin (hutt): [fndg]), (subset: []), (autism genetic resource exchange (agre): [mobd]), (error: []), (important confounder: []), (type: [qnco]), (analysis: [resa]), (fhs: [dsyn]), (hutt: []), (extensive quality control: []), (sufficient evidence: []), (signals: [phpr]), (agre: []), (many signals: [phpr]), (multiple snps: [nusq]), (pattern: []), (several candidate regions: [qnco]), (data set: []), (locus: [gngm]), (genome-wide significant tdt: [gngm]), (combined female: [orga]), (male transmissions: [patf]), (signature: [amas]), (recent positive selection: [lbpr]), (paternal td signal: [phpr]), (same region: []), (significant td signal: [phpr]), (european males: [orga]), (region: []), ( however: []), (paternal signal: [phpr]), (sperm competition assays: [lbpr]), (allelic imbalance: [comd]), (sperm: [cell]), (maternal transmissions: [patf]), (strong signals: [phpr]), (centromeres: [celc]), (regions: []), (female-specific meiotic drive: [menp]), (significant enrichment: [qnco]), (top signals: [phpr]), (genes: [gngm]), (cell junctions: [bsoj]), (results: [fndg]), (potential benefits: [qnco]), (challenges: [hlca]), (tdt: [gngm]), (transmission distortion: [patf]), (candidates: []), (investigation: [hlca]), (future studies: [lbpr]), 
ASD Terms: (autism genetic resource exchange, 'Autism Phenotype')

PMCID: 3338748
SFARI Genes: TSC1, TSC2, SHANK3, TSC1, TSC2, SHANK3, HOMER1, Shank3, HOMER1, Shank3, HOMER1, HOMER1, 
Non SFARI Genes: 
Named Entities: (identification: [menp]), (common molecular pathways: [moft]), (genetic variation: [npop]), (autism: [mobd]), (disease pathogenesis: [dsyn]), (effective therapies: [topp]), (here: []), (hypothesis: []), (rare genetic variation: [npop]), (metabotropic glutamate-receptor (mglur): [aapp,rcpt]), (contributes: [acty]), (susceptibility: [clna]), (single-nucleotide variants: [fndg]), (genes: [gngm]), (components: []), (mglur: []), (pathway: [moft]), (high-throughput multiplex sequencing: [mbrt]), (pooled samples: [sbst]), (non-syndromic autism cases: [mobd]), (controls: [sbst]), (independent next-generation platforms: [acty]), (analysis: [resa]), (significant enrichment: [qnco]), (rare functional variants: [gngm]), (mglur pathway: [moft]), (autism cases: [mobd]), (burdens: []), (rare: [gngm]), (deleterious variants: []), (pathway genes: [gngm]), (syndromic autism spectrum disorder: [mobd]), ( tsc1: [aapp,imft]), ( tsc2: [dsyn]), (shank3: [gngm]), (non-syndromic autism: [mobd]), (homer1: [gngm]), (postsynaptic density-localized scaffolding protein: [moft]), (mglur activity: [acty]), (novel autism-risk gene: [gngm]), (deleterious homer1 variants: [gngm]), (autism population: [mobd]), (important protein regions: [amas]), (regulatory sequences: [nusq]), (children: [aggp]), (affected families: [famg]), (rare asd-associated coding variants: [cgab]), (damaging effects: []), (ras/mapk cascade: [gngm]), (collectively: []), (findings: [clna]), (downstream: []), (mglurs contributes: [acty]), (pathogenesis: [patf]), 
ASD Terms: (autism, 'Autism Phenotype')(autism susceptibility, 'Autism Phenotype')(non-syndromic autism cases, 'Autism Phenotype')(autism cases, 'Autism Phenotype')(autism cases, 'Autism Phenotype')(syndromic autism spectrum disorder, 'Autism Phenotype')(non-syndromic autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism population, 'Autism Phenotype')(non-syndromic autism, 'Autism Phenotype')

PMCID: 3404662
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background: autism spectrum disorders: [mobd]), (many parts: [qnco]), (world: [popg]), (portion: []), (cases: [qnco]), (environmental exposures: [inpo]), (conclusive: []), (findings: [clna]), (specific exposure; however: [clna]), (evidence: []), (gestational pesticides exposures: [hops]), (strong candidates: []), (multiple developmental processes: [ortf]), (asds: [cgab]), (gestation: [orgf]), (early life: []), (biological plausibility: []), (agents: [chvf]), (core: [bdsu]), (pathophysiological features: [patf]), (objectives:: []), (objectives: []), (mechanisms: []), (autism pathophysiology: [mobd]), (effects: []), (pesticide exposures: [hops]), (neuroexcitability: []), ( oxidative stress: [comd]), (immune functions: [ortf]), (biological correlates: []), (pesticide exposure: [hops]), (autism risk: [mobd]), (methods:: []), (previous research: [resa]), (risk: []), ( developmental effects: [orgf]), (early pesticide exposure: [hops]), (basic biological mechanisms: []), (pesticides: [hops]), (autism: [mobd]), (discussion:: [socb]), (basis: [phsu]), (observational research: [resa]), (certain pesticides: [hops]), (core features: [bdsu]), (timing: []), (dose: [qnco]), (various mechanisms: [phsu]), (condition: [dsyn]), (conclusions:: []), (animal studies: [anim]), (research: [resa]), (gene  environment interactions: [genf]), (experimental exposure: [clna]), (mixtures: [sbst]), (compounds: [chem]), (similarly: []), (epidemiologic studies: [resa]), (humans: [humn]), (high exposures: [phpr]), (pesticide classes: [hops]), (concern: []), (studies: [lbpr]), (gene  environment: [gngm]), (susceptible subpopulations: [popg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(environmental exposures, 'Exposures')(specific exposure, 'Exposures')(gestational pesticides exposures, 'Perinatal History')(autism spectrum disorders, 'Autism Phenotype')(gestation, 'Perinatal History')(autism pathophysiology, 'Autism Phenotype')(pesticide exposures, 'Exposures')(pesticide exposure, 'Exposures')(autism risk, 'Autism Phenotype')(autism risk, 'Autism Phenotype')(early pesticide exposure, 'Exposures')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(experimental exposure, 'Exposures')(pesticide exposures, 'Exposures')(high exposures, 'Exposures')

PMCID: 3425128
SFARI Genes: IL-6, IL-6, 
Non SFARI Genes: 
Named Entities: (recent clinical observations: [hlca]), (certain gut: [bdsy]), (dietary factors: []), (symptoms: [sosy]), (autism: [mobd]), (propionic acid (pa): [orch]), (short chain: [qnco]), (fatty acid: [orch]), (important intermediate: [lbtr]), (cellular metabolism: [celf]), (pa: [gngm]), (several beneficial biological effects: [qnco]), (accumulation: [fndg]), (groups: [popg]), (young western albino male rats: [orga]), (grams: [qnco]), (days: []), (present study: [qnco]), (first group: [popg]), (pa-treated rats: [mamm]), (neurotoxic dose: [inpo]), (mg/kg body weight/day: [qnco]), (=: []), (second group: [popg]), (rats: [mamm]), (saline: [sbst]), (control: [sbst]), (biochemical parameters: [fndg]), (oxidative stress: [comd]), ( energy metabolism: [phsf]), (neuroinflammation: []), ( neurotransmission: [celf]), (apoptosis: [celf]), (brain homogenates: [bpoc]), (biochemical analyses: [resa]), (increase: []), (oxidative stress markers: [comd]), (example: []), ( lipid peroxidation): [moft]), (decrease: [qnco]), (glutathione (gsh): [aapp,bacs]), (glutathione peroxidase (gpx): [aapp,enzy]), (catalase activities: [moft]), (impaired energy metabolism: [phsf]), (lactate dehydrogenase: [aapp,enzy]), (activation: [acty]), (creatine kinase (ck): [aapp,enzy]), (il-6: [gngm]), ( tnf: [aapp,bacs]), ( ifn: []), (heat shock: [phsf]), ((hsp70): [aapp,bacs]), (neuroinflammatory effect: []), (moreover: []), ( elevation: [topp]), (caspase3: [aapp,enzy]), (dna fragmentation: [moft]), (neurotoxic effect: [inpo]), (pups: []), (results: [fndg]), (animal models: [anim]), (clinical data: []), (biochemical profile: [lbpr]), (autistic patients: [mobd]), (study: [resa]), (neurotoxicity: [inpo]), (environmental factor: []), (central role: [socb]), (etiology: []), (autistic biochemical features: [fndg]), 
ASD Terms: (autism, 'Autism Phenotype')(impaired energy metabolism, 'Metabolic Indications')(autism, 'Autism Phenotype')

PMCID: 3386011
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (diathesis-stress model: [clna]), (psychiatric conditions: [mobd]), (view: []), ('differential susceptibility': [clna]), (genes: [gngm]), (individual vulnerability: [humn]), (same allelic variation: [gngm]), (psychiatric disorder: [mobd]), (early) environmental adversity: []), (better-than-average functional outcome: [qnco]), (same domain: []), ((or favourable): []), (environmental conditions: [dsyn]), (studies: [lbpr]), (polymorphic variations: []), (serotonin transporter: [aapp,bacs]), (monoamino-oxidase-inhibitor a coding gene: [gngm]), (dopamine d4 receptor gene: [aapp,rcpt]), (early environment: []), (crucial role: [socb]), (development: [orgf]), (favourable versus: []), (unfavourable outcomes: []), (current evidence: [npop]), (limited: [fndg]), ( however: []), (link: []), (genetic variation: [npop]), (behavioural phenotypes: [bhvr]), (plasticity: [npop]), (neuroanatomical level: [phsu]), ('hard-wired' correlate: []), (observable behaviour: [inbe]), (present review article: [qnco]), (argument: [socb]), (favour: [orch,phsu,vita]), (differential susceptibility theory: [clna]), (findings: [clna]), (neuroanatomical studies: [lbpr]), (relation: [socb]), (oxytocin receptor gene: [aapp,rcpt]), (polymorphic variation: []), (oxytocin receptor gene (rs2254298): [aapp,rcpt]), (sociability: [socb]), ( amygdala volume: [bpoc]), (differential risk: []), (autism: [mobd]), ( depression: [mobd]), (anxiety disorder: [mobd]), (quality: []), (early environmental experiences: [menp]), (core: [bdsu]), (developmental plasticity: [npop]), (contrast: [irda]), (diathesis-stress perspective: [clna]), (evolution: [genf]), (natural selection: [npop]), (such 'risk' alleles: [gngm]), (gene pool: []), (population: [popg]), (please: []), (related manuscript: http://www.biomedcentral.com/1741-7015/10/37: [inpr,mnob]), 
ASD Terms: (diathesis-stress model of psychiatric conditions, 'Mental Disorders')(psychiatric conditions, 'Mental Disorders')(psychiatric disorder, 'Mental Disorders')(differential risk for psychiatric conditions, 'Mental Disorders')(autism, 'Autism Phenotype')(depression, 'Depressive Disorder')(anxiety disorder, 'Anxiety Disorders')

PMCID: 3325173
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (clear genetic component: [fndg]), (high genetic heterogeneity: [orga]), (disorder: [dsyn]), (challenge: [hlca]), (identification: [menp]), (causative genes: [gngm]), (homozygosity analysis: [orga]), (probands: [orga]), (nonconsanguineous families: [famg]), (evidence: []), (ancestry: []), (recessive mutations: [genf]), (whole-exome sequencing: [mbrt]), (validated homozygous: [orga]), (pathogenic recessive mutations: [genf]), (disease: [dsyn]), (families: [famg]), (candidate genes (ube3b: [gngm]), ( cltcl1: [gngm]), ( nckap5l: [gngm]), ( znf18) encode proteins: [aapp,bacs]), (proteolysis: [moft]), ( gtpase-mediated signaling: [aapp,enzy]), ( cytoskeletal organization: [celf]), (other pathways: [moft]), (furthermore: []), (neuronal depolarization: [imft]), (transcription: [genf]), (genes: [gngm]), (potential activity-dependent roles: [socb]), (neurons: [cell]), (multidimensional strategy: [menp]), (whole-exome sequence data: [nusq]), (candidate recessive mutations: [genf]), (applicability: []), (other complex: [chvs]), (heterogeneous disorders: [fndg]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3763210
SFARI Genes: 
Non SFARI Genes: impact, impact, 
Named Entities: (systematic review: []), (epidemiological surveys: []), (autistic disorder: [mobd]), (pervasive developmental disorders: [mobd]), (worldwide: []), (secondary aim: [neop]), (possible impact: [gngm]), (geographic: []), ( cultural/ethnic: [popg]), (socioeconomic factors: [grpa]), (prevalence estimates: [qnco]), (clinical presentation: []), (pdd: [dsyn]), (evidence: []), (median: [qnco]), (autism spectrum disorders: [mobd]), (estimates: [qnco]), (differences: [qnco]), (pdd prevalence: [qnco]), (geographic region: []), (strong impact: [gngm]), (however: []), ( power: [hcpp]), (such effects: []), (data sets: []), (low-income countries: [grpa]), (time: []), (different neighboring: []), (distant regions: []), (findings: [clna]), (likely represent broadening: [acty]), (diagnostic concets: [fndg]), (diagnostic switching: [fndg]), (other developmental disabilities: [mobd]), ( service availability: []), (awareness: [menp]), (autistic spectrum disorders: [mobd]), (lay: []), (professional public: []), (lack: []), (majority: [socb]), (world's population: [popg]), (critical need: []), (further research: [resa]), (capacity building: [hlca]), (middle-income countries: [qnco]), (autism res: [mobd]), (international society: [orgt]), (autism research: [mobd]), ( wiley periodicals: []), ( inc: []), 
ASD Terms: (autistic disorder, 'Autistic Disorder')(autism spectrum disorders, 'Autism Phenotype')(diagnostic switching from other developmental disabilities, 'Learning Disorders')(autistic spectrum disorders, 'Autistic Disorder')(other developmental disabilities, 'Learning Disorders')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 3613847
SFARI Genes: CHD8, KATNAL2, CHD8, KATNAL2, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (environmental origins: [fndg]), (modest fraction: [qnco]), (individuals: [humn]), (causes: []), (genetic risk factors: []), (role: [socb]), (mutations: [genf]), (asd: [cgab]), (exomes: [gngm]), (asd cases: [cgab]), (parents: []), (trios): [aapp,enzy]), (half: [qnco]), (cases: [qnco]), (missense: [fndg]), (nonsense: [comd]), (variant: []), (overall rate: [qnco]), (mutation: [genf]), (expected rate: [qnco]), (contrast: [irda]), (connectivity: []), (proteins: [aapp,bacs]), (genes: [gngm]), (nonsense mutations: [comd]), (excess connectivity: []), (asd genes: [cgab]), (major effect: []), (subset: []), (observed events: [evnt]), (asd risk: [cgab]), (small increase: [qnco]), (rate: [qnco]), (events: [evnt]), (connections: []), (limited role: [socb]), (point mutations: [comd]), (copy number variants: [nusq]), (genetic models: []), (data: [euka]), (majority: [socb]), (risk: []), (many genes: [gngm]), (penetrant (i.e.: [diap,inpr]), (results: [fndg]), (polygenic models: [genf]), (large number: [qnco]), (genes increases risk: [gngm]), (challenge: [hlca]), (such models: []), ( results: [fndg]), (novo events: [evnt]), (large parallel case-control study: [resa]), (strong evidence: []), (favor: [orch,phsu,vita]), (chd8: [gngm]), (katnal2: [gngm]), (genuine autism risk factors: [qnco]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(genuine autism risk factors, 'Autism Phenotype')

PMCID: 3350576
SFARI Genes: CHD8, NTNG1, CHD8, NTNG1, GRIN2B, LAMC3, SCN1A, GRIN2B, LAMC3, SCN1A, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (strong genetic component: [gngm]), (however: []), (cases: [qnco]), (underlying genetic cause: [topp]), (hypothesis: []), (mutations: [genf]), (substantial fraction: [qnco]), (risk: []), (asd: [cgab]), (families: [famg]), (previous history: [orga]), (phenotypesso-called sporadic: [fndg]), (simplex families2: [bpoc]), (3: [fndg]), (regions: []), (genome: [gngm]), ( i.e: [diap,inpr]), (exome: [gngm]), (parent-child trios: [aapp,enzy]), (sporadic asd: [cgab]), (new trios: [aapp,enzy]), (reported4: []), (additionally: []), (exomes: [gngm]), (unaffected siblings: [famg]), (new (n: [aapp,imft]), (trios (n: [aapp,enzy]), (total: [qnco]), (point mutations: [comd]), (origin (4:1 bias): [bird]), (paternal age: []), (children: [aggp]), (fathers: [famg]), (asd5: [cgab,dsyn]), (moreover: []), ((49/126): []), (interconnected beta-catenin/chromatin: [aapp]), (protein network: [popg]), (autism candidate genes: [mobd]), (proband: [famg]), ( recurrent protein-altering mutations: [genf]), (genes: [gngm]), ( chd8: [gngm]), (ntng1: [gngm]), (mutation screening: [genf]), (candidate genes: [gngm]), (asd probands: [cgab]), (protein-altering mutations: [genf]), (grin2b: [gngm]), ( lamc3: [gngm]), (scn1a: [gngm]), (copy number: [qnco]), (variant (cnv) data: [nusq]), (results: [fndg]), (extreme locus heterogeneity: []), (target: [diap]), (future discovery: [acty]), ( diagnostics: [fndg]), (therapeutics: [orch,phsu]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism candidate genes, 'Autism Phenotype')

PMCID: 3337277
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mental: [menp]), (behavioral disorders: [mobd]), (adults: [aggp]), (usher syndrome: [cgab,dsyn]), (case studies: []), (research: [resa]), (children: [aggp]), (article: []), (prevalence: [qnco]), (characteristics: []), (years: []), (age: [orga]), (behavioral disorder (1: [fndg]), (schizophrenia: [mobd]), (mild mental retardation: [mobd]), (atypical autism: [mobd]), (severe mental retardation: [mobd]), (conduct disorder): [mobd]), (behavioral disorder: [mobd]), (childhood: []), (vision impairment: [fndg]), (first manifests: [qnco]), (late childhood: []), (aetiology: []), (treatment: [topp]), (discussed: [socb]), (parents: []), (clinical support: []), (development: [orgf]), 
ASD Terms: (years of age, 'Onset of Symptoms')

PMCID: 3310790
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (heritable neurodevelopmental disorder: [mobd]), (genetic underpinnings: [topp]), (disorder: [dsyn]), (aberrant brain overgrowth: [bpoc]), (well-replicated observation: [hlca]), (autism literature;: [mobd]), (association: [menp]), ( linkage: [moft]), (expression studies: [topp]), (genetic factors: [fndg]), (trajectory: []), (few studies: [lbpr]), (sufficient statistical power: [resa]), (whole-genome gene expression: [genf]), (genotypic variation: [orga]), (autistic brain: [mobd]), (regions: []), (growth abnormality: [fndg]), (previous functional genomic studies: [lbpr]), (possible alterations: []), (transcript levels: [nnon]), (genes: [gngm]), (immune function: [ortf]), (thus: []), (need: []), (genetic studies: [resa]), (key brain regions: [blor]), (findings: [clna]), (role: [socb]), (particular functional pathways: [moft]), (autism pathogenesis: [mobd]), (abnormal brain gene expression patterns: [genf]), (whole-genome analysis: [gngm]), (mrna levels: [bacs,nnon]), (copy number variations: [nusq]), (control postmortem brain samples: [diap]), (prefrontal cortex tissue: [bpoc]), (excess neuron numbers: [cell]), (cortical overgrowth: [bpoc]), (majority: [socb]), (autism cases: [mobd]), (evidence: []), (dysregulation: []), (pathways: [moft]), (cell: [gngm]), (cortical patterning: [bpoc]), (differentiation: [celf]), (young autistic prefrontal cortex: [bpoc]), (contrast: [irda]), ( adult: [aggp]), (autistic prefrontal cortex: [bpoc]), (repair pathways: [orgf]), (cell cycle: [celf]), (autism-specific cnvs: [nusq]), (dna: [bacs,nnon]), (prefrontal cortex: [bpoc]), (genome-wide association study datasets: [mbrt]), (results: [fndg]), (cnvs: [nusq]), (age-dependent gene expression changes: [genf]), (distinct pathological processes: [patf]), (mature: []), (hypothesis: []), (genetic dysregulation: [topp]), (developing brain: [bpoc]), (abnormal regional patterning: [qnco]), (excess prefrontal neurons: [cell]), ( cortical overgrowth: [bpoc]), (neural dysfunction: [dsyn]), 
ASD Terms: (autism, 'Autism Phenotype')(heritable neurodevelopmental disorder, 'Learning Disorders')(autism literature, 'Autism Phenotype')(autism pathogenesis, 'Autism Phenotype')(autism cases, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3309999
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (cognitive functions: [menp]), (accurate sequencing: [mbrt]), (events: [evnt]), (action planning: [menp]), (execution: [acty]), ( verbal: []), (nonverbal communication: [menp]), (social interaction: [fndg]), (well-tuned coding: []), (temporal event-structure: [evnt]), (visual temporal event-structure coding: [anst]), (high-functioning adolescents: [aggp]), (adults: [aggp]), (autism spectrum disorder (asd): [mobd]), (typically-developing (td) individuals: [humn]), (perceptual simultaneity paradigm: [resa]), (visual simultaneity thresholds: [ortf]), (individuals: [humn]), (asd: [cgab]), (td individuals: [humn]), (autism: [mobd]), (increased parsing: [qnco]), (decreased capability: [qnco]), (integration: [genf]), (time: []), (perceptual simultaneity thresholds: []), (developmental communication difficulties: [socb]), (results: [fndg]), (local processing bias: [bird]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(cognitive functions, 'Cognitive Ability')(action planning, 'Planning')(nonverbal communication, 'Non-Verbal Communication')(autism spectrum disorder, 'Autism Phenotype')(visual temporal event-structure coding, 'Visual Thinking')(visual simultaneity thresholds, 'Visual Thinking')(autism, 'Autism Phenotype')(developmental communication difficulties, 'Learning Disorders')

PMCID: 3309533
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (neurological developmental disorders: [mobd]), (several studies: [lbpr]), (candidate biomarker: [clna]), (development: [orgf]), (disorders: [dsyn]), (date: []), (reliable biomarker: [clna]), (mass spectrometry techniques: [lbpr]), (protein profiling: [lbpr]), (blood plasma: [bdsu]), (children: [aggp]), (such disorders: [dsyn]), (order: [acty]), (proteins/peptides: [aapp]), (biomarkers: [clna]), (detection: [topp]), (peptides: [aapp]), (masscharge (m/z) values: [phpr]), (da: [anab]), (heparin plasma: [bdsu]), (asd: [cgab]), (peptide pattern: [aapp]), (non-asd control group: [cgab]), (here: []), (novel set: [menp]), (biomarkers allows: [clna]), (reliable blood-based diagnostic tool: [bdsu]), (diagnosis: [fndg]), (potentially: []), (prognosis: [hlca]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(neurological developmental disorders, 'Neurologic Indications')(diagnosis, 'Diagnosis')

PMCID: 3295800
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (williams-beuren syndrome: [cgab,dsyn]), (rare developmental disorder: [dsyn]), (deletion: [genf]), (contiguous genes: [gngm]), (strengths: []), (socialization (overfriendliness): [edac]), (communication: [socb]), ((excessive talkativeness): [mobd]), (wbs: [gngm]), (polar opposite behavioral phenotype: [bhvr]), (objective: []), (range: [qnco]), (phenotypic expression: [orga]), (relationship: []), (autistic disorder: [mobd]), (methodology: []), (study: [resa]), (french individuals: [humn]), (years: []), (behavioral assessments: [hlca]), (autism diagnostic: [mobd]), (interview-revised (adi-r): [acty]), (autism diagnostic observation schedule (ados) scales: [hlca]), (molecular characterization: [acty]), (critical region: []), (fish: [gngm]), (findings fish analysis: [fish]), (patients: [podg]), (common wbs deletion: [genf]), (adi-r: [clna]), (ados: [aapp,enzy]), (diagnostic criteria: []), (autism: [mobd]), (stereotypies: [mobd]), (severe impairments: [patf]), (social interaction: [fndg]), (absence: [anab]), (expressive language): [lang]), (additionally: []), ( patients: [podg]), (improvement: []), (social communication: [socb]), (time: []), (results: [fndg]), (comorbid autism: [mobd]), (continuum: []), (social communication impairment: [mobd]), (excessive talkativeness: [mobd]), (overfriendliness: [mobd]), (verbal language: [lang]), (poor social relationships: [grpa]), (appreciation: []), (possible co-occurrence: []), (common view: [qnco]), (opposite behavioral phenotype: [bhvr]), (improved recognition: [menp]), (individuals: [humn]), 
ASD Terms: (autistic disorder, 'Autistic Disorder')(autism diagnostic, 'Autism Phenotype')(autism diagnostic observation schedule scales, 'Autism Phenotype')(autism, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(autism diagnostic observation schedule, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')(social communication impairment, 'Reciprocal Social Interaction')(comorbid autism, 'Comorbidities')(autism, 'Autism Phenotype')

PMCID: 3280447
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract autism: [mobd]), (heterogeneous group: [popg]), (complex developmental disabilities: [mobd]), (number: [qnco]), (possible etiologies: []), (well-known number: [qnco]), (comorbidities: []), (autism spectrum disorders: [mobd]), (including: []), ( commonly: []), ( gastrointestinal (gi) pathology: [patf]), (variable combinations: [phsu]), (constipation: [sosy]), (diarrhea: [sosy]), ( abdominal pain: [sosy]), ( gastroesophageal reflux: [dsyn]), (vomiting: [sosy]), (american academy: [orgt]), (pediatrics consensus panel: [socb]), (prospective studies: [resa]), (prevalence: [qnco]), (gi disorders: [dsyn]), (asd: [cgab]), (pathophysiologic basis: [phsu]), (recent article: []), ( williams: []), (al: [lbpr]), ([b. l. williams: []), ( m. hornig: [aapp,imft]), ( t. parekh: [clna]), (w. i. lipkin: [inch]), (such study: [resa]), (autism: [mobd]), (gi comorbidities: [gngm]), (evidence: []), (sutterella species: [bact]), (ileal mucosal biopsy specimens: [tisu]), (patients: [podg]), (control children: [aggp]), (gi symptoms: [sosy]), (specific role: [socb]), (sutterella: [bact]), (sutterella sequences: [nusq]), (~1: [fndg]), (total bacterial sequences: [nusq]), (large effect size: [qnco]), (ileal: [bpoc]), (mucosal composition: [tisu]), (autism phenotype: [mobd]), (effect size: [qnco]), (ileal crohns disease phenotype: [dsyn]), (study: [resa]), (new field: [irda]), (investigation: [hlca]), (etiology: []), (consequences: []), 
ASD Terms: (heterogeneous group of complex developmental disabilities, 'Learning Disorders')(abstract autism, 'Autism Phenotype')(complex developmental disabilities, 'Learning Disorders')(comorbidities, 'Comorbidities')(autism spectrum disorders, 'Autism Phenotype')(abdominal pain, 'Pain')(gastroesophageal reflux, 'Gastroesophageal Reflux')(gastrointestinal disorders, 'Gastrointestinal Diseases')(autism, 'Autism Phenotype')(gastrointestinal comorbidities, 'Comorbidities')(total bacterial sequences, 'Bacterial Infections')(autism phenotype, 'Autism Phenotype')(ileal crohns disease phenotype, 'Crohn Disease')(gastrointestinal comorbidities, 'Comorbidities')

PMCID: 3554878
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (attention deficit hyperactivity disorder (adhd): [mobd]), (autism spectrum disorder (asd): [mobd]), (share: [socb]), (behavioural-cognitive abnormalities: [mobd]), (sustained attention: [menp]), (key question: []), (cognitive phenotype: [orga]), (different underlying pathophysiologies: [patf]), (question: []), (boys: [aggp]), (adhd: [mobd]), (age: [orga]), (iq: []), (asd: [cgab]), (healthy boys: [aggp]), (functional magnetic resonance: [npop]), ((fmri): [diap]), (vigilance task: [menp]), (load: [acty]), (asd boys: [cgab]), (activation relative: [qnco]), (controls: [sbst]), (bilateral striatothalamic regions: []), (dorsolateral prefrontal cortex (dlpfc): [bpoc]), (superior parietal cortex: [bpoc]), (groups: [popg]), (precuneus activation relative: [qnco]), (precuneus: [bpoc]), (dlpfc activation: [acty]), (attention load: [menp]), (problems: []), (deactivation: []), (task-related default mode network: [popg]), (disorders: [dsyn]), (however: []), (dlpfc underactivation: []), (furthermore: []), (sustained performance measures: [qnco]), (adhd patients: [mobd]), (other hand: [bpoc]), (disorder-specific: [dsyn]), (cerebellar activation relative: [bpoc]), (compensation: [menp]), (findings: [clna]), (disorder-specific abnormalities: [dsyn]), (brain function: [ortf]), (deficits: []), (frontostriatoparietal activation: [acty]), (default mode suppression: [qnco]), (differences: [qnco]), (severe dlpfc dysfunction: [fndg]), (disorder-specific frontostriatocerebellar dysregulation: [dsyn]), 
ASD Terms: (attention deficit hyperactivity disorder, 'Overactivity')(autism spectrum disorder, 'Autism Phenotype')(cognitive phenotype, 'Cognitive Ability')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention deficit hyperactivity disorder relative, 'Overactivity')(attention deficit hyperactivity disorder patients, 'Overactivity')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 3398286
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (plasma concentrations: [qnco]), (amyloid beta (a): [aapp]), (protein derivatives: [aapp,bacs]), (central role: [socb]), (etiology: []), (autistic features: [mobd]), (design: [acty]), (concentrations: [menp]), (human a: [humn]), ((1-42): [fndg]), ( a (1-40): [qnco]), (a (40/42): [qnco]), (plasma: [bdsu]), (autistic children: [podg]), (3-16 years): [fndg]), (age-matched control subjects: [humn]), (elisa technique: [lbpr]), (compared: [acty]), (subjects: [humn]), ( autistic children: [podg]), (a (1-40): [qnco]), (a (1-42): []), (a (40/42) concentration ratio: [menp]), (characteristics: []), ((roc) analysis: [qnco]), (measurements: []), (a peptides: [aapp]), (high specificity: [qnco]), (sensitivity: [patf]), (control subjects: [sbst]), (loss: [qnco]), (a equilibrium: [orgf]), (brain: [bpoc]), (imbalance: [sosy]), (a: []), (and/or impairment: [patf]), (- secretase's concentration: [aapp,enzy]), (kinetics: [npop]), (enzymes: [enzy,orch]), (a production: []), 
ASD Terms: 

PMCID: 3252763
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract gastrointestinal disturbances: [fndg]), (children: [aggp]), (autism: [mobd]), (compositional changes: [qnco]), (intestinal bacteria: [bact]), (previous report: [hlca]), (intestinal microbiota: [orgm]), (ileal: [bpoc]), (cecal biopsy samples: [tisu]), (gastrointestinal dysfunction (aut-gi): [dsyn]), (only gastrointestinal dysfunction (control-gi): [dsyn]), (results: [fndg]), (presence: [qnco]), (members: [popg]), (family alcaligenaceae: [bact]), (aut-gi children: [aggp]), (control-gi children: [aggp]), (alcaligenaceae sequences: [bact]), (levels: []), (alcaligenaceae: [bact]), (intestinal biopsy samples: [bpoc]), (aut-gi children result: [aggp]), (high levels: [qnco]), (genus sutterella: [bact]), (first sutterella-specific pcr assays: [mbrt]), (detecting: [fndg]), ( quantitating: []), (sutterella species: [bact]), (environmental samples: [sbst]), (sutterella: [bact]), (rrna gene sequences: [gngm]), (none: []), (phylogenetic analysis: [resa]), (predominance: []), (sutterella wadsworthensis: [bact]), (sutterella stercoricanis: [bact]), (individual sutterella-positive aut-gi patients;: [podg]), (aut-gi patient: [podg]), ( sutterella sequences: [nusq]), (species-level classification: [phsu]), (sutterella isolates: [phsu]), (western immunoblots: [lbpr]), (plasma igg: [bdsu]), (igm antibody reactivity: [celc]), (sutterella wadsworthensis antigens: [imft]), (aut-gi patients: [podg]), (pcr positive: [mbrt]), (immune response: [ortf]), 
ASD Terms: (autism, 'Autism Phenotype')(intestinal bacteria, 'Bacterial Infections')(sutterella wadsworthensis antigens in 11 aut-gi patients, 'Allergies')(sutterella wadsworthensis antigens, 'Allergies')

PMCID: 3269681
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (establishment: []), (efficient approaches: []), (developmental neurotoxicity: [inpo]), ((dnt): [hops,orch]), (issue: [fndg]), (childrens environmental health: [hlca]), (systematic approach: []), (dnt: [hops,orch]), (neuronal differentiation: [fndg]), (mouse: [mamm]), (embryonic stem cells: [cell]), (model: []), (fetal programming: [biof]), (embryoid body (eb) formation: [cell]), ( mescs: [cell]), (chemicals: [chem]), (h: [gngm]), (global gene expression profiling: [lbpr,mbrt]), (whole genome microarray analysis: [lbpr]), (gene expression signatures: [qnco]), (kinds: []), (gene sets: [gngm]), (neuronal development: [celf]), (neuronal diseases: [dsyn]), (further analysis: [resa]), (later stages: [clna]), (neuronal cell differentiation: [fndg]), (ebs: []), (neuronal phenotypic parameters: [orga]), (high-content image analyzer: [menp]), (bayesian network analysis: [qnco]), (global gene expression: [genf]), (neuronal phenotypic data: [orga]), (comprehensive networks: []), (linkage: [moft]), (early events: [evnt]), (probability distribution values: [qnco]), (strength: [qnco]), (parameters: [fndg]), (network: [popg]), (principal component analysis: [qnco]), (characterization: [acty]), (neurotoxic potential reveals: [inpo]), (multi-parametric analysis: [resa]), (phenotype: [orga]), (gene expression: [genf]), (mescs: [cell]), (useful tool: []), (neurotoxic compounds: [inpo]), 
ASD Terms: 

PMCID: 3261830
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (neurogenic inflammation: [inpo]), (large number: [qnco]), (neuropeptides: [aapp,bacs]), (tachykinins: [aapp,horm]), (p: [gngm]), (a: []), (neurokinin b): [aapp,bacs]), (pro-inflammatory neuropeptides: [aapp,bacs]), (important role: [socb]), (autoimmune neuroinflammatory diseases: [dsyn]), (autoimmunity: [patf]), (role: [socb]), (pathogenesis: [patf]), (autism: [mobd]), (patients: [podg]), (levels: []), (autistic children: [podg]), (relationship: []), (serum levels: [bdsu]), (neurokinin: [aapp,bacs]), (anti-ribosomal p protein antibodies: [lbpr]), (serum: [bdsu]), (comparison: [acty]), (healthy-matched children: [fndg]), (a levels: []), (healthy controls: []), (children: [aggp]), (severe autism: [fndg]), (autism (p: [mobd]), (significant positive correlations: [fndg]), (severity: []), (however: []), (initial report: [hlca]), (warrants: []), (further research: [resa]), (pathogenic role: [socb]), (possible link: []), (therapeutic role: [socb]), (tachykinin receptor: [aapp,rcpt]), (potential new class: []), (anti-inflammatory medications: [phsu]), 
ASD Terms: (autoimmune neuroinflammatory diseases, 'Autoimmune Diseases')(autism, 'Autism Phenotype')(severe autism, 'Autism Phenotype')(moderate autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(anti-inflammatory medications, 'Medications')

PMCID: 3235126
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (molecular underpinnings: []), (complex psychiatric disorders: [mobd]), (autism spectrum disorders: [mobd]), (increasingly: []), (structural variations: []), (discrete chromosomal loci: [celc]), (asd: [cgab]), (search space: [acty]), (disease etiology: []), (high genetic heterogeneity: [orga]), (predictive map: [lbpr]), (candidate genes: [gngm]), (integrated bioinformatics: [genf]), (reference set: [menp]), (rare: [gngm]), (syndromic candidate asd genes: [cgab]), (composite reference profile: [lbpr]), (expression analyses: [resa]), (first: [qnco]), (functional profile: [lbpr]), (autref84: []), (gene ontology (go) enrichment analysis: [resa]), (cell adhesion: [celf]), (ion channel activity: [moft]), (second: [qnco]), (expression profile: [lbpr]), (david analysis: [resa]), (enrichment: []), (brain regions: [blor]), (sensory information: []), ((olfactory bulb: [bpoc]), (occipital lobe): [bpoc]), ( executive function: [menp]), ((prefrontal cortex): [bpoc]), (hormone secretion (pituitary): [bpoc]), (disease specificity: [qnco]), (dual autref84 profile: [lbpr]), (comparative analysis: [resa]), (control: [sbst]), ( diabetes: [dsyn]), (non-specific gene sets: [gngm]), (human genome: [gngm]), (set: [menp]), (potential asd candidate genes: [cgab]), (importantly: []), (power: [hcpp]), (predictive gene map: [lbpr,mbrt]), (asd-associated genes: [cgab]), (part: [qnco]), (autref84 input dataset: []), (genes: [gngm]), (novel putative asd risk genes: [cgab]), (together: []), (composite asd reference profile: [cgab]), (novel asd candidate genes: [cgab]), (future research: [resa]), 
ASD Terms: (complex psychiatric disorders, 'Mental Disorders')(autism spectrum disorders, 'Autism Phenotype')(sensory information processing, 'Ability to Convey Information')(executive function, 'Executive Function')(diabetes, 'Diabetes Mellitus Type 1')(diabetes, 'Diabetes Mellitus Type 1')

PMCID: 3245106
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (heterogeneous neurodevelopmental disorder: [orga]), (prevalence: [qnco]), (twin studies: [famg]), (heritability: []), (strong genetic contributions: [acty]), (many genes: [gngm]), (asd: [cgab]), (evidence is: []), (comprehensive review: []), (analysis: [resa]), (literature: [inpr,mnob]), (data: [euka]), (clearer: [fndg]), (big picture: [qnco]), (autism genetics: [mobd]), (genes: [gngm]), (snps/vntrs: [bacs,nnon]), (copy number variations: [nusq]), (linkage regions: [moft]), (gwas: [mbrt]), (genome-wide cnv studies: [nusq]), ( linkage: [moft]), (low-scale genetic association studies: [lbpr]), ( expression profiling: [mbrt]), (other low-scale experimental studies: [resa]), (evidence: []), (metadata: []), (study: [resa]), (demographic features: []), (experimental design: [resa]), (statistical significance: [qnco]), (scoring: [qnco]), (approach: []), (core data set: [bdsu]), (high-confidence genes: [gngm]), (neuroactive ligandreceptor interaction: []), ( synapse transmission: [bsoj]), (axon guidance: [celf]), (databases: []), (extensive data: [euka]), (expression patterns: [topp]), ( protein: [aapp,bacs]), (animal models: [anim]), (pharmacogenetics: []), (mysql-based online database: []), (share: [socb]), (autism research community: [mobd]), (http://autismkb.cbi.pku.edu.cn: [dsyn]), (sophisticated browsing: []), (functionalities: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(heterogeneous neurodevelopmental disorder, 'Learning Disorders')(autism genetics, 'Autism Phenotype')(autism research community, 'Autism Phenotype')

PMCID: 3517299
SFARI Genes: Cav1.2, Cav1.2, Cav1.2, Cav1.2, 
Non SFARI Genes: 
Named Entities: (monogenic: []), (neurodevelopmental disorders: [mobd]), (key insights: [menp]), (pathogenesis: [patf]), (disease: [dsyn]), (specific genes: [gngm]), (development: [orgf]), (human brain: [humn]), (timothy syndrome: [dsyn]), (missense mutation: [genf]), (l-type calcium channel cav1.2: [aapp,bacs]), (developmental delay: [mobd]), (autism: [mobd]), (cortical neuronal precursor cells: [bpoc]), (neurons: [cell]), (induced pluripotent stem cells: [cell]), (individuals: [humn]), (cells: [cell]), (defects: []), (calcium (ca2+): [bacs,elii,phsu]), (activity-dependent gene expression: [genf]), (abnormalities: [cgab]), (differentiation: [celf]), (decreased expression: [topp]), (genes: [gngm]), (cortical layers: [bpoc]), (callosal projection neurons: [cell]), (addition: []), ( neurons: [cell]), (timothy: [plnt]), (show: [anim]), (abnormal expression: [topp]), (tyrosine hydroxylase: [aapp,enzy]), (increased production: [qnco]), (norepinephrine: [horm,orch,phsu]), (dopamine: [bacs,orch,phsu]), (phenotype: [orga]), (treatment: [topp]), (roscovitine: [orch,phsu]), (cyclin-dependent kinase inhibitor: [aapp,bacs]), (atypical l-typechannel blocker: [fndg]), (findings: [clna]), (strong evidence: []), (cav1.2: [gngm]), (cortical neurons: [bpoc]), (humans: [humn]), (new insights: [menp]), (causes: []), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(developmental delay, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3228874
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (summary tuberous sclerosis complex: [neop]), (fragile x syndrome: [cgab,dsyn]), (genetic diseases: [fndg]), (intellectual disability: [mobd]), (autism: [mobd]), (syndromes: [dsyn]), (mutations: [genf]), (genes: [gngm]), (protein synthesis: [moft]), (neurons: [cell]), (excessive protein synthesis: [moft]), (core: [bdsu]), (pathophysiological mechanism: [patf]), (biochemical assays: [lbpr]), (neuronal protein synthesis: [moft]), (hippocampus: [bpoc]), (tsc2+/: [dsyn]), (fmr1/y: [gngm]), (synaptic dysfunction: [dsyn]), (opposite ends: []), (physiological spectrum: [qnco]), (synaptic: []), (cognitive defects: [mobd]), (mutants: [comd]), (treatments: [topp]), (metabotropic: []), (receptor: [aapp,rcpt]), (opposite directions: []), (deficits: []), (mice: [mamm]), (thus: []), (normal synaptic plasticity: [ortf]), (cognition occur: [menp]), (optimal range: [qnco]), (metabotropic glutamate: [aapp,bacs]), (receptor-mediated protein synthesis: [moft]), (deviations: [fndg]), (direction: []), (behavioral impairments: [inbe]), 
ASD Terms: (summary tuberous sclerosis complex, 'Tuberous Sclerosis')(fragile x syndrome, 'Fragile X Syndrome')(intellectual disability, 'Learning Disorders')(autism, 'Autism Phenotype')(pathophysiological mechanism of intellectual disability, 'Learning Disorders')(cognitive defects, 'Cognitive Ability')(cognition occur, 'Cognitive Ability')(behavioral impairments, 'Personal Traits')

PMCID: 3270696
SFARI Genes: TBX1, TBX1, GNB1L, GNB1L, GNB1L, GNB1L, GNB1L, GNB1L, GNB1L, GNB1L, 
Non SFARI Genes: Mb, 
Named Entities: (structural variations: []), (chromosome: [celc]), (region: []), (nonallelic homologous recombination result: [genf]), (deletion (del22q11.2): [genf]), (duplication (dup22q11.2) syndromes: [dsyn]), (majority: [socb]), (del22q11.2 cases: [qnco]), (cardiac malformations: [cgab]), ( immunologic impairments: [patf]), (specific cognitive profile: [lbpr]), (risk: []), (schizophrenia: [mobd]), (autism spectrum disorders: [mobd]), (phenotype: [orga]), (dup22q11.2: []), (physical features: [hlca]), (spectrum: [qnco]), (neurocognitive abnormalities: [cgab]), (substantial evidence: []), (haploinsufficiency: [comd]), (tbx1: [gngm]), (role: [socb]), (del22q11.2: []), (gene(s): [gngm]), (mb region: []), (observed spectrum: [qnco]), (behavioral phenotypes: [bhvr]), (individual: [humn]), (balanced translocation: [comd]), (behavioral phenotype: [bhvr]), (cognitive impairment: [mobd]), ( autism: [mobd]), (absence: [anab]), (congenital malformations: [cgab]), (somatic cell hybrids: [cell]), (comparative genomic hybridization: [mbrt]), (chromosome-22 breakpoint: [nnon]), (gnb1l gene: [gngm]), (copy number evaluations: [hlca]), (direct dna sequencing: [nusq]), (gnb1l: [gngm]), (autism cases: [mobd]), (families: [famg]), (autism: [mobd]), (private gnb1l missense variants: [gngm]), (conserved residues: [evnt]), (identified missense variants: [fndg]), (residues: [evnt]), (wd40 repeat domains: [amas]), (deleterious effects: []), (protein: [aapp,bacs]), (prior studies: [lbpr]), (evidence: []), (findings support involvement: [clna]), (asds: [cgab]), (well: []), (wiley periodicals: []), ( inc: []), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(cardiac malformations, 'Cardiovascular Diseases')(specific cognitive profile, 'Cognitive Ability')(autism spectrum disorders, 'Autism Phenotype')(neurocognitive abnormalities, 'Cognitive Ability')(absence of congenital malformations, 'Congenital Abnormalities')(cognitive impairment, 'Cognitive Ability')(autism, 'Autism Phenotype')(congenital malformations, 'Congenital Abnormalities')(autism cases, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 3213131
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (numerous studies: [lbpr]), (copy number variants: [nusq]), (range: [qnco]), (neurological phenotypes: [orga]), (impact: [gngm]), (severity: []), (small sample: [sbst]), (sizes: []), ( lack: []), (phenotypic details: [orga]), (heterogeneity: [orga]), (platforms: []), (discovery: [acty]), (customized microarray: [acty]), (genomic hotspots: [gngm]), (large cnvs: [nusq]), (individuals: [humn]), (various neurological deficits: [fndg]), (dyslexia (376): [mobd]), (sporadic autism (350): [mobd]), (intellectual disability (id) (501): [mobd]), (controls: [sbst]), (frequency: [qnco]), (large cnvs (>1 mbp): [nusq]), (idassociated phenotypes: [orga]), ((p =: [aapp,imft]), (odds: []), (dyslexia (p: [mobd]), (striking difference: [qnco]), (rare cnvs (>50 kbp): [aapp,enzy,rcpt]), (autism (10%: [mobd]), ( p: [aapp,imft]), (id (16%: [lbpr]), ((2%): [qnco]), (difference: [qnco]), (large cnv burden: [nusq]), (dyslexia patients: [mobd]), (rare cnvs: [nusq]), (id: [lbpr]), ((40%): [qnco]), ((0%): [fndg]), (multiple congenital anomalies: [cgab]), (data: [euka]), (childhood disability: id: [lbpr]), (mca: [bpoc]), (dyslexics: [podg]), (autism: [mobd]), (increase: []), (cnv burden: [nusq]), (controls (p: [aapp,imft]), 
ASD Terms: (neurological phenotypes, 'Neurologic Indications')(various neurological deficits, 'Neurologic Indications')(sporadic autism, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(autism, 'Autism Phenotype')(intellectual disability with multiple congenital anomalies, 'Congenital Abnormalities')(autism, 'Autism Phenotype')

PMCID: 3225379
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (biomedical events: [evnt]), (text-mining applications; however: [mcha]), (such events: [evnt]), (scientific significance: [qnco]), (development: [orgf]), (biont: []), (database: []), (negated sentences: []), (such negated events: [evnt]), (description currently biont: []), (biomedical sentences: []), (resources:: []), (full-text biomedical articles: []), (elsevier: []), (pubmed central: [lbpr]), (20: [fndg]), (abstracts: []), (pubmed: []), (important genetic disorders: autism: [mobd]), ( alzheimer's disease: [dsyn]), (parkinson's disease: [dsyn]), (negated events: [evnt]), (experts: []), (biont database: []), (useful resource: []), (biomedical researchers: []), (http://bionot.askhermes.org/: []), (future work: []), (semantic web: []), (related technologies: [fndg]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3199189
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (problems: []), (communication: [socb]), ( social skills: [socb]), (repetitive behavior: [fndg]), (recent studies: [lbpr]), (inflammatory mechanisms: []), (pathogenesis: [patf]), (disorder: [dsyn]), (nuclear factor-b (nf-b): [aapp,imft]), (important gene: [gngm]), (transcriptional factor: [aapp,bacs]), (mediation: [socb]), (inflammation: [patf]), (apoptosis: [celf]), (study: [resa]), (activities: [acty]), (nf-b: []), (pathway: [moft]), (brain: [bpoc]), (autistic subjects: [mobd]), (age-matched controls: [orga]), (nf-b activation: [acty]), (btbr mice: [mamm]), (promising animal model: [emod]), (pathogenic mechanisms: [fndg]), (results: [fndg]), (level: [phsu]), (ikk kinase: [aapp,enzy]), (inhibitory subunit ib: [aapp,enzy]), (cerebellum: [bpoc]), (however: []), (expression: [topp]), (phosphorylation: [moft]), (ib: [aapp,enzy]), (nf-b (p65): [aapp,enzy]), (phosphorylation/activation: [moft]), (ser536: []), (cortex: [bpoc]), (findings: [clna]), (processes: [phpr]), (abnormal inflammatory responses: [anab]), (autistic brain: [mobd]), 
ASD Terms: (social skills, 'Ability to Converse in Social Settings')(autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(social skills, 'Ability to Converse in Social Settings')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(inhibitory subunit ib, 'Irritable Bowel Syndrome')(ib, 'Irritable Bowel Syndrome')

PMCID: 3198479
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (complex genetic disorder: [dsyn]), (multiple etiologies: []), (molecular genetic basis: [phsu]), (number: [qnco]), (rare mutations: [genf]), (dosage abnormalities: [cgab]), (cases: [qnco]), (high heritability: [qnco]), (low recurrence risk: [phpr]), (multifactorial inheritance: [genf]), (numerous loci: [gngm]), (other factors: []), (risk: []), (study: [resa]), (effect: []), (birth rank: [orgf]), (disease risk: [fndg]), (hereditary genetic models: []), (data: [euka]), (available autism family collections: [mobd]), (usa: []), (potential birth order effects: [qnco]), (statistical properties: []), (tests: [lbpr]), (adequate power: [hcpp]), (effects: []), (varying: []), ( patterns: []), (birth order effects: [qnco]), (collections: []), (multiplex families: [famg]), (v-shaped effects: []), (middle births: [orgf]), (high risk;: [fndg]), (simplex families: [famg]), (linear effects: []), (risk increases: [qnco]), (additional birth: [orgf]), (moreover: []), (birth order effect: [qnco]), (simplex collection: [bpoc]), (patterns: []), (ascertainment biases: []), (biological factors: [bacs]), (nevertheless: []), (further investigation: [hlca]), (parental age-dependent risks yields patterns: [grpa]), (part: [qnco]), (search: [acty]), (genes: [gngm]), (statistical power: [resa]), (uncover novel: []), (molecular etiologies: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(available autism family collections, 'Autism Phenotype')

PMCID: 3309488
SFARI Genes: MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, 
Non SFARI Genes: 
Named Entities: (contribution: [acty]), (peripheral immunity: [phsf]), (spectrum disorders: [dsyn]), (risk: []), (mothers: [famg]), (children: [aggp]), (asd: [cgab]), (autoantibodies: [aapp,imft]), (brain proteins: [bpoc]), (possibility: []), (subset: []), (asd cases: [cgab]), (maternal antibody response: [biof]), (gestation: [orgf]), (mechanism: []), (maternal immune system breaks tolerance: [fndg]), (decreased expression: [topp]), (met receptor tyrosine: [aapp,bacs,phsu]), (asd risk gene: [cgab]), (key negative regulator: [fndg]), (immune responsiveness: []), (sample: [sbst]), (functional met promoter variant rs1858830 c allele: [gngm]), (presence: [qnco]), (asd-specific 37+73-kda band pattern: [cgab]), (maternal autoantibodies: [aapp,imft]), (fetal brain proteins: [aapp,bacs]), (genetic association: []), (met protein: [aapp,rcpt]), (cytokine production: [orgf]), (prepared peripheral blood: [bdsu]), (mononuclear cells: [cell]), (met rs1858830 c allele: [gngm]), (met protein expression (p=0.025): [aapp,rcpt]), (moreover: []), (expression: [topp]), (regulatory cytokine il-10: [aapp,imft]), (met gene c: [gngm]), ((p=0.001): [fndg]), (reduced met protein levels: [aapp,rcpt]), (results: [fndg]), (genetic distinction: [topp]), (asd-associated antibodies: [aapp,imft]), (potential mechanism: []), (decrease: [qnco]), (met protein production: [aapp,rcpt]), (reduction: [npop]), (immune regulation: [biof]), 
ASD Terms: (autism spectrum disorders risk, 'Autism Phenotype')(gestation, 'Perinatal History')

PMCID: 3213048
SFARI Genes: IL6, IL6, IL6, IL6, IL6, IL6, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (developmental disorder: [mobd]), (emotional deficits: [menp]), ( language impairments: [mobd]), (behaviors: [inbe]), (early postnatal life: []), (study: [resa]), (relationship: []), (amongst absolute: []), (relative concentrations: [menp]), (k+: [qnco]), ( na+: [elii]), ( ca2+: [elii,phsu]), ( mg2+: [gngm]), (proinflammatory: []), (proapoptotic biomarkers: [clna]), (materials: [sbst]), (methods na+: [elii]), ( k+: [qnco]), ( na+/k+: [qnco]), ( ca2+/mg2+: [gngm]), (il6: [gngm]), ( tnf: [aapp,bacs]), (proinflammatory cytokines: [aapp,imft]), (caspase3: [aapp,enzy]), (proapoptotic biomarker: [clna]), (plasma: [bdsu]), (saudi: []), (autistic male patients: [mobd]), (age: [orga]), (control samples: []), (data: [euka]), (autistic patients: [mobd]), (plasma caspase3: [aapp,enzy]), ( il6: [aapp,imft]), (gender matching controls: [orga]), (other hand: [bpoc]), (mg2+: [gngm]), (na+: [elii]), (pearson correlations: []), (plasma concentrations: [qnco]), (cytokines: [aapp,imft]), (caspase-3: [aapp,enzy]), (ca2+: [elii,phsu]), (ca2+/k+ ratio: [qnco]), (characteristics: []), ((roc) analysis: [qnco]), (measured parameters: [fndg]), (satisfactory levels: []), (specificity: [qnco]), (sensitivity: [patf]), (alteration: []), (measured ions confirms: [elii]), (stress: [fndg]), (defective mitochondrial energy production: [celc]), (pathogenesis: [patf]), (moreover: []), (ions: [elii]), (set: [menp]), (pathways: [moft]), (role: [socb]), (prevalent disorder: [qnco]), (possible proinflammation: []), (proapoptic mechanisms: []), (autistics' brains: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(language impairments, 'Language Ability')(autism, 'Autism Phenotype')

PMCID: 3264868
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (etiology: []), (autism spectrum disorders: [mobd]), (oxidative stress: [comd]), (pathological role: [socb]), (serum levels: [bdsu]), (sonic hedgehog (shh) protein: [aapp,bacs]), (brain-derived neurotrophic factor (bdnf): [aapp,bacs]), (asd: [cgab]), (whole blood: [bdsu]), (polymorphonuclear leukocytes: [cell]), (autistic children: [podg]), (level: [phsu]), (oxygen: [elii,phsu]), (free radicals: [bacs,chvs]), (addition: []), (levels: []), (serum shh protein: [aapp,bacs]), (children: [aggp]), (mild: []), (severe form: []), (autism: [mobd]), (serum level: [bdsu]), (bdnf: [gngm]), (mild form: []), (disorder: [dsyn]), (findings: [clna]), (correlation: []), (shh: [gngm]), ( bdnf: [aapp,bacs,phsu]), (ofr: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 3183050
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (autism: [mobd]), (few interventions: [hlca]), (significant improvements: [qnco]), (speech output: [orgf]), (novel intervention: [hlca]), (auditory-motor mapping training (ammt): [edac]), (speech production: [orgf]), (association: [menp]), (sounds: [npop]), (articulatory actions: []), (intonation: []), (bimanual motor activities: [dora]), (ammt: []), (inherent musical strengths: []), (activities: [acty]), (network: [popg]), (brain regions: [blor]), (here: []), (initial efficacy study: [resa]), (concept: []), (non-verbal children: [aggp]), (autism participated: [mobd]), (intelligible words: []), (individual sessions: [evnt]), (times: [qnco]), (week: []), (8-week period: []), (probe assessments: [hlca]), (baseline: [bodm]), ( therapy: [topp]), (follow-up sessions: [evnt]), (therapy: [topp]), (ability: [orga]), (words: []), (phrases: []), (generalization: [menp]), (items: []), (therapy sessions: [evnt]), (minimal vocal output: []), (acquisition: [acty]), (speech sounds: [hcpp]), (word approximations: []), (critical step: [qnco]), (expressive language development: [menp]), 
ASD Terms: (autism, 'Autism Phenotype')(speech output, 'Language Ability')(promote speech production, 'Language Ability')(intonation, 'Prosody')(autism, 'Autism Phenotype')(autism participated, 'Autism Phenotype')(speech sounds, 'Vocalizations')(expressive language development, 'Language Development')(autism, 'Autism Phenotype')(minimal vocal output, 'Vocalizations')

PMCID: 3174969
SFARI Genes: 
Non SFARI Genes: CDX2, 
Named Entities: (gastrointestinal disturbances: [fndg]), (children: [aggp]), (autism: [mobd]), ( complicate: []), (clinical management: [hlca]), (behavioral impairment: [inbe]), (reports: [hlca]), (deficiencies: [dsyn]), (disaccharidase enzymatic activity: [aapp,enzy]), (beneficial responses: [orga]), (dietary therapies: [topp]), (survey gene expression: [genf]), (mucoepithelial microbiota: [orgm]), (intestinal biopsies: [diap]), (gastrointestinal disease: [dsyn]), (gastrointestinal disease alone: [dsyn]), (ileal transcripts: [bpoc]), (disaccharidases: [aapp,enzy]), (hexose transporters: [aapp,bacs]), (impairment: [patf]), (primary pathway: [moft]), (carbohydrate digestion: [orgf]), (transport: [celf]), (enterocytes: [cell]), (deficient expression: [topp]), (enzymes: [enzy,orch]), (transporters: [aapp,bacs]), (expression: [topp]), (intestinal transcription factor: [aapp,bacs]), ( cdx2: []), (metagenomic analysis: [resa]), (intestinal bacteria: [bact]), (compositional dysbiosis manifest: [patf]), (decreases: [qnco]), (bacteroidetes: [bact]), ( increases: [qnco]), (ratio: [qnco]), (firmicutes: [bact]), (increases: [qnco]), (betaproteobacteria: [bact]), (expression levels: [qnco]), (abundance: []), (affected bacterial phylotypes: []), (results: [fndg]), (relationship: []), (human intestinal gene expression: [humn]), (bacterial community structure: [anst]), (insights: [menp]), (pathophysiology: [patf]), 
ASD Terms: (autism, 'Autism Phenotype')(behavioral impairment, 'Personal Traits')(autism, 'Autism Phenotype')(gastrointestinal disease, 'Gastrointestinal Diseases')(gastrointestinal disease alone, 'Gastrointestinal Diseases')(autism, 'Autism Phenotype')(intestinal bacteria, 'Bacterial Infections')(affected bacterial phylotypes, 'Bacterial Infections')(autism, 'Autism Phenotype')(bacterial community structure, 'Bacterial Infections')

PMCID: 3174190
SFARI Genes: MECP2, MECP2, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (severe neuropsychiatric disorder: [fndg]), (complex pathobiology: [chvs]), (profound influences: []), (genetic factors: [fndg]), (development: [orgf]), (numerous autism: [mobd]), (susceptible genes: [gngm]), (etiology: []), (autism: [mobd]), (dna microarray: [mbrt]), (gene expression: [genf]), (peripheral blood: [bdsu]), (individuals: [humn]), (groups;: [popg]), (young adults: [aggp]), (asd: [cgab]), (gender-matched healthy subjects: [orga]), ((asd control): [cgab]), (healthy mothers: [famg]), (children: [aggp]), (asd (asdmo): [cgab]), (asdmo control: [sbst]), (blood relationship: [bdsu]), (asd group: [cgab]), (control: [sbst]), (genes: [gngm]), (cell morphology: [clna]), (cellular assembly: [celf]), (organization: [orgt]), (nerve system development: [ortf]), (function: [phsf]), (asdmo group: [popg]), (unique gene expression signature: [qnco]), (significant alterations: [qnco]), (protein synthesis: [moft]), (nonautistic diagnostic status: [fndg]), (moreover: []), (asd-associated gene expression signature: [cgab]), (unique gene expression: [genf]), (peripheral leukocytes: [cell]), (affected subjects: [humn]), (unaffected mothers: [famg]), (asd children: [cgab]), (genetic predisposition: [orga]), (peripheral cells: [cell]), (altered expression: [topp]), (several autism candidate genes: [mobd]), (fmr-1: [gngm]), (mecp2: [gngm]), (leukocytes: [cell]), (together: []), (findings: [clna]), (asd-associated genes: [cgab]), (genetic: [topp]), ( epigenetic: []), (environmental background: []), (potential tools: []), (crucial factors: []), (clinical onset: [qnco]), (disorder: [dsyn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(numerous autism, 'Autism Phenotype')(several autism candidate genes, 'Autism Phenotype')(clinical onset, 'Onset of Symptoms')

PMCID: 3179967
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (gene expression assays: [genf]), (high quality: [qnco]), (genome-wide data: [gngm]), (rna samples: [nnon]), (however: []), (methods: []), (human brain: [humn]), (poor rna quality: [grpa]), (other technical limitations: []), (many assays: [lbpr]), (cdna-mediated annealing: [nnon]), ( selection: [genf]), (ligation (dasl)-: [topp]), (vitro transcription: [genf]), ((ivt)-based genome-wide expression: [gngm]), (assays: [lbpr]), (reference pools: [clna]), (frozen brain tissue: [npop]), (formalin-fixed brain tissue: [hops,orch,phsu]), (dasl-based platform: []), (expression results: [fndg]), (reliability: [qnco]), (ivt-based platform: []), (reference brain rna: [nnon]), (rna: [nnon]), (frozen tissue-based samples: [npop]), (data: [euka]), (small sample: [sbst]), (formalin-fixed rna samples: [hops,orch,phsu]), (subset: []), (probes: [chvf]), (samples: [sbst]), (results: [fndg]), (dasl-based gene: [gngm]), (expression-profiling platform: [mbrt]), (advantages: []), (mrna assays: [bacs,nnon]), (brain: [bpoc]), (traditional ivt-based methods: []), (implications: []), (investigations: [hlca]), (neuropsychiatric disorders: [dsyn]), 
ASD Terms: 

PMCID: 3166116
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (severe neurodevelopmental disorder: [mobd]), (impaired language: [lang]), ( communication: [socb]), (social skills: [socb]), (regressive autism: [mobd]), (children: [aggp]), (first show signs: [qnco]), (language development: [menp]), (skills: [inbe]), (autistic behavior: [mobd]), (protein kinases: [aapp,enzy]), (g-protein-coupled: [aapp,enzy]), (receptor-mediated signal transduction: [moft]), (neuronal functions: [imft]), ( gene: [gngm]), (expression: [topp]), ( memory: [menp]), (cell differentiation: [celf]), (activity: [acty]), (protein: [aapp,bacs]), (a (pka): []), (cyclic ampdependent protein kinase: [aapp,enzy]), (postmortem brain tissue samples: [bpoc]), (frontal: []), ( temporal: []), ( parietal: []), (occipital cortices: [bpoc]), (cerebellum: [bpoc]), (individuals: [humn]), (regressive autism;: [mobd]), (autistic subjects: [mobd]), (clinical history: [orga]), (regression;: [menp]), (normal control subjects: [humn]), (pka: []), (catalytic subunit: [amas]), (frontal cortex: [bpoc]), (subjects: [humn]), (non-regressive autism: [mobd]), (such changes: [qnco]), (cortices: [bpoc]), (temporal: []), (occipital regions: [bpoc]), (brain: [bpoc]), (addition: []), (significant difference: [qnco]), (pka activity: [acty]), (control groups: [grup]), (results: [fndg]), (regression: [menp]), (part: [qnco]), (decreased pka-mediated phosphorylation: [moft]), (proteins: [aapp,bacs]), (abnormalities: [cgab]), (cellular signaling: [celf]), 
ASD Terms: (autism, 'Autism Phenotype')(severe neurodevelopmental disorder, 'Learning Disorders')(impaired language, 'Language Ability')(social skills, 'Ability to Converse in Social Settings')(regressive autism, 'Autism Phenotype')(language development, 'Language Development')(memory, 'Working Memory')(non-regressive autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3309504
SFARI Genes: Auts2, Auts2, 
Non SFARI Genes: 
Named Entities: (offspring: [famg]), (fathers: [famg]), (risk: []), (neurodevelopmental disorders: [mobd]), (schizophrenia: [mobd]), (autism: [mobd]), (light: [gngm]), (evidence: []), (copy number variants: [nusq]), (mouse model: [emod]), (hypothesis: []), (males: [orga]), (cnvs: [nusq]), (c57bl/6j sires: [mamm]), (3-month-old dams: [gngm]), (control: [sbst]), (old sires: []), ( respectively: []), (genome-wide microarray: [gngm]), (distinct cnvs: [nusq]), (set: [menp]), (parents: []), (competitive quantitative pcr: [mbrt]), (original set: [menp]), (frequency: [qnco]), (independent set: [menp]), (basis: [phsu]), (combined samples: [sbst]), (sires: []), (none: []), (control group: [grup]), (behavioral and/or neuroanatomical phenotypic features: [inbe]), (auts2 (autism susceptibility candidate: [mobd]), (other cnvs: [nusq]), (genes: [gngm]), (brain development: [ortf]), (first experimental demonstration: [qnco]), (results: [fndg]), (generation: [acty]), (male germline: [cell]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(offspring, 'Perinatal History')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(other copy number variants, 'Imitation')(autism, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')

PMCID: 3162001
SFARI Genes: LMX1B, LMX1B, LMX1B, LMX1B, LMX1B, LMX1B, LMX1B, LMX1B, LMX1B, LMX1B, LMX1B, LMX1B, 
Non SFARI Genes: 
Named Entities: (multiple lines: [qnco]), (evidence: []), (serotoninergic dysfunction: [dsyn]), (autism: [mobd]), (role: [socb]), (lmx1b: [gngm]), (development: [orgf]), (maintenance: [acty]), (serotoninergic neurons: [cell]), (order: [acty]), (any: []), (trio-based snp association study: [menp]), (family samples: [famg]), (agre: []), (performed: []), (method: [lbpr]), (snps: [nusq]), (hapmap data: [orga]), (location: [blor]), (minor allele frequency: [qnco]), (snps (rs10732392: [nusq]), (rs12336217): []), (moderate association: [menp]), (p values: [qnco]), (transmission disequilibrium test: [dsyn]), (haplotype agcgtg: [orga]), (significant association (p: [menp]), (further: []), ( lmx1b mrna expressions: [genf]), (postmortem brain tissues: [diap]), (autism subjects: [mobd]), (healthy controls: []), (lmx1b transcripts: [nnon]), (anterior cingulate gyrus region: [blor]), (autism patients: [mobd]), (controls: [sbst]), (study: [resa]), (possible role: [socb]), (pathophysiology: [patf]), (previous reports: [hlca]), (seretoninergic mechanism: []), (first report: [qnco]), (association: [menp]), (caution: []), (modest associations: [menp]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism subjects, 'Autism Phenotype')(autism patients, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3159129
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (dysfunction: [dsyn]), (limbic gabaergic circuits: []), (neurodevelopmental disorders: [mobd]), (humans: [humn]), (schizophrenia: [mobd]), ( autism: [mobd]), (epilepsy: [dsyn]), (current paper: [npop]), (characteristics: []), (great diversity: [qnco]), (cortical gabaergic interneurons: [bpoc]), (multiple roles: [socb]), (cells: [cell]), (mature circuits: []), (aforementioned disorders: [dsyn]), (furthermore: []), (genetic cascades: [topp]), (fate: [gngm]), (cortical interneurons: [bpoc]), (genes: [gngm]), (generation: [acty]), ( specification: []), ( maturation: [phsf]), (function: [phsf]), (disorders: [dsyn]), 
ASD Terms: (multiple neurodevelopmental disorders, 'Learning Disorders')(neurodevelopmental disorders, 'Learning Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(epilepsy, 'Epilepsy')

PMCID: 3215885
SFARI Genes: CNTN5, CNTN5, 
Non SFARI Genes: 
Named Entities: (recent array-based studies: [lbpr]), (wealth: []), (copy number variations: [nusq]), (patients: [podg]), (autism spectrum disorders: [mobd]), (cnvs: [nusq]), (contributions: [acty]), (patients phenotype: [orga]), (cohort: [popg]), (children: [aggp]), (symptoms: [sosy]), (asd: [cgab]), ( diagnosis: [fndg]), (index patient: [podg]), (ados-g: [aapp,enzy]), (adi-r: [clna]), (performed: []), (social responsiveness scale (srs): [acty]), (index: [qnco]), (parents: []), (available siblings: [famg]), (snp arrays: [mbrt]), (fish: [gngm]), (array cgh: [dsyn]), (clinical significance: [fndg]), (families: [famg]), (multiple affected children (multiplex): [aggp]), (single affected child (simplex): [fndg]), (child: [aggp]), (cnv: [nusq]), (brain-transcribed gene: [gngm]), (genes: [gngm]), (pathways: [moft]), (phosphoinositol: []), ((pik3ca: [aapp,enzy]), ( girdin): [gngm]), (contactin-based networks: [aapp,bacs]), (cell communication (cntn6): [celf]), (microcephalin (mcph1): [aapp,bacs]), (co-segregate: []), (asd phenotypes: [cgab]), (family: [famg]), (loss: [qnco]), (cntn5: [gngm]), (disease: [dsyn]), (phenotype: [orga]), (epistatic interactions: [fndg]), (inherited (transmitted) mutations: [genf]), (non-genetic factors: [fndg]), (study: [resa]), (scope: []), (genome-wide cnv: [nusq]), (sporadic patients: [podg]), (heritability: []), (genome-wide screening studies: [topp]), (complex psychiatric disorders: [mobd]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(symptoms of asd, 'Complaints and Indications')(diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')(asd phenotypes, 'Autism Phenotype')(complex psychiatric disorders, 'Mental Disorders')

PMCID: 3150391
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (autistic traits: [mobd]), (continuum: []), (general population: [popg]), (clinical autism: [mobd]), (extreme end: []), (quantitative distribution: [qnco]), (nature: []), (severity: []), (symptoms: [sosy]), (study: [resa]), (long-term stability: []), (at: []), (toddlers: [aggp]), (current investigation: [hlca]), (males: [orga]), (decades: [qnco]), (pervasive developmental disorder subscale: [mobd]), (child behavior checklist: [diap,inpr]), (childhood (m: [aapp,imft]), (years; sd: [mamm]), (autism-spectrum quotient: [qnco]), (adulthood (m: [aapp,imft]), (items: []), (scale: [acty]), (social (difficulties: [fndg]), (social interaction: [fndg]), (communication): [socb]), (repetitive behaviours: [inbe]), (interests) at: [menp]), (association: [menp]), (child: [aggp]), (adult measurements: [aggp]), (influence: []), (obstetric variables: []), (pearson's correlations: []), (linear regression: [qnco]), ( total at: [qnco]), (childhood: []), (total at (r = .16: [clna]), ( p = .002): [aapp,imft]), (social at (r = .16: [clna]), (adulthood: []), (positive correlation: [fndg]), (social at: []), (early childhood: []), (total (r = .17: [qnco]), ( p = .001): [aapp,imft]), (correlations: []), (non-social at: []), (significance: [qnco]), (furthermore: []), (significant longitudinal association: [menp]), (females: [orga]), (constraints: []), (different measures: [qnco]), (different raters: []), (ages: [bacs,orch]), (modest developmental stability: [orgf]), (boys: [aggp]), 
ASD Terms: (clinical autism, 'Autism Phenotype')

PMCID: 3150222
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (cortical circuits: [bpoc]), (brain: [bpoc]), (experience: [menp]), (critical periods: []), (postnatal life: []), (balance: [fndg]), (excitatory: []), (inhibitory: [acty]), ((e/i) neurotransmission: [celf]), (development: [orgf]), (evidence: []), (e/i imbalance: [inch]), (autism: [mobd]), (complex genetic neurodevelopmental disorder: [mobd]), (abnormal socialization: [edac]), (communication: [socb]), (repetitive behaviors: [fndg]), (interests: [menp]), (underlying cause: []), (effective treatment: []), (cure: []), (alteration: []), (expression: [topp]), (timing: []), (critical period circuit refinement: []), (primary sensory brain areas: [bpoc]), (autistic phenotypes: [mobd]), (behavioral impairments: [inbe]), (dissection: [topp]), (molecular mechanisms: []), (well-established critical periods: []), (powerful tool: []), (new potential therapeutic targets: [diap]), (normal plasticity: [npop]), (function: [phsf]), (affected neuronal circuits: [imft]), 
ASD Terms: (autism, 'Autism Phenotype')(complex genetic neurodevelopmental disorder, 'Learning Disorders')(abnormal socialization, 'Social Competence')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(behavioral impairments, 'Personal Traits')

PMCID: 3144901
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (account interaction synchrony: [clna]), (autism (ad): [mobd]), (intellectual disability (id): [mobd]), (typical development (td): [orgf]), (family home movies: [famg]), (infants: [aggp]), (months: []), (computational methods: [resa]), (methodology: []), (principal findings first: [clna]), (interactive sequences: [nusq]), (home movies: []), (children: [aggp]), (ad (n =: [aapp,imft]), (id (n: [lbpr]), (td (n: [aapp,imft]), (infant: [aggp]), (caregiver behavior scale (icbs): [acty]), (second: [qnco]), (discrete behaviors: [inbe]), (baby (bb): [aggp]), (care giver (cg) co-occurring: [acty]), (seconds: []), (single interactive patterns: [fndg]), (dyadic events): [evnt]), (analysis: [resa]), (directions: []), (interaction (cgbb: []), (bbcg): []), (group: [popg]), (semester: []), (so: []), (markov assumption: []), (generalized linear mixed model: [qnco]), (negative matrix factorization: [phsu]), (td children: [aggp]), ( bbs: []), (ad exhibit: []), (deviant development: [cgab]), (interactive patterns whereas: []), (id: [lbpr]), (initial delay: []), (development: [orgf]), (parents: []), (ad: []), (td: []), (child: [aggp]), (however: []), (interaction: []), ( parents: []), (regulation: [biof]), (behaviors: [inbe]), (first semester: [qnco]), (interactive patterns: []), (deviant autistic behaviors: [mobd]), (lack: []), (interactive initiative: [menp]), (responsiveness: []), (babies: [aggp]), (credence: []), (intuition: [menp]), (pathological process: [patf]), (interactive pattern: []), 
ASD Terms: (differentiate autism, 'Autism Phenotype')(typical development in family home movies, 'Home Life Skills')(better differentiate autism, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(autism, 'Autism Phenotype')(growing deviant development of interactive patterns whereas, 'Conversational Skills')(initial delay of development, 'Learning Disorders')(autism exhibit, 'Autism Phenotype')(autism, 'Autism Phenotype')(interactive initiative, 'Initiating Social Interaction')

PMCID: 3309518
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (siblings: [famg]), (individuals: [humn]), (autism: [mobd]), (times: [qnco]), (population risk: [popg]), (evidence: []), (comparable: []), (marked: []), ( cognitive: []), (social communication deficits: [socb]), (role: [socb]), (traits: [gngm]), (search: [acty]), (biomarkers: [clna]), (familial risk: [famg]), (however: []), (first time: [qnco]), (neural response: [fndg]), (facial expression: [fndg]), (emotion differs: [menp]), (unaffected siblings: [famg]), (healthy controls: []), (family history: [fndg]), (strikingly: []), (functional magnetic resonance: [npop]), ((fmri) response: [diap]), (happy versus: [menp]), (controls: [sbst]), (number: [qnco]), (brain areas: [bpoc]), (empathy: [inbe]), (face processing: [emst]), (response: [fndg]), (furthermore: []), ( investigation: [hlca]), (versus fixation crosses: [topp]), (that: []), (context: [fndg]), (study: [resa]), (atypical response: [fndg]), (happy faces: [blor]), (general: [hlca]), ( accounts: [clna]), (observed sibling versus: [famg]), (difference: [qnco]), (clear biomarker: [clna]), (findings: [clna]), (atypical implicit response: [fndg]), (emotion: [menp]), (basis: [phsu]), (impaired emotional reactivity: [fndg]), (autism phenotype: [mobd]), (relatives: [famg]), (results: [fndg]), (fmri response: [diap]), (candidate neuroimaging endophenotype: [diap]), (far-reaching insights: [menp]), (etiology: []), 
ASD Terms: (autism, 'Autism Phenotype')(social communication deficits, 'Reciprocal Social Interaction')(cognitive, 'Cognitive Ability')(facial expression, 'Integrated Verbal and NonVerbal Communication')(autism, 'Autism Phenotype')(empathy, 'Empathy')(face processing, 'Integrated Verbal and NonVerbal Communication')(autism, 'Autism Phenotype')(facial expression, 'Integrated Verbal and NonVerbal Communication')(autism phenotype, 'Autism Phenotype')(facial expression, 'Integrated Verbal and NonVerbal Communication')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3134991
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (major goal: []), (neuroscience: []), (development: [orgf]), (strategies: [menp]), (neural plasticity: [ortf]), (adult central nervous system: [aggp]), (functional recovery: [sosy]), (brain disease: [dsyn]), (injury: [inpo]), (new evidence: []), (pivotal role: [socb]), (cortical inhibitory circuitries: [bpoc]), (plasticity: [npop]), (adulthood: []), (paper: []), (recent findings: [clna]), (inhibition-excitation balance controls: [celf]), (brain plasticity: [bpoc]), (core: [bdsu]), (pathogenesis: [patf]), (neurodevelopmental disorders: [mobd]), (down syndrome: [cgab,dsyn]), (rett syndrome: [dsyn]), 
ASD Terms: (development of strategies, 'Problem Solving Ability')(brain disease, 'Central Nervous System Diseases')(neurodevelopmental disorders, 'Learning Disorders')(down syndrome, 'Down Syndrome')(rett syndrome, 'Rett Syndrome')

PMCID: 3142225
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (consistent biological findings: []), (autism: [mobd]), (elevated blood serotonin levels: [lbpr]), (immune abnormalities: [cgab]), (autoimmunity: [patf]), (production: []), (brain: [bpoc]), (specific auto-antibodies: [aapp,imft]), (disorder: [dsyn]), (hyperserotonemia: []), (factors: []), (patients: [podg]), (reduction: [npop]), (t-helper (th): []), (cytokines: [aapp,imft]), (possible role: [socb]), (induction: [topp]), (serum anti-myelin-basic protein: [aapp,bacs]), ((anti-mbp) auto-antibodies: [aapp,imft]), (serum levels: [bdsu]), (serotonin: [bacs,orch]), (anti-mbp auto-antibodies: [aapp,imft]), (elisa: [lbpr]), (autistic patients: [mobd]), (years: []), (healthy-matched children: [fndg]), (autistic children: [podg]), (healthy children: [fndg]), (p <: [aapp,imft]), (respectively): []), (severe autism: [fndg]), (serum serotonin levels: [bacs,orch]), (children: [aggp]), (mild: []), (autism (p: [mobd]), (significant correlations: [qnco]), (increased frequency: [qnco]), (serum anti-mbp auto-antibodies: [aapp,imft]), (data: [euka]), (caution: []), (further investigations: [hlca]), (however: []), ( inclusion: [celc]), (correlate: []), (other future immune studies: [lbpr]), (long-standing mystery: [phsf]), (pathophysiology: [patf]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(severe autism, 'Autism Phenotype')(moderate autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3120811
SFARI Genes: APP, APP, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (deficits: []), (verbal communication: [socb]), (social interactions: [fndg]), (presence: [qnco]), (repetitive: []), (compulsive behaviors: [mobd]), (excessive early brain growth: [bpoc]), (patients: [podg]), (phenotype: [orga]), (reports: [hlca]), (increased levels: [qnco]), (brain-derived neurotrophic factor (bdnf): [aapp,bacs]), (other neurotrophic-like factors: []), (autistic neonates: [aggp]), (anabolic activity: [acty]), (cns: [bdsy]), (overgrowth effect: [fndg]), (subset: []), (severe autism: [fndg]), (aggression: [mobd]), ( plasma levels: [bdsu]), (secreted amyloid- (a) precursor: [aapp,imft]), (protein-alpha form (sapp): [aapp,bacs]), (relative: [qnco]), (controls: [sbst]), (mild-to-moderate autism: [mobd]), (hypothesis: []), (levels: []), (sapp: []), (sapp (proteolytic cleavage products: [celf]), (app: [gngm]), (-secretase: [aapp,enzy]), ( respectively): []), (anabolic environment: [orch,phsu]), (brain overgrowth: [bpoc]), (plasma levels: [bdsu]), ( sapp: []), ( a peptides: [aapp]), (bdnf: [gngm]), (elisa: [lbpr]), (set: [menp]), (subjects: [humn]), (analysis: [resa]), (control: [sbst]), (mild-to-moderate: []), (autistic patient plasma samples: [mobd]), (sapp levels: []), (bdnf levels: [aapp,bacs,phsu]), (plasma: [bdsu]), (a1-40: [qnco]), ( a1-42: []), (findings: [clna]), (biochemical correlate: []), (phenotypic severity: [orga]), (together: []), (study: [resa]), (evidence: []), (aberrant non-amyloidogenic processing: [acty]), 
ASD Terms: (autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(social interactions, 'Reciprocal Social Interaction')(compulsive behaviors, 'Obsessive-Compulsive Disorder')(mild-to-moderate autism, 'Autism Phenotype')(severe autism, 'Autism Phenotype')(aggression, 'Aggressive Behavior')(mild-to-moderate autism, 'Autism Phenotype')

PMCID: 3173108
SFARI Genes: CaV1.2, CaV1.2, CaV1.2, CaV1.2, CaV1.2, CaV1.2, 
Non SFARI Genes: IV, 
Named Entities: (timothy syndrome mutations g402s: [dsyn]), (g406r: []), (abolish inactivation: []), (cav1.2: [gngm]), (multiorgan dysfunction: [dsyn]), (lethal arrhythmias: [fndg]), (insights: [menp]), (consequences: []), (g402s mutation: [genf]), (structure: []), (function: [phsf]), (channel: []), (corresponding gly-432: [aapp,bacs,phsu]), (rabbit channel: [mamm]), (applied homology modeling: [mbrt]), (mutations: [genf]), (gly-432 (g432a/m/n/v/w): [aapp,bacs,phsu]), (channel inactivation: []), (homology: [gngm]), (gly-432 forms part: [aapp,bacs,phsu]), (conserved structure motif (g/a/g/a): [amas]), (small residues: [evnt]), (homologous positions: [gngm]), (domains: []), ((gly-432 (is6): [aapp,bacs,phsu]), ( ala-780 (iis6): [euka]), ( gly-1193 (iiis6): [aapp,bacs,phsu]), ( ala-1503 (ivs6)): [euka]), (domains ii: []), ( iii: []), (iv induced: []), (contrast: [irda]), (parallel shifts: [resa]), (activation: [acty]), (inactivation curves: []), (preserved coupling: [lbpr]), (processes: [phpr]), (disruption: []), (inactivation: []), (gly-432: [aapp,bacs,phsu]), (domain i. mutations: [inch]), (inactivation irrespective: []), (changes: [qnco]), (domains residues g/a/g/a: [aapp,bacs]), (close contact: [fndg]), (bulky amino acids: [aapp,bacs,phsu]), (s6 helices: [euka]), (interactions: []), (adhesion points: [patf]), (activation gate: [acty]), (closed state: []), (structural hypothesis: []), (activation gating: [acty]), (g/a/g/a residues: [evnt]), (structural implications: []), (cav1.2 activation: [acty]), (inactivation gating: []), (discussed: [socb]), 
ASD Terms: 

PMCID: 3197027
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (several lines: [qnco]), (evidence: []), (role: [socb]), (mutations: [genf]), (mechanism: []), (common disorders: [dsyn]), (autism: [mobd]), (schizophrenia: [mobd]), (mutation rate: []), (humans: [humn]), (new mutations: [comd]), (high frequency: []), (population: [popg]), (however: []), (common diseases: [dsyn]), (genes: [gngm]), (diseases: [dsyn]), (strong negative selection: [lbpr]), (phenotype: [orga]), (lethality: []), (embryonic stages: []), (reduced reproductive fitness: [genf]), (family members: [famg]), (linkage gene mapping: [lbpr,mbrt]), (association studies: [menp]), (observation: [hlca]), (high concordance: [socb]), (monozygotic twins: [famg]), (low concordance: [socb]), (dizygotic twins: [famg]), (hypothesis: []), (significant fraction: [qnco]), (cases: [qnco]), (case: []), (second: [qnco]), (reduced reproductive fitness1: [orgf]), (incidence: [qnco]), (constant rate: [qnco]), (worldwide: []), (mutational load: [genf]), (balance: [fndg]), (selection: [genf]), (deleterious mutation: [comd]), (production: []), (mutation: [genf]), (rates: [qnco]), (reproduction: [orgf]), (negative selection factor: [lbpr]), (number: [qnco]), (mutant alleles: [gngm]), (decreased disease prevalence: [qnco]), (selective pressures: [phpr]), (different intensity: []), (different environments: []), (nonetheless: []), (severe mental disorders: [mobd]), (high prevalence: [qnco]), (worldwide population: [popg]), (wide range: [qnco]), (cultures: [lbpr]), (countries: []), (them2: [gngm]), (high new mutation rate: [comd]), (effects: []), (paternal age:: []), (risk: []), (disease: [dsyn]), (paternal age: []), (age: [orga]), (related increase: [fndg]), (schizophrenia3: []), (male-to-female ratio: [orga]), (germ-cell divisions: [celf]), (males: [orga]), (therefore: []), (males4: []), (high rate: [qnco]), (part: [qnco]), (genetic studies: [resa]), (many genes: [gngm]), (human genome: [gngm]), (identification: [menp]), (cause: []), (targeted molecular approach: []), (parents: []), (subjects: [humn]), (process: [phpr]), (genetic basis: [phsu]), (molecular approach: []), (link: []), (examples: []), 
ASD Terms: (autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(severe mental disorders, 'Mental Disorders')(autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 3324676
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (sensory hypersensitivity: [patf]), (recent study: [resa]), (visual acuity (va): [clna]), (asd: [cgab]), (region: []), (birds: [bird]), (prey: [gngm]), (validity: [qnco]), (results: [fndg]), (study: [resa]), (va: [hcro,mnob]), (individuals: [humn]), (schizophrenia (sch): [mobd]), ((typ): [gngm]), (participants: [popg]), (sch: [gngm]), (typ: [gngm]), (substantial correlations: []), (clinical severity: []), (eagle-eyed acuity hypothesis: [bird]), (evidence: []), (connection: []), (clinical phenotypes: [orga]), (research: [resa]), (origins: []), (circumstances: []), (altered sensory: [sosy]), (perceptual processing: [acty]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(visual acuity, 'Visual Thinking')(visual acuity, 'Visual Thinking')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(visual acuity, 'Visual Thinking')(visual acuity, 'Visual Thinking')

PMCID: 3110727
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mpas (minor: [popg]), (physical anomalies): [hlca]), (neurodevelopmental disorders: [mobd]), (face: [gngm]), (brain: [bpoc]), (neuroectoderm: [emst]), (first trimester: []), (conventionally: []), ( mpas: []), (evaluation: [hlca]), (external appearance: [orga]), (mri: [gngm]), (inherent observer bias: []), (multi-centre data acquisition: [acty]), (mpas: []), (brain dysmorphology: [bpoc]), (same individual: [humn]), (optical mpas exhibit: [orgf]), (trajectory: []), (fetal: [emst]), ( postnatal: []), (adult life: [aggp]), (head size enlarges: [fndg]), (age: [orga]), ( inter-orbital distance increases: [qnco]), (years: []), (optical mpas: [orgf]), (retrospective window: [resa]), (early neurodevelopment; specifically: [ortf]), (inter-orbital distance increase: [qnco]), (biomarker: [clna]), (early brain dysmaturation: [bpoc]), (autism: [mobd]), (children: [aggp]), (autism spectrum disorder: [mobd]), (controls: [sbst]), (normal iq: [fndg]), (inter-orbital distance: [qnco]), (t1-weighted mri scans: [orga]), (value: [qnco]), (voxel-by-voxel linear regression analysis: [qnco]), (grey matter: [tisu]), (bimodal mri data-set: [diap]), (total brain tissue volume: [qnco]), (covariates: []), (intra-class coefficient: [qnco]), (measurement: []), (autism group (p: [mobd]), (autism group: [mobd]), (significant relationship: [qnco]), (grey matter volume: [tisu]), (bilateral amygdalae: [bpoc]), (unci: [bpoc]), (inferior temporal poles: [blor]), (greater: [qnco]), (healthy controls: []), (infant head size expansion: [aggp]), (volume: [qnco]), (medial temporal lobe structures: [bpoc]), (link: []), (social brain dysmorphology: [bpoc]), (data: [euka]), (role: [socb]), (fossil record: [sbst]), (early aberrant neurodevelopment: [ortf]), (potential biomarker: [clna]), (brain dysmaturation: [bpoc]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism group, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3170664
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (human: [humn]), (neural progenitors: [famg]), (variety: []), (sources: [fndg]), (present new opportunities: [qnco]), (aspects: [qnco]), (human neuropsychiatric disease: [humn]), (vitro: []), (vitro models: []), (advantages: []), (human genetic background: [humn]), (easy manipulation: [topp]), (useful adjuncts: []), (models: []), (here: []), (human neuronal culture system: [humn]), (transcriptional program: [genf]), (human neural differentiation: [humn]), (molecular features: []), (neurodevelopmental disorder: [mobd]), (autism: [mobd]), (primary: [topp]), (normal human neuronal progenitors: [humn]), (post-mitotic neuronal state: [imft]), (addition: []), (specific growth factors: [aapp,bacs]), (whole-genome gene expression: [genf]), (time course: []), (neuronal differentiation: [fndg]), (weeks: []), (differentiation: [celf]), (significant number: [qnco]), (genes: [gngm]), (autism spectrum disorders: [mobd]), (asd susceptibility gene neurexin: [cgab]), (distinct pattern: []), (vivo: []), (fetal human brain: [emst]), (weighted gene co-expression network analysis (wgcna): [orga]), (network structure: [popg]), (transcriptional regulation: [genf]), (unbiased analysis: [resa]), (asd candidate genes: [cgab]), (differentiation process: [celf]), (nhnps: []), (effects: []), (mutations: [genf]), (multiple asd candidate genes: [cgab]), (gene expression: [genf]), (combination: [fndg]), (potential therapeutic molecules: [sbst]), (data: [euka]), (step: [gngm]), (understanding: [menp]), (pathways: [moft]), (asd: [cgab]), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 3130139
SFARI Genes: CNTNAP2, CNTNAP2, CNTNAP2, CNTNAP2, CNTNAP2, CNTNAP2, CNTNAP2, CNTNAP2, 
Non SFARI Genes: 
Named Entities: (early language development: [menp]), (genetic influence: [topp]), (genes: [gngm]), (normal variation: [fndg]), (general population: [popg]), (recent studies: [lbpr]), (disorder: [dsyn]), (variants: []), (cntnap2 gene: [gngm]), (language deficits: [lang]), (specific language: [lang]), (impairment (sli): [aapp,bacs]), (language delays: [lang]), (autism: [mobd]), (hypothesis: []), (cntnap2 variants: [aapp,bacs]), (communicative behavior: [socb]), (years: []), (age: [orga]), (large epidemiological sample: [sbst]), (western australian pregnancy cohort (raine) study: [orgf]), (singlepoint analyses: [resa]), (children: [aggp]), ((606 males: [orga]), (females): [orga]), (patterns: []), (association: [menp]), (previous investigations: [hlca]), (impaired language: [lang]), (same genetic markers: [genf]), (consistent direction: []), (effect (rs2710102: []), ( p: [aapp,imft]), (rs759178: []), (basis: [phsu]), (findings: [clna]), (analyses: [resa]), (four-marker haplotypes: [orga]), (rs2710102rs759178rs17236239rs2538976: []), (significant association (haplotype ttaa: [menp]), (haplotype gcag: [orga]), ( p = .0014): [aapp,imft]), (study: [resa]), (common variants: [qnco]), (exon: [bacs,nnon]), (region: []), (cntnap2 influence: [aapp,bacs]), (early language acquisition: [menp]), (susceptibility: [clna]), (sli: [gngm]), (other risk factors: [qnco]), 
ASD Terms: (early language development, 'Language Development')(specific language impairment, 'Language Ability')(autism, 'Autism Phenotype')(language deficits, 'Language Ability')(language delays, 'Language Ability')(years of age, 'Onset of Symptoms')(impaired language, 'Language Ability')

PMCID: 3130692
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (several statistical tests: [qnco]), (genome-wide association data: [menp]), (gene: [gngm]), (pathway information: [moft]), (terms: [orgf]), (gene sets: [gngm]), (methods: []), ( hundreds: []), (tested gene sets: [gngm]), (probability: [qnco]), (false positives: [lbtr]), (results: [fndg]), (many gene sets: [gngm]), (statistical significance: [qnco]), (flexible statistical framework: []), (problems: []), (spatial scan statistics: [diap]), (clustering: [resa]), (disease occurrence: [dsyn]), (field: [irda]), (epidemiology: [hlca]), (scan statistic: [diap]), (disease-associated gene clusters: [qnco]), (whole gene pathway: [gngm]), (few significant gene clusters: [gngm]), (global pathway: [moft]), (overall false positive probability: [qnco]), (increased statistical power: [resa]), (interpretation: [clna]), (test results: [fndg]), (present study: [qnco]), (method: [lbpr]), (rare copy-number variations: [nusq]), (common diseases: [dsyn]), (application: [qnco]), (simulated dataset: [bodm]), (high accuracy: [qnco]), (scan statistic approach: [diap]), (high level: [qnco]), (accuracy: []), (gene clusters: [gngm]), (study: [resa]), (sound statistical framework: [npop]), (genome-wide rare cnv data: [nusq]), (topological information: []), (gene pathway: [gngm]), 
ASD Terms: 

PMCID: 3607626
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (heritable neuro-developmental condition: [mobd]), (marked genetic heterogeneity13: [topp]), (fundamental question: []), (autism: [mobd]), (heterogeneous disorder: [fndg]), (myriad: []), (environmental risk factors: []), (common underlying molecular pathways: [moft]), (brain4: []), (here: []), (consistent differences: [qnco]), (transcriptome organization: [nusq]), (normal brain: [bpoc]), (gene co-expression network analysis: [popg]), (remarkably: []), (regional patterns: []), (gene expression: [genf]), (distinguish frontal: []), (temporal cortex: [bpoc]), (asd brain: [cgab]), (abnormalities: [cgab]), (cortical patterning: [bpoc]), (discrete modules: []), (co-expressed genes: [gngm]), (autism:: [mobd]), (neuronal module: [imft]), (autism susceptibility genes: [mobd]), (factor a2bp1/fox1: [gngm]), (module: []), (immune genes: [gngm]), (glial markers: [clna]), (dysregulated splicing: [genf]), (a2bp1-dependent: [gngm]), (alternative exons: [bacs,nnon]), (moreover: []), (autism gwas dataset: [mbrt]), (variants: []), (independent support: [fndg]), (causal involvement: []), (genes: [gngm]), (immune-glial module: [cell]), (enrichment: []), (autism gwas signals: [mbrt]), (non-genetic etiology: [topp]), (process: [phpr]), (collectively: []), (results: [fndg]), (strong evidence: []), (convergent: [acty]), (molecular abnormalities: [fndg]), (asd: [cgab]), (implicate transcriptional: [genf]), (dysregulation: []), (underlying mechanisms: []), (neuronal dysfunction: [dsyn]), (disorder: [dsyn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism susceptibility genes, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism gwas dataset, 'Autism Phenotype')(autism gwas signals, 'Autism Phenotype')

PMCID: 3252613
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, SHANK3, SHANK3, 
Non SFARI Genes: 
Named Entities: (genetic mutations: [genf]), (shank3: [gngm]), (patients: [podg]), (intellectual disability: [mobd]), ( autism spectrum disorder (asd): [mobd]), (schizophrenia: [mobd]), (synapse: [bsoj]), ( shank3/prosap2: [aapp]), (protein: [aapp,bacs]), (glutamate receptors: [aapp,rcpt]), (actin cytoskeleton: [celc]), (chain: []), (intermediary elements: [elii]), (genetic studies: [resa]), (association: [menp]), (shank3 mutations: [genf]), (susceptibility: [clna]), (neuronal consequences: [imft]), (mutations: [genf]), (here: []), (functional effects: []), (q321r): []), (inherited variations: []), (r300c): []), (asd: [cgab]), (tip: [gngm]), (actin filaments: [celc]), (polymerization: [phpr]), (growth cone motility: [celc]), (neurons: [cell]), (mutation (stop): [genf]), (development: [orgf]), (morphology: [fndg]), (dendritic spines: [celc]), ( reduces: []), (synaptic transmission: [celf]), (mature neurons: [cell]), (effect: []), (mutation: [genf]), (ankyrin domain: [aapp,bacs]), (roles: [socb]), (spine induction: [bpoc]), (actin accumulation: [aapp,bacs]), (spines: [bpoc]), (affects growth: [orgf]), (motility: [orgf]), (inherited mutations: [genf]), (intermediate effects: [lbtr]), (spine density: [bpoc]), (therefore: []), (healthy parents: []), (risk factors: [qnco]), (data: [euka]), (new insights: [menp]), (synaptic alterations: []), (humans: [humn]), (robust cellular readout: [cell]), (knowledge-based therapies: [topp]), 
ASD Terms: (patients with intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 3114764
SFARI Genes: IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, IL-6, 
Non SFARI Genes: 
Named Entities: (cellular mechanisms: [cell]), (pathogenesis: [patf]), (autism: [mobd]), (number: [qnco]), (studies: [lbpr]), (localized inflammation: [fndg]), (central nervous system (cns): [bdsy]), (development: [orgf]), (recent evidence shows: [anim]), (il-6: [gngm]), (crucial role: [socb]), (plasticity: [npop]), (cns: [bdsy]), (immunohistochemistry studies: [diap]), (il-6 expression: [aapp,imft]), (cerebellum: [bpoc]), (study subjects: [humn]), (vitro adenoviral gene delivery approach: [virs]), (over-express il-6: [aapp,imft]), (cultured cerebellar granule cells: [celc]), (cell adhesion: [celf]), (migration assays: [lbpr]), ( dii: []), (to-pro-3 staining: [orch,phsu]), (immunofluorescence: [lbpr]), (migration: [phpr]), (dendritic spine morphology: [celc]), ( cell apoptosis: [celf]), (synaptic protein expression respectively: [genf]), (study: [resa]), (autistic subjects: [mobd]), (neural cell development: [celf]), (function: [phsf]), (cerebellar granule cells: [bpoc]), (il-6 viral expression vector: [aapp,imft]), (il-6 over-expression: [aapp,imft]), (granule cells: [cell]), (impairments: [patf]), (granule cell adhesion: [celc]), (little effect: [fndg]), (formation: [biof]), (dendritic spines: [celc]), (granule cell apoptosis: [celf]), (however: []), ( il-6 over-expression: [aapp,imft]), (granule cell excitatory synapses: [celc]), (inhibitory synapses: [celc]), (results: [fndg]), (further evidence: []), (aberrant il-6: [aapp,imft]), (elevated il-6: [fndg]), (autistic brain: [mobd]), (neural cell: [cell]), (adhesion: [patf]), ( migration: [phpr]), (imbalance: [sosy]), (excitatory: []), (inhibitory circuits: [acty]), (thus: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(vitro adenoviral gene delivery approach, 'Perinatal History')(autism, 'Autism Phenotype')

PMCID: 3113723
SFARI Genes: DISC1, DISC1, DISC1, DISC1, DISC1, DISC1, DISC1, DISC1, DISC1, DISC1, DISC1, DISC1, 
Non SFARI Genes: 
Named Entities: (disrupted-in-schizophrenia: [mobd]), ((disc1) gene: [gngm]), (promising candidate genes: [gngm]), (major mental disorders: [mobd]), (previous study: [resa]), (finnish group: [popg]), (disc1 polymorphisms: [genf]), (autism: [mobd]), (asperger: []), (however: []), (results: [fndg]), (korean population: [popg]), (disc1: [gngm]), (chinese han population: [popg]), (family-based association study: [socb]), (tag: [gngm]), (polymorphisms (snps): [nusq]), (kb: []), (autism trios (singleton: [aapp,enzy]), (biological parents): [famg]), (individuals: [humn]), (single snp association: [fndg]), (haplotype association analysis: [menp]), (family-based association test (fbat): [socb]), (haploview: []), (snps: [nusq]), (significant associations: [menp]), (autism (rs4366301: g > c: [mobd]), ( z: []), (p: [gngm]), (rs11585959: t > c: [clna]), (rs6668845: a > g: [qnco]), (bonferroni correction: []), ( snp rs4366301: [nusq]), (first intron: [bacs,nnon]), (haplotype: [orga]), (haplotypes: [orga]), (significant association: [menp]), (permutation method: [lbpr]), (empirical p values: [qnco]), (study: [resa]), (evidence: []), (susceptibility gene: [gngm]), (role: [socb]), (pathogenesis: [patf]), 
ASD Terms: (major mental disorders, 'Mental Disorders')(autism, 'Autism Phenotype')(asperger, 'Asperger Syndrome')(autism, 'Autism Phenotype')(autism trios, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3090385
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (several children: [aggp]), (autism show regression: [mobd]), (language: [lang]), (social development: [socb]), (normal motor milestones: [fndg]), (clear period: [fndg]), (normal development: [fndg]), (regression: [menp]), (subsequent improvement: []), (multifactorial etiology: []), (role: [socb]), (inflammation: [patf]), (autism: [mobd]), (major area: []), (study: [resa]), (viral: []), (bacterial infections: [dsyn]), ( hypoxia: [patf]), (medication: [phsu]), (foetus: [tisu]), (infant: [aggp]), (stressors: []), (transcription factors: [aapp,bacs]), (nuclear factor kappa b (nf-b): [aapp,imft]), (master switch: []), (many genes: [gngm]), (tumor necrosis factor (tnf): [aapp,imft]), (hypothesis: []), (nf-b: []), (children: [aggp]), (peripheral blood samples: [bdsu]), (control children: [aggp]), (electrophoretic mobility shift: [lbpr]), ((emsa): [lbpr]), (phosphor imaging technique: [diap]), (values: []), (fold increase: [phpr]), (control sample: [sbst]), (statistical analysis: [resa]), (spss: [gngm]), (significant increase: [qnco]), (nf-b dna: [bacs,nnon]), (activity: [acty]), (cases: [qnco]), (controls (n: [aapp,imft]), (significant difference (3.14: [fndg]), (respectively; p<0.02): [fndg]), (finding: [sosy]), (value: [qnco]), (known biochemical changes: [qnco]), (response: [fndg]), (several kinds: [qnco]), ( autism: [mobd]), (part: [qnco]), (nf-b pathway: [moft]), 
ASD Terms: (autism show regression, 'Autism Phenotype')(social development, 'Ability to Converse in Social Settings')(autism, 'Autism Phenotype')(bacterial infections, 'Bacterial Infections')(medication, 'Medications')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3087757
SFARI Genes: CD26, CD38, CD26, CD38, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (impairments: [patf]), (social behavior: [socb]), ( communication difficulties: [socb]), (occurrence: []), (repetitive: []), (behaviors: [inbe]), (substantial evidence: []), (dysregulation: []), (immune system: [bdsy]), (differences: [qnco]), (number: [qnco]), (phenotype: [orga]), (blood cells: [cell]), (young children: [aggp]), (autism (n: [mobd]), (age-matched controls: [orga]), (children: [aggp]), (confirmed diagnosis: [fndg]), (years: []), (age): [orga]), (low (iq<68: [qnco]), ( n: [aapp,imft]), (high functioning (iq68: [qnco]), (groups: [popg]), (control group: [grup]), (primary: [topp]), (secondary variables: [neop]), (cell counts: [lbpr]), (abundance: []), (cell surface antigens: [imft]), (microvolume laser: [plnt]), (cytometry: [lbpr]), (multiple differences: [qnco]), (immune cell populations: [popg]), (control groups: [grup]), (absolute number: [qnco]), (b cells: [cell]), (volume: [qnco]), (blood: [bdsu]), (nk cells: [cell]), (higher: []), (variables: []), (significant difference: [qnco]), (high functioning autism groups: [popg]), (t cells: [cell]), (cellular activation markers: [clna]), (hla-dr: [aapp,imft]), (cd26: [gngm]), (cd38: [gngm]), (autism group: [mobd]), (results: [fndg]), (previous findings: [clna]), (immune dysfunction: [dsyn]), (further evaluation: [hlca]), (nature: []), (dysfunction: [dsyn]), (role: [socb]), (etiology: []), (facets: [blor]), (autism neuropathology: [mobd]), (behavior: [inbe]), 
ASD Terms: (social behavior, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')(confirmed diagnosis, 'Diagnosis')(cell surface antigens, 'Allergies')(autism, 'Autism Phenotype')(high functioning autism groups, 'Autism Phenotype')(autism group, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism neuropathology, 'Autism Phenotype')

PMCID: 4234331
SFARI Genes: Met, Met, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (lifelong neurodevelopmental disorder: [mobd]), (aims: [phsu]), (study: [resa]), (children: [aggp]), (caries: [dsyn]), (periodontal problems: []), (treatment needs: [topp]), (control group: [grup]), (non-autistic patients: [mobd]), (baseline data: [bodm]), (comparison: [acty]), (future planning: [menp]), (dental services: [topp]), (autistic children: [podg]), (material: [sbst]), (patients: [podg]), (years: []), ((45 males: [orga]), (females): [orga]), (dubai: []), (sharjah autism: [mobd]), (relatives: [famg]), (friends: [popg]), (autistic patients: [mobd]), (attempt: [evnt]), (age: [orga]), ( sex: [orgf]), (socioeconomic status: []), (patient: [podg]), (periodontal examination: []), ( assessment: [acty]), (caries prevalence: [qnco]), (other conditions: [dsyn]), (dental plaque: [dsyn]), ( gingivitis: [dsyn]), ( restorations: []), (chi-square: [qnco]), (fisher's: [mamm]), (exact test: []), (significance: [qnco]), (groups: [popg]), (autism group: [mobd]), (male-tofemale ratio: [orga]), (decayed: [acab]), (teeth: [bpoc]), (unaffected patients: [podg]), (restorative dental treatment: [topp]), (restorative index (ri): [qnco]), (met need index (mni): [qnco]), (respectively: []), (majority: [socb]), ((36/61): []), ((23/61) oral hygiene: [inbe]), (healthy control subjects: [humn]), (likewise: []), ((59/61): []), (gingivitis: [dsyn]), (poor oral hygiene: [fndg]), (extensive unmet needs: [acty]), (dental treatment: [topp]), (non-autistic healthy control group: [grup]), (oral health program: [hlca]), (prevention: [resa]), (particular importance: []), (young people: [popg]), 
ASD Terms: (autism, 'Autism Phenotype')(lifelong neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(future planning, 'Planning')(autism, 'Autism Phenotype')(sharjah autism, 'Autism Phenotype')(autism group, 'Autism Phenotype')(autism, 'Autism Phenotype')(oral hygiene, 'Hygiene')(autism, 'Autism Phenotype')(poor oral hygiene, 'Hygiene')(autism, 'Autism Phenotype')

PMCID: 3083416
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (heterogeneity: [orga]), (symptoms: [sosy]), (autism spectrum disorders: [mobd]), (significant challenge: [hlca]), (genetic analyses: [lbpr]), (associations: [menp]), (genetic variants: [npop]), (specific trait: [orga]), (characteristic: []), (autism: [mobd]), (here: []), (quantitative trait analyses: [resa]), (asd symptoms: [cgab]), (case-control association analyses: [menp]), (distinct asd subphenotypes: [cgab]), (basis: [phsu]), (symptomatic profiles: [lbpr]), (identification: [menp]), (significant associations: [menp]), (novel single nucleotide polymorphisms: [nusq]), (symptom categories: [clna]), (deficits: []), (language: [lang]), (usage: []), ( non-verbal communication: [menp]), (social development: [socb]), (skills: [inbe]), (insistence: []), (sameness: []), (ritualistic behaviors: []), (trait-associated snps: [nusq]), (quantitative trait loci (qtl): [gngm]), (subtype: []), (partial replication: [genf]), (identified qtl: [gngm]), (notably: []), ( none: []), (novel snps: [nusq]), (exonic region: [bacs,nnon]), (hereditary components: []), (asds: [cgab]), (gene: [gngm]), (regulatory processes: [biof]), (gene expression): [genf]), (functional changes: [topp]), (gene products: [aapp,bacs]), (qtl reside: [gngm]), (intergenic chromosomal regions: [celc]), (rare copy number variants: [nusq]), (autistic samples: [mobd]), (pathway analyses: []), (genes: [gngm]), (qtl: [gngm]), (study: [resa]), (neurological functions: [ortf]), (disorders: [dsyn]), (autism pathophysiology: [mobd]), (advantage: []), (quantitative traits: [gngm]), (subphenotypes: []), (large-scale genome-wide analyses: [gngm]), (complex disorders: [dsyn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(asd symptoms, 'Complaints and Indications')(included deficits in language, 'Language Ability')(social development, 'Ability to Converse in Social Settings')(autism spectrum disorders, 'Autism Phenotype')(neurological functions, 'Neurologic Indications')(autism pathophysiology, 'Autism Phenotype')

PMCID: 3104945
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autoimmunity: [patf]), (central nervous system (cns): [bdsy]), (pathogenic role: [socb]), (subgroup: [virs]), (patients: [podg]), (autism: [mobd]), (study: [resa]), (frequency: [qnco]), (serum anti-ganglioside m1 auto-antibodies: [aapp,imft]), (indicators: [irda]), (presence: [qnco]), (cns: [bdsy]), (group: [popg]), (autistic children: [podg]), (relationship: []), (antibodies: [aapp,imft]), (degree: [qnco]), (severity: []), (serum: [bdsu]), (anti-ganglioside m1 antibodies: [aapp,imft]), (elisa: [lbpr]), (years: []), (comparison: [acty]), (healthy-matched children: [fndg]), (autistic severity: [mobd]), (childhood autism rating scale (cars): [mobd]), (serum levels: [bdsu]), (healthy children: [fndg]), (seropositivity: []), ((40/54): [qnco]), (severe autism (63%): [fndg]), (autism (37%): [mobd]), ( p: [aapp,imft]), (moreover: []), (significant positive correlations: [fndg]), (cars (p: [aapp,enzy]), (many autistic children: [podg]), (also: []), (levels: []), (thus: []), ( autism: [mobd]), (pediatric autoimmune: [patf]), (neuropsychiatric disorders: [dsyn]), (wide-scale studies: [lbpr]), (light: [gngm]), (possible etiopathogenic role: [socb]), (anti-ganglioside m1 auto-antibodies: [aapp,imft]), (role: [socb]), (immunotherapy: [topp]), (autistic patients: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(severe autism, 'Autism Phenotype')(moderate autism, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3107800
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (backgrounds autism: [mobd]), (family: [famg]), (developmental disorders: [mobd]), (unknown origin: []), (disorder: [dsyn]), (behavioral: [inbe]), ( developmental: [orgf]), (sensory abnormalities: [cgab]), (ages: [bacs,orch]), (peak prevalence rates: [qnco]), (children: [aggp]), (5-8 years: [qnco]), (recently: []), (interest: [menp]), (role: [socb]), (plasma free fatty acids (fa): [bdsu]), (pathology: [patf]), (neurological disorders: [dsyn]), (aim: [phsu]), (study: [resa]), (plasma fatty acid profiles: [bdsu]), (saudi: []), (autistic patients: [mobd]), (age-matching control: [sbst]), (attempt: [evnt]), (fa: [gngm]), (etiology: []), (autism: [mobd]), (26-age-matching controls: [sbst]), (present study: [qnco]), (methyl esters: [orch]), (hexane: [hops,orch]), (fatty acid composition: [orch]), (extract: [sbst]), (gas chromatography: [lbpr]), (data: [euka]), (fatty acids: [orch]), (plasma: [bdsu]), (increase: []), (saturated fatty acids: [food,orch]), (propionic acid: [orch]), (decrease: [qnco]), (polyunsaturated fatty acids: [bacs,orch]), (altered fatty acid profile: [orch]), (relation: [socb]), (stress: [fndg]), ( mitochondrial dysfunction: [fndg]), (high lead (pb) concentration: [menp]), (statistical analysis: [resa]), (data shows: [euka]), (age: [orga]), (controls: [sbst]), (operating characteristic (roc) curve analysis: [qnco]), (satisfactory values: []), (area: []), (curve (auc): [qnco]), (high degree: [qnco]), (specificity: [qnco]), (sensitivity: [patf]), (altered fatty acids: [orch]), (biomarkers: [clna]), (saudi arabia: []), 
ASD Terms: (backgrounds autism, 'Autism Phenotype')(sensory abnormalities, 'Reaction to Sensory Stimuli')(neurological disorders, 'Neurologic Indications')(autism, 'Autism Phenotype')

PMCID: 3090611
SFARI Genes: Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, Shank3, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (range: [qnco]), (disorders: [dsyn]), (share: [socb]), (core: [bdsu]), (neurobehavioural deficits: []), (widespread abnormalities: [cgab]), (social interactions: [fndg]), ( deficits: []), (communication: [socb]), (interests: [menp]), (repetitive behaviours: [inbe]), (neurological basis: [phsu]), (circuitry mechanisms: []), (abnormal behaviours: [mobd]), (shank3: [gngm]), (postsynaptic protein: [aapp,bacs]), (disruption: []), (genetic level: [phsu]), (development: [orgf]), (deletion: [genf]), ((phelan-mcdermid syndrome): [dsyn]), (other non-syndromic asds: [cgab]), (mice: [mamm]), (shank3 gene deletions: [genf]), (self-injurious repetitive grooming: [inbe]), (deficits: []), (social interaction: [fndg]), (cellular: [cell]), (biochemical analyses: [resa]), (uncovered defects: []), (striatal synapses: [bpoc]), (cortico-striatal circuits: [bpoc]), (shank3 mutant mice: [mamm]), (findings: [clna]), (critical role: [socb]), (normal development: [fndg]), (neuronal connectivity: [imft]), (causality: []), (shank3 gene: [gngm]), (genesis: [gngm]), (autistic like-behaviours: [mobd]), 
ASD Terms: (social interactions, 'Reciprocal Social Interaction')(autism spectrum disorders, 'Autism Phenotype')(repetitive behaviours, 'Restricted and Repetitive Behavior')(neurological basis, 'Neurologic Indications')(abnormal behaviours, 'Personal Traits')(other non-syndromic autism spectrum disorders, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(self-injurious repetitive grooming, 'Self-Injurious Behavior')

PMCID: 3043069
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autistic spectrum disorder (asd): [mobd]), (impaired language: [lang]), ( communication: [socb]), (social skills: [socb]), (repetitive: []), (stereotypic patterns: [menp]), (behavior: [inbe]), (many autistic subjects: [mobd]), (dysregulation: []), (immune system: [bdsy]), (unresolved viral infection: [dsyn]), (prenatal onset: [fndg]), (vertical viral transmission: [patf]), (xenotropic murine leukemia: [mamm]), (virus-related virus (xmrv): [virs]), (chronic fatigue syndrome (cfs): [dsyn]), (prostate cancer: [neop]), (several: [qnco]), (studies: [lbpr]), (methodology/principal findings: [clna]), (xmrv: [virs]), (other murine leukemia: [mamm]), ((mlv)-related viruses: [virs]), (autistic disorder: [mobd]), (pcr: [mbrt]), (genomic sequences: [nusq]), (dna samples: [bacs,nnon]), ((i) peripheral blood: [inch]), (asd patients: [cgab]), (controls: [sbst]), ((ii) post-mortem brain samples: [bpoc]), (age-matched controls: [orga]), ( (iii) semen samples: [bdsu]), (fathers: [famg]), (asd: [cgab]), (infertile individuals: [patf]), (fertile controls: [topp]), (xmrv gag dna sequences: [nusq]), (detected: [fndg]), ( whereas peripheral blood samples: [bdsu]), ((3.1%) controls: [sbst]), (mlv: [virs]), (conclusions|significance: [qnco]), (mlv-related virus: [virs]), (blood: [bdsu]), ( brain: [bpoc]), (semen samples: [bdsu]), (hence infection: [dsyn]), (other mlv-related viruses: [virs]), (pathogenesis: [patf]), 
ASD Terms: (social skills, 'Ability to Converse in Social Settings')(stereotypic patterns, 'Stereotyped, Restricted, and Repetitive Behavior')(autistic spectrum disorder, 'Autistic Disorder')(impaired language, 'Language Ability')(prenatal onset, 'Onset of Symptoms')(unresolved viral infection, 'Virus Diseases')(virus-related virus, 'Virus Diseases')(other murine leukemia virus, 'Virus Diseases')(autistic disorder, 'Autistic Disorder')(virus-related virus gag dna sequences, 'Virus Diseases')(mlv-related virus, 'Virus Diseases')(autism pathogenesis, 'Autism Phenotype')

PMCID: 3043074
SFARI Genes: Fmr1, Fmr1, Fmr1, Fmr1, 
Non SFARI Genes: 
Named Entities: (animal models: [anim]), (autism spectrum disorders: [mobd]), (good construct validity: []), (genetic models: []), (pathologies: []), (asd-like deficits: [cgab]), (known causes: []), (promising strategy: [menp]), (fmr1-ko mouse: [mamm]), (example: []), (approach: []), (fragile x: [comd]), (well-known genetic disorder: [dsyn]), (asd symptoms: [cgab]), (fmr1-ko: [bdsy]), (different genetic backgrounds: [orga]), (versus c57bl/6): [mamm]), (conflicting results: [inbe]), (mutants: [comd]), (fmr1 ko: [bdsy]), (wild-type littermates: [gngm]), (fvb: [mamm]), (c57bl/6: [mamm]), (genetic backgrounds: [orga]), (battery: [inpo]), (tests: [lbpr]), (clinical symptoms: [sosy]), (asd: [cgab]), (triad: [bodm,orch]), (core symptoms (alterations: [sosy]), (social interaction: [fndg]), (communication: [socb]), ( presence: [qnco]), (repetitive behaviors): [fndg]), (secondary symptoms (disturbances: [neop]), (sensori-motor reactivity: []), (circadian patterns: []), (activity: [acty]), ( epileptic events): [dsyn]), (fmr1-ko mice: [mamm]), (autistic-like core symptoms: [mobd]), (altered social interaction: [fndg]), (occurrence: []), (repetitive behaviors: [fndg]), (additional hyperactivity: [mobd]), (genetic background: [orga]), (effects: []), (fmr1 deletion: [genf]), (c57bl/6 background: [mamm]), (further research: [resa]), (core autistic-like symptoms: [mobd]), (fmr1-mouse line: [mamm]), (main core: [bdsu]), (secondary asd symptoms: [cgab]), (neurobiological mechanisms: []), (specific asd-like endophenotypes: [cgab]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(fragile x, 'Fragile X Syndrome')(asd symptoms, 'Complaints and Indications')(clinical symptoms of asd, 'Complaints and Indications')(altered social interaction, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(additional hyperactivity, 'Overactivity')(secondary asd symptoms, 'Complaints and Indications')

PMCID: 3041792
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (many previous studies: [lbpr]), (variants: []), (guilt-by-association: [menp]), ( gene function predictions: [genf]), (high statistical confidence: [qnco]), (studies: [lbpr]), (associations: [menp]), (data (e.g.: [euka]), ( protein interaction partners): [famg]), (gene: [gngm]), (guilt: [menp]), (paper: []), (multifunctionality: []), (association: [menp]), (primary driver: [popg]), (gene function prediction: [genf]), (knowledge: []), (degree: [qnco]), (strong performance: [inbe]), (predictor: []), (gene function: [genf]), (gene interaction data: [euka]), (protein interactions: [moft]), (coexpression networks): []), (gene function prediction algorithms: [genf]), (high-quality gene function predictions: [genf]), (data: [euka]), (information: []), (gene interacts: [gngm]), (which: []), (wide range: [qnco]), (networks: []), (yeast: [fngs]), (multiple prediction methods: [topp]), (evaluation metrics: [orch,phsu]), (evidence: []), (problem: [fndg]), (failings: []), (particular algorithm: [lbpr]), (data type: []), (computational controls: [sbst]), (meaningful control: [sbst]), (gene function prediction performance: [gngm]), (source: [fndg]), (bias: [bird]), (for: []), (widespread implications: []), (interpretation: [clna]), (genomics: []), 
ASD Terms: (computational controls, 'Isolated Cognitive Skills')

PMCID: 3040743
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (causal role: [socb]), (mutations: [genf]), (multiple general transcription factors: [aapp,bacs]), (neurodevelopmental disorders: [mobd]), (autism: [mobd]), (alterations: []), (global levels: []), (gene expression regulation: [genf]), (risk: []), (sporadic cases: [qnco]), (premise: []), (changes: [qnco]), (overall distribution: []), (gene expression levels: [genf]), (instance: []), (mice: [mamm]), ( variability: []), (hippocampal-dependent behaviors: [inbe]), (variability: []), (pattern: []), (variance: [qnco]), (distribution: []), (hippocampus: [bpoc]), (similar change: [qnco]), (children: [aggp]), (gene expression microarrays: [mbrt]), (unique rna transcripts: [nnon]), (rna: [nnon]), (peripheral blood lymphocytes: [cell]), (autism (n: [mobd]), (controls (n: [aapp,imft]), (microarray: []), (groups: [popg]), (risk factor: [qnco]), (paternal age: []), (decrease: [qnco]), (pbl: [cell]), (diagnosis: [fndg]), (traditional approaches: []), (analysis: [resa]), (gene expression: [genf]), (possible mechanism: []), (decreased variance: [qnco]), (gene expression pathways: [genf]), (transcriptional regulation: [genf]), (blood: [bdsu]), (fathers: [famg]), (thus: []), ( results: [fndg]), (gene: [gngm]), (specific approaches: []), (microarray data: [euka]), (hypothesis: []), (global level: [phsu]), (global regulation: [biof]), (transcription: [genf]), ( thus: []), (possible point: [qnco]), (convergence: [acty]), (multiple etiologies: []), (other neurodevelopmental disorders: [mobd]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(other neurodevelopmental disorders, 'Learning Disorders')

PMCID: 3040206
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (pervasive neurodevelopmental disorder: [mobd]), (deficits: []), (social behavior: [socb]), (interpersonal communication: [socb]), (stereotyped: [menp]), ( repetitive behaviors: [fndg]), (towards males: [orga]), (ratio: [qnco]), (41: []), (clear understanding: [menp]), (sex hormones: [horm,phsu]), (role: [socb]), (autism susceptibility: [clna]), (male: [orga]), (female hormones: [lbtr]), (expression: [topp]), (novel autism candidate gene: [mobd]), (acid-related orphan receptor-alpha (rora): [chem]), (neuronal cell: [gngm]), (sh-sy5y: []), (addition: []), (rora: [gngm]), (enzyme: [enzy,orch]), (testosterone: [horm,orch,phsu]), (aromatase protein: [aapp,enzy]), (frontal cortex: [bpoc]), (autistic subjects: [mobd]), (age-matched controls: [orga]), (rora protein levels: [lbtr]), (brain: [bpoc]), (results: [fndg]), (positive feedback regulation: [phpr]), ( respectively: []), (transcriptional targets: [genf]), ( aromatase: [aapp,enzy]), (mechanism: []), (sex bias: [socb]), (autism: [mobd]), 
ASD Terms: (social behavior, 'Reciprocal Social Interaction')(autism susceptibility, 'Autism Phenotype')(pervasive neurodevelopmental disorder, 'Learning Disorders')(stereotyped, 'Stereotyped, Restricted, and Repetitive Behavior')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(novel autism candidate gene, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3077925
SFARI Genes: CaV1.2, CaV1.2, 
Non SFARI Genes: 
Named Entities: (individuals: [humn]), (congenital: []), (prolongation: []), (qt interval: [clna]), (long qt syndrome (lqts): [dsyn]), (risk: []), (life: []), (ventricular arrhythmia: [patf]), (lqts: []), (origin: []), (environmental factors1: []), (missense mutation: [genf]), (l-type calcium channel cav1.2: [aapp,bacs]), (patients: [podg]), (timothy: [plnt]), (effect: []), (ts mutation: [genf]), (electrical activity: [ortf]), (contraction: [patf]), (human cardiomyocytes: [humn]), (human skin cells: [bdsy]), (ts patients: [podg]), (induced pluripotent stem cells: [cell]), (cells: [cell]), (cms: [gngm]), (electrophysiological recording: [diap]), (calcium (ca2+): [bacs,elii,phsu]), (studies: [lbpr]), (irregular contraction: [patf]), (excess ca2+ influx: [elii,phsu]), (action potentials: [celf]), (irregular electrical activity: [ortf]), (abnormal calcium transients: [fndg]), (ventricular-like cells: [bpoc]), (roscovitine: [orch,phsu]), (compound: [chem]), (voltage-dependent inactivation (vdi): [qnco]), (cav1.268: [aapp,bacs]), (ca2+: [elii,phsu]), (properties: []), (study: [resa]), (new avenues: []), (cellular mechanisms: [cell]), (cardiac arrhythmias: [fndg]), (humans: [humn]), (robust assay: [lbpr]), (new drugs: [phsu]), (diseases: [dsyn]), 
ASD Terms: 

PMCID: 3060452
SFARI Genes: CaV1.2, CaV1.2, CaV1.2, CaV1.2, 
Non SFARI Genes: 
Named Entities: (cav1.2 calcium channels: [aapp,bacs]), (roles: [socb]), (diverse cellular processes: [celf]), (gene: [gngm]), (muscle contraction: [phsf]), (membrane excitation: [celc]), (activity: [acty]), (extensive alternative splicing: [genf]), (cav1.2 mrna: [bacs,nnon]), (exclusive exons: [bacs,nnon]), (encode alternate forms: [acty]), (transmembrane segment: [celc]), ((is6): []), (channel domain: []), (human genetic disorder timothy syndrome: [humn]), (mutations: [genf]), (cav1.2: [gngm]), (ca2+ homeostasis: [biof]), (severe pleiotropic disease phenotypes: [orga]), (tissue-specific pattern: [bdsu]), (leads: [elii,hops]), (differences: [qnco]), (symptoms: [sosy]), (patients: [podg]), (mechanisms: []), (exon: [bacs,nnon]), (splicing choice: [inbe]), (spectrum: [qnco]), (defects: []), (disease: [dsyn]), (polypyrimidine tract-binding protein (ptb): [aapp,bacs]), (switch: []), (splicing: [genf]), (ptb: [gngm]), (neuronal homolog: [gngm]), ( nptb: [gngm]), (regulators: []), (large sets: [menp]), (alternative exons: [bacs,nnon]), (neuronal development: [celf]), ( ptb expression: [topp]), (concurrent increase: []), (nptb expression: [topp]), (embryonic mouse brain: [tisu]), (neuronal differentiation: [fndg]), (repression: [menp]), (direct binding: [moft]), (elements: [elii]), (nptb protein: [aapp,bacs]), (repressor: [aapp,bacs]), (shift: [phpr]), (exon choice: [bacs,nnon]), (nptb replaces ptb: [gngm]), (cells: [cell]), (results: [fndg]), (mechanistic understanding: [menp]), (human disease: [humn]), (controlled: [fndg]), 
ASD Terms: 

PMCID: 3042898
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (post-genomic era: [gngm]), ( multi-faceted research: [resa]), (complex disorders: [dsyn]), (autism: [mobd]), (diverse types: []), (molecular information: []), (pathogenesis: [patf]), (rapid accumulation: [fndg]), (putative candidate genes/loci: [gngm]), (autism spectrum disorders (asd): [mobd]), (asd-related: [cgab]), (animal models: [anim]), (major challenge: [hlca]), (systematic analysis: []), (content: [menp]), (autism database (autdb): [mobd]), (available web portal: [blor]), (collection: []), (manual annotation: [inpr,mnob]), (visualization: [menp]), (genes: [gngm]), (asd: [cgab]), (here: []), (design: [acty]), ( development: [orgf]), (integration: [genf]), (new module: []), (autdb: []), (comprehensive cataloguing: []), (asd-related animal models: [cgab]), (description: []), (original autdb: []), (data: [euka]), (published: []), ( peer-reviewed scientific literature: [hlca]), (new standardized vocabulary: []), (phenotypic terms: [orgf]), (researchers: []), (diverse clinical manifestations: []), (new animal model module: [emod]), (dissemination: []), (diverse information: []), (animal model entries: [emod]), (candidate genes: [gngm]), (original "human gene" module: [humn]), (resource: []), (cross-modal navigation: [acty]), (gene models: [gngm]), (human gene studies: [gngm]), (current release: [hlca]), (animal model module: [emod]), (models: []), (expandable framework: []), (additional species: []), (non-genetic etiological models: []), (future: []), (importantly: []), (modular asd database: [cgab]), (platform: []), (data mining: [mcha]), (and/or computational biology strategies: [menp]), (predictive disease models: [dsyn]), (further insights: [menp]), (molecular underpinnings: []), (disorder: [dsyn]), (general model: [hlca]), (disease-driven databases: [dsyn]), (phenotypic characteristics: [orga]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(visualization, 'Visual Thinking')(autism database, 'Autism Phenotype')(autism database, 'Autism Phenotype')(original autism database, 'Autism Phenotype')(autism database, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3023760
SFARI Genes: c3orf58, c3orf58, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (group: [popg]), (occurring: [acty]), ( highly-heritable developmental disabilities: [mobd]), (human genes c3orf58: [gngm]), (autism-1 (dia1): [mobd]), (cxorf36: [gngm]), (autism-1 related (dia1r): [mobd]), (asd: [cgab]), (mental retardation: [mobd]), (gene products: [aapp,bacs]), (signal peptides: [amas]), (secretory pathway: [celf]), (evolutionary medicine: [genf]), (key tool: []), (numbers: [qnco]), (human diseases: [humn]), (evolutionary approach: [genf]), (dia1: [gngm]), (dia1r: [gngm]), (cnidarians: [euka]), (dia1 evolution: [genf]), (development: [orgf]), (first primitive synapses: [bsoj]), (nematodes: [euka]), (dia1 homologue: [gngm]), (caenorhabditis elegans: [euka]), (aspects: [qnco]), (zebrafish encode: [fish]), (dia1 paralogues: []), (contrast: [irda]), ( dia1r: [gngm]), (vertebrates: [vtbt]), (origin: []), (whole-genome duplication events: [gngm]), (vertebrate lineage: [vtbt]), (evolution: [genf]), (complex vertebrate: [vtbt]), (nervous system: [bdsy]), (strikingly: []), (fish: [gngm]), (solitary lifestyle: [socb]), (additional dia1-related gene: [gngm]), (dia1-like (dia1l): []), (signal peptide: [amas]), (genomes: [gngm]), (echinoderm strongylocentrotus purpuratus: [euka]), (cephalochordate branchiostoma floridae: [euka]), (evidence: []), (remarkable dia1l gene expansion: [gngm]), (b. floridae: []), (amino: []), (acid alignments: [chem]), (dia1 family gene products: [famg]), (potential golgi-retention motif: [celc]), (number: [qnco]), (conserved motifs: [amas]), (unknown function: [phsf]), (furthermore: []), (glycine: [aapp,bacs,phsu]), (cysteine residues: [aapp,bacs]), (dia1-family proteins: [famg]), (critical role: [socb]), (protein structure: [aapp]), (function: [phsf]), (new metazoan protein: [aapp,bacs]), (dia1-family: [famg]), (biological roles: [socb]), (dia1-family members: [famg]), (implications: []), (understanding: [menp]), (autism: [mobd]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(highly-heritable developmental disabilities, 'Learning Disorders')(mental retardation, 'Mental Retardation')(autism, 'Autism Phenotype')

PMCID: 3029221
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (diphenyl ethers: [orch]), (flame retardants: [chvf]), (amounts: [qnco]), (u.s: []), (last few decades: [qnco]), (pbdes: [orch]), (metabolites: [bacs]), (placenta: [emst]), (studies: [lbpr]), (rodents: [mamm]), (demonstrate neurodevelopmental toxicity: [inpo]), (prenatal exposures: [fndg]), (pbde: [orch]), (breastfeeding: [orgf]), (hand-to-mouth activities: [bpoc]), (small children: [aggp]), (participants: [popg]), (children: [aggp]), (charge (childhood autism risk: [mobd]), (genetics: []), (environment) study: [resa]), (case-control epidemiologic investigation: [hlca]), (autism/autism spectrum disorder: [mobd]), (developmental delay: [mobd]), (general population: [popg]), (diagnoses: [fndg]), (autism: [mobd]), (autism diagnostic observation schedule: [hlca]), (autism diagnostic inventory-revised: [mobd]), (mullen's scales: [plnt]), (early learning: [menp]), (vineland adaptive behavior scales: []), (controls: [sbst]), (evidence: []), (delay: []), ( autism: [mobd]), (autism spectrum disorder: [mobd]), (pbde congeners: [orch]), (gas chromatography/mass spectrometry: [lbpr]), (serum specimens: [bdsu]), (assessed: [acty]), (logistic regression: [resa]), (association: [menp]), (plasma pbdes: [orch]), (levels: []), (groups: [popg]), (plasma samples: [bdsu]), (post-diagnosis: [fndg]), (study: [resa]), (early life exposures: [phpr]), (changes: [qnco]), (introduction: [hlca]), (new household products: [famg]), (direct measurements: []), (prenatal: [aggp]), (infant exposures: [aggp]), (possible causal role: [socb]), (compounds: [chem]), (autism spectrum disorders: [mobd]), 
ASD Terms: (flame retardants, 'Mental Retardation')(prenatal exposures, 'Exposures')(neurodevelopmental toxicity, 'Learning Disorders')(demonstrate neurodevelopmental toxicity, 'Learning Disorders')(with developmental delay, 'Learning Disorders')(developmental delay, 'Learning Disorders')(autism, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(autism diagnostic inventory-revised, 'Autism Phenotype')(vineland adaptive behavior scales, 'Adaptive Life Skills')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(early life exposures, 'Exposures')(autism spectrum disorders, 'Autism Phenotype')(infant exposures, 'Exposures')

PMCID: 3006426
SFARI Genes: Pax6, Pax6, Pax6, Pax6, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (variable brain: [bpoc]), (developmental disorder: [mobd]), (strong genetic basis: [phsu]), (pax6: [gngm]), (pivotal player: []), (brain development: [ortf]), (maintenance: [acty]), (adult neural stem cells: [cell]), (astrocytes: [cell]), (entire central nervous system: [bdsy]), (neurons: [cell]), (olfactory bulb: [bpoc]), ( amygdala: [bpoc]), ( thalamus: [bpoc]), (cerebellum: [bpoc]), ( functioning: []), (context-dependent manners: [fndg]), (heterozygous mutant (rsey2/+) rats: [mamm]), (spontaneous mutation: [genf]), (pax6 gene: [gngm]), ( show: [anim]), (prepulse inhibition (ppi): [phsf]), (present study: [qnco]), (examined behaviors: [inbe]), (rsey2/+ rats: [mamm]), (abnormality: [fndg]), (social interaction: [fndg]), (aggression: [mobd]), (withdrawal): [acty]), (addition: []), (activity: [acty]), (fear-conditioned memory: [menp]), (ultrasonic vocalization (usv): [npop]), (rsey2+ rat pups: [mamm]), (male: [orga]), (female: [orga]), (moreover: []), ( treatment: [topp]), (clozapine: [orch,phsu]), (defects: []), (sensorimotor: []), (function: [phsf]), (prior human genetic data: [inpr,resa]), (results: [fndg]), (other literatures: []), ( rsey2/+ rats: [mamm]), (phenotypic components: [orga]), 
ASD Terms: (autism, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(fear-conditioned memory, 'Working Memory')(ultrasonic vocalization, 'Vocalizations')(autism, 'Autism Phenotype')

PMCID: 3114825
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (environmental causes: []), (factors: []), (autism: [mobd]), (basic science: [resa]), (epidemiologic research: [resa]), (oxidative stress: [comd]), (inflammation: [patf]), (role: [socb]), (disease development: [dsyn]), (traffic-related air: [inch,phsu]), (common exposure: [clna]), (effects: []), (pathways: [moft]), (substances: [sbst]), (adverse prenatal effects: [patf]), (association: [menp]), (proximity: []), (residence: []), (freeways: []), (major roadways: []), (pregnancy: [orgf]), (time: []), (delivery: [topp]), (surrogate: [famg]), (air pollution exposure: [eehu]), (data: [euka]), (autism cases: [mobd]), (controls: [sbst]), (childhood autism risks: [mobd]), (genetics: []), (environment (charge) study: [orga]), (mothers address: [famg]), (birth certificate: [clna]), (trimester-specific addresses: []), (residential history: [orga]), (questionnaire: []), (measures: [qnco]), (distance: [qnco]), (major roads: []), (arcgis software: [inpr,mnob]), (logistic regression models: [inpr,qnco]), (residential proximity: [humn]), (sociodemographic factors: []), (maternal smoking: [inbe]), (maternal residence: [famg]), (freeway: []), (m): [aapp,imft]), (cases: [qnco]), (controls [odds: [sbst]), ((or) =: []), (confidence interval: [qnco]), (third trimester (or: []), (ci: [gngm]), (adjustment: [inbe]), (sociodemographic characteristics: []), (associations: [menp]), (other major roads: []), (birth: [orgf]), (examination: []), (measured air pollutants: [hops]), 
ASD Terms: (autism, 'Autism Phenotype')(common exposure, 'Exposures')(autism, 'Autism Phenotype')(delivery, 'Perinatal History')(air pollution exposure, 'Exposures')(childhood autism risks, 'Autism Phenotype')(autism cases, 'Autism Phenotype')(autism cases, 'Autism Phenotype')(delivery, 'Perinatal History')(maternal smoking, 'Smoking')

PMCID: 3116738
SFARI Genes: Met, Met, MET, MET, Met, Met, MET, MET, MET, MET, 
Non SFARI Genes: 
Named Entities: (met receptor tyrosine kinase: [aapp,enzy,rcpt]), (growth: [orgf]), (development: [orgf]), (axons: [celc]), (wiring: [topp]), (limbic circuits: []), (rodent forebrain: [mamm]), (orthologous met receptor functions: [phsf]), (primate forebrain: [mamm]), (considerable interest: [menp]), (association: [menp]), (variant met alleles: [gngm]), (communication phenotypes: [socb]), (autism: [mobd]), (question: []), (met/met protein expression: [aapp,rcpt]), (developing mouse: [mamm]), (rhesus macaque forebrain: [mamm]), (strong temporal conservation: []), (expression: [topp]), (time: []), (rapid axon development: [celf]), (onset: [qnco]), (robust synapse formation: [ortf]), (expression patterns: [topp]), (met/met: [dsyn]), (limbic-related structures: [fndg]), (species: []), (marked contrast: [irda]), (divergent expression: [topp]), (neocortex: [bpoc]), (mouse: [mamm]), ( met: [dsyn]), (macaque: [mamm]), (robust met expression: [topp]), (posterior cingulate: [bpoc]), (inferior temporal: [socb]), (posterior parietal: []), (visual cortices: [bpoc]), (face processing regions: [blor]), (pattern: []), (importance: []), (vision: [orgf]), (social repertoire: []), (primate: [mamm]), (collectively: []), (data: [euka]), (conserved developmental function: [phsf]), (met receptor: [aapp,rcpt]), (neocortical circuits: []), (species-appropriate responses: [orga]), (social behavior: [socb]), 
ASD Terms: (autism, 'Autism Phenotype')(onset, 'Onset of Symptoms')(visual cortices, 'Visual Thinking')(face processing regions, 'Integrated Verbal and NonVerbal Communication')(social behavior, 'Reciprocal Social Interaction')

PMCID: 3001695
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (neurodevelopmental disorders: [mobd]), (difficulties: [fndg]), (communication: [socb]), ( cognitive: []), (deficits: []), (stereotypic behaviors: [mobd]), (majority: [socb]), (cases: [qnco]), (reliable biomarkers: [clna]), (distinct pathogenesis: [patf]), (however: []), (evidence indicates asd: [cgab]), (immune dysregulation: [fndg]), (neuroimmune component: []), (peptide neurotensin (nt): [aapp,horm]), (autistic children: [podg]), (nt: [diap]), (release: [hlca]), (extracellular mitochondrial dna (mtdna): [bacs,nnon]), ("autoimmune" trigger: [clna]), (serum: [bdsu]), (young autistic patients: [mobd]), (mtdna (n =: [bacs,nnon]), (cytochrome b: [aapp,enzy]), ( p: [aapp,imft]), (p =: [aapp,imft]), (anti-mitochondrial antibody type: [aapp,imft]), ((n: [aapp,imft]), (p: [gngm]), (unrelated controls: [sbst]), (extracellular blood mtdna: [bacs,nnon]), (other components: []), (autistic endophenotype: [mobd]), (pathogenesis: [patf]), (autoimmune responses: [patf]), 
ASD Terms: (cognitive, 'Cognitive Ability')(learning deficits, 'Learning Disorders')(stereotypic behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorders, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(cognitive, 'Cognitive Ability')

PMCID: 3057962
SFARI Genes: MECP2, MECP2, RTT, RTT, Mecp2, RTT, Mecp2, RTT, RTT, RTT, 
Non SFARI Genes: 
Named Entities: (summary mutations: [genf]), (x-linked mecp2: [aapp,bacs]), (transcriptional regulator: [genf]), (methyl-cpg-binding protein: [gngm]), ((mecp2) cause rett syndrome (rtt): [dsyn]), (several neurodevelopmental disorders: [mobd]), (cognitive disorders: [mobd]), (juvenile-onset schizophrenia: [mobd]), (encephalopathy: [dsyn]), (early lethality: [fndg]), (rtt: [gngm]), (normal early development: [fndg]), (regression: [menp]), ( motor abnormalities: [fndg]), ( seizures: [sosy]), (features: []), (autism: [mobd]), (behaviors: [inbe]), (mechanisms: []), (striking features: []), (mice: [mamm]), (mecp2: [gngm]), (-amino-butyric-acid-(gaba)-ergic neurons: [cell]), (numerous rtt: [dsyn]), (autistic features: [mobd]), (repetitive behaviors: [fndg]), (loss: [qnco]), (subset: []), (forebrain gabaergic neurons: [bpoc]), (many features: []), (mecp2-deficient gabaergic neurons: [aapp,bacs]), (reduced inhibitory quantal size consistent: [acty]), (presynaptic reduction: [npop]), (glutamic acid decarboxylase-1: [lbpr]), (-2 levels: []), (gaba immunoreactivity: [aapp,bacs]), (data demonstrate: [euka]), (normal gabaergic: [fndg]), (neuronal function: [phsf]), (subtle dysfunction: [dsyn]), (gabaergic neurons: [cell]), (numerous neuropsychiatric phenotypes: [orga]), 
ASD Terms: (cognitive disorders, 'Cognitive Ability')(autism, 'Autism Phenotype')(juvenile-onset schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(cause rett syndrome, 'Rett Syndrome')(several neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')(motor abnormalities, 'Motor Skills')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 2987909
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (disorder: [dsyn]), (early childhood: []), (social impairment: [patf]), ( communication abnormalities: [socb]), (behaviors: [inbe]), (hypothalamic-pituitary-adrenocortical (hpa) axis: [bdsy]), (special attention: [menp]), (basis: [phsu]), (emotions: [menp]), (social interactions: [fndg]), (basal: []), (plasma cortisol: [lbpr]), (adrenocorticotropic hormone (acth) levels: [lbpr]), (autistic children: [podg]), (relationship: []), (characteristics: []), (fifty: [qnco]), (comparison: [acty]), (healthy age-: [orga]), ( sex-: [orgf]), (pubertal stage-: [fndg]), (children: [aggp]), (subjects: [humn]), (clinical evaluation: [hlca]), (measurement: []), (plasma cortisol (basal: [lbpr]), (stimulated): [npop]), (acth: [gngm]), (addition: []), ( electroencephalography (eeg): [diap]), (intelligence quotient: [orga]), ((iq) assessment: [acty]), (sixteen%: [qnco]), (autistic patients: [mobd]), (high acth: [horm,phsu]), (low basal cortisol: [fndg]), (adequate cortisol response: [horm,orch,phsu]), (acth stimulation: [npop]), (basal (p: [aapp,imft]), (cortisol (p: [horm,orch,phsu]), (acth (p: [horm,phsu]), (controls: [sbst]), (childhood autism rating scale (cars) score: [mobd]), (acth (r: [horm,phsu]), (p =: [aapp,imft]), (basal (r = -0.64: [fndg]), ( p: [aapp,imft]), (cortisol (r = -0.88: [horm,orch,phsu]), (hormonal profile: [lbpr]), (relation: [socb]), (eeg abnormalities: [fndg]), ( iq: []), (self- aggressive symptoms: [mobd]), (observed hormonal changes: [fndg]), (dysfunction: [dsyn]), (hpa axis: [bpoc]), (autistic individuals: [mobd]), (further studies: [lbpr]), (role: [socb]), (hpa: [gngm]), (axis dysfunction: [bpoc]), (pathogenesis: [patf]), 
ASD Terms: (autism, 'Autism Phenotype')(social impairment, 'Social Competence')(social interactions, 'Reciprocal Social Interaction')(childhood autism rating scale score, 'Autism Phenotype')(intelligence quotient, 'IQ')(self- aggressive symptoms, 'Aggressive Behavior')(autism, 'Autism Phenotype')

PMCID: 3003876
SFARI Genes: CDH8, CDH8, CDH8, CDH8, CDH8, CDH8, CDH8, CDH8, 
Non SFARI Genes: PPL, Mb, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (impairments: [patf]), (social communication: [socb]), (pattern: []), (repetitive behaviours: [inbe]), (disability (ld): [fndg]), (cases: [qnco]), (recent study: [resa]), (ppl: [gngm]), (statistical framework: []), (novel region: []), (genetic linkage: [moft]), (chromosome: [celc]), (asd families: [cgab]), (ld: [gngm]), (study: [resa]), (families: [famg]), (autism and/or ld: [mobd]), (rare >1.6 mb microdeletions: [gngm]), (linkage region: [moft]), (deletion breakpoints: [genf]), (base-pair resolution: [moft]), (segregation analysis: [socb]), (combination: [fndg]), (polymorphism (snp) technology: [nusq]), ( array: []), (comparative genomic hybridisation: [mbrt]), (long-range pcr: [mbrt]), (sanger: []), (frequency: [qnco]), (similar genomic variants: [gngm]), (control subjects: [sbst]), (analysis: [resa]), (snp array data: [euka]), (expression: [topp]), (cdh8: [gngm]), (only gene: [gngm]), (microdeletions: []), (reverse transcriptase pcr: [mbrt]), (situ hybridisation analysis: [mbrt]), (week: []), (human embryos: [emst]), (deletion: [genf]), (chr16:: []), (boys: [aggp]), (autism: [mobd]), (none: []), (unaffected siblings: [famg]), (unaffected mother: [famg]), (second family: [famg]), (individual: [humn]), (severe ld: [bpoc]), (father: [famg]), (moderate ld: [bpoc]), (copy number variations: [nusq]), (controls: [sbst]), (expression analysis: [resa]), (cdh8 isoforms: [aapp]), (human cortex: [humn]), (rare: [gngm]), (expression analysis implicate cdh8: [gngm]), (susceptibility: [clna]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(repetitive behaviours, 'Restricted and Repetitive Behavior')(autism spectrum disorder, 'Autism Phenotype')(autism and/or, 'Autism Phenotype')(autism, 'Autism Phenotype')(learning disability, 'Learning Disorders')(father with moderate learning disability, 'Learning Disorders')(moderate learning disability, 'Learning Disorders')

PMCID: 2965350
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (summary large: [qnco]), ( rare: [gngm]), (chromosomal deletions: [comd]), (duplications: []), (copy number variants: [nusq]), (neurodevelopmental disorders: [mobd]), (attention-deficit hyperactivity disorder (adhd): [mobd]), (burden: []), (cnvs: [nusq]), (adhd: [mobd]), (identified cnvs: [nusq]), (loci: [gngm]), (autism: [mobd]), (schizophrenia: [mobd]), (genome-wide analysis: [gngm]), (children: [aggp]), (controls: [sbst]), (british birth cohort: [qnco]), (white uk origin: [popg]), (years: []), (diagnostic criteria: []), (hyperkinetic disorder: [mobd]), (community child psychiatry: [aggp]), (paediatric outpatient clinics: [hcro,mnob]), (single: [fndg]), ((snps): [nusq]), (groups: [popg]), (arrays; cnv analysis: [nusq]), (snps: [nusq]), (arrays: []), (samples: [sbst]), (high-quality data: [qnco]), (adhd group: [mobd]), (comparative genomic hybridisation: [mbrt]), (genome-wide burden: [gngm]), (large (>500 kb): [qnco]), (rare (<1% population frequency) cnvs: [nusq]), (average number: [qnco]), (sample: [sbst]), (significance: [qnco]), (permutation: []), (locus-specific tests: [lbpr]), (association: [menp]), (test regions: [lbpr]), (findings: [clna]), (icelandic patients: [podg]), (icelandic controls: [lang]), (findings data: [euka]), (full analyses: [resa]), (large: [gngm]), ( rare cnvs: [nusq]), (rate: [qnco]), (adhd (0156: [mobd]), (p=89105): [aapp,imft]), (intellectual disability (0424;: [mobd]), (significant excess: [qnco]), (cases: [qnco]), (such disability (0125: [fndg]), ( p=00077): [aapp,imft]), (excess: []), (chromosome: [celc]), (adhd group (p=00008: [mobd]), (correction: []), (multiple testing): [qnco]), (finding: [sosy]), (icelandic sample (p=0031): [aapp,imft]), (adhd cohort: [mobd]), (autism (p=00095): [mobd]), (schizophrenia (p=0010): [mobd]), (interpretation: [clna]), (genetic evidence: [topp]), (increased rate: [qnco]), (large cnvs: [nusq]), (individuals: [humn]), (social construct: []), (action research; baily thomas charitable trust; wellcome trust; uk medical research council; european union: [inbe]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(attention-deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(attention-deficit hyperactivity disorder, 'Overactivity')(attention-deficit hyperactivity disorder, 'Overactivity')(attention-deficit hyperactivity disorder group, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit hyperactivity disorder, 'Overactivity')(attention-deficit hyperactivity disorder, 'Overactivity')(attention-deficit hyperactivity disorder, 'Overactivity')(intellectual disability, 'Learning Disorders')(attention-deficit hyperactivity disorder cohort, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit hyperactivity disorder, 'Overactivity')(uk medical research council, 'Medications')

PMCID: 2953007
SFARI Genes: 
Non SFARI Genes: TLR3, 
Named Entities: (maternal infection: [fndg]), (pregnancy: [orgf]), (wide range: [qnco]), (rna: [nnon]), (dna viruses: [virs]), (risk: []), (schizophrenia: [mobd]), (autism: [mobd]), (offspring: [famg]), (common feature: [qnco]), (exposures: [phpr]), (virus replication induces: [celf]), (immunity: [phsf]), (interaction: []), (toll-like receptors: [aapp,rcpt]), (mouse model wherein: [emod]), (pregnant mice: [mamm]), (polyinosinic-polycytidylic acid [poly(i  c)]: [nnon,phsu]), (synthetic: [acty]), ( double-stranded rna: [bacs,nnon]), (molecular mimic: []), (virus: [virs]), (poly(i  c): [nnon,phsu]), (embryonic neuronal stem cell replication: [celf]), (population: [popg]), (superficial layers: [bpoc]), (neocortex: [bpoc]), (neurons: [cell]), (impaired neonatal locomotor development: [fndg]), (abnormal sensorimotor: [qnco]), (responses: [orga]), (adult offspring: [famg]), (toll-like receptor: [aapp,rcpt]), ((tlr3)-deficient mice: [mamm]), (effects: []), (tlr3: [gngm]), (inhibition: [acty]), (stem cell proliferation: [celf]), (pretreatment: [acty]), (nonsteroidal anti-inflammatory drug (nsaid): [phsu]), (cyclooxygenase (cox) inhibitor: [phsu]), (findings: [clna]), (insights: [menp]), (mechanisms: []), (subtle neuropathology: [patf]), (behavioral dysfunction: [inbe]), (strategies: [menp]), (neuropsychiatric disorders: [dsyn]), (prenatal exposures: [fndg]), (pathogens: [orgm]), (other triggers: [clna]), (innate immunity: [orga]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')(offspring, 'Perinatal History')(exposures, 'Exposures')(virus replication induces, 'Virus Diseases')(virus, 'Virus Diseases')(adult offspring, 'Perinatal History')(impaired neonatal locomotor development, 'Learning Disorders')(behavioral dysfunction, 'Personal Traits')(prenatal exposures, 'Exposures')

PMCID: 2946294
SFARI Genes: 
Non SFARI Genes: Mb, 
Named Entities: (previous studies: [lbpr]), (candidate genes: [gngm]), (chromosomal regions: [cell]), (several copy number variations: [nusq]), (increased risk: [qnco]), (autism: [mobd]), (autism spectrum disorders: [mobd]), (17-year-old girl: [aggp]), (severe mental retardation: [mobd]), ( epilepsy: [dsyn]), (duplication syndrome features: [dsyn]), (gtg-banded chromosome analysis: [lbpr,mbrt]), (female karyotype: [resa]), (marker chromosome: [comd]), (metaphases: [celf]), (array cgh analysis: [dsyn]), (gain: [qnco]), (mb: [gngm]), (duplication: [comd]), (proband: [famg]), (parents: []), (unaffected siblings: [famg]), (ethnic controls: [popg]), (other copy number variations: [nusq]), (patient: [podg]), (family: [famg]), (detailed analysis: [resa]), (duplicated region revealed:: []), (area: []), (critical region: []), (duplication syndrome;: [dsyn]), (region: []), (normal individual;: [humn]), (potential asd locus: [cgab]), (asd candidate locus: [cgab]), (genes: [gngm]), (autistic features: [mobd]), (potential asd locus (9p24.3: [cgab]), (gene(s): [gngm]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(severe mental retardation, 'Mental Retardation')(epilepsy, 'Epilepsy')(other copy number variations, 'Imitation')

PMCID: 3094531
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (siblings: [famg]), (probands: [orga]), (autism spectrum disorders: [mobd]), (risk: []), (broad autism phenotype (bap): [mobd]), (linguistic abilities: [orga]), (pragmatic language: [lang]), ( school achievements: [inbe]), (underling reading processes): [dora]), (school-age siblings: [famg]), (children: [aggp]), (autism: [mobd]), (typical development: [orgf]), (results: [fndg]), (pragmatic abilities: [orga]), (subgroup: [virs]), (sibs-a: [famg]), (bap: [gngm]), (related difficulties: [fndg]), ((sibs-a-bap) whereas school achievements: [famg]), (processes: [phpr]), (furthermore: []), (sibs-a-bap: [famg]), (significant negative correlations: [fndg]), (severity: []), (autism diagnostic observation schedule: [hlca]), (verbal iq scores: [clna]), (context: [fndg]), (developmental trajectories: [orgf]), (relation: [socb]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(broad autism phenotype, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism-broad autism phenotype, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2935882
SFARI Genes: CNTNAP2, CNTNAP2, 
Non SFARI Genes: 
Named Entities: (traits: [gngm]), (autism: [mobd]), (spectrum: [qnco]), (clear boundary: [fndg]), (atypical behaviour: [inbe]), (dimensional traits: [gngm]), (autism phenotype: [mobd]), (methods: []), (principal findings ninety-three: [qnco]), (individual measures: [qnco]), (components: []), (social: []), ( communication: [socb]), (repetitive behaviours: [inbe]), (autistic spectrum disorder (asd): [mobd]), (ages: [bacs,orch]), (months: []), (years: []), (alspac database: []), (value imputation: [qnco]), ( data: [euka]), (children: [aggp]), (analysed: []), (factor analysis: [qnco]), (existence: []), (factors: []), (variance: [qnco]), (labelled: verbal ability: [menp]), ( language: [lang]), (acquisition: [acty]), ( social understanding: [menp]), ( semantic-pragmatic skills: [inbe]), (repetitive-stereotyped behaviour: [mobd]), ( articulation: [bsoj]), (social inhibition: [acty]), (phenotype: [orga]), (other co-morbid conditions: [dsyn]), (other factors: []), (difficulties: [fndg]), (specific language impairment: [dsyn]), (nevertheless: []), (explanation: []), (asd (p<0.001): [cgab]), (exploration: [topp]), (putative genetic causal factors: [fndg]), (variants: []), (cntnap2 gene: [gngm]), (pattern: []), (associations: [menp]), (alternative predictive model: []), (asd: [cgab]), (coherence subscale: [fndg]), (children's communication checklist: [aggp]), (communication disorders checklist (91: [mobd]), (repetitive behaviour (69 m): [fndg]), (sociability subscale: [socb]), (emotionality activity: [acty]), (sociability measure (38 m): [qnco]), (combined explanations: []), (similar (r2 =: [neop]), (conclusions: []), (significance: [qnco]), (results: [fndg]), (fractional nature: [qnco]), (different aetiological origins: []), (pleiotropic genetic effects: [gngm]), (observed: []), 
ASD Terms: (autism, 'Autism Phenotype')(atypical behaviour, 'Personal Traits')(autism phenotype, 'Autism Phenotype')(repetitive behaviours, 'Restricted and Repetitive Behavior')(autistic spectrum disorder, 'Autistic Disorder')(social understanding, 'Ability to Converse in Social Settings')(specific language impairment, 'Language Ability')(repetitive behaviour, 'Restricted and Repetitive Behavior')

PMCID: 2932694
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (common heritable neurodevelopmental disorder: [mobd]), (complex etiology: [chvs]), (several genome-wide linkage: [gngm]), (association scans: [menp]), (regions: []), (genes: [gngm]), (autism spectrum disorders: [mobd]), (mixed results: [fndg]), (overlap: [topp]), (autism features: [mobd]), (genetic abnormalities: [fndg]), (possible reason: []), (lack: []), (consistency: [qnco]), (influence: []), (parent-of-origin effects: []), (ability: [orga]), (linkage: [moft]), (association: [menp]), (methods: []), (findings: [clna]), (genome-wide linkage: [gngm]), (accounts: [clna]), (potential parent-of-origin effects: []), (snps: [nusq]), (families: [famg]), (autism genetic resource exchange (agre): [mobd]), (national institute: [orgt]), (mental health (nimh) autism repository: [hcro]), (parametric (gh: [aapp,horm]), ( genehunter): []), (allele-sharing linkage (aspex) results: [gngm]), (broad spectrum disorder case definition: [qnco]), (significant linkage: [moft]), (chromosomes: [celc]), ((lodgh: []), (empirical p<0.005: [fndg]), (lodaspex =: []), (p: [gngm]), (empirical p: []), (sites: []), (development: [orgf]), (offer: []), (fruitful domains: []), (molecular investigation: [hlca]), (role: [socb]), (epigenetic mechanisms: [genf]), 
ASD Terms: (common heritable neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(autism features, 'Autism Phenotype')(mental health autism repository, 'Autism Phenotype')(autism genetic resource exchange, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2923607
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (environmental risk factors: []), (autistic spectrum disorders: [mobd]), (social interaction: [fndg]), ( communication: [socb]), ( emotion processing: [menp]), ( sensorimotor gating: [phsf]), (executive function: [menp]), (both: []), (stimulating debate: [npop]), (conditions: [dsyn]), (brain imaging studies: [bpoc]), (resource: []), (brain: [bpoc]), (structural phenotype: [orga]), (disorders: [dsyn]), (datasets: []), (asd: [cgab]), (schizophrenia: [mobd]), (common framework: [qnco]), (structural similarities: []), (novel modification: []), (anatomical likelihood estimation: [qnco]), (foci: []), (voxel-based studies: [lbpr]), (participants: [popg]), ((308 asd: [cgab]), (first-episode schizophrenia): [mobd]), (controls: [sbst]), (results: [fndg]), (grey matter volumes: [tisu]), (limbic-striato-thalamic circuitry: [bpoc]), (unique features: []), (disorder: [dsyn]), (grey matter volume: [tisu]), (amygdala: [bpoc]), ( caudate: []), ( frontal: []), (medial gyrus: []), (putamen: [bpoc]), (autism: [mobd]), (thus: []), (terms: [orgf]), (brain volumetrics: [bpoc]), ( asd: [cgab]), (clear degree: [qnco]), (overlap: [topp]), (etiological mechanisms: []), (however: []), (distinctive neuroanatomy: []), (condition: [dsyn]), (question: []), (context: [fndg]), (common etiological pressures: [phpr]), 
ASD Terms: (autistic spectrum disorders, 'Autistic Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(social interaction, 'Reciprocal Social Interaction')(executive function, 'Executive Function')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')

PMCID: 2947401
SFARI Genes: MACROD2, MACROD2, ST8SIA2, TAF1C, ST8SIA2, TAF1C, 
Non SFARI Genes: PLD5, POU6F2, 
Named Entities: (autism spectrum disorders: [mobd]), (substantial genetic basis: [phsu]), (genetic risk: [qnco]), (variants: []), (copy number variants: [nusq]), (common risk: [qnco]), (autism genome project (agp) consortium: [mobd]), (asd families: [cgab]), (single-nucleotide polymorphisms (snps): [nusq]), (snp genotypes: [nusq]), (association: [menp]), (asd: [cgab]), (primary association: [menp]), (association signal: [menp]), (marker rs4141463: [clna]), (macrod2: [gngm]), (genome-wide association significance threshold: [menp]), (p <: [aapp,imft]), (replication sample: [genf]), (risk allele: [gngm]), (rs4141463: []), (over-transmitted; yet: [patf]), ( consistent: []), (winner's: []), (effect size: [qnco]), (much smaller; and: [qnco]), (combined samples: [sbst]), (threshold: []), (exploratory analyses: [resa]), (phenotypic subtypes: [orga]), (significant associations: [menp]), (correction: []), (multiple testing: [qnco]), (however: []), ( yield: []), (strong signals: [phpr]), (several genes: [famg]), ( kiaa0564: []), ( pld5: [gngm]), ( pou6f2: [gngm]), ( st8sia2: [aapp,enzy]), (taf1c: [gngm]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism genome project consortium, 'Autism Phenotype')

PMCID: 2921070
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (traditionally: []), (autistic spectrum disorder (asd): [mobd]), (specific language impairment (sli): [dsyn]), (distinct conditions: [dsyn]), (separate etiologies: []), (disorders: [dsyn]), (chance levels: []), (etiology: []), (simulations: [resa]), ( however: []), ( show: [anim]), (additive pleiotropic genes: [gngm]), (account: [clna]), (observed rates: [qnco]), (language impairment: [mobd]), (relatives: [famg]), (probands: [orga]), (sli: [gngm]), (asd + language impairment: [mobd]), (alternative account: [clna]), (terms: [orgf]), (phenomimicry: []), (i.e.: [diap,inpr]), ( language impairment: [mobd]), (comorbid cases: [qnco]), (consequence: []), (asd risk factors: [qnco]), (however: []), (cannot: []), (molecular genetic studies: [lbpr]), (common risk genotype: [orga]), (asd: [cgab]), (paper: []), (nonadditive genetic influences: [topp]), (family: [famg]), (molecular findings: [clna]), (modified simulation: [resa]), (g  g interactions: [qnco]), (levels: []), (comorbidity: []), (rates: [qnco]), (impairment: [patf]), (observed values: []), (shape: []), (distributions: []), (phenotypic trait scores: [orga]), (different genotypes: [orga]), (evidence: []), (gene: [gngm]), (epistasis: [fndg]), 
ASD Terms: (autistic spectrum disorder, 'Autistic Disorder')(specific language impairment, 'Language Ability')(language impairment, 'Language Ability')(specific language impairment, 'Language Ability')(asd + language impairment, 'Language Ability')(comorbid cases, 'Comorbidities')(language impairment, 'Language Ability')(language impairment, 'Language Ability')(comorbidity, 'Comorbidities')

PMCID: 2892398
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prevalence: [qnco]), (autism spectrum disorders (asd): [mobd]), (years: []), (whether asd: [cgab]), (burden: []), (human: [humn]), (economic terms: [orgf]), (autism: [mobd]), (mental disorders: [mobd]), (pathogenesis: [patf]), (environmental factors: []), (proposed; however: []), ( none: []), (furthermore: []), (biomarkers: [clna]), (asd: [cgab]), (risk: []), (autism birth cohort (abc): [mobd]), (gene  environment  timing interactions: [genf]), (early diagnosis: [diap]), (large: [gngm]), (unselected birth cohort wherein cases: [qnco]), (population screening: [popg]), (samples: [sbst]), (pregnancy: [orgf]), (childhood: []), (parental blood: [bdsu]), ( maternal urine: [bdsu]), ( cord blood: [tisu]), ( milk teeth: [bpoc]), (rectal swabs: [bdsu]), (children: [aggp]), (national registry: [popg]), (cases: [qnco]), (control group: [grup]), (same cohort: [popg]), (nested case-control design: [acty]), (early screening: [diap]), (diagnostic assessments: [diap]), (re-assessments: [hlca]), (rich view: []), (longitudinal trajectory: []), (genetic: [topp]), ( proteomic: []), ( immunologic: []), ( metagenomic: []), (microbiological tools: []), (unique biological samples: []), (abc: [dsyn]), (paradigm: [resa]), (role: [socb]), (complex disorders: [dsyn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(mental disorders, 'Mental Disorders')(autism birth cohort, 'Autism Phenotype')(early diagnosis, 'Diagnosis')

PMCID: 3005119
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (morphological features: []), (large group: [grpa]), (children: [aggp]), (autism spectrum disorder: [mobd]), (normal controls: []), (patients: [podg]), (controls: [sbst]), (pairs: []), (created: [acty]), (prevalence rates: [qnco]), (odds ratios: [qnco]), (conditional regression analysis: []), ( mcnemar test: [lbpr]), (t-test matched pairs: [resa]), (morphological abnormalities: [anab]), (autism: [mobd]), (normal control group: [grup]), (findings: [clna]), (potential underlying genetic mechanisms: [topp]), (association: [menp]), (understanding: [menp]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-010-1018-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder versus, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2866544
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (neuronal calcium: [bacs,elii,phsu]), (sensor-1 (ncs-1): [gngm]), (ca2+ sensor protein: [aapp,bacs]), (regulation: [biof]), (various aspects: [qnco]), (neuronal development: [celf]), (neurotransmission: [celf]), (effects: []), (interactions: []), (range: [qnco]), (target: [diap]), (interleukin receptor: [aapp,imft,rcpt]), (accessory protein like-1 (il1rapl1) protein: [aapp,rcpt]), (mutations: [genf]), (il1rapl1: [gngm]), (autism spectrum disorders: [mobd]), (missense mutation (r102q): [genf]), (ncs-1: [gngm]), (individual: [humn]), (autism: [mobd]), (effect: []), (mutation: [genf]), (structure: []), (function: [phsf]), (use: []), (nmr: [gngm]), (r102q: []), (protein: [aapp,bacs]), (increase: []), (extent: []), (conformational exchange: [clna]), (c-terminus: []), (change ncs-1(r102q): [gngm]), (changes: [qnco]), (affinity: [npop]), (ca2+: [elii,phsu]), (intracellular localisation: [celf]), (assessment: [acty]), (ncs-1 dynamics: [npop]), (cycle: []), (membrane pools: [celc]), (cycling: []), (plasma membrane: [celc]), (ncs-1(r102q): [gngm]), (loss: [qnco]), (ca2+ -dependent component: [elii,phsu]), (data: [euka]), (impairment: [patf]), (normal cycling: [fndg]), (r102q mutation: [genf]), (subtle effects: [clna]), (neuronal signalling: [biof]), (physiology: [phsf]), (developing: []), (adult brain: [bpoc]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 2898030
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (aim: [phsu]), (pilot study: [resa]), (autistic children: [podg]), ( siblings: [famg]), (parents: []), (biometric device: [resa]), (gas discharge visualization (gdv) technique: [hlca]), (order: [acty]), (physiological functional state: []), (activity: [acty]), (autonomic nervous system: [bdsy]), (hypothesis:: []), (biometric assessment: [resa]), (gdv: []), (us: (1): [fndg]), (specific features: []), (autism spectrum disorder (asd): [mobd]), (siblings: [famg]), ((2): [qnco]), (differences: [qnco]), (individual values: [humn]), (normal children: [aggp]), (results: out: [fndg]), (total: [qnco]), (acupuncture points: [topp]), (ten fingertips: [dsyn]), (hands: [bpoc]), (systems: []), ( autistic children: [podg]), (controls (p: [aapp,imft]), ((images: []), (filter): []), ((p: [aapp,imft]), ( fathers: [famg]), (controls: [sbst]), (mothers: [famg]), (filter) acupuncture points: [topp]), (conclusions: all: []), (groups: [popg]), (significant difference: [qnco]), (psycho-emotional (images: [menp]), (physiological (images: []), (filter) levels: []), (however: []), (psycho-emotional level: [menp]), (other groups: [popg]), (sympathetic autonomic: [bdsy]), (nervous system: [bdsy]), (children: [aggp]), (autism: [mobd]), (biometric method: [resa]), (promising step: [qnco]), (autism research: [mobd]), (towards: []), (disease profile: [dsyn]), (unique signature/biomarker: [amas]), (further work: []), (participants: [popg]), (findings: [clna]), 
ASD Terms: (gas discharge visualization technique, 'Visual Thinking')(gas discharge visualization, 'Visual Thinking')(autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism research, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3001124
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (research: [resa]), (mutations: [genf]), (gene: [gngm]), (neurexin-1 (nrxn1): [gngm]), (variety: []), (conditions: [dsyn]), (autism: [mobd]), ( schizophrenia: [mobd]), (nicotine dependence: [mobd]), (knowledge: []), (reports: [hlca]), (breadth: []), (phenotype: [orga]), (nrxn1: [gngm]), (medical record review: [hlca]), (subjects: [humn]), (deletions: [genf]), (exonic sequences: [bacs,nnon]), (cases: [qnco]), (individuals: [humn]), (comparative genomic hybridization: [mbrt]), (march: []), (january: []), (twelve subjects: [humn]), (exonic deletions: [bacs,nnon]), (nrxn1 deletion: [genf]), (autism spectrum disorders: [mobd]), (mental retardation: [mobd]), ( language delays: [lang]), (hypotonia: [fndg]), (significant increase: [qnco]), (clinical sample: [sbst]), (populations: [popg]), (literature (p: [inpr,mnob]), (additional subjects: [humn]), (nrxn1 deletions: [genf]), (homozygosity mapping collaborative: [socb]), (deletion: [genf]), (study: [resa]), (wide spectrum: [qnco]), (developmental disorders: [mobd]), (wiley-liss: [lbpr]), ( inc: []), 
ASD Terms: (autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(medical record review, 'Medications')(autism spectrum disorders, 'Autism Phenotype')(mental retardation, 'Mental Retardation')(language delays, 'Language Ability')(autism, 'Autism Phenotype')

PMCID: 2974190
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (casecontrol study: [resa]), (han children: [aggp]), (autism: [mobd]), (perinatal risk factors: [qnco]), (china: []), (cases: [qnco]), (public special education schools: [edac]), (controls: [sbst]), (regular public schools: [mnob,orgt]), (same region (tianjin): []), (frequency: [qnco]), (sex: [orgf]), (birth year: []), (analyses: [resa]), (adjusted analysis: [resa]), (risk factors: [qnco]), (significant association: [menp]), (autism: maternal second-hand smoke: [eehu]), (maternal chronic: [famg]), (medical conditions: [dsyn]), (maternal unhappy emotional state: [clna]), (gestational complications: [dsyn]), ( edema: [fndg]), (abnormal gestational age (<35: [orga]), (weeks): []), ( nuchal cord: [fndg]), ( gravidity >1: [fndg]), (paternal age: []), (delivery: [topp]), (year-old): []), 
ASD Terms: (autism, 'Autism Phenotype')(perinatal risk factors, 'Perinatal Exposures')(autism, 'Autism Phenotype')(maternal second-hand smoke, 'Smoking')(delivery, 'Perinatal History')(maternal second-hand smoke, 'Smoking')(medical conditions, 'Medications')(maternal unhappy emotional state, 'Depression')(gestational complications, 'Perinatal History')(abnormal gestational age, 'Perinatal History')

PMCID: 2848579
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (number: [qnco]), (studies: [lbpr]), (ages: [bacs,orch]), (parents: []), (children: [aggp]), (autistic spectrum disorders: [mobd]), (paternal age effects: [fndg]), (relationships: []), (grandparental ages: [famg]), (methods: []), (findings: [clna]), (parental: []), (population-based avon longitudinal study: [resa]), (children (alspac): [aggp]), (scores: [clna]), (regard: []), (autistic trait measures: [mobd]), (diagnosis: [fndg]), (asd: [cgab]), (mean maternal: [famg]), (paternal ages: []), (asd cases: [cgab]), (maternal grandmother age effect (p: [aapp,imft]), (or: []), (10-year increase: [fndg]), (grandmother's age: [famg]), (birth: [orgf]), (mother: [famg]), (trait measures: [qnco]), (association: [menp]), (maternal grandmother's age: [orga]), (major autistic traitthe coherence scale (regression coefficient b: [mobd]), ([95%ci: [lbpr]), (=: []), (confounders: []), (effect size: [qnco]), (year increase: []), (age: [orga]), (relationship: []), (major autistic trait: [mobd]), (biological plausibility: []), (maternal side: [famg]), (least: [qnco]), (timing: []), (female meiosis: [celf]), (direct effects: []), (grandchild's genome: [gngm]), (grandmother's pregnancy: [orgf]), (alternative explanation: []), (meiotic mismatch methylation (3 m) hypothesis: [phsu]), (first time: [qnco]), (hypothesis: []), (corroborative results: [fndg]), (other studies: [lbpr]), 
ASD Terms: (autistic spectrum disorders, 'Autistic Disorder')(diagnosis, 'Diagnosis')(year increase in age, 'Onset of Symptoms')

PMCID: 2847695
SFARI Genes: MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, 
Non SFARI Genes: 
Named Entities: (methyl cpg: [bacs,nnon]), (protein-2 (mecp2): [aapp,bacs]), (essential epigenetic regulator: []), (human brain development: [ortf]), (rett: []), (primary disorder: [dsyn]), (mutations: [genf]), (x-linked mecp2 gene: [gngm]), (period: []), (cognitive decline: [mobd]), (development: [orgf]), (hand stereotypies: [bpoc]), (seizures: [sosy]), (normal early infancy: [fndg]), (addition: []), ( mecp2 mutations: [aapp,bacs]), (duplications: []), (spectrum: [qnco]), (neurodevelopmental disorders: [mobd]), (severe neonatal encephalopathy: [dsyn]), ( x-linked mental retardation: [dsyn]), (autism: [mobd]), (mecp2: [gngm]), (essential regulator: []), (postnatal brain development: [bpoc]), (review: []), (mutation types: [genf]), (inheritance patterns: [genf]), (human disorders: [humn]), (current understanding: [menp]), (central epigenetic regulator: [lbpr]), (activity-dependent synaptic maturation: [ortf]), (central role: [socb]), (pathogenesis: [patf]), (multiple neurodevelopmental disorders: [mobd]), (investigation: [hlca]), (mecp2 function: [aapp,bacs]), (regulatory pathways: []), (promise: []), (broad-spectrum therapies: [topp]), 
ASD Terms: (cognitive decline, 'Cognitive Ability')(rett, 'Rett Syndrome')(normal early infancy, 'Perinatal History')(neurodevelopmental disorders, 'Learning Disorders')(x-linked mental retardation, 'Mental Retardation')(autism, 'Autism Phenotype')(multiple neurodevelopmental disorders, 'Learning Disorders')

PMCID: 2838793
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (united: []), (autism spectrum disorders: [mobd]), (causes: []), (treatments: [topp]), (mice: [mamm]), (deletion: [genf]), (fragile x: [comd]), (mental retardation: [mobd]), ((fmr1) gene: [gngm]), (autism: [mobd]), (loss: [qnco]), (fmr1 gene function causes fragile x syndrome (fxs): [cgab,dsyn]), (many people: [popg]), (fxs exhibit: []), (autistic-like behaviors: [mobd]), (glycogen: [bacs,orch]), (kinase-3 (gsk3): [aapp,enzy]), (brains: [bpoc]), (fmr1 knockout mice: [mamm]), (inhibition: [acty]), (gsk3: [aapp,enzy]), (lithium administration: [elii,phsu]), (behavioral impairment: [inbe]), (studies: [lbpr]), (association: [menp]), (behaviors: [inbe]), (mouse models: [mamm]), (disrupted regulation: [biof]), ( fmr1 knockout mice: [mamm]), (gsk3 knockin mice: [mamm]), (inhibitory serines: [aapp,bacs,phsu]), (isoforms: [aapp]), ( gsk3: [aapp,enzy]), (methodology/principal findings: [clna]), (sociability: [socb]), ( test mice: [mamm]), (restrained stimulus mouse (s1): [mamm]), (min: [neop]), (introduction: [hlca]), (second restrained stimulus mouse (s2): [mamm]), (social preference: []), (fmr1 knockout: [emod]), (deficit: [dsyn]), (s1 mouse: [mamm]), (wild-type mice: [mamm]), (novel s2 mouse: [mamm]), (anxiety-related behaviors: [mobd]), (social interaction (grooming: [inbe]), ( rearing: []), (digging): [neop]), (chronic lithium treatment: [elii,phsu]), (conclusions/significance: [qnco]), (results: [fndg]), (impaired inhibitory regulation: [acty]), (fmr1: [gngm]), (socialization deficits: [edac]), (lithium treatment: [elii,phsu]), (certain socialization impairments: [edac]), (present work: [qnco]), (role: [socb]), (social behaviors: [socb]), (implicate inhibition: [acty]), (potential therapeutic: [topp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(model autism, 'Autism Phenotype')(fragile x syndrome exhibit, 'Fragile X Syndrome')(fragile x, 'Fragile X Syndrome')(mental retardation, 'Mental Retardation')(gene function causes fragile x syndrome, 'Fragile X Syndrome')(mental retardation, 'Mental Retardation')(behavioral impairment, 'Personal Traits')(socialization behaviors, 'Reciprocal Social Interaction')(mental retardation, 'Mental Retardation')(social interaction, 'Reciprocal Social Interaction')(socialization deficits, 'Social Competence')(certain socialization impairments, 'Social Competence')(social behaviors, 'Reciprocal Social Interaction')

PMCID: 2869041
SFARI Genes: cut, cut, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (broad spectrum: [qnco]), (clinical manifestations: []), (qualitative impairments: [patf]), (social interactions: [fndg]), (communication: [socb]), (patterns: []), (behavior: [inbe]), (abnormal acceleration: [phpr]), (brain growth: [orgf]), (early childhood: []), ( signs: [fndg]), (growth: [orgf]), (neurons: [cell]), (minicolumn: []), (developmental abnormalities: [cgab]), (multiregional alterations: []), (aim: [phsu]), (study: [resa]), (focal qualitative developmental defects: [acab]), (brain regions: [blor]), (developmental alterations: [orgf]), (formalin-fixed brain hemispheres: [hops,orch,phsu]), (years: []), (age): [orga]), (age-matched control subjects: [humn]), (celloidin: [bodm,phsu]), (200-m-thick coronal sections: [qnco]), (cresyl violet: [irda,orch]), (neuropathological evaluation: [hlca]), (thickening: [fndg]), (subependymal cell layer: [bird]), (brains: [bpoc]), (subependymal nodular dysplasia: [patf]), (brain: [bpoc]), (active neurogenesis: [orgf]), (autistic children: [podg]), (subcortical: [blor]), ( periventricular: []), ( hippocampal: [bpoc]), (cerebellar heterotopias: [fndg]), (autistic subjects: [mobd]), (abnormal neuronal migration: [cgab,dsyn]), (multifocal cerebral dysplasia: [comd]), (local distortion: [anab]), (cytoarchitecture: []), (neocortex: [bpoc]), (entorhinal cortex: [bpoc]), (cornu ammonis: [bpoc]), (dentate gyrus: [bpoc]), (cerebellar flocculonodular dysplasia: [fndg]), (subjects: [humn]), ((46%): []), ( focal dysplasia: [comd]), (vermis: [bpoc]), (case: []), (hypoplasia: [patf]), (local failure: [inbe]), (cerebellar development: [ortf]), (detection: [topp]), (flocculonodular dysplasia: [patf]), (control: [sbst]), (focal qualitative neuropathological developmental changes: [orgf]), (examined brains: [bpoc]), (multiregional dysregulation: []), (neurogenesis: [orgf]), ( neuronal migration: [gngm]), (maturation: [phsf]), (heterogeneity: [orga]), (clinical phenotype: [orga]), 
ASD Terms: (social interactions, 'Reciprocal Social Interaction')(stereotyped patterns of behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')(developmental abnormalities, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2826417
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (high rates: [qnco]), (genomic aberrations: [gngm]), (chromosomal rearrangements: [comd]), (copy-number variations: [nusq]), (observations: [hlca]), (cancer: [euka]), (disease: [dsyn]), (genomic rearrangements: [gngm]), (role: [socb]), (correlative epidemiological study: [resa]), (possibility: []), (risk factors: [qnco]), (specific types: []), (methodology/principal findings: [clna]), (significant correlations: [qnco]), (prevalence: [qnco]), (incidence: [qnco]), (state-wide data: [euka]), (age: [orga]), (gender: [orga]), (united states: []), (autism data: [mobd]), (u.s. department: [orgt]), (education: [fndg]), (individuals: [humn]), (disabilities education act (idea) (20002007: [topp]), (age group): [aggp]), (cancer incidence data: [qnco]), (disease control: [topp]), (prevention (cdc) (19992005): [hcro]), (idea data: [euka]), (method: [lbpr]), (autism (dsm iv: [mobd]), (code: []), (federal regulations: []), (criteria): []), (spearman rank correlations: []), (possible pairwise combinations: [phsu]), (annual autism rates: [mobd]), (specific cancers: [euka]), (this: []), ( bonferroni's correction: []), (values: []), (independent methods: [fndg]), (p-value: [qnco]), (dependent correlations: []), (set: [menp]), (calculations: [acty]), (high correlations: [qnco]), (autism rates: [mobd]), (situ breast cancer (p1010: [neop]), (inverse chi square: [qnco]), (data: [euka]), (states: []), (contrast: [irda]), ( few significant correlations: [qnco]), (autism prevalence: [qnco]), (other female: [orga]), (male cancers: [orga]), (findings: [clna]), (association: [menp]), (specific forms: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism data, 'Autism Phenotype')(diagnose autism, 'Autism Phenotype')(annual autism rates, 'Autism Phenotype')(autism rates, 'Autism Phenotype')(autism prevalence, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2839489
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (attention-deficit/hyperactivity disorder (adhd): [mobd]), (autism spectrum disorder (asd): [mobd]), (heritable neurodevelopmental disorders: [mobd]), (evidence: []), (disorders: [dsyn]), (high frequency: []), (children: [aggp]), (adhd meeting criteria: [mobd]), (asd: [cgab]), (asd children: [cgab]), (criteria: []), (adhd: [mobd]), (review: []), (overview: []), (available studies: [lbpr]), (twin: [famg]), ( candidate gene: [gngm]), ( linkage: [moft]), (wide association (gwa) studies]: [mbrt]), (light: [gngm]), (role: [socb]), (genetic underpinnings: [topp]), (family: [famg]), (twin studies: [famg]), (support: []), (hypothesis: []), (similar familial/genetic factors: [fndg]), (few candidate gene: [gngm]), (studies: [lbpr]), ( linkage studies: [moft]), (gwa studies: [mbrt]), (co-occurrence: []), ( pinpointing: [fndg]), (promising pleiotropic genes: [gngm]), ( loci: [gngm]), (single nucleotide polymorphisms (snps): [nusq]), (research field: [resa]), (urgent need: [topp]), (complex issue: [fndg]), (future studies: [lbpr]), (familial etiological factors: [famg]), (family-based design: [famg]), (same phenotypic (adhd: [mobd]), (asd): [cgab]), (endophenotypic: []), (environmental measurements: []), (family members: [famg]), (multivariate multi-level models: [phsu]), (statistical analysis: [resa]), 
ASD Terms: (attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism spectrum disorder, 'Autism Phenotype')(heritable neurodevelopmental disorders, 'Learning Disorders')(attention-deficit/hyperactivity disorder meeting criteria, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 2815936
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent genetic studies: [resa]), (view: []), (current approaches: [npop]), (diagnosis: [fndg]), (classification: []), (major psychiatric illness: [mobd]), (findings: [clna]), (distinction: []), (schizophrenia: [mobd]), (bipolar disorder: [mobd]), (attention: [menp]), (relationship: []), (functional psychoses: [mobd]), (neurodevelopmental disorders: [mobd]), (autism: [mobd]), (transitional period: []), (several years: [qnco]), (psychiatry: []), (traditional descriptive diagnoses: [fndg]), (clinical entities: []), (dimensions): [qnco]), (underlying workings: []), (brain: [bpoc]), 
ASD Terms: (diagnosis, 'Diagnosis')(major psychiatric illness, 'Mental Disorders')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(bipolar disorder, 'Bipolar Disorder')(neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')

PMCID: 2797846
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (separate genome-wide association studies: [mbrt]), (single nucleotide polymorphisms (snps): [nusq]), (nonsocial autistic-like traits: [mobd]), (snps: [nusq]), (non-social autistic-like traits: [mobd]), (different snps: [nusq]), (stage: [clna]), (study: [resa]), (allele frequency differences: [qnco]), (autosomal snps: [nusq]), (dna: [bacs,nnon]), (microarrays: []), (high-scoring versus: [qnco]), (low-scoring boys: [aggp]), (general population sample (n = ~400/group): [popg]), (non-social studies: []), ( respectively: []), (qtl association: [gngm]), (independent community sample: [sbst]), (boys: [aggp]), (snp (rs11894053): [nusq]), ((p < .05: [aapp,imft]), (multiple testing): [qnco]), (social autistic-like traits: [mobd]), (sample: [sbst]), (additional snps: [nusq]), (significant (p < .05): [qnco]), ( however: []), (significant association: [menp]), (transmission disequilibrium analyses: [dsyn]), (diagnosed asd families: [cgab]), 
ASD Terms: 

PMCID: 3428055
SFARI Genes: GABRB3, GABRB3, 
Non SFARI Genes: 
Named Entities: (maternal 15q11-q13 duplication: [comd]), (common copy number variant: [nusq]), (autism: [mobd]), ( accounting: []), (1-3%: [fndg]), (cases: [qnco]), (15q11-q13 region: [celc]), (epigenetic regulation: [biof]), (genomic copy number losses: [gngm]), (gains: [qnco]), (genomic disorders: [dsyn]), (parent-of-origin-specific manner: []), (15q11-q13 locus: [gngm]), (gabaa receptor 3 subunit gene (gabrb3): [aapp,rcpt]), (several studies: [lbpr]), (absence epilepsy: [dsyn]), (co-morbidity: []), (epilepsy: [dsyn]), (maternal transmission: [patf]), (gabrb3: [gngm]), (signal peptide variant (p11s): [amas]), (childhood absence epilepsy: [dsyn]), (analysis: [resa]), (mutant 3 subunit-containing 132 gabaa receptors: [aapp,rcpt]), (reduced whole cell: [cell]), (decreased 3 subunit protein: [aapp]), (cell surface: [celc]), (impaired intracellular 3 subunit processing: [celc]), (first evidence: [qnco]), (association: [menp]), (specific gabaa receptor defect: [aapp,rcpt]), (direct evidence: []), (synaptic dysfunction: [dsyn]), (first maternal risk effect: [qnco]), (15q11-q13 autism duplication region: [mobd]), (coding variant: []), 
ASD Terms: (autism, 'Autism Phenotype')(epilepsy, 'Epilepsy')(absence epilepsy, 'Epilepsy')(childhood absence epilepsy, 'Epilepsy')(15q11-q13 autism duplication region, 'Autism Phenotype')

PMCID: 3006666
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (gene expression: [genf]), (blood: [bdsu]), (mercury levels: [lbtr]), (5-year-old boys: [aggp]), (autism (au): [mobd]), ((td) control boys: [aggp]), (possibility: []), (groups: [popg]), (toxicants: [hops]), (mercury: [elii,hops]), (rna: [nnon]), (whole genome affymetrix human u133 expression microarrays: [gngm]), (plasma mass spectrometer: [bdsu]), (analysis: [resa]), (covariance (ancova): [qnco]), (partial correlations: [qnco]), (age: [orga]), (batch effects: [qnco]), (false positives: [lbtr]), (genes: [gngm]), (ancova models: [qnco]), (au: [gngm]), (td: []), (expression: [topp]), (large number: [qnco]), (genes (n: [gngm]), (au boys (p: [aapp,imft]), (represented biological functions: [biof]), (cell death: [celf]), (cell morphology: [clna]), (td boys (p: [aapp,imft]), ( amino acid metabolism: [moft]), (antigen presentation: [celf]), (data: [euka]), (companion study: [anim]), (correlation: []), (lead levels: [lbtr]), (td children: [aggp]), (different correlations: []), (transcript levels: [nnon]), (low levels: [qnco]), (lead: [elii,hops]), (findings: [clna]), (different genetic transcriptional programs: [genf]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s12640-009-9137-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')(autism boys, 'Autism Phenotype')(autism, 'Autism Phenotype')(antigen presentation, 'Allergies')(autism, 'Autism Phenotype')

PMCID: 3006638
SFARI Genes: 
Non SFARI Genes: CD74, 
Named Entities: (objective: []), (study: [resa]), (correlation: []), (gene expression: [genf]), (lead (pb) levels: [elii,hops]), (blood: [bdsu]), (children: [aggp]), (autism (au: [mobd]), (controls (td: [sbst]), (lead levels: [lbtr]), (groups: [popg]), ( au children: [aggp]), (lead: [elii,hops]), (td children: [aggp]), (rna: [nnon]), (affymetrix microarrays: []), (separate analyses: [resa]), (covariance (ancova): [qnco]), (age: [orga]), (gender: [orga]), (td: []), ( au: []), (subjects: [humn]), (td): []), (false positives: [lbtr]), (genes: [gngm]), (ancovas: []), (considered: []), (probe sets: [menp]), (au: [gngm]), (td subjects: [humn]), (log2 pb): [gngm]), (inflammatory processes: [phpr]), (mhc class ii family members: [gngm]), (cd74: [gngm]), (large number (n =: [aapp,imft]), ((p: [aapp,imft]), (au subjects;: [humn]), (many probe sets: [menp]), (similar manner: []), (td groups: [popg]), (data: [euka]), (different associations: [menp]), (transcript levels: [nnon]), (low levels: [qnco]), (underlying genetic differences: [comd]), (other explanations: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s12640-009-9126-x) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')

PMCID: 2774338
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (spectrum: [qnco]), (cognitive disturbances: [fndg]), (childhood development: [orgf]), (numerous approaches: [qnco]), (genes: [gngm]), (development: [orgf]), (autism cases: [mobd]), (single gene disorders: [fndg]), (use: []), (high-resolution: [lbpr]), (genome-wide tilepath microarrays: [gngm]), (comparative genomic hybridization: [mbrt]), (copy number variants: [nusq]), (probands: [orga]), (multiplex autism families: [famg]), (dna methylation analysis: [mbrt]), (bisulfite sequencing: [mbrt]), (proband: [famg]), (family: [famg]), (analysis: [resa]), (methylation analysis: [moft]), (peripheral blood: [bdsu]), (temporal cortex dna: [bpoc]), (controls: [sbst]), (independent datasets: [fndg]), (oxytocin receptor (oxtr) gene expression: [aapp,rcpt]), (temporal cortex tissue: [bpoc]), (quantitative real-time polymerase chain reaction (pcr): [mbrt]), (genomic deletion: [genf]), (oxytocin receptor gene: [aapp,rcpt]), ( oxtr (mim accession no: [gngm]), (autism proband: [mobd]), (mother: [famg]), (symptoms: [sosy]), (obsessive-compulsive disorder: [mobd]), (proband's: [famg]), (deletion: [genf]), (epigenetic misregulation: []), (gene: [gngm]), (aberrant gene silencing: [genf]), (dna methylation: [moft]), (cpg island: [bacs,nnon]), (oxtr expression: [topp]), (several cpg dinucleotides: [bacs,nnon]), (significant increases: [qnco]), (dna methylation status: [moft]), (peripheral blood cells: [cell]), (temporal cortex: [bpoc]), (individuals: [humn]), (samples: [sbst]), (increase: []), (methylation: [moft]), (cpg dinucleotides: [bacs,nnon]), (oxtr mrna: [bacs,nnon]), (decreased expression: [topp]), (age: [orga]), (sex: [orgf]), (data: [euka]), (further evidence: []), (role: [socb]), (oxtr: [gngm]), (oxytocin: [aapp,horm,phsu]), (pathway: [moft]), (etiology: []), (autism and: [mobd]), (first time: [qnco]), (epigenetic regulation: [biof]), (disorder: [dsyn]), (related commentary: [fndg]), (gurrieri: []), (neri:: []), 
ASD Terms: (cognitive disturbances, 'Cognitive Ability')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism cases, 'Autism Phenotype')(multiplex autism families, 'Autism Phenotype')(autism cases, 'Autism Phenotype')(obsessive-compulsive disorder, 'Obsessive-Compulsive Disorder')(autism proband, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism cases, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism and, 'Autism Phenotype')

PMCID: 2770459
SFARI Genes: OXTR, OXTR, OXTR, OXTR, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (group: [popg]), (conditions: [dsyn]), (neurobehavioral impairment: [patf]), (children: [aggp]), (clinical presentation: []), (etiology: []), (major role: [socb]), (genetic factors: [fndg]), (number: [qnco]), (genetic studies: [resa]), (identification: [menp]), (genes and/or: [gngm]), (number variants: [qnco]), (alterations: []), (autism: [mobd]), (specific factor: []), (substantial proportion: [qnco]), (cases: [qnco]), (epigenetic modifications: [genf]), (role: [socb]), (occurrence: []), (genetic conditions: [dsyn]), (mutations: [genf]), (imprinted genes: [gngm]), (regions: []), (article: []), (gregory: []), (al: [lbpr]), (month: []), (bmc medicine: [hops,orch,phsu]), ( reports: [hlca]), (epigenetic alterations: []), (oxtr: [gngm]), (gene: [gngm]), (receptor: [aapp,rcpt]), (oxytocin: [aapp,horm,phsu]), (involvement: []), (deletion: [genf]), (autistic patient: [mobd]), (subsequent analysis: [resa]), (unrelated autistic subjects: [mobd]), (oxtr deletion: [genf]), (hypermethylation: [genf]), (gene promoter: [bacs,nnon]), (reduced mrna expression: [genf]), (findings: [clna]), (major points: [qnco]), (current debate: [acty]), (pathogenesis: [patf]), (human behavior: [inbe]), (possible involvement: []), (epigenetic mechanisms: [genf]), (nature: []), (epigenetic dysregulation: []), (unknown but: []), (failure: [inbe]), (sequence alterations: [genf]), (host: [orgm]), (candidate genes: [gngm]), (practical implications: []), (extension: []), (validation: [resa]), (scale: [acty]), (value: [qnco]), (research paper: [resa]), (al:: [lbpr]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(neurobehavioral impairment, 'Central Nervous System Diseases')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2831962
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (authors: []), (blood mercury (hg) levels: [elii,hops]), (persons: [popg]), (unaffected controls: [sbst]), (blood: [bdsu]), (total hg concentrations: [elii,hops]), (children: [aggp]), (autism: [mobd]), (spectrum disorder (au/asd): [cgab]), ((td) controls: [sbst]), (population-based samples: [popg]), (role: [socb]), (fish consumption: [fish]), (differences: [qnco]), (childhood autism risk: [mobd]), (genetics: []), (environment (charge) study: [orga]), (years: []), (age: [orga]), (diagnostic evaluation: [diap]), (groups: au/asd: [cgab]), ( non-au/asd: [cgab]), (developmental delay (dd): [mobd]), (population-based td controls: [popg]), (mothers: [famg]), (household: [famg]), ( medical: [hlca]), (dietary exposures: [phpr]), (blood hg: [bdsu]), (plasma mass spectrometry: [bdsu]), (multiple linear regression analysis: [qnco]), ((n: [aapp,imft]), (diagnostic status: [fndg]), (hg sources: [elii,hops]), (total hg concentration: [menp]), (au/asd children: [cgab]), (adjustment: [inbe]), (fish: [gngm]), (other hg sources: [elii,hops]), ( blood hg levels: [bdsu]), (td children: [aggp]), (non-fish eaters: [fish]), (direct effect: []), (au/asd diagnosis: [cgab]), (indirect pathway: [moft]), (altered fish consumption: [fish]), (reduction: [npop]), (dd children: [aggp]), (blood hg concentrations: [elii,hops]), (analyses: [resa]), (dental amalgams: [bodm,inch]), (gum-chewing: [bodm]), (teeth-grinding habits: [inbe]), (levels: []), (other differences: [qnco]), (hg: [elii,hops]), (total hg: [elii,hops]), (charge study preschoolers: [aggp]), (au/asd: [cgab]), (representative samples: [sbst]), 
ASD Terms: (autism, 'Autism Phenotype')(childhood autism risk, 'Autism Phenotype')(years of age, 'Onset of Symptoms')(spectrum disorder with developmental delay, 'Learning Disorders')(autism, 'Autism Phenotype')(developmental delay, 'Learning Disorders')(medical, 'Medications')(dietary exposures, 'Exposures')(autism spectrum disorder children, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(spectrum disorder diagnosis, 'Diagnosis')(developmental delay children, 'Learning Disorders')(autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 2772655
SFARI Genes: met, met, SEMA5A, SEMA5A, 
Non SFARI Genes: 
Named Entities: (summary: []), (autism: [mobd]), (heritable neurodevelopmental disorder: [mobd]), ( attempts: [evnt]), (specific susceptibility genes: [gngm]), (limited success: [socb]), (genome-wide association studies: [mbrt]), (markers: [clna]), (large sample sizes: [sbst]), (meta-analysis: [resa]), (great success: [socb]), (genes: [gngm]), (other complex genetic traits (http://www.genome.gov/26525384): [gngm]), (consequently: []), (linkage: [moft]), (association mapping study: [menp]), (genome-wide snps: [nusq]), (common set: [menp]), (multiplex autism families: [famg]), (affected offspring): [famg]), (regions: []), (significant linkage: [moft]), (chromosomes: [celc]), (respectively: []), (initial analysis: [resa]), (genome-wide significant associations; however: [menp]), ( genotyping: [lbpr]), (top hits: [fndg]), (additional families: [famg]), (snp: [nusq]), (chromosome: [celc]), ((between sema5a: [gngm]), (tas2r1): [gngm]), (autism (p: [mobd]), (expression: [topp]), (sema5a: [gngm]), (brains: [bpoc]), (autistic patients: [mobd]), (autism susceptibility gene: [mobd]), (linkage regions: [moft]), (provide targets: [acty]), (rare variation: [gngm]), (discovery: [acty]), (single novel association: [fndg]), (action: [acty]), (common variants: [qnco]), 
ASD Terms: (autism, 'Autism Phenotype')(heritable neurodevelopmental disorder, 'Learning Disorders')(multiplex autism families, 'Autism Phenotype')(autism susceptibility gene, 'Autism Phenotype')

PMCID: 2761880
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (heritable complex neurodevelopmental disorder: [mobd]), (genetic basis: [phsu]), (challenging: [hlca]), (numerous susceptibility genes: [gngm]), (chromosomal abnormalities: [comd]), (association: [menp]), (discoveries: [acty]), (account: [clna]), (small effect: [qnco]), (thus: []), (cases: [qnco]), (causative genetic mechanisms: [topp]), (present work: [qnco]), (autism genetic database (agd): [mobd]), (literature-driven: [inpr,mnob]), ( web-based: []), (access database: []), (aim: [phsu]), (comprehensive repository: []), (genes: [gngm]), (genomic copy number variations: [nusq]), (order: [acty]), (assessment: [acty]), (autism susceptibility: [clna]), (genetic factors: [fndg]), (description agd: []), (relational database: [socb]), (data: [euka]), (exhaustive literature searches: [inpr,mnob]), (susceptibility genes: [gngm]), (cnvs: [nusq]), (furthermore: []), (genomic information: [gngm]), (human fragile sites: [humn]), (rnas: [nnon]), (mirbase: []), ( snorna-lbme-db: [bacs,nnon]), ( pirnabank: []), (mit/icbp sirna database: [bacs,nnon]), (web client genome browser: [gngm]), (features: []), (web client query tool: [grup]), (access: []), (specific information: []), (applicable: []), ( links: []), (external databases: []), (genbank: []), ( pubmed: []), (snorna-lbme-db: [bacs,nnon]), (mit sirna database: [bacs,nnon]), (provided: [acty]), (agd: []), (comprehensive list: []), (copy number variations: [nusq]), (to-date: [aapp,enzy]), (rna genes: [gngm]), (fragile sites: [nusq]), (inclusive autism: [mobd]), (genetic database: []), (evaluation: [hlca]), (autism susceptibility factors: [mobd]), (relation: [socb]), (human diseases: [humn]), (result: [fndg]), (new autism database: [mobd]), (valuable tool: []), (research community: [resa]), (genetic findings: [lbtr]), (complex multifactorial disorder: [dsyn]), (integrated format: [genf]), (genome browser: [gngm]), (web: []), (query client: [grup]), (interest: [menp]), 
ASD Terms: (autism, 'Autism Phenotype')(heritable complex neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism genetic database, 'Autism Phenotype')(autism susceptibility, 'Autism Phenotype')(description autism genetic database, 'Autism Phenotype')(autism susceptibility factors, 'Autism Phenotype')(inclusive autism, 'Autism Phenotype')(new autism database, 'Autism Phenotype')

PMCID: 2730532
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (number: [qnco]), (recombination events: [genf]), (meiosis varies: [celf]), (recombination phenotype differs: [genf]), (male: [orga]), (individuals: [humn]), (gender: [orga]), (study: [resa]), (high-density snp genotypes: [nusq]), (offspring: [famg]), (datasets: []), (recombination landscape: [genf]), (genetic variants: [npop]), (variation: []), (recombination phenotypes: [genf]), (genetic loci: [gngm]), ((rnf212: [gngm]), (inversion: [comd]), (chromosome: [celc]), (icelandic population: [popg]), (first replication: [genf]), (other population: [popg]), (loci (kiaa1462: [gngm]), ( pdzk1: [gngm]), ( ugcg: [gngm]), ( nub1): [gngm]), ( results: [fndg]), (expression studies: [topp]), (support: []), (roles: [socb]), (meiosis: [celf]), (variants: []), (small fraction: [qnco]), (individual variation: [humn]), (recombination: [genf]), (notably: []), (different sequence variants: [npop]), (male recombination phenotypes: [genf]), (different genes: [gngm]), (characterization: [acty]), (natural variation: []), (meiotic recombination: [celf]), (understanding: [menp]), (normal meiotic events: [phsu]), (primary cause: [topp]), (pregnancy loss: [patf]), 
ASD Terms: (offspring in two datasets, 'Perinatal History')(offspring, 'Perinatal History')

PMCID: 2731203
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (dysfunctions: [dsyn]), (prefrontal cortex: [bpoc]), (individuals: [humn]), (autism spectrum disorders: [mobd]), (previous studies: [lbpr]), (first-degree relatives: [qnco]), (asd: [cgab]), (atypical brain activity: [phsf]), (tasks: []), (social function: [socb]), (however: []), (developmental changes: [orgf]), (prefrontal dysfunction: [dsyn]), (genetic influences: [topp]), (phenomena: [phpr]), (present study: [qnco]), (change: [qnco]), (hemoglobin concentration: [lbpr]), (near-infrared spectroscopy: [lbpr]), (children: [aggp]), (adults: [aggp]), (letter fluency test: [lbpr]), (moreover: []), (unaffected siblings: [famg]), (asd participants: [cgab]), (methodology/principal findings study participants: [humn]), (high-functioning asd: [cgab]), ( age-: [orga]), (healthy non-affected siblings: [famg]), (unrelated healthy controls: [fndg]), (years: []), (relative concentration: [menp]), (hemoglobin ([hb]): [aapp,bacs]), (letter fluency task: [clna]), ([oxy-hb] change: [aapp,bacs]), (task: [gngm]), (task performances: [topp]), (groups: [popg]), ([oxy-hb] increases: [aapp,bacs]), (bilateral prefrontal cortex: [bpoc]), (control subjects: [sbst]), (adult: [aggp]), (controls: [sbst]), (asds: [cgab]), (conclusion/significance: [qnco]), (cross-sectional design: [acty]), (results: [fndg]), (study: [resa]), (age-related change: [aggp]), (prefrontal activity: [acty]), (executive processing: [acty]), (first near-infrared spectroscopy study: [lbpr]), (alteration: []), (age-related changes: [aggp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(social function, 'Ability to Converse in Social Settings')(developmental changes in prefrontal dysfunction, 'Learning Disorders')(task performances, 'Task Performance')(task performances, 'Task Performance')

PMCID: 2721832
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, 
Non SFARI Genes: 
Named Entities: (heterogeneous disease: [fndg]), (genetic psychiatry disorder: [dsyn]), (recently: []), ( abnormalities: [cgab]), (synapse: [bsoj]), (etiology: []), (autism.shank3 (sh3: [mobd]), (multiple ankyrin repeat: [moft]), (protein) gene: [gngm]), (master: []), (synaptic scaffolding protein: [aapp,bacs]), (postsynaptic density (psd): [celc]), (excitatory synapse: [celc]), (rare mutations: [genf]), (copy number variation (cnv) evidence: [nusq]), (shank3: [gngm]), (strong candidate gene: [gngm]), (pathogenesis: [patf]), (autism: [mobd]), (association study: [menp]), (shank3 gene polymorphisms: [genf]), (chinese han population: [popg]), (association: [menp]), (single nucleotide: [fndg]), ((snps): [nusq]), (shank3 gene: [gngm]), (chinese han trios: [aapp,enzy]), (family: [famg]), (association test (fbat): [diap]), (linkage disequilibrium (ld) analysis: [dsyn]), (presence: [qnco]), (ld: [gngm]), (pairwise markers: [clna]), (locus: [gngm]), (mutation screening: [genf]), (mutations: [genf]), (previously: []), (significant evidence: [qnco]), (snps: [nusq]), (cohort: [popg]), (major susceptibility gene: [gngm]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3710970
SFARI Genes: 6.3, 6.3, 
Non SFARI Genes: Mb, 
Named Entities: (summary substantial evidence: []), (chromosomal abnormalities: [comd]), (risk: []), (autism: [mobd]), (duplication: [comd]), (human chromosome: [celc]), (frequent cytogenetic abnormality: [comd]), (genetic change: [comd]), (mice: [mamm]), (chromosome engineering: [celc]), (mb duplication: [comd]), (conserved linkage group: [popg]), (mouse chromosome: [mamm]), (paternal duplication display: [comd]), (poor social interaction: [mobd]), (behavioral inflexibility: [inbe]), (abnormal ultrasonic vocalizations: [npop]), (correlates: []), (anxiety: [mobd]), (mbii52 snorna: [bacs,nnon]), (duplicated region: []), (serotonin: [bacs,orch]), (receptor: [aapp,rcpt]), ((5-ht2cr): [qnco]), ( correlates: []), (altered intracellular ca2+ responses: [celc]), (5-ht2cr agonist: [phsu]), (neurons: [cell]), (paternal duplication: [comd]), (chromosome-engineered mouse model: [celc]), (various aspects: [qnco]), (human autistic phenotypes: [humn]), (relevance: []), (human chromosome abnormality: [humn]), (model: []), (forward genetics: []), (developmental brain disorders: [mobd]), (invaluable tool: []), (therapeutic development: [orgf]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(anxiety, 'Anxiety Disorders')(poor social interaction, 'Reciprocal Social Interaction')(abnormal ultrasonic vocalizations, 'Vocalizations')(autism, 'Autism Phenotype')

PMCID: 2695001
SFARI Genes: NRXN1, UBE3A, NRXN1, UBE3A, BZRAP1, BZRAP1, MDGA2, MDGA2, 
Non SFARI Genes: 
Named Entities: (genetics: []), (autism spectrum disorders: [mobd]), (poorly understood: [menp]), (previous work: []), (important role: [socb]), (structural variation: []), (subset: []), (cases: [qnco]), (resolution: [qnco]), (detection: [topp]), (large regions: [qnco]), (potential interest: [menp]), (identification: [menp]), (individual genes: [gngm]), (genes: [gngm]), (asd etiology: [cgab]), (high density: [qnco]), (multiplex families: [famg]), (autism genetics resource exchange (agre) collection: [mobd]), (results: [fndg]), (healthy controls: []), (prioritization: []), (exonic deletions: [bacs,nnon]), (exonic duplications: [bacs,nnon]), (whole gene duplication events: [genf]), (rare variants: [gngm]), (multiple unrelated probands: [orga]), (controls: [sbst]), (importantly: []), (examination: []), (independent replication cohort: [genf]), (loci: [gngm]), (nrxn1: [gngm]), (whole gene duplications: [genf]), (ube3a: [gngm]), (several other genes: [gngm]), (region: []), (course: []), (analyses: [resa]), (strong support: []), (bzrap1: [gngm]), (adaptor molecule: [sbst]), (synaptic transmission: [celf]), (edels: []), (edups: []), (twelve: [qnco]), (unrelated cases: [qnco]), (less: [qnco]), (mdga2: [gngm]), (case-specific (p: [aapp,imft]), (encoded protein: [aapp,bacs]), (high similarity: [qnco]), (contactin: [aapp,bacs]), ((blast e-value =: [qnco]), (hundreds: []), (distinct rare variants: [gngm]), (further highlights complexity: [chvs]), (asds: [cgab]), (points: [qnco]), (need: []), (cohorts: [popg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism genetics resource exchange collection, 'Autism Phenotype')

PMCID: 2921284
SFARI Genes: 
Non SFARI Genes: Mb, Mb, 
Named Entities: (child: [aggp]), (autism: [mobd]), (mild microcephaly: [fndg]), (mb microdeletion: []), (chromosome: [celc]), (hypothesis: []), (microdeletion: []), (genes: [gngm]), (autism phenotype: [mobd]), (other children: [aggp]), (autism spectrum disorders: [mobd]), (submicroscopic: []), (chromosomal rearrangements: [comd]), ( array: []), (comparative genomic hybridisation (acgh): [mbrt]), (k: [qnco]), (whole genome: [gngm]), (human bacterial artificial chromosome (bac) array: [humn]), (illumina: []), (610-quad beadchip microarray: [phsu]), (ingenuity pathway analysis (ipa): []), (functional biological networks: []), (candidate autism genes: [mobd]), (putative functional variants: []), (candidate genes: [gngm]), ( mutation screening: [genf]), (polymerase chain reaction (pcr): [mbrt]), (sanger: []), (unrelated autism patients: [mobd]), (control subjects: [sbst]), (mb deletion: [genf]), (43 genes: [gngm]), (fluorescence: [npop]), (situ hybridization (fish): [mbrt]), (literature review: []), (bioinformatics analyses: [resa]), (regulating synaptic membrane exocytosis: [celc]), ((rims3): [gngm]), (promising autism candidate gene: [mobd]), (mutation screening: [genf]), (gene: [gngm]), (autism patients: [mobd]), (variants: []), ((p.e177a): [aapp,imft]), (sibship: []), (controls: [sbst]), (case report: [clna]), (mutation: [genf]), (data: [euka]), (rims3: [gngm]), (autism causative: [mobd]), (contributory gene: [gngm]), (functional studies: [lbpr]), (rims3 variants: [gngm]), (p.e177a: [aapp,imft]), (additional insight: [menp]), (role: [socb]), (synaptic proteins: [aapp,bacs]), (pathophysiology: [patf]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(autism phenotype, 'Autism Phenotype')(human bacterial artificial chromosome array, 'Bacterial Infections')(candidate autism genes, 'Autism Phenotype')(unrelated autism patients, 'Autism Phenotype')(promising autism candidate gene, 'Autism Phenotype')(autism patients, 'Autism Phenotype')(autism causative, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2705351
SFARI Genes: NOS, NOS, 
Non SFARI Genes: 
Named Entities: (individuals: [humn]), (autism spectrum disorders: [mobd]), (symptoms: [sosy]), (other diagnostic categories: [fndg]), (studies: [lbpr]), (psychosocial outcome: [fndg]), (adult patients: [aggp]), (asds: [cgab]), (concomitant intellectual disability: [mobd]), (objective: []), (paper: []), (clinical psychiatric presentation: [hlca]), (important outcome measures: [qnco]), (large group: [grpa]), (normal-intelligence adult patients: [aggp]), (autistic symptomatology: [mobd]), (dsm-iv-criteria: []), (gillberg: []), (gillberg research criteria: [resa]), ( patterns: []), (comorbid psychopathology: []), (adults: [aggp]), (normal intelligence asds: [cgab]), (subjects: [humn]), (patients: [podg]), (autistic disorder: [mobd]), (asperger's disorder (as): [mobd]), (pervasive developmental disorder: [mobd]), ((pdd nos): [dsyn]), (study group: [popg]), (similar protocols: []), (outpatient basis: [podg]), (clinicians: []), (core: [bdsu]), (autistic symptoms: [mobd]), (asd subgroups: [cgab]), (ad subjects: [humn]), (pervasive problems: []), ( restrictions: []), (non-verbal communication: [menp]), (subgroups: [virs]), (current dsm criteria: [npop]), (verbal communication deficits: [socb]), (lifetime: []), (psychiatric axis: [bpoc]), (comorbidity: []), (mood: [menp]), (anxiety disorders: [mobd]), (adhd: [mobd]), (psychotic disorders: [mobd]), (frequency: [qnco]), (diagnoses: [fndg]), (males: [orga]), (females: [orga]), (antisocial personality disorder: [mobd]), (substance abuse: [mobd]), (pdd nos group: [dsyn]), (independent life: [fndg]), (long-term relationship: []), (female subjects: [orga]), (school: [mnob,orgt]), (male subjects: [orga]), (clinical syndromes: []), (impaired social interaction: [mobd]), (adulthood: []), (childhood: []), (high risk: [fndg]), (co-existing mental health problems: [fndg]), (broad spectrum: [qnco]), (disorders: [dsyn]), (unfavourable psychosocial life circumstances: [phpr]), (next revision: [topp]), (dsm: []), (findings: [clna]), (importance: []), (careful examination: [acty]), (exclusion criterion: [acty]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(concomitant intellectual disability, 'Learning Disorders')(comorbid psychopathology, 'Comorbidities')(normal intelligence autism spectrum disorders, 'Autism Phenotype')(autistic disorder, 'Autistic Disorder')(autistic symptoms, 'Complaints and Indications')(autistic disorder subjects, 'Autistic Disorder')(comorbidity, 'Comorbidities')(mood, 'Mood')(anxiety disorders, 'Anxiety Disorders')(psychotic disorders, 'Schizophrenia and Disorders with Psychotic Features')(substance abuse, 'Substance Abuse')(impaired social interaction, 'Reciprocal Social Interaction')(high risk for co-existing mental health problems, 'Mental Retardation')(co-existing mental health problems, 'Mental Retardation')

PMCID: 2685981
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (identification: [menp]), (numerous autism susceptibility: [clna]), (pathobiology: []), (autism: [mobd]), (present case-control study: [resa]), (global approach: []), (molecular basis: []), (autism spectrum disorders: [mobd]), (large-scale gene expression profiling: [lbpr,mbrt]), (dna microarray analyses: [mbrt]), (lymphoblastoid cell lines: [cell]), (sib pairs: [famg]), (sibling: [famg]), (diagnosis: [fndg]), (order: [acty]), (pathways: [moft]), (cells: [cell]), (nonautistic siblings: [famg]), (bioinformatics: []), (gene: [gngm]), (ontological analyses: [resa]), (data implicate genes: [gngm]), (nervous system: [bdsy]), (development: [orgf]), ( inflammation: [patf]), (cytoskeletal organization: [celf]), (addition: []), (genes: [gngm]), (other physiological symptoms: [sosy]), (moreover: []), (data: [euka]), (processes: [phpr]), (cholesterol/steroid metabolism: [bacs,orch]), (level: [phsu]), (androgenic hormones: [horm,phsu]), (elevation: [topp]), (male hormones: [horm]), (turn: [fndg]), (possible factor: []), (susceptibility: [clna]), (4 times: [qnco]), (many males: [orga]), (females: [orga]), (preliminary metabolic profiling: []), (steroid hormones: [horm,orch]), (several pairs: [qnco]), (siblings reveals: [famg]), (levels: []), (testosterone: [horm,orch,phsu]), (autistic sibling: [famg]), (increased expression: [topp]), (steroidogenesis pathway: [moft]), (global gene expression profiling: [lbpr,mbrt]), (cultured cells: [cell]), (asd: [cgab]), (serves: []), (window: []), (deficits: []), 
ASD Terms: (numerous autism susceptibility, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')

PMCID: 2705502
SFARI Genes: BDNF, BDNF, BDNF, BDNF, 
Non SFARI Genes: 
Named Entities: (single: [fndg]), ((snps): [nusq]), (important markers: [clna]), (association studies: [menp]), (susceptible genes: [gngm]), (complex diseases: [dsyn]), (high-throughput methods: [qnco]), (snp: [nusq]), (large number: [qnco]), (samples: [sbst]), (study: [resa]), (polyacrylamide gel-based microarray: [bodm,phsu]), (dual-color hybridization: [genf]), (association study: [menp]), (bdnf polymorphisms: [aapp,bacs,phsu]), (autism: [mobd]), (snps: [nusq]), (patients: [podg]), (controls: [sbst]), (c270t polymorphism: [genf]), (significant differences: [qnco]), (frequency: [qnco]), (allele (2 =: [gngm]), (p =: [aapp,imft]), (genotype (2 =: [orga]), (p: [gngm]), (haplotype association: [menp]), (significant difference: [qnco]), (global haplotype distribution: [orga]), (groups: [popg]), (bdnf: [gngm]), (possible role: [socb]), (pathogenesis: [patf]), (rapid: []), ( simple: []), (high-throughput method: [lbpr]), (snps genotyping: [mbrt]), (susceptible gene: [gngm]), (disorders: [dsyn]), (large samples: [sbst]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2683930
SFARI Genes: RAI1, RAI1, 
Non SFARI Genes: BRD1, 
Named Entities: (recent identification: [menp]), (copy-number variation: [nusq]), (human genome: [gngm]), (new avenues: []), (discovery: [acty]), (positional candidate genes: [gngm]), (complex genetic disorders: [dsyn]), (field: [irda]), (psychiatric disease: [mobd]), (major challenge: [hlca]), (susceptibility genes: [gngm]), (multitude: []), (disease-associated loci: [dsyn]), (challenge: [hlca]), (reconstruction: [topp]), (functional gene-networks: [moft]), (genes: [gngm]), (loci: [gngm]), (approach: []), (spectrum disorder (asd): [cgab]), (copy-number changes: [qnco]), (dna: [bacs,nnon]), (asd patients: [cgab]), (healthy individuals: [humn]), (illumina humanhap300 beadchips: []), (subsequently: []), (gene-network: [moft]), ( prioritizer: []), (candidate genes: [gngm]), (segmental gains: [qnco]), (losses: [qnco]), (autism cohort: [mobd]), (analysis: [resa]), (several candidate genes: [gngm]), (neuropsychiatric disorders: [dsyn]), (rai1: [gngm]), ( brd1: [gngm]), (large: [gngm]), (large gene: [gngm]), (part: [qnco]), (sub-network: [popg]), (glycobiology: []), ( present: [qnco]), (autism patients: [mobd]), (limited co-morbidity: [fndg]), (de novo: []), (patients: [podg]), (complex phenotype: [orga]), (healthy controls: []), (such sub-network: [popg]), (independent systematic analysis: [fndg]), (published autism susceptibility loci: [mobd]), (involvement: []), (similar genes: [gngm]), (findings: [clna]), (occurrence: []), (genomic gains: [gngm]), (important contributors: []), (development: [orgf]), (asd: [cgab]), 
ASD Terms: (psychiatric disease, 'Mental Disorders')(autism cohort, 'Autism Phenotype')(autism patients, 'Autism Phenotype')(published autism susceptibility loci, 'Autism Phenotype')

PMCID: 2682483
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (researchers: []), (theory: []), (cause autism: [mobd]), (many parents: []), (them: []), (scientists: []), (gap: [gngm]), (evidence: []), (doubt?: [menp]), 
ASD Terms: (cause autism, 'Autism Phenotype')

PMCID: 4023913
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (genetic studies: [resa]), (autism: [mobd]), (past decade: [qnco]), (complex landscape: [chvs]), (multiple genes: [fndg]), (face: [gngm]), (heterogeneity: [orga]), ( studies: [lbpr]), (large extended pedigrees: [qnco]), (valuable insight: [menp]), (few susceptibility genes: [gngm]), (single large families: [fndg]), (genome-wide screen: [gngm]), (families: [famg]), (pedigrees: []), (moderate-sized families: [famg]), (generations: []), (center: [fndg]), (inherited disease research (cidr): [resa]), (illumina linkage panel: [moft]), (polymorphism (snp) platform: [nusq]), (results: [fndg]), (subjects: [humn]), (autism spectrum disorder (asd): [mobd]), (relatives: [famg]), (genome-wide significance: [gngm]), (chromosome: [celc]), (distinct peaks:: [qnco]), (15q13.1-q14 (hlod=4.09: [fndg]), (15q14-q21.1 (hlod=3.59: [fndg]), (15q21.1-q22.2 (hlod=5.31: [celc]), (peaks: [qnco]), (previous findings: [clna]), (additional suggestive results: [fndg]), (chromosomes: [celc]), (2p25.3-p24.1 (hlod=1.87): [celc]), ( 7q31.31-q32.3 (hlod=1.97): [celc]), (13q12.11-q12.3 (hlod=1.93): [celc]), (affected subjects: [humn]), (linkage peaks: [moft]), (study: [resa]), (strong evidence: []), (distinct phenotypic subgroups: [orga]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 2889141
SFARI Genes: CACNA1G, CACNA1G, CACNA1G, CACNA1G, 
Non SFARI Genes: 
Named Entities: (chromosome: [celc]), (region: []), (genome: [gngm]), (susceptibility: [clna]), ((mim[209850]): [gngm]), (prior evidence: [evnt]), (linkage: [moft]), (disorder: [dsyn]), (pedigrees: []), (male probands: [orga]), (autism genetic resource exchange (agre): [mobd]), (previously: []), ( stone: [bdsu]), (high-density snp association study: [menp]), (interval: []), (common variant association: [menp]), (linkage signal: [moft]), (snp-based association study: [menp]), (coverage: []), (lod support interval: [qnco]), (linkage peak: [moft]), (majority: [socb]), (common alleles: [gngm]), (mo trios: [aapp,enzy]), (conclusions markers: [clna]), (gene cacna1g: [gngm]), (autism spectrum disorder: [mobd]), (significant level (p: [aapp,imft]), (cacna1g: [gngm]), (novel candidate: []), (autism: [mobd]), (alleles: [gngm]), (sufficient genetic effect: [topp]), (observed linkage: [moft]), (substantial genetic heterogeneity: [orga]), (clear linkage signal: [moft]), (likely harbors: []), (combination: [fndg]), (rare alleles: [gngm]), (genetic risk: [qnco]), (data: [euka]), (previous studies: [lbpr]), (chromosomes: [celc]), (major common risk alleles: [gngm]), (asd risk: [cgab]), (major linkage peaks: [moft]), (agre sample: [sbst]), (important evidence: []), (strategies: [menp]), (asd genes: [cgab]), (rare variants: [gngm]), (common variants: [qnco]), (small effect: [qnco]), 
ASD Terms: (autism (mim), 'Autism Phenotype')(autism genetic resource exchange, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism genetic resource exchange sample, 'Autism Phenotype')

PMCID: 2727366
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (ados algorithms: [aapp,enzy]), (gotham: []), (al: [lbpr]), ((j autism dev disord: [mobd]), (independent sample: [sbst]), (dutch children: [aggp]), (algorithms: []), (sensitivity: [patf]), (specificity: [qnco]), (modules: []), (efficiency: [qnco]), (classification: []), (restricted repetitive behaviour domain: [fndg]), (algorithm: [lbpr]), (clinical asd classification: [cgab]), (module: []), (results: [fndg]), (improvement: []), (low-functioning population: [popg]), (advantages: []), (strength: [qnco]), (original algorithm: [lbpr]), 
ASD Terms: (restricted repetitive behaviour domain, 'Restricted and Repetitive Behavior')

PMCID: 2758571
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (typically-developing human infants: [humn]), (biological motion: [npop]), (first days: [qnco]), (life1: []), (ability: [orga]), (species2: []), (3: [fndg]), (filial attachment: [acty]), (detection: [topp]), (predators4: []), (neural underpinnings: []), (biological motion perception: [menp]), (brain regions: [blor]), (perception: [menp]), (basic social signals: [phpr]), (facial expression: [fndg]), (gaze direction5: [fndg]), (preferential attention: [menp]), (precursor: []), (capacity: [qnco]), (intentions: [menp]), (however: []), (serendipitous observation7: []), (infant: [aggp]), (autism: [mobd]), (point-light displays: [npop]), (presence: [qnco]), (non-social: []), ( physical contingency: [hlca]), (stimuli: [phpr]), (chance: []), (observation: [hlca]), (hypothesis: []), (children: [aggp]), (early age: [orga]), (consequences: []), (social development: [socb]), (lifelong impairments: [patf]), (social interaction: [fndg]), (hallmark: []), (autism spectrum disorders8: [mobd]), (two-year-olds: [qnco]), (towards: []), (viewing behavior: [inbe]), (response: [fndg]), ( physical contingencies: [hlca]), (physical contingencies: [hlca]), (control children: [aggp]), (far-reaching implications: [orgf]), (altered neurodevelopmental trajectory: [ortf]), (brain specialization: [bpoc]), (autism9: []), 
ASD Terms: (biological motion perception, 'Cognitive Ability')(perception, 'Cognitive Ability')(facial expression, 'Integrated Verbal and NonVerbal Communication')(autism, 'Autism Phenotype')(perception, 'Cognitive Ability')(autism, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(autism spectrum disorders8, 'Autism Phenotype')(social development, 'Ability to Converse in Social Settings')(autism, 'Autism Phenotype')(neurodevelopmental trajectory, 'Learning Disorders')(altered neurodevelopmental trajectory, 'Learning Disorders')

PMCID: 2678711
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (association: [menp]), (gamma-aminobutyric acid-a (gaba-a) receptor subunit 3 (gabrb3) gene: [aapp,rcpt]), (autism spectrum disorders: [mobd]), (korea: []), (fifty-eight children: [aggp]), (asd [47: [cgab]), (years: []), (family trios: [aapp,enzy]), (healthy control: []), ([71 males: [orga]), (recruited: []), (transmission disequilibrium test: [dsyn]), (bp: [gngm]), (gabrb3 gene: [gngm]), (families: [famg]), (asd (p: [cgab]), (population-based case-control study: [resa]), ( however: []), (asd: [cgab]), (gabrb3: [gngm]), (polymorphism: [genf]), (data: [euka]), (preliminary evidence: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 2934739
SFARI Genes: IMMP2L, DOCK4, IMMP2L, DOCK4, DOCK4, DOCK4, 
Non SFARI Genes: AUTS1, AUTS1, AUTS1, 
Named Entities: (autism spectrum disorders: [mobd]), (group: [popg]), (heritable neurodevelopmental disorders: [mobd]), (complex genetic etiology: [chvs]), (international molecular genetic study: [resa]), (autism consortium: [mobd]), (linkage loci: [moft]), (chromosomes: [celc]), (auts1: [gngm]), (auts5: [dsyn]), ( respectively: []), (study: [resa]), (high-density association analysis: [menp]), (polymorphisms (snps): [nusq]), (genes: [gngm]), (region: []), (snps: [nusq]), (sequences: [nusq]), (snp genotype data: [nusq]), (copy number variation: [nusq]), (regions: []), (study sample: [sbst]), (families: [famg]), (linkage: [moft]), (respectively: []), (gender-matched controls: [orga]), (further investigation: [hlca]), (association results: [menp]), (independent european family: [famg]), (affected individuals: [humn]), (association: [menp]), (number: [qnco]), (variant analysis: [resa]), (several genes: [famg]), (immp2l: [gngm]), (dock4: [gngm]), (chromosome: [celc]), (evidence: []), (involvement: []), (autism susceptibility: [clna]), (independent replication: [genf]), (rs2217262: []), (finding: [sosy]), (deletion segregating: [genf]), (sib-pair family: [famg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(heritable neurodevelopmental disorders, 'Learning Disorders')(autism consortium, 'Autism Phenotype')(autism susceptibility, 'Autism Phenotype')

PMCID: 2752466
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, 
Non SFARI Genes: 
Named Entities: (shank3: [gngm]), (chromosome: [celc]), (scaffold protein: [aapp,bacs]), (excitatory synapses: [celc]), (pre-synaptic active zone: [celc]), (binding partner: [moft]), (genes: [gngm]), (mutations: [genf]), (small subset: [qnco]), (individuals: [humn]), (autism: [mobd]), (autism spectrum disorders: [mobd]), (several studies: [lbpr]), (deletions: [genf]), (hundreds: []), (kilobases: [qnco]), (asds: [cgab]), (chromosomal aberrations: [comd]), (involvement: []), (asd: [cgab]), (international molecular genetic study: [resa]), (autism consortium (imgsac) multiplex family: [famg]), (families: [famg]), (snp association: [menp]), (copy number variants: [nusq]), (collection: []), (imgsac: []), (italian probands: [orga]), (singleton families: [famg]), (multiplex ligation-dependent probe amplification: [mbrt]), (cnvs: [nusq]), (snp associations: [menp]), (sample set: [menp]), (sequencing: [mbrt]), (gene: [gngm]), (data: [euka]), (shank3 deletions: [genf]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(autism consortium, 'Autism Phenotype')(autism consortium multiplex family, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2663032
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (normal behavioural development: [inbe]), (interplay: []), (environmental influences: []), (case: []), (psychiatric disorders: [mobd]), (emphasis: []), (past decades: [qnco]), (biological determinism: []), (thus: []), (previous studies: [lbpr]), (autistic spectrum disorders (asd): [mobd]), (parental style: []), (however: []), (animal research: [resa]), (different behavioural traits: [gngm]), (genetic/environmental factors: [topp]), (methodology/ principal findings: [clna]), (present study: [qnco]), (asd: [cgab]), ( language disorders: [mobd]), (social factors: [grpa]), (language: [lang]), (social act: [topp]), (social influences: []), (autism diagnostic interview-revised: [acty]), (early characteristics: []), (sensori-motor: []), (language development: [menp]), (large sample: [sbst]), (children: [aggp]), (asd (n: [cgab]), (parents: []), (different levels: []), (education: [fndg]), (results: [fndg]), (high level: [qnco]), (moreover: []), (first words: [qnco]), (phrases: []), (mother: [famg]), (additional gender effect: [orga]), (conclusions/significance: [qnco]), (knowledge: []), (study: [resa]), (important new lines: []), (thought: [menp]), (help: []), (biological perspectives: []), (new hopes: [menp]), (therapies: [topp]), 
ASD Terms: (psychiatric disorders, 'Mental Disorders')(different behavioural traits, 'Personal Traits')(autism diagnostic interview-revised, 'Autism Phenotype')(language development, 'Language Development')

PMCID: 2708322
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (comorbid problems: []), ((oppositional defiant behaviors: [inbe]), ( anxiety: [mobd]), (autistic traits: [mobd]), ( motor coordination problems: [sosy]), (reading problems): [fndg]), (attention-deficit/hyperactivity disorder (adhd);: [mobd]), (executive: []), (motor problems: []), (endophenotype level: [phsu]), (adhd;: [mobd]), ((ef)and motor-endophenotypes: []), (hypothesis: []), (adhd: [mobd]), (different phenotype: [orga]), (efand: []), (neuropsychological tasks: []), (children: [aggp]), (adhdand control-families: [famg]), (additional data: [euka]), (questionnaires: []), (results: [fndg]), (oppositional defiant behaviors: [inbe]), (important comorbid problems: []), (motor coordination problems: [sosy]), (reading problems: [fndg]), (efand motor-endophenotype: []), (siblings: [famg]), (problems: []), (share: [socb]), (familial/genetic ef: [famg]), (motor deficits: [fndg]), (such results: [fndg]), (anxiety: [mobd]), (co-occurrence: []), (distinct subtype: []), (further research: [resa]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10802-009-9312-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (adhd, 'Attention Deficit Disorder with Hyperactivity')(adhd, 'Attention Deficit Disorder with Hyperactivity')(comorbid problems, 'Comorbidities')(adhd, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(motor problems, 'Motor Skills')(comorbid problems, 'Comorbidities')(adhd, 'Attention Deficit Disorder with Hyperactivity')(important comorbid problems, 'Comorbidities')(motor coordination problems, 'Motor Skills')(anxiety, 'Anxiety Disorders')(motor coordination problems, 'Motor Skills')(motor deficits, 'Motor Skills')(adhd, 'Attention Deficit Disorder with Hyperactivity')(adhd, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 2662857
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (several uncontrolled studies: [resa]), (hyperbaric treatment: [topp]), (children: [aggp]), (autism: [mobd]), (clinical improvements; however: []), (treatment: [topp]), (date: []), (study: [resa]), (multicenter: []), ( randomized: [resa]), ( double-blind: [resa]), (trial: [resa]), (efficacy: [resa]), (centers: []), ( ages: [bacs,orch]), (years: []), (hourly treatments: [topp]), (atmosphere (atm): [npop]), (oxygen ("treatment group": [elii,phsu]), (pressurized room air: [sbst]), (atm: [gngm]), (oxygen ("control group": [grup]), (outcome measures: [qnco]), (clinical global impression (cgi) scale: [fndg]), ( aberrant behavior checklist (abc): [inbe]), (autism treatment evaluation checklist (atec): [mobd]), (sessions: [evnt]), ( mean physician cgi: [clna]), (treatment group: [popg]), (controls: [sbst]), (overall functioning (p: [aapp,imft]), (receptive language: [lang]), (social interaction (p: [fndg]), (eye contact (p: [aapp,imft]), (much improved": [qnco]), ("much improved": [qnco]), ((8%): []), (controls (p: [aapp,imft]), ((80%): [fndg]), ((38%): []), (mean: [qnco]), (parental cgi: []), (abc: [dsyn]), (significant improvements: [qnco]), (total score: [qnco]), ( irritability: [fndg]), ( stereotypy: [mobd]), ( hyperactivity: [mobd]), (speech (p: [orgf]), (each): []), (control group: [grup]), (control: [sbst]), (group: [popg]), ( mean changes: [qnco]), (subscales: []), (number: [qnco]), (irritability (p: [fndg]), (atec: []), (sensory/cognitive awareness: [menp]), ((p: [aapp,imft]), (post-hoc analysis: [resa]), (age: [orga]), (initial autism severity: [mobd]), (robust improvements: []), (oxygen: [elii,phsu]), (hourly sessions: [evnt]), (overall functioning: []), ( receptive language: [lang]), (social interaction: [fndg]), ( eye contact: [socb]), (room air: [fndg]), (trial registration clinicaltrials.gov nct00335790: [resa]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism treatmosphereent evaluation checklist, 'Autism Phenotype')(receptive language, 'Receptive Language')(social interaction, 'Reciprocal Social Interaction')(eye contact, 'Eye Contact')(hyperactivity, 'Overactivity')(hyperactivity, 'Overactivity')(speech, 'Language Ability')(autism treatment evaluation checklist, 'Autism Phenotype')(initial autism severity, 'Autism Phenotype')(autism, 'Autism Phenotype')(receptive language, 'Receptive Language')(receptive language, 'Receptive Language')(eye contact, 'Eye Contact')

PMCID: 2680219
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (deficits: []), (reciprocal social interaction: [fndg]), (communication: [socb]), (stereotyped behaviors: [mobd]), (interests: [menp]), (previous genetic studies: [resa]), (evidence: []), (linkage: [moft]), (however: []), (complexity: [chvs]), (heterogeneity: [orga]), (disorder: [dsyn]), (success: [socb]), (candidate gene studies: [gngm]), (autistic population: [mobd]), (structural chromosome abnormalities: [comd]), (article: []), (molecular cytogenetic characterization: [acty]), (chromosome: [celc]), (deletions: [genf]), (lies: []), (autistic spectrum: [mobd]), (patients: [podg]), (developmental disorders: [mobd]), (language delay: [fndg]), (communication difficulties: [socb]), (previous karyotype analyses: [resa]), ([46: []), (xx: [orga]), (del(2)(q24.1q24.2)dn]: [comd]), (breakpoint refinement: []), (fish mapping: [fish]), (region: []), (genepotassium: []), (channel: []), (j: []), ( member: [popg]), ((kcnj3): [gngm]), (mutation screen: [genf]), (gene: [gngm]), (autistic probands: [mobd]), (variants: []), (nevertheless: []), (flanking genes: [gngm]), (locus: [gngm]), 
ASD Terms: (reciprocal social interaction, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(stereotyped behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')(developmental disorders with language delay, 'Learning Disorders')(language delay, 'Language Ability')(autism, 'Autism Phenotype')

PMCID: 3181906
SFARI Genes: SHANK3, SHANK3, 
Non SFARI Genes: 
Named Entities: (recent studies: [lbpr]), (autism spectrum disorders: [mobd]), (support: []), (important role: [socb]), (multiple rare variants: [qnco]), (conditions: [dsyn]), (important finding: [sosy]), (demonstration: []), (significant proportion: [qnco]), (asds: [cgab]), (result: [fndg]), (rare: [gngm]), ( etiological genetic variants: [npop]), (use: []), (behavioral analyses: [hlca]), (diagnosis: [fndg]), (interventions: [hlca]), (development: [orgf]), (evaluations: [hlca]), (promise: []), (improved treatment: [topp]), (furthermore: []), (rare variants: [gngm]), (neuronal genes: [gngm]), (specific paihvi/ays: []), ( cells: [cell]), (subcellular compartments: [npop]), (turn: [fndg]), (novel therapeutic approaches: [topp]), (particular recent interest: [menp]), (synaptic cell adhesion: [celf]), (molecules: [sbst]), (shank3: [gngm]), (glutamatergic: []), (synapse abnormalities: [bsoj]), (current review: [npop]), (evidence: []), (genetic etiology: [topp]), (recent genetic findings: [lbtr]), (disorders: [dsyn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(diagnosis, 'Diagnosis')(autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 2805335
SFARI Genes: ASPM, ASPM, 
Non SFARI Genes: 
Named Entities: (twin: [famg]), (family studies: [famg]), (cognitive traits: [gngm]), (neurodevelopmental disorders: [mobd]), (dyslexia: [mobd]), ( autism: [mobd]), (specific language impairment (sli): [dsyn]), (strong genetic influence: [topp]), (nevertheless: []), (researchers: []), (genes: [gngm]), (substantial amounts: [qnco]), (variance: [qnco]), (disorders: [dsyn]), (observation: [hlca]), (multifactorial model: [fndg]), (complex human traits: [humn]), (numerous genes: [famg]), (another: []), (environment: []), (specific phenotype: [orga]), (model: []), (genetic influences: [topp]), (cognition: [menp]), (course: []), (human evolution: [humn]), (recent linkage: [moft]), (association studies: [menp]), (sli: [gngm]), (points: [qnco]), (role: [socb]), (nonheritable genetic mutations: [genf]), (copy number variants): [nusq]), (autism: [mobd]), (finally: []), ( research: [resa]), (phenotypic correlates: [orga]), (allelic variation: [gngm]), (genes aspm: [gngm]), (microcephalin: [aapp,bacs]), (considered; initial interest: [menp]), (brain size: [qnco]), (intelligence: [menp]), (failure: [inbe]), (phenotypic differences: [orga]), (people: [popg]), (different versions: []), (current vogue: [npop]), (investigators: []), (measures: [qnco]), (allelic variants: [gngm]), (studies: [lbpr]), (cognitive disorders: [mobd]), (effect: []), (variants: []), (large sample sizes: [sbst]), 
ASD Terms: (cognitive traits, 'Cognitive Ability')(neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')(specific language impairment, 'Language Ability')(cognition, 'Cognitive Ability')(specific language impairment, 'Language Ability')(cognition, 'Cognitive Ability')(cognitive disorders, 'Cognitive Ability')

PMCID: 2671988
SFARI Genes: 
Non SFARI Genes: Mb, 
Named Entities: (autism spectrum disorders: [mobd]), (group: [popg]), (severe neurodevelopmental conditions: [mobd]), (complex multifactorial etiology: [chvs]), (order: [acty]), (hypothesis: []), (genomic rearrangements: [gngm]), (asd cases: [cgab]), (spanish patients: [popg]), (idiopathic asd: [cgab]), (laboratory screening: [mnob,orgt]), (array: []), (comparative genomic hybridization (acgh): [mbrt]), (homemade bacterial artificial chromosome (bac) array: []), (copy number alterations: [qnco]), (size: []), (kb: []), (mb: [gngm]), (autistic population: [mobd]), (individuals: [humn]), (validation: [resa]), (additional molecular techniques: [mbrt]), (novel candidate regions: []), (different genes: [gngm]), (alterations: []), (regions: []), (chromosome: [celc]), (asd phenotype: [cgab]), (genes: [gngm]), (asd-specific copy number variants act: [topp]), (common pathways: [moft]), (phosphatidylinositol signaling: [bacs,orch]), (glutamatergic: []), (several genetic syndromes: [dsyn]), (autism: [mobd]), (asd: [cgab]), (work: []), (idea: []), (functional alteration: []), (related neuronal networks: [fndg]), (etiology: []), (significant diagnostic yield: [fndg]), (acgh: []), (diagnostic workup: [diap]), 
ASD Terms: (severe neurodevelopmental conditions, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')(homemade bacterial artificial chromosome array, 'Bacterial Infections')(asd phenotype, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2644762
SFARI Genes: SEZ6L2, SEZ6L2, Sez6l2, Sez6l2, SEZ6L2, SEZ6L2, SEZ6L2, SEZ6L2, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (complex childhood: [chvs]), (neurodevelopmental disorder: [mobd]), (strong genetic basis: [phsu]), (microdeletion: []), (duplication: [comd]), (500700-kb genomic rearrangement: [gngm]), (genes: [gngm]), (frequent chromosomal disorder: [cgab,dsyn]), (role: [socb]), (sequence variants: [npop]), (autism etiology: [mobd]), (methodology/principal findings: [clna]), (variants: []), (potential role: [socb]), (association studies: [menp]), (data: [euka]), (microarray platforms: affymetrix: []), ((777: []), (illumina: []), (k (943 families): [famg]), (affymetrix: []), (k (60 families): [famg]), (common variants: [qnco]), (rare variants: [gngm]), (promoter regions: [bacs,nnon]), (candidate genes: [gngm]), (expression patterns: [topp]), (functions: [phsf]), (total: [qnco]), (novel variants: []), (exonic (nine: [bacs,nnon]), (synonymous: []), (untranslated region): [nnon]), (promoter variants: [bacs,nnon]), (significant association: [menp]), (coding variant: []), (seizure-related gene sez6l2 (12/1106 autism: [gngm]), (controls; p: [aapp,imft]), (sez6l2 expression: [topp]), (mouse embryos: [mamm]), (spinal cord: [bpoc]), (brain: [bpoc]), (human fetal brain: [humn]), (post-mitotic cortical layers: [bpoc]), ( hippocampus: [bpoc]), ( amygdala: [bpoc]), (thalamus: [bpoc]), (association analysis: [menp]), (sez6l2: [gngm]), (independent sample: [sbst]), (initial findings: [clna]), (conclusions/significance: [qnco]), (sequence variation: [npop]), (candidate gene: [gngm]), (novel genetic risk factor: [qnco]), (however: []), (further studies: [lbpr]), (preliminary findings: [clna]), 
ASD Terms: (autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(frequent chromosomal disorder, 'Down Syndrome')(autism etiology, 'Medical History')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2635956
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (clinical relevance: []), (mr: [gngm]), (children: [aggp]), (autism: [mobd]), (open question: []), (light: [gngm]), (evolution: [genf]), (technology: []), (mri: [gngm]), (insufficient value: [qnco]), (standard clinical evaluation: [hlca]), (guidelines: []), (american academy: [orgt]), (neurology: []), (child neurology society: [orgt]), ([1]: [fndg]), (however: []), (statement: []), (results: [fndg]), (small samples: [sbst]), (patients: [podg]), (importantly: []), (insufficient mri sequences: [nusq]), (main objective: []), (prevalence: [qnco]), (brain abnormalities: [dsyn]), (large group: [grpa]), (non-syndromic autistic disorder (ad): [mobd]), (t1: [gngm]), ( t2: []), (flair mri sequences: [nusq]), (methodology mri inspection: [diap]), (adolescents: [aggp]), (non-syndromic ad (mean age: [dsyn]), (performed: []), (dsm-iv: []), (adi r criteria: [clna]), (biological screenings: [hlca]), (infectious: [dsyn]), ( metabolic: [celf]), (genetic diseases: [fndg]), ( seizures: [sosy]), (other neurological symptoms: [sosy]), (identical mri inspections: [diap]), ((mean age: [orga]), (ad: []), ( developmental: [orgf]), (neurological disorders: [dsyn]), (mris: [diap]), (1.5-t signa ge: [gngm]), ((3-d t1-fspgr: [diap]), ( flair: [orch,phsu]), (axial sequences): [nusq]), (neuroradiologists: []), (sub-cortical regions: [bpoc]), (principal findings mris: [diap]), ((8/77): []), (cases: [qnco]), (patients): [podg]), ( abnormalities: [cgab]), (reported: [hlca]), (predominant abnormalities: [cgab]), (white matter signal abnormalities: [patf]), (virchowrobin spaces (12/69): [qnco]), (temporal lobe abnormalities: [bpoc]), (normal (36/69 patients): [podg]), (unexpectedly high rate: [qnco]), (mri abnormalities: [diap]), (first large series: [qnco]), (clinical mri investigations: [diap]), (non-syndromic autism: [mobd]), (further etiopathogenetic research: [resa]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(neurology, 'Neurologic Indications')(child neurology society, 'Neurologic Indications')(non-syndromic autistic disorder, 'Autistic Disorder')(non-syndromic autistic disorder, 'Autistic Disorder')(autism, 'Autism Phenotype')(other neurological symptoms, 'Neurologic Indications')(autistic disorder, 'Autistic Disorder')(neurological disorders, 'Neurologic Indications')(non-syndromic autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2645381
SFARI Genes: L10, L10, L10, L10, L10, L10, L10, L10, L10, L10, L10, L10, L10, L10, L10, L10, L10, L10, L10, L10, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (severe neurodevelopmental disorders: [mobd]), (male:female ratio: [orga]), (contribution: [acty]), (x chromosome: [celc]), (genetic factors: [fndg]), (susceptibility: [clna]), (asd: [cgab]), (ribosomal protein l10 (rpl10) gene: [gngm]), (chromosome xq28: [celc]), (key protein: [aapp,bacs]), (large ribosomal subunit: [celc]), (protein synthesis: [moft]), (non-synonymous mutations: [genf]), (rpl10: [gngm]), ( l206m: []), (h213q: []), (boys: [aggp]), (moreover: []), (functional studies: [lbpr]), (mutant rpl10: [aapp,bacs]), (yeast: [fngs]), (aberrant ribosomal profiles: [celc]), (results: [fndg]), (novel aspect: [qnco]), (disease mechanisms: [dsyn]), (autism: [mobd]), (aberrant processes: [phpr]), (ribosome biosynthesis: [celf]), (translation: [moft]), (initial findings: [clna]), (re-sequenced rpl10 exons: [bacs,nnon]), (mrna: [bacs,nnon]), (transcript level: [phsu]), (samples: [sbst]), (individuals: [humn]), (study: [resa]), (rpl10 exons: [bacs,nnon]), (junctions: []), (furthermore: []), (level: [phsu]), (b lymphoblastoid cell lines (blcl): [cell]), (patients: [podg]), (controls: [sbst]), (method: [lbpr]), (sybr green: [fndg]), (quantitative pcr: [mbrt]), (sets: [menp]), (primer pairs: [nnon]), (mrna expression level: [bacs,nnon]), (rpl10: rpl10-a: [aapp,bacs]), (rpl10-b: [aapp,bacs]), (cohort: [popg]), (male controls: [orga]), (similar transcript level: [phsu]), (female controls: [orga]), ((rpl10-a: [aapp,bacs]), ( u =: []), (p: [gngm]), (significant difference: [qnco]), (rpl10 transcript levels: [aapp,bacs]), (cases: [qnco]), (major effect: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(severe neurodevelopmental disorders, 'Learning Disorders')(autism, 'Autism Phenotype')

PMCID: 2603481
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (group: [popg]), (developmental disorders: [mobd]), (strong genetic underpinnings: [topp]), (several cytogenetic abnormalities: [comd]), (novo mutations: [genf]), (autism: [mobd]), (study: [resa]), (literature: [inpr,mnob]), (genotypephenotype correlations: []), (causal gene mutations: [genf]), (cytogenetic abnormalities: [comd]), (morphological phenotypes: [orga]), (information: []), (set: [menp]), (practical guidelines: []), (clinical geneticists: []), (genetic testing: [lbpr]), (patients: [podg]), (clinical phenotype: [orga]), (genomic aetiology: [gngm]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(cause autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2584230
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (previous reports: [hlca]), (association: [menp]), (autism spectrum disorders: [mobd]), (disorders: [dsyn]), (mitochondrial oxidative phosphorylation: [celc]), (study: [resa]), (children: [aggp]), (diagnoses: [fndg]), (idiopathic autism: [mobd]), (however: []), (detailed analyses: [resa]), (laboratory findings: [fndg]), (large cohort: [popg]), (comprehensive review: []), (patients: [podg]), (asd: [cgab]), (mitochondrial disorder: [dsyn]), (methodology/principal findings: [clna]), (medical records: [clna]), (primary diagnosis: [clna]), (dsm-iv-tr criteria: [gngm]), (mutation-defined mitochondrial electron transport chain (etc) dysfunction: [genf]), (major clinical abnormalities: [cgab]), (histories: []), (significant non-neurological medical problems: [fndg]), (nineteen patients: [podg]), (constitutional symptoms: [sosy]), (excessive fatigability: [sosy]), (fifteen patients: [podg]), (abnormal neurological findings: [fndg]), (unusual developmental phenotypes: [orga]), (marked delay: []), (early gross motor milestones (32%): []), (unusual patterns: []), (regression (40%): [menp]), (levels: []), (blood lactate: [bacs,orch,phsu]), ( plasma alanine: [bdsu]), (serum alt: [lbpr]), (ast: [gngm]), ( respectively: []), (common etc disorders: [dsyn]), (deficiencies: [dsyn]), (complex iii (20%): [aapp,enzy]), (rare mtdna mutations: [cgab]), (likely pathogenicity: [orga]), (conclusions/significance: [qnco]), (patients' initial diagnosis: [podg]), (biochemical assessment: [acty]), (clinical findings: [sosy]), (data: [euka]), (disturbance: []), (mitochondrial energy production: [celc]), (underlying pathophysiological mechanism: [patf]), (subset: []), (individuals: [humn]), (autism: [mobd]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(idiopathic autism, 'Autism Phenotype')(medical records, 'Medications')(primary diagnosis, 'Diagnosis')(significant non-neurological medical problems, 'Medications')(abnormal neurological findings, 'Neurologic Indications')(included marked delay in early gross motor milestones, 'Motor Skills')(idiopathic autism, 'Autism Phenotype')(patients' initial diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')

PMCID: 2625336
SFARI Genes: 
Non SFARI Genes: TLR4, TLR4, 
Named Entities: (patients: [podg]), (autism spectrum disorders: [mobd]), (clinic: [hcro,mnob]), (subset: []), (other asd children: [cgab]), (frequent infections: [fndg]), (behavioural symptoms: [sosy]), (and/or loss/decrease: [qnco]), (skills: [inbe]), (study: [resa]), (clinical features: [clna]), (asd subset: [cgab]), (atopy: [patf]), ( asthma: [dsyn]), ( food allergy (fa): [patf]), (primary immunodeficiency (pid): [dsyn]), (immune responses: [ortf]), (viral infections: [dsyn]), (asd children: [cgab]), ((asd test: [cgab]), ( n: [aapp,imft]), (following controls: asd: [cgab]), ((n =: [aapp,imft]), (non-asd controls: [cgab]), (fa (n: [aapp,imft]), (chronic rhinosinusitis/recurrent otitis media: [dsyn]), (n =: [aapp,imft]), (normal controls: []), (prevalence: [qnco]), ( fa: []), ( crs/rom: [cgab,dsyn]), (pid: [dsyn]), (innate: []), (production: []), (proinflammatory: []), (counter-regulatory cytokines: [aapp,imft]), (peripheral blood mononuclear cells: [cell]), (response: [fndg]), (agonists: [phsu]), (toll-like receptors: [aapp,rcpt]), (pre-treatment: []), (tlr4 agonist: [phsu]), (non-ige: []), (fa: [gngm]), (asd test: [cgab]), (asd control groups: [cgab]), (frequency: [qnco]), (allergic: []), (atopic/non-atopic asthma: [dsyn]), (atopic dermatitis: [dsyn]), (study groups: [popg]), (crs/rom group: [clna]), (non-atopic asthma: [dsyn]), (prevalent (52.6%): [qnco]), (crs/rom: [cgab,dsyn]), (specific polysaccharide antibody deficiency: [orch,phsu]), (asd test group: [cgab]), (asd control: [cgab]), (normal control: []), (vs: []), (crs/ros: [cgab,dsyn]), (spad: [bodm,orch]), (however: []), ( crs/rom patients: [cgab,dsyn]), (spad (34.2%): [bodm,orch]), (asd: [cgab]), (normal case controls: [sbst]), ( pbmcs: [cell]), (non-spad: [bodm,orch]), ( asd test group children: [cgab]), (tlr7/8 agonist: [phsu]), (tlr2/6 agonist: [phsu]), (lps pre-treatment: [orch]), (tlr4/7/8 agonists: [phsu]), (cytokines: [aapp,imft]), (neuro-immune network: [popg]), (altered tlr responses: [orga]), (neuro-immune interactions: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(asthma, 'Asthma')(food allergy, 'Allergies')(viral infections, 'Virus Diseases')(food allergy, 'Allergies')(chronic rhinosinusitis/recurrent otitis media, 'Otitis')(asthma, 'Asthma')(food allergy, 'Allergies')(asthma, 'Asthma')(food allergy, 'Allergies')(allergic, 'Allergies')(atopic/non-atopic asthma, 'Asthma')(non-atopic asthma, 'Asthma')(food allergy, 'Allergies')(asthma, 'Asthma')(food allergy, 'Allergies')

PMCID: 2686502
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent advances: []), (studies: [lbpr]), (autism spectrum disorders (asd): [mobd]), (many new candidate genes: [gngm]), (accelerated pace: [aapp,enzy]), (genetic complexity: [chvs]), (asd: [cgab]), (autdb: []), (on-going collection: []), (manual annotation: [inpr,mnob]), (visualization: [menp]), (genes: [gngm]), (disorder: [dsyn]), (disease-driven database model: [dsyn]), (genetic variation: candidates: [npop]), (genetic association studies: [lbpr]), (rare single gene mutations: [fndg]), (autism: [mobd]), (gene entries: [gngm]), (relevance: []), (in-depth view: [gngm]), (molecular functions: [moft]), (content: [menp]), (autdb originates: []), (scientific literature: []), (use: []), (research community: [resa]), (main focus: []), (resource: []), (up-to-date: []), ( annotated list: []), (asd candidate genes: [cgab]), (form: []), (reference dataset: []), (molecular mechanisms: []), (model: []), (consolidated knowledge representation: [menp]), (complex disorders: [dsyn]), (other such disorders: [dsyn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(visualization, 'Visual Thinking')(syndromic autism, 'Autism Phenotype')

PMCID: 2638799
SFARI Genes: MECP2, MECP2, MECP2, MECP2, MECP2, Bdnf, MECP2, Bdnf, MECP2, MECP2, MECP2, MBD1, MBD4, MECP2, MBD1, MBD4, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, MECP2, RTT, RTT, RTT, RTT, 
Non SFARI Genes: JUNB, MBD2, 
Named Entities: (mutations: [genf]), (mecp2: [gngm]), (methyl-cpg-binding protein: [gngm]), ((mecp2): [aapp,bacs]), ( cause: []), (neurodevelopmental disorder rett syndrome (rtt): [dsyn]), (mecp2 mutations: [aapp,bacs]), (idiopathic autism: [mobd]), (mecp2 levels: [aapp,bacs]), (autism cortex: [bpoc]), (postnatal neuronal maturation: [orgf]), (modulator: []), (activity-dependent genes: [gngm]), (bdnf: [gngm]), ((brain-derived neurotropic factor): [bpoc]), (junb: [gngm]), (activity-dependent early growth response gene: [orgf]), ((egr2): [gngm]), (early hindbrain development: [ortf]), (neuronal function: [phsf]), (sites: []), (promoters: [bacs,nnon]), (relevant genes: [gngm]), (conversely: []), ( mecp2 family members mbd1: [aapp,bacs]), ( mbd2: [gngm]), (mbd4: [gngm]), (methylated cpg island: [bacs,nnon]), (enhancer region: [nnon]), (egr2 intron: [bacs,nnon]), (study: [resa]), (hypothesis: []), (egr2: [gngm]), (others expression: [topp]), (neuronal maturation: [celf]), (postnatal brain development: [bpoc]), (chromatin immunoprecipitation analysis: [lbpr]), (mecp2 promoter: [aapp,bacs]), (mecp2 binding: [aapp,bacs]), (reduction: [npop]), (cultured human neuroblastoma cells: [humn]), (rna interference: [genf]), (expression: [topp]), (protein products: [aapp,bacs]), (role: [socb]), ( mecp2-deficient mouse cortex samples: [aapp,bacs]), (quantitative immunofluorescence: [lbpr]), (furthermore: []), ( mecp2: [aapp,bacs]), (increased levels: [qnco]), (postnatal development: [orgf]), (mouse: [mamm]), (human cortex: [humn]), (contrast: [irda]), (age-matched controls: [orga]), ( rtt: [dsyn]), (autism postmortem cortex samples: [bpoc]), (significant reduction: [npop]), (data support: [euka]), (dysregulation: []), (activity-dependent egr2/mecp2 pathway: [aapp,bacs]), (rtt: [gngm]), 
ASD Terms: (neurodevelopmental disorder rett syndrome, 'Learning Disorders')(idiopathic autism, 'Autism Phenotype')(autism cortex, 'Autism Phenotype')(autism postmortem cortex samples, 'Autism Phenotype')

PMCID: 2639206
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (link: []), (developmental language disorders: [mobd]), (atypical cerebral lateralization: [ortf]), (evidence: []), (inconsistent: []), (current study: [resa]), (proposal: []), (functional transcranial doppler ultrasonography (ftcd): [diap]), (blood flow: [orgf]), (middle cerebral arteries: [bpoc]), (left: []), (right cerebral hemispheres: [bpoc]), (group: [popg]), (young adults: [aggp]), (specific language: [lang]), (impairment (sli; n: [aapp,bacs]), (comparison groups: (i) adults: [inch]), (history: [orga]), (childhood sli: [aapp,bacs]), (criteria: []), (language impairment: [mobd]), (adulthood (sli-history; n: [aapp,bacs]), ((ii) adults: [aggp]), (autism spectrum disorder: [mobd]), (comorbid language: [lang]), (impairment (asd; n: [cgab]), ((iii) adults: [aggp]), (developmental disorder (typical;: [mobd]), (difference: [qnco]), (chronological age: [orga]), (groups: [popg]), (sli: [gngm]), (typical groups: [popg]), (gender: [orga]), (handedness: [orga]), (ftcd measurement: [gngm]), ( participants: [popg]), (words: []), (letter: [clna]), (these: []), (participants: [popg]), (sli-history group: [aapp,bacs]), (majority: [socb]), (asd (81.8%): [cgab]), (typical (90.9%) groups: [popg]), (activation: [acty]), (right middle cerebral arteries: [bpoc]), ( indicating: []), (hemisphere dominance: []), (contrast: [irda]), (sli groups: [aapp,bacs]), (language function: [lang]), (right: []), ((54.5%): []), (findings: [clna]), (atypical cerebral dominance: [ortf]), (cases: [qnco]), (poor language development (i.e: [fndg]), (asd: [cgab]), (sli-history groups): [aapp,bacs]), (biological marker: [clna]), 
ASD Terms: (language impairment, 'Language Ability')(specific language impairment, 'Language Ability')(autism spectrum disorder, 'Autism Phenotype')(comorbid language impairment, 'Comorbidities')(language function, 'Development or Regression of Language Skills')(poor language development, 'Language Development')

PMCID: 2670970
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (search: [acty]), (susceptibility genes: [gngm]), (autism: [mobd]), (autism spectrum disorders: [mobd]), (possible small effects: [qnco]), (individual genes: [gngm]), (genetic (locus) heterogeneity: [gngm]), (method: [lbpr]), (autism-related subphenotypes: [mobd]), (categorical diagnosis: [fndg]), (underlying susceptibility loci: [clna]), (strategy: [menp]), (analyze subsets: []), (families: [famg]), (certain clinical criteria: []), (genetic heterogeneity: [orga]), (study: [resa]), (multiplex families: [famg]), (autism genome project: [mobd]), (genome-wide linkage analyses: [gngm]), (total scores: [qnco]), (reciprocal social interaction domain: [fndg]), (restricted: []), ( repetitive: []), (patterns: []), (behavior domain: []), (autism diagnostic interview-revised: [acty]), (subsets: []), (asd families: [cgab]), (binary subphenotypes: []), (onset: [qnco]), (first phrases: [qnco]), (verbal status: []), (iq: []), (logarithm: []), (odds (lod) score: [qnco]), (chromosome: [celc]), (lod score: [qnco]), (delayed onset: [qnco]), (significant evidence: [qnco]), (linkage: [moft]), (quantitative traits: [gngm]), (selection: [genf]), (informative subphenotypes: []), (homogeneous set: [menp]), (susceptibility loci: [clna]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(categorical diagnosis, 'Diagnosis')(stereotyped patterns of behavior domain, 'Stereotyped, Restricted, and Repetitive Behavior')(autism genome project, 'Autism Phenotype')(reciprocal social interaction domain, 'Reciprocal Social Interaction')(autism diagnostic interview-revised, 'Autism Phenotype')(onset, 'Onset of Symptoms')(delayed onset, 'Onset of Symptoms')(autism, 'Autism Phenotype')

PMCID: 2516927
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (btbr t+ tf/j (btbr): [aapp,imft]), (inbred mouse strain: [mamm]), (social abnormalities: [cgab]), (repetitive behaviors: [fndg]), (third diagnostic symptoms: [sosy]), (autism: [mobd]), (ultrasonic vocalizations: [npop]), (btbr: [mamm]), (second diagnostic symptom: [clna]), ( communication deficits: [socb]), (c57bl/6j (b6): [mamm]), (btbr pups: [mamm]), (mothers: [famg]), (siblings: [famg]), (detailed analysis: [resa]), (ten categories: [dsyn]), (calls: [menp]), (unusual pattern: []), (high levels: [qnco]), (harmonics: []), ( two-syllable: [qnco]), (composite calls: [menp]), (minimal numbers: [qnco]), (chevron-shaped syllables: []), (upward: []), ( downward: []), (short calls: [menp]), (body weights: [orga]), (b6: [mamm]), (possible explanation: []), (thoracic size: []), (louder: []), (different distribution: []), (syllable categories: []), (possibility: []), (separation calls: [menp]), (fvb/nj: [mamm]), (strain: [menp]), (outlier: [qnco]), (number: [qnco]), (low numbers: [qnco]), (complex: [chvs]), ( chevron: []), ( short: [qnco]), (frequency steps: [qnco]), (high harmonics: [qnco]), (composites: []), (further: []), (developmental milestones: []), (growth rates: []), (unusual neurodevelopmental trajectory: [ortf]), (overall: []), (findings: [clna]), (strain-specific patterns: [menp]), (ultrasonic calls: [npop]), (different lexicons: []), (innate variations: []), (complex vocal repertoires: [chvs]), (distinct strains: [inpo]), (mice: [mamm]), (intriguing: []), (vocalizations: [fndg]), (frequent: []), ( loud harmonics: []), (btbr mouse model: [mamm]), (atypical vocalizations: [fndg]), (autistic infants: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(social abnormalities, 'Social Competence')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(ultrasonic vocalizations, 'Vocalizations')(autism, 'Autism Phenotype')(unusual neurodevelopmental trajectory, 'Learning Disorders')(complex vocal repertoires, 'Vocalizations')(vocalizations, 'Vocalizations')(autism, 'Autism Phenotype')(loud harmonics, 'Immoderate Behavior')(atypical vocalizations, 'Vocalizations')

PMCID: 2518921
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (gamma-band oscillations: [npop]), (human electrophysiological recordings: [humn]), (perceptual binding: [moft]), (neuronal connectivity: [imft]), (people: [popg]), (autism: [mobd]), (transient auditory gamma-band responses: [npop]), ( however: []), (first-degree relatives: [qnco]), (persons: [popg]), (transient: [popg]), (magnetic gamma-band power: [npop]), (inter-trial phase-locking consistency: [qnco]), (magnetoencephalographic recordings: [diap]), (parents: []), (children: [aggp]), (adults: [aggp]), (control participants: [popg]), (source space projection: [fndg]), (left: []), (right: []), (transient gamma-band measures: [npop]), (power: [hcpp]), (phase-locking: []), (gamma-power: [npop]), (hz: [qnco]), (parent: []), (autism groups: [mobd]), (controls: [sbst]), (gamma-band power: [npop]), (phase-locking factor: []), (measure: [qnco]), (phase consistency: [qnco]), (neuronal responses: [orga]), (external stimuli: [phpr]), (subjects: [humn]), (autism parent group: [mobd]), (difference: [qnco]), (induced power results: [hcpp]), (findings: [clna]), (first degree relatives: [qnco]), (gamma-band phase consistency: [npop]), (changes: [qnco]), (induced versus: []), (useful endophenotypes: []), (molecular mechanisms: []), (generation: [acty]), (gamma-band signals: [npop]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism groups, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism parent group, 'Autism Phenotype')

PMCID: 3823459
SFARI Genes: PON1, PON1, PON1, PON1, PON1, PON1, PON1, PON1, PON1, PON1, 
Non SFARI Genes: 
Named Entities: (abstract autism spectrum disorders: [mobd]), (heterogeneous group: [popg]), (conditions: [dsyn]), (unknown aetiology: [fndg]), (significant disturbances: [qnco]), (social: []), ( communicative: [socb]), (behavioural functioning: [inbe]), (recent studies: [lbpr]), (possible implication: []), (high-density lipoprotein: [aapp,bacs]), (esterase/lactonase paraoxonase: [aapp,enzy]), ((pon1): [aapp,enzy]), (asd: [cgab]), (present study: [qnco]), (pon1 status: [aapp,enzy]), (group: [popg]), (children: [aggp]), (healthy age: [orga]), (sex: [orgf]), (control participants: [popg]), (pon1 bioavailability (i.e: [qnco]), (arylesterase activity): [moft]), (catalytic activity (i.e: [qnco]), (paraoxonase activity): [moft]), (plasma: [bdsu]), (spectrophotometric methods: [lbpr]), (common polymorphisms: [genf]), (pon1: [gngm]), (region (q192r: []), ( l55m): []), (light cycler: [npop]), (real-time pcr: [mbrt]), (pon1 arylesterase: [aapp,enzy]), (pon1 paraoxonase activities: [aapp,enzy]), (autistic patients: [mobd]), (p <: [aapp,imft]), (p: [gngm]), (association: [menp]), (active variants: []), (pon1 gene: [gngm]), (pon1 phenotype: [aapp,enzy]), (two-dimensional enzyme analysis: [enzy,orch]), (similar distribution: []), (asd group: [cgab]), (control group: [grup]), (conclusion: []), (bioavailability: [qnco]), (catalytic activity: [qnco]), (q192r: []), (l55m polymorphisms: [genf]), (normal distribution: [qnco]), 
ASD Terms: (significant disturbances in social, 'Social Competence')(abstract autism spectrum disorders, 'Autism Phenotype')

PMCID: 2492880
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mlpa method: [mbrt]), (useful semi-quantitative method: [lbpr]), (copy number alterations: [qnco]), (targeted regions: []), (paper: []), (method: [lbpr]), (normalization procedure: [topp]), (non-linear mixed-model: [fndg]), (new approach: []), (statistical significance: [qnco]), (probes: [chvf]), (linear mixed-model: [qnco]), (threshold: []), (different tolerance intervals: [fndg]), (specific random error variability: [resa]), (test sample: [lbpr]), (simulation studies: [lbpr]), (methods: []), (simple threshold rules: []), (iterative regression: [menp]), (mlpa assay: [mbrt]), (copy number: [qnco]), (individuals: [humn]), (different disorders: [dsyn]), (prader-willi: []), ( digeorge: []), (autism: [mobd]), (performace: []), (mixed-model: [fndg]), (thresholds: []), (region: []), (threholds: []), (individual: [humn]), (experimental variability: []), (improved sensitivity: [patf]), (specificity: [qnco]), (examples: []), (real data: [euka]), (revealed: []), 
ASD Terms: (prader-willi, 'Prader-Willi Syndrome')(autism, 'Autism Phenotype')

PMCID: 2488334
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (research: [resa]), (last fifty years: [qnco]), (many autistic individuals: [mobd]), (serotonin (5-hydroxytryptamine: [bacs,orch]), ( 5-ht) levels: [bacs,orch]), (blood platelets: [cell]), (phenomenon: [phpr]), (platelet hyperserotonemia: [cell]), (autism: [mobd]), (well-replicated findings: [clna]), (biological psychiatry: []), (replicability: []), (genes: [gngm]), (small number: [qnco]), (biological networks: []), (networks: []), (role: [socb]), (early development: [orgf]), (autistic brain: [mobd]), (equation: []), (calculation: [acty]), (platelet: [cell]), (5-ht concentration: [bacs,orch]), (function: [phsf]), (measurable biological parameters: [fndg]), (information: []), (sensitivity: [patf]), (5-ht levels: [bacs,orch]), (parameters: [fndg]), (interactions: []), (model yields: []), (5-ht concentrations: [bacs,orch]), (values: []), (experimental studies: [resa]), (model: []), (changes: [qnco]), (5-ht uptake rate: [moft]), (proportion: [qnco]), (liver: [bpoc]), (gut 5-ht production rate: [dsyn]), (regulation: [biof]), (volume: [qnco]), (gut wall: [blor]), (non-linear interactions: []), (other parameters: [fndg]), (design: [acty]), (interpretation: [clna]), 
ASD Terms: (autism, 'Autism Phenotype')

PMCID: 2391141
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (glutathione (gsh): [aapp,bacs]), (important role: [socb]), (anti-oxidant defense: [chvf]), (detoxification reactions: [orgf]), (liver: [bpoc]), (transsulfuration pathway: [moft]), (precursors: []), (situ gsh synthesis: [dsyn]), (other tissues: [tisu]), (deficits: []), (glutathione: [aapp,bacs]), (host: [orgm]), (diseases: [dsyn]), (alzheimer's disease: [dsyn]), ( parkinson's: [plnt]), (cardiovascular disease: [dsyn]), (down syndrome: [cgab,dsyn]), (autism: [mobd]), (approach: []), (properties: []), (glutathione metabolism: [moft]), (mathematical model: []), (one-carbon metabolism: [moft]), (glutathione synthesis: [moft]), ( transport: [celf]), (breakdown: [orgf]), (model: []), (known properties: []), (enzymes: [enzy,orch]), (regulation: [biof]), (oxidative stress: [comd]), (half-life: []), (sensitivity: [patf]), (fluctuations: [sosy]), (amino acid input: [aapp,bacs,phsu]), (metabolic profiles: [phsf]), (model results: [fndg]), (clinical data: []), (hepatic cells: [cell]), (blood: [bdsu]), (explanation: []), (model predictions: []), (contrast: [irda]), (hepatic glutathione pools: [aapp,bacs]), (level: [phsu]), (overexpression: [genf]), (genes: [gngm]), (chromosome: [celc]), (increase: []), (metabolic profile: [phsf]), (adenosine concentration: [bacs,nnon,phsu]), (individual variation arises: [humn]), (consequences: []), (one-carbon: [elii]), 
ASD Terms: (cardiovascular disease, 'Cardiovascular Diseases')(down syndrome, 'Down Syndrome')(autism, 'Autism Phenotype')(down syndrome, 'Down Syndrome')(autism, 'Autism Phenotype')

PMCID: 2373955
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (high incidence: [qnco]), (chromosomal aberrations: [comd]), (population: [popg]), (persons: [popg]), (autism: [mobd]), (causal relationship: []), (certain chromosomal aberrations: [comd]), (occurrence: []), (isolated idiopathic autism: [mobd]), (cytogenetic findings: [clna]), (male patient: [orga]), (physical abnormalities: [hlca]), (translocation: [comd]), (g-banded chromosomes: [celc]), (fluorescent: [irda,orch]), (situ hybridization (fish): [mbrt]), (patient's karyotype: [resa]), (parents': []), (fish: [gngm]), (specific rp11-bac clones: [dsyn]), (location: [blor]), (breakpoints: []), (is: []), (knowledge: []), (first report: [qnco]), (individual: [humn]), (specific chromosomal aberration: [comd]), 
ASD Terms: (isolated idiopathic autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3111012
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (collection: []), (conditions: [dsyn]), (have: []), (common: [qnco]), (impaired socialization: [edac]), (communication: [socb]), (association: [menp]), (stereotypic behaviors: [mobd]), (incidence: [qnco]), (past decade: [qnco]), (large amount: [qnco]), (attention: [menp]), (lay: []), (professional groups: [popg]), (influences: []), (marked increase: []), (number: [qnco]), (referrals: [hlca]), (clinical geneticists: []), (evaluation: [hlca]), (persons: [popg]), (primary role: [socb]), (geneticist: []), (process: [phpr]), (etiology: []), (possible: []), (counseling: [hlca]), (contribute: [acty]), (case management: [hlca]), (results: [fndg]), (such investigations: [hlca]), (appropriate evaluation scheme: [hlca]), (particular patient: [podg]), (host: [orgm]), (different factors: []), (such considerations: [fndg]), ((1) assuring: [fndg]), (accurate diagnosis: [fndg]), (autism: [mobd]), (investigation: [hlca]), ((2): [qnco]), (options: []), ( diagnostic yields: [fndg]), (patient investment: [podg]), ((3) communication: [socb]), (coordination: [phsf]), (patients: [podg]), (medical home: [hlca]), ((4): []), (continuously: []), (list: []), (available laboratory: [mnob,orgt]), (modalities: []), (light: [gngm]), (evidence-based medicine: []), ((5): [qnco]), (phenotypes: [orga]), (metabolic conditions: [dsyn]), ((6): []), (individualized evaluation scheme: [hlca]), (unique history: [orga]), (clinical features: [clna]), (patient: [podg]), (guidelines: []), (article: []), (clinician: []), (consideration: [fndg]), (factors: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(impaired socialization, 'Social Competence')(stereotypic behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(accurate diagnosis, 'Diagnosis')(coordination, 'Motor Skills')(medical home, 'Medications')(metabolic conditions, 'Metabolic Indications')

PMCID: 2567426
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (frontal lobe: [bpoc]), (white matter: [tisu]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (diffusion tensor: [npop]), ((dti): [diap]), (asd children: [cgab]), (months: []), (males): [orga]), (apparent diffusion coefficient (adc): []), (whole frontal lobe (p: [bpoc]), (long (p <: [aapp,imft]), (short range (p =: [aapp,imft]), (association fibers: [menp]), (asd group: [cgab]), (trend: []), (statistical significance: [qnco]), (fractional anisotropy (fa): [npop]), (whole frontal lobe fibers: [tisu]), (fa: [gngm]), (short range fibers: [tisu]), (long range fibers: [tisu]), (significant [ns]): [qnco]), (between-group difference: [popg]), (number: [qnco]), (frontal lobe fibers: [bpoc]), ((p = ns): [aapp,imft]), (fiber length distribution: [anim]), (normal population: [popg]), (asd group (p: [cgab]), (long range association fibers: [menp]), (left: []), (right hemispheres): []), (abnormal: [qnco]), (frontal fa: []), (adc: [gngm]), (white matter organization abnormalities: [patf]), (asd: [cgab]), (lack: []), (evidence: []), (excessive short range connectivity: [qnco]), (study: [resa]), (future advances: []), (dti technology: [diap]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 2643049
SFARI Genes: CNTN4, CNTN4, CNTN4, CNTN4, 
Non SFARI Genes: 
Named Entities: (background: autism: [mobd]), (disorder (asd): [cgab]), (developmental disorder: [mobd]), (central nervous system: [bdsy]), (unknown aetiology: [fndg]), (prevalence: [qnco]), (syndrome: [dsyn]), (need: []), (biological markers: [clna]), (clearer understanding: [menp]), (pathogenesis: [patf]), (genetic study: [resa]), (idiopathic asd: [cgab]), (methods: []), (array: []), (comparative genomic hybridisation: [mbrt]), (chromosome: [celc]), (copy number variation (cnv): [nusq]), (subjects:: [humn]), (deletion: [genf]), (siblings: [famg]), (duplication: [comd]), (third: [qnco]), (unrelated individual: [fndg]), (variations: []), (fluorescence: [npop]), (situ hybridisation (fish): [mbrt]), (end: [gngm]), (custom: [acty]), (oligonucleotide array: []), (polymerase chain reaction (pcr) products: [mbrt]), (rearrangements: [genf]), (sequence analysis: [lbpr,mbrt]), (alu y: []), (unequal recombinations: [genf]), (contactin: [aapp,bacs]), ((cntn4): [gngm]), (conclusion: cntn4: [gngm]), (essential role: [socb]), (formation: [biof]), ( maintenance: [acty]), (plasticity: [npop]), (neuronal networks: [imft]), (disruption: []), (gene: [gngm]), (developmental delay: [mobd]), (mental retardation: [mobd]), (report: [hlca]), (mutations: [genf]), (cntn4 function: [phsf]), (asd pathogenesis: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(developmental delay, 'Learning Disorders')(mental retardation, 'Mental Retardation')

PMCID: 2265260
SFARI Genes: C4B, C4B, C4B, C4B, C4B, C4B, C4B, C4B, C4B, C4B, 
Non SFARI Genes: CYP21A2, CYP21A2, CYP21A2, CYP21A2, CYP21A2, 
Named Entities: (research: [resa]), (etiology: []), (autism: [mobd]), (strong genetic component: [gngm]), (search: [acty]), (genes: [gngm]), (disorder: [dsyn]), (several whole genome scans: [mbrt]), (few consistent findings: [qnco]), (however: []), (studies: [lbpr]), (complement c4b gene: [aapp,imft]), (null allele: [comd]), (nonfunctional c4b gene): [gngm]), (individuals: [humn]), (close proximity: [fndg]), (cyp21a2 gene: [gngm]), (c4b locus (3: [fndg]), (samples: [sbst]), (autistic subjects: [mobd]), (known c4b null alleles: [comd]), (common cyp21a2 mutations: [genf]), (subjects: [humn]), (non-autistic controls: [mobd]), (c4b: [gngm]), (null alleles: [comd]), (allele: [gngm]), (specific polymerase chain reaction (pcr) methods: [mbrt]), (common cyp21a2: [qnco]), (genetic mutations: [genf]), (enzyme: [enzy,orch]), (combined autism: [mobd]), (control study subjects: [humn]), (c4b null: [qnco]), (cyp21a2 mutations: [genf]), (genotypes: [orga]), (mutations: [genf]), (autistic samples: [mobd]), (controls: [sbst]), (frequency: [qnco]), (control samples: []), (individual (autistic): [mobd]), (chromosome: [celc]), (c4b null allele: [comd]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(combined autism, 'Autism Phenotype')

PMCID: 2222245
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (complex: [chvs]), ( heterogeneous: [orga]), (behaviorally-defined disorder: [dsyn]), (disruptions: []), (nervous system: [bdsy]), (other systems: []), (pituitary-hypothalamic axis: [bpoc]), (previous genome: [gngm]), (wide screen: [hlca]), (linkage: [moft]), (megabase interval: [qnco]), (chromosome: [celc]), (current study: [resa]), (genes: [gngm]), (region: []), (development: [orgf]), (paired-like homeodomain transcription factor: [aapp,bacs]), ((pitx1): [gngm]), (key regulator: []), (hormones: [horm]), (neurogenin: []), (transcription factor: [aapp,bacs]), (neurogenesis: [orgf]), (histone family member y (h2afy): [aapp,bacs]), (x-chromosome inactivation: [genf]), (females: [orga]), (male:female gender distortion present: [orga]), (total: [qnco]), (families: [famg]), (autism genetic resource exchange (agre) repository: [mobd]), (individuals: [humn]), (affected children: [aggp]), (study: [resa]), (single: [fndg]), (candidate genes: [gngm]), (initial linkage sample: [moft]), (second step: [qnco]), (analysis: [resa]), (snps: [nusq]), (pitx1 gene: [gngm]), (association: [menp]), (fbat software version: []), (single snp analysis: [fndg]), (hbat command: []), (same package: [qnco]), (haplotype analysis respectively: [orga]), (pitx1: [gngm]), (haplotype analysis: [orga]), (evidence: []), (overtransmission: []), (a-c haplotype: [orga]), (markers: [clna]), (rs6596189 (p: [aapp,imft]), (a-c haplotype risk allele: [gngm]), (fold: [phpr]), (allele: [gngm]), ( respectively: []), (consistent association: [menp]), (data: [euka]), (etiology: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism genetic resource exchange repository, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 2244616
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recently: []), (hyperbaric oxygen therapy (hbot): [topp]), (popularity: [socb]), (treatment: [topp]), (autism: [mobd]), (numerous studies: [lbpr]), (oxidative stress: [comd]), (inflammation: [patf]), (individuals: [humn]), (conditions: [dsyn]), (improvement: []), (hbot: []), (enhancement: [acty]), (neurological function: [ortf]), (cognitive performance: [inbe]), (study: [resa]), ( children: [aggp]), (atmospheric pressures: [npop]), (oxygen concentrations: [fndg]), (current use: [npop]), (condition: [dsyn]), (changes: [qnco]), (markers: [clna]), (measured: [diap]), (children: [aggp]), (clinical effects: []), (safety: [hcpp]), (eighteen children: [aggp]), ( ages: [bacs,orch]), (hyperbaric sessions: [evnt]), (minutes: [qnco]), (atmospheres (atm): [npop]), (oxygen: [elii,phsu]), (atm: [gngm]), (measurements: []), (c-reactive protein (crp): [aapp,imft]), (glutathione (gssg): [aapp,phsu]), (blood draws: [bdsu]), (treatments: [topp]), (clinical symptoms: [sosy]), (parents: []), (potential adverse effects: [patf]), (endpoint: [qnco]), (group: [popg]), (significant changes: [qnco]), (mean plasma gssg: [aapp,phsu]), (intracellular oxidative stress: [comd]), (regimen: [topp]), (trend towards improvement: []), (mean crp: [aapp,imft]), (improvements: []), (elevations: []), (crp: [gngm]), (significant improvement: [qnco]), ((p: [aapp,imft]), (post-parental observations: [hlca]), (significant improvements: [qnco]), (motivation: [menp]), ( speech: [orgf]), (cognitive awareness (p: [menp]), (major adverse events: [patf]), (prospective pilot study: [resa]), ( hbot: []), (maximum pressure: [phpr]), (decreased inflammation: [patf]), (crp levels: [aapp,imft]), (parental observations: [hlca]), (anecdotal accounts: [clna]), (several domains: [qnco]), (however: []), (open-label study: [resa]), (definitive statements: []), (efficacy: [resa]), (results: [fndg]), (trials: [resa]), (trial registration clinicaltrials.gov nct00324909: [resa]), 
ASD Terms: (autism, 'Autism Phenotype')(neurological function, 'Neurologic Indications')(cognitive performance, 'Cognitive Ability')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(speech, 'Language Ability')(cognitive awareness, 'Cognitive Ability')(autism, 'Autism Phenotype')

PMCID: 2248565
SFARI Genes: NSD1, NSD1, NSD1, NSD1, NSD1, NSD1, NSD1, NSD1, NSD1, NSD1, 
Non SFARI Genes: 
Named Entities: (sotos syndrome: [cgab,dsyn]), (overgrowth syndrome: [dsyn]), (macrocephaly: [cgab]), (bone age: [fndg]), (characteristic facial features: [orga]), (disabilities: [fndg]), (mutations: [genf]), (deletions: [genf]), (nsd1 gene: [gngm]), (number: [qnco]), (patients: [podg]), (autism spectrum disorders: [mobd]), (nsd1: [gngm]), (other cases: [qnco]), (autism: [mobd]), (circumference: [qnco]), (standard deviations: [qnco]), (mean): [qnco]), (mutation analysis: [lbpr]), (direct sequencing: [mbrt]), (exons: [bacs,nnon]), (regions: []), (dosage analysis: [resa]), (multiplex ligation-dependent probe amplification: [mbrt]), (missense variants: [fndg]), (s822c: []), (e1499g): []), (patient each: [podg]), (none: []), (functional domain: []), (addition: []), ( segregation analysis: [socb]), (variants: []), (healthy parents: []), (cases: [qnco]), (unaffected siblings: [famg]), (whole gene deletions/duplications: [genf]), (findings: [clna]), (rare cause: [gngm]), (nsd1 mutations: [aapp,bacs]), (absence: [anab]), (other features: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 2022638
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (ambient levels: []), (pesticides: [hops]), (drift): []), (residences: []), (agricultural field sites: []), (goal: []), (hypothesis: []), (maternal residence: [famg]), (agricultural pesticide applications: [hops]), (key periods: []), (gestation: [orgf]), (development: [orgf]), (autism spectrum disorders: [mobd]), (children: [aggp]), (asd: [cgab]), (california department: [orgt]), (developmental services: [orgf]), (electronic files: []), (maternal date: [famg]), (last menstrual period: []), (live-born: [orgf]), ( normal-birth-weight: [fndg]), ( term infants: [aggp]), (controls: [sbst]), (proximity: []), (applications: [hlca]), (pesticide regulation records: [hops]), (department: [orgt]), (water: [sbst]), (land use polygons: []), (staged analytic design: [acty]), (priori criteria: []), (results: [fndg]), (conditional logistic regressions: [resa]), (associations: [menp]), (error: []), (organochlorine pesticide: [hops,orch]), (dicofol: [hops,orch]), (period: []), (concurrent: []), (central nervous system: [bdsy]), ((clinical weeks: []), (criteria: []), (result: [fndg]), (multiple testing: [qnco]), (multivariate: []), (posteriori models: []), (mothers: [famg]), (m: [aapp,imft]), (field sites: [irda]), (nonzero quartile: []), (organochlorine poundage: []), (odds ratio: [qnco]), ((95% confidence interval: [qnco]), (asd risk: [cgab]), (poundage: []), (organochlorine: []), (distance: [qnco]), (association: [menp]), (residential proximity: [humn]), (pesticide applications: [hops]), (further studied: [resa]), 
ASD Terms: (gestation, 'Perinatal History')(autism spectrum disorders, 'Autism Phenotype')(gestation, 'Perinatal History')

PMCID: 1914111
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (group: [popg]), (neurodevelopmental conditions: [dsyn]), (incidence: [qnco]), (epidemic proportions: [phpr]), (children: [aggp]), (autistic disorder: [mobd]), (autism: [mobd]), (common form: [qnco]), (asd: [cgab]), (several neurophysiological alterations: [qnco]), ( immune abnormalities: [cgab]), (neural hypoperfusion: [patf]), (correlation: []), (altered inflammatory responses: [patf]), (hypoperfusion: [patf]), (symptology: []), (mesenchymal stem cells: [cell]), (late phases: []), (clinical development: [orgf]), (treatment: [topp]), (graft versus host disease: [dsyn]), (crohn's disease: [dsyn]), (conditions: [dsyn]), (immune dysregulation: [fndg]), (cord blood cd34+ cells: [tisu]), (potent angiogenic stimulators: [phsu]), (positive effects: [fndg]), (peripheral ischemia: [patf]), (models: []), (cerebral ischemia: [dsyn]), (additionally: []), (anecdotal clinical cases: [qnco]), (responses: [orga]), (autistic children: [podg]), (combined use: []), (msc: [gngm]), (cord blood cd34+cells: [tisu]), 
ASD Terms: (neurodevelopmental conditions, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')(autistic disorder, 'Autistic Disorder')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 1888683
SFARI Genes: NRG1, NRG1, NRG1, NRG1, NRG1, NRG1, 
Non SFARI Genes: Mb, 
Named Entities: (genetic study: [resa]), (autism: [mobd]), (isolated population: [popg]), (central valley: [lbpr]), (costa rica (cvcr): []), (novel neuregulin: [aapp,horm]), ((nrg1) missense variant: [aapp,bacs]), (g>t): [qnco]), (psychosis: [mobd]), (schizophrenia (scz): [mobd]), (same population isolate: [popg]), (nrg1: [gngm]), (missense variant: [fndg]), (cases: [qnco]), (autism spectrum disorder: [mobd]), (cvcr ancestry: []), (parents: []), (available (n: [aapp,imft]), (parents): []), (independent families: [famg]), (additional microsatellites: [bacs,nnon]), (haplotypes: [orga]), (exon: [bacs,nnon]), (variant: []), (g>t variant: [qnco]), (occurrence: []), (frequency: [qnco]), (case chromosomes: [celc]), (parental non-transmitted chromosomes: [celc]), (mb: [gngm]), (t allele: [gngm]), (independent individuals: [humn]), (family history: [fndg]), (psychiatric disorder: [mobd]), (megabase haplotype: [orga]), (cvcr: []), 
ASD Terms: (autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorder, 'Autism Phenotype')(psychiatric disorder, 'Mental Disorders')

PMCID: 1865561
SFARI Genes: Klf16, Klf16, 
Non SFARI Genes: KLF14, KLF14, Klf14, Klf14, Klf14, KLF14, KLF14, 
Named Entities: (genes: [gngm]), (parent-of-origin manner: []), (clusters: [qnco]), (genome: [gngm]), (aberrations: []), (expression: [topp]), (imprinted genes: [gngm]), (human chromosome: [celc]), (role: [socb]), (etiologies: []), (russell-silver syndrome: [dsyn]), (imprinting: [menp]), (klf14: [gngm]), (intronless member: [popg]), (krppel-like family: [famg]), (transcription factors: [aapp,bacs]), (chromosome: [celc]), (monoallelic maternal expression: [topp]), (extra-embryonic tissues: [emst]), (mouse: [mamm]), (epigenetic modifications: [genf]), (klf14 cpg island: [bacs,nnon]), (species: []), (region: []), (addition: []), (chromatin immunoprecipitation: [lbpr]), (murine klf14 cpg island: [mamm]), (allele-specific histone modifications: [gngm]), (absence: [anab]), (analysis: [resa]), (dna methyltransferase: [aapp,enzy]), (conditional knockout mice reveals: [mamm]), (gene's expression: [genf]), (intronless nature: []), (homology: [gngm]), (klf16: [gngm]), (gene: [gngm]), (ancient: []), (copy: []), (sequence analysis: [lbpr,mbrt]), (numerous species: [qnco]), (timing: []), (event: [evnt]), (divergence: []), (marsupialia: [mamm]), (xenarthra superclade: [mamm]), (large number: [qnco]), (sequence variants: [npop]), (klf14 and: [gngm]), (several measures: [qnco]), (diversity: []), (variability: []), (human lineage: [humn]), (increased number: [qnco]), (nonsynonymous changes: [qnco]), (human-specific accelerated evolution: [humn]), (thus: []), ( klf14: [gngm]), (first example: [qnco]), (imprinted transcript: [menp]), (evolution: [genf]), 
ASD Terms: 

PMCID: 1868708
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (quality: []), (life (qol): [sosy]), (parents: []), (children: [aggp]), (developmental diseases: [mobd]), (psychiatric disorders: [mobd]), (aims: [phsu]), (present study were:: [qnco]), (qol: [sosy]), (pervasive development disorder (pdds): [mobd]), ( cerebral palsy (cp): [dsyn]), (mental retardation (mr): [mobd]), (control group (cg);: [grup]), (patients: [podg]), (different types: []), (pdds: []), (autistic disorder (ad): [mobd]), ( high function autism/asperger syndromes (hfa/as): [mobd]), (pervasive developmental disorder: [mobd]), ((ppd-nos);: [aapp,imft,irda]), (level: [phsu]), (impairment: [patf]), (mothers: [famg]), (fathers: [famg]), ( cp: []), ( mr groups: [popg]), (ad: []), ( hfa/as: [dsyn]), ( pdd-nos sub-groups: [dsyn]), (sample: [sbst]), ((115 mothers: [famg]), (fathers): [famg]), (adolescents: [aggp]), ( mr: [gngm]), (cp: [gngm]), (additional sample: [sbst]), ((42 mothers: [famg]), (healthy children: [fndg]), (control group: [grup]), (whoqol-bref questionnaire: []), ( parents: []), (pdds group: [popg]), (physical activity (p: [dora]), (social relationships: []), (overall perception: [menp]), (qol (p =: [aapp,imft]), (health (p: [aapp,imft]), (scores: [clna]), (physical (p =: [hlca]), (psychological (p: [aapp,imft]), (domains: []), (mr group cp group respectively: [popg]), (little differences: [qnco]), (mr: [gngm]), (groups: [popg]), (well-being: []), (cp groups: [popg]), (other groups: [popg]), (other domains: []), (qql impairment: [patf]), (significant differences: [qnco]), (pdd-nos sub-groups: [dsyn]), (hfa/as sub-group: [dsyn]), (ad sub-group: [popg]), (burden: []), (combination: [fndg]), (genetic factors: [fndg]), (group: [popg]), (hfa: [dsyn]), (people: [popg]), (stress: [fndg]), (finding: [sosy]), (account: [clna]), (policy making: []), (specific supports: []), (interventions: [hlca]), (diseases: [dsyn]), 
ASD Terms: (psychiatric disorders, 'Mental Disorders')(different types of pervasive development disorder, 'Learning Disorders')(mental retardation groups, 'Mental Retardation')(mental retardation, 'Mental Retardation')(autistic disorder, 'Autistic Disorder')(mental retardation groups, 'Mental Retardation')(mental retardation, 'Mental Retardation')(overall perception, 'Cognitive Ability')(mental retardation group cerebral palsy group respectively, 'Mental Retardation')(autistic disorder sub-group, 'Autistic Disorder')

PMCID: 1851007
SFARI Genes: TPH2, TPH2, TPH2, TPH2, GLO1, GLO1, GLO1, GLO1, TPH2, GLO1, TPH2, GLO1, TPH2, TPH2, GLO1, GLO1, TPH2, TPH2, GLO1, GLO1, 
Non SFARI Genes: 
Named Entities: (tph2 gene: [gngm]), (enzyme: [enzy,orch]), (serotonin (5-ht) synthesis: [bacs,orch]), (central nervous system: [bdsy]), (stereotypic: [menp]), (repetitive behaviors: [fndg]), (initial studies: [lbpr]), (association: [menp]), (tph2 alleles: [gngm]), (childhood-onset obsessive-compulsive disorder (ocd): [mobd]), (autism: [mobd]), (glo1: [gngm]), (glyoxalase i: [aapp,enzy]), (-oxoaldehydes: []), (methylglyoxal: [irda,orch]), (living cells: [cell]), (a111e glo1 protein variant: [aapp,bacs]), (snp c419a: [nusq]), (autopsied autistic brains: [diap]), (autism susceptibility factor: [mobd]), (hyperserotoninemia: []), ( macrocephaly: [cgab]), (peptiduria: []), (best-characterized endophenotypes: [acty]), (autism research: [mobd]), (case-control association studies: [menp]), (clinical samples: [sbst]), (simplex: [bpoc]), (multiplex families: [famg]), (non-syndromic autistic patients: [mobd]), (unaffected siblings: [famg]), (controls: [sbst]), (tph2 snps rs4570625: [nusq]), (rs4565946: []), (taqman assay; glo1 snp c419a: [nusq]), (pcr: [mbrt]), (allele-specific restriction digest: [gngm]), (family-based association analyses: [socb]), (tdt: [gngm]), (fbat: []), ( case-control: [hlca]), (2: [qnco]), ( endophenotypic analyses: [resa]), (5-ht blood levels: [bacs,orch]), (cranial circumference: [bpoc]), (urinary peptide excretion rates: [aapp]), (anova: [gngm]), (haplotypes: [orga]), (sample: [sbst]), (autism (rs4570625: tdt p =: [mobd]), (fbat p: []), (rs4565946: tdt p =: [aapp,enzy]), (haplotype p: [orga]), (endophenotype: []), (presence/absence: []), (prominent repetitive: []), (behaviors (motor: [inbe]), (p =: [aapp,imft]), (verbal stereotypies: p: [mobd]), (rs4570625: []), ( respectively): []), (glo1 alleles: [gngm]), (autism (191 patients: [mobd]), ( p: [aapp,imft]), (tdt p =: [aapp,enzy]), (protective gene variant: [gngm]), (a419 allele (tdt p: [gngm]), (patients: [podg]), (unaffected siblings tdt: [famg]), (tph2 gene variants: [gngm]), (prominent repetitive behaviors: [fndg]), (influence: []), (intensity: []), (behaviors: [inbe]), (autism cannot: [mobd]), (glo1 gene variants: [gngm]), (autism vulnerability: [mobd]), (allele a419: [gngm]), (protective effect: []), (interest: [menp]), (functional correlates: []), (c419a snp: [nusq]), 
ASD Terms: (stereotypic, 'Stereotyped, Restricted, and Repetitive Behavior')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(childhood-onset obsessive-compulsive disorder, 'Obsessive-Compulsive Disorder')(autism, 'Autism Phenotype')(autism susceptibility factor, 'Autism Phenotype')(autism research, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(prominent repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism cannot, 'Autism Phenotype')(confer autism vulnerability, 'Autism Phenotype')

PMCID: 1781426
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction autism: [mobd]), (complex neuro-developmental disorder: [mobd]), (symptomatic diagnosis: [fndg]), (patients: [podg]), (disorders: [dsyn]), (language/communication: [lang]), ( behavior: [inbe]), (social interactions: [fndg]), (exact causes: []), (autism: [mobd]), (immune: []), (inflammatory responses: [patf]), (th2 type: [qnco]), (thiazolidinediones (tzds): [orch,phsu]), (agonists: [phsu]), (peroxisome proliferator: [hops]), (receptor gamma: [npop]), (nuclear hormone receptor: [aapp,rcpt]), (insulin sensitivity: [patf]), (apoptosis: [celf]), (activated t-lymphocytes: [lbpr]), (exert anti-inflammatory effects: [orgf]), (glial cells: [cell]), (tzd pioglitazone (actos): [orch,phsu]), (fda-approved ppar agonist: [hcro]), (diabetes: [dsyn]), (good safety profile: [hcpp]), (clinical trials: [resa]), (other neurological diseases: [dsyn]), (ad: []), (ms: [gngm]), (safety: [hcpp]), (therapeutic potential: [topp]), (oral pioglitazone: [orch,phsu]), (small cohort: [popg]), (children: [aggp]), (diagnosed autism: [mobd]), (case description: []), (rationale: []), (risks: []), (pioglitazone: [orch,phsu]), (parents: []), ( consent: []), (treatment: [topp]), (mg: [elii,phsu]), (day p.o: []), (total: [qnco]), ((average age: [orga]), (year old): []), (measurements: []), (metabolic profiles: [phsf]), (blood pressure; effects: [orgf]), (behavioral symptoms: [sosy]), (aberrant behavior checklist (abc): [inbe]), (hyperactivity: [mobd]), ( inappropriate speech: [orgf]), ( irritability: [fndg]), ( lethargy: [sosy]), (baseline: [bodm]), (months: []), (discussion: [socb]), (evaluation: [hlca]), (autistic children: [podg]), ( daily treatment: [topp]), (mg p.o: [elii,phsu]), (apparent clinical improvement: []), (adverse events: [patf]), (adverse effects: [patf]), (behavioral measurements: [inbe]), (significant decrease: [qnco]), (subcategories: []), (lethargy: [sosy]), ( stereotypy: [mobd]), (hyperactivity): [mobd]), (behaviors: [inbe]), (patient age: [podg]), (effects: []), (further testing: []), (autistic patients: [mobd]), 
ASD Terms: (symptomatic diagnosis, 'Diagnosis')(introduction autism, 'Autism Phenotype')(social interactions, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(other neurological diseases, 'Neurologic Indications')(diabetes, 'Diabetes Mellitus Type 1')(diagnosed autism, 'Autism Phenotype')(hyperactivity, 'Overactivity')(inappropriate speech, 'Language Ability')

PMCID: 2000292
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (attention deficit hyperactivity disorder (adhd): [mobd]), (autism: [mobd]), (neurodevelopmental disorders: [mobd]), (prominent executive dysfunction: [mobd]), (disruption: []), (fronto-parietal circuits: []), (executive function: [menp]), (disorders: [dsyn]), (sustained attention task: [menp]), (validated brain-behaviour basis: [bpoc]), (twenty-three children: [aggp]), (adhd: [mobd]), (children: [aggp]), (high-functioning autism (hfa): [mobd]), (control children: [aggp]), (sustained attention: [menp]), (response task (sart): [fndg]), (fixed sequence version: [nusq]), (task: [gngm]), ( children: [aggp]), (response: [fndg]), (no-go target (3): [bacs,inch,phsu]), (digit sequence;: [nusq]), (random version: [resa]), (sequence: [nusq]), (adhd group: [mobd]), (clear deficits: [fndg]), (response inhibition: [acty]), (attention: [menp]), (errors: []), (commission: []), (omission: [fndg]), (sart versions: []), (hfa group: [dsyn]), (sustained attention deficits: [mobd]), (normal number: []), (omission errors: [fndg]), (dissociation: [mobd]), (response inhibition performance: [acty]), (commission errors: []), (fixed sart: [phpr]), (stimuli: [phpr]), (many commission errors: []), (greater slow-frequency variability: [qnco]), (response time: []), (slowing: []), (mean response time: [qnco]), (impaired arousal processes: [menp]), (fast-frequency variability: [fndg]), ( indicative: []), (impaired top-down control: [sbst]), ( relative: [qnco]), (hfa: [dsyn]), (groups: [popg]), (data: [euka]), (involvement: []), (fronto-parietal attentional networks: [menp]), (sub-cortical arousal systems: [bpoc]), (pathology: [patf]), (prefrontal cortex dysfunction: [bpoc]), 
ASD Terms: (attention deficit hyperactivity disorder, 'Overactivity')(autism, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(executive function, 'Executive Function')(attention deficit hyperactivity, 'Overactivity')(high-functioning autism, 'Autism Phenotype')(response inhibition, 'Response Inhibition')(attention deficit hyperactivity disorder group, 'Overactivity')(high-functioning autism group, 'Autism Phenotype')(response inhibition performance, 'Response Inhibition')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 1570060
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objective: []), (possible associations: [menp]), (autism spectrum disorders: [mobd]), (environmental exposures: [inpo]), (california autism surveillance system: [mobd]), (hazardous air: [inch,phsu]), (pollutant (hap) concentrations: [menp]), (u.s. environmental protection agency: [orgt]), (subjects: [humn]), (children: [aggp]), (asd: [cgab]), (controls: [sbst]), (san francisco bay area: [inbe]), (exposure level: [phsu]), (census tract: []), (birth residence: [orgf]), (chemicals: [chem]), (potential neurotoxicants: []), (developmental toxicants: [hops]), ( and/or: []), (endocrine disruptors: [hops]), (haps database: []), (concentrations: [menp]), (structural groups: [popg]), (summary index scores: [clna]), (asd risk: [cgab]), (upper quartiles: []), (group: [popg]), (individual chemical concentrations: [menp]), (median: [qnco]), (demographic factors: []), (odds ratios: [qnco]), (top quartile: []), (chlorinated solvents: [orch]), (heavy metals: [elii]), (confidence intervals: [qnco]), (aromatic solvents: [orch]), (groups: [popg]), (decreased risks: [qnco]), (solvents: [irda]), (risk: []), (metals: [inch]), (metals:: [inch]), (fourth quartile =: [qnco]), (ci: [gngm]), (third quartile =: [qnco]), (individual compounds: [chem]), (associations: [menp]), (mercury: [elii,hops]), ( cadmium: [elii,hops]), ( nickel: [bacs,elii]), ( trichloroethylene: [orch,phsu]), (vinyl chloride: [hops,orch]), (results: [fndg]), (potential association: [menp]), (autism: [mobd]), (metal concentrations: [inch]), (ambient air: [inch,phsu]), (confirmation: []), (refined exposure assessment: [acty]), (future studies: [lbpr]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(environmental exposures, 'Exposures')(california autism surveillance system, 'Autism Phenotype')(exposure level, 'Exposures')(autism, 'Autism Phenotype')(exposure assessment, 'Exposures')(refined exposure assessment, 'Exposures')

PMCID: 1513515
SFARI Genes: GABRA4, GABRB1, GABRA4, GABRB1, GABRB1, GABRA4, GABRB1, GABRA4, GABRA4, GABRB1, GABRA4, GABRB1, GABRA4, GABRB1, GABRA4, GABRB1, GABRA4, GABRB1, GABRA4, GABRB1, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (complex genetics: [chvs]), (impairment: [patf]), (social interaction: [fndg]), (communication: [socb]), (repetitive behavior: [fndg]), (multiple lines: [qnco]), (evidence: []), (alterations: []), (levels: []), (gaba: [aapp,bacs]), (gaba receptors: [aapp,rcpt]), (autistic patients: [mobd]), (gabaergic system: []), (synaptic inhibition: [acty]), (adult brain: [bpoc]), (previous studies: [lbpr]), (lab: [gngm]), (association: [menp]), (single nucleotide polymorphisms (snps): [nusq]), (gaba receptor subunit gene: [aapp,rcpt]), (chromosome: [celc]), (gabra4: [gngm]), (interaction: []), (snps: [nusq]), (gabrb1 (also: [gngm]), (caucasian autism patients: [mobd]), (studies: [lbpr]), (genetic variation: [npop]), (african-american autism families: [popg]), (analysis: [resa]), (independent population: [popg]), (african-american families: [popg]), (gabrb1: [gngm]), (involvement: []), (autism risk: [mobd]), (caucasians (rs17599165: [popg]), ( p=0.0015; rs1912960: [fndg]), ( p=0.0073;: [fndg]), (rs17599416: []), ( p=0.0040): [fndg]), (significant association: [menp]), (african-americans (rs2280073: [popg]), ( p=0.0287: [fndg]), (rs16859788: []), ( p=0.0253): [fndg]), (gabrb1 interaction: [gngm]), (caucasian dataset (most: [popg]), (significant pair: [qnco]), ( rs1912960: []), (rs2351299; p=0.004): [fndg]), (subset: []), (families: [famg]), (positive history: [orga]), (seizure activity: [fndg]), (autism patient: [mobd]), (gabra4; however: [gngm]), (significant allelic association; rs2351299 (p=0.0163): [gngm]), ( rs4482737 (p=0.0339): [fndg]), (rs3832300 (p=0.0253): [fndg]), (results: [fndg]), (findings: [clna]), (genes: [gngm]), (effect: []), (ethnic groups: [popg]), (seizures: [sosy]), (stratifying phenotype: [orga]), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(social interaction, 'Reciprocal Social Interaction')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')(caucasian autism patients, 'Autism Phenotype')(african-american autism families, 'Autism Phenotype')(autism risk, 'Autism Phenotype')(autism patient, 'Autism Phenotype')

PMCID: 1525191
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (autism spectrum: [mobd]), (set: [menp]), (complex multigenic developmental disorders: [mobd]), (development: [orgf]), (language: [lang]), ( non-verbal communication: [menp]), (social skills: [socb]), (odd: [gngm]), ( stereotyped: [menp]), (repetitive behavior: [fndg]), (interests: [menp]), (diagnosis: [fndg]), (disorders relies: [dsyn]), (behavioral observations: [topp]), (delayed speech: [mobd]), (aberrant behavior: [inbe]), (known genes: [gngm]), (definitive biomarkers: [clna]), (disorders: [dsyn]), (first time: [qnco]), (cell lines: [cell]), (monozygotic twins: [famg]), (respect: [socb]), (severity: []), (autism: [mobd]), (and/or language: [lang]), (impairment exhibit: [patf]), (differential gene expression patterns: [genf]), (dna microarrays: []), (genes: [gngm]), ( structure: []), (and/or function: [phsf]), (nervous system: [bdsy]), (silico: []), (regions: []), (autism candidate genes: [mobd]), (quantitative trait loci: [gngm]), (results: [fndg]), (evidence: []), (novel candidate genes: [gngm]), (lymphoid cell lines: [cell]), (individuals: [humn]), (autism spectrum disorders: [mobd]), (finding: [sosy]), (possibility: []), (molecular screen: [hlca]), (expressed biomarkers: [clna]), (peripheral blood: [bdsu]), (accessible tissue: [tisu]), (addition: []), ( gene networks: [moft]), (role: [socb]), (pathophysiology: [patf]), 
ASD Terms: (development of language, 'Language Development')(autism spectrum, 'Autism Phenotype')(social skills, 'Ability to Converse in Social Settings')(stereotyped, 'Stereotyped, Restricted, and Repetitive Behavior')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(diagnosis, 'Diagnosis')(delayed speech, 'Idiosyncratic and Routinized Speech')(autism, 'Autism Phenotype')(autism candidate genes, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 1513329
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (causes: []), (factors: []), (autism: [mobd]), (evidence: []), (prevalence: [qnco]), (extent: []), (diagnostic changes: [qnco]), (improvements: []), (ascertainment contribute: [acty]), (increase: []), (environmental factors: []), (etiologically: []), (twin: [famg]), ( family: [famg]), (genetic studies: [resa]), (role: [socb]), (inherited predisposition: [orga]), (development: [orgf]), (nonetheless: []), ( clinical: []), ( neuroanatomic: []), ( neurophysiologic: [phsf]), (epidemiologic studies: [resa]), (gene penetrance: [qnco]), (expression: [topp]), (cases: [qnco]), (prenatal: [aggp]), (early postnatal environmental milieu: []), (sporadic studies: [lbpr]), (xenobiotic chemicals: [bacs,hops]), (viruses: [virs]), (rigorous investigations: [sosy]), (light: [gngm]), (major gaps: []), (understanding: [menp]), (large casecontrol investigation: [hlca]), (genetic causes: [topp]), (triggers: [clna]), (regression: [menp]), (charge (childhood autism risks: [mobd]), (genetics: []), (environment) study: [resa]), (wide spectrum: [qnco]), (chemical: [chem]), (biologic exposures: [phpr]), ( susceptibility factors: [clna]), (interactions: []), (phenotypic variation: [fndg]), (children: [aggp]), (similarities: []), (differences: [qnco]), (developmental delay: [mobd]), (charge study infrastructure: [orga]), (detailed developmental assessments: [hlca]), (medical information: [hlca]), ( questionnaire data: [euka]), (biologic specimens: [sbst]), (charge study: [orga]), (university: [mnob,orgt]), (californiadavis center: [fndg]), (childrens environmental health laboratories: [mnob,orgt]), (immunology: []), ( xenobiotic measurement: [bacs,hops]), ( cell signaling: [celf]), ( genomics: []), (proteomics: []), (goals: []), ( study design: [resa]), (data collection protocols: [resa]), (preliminary demographic data: [euka]), (study participants: [humn]), (diagnoses: [fndg]), (california department: [orgt]), (developmental: [orgf]), (regional center system: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(biologic exposures, 'Exposures')(differences with developmental delay, 'Learning Disorders')(developmental delay, 'Learning Disorders')(medical information, 'Medications')

PMCID: 1409812
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (convoluted cortex: [bpoc]), (primates: [mamm]), (principal morphologic features: [fndg]), (complex finer structure: [chvs]), (various hypotheses: [phsu]), (mechanisms: []), (formation: [biof]), (analysis: [resa]), (databases: []), (quantitative architectonic: [qnco]), (connection data: [euka]), (primate: [mamm]), (prefrontal cortices: [bpoc]), (support: []), (hypothesis: []), (tension: [mobd]), (corticocortical connections: []), (significant factor: [qnco]), (cerebral cortical landscape: [bpoc]), (moreover: []), ( forces: [phpr]), (influence laminar morphology: [fndg]), (unsuspected impact: [gngm]), (cellular migration: [celf]), (cortical development: [ortf]), (evidence: []), (significant role: [socb]), (mechanical factors: []), (cortical morphology: [bpoc]), (possibility: []), (computational models: [acty]), (cortical develoment: [bpoc]), (physical principles: [hlca]), (such models: []), (relationship: []), (connectivity: []), (normal brains: [bpoc]), (altered brains: [bpoc]), (diseases: [dsyn]), (developmental origin: [gngm]), (schizophrenia: [mobd]), (autism: [mobd]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism, 'Autism Phenotype')

PMCID: 1382247
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (certain loci: [gngm]), (human genome: [gngm]), (glutathione s-transferase m1 (gstm1): [aapp,enzy]), (heterozygotes: [orga]), (methods: []), (association: [menp]), (locus: [gngm]), (disease: [dsyn]), (case-control design: [acty]), (subjects: [humn]), (case-parent design: [acty]), (question: []), (data: [euka]), (disease association: []), (likelihood ratio test: [qnco]), (case-parents design: [acty]), (power: [hcpp]), (pearson's: []), (chi-squared test: []), (test: [lbpr]), (novel dataset: []), (genotype relative risk: [qnco]), (homozygous gstm1 deletion genotype: [genf]), (autism: [mobd]), (mainstay: []), (deletion: [genf]), (part: [qnco]), (case-parent study design: [resa]), (advantage: []), (incomplete case-parent trios: [aapp,enzy]), (independent cases: [qnco]), (controls: [sbst]), (support (p: [aapp,imft]), ( p: [aapp,imft]), (case-control: [hlca]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 1310613
SFARI Genes: DLX1, DLX2, DLX1, DLX2, 
Non SFARI Genes: DLX5, 
Named Entities: (linkage studies: [moft]), (autism: [mobd]), (susceptibility loci: [clna]), (chromosomes: [celc]), (regions: []), (dlx1/2: [gngm]), (dlx5/6 bigene clusters: [qnco]), (dlx genes: [gngm]), (transcription factors: [aapp,bacs]), (craniofacial patterning: [bpoc]), (differentiation: [celf]), (survival: [acty]), (forebrain inhibitory neurons: [acty]), (role: [socb]), (sequence variants: [npop]), (in-depth resequencing: [mbrt]), (genes: [gngm]), (autism probands: [mobd]), (agre collection: []), (exons: [bacs,nnon]), ( exon/intron boundaries: [bacs,nnon]), (known enhancers: [nnon]), (dlx1: [gngm]), (identified several nonsynonymous variants: [fndg]), (dlx2: [gngm]), (dlx5: [gngm]), (variant: []), (dlx5/6intragenic enhancer: [nnon]), (nonsynonymous variants: []), (families: [famg]), (samples: [sbst]), (snps: [nusq]), (undiagnosed samples: [sbst]), (north american populations: [popg]), (sample each: [sbst]), (segregation: [socb]), (variants: []), (pedigrees: []), (contribution: [acty]), (susceptibility: [clna]), (functional analyses: [hlca]), (insight: [menp]), (biological understanding: [menp]), (important proteins: [aapp,bacs]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism probands, 'Autism Phenotype')(autism susceptibility, 'Autism Phenotype')

PMCID: 1199627
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (wide range: [qnco]), (abnormalities: [cgab]), (autistic brains: [mobd]), (result: [fndg]), (underlying developmental alteration: [orgf]), (time autism: [mobd]), (consistent biological finding: []), (autistic individuals: [mobd]), (levels: []), (5-hydroxytryptamine (5-ht: [bacs,orch]), ( serotonin): [bacs,orch]), (blood platelets: [cell]), (hyperserotonemia): []), (early developmental alteration: [orgf]), (autistic brain: [mobd]), (autistic platelet hyperserotonemia: [mobd]), (same biological factor: [bacs]), (brain: [bpoc]), ( respectively: []), ( blood platelets: [cell]), (life span: [grpa]), (factor: []), (brain years: [bpoc]), (statistical distributions: [qnco]), (platelet: [cell]), (5-ht levels: [bacs,orch]), (autistic groups: [mobd]), (characteristic features: []), (information: []), (nature: []), (unidentified factor: []), (identity: [menp]), (novel: []), ( quantitative approach: [resa]), (distributions: []), (data: [euka]), (hypothesis: []), (brain development: [ortf]), (autism: [mobd]), (release: [hlca]), (gut enterochromaffin cells: [cell]), (numerical analysis: [resa]), (biological factors: [bacs]), (abnormal function: [phsf]), (development: [orgf]), (gut years: [bdsy]), (birth: [orgf]), (present model: [qnco]), (future efforts: [orgf]), (limited number: [qnco]), (gene: [gngm]), (5-ht4 receptor gene): [aapp,rcpt]), (experimental studies: [resa]), 
ASD Terms: (time autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 1097741
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (present study: [qnco]), (order: [acty]), (set: [menp]), (clinical features: [clna]), (dsm-iv: []), (icd-10: []), (asperger syndrome (as): [mobd]), (as: []), (familial trait: [famg]), (diagnosis: [fndg]), (total: [qnco]), (persons: [popg]), (individuals: [humn]), (diagnostic criteria: []), (criteria: []), (structured interview: [resa]), (possible presence: [qnco]), (face recognition difficulties: [fndg]), (aberrant sensibility: []), (habits: [inbe]), (disturbances: []), (prevalence: [qnco]), (control group: [grup]), (corresponding figures: []), (presence: [qnco]), (aberrant sensibilities: []), (aberrant eating habits: [inbe]), (respectively: []), (aberrant processing: [acty]), (sensory information: []), (common feature: [qnco]), (impact: [gngm]), (other clinical features: [clna]), (understanding: [menp]), (clinical traits: [gngm]), (behavioural characteristics: [inbe]), 
ASD Terms: (asperger syndrome, 'Asperger Syndrome')(diagnosis, 'Diagnosis')(asperger syndrome, 'Asperger Syndrome')(asperger syndrome, 'Asperger Syndrome')(aberrant processing of sensory information, 'Ability to Convey Information')(asperger syndrome, 'Asperger Syndrome')(asperger syndrome, 'Asperger Syndrome')

PMCID: 1084355
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (heritable developmental disorder: [mobd]), (communication: [socb]), (socialization: [edac]), (hispanic populations: [popg]), (possible cases: [qnco]), (population isolate: [popg]), (central valley: [lbpr]), (costa rica (cvcr): []), (genetic study: [resa]), (subjects: [humn]), (parents: []), (appropriate: []), (spanish versions: [popg]), (autism diagnostic: [mobd]), (interview-revised (adi-r): [acty]), (autism diagnostic observation schedule (ados): [hlca]), (tests: [lbpr]), (intelligence: [menp]), (adaptive behavior: [inbe]), (family: [famg]), (medical/psychiatric histories: [fndg]), (cases: [qnco]), (fragile x: [comd]), (cytogenetic abnormalities: [comd]), (date: []), (clinical evaluations: [hlca]), (possible autism: [mobd]), (study: [resa]), (report data: [resa]), (complete cases: [qnco]), (mean age: [orga]), (probands: [orga]), (years: []), (iqs <50: [fndg]), (iqs: []), (half: [qnco]), (mothers: [famg]), (complications: [patf]), (pregnancy and/or: [orgf]), (pku: [dsyn]), (chromosomal g-banding: [celc]), (diagnostic data: [euka]), (cvcr: []), (adi-r: [clna]), (ados: [aapp,enzy]), (studies: [lbpr]), (english-speaking cases: [qnco]), (however: []), (normal range: [qnco]), (figure: []), (result: [fndg]), (ascertainment bias: [bird]), (severe cases: [qnco]), (treatment: [topp]), (government-sponsored support programs: []), (early intervention programs: [hlca]), (incentive: []), (severity: []), (mental retardation: [mobd]), (lack: []), (use: []), (iq tests: [lbpr]), (costa rican norms: [fndg]), (still: []), (healthcare providers: []), (teachers: []), (autistic cases: [mobd]), (normal iqs: [fndg]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism diagnostic, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(adaptive behavior, 'Adaptive Life Skills')(fragile x, 'Fragile X Syndrome')(possible autism, 'Autism Phenotype')(had complications during pregnancy and/or, 'Pregnancy Complications')(pku, 'Phenylketonurias')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(diagnose autism, 'Autism Phenotype')(mental retardation, 'Mental Retardation')

PMCID: 548305
SFARI Genes: FRAXA, FRAXA, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (behavioral disorder: [mobd]), (impaired social interaction: [mobd]), ( communication: [socb]), (stereotypic behaviors: [mobd]), (%: []), (individuals: [humn]), (environmental agent: []), ( chromosome abnormality: [comd]), (single gene disorder: [fndg]), (ninety percent: [qnco]), (idiopathic autism: [mobd]), (major gene: [gngm]), (identified: [fndg]), (incidence: [qnco]), (chromosome abnormalities: [comd]), (fragile x syndrome: [cgab,dsyn]), (population: [popg]), (autistic patients: [mobd]), (laboratory: [mnob,orgt]), (data: [euka]), (patients: [podg]), (autistic traits: [mobd]), (chromosome analysis and/or fluorescence: [npop]), (situ hybridization (fish): [mbrt]), (southern: []), (pcr methods: [mbrt]), (median age: [orga]), (years: []), (sex ratio: [qnco]), (males: [orga]), (female [354:79]: [orga]), (chromosome (cs) abnormality: [comd]), ([3.33 %] cases: [qnco]), (aberrations: []), ([28%] supernumerary markers;: [clna]), ([28%] deletions;: [genf]), ([7%] duplication;: [comd]), ([21%] inversions;: [comd]), ([14%] translocations: [comd]), (fish: [gngm]), (cases: [qnco]), (reasons: []), (cytogenetic abnormality: [comd]), (fragile-x testing: [comd]), (southern blots: [mbrt]), (pcr analysis: [lbpr]), ([2.2 %]: [qnco]), (abnormal result: [fndg]), (mutations: [genf]), (full mutation (fm): [genf]), (abnormal methylation: [moft]), ([43 %]: []), ( mosaic mutations: [genf]), (partial methylation: [moft]), (variable clinical significance: [fndg]), ([43%]: []), (permutation carrier [14%]: [fndg]), (frequency: [qnco]), (chromosome: [celc]), (fragile-x abnormalities: [cgab]), (range: [qnco]), (surveys: []), (4.8-1.7%: []), ( frax: []), (limitations: []), (retrospective study: [resa]), (paucity: []), (behavioral diagnostic information: [inbe]), (specific clinical criterion: []), (testing: []), (twenty-eight percent: [qnco]), (study: [resa]), (high resolution: [lbpr]), (cytogenetic study: [lbpr]), (scrutiny: []), (xp23.3 region: []), (standard practice: [menp]), (indication: []), (mosaic fragile-x mutations: [genf]), (fraxa: [gngm]), (positive population [50%: [popg]), (suggests: []), (bands: []), (variations: []), (southern band pattern: [celc]), 
ASD Terms: (impaired social interaction, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(stereotypic behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(idiopathic autism, 'Autism Phenotype')(fragile x syndrome, 'Fragile X Syndrome')(fragile x syndrome, 'Fragile X Syndrome')(fraxa, 'Fragile X Syndrome')

PMCID: 546213
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurobehavioral spectrum: [qnco]), (phenotypes: [orga]), (deficits: []), (development: [orgf]), (language: [lang]), (social relationships: []), (patterns: []), (repetitive: []), (compulsive behaviors: [mobd]), (twin: [famg]), (family studies: [famg]), (significant genetic etiology: [qnco]), (several groups: [popg]), (genomic linkage screens: [gngm]), (susceptibility loci: [clna]), (genome-wide linkage screen: [gngm]), (combined tufts: []), ( vanderbilt: []), (agre (autism genetics research exchange): [mobd]), (autism families: [famg]), (nonparametric methods: []), (categorical autism diagnosis: [mobd]), (loci: [gngm]), (main effect: []), (interdependence: [socb]), (genetic risk factors: []), (exploratory studies: [lbpr]), (ordered-subset analysis (osa) approach: [resa]), (lod scores: [qnco]), (trait covariate: [orga]), (families: [famg]), (osa: [dsyn]), (interlocus correlations: []), (lod scores 1.5: [qnco]), (significance: [qnco]), (linkage: [moft]), (optimal osa subsets: [dsyn]), (permutation testing: []), (phenotypic correlates: [orga]), (basis: [phsu]), (linkage increases: [moft]), (comparison: [acty]), (mean scores: [qnco]), (quantitative trait-based subsets: [qnco]), (optimal subsets: []), (genome-wide screen: [gngm]), (autism loci: [mobd]), (evidence: []), (maximum multipoint heterogeneity lod scores: [qnco]), (respectively: []), (suggestive linkage (lod: [qnco]), (other loci: [gngm]), (positive correlations: [fndg]), (locus: [gngm]), (potential phenotypic correlates: [orga]), (findings: [clna]), (chromosome: [celc]), (combination: [fndg]), ( differences: [qnco]), (rapid achievement: [bhvr]), ("developmental milestones": []), (osa-defined subsets: [dsyn]), (hypothesis: []), (milestones: []), (lod* scores: [qnco]), (results: [fndg]), (autism susceptibility: [clna]), (confirm: []), (other linkage findings: [moft]), (need: []), (discreet trait-based subsets: [orga]), (complex phenotypes: [orga]), (ability: [orga]), (genetic effects: [topp]), 
ASD Terms: (neurobehavioral spectrum, 'Central Nervous System Diseases')(development of language, 'Language Development')(autism, 'Autism Phenotype')(compulsive behaviors, 'Obsessive-Compulsive Disorder')(autism families, 'Autism Phenotype')(categorical autism diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')(autism loci, 'Autism Phenotype')(autism susceptibility, 'Autism Phenotype')

PMCID: 509312
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (research focuses: [resa]), ("curing" autism: [mobd]), (diagnostics: [fndg]), (early intervention: [hlca]), (behavioral therapies: [topp]), (insight: [menp]), (autistic brain: [mobd]), 
ASD Terms: ("curing" autism, 'Autism Phenotype')

PMCID: 420465
SFARI Genes: NRCAM, KIAA0716, NRCAM, KIAA0716, LAMB1, LAMB1, NRCAM, KIAA0716, NRCAM, KIAA0716, LAMB1, LAMB1, 
Non SFARI Genes: Mb, LRRN3, LRRN3, 
Named Entities: (substantial body: [humn]), (research: [resa]), (genetic involvement: [topp]), (autism: [mobd]), (furthermore: []), ( results: [fndg]), (various genomic screens: [gngm]), (region: []), (chromosome: [celc]), (autism susceptibility variant: [mobd]), (cm region: []), (cm: []), (critical region: []), (d7s496: []), (d7s2418): []), (collaborative linkage study: [moft]), (autism (clsa) chromosome: [celc]), (families: [famg]), (mb: [gngm]), (genomic dna: [nnon]), (genes: [gngm]), (candidate genes (nrcam: [aapp,bacs]), ( lrrn3: [gngm]), ( kiaa0716: [gngm]), (lamb1): [gngm]), (examination: []), (proximity: []), (marker: [clna]), (tissue expression patterns: [tisu]), (likely biological relevance: []), (thirty-six intronic: [bacs,nnon]), (exonic single nucleotide polymorphisms (snps): [bacs,nnon]), (microsatellite marker: [bacs,nnon]), (candidate genes: [gngm]), (multiple snps: [nusq]), (complete coverage: []), (linkage disequilibrium: [qnco]), (short distances: [qnco]), (gene: [gngm]), (analyses: [resa]), (data: [euka]), (pedigree disequilibrium test: [dsyn]), (single markers: [fndg]), (multilocus likelihood ratio test: [qnco]), (expected: []), ( linkage disequilibrium: [qnco]), (significant ld: [bpoc]), (none: []), (polymorphisms: [genf]), (nrcam: [gngm]), (kiaa0716: [gngm]), (autism susceptibility: [clna]), (subset: []), (7-linked families: [famg]), (however: []), (lamb1: [gngm]), (allelic association analysis: [gngm]), (suggestive evidence: []), (positive association: [menp]), (individual snp (p =: [nusq]), (separate two-snp haplotypes: [nusq]), (gene (p: [gngm]), (evidence: []), (variation: []), (lamb1 gene: [gngm]), 
ASD Terms: (autism, 'Autism Phenotype')(autism susceptibility variant, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism susceptibility, 'Autism Phenotype')

PMCID: 411038
SFARI Genes: met, met, 
Non SFARI Genes: GLRA3, GLRB, NPY1R, NPY5R, GLRA3, GLRB, NPY1R, NPY5R, NPY1R, NPY5R, 
Named Entities: (autism: [mobd]), (pervasive developmental disorder: [mobd]), (triad: [bodm,orch]), (deficits: qualitative impairments: [patf]), (social interactions: [fndg]), ( communication deficits: [socb]), (patterns: []), (behavior: [inbe]), (heterogeneous: [orga]), ( family: [famg]), (twin studies: [famg]), (definite genetic basis: [phsu]), (inheritance: [qnco]), (idiopathic autism: [mobd]), (many genes: [gngm]), (environmental factors: []), (analysis: [resa]), (chromosome abnormalities: [comd]), (autism contributes: [mobd]), (identification: [menp]), (autism candidate genes: [mobd]), (case presentation: []), (child: [aggp]), (autistic disorder: [mobd]), (interstitial deletion: [genf]), (chromosome: [celc]), (months: []), (age: [orga]), (developmental delay: [mobd]), (minor dysmorphic features: [popg]), (years: []), (diagnosis: [fndg]), (made: []), (diagnostic criteria: []), (cytogenetic studies: [lbpr]), (deletion: [genf]), (karyotype: [resa]), (xy: [orga]), ((q31.3-q33): []), (clinical phenotype: [orga]), (molecular characterization: [acty]), (molecular cytogenetic techniques: [mbrt]), (polymorphic markers: [clna]), (studies: [lbpr]), (megabase deletion: [genf]), (new markers: [clna]), (study: [resa]), (date: []), (genes: [gngm]), (known: []), (function: [phsf]), (consequence: []), (ampa: [irda,orch,phsu]), (gene: [gngm]), (glutamate receptor glur2: [aapp,rcpt]), (sub-unit: [qnco]), ( glra3: [gngm]), (glrb genes: [gngm]), (glycine receptor subunits: [aapp,rcpt]), (neuropeptide y receptor genes npy1r: [aapp,rcpt]), (npy5r: [gngm]), (autistic subject: [mobd]), (specific autism candidate genes: [mobd]), (glra3: [gngm]), ( glrb: [gngm]), ( npy1r: [gngm]), (glur2: [gngm]), (major determinant: []), (ampa receptor structure: [aapp,rcpt]), (glutamate receptors: [aapp,rcpt]), (functional plasticity: [npop]), (synapses: [bsoj]), (neuropeptide y: [aapp,bacs]), (receptors npy1r: [gngm]), (role: [socb]), (hippocampal learning: [menp]), (memory: [menp]), (glycine receptors: [aapp,rcpt]), (early cortical development: [ortf]), (molecular cytogenetic studies: [lbpr]), (dna sequence analysis: [lbpr,mbrt]), (other patients: [podg]), 
ASD Terms: (stereotyped patterns of behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')(social interactions, 'Reciprocal Social Interaction')(idiopathic autism, 'Autism Phenotype')(autism candidate genes, 'Autism Phenotype')(autism contributes, 'Autism Phenotype')(autistic disorder, 'Autistic Disorder')(developmental delay, 'Learning Disorders')(years of age, 'Onset of Symptoms')(diagnosis, 'Diagnosis')(years of age, 'Onset of Symptoms')(autism, 'Autism Phenotype')(specific autism candidate genes, 'Autism Phenotype')(memory, 'Working Memory')

PMCID: 394332
SFARI Genes: 6.3, 6.3, 
Non SFARI Genes: 
Named Entities: (validity: [qnco]), (computerized diagnoses: [fndg]), (autism: [mobd]), (large case-control study: [resa]), (possible association: [menp]), (measles: [dsyn]), ( mumps: [dsyn]), (rubella vaccine: [aapp,imft,phsu]), (uk: []), (general practitioner research database: [resa]), (anonymized copies: []), (relevant available clinical reports: []), (general practitioners' (gp): []), (consultant: []), ( speech therapy: [hlca]), (educational psychologists: []), (subjects: [humn]), (diagnosis: [fndg]), (related disorder: [dsyn]), (electronic general practice record: [qnco]), (data: [euka]), (case validation form: [resa]), (identification: [menp]), (developmental symptoms: [sosy]), (pervasive developmental disorders: [mobd]), (information: []), (other background: []), (familial features: [grpa]), (subset: []), (notes: [clna]), (raters: []), (reliability estimates: [qnco]), (key clinical characteristics: [clna]), (pdd: [dsyn]), (review: []), (records: [qnco]), (criteria: []), (autistic disorder: [mobd]), (mean age: [orga]), (first recording: [qnco]), (pdd diagnosis: [dsyn]), (gprd database: []), (years: []), (proportion: [qnco]), (regression: [menp]), (course: []), (development: [orgf]), (inter-rater reliability: [qnco]), (presence: [qnco]), (good (kappa = .73): []), (agreement: [socb]), (clinical features: [clna]), ( age: [orga]), (parental recognition: [menp]), (first symptoms: [sosy]), ( language delay: [fndg]), (epilepsy: [dsyn]), (good (kappas: []), (.56: []), (study: [resa]), (evidence: []), (positive predictive value: [qnco]), (gprd: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(mumps, 'Mumps')(rubella vaccine, 'Rubella')(autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')(speech therapy, 'Language Ability')(diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')(autistic disorder, 'Autistic Disorder')(pdd diagnosis, 'Diagnosis')(epilepsy, 'Epilepsy')(language delay, 'Language Ability')(autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')

PMCID: 1247186
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (article: []), (possibility: []), (contaminants: [sbst]), (prevalence: [qnco]), (attention deficit hyperactivity disorder: [mobd]), ( autism: [mobd]), (behavioral problems: [mobd]), (developed countries: []), (exquisite sensitivity: [patf]), (embryo: [emst]), (fetus: [tisu]), (disturbance: []), (evidence: []), (human: [humn]), (utero exposure: [bpoc]), (thyroid: [bpoc]), (prenatal exposure: [fndg]), (specific chemical: [chem]), (neurodevelopmental damage: [inpo]), (humans: [humn]), (present alternate models: [qnco]), (associations: [menp]), (exposure: [clna]), (specific chemicals: [chem]), (chemical classes: [hlca]), (developmental difficulties: [fndg]), (laboratory animals: [anim]), ( wildlife: [anim]), 
ASD Terms: (attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism, 'Autism Phenotype')(behavioral problems in developed countries, 'Personal Traits')(autism, 'Autism Phenotype')(behavioral problems, 'Personal Traits')(thyroid disturbance, 'Thyroid Diseases')(utero exposure, 'Exposures')(neurodevelopmental damage, 'Learning Disorders')(developmental difficulties in laboratory animals, 'Learning Disorders')(prenatal exposure, 'Exposures')(exposure, 'Exposures')(developmental difficulties, 'Learning Disorders')

PMCID: 329128
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (pocus (prioritization: []), (candidate genes: [gngm]), (statistics): []), (novel computational approach: [acty]), (candidate disease genes: [gngm]), (over-representation: [acty]), (functional annotation: []), (loci: [gngm]), (same disease: [dsyn]), 
ASD Terms: 

PMCID: 194752
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (significant increase: [qnco]), (prevalence rate: [qnco]), (autism: [mobd]), (reasons: []), (increase: []), (unknown: []), ( however: []), (substantial body: [humn]), (evidence: []), (etiology: []), (infections: [patf]), (pregnant mother: [famg]), (young child: [aggp]), (fever: [fndg]), (antipyretics: [phsu]), (acetaminophen: [orch,phsu]), (blocking: [mobd]), (fever inhibits: [fndg]), (millions: [qnco]), (years: []), (microbial attack: [socb]), (immune mechanisms: []), (central nervous system: [bdsy]), (part: [qnco]), (protective process: [phpr]), (hypothesis: []), (blockage: [fndg]), (antipyretics interferes: [phsu]), (normal immunological development: [fndg]), (brain: [bpoc]), (neurodevelopmental disorders: [mobd]), (individuals: [humn]), (hypothesis epidemiological studies: [resa]), (associations: [menp]), (use: []), (biochemical tests: [lbpr]), (examination: []), (fluids/serum: [bdsu]), (mass spectrometry: [lbpr]), (determination: [lbpr]), (cytokine/chemokine levels: [aapp,imft]), (serum: [bdsu]), (cell culture fluids: [lbpr]), (stimulation: [npop]), (fever-inducing molecules: [fndg]), (bacteria: [bact]), ( viruses: [virs]), (yeast: [fngs]), (postmortem brain: [diap]), (immunohistochemistry: [diap]), (other methods: []), (fluorescent: [irda,orch]), (situ hybridization (fish): [mbrt]), (altered expression levels: [qnco]), (chemokines/cytokines: [aapp,imft]), (other molecules: [sbst]), (implications: []), (pregnancy: [orgf]), (young children: [aggp]), (severe fevers: [fndg]), (perplexing: []), (genetic findings: [lbtr]), (understood: [menp]), (genes: [gngm]), (functional pathways: [moft]), (new treatments: [topp]), (immune: []), ( cell: [gngm]), ( pharmacological: []), (heat therapies: [topp]), (developed: []), 
ASD Terms: (autism, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(bacteria, 'Bacterial Infections')(autism, 'Autism Phenotype')

PMCID: 64493
SFARI Genes: NDNL2, NDNL2, MAGED1, MAGEL2, MAGED1, MAGEL2, 
Non SFARI Genes: Chr, NDN, 
Named Entities: (proximal chromosome: [celc]), (neurodevelopmental disorders: [mobd]), (prader-willi: []), (angelman: []), (autistic disorder: [mobd]), (developmental abnormalities: [cgab]), (chromosomal deletions: [comd]), (duplications: []), (subset: []), (genes: [gngm]), (region: []), (expression: [topp]), (gene: [gngm]), (parental allele: [gngm]), (ndnl2 (also: [gngm]), (mage-g) gene: [gngm]), (autistic disorder susceptibility region: [mobd]), (murine homolog: [mamm]), (synteny: [moft]), (necdin (ndn): [aapp,bacs]), (mouse chr: [mamm]), (ndnl2/mage-g: [qnco]), (member: [popg]), (large gene family: [gngm]), (x-linked mage cluster: [qnco]), ( maged1 (nrage): [aapp,bacs]), ( magel2: [gngm]), (ndn: [gngm]), (prader-willi syndrome: [cgab]), (ndnl2/ndnl2: [gngm]), (mouse: [mamm]), (human fetal: [humn]), (adult tissues: [aggp]), (imprinting: [menp]), (pws/as imprinting center: [cgab]), (defined chromosome: [celc]), (wide expression pattern: [topp]), (lack: []), (imprinted expression: [menp]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(prader-willi, 'Prader-Willi Syndrome')(autistic disorder, 'Autistic Disorder')(developmental abnormalities, 'Learning Disorders')(autistic disorder susceptibility region, 'Autistic Disorder')(prader-willi syndrome, 'Prader-Willi Syndrome')

PMCID: 59656
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recently: []), (relationship: []), (therapy: [topp]), (antibiotics: [antb]), (onset: [qnco]), (autism;: [mobd]), (children: [aggp]), (subsequent treatment: [topp]), (different antibiotic: [antb]), (here: []), (aminoglycoside antibiotics: [antb,orch]), (autism: [mobd]), (presentation: []), (autism syndrome: [dsyn]), (susceptible infants: [aggp]), (stop codon readthrough: [nusq]), (misreading: []), (genetic code: [mosq]), (hypothetical critical gene: [gngm]), ( and/or b): []), (autism symptoms: [mobd]), (premature: [fndg]), (codon mutation: [nusq]), (hypothetical polymorphic gene: [gngm]), (investigate: []), ( retrospectively: []), (link: []), (aminoglycoside use (which: [orch,phsu]), (children): [aggp]), (amino glycoside use: [orch,phsu]), (improvement: []), (symptoms: [sosy]), ("b"): []), (prospective study: [resa]), (hypothesis "a": []), (study: [resa]), (hypothesis "b": []), (implications: []), (stage: [clna]), (direct evidence: []), (speculative hypothesis: []), (main purpose: []), (development: [orgf]), (new ideas: [menp]), (that: []), ( eventually: []), (understanding: [menp]), (pathobiology: []), 
ASD Terms: (autism, 'Autism Phenotype')(onset, 'Onset of Symptoms')(autism syndrome, 'Autism Phenotype')(improve autism symptoms, 'Complaints and Indications')(autism symptoms, 'Complaints and Indications')(onset, 'Onset of Symptoms')(autism, 'Autism Phenotype')

PMCID: 4924297
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prevalence: [qnco]), (autism spectrum disorders: [mobd]), (people: [popg]), (epilepsy ranges: [dsyn]), (%: []), ((clarke et al: [lbpr]), (epilepsia: [dsyn]), (special relationship: []), (disorders: [dsyn]), (lack: []), (systematic studies: [lbpr]), (behavioral phenotype: [bhvr]), (autistic individuals: [mobd]), (epilepsy: [dsyn]), (study: [resa]), (co-occurrence: []), (autism spectrum disorder (asd): [mobd]), (autistic characteristics: [mobd]), (social responsiveness scale (srs): [acty]), (measure: [qnco]), (autism symptoms: [mobd]), (previous studies: [lbpr]), (research: [resa]), (individuals: [humn]), (autism: [mobd]), (autistic disorder: [mobd]), (asd: [cgab]), (complete medical records: [clna]), (participants: [popg]), (single tertiary care: [fndg]), (referral center: [fndg]), (january: []), (july: []), (complete child: [aggp]), (adolescent psychiatric assessments: [aggp]), (autism spectrum disorder: [mobd]), (types: []), (complex partial seizure: [dsyn]), (tonicclonic seizure: [dsyn]), (infantile spasm: [dsyn]), (propensity score matching: [qnco]), (children: [aggp]), (only autism spectrum disorder: [mobd]), (age: [orga]), ( gender: [orga]), (intelligence quotient (iq): [orga]), (social functioning: [socb]), (social responsiveness scale: [acty]), (categories:: []), (social awareness: [menp]), ( social cognition: [socb]), (social communication: [socb]), (social motivation: [menp]), (autistic mannerisms: [mobd]), (bivariate analyses: [qnco]), (asd participants: [cgab]), (epilepsy group: [dsyn]), (asd-only group: [cgab]), (clinical characteristics: [clna]), (chi square: [qnco]), (t test p values: [qnco]), (appropriate: []), (significant difference: [qnco]), (age (p: [orga]), (gender (p: [orga]), (iq (fsiq: []), ( p: [aapp,imft]), (viq: []), (piq: [gngm]), (groups: [popg]), (measures: [qnco]), (social awareness (p: [menp]), (social communication (p: [socb]), (total srs t-score: [qnco]), (relationship: []), (appropriate management (e.g: [hlca]), (social skills: [socb]), (training: [edac]), ( seizure control): [sosy]), (co-occurring epilepsy: [dsyn]), (results: [fndg]), (mechanisms: []), (role: [socb]), (autistic features: [mobd]), (poor social functioning: [grpa]), (prospective study: [resa]), (sample sizes: [sbst]), (association: [menp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(epilepsy ranges, 'Epilepsy')(epilepsy, 'Epilepsy')(epilepsy, 'Epilepsy')(autism symptoms, 'Complaints and Indications')(autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(autistic disorder, 'Autistic Disorder')(complete medical records, 'Medications')(epilepsy, 'Epilepsy')(infantile spasm, 'Tourette Syndrome')(only autism spectrum disorder, 'Autism Phenotype')(intelligence quotient, 'IQ')(social functioning, 'Social Competence')(social cognition, 'Cognitive Ability')(social communication, 'Reciprocal Social Interaction')(epilepsy group, 'Epilepsy')(epilepsy, 'Epilepsy')(social functioning, 'Social Competence')(epilepsy, 'Epilepsy')(co-occurring epilepsy, 'Epilepsy')(poor social functioning, 'Ability to Converse in Social Settings')

PMCID: 4938850
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (motor: []), (social difficulties: [fndg]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (developmental coordination disorder (dcd): [hops,orch]), (degrees: [qnco]), (study: [resa]), (extent: []), (overlap: [topp]), (problems: []), (years: []), (diagnosis: [fndg]), (asd: [cgab]), (dcd: [gngm]), (typically-developing controls: [sbst]), (face processing assessments: [hlca]), (parents: []), (questionnaires: []), (childs: [aggp]), (current motor: [npop]), (social skills: [socb]), (considerable overlap: [topp]), (dcd groups: [hops,orch]), (social assessments: [hlca]), (groups: [popg]), (controls: [sbst]), (furthermore: []), ( motor skill: [orgf]), (social functioning: [socb]), (future research: [resa]), (relationships: []), (core symptoms: [sosy]), (consequences: []), (other domains: []), 
ASD Terms: (social difficulties, 'Social Competence')(autism spectrum disorder, 'Autism Phenotype')(developmental coordination disorder, 'Motor Skills')(diagnosis, 'Diagnosis')(face processing assessments, 'Integrated Verbal and NonVerbal Communication')(social skills, 'Ability to Converse in Social Settings')(developmental coordination disorder groups, 'Motor Skills')(social functioning, 'Ability to Converse in Social Settings')

PMCID: 5795277
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (potocki-lupski syndrome (ptls): [dsyn]), (smith-magenis syndrome (sms): [dsyn]), (genomic disorders: [dsyn]), (duplication: [comd]), (ptls): [dsyn]), (reciprocal recombination product: [qnco]), (sms microdeletion: []), (sms: [gngm]), (well-delineated behavioural phenotype: [bhvr]), (behavioural profile: [inbe]), (ptls: [dsyn]), (purported associations: [menp]), (autism spectrum disorder (asd): [mobd]), (suggestion: []), (behaviours: [inbe]), (caregivers: []), (individuals: [humn]), (ptls (n: [dsyn]), (m age: [orga]), (sd: [gngm]), (online behavioural questionnaires: [inbe]), (challenging behaviour questionnaire: [fndg]), (activity questionnaire: [acty]), (repetitive behaviour questionnaire: [fndg]), (mood: [menp]), ( interest: [menp]), (pleasure questionnaire-short form (mipq-s): [menp]), (social communication questionnaire (scq): [socb]), (asd: [cgab]), (age: [orga]), (adaptive functioning: []), (sms (n: [aapp,imft]), (idiopathic asd (n: [cgab]), (dataset: []), (idiopathic asd: [cgab]), (communication: [socb]), (reciprocal social interaction subscales: [fndg]), (scq: []), (syndrome group: [dsyn]), (restricted: []), ( repetitive: []), (behaviours subscale: [inbe]), (repetitive behaviour measure: [qnco]), ( individuals: [humn]), (compulsive behaviour subscale: [mobd]), (rates: [qnco]), (self-injury: [inpo]), (property destruction: [acty]), (between-syndrome differences: [dsyn]), (relation: [socb]), (overactivity: [fndg]), (mood; however: [menp]), ( impulsivity: [inbe]), (findings: [clna]), (overlap: [topp]), (behavioural phenotype: [bhvr]), (features: []), (asd symptomatology;: [cgab]), (overall profile: [lbpr]), ( ptls: [dsyn]), (social interaction deficits: [fndg]), (however: []), (repetitive behaviours: [inbe]), (compulsive behaviours: [mobd]), (several behavioural differences: [inbe]), (little evidence: [fndg]), (diametric behavioural phenotypes: [bhvr]), (social behaviour: [socb]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(repetitive behaviour questionnaire, 'Restricted and Repetitive Behavior')(mood, 'Mood')(social communication questionnaire, 'Reciprocal Social Interaction')(adaptive functioning, 'Adaptive Life Skills')(reciprocal social interaction subscales, 'Reciprocal Social Interaction')(repetitive behaviour measure, 'Restricted and Repetitive Behavior')(compulsive behaviour subscale, 'Obsessive-Compulsive Disorder')(self-injury, 'Self-Injurious Behavior')(overactivity, 'Overactivity')(social interaction deficits, 'Reciprocal Social Interaction')(repetitive behaviours, 'Restricted and Repetitive Behavior')(compulsive behaviours, 'Obsessive-Compulsive Disorder')(several behavioural differences, 'Personal Traits')(social behaviour, 'Reciprocal Social Interaction')

PMCID: 4230543
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder: [mobd]), (reciprocal social-communication: [socb]), (impairments: [patf]), ( several studies: [lbpr]), (evidence: []), (social cognition test performance: [diap]), (study: [resa]), (explicit (i.e: [diap,inpr]), (prompted): []), (implicit (i.e: [diap,inpr]), (spontaneous) variants: []), (social cognition: [socb]), (sample: [sbst]), (adolescents: [aggp]), (controls: [sbst]), (dewey story test: [lbpr]), (explicit (multiple-choice answering format): [inbe]), (implicit (free interview) measures: [acty]), (autism spectrum disorder participants: [mobd]), (explicit social cognition performance: [inbe]), (however: []), (autism spectrum disorder group: [mobd]), (implicit social cognition performance: [inbe]), (terms: [orgf]), (spontaneous perspective taking: []), (social awareness: [menp]), (findings: [clna]), (social cognition alterations: [socb]), (nature: []), (apparent absence: [anab]), (social cognition difficulties: [menp]), (certain tests: [lbpr]), (formats: []), (social cognition typicality: [socb]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social cognition test performance, 'Cognitive Ability')(social cognition, 'Cognitive Ability')(social cognition, 'Cognitive Ability')(autism spectrum disorder participants, 'Autism Phenotype')(explicit social cognition performance, 'Cognitive Ability')(implicit social cognition performance, 'Cognitive Ability')(autism spectrum disorder group, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(social cognition alterations, 'Cognitive Ability')(social cognition difficulties, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(mean social cognition typicality, 'Cognitive Ability')(social cognition typicality, 'Cognitive Ability')

PMCID: 4513197
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autistic traits: [mobd]), (general population: [popg]), (cognition: [menp]), (present study: [qnco]), (pro-social behaviour: [aapp,bacs]), (influence: []), (expectations: []), (novel task: []), (characters: [menp]), (need: []), (help: []), (students: [popg]), (high versus low: [qnco]), (autism-spectrum quotient: [qnco]), (scenarios: []), (variants: []), (ambiguous social rule: [orga]), (participants: [popg]), (high versus: [qnco]), (low autistic traits: [mobd]), (sympathetic overall towards: []), (groups ratings: [popg]), (characters expectations: [menp]), (comparable: []), (high autistic traits: [mobd]), (rule-based rationales: []), (clear-cut condition: [dsyn]), (pattern: []), (intact knowledge: [fndg]), (context: [fndg]), (reduced pro-social behaviour: [aapp,bacs]), (implications: []), (social skill: [socb]), (programmes: []), 
ASD Terms: (cognition, 'Cognitive Ability')(implications for social skill, 'Ability to Converse in Social Settings')(social skill, 'Ability to Converse in Social Settings')

PMCID: 5040734
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (equine-assisted activities: [mamm]), (therapies: [topp]), (popularity: [socb]), (treatment: [topp]), (asd symptoms: [cgab]), (research: [resa]), (effects: []), (5-week programme: [phsu]), (social functioning: [socb]), (children/adolescents (n: [aggp]), (asd: [cgab]), (effectiveness: []), (programme: [phsu]), (autism spectrum: [mobd]), (vineland adaptive behaviour scale: []), (empathising: []), (systemising quotient: [qnco]), (results: [fndg]), (tr intervention: [hlca]), (reduced maladaptive behaviours: [fndg]), (findings: [clna]), (specific adaptive behaviours: [inbe]), (socialization: [edac]), (communication: [socb]), (intervention: [hlca]), (complex picture: [chvs]), (intervention emerges:: [hlca]), (tr: [gngm]), (childs: [aggp]), (specific aspects: [qnco]), (maladaptive asd traits: [cgab]), 
ASD Terms: (asd symptoms, 'Complaints and Indications')(social functioning, 'Social Competence')(autism spectrum, 'Autism Phenotype')(vineland adaptive behaviour scale, 'Adaptive Life Skills')(specific adaptive behaviours, 'Adaptive Life Skills')(social functioning, 'Social Competence')

PMCID: 5953451
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (little evidence: [fndg]), (effects: []), (group intervention: [popg]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (important outcomes: []), (meta-analyses: [resa]), (random effects model: [resa]), (effectiveness: []), (individual: [humn]), (group intervention studies: [popg]), (types: []), (possible: []), (main analysis: [resa]), (studies: [lbpr]), (high risk: [fndg]), (bias (analysis i): [inch]), (trials: [resa]), (asd6 years: [cgab,dsyn]), (age (594 children): [aggp]), (results: [fndg]), (group interventions: [popg]), (significant effects: [qnco]), (control condition: [topp]), (reciprocity: [socb]), (social interaction towards: [fndg]), ((standard mean difference[smd] [95%confidence interval{ci}]: [qnco]), (p: [gngm]), (respectively): []), (individual interventions: [hlca]), (parental synchrony (smd [95%ci]: [dsyn]), (p<0.01): [fndg]), (significant differences: [qnco]), (autism: [mobd]), (general symptoms (no study: [sosy]), (group intervention): [popg]), ( developmental quotient (no study: [resa]), (expressive language (p: [lang]), (receptive language (p: [lang]), ((p: [aapp,imft]), (adaptive behaviour (p: [inbe]), (sensitivity analyses: [patf]), (potential bias (analysis ii): [bird]), (social interactions towards: [fndg]), (individual intervention: [hlca]), (control condition (0.50[0.31: [fndg]), (0.69]: [fndg]), ( p<0.001): [fndg]), (parental synchrony (0.98[0.30: [fndg]), (1.66]: [fndg]), ( p: [aapp,imft]), (sensitivity analysis: [patf]), (significant difference: [qnco]), (outcomes: []), (data: [euka]), (cluster-robust standard errors: [qnco]), (sensitivity: [patf]), (iii): []), (analysis iii: [resa]), (intervention condition: [dsyn]), (analysis ii: [resa]), (iv): []), (social interaction towards others: [fndg]), ("parental synchrony": []), ((mean estimate[95%ci]: [lbpr]), (robust standard error: [qnco]), (none: []), (discrepancies: [fndg]), (main analysis (analysis i): [inch]), (ii: [gngm]), ( iii: []), (small number: [qnco]), (included studies: [lbpr]), (outcome: []), (dependent variable: []), (context-bound setting: [qnco]), (child's parent: [famg]), (pre-school children: [aggp]), (asd: [cgab]), (generalised skills: [inbe]), (reciprocal interactions: []), (interventions: [hlca]), (however: []), (targets: [diap]), (parental synchrony: []), (promising target: [diap]), (trial registration: (crd42011001349): [resa]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social interaction towards, 'Reciprocal Social Interaction')(social interaction towards, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(expressive language, 'Expressive Language')(receptive language, 'Receptive Language')(adaptive behaviour, 'Adaptive Life Skills')(social interactions towards, 'Reciprocal Social Interaction')(social interaction towards others, 'Reciprocal Social Interaction')(reciprocal interactions, 'Reciprocal Social Interaction')

PMCID: 5551214
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (paper: []), (case-control study: [resa]), (horse: [mamm]), (intervention: [hlca]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (sample: [sbst]), (years: []), (intervention (n: [hlca]), (group conditions: [dsyn]), (post-tests: [lbpr]), (childhood autism rating scale: [mobd]), ( second edition (cars2): [gngm]), (aberrant behaviour checklist-community edition (abc-c): [inbe]), (observational measure: [resa]), (compliance: [inbe]), (behaviour: [inbe]), (sessions: [evnt]), (intervention group: [popg]), (significant reduction: [npop]), (severity: []), (asd symptoms: [cgab]), (hyperactivity: [mobd]), (results: [fndg]), (aspects: [qnco]), (social functioning: [socb]), (asd: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(asd symptoms, 'Complaints and Indications')(hyperactivity, 'Overactivity')(social functioning, 'Social Competence')

PMCID: 4822328
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent research: [resa]), (differences: [qnco]), (relative attention: [menp]), (social versus: []), (non-social video stimuli: [phpr]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (whether: []), (attentional allocation: [menp]), (potential threat: []), (stimuli: [phpr]), (current study: [resa]), (extent: []), (towards: []), (viewer: []), (furthermore: []), (such differences: [qnco]), (other neurodevelopmental disorders: [mobd]), (study: [resa]), (adolescents: [aggp]), (asd demonstrate differences: [cgab]), (pairs: []), (actor: []), (moves towards: [fndg]), (moves: [fndg]), (comparison: [acty]), (asd: [cgab]), (genetic syndromes: [dsyn]), (social phenotypes: [orga]), (demonstrate differences: [qnco]), (same stimuli: [phpr]), (control participants: [popg]), (formats: []), (viewer): []), (eye movements: [ortf]), (recorded: [qnco]), (paradigm: [resa]), (groups: [popg]), (fragile x: [comd]), ( cornelia: []), (lange: []), (rubinstein-taybi syndromes: [cgab,dsyn]), (chronological age: [orga]), (global adaptive behaviour: [inbe]), (verbal adaptive behaviour (study: [inbe]), (non-social videos: []), (towards them: []), (genetic syndrome groups: [popg]), (fixation latency: [topp]), (social stimuli: [phpr]), (studies: [lbpr]), (between-group differences: [popg]), (attention: [menp]), (results: [fndg]), (strong evidence: []), (differential visual attention: [menp]), (populations: [popg]), (socio-behavioural phenotypes: [bhvr]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(other neurodevelopmental disorders, 'Learning Disorders')(fragile x, 'Fragile X Syndrome')(global adaptive behaviour, 'Adaptive Life Skills')(verbal adaptive behaviour, 'Adaptive Life Skills')(differential visual attention, 'Visual Thinking')

PMCID: 5264460
SFARI Genes: 
Non SFARI Genes: impact, impact, 
Named Entities: (d-cycloserine (dcs) enhances extinction: [menp]), (species: []), (consistent benefit: [qnco]), (dcs: [dsyn]), (therapeutic interventions: [topp]), (placebo-controlled trial: [resa]), (social skills: [socb]), (autism spectrum disorder (asd): [mobd]), (substantial improvement: []), (placebo groups: [popg]), (conclusion: []), (active treatment: [topp]), (here: []), (impact: [gngm]), (weeks: []), (treatment response durability: [topp]), (study participants: [humn]), (outpatient youth: [aggp]), (asd: [cgab]), (years: []), (iq: []), (impaired social functioning: [mobd]), (10-week active treatment phase: [topp]), (weekly single doses: [fndg]), (mg: [elii,phsu]), (placebo: [topp]), (min: [neop]), (group: [popg]), (follow-up assessments: [hlca]), (week: []), (primary outcome measure: []), (durability: []), (treatment evaluation: [hlca]), (parent-rated social responsiveness scale (srs): [acty]), (total raw score: [diap]), (analysis: [resa]), (srs: [gngm]), (significant decrease: [qnco]), (dcs group: [dsyn]), (placebo group (p: [popg]), (indicating: []), (maintenance: [acty]), (treatment effect: [fndg]), (irritability: [fndg]), (adverse effect: [patf]), (groups: [popg]), (findings: [clna]), (study: [resa]), (skills: [inbe]), (sort-term social skills: [orgf]), (larger-scale studies: [lbpr]), (follow-up: [hlca]), (long-term impact: [gngm]), (trial registration clinicaltrials.gov: [resa]), ( nct01086475: []), 
ASD Terms: (social skills, 'Ability to Converse in Social Settings')(autism spectrum disorder, 'Autism Phenotype')(impaired social functioning, 'Ability to Converse in Social Settings')(sort-term social skills, 'Ability to Converse in Social Settings')

PMCID: 5608197
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (ways: []), (trajectory: []), (symptoms: [sosy]), (autism spectrum disorder: [mobd]), (research: [resa]), (natural prognosis: [hlca]), (course: []), (objective: []), (study: [resa]), (temporal stability: []), (autism diagnosis: [mobd]), (longitudinal trajectories: []), (autism core symptom severity: [mobd]), (possible predictors: []), (change: [qnco]), (pubmed: []), ( psycinfo: []), ( embase: []), ( web: []), (science: []), ( cochrane library: [gngm,nnon]), (october: []), (prospective cohort studies: [resa]), (autism spectrum disorder/autism: [mobd]), (diagnostic stability: [fndg]), (prospective studies: [resa]), (intervention effects: [hlca]), (people: [popg]), (ages: [bacs,orch]), (risk: []), (months: []), (autism diagnostic observation schedule (ados): [hlca]), (continuous ados scores: [aapp,enzy]), (dichotomous diagnostic categories: [fndg]), (random-effects meta-analysis: [resa]), (meta-regression: [menp]), (abstracts: []), (eligible: []), (studies: [lbpr]), (appropriate data: [euka]), (meta-analysis: [resa]), (total: [qnco]), (participants: [popg]), (age: [orga]), (years: []), (analyses: [resa]), (ados scores: [aapp,enzy]), (time: []), (calibrated severity scores (mean difference [md]: [qnco]), (ci -0.26: [fndg]), (significant change: [qnco]), (ados: [aapp,enzy]), (total raw scores: [diap]), (= -1.51: [fndg]), (ci -2.70: [aapp,phsu]), (improvement: []), (repetitive behaviours: [inbe]), (md [smd] =: [dsyn]), (ci -0.19: [fndg]), (minor improvement: [popg]), (social affect: [menp]), ((smd = -0.31: [dsyn]), (ci -0.50: [fndg]), (changes: [qnco]), (autism spectrum disorder criteria: [mobd]), ((risk difference [rd] =: [qnco]), (ci -0.03: [fndg]), (autism criteria: [mobd]), ((rd = -0.18: [fndg]), (ci -0.29: [fndg]), (average: [qnco]), (high heterogeneity: [orga]), (studies (i2: [lbpr]), (discussion: [socb]), (autism: [mobd]), (spectrum disorder: [dsyn]), (overall autism spectrum disorder prevalence: [qnco]), (overall autism core symptoms: [mobd]), (childhood indicating: []), (intervention studies: []), (other areas: []), (quality: []), (life: []), (adaptive functioning: []), (however: []), (number: [qnco]), (limitations: []), (results: [fndg]), (caution: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism core symptom severity, 'Complaints and Indications')(autism diagnosis, 'Diagnosis')(autism spectrum disorder/autism, 'Autism Phenotype')(autism spectrum disorder/autism, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(continuous autism diagnostic observation schedule scores, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(repetitive behaviours, 'Restricted and Repetitive Behavior')(autism spectrum disorder criteria, 'Autism Phenotype')(autism criteria, 'Autism Phenotype')(overall autism spectrum disorder prevalence, 'Autism Phenotype')(overall autism core symptoms, 'Complaints and Indications')(adaptive functioning, 'Adaptive Life Skills')

PMCID: 4820467
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (term: [orgf]), (pathological demand avoidance (pda): [mobd]), (elizabeth newson: []), (children: [aggp]), (autism spectrum: [mobd]), (obsessive resistance: [menp]), (demands: [topp]), (requests (newson: []), (al.: [lbpr]), ( arch dis child: [aggp]), (clinical accounts: [clna]), (describe avoidance strategies: [menp]), (strategic use: [menp]), (distraction: [topp]), (shocking behaviour: [patf]), (obsessive need: []), (control: [sbst]), (behaviour: [inbe]), (peers: [popg]), (adults: [aggp]), (educational: []), (management approaches: [hlca]), (pda: [cgab]), (typical autism spectrum disorders: [mobd]), (novelty: []), ( humour: [topp]), (flexibility: []), (identification: [menp]), (individuals: [humn]), (asd: [cgab]), (important implications: []), (management (eaton: [hlca]), (banting: []), ( j learn disabil offending behav: [menp]), (clinician-rated instrument: [acty]), (developed: []), (here: []), ( items: []), (diagnostic interview: [acty]), (social: []), (communication disorder (disco): [mobd]), ( j child psychol psychiatry: []), (pda-specific subset: [cgab]), (relevant disco items: []), (low endorsement: [qnco]), (sample: [sbst]), (possible asd: [cgab]), (disco: []), (disco pda items: [cgab]), (measure: [qnco]), (subset: []), (high number: [qnco]), (features: []), (newsons descriptions: []), (group: [popg]), (lack: []), (co-operation: [acty]), ( use: []), (manipulative behaviour: [fndg]), ( difficulties: [fndg]), (other people: [popg]), ( anxiety: [mobd]), (sudden behavioural changes: [mobd]), (case: []), (criteria: []), (study: [resa]), (field: [irda]), (step: [gngm]), (clinician-rated measure: [qnco]), (pda features: [cgab]), (highlights: []), (need: []), (further elucidation: []), (pda phenotype: [cgab]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s00787-015-0740-2) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum, 'Autism Phenotype')(obsessive resistance, 'Obsessive-Compulsive Disorder')(obsessive need, 'Obsessive-Compulsive Disorder')(typical autism spectrum disorders, 'Autism Phenotype')(anxiety, 'Anxiety Disorders')(anxiety, 'Anxiety Disorders')

PMCID: 5408391
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (infants: [aggp]), (sibling: [famg]), (autism spectrum disorder (asd) exhibit asd: [mobd]), (age: [orga]), (years: []), (longerterm outcomes: []), (highrisk infants: [aggp]), (symptoms: [sosy]), (asd: [cgab]), ( attentiondeficit/hyperactivity disorder (adhd): [mobd]), (anxiety: [mobd]), ( language: [lang]), ( iq: []), (adaptive behaviour: [inbe]), (high: [qnco]), (lowrisk children: [aggp]), (first year: [qnco]), (life: []), (clinical outcomes: []), (highrisk children: [aggp]), (diagnostic criteria: []), ((hrasd7 group: [popg]), (asd (hrnonasd7 group: [cgab]), ( n: [aapp,imft]), (control children: [aggp]), (group: [popg]), ( n =: [aapp,imft]), (diagnostic stability: [fndg]), (children: [aggp]), (diagnosis: [fndg]), (opposite pattern: []), (hrasd7 group: [popg]), (adhd: [mobd]), (anxiety symptoms: [fndg]), (adaptive behaviour scores: [inbe]), (lr controls: [sbst]), (hrnonasd7 group: [popg]), (repetitive behaviour: [fndg]), (adaptive functioning: []), (elevated scores: [clna]), (subscale (separation anxiety): [mobd]), (evidence: []), (subclinical asd symptoms (the: [cgab]), (autism phenotype: [mobd]), ( bap): [aapp,enzy]), (subgroup: [virs]), (elevated asd traits: [cgab]), (difficulties: [fndg]), (highrisk siblings: [famg]), (schoolage: []), (asd symptoms: [cgab]), (pattern: []), (understanding: [menp]), (developmental trajectories: [orgf]), (psychopathology: []), (autism res: [mobd]), (autism research: [mobd]), (wiley periodicals: []), ( inc: []), (behalf: []), (international society: [orgt]), 
ASD Terms: (autism spectrum disorder exhibit asd, 'Autism Phenotype')(examined symptoms of asd, 'Complaints and Indications')(adaptive behaviour, 'Adaptive Life Skills')(anxiety, 'Anxiety Disorders')(diagnosis, 'Diagnosis')(adaptive behaviour scores, 'Adaptive Life Skills')(anxiety symptoms, 'Anxiety Disorders')(anxiety subscale, 'Anxiety Disorders')(subclinical asd symptoms, 'Complaints and Indications')(repetitive behaviour, 'Restricted and Repetitive Behavior')(adaptive functioning, 'Adaptive Life Skills')(asd symptoms, 'Complaints and Indications')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 6105175
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder: [mobd]), (core: [bdsu]), (deficit: [dsyn]), (social communication: [socb]), (presence: [qnco]), (repetitive behaviors: [fndg]), (interests: [menp]), (currently: []), (us food: [imft,phsu]), (drug administration-approved drug: [fndg]), (core symptoms: [sosy]), (article: []), (biological origins: []), (social function deficit: [socb]), (drug therapies: [topp]), (review: []), (history: [orga]), (autism: [mobd]), (social interaction: [fndg]), (feature: []), (concept: []), (conception: [orgf]), (abnormalities: [cgab]), (early social skill development: [socb]), (overview: []), (pathophysiology abnormalities: [cgab]), (brain circuits: [bpoc]), (ongoing clinical trials: [resa]), (agents: [chvf]), (potential: []), (social deficits: []), (detail: []), (discussion: [socb]), (oxytocin: [aapp,horm,phsu]), (propranolol: [orch,phsu]), (undergoing active investigation: [hlca]), (other agents: [chvf]), (vasopressin agonists: [aapp,horm,phsu]), (antagonists: [chvf]), (activity: [acty]), (evidence: []), (time: []), (addition: []), ( agents: [chvf]), (bumetanide: [orch,phsu]), (manipulation: [topp]), (enteric microbiome: [orgm]), (microbiota transfer therapy: [orgm]), (promising effects: []), (core autism spectrum disorder symptoms: [mobd]), (social function: [socb]), (other pertinent issues: [fndg]), (treatments: [topp]), (disease heterogeneity: [orga]), (high placebo response: [topp]), (trial design: []), (appropriate way: []), (effects: []), (social skills: [socb]), ((outcome measures): [qnco]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorder, 'Autism Phenotype')(social function deficit, 'Ability to Converse in Social Settings')(autism, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(early social skill development, 'Ability to Converse in Social Settings')(social deficits, 'Social Competence')(core autism spectrum disorder symptoms, 'Complaints and Indications')(social function, 'Ability to Converse in Social Settings')(autism spectrum disorder, 'Autism Phenotype')(assessing effects on social skills, 'Ability to Converse in Social Settings')(social skills, 'Ability to Converse in Social Settings')

PMCID: 5623420
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (update: []), (prevalence: [qnco]), (parent-reported autism spectrum disorder (asd) diagnosis: [mobd]), (new information: [fndg]), (teacher-reported asd: [cgab]), (representative australian cohorts: [popg]), (ages: [bacs,orch]), (years: []), ((2) examine differences: [qnco]), (cohort demographic: [popg]), (clinical profiles: [lbpr]), ((3): [fndg]), (changes: [qnco]), (categorisation: []), (time: []), (cohorts: [popg]), (design: [acty]), (secondary analyses: [neop]), (data: [euka]), (longitudinal study: [resa]), (australian children (lsac): [aggp]), (participants children: [aggp]), (kindergarten age (k cohort; birth year: [orga]), (birth: [orgf]), (cohort; birth year: [popg]), (follow-up: [hlca]), (waves: [gngm]), (primary outcome measures: [qnco]), (teacher-reported asd diagnosis: [cgab]), (time points: []), (age: [orga]), (adjusted prevalence: [qnco]), (parent-reported asd diagnosis: [cgab]), ((95% ci: [lbpr]), (b: []), (k: [qnco]), (respectively: []), (teacher-reported prevalence: [qnco]), (asd: [cgab]), (b cohort: [popg]), (k cohort: [popg]), (parents: []), (conduct: [inbe]), (problems: []), (teachers: []), (pro-social behaviour: [aapp,bacs]), (b relative: [qnco]), (k cohort asd children: [cgab]), (children: [aggp]), (later-born b cohort: [orgf]), (behaviour problems: [mobd]), (teacher-agreed cases: [qnco]), (individual switching: [humn]), (other categories: []), (low (k cohort n=5: [qnco]), ( b cohort n=6): [popg]), ( teachers: []), (emotional/ behavioural problems: [mobd]), (later-born cohort: [orgf]), (milder: []), (behavioural problems: [mobd]), (change: [qnco]), (use: []), (diagnostic categories: [fndg]), (schools: [mnob,orgt]), 
ASD Terms: (parent-reported autism spectrum disorder diagnosis, 'Diagnosis')(teacher-reported asd diagnosis, 'Diagnosis')(parent-reported asd diagnosis, 'Diagnosis')(behaviour problems, 'Personal Traits')(children with emotional/ behavioural problems, 'Personal Traits')(emotional/ behavioural problems, 'Personal Traits')(behavioural problems as asd, 'Personal Traits')(behavioural problems, 'Personal Traits')

PMCID: 5520775
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (core symptoms: [sosy]), (autism spectrum disorder (asd): [mobd]), (impaired social communication: [socb]), (repetitive behaviors: [fndg]), (interests: [menp]), (effective pharmacotherapy: [topp]), (core deficits: [bdsu]), (domain: []), (social communication: [socb]), (vasopressin system: [aapp,horm,phsu]), (social cognition: [socb]), (deficits: []), (asd: [cgab]), (potential therapeutic target: [diap]), (effects: []), (mg: [elii,phsu]), (intravenous dose: [qnco]), (arginine vasopressin receptor: [aapp,rcpt]), ((v1a) antagonist: [ortf]), ( rg7713: []), (exploratory biomarkers: [clna]), (clinical measures: [qnco]), (communication: [socb]), ((affective speech recognition: [menp]), (mind: [menp]), (eyes: [bpoc]), ( olfactory identification: [orgf]), (interaction): []), (safety: [hcpp]), (tolerability: [resa]), (multicenter: []), ( randomized: [resa]), ( double-blind: [resa]), ( placebo-controlled: [resa]), ( cross-over study: [resa]), (high-functioning adult: [aggp]), (male subjects: [orga]), (dsm-iv autistic disorder (age: [mobd]), (full scale iq >70; abc-irritability subscale 13): [dsyn]), (eye-tracking: [bpoc]), (increase: []), (biological motion: [npop]), (preference: []), (rg7713 (es=0.8: [neop]), ( p=0.047): [fndg]), (non-significant improvement: [qnco]), (composite score (es=0.2: [neop]), ( p=0.29): [fndg]), (rg7713: []), (ability: [orga]), (lust (es=0.8: [neop]), ( p=0.03): [fndg]), (fear: [menp]), (p=0.07): [fndg]), (asr: []), (however: []), (individual emotion subscales: [menp]), (overall asr performance: [inbe]), (reduction: [npop]), (non-significant (es=0.1: [neop]), ( p=0.59): [fndg]), (thirteen adverse events: [patf]), (subjects;: [humn]), (mild (11/13): []), (moderate (2/13) severity: [qnco]), (interpretation: [clna]), (multiple comparisons: [acty]), (small sample size: [qnco]), (results: [fndg]), (preliminary evidence: []), (behavioral biomarkers: [clna]), (blockade: [phsu]), (v1a receptor: [bpoc]), (adults: [aggp]), (high-functioning asd: [cgab]), (clinicaltrials.gov identifier: nct01474278 a study: [resa]), (ro5028442: [orch,phsu]), (adult male high-functioning autistic patients: [mobd]), (available at: https://clinicaltrials.gov/ct2/show/nct01474278: [anim]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(social communication, 'Reciprocal Social Interaction')(social cognition, 'Cognitive Ability')(social cognition, 'Cognitive Ability')(dsm-iv autistic disorder, 'Autistic Disorder')(social communication, 'Reciprocal Social Interaction')

PMCID: 6001054
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (impaired social interactions: [mobd]), (repetitive patterns: []), (behavior: [inbe]), (symptoms: [sosy]), (early life: []), (persist: []), (adulthood: []), (social stimulation: [npop]), (biological mechanisms: []), (therapies: [topp]), (effects: []), (early social stimulation: [npop]), (asd-related behavior: [cgab]), (mouse: [mamm]), (brain structures: [bpoc]), (behaviors: [inbe]), (pregnant mice: [mamm]), (600-mg/kg valproic acid (vpa): [orch,phsu]), (saline (sal): [sbst]), (gestational day: []), (effect: []), (offspring: [famg]), (cages: []), (vpa: []), (sal: [bacs,inch,phsu]), (juvenile play: [dora]), (pd21: []), (battery: [inpo]), (behavioral tests: [diap]), (preclinical pet imaging: [anim]), (unbiased analysis: [resa]), (whole brain: [bpoc]), (mice: [mamm]), (function: [phsf]), (piriform cortex: [bpoc]), (c-fos immunoreactivity: [gngm]), (hplc: [lbpr]), (animals: [anim]), ( vpa-exposed animals: [anim]), (juveniles: [aggp]), (frequency: [qnco]), (social interaction: [fndg]), (other vpa mice: [mamm]), (social odors: [npop]), (habituation/dishabituation olfactory test: [orgf]), (however: []), (vpa animals: [anim]), (control: [sbst]), (behavioral alterations: [inbe]), (interestingly: []), (repetitive behaviors: [fndg]), (depression-related behaviors: [mobd]), (social enrichment: []), (present high levels: [qnco]), (glucose metabolism: [moft]), (region: []), (social behaviors: [socb]), (moreover: []), (alterations: []), (somatosensory: []), ( motor: []), (insular cortices: [bpoc]), (remarkably: []), (changes: [qnco]), (pir: [gngm]), (neuronal activity: [acty]), (dopamine turnover: [bacs,orch,phsu]), (early social enrichment: []), (social deficits: []), (mouse model: [emod]), (asd: [cgab]), (results: [fndg]), (structure: []), (vpa-exposure: [clna]), (key component: []), (social brain circuitry: [bpoc]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0221-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (repetitive patterns of behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorder, 'Autism Phenotype')(impaired social interactions, 'Reciprocal Social Interaction')(gestational day, 'Perinatal History')(offspring in cages, 'Perinatal History')(offspring, 'Perinatal History')(social interaction, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(social behaviors, 'Reciprocal Social Interaction')(social deficits, 'Social Competence')

PMCID: 5360843
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prevalence: [qnco]), (autism spectrum disorder (asd): [mobd]), (many parts: [qnco]), (world: [popg]), (however: []), ( data: [euka]), (china: []), (here: []), (suitability: []), (chinese version: [lang]), (newly-developed asd screening: [cgab]), (modified chinese autism spectrum rating scales (mc-asrs): [inpr,qnco]), (asd: [cgab]), (chinese children: [aggp]), (years: []), (comparison: [acty]), (social responsiveness scale (srs): [acty]), (asd screening: [cgab]), (parents/caregivers: []), (typically-developing children: [aggp]), (children: [aggp]), (mc-asrs: []), (srs: [gngm]), (validity: [qnco]), (scales: [bpoc]), (typically: []), (results: [fndg]), (sensitivity: [patf]), ( specificity: [qnco]), (area-under-the-curve (both >0.95): [fndg]), (receiver operating: []), (characteristic analysis: [resa]), (fair false-negative rate: [lbtr]), (promising tool: []), (general chinese population: [popg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(modified chinese autism spectrum rating scales, 'Autism Phenotype')

PMCID: 4985921
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (feasibility: []), (recruitment: [acty]), ( retention: [menp]), ( outcome measures: [qnco]), (intervention training/delivery: [topp]), (teachers: []), ( parents: []), (children: [aggp]), (sample size estimation: [qnco]), (full trial: [resa]), (single-centre: [fndg]), ( unblinded: []), ( cluster feasibility: [qnco]), (trial: [resa]), (social: []), (school environment: [eehu]), (attentional control: [menp]), (primary schools: [mnob,orgt]), (york: []), ( uk: []), (participants: [popg]), (cluster randomisation approach: [resa]), (school: [mnob,orgt]), (treatment group: [popg]), (waiting list control group: [grup]), (outcome: []), (acceptability: []), ( intervention: [hlca]), (measurements: []), (outcomes: []), (definitive trial: [resa]), (assessment: [acty]), (questionnaire completion rates: [qnco]), (primary outcome measure: []), (social responsiveness scale (srs)-2: [acty]), (goal-based measure: [qnco]), (levels: []), (completion rates: [qnco]), (primary follow-up point (6 weeks postintervention): [qnco]), (behaviour outcomes: [inbe]), (power calculations: [hcpp]), (outcome measures: [qnco]), (total: [qnco]), (sample size: [qnco]), (participant groups: [popg]), (results: [fndg]), (future trial: [resa]), (policy: []), (practice: [menp]), (mainstream schools: [edac]), (trial registration number isrctn96286707; results: [resa]), 
ASD Terms: 

PMCID: 6153919
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (social motivation: [menp]), (social behavioural symptoms: [sosy]), (autism spectrum disorder (asd): [mobd]), (extent: []), (social stimuli: [phpr]), (privileged access: []), (asd: [cgab]), (continuous flash suppression: [qnco]), (individuals: [humn]), (scenes: []), (stimulus features: [phpr]), (strong evidence: []), (nonsocial scenes: []), (neurotypical adults: [aggp]), (such privileged access: []), (asd individuals: [cgab]), (moderate support: []), (null model: [qnco]), (results: [fndg]), (purported deficits: []), (early processing mechanisms: [acty]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(underlie social behavioural symptoms, 'Reciprocal Social Interaction')(social behavioural symptoms, 'Reciprocal Social Interaction')(purported deficits in social motivation, 'Social Competence')

PMCID: 4805089
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (atypical connectivity: [fndg]), (higher-order association areas: [menp]), (diffusion imaging: [npop]), ( catani: []), (al: [lbpr]), (reveal associations: [menp]), (asd: [cgab]), (white matter abnormalities: [patf]), (frontal lobe: [bpoc]), (condition: [dsyn]), (developmental trajectories: [orgf]), (frontal networks: []), (adulthood: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 4786596
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (syndromic autism: [mobd]), (children: [aggp]), (orphanage rearing: [mnob,orgt]), (family breakdown: [famg]), (families: [famg]), (adopted children: [famg]), (years: []), (months; sd: [mamm]), (% male): [orga]), (screening questionnaires: [resa]), (autism spectrum disorder: [mobd]), ((39 %): []), (positive: [fndg]), (in-person phenotyping: [lbpr]), (screen positive cases: [hlca]), (asd: [cgab]), ((11 %): []), ( broad asd (sub: [cgab]), (traits): [gngm]), ((9 %): []), (false positive: [lbtr]), (asd group: [cgab]), (impairments: [patf]), (social communication: [socb]), (restrictive repetitive behaviour domains: [fndg]), ( broad asd: [cgab]), (population prevalence: [qnco]), (institutionalised samples: [sbst]), (implications: []), (developmental science: [orgf]), (assessment: [acty]), ( treatment: [topp]), (policy: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-015-2680-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (syndromic autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')(restrictive repetitive behaviour domains, 'Restricted and Repetitive Behavior')

PMCID: 5390705
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract next: []), (social problems: [fndg]), ( individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (severe sensory difficulties: [fndg]), (altered processing: [acty]), (touch: [ortf]), (mediator: [aapp,bacs]), (social symptoms severity: [fndg]), (processing: [acty]), (instance vision: [orgf]), (audition: [phsf]), (case?: []), (sensory difficulties: [fndg]), (asd: [cgab]), (insufficient self-other distinction: []), (means: []), (eeg: [diap]), (brain: [bpoc]), (adults: [aggp]), (tactile consequence: [gngm]), (observed action: [acty]), (own touch: [ortf]), (matched controls: [resa]), (action-based somatosensory congruency paradigm: [resa]), (participants: [popg]), (wooden hand: [bpoc]), (surface: []), (tap-like tactile sensation: [hlca]), (observed movement: [orgf]), (asd group: [cgab]), (diminished congruency effect: [qnco]), (human hands: [humn]), (p3-complex: [chvs]), (difficulties: [fndg]), (action-based touch: [ortf]), (others: [fndg]), (own touch experiences: [ortf]), (crucially: []), (effect: []), (sensory everyday difficulties: [fndg]), (findings: [clna]), (novel theoretical link: []), (sensory: []), (social impairments: [patf]), (autism spectrum: [mobd]), 
ASD Terms: (social problems, 'Social Competence')(autism spectrum disorder, 'Autism Phenotype')(severe sensory difficulties, 'Reaction to Sensory Stimuli')(social problems in asd, 'Social Competence')(sensory difficulties, 'Reaction to Sensory Stimuli')(sensory everyday difficulties in asd, 'Reaction to Sensory Stimuli')(sensory everyday difficulties, 'Reaction to Sensory Stimuli')(social impairments, 'Social Competence')(autism spectrum, 'Autism Phenotype')

PMCID: 4887819
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (transition: [acty]), (secondary school (school transition): [mnob,orgt]), (children: [aggp]), (autism spectrum disorder: [mobd]), (high levels: [qnco]), (behavioural difficulties: [fndg]), (systemic transition: [acty]), (education programme: [edac]), (autism spectrum disorder (step-asd): [mobd]), (new: []), (manualised school transition intervention: [mnob,orgt]), (feasibility: []), (efficacy: [resa]), (autism spectrum disorder (n: [mobd]), (mean age: [orga]), (years;: []), (mean iq =: [qnco]), (unblinded: []), ( non-randomised: []), (design: [acty]), (teachers: []), (intervention: [hlca]), (step-asd (n: [cgab]), (large (cohens d: [qnco]), (reduction: [npop]), ( whereas: []), ((n =: [aapp,imft]), (slight increase (d = 0.1) (p: [aapp,imft]), (encouraging findings: [clna]), (value: [qnco]), (step-asd: [cgab]), (low-intensity intervention: [hlca]), (problem behaviours: [mobd]), (distress: [menp]), (secondary school: [mnob,orgt]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(behavioural difficulties, 'Personal Traits')(problem behaviours, 'Personal Traits')

PMCID: 5676829
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (social anxiety disorder (sad): [mobd]), (symptoms: [sosy]), (gaze avoidance: [menp]), (sad: [menp]), (asd: [cgab]), (differences: [qnco]), (social attention: [menp]), (conditions: [dsyn]), (eye movements: [ortf]), (group: [popg]), (treatment-seeking adolescents: [aggp]), (sad (n: [aapp,imft]), (asd dimensionally: [cgab]), (results: [fndg]), (double dissociation: [mobd]), (measures: [qnco]), (symptom dimensions: [qnco]), (social anxiety: [mobd]), (autistic traits: [mobd]), (eyes: [bpoc]), (distractors: []), (contrast: [irda]), (social anxiety levels: [fndg]), (distinction: []), (understanding: [menp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social anxiety disorder, 'Anxiety Disorders')(differences in social attention, 'Social Competence')(social anxiety, 'Anxiety Disorders')(social anxiety levels, 'Anxiety Disorders')

PMCID: 5100325
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mimetic desire: [menp]), (spontaneous propensity: []), (goals: []), (others: [fndg]), (case: []), (social influence: []), (preferences: []), (autism spectrum disorder (asd): [mobd]), (atypical interests: [menp]), (social interaction: [fndg]), (md: []), (adults: [aggp]), (asd: [cgab]), (developed adults: [aggp]), (social anhedonia: [mobd]), (social judgment: [menp]), (aspects: [qnco]), (atypical social functioning: [socb]), (autism: [mobd]), (hypotheses: []), ( md: []), (groups: [popg]), (anhedonia: [mobd]), (control groups: [grup]), (results: [fndg]), (previous findings: [clna]), (basic mechanisms: []), (finding: [sosy]), (intact md: [fndg]), (asd stands: [cgab]), (intuitive idea: []), (possibility: []), (special interests: [menp]), (intrinsic properties: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(atypical interests, 'Unusual Sensory Interests')(social interaction, 'Reciprocal Social Interaction')(atypical social functioning, 'Social Competence')(autism, 'Autism Phenotype')

PMCID: 4689504
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (behaviour problems: [mobd]), (young children: [aggp]), (autism spectrum disorder (asd): [mobd]), (many different tools: []), (behavior problems: [mobd]), (validity: [qnco]), (population: [popg]), (measurement properties: []), (behaviour problems tools: [mobd]), (evaluation: [hlca]), (intervention: [hlca]), (observational research studies: [resa]), (children: [aggp]), (asd: [cgab]), (age: [orga]), (years: []), (behaviour measurement tools: [hlca]), (part: [qnco]), (stage: [clna]), ( systematic review: []), (first: [qnco]), (sixteen major electronic databases: [fndg]), (grey literature: [inpr,mnob]), (research registers: [resa]), (tools: []), (second: [qnco]), (methodological filters: []), (articles: []), (use: []), (eric: [gngm]), ( medline: []), ( embase: []), ( cinahl: []), (psycinfo: []), (quality: []), (papers: []), (cosmin checklist: []), (twelve tools: [qnco]), (fifteen studies: [qnco]), (evidence: []), (questionnaires: []), (measurement: []), (child behavior checklist: [diap,inpr]), (home situations questionnairepervasive developmental disorders version: [mobd]), (patchy evidence: []), (reliability: [qnco]), (systematic research: [resa]), (responsiveness: []), (outcomes: []), (prospero registration number crd42012002223: [qnco]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(behaviour problems, 'Personal Traits')(behavior problems, 'Personal Traits')(measurement properties of behaviour problems tools, 'Personal Traits')(age of six years, 'Onset of Symptoms')(behaviour problems tools, 'Personal Traits')(measure behaviour problems in young children, 'Personal Traits')(measure behaviour problems in young children, 'Personal Traits')

PMCID: 4964357
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent theories: []), (decision: [menp]), (value-related brain mechanism: [bpoc]), (social rewards: [menp]), (model: []), (children: [aggp]), (attention-deficit/hyperactivity disorder (adhd): [mobd]), ( children: [aggp]), (autism spectrum disorder (asd): [mobd]), (brain dynamics: [bpoc]), (high density-electroencephalography: [diap]), (social reward tasks: [menp]), (control children: [aggp]), (feedback error-related negativity (fern) modulation: [phpr]), (anterior cingulate cortex (acc) source activation: [acty]), (tasks: []), (remarkably: []), (cooperation: [socb]), (losses: [qnco]), (participants: [popg]), (betrayal options: []), (fern responses: [plnt]), (adhd subjects: [mobd]), (absence: [anab]), (fern modulation: [plnt]), (reduced acc activation: [cgab]), (asd subjects: [cgab]), (normal fern modulation: [plnt]), (monetary choices: [inbe]), (inverted fern/acc responses: [plnt]), (social options: []), (results: [fndg]), (neurotypicals: []), ( monetary losses: [qnco]), (disloyal social decisions: [menp]), (similar activity: [acty]), (brain value system: [bpoc]), (adhd children: [mobd]), ( difficulties: [fndg]), (reward processing: [menp]), (early brain signatures: [amas]), (social decisions: [menp]), (conversely: []), ( asd children: [cgab]), (intact neural markers: [clna]), (value-related monetary mechanisms: [qnco]), (brain modulation: [bpoc]), (prosociality: []), (social task: []), (atypical developments: [orgf]), (neural correlates: []), (social reward processing: [menp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder subjects, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder children, 'Attention Deficit Disorder with Hyperactivity')(atypical developments of neural correlates, 'Learning Disorders')(atypical developments, 'Learning Disorders')

PMCID: 6180594
SFARI Genes: 
Non SFARI Genes: RAN, RAN, RAN, RAN, RAN, RAN, RAN, 
Named Entities: (rapid: []), ((ran; naming: [menp]), (familiar items: []), (array): []), (task: [gngm]), (fundamental neurocognitive processes: [phpr]), (number: [qnco]), (complex psychiatric conditions: [mobd]), (deficits: []), (ran: [gngm]), (autism spectrum disorder (asd): [mobd]), (first-degree relatives: [qnco]), (features: []), (index: [qnco]), (genetic liability: [topp]), (study: [resa]), (eye: [bpoc]), (neurocognitive mechanisms: []), (ran performance: [inbe]), (asd: [cgab]), (investigated links: []), (language: [lang]), (clinical-behavioral features: [inbe]), (fifty-one individuals: [humn]), (biological parents: [famg]), (individuals: [humn]), (asd (n =: [cgab]), (respective control groups: [grup]), (asd controls;: [cgab]), (parent controls): [socb]), (eye tracker: [bpoc]), (variables: []), (time: []), ( frequency: [qnco]), (errors: []), (measures: [qnco]), (eye movement: [ortf]), (ran (eye-voice: [bpoc]), (span: [qnco]), ( number: [qnco]), (fixations: [topp]), (refixations): [topp]), (parent-asd groups: [cgab]), (atypical eye-movement patterns: [ortf]), (differences: [qnco]), (spousal resemblance: []), (ran ability: [orga]), (eye movement patterns: [ortf]), (increased social-communicative impairment: [mobd]), (repetitive behaviors: [fndg]), (longer ran times: [qnco]), (refixations: [topp]), (parent-asd group: [cgab]), (subgroup: [virs]), (broad autism phenotype (bap): [mobd]), (finally: []), (parent-child dyad correlations: [famg]), (associations: [menp]), (parents: []), (bap: [gngm]), (child: [aggp]), (links: []), (social-communicative abilities: [socb]), ( clinical features: [clna]), (parent-child associations: [socb]), (ran-related abilities: [orga]), (meaningful neurocognitive markers: [clna]), (connections: []), (biology: []), (asd symptomatology: [cgab]), 
ASD Terms: (number of complex psychiatric conditions, 'Mental Disorders')(fundamental neurocognitive processes, 'Cognitive Ability')(complex psychiatric conditions, 'Mental Disorders')(autism spectrum disorder, 'Autism Phenotype')(neurocognitive mechanisms, 'Cognitive Ability')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(broad autism phenotype, 'Autism Phenotype')(meaningful neurocognitive markers, 'Cognitive Ability')

PMCID: 4345534
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (individuals: [humn]), (autism spectrum disorder (asd) demonstrate difficulty: [mobd]), (social interactions: [fndg]), (relationships: []), (neural mechanisms: []), (difficulties: [fndg]), (social difficulties: [fndg]), (asd: [cgab]), (context: [fndg]), (interactions: []), (other people: [popg]), (neuroscience research: [resa]), (limited insight: [menp]), (complex dynamics: [npop]), (development: [orgf]), (novel: []), ( innovative interactive social neuroscience methods: [menp]), (brain: [bpoc]), (contexts: [fndg]), (humans: [humn]), (necessary advance: []), (asd research: [cgab]), (studies: [lbpr]), (interactive neuroscience approach: []), (brains: [bpoc]), (significant differences: [qnco]), (neural processes: [phpr]), (interaction: []), (observation: [hlca]), (brain regions: [blor]), (neuropathology: [patf]), (interactive social neuroscience methods: []), (mechanisms: []), (communication deficits: [socb]), 
ASD Terms: (autism spectrum disorder demonstrate difficulty, 'Autism Phenotype')(social interactions, 'Reciprocal Social Interaction')(social difficulties in asd, 'Social Competence')(social difficulties, 'Social Competence')(innovative interactive social neuroscience methods, 'Reciprocal Social Interaction')(innovative interactive social neuroscience methods, 'Reciprocal Social Interaction')(interactive social neuroscience methods, 'Reciprocal Social Interaction')

PMCID: 6082980
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (purpose autism spectrum disorder (asd): [mobd]), (neurodevelopmental disorder: [mobd]), (social communication impairments: [mobd]), (repetitive behaviors: [fndg]), (interests: [menp]), (impaired: []), (pragmatic language comprehension: [menp]), (universal feature: [bodm,orch]), (individuals: [humn]), (asd: [cgab]), (however: []), (underlying neural basis: [phsu]), (pragmatic language: [lang]), (present study: [qnco]), (neural activation patterns: [acty]), (impaired pragmatic language comprehension: [menp]), (children (tdc): [aggp]), (materials: [sbst]), (functional: []), (magnetic resonance: [npop]), ((fmri): [diap]), (children: [aggp]), (tdc: []), (korean: [popg]), (pragmatic language task: [lang]), (idioms: []), (mismatched images: []), (condition): [dsyn]), (different patterns: []), (neural activity: [acty]), (conditions: [dsyn]), (matched: [resa]), (mismatched): []), (specifically: []), ( children: [aggp]), (decreased activation: [acty]), (right inferior frontal gyrus (ifg) (brodmann area: [blor]), (mismatched condition: [dsyn]), (tdc (ifg; t(31)=3.17: [gngm]), ( p<0.001): [fndg]), (results: [fndg]), (asd face difficulties: [cgab]), (pragmatic expressions: [topp]), (different pragmatic language: [lang]), (neural level: [phsu]), 
ASD Terms: (purpose autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(social communication impairments, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(pragmatic language comprehension, 'Development or Regression of Language Skills')(impaired pragmatic language comprehension, 'Language Ability')(different pragmatic language, 'Language Ability')

PMCID: 5889995
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (development: [orgf]), (emotional expressions: [inbe]), (vocalizations: [fndg]), (joint attention (ja) behaviors: [menp]), (korean-speaking children: [aggp]), (autism spectrum disorder (asd): [mobd]), (developmental delay (dd): [mobd]), (materials: [sbst]), (video samples: [sbst]), (toddlers: [aggp]), (asd: [cgab]), (age-matched toddlers: [aggp]), (dd: [gngm]), (detail: []), (purpose: []), (retrospective research: [resa]), (addition: []), (statistical analysis: [resa]), (language analysis: [lang]), (final results: [fndg]), (number: [qnco]), (asd group: [cgab]), (social interactions: [fndg]), (caretakers: []), (dd group did: [popg]), (children: [aggp]), (atypical vocalizations: [fndg]), (unengaged vocalizations: [fndg]), (dd did: [gngm]), (ja: []), (particular: []), (triadic types: [bodm,orch]), (frequency: [qnco]), (dd group: [popg]), (results: [fndg]), (importance: []), (early vocalizations: [fndg]), (common symptoms: [sosy]), (lack: []), (typical: []), ( emotional: [menp]), (social functions: [socb]), (screening: [diap]), (intervention programs: [hlca]), 
ASD Terms: (vocalizations, 'Vocalizations')(joint attention behaviors, 'Joint Attention')(autism spectrum disorder, 'Autism Phenotype')(developmental delay, 'Learning Disorders')(age-matched toddlers with developmental delay, 'Learning Disorders')(vocalizations, 'Vocalizations')(social interactions, 'Reciprocal Social Interaction')(developmental delay group did, 'Learning Disorders')(children with developmental delay did, 'Learning Disorders')(atypical vocalizations, 'Vocalizations')(unengaged vocalizations, 'Vocalizations')(developmental delay did, 'Learning Disorders')(joint attention, 'Joint Attention')(developmental delay group, 'Learning Disorders')(early vocalizations, 'Vocalizations')(common symptoms of asd, 'Complaints and Indications')(social functions, 'Social Competence')(early vocalizations, 'Vocalizations')

PMCID: 4582069
SFARI Genes: 
Non SFARI Genes: HR, HR, HR, 
Named Entities: (adults: [aggp]), (autism spectrum disorder (asd): [mobd]), (reduced sensitivity (degree: [fndg]), (selective response): [genf]), (social stimuli: [phpr]), (human voices: [humn]), (order: [acty]), (reduced sensitivity: [fndg]), (consequence: []), (years: []), (poor social interaction: [mobd]), (communication: [socb]), (significant experience: [menp]), (functional mri: [diap]), (cortical sensitivity: [bpoc]), (stimuli: [phpr]), (infants: [aggp]), (high familial risk: [famg]), (asd (hr group: [cgab]), ( n: [aapp,imft]), (family history: [fndg]), (asd (lr group: [cgab]), (months): []), (voice: [orgf]), (environmental sounds: [npop]), (asleep: [fndg]), (scanner: []), (behaviour: [inbe]), (context: [fndg]), (observed parentinfant interaction: []), (whereas lr infants: [aggp]), (early specialisation: []), (human voice processing: [humn]), (right temporal: []), (medial frontal: []), (hr infants: [aggp]), (similarly: []), ( lr infants: [aggp]), (sensitivity: [patf]), (sad vocalisations: [fndg]), (right fusiform gyrus: [bpoc]), (hippocampus: [bpoc]), (also: []), (hr group only: [popg]), (association: [menp]), (infant's degree: [aggp]), (engagement: [fndg]), (social interaction: [fndg]), (degree: [qnco]), (voice sensitivity: [orgf]), (key cortical regions: [bpoc]), (results: [fndg]), (high-risk: [fndg]), (asd: [cgab]), (atypical neural responses: [orga]), (human voice: [humn]), (emotional valence: [menp]), (further exploration: [topp]), (relationship: []), (voice processing: [orgf]), (mechanisms: []), (different outcomes: []), (risk populations: [popg]), 
ASD Terms: (autism spectrum disorder show, 'Autism Phenotype')(poor social interaction, 'Reciprocal Social Interaction')(sad vocalisations, 'Depression')(social interaction, 'Reciprocal Social Interaction')

PMCID: 5135772
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (atypical social-communicative behaviour: [socb]), (restricted range: [qnco]), (interests: [menp]), (repetitive behaviours: [inbe]), (features: []), (continuum: []), (general population: [popg]), (behavioural measures: [qnco]), (cultures: [lbpr]), (languages: [lang]), (dimensional traits: [gngm]), (non-social domains: []), (bengali: []), (spoken language: [fndg]), (world: [popg]), (however: []), (serious dearth: []), (data: [euka]), (standard measures: [qnco]), (visual cognition: [menp]), (bengali translations: []), (measures: [qnco]), ((the childrens: []), (mind: [menp]), (eyes test (rmet): [bpoc]), (facial emotion recognition test: [menp]), (stimuli: [phpr]), (karolinska directed emotional faces: [blor]), (measure: [qnco]), ((the embedded figures test): []), (questionnaire measure (the childrens empathy quotient): [inbe]), (children: [aggp]), (autism spectrum conditions: [mobd]), (control children: [aggp]), ((mean age: [orga]), (years): []), (kolkata: []), ( india: [fish]), (group differences: [popg]), (t test: []), (multiple regression (after accounting: []), (potential effects: []), (gender: [orga]), ( iq: []), (behavioural: [inbe]), (trait measures: [qnco]), (expected directions: asc children: [aggp]), (childrens empathy quotient: [inbe]), (rmet: []), (facial emotion recognition: [menp]), (accurate: []), (embedded figures test: []), (distributional properties: []), (groups: [popg]), (western countries: []), (results: [fndg]), (empirical demonstration: []), (cross-cultural generalisability: []), (applicability: []), (standard behavioural: [inbe]), (major world language: [lang]), 
ASD Terms: (restricted range of interests, 'Restricted Range of Interests')(autism, 'Autism Phenotype')(atypical social-communicative behaviour, 'Personal Traits')(repetitive behaviours, 'Restricted and Repetitive Behavior')(autism, 'Autism Phenotype')(visual cognition, 'Visual Thinking')(facial emotion recognition test, 'Empathy')(visual perceptual disembedding, 'Visual Thinking')(autism spectrum conditions, 'Autism Phenotype')(karolinska directed emotional faces, 'Emotional Regulation and Control')(facial emotion recognition, 'Empathy')(autism spectrum conditions children, 'Autism Phenotype')(childrens empathy quotient, 'Empathy')

PMCID: 5861622
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (wide range: [qnco]), (ability: [orga]), (disability: [fndg]), (asd: [cgab]), (need: []), (tools: []), (phenotypic heterogeneity: [fndg]), (meaningful subtypes: []), (eye: [bpoc]), (past studies: [lbpr]), (geometric images: []), (subset: []), (asd toddlers: [cgab]), (toddlers: [aggp]), (symptom severity: [fndg]), (social attention: [menp]), (study: [resa]), (geopref test effect: [lbpr]), (different social stimuli: [phpr]), (twenty-seven toddlers: [aggp]), (asd): [cgab]), (90-s video: [fndg]), (complex social geopref test: [lbpr]), (dynamic geometric images: []), (social images: []), (children: [aggp]), (moving: [orgf]), (proportion: [qnco]), (visual fixation time: [ortf]), (number: [qnco]), (saccades: [ortf]), (second: [qnco]), (images: []), (calculated: [lbpr]), (cross-paradigm comparisons: [acty]), (original geopref test: [lbpr]), (measures: [qnco]), (cognitive: []), (social functioning (msel: [socb]), ( ados: [aapp,enzy]), ( vabs): []), (data: [euka]), (utility: [orgt]), (diagnostic indicator: [irda]), ( validation statistics: [resa]), (sensitivity: [patf]), ( specificity: [qnco]), ( roc: [qnco]), ( auc): [qnco]), (amount: [qnco]), (time: []), (other diagnostic group: [popg]), (fixation patterns: [topp]), (tests: [lbpr]), (significant correlation: [qnco]), (idea: []), (meaningful asd subgroup: [cgab]), (use: []), (complex social geopref tests: [lbpr]), (subgroup: [virs]), (geopref subtype (sensitivity: [patf]), (specificity: [qnco]), (auc: [qnco]), (previous studies: [lbpr]), (ados symptom severity: [aapp,enzy]), (complexity: [chvs]), ((low: [qnco]), (original geopref test vs: [lbpr]), (new complex social geopref test): [lbpr]), ( eye tracking: [bpoc]), (specific asd geopref subtype: [cgab]), (elevated symptom severity: [fndg]), (geopref tests: [lbpr]), (individual subject level: [phsu]), (various clinical applications: [hlca]), (early identification: [topp]), ( prognosis: [hlca]), (development: [orgf]), (subtype-specific treatments): [topp]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0202-z) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (symptom severity than asd toddlers, 'Complaints and Indications')(different social stimuli, 'Social Competence')(visual fixation time, 'Visual Thinking')(cognitive, 'Cognitive Ability')(social functioning, 'Ability to Converse in Social Settings')(eye tracking, 'Eye Contact')(specific asd geopref subtype with elevated symptom severity, 'Complaints and Indications')

PMCID: 5828311
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (deficits: []), (motor movement: []), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (human observers: [humn]), (clinicians: []), (importance: []), (atypical head: [blor]), ((e.g: []), (social peering: [popg]), (repetitive head banging): [mobd]), (asd: [cgab]), (quantitative understanding: [menp]), (head movement: [orgf]), (here: []), (quantitative comparison: [acty]), (head movement dynamics: [orgf]), (automated: []), ( person-independent computer-vision: [orgf]), (head: [blor]), ((zface): []), (preferential attention: [menp]), (nonsocial versus: []), (social stimuli: [phpr]), (stimulus sociality: [phpr]), (current study: [resa]), (differences: [qnco]), ((n =: [aapp,imft]), (asd (n: [cgab]), (16-min video: [neop]), (nonsocial stimuli: [phpr]), (dimensions: [qnco]), (rigid head movementpitch (head: [sosy]), (nods): [mamm]), ( yaw (head turns): [dsyn]), (roll: []), ((lateral head: [blor]), (zface: []), (root: [bpoc]), (mean square: [qnco]), (pitch: [qnco]), ( yaw: [dsyn]), (index: [qnco]), (magnitude: [qnco]), (angular displacement (quantity: [menp]), (head movement): [orgf]), (angular velocity (speed): [qnco]), ( children: [aggp]), (yaw displacement: [dsyn]), (head turning: [fndg]), (velocity: [qnco]), (yaw: [dsyn]), ( indicating: []), (inclination: []), (follow-up analyses: [resa]), (nonsocial stimulus condition: [dsyn]), (head movement dynamics (displacement: [orgf]), (velocity): [qnco]), (quantitative foundation: [orgt]), (previous clinical reports: []), (head movement differences: [orgf]), (lateral (yaw: [dsyn]), (roll): []), (vertical (pitch) movement: [orgf]), (nonsocial condition: [dsyn]), (levels: []), (heads: [blor]), (perception: [menp]), (social scenes: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0198-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (deficits in motor movement, 'Motor Skills')(autism spectrum disorder, 'Autism Phenotype')(perception, 'Cognitive Ability')(social scenes, 'Social Interest')

PMCID: 6053619
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (highlights  autistic traits: [mobd]), (adaptation magnitude: [orgf]), (non-social cues: []), (social eye-gaze: [bpoc]), (adults: [aggp]), (asd: [cgab]), (high ados scores: [aapp,enzy]), (aftereffects: [fndg]), (head: [blor]), (eye-gaze direction: [bpoc]), (diminished adaptation: [orgf]), (autistic adults: [mobd]), (impaired perceptual domains: []), 
ASD Terms: (adaptation magnitude, 'Adaptive Life Skills')(adaptation magnitude, 'Adaptive Life Skills')(adaptation, 'Adaptive Life Skills')(diminished adaptation, 'Adaptive Life Skills')

PMCID: 5681971
SFARI Genes: 
Non SFARI Genes: IV, IV, IV, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (mitochondrial dysfunction: [fndg]), (few studies: [lbpr]), (relationship: []), (mitochondrial function: [celc]), (asd symptoms: [cgab]), (complex: [chvs]), (iv: [gngm]), (synthase activities: [moft]), (children: [aggp]), (asd: [cgab]), (vitamin supplementation: [phsu]), (medication: [phsu]), (language: [lang]), (preschool language scales: [lang]), (clinical evaluation: [hlca]), (language fundamentals: [lang]), (adaptive behavior: [inbe]), (vineland adaptive behavioral scale: [inbe]), (social function: [socb]), (social responsiveness scale: [acty]), (aberrant behavior checklist: [inbe]), ( childhood behavior checklist: [diap,inpr]), (ohio autism clinical impression scale: [mobd]), (variation: []), (mitochondrial activity: [celc]), (controls: [sbst]), (asd children: [cgab]), (enzyme activity: [moft]), (normal range: [qnco]), (citrate synthase (24%): [aapp,enzy]), ( complex: [chvs]), (complex iv (11%): [aapp,enzy]), (poorer: [grpa]), (adaptive skills: [inbe]), (complex iv activity: [moft]), (average: [qnco]), (behavior: [inbe]), (citrate synthase activity: [moft]), (previous studies: [lbpr]), (mitochondrial underactivity: [celc]), (overactivity: [fndg]), (study: [resa]), (expanded variation: []), (demonstrates: [acty]), (first time: [qnco]), (such variations: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(asd symptoms, 'Complaints and Indications')(vitamin supplementation, 'Dietary Supplements')(medication, 'Medications')(adaptive behavior, 'Adaptive Life Skills')(vineland adaptive behavioral scale, 'Adaptive Life Skills')(social function, 'Ability to Converse in Social Settings')(ohio autism clinical impression scale, 'Autism Phenotype')(adaptive skills, 'Adaptive Life Skills')(overactivity, 'Overactivity')

PMCID: 5468258
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (atypical responsivity: [menp]), (social rewards: [menp]), (young children: [aggp]), (risk: []), (autism spectrum disorders: [mobd]), (observations: [hlca]), (hypothesis: []), (social motivation: [menp]), (asd: [cgab]), (current study: [resa]), (novel task: []), (social reward preference: [menp]), (tablet computer: []), (buttons: []), (nonsocial rewarding image respectively: [menp]), (months: []), (diagnosis: [fndg]), (part: [qnco]), (study: [resa]), (experimental sessions: [evnt]), (video: []), (in-built webcam: []), (tablet: [bodm]), (external camera: []), (children: [aggp]), (reduced relative preference: [qnco]), (proportion: [qnco]), (touches: [ortf]), (button: []), (social reward image: [menp]), (greater: [qnco]), (social preference: []), (tablet-based task: [bodm]), (use: []), (social communicative behaviour: [socb]), (eye contact: [socb]), (experimenter: []), (social smile: [socb]), (response: [fndg]), (results: [fndg]), (findings: [clna]), (eye-tracking studies: [bpoc]), (novel empirical insights: [menp]), (atypical social reward responsivity: [menp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(diagnosis, 'Diagnosis')(social communicative behaviour, 'Reciprocal Social Interaction')(eye contact, 'Eye Contact')(provide novel empirical insights into atypical social reward responsivity, 'Social Competence')(atypical social reward responsivity, 'Social Competence')

PMCID: 5293204
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prenatal factors: [aggp]), (autism spectrum disorder (asd) incidence: [qnco]), (children: [aggp]), (asd symptoms: [cgab]), (offspring: [famg]), (animal models: [anim]), (maternal immune activation (mia): [acty]), (bacterial infection: [dsyn]), (first trimesters: []), (unfortunately: []), ( regardless: []), (asd: [cgab]), (drugs: [topp]), (core symptoms: [sosy]), (century: [phsu,vita]), (ketogenic diet (kd): [fndg]), (seizures: [sosy]), (recent insights: [menp]), (mechanisms: []), (recognition: [menp]), (immune/inflammatory conditions: [dsyn]), (asd risk: [cgab]), (interest: [menp]), (kd: [dsyn]), (treatment: [topp]), (effects: []), (core asd symptoms: [cgab]), (mia: [gngm]), (pregnant c57bl/6 mice: [fndg]), (viral mimic polyinosinic-polycytidylic acid;: [nnon,phsu]), (weeks: []), (asd phenotype: [cgab]), (incidence: [qnco]), (males: [orga]), ( control: [sbst]), (diet-fed mia male: [dsyn]), (exhibited high levels: [qnco]), (repetitive self-directed behaviors; female: [orga]), (however: []), ( kd: [dsyn]), (mia-induced: [gngm]), (behavioral abnormalities: [mobd]), (males;: [orga]), (effect: []), (behavior: [inbe]), (females: [orga]), (kd-induced: [dsyn]), (metabolic changes: [qnco]), (reduced blood glucose: [orch]), (blood ketones: [bdsu]), (sexes: [orgf]), (prior work: [evnt]), (laboratory: [mnob,orgt]), (others: [fndg]), (kds: [gngm]), (relevant behaviors: [inbe]), (several asd models: [cgab]), (clear benefits: [fndg]), (mia model: [gngm]), (studies: [lbpr]), (broad utility: [orgt]), (metabolic therapy: [topp]), (support: []), (research: [resa]), (ketogenic and/or: [moft]), (metabolic strategies: [menp]), (patients: [podg]), 
ASD Terms: (autism spectrum disorder incidence, 'Autism Phenotype')(increase asd symptoms, 'Complaints and Indications')(offspring, 'Perinatal History')(bacterial infection, 'Bacterial Infections')(ketogenic diet, 'Dietary Restrictions')(ketogenic diet, 'Dietary Restrictions')(core asd symptoms, 'Complaints and Indications')(control diet, 'Dietary Restrictions')(repetitive self-directed behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(asd phenotype, 'Autism Phenotype')(maternal immune activation-induced behavioral abnormalities in males, 'Personal Traits')(maternal immune activation-induced behavioral abnormalities, 'Personal Traits')(ketogenic diet, 'Dietary Restrictions')(ketogenic diets, 'Dietary Restrictions')

PMCID: 6322109
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction: [hlca]), (autism spectrum disorder: [mobd]), (recent years: []), (similarities: []), (schizophrenia: [mobd]), (cognitive dysfunction: [mobd]), (disorders: [dsyn]), (rich array: []), (interventions: [hlca]), (few such treatments: [topp]), (study: [resa]), (useful approach: []), (regard: []), (characteristics: []), (therapeutic response: [clna]), (remediation therapy: [topp]), (patients: [podg]), (frontal/executive programme: [phsu]), (intervention: [hlca]), (autism spectrum disorder patients: [mobd]), (schizophrenia patients: [mobd]), (evaluation: [hlca]), (cognitive function: [menp]), (social function: [socb]), (changes: [qnco]), (cognitive: []), (treatment: [topp]), (patient group: [popg]), (mannwhitneys u test: [lbpr]), (severity: []), (subjects: [humn]), (same therapeutic response: [clna]), (recent debate: [acty]), (similarity: []), (disease concepts: [dsyn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(cognitive dysfunction, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(cognitive dysfunction, 'Cognitive Ability')(cognitive remediation therapy, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(cognitive dysfunction, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorder patients, 'Autism Phenotype')(cognitive function, 'Cognitive Ability')(schizophrenia patients, 'Schizophrenia and Disorders with Psychotic Features')(social function, 'Ability to Converse in Social Settings')(cognitive, 'Cognitive Ability')(social function, 'Social Competence')(cognitive dysfunction, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorder, 'Autism Phenotype')(cognitive dysfunction, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 4511760
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (brain arginine vasopressin (avp): [aapp,horm,phsu]), (normative social behavior: [socb]), (mammals: [mamm]), (experimental disruption: []), (avp: [gngm]), (social impairments: [patf]), (rodent models: [mamm]), (deficits: []), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (blood measures: [bdsu]), (brain measures): [bpoc]), (brain avp activity: [phsf]), ( study: [resa]), (relationship: []), (avp concentrations: [menp]), (blood: [bdsu]), (csf samples: [sbst]), (adults: [aggp]), (undergoing clinical procedures: [topp]), (study: [resa]), (blood avp: [bdsu]), (asd (n: [cgab]), (asd discordant siblings: [famg]), (neurotypical controls: [sbst]), (nepsy-ii theory: []), (mind: [menp]), (affect recognition tasks: [menp]), (social responsiveness scale): [acty]), (large: [gngm]), ( well-characterized child cohort: [popg]), (blood avp concentrations: [lbtr]), (csf avp concentrations: [menp]), (r: [clna]), (p: [gngm]), (groups: [popg]), (sex: [orgf]), (theory: []), (mind performance: [inbe]), (asd: [cgab]), (non-asd children: [cgab]), (surrogate: [famg]), (humans;: [humn]), (robust biomarker: [clna]), (mind ability: [orga]), (findings: [clna]), (avp biology: [gngm]), (promising therapeutic target: [diap]), (social cognition: [socb]), (individuals: [humn]), 
ASD Terms: (normative social behavior, 'Reciprocal Social Interaction')(social impairments in rodent models, 'Social Competence')(social impairments, 'Social Competence')(social impairments in children, 'Social Competence')(autism spectrum disorder, 'Autism Phenotype')(social functioning, 'Ability to Converse in Social Settings')(social cognition, 'Cognitive Ability')

PMCID: 5286449
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (support: []), ( face: [blor]), (severe difficulties: [fndg]), (everyday social interactions: [fndg]), (research: [resa]), (area: []), (cognitive: []), (neurological differences: [qnco]), (social impairments: [patf]), (social interaction: [fndg]), (definition: []), (person: [grup]), (social difficulties: [fndg]), (people: [popg]), (asd themselves: [cgab]), (perceptions: [menp]), ( judgments: [menp]), (social decisions: [menp]), (them: []), (here: []), (studies: [lbpr]), (first impressions: [inbe]), (asd: [cgab]), (thin slices: [sbst]), (real-world social behavior: [socb]), (typically-developing observers: []), (range: [qnco]), (trait judgments: [menp]), (reduced intentions: [menp]), (patterns: []), (robust: []), ( occur: [acty]), (seconds: []), (increased exposure: [clna]), (persist: []), (child: [aggp]), (adult age groups: [aggp]), (however: []), (biases: []), (impressions: [inbe]), (conversational content: [fndg]), (audio-visual cues: [inpr,mnob]), (style: []), (substance: [sbst]), ( drives: [menp]), (negative impressions: [inbe]), (collectively: []), (findings: [clna]), (perspective: []), (individuals impairments: [patf]), (potential social partners: [famg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(everyday social interactions, 'Reciprocal Social Interaction')(social interaction, 'Reciprocal Social Interaction')(cognitive, 'Cognitive Ability')(neurological differences, 'Neurologic Indications')(social impairments, 'Social Competence')(social difficulties, 'Social Competence')(perceptions, 'Cognitive Ability')(real-world social behavior, 'Reciprocal Social Interaction')(increased exposure, 'Exposures')(perspective of social difficulties, 'Social Competence')

PMCID: 6016974
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prevalence: [qnco]), (autism spectrum disorder (asd): [mobd]), (african continent: [popg]), (call: [gngm]), (further research: [resa]), (asd: [cgab]), (africa: []), (means: []), (early diagnosis: [diap]), (intervention possible: [hlca]), (study: [resa]), (awareness: [menp]), (dialogue: []), (possible intervention strategies: [topp]), (low resource settings: [qnco]), (qualitative mixed method case study: [resa]), (literature: [inpr,mnob]), (order: [acty]), (context: [fndg]), (research: [resa]), (data reduction: [npop]), (case study: []), (temple grandin: [blor]), (psychobiographical approach: []), (erikson's (1950/1973) theory: []), (psychosocial development: [menp]), (life: []), (findings: [clna]), (further data reduction: [npop]), (possible interventions: [hlca]), (primary interventions: []), (development: [orgf]), (individual: [humn]), (namely; speech therapy: [hlca]), (creative endeavours: []), ( animals: [anim]), ((human-animal interaction): [humn]), (mentored: [popg]), (untreated cases: [qnco]), (asd place: [cgab]), (undue psychosocial: [fndg]), (economic burden: [qnco]), (families: [famg]), (communities: []), (government support: [orgt]), (health policies: []), (creative adaptation: [orgf]), (knowledge: []), ( communities: []), (valuable resource: []), (asd intervention strategies: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(early diagnosis, 'Diagnosis')(speech therapy, 'Language Ability')(creative adaptation, 'Adaptive Life Skills')

PMCID: 5838868
SFARI Genes: met, met, 
Non SFARI Genes: cope, 
Named Entities: (euthanasia: [hlca]), (suicide (eas): [fndg]), (netherlands: []), (statutory due care criteria: [acty]), (met: [gngm]), ( including: (a): []), (well-considered request; (b): []), (prospect: []), (improvement; (c): []), (patient; (d) lack: [podg]), (reasonable alternative;: []), ((e) independent second physicians opinion: [menp]), (unbearable suffering: [mobd]), (medical basis: [phsu]), (requirement: []), (limited life expectancy: [grpa]), (eas cases: [qnco]), (regional review committees: []), (purpose: []), (study: [resa]), (particular difficulties: [fndg]), (eas: []), (due care criteria: [acty]), (patients: [podg]), (intellectual disability: [mobd]), (autism spectrum disorder: [mobd]), (case summaries: []), (rte website (20122016): [cell]), (intellectual disability (6): [mobd]), (autism spectrum disorder (3): [mobd]), (direct content analysis: [resa]), (cases: [qnco]), (assessment: [acty]), (decisional capacity: [qnco]), (few details: []), (uncertainty: [fndg]), (disagreement: [socb]), (capacity: [qnco]), (progressive somatic conditions: [cell]), (most: []), ( suffering: [mobd]), (inability: []), (circumstances: []), (dependency;: [menp]), (several cases: [qnco]), (terms: [orgf]), (characteristics: []), (living: []), (acquired medical condition: [dsyn]), (physicians: []), (patients perspective: [podg]), (treatment refusal: [inbe]), (common theme: [qnco]), (option: []), (lack: []), (detail: []), (social circumstances: []), (prognosis: [hlca]), (autonomy: []), (intellectual disabilities: [mobd]), (capacity tests: [qnco]), (suffering: [mobd]), (life-long disability: [fndg]), (brief time frames: []), (limited number: [qnco]), (physician-patient meetings: [socb]), (decision: [menp]), (dutch eas: [popg]), (people: [popg]), (adequate safeguards: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s12910-018-0257-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (suicide, 'Depressive Disorder')(medical basis, 'Medications')(suicide cases, 'Depressive Disorder')(intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(acquired medical condition, 'Medications')(patients with intellectual disabilities, 'Learning Disorders')(intellectual disabilities, 'Learning Disorders')(people with intellectual disabilities, 'Learning Disorders')

PMCID: 6155047
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mu: [gngm]), (opioid receptor (mor): [aapp,rcpt]), (critical role: [socb]), (social behavior: [socb]), (humans: [humn]), (animals: [anim]), (accordingly: []), ( mor: [aapp,bacs]), (null mice display: [mamm]), (severe alterations: []), (social repertoire: []), (multiple other behavioral deficits: [inbe]), (core: [bdsu]), (secondary symptoms: [neop]), (autism spectrum disorder (asd): [mobd]), (such behavioral profile: [inbe]), (mor dysfunction: [aapp,bacs]), (this: []), (reward: [menp]), (asd etiopathology: [cgab]), (interestingly: []), (only treatments: [topp]), (efficacy: [resa]), (core symptoms: [sosy]), (asd: [cgab]), (early behavioral intervention programs: [hlca]), (positive reinforcement: [topp]), (behavior: [inbe]), (neurobiological underpinnings: []), (beneficial effects: []), ( however: []), (back-translated applied behavior analysis: [blor]), ((aba)-based behavioral interventions: [topp]), (mor (oprm1/): [aapp,bacs]), (model: []), (autism: [mobd]), (blunted reward processing: [menp]), (palatable food reward: [menp]), (daily encounter: [bhvr]), (wild-type congener: [chvs]), (social interaction: [fndg]), (preference: []), (oprm1/ mice: [mamm]), (expression: [topp]), (marker genes: [gngm]), (neuronal activity: [acty]), (plasticity: [npop]), (genes: [gngm]), (oxytocin/vasopressin system: [aapp,horm,phsu]), (reward/social circuitry: [menp]), (study: [resa]), (further evidence: []), (critical involvement: []), (reward processes: [menp]), (new perspectives: []), (therapeutic intervention: [topp]), 
ASD Terms: (social behavior, 'Reciprocal Social Interaction')(social repertoire as well as multiple other behavioral deficits, 'Personal Traits')(autism spectrum disorder, 'Autism Phenotype')(multiple other behavioral deficits, 'Personal Traits')(relieving core symptoms of asd, 'Complaints and Indications')(autism, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')

PMCID: 5568880
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (social disorganisation (sd): [socb]), (schizotypal phenotype: [orga]), (subclinical population: [popg]), (auditory processing deficits: [acty]), (mismatch negativity/field (mmn/f): [irda]), (spectrum disorders: [dsyn]), (study: [resa]), (differences: [qnco]), (mmn/f: [inch,phsu]), (cortical spatio-temporal source activity: [bpoc]), (quintiles: [clna]), (sd spectrum: [qnco]), (sixteen: [qnco]), (low (9 female): [orga]), (high (9 female) sd: [orga]), (subclinical adults: [aggp]), ((1840years) underwent magnetoencephalography (meg): [diap]), (mmf paradigm: [topp]), (standard tones: [phsu]), (infrequent duration deviants: [inbe]), (spatio-temporal source cluster analysis: [resa]), (permutation: []), (difference: [qnco]), (groups: [popg]), (source activation: [acty]), (standard tone: [phsu]), (deviant tone however: [phsu]), (insular cortex activation: [bpoc]), (high sd group: [popg]), (mmf: [topp]), (product: [qnco]), (cortical response: [bpoc]), (deviant minus: [inbe]), (standard: []), (low social disorganisation groups: [socb]), (data: [euka]), (deficit: [dsyn]), (right fronto-temporal processing: [acty]), (auditory change: [qnco]), (sd phenotype: [orga]), (right fronto-temporal auditory processing: [acty]), (psychosocial functioning: [fndg]), 
ASD Terms: 

PMCID: 5064621
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (social abcs: [dsyn]), (parentmediated intervention: [hlca]), (toddlers: [aggp]), (confirmed autism spectrum disorder (asd): [mobd]), (multisite pilot study: [resa]), (feasibility: []), (acceptability: []), (trends: []), (child: [aggp]), (parent behavior: [inbe]), (future research: [resa]), (sample: [sbst]), (rigorous research design: [sosy]), (program: [phsu]), (weeks: []), (parent coaching: []), (weeks': []), (followup assessment: [acty]), (parenttoddler dyads: [popg]), (months): []), (parents: []), (techniques: []), (intervention: [hlca]), (paired samples ttests: [sbst]), (significant gains: [qnco]), (children's functional communication (responsivity: [aggp]), ( initiations): [menp]), (language gains (ageequivalents: [lang]), (standardized measures) commensurate: [qnco]), (typical developmental rates: [qnco]), (significant increases: [qnco]), (smiling: [socb]), (social orienting: []), (followup: [hlca]), (parents' fidelity: [socb]), (child responsivity: [aggp]), (mediators: [orch,phsu]), (acceptable approach: []), (costeffective opportunity: [qnco]), (intensive intervention: [menp]), (young age: [orga]), (first signs: []), (asd risk: [cgab]), (parent gains: [qnco]), (several key variables: [qnco]), (promise: []), (autism res: [mobd]), (autism research: [mobd]), (wiley periodicals: []), ( inc: []), (behalf: []), (international society: [orgt]), 
ASD Terms: (confirmed autism spectrum disorder, 'Autism Phenotype')(revealed significant gains in children's functional communication, 'Reciprocal Social Interaction')(children's functional communication, 'Reciprocal Social Interaction')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 5360851
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (aim: [phsu]), (study: [resa]), (differences: [qnco]), (boys: [aggp]), (girls: [aggp]), (diagnosis: [fndg]), (clinical phenotypes: [orga]), (autism spectrum disorder (asd): [mobd]), (china's mainland: []), (children: [aggp]), (asd (n: [cgab]), (females): [orga]), (analysis: [resa]), (autism diagnostic: [mobd]), (interview-revised (adi-r): [acty]), (autism diagnostic observation schedule (ados): [hlca]), (results: [fndg]), (adi-r: [clna]), (socio-emotional reciprocity: [menp]), (ados: [aapp,enzy]), (repetitive behaviors: [fndg]), (meanwhile: []), (proportions: [qnco]), (diagnostic cut-off scores: [qnco]), (adi-r rrbs domain: [clna]), (boys (p: [aggp]), (asd: [cgab]), (rrbs: []), (type: [qnco]), (assessment: [acty]), (rrbs domain: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(diagnosis, 'Diagnosis')(autism diagnostic, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism diagnostic interview-revised, 'Autism Phenotype')

PMCID: 4917597
SFARI Genes: OXT, OXT, OXT, OXT, OXT, OXT, 
Non SFARI Genes: 
Named Entities: (study: [resa]), (baseline plasma oxytocin (oxt) concentrations: [aapp,horm,phsu]), (effects: []), (oxt: [gngm]), (social orienting: []), (males: [orga]), (autism spectrum disorder (asd): [mobd]), (thirty: [qnco]), (healthy males: [orga]), (double-blind placebo-controlled crossover trial: [resa]), (administration: [topp]), (compound: [chem]), ( participants: [popg]), (pictures: []), (international affective picture system: [fndg]), (systematic variation: []), (pleasant: [menp]), (neutral scenes: [fndg]), (humans: [humn]), (outcome measures: [qnco]), (response (ecr): [fndg]), (cortical evoked: [bpoc]), (long latency: []), (parietal positivity (lpp): [gngm]), (asd: [cgab]), (plasma baseline levels: [bodm]), (controls: [sbst]), (absence: [anab]), (general treatment effects: [hlca]), (baseline concentrations: [bodm]), (treatment: [topp]), (group: [popg]), (post-treatment plasma oxt concentrations: [qnco]), (treatment effects: [fndg]), (responses: [orga]), (placebo situation: [topp]), (findings: [clna]), (central availability: [lbpr]), (bloodstream: [phsf]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5633643
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (use: []), (cognitive-behavioural therapy (cbt): [topp]), (treatment: [topp]), (children: [aggp]), (adolescents: [aggp]), (autism spectrum disorder (asd): [mobd]), (number: [qnco]), (trials: [resa]), (whilst cbt: [dsyn]), (usual: []), ( few studies: [lbpr]), (cbt: [gngm]), (control group: [grup]), (alternative therapy: [topp]), (trial: [resa]), (person-centred counselling: [topp]), (anxiety: [mobd]), (young people: [popg]), (asd: [cgab]), (outcome measures: [qnco]), (self-reports: [resa]), (social disability: [fndg]), (whilst: []), (therapy: [topp]), (improvements: []), (participants: [popg]), (significant degree: [qnco]), (measure: [qnco]), (findings: [clna]), (adults: [aggp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(anxiety, 'Anxiety Disorders')(anxiety, 'Anxiety Disorders')(social disability, 'Social Competence')

PMCID: 5416705
SFARI Genes: 
Non SFARI Genes: ms, 
Named Entities: (attentional preference: [menp]), (symptoms: [sosy]), (social anxiety: [mobd]), (autism spectrum disorders: [mobd]), (neuropeptide oxytocin triggers: [aapp,horm,phsu]), (anxiolytic functions: [phsu]), (enhances eye: [bpoc]), (facial emotion recognition: [menp]), (neural correlates: []), (face processing: [emst]), (asd: [cgab]), (single dose: [fndg]), (oxytocin increases attention: [aapp,horm,phsu]), (secondary question: [neop]), (influence: []), (effects: []), (oxytocin's effects: [aapp,horm,phsu]), (attention: [menp]), (houses: []), (sample: [sbst]), (autistic individuals: [mobd]), (control participants: [popg]), (dot-probe paradigm: [topp]), (different presentation times: [qnco]), (ms): [aapp,enzy]), (iu oxytocin: [aapp,horm,phsu]), (randomized: [resa]), ( double-blind placebo-controlled: [resa]), ( cross-over design: [resa]), (placebo: [topp]), ( asd individuals: [cgab]), (ms: [gngm]), (oxytocin administration: [aapp,horm,phsu]), (allocation: [acty]), (level: [phsu]), (controls: [sbst]), (secondary analyses: [neop]), (oxytocin effects: [aapp,horm,phsu]), (asd individuals: [cgab]), (high levels: [qnco]), (attentional avoidance: [menp]), (results: [fndg]), (positive influence: [fndg]), (intranasal oxytocin: [aapp,horm,phsu]), (social attention: [menp]), (further: []), (oxytocin: [aapp,horm,phsu]), (facial information: [blor]), (high social anxiety: [mobd]), (oxytocin's anxiolytic properties: [phsu]), (positive effects: [fndg]), (socio-cognitive functioning: [menp]), (enhanced eye gaze: [bpoc]), 
ASD Terms: (social anxiety, 'Anxiety Disorders')(autism spectrum disorders, 'Autism Phenotype')(face processing, 'Integrated Verbal and NonVerbal Communication')(facial emotion recognition, 'Empathy')(social anxiety, 'Anxiety Disorders')(high social anxiety, 'Anxiety Disorders')

PMCID: 6331495
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (many individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (symptoms: [sosy]), (sensory hypersensitivity: [patf]), (several studies: [lbpr]), (high individual variations: [qnco]), (temporal processing: [acty]), (tactile stimuli: [phpr]), (individual differences: [menp]), (differences: [qnco]), (hyper-reactivity: [mobd]), (individuals: [humn]), (asd: [cgab]), (participants: [popg]), (tasks: []), (temporal order judgement task: [menp]), (detection task: [topp]), (temporal resolution: [lbtr]), (severe hypersensitivity symptoms: [patf]), (contrast: [irda]), (tactile detection threshold/sensitivity: [patf]), (severities: []), (stereotyped behaviour: [mobd]), (interests: [menp]), (findings: [clna]), (sensory stimuli: [npop]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1007/s10803-018-3677-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(stereotyped behaviour, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 5837293
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (autism spectrum disorder (asd) exhibit impairments: [mobd]), (ability: [orga]), (effective social interactions: [fndg]), (multiple contexts: [fndg]), (aspect: [qnco]), (subtle nonverbal communication: [menp]), (role: [socb]), (impairment: [patf]), (whole-body motor coordination: [ortf]), (people: [popg]), (conversation: [socb]), (current study: [resa]), (time-dependent: []), ( coordinated whole-body movements: [fndg]), (asd: [cgab]), (conversational exchange: [clna]), (tools: []), (nonlinear dynamics: []), (influence: []), (interpersonal coordination: [phsf]), (social interaction feelings: [fndg]), (important associations: [menp]), (dynamic motor movement measures: [qnco]), (measures: [qnco]), (impairment (ados-2: [aapp,enzy]), ( joint attention: [menp]), (theory: []), (mind): [menp]), (study: [resa]), (bodily movements: [orgf]), (clinician: []), (movements: [orgf]), (complexity: [chvs]), (childrens movements: [orgf]), (clinicians movements: [orgf]), (importantly: []), (degree: [qnco]), (bodily coordination: [phsf]), (social cognitive ability: [socb]), (social competence: [socb]), (conversations: [socb]), (importance: []), (subtle: [clna]), (important bodily movement coordination: [orgf]), (social interaction: [fndg]), 
ASD Terms: (autism spectrum disorder exhibit impairments, 'Autism Phenotype')(effective social interactions, 'Reciprocal Social Interaction')(subtle nonverbal communication, 'Non-Verbal Communication')(whole-body motor coordination, 'Motor Skills')(coordinated whole-body movements between children, 'Motor Skills')(coordinated whole-body movements, 'Motor Skills')(interpersonal coordination, 'Motor Skills')(social interaction feelings, 'Reciprocal Social Interaction')(bodily coordination, 'Motor Skills')(social cognitive ability, 'Ability to Converse in Social Settings')(social competence, 'Social Competence')(social interaction, 'Reciprocal Social Interaction')(important bodily movement coordination, 'Motor Skills')

PMCID: 4131154
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder: [mobd]), (neurodevelopmental disorder: [mobd]), (impairments: [patf]), (social interactions: [fndg]), (verbal communication abilities: [orga]), (repetitive behaviors: [fndg]), (interests: [menp]), (complex condition: [dsyn]), (environmental factors;: []), (high heritability: [qnco]), (disorder: [dsyn]), (presence: [qnco]), (significant genetic contribution: [acty]), (many studies: [lbpr]), (copy-number variants: [nusq]), (etiology: []), (recently: []), (nephronophthisis: [dsyn]), (gene: [gngm]), (patients: [podg]), (knowledge: []), (autism spectrum disorder cases: [mobd]), (duplications: []), (intellectual dysfunction: [dsyn]), (verbal dysfunction: [dsyn]), (patient: [podg]), ( below-average: [qnco]), (verbal intellectual ability: [menp]), (intellectual disability: [mobd]), (study: [resa]), (unrelated japanese patients: [podg]), (high-resolution single-nucleotide polymorphism array: [mbrt]), (report: [hlca]), (duplication: [comd]), (autism spectrum disorder patient: [mobd]), (average verbal intelligence quotient: [orga]), (average performance intelligence quotient: [orga]), (however: []), (second autism spectrum disorder patient: [mobd]), (below-average performance intelligence quotient: [orga]), (physical dysfunction: [hlca]), ( motor: []), (developmental delay: [mobd]), (neurological abnormalities: [cgab,dsyn]), (clinical observation: [hlca]), (understanding: [menp]), (clinical phenotype: [orga]), 
ASD Terms: (social interactions, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(verbal communication abilities, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorder cases, 'Autism Phenotype')(intellectual disability in four patients, 'Learning Disorders')(intellectual dysfunction, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(autism spectrum disorder patient, 'Autism Phenotype')(average verbal intelligence quotient, 'IQ')(average performance intelligence quotient, 'IQ')(second autism spectrum disorder patient, 'Autism Phenotype')(below-average performance intelligence quotient, 'IQ')(developmental delay, 'Learning Disorders')(neurological abnormalities, 'Neurologic Indications')(autism spectrum disorder cases, 'Autism Phenotype')

PMCID: 5360854
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (pervasive neurodevelopmental condition: [mobd]), (variable impairments: [patf]), (communication: [socb]), (social interaction: [fndg]), (interests: [menp]), (repetitive behaviors: [fndg]), (heterogeneity: [orga]), (presentation: []), (hallmark: []), (investigations: [hlca]), (immune system problems: [bdsy]), (asd: [cgab]), (aberrations: []), (cytokine profiles: [aapp,imft]), (signaling: [celf]), (recent times: [qnco]), (subject: [humn]), (interest: [menp]), (aim: [phsu]), (cytokines: [aapp,imft]), (utility: [orgt]), (potential biomarkers: [clna]), (subgroup: [virs]), (function: [phsf]), (objective measure: [qnco]), (response: [fndg]), (review: []), (role: [socb]), (immune system: [bdsy]), (relationship: []), (immune: []), (brain: [bpoc]), (behavior: [inbe]), (presents: [qnco]), (previously-identified immune system abnormalities: [cgab]), (roles: [socb]), (identification: [menp]), (biomarkers: [clna]), (respect: [socb]), (profiles: [lbpr]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(pervasive neurodevelopmental condition, 'Learning Disorders')(social interaction, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 5487761
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (deficits: []), (theory: []), (mind (tom)the ability: [orga]), (others beliefs: [fndg]), ( intentions: [menp]), (ability: [orga]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (normative ways: []), (study: [resa]), (psychometric data: [diap]), (adult-theory: [aggp]), (mind: [menp]), ((a-tom) measure: [qnco]), (video-scenarios: []), (part: [qnco]), (happs (instructions: [clna]), (mind story: [menp]), (strange stories test: [lbpr]), (final items: []), (iq-matched adults: [aggp]), (asd: [cgab]), (controls: [sbst]), (physical items: [hlca]), (additional validity data: [euka]), (two-component principal components: [qnco]), (solution: [bodm]), ( correlations: []), (tom scales: [bpoc]), (absence: [anab]), (correlations: []), (self-report measures: [resa]), (empathy: [inbe]), (social anxiety (not: [mobd]), (inferences: [menp]), (intent: [menp]), (others): [fndg]), (group differences: [popg]), (tom: [gngm]), (marked variability: []), (asd sample: [cgab]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-017-3080-x) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(empathy, 'Empathy')(social anxiety, 'Anxiety Disorders')

PMCID: 4712595
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (researchers: []), (d-cycloserine (dcs): [aapp,phsu]), (effects: []), (behavioral interventions: [topp]), (adults: [aggp]), (anxiety: [mobd]), (prosocial behavior: [inbe]), (animal models: [anim]), (autism spectrum disorders: [mobd]), (study: [resa]), (background: []), (dcs: [dsyn]), (behavioral social skills therapy: [socb]), (youth: [aggp]), (asd: [cgab]), (impact: [gngm]), (core: [bdsu]), (social deficits: []), (combination: [fndg]), (social skills: [socb]), (acquisition: [acty]), (children: [aggp]), (10-week: [fndg]), ( double-blind: [resa]), ( placebo-controlled trial: [resa]), (dcs (50: [dsyn]), (group: [popg]), (social skills training: [edac]), (sites: []), (weeks: []), ((10 doses): [qnco]), (placebo: [topp]), (ratio: [qnco]), (significant difference: [qnco]), (drug treatment: [hlca]), (change: [qnco]), (primary outcome: [topp]), (social responsiveness scale (srs): [acty]), (total score (p: [aapp,imft]), (secondary outcome measures: [neop]), (results: [fndg]), (trial: [resa]), (drug-related short-term improvement: [phsu]), (primary outcome measure: []), (however: []), (overall significant improvement: [qnco]), (srs: [gngm]), (total raw score: [diap]), (baseline: [bodm]), (treatment: [topp]), (entire group: [popg]), (need: []), (efficacy: [resa]), (protocol: [fndg]), (limitations: []), (current study: [resa]), (areas: []), (future research: [resa]), (discussed: [socb]), (trial registration clinicaltrials.govnct01086475: [resa]), 
ASD Terms: (anxiety, 'Anxiety Disorders')(autism spectrum disorders, 'Autism Phenotype')(behavioral social skills therapy, 'Reciprocal Social Interaction')(social deficits of asd, 'Social Competence')(social deficits, 'Social Competence')(combination with social skills, 'Ability to Converse in Social Settings')(acquisition of social skills, 'Ability to Converse in Social Settings')(social skills, 'Ability to Converse in Social Settings')(social skills training, 'Ability to Converse in Social Settings')

PMCID: 5708820
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (children worldwide: [aggp]), (two-thirds: [qnco]), (validated diagnostics: [fndg]), (gold standard: []), (diagnostic tools: [fndg]), (evaluations: [hlca]), (currently: []), (diagnosis: [fndg]), (asd: [cgab]), (expensive tests: [lbpr]), (addition: []), (clinical confirmation: []), (therefore: []), ( fast: [fndg]), ( cheap: []), ( portable: []), (easy-to-administer screening instruments: [diap]), (several studies: [lbpr]), (children: [aggp]), (preference: []), (social scenes: []), (measurement: []), (gaze preference: [fndg]), (screening tool: [diap]), (available eye-tracking software: [bpoc]), (intensive calibration: [qnco]), ( training: [edac]), (holding: []), (head: [blor]), (interference: []), (gaze recognition: [menp]), (use: []), (study: [resa]), (simple eye-tracking algorithm: [bpoc]), (calibration: [qnco]), (head holding: [blor]), (platform: []), (future validation: [resa]), (cost-effective asd potential screening instrument: [cgab]), (system: []), (inexpensive tablet: [bodm]), (scenes: []), (child: [aggp]), (one-minute stimulus video: [qnco]), (social scene: []), (left side: []), (abstract scene: []), (right side: []), (tablets screen: [bodm]), (stimulus videos: [phpr]), (social/abstract scenes: []), (videos: []), (random order: [resa]), (eye-tracking algorithm: [bpoc]), (childs gaze preference: [aggp]), (abstract scenes: []), (percentage: [qnco]), (accumulated time: []), (left: []), (screen: [hlca]), ( respectively: []), (twenty-three children: [aggp]), (prior history: [orga]), (clinical diagnosis: []), (recorded video: [qnco]), (childs eye movement: [ortf]), (observer: []), (algorithm: [lbpr]), (visual preference: []), (abstract scenes): []), ( identifies distractions: [topp]), (maintains: [acty]), (high accuracy: [qnco]), (manual classification: [inpr,mnob]), (error: []), (manual observation: [hlca]), (discussion: [socb]), (tablet-based gaze: [bodm]), (preference/eye-tracking algorithm: [bpoc]), (high degree: [qnco]), (accuracy: []), (need: []), (restraint: []), (low-resource settings: [qnco]), (cost-effective potential screening tool: [qnco]), 
ASD Terms: (autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')(social scenes, 'Social Interest')(social scene, 'Social Interest')(clinical diagnosis, 'Diagnosis')(visual preference, 'Visual Thinking')

PMCID: 4701177
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (biological mechanisms: []), (human neuropsychiatric disorders: [humn]), (autism spectrum disorder (asd): [mobd]), (lack: []), (robust: []), ( translational animal model: [emod]), (rhesus monkeys: [mamm]), (same social behaviors: [socb]), (asd: [cgab]), (excellent animal species: [anim]), (social impairments: [patf]), (however: []), (extreme ends: []), (continuous distribution: [qnco]), (traits: [gngm]), (thus: []), (rhesus monkey: [mamm]), (animal model: [emod]), (strong translational relevance: [genf]), ( researchers: []), (easily-implemented measurement tool: []), (variation: []), (social behavior dimensionally: [socb]), (social responsiveness scale (srs): [acty]), (65-item survey: [fndg]), (atypical social behaviors: [socb]), (humans: [humn]), (asd symptom severity: [cgab]), (chimpanzee srs: [mamm]), (current study: [resa]), (tool: []), (use: []), (rhesus monkey (msrs): [mamm]), (fifteen raters: [qnco]), (msrs: [gngm]), (yerkes national primate research center: [mamm]), (unimodal distribution: []), (positive skew: [fndg]), (statistical outliers: [qnco]), (inter-rater reliability: [qnco]), (questions: []), (positive intra-item reliability: [qnco]), (results: [fndg]), (exploratory factor analysis: [qnco]), (factors: []), (variance: [qnco]), (items: []), (primary factor: [topp]), (behaviors: [inbe]), (social avoidance: [socb]), (social anxiety: [mobd]), (inflexibility: []), (social confidence: [menp]), (initial findings: [clna]), (variability: []), (social responsiveness: []), (msrs:: [gngm]), (human disorders: [humn]), (further modification: []), (promising new direction: []), (research: [resa]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(same social behaviors, 'Reciprocal Social Interaction')(social impairments, 'Social Competence')(social behavior, 'Reciprocal Social Interaction')(social behavior dimensionally, 'Reciprocal Social Interaction')(atypical social behaviors, 'Restricted and Repetitive Behavior')(asd symptom severity, 'Complaints and Indications')(social anxiety, 'Anxiety Disorders')

PMCID: 4702244
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (transition: [acty]), (secondary education (hereafter school transition): [mnob,orgt]), (major ecological shift: [phpr]), (considerable social: []), ( emotional: [menp]), (organisational challenges: [orgt]), (school transition: [mnob,orgt]), (children: [aggp]), (autism spectrum disorder: [mobd]), (idea: []), (anecdotal evidence: []), (systematic investigation: [hlca]), (change: [qnco]), (continuity: []), (autism spectrum disorder (n: [mobd]), (mean age: [orga]), (years: []), ( mean full-scale iq =: [acty]), (mainstream education: [edac]), (secondary school: [mnob,orgt]), (levels: []), (psychopathology: []), (adaptive functioning: []), (victimisation: [hcpp]), (parent: []), ( self: []), (teacher report: [fndg]), (last year: []), (primary school: [mnob,orgt]), (term: [orgf]), (participants: [popg]), (evidence: []), (marked escalation: []), (difficulties: [fndg]), (instead: []), (high levels: [qnco]), (maladaption: [mobd]), (baseline: [bodm]), (cases: [qnco]), (parent report: [hlca]), ( levels: []), (future research: [resa]), (factors: []), (school characteristics: [mnob,orgt]), (influence: []), (move: [fndg]), (secondary education: []), (development: [orgf]), (interventions: [hlca]), (successful school transition: [mnob,orgt]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(adaptive functioning, 'Adaptive Life Skills')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 6150959
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prior evidence shows: [anim]), (intervention: [hlca]), (autism: [mobd]), (treatment effects: [fndg]), (intervention context: []), (early autism intervention: [hlca]), (generalisation: [menp]), (therapy-acquired skills: [inbe]), (home: []), (school contexts: []), (adaptive function: [phsf]), (symptoms: [sosy]), (detailed mechanism study: [resa]), (process: [phpr]), (such generalisation: [menp]), (pact-g intervention: [hlca]), (symptom outcome: [clna]), (school context: []), (primary outcome research setting: [qnco]), (mechanism analysis: [resa]), (evidence: []), (skills: [inbe]), (contexts: [fndg]), (additive effects: [sbst]), (primary outcome: [topp]), (methods/design: [acty]), (three-site: [blor]), ( two-parallel-group: [popg]), (controlled trial: [resa]), (experimental treatment: [topp]), (treatment: [topp]), (usual (tau) versus tau alone: [resa]), (children: [aggp]), (years: []), ((122 intervention/122 tau;: [resa]), (meeting criteria: [acty]), (core autism: [mobd]), (experimental intervention builds: [hlca]), (clinic-based pre-school autism communication treatment model (pact): [mobd]), (primary caregiver: [humn]), (additional theory-: []), (evidence-based strategies: [menp]), (effects: []), (naturalistic home: []), (education contexts: [eehu]), (control intervention: [hlca]), (tau: [gngm]), (standardised protocol: [fndg]), (secondary outcomes: autism symptoms: [mobd]), ( child interaction: [aggp]), (parent: []), (teacher: [fndg]), ( language: [lang]), (functional outcomes: []), (school settings: []), (baseline: [bodm]), (12-month endpoint: [qnco]), (settings: [qnco]), (interim interaction measurements: []), (months): []), (treatment effect mechanisms: [fndg]), (primary analysis: [resa]), (between-group difference: [popg]), (analysis: [resa]), (covariance: []), (test: [lbpr]), (homogeneity: []), (effect: []), (age group: [aggp]), (regression models: [menp]), (mediation: [socb]), (staff-child social interaction: [fndg]), (discussion: [socb]), (efficacy: [resa]), (mechanism trial: [resa]), (evidence-based autism treatment: [mobd]), (data: [euka]), (naturalistic contexts enhances: [acty]), (overall effect: []), (mechanism: []), (autism development: [mobd]), (developmental skills: [inbe]), (trial registration isrctn: [resa]), ( id:: [lbpr]), (march: []), (electronic: []), (supplementary material: []), (online version: []), (article: []), ((10.1186/s13063-018-2881-3) contains: [acty]), (users: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')(early autism intervention, 'Autism Phenotype')(adaptive function, 'Adaptive Life Skills')(autism communication treatment, 'Autism Phenotype')(core autism, 'Autism Phenotype')(clinic-based pre-school autism communication treatment model, 'Autism Phenotype')(autism symptoms, 'Complaints and Indications')(reported functional outcomes in home, 'Home Life Skills')(autism symptoms, 'Complaints and Indications')(staff-child social interaction, 'Reciprocal Social Interaction')(evidence-based autism treatment, 'Autism Phenotype')(autism development, 'Autism Phenotype')

PMCID: 5357301
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (aim: [phsu]), (study: [resa]), (specific cognitive abilities: [menp]), (functional outcome: []), (high-functioning adults: [aggp]), (autism spectrum disorder (asd): [mobd]), (contribution: [acty]), (abilities: [orga]), (relationships: []), (adults: [aggp]), (asd: [cgab]), (cognitive tasks: []), (broad range: [qnco]), (social cognitive domains: []), (information: []), (functional outcomes: []), (regression analyses: []), (emotion perception: [menp]), (verbal generativity: [menp]), (adaptive functioning directly: []), (other two: [qnco]), (findings: [clna]), (first evidence: [qnco]), (triadic relationship: [bodm,orch]), (social cognition: [socb]), (population: [popg]), (results: [fndg]), (psychosocial interventions: [topp]), (cognitive abilities: [menp]), (social adaptation: [socb]), 
ASD Terms: (specific cognitive abilities, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(cognitive tasks, 'Cognitive Ability')(social cognitive domains, 'Cognitive Ability')(emotion perception, 'Visual Perception')(adaptive functioning directly, 'Adaptive Life Skills')(social cognition, 'Cognitive Ability')(social adaptation, 'Adaptive Life Skills')(cognitive abilities, 'Cognitive Ability')

PMCID: 6009817
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (nausea: [sosy]), (pregnancy (nvp): [orgf]), (changes: [qnco]), (maternal hormones: [horm]), (pregnancy: [orgf]), (differences: [qnco]), (hormone exposure: [horm]), (prenatal life: [aggp]), (causal: []), (cases: [qnco]), (autism spectrum disorder (asd): [mobd]), (however: []), (study: [resa]), (presence: [qnco]), (severity: []), (nvp: [orch,phsu]), (asd: [cgab]), (large sample: [sbst]), (children: [aggp]), (asd (227 males: [cgab]), (females: [orga]), (years): []), (clinical assessment: [hlca]), (parents: []), (questionnaires: []), (childs: [aggp]), (social (social responsiveness scale: [acty]), ( srs): []), (communication (childrens communication checklist2nd: [socb]), (ccc-2) symptoms: [sosy]), (5-point scale: [qnco]), (frequency: [qnco]), (nvps: []), (child: [aggp]), (assessed: (1): [fndg]), ( (2): [qnco]), (occasional nausea: [sosy]), (vomiting: [sosy]), ( (3) daily nausea: [sosy]), (occasional vomiting: [sosy]), ((5) daily nausea: [sosy]), (impairments: [patf]), (social responsiveness: []), (offspring: [famg]), (srs: [gngm]), (total score: [qnco]), (function: [phsf]), (mothers nvp: [famg]), (level: [phsu]), (language difficulties: [fndg]), (global communication composite: [socb]), (ccc-2: []), (strong: []), (positive association: [menp]), (asd severity: [cgab]), (further evidence: []), (exposure: [clna]), (atypical hormonal environment: [fndg]), (neurodevelopment: [ortf]), (contribute: [acty]), (asd phenotype: [cgab]), (measure: [qnco]), (nvp symptoms: [orch,phsu]), (current study: [resa]), (retrospective recall: [resa]), ( replication: [genf]), (finding: [sosy]), (strong conclusions: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0223-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (hormone exposure, 'Exposures')(autism spectrum disorder, 'Autism Phenotype')(impairments in social responsiveness, 'Social Competence')(level of language difficulties, 'Language Ability')(offspring, 'Perinatal History')(language difficulties, 'Language Ability')(atypical hormonal environment during prenatal life, 'Endocrine System Diseases')(exposure, 'Exposures')(atypical hormonal environment, 'Endocrine System Diseases')(asd phenotype, 'Autism Phenotype')

PMCID: 5941093
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (parents: []), (web-based communities: []), (suspicions: [menp]), (autism spectrum disorder markers: [mobd]), (child: [aggp]), (automated tools support: []), (human decisions: [humn]), (many domains: []), (support: []), (objective: []), (study: [resa]), (feasibility: []), (autism spectrum disorder risk: [mobd]), (parental concerns: [fndg]), (web-based sources: [fndg]), (text analysis tools: [resa]), (minimal standard questioning: [menp]), (participants: [popg]), (concerns: []), (childs social-communication development: [orgf]), (children: [aggp]), (30-months old: [fndg]), ((66/115): []), (family history: [fndg]), (autism spectrum disorder: [mobd]), (concerns online: []), (autism spectrum: [mobd]), (disorder-specific screener: [dsyn]), (modified checklist: []), (autism: [mobd]), (toddlers-revised: [topp]), (follow-up (m-chat-r/f): [aapp,enzy]), (broad developmental: [orgf]), (ages: [bacs,orch]), (stages questionnaire (asq): [clna]), (algorithm: [lbpr]), (combination: [fndg]), (parent's text: []), (single screening question: [fndg]), (prediction accuracy: []), (measures: [qnco]), ((67/115): []), ((101/115): []), (risk: []), (times: [qnco]), (prediction: []), (childs risk: [aggp]), (asq: []), (m-chat-r: [aapp,enzy]), (text: []), (m-chat-r question: [aapp,enzy]), (text alone: [fndg]), (m-chat-r questions: [aapp,enzy]), (risk were:: []), (point: [qnco]), ( make-believe play: [dora]), (concern: []), (deafness: [fndg]), (internet: []), (questions: []), (process: [phpr]), 
ASD Terms: (autism spectrum disorder markers, 'Autism Phenotype')(suspicions, 'Suspicious of Others')(autism spectrum disorder risk, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism spectrum, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(show autism spectrum disorder risk, 'Autism Phenotype')(deafness, 'Hearing Loss')

PMCID: 4949660
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (deficit: [dsyn]), (empathy: [inbe]), (social behavioural atypicalities: [socb]), (autism: [mobd]), (parallel theoretical account: [resa]), (social motivation (i.e.: [menp]), (low responsivity: [menp]), (social rewards): [menp]), (atypicalities: []), (recent evidence: []), (autistic traits: [mobd]), (link: []), (reward: [menp]), (proxy metrics: [orch,phsu]), (evaluative conditioning paradigm: [menp]), (low rewards: [menp]), (faces: [blor]), (previous study: [resa]), (individuals: [humn]), (spontaneous facial mimicry: [blor]), (low reward: [menp]), (observation: [hlca]), (possibility: []), (magnitude: [qnco]), (evaluative conditioning: [menp]), (this: []), (ability: [orga]), (reward value: [menp]), (social stimulus (reward learning/conditioning: [menp]), (implicit association task: [menp]), ( iat); (b): []), (association: [menp]), (participants prosocial behaviour (i.e.: [inbe]), (social reciprocity: [socb]), (cyberball task); (c): []), (strength: [qnco]), (modulation: []), (neurotypical participants: [popg]), (relationship: []), (social reward: [menp]), (prosocial behaviour: [inbe]), (itself: []), (evidence: []), (social reward learning: [menp]), (social rewards: [menp]), (autism res: [mobd]), (autism research: [mobd]), (wiley periodicals: []), ( inc: []), (behalf: []), (international society: [orgt]), 
ASD Terms: (empathy, 'Empathy')(autism, 'Autism Phenotype')(underlie social behavioural atypicalities, 'Psychologic Indications')(social behavioural atypicalities, 'Personal Traits')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 5726066
SFARI Genes: met, met, 
Non SFARI Genes: NHS, 
Named Entities: (introduction interventions: [hlca]), (robot-assisted therapy: [hlca]), (social skills development: [socb]), (children: [aggp]), (autism spectrum disorder (asd); however: [mobd]), (trials (rcts): [resa]), (present research: [resa]), (feasibility: []), (rct: []), (effectiveness: []), (social skills intervention: [socb]), (kinesics: []), (synchronisation: []), (personal assistant robotics (kaspar): [orch]), (asd: [cgab]), (methods: []), (analysis forty children: [aggp]), (inclusion criteria: []), (following:: []), (years: []), (asd diagnosis: [cgab]), ( iq: []), (english-language comprehension: [menp]), (carer: []), (questionnaires: []), (english: [lang]), (current participation: [npop]), (private social communication intervention: [topp]), (intervention: [hlca]), (therapist: []), (kaspar: [orch]), (therapist only: [qnco]), (familiarisation sessions: [evnt]), (treatment sessions: [evnt]), (weeks: []), (baseline: [bodm]), (primary outcome: [topp]), (study: [resa]), (predetermined feasibility criteria: []), (full-scale trial: [resa]), (met: [gngm]), (potential primary outcome measures: [qnco]), (social communication questionnaire: [socb]), (social skills improvement system: [socb]), (preliminary economic analysis: []), (sample: [sbst]), (participants: [popg]), (families: [famg]), (semistructured interviews: [acty]), (acceptability: []), (studys methods: []), (ethics: []), (dissemination parents/carers: []), (informed consent: []), (assent: []), (appropriate: []), (care: [acty]), (pressure: [phpr]), (coercion: [socb]), (aftercare: [hlca]), (recruiting nhs trust: [hcro]), (phased withdrawal protocol: [fndg]), (robot: []), (results: [fndg]), (audiences: [popg]), (non-academic stakeholders: [orgt]), (example: []), ( families: [famg]), ( support groups: [shro]), ( clinicians: []), (charities: [shro]), (trial registration number isrctn registry: [resa]), (pre-results: [fndg]), 
ASD Terms: (social skills development of children, 'Ability to Converse in Social Settings')(social skills development, 'Ability to Converse in Social Settings')(autism spectrum disorder, 'Autism Phenotype')(social skills intervention, 'Ability to Converse in Social Settings')(asd diagnosis, 'Diagnosis')(private social communication intervention, 'Reciprocal Social Interaction')(social communication questionnaire, 'Reciprocal Social Interaction')(social skills improvement system, 'Ability to Converse in Social Settings')

PMCID: 6051493
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (unique awareness: [menp]), (own body: [humn]), (difficulties: [fndg]), (gestural interaction: [socb]), ((td) individuals: [humn]), (perception: [menp]), (body parts: [bpoc]), (various brain regions: [blor]), (instance: []), ( activation: [acty]), (lateral occipito-temporal cortex (lotc): [bpoc]), (third-person perspective): [grup]), (identity: [menp]), (person's body): [humn]), (present study: [qnco]), (brain activation: [bpoc]), (asd: [cgab]), (identity-dependent brain activation: [bpoc]), (gestural imitation abilities: [socb]), (eighteen young adults: [aggp]), (td individuals: [humn]), (fmri study: [diap]), (participants: [popg]), (person's hands: [bpoc]), (third-person perspectives: [grup]), (perspective: []), (brain: [bpoc]), (activity: [acty]), (gestural imitation difficulties: [socb]), (td: []), (left lotc: []), (hand: [bpoc]), (third-person perspective: [grup]), (first-person perspective: [qnco]), (perspective effect: []), (asd group: [cgab]), (significant group differences: [popg]), (medial prefrontal cortex (mpfc): [celc]), (correlation analysis: [inpr,resa]), (inferior parietal lobule (ipl): [bpoc]), (cerebellum: [bpoc]), (gestural imitation ability: [socb]), (study: [resa]), (atypical visual self-body recognition: [humn]), (altered perspective effect: []), (lotc: []), (mpfc: []), (core selves: [bdsu]), ( respectively: []), (gestural imitation difficulty: [socb]), (altered activation: [acty]), (ipl: [gngm]), (findings: [clna]), (light: [gngm]), (divergent neural mechanisms: []), (atypical visual self-body awareness: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(gestural interaction, 'Integrated Verbal and NonVerbal Communication')(perception, 'Cognitive Ability')(gestural imitation abilities, 'Integrated Verbal and NonVerbal Communication')(gestural imitation difficulties, 'Integrated Verbal and NonVerbal Communication')(gestural imitation ability, 'Integrated Verbal and NonVerbal Communication')(atypical visual self-body recognition, 'Visual Thinking')(gestural imitation difficulty, 'Integrated Verbal and NonVerbal Communication')(gestural interaction, 'Integrated Verbal and NonVerbal Communication')(atypical visual self-body awareness, 'Visual Thinking')

PMCID: 5993745
SFARI Genes: IL-6, IL-6, 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (preterm: [fndg]), (united states: []), (third trimester: []), (birth: [orgf]), (week: []), (gestation: [orgf]), (risks: []), (autism spectrum disorder (asd): [mobd]), (non-autistic social impairment: [mobd]), (general population: [popg]), (relationship: []), (top quartile: []), (inflammation-related protein concentrations: [patf]), (asd: [cgab]), (high score: [clna]), (social responsiveness scale (srs: [acty]), (total score 65): [qnco]), (information: []), (subset: []), (das-ii verbal: [orch,phsu]), (non-verbal iq: [fndg]), (proteins: [aapp,bacs]), (blood: [bdsu]), (2 days: []), (asd (n: [cgab]), (age: [orga]), (years: []), (recurrent top quartile concentrations: [menp]), (inflammation-related proteins: [patf]), (first post-natal month (e.g.: [qnco]), ( saa odds: [aapp,imft]), (confidence interval: [qnco]), (il-6 (or;: [aapp,imft]), (ci:: [lbpr]), (top quartile concentrations: [menp]), (neurotrophic proteins: [aapp,bacs]), (risk: []), (high (top quartile) concentrations: [menp]), (saa: [gngm]), (elevated risk: []), (asd (2.8;: [cgab]), (ang-1 concentrations: [aapp,bacs]), (similarly: []), (high concentrations: [menp]), (tnf-: [aapp,bacs]), (srs-defined social impairment (n: [aapp,imft]), ((2.0;: [qnco]), 
ASD Terms: (gestation, 'Perinatal History')(autism spectrum disorder, 'Autism Phenotype')(non-autistic social impairment, 'Social Competence')(heightened risk of srs-defined social impairment, 'Social Competence')(srs-defined social impairment, 'Social Competence')

PMCID: 5789641
SFARI Genes: theta, theta, theta, theta, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (complex neurodevelopmental condition: [mobd]), (multiple theories: [qnco]), (core: [bdsu]), (social deficits: []), (social motivation hypothesis: [menp]), (deficits: []), (social reward system cause individuals: [menp]), (asd: [cgab]), (social interaction: [fndg]), (intense world hypothesis: [popg]), ((sensory over-responsivity) proposes: [menp]), (individuals: [humn]), (hypersensitivity: [patf]), (interactions: []), (eeg: [diap]), (reward anticipation: [menp]), (reward processing: [menp]), (alpha asymmetry: []), (post-feedback theta: [phpr]), (post-feedback alpha suppression: [phpr]), (attention: [menp]), (salience: []), (participants: [popg]), (8-year-olds: []), ((n =: [aapp,imft]), ((n: [aapp,imft]), (children: [aggp]), (left-dominant alpha suppression: [qnco]), (rewards: [menp]), (nonsocial stimuli: [phpr]), (social stimuli: [phpr]), ( children: [aggp]), (theta activity: [acty]), (alpha activity: [acty]), (feedback: [phpr]), (opposite pattern: children: [aggp]), (alpha suppression: [qnco]), (td children: [aggp]), (significant correlations: [qnco]), (behavioral measures: [qnco]), (autism severity: [mobd]), (eeg activity: [diap]), (reward processing time periods: [menp]), (findings: [clna]), (evidence: []), (approach motivation: [menp]), (stimuli: [phpr]), (results: [fndg]), (feedback suggest: [phpr]), (asd evidence: [cgab]), (robust activity: [acty]), (evaluation: [hlca]), (processing: [acty]), (rewards (e.g.: [menp]), ( theta): [gngm]), (however: []), (general cognitive engagementwhich: [hlca]), (intense: []), (aspects: [qnco]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(complex neurodevelopmental condition, 'Learning Disorders')(social deficits, 'Social Competence')(social interaction, 'Reciprocal Social Interaction')(autism severity, 'Autism Phenotype')(general cognitive engagementwhich, 'Cognitive Ability')

PMCID: 5990012
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (sensory over-responsivity (sor): [menp]), (common condition: [dsyn]), (autism spectrum disorders: [mobd]), (social impairment: [patf]), (however: []), (mechanisms: []), (sensory stimuli: [npop]), (social functioning: [socb]), (study: [resa]), (fmri: [diap]), (brain activity: [phsf]), (communicative intent: [menp]), (high-functioning youth: [aggp]), (asd: [cgab]), (iq-matched typically-developing (td) controls: [resa]), (participants: [popg]), (task: [gngm]), (tactile sensory distracter: [ortf]), (instructions: [clna]), (attention: [menp]), (social cues: []), (presence: [qnco]), (sensory distracter: []), ( td youth: [aggp]), (increased activity: [fndg]), (auditory language: [lang]), (frontal regions: [bpoc]), (asd youth: [cgab]), (decreased activation: [acty]), (areas: []), (effect: []), (activation: [acty]), (tactile stimulation;: [npop]), (asd group: [cgab]), (medial prefrontal activity: [acty]), (sor severity: [moft]), (tactile stimulus: [phpr]), (social processing: [acty]), (results: [fndg]), (first time: [qnco]), (neural mechanism: []), (disruption: []), (social cognition: [socb]), (attentional modulation: [menp]), (neural processing: [acty]), (prefrontal regulation: [biof]), (findings: [clna]), (implications: []), (novel: []), ( integrative interventions: [hlca]), (attentional directives: [menp]), (social symptoms: [sosy]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(social impairment, 'Social Competence')(social functioning, 'Ability to Converse in Social Settings')(social cues, 'Awareness of Social Cues')(social cognition, 'Cognitive Ability')(social cues, 'Awareness of Social Cues')

PMCID: 5791186
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (impairments: [patf]), (social communication: [socb]), (core feature: [bdsu]), (autism spectrum disorder (asd): [mobd]), (ability: [orga]), (other peoples emotions: [menp]), (facial expressions: [fndg]), (many aspects: [qnco]), ( deficits: []), (expression recognition: [menp]), (plausible candidate marker: [clna]), (asd: [cgab]), (however: []), (previous studies: [lbpr]), (facial expression recognition: [menp]), (mixed results: [fndg]), (differences: [qnco]), (sensitivity: [patf]), (many tests: [lbpr]), (heterogeneity: [orga]), (individuals: [humn]), (diagnostic marker: [clna]), (people: [popg]), (comparison group): [popg]), (stratification marker (which: [clna]), (homogeneous subgroups): [virs]), (crucial first step: [bodm]), (identification: [menp]), (mean group differences: [popg]), (frequency: [qnco]), (severity: []), (study: [resa]), ((td) participants: [popg]), (films expression task: [sbst]), (key features: []), (real-life expression recognition:: [menp]), (naturalistic facial expressions: [fndg]), (broad range: [qnco]), (complex emotions: [menp]), (short presentation time: [qnco]), (test-retest reliability: [resa]), (main study: [resa]), (acceptable reliability (icc r = .74): [neop]), (case-control comparisons: [acty]), (significant mean group differences: [popg]), (accuracy (p: [aapp,imft]), (effect size (cohens d: [qnco]), (mean effect size: [qnco]), (previous meta-analysis (uljarevic: [resa]), (hamilton: []), (j autism dev disord): [mobd]), (asd group: [cgab]), (mean reaction times: [qnco]), (overall (p = .00015: [aapp,imft]), ( d = .83): []), (correct trials: [resa]), (= .0002: []), ( d = .78): []), (severe deficits: []), (standard deviations: [qnco]), (td: []), (small subgroup (15.3%): [virs]), (standard deviation: [qnco]), (mean): [qnco]), (findings: [clna]), (majority: [socb]), (severe expression recognition deficits: [menp]), (films expression test: [sbst]), (sensitive task: [patf]), (biomarker research: [resa]), (future work: []), (asd subgroups: [cgab]), (expression recognition deficits: [menp]), (terms: [orgf]), (symptom profile: [lbpr]), (neurobiological underpinnings: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0187-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')(facial expressions, 'Integrated Verbal and NonVerbal Communication')(facial expression recognition, 'Integrated Verbal and NonVerbal Communication')(naturalistic facial expressions, 'Integrated Verbal and NonVerbal Communication')

PMCID: 4514956
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (copy number variations: [nusq]), (recurrent ~600 kb: []), (chromosomal locus: [celc]), (wide range: [qnco]), (neurodevelopmental disorders: [mobd]), (autism spectrum disorder (asd): [mobd]), (however: []), (social brain phenotype: [bpoc]), (cnv: [nusq]), (phenotype: [orga]), (social impairments: [patf]), (cnvs: [nusq]), (locus: [gngm]), (aim: [phsu]), (preliminary study: [resa]), (molecular subtyping: []), (individuals: [humn]), (patterns: []), (typical development: [orgf]), (asd: [cgab]), (mu attenuation: [acty]), (children: [aggp]), (adults: [aggp]), (duplication carriers: [fndg]), (deletion carriers: [genf]), (idiopathic asd (n =: [cgab]), (neurotypical controls: [sbst]), (participants: [popg]), (nonsocial motion: [npop]), (electroencephalogram (eeg): [lbtr]), (overall: []), (typical group: [popg]), (mu modulation: [qnco]), (social information (e.g.: []), (nonsocial motion): [npop]), (cnv groups: [nusq]), (social motion: [npop]), (asd group: [cgab]), (conditions: [dsyn]), (single-trial analysis: [fndg]), (time: []), (duplication group: [popg]), (typical patterns: []), (initial exposure: [clna]), (results: [fndg]), (unique patterns: []), (deletion: [genf]), (need: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s11689-015-9118-5) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(social impairments, 'Social Competence')(initial exposure, 'Exposures')

PMCID: 5737648
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (overlaps: [topp]), (autism: [mobd]), (schizophrenia: [mobd]), (social domains: []), (functioning individuals: [humn]), (autism spectrum disorders: [mobd]), (schizotypal personality disorder (spd): [mobd]), (social deficits: []), (distinct brain mechanisms: [bpoc]), (social cognition: [socb]), (asd: [cgab]), (spd: [gngm]), (functional magnetic resonance imaging (fmri): [diap]), (twenty-one individuals: [humn]), (controls: [sbst]), (respect: [socb]), (clinical symptoms: [sosy]), (positive: [fndg]), (negative syndrome scale;: [dsyn]), (social judgment task: [menp]), (ekman: []), (task;: []), (brain activation: [bpoc]), (fmri task: [diap]), (social judgment: [menp]), (spd groups: [dsyn]), (few differences: [qnco]), (symptoms: [sosy]), (however: []), ( fmri: [diap]), (that: []), (spd group: [dsyn]), (activation: [acty]), (judgments: [menp]), (amygdala: [bpoc]), (clusters:: [qnco]), (posterior cerebellum: [bpoc]), (fusiform: []), (inferior temporal gyri;: [bpoc]), (posterior cerebellum;: [bpoc]), (intraparietal sulcus: [bsoj]), (medial portions: []), (temporal gyri: [bpoc]), (fusiform gyrus (all p < .05: [bsoj]), (family-wise error corrected): [famg]), (control activations: [acty]), (social cognitive deficits: [mobd]), (result: [fndg]), (different brain mechanisms: [bpoc]), (findings: [clna]), (implications: []), (therapeutic interventions: [topp]), (social dysfunction: [dsyn]), (conditions: [dsyn]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(social deficits, 'Social Competence')(social cognition, 'Cognitive Ability')(social cognitive deficits, 'Cognitive Ability')(social dysfunction, 'Social Competence')

PMCID: 5073106
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (social skills: [socb]), ((sst): []), (high-functioning children: [aggp]), (autism spectrum disorders: [mobd]), (outpatient: [podg]), (between-: []), (within-subject design: [acty]), (sst: [gngm]), (list condition: [dsyn]), (compared: [acty]), (parents: []), (improvement: []), (list: []), (effects: []), (months: []), (between-group effects: [popg]), (general scores: [qnco]), (outcome measure: [qnco]), (social anxiety: [mobd]), ( adhd symptoms: [mobd]), ( theory: []), (mind: [menp]), (desire: [menp]), (social interaction: [fndg]), (altogether: []), ( sst: []), (effective intervention: [hlca]), (asd: [cgab]), (daily clinical practice: [menp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(social skills, 'Ability to Converse in Social Settings')(improvement of social skills, 'Ability to Converse in Social Settings')(effects of social skills, 'Ability to Converse in Social Settings')(social anxiety, 'Anxiety Disorders')(adhd symptoms, 'Attention Deficit Disorder with Hyperactivity')(social interaction, 'Reciprocal Social Interaction')(adhd symptoms, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 4924047
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objective: []), (study: [resa]), (effectiveness: []), (simultaneous training: [edac]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (parents: []), (focus: []), (social skills: [socb]), (enhancement (stsse): [acty]), (behavioral changes: [mobd]), (asd: [cgab]), (changes: [qnco]), (family functioning: [socb]), (stsse: []), (elementary school age: [orga]), (scores: [clna]), (social skills scale: [socb]), (education: [fndg]), (child behavior: [inbe]), (feetham family functioning survey (fffs): [socb]), (confidence degree questionnaire: [fndg]), (families (cdq): [famg]), (improvements: []), (communication skills: [orga]), (childrens ss-scale (p: [aapp,imft]), (significant improvements: [qnco]), (mothers fffs scores: [famg]), (factor: illness: [sosy]), (worries (p: [aapp,imft]), (median cdq scores: [clna]), (items: []), (stsse (p: [aapp,imft]), (additional studies: [lbpr]), (sample sizes: [sbst]), (findings: [clna]), (positive changes: [qnco]), (result: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(focus on social skills, 'Attention and Focus')(social skills, 'Ability to Converse in Social Settings')(social skills enhancement, 'Ability to Converse in Social Settings')(social skills scale for education, 'Ability to Converse in Social Settings')(effectiveness of social skills, 'Ability to Converse in Social Settings')(social skills scale, 'Ability to Converse in Social Settings')(social skills scale for education, 'Ability to Converse in Social Settings')(communication skills, 'Reciprocal Social Interaction')(items after social skills enhancement, 'Ability to Converse in Social Settings')(result of social skills enhancement, 'Ability to Converse in Social Settings')

PMCID: 5676836
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (effectiveness: []), (school-based cognitive behavioural therapy (cbt): [topp]), (symptoms: [sosy]), (anxiety: [mobd]), ( social worry: [fndg]), (social responsiveness: []), (indices: [lbpr]), (attentional control: [menp]), (attentional biases: [menp]), (threat: []), (adolescents: [aggp]), (autism spectrum disorder: [mobd]), (thirty-five young people: [popg]), (years; iq: []), (asd: [cgab]), (teacher: [fndg]), (parent: []), (sessions: [evnt]), (exploring feelings cbt intervention (attwood: [dsyn]), (exploring feelings (anxiety): [mobd]), (future horizons: []), ( arlington: []), ((n: [aapp,imft]), (wait-list control group (n: [grup]), (intervention: [hlca]), (wait-list control) group: [grup]), (positive change: [qnco]), ( teacher: [fndg]), (self-reported anxiety symptoms: [fndg]), (marginal effects: [fndg]), (increased teacher-reported social responsiveness: [qnco]), (discussion: [socb]), (potential value: [qnco]), (limitations: []), (school-based cbt: [dsyn]), (young people: [popg]), 
ASD Terms: (school-based cognitive behavioural therapy, 'Cognitive Ability')(anxiety, 'Anxiety Disorders')(autism spectrum disorder, 'Autism Phenotype')(exploring feelings cognitive behavioural therapy intervention, 'Cognitive Ability')(self-reported anxiety symptoms, 'Anxiety Disorders')(school-based cognitive behavioural therapy, 'Cognitive Ability')

PMCID: 5552034
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (social skills: [socb]), (human trainers: [humn]), (well-established method: [lbpr]), (appropriate skills: [inbe]), (social interaction: [fndg]), (previous work: []), (process: [phpr]), (dialogue system: []), (social communication skills: [socb]), (interaction: []), (computer avatar: []), (linguistic information: []), (human social skills trainers: [humn]), (account: [clna]), (other non-verbal features: [fndg]), (paper: []), (system: []), (gap: [gngm]), (audiovisual features: []), (ratio: [qnco]), (head: [blor]), ((yaw: [dsyn]), (pitch): [qnco]), (previous system: []), (graduate students;: []), (children: [aggp]), (young adults: [aggp]), (autism spectrum disorders: [mobd]), (experimental evaluation: [hlca]), (members: [popg]), (general population: [popg]), (people: [popg]), (multimodal system: [diap]), (experienced human social skills: [humn]), (users: [humn]), (systems effectiveness: []), (post-training scores: [clna]), (significant improvement: [qnco]), (computer-based social skills training: [edac]), (social difficulties: [fndg]), (teachers: []), ( therapists: []), (social skills trainers: [socb]), (rehabilitation: [topp]), (supplemental use: []), (human-based training: [humn]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(social skills, 'Ability to Converse in Social Settings')(process of social skills, 'Ability to Converse in Social Settings')(social communication skills, 'Reciprocal Social Interaction')(human social skills trainers, 'Ability to Converse in Social Settings')(autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(experienced human social skills, 'Ability to Converse in Social Settings')(computer-based social skills training, 'Ability to Converse in Social Settings')(social difficulties, 'Social Competence')(social skills trainers for rehabilitation, 'Ability to Converse in Social Settings')(supplemental use, 'Dietary Supplements')(social skills trainers, 'Ability to Converse in Social Settings')

PMCID: 4973931
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (empathy: [inbe]), (multidimensional process: [phpr]), (emotional sharing dimensions: [menp]), (empathic competencies: [inbe]), (interpersonal relationships: [socb]), (other people: [popg]), (adequate social behaviour: [socb]), (lack: []), (social components: []), (isolation: [topp]), (exclusion: [acty]), (healthy populations: [popg]), (however: []), (few studies: [lbpr]), (social skills: [socb]), (recent study: [resa]), ( kidd: []), (castano (2013): []), (literary fiction increases: [qnco]), (ability: [orga]), (people: [popg]), (other peoples emotions: [menp]), (mental states: [fndg]), (aim: [phsu]), (study: [resa]), (effects: []), (literary fiction: []), (nonfiction: []), (science fiction: []), (empathic abilities: [inbe]), (previous studies: [lbpr]), (variety: []), (empathy measures: [inbe]), (pre: [mamm]), (post-test design: [acty]), (healthy participants: [popg]), (book representative: [acty]), (literary genres: []), ((literary fiction: []), ( nonfiction: []), ( science fiction): []), (participants: [popg]), (reading phase: [dora]), (emotional sharing tests: [menp]), (zaki: []), (ochsner: []), ((2012) model: []), (comparisons: [acty]), (sociodemographic: []), ( mentalizing: []), (emotional sharing variables: [menp]), (conditions: [dsyn]), (anova: [gngm]), (results: [fndg]), (reading: [dora]), (literary fiction group: [popg]), (improvement: []), (abilities: [orga]), (discernible effect: []), (emotional sharing abilities: [orga]), (important goals: []), (future low-cost rehabilitation protocols: [topp]), (several disorders: [dsyn]), (mentalizing deficit: [dsyn]), (disease: [dsyn]), (autism spectrum disorders: [mobd]), (schizophrenia: [mobd]), 
ASD Terms: (empathy, 'Empathy')(adequate social behaviour, 'Reciprocal Social Interaction')(social skills, 'Ability to Converse in Social Settings')(empathy measures, 'Empathy')(discernible effect on emotional sharing abilities, 'Sharing')(emotional sharing abilities, 'Sharing')(mentalizing deficit, 'Mental Retardation')(autism spectrum disorders, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 5513455
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction children: [aggp]), (autism spectrum disorders (asds): [mobd]), (problems: []), (social skills: [socb]), (groups: [popg]), (therapeutic strategies: [menp]), (efficacy: [resa]), (objective: []), (implicit social skills: [socb]), (group: [popg]), (children: [aggp]), (asds: [cgab]), (intellectual disability: [mobd]), (before-and-after study: [resa]), (asd: [cgab]), (child psychiatry day: []), (implicit group: [popg]), (cooperative games: [dora]), (social-emotional profile: [menp]), (childhood autism rating scale (cars): [mobd]), (empathy quotient (eq): [inbe]), (weeks: []), (patients: [podg]), (years: []), (significant increase: [qnco]), (overall adaptation: [orgf]), (points): [qnco]), (sep: [gngm]), (addition: []), (significant reduction: [npop]), (cars: [gngm]), (field: [irda]), (social relationships: []), (eq: [qnco]), (two-fold: [phpr]), (discussion: [socb]), (childrens: []), (maintenance: [acty]), (skills: [inbe]), (time: []), ( examine: []), (widespread results: [fndg]), (compare implicit: [acty]), (explicit groups: [popg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(problems with social skills, 'Ability to Converse in Social Settings')(social skills, 'Ability to Converse in Social Settings')(autism spectrum disorders, 'Autism Phenotype')(implicit social skills, 'Ability to Converse in Social Settings')(intellectual disability, 'Learning Disorders')(asd without intellectual disability, 'Learning Disorders')(childhood autism rating scale, 'Autism Phenotype')(empathy quotient, 'Empathy')(overall adaptation, 'Adaptive Life Skills')(childhood autism rating scale score, 'Autism Phenotype')

PMCID: 4804639
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (gaze abnormality: [fndg]), (diagnostic criterion: [fndg]), (autism spectrum disorder (asd): [mobd]), (however: []), (few easy-to-use clinical tools: [qnco]), (unique eye-gaze patterns: [bpoc]), (asd: [cgab]), (recently: []), (gazefinder: []), (all-in-one eye-tracking system: [bpoc]), (early detection: [diap]), (toddlers: [aggp]), (abnormal gaze patterns: [fndg]), (various asd age groups: [cgab]), (adolescents: [aggp]), (adults: [aggp]), (study: [resa]), (unique gaze patterns: [fndg]), (percentage: [qnco]), (eye fixation time: [ortf]), (particular objects: []), (movies (i.e.: [diap,inpr]), ( eyes: [bpoc]), (mouth: [bsoj]), (human face movies: [humn]), (inverted biological motion: [npop]), (movies: []), (stimuli simultaneously: [phpr]), (people: [popg]), (geometry: []), (stimuli: [phpr]), (male adolescents: [aggp]), (asd (n =: [cgab]), (age-matched males: [orga]), (typical development (td; n: [aapp,imft]), (percentages: [qnco]), (groups: [popg]), (td): []), (scores: [clna]), (social responsiveness scale (srs): [acty]), (discriminant analyses: [resa]), (fixation times: [qnco]), (individuals: [humn]), (td: []), (asd group: [cgab]), (fixation time: [topp]), (locations: []), (salient social information (i.e.: [diap,inpr]), (movie: []), (lip movement: [bpoc]), (geometry): []), (significant groupwise differences: [qnco]), (responses: [orga]), (biological motion: [npop]), (within-group correlation: [popg]), (fixation-time items: [topp]), (srs: [gngm]), (items: []), (td groups: [popg]), (percentage fixation times: [qnco]), (eyes: [bpoc]), (large effect: [qnco]), (group difference: [popg]), (sensitivity: [patf]), (%: []), (specificity: [qnco]), (findings: [clna]), (easy-to-use tool: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-016-0083-y) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(lip movement, 'Fine Motor Skills')

PMCID: 5622482
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (boys: [aggp]), (girls: [aggp]), (cutting-edge: [topp]), (behavioral imaging: [diap]), (camouflaging: []), (asd: [cgab]), (social behaviors: [socb]), (diagnosis: [fndg]), (present study: [qnco]), (new kind: []), (camouflage: []), (language differences: [lang]), (pauses: [fndg]), (conversation: [socb]), (words: []), (um: []), (uh: []), (research: [resa]), (distinct (e.g.: []), ( um: []), (social communicative sophistication: [socb]), (uh): []), (large-scale research: [resa]), (women: [popg]), (people: [popg]), (rates: [qnco]), (conversational pauses: [clna]), (men: [gngm]), (children: [aggp]), (adolescents: [aggp]), (typical peers: [popg]), (sufficient numbers: [qnco]), (sex: [orgf]), (effect: []), (here: []), (um vs: []), (school-aged boys: [popg]), (filled pauses: [acty]), (dimensional measures: [qnco]), (autism symptom severity: [mobd]), (sixty-five verbal school-aged participants: [popg]), (asd (49: [cgab]), ( iq: []), (average range) participated: [qnco]), (small comparison group: [grpa]), (children (8: [aggp]), (girls): [aggp]), (speech samples: [orgf]), (autism diagnostic observation schedule: [hlca]), (parents: []), (social communication questionnaire: [socb]), (vineland adaptive behavior scales: []), (diagnostic groups: [popg]), (uh suppression: [qnco]), (um ratios: [qnco]), (pause rates: [qnco]), (typical children: [aggp]), (socialization: [edac]), (use: []), (symptoms: [sosy]), (pragmatic language markers: [lang]), (distinguish girls: [aggp]), (sex differences: [orga]), (general population: [popg]), (implication: []), (finding: [sosy]), (typical-sounding disfluency patterns (i.e.: [diap,inpr]), (relative uh production: [qnco]), (um ratios): [qnco]), (way girls: [aggp]), (asd sound relative: [cgab]), (linguistic camouflage: []), (nave listener: []), (first-of-its-kind study highlights: [qnco]), (importance: []), (continued commitment: [menp]), (gender change: [orga]), (way: []), (asd manifests: [cgab]), (potential: []), (natural language: [lang]), (objective behavioral imaging diagnostics: [diap]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social behaviors, 'Reciprocal Social Interaction')(diagnosis, 'Diagnosis')(language differences, 'Language Ability')(autism symptom severity, 'Complaints and Indications')(speech samples, 'Language Ability')(autism diagnostic observation schedule, 'Autism Phenotype')(social communication questionnaire, 'Reciprocal Social Interaction')(vineland adaptive behavior scales, 'Adaptive Life Skills')

PMCID: 4390314
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (social motivation hypothesis: [menp]), (autism: [mobd]), ( individuals: [humn]), (high levels: [qnco]), (autistic traits experience: [mobd]), (levels: []), (reward: [menp]), (social interactions: [fndg]), (however: []), (empirical evidence: []), (date: []), (studies: [lbpr]), (social reward: [menp]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (others: [fndg]), (difference: [qnco]), (controls: [sbst]), (subclinical condition: [dsyn]), (reduced ability: [orga]), (ones own emotions: [menp]), (other affective difficulties: [fndg]), (asd: [cgab]), (current study: [resa]), (nonclinical sample (n: [aapp,imft]), (associations: [menp]), (autistic traits: [mobd]), (value: [qnco]), (types: []), (social reward questionnaire: [menp]), (addition: []), (alexithymia: [sosy]), (main findings: [clna]), (firstly: []), (admiration: []), (sociability: [socb]), (models: []), (additional variance: [qnco]), (secondly: [qnco]), (reduced levels: []), (enjoyment: [menp]), (prosocial interactions: []), (sexual relationships: [socb]), (thirdly: [qnco]), (passivity: [inbe]), (negative social potency: [fndg]), (co-occurring alexithymia: [sosy]), (apparent associations: [menp]), (current findings: [clna]), (novel: []), (nuanced picture: [gngm]), (relationship: []), 
ASD Terms: (autism, 'Autism Phenotype')(social interactions, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5031348
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (neurodevelopmental conditions: [dsyn]), (severe impairments: [patf]), (social communication: [socb]), (interaction: []), (research: [resa]), (oxytocin: [aapp,horm,phsu]), (motivation: [menp]), ( cognition: [menp]), (attention: [menp]), (social cues: []), (patients: [podg]), (autism spectrum disorder: [mobd]), (aim: [phsu]), (clinical trial: [resa]), (basic mechanisms: []), (action: [acty]), (treatment: [topp]), (neural levels: []), (changes: [qnco]), (different levels: []), (-cognitive functioning: [menp]), (clinical study: [resa]), (randomized: [resa]), ( double-blind: [resa]), ( cross-over: [resa]), ( placebo-controlled: [resa]), ( multicenter: []), (functional magnetic resonance imaging study: [diap]), (arms: [gngm]), (sample: [sbst]), (male autism spectrum disorder patients: [mobd]), (infantile autistic disorder (f84.0: [mobd]), (icd-10): []), ( asperger syndrome (f84.5: [mobd]), (atypical autism (f84.1: [mobd]), (placebo nasal spray: [topp]), (different days: []), (autism: [mobd]), (spectrum disorder patients: [fndg]), (second visit: [hlca]), (healthy control participants: [popg]), (case-control: [hlca]), (autism spectrum disorder patients: [mobd]), (primary outcome: [topp]), (neural network activity: [acty]), (functional magnetic resonance: [npop]), (participants: [popg]), (-cognitive tasks: []), (behavioral markers: []), (theory: []), (mind accuracy ratings: [acty]), (response times: []), (secondary outcomes: [neop]), (addition: []), (physiological measures: [qnco]), (skin conductance: [ortf]), (trait measures: [qnco]), (alexithymia: [sosy]), ( interpersonal reactivity: []), (social anxiety: [mobd]), (additionally: []), (effect: []), (oxytocin receptor gene variants: [aapp,rcpt]), (primary: [topp]), (secondary outcome measures: [neop]), (functional: []), (magnetic resonance: [npop]), (assessments: [hlca]), (place: [acty]), (time points: []), (weeks: []), (sufficient wash-out time: [menp]), (oxytocin treatment: [aapp,horm,phsu]), (study: [resa]), (ethical review board: [hlca]), (competent authority: [socb]), (discussion: [socb]), (mechanisms: []), (acute oxytocin administration: [aapp,horm,phsu]), (-cognitive domains: []), (hand: [bpoc]), (further step towards: [qnco]), (therapeutic interventions: [topp]), (trial registration german clinical trial register drks00010053: [resa]), (trial: [resa]), (april: [gngm]), 
ASD Terms: (neurodevelopmental conditions, 'Learning Disorders')(autism spectrum disorders, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')(social cues, 'Awareness of Social Cues')(cognition, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(male autism, 'Autism Phenotype')(male autism spectrum disorder patients, 'Autism Phenotype')(infantile autistic disorder, 'Autistic Disorder')(asperger syndrome, 'Asperger Syndrome')(atypical autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism spectrum disorder patients, 'Autism Phenotype')(social anxiety, 'Anxiety Disorders')

PMCID: 5330469
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder: [mobd]), (children: [aggp]), (harmful health outcomes: []), (obesity): [dsyn]), (low levels: [qnco]), (physical activity: [dora]), (high levels: [qnco]), (sedentary behaviors: [fndg]), (prevalence: [qnco]), (correlates: []), (electronic databases: [fndg]), (sportdiscus: []), ( embase: []), ( medline): []), (inception: []), (november: []), (review: []), (prospero (crd42014013849): [plnt]), (peer-reviewed: [hlca]), ( english language studies: [lang]), (reviewers: [popg]), (relevant articles: []), (outcomes: []), (interest: [menp]), (sedentary behaviour levels: [fndg]), (potential correlates: []), (data: [euka]), (studies: [lbpr]), (physical activity prevalence: [qnco]), (physical activity correlates: [dora]), (sedentary behavior prevalence: [qnco]), (sedentary behavior correlates: [fndg]), (estimates: [qnco]), (childrens physical activity (34166 mins/day: [dora]), ( average: [qnco]), (mins/day): []), (sedentary behavior (126558 mins/day: [fndg]), (mins/day;: []), (mins/day: []), (total sedentary behavior: [fndg]), (age: [orga]), (sex: [orgf]), (sedentary behavior: [fndg]), (sample sizes: [sbst]), (high risk: [fndg]), (bias: [bird]), (few correlates: []), (sufficient studies: [lbpr]), (overall estimates: [qnco]), (associations: [menp]), (physical environment: []), (review highlights: []), (levels: []), (research: [resa]), (behaviors: [inbe]), (critical need: []), (interventions: [hlca]), (healthy levels: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(low levels of physical activity, 'Abnormal Activity or Energy Level')(varying levels of physical activity, 'Abnormal Activity or Energy Level')

PMCID: 4729153
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (ability: [orga]), (gaze: [fndg]), (important prerequisite: []), (joint attention: [menp]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (direction: []), (head: [blor]), (eyes: [bpoc]), (cues: []), (other peoples attention direction: [menp]), (previous studies: [lbpr]), (factors: []), (relation: [socb]), (asd susceptibility: [cgab]), (development: [orgf]), (asd diagnosis: [cgab]), (studies: [lbpr]), (high-risk populations: [popg]), (eye tracking: [bpoc]), (interaction: []), (group: [popg]), (10-month-old infants: [aggp]), (high familial risk: [famg]), (asd: [cgab]), ((high-risk group): [popg]), (infants: [aggp]), (family history: [fndg]), ((low-risk group): [popg]), (experimenter gaze: [fndg]), (objects: []), (periphery: []), (performance: [inbe]), (conditions:: [dsyn]), (experimenter: []), (objects (eyes: [bpoc]), (head condition): [dsyn]), (movement: [orgf]), (condition): [dsyn]), (condition interaction effect: [dsyn]), (found: [qnco]), (specifically: []), ( whereas: []), (accuracy: []), (conditions: [dsyn]), (low-risk group: [popg]), ( infants: [aggp]), (high-risk group: [popg]), (head condition: [dsyn]), (eyes only condition: [dsyn]), (valid social situation: [socb]), ( responses: [orga]), (risk: []), (results: [fndg]), (information: []), (point: [qnco]), (importance: []), (social perception: [menp]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-016-0069-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (joint attention, 'Joint Attention')(autism spectrum disorder, 'Autism Phenotype')(asd diagnosis, 'Diagnosis')(eye tracking, 'Eye Contact')(valid social situation, 'Social Competence')(social perception, 'Cognitive Ability')

PMCID: 5324603
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (difficulties: [fndg]), (social functioning: [socb]), (interactions: []), (other people: [popg]), (yet: []), (studies: [lbpr]), (social difficulties: [fndg]), (static images: []), (best: [gngm]), ( videos: []), (social stimuli: [phpr]), (scope: []), (real interaction: []), (here: []), (crucial aspect: [qnco]), (social interactionsgaze: []), (interactive setting: [qnco]), (first: [qnco]), (typical individuals: [humn]), (videos: []), (experimenter and: []), (means: []), (deception procedure: [inbe]), (experimenter: []), (live videofeed: [acty]), (prerecorded: []), (participants' eye movements: [ortf]), (person: [grup]), (experimenter video: []), (interestingly: []), (reduction: [npop]), (behaviour: [inbe]), (response: [fndg]), (live presence: [qnco]), (individuals: [humn]), (autistic traits: [mobd]), (relative insensitivity: [fndg]), (social presence alone: [fndg]), (participants: [popg]), (realtime interaction: []), ( however: []), (high autistic trait individuals: [mobd]), (low autistic trait individuals: [mobd]), (results: [fndg]), (findings: [clna]), (atypical gaze behaviour: [inbe]), (active engagement: [fndg]), (social interaction: [fndg]), (looking: [orga]), (spatiotemporal dynamics: [npop]), (real social interactions: [fndg]), (social stimulus: [phpr]), (effects: []), (importance: []), (valid methods: []), (social cognition: [socb]), (autism res: [mobd]), (autism research: [mobd]), (wiley periodicals: []), ( inc: []), (behalf: []), (international society: [orgt]), 
ASD Terms: (social functioning, 'Social Competence')(autism, 'Autism Phenotype')(social difficulties, 'Social Competence')(findings of atypical gaze behaviour, 'Personal Traits')(atypical gaze behaviour, 'Personal Traits')(active engagement, 'Engagement in Social Activities')(social interaction, 'Reciprocal Social Interaction')(real social interactions, 'Reciprocal Social Interaction')(social cognition, 'Cognitive Ability')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 4717584
SFARI Genes: met, met, met, met, 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (attention deficit/hyperactivity disorder (adhd): [mobd]), (social difficulties: [fndg]), (extent: []), (symptoms: [sosy]), (autism spectrum disorder (asd): [mobd]), (directly-observed asd symptoms: [cgab]), (autism diagnostic: [mobd]), (interview-revised (adi-r): [acty]), (autism diagnostic observation schedule (ados): [hlca]), (asd-specialty clinics: [cgab]), (diagnoses: [fndg]), (adhd (n: [mobd]), (asd (n: [cgab]), (adhd: [mobd]), (%: []), (asd cut-offs: [cgab]), (ados: [aapp,enzy]), (domains: []), (adi-r. four: [qnco]), (social communication ados items (quality: [aapp,enzy]), (social overtures: []), ( unusual eye contact: [socb]), ( facial expressions directed: [fndg]), (examiner: []), (amount: [qnco]), (reciprocal social communication): [socb]), (groups: [popg]), (none: []), (items: []), (adi-r: [clna]), (criteria: []), (adequate discrimination: [socb]), (results: [fndg]), (work: []), (challenges: [hlca]), (clinicians: []), (researchers: []), (asd: [cgab]), (other disorders: [dsyn]), (fluent: []), ( school-age children: [aggp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(attention deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(social difficulties, 'Social Competence')(autism, 'Autism Phenotype')(directly-observed asd symptoms, 'Complaints and Indications')(autism diagnostic, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(autism diagnostic interview-revised, 'Autism Phenotype')(social communication autism diagnostic observation schedule items, 'Reciprocal Social Interaction')

PMCID: 4630050
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (purpose high-functioning autism spectrum disorder (asd): [mobd]), (pragmatic impairment: [patf]), (language skills: [menp]), (numerous tasks: [qnco]), (pragmatic linguistic skills: [inbe]), ( idioms: []), (high-functioning asd: [cgab]), (nevertheless: []), (assessment tool: [acty]), (specific consideration: [fndg]), (korean culture: [lbpr]), (therefore: []), (korean autism social language task (kaslat): [mobd]), (idiom comprehension: [menp]), (asd: [cgab]), (aim: [phsu]), (current study: [resa]), (novel psychological tool: [mobd]), (idiom comprehension deficits: [menp]), (materials: [sbst]), (participants: [popg]), (children: [aggp]), ( ages: [bacs,orch]), (6-11 years: [fndg]), (child: [aggp]), (psychiatric clinic: [hcro,mnob]), (april: [gngm]), (may: []), (asd group: [cgab]), (children;: [aggp]), (attention deficit hyperactivity disorder (adhd) group: [mobd]), (normal control children: [aggp]), (disorder: [dsyn]), (study: [resa]), (idiom comprehension ability: [orga]), (groups: [popg]), (kaslat: []), (adhd groups: [mobd]), (scores: [clna]), (tasks: []), (adhd: [mobd]), (normal control: []), (however: []), (significant differences: [qnco]), (asd groups: [cgab]), (findings: [clna]), (asd exhibit: [cgab]), (impairment: [patf]), 
ASD Terms: (pragmatic impairment of language skills, 'Development or Regression of Language Skills')(purpose high-functioning autism spectrum disorder, 'Autism Phenotype')(language skills, 'Development or Regression of Language Skills')(korean autism social language task, 'Autism Phenotype')(attention deficit hyperactivity disorder group, 'Overactivity')(attention deficit hyperactivity disorder groups, 'Overactivity')(korean autism, 'Autism Phenotype')(attention deficit hyperactivity disorder, 'Overactivity')

PMCID: 6223809
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (present study: [qnco]), (prevalence: [qnco]), (autistic traits: [mobd]), (self-reported autism: [mobd]), (spectrum quotient-short (aq-short): [qnco]), (transgender: [popg]), (clinical population (n: [popg]), (age: [orga]), (sex: [orgf]), (birth: [orgf]), (cisgender community sample: [sbst]), (results: [fndg]), (cisgender people: [popg]), (similar levels: []), (possible autistic caseness: [mobd]), (transgender people: [popg]), (significant autistic traits: [mobd]), (other group: [popg]), (difference: [qnco]), (male: [orga]), (high aq scores: [clna]), (presence: [qnco]), (autism: [mobd]), (spectrum condition: [dsyn]), (groups: [popg]), (social behaviours;: [socb]), (such scores: [clna]), (reflection: [menp]), (transgender peoples: [popg]), (high social anxiety levels: [fndg]), (negative past experiences: [menp]), 
ASD Terms: (self-reported autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(social behaviours, 'Reciprocal Social Interaction')(high social anxiety levels, 'Anxiety Disorders')

PMCID: 5390729
SFARI Genes: 
Non SFARI Genes: STS, STS, STS, 
Named Entities: (abstract individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (severe deficits: []), (social communication: [socb]), (nature: []), (impairments: [patf]), (emotional prosody processing: [menp]), (here: []), (individuals: [humn]), (asd: [cgab]), (controls: [sbst]), (novel: []), ( lifelike behavioral: [inbe]), (neuroimaging paradigms: [diap]), (reduced emotional prosody recognition accuracy: [menp]), (behavioral task: [inbe]), (neural level: [phsu]), ( individuals: [humn]), (reduced activity: [acty]), (sts: [gngm]), ( insula: [bpoc]), (amygdala: [bpoc]), (complex vs: [chvs]), (basic emotions: [menp]), (moreover: []), (coupling: []), (asd group: [cgab]), (finally: []), ( groups: [popg]), (respect: [socb]), (relationship: []), (brain activity: [phsf]), (behavioral performance: [inbe]), (prosody recognition accuracy: [menp]), (asd participants: [cgab]), (contrast: [irda]), (anterior cingulate cortex (acc) activity: [acty]), (behavioral task performance: [topp]), (control group: [grup]), (results: [fndg]), (evidence: []), (aberrant emotional prosody processing: [menp]), (differences: [qnco]), (behavioral level: [inbe]), (observed deficits: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')(emotional prosody processing, 'Prosody')(investigated emotional prosody processing, 'Prosody')(reduced emotional prosody recognition accuracy, 'Prosody')(emotional prosody processing, 'Prosody')(prosody recognition accuracy, 'Prosody')(behavioral task performance, 'Task Performance')(aberrant emotional prosody processing, 'Prosody')(social communication, 'Reciprocal Social Interaction')

PMCID: 6290670
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (scerts: []), (model-based intervention: [hlca]), (different durations: []), (children: [aggp]), (autism spectrum disorder (asd) (age: [mobd]), (months): []), (hong kong: [fish]), (intervention: [hlca]), (chinese psychoeducational profile-third edition (cpep-3): [orch]), (developmental assessment chart (dac): [acty]), (educators: []), (parents: []), (views: []), (focus groups: [grup]), (results: [fndg]), (social communication: [socb]), (emotional behavior: [inbe]), (dac: [gngm]), (cpep-3: [orch]), (likewise: []), ( educators: []), (positive views: [fndg]), (childrens improvement: []), (emotional regulation: [menp]), (other skills: [inbe]), (asd: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')(emotional regulation, 'Emotional Regulation and Control')

PMCID: 5123360
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (spectrum conditions (asc): [dsyn]), (motor coordination difficulties: [fndg]), (however: []), (studies: [lbpr]), (prevalence: [qnco]), (dyspraxia: [mobd]), (large sample: [sbst]), (individuals: [humn]), (asc: [gngm]), (associations: [menp]), (autistic traits: [mobd]), (seventy-one adults (with asc): [aggp]), (controls: [sbst]), (asc): []), (subsample: []), (participants: [popg]), (autism spectrum quotient (aq;: [qnco]), (controls): [sbst]), (empathy quotient (eq;: [inbe]), (controls) online: [sbst]), (autism research centre website: [mobd]), (aq: []), (eq scores: [clna]), (groups: (1) adults: [aggp]), ( (2) adults: [aggp]), ( (3) controls: [fndg]), ((4) controls: [sbst]), (adults: [aggp]), (diagnosis: [fndg]), (dyspraxia (6.9%): [mobd]), (asc (0.8%): [fndg]), (asc group: [popg]), (co-morbid diagnosis: [fndg]), (different aq: []), (co-morbid dyspraxia: [mobd]), (control group (without asc): [grup]), (reports: [hlca]), (group: [popg]), (interestingly: []), (general population: [popg]), ( dyspraxia: [mobd]), (empathy: [inbe]), (results: [fndg]), (motor coordination skills: [orgf]), (effective social skills: [socb]), 
ASD Terms: (autism spectrum conditions, 'Autism Phenotype')(motor coordination difficulties, 'Motor Skills')(autism spectrum quotient, 'Autism Phenotype')(empathy quotient online, 'Empathy')(autism research centre website, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')(co-morbid diagnosis, 'Diagnosis')(autism spectrum conditions, 'Autism Phenotype')(motor coordination difficulties, 'Motor Skills')(empathy, 'Empathy')(motor coordination skills, 'Motor Skills')(effective social skills, 'Ability to Converse in Social Settings')

PMCID: 4188367
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (causal factors: []), (autism spectrum disorder (asd): [mobd]), (new assays: [lbpr]), (animal models: [anim]), (factors: []), (recent evidence: []), (deficits: []), (social motivation: [menp]), (core: [bdsu]), (asd: [cgab]), (development: [orgf]), (quantitative measures: [qnco]), (goal: []), (study: [resa]), (novel assays: [lbpr]), (mice: [mamm]), (order: [acty]), (validity: [qnco]), (paradigms: [resa]), (btbr strain: [mamm]), (social deficits: []), (prosocial c57bl/6j strain: [mamm]), (test mouse: [mamm]), (access: []), (social partner: [popg]), (test mice lever: [mamm]), (social reward: [menp]), (reward contingency: [menp]), (progressive ratio: [qnco]), (reinforcement: [menp]), (number: [qnco]), (lever presses: []), (final trial: [resa]), (session (breakpoint): [evnt]), (index: [qnco]), (valence comparison task: [acty]), ( motivation: [menp]), (food reward: [menp]), (activity: [acty]), ( social affiliation: []), (preference: []), (social novelty: []), (series: [qnco]), (tasks: []), (any-maze video-tracking system: [topp]), (open-field arena: [irda]), (btbr mice: [mamm]), (breakpoints: []), (social motivation paradigm: [menp]), (c57bl/6j mice: [mamm]), (however: []), (results: [fndg]), (conditioning paradigms: [menp]), (overall deficit: [dsyn]), (motivated behavior: [inbe]), (open-field observations: [hlca]), (social differences: [socb]), (anxiety induced: [mobd]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(deficits in social motivation, 'Social Competence')(social deficits, 'Social Competence')(overall deficit in motivated behavior, 'Personal Traits')(social differences, 'Social Competence')(anxiety induced, 'Anxiety Disorders')

PMCID: 5830347
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (suboptimal physical activity levels: [dora]), (tolerance: [fndg]), (poor motor skills: [grpa]), (poor physical health: [fndg]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (social interaction: [fndg]), (communication deficits: [socb]), (asd: [cgab]), (major factors: []), (group: [popg]), (physical activities: [dora]), (previous studies: [lbpr]), (exercise intervention: [topp]), (motor skills: [orgf]), (behavioral outcomes: [inbe]), (programs: [phsu]), (single sport: [fndg]), (interests: [menp]), (different children: [aggp]), (protocol: [fndg]), (game-based exercise training program: [dora]), (multi-disciplinary team (pediatrics: [hlca]), (physical education: [edac]), (psychology): []), (front-line healthcare providers: [sbst]), (train-the-trainer (ttt) model: [orgt]), (trial design: []), (effectiveness: []), (game-based exercise program: [dora]), (young children: [aggp]), (groups: [popg]), (arms: [gngm]), (waitlist conditions: [dsyn]), (assessment: [acty]), (psychological traits: [gngm]), (32-weeks (follow-up): [hlca]), (program: [phsu]), (discussion: [socb]), (interventions: [hlca]), (asd children: [cgab]), (physical conditions: [orga]), (states: []), (recognition: [menp]), (bidirectional relations: [socb]), (physical health: [orga]), (present game-based exercise program: [dora]), (multiple level: [phsu]), (difficulties: [fndg]), (necessary skills: [inbe]), (sustainable team sports: [dora]), (professional sport training: [dora]), (effective: []), (training: [edac]), (whole-person development: [orgf]), (trial registration: [resa]), (study: [resa]), (chinese clinical trial registry (chictr-ior-17011898): [resa]), (july: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(suboptimal physical activity levels, 'Abnormal Activity or Energy Level')(social interaction, 'Reciprocal Social Interaction')

PMCID: 3535343
SFARI Genes: TSC1, TSC2, TSC1, TSC2, 
Non SFARI Genes: 
Named Entities: (impairment: [patf]), (reciprocal social interaction: [fndg]), (core symptom: [clna]), (autism spectrum disorder: [mobd]), (genetic disorders: [dsyn]), (tuberous sclerosis complex: [neop]), (haploinsufficiency: [comd]), (tsc1: [gngm]), (tsc2 genes: [gngm]), (evidence: []), (relationship: []), (signal transduction: [celf]), (tuberous sclerosis: [neop]), (mammalian target: [mamm]), (rapamycin: [antb,orch]), (behavioural abnormalities: [mobd]), (spectrum disorder: [dsyn]), (recovery: [acty]), (rapamycin inhibitor rapamycin: [antb,orch]), (mouse models: [mamm]), (tsc2+/ mice: [mamm]), (enhanced transcription: [genf]), (multiple genes: [fndg]), (rapamycin signalling: [antb,orch]), (activated mammalian target: [mamm]), (minimal influence: []), (akt: [gngm]), (findings: [clna]), (crucial role: [socb]), (deficient social behaviour: [socb]), (notion: []), (rapamycin inhibitors: [antb,orch]), (pharmacological treatment: [topp]), (other conditions: [dsyn]), 
ASD Terms: (reciprocal social interaction, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(tuberous sclerosis complex, 'Tuberous Sclerosis')(autism spectrum disorder, 'Autism Phenotype')(tuberous sclerosis, 'Tuberous Sclerosis')(tuberous sclerosis complex, 'Tuberous Sclerosis')(behavioural abnormalities, 'Personal Traits')(deficient social behaviour, 'Reciprocal Social Interaction')(tuberous sclerosis complex, 'Tuberous Sclerosis')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5832686
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (past decade: [qnco]), ( research: [resa]), (biological basis: [phsu]), (sensory processing sensitivity (sps)a: [patf]), (trait: [orga]), (sensitivity: [patf]), (responsivity: [menp]), (social stimulihas burgeoned: []), (researchers: []), (sps: [gngm]), (clinical disorders: [dsyn]), (symptoms: [sosy]), (environment: []), (hyper-responsiveness: [mobd]), (stimuli: [phpr]), (thus: []), (review: []), (neural regions: []), (fmri studies: [diap]), (spectrum disorder (asd): [cgab]), ( schizophrenia (sz): [mobd]), (post-traumatic stress disorder (ptsd): [mobd]), (neural markers: [clna]), (cardinal features: [euka]), (related clinical disorders: [dsyn]), (stable trait: [orga]), (empathy: [inbe]), ( awareness: [menp]), ( responsivity: [menp]), (depth: []), (asd: [cgab]), ( sz: [sosy]), (ptsd: [mobd]), (response: [fndg]), (emotional stimuli: [menp]), ( sps: [gngm]), (brain regions: [blor]), (reward processing: [menp]), (memory: [menp]), ( physiological homeostasis: [biof]), (self-other processing: [acty]), ( empathy: [inbe]), (awareness: [menp]), (species: []), (deep integration: [genf]), (social information: []), (well-being: []), (cooperation: [socb]), (article: []), (part: [qnco]), (theme issue diverse: [fndg]), (diversity: multi-disciplinary approaches: [qnco]), (taxonomies: []), (individual differences: [menp]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(post-traumatic stress disorder, 'Post-Traumatic Stress Disorders')(empathy, 'Empathy')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(memory, 'Working Memory')(empathy, 'Empathy')

PMCID: 5126659
SFARI Genes: 
Non SFARI Genes: bad, bad, bad, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (problems: []), (reciprocal social interaction: [fndg]), (repetitive behaviours/narrow interests: [inbe]), (impairments: [patf]), (social cognition: [socb]), (emotional processing: [menp]), (intention-based moral judgements: [menp]), (aim: [phsu]), (study: [resa]), (information: []), (early adolescents: [aggp]), (asd: [cgab]), (story protagonists: []), (bad: [gngm]), (adolescents: [aggp]), (protagonists behaviour: [inbe]), ((td) adolescents: [aggp]), (protagonists characteristics: []), (judgements: [menp]), (experiment: [resa]), (sentence: []), (sentence reading times: [dora]), (percentages: [qnco]), (bad judgements: [menp]), (participants: [popg]), (protagonist: []), (results: [fndg]), (protagonist behaviours: [inbe]), (td adolescents: [aggp]), (protagonist characteristics: []), ( behaviours: [inbe]), (outcomes: []), (characteristics information: []), (together: []), (situations: []), (assess (experiment: [acty]), (comparable situations: []), (individual characteristics: [humn]), (moral judgements: [menp]), 
ASD Terms: (reciprocal social interaction, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(repetitive behaviours/narrow interests, 'Stereotyped, Restricted, and Repetitive Behavior')(social cognition, 'Cognitive Ability')

PMCID: 5456304
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (present study: [qnco]), (nature: []), (developmental trajectory: [orgf]), (self-injurious behaviour: [inbe]), (prader willi syndrome (pws): [cgab]), (autism spectrum disorder (asd): [mobd]), (development: [orgf]), (interventions: [hlca]), (gene: [gngm]), (pathways: [moft]), (accurate description: []), (behaviour phenotype: [bhvr]), (is: []), (types: []), (natural history: []), (pws: [cgab]), (asd: [cgab]), (other forms: []), (developmental disability: [mobd]), (self-injury: [inpo]), (individuals: [humn]), (group: [popg]), (intellectual disability: [mobd]), (mixed aetiology (id group): [popg]), (self-injurious behaviours: [inbe]), (self): []), (occasions: []), (years: []), (developmental behaviour checklist: [inbe]), (well-validated caregiver report measure: [qnco]), (rates: [qnco]), (skin picking: [mobd]), (self: []), (id group: [popg]), (head banging: [mobd]), (groups: [popg]), (age: [orga]), (pws group: [cgab]), (mixed id groups: [popg]), (findings: [clna]), (typology: [hlca]), (developmental trajectories: [orgf]), 
ASD Terms: (self-injurious behaviour, 'Self-Injurious Behavior')(prader willi syndrome, 'Prader-Willi Syndrome')(autism spectrum disorder, 'Autism Phenotype')(self-injurious behaviour, 'Self-Injurious Behavior')(other forms of developmental disability, 'Learning Disorders')(developmental disability, 'Learning Disorders')(prader willi syndrome, 'Prader-Willi Syndrome')(self-injury, 'Self-Injurious Behavior')(intellectual disability, 'Learning Disorders')(self-injurious behaviours, 'Self-Injurious Behavior')(prader willi syndrome, 'Prader-Willi Syndrome')(prader willi, 'Prader-Willi Syndrome')(self-injurious behaviours, 'Self-Injurious Behavior')

PMCID: 5526922
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (pupil: [bpoc]), (range: [qnco]), (physiological variables: []), (cognitive effort: [orgf]), ( arousal: [menp]), ( attention: [menp]), (autism spectrum disorder (asd): [mobd]), (work: []), (pupil physiology: [ortf]), (patients: [podg]), (autism: [mobd]), (heterogeneity: [orga]), (asd: [cgab]), (relationship: []), (quantitative traits: [gngm]), (physiological markers: []), (biological basis: [phsu]), (atypical responses: [orga]), (behaviors: [inbe]), (novel paradigm: [resa]), (patterns: []), (pupil adaptation: [orgf]), (sustained periods: []), (dark: []), (light conditions: [npop]), (pediatric sample: [sbst]), (intellectual ability: [fndg]), (clinical features: [clna]), (pupil metrics: [orch,phsu]), (novel task: []), (quantitative behavioral traits: [inbe]), (autism phenotype: [mobd]), (constriction: [patf]), (dilation: [patf]), (baseline metrics: [orch,phsu]), (pupil dilation metrics: [orch,phsu]), (individual differences: [menp]), (social responsiveness scale: [acty]), (quantitative measure: [qnco]), (autism traits: [mobd]), (results: [fndg]), (novel: []), (simple: [gngm]), ( paradigm: [resa]), (meaningful pupil metrics: [orch,phsu]), (srs: [gngm]), 
ASD Terms: (cognitive effort, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(pupil adaptation, 'Adaptive Life Skills')(autism phenotype, 'Autism Phenotype')(autism traits, 'Autism Phenotype')(autism traits, 'Autism Phenotype')

PMCID: 5718481
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (number: [qnco]), (trials: [resa]), (psychosocial intervention programmes: [topp]), (pre-school children: [aggp]), (autism spectrum disorder (asd): [mobd]), (quality: []), (unbiased evidence: []), (effectiveness: []), (asd interventions: [cgab]), (comprehensive review: []), (studies: [lbpr]), (adequate quality standards: []), (controlled trials: [resa]), (different types: []), (intervention: [hlca]), (study: [resa]), (interventions: [hlca]), (asd: [cgab]), (behavioural: [inbe]), ( social-communication focused: [socb]), (multimodal developmental: [diap]), (howlins classification: []), (early interventions: [hlca]), (children: [aggp]), (aim: [phsu]), (models: []), (strengths: []), (weaknesses: [sosy]), (type: [qnco]), (approaches: []), (successful outcome: [socb]), (autism: [mobd]), (systematic review: []), (meta-analysis: [resa]), (rcts: []), (years: []), (younger: []), (random effects model: [resa]), (effect estimate: [qnco]), (outcomes: []), (combined meta-analyses: [resa]), (overall effectiveness: []), (intervention programmes: [hlca]), (inclusion: [celc]), (data: [euka]), (significant difference: [qnco]), (effects: []), (general symptoms: [sosy]), (social-communication-focused model: [socb]), (multimodal developmental model (p: [diap]), (results: [fndg]), (evidence: []), (effect: []), (reciprocity: [socb]), (social interaction towards: [fndg]), ((standard mean difference [95%: [qnco]), (confidential interval]: [qnco]), (p<0.01): [fndg]), (parental synchrony (smd: [dsyn]), (small number: [qnco]), (present study: [qnco]), (ability: [orga]), (inferences: [menp]), (respect: [socb]), (important outcomes: []), (outcome: []), (social interaction towards others: [fndg]), (dependent variable: []), (interactions: []), (childs parent: [famg]), (significant effects: [qnco]), (skill: [inbe]), (reciprocal interactions: []), (others: [fndg]), (however: []), (parental synchrony: []), (targets: [diap]), (trial registration prospero crd42011001349: [resa]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(social interaction towards, 'Reciprocal Social Interaction')(reciprocal interactions, 'Reciprocal Social Interaction')(social interaction towards others, 'Reciprocal Social Interaction')

PMCID: 4951130
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (predictions: []), (humans: [humn]), (uncertainties: [fndg]), (social interactions: [fndg]), (here: []), (implicit person: [grup]), (different people: [popg]), (different situationsshape: []), (novel action identification task: [menp]), ( participants: [popg]), (actors: []), (objects: []), (experiments: [resa]), (actors action likelihoods: [qnco]), (situations: []), (actor: []), (object: []), (withdrew: [acty]), (other: []), (other actor: []), (opposite behaviour: [inbe]), (experiment: [resa]), (participants: [popg]), (explicit information: []), (individuals: [humn]), (actual behaviours: [inbe]), (data: [euka]), (dissociable effects: []), (kinds: []), (person information: []), (action identification: [menp]), (implicit action likelihoods: [qnco]), (response times: []), (identification: [menp]), (typical relative: [qnco]), (atypical actions: [fndg]), ( irrespective: []), (explicit knowledge: []), (individuals behaviour: [inbe]), (explicit person knowledge: [grup]), (contrast: [irda]), (error rates: [qnco]), (expectations: []), (observed behaviour: [inbe]), (valid: []), (data show: [euka]), (internal models: []), (others behaviour: [inbe]), (action observation: [hlca]), (first evidence: [qnco]), (person-specific social anticipation system: [grup]), (actions: []), (individuals prior behaviour: [inbe]), (situation: []), (recent models: []), (predictive coding: []), (non-social domain: []), (similar dissociations: [mobd]), (implicit effects: []), (stimulus identification: [menp]), (explicit behavioural wagers: [inbe]), 
ASD Terms: (social interactions, 'Reciprocal Social Interaction')

PMCID: 5442365
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disorder: [mobd]), (dysfunctions: [dsyn]), (social interactions: [fndg]), (complex interplay: [chvs]), (environmental risk factors: []), (autoimmunity: [patf]), (major etiological component: []), (asd: [cgab]), (whether: []), (specific autoantibodies: [aapp,imft]), (brain targets: [bpoc]), (open question: []), (here: []), (cohort: [popg]), (asd patient: [cgab]), (autoantibodies: [aapp,imft]), (glutamate nmda receptor (nmdar-ab): [aapp,rcpt]), (patient: [podg]), (alexithymia: [sosy]), (major depressive episodes: [mobd]), (psychotic symptoms: [sosy]), (approach: []), (nmdar-ab type g immunoglobulin: [aapp,rcpt]), (asd patient serum: [cgab]), (seropositive healthy subject: [popg]), (membrane nmdar complexes: [aapp,rcpt]), (synapses: [bsoj]), (findings: [clna]), (autistic patient nmdar-abs: [aapp,rcpt]), (direct role: [socb]), (etiology: []), (other autoantibodies: [aapp,imft]), (neuronal targets: [diap]), 
ASD Terms: (social interactions, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(major depressive episodes, 'Depressive Disorder')

PMCID: 4729526
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (appropriate distance: [qnco]), (others: [fndg]), (effective communication: [fndg]), (good interpersonal relations: [socb]), (autism spectrum disorder (asd): [mobd]), (developmental disorder: [mobd]), (social difficulties: [fndg]), (individuals: [humn]), (asd: [cgab]), (atypical degrees: [qnco]), (social distance: [socb]), (atypicality: []), (social distancing: [socb]), (daily social interactions: [fndg]), (preferred distances: [qnco]), ((td) individuals: [humn]), (other people: [popg]), (male experimenter): [orga]), (objects: []), (coat rack: [bpoc]), (clothes): []), (them: []), (reduced interpersonal distances: [qnco]), (td individuals: [humn]), (same tendency: []), (participants: [popg]), (preferred distance: [qnco]), (addition: []), (interpersonal distances: [qnco]), (eye contact: [socb]), (results: [fndg]), (small personal space: [qnco]), (persons: [popg]), 
ASD Terms: (atypical degrees of social distance, 'Social Competence')(autism spectrum disorder, 'Autism Phenotype')(social difficulties, 'Social Competence')(atypicality of social distancing, 'Social Competence')(daily social interactions, 'Reciprocal Social Interaction')(eye contact, 'Eye Contact')(small personal space, 'Awareness of Social and Personal Space')

PMCID: 5287487
SFARI Genes: HSF, HSF, 
Non SFARI Genes: 
Named Entities: (individuals: [humn]), (autism spectrum disorder (asd) show: [mobd]), (superior performance: [inbe]), (fine detail: []), (impaired gestalt face perception: [menp]), (ventral visual stream: [npop]), (primary visual cortex (v1): [bpoc]), (fusiform gyrus (v4): [bsoj]), (important role: [socb]), (form: []), (faces): [blor]), (color perception: [menp]), (aim: [phsu]), (study: [resa]), (ventral stream: [npop]), (asd: [cgab]), (potentials: []), (high-functioning asd adults (n: [cgab]), ((td) adults: [aggp]), (types: []), (visual stimuli: [ortf]), (follows:: []), (isoluminant chromatic (red/green: [npop]), ( rg): [gngm]), (high-contrast achromatic (black/white: [popg]), ( bw) gratings: [orga]), (high spatial frequency: []), (cycles/degree): [qnco]), (face (neutral: [blor]), ( happy: [menp]), (angry faces) stimuli: [blor]), (td controls: [sbst]), ( asd adults: [cgab]), (n1 latency: [fndg]), (rg: [gngm]), ( shorter n1 latency: [fndg]), (bw: [orga]), (p1 latency: [diap]), (n170 latency: []), (face stimuli: [blor]), (moreover: []), (difference: [qnco]), (latency: []), (p1: [gngm]), (n170: []), (n1: [fndg]), (prolongation: []), (cortico-cortical conduction time: [bpoc]), (v1: [bpoc]), (v4): [elii]), (asd adults: [cgab]), (findings: [clna]), (fine-form (local hsf) processing: [aapp,imft]), (impaired color processing: [npop]), (addition: []), (impaired gestalt face: [blor]), (deficits: []), (integration: [genf]), (multiple local hsf: [aapp,imft]), (facial information: [blor]), (v4: [elii]), (thus: []), (ventral stream function: [npop]), (abnormal social processing: [acty]), 
ASD Terms: (autism spectrum disorder show, 'Autism Phenotype')(impaired gestalt face perception, 'Cognitive Ability')(ventral visual stream, 'Visual Thinking')(primary visual cortex, 'Visual Thinking')(color perception, 'Color Perception')(visual stimuli, 'Visual Thinking')(visual cortex, 'Visual Thinking')(abnormal social processing in asd, 'Social Competence')(abnormal social processing, 'Social Competence')

PMCID: 4730628
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (amygdala dysfunction: [bpoc]), (social deficits: []), (autism spectrum disorders: [mobd]), (however: []), (neurobiological basis: [phsu]), (hypothesis: []), (asd: [cgab]), (abnormalities: [cgab]), (amygdaloid input: []), (output nuclei: [celc]), (here: []), (functional connectivity: []), (amygdaloid social-perceptual input nuclei: [bpoc]), (emotion-regulation output nuclei: [celc]), (asd versus controls: [cgab]), (state: []), (functional magnetic resonance: [npop]), ((fmri) data: [diap]), (optimal sensitivity: [patf]), (amygdala: [bpoc]), (neocortex: [bpoc]), (adolescents: [aggp]), (young adults: [aggp]), (controls: [sbst]), (regular correlation analysis: [inpr,resa]), (entire amygdala (ea): [bpoc]), (whole brain: [bpoc]), (partial correlation analysis: [inpr,resa]), (whole-brain functional connectivity: [bpoc]), (amygdaloid subregions: []), (between-group comparison: [popg]), (regular ea correlations: [orch,phsu]), (connectivity: []), (superior parietal areas: []), (effect: []), (left superficial: []), (right laterobasal input subregions: []), (centromedial output nuclei: [celc]), (results: [fndg]), (reduced connectivity: []), (amygdaloid sensory input channels: []), (abnormal amygdalo-cortical connectivity: [bpoc]), (socio-perceptual pathways: [moft]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-015-0060-x) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (social deficits, 'Social Competence')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 4091400
SFARI Genes: 
Non SFARI Genes: NHS, 
Named Entities: (introduction current evidence: [npop]), (social: []), (problem behaviours: [mobd]), (children: [aggp]), (autism spectrum disorder: [mobd]), (meaning: []), (behaviour: [inbe]), (child's perspective: [aggp]), (stories: []), (social information: []), (needs: []), (case reports: []), (autism: [mobd]), (number: [qnco]), (benefits: [qnco]), (improvements: []), (social interactions: [fndg]), (choice making: [inbe]), (educational settings: [eehu]), (methods: []), (analysis: [resa]), (feasibility: []), (cost-effectiveness: [qnco]), (social stories toolkit: []), (control framework: [sbst]), (participants: [popg]), (intervention: [hlca]), (comparator group: [popg]), (standard stories: []), (equivalent amount: [qnco]), (time: []), (statistics: []), (recruitment rates: [qnco]), (follow-up rates: [hlca]), (economic analysis: []), (appropriate measures: [qnco]), (generic health: [phsu]), (resource use categories: []), (cost-effectiveness analysis: []), (qualitative analysis: [resa]), (information: []), (perceptions: [menp]), (acceptability: []), (ethics: []), (dissemination national health service ethics approval (nhs;: [cgab,dsyn]), (trial protocol: []), (nhs research: [cgab,dsyn]), (development permission: [orgf]), (leeds: []), (york partnership nhs foundation trust: [orgt]), (adverse events: [patf]), (study data monitoring ethics committee: [resa]), (article: []), (peer: [popg]), (journal: [inpr,mnob]), (research findings: [resa]), (relevant conferences: [hcpp]), (trial registration number isrctn96286707: [resa]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(problem behaviours, 'Personal Traits')(social interactions, 'Reciprocal Social Interaction')(choice making, 'Decision Making Ability')(autism, 'Autism Phenotype')(perceptions, 'Cognitive Ability')

PMCID: 4670704
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent studies: [lbpr]), (cognitive behavior therapy (cbt): [topp]), (people: [popg]), (autism spectrum disorder (asd): [mobd]), (method: [lbpr]), (relation: [socb]), (cognitive profile: [lbpr]), (aim: [phsu]), (study: [resa]), (effect: []), (cbt: [gngm]), (is: []), (visualized language: [lang]), (entire session: [evnt]), (clients: [grup]), (asd: [cgab]), (anxiety: [mobd]), (avoidance behavior: [menp]), (modification: []), (cbt protocols: [dsyn]), (anxiety disorders: [mobd]), (depression: [mobd]), (the invisible: []), (conversation: [socb]), (order: [acty]), (social: []), (emotional context: [menp]), (self: []), (others: [fndg]), (misunderstandings: []), (asd clients: [cgab]), (help: []), (invisible code: []), (social interaction: [fndg]), (communication: [socb]), (level: [phsu]), (frequency: [qnco]), (target behavior: [inbe]), (measured: [diap]), (assessments: [hlca]), (pre-assessment: [acty]), (mid-therapy: [topp]), (end: [gngm]), (therapy respectively: [topp]), (generally: []), ( results: [fndg]), (improvement: []), (pre-treatment period: []), (significant improvement: [qnco]), (treatment: [topp]), (values: []), (occupational ability: [orga]), (function: [phsf]), (global function rating scale: [phsf]), (preliminary conclusion: []), (pilot study: [resa]), (use: []), (cbt therapy sessions: [dsyn]), (promising modification: []), (current cbt protocols: [dsyn]), (individuals: [humn]), (studies: [lbpr]), (study designs: [resa]), (results: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(cognitive behavior therapy, 'Cognitive Ability')(cognitive profile, 'Cognitive Ability')(modified cognitive behavior therapy, 'Cognitive Ability')(visualized language, 'Visual Thinking')(anxiety, 'Anxiety Disorders')(cognitive behavior therapy, 'Cognitive Ability')(anxiety disorders, 'Anxiety Disorders')(depression, 'Depressive Disorder')(social interaction, 'Reciprocal Social Interaction')(anxiety, 'Anxiety Disorders')(occupational ability, 'Job Performance')(visualized language, 'Visual Thinking')(current cognitive behavior therapy, 'Cognitive Ability')(cognitive behavior therapy therapy sessions, 'Cognitive Ability')

PMCID: 4906972
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (repetitive behaviours: [inbe]), (core symptom domain: [bdsu]), (autism spectrum disorder (asd): [mobd]), (however: []), (nature: []), (rrbs: []), (context: [fndg]), (broader autism phenotype (bap): [mobd]), (relationship: []), (asd probands: [cgab]), (parents: []), (current study: [resa]), (link: []), (parental rrbs: []), (interest: [menp]), (patterns: []), (resistance: [menp]), (changes subscales: [qnco]), (autism quotient: [mobd]), (childrens rrbs: []), (autism diagnostic observation schedule rrb: [hlca]), (domain score: [clna]), (findings: [clna]), (%: []), (rrb scores: [clna]), (increase: []), (children;: [aggp]), (parent-of-origin effects: []), (trend: []), (changes: [qnco]), (paper: []), (significant contribution: [acty]), (understanding: [menp]), (association: [menp]), (children: [aggp]), (asd: [cgab]), (future work: []), (bap: [gngm]), (distinct genetic subtypes: [topp]), ((whole chromosome aneuploidies: [comd]), (single gene mutations: [fndg]), (number variations): [qnco]), (neuropsychiatric disorders: [dsyn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(repetitive behaviours, 'Restricted and Repetitive Behavior')(broader autism phenotype, 'Autism Phenotype')(repetitive behaviours, 'Restricted and Repetitive Behavior')(autism quotient, 'Autism Phenotype')(autism diagnostic observation schedule rrb, 'Autism Phenotype')(repetitive behaviours, 'Restricted and Repetitive Behavior')(autism phenotype, 'Autism Phenotype')

PMCID: 5106821
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prominent diagnostic criterion: [fndg]), (autism spectrum disorder (asd): [mobd]), (abnormal: [qnco]), (use: []), (facial expressions: [fndg]), (mechanisms: []), (feature: []), (asd: [cgab]), (children: [aggp]), (video clips: [lbpr]), (order: [acty]), (individual differences: [menp]), (spontaneous production: []), (facial expression analysis software: [fndg]), (hierarchical multiple regression: []), (alexithymia: [sosy]), (difficulties: [fndg]), (ones own feeling states): [menp]), (facial expression production: [fndg]), (groups: [popg]), ( alexithymic traitsbut: []), (asd traits: [cgab]), ( iq: []), (quantity: [qnco]), (results: [fndg]), (body: [humn]), (research: [resa]), (many emotion: [menp]), (abnormalities: [cgab]), (co-occurring alexithymia: [sosy]), (developmental: [orgf]), (clinical considerations: [fndg]), (ignored trait: [orga]), (implications: []), (individuals: [humn]), (autism spectrum: [mobd]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(facial expressions, 'Integrated Verbal and NonVerbal Communication')(facial expression analysis software, 'Integrated Verbal and NonVerbal Communication')(facial expression production, 'Integrated Verbal and NonVerbal Communication')(facial expression production, 'Integrated Verbal and NonVerbal Communication')(autism spectrum, 'Autism Phenotype')

PMCID: 4518448
SFARI Genes: 
Non SFARI Genes: ms, 
Named Entities: (summary internal action models: [acty]), (brain templates: [bpoc]), (sensory-motor coordination: [ortf]), (diverse behaviors: [inbe]), (theory: []), (impaired iams: []), (common theme: [qnco]), (autism spectrum disorder (asd) [24]: [mobd]), (however: []), (sensory systems: [bdsy]), (major phenotype: [orga]), (asd: [cgab]), (social communication [5]: [socb]), (olfaction relies: [orgf]), (iam: []), (sniff response: [fndg]), (sniff magnitude: [qnco]), (odor valence [612]: [npop]), (failed iam theory: []), (olfaction: [orgf]), (non-verbal non-task-dependent sniff response concurrent: [menp]), (unpleasant odors: [npop]), (children18: []), ((td) controls: [sbst]), (whereas td children: [aggp]), (typical adult-like sniff response: [aggp]), (ms: [gngm]), (odor onset: [qnco]), ( asd children: [cgab]), (odor valance: [npop]), (difference: [qnco]), (odor perception: [npop]), (correct asd classification: [cgab]), ((binomial: []), (moreover: []), (aberrant sniffing: []), (severe asd (r = 0.75: [cgab]), ( p: [aapp,imft]), (social (r = 0.72: [fndg]), ((r < 0.38: [fndg]), (impairment: [patf]), (results: [fndg]), (novel asd marker: [cgab]), (mechanistic link: []), (underpinnings: []), (impaired iam: []), (impaired social abilities: [socb]), 
ASD Terms: (sensory-motor coordination, 'Motor Skills')(autism spectrum disorder, 'Autism Phenotype')(major phenotype of asd, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')(odor onset, 'Onset of Symptoms')(odor perception, 'Cognitive Ability')(impaired iam with impaired social abilities, 'Ability to Converse in Social Settings')(impaired social abilities, 'Ability to Converse in Social Settings')

PMCID: 5825385
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (highlights: []), (social motivation theory: [menp]), (asd: [cgab]), (social impairments: [patf]), (value: [qnco]), (social stimuli: [phpr]), (reward value: [menp]), (human motion: [humn]), (people: [popg]), (range: [qnco]), (aq scores: [clna]), (subjects value: [humn]), (motion: [npop]), (preference: []), 
ASD Terms: (social impairments, 'Social Competence')

PMCID: 5843023
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (meta-analysis: [resa]), (studies: [lbpr]), (figurative language comprehension: [menp]), (individuals: [humn]), (autism spectrum disorder: [mobd]), (controls: [sbst]), (chronological age or/and language ability: [orga]), (total: [qnco]), (independent effect sizes: [fndg]), (predetermined inclusion criteria: []), (group: [popg]), (strategy: [menp]), (age: [orga]), ( types: []), (figurative language: [lang]), (cross-linguistic differences: [qnco]), (predictors: []), (heterogeneity: [orga]), (effect sizes: []), (overall: []), ( individuals: [humn]), (comprehension: [menp]), (peers: [popg]), (g = 0.57): [fndg]), (meta-regression analysis: [resa]), (types: []), (differences: [qnco]), (chronological age: [orga]), (groups: [popg]), (language ability: [menp]), (metaphors: []), (sarcasm: []), (findings: [clna]), (critical role: [socb]), (core language skills: [menp]), (interventions: [hlca]), (educational programmes: []), (social communication skills: [socb]), (addition: []), (social skills: [socb]), 
ASD Terms: (figurative language comprehension, 'Language Ability')(autism spectrum disorder, 'Autism Phenotype')(chronological age or/and language ability, 'Development or Regression of Language Skills')(autism spectrum disorder, 'Autism Phenotype')(comprehension of figurative language, 'Development or Regression of Language Skills')(language ability, 'Development or Regression of Language Skills')(autism spectrum disorder, 'Autism Phenotype')(sarcasm, 'Skill in Understanding Humor')(critical role of core language skills, 'Development or Regression of Language Skills')(core language skills, 'Development or Regression of Language Skills')(social communication skills, 'Reciprocal Social Interaction')(target core language skills in addition, 'Development or Regression of Language Skills')(target core language skills, 'Development or Regression of Language Skills')(social skills, 'Ability to Converse in Social Settings')

PMCID: 5031219
SFARI Genes: 
Non SFARI Genes: ran, 
Named Entities: (background: motor milestones: []), (onset: [qnco]), (important developmental markers: [clna]), (motor skills: [orgf]), (widespread socialcognitive development: [orgf]), (aim: [phsu]), (current study: [resa]), (gross motor abilities: [orgf]), (walking: [dora]), (subsequent rate: [qnco]), (language development: [menp]), (large cohort: [popg]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (methods:: []), (growth curve models: [orgf]), (receptive language: [lang]), (years: []), (autistic children: [podg]), (measures: [qnco]), (gross motor: []), (visual reception: [ortf]), (autism symptoms: [mobd]), (year visit: [hlca]), (model: []), (predictor: []), (slope: [qnco]), (measure: [qnco]), (nonverbal iq: [fndg]), (autism: [mobd]), (symptom severity: [fndg]), (covariates: []), (final model: []), ( model: []), (gross motor ability: [orgf]), (results:: [fndg]), (first model: [qnco]), (age: [orga]), (relationship: []), (gross motor skill: [ortf]), (nonverbal ability: [orga]), (autism severity scores: [mobd]), ((models: []), (gross motor score: [clna]), ( however: []), (significant predictor: [qnco]), (receptive language development: [menp]), (conclusions: taken: []), (model results: [fndg]), (evidence: []), (early motor abilities: [orgf]), (young children: [aggp]), (asd: [cgab]), (longitudinal crossdomain influences: []), (part: [qnco]), (linguistic difficulties: [fndg]), (autism res: [mobd]), (autism research: [mobd]), (wiley periodicals: []), ( inc: []), (behalf: []), (international society: [orgt]), 
ASD Terms: (onset, 'Onset of Symptoms')(onset, 'Onset of Symptoms')(language development, 'Language Development')(autism spectrum disorder, 'Autism Phenotype')(receptive language, 'Receptive Language')(visual reception, 'Visual Thinking')(autism symptoms, 'Complaints and Indications')(language development, 'Language Development')(autism, 'Autism Phenotype')(language development, 'Language Development')(gross motor skill, 'Gross Motor Skills')(autism severity scores, 'Autism Phenotype')(receptive language development, 'Language Development')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 5820623
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (purpose: []), (study: [resa]), (effects: []), (structured physical activity program: [dora]), (social interaction: [fndg]), (communication: [socb]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (fifty children: [aggp]), (asd: [cgab]), (special school: [mnob,orgt]), (control groups: [grup]), (experimental group: [popg]), (control group: [grup]), (regular physical activity: [dora]), (total: [qnco]), (forty-one participants: [popg]), (12-week structured physical activity program: [dora]), (exercise sessions: [dora]), (quasi-experimental design: [resa]), (data: [euka]), (qualitative instruments: []), (ssis: []), (ablls-r results: [fndg]), (overall improvement: []), (social skills: [socb]), (interim: []), (posttests: []), ( f: [inch,phsu]), (p: [gngm]), ((p: [aapp,imft]), (significant improvements: [qnco]), (self-control subdomains: [inbe]), (conversely: []), (significant differences: [qnco]), (control group (p: [grup]), (special structured physical activity program: [dora]), (communication skills: [orga]), ( communication: [socb]), ( prompt response: [fndg]), (frequency: [qnco]), (expression: [topp]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(overall improvement in social skills, 'Ability to Converse in Social Settings')(social skills, 'Ability to Converse in Social Settings')(communication skills of children, 'Reciprocal Social Interaction')(especially in social skills, 'Ability to Converse in Social Settings')(communication skills, 'Reciprocal Social Interaction')

PMCID: 6089261
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (quattrocki: []), (friston (2014): []), (abnormalities: [cgab]), (interoceptionthe process: [phpr]), (ones internal physiological statescould lie: [qnco]), (heart: [bpoc]), (autism: [mobd]), (critical role interoception: [menp]), (ontogeny: [orgf]), (social-affective processes: [phpr]), (proposal: []), (criticism: [socb]), (proponents: []), (alexithymia hypothesis: [sosy]), (underlying interoceptive impairments: [patf]), (feature: []), (se: [gngm]), (alexithymia (a condition: [sosy]), (difficulties: [fndg]), (own emotions): [menp]), (importance: []), (debate: [acty]), (understanding: [menp]), (autism spectrum disorder (asd): [mobd]), (role: [socb]), (interoceptive impairments: [patf]), (psychopathology: []), (generally: []), ( direct empirical evidence: []), (sample: [sbst]), (neurotypical (nt) individuals: [humn]), (association: [menp]), (autistic traits: [mobd]), ( alexithymia: [sosy]), (interoceptive accuracy (ia): []), (standard heartbeat-tracking measure: [qnco]), (ia: [mamm]), (experiment: [resa]), (adults: [aggp]), (asd (27: [cgab]), (significant alexithymia): [sosy]), (nt adults: [diap]), (strong associations: [menp]), (alexithymia: [sosy]), (evidence: []), (interoceptive difficulties: [fndg]), (similarly: []), ( experiment: [resa]), (autistic adults: [mobd]), ( irrespective: []), (co-occurring alexithymia: [sosy]), (null hypothesis: [qnco]), (observations: [hlca]), (significant challenge: [hlca]), (notions: []), (impairments: [patf]), (core feature: [bdsu]), (asd: [cgab]), (direct perception: [menp]), (interoceptive signals: [phpr]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(direct perception, 'Cognitive Ability')

PMCID: 4444114
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (current study: [resa]), (fine-grained: [plnt]), ( efficient characterization: [acty]), (concurrent neuropsychological contributions: [acty]), (social functioning: [socb]), (neuropsychologically-referred youth: [aggp]), (secondary aim: [neop]), (useful statistic approach: [qnco]), (such investigations: [hlca]), ((partial least squares regression; plsr): [qnco]), (field: [irda]), (forty-five participants: [popg]), (months; mage: [aapp,bacs]), (male): [orga]), (large neuropsychological assessment clinic: [hcro,mnob]), (participants: [popg]), (subtests: []), (nepsy-ii focusing: [clna]), (neuropsychological constructs: []), (social memory: [menp]), ( motor: []), (visuomotor skills: [inbe]), ( response inhibition: [acty]), ( attention: [menp]), (verbal comprehension): [menp]), (mothers: [famg]), (basc-2: []), (atypicality: []), (social skills scales: [socb]), (analyzed: [resa]), (plsr: []), (difficulty: [fndg]), ( sensorimotor integration: [ortf]), (ability: [orga]), (discriminate auditory stimuli: [phsf]), (odd behavior: [mobd]), (terms: [orgf]), (factors: []), (first factor: [qnco]), (that: []), ( counterintuitively: []), (emotional perception: [menp]), (visuospatial perception: [menp]), ( ability: [orga]), (understand instructions: [menp]), (social skills: [socb]), (second factor: [qnco]), (pattern: []), (facial memory: [menp]), (sensorimotor ability (execution: [orga]), (distinct profile: [lbpr]), (social ability: [socb]), (plsr results: [fndg]), (traditional ols: []), (backwards stepwise regression approaches: [menp]), (results: [fndg]), (findings: [clna]), (age: [orga]), ( gender: [orga]), (diagnostic group: [popg]), (common neuropsychological substrates: [sbst]), (sample: [sbst]), (referred youth: [aggp]), (study: [resa]), (first characterization: [acty]), (optimized combinations: [phsu]), (neuropsychological variables: []), (assessment clinic-referred youth: [aggp]), (introduces: []), (literature: [inpr,mnob]), (valuable statistical approach: []), (such characterizations: [acty]), 
ASD Terms: (social functioning, 'Social Competence')(social skills scales, 'Ability to Converse in Social Settings')(social memory, 'Working Memory')(emotional perception, 'Visual Perception')(visuospatial perception, 'Cognitive Ability')(social skills, 'Ability to Converse in Social Settings')(facial memory, 'Working Memory')(social ability, 'Ability to Converse in Social Settings')(social functioning, 'Social Competence')(social functioning, 'Social Competence')

PMCID: 5292795
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (researchers: []), (several different countries: [qnco]), (social responsiveness scale (srs): [acty]), (good psychometric properties: [diap]), (however: []), (knowledge: []), (studies: [lbpr]), (subject: [humn]), (mainland china: []), (study: [resa]), (psychometric properties: [diap]), (chinese mandarin version: [lang]), (srs: [gngm]), (reliability: [qnco]), (validity: [qnco]), (parent-report srs: []), (sample: [sbst]), (children: [aggp]), (clinical participants: [popg]), (autism spectrum disorder (asd)): [mobd]), (internal consistency: [qnco]), (total scale (0.8710.922): [acty]), (reliability (0.810.94): [qnco]), (convergent validity: [qnco]), (autism behavior checklist (abc) (0.3020.647): [mobd]), (satisfactory: []), (total score: [qnco]), (asd: [cgab]), (other developmental disorders: [mobd]), (characteristic (roc) analyses: [qnco]), (youth asd: [cgab]), (exploratory factor analysis (efa): [qnco]), (single-factor solution: [fndg]), (asd subsample: [cgab]), (confirmatory factor analysis (cfa): [qnco]), (theoretical construct: []), (factors model: []), (inadequate fit: [sosy]), (overall: []), (findings: [clna]), (asd screening instrument: [cgab]), (addition: []), (use: []), (separate cut-offs: [phpr]), (purposes: []), (sensitivity): [patf]), (clinical confirmation: []), (specificity): [qnco]), (considered: []), 
ASD Terms: (autism behavior checklist, 'Autism Phenotype')

PMCID: 6072130
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (social interactions: [fndg]), (caregivers: []), (children: [aggp]), (crucial role: [socb]), (childhood development; therefore: [orgf]), ( caregivers feelings: [menp]), (development: [orgf]), (social minds: [menp]), (mothers: [famg]), (autism spectrum disorder (asd): [mobd]), (levels: []), (stress: [fndg]), (however: []), ( knowledge: []), (mothers feelings: [famg]), (clinical diagnosis: []), (study: [resa]), (time course: []), (time: []), (birth: [orgf]), (effect: []), (protective factors: [inbe]), (participants: [popg]), (8-year-old children: []), (asd diagnosis: [cgab]), (asd: [cgab]), (positive feelings: [menp]), (developed (td) children: [aggp]), (intriguingly: []), (prior knowledge: [evnt]), (maternal mental distress: [patf]), (child-rearing years: [socb]), (diagnosis: [fndg]), 
ASD Terms: (social interactions, 'Reciprocal Social Interaction')(development of social minds, 'Ability to Converse in Social Settings')(autism spectrum disorder, 'Autism Phenotype')(clinical diagnosis, 'Diagnosis')(asd diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')

PMCID: 5110595
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mimicry: [mobd]), (actions: []), (others: [fndg]), (evidence: []), (autistic people: [mobd]), (goal: []), (observed action: [acty]), (show differences: [anim]), (autism spectrum disorder (asd): [mobd]), (two-dimensional virtual reality environment: [mcha]), (participants: [popg]), (imitation game: [dora]), (avatar: []), (autistic participants: [mobd]), (neurotypical participants: [popg]), (kinematics: []), (avatars movements: [orgf]), (however: []), (less: [qnco]), (social engagement: [fndg]), (group: [popg]), (results: [fndg]), (feasibility: []), (virtual reality: [mcha]), (mimicry differences: [qnco]), (asd: [cgab]), (avatars: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(imitation game, 'Imitation')(social engagement, 'Engaging in Social Conversation')

PMCID: 5298619
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (paper: []), (state-of-the-art: [gngm]), (technologies: []), (autism spectrum disorder (asd) screening: [mobd]), (therapy: [topp]), (disorder: [dsyn]), (difficulties: [fndg]), (social communication: [socb]), (social interactions: [fndg]), (repetitive behaviors: [fndg]), (years: []), (life: []), (intensive interventions: [menp]), (developmental trajectory: [orgf]), (affected children: [aggp]), (diagnosis: [fndg]), (sooner: []), (intervention therapy: [topp]), (early diagnosis: [diap]), (important research goal: [resa]), (technological innovations: []), (tremendous potential: []), (intervention programs: [hlca]), (need: []), (methodological evaluation: [hlca]), (order: [acty]), (therapists: []), (clinicians: []), (selection: [genf]), (suitable tools: []), (developers: []), (hardware: []), (software: [inpr,mnob]), (survey: []), (literatures: []), (asd: [cgab]), (eye: [bpoc]), (trackers: []), ( movement trackers: [orgf]), (electrodermal activity monitors: [acty]), ( tactile: [gngm]), (sensors: []), ( vocal prosody: [fndg]), (speech detectors: [orgf]), (sleep quality assessment devices: []), (effectiveness: []), (limitations: []), (challenges: [hlca]), (field: [irda]), (theoretical potential: []), 
ASD Terms: (autism spectrum disorder screening, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')(social interactions, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(diagnosis, 'Diagnosis')(early diagnosis, 'Diagnosis')(vocal prosody, 'Prosody')(speech detectors, 'Language Ability')

PMCID: 5617879
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (cross-sectional study: [resa]), (loneliness: [fndg]), (correlates: []), (children: [aggp]), (years): []), (adolescents: [aggp]), (autism spectrum disorders: [mobd]), (groups: [popg]), ((adhd: [mobd]), (n =: [aapp,imft]), (non-clinical (n =: [aapp,imft]), (youths: [aggp]), (questionnaires: []), (desire: [menp]), (social interaction: [fndg]), (parents: []), (teachers: []), (scales: [bpoc]), (other aspects: [qnco]), (childrens social functioning: [socb]), (results: [fndg]), (adolescent: [aggp]), (asd group: [cgab]), (levels: []), (control groups: [grup]), (low levels: [qnco]), (similar increase: []), (wish: [gngm]), (adolescence: []), (participants: [popg]), (social competence: [socb]), (social skills: [socb]), (social problems: [fndg]), (social anxiety: [mobd]), (social variables: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(childrens social functioning, 'Ability to Converse in Social Settings')(social competence, 'Social Competence')(levels of social problems, 'Social Competence')(social skills, 'Ability to Converse in Social Settings')(social problems, 'Social Competence')(social anxiety, 'Anxiety Disorders')

PMCID: 6114703
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (influence: []), (persons environment: []), (participation: []), (childhood disabilities: [fndg]), (adolescents: [aggp]), (autism spectrum disorder (asd): [mobd]), (review: []), (aim: [phsu]), (existing literature: [inpr,mnob]), (environments: []), (asd: [cgab]), (sources: [fndg]), (scientific evidence: []), (databases: []), (inclusion criteria: []), (perspectives: []), (families: [famg]), ( peers: [popg]), (significant others; ecologic validity;: [famg]), (clear connection: [fndg]), (environment: []), (publication dates: [inpr,mnob]), (international classification: []), (functioning: []), ( disability: [fndg]), (health (icf): []), (guiding framework: []), (inclusion/exclusion: []), (selection process: [genf]), (thematic analysis: [resa]), (independent reviewers: [popg]), (results: [fndg]), (stakeholders: []), (articles: []), (studies: [lbpr]), (main themes: []), (security: []), (parental: []), ( physical: [hlca]), (informational environments: []), (securing: [bodm]), (intimidating effect: []), (second theme: [qnco]), (indicates: []), (support: []), (social relationships: []), (social activities: [socb]), (hence participation: []), (additional third main theme: [qnco]), ( tension: [mobd]), ( relates: [orch]), (ambiguities: []), (isolation: [topp]), (value-laden concept: [qnco]), (research: [resa]), (field: [irda]), (attention: [menp]), (responsibility: [inbe]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social activities, 'Engagement in Social Activities')

PMCID: 5314125
SFARI Genes: mark, mark, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (complex neurodevelopmental disorders: [mobd]), (social: []), ( communication: [socb]), (behavioral deficits: [inbe]), (behavioral interventions: [topp]), (favorable resultshowever: []), (promise: []), (precision medicine: [topp]), (asd: [cgab]), (lack: []), (sensitive: [patf]), ( objective neurobiological markers: [clna]), (subgroups: [virs]), (young children: [aggp]), (specific treatments: [topp]), (such neurobiomarkers: []), (early childhood: []), (sensitive window: [patf]), (opportunity: []), (intervention: [hlca]), (unsuccessful intervention: [hlca]), (families: [famg]), (society: [orgt]), (functional magnetic resonance: [npop]), (imaging-based stratification neurobiomarkers: [diap]), (responses: [orga]), (evidence-based behavioral treatmentpivotal response treatment: [topp]), (neural predictors: []), (pretreatment levels: [acty]), (activity: [acty]), (response: [fndg]), (biological vs: []), (motion: [npop]), (neural circuits: [bpoc]), (social information: []), ((superior temporal sulcus: [bsoj]), ( fusiform gyrus: [bsoj]), ( amygdala: [bpoc]), (inferior parietal cortex: [bpoc]), (superior parietal lobule): [bpoc]), (social motivation/reward: [menp]), ((orbitofrontal cortex: [blor]), ( insula: [bpoc]), ( putamen: [bpoc]), ( pallidum: [bpoc]), (ventral striatum): [bpoc]), (predictive value: []), (findings: [clna]), (individual children: [aggp]), (multivariate pattern analysis: [qnco]), (cross validation: [resa]), (particular treatment: [topp]), (current findings: [clna]), (first evidence: [qnco]), (prediction/stratification biomarkers: [clna]), (implications: []), (progress: []), (precise: []), (effective treatments: []), (core deficits: [bdsu]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(complex neurodevelopmental disorders, 'Learning Disorders')(behavioral deficits, 'Personal Traits')(pretreatment levels of activity, 'Abnormal Activity or Energy Level')(social information processing, 'Ability to Convey Information')

PMCID: 5098193
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (effects: []), (seizures: [sosy]), (genetic mutation: [genf]), (known involvement: []), (autism spectrum disorder: [mobd]), (epilepsy: [dsyn]), (neuron-subset: [cell]), (specific (ns)-pten heterozygous (ht): [aapp,enzy]), (wildtype (wt) adult mice: [aggp]), (intraperitoneal injections: [topp]), (kainic acid (20 mg/kg): [orch,phsu]), (status epilepticus: [dsyn]), (vehicle (saline): [sbst]), (animals: [anim]), (battery: [inpo]), (behavioral tasks: [inbe]), (order: [acty]), (activity: [acty]), (levels: []), ( anxiety: [mobd]), ( repetitive-stereotyped behavior: [mobd]), (social behavior: [socb]), ( learning: [menp]), (memory: [menp]), (open field task: [irda]), (ht mice: [mamm]), (significant increase: [qnco]), (total activity: [acty]), (total distance: [qnco]), (surround region: []), (open field: [irda]), (maze task: [topp]), (velocity: [qnco]), (undergo seizures: [sosy]), (wt controls: [fish]), (social chamber test: [lbpr]), (impairment: [patf]), (findings: [clna]), (long-term alterations: []), (mice: [mamm]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(epilepsy, 'Epilepsy')(anxiety, 'Anxiety Disorders')(social behavior, 'Reciprocal Social Interaction')(memory, 'Working Memory')(social behavior, 'Reciprocal Social Interaction')(social behavior, 'Reciprocal Social Interaction')

PMCID: 5943701
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (communicative difficulties: [socb]), (autism spectrum disorder (asd): [mobd]), (striking feature: []), (disorder: [dsyn]), (research: [resa]), (individuals: [humn]), (asd show abnormalities: [cgab]), (brain regions: [blor]), (processing: [acty]), (social information: []), (importantly: []), (recent study: [resa]), (functional nearinfrared spectroscopy (fnirs): [lbpr]), (first evidence: [qnco]), (atypicalities: []), (neural processing: [acty]), (infants: [aggp]), (high familial risk: [famg]), (asd: [cgab]), (findings: [clna]), (important step: [qnco]), (search: [acty]), (early markers: [clna]), (potential: []), (techniques: []), (atypical patterns: [fndg]), (neural activity: [acty]), (manifestation: []), (behavioural symptoms: [sosy]), (study: [resa]), (reduced neural sensitivity: [fndg]), (social stimuli: [phpr]), (independent cohort: [popg]), (twentynine: []), ((13 lowrisk infants: [aggp]), (highrisk infants): [aggp]), (nonsocial visual stimuli: [ortf]), (previous experiment: [resa]), (nonsocial dynamic motion control condition: [npop]), (comparison: [acty]), (nonsocial: []), ( static: []), (dynamic stimuli: [phpr]), (lowrisk infants: [aggp]), (activation: [acty]), (right posterior temporal cortex: [bpoc]), (high risk: [fndg]), (current sample size: [qnco]), (results: [fndg]), (previous work: []), (evidence: []), (social processing difference: [socb]), (risk: []), (autism: [mobd]), (future research: [resa]), (differences: [qnco]), (eventual asd diagnosis: [cgab]), (autism phenotype: [mobd]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(processing of social information, 'Ability to Convey Information')(neural processing of social information, 'Ability to Convey Information')(nonsocial visual stimuli, 'Visual Thinking')(social processing difference in infants, 'Social Competence')(autism, 'Autism Phenotype')(social processing difference, 'Social Competence')(eventual asd diagnosis, 'Diagnosis')(autism phenotype, 'Autism Phenotype')

PMCID: 5771589
SFARI Genes: 
Non SFARI Genes: SST, SST, SST, 
Named Entities: (involvement: []), (children: [aggp]), (adolescents: [aggp]), (autism spectrum disorder (asd): [mobd]), (study: [resa]), (effects: []), (theory: []), (mind performance: [inbe]), ((tompt): []), (high-functioning asd: [cgab]), (tompt (n =: [aapp,imft]), (social skills: [socb]), ((sst; n =: [aapp,imft]), (programs: [phsu]), (participants: [popg]), (groups: [popg]), (mothers: [famg]), (pretraining: []), (chinese version: [lang]), (school bullying experience questionnaire: [mobd]), (paired t test: []), (changes: [qnco]), (victimization: [hcpp]), (perpetration: []), (posttraining assessments: [hlca]), (linear mixed-effect model: [qnco]), (difference: [qnco]), (training effect: [edac]), (tompt: []), (sst groups: [popg]), (severities: []), (self-reported (p = .039): [resa]), (mother-reported (p = .003): [famg]), (assessments: [hlca]), ( whereas: []), (sst group: [popg]), (self-reported bullying victimization: [mobd]), ((p = .027): [aapp,imft]), (sst: [gngm]), (tompt program: [phsu]), (severity: []), (mother-reported bullying victimization (p = .041): [famg]), (present study: [qnco]), (mother-reported bullying victimization: [famg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(reducing bullying involvement in children, 'Poor Treatment by Others in Social Settings')(social skills, 'Ability to Converse in Social Settings')(posttraining bullying involvement of participants, 'Poor Treatment by Others in Social Settings')(school bullying experience questionnaire, 'Poor Treatment by Others in Social Settings')(mother-reported bullying victimization, 'Poor Treatment by Others in Social Settings')(self-reported bullying victimization, 'Poor Treatment by Others in Social Settings')(mother-reported bullying victimization, 'Poor Treatment by Others in Social Settings')(mother-reported bullying victimization, 'Poor Treatment by Others in Social Settings')

PMCID: 5749804
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (novel interventions: [hlca]), (autism spectrum disorder (asd) core symptoms: [mobd]), ( valid: []), ( reliable: []), (sensitive longitudinal outcome measures: [qnco]), (symptom change: []), (time: []), (here: []), (computerized analysis: [resa]), (quantitative facial expression measures: [fndg]), (marker: [clna]), (core asd: [cgab]), (social symptoms: [sosy]), (facial expression intensity values: [fndg]), (interactive situation: []), (autism diagnostic observation schedule (ados): [hlca]), (dedicated software: [acty]), (high-functioning adult males: [aggp]), (asd: [cgab]), (controls: [sbst]), (age-: [orga]), ( gender-: [orga]), ( parental socioeconomic background-: []), ((td) individuals: [humn]), (statistical analyses: [resa]), (values: []), (strength: [qnco]), (variability: []), (facial expression element: [fndg]), (td groups: [popg]), (ados: [aapp,enzy]), (reciprocal social interaction scores: [fndg]), (td controls: [sbst]), (facial expressions: [fndg]), (asd group: [cgab]), (neutral (d =: [fndg]), (p: [gngm]), (pfdr: []), (variation: []), (neutral expression (d: [aapp,imft]), (expressions: [topp]), (happy (d = 0.78: [aapp,imft]), ( p: [aapp,imft]), (happy expression (d: [aapp,imft]), (moreover: []), (neutral facial expressions: [fndg]), (asd participants: [cgab]), (findings: [clna]), (method: [lbpr]), (facial expressivity: [fndg]), (social interactions: [fndg]), (promising marker: [clna]), 
ASD Terms: (autism, 'Autism Phenotype')(quantitative facial expression measures, 'Integrated Verbal and NonVerbal Communication')(facial expression intensity values, 'Integrated Verbal and NonVerbal Communication')(autism diagnostic observation schedule, 'Autism Phenotype')(facial expression element, 'Integrated Verbal and NonVerbal Communication')(reciprocal social interaction scores, 'Reciprocal Social Interaction')(facial expressions, 'Integrated Verbal and NonVerbal Communication')(neutral facial expressions, 'Integrated Verbal and NonVerbal Communication')(facial expressivity, 'Integrated Verbal and NonVerbal Communication')(social interactions, 'Reciprocal Social Interaction')

PMCID: 4706589
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (discriminative ability: [orga]), (autism diagnostic observation schedule: [hlca]), (algorithm (hus: [gngm]), (lord: [gngm]), (j autism dev disord: [mobd]), (dutch males: [orga]), (autism spectrum disorder (asd): [mobd]), (psychopathy: [mobd]), (controls: [sbst]), (algorithm asd cut-off: [cgab]), (original algorithm asd cut-off:: [cgab]), (sensitivity: [patf]), (hus: [gngm]), (lord (2014; i.e: [gngm]), (asd .61: [cgab]), ( ad .53): []), (algorithm ad cut-off: [lbpr]), (improved sensitivity: [patf]), (original algorithm: [lbpr]), (asd: [cgab]), (schizophrenia: [mobd]), (better-balanced sensitivity (.53): [patf]), (specificity (.78): [qnco]), (clinicians differential diagnosis: [diap]), (findings support: [clna]), (algorithm: [lbpr]), (other modules: []), (comparability: []), (lifespan: [grpa]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(clinicians differential diagnosis, 'Diagnosis')

PMCID: 5736092
SFARI Genes: 
Non SFARI Genes: NHS, 
Named Entities: (introduction high rates: [qnco]), (co-occurring depression: [mobd]), (autism spectrum disorder: [mobd]), (neurodevelopmental condition: [mobd]), (social communication impairments: [mobd]), (repetitive behaviours: [inbe]), (cognitive-behavioural interventions: [topp]), (asd: [cgab]), (anxiety problems: [mobd]), (evaluation studies: []), (group: [popg]), (cognitive-behavioural therapy: [topp]), (randomised trials: [resa]), (low-intensity psychological interventions: [hlca]), (clinical guidelines: []), (mild-moderate depression: [mobd]), (methods: []), (analysis a feasibility study: [inpr,resa]), (trial (rct): [resa]), (nested qualitative evaluation: []), (way: []), (preparation: [acty]), (definitive rct: []), (participants: [popg]), (guided self-help:: [inbe]), (low-intensity psychological intervention: [hlca]), (behavioural activation: [inbe]), (treatment: [topp]), (usual: []), (depression symptoms: [sosy]), (social function: [socb]), (service use: [inbe]), (weeks postrandomisation: []), (group allocation: [popg]), (measures: [qnco]), (analysis: [resa]), (rates: [qnco]), (recruitment: [acty]), (retention: [menp]), (larger-scale rct: [qnco]), (appropriate measure: [qnco]), (depression: [mobd]), (primary outcome: [topp]), (qualitative study: [resa]), (treatment group: [popg]), (acceptability: []), (feasibility: []), (intervention: [hlca]), (trial design: []), (ethics: []), (dissemination ethical approval: []), (wales rec: [gngm]), ((iras project id:: [lbpr]), (health research authority: [resa]), (r&d approval: [clna]), (avon: []), (wiltshire mental health partnership: [menp]), (northumberland: []), ( tyne: []), (wear foundation nhs trusts: [inbe]), (knowledge: []), (first study: [qnco]), (low-intensity intervention: [hlca]), (adults: [aggp]), (autism: [mobd]), (results: [fndg]), (design: [acty]), (dissemination: []), (peer-reviewed journal publications: [hlca]), (qualitative research findings: [resa]), (study: [resa]), (presentations: []), (international conferences: [hcpp]), (trial registration number isrctn54650760; pre-results: [resa]), 
ASD Terms: (co-occurring depression, 'Depressive Disorder')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental condition, 'Learning Disorders')(social communication impairments, 'Reciprocal Social Interaction')(repetitive behaviours, 'Restricted and Repetitive Behavior')(anxiety problems, 'Anxiety Disorders')(co-occurring depression, 'Depressive Disorder')(mild-moderate depression, 'Depressive Disorder')(depression symptoms, 'Depressive Disorder')(social function, 'Ability to Converse in Social Settings')(depression, 'Depressive Disorder')(depression, 'Depressive Disorder')(autism, 'Autism Phenotype')

PMCID: 5521115
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (self-regulation: [inbe]), (insistence: []), (sameness (is): []), (common feature: [qnco]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (here: []), (is-self-regulation-anxiety interrelationship: [inbe]), (potential contribution: [acty]), (effortful control (ec): [sbst]), (is-anxiety relationship: [mobd]), (sample: [sbst]), (adolescents: [aggp]), (young adults: [aggp]), (asd: [cgab]), (adults: [aggp]), (asd (49: [cgab]), (females; m age: [orga]), (years: []), ( sd: [mamm]), (range: [qnco]), (adult repetitive behaviour questionnaire-2: [aggp]), ( effortful control scale: [acty]), (adult temperament questionnaire: [aggp]), (dsm-5 dimensional anxiety scales: [mobd]), (is: []), (ec (r = .39: [clna]), ( p = .001): [aapp,imft]), (anxiety (r = .45: [mobd]), ( p < .001): [aapp,imft]), (anxiety: [mobd]), (turn: [fndg]), (ec (r = .44: [clna]), (nature: []), (mediation analyses: [resa]), (serial mediation model: [socb]), (process: [phpr]), (resamples: []), (bootstrapping: [qnco]), (significant indirect effect: [qnco]), (ec: []), (is (b = .06; bca: [gngm]), (ci [.13: [lbpr]), ( .02]): []), (indirect effect: []), (ec (b =: []), (bca: [gngm]), (ci: [gngm]), (mediators: [orch,phsu]), (total effect: [qnco]), ( respectively: []), (study: [resa]), (first exploration: [topp]), (is-anxiety-self-regulation link: [inbe]), (finding: [sosy]), (levels: []), (points: [qnco]), (viable intervention target: [diap]), (is behaviours: [inbe]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(adult repetitive behaviour questionnaire-2, 'Restricted and Repetitive Behavior')(dsm-5 dimensional anxiety scales, 'Anxiety Disorders')(anxiety, 'Anxiety Disorders')(anxiety, 'Anxiety Disorders')(anxiety, 'Anxiety Disorders')

PMCID: 5040731
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (framework analysis: [resa]), (female autism phenotype: [mobd]), (impact: [gngm]), (under-recognition: [menp]), (autism spectrum conditions: [mobd]), (girls: [aggp]), (women: [popg]), (fourteen women: [popg]), (asc: [gngm]), (years): []), (late adolescence: []), (adulthood: []), (in-depth accounts: [clna]), (gender: [orga]), (various professionals: [phsu]), (asc;: []), (conflicts: [inbe]), (traditional feminine identity: [menp]), (experiences: [menp]), (sexual abuse: [mobd]), (sample: [sbst]), (specific vulnerabilities: []), (female: [orga]), (undiagnosed asc: [fndg]), (training: [edac]), (teachers: []), (clinicians recognition: [menp]), (females: [orga]), (timely identification: [menp]), (risks: []), (autism spectrum: [mobd]), 
ASD Terms: (autism spectrum conditions, 'Autism Phenotype')(female autism phenotype, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(undiagnosed autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum, 'Autism Phenotype')

PMCID: 5639250
SFARI Genes: 
Non SFARI Genes: impact, impact, 
Named Entities: (applied: []), (behavior analysis (aba): [resa]), (effective treatment: []), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (many researchers: []), (factors: []), (treatment outcomes: []), (however: []), (few studies: [lbpr]), (treatment intensity: []), (duration: [phsu]), (differential influences: []), (separate skills: [inbe]), (aim: [phsu]), (current study: [resa]), (duration impact: [gngm]), (different treatment domains: [topp]), (academic: [orgt]), ( adaptive: []), ( cognitive: []), ( executive function: [menp]), (language: [lang]), ( motor: []), ( play: [dora]), (social: []), (separate multiple linear regression analyses: [qnco]), (relationships: []), (participants: [popg]), (children: [aggp]), (asd: [cgab]), (months: []), (years: []), (m=7.57 years: [aapp,imft]), ( s.d.=2.37: []), (aba services: []), (results: [fndg]), (significant predictors: [qnco]), (objectives: []), (treatment domains: [topp]), (language domains: [lang]), (response: [fndg]), (effect sizes: []), (treatment duration: []), ( respectively: []), (findings: [clna]), (previous research: [resa]), (total dosage: [qnco]), (treatment: [topp]), (outcomes: []), (extant literature: [inpr,mnob]), (understanding: [menp]), (differential impact: [gngm]), (treatment variables: [topp]), (various treatment domains: [topp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(adaptive, 'Adaptive Life Skills')(cognitive, 'Cognitive Ability')(executive function, 'Executive Function')

PMCID: 5667845
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (adolescence: []), (unique developmental period: [orgf]), (emotional growth: [orgf]), (significant maturation: [phsf]), (social skills: [socb]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (vulnerable period: []), (circumscribed interests (cis): [euka]), (idiosyncratic areas: [fndg]), (intense interest: [menp]), (focus: []), (core symptom: [clna]), (asd: [cgab]), (social development: [socb]), (yet: []), (expression: [topp]), (cis: [gngm]), (adolescents: [aggp]), (many studies: [lbpr]), (images: []), (items: []), (special interest; however: [menp]), (adolescent studies: [aggp]), (goal: []), (study: [resa]), (insight: [menp]), (types: []), (studies: [lbpr]), (end: [gngm]), (mixed methods design: [acty]), (one-on-one interviews: [acty]), (td): []), (categories: []), (high autism interest (hai): [mobd]), (high: [qnco]), (interest (htd): [menp]), (online survey: []), (fifty-three adolescents: [aggp]), (asd (42 male): [cgab]), ((td) adolescents: [aggp]), ((55 male): [orga]), (hai: [gngm]), (htd images: []), (significant interaction: [qnco]), (htd categories: []), (group: [popg]), (category: []), (other: []), (individual category ('celebrities'): [popg]), (significant group effect: [popg]), (td adolescents: [aggp]), (males: [orga]), (hai images: [dsyn]), (social content relative: [qnco]), (findings: [clna]), (neural responses: [orga]), (ci-related stimuli: [phpr]), (stereotypical asd interests: [cgab]), (trains: [orgt]), ( gadgets): []), (represent individual adolescents: [aggp]), (show interests: [menp]), (video games): []), 
ASD Terms: (social skills, 'Ability to Converse in Social Settings')(autism spectrum disorder, 'Autism Phenotype')(intense interest, 'Intense Interests')(core symptom of asd, 'Complaints and Indications')(social development, 'Ability to Converse in Social Settings')(high autism interest, 'Autism Phenotype')(high autism interest, 'Autism Phenotype')(stereotypical asd interests, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 5436824
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (spectrum condition (asc): [dsyn]), (differences: [qnco]), (social interaction: [fndg]), (behavioural inflexibility: [inbe]), (addition: []), (core symptoms: [sosy]), (atypical sensory responses: [orga]), (asc phenotype: [orga]), (anomalous perception: [menp]), ( i.e: [diap,inpr]), (hallucinatory: []), (body experiences: [humn]), (adults: [aggp]), (asc: [gngm]), (thirty participants: [popg]), (asc diagnosis: [fndg]), (thirty neurotypical controls: [sbst]), (cardiff anomalous perception scale (caps): [menp]), (social responsiveness scale (srs-2): [acty]), (caps: [gngm]), (32-item questionnaire: []), (participants: [popg]), (range: [qnco]), (rate: [qnco]), (experiences: [menp]), (srs-2: []), (extent: []), (series: [qnco]), (statements: []), (behaviours: [inbe]), (autism phenotype: [mobd]), (total caps score: [dsyn]), (asc (mean =: [qnco]), (s.d: [clna]), (frequency: [qnco]), (level: [phsu]), (distraction: [topp]), (distress: [menp]), (experience: [menp]), (importantly: []), (anomalous perceptual experiences: [menp]), (sample: [sbst]), (non-autistic participants: [mobd]), (hospital: [hcro,mnob]), (current psychotic episode: [mobd]), (data: [euka]), (high level: [qnco]), (origins: []), (implication: []), (phenomenon: [phpr]), (considered: []), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(atypical sensory responses, 'Reaction to Sensory Stimuli')(anomalous perception, 'Cognitive Ability')(autism spectrum condition, 'Autism Phenotype')(autism spectrum condition diagnosis, 'Diagnosis')(cardiff anomalous perception scale, 'Cognitive Ability')(autism phenotype, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(total cardiff anomalous perception scale score, 'Cognitive Ability')(autism spectrum condition, 'Autism Phenotype')(hospital, 'Hospitalizations')(autism, 'Autism Phenotype')(anomalous perception, 'Cognitive Ability')

PMCID: 4545680
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract accumulating evidence: []), (autonomic signals: [bdsy]), (cortical representations: [bpoc]), (emotional processes: [menp]), (related abnormalities: [cgab]), (social deficits: []), (socioemotional impairments: [patf]), (defining feature: []), (autism spectrum disorder (asd): [mobd]), (empirical evidence: []), (link: []), (autonomic: [bdsy]), ( cortical: [bpoc]), (socioemotional abnormalities: [cgab]), (asd: [cgab]), (study: [resa]), (autonomic arousal: [menp]), (skin conductance responses: [ortf]), (concurrent cortical responses: [bpoc]), (functional magnetic resonance imaging: [diap]), (effective brain connectivity: [bpoc]), (dynamic causal: []), (seventeen unmedicated highfunctioning adults: [aggp]), (controls: [sbst]), (empathyforpain task: []), (adults: [aggp]), (enhanced scr: [gngm]), (empathetic pain: [sosy]), (increased neural activity: [fndg]), (anterior insular cortex: [bpoc]), (behavioral empathetic pain discriminability: [sosy]), (overall scr: [gngm]), (decreased: [qnco]), (asd individuals: [cgab]), (enhanced correlation: [acty]), (scr: [gngm]), (neural activities: [acty]), (importantly: []), (significant group differences: [popg]), (reduction: [npop]), (negative intrinsic connectivity: [fndg]), (asd group: [cgab]), (failure: [inbe]), (anterior insular responses: [orga]), (results: [fndg]), (aberrant interoceptive precision: []), (abnormalities: [cgab]), (autonomic activity: [bdsy]), (central representations: [acty]), (empathy deficits: [inbe]), (hum brain mapp: [bpoc]), (human brain mapping published bywiley periodicals: [diap]), ( inc: []), 
ASD Terms: (social deficits, 'Social Competence')(autism spectrum disorder, 'Autism Phenotype')(empathetic pain, 'Pain')(behavioral empathetic pain discriminability, 'Pain')(underlie empathy deficits, 'Empathy')(empathy deficits, 'Empathy')

PMCID: 4577974
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (describe: []), (autism spectrum database-uk (asd-uk): [mobd]), (representativeness: [acty]), (children: [aggp]), (families: [famg]), (to; (3): [aapp,enzy]), (reliability: [qnco]), (parent-reported autism spectrum disorder (asd) diagnoses: [mobd]), (present evidence: [qnco]), (validity: [qnco]), (diagnoses: [fndg]), (asd; (4): [cgab]), (asd-uk children: [cgab]), (characteristics: []), (regional database: []), (asd living: [cgab]), (north east (daslne): []), (epidemiological studies: [resa]), (recruitment: [acty]), (network: [popg]), (uk child health teams: [hlca]), (self-referral: [hlca]), (patients parents/carers: [podg]), (child: [aggp]), (asd: [cgab]), (years: []), (questionnaires: []), (professionals reports: [hlca]), (asd-uk: [cgab]), (months: []), (similar on: gender: [orga]), (ratio: [qnco]), ( year: []), (birth: [orgf]), ( asd diagnosis: [cgab]), (social deprivation score: [clna]), (parent-reported asd diagnoses: [cgab]), (clinical reports: []), (database child: [aggp]), (comparison: [acty]), (gender: [orga]), ( age: [orga]), (diagnosis: [fndg]), ( school placement: [mnob,orgt]), (disability: [fndg]), (deprivation score: [clna]), (daslne: []), (population studies: [resa]), (asd-uk families: [cgab]), (asd overall: [cgab]), (parent-reported data: [resa]), (family: [famg]), (uk children: [aggp]), (databases: []), (researchers: []), (uk autism research: [mobd]), 
ASD Terms: (autism spectrum database-uk, 'Autism Phenotype')(parent-reported autism spectrum disorder diagnoses, 'Autism Phenotype')(autism spectrum database-uk children, 'Autism Phenotype')(autism, 'Autism Phenotype')(asd diagnosis, 'Diagnosis')(asd diagnosis, 'Diagnosis')(asd diagnosis, 'Diagnosis')(autism spectrum database-uk, 'Autism Phenotype')(asd diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')(autism spectrum database-uk families, 'Autism Phenotype')(uk autism research, 'Autism Phenotype')

PMCID: 5843146
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (behavioural components: [inbe]), (attitudes: [menp]), (various stages: [phsu]), (siblings lifespan: [famg]), (clinicians: []), (support: []), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (families: [famg]), (however: []), (research: [resa]), (adolescent siblings: [famg]), (asd: [cgab]), (south african context towards: [fndg]), (sibling: [famg]), (primary aim: [phsu]), (study: [resa]), (adolescents: [aggp]), (past attitudes: [menp]), (present attitudes: [menp]), (thirty: [qnco]), (siblings: [famg]), (survey: []), (lifespan sibling relationship scale: [socb]), (cross-sectional design: [acty]), (results: [fndg]), (measure: [qnco]), (internal consistency: [qnco]), (sample: [sbst]), (wilcoxon: []), (signed-ranks tests: [lbpr]), (significant differences: [qnco]), (mean values: [qnco]), (self-reported time periods: [resa]), (friedman analysis: [resa]), (variances (anovas): [qnco]), (components: []), (affect: [menp]), ( behaviour: [inbe]), (cognition: [menp]), (participants: [popg]), (positive attitudes: [menp]), (current emotions towards: [menp]), (beliefs: []), (current interaction experiences: [menp]), (siblings attitudes: [famg]), (time: []), ( clinicians: []), (lifespan approach: [grpa]), (supports: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(cognition, 'Cognitive Ability')

PMCID: 5573942
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (abstract individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (range: [qnco]), (health: []), ( community: []), (social support needs: [socb]), (lifespan: [grpa]), (agespecific challenges: [hlca]), (service sectors: []), (study: [resa]), (priority needs: [menp]), (individuals: [humn]), (asd: [cgab]), (factors: []), (priority services: [menp]), (participants: [popg]), (canadawide online caregiver survey: []), (age groups: [aggp]), (elementary school age: [orga]), (adulthood: []), ( adulthood): []), (priority receipt: [menp]), (ratio: [qnco]), (current services: [npop]), (priority need: [menp]), (agestratified poisson regression analyses: []), (systemic predictors: []), (results: [fndg]), (distribution: []), (priority: [menp]), (age: [orga]), (social skills: [socb]), (groups: [popg]), (number: [qnco]), (moderate priority needs: [menp]), (overall: []), (none: []), (systemic factors: []), (patterns: []), (correlates: []), (use: []), (different age groups: [aggp]), (policies: []), (service access: []), (autism res: [mobd]), (international society: [orgt]), (autism research: [mobd]), ( wiley periodicals: []), ( inc: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(except for social skills, 'Ability to Converse in Social Settings')(social skills, 'Ability to Converse in Social Settings')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 5656100
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (case study: []), (effort: [orgf]), (children/adolescents: [aggp]), (autism spectrum disorder (asd) experience improvement: [mobd]), (comorbid adhd: [mobd]), (cogmed working memory training (cwmt): [menp]), (treatment intervention: [hlca]), (adhd symptoms: [mobd]), (children: [aggp]), (adolescents; however: [aggp]), (studies: [lbpr]), (use: []), (individuals: [humn]), (asd: [cgab]), (material/ cwmt: [sbst]), (computer-based program: [inpr,mnob]), (auditory: []), (visual: []), ( visual spatial: [gngm]), (exercises: [dora]), (minutes: [qnco]), (days: []), (week: []), (weeks: []), (fifteen children/adolescents: [aggp]), (ages: [bacs,orch]), (years: []), (adhd: [mobd]), (trial: [resa]), (cwmt: []), (1-month follow-up: [hlca]), (longitudinal follow-ups: [neop]), (retrospective chart analysis: [resa]), (follow-up demonstrated improvement: [hlca]), (attention: [menp]), (focus: []), ( impulsivity: [inbe]), ( emotional reactivity: [fndg]), (academic achievement: [fndg]), (benefits: [qnco]), (time: []), (number: [qnco]), (participants: [popg]), (social interaction/social awareness: [menp]), (effective treatment intervention: [hlca]), (adolescents: [aggp]), (benign computer-based nature: []), (unique learning style: [fndg]), (population: [popg]), (authors: []), (paper: []), (others: [fndg]), (ability: [orga]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum disorder experience improvement, 'Autism Phenotype')(comorbid adhd, 'Comorbidities')(cogmed working memory training, 'Working Memory')(adhd symptoms, 'Attention Deficit Disorder with Hyperactivity')(improve adhd symptoms, 'Attention Deficit Disorder with Hyperactivity')(material/ cogmed working memory training, 'Working Memory')(visual, 'Visual Thinking')(visual spatial, 'Visual Thinking')(memory training, 'Working Memory')(memory training, 'Working Memory')(adhd symptoms, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 6331502
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (relation: [socb]), (vocal emotion: [menp]), (vocal pitch perception abilities: [menp]), (adults: [aggp]), (high-functioning autism spectrum disorder (asd): [mobd]), (pairwise: []), (typical development: [orgf]), (asd group: [cgab]), (typical non-vocal pitch: [ortf]), (vocal timbre perception abilities: [orga]), (accurate vocal emotion perception: [menp]), (comparison group: [popg]), (vocal emotion perception abilities: [orga]), (traits: [gngm]), (symptoms: [sosy]), (asd: [cgab]), (vocal pitch: [ortf]), (results: [fndg]), (vocal emotion recognition difficulties: [menp]), (difficulties: [fndg]), (complex social tasks: [chvs]), (processing: [acty]), (basic sensory features: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1007/s10803-018-3681-z) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (vocal emotion, 'Vocalizations')(vocal pitch perception abilities, 'Cognitive Ability')(high-functioning autism spectrum disorder, 'Autism Phenotype')(vocal timbre perception abilities, 'Cognitive Ability')(accurate vocal emotion perception, 'Visual Perception')(vocal emotion perception abilities, 'Visual Perception')(vocal pitch, 'Vocalizations')(vocal emotion recognition difficulties, 'Vocalizations')(difficulties with complex social tasks, 'Social Competence')

PMCID: 5530457
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (lack: []), (agreement: [socb]), (functional connectivity differences: [qnco]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (studies: [lbpr]), (absolute strength: [qnco]), (connectivity: []), (relative strengtha measure: [qnco]), (system topologyreveal: []), (mixed findings: [clna]), (functional connectivity: []), (resting-state echo planar: [topp]), (t: [clna]), (functional magnetic resonance imaging scans: [diap]), (siemens verio scanner: [qnco]), (17-year-old youth: [aggp]), (asd (n =: [cgab]), (control group (n: [grup]), (functional time series data: [euka]), (confound regression procedure: [menp]), (large-scale developmental datasets: [orgf]), (influence: []), (motion artifact: [npop]), (connectivity data: [euka]), (time series data: [euka]), (333-node parcellation scheme: [bpoc]), (functional systems: [bdsy]), (pearsons correlation: []), (fishers z: [mamm]), (pair: []), (nodes: [bpoc]), (adjacency matrix: []), (mean: [qnco]), (functional connectivity strength: [qnco]), (mean fishers z: [qnco]), (matrix: [phsu]), (relative functional connectivity: [qnco]), (individual differences: [menp]), (mean absolute functional connectivity (i.e.: [diap,inpr]), (connection: []), (mean z): [qnco]), (functional networks: []), (parcellation scheme: []), (absolute: []), (asd: [cgab]), (asd symptom severity: [cgab]), (asd group: [cgab]), (ventral attention: [menp]), (retrosplenial-temporal systems: []), (cross-system: []), (somatomotor-mouth systems: [bsoj]), (retro-splenial systems: [bpoc]), (context: [fndg]), ( youth: [aggp]), (atypical topology: [fndg]), (brain systems: [bpoc]), (social perception: [menp]), (communication: [socb]), (study: [resa]), (mixed results: [fndg]), (observed direction: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0156-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(asd symptom severity, 'Complaints and Indications')(social perception, 'Cognitive Ability')

PMCID: 6173917
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (many young people: [popg]), (autism spectrum disorder (asd) experience: [mobd]), (behavioural problems: [mobd]), (however: []), (causes: []), (co-occurring difficulties: [fndg]), (perceptual processing atypicalities: [acty]), (individuals: [humn]), (asd: [cgab]), (few studies: [lbpr]), (objective measurement: []), (perceptual processing: [acty]), (event-related potentials: [ortf]), (response: [fndg]), (deviant stimuli: [phpr]), (pitch): [qnco]), (auditory oddball paradigm: [resa]), (adolescents: [aggp]), ((mean age: [orga]), (years: []), ( sd: [mamm]), (range: [qnco]), (asd (n: [cgab]), (wide range: [qnco]), (iq (mean iq: [qnco]), (sd: [gngm]), (stimuli (as: [phpr]), (mismatch negativity (mmn)): [fndg]), (presentations: []), (standard stimuli: [phpr]), (measured: [diap]), (multivariate regression: [menp]), (association: [menp]), (neural indices: [lbpr]), (greater sensitivity: [patf]), (changes: [qnco]), (pitch: [qnco]), (auditory information (discrimination): [socb]), (increased mmn amplitude: [qnco]), (levels: []), (parent-rated behaviour problems: [mobd]), (mmn amplitude: []), (trend: []), (positive correlation: [fndg]), (parent-rated sensory hyper-sensitivity: [mobd]), (conversely: []), (habituation: [mobd]), (later n2 component: [elii]), (emotional problems: [mobd]), (detailed analyses: [resa]), (erp response: [fndg]), (first (but: [qnco]), (third) standard stimuli: [qnco]), (similar pattern: []), (other measures: [qnco]), (anxiety: [mobd]), (results: [fndg]), (covariation analyses: [resa]), (age: [orga]), ( sex: [orgf]), (iq: []), (problems: []), (asd severity: [cgab]), (findings: [clna]), (alterations: []), (mechanisms: []), (discrimination: [socb]), (young people: [popg]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0236-2) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')(behavioural problems, 'Personal Traits')(levels of parent-rated behaviour problems, 'Personal Traits')(parent-rated behaviour problems, 'Personal Traits')(anxiety, 'Anxiety Disorders')(behaviour problems, 'Personal Traits')(behavioural problems in young people, 'Personal Traits')

PMCID: 5575423
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (parent training programs: [phsu]), (families: [famg]), (urban areas: []), (social behavior: [socb]), (communication skills: [orga]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (however: []), (review: []), (programs: [phsu]), (aim: [phsu]), (study: [resa]), ((1): [fndg]), (evidence: []), (studies: [lbpr]), (parent-mediated intervention training: [edac]), (parents: []), (asd: [cgab]), (urban areas; (2): [qnco]), (overview: []), (current parent training interventions: [hlca]), (population; (3): [popg]), (method: [lbpr]), (delivery: [topp]), (parent training interventions: [hlca]), (population: [popg]), (preferred reporting items: [hlca]), (systematic reviews: []), (meta-analyses: [resa]), ((prisma) statement: [orch,phsu]), (comprehensive review: []), (electronic databases: [fndg]), (embase: []), ( eric: [gngm]), ( psycinfo: []), (pubmed): []), (july: []), (urban centers: []), (child: [aggp]), (independent researchers: [fndg]), (articles: []), (inclusion: [celc]), (assessment: [acty]), (methodological quality: [resa]), (kmet appraisal checklist: []), (seven studies: [lbpr]), (eligibility criteria: []), (prepost cohort: [popg]), (multiple baseline studies: [bodm]), (trials: [resa]), (interventions: [hlca]), (self-guided websites:: []), (therapist assistance (n=6): [socb]), (training videos: [edac]), (manuals: [inpr,mnob]), (videoconferencing: [mcha]), (post intervention: []), ( studies: [lbpr]), (significant improvements (p<.05): [aapp,imft]), (parent knowledge (n=4): [fndg]), ( parent intervention fidelity (n=6): [aapp,imft]), (improvements: []), (childrens social behavior: [socb]), (high risk: [fndg]), (bias: [bird]), (range: [qnco]), (factors: []), (small sample sizes: [sbst]), (use: []), (standardized outcome measures: [qnco]), (lack: []), (control groups: [grup]), (confounding factors: []), (preliminary evidence: []), (parent knowledge: [fndg]), ( increase parent intervention fidelity: [socb]), (low number: [qnco]), (rcts: []), ( difficulty: [fndg]), (locality: []), (paucity: []), (standardized measures: [qnco]), (generalization: [menp]), (findings: [clna]), (target population: [popg]), (future studies: [lbpr]), (appropriateness: []), (feasibility: []), (utilize standard outcome measures: [qnco]), 
ASD Terms: (communication skills in children, 'Reciprocal Social Interaction')(social behavior, 'Reciprocal Social Interaction')(communication skills, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(delivery, 'Perinatal History')(social behavior, 'Reciprocal Social Interaction')(childrens social behavior, 'Reciprocal Social Interaction')(communication skills for children, 'Reciprocal Social Interaction')

PMCID: 6044100
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (research: [resa]), (diagnostic procedures: [diap]), (autism spectrum disorder: [mobd]), (practice: [menp]), (diagnostic rates: [qnco]), (social drivers: [popg]), (purpose: []), (review: []), (content: [menp]), (clinical practice guidelines: []), (diagnoses: [fndg]), (uk;: []), (where: []), (guidelines: []), ( social factors: [grpa]), (influences: []), (multiple databases: [qnco]), (evidence base; trip; social policy: [gora,inpr]), (practice; us national guidelines clearinghouse; hmic;: [orch]), (cochrane library; embase; global health; ovid; psycharticles; psychinfo): [gngm,nnon]), (relevant web sources: [fndg]), (regional nhs websites): [cgab,dsyn]), (details: []), (key diagnostic elements: [elii]), (assessment process: [hlca]), (diagnostic tools: [fndg]), (qualitative narrative analysis: []), (social factors: [grpa]), (documents: []), (recommendations: []), (use: []), (assessment procedures: [hlca]), (multidisciplinary assessment: [diap]), (ideal: []), (healthcare professional: []), (contextual areas: []), (complexity: [chvs]), (few concrete recommendations: [qnco]), (factors: []), (diagnostic outcomes: [fndg]), (individual guidelines: [humn]), (coherent: [fndg]), (systematic assessment process: [hlca]), (choices: [inbe]), (professionals: []), (confusing: []), (explicit acknowledgement: []), (advice: [hlca]), (consistency: [qnco]), (transparency: []), (diagnosis: [fndg]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s12888-018-1800-1) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(diagnosis, 'Diagnosis')

PMCID: 6284419
SFARI Genes: NRG1, NRG1, NRG1, NRG1, NRG1, NRG1, NRG1, NRG1, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (pediatric heterogeneous psychiatric: [orga]), (neurodevelopmental disorder: [mobd]), (communication deficits: [socb]), ( language impairment: [mobd]), (repetitive behaviors: [fndg]), (asd: [cgab]), (significant genetic bases: [chvf]), (candidate genes: [gngm]), (molecular mechanisms: []), (disorder: [dsyn]), (neuregulin1 (nrg1) gene: [gngm]), (development: [orgf]), (central nervous system: [bdsy]), (candidate gene: [gngm]), (schizophrenia: [mobd]), (mrna level: [bacs,nnon]), (types i: []), ( ii: []), (iii: []), (nrg1 gene: [gngm]), (peripheral blood: [bdsu]), (asd patients: [cgab]), (control children: [aggp]), (quantitative real time pcr: [mbrt]), (domains: []), (executive functions: [menp]), (memory: [menp]), ( response inhibition: [acty]), (vigilance): [menp]), (subjects: [humn]), (findings: [clna]), (types: []), (significant deficiencies: [dsyn]), (ef deficiencies: [dsyn]), (down expression: [topp]), (correlations: []), (nrg1 expression: [aapp,bacs]), (gender: [orga]), (severity: []), (asd symptoms: [cgab]), (interpretations findings: [clna]), (involvement: []), (nrg1: [gngm]), (etiology: []), (correlation: []), (level: [phsu]), (lights: [npop]), (ef mechanisms: []), (targeted treatments: [topp]), (particular executive functions: [menp]), (fund young researchers: [qnco]), (club: [orgt]), (project: []), (annual grant: [qnco]), (special talents: [menp]), (arvin haghighatfard: [aapp,enzy,phsu]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(language impairment, 'Language Ability')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(executive functions, 'Executive Function')(executive functions, 'Executive Function')(executive functions deficiencies, 'Executive Function')(asd symptoms, 'Complaints and Indications')(executive functions deficiencies, 'Executive Function')(executive functions mechanisms, 'Executive Function')(particular executive functions, 'Executive Function')

PMCID: 5584522
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (neuropeptide oxytocin: [aapp,horm,phsu]), (promise: []), (treatment: [topp]), (symptoms: [sosy]), (autism spectrum disorders: [mobd]), (however: []), (clinical research progress: [resa]), (poor understanding: [grpa]), (oxytocins doseresponse: [resa]), (sub-optimal intranasal delivery methods: [topp]), (doses: [qnco]), (oxytocin: [aapp,horm,phsu]), (novel breath powered intranasal delivery device: [hcpp]), (direct nose-to-brain activity: [bpoc]), (double-blind: [resa]), ( crossover: [resa]), ( randomized: [resa]), (placebo-controlled trial: [resa]), (randomized sequence: [nusq]), (single-dose sessions: [fndg]), (male adults: [aggp]), (asd: [cgab]), (international units: [qnco]), (placebo: [topp]), (social-cognitive tasks: [socb]), (omnibus main effect: []), (primary outcome measure: []), (overt emotion salience: [menp]), (emotional ratings: [menp]), ((2=0.18): [qnco]), (d=0.63): [aapp,imft]), (significant increase: [qnco]), (treatment (p=0.12: [topp]), ( d=0.4): [aapp,imft]), (effects: []), (peripheral blood plasma oxytocin concentrations: [bdsu]), (significant effects: [qnco]), (mind: [menp]), (eyes task performance: [topp]), (secondary outcome social-cognitive tasks: [neop]), ((emotional dot probe: [topp]), (face-morphing): [orch,phsu]), (knowledge: []), (first trial: [resa]), (dose-dependent effects: [qnco]), (single oxytocin administration: [fndg]), (results: [fndg]), (low dose: [qnco]), (minimal systemic exposure: [clna]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(sub-optimal intranasal delivery methods, 'Perinatal History')(novel breath powered intranasal delivery device, 'Perinatal History')(eyes task performance, 'Task Performance')(minimal systemic exposure, 'Exposures')

PMCID: 4577211
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (core features: [bdsu]), (autism spectrum disorder (asd): [mobd]), (impaired reciprocal social interaction: [mobd]), (emotional information: [menp]), (social robots: []), (children: [aggp]), (asd: [cgab]), (initiative: [menp]), (robotic tools: []), (emotional responses: [menp]), (however: []), (evidence: []), (poor trial designs: [resa]), (purpose: []), (study: [resa]), (computational evidence: [acty]), (support: []), (robot-assisted therapy: [hlca]), (emotional model: [menp]), (bayesian model: []), (uncanny valley effect: []), (human-looking robot: [humn]), (repulsion: [menp]), (sensations: [ortf]), (eeriness: []), (unique emotional responses: [menp]), (robots: []), (unique emotional response curve: [menp]), (cliff: []), (valley: []), (thus: []), (numerical simulations: [resa]), (effects: []), (results: [fndg]), (stimulus: [phpr]), (uncanny valley: []), (typical condition: [dsyn]), (uncanny cliff: []), (asd condition: [cgab]), (consequently: []), ( individuals: [humn]), (emotional response: [menp]), (humans: [humn]), (typical individuals: [humn]), (model: []), (human-looking robots: [humn]), (potential advantages: []), (social interactions: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(impaired reciprocal social interaction, 'Reciprocal Social Interaction')(emotional responses, 'Empathy')(unique emotional responses, 'Empathy')(unique emotional response curve, 'Empathy')(emotional response, 'Empathy')(social interactions, 'Reciprocal Social Interaction')

PMCID: 5457440
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (faces: [blor]), (valuable information: []), (social cognition: [socb]), (effective interpersonal interaction: [socb]), (non-verbal communication: [menp]), (face perception: [menp]), (autism: [mobd]), (origin: []), (deficit: [dsyn]), (dominant featural face encoding: [blor]), (face: [gngm]), (scarcity: []), (face-n-food paradigm: [blor]), (individuals: [humn]), (autistic spectrum disorders: [mobd]), (key benefit: [qnco]), (images: []), (single components: [fndg]), (trigger face processing: [clna]), (spontaneous recognition task: [menp]), ( adolescents: [aggp]), (controls: [sbst]), (set: [menp]), (face-n-food images: [blor]), (different degree: [qnco]), (giuseppe arcimboldo style): []), (predetermined order: [acty]), (thresholds: []), (recognition: [menp]), (asd individuals: [cgab]), (controls:: [sbst]), (face responses: [blor]), (outcome: []), (support: []), (atypical face tuning: [blor]), (novel insights: [menp]), (deficits: []), 
ASD Terms: (social cognition, 'Cognitive Ability')(effective interpersonal interaction, 'Interpersonal Interactions')(face perception, 'Cognitive Ability')(autism, 'Autism Phenotype')(autistic spectrum disorders, 'Autistic Disorder')(trigger face processing, 'Integrated Verbal and NonVerbal Communication')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5282530
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (sensory disturbance: [dsyn]), (socio-emotional problems: [mobd]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (studies: [lbpr]), (sensory symptoms: [fndg]), (self-reports: [resa]), (language ability: [menp]), (self-awareness: [menp]), (study: [resa]), (contact heat-evoked potentials: [ortf]), (asd individuals: [cgab]), (clinical correlates: []), (chep parameters: [fndg]), (pain: [sosy]), (years): []), (typically-developing controls: [sbst]), (self-reported sensory symptoms: [fndg]), (attention/socio-emotional symptoms: [menp]), (p2-wave amplitudes: [ortf]), (td: []), (similar level: [phsu]), (p2-wave amplitude: [ortf]), (scores: [clna]), (low registration: [mcha]), ( attention: [menp]), (attention: [menp]), (difficulties.: [fndg]), (n2-wave latency: [diap]), (sensory sensitivity: [patf]), (socio-emotional problems;: [mobd]), (: []), (overall autistic severity: [mobd]), (findings: [clna]), (attenuated chep response: [fndg]), (asd: [cgab]), (potential role: [socb]), (chep: []), (sensory disturbances: [dsyn]), 
ASD Terms: (sensory disturbance, 'Reaction to Sensory Stimuli')(autism spectrum disorder, 'Autism Phenotype')(language ability, 'Development or Regression of Language Skills')(investigate sensory disturbance by contact heat-evoked potentials, 'Reaction to Sensory Stimuli')(pain, 'Pain')(pain, 'Pain')(studying sensory disturbances in asd, 'Reaction to Sensory Stimuli')(sensory disturbances, 'Reaction to Sensory Stimuli')

PMCID: 5216408
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (atypical trajectory: [fndg]), (brain maturation: [ortf]), (developmental abnormalities: [cgab]), (brain function: [ortf]), (current study: [resa]), (effect: []), (age: [orga]), (amplitude: []), (low-frequency fluctuations: [sosy]), (asd: [cgab]), (typical controls: []), (cross-sectional design: [acty]), (participants: [popg]), (age cohorts: child (<11: [aggp]), (adolescent (1118: [aggp]), (adult (18: [aggp]), (two-way analysis: [resa]), (variance (anova): [qnco]), (main effects: []), (interaction effects: []), (whole brain alff maps: [aapp,bacs]), (results: [fndg]), (significant main effect: [qnco]), (diagnosis: [fndg]), (decreased alff: [qnco]), (right precuneus: [bpoc]), (middle occipital gyrus: [bpoc]), (developmental stages: []), (significant diagnosis-by-age interaction: [fndg]), (medial prefrontal cortex (mpfc): [celc]), (alff: []), (autistic children: [podg]), (autistic adolescents: [mobd]), (adults: [aggp]), (specifically: []), (remarkable quadratic change: [qnco]), (mpfc: []), (tc group: [elii]), (additionally: []), (abnormal alff values: [qnco]), (diagnosis-related brain regions: [blor]), (social deficits: []), (findings: [clna]), (aberrant developmental patterns: [orgf]), (spontaneous brain activity: [phsf]), (crucial role: [socb]), (default mode network: [popg]), (development: [orgf]), (disease: [dsyn]), 
ASD Terms: (developmental abnormalities in brain function, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(developmental abnormalities, 'Learning Disorders')(diagnosis, 'Diagnosis')(social deficits in asd, 'Social Competence')(social deficits, 'Social Competence')(social deficits in asd, 'Social Competence')

PMCID: 4573091
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (functional pathology: [patf]), (default mode network: [popg]), (social-cognitive impairment: [mobd]), (autism spectrum disorders: [mobd]), (altered: []), (functional connectivity: []), (default mode: [qnco]), (network's midline core: [popg]), (potential endophenotype: []), (social deficits: []), (asd: [cgab]), (generalizability: []), (prior studies: [lbpr]), (inclusion: [celc]), (medicated participants: [popg]), (methods: []), (restricted examination: []), (network function: [popg]), (study: [resa]), (resting-state functional connectivity: [fndg]), (year-old non-medicated children: [phsu]), (controls: [sbst]), (network segregation: [socb]), (functional connectivity methods: [topp]), (asd group: [cgab]), (over-functional connectivity: []), (non-default mode regions: [qnco]), ( respectively: []), (asd symptoms: [cgab]), (connection strength: [qnco]), (coremedial prefrontal cortexposterior cingulate cortex: [bpoc]), (network segregation analysis: [socb]), (participation coefficient: [qnco]), (area: []), (curve: []), (findings: [clna]), (pattern: []), (poor segregation: [socb]), (functional connectivity metrics: [orch,phsu]), (potential: []), (functional connection: []), (midline core: [bdsu]), (endophenotype: []), (excitation/inhibition imbalance model: [acty]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(potential endophenotype for social deficits, 'Social Competence')(social deficits, 'Social Competence')(medicated participants, 'Medications')(asd symptoms, 'Complaints and Indications')(endophenotype for social deficits, 'Social Competence')

PMCID: 4501115
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (impairments: [patf]), (social interaction: [fndg]), (communication: [socb]), (patterns: []), (behaviour: [inbe]), (unusual sensory sensitivities: [fndg]), (hypotheses: []), (adult patients: [aggp]), (asd: [cgab]), (caries: [dsyn]), (risk factors: [qnco]), (caries development: [dsyn]), (utilize dental health care: [topp]), (extent: []), (people: [popg]), (normal population: [popg]), (forty-seven adults: [aggp]), ( (25: []), (women: [popg]), ( mean age: [orga]), (years): []), (normal intelligence: [fndg]), (sex-matched typical controls: [orgf]), (dental examination: [diap]), (questionnaires: []), (oral health: [hlca]), (dental hygiene: [inbe]), (dietary habits: [inbe]), (previous contacts: [hlca]), (dental care: [topp]), (increased number: [qnco]), (buccal gingival: [bpoc]), (adults: [aggp]), (control group: [grup]), (group: [popg]), (frequent brushing: [topp]), (teeth: [bpoc]), (mornings: []), (stimulated saliva secretion: [ortf]), (asd group: [cgab]), ( regardless: []), (medication: [phsu]), (frequencies: []), (dental care contacts: [topp]), (groups: [popg]), (common reason: [qnco]), (dental appointment: [hlca]), (gingival recessions: [dsyn]), (saliva flow: [bdsu]), (healthy controls: []), (equal caries: [dsyn]), (risk: []), (reduced oral health: [hlca]), (decreased salivary flow: [npop]), (consideration: [fndg]), (planning dental care: [topp]), (patients: [podg]), (written reminders: [fndg]), (dental appointments: [hlca]), (verbal report: []), (oral health status: [fndg]), (oral hygiene instructions: [topp]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(restricted patterns of behaviour, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorder, 'Autism Phenotype')(dental hygiene, 'Hygiene')(medication, 'Medications')(planning dental care for patients, 'Planning')(planning dental care, 'Planning')(oral hygiene instructions, 'Hygiene')

PMCID: 6008282
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (development: [orgf]), (brain connectivity: [bpoc]), (white matter abnormalities: [patf]), (dyscoordination: [sosy]), (activity: [acty]), (brain regions: [blor]), (rise: []), (features: []), (little consensus: [socb]), (nature: []), ( timing: []), (location: [blor]), (diffusion-weighted mri: [diap]), (inconsistent findings: [clna]), (small sample: [sbst]), (sizes: []), ( motion confounds: [npop]), (sample heterogeneity: [orga]), (different age: [orga]), (studies: [lbpr]), (microstructural integrity: [inbe]), (major white matter tracts: [tisu]), (relation: [socb]), (age: [orga]), (asd: [cgab]), ((td) participants: [popg]), (diffusion-weighted scans: [orga]), (strict data-quality criteria: [clna]), (group: [popg]), (motion: [npop]), (overall group differences: [popg]), (diffusion: [npop]), (groups: [popg]), (different relations: [socb]), (td group: [popg]), (positive correlations: [fndg]), (fractional anisotropy: [npop]), (parallel: [resa]), ( axial diffusivity: []), (td: []), (inverse correlations: []), (participants: [popg]), (axial diffusivity: []), (td peers: [popg]), (opposite: []), (affected tracts: [bpoc]), (cingulum bundle: [bpoc]), ( inferior: [socb]), (superior longitudinal fasciculi: [bpoc]), (association bundles: [menp]), (emotional functions: [menp]), (manifestations: []), (abnormal white matter development: [tisu]), (diffusion-weighted mri depend: [diap]), (altered white matter development: [tisu]), (childhood: []), (early adulthood: [aggp]), (abnormal brain function: [ortf]), (contribute: [acty]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(showed different relations with age, 'Relating to Others')(manifestations of abnormal white matter development, 'Learning Disorders')(abnormal white matter development, 'Learning Disorders')

PMCID: 4562099
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objective: []), (study: [resa]), (discuss: [socb]), (proposals: []), (diagnostic comorbidity: [fndg]), (depression: [mobd]), (children: [aggp]), (adolescents: [aggp]), (autism spectrum disorder (hfasd): [mobd]), (following aspects: [qnco]), ((1) prevalence: [qnco]), (elevated depression rate: [mobd]), (need: []), (longitudinal studies: [resa]), (prevalence: [qnco]), (incidence: [qnco]), (level: [phsu]), ( autistic symptoms: [mobd]), ( gender: [orga]), (age: [orga]), ( type: [qnco]), ( prognosis: [hlca]), ( duration: [phsu]), (treatment: [topp]), (explicative hypotheses: []), (vulnerability: []), (factors: []), (specific risk: []), (cognitive functioning: [menp]), ( self-awareness: [menp]), (deficit: [dsyn]), ( capacity: [qnco]), (introspection: []), (stressful life events: [evnt]), (adolescence: []), ( quality: []), (social relationships: []), (alexithymia: [sosy]), ((3) risk: [fndg]), (suicide: [fndg]), (control: [sbst]), (detection: [topp]), (suicidal tendencies: [fndg]), (bullying: [mobd]), (depressive symptoms: [sosy]), (indicators: [irda]), (early detection: [diap]), (overlap: [topp]), (hfasd: []), (assessment techniques: [resa]), (specific adapted tests: [lbpr]), 
ASD Terms: (diagnostic comorbidity, 'Comorbidities')(depression, 'Depressive Disorder')(autism spectrum disorder, 'Autism Phenotype')(depression, 'Depressive Disorder')(elevated depression rate, 'Depressive Disorder')(autistic symptoms, 'Complaints and Indications')(cognitive functioning, 'Cognitive Ability')(suicide, 'Depressive Disorder')(suicidal tendencies, 'Depressive Disorder')(bullying, 'Poor Treatment by Others in Social Settings')(depressive symptoms, 'Depressive Disorder')(specific adapted tests, 'Adaptive Life Skills')

PMCID: 5966929
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (past studies: [lbpr]), (robot-based intervention: [hlca]), (gestural use: [socb]), (children: [aggp]), (autism spectrum disorders: [mobd]), (present study: [qnco]), (asd: [cgab]), (level: [phsu]), (gestural production: [socb]), (age-matched children: [aggp]), (typical development: [orgf]), (increase: []), (verbal imitation: [socb]), (completion: []), (robot-based training: [edac]), (cognitive: []), (motor skills: [orgf]), (gestural learning: [socb]), (groups: [popg]), (6-year-old children: []), (intervention group (n: [popg]), (30-min robot-based gestural training sessions: [socb]), (session: [evnt]), (social robot: []), ( nao: [orch,phsu]), (stories: []), ((e.g.: []), (hands: [bpoc]), (awesome expression): [topp]), (gestures: [socb]), (training: [edac]), (wait-list control group (n: [grup]), (typical development (n: [aapp,imft]), (gestural training: [socb]), (research: [resa]), (standardized pretests: [hlca]), (posttests: []), (delayed): []), (accuracy: []), (appropriateness: []), (novel stories: []), (childrens language: [lang]), (communication: [socb]), (gestural recognition skills: [socb]), (fine motor proficiencies: []), (attention skills: [menp]), (intervention condition: [dsyn]), (accurate: []), (appropriate intransitive gestures: [socb]), (wait-list control: [sbst]), (positive learning outcomes: [menp]), (delayed posttests: []), (gestural production accuracy: [socb]), (delayed posttest: []), (verbal markers: [clna]), (learning: [menp]), (such relation: [socb]), (spontaneous imitation: [socb]), (gestural delay: [socb]), (early childhood: []), 
ASD Terms: (gestural use, 'Integrated Verbal and NonVerbal Communication')(autism spectrum disorders, 'Autism Phenotype')(gestural production, 'Integrated Verbal and NonVerbal Communication')(verbal imitation, 'Imitation')(cognitive, 'Cognitive Ability')(gestural learning, 'Integrated Verbal and NonVerbal Communication')(30-min robot-based gestural training sessions, 'Integrated Verbal and NonVerbal Communication')(gestures, 'Integrated Verbal and NonVerbal Communication')(gestural training, 'Integrated Verbal and NonVerbal Communication')(gestural production, 'Integrated Verbal and NonVerbal Communication')(gestural recognition skills, 'Integrated Verbal and NonVerbal Communication')(fine motor proficiencies, 'Fine Motor Skills')(appropriate intransitive gestures, 'Integrated Verbal and NonVerbal Communication')(gestural production accuracy, 'Integrated Verbal and NonVerbal Communication')(gestural production, 'Integrated Verbal and NonVerbal Communication')(gestural production accuracy, 'Integrated Verbal and NonVerbal Communication')(spontaneous imitation, 'Imitation')(gestural delay, 'Integrated Verbal and NonVerbal Communication')

PMCID: 5868819
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction: [hlca]), (purpose: []), (study: [resa]), (viewpoints: []), (parents: []), (young people: [popg]), (autism spectrum disorder (asd): [mobd]), (relation: [socb]), (childs transition: [aggp]), (data: [euka]), (structured focus groups: [grup]), (asd: [cgab]), (average: [qnco]), (high intellectual capacities: [qnco]), (units: [qnco]), (focus groups: [grup]), (international classification: []), (functioning: []), ( disability: [fndg]), (health (icf): []), (major themes: []), (world: [popg]), (icf domains: []), (activity: [acty]), (participation: []), (environmental factors: []), (potential: []), (transition outcomes: [acty]), (policies: []), (services: []), (strengths: []), (education: [fndg]), ( employment: []), (independent living: [dora]), (amongst young people: [popg]), (interventions: [hlca]), (adult life: [aggp]), (individualised approaches: []), (approach: []), (transition: [acty]), (people: [popg]), (outcomes: []), (adulthood: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5838552
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract autism spectrum disorder (asd): [mobd]), (impairments: [patf]), (social cognition: [socb]), (function: [phsf]), (amygdala: [bpoc]), (subdivisions: [fndg]), (specificity: [qnco]), (structure: []), ( connectivity: []), (amygdala connectivity: [bpoc]), (asd: [cgab]), (aim: [phsu]), (study: [resa]), (microstructural properties: []), (amygdalacortical connections: []), (association: [menp]), (asd behaviours: [cgab]), (connectivity: []), (specific amygdala subregions: [bpoc]), (particular asd traits: [cgab]), (brains: [bpoc]), (young adults: [aggp]), (asd;: [cgab]), (controls): [sbst]), (mri: [gngm]), (amygdala volume: [bpoc]), (amygdalacortical connectivity: []), (probabilistic tractography: []), (iterative winner: [fndg]), (all algorithm: [lbpr]), (primary cortical connections: [bpoc]), (measures: [qnco]), (clinical scores: [qnco]), (comparison: [acty]), (controls: [sbst]), ( amygdala volume: [bpoc]), (asd (f(1: [cgab]), (94): []), (p = .04): [aapp,imft]), (white matter (wm): [tisu]), (right amygdala: [bpoc]), (right cortex: [bpoc]), ( asd: [cgab]), (mean diffusivity (t: [clna]), (p = .05): [aapp,imft]), (severity: []), (emotion recognition deficits: [menp]), (= 0.53; p = .01): [fndg]), (amygdala parcellation: [bpoc]), (asd subjects: [cgab]), (fractional anisotropy: [npop]), (wm: []), (left amygdala: [bpoc]), (temporal cortex: [bpoc]), (attention: [menp]), (impairment (rho = 0.61; p = .02): [patf]), (microstructure: []), (connections: []), (cortex: [bpoc]), (findings: [clna]), (right amygdala wm tracts: [bpoc]), (overall asd severity: [cgab]), (investigation: [hlca]), (amygdala subregions: [bpoc]), (specific associations: [menp]), 
ASD Terms: (social cognition, 'Cognitive Ability')(abstract autism spectrum disorder, 'Autism Phenotype')(asd behaviours, 'Autism Phenotype')(emotion recognition deficits, 'Empathy')

PMCID: 6340178
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (fragile x syndrome (fxs): [cgab,dsyn]), (inherited cause: []), (autism spectrum disorder: [mobd]), (debate: [acty]), (clinical presentation: []), (social deficits: []), (fxs: []), (aim: [phsu]), (study: [resa]), (individuals: [humn]), (controls (tdc): [sbst]), (idiopathic autism spectrum disorder (asd): [mobd]), (social eye: [bpoc]), (paradigms: [resa]), (gender-matched tdc: [orga]), (idiopathic asd: [cgab]), (emotional face: [blor]), (social preference eye: [bpoc]), (tasks: []), (gaze aversion: [orch,phsu]), (social interest: [menp]), ( respectively: []), (participants: [popg]), (battery: [inpo]), (cognitive testing: []), (caregiver-reported measures: [qnco]), (neurobehavioral characterization: [acty]), (eye: [bpoc]), (mouth gaze: [bsoj]), (gaze: [fndg]), (aversive findings: [menp]), (measures: [qnco]), (anxiety: [mobd]), ( social communication deficits: [socb]), (behavioral problems: [mobd]), (social interest task: [menp]), (social preference: []), ( individuals: [humn]), (findings: [clna]), (fragile x syndrome: [cgab,dsyn]), (social deficits center: [fndg]), (social anxiety: [mobd]), (prominent reduction: [npop]), (techniques: []), (nature: []), (applications: [hlca]), (phenotyping: [lbpr]), (interventions: [hlca]), (social functioning impairments: [socb]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(clinical presentation of social deficits, 'Social Competence')(fragile x syndrome, 'Fragile X Syndrome')(social deficits, 'Social Competence')(fragile x, 'Fragile X Syndrome')(idiopathic autism spectrum disorder, 'Autism Phenotype')(fragile x, 'Fragile X Syndrome')(social interest, 'Social Interest')(cognitive testing, 'Cognitive Ability')(neurobehavioral characterization, 'Central Nervous System Diseases')(fragile x, 'Fragile X Syndrome')(anxiety, 'Anxiety Disorders')(social communication deficits, 'Reciprocal Social Interaction')(social communication deficits, 'Reciprocal Social Interaction')(behavioral problems, 'Personal Traits')(social interest task, 'Social Interest')(fragile x, 'Fragile X Syndrome')(social anxiety, 'Anxiety Disorders')(social interest, 'Social Interest')(social deficits center, 'Social Competence')(nature of social deficits, 'Social Competence')(social functioning impairments, 'Ability to Converse in Social Settings')

PMCID: 5774035
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (great demand: [topp]), (non-medical treatment: [topp]), (support: []), (needs: []), (adolescents: [aggp]), (young adults: [aggp]), (autism spectrum disorder (asd): [mobd]), (attention-deficit/hyperactivity disorder (adhd): [mobd]), (lack: []), (qualitative studies: [resa]), (in-depth insight: [menp]), (individuals own experiences: [menp]), (area: []), (current study: [resa]), (adhd: [mobd]), ( asd: [cgab]), (part: [qnco]), (internet-based support: []), (coaching intervention: [hlca]), (sixteen participants: [popg]), (asd: [cgab]), ( adhd: [mobd]), (8-week internet-based support: []), (model: []), (semi-structured interviews: [resa]), (data: [euka]), (qualitative content analysis: [resa]), (analysis: [resa]), (themes;: []), (taking part: [qnco]), (coaching process: [phpr]), (significance: [qnco]), (format: []), (various motives: [menp]), (participants: [popg]), (technology: []), (situation: []), (unfulfilled need: []), (intervention: [hlca]), (coaches competence: []), (knowledge: []), (light: [gngm]), (negative experiences: [menp]), (someone: []), (view: []), (obstacles: []), (help: []), (advice: [hlca]), (matters: []), (diagnosis: [fndg]), (findings: [clna]), (revealed appreciation: []), (aspects: [qnco]), (word: []), (ones own home: [qnco]), (experience: [menp]), (immediacy: []), (disadvantages: []), (incomplete personal interaction: [qnco]), (suggestions: []), (flexibility: []), (in-depth qualitative data: [gngm]), (study: [resa]), (current model: [npop]), (internet-based format: []), (specific qualities: []), (important role: [socb]), (replacement: [topp]), (face-to-face interaction: []), (promising complement: [aapp,imft]), (other support: []), (treatment options: [topp]), (trial registration: [resa]), (young people: [popg]), (autism: [mobd]), (controlled study: [resa]), (www.clinicaltrials.gov (clinicaltrials.gov identifier: nct02300597): [gngm]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')

PMCID: 4858900
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (few studies: [lbpr]), (persistence: [menp]), (self-injury: [inpo]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (data: [euka]), (demographic characteristics: [grpa]), (longitudinal study: [resa]), (cohort: [popg]), (asd: [cgab]), (years: []), (carers: []), ((median age: [orga]), (interquartile range: [qnco]), (questionnaires: []), (presence: [qnco]), (topography: []), (t1: [gngm]), (t2: [gngm]), (analyses: [resa]), (self-injurious behaviour: [inbe]), (%: []), (behavioural correlates: [inbe]), (ability: [orga]), (levels: []), (overactivity: [fndg]), ( impulsivity: [inbe]), (repetitive behaviour: [fndg]), (time points: []), (risk markers: []), (impulsivity (p: [inbe]), (deficits: []), (social interaction (p: [fndg]), (impulsivity: [inbe]), (social interaction: [fndg]), (persistent self-injury: [inpo]), (behavioural risk markers: [inbe]), (identification: [menp]), (role: [socb]), (behaviour dysregulation: [inbe]), (development: [orgf]), (maintenance: [acty]), (findings: [clna]), (clinical implications: []), (proactive intervention;: [hlca]), (behavioural characteristics: [inbe]), (at risk individuals: [humn]), (early intervention: [hlca]), 
ASD Terms: (self-injury, 'Self-Injurious Behavior')(autism spectrum disorder, 'Autism Phenotype')(self-injury, 'Self-Injurious Behavior')(self-injury, 'Self-Injurious Behavior')(self-injurious behaviour, 'Self-Injurious Behavior')(overactivity, 'Overactivity')(repetitive behaviour, 'Restricted and Repetitive Behavior')(social interaction, 'Reciprocal Social Interaction')(self-injury, 'Self-Injurious Behavior')(social interaction, 'Reciprocal Social Interaction')(persistent self-injury, 'Self-Injurious Behavior')(self-injury, 'Self-Injurious Behavior')

PMCID: 5695075
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (aim: [phsu]), (characteristics: []), (successful transition: [acty]), (school outcomes: [mnob,orgt]), (preschool: [fndg]), (children: [aggp]), (autism: [mobd]), (methods: []), (participants: [popg]), (early intervention program: [hlca]), (time points;: []), (end: [gngm]), (preschool placement: [hlca]), (mo: []), (transition: [acty]), (child characteristics: [aggp]), (mullen scales: [plnt]), (early learning: [menp]), ( vineland adaptive behaviour scales: [inbe]), ( social communication questionnaire: [socb]), (repetitive behaviour scale: [acty]), (transition outcomes: [acty]), (teacher rating scale: [inpr,qnco]), (school adjustment: [inbe]), (social skills improvement system rating scales: [socb]), (understanding: [menp]), (childs school adjustment: [aggp]), (relationship: []), (results cognitive ability: [menp]), (adaptive behaviour: [inbe]), (participation: []), (classroom: []), (classroom teacher: [fndg]), (factors: []), (social skills: [socb]), (assertiveness: [inbe]), (engagement: [fndg]), (conclusion supporting children: [aggp]), (spectrum: [qnco]), (domains: []), (cognitive ability: [menp]), (language skills: [menp]), (appropriate support: []), (transition programs: [phsu]), (important transition: [acty]), (learning: [menp]), (behavioural potential: [inbe]), 
ASD Terms: (autism, 'Autism Phenotype')(adaptive behaviour scales, 'Adaptive Life Skills')(social communication questionnaire, 'Reciprocal Social Interaction')(vineland adaptive behaviour scales, 'Adaptive Life Skills')(social communication questionnaire, 'Reciprocal Social Interaction')(repetitive behaviour scale, 'Restricted and Repetitive Behavior')(social skills improvement system rating scales, 'Ability to Converse in Social Settings')(results cognitive ability, 'Cognitive Ability')(adaptive behaviour, 'Adaptive Life Skills')(social skills, 'Ability to Converse in Social Settings')(adaptive behaviour, 'Adaptive Life Skills')(cognitive ability, 'Cognitive Ability')(language skills, 'Development or Regression of Language Skills')

PMCID: 5689117
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract objective: autism behavior inventory (abi): [diap]), (new measure: [qnco]), (changes: [qnco]), (core: [bdsu]), (symptoms: [sosy]), (autism spectrum disorder (asd): [mobd]), (participants: [popg]), (years-adulthood): []), (asd: [cgab]), (web-based tool: []), (domains: []), ((two asd core domains:: [cgab]), (social communication: [socb]), (repetitive behaviors;: [fndg]), (domains:: []), (mental health: [menp]), ( self-regulation: [inbe]), (challenging behavior): [fndg]), (study: [resa]), (design: [acty]), ( development: [orgf]), (initial psychometric properties: [diap]), (abi: [clna]), (methods: abi items: [clna]), (review: []), (measures: [qnco]), (inputs: []), (expert clinicians: []), (initial abi scale: [clna]), (items: []), (factor: []), (analytic model: []), (adequate reliability: [qnco]), (versions: []), (scale: [acty]), ( abi-full: [clna]), (items): []), (abi-short version: [clna]), (psychometric properties: [diap]), (validity comparisons: [acty]), (scales: [bpoc]), (parents: []), (healthcare professionals: []), (study participants: [humn]), (results: testretest reliability (intraclass correlation coefficient [icc]: [fndg]), (parent ratings: [acty]), (correlations: []), (hcp ratings: [acty]), (versus parent ratings: [acty]), (abi core domains: [clna]), (comparison measures: [qnco]), ((r: [clna]), (good concurrent validity: [qnco]), (conclusions: overall: []), ( abi: [clna]), (tool: []), (change: [qnco]), (core symptoms: [sosy]), (autism: [mobd]), (clinical studies: [resa]), (further validation required: [resa]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism behavior inventory, 'Autism Phenotype')(autism behavior inventory items, 'Autism Phenotype')(initial autism behavior inventory scale, 'Autism Phenotype')(autism behavior inventory-full, 'Autism Phenotype')(autism behavior inventory-short version, 'Autism Phenotype')(autism behavior inventory, 'Autism Phenotype')(autism behavior inventory core domains, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism behavior inventory, 'Autism Phenotype')

PMCID: 4873740
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (key behavioural traits: [inbe]), (autism spectrum disorders (asd): [mobd]), (impairments: [patf]), (early activation: [acty]), (mechanisms: []), (typical development bias newborns: [aggp]), (social visual stimuli: [ortf]), (challenge: [hlca]), (hypothesis: []), (autism: [mobd]), (child: [aggp]), (years: []), (here: []), (difficulty: [fndg]), (predispositions: [clna]), (attention: [menp]), (social stimuli: [phpr]), (newborns: [aggp]), (high familial risk: [famg]), (results: [fndg]), (visual preferences: []), (low-risk newborns: [aggp]), (significant predictors: [qnco]), (high-risk newborns: [aggp]), (accurate biomarker: [clna]), (early behavioural characteristics: [inbe]), (familial risk: [famg]), (asd: [cgab]), (prospective approach: [resa]), (emergence: []), (early infancy: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(key behavioural traits, 'Personal Traits')(social visual stimuli, 'Visual Thinking')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(pay attention, 'Attention and Focus')(visual preferences, 'Visual Thinking')(autism, 'Autism Phenotype')(early infancy, 'Perinatal History')

PMCID: 5559781
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (ability: [orga]), (optimal decisions: [menp]), (uncertainty: [fndg]), (integral part: [qnco]), (everyday life: []), ( individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (difficulties: [fndg]), (skill: [inbe]), (behavioral economics: []), ( researchers: []), (types: []), (decision-making: [menp]), (setting: risk (known probabilities): [qnco]), (ambiguity: []), (probabilities): [qnco]), (however: []), (individuals: [humn]), (asd: [cgab]), (risk: []), (evidence: []), (altered decision-making: []), (previous research: [resa]), (attitudes: [menp]), (negative contexts (i.e.: [diap,inpr]), ( gain: [qnco]), (loss): [qnco]), (gain contexts: [fndg]), (significant difference: [qnco]), (groups: [popg]), (risk attitudes: [menp]), (ambiguity aversion: [orch,phsu]), (loss contexts: [fndg]), ( ambiguity attitudes: [menp]), (asd participants: [cgab]), (controls: [sbst]), (addition: []), ( insensitivity: [fndg]), (context change: [qnco]), (poor social skills: [grpa]), (results: [fndg]), (understanding: [menp]), (asd individuals: [cgab]), (behavioral economic tools: []), (insights: [menp]), (mechanisms: []), (behavioral disturbances: [mobd]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0162-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (make optimal decisions under uncertainty, 'Decision Making Ability')(autism spectrum disorder, 'Autism Phenotype')(poor social skills, 'Ability to Converse in Social Settings')(underlying behavioral disturbances in asd, 'Personal Traits')(behavioral disturbances, 'Personal Traits')

PMCID: 6334505
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (underlying difficulties: [fndg]), (theory: []), (mind; tom): [gngm]), (few behavioural symptoms: [sosy]), (core cognitive deficits: [mobd]), (mechanisms: []), (underpinning compensation: [menp]), (potential impact: [gngm]), (mental health: [menp]), (study: [resa]), (compensation patterns: [menp]), (asd: [cgab]), (overt social behaviour: [socb]), (tom task performance: [topp]), (order: [acty]), (characteristics: []), (low: [qnco]), (high compensators: [qnco]), (total: [qnco]), (autistic adolescents: [mobd]), (social relationships study: [resa]), (range: [qnco]), (cognitive tasks: []), (autistic diagnostic observation schedule (ados): [hlca]), (selfreport anxiety questionnaire: [resa]), (participants: [popg]), (compensation group: [popg]), (high: [qnco]), (good ados scores: [aapp,enzy]), (poor tom performance: [grpa]), (low compensators: [qnco]), (poor tom: [grpa]), (poor ados scores: [grpa]), (iq: []), (executive function (ef): [menp]), (anxiety: [mobd]), (such differences: [qnco]), (good versus: []), (tom performance: [inbe]), (other core: [bdsu]), (autistic characteristics: [mobd]), ((weak central coherence: [lbpr]), (nonsocial symptoms): [sosy]), ( ef: []), (processes: [phpr]), (certain autistic young people: [mobd]), (underlying tom difficulties: [fndg]), (tendency: []), (severity: []), (hit: [dsyn]), (se: [gngm]), (wellcompensated individuals: [humn]), (milder form: []), (construct: []), (compensation: [menp]), (implications: []), (research: [resa]), (clinical practice: [menp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(core cognitive deficits, 'Cognitive Ability')(overt social behaviour, 'Reciprocal Social Interaction')(tom task performance, 'Task Performance')(cognitive tasks, 'Cognitive Ability')(selfreport anxiety questionnaire, 'Anxiety Disorders')(executive function, 'Executive Function')(anxiety, 'Anxiety Disorders')(executive function, 'Executive Function')

PMCID: 4760734
SFARI Genes: 
Non SFARI Genes: impact, impact, impact, 
Named Entities: (scientific literature: []), (value: [qnco]), (assistance dogs: [mamm]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (however: []), (effects: []), (pet (as: [anim]), (dogs: [mamm]), (particular: []), (scales: [bpoc]), (behaviours: [inbe]), (presence: [qnco]), (dog: [mamm]), (efficacy: [resa]), (pet dogs: [mamm]), (families: [famg]), (additionally: []), (individualised nature: []), (asd: [cgab]), (benefits: [qnco]), (dog ownership: [mamm]), (research: [resa]), (effect: []), (individual differences: [menp]), (pilot study: [resa]), (development: [orgf]), (28-item scale: [acty]), (perceived impact: [menp]), (pet dog: [mamm]), (child: [aggp]), (autism: [mobd]), (parents: []), ((lincoln autism pet dog impact scalelapdis): [mamm]), (scale: [acty]), (factors: adaptability: [menp]), ( social skills: [socb]), (conflict management: [hlca]), (scores: [clna]), (factors: []), (aspects: [qnco]), (ratings: [acty]), (child aspects (including: contact: [aggp]), (horses: [mamm]), ( child: [aggp]), (age: [orga]), ( disability level: [phsu]), (language abilities): [menp]), (impact: [gngm]), (social skills: [socb]), ((formal training: [edac]), (attendance: [acty]), (paws workshops: [edac]), (good): []), (results: [fndg]), (training approach: [edac]), (important considerations: [fndg]), (positive impact: [gngm]), (differences: [qnco]), (family features: [famg]), (further investigations: [hlca]), (early stage: [clna]), (field: [irda]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(adaptability, 'Adaptive Life Skills')(social skills, 'Ability to Converse in Social Settings')(scores on social skills, 'Ability to Converse in Social Settings')

PMCID: 4827274
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (abstract virtual environments (ves): [hlca]), (social skills interventions: [socb]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (immersive ves provide opportunities: [dsyn]), (asd: [cgab]), (practice skills: [inbe]), (replicable setting: [qnco]), (however: []), (ves: [dsyn]), (same technology: []), (level: [phsu]), (immersion differs: [fndg]), (settings: [qnco]), (group studies: [popg]), (high-immersion categories: [fndg]), (aspects: [qnco]), (immersion: [fndg]), (so: []), (conclusions: []), (influence: []), (technical manipulation: [topp]), (efficacy: [resa]), (tool: []), (social skills: [socb]), (ways: []), (future studies: [lbpr]), (understanding: [menp]), (manipulating aspects: [qnco]), (intervention success: [socb]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social skills interventions, 'Ability to Converse in Social Settings')(social skills, 'Ability to Converse in Social Settings')

PMCID: 4809081
SFARI Genes: 
Non SFARI Genes: NHS, 
Named Entities: (introduction co-occurring: [hlca]), (psychiatric conditions: [mobd]), (behaviours: [inbe]), (individuals: [humn]), (autism spectrum disorders: [mobd]), (long-term outcomes: []), (cognitive rigidity: [sosy]), (deficits: []), (emotional literacy: [menp]), (verbal behaviour: [inbe]), (asd: [cgab]), (clinicians confidence: []), (mental health problems: [fndg]), (need: []), (measure: [qnco]), (towards individuals: [humn]), (differentiates: []), (symptoms: [sosy]), (psychopathology: []), (core asd symptoms: [cgab]), (protocol: [fndg]), (intended development: [orgf]), (validation: [resa]), (assessment: [acty]), (concerning behaviour (acb) scale: [inbe]), (acb: []), (multidimensional measure: [qnco]), (self-report: [resa]), ( parent/carer: []), ( teacher/employer: [fndg]), (clinician report versions: [hlca]), (lifespan: [grpa]), (spectrum: [qnco]), (intellectual ability: [fndg]), (methods: []), (analysis: [resa]), (study: [resa]), (us food: [imft,phsu]), (drug administration guidance: [hlca]), (industry patient-reported outcome measures: [qnco]), (literature review: []), (cognitive interviews: [acty]), (groups: [popg]), (experience: [menp]), (asds: [cgab]), (item generation: [acty]), (sample: [sbst]), (children: [aggp]), (adults: [aggp]), (addition: []), (other gold standard measures: [qnco]), (behaviour: [inbe]), (order: [acty]), (initial psychometric properties: [diap]), (scale: [acty]), (ethics: []), (dissemination: []), (ethical approval: []), (nhs research ethics committee: london-camden: [cgab,dsyn]), (king's cross: []), (study findings: [fndg]), (professionals: []), (scientists: []), (field: [irda]), (publication: [inpr,mnob]), (peer-reviewed journals: [hlca]), (conference presentations: [hcpp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(psychiatric conditions, 'Mental Disorders')(cognitive rigidity, 'Cognitive Ability')(mental health problems, 'Mental Retardation')(core asd symptoms, 'Complaints and Indications')(concerning behaviours in asd, 'Autism Phenotype')(cognitive interviews, 'Cognitive Ability')

PMCID: 5705114
SFARI Genes: 
Non SFARI Genes: cope, 
Named Entities: (tendency: []), (eye contact: [socb]), (early indicator: [irda]), (autism spectrum disorder (asd): [mobd]), (difficulties: [fndg]), (lifespan: [grpa]), (eye contact difficulties: [fndg]), (social cognitive deficits: [mobd]), (asd: [cgab]), (occupational barriers: []), (thus: []), (topic: []), (substantial research: [resa]), (clinical attention: [menp]), (study: [resa]), (qualitative methods: []), (self-reported experiences: [menp]), (teens: [aggp]), (adults: [aggp]), (self-declared asd: [cgab]), (results: [fndg]), (people: [popg]), (self- declared asd diagnosis experience: [cgab]), (adverse emotional: [menp]), (physiological reactions: []), ( feelings: [menp]), (sensory overload: []), (addition: []), (social nuances: [gngm]), (nonverbal information: [fndg]), (data support: [euka]), (mindblindness frameworks: []), (hyperarousal: []), (hypoarousal theories: []), (novel findings: [clna]), (frameworks: []), (innovative strategies people: [popg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(eye contact, 'Eye Contact')(avoid eye contact, 'Eye Contact')(underlie social cognitive deficits, 'Cognitive Ability')(eye contact difficulties, 'Eye Contact')(social cognitive deficits, 'Social Competence')(occupational barriers, 'Job Performance')(eye contact, 'Eye Contact')(eye contact, 'Eye Contact')(self- declared asd diagnosis experience, 'Diagnosis')(eye contact, 'Eye Contact')

PMCID: 5416661
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (animal models: [anim]), (autism spectrum disorder: [mobd]), (nkcc1 chloride-importer inhibitor bumetanide: [orch,phsu]), (physiological (cl)i levels: [elii]), ( enhances gabaergic inhibition: [acty]), (behavioral symptoms: [sosy]), (asd: [cgab]), (phase: []), (trial; bumetanide: [orch,phsu]), (severity: []), (children: [aggp]), (adolescents: [aggp]), (years: []), (results: [fndg]), (multicenter phase: []), (study: [resa]), (dose/response: [resa]), (safety effects: [hcpp]), (bumetanide: [orch,phsu]), (efficacy: [resa]), (outcome measures: [qnco]), (childhood autism rating scale: [mobd]), (social responsive scale (srs): [acty]), (clinical global impressions (cgi) improvement scale (cgi-i): [inch]), (eighty-eight patients: [podg]), (entire pediatric population: [popg]), (age groups: [aggp]), (daily): []), (placebo: [topp]), (months: []), (mean cars value: [qnco]), (completers group: [popg]), (treated children: [aggp]), (six-point improvement: [qnco]), (cars: [gngm]), (placebo-treated individual: [topp]), (cgi (p:: [aapp,imft]), (srs score: [clna]), (points: [qnco]), (frequent adverse events: [patf]), (hypokalemia: [fndg]), (urine elimination: [fndg]), ( loss: [qnco]), (appetite: [orgf]), ( dehydration: [dsyn]), (asthenia: [sosy]), (beginning: []), (treatment: [topp]), (mg twice-daily doses: [qnco]), (oral potassium supplements: [elii]), (frequency: [qnco]), (incidence: [qnco]), (adverse event: [patf]), (dose: [qnco]), (therefore: []), ( bumetanide: [orch,phsu]), (core symptoms: [sosy]), (favorable benefit/risk: []), (mg: [elii,phsu]), (daily: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(behavioral symptoms of asd, 'Complaints and Indications')(childhood autism rating scale, 'Autism Phenotype')(mean childhood autism rating scale value, 'Autism Phenotype')(oral potassium supplements, 'Dietary Supplements')(core symptoms of asd, 'Complaints and Indications')

PMCID: 6214554
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (current study contributes: [acty]), (previous work: []), (social phenotype: [orga]), (autism spectrum disorder (asd): [mobd]), (multidimensional test: [lbpr]), (social competence: [socb]), (use: []), (individuals: [humn]), (asd: [cgab]), (multidimensional social competence scale (mscs): [socb]), (parent-rating scale: []), (years: []), (intellectual disability: [mobd]), (adolescents: [aggp]), (comparable age: [orga]), (current study: [resa]), (validation: [resa]), (self-report version: [resa]), (mscs: [moft]), (non-clinical young adult population (n: [aggp]), (males: [orga]), (females: [orga]), (age range: [qnco]), (years): []), (domains: []), (social competence:: [socb]), (social motivation: [menp]), (social inferencing: []), (empathic concern: [inbe]), ( social knowledge: []), (verbal conversation skills: [inbe]), (nonverbal sending skills: [inbe]), (emotion regulation: [menp]), (higher-order construct: [acty]), (second higher-order theorization: [acty]), (mscs structure: [moft]), (factors: []), (social responsiveness: []), (social understanding: [menp]), (findings: [clna]), (support: []), (theorized multidimensional factor structures: []), (reliability: [qnco]), (optimal scoring: [qnco]), ( convergent: [acty]), (discriminant validity: [qnco]), (measure: [qnco]), (implications: []), (future research: [resa]), (discussed: [socb]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social competence, 'Social Competence')(multidimensional social competence scale, 'Social Competence')(intellectual disability, 'Learning Disorders')(social competence scale, 'Social Competence')(verbal conversation skills, 'Conversational Skills')(emotion regulation, 'Emotional Regulation and Control')(social competence, 'Social Competence')(social competence scale structure, 'Social Competence')(social understanding, 'Ability to Converse in Social Settings')

PMCID: 5412284
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (force control deficits: [phpr]), (autism spectrum disorder (asd): [mobd]), (daily living skill impairments: [patf]), (patients: [podg]), (mechanistic understanding: [menp]), (peripheral processes: [phpr]), (development: [orgf]), (treatments: [topp]), (multiple outcomes: [qnco]), (asd: [cgab]), (neuromuscular mechanisms: []), (seventeen individuals: [humn]), (healthy controls: []), (isometric index finger abduction test: [diap]), (maximum voluntary contraction (mvc): [qnco]), (recording: []), (first dorsal: [qnco]), (interosseous (fdi) muscle: [tisu]), (neuromuscular processes: [orgf]), (sustained force variability: [phpr]), (central modulation: [lbpr]), (motorneuron pool activation: [cell]), (fdi muscle: [tisu]), (delta (04 hz): [qnco]), ((410 hz): [qnco]), ( beta (1035 hz): [plnt]), (gamma (3560 hz) frequency bands: [npop]), (asd patients: [cgab]), (force variability: [phpr]), (controls: [sbst]), (constant force: [phpr]), (increased central modulation: [lbpr]), (motorneuron pool: [cell]), (beta: [plnt]), (gamma bands: [npop]), (reduced delta frequency modulation: [qnco]), (motorneuron pool activity: [cell]), (increased modulation: [qnco]), (contrast: [irda]), ( delta: [qnco]), ( beta: [plnt]), (gamma frequency oscillations: [npop]), (findings: [clna]), (alterations: []), (central mechanisms: [lbpr]), (pool firing: [clna]), (symptoms: [sosy]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(impairing symptoms of asd, 'Complaints and Indications')

PMCID: 5358845
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (individuals: [humn]), (autism-spectrum disorder (asd) exhibit impairments: [mobd]), (response: [fndg]), (pain: [sosy]), (evidence: []), (features: []), (autism: [mobd]), (asd: [cgab]), (autistic traits: [mobd]), (general population: [popg]), (association: [menp]), (responses: [orga]), (autism-spectrum quotient (aq): [qnco]), (group: [popg]), (healthy adults: [fndg]), (participants: [popg]), ((30 males: [orga]), (females): [orga]), (aq scores: [clna]), (difficulties: [fndg]), (study: [resa]), (visual task: []), (auditory task: []), (behavioral differences: [inbe]), (high-aq: [qnco]), (low-aq groups responses: [popg]), (modalities: []), ( participants: [popg]), (pictures: []), (others pain: [fndg]), (stimuli: [phpr]), (not): []), ( judge others pain intensity: [clna]), (unpleasantness: []), (experimental procedures: [resa]), (painful voices: [sosy]), (added: []), (results: [fndg]), (high-aq group: [popg]), (low-aq group: [popg]), (moreover: []), (low-aq males: [orga]), ( high-aq males: [orga]), (reaction times: []), (however: []), ( high-aq: [qnco]), (low-aq females: [orga]), (similar reaction times: []), (tasks: []), (findings: [clna]), (identification: [menp]), (extent: []), ( gender: [orga]), (modality: [diap]), 
ASD Terms: (others pain, 'Pain')(autism, 'Autism Phenotype')(test behavioral differences between high-autism-spectrum quotient, 'Personal Traits')(visual task, 'Visual Thinking')(behavioral differences, 'Personal Traits')(judge others pain intensity, 'Pain')(painful voices, 'Pain')(demonstrated identification of others pain, 'Pain')

PMCID: 5599599
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (oxytocin: [aapp,horm,phsu]), (pituitary neuropeptide: [bpoc]), (social behaviour: [socb]), (single: [fndg]), ((snps): [nusq]), (oxytocin receptor gene: [aapp,rcpt]), (variability: []), (social abilities: [socb]), (control populations: []), (variants: []), (severity: []), (social deficits: []), (children: [aggp]), (neurodevelopmental disorders: [mobd]), (group: [popg]), (autism spectrum disorder (asd: [mobd]), (attention deficit hyperactivity disorder (adhd: [mobd]), (social measures: [qnco]), (scores: [clna]), (oxtr genotype (rs53576: [orga]), ( rs237887: []), ( rs13316193: []), ( rs2254298): []), (oxtr snps: [nusq]), (general population (rs53576: [popg]), (rs2254298): []), (increased severity: [qnco]), (asd (p <: [cgab]), (adhd (p =: [mobd]), (genetic modifier alleles: [gngm]), (respect: [socb]), (impact: [gngm]), (social abilities;: [socb]), (molecular investigations: [hlca]), 
ASD Terms: (social behaviour, 'Reciprocal Social Interaction')(variability in social abilities, 'Ability to Converse in Social Settings')(social abilities, 'Ability to Converse in Social Settings')(severity of social deficits, 'Social Competence')(neurodevelopmental disorders, 'Learning Disorders')(social deficits, 'Social Competence')(autism spectrum disorder, 'Autism Phenotype')(attention deficit hyperactivity disorder, 'Overactivity')(increased severity of social deficits, 'Social Competence')(adhd, 'Attention Deficit Disorder with Hyperactivity')(impact on social abilities, 'Ability to Converse in Social Settings')

PMCID: 5509841
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (emotions: [menp]), (others: [fndg]), (social decisions: [menp]), (brain responses: [bpoc]), (autism spectrum disorders: [mobd]), (neural mechanisms: []), (fairness decisions: [menp]), (response: [fndg]), (boys: [aggp]), (asd: [cgab]), ((td) boys: [aggp]), (participants: [popg]), (allocation behavior: [inbe]), (td controls: [sbst]), (precental gyrus: []), (asd versus td group: [cgab]), (happy versus: [menp]), (angry reactions: [mobd]), (autistic traits: [mobd]), (activity: [acty]), (postcentral gyrus: [blor]), (results: [fndg]), (indications: []), (role: [socb]), (social-affective difficulties: [fndg]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-017-3159-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 5767603
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (social dysfunction: [dsyn]), (executive dysfunction: [mobd]), (asd: [cgab]), (findings: [clna]), (different definitions: []), (executive function (ef): [menp]), (part: [qnco]), (ef: []), (vs: []), (unstructured tasks: []), ( inclusion: [celc]), (different moderators: []), (iq: []), ( sex): [orgf]), (different diagnostic categories: [fndg]), (spectrum: [qnco]), (main finding: [sosy]), (people: [popg]), (ef difficulties: [fndg]), (normal controls: []), (difficulties: [fndg]), (open-end tasks: []), (structured cognitive tasks: []), (laboratory setting: [mnob,orgt]), (informant measures: [qnco]), (ecological validity: [qnco]), (neuropsychological tests: [diap]), (evidence: []), (executive dysfunctions: [mobd]), (social impairments: [patf]), (few studies: [lbpr]), (details: []), (relationship: []), (types: []), (ef deficits: []), (social problems: [fndg]), (individuals: [humn]), (ef domains: []), (various domains: [phsu]), (social function: [socb]), (parent-rated measures: [qnco]), (total: [qnco]), (children: [aggp]), (adolescents: [aggp]), (diagnosis: [fndg]), (general cognitive abilities: [fndg]), (parents: []), (behavior rating inventory: [diap]), (executive function (brief): [menp]), (social responsiveness scale (srs): [acty]), (multiple regression analysis: [resa]), (significant associations: [menp]), (srs scores: [clna]), (sex: [orgf]), ( total iq: [qnco]), (brief indexes: []), (metacognition index: []), (brief: []), (prediction: []), (srs: [gngm]), (total score: [qnco]), (subscales social communication: [socb]), ( social motivation: [menp]), (autistic mannerisms: [mobd]), (metacognitive aspects: [menp]), (particular importance: []), (social abilities: [socb]), (research: [resa]), ((td) children: [aggp]), (different relationship: []), (td children: [aggp]), (ef domain: []), (behavioral regulation: [inbe]), (results: [fndg]), (current study: [resa]), (implications: []), (cognitive components: []), (targeted clinical ef interventions: [hlca]), (asd dysfunctions: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social dysfunction, 'Social Competence')(executive function, 'Executive Function')(executive function, 'Executive Function')(executive function difficulties, 'Executive Function')(structured cognitive tasks, 'Cognitive Ability')(executive function deficits, 'Executive Function')(social problems of individuals, 'Social Competence')(social impairments, 'Social Competence')(social problems, 'Social Competence')(social function, 'Social Competence')(executive function domains, 'Executive Function')(diagnosis, 'Diagnosis')(general cognitive abilities, 'Cognitive Ability')(executive function, 'Executive Function')(subscales social communication, 'Reciprocal Social Interaction')(executive function, 'Executive Function')(particular importance for social abilities, 'Ability to Converse in Social Settings')(social abilities, 'Ability to Converse in Social Settings')(executive function, 'Executive Function')(social function, 'Social Competence')(executive function domain, 'Executive Function')(cognitive components, 'Cognitive Ability')(targeted clinical executive function interventions, 'Executive Function')

PMCID: 4589806
SFARI Genes: spin, spin, 
Non SFARI Genes: 
Named Entities: (studies: [lbpr]), (light: [gngm]), (neurobiological underpinnings: []), (autism spectrum disorders: [mobd]), (brain: [bpoc]), (altered baseline metabolism: [bodm]), (pet/spect: [diap]), (functional connectivity (fc): []), (intrinsic brain networks: [bpoc]), (resting-state fmri: [diap]), (however: []), (study: [resa]), (physiological parameters: [fndg]), (brain function jointly: [ortf]), (relationship: []), (measures: [qnco]), (asd: [cgab]), (severity: []), (here: []), (pseudo-continuous arterial spin: [bpoc]), (background-suppressed grase: []), (cerebral blood flow (cbf): [fndg]), (fc: [acty]), (youth: [aggp]), (children: [aggp]), (pattern: []), (perfusion: [topp]), (asd versus td children: [cgab]), (frontotemporal hyperperfusion: []), (hypoperfusion: [patf]), (dorsal: []), (anterior cingulate cortex: [bpoc]), (local fc: [acty]), (anterior module: []), (default mode network (dmn): [popg]), (decreased cbf: [qnco]), (same area: []), (cohort: [popg]), (alterations: []), (social impairments: [patf]), (social responsiveness scale: [acty]), ((srs-total t scores): [qnco]), (cbf: []), (td children: [aggp]), (association: [menp]), (baseline perfusion: [bodm]), (furthermore: []), (long-range fc: [acty]), (posterior modules: []), (dmn: [gngm]), (findings: [clna]), (new avenues: []), (markers: [clna]), (asd symptomatology: [cgab]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(social impairments, 'Social Competence')

PMCID: 4259989
SFARI Genes: 
Non SFARI Genes: ran, 
Named Entities: (oxytocin (ot): [aapp,horm,phsu]), (mammalian social behavior: [mamm]), (clinical trials: [resa]), (treatment: [topp]), (autism spectrum disorder (asd): [mobd]), (previous studies: [lbpr]), (healthy rodents: [mamm]), ((prairie voles: [mamm]), (c57bl/6j mice): [mamm]), (detrimental effects: []), (long-term intranasal: []), (questions: []), (safety: [hcpp]), (efficacy: [resa]), (effects: []), (ot: [gngm]), (aspects: [qnco]), (asd phenotype: [cgab]), (first study: [qnco]), (chronic intranasal ot: [hlca]), (well-validated mouse model: [emod]), (btbr t+ itpr3tf/j: [mamm]), (strain (btbr): [mamm]), (low sociability: [socb]), (high repetitive behaviors: [fndg]), (btbr: [mamm]), (c57bl/6j (b6) mice (n=94): [mamm]), (iu/kg: [qnco]), (days: []), (day: []), (well-characterized set: [menp]), (behavioral tasks: [inbe]), (associated symptoms: [sosy]), (juvenile reciprocal social interactions: [fndg]), (three-chambered social approach: [qnco]), (open-field exploratory: [irda]), (activity: [acty]), ( repetitive self-grooming: [inbe]), (fear-conditioned learning: [menp]), (post treatment: []), (intranasal ot: [hlca]), (autism-relevant behaviors: [mobd]), (female sniffing: [orga]), (three-chambered social interaction test: [fndg]), (male saline-treated btbr mice: [sbst]), (increased interest: [menp]), (novel mouse: [mamm]), (chamber time: [bpoc]), (time: []), ( whereas ot-treated male btbr mice: [orga]), (preference: []), (time only: [qnco]), (deleterious effects: []), (b6: [mamm]), (lack: []), (novel mouse's chamber: [mamm]), (ot-treated male btbr mice: [orga]), (results: [fndg]), (complexity inherent: [chvs]), (behavior: [inbe]), (future investigations: [hlca]), (wider dose range: [qnco]), (early developmental time points: [orgf]), (asd models: [cgab]), 
ASD Terms: (mammalian social behavior, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(asd phenotype, 'Autism Phenotype')(high repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(juvenile reciprocal social interactions, 'Reciprocal Social Interaction')(three-chambered social interaction test, 'Reciprocal Social Interaction')

PMCID: 5412163
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (type: [qnco]), (neurodevelopmental disorder: [mobd]), (core impairments: [patf]), (social relationships: []), ( communication: [socb]), ( imagination: [menp]), (flexibility: []), (thought: [menp]), (repertoire: []), (activity: [acty]), (interest: [menp]), (work: []), (new computer: []), (diagnosis (cad): [gngm]), (autism: [mobd]), (electroencephalography (eeg) signal analysis: [diap]), (method: [lbpr]), (discrete wavelet transform (dwt): [resa]), ( entropy (en): [phpr]), (artificial neural network (ann): [orgf]), (dwt: [qnco]), (eeg signals: [diap]), (approximation: []), (details coefficients: [qnco]), (eeg subbands: [diap]), (feature vector: [nnon]), (shannon entropy values: [phpr]), (eeg subband: [diap]), (ann: []), (corresponding eeg signal: [diap]), (features: []), (experimental results: [fndg]), (effectiveness: []), (autism diagnosis: [mobd]), (receiver: []), (characteristic (roc) curve: [qnco]), (performance: [inbe]), (promising results: [fndg]), (real dataset: []), (abdulaziz hospital: [hcro,mnob]), ( jeddah: []), ( saudi arabia: []), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(imagination, 'Imagination')(autism, 'Autism Phenotype')(aided diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')(autism diagnosis, 'Diagnosis')(abdulaziz hospital, 'Hospitalizations')

PMCID: 6160704
SFARI Genes: 
Non SFARI Genes: BAZ1B, GTF2IRD1, 
Named Entities: (abstract large: [qnco]), (multigenic deletions: [genf]), (chromosome: [celc]), (result: [fndg]), (penetrant constellation: []), (behavioral symptoms: [sosy]), (williamsbeuren: []), ((ws): []), (particular interest: [menp]), (unusual socialcognitive profile: [lbpr]), (deficits: []), (social cognition: [socb]), (communication reminiscent: [socb]), (autism spectrum disorders: [mobd]), (enhanced social motivation: [menp]), (interestingly: []), ( duplications: []), (same region: []), (asdlike phenotypes: [orga]), (social phobias: [mobd]), (thus: []), (region: []), (human social motivation: [humn]), (behavior: [inbe]), (relevant gene(s): [gngm]), (here: []), (individuals: [humn]), (ws: [gngm]), (rare variation: [gngm]), (association: [menp]), (variance: [qnco]), (social behavior: [socb]), (social responsiveness scale: [acty]), (unusual juxtaposition: []), (new patient collection: [podg]), (new alleles: [gngm]), (large effect: [qnco]), (targeted analysis: [resa]), (copy: []), (genes: [gngm]), (williams: []), (critical region: []), (however: []), (significant snps: [nusq]), (cognitive: []), (social phenotypes: [orga]), (baz1b: [gngm]), (gtf2ird1: [gngm]), (secondary discovery driven explorations: [neop]), (asd genes: [cgab]), (variants: []), (whole exome sequencing: [mbrt]), (hypothesis: []), (syndrome critical region: [dsyn]), (contribute: [acty]), (social phenotype: [orga]), (deeply: [fndg]), (patient cohort: [podg]), (defined mutation: [genf]), (opportunity: []), (similar analyses: [resa]), (variation: []), (other phenotypic domains: [orga]), 
ASD Terms: (social cognition, 'Cognitive Ability')(autism spectrum disorders, 'Autism Phenotype')(social behavior, 'Reciprocal Social Interaction')(cognitive, 'Cognitive Ability')

PMCID: 5480052
SFARI Genes: fat, fat, 
Non SFARI Genes: 
Named Entities: (nonalcoholic: []), (disease: [dsyn]), (western diet (wd): [topp]), (peripheral inflammation: [patf]), (altered emotionality: [fndg]), (changes: [qnco]), (abnormalities: [cgab]), (social behaviour: [socb]), (hippocampus-dependent cognitive functions: [bpoc]), (metabolism: [orgf]), (female c57bl/6j mice: [mamm]), (regular chow: [mamm]), (wd: [gngm]), (cholesterol: [bacs,orch]), (fat: [gngm]), (weeks: []), (wd-treated mice: [mamm]), (social avoidance: [socb]), ( crawl-over: [fndg]), (behaviours: [inbe]), (body-body contacts: [humn]), (hyperlocomotion: []), (wd-fed group: [dsyn]), (deficits: []), (hippocampal-dependent performance: [inbe]), (contextual memory: [menp]), (fear conditioning: [menp]), (pellet displacement paradigms: [menp]), (reduction: [npop]), (glucose tolerance: [phsf]), (elevated levels: []), (serum cholesterol: [lbpr]), (leptin: [aapp,horm]), (peroxisome proliferator-activated receptor gamma coactivator: [aapp,rcpt]), (1-alpha (ppargc1a) mrna: [bacs,nnon]), (marker: [clna]), (mitochondrial activity: [celc]), (prefrontal cortex: [bpoc]), ( hippocampus: [bpoc]), ( hypothalamus: [bpoc]), (dorsal: []), (brain: [bpoc]), (mitochondrial functions: [celc]), (liver: [bpoc]), (first report: [qnco]), (social interactions: [fndg]), (dominant-like behaviours: [inbe]), (nave adult mice: [mamm]), (spectrum: [qnco]), (symptoms: [sosy]), (autism: [mobd]), ( and: []), (humans: [humn]), (autism spectrum disorder: [mobd]), 
ASD Terms: (western diet, 'Dietary Restrictions')(social behaviour, 'Reciprocal Social Interaction')(hippocampus-dependent cognitive functions, 'Cognitive Ability')(contextual memory, 'Working Memory')(social interactions, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(exacerbate autism spectrum disorder, 'Autism Phenotype')

PMCID: 6380693
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (supplemental digital content: []), (text: []), 
ASD Terms: (supplemental digital content, 'Dietary Supplements')

PMCID: 4512679
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (social cognitive deficits: [mobd]), (pervasive difficulties: [fndg]), (social interaction: [fndg]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (neuroimaging studies: [diap]), (visual perceptual impairments: [fndg]), (role: [socb]), (people: [popg]), (asd: [cgab]), (robust bias towards: [bird]), (information: []), (expense: [qnco]), (global information: []), (mechanisms: []), (phenomenon: [phpr]), (issue: [fndg]), (functional field: [irda]), (view: []), (group: [popg]), (high-functioning children: [aggp]), (autism (n: [mobd]), (paired non-asd group (n: [cgab]), (results: [fndg]), (ability: [orga]), (stimuli: [phpr]), (eccentricity: []), (fovea: [bpoc]), (probe analysis: [resa]), (asd group: [cgab]), (retinal eccentricity: [bpoc]), (children: [aggp]), (thus: []), ( children: [aggp]), (conventional hypothesis: []), (deficit: [dsyn]), (global processing: [acty]), (weak central coherence: [lbpr]), (alternatively: []), (data: [euka]), (bias: [bird]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(social cognitive deficits, 'Social Competence')(visual perceptual impairments, 'Visual Thinking')(autism, 'Autism Phenotype')

PMCID: 5822449
SFARI Genes: Shank3, Shank3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, Shank3, Shank3, SHANK3, SHANK3, 
Non SFARI Genes: 
Named Entities: (shank3: [gngm]), (structural protein: [aapp,bacs]), (postsynaptic density: [celc]), (mutations: [genf]), (shank3 gene: [gngm]), (risk: []), (autism spectrum disorder (asd): [mobd]), (induced pluripotent stem cells: [cell]), (control individuals: [humn]), (human donors: [humn]), (asd: [cgab]), (microdeletions: []), (addition: []), (zinc finger nucleases: [amas]), (isogenic shank3 knockout: [emod]), (human embryonic stem (es) cell lines: [cell]), (pluripotent cells: [cell]), (olfactory placodal neurons: [orgf]), (patient-derived placodal neurons: [cell]), (synapses: [bsoj]), (control cells: [cell]), (moreover: []), (patient-derived cells: [podg]), (developmental phenotype:: [orga]), (young postmitotic neurons: [cell]), (cell: [gngm]), (neurites: [celc]), (reduced motility: [orgf]), (controls: [sbst]), (phenotypes: [orga]), (shank3-edited es cells: [cell]), (transduction: [orgf]), (shank3 expression construct: [topp]), (developmental phenotype: [orga]), (same ipsc lines: []), (cortical neurons: [bpoc]), (critical role: [socb]), (neuronal morphogenesis: [orgf]), (placodal neurons: [cell]), (early defects: []), (asd-associated mutations: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5351200
SFARI Genes: 
Non SFARI Genes: ms, 
Named Entities: (socio-emotional difficulties: [menp]), (autism spectrum disorder (asd): [mobd]), (impaired functional connectivity: []), (social brain: [bpoc]), (whole-brain characterization: [acty]), (fast responses: [fndg]), (functional connectivity: []), (implicit processing: [acty]), (adults: [aggp]), (asd: [cgab]), (present study: [qnco]), (magnetoencephalography: [diap]), (early responses: [orga]), (interregional phase synchronization: []), (happy faces: [blor]), (sample (n: [aapp,imft]), (young adults: [aggp]), (developed (td) controls: [sbst]), (phase-synchrony: []), (beta band: [celc]), (ms: [gngm]), (processing: [acty]), (td group: [popg]), (key areas: []), (same time: []), (window: []), ( de-synchronization: []), (amygdala: [bpoc]), (asd group: [cgab]), (conditions: [dsyn]), (first demonstration: [qnco]), (local synchrony patterns: []), (emotional faces: [blor]), (present results replicate: [fndg]), (previous findings: [clna]), (adolescents: [aggp]), ( highlighting: []), (atypical brain synchrony: [bpoc]), (socio-emotional stimuli: [menp]), (hallmark: []), (clinical sequelae: [fndg]), (autism: [mobd]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0123-2) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5324587
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (social stimuli: [phpr]), (eyes: [bpoc]), (results: [fndg]), (atypicalities: []), (phasic alerting: [orch,phsu]), (role: [socb]), (social orienting: []), (asd: [cgab]), (unisensory (visual) trials: [resa]), ( children: [aggp]), ((among distractors): []), (controls: [sbst]), (age: [orga]), ( sex: [orgf]), (nonverbal iq: [fndg]), (however: []), (condition: [dsyn]), (nonpredictive sound: [npop]), (visual targets: [diap]), (group effect: [popg]), (reversed: []), (social versus: []), (nonsocial stimuli: [phpr]), (mechanisms: []), (young children: [aggp]), (autism res: [mobd]), (autism research: [mobd]), (wiley periodicals: []), ( inc: []), (behalf: []), (international society: [orgt]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 5351210
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (repetitive behaviors: [fndg]), (features: []), (autism spectrum disorder (asd): [mobd]), (diagnostic criteria: []), (asd: [cgab]), (behavioral domain: []), (atypical responses: [orga]), (stimuli: [phpr]), (neural circuitry: [bpoc]), (life: []), (longitudinal diffusion tensor: [npop]), (data: [euka]), (infants: [aggp]), (high familial risk: [famg]), (age: [orga]), (cortical: [bpoc]), ( cerebellar: [bpoc]), (striatal white matter pathways: [bpoc]), (ages: [bacs,orch]), (months: []), (dependent variables: []), (repetitive behavior: [fndg]), (sensory experiences questionnaire: [menp]), (children: [aggp]), (sensory response patterns: [fndg]), (accounting: []), (developmental level: [orgf]), (social impairment: [patf]), (longitudinal analyses: [resa]), (genu: [bpoc]), (cerebellar pathways: [bpoc]), (sensory responsiveness: []), (social deficits: []), ( fractional anisotropy: [npop]), (exploratory analyses: [resa]), (possible disordinal interaction: []), (diagnostic status: [fndg]), (association: [menp]), (fractional anisotropy: [npop]), (findings: [clna]), (diagnosis: [fndg]), (years: []), (structural properties: []), (callosal: []), (cerebellar white matter pathways: [moft]), (infancy: []), (toddlerhood: []), (unusual sensory response: [fndg]), (co-occur: [acty]), (share: [socb]), (common brain-behavior relationships: [bpoc]), (results: [fndg]), (absence: [anab]), (pathways: [moft]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0126-z) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(sensory response patterns, 'Reaction to Sensory Stimuli')(social impairment, 'Social Competence')(sensory responsiveness, 'Reaction to Sensory Stimuli')(social deficits, 'Social Competence')(sensory responsiveness, 'Reaction to Sensory Stimuli')(diagnosis, 'Diagnosis')(infancy, 'Perinatal History')(unusual sensory response, 'Reaction to Sensory Stimuli')

PMCID: 5509828
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (influence: []), (autism phenotype (bap): [mobd]), (adjustment: [inbe]), (siblings: [famg]), (children: [aggp]), (autism: [mobd]), (western cultures: [lbpr]), (present research: [resa]), (diathesis-stress model: [clna]), (questionnaire study: [resa]), (dyads: [popg]), (taiwan: []), (united kingdom (uk): []), (uk siblings: [famg]), (elevated adjustment difficulties: [inbe]), (taiwanese sample: [sbst]), (data: [euka]), (whilst: []), (bap levels: [aapp,enzy]), (adjustment difficulties: [inbe]), ( differences: [qnco]), (cultures: [lbpr]), (respondents: [popg]), (significant diathesis-stress interactions: [clna]), (opposite direction: []), (model: []), (cultural settings: [qnco]), (implications: []), (culturally-sensitive sibling support: [famg]), (considered: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism phenotype, 'Autism Phenotype')(autism phenotype levels, 'Autism Phenotype')

PMCID: 5015226
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (williams: []), ((ws): []), (difficulties: [fndg]), (nature: []), (remains: []), (study: [resa]), (behavioral paradigms: [inbe]), (preschoolers: [aggp]), (asd: [cgab]), (iq-matched peers: [popg]), (ws: [gngm]), (novel behaviors: [inbe]), (outcomes: []), (own actions: []), ((non-social learning): [menp]), ( (2): [qnco]), (imitation: [socb]), (others actions: [dora]), ((social learning): [menp]), (situations: []), (imitative learning: [menp]), (instrumental function: [phsf]), (social affiliation motives: []), (groups: [popg]), (similar abilities: [orga]), (consequences: []), (new actions: []), (achievement: [bhvr]), (tangible goal: []), (attention: [menp]), (imitative learning performance: [inbe]), (model: []), (engaging manner: [fndg]), (abnormalities: [cgab]), (instrumental dimensions: [qnco]), (learning: [menp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(imitation, 'Imitation')(imitative learning, 'Imitation')(imitative learning performance, 'Imitation')(learning abnormalities in asd, 'Learning Disorders')

PMCID: 6199690
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract experiences: [menp]), (autism-spectrum disorder: [mobd]), (social scientists: []), (humananimal relations: [socb]), (major focus: []), (social inquiry: [resa]), (recent years: []), (horse-assisted therapy: [topp]), (autistic spectrum disorders: [mobd]), (first paper: [qnco]), (fields: [irda]), (participant observation: [hlca]), (interviews: [acty]), (uk horse therapy centre: [mamm]), (article: []), (staff: []), (parents: []), (riders: []), (successes: [socb]), (limitations: []), (equine therapy: [mamm]), (respondents: [popg]), (open up autistic children: [podg]), (possible interactions: []), (impossible before: []), (horses: [mamm]), (emergence: []), (social behaviours: [socb]), (eye contact: [socb]), ( pointing: [qnco]), (speech: [orgf]), (key explanations: []), (therapeutic success:: [socb]), (sensorial: []), (experience: [menp]), (horse;: [mamm]), (specific movements: [orgf]), (rhythms: [fndg]), (personality: [mobd]), (horse: [mamm]), (form: []), (multispecies: []), (resonance: [npop]), (rider: []), (horse seeming: [mamm]), (new attunement: []), (humans: [humn]), (practices: [menp]), (perceptions: [menp]), (efficacy: [resa]), ( serve: []), (turn: [fndg]), (version: []), (empathy: [inbe]), (sensorial interactions: []), (particular kinds: []), 
ASD Terms: (autistic spectrum disorders, 'Autistic Disorder')(social behaviours, 'Reciprocal Social Interaction')(eye contact, 'Eye Contact')(speech, 'Language Ability')(rhythms, 'Prosody')(empathy, 'Empathy')(perceptions, 'Cognitive Ability')

PMCID: 4860196
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (profound difficulties: [fndg]), (empathic processing: [inbe]), (executive control: [menp]), (links: []), (processes: [phpr]), (populations: [popg]), (autism: [mobd]), ( few studies: [lbpr]), (subclinical level: [phsu]), (contribution: [acty]), (alexithymia: [sosy]), (trait: [orga]), (impaired interoceptive awareness: [menp]), (empathy: [inbe]), (asd: [cgab]), (present two-part study: [resa]), (comprehensive battery: [inpo]), (tasks: []), (findings: [clna]), (notion: []), (executive function: [menp]), (theory: []), (mind: [menp]), (individuals: [humn]), (elevated levels: []), (autism-like traits: [mobd]), (similar pattern: []), (executive function difficulties: [menp]), (impairments: [patf]), (co-occurring alexithymia: [sosy]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(empathy, 'Empathy')(executive function, 'Executive Function')(executive function difficulties, 'Executive Function')

PMCID: 5825895
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), ( schizophrenia (scz): [mobd]), (intellectual disability (id): [mobd]), (remarkable overlap: [topp]), (symptoms: [sosy]), (impairments: [patf]), (cognition: [menp]), ( social behavior: [socb]), (communication: [socb]), (human: [humn]), (genetic studies: [resa]), (enrichment: []), (mutations: [genf]), (actin-related genes: [gngm]), (disorders: [dsyn]), (candidate genes control actin dynamics: [aapp,bacs]), (findings: [clna]), (hypotheses: (i): [inch]), (asd: [cgab]), ( scz: []), (id share: [socb]), (common disease mechanisms;: [dsyn]), ((ii) that: []), (subgroup: [virs]), (affected individuals: [humn]), ( defects: []), (actin cytoskeleton cause: [celc]), (contribute: [acty]), (pathologies: []), (cofilin1: []), (key regulator: []), (actin dynamics: [aapp,bacs]), (critical role: [socb]), (synaptic plasticity: [ortf]), (associative learning: [menp]), (notably: []), (recent studies: [lbpr]), (over-activation: [acty]), (mutant mice: [mamm]), (asd-: [cgab]), (scz-like behavioral phenotypes: [bhvr]), (cofilin1-dependent actin dynamics: [aapp,bacs]), (behavioral abnormalities: [mobd]), (deficits: []), (social behavior: [socb]), ((i): [inch]), (cognitive impairments: [mobd]), ( cofilin1 mutants: [comd]), (additional behavioral deficits: [inbe]), (relevance: []), (scz;: []), (cofilin1 mutants: [comd]), (valuable tool: []), (underlying disease mechanisms: [dsyn]), (hypotheses: []), (ultrasonic communication: [npop]), (juvenile mutants: [comd]), (evidence: []), (impaired direct reciprocal social interaction: [fndg]), (social approach: []), (social memory: [menp]), (moreover: []), (concomitant emission: [bdsu]), (ultrasonic vocalizations: [npop]), (social activity: [socb]), (notion: []), (pro-social communicative function: [aapp,bacs]), (social contact: [socb]), (social proximity: []), (finally: []), (abnormal repetitive behaviors: [mobd]), (instead: []), (weaker: [sosy]), (novel object recognition: [menp]), (non-matching-to-sample learning: [menp]), (absence: [anab]), (scz-like phenotype: [orga]), (non-social cognition: [socb]), 
ASD Terms: (cognition, 'Cognitive Ability')(social behavior, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(intellectual disability, 'Learning Disorders')(social behavior, 'Reciprocal Social Interaction')(intellectual disability share, 'Learning Disorders')(social behavior, 'Reciprocal Social Interaction')(behavioral abnormalities, 'Personal Traits')(additional behavioral deficits with relevance, 'Personal Traits')(cognitive impairments, 'Cognitive Ability')(additional behavioral deficits, 'Personal Traits')(impaired direct reciprocal social interaction, 'Reciprocal Social Interaction')(social memory, 'Working Memory')(ultrasonic vocalizations, 'Vocalizations')(ultrasonic vocalizations, 'Vocalizations')(pro-social communicative function as social contact, 'Reciprocal Social Interaction')(social activity, 'Engagement in Social Activities')(pro-social communicative function, 'Reciprocal Social Interaction')(abnormal repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(non-social cognition, 'Cognitive Ability')

PMCID: 6080759
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (repetitive thinking: [menp]), (high rates: [qnco]), (depression: [mobd]), (extent: []), (repetitive negative thinking: [menp]), (asd: [cgab]), (autistic stereotypy: [mobd]), (general depressive thinking patterns: [menp]), (rumination): [mobd]), (treatment research: [resa]), (emotional health: [menp]), (associations: [menp]), (rumination: [mobd]), ( depressive symptoms: [sosy]), (pupil response: [orgf]), (social-emotional material: [menp]), (adults: [aggp]), ((td) adults: [aggp]), (n: [aapp,imft]), (fluent young adults: [aggp]), (cohorts: asd: [cgab]), (never-depressed td-controls: [fndg]), ( n: [aapp,imft]), (participants: [popg]), (ruminative response scale: [mobd]), (beck depression inventory self-reports: [resa]), (passive-viewing task: []), (emotionally-expressive faces: [blor]), (pupillary motility: [bpoc]), (cognitive-affective load: [acty]), (main: []), (interactive effects: []), (cohort: [popg]), ( emotion condition: [mobd]), (time: []), (pupil: [bpoc]), (linear mixed effects analysis: [resa]), (variance: [qnco]), (maximum likelihood estimation: [resa]), (similar procedures: [topp]), (effects: []), (depressive symptoms: [sosy]), (pupil amplitude: [bpoc]), (responsive pupil dilation: [sosy]), (asd cohort: [cgab]), (comparable levels: []), (trial end: [resa]), (sad faces: [blor]), ( individuals: [humn]), (depression scores: [mobd]), (td-depressed participants faster: [fndg]), ( larger: [qnco]), (early pupil response: [orgf]), (faces: [blor]), (people: [popg]), (elevated depressive symptoms: [sosy]), (increases: [qnco]), (pupil-indexed neural activation: [bpoc]), (sad stimuli: [phpr]), ( regardless: []), (asd status: [cgab]), (utility: [orgt]), (depression-like: [mobd]), (treatment: [topp]), (ruminative processes: [mobd]), (potential utility: [orgt]), (interventions: [hlca]), (reactions: []), (findings: [clna]), (importance: []), (variables: []), (asd research: [cgab]), 
ASD Terms: (depression, 'Depressive Disorder')(autism spectrum disorder, 'Autism Phenotype')(general depressive thinking patterns, 'Depressive Disorder')(depressive symptoms, 'Depressive Disorder')(depressive symptoms, 'Depressive Disorder')(beck depression inventory self-reports, 'Depressive Disorder')(depressive symptoms, 'Depressive Disorder')(viewing sad faces, 'Depression')(sad faces, 'Depression')(depression scores, 'Depressive Disorder')(sad faces, 'Depression')(elevated depressive symptoms, 'Depressive Disorder')(sad stimuli, 'Depression')

PMCID: 5536272
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (schizophrenia spectra: [mobd]), (large degree: [qnco]), (interpersonal domains: []), (similarly: []), (abnormal excitatory glutamate: [aapp,bacs]), (inhibitory -aminobutyric acid (gaba) neurotransmitter concentrations: [aapp,bacs]), (spectra: [qnco]), (interplay: []), (neurotransmitters: [bacs]), (cortical excitation: [bpoc]), (inhibition regulation: [acty]), (study: [resa]), (neurotransmitter abnormalities: [bacs]), (symptomatology: []), (degree: [qnco]), (abnormality increases: [fndg]), (symptom severity: [fndg]), (hence: []), (relationship: []), (glutamate/gaba ratio: [aapp,bacs]), (schizophrenia spectrum traits: [mobd]), (unmedicated: []), ( subclinical population: [popg]), (total: [qnco]), (adults: [aggp]), (male): [orga]), (years: []), (autism spectrum quotient (aq): [qnco]), (schizotypal personality questionnaire (spq): [mobd]), (resting state proton: [elii]), (magnetic resonance spectroscopy study: [diap]), (sequences: [nusq]), (quantification: [qnco]), (glutamate: [aapp,bacs]), (gaba+ concentration: [aapp,bacs]), (right: []), (superior temporal voxel: []), (significant: [qnco]), ( moderate: []), (positive relationships: [fndg]), (right superior temporal glutamate/gaba+ ratio: [aapp,bacs]), (aq: []), ( spq: []), (aq+spq: []), (total scores: [qnco]), (spq: []), (social anxiety: [mobd]), ( no close friend: [grup]), ( constricted affect: [menp]), ( odd behaviour: [mobd]), ( odd speech: [orgf]), ( ideas: [menp]), (reference: []), (suspiciousness: [fndg]), (social skills: [socb]), ( communication: [socb]), (attention switching (p<0.05);: [menp]), (glutamate/gaba+: [aapp,bacs]), (scores: [clna]), (subscales: []), (relationships: []), (glutamate/gaba+ ratio: [aapp,bacs]), ( social skills: [socb]), (communication: [socb]), (multiple comparison correction: [acty]), (left: []), (superior temporal glutamate/gaba+ ratio: [aapp,bacs]), (imagination (p<0.05): [menp]), (findings: [clna]), (evidence: []), (association: [menp]), (excitatory/inhibitory neurotransmitter concentrations: [acty]), (symptoms: [sosy]), 
ASD Terms: (autism, 'Autism Phenotype')(schizophrenia spectra, 'Schizophrenia and Disorders with Psychotic Features')(schizophrenia spectrum traits, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum quotient, 'Autism Phenotype')(social anxiety, 'Anxiety Disorders')(odd speech, 'Language Ability')(odd speech, 'Language Ability')(suspiciousness, 'Suspicious of Others')(social skills, 'Ability to Converse in Social Settings')(social skills, 'Ability to Converse in Social Settings')(imagination, 'Imagination')

PMCID: 4858588
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (impairments: [patf]), (social motivational processes: [menp]), (differences: [qnco]), (social interaction: [fndg]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (social motivation hypothesis: [menp]), (association: [menp]), (hedonic capacity: [qnco]), (asd: [cgab]), (however: []), (findings: [clna]), (hedonic deficits: []), (asd; adults: [cgab]), (levels: []), (physical pleasure whereas: [menp]), (report: [hlca]), (social pleasure: [menp]), (moreover: []), (few studies: [lbpr]), (anhedonia: [mobd]), (autistic traits: [mobd]), (measures: [qnco]), (hedonic response: [fndg]), (temporal aspects: [qnco]), (pleasure: [menp]), (account: [clna]), (present study: [qnco]), (associations: [menp]), (experience: [menp]), (non-clinical sample: [sbst]), (young adults: [aggp]), (nature: []), (autism phenotype (bap): [mobd]), (results: [fndg]), (general pleasure: [menp]), (regression analyses: []), (predictor: []), (social hedonic capacity: [qnco]), (general population: [popg]), (conceptualizations: [menp]), (bap: [gngm]), 
ASD Terms: (impairments in social motivational processes, 'Social Competence')(social interaction, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(autism phenotype, 'Autism Phenotype')

PMCID: 4847244
SFARI Genes: 
Non SFARI Genes: cope, 
Named Entities: (perspectives: []), (caregivers: []), (children: [aggp]), (developmental disorders: [mobd]), (low-income countries: [grpa]), (intervention programmes: [hlca]), (purpose: []), (study: [resa]), (stigma: [fndg]), (experiences: [menp]), ( explanatory models: []), (preferred interventions: [hlca]), (mechanisms: []), (ethiopia: []), (participants: [popg]), (child mental health clinics: [hcro,mnob]), (addis ababa: []), (majority (66.7 %;: [socb]), (diagnosis: [fndg]), (intellectual disability: [mobd]), ((33.3 %): []), (autism spectrum disorder (asd): [mobd]), (primary diagnosis: [clna]), (structured questionnaire: []), (face-to-face interview: [resa]), (adaptation: [orgf]), (family interview schedule: [famg]), (questions: []), (socio-demographic characteristics: [grpa]), (explanatory models: []), (illness: [sosy]), ( type: [qnco]), (interventions: [hlca]), (strategies: [menp]), (question: []), (familys: []), (unmet needs: [acty]), (experience: [menp]), (%: []), (childs condition: [dsyn]), (effort: [orgf]), (childs condition secret: [dsyn]), (type: [qnco]), (developmental disorder: [mobd]), (childs age: [aggp]), (gender: [orga]), (age: [orga]), (level: [phsu]), (education: [fndg]), (caregiver (all p: [aapp,imft]), (traditional help: []), (provided supernatural explanations: [acty]), (childs condition (p = .02): [dsyn]), (orthodox christian faith (p = .03): [aapp,imft]), (mixture: [sbst]), (biomedical explanations: []), (head injury (30.4 %): [inpo]), (birth complications: [fndg]), (%)): []), (supernatural explanations: []), (spirit possession (40.2 %): [qnco]), (sinful act (27.5 %)): [topp]), (unmet need: [acty]), (educational provision: [edac]), (child (74.5 %): [aggp]), (treatment: [topp]), (health: []), (professional (47.1 %): []), (financial support (30.4 %): [fndg]), (expert help: []), (childs development (27.5 %): [orgf]), (health professionals: []), (%): []), (family (85.3 %): [famg]), (many caregivers: []), (support: []), (friends: [popg]), ((76.5 %): []), (prayer (57.8 %): []), (families: [famg]), (child: [aggp]), (low-income settings: [grpa]), (awareness: [menp]), ( decrease stigma: [fndg]), (access: []), (caregivers support: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s12913-016-1383-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (diagnosis, 'Diagnosis')(intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(primary diagnosis, 'Diagnosis')(adaptation, 'Adaptive Life Skills')(birth complications, 'Obstetric Delivery Complications')

PMCID: 5870086
SFARI Genes: 
Non SFARI Genes: impact, pole, pole, 
Named Entities: (intranasal: []), ((ot): [hlca]), (social communication functioning: [socb]), (individuals: [humn]), (autism spectrum disorder (asd) and: [mobd]), ( thus: []), (considerable interest: [menp]), (potential asd: [cgab]), (therapeutic agent: [phsu]), (preclinical research: [resa]), (ot: [gngm]), (functional output: []), (mesocorticolimbic dopamine system: [bacs,orch,phsu]), (clinical brain imaging study: [bpoc]), (date: []), (effects: []), (system: []), (reward processing paradigm: [menp]), (this: []), (incentive delay task: []), (single dose: [fndg]), (intranasal ot: [hlca]), ( versus placebo (plc): [topp]), (neural responses: [orga]), (nonsocial rewards: [menp]), (children: [aggp]), (asd: [cgab]), (placebo-controlled double-blind study: [resa]), (adolescents: [aggp]), (asd (age: m: [cgab]), (years: []), ( sd: [mamm]), (fmri scans: [diap]), (intranasal ot administration: [topp]), (plc administration: [topp]), (sessions: [evnt]), ( participants: [popg]), (nonsocial incentive delay tasks: []), (task-based neural activation: [acty]), (connectivity: []), (impact: [gngm]), (plc: []), (mesocorticolimbic brain responses: [bpoc]), (nonsocial reward anticipation: [menp]), (outcomes: []), (central analyses: [resa]), (plc conditions: [dsyn]), (activation: [acty]), (right nucleus accumbens: [bpoc]), (anterior cingulate cortex (acc): [bpoc]), (bilateral orbital frontal cortex (ofc): [bpoc]), (superior frontal cortex: [bpoc]), (right frontal pole (fp): [bpoc]), (ot condition relative: [dsyn]), (alternatively: []), (social reward anticipation: [menp]), (significant increases: [qnco]), (brain activation: [bpoc]), (treatment group  reward condition interaction: [menp]), (right nacc: []), ( right caudate nucleus: [bpoc]), (acc: [gngm]), (right ofc: [dsyn]), (additionally: []), (analyses: [resa]), (nonsocial reward outcomes: [menp]), (fp: [gngm]), (finally: []), (functional connectivity: []), (changes: [qnco]), (frontostriatal connections: []), (response: [fndg]), (social: []), ( rewards: [menp]), (mesocorticolimbic brain systems: [bpoc]), (rewards: [menp]), (processing: [acty]), (nonsocial incentive salience stimuli: [phpr]), (findings: [clna]), (implications: []), (neural systems: [bdsy]), (experimental trials: [resa]), (novel asd treatments: [cgab]), (social communication impairments: [mobd]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s11689-018-9228-y) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (social communication functioning, 'Reciprocal Social Interaction')(autism spectrum disorder and, 'Autism Phenotype')(ameliorate social communication impairments, 'Reciprocal Social Interaction')(social communication impairments, 'Reciprocal Social Interaction')

PMCID: 6196530
SFARI Genes: RAI1, RAI1, Rai1, Rai1, 
Non SFARI Genes: 
Named Entities: (significance: [qnco]), (copy: []), (rai1 gene causes smithmagenis: [gngm]), (neurodevelopmental disorder: [mobd]), (sms mouse model: [emod]), (study: [resa]), (rai1 gene dose: [qnco]), (early postnatal window: []), (gene expression: [genf]), (social interaction deficits: [fndg]), (sms model: []), (reduced density: [fndg]), (dendritic spines: [celc]), ( anatomical correlates: []), (excitatory synapses: [celc]), (prefrontal cortex: [bpoc]), (artificial activation: [acty]), (prefrontal cortex neurons: [bpoc]), (behavioral deficits: [inbe]), (findings: [clna]), (rett syndrome: [dsyn]), ( sms: []), (disruption: []), (chromatin-modifying gene: [aapp]), (reversible developmental phenotypes: [orga]), (potential treatment windows: [topp]), (childhood: []), (adolescence: []), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(social interaction deficits, 'Reciprocal Social Interaction')(behavioral deficits, 'Personal Traits')(rett syndrome, 'Rett Syndrome')

PMCID: 5800535
SFARI Genes: 
Non SFARI Genes: cope, 
Named Entities: (emotions: [menp]), (culture: [lbpr]), (pivotal role: [socb]), (friends: [popg]), (peers: [popg]), (social participation: [socb]), (students: [popg]), (autism spectrum disorders: [mobd]), (emotional life: [menp]), (context: [fndg]), (school cultures: [mnob,orgt]), (anxiety: [mobd]), (loneliness: [fndg]), (friendships: [socb]), (daily encounters: [bhvr]), (adolescents: [aggp]), (asd: [cgab]), (specific context: [fndg]), (japanese schools: [mnob,orgt]), (facilitators: []), (barriers: []), (social interaction: [fndg]), (individuals: [humn]), (them: []), (present qualitative study: [resa]), (perceptions: [menp]), (everyday school life: [mnob,orgt]), (japan: []), (data: [euka]), (means: []), (semi-structured individual interviews: [acty]), (wide range: [qnco]), (motivations: [menp]), (socialization: [edac]), (limited future prospects: [fndg]), ( robust self-awareness: [menp]), (ones own social challenges: [qnco]), (conscious efforts: [menp]), (challenges: [hlca]), (inductive approach: [topp]), (analysis: [resa]), (themes:: []), (social motivation: [menp]), ( loneliness: [fndg]), ( anxiety: [mobd]), (distress: [menp]), (knowledge: []), (first study: [qnco]), (rich emotional life: [menp]), (asian culture: [popg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(anxiety, 'Anxiety Disorders')(social interaction, 'Reciprocal Social Interaction')(investigated perceptions, 'Cognitive Ability')(perceptions, 'Cognitive Ability')(own social challenges, 'Social Competence')(ones own social challenges, 'Social Competence')(anxiety, 'Anxiety Disorders')

PMCID: 3561169
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (group-based social skills: [socb]), ((sst): []), (treatment: [topp]), (choice: [inbe]), (high-functioning autism spectrum disorder (hfasd): [mobd]), (trial: [resa]), (efficacy: [resa]), (safety: [hcpp]), (sst: [gngm]), (children: [aggp]), (adolescents: [aggp]), (hfasd: []), (randomised: []), ( multi-centre: []), (add-on group-based sst: [popg]), (weeks: []), (sostafra program: [phsu]), (improved social responsiveness: []), (parent: []), (social responsiveness scale: [acty]), ( srs): []), (usual (tau): [resa]), (further expected: []), (self: []), (anxiety: [mobd]), (depressive symptoms: [sosy]), (pro-social behaviour: [aapp,bacs]), (treatment group: [popg]), (neurophysiological study: [resa]), (frankfurt hfasd subgroup: [virs]), (post treatment: []), (changes: [qnco]), (neural function: [phsf]), (sst versus tau: [resa]), (methods/design: [acty]), (sosta: []), (net trial: [resa]), (prospective: [resa]), ( randomised: []), (parallel: [resa]), (primary outcome: [topp]), (srs score: [clna]), (intervention: [hlca]), (months: []), (several secondary outcome measures: [neop]), (target sample: [sbst]), (individuals: [humn]), (asd: [cgab]), (study centres: [resa]), (discussion: [socb]), (study: [resa]), (trials: [resa]), (hfasd worldwide: []), (several advantages: [qnco]), (regard: []), (exclusion criteria: []), ( study methods: [resa]), (therapeutic approach chosen: [acty]), (non-university-based clinical settings: [mnob,orgt]), (trial registration isrctn94863788  sosta: [resa]), (autism spectrum disorder: [mobd]), 
ASD Terms: (group-based social skills training, 'Ability to Converse in Social Settings')(high-functioning autism spectrum disorder, 'Autism Phenotype')(safety of social skills, 'Ability to Converse in Social Settings')(high-functioning autism spectrum disorder, 'Autism Phenotype')(social skills, 'Ability to Converse in Social Settings')(high-functioning autism spectrum disorder, 'Autism Phenotype')(add-on group-based social skills, 'Ability to Converse in Social Settings')(anxiety, 'Anxiety Disorders')(depressive symptoms, 'Depressive Disorder')(high-functioning autism spectrum disorder subgroup, 'Autism Phenotype')(trials on social skills, 'Ability to Converse in Social Settings')(high-functioning autism spectrum disorder worldwide, 'Autism Phenotype')(group-based social skills, 'Ability to Converse in Social Settings')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5858410
SFARI Genes: met, met, met, met, 
Non SFARI Genes: 
Named Entities: (parent carers: []), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (levels: []), (stress: [fndg]), ( depression: [mobd]), (anxiety: [mobd]), (unmet parent carer: [acty]), (mental health needs: [menp]), (significant risk: [qnco]), (psychological: [mobd]), ( physical: [hlca]), (social well-being: [socb]), (parents: []), (child: [aggp]), (asd: [cgab]), (adaptive functioning: []), (family: [famg]), (potential: []), (systematic review identifies: []), (key qualities: []), (interventions: [hlca]), (mental health: [menp]), (practitioner-parent carer support guidelines: [hlca]), (search: [acty]), (databases: []), (pubmed: []), ( psycinfo: []), (social science data): [euka]), (studies: [lbpr]), (criteria:: []), (intervention: [hlca]), (age: [orga]), (years;: []), (research design: [resa]), (comparison: [acty]), (outcomes: []), (groups;: [popg]), ((3) outcome measures: [qnco]), (total: [qnco]), (inclusion criteria: []), (critical interpretive synthesis approach: [biof]), (integrated conceptualization: [menp]), (evidence: []), (findings: [clna]), (practitioner guidelines: []), (wellbeing: []), (parents self-perspective taking: []), (skill: [inbe]), (real time problem-solving: [menp]), 
ASD Terms: (depression, 'Depressive Disorder')(autism spectrum disorder, 'Autism Phenotype')(depression, 'Depressive Disorder')(anxiety, 'Anxiety Disorders')(adaptive functioning, 'Adaptive Life Skills')

PMCID: 5309295
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (social motivation theory (chevallier: [menp]), (al.: [lbpr]), ( trends: []), (cognitive sciences: []), (suggests: []), (social difficulties: [fndg]), (autism spectrum condition (asc): [mobd]), (difference: [qnco]), (motivation: [menp]), (other people: [popg]), (adolescents: [aggp]), ((n =: [aapp,imft]), ((n: [aapp,imft]), (asc: [gngm]), (choose-a-movie paradigm: [acty]), (social seeking: []), (results: [fndg]), (preference: []), (objects: []), (line: [sbst]), (theory: []), (low social motivation: [fndg]), (however: []), (typical adolescents: [aggp]), (stimuli preferences: [phpr]), (questions: []), (developmental changes: [orgf]), (social motivation: [menp]), (age: [orga]), (significant role: [socb]), (choice behaviour: [inbe]), (participants: [popg]), (implications: []), (findings: [clna]), (detail: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-016-2974-3) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (suggests that social difficulties, 'Social Competence')(social difficulties, 'Social Competence')(autism spectrum condition, 'Autism Phenotype')

PMCID: 5107264
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (social cognition: [socb]), (hallmark: []), (autism spectrum disorder: [mobd]), (neurobiological theories: []), (precedence: []), (causation studies: [lbpr]), (researchers: []), (abnormalities: [cgab]), (brain development: [ortf]), (cause: []), (deficits: []), (social behavior: [socb]), (cognitive processes: [menp]), (language: [lang]), (discovery: [acty]), (mirror neurons: [cell]), (dominant theory: []), (mirror neuron system: [cell]), (critical role: [socb]), (pathophysiology: [patf]), (various symptoms: [sosy]), (autism: [mobd]), (decades: [qnco]), (theory: []), (suggestion: []), (broken mirror neuron system: [cell]), (impairments: [patf]), (mirror neuron circuitry: [bpoc]), (total support: [qnco]), (comprehensive analysis: [resa]), (body: [humn]), (research: [resa]), (light: [gngm]), (benefits: [qnco]), (disadvantage: []), (connection: []), 
ASD Terms: (social cognition, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(abnormalities in brain development, 'Learning Disorders')(social behavior, 'Reciprocal Social Interaction')(cognitive processes, 'Cognitive Ability')(autism, 'Autism Phenotype')

PMCID: 5789214
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (neuropsychological assessment: [diap]), (profound analysis: [resa]), (cognitive functioning: [menp]), (people: [popg]), (autism spectrum disorder (asd): [mobd]), (individuals: [humn]), (autistic spectrum: [mobd]), (high level: [qnco]), (anxiety: [mobd]), (comorbidities: []), (quality: []), (life: []), (yet: []), (cognitive strengths: []), (order: [acty]), (effective support strategies: [menp]), (article: []), (overview: []), (cognitive areas: []), (neuropsychological evaluation (ie: [diap]), ( intelligence: [menp]), ( attention: [menp]), ( executive: []), (social cognition: [socb]), (praxis): [euka]), (underlying causes: []), (behavioral problems: [mobd]), (persons: [popg]), (asd: [cgab]), (importance: []), (regard: []), (method: [lbpr]), (single cognitive processes: [fndg]), (targeted manner: []), (objective test results: [fndg]), (improved sense: [ortf]), (coherence: [fndg]), (line: [sbst]), (salutogenic model: [hlca]), (human health: [humn]), (well-being: []), 
ASD Terms: (cognitive functioning, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(anxiety, 'Anxiety Disorders')(comorbidities, 'Comorbidities')(cognitive strengths, 'Cognitive Ability')(cognitive areas, 'Cognitive Ability')(underlying causes of behavioral problems, 'Personal Traits')(behavioral problems, 'Personal Traits')(single cognitive processes, 'Cognitive Ability')

PMCID: 4596848
SFARI Genes: cut, cut, 
Non SFARI Genes: 
Named Entities: (ambition: [menp]), (adults: [aggp]), (autism spectrum disorder (asd): [mobd]), (limited opportunities: [fndg]), (competitive employment: [socb]), (group: [popg]), (employment: []), (entitlement: []), (others: [fndg]), (society: [orgt]), (asd: [cgab]), (economic benefits: [qnco]), (productivity: [qnco]), (resource costs: [qnco]), (few studies: [lbpr]), (cost-benefit ratio: [qnco]), (viewpoint: []), (employer: []), (situation: []), (such study: [resa]), (employers: []), (objective: []), (review: []), (costs: [qnco]), ( benefits: [qnco]), (societal perspective: []), (perspective: []), (databases: []), (scientific studies: [lbpr]), (inclusion criteria: []), (cinahl plus: []), ( cochrane library: [gngm,nnon]), ( emerald: [bird]), ( ovid medline: [mamm]), ( proquest: []), ( psycinfo: []), ( scopus: [bird]), (web: []), (science: []), (results: [fndg]), (opportunities: []), (workforce: []), (inclusiveness viewpoint: []), (strict economic standpoint: []), (employment services: [shro]), (cost: [qnco]), (standard care: [acty]), (outcomes: []), (fact: [gngm]), (expensive group: [popg]), (vocational rehabilitation services for: [topp]), ( adults: [aggp]), (strong chance: []), (appropriate measures: [qnco]), (place: [acty]), (hence: []), ( rehabilitation services: [hlca]), (worthwhile investment: []), (current systematic review: [npop]), (benefits: [qnco]), (adult: [aggp]), (need: []), (topic: []), (further explored: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5446693
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (heterogeneous disorder: [fndg]), (initiatives: [menp]), (interdisciplinary characterization: [acty]), (asd: [cgab]), (phenotypic subtypes: [orga]), (specific likely gene-disrupting mutations: [genf]), (however: []), (role: [socb]), (lgdms: []), (neural social phenotype: [orga]), (study: [resa]), (children: [aggp]), (asd (n: [cgab]), (lgdm): []), (control children: [aggp]), (patterns: []), (mu attenuation: [acty]), (habituation: [mobd]), (videos: []), (nonsocial motions: [npop]), (electroencephalography acquisition: [diap]), (diagnostic comparisons: [acty]), (prior work: [evnt]), (aberrant mu attenuation: [acty]), (upper mu band (1012 hz): [orch]), (typical patterns: []), (mu band (810 hz): [celc]), (preliminary exploration: [topp]), (distinct social sensitization patterns: [orgf]), (social motion): [npop]), (lgdm: []), (embryonic development: [ortf]), (contrast: [irda]), ( children: [aggp]), (post-embryonic development: [orgf]), (stable typical patterns: []), (neural social indices: [lbpr]), (social responsiveness: []), (findings: [clna]), (unique neurophysiological profiles: [lbpr]), (certain genetic etiologies: [topp]), (possible genetic functional subtypes: [topp]), (insight: [menp]), (mechanisms: []), (targeted treatment approaches: [topp]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s11689-017-9199-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5655917
SFARI Genes: met, met, met, met, 
Non SFARI Genes: 
Named Entities: (housing 18%: []), (world's: [popg]), (population: [popg]), ( india: [fish]), (estimate: [qnco]), (prevalence: [qnco]), (autism: [mobd]), (study: [resa]), (selected population: [popg]), (schoolchildren: []), (india: [fish]), (n: [aapp,imft]), (children: [aggp]), ((mean age: [orga]), ([sd: [mamm]), (females): [orga]), (various school types: [phsu]), (boroughs: []), (kolkata: []), (parents/caregivers: []), (teachers: []), (communication disorders: [mobd]), ((scdc): []), (children meeting cutoff: [aggp]), (parentreported scdc: []), (social communication questionnaire (scq): [socb]), (scqpositive children: [aggp]), (diagnostic observation schedule (ados): [hlca]), (teacher report: [fndg]), (scdc: []), (parentreport scdc scores: [clna]), (mean scores: [qnco]), (teacher scdc: [fndg]), (parent scdc: []), (scdcpositive children: [aggp]), (scq: []), (cutoff score: [clna]), (criteria: []), ( autism spectrum disorder (asd): [mobd]), (autism spectrum: [mobd]), (ados: [aapp,enzy]), (weighted estimate: [orga]), (suprathreshold scq scores: [clna]), (weighted prevalence estimate: [orga]), (positive scores: [clna]), (autism spectrum + asd + autism): [cgab]), ((0.070.46%): [fndg]), (20% children: [aggp]), (state: []), (school system: [mnob,orgt]), (asd prevalence: [qnco]), (group: [popg]), (lowerbound: []), (true prevalence: [qnco]), (preliminary data: [euka]), (broaderspectrum autism: [mobd]), (suprathreshold autistic traits: [mobd]), (population sample: [popg]), (school children: [aggp]), (eastern india: [fish]), (autism res: [mobd]), (autism research: [mobd]), (wiley periodicals: []), ( inc: []), (behalf: []), (international society: [orgt]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(social communication questionnaire, 'Reciprocal Social Interaction')(social communication, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism spectrum, 'Autism Phenotype')(suprathreshold social communication questionnaire scores, 'Reciprocal Social Interaction')(broaderspectrum autism, 'Autism Phenotype')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 4488062
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (clinical setting: []), (large proportion: [qnco]), (children: [aggp]), (autism spectrum disorder (asd) experience anxiety symptoms: [mobd]), (anxiety: [mobd]), (important cause: []), (impairment: [patf]), (asd: [cgab]), (effective anxiety interventions: [mobd]), (serious game: [dora]), (mindlight: []), (approach: []), (recent research: [resa]), (video games: []), (intervention vehicle: [bodm]), (mental health: [menp]), (present study: [qnco]), ((sub) clinical anxiety symptoms: [mobd]), (methods/design: [acty]), (randomized: [resa]), (trial (rct): [resa]), (conditions: [dsyn]), ((experimental versus control): [sbst]), (study: [resa]), ( children: [aggp]), (years: []), (diagnosis: [fndg]), ((sub): [qnco]), (clinical anxiety symptoms: [mobd]), (experimental (n =: [aapp,imft]), (control (n =: [aapp,imft]), (condition: [dsyn]), (experimental condition: [dsyn]), (hour: [qnco]), (week: []), (consecutive weeks: []), (control condition: [topp]), (puzzle game triple town: [dora]), (assessments: [hlca]), (baseline: [bodm]), ( post-intervention: []), (3-months follow-up: [hlca]), (furthermore: []), ( parents: []), (teachers: []), (complete assessments: [hlca]), (same time points: []), (primary outcome: [topp]), (child report: []), (anxiety symptoms: [fndg]), (secondary outcomes: [neop]), (parent report: [hlca]), (child anxiety: [mobd]), ( child/parent report: [aggp]), (depressive symptoms: [sosy]), (parent/teacher report: [hlca]), (social functioning: [socb]), (behavior problems: [mobd]), (discussion: [socb]), (paper: []), (effect: []), (serious game mindlight: [dora]), (age: [orga]), (levels: []), (important contribution: [acty]), (existing interventions: [hlca]), (evidence-based treatment: [topp]), (mental health institutes: [orgt]), (special education schools: [edac]), (trial registration dutch trial register ntr5069: [resa]), (april: [gngm]), 
ASD Terms: (autism spectrum disorder experience anxiety symptoms, 'Complaints and Indications')(anxiety, 'Anxiety Disorders')(effective anxiety interventions, 'Anxiety Disorders')(anxiety, 'Anxiety Disorders')(clinical anxiety symptoms, 'Anxiety Disorders')(clinical anxiety symptoms, 'Anxiety Disorders')(diagnosis, 'Diagnosis')(anxiety symptoms, 'Anxiety Disorders')(child anxiety, 'Anxiety Disorders')(social functioning, 'Social Competence')(depressive symptoms, 'Depressive Disorder')(behavior problems, 'Personal Traits')(clinical anxiety symptoms, 'Anxiety Disorders')(age of 816 years, 'Onset of Symptoms')(anxiety symptoms, 'Anxiety Disorders')(anxiety, 'Anxiety Disorders')(anxiety symptoms, 'Anxiety Disorders')(mental health institutes, 'Psychiatric Hospitalization')

PMCID: 4471393
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (poor reciprocity: [grpa]), (defining feature: []), (autism spectrum disorder (asd): [mobd]), (current study: [resa]), (reliability: [qnco]), (validity: [qnco]), (interactive drawing test: [lbpr]), (new instrument: []), (reciprocal behavior: [inbe]), (idt: []), (children: [aggp]), (adolescents: [aggp]), (asd (n =: [cgab]), (group (n: [popg]), (excellent inter-rater reliability: [qnco]), (good testretest reliability: [qnco]), (results: [fndg]), (distinctive response patterns: [fndg]), (asd group: [cgab]), (verbal iq: []), (convergent validity: [qnco]), (sensitivity: [patf]), (predictive accuracy: []), (detailed levels: []), (autism: [mobd]), (discussed: [socb]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(detailed levels, 'Ability to Convey Appropriate Level of Detail')(autism, 'Autism Phenotype')

PMCID: 5509180
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction: [hlca]), (provision: []), (peer mentoring: [popg]), (tertiary education outcomes: [fndg]), (students: [popg]), (autism spectrum disorder (asd): [mobd]), (study: [resa]), (pilot year: [gngm]), (curtin specialist mentoring program: [popg]), (specialised peer: [popg]), (program: [phsu]), (university students: []), (asd: [cgab]), (self-reported well-being: [resa]), ( academic success: [inbe]), (retention: [menp]), (university studies: [mnob,orgt]), (single group: [resa]), (pre-test: [lbpr]), ( post-test design: [acty]), (qualitative evaluations: []), (young adults: [aggp]), (effectiveness: []), (acceptability: []), (csmp program: [phsu]), (battery: [inpo]), (questionnaires: []), (general anxiety: [mobd]), ( state communication apprehension: [menp]), (communication competence: [menp]), (communication apprehension: [menp]), (prior to: []), (months: []), (enrolment: [hlca]), (csmp: []), (information: []), (academic success: [inbe]), (interviews: [acty]), (participants: [popg]), (further insight: [menp]), (experience: [menp]), (significant improvement: [qnco]), (social support: [socb]), (general communication apprehension assessment scores: [clna]), (key features: []), (positive outcomes: [fndg]), (current study: [resa]), (preliminary evidence: []), (well-being: []), (importance: []), (interventions: [hlca]), (individualised: []), ( flexible: []), (social model: []), (target: [diap]), (environmental factors: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(general anxiety, 'Anxiety Disorders')

PMCID: 5325134
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (children: [aggp]), (childs ability: [orga]), (social skills: [socb]), (application: [qnco]), (effective interventions: [hlca]), (lifelong impact: [gngm]), (independence: []), (functioning: []), (research: [resa]), (music therapy: [topp]), (social outcomes: []), (asd: [cgab]), (outcome measures: [qnco]), (standardized nonmusical scales: [bpoc]), (social functioning: [socb]), (parent: []), (clinician perspective: []), (certified music therapists: []), (musical engagement: [fndg]), (part: [qnco]), (individuals profile: [lbpr]), (measures: [qnco]), (assessment: [acty]), (individuals social functioning: [socb]), (music therapy session: [topp]), (generalizability: []), (nonmusical settings: [qnco]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social skills, 'Ability to Converse in Social Settings')(lifelong impact that social skills, 'Ability to Converse in Social Settings')(social functioning, 'Social Competence')(individuals social functioning, 'Ability to Converse in Social Settings')

PMCID: 6074644
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract: []), (virtual reality: [mcha]), ((vr)-based treatment: [topp]), (training: [edac]), (vr: []), (immersive experience: [fndg]), (simulated environment: [bodm]), (autism spectrum disorder (asd): [mobd]), (social communication deficits: [socb]), (repetitive behaviours: [inbe]), (children: [aggp]), (asd: [cgab]), (social skills: [socb]), (safe: []), (controllable environment: []), (practice skills: [inbe]), (centre: [fndg]), (innovative applications: [hlca]), (internet: []), (multimedia technologies (aimtech centre): [fndg]), (city university: [mnob,orgt]), (hong kong: [fish]), (vr-enabled training program: [phsu]), (efficacy: [resa]), (vr scenarios: []), (daily lives: [fndg]), (typical children: [aggp]), (mainstream primary schools: [edac]), (study: [resa]), (analysis: [resa]), (group: [popg]), (emotion expression: [inbe]), (regulation (m: [aapp,imft]), (sd: [gngm]), (training (m: [aapp,imft]), (t(35) = 2.174: [qnco]), ( p = .037): [aapp,imft]), (social interaction: [fndg]), (adaptation: [orgf]), ((m: [aapp,imft]), (t(35) = 3.987: [fndg]), ( p < .0005): [aapp,imft]), (significant interaction: [qnco]), (time: []), (affective expressions: [topp]), ( f(1: [inch,phsu]), (p = .025: [aapp,imft]), (partial 2 = .069: [qnco]), (social reciprocity: [socb]), (p = .007: [aapp,imft]), (partial 2 = .100: [qnco]), (initial challenges: [hlca]), (goggles: []), (reasons: []), (adoption: [socb]), (head-mounted displays: [blor]), (portable: []), ( cost-effective device: [qnco]), (promising asset: []), (traditional training: [edac]), (therapy: [topp]), (importance trainers: []), (therapists support: []), (further investigated: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social communication deficits, 'Reciprocal Social Interaction')(repetitive behaviours, 'Restricted and Repetitive Behavior')(social skills, 'Ability to Converse in Social Settings')(social skills with six vr scenarios, 'Ability to Converse in Social Settings')(social interaction, 'Reciprocal Social Interaction')(adaptation, 'Adaptive Life Skills')

PMCID: 5179565
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (difficulties: [fndg]), (social interaction: [fndg]), (communication: [socb]), (school: [mnob,orgt]), (structured situations: []), (recess: []), (opportunities: []), (relationship: []), (peers: [popg]), (natural context: [fndg]), (students: [popg]), (asd: [cgab]), (necessary skills: [inbe]), (support: []), (single-case design: [fndg]), (intervention: [hlca]), (social interaction skills: [inbe]), (student: [popg]), (high-functioning asd: [cgab]), (second grade: [fndg]), (elementary school: [mnob,orgt]), (different strategies: [menp]), (direct instruction: [edac]), ( modeling: [resa]), (social reinforcement: [socb]), (recess setting: [qnco]), (sessions: [evnt]), ( changes: [qnco]), (rates: [qnco]), (initiating: []), (negative trend: [fndg]), (percentage: [qnco]), (time: []), (low-intensity interactions: [npop]), (teachers: []), (family: [famg]), (improvements: []), (social skills: [socb]), (peer acceptance: [socb]), (increase: []), (frequency: [qnco]), (duration: [phsu]), (social interactions: [fndg]), (research-based practices: [resa]), (high-functioning students: [popg]), (autism: [mobd]), (inclusive school environments: [eehu]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(social interaction skills, 'Reciprocal Social Interaction')(perceived improvements in social skills, 'Ability to Converse in Social Settings')(social interactions, 'Reciprocal Social Interaction')(social skills, 'Ability to Converse in Social Settings')(social interaction skills, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')

PMCID: 5222937
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (paper: []), (overview: []), (design: [acty]), (cohort characteristics: [popg]), (social spectrum study:: [resa]), (clinical cohort study: [qnco]), (two-phase sampling design: [acty]), (children: [aggp]), (risk: []), (asd: [cgab]), (years: []), (mental health services: [hlca]), (netherlands: []), ( children: [aggp]), (asd (n =: [cgab]), (random selection: [resa]), (screen negatives: [fndg]), (diagnostic assessments: [diap]), (questionnaires: []), (child: [aggp]), ( family: [famg]), (society: [orgt]), (1-year follow-up: [hlca]), (results: [fndg]), (study: [resa]), (identification: [menp]), (characterization: [acty]), ( family processes: [famg]), (impact: [gngm]), (family: [famg]), 
ASD Terms: 

PMCID: 4990619
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (systematic research: [resa]), (sexual development: [orgf]), (adolescents: [aggp]), (autism spectrum disorder (asd): [mobd]), (often-suggested relation: [socb]), (asd: [cgab]), ( atypical: [fndg]), (offensive behaviours: [inbe]), (study: [resa]), (follow-up data: [euka]), (sexual experience (ltse): [bhvr]), (homogeneous group: [popg]), (adolescent boys: [aggp]), (asd (n: [cgab]), (matched group: [grup]), (boys: [aggp]), (general population (n: [aapp,imft]), (control groups: [grup]), (masturbation: [inbe]), (orgasm: [orgf]), (proportion: [qnco]), (partnered sexual experience: [bhvr]), (control group: [grup]), (difference: [qnco]), (controls: [sbst]), (experience: [menp]), (kissing: [socb]), (petting;: [socb]), (significant differences: [qnco]), (sexual experiences: [bhvr]), (results: [fndg]), (existence: []), (subgroup: [virs]), (arena: []), (partnered sexual experiencesa: [bhvr]), (line: [sbst]), (research: [resa]), (adult samples: [aggp]), (differences: [qnco]), (sexual abuse: [mobd]), (coercion: [socb]), (exploration: [topp]), (partnered experiences: [menp]), (variety: []), (types: []), (partners: [popg]), (comparable age: [orga]), (several boys: [aggp]), (sexual debut: [bhvr]), (regret afterward: [menp]), (hypothesised sexual developmental trajectories: [orgf]), (further research: [resa]), (sexual experience: [bhvr]), (sample: [sbst]), (assumed developmental differences: [qnco]), (need: []), (early: []), ( attuned: []), (comprehensive sexuality-related education: [edac]), (communication: [socb]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(assumed developmental differences, 'Learning Disorders')(comprehensive sexuality-related education, 'Performance in School')

PMCID: 6053156
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objective: []), (present study: [qnco]), (intervention study: []), (emotion recognition: [menp]), (chinese children: [aggp]), (asd: [cgab]), (animated vehicles: [bodm]), (real emotional faces: [blor]), (total: [qnco]), (children: [aggp]), (current study; participants: [popg]), ((2 girls): [aggp]), (formal diagnosis: [fndg]), (participants: [popg]), (emotional vocabulary: [menp]), (situation-facial expression: [fndg]), (intervention: [hlca]), (results: [fndg]), (childrens emotion recognition: [menp]), (pre-intervention scores: [clna]), (findings: [clna]), (emotional recognition intervention: [menp]), (transporters): [aapp,bacs]), (effective early intervention: [hlca]), 
ASD Terms: (emotion recognition, 'Empathy')(improve emotion recognition, 'Empathy')(formal diagnosis, 'Diagnosis')(childrens emotion recognition, 'Empathy')(emotional recognition intervention, 'Empathy')

PMCID: 4610885
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (purpose: []), (present study: [qnco]), (motivation: [menp]), (contextual nature: []), (motivations: [menp]), (social participation: [socb]), (able adolescents: [orga]), (adults: [aggp]), (autism spectrum disorder: [mobd]), (self-determination theory: []), (theoretical framework: []), (years): []), (aspergers syndrome: [mobd]), (high functioning autism: [mobd]), (device: []), (times/day: [qnco]), (days: []), (whom: []), (difficulty: [fndg]), (social reciprocity: [socb]), (reasons: []), (situation: []), (degree: [qnco]), (self-determination: []), (multilevel: []), (participants: [popg]), (solitary/parallel leisure: [resa]), (social activities: [socb]), (other types: []), (activities: [acty]), (interactions: []), (family members: [famg]), (friends: [popg]), (self-determined motivation: [menp]), (further: []), ( participants: [popg]), (levels: []), (interaction: []), (casual/intimate friends: [popg]), (other people: [popg]), (global social anxiety: [mobd]), (moderator: []), (perceptions: [menp]), (social engagement: [fndg]), (findings: [clna]), (context-dependent motivations: [menp]), (able individuals: [orga]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(aspergers syndrome, 'Asperger Syndrome')(high functioning autism, 'Autism Phenotype')(social activities, 'Engagement in Social Activities')(solitary/parallel leisure, 'Use of Free Time')(interactions with family members, 'Interactions with Friends and Family')(interaction with casual/intimate friends, 'Interactions with Friends and Family')(perceptions, 'Cognitive Ability')(social engagement, 'Engaging in Social Conversation')(global social anxiety, 'Anxiety Disorders')(social engagement, 'Engaging in Social Conversation')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 6361977
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), ( attention-deficit/hyperactivity disorder (adhd): [mobd]), (obsessive-compulsive disorder (ocd): [mobd]), (difficulties: [fndg]), (social cues: []), (studies: [lbpr]), (social brain;: [bpoc]), (specific neural substrates: [sbst]), (social deficits: []), (neurodevelopmental disorders: [mobd]), (children: [aggp]), (underwent structural magnetic resonance imaging: [diap]), (brain (controls: [bpoc]), (ocd: [mobd]), (adhd: [mobd]), (asd: [cgab]), (mean age: [orga]), (social communication questionnaire (scq): [socb]), (mind: [menp]), (eyes test (rmet): [bpoc]), (multivariable regression models: [menp]), (structural neuroimaging correlates: [diap]), (region: []), (interest: [menp]), (whole-brain vertex-wise approach: [gngm]), (interest analysis: [resa]), (social brain regions: [blor]), (networks: (1): [fndg]), (lateral mentalization (e.g.: []), (temporalparietal junction): []), ( (2): [qnco]), (frontal cognitive (e.g.: []), (orbitofrontal cortex): [blor]), ((3): [fndg]), (subcortical affective (e.g.: [blor]), (limbic system) regions: [bdsy]), (overall: []), (social communication deficits: [socb]), (scq: []), (thinner cortices: [bpoc]), (left lateral regions: [blor]), (right insula: [bpoc]), (decreased volume: [qnco]), (ventral striatum: [bpoc]), (diagnostic groups: [popg]), (smaller: [qnco]), (subcortical volumes: [qnco]), (severe social deficits: []), (severe deficits: []), (rmet: []), (amygdala/hippocampal volumes: [bpoc]), (deficits: []), (groups: [popg]), ( patterns: []), (associations: [menp]), (common underlying biology: [qnco]), (blurring: [sosy]), (diagnostic boundaries: [fndg]), (disorders: [dsyn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(obsessive-compulsive disorder, 'Obsessive-Compulsive Disorder')(social cues, 'Awareness of Social Cues')(neurodevelopmental disorders, 'Learning Disorders')(social deficits, 'Social Competence')(social communication questionnaire, 'Reciprocal Social Interaction')(structural neuroimaging correlates of social deficits, 'Social Competence')(frontal cognitive, 'Cognitive Ability')(social communication deficits, 'Reciprocal Social Interaction')(social communication questionnaire, 'Reciprocal Social Interaction')(obsessive-compulsive disorder, 'Obsessive-Compulsive Disorder')(severe social deficits, 'Social Competence')

PMCID: 6325753
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mammalian target: [mamm]), (rapamycin (mtor): [aapp,enzy]), (crucial role: [socb]), (cell metabolism: [cell]), ( growth: [orgf]), (proliferation: [patf]), (overactivation: []), (mtor: [gngm]), (pathogenesis: [patf]), (syndromic autism spectrum disorder (asd): [mobd]), (tuberous sclerosis complex (tsc): [neop]), (treatment: [topp]), (mtor inhibitor rapamycin: [antb,orch]), (social interaction deficits: [fndg]), (mouse models: [mamm]), (tsc: [gngm]), (prenatal exposure: [fndg]), (acid (vpa): [chem]), (incidence: [qnco]), (asd: [cgab]), (rodent pups: [mamm]), (vpa: []), (utero: [bpoc]), (animal model: [emod]), (activation: [acty]), (pathway: [moft]), (rodents: [mamm]), (present study: [qnco]), (effect: []), (rapamycin: [antb,orch]), (adolescence: []), (adulthood: []), (gene expressions: [genf]), (mice: [mamm]), (mg/kg vpa: [qnco]), (pregnant mice: [mamm]), (gestational day: []), (pups: []), (model: []), (equal volume: [qnco]), (vehicle: [bodm]), (consecutive days: []), (social interaction test: [fndg]), (offspring: [famg]), (last rapamycin administration: [antb,orch]), (weeks: []), (ages: [bacs,orch]), (age (adulthood): [orga]), (whole brains: [bpoc]), (microarray: []), (western blot analyses: [lbpr]), (performed: []), (decrease: [qnco]), (social interaction: [fndg]), (control mice: [mamm]), (rapamycin treatment: [antb,orch]), (vpa-exposed mice: [mamm]), (social deficits: []), (aberrant expression: [topp]), (genes: [gngm]), (changes: [qnco]), (expression: [topp]), (fyb: [gngm]), (a330094k24rik: []), (s6 phosphorylation: [moft]), (aberrant gene expression: [genf]), (effective treatment: []), (non-syndromic asd: [cgab]), (adolescent: [aggp]), (adult patients: [aggp]), (impairments: [patf]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13041-018-0423-2) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (syndromic autism spectrum disorder, 'Autism Phenotype')(tuberous sclerosis complex, 'Tuberous Sclerosis')(social interaction deficits, 'Reciprocal Social Interaction')(prenatal exposure, 'Exposures')(gestational day, 'Perinatal History')(social interaction test, 'Reciprocal Social Interaction')(offspring, 'Perinatal History')(social interaction, 'Reciprocal Social Interaction')(social deficits, 'Social Competence')(social interaction deficits, 'Reciprocal Social Interaction')

PMCID: 4017702
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (research reporting prevalence rates: [qnco]), (aggressive behaviour: [mobd]), (people: [popg]), (tuberous sclerosis: [neop]), (complex (tsc): [chvs]), (studies: [lbpr]), (rates: [qnco]), (behaviours: [inbe]), (tsc: [gngm]), (other syndrome groups: [dsyn]), (degree: [qnco]), (disability: [fndg]), (risk markers: []), (data: [euka]), (challenging behaviour questionnaire: [fndg]), (children: [aggp]), (years: []), (odds ratios: [qnco]), (self-injury: [inpo]), (aggression: [mobd]), (idiopathic autism spectrum disorder (asd): [mobd]), ( fragile x: [comd]), ( cornelia: []), (lange: []), (down syndromes: [dsyn]), (characteristics: []), (mood interest: [menp]), (pleasure questionnaire: [menp]), (activity questionnaire: [acty]), (social communication questionnaire: [socb]), (repetitive behaviour questionnaire: [fndg]), (wessex behaviour schedule: [inbe]), (non-communicating children pain checklist: [orch,phsu]), (mann-whitney u analyses: [resa]), (individuals: [humn]), (respectively: []), (down syndrome: [cgab,dsyn]), (pain-related behaviours: [sosy]), (low mood: [fndg]), ( hyperactivity: [mobd]), ( impulsivity: [inbe]), (repetitive use: []), (language: [lang]), (levels: []), (interest: [menp]), (pleasure: [menp]), (insistence: []), (sameness: []), (repetitive behaviour: [fndg]), (majority: [socb]), (associations: [menp]), (association: [menp]), (level: [phsu]), (adaptive functioning: []), (for: []), (behavioural profiles: [inbe]), (risk: []), (further research: [resa]), (influence: []), (such internal factors: [aapp,bacs,phsu]), (mood: [menp]), ( asd symptomatology: [cgab]), (pain: [sosy]), (behaviour: [inbe]), (intellectual disability: [mobd]), 
ASD Terms: (aggressive behaviour, 'Aggressive Behavior')(tuberous sclerosis complex, 'Tuberous Sclerosis')(tuberous sclerosis complex, 'Tuberous Sclerosis')(tuberous sclerosis complex, 'Tuberous Sclerosis')(self-injury, 'Self-Injurious Behavior')(aggression, 'Aggressive Behavior')(tuberous sclerosis complex, 'Tuberous Sclerosis')(fragile x, 'Fragile X Syndrome')(idiopathic autism spectrum disorder, 'Autism Phenotype')(down syndromes, 'Down Syndrome')(mood interest, 'Mood')(social communication questionnaire, 'Reciprocal Social Interaction')(repetitive behaviour questionnaire, 'Restricted and Repetitive Behavior')(non-communicating children pain checklist, 'Pain')(self-injury, 'Self-Injurious Behavior')(tuberous sclerosis complex, 'Tuberous Sclerosis')(aggression, 'Aggressive Behavior')(down syndrome, 'Down Syndrome')(repetitive use of language, 'Expressive Language')(low mood, 'Depressive Disorder')(hyperactivity, 'Overactivity')(repetitive behaviour, 'Restricted and Repetitive Behavior')(adaptive functioning, 'Adaptive Life Skills')(mood, 'Mood')(pain, 'Pain')(intellectual disability, 'Learning Disorders')

PMCID: 5848550
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disorder: [mobd]), (restricted: []), (behaviors: [inbe]), (impairments: [patf]), (social communication: [socb]), (underlying biological mechanisms: []), (asd: [cgab]), (understood: [menp]), ( recent preclinical research: [resa]), (endogenous cannabinoid (or: [bacs,orch]), (significant neuromodulator: [bacs]), (rodent models: [mamm]), (promising preclinical evidence: []), (clinical studies: [resa]), (date: []), (endocannabinoids: [bacs,orch]), (individuals: [humn]), (here: []), (critical gap: []), (knowledge: []), (liquid chromatography-tandem mass spectrometry methodology: [lbpr]), (anandamide concentrations: [bacs,orch]), (banked blood samples: [bdsu]), (cohort: [popg]), (children: [aggp]), (asd (n: [cgab]), (findings anandamide concentrations: [bacs,orch]), (asd cases (n: [cgab]), (controls (n: [aapp,imft]), (asd (p: [cgab]), (notion: []), ( anandamide concentrations: [bacs,orch]), (children (p: [aggp]), (findings: [clna]), (first empirical human data: [inpr,resa]), (preclinical rodent findings: [mamm]), (link: []), (plasma anandamide concentrations: [bacs,orch]), (data: [euka]), (pathophysiology: [patf]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')

PMCID: 6282609
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (validated measures: [qnco]), (core: [bdsu]), (social functions: [socb]), (development stages: [orgf]), (clinical trials: [resa]), (concurrent validity: [qnco]), (asd: [cgab]), (clinical measures: [qnco]), (putative biomarkers: [clna]), (core deficits: [bdsu]), (feasibility: []), (implementation: [acty]), (human studies: [humn]), (datasets: []), (adult asd studies: [cgab]), ((observational study [n =: [resa]), (interventional study baseline data [n: [bodm]), (potential biomarkers: [clna]), (eyetracking: []), ( olfaction: [orgf]), (auditory: []), (visual emotion recognition: [menp]), (affective speech recognition test (asr): [orgf]), (readingthemindintheeyes test (rmet): [lbpr]), (current functioning: [npop]), (intelligence quotient (iq): [orga]), ( adaptive skill testing: [inbe]), (behavioral ratings: [inbe]), (autism severity: [mobd]), (autism diagnostic observation scale2: [hlca]), (social communication interaction test (scit): [fndg]), (exploratory measures: [qnco]), (significant associations: [menp]), (asd severity: [cgab]), (adaptive skills: [inbe]), (behavior: [inbe]), (eye: [bpoc]), (endpoints: []), (little relationship: [fndg]), (adaptive ability: [orga]), (severity: []), (asr: []), (adaptive behavior domains: [inbe]), (olfaction: [orgf]), (auditory emotion recognition: [menp]), (scit scores: [clna]), (severity domains: []), (only measure: [qnco]), (iq: []), (rmet accuracy: []), (asd features: [cgab]), (eye tracking: [bpoc]), ( scit: []), (high testretest reliability: [qnco]), (associations: [menp]), (proximal biomarkers: [clna]), (multiple asd dimensions: [cgab]), (exception: []), (scit: []), (correlations: []), (utility: [orgt]), (proxy measures: [grup]), (social communication: [socb]), (reliability: [qnco]), ( asr: []), (overall: []), (several novel experimental paradigms: [resa]), (social biomarkers: [clna]), (surrogate markers: []), (autism research: [mobd]), (authors: []), (international society: [orgt]), (wiley periodicals: []), ( inc. lay summary more: []), (accurate measurements: []), (treatment effects: [fndg]), (development: [orgf]), (new drug treatments: [hlca]), (autism spectrum disorders: [mobd]), (study: [resa]), (relationship: []), (assessments: [hlca]), (behaviors: [inbe]), (cognition: [menp]), (diagnostic assessments: [diap]), (symptom severity: [fndg]), ( auditory: []), (visual social stimuli recognition: [menp]), (olfaction identification: [orgf]), (use: []), (evaluation: [hlca]), (treatments: [topp]), (social difficulties: [fndg]), 
ASD Terms: (social functions, 'Social Competence')(autism spectrum disorder lacks, 'Autism Phenotype')(visual emotion recognition, 'Visual Thinking')(affective speech recognition test, 'Language Ability')(intelligence quotient, 'IQ')(adaptive skill testing, 'Adaptive Life Skills')(autism severity, 'Autism Phenotype')(autism diagnostic observation scale2, 'Autism Phenotype')(social communication interaction test, 'Reciprocal Social Interaction')(adaptive skills, 'Adaptive Life Skills')(adaptive ability, 'Adaptive Life Skills')(adaptive behavior domains, 'Adaptive Life Skills')(speech recognition test, 'Language Ability')(auditory emotion recognition, 'Empathy')(social communication interaction test scores, 'Reciprocal Social Interaction')(social communication interaction test, 'Reciprocal Social Interaction')(social communication, 'Reciprocal Social Interaction')(speech recognition test, 'Language Ability')(autism research, 'Autism Phenotype')(autism research, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(cognition, 'Cognitive Ability')(social difficulties in asd, 'Social Competence')(visual social stimuli recognition, 'Visual Thinking')(social difficulties, 'Social Competence')

PMCID: 5509825
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (camouflaging: []), (autistic characteristics: [mobd]), (social situations: [socb]), (common social coping strategy: [inbe]), (adults: [aggp]), (autism spectrum conditions: [mobd]), (diagnosis: [fndg]), ( quality: []), (life: []), (long-term outcomes: []), (it: []), (qualitative study: [resa]), (experiences: [menp]), (asc: [gngm]), (questions: []), (nature: []), ( motivations: [menp]), (consequences: []), (thematic analysis: [resa]), (key elements: [elii]), (development: [orgf]), (three-stage model: [qnco]), (camouflaging process: [phpr]), (first: [qnco]), (fitting: [sosy]), (connections: []), (others: [fndg]), (second: [qnco]), (combination: [fndg]), (masking: []), (compensation techniques: [menp]), (third: [qnco]), (long-term consequences: []), (stereotypes: [mobd]), (threats: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-017-3166-5) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (social situations, 'Social Competence')(autism spectrum conditions, 'Autism Phenotype')(impact diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')(autism spectrum conditions, 'Autism Phenotype')(stereotypes, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 5759305
SFARI Genes: 
Non SFARI Genes: impact, EBP, EBP, 
Named Entities: (study: [resa]), (system-wide (i.e.: [diap,inpr]), ( region: []), ( district: []), (school) mechanisms: [mnob,orgt]), (leadership support: [socb]), ( training requirements: [edac]), ( structure: []), ( collaboration: [socb]), (education: [fndg]), (use: []), (evidence-based practices: []), (schools: [mnob,orgt]), (outcomes: []), (students: [popg]), (autism spectrum disorder (asd): [mobd]), (evidence: []), (positive effects: [fndg]), (ebps: [gngm]), (asd: [cgab]), (practices: [menp]), (special education programs: [edac]), (few evidence-based methods: [qnco]), (selecting: [acty]), ( implementing: []), (sustaining ebps: [gngm]), (research: [resa]), (teacher training: [fndg]), (attention: [menp]), (contextual factors: []), (implementation climate: [npop]), ( attitudes: [menp]), ( resource allocation: [qnco]), (social networks): [popg]), (implementation science framework: [acty]), (project: []), (relations: [socb]), (system-wide factors: []), (teachers use: []), (student education outcomes: [popg]), (methods/design survey data: [euka]), (regional special education directors: [edac]), (regional program specialists: []), (district: []), (special education directors: [edac]), (behavior specialists: [inbe]), (school principals: [mnob,orgt]), (special education teachers: []), (paraprofessionals: []), (administrative data: [euka]), (teachers: []), (total: [qnco]), (school-level personnel: [mnob,orgt]), (social network interviews: [acty]), (mixed methods: [fndg]), (surveys: []), ( administrative data: [euka]), (observational checklists: [resa]), (in-depth information: [gngm]), (system-wide malleable factors: []), (implementation: [acty]), (student outcomes: [popg]), (multi-level modeling: [resa]), (ebp implementation: [acty]), (trainer: []), ( teacher: [fndg]), (moderators (e.g.: []), ( district size: []), ( special education local plan area: [dsyn]), (teachers asd experience): [cgab]), (finally: []), (dynamic social network approach: [popg]), (ebp-related connectivity: [gngm]), (levels: []), (system: []), (regions: []), (dynamic network analysis: []), (degree: [qnco]), (ways: []), (ebp trainings: [edac]), ( resources: []), (interventions: [hlca]), (school staff: [mnob,orgt]), (discussion results: [socb]), (development: [orgf]), (system-wide interventions: [hlca]), (school-based implementation: [mnob,orgt]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5570802
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (conclusions: []), (disfluency production: [dsyn]), (high-functioning forms: [qnco]), (autism spectrum disorder (hfa): [mobd]), (previous studies: [lbpr]), (individuals: [humn]), (hfa: [dsyn]), (theoretical question: []), (listener-oriented disfluencies: [fndg]), (poor pragmatic language skills: [grpa]), (listener-oriented disfluency: [dsyn]), (however: []), (individual differences variables: [menp]), (disfluency: [dsyn]), (unmatched controls: [sbst]), (repairs: [orgf]), (silent pauses: [clna]), (difference: [qnco]), (controls: [sbst]), (groups: [popg]), (results: [fndg]), (limitations: []), (prior research: [resa]), (light: [gngm]), (relationship: []), (autism spectrum disorders: [mobd]), (disfluent speech: [orgf]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-017-3215-0) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(poor pragmatic language skills, 'Development or Regression of Language Skills')(autism spectrum disorders, 'Autism Phenotype')(disfluent speech, 'Language Ability')

PMCID: 5973967
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (tuberous sclerosis complex (tsc): [neop]), (high prevalence: [qnco]), (autism spectrum disorders: [mobd]), (relation: [socb]), (cortical dysplasia: [cgab,dsyn]), (asd severity: [cgab]), (tsc: [gngm]), (autism diagnostic observation scale): [hlca]), ( tuber: [plnt]), (radial migration line (rml) count: [qnco]), (location: [blor]), (cognitive functioning: [menp]), (children: [aggp]), (regression: [menp]), (mediation analyses: [resa]), (tuber: [plnt]), (rml count: [qnco]), (however: []), (majority: [socb]), (associations: [menp]), (only total tuber count: [plnt]), (severity: []), (restricted/repetitive behaviors: [fndg]), (occipital rml count: [qnco]), (overall asd severity: [cgab]), (social communication/interaction deficit severity specifically: [fndg]), (study: [resa]), (important explanatory role: [socb]), (association: [menp]), (relevance: []), (asd subdomains: [cgab]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s00787-017-1066-z) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(tuberous sclerosis complex, 'Tuberous Sclerosis')(tuberous sclerosis complex, 'Tuberous Sclerosis')(cognitive functioning, 'Cognitive Ability')(tuber, 'Tuberous Sclerosis')(only total tuber count, 'Tuberous Sclerosis')(social communication/interaction deficit severity specifically, 'Social Competence')(cognitive functioning, 'Cognitive Ability')

PMCID: 5389998
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mimicry: [mobd]), (actions: []), (others: [fndg]), (ubiquitous behavior: [inbe]), (social interactions: [fndg]), (long debate: [acty]), (people: [popg]), (autism spectrum conditions: [mobd]), (causes: []), (differences: [qnco]), (wang: []), (hamiltons (2012): []), (social top-down response modulation (storm) model: [inpo]), (asc: [gngm]), (mimic but: []), (neurotypical participants: [popg]), ( fail: []), (social context: []), (study: [resa]), (mimicry paradigm: [resa]), (hypothesis: []), (direct gaze: [fndg]), (congruent hand actions: [bpoc]), (asc sample: [sbst]), ( direct gaze: [fndg]), (reaction times: []), (congruent: []), (incongruent movements: [orgf]), (result: [fndg]), (gaze: [fndg]), (storm: [inpo]), 
ASD Terms: (social interactions, 'Reciprocal Social Interaction')(autism spectrum conditions, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5724485
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (interest: [menp]), (potential: []), (preemptive interventions: [hlca]), (prodrome: [sosy]), (autism: [mobd]), (little investigation: [hlca]), (effect: []), (twosite: []), ( twoarm: []), (trial (rct): [resa]), (social communication intervention: [topp]), (months: []), (age (intervention: [orga]), (british autism study: [mobd]), (infant siblingsvideo interaction: [aggp]), (positive parenting): [socb]), (intervention: [hlca]), (infants: [aggp]), (nonintervention): []), (familial risk: [famg]), (developmental atypicality: [orgf]), (treatment endpoint: [qnco]), (followup: [hlca]), (primary outcome: severity: [topp]), (prodromal symptoms: [sosy]), (autism observation schedule: [hlca]), (autism diagnostic observation schedule: [hlca]), (edition: []), (assessment points: [acty]), (secondary outcomes:: [neop]), (parentchild interaction: []), (child language;: [inbe]), (parentrated communication: [socb]), (socialisation: [edac]), (prespecified intentiontotreat analysis: [resa]), (estimates: [qnco]), (measures: [qnco]), (regressions: [menp]), (overall effect: []), (infancy intervention: [hlca]), (time: []), (effect estimates: [qnco]), (favour: [orch,phsu,vita]), ( maximal: [qnco]), (confidence intervals: [qnco]), (separate time point: []), (null: [qnco]), (significant overall effect: [qnco]), (course: []), (followup period: [hlca]), ((effect size [es]: [qnco]), (ci: [gngm]), (p = .026): [aapp,imft]), (effects: []), (proximal intervention targets: [diap]), (parent nondirectiveness/synchrony (es: [neop]), (p = .013): [aapp,imft]), (child attentiveness/communication initiation (es: [neop]), (p = .015): [aapp,imft]), (similar results: [fndg]), (categorical diagnostic outcome: [fndg]), (formal language measures: [lang]), (years: []), (first rct: [qnco]), (early social communication intervention: [hlca]), (treatment effect: [fndg]), (intervention end: [hlca]), (overall severity: []), (autism prodromal symptoms: [mobd]), (parentchild dyadic social communication: [socb]), (period: []), (value: [qnco]), (repeat assessment: [acty]), (early intervention trials: [resa]), 
ASD Terms: (autism, 'Autism Phenotype')(social communication intervention, 'Reciprocal Social Interaction')(developmental atypicality, 'Learning Disorders')(autism, 'Autism Phenotype')(autism observation schedule, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(infancy intervention, 'Perinatal History')(autism, 'Autism Phenotype')(social communication intervention, 'Reciprocal Social Interaction')(autism prodromal symptoms, 'Complaints and Indications')(early social communication intervention, 'Reciprocal Social Interaction')(parentchild dyadic social communication, 'Reciprocal Social Interaction')

PMCID: 3540960
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disorder: [mobd]), (abnormalities: [cgab]), (communicative behaviors: [socb]), (inflexible adherence: []), (patterns: []), (thought: [menp]), (behavior: [inbe]), (laboratory studies: [mnob,orgt]), (autistic individuals experience difficulties: [mobd]), (emotional expressions: [inbe]), (others: [fndg]), (naturalistic observations: [hlca]), (such expressions: [topp]), (social exchanges: [socb]), (dominant theories: []), (facet: [blor]), (asd phenotype: [cgab]), (social brain network: [popg]), (social-cognitive processes: [menp]), (face processing: [emst]), (mental state understanding: [menp]), (empathy: [inbe]), (such theories: []), (emotion: [menp]), (related processes: [phpr]), (social cognition: [socb]), (asd: [cgab]), (evidence: []), (disorder: [dsyn]), (widespread anomalies: []), (domain: []), (emotions: [menp]), (review: []), (relevant literature: [inpr,mnob]), (argue: []), (social-emotional characteristics: [inbe]), (understood: [menp]), (terms: [orgf]), (disruption: []), (domain-general interplay: [hlca]), (cognition: [menp]), (developmental consequence: [orgf]), (anomalies: []), (emotional responses: [menp]), (environment: []), (wide range: [qnco]), (cognitive processes: [menp]), (social world: [popg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(social exchanges, 'Reciprocal Social Interaction')(asd phenotype, 'Autism Phenotype')(face processing, 'Integrated Verbal and NonVerbal Communication')(empathy, 'Empathy')(social cognition, 'Cognitive Ability')(cognition, 'Cognitive Ability')(cognitive processes, 'Cognitive Ability')(emotional responses, 'Empathy')

PMCID: 4550412
SFARI Genes: Pten, Pten, Pten, Pten, Pten, Pten, Pten, Pten, Pten, Pten, 
Non SFARI Genes: Htr2c, Htr2c, 
Named Entities: (development: [orgf]), (social behavior: [socb]), (serotonin system: [bacs,orch]), (serotonin: [bacs,orch]), (receptor: [aapp,rcpt]), (context: [fndg]), (pharmacological modulation: []), (5-ht2cr activity alters: [acty]), (social interaction: [fndg]), (adult rodents: [mamm]), (however: []), (role: [socb]), (htr2c knockout mice: [mamm]), (animals: [anim]), (social behavior deficits: [socb]), (adults: [aggp]), (juveniles: [aggp]), (moreover: []), (age: [orga]), (onset: [qnco]), (deficits displays: []), (similar timing: []), (susceptibility: [clna]), (spontaneous death: [fndg]), (audiogenic-seizures: [dsyn]), ( consistent: []), (hypothesis: []), (excitation: [acty]), (inhibition (e/i): [inch]), (social behavioral deficits: [inbe]), (autism spectrum disorder (asd): [mobd]), (epilepsy: [dsyn]), (pten: [gngm]), (second site mutation: [genf]), (asd risk gene pten: [cgab]), (phenotypes: [orga]), (mice: [mamm]), (double mutant: [acty]), (htr2c: [gngm]), (single mutants: [fndg]), (pharmacological antagonism: [socb]), (5-ht2cr activity: [acty]), (adult animals: [anim]), (seizures: [sosy]), (pten haploinsufficient mice: [mamm]), (sb: []), (5-ht2cr selective antagonist: [genf]), (together: []), (results: [fndg]), (modulation: []), (seizure susceptibility: [sosy]), (normal development: [fndg]), 
ASD Terms: (social behavior, 'Reciprocal Social Interaction')(social interaction, 'Reciprocal Social Interaction')(social behavior, 'Reciprocal Social Interaction')(social behavior deficits, 'Reciprocal Social Interaction')(onset, 'Onset of Symptoms')(onset, 'Onset of Symptoms')(social behavioral deficits, 'Personal Traits')(autism spectrum disorder, 'Autism Phenotype')(epilepsy, 'Epilepsy')(social behavioral deficits, 'Reciprocal Social Interaction')(social behavior, 'Reciprocal Social Interaction')

PMCID: 5635344
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (goal: []), (present study: [qnco]), (autism spectrum disorder (asd) patients: [mobd]), (large brain: [bpoc]), (dataset: []), (patients brain activation patterns: [hlca]), (asd patients brain: [cgab]), (data: [euka]), (world-wide multi-site database: [blor]), (abide (autism brain imaging data exchange): [mobd]), (asd: [cgab]), (brain-based disorder: [dsyn]), (social deficits: []), (repetitive behaviors: [fndg]), (disease control: [topp]), (children: [aggp]), (united states: []), (patterns: []), (functional connectivity: []), (asd participants: [cgab]), (functional brain imaging data: [diap]), (neural patterns: []), (classification: []), (results: [fndg]), (accuracy: []), (identification: [menp]), (control patients: [podg]), (anticorrelation: []), (brain function: [ortf]), (posterior areas: [bpoc]), (brain;: [bpoc]), (current empirical evidence: [npop]), (anterior-posterior disruption: []), (brain connectivity: [bpoc]), (areas: []), (brain: [bpoc]), (controls: [sbst]), (deep learning model: [menp]), 
ASD Terms: (identify autism, 'Autism Phenotype')(social deficits, 'Social Competence')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 5524336
SFARI Genes: 
Non SFARI Genes: ms, 
Named Entities: (previous event-related potential (erp) research: [resa]), (oddball stimulus paradigms: [resa]), (processing: [acty]), (non-speech sounds: [orgf]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (however: []), ( brain mechanisms: [bpoc]), (speech processing abnormalities: [fndg]), (extent: []), (poor language abilities: [orga]), (population: [popg]), (current study: [resa]), (novel: []), (repetition paradigm: [resa]), (order: [acty]), (erp responses: [orga]), (detection: [topp]), (discrimination: [socb]), (speech: [orgf]), (old children: []), (asd: [cgab]), (gender: [orga]), (verbal age: [orga]), (controls: [sbst]), (erps: [ortf]), (pairs: []), (stimuli: [phpr]), ( speech: [orgf]), (control participants: [popg]), (n330 match/mismatch responses: [orga]), (temporal electrodes: []), (non-speech detection: [orgf]), ( bilaterally: []), ( whereas children: [aggp]), (effect: []), (left hemisphere: []), (furthermore: []), (control groups: [grup]), (match/mismatch effects: [resa]), (ms (central n600: [aapp,enzy]), (temporal p600): [gngm]), (non-speech sound: [hcpp]), (speech sound: [hcpp]), (effects: []), (asd group: [cgab]), (findings: [clna]), (emotional aspects: []), (speech detection: [orgf]), (speech stimuli: [orgf]), (together: []), (results: [fndg]), (presence: [qnco]), (atypical speech: [orgf]), (non-speech processing: [orgf]), 
ASD Terms: (non-speech sounds, 'Vocalizations')(autism spectrum disorder, 'Autism Phenotype')(speech processing abnormalities, 'Idiosyncratic and Routinized Speech')(poor language abilities, 'Development or Regression of Language Skills')(speech, 'Language Ability')(speech, 'Language Ability')(non-speech sound, 'Vocalizations')(speech sound, 'Vocalizations')(speech detection, 'Language Ability')(emotional aspects, 'Emotional Traits')(speech stimuli, 'Language Ability')(atypical speech, 'Idiosyncratic and Routinized Speech')

PMCID: 5529736
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (significant need: [qnco]), (strategies: [menp]), (access: []), (evidence-based interventions: [hlca]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (novel approach: []), (parents: []), (child: [aggp]), (asd: [cgab]), (telehealth: [hlca]), (pilot work: [gngm]), (efficacy: [resa]), (such program: [phsu]), ( impact online: [gngm]), (high rate: [qnco]), (parent program: [phsu]), (low attrition: [acab]), (associated gains: [qnco]), (parent learning: [menp]), (social communication: [socb]), (objective: []), (study: [resa]), (open trial: [resa]), (impact online: [gngm]), (dissemination potential: []), (reach: [orgf]), (representativeness: [acty]), (families: [famg]), ((n=36): [aapp,imft]), ((n=139): [aapp,imft]), (referral site: [blor]), (demographics: []), (open trial (n=112): [resa]), (controlled trials: [resa]), (same program (n=50): [fndg]), (metrics: [orch,phsu]), (program engagement: [fndg]), (relationship: []), (changes: [qnco]), (parents intervention knowledge: [fndg]), (program evaluation: []), (participants: [popg]), ((36/139): []), (information: []), (program: [phsu]), (childs: [aggp]), (diagnostic feedback session: [phpr]), (open (ot): [hlca]), (trials: [resa]), (respectively: []), (gender (ot:: [orga]), ((95/112); ct:: [aapp]), ((44/50): [fndg]), (marital status: [grpa]), ((90/112): [fndg]), (ct:: [aapp]), ((32/46): []), ( married): [fndg]), ( education: [fndg]), ((65/112); ct:: [aapp]), ((27/50): [fndg]), ( college degree: [qnco]), (higher): []), (employment status: [fndg]), ((32/49): []), (home): []), (child participants: [aggp]), (terms: [orgf]), (gender: [orga]), ((93/112); ct:: [aapp]), ((38/50): [fndg]), ( male): [orga]), (race: [gngm]), (ethnicity: [popg]), ((43/112); ct:: [aapp]), ((12/50): [fndg]), ( minority): [popg]), (however: []), (mean chronological age: [orga]), (open trial group: [podg]), ((mean=60.0 months): [qnco]), (controlled trial group (mean=43.0 months): [resa]), (t160=5.22: [qnco]), ( p<.001: [aapp,imft]), (rate: [qnco]), (controlled trial: [resa]), ( f3: [aapp,imft]), (81=21.14: []), (gains: [qnco]), (parent intervention knowledge: [fndg]), (groups: [popg]), ( beta=.41: [plnt]), ( t=2.43: [clna]), ( p=.02: [aapp,imft]), (open access trial: [resa]), (program highly: [phsu]), (several barriers: [qnco]), (data: [euka]), (additional strategies: [menp]), (telehealth-based parent-mediated intervention: [hlca]), (community settings: [qnco]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')

PMCID: 5470196
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (human somatosensory system: [humn]), (dissociable paths: [lbpr]), (affective touch: [ortf]), (separate peripheral afferent populations: [popg]), (distinct cortical targets: [bpoc]), (differences: [qnco]), (neural responses: [orga]), (touch: [ortf]), (important developmental role: [socb]), (early social experiences: [menp]), (autism spectrum disorder (asd): [mobd]), (probabilistic tractography: []), (structural integrity: [inbe]), (white matter pathways: [tisu]), (young children: [aggp]), (asd: [cgab]), ((td) peers: [popg]), (tracts:: [bpoc]), (tract: [bpoc]), (thalamus: [bpoc]), (primary somatosensory cortex: [bpoc]), (discriminative tactile information: [socb]), (posterior insulathe cortical projection target: [bpoc]), (unmyelinated tactile afferents: [gngm]), (affective touchwith: []), (anterior insula: [bpoc]), (sensory: []), (visceral inputs: []), (emotional salience: [menp]), (sensory stimuli: [npop]), (associations: [menp]), (tract integrity: [inbe]), (performance: [inbe]), (standardized observational assessment: [hlca]), (tactile discrimination: [socb]), (affective responses: [orga]), (intrainsular tracts: [bpoc]), (reduced integrity: [inbe]), (mean diffusivity): [qnco]), (asd group: [cgab]), (td group: [popg]), (previous findings: [clna]), (impaired tactile discriminative ability: [orga]), (tactile defensiveness: [inbe]), ((e.g.: []), (enthusiastic play: [dora]), (repetitive engagement: [fndg]), (specific tactile stimulus): [phpr]), (significant relation: [socb]), (intrainsular tract integrity: [inbe]), (tactile seeking: [gngm]), (direction: []), (relation: [socb]), (groups:: [popg]), (diffusivity (md): []), (tract integrity): [inbe]), (tactile: [gngm]), (decreased tactile: [gngm]), (intrainsular md: []), (discriminative touch: [ortf]), (integrity: [inbe]), (group: [popg]), (results: [fndg]), (central role: [socb]), (insula: [bpoc]), (affective response: [fndg]), (somatosensory tracts: [bpoc]), (restriction: []), (brainbehavior associations: [menp]), (intrainsular tract: [bpoc]), (higher-order influence: [acty]), (discrimination: [socb]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5885471
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background: theory: []), (mind (tom): [gngm]), (ability: [orga]), (mental states: [fndg]), (autism spectrum disorder (asd): [mobd]), (altered activation: [acty]), (social brain regions: [blor]), (conversely: []), ( typically developing (td) individuals: [humn]), (tom: [gngm]), (strong tendency: []), (biological motion: [npop]), (environment: []), (less: [qnco]), (degree: [qnco]), (anthropomorphism influences: []), (intentional attribution: [menp]), (engagement: [fndg]), (social brain: [bpoc]), (asd: [cgab]), (fmri study: [diap]), (extent: []), (anthropomorphism: []), (role: [socb]), (social attribution: [menp]), (underlying neural responses: [orga]), (td: []), (series: [qnco]), (human stick figures: [humn]), (geometrical shapes: []), (methods:: []), (td adults: [aggp]), (videos: []), (stick figures: [bodm]), (triangles: []), (random: [resa]), (meaningful ways: []), (fmri scanner: [diap]), (addition: []), (out-of-scanner measures: [qnco]), (tom skill: [inbe]), (real-world social deficits: [popg]), (whole brain: [bpoc]), (statistical analysis: [resa]), (regression: [menp]), (group comparisons: [popg]), (conditions: [dsyn]), (spm12s implementation: [acty]), (general linear model: [qnco]), (results: tom network regions: [popg]), (response: [fndg]), (social movement: [socb]), (human-like characters: [humn]), (tom ability: [orga]), (increased tpj: [qnco]), (mpfc activity: [acty]), (stick figures; whereas: [bodm]), (severe social symptoms: [fndg]), (reduced right tpj activation: [acty]), (conclusion:: []), (results: [fndg]), (affect social attribution: [menp]), (importance: []), (tpj: []), 
ASD Terms: (altered activation of social brain regions, 'Engagement in Social Activities')(autism spectrum disorder, 'Autism Phenotype')(real-world social deficits, 'Social Competence')

PMCID: 5534954
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (attention deficit hyperactivity disorder (adhd): [mobd]), (>10%: [fndg]), (children: [aggp]), (united states: []), (considerable behavioral overlaps: [inbe]), (disorders: [dsyn]), (differential diagnosis: [diap]), (currently: []), (test: [lbpr]), (times: [qnco]), (initial suspicion: [menp]), (upwards: []), (year: []), ( methods: []), (assess risk: [acty]), (other developmental disorders: [mobd]), (previous study: [resa]), (machine-learning algorithms: [mcha]), (curve (auc)>0.96): [qnco]), (distinguish asd: [cgab]), (adhd: [mobd]), (small subset: [qnco]), (items: []), (social responsiveness scale (srs): [acty]), (here: []), (prior work: [evnt]), (novel: []), (data set: []), (responses: [orga]), (srs-derived questions: []), (parents: []), (asd (n=248): [cgab]), (adhd (n=174): [mobd]), (models capability: []), (real-world data: [euka]), (novel survey data: [euka]), (initial archival sample (n=3417): [aapp,imft]), (cross-validation: [resa]), (subsampling: []), (classification algorithm: [lbpr]), (auc=0.890.01: [qnco]), (questions: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(attention deficit hyperactivity disorder, 'Overactivity')(differential diagnosis, 'Diagnosis')(initial suspicion, 'Suspicious of Others')(diagnosis upwards, 'Diagnosis')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 5824534
SFARI Genes: spin, spin, spin, spin, met, met, 
Non SFARI Genes: 
Named Entities: (neurofibromatosis: [gngm]), ((nf1): [gngm]), (monogenic model: []), (syndromic autism: [mobd]), (statins: [orch,phsu]), (cognitive phenotype: [orga]), (animal knockout models: [anim]), (translational trials: [resa]), (subjects: [humn]), (years: []), (cognition/behaviour outcomes: [inbe]), (mixed results: [fndg]), (trial: [resa]), (new ground: [topp]), (statin effects: [orch,phsu]), (first time: [qnco]), (children: [aggp]), (nf1: [gngm]), (co-morbid autism: [mobd]), (multiparametric imaging outcomes: [diap]), (single-site triple-blind rct: [resa]), (simvastatin: [orch,phsu]), (placebo: [topp]), (assessment (baseline: [bodm]), (12-week endpoint): [qnco]), (peripheral mapk assay: [lbpr]), ( awake: [fndg]), (magnetic resonance: [npop]), (spectroscopy (mrs; gaba: [aapp,bacs]), ((glx)): []), (arterial spin: [bpoc]), ((asl): [gngm]), ( apparent diffusion coefficient (adc): []), (state: []), (functional mri: [diap]), (autism: [mobd]), (behavioural outcomes: [inbe]), (behaviour checklist: [inbe]), (clinical global impression): [fndg]), (thirty subjects: [humn]), (mean age: [orga]), (amount: [qnco]), (data: [euka]), (test: [lbpr]), (simvastatin treatment: [orch,phsu]), ((i): [inch]), (frontal white matter mrs gaba (t(12) =: [aapp,bacs]), (p = .055): [aapp,imft]), ( gaba/glx ratio (t(12) =: [aapp,bacs]), (p = .016): [aapp,imft]), (grey nuclei glx (ancova p: [celc]), (mann-whitney p: []), ((ii): []), (asl perfusion: [topp]), (ventral diencephalon (mann-whitney p: [bpoc]), ((iii): []), (adc: [gngm]), (cingulate gyrus: [bpoc]), ((mann-whitney p: []), (machine-learning classification: [mcha]), (outcomes: []), ((p < .05) accuracy: [aapp,imft]), (groups: [popg]), (endpoint: [qnco]), (chance level (64%: [phsu]), ( p: [aapp,imft]), (baseline: [bodm]), ((25%): []), (simvastatin cases: [orch,phsu]), (none: []), (clinical responder criteria: []), (behavioural outcome: [inbe]), (feasibility: []), (autism symptom measurement: [mobd]), (study: [resa]), (effectiveness: []), (multiparametric: []), (suggests: []), (possible simvastatin effects: [orch,phsu]), (brain areas: [bpoc]), (nf1 pathophysiology: [gngm]), (social brain network: [popg]), (trial registration eu clinical trial register (eudract): [resa]), (2012-005742-38 (www.clinicaltrialsregister.eu) electronic: [orgt]), (supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0190-z) contains: [acty]), (users: [humn]), 
ASD Terms: (syndromic autism, 'Autism Phenotype')(cognitive phenotype, 'Cognitive Ability')(co-morbid autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(mean age of 8.1 years, 'Onset of Symptoms')(autism symptom measurement, 'Complaints and Indications')

PMCID: 5110591
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (reputation: []), (important social skill: [socb]), (autistic children: [podg]), (study: [resa]), (typical children: [aggp]), (cognitive processestheory: []), (mind: [menp]), ( social motivation: [menp]), ( inhibitory control: [celf]), (reciprocitycontribute: []), (reputation management: [hlca]), (results: [fndg]), (group: [popg]), (group difference: [popg]), (explicit reputation management: [hlca]), (different mechanisms: []), (management: [hlca]), (groupssocial motivation: [menp]), (reciprocity: [socb]), (individual differences: [menp]), (relationship: []), (cognitive processes: [menp]), 
ASD Terms: (important social skill, 'Ability to Converse in Social Settings')(cognitive processestheory, 'Cognitive Ability')(cognitive processes, 'Cognitive Ability')

PMCID: 4154717
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder: [mobd]), (schizophrenia share: [mobd]), (substantial number: [qnco]), (phenotypic characteristics: [orga]), (still: []), (direct comparison: [acty]), (disorders: [dsyn]), (differences: [qnco]), (commonalities: []), (brain structure: [bpoc]), (voxel: []), (morphometry: [lbpr]), (patients: [podg]), (autism spectrum: [mobd]), (schizophrenia: [mobd]), (control subjects: [sbst]), (regional brain volume alterations: [qnco]), (global gray matter: [tisu]), (white matter differences: [tisu]), (groups: [popg]), (regional data: [euka]), ( patients: [podg]), (gray matter volume: [tisu]), (amygdala: [bpoc]), ( insula: [bpoc]), (anterior medial prefrontal cortex: [bpoc]), (left insula: [bpoc]), (disorder: [dsyn]), (specific positive correlations: [fndg]), (ability: [orga]), (amygdala volume: [bpoc]), (hallucinatory behavior: [inbe]), (insula volume: [bpoc]), (results: [fndg]), (involvement: []), (social brain areas: [bpoc]), (further studies: [lbpr]), (findings: [clna]), (amount: [qnco]), (neural correlates: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(schizophrenia share, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5352011
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (deficits: []), (social communication: [socb]), (pragmatic language: [lang]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (speech disfluencies: [orgf]), (pragmatic functions: [phsf]), (problems: []), (previous studies: [lbpr]), (speakers: []), (asd: [cgab]), ((td) speakers: []), (types: []), (patterns: []), (disfluencies: []), (detailed characterizations: [acty]), (methods: []), (cross-study comparison difficult: [fndg]), (study: [resa]), (simple schema: []), (major disfluency types: [dsyn]), (schema: []), (exploratory analysis: [resa]), (differences: [qnco]), (disfluency rates: [qnco]), (children: [aggp]), (td: []), (language: [lang]), (impaired (sli) groups: [aapp,bacs]), (study (asd =: [cgab]), (sli: [gngm]), (battery: [inpo]), (experimental tasks: []), (assessments: [hlca]), (measures: [qnco]), (syntactic complexity: [chvs]), (word: []), (disfluency counts: [qnco]), (transcripts: [nnon]), (autism diagnostic observation schedule (ados): [hlca]), (high inter-annotator agreement: [qnco]), (use: []), (analyses: [resa]), (asd children: [cgab]), (ratio: [qnco]), (content: [menp]), (td children: [aggp]), (relative frequencies: [qnco]), (repetitions: [mobd]), ( revisions: []), (false starts: []), (groups: [popg]), (cued disfluencies: []), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(speech disfluencies, 'Language Ability')(autism diagnostic observation schedule, 'Autism Phenotype')

PMCID: 5356303
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (suggested link: []), (anorexia nervosa (an): [mobd]), (autism spectrum disorder (asd): [mobd]), (previous studies: [lbpr]), (self-report: [resa]), (diagnostic criteria: []), (asd: [cgab]), (an populations: [popg]), (direct observation: [hlca]), (symptom characteristic: [clna]), (aim: [phsu]), (study: [resa]), (standardised: []), ( clinical assessment: [hlca]), (autism diagnostic observation schedule: [hlca]), (edition (ados-2): [aapp,enzy]), (presence: [qnco]), (autistic symptoms: [mobd]), (cross-sectional sample: []), (women: [popg]), (an: []), (sixty women: [popg]), (inpatient: [podg]), (day-patient specialist: [podg]), (disorder services: [dsyn]), (participant: [popg]), (ados-2 assessment: [aapp,enzy]), (set: [menp]), (self-report questionnaires: [resa]), (disorder pathology: [dsyn]), (other psychiatric symptoms: [sosy]), (iq: []), (fourteen women: [popg]), (clinical cutoff: []), (ados-2: [aapp,enzy]), (restrictive behaviours: [mobd]), (difficulties: [fndg]), (social affect: [menp]), (asd symptoms: [cgab]), (increased alexithymia: [sosy]), (obsessive-compulsive symptoms: [sosy]), (severe an: []), (further investigation: [hlca]), (consideration: [fndg]), (treatment: [topp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autistic symptoms, 'Complaints and Indications')(autism diagnostic observation schedule, 'Autism Phenotype')(inpatient, 'Hospitalizations')(had difficulties with social affect, 'Social Competence')(restrictive behaviours, 'Stereotyped, Restricted, and Repetitive Behavior')(asd symptoms, 'Complaints and Indications')

PMCID: 4513199
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (research: [resa]), (mental health: [menp]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (intellectual disability (id): [mobd]), (deficits: []), (individual (i.e.: [humn]), (sociocommunicative skills: [inbe]), (adaptive behavior: [inbe]), (functional cognitive skills): [inbe]), (contextual (i.e.: [diap,inpr]), ( home: []), ( school: [mnob,orgt]), (community: []), (correlates: []), (youth: [aggp]), (id: [lbpr]), (asd: [cgab]), (years: []), (age (m: [orga]), (sd: [gngm]), (peers: [popg]), (id only: [lbpr]), (group differences: [popg]), (sociocommunicative ability: [orga]), (school participation: [mnob,orgt]), (relationship: []), (thriving: [phsu]), (developmental-contextual framework: [orgf]), (interventions: [hlca]), (wellness: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(youth with intellectual disability, 'Learning Disorders')(intellectual disability only, 'Learning Disorders')(peers with intellectual disability only, 'Learning Disorders')

PMCID: 6388164
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental condition: [mobd]), (impaired social communication: [socb]), (repetitive: []), (stereotypic behaviours: [menp]), (utero exposure: [bpoc]), (environmental chemicals: [chem]), ((pcbs): [orch,phsu]), (role: [socb]), (etiology: []), (asd: [cgab]), (relation: [socb]), (plasma pcb concentrations: [orch,phsu]), (pregnancy: [orgf]), (autistic behaviours: [mobd]), (subset: []), (children: [aggp]), (years: []), (maternal-infant research: [resa]), (environmental chemicals (mirec) study: [resa]), (birth cohort: [qnco]), (mother-infant pairs: [famg]), (canada: []), (concentrations: [menp]), (pcb congeners: [orch,phsu]), (>40%: [qnco]), (plasma samples: [bdsu]), (trimester: []), (age: [orga]), ( caregivers: []), (social responsiveness scale-2: [acty]), (reliable measure: [qnco]), (repetitive behaviours: [inbe]), (interests: [menp]), (srs scores: [clna]), (binary outcome: []), (bayesian predictive odds ratios: [qnco]), (latent: []), (variable model: []), (evidence: []), (association: [menp]), (autistic behaviour: [mobd]), (however: []), (imprecise increases: [qnco]), (mean srs score: [clna]), (odds: []), (category: []), (category;: []), (instance: []), (average increase: [qnco]), ((95%pci:: []), (mean srs (exposure contrast: [irda]), (versus: []), (pcb category): [orch,phsu]), (pcb138: []), (odds ratio: [qnco]), (findings: [clna]), (importance: []), (associations: [menp]), (pcbs: [orch,phsu]), (binary scales: [bpoc]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental condition, 'Learning Disorders')(impaired social communication, 'Reciprocal Social Interaction')(stereotypic behaviours, 'Stereotyped, Restricted, and Repetitive Behavior')(utero exposure, 'Exposures')(repetitive behaviours, 'Restricted and Repetitive Behavior')

PMCID: 4893248
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (high prevalence: [qnco]), (variety: []), (gastrointestinal (gi) symptoms: [sosy]), (patients: [podg]), (autism spectrum disorders: [mobd]), (gi disturbances: [gngm]), (asd: [cgab]), (dysbiosis: [patf]), (observable phenotype: [orga]), (gut-brain axis disruption: [bpoc]), (exploitation: []), (strategies: [menp]), (normal gut microbiota: [orgm]), (gut production: [bdsy]), (absorption: [npop]), (toxins: [bacs,hops]), (probiotics addition/supplementation: [bact]), (diet: [hlca]), (non-pharmacological option: []), (treatment: [topp]), (aim: [phsu]), (controlled trial: [resa]), (effects: []), (supplementation: [topp]), (probiotic mixture (vivomixx): [bact]), (asd children: [cgab]), (specific gi symptoms: [sosy]), (core deficits: [bdsu]), (disorder: [dsyn]), (cognitive: []), (language development: [menp]), (brain function: [ortf]), (connectivity: []), (ancillary aim: [phsu]), (possible effects: []), (probiotic supplementation: [bact]), (urinary concentrations: [ortf]), (phthalates: [orch]), ((chemical pollutants): [hops]), (group: [popg]), (preschoolers: [aggp]), (belonging: []), (gi group: [popg]), (non-gi (ngi) group: [popg]), (basis: [phsu]), (symptom severity index: [fndg]), (gi disorders: [dsyn]), (order: [acty]), (arms: [gngm]), ( subjects: [humn]), (groups: [popg]), (ngi): []), (regular diet: [dora]), (probiotics: [bact]), (placebo: [topp]), (months: []), (participants: [popg]), (baseline: [bodm]), (possible changes: [qnco]), ((1) gi symptoms; (2) autism symptoms: [mobd]), (behavioral comorbid symptoms; (4) plasmatic: [bdsu]), (fecal biomarkers: [clna]), (abnormal intestinal function; (5): [orgf]), (neurophysiological patterns: [phsf]), (discussion: [socb]), (treatments: [topp]), (children: [aggp]), (trials: [resa]), (impact: [gngm]), (current trial sets: [resa]), (new insights: [menp]), (gut-brain connection: [bpoc]), (asd patients: [cgab]), (moreover: []), ( results: [fndg]), (information: []), (relationship: []), (clinical features: [clna]), (trial registration clinicaltrials.gov identifier: nct02708901: [resa]), (march: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(diet, 'Dietary Restrictions')(supplementation, 'Dietary Supplements')(cognitive, 'Cognitive Ability')(language development, 'Language Development')(probiotic supplementation, 'Dietary Supplements')(gastrointestinal disorders, 'Gastrointestinal Diseases')(regular diet, 'Dietary Restrictions')(autism symptoms, 'Complaints and Indications')(behavioral comorbid symptoms, 'Comorbidities')

PMCID: 5015758
SFARI Genes: app, app, 
Non SFARI Genes: impact, 
Named Entities: (study: [resa]), (technology-based early intervention: [hlca]), (social communication skills: [socb]), (pre-schoolers: [mamm]), (trial: [resa]), (participants: [popg]), (children: [aggp]), (years: []), (diagnosis: [fndg]), (autism: [mobd]), (intervention: [hlca]), (control conditions: [topp]), (app: [gngm]), (consistently: []), ( regardless: []), (developmental level: [orgf]), (parents: []), (significant group differences: [popg]), (parent-report measures: [qnco]), (measure: [qnco]), (parentchild play: [dora]), (therefore: []), (observable impact: [gngm]), (real-world social communication skills: [socb]), (caution: []), (potential usefulness: []), (ipad apps: []), (amelioration: []), (difficulties: [fndg]), (interaction: []), (however: []), (positive attitudes: [menp]), ( lack: []), (harms: []), (potential: []), (apps: []), (therapeutic content: [menp]), (low economic cost: [qnco]), (approach: []), (further: []), (other skill domains: [inbe]), 
ASD Terms: (social communication skills, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(diagnosis, 'Diagnosis')(real-world social communication skills, 'Reciprocal Social Interaction')

PMCID: 6381857
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (~1: [fndg]), (people: [popg]), (north america: []), (diagnoses: [fndg]), ((center: [fndg]), (disease control: [topp]), (prevention: [resa]), (exact cause: []), (asd: [cgab]), (therapy: [topp]), (primary means: [topp]), (intervention: [hlca]), (asd experience: [cgab]), (behavioral deficits: [inbe]), (disorder: [dsyn]), (aspects: [qnco]), (life: []), (academics: [orgt]), ( relationships: []), (physical activity: [dora]), (research: [resa]), (relationship: []), (social skills: [socb]), (individuals; however: [humn]), (purpose: []), (review: []), (social functioning: [socb]), (authors: []), (databases: []), (primary research articles: [resa]), (bidirectional: social functioning influences: [socb]), (extent): []), (regrettably: []), (many limitations: []), (articles: []), (small sample sizes: [sbst]), (under-representation: [acty]), (females: [orga]), (adults: [aggp]), (therefore: []), (review highlights: []), (several directions: [qnco]), (future research: [resa]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(behavioral deficits, 'Personal Traits')(social skills, 'Ability to Converse in Social Settings')(social functioning, 'Ability to Converse in Social Settings')(social functioning, 'Social Competence')(social functioning influences, 'Ability to Converse in Social Settings')

PMCID: 4995545
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (interventions: [hlca]), (autism: [mobd]), (synthetic hormone oxytocin: [aapp,horm,phsu]), (potential treatment: [topp]), (core: [bdsu]), (behavioral difficulties: [fndg]), (efficacy: [resa]), (young children: [aggp]), (extent: []), ( tolerability: [resa]), (safety: [hcpp]), (oxytocin treatment: [aapp,horm,phsu]), (double-blind: [resa]), ( randomized: [resa]), (placebo-controlled: [resa]), ( crossover: [resa]), (clinical trial: [resa]), (children: [aggp]), (international units (iu): [qnco]), (oxytocin: [aapp,horm,phsu]), (placebo nasal spray morning: [topp]), (night (24 iu: [nnon]), (day): []), (weeks: []), (4-week washout period: [fndg]), (treatment: [topp]), (placebo: [topp]), ( oxytocin: [aapp,horm,phsu]), (significant improvements: [qnco]), (primary outcome: [topp]), (caregiver-rated social responsiveness: [acty]), (overall: []), ( nasal spray: [bodm]), (adverse events: [patf]), (thirst: [phsf]), ( urination: [orgf]), (constipation: [sosy]), (study: [resa]), (first clinical trial: [resa]), (potential: []), (early intervention: [hlca]), (social interaction deficits: [fndg]), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(behavioral difficulties, 'Personal Traits')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(social interaction deficits, 'Reciprocal Social Interaction')

PMCID: 5606140
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neuropsychiatric disorder: [dsyn]), (impairment: [patf]), (social reciprocity: [socb]), ( interaction/language: [lang]), (behavior: [inbe]), (stereotypes: [mobd]), (signs: [fndg]), (sensory function deficits: [ortf]), (electroencephalography (eeg): [diap]), (noninvasive tool: []), (neurophysiological characterization: [acty]), (monitoring: [resa]), (brain: [bpoc]), (electrical activity: [ortf]), (abnormalities: [cgab]), (connectivity: []), (lateralization: []), (brain functions: [ortf]), (research: [resa]), (evidence: []), (quantitative differences: [qnco]), (frequency spectrum pattern: [qnco]), (eeg signals: [diap]), (children: [aggp]), (asd: [cgab]), (visualization: [menp]), (neutral: [fndg]), ( happy: [menp]), (angry: [menp]), (quantitative clinical evaluations: [qnco]), (neuropsychological evaluation: [diap]), (eeg: [diap]), (age: [orga]), (gender: [orga]), (results: [fndg]), (activation: [acty]), (frequencies: []), (hz): [qnco]), (frontal: []), ( central: [lbpr]), ( parietal: []), (occipital regions: [bpoc]), (asd group: [cgab]), (pattern: []), (developmental characteristics: [orgf]), 
ASD Terms: (stereotypes, 'Stereotyped, Restricted, and Repetitive Behavior')(signs of sensory function deficits, 'Reaction to Sensory Stimuli')(autism spectrum disorder, 'Autism Phenotype')(sensory function deficits, 'Reaction to Sensory Stimuli')(lateralization of brain functions, 'Functional Laterality')(visualization, 'Visual Thinking')

PMCID: 4437371
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (sex differences: [orga]), (diagnostic categories: [fndg]), (clinical symptoms: [sosy]), (adaptive behavior: [inbe]), (persons: [popg]), (autism spectrum disorders: [mobd]), (sex-specific correlations: [orgf]), (adaptive caracteristics: []), (study: [resa]), (patients: [podg]), (years: []), (assessment: [acty]), (adi-r: [clna]), (vineland adaptive behavior scale ii: []), (males: [orga]), (typical autism: [mobd]), (autistic symptoms: [mobd]), (females: [orga]), (daily: []), (skills: [inbe]), (significant difference (p: [aapp,imft]), (different associations: [menp]), (different aspects: [qnco]), (social reciprocity: [socb]), (social domain: []), (positive direction: [fndg]), (findings: [clna]), ( females: [orga]), (results: [fndg]), (sex: [orgf]), (way: []), (core feature: [bdsu]), (asd: [cgab]), (therapeutical implications: []), (need: []), (individualized: []), ( sex-specific treatment: [orgf]), (group: [popg]), (disorders: [dsyn]), 
ASD Terms: (adaptive behavior, 'Adaptive Life Skills')(autism spectrum disorders, 'Autism Phenotype')(adaptive caracteristics, 'Adaptive Life Skills')(vineland adaptive behavior scale ii, 'Adaptive Life Skills')(typical autism, 'Autism Phenotype')(autistic symptoms, 'Complaints and Indications')(autistic symptoms, 'Complaints and Indications')(adaptive behavior, 'Adaptive Life Skills')(adaptive behavior, 'Adaptive Life Skills')(autistic symptoms, 'Complaints and Indications')

PMCID: 6318495
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (areas: []), (social cognition: [socb]), (theory: []), (mind (tom): [gngm]), (capacity: [qnco]), (infer: [menp]), (mental states: [fndg]), (behavior: [inbe]), (others: [fndg]), (social cognition studies: [lbpr]), (neurodevelopmental disorders: [mobd]), (skill: [inbe]), (children: [aggp]), (specific learning disorder (sld): [mobd]), (study: [resa]), ( social cognition skills: [socb]), (attention deficit hyperactivity disorder (adhd): [mobd]), ( sld: [gngm]), (autism spectrum disorder (asd): [mobd]), (puberty: [phsf]), (controls: [sbst]), (tom: [gngm]), (secondorder: []), (false belief: []), (hinting task: [gngm]), (faux pas test: [orch,phsu]), (mind: [menp]), (eyes task: [bpoc]), (adhd: [mobd]), ( asd: [cgab]), (sld: [gngm]), (tom deficits: [gngm]), (intelligence: [menp]), (language development: [menp]), (significant correlation: [qnco]), (social cognition deficits: [socb]), (problems: []), (many areas: []), (social communication: [socb]), (interaction: []), ( attention: [menp]), ( behavior: [inbe]), (learning: [menp]), (important area: []), (impairment: [patf]), (strong relationship: []), (clinical symptoms: [sosy]), (impaired functionality: []), 
ASD Terms: (social cognition, 'Cognitive Ability')(neurodevelopmental disorders, 'Learning Disorders')(social cognition studies, 'Cognitive Ability')(children with specific learning disorder, 'Learning Disorders')(specific learning disorder, 'Learning Disorders')(social cognition skills, 'Cognitive Ability')(social cognition skills, 'Cognitive Ability')(attention deficit hyperactivity disorder, 'Overactivity')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorders, 'Learning Disorders')(language development, 'Language Development')(social cognition deficits, 'Cognitive Ability')(social communication, 'Reciprocal Social Interaction')

PMCID: 5010684
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders (asd): [mobd]), (disabling: []), (lifelong neuro-developmental disorder: [mobd]), (behaviours: [inbe]), (aggression: [mobd]), (self injury: [inpo]), (common maladaptive behaviours: [fndg]), (asd: [cgab]), (mental health: [menp]), (affected children: [aggp]), (caregivers: []), (parent-delivered behavioural intervention: [topp]), (children: [aggp]), (research: [resa]), (feasibility: []), (intervention: [hlca]), (sub-saharan africa: []), (study: [resa]), (parent-mediated behavioural intervention: [topp]), (behaviour: [inbe]), (nigeria: []), (pre-post intervention pilot study: [resa]), (mothers: [famg]), (dsm-5 diagnosis: [fndg]), (child: [aggp]), (adolescent mental health service: [hlca]), (out-patient unit: [podg]), (sessions: [evnt]), (group-based intervention: [popg]), (march: []), (functional behavioural analysis: [inbe]), (individualised behaviour management plan: [dsyn]), (primary outcome measure: []), (self injury questionnaire: [inpo]), (person: [grup]), (property (app): []), (self injurious behaviour (sib): [inbe]), (mothers knowledge: [famg]), (intervention content: [menp]), (secondary outcome: [neop]), (outcome measures: [qnco]), (baseline: [bodm]), (mothers level: [famg]), (satisfaction: [menp]), (programme: [phsu]), (treatment effect: [fndg]), (wilcoxon signed rank tests: []), (post-intervention scores: [clna]), (years: []), ( sd: [mamm]), (years): []), (mothers ages: [famg]), (post intervention scores: [clna]), (domains: []), (app: [gngm]), (sib: [famg]), (pre-intervention scores: [clna]), (post-intervention: []), (vast majority (75 %): [socb]), (participants: [popg]), ((100 %): [qnco]), (friend: [popg]), (similar difficulties: [fndg]), (promising treatment: [topp]), (behavioural intervention: [topp]), (integral component: [qnco]), (services: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(common maladaptive behaviours in asd, 'Autism Phenotype')(aggression, 'Aggressive Behavior')(dsm-5 diagnosis, 'Diagnosis')(individualised behaviour management plan, 'Planning')

PMCID: 6191468
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (executive: []), ((ef) deficits: []), (autism spectrum disorder (asd): [mobd]), (longitudinal trajectory: []), (everyday ef: []), (links: []), (behavioral outcomes: [inbe]), (asd: [cgab]), (study: [resa]), (profile: [lbpr]), (parent-reported measures: [qnco]), (years: []), (prior estimates: [qnco]), (ef: []), (co-morbid psychopathology: []), (social functioning: [socb]), (children: [aggp]), ((td) children: [aggp]), (years): []), (parent reports: [hlca]), ( children: [aggp]), (scores: [clna]), (domains: []), (time points: []), (significant improvement: [qnco]), (regression analyses: []), (behavior regulation difficulties: [fndg]), (time: []), (emotional (i.e.: [menp]), ( symptoms: [sosy]), (anxiety/depression): [mobd]), (behavioral (i.e.: [inbe]), ( oppositionality/aggressiveness) problems: [mobd]), (furthermore: []), (improvement: []), (metacognitive skills: [menp]), (reduction: [npop]), (social difficulties: [fndg]), (results: [fndg]), (potential target: [diap]), (intervention: [hlca]), (social competence: [socb]), (youth: [aggp]), (findings: [clna]), (behavioral functioning: [inbe]), ( whereas ef: []), (cognition: [menp]), (treatment: [topp]), (future studies: [lbpr]), (effectiveness: []), (ef-based interventions: [hlca]), (cognitive: []), (social outcomes: []), (high priority: []), 
ASD Terms: (everyday executive functioning, 'Executive Function')(autism spectrum disorder, 'Autism Phenotype')(social functioning, 'Social Competence')(executive functioning, 'Executive Function')(prior estimates of behavior regulation difficulties, 'Personal Traits')(behavioral problems in children, 'Personal Traits')(behavior regulation difficulties, 'Personal Traits')(behavioral problems, 'Personal Traits')(reduction of social difficulties, 'Social Competence')(social difficulties, 'Social Competence')(social competence, 'Social Competence')(cognition, 'Cognitive Ability')(cognitive, 'Cognitive Ability')

PMCID: 5975568
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (urinary metabolites: [bpoc]), (impairments: [patf]), (several pathways: [moft]), (oxidative stress: [comd]), ( inflammation: [patf]), (mitochondrial dysfunction: [fndg]), (gut microbiome alterations: [orgm]), (supplement: []), (indirect antioxidant effects: [phsf]), (broccoli sprouts: [plnt]), (seeds: [plnt]), (improvements: []), (behavior: [inbe]), (social responsiveness: []), (asd: [cgab]), (current open-label study: [resa]), (changes: [qnco]), (clinical improvements: []), (goal: []), (potential mechanism: []), (action: [acty]), (young adults: [aggp]), (school: [mnob,orgt]), (neurodevelopmental disorders: [mobd]), (12-week: []), ( open-label study: [resa]), (sulforaphane: [orch,phsu]), (measures: [qnco]), ((aberrant behavior checklistabc): [inbe]), ((social responsiveness scalesrs): []), (baseline: [bodm]), (end: [gngm]), (study: [resa]), (pearsons correlation coefficient: [qnco]), (post-intervention change: [qnco]), (clinical scales: [bpoc]), (srs): []), (change: [qnco]), (metabolite: [bacs]), (fifteen children: [aggp]), (12-week study: [resa]), (mean scores: [qnco]), (symptom measures: [qnco]), (study period: [resa]), (srs: [gngm]), (abc: [dsyn]), (points: [qnco]), ((95% ci: [lbpr]), (symptoms: [sosy]), (pathways: [moft]), ( amino: []), (microbiome: [orgm]), ( neurotransmitters: [bacs]), ( hormones: [horm]), (sphingomyelin metabolism: [moft]), (urinary metabolomics analysis: [lbpr]), (useful tool: []), (mechanism: []), (treatments: [topp]), (abnormal physiology: [phsf]), (trial registration: [resa]), (clinicaltrials.gov (nct02654743): [gngm]), (january: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(supplement, 'Dietary Supplements')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 6217788
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (global need: []), (brief screening instruments: [diap]), (key indicators: [irda]), (autism: [mobd]), (frontline professionals: []), (referral decision-making: [menp]), (universal set: [menp]), (conditions: [dsyn]), (subtle differences: [qnco]), (expression: [topp]), ( identification: [menp]), (reporting: [hlca]), (autistic traits: [mobd]), (cultures: [lbpr]), (order: [acty]), (potential: []), (measure: [qnco]), (cross-cultural screening use: [diap]), (relative performance: [inbe]), (such measures: [qnco]), (different cultures: []), (study: [resa]), (items: []), (autism spectrum quotient (aq)-child: [aggp]), (autism diagnosis: [mobd]), (children: [aggp]), (years: []), (samples: [sbst]), (india: [fish]), ( japan: []), (uk: []), (parent-reported aq-child data: [euka]), (india (73 children: [aggp]), (neurotypical children): [aggp]), ( japan (116 children: [aggp]), (uk (488 children: [aggp]), (none: []), (diagnosis: [fndg]), (intellectual disability: [mobd]), (discrimination indices (di): [socb]), (positive predictive values: [qnco]), (predictive items: []), (country: []), (sixteen items: [qnco]), (indian sample: [sbst]), (japanese sample: [sbst]), (uk sample: [sbst]), (excellent discriminatory power (di: [hcpp]), (ppv: [qnco]), (indicators: [irda]), (countries: []), (good performing items: []), (key indicator items: [irda]), (track: []), (several different peoples conversations: [socb]), (someone: []), (him/her: []), (social chit-chat: [aapp,enzy]), ( finds: [fndg]), (peoples intentions): [menp]), (potential cultural differences: []), (item: []), (japan: []), (discriminative (di <: [socb]), (further item: []), (excellent discrimination properties: [socb]), (japanese samples: [sbst]), (additional items: []), (third: [qnco]), (cross-cultural overlap: [topp]), (general notion: [hlca]), (universality: [bodm,orch]), (autistic traits whilst: [mobd]), (cultural differences: []), (certain autistic traits: [mobd]), (findings: [clna]), (development: [orgf]), (brief global screening tool: [diap]), (further development: [orgf]), (evaluation work: [hlca]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0235-3) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism, 'Autism Phenotype')(autism diagnosis, 'Diagnosis')(autism spectrum quotient -child, 'Autism Phenotype')(diagnosis, 'Diagnosis')(intellectual disability, 'Learning Disorders')(autism, 'Autism Phenotype')

PMCID: 3769633
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (psychiatric disorders: [mobd]), (twin: [famg]), (family studies: [famg]), (monozygotic concordance rate: [qnco]), (dizygotic concordance: [socb]), (20-fold increase: [fndg]), (risk: []), (first-degree relatives: [qnco]), (major advances: []), (genetics: []), (relationship: []), (different aspects: [qnco]), (cognitive phenotype: [orga]), (underlying genetic liability: [topp]), (heterogeneity: [orga]), (autism: [mobd]), (phenotypic levels: [orga]), (method: [lbpr]), (homogeneous entities: []), (specific genotypes: [orga]), (endophenotypes: []), (evidence: []), (neuroimaging: [diap]), ( eye tracking: [bpoc]), (electrophysiology studies: [diap]), (hypothesis that: []), ( building: []), (genetic vulnerability: [topp]), ( asd: [cgab]), (developmental cascade: [orgf]), (deficit: [dsyn]), (attention: [menp]), (social stimuli: [phpr]), (interactions: []), (primary caregivers: [popg]), (results: [fndg]), (abnormal development: [cgab]), (neurocircuitry: []), (social cognition: [socb]), (turn: [fndg]), (functional domains: []), (early processes: [phpr]), (language development: [menp]), (model: []), (heterogeneous clinical phenotype: [orga]), (studies: [lbpr]), (clinical outcomes: []), (treatment: [topp]), (treatment response: [fndg]), (intensive early behavioral intervention: [hlca]), (asd: [cgab]), (variable; however: []), (specific elements: [elii]), (clinical phenotype: [orga]), (response: [fndg]), (current behavioral treatments: [topp]), (paper: []), (literature: [inpr,mnob]), (genotypes: [orga]), ( phenotypes: [orga]), (predictors: []), (behavioral intervention: [topp]), (presents suggestions: [qnco]), (future research: [resa]), (linkages: [moft]), (identification of: [menp]), (treatment efficacy for: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(psychiatric disorders, 'Mental Disorders')(cognitive phenotype, 'Cognitive Ability')(autism, 'Autism Phenotype')(eye tracking, 'Eye Contact')(eye tracking, 'Eye Contact')(results in abnormal development, 'Learning Disorders')(abnormal development, 'Learning Disorders')(social cognition, 'Cognitive Ability')(language development, 'Language Development')

PMCID: 6258310
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (pioglitazone: [orch,phsu]), (promising compound: [chem]), (treatment: [topp]), (core autism spectrum disorder (asd) symptoms: [mobd]), (multiple relevant pathways: [moft]), (immune system alterations: [bdsy]), (objective: []), (pilot study: [resa]), (maximum: [qnco]), (dose: [qnco]), ( safety: [hcpp]), (preliminary evidence: []), (efficacy: [resa]), (appropriate outcome measures: [qnco]), (autistic children: [podg]), (years: []), (16-week prospective cohort: [resa]), (single blind: [resa]), (single arm: [fndg]), ( 2-week placebo: [topp]), (run-in: []), ( dose-finding study: [sosy]), (twenty-five participants: [popg]), (method: [lbpr]), (safety: [hcpp]), (dose response: [resa]), (mg/kg: [qnco]), (dose:: [qnco]), (serious adverse events: [fndg]), (range: [qnco]), (safety:: [hcpp]), (participants: [popg]), (intervention: [hlca]), (non-efficacy: [resa]), (inability: []), (interim blood work: [bdsu]), (mild neutropenia: [fndg]), (early evidence: []), (efficacy:: [resa]), (significant improvement: [qnco]), (social withdrawal: [fndg]), (repetitive behaviors: [fndg]), (behaviors: [inbe]), (aberrant behavior checklist (abc): [inbe]), ( child yale-brown obsessive compulsive scale (cy-bocs): [aggp]), (repetitive behavior: [fndg]), ((rbs-r): [cgab,dsyn]), (forty-six percent: [qnco]), (global responders: []), (conclusions: []), (relevance pioglitazone: [orch,phsu]), (potential signal: [phpr]), (measures: [qnco]), ( repetitive: []), (controlled trials: [resa]), (trial registration clinicaltrials.gov: [resa]), ( nct01205282: []), (registration: [mcha]), (september: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0241-5) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (core autism spectrum disorder symptoms, 'Complaints and Indications')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(child yale-brown obsessive compulsive scale child yale-brown obsessive compulsive scale), 'Obsessive-Compulsive Disorder')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 4310919
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (aim: [phsu]), (study: [resa]), (abnormal findings: [fndg]), (social brain network: [popg]), (korean children: [aggp]), (autism spectrum disorder (asd): [mobd]), (children (tdc): [aggp]), (functional: []), (magnetic resonance: [npop]), ((fmri): [diap]), (brain activations: [bpoc]), (processing: [acty]), ((happy: [menp]), ( fearful: [menp]), (neutral): [fndg]), (children: [aggp]), (asd: [cgab]), (tdc: []), (emotional face stimuli: [blor]), (various areas: [phsu]), (social brain: [bpoc]), (social cognition: [socb]), (activation: [acty]), (specifically: []), ( asd children: [cgab]), (right amygdala: [bpoc]), (right superior temporal sulcus (sts): [orch,phsu]), (right inferior frontal gyrus (ifg): [bpoc]), (tdc group: [popg]), (shown: [anim]), (left insular cortex: [bpoc]), (right ifg: [gngm]), (response: [fndg]), (asd group: [cgab]), (similar findings: [clna]), (left superior insular gyrus: [bpoc]), (right insula: [bpoc]), (case: []), (neutral stimulation: [npop]), (findings: [clna]), (different processing: [acty]), (emotional experience: [menp]), (neural level: [phsu]), (deficit: [dsyn]), (deterioration: [phpr]), (capacity: [qnco]), (visual analysis: [resa]), (emotional faces: [blor]), (subsequent inner imitation: [socb]), (mirror neuron system (mns): [cell]), (ability: [orga]), (limbic system: [bdsy]), (transmitted emotion: [patf]), 
ASD Terms: (investigate abnormal findings of social brain network, 'Social Competence')(autism spectrum disorder, 'Autism Phenotype')(social cognition, 'Cognitive Ability')(social cognition, 'Cognitive Ability')(visual analysis, 'Visual Thinking')(subsequent inner imitation, 'Imitation')

PMCID: 4318440
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prevalence estimates: [qnco]), (autism spectrum disorder (asd): [mobd]), (down syndrome (ds): [cgab,dsyn]), (variation: []), (difficulty: [fndg]), (comorbid asd: [cgab]), (individuals: [humn]), (syndrome: [dsyn]), (own set: [menp]), (social communicative: [socb]), (behavioral difficulties: [fndg]), (aim: [phsu]), (study: [resa]), (typical range: [qnco]), (social communicative impairments: [mobd]), (children: [aggp]), ( adolescents: [aggp]), (young adults: [aggp]), (ds: [gngm]), (patterns: []), (scores: [clna]), (subscales: []), (social responsiveness scale (srs): [acty]), (years): []), (comorbid asd relative: [cgab]), (normative sample: [sbst]), (correlations: []), (srs symptomatology: []), (age: [orga]), (nonverbal cognition: [menp]), (receptive language: [lang]), (srs scores: [clna]), (asd symptoms: [cgab]), (mean scores: [qnco]), (significant range: [qnco]), (analysis: [resa]), (subscale: []), (specific pattern: []), (autistic mannerisms: [mobd]), (social cognition: [socb]), (social communication: [socb]), (social awareness: [menp]), (social motivation scores: [menp]), (other measures: [qnco]), (general: [hlca]), (asd symptomatology: [cgab]), (srs: [gngm]), (need: []), (population-based norms: [popg]), (pattern: []), (clinicians: []), (behaviors: [inbe]), (atypical patterns: [fndg]), (behavior: [inbe]), (full asd evaluation: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(down syndrome, 'Down Syndrome')(comorbid asd, 'Comorbidities')(social communicative, 'Reciprocal Social Interaction')(behavioral difficulties, 'Personal Traits')(social communicative impairments, 'Reciprocal Social Interaction')(young adults with down syndrome, 'Down Syndrome')(have comorbid asd, 'Comorbidities')(comorbid asd relative, 'Comorbidities')(nonverbal cognition, 'Cognitive Ability')(receptive language, 'Receptive Language')(social cognition, 'Cognitive Ability')(social communication, 'Reciprocal Social Interaction')(down syndrome so that individuals, 'Down Syndrome')(atypical patterns of behavior, 'Restricted and Repetitive Behavior')

PMCID: 5481916
SFARI Genes: FMR1, Fmr1, FMRP, FMR1, Fmr1, FMRP, Fmr1, Fmr1, FMRP, FMRP, Fmr1, Fmr1, 
Non SFARI Genes: 
Named Entities: (people: [popg]), (fragile x syndrome (fxs): [cgab,dsyn]), (deficits: []), (social behavior: [socb]), (substantial portion meet criteria: [phpr]), (autism spectrum disorder: [mobd]), (genetic cause: [topp]), (fxs: []), (silencing: [mobd]), (fmr1: [gngm]), (fmr1 null mouse model: [mamm]), (lesion: [fndg]), (contributions: [acty]), (gene: [gngm]), (protein product: [aapp,bacs]), ( fmrp: [aapp,bacs]), (null mice: [mamm]), (wildtype littermates: [gngm]), (non-social stimulus: [phpr]), (experiment: [resa]), ( subjects: [humn]), (expression: [topp]), (inducible transcription factor c-fos: [aapp,enzy]), (response: [fndg]), (stimulus: [phpr]), (brain regions: [blor]), (social-specific activity: [socb]), (separate experiment: [resa]), ( tissue: [tisu]), (differential activity: [acty]), (rna sequencing: [nusq]), (immunohistochemistry: [diap]), (number: [qnco]), (c-fos-positive cells: [gngm]), (lateral amygdala: [bpoc]), (medial amygdala: [bpoc]), (brains: [bpoc]), (mice: [mamm]), (social stimulus: [phpr]), (prelimbic cortex: [bpoc]), (significant effect: [qnco]), (social stimulus;: [phpr]), (social condition: []), (non-social condition: []), (c-fos: [gngm]), (amygdala: [bpoc]), (rna: [nnon]), (genes: [gngm]), (molecules: [sbst]), (fmrp: [gngm]), (autism-related genes: [gngm]), (simons foundation autism research initiative gene database: [mobd]), (ingenuity pathway analysis: []), (enrichment: []), (networks: []), (pathways: [moft]), (neuronal development: [celf]), (intracellular signaling: [moft]), (inflammatory response: [patf]), (fragile x syndrome: [cgab,dsyn]), ( gene networks: [moft]), (molecular pathways: [moft]), (findings: [clna]), (future experiments: [resa]), (role: [socb]), (specific gene networks: [moft]), (light: [gngm]), (neural mechanisms: []), (social behaviors: [socb]), (broadly: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0148-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (fragile x, 'Fragile X Syndrome')(social behavior, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(fragile x syndrome, 'Fragile X Syndrome')(fragile x syndrome, 'Fragile X Syndrome')(social condition, 'Social Competence')(simons foundation autism research initiative gene database, 'Autism Phenotype')(fragile x syndrome, 'Fragile X Syndrome')(social behaviors, 'Reciprocal Social Interaction')(fragile x syndrome, 'Fragile X Syndrome')

PMCID: 6113401
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (amygdala: [bpoc]), (researched brain structure: [bpoc]), (social processing: [acty]), (multiple major clinical disorders: [dsyn]), (functions: [phsf]), (brain structure: [bpoc]), (basis: [phsu]), (neuroanatomical connectivity findings: [clna]), (behavioral: [inbe]), (physiological findings: [fndg]), (neuroanatomical interconnections: [socb]), (perirhinal cortex (prc): [bpoc]), (theoretical literature: [inpr,mnob]), (prc: [gngm]), (complex: [chvs]), ( multimodal: [diap]), (fine-grained distributed representations: [acty]), (objects: []), (conspecifics: []), (connectivity: []), ( amygdala: [bpoc]), (fine-grained representations: [acty]), (intangible knowledge: []), (integration: [genf]), (support: []), (amygdala mediation: [bpoc]), (diversity: []), (such representations: [acty]), (representations: [acty]), (subjective valence: []), (impact: [gngm]), ( economic value: [qnco]), ( noxiousness: []), ( importance: []), ( ingroup: []), (social status: []), ( popularity: [socb]), ( trustworthiness: [menp]), (moral features: []), (formation: [biof]), (amygdala representations: [bpoc]), (cognition mechanisms: [menp]), (hypothesis builds: []), (work: []), (multiple novel contributions: [acty]), (literature: [inpr,mnob]), (factor: []), (other behaviors: [inbe]), (neglected amygdala-prc interconnections: [bpoc]), (amygdala-mediated intangible knowledge representations: [bpoc]), (social brain region: [blor]), (species-typical social behaviors: [bhvr]), (novel proposal: []), (role: [socb]), (hypothesis: []), (amygdalas involvement: [bpoc]), (several core symptoms: [sosy]), (autism spectrum disorder (asd): [mobd]), (specifically: []), ( novel: []), (testable explanations: []), (asd symptoms: [cgab]), (disorganized visual scanpaths: []), (apparent social disinterest: []), ( preference: []), (concrete cognition: [menp]), ( aspects: [qnco]), (disorders heterogeneity: [orga]), (impairment: [patf]), (activities: [acty]), (daily living: []), (presented hypothesis: []), (substantial explanatory potential: []), (clinical domains: []), 
ASD Terms: (social status, 'Engagement in Social Activities')(cognition mechanisms, 'Cognitive Ability')(species-typical social behaviors, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(asd symptoms, 'Complaints and Indications')(disorganized visual scanpaths, 'Visual Thinking')(concrete cognition, 'Cognitive Ability')

PMCID: 5121131
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (early intervention: [hlca]), (long-term autism symptom outcomes: [mobd]), (preschool autism communication trial (pact): [resa]), (pact intervention: [hlca]), (long-term effect: [phpr]), (autism symptoms: [mobd]), (continued effects: []), (parent: []), (social interaction: [fndg]), (pact: [gngm]), (randomised controlled trial: [inpr,resa]), (parent-mediated social communication intervention: [topp]), (children: [aggp]), (years: []), (core autism: [mobd]), (follow-up ascertainment: [hlca]), (clinical services centres: [hlca]), (uk (london: []), ( manchester: []), (newcastle): []), (median: [qnco]), (original trial endpoint: [resa]), (main blinded outcomes: [resa]), (comparative severity score (css): [qnco]), (autism diagnostic observation schedule: [hlca]), (dyadic communication assessment measure (dcma): [socb]), (proportion: [qnco]), (child initiatiations: [aggp]), (expressive-receptive language composite: [lang]), (intention-to-treat principle: [menp]), (isrctn registry: []), ( number isrctn58133827: [qnco]), (findings: [clna]), ((80%): [fndg]), (trial participants: [popg]), ([77%]: []), (pact intervention vs: [hlca]), ([83%]: []), (treatment: [topp]), (july: []), (september: []), (mean age: [orga]), (follow-up: [hlca]), (group difference: [popg]), (favour: [orch,phsu,vita]), (ados css: [cgab,dsyn]), (log-odds effect size (es): [qnco]), ((95% ci: [lbpr]), (treatment endpoint: [qnco]), (es: [neop]), ((95% ci 005: [lbpr]), (overall reduction: [npop]), (symptom severity: [fndg]), (course: []), (whole trial: [resa]), (follow-up period: [hlca]), (ci: [gngm]), (p=0004): [aapp,imft]), (dcma child initiations: [dsyn]), (cohen's d es: [neop]), ((95% ci 0.02: [fndg]), (study: [resa]), (group: [popg]), (language: [lang]), (follow-up (es: [neop]), (ci 023: [lbpr]), (interpretation: [clna]), (results: [fndg]), (long-term symptom reduction: [npop]), (autism spectrum disorder: [mobd]), (clinical value: [qnco]), (implications: []), (developmental theory: [orgf]), (funding medical research council: [qnco]), 
ASD Terms: (long-term autism symptom outcomes, 'Complaints and Indications')(autism symptoms, 'Complaints and Indications')(preschool autism communication trial, 'Autism Phenotype')(preschool autism communication trial intervention, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(parent-mediated social communication intervention, 'Reciprocal Social Interaction')(core autism, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(funding medical research council, 'Medications')

PMCID: 4150424
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (autism spectrum disorder (asd) show impairment: [mobd]), (reciprocal social communication: [socb]), (deficits: []), (social cognition: [socb]), (behavior: [inbe]), (social behavior: [socb]), (social processes: [phpr]), (multiple levels: [qnco]), (analysis: [resa]), (neuropsychological measures: [qnco]), (face processing: [emst]), (reveal deficits: []), (asd: [cgab]), (ability: [orga]), (facial information: [blor]), (however: []), (extent: []), (real-world social behavior: [socb]), (study: [resa]), (face processing (identity: [menp]), ( affect: [menp]), (memory): [menp]), (peer interaction paradigm: [resa]), (observation: [hlca]), (coding: []), (natural social interaction behaviors: [socb]), (play: [dora]), (peers: [popg]), (self-play: [dora]), ( cooperative play: [dora]), ( verbal bout): []), (ancova: [qnco]), ( regression: [menp]), (correlation models: []), (between-group differences: [popg]), (strength: [qnco]), (associations: [menp]), (memory: [menp]), (faces delayed: [blor]), (peer interaction: [popg]), (verbal bout: []), (regression models: [menp]), (amount: [qnco]), ( equipment use alone: [fndg]), (cooperative play: [dora]), (playground: []), (autism: [mobd]), (verbal exchange: [clna]), (face memory: [menp]), (relevant social engagement patterns: [fndg]), (impairment: [patf]), (facial memory: [menp]), (reduced real-world social interaction: [clna]), ( whereas: []), (performance: [inbe]), (results: [fndg]), (strong connection: []), (reciprocal social interaction: [fndg]), (improvement: []), (other: []), 
ASD Terms: (autism spectrum disorder show impairment, 'Autism Phenotype')(social cognition, 'Cognitive Ability')(reciprocal social communication, 'Reciprocal Social Interaction')(social behavior, 'Reciprocal Social Interaction')(face processing, 'Integrated Verbal and NonVerbal Communication')(social cognition, 'Cognitive Ability')(real-world social behavior, 'Reciprocal Social Interaction')(face processing, 'Integrated Verbal and NonVerbal Communication')(natural social interaction behaviors, 'Reciprocal Social Interaction')(memory, 'Working Memory')(memory, 'Working Memory')(autism, 'Autism Phenotype')(face memory, 'Working Memory')(relevant social engagement patterns, 'Engaging in Social Conversation')(facial memory, 'Working Memory')(face memory, 'Working Memory')(reduced real-world social interaction, 'Reciprocal Social Interaction')(face memory, 'Working Memory')(reciprocal social interaction, 'Reciprocal Social Interaction')

PMCID: 3707861
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, met, met, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, 
Non SFARI Genes: Mb, 
Named Entities: (deletion syndrome: [genf]), (phelan-mcdermid syndrome: [dsyn]), (neurodevelopmental disorder: [mobd]), (intellectual disability: [mobd]), ( hypotonia: [fndg]), (absent speech: [fndg]), (autistic features: [mobd]), (shank3: [gngm]), (critical gene: [gngm]), (behavioral aspects: [inbe]), (syndrome: [dsyn]), (phenotype: [orga]), (shank3 deficiency: [dsyn]), (case studies: []), (limited evaluation: [hlca]), (cognitive deficits: [mobd]), (present study: [qnco]), (prospective design: [resa]), (inter-disciplinary clinical evaluations: [hlca]), (patients: [podg]), (goal: []), (comprehensive picture: []), (behavioral profile: [inbe]), (ascertained sample: [sbst]), (shank3 deficiency (n: [dsyn]), (team: [grup]), (child psychiatrists: []), (neurologists: []), ( clinical geneticists: []), (molecular geneticists: []), (psychologists: []), (autism spectrum disorder: [mobd]), (autism diagnostic: [mobd]), (autism diagnostic observation schedule-g. thirty participants: [hlca]), (deletions: [genf]), (size: []), (kb: []), (mb: [gngm]), (participants: [popg]), (shank3 mutations: [genf]), (sample: [sbst]), (high rates: [qnco]), (autism spectrum: [mobd]), ((84%): []), (criteria: []), ((75%): []), (autistic disorder: [mobd]), ((19%): []), (words: []), (dysmorphic features: [cgab]), ( gait disturbance: [fndg]), (upper respiratory tract: [bdsy]), (infections: [patf]), ( gastroesophageal reflux: [dsyn]), (seizures: [sosy]), (analysis: [resa]), (genotype-phenotype correlations: [fndg]), (increased levels: [qnco]), ( medical comorbidities: [hlca]), (social communication impairments: [mobd]), (analyses: [resa]), (individuals: [humn]), (small deletions: [genf]), (point mutations: [comd]), (features: []), (shank3 haploinsufficiency: [comd]), (asd: [cgab]), ( seizures: [sosy]), (abnormal eeg: [fndg]), ( sleep disturbances: [dsyn]), (abnormal brain mri: [fndg]), (certain dysmorphic features: [cgab]), (study: [resa]), (findings: [clna]), (previous research: [resa]), (severity: []), (intellectual: []), ( motor: []), (speech impairments: [dsyn]), (prominence: []), (limitations: []), (evaluation tools: [hlca]), (need: []), (natural history studies: [lbpr]), (clinical monitoring: [resa]), (treatment development: [orgf]), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(absent speech, 'Language Ability')(cognitive deficits, 'Cognitive Ability')(autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism diagnostic, 'Autism Phenotype')(autism diagnostic observation schedule-g. thirty participants, 'Autism Phenotype')(autism spectrum, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autistic disorder, 'Autistic Disorder')(gastroesophageal reflux, 'Gastroesophageal Reflux')(medical comorbidities, 'Comorbidities')(medical comorbidities, 'Comorbidities')(social communication impairments, 'Reciprocal Social Interaction')(sleep disturbances, 'Sleeping Problems')(gastroesophageal reflux, 'Gastroesophageal Reflux')(autism spectrum disorder, 'Autism Phenotype')(speech impairments, 'Idiosyncratic and Routinized Speech')

PMCID: 4300004
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (impaired: []), (social interaction: [fndg]), (hallmarks: []), (autism spectrum disorder (asd): [mobd]), (critical visual social stimuli: [ortf]), (ability: [orga]), (recognize: []), (interpret emotions: [menp]), (communication: [socb]), (healthy social development: [socb]), (however: []), (understanding: [menp]), (cognitive mechanisms: []), (emotional face processing: [menp]), (adolescents: [aggp]), (asd: [cgab]), (controls: [sbst]), (participants: [popg]), (implicit emotional face: [blor]), (task: [gngm]), (meg: [horm,orch,phsu]), (spatiotemporal differences: [qnco]), (neural activation: [acty]), (groups: [popg]), (happy face processing: [fndg]), (differences: [qnco]), (response latencies: []), (emotions: [menp]), ( adolescents: [aggp]), (accuracy: []), (implicit emotional face processing task: [menp]), (trials: [resa]), (angry faces: [menp]), (meg data: [horm,orch,phsu]), (atypical neural activity: [acty]), (atypical activity: [acty]), (insula: [bpoc]), ( anterior: []), (posterior cingulate: [bpoc]), (orbitofrontal regions: [blor]), (findings demonstrate differences: [clna]), (neural activity: [acty]), (angry face processing: [menp]), (activation: [acty]), (social cognitive regions: [socb]), (index: [qnco]), (difficulties: [fndg]), (face processing: [emst]), (comprehension: [menp]), (social reward: [menp]), (punishment: []), (asd group: [cgab]), (thus: []), (results: [fndg]), (atypical neural activation contributes: [acty]), (affect processing: [menp]), (social cognition: [socb]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(critical visual social stimuli, 'Visual Thinking')(healthy social development, 'Ability to Converse in Social Settings')(emotional face processing, 'Integrated Verbal and NonVerbal Communication')(cognitive mechanisms, 'Cognitive Ability')(happy face processing, 'Integrated Verbal and NonVerbal Communication')(implicit emotional face processing task, 'Integrated Verbal and NonVerbal Communication')(angry face processing, 'Integrated Verbal and NonVerbal Communication')(face processing, 'Integrated Verbal and NonVerbal Communication')(comprehension of social reward, 'Ability to Converse in Social Settings')(social cognitive regions, 'Cognitive Ability')(social cognition, 'Cognitive Ability')

PMCID: 4860193
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (clinical initiatives: [menp]), (age: [orga]), (asd diagnosis: [cgab]), (uk: []), (study: [resa]), (median age: [orga]), (diagnosis: [fndg]), (childhood: []), (recent years: []), (factors: []), (data: [euka]), (children: [aggp]), (asd: [cgab]), (large family databases: [famg]), (results: [fndg]), (asds: [cgab]), (months: []), (autism diagnosis: [mobd]), (other asd): [cgab]), ( language regression: [lang]), ( language delay: [fndg]), (socioeconomic status: []), (degree: [qnco]), (support required: []), (effective clinical strategies: [menp]), (characteristics: []), (past delayed asd diagnosis: [cgab]), 
ASD Terms: (asd diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')(asd diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')(autism diagnosis, 'Diagnosis')(language delay, 'Language Ability')(past delayed asd diagnosis, 'Diagnosis')

PMCID: 4860203
SFARI Genes: met, met, met, met, 
Non SFARI Genes: 
Named Entities: (psychiatric problems: [mobd]), (old age: [popg]), (general population: [popg]), (individuals: [humn]), (autism spectrum disorders: [mobd]), (psychiatric symptoms: [sosy]), (disorders: [dsyn]), (young: []), ( middle-aged: [aggp]), (adults: [aggp]), (asd (nmax: [cgab]), (age: [orga]), (years: []), ( iq: []), (albeit: []), (other psychiatric patients: [podg]), ( levels: []), (symptoms: [sosy]), (psychological distress: [mobd]), (adult: [aggp]), (%: []), (criteria: []), (psychiatric disorder: [mobd]), (lives: [fndg]), (depression: [mobd]), (anxiety: [mobd]), (however: []), (psychiatric diagnosis and: [mobd]), (social phobia: [mobd]), (hence: []), (marked psychological distress: [mobd]), (asd: [cgab]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-016-2722-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(psychiatric problems, 'Mental Disorders')(psychiatric disorder, 'Mental Disorders')(depression, 'Depressive Disorder')(anxiety, 'Anxiety Disorders')(psychiatric diagnosis and, 'Mental Disorders')

PMCID: 6307213
SFARI Genes: 
Non SFARI Genes: HR, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (impairments: [patf]), (social communication: [socb]), (presence: [qnco]), (repetitive behavior and/or: [fndg]), (interests: [menp]), (evidence: []), (motor impairments: [patf]), (contributing factor: [acty]), (asd phenotype: [cgab]), (purpose: []), (study: [resa]), (motor act: [topp]), (reaching-to-grasp: [gngm]), (children: [aggp]), (high risk (hr;: [fndg]), (sibling: [famg]), (asd): [cgab]), (low-risk (lr;: [fndg]), (family history: [fndg]), (asd: [cgab]), (differences: [qnco]), (status: []), (diagnostic outcome: [fndg]), (months: []), (age: [orga]), (reach-to-grasp movement: [aapp,enzy]), (qualitative: []), (scale: [acty]), (sex-related differences: [orga]), (mechanics: [npop]), (mixed models analysis: [resa]), (gold-standard diagnostic assessment: [diap]), (outcome groups: hr children: [aggp]), ((hr-asd; n: [cgab]), (hr children: [aggp]), ((hr-n; n: [aapp,imft]), (low-risk children: [aggp]), (asd (lr;: [cgab]), (group: [popg]), ((hr-asd group): [cgab]), ((worse) total scores: [fndg]), (scores: [clna]), (components: []), (orient: [popg]), ( lift: [acty]), (pronate: []), (lr: []), (hr-n groups: [popg]), (results: [fndg]), (literature: [inpr,mnob]), (asd show: [cgab]), (early motor performance: [orgf]), (importance: []), (early surveillance: [hlca]), (elevated risk: []), (early initiatives: [menp]), (early signs: [fndg]), (phenotype: [orga]), (movement: [orgf]), (sensory differences: [qnco]), ((prodromal signs) prior: [sosy]), (emergence: []), (diagnostic characteristics: [fndg]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s11689-018-9259-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(repetitive behavior and/or, 'Stereotyped, Restricted, and Repetitive Behavior')(evidence that motor impairments, 'Motor Skills')(autism spectrum disorder, 'Autism Phenotype')(motor impairments, 'Motor Skills')(asd phenotype, 'Autism Phenotype')(sensory differences, 'Reaction to Sensory Stimuli')

PMCID: 5543091
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disorder: [mobd]), (behavioral impairment: [inbe]), (social interactions: [fndg]), (empirical evidence: []), (impairment: [patf]), (social brain network: [popg]), (neural underpinnings: []), (asd: [cgab]), (previous structural magnetic resonance: [npop]), ((mri) studies: [diap]), (adults: [aggp]), (clear support: [fndg]), (this: []), (factors: []), (language impairments: [mobd]), (issue: [fndg]), (structural mri data: [diap]), (analyzed gray matter volume: [tisu]), (asd (n =: [cgab]), (aspergers disorder: [mobd]), (pervasive developmental disorder: [mobd]), (symptoms: [sosy]), (aspergers disorder): [mobd]), (comorbidity: []), (medications: [clna]), ((td): []), ((n =: [aapp,imft]), (univariate: []), (voxel-based morphometry analyses: [lbpr]), (regional gray matter volume: [tisu]), (control group: [grup]), (several brain regions: [blor]), (right inferior occipital gyrus: [bpoc]), (fusiform gyrus: [bsoj]), (middle temporal gyrus: [bpoc]), (right inferior frontal gyrus: [bpoc]), (right orbitofrontal cortex: [bpoc]), (dorsomedial prefrontal cortex: [bpoc]), (multivariate approach: []), (partial least squares: [qnco]), (method: [lbpr]), (regions: []), (network: [popg]), (td groups: [popg]), (pls discriminant analysis: [resa]), (information: []), (high accuracy: [qnco]), ( sensitivity: [patf]), ( specificity: [qnco]), (precision (>80%): [fndg]), (groups: [popg]), (results: [fndg]), (gray matter volume: [tisu]), (behavioral social malfunctioning: [inbe]), 
ASD Terms: (social interactions, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(behavioral impairment, 'Personal Traits')(language impairments, 'Language Ability')(comorbidity, 'Comorbidities')(medications, 'Medications')(behavioral social malfunctioning, 'Reciprocal Social Interaction')

PMCID: 5070062
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (joint attention (ja): [menp]), (deficit: [dsyn]), (early risk marker: [clna]), (autism spectrum disorder (asd): [mobd]), (dimensions: (1): [fndg]), (ja: []), ((2): [qnco]), (eye-tracking technology: [bpoc]), (young children: [aggp]), (asd: [cgab]), (aim: [phsu]), (study: [resa]), (differences: [qnco]), (visual patterns: []), (toddlers: [aggp]), (typical development (td): [orgf]), (ja tasks: []), (gaze: [fndg]), (children: [aggp]), (age-matched children: [aggp]), (td: []), (presentation: []), (short video sequences: [nusq]), (ja-1: []), (ja-2): []), (gaze accuracy: [fndg]), ( transitions: [acty]), (fixations: [topp]), (ja task: []), ( whereas: []), (initiating ja tasks: []), (different patterns: []), (fixation: [topp]), (transitions: [acty]), (groups: [popg]), (results: [fndg]), (different visual patterns: []), (joint attention: [menp]), (attention: [menp]), (asd impairments: [cgab]), (visual disengagement: []), (face: [gngm]), (global scanning: [diap]), (scene: []), (ability: [orga]), (object's: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(joint attention, 'Joint Attention')(joint attention, 'Joint Attention')(visual patterns, 'Visual Thinking')(joint attention tasks, 'Joint Attention')(joint attention task, 'Joint Attention')(initiating joint attention tasks, 'Task Performance')(different visual patterns, 'Visual Thinking')(visual disengagement, 'Visual Thinking')

PMCID: 4095949
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction: [hlca]), (autistic spectrum disorder: [mobd]), (difficulties: [fndg]), (mentalising: []), (ways: []), (everyday behaviour: [inbe]), (study: [resa]), (nature: []), (extent: []), (everyday social functioning: [socb]), (adults: [aggp]), (asperger's syndrome (as): [mobd]), (understanding: [menp]), (development: [orgf]), (effective intervention strategies: [topp]), (individuals: [humn]), (as (n: [aapp,imft]), (healthy control participants: [popg]), (tests: [lbpr]), (social cognition:: [socb]), (mentalistic interpretation task: [clna]), (interpretation: [clna]), (sarcasm: []), (social problem fluency: [fndg]), (ability: [orga]), (problem solutions;: [sbst]), (social problem resolution task: [fndg]), (judgement: [menp]), (problem solutions: [sbst]), (comprehension: [menp]), (sarcastic remarks: []), (actions: []), (as: []), (participants: [popg]), (awkward elements: [elii]), (everyday social scenarios: []), (alternative solutions: [sbst]), (resolution tasks: [qnco]), (tasks: []), (means: []), (strengths: []), (weaknesses: [sosy]), (social processing: [acty]), (turn: [fndg]), (implications: []), (clinical evaluation: [hlca]), (training: [edac]), 
ASD Terms: (autistic spectrum disorder, 'Autistic Disorder')(everyday social functioning, 'Social Competence')(sarcasm, 'Skill in Understanding Humor')(social cognition, 'Cognitive Ability')(social problem fluency, 'Social Competence')(social problem resolution task, 'Social Competence')(awkward elements, 'Social Awkwardness')

PMCID: 4976760
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (ability: [orga]), (mental states (theory: [fndg]), (mind [tom]): [gngm]), (individual differences: [menp]), (social ability: [socb]), (social impairments: [patf]), (conditions: [dsyn]), (autism spectrum disorder (asd): [mobd]), (mind: [menp]), (eyes test (rmet): [bpoc]), (popular measure: [qnco]), (tom ability: [orga]), (part: [qnco]), (poor performance: [grpa]), (asd: [cgab]), (however: []), (rmet: []), (recognition: [menp]), (facial emotion: [blor]), (alexithymia: [sosy]), (thus: []), (rmet indexes emotion recognition: [menp]), (tom: [gngm]), (independent contributions: [acty]), (performance: [inbe]), (alexithymia-matched control participants: [sosy]), (rmet performance: [inbe]), ( whereas asd participants: [cgab]), (impaired performance: [inbe]), (alternative test: [lbpr]), (movie: []), (assessment: [acty]), (social cognition (masc): [neop]), (furthermore: []), ( alexithymia: [sosy]), (influenced rmet performance: [inbe]), (masc performance: [neop]), (results: [fndg]), (emotion recognition: [menp]), (alexithymia hypothesis: [sosy]), (emotion-related deficits: [menp]), 
ASD Terms: (represent mental states (theory of mind, 'Mood')(understanding individual differences in social ability, 'Social Competence')(social ability, 'Ability to Converse in Social Settings')(social impairments, 'Social Competence')(autism spectrum disorder, 'Autism Phenotype')(recognition of facial emotion, 'Empathy')(eyes test indexes emotion recognition, 'Empathy')(social cognition, 'Cognitive Ability')(social cognition performance, 'Cognitive Ability')(emotion recognition, 'Empathy')

PMCID: 5294368
SFARI Genes: 
Non SFARI Genes: impact, impact, 
Named Entities: (adolescents: [aggp]), (autism spectrum disorder (asd): [mobd]), (time: []), (electronic screen media: [tisu]), (neurotypical peers;: [popg]), (preliminary evidence: []), (web-based interventions: [hlca]), (social skills: [socb]), (current generation: [acty]), (internet: []), (computers: []), (phones: []), (daily: []), (facebook: []), (social media platform: [acty,inpr]), (teenagers: [aggp]), (first research study: [resa]), (use: []), (therapeutic tool: [topp]), (asd: [cgab]), (objective: []), (feasibility: []), (clinical impact: [gngm]), (web-based social platform: []), (combination: [fndg]), (pilot study: [resa]), (participants: [popg]), ((all males; mean age: [orga]), (years): []), (online social skills: [socb]), (group: [popg]), (data: [euka]), (behavioral functioning: [inbe]), (start: []), (conclusion: []), (intervention: [hlca]), (outcome measures: [qnco]), (social responsiveness scale-2: [acty]), (social skills improvement system rating scale: [socb]), (project rex parent survey: [mamm]), (experience: [menp]), (significant differences: [qnco]), (measurable outcomes: []), (however: []), (online addition: []), (parents: []), (facebook intervention: [hlca]), (careful privacy protocol: [topp]), (place: [acty]), (minimal safety risk: [hcpp]), (utilization: []), (delivery: [topp]), (addition: []), (social difficulties: [fndg]), (online platform: []), (assistance: [socb]), (peers: [popg]), (online environment: []), (web-based intervention: [hlca]), (study: [resa]), (mass number: [dsyn]), (patients: [podg]), (disparities: []), (access: []), (in-person treatment services: [topp]), (complexity: [chvs]), (nature: []), (facebooks website: []), (privacy settings: [qnco]), (number: [qnco]), (unique online safety concerns: [hcpp]), (clinical utility: [orgt]), (issues: [fndg]), (development: [orgf]), (alternative: []), (target audience: [grup]), (asd;: [cgab]), (platform: []), (setting: [qnco]), (small sample size: [qnco]), (significant improvements: [qnco]), (target: [diap]), (promising area: []), (research: [resa]), (further investigation: [hlca]), (future obstacles: []), (safety: [hcpp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social skills, 'Ability to Converse in Social Settings')(online social skills, 'Ability to Converse in Social Settings')(social skills improvement system rating scale, 'Ability to Converse in Social Settings')(facilitate delivery, 'Perinatal History')(social difficulties of participants, 'Social Competence')(social difficulties, 'Social Competence')

PMCID: 6238819
SFARI Genes: met, met, met, met, 
Non SFARI Genes: 
Named Entities: (new technologies: []), (communication: [socb]), (autistic children: [podg]), (interaction processes: [phpr]), (social development: [socb]), (aim: [phsu]), (study: [resa]), (instruments: []), (communication skills: [orga]), (children: [aggp]), (autism spectrum disorder: [mobd]), (pubmed: []), (web: []), (science databases: []), (descriptors: []), (asperger: []), ( education: [fndg]), ( children: [aggp]), (assistive technology: []), (articles: []), (following inclusion criteria:: []), (original research; (ii): [resa]), (english; (iii): [lang]), (participants: [popg]), (primary diagnosis: [clna]), (autism spectrum disorder;: [mobd]), ((iv): []), (instrument: []), (search: [acty]), (inclusion criteria: []), (data: [euka]), (measurement properties: []), (information: []), (outcomes: []), (presentation: []), (used interventions: [hlca]), (treatment: [topp]), (education: [fndg]), (autistic: [mobd]), (related communication handicapped children program: [aggp]), (picture exchange communication system: [clna]), (improvements: []), ( socialization: [edac]), (self-care skills: [inbe]), (inconsistent results: [fndg]), (results: [fndg]), (identified studies: [fndg]), (significant importance: [qnco]), (communicative process: [socb]), 
ASD Terms: (social development, 'Ability to Converse in Social Settings')(communication skills of children, 'Reciprocal Social Interaction')(communication skills, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(primary diagnosis, 'Diagnosis')(asperger, 'Asperger Syndrome')(self-care skills, 'Self-Care')

PMCID: 5948870
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (outcomes: []), (psycho-educational interventions: [topp]), (autism spectrum disorders (asds) comorbid: [mobd]), (intellectual disability (id): [mobd]), (prospective study: [resa]), (developmental individual: [humn]), ( interactive: []), (intensive approach: [menp]), (3i method: [lbpr]), (play therapy: [topp]), (dsm-iv-tr asd subjects: [cgab]), ((mean chronological age: [orga]), (months;: []), (mean developmental age: [orga]), (months): []), (method: [lbpr]), (months: []), (developmental: [orgf]), (behavioural skills: [inbe]), (baseline: [bodm]), (vabs: []), ( pep-r: [aapp,enzy]), (nadel imitation scale: [acty]), (autism severity: [mobd]), (child autism rating scale (cars): [mobd]), (autism diagnostic interview (adi-r): [acty]), (years: []), (primary outcome variables: [topp]), ((vabs developmental age: [orga]), (socialization: [edac]), (age: [orga]), (communication: [socb]), (nadel imitation score: [clna]), (pep-r domains: [aapp,enzy]), (additionally: []), (vabs socialization score: [edac]), (total number: [qnco]), (treatment hours: [topp]), (cars: [gngm]), (adi-r areas: [clna]), (diagnoses: [fndg]), (subjects: [humn]), (pdd-nos: [dsyn]), (id: [lbpr]), (pdd): [dsyn]), (children: [aggp]), (developmental skills: [inbe]), (clear decrease: [qnco]), (results: [fndg]), (autistic children: [podg]), (daily interactions: []), (social environment: []), (trial registration: [resa]), (may: []), (french agency: [orgt]), (drug: [phsu]), (health (ansm): []), (number: [qnco]), (id-rcb 2014-a0054245: [lbpr]), ( reference: b14855831: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s12887-018-1126-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders comorbid, 'Comorbidities')(intellectual disability, 'Learning Disorders')(nadel imitation scale, 'Imitation')(autism severity, 'Autism Phenotype')(child autism rating scale, 'Autism Phenotype')(autism diagnostic interview, 'Autism Phenotype')(autism diagnostic interview areas, 'Autism Phenotype')(autism severity, 'Autism Phenotype')

PMCID: 6196239
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (eye-tracking studies: [bpoc]), (visual encoding: [acty]), (social processes: [phpr]), (socio-moral reasoning: [menp]), (alterations: []), (faces: [blor]), (example: []), (social phenotype: [orga]), (autism spectrum disorders: [mobd]), (communication impairments: [mobd]), (yet: []), ( people: [popg]), (asd: [cgab]), (neurotypical participants: [popg]), (measures: [qnco]), (moral reasoning: [menp]), (hypothesis: []), (differential mechanisms: []), (objective: []), (study: [resa]), (neurotypical individuals: [humn]), (visual: []), (paradigm: [resa]), (groups: [popg]), (control): [sbst]), (age: [orga]), (iq: []), (somoral: []), (set: [menp]), (picture situations: []), (everyday moral dilemmas: []), (eye movements: [ortf]), (pupil dilation: [sosy]), (recorded: [qnco]), (moral understanding: [menp]), ( decision-making: [menp]), (justification: []), (participants: [popg]), (time: []), (first fixation: [topp]), (dilemmas: []), (adaptive responses: [orga]), (similar average level: [phsu]), (justifications: []), (same way: []), (significant predictor: [qnco]), (moral decision-making: [menp]), (moral justification: []), (results: [fndg]), (context: [fndg]), (alternative mechanisms: []), 
ASD Terms: (visual encoding, 'Visual Thinking')(visual encoding, 'Visual Thinking')(autism spectrum disorders, 'Autism Phenotype')(visual, 'Visual Thinking')(adaptive responses, 'Adaptive Life Skills')

PMCID: 4099494
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autonomic dysregulation: [fndg]), (feature: []), (autism spectrum disorder (asd): [mobd]), (however: []), (nature: []), (autonomic atypicalities: [bdsy]), (asd: [cgab]), (goal: []), (study: [resa]), (cardiac autonomic profile: [bdsy]), (children: [aggp]), (domains: []), (asd (anxiety: [cgab]), (response inhibition: [acty]), (social cognition): [socb]), (measures: [qnco]), (autonomic cardiac regulation: [phsf]), (children (n: [aggp]), (asd (n: [cgab]), (tasks: []), (anxiety: [mobd]), ( attention: [menp]), ( response inhibition: [acty]), (social cognition: [socb]), (heart rate: [clna]), (overall autonomic arousal: [menp]), (respiratory sinus arrhythmia (rsa): [phsf]), (index: [qnco]), (vagal influences: [bpoc]), (associations: [menp]), (atypical autonomic findings: [bdsy]), (intellectual functioning (weschler scale): [menp]), ( asd symptomatology: [cgab]), ((social communication questionnaire score): [socb]), (co-morbid anxiety: [mobd]), (childrens anxiety: [mobd]), (depression scale): []), (asd group: [cgab]), (basal heart rate: [clna]), (decreased heart rate reactivity: [patf]), (social anxiety: [mobd]), (rsa reactivity: []), (social cognition task: [socb]), (group: [popg]), ( heart rate reactivity: [clna]), (social anxiety task: [mobd]), (iq: []), (task performance: [topp]), (generalized anxiety: [mobd]), (data: [euka]), (overall autonomic hyperarousal: [bdsy]), (selective atypical reactivity: [genf]), (social tasks: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(anxiety, 'Anxiety Disorders')(response inhibition, 'Response Inhibition')(social cognition, 'Cognitive Ability')(intellectual functioning, 'Mental Retardation')(co-morbid anxiety, 'Anxiety Disorders')(social anxiety, 'Anxiety Disorders')(social cognition task, 'Cognitive Ability')(social anxiety task, 'Anxiety Disorders')(task performance, 'Task Performance')(generalized anxiety, 'Anxiety Disorders')

PMCID: 5894192
SFARI Genes: 
Non SFARI Genes: Bid, Bid, Bid, 
Named Entities: (multiple eye-tracking studies: [bpoc]), (atypical nature: [fndg]), (social attention: [menp]), (autism: [mobd]), (however: []), (method: [lbpr]), (moments: []), (members: [popg]), (group: [popg]), (similar places: []), ((high-cohesion time frames; hctfs): [qnco]), (typicality: []), (proximity: []), (gaze points: [fndg]), ((td) gaze points: [fndg]), (td hctfs: []), (toddlers: [aggp]), (asd (n: [cgab]), ((dd: [gngm]), (n =: [aapp,imft]), (td (n: [aapp,imft]), (video: []), (dyadic bid: [popg]), ( sandwich-making: []), ( joint attention: [menp]), (animated toys conditions: [dsyn]), ((a): []), (individual typicality scores: [clna]), (relationship: []), (symptom severity: [fndg]), ((c) hctf distributions: []), (diagnostic group: [popg]), (asd group: [cgab]), (gaze typicality scores: [clna]), (td: []), (dd groups: [popg]), (sandwich-making conditions: [dsyn]), (animated toys: []), (dd: [gngm]), (td groups: [popg]), (condition: [dsyn]), (correlational analyses: [inpr,resa]), (typicality scores: [clna]), (pre-planned locations: [mamm]), (scene: []), (experimental condition: [dsyn]), (gaze typicality: [fndg]), (severe autism symptoms: [mobd]), (asd hctfs: [cgab]), (gaze: [fndg]), (asd: [cgab]), (contrast: [irda]), (non-asd groups: [cgab]), ( toddlers: [aggp]), (high cohesion: [npop]), (salient nonsocial events: [evnt]), (consistency: [qnco]), (strategies: [menp]), (perceptual features: []), (findings: [clna]), (individual differences: [menp]), (visual attention: [menp]), (design: [acty]), (sensitive biomarker tasks: [clna]), (stratification: [resa]), ( between-group differentiation: [celf]), (response: [fndg]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0211-y) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (atypical nature of social attention, 'Social Competence')(autism, 'Autism Phenotype')(joint attention, 'Joint Attention')(joint attention, 'Joint Attention')(severe autism symptoms, 'Complaints and Indications')(visual attention, 'Visual Thinking')

PMCID: 4656818
SFARI Genes: BDNF, Shank3, ERK1, BDNF, Shank3, ERK1, 
Non SFARI Genes: Caskin1, 
Named Entities: (autism spectrum disorders: [mobd]), (complex heterogeneous neurodevelopmental disorders: [orga]), (unclear etiology: []), (cure: []), (prior studies: [lbpr]), (tan: [inbe]), ( brachyury (btbr) t+ itpr3tf/j mouse strain: [mamm]), (behavioral phenotype: [bhvr]), (asd-like features: [cgab]), (btbr t+ itpr3tf/j mice: [mamm]), (btbr) display deficits: [mamm]), (social functioning: [socb]), ( lack: []), (communication ability: [fndg]), (engagement: [fndg]), (stereotyped behavior: [mobd]), (extensive behavioral phenotypic characterization: [acty]), (genes: [gngm]), (proteins: [aapp,bacs]), (presentation: []), (asd-like phenotype: [cgab]), (btbr mouse model: [mamm]), (study: [resa]), (bioinformatics techniques: []), (wide-scale understanding: [menp]), (proteomic changes: [qnco]), (btbr mice: [mamm]), (number: [qnco]), (c57bl/6j (b6) control mice controls: [mamm]), (bdnf: [gngm]), ( shank3: [aapp]), (erk1: [gngm]), (prior investigations: [hlca]), (asd: [cgab]), (distinct functional pathways: [moft]), (b6 controls: [mamm]), (mouse models: [mamm]), (human clinical populations: [popg]), (possible etiological mechanism: []), (axon guidance: [celf]), (regulation: [biof]), (actin cytoskeleton.: [celc]), (wide-scale bioinformatics approach: [acty]), (unidentified genes: [gngm]), (asd phenotype: [cgab]), (caskin1: [gngm]), (bioinformatics: []), (avenue: []), (novel therapeutic targets: [diap]), (result: [fndg]), (informed use: []), (synergistic bioinformatics applications: [hlca]), (invaluable tool: []), (etiology: []), (complex disorders: [dsyn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(complex heterogeneous neurodevelopmental disorders, 'Learning Disorders')(behavioral phenotype with asd-like features, 'Autism Phenotype')(social functioning, 'Social Competence')(stereotyped behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(communication ability, 'Reciprocal Social Interaction')(asd phenotype, 'Autism Phenotype')

PMCID: 4742252
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (awareness: [menp]), (concern: []), (children: [aggp]), (developmental disabilities: [mobd]), (adult supervision: [aggp]), (paucity: []), (research: [resa]), (elopement: [fndg]), (first study: [qnco]), (prevalence: [qnco]), (correlates: []), (representative sample: [sbst]), (school-age children: [aggp]), (united: []), (autism spectrum disorder (asd): [mobd]), (cognitive impairment: [mobd]), (data: [euka]), (cdc's "pathways" survey: [hcro]), (follow-up telephone survey: [resa]), (parents: []), (developmental condition: [mobd]), (asd: [cgab]), (intellectual disability (id): [mobd]), ( and/or: []), (developmental delay (dd): [mobd]), (time: []), (survey administration: [hlca]), (analysis: [resa]), (condition: [dsyn]), (asd-only; id/dd-only; asd+id/dd: [cgab]), (logistic regression analyses: [resa]), (rates: [qnco]), (preventive measure use (barriers: [qnco]), (electronic devices): []), (condition groups: [dsyn]), (demographic correlates: []), (t-tests: []), (scores: [clna]), (children's social behavior questionnaire (csbq): [socb]), (wanderers: [dsyn]), (non-wanderers: [dsyn]), (overall: []), (previous year: []), (public places: []), (asd-only: [cgab]), (asd+id/dd: [cgab]), (id/dd-only: [gngm]), (groups: [popg]), ( wanderers: [dsyn]), (csbq subscales;: []), (danger: [gngm]), (difficulty: [fndg]), (strangers: [popg]), (familiar people: [popg]), (sudden mood changes: [mobd]), (angry quickly: [menp]), (new situations: []), (change occurs: [qnco]), (elopement history: [orga]), ( parents: []), (asd+id/dd group: [cgab]), (other condition groups: [dsyn]), (electronic measures: [qnco]), (wandering: [bhvr]), 
ASD Terms: (developmental disabilities, 'Learning Disorders')(autism spectrum disorder and/or, 'Autism Phenotype')(cognitive impairment, 'Cognitive Ability')(developmental condition, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(and/or developmental delay, 'Learning Disorders')(children's social behavior questionnaire, 'Reciprocal Social Interaction')(children's social behavior questionnaire subscales, 'Reciprocal Social Interaction')(sudden mood changes, 'Emotional Swings')

PMCID: 5996001
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (research: [resa]), (sex-related differences: [orga]), (autism spectrum disorder (asd): [mobd]), (small samples: [sbst]), (datasets: []), (sites: []), (european countries: []), (sex differences: [orga]), (asd phenotype: [cgab]), (adi-r (376 females: [orga]), (males): [orga]), (ados (233 females: [aapp,enzy]), (adi-r: [clna]), (early childhood: []), (repetitive behaviours: [inbe]), (females: [orga]), (males: [orga]), (comparable levels: []), (social interaction: [fndg]), (communication difficulties: [socb]), (current adi-r: [clna]), (ados scores: [aapp,enzy]), (asd severity: [cgab]), (socio-communicative symptoms: [socb]), (large european asd sample: [cgab]), (literature: [inpr,mnob]), (sex: [orgf]), (age variations: [orga]), (asd symptomatology: [cgab]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1007/s10803-018-3510-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(asd phenotype, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(repetitive behaviours, 'Restricted and Repetitive Behavior')

PMCID: 6199253
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (music: []), (strength: [qnco]), (people: [popg]), (autism spectrum disorder; however: [mobd]), (neuroscientific evidence: []), (benefits: [qnco]), (universal appeal: [bodm,orch]), ( intrinsic reward value: [menp]), (ability: [orga]), (brain: [bpoc]), (behaviour: [inbe]), ( music: []), (potential therapeutic aid: [gngm]), (autism: [mobd]), (neurobehavioural outcomes: []), (music intervention: [hlca]), (non-music control intervention: [hlca]), (social communication: [socb]), (brain connectivity: [bpoc]), (school-age children: [aggp]), (children: [aggp]), (years: []), (weeks: []), (music (n: [aapp,imft]), (non-music intervention (n: [aapp,imft]), (use: []), (improvisational approaches: []), (song: []), (rhythm: [fndg]), (non-music control: [sbst]), (behavioural intervention: [topp]), (non-musical context: [fndg]), (groups: [popg]), (intervention: [hlca]), (resting-state functional connectivity: [fndg]), (fronto-temporal brain networks: [bpoc]), (communication scores: [socb]), (music group post-intervention (difference score: [popg]), (p = .01): [aapp,imft]), (post-intervention resting-state brain: [bpoc]), (functional connectivity: []), (non-music groups: [popg]), (auditory: []), (subcortical regions: [blor]), (p < .0001): [aapp,imft]), (fronto-motor regions: []), (post-intervention brain connectivity: [bpoc]), (visual regions: []), (autism (z: [mobd]), (p < .00001): [aapp,imft]), (music group: [popg]), (communication improvement (z: [socb]), (study: [resa]), (first evidence: [qnco]), (individual music intervention: [hlca]), (functional brain connectivity: [bpoc]), (support: []), (further investigations: [hlca]), (models: []), (music interventions: [hlca]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(rhythm, 'Prosody')(social communication, 'Reciprocal Social Interaction')(visual regions, 'Visual Thinking')

PMCID: 5461345
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (male: [orga]), (ratio: [qnco]), (clinical detection: [topp]), (autism spectrum disorder (asd) prevents research: [mobd]), (female phenotype: []), (current open access repositories: [npop]), (autism brain imaging data exchange (abide i-ii)] contain: [inch]), (large numbers: [qnco]), (females: [orga]), (new characterization: [acty]), (autistic spectrum: [mobd]), (new methods: []), (data: [euka]), (scale-free manner: [acty]), (continuous biophysical rhythms: [fndg]), (nervous systems: [bdsy]), (discrete (ordinal): []), (observational scores: [resa]), (methods: new data-types: []), (image-based involuntary head motions: [npop]), (personalized statistical platform: []), (data-driven approach: [menp]), (sub-groups: [popg]), (female cohort: [orga]), (further: []), (clinical dsm-based asd: [cgab]), (asperger's syndrome (as): [mobd]), (distributional analyses: [resa]), (ordinal score data: [euka]), (autism diagnostic observation schedule: [hlca]), ((ados)-based criteria: [aapp,enzy]), (female: [orga]), (male phenotypes: []), (results: separate clusters: [qnco]), (differential levels: []), (severity: []), (as-subgroup: [virs]), (excess level: [phsu]), (noise: [phpr]), (randomness: [resa]), (involuntary head micro-movements: [orgf]), (methods: []), (males: [orga]), (abide: []), (asd-males: [cgab]), (thorough study: [resa]), (ados-2: [aapp,enzy]), (ados-g scores: [aapp,enzy]), (results: [fndg]), (asd vs. as male comparison: [cgab]), (asd-phenotype: [cgab]), (ados-g: [aapp,enzy]), (as: []), (asd-females: [cgab]), (ados test versions: [aapp,enzy]), (scores: [clna]), (evidence: []), (however: []), (statistical landscapes: []), (male scores: [orga]), (disparate: []), (such: []), (further interpretation: [clna]), (ados data: [aapp,enzy]), (critical need: []), (social behavior: [socb]), (conclusions:: []), (outcome: []), (objective: []), ( data-driven analyses: [menp]), (subjective clinical observation: [hlca]), (proposition: []), (social behavioral male ruler: [orga]), (female autistic phenotype: [mobd]), (new observational behavioral tests: [diap]), (normative scales: [bpoc]), (objective data-driven approaches: [menp]), (human lifespan: [humn]), 
ASD Terms: (autism spectrum disorder prevents research, 'Autism Phenotype')(continuous biophysical rhythms, 'Prosody')(autism, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(social behavior, 'Reciprocal Social Interaction')(social behavioral male ruler, 'Reciprocal Social Interaction')

PMCID: 4717641
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (atypical responsiveness: [fndg]), (olfactory stimuli: [npop]), (predictor: []), (social impairment: [patf]), (children: [aggp]), (autism spectrum disorders: [mobd]), (however: []), (previous laboratory-based sensory psychophysical studies: [lbpr]), (olfactory sensitivity: [orgf]), (asd: [cgab]), (inconsistent results: [fndg]), (methodology: []), (studies: [lbpr]), (several factors: [qnco]), (sophisticated approaches: []), (consistent results: [fndg]), (olfactory detection thresholds: [ortf]), (typical development (td): [orgf]), (pulse ejection systema: [clna]), (problems: []), (previous studies: [lbpr]), (odorants: [chvf]), (stimuli: [phpr]), (isoamyl acetate: [irda,orch]), (allyl caproate: [orch,phsu]), (forty-three participants: [popg]), (part: [qnco]), (study:: [resa]), ((6: []), (males) children: [aggp]), (td (6: []), (males): [orga]), (td children: [aggp]), (isoamyl acetate (2.85: [irda,orch]), (vs: []), (p <: [aapp,imft]), (p: [gngm]), (impaired olfactory detection thresholds: [ortf]), (results: [fndg]), (understanding: [menp]), (olfactory: [orgf]), (asd experience: [cgab]), (role: [socb]), (effect: []), (odors: [npop]), (daily lives: [fndg]), ( insensitivity: [fndg]), (tremendous impact: [gngm]), (future studies: [lbpr]), (olfactory processing: [orgf]), (important links: []), (brain function: [ortf]), (relevant behavior: [inbe]), (treatment: [topp]), 
ASD Terms: (predictor of social impairment, 'Social Competence')(autism spectrum disorders, 'Autism Phenotype')(social impairment, 'Social Competence')

PMCID: 6371421
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (common lifelong condition: [dsyn]), (people: [popg]), (asd: [cgab]), (person: [grup]), (others: [fndg]), (world: [popg]), (them: []), (difficulty: [fndg]), (sensory information (noise: [phpr]), ( touch: [ortf]), ( movement: [orgf]), ( taste: [ortf]), ( sight): [orgf]), (loud: []), (constant low-level noise (e.g: [fndg]), (classroom): []), (affected children: [aggp]), (response: [fndg]), (sensory cues: []), (sensory processing difficulties: [fndg]), (behaviour: [inbe]), (socialisation problems: [edac]), (affect education: [menp]), ( relationships: []), (participation: []), (daily life: []), (sensory integration therapy (sit): [topp]), (face-to-face therapy: [topp]), (treatment: [topp]), (trained occupational therapists: [orgt]), (play-based sensory-motor activities: [dora]), (just-right challenge: [hlca]), (way: []), (child: [aggp]), (distress: [menp]), (motor skills: [orgf]), (adaptive responses: [orga]), ( concentration: [menp]), (interaction: []), (limited research: [resa]), (sit: [gngm]), (protocol: [fndg]), (detail: []), (intervention: [hlca]), (trial: [resa]), (internal pilot: [gngm]), (usual care: [acty]), (primary school: [mnob,orgt]), (children: [aggp]), (years): []), (sensory processing difficulties;: [fndg]), (multiple sources: [fndg]), (therapy: [topp]), (clinics: [hcro,mnob]), (full fidelity criteria: [socb]), (manualised sit: [fndg]), (weeks: []), (week: []), (month: []), (months; telephone: []), (months): []), (follow-up assessments: [hlca]), (months: []), (therapists: []), (focus groups/interviews: [grup]), (trial regions; carers: [resa]), (online survey: []), (experience: [menp]), (services: []), (recruitment: [acty]), ( carers: []), (diaries: []), (contact: [acty]), ( carer: []), (therapist interviews: [acty]), (discussion results: [socb]), (high-quality evidence: [qnco]), (cost effectiveness: [qnco]), (behavioural: [inbe]), ( functional: []), ( social: []), ( educational: []), (well-being outcomes: []), (carers: []), (families: [famg]), (trial registration isrctn14716440: [resa]), (november: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13063-019-3205-y) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(loud, 'Immoderate Behavior')(sensory processing difficulties, 'Reaction to Sensory Stimuli')(trained occupational therapists, 'Job Performance')(adaptive responses, 'Adaptive Life Skills')

PMCID: 4710161
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract introduction: [hlca]), (decades: [qnco]), ( researchers: []), (various approaches: [phsu]), (relationship: []), (any: []), (autism spectrum disorder (asd): [mobd]), (violence: [mobd]), (need: []), (tragic mass shooting: [dsyn]), (sandy hook elementary school: [bodm,inch]), (newtown: []), ( connecticut: []), (december: []), (individual: [humn]), (aspergers syndrome: [mobd]), (purpose: []), (article: []), (updated review: []), (literature: [inpr,mnob]), (association: [menp]), (asd: [cgab]), ((2): [qnco]), (implications: []), (treating: []), (violence by: [mobd]), ( individuals: [humn]), (review: []), (paper searches: [acty]), (case reports: []), (violence risk: [fndg]), (individuals: [humn]), (general population: [popg]), ( prevalence studies: [qnco]), (conclusive evidence: []), (suggestion: []), (generative (e.g.: [acty]), ( comorbid: []), (social-cognition deficits: [socb]), ( emotion-regulation problems): [mobd]), (associational (e.g.: [menp]), (age: [orga]), ( aspergers syndrome diagnosis: [mobd]), (repetitive behavior) risk factors: [qnco]), (violent behavior: [fndg]), (specific generative: [acty]), (associational risk factors: [qnco]), (further research: [resa]), (potential directions: []), (evaluation: [hlca]), ( treatment: [topp]), (prevention: [resa]), (empirical support: []), (forensic testimony: []), (defendants: []), (violent crimes: [socb]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(aspergers syndrome, 'Asperger Syndrome')

PMCID: 4761981
SFARI Genes: 
Non SFARI Genes: ms, 
Named Entities: (autism spectrum disorders: [mobd]), (difficulties: [fndg]), (social cognition: [socb]), (atypicalities: []), (sensory: []), (perceptual processing: [acty]), (several groups: [popg]), (autistic individuals: [mobd]), (integration: [genf]), (relevant audiovisual signals: [phpr]), (cognitive difficulties: [fndg]), (autism: [mobd]), (technique: []), (instantaneous adaptation: [orgf]), (audiovisual asynchrony: [phpr]), (typical participants: [popg]), (sequences: [nusq]), (auditory stimuli: [phsf]), (asynchrony: [phpr]), (wide range: [qnco]), (ms: [gngm]), (typical adults: [aggp]), (strong adaptation effects: [orgf]), (trials: [resa]), (auditory-lead needing: [elii,hops]), (simultaneous: []), (vice versa: []), (however: []), (autistic observers: [mobd]), (simultaneity curves: []), (result: [fndg]), (recent bayesian models: []), (predict: []), (adaptation effects: [orgf]), (rapid audiovisual recalibration: []), (optimisation: [acty]), (speech comprehension: [orgf]), ( recalibration problems: []), (language: [lang]), (social communication: [socb]), 
ASD Terms: (social cognition, 'Cognitive Ability')(atypicalities in sensory, 'Reaction to Sensory Stimuli')(autism spectrum disorders, 'Autism Phenotype')(cognitive difficulties, 'Cognitive Ability')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(instantaneous adaptation, 'Adaptive Life Skills')(strong adaptation effects, 'Adaptive Life Skills')(autism, 'Autism Phenotype')(adaptation effects, 'Adaptive Life Skills')(speech comprehension, 'Language Ability')(social communication, 'Reciprocal Social Interaction')

PMCID: 6375895
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (work: []), (results: [fndg]), (first experimentation: [resa]), (+me-the first prototype: [qnco]), (transitional wearable companionrun: []), (developed (td) children: [aggp]), (ages: [bacs,orch]), (months: []), (+me: []), (interactive device: []), (teddy bear: [mamm]), (neck: [blor]), (touch sensors: [ortf]), (lights: [npop]), (sounds: [npop]), (input-output contingencies: []), (tablet: [bodm]), (bluetooth: []), (participants: [popg]), (social play activities: [dora]), (device: []), (adult experimenter: [aggp]), (objective: []), (intrinsic allure: []), (attractive toy: []), (social interactions: [fndg]), (eye contact: [socb]), (taking: []), ( imitation: [socb]), ( social smiles): [fndg]), (aspect: [qnco]), (therapy: [topp]), (autism spectrum disorders (asd): [mobd]), (other pervasive developmental disorders: [mobd]), (main purpose: []), (preliminary study: [resa]), (general acceptability: [hlca]), (toy: []), (td children: [aggp]), (elicited behaviors: [inbe]), (preparation: [acty]), (future experiments: [resa]), (children: [aggp]), (asd: [cgab]), (other pdd: [dsyn]), (first: [qnco]), (video recording: []), (show: [anim]), (+me stimulates: []), (good social engagement: [fndg]), (age: [orga]), 
ASD Terms: (social play activities, 'Engaging in Social Play')(autism spectrum disorders, 'Autism Phenotype')(social interactions, 'Reciprocal Social Interaction')(good social engagement, 'Engaging in Social Conversation')

PMCID: 5005316
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (social interactions: [fndg]), (movements: [orgf]), (body: [humn]), (time: []), (spontaneous interactional synchrony: []), (essential part: [qnco]), (successful human interaction: [humn]), (however: []), (understanding: [menp]), (importance: []), (temporal dimensions: [qnco]), (social motor synchrony: []), (social dysfunction: [dsyn]), (here: []), (pendulum coordination paradigm: [resa]), (dynamic: []), ( process-oriented measures: [qnco]), (adolescents: [aggp]), (autism spectrum disorder (asd): [mobd]), (data: [euka]), (asd demonstrate: [cgab]), (synchronization: []), (intentional interpersonal coordination: [phsf]), (oscillator: []), (suggests: []), (participants: [popg]), (synchronization dynamic: []), (coupling strength: [qnco]), (sensitivity: [patf]), (decreased attention: [sosy]), (other person: [grup]), (evidence: []), (delay: []), (information transmission: [patf]), (implication: []), (findings: [clna]), (asd-specific social synchronization deficit: [cgab]), (objective: []), ( bio-behavioral marker: [clna]), 
ASD Terms: (social interactions, 'Reciprocal Social Interaction')(social motor synchrony in social dysfunction, 'Social Competence')(social dysfunction, 'Social Competence')(pendulum coordination paradigm, 'Motor Skills')(autism spectrum disorder, 'Autism Phenotype')(intentional interpersonal coordination, 'Motor Skills')(asd-specific social synchronization deficit, 'Social Competence')

PMCID: 6037572
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (traits: [gngm]), (relatives: [famg]), (patients: [podg]), (schizophrenia: [mobd]), (autism spectrum disorder: [mobd]), (causal-comparative research design: [resa]), (fifty individuals: [humn]), (first degree relatives: [qnco]), (individuals: [humn]), (schizophrenia spectrum disorder: [mobd]), (autistic-like traits: [mobd]), (autism-spectrum quotient (aq): [qnco]), (multivariate analysis: [qnco]), (variance: [qnco]), (groups: [popg]), (results: first: [qnco]), (scores: [clna]), (deficiency: [dsyn]), (social skill: [socb]), ( deficiency: [dsyn]), (communication: [socb]), (attention: [menp]), (imagination: [menp]), (comparison: [acty]), (conclusion: relatives: [famg]), (rates: [qnco]), (exception: []), (imagination subscale: [menp]), 
ASD Terms: (schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorder, 'Autism Phenotype')(schizophrenia spectrum disorder, 'Schizophrenia and Disorders with Psychotic Features')(social skill, 'Ability to Converse in Social Settings')(imagination, 'Imagination')(imagination subscale, 'Imagination')

PMCID: 4706585
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (typically-developed adults: [aggp]), (adults: [aggp]), (asd: [cgab]), (cartoon faux pas test: [orch,phsu]), (over-detected faux pas: [orch,phsu]), (good comprehension abilities: [orga]), (responding: []), (signal detection analysis: [menp]), (asd participants: [cgab]), (difficulty: [fndg]), (cartoon: []), (faux pas: [orch,phsu]), (liberal response bias: []), (test item analysis: [edac]), (asd group: [cgab]), (agreement: [socb]), (reference control group (n: [grup]), (non-faux pas items: [orch,phsu]), (results: [fndg]), (participants: [popg]), (primary problem: [fndg]), (factor: []), (work: []), (relates: [orch]), (choice: [inbe]), (liberal response criterion: [fndg]), 
ASD Terms: 

PMCID: 5504272
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (theoretically: []), ( autism: [mobd]), (aberrant brain dynamics: [bpoc]), (however: []), (brain activity changes: [phsf]), (time: []), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (brain dynamics: [bpoc]), (autism: [mobd]), (energy-landscape analysis: [resa]), (resting-state fmri data: [diap]), (whereas: []), (neurotypical brain activity: [phsf]), (major brain states: [bpoc]), (intermediate state: [lbtr]), ( high-functioning adults: [aggp]), (asd: [cgab]), (neural transitions: [acty]), (unstable intermediate state: [lbtr]), (infrequent transitions: [acty]), (severity: []), (moreover: []), (contrast: [irda]), (controls: [sbst]), (iq: []), (neural transition frequency: [qnco]), ( iq scores: [clna]), (stability: []), (finally: []), (such brainbehaviour associations: [menp]), (functional segregation: [socb]), (brain networks: [bpoc]), (findings: [clna]), (atypical functional coordination: [phsf]), (brains: [bpoc]), (adults: [aggp]), (asd underpins: [cgab]), (stable neural dynamics: [npop]), (asd symptoms: [cgab]), (cognitive abilities: [menp]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(atypical functional coordination, 'Motor Skills')(asd symptoms, 'Complaints and Indications')(cognitive abilities, 'Cognitive Ability')

PMCID: 6208873
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (difficulties: [fndg]), (social interaction: [fndg]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (developmental coordination disorder (dcd): [hops,orch]), (disorders: [dsyn]), (different diagnostic characteristics: [fndg]), (assessment: [acty]), (social skills: [socb]), (dcd population: [hops,orch]), (paper-based assessment: [acty]), (parent report: [hlca]), (present study: [qnco]), (eye: [bpoc]), (methodology: []), (socially-relevant stimuli: [phpr]), (dcd: [gngm]), (asd: [cgab]), (typically-developing (td) age-matched controls: [orga]), (eye movements: [ortf]), (images: []), ( half: [qnco]), (individual (one person: [popg]), (scene: []), (direct gaze): [fndg]), (other half: [qnco]), (naturalistic scenes: []), (interaction): []), (time: []), (face/eye regions: [blor]), (td children: [aggp]), (td groups: [popg]), (respect: [socb]), (reduced tendency: []), (gaze: [fndg]), (comparison: [acty]), (asd group: [cgab]), (findings: [clna]), (social atypicalities: []), (extent dcd: [hops,orch]), (different pattern: []), (future research: [resa]), (developmental nature: [orgf]), (observed findings: [clna]), (implications: []), (support: []), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(developmental coordination disorder, 'Motor Skills')(autism spectrum disorder, 'Autism Phenotype')(assessment of social skills, 'Ability to Converse in Social Settings')(social skills, 'Ability to Converse in Social Settings')(developmental coordination disorder population, 'Motor Skills')(developmental coordination disorder, 'Motor Skills')(developmental coordination disorder, 'Motor Skills')(developmental coordination disorder, 'Motor Skills')(social atypicalities, 'Social Competence')

PMCID: 4865518
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (imitated: []), (social effects: []), (imitation: [socb]), (child's actions: [aggp]), (strategy: [menp]), (social engagement: [fndg]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (observation: [hlca]), (someone: []), (indeed: []), ( neural areas: []), (social cognition: [socb]), (studies: [lbpr]), (behavioral consequences: [inbe]), (asd: [cgab]), (social skills: [socb]), (factors: []), (response: [fndg]), (imitated strategy: [menp]), (social gazes: [fndg]), (proximal social behaviors: [socb]), (low developmental level: [orgf]), (children's mothers: [socb]), (tool: []), (early intervention: [hlca]), (effects: []), (intervention: [hlca]), (neural level: [phsu]), 
ASD Terms: (social engagement, 'Engaging in Social Conversation')(imitated, 'Imitation')(imitation, 'Imitation')(autism spectrum disorder, 'Autism Phenotype')(social cognition, 'Cognitive Ability')(being imitated in children, 'Imitation')(social skills, 'Ability to Converse in Social Settings')(imitated strategy, 'Imitation')(proximal social behaviors, 'Reciprocal Social Interaction')

PMCID: 5487447
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (toys: []), (other people: [popg]), (social communication skills: [socb]), (however: []), ( children: [aggp]), (autism spectrum disorder (asd): [mobd]), (significant impairment: [patf]), (social interaction: [fndg]), (deficits: []), (play skills: [dora]), (reason: []), ( methods: []), (young children: [aggp]), (asd: [cgab]), (previous studies: [lbpr]), (variety: []), (instructional strategies: [edac]), (skills: [inbe]), ( few studies: [lbpr]), (potential: []), (robotic devices: []), (purpose: []), (present study: [qnco]), (automatic feedback: [phpr]), (colored lights: [npop]), (vibration: [npop]), ( cololo: []), (social play behaviors: [dora]), (children: [aggp]), (social play: [dora]), (cololo: []), (system: []), (paired spherical devices: []), (soft fabric: [dsyn]), (participants: [popg]), (study: [resa]), (volunteers: []), (department: [orgt]), (psychology: []), (keio university: [mnob,orgt]), (pilot study: [resa]), (pervasive developmental disorders: [mobd]), (6-year-old boys): [aggp]), (experimental conditions: [dsyn]), (devices: []), (lights: [npop]), (vibration): [npop]), (results: [fndg]), (condition: [dsyn]), (feedback: [phpr]), (increased rates: [qnco]), (ball contact: [acty]), (therapists ball: []), (eye contact: [socb]), (positive affect: [menp]), (experimental study: [resa]), (systematic replication: [genf]), (other participants: [popg]), (pdds: []), (a-b-a-b design: [acty]), (that: []), (effect: []), (findings: [clna]), (terms: [orgf]), (method: [lbpr]), 
ASD Terms: (social communication skills, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(social play behaviors, 'Reciprocal Social Interaction')(social play, 'Engaging in Social Play')(eye contact, 'Eye Contact')(social play, 'Engaging in Social Play')

PMCID: 5481358
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (attention deficit hyperactivity disorder (adhd): [mobd]), (neurodevelopmental disorders: [mobd]), (social impairments: [patf]), (first objective: [qnco]), (study: [resa]), (social cognition deficits: [socb]), (children: [aggp]), (adhd: [mobd]), (high-functioning asd (hfasd): [cgab]), (typical development (td): [orgf]), (performance: [inbe]), (explicit: []), (applied measures: [qnco]), (theory: []), (mind (tom): [gngm]), (second objective: [qnco]), (relationships: []), (executive functions: [menp]), (social cognition: [socb]), (hfasd: []), (11-year old children: []), (td: []), (nepsy-ii: []), (social perception subtests: [menp]), (parents: []), (children's tom: [aggp]), (mind inventory (tomi): [diap]), (teacher-reported data: [resa]), (behavior rating inventory: [diap]), (executive function (brief): [menp]), (adhd groups: [mobd]), (verbal tom task: [gngm]), (td group: [popg]), (hfasd group: [popg]), (contextual tom task: [gngm]), (difficulties: [fndg]), (applied tom: [gngm]), (td groups: [popg]), (furthermore: []), (different executive function-theory: [menp]), (mind link: [menp]), (behavioral regulation: [inbe]), (inhibition: [acty]), (emotional control: [menp]), ( whereas: []), (metacognitive processes: [menp]), (initiation: [menp]), (planning: [menp]), (strong association: [menp]), (findings: [clna]), (implications: []), (social perception deficits: [menp]), (need: []), (early intervention: [hlca]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(attention deficit hyperactivity disorder, 'Overactivity')(neurodevelopmental disorders, 'Learning Disorders')(social impairments, 'Social Competence')(analyze social cognition deficits, 'Cognitive Ability')(social cognition deficits, 'Social Competence')(attention deficit hyperactivity, 'Overactivity')(executive functions, 'Executive Function')(social cognition, 'Cognitive Ability')(social perception subtests, 'Cognitive Ability')(executive function, 'Executive Function')(attention deficit hyperactivity disorder groups, 'Overactivity')(social cognition, 'Cognitive Ability')(social cognition, 'Cognitive Ability')(emotional control, 'Control of Emotional Reactions')(planning, 'Planning')(neurodevelopmental disorders, 'Learning Disorders')(social perception deficits, 'Cognitive Ability')

PMCID: 4471385
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (comprehensive picture: []), (core elements: [elii]), (desires: [menp]), ( beliefs): []), (theory: []), (mind (tom): [gngm]), (young children: [aggp]), (autism spectrum disorder (asd: [mobd]), (mage: [aapp,bacs]), (months): []), (children (td: [aggp]), (asd: [cgab]), (td children: [aggp]), (intentional actions: []), (children: [aggp]), (social interest: [menp]), (share intentions: [menp]), (additionally: []), ( children: [aggp]), (difficulties: [fndg]), (others desires: [fndg]), (beliefs: []), (td peers: [popg]), (tom delay: [gngm]), (conceptual problem: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social interest, 'Social Interest')

PMCID: 6025870
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction: [hlca]), (use: []), (therapeutic body wraps (tbw): [humn]), (small series: [qnco]), (case reports: []), (controversial: [socb]), (feasibility: []), ( multicentre: []), ( randomized: [resa]), (open-label trial: [resa]), (blinded outcome assessment (probe design): [acty]), (children: [aggp]), (autism: [mobd]), (severe-injurious behaviours: [inbe]), (specialized clinics: [hcro,mnob]), (interventions dry-sheet tbw (dry group): [npop]), (wet-sheet tbw (wet group): [popg]), (primary outcome measures: [qnco]), (3-month change: [qnco]), (aberrant behaviour checklist irritability: [fndg]), (per-protocol (pp) sample: [sbst]), (january: []), (years: []), (male): [orga]), (patients: [podg]), (dry group: [npop]), (wet group): [popg]), (study: [resa]), (pp analysis: [resa]), (endpoint: [qnco]), ( abc-irritability: [fndg]), (groups: [popg]), ((standard deviation) = -11.15 (8.05): [qnco]), (-10.57 (9.29): [fndg]), (other abc scores: [dsyn]), (children autism rating scale score: [mobd]), (however: []), (significant difference: [qnco]), (much improved: [qnco]), (repeated-measures analysis: [qnco]), (significant improvement: [qnco]), (abc-irritability scores: [fndg]), (time (p < .0001): [aapp,imft]), (effect: p = .55; interaction time x group: p = .27): [popg]), (mean 3-month change: [qnco]), (baseline: [bodm]), (abc-irritability score: [dsyn]), (-10.90 (effect size: [qnco]), (p < .0001): [aapp,imft]), (overall satisfactory: []), (slow recruitment rate: [qnco]), (good attrition rate: [socb]), (tbw: [diap]), (safe complementary therapy: [topp]), (population: [popg]), (difference: [qnco]), (wet: []), (dry tbw: [npop]), (months: []), (abc-irritability: [fndg]), (dry sheet tbw: [npop]), (medication: [phsu]), (behavioural intervention: [topp]), (sib: [famg]), (asd: [cgab]), (randomized comparative trial (e.g: [inpr,resa]), (tbw vs. antipsychotics): [phsu]), (trial registration clinicaltrials.gov nct03164746: [resa]), 
ASD Terms: (autism, 'Autism Phenotype')(children autism rating scale score, 'Autism Phenotype')(treating severe-injurious behaviours in asd, 'Autism Phenotype')(medication, 'Medications')

PMCID: 6220950
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (detection: [topp]), (deception: [inbe]), (fundamental importance: []), (everyday social life: [socb]), (mindreading (the ability: [orga]), (others mental states): [fndg]), (people: [popg]), (diminished mindreading: [qnco]), (autism spectrum disorder (asd): [mobd]), (risk: []), (manipulation: [topp]), (lie detection difficulties: [fndg]), (experiment: [resa]), (performance: [inbe]), (neurotypical adults: [aggp]), (realistic lie detection paradigm: [resa]), (number: [qnco]), (asd traits: [cgab]), (ability: [orga]), (bayesian analyses: [qnco]), (null hypothesis significance testing: [resa]), (data: [euka]), (alternative hypothesis: []), (key respect: [socb]), (cross validation: [resa]), (results: [fndg]), (full sample: [sbst]), (subsamples: []), (analyses: [resa]), (association: [menp]), (lie detection: [topp]), (reliability: [qnco]), (findings: [clna]), (adults: [aggp]), (diagnosis: [fndg]), (asd: [cgab]), (matched comparison participants: [popg]), (asd (or asd traits): [cgab]), (lie detection training: [edac]), (autism res: [mobd]), (autism research: [mobd]), (international society: [orgt]), (wiley periodicals: []), ( inc. lay summary detection: [topp]), (diminished understanding: [menp]), (other minds: [menp]), (lie detection ability: [orga]), (many asd traits: [cgab]), (neurotypical people: [popg]), (full diagnosis: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(diagnosis, 'Diagnosis')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')(full diagnosis, 'Diagnosis')

PMCID: 4566871
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (biological motion perception: [menp]), (variety: []), (tasks: []), (11-year-old children: []), (low birth weight (<1500 g): [fndg]), (full-term controls: [fndg]), (extraction: [lbpr]), (local motion: [npop]), (ability: [orga]), (group: [popg]), (cues: []), (information: []), (body structure: [bpoc]), (order processes: [phpr]), (action recognition: [menp]), (person identification: [menp]), (preterm children: [fndg]), (difficulties: [fndg]), (aspects: [qnco]), (however: []), ( intercorrelations: []), (test scores: [clna]), (preterm childrena: [fndg]), (view: []), (processes: [phpr]), (autistic-like traits: [mobd]), (full-term peers: [popg]), (preterm: [fndg]), (full-term) children: [aggp]), (traits: [gngm]), (performance: [inbe]), (task: [gngm]), (structure-from-motion processing: [npop]), ( r(30) = .36: [fndg]), ( p < .05): [aapp,imft]), (identity: [menp]), ( r(30) = .45: [fndg]), (findings: [clna]), (previous reports: [hlca]), (vulnerability: []), (systems: []), (dynamic cues: []), (core deficit: [dsyn]), (social perception/cognition: [menp]), (development: [orgf]), (behavioral difficulties: [fndg]), (members: [popg]), (population: [popg]), (normal range intellectually: [qnco]), (results: [fndg]), (screening: [diap]), ( diagnostic: [fndg]), (intervention tools: [hlca]), 
ASD Terms: (biological motion perception, 'Cognitive Ability')(biological motion perception, 'Cognitive Ability')(core deficit in social perception/cognition, 'Social Competence')(behavioral difficulties even in members, 'Personal Traits')(behavioral difficulties, 'Personal Traits')

PMCID: 4742532
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (individuals: [humn]), (autistic spectrum disorder (asd) display diverse deficits: [mobd]), (social: []), ( cognitive: []), (behavioral functioning: [inbe]), (mixed findings: [clna]), (profile: [lbpr]), (executive function deficits: [menp]), (high-functioning adults: [aggp]), (asd: [cgab]), (conceptual distinction: []), (cold: [npop]), (hot executive functions: [npop]), (cold executive functions: [npop]), (mechanistic higher-order: [acty]), (cognitive operations: []), (memory): [menp]), ( whereas: []), (cognitive abilities: [menp]), (emotional awareness: [menp]), (social perception (e.g.: [menp]), (social cognition): [socb]), (study: [resa]), (independence: []), (deficits: []), (forty-two adults: [aggp]), (asd (64%: [cgab]), (years): []), (age: [orga]), (gender: [orga]), (controls: [sbst]), (awareness: [menp]), (social inference test (tasit; emotion recognition: [menp]), (social inference): [menp]), ( letter number sequencing: [mbrt]), (hayling sentence completion test (response initiation: [menp]), (suppression): [qnco]), (between-group analyses: [popg]), (asd group: [cgab]), (measures: [qnco]), (hierarchical multiple regression analyses: [qnco]), (asd sample: [cgab]), (emotion recognition: [menp]), (social inference tasks: [menp]), (employment status: [fndg]), (findings: [clna]), (ability: [orga]), (emotions: [menp]), (social inferences: [menp]), (memory: [menp]), (response initiation: [menp]), (suppression processes: [phpr]), (distinction: []), (cold executive function impairments: [npop]), (adults: [aggp]), (moreover: []), (higher-order impairments: [patf]), (social interaction difficulties: [fndg]), (population which: [popg]), (turn: [fndg]), (diagnosis: [fndg]), (intervention programs: [hlca]), 
ASD Terms: (autistic spectrum disorder display diverse deficits, 'Autistic Disorder')(cognitive, 'Cognitive Ability')(executive function deficits, 'Executive Function')(hot executive functions, 'Executive Function')(cold executive functions, 'Executive Function')(cognitive operations, 'Cognitive Ability')(executive functions, 'Executive Function')(cognitive abilities, 'Cognitive Ability')(emotional awareness, 'Empathy')(social perception, 'Cognitive Ability')(cold executive functions, 'Executive Function')(emotion recognition, 'Empathy')(memory, 'Working Memory')(cold executive function impairments, 'Executive Function')(social interaction difficulties, 'Reciprocal Social Interaction')(diagnosis, 'Diagnosis')

PMCID: 4383414
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder: [mobd]), (other psychiatric disorders: [mobd]), (high prevalence: [qnco]), (autistic-like traits/symptoms: [mobd]), (pediatric psychiatric population: [popg]), (normal intelligence: [fndg]), (reports: [hlca]), (adult: [aggp]), (psychiatric population: [popg]), (study: [resa]), (prevalence: [qnco]), (patients: [podg]), (adult-onset psychiatric disorders: [aggp]), (major depressive disorder (mdd): [mobd]), (bipolar disorder: [mobd]), (schizophrenia: [mobd]), (association: [menp]), (symptom severity: [fndg]), (subjects: [humn]), (adults: [aggp]), (years: []), (age (mdd: [mobd]), ( n=56; schizophrenia: [mobd]), (healthy controls: []), ( n=65): [fndg]), (social responsiveness scale: [acty]), (positive: [fndg]), (negative symptoms scale: [acty]), (hamilton depression rating scale: []), (young mania rating scale: [inpr,qnco]), (half: [qnco]), (clinical subjects: [popg]), (remitted mdd: [mobd]), (levels: []), (threshold autism spectrum disorder: [mobd]), (proportion: [qnco]), (psychiatric patients: [podg]), (high autistic-like traits/symptoms: [mobd]), (unremitted subjects: [humn]), (other hand: [bpoc]), (mdd: [mobd]), (regard: []), (degree: [qnco]), (substantial proportion: [qnco]), (pathophysiology: [patf]), (psychiatric disorders: [mobd]), (conversely: []), (autistic-like traits: [mobd]), (depressive symptom severity: [sosy]), (findings: [clna]), (importance: []), (best-suited treatment: [topp]), (further studies: [lbpr]), (prospective design: [resa]), (samples: [sbst]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(other psychiatric disorders, 'Mental Disorders')(adult-onset psychiatric disorders, 'Mental Disorders')(major depressive disorder, 'Depressive Disorder')(bipolar disorder, 'Bipolar Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(years of age, 'Onset of Symptoms')(hamilton depression rating scale, 'Depressive Disorder')(remitted major depressive disorder, 'Depressive Disorder')(threshold autism spectrum disorder, 'Autism Phenotype')(bipolar disorder, 'Bipolar Disorder')(major depressive disorder, 'Depressive Disorder')(autism spectrum disorder, 'Autism Phenotype')(psychiatric disorders, 'Mental Disorders')(depressive symptom severity, 'Depressive Disorder')

PMCID: 3541232
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (social understanding: [menp]), (other people: [popg]), (subtle social cues: [clna]), (order: [acty]), (nature: []), (social attention: [menp]), (people: [popg]), (social aspects: [qnco]), (world: [popg]), (factors: []), (models: []), (disordered social attention: [mobd]), ( e.g: []), (model: []), (autism: [mobd]), (behaviour: [inbe]), (one-to-one social interactions: [fndg]), (experimenter: []), (interactions: []), (video (social presence manipulation): [topp]), (participant: [popg]), (questions: []), (experimenter eye-contact: [socb]), (averted: []), (additionally: []), (influence: []), (participant self-reported autistic traits: [mobd]), (regardless: []), (interaction: []), (video: []), ( participants: [popg]), (experimenter's face: [blor]), (question: []), (answering: []), (critical differences: [qnco]), (video interactions: []), (modifications: []), (experimenter eye contact: [socb]), (participants' eye movements: [ortf]), (live interaction only;: [acty]), (autistic traits: [mobd]), (patterns: []), (eye-movements: [ortf]), (response: [fndg]), (video stimuli: [phpr]), (natural real-world stimuli: [phpr]), (field's understanding: [menp]), 
ASD Terms: (social understanding, 'Ability to Converse in Social Settings')(subtle social cues, 'Awareness of Social Cues')(disordered social attention, 'Attention Deficit Disorder with Hyperactivity')(autism, 'Autism Phenotype')(one-to-one social interactions, 'Reciprocal Social Interaction')(answer questions, 'Ability to Convey Information')(critical differences in social attention, 'Social Competence')(experimenter eye contact, 'Eye Contact')

PMCID: 4345537
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (literature: [inpr,mnob]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (treatment: [topp]), (optimal outcome. rates: [qnco]), (definitions: []), (optimal outcome vary widely: []), (current case series: [resa]), (validated behavioral treatment approach: [topp]), (pivotal response treatment (prt): [topp]), (preschool-aged children: [aggp]), (intensive course: [menp]), (prt: [aapp,enzy]), (trajectory: []), (potential optimal outcome: []), (response: [fndg]), (predictors: []), (medicine: [phsu]), (match children: [aggp]), (customized treatment programs: [phsu]), (varied needs: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 4665260
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (impairment: [patf]), (social interactions: [fndg]), (primary characteristic: [topp]), (people: [popg]), (autism spectrum disorder (asd): [mobd]), (individuals: [humn]), (naturalistic social cues: []), ((td) individuals: [humn]), ( laboratory experiments: [mnob,orgt]), (social orienting: []), (asd: [cgab]), (failure: [inbe]), (voluntary (goal-directed) social orienting processes: [inbe]), (purpose: []), (present study: [qnco]), (potential reflexive and/or: []), (differences: [qnco]), (td controls: [sbst]), (subjects: [humn]), (high-functioning asd: [cgab]), (matched control group: [grup]), (gaze: [fndg]), (tasks: []), (ipad: []), (face: [gngm]), (averted gaze: [fndg]), (target: [diap]), (variable delay: []), (congruent (target: [diap]), (gaze direction): [fndg]), (incongruent (target: [diap]), (gaze direction) trials: [resa]), ( respectively: []), (task: [gngm]), (same trials: [resa]), (congruent: []), (half incongruent): [qnco]), (intermixed randomly: []), (response times: []), (reflexive (incongruent condition rtcongruent condition rt): [dsyn]), (voluntary (non-predictive condition rtpredictive condition rt) gaze: [dsyn]), (effects: []), (additional non-social orienting tasks (propoint: []), (antipoint): []), (asd demonstrate: [cgab]), (deficient voluntary gaze following: [fndg]), (similar results: [fndg]), (separate test: [lbpr]), (non-social orienting: []), (problems: []), (social cues: []), (goal-directed fashion: []), (sample: [sbst]), (high-functioning individuals: [humn]), (such findings: [clna]), (inconclusive previous findings: [clna]), (social dysfunctions: [dsyn]), (future interventions: [hlca]), 
ASD Terms: (social interactions, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(naturalistic social cues, 'Awareness of Social Cues')(social cues, 'Awareness of Social Cues')(understanding social dysfunctions in asd, 'Ability to Converse in Social Settings')(social dysfunctions, 'Social Competence')

PMCID: 5095893
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (interest: [menp]), (partial forms: [qnco]), (diagnostic boundaries: [fndg]), (conditions: [dsyn]), (aspergers disorder: [mobd]), (important retrieval: [hlca]), (european: [popg]), (classical psychopathological concepts: []), (adult autism: [mobd]), (hans asperger: [lang]), (work: []), (review: []), (asperger's autistische psychopathie: []), (first descriptions: [qnco]), (dsm-iv aspergers disorder: [mobd]), (recent dsm-5 autism spectrum disorder: [mobd]), (paper: []), (subthreshold autism spectrum model: [mobd]), (threshold-level manifestations: [phsu]), (mild/atypical symptoms: [fndg]), (gender-specific features: [orga]), ( behavioral manifestations: [inbe]), (personality traits: [fndg]), (autism spectrum disorder: [mobd]), (model includes: [acty]), (so-called broad autism phenotype: [mobd]), (general population: [popg]), (autism spectrum disorder criteria: [mobd]), (perspective: []), (subthreshold autism: [mobd]), (unique psychological/behavioral model: [inbe]), (research: [resa]), (neurodevelopmental trajectories: [ortf]), (autistic traits: [mobd]), (broad range: [qnco]), (mental disorders: [mobd]), 
ASD Terms: (aspergers disorder, 'Asperger Syndrome')(adult autism, 'Autism Phenotype')(hans asperger, 'Asperger Syndrome')(dsm-iv aspergers disorder, 'Asperger Syndrome')(recent dsm-5 autism spectrum disorder, 'Autism Phenotype')(subthreshold autism spectrum model, 'Autism Phenotype')(personality traits, 'Personal Traits')(autism spectrum disorder, 'Autism Phenotype')(so-called broad autism phenotype, 'Autism Phenotype')(meet autism spectrum disorder criteria, 'Autism Phenotype')(subthreshold autism, 'Autism Phenotype')(neurodevelopmental trajectories, 'Learning Disorders')(mental disorders, 'Mental Disorders')

PMCID: 4375648
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (neuroanatomical differences: [qnco]), (cerebellum: [bpoc]), (consistent findings: []), (autism spectrum disorder (asd): [mobd]), (relationship: []), (cerebellar dysfunction: [dsyn]), (core asd symptoms: [cgab]), (newly-emerging existence: []), (cerebellar sensorimotor: [bpoc]), (cognitive subregions: []), (new framework: []), (functional significance: [qnco]), (cerebellar findings: [bpoc]), (asd: [cgab]), (complementary analyses: [resa]), (whole-brain voxel-based morphometry (vbm): [lbpr]), (suit: []), (cerebellar atlas: [bpoc]), (cerebellar regional gray matter (gm): [bpoc]), (volumetric lobular measurements: []), (children: [aggp]), (typically-developing (td) children: [aggp]), ((mean age: [orga]), (years; range: [qnco]), (years): []), (relationships: []), (cerebellar structure: [bpoc]), ( correlations: []), (scores: [clna]), (autism diagnostic observation schedule (ados): [hlca]), (autism diagnostic interview (adi): [acty]), (vbm: [topp]), (volumetric data: [euka]), (gm: [gngm]), (asd children: [cgab]), (cerebellar lobule vii (crus i/ii): [bpoc]), (degree: [qnco]), (lobular gray matter reductions: [tisu]), (different cerebellar subregions: [bpoc]), (severity: []), (symptoms: [sosy]), (social interaction: [fndg]), ( communication: [socb]), (repetitive behaviors: [fndg]), (structural differences: [qnco]), (behavioral correlations: [inbe]), (right cerebellar crus i/ii: [bpoc]), (region: []), (functional connectivity: []), (default mode networks: [qnco]), (results: [fndg]), (importance: []), (location: [blor]), (potential functional impact: [gngm]), (gm differences: [antb,orch]), (cerebellar right crus i/ii: [bpoc]), (core asd profile: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(core asd symptoms, 'Complaints and Indications')(cognitive subregions, 'Cognitive Ability')(autism diagnostic observation schedule, 'Autism Phenotype')(autism diagnostic interview, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 5309311
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (current study: [resa]), (attentional processing: [menp]), (non-social stimuli: [phpr]), (asd: [cgab]), (context: [fndg]), (hazard perception task: [menp]), (participants: [popg]), (videos: []), (road scenes: []), (hazards: []), (eye movements: [ortf]), (recorded: [qnco]), (individuals: [humn]), (good detection: [topp]), (greater: [qnco]), (attentional capture: [menp]), (time: []), (hazards onset: [qnco]), (verbal iq: []), (findings: [clna]), (attention: [menp]), 
ASD Terms: (hazard perception task, 'Cognitive Ability')(hazards onset, 'Onset of Symptoms')

PMCID: 5599320
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (disruption: []), (laminar: []), (columnar organization: [orgt]), (brain: [bpoc]), (several psychiatric disorders: [mobd]), (utero gain-of-function: [phsf]), (psychiatric risk gene transcription factor: [aapp,bacs]), ((tcf4): [aapp,bacs]), (medial prefrontal cortex (mpfc): [celc]), (activity-dependent manner: [acty]), (morphological phenotype: [orga]), (co-expression: [topp]), (tcf4: [gngm]), (calmodulin: [aapp,bacs]), (calcium-dependent manner: [bacs,elii,phsu]), (neuronal excitability: [sosy]), (potassium channel (kir2.1): [aapp,bacs]), (first time: [qnco]), (nmda: [aapp,bacs,phsu]), (receptor-dependent ca2+ transients: [fndg]), (organization: [orgt]), (crispr/cas9-mediated mutation: [nnon]), (nmda receptors: [aapp,rcpt]), (tcf4-dependent morphological phenotypes: [aapp,bacs]), (transcriptional regulation: [genf]), (psychiatric risk gene tcf4: [aapp,bacs]), (receptor-dependent early network oscillations: [popg]), (novel findings: [clna]), (tcf4-dependent transcription: [aapp,bacs]), (proper formation: [biof]), (prefrontal cortical minicolumns: [bpoc]), (expression: [topp]), (genes: [gngm]), (spontaneous neuronal activity: [acty]), (results: [fndg]), (insights: [menp]), (potential pathophysiological mechanisms: [patf]), (psychiatric disorders: [mobd]), 
ASD Terms: (several psychiatric disorders, 'Mental Disorders')(psychiatric disorders, 'Mental Disorders')

PMCID: 4574517
SFARI Genes: 
Non SFARI Genes: impact, impact, 
Named Entities: (adolescent females: [aggp]), (autism spectrum disorder (asd): [mobd]), (understudied population: [popg]), (complexities: [chvs]), (social interaction: [fndg]), (risk: []), (symptoms: [sosy]), (adolescence: []), (research literature: [inpr,mnob]), (males: [orga]), (asd: [cgab]), (understanding: [menp]), (social experiences: [menp]), (females: [orga]), (potential: []), (inform supports: [aapp,imft,phsu]), (intervention: [hlca]), (social-emotional functioning: [socb]), (study: [resa]), (similarities: []), (differences: [qnco]), (selected indicators: [irda]), (social-emotional health: [menp]), ((social competence: [socb]), (self-perception: [menp]), ( quality: []), (life): []), (problematic behaviors: [inbe]), (quantitative design: [acty]), (utilizing correlational analysis: [inpr,resa]), (t test comparisons: [acty]), (indicators: [irda]), (problematic symptoms: [sosy]), (social skills improvement system (ssis): [socb]), ( youth quality: [aggp]), (life instrument (yqol): []), (self-perceptions profile: [menp]), (adolescents (sppa): [aggp]), (relation: [socb]), (peers: [popg]), (significant differences: [qnco]), (terms: [orgf]), (self-ratings: []), (no-asd group: [cgab]), (areas: []), (findings: [clna]), (strong relationships: []), (constructs: []), (parent reports: [hlca]), (autism symptoms: [mobd]), (autism: [mobd]), (severe: []), (impact: [gngm]), (individuals social competence: [socb]), (social competence: [socb]), ( self-worth: [menp]), (quality: []), (life: []), (levels: []), (internalizing: []), (parent ratings: [acty]), (support: []), (postulate: []), (counterparts: []), (compounded impact: [gngm]), (asd symptoms: [cgab]), (disorders: [dsyn]), (adolescent girls: [aggp]), (limitations: []), (implications: []), (further research: [resa]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(understanding of social experiences, 'Ability to Converse in Social Settings')(social skills improvement system, 'Ability to Converse in Social Settings')(autism symptoms, 'Complaints and Indications')(autism, 'Autism Phenotype')(social competence, 'Social Competence')(individuals social competence, 'Social Competence')(autism symptoms, 'Complaints and Indications')(social competence, 'Social Competence')(asd symptoms, 'Complaints and Indications')

PMCID: 3584132
SFARI Genes: met, met, 
Non SFARI Genes: pigs, 
Named Entities: (previous research: [resa]), (capacity: [qnco]), (animal presence: [anim]), (social interaction: [fndg]), (humans: [humn]), (purpose: []), (study: [resa]), (interactions: []), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (adult: [aggp]), (typically-developing peers: [popg]), (presence: [qnco]), (animals: [anim]), (guinea pigs): [mamm]), (ninety-nine children: [aggp]), (classrooms: []), (schools: [mnob,orgt]), (inclusion criteria: []), (groups: [popg]), ((1: [fndg]), (asd: [cgab]), (typically-developing peers): [popg]), (group: [popg]), (10-minute: [qnco]), ( free-play sessions: [dora]), (toys: []), (guinea pigs: [mamm]), (observers: []), (behavior: [inbe]), (peers: [popg]), (nested study design: [resa]), ( data: [euka]), (linear modeling: [resa]), (participants: [popg]), (social approach behaviors: [inbe]), (talking: [orgf]), (faces: [blor]), (tactile contact): [acty]), (social approaches: []), (prosocial behaviors: [inbe]), (positive affect (i.e.: [menp]), ( smiling: [socb]), (laughing): [socb]), (self-focused behaviors: [inbe]), (negative affect (i.e.: [menp]), ( frowning: []), ( crying: [inbe]), (whining): [inbe]), (results: [fndg]), (animal: [anim]), (positive social behaviors: [socb]), 
ASD Terms: (stimulate social interaction, 'Reciprocal Social Interaction')(social interaction, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(social approach behaviors, 'Reciprocal Social Interaction')(positive social behaviors, 'Reciprocal Social Interaction')

PMCID: 6153757
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (false-belief (fb): []), (task: [gngm]), (use: []), (computer tablet: [bodm]), (fb: []), (social way: []), (classical fb protocols: []), (manipulation: [topp]), (language: [lang]), (attempt: [evnt]), (facilitating effect: []), (linguistic support: []), (fb processing: [acty]), (specifically: []), (fb task: []), (auditory conditions:: [dsyn]), (narrative: [socb]), ( silent: [fndg]), (interference: []), (new light: [npop]), (fb difficulties: [fndg]), (autism spectrum disorder (asd): [mobd]), (sixty-eight children: [aggp]), (asd (m: [cgab]), (years): []), (age: [orga]), (comparison group: [popg]), ((td) children: [aggp]), (children: [aggp]), (asd: [cgab]), (chance level: [phsu]), (condition: [dsyn]), (significant differences: [qnco]), (success rates: [socb]), (groups: [popg]), (conditions: [dsyn]), (td children: [aggp]), (better: []), (implications: []), ( limitations: []), (further developments: [orgf]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1007/s10936-018-9579-2) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5141337
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (online communities: []), (platforms: []), (parents: []), (health concerns: []), (child: [aggp]), (public awareness: [menp]), (autism spectrum disorders: [mobd]), (asd: [cgab]), (early identification: [topp]), (early intervention: [hlca]), (symptoms: [sosy]), (online queries: []), (efficacy: [resa]), (machine learning tools: [mcha]), (childs risk: [aggp]), (parents narrative: [socb]), (end: [gngm]), (warning signs: []), (asd-specific: [cgab]), (non-asdspecific domains: []), (data: [euka]), (trained machine: [orgt]), (tool: []), (degree: [qnco]), (asd risk: [cgab]), (yahoo answers: []), (social site: [blor]), (queries: []), (answers: []), (community: []), (total: [qnco]), (study: [resa]), ((mean child age=38.0: [aggp]), ([160/189] boys): [aggp]), (content: [menp]), (text analysis: [resa]), (types: []), (clinical judgment: [menp]), (childs asd-risk level: [cgab]), (concerns: []), (behaviors: [inbe]), (interests: [menp]), (prevalent (75.4%: [qnco]), (language: [lang]), (emotional markers: [clna]), ((36/195): []), (clinical experts: []), ((60/195): [fndg]), (medium-risk: [fndg]), ((99/195): []), (high-risk: [fndg]), (risk groups: [popg]), (rate: [qnco]), ( social: []), ( communication: [socb]), (rrbi domains: []), (automatic classifier (decision tree): []), (query: []), (text: []), (coded symptoms: [sosy]), ( performance: [inbe]), (area: []), (receiver: []), (curve (roc) curve: [qnco]), (0.50-0.78): [fndg]), ( whereas: []), (coded signs: [fndg]), (curve: []), (findings: [clna]), (health care providers: []), (parental asd-related concerns: [cgab]), (guidelines: []), (need: []), (systems: []), (parents narratives: [socb]), (decision tree: []), (method: [lbpr]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 6018399
SFARI Genes: SHANK, SHANK, SHANK, SHANK, Shank2, Shank2, Shank2, Shank2, mGluR1, mGluR1, mGluR1, mGluR1, Shank2, Shank2, Shank2, Shank2, 
Non SFARI Genes: 
Named Entities: (mutations: [genf]), (shank family: [famg]), (genes: [gngm]), (genomic screens: [gngm]), (autism spectrum disorder (asd): [mobd]), (functional overlap: [topp]), (shank: [gngm]), (several other asd-associated genes: [cgab]), (synaptic dysfunction: [dsyn]), (convergent mechanism: [acty]), (pathophysiology: [patf]), (asd: [cgab]), (many asd-related mutations: [cgab]), (alterations: []), (synaptic function: [phsf]), (nature: []), (dysfunctions: [dsyn]), (consequential behavioral manifestations: [inbe]), (genetic mouse models: [mamm]), (phylogenetic conservation: []), (phenotypes resultant: [orga]), (shank2 loss-of-function: [phsf]), (relevant animal model: [emod]), (novel transgenic rat: [mamm]), (targeted mutation: [genf]), (shank2 gene: [gngm]), (evaluation: [hlca]), (gene-associated phenotypes: [gngm]), (elucidation: []), (complex behavioral phenotypes: [bhvr]), (characterization: [acty]), (potential translational biomarkers: [clna]), (shank2 loss-of-function mutation: [phsf]), (notable phenotype: [orga]), (hyperactivity: [mobd]), (hypermotivation: []), (locomotion: [orgf]), (repetitive behaviors: [fndg]), (mutant rats: [mamm]), (deficits: []), (social behavior: [socb]), (development: [orgf]), (acquisition: [acty]), (operant tasks: []), (hyperactive phenotype: [mobd]), (upregulation: [genf]), (mglur1 expression: [aapp,rcpt]), (dendritic branching: [celc]), (long-term depression (ltd): [ortf]), (striatum: [bpoc]), (cellular alterations: [comd]), (hippocampus (hp): [bpoc]), (administration: [topp]), (mglur1 antagonist jnj16259685: [aapp,rcpt]), (expression: [topp]), (physiology: [phsf]), (effect: []), (social deficits: []), (finally: []), ( shank2 mutant animals: [anim]), (electroencephalography (eeg): [diap]), (spectral power: [hcpp]), (event-related potentials: [ortf]), (translatable eeg biomarkers: [diap]), (synaptopathic alterations: []), (results: [fndg]), (novel hypermotivation phenotype: [orga]), (rat model: [mamm]), (shank2 dysfunction: [dsyn]), (addition: []), (traditional hyperactive: [mobd]), (mouse models: [mamm]), (striatal dysfunction: [bpoc]), (targetable mechanism: []), (impairment: [patf]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(complex behavioral phenotypes, 'Executive Function')(hyperactivity, 'Overactivity')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(social behavior, 'Reciprocal Social Interaction')(hyperactive phenotype, 'Overactivity')(long-term depression, 'Depressive Disorder')(effect on social deficits, 'Social Competence')(social deficits, 'Social Competence')(traditional hyperactive, 'Overactivity')

PMCID: 4720778
SFARI Genes: OXT, OXT, OXT, OXT, OXT, OXT, OXT, OXT, OXT, OXT, OXT, OXT, OXT, OXT, 
Non SFARI Genes: 
Named Entities: (half: [qnco]), (autism spectrum disorder (asd) individuals: [mobd]), (comorbid: []), (intellectual disabilities: [mobd]), (oxytocin (oxt) receptors: [aapp,rcpt]), (temporal lobe structures: [bpoc]), (modulatory role: [socb]), (excitatory/inhibitory balance: [acty]), (animal model findings: [emod]), (thus: []), (representative group: [popg]), (kanner-type asd subjects: [cgab]), ( oxt: []), (beneficial effect: []), (social communication: [socb]), (social interaction: [fndg]), (aim: [phsu]), (pilot study: [resa]), (feasibility: []), (adverse events: [patf]), (epilepsy: [dsyn]), (long-term administration: [hlca]), (intranasal oxt: []), (adolescent: [aggp]), (adult asd: [cgab]), (id: [lbpr]), (such patients: [podg]), (seizures: [sosy]), (question: []), (oxt effects: []), (core symptoms: [sosy]), (social deficits: []), (relative difficulty: [fndg]), (objective measurements: []), (twenty-nine males: [orga]), (years: []), (placebo-controlled crossover study (each: [resa]), (weeks): []), (oxt (16 iu/day): [qnco]), (participant: [popg]), (other serious adverse events: [fndg]), (secondary outcomes: [neop]), (childhood autism rating scale: [mobd]), (several standard scales: [bpoc]), ( respectively: []), (difference: [qnco]), (oxt: [gngm]), (placebo groups: [popg]), (instead: []), (exploratory: []), (social interactions: [fndg]), (play sessions: [dora]), (daily life: []), (initial half period: [fndg]), (oxt-first arm: [blor]), (crossover trial: [resa]), (significant correlations: [qnco]), (plasma oxt concentration: [qnco]), (subscale scores: [clna]), (irritability: [fndg]), (aberrant behavior checklist: [inbe]), (conclusion: []), (representative cohort: [popg]), (asd individuals: [cgab]), (future multicenter trials: [resa]), (measurements: []), (reciprocal social interactions: [fndg]), (surveillance: [hlca]), (trial registration: umin000007250: [resa]), 
ASD Terms: (autism spectrum disorder individuals, 'Autism Phenotype')(comorbid, 'Comorbidities')(intellectual disabilities, 'Learning Disorders')(social communication, 'Reciprocal Social Interaction')(social interaction, 'Reciprocal Social Interaction')(epilepsy, 'Epilepsy')(core symptoms of social deficits, 'Social Competence')(social deficits, 'Social Competence')(childhood autism rating scale, 'Autism Phenotype')(social interactions, 'Reciprocal Social Interaction')(reciprocal social interactions, 'Reciprocal Social Interaction')(epilepsy, 'Epilepsy')

PMCID: 5836005
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (social interaction disorder: [mobd]), (second-person approach: [grup]), (social cognition: [socb]), (promising framework: []), (asd: [cgab]), (classical approaches: []), (capacities: [qnco]), (detached: []), ( observer-based arrangements: []), ( embodied: []), ( perceptual: []), (interactive capabilities: []), (others: [fndg]), (dynamics: [npop]), (real-time sensorimotor interaction: []), (pairs: []), (control participants: [popg]), (participants: [popg]), (high-functioning autism (hfa): [mobd]), (minimalistic human-computer interface paradigm: [resa]), (perceptual crossing (pc): []), (hfa: [dsyn]), (impaired detection: [topp]), (social contingency: []), ( i.e.: [diap,inpr]), (reduced sensitivity: [fndg]), (others responsiveness: [fndg]), (own behavior: [inbe]), (surprisingly: []), (analysis reveals: [resa]), (conditions: [dsyn]), (simplified: []), ( computer-mediated: [socb]), ( embodied form: []), (social interaction: [fndg]), ( people: [popg]), (hfa perform: [dsyn]), (controls: [sbst]), (finding: [sosy]), (use: []), (virtual reality interfaces: [mcha]), (people: [popg]), (compensate: []), (social disabilities: [fndg]), (dynamical analyses: [resa]), (understanding: [menp]), (mechanisms: []), (surprising results: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social interaction disorder, 'Reciprocal Social Interaction')(social cognition, 'Cognitive Ability')(interactive capabilities, 'Conversational Skills')(high-functioning autism, 'Autism Phenotype')(impaired detection of social contingency, 'Social Competence')(social interaction, 'Reciprocal Social Interaction')(high-functioning autism perform, 'Autism Phenotype')(social disabilities, 'Social Competence')

PMCID: 6063395
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (difficulties: [fndg]), (aspects: [qnco]), (social interaction: [fndg]), (empathy: [inbe]), ( comprise: [acty]), (core symptom: [clna]), (autism spectrum conditions: [mobd]), (sympathy: [menp]), (specific form: []), (affective empathy: [inbe]), (data: [euka]), (new task: []), (self-reported sympathy: [menp]), (personal distress: [menp]), (participants: [popg]), (autism (93: [mobd]), (females): [orga]), (controls (40: [qnco]), (part: [qnco]), (online survey: []), (autism research centre: [mobd]), (cambridge psychology websites: []), (task: [gngm]), (rate: [qnco]), (photographic images: [clna]), (happy scenes: [menp]), (amount: [qnco]), (individual: [humn]), (photo: []), (degree: [qnco]), (empathy quotient (eq): [inbe]), (significant differences: [qnco]), (autism: [mobd]), (control groups: [grup]), (ratings: [acty]), (controls: [sbst]), (control: [sbst]), (control males: [orga]), (distress: [menp]), (distress ratings: [acty]), (autism group: [mobd]), (sex: [orgf]), (eq: [qnco]), (positive correlations: [fndg]), (distress scores: [clna]), (new measure: [qnco]), (males: [orga]), (females: [orga]), (people: [popg]), (scenarios: []), 
ASD Terms: (autism spectrum conditions, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(empathy, 'Empathy')(affective empathy, 'Empathy')(autism spectrum conditions, 'Autism Phenotype')(autism research centre, 'Autism Phenotype')(empathy quotient, 'Empathy')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5518253
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (prevalence: [qnco]), (autism spectrum disorder: [mobd]), (children: [aggp]), (huge family burdens: [famg]), (concern: []), (academic field: [irda]), (society: [orgt]), (personality characteristics: [fndg]), (neurocognitive functions: [phsf]), (chinese parents: [lang]), (autism spectrum disorder (asd): [mobd]), (parents: []), (well-developed children: [fndg]), (study: [resa]), (chinese children: [aggp]), (diagnostic criteria: []), (diagnostic: [fndg]), (statistical manual: [inpr,mnob]), (mental disorders-iv (dsm-iv): [mobd]), (biological parents: [famg]), (means: []), (eysenck personality questionnaire (epq): []), (set: [menp]), (neuropsychological tests: [diap]), (normal control group: [grup]), (age: [orga]), (gender: [orga]), (epq scores: [clna]), (p scale: [acty]), (asd: [cgab]), (p=0.039): [fndg]), (scores: [clna]), (e scale: [acty]), (l scale: [acty]), ((t=1.84: [clna]), ( p=0.035; t=2.07: [fndg]), ( p=0.023): [fndg]), (time: []), (normal control: []), (trail making test (tmt) part a: [qnco]), (part b-m (t=1.57: [qnco]), ( p=0.013; t=0.83: [fndg]), ( p=0.019): [fndg]), (unconcerned: []), ( rigid: [sosy]), ( stubborn: [mobd]), ( introverted: [fndg]), (reticent: []), (novelty: []), (thrill-seeking behaviors: [inbe]), (social skills: [socb]), (maturity: []), (general cognitive functions: [menp]), (iq: []), (impairments: [patf]), (planning: [menp]), ( flexibility: []), (visual processing functions: [phsf]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(personality characteristics, 'Personal Traits')(neurocognitive functions, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(social skills, 'Ability to Converse in Social Settings')(general cognitive functions, 'Cognitive Ability')(planning, 'Planning')(visual processing functions, 'Visual Thinking')

PMCID: 4397440
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (purpose: []), (autism spectrum disorder (asd): [mobd]), (neural abnormality: [fndg]), (social reward system: [menp]), (functional mri (fmri): [diap]), (materials: [sbst]), (asds: [cgab]), (controls: [sbst]), (study: [resa]), (social reward task: [menp]), (participants: [popg]), (task: [gngm]), (fmri scanning: [diap]), (tdcs: [topp]), (social reward: [menp]), (effect: []), (basis: [phsu]), (behavior data: [inbe]), (significant differences: [qnco]), (brain activation: [bpoc]), (reduced activity: [acty]), (right dorsolateral prefrontal cortex: [bpoc]), (right orbitofrontal cortex: [bpoc]), (right parietal lobe: [bpoc]), (occipital lobe; however: [bpoc]), (activity: [acty]), (right parahippocampal gyrus: [bpoc]), (superior temporal gyrus: [bpoc]), (findings: [clna]), (system: []), (several potential limitations: [qnco]), (novel findings: [clna]), (different neural mechanisms: []), (social reward learning: [menp]), (children: [aggp]), (asd: [cgab]), (possible useful biomarker: [clna]), (high-functioning asds: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(different neural mechanisms of social reward learning, 'Social Competence')

PMCID: 6237017
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (observation: [hlca]), (human-animal interaction: [humn]), (research (ohaire): [resa]), (tool: []), (behavior: [inbe]), (children: [aggp]), (social partners: [famg]), (animals: [anim]), (naturalistic settings: [qnco]), (ohaire: []), (behavioral categories: [inbe]), (focus: []), (emotional displays: [menp]), ( social communication behaviors: [socb]), (adults: [aggp]), (peers: [popg]), ( behaviors: [inbe]), (experimental control objects: [sbst]), (interfering behaviors: [inbe]), (coders: []), (min: [neop]), (video: []), (studies: [lbpr]), (total: [qnco]), (participants: [popg]), (years: []), (sd: [gngm]), (animal-assisted intervention: [anim]), (species: []), (dogs: [mamm]), ( horses: [mamm]), (guinea pigs): [mamm]), (populations: [popg]), (autism spectrum: [mobd]), (attention-deficit hyperactivity disorder: [mobd]), (children): [aggp]), (school: [mnob,orgt]), (therapeutic horseback: [topp]), (program: [phsu]), (group therapy program: [topp]), (hospital setting: [hcro,mnob]), (psychometric properties: [diap]), (analyses: [resa]), (inter-rater reliability: [qnco]), ( intra-rater reliability: [qnco]), ( convergent: [acty]), (divergent validity: [qnco]), (internal structure: []), (data: [euka]), (human-animal interaction studies: [humn]), (average inter-rater reliability: [qnco]), (excellent (kappa: []), (good reliability: [qnco]), (intra-rater reliability: [qnco]), (excellent (0.87: [fndg]), (0.96): [fndg]), (cronbach's alpha: []), (exploratory use: []), (subscales: []), (social communication behaviors: [socb]), (interactions: []), (control: [sbst]), (( =: []), (use: []), (subscale: []), (correlation analyses: [inpr,resa]), (multiple questionnaires: [qnco]), (convergence: [acty]), (positive emotional display: [menp]), (social behaviors: [socb]), (social skills: [socb]), (social skills rating system (ssrs): [socb]), (social communication: [socb]), (little concordance: [socb]), (social responsiveness scale (srs): [acty]), (aberrant behavior checklist-community (abc): [inbe]), (ohaire shows: [anim]), (field: [irda]), (need: []), (generalization: [menp]), (settings: [qnco]), (ages: [bacs,orch]), 
ASD Terms: (emotional displays, 'Showing Emotion')(social communication behaviors, 'Reciprocal Social Interaction')(social communication behaviors, 'Reciprocal Social Interaction')(hospital setting, 'Hospitalizations')(social communication behaviors, 'Reciprocal Social Interaction')(positive emotional display, 'Showing Emotion')(social behaviors, 'Reciprocal Social Interaction')(social skills, 'Ability to Converse in Social Settings')(social skills rating system, 'Ability to Converse in Social Settings')(social communication questionnaires, 'Reciprocal Social Interaction')

PMCID: 6175061
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, Shank3, Shank3, Shank3, Shank3, 
Non SFARI Genes: 
Named Entities: (abstract phelanmcdermid: []), (syndrome (pms): [dsyn]), (rare genetic disorder: [dsyn]), (copy: []), (shank3 gene: [gngm]), (global developmental delay: [fndg]), (intellectual disability (id): [mobd]), (multiple: [qnco]), (intragenic promoters: [bacs,nnon]), (spliced exons: [bacs,nnon]), (formation: [biof]), (numerous isoforms: [aapp]), (many genetically-modified mouse models: [mamm]), (pms: [gngm]), (isoforms: [aapp]), (contrast: [irda]), (vast majority: [socb]), (shank3 mutations: [genf]), (patients: [podg]), (deletions: [genf]), (here: []), (production: []), (thorough behavioral characterization: [inbe]), (new mouse model: [emod]), (shank3 isoforms: [aapp]), (domains: []), (tasks: []), (adults: [aggp]), (measures: [qnco]), (general health: [clna]), (neurological reflexes: [ortf]), ( motor: []), (abilities: [orga]), ( sensory reactivity: []), (social behavior: [socb]), (repetitive behaviors: [fndg]), ( cognition: [menp]), (behavioral inflexibility: [inbe]), (anxiety: [mobd]), (mice: [mamm]), (models: []), (deficits: []), (homozygotes: [orga]), (intermediate phenotype: [orga]), (heterozygotes: [orga]), (many paradigms: [resa]), (other shank3 mouse models: [mamm]), (increased grooming: [inbe]), (additionally: []), (sensory alterations: []), (adult mice: [mamm]), (motor behavior: [dora]), (open field: [irda]), (rotarod locomotor tests: [lbpr]), (social behaviors: [socb]), (three-chambered social approach: [qnco]), (male-female interaction tests: [orga]), (impacted: [anab]), ( shank3-deficient mice: [mamm]), (strong escape behavior: [inbe]), (avoidance: [menp]), (inanimate objects: []), (novel object recognition: [menp]), ( repetitive novel: []), (contact: [acty]), (marble burying: [inch]), (building tasks: []), (novelty-induced anxiety: [mobd]), (similarly: []), (freezing: [npop]), (fear: [menp]), (training: [edac]), (amygdala-dependent cued retrieval: [bpoc]), (finally: []), ( deficits: []), (initial training: [edac]), (reversal: []), (barnes maze: [topp]), (contextual fear testing: [menp]), (memory tasks: [menp]), (hippocampal-prefrontal circuits: [bpoc]), (memory: [menp]), (y-maze: [topp]), (spontaneous alternation test: [lbpr]), (represent human mutations: [humn]), (symptoms: [sosy]), (improvements: []), (construct: []), (face validity: []), (previous models: []), 
ASD Terms: (global developmental delay, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(autism, 'Autism Phenotype')(neurological reflexes, 'Neurologic Indications')(social behavior, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(cognition, 'Cognitive Ability')(anxiety, 'Anxiety Disorders')(social behaviors, 'Reciprocal Social Interaction')(novelty-induced anxiety, 'Anxiety Disorders')(memory tasks, 'Working Memory')(memory, 'Working Memory')

PMCID: 6201514
SFARI Genes: 
Non SFARI Genes: impact, impact, 
Named Entities: (longitudinal evidence: []), (motor proficiency: []), (important role: [socb]), (development: [orgf]), (social skills: [socb]), (however: []), ( stereopsis: [menp]), (depth perception: [menp]), (fundamental role: [socb]), (social skill development: [socb]), (impact: [gngm]), (motor skills: [orgf]), (direct route: []), (systematic study: [resa]), (relationship: []), (motor ability: [orgf]), (general adult population: [aggp]), (poor stereopsis: [menp]), (association: [menp]), (implications: []), (clinical populations: [popg]), (research: [resa]), (associations: [menp]), (motor abnormalities: [fndg]), (autism spectrum disorder: [mobd]), (developmental coordination disorder: [mobd]), (fifty adults: [aggp]), (stereopsis: [menp]), (adult developmental coordination disorder checklist: [mobd]), (autism spectrum quotient: [qnco]), (exploratory factor analysis: [qnco]), (pooled items: [sbst]), (measures: [qnco]), (factors: []), (items: []), (single scale: [fndg]), (co-occurrence: []), (difficulties: [fndg]), (social interaction cannot: [fndg]), (single underlying mechanism: [fndg]), (correlations: []), (extracted factor scores: [clna]), (motor skill: [orgf]), (social skill: [socb]), (mediation analyses: [resa]), (whilst fine motor skill: [ortf]), (coordination: [phsf]), (extent: []), (substantial direct effect: []), (first study: [qnco]), (functional significance: [qnco]), (ability: [orga]), (social functioning: [socb]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0234-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (development of social skills, 'Ability to Converse in Social Settings')(social skills, 'Ability to Converse in Social Settings')(fundamental role in social skill development, 'Ability to Converse in Social Settings')(depth perception, 'Cognitive Ability')(social skill development, 'Ability to Converse in Social Settings')(relationship between social skills, 'Ability to Converse in Social Settings')(shown associations between motor abnormalities, 'Motor Skills')(autism spectrum disorder, 'Autism Phenotype')(depth perception, 'Cognitive Ability')(motor abnormalities, 'Motor Skills')(developmental coordination disorder, 'Motor Skills')(adult developmental coordination disorder checklist, 'Motor Skills')(autism spectrum quotient, 'Autism Phenotype')(social interaction cannot, 'Reciprocal Social Interaction')(social skill, 'Ability to Converse in Social Settings')(substantial direct effect upon social skill, 'Ability to Converse in Social Settings')(whilst fine motor skill, 'Fine Motor Skills')(coordination, 'Motor Skills')(social functioning, 'Ability to Converse in Social Settings')

PMCID: 6194190
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (heterogeneous brain disorder: [dsyn]), (effective therapeutic interventions: [topp]), (knowledge: []), (brain regions: [blor]), (malfunction: [patf]), (asd-relevant behaviors: [cgab]), (study: [resa]), (insights: [menp]), (novel social stimulus: [phpr]), (activation pattern differs: [acty]), (mice: [mamm]), (autism-like disabilities: [mobd]), (control littermates: [sbst]), (adenomatous polyposis coli (apc) conditional knockout (cko) mice display: [mamm]), (social interest: [menp]), (repetitive behaviors: [fndg]), (dysfunction: [dsyn]), (-catenin pathway: [aapp,bacs]), (convergent target: [diap]), (numerous asd-linked human genes: [humn]), (here: []), (non-social stimulus: [phpr]), (neuronal activation: [acty]), (protein c-fos: [aapp,bacs,phsu]), (role: [socb]), (social behavior: [socb]), ( apc ckos display: [neop]), (excessive activation: [acty]), (increased number: [qnco]), (excitatory pyramidal neurons: [cell]), (c-fos: [gngm]), (medial prefrontal cortex (mpfc): [celc]), (infralimbic sub-region: [qnco]), (contrast: [irda]), (other social brain: [bpoc]), (medial amygdala: [bpoc]), (piriform cortex: [bpoc]), (normal levels: [fndg]), (neuron activation: [cell]), (additionally: []), ( apc: [neop]), (ckos exhibit: []), (frequency: [qnco]), (miniature excitatory: []), (postsynaptic currents: [ortf]), (layer: [bird]), (pyramidal neurons: [cell]), (further: []), ( immunostaining: []), (inhibitory interneuron markers: [clna]), ((pv): [neop]), (somatostatin (sst): [aapp,horm,phsu]), (apc cko mpfc: [neop]), (findings: [clna]), (aberrant excitatory-inhibitory balance: [acty]), (activation patterns: [acty]), (-catenin: [aapp,bacs]), (core pathway: [moft]), (asd: [cgab]), (mpfc: []), (critical brain region: [blor]), (autism-relevant social behavior: [mobd]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social interest, 'Social Interest')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(social behavior, 'Reciprocal Social Interaction')(normal levels of neuron activation, 'Abnormal Activity or Energy Level')(autism-relevant social behavior, 'Reciprocal Social Interaction')

PMCID: 6203776
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (impairments: [patf]), (social cognition: [socb]), (disorders: [dsyn]), (difficulties: [fndg]), (social interaction: [fndg]), (little transdiagnostic investigation: [hlca]), (social cognition domains: [menp]), (young adults: [aggp]), (total: [qnco]), (autism spectrum disorder (asd; n: [mobd]), (early psychosis (ep; n =: [mobd]), (social anxiety disorder (sad; n: [mobd]), (neurotypical controls: [sbst]), (n =: [aapp,imft]), (battery: [inpo]), (self-report social cognition measures: [resa]), (asd: [cgab]), (ep: [gngm]), ( participants: [popg]), (impaired performance: [inbe]), (lower-order emotion recognition tasks: [menp]), (higher-order: [acty]), (social cognition test: [lbpr]), (self-reports: [resa]), (empathy: [inbe]), (clinical groups: [popg]), (sad: [menp]), (objective social cognition: [socb]), (impairment: [patf]), ( self-reported empathy: [inbe]), (same level: [phsu]), (discriminant analysis: [resa]), (lower-order emotion recognition tests: [menp]), (capacity: [qnco]), (groups: [popg]), (regressions: [menp]), (disability: [fndg]), (depression: [mobd]), (predictor: []), (disability measures: [qnco]), (additional predictive value: []), (social disability: [fndg]), (social interaction anxiety: [mobd]), (overall: []), ( results: [fndg]), (similar social-cognitive development profile: [socb]), (self-reported empathy: [inbe]), ( discrepancy: [fndg]), (objective social cognition test performance: [diap]), (sad group: [popg]), (probable threat-related self-monitoring report: [qnco]), (further influence: []), (group: [popg]), (important predictors: []), ( regardless: []), (diagnostic group: [popg]), ( research: [resa]), (targeted interventions: [hlca]), (domains: []), 
ASD Terms: (social cognition, 'Cognitive Ability')(social interaction, 'Reciprocal Social Interaction')(social cognition domains, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(social anxiety disorder, 'Anxiety Disorders')(self-report social cognition measures, 'Cognitive Ability')(lower-order emotion recognition tasks, 'Empathy')(social cognition test, 'Cognitive Ability')(empathy, 'Empathy')(sad, 'Depression')(objective social cognition, 'Cognitive Ability')(self-reported empathy, 'Empathy')(lower-order emotion recognition tests, 'Empathy')(depression, 'Depressive Disorder')(provided additional predictive value for social disability, 'Social Competence')(social disability, 'Social Competence')(social interaction anxiety, 'Anxiety Disorders')(objective social cognition test performance, 'Cognitive Ability')(sad group, 'Depression')

PMCID: 5487751
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism-spectrum quotient (aq): [qnco]), (scales: [bpoc]), (autistic traits: [mobd]), (general population: [popg]), (however: []), (aspects: [qnco]), (aq: []), (scale: [acty]), (swedish: [popg]), (data: [euka]), (adults: [aggp]), (autism spectrum disorder (asd): [mobd]), (asd: [cgab]), (rasch: []), (several scale properties: [qnco]), (criterion: []), (unidimensional measure: [qnco]), (rasch analysis: [resa]), (50-item aq: [fndg]), (12-item subset: []), (little loss: [qnco]), (explanatory power: [hcpp]), (degree: [qnco]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5816912
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objective: development: [orgf]), (early social skills: [socb]), (children: [aggp]), (complex process: [phpr]), (process: [phpr]), (weaknesses: [sosy]), (other developmental domains: [orgf]), (skills: [inbe]), (present study: [qnco]), (association: [menp]), (motor skills: [orgf]), (imitation ability: [orga]), (early social communication skills: [socb]), (autism spectrum disorder (asd): [mobd]), (method:: [lbpr]), (study: [resa]), (asd: [cgab]), (years: []), (sd: [gngm]), (participated: []), (dsm-v criteria: []), (independent child psychiatrist: [aggp]), (additionally: []), ( autism diagnostic: [mobd]), (subsequent diagnostic confirmation: [fndg]), (test: [lbpr]), (gross motor development: [orgf]), (motor imitation scale (mis): [acty]), (early social communication scales (escs): [socb]), (examinations: [hlca]), (subsequent scoring: [qnco]), (relationship: []), (pearson correlation coefficient: [qnco]), (strong correlation: []), (tgmd: []), (total score: [qnco]), (imitation: [socb]), (total score (r =.776; p <0.001): [qnco]), (however: []), (mis subscales: [gngm]), (tgmd-2 locomotor subtest scores: [clna]), (significant (p>0.05): [qnco]), (significant correlation: [qnco]), (mis: [gngm]), (total scores: [qnco]), (initiating joint attention: [menp]), (responding: []), (joint attention (p0/025): [menp]), (escs subscales: [dsyn]), (social interaction: [fndg]), (behavioral requests: [inbe]), (conclusion:: []), (results: [fndg]), (motor function: []), 
ASD Terms: (development of early social skills, 'Ability to Converse in Social Settings')(early social skills, 'Ability to Converse in Social Settings')(early social communication skills, 'Reciprocal Social Interaction')(imitation ability, 'Imitation')(autism spectrum disorder, 'Autism Phenotype')(autism diagnostic, 'Autism Phenotype')(motor imitation scale, 'Imitation')(early social communication scales, 'Reciprocal Social Interaction')(imitation, 'Imitation')(motor imitation scale subscales, 'Imitation')(joint attention, 'Joint Attention')(early social communication scales subscales, 'Reciprocal Social Interaction')(joint attention, 'Joint Attention')(initiating joint attention, 'Joint Attention')(social interaction, 'Reciprocal Social Interaction')(motor function, 'Motor Skills')

PMCID: 6061026
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (autism-like traits: [mobd]), (deficits: []), (face memory: [menp]), (deficit: [dsyn]), (specific aspect: [qnco]), (asd/autism-like phenotype: [cgab]), (issue: [fndg]), (neurotypical sample: [sbst]), (adolescent twins: [aggp]), ((ncomplete pairs: []), (drawn: []), (twins early development study: [famg]), (face: [gngm]), (object memory performance: [menp]), (core aspects: [qnco]), (autism-like traits: (i) difficulties: [inch]), (social behavior/interactions: [fndg]), ((ii) attention: [menp]), (negative association: [menp]), (face memory ability: [orga]), (difficulties: [fndg]), (association: [menp]), (overlapping genetic etiology:: [topp]), (heritable influences: []), (social difficulties aspects: [qnco]), 
ASD Terms: (face memory, 'Working Memory')(autism spectrum disorder, 'Autism Phenotype')(object memory performance, 'Working Memory')(face memory ability, 'Working Memory')(difficulties with social behavior/interactions, 'Social Competence')(social difficulties aspects of autism-like traits, 'Social Competence')(social difficulties aspects, 'Social Competence')

PMCID: 4927115
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (attention-deficit/hyperactivity disorder (adhd): [mobd]), (prevalent neurodevelopmental disorder: [qnco]), (early onset: [fndg]), (adhd: [mobd]), (significant morbidity: [qnco]), (mortality: [qnco]), (diagnosis: [fndg]), (identification: [menp]), (children: [aggp]), (high risk: [fndg]), (negative trajectory: [fndg]), (illness: [sosy]), (better: []), (psychosocial adversity: [fndg]), (likely etiological risk factor: [qnco]), ( markers: [clna]), (construct: []), (early identification: [topp]), (therefore: []), (rutters indicators: [irda]), (adversity (low: [qnco]), (social class: []), (severe marital discord: [fndg]), (large family: [famg]), (paternal criminality: [socb]), (maternal mental disorder: [mobd]), (placement: [hlca]), (out-of-home care): [hlca]), (infancy: []), (early predictors: []), (development: [orgf]), (methods: []), (findings: [clna]), (data: [euka]), (danish nationwide population-based registers: [inpr,qnco]), (cohort: [popg]), (denmark: []), (january: []), (december: []), (dichotomous values: []), (adversity: []), (age: [orga]), (months: []), (cohort member: [popg]), (cohort members: [popg]), (second birthday: [qnco]), (association: [menp]), (sum: [qnco]), (adversity (ria-score): [lbpr]), (subsequent development: [orgf]), (means: []), (cox regression: [menp]), (number: [qnco]), ((nns): []), (case: []), (ria-scores: [lbpr]), (calculated: [lbpr]), (males: [orga]), (females: [orga]), (marked dose-response relationship: [biof]), (risk: []), (hazard ratios: [qnco]), ((95%ci:: [lbpr]), (respectively: []), (nns: []), (knowledge: []), 
ASD Terms: (early onset, 'Onset of Symptoms')(prevalent neurodevelopmental disorder, 'Learning Disorders')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(delayed diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(infancy, 'Perinatal History')(infancy, 'Perinatal History')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 5197937
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (treatment: [topp]), (deficits: []), (social interaction: [fndg]), (symptom cluster: [dsyn]), (persons: [popg]), (schizophrenia (negative symptoms): [mobd]), (autism: [mobd]), (spectrum disorder: [dsyn]), ((dsm-5 a-criterion): []), (common approaches: [qnco]), (psychotherapy: [topp]), (alternative approach: []), (embodiment brings: []), (body-oriented intervention methods: [humn]), (theoretic framework: []), (disorders: [dsyn]), (basic level: [phsu]), (common theory: [qnco]), (mind approaches: [menp]), (trial: [resa]), (hand: [bpoc]), (effects: []), (10-week manualized dance: [dora]), (movement therapy intervention: [orgf]), (negative symptoms: [fndg]), (participants: [popg]), (autism spectrum disorder: [mobd]), (observed effects: []), (significance: [qnco]), (threshold: []), (undersized sample: [sbst]), (encouraging trend towards: []), (symptom reduction: [npop]), (treatment group: [popg]), (overall negative symptoms: [fndg]), (subtypes: []), (0.10-level: [phsu]), (effect sizes: []), (meaningful: []), (patterns: []), (accordance: []), (theoretical expectations: []), (study: [resa]), (hand contributes: [bpoc]), (effective treatment approach: []), (notion: []), (embodiment: []), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 4428105
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, 
Non SFARI Genes: 
Named Entities: (phelan-mc dermid syndrome: [dsyn]), (contiguous disorder: [dsyn]), (deletion: [genf]), (shank3 gene: [gngm]), (typical phenotype: [orga]), (neonatal hypotonia: [dsyn]), ( moderate: []), (intellectual disability: [mobd]), ( absent: [fndg]), (speech: [orgf]), (minor dysmorphic features: [popg]), (autism: [mobd]), (autistic-like behaviour: [mobd]), (recently: []), ( point mutations: [comd]), (micro-deletions: [genf]), (initial clinically description: []), (phelan mcdermid syndrome: [dsyn]), (case presentation: []), (case studies: []), (similar psychiatric: [hlca]), (genetic diagnosis: [fndg]), (similar clinical history: [orga]), (evolution: [genf]), (patients: [podg]), (autism spectrum disorders: [mobd]), (childhood: []), (regression: [menp]), (catatonia features: [mobd]), (behavioural disorders: [mobd]), (stressful event: [evnt]), (adolescence: []), (interestingly: []), (mutation/microdeletion: [genf]), (premature stop codon: [nusq]), (different: []), (pharmacological treatments: [topp]), (benzodiazepines: [orch,phsu]), ( mood stabilizer drugs: [topp]), ( antidepressants: [phsu]), (methylphenidate): [orch,phsu]), (clinical symptoms: [sosy]), (lead: [elii,hops]), (multiple adverse events: [patf]), (contrast: [irda]), ( lithium therapy: [topp]), (clinical regression: [menp]), (behavioural symptoms: [sosy]), (pre-catatonia level: [mobd]), (functioning: []), (significant side effects: [patf]), (cases: [qnco]), (hypothesis: []), (specific shank3 phenotype: [orga]), (phenotype: [orga]), (catatonia-like deterioration: [mobd]), (lithium use: [fndg]), (efficient treatment: [topp]), (important contribution: [acty]), (field: [irda]), (research: [resa]), ( clinical genetics: []), (possible pharmacological answers: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s12888-015-0490-1) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (intellectual disability, 'Learning Disorders')(speech, 'Language Ability')(autism, 'Autism Phenotype')(genetic diagnosis, 'Diagnosis')(autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5317002
SFARI Genes: 
Non SFARI Genes: impact, impact, 
Named Entities: (emotional processing: [menp]), (individuals: [humn]), (autism spectrum disorders (asd): [mobd]), (impressive number: [qnco]), (picture: []), (research: [resa]), (studies: [lbpr]), (typically developing (td) individuals: [humn]), (asd: [cgab]), (emotion recognition tasks: [menp]), ( others: [fndg]), (such difference: [qnco]), (paper: []), (potential group differences: [popg]), (behaviour: [inbe]), (pressing question:: []), (same mechanisms: []), (emotional cues?: [menp]), (end: [gngm]), (model-based analyses: [resa]), (participants accuracy: [popg]), (emotion categorisation task: [menp]), (displays: []), (anger: [menp]), (fear: [menp]), (gaze: [fndg]), (behavioural data: [inbe]), (td adolescents: [aggp]), (asd group: [cgab]), (overall performance: [inbe]), (yet: []), (gaze direction: [fndg]), (similar impact: [gngm]), (emotion categorisation: [menp]), (groups: [popg]), (accuracy: []), (salient combinations: [phsu]), (critically: []), (computational modelling: [acty]), (participants behaviour reveals: [inbe]), (same mechanism: []), ( i.e: [diap,inpr]), (perceptual sensitivity: [patf]), (contextual impact: [gngm]), (specific experimental conditions: [dsyn]), (emotion processing: [menp]), (automatic integration: [genf]), (contextual information: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(emotion recognition tasks, 'Empathy')(potential group differences in behaviour, 'Personal Traits')(behavioural data of 20 asd, 'Autism Phenotype')

PMCID: 6006579
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (gene mutations: [genf]), (ras-mapk signaling cascade result: [gngm]), (noonan: []), ((ns): []), ( neurofibromatosis type: [gngm]), ((nf1): [gngm]), (related disorders: [dsyn]), (recent research: [resa]), (risk: []), (social difficulties: [fndg]), (features: []), (autism spectrum disorder (asd): [mobd]), (children: [aggp]), (conditions: [dsyn]), (neuropsychological characteristics: []), (social skills deficits: [socb]), (ns: [gngm]), (parents: []), (ns (n: [aapp,imft]), (nf1 (n =: [gngm]), (unaffected siblings: [famg]), (ages: [bacs,orch]), (years: []), (well-validated caregiver questionnaires: []), (childs: [aggp]), (social skills: [socb]), ( language: [lang]), (attention-deficit hyperactivity disorder (adhd) symptoms: [mobd]), (anxiety: [mobd]), (respect: [socb]), (overall social skills: [socb]), (average ratings: [acty]), (clinical groups: [popg]), (ratings: [acty]), (normal limits: [qnco]), (ten children: [dsyn]), (deficits: []), (mild/moderate: []), (fifteen percent: [qnco]), (nf1: [gngm]), (severe social skills: [socb]), (impairment (<: [patf]), (independent: [fndg]), (diagnosis: [fndg]), (adhd symptoms: [mobd]), (social-pragmatic language skills: [socb]), (amidst efforts: [orgf]), (social skill development: [socb]), (adolescents: [aggp]), (rasopathies: []), (neuropsychological correlates: []), (social language competence: [socb]), ( attention: [menp]), (behavioral self-regulation: [inbe]), (important targets: [diap]), (intervention: [hlca]), 
ASD Terms: (increased risk for social difficulties, 'Social Competence')(autism, 'Autism Phenotype')(social difficulties, 'Social Competence')(social skills deficits, 'Ability to Converse in Social Settings')(social skills, 'Ability to Converse in Social Settings')(attention-deficit hyperactivity disorder symptoms, 'Attention Deficit Disorder with Hyperactivity')(anxiety, 'Anxiety Disorders')(overall social skills, 'Ability to Converse in Social Settings')(ratings of social skills, 'Ability to Converse in Social Settings')(severe social skills impairment, 'Ability to Converse in Social Settings')(diagnosis, 'Diagnosis')(social-pragmatic language skills, 'Development or Regression of Language Skills')(support social skill development among children, 'Ability to Converse in Social Settings')(social skill development, 'Ability to Converse in Social Settings')(social language competence, 'Social Competence')

PMCID: 6001642
SFARI Genes: 
Non SFARI Genes: hr, impact, 
Named Entities: (treatment efficacy: []), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (behaviors: [inbe]), (limited evidence: [fndg]), (neural mechanisms: []), (behavioral gains: [inbe]), (pilot study: [resa]), (void: [orgf]), (behavioral changes: [mobd]), (phase: []), (trial: [resa]), (young adults: [aggp]), (asd: [cgab]), (evidencebased behavioral intervention: [topp]), ( virtual realitysocial cognition training: [menp]), (weeks: []), (total: [qnco]), (hr: [gngm]), (participants: [popg]), (pre: [mamm]), (validated biological/social versus: []), (scrambled/nonsocial motion: [npop]), (task: [gngm]), (regions: []), (social brain networks: [popg]), (significant brainbehavior changes: [qnco]), (right posterior: []), (superior temporal sulcus: [bsoj]), (hub: [gngm]), (sociocognitive processing: [acty]), (increased brain activation: [bpoc]), (social versus: []), (nonsocial stimuli: [phpr]), (gains: [qnco]), (theoryofmind measure: [qnco]), (second: [qnco]), (left: []), (inferior frontal gyrus: [bpoc]), (region: []), (socioemotional processing: [acty]), (individual gains: [qnco]), (emotion recognition: [menp]), (decreased activation: [acty]), (superior parietal lobule: [bpoc]), (visual attention: [menp]), (activation: [acty]), (nonsocial versus: []), (social stimuli: [phpr]), (attention: [menp]), (nonsocial contingencies: []), (aspect: [qnco]), (study: [resa]), (first evidence: [qnco]), (harnessable neuroplasticity: [ortf]), (adults: [aggp]), (ageappropriate intervention: [hlca]), (brain regions: [blor]), (social abilities: [socb]), (pilot trial: [resa]), (future efforts: [orgf]), (social interventions: [hlca]), (brain networks: [bpoc]), (autism res: [mobd]), (autism research: [mobd]), (international society: [orgt]), (wiley periodicals: []), ( inc. lay summary: []), (treatment: [topp]), (brain changes: [bpoc]), (vrsct: []), (biological motion stimuli: [npop]), (mri scanner: [diap]), (changes: [qnco]), (social brain network: [popg]), (results: [fndg]), (neuroplasticity: [ortf]), (age population: [aggp]), (window: []), (opportunity: []), (interventions: [hlca]), (social competency: [socb]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(virtual realitysocial cognition training, 'Cognitive Ability')(virtual realitysocial cognition training, 'Cognitive Ability')(emotion recognition, 'Empathy')(visual attention, 'Visual Thinking')(social abilities, 'Ability to Converse in Social Settings')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')(impact social competency, 'Social Competence')(social competency, 'Social Competence')

PMCID: 4810325
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (hypothetical moral choices: [inbe]), (adults: [aggp]), (high-functioning autism: [mobd]), (role: [socb]), (alexithymia: [sosy]), (such choices: [inbe]), (salient moral dilemma task: []), (autistics hypothetical moral evaluations: [hlca]), (harmful utilitarian behaviours: [inbe]), (welfare: [shro]), (results: [fndg]), (normal pattern: [fndg]), (moral judgments: [menp]), (deficits: []), (social cognition: [socb]), (emotional processing: [menp]), (further analyses: [resa]), (biases: []), (alexithymic traits: [gngm]), (variance: (a): [qnco]), (autistic traits: [mobd]), (reduced utilitarian bias: [bird]), (elevated personal distress: [menp]), (social situations: [socb]), ((b) alexithymic traits: [gngm]), (increased utilitarian bias: [bird]), (account: [clna]), (reduced empathic concern: [inbe]), (victim: [popg]), (additionally: []), ( autistics: [mobd]), (non-verbal reasoning skills: [inbe]), (harm-norms: [fndg]), (thus: []), (utilitarian moral judgments: [menp]), (autism: [mobd]), (opposite influences: []), (compensatory intellectual strategies: [menp]), (findings: [clna]), (importance: []), (empathy: [inbe]), (autistic moral cognition: [mobd]), (methodological implications: []), (several other clinical populations: [popg]), 
ASD Terms: (high-functioning autism, 'Autism Phenotype')(social cognition, 'Cognitive Ability')(social situations, 'Social Competence')(non-verbal reasoning skills, 'Reasoning')(autism, 'Autism Phenotype')(empathy, 'Empathy')(autistic moral cognition, 'Cognitive Ability')

PMCID: 5789215
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (adults: [aggp]), ( individuals: [humn]), (autism spectrum disorders: [mobd]), (entire range: [qnco]), (sexual behaviors: [bhvr]), (however: []), (core symptoms: [sosy]), (disorder spectrum: [dsyn]), (deficits: []), (social skills: [socb]), ( sensory hypo-: []), (hypersensitivities: [patf]), (repetitive behaviors: [fndg]), (asd individuals: [cgab]), (above-average: [qnco]), (nonnormative sexual behaviors: [bhvr]), (interests: [menp]), (relevant literature: [inpr,mnob]), (sexuality: [bhvr]), (high-functioning asd individuals: [cgab]), (novel findings: [clna]), (frequency: [qnco]), (normal sexual behaviors: [fndg]), (assessment: [acty]), (paraphilic fantasies: [menp]), (behaviors: [inbe]), (own study: [resa]), (individuals: [humn]), (asd: [cgab]), (general-population studies: [resa]), (inconsistency: []), (observations: [hlca]), (male participants: [orga]), (fact: [gngm]), (women: [popg]), (asd symptomatology: [cgab]), (peculiarities: []), (asd patients: [cgab]), (sexual education: [fndg]), (therapeutic approaches: [topp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(including deficits in social skills, 'Ability to Converse in Social Settings')(social skills, 'Ability to Converse in Social Settings')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 4426713
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (strong evidence: []), (sleep: [orgf]), (longitudinal relationship: []), (emotional well-being: [clna]), (gap: [gngm]), (knowledge: []), (current study: [resa]), (infancy: []), (actigraphy: [diap]), (predictor: []), (social-emotional problems: [fndg]), (toddlers: [aggp]), (total: [qnco]), (children: [aggp]), ((29 males): [orga]), (longitudinal study: [resa]), (time: []), (one: [qnco]), ( actigraphy measures: [diap]), (4-month-old infants: [aggp]), (two: [qnco]), ( parents: []), (24-month-old toddlers social-emotional well-being: [menp]), (brief infant toddler social emotional assessment: [aggp]), (results: [fndg]), (boys: [aggp]), (levels: []), (behaviors: [inbe]), (additionally: []), (sleep durations: [fndg]), (sleep efficiency: [qnco]), (girls: [aggp]), ( sleep duration: [fndg]), (significant predictor: [qnco]), (autism spectrum disorder behaviors: [mobd]), (approached significance: [qnco]), (problems: []), (toddlerhood: []), (findings: [clna]), (relationship: []), (autism spectrum disorder symptomatology: [mobd]), (early childhood: []), (etiology: []), (genders: [orga]), (possibility: []), (cycles: []), (spectrum disorder symptoms: [dsyn]), 
ASD Terms: (infancy, 'Perinatal History')(infancy, 'Perinatal History')(autism spectrum disorder behaviors, 'Autism Phenotype')(autism spectrum disorder symptomatology, 'Autism Phenotype')(autism spectrum disorder symptoms, 'Complaints and Indications')

PMCID: 4975602
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (difficulties: [fndg]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (neurotypical (nt: [diap]), (nonautistic) individuals: [humn]), (failure: [inbe]), (emotions: [menp]), (mental states: [fndg]), (nt interaction partner: [diap]), (possible: []), ( however: []), (difficulty: [fndg]), (nt individuals: [diap]), (emotional states: [menp]), (asd interaction partners: [cgab]), (previous research: [resa]), (deficits: []), (typical facial emotion recognition: [menp]), (asd: [cgab]), (atypical representations: [acty]), (emotional expressions: [inbe]), (little research: [resa]), (ability: [orga]), (recognizable emotional expressions: [inbe]), (thus: []), (autistic emotional expressions: [mobd]), (few studies: [lbpr]), (nt: [diap]), (study: [resa]), (asd posers: [cgab]), (conditions: [dsyn]), (potential group differences: [popg]), (atypical cognitive representations: [acty]), (emotion: [menp]), (impaired understanding: [menp]), (communicative value: [socb]), (expressions: [topp]), (poor proprioceptive feedback: [phpr]), (results: [fndg]), (asd expressions: [cgab]), (nt expressions: [diap]), (genuine deficit: [dsyn]), (representation: [acty]), (typical emotional expressions: [inbe]), (population: [popg]), (further: []), ( asd expressions: [cgab]), (idiosyncratic: [fndg]), (autism res: [mobd]), (international society: [orgt]), (autism research: [mobd]), ( wiley periodicals: []), ( inc: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(typical facial emotion recognition, 'Empathy')(atypical cognitive representations, 'Cognitive Ability')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 4280745
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (link: []), (anorexia nervosa: [mobd]), (autism spectrum disorders: [mobd]), (aims: [phsu]), (study: [resa]), (adolescents: [aggp]), (spectrum and/or obsessive-compulsive traits: [qnco]), (diagnostic criteria: []), (autism spectrum disorder: [mobd]), (traits: [gngm]), (parents: []), (total: [qnco]), (outpatient treatment: [hlca]), (subthreshold anorexia nervosa: [mobd]), (disorder sections: [dsyn]), (development: [orgf]), (well-being assessment: [acty]), (patients: [podg]), (children: [aggp]), (yale-brown obsessive-compulsive scale: [npop]), (other measures: [qnco]), (psychiatric morbidity: [qnco]), (short autism quotient: [mobd]), (obsessive-compulsive inventory revised: [topp]), (below average social aptitude (19%: [menp]), (cut-off): []), (high levels: [qnco]), (peer relationship problems: [fndg]), (obsessive-compulsive symptoms: [sosy]), (six cases: [qnco]), (females): [orga]), (possible (n: [aapp,imft]), (diagnosis: [fndg]), (parental levels: []), (autism spectrum: [mobd]), (obsessive-compulsive traits: [fndg]), (normal range: [qnco]), (levels: []), (small proportion: [qnco]), (probable autism spectrum disorder: [qnco]), (comorbidity: []), (poorer prognosis: [fndg]), (therefore: []), ( adaptation: [orgf]), (treatment: [topp]), (subgroup: [virs]), (warranted: []), (trial registration controlled-trials.com: isrctn83003225: [resa]), (september: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(short autism quotient, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(definite diagnosis, 'Diagnosis')(autism spectrum, 'Autism Phenotype')(autism spectrum, 'Autism Phenotype')(probable autism spectrum disorder, 'Autism Phenotype')(comorbidity, 'Comorbidities')(adaptation, 'Adaptive Life Skills')(adaptation, 'Adaptive Life Skills')

PMCID: 5931764
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (reciprocal social behavior: [socb]), (early-emerging capacity: [qnco]), (social contingencywhich: []), (social learning: [menp]), (social competencyis: []), (autism spectrum disorder (asd): [mobd]), (ability: [orga]), (full range: [qnco]), (rsb: []), (toddler period: [gngm]), (core symptoms: [sosy]), (asd: [cgab]), (early risk: []), (social development: [socb]), (response: [fndg]), (early interventions: [hlca]), (however: []), (important parameters: [fndg]), (variation: []), (rsbespecially: []), (development: [orgf]), (questionnaire-based methods: []), (challenge: [hlca]), (system: []), (quantitative variation: [qnco]), (toddlers (ages: [bacs,orch]), (months): []), (standard questionnaire data: [euka]), (caregivers: []), (novel set: [menp]), (video-referenced items: []), (respondent: [popg]), (behavior: [inbe]), (subject: [humn]), (short video: [qnco]), (young child: [aggp]), (competent level: [phsu]), (social communication: [socb]), (measure: [qnco]), (general population sample: [popg]), (twins: [famg]), (rsb total score: [qnco]), ((video-referenced items: []), (non-video-referenced items): []), (unimodal: []), ( continuous distributions: [qnco]), (strong internal consistency: [qnco]), (preservation: [lbpr]), (individual differences: [menp]), (high heritability: [qnco]), (addition: []), ( video-referenced items: []), (incremental changes: [qnco]), (major element: [elii]), (course: []), (early childhood development: [phpr]), (scores: [clna]), (vrrsb: []), (children: [aggp]), (data: [euka]), (initial validation: [resa]), (promising method: [lbpr]), (early rsbcross-sectionally: []), (time: []), (function: [phsf]), (early intervention: [hlca]), 
ASD Terms: (reciprocal social behavior, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(core symptoms of asd, 'Complaints and Indications')(social behavior, 'Reciprocal Social Interaction')(social development, 'Ability to Converse in Social Settings')(social behavior, 'Reciprocal Social Interaction')(social communication, 'Reciprocal Social Interaction')(social behavior total score, 'Reciprocal Social Interaction')(social communication, 'Reciprocal Social Interaction')(vrreciprocal social behavior, 'Reciprocal Social Interaction')

PMCID: 5240249
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (disruptive behavior: [fndg]), (autism spectrum disorder (asd): [mobd]), (important clinical problem: [fndg]), (neural basis: [phsu]), (current research: [resa]), (neural underpinnings: []), (asd: [cgab]), (core asd symptoms: [cgab]), (participants: [popg]), (male children: [aggp]), (asd (7: [cgab]), (high disruptive behavior): [fndg]), ((td) controls: [sbst]), (sex: [orgf]), ( age: [orga]), (iq: []), (asd participants: [cgab]), ( autism symptom: [mobd]), ( anxiety symptoms: [fndg]), (adhd symptoms: [mobd]), (measured: [diap]), (biological motion (bio): [npop]), (scrambled motion (scr): [npop]), (fmri contrasts: [diap]), (analyzed: social perception (bio > scr): [menp]), (default mode network (dmn) deactivation (fixation > bio): [popg]), (age: [orga]), (covariates: []), (interest: [menp]), (analyses: [resa]), (between-group analyses: [popg]), (bio > scr: [fndg]), (hypoactivation: []), (social perception circuitry: [menp]), (low disruptive behavior: [fndg]), (similar patterns: []), (fixation > bio: [fndg]), (high disruptive behavior: [fndg]), (dmn deactivation: [hops,orch]), (td: []), (within-asd analyses: [cgab]), ((a) autism: [mobd]), (symptom severity (but: [fndg]), (disruptive behavior): [fndg]), (activation: [acty]), (social perception regions: [menp]), (posterior superior temporal sulcus: [bsoj]), (inferior frontal gyrus; (b): [bpoc]), (disruptive behavior (but: [fndg]), (symptom severity): [fndg]), (medial prefrontal cortex (mpfc): [celc]), (lateral parietal cortex;: [bpoc]), ((c) anxiety symptoms: [fndg]), (link: []), (anterior cingulate cortex (acc): [bpoc]), (mpfc: []), (acc: [gngm]), (boys: [aggp]), (reduced dmn deactivation: [hops,orch]), (differential neurobiological markers: [clna]), (neural targets: [diap]), (predictors: []), (interventions: [hlca]), (core symptoms: [sosy]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s11689-017-9183-z) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(core asd symptoms, 'Complaints and Indications')(autism symptom, 'Complaints and Indications')(anxiety symptoms, 'Anxiety Disorders')(adhd symptoms, 'Attention Deficit Disorder with Hyperactivity')(social perception, 'Cognitive Ability')(social perception circuitry, 'Cognitive Ability')(adhd symptoms, 'Attention Deficit Disorder with Hyperactivity')(autism, 'Autism Phenotype')(social perception regions, 'Cognitive Ability')(core symptoms in asd, 'Complaints and Indications')

PMCID: 5558936
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (spectrum condition (asc): [dsyn]), (behavioural symptoms: [sosy]), (social: []), ( sensory: []), (motor aspects: [qnco]), (stereotyped: [menp]), ( repetitive motor movements: [fndg]), (diagnosis: [fndg]), ( quantitative measures: [qnco]), (kinematic characteristics: []), (movement patterns: [fndg]), (autistic individuals: [mobd]), (advances: []), (aetiology: []), (motor impairment: [patf]), (wider range: [qnco]), (motor characteristics: []), (aim: [phsu]), (study: [resa]), (data-driven machine learning: [mcha]), (methods: []), (fundamental problems: []), (regard: []), (discriminative test conditions: [socb]), (kinematic parameters: [fndg]), (asc: [gngm]), (neurotypical controls: [sbst]), (data: [euka]), (previous task: []), (asc participants: [popg]), (age: [orga]), ( iq: []), (controls: [sbst]), (series: [qnco]), (hand movements: [orgf]), (imitation conditions: [dsyn]), (machine: []), (optimal imitation conditions: [dsyn]), (significant kinematic parameters: [fndg]), (standard attribute evaluators: []), (knowledge: []), (first attempt: [evnt]), (movement parameters: [orgf]), (imitation: [socb]), (identification: [menp]), (small sample: [sbst]), (work: []), (feasibility: []), (high-dimensional data: [euka]), (potential: []), (machine learning: [mcha]), (kinematic biomarkers: [clna]), (diagnostic classification: []), 
ASD Terms: (autism, 'Autism Phenotype')(aetiology of motor impairment, 'Motor Skills')(stereotyped, 'Stereotyped, Restricted, and Repetitive Behavior')(repetitive motor movements, 'Stereotyped, Restricted, and Repetitive Behavior')(diagnosis, 'Diagnosis')(motor impairment, 'Motor Skills')(hand movements, 'Fine Motor Skills')(imitation conditions, 'Imitation')(optimal imitation conditions, 'Imitation')(hand movements, 'Fine Motor Skills')(imitation, 'Imitation')(autism spectrum condition, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 3731783
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (antibodies: [aapp,imft]), (fetal brain proteins: [aapp,bacs]), (kda: [qnco]), (molecular weight: [qnco]), (mothers: [famg]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (finding: [sosy]), (possibility: []), (immunoglobulin g (igg) class antibodies: [aapp,imft]), (placenta: [emst]), (pregnancy: [orgf]), (impact brain development: [ortf]), (form: []), (asd: [cgab]), (pathogenic potential: [fndg]), (nonhuman primate model: [mamm]), (igg: []), (purified igg: []), (groups: [popg]), (female rhesus monkeys: [mamm]), (igg-con; n=8): [aapp,imft]), (second trimesters: []), (control group: [grup]), (pregnant monkeys: [mamm]), (brain: [bpoc]), (behavioral development: [orgf]), (offspring: [famg]), (years: []), (behavioral differences: [inbe]), (macaque mothers: [mamm]), (igg-asd offspring: [cgab]), (heightened protectiveness: [phsu]), (early development: [orgf]), (species-typical social norms: []), (familiar peers: [popg]), (increased approach: [qnco]), (social interactions: [fndg]), (striking: []), ( igg-asd: [cgab]), (displayed inappropriate approach behavior: [inbe]), (normal macaque social behavior: [mamm]), (longitudinal: []), (magnetic resonance imaging analyses: [diap]), (male igg-asd offspring: [cgab]), (brain volume: [qnco]), (controls: [sbst]), (white matter volume increases: [tisu]), (brain differences: [bpoc]), (differences: [qnco]), (frontal lobes: [bpoc]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(offspring, 'Perinatal History')(immunoglobulin g-asd offspring with heightened protectiveness, 'Perinatal History')(behavioral differences, 'Personal Traits')(immunoglobulin g-asd offspring, 'Perinatal History')(species-typical social norms, 'Recognition of Social Norms')(social interactions, 'Reciprocal Social Interaction')(normal macaque social behavior, 'Reciprocal Social Interaction')(male immunoglobulin g-asd offspring, 'Perinatal History')

PMCID: 4077823
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (associations: [menp]), (maternal social networks: [popg]), (perceptions: [menp]), (trust: [inbe]), (prevalence: [qnco]), (suspected autism spectrum disorders: [mobd]), (18-month-old offspring: [famg]), (japan: []), (questionnaires: []), (measurements: []), (maternal social networks (number: [popg]), (relatives: [famg]), (friends: [popg]), (assistance): [socb]), ( maternal perceptions: [menp]), ( mutual assistance (i.e: [socb]), (individual measures: [qnco]), (cognitive social capital): []), (social participation (i.e: [socb]), (structural social capital): []), (modified checklist: []), (autism: [mobd]), (toddlers: [aggp]), (suspected autism spectrum disorder (asd): [mobd]), (tools: []), (families: [famg]), (18-month-old toddlers: [aggp]), (chiba: []), (city: [clna]), (tokyo (n: [aapp,imft]), (response rate:: []), (association: [menp]), (social capital: []), (social network indicators: [popg]), (asd: [cgab]), (covariates: []), (logistic regression analysis: [resa]), (low maternal social trust: [inbe]), (suspected asd: [cgab]), (high maternal social trust: [inbe]), (odds: []), (confidence interval: [qnco]), (mutual aid: [fndg]), (related (low vs. high: or: [qnco]), (ci:: [lbpr]), (however: []), ( maternal community participation: [acty]), (u-shape association: [menp]), (offspring: [famg]), (maternal: [famg]), (social network: [popg]), (consistent inverse associations: []), ( regardless: []), (type: [qnco]), (social connection (e.g.: []), ( relatives: [famg]), ( neighbors: [popg]), (neighborhood): []), (mothers': [famg]), (cognitive social capital: []), (social networks: [popg]), (structural social capital: []), 
ASD Terms: (perceptions, 'Cognitive Ability')(suspected autism spectrum disorders, 'Autism Phenotype')(18-month-old offspring, 'Perinatal History')(maternal perceptions, 'Cognitive Ability')(autism, 'Autism Phenotype')(suspected autism spectrum disorder, 'Autism Phenotype')(offspring, 'Perinatal History')(suspected asd in offspring, 'Perinatal History')(cognitive social capital, 'Cognitive Ability')

PMCID: 4964927
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent research: [resa]), (adults: [aggp]), (autism spectrum disorders: [mobd]), (difficulty: [fndg]), (others' emotional responses: [menp]), (order: [acty]), (difficulty;: [fndg]), (important cues: []), (paced dynamic stimuli: [aapp,enzy]), (spontaneous emotional responses: [menp]), (asd: [cgab]), (possibilities: []), (adolescents: [aggp]), (neurotypical controls: [sbst]), (videos: []), (pictures: []), (peoples' emotional responses: [menp]), (gifts: []), (handmade novelty: []), (monopoly: []), (person: [grup]), (emotion: [menp]), (eye movements: [ortf]), (measured: [diap]), (participants: [popg]), (accurate: []), (chocolate: [plnt]), (gift: [fndg]), (stimuli: [phpr]), (monopoly money: []), (groups: [popg]), (similar emotion attributions: [menp]), (conditions: [dsyn]), (homemade: []), (monopoly money): []), (fixations: [topp]), (eyes: [bpoc]), (face: [gngm]), (typical controls: []), (results: [fndg]), (subtle emotion cues: [menp]), (certain emotions: [menp]), (positive): [fndg]), (sufficient processing time: [acty]), ( however: []), (dynamic cues: []), (emotion blends: [menp]), (confusion): [mobd]), (difficulties: [fndg]), (complex emotion responses: [menp]), (autism res: [mobd]), (international society: [orgt]), (autism research: [mobd]), ( wiley periodicals: []), ( inc: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(others' emotional responses, 'Empathy')(spontaneous emotional responses, 'Empathy')(peoples' emotional responses, 'Empathy')(complex emotion responses, 'Empathy')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')

PMCID: 5967343
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (inflexible behaviours: [inbe]), (people: [popg]), (autism spectrum disorder (asd): [mobd]), (social communication: [socb]), (meanwhile: []), ( flexibility: []), (cognitive control: [sbst]), (situations; however: []), (asd: [cgab]), (face: [gngm]), (conflicts: [inbe]), (respect: [socb]), (ultimatum game (ug): [dora]), (implicit-association test (iat): [diap]), (conflict: [inbe]), (addition: []), (detail: []), (flexibility questionnaire (dflex): []), (inflexible everyday behaviour: [inbe]), (diminished cognitive control: [fndg]), (attention shifting: [menp]), (decreased flexibility: [qnco]), (participants: [popg]), (asd (dflex: [cgab]), (iat);: []), (iat: []), (dflex: []), (however: []), (ug: [qnco]), ( contrary: []), (prediction: []), ( participants: [popg]), (unfair offers: []), (td: []), (results: [fndg]), (automatic/attention: [menp]), (level: [phsu]), (useful approach: []), (behavioural flexibility: [inbe]), (multiple response strategies: [menp]), (economic rationality: []), (severity: []), (inflexible daily behaviours: [inbe]), (flexible attitude: [menp]), (automatic level: [phsu]), (attention processing: [menp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')(cognitive control, 'Cognitive Ability')(diminished cognitive control, 'Cognitive Ability')(attention shifting, 'Transitioning Ability')(study behavioural flexibility among asd, 'Autism Phenotype')

PMCID: 6208958
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (rationale standard: []), (therapeutic approaches: [topp]), (social anxiety: [mobd]), (autistic adults: [mobd]), (effectiveness: []), (3: [fndg]), (4-methylenedioxymethamphetamine (mdma)-assisted psychotherapy shows: [hops,orch,phsu]), (treatment: [topp]), (other anxiety: [mobd]), (blinded: [resa]), ( placebo-controlled pilot study: [inpr,resa]), (conducted: [inbe]), (feasibility: []), (safety: [hcpp]), (mdma-assisted psychotherapy: [hops,orch,phsu]), (reduction: [npop]), (social fear: [mobd]), (avoidance: [menp]), (autistic population: [mobd]), (severe social anxiety: [mobd]), (mdma (75: [hops,orch,phsu]), (mg: [elii,phsu]), (inactive placebo (0 mg: [topp]), ( n: [aapp,imft]), (8-h psychotherapy sessions: [elii]), (sessions): [evnt]), (controlled clinical setting: [fndg]), (double-blinded experimental sessions: [acty]), (month: []), (non-drug psychotherapy sessions: [topp]), (each: []), (primary outcome: [topp]), (change: [qnco]), (leibowitz social anxiety scale (lsas) total scores: [qnco]), (baseline: [bodm]), (second experimental session: [evnt]), (outcomes: []), (months: []), (last experimental session: [evnt]), (improvement: []), (lsas scores: [dsyn]), (primary endpoint: [irda]), (mdma group: [hops,orch,phsu]), (placebo group (p: [popg]), (placebo-subtracted cohens d effect size: [topp]), (large (d =: [qnco]), (ci: [gngm]), (6-month follow-up: [hlca]), (similar positive results: [fndg]), (cohens d effect size: [qnco]), ((ci: [lbpr]), (participants: [popg]), (active treatment phase: [topp]), (pilot trial: [resa]), (durable improvement: []), (social anxiety symptoms: [mobd]), (initial safety: [hcpp]), (efficacy outcomes: [resa]), (support expansion: []), (research: [resa]), (samples: [sbst]), (novel treatment: [topp]), (trial registration clinicaltrials.gov identifier: [resa]), ( nct02008396 electronic: []), (supplementary material: []), (online version: []), (article: []), ((10.1007/s00213-018-5010-9) contains: [acty]), (users: [humn]), 
ASD Terms: (social anxiety, 'Anxiety Disorders')(other anxiety, 'Anxiety Disorders')(social fear, 'Social Anxiety')(severe social anxiety, 'Anxiety Disorders')(leibowitz social anxiety, 'Anxiety Disorders')(leibowitz social anxiety scale total scores, 'Anxiety Disorders')(leibowitz social anxiety scale scores, 'Anxiety Disorders')(leibowitz social anxiety scale scores, 'Anxiety Disorders')(social anxiety symptoms, 'Anxiety Disorders')(social anxiety, 'Anxiety Disorders')

PMCID: 4253134
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (findings: [clna]), (studies: [lbpr]), (infants: [aggp]), (familial high risk: [famg]), (autism spectrum disorder (asd): [mobd]), (sibling: [famg]), (diagnosis: [fndg]), ( suggest: []), (asd: [cgab]), (early impairments: [patf]), (processing: [acty]), (stimuli: [phpr]), (non-social content: [menp]), (social-communication impairments: [mobd]), (repetitive behaviours: [inbe]), (majority: [socb]), (cognitive theories: []), (single underlying factor: [fndg]), (development: [orgf]), (secondary effects: [neop]), (domains: []), (first high-risk study: [resa]), (theoretical models: []), (high-risk siblings: [famg]), (multiple risk factors: [qnco]), (prediction: []), (asd outcome: [cgab]), (attention: [menp]), (non-social stimuli: gaze: [fndg]), (attentional disengagement: [menp]), (months: []), (low-risk controls: [fndg]), (high-risk asd infants: [cgab]), (years): []), (same regression: [menp]), (13-month measures: [qnco]), (years: []), (age: [orga]), (data: [euka]), (additive model: [sbst]), (non-social attention: [menp]), ( disengagement: []), (social attention: [menp]), (gaze following: [fndg]), (cumulative impact: [gngm]), (asd risk: [cgab]), (data argue: [euka]), (effects: []), (early development: [orgf]), (support: []), (multiple impairment models: [patf]), (neurobiological evidence: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(diagnosis, 'Diagnosis')(cognitive theories, 'Cognitive Ability')(repetitive behaviours, 'Restricted and Repetitive Behavior')(cognitive theories, 'Cognitive Ability')

PMCID: 6292037
SFARI Genes: spin, spin, spin, spin, spin, spin, 
Non SFARI Genes: 
Named Entities: (research: [resa]), (neurobiological markers: [clna]), (autism spectrum disorder (asd): [mobd]), (however: []), (radionuclide studies: [elii]), (cerebral blood flow (cbf): [fndg]), (decreased blood flow (hypoperfusion): [patf]), (temporal lobes: [bpoc]), (individuals: [humn]), (asd: [cgab]), (ages: [bacs,orch]), (intelligence: [menp]), (observation: [hlca]), (current neuroscientific models: [npop]), (implicate temporal regions: [bpoc]), (social perception: [menp]), (social cognition: [socb]), (arterial spin: [bpoc]), (perfusion mri: [diap]), (noninvasive quantification: [qnco]), (regional cbf: []), (part: [qnco]), (multimodal mri protocol: [diap]), (method: [lbpr]), (asd research: [cgab]), (priori hypothesis: []), (children: [aggp]), (hypoperfusion: [patf]), (temporal lobesmost: []), (fusiform gyrus: [bsoj]), (prominent role: [socb]), (social perception deficits): [menp]), (reproducibility: []), (cbf measures: [qnco]), (relationship: []), (individual differences: [menp]), (facial recognition: [menp]), (asd symptoms: [cgab]), (total: [qnco]), (males: [orga]), (asd): [cgab]), (years: []), (study: [resa]), (arterial spin labeling: [irda]), (structural (t1) scans: [diap]), (t siemens verio: [clna]), (weeks: []), (time: []), (diagnostic measures: [qnco]), (benton facial recognition test: []), (cbf: []), (key dependent variable: []), (facial recognition performance: [menp]), (scans: [diap]), (reliability analyses: [resa]), (asd group: [cgab]), (bilateral fusiform gyrus: [bsoj]), (right inferior temporal gyrus: [bpoc]), (intra-class correlations: []), (good reliability: [qnco]), (groups: [popg]), (diagnostic group: [popg]), (time interactions: []), (left fusiform gyrus: [bpoc]), (significant correlations: [qnco]), (core asd symptoms: [cgab]), (regions: []), (cognition: [menp]), (important role: [socb]), (region: []), (normative facial recognition performance: [menp]), (important first step: [bodm]), (reliable marker: [clna]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social perception, 'Cognitive Ability')(social cognition, 'Cognitive Ability')(asd symptoms, 'Complaints and Indications')(core asd symptoms, 'Complaints and Indications')(cognition, 'Cognitive Ability')

PMCID: 6391069
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (vocal sounds: [orgf]), (childrens social-emotional learning: [menp]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (out voices: [orgf]), (environment: []), (neurobiological basis: [phsu]), (voice processing: [orgf]), (link: []), (social impairments: [patf]), (asd: [cgab]), (here: []), (first comprehensive brain network analysis: [bpoc]), (neural responses: [orga]), (unfamiliar voices: [orgf]), (mothers: [famg]), (salient voice: [orgf]), (social learning: [menp]), (striking relationship: []), (social communication abilities: [socb]), (activation: [acty]), (key structures: []), (reward: [menp]), (salience processing regions: [acty]), (functional connectivity: []), (reward regions: [menp]), (social communication: [socb]), (results: [fndg]), (social motivation theory: [menp]), (reward system deficits: [menp]), (processing: [acty]), (critical social stimulus: [phpr]), ( mothers voice: [famg]), (editorial note:: [clna]), (article: []), (editorial process: [phpr]), (authors: []), (issues: [fndg]), (peer review: [hlca]), (reviewing editor's assessment: [acty]), (minor issues: [popg]), (unresolved (see decision letter): [orgf]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(vocal sounds, 'Vocalizations')(social impairments in asd, 'Social Competence')(social impairments, 'Social Competence')(social communication abilities, 'Reciprocal Social Interaction')(social communication, 'Reciprocal Social Interaction')

PMCID: 6190900
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (impaired social communication: [socb]), (behaviors: [inbe]), (neuropeptide oxytocin (oxt): [aapp,horm,phsu]), (critical role: [socb]), (social behaviors: [socb]), (central nervous system: [bdsy]), (animal studies: [anim]), (central oxt deficit: [dsyn]), (causes: []), (etiology: []), (asd: [cgab]), (social impairments: [patf]), (hypothesis: []), ( central oxt system: [lbpr]), (valproic acid (vpa)-induced rat model: [mamm]), (autism (vpa rat): [mamm]), (results: [fndg]), (adolescent vpa rats: [mamm]), (level: [phsu]), (oxt mrna: [bacs,nnon]), (oxt-ir cells: [aapp,rcpt]), (hypothalamus: [bpoc]), (control rats: [mamm]), (additionally: []), ( oxt concentration: [menp]), (cerebrospinal fluid (csf): [bdsu]), (reduced: []), (number: [qnco]), (supraoptic nucleus (son): [bpoc]), (neonatal vpa rats: [mamm]), (autistic-like behaviors: [mobd]), (animals: [anim]), (well: []), (acute: []), (intranasal administration: [topp]), (exogenous oxt: []), (social preference: []), (early postnatal oxt treatment: [topp]), (long-term effects: [phpr]), (repetitive behaviors: [fndg]), (vpa rats: [mamm]), (adolescence: []), (increase: []), (together: []), (central oxt deficiency: [dsyn]), (vpa-induced rat model: [mamm]), (autism: [mobd]), (evidence: []), (long-term therapeutic effect: [phpr]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(impaired social communication, 'Reciprocal Social Interaction')(social behaviors, 'Reciprocal Social Interaction')(social impairments, 'Social Competence')(autism, 'Autism Phenotype')(cerebrospinal fluid, 'Hydrocephalus')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')

PMCID: 5360858
SFARI Genes: AVP, AVP, AVP, AVP, AVP, AVP, AVP, AVP, AVP, AVP, AVP, AVP, 
Non SFARI Genes: 
Named Entities: (dysfunction: [dsyn]), (brain-derived arginine-vasopressin (avp) systems: [aapp,horm,phsu]), (etiology: []), (autism spectrum disorder (asd): [mobd]), (certain regions: []), (hypothalamus: [bpoc]), ( amygdala: [bpoc]), (hippocampus: [bpoc]), (avp neurons: [cell]), (terminals: []), (important role: [socb]), (complex social behaviors: [socb]), (present study: [qnco]), (concomitant changes: [qnco]), (autistic behaviors: [mobd]), (avp levels: [gngm]), (structure: []), (functional connectivity (fc): []), (specific brain regions: [blor]), (autistic children: [podg]), (children: [aggp]), (years: []), (results: [fndg]), ((1) children: [aggp]), (asd: [cgab]), (increased volume: [qnco]), (left amygdala: [bpoc]), (volume: [qnco]), (bilateral hypothalamus: [bpoc]), (tdc: []), (plasma avp level: [bdsu]), (negative fc: [acty]), (bilateral supramarginal gyri: [bpoc]), (degree: [qnco]), (amygdala: [bpoc]), (supramarginal gyrus: [bpoc]), (score: [clna]), (clinical autism behavior checklist: [mobd]), (lowering: [acty]), (avp concentration: [menp]), (boys: [aggp]), (fc: [acty]), (right subcortical area: [blor]), (avp: [gngm]), (response score: [clna]), (childhood autism rating scale: [mobd]), (changes: [qnco]), (brain regions: [blor]), (autism: [mobd]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s12264-017-0109-2) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(complex social behaviors, 'Executive Function')(clinical autism behavior checklist, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4488831
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (emotional facial expressions: [fndg]), (indispensable communicative tools: []), (social interactions: [fndg]), (facial expressions: [fndg]), (psychiatric disorders: [mobd]), (recent studies: [lbpr]), (perception: [menp]), (dynamic facial expressions: [fndg]), (normal participants: [popg]), (exaggerated perception: [menp]), (autism spectrum disorder (asd): [mobd]), (notion: []), (asd: [cgab]), (schizophrenia spectrum disorder: [mobd]), (extremes: []), (continuum: []), (respect: [socb]), (social impairment: [patf]), (schizophrenic characteristics: []), (hypothesis: []), (relationship: []), (schizotypal traits: [gngm]), (normal population: [popg]), (static facial expressions: [fndg]), (participants: [popg]), (emotional face display: [blor]), (perceived final image: [menp]), (presence: [qnco]), (degree: [qnco]), (exaggeration: []), (dynamic: []), (static: []), ( facial expressions: [fndg]), (subscales: []), (paranoia trait: [mobd]), (results: [fndg]), (tendency: []), (over-attribute mental states: [fndg]), 
ASD Terms: (emotional facial expressions, 'Integrated Verbal and NonVerbal Communication')(social interactions, 'Reciprocal Social Interaction')(facial expressions, 'Integrated Verbal and NonVerbal Communication')(psychiatric disorders, 'Mental Disorders')(perception, 'Cognitive Ability')(dynamic facial expressions, 'Integrated Verbal and NonVerbal Communication')(exaggerated perception, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(exaggerated perception, 'Cognitive Ability')(dynamic facial expressions, 'Integrated Verbal and NonVerbal Communication')(schizophrenia spectrum disorder, 'Schizophrenia and Disorders with Psychotic Features')(social impairment, 'Social Competence')(schizophrenic characteristics, 'Schizophrenia and Disorders with Psychotic Features')(perception, 'Cognitive Ability')(facial expressions, 'Integrated Verbal and NonVerbal Communication')(static facial expressions, 'Integrated Verbal and NonVerbal Communication')(emotional face display, 'Showing Emotion')(facial expressions, 'Integrated Verbal and NonVerbal Communication')(facial expressions, 'Integrated Verbal and NonVerbal Communication')(exaggerated perception, 'Cognitive Ability')(facial expressions, 'Integrated Verbal and NonVerbal Communication')(perception, 'Cognitive Ability')(emotional facial expressions, 'Integrated Verbal and NonVerbal Communication')

PMCID: 6311865
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (impairments: [patf]), (social behavior: [socb]), (many neuropsychiatric disorders: [dsyn]), (recent studies: [lbpr]), (role: [socb]), (endoplasmic reticulum (er) stress: [comd]), (underlying mechanism: []), (present study: [qnco]), (transglutaminase: [aapp,enzy]), ((tg2): []), (calcium-dependent enzyme: [bacs,elii,phsu]), (er stress: [inbe]), (mice: [mamm]), (tunicamycin administration: [antb,bacs,nnon]), (tg2 protein levels: [lbtr]), (mouse: [mamm]), (prefrontal cortex (pfc): [bpoc]), (pfc-specific inhibition: [acty]), (tg2: []), (er: [gngm]), (stress-induced deficits: [fndg]), (conversely: []), ( overexpression: [genf]), (pfc: [gngm]), (social behavior impairments: [socb]), (addition: []), ( systemic administration: [topp]), (tg2 inhibitor: []), (social behavior deficits: [socb]), (preliminary findings: [clna]), (postmortem: [diap]), (human brain samples: [humn]), (increases: [qnco]), (tg2 mrna: [bacs,nnon]), (protein levels: [lbtr]), (middle frontal gyrus: [bpoc]), (subjects: [humn]), (autism spectrum disorder: [mobd]), (findings: [clna]), (human postmortem brain samples: [humn]), (changes: [qnco]), (tg2 activity: [acty]), (possible dysregulation: []), 
ASD Terms: (social behavior, 'Reciprocal Social Interaction')(social behavior, 'Reciprocal Social Interaction')(social behavior, 'Reciprocal Social Interaction')(social behavior impairments, 'Reciprocal Social Interaction')(social behavior deficits, 'Personal Traits')(autism spectrum disorder, 'Autism Phenotype')(social behavior, 'Reciprocal Social Interaction')

PMCID: 6129682
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (significant impairment: [patf]), (social communication: [socb]), (presence: [qnco]), (repetitive behaviour: [fndg]), (interest: [menp]), (intervention: [hlca]), (early childhood: []), (asd symptoms: [cgab]), (effective intervention: [hlca]), (cognitive: []), ( developmental: [orgf]), (behavioural approaches: [inbe]), (factors: []), (effectiveness: []), (systematic review: []), (meta-analysis: [resa]), (interventions: [hlca]), (asd: [cgab]), (preschool-aged children: [aggp]), (electronic databases: [fndg]), (related articles: [fndg]), (trial (rct): [resa]), (outcome measures: [qnco]), (cognitive skills: [inbe]), (standardised mean differences: [qnco]), (control group: [grup]), (random-effects model: [resa]), (pooled estimate effect: [qnco]), (between-study variability: [resa]), (number: [qnco]), (study: [resa]), (crd42017035354: []), (findings out: [clna]), (studies: [lbpr]), (rcts (746 children): [aggp]), (final systematic review: []), ((95% confidence interval: [qnco]), ( ci [0.080.37]): [lbpr]), (between-study heterogeneity (i2: [orga]), (p: [gngm]), (music therapy interventions: [topp]), (outcome effects: []), (duration: [phsu]), (intensity: []), (smd: [dsyn]), (music therapies: [topp]), (ci [0.22: [lbpr]), (quality: []), (health care: [hlca]), (important role: [socb]), (interpretation music therapy: [topp]), (effective tool: []), (social interaction: [fndg]), (however: []), (evidence-based trials: [resa]), (music therapy: [topp]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(repetitive behaviour, 'Restricted and Repetitive Behavior')(decrease asd symptoms, 'Complaints and Indications')(cognitive, 'Cognitive Ability')(cognitive skills, 'Cognitive Ability')(social interaction, 'Reciprocal Social Interaction')

PMCID: 6136574
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (driver's licence: [clna]), (independence: []), (improved quality: []), (life: []), (individuals: [humn]), (families: [famg]), (motor vehicle: []), (safe on-road skills: [inbe]), (people: [popg]), (autism spectrum: [mobd]), (many countries: []), (autism-specific licencing requirements: [mobd]), (learner drivers: [popg]), (general lack: [hlca]), (asd-specific support: [cgab]), (training packages: [qnco]), (driving instructors: []), (review: []), (peer-reviewed literature: [hlca]), (characteristics: []), (drivers: [popg]), (spectrum: [qnco]), (driver training: [edac]), (cohort: [popg]), (evidence: []), (autism spectrum drive: [menp]), (neurotypical counterparts: []), (shortcomings: []), (tactical skills: [inbe]), (extent: []), (own safety: [hcpp]), (safety: [hcpp]), (other road users: [humn]), (training programs: [phsu]), (spectrum-specific learner training programs: [phsu]), (development: [orgf]), (effective training program: [phsu]), (road: []), 
ASD Terms: (autism spectrum, 'Autism Phenotype')(autism spectrum drive, 'Autism Phenotype')

PMCID: 5406682
SFARI Genes: 
Non SFARI Genes: son, 
Named Entities: (quality: []), (life: []), (families: [famg]), (children: [aggp]), (additional needs: []), (case: []), (autism spectrum disorder (asd): [mobd]), (effects: []), (diagnostic status specifically: [fndg]), (asd diagnosis: [cgab]), (others: [fndg]), (signs: [fndg]), (asd;: [cgab]), (asd: [cgab]), (diagnosis: [fndg]), (mothers: [famg]), (standardised questionnaires: []), ( stress: [fndg]), ( service provision: []), (behaviour: [inbe]), (presence: [qnco]), (severity: []), (asd traits: [cgab]), (group: [popg]), (young people: [popg]), (family quality: [famg]), (son: [gngm]), (daughter: [famg]), (life scores: [clna]), (other groups: [popg]), (increased maternal stress: [menp]), (turn: [fndg]), (decreased family: [famg]), (maternal quality: [famg]), (stress: [fndg]), (individuals: [humn]), (pattern: []), (lack: []), (access: []), (rates: [qnco]), (intellectual disability: [mobd]), (sub-group: [popg]), (finding: [sosy]), (poor quality: [grpa]), (high stress: [fndg]), (interesting topic: [menp]), (further investigation: [hlca]), (receipt: []), (levels: []), (maternal stress: [menp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(asd diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')(rates of intellectual disability, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(diagnosis, 'Diagnosis')

PMCID: 4820486
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (interictal electroencephalogram (eeg) abnormalities: [fndg]), (autism spectrum disorders: [mobd]), (relationship: []), (clinical features: [clna]), (asd: [cgab]), (regressive onset: [qnco]), (aim: [phsu]), (study: [resa]), (characteristics: []), (interictal eeg abnormalities: [fndg]), (definite phenotypes: [orga]), (heterogeneity: [orga]), (awake: [fndg]), (sleep interictal eegs: [orgf]), (individuals: [humn]), (idiopathic asd: [cgab]), (history: [orga]), (seizures: [sosy]), (eeg findings: [fndg]), (respect: [socb]), (set: [menp]), (clinical variables: []), (significant associations: [menp]), (brain morphometry study: [bpoc]), (subgroup: [virs]), (patients: [podg]), (eeg abnormalities: [fndg]), ((70 %): [fndg]), (focal (p: [aapp,imft]), (anterior localization (p: [aapp,imft]), (sleep (p <: [orgf]), (asd (p: [cgab]), (focal temporal localization (p: [aapp,imft]), (association: [menp]), (regressive patients: [podg]), (concurrent macrocephaly: [cgab]), (relative volumetric reduction: [npop]), (right temporal cortex (p: [bpoc]), (indeed: []), ( concurrence: []), (temporal eeg abnormalities: [fndg]), ( regression: [menp]), (macrocephaly: [cgab]), (distinct endophenotype: []), (eeg-based endophenotypes: [diap]), (complexity: [chvs]), (pathophysiologic subtypes: [patf]), (disorder: [dsyn]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s00787-015-0746-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(regressive onset, 'Onset of Symptoms')(regressive onset, 'Onset of Symptoms')

PMCID: 3544832
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (atypical face processing: [emst]), (key role: [socb]), (social interaction difficulties: [fndg]), (individuals: [humn]), (autism: [mobd]), (current fmri: [diap]), (thatcher illusion: [mobd]), (several aspects: [qnco]), (face processing: [emst]), (young adults: [aggp]), (high-functioning autism spectrum disorder (asd): [mobd]), (neurotypical controls: [sbst]), (thatcherized stimuli: [phpr]), (eyes: [bpoc]), (mouth: [bsoj]), (participants: [popg]), (pairs: []), (features: []), (inverted orientation: [menp]), (behavioral data: [inbe]), (sensitivity: [patf]), (illusion: [mobd]), (intact configural processing: [acty]), (asd: [cgab]), (attention: [menp]), (improved discrimination: [socb]), ((2): [qnco]), (activation: [acty]), (areas: []), (emotional processing; (3): [menp]), (subcortical face-processing areas: [blor]), (findings: [clna]), ( activation: [acty]), (cortical areas: [bpoc]), (emotional aspects: []), (impairments: [patf]), (deficit: [dsyn]), (social attention: [menp]), (specific cues: []), (eye-region: [blor]), (behavioral therapies: [topp]), (social skills: [socb]), (outcome: []), 
ASD Terms: (social interaction difficulties, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(atypical face processing, 'Integrated Verbal and NonVerbal Communication')(face processing, 'Integrated Verbal and NonVerbal Communication')(high-functioning autism spectrum disorder, 'Autism Phenotype')(emotional aspects, 'Emotional Traits')(face processing, 'Integrated Verbal and NonVerbal Communication')(deficit in social attention, 'Social Competence')(social skills, 'Ability to Converse in Social Settings')

PMCID: 5097108
SFARI Genes: 
Non SFARI Genes: rest, 
Named Entities: (heterogeneity: [orga]), (behavioral manifestation: [inbe]), (autism spectrum disorders: [mobd]), (model: []), (understanding: [menp]), (dynamic differences: [qnco]), (neural processing: [acty]), (asd: [cgab]), ((td) populations: [popg]), (network approach: [popg]), (characterization: [acty]), (spatiotemporal dynamics: [npop]), (eeg data: [diap]), (td: []), (asd youths: [cgab]), (eeg: [diap]), (wakeful rest: [menp]), (state): []), (socialvisual task: []), (cross-correlation analysis: [inpr,resa]), (32-channel time series: []), (weighted: [orga]), (undirected graphs: []), (functional brain networks: [bpoc]), (stability: []), (networks: []), (novel use: []), (l1-norm: [fndg]), (matrix entries: [phsu]), (distance): [qnco]), (number: [qnco]), (stable networks: []), (condition: [dsyn]), (task condition: [dsyn]), (populations: [popg]), (state: []), (time: []), (children: [aggp]), (td children; networks: [aggp]), (asd children: [cgab]), (diameter: [qnco]), ( indicative: []), (long-range connectivity: [qnco]), (analysis combines: [resa]), (key features: []), (microstate: []), (network analyses: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 5155168
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (autism: [mobd]), (gastrointestinal problems: []), (abdominal pain: [sosy]), ( constipation: [sosy]), (diarrhea: [sosy]), (recent years: []), (interest: [menp]), (use: []), (probiotics: [bact]), (population: [popg]), (bowel habits: [orgf]), (social functioning: [socb]), (individuals: [humn]), (gut microbiome: [orgm]), (important role: [socb]), (pathophysiology: [patf]), (functional gastrointestinal disorders: [dsyn]), (microbial modification: [orgm]), (antibiotics: [antb]), ( probiotics: [bact]), (fecal transplantation: [topp]), (treatment: [topp]), (conditions: [dsyn]), (recurrent clostridium difficile infection: [dsyn]), ( pouchitis: [dsyn]), (irritable bowel syndrome: [dsyn]), (present review: [qnco]), (number: [qnco]), (microbiome-related changes: [orgm]), (gut inflammation: [patf]), ( permeability concerns: [npop]), (absorption abnormalities: [npop]), (problems: []), (animal studies: [anim]), (potential role: [socb]), (gastrointestinal symptoms: [sosy]), 
ASD Terms: (autism, 'Autism Phenotype')(abdominal pain, 'Pain')(social functioning, 'Ability to Converse in Social Settings')(functional gastrointestinal disorders, 'Gastrointestinal Diseases')(irritable bowel syndrome, 'Irritable Bowel Syndrome')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5855319
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (recent analyses: [resa]), (trait-disorder overlap: [dsyn]), (psychiatric dimensions: [qnco]), (distinct sets: [menp]), (genes: [gngm]), (maximum influence: [qnco]), (different periods: []), (development: [orgf]), (analyses: [resa]), (social communication difficulties: [socb]), (developmental stage: []), (genetic links: [topp]), (autism spectrum disorder: [mobd]), (schizophrenia: [mobd]), (multivariate analysis framework: [qnco]), (unrelated individuals: [fndg]), (developmental profile: [lbpr]), (genetic influences: [topp]), (traits: [gngm]), (10-year period: [fndg]), (childhood: []), (adolescence: []), (quantitative social communication problems: [fndg]), (participants: [popg]), (united kingdom birth cohort (avon longitudinal study: [resa]), (parents: []), (children; age: [aggp]), (years): []), (measures: [qnco]), ( genetic architectures: [topp]), (novel multivariate genetic-relationship-matrix structural equation models: [resa]), (whole-genome genotyping information: [gngm]), (research: [resa]), ( genetic-relationship-matrix structural equation models: [resa]), (cholesky decomposition: []), (common pathway: [moft]), (independent pathway models: [moft]), (two-factor cholesky decomposition model: [qnco]), (data best: [euka]), (genetic factor: [topp]), (social communication disorder checklist: [mobd]), (development;: [orgf]), (independent variation: [fndg]), (years: []), (later: []), ( consistent: []), (distinct developmental profiles: [lbpr]), (importantly: []), (genetic factors: [fndg]), (genetic variation: [npop]), (latent factor models: []), (developmental changes: [orgf]), (genetic architecture: [topp]), (understanding: [menp]), (schizophrenia-related dimensions: [mobd]), (generally: []), (framework: []), (genetic etiologies: [topp]), (phenotypes: [orga]), (prior information: [evnt]), (respect: [socb]), (patterns: []), (continuity: []), 
ASD Terms: (social communication difficulties, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(quantitative social communication problems, 'Reciprocal Social Interaction')(social communication disorder checklist, 'Reciprocal Social Interaction')(social communication difficulties, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 6186137
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (savant syndrome: [mobd]), (condition: [dsyn]), (prodigious talent: [menp]), (developmental conditions: [mobd]), (autism spectrum conditions: [mobd]), (autistic people: [mobd]), (savant skills: [inbe]), (others: [fndg]), (groups: [popg]), (adults: autistic individuals: [mobd]), (skills: [inbe]), ( autistic individuals: [mobd]), (typical controls: []), (autism: [mobd]), (cognitive: []), (behavioural profiles: [inbe]), (participants: [popg]), (battery: [inpo]), (self-report measures: [resa]), (sensory sensitivity: [patf]), ( obsessional behaviours: [inbe]), (cognitive styles: [menp]), (autism-related traits: [mobd]), (social communication: [socb]), (systemising: []), (novel savant skillcalendar calculation: [acty]), (technical/spatial abilities: [menp]), (key aspects: [qnco]), (savant profile distinct: [lbpr]), (autism alone: [mobd]), (different approach: []), (learning: [menp]), (results: [fndg]), (unique cognitive: []), (behavioural profile: [inbe]), (autistic adults: [mobd]), (savant skill: [inbe]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0237-1) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (developmental conditions, 'Learning Disorders')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(cognitive, 'Cognitive Ability')(cognitive styles, 'Cognitive Ability')(autism, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')(autism spectrum conditions, 'Autism Phenotype')(unique cognitive, 'Cognitive Ability')

PMCID: 5485472
SFARI Genes: RAI1, RAI1, Rai1, Rai1, Rai1, Rai1, 
Non SFARI Genes: 
Named Entities: (background: autism: [mobd]), (difficulties: [fndg]), (social interaction: [fndg]), ( communication: [socb]), (repetitive behaviors;: [fndg]), (different degrees: [qnco]), (severity: []), (core areas: [bdsu]), (haploinsufficiency: [comd]), (point mutations: [comd]), (rai1: [gngm]), (smith-magenis syndrome: [dsyn]), (genetic condition: [dsyn]), (autism spectrum range: [qnco]), (social responsiveness: []), (communication: [socb]), (neurobehavioral abnormalities: [cgab]), (intellectual disability: [mobd]), (developmental delay: [mobd]), ( sleep disturbance: [dsyn]), (self-injurious behaviors: [inbe]), (methods:: []), (relationship: []), (social impairment: [patf]), (rai1+/ mice: [mamm]), (battery: [inpo]), (tests: [lbpr]), (social behavior: [socb]), (mice: [mamm]), (results:: [fndg]), (mutant mice: [mamm]), (diminished interest: [fndg]), (social odors: [npop]), (abnormal submissive tendencies: [qnco]), (repetitive behaviors: [fndg]), (type littermates: [qnco]), (conclusions:: []), (findings: [clna]), (candidate gene: [gngm]), (social behaviors: [socb]), (smith-magenis syndrome patients: [dsyn]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')(autism spectrum range, 'Autism Phenotype')(neurobehavioral abnormalities, 'Central Nervous System Diseases')(intellectual disability, 'Learning Disorders')(developmental delay, 'Learning Disorders')(sleep disturbance, 'Sleeping Problems')(self-injurious behaviors, 'Self-Injurious Behavior')(social behavior, 'Reciprocal Social Interaction')(social impairment, 'Social Competence')(showed diminished interest in social odors, 'Social Interest')(social behavior, 'Reciprocal Social Interaction')(social behaviors, 'Reciprocal Social Interaction')

PMCID: 4363528
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (eye-tracking studies: [bpoc]), (young children: [aggp]), (autism spectrum disorder (asd): [mobd]), (visual attention preference: [menp]), (geometric patterns: []), (dynamic social images: []), (dynamic geometric images: []), (present study: [qnco]), ( eye-tracking: [bpoc]), (presentations: []), (dsis: [orch]), (dgis: []), (group: [popg]), (children: [aggp]), (years: []), (asd: [cgab]), (children (tdc): [aggp]), (results: [fndg]), (control: [sbst]), (similar dsis: [orch]), (single child: [fndg]), (6-year-old children: []), (asds: [cgab]), ( therefore: []), (type: [qnco]), (visual stimuli: [ortf]), 
ASD Terms: (visual attention preference, 'Visual Thinking')(autism spectrum disorder, 'Autism Phenotype')(visual stimuli, 'Visual Thinking')

PMCID: 6031367
SFARI Genes: CACNA1C, CACNA1C, Cacna1c, Cacna1c, Cacna1c, Cacna1c, Cacna1c, Cacna1c, Cacna1c, Cacna1c, Cacna1c, Cacna1c, Cacna1c, Cacna1c, Cacna1c, Cacna1c, 
Non SFARI Genes: 
Named Entities: (cross-disorder risk gene cacna1c: [gngm]), (multiple neuropsychiatric disorders: [dsyn]), (autism spectrum disorder (asd): [mobd]), (bipolar disorder (bpd): [mobd]), (schizophrenia (scz): [mobd]), (deficits: []), (social functioning: [socb]), (major neuropsychiatric disorders: [dsyn]), (present study: [qnco]), (role: [socb]), (cacna1c: [gngm]), (disorder-relevant behavioral phenotypes: [dsyn]), (socio-affective communication: [socb]), (critical developmental period: [orgf]), (adolescence: []), (rats: [mamm]), (aim: [phsu]), (genetic cacna1c rat model: [mamm]), (reciprocal approach: []), (communication: [socb]), (ultrasonic vocalizations: [npop]), (sender: []), (receiver: []), (results: [fndg]), (deletion: [genf]), (social behavior: [socb]), (pro-social 50-khz ultrasonic communication: [aapp,bacs]), (levels: []), (50-khz ultrasonic vocalizations: [npop]), (rough-and-tumble play: [dora]), (cacna1c haploinsufficient rats: [mamm]), (reward: [menp]), (playful social interactions: [dora]), (emission: [bdsu]), ( cacna1c deletion: [genf]), (social approach behavior: [inbe]), (playback: []), (cacna1c haploinsufficiency: [comd]), (detrimental effects: []), (50-khz ultrasonic communication: [npop]), (data: [euka]), (prominent role: [socb]), (relevance: []), (asd: [cgab]), ( bpd: []), (scz: []), (article: []), (first person interview: [acty]), (first author: [qnco]), (paper: []), 
ASD Terms: (social functioning, 'Social Competence')(autism spectrum disorder, 'Autism Phenotype')(bipolar disorder, 'Bipolar Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(ultrasonic vocalizations, 'Vocalizations')(social behavior, 'Reciprocal Social Interaction')(50-khz ultrasonic vocalizations, 'Vocalizations')(playful social interactions, 'Reciprocal Social Interaction')(50-khz ultrasonic vocalizations, 'Vocalizations')(social approach behavior, 'Reciprocal Social Interaction')

PMCID: 5056356
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (spontaneous face-to-face interactions: []), (mothers: [famg]), (children: [aggp]), (crucial roles: [socb]), (development: [orgf]), (social minds; however: [menp]), (inter-brain dynamics: [bpoc]), (pilot study: [resa]), (meg: [horm,orch,phsu]), (mu suppression: [qnco]), (face-to-face spontaneous non-linguistic interactions: []), (autism spectrum disorder (asd): [mobd]), (meg hyperscanning system (i.e.: [horm,orch,phsu]), (simultaneous recording): []), (results: [fndg]), (significant correlations: [qnco]), (index: [qnco]), (mu suppression (ims): [qnco]), (right precentral area: []), (traits (or severity): [gngm]), (asd: [cgab]), ((meg data: [horm,orch,phsu]), (motion noise): [phpr]), (addition: []), (ims values: []), (strong mu suppression): [qnco]), (behavioral contingency: [topp]), (cross correlations: [qnco]), (magnitude: [qnco]), (mother: [famg]), (child head-motion: [npop]), (meg recordings: [horm,orch,phsu]), (result: [fndg]), (head motions: [npop]), (childs head: [aggp]), (magnitudes: [qnco]), (mothers precentral area: [famg]), (further studies: [lbpr]), (sample sizes: [sbst]), (typical interactions: []), 
ASD Terms: (development of social minds, 'Ability to Converse in Social Settings')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5327534
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (young individuals: [humn]), (anorexia: [dsyn]), (nervosa (an): []), (an display impairments: [patf]), (social function: [socb]), (however: []), (controls: [sbst]), (respect: [socb]), (neurocognitive performance: [inbe]), (functions: [phsf]), (individuals: [humn]), (an: []), (young females: [orga]), (first-episode an: []), (adolescent-onset an: [qnco]), (control individuals: [humn]), (comorbid autism spectrum disorder: [fndg]), (performance: [inbe]), (participants: [popg]), (groups: [popg]), (neurocognitive functions: [phsf]), (social functioning: set-shifting: [socb]), ( local processing: [acty]), ( processing speed: [acty]), (memory: [menp]), (attention: [menp]), ( verbal memory: [menp]), (verbal abstraction: []), (further: []), (association: [menp]), (neurocognitive function: [phsf]), (autism diagnostic observation schedule (ados): [hlca]), (ordinal logistic regression model: [inpr,qnco]), (first: [qnco]), ( participants: [popg]), (second: [qnco]), (neurocognitive function verbal memory: [phsf]), (verbal memory: [menp]), (odds: []), (impaired social function: [socb]), (diagnostic group: [popg]), (significant factor: [qnco]), (absence: [anab]), (interaction: []), (group: [popg]), (group membership: [popg]), 
ASD Terms: (social function, 'Social Competence')(neurocognitive performance, 'Cognitive Ability')(comorbid autism spectrum disorder, 'Comorbidities')(neurocognitive functions, 'Cognitive Ability')(social functioning, 'Ability to Converse in Social Settings')(memory, 'Working Memory')(verbal memory, 'Working Memory')(neurocognitive function, 'Cognitive Ability')(autism diagnostic observation schedule, 'Autism Phenotype')(neurocognitive function, 'Cognitive Ability')(neurocognitive function verbal memory, 'Cognitive Ability')(verbal memory, 'Working Memory')(impaired social function, 'Social Competence')(verbal memory, 'Working Memory')

PMCID: 4103818
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum conditions (asc): [mobd]), (heterogeneous impairments: [orga]), (social reciprocity: [socb]), (sensory processing: [ortf]), (voices: [orgf]), (relevant information: []), (whether voice processing: [orgf]), (impaired remains: []), (study: [resa]), (mismatch negativity (mmn): [fndg]), (syllables: []), (nonvocal sounds: [npop]), (subjects: [humn]), (asc: [gngm]), (controls: [sbst]), (people: [popg]), (mmn response: [fndg]), (emotional syllables: [menp]), (reduced mmn: []), (general impairments: [patf]), (affective voice: [orgf]), (acoustic discrimination: [menp]), (weaker: [sosy]), (angry mmn amplitudes: [menp]), (autistic traits: [mobd]), (receiver operator: [humn]), (characteristic analysis: [resa]), (value: [qnco]), ((p<.001): [aapp,imft]), (results: [fndg]), (emotional voices: [orgf]), (atypical fashion: [fndg]), (automatic stage: [clna]), (processing abnormality: [fndg]), (enable social deficits: [menp]), 
ASD Terms: (heterogeneous impairments of social reciprocity, 'Social Competence')(autism spectrum conditions, 'Autism Phenotype')(relevant information, 'Ability to Convey Correct Information')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(enable social deficits in people, 'Social Competence')(enable social deficits, 'Social Competence')

PMCID: 5012044
SFARI Genes: P300, P300, 
Non SFARI Genes: 
Named Entities: (impaired: []), (social stimuli: [phpr]), (core: [bdsu]), (early symptoms: [sosy]), (autism spectrum disorder (asd): [mobd]), (however: []), (contrast: [irda]), (name processing: [acty]), (individuals: [humn]), (asd: [cgab]), (here: []), (brain activity: [phsf]), (functional connectivity: []), (recognition: [menp]), (names: []), (high-functioning asd group: [cgab]), (control group: [grup]), (eeg: [diap]), (young males: [orga]), (control individuals: [humn]), (eeg data: [diap]), (event-related potential (erp): [ortf]), (event-related desynchronization: [evnt]), (event-related synchronization (erd/s): [evnt]), (coherence: [fndg]), (direct transfer function (dtf) methods: [menp]), (categories: []), (close-others: [fndg]), ( famous: []), (unknown: []), (differences: [qnco]), (control groups: [grup]), (erp: [gngm]), ( coherence: [fndg]), (dtf: []), ( p300 (a: [aapp,bacs]), (positive erp component): [fndg]), (own-name: []), (close-others name: [fndg]), (similar whereas: []), (control participants: [popg]), ( p300: [aapp,bacs]), (other names: []), (analysis: [resa]), (disruption: []), (fronto-posterior task-related connectivity: [fndg]), (beta range frequencies: [plnt]), (moreover: []), ( dtf: []), (directionality: []), (impaired connectionsthey: []), (frontal regions: [bpoc]), (inter-group differences: [popg]), (short-range connectivity: weaker connections: [sosy]), (frontal region: [bpoc]), (connections: []), (occipital region: [bpoc]), (asd group: [cgab]), (comparison: [acty]), (findings: [clna]), (lack: []), (self-preference effect: []), (impaired functioning: []), (attentional network: [popg]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-016-0102-z) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')

PMCID: 5791309
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (neurobiological research: [resa]), (autism spectrum disorders: [mobd]), (little attention: [menp]), (brain mechanisms: [bpoc]), (repetitive behaviors: [fndg]), (interests: [menp]), (evidence: []), (imbalance: [sosy]), (brains reward system responsiveness: [menp]), (non-social stimuli: [phpr]), (social deficits: []), (rrbis: []), (thus: []), (studys central aim: [phsu]), (brain responsiveness: [bpoc]), (individual rrbi (i.e.: [diap,inpr]), (social rewards: [menp]), (social approval): [socb]), (youth: [aggp]), (asd: [cgab]), (controls (tdcs): [topp]), (functional magnetic resonance: [npop]), ((fmri) study: [diap]), (blood-oxygenation-level-dependent effect: [bdsu]), (personalized circumscribed interest rewards: [menp]), (tdc: []), (reward system: [menp]), (short video clips: [lbpr]), (reinforcement: [menp]), (instrumental incentive delay task: []), (optimization: [acty]), (tasks ecological validity: [qnco]), (line: [sbst]), (research: [resa]), (tdcs: [topp]), ( youth: [aggp]), (reward system responses: [menp]), (cis: [gngm]), (non-social realm (e.g.: []), ( video games): []), (approval): []), (additionally: []), (caudate nucleus responsiveness: [bpoc]), (social impairment: [patf]), (current data support: [euka]), (idea: []), (reward system dysfunction: [menp]), (motivation: [menp]), (diminished motivation: [fndg]), (social engagement: [fndg]), (emergence: []), (maintenance: [acty]), (non-social symptoms: [sosy]), (future treatment endeavors: [topp]), (efficacious treatment practices: [menp]), (outcomes: []), (individuals: [humn]), (families: [famg]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0195-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(social deficits, 'Social Competence')(social impairment, 'Social Competence')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(social engagement, 'Engaging in Social Conversation')(non-social symptoms of asd, 'Complaints and Indications')

PMCID: 5769200
SFARI Genes: 
Non SFARI Genes: camp, 
Named Entities: (context: youth: [aggp]), (autism spectrum disorder (asd): [mobd]), (impairment: [patf]), (ability: [orga]), (others: [fndg]), (participation: []), (groups: [popg]), ( interaction: []), (peers: [popg]), (building: []), (successful life relationships: [socb]), (aim: [phsu]), (exploratory study: [resa]), (effects: []), (novel multimodal mandala yoga program: [topp]), (emotional skills: [menp]), (youth: [aggp]), (asd: [cgab]), (subjects: [humn]), (methods: five males: [orga]), (h yoga sessions: [elii]), (week: []), (weeks: []), (multimodal mandala yoga: [topp]), (circular partner/group poses: [popg]), ( color: [npop]), (sheets: []), ( rhythmic chanting: [socb]), ( yoga cards: [topp]), (games: [dora]), (treatment: [topp]), (research institute: [orgt]), (asd social skills assessment (tssa) scores: [cgab]), (yoga sessions: [topp]), (modified facial mood scale (mfms): [blor]), (mood changes: [mobd]), (yoga class: [topp]), (sample t-tests: [lbpr]), (tssa: []), (mfms scores: [clna]), (emotional differences: [menp]), (4-week camp: [nnon,phsu]), (narrative field notes: [socb]), (significant improvement: [qnco]), (post-test: [lbpr]), (overall tssa (t(4) = 5.744: [qnco]), ( p =: [aapp,imft]), (respondent: [popg]), ((t(4) = 3.726: [fndg]), ( p: [aapp,imft]), (interaction (t(4) = 8.5: []), (affective understanding: [menp]), (perspective taking subscales: [hlca]), (= 5.171 p: [qnco]), (youth's mfms scores: [aggp]), (end: [gngm]), (pleasant: [menp]), (positive mood: [menp]), (thematic analysis: [resa]), (narrative notes: [socb]), (key factors: []), (yoga experience: (a): [topp]), (mood: [menp]), (emotional expression: [inbe]), ( (b): []), ((c): []), (teamwork skills: [inbe]), (conclusion:: []), (multimodal mandala yoga training: [topp]), (implication: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(research institute for asd social skills assessment scores, 'Ability to Converse in Social Settings')(asd social skills assessment scores, 'Ability to Converse in Social Settings')(modified facial mood scale, 'Mood')(observe mood changes, 'Emotional Swings')(social skills assessment, 'Ability to Converse in Social Settings')(overall social skills assessment = 5.744, 'Ability to Converse in Social Settings')(youth's modified facial mood scale scores, 'Mood')(positive mood, 'Mood')(mood, 'Mood')

PMCID: 4230566
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (adults: [aggp]), (autism spectrum disorder: [mobd]), (patient population: [popg]), (few treatment options: [topp]), (preliminary randomized: [resa]), (open trial: [resa]), (parallel design: [acty]), (group interventions: [popg]), (autism spectrum disorders: [mobd]), (intelligence: [menp]), (normal range:: [qnco]), (cognitive behavioural therapy: [topp]), (recreational activity: [dora]), (interventions: [hlca]), (weekly 3-h sessions: [elii]), (therapists: []), (groups: [popg]), (patients: [podg]), (total: [qnco]), (psychiatric patients: [podg]), (study: [resa]), (outcome measures: [qnco]), (quality: []), (life inventory: [diap]), ( sense: [ortf]), (coherence scale: [acty]), ( rosenberg self-esteem scale: []), (exploratory analysis: [resa]), (measures: [qnco]), (psychiatric health: [hlca]), (participants: [popg]), (treatment conditions: [dsyn]), (increased quality: [qnco]), (life: []), (post-treatment (d =: []), (p: [gngm]), (difference: [qnco]), (amelioration: []), (psychiatric symptoms: [sosy]), (dropout rate: [qnco]), (expression: [topp]), (needs: []), (understanding: [menp]), (difficulties: [fndg]), (promising treatment options: [topp]), (similar efficacy: [resa]), (common elements: [elii]), ( structure: []), (group setting: [topp]), (terms: [orgf]), (specific skills: [inbe]), (dropout: [popg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism spectrum disorders, 'Autism Phenotype')(cognitive behavioural therapy, 'Cognitive Ability')(recreational activity, 'Use of Free Time')(recreational activity, 'Use of Free Time')(cognitive behavioural therapy, 'Cognitive Ability')(cognitive behavioural therapy, 'Cognitive Ability')

PMCID: 5179566
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background:: []), (experiences: [menp]), (world: [popg]), (critical role: [socb]), (behavioral development: [orgf]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (disproportionate amount: [qnco]), (time: []), (to: []), (aspects: [qnco]), (environment: []), (nature: []), (study: [resa]), (method: [lbpr]), (visual choice: [inbe]), (hypothesis: []), (preference: []), (nonsocial sources: [fndg]), (stimulation diminishes orientation: [menp]), (attention: [menp]), (social sources: [fndg]), (stimulation: [npop]), (asd: [cgab]), (method: preferential: [lbpr]), (tasks: []), (objective measures: [qnco]), (proportion: [qnco]), (item: []), (increased preference: [qnco]), (current task: [npop]), (gaze-tracking technology: [fndg]), (patterns: []), (visual orientation: [menp]), (pairs: []), (social (faces): [blor]), (nonsocial content: [menp]), ((high autism interest: [mobd]), (low autism interest): [mobd]), (participants: [popg]), (adolescents: [aggp]), (developing; groups: [popg]), (iq: []), (gender: [orga]), (results: repeated: [fndg]), (anova: [gngm]), (individuals: [humn]), (latency: []), (first fixate: [qnco]), (social images: []), (image: []), (high autism interest image: [mobd]), (low autism interest image pairing: [mobd]), (total look time: [qnco]), (faces: [blor]), (groups: [popg]), (number: [qnco]), (average duration: [phsu]), (fixations: [topp]), (object images: []), (asd group: [cgab]), (measure: [qnco]), (nonsocial interest: [menp]), (reduced preference: []), (high autism interest images: [mobd]), (conclusions:: []), (presence: [qnco]), (look time: [orga]), (information: []), (results: [fndg]), (atypicalities: []), (social motivation: [menp]), (degree: [qnco]), (plasticity: [npop]), (social motivation accounts: [menp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(visual choice, 'Visual Thinking')(visual orientation, 'Visual Thinking')(high autism interest image, 'Autism Phenotype')(low autism interest image pairing, 'Autism Phenotype')(high autism interest images, 'Autism Phenotype')(atypicalities in social motivation, 'Social Competence')

PMCID: 4936708
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (deficits: []), (visual processing: [menp]), (autism spectrum disorder: [mobd]), ((asd) individuals: [cgab]), (atypical brain organization: [bpoc]), (function: [phsf]), (studies: [lbpr]), (asymmetric brain function: [ortf]), (asd individuals: [cgab]), (facial processing: [blor]), (neurotypical (nt) individuals: [humn]), (asd: [cgab]), (functional near-infrared spectroscopy (fnirs): [lbpr]), (first test: [qnco]), (theory: []), (patterns: []), (lateralized brain activity: [phsf]), (homologous temporal-occipital facial processing regions: [bpoc]), (observation: [hlca]), (asd group: [cgab]), (nt group: [diap]), (asd participants: [cgab]), (reduced right hemisphere asymmetry: []), (human faces: [humn]), (nt participants: [diap]), (recent behavioral reports: [inbe]), (robots: []), (verbal interaction: []), (human counterparts: [humn]), (responses: [orga]), (activation: [acty]), (group: [popg]), (exploratory: []), (groups: [popg]), (similar asymmetry patterns: []), (robot faces: [blor]), (findings: [clna]), (literature: [inpr,mnob]), (reduced asymmetry: []), (preliminary foundation: [orgt]), (future testing: []), (use: []), (different social stimuli: [phpr]), (clinical setting: []), (population: [popg]), 
ASD Terms: (visual processing, 'Visual Thinking')(autism spectrum disorder individuals, 'Autism Phenotype')(facial processing, 'Integrated Verbal and NonVerbal Communication')(homologous temporal-occipital facial processing regions, 'Integrated Verbal and NonVerbal Communication')(different social stimuli, 'Social Competence')

PMCID: 5826960
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (social cognition: [socb]), (autism spectrum disorder (asd): [mobd]), (ability: [orga]), (affect: [menp]), (successful social functioning: [socb]), (extended developmental course: [orgf]), (however: []), (neural mechanisms: []), (emotional face processing: [menp]), (asd: [cgab]), (magnetoencephalography: [diap]), (present study: [qnco]), (neural activation: [acty]), (implicit emotional face processing: [menp]), (young adults: [aggp]), (twenty-six young adults: [aggp]), (healthy controls: []), (recruited: []), (participants: [popg]), (location: [blor]), (scrambled pattern (target): [diap]), (angry face: [menp]), (emotion-related activation sources: [menp]), (emotion: [menp]), (empirical bayes beamformer (pcorr: []), (statistical parametric mapping: []), ((spm12): []), (elevated fusiform: []), ( amygdala: [bpoc]), (anterior insula: [bpoc]), (reduced anterior cingulate cortex (acc) activity: [acty]), (adults: [aggp]), (group comparisons: [popg]), (distinct neural activity: [acty]), (distinction: []), (data: [euka]), (difficulties: [fndg]), (affect processing: [menp]), (atypical recruitment: [acty]), (traditional emotional processing areas: [menp]), (early differences: [qnco]), (social reward: [menp]), (salience: []), (immature threat processing system: [acty]), (deficits: []), 
ASD Terms: (social cognition, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(successful social functioning, 'Ability to Converse in Social Settings')(emotional face processing, 'Integrated Verbal and NonVerbal Communication')(implicit emotional face processing, 'Integrated Verbal and NonVerbal Communication')(emotional face processing, 'Integrated Verbal and NonVerbal Communication')

PMCID: 4968978
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (previous studies: [lbpr]), (genetic testing: [lbpr]), (chromosomal abnormalities: [comd]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (~80%: [fndg]), (negative genetic test results (ngtrs): [fndg]), (~20%: [fndg]), (positive genetic test results: [lbpr]), (~7%: []), (mutations: [genf]), (research: [resa]), (parental age: [grpa]), (risk factor: [qnco]), (asd diagnosis: [cgab]), (study: [resa]), (genotypic variation: [orga]), (asd: [cgab]), (relationship: []), (phenotype: [orga]), (detailed clinical information: [clna]), (genotype: [orga]), (high-resolution blood chromosome: [celc]), (blood: [bdsu]), (whole-genome copy number: [gngm]), (consecutive cohort: [popg]), (subjects: [humn]), (asd (n=218): [cgab]), (ngtrs: []), (pgtrs: []), (pdnms: []), (ngtr subjects: [humn]), ((the risk: []), (recent birth year): []), (malefemale ratio: [qnco]), (pdnm subjects: [humn]), (mean parental age: [grpa]), (paternal age: []), (subjects birth (the risk: [orgf]), (pdnm increasing: []), (year: []), (parental: []), (paternal age): []), (pgtr: []), (significant improvements: [qnco]), (speech/language/communication: [socb]), (age: [orga]), (pgtr subjects: [humn]), (sociability: [socb]), (core feature: [bdsu]), ( whereas ngtr subjects: [humn]), (significant worsening: [fndg]), (different phenotypic asd subtypes: [cgab]), (need: []), (differential diagnostic classifications: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(asd diagnosis, 'Diagnosis')(different phenotypic asd subtypes, 'Autism Phenotype')

PMCID: 2940215
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (aim:: [phsu]), (last years: []), ( health-related quality: [fndg]), (life (hrqol): []), (important measure: [qnco]), (somatic medicine: [cell]), (psychiatry: []), (few reports: [hlca]), (hrqol: []), (patients: [podg]), (autism-spectrum disorder (asd): [mobd]), (study: [resa]), (asd patients: [cgab]), (iq >70: [fndg]), (self-report hrqol questionnaire: [resa]), (cross-cultural validity: [qnco]), (methods:: []), (cross-sectional study: [resa]), (twenty-six male adolescents: [aggp]), (young adults: [aggp]), (diagnosis: [fndg]), (asperger syndrome: [mobd]), (high functioning autism: [mobd]), (atypical autism: [mobd]), (german version: [popg]), (whoqol-bref hrqol questionnaire: []), (results: mean whoqol-bref: [fndg]), (global scores: [qnco]), ((sd 26.1): [imft]), ( mean whoqol-bref subscale scores: [clna]), ((sd 19.1): [imft]), (domain: []), (physical health: [orga]), ((sd 21.9): [mamm]), (psychological health: [menp]), ((sd 23.5): [qnco]), (social relationships: []), ((sd 17.4): [mamm]), (domain environment: []), (reference population: [popg]), (sample: [sbst]), (whoqol-bref domains: []), (comparison: [acty]), (reference sample: [sbst]), (individuals: [humn]), (schizophrenia spectrum disorder (ssd): [mobd]), ( hrqol: []), (domains: []), (social relations domain: [socb]), (significant association: [menp]), (vineland adaptive behavior scales: []), (skills: [inbe]), (age: [orga]), ( iq: []), (ados-g: [aapp,enzy]), (summary scores: [clna]), (conclusion: overall: []), (self-reported hrqol: [resa]), (asd: [cgab]), (healthy individuals: [humn]), (ssd: [orch,phsu]), (also: []), (daily living skills: [inbe]), (interrelationship: []), (design: [acty]), (application: [qnco]), (treatment programmes: [topp]), (importance: []), (level: [phsu]), (self-perceived hrqol: [menp]), 
ASD Terms: (asperger syndrome, 'Asperger Syndrome')(diagnosis, 'Diagnosis')(high functioning autism, 'Autism Phenotype')(atypical autism, 'Autism Phenotype')(schizophrenia spectrum disorder, 'Schizophrenia and Disorders with Psychotic Features')(vineland adaptive behavior scales, 'Adaptive Life Skills')(schizophrenia spectrum disorder, 'Schizophrenia and Disorders with Psychotic Features')

PMCID: 4633503
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (cerebellum: [bpoc]), (consistent sites: []), (abnormality: [fndg]), (autism spectrum disorder (asd): [mobd]), (cerebellar damage: [bpoc]), (risk: []), (asd symptoms: [cgab]), (cerebellar dysfunction: [dsyn]), (crucial role: [socb]), (etiology: []), (asd: [cgab]), (multiple closed-loop circuits: [qnco]), (cerebral cortical regions: [bpoc]), (social processing: [acty]), (circuits: []), (dysfunction: [dsyn]), (core asd symptoms: [cgab]), (communication deficits: [socb]), (behaviors: [inbe]), (topography: []), (sensorimotor: []), ( cognitive: []), (affective subregions: []), (new framework: []), (significance: [qnco]), (regional cerebellar findings: [bpoc]), (relationship: []), (cerebro-cerebellar circuits: [bpoc]), (further: []), (recent research: [resa]), (idea: []), (integrity: [inbe]), (cerebro-cerebellar loops: [bpoc]), (early cortical development; disruptions: [ortf]), (specific cerebro-cerebellar loops: [bpoc]), (specialization: []), (cortical regions: [bpoc]), (motor control: [sbst]), ( language: [lang]), (social interaction: [fndg]), (impairments: [patf]), (domains: []), (concept: []), ( structural: []), (functional differences: [qnco]), (sensorimotor regions: []), (deficits: []), (repetitive: []), ( communication: [socb]), (social impairments: [patf]), (atypical activation: [acty]), (structure: []), (underpinning language: [lang]), (social cognition: [socb]), (finally: []), (evidence: []), (structural: []), ( functional: []), (connectivity neuroimaging studies: [diap]), (cerebellar right crus i/ii abnormalities: [inch]), (severe asd impairments: [cgab]), (cerebellar abnormalities: [fndg]), (optimization: [acty]), (function: [phsf]), (specific cerebro-cerebellar circuits: [bpoc]), 
ASD Terms: (asd symptoms, 'Complaints and Indications')(autism spectrum disorder, 'Autism Phenotype')(core asd symptoms, 'Complaints and Indications')(cognitive, 'Cognitive Ability')(cognitive, 'Cognitive Ability')(social interaction, 'Reciprocal Social Interaction')(deficits in motor control, 'Motor Skills')(stereotyped behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(social impairments, 'Social Competence')(social cognition, 'Cognitive Ability')

PMCID: 4860197
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (studies: [lbpr]), (reality monitoring (rm): [resa]), (medial prefrontal cortex (mpfc): [celc]), (external information: []), (region: []), (autism-related deficits: [mobd]), (self-referential information processing: [menp]), ( executive function: [menp]), (memory: [menp]), (study: [resa]), (rm conditions: [dsyn]), (rm: [blor]), (metamemory: [menp]), (adults: [aggp]), (autism: [mobd]), (autism group: [mobd]), (deficit: [dsyn]), (source conditions: [dsyn]), (groups: [popg]), (self-encoding benefit: [qnco]), (recognition: [menp]), (source memory: [menp]), (perceived-imagined information: [menp]), (self-other information: []), (therefore: []), ( reality monitoring: [resa]), (function: [phsf]), ( appear: []), (difficulty: [fndg]), (external details: []), (past events: [evnt]), 
ASD Terms: (self-referential information processing, 'Ability to Convey Information')(executive function, 'Executive Function')(memory, 'Working Memory')(autism, 'Autism Phenotype')(autism group, 'Autism Phenotype')(source memory, 'Working Memory')

PMCID: 5082922
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (social cognition impairments: [patf]), (basic disease mechanisms: [dsyn]), (progress: []), (absence: [anab]), (animal models: [anim]), (behavioral phenotypes: [bhvr]), (rhesus monkeys: [mamm]), (ideal model organism: [orgm]), (barrier: []), (social: []), ( possess: [mobd]), (complex social cognition abilities: [socb]), (exhibit: []), (pronounced individual differences: [menp]), (social functioning: [socb]), (moreover: []), (low-social (ls): [qnco]), (high-social (hs) adult male monkeys: [mamm]), (social motivation: [menp]), (social skills: [socb]), (known: []), ( however: []), (social deficits: []), (goals: []), (study: [resa]), (juvenile ls: [aggp]), (hs monkeys: [mamm]), (infants: [aggp]), (ability: [orga]), (social information: []), (infant social abilities: [socb]), (social classification (i.e.: [diap,inpr]), ( ls: []), (hs): []), (order: [acty]), (identification: [menp]), (monkeys: [mamm]), (risk: []), (poor social outcomes: [fndg]), (social classification: []), (n =: [aapp,imft]), (ls: []), (hs male monkeys: [mamm]), (years: []), (age: [orga]), (part: [qnco]), (colony-wide assessment: [acty]), ( tests: [lbpr]), (face recognition memory: [menp]), (social signals: [phpr]), (hs: [gngm]), (impairments: [patf]), (species-typical adaptive ability: [orga]), (avert: []), (scenes: []), (conspecific aggression: [mobd]), (additionally: []), ( multivariate: []), (logistic regression: [resa]), (infant social ability measures: [socb]), (findings: [clna]), (early capacity: [qnco]), (important social information: []), (differences: [qnco]), (rhesus monkeys motivation: [mamm]), (competence: []), (social relationships: []), (life: []), (further development: [orgf]), (model: []), (novel biological targets: [diap]), (intervention: [hlca]), (social outcomes: []), (at-risk young monkeys: [mamm]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social cognition impairments, 'Social Competence')(social functioning, 'Social Competence')(complex social cognition abilities, 'Ability to Converse in Social Settings')(social skills, 'Ability to Converse in Social Settings')(social deficits, 'Social Competence')(infant social abilities, 'Ability to Converse in Social Settings')(years of age, 'Onset of Symptoms')(face recognition memory, 'Working Memory')(conspecific aggression, 'Aggressive Behavior')(species-typical adaptive ability, 'Adaptive Life Skills')(infant social ability measures, 'Ability to Converse in Social Settings')(maintain social relationships later in life, 'Relating to Others')

PMCID: 5048207
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (core deficits: [bdsu]), (social functioning: [socb]), (neurodevelopmental disorders: [mobd]), (identification: [menp]), (development: [orgf]), (effective pharmacological interventions: [hlca]), (recent data: [euka]), (intriguing possibility: []), (class: []), (lipid neuromodulators: [bacs]), (regulation: [biof]), (neurotransmitter release: [celf]), (species-typical social functioning: [socb]), (systematic study: [resa]), (endogenous cannabinoid: [bacs,orch]), (could: []), (therefore: []), ( yield: []), (novel approaches: []), (neurobiological underpinnings: []), (atypical social functioning: [socb]), (article: []), (critical review: []), (major components: []), (endogenous cannabinoid system: [bacs,orch]), (primary receptors: [aapp,rcpt]), (effectors9-tetrahydrocannabinol: [orch,phsu]), ( cannabidiol: [orch,phsu]), ( anandamide: [bacs,orch]), (contributions: [acty]), (cannabinoid: [orch,phsu]), (data: [euka]), (context: [fndg]), (research domain criteria: [resa]), ((for example: []), ( anxiety: [mobd]), (chronic stress: [fndg]), ( reward learning: [menp]), (memory: [menp]), ( affiliation: []), (attachment: [acty]), (social communication): [socb]), (interrogation: []), (diagnostic categories: [fndg]), (empirical evidence: []), (role: [socb]), (pathophysiology: [patf]), (deficits: []), (brain disorders: [dsyn]), (autism spectrum disorder: [mobd]), ( schizophrenia: [mobd]), (major depressive disorder: [mobd]), (posttraumatic stress disorder: [mobd]), (bipolar disorder: [mobd]), (moreover: []), (findings: [clna]), (exceptional promise: []), (biological marker of: [clna]), (potential treatment target: [diap]), (impairments: [patf]), 
ASD Terms: (social functioning, 'Social Competence')(neurodevelopmental disorders, 'Learning Disorders')(species-typical social functioning, 'Ability to Converse in Social Settings')(atypical social functioning, 'Social Competence')(social functioning, 'Social Competence')(autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(major depressive disorder, 'Depressive Disorder')(posttraumatic stress disorder, 'Post-Traumatic Stress Disorders')(bipolar disorder, 'Bipolar Disorder')(social functioning, 'Social Competence')

PMCID: 5870494
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (adults: [aggp]), (autism spectrum disorders: [mobd]), (experience challenges: [hlca]), (labour market: []), (struggle: []), (appropriate professional positions: []), (impairments: [patf]), (communication: [socb]), (social interaction: [fndg]), (studies: [lbpr]), (high rates: [qnco]), (unemployment: [fndg]), (evidence: []), (inadequate employment: []), (knowledge: []), (participation: []), (german labour market: [popg]), (aim: [phsu]), (study: [resa]), (employment status: [fndg]), ( type: [qnco]), (occupation: []), (sample: [sbst]), (disabled adults: [aggp]), (asd: [cgab]), (germany: []), (cross-sectional-survey: [resa]), (late-diagnosed adults: [aggp]), (level: [phsu]), (formal education: [edac]), (training: [edac]), (postal questionnaire: []), (practised occupation: []), (participants information: [popg]), (skill levels: [inbe]), (classification: []), (occupations: []), (german federal employment agency: [orgt]), (participants level: [phsu]), (response rate: []), ((n: [aapp,imft]), (n =: [aapp,imft]), (potential participants): [popg]), (years: []), (age: [orga]), (older: []), (general university: [mnob,orgt]), (entrance-level qualification: [phsu]), (masters: []), (vocational qualification: []), (time: []), (these: []), (health reasons: []), (proportion: [qnco]), (participants: [popg]), (occupational area health: []), (social sector: []), ( teaching: [edac]), (education (22.4%: [fndg]), (respectively): []), (respect: [socb]), (relation: [socb]), (longest-practised occupation: []), (current occupation: [npop]), (percentage: [qnco]), (overeducation: []), (general population: [popg]), (high formal qualifications: [qnco]), (rates: [qnco]), ( early retirement: [fndg]), (employment support programs: []), (employment outcomes: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s12888-018-1645-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders experience challenges, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(occupation, 'Job Performance')(occupation, 'Job Performance')(occupations, 'Job Performance')(practised occupation, 'Job Performance')(years of age, 'Onset of Symptoms')(occupational area health, 'Job Performance')(longest-practised occupation, 'Job Performance')(current occupation, 'Job Performance')

PMCID: 4832089
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (state: []), (fmri (rs-fmri): [diap]), (biomarkers: [clna]), (psychiatric illnesses: [mobd]), ( analytical choices: [inbe]), (seed size: [plnt]), (placement: [hlca]), (variable findings: [clna]), (seed placement: [plnt]), (rs-fmri studies: [diap]), (autism spectrum disorder (asd): [mobd]), (individuals: [humn]), (asd: [cgab]), (variable network topographies: [popg]), (here: []), (novel pipeline: []), (rs-fmri: [diap]), (cingulate cortex: [bpoc]), (exemplar anatomical region: [blor]), (interest: [menp]), (seeds: [plnt]), (previous literature: [inpr,mnob]), (gross morphology: [clna]), (combination: [fndg]), (task-dependent functional connectivity: []), ((meta-analytic connectivity modeling): [resa]), (subregions: []), (unique connectivity fingerprints: []), (diverse behavioural profiles: [inbe]), (parcellation: []), (groups: [popg]), (detection): [topp]), (organisation: [orgt]), (cortico-cingulo connections: []), (however: []), (results: [fndg]), (age-related increase: [orga]), (connectivity: []), (anterior middle cingulate cortex: [bpoc]), (right lateral prefrontal cortex: [bpoc]), ( whilst: []), (controls: [sbst]), (group  grey matter (gm): [tisu]), (anterior cingulate cortex: [bpoc]), (rectal gyrus: [bpoc]), (concert: []), (rectal gyrus gm: [antb,orch]), (approach: []), (methods: []), (network detection: [popg]), (ability: [orga]), (group differences: [popg]), (mm radius: [bpoc]), (varies: []), (multi-modal approach: [qnco]), (disrupted cortico-cingulo circuits that: []), (task-dependent information: []), (asd deficits: [cgab]), (attention: [menp]), (social interaction: [fndg]), (moreover: []), (sensitive approaches: [patf]), (reproducible connectivity-based biomarkers: [clna]), (psychiatric disorders: [mobd]), 
ASD Terms: (psychiatric illnesses, 'Mental Disorders')(autism spectrum disorder, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(psychiatric disorders, 'Mental Disorders')

PMCID: 4766445
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (ample behavioral evidence: [inbe]), (diminished orientation towards: [menp]), (presence: [qnco]), (face perception impairments: [menp]), (autism spectrum disorder (asd): [mobd]), (underlying mechanisms: []), (deficits: []), (face-like object stimuli: [blor]), (pareidolia: []), ((td) individuals: [humn]), (effect: []), (global face-like configuration: [blor]), (orientation: [menp]), (perceptual processes: [phpr]), (young children: [aggp]), (asd: [cgab]), (age-matched td controls: [sbst]), (td children: [aggp]), (first towards: [qnco]), (upright face-like objects: [blor]), (children: [aggp]), (orientation bias: [menp]), (however: []), (stimuli: [phpr]), (groups: [popg]), (time: []), (upright face-like object: [blor]), (face: [gngm]), (results: [fndg]), (agreement: [socb]), (abnormal social orienting: [qnco]), (abnormal tuning: [qnco]), (subcortical pathway: [moft]), (poor orienting: [grpa]), (attention towards: [menp]), (generic face holistically: [blor]), (holistic processing: [acty]), 
ASD Terms: (face perception impairments, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(agreement with abnormal social orienting, 'Social Competence')(abnormal social orienting, 'Social Competence')

PMCID: 4635003
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (background: []), (study: [resa]), (impact: [gngm]), (socioeconomic status: []), (autism spectrum disorders: [mobd]), (severe intellectual disabilities (id): [mobd]), (results: [fndg]), (recent european studies: [lbpr]), (reports: [hlca]), (united states: []), (low socioeconomic status: [qnco]), (risk: []), (asd: [cgab]), (intellectual disabilities: [mobd]), (links: []), (severity: []), (prevalence: [qnco]), (asd (with: [cgab]), (id): [lbpr]), (severe id: [lbpr]), (children: [aggp]), (severe id (iq <50): [fndg]), (years: []), (french population-based registry: [qnco]), (inclusions: [celc]), (clinical diagnoses: []), (medical records: [clna]), (international classification: []), (diseases: [dsyn]), (revision: [topp]), (indicators: [irda]), (block census level: [qnco]), (population: [popg]), (childs area: [aggp]), (residence: []), (measures: [qnco]), (deprivation: []), ( employment: []), ( occupation: []), (education: [fndg]), ( immigration: [acty]), (family structure: [famg]), (prevalences: [qnco]), (groups: [popg]), (census units: [qnco]), (tertiles: []), (socioeconomic level: [phsu]), (general population: [popg]), (associated id: [lbpr]), (areas: []), (level: [phsu]), (percentage: [qnco]), (unemployed adults: [fndg]), ( persons: [popg]), (diploma: []), ( immigrants: [popg]), (single-parent families: [famg]), (association: [menp]), (occupational class: []), (id: [lbpr]), (immigrants: [popg]), (other socioeconomic indicators: []), (disadvantaged groups: [popg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(severe intellectual disabilities, 'Learning Disorders')(intellectual disabilities, 'Learning Disorders')(children with severe intellectual disabilities, 'Learning Disorders')(medical records, 'Medications')(occupation, 'Job Performance')(occupation, 'Job Performance')(occupational class, 'Job Performance')

PMCID: 6085410
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (neuronal mechanisms: [imft]), (aggression: [mobd]), (patients: [podg]), (autism spectrum disorder (asd): [mobd]), (treatments: [topp]), (prognosis: [hlca]), (neuroligin-3 (nl3)r451c: [aapp,rcpt]), (model: []), (asd: [cgab]), (aggressive phenotype: [mobd]), (biological mechanisms: []), (behavior: [inbe]), (nl3r451c mice: [mamm]), (excitatory: []), (inhibitory synaptic activity: [acty]), (hippocampus: [bpoc]), (somatosensory cortex: [bpoc]), (amygdala: [bpoc]), (role: [socb]), (aggressive behavior: [mobd]), (potential changes: [qnco]), (synaptic activity: [acty]), (region: []), (mice: [mamm]), (r451c mutation: [genf]), (congenic background strain: [anim]), (endocannabinoids influence: [bacs,orch]), (social interaction: [fndg]), (effects: []), (cannabinoid receptor: [aapp,rcpt]), ((cb1) agonist: [phsu]), (amplitude: []), (miniature excitatory: []), (postsynaptic currents: [ortf]), (concomitant decrease: [qnco]), (inhibitory postsynaptic currents: [ortf]), (basolateral amygdala: [bpoc]), (importantly: []), (nl3r451c: []), (c57bl/6 background strain exhibit: [menp]), (non-sedating doses: [qnco]), (mg/kg): [qnco]), (cb1 receptor agonist win55: [aapp,rcpt]), (212-2 (win): [gngm]), (significant reduction: [npop]), (findings: [clna]), (nl3r451c mouse model: [emod]), (useful preclinical tool: []), (cb1 receptor function: [aapp,rcpt]), 
ASD Terms: (aggression, 'Aggressive Behavior')(autism spectrum disorder, 'Autism Phenotype')(aggressive phenotype, 'Aggressive Behavior')(aggressive behavior, 'Aggressive Behavior')(social interaction, 'Reciprocal Social Interaction')(aggressive behavior, 'Aggressive Behavior')(aggressive behavior, 'Aggressive Behavior')

PMCID: 4585508
SFARI Genes: 
Non SFARI Genes: pole, 
Named Entities: (potential source: [fndg]), (heterogeneity: [orga]), (autism: [mobd]), (spectrum conditions: [dsyn]), (language development: [menp]), (ability: [orga]), (high-functioning male adults: [aggp]), (asc: [gngm]), (variations: []), (current structural language: [lang]), (current neuroanatomy: [npop]), (groups: [popg]), (language delay: [fndg]), (early social reciprocity: [socb]), (current language: [lang]), (current autistic features: [mobd]), (total gray matter (gm): [tisu]), (relative volume: [qnco]), (bilateral insula: [bpoc]), ( ventral basal ganglia: [bpoc]), (right superior: []), ( middle: []), (polar temporal structures: [qnco]), (pons: [bpoc]), (medulla oblongata: [bpoc]), (adulthood: []), (significant commonality: [qnco]), (morphometric features: [lbpr]), (matched neurotypical individuals: [humn]), (increased gm volume: [antb,orch]), (bilateral temporal pole: [bpoc]), (cerebellar structures: [bpoc]), (white matter volume: [tisu]), (distributed frontal: []), (insular regions: [bpoc]), (furthermore: []), (current languageneuroanatomy correlation patterns: [npop]), (subgroups: [virs]), (high-functioning adult males: [aggp]), (neuroanatomical variations: []), (current language characteristics: [lang]), (importance: []), (specifiers: []), 
ASD Terms: (autism, 'Autism Phenotype')(language development, 'Language Development')(autism spectrum conditions, 'Autism Phenotype')(language delay, 'Language Ability')(autism spectrum, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')

PMCID: 5549436
SFARI Genes: CB1, CB1, CB1, CB1, 
Non SFARI Genes: 
Named Entities: (abstract introduction:: [hlca]), (mechanism: []), (endocannabinoid anandamide: [bacs,orch]), (action: [acty]), (oxytocin: [aapp,horm,phsu]), (neuropeptide: [aapp,bacs]), (social behavior: [socb]), (social reward: [menp]), (oxytocin signaling: [aapp,horm,phsu]), (autism spectrum disorder (asd): [mobd]), (key aspect: [qnco]), (social functioning: [socb]), (asd: [cgab]), (therefore: []), (proof: [qnco]), (principle: []), (core component: [bdsu]), (asdsocial impairmentwe: []), (endocannabinoid-enhancing compound: [bacs,orch]), (mouse models: [mamm]), (btbr: [mamm]), (fmr1/ (model: [gngm]), (fragile x syndrome): [cgab,dsyn]), (methods:: []), (three-chambered social approach test: [lbpr]), (activity: [acty]), (anandamide: [bacs,orch]), (compound urb597: [orch]), (selective inhibitor: [genf]), (hydrolase: [aapp,enzy]), (hydrolytic enzyme: [npop]), (results: remarkably: [fndg]), (faah: [gngm]), (social impairment: [patf]), (cb1 receptor blockade: [aapp,rcpt]), (prosocial action: [acty]), (faah inhibition: [acty]), (btbr mice: [mamm]), (results: [fndg]), (effects: []), (anxiety: [mobd]), (performance: [inbe]), (conclusions:: []), (anandamide activity: [bacs,orch]), (cb1 receptors: [aapp,rcpt]), (asd-related social impairment: [cgab]), (novel therapeutic target: [diap]), 
ASD Terms: (social behavior, 'Reciprocal Social Interaction')(social functioning, 'Social Competence')(autism spectrum disorder, 'Autism Phenotype')(social impairment, 'Social Competence')(anxiety, 'Anxiety Disorders')(asd-related social impairment, 'Social Competence')

PMCID: 4553147
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (empathy quotient (eq): [inbe]), (quotient (sq): [qnco]), (peoples empathizing: [popg]), (cognitive styles: [menp]), (study: [resa]), (psychometric properties: [diap]), (dutch eq: [qnco]), (sq: [qnco]), (healthy participants: [popg]), (high functioning males: [orga]), (autism spectrum disorder (n: [mobd]), (factor analysis: [qnco]), (support: []), (subscales: []), (abridged 28-item eq: cognitive empathy: [inbe]), ( emotional empathy: [inbe]), (social skills: [socb]), (valid tools: []), (cognitive style: [menp]), (healthy adults: [fndg]), (high functioning adults: [aggp]), (autism: [mobd]), (literature: [inpr,mnob]), (good cross-cultural stability: []), (eq: [qnco]), (western countries: []), (asian countries eq: [qnco]), (differences: [qnco]), 
ASD Terms: (empathy quotient, 'Empathy')(cognitive styles, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(cognitive empathy, 'Cognitive Ability')(emotional empathy, 'Empathy')(social skills, 'Ability to Converse in Social Settings')(cognitive style, 'Cognitive Ability')(autism, 'Autism Phenotype')

PMCID: 5376399
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objective social anxiety (sa): [mobd]), (common condition: [dsyn]), (communication (sc) difficulties: [socb]), (young people: [popg]), (autism spectrum disorder (asd): [mobd]), (whether sc difficulties: [fndg]), (children: [aggp]), (risk: []), (sa: [gngm]), (longitudinal design: [acty]), (present study: [qnco]), (relationship: []), (sa symptoms: [sosy]), (sc difficulties: [fndg]), (population-based sample: [popg]), (avon longitudinal study: [resa]), (parents: []), (parent-reported data: [resa]), (ages: [bacs,orch]), (years: []), (cross-lagged panel model: [gngm]), (longitudinal stability: []), (directional relationship: []), (latent sc difficulties: [fndg]), (sa constructs: [gngm]), (time: []), (significant amount: [qnco]), (variance: [qnco]), (later sa symptoms: [sosy]), (reverse relationship: []), (age: [orga]), (sex differences: [orga]), (evidence: []), (important risk factor: [qnco]), (development: [orgf]), (findings: [clna]), (potential usefulness: []), (social skills: [socb]), (effective interventions: [hlca]), (symptoms: [sosy]), (childhood: []), 
ASD Terms: (objective social anxiety, 'Anxiety Disorders')(autism spectrum disorder, 'Autism Phenotype')(social anxiety, 'Anxiety Disorders')(social anxiety symptoms, 'Anxiety Disorders')(social anxiety constructs, 'Anxiety Disorders')(social anxiety, 'Anxiety Disorders')(social anxiety, 'Anxiety Disorders')(social anxiety, 'Anxiety Disorders')(social skills, 'Ability to Converse in Social Settings')

PMCID: 6217001
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background: linking genotype: [orga]), (major aim: [phsu]), (genetics: []), (underlying biochemical mechanisms: [moft]), (many complex conditions: [dsyn]), (recent research: [resa]), (evidence: []), (relevant gene-phenotype associations: [orga]), (study: [resa]), (intellectual disability (id): [mobd]), (work: []), (distinctive gene interaction modules: [moft]), (unique enrichment patterns reflective: [menp]), (associated clinical features: [clna]), (id: [lbpr]), (methods:: []), (twelve forms: [qnco]), (monogenic id: [lbpr]), (comorbidities: []), (autism: [mobd]), (epilepsy: [dsyn]), (groups: [popg]), (secondary clinical manifestations: [neop]), (simple facial dysmorphia: [cgab]), (neurodegenerative-like features: []), (clinical prominence: []), (modest symptom overlap: [topp]), (probable etiological divergence: [qnco]), (aggregate gene interaction id network: [moft]), (phenotype subgroups: [orga]), (public database: []), (gene: [gngm]), (interactions: protein-protein: [aapp,bacs]), ( genetic: [topp]), (mrna coexpression: [bacs,nnon]), (additional annotation resources: []), (ontology: []), ( human phenotype ontology: []), ( transfac/jaspar: []), (kegg/wikipathways): []), (phenotypic enrichment patterns: [orga]), (subgroups: [virs]), (results: phenotypic analysis: [orga]), (high rates: [qnco]), (complex facial dysmorphia: [cgab]), (comorbid autism: [mobd]), (contrast: [irda]), ( neurodegenerative-like features: []), (network analysis: []), (gene groups: [gngm]), (clinical features: [clna]), (interest: [menp]), (distinctive interaction clusters: [qnco]), (unique functional enrichments: []), (gene set: [gngm]), (conclusions:: []), (data: [euka]), (specific comorbid: []), (secondary clinical features: [neop]), (genotype: [orga]), (summary: []), ( id form unique clusters: [lbpr]), (individual conditions: [dsyn]), (remarkable genotypic: [orga]), (phenotypic overlap: [orga]), 
ASD Terms: (study of intellectual disability, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(associated clinical features in intellectual disability, 'Learning Disorders')(hundred twelve forms of monogenic intellectual disability, 'Learning Disorders')(autism, 'Autism Phenotype')(comorbidities, 'Comorbidities')(monogenic intellectual disability, 'Learning Disorders')(epilepsy, 'Epilepsy')(intellectual disability network, 'Learning Disorders')(comorbid autism, 'Comorbidities')(epilepsy, 'Epilepsy')(secondary clinical features in intellectual disability, 'Learning Disorders')(specific comorbid, 'Comorbidities')(intellectual disability form unique clusters, 'Learning Disorders')

PMCID: 3360871
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (literature: [inpr,mnob]), (descriptions: []), (adaptive outcomes: []), (people: [popg]), (autism spectrum disorder (asd): [mobd]), (natural disasters: [npop]), (aim: [phsu]), (study: [resa]), (adaptive behaviour: [inbe]), (participants: [popg]), (asd: [cgab]), (year: []), (exposure: [clna]), (earthquake: [npop]), (laquila (italy): []), (unexposed peer group: [popg]), (italian form: [lang]), (vineland adaptive behaviour scales (vabs): []), (months: []), (exposed participants: [popg]), (first months: [qnco]), (earthquake (p: [npop]), (vabs dimensions): [qnco]), (however: []), (immediate intensive post-disaster intervention: [phpr]), (children: [aggp]), (adolescents: [aggp]), (autism: [mobd]), (trend: []), (partial recovery: [acty]), (adaptive functioning: []), 
ASD Terms: (adaptive outcomes, 'Adaptive Life Skills')(autism spectrum disorder, 'Autism Phenotype')(adaptive behaviour, 'Adaptive Life Skills')(exposure, 'Exposures')(vineland adaptive behaviour scales, 'Adaptive Life Skills')(autism, 'Autism Phenotype')(adaptive functioning, 'Adaptive Life Skills')

PMCID: 5371758
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (paper: []), (movement-informed perspective: [orgf]), (social attunement: []), (autism spectrum disorders: [mobd]), (background: dance movement therapy (dmt): [topp]), (psychotherapeutic intervention: [phsu]), (participants: [popg]), (asd: [cgab]), (various settings: [qnco]), (regular clinical outcome monitoring: [resa]), (outpatient setting: [podg]), (netherlands: []), (positive effects: [fndg]), (social attunement capacities: [qnco]), (young people: [popg]), (however: []), (systematic study: [resa]), (development: [orgf]), (social attunement movement behaviors: [orgf]), (dmt intervention: [bacs,orch]), (methods: a series: [qnco]), (individual cases: [qnco]), (dmt: [gngm]), (asd (mean age: [cgab]), (years.): []), (changes: [qnco]), (interpersonal movement behaviors: [orgf]), (video-based retrospective observation: [resa]), (findings: [clna]), (observation scale: [hlca]), (scale: [acty]), (applicability: []), (monitoring: [resa]), (social attunement behaviors: [socb]), (therapy: [topp]), (inventory changes: [diap]), (relevance: []), (concept: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(social attunement movement behaviors, 'Reciprocal Social Interaction')(social attunement behaviors, 'Reciprocal Social Interaction')(social attunement behaviors, 'Reciprocal Social Interaction')

PMCID: 5510039
SFARI Genes: 
Non SFARI Genes: AEs, 
Named Entities: (abstract objective: abnormal: [qnco]), (glutamatergic neurotransmission: [celf]), (pathophysiology: [patf]), (autism spectrum disorder (asd): [mobd]), (study: [resa]), (safety: [hcpp]), ( tolerability: [resa]), (efficacy: [resa]), (glutamatergic n-methyl-d-aspartate (nmda) receptor: [aapp,rcpt]), (antagonist memantine (once-daily extended-release [er]): [orch,phsu]), (children: [aggp]), (autism: [mobd]), (week trial: [resa]), (week: []), (open-label extension: [resa]), (methods: a total: [qnco]), (years: []), (age: [orga]), (diagnostic: [fndg]), (statistical manual: [inpr,mnob]), (mental disorders: [mobd]), (ed.: []), ( text revision: [topp]), ((dsm-iv-tr)-defined autistic disorder: [mobd]), ((1:1): [fndg]), (er: [gngm]), (weeks;: []), (subsequent extension trial: [resa]), (maximum memantine doses: [orch,phsu]), (body weight: [orga]), (mg/day: [qnco]), (results:: [fndg]), (serious adverse event (sae) (affective disorder: [mobd]), (memantine): [orch,phsu]), (week study: [resa]), (sae (lobar pneumonia): [dsyn]), (other aes: [gngm]), (significant changes: [qnco]), (clinical laboratory values: [hlca]), (vital signs: [clna]), (electrocardiogram (ecg): [fndg]), (significant between-group difference: [qnco]), (primary efficacy outcome: [resa]), (caregiver/parent ratings: [acty]), (social responsiveness scale (srs): [acty]), (improvement: []), (baseline: [bodm]), (groups: [popg]), (trend: []), (end: [gngm]), (week extension: []), (improvements: []), (active group: [popg]), (secondary end-points: [neop]), (communication measure: [socb]), (memantine: [orch,phsu]), (placebo (p =: [topp]), (weeks: []), (conclusions:: []), (trial: [resa]), (clinical efficacy: []), (memantine er: [orch,phsu]), (autism;: [mobd]), (tolerability: [resa]), (safety data: [hcpp]), (results: [fndg]), (future trial design: []), (population: [popg]), (investigation: [hlca]), (other clinical applications: [hlca]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(years of age, 'Onset of Symptoms')(mental disorders, 'Mental Disorders')(autistic disorder, 'Autistic Disorder')

PMCID: 4659895
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (social cognition: [socb]), (complex process: [phpr]), (integration: [genf]), (wide variety: []), (behaviors: [inbe]), (salience: []), ( reward-seeking: [menp]), ( motivation: [menp]), ( knowledge: []), (self: []), (others: [fndg]), (behavior: [inbe]), (social groups: [popg]), (surprisingly: []), ( social cognition: [socb]), (sensitive domain: [patf]), (pathology: [patf]), (variety: []), (psychiatric disorders: [mobd]), (autism spectrum disorder (asd): [mobd]), (schizophrenia (scz): [mobd]), (here: []), (convergent research: [resa]), (animal models: [anim]), (human disease: [humn]), (prefrontal cortex (pfc): [bpoc]), (key regulator: []), (disruptions: []), (prefrontal microcircuitry: []), (essential role: [socb]), (pathophysiology: [patf]), (social deficits: []), (translational perspective: [genf]), (key behaviors: [inbe]), (normal social processing: [acty]), (rodents: [mamm]), (humans: [humn]), (social motivation: [menp]), (social recognition: [menp]), (dominance hierarchy: [socb]), (prefrontal circuitry: []), (social cognition deficits: [socb]), (neurodevelopmental disorders: [mobd]), (asd: [cgab]), (scz: []), (altered balance: [fndg]), (excitation: [acty]), (inhibition (e/i ratio): [inch]), (cortex generally: [bpoc]), (pfc specifically: [gngm]), (clear picture: [fndg]), (mechanisms: []), (e/i ratio: [inch]), (pfc: [gngm]), (future studies: [lbpr]), (disrupted developmental trajectory: [orgf]), (altered e/i balance: [inch]), (subsequent deficits: []), (social domain: []), 
ASD Terms: (adjusting behavior in social groups, 'Reciprocal Social Interaction')(social cognition, 'Cognitive Ability')(social cognition, 'Cognitive Ability')(psychiatric disorders, 'Mental Disorders')(autism spectrum disorder, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(social cognition, 'Cognitive Ability')(social deficits, 'Social Competence')(social cognition, 'Cognitive Ability')(social cognition deficits, 'Cognitive Ability')(neurodevelopmental disorders, 'Learning Disorders')(social cognition, 'Cognitive Ability')

PMCID: 6153399
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (heterogeneous neurodevelopmental disorder: [orga]), (impaired social interactions: [mobd]), (restrictive interests: [menp]), (repetitive stereotypic behaviors: [mobd]), (various mechanisms: [phsu]), (pathogenesis: [patf]), (asd: [cgab]), ( dysfunctions: [dsyn]), (dopaminergic signaling: [bacs,orch,phsu]), (mitochondria: [celc]), (core symptoms: [sosy]), (children: [aggp]), (however: []), (few studies: [lbpr]), (pathological association: [menp]), (dopaminergic neurons: [cell]), (patient-derived stem cells: [cell]), (vitro: []), (neurons: [cell]), (stem cells: [cell]), (deciduous teeth (shed): [bpoc]), (neural crest-derived mesenchymal stem cells: [cell]), (dental pulp: [bpoc]), (cells: [cell]), (study: [resa]), (development: [orgf]), (dn: [dsyn]), (shed: []), (patient-specific cellular model: [podg]), (neurobiology: []), (impaired neurite outgrowth: [celf]), (branching: []), (decreased mitochondrial membrane potential: [celf]), ( atp: [aapp,enzy]), (number: [qnco]), (neurites: [celc]), ( amount: [qnco]), (cell area: [gngm]), (intracellular calcium level: [celc]), (addition: []), (asd-derived dn: [cgab]), (brain-derived neurotrophic factor: [aapp,bacs]), (impairment: [patf]), (bdnf: [gngm]), (results: [fndg]), (intracerebral dopamine production: [bacs,orch,phsu]), (age: [orga]), (deciduous teeth: [bpoc]), (humans: [humn]), (years: []), (vitro analysis: [resa]), (shed-derived dn: [dsyn]), (neurobiological information: []), (treatment strategies: [menp]), (early stages: [clna]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(heterogeneous neurodevelopmental disorder, 'Learning Disorders')(impaired social interactions, 'Reciprocal Social Interaction')(restrictive interests, 'Restricted Range of Interests')(repetitive stereotypic behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 6208182
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disorder: [mobd]), (genetics: []), (key aetiological role: [socb]), (gene: [gngm]), (nad(p)h: [bacs,nnon,phsu]), (steroid dehydrogenase-like protein (nsdhl): [aapp,enzy]), (cortical neurons: [bpoc]), (glia: [cell]), (mutation: [genf]), (intellectual disability: [mobd]), (congenital hemidysplasia: []), (case presentation: []), (8-year-old boy: [aggp]), (260-kb nsdhl-containing duplication: [comd]), (xq28 (151: [celc]), (868: []), (909: []), (mother: [famg]), (clinical features: [clna]), (defects: []), (social communication: [socb]), (interaction: []), (interests: [menp]), ( attention deficit: [mobd]), (impulsive behaviour: [inbe]), (minor facial anomalies: [popg]), (serum free fatty acid abnormality: [bdsu]), (first report: [qnco]), (asd patient: [cgab]), (related nsdhl-containing duplication: [comd]), (xq28: [celc]), (further studies: [lbpr]), (case reports: []), (genetic research: [resa]), (duplication: [comd]), (neurodevelopmental diseases: [mobd]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s12881-018-0705-7) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(intellectual disability, 'Learning Disorders')(social communication, 'Reciprocal Social Interaction')(neurodevelopmental diseases, 'Learning Disorders')

PMCID: 6158250
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (psychotic experiences: [menp]), (psychosis: [mobd]), (general population studies: [resa]), (significant associations: [menp]), (polygenic risk scores (prs): [qnco]), (pes: [gngm]), (previous work: []), (significant risk: [qnco]), (social impairment: [patf]), (data: [euka]), (large longitudinal imagen cohort: [popg]), (14-year old adolescents: [aggp]), (age: [orga]), (association: [menp]), (polygenic risk: [genf]), ((increasing) impairments: [patf]), (social functioning: [socb]), (social cognitive processes: [menp]), (structural equation: []), ((sem): []), (subset: []), (participants: [popg]), (complete baseline: [bodm]), (follow-up data: [euka]), (pathways: [moft]), (high polygenic risk: [fndg]), (schizophrenia (p: [mobd]), (reduced brain activity: [phsf]), (emotional stimuli: [menp]), (social impairments: [patf]), (late adolescence (p: [aapp,imft]), (early adolescence): []), (severity: []), (pathway: [moft]), (autism spectrum disorder: [mobd]), (late adolescence: []), ((indirect pathway; p: [aapp,imft]), (findings point: [qnco]), (indirect pathways: [moft]), (different processes: [phpr]), (genetic loading: [acty]), (environment: []), (results: [fndg]), (treatments: [topp]), (prevention: [resa]), (individuals: [humn]), (genetic risk: [qnco]), (autism: [mobd]), (order: [acty]), (risk: []), 
ASD Terms: (social impairment, 'Social Competence')(social functioning, 'Social Competence')(social cognitive processes, 'Cognitive Ability')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(social impairments in late adolescence, 'Social Competence')(social impairments, 'Social Competence')(social impairments in late adolescence, 'Social Competence')(autism spectrum disorder, 'Autism Phenotype')(targeting prevention of social impairment, 'Social Competence')(autism, 'Autism Phenotype')

PMCID: 5318566
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction children: [aggp]), (autistic spectrum disorder (asd): [mobd]), (behavioural difficulties: [fndg]), (challenge: [hlca]), (parents: []), (parenting: [socb]), (theory-based parenting programmes: [socb]), (incredible years: []), (parent programmes: []), (however: []), (programmes: []), (children: [aggp]), (asd: [cgab]), (new addition: []), (iy suite: []), (iy autistic spectrum: [mobd]), (language delays: [lang]), ((iy-asld) parent programme: [phsu]), (main aims: []), (present study: [qnco]), (feasibility: []), (programme: [phsu]), (child health services: [hlca]), (initial evidence: []), (effectiveness: []), (economic costs: [qnco]), (methods: []), (analysis: [resa]), (autism: [mobd]), ( language: [lang]), (communication evaluation study (palaces) trial: [resa]), (pragmatic: [socb]), ( multicentre: []), ( pilot: [gngm]), (trial: [resa]), (iy-asld programme: [phsu]), (wait-list control condition: [topp]), (years): []), (intervention: [hlca]), (control condition: [topp]), (data: [euka]), (randomisation: [resa]), (months postrandomisation: []), (families: [famg]), (intervention condition: [dsyn]), (study: [resa]), (iy-asld: []), (limited economic evidence: [fndg]), (term: [orgf]), (important component: []), (evaluations: [hlca]), (ethics: []), (dissemination approval: []), (research ethics committee: []), (school: [mnob,orgt]), (psychology: []), ( bangor university (reference: [mnob,orgt]), (north wales research ethics committee: [popg]), ( uk (reference: []), (findings: [clna]), (research conferences: [hcpp]), (peer-reviewed journals: [hlca]), (trial registration number isrctn57070414; pre-results: [resa]), 
ASD Terms: (autistic spectrum disorder, 'Autistic Disorder')(behavioural difficulties, 'Personal Traits')(language delays parent programme, 'Language Ability')(autism, 'Autism Phenotype')

PMCID: 4555066
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (basic needs: []), (survival: [acty]), (people: [popg]), (deficits: []), (social cognition: [socb]), (abnormal behaviors: [mobd]), (many challenges: [hlca]), (social-dependent world: [popg]), (challenges: [hlca]), (limitations: []), (subjective impact: [gngm]), (many conditions: [dsyn]), (treatments: [topp]), (recent research: [resa]), (studies: [lbpr]), (non-invasive neuromodulatory techniques: []), (social plasticity: [npop]), (developmental disorders: [mobd]), (populations: [popg]), (non-invasive brain stimulation: [topp]), (promising approach: []), (social plasticity: schizophrenia: [mobd]), ( autism spectrum disorder (asd): [mobd]), (williams syndrome (ws): [cgab,dsyn]), (few studies: [lbpr]), (effects: []), (transcranial direct current stimulation (tdcs): [topp]), (transcranial magnetic stimulation (tms): [topp]), (however: []), (promising: []), (preliminary evidences: []), (review: []), (limited amount: [qnco]), (clinical interventions: [hlca]), (social cognition deficits: [socb]), (social neuroscientist arsenal: [orch,phsu]), (non-invasive brain stimulation techniques: [topp]), (rehabilitation: [topp]), (promotion: [acty]), 
ASD Terms: (social cognition, 'Cognitive Ability')(abnormal behaviors, 'Personal Traits')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorder, 'Autism Phenotype')(social cognition deficits, 'Social Competence')

PMCID: 3930918
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (evidence: []), (years: []), (behavioral research: [resa]), (testicular androgens: [horm,phsu]), (prenatal life: [aggp]), (puberty contribute: [phsf]), (masculinization: [patf]), (human behavior: [inbe]), (however: []), (behavioral significance: [inbe]), (transient activation: [acty]), (hypothalamicpituitarygonadal (hpg) axis: [bpoc]), (early postnatal life: []), (early research: [resa]), (non-human primates: [humn]), (suppression: [qnco]), (postnatal surge: []), (measurable effects: []), (later expression: [topp]), (male behavioral phenotype: [orga]), (recent research: [resa]), (laboratory: [mnob,orgt]), (postnatal testosterone concentrations: [horm,orch,phsu]), (male infant preferences: [aggp]), (social groups: [popg]), (temperament characteristics: [menp]), (development: [orgf]), (aggression: [mobd]), (later assessment: [acty]), (gender-linked behavior: [orga]), (second year: [qnco]), (life: []), ( concentrations: [menp]), (testosterone: [horm,orch,phsu]), (months: []), (age: [orga]), (choices: [inbe]), (activity levels: [fndg]), (toy play: [dora]), (concentrations: [menp]), (vocalization: [fndg]), (toddlers: [aggp]), (parental ratings: [acty]), (screening measure: [qnco]), (autism spectrum disorder: [mobd]), (findings: [clna]), (role: [socb]), (hpg axis: [bpoc]), (atypical male: [orga]), (social relations: [socb]), (future research: [resa]), (exaggerated rise: []), (testosterone secretion: [ortf]), (preterm infants: [aggp]), (exposure: [clna]), (disruptors: []), (assessment: [acty]), (gender-relevant behavioral outcomes: [orga]), (childhood disorders: [dsyn]), (sex-biased prevalence rates: [qnco]), 
ASD Terms: (aggression, 'Aggressive Behavior')(activity levels, 'Abnormal Activity or Energy Level')(vocalization, 'Vocalizations')(autism spectrum disorder, 'Autism Phenotype')(exposure, 'Exposures')

PMCID: 3693509
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (others' emotional states: [menp]), (effective social interaction: [fndg]), (facial emotion recognition tasks: [menp]), (explicit prompts: [phsu]), (real life: []), (recent attempts: [evnt]), (social cognition: [socb]), (dual process perspective: [anim]), (explicit: []), (implicit processes: [phpr]), (independently: []), (however: []), (differences: [qnco]), (methodology: []), (direct comparison: [acty]), (implicit: []), (explicit social cognition: [socb]), (challenge: [hlca]), (here: []), (new tool: []), (measure implicit: [qnco]), (explicit processing aspects: [qnco]), (complex emotions: [menp]), (facial expressions: [fndg]), (video-based tasks: []), (similar answer formats: []), (performance: [inbe]), (respective facial emotion recognition processes: face puzzle: [menp]), ( implicit: []), (tasks' sensitivity: [patf]), (atypical social cognition: [socb]), (interrelationship patterns: []), (atypical development: [orgf]), (healthy adults: [fndg]), ((nt: [diap]), ( n =: [aapp,imft]), (adults: [aggp]), (autism spectrum disorder (asd: [mobd]), (item analyses: [resa]), (good reliability: [qnco]), (new tasks: []), (group-specific results: [popg]), (sensitivity: [patf]), (social impairments: [patf]), (high-functioning asd: [cgab]), (correlation: []), (explicit socio-cognitive measures: [qnco]), (favor: [orch,phsu,vita]), (tasks' external validity: [qnco]), (between group comparisons: [popg]), (first hints: [qnco]), (differential relations: [socb]), (explicit aspects: [qnco]), (facial emotion recognition: [menp]), (asd participants: [cgab]), (increased magnitude: [qnco]), (group differences: [popg]), (implicit task: []), (speed-accuracy composite measure: [qnco]), (new face puzzle tool: [blor]), (implicit social functioning: [socb]), (instance: []), (subtle impairments: [patf]), (potential improvements: []), (social cognitive interventions: [hlca]), 
ASD Terms: (effective social interaction, 'Reciprocal Social Interaction')(facial emotion recognition tasks, 'Empathy')(social cognition, 'Cognitive Ability')(explicit social cognition, 'Cognitive Ability')(facial expressions, 'Integrated Verbal and NonVerbal Communication')(respective facial emotion recognition processes, 'Integrated Verbal and NonVerbal Communication')(autism spectrum disorder, 'Autism Phenotype')(atypical social cognition, 'Social Competence')(atypical development, 'Learning Disorders')(subtle social impairments in high-functioning asd, 'Social Competence')(social impairments, 'Social Competence')(facial emotion recognition, 'Empathy')(implicit social functioning, 'Social Competence')(social cognitive interventions, 'Cognitive Ability')

PMCID: 6339889
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (results: [fndg]), (control trial [rct; nct02301195: [resa]), ( (1)]: [fndg]), (therapeutic horseback riding (thr): [dora]), (children: [aggp]), (adolescents: [aggp]), (autism spectrum disorder (asd): [mobd]), (different riding center: [fndg]), (treatment effects: [fndg]), (differences: [qnco]), (expression: [topp]), (associations: [menp]), (problem behavior: [mobd]), (activity: [acty]), (hypothalamic-pituitary-adrenal (hpa) axis: [bdsy]), (participants: [popg]), (asd (n: [cgab]), (ages: [bacs,orch]), (years: []), (nonverbal intelligence quotient: [orga]), (10-week thr group (n: [aapp,bacs,phsu]), (horse interaction barn activity (ba) control group (n: [mamm]), (outcome measures: [qnco]), (standard speech-language sample: [sbst]), (caregiver-report: [hlca]), (aberrant: []), (social behaviors: [socb]), (participants' saliva: [bdsu]), (consistent afternoon time: []), (min' post-condition (later: [neop]), (cortisol): [horm,orch,phsu]), (intent-to-treat analysis: [menp]), (thr participants: [aapp,bacs,phsu]), (significant improvements: [qnco]), (hyperactivity: [mobd]), (social awareness: [menp]), (significance level: [resa]), (irritability: [fndg]), (social communication behaviors: [socb]), (number: [qnco]), (words: []), (new words: []), (standard language sample: [lang]), (linear mixed effects: [fndg]), (analysis: [resa]), (weekly pre-lesson irritability levels: [fndg]), (post-lesson reduction: [npop]), (salivary cortisol levels: [lbtr]), (weekly pre-lesson hyperactivity levels: [fndg]), (cortisol reduction: [fndg]), (thr group: [aapp,bacs,phsu]), (ba control group: [grup]), (findings: [clna]), (partial replication: [genf]), (prior results: [fndg]), (prior observations: [hlca]), (thr effects: [aapp,bacs,phsu]), (biobehavioral relationships: []), (cortisol: [horm,orch,phsu]), (target mediator: [aapp,bacs]), (hyperactivity behaviors: [mobd]), (youth: [aggp]), (asd: [cgab]), (clinical trial registration: trial: [resa]), (therapeutic horseback riding: [dora]), (autism spectrum disorder; http://clinicaltrials.gov: [mobd]), ( identifier: nct02301195: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(problem behavior, 'Personal Traits')(nonverbal intelligence quotient, 'IQ')(horse interaction barn activity control group, 'Conversational Skills')(social behaviors, 'Reciprocal Social Interaction')(hyperactivity, 'Overactivity')(social communication behaviors, 'Reciprocal Social Interaction')(weekly pre-lesson hyperactivity levels, 'Overactivity')(hyperactivity behaviors, 'Overactivity')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 6039957
SFARI Genes: 
Non SFARI Genes: camp, 
Named Entities: (background: autism: [mobd]), (disorder (asd) refers: [cgab]), (group: [popg]), (complex neurodevelopment disorders: [mobd]), (characteristic patterns: []), (behavior: [inbe]), (difficulties: [fndg]), (social communication: [socb]), (interaction: []), (bangladesh: []), ( autism: [mobd]), (children: [aggp]), (significant burden: [qnco]), (disease: [dsyn]), (early identification: [topp]), (asd: [cgab]), (quality: []), (life: []), (study: [resa]), (prevalence: [qnco]), (rural community children: [aggp]), (18-36 months: [fndg]), (methods: a cross sectional study: [resa]), (rural community: [popg]), (household level data: [famg]), (tool mchat: []), (final diagnosis: []), (health camp: [nnon,phsu]), (diagnosis: [fndg]), (primary screening: [diap]), (validation: [resa]), (mchat: []), (flash card: [diap]), (paediatric neurologists: []), ( child: [aggp]), (clinical psychologists: []), (development therapist: [orgf]), (diagnostic tools: [fndg]), (ados): [aapp,enzy]), (results:: [fndg]), (autism spectrum disorder (asd): [mobd]), (asd cases: [cgab]), (boys: [aggp]), (girl: [aggp]), (age range: [qnco]), (months: []), (prevalence rate: [qnco]), (cerebral palsy: [dsyn]), (developmental delay (2.6/1000): [mobd]), (conclusions: age: [orga]), (specific autism: [mobd]), ((18-36 months): [fndg]), (order: [acty]), (comprehensive information: []), (autism: [mobd]), (other age groups: [aggp]), (early detection: [diap]), (policy makers: []), (decentralization: []), (health services: [hlca]), (asd children: [cgab]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(final diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')(autism spectrum disorder, 'Autism Phenotype')(developmental delay, 'Learning Disorders')(specific autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4344805
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (lack: []), (social skills: [socb]), (reduced ability: [orga]), (common symptoms: [sosy]), (autism spectrum disorder (asd): [mobd]), (approach: []), (virtual environments: [hlca]), (natural interfaces: []), (safety skills: [hcpp]), (adults: [aggp]), (asd: [cgab]), (pedestrian skills: [popg]), (traffic lights: []), (road signs: [fndg]), (seven adults: [aggp]), (virtual environment (ve): [hlca]), (city (buildings: [clna]), (streets: []), ( squares): []), (wide screen: [hlca]), (markerless motion capture device: [npop]), (subjects movements: [orgf]), (control: [sbst]), (ve: [fndg]), (predefined vocabulary: []), (gestures: [socb]), (treatment protocol: [topp]), (ten 45-minutes sessions: [dsyn]), (session/week): [evnt]), (familiarization: []), (participants: [popg]), (vocabulary: []), (subsequent training phase: []), ( participants: [popg]), (police station: []), (pharmacy): [hlca]), (performance: [inbe]), (street: [fndg]), ((number: [qnco]), (type: [qnco]), (errors): []), (navigation: [acty]), (speed: [qnco]), ( path length: [qnco]), (ability: [orga]), (stopping): [inch,phsu]), (understanding: [menp]), (practiced skill: [inbe]), (treatment subjects: [topp]), (test questionnaire: [lbpr]), (transfer: [menp]), (skill: [inbe]), (real-life situations: []), (specific questionnaire: []), (parents/legal guardians: [popg]), (subjects personal caregivers: [humn]), (subject: [humn]), (familiarization phase: []), (problems: []), (depth perception: [menp]), (subjects: [humn]), (protocol: [fndg]), (simple body gestures: [socb]), (sessions: [evnt]), (navigation performance: [inbe]), (errors: []), (street crossing: [fndg]), (significant reduction: [npop]), (number: [qnco]), (however: []), (parents: []), (caregivers: []), (significant improvement: [qnco]), (subjects street: [humn]), (answers: []), (significant transfer: [menp]), (real-life behaviors: [inbe]), (rehabilitation: [topp]), (educational interventions: [topp]), (impact: [gngm]), (quality: []), (life: []), (results: [fndg]), (interaction: []), (ves: [dsyn]), (acquisition: [acty]), (skills: [inbe]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s12984-015-0010-z) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (lack of social skills, 'Ability to Converse in Social Settings')(autism spectrum disorder, 'Autism Phenotype')(social skills, 'Ability to Converse in Social Settings')(gestures, 'Integrated Verbal and NonVerbal Communication')(gestures, 'Integrated Verbal and NonVerbal Communication')(depth perception, 'Cognitive Ability')(simple body gestures, 'Integrated Verbal and NonVerbal Communication')

PMCID: 5663971
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (early-life institutional deprivation produces: [hcro,mnob]), (social engagement (dse): [gngm]), (childhood condition: [dsyn]), (persistence: [menp]), (dse-type behaviours: [inbe]), (into: []), ( presentation during: []), (impact: [gngm]), (adulthood: []), (issues: [fndg]), (young adult follow-up: [aggp]), (english: [lang]), (romanian adoptees study: [resa]), (total: [qnco]), (romanian adoptees: [famg]), (months: []), (children: [aggp]), (ceauescu's romanian orphanages: [mnob,orgt]), (uk adoptees: [famg]), (dse behaviours: [inbe]), ( neurodevelopmental: [ortf]), (mental health problems: [fndg]), (impairment: [patf]), (ages: [bacs,orch]), (years: []), (young adult dse behaviour: [aggp]), (early childhood deprivation: []), (sixfold increase: []), (institutions: []), (however: []), (dse: [gngm]), (autism spectrum disorder: [mobd]), (attention-deficit hyperactivity disorder symptoms: [mobd]), (itself: []), (patterns: []), (impairments: [patf]), (daily functioning: []), (young adulthood: [aggp]), (dse behaviour: [inbe]), (prominent: []), (benign: []), ( young adult feature: [aggp]), (adoptees: [famg]), (early deprivation: []), 
ASD Terms: (social engagement, 'Engaging in Social Conversation')(social engagement-type behaviours, 'Reciprocal Social Interaction')(social engagement behaviours, 'Reciprocal Social Interaction')(mental health problems, 'Mental Retardation')(social engagement behaviour, 'Reciprocal Social Interaction')(patterns of mental health problems, 'Mental Retardation')(autism spectrum disorder, 'Autism Phenotype')(attention-deficit hyperactivity disorder symptoms, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 4980803
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (extensive literature: [inpr,mnob]), (mechanisms: []), (sex bias: [socb]), (autism spectrum disorder (asd): [mobd]), (study: [resa]), (sex differences: [orga]), (asd: [cgab]), (neurofibromatosis type: [gngm]), (single-gene model: [fndg]), (syndromic autism: [mobd]), (data: [euka]), (children: [aggp]), (years: []), (autism diagnostic: [mobd]), (interview-revised (adi-r): [acty]), ( autism diagnostic observation schedule (ados): [hlca]), (verbal iq: []), ( social responsiveness scale (srs): [acty]), (conners: []), (male:female ratio: [orga]), (asd criteria: [cgab]), (deep phenotyping measures: [qnco]), (symptom profile: [lbpr]), ( males: [orga]), ((nf1) + asd: [gngm]), (reciprocal social interaction: [fndg]), (communication domains: [socb]), (adi-r: [clna]), (differences: [qnco]), (restricted: []), (repetitive behaviours: [inbe]), (domain: []), (ados: [aapp,enzy]), (nf1 asd males: [gngm]), (females: [orga]), (inattention/hyperactivity: [mobd]), (conners questionnaire: []), (significant male bias: [orga]), (prevalence: [qnco]), (nf1: [gngm]), (phenotypic profile: [orga]), (nf1 + asd cases: [gngm]), (social communication impairment: [mobd]), (males: [orga]), (implications: []), (findings: [clna]), (rationale: []), (model: []), (idiopathic asd: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(syndromic autism, 'Autism Phenotype')(autism diagnostic, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(reciprocal social interaction, 'Reciprocal Social Interaction')(repetitive behaviours domain, 'Restricted and Repetitive Behavior')(social communication impairment, 'Reciprocal Social Interaction')

PMCID: 4956181
SFARI Genes: Shank, Shank, Shank2, Shank2, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder: [mobd]), (mental illness: [mobd]), (social issue: [socb]), (autism: [mobd]), (spectrum disorder patients: [fndg]), (social isolation: [socb]), (cognitive deficits: [mobd]), (compulsive behavior: [mobd]), (sensory deficits: [dsyn]), (hyposensitivity: [fndg]), (however: []), (recent studies: [lbpr]), (autism spectrum disorder patients: [mobd]), (physiological pain response and: [fndg]), (cases: [qnco]), (intense pain response: [fndg]), (stimulation: [npop]), (recently: []), ( shank gene family: [gngm]), (genetic risk factors: []), (thus: []), (study: [resa]), (shank2/ (shank2: [gngm]), (knock-out: [emod]), ( ko) mice: [mamm]), (controversial pain sensitivity issue: [fndg]), (shank2 ko mice: [mamm]), (tactile perception: [menp]), (analgesia: [topp]), (pain: [sosy]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(mental illness, 'Mental Disorders')(social issue, 'Social Competence')(autism, 'Autism Phenotype')(cognitive deficits, 'Cognitive Ability')(compulsive behavior, 'Obsessive-Compulsive Disorder')(sensory deficits, 'Reaction to Sensory Stimuli')(autism spectrum disorder patients, 'Autism Phenotype')(physiological pain response and, 'Pain')(intense pain response, 'Pain')(autism spectrum disorder, 'Autism Phenotype')(controversial pain sensitivity issue, 'Pain')(tactile perception, 'Cognitive Ability')(chronic pain, 'Pain')

PMCID: 4265725
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (spectrum conditions (asc): [dsyn]), (deficits: []), (understanding: [menp]), (emotions: [menp]), (difficulty: [fndg]), (emotion words: [menp]), (words: []), (brain: [bpoc]), (semantic category: []), (difficulties: [fndg]), (asc predict: []), (activation: [acty]), (emotion-related words: [menp]), (limbic structures: []), (affective processing: [acty]), (semantic theories: []), (emotion actions: [menp]), (semantic relationship: []), (word: []), (emotion: [menp]), (cortical motor systems: [blor]), (facial expressions: [fndg]), (asc: [gngm]), (motor deficits: [fndg]), (atypical brain structure: [bpoc]), (function: [phsf]), (regions: []), ( motor structures: []), (reduced activation: [acty]), (emotion-semantic processing: [menp]), (event-related fmri: [diap]), (passive processing: [acty]), (comparison: [acty]), (verbs: []), (animal names: [anim]), (typically-developing controls: [sbst]), (individuals: [humn]), (reduced brain activation: [bpoc]), (control words: [sbst]), (motor areas: [blor]), (cingulate cortex: [bpoc]), (degree: [qnco]), (motor system: []), (extent: []), (autistic traits: [mobd]), (autism spectrum quotient: [qnco]), (hypoactivation: []), (motor: []), (limbic regions: []), (emotion word processing: [mcha,ocac]), (emotional language: [lang]), (role: [socb]), (sensorimotor systems: [bdsy]), (connections: []), (social-communication difficulties: [socb]), 
ASD Terms: (autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(facial expressions, 'Integrated Verbal and NonVerbal Communication')(motor deficits, 'Motor Skills')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum quotient, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')(autism spectrum conditions, 'Autism Phenotype')

PMCID: 4123873
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (ability: [orga]), (appropriate physical distance (i.e.: [hlca]), (interpersonal distance): [qnco]), (others: [fndg]), (critical aspect: [qnco]), (social interaction: [fndg]), (real-life social functioning: [socb]), (study: [resa]), (parent-report data: [resa]), (large number: [qnco]), (individuals (ages: [bacs,orch]), (years): []), (autism genetic resource exchange: [mobd]), (simons simplex collection: [bpoc]), (autism spectrum disorder (asd;: [mobd]), (space: []), (unaffected siblings: [famg]), (abnormality: [fndg]), (asd: [cgab]), (diagnostic categories: [fndg]), (clinical measures: [qnco]), (communication: [socb]), (social functioning: [socb]), (laboratory experiments: [mnob,orgt]), (sample: [sbst]), (high-functioning adults: [aggp]), (altered relationship: [fndg]), (interpersonal distance: [qnco]), (personal space: []), (complete absence: [anab]), (individuals: [humn]), (furthermore: []), (anecdotal self-report: []), (several participants: [popg]), (violations: []), (social distancing conventions: [socb]), (real-world interactions: [popg]), (adulthood: []), (atypical social distancing behavior: [socb]), (sensitive measure: [qnco]), (social dysfunction: [dsyn]), (neurological substrates: [sbst]), (further investigated: []), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(real-life social functioning, 'Ability to Converse in Social Settings')(autism genetic resource exchange, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(social functioning, 'Ability to Converse in Social Settings')(personal space, 'Awareness of Social and Personal Space')(sensitive measure of social dysfunction, 'Social Competence')(atypical social distancing behavior, 'Restricted and Repetitive Behavior')(social dysfunction, 'Social Competence')(neurological substrates, 'Neurologic Indications')

PMCID: 6210585
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background:: []), (iranian children: [aggp]), (disabilities: [fndg]), (special schools: [mnob,orgt]), (education entirely: [fndg]), (information: []), (preschool education: [edac]), (mirrors: []), (situation: []), (schools: [mnob,orgt]), (lack: []), (terms: [orgf]), (parental preferences: []), (teachers experiences: [menp]), (inclusion: [celc]), (iran: []), (method:: [lbpr]), (feasibility studies: [inpr,resa]), (parents: []), (children: [aggp]), (autism: [mobd]), (intellectual disabilities: [mobd]), (head teachers: []), (private kindergartens: [fndg]), (results: two-thirds: [fndg]), (inclusive schools;: [mnob,orgt]), (favor: [orch,phsu,vita]), (child: [aggp]), (ordinary schools: [mnob,orgt]), (specialist preschool facility: [fndg]), (justified inclusion: [celc]), (childrens rights: []), (main challenges:: [hlca]), (diverse level: [phsu]), (functioning: []), (need: []), (special devices: []), (training: [edac]), (teachers: []), (negative reactions: [fndg]), (non-disabled children: [podg]), (conclusions: further exploration: [topp]), (views: []), (practices: [menp]), (moreover: []), (preparation: [acty]), (however: []), (social values: []), (beliefs towards disabilities: [fndg]), 
ASD Terms: (autism, 'Autism Phenotype')(intellectual disabilities, 'Learning Disorders')

PMCID: 4858912
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (common genetic variants: [npop]), (autism spectrum disorder (asd): [mobd]), (duplications: []), (chromosome: [celc]), (15q11.2-q13.1 (dup15q syndrome): [dsyn]), (distinctive developmental: [orgf]), (behavioral features: [inbe]), (dup15q syndrome: [dsyn]), (social communication: [socb]), ( adaptive: []), (cognitive skills: [inbe]), (clinic-referred subjects: [popg]), (characteristics: []), (children: [aggp]), (age/iq-matched children: [aggp]), (non-syndromic asd: [cgab]), (behavior: [inbe]), (development: [orgf]), (dup15q group: [popg]), (differences: [qnco]), (number: [qnco]), (participants: [popg]), (mental age: [menp]), (months12 years: []), ( ten participants: [dsyn]), (interstitial duplications: [blor]), (active epilepsy (all isodicentric): [dsyn]), (non-verbal cognition: [menp]), ( asd characteristics: [cgab]), (autism diagnostic observation schedule (ados): [hlca]), (adaptive function: [phsf]), (vineland adaptive behavior scales (vabs): []), (group comparisons: [popg]), (dup15q: []), (asd participants: [cgab]), (duplication type: [qnco]), (epilepsy status: [dsyn]), (criteria: []), (asd; asd severity scores: [cgab]), (non-syndromic asd group: [cgab]), (ados profiles: [aapp,enzy]), (relative strength: [qnco]), (items: []), (social interest: [menp]), (motor: []), (daily living skills: [inbe]), ( children: [aggp]), (epilepsy: [dsyn]), (responsiveness: []), (context: [fndg]), (impaired motor skills: [orgf]), (important avenue: []), (intervention: [hlca]), (aggressive treatment: [mobd]), (consistent focus: []), (motor skills: [orgf]), (joint attention: [menp]), (language: [lang]), (play context: [dora]), (order: [acty]), (social communication abilities: [socb]), (longitudinal research: [resa]), (early development: [orgf]), (temporal relationships: []), (developmental domains: [orgf]), (neurological comorbidities: [clna]), (high risk: [fndg]), (neurodevelopmental disorders: [mobd]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(cognitive skills, 'Cognitive Ability')(social communication, 'Reciprocal Social Interaction')(adaptive, 'Adaptive Life Skills')(active epilepsy, 'Epilepsy')(non-verbal cognition, 'Cognitive Ability')(autism diagnostic observation schedule, 'Autism Phenotype')(adaptive function, 'Adaptive Life Skills')(vineland adaptive behavior scales, 'Adaptive Life Skills')(epilepsy status, 'Epilepsy')(autism diagnostic observation schedule profiles, 'Autism Phenotype')(social interest, 'Social Interest')(epilepsy, 'Epilepsy')(context of impaired motor skills, 'Motor Skills')(consistent focus on motor skills, 'Attention and Focus')(impaired motor skills, 'Motor Skills')(aggressive treatment, 'Aggressive Behavior')(joint attention, 'Joint Attention')(social communication abilities, 'Ability to Converse in Social Settings')(neurological comorbidities, 'Comorbidities')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 6092012
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objective/: []), (parents: []), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (difficulties: [fndg]), (selective eating behaviour: [inbe]), (study: [resa]), (intervention programme: [topp]), (asd: [cgab]), (effectiveness: []), (participants: [popg]), (years): []), (education programme: [edac]), (session: [evnt]), (approaches: []), (selective eating: [orgf]), (attitudes: [menp]), (meal times: []), (discussion: [socb]), (intervention: [hlca]), (underlying factors: []), (self-efficacy: [menp]), (significant differences: [qnco]), (degree: [qnco]), (difficulty: [fndg]), (number: [qnco]), (recommendations: []), (subjective view: []), (dietary imbalance: [sosy]), (food items: [imft,phsu]), (interventional programme: [topp]), (programme: [phsu]), (occupational therapists: []), (factors: []), (order: [acty]), (early intervention: [hlca]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(occupational therapists, 'Job Performance')

PMCID: 5697632
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (spectrum conditions: [dsyn]), (increased risk: [qnco]), (suicidality: [clna]), (however: []), (studies: [lbpr]), (autistic traits: [mobd]), (current models: [npop]), (suicidal behavior: [fndg]), (nonclinical population: [popg]), (current study: [resa]), (selfreported autistic traits interact: [mobd]), (perceived burdensomeness: [menp]), (belongingness: []), (context: [fndg]), (interpersonalpsychological theory: []), (suicide (ipts): [fndg]), (young adults: [aggp]), (years): []), (online survey: []), (measures: [qnco]), (belonging: []), (burdensomeness (interpersonal needs questionnaire): []), (autistic traits (autism spectrum quotient): [mobd]), (current depression (centre: [mobd]), (depression scale): []), (lifetime suicidality (suicide behavior questionnairerevised): [clna]), (results: [fndg]), (burdensomeness: []), (relationship: []), (depression: [mobd]), (ipts: [gngm]), (useful framework: []), (influence: []), (psychometric properties: [diap]), (diagnosis: [fndg]), (asc: [gngm]), (autism res: [mobd]), (autism research: [mobd]), (international society: [orgt]), (wiley periodicals: []), ( inc. lay summary recent research: [resa]), (people: [popg]), (high autistic traits: [mobd]), (suicide: [fndg]), (why: []), (feelings: [menp]), (world: [popg]), (burden: []), (others: [fndg]), (likelihood: [qnco]), (inclusion: [celc]), (independence: []), 
ASD Terms: (suicidality, 'Depressive Disorder')(autism spectrum conditions, 'Autism Phenotype')(suicidal behavior, 'Depressive Disorder')(suicide, 'Depressive Disorder')(current depression, 'Depressive Disorder')(lifetime suicidality, 'Depressive Disorder')(depression, 'Depressive Disorder')(suicidal behavior, 'Depressive Disorder')(suicide, 'Depressive Disorder')(autism spectrum conditions, 'Autism Phenotype')(diagnosis, 'Diagnosis')(autism res, 'Autism Phenotype')(autism research, 'Autism Phenotype')(attempt suicide, 'Depressive Disorder')

PMCID: 6122716
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (body: [humn]), (anecdotal evidence: []), (use: []), (robots: []), (unique opportunities: []), (children: [aggp]), (autism spectrum disorders: [mobd]), (however: []), (previous studies: [lbpr]), (effects: []), (interventions: [hlca]), (joint attention (ja): [menp]), (asd: [cgab]), (insufficient results: [fndg]), (studies: [lbpr]), (eyes: [bpoc]), (limitation: []), (robot: []), (human agent: [humn]), (behavior: [inbe]), (typical development (td): [orgf]), (ja elicitation task: []), (robotic agent: [chvf]), (robot commu: []), (: []), (clear eyes: [orch,phsu]), (robotic intervention: [hlca]), (age range: [qnco]), (participants: [popg]), (years: []), (sixty-eight participants: [popg]), (study: [resa]), ((10 females: [orga]), (males) children: [aggp]), ((13 females: [orga]), (td: []), (robotic intervention group: [popg]), (control group: [grup]), (ja: []), (human agent intervention: [humn]), (improved performance: [inbe]), (ja task: []), (robotic agents: [chvf]), (td children: [aggp]), (findings: [clna]), (literature: [inpr,mnob]), (impact: [gngm]), (information: []), (suitability: []), (specific robot types: []), (therapeutic use: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0230-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(joint attention, 'Joint Attention')(joint attention elicitation task, 'Joint Attention')(joint attention task, 'Joint Attention')

PMCID: 5482711
SFARI Genes: NRXN1, NRXN1, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder: [mobd]), (developmental condition: [mobd]), (early childhood onset: [fndg]), (socio-communicative functioning: [socb]), (etiology: []), (currently: []), (genomic loci: [gngm]), (susceptibility: [clna]), (unbalanced copy number variants: [nusq]), (insertions: [hlca]), (deletions: [genf]), (complex structural variants: [chvs]), (single-nucleotide variants: [fndg]), (pathological significance: [qnco]), (however: []), (phenotypes: [orga]), (genes: [gngm]), (penetrance: [qnco]), (clinical descriptions: []), (case report: [clna]), (family: [famg]), (copy number variant microdeletions: [nusq]), (regions: []), (nrxn1: [gngm]), (mbd5each: []), (association: [menp]), (risk: []), (other neurodevelopmental disorders: [mobd]), (copy number variant: [nusq]), (genomic alterations: [gngm]), (unaffected father: [famg]), (proband: [famg]), (unaffected sibling: [famg]), (family case: [famg]), (importance: []), (phenotype: [orga]), (variants: []), (same gene: [gngm]), (need: []), (such variants: []), (order: [acty]), (risks: []), 
ASD Terms: (early childhood onset, 'Onset of Symptoms')(autism spectrum disorder, 'Autism Phenotype')(developmental condition, 'Learning Disorders')(other neurodevelopmental disorders, 'Learning Disorders')

PMCID: 4375647
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (impairments: [patf]), (social communication: [socb]), (repetitive behaviors: [fndg]), (behavioral symptoms: [sosy]), (well-documented: [hlca]), ( investigations: [hlca]), (neurobiological underpinnings: []), (asd: [cgab]), (firm biomarkers: [clna]), (variability: []), (findings: [clna]), (structural neuroimaging studies: [diap]), (brain morphology: [fndg]), (individuals: [humn]), (inconsistencies: []), (heterogeneity: [orga]), (age-range: [qnco]), (participants: [popg]), (mri studies: [diap]), (previous meta-analyses: [resa]), (current study: [resa]), (coordinate-based anatomical likelihood estimation (ale) analysis: [qnco]), (voxel-based morphometry (vbm) studies: [lbpr]), (high-functioning individuals: [humn]), (meta-analysis: [resa]), ((506 asd: [cgab]), (individuals): [humn]), (results: [fndg]), (grey: [qnco]), ( white: [popg]), (global differences: [phpr]), (cortical matter: [bpoc]), (groups: [popg]), (anatomical maps: [aapp,bacs]), (concentration: [menp]), ( thickness: []), (volume metrics: [orch,phsu]), (white matter: [tisu]), (clusters: [qnco]), (age-related decreases: [orga]), (inferior temporal regions: [bpoc]), (brain: [bpoc]), (age-related increases: [qnco]), (grey matter: [tisu]), (anterior-temporal regions: [bpoc]), (white matter alterations: [patf]), (fiber tracts: [bpoc]), (key roles: [socb]), (information processing: [menp]), (sensory integration: [orgf]), (many current theories: [npop]), (pathobiology asd: [cgab]), (brains: [bpoc]), (less-functional long-range (anterior-to-posterior) connections: [qnco]), (decreased cortical matter: [bpoc]), (occipital regions: [bpoc]), (thickening: [fndg]), (frontal cortices: [bpoc]), (adults: [aggp]), (altered cortical anatomy: [bpoc]), (neurodevelopmental adaptations: [orgf]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(autism spectrum disorders, 'Autism Phenotype')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(information processing, 'Ability to Convey Information')(neurodevelopmental adaptations, 'Learning Disorders')

PMCID: 4791854
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disorder: [mobd]), (%: []), (population: [popg]), (infants: [aggp]), (sibling: [famg]), (asd: [cgab]), (significant progress: [qnco]), (emergence: []), (behavioral symptoms: [sosy]), (underlying disruptions: []), (early learning: [menp]), (recent models: []), (core aspects: [qnco]), (causal path: [lbpr]), (early infancy: []), (here: []), (social attention: [menp]), (12-month-old infants: [aggp]), (criteria: []), (months: []), (electrophysiological methods: [topp]), (reduction: [npop]), (attention engagement: [menp]), (prospective longitudinal design: [resa]), (measures: [qnco]), (visual attention (habituation): [mobd]), (brain function: [ortf]), ((event-related potentials: [ortf]), (objects): []), (relationship: []), (asd outcome: [cgab]), (high-risk infants: [fndg]), (epochs: [topp]), (visual attention: [menp]), (prolonged neural activation: [acty]), (sensitization responses: [orga]), (looking): [orga]), (months;: []), (differences: [qnco]), (findings: [clna]), (disrupted engagement: [fndg]), (sustained attention: [menp]), (social stimuli: [phpr]), (fundamental early disruptions: []), (consequences: []), (social functioning: [socb]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s11689-016-9139-8) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(early infancy, 'Perinatal History')(visual attention, 'Visual Thinking')(visual attention, 'Visual Thinking')(social functioning, 'Ability to Converse in Social Settings')

PMCID: 5565080
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objective retinal dehydrogenase: [aapp,enzy]), ((raldh1): [aapp,enzy]), (cytosolic enzyme: [celc]), (source: [fndg]), (retinoic acid (ra): [orch,phsu,vita]), (detoxification enzyme: [orgf]), (raldh1: [gngm]), (key functions: [phsf]), (midbrain dopaminergic system: [bacs,orch,phsu]), (motivation: [menp]), ( cognition: [menp]), (social behavior: [socb]), (dopamine: [bacs,orch,phsu]), (spectrum disorder (asd): [cgab]), (autistic phenotype: [mobd]), (first time: [qnco]), (levels: []), (autistic patients: [mobd]), (detoxification function: [orgf]), (4-hydroxynonenal protein: [orch,phsu]), ((4-hne pas): [orch,phsu]), (glutathione (gsh) levels: [aapp,bacs]), (moreover: []), (effect: []), (testosterone: [horm,orch,phsu]), (raldh1 expression: [aapp,enzy]), (fourth digit: [bpoc]), ((2d:4d ratio): [qnco]), (hands: [bpoc]), (exposure: [clna]), (male patients: [orga]), (asd (n=18;: [cgab]), (months): []), (healthy controls: []), (erythrocyte raldh1: [aapp,enzy]), (4-hne pas: [orch,phsu]), (gsh levels: [dsyn]), (colorimetric assays: [lbpr]), (digit lengths: [qnco]), (digital calipers: []), ((42.9%) raldh1 levels: [aapp,enzy]), (controls (p=0.032): [sbst]), (however: []), (difference: [qnco]), (4-hne pas levels: [orch,phsu]), (ratios: [qnco]), (left hand: [bpoc]), ( p=0.584: [fndg]), (right hand): [bpoc]), (autistic subjects: [mobd]), (subset: []), (low raldh1 level: [aapp,enzy]), (results: [fndg]), (low raldh1 levels: [aapp,enzy]), (dopaminergic dysfunction: [bacs,orch,phsu]), 
ASD Terms: (cognition, 'Cognitive Ability')(social behavior, 'Reciprocal Social Interaction')(exposure, 'Exposures')

PMCID: 5466762
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (fact: [gngm]), (deficits: []), (social communication: [socb]), (interaction: []), (core: [bdsu]), (autism spectrum conditions (asc): [mobd]), (study: [resa]), (individuals: [humn]), (continuum: []), (neurotypical development: [orgf]), (autism: [mobd]), (on-line: [sbst]), ( cooperative: [orgt]), (joint action task: [bsoj]), (degree: [qnco]), (autistic traits affects: [mobd]), (ability: [orga]), (motor behavior: [dora]), (joint grasping task: [bsoj]), (role: [socb]), (sixteen pairs: [qnco]), (adult participants: [aggp]), (cooperative social interactive game: [fndg]), (reach-to-grasp movements: [aapp,enzy]), (pairs: []), (asc: [gngm]), (cognitive disability: [fndg]), (alternate experimental blocks: [sbst]), (participant: [popg]), (action: [acty]), (role): [socb]), (partners action: [acty]), (adaptive condition: [dsyn]), ( participants: [popg]), (partner: [popg]), (participants: [popg]), (non-social control game: [dora]), (non-biological stimulus: [phpr]), (social interactive task: [fndg]), (autistic traits: [mobd]), (joint action: [bsoj]), (interactive role: [socb]), (non-social task: []), (predict differences: [qnco]), (movement preparation: [orgf]), (planning: [menp]), (possibility: []), (social interactive task results: [fndg]), (basic motor: []), (executive function difficulties: [menp]), (furthermore: []), (non-social game: [dora]), (first time: [qnco]), (high autistic traits: [mobd]), (stereotypical interaction style: [mobd]), (movements: [orgf]), (order: [acty]), (specifically: []), (infrequent emergence: []), (role-based motor: [socb]), (behavior modulation: [inbe]), (on-line motor cooperation: [socb]), (high autistic traits sheds light: [npop]), (numerous difficulties: [fndg]), (nonverbal social interactions: [fndg]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0141-0) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum conditions, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(cooperative social interactive game, 'Reciprocal Social Interaction')(cognitive disability, 'Cognitive Ability')(adaptive condition, 'Adaptive Life Skills')(social interactive task, 'Reciprocal Social Interaction')(social interactive task results, 'Reciprocal Social Interaction')(planning, 'Planning')(executive function difficulties, 'Executive Function')(stereotypical interaction style, 'Stereotyped, Restricted, and Repetitive Behavior')(numerous difficulties autism spectrum conditions, 'Autism Phenotype')(nonverbal social interactions, 'Non-Verbal Communication')

PMCID: 5789678
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (difficulties: [fndg]), (executive functioning (ef): [menp]), (individuals: [humn]), (range: [qnco]), (developmental disorders: [mobd]), (autism spectrum disorder (asd): [mobd]), (interventions: [hlca]), (underlying mechanisms: []), (ef: []), (development: [orgf]), (infant markers: [aggp]), (such mechanisms: []), (order: [acty]), (prospective studies: [resa]), (infants: [aggp]), (high familial risk (hr): [famg]), (asd: [cgab]), (surprising tendency: []), (hr toddlers: [aggp]), (epochs: [topp]), (attention: [menp]), (low-risk (lr) controls: [fndg]), (typical development: [orgf]), ( decreases: [qnco]), (look durations: [orga]), (end: [gngm]), (first year: [qnco]), (life: []), (executive: []), (attentiona foundational component: [orgt]), (here: []), (hypothesis: []), (visual stimuli: [ortf]), (faces): [blor]), (early differences: [qnco]), (executive attention: [menp]), (longitudinal prospective study: [resa]), (hr: [gngm]), (lr: []), (behaviour: [inbe]), (non-social visual stimuli: [ortf]), (ages: [bacs,orch]), (months: []), (age: [orga]), (years: []), (children: [aggp]), (battery: [inpo]), (clinical research measures: [resa]), (parental report: [hlca]), (effortful control (ec)a temperament trait: [menp]), (contingent: []), (previous studies: [lbpr]), (attenuated reduction: [npop]), (peak look durations: [qnco]), (hr group: [popg]), (lr group: [popg]), (ec: []), (hr-asd group: [cgab]), (line: [sbst]), ( change: [qnco]), (peak look duration: [phsu]), ( disruption: []), (early development: [orgf]), (executive attention results: [menp]), (time: []), (effects: []), (early biases: []), (towards: []), (further: []), ( attention difficulties: [menp]), (differences: [qnco]), (social information processing: [menp]), (prolonged attention: [menp]), (early indicator: [irda]), (disruption: []), (executive attention system: [menp]), (potential value: [qnco]), (risk: []), (ef difficulties: [fndg]), (evaluation: [hlca]), (intervention outcomes: [hlca]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s11689-017-9219-4) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (executive functioning, 'Executive Function')(autism spectrum disorder, 'Autism Phenotype')(executive functioning, 'Executive Function')(visual stimuli, 'Visual Thinking')(non-social visual stimuli, 'Visual Thinking')(social information processing, 'Ability to Convey Information')

PMCID: 6018411
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (neuropeptide oxytocin (oxt): [aapp,horm,phsu]), (crucial mediator: [aapp,bacs]), (parturition: [orgf]), (milk ejection: [ortf]), (major modulator: []), (various social behaviors: [socb]), (social recognition: [menp]), ( aggression: [mobd]), (parenting: [socb]), (past decade: [qnco]), (significant excitement: [menp]), (possible use: []), (oxt: [gngm]), (behavioral deficits: [inbe]), (neurodevelopmental disorders: [mobd]), (autism spectrum disorder (asd): [mobd]), (yet: []), (fast move: [fndg]), (clinical trials: [resa]), (little attention: [menp]), (possibility: []), (oxt system: []), (brain: [bpoc]), (disorders: [dsyn]), (extent: []), (such perturbations: []), (social behavior deficits: [socb]), (large-scale whole-exome sequencing studies: [gngm]), (subjects: [humn]), (asd: [cgab]), (electrophysiological studies: [diap]), (animal models: [anim]), (disorder: [dsyn]), (indicate several risk genes: [famg]), (essential role: [socb]), (brain synapses: [bsoj]), (deficits: []), (synaptic activity: [acty]), (plasticity: [npop]), (pathophysiology: [patf]), (considerable portion: []), (cases: [qnco]), (vitro: []), (vivo: []), (synaptic properties: []), (neural activity: [acty]), (circuits: []), (social behavior: [socb]), (together: []), (findings: [clna]), (failure: [inbe]), (early development: [orgf]), (indirect consequence: []), (genetic mutations: [genf]), (article: []), (evidence: []), (support: []), (hypothesis: []), 
ASD Terms: (various social behaviors, 'Reciprocal Social Interaction')(aggression, 'Aggressive Behavior')(neurodevelopmental disorders, 'Learning Disorders')(behavioral deficits, 'Personal Traits')(autism spectrum disorder, 'Autism Phenotype')(social behavior deficits, 'Personal Traits')(social behavior, 'Reciprocal Social Interaction')

PMCID: 4928826
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abnormalities: [cgab]), (tactile perception: [menp]), (sensory defensiveness: [inbe]), (common features: [qnco]), (autism spectrum disorder (asd): [mobd]), (diagnostic criterion: [fndg]), (asd: [cgab]), ( deficits: []), (tactile perception contribute: [menp]), (observed lack: []), (social communication skills: [socb]), (however: []), (influence: []), (tactile perception deficits: [menp]), (development: [orgf]), (social behaviors: [socb]), (effects: []), (neuronal circuits: [imft]), (emotional regulation: [menp]), (social interactions: [fndg]), (neonatal rodents: [mamm]), ( whiskers: [bpoc]), (important tactile apparatus: [anst]), (bilateral whisker trimming: [bpoc]), (model: []), (early tactile deprivation: [gngm]), (tactile deprivation: [gngm]), (adult behavior: [inbe]), (bilateral whisker: [bpoc]), (mice: [mamm]), (days: []), (birth (bwt10 mice): [mamm]), ( tactile discrimination: [socb]), (c-fos expression: [gngm]), (marker: [clna]), (neural activation: [acty]), (adults: [aggp]), (full whisker regrowth: [bpoc]), (adult bwt10 mice: [mamm]), (crossable distances: [qnco]), (gap-crossing test: [lbpr]), (age-matched controls: [orga]), (persistent deficits: []), (whisker-dependent tactile perception: [menp]), (contrast: [irda]), (bwt10 mice: [mamm]), (preference: []), (social compartment: []), (conspecific: []), (three-chamber test: [lbpr]), (amygdala circuitry: [bpoc]), (c-fos expression pattern: [gngm]), ( hyperactivity: [mobd]), (bwt10: []), (circuits: []), (fear/anxiety-related responses: [orga]), (stress: [fndg]), (reward stimuli: [menp]), (whisker-dependent cued learning: [menp]), (results: [fndg]), (neonatal whisker trimming: [bpoc]), (concomitant whisker-dependent tactile discrimination impairment: [socb]), (amygdala-dependent emotional regulation: [bpoc]), 
ASD Terms: (tactile perception, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(social communication skills, 'Reciprocal Social Interaction')(tactile perception contribute, 'Cognitive Ability')(tactile perception deficits, 'Cognitive Ability')(social behaviors, 'Reciprocal Social Interaction')(emotional regulation, 'Emotional Regulation and Control')(social interactions, 'Reciprocal Social Interaction')(whisker-dependent tactile perception, 'Cognitive Ability')(hyperactivity, 'Overactivity')(amygdala-dependent emotional regulation, 'Emotional Regulation and Control')

PMCID: 6061017
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (deficits: []), (autism spectrum disorder (asd): [mobd]), (impaired imaginative play: [dora]), (form: []), (imaginative play: [dora]), ((td) children: [aggp]), (imaginary companion (ic): [anim]), (occurrence: []), (ics: [cgab,dsyn]), (children: [aggp]), (asd: [cgab]), (differences: [qnco]), (parent report: [hlca]), (ic: []), (td: []), (asd populations: [cgab]), ((111: []), (asd): [cgab]), (gender-matched children: [orga]), (years: []), (findings: [clna]), (many between-group similarities: [popg]), (ic forms: []), (functions: [phsf]), (results: [fndg]), (terms: [orgf]), (qualitative differences: [qnco]), (play: [dora]), ( social attributions: [menp]), (ics minds: [cgab,dsyn]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1007/s10803-018-3540-y) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(impaired imaginative play, 'Imagination')(imaginative play, 'Imagination')

PMCID: 5823940
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (population density: [qnco]), (social interactions: [fndg]), (individuals: [humn]), (underlying neural mechanisms: []), (contrast: [irda]), ( neurotransmission: [celf]), (monoamines: [orch]), (dopamine (da): [bacs,orch,phsu]), (important roles: [socb]), (social behaviors: [socb]), (here: []), (housing density: [qnco]), (rodents: [mamm]), (non-human primates: [humn]), (groups: [popg]), (correlations: []), (japanese macaques: [mamm]), (plasma 5-ht: [dsyn]), (da: [anab]), ( concentrations: [menp]), (rhesus macaques: [mamm]), (similarly: []), ( c57bl/6: [mamm]), (plasma: [bdsu]), (brain tissue: [bpoc]), (5-ht concentrations: [bacs,orch]), (dba2 mice: [mamm]), (crowding: [socb]), ( c57bl/6 mice: [mamm]), (prominent social avoidance: [socb]), (mates: [phsu]), ( respectively: []), (elevated plasma stress hormones: [horm]), (such stress hormone elevations: [horm]), (c57bl/6 mice: [mamm]), (administration: [topp]), (parachlorophenylalanine: [aapp,phsu]), (5-ht synthesis: [bacs,orch]), (stress hormones: [horm]), (results: [fndg]), (that: []), ( animals: [anim]), (hyperserotonemia: []), (social avoidance: [socb]), (adaptive behavioral strategy: [inbe]), (stress: [fndg]), (environments: []), (disorder: [dsyn]), (autism spectrum disorder: [mobd]), 
ASD Terms: (affect social interactions, 'Reciprocal Social Interaction')(social interactions, 'Reciprocal Social Interaction')(social behaviors, 'Reciprocal Social Interaction')(social interactions, 'Reciprocal Social Interaction')(adaptive behavioral strategy, 'Adaptive Life Skills')(psychiatric disorder, 'Mental Disorders')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 4801394
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction: [hlca]), (limited research: [resa]), (autism spectrum disorders (asd): [mobd]), (females: [orga]), (empathy construct: [inbe]), (autism: [mobd]), ( little attention: [menp]), (adult women: [aggp]), (condition: [dsyn]), (differences: [qnco]), (disorder: [dsyn]), (objective self-reported empathy: [inbe]), (asd: [cgab]), (men: [gngm]), (women: [popg]), (online databases: []), (articles: []), (self-reported empathy: [inbe]), (studies: [lbpr]), (identified: [fndg]), (levels: []), (empathy: [inbe]), (developed men: [popg]), (similar levels: []), (self-reported empathic ability: [inbe]), (asd resembles: [cgab]), (male counterparts: [orga]), (hypermasculinisation: []), (large gender difference: [orga]), (general population: [popg]), (discussion: [socb]), (limitations: []), (review: []), (current diagnostic criteria: [npop]), (male-specific behaviour: [orga]), (gender: [orga]), (specific characteristics: []), (hence: []), ( women: [popg]), (male end: [orga]), (continuum: []), (suggested hypermasculinisation: []), (spectrum: [qnco]), (evident: []), (selection bias: [qnco]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(empathy construct, 'Empathy')(autism, 'Autism Phenotype')(objective self-reported empathy, 'Empathy')(self-reported empathy, 'Empathy')(empathy, 'Empathy')(empathy, 'Empathy')(empathy, 'Empathy')

PMCID: 4685527
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (psychological theories: []), (autism: [mobd]), (clinical features: [clna]), (condition: [dsyn]), (terms: [orgf]), (sensory processing impairments: [patf]), (arrival: [acty]), (domain-specific social cognitive theories: []), (focus: []), (primary: [topp]), (specific psychological impairment: [patf]), (social cognition: [socb]), (years: []), ( evidence: []), (support: []), (social cognitive: [socb]), (social attention explanations: [menp]), (however: []), (evidence: []), (general non-social cognitive impairments: [mobd]), (representational understanding: [menp]), ( attention allocation: [menp]), (sensory processing: [ortf]), (here: []), (recent findings: [clna]), (case: []), (specificity: [qnco]), (primacy: []), (social cognitive impairment: [mobd]), (valid features: []), (insights: [menp]), (integration: [genf]), (social: []), (non-social cognition: [socb]), 
ASD Terms: (autism, 'Autism Phenotype')(sensory processing impairments, 'Reaction to Sensory Stimuli')(domain-specific social cognitive theories, 'Cognitive Ability')(social cognition, 'Cognitive Ability')(social cognitive, 'Cognitive Ability')(autism, 'Autism Phenotype')(general non-social cognitive impairments, 'Cognitive Ability')(social cognitive impairment, 'Social Competence')(non-social cognition, 'Cognitive Ability')

PMCID: 2931520
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (unknown etiology: [fndg]), (recent studies: [lbpr]), (autistic children: [podg]), (functional abnormalities: [cgab]), (temporal association cortex (tea): [bpoc]), (structures: []), (trajectory: []), (postnatal development: [orgf]), (regions: []), (accelerated maturational alterations: [phsf]), (sensory recognition: [menp]), (social interaction: [fndg]), (indeed: []), (temporal association regions: [bpoc]), (last regions: []), (potential vulnerability: []), (early maturation: [aggp]), (however: []), (direct evaluation: [hlca]), (hypothesis: []), (altered time course: []), (early postnatal development: [orgf]), (asd phenotype: [cgab]), (electrophysiological: [diap]), ( histological: []), (behavioural techniques: [inbe]), (neuronal maturational promoter valproate: [orch,phsu]), (culture systems: [lbpr]), (normal developmental trajectory: [fndg]), (tea: []), (vivo: []), (brain sections: [bpoc]), (postnatal rat pups: [mamm]), (vpa: []), (cortical cells: [bpoc]), (adult-like intrinsic electrophysiological properties: [aggp]), (gross cortical hypertrophy: [bpoc]), (reduced predisposition: [clna]), (social play behaviour: [dora]), (co-manifestation: []), (functional: []), ( structural: []), (behavioural features: [inbe]), (alteration: []), (developmental time course: [orgf]), (certain high-order cortical networks: [bpoc]), (important role: [socb]), (neurophysiological basis: [phsu]), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(asd phenotype, 'Autism Phenotype')(social play behaviour, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')

PMCID: 6373531
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (interventions: [hlca]), (applied behaviour analysis: [resa]), (evidence: []), (practice: [menp]), (autism spectrum disorders: [mobd]), (shortage: [qnco]), (qualified professionals: []), (delivery: [topp]), (innovative models: [menp]), (telehealth: [hlca]), (telehealth utilises technology: [hlca]), (remote training: [edac]), (supervision: [topp]), (purpose: []), (study: [resa]), (literature: [inpr,mnob]), (aba: []), (intervention characteristics: [hlca]), ( outcomes: []), (research quality: [resa]), (studies: [lbpr]), (gaps: []), ((1) research design: [resa]), (participants (3) technology (4) dependent variables: [fndg]), (aims: [phsu]), (outcomes: []), (improvements: []), (variable: []), (quality ratings: [acty]), (implications: []), (future research: [resa]), (light: [gngm]), (identified methodological downfalls: [fndg]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(delivery, 'Perinatal History')

PMCID: 5807492
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (amygdala dysfunction: [bpoc]), (role: [socb]), (social impairments: [patf]), (autism spectrum disorders: [mobd]), (subregions: []), (asd: [cgab]), (study: [resa]), (volume: [qnco]), (functional connectivity (fc) strength: [qnco]), (fc-defined amygdala subregions: [bpoc]), (controls: [sbst]), (relation: [socb]), (social skills: [socb]), (subregion: []), (social perception network: [popg]), (asd (f1: [cgab]), (p = .008): [aapp,imft]), (symptom severity (social skills: r = .548: [socb]), ( p = .009): [aapp,imft]), (posthoc analysis: [resa]), (enlargement: [patf]), (vmpfc amygdala network: [bpoc]), (findings: [clna]), (understanding: [menp]), (abnormal amygdala connectivity: [bpoc]), (future strategies: [menp]), (therapeutic interventions: [topp]), (amygdalofrontal pathway: [moft]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(social impairments, 'Social Competence')(social skills in asd, 'Ability to Converse in Social Settings')(social skills, 'Ability to Converse in Social Settings')(social perception network, 'Cognitive Ability')(understanding of abnormal amygdala connectivity, 'Understanding Logical Progression')

PMCID: 6220918
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background/objective teacher's reports: [hlca]), (child psychopathology: []), (children's development: [orgf]), (normative peer group: [popg]), (edutea questionnaire: []), (clinicians: []), (researchers: []), (brief tool: []), (autism spectrum disorders: [mobd]), (social communication disorders: [mobd]), (school settings: []), (method:: [lbpr]), (dsm-5 criteria: []), (sample: [sbst]), (spanish schoolers: [popg]), (edutea: []), (two-factor structure: [qnco]), (high internal reliability: social communication impairments: [mobd]), (restricted behaviour patterns: [inbe]), (roc curve: [qnco]), (area: []), (curve: []), (predictive (.90): [fndg]), (cut-off score: [clna]), (high values: [qnco]), (sensitivity (87%): [patf]), ( specificity (91.2%): [qnco]), (positive predictive value (.87): [qnco]), (moderate correlations: []), (severity score: [qnco]), (autism diagnostic observation schedule (ados-2): [hlca]), (child: [aggp]), (pragmatic competence: [socb]), (conclusions:: []), (asd screening protocols: [cgab]), (schools: [mnob,orgt]), 
ASD Terms: (social communication disorders, 'Reciprocal Social Interaction')(screen autism spectrum disorders, 'Autism Phenotype')(social communication impairments, 'Reciprocal Social Interaction')(social communication impairments, 'Reciprocal Social Interaction')(restricted behaviour patterns, 'Stereotyped, Restricted, and Repetitive Behavior')(autism diagnostic observation schedule, 'Autism Phenotype')

PMCID: 5879814
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (population: [popg]), (core symptoms: [sosy]), (social development: [socb]), (children: [aggp]), (asd: [cgab]), (comorbid anxiety disorders: [mobd]), (general development: [fndg]), (quality: []), (life: []), (main goal: []), (study: [resa]), (effectiveness: []), (manualized cognitive behavioral therapy: [topp]), ((cbt) anxiety program: [dsyn]), (trial (rct): [resa]), (fifty children: [aggp]), (years: []), (group cbt: [dsyn]), (wait-list control (wl) condition: [dsyn]), (design: [acty]), ((cbt: [dsyn]), (wl): []), ((prepost assessment): [acty]), (control group: [grup]), (intervention: [hlca]), (waitlist period: [fndg]), (weeks: []), (primary outcomes: [topp]), (diagnostic status: [fndg]), (severity: []), (anxiety disorders: [mobd]), (anxiety disorder interview schedule: [mobd]), (dsm-iv: []), ( parent: []), (child versions: [aggp]), (secondary outcomes: [neop]), (parent: []), (child ratings: [aggp]), (questionnaires: []), (childs level: [aggp]), (anxiety: [mobd]), (impact: [gngm]), (everyday life: []), (additional: []), (information: []), (parents: []), ( child: [aggp]), (teachers: []), (childs behavior: [inbe]), (negative self-statements: [fndg]), ( together: []), (adaptive skills: [inbe]), (follow-up data: [euka]), (months: []), (discussion: [socb]), (manualized cbt program: [dsyn]), (danish children: [aggp]), (mental health clinic setting: [qnco]), (hypothesis: []), (anxiety reduction skills: [inbe]), (psychosocial development: [menp]), (child: [aggp]), (general: [hlca]), (trial registration https://clinicaltrials.gov (nct02908321): [resa]), (september: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13063-018-2591-x) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social development, 'Ability to Converse in Social Settings')(comorbid anxiety disorders, 'Anxiety Disorders')(manualized cognitive behavioral therapy anxiety program, 'Anxiety Disorders')(cognitive behavioral therapy, 'Cognitive Ability')(anxiety disorder interview schedule, 'Anxiety Disorders')(anxiety disorders, 'Anxiety Disorders')(anxiety, 'Anxiety Disorders')(adaptive skills, 'Adaptive Life Skills')(cognitive behavioral therapy program, 'Cognitive Ability')(manualized cognitive behavioral therapy program, 'Cognitive Ability')(decrease anxiety, 'Anxiety Disorders')(anxiety reduction skills, 'Anxiety Disorders')

PMCID: 5118619
SFARI Genes: OXTR, OXTR, OXTR, OXTR, OXTR, OXTR, 
Non SFARI Genes: 
Named Entities: (limited treatments: [topp]), (autism spectrum disorder (asd): [mobd]), (studies: [lbpr]), (significant associations: [menp]), (receptor genes: [gngm]), (oxytocin (ot): [aapp,horm,phsu]), (vasopressin (avp): [aapp,horm,phsu]), (asd diagnosis: [cgab]), (asd-related phenotypes: [cgab]), (researchers: []), (manipulation: [topp]), (systems: []), (repetitive behaviors: [fndg]), ( core characteristics: [bdsu]), (asd: [cgab]), (consequently: []), ( research: [resa]), (oxytocin/vasopressin: [aapp,horm,phsu]), (intervention targets: [hlca]), (increased: [qnco]), (therefore: []), (further examination: []), (relationship: []), (neuropeptides: [aapp,bacs]), (study: [resa]), (associations: [menp]), (variants: []), (vasopressin (avpr1a: [aapp,horm,phsu]), ( avpr1b): [rcpt]), (related subphenotypes: [fndg]), (methods:: []), (autism diagnostic interview-revised: [acty]), ( autism diagnostic observation schedule: [hlca]), (clinical dsm-iv-tr criteria: [gngm]), (single: [fndg]), ((snps): [nusq]), (avpr1b: [gngm]), (oxtr: [gngm]), (microsatellites: [bacs,nnon]), (avpr1a: [gngm]), (~200 families: [famg]), (proband: [famg]), (family-based association: [socb]), ((fbat): []), (haplotypes: [orga]), (oxtr snps (i.e.: [nusq]), ( rs53576-rs2254298-rs2268493): []), (results:: [fndg]), (additive inheritance model: [qnco]), (fbat: []), (avpr1b snps (rs28632197: [nusq]), ( p: [aapp,imft]), (rs35369693: []), (other studies: [lbpr]), ( oxtr rs2268493 (p: [aapp,imft]), (diagnosis: [fndg]), (rs2268493: []), (asd subphenotypes: [cgab]), (social withdrawal (p: [aapp,imft]), (insistence: []), (sameness (p: [aapp,imft]), (further analyses: [resa]), (haplotype: [orga]), ( rs2254298rs2268493: []), ((a-t; p: [aapp,imft]), (avpr1a microsatellites (rs1: [bacs,nnon]), (rs3): []), (length variants: [qnco]), (restrictive: []), ( repetitive behaviors: [fndg]), (overall diagnosis: [fndg]), (correction: []), (multiple comparisons: [acty]), (snps: [nusq]), (gene: [gngm]), (avpr1b snps: [nusq]), (conclusions: autism: [mobd]), (heterogeneous disorder: [fndg]), (many genes: [gngm]), (pathways: [moft]), (development: [orgf]), (ot: [gngm]), (avp: [gngm]), (measures: [qnco]), (social behavior: [socb]), (novel association: [menp]), (understanding: [menp]), (genotype-phenotype relationships: [orga]), (pharmacological interventions: [hlca]), (ot/avp system: [hlca]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(asd diagnosis, 'Diagnosis')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(asd diagnosis, 'Diagnosis')(autism diagnostic interview-revised, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(diagnosis, 'Diagnosis')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(overall diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')(social behavior, 'Reciprocal Social Interaction')

PMCID: 5605503
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (strength: [qnco]), (implicit social inferences: [menp]), (adolescents: [aggp]), (autism spectrum disorder (asd): [mobd]), (chasing paradigm: [resa]), (participants: [popg]), (absence/presence: [qnco]), (chase: []), (display: []), (dots: [topp]), (others: [fndg]), (role: [socb]), (chasing (wolf): [mamm]), (dot: [topp]), (chase-present (but: [qnco]), (chase-absent) trials: [resa]), (wolf: [mamm]), (behavior: [inbe]), (degree: [qnco]), (towards: []), (sheep: [mamm]), (subtlety): [clna]), (previous research: [resa]), (subtlety: [clna]), (chase detection: [topp]), ((td) adults: [aggp]), (finding: [sosy]), (asd: [cgab]), (non-social cue: []), (displays: []), (results: [fndg]), (importance: []), (social: []), (non-social: []), ( information: []), (improved chase detection performance: [inbe]), (interestingly: []), (performance: [inbe]), (td counterparts: []), (nonetheless: []), ( adolescents: [aggp]), (use: []), (added social (or non-social) cue: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(added social cue, 'Awareness of Social Cues')

PMCID: 5093957
SFARI Genes: DPYD, DPYD, 
Non SFARI Genes: MIR137, MIR137, MIR137, 
Named Entities: (deletions: [genf]), (long arm: [fndg]), (chromosome: [celc]), (patients: [podg]), (phenotype: [orga]), (obesity: [dsyn]), ( intellectual disability: [mobd]), (autism-spectrum disorder: [mobd]), (minimal region: []), (overlap comprises: [acty]), (genes: dpyd: [aapp,enzy]), (mir137: [gngm]), (case presentation: []), (10-year-old boy: [aggp]), (syndromic obesity: [dsyn]), (deletion: [genf]), (critical region: []), (mir137 gene only: [gngm]), (study: [resa]), (mediator: [aapp,bacs]), (obesity phenotype: [dsyn]), (microdeletions: []), 
ASD Terms: (intellectual disability, 'Learning Disorders')

PMCID: 3513684
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (research: [resa]), (psychosocial interventions: [topp]), (cognitive-behavior therapies: [topp]), (social skills: [socb]), (social-communication deficits: [socb]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (past decade: [qnco]), (empirical support: []), (efficacy: [resa]), (interventions: [hlca]), ( little work: [fndg]), (therapeutic mechanismsthe when: [topp]), ( why: []), ( how: []), (whom: []), (conditions: [dsyn]), (intervention: [hlca]), (identification: [menp]), (mechanisms: []), (effects: []), (asd intervention research: [cgab]), (article: []), (methods: []), (such mechanisms: []), (mediators: [orch,phsu]), (moderators): []), (presents: [qnco]), (candidates: []), (common mechanisms: [qnco]), (treatment response: behavior: [inbe]), (therapeutic relationship: [topp]), (social knowledge: []), (social motivation: [menp]), ( social information processing: [menp]), ( executive functioning: [menp]), (internalizing comorbidities: []), (finally: []), (future directions: []), (program: [phsu]), (psychosocial intervention research: [resa]), (predictors: []), (individual differences: [menp]), (treatment response: [fndg]), (biomarkers): [clna]), ( isolate: [phsu]), (active therapeutic ingredients: [topp]), (promote dissemination: [acty]), (optimized interventions: [hlca]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social information processing, 'Ability to Convey Information')(executive functioning, 'Executive Function')(internalizing comorbidities, 'Comorbidities')

PMCID: 5684146
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (individuals: [humn]), (autism spectrum disorder (asd) show: [mobd]), (superior performance: [inbe]), (fine details; however: []), (impairments: [patf]), (gestalt face: [blor]), (global motion perception: [menp]), (visual attention: [menp]), (core: [bdsu]), (social deficits: []), (evidence: []), (asd arise: [cgab]), (structural connectivities: []), (distributed cortical networks: [bpoc]), (social information processing: [menp]), (human visual system: [humn]), (set: [menp]), (parallel: [resa]), ( hierarchical: []), ( multistage network systems: [popg]), (altered connectivity: []), (visual networks: []), (social cognition impairment: [patf]), (asd: [cgab]), (present review: [qnco]), (studies: [lbpr]), (attention networks: [menp]), (visual evoked potentials: [ortf]), (event-related potentials: [ortf]), (diffusion tensor: [npop]), ((dti): [diap]), (series: [qnco]), (vep: []), ( erp: [fndg]), (dti studies: [diap]), (laboratory: [mnob,orgt]), (complex alterations (impairment: [patf]), (enhancement): [acty]), (recent data: [euka]), (atypical visual perception: [orgf]), (parallel visual pathways: [bpoc]), (attention: [menp]), (impaired social communication: [socb]), (underlying pathophysiological mechanism: [patf]), (connectopathy.: []), 
ASD Terms: (autism spectrum disorder show, 'Autism Phenotype')(visual attention, 'Visual Thinking')(global motion perception, 'Cognitive Ability')(social deficits, 'Social Competence')(social deficits in asd arise, 'Social Competence')(social information processing, 'Ability to Convey Information')(visual networks, 'Visual Thinking')(social cognition impairment, 'Cognitive Ability')(human visual system, 'Visual Thinking')(visual evoked potentials, 'Visual Thinking')(parallel visual pathways, 'Visual Thinking')(atypical visual perception, 'Visual Thinking')(impaired social communication, 'Reciprocal Social Interaction')

PMCID: 6158856
SFARI Genes: 
Non SFARI Genes: GMPPB, GMPPB, GMPPB, 
Named Entities: (dystroglycanopathy (-dg): [qnco]), (heterogeneous category: [orga]), (congenital forms: []), (muscular dystrophy (cmd): [cgab,dsyn]), (limb-girdle muscular dystrophy (lgmd): [dsyn]), (mutations: [genf]), (genes: [gngm]), (them: []), ( gmppb: [gngm]), (guanosine-diphosphate-mannose (gdp-mannose) pyrophosphorylase b protein: [aapp,enzy]), (wide clinical spectrum: [qnco]), (severe walker-warburg syndrome: [cgab,dsyn]), (pseudo-metabolic myopathy: [dsyn]), (congenital myasthenic syndromes: [dsyn]), (full set: [menp]), (known disease genes: [gngm]), (italian patients: [podg]), (evidence: []), (genotype-phenotype correlations: [fndg]), (cohort: [popg]), (innovative bioinformatic tools: [menp]), (effects: []), (gmppb mutations: [genf]), (protein function: [moft]), (phenotypic expressions: [orga]), (additional cases: [qnco]), (families: [famg]), (novel mutations: [comd]), (patients: [podg]), (variable phenotypes: [fndg]), (typical pictures: []), (asymptomatic hyperckemia: [fndg]), (arthrogryposis: [dsyn]), (congenital clubfoot: [cgab]), (birth: [orgf]), (neurodevelopmental comorbidities: [ortf]), (seizures: [sosy]), (ataxic gait: [sosy]), (autism-spectrum disorder: [mobd]), (clinical reports: []), (dystroglycanopathies: []), (few mutations: [genf]), (italian gmppb-mutated population: [popg]), (alterations: []), (protein stability: []), (main effects: []), (gmppb missense variants: [gngm]), (work: []), (data: [euka]), (new bionformatic tools: []), (conceptual framework: []), (complexity: [chvs]), (disorders: [dsyn]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13023-018-0863-x) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (congenital myasthenic syndromes, 'Congenital Abnormalities')(neurodevelopmental comorbidities, 'Learning Disorders')

PMCID: 3411654
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (individuals: [humn]), (autism spectrum disorders: [mobd]), (demonstrate: []), (visual attention: [menp]), (brain reward circuitry responses: [menp]), (images: []), (interests: [menp]), (heightened affective response: [fndg]), (ci: [gngm]), (disproportionate salience: []), (reward value: [menp]), (asd: [cgab]), ((td) adults: [aggp]), (subjective emotional experience: [menp]), (object images: []), (non-ci object images: [lbpr]), (social images: []), (td adults: [aggp]), (adults: [aggp]), (arousal ratings (sensation: [ortf]), (dimension: [qnco]), (calm: [gngm]), (ratings (emotionality: [fndg]), (approach: []), (series: [qnco]), (previous research: [resa]), (groups: [popg]), (arousal ratings: [menp]), (image type: []), (asd adults: [cgab]), (valence ratings: [acty]), (ci-related images: [lbpr]), (effects: []), (sex: [orgf]), (asd group: [cgab]), (td group: [popg]), (ci images: [lbpr]), (findings: [clna]), (additional evidence: []), (preference: []), (certain categories: []), (non-social objects: []), (reduced preference: []), (social stimuli: [phpr]), (dissemination: []), (image: []), (aspects: [qnco]), (circumscribed interest phenotype: [orga]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(visual attention, 'Visual Thinking')(circumscribed interests images than social images, 'Social Interest')(circumscribed interest phenotype in asd, 'Autism Phenotype')

PMCID: 4598097
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (protocol: [fndg]), ( social motivation: [menp]), (mice: [mamm]), (pair: []), (operant conditioning paradigms: [menp]), (experiments: [resa]), ( two-chambered shuttle boxes: [qnco]), (operant levers: []), (right): []), (food receptacle: [plnt]), (chamber: [bpoc]), (second chamber: [bpoc]), (automated guillotine door: []), (wire grid: [gngm]), (different stimulus mice: [mamm]), (days: []), (social stimulus: [phpr]), (opening: []), (guillotine door: []), (test mice: [mamm]), (press: []), (order: [acty]), (door: []), (gain access: [qnco]), (stimulus partner: [popg]), (sec: []), (number: [qnco]), (lever presses: []), (social reward: [menp]), (fixed schedule: [phpr]), (sessions: [evnt]), (consecutive minutes: [qnco]), (last reinforced ratio: [qnco]), (breakpoint: []), (quantitative measure: [qnco]), (social motivation: [menp]), (second paradigm: [resa]), ( test mice: [mamm]), (left: []), (right lever presses: []), (food reward: [menp]), (presses: []), (respective lever: []), (food: [imft,phsu]), (social rewards: [menp]), (measurement: []), (value: [qnco]), (reward: [menp]), (ratio: [qnco]), (reward type: [menp]), (mouse strains: [mamm]), (change: [qnco]), (satiation: [menp]), (quantification: [qnco]), (mouse models: [mamm]), (autism: [mobd]), (other disorders: [dsyn]), (social behavior: [socb]), 
ASD Terms: (autism, 'Autism Phenotype')(social behavior, 'Reciprocal Social Interaction')

PMCID: 4263237
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (research: [resa]), (children: [aggp]), (risk: []), (behavioral difficulties: [fndg]), (full-term children: [aggp]), (autism spectrum disorders: [mobd]), (core deficits: [bdsu]), (difficulties: [fndg]), (study: [resa]), (social perceptual skills: [socb]), (11-year-old children: []), (low birthweight (vlbw) (<1: [sosy]), (500 g): [qnco]), (age-matched: [orga]), ( full-term controls: [fndg]), (child: [aggp]), (adolescent social perception measure: [menp]), (behavioral outcomes: [inbe]), (parent-report measures: [qnco]), (asd screening: [cgab]), (preterm group: [fndg]), (normal range: [qnco]), (verbal iq: []), (however: []), (ability: [orga]), (nonverbal cues: [fndg]), (bodies: [humn]), (situational cues: []), (emotions: [menp]), (characters: [menp]), (videotaped social interactions: [fndg]), (performance: [inbe]), (task: [gngm]), (number: [qnco]), (autistic-like traits: [mobd]), (links: []), (social perceptual deficits: []), (results: [fndg]), (major intellectual/language problems: [mobd]), (behavioral problems: [mobd]), (clinical concern: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(behavioral difficulties, 'Personal Traits')(social perceptual skills, 'Ability to Converse in Social Settings')(adolescent social perception measure, 'Cognitive Ability')(videotaped social interactions, 'Reciprocal Social Interaction')(links between social perceptual deficits, 'Social Competence')(social perceptual deficits, 'Social Competence')(behavioral problems, 'Personal Traits')

PMCID: 3113442
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (core deficits: [bdsu]), (social behavior: [socb]), ( communication: [socb]), (behavioral flexibility: [inbe]), (several lines: [qnco]), (evidence: []), (oxytocin: [aapp,horm,phsu]), (receptor (oxtr): [gngm]), (wide range: [qnco]), (social behaviors: [socb]), (attempts: [evnt]), (genetic variations: [npop]), (system contribute: [acty]), (asd: [cgab]), (recent reports: [hlca]), (association: [menp]), (common genetic polymorphisms: [genf]), (oxtr gene: [gngm]), (small sample sizes: [sbst]), (families) and: [famg]), (oxtr polymorphisms: [genf]), (measures: [qnco]), (individuals: [humn]), (genetic association analysis: [lbpr]), (markers: [clna]), (oxtr locus: [gngm]), (pedigrees: []), (asd susceptibility: [cgab]), ( rs2268493 (p: [aapp,imft]), (rs1042778 (p: [aapp,imft]), ((p =: [aapp,imft]), (observed: []), (further: []), (genetic markers: [genf]), (multiple core asd phenotypes: [cgab]), (social domain dysfunction: [dsyn]), (standardized instruments: []), (data: [euka]), (oxtr: [gngm]), (genetic polymorphisms: [genf]), (results: [fndg]), (caution: []), (none: []), (significant associations: [menp]), (appropriate correction: []), (multiple comparisons: [acty]), (however: []), (current findings: [clna]), (large independent cohort: [popg]), (previous results: [fndg]), (biological plausibility: []), (participation: []), (system: []), (social disruptions: []), (functional polymorphisms: [genf]), (asd risk: [cgab]), (subset: []), (families: [famg]), 
ASD Terms: (social behavior, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(social behaviors, 'Reciprocal Social Interaction')(social behavior, 'Reciprocal Social Interaction')(multiple core asd phenotypes, 'Autism Phenotype')(social domain dysfunction, 'Social Competence')

PMCID: 5643347
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (neurobiological basis: [phsu]), (social dysfunction: [dsyn]), (high male prevalence: [orga]), (autism spectrum disorder (asd): [mobd]), (network alterations: [popg]), (development: [orgf]), (autistic-like behaviors: [mobd]), (clear pattern: [fndg]), (connectivity differences: [qnco]), (asd: [cgab]), (heterogeneous nature: [orga]), (asd hinders investigations: [cgab]), (human subjects: [humn]), (brain connectivity: [bpoc]), (homogenous rat model: [mamm]), (exposure: [clna]), (acid (vpa): [chem]), (partial correlation analysis: [inpr,resa]), (cross-sectional resting-state 18f-fluorodeoxyglucose positron emission tomography scans: [diap]), (control rats: [mamm]), (metabolic connectivity: [celf]), (conducted canonical correlation analysis: [inbe]), (metabolic activity: [acty]), (behavior scores: [inbe]), (vpa-treated rats: [mamm]), (impairments: [patf]), (social behaviors: [socb]), (difference: [qnco]), (male: [orga]), (female rats: [mamm]), (similarly: []), (current analyses: [resa]), (sex-specific changes: [topp]), (network connectivity: [popg]), (distinct alterations: []), (distributed metabolic activity patterns: [acty]), (autistic-like social deficits: [mobd]), (specifically: []), (activity: [acty]), (salience network: [popg]), (enhanced activity: [qnco]), (cortico-cerebellar circuit: [bpoc]), (severity: []), (social behavioral deficits: [inbe]), (such metabolic connectivity features: [celf]), (neurobiological substrates: [sbst]), (autistic-like behavior: [mobd]), (males: [orga]), (pathognomonic sign: [sosy]), (vpa rat model: [mamm]), 
ASD Terms: (neurobiological basis of social dysfunction, 'Social Competence')(autism spectrum disorder, 'Autism Phenotype')(social dysfunction, 'Social Competence')(exposure, 'Exposures')(social behaviors, 'Reciprocal Social Interaction')(autistic-like social deficits, 'Social Competence')(social behavioral deficits, 'Reciprocal Social Interaction')

PMCID: 5968048
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (combined mindfulness-based program: [menp]), (children: [aggp]), (parents (mymind): []), (adolescents: [aggp]), (autism spectrum disorder (asd): [mobd]), (study: [resa]), (program: [phsu]), (asd: [cgab]), (effects: []), (common comorbid problems: [qnco]), (forty-five children: [aggp]), (years: []), (parents: []), (measures: [qnco]), (childrens: []), (parents social communication: [socb]), (behavioral functioning: [inbe]), (mindful awareness: [menp]), (pre-intervention: []), ( post: []), (1-year follow-up: [hlca]), (significant changes: [qnco]), (social communication problems: [fndg]), (behavioral functioning improved: [inbe]), (results: [fndg]), (occasion; improvements: []), (2-month follow-up: [hlca]), (childrens improvements: []), (occasions: []), (increased mindful awareness: [menp]), (intervention: [hlca]), (improvements: []), (qualitative investigation: []), (experienced change: [qnco]), (open-ended questions: []), (mindfulness-based program: [menp]), (parallel sessions: [evnt]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(common comorbid problems, 'Comorbidities')(parents social communication, 'Reciprocal Social Interaction')(social communication problems, 'Reciprocal Social Interaction')

PMCID: 5629347
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (reality (ar) smartglasses: [fndg]), (technology: []), (investigation: [hlca]), (social communication aid: []), (children: [aggp]), (adults: [aggp]), (autism spectrum disorder (asd): [mobd]), (research tool: [resa]), (aid: [gngm]), (digital phenotyping: [lbpr]), (tolerability: [resa]), (wearable technology: []), (people: [popg]), (asd: [cgab]), (important area: []), (research: [resa]), (individuals: [humn]), (sensory: []), ( cognitive: []), (attentional challenges: [menp]), (aim: [phsu]), (study: [resa]), (usability: []), (novel smartglasses system: []), (autism (the brain power autism system: [mobd]), (bpas: [gngm]), (google glass explorer edition: [dsyn]), (other smartglasses: []), (ar: [gngm]), (affective artificial intelligence: []), (users: [humn]), (emotional skills: [menp]), (total: [qnco]), (spectrum: [qnco]), (severity: []), (coaching session: [evnt]), (users tolerability: [resa]), (smartglasses: []), ( user: [humn]), (minute (initial tolerability threshold): [qnco]), (user: [humn]), (entire duration: [phsu]), (coaching session (whole session tolerability threshold): [evnt]), (caregiver report: [hlca]), ((91%): []), (measures: [qnco]), (caregivers: []), (experience: [menp]), (study staff: [resa]), (initial tolerability (91%): [resa]), (initial tolerability: [resa]), ((100%): [qnco]), (entire session (whole session tolerability threshold): [evnt]), (caregiver expectations: []), (cases: [qnco]), (comfortable (94%): []), (preliminary report: [hlca]), (severity-range: [qnco]), (devices: []), (assistive technologies: []), (further research: [resa]), (smartglasses design: [acty]), (efficacy: [resa]), (social communication: [socb]), 
ASD Terms: (social communication aid, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(cognitive, 'Cognitive Ability')(social communication aid, 'Reciprocal Social Interaction')(autism (the brain power autism system, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')

PMCID: 3958534
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (autism spectrum disorder: [mobd]), (deficits: []), (social interaction: [fndg]), (communication: [socb]), (restrictive behavior: [mobd]), (intelligence: [menp]), (general cognitive functioning: [menp]), (preserved: [lbpr]), (weak central coherence account: [clna]), ( individuals: [humn]), (information: []), (expense: [qnco]), (global form: []), (processing bias: [bird]), (sensorimotor gating: [phsf]), (mechanism: []), (overstimulation: []), (transformation: [resa]), (sensory input: []), (motor action: [dora]), (prepulse inhibition: [phsf]), (operational measure: [qnco]), (extensive attenuation: [acty]), (startle reflex: [phsf]), (startling pulse: [clna]), (prepulse: []), (present study: [qnco]), (acoustic startle: [npop]), (adults: [aggp]), (intelligence-matched controls: [menp]), (means: []), (electromyography: [diap]), (results: [fndg]), (participants: [popg]), (startle amplitudes: []), (control group: [grup]), (however: []), ( groups: [popg]), (regard: []), (ppi: [phsu]), (habituation: [mobd]), (startle: []), (discussion: [socb]), (findings: [clna]), (previous studies: [lbpr]), (prepulse inhibition deficits: [phsf]), (high-functioning autism: [mobd]), (certain subgroups: [virs]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(restrictive behavior, 'Restricted and Repetitive Behavior')(autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(general cognitive functioning, 'Cognitive Ability')(autism, 'Autism Phenotype')(process information, 'Ability to Convey Information')(high-functioning autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 5651454
SFARI Genes: IL-6, IL-6, 
Non SFARI Genes: GFAP, 
Named Entities: (objective(s):: []), (prenatal exposure: [fndg]), (tak242 affects: [menp]), (autism: [mobd]), (offspring: [famg]), (animal models: [anim]), (autism spectrum disorder (asd): [mobd]), (materials: [sbst]), (methods:: []), (pregnant rats: [mamm]), (asd model: [cgab]), (tak242 treatment group: [popg]), (control group: [grup]), (ip: [gngm]), (lps: [gngm]), (blood samples: [bdsu]), (cytokine evaluation: [hlca]), (social interaction test: [fndg]), (asd rats: [mamm]), (rats: [mamm]), (hippocampus: [bpoc]), ( cerebral cortex: [bpoc]), (cerebellum: [bpoc]), (immunohistochemical study: [lbpr]), (results: as: [fndg]), (control: [sbst]), (levels: []), (ifn-: []), ( il-1: [aapp,imft]), ( il-2: [aapp,imft]), (il-6: [gngm]), ((p<0.05): [fndg]), (il-4: [gngm]), ( il-10: [aapp,imft]), (tgf-: [aapp,bacs]), ((p <0.05): [fndg]), (asd rats; whereas: [mamm]), (cytokines: [aapp,imft]), (tak242 (p<0.05): [orch]), (hesitation time: []), (none-social interaction time: [fndg]), (control (p<0.05);: [sbst]), (social interaction time (p<0.05): [fndg]), (expression: [topp]), (gfap: [gngm]), (iba1: [gngm]), (cortex: [bpoc]), ( hippocampus: [bpoc]), (lps group: [orch]), (group: [popg]), (effect: []), (conclusion: prenatal exposure: [fndg]), (cytokines levels: [aapp,imft]), (social interaction time: [fndg]), (rat: [mamm]), (asd: [cgab]), 
ASD Terms: (offspring in animal models, 'Perinatal History')(prenatal exposure, 'Exposures')(autism, 'Autism Phenotype')(offspring, 'Perinatal History')(autism spectrum disorder, 'Autism Phenotype')(offspring, 'Perinatal History')(social interaction test, 'Reciprocal Social Interaction')(offspring, 'Perinatal History')(social interaction time, 'Reciprocal Social Interaction')(social interaction time, 'Reciprocal Social Interaction')(prenatal exposure, 'Exposures')

PMCID: 4484636
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (research evidence: [resa]), (subclinical autistic traits: [mobd]), (relatives: [famg]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (general population: [popg]), (share: [socb]), (common etiology: [qnco]), (asd: [cgab]), (number: [qnco]), (measures: [qnco]), (autistic traits: [mobd]), (unselected samples: [sbst]), (autism: [mobd]), (toddlers (q-chat): [aapp,enzy]), (few measures: [qnco]), (use: []), (toddlers: [aggp]), (months: []), (measurement properties: []), (factor structure: []), (present study: [qnco]), (internal consistency: [qnco]), ( factor: []), (test-retest stability: [lbpr]), (convergent validity: [qnco]), (q-chat: [aapp,enzy]), (sample: [sbst]), (singapore: [fish]), (caregivers: []), ((n =: [aapp,imft]), (factors: []), (accounting: []), (%: []), (variance: social/communication: [socb]), (non-social/behavioral traits: [inbe]), (speech/language factor: [fndg]), (total: [qnco]), (speech/language scores: [clna]), (social/communication: [socb]), (non-social/behavioral factor scores: [inbe]), (scores: [clna]), (pervasive developmental disorders subscale: [mobd]), (child behavior checklist (cbcl): [diap,inpr]), (children: [aggp]), (q-chat total scores: [aapp,enzy]), (other unselected samples: [sbst]), (uk: []), (three-factor structure: [qnco]), (acceptable internal consistency: [qnco]), (main factor scores (social/communication: [socb]), (distributed scores: [clna]), (unselected sample: [sbst]), (similar structure: []), (studies: [lbpr]), (findings: [clna]), (relation: [socb]), (literature: [inpr,mnob]), (future directions: []), (validation: [resa]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 5875886
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (current work: [npop]), (unique contribution: [acty]), (autistic traits: [mobd]), (social anxiety: [mobd]), (tasks: []), (attention: [menp]), (emotion processing: [menp]), (study: [resa]), (typically-developing college students: [popg]), (flanker task: []), (control: [sbst]), (emotion identification: [menp]), (visual search task: [acty]), (identification: [menp]), (series: [qnco]), (different emotions: [menp]), (participants: [popg]), (self-reported autistic traits: [mobd]), (stimuli: [phpr]), (complex emotions: [menp]), (trials: [resa]), (complex faces; participants: [blor]), (differences: [qnco]), (studies: [lbpr]), (traits: [gngm]), (autism: [mobd]), (impact social cognitive processing: [menp]), 
ASD Terms: (social anxiety, 'Anxiety Disorders')(visual search task, 'Visual Thinking')(social anxiety, 'Anxiety Disorders')(autism, 'Autism Phenotype')(impact social cognitive processing, 'Cognitive Ability')

PMCID: 4183378
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (attention-deficit/hyperactivity disorder (adhd): [mobd]), (extreme end: []), (traits: [gngm]), (general population: [popg]), (twin studies: [famg]), (adhd: [mobd]), (shares: [socb]), (genetic susceptibility: [orga]), (autism spectrum disorder (asd): [mobd]), (asd-related traits: [cgab]), (aims: [phsu]), (study: [resa]), (composite: []), (common molecular genetic variants: [fndg]), (polygenic risk scores: [qnco]), (avon longitudinal study: [resa]), (parents: []), (children (alspac) population sample (n =: [aggp]), (discovery case-control: [hlca]), (genome-wide association study: [mbrt]), (childhood adhd: [mobd]), (regression analyses: []), (polygenic scores: [clna]), (adhd traits: [mobd]), (asd-related measures: [cgab]), ((pragmatic language abilities: [menp]), (social cognition): [socb]), (alspac sample: [sbst]), (boys: [aggp]), (girls: [aggp]), (1) adhd item (n: [mobd]), (polygenic risk: [genf]), (positive association: [menp]), ((hyperactive-impulsive: [mobd]), ( p = .0039; inattentive: [fndg]), ( p = .037): [aapp,imft]), (pragmatic language abilities: [menp]), (= .037): []), (social cognition (p = .43): [socb]), (children: [aggp]), (rating 1: [fndg]), ( girls: [aggp]), (polygenic score: [clna]), ((p = .003): [aapp,imft]), (findings: [clna]), (molecular genetic evidence: []), (risk alleles: [gngm]), (categorical disorder: [dsyn]), (adhd influence: [mobd]), (attentional traits: [menp]), (results: [fndg]), (common genetic variation: [npop]), (adhd diagnosis: [mobd]), (extreme: []), (characteristic feature: []), (asd: [cgab]), 
ASD Terms: (attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism spectrum disorder, 'Autism Phenotype')(predicts attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(childhood attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder traits, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder item, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder traits, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(pragmatic language abilities, 'Development or Regression of Language Skills')(social cognition, 'Cognitive Ability')(attention-deficit/hyperactivity disorder traits, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder influence, 'Attention Deficit Disorder with Hyperactivity')(attention-deficit/hyperactivity disorder diagnosis, 'Attention Deficit Disorder with Hyperactivity')

PMCID: 3851306
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (efforts: [orgf]), (risk genotypes: [orga]), (familial nature: [famg]), (autism spectrum disorder (asd): [mobd]), (success: [socb]), (study: [resa]), (pedigrees: []), (additional asd-related phenotypes: [cgab]), (linkage analysis: [lbpr]), (alternative approach: []), (search: [acty]), (inherited asd susceptibility variants: [cgab]), (traditional methods: []), (genetics: []), (asd: [cgab]), (evidence: []), (linkage: [moft]), (extended pedigrees: []), (asd cases: [cgab]), (cases: [qnco]), (nuclear families: [famg]), (compound: [chem]), ((i.e.: [diap,inpr]), ( asd and: [cgab]), (non-asd individuals: [cgab]), (broad autism phenotype): [mobd]), (defined components: []), (phenotypes: [orga]), (repetitive behavior: [fndg]), (pragmatic language: [lang]), (anxiety: [mobd]), (goal: []), (aggregate information: []), (maximum number: [qnco]), (individuals: [humn]), (syndromic phenotypes: [dsyn]), (order: [acty]), (genetic underpinnings: [topp]), (narrowly: []), (aspects: [qnco]), (asd behavior: [cgab]), (results: [fndg]), (substantial between-family locus heterogeneity: [famg]), (importance: []), (asd loci: [cgab]), (inherited: []), ( familial: [famg]), ( forms: []), (additional loci: [gngm]), (asd analyses: [cgab]), ( show evidence: [anim]), (broad autism phenotype (bap): [mobd]), (bap peaks: [aapp,enzy]), (multiple subphenotypes: [qnco]), ( pragmatic language: [lang]), (social behavior): [socb]), (regions: []), (compound bap phenotype: [orga]), (whereas: []), (behavior: [inbe]), ((posterior probability: [qnco]), (other compound: [chem]), (narrow phenotypes: [orga]), (support: []), (presence: [qnco]), (key features: []), (complexity: [chvs]), (genetic architecture: [topp]), (asd:: [cgab]), (bap: [gngm]), (sets: [menp]), (subclinical features: []), (different features: []), (asd phenotype segregate: [cgab]), (another: []), (findings: [clna]), (additional study: [resa]), (informative pedigrees: []), (measurement: []), (biomarker-based phenotypes: [orga]), (non-affected individuals: [humn]), (complex genetics: [chvs]), (familial asd: [cgab]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(anxiety, 'Anxiety Disorders')(broad autism phenotype, 'Autism Phenotype')(broad autism phenotype peaks, 'Autism Phenotype')(broad autism phenotype phenotype, 'Autism Phenotype')(asd phenotype segregate, 'Autism Phenotype')

PMCID: 4275596
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (social communication deficits: [socb]), (prevalent amongst children: [qnco]), (anxiety disorders;: [mobd]), (children: [aggp]), (social anxiety disorder: [mobd]), (study: [resa]), (comparison: [acty]), (other forms: []), (anxiety disorder: [mobd]), (parents: []), (diagnosed anxiety disorder: [mobd]), (social communication questionnaire (scq; rutter: [socb]), ( m.: [aapp,imft]), ( bailey: []), ( a.: []), ( lord: [gngm]), ( c.: []), (social communication questionnaire  manual: [inpr,mnob]), (western psychological services: [mobd]), ( los angeles: []), ( ca): [bpoc]), (diagnosis: [fndg]), (social anxiety disorder (n=262): [mobd]), (anxious children: [aggp]), (social anxiety disorder (n=142): [mobd]), (scq total: [qnco]), (subscale scores: [clna]), (frequency: [qnco]), (participants: [popg]), (clinical cut-offs: [phpr]), (scq: []), (total (t(352)=4.85: [qnco]), ( p<.001: [aapp,imft]), ( d=.55: []), (reciprocal social interaction (t(351)=4.73: [fndg]), ( r=.27): [clna]), ( communication (t(344)=3.62: [socb]), ( d=.43: []), ( r=.21): [clna]), (stereotyped behaviors subscales: [mobd]), (p=.002: [aapp,imft]), ( d=.37: []), ( r=.18): [clna]), (furthermore: []), ( children: [aggp]), (times: [qnco]), (above clinical cut-offs: [phpr]), (affluent group: [popg]), (non-minority status: [popg]), (social communication difficulties: [socb]), (parental report: [hlca]), (extraneous factors: []), (treatments: [topp]), (specific focus: []), (social communication skills: [socb]), (future research: [resa]), (objective assessments: [hlca]), 
ASD Terms: (anxiety disorders, 'Anxiety Disorders')(social anxiety disorder, 'Anxiety Disorders')(social communication deficits, 'Reciprocal Social Interaction')(examine social communication deficits, 'Reciprocal Social Interaction')(social anxiety disorder, 'Anxiety Disorders')(anxiety disorder, 'Anxiety Disorders')(diagnosed anxiety disorder, 'Anxiety Disorders')(social communication questionnaire, 'Reciprocal Social Interaction')(diagnosis, 'Diagnosis')(social anxiety disorder, 'Anxiety Disorders')(social anxiety disorder, 'Anxiety Disorders')(anxious children, 'Anxiety Disorders')(social anxiety disorder, 'Anxiety Disorders')(social anxiety disorder, 'Anxiety Disorders')(anxious children, 'Anxiety Disorders')(reciprocal social interaction =4.73, 'Reciprocal Social Interaction')(stereotyped behaviors subscales, 'Stereotyped, Restricted, and Repetitive Behavior')(social anxiety disorder, 'Anxiety Disorders')(social communication difficulties, 'Reciprocal Social Interaction')(social anxiety disorder, 'Anxiety Disorders')(social communication skills, 'Reciprocal Social Interaction')

PMCID: 5534041
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (memory (wm): [menp]), (autism spectrum disorder (asd): [mobd]), (such impairment: [patf]), (core deficits: [bdsu]), (cognition: [menp]), (social functioning: [socb]), (transcranial direct current stimulation (tdcs): [topp]), (wm: []), (healthy adults: [fndg]), (clinical populations: [popg]), (efficacy: [resa]), (asd: [cgab]), (bifrontal tdcs: [topp]), (wm performances: [inbe]), (adults: [aggp]), (high-functioning autism: [mobd]), (active stimulation: [npop]), (stimulation: [npop]), (such enhancement: [acty]), (untrained task: []), (twelve adults: [aggp]), (high-functioning asd: [cgab]), (battery: [inpo]), (wm tasks: []), (spatial span: [qnco]), ( backward digit: [qnco]), (span: [qnco]), ( spatial n-back: [blor]), (letter n-back: [blor]), (min: [neop]), (ma: [fndg]), (bifrontal stimulation: [npop]), (left: []), (right dorsolateral prefrontal cortices: [bpoc]), (single-blind crossover: [resa]), (participant: [popg]), (left anodal/right cathodal stimulation: [npop]), (cathodal stimulation: [npop]), (sham stimulation: [topp]), (counterbalanced order: [acty]), (separate days: []), (tdcs: [topp]), ( participants: [popg]), (letter: [clna]), (spatial n-back tasks: [blor]), (brief test: [lbpr]), (attention (bta): [menp]), (repeated-measures anova: [qnco]), (overall performance: [inbe]), (wm battery: [inpo]), (composite: []), (z-scores: [qnco]), (measures: [qnco]), (post hoc anovas: []), ( t tests: []), ( friedmans tests: [lbpr]), (wilcoxon: []), (signed-rank tests: []), (online: []), (offline effects: []), (performances: [inbe]), (individual measures: [qnco]), (dlpfc: []), (anodal stimulation: [npop]), (p =: [aapp,imft]), (right dlpfc: []), (p: [gngm]), (overall wm performance: [inbe]), (right anodal stimulation: [npop]), (enhanced performances: [inbe]), (enhancement: [acty]), (tasks: []), (effects: []), (spatial span backward: [qnco]), (bta (z: [aapp,imft,phsu]), (active bifrontal tdcs: [topp]), (performance: [inbe]), (tdcs benefits: [topp]), (results: [fndg]), (wm task performance: [topp]), (autism: [mobd]), (trial registration nct01602263: [resa]), 
ASD Terms: (memory, 'Working Memory')(autism spectrum disorder, 'Autism Phenotype')(cognition, 'Cognitive Ability')(social functioning, 'Ability to Converse in Social Settings')(enhance working memory, 'Working Memory')(memory performances, 'Working Memory')(high-functioning autism, 'Autism Phenotype')(improve working memory performances, 'Working Memory')(memory tasks, 'Working Memory')(working memory battery, 'Working Memory')(overall working memory performance, 'Working Memory')(autism, 'Autism Phenotype')(improve working memory task performance, 'Working Memory')

PMCID: 5305234
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (personality: [mobd]), (behavioral traits: [inbe]), (social imperviousness: []), ( directness: []), (conversation: [socb]), ( lack: []), (imagination: [menp]), ( affinity: [npop]), (solitude: []), ( difficulty: [fndg]), (emotions): [menp]), ((with whom?): []), (reference group: [popg]), (questionnaire-based assessments: [hlca]), (autistic traits: [mobd]), (therefore: []), (experiments: [resa]), (effects: []), (contexts: [fndg]), (reference groups: [popg]), (non-autistic participants: [mobd]), (non-autistic participants): [mobd]), (context matters: [fndg]), (p < .001: [aapp,imft]), ( 2p = .523): [nusq]), (context: [fndg]), (broad autism phenotype questionnaire: [mobd]), (participants: [popg]), (out-group (e.g.: [popg]), ( i: [inch]), (non-autistic people: [mobd]), (i: [inch]), (autistic people): [mobd]), (autistic traits;: [mobd]), (in-group: [popg]), ( participants: [popg]), (reference group matters: [popg]), ( 2p = .541): [nusq]), (social responsiveness scale: [acty]), (unusual eye contact): [socb]), (autistic participants: [mobd]), ( autistic participants: [mobd]), (group: [popg]), (exploratory analyses: [resa]), (autism-spectrum quotient): [qnco]), (majority: [socb]), ((non-autistic people): [mobd]), (implied context: [fndg]), 
ASD Terms: (broad autism phenotype questionnaire, 'Autism Phenotype')

PMCID: 4150363
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (complex heterogeneous neurodevelopmental disorder: [orga]), (alterations: []), (social functioning: [socb]), (communicative abilities: [fndg]), (engagement: [fndg]), (restrictive behaviors: [mobd]), (process: [phpr]), (individuals: [humn]), (autism: [mobd]), (related neurodevelopmental disorders: [mobd]), (fact: [gngm]), (number: [qnco]), (asd: [cgab]), (years: []), (effects: []), (context: [fndg]), (modified central nervous system: [bdsy]), (age: [orga]), (btbr t + tf/j mouse: [aapp,imft]), (mouse model: [emod]), (asd-like phenotype: [cgab]), (reduction: [npop]), (social behavior persists: [socb]), (old age: [popg]), (male btbr t + tf/j mice: [aapp,imft]), (quantitative proteomics: [qnco]), (potential alterations: []), (systems: []), (btbr mice: [mamm]), (proteomic analysis: [resa]), (hippocampal: [bpoc]), (cortical tissue: [bpoc]), (age-matched wild-type controls: [sbst]), (significant decrease: [qnco]), (brain: [bpoc]), (derived neurotrophic factor: [aapp,bacs]), (significant increases: [qnco]), (multiple synaptic markers: [clna]), (synapsin i: [aapp,bacs]), ( psd: [gngm]), (neun): [gngm]), (distinct changes: [qnco]), (functional pathways: [moft]), (proteins: [aapp,bacs]), (neural synaptic plasticity regulation: [ortf]), (neurotransmitter secretion regulation. taken: [biof]), (results: [fndg]), (understanding: [menp]), (asd-like mouse model: [cgab]), (regards: []), (behavior: [inbe]), (protein: [aapp,bacs]), (additional studies: [lbpr]), (complex interplay: [chvs]), (mouse models: [mamm]), 
ASD Terms: (social functioning, 'Social Competence')(autism spectrum disorder, 'Autism Phenotype')(complex heterogeneous neurodevelopmental disorder, 'Learning Disorders')(communicative abilities, 'Reciprocal Social Interaction')(restrictive behaviors, 'Restricted and Repetitive Behavior')(autism, 'Autism Phenotype')(related neurodevelopmental disorders, 'Learning Disorders')(social behavior persists, 'Reciprocal Social Interaction')

PMCID: 6328175
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (complex neurodevelopmental disorder: [mobd]), (impaired social interactions: [mobd]), ( difficulty: [fndg]), (communication: [socb]), (repetitive behavior patterns: [inbe]), (humans: [humn]), (asd: [cgab]), (male pre-disposition: [orga]), (condition: [dsyn]), (male: [orga]), (ratio: [qnco]), (part: [qnco]), (complex etiology: [chvs]), (environmental interplay: []), (available medical therapies: [topp]), (social deficits: []), (studies: [lbpr]), (rodent models: [mamm]), (promising therapeutic effects: [clna]), (oxytocin: [aapp,horm,phsu]), (social adaptation: [socb]), (pharmacological approach: []), (oxytocinergic activity: [acty]), (melanocortin receptor: [aapp,rcpt]), (agonist melanotan-ii (mt-ii): [aapp,phsu]), (effects: []), (environmental rodent autism models: [mamm]), (maternal immune activation (mia) mouse model: [emod]), (autism: [mobd]), (therapeutic potential: [topp]), (mt-ii: []), (autism-like features: [mobd]), (adult male mice: [mamm]), (male mia: [orga]), (impaired social behavioral metrics: [orch,phsu]), (vocal communication: [socb]), (repetitive behaviors: [fndg]), (continuous administration: [topp]), (mia mice: [mamm]), (seven-day course: []), (rescue: []), (social behavioral metrics: [orch,phsu]), (normal background c57 male mice: [mamm]), (significant alteration: [qnco]), (additionally: []), (change: [qnco]), (anxiety-like: [mobd]), (mt-ii treatment: [topp]), (normal c57 mice: [mamm]), (significant weight loss: [fndg]), (subacute treatment: [topp]), (data: [euka]), (effective agent: [chvf]), (autism-like behavioral deficits: [mobd]), (adult male mia mouse model: [aggp]), 
ASD Terms: (impaired social interactions, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(complex neurodevelopmental disorder, 'Learning Disorders')(repetitive behavior patterns, 'Stereotyped, Restricted, and Repetitive Behavior')(social deficits of asd, 'Social Competence')(available medical therapies, 'Medications')(social deficits, 'Social Competence')(social adaptation, 'Adaptive Life Skills')(environmental rodent autism models, 'Autism Phenotype')(autism, 'Autism Phenotype')(impaired social behavioral metrics, 'Personal Traits')(vocal communication, 'Vocalizations')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(social behavioral metrics, 'Reciprocal Social Interaction')(social behavioral metrics, 'Reciprocal Social Interaction')(autism-like behavioral deficits, 'Personal Traits')

PMCID: 5417526
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (autism spectrum disorders: [mobd]), (neurodevelopmental impairments: [patf]), (social communication: [socb]), (school: [mnob,orgt]), (difficulties: [fndg]), (class: []), (exact cause: []), (maladaptation: [mobd]), (such children: [aggp]), (difficulty: [fndg]), (attention: [menp]), (objects: []), (teachers: []), (gaze behavior analysis: [resa]), (asd: [cgab]), (classroom: []), (subjects: [humn]), (asd (19 boys: [cgab]), (girls;: [aggp]), (years): []), (age-matched children: [aggp]), (typical development (td) (14 boys: [orgf]), (eye movements: [ortf]), (free viewing: []), (movies: []), (actual classes:: [hlca]), (japanese class: [popg]), (teacher: [fndg]), (cartoon characters: [menp]), (arithmetic class: []), (geometric figures: []), (analysis: [resa]), (regions: []), (interest (rois): [menp]), (teachers face: [blor]), (teacher pointed: [fndg]), (classroom wall: []), (total gaze time: [qnco]), (roi: [clna]), (td: []), (two-way anova: [qnco]), (asd spent: [cgab]), (gaze time: [fndg]), (teacher;: [fndg]), (wall: []), (classroom scenes: []), (proportion: [qnco]), (results: [fndg]), (teachers instructions: [edac]), (persist: []), (inappropriate visual areas: []), (walls: []), (understanding content: [menp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(neurodevelopmental impairments, 'Learning Disorders')(social communication, 'Reciprocal Social Interaction')(inappropriate visual areas, 'Visual Thinking')

PMCID: 3622030
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (extant literature: [inpr,mnob]), (face recognition skills: [inbe]), (autism spectrum disorder (asd) shows: [mobd]), (clear impairments: [patf]), (controls: [sbst]), (group: [popg]), (distribution: []), (scores: [clna]), (asd: [cgab]), (present research: [resa]), (dimensional approach: [qnco]), (differences: [qnco]), (social attention: [menp]), (eye: [bpoc]), (experiment correlate: [resa]), (tdc: []), (emotional discrimination: [socb]), (person identity perception face processing skills: [blor]), (let's face it!: [blor]), (skills battery: [inpo]), (children: [aggp]), (infrared eye gaze: [bpoc]), (passive viewing: []), (movies: []), (facial expressions: [fndg]), (objects: []), (computer screen: [hlca]), (face processing skills: [inbe]), (measures: [qnco]), (attention: [menp]), (social skills: [socb]), (social communication questionnaire (scq): [socb]), (prior research: [resa]), ( children: [aggp]), (but: []), ( unexpectedly: []), ( group differences: [popg]), (amount: [qnco]), (objects): []), (possible methodological contributions: [acty]), (null finding: [sosy]), (importance: []), (developmental origins: [gngm]), (reduced face perception skills: [menp]), (need: []), (longitudinal research: [resa]), (social motivation: [menp]), (social attention influence: [menp]), (development: [orgf]), (social perceptual skills: [socb]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(differences in social attention, 'Social Competence')(person identity perception face processing skills, 'Cognitive Ability')(facial expressions, 'Integrated Verbal and NonVerbal Communication')(face processing skills, 'Integrated Verbal and NonVerbal Communication')(social skills, 'Ability to Converse in Social Settings')(social communication questionnaire, 'Reciprocal Social Interaction')(reduced face perception skills, 'Cognitive Ability')(development of social perceptual skills, 'Ability to Converse in Social Settings')(social perceptual skills, 'Ability to Converse in Social Settings')

PMCID: 3215697
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (patterns: []), (participation: []), (social activities: [socb]), (adolescents: [aggp]), (autism spectrum disorder (asd): [mobd]), (objectives: []), (representative (u.s.) estimates: [qnco]), (asd: [cgab]), (estimates: [qnco]), (other groups: [popg]), (disabilities: [fndg]), (correlates: []), (limited social participation: [socb]), (methods: []), (findings: [clna]), (data: [euka]), (national longitudinal transition study: [resa]), (large cohort study: [qnco]), (special education: [edac]), (comparison groups: [popg]), ( mental retardation: [mobd]), (speech/language impairments: [dsyn]), (friends: [popg]), (school (43.3%): [mnob,orgt]), (friends (54.4%): [popg]), (low family income: [grpa]), (impairments: [patf]), (conversational ability: [orga]), ( social communication: [socb]), (functional cognitive skills: [inbe]), (study: [resa]), (inquiry: [resa]), (area: []), (range: [qnco]), (social participation indicators: [irda]), (external validity: [qnco]), (under-studied developmental stage: []), (adolescence: []), (ecological approach: []), (many potential correlates: []), (social participation: [socb]), (notable differences: [qnco]), (dimension: [qnco]), (social context seldom: []), (research: [resa]), (asds: [cgab]), 
ASD Terms: (social activities, 'Engagement in Social Activities')(autism spectrum disorder, 'Autism Phenotype')(social activities, 'Engagement in Social Activities')(mental retardation, 'Mental Retardation')(having impairments in conversational ability, 'Conversational Skills')(social communication, 'Reciprocal Social Interaction')(conversational ability, 'Conversational Skills')(social communication, 'Reciprocal Social Interaction')(functional cognitive skills, 'Cognitive Ability')(were notable differences in social participation, 'Social Competence')

PMCID: 3779167
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (persons beliefs: []), (theory: []), (mind processes: [menp]), (elicits: []), (reliable brain activation: [bpoc]), (individuals: [humn]), (experimental paradigms: [resa]), (functional magnetic resonance imaging: [diap]), (activation: [acty]), (story task: []), (mind processing: [menp]), (large sample: [sbst]), (neurotypical (n =: [aapp,imft]), (group: [popg]), (high-functioning individuals: [humn]), (autism spectrum disorders: [mobd]), (whole-brain analyses: [resa]), (group differences: [popg]), (brain activation: [bpoc]), (mind tasks: [menp]), (high sensitivity: [lbpr]), (differences: [qnco]), (neurotypical participants: [popg]), (autism spectrum disorder: [mobd]), (results: [fndg]), (social cognitive impairments: [mobd]), (measurable changes: [qnco]), (size: []), ( location: [blor]), (response magnitude: [qnco]), (activity: [acty]), (explicit theory: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(social cognitive impairments, 'Social Competence')

PMCID: 6341115
SFARI Genes: 
Non SFARI Genes: DLGAP4, 
Named Entities: (humans: [humn]), ( genetic variants: [npop]), (dlgap1-4: [gngm]), (neuropsychiatric conditions: [dsyn]), (autism spectrum disorder (asd): [mobd]), (findings: [clna]), (encoded postsynaptic proteins: [aapp,bacs]), ( sapap1-4: [gngm]), (etiology: []), (neurobiological mechanisms: []), (contribution: [acty]), (sapap4: [gngm]), (disorders: [dsyn]), (sapap4-deficient mice: [mamm]), (study reveals: [resa]), (loss: [qnco]), (sapap4 triggers: [clna]), (behavioural abnormalities: [mobd]), (cognitive deficits: [mobd]), (impaired vocal communication: [socb]), (social interaction: [fndg]), ( phenotypes reminiscent: [orga]), (asd: [cgab]), (behavioural alterations: [inbe]), (dramatic changes: [qnco]), (synapse morphology: [bsoj]), ( function: [phsf]), (plasticity: [npop]), ( indicating: []), (development: [orgf]), (functional neuronal networks: [imft]), (mutations: [genf]), (corresponding human gene: [gngm]), ( dlgap4: [gngm]), (deficits: []), (cognitive functioning relevant: [menp]), (asd-like: [cgab]), (neurodevelopmental disorders: [mobd]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(phenotypes reminiscent of asd, 'Autism Phenotype')(behavioural abnormalities, 'Personal Traits')(cognitive deficits, 'Cognitive Ability')(impaired vocal communication, 'Vocalizations')(cognitive functioning relevant, 'Cognitive Ability')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 5006292
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objectives: autism spectrum disorder: [mobd]), (neurodevelopmental condition: [mobd]), (socio-communicative impairment: [mobd]), (stereotyped interests: [menp]), (activities: [acty]), (gastrointestinal disturbances: [fndg]), (case: []), (boy: [aggp]), (autism spectrum disorder (asd) diagnosis: [mobd]), (severe cognitive disability: [fndg]), (celiac disease: [dsyn]), (unexpected improvement: []), (autistic core symptoms: [mobd]), (months: []), (probiotic treatment: [bact]), (method:: [lbpr]), (case study refers: []), (years: []), (old boy: [aggp]), (asd: [cgab]), (villa santa maria institute: [orgt]), (resident care: [hlca]), (diagnosis: [fndg]), (asds: [cgab]), (dsm-v criteria: []), (ados-2 assessment (autism diagnostic observation schedule): [hlca]), (medication: [phsu]), (vsl#3: [phsu]), (multi-strain mixture: [sbst]), (ten probiotics: [bact]), (treatment: [topp]), (weeks: []), (month follow-up: [hlca]), (rehabilitation program: [topp]), (diet: [hlca]), (treatment period: [topp]), (follow up: [hlca]), (ados-2: [aapp,enzy]), (times: [qnco]), (treatment;: [topp]), (interruption: []), (severity: []), (abdominal symptoms: [sosy]), (improvement: []), (few weeks: [qnco]), (probiotic treatment start: [bact]), (score: [clna]), (social affect domain: [menp]), (ados: [aapp,enzy]), (months treatment: [topp]), (further reduction: [npop]), (point: [qnco]), (level: [phsu]), (follow: []), (period: []), (ados score: [aapp,enzy]), (along time: []), (conclusions:: []), (appropriate use: []), (probiotics deserves: [bact]), (research: [resa]), (new avenues: []), (fight: [socb]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental condition, 'Learning Disorders')(stereotyped interests, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorder diagnosis, 'Diagnosis')(autistic core symptoms, 'Complaints and Indications')(severe cognitive disability, 'Cognitive Ability')(celiac disease, 'Celiac Disease')(diagnosis, 'Diagnosis')(medication, 'Medications')(diet, 'Dietary Restrictions')(autistic core symptoms, 'Complaints and Indications')

PMCID: 6005789
SFARI Genes: ATP1A3, ATP1A3, 
Non SFARI Genes: NLRP3, NLRP3, NLRP3, 
Named Entities: (complex phenotypes: [orga]), (novel syndromes: [dsyn]), (composite interaction: []), (environmental factors: []), (9-year old male: [orga]), (autism spectrum disorder: [mobd]), (muckle-wells syndrome: [dsyn]), (age: [orga]), (years: []), (perseverations: [mobd]), (functioning: []), (home: []), (school: [mnob,orgt]), (intermittent episodes: []), (fatigue: [sosy]), (somnolence lasting: [fndg]), (hours: []), (weeks: []), (course: []), (months: []), (chronic hypersomnia: [dsyn]), (whole exome sequencing: [mbrt]), (mutations: [genf]), (genes: [gngm]), (clinical phenotype: [orga]), (patient: [podg]), (pathogenic: [fndg]), (heterozygous p.ala681thr mutation: [genf]), (atp1a3 gene (chr19:42480621c>t: [gngm]), ( grch37/hg19): [fndg]), (gene: [gngm]), (alternating hemiplegia: [dsyn]), (childhood: []), ( rapid onset dystonia parkinsonism: [dsyn]), (capos: [dsyn]), (autistic features: [mobd]), (heterozygosity: [orga]), (p.arg490lys/p.val200met mutations: [genf]), (nlrp3 gene (chr1:247588214g>a: [gngm]), (chr1:247587343g>a: []), ( respectively): []), (nlrp3 mutations: [genf]), (autosomal dominant manner: [genf]), (auto-inflammatory conditions: [dsyn]), (p.arg490lys: [aapp,imft]), (known pathogenic mutation: [genf]), (patient's father: [famg]), (p.val200met mutation: [genf]), (mother: [famg]), (variant: []), (unknown significance (vus): [fndg]), (novoatp1a3mutation: []), (role: [socb]), (patient's episodes: [podg]), (somnolence: [fndg]), (unprecedented combination: [fndg]), (other aspects: [qnco]), (complex phenotype: [orga]), 
ASD Terms: (years of age, 'Onset of Symptoms')(functioning at home, 'Home Life Skills')(autism spectrum disorder, 'Autism Phenotype')(perseverations, 'Involuntary Behaviors')(rapid onset dystonia parkinsonism, 'Onset of Symptoms')(rapid onset dystonia parkinsonism, 'Onset of Symptoms')

PMCID: 5996536
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (several genetic variants: [npop]), (autism spectrum disorder (asd): [mobd]), (progress: []), (disorder: [dsyn]), (majority: [socb]), (cases: [qnco]), (objective: []), (study: [resa]), (chromosomal regions: [cell]), (inherited variants: []), (risk: []), (asd: [cgab]), (approach: []), (broad autism: [mobd]), (phenotype (bap): [orga]), (unique sample: [sbst]), (extended pedigrees: []), (bap: [gngm]), (standardized tools: []), (pedigrees: []), (canada: []), (usa: []), (asd-diagnosed individuals: [cgab]), (nuclear families: [famg]), (genome-wide linkage analysis: [gngm]), (posterior probability: [qnco]), (linkage (ppl): [moft]), (quasi-bayesian method: [qnco]), (strength: [qnco]), (evidence: []), (linkage: [moft]), (model-free manner: []), (outcomes: []), (probability scale: [qnco]), (results: [fndg]), (appreciable interfamilial heterogeneity: [orga]), (high level: [qnco]), (intrafamilial heterogeneity: [orga]), (asd/bap: [cgab]), (specific loci: [gngm]), (inclusion: [celc]), (subclinical phenotypes: [orga]), (genetic studies: [resa]), (way: []), (genetic variants: [npop]), (moreover: []), (need: []), (approaches: []), (genetic risk factors: []), (high levels: [qnco]), (inter/intrafamilial locus: [gngm]), (allelic heterogeneity: []), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s11689-018-9238-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(broad autism phenotype, 'Autism Phenotype')(asd/broad autism phenotype, 'Autism Phenotype')

PMCID: 3744120
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (paper: []), (current literature: [inpr,mnob]), (group-based social skills interventions: [socb]), (adolescents (ages: [bacs,orch]), (years): []), (higher-functioning autism spectrum disorder: [mobd]), (key concepts: []), (future research: [resa]), (gssis: []), (research: [resa]), (intervention: [hlca]), (assessment: [acty]), (research methodology: [resa]), (results: [fndg]), (interconnected components: [socb]), (gssi literature: [inpr,mnob]), (components: []), (participant characteristics: [popg]), (age: [orga]), ( iq: []), ( sex): [orgf]), (intervention characteristics: [hlca]), (social skills: [socb]), (strategies: [menp]), ( duration: [phsu]), (intensity) vary: []), (gssis;: []), (participant: [popg]), (intervention efficacy: [resa]), (multiple assessments: [hlca]), ((eg: []), ( parent-report: []), ( child-report: []), ( social cognitive assessments): [hlca]), (efficacy: [resa]), (limitations: []), (current measurement approaches: [npop]), (accurate: []), ( sensitive: [patf]), (comprehensive measurement approaches: []), (few consistent findings: [qnco]), (studies: [lbpr]), (high parent: [qnco]), (child satisfaction: [menp]), (intervention); future research: [resa]), (rigorous methodological standards: [sosy]), (understanding: [menp]), (current gssi literature: [inpr,mnob]), (rigorous analysis: [sosy]), (clarity: [clna]), (questions: []), (individuals: [humn]), (autism spectrum disorder: [mobd]), 
ASD Terms: (current literature on group-based social skills interventions, 'Ability to Converse in Social Settings')(higher-functioning autism spectrum disorder, 'Autism Phenotype')(future research on group-based social skills, 'Ability to Converse in Social Settings')(group-based social skills interventions, 'Ability to Converse in Social Settings')(group-based social skills, 'Ability to Converse in Social Settings')(efficacy of group-based social skills, 'Ability to Converse in Social Settings')(results of group-based social skills interventions, 'Ability to Converse in Social Settings')(efficacy of group-based social skills interventions, 'Ability to Converse in Social Settings')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 6018460
SFARI Genes: SHANK3, SHANK3, Shank2, Shank3, Cntn4, Shank2, Shank3, Cntn4, GluA1, GluN1, GluA1, GluN1, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd) refers: [mobd]), (large set: [menp]), (neurodevelopmental disorders: [mobd]), (repetitive behavior: [fndg]), (abnormalities: [cgab]), (social interactions: [fndg]), (communication: [socb]), (interestingly: []), (forms: []), (asd: [cgab]), (strong genetic contribution: [acty]), (however: []), (molecular underpinnings: []), (disorder: [dsyn]), (shank3 gene (and: [gngm]), (degree shank2): [gngm]), (encode: [acty]), (postsynaptic density (psd): [celc]), (shank3/shank2: [gngm]), (contactin: [aapp,bacs]), (gene: [gngm]), (neuronal glycoprotein contactin4 (cntn4) exhibit: [aapp,bacs]), (variants: []), (other genes: [gngm]), (shanks: [blor]), (cntn4: [gngm]), (synapse formation: [ortf]), (function: [phsf]), (proper development: [orgf]), (capability: []), (excitatory: []), (inhibitory neuronal networks: [acty]), (adult: [aggp]), (mammal brain: [mamm]), (study: [resa]), (mutant/knock-out mice: [mamm]), (shank2 (shank2/): [gngm]), ( shank3 (shank3/): [aapp]), (cntn4 (cntn4/): [gngm]), (asd-models: [cgab]), (mice share: [mamm]), (molecular signature: [clna]), (glutamatergic: []), (gabaergic: []), (synaptic transmission: [celf]), (asd-related brain regions: [cgab]), (biotinylation assay: [lbpr]), (subsequent western blotting: [lbpr,mbrt]), (analysis: [resa]), (cell surface expression: [celc]), (several ionotropic glutamate: [aapp,bacs]), (gaba receptor subunits: glua1: [aapp,rcpt]), ( glua2: [gngm]), (glun1: [gngm]), (excitatory synaptic transmission: [ortf]), (1 subunit: [aapp]), (gabaa receptor: [aapp,rcpt]), (inhibitory synaptic transmission: [celf]), (shank2/: [gngm]), (shank3/ mice exhibit: [mamm]), (reduced levels: []), (several cell surface glutamate receptors: [aapp,bacs]), (analyzed brain: [bpoc]), (striatum: [bpoc]), (thalamuswhen: []), (controls: [sbst]), (cntn4/ mice: [mamm]), (cell surface glutamate receptors: [aapp,bacs]), (cortex: [bpoc]), (hippocampus: [bpoc]), (levels: []), (moreover: []), ( cntn4/ mice: [mamm]), (brain: [bpoc]), (region-specific alterations: []), (downregulation: [moft]), (cell surface gaba receptors: [aapp,bacs]), (analyzed brain regions: [blor]), (results: [fndg]), (mutations: [genf]), (defined genes: [gngm]), (common molecular phenotype: [orga]), (surface expression: [topp]), (gabaergic receptor subunits: [aapp]), (defined brain regions: [blor]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(social interactions, 'Reciprocal Social Interaction')(autism spectrum disorder refers, 'Autism Phenotype')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 6181799
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (repetitive patterns: []), (behaviours: [inbe]), ( interests: [menp]), (activities: [acty]), (critical diagnostic criterion: [fndg]), (autism spectrum disorder (asd): [mobd]), (previous studies: [lbpr]), (paradigms: [resa]), (asd populations: [cgab]), (that: []), (control participants: [popg]), ( people: [popg]), (diagnosis: [fndg]), (asd: [cgab]), (particular response: [fndg]), (magnitude: [qnco]), (potential outcomes: []), (gains: [qnco]), (losses: [qnco]), (test: [lbpr]), (calculation: [acty]), (response consistency: [qnco]), (choices: [inbe]), (situations: []), (outcomes: []), (terms: [orgf]), (task: [gngm]), (adults: [aggp]), (asds: [cgab]), (group: [popg]), (typically-developed (td) control participants: [popg]), (age: [orga]), (iq: []), (participants: [popg]), (risky gamble: [inbe]), (safe choice: [inbe]), (chance: []), (5: [qnco]), (asd participants: [cgab]), (tds: [orch]), (overall risk-taking behaviour: [inbe]), (however: []), (individual choices: [inbe]), (trial: [resa]), (proportion: [qnco]), (invariate response strategy (e.g.: [menp]), (safe option): []), (asd group: [cgab]), (controls: [sbst]), (additionally: []), (responses: [orga]), (win frame: [nusq]), (first half: [fndg]), (lose frame: [nusq]), (end: [gngm]), (decision times: [menp]), (td controls: [sbst]), (findings: [clna]), (asd tendency towards: [cgab]), (behaviour: [inbe]), (high-level decision-making tasks: [menp]), (such tasks: []), 
ASD Terms: (repetitive patterns of behaviours, 'Restricted and Repetitive Behavior')(autism spectrum disorder, 'Autism Phenotype')(diagnosis, 'Diagnosis')(diagnosis, 'Diagnosis')

PMCID: 5365326
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (number: [qnco]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (dramatically: []), (however: []), (etiology: []), (asd: [cgab]), (study: [resa]), (mammalian target: [mamm]), (rapamycin inhibitor rapamycin: [antb,orch]), (effect: []), (new therapeutic strategies: [menp]), (asd rat model: [mamm]), (valproic acid (vpa): [orch,phsu]), (rats: [mamm]), (pregnancy day: [orgf]), (vpa group: [popg]), (asd group: [cgab]), (asd + rapamycin (asd + rapa) group: [cgab]), (frequency: [qnco]), (duration: [phsu]), (social behavior: [socb]), (straight times: [popg]), (grooming times: [inbe]), (meanwhile: []), (average escape latency: [qnco]), (plates: []), (apoptotic index (ai): [qnco]), (tunel assay: [mbrt]), (expression: [topp]), (brain-derived neurotrophic factor (bdnf): [aapp,bacs]), (b-cell: [cell]), (great difference: [qnco]), (normal group: [popg]), ( rapamycin treatment: [antb,orch]), (asd rats: [mamm]), (asd-like: [cgab]), (frequencies: []), (straight: [popg]), (grooming: [inbe]), (furthermore: []), ( rapamycin: [antb,orch]), (hippocampus: [bpoc]), (ai: [dsyn]), (levels: []), (bdnf: [gngm]), (bcl-2 (p<0.01): [gngm]), (findings: [clna]), (rapamycin: [antb,orch]), (bcl-2: [gngm]), (hippocampus apoptosis: [bpoc]), (vpa-induced asd rats: [mamm]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social behavior, 'Reciprocal Social Interaction')

PMCID: 6194137
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (emergence: []), (eusociality: []), (major evolutionary transition: [genf]), (group reproduction: [orgf]), (eusocial species: []), ( honey bees: [euka]), (ants: [aapp,bacs]), ( represent: [acty]), (behavioral extremes: [inbe]), (social evolution: [hcpp]), (close relatives: [famg]), (halictid bee lasioglossum: [euka]), (eusocial nests: []), (intraspecific variation: []), (genetic basis: [phsu]), (here: []), (genetic variants: [npop]), (polymorphism: [genf]), (intron: [bacs,nnon]), (syntaxin: [aapp,bacs]), ((syx1a): []), (gene: [gngm]), (synaptic vesicle release: [celc]), (variant: []), (gene expression: [genf]), (pattern: []), (differences: [qnco]), (solitary bees: [euka]), (surprisingly: []), ( syx1a: []), (several other genes: [gngm]), (sociality: []), (l. albipes: [qnco]), (autism spectrum disorder: [mobd]), (humans: [humn]), (thus: []), ( genes: [gngm]), (behavioral variation: [inbe]), (social behaviors: [socb]), (wide range: [qnco]), (taxa: []), 
ASD Terms: (behavioral extremes of social evolution, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(social behaviors, 'Reciprocal Social Interaction')

PMCID: 3989041
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (association: [menp]), (autistic traits: [mobd]), (emotion recognition: [menp]), (large community sample: [sbst]), (children: [aggp]), (social motion cues: [npop]), (gender: [orga]), (general population sample: [popg]), (avon longitudinal study: [resa]), (parents: []), (children (alspac): [aggp]), (ability: [orga]), (emotions: [menp]), (diagnostic analysis: [resa]), (non-verbal accuracy: [fndg]), (emotional triangles task: [menp]), (novel test: [lbpr]), (recognition: [menp]), (emotion: [menp]), (autistic-like social communication difficulties: [mobd]), (social communication disorders checklist: [mobd]), (such difficulties: [fndg]), (genders: [orga]), (facial emotion recognition: [menp]), (boys: [aggp]), (ratio: [qnco]), (ci: [gngm]), (p = .0001): [aapp,imft]), (finding: [sosy]), (light: [gngm]), (power: [hcpp]), (differences: [qnco]), (girls: [aggp]), (community sample: [sbst]), (deficits: []), (social communication skills: [socb]), (discrimination: [socb]), (underlying continuum: []), (liability: []), (characteristics: []), (similar degree: [qnco]), (social motion: [npop]), (good performance: [inbe]), (familiar task: []), (facial emotion discrimination: [socb]), (compensatory mechanisms: []), (study: [resa]), (existence: []), (cognitive process: [menp]), (underlying autistic traits: [mobd]), (covert deficits: []), (further investigation: [hlca]), 
ASD Terms: (emotion recognition, 'Empathy')(social motion cues, 'Awareness of Social Cues')(assessing recognition of emotion, 'Empathy')(autistic-like social communication difficulties, 'Reciprocal Social Interaction')(social communication disorders checklist, 'Reciprocal Social Interaction')(recognition of emotion, 'Empathy')(facial emotion recognition, 'Empathy')(social communication skills, 'Reciprocal Social Interaction')(emotion recognition, 'Empathy')(cognitive process, 'Cognitive Ability')

PMCID: 6096837
SFARI Genes: met, met, 
Non SFARI Genes: HR, HR, 
Named Entities: (adaptive behaviour abilities: [orga]), (life: []), (important clinical prognostic information: [clna]), (stability: []), (such skills: [inbe]), (children: [aggp]), (high familial risk: [famg]), (asd: [cgab]), (diagnostic criteria: []), (age: [orga]), (years: []), ((hr-asd: [cgab]), ( n =: [aapp,imft]), ((hr-non-asd: [cgab]), ( n: [aapp,imft]), (low-risk control children: [aggp]), (infancy: []), (hr groups: [popg]), ( cognitive skills: [inbe]), (time: []), (lr children: [aggp]), (hr-asd children: [cgab]), (difficulties: [fndg]), (adaptive behaviour: [inbe]), (hr-non-asd children: [cgab]), (such difficulties: [fndg]), (pattern: []), (change: [qnco]), (understanding: [menp]), (developmental profiles: [lbpr]), (hr siblings: [famg]), (core asd symptoms: [cgab]), 
ASD Terms: (adaptive behaviour abilities, 'Adaptive Life Skills')(infancy, 'Perinatal History')(cognitive skills, 'Cognitive Ability')(adaptive behaviour, 'Adaptive Life Skills')(core asd symptoms, 'Complaints and Indications')

PMCID: 4031083
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (core symptom: [clna]), (disorder: [dsyn]), ( individuals: [humn]), (autism: [mobd]), (selective impairments: [genf]), (face processing abilities: [orga]), (importantly: []), (reciprocal connection: []), (autistic traits: [mobd]), (face perception: [menp]), (population: [popg]), (study: [resa]), ( university participants: [mnob,orgt]), (social sciences: []), (physical sciences: []), (humanities: []), (battery: [inpo]), (measures: [qnco]), (face: [gngm]), (emotion recognition: [menp]), (general perceptual-cognitive style: [menp]), (sub-clinical autistic traits: [mobd]), (autism quotient (aq)): [mobd]), (separate hierarchical multiple regression: []), (factors: []), (face recognition scores: [clna]), (aq scores: [clna]), (gender: [orga]), (object recognition performance: [inbe]), (face recognition behaviour: [inbe]), (specifically: []), ( males: [orga]), (object recognition scores: [clna]), (face recognition test: []), (conversely: []), ( university major: [mnob,orgt]), ( gender: [orga]), (face recognition performance: [inbe]), (science majors: []), (individuals: [humn]), (poor face recognition skills: [grpa]), (autistic-like traits: [mobd]), (results: [fndg]), (autism phenotype: [mobd]), (face recognition: [menp]), 
ASD Terms: (autism, 'Autism Phenotype')(face processing abilities, 'Integrated Verbal and NonVerbal Communication')(face perception, 'Cognitive Ability')(emotion recognition abilities, 'Empathy')(emotion recognition, 'Empathy')(autism phenotype, 'Autism Phenotype')

PMCID: 4345538
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background:: []), (paucity: []), (research: [resa]), (individuals: [humn]), (autism spectrum disorders: [mobd]), (education: [fndg]), (method:: [lbpr]), (study: [resa]), (gap: [gngm]), (literature: [inpr,mnob]), (asd: [cgab]), (college students: [popg]), (college: []), (results:: [fndg]), (thirty-five individuals: [humn]), (online survey: []), (extensive academic supports: [orgt]), (academic success: [inbe]), (difficulties: [fndg]), (emotional domains: [menp]), (addition: []), (areas: []), (campus life: []), (service offices: []), (conclusions: overall: []), (results: [fndg]), (survey: []), (importance: []), (self-advocacy: [socb]), (need: []), (institutions: []), (comprehensive supports: []), (academic: [orgt]), ( social: []), (order: [acty]), (group: [popg]), (campus environment: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 4193263
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (hallmark characteristic: []), (autism spectrum disorder (asd): [mobd]), (poor reciprocal social communication: [fndg]), (interventions: [hlca]), (core deficit: [dsyn]), (social skills interventions: [socb]), (direct training: [edac]), ( peer mediation: [socb]), (video modeling: [resa]), (improvements: []), (various social skills: [socb]), (children: [aggp]), (asd: [cgab]), (paper: []), (social competence interventions: [socb]), (hypothesized critical components: []), (advancing: []), ( maintaining: [acty]), (generalizing skills: [inbe]), ((1): [fndg]), (mediation: [socb]), ( (2): [qnco]), (active learning: [edac]), ((3) implementation: [fndg]), (supportive: []), ( natural contexts: [fndg]), (framework: []), (approaches: []), (conceptual paper: []), (sense theatre: [ortf]), (novel intervention: [hlca]), (combines: []), (peers: [popg]), (performance-based theatrical treatment: [topp]), ( community-based environment: []), (review: []), (previous research: [resa]), (early feasibility: []), (stage: [clna]), (rigorous studies: [sosy]), (intervention package: [qnco]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(poor reciprocal social communication, 'Reciprocal Social Interaction')(improvements in various social skills, 'Ability to Converse in Social Settings')(social skills interventions, 'Ability to Converse in Social Settings')(various social skills, 'Ability to Converse in Social Settings')(social competence interventions, 'Social Competence')

PMCID: 6160544
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (previous studies: [lbpr]), (individuals: [humn]), (different social skills: [socb]), (performance: [inbe]), (rhythmic interpersonal motor coordination: [ortf]), (social skills: [socb]), (autism spectrum disorder: [mobd]), (schizophrenia: [mobd]), (actions: []), (partners: [popg]), (study: [resa]), (finding: [sosy]), (pairs: []), (disability: [fndg]), (this: []), (interpersonal motor coordination task: [ortf]), (participants: [popg]), (rhythmic movements: [orgf]), (interpersonal relative phase pattern: [qnco]), (roles: [socb]), (preceding: []), (roles): [socb]), ( meaning: []), (others movements: [orgf]), (verbal communication: [socb]), (individual social skills: [socb]), (autism-spectrum quotient (aq): [qnco]), (aq scores: [clna]), (similar aq scores: [clna]), (present task: [qnco]), (opposite result: [fndg]), (findings: [clna]), (interpersonal coordination performance: [inbe]), (tasks: []), (roles themselves: [socb]), 
ASD Terms: (combining individuals with different social skills, 'Ability to Converse in Social Settings')(rhythmic interpersonal motor coordination, 'Motor Skills')(autism spectrum disorder, 'Autism Phenotype')(different social skills, 'Ability to Converse in Social Settings')(social skills, 'Ability to Converse in Social Settings')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(interpersonal motor coordination task, 'Motor Skills')(individual social skills, 'Ability to Converse in Social Settings')(interpersonal coordination performance, 'Motor Skills')

PMCID: 6155256
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (disability burden: [fndg]), (clinical cohorts: [popg]), (social impairment: [patf]), (poor functional outcomes: [fndg]), (impairment: [patf]), (dysfunction: [dsyn]), (study: [resa]), (transdiagnostic approach: []), (executive function (ef): [menp]), (young adults: [aggp]), (contribution: [acty]), (comparisons: [acty]), (prominent disorders: [dsyn]), (social impairments: [patf]), ( autism spectrum disorder (asd): [mobd]), ( early psychosis (ep): [mobd]), (social anxiety disorder (sad): [mobd]), (group (typ): [popg]), (overall disability: [fndg]), (self-report assessments: [resa]), (ef: []), (asd participants: [cgab]), (impaired performance: [inbe]), (domains: []), (typ group (mental flexibility: [popg]), (attention: [menp]), (fluency): []), (ep group: [popg]), (sustained attention: [menp]), (attentional shifting: [menp]), (sad participants: [popg]), (ef impairment: [patf]), (self-report ratings: [hlca]), (objective performance: [inbe]), (self-reports: [resa]), (significant percentage (17%): [qnco]), (disability: [fndg]), (addition: []), (variance: [qnco]), (other predictors: []), (asd: [cgab]), (first study: [qnco]), (ef measures: [qnco]), (clinical groups: [popg]), (unique cognitive-circuitry: []), (groups: [popg]), (impairments: [patf]), ( ep impairments: [patf]), (attentional processes: [menp]), (sad impairments: [patf]), (negative self-monitoring: [fndg]), (self-report: [resa]), (performance-based ef: [inbe]), (capacity: [qnco]), (findings: [clna]), (transdiagnostic circuitry models: []), (intervention strategies: [topp]), 
ASD Terms: (social impairment, 'Social Competence')(executive function, 'Executive Function')(social impairments, 'Social Competence')(autism spectrum disorder, 'Autism Phenotype')(social anxiety disorder, 'Anxiety Disorders')(executive function, 'Executive Function')(executive function, 'Executive Function')(attentional shifting, 'Transitioning Ability')(executive function impairment, 'Executive Function')(social anxiety disorder participants, 'Anxiety Disorders')(executive function, 'Executive Function')(compare executive function measures, 'Executive Function')(executive function measures, 'Executive Function')(executive function, 'Executive Function')(social anxiety disorder impairments, 'Anxiety')(performance-based executive function, 'Executive Function')

PMCID: 6135829
SFARI Genes: OXT, OXT, OXT, OXT, 
Non SFARI Genes: 
Named Entities: (disturbance: []), (neurotransmitters: [bacs]), (neuromodulators: [bacs]), (pathophysiology: [patf]), (autism spectrum disorder (asd): [mobd]), (studies: [lbpr]), (dup mouse models: [mamm]), (asd: [cgab]), (duplication: [comd]), (serotonin (5-ht) levels: [bacs,orch]), (asd-related symptoms: [cgab]), (adults: [aggp]), (however: []), (behavioral symptoms: [sosy]), (contrast: [irda]), ( oxytocin (oxt): [aapp,horm,phsu]), (affiliative behaviors: [inbe]), (study: [resa]), (serotonin-oxt interaction: [bacs,orch]), (early postnatal period: []), (critical role: [socb]), (restoration: []), (social abnormality: [fndg]), (dup mice: [mamm]), (oxt: [gngm]), (5-ht1a receptor: [aapp,rcpt]), (agonist 8oh-dpat treatment: [topp]), (postnatal day: []), ((pd7): []), (pd21: []), (three-chamber social interaction test: [fndg]), (adult: [aggp]), (effect: []), (8oh-dpat: []), (blockade: [phsu]), (oxt receptors: [aapp,rcpt]), (thus: []), (5-ht1a receptors: [aapp,rcpt]), (normal development: [fndg]), (social behavior: [socb]), (therefore: []), (novel therapeutic strategy: [menp]), (treatment: [topp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(behavioral symptoms of asd, 'Complaints and Indications')(restoration of social abnormality, 'Social Competence')(social abnormality, 'Social Competence')(three-chamber social interaction test, 'Reciprocal Social Interaction')(social behavior, 'Reciprocal Social Interaction')

PMCID: 6121008
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (face recognition: [menp]), (important index: [qnco]), (formation: [biof]), (social cognition: [socb]), (neurodevelopment: [ortf]), (humans: [humn]), (changes: [qnco]), (face perception: [menp]), (memory: [menp]), (altered sociability: [socb]), (symptom: [clna]), (numerous brain conditions: [dsyn]), (autism spectrum disorder (asd): [mobd]), (various brain regions: [blor]), (neuropeptides: [aapp,bacs]), (face processing: [emst]), (neuropeptide oxytocin (ot): [aapp,horm,phsu]), (important role: [socb]), (various social behaviors: [socb]), (face: [gngm]), (emotion recognition: [menp]), (nasal ot administration: [topp]), (promising new therapy: [fndg]), (social cognition deficits: [socb]), (individuals: [humn]), (asd: [cgab]), (new: []), (instrumental neurotechnologies: []), (assessment: [acty]), (brain region activation: [acty]), (specific social tasks: []), (therapies: [topp]), (involvement: []), (genes: [gngm]), (peptides: [aapp]), (impaired neurodevelopment: [ortf]), (present review: [qnco]), (mechanisms: []), (ability: [orga]), (ot: [gngm]), (new perspectives: []), (technologies: []), (research: [resa]), (rehabilitation: [topp]), 
ASD Terms: (social cognition, 'Cognitive Ability')(face perception, 'Cognitive Ability')(memory, 'Working Memory')(autism spectrum disorder, 'Autism Phenotype')(face processing, 'Integrated Verbal and NonVerbal Communication')(various social behaviors, 'Reciprocal Social Interaction')(emotion recognition, 'Empathy')(address social cognition deficits, 'Cognitive Ability')(social cognition deficits, 'Social Competence')(modulate social cognition, 'Cognitive Ability')

PMCID: 5218556
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (purpose proton: [elii]), (magnetic resonance spectroscopy (1h mrs): [diap]), (noninvasive neuroimaging method: [diap]), (biochemical metabolites: [bacs]), (vivo: []), (powerful tool: []), (neurobiochemical profiles: [lbpr]), (brain: [bpoc]), (aspergers syndrome (as): [mobd]), (type: [qnco]), (autism spectrum disorder: [mobd]), (impaired social skills: [socb]), (repetitive patterns: []), (interest: [menp]), (activities: [acty]), (intellectual levels: []), (language skills: [menp]), (clinical aspects: [clna]), (well-characterized: [acty]), ( neurometabolic profiling: [lbpr]), (as: []), (present study: [qnco]), (proton: [elii]), (pediatric as: []), (measurable neurometabolic abnormalities: [cgab]), (new information: [fndg]), (neurobiological underpinnings: []), (disorder: [dsyn]), (study participants: [humn]), (children: [aggp]), (as (212 years: []), (mean age: [orga]), ((2.0);: [qnco]), (boys): [aggp]), (developed children: [aggp]), (years: []), (old; mean age: [orga]), ((2.6);: [qnco]), (normal control group: [grup]), (mrs data: [euka]), (regions: []), (interest:: [menp]), (anterior cingulate cortex (acc): [bpoc]), (cerebellum: [bpoc]), (acc: [gngm]), ( levels: []), (n-acetylaspartate (naa): [aapp,bacs]), (total creatine (tcr): [aapp,bacs]), (total choline-containing compounds: [bacs,orch,phsu]), (myo-inositol (mi): [orch,phsu,vita]), (other hand: [bpoc]), (significant group differences: [popg]), (metabolites: [bacs]), (left cerebellum: [bpoc]), (age: [orga]), (sex: [orgf]), (metabolic findings: [fndg]), (finding: [sosy]), (decreased levels: [qnco]), (naa: [aapp,bacs]), ( tcr: [aapp,imft,rcpt]), ( tcho: []), (mi: [gngm]), (left cerebellar voxels: [bpoc]), (neuronal density: [qnco]), (present as cohort: [qnco]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(repetitive patterns of interest, 'Stereotyped, Restricted, and Repetitive Behavior')(aspergers syndrome, 'Asperger Syndrome')(impaired social skills, 'Ability to Converse in Social Settings')(language skills, 'Development or Regression of Language Skills')(aspergers, 'Asperger Syndrome')(pediatric aspergers syndrome, 'Asperger Syndrome')(aspergers, 'Asperger Syndrome')(aspergers, 'Asperger Syndrome')(present aspergers syndrome cohort, 'Asperger Syndrome')

PMCID: 4166357
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (relationship: []), (visual attention: [menp]), (social information: []), (oxytocin (ot) levels: [aapp,horm,phsu]), (japanese preschool children: [aggp]), (autism spectrum disorder (asd): [mobd]), (poor visual attention: [fndg]), (low ot levels: [hlca]), (important risk factors: [qnco]), (asd: [cgab]), (pattern: []), (gaze fixation: [ortf]), (eye-tracking system: [bpoc]), (salivary ot levels: [hlca]), (enzyme-linked immunosorbent assay (elisa): [lbpr]), (positive association: [menp]), (fixation duration: [phsu]), (indicated object area: [fndg]), (finger-pointing movie: []), (children: [aggp]), (however: []), (association: [menp]), (variables: []), (moreover: []), ( age: [orga]), (individual's attention: [menp]), (people: [popg]), (pointed-at objects: [qnco]), (attention: [menp]), (mouth-in-the-face recognition: [bsoj]), (geometric patterns: []), (biological motions: [npop]), (thus: []), ( ot levels: [hlca]), (td children: [aggp]), (further: []), (preschool children: [aggp]), (considerable effect: []), 
ASD Terms: (visual attention, 'Visual Thinking')(autism spectrum disorder, 'Autism Phenotype')(poor visual attention, 'Visual Thinking')(visual attention, 'Visual Thinking')(visual attention, 'Visual Thinking')

PMCID: 4526814
SFARI Genes: 
Non SFARI Genes: CA3, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disorder characterized: [mobd]), (part: [qnco]), (inability: []), (social cues: []), (patients: [podg]), (asd: [cgab]), (other peoples emotional perspective: [menp]), (neuronal correlates: [imft]), (impairment: [patf]), (behavioral phenotype: [bhvr]), (mouse model: [emod]), (autism: [mobd]), (neuronal background: [imft]), (problem: [fndg]), (btbr t+itpr3tf/j (btbr): [mamm]), ((b6) mice: [mamm]), (transfer: [menp]), (emotional information test: [menp]), (social proximity test: [lbpr]), (tests btbr mice: [lbpr]), (asocial behavior: [inbe]), (c-fos protein expression: [aapp,bacs]), (several brain regions: [blor]), (tests: [lbpr]), (that: []), (b6 mice: [mamm]), ( btbr mice react: [mamm]), (stressed cagemate exposure: [clna]), (increase: []), (c-fos expression: [gngm]), (prefrontal cortex: [bpoc]), (amygdala: [bpoc]), (however: []), (social proximity exposure: [clna]), (strong increase: []), (ca3 field: [bpoc]), (hippocampus: [bpoc]), (hypothalamic regions: [bpoc]), (btbr brains: [bpoc]), (response: [fndg]), (strong activation: [acty]), (periaqueductal regions: []), (btbr mice: [mamm]), (unavoidable social interaction: [fndg]), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder characterized, 'Learning Disorders')(social cues, 'Awareness of Social Cues')(autism, 'Autism Phenotype')(stressed cagemate exposure, 'Exposures')(social proximity exposure, 'Exposures')(unavoidable social interaction, 'Reciprocal Social Interaction')

PMCID: 4138786
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (ability relies: [orga]), (social factors: [grpa]), (performance: [inbe]), (healthy controls: []), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (schizophrenia (sz): [mobd]), (experimental task: []), (participants: [popg]), (correspondences: []), (drawings: []), (scenes: []), (item: []), (scene: []), (relational item: [socb]), (second scene: [qnco]), (relational complexity: [chvs]), ( presence: [qnco]), (distraction: [topp]), (type: [qnco]), (objects: []), (analogies: []), (non-living items): []), (cognitive differences: [mobd]), (sz: [sosy]), (relational inferences: [menp]), (asd: [cgab]), (hc: [gngm]), (item problems: []), (social function scores: [socb]), (overall accuracy: []), (hc relative: [horm,orch,phsu]), ( consistent: []), (prior research: [resa]), (groups: [popg]), (analogical responding: [chvs]), (presence: [qnco]), (non-living items: []), (separate group: [popg]), (asd group: [cgab]), (problems: []), (distractors: []), (present: [qnco]), (sz group: [sosy]), (differences: [qnco]), (problem type: [qnco]), (significant correlations: [qnco]), (social cognitive ability: [socb]), (analogical reasoning: [menp]), (results: [fndg]), (social abilities: [socb]), (ability: [orga]), (analogical correspondences: [chvs]), (numbers: [qnco]), (relational elements: [elii]), (types: []), 
ASD Terms: (reasoning performance in healthy controls, 'Reasoning')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(autism spectrum disorder, 'Autism Phenotype')(cognitive differences, 'Cognitive Ability')(social function scores, 'Ability to Converse in Social Settings')(schizophrenia group, 'Schizophrenia and Disorders with Psychotic Features')(social cognitive ability, 'Cognitive Ability')(social abilities, 'Ability to Converse in Social Settings')

PMCID: 4717545
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (genetic: [topp]), ( hormonal: []), (environmental factors: []), (infancy: []), (sexual dimorphism: [ortf]), (regional brain structures: [bpoc]), (subjects: [humn]), (typical development: [orgf]), (however: []), (neuroanatomical differences: [qnco]), (male: [orga]), (female children: [aggp]), (autism spectrum disorders: [mobd]), (intriguing: []), (issue: [fndg]), (study: [resa]), (brain: [bpoc]), (young children: [aggp]), (asd: [cgab]), (sex-related structural differences: [orga]), (correlation: []), (clinical asd features: [cgab]), (neuroanatomical underpinnings: []), (total: [qnco]), (structural mri scans: [qnco]), (specifically: []), (asd (38 males: [cgab]), (years: []), (age; mean =: [orga]), (months: []), ( standard deviation: [qnco]), (months): []), (support vector machine: [qnco]), ((svm)-based analysis: [resa]), (grey matter (gm): [tisu]), (group comparisons: [popg]), (non-verbal-intelligence quotient-matched children: [aggp]), (idiopathic developmental delay: [mobd]), (autism: [mobd]), (genders: [orga]), (svm: []), (gm volume: [antb,orch]), (respect: [socb]), (bilateral superior frontal gyrus (brodmann area: [blor]), (bilateral precuneus: [bpoc]), (bilateral superior temporal gyrus: [bpoc]), (whereas: []), (gm: [gngm]), (patients: [podg]), (right inferior temporal gyrus: [bpoc]), (gender comparisons: [orga]), (females: [orga]), (asd vs. controls: [cgab]), (males: [orga]), (controls): [sbst]), (regions: []), (superior frontal gyrus: [bpoc]), (detected: [fndg]), (sex-by-group analyses: [orgf]), (controls: [sbst]), (male-specific regions: [orga]), (increased gm volume: [antb,orch]), (middle occipital gyrusba: [blor]), (right superior temporal gyrusba: []), (comparisons: [acty]), (gm volumes: [antb,orch]), (bilateral frontal regions: [bpoc]), (additional regions: []), (right anterior cingulate cortex: [bpoc]), (right cerebellum: [bpoc]), (specific behavioural correlates: [inbe]), (sex-dimorphism: [orga]), ( brain morphology: [fndg]), (investigations: [hlca]), (evidence: []), (structural brain gender differences: [orga]), (different phenotypic disease manifestations: [dsyn]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-015-0067-3) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (infancy, 'Perinatal History')(autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(idiopathic developmental delay, 'Learning Disorders')

PMCID: 6156544
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (membrane transporter at1/slc33a1: [aapp,bacs]), (lumen: [bsoj]), (endoplasmic reticulum (er): [celc]), (quality control mechanisms: []), (secretory pathway: [celf]), (mutations: [genf]), (duplication events: [evnt]), (at1/slc33a1: [gngm]), (diseases: [dsyn]), (spastic paraplegia: [dsyn]), (developmental delay: [mobd]), ( autism spectrum: [mobd]), (intellectual disability: [mobd]), ( propensity: []), (biology: []), (key transporter: [aapp,bacs]), (systemic overexpression: [genf]), (at1: [gngm]), (mouse: [mamm]), (segmental form: []), (progeria: [dsyn]), (dysmorphism: [cgab]), (metabolic alterations: [celf]), (phenotype: [orga]), (growth: [orgf]), (short lifespan: [grpa]), ( alopecia: [dsyn]), ( skin lesions: [dsyn]), (rectal prolapse: [dsyn]), ( osteoporosis: [dsyn]), ( cardiomegaly: [fndg]), ( muscle atrophy: [patf]), (terms: [orgf]), (homeostasis: [biof]), (at1 overexpressing mouse displays: [mamm]), (glycemia: [orch]), (indices: [lbpr]), (systemic inflammation: [patf]), (mechanistically: []), (block: [qnco]), (atg9afam134blc3: []), (atg9asec62lc3 interactions: []), (defective reticulophagy: []), (autophagic recycling: [hcpp]), (er: [gngm]), (inhibition: [acty]), (atase1/atase2 acetyltransferase: [aapp,enzy]), (downstream: []), (at1 restores: [gngm]), (animals: [anim]), (data: [euka]), (acetylcoa flux: [bacs,nnon]), (defects: []), (autophagy: [celf]), (recycling: [hcpp]), (subcellular structures: [celc]), (diversion: [fndg]), (acetylcoa: [bacs,nnon]), (cytosol: [celc]), (progeria phenotype: [dsyn]), (collectively: []), (cytosoltoer flux: [npop]), (novel event: [evnt]), (pace: [gngm]), (phenotypes: [orga]), (intracellular acetylcoadependent: [celc]), (homeostatic mechanisms: [orgf]), (metabolism: [orgf]), (inflammation: [patf]), 
ASD Terms: (developmental delay, 'Learning Disorders')(autism spectrum, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')

PMCID: 6344899
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract autism spectrum disorder (asd): [mobd]), (heterogeneous neurodevelopmental disorder: [orga]), (social communication deficits: [socb]), (presence: [qnco]), (restricted interests: [menp]), (repetitive behaviors: [fndg]), (significant improvements: [qnco]), (social functioning: [socb]), (communication abilities: [fndg]), (clinical symptoms: [sosy]), (children: [aggp]), (asd: [cgab]), (treatment: [topp]), (single infusion: [fndg]), (autologous cord blood: [tisu]), (phase: []), (trial: [resa]), (current study: [resa]), (improvements: []), (concurrent changes: [qnco]), (brain: [bpoc]), (structural connectivity: []), (clinical outcome measures: [qnco]), (vineland adaptive behavior scalesii socialization subscale: [edac]), ( expressive oneword picture vocabulary test4: [topp]), (clinical global impressionimprovement scale: [acty]), (baseline: [bodm]), (months: []), (subset: []), (diffusion tensor imaging: [diap]), (deterministic tractography: []), (behavioral improvements: [inbe]), (increased white matter connectivity: [tisu]), (frontal: []), ( temporal: []), (subcortical regions (hippocampus: [bpoc]), (basal ganglia): [bpoc]), (anatomical: []), ( connectivity: []), (functional abnormalities: [cgab]), (current results: [npop]), (social communication skills: [socb]), (reduction: [npop]), (symptoms: [sosy]), (autologous cord blood infusion: [tisu]), (increased structural connectivity: [qnco]), (brain networks: [bpoc]), (social: []), ( communication: [socb]), (language abilities: [menp]), (stem cells: [cell]), (translational medicine: [resa]), 
ASD Terms: (restricted interests, 'Restricted Range of Interests')(abstract autism spectrum disorder, 'Autism Phenotype')(heterogeneous neurodevelopmental disorder, 'Learning Disorders')(social communication deficits, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(social functioning, 'Ability to Converse in Social Settings')(communication abilities, 'Reciprocal Social Interaction')(vineland adaptive behavior scalesii socialization subscale, 'Reciprocal Social Interaction')(social communication skills, 'Reciprocal Social Interaction')(language abilities, 'Development or Regression of Language Skills')

PMCID: 5810773
SFARI Genes: Cntn5, Cntn5, Cntn5, Cntn5, Cntn5, Cntn5, Cntn5, Cntn5, Cntn5, Cntn5, Cntn5, Cntn5, Cntn5, Cntn5, 
Non SFARI Genes: 
Named Entities: (abstract contactin-5 (cntn5): [gngm]), (immunoglobulin cell adhesion molecule: [aapp,bacs]), (central nervous system: [bdsy]), (view: []), (association: [menp]), (neurodevelopmental disorders: [mobd]), (spectrum disorder (asd): [cgab]), (study: [resa]), (cntn5-positive areas: [gngm]), (forebrain: [bpoc]), (behavioral phenotypes: [bhvr]), (cntn5 null mutant (cntn5/) mouse: [mamm]), (relation: [socb]), (areas: []), (asd symptomatology: [cgab]), (antibody: [aapp,imft]), (spatial expression pattern: [topp]), (cntn5: [gngm]), (p7: [gngm]), (wild type (cntn5+/+) mice: [mamm]), (cntn5 expression pattern: [gngm]), (strong expression: [topp]), (cerebral cortex: [bpoc]), ( hippocampus: [bpoc]), (mammillary bodies: [bpoc]), (addition: []), (brain nuclei: [bpoc]), (auditory pathway: [bpoc]), (dorsal thalamus: [bpoc]), (thinning: []), (primary somatosensory (s1) cortex: [bpoc]), (cntn5/ mice: [mamm]), (misplacement: []), (cntn5-ablated cells: [cell]), (phenotype: [orga]), (reduction: [npop]), (barrel/septa ratio: [qnco]), (s1 barrel field: [irda]), (structure: []), (morphology: [fndg]), (hippocampus: [bpoc]), (set: [menp]), (behavioral experiments: [inbe]), (social: []), ( exploratory: []), (repetitive behaviors: [fndg]), (data: [euka]), (selective role: [socb]), (development: [orgf]), (overt behavioral phenotypes: [bhvr]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 4296675
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (aspergers syndrome (as): [mobd]), (autism spectrum disorder: [mobd]), (significant difficulties: [fndg]), (social interaction: [fndg]), (nonverbal communication: [menp]), (repetitive patterns: []), (behavior: [inbe]), (interests: [menp]), (difficulties: [fndg]), (respect: [socb]), (pragmatic speech: [orgf]), (social cues: []), (fact: [gngm]), (fiction: []), (account: [clna]), (influence: []), (context: [fndg]), (statement: []), (features: []), (however: []), ( hitherto: []), (questionnaires: []), (symptoms: [sosy]), (study: [resa]), (short (11 questions) questionnaire: [qnco]), (self-rated pragmatic speech: [orgf]), (freiburg questionnaire: []), (linguistic pragmatics: [socb]), (psychometric properties: [diap]), (questionnaire: []), (sample: [sbst]), (patients: [podg]), (aspergers syndrome: [mobd]), (other psychiatric disorders: [mobd]), (convenience sample: [resa]), (people: [popg]), (reliability analysis: [resa]), (high cronbachs: [qnco]), (strong correlations: []), (fqlp: []), (autism quotient: [mobd]), (empathy quotient: [inbe]), (divergent validity: [qnco]), (moderate correlation: []), (self-rated symptoms: [sosy]), (personality disorders: [mobd]), (significant correlation: [qnco]), (vocabulary skills: [inbe]), (receiver: []), (characteristics curve: []), (excellent diagnostic accuracy: []), (fqlp (.97): [qnco]), (control group: [grup]), (mental disorder: [mobd]), (different psychiatric disorders: [mobd]), (results: [fndg]), (construct: []), (peculiarities: []), (as: []), (reliable: []), ( brief: []), (valid instrument: []), (first results: [fndg]), (sensitivity: [patf]), (specificity: [qnco]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s12888-014-0374-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(repetitive patterns of behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(aspergers syndrome, 'Asperger Syndrome')(autism spectrum disorder, 'Autism Phenotype')(nonverbal communication, 'Non-Verbal Communication')(pragmatic speech, 'Language Ability')(social cues, 'Awareness of Social Cues')(self-rated pragmatic speech, 'Language Ability')(other psychiatric disorders, 'Mental Disorders')(autism quotient, 'Autism Phenotype')(empathy quotient, 'Empathy')(patients with different psychiatric disorders, 'Mental Disorders')(aspergers, 'Asperger Syndrome')(mental disorder, 'Mental Disorders')(different psychiatric disorders, 'Mental Disorders')

PMCID: 6370474
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (heterogeneous neurodevelopmental disorder: [orga]), (impairments: [patf]), (social communication: [socb]), (repetitive behaviors: [fndg]), (studies: [lbpr]), (complex patterns: [chvs]), (functional connectivity (fc): []), (asd: [cgab]), (clear consensus: [socb]), (brain-behavior relationships: [bpoc]), (patterns: []), (fc: [acty]), (controls: [sbst]), (here: []), (dimensional approach: [qnco]), (distinct clusters: [qnco]), (fc patterns: [acty]), (asd participants: [cgab]), (k-means clustering: [resa]), (multivariate statistical analyses: [qnco]), (categorical approach: []), (differences: [qnco]), (subtypes: []), (diagnostic groups: [popg]), (subtype: []), (increased fc: [acty]), (resting-state networks: [fndg]), (networks: []), (other subtype: []), (separate fc pattern: [acty]), (default: []), (mode: [qnco]), ( cingulo-opercular: [bpoc]), ( sensorimotor: []), (occipital networks: [blor]), (significant interaction: [qnco]), (finally: []), (dimensional analysis: [resa]), (behavioral measures: [qnco]), (iq: []), (social responsiveness: []), (asd severity: [cgab]), (unique brain-behavior relations: [bpoc]), (continuum: []), (brain-behavior relations: [bpoc]), (results: [fndg]), (fc subtypes: [acty]), (unique information: []), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(heterogeneous neurodevelopmental disorder, 'Learning Disorders')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(shared patterns of functional connectivity, 'Sharing')

PMCID: 2582449
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (much controversy: [socb]), (clinical efficacy: []), (developmental interventions: [hlca]), (core symptoms: [sosy]), (autism spectrum disorders: [mobd]), (systematic review: []), (evidence: []), (effectiveness: []), (asd: [cgab]), (methods: []), (findings comprehensive searches: [acty]), (electronic databases: [fndg]), (may: []), (further information: []), (hand: [bpoc]), (journals: [inpr,mnob]), (reference lists: []), ( databases: []), (theses: []), (dissertations: []), (experts: []), (field: [irda]), (observational analytic studies: [resa]), (english: [lang]), (efficacy: [resa]), (developmental intervention: [hlca]), (individuals: [humn]), (independent reviewers: [popg]), (final study selection: [genf]), (data: [euka]), (consensus: [socb]), (study quality: [resa]), (results: [fndg]), (possible: []), ( meta-analyses: [resa]), (study results: [fndg]), (one-hundred-and-one studies: [qnco]), (high risk: [fndg]), (bias: [bird]), (inconsistent results: [fndg]), (various interventions: [hlca]), (review: []), (meta-analyses: [resa]), (clinical trials: [resa]), (lovaas treatment: [topp]), (special education: [edac]), (measures: [qnco]), (adaptive behaviour: [inbe]), ( communication: [socb]), (interaction: []), ( comprehensive language: [menp]), (skills: [inbe]), ( expressive language: [lang]), (overall intellectual functioning: [menp]), (socialization: [edac]), (high-intensity lovaas: []), (low-intensity lovaas: [npop]), (intellectual functioning: [menp]), (retrospective cohort studies: [resa]), (randomized: [resa]), (trials: [resa]), (developmental approaches: [orgf]), (initiative interaction: [menp]), (amount: [qnco]), (time: []), (stereotyped behaviours: [mobd]), (distal social behaviour: [socb]), (effect sizes: []), (significant differences: [qnco]), (lovaas versus: []), (non-verbal intellectual functioning; lovaas versus developmental individual-difference: [menp]), (relationship-based intervention: [hlca]), (communication skills; computer: [orga]), (instruction: [edac]), (treatment: [topp]), (facial expression recognition;: [menp]), (teacch versus standard care: [acty]), (imitation skills: [inbe]), (eye-hand integration: [bpoc]), (lovaas: []), (findings: [clna]), (pooling: []), (few: [qnco]), (weak studies: [lbpr]), (few participants: [popg]), (short-term follow-up: [hlca]), (definitive behavioural: [inbe]), (symptoms: [sosy]), (clinical management: [hlca]), (individual needs: [humn]), (availability: []), (resources: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(adaptive behaviour, 'Adaptive Life Skills')(comprehensive language, 'Development or Regression of Language Skills')(expressive language, 'Expressive Language')(overall intellectual functioning, 'Mental Retardation')(intellectual functioning, 'Mental Retardation')(initiative interaction, 'Initiating Social Interaction')(stereotyped behaviours, 'Stereotyped, Restricted, and Repetitive Behavior')(distal social behaviour, 'Reciprocal Social Interaction')(non-verbal intellectual functioning, 'Mental Retardation')(relationship-based intervention for communication skills, 'Reciprocal Social Interaction')(facial expression recognition, 'Integrated Verbal and NonVerbal Communication')(imitation skills, 'Imitation')(communication skills, 'Reciprocal Social Interaction')(core symptoms of asd, 'Complaints and Indications')

PMCID: 5897402
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (biological predispositions: [clna]), (visual cues: []), (face-like stimuli: [blor]), (biological motion: [npop]), (social behavior: [socb]), (first moments: [qnco]), (life: []), (human neonates: [humn]), ( infant monkeys: [mamm]), (domestic chicks: [anim]), (impairments: [patf]), (social predispositions: [clna]), (neonates: [aggp]), (high familial risk: [famg]), (autism spectrum disorder (asd): [mobd]), (embryonic exposure: [clna]), ((vpa): []), (anticonvulsant: [phsu]), (risk: []), (asd: [cgab]), (behavioral deficits: [inbe]), (spontaneous social predispositions: [clna]), (approach responses: [orga]), (stimulus: [phpr]), (face configuration: [blor]), (stuffed hen: []), (scrambled version: []), (it: []), (social predisposition: [clna]), (vpa-treated chicks: [bird]), (experience-dependent mechanisms: [menp]), (results: [fndg]), (specific effect: []), (vpa: []), (development: [orgf]), (new perspectives: []), (neurobiological mechanisms: []), (early asd symptoms: [cgab]), 
ASD Terms: (visual cues, 'Visual Thinking')(social behavior, 'Reciprocal Social Interaction')(impairments of social predispositions, 'Social Competence')(autism spectrum disorder, 'Autism Phenotype')(behavioral deficits in domestic chicks, 'Personal Traits')(embryonic exposure, 'Exposures')(behavioral deficits, 'Personal Traits')(early asd symptoms, 'Complaints and Indications')

PMCID: 4688330
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (impairment: [patf]), (behavioral domains:: []), (social interaction/communication: [socb]), (presence: [qnco]), (stereotyped behaviors: [mobd]), (interests: [menp]), (heterogeneity: [orga]), (phenotype: [orga]), (patients: [podg]), (complex etiology: [chvs]), (disorder: [dsyn]), (advancement: []), (development: [orgf]), (successful pharmacotherapies: [topp]), (however: []), (recent years: []), (integration: [genf]), (findings: [clna]), (multiple levels: [qnco]), (research: [resa]), (human genetics: []), (models: []), (considerable progress: []), (understanding: [menp]), (asd pathophysiology: [cgab]), (effective targeted drug therapies: [topp]), (present review: [qnco]), (current state: [clna]), (pharmacological research: [resa]), (asd: [cgab]), (common pathophysiology signature: [amas]), 
ASD Terms: (impairment in two behavioral domains, 'Personal Traits')(stereotyped behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 6336705
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (social interaction disorder: [mobd]), (researchers: []), (second-person stance: [grup]), (experimental setups: [acty]), (bidirectional interactions: []), (present work: [qnco]), (quantitative description: [qnco]), (movement patterns: [fndg]), (computer-mediated real-time sensorimotor interaction: [socb]), (dyads: [popg]), (adult participants: [aggp]), (control: [sbst]), (individual (ctrl): [gngm]), (individual: [humn]), (high-functioning autism (hfa): [mobd]), (time-series analyses: [resa]), (movements: [orgf]), (main results: [fndg]), (first: [qnco]), (multi-scale coordination: [phsf]), (participants: [popg]), (present: [qnco]), (second: [qnco]), (dyadic alignment: [qnco]), (previous finding: [sosy]), (individuals: [humn]), (hfa: [dsyn]), (others presence: [qnco]), ( individuals movements: [orgf]), (style:: []), (contrast: [irda]), (ctrls: [gngm]), ( hfa participants: [dsyn]), (mutual interaction: []), (virtual environment: [hlca]), (generally: []), (finding: [sosy]), (social motivation deficit accounts: [clna]), (asd: [cgab]), (hypersensitivity-motivated avoidance: [patf]), (overstimulation: []), (research: [resa]), (utility: [orgt]), (time series analyses: [resa]), (complements: [aapp,imft]), (previous work: []), (performance-based variables: [inbe]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social interaction disorder, 'Reciprocal Social Interaction')(high-functioning autism, 'Autism Phenotype')(multi-scale coordination, 'Motor Skills')(high-functioning autism participants, 'Autism Phenotype')(social motivation deficit accounts of asd, 'Social Competence')(social motivation deficit accounts, 'Social Competence')

PMCID: 6354384
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (endocannabinoid system (ecs): [bacs,orch]), (major regulator: []), (synaptic plasticity: [ortf]), (neuromodulation: []), (alterations: []), (ecs: [topp]), (several animal models: [anim]), (autism spectrum disorder (asd): [mobd]), (models: []), (social deficits: []), (evidence: []), (dysregulations: []), (human asd: [humn]), (comprehensive assessments: [hlca]), (correlations: []), (disease characteristics: [patf]), (yet: []), (serum levels: [bdsu]), (main endocannabinoids: [bacs,orch]), ( n-arachidonoylethanolamine (aea: [orch]), (anandamide): [bacs,orch]), (2-arachidonoylglycerol (2-ag): [orch,phsu]), (related endogenous compounds: [chem]), (arachidonic acid (aa): [orch]), ( n-palmitoylethanolamine (pea): [plnt]), (n-oleoylethanolamine (oea): [orch,phsu]), (liquid chromatography/tandem mass spectrometry: [lbpr]), (children: [aggp]), (asd (age: [cgab]), (range: [qnco]), (boys): [aggp]), (gender-matched neurotypical children: [orga]), (results: [fndg]), (gender: [orga]), (use: []), (medications: [clna]), (age: [orga]), ( bmi: []), (adaptive functioning: []), (asd participants: [cgab]), (scores: [clna]), (autism diagnostic observation schedule: [hlca]), ((ados-2): [aapp,enzy]), ( vineland adaptive behavior scale-ii (vabs-ii): []), (social responsiveness scale-ii (srs-2): [acty]), (asd: [cgab]), (levels: []), (mean  sem): [qnco]), (aea (0.722: [fndg]), (p: [gngm]), (effect size: [qnco]), (oea (17.3: []), (pea (4.93: [plnt]), (aa: [gngm]), (aea: []), ( oea: []), (pea: [plnt]), ( gender: [orga]), ( medications: [clna]), (control group: [grup]), (bmi: []), (aea levels: []), (however: []), (correction: []), (multiple comparisons: [acty]), ( pea: [plnt]), (oea: []), (further studies: [lbpr]), (endocannabinoid levels: [bacs,orch]), (stratification biomarkers: [clna]), (significant subgroups: [virs]), (autism spectrum: [mobd]), (endocannabinoid tone: [bacs,orch]), (brain: [bpoc]), (animal models: [anim]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-019-0256-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social deficits, 'Social Competence')(medications, 'Medications')(adaptive functioning, 'Adaptive Life Skills')(autism, 'Autism Phenotype')(autism diagnostic observation schedule, 'Autism Phenotype')(vineland adaptive behavior scale-ii, 'Adaptive Life Skills')(adaptive functioning, 'Adaptive Life Skills')(medications, 'Medications')(autism spectrum, 'Autism Phenotype')

PMCID: 4803268
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (patients: [podg]), (autism spectrum disorder (asd): [mobd]), (social skills: [socb]), (effective interventions: [hlca]), (new treatment modalities: [topp]), (prosocial online game: [dora]), (social cognition: [socb]), (asd adolescents: [cgab]), (metrics: [orch,phsu]), (social communication: [socb]), (facial recognition: [menp]), (emotional words: [menp]), (underwent cognitive behavior therapy (cbt): [topp]), (ten asd adolescents: [cgab]), (baseline: [bodm]), (weeks: []), (later: []), ( social communication quality: [socb]), (identification: [menp]), (facial emoticons: [blor]), (brain activity: [phsf]), (groups: [popg]), (social communication quality: [socb]), (correct response rate: []), (course: []), (intervention: [hlca]), (significant differences: [qnco]), (response: [fndg]), (parietal cortices: [bpoc]), (game-cbt group: [dsyn]), (cingulate: []), (offline-cbt group: [dsyn]), (addition: []), ( asd adolescents: [cgab]), (increased brain activity: [bpoc]), (right cingulate gyrus: [bpoc]), (medial frontal gyrus: [bpoc]), (cerebellum: [bpoc]), (fusiform gyrus: [bsoj]), (insular cortex: [bpoc]), (sublobar area: []), (cbt: [gngm]), (offline-cbt: [dsyn]), (participation: []), (game: [dora]), (social arousal: [menp]), (emotion: [menp]), (therapy: [topp]), (participants: [popg]), (associated environments: []), (facial emotional stimulation: [blor]), (however: []), (online cbt: [dsyn]), (emotions: [menp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social skills, 'Ability to Converse in Social Settings')(social cognition, 'Cognitive Ability')(social communication, 'Reciprocal Social Interaction')(underwent cognitive behavior therapy, 'Cognitive Ability')(social communication quality, 'Reciprocal Social Interaction')(correct response rate of emotional words, 'Empathy')(cognitive behavior therapy, 'Cognitive Ability')(evoking emotions in response, 'Empathy')(online cognitive behavior therapy, 'Cognitive Ability')

PMCID: 5633227
SFARI Genes: MTHFR, MTHFR, MTHFR, MTHFR, MTHFR, MTHFR, 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (a: []), (impairment: [patf]), (social communication: [socb]), (repetitive routines: [fndg]), (interests: [menp]), (increased risk: [qnco]), (asds: [cgab]), (common mutations: [genf]), (folate/methylation cycle: [orch,phsu,vita]), (aim: [phsu]), (study: [resa]), (c677t: []), (polymorphic genotypes: [orga]), (mthfr gene: [gngm]), (sample: [sbst]), (egyptian children: [aggp]), (phenotype-genotype correlation: [fndg]), (autistic patients: [mobd]), (case-control study: [resa]), (children: [aggp]), (normal control: []), (mean age: [orga]), (patients: [podg]), (control: [sbst]), (comparable (4.5 years: [qnco]), (males: [orga]), (groups: [popg]), (dsm-v-tr: [gngm]), (criteria: []), ( stanford-binet intelligence scale v: [topp]), (autism rating scale (cars): [mobd]), (assessments: [hlca]), (polymorphic loci c677t: [gngm]), (amplified dna: [bacs,nnon]), (pcr: [mbrt]), (subsequent reverse hybridization: [genf]), (restriction fragment length polymorphisms: [comd]), (data: [euka]), (spss version: [gngm]), (chi-square: [qnco]), ( independent-samples t-test: [lbpr]), (anova: [gngm]), (significant relationship: [qnco]), (low birth weight: [fndg]), (occurrence: []), (autism (p<0.01): [mobd]), (motor: []), (social milestones: []), (cases: [qnco]), (controls (p<0.01): [sbst]), (heterozygosity: [orga]), (a1298c polymorphism: [genf]), (mutant genotype cc: [orga]), (normal aa (wild) type: [gngm]), (allele c: [gngm]), (control (56.45%: [sbst]), ((p<0.001): [fndg]), (c667t polymorphism: [genf]), ( heterozygosity: [orga]), (wild type genotypes c677 (38.7%): [orga]), (mutant genotypes: [orga]), (allele t: [gngm]), (control (31.10 %vs: [sbst]), ((p<0.00): [fndg]), (ct: [gngm]), (ac genotypes: [aapp,enzy]), (severe autism: [fndg]), (significant association: [menp]), (severity: []), (mthfr gene polymorphisms c677t: [aapp,enzy]), (a1298c: []), (further studies: [lbpr]), (scale: [acty]), (other genes polymorphisms: [genf]), (genetic basis: [phsu]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(autism rating scale, 'Autism Phenotype')(autism, 'Autism Phenotype')(severe autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 6143990
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (parents: []), (children: [aggp]), (characteristics: []), (family well-being: [famg]), (healthy levels: []), (stress: [fndg]), (research: [resa]), (autism spectrum disorder (asd): [mobd]), (levels: []), (parental stress: [fndg]), (communication: [socb]), (core symptom: [clna]), (asd: [cgab]), (aim: [phsu]), (article: []), (connection: []), (non-verbal communication impairment: [mobd]), (parental psychological distress: [mobd]), (families: [famg]), (interaction: []), (atypical communication: [socb]), (distress: [menp]), (cascade effect: []), (parent-child dyad;: [popg]), (fact: [gngm]), (quality: []), (frequency: [qnco]), (interactions: []), (establishment: []), (healthy parent-child relationship: [socb]), (series: [qnco]), (collateral problems: [bpoc]), (perspective: []), (childrens atypical communicative behaviour: [socb]), (interactional routine: []), (observation: [hlca]), (importance: []), (interventions: [hlca]), (dyad: [popg]), (early development: [orgf]), (diagnosis: [fndg]), (communicative impairment: [mobd]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(core symptom of asd, 'Complaints and Indications')(childrens atypical communicative behaviour, 'Personal Traits')(diagnosis, 'Diagnosis')

PMCID: 4938848
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (juveniles: [aggp]), (sexual offense (jsos): [mobd]), (abnormal sexual development: [fndg]), (asd symptoms: [cgab]), (current study: [resa]), (sexual development: [orgf]), (behavior: [inbe]), (stability: []), (asd-like symptoms: [cgab]), (sample: [sbst]), (male jsos (mean age: [orga]), (years): []), (years: []), (sexual offence: [mobd]), (jsos: []), (knowledge: []), (sexuality: [bhvr]), (positive attitudes towards pornography: [menp]), (victim: [popg]), (verbal sexual intimidation: [bhvr]), (matched normal population sample: [popg]), (follow-up: [hlca]), ( indicating: []), (social difficulties: [fndg]), (part: [qnco]), (life-long autistic-like traits: [mobd]), (however: []), ( asd symptoms: [cgab]), (alterations: []), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1007/s10803-016-2805-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (abnormal sexual development, 'Sexual Issues')(asd symptoms, 'Complaints and Indications')(indicating that social difficulties, 'Social Competence')(social difficulties, 'Social Competence')(asd symptoms, 'Complaints and Indications')

PMCID: 4917546
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (background:: []), (many children: [aggp]), (autism spectrum disorder (asd): [mobd]), (social interactions: [fndg]), (previous research: [resa]), (youth: [aggp]), (asd exhibit: [cgab]), (physiological stress response: [phsf]), (peer interaction: [popg]), ((td) peers: [popg]), (sensory sensitivity: [patf]), (maladaptive patterns: [mobd]), (stress: [fndg]), (anxiety: [mobd]), (current study: [resa]), (between-group differences: [popg]), (stress response: [phsf]), (interaction: []), (role: [socb]), (methods: participants: [popg]), (children: [aggp]), ((40 asd): [cgab]), (years: []), (peer interaction paradigm: [resa]), (valid protocol: [fndg]), (real-world social interaction: [fndg]), (salivary cortisol: [horm,orch,phsu]), (min pip: [gngm]), (parents: []), (questionnaires: []), (stress (stress survey schedule): [fndg]), (sensory sensitivity (short sensory profile): [patf]), (statistical analyses: [resa]), (t-tests: []), (ancova models: [qnco]), (cortisol: [horm,orch,phsu]), (play; pearson correlations: [dora]), (relations: [socb]), ( play: [dora]), (questionnaire scores;: [qnco]), (moderation analyses: [resa]), (interactions: []), (variables: []), (results: controlling: [phpr]), (baseline cortisol values: [horm,orch,phsu]), ( children: [aggp]), (asd: [cgab]), (cortisol levels: [lbtr]), (td peers: [popg]), (response: [fndg]), (pip [f(1: [inch,phsu]), (p: [gngm]), (play: [dora]), (scores: [clna]), (ssp (r = 0.242: [fndg]), ( p: [aapp,imft]), (sss (r: [dsyn]), (p =: [aapp,imft]), (indicating: []), (sensory sensitivity (lower ssp: [patf]), (enhanced stress: [fndg]), (various contexts (higher sss: [dsyn]), (furthermore: []), ( diagnosis: [fndg]), (significant moderator: [qnco]), (relation: [socb]), (ssp: [neop]), (multiple time points: [qnco]), (pip (p: [aapp,imft]), (previous findings: [clna]), (physiological arousal: [phsf]), (heightened sensory sensitivity: [phpr]), (pattern: []), (increased stress: []), (various contexts: [fndg]), (results: [fndg]), (context: [fndg]), (need: []), (relationships: []), (social: []), ( behavioral: [inbe]), (physiological profiles: [lbpr]), (understanding: [menp]), (treatments: [topp]), (sensory dysfunction: [dsyn]), (social skills: [socb]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social interactions, 'Reciprocal Social Interaction')(anxiety, 'Anxiety Disorders')(real-world social interaction, 'Reciprocal Social Interaction')(diagnosis, 'Diagnosis')(sensory dysfunction, 'Reaction to Sensory Stimuli')(social skills, 'Ability to Converse in Social Settings')

PMCID: 4938855
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (order: [acty]), (problems: []), (individuals: [humn]), (autism spectrum disorders (asd): [mobd]), (morphosyntax: []), (twenty high-functioning greek-speaking children: [aggp]), (children: [aggp]), (environments: []), (object clitics: []), (corresponding noun phrase: []), (asd: [cgab]), (comprehending: []), (simple clitics: []), (noun phrases: []), (focus structures: []), (groups: [popg]), (clitics: []), (clitic left dislocation: [inpo]), (non-focus structures: []), (difficulties: [fndg]), (interface: []), ((morpho)syntax: [euka]), (pragmatics: [socb]), (prosody: [fndg]), (discourse prominent element: [elii]), (intonation relevant: []), (particular interpretation: [clna]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(producing noun phrases in focus structures, 'Expressive Semantics')(producing noun phrases in non-focus structures, 'Expressive Semantics')(prosody, 'Prosody')(intonation relevant, 'Prosody')

PMCID: 5900943
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract autism spectrum disorder (asd): [mobd]), (heritable: []), ( developmental disorder: [mobd]), (laterborn siblings: [famg]), (diagnosed children: [aggp]), (risk: []), (asd: [cgab]), (general population: [popg]), (emergence: []), (behavioural symptoms: [sosy]), (toddlerhood: []), (development: [orgf]), (first months: [qnco]), (life: []), (infants: [aggp]), (familial risk: [famg]), (prospective longitudinal study: [resa]), (months: []), (functional nearinfrared spectroscopy (fnirs) brain responses: [bpoc]), (social videos: []), (people: [popg]), (peekaboo): []), (nonsocial images: []), (human vocalizations: [humn]), (nonvocal sounds: [npop]), ( infants: [aggp]), (years: []), (evidencedreduced activation: [acty]), (visual social stimuli: [ortf]), (inferior frontal (ifg): [gngm]), (posterior temporal (pststpj) regions: []), (cortex: [bpoc]), (furthermore: []), (reduced activation: [acty]), (vocal sounds: [orgf]), (enhanced activation: [acty]), (left lateralized temporal (amtgstg/pststpj) regions: []), (lowrisk infants: [aggp]), (highrisk infants: [aggp]), (asd (n: [cgab]), (degree: [qnco]), (activation: [acty]), (auditory stimuli: [phsf]), (parentreported asd symptomology: [cgab]), (preliminary findings: [clna]), (later atypical social brain responses: [bpoc]), (children: [aggp]), (adults: [aggp]), (need: []), (further work: []), (atypical processing: [acty]), (early infancy: []), (social interaction: [fndg]), (communication difficulties characteristic: [socb]), 
ASD Terms: (abstract autism spectrum disorder, 'Autism Phenotype')(human vocalizations, 'Vocalizations')(visual social stimuli, 'Visual Thinking')(vocal sounds, 'Vocalizations')(early infancy, 'Perinatal History')(later atypical social brain responses, 'Social Competence')(social interaction, 'Reciprocal Social Interaction')

PMCID: 4946094
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (atypical lateralization: [fndg]), (language-related functions: [lang]), (individuals: [humn]), (autism spectrum conditions: [mobd]), (few studies: [lbpr]), (deviations: [fndg]), (asymmetry: []), (other lateralized cognitive: []), (behavioural domains: []), (motor deficits: [fndg]), (prominent symptoms: [sosy]), (asc: [gngm]), (core: [bdsu]), (communicative symptoms: [socb]), (here: []), (motor circuit connectivity: []), (children: [aggp]), ((2): [qnco]), (autistic symptoms: [mobd]), (motor performance: [orgf]), (participants: [popg]), (right-handed high-functioning children: [aggp]), (autism (36: [mobd]), (females): [orga]), (control children: [aggp]), (age: [orga]), ( sex: [orgf]), (performance iq: [orga]), (lateralization: []), (functional motor circuit connectivity: []), (homotopic seeds: [plnt]), (peak activations: [acty]), (finger: [blor]), (paradigm: [resa]), (physical: [hlca]), (neurological examination: [diap]), (subtle signs (paness): [fndg]), (rightward lateralization: []), (mean motor circuit connectivity: [qnco]), (performance: [inbe]), (paness measures: [qnco]), (findings: [clna]), (language functions: [lang]), (circuits: []), (motor functions: []), (future studies: [lbpr]), (age-invariant finding: [sosy]), (adolescents: [aggp]), (adults: [aggp]), (asymmetries: []), (language domain: [lang]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-016-0096-6) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (atypical lateralization of language-related functions, 'Functional Laterality')(autism spectrum conditions, 'Autism Phenotype')(other lateralized cognitive, 'Cognitive Ability')(motor deficits, 'Motor Skills')(autism spectrum conditions, 'Autism Phenotype')(autistic symptoms, 'Complaints and Indications')(autism, 'Autism Phenotype')(functional motor circuit connectivity, 'Motor Skills')(neurological examination, 'Neurologic Indications')(autism spectrum conditions, 'Autism Phenotype')(neurological examination, 'Neurologic Indications')(autism spectrum conditions, 'Autism Phenotype')(underlie motor deficits in children, 'Motor Skills')(language functions, 'Development or Regression of Language Skills')(motor functions, 'Motor Skills')(underlie motor deficits, 'Motor Skills')

PMCID: 6305412
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (defective attention: [menp]), (eyes: [bpoc]), (autism spectrum disorder (asd): [mobd]), (role: [socb]), (contingent information: []), (task instructions: [clna]), (remains: []), (study: [resa]), (face-orienting response: [blor]), (subsequent attentive selection: [menp]), (presence: [qnco]), (individuals: [humn]), (typical development: [orgf]), (twenty: [aggp]), (young adults: [aggp]), (asd: [cgab]), (eye-tracking study: [bpoc]), (participants: [popg]), (different instructions: [clna]), (beginning: []), (trial: [resa]), (scenes: []), (social interaction: [fndg]), (instructions: [clna]), (object (visual-search: [acty]), ( vs): []), (actor: []), (attention: [menp]), (conversation: [socb]), ((gaze-reading: [dora]), ( gr): []), (video: []), ((free-viewing: []), ( fv): []), (groups: [popg]), (terms: [orgf]), (proportion: [qnco]), (first fixations: [topp]), (face: [gngm]), (nonetheless: []), (time: []), (furthermore: []), (task-dependent: []), (asd group only: [cgab]), (maximum proportion: [qnco]), (gr: [gngm]), (minimum: [qnco]), (vs condition: [dsyn]), (result cannot: [fndg]), (lack: []), (initial bias: [bird]), (face-orienting tendency: [blor]), (control group: [grup]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')

PMCID: 6276214
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (youths: [aggp]), (autism spectrum disorder (asd): [mobd]), (behavioural characteristics: [inbe]), (severe social disabilities: [fndg]), (current study: [resa]), (prevalence: [qnco]), (peer victimisation: [hcpp]), (population: [popg]), (france: []), (juvenile victimization questionnairescreener sum version: [hcpp]), (french sample: [sbst]), (asd: [cgab]), ((td) children: [aggp]), (association: [menp]), (victimisation: [hcpp]), (socio-demographic factors: []), (clinical factors: []), (anxiety: [mobd]), (post-traumatic stress: [fndg]), (results: [fndg]), (subjects: [humn]), (previous year: []), (entire lifetime: [qnco]), (students: [popg]), (course: []), (lives: [fndg]), (school: [mnob,orgt]), (peer victimisation score: [hcpp]), (td group: [popg]), (deficit: [dsyn]), (social skills: [socb]), (severity: []), (post-traumatic symptoms: [sosy]), (symptoms: [sosy]), (parents: []), (cases: [qnco]), (discussion: [socb]), (importance: []), (impacts: [gngm]), (needs: []), (school integration: [mnob,orgt]), (order: [acty]), (phenomena: [phpr]), (consequences: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(severe social disabilities, 'Social Competence')(anxiety, 'Anxiety Disorders')(post-traumatic stress, 'Post-Traumatic Stress Disorders')(deficit in social skills, 'Ability to Converse in Social Settings')(social skills, 'Ability to Converse in Social Settings')(anxiety, 'Anxiety Disorders')

PMCID: 6245048
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (several studies: [lbpr]), (overrepresentation: []), ((symptoms: [sosy]), (of) autism spectrum disorder (asd): [mobd]), (individuals: [humn]), (gender dysphoria: [mobd]), (studies: [lbpr]), (inverse approach: []), (children: [aggp]), (asd: [cgab]), (parent report: [hlca]), (wish: [gngm]), (opposite gender: [orga]), (group: [popg]), (study: [resa]), (self-reported wish: [aapp]), (opposite gender (one item: [orga]), (youth self-report [ysr]: [resa]), (adult self-report [asr]): [resa]), (adolescents: [aggp]), (boys: [aggp]), (girls): [aggp]), (adults: [aggp]), (males: [orga]), (females): [orga]), (general population: [popg]), (behavioral problems: [mobd]), (dsm-oriented scales: [bpoc]), (ysr: []), (asr: []), (childrens social behavior questionnaire: [socb]), (adult social behavior questionnaire: [socb]), (specific subdomains: []), (asd spectrum: [cgab]), (item: []), (general population (35%): [popg]), (girls: [aggp]), (significant gender differences: [orga]), (addition: []), ( adolescents: [aggp]), (gender item: [orga]), (scores: [clna]), (without: []), (significant associations: [menp]), (endorsement: []), (specific subdomain: []), (evidence: []), (sole role: [socb]), (asd subdomains: [cgab]), 
ASD Terms: (autism, 'Autism Phenotype')(behavioral problems, 'Personal Traits')(childrens social behavior questionnaire, 'Reciprocal Social Interaction')(adult social behavior questionnaire, 'Reciprocal Social Interaction')

PMCID: 5813031
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (literature evidence: [inpr,mnob]), (deficits: []), (non-social cognition: [socb]), (patients: [podg]), (autistic spectrum disorder (asd): [mobd]), (schizophrenia: [mobd]), (difference: [qnco]), (neural correlates: []), (impairments: [patf]), (disorders: [dsyn]), (brain function: [ortf]), (response: [fndg]), (social cognition task: [socb]), (functional near-infrared spectroscopy (fnirs): [lbpr]), (asd: [cgab]), (scz: []), (healthy subjects: [popg]), (participants: [popg]), (verbal fluency task: []), (emotional facial recognition task: [menp]), (brain activation: [bpoc]), (left frontotemporal area: []), (tasks: []), (score: [clna]), (attention: [menp]), (autism spectrum quotient: [qnco]), (activation: [acty]), (area: []), (severe symptoms: [fndg]), (task: [gngm]), (results: [fndg]), (distinct areas: []), (distinctive brain pathophysiology relevant: [dsyn]), (processing: [acty]), 
ASD Terms: (non-social cognition, 'Cognitive Ability')(autistic spectrum disorder, 'Autistic Disorder')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(social cognition task, 'Cognitive Ability')(emotional facial recognition task, 'Empathy')(autism spectrum quotient, 'Autism Phenotype')(cognitive processing, 'Cognitive Ability')

PMCID: 3619188
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (autism spectrum disorder (asd) suffer: [mobd]), (numerous impairments: [patf]), (social interaction: [fndg]), (mental: [menp]), (bodily coordination: [phsf]), (others: [fndg]), (interpersonal motor coordination: [ortf]), (important key: []), (profound social problems: [fndg]), (asd: [cgab]), (set: [menp]), (experimental techniques: [resa]), (traditional cognitive measures: [qnco]), (social competence: [socb]), (dynamical structure: []), (social coordination: [phsf]), (dynamical measures: [qnco]), (social motor coordination: [ortf]), (time series records: [qnco]), (behavior: [inbe]), (preliminary findings: [clna]), (many social performance outcome measures: [qnco]), (however: []), (significant relationships: [qnco]), (cognitive social measures: [qnco]), (intentionality): []), (dynamical social motor measures: [qnco]), (addition: []), (perceptually-based measures: [qnco]), (findings: [clna]), (unitary construct: [qnco]), (point: [qnco]), (promise: []), (process-oriented approach: [fndg]), (important pathway: [moft]), (asd-specific: [cgab]), (social deficits: []), 
ASD Terms: (autism spectrum disorder suffer, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(coordination, 'Motor Skills')(bodily coordination, 'Motor Skills')(profound social problems of children, 'Social Competence')(interpersonal motor coordination, 'Motor Skills')(profound social problems, 'Social Competence')(social competence, 'Social Competence')(traditional cognitive measures, 'Cognitive Ability')(social coordination, 'Motor Skills')(social motor coordination, 'Motor Skills')(developing children on many social performance outcome measures, 'Ability to Converse in Social Settings')(cognitive social measures, 'Cognitive Ability')(social coordination, 'Motor Skills')(social deficits, 'Social Competence')

PMCID: 4860194
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (present study: [qnco]), (adults: [aggp]), (autism (hfa): [mobd]), (difficulties: [fndg]), ((1): [fndg]), (self-reported ability: [orga]), (others: [fndg]), (ability: [orga]), (mental states: [fndg]), (others eyes: [bpoc]), (asperger: []), ((as): []), (empathy quotient (eq): [inbe]), (mind: [menp]), (eyes test (eyes test): [bpoc]), (as: []), (hfa: [dsyn]), (significant difference: [qnco]), (eq score: [clna]), (groups: [popg]), (eyes test: [bpoc]), (complex emotion recognition: [menp]), (questions: []), (existence: []), (subgroups: [virs]), (autism spectrum conditions: [mobd]), 
ASD Terms: (asperger syndrome, 'Asperger Syndrome')(autism, 'Autism Phenotype')(asperger syndrome, 'Asperger Syndrome')(autism, 'Autism Phenotype')(empathy quotient, 'Empathy')(high functioning autism, 'Autism Phenotype')(empathy quotient score, 'Empathy')(asperger syndrome, 'Asperger Syndrome')(complex emotion recognition, 'Empathy')(autism spectrum conditions, 'Autism Phenotype')

PMCID: 4922773
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disorder: [mobd]), (persistent difficulties: [fndg]), (social communication: [socb]), (social interaction: [fndg]), (restricted: []), ( repetitive patterns: []), (behavior: [inbe]), (interest: [menp]), (research: [resa]), (aggression rates: [mobd]), (individuals: [humn]), (asd: [cgab]), (other developmental disabilities: [mobd]), (aggression: [mobd]), (negative outcomes: [fndg]), (children: [aggp]), (caregivers: []), (decreased quality: [qnco]), (life: []), (stress levels: [fndg]), (reduced availability: []), (social support: [socb]), (therapeutic strategies: [menp]), (functional behavioral assessment: [hlca]), ( reinforcement strategies: [menp]), (functional communication training: [socb]), (significant impact: [gngm]), (frequency: [qnco]), (intensity: []), (aggressive behavior: [mobd]), (pharmacologic: []), (use: []), (second-generation antipsychotics: [phsu]), (benefit: [qnco]), (ever-increasing rate: [qnco]), (asd diagnosis: [cgab]), ( development: [orgf]), (pharmacologic methods: []), (outcomes: []), (disorder: [dsyn]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(repetitive patterns of behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(social interaction, 'Reciprocal Social Interaction')(aggression rates, 'Aggressive Behavior')(other developmental disabilities, 'Learning Disorders')(aggression, 'Aggressive Behavior')(aggressive behavior, 'Aggressive Behavior')(functional communication training, 'Reciprocal Social Interaction')(aggression, 'Aggressive Behavior')(asd diagnosis, 'Diagnosis')

PMCID: 6160549
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disorder (ndd): [mobd]), (impairments: [patf]), (social communication: [socb]), (social interactions: [fndg]), (repetitive behavior: [fndg]), (interests: [menp]), (asd: [cgab]), (etiological heterogeneity: [orga]), (neurobiological mechanisms: []), (pathogenesis: [patf]), (recently: []), (mutations: [genf]), (strong source: [fndg]), (genetic causality: [topp]), (here: []), (different aspects: [qnco]), (dnms: []), (functional annotation: []), (classification: []), (addition: []), (recent advances: []), (area: []), (detection: [topp]), (pzms: []), ((post-zygotic mutations): [emst]), (main bioinformatics tools: []), (these: []), (approaches: []), (available allow dnms: [socb]), (context: [fndg]), (gene networks: [moft]), (pathways: [moft]), (light: [gngm]), (biological processes: [biof]), (review: []), (brief insight: [menp]), (future: []), (genetic studies: [resa]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(social interactions, 'Reciprocal Social Interaction')(repetitive behavior, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 6111797
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disease: [mobd]), (impairments: [patf]), (social communication: [socb]), (social skills: [socb]), (asd: [cgab]), (high prevalence: [qnco]), (children: [aggp]), (subjects: [humn]), (virtual reality (vr): [mcha]), (effective tool: []), (intervention: [hlca]), (health field: [irda]), (different recent papers: []), (vr-based treatments: [topp]), (important limitation: []), (clinical databases: []), (important technical indexes: []), (web: []), (science index: [qnco]), (scimago journal: [inpr,mnob]), (country rank: []), (knowledge: []), (first contribution: [acty]), (evidence-based systematic review: []), (technical databases: []), (effectiveness: []), (vr-based intervention: [hlca]), (initial search: [acty]), (total: [qnco]), (records: [qnco]), (exclusion: [acty]), (papers: []), (articles: []), (screening: [diap]), (abstract: []), (full text: []), (pico (population: [popg]), ( intervention: [hlca]), ( comparison: [acty]), (outcomes) criteria: []), (analysis: [resa]), (studies: [lbpr]), (moderate evidence: []), (vr: []), (many advantages: []), (treatment: [topp]), (asd symptomatology: [cgab]), (consistent validations: [resa]), (future studies: [lbpr]), (state: []), (traditional treatments: [topp]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disease, 'Learning Disorders')(social skills, 'Ability to Converse in Social Settings')

PMCID: 6080067
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (effects: []), (child: [aggp]), (autism spectrum disorder (asd): [mobd]), (parents: []), (ample evidence: []), (families: [famg]), (severe stress: [fndg]), (several knowledge gaps: [qnco]), (unresolved questions: []), (study: [resa]), (objective burden: []), (asd: [cgab]), (mothers: [famg]), (fathers: [famg]), (understanding: [menp]), (interplay: []), (parental burden: []), ( childs characteristics: [aggp]), (parents coping resources: [inbe]), (strategies: [menp]), (methods:: []), (children/adolescents: [aggp]), (age-matched patients: [podg]), (down syndrome (n=145): [cgab,dsyn]), (type: [qnco]), (diabetes: [dsyn]), ((n=155): [aapp,imft]), (childs: [aggp]), (clinical characteristics: [clna]), (burden: []), ( psychological distress: [mobd]), (resources: []), (children: [aggp]), (subjective burden: []), (frequent psychological distress: [mobd]), (social support: [socb]), (structural equation modeling: [resa]), (negative predictors: [fndg]), (symptom severity: [fndg]), ( respectively: []), (other positive predictors: [fndg]), (engagement: [fndg]), ( distraction: [topp]), (disengagement coping: [inbe]), (intellectual disability: [mobd]), (adaptive functioning: []), (other negative predictors: [fndg]), (spiritual wellbeing: [fndg]), (hardiness: [orga]), (conclusion:: []), (huge caregiving burden: []), (factors: []), (findings: [clna]), (design: [acty]), (effective interventions: [hlca]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(down syndrome, 'Down Syndrome')(diabetes mellitus, 'Diabetes Mellitus Type 1')(intellectual disability, 'Learning Disorders')(adaptive functioning, 'Adaptive Life Skills')

PMCID: 6061008
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (study: [resa]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (receptive language share resources: [lang]), (age-appropriate versions: [orga]), (ultimatum: []), (dictator games: [dora]), (real stickers: []), (interactive partner: [popg]), (groups: [popg]), (similar numbers: [qnco]), (stickers: []), (equality: []), (ultimatum game: [dora]), (fairness: []), (similar rates: [qnco]), (however: []), ( children: [aggp]), (asd: [cgab]), (unfair offers: []), (puppets offers: []), (failure: [inbe]), (fair sharing: [socb]), (social cohesion: [socb]), (childrens ability: [orga]), (relationships: []), (important differences: [qnco]), (deficits: []), (social-cognitive development: [socb]), (self-other understanding: [menp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(receptive language share resources, 'Receptive Language')(broader deficits in social-cognitive development, 'Learning Disorders')

PMCID: 6258483
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (majority: [socb]), (previous research: [resa]), (repetitive behaviours (rrbs): [inbe]), (children: [aggp]), (lack: []), (suitable measures: [qnco]), (rrbs: []), (adults: [aggp]), (study: [resa]), (psychometric properties: [diap]), (adult repetitive behaviour: [inbe]), (questionnaire-2 (rbq-2a): []), (large sample: [sbst]), (autistic adults: [mobd]), (self-report questionnaire method: [resa]), (rbq-2a: []), (autism-spectrum quotient (aq): [qnco]), (online: []), (data: [euka]), ((m: [aapp,imft]), (sd: [gngm]), (men: [gngm]), (women): [popg]), (polychoric principal components analysis: [qnco]), (reliability: [qnco]), (validity: [qnco]), (cronbachs alpha: []), (correlation analyses: [inpr,resa]), (pca: [gngm]), (components: []), (repetitive sensory: []), (motor behaviours (rsmb): [dora]), (insistence: []), (sameness (is): []), (acceptable internal consistency ( = .70: [fndg]), (.81 respectively): []), (scores: [clna]), (aq (rs = .25: [dsyn]), (participants scores: [clna]), (is: []), (rsmb: []), (years): []), (gender differences: [orga]), (valid self-report measure: [resa]), (present sample: [sbst]), (few measures: [qnco]), (ability: [orga]), (self-report questionnaire: [resa]), (results: [fndg]), (previous work: []), (repetitive behaviour questionnaire-2 (rbq-2): [fndg]), 
ASD Terms: (repetitive behaviours, 'Restricted and Repetitive Behavior')(adult repetitive behaviour questionnaire-2, 'Restricted and Repetitive Behavior')(repetitive behaviour questionnaire-2, 'Restricted and Repetitive Behavior')

PMCID: 6054954
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (paper: []), (6-month follow-up data: [euka]), ((n: [aapp,imft]), (participants (ages: [bacs,orch]), (years): []), (diagnosis: [fndg]), (autism spectrum disorder: [mobd]), (previously-published randomized: [resa]), (trial: [resa]), (therapeutic horseback: [topp]), ((thr): [aapp,bacs,phsu]), (no-horse contact: [mamm]), (active control: [resa]), (objective: []), (study: [resa]), (significant improvements: [qnco]), (irritability: [fndg]), ( hyperactivity: [mobd]), ( social: []), (communication behaviors: [socb]), (participants: [popg]), (10-week manual-based thr intervention: [inpr,mnob]), (months: []), (intervention conclusion: [hlca]), (participants' caregivers: [popg]), (thr (n =: [aapp,bacs,phsu]), (active control (n: [resa]), (groups: [popg]), (measure: [qnco]), (hyperactivity behaviors: [mobd]), ((primary outcome variables): [topp]), (additionally: []), (thr group participants: [aapp,bacs,phsu]), (full battery: [inpo]), (study outcomes: [resa]), (between group comparisons: [popg]), (extended interval: []), (baseline (1-month pre-intervention assessment): [bodm]), (intervention: [hlca]), (thr group: [aapp,bacs,phsu]), (reductions: [npop]), (irritability behavior: [fndg]), (level: [phsu]), ((effect size: [qnco]), (p: [gngm]), (p =: [aapp,imft]), (efficacy: [resa]), (primary post-intervention endpoint: [irda]), (1-month post-intervention): []), (same trend: []), (comparisons: [acty]), (baseline: [bodm]), (6-months: []), (significant initial improvements: [qnco]), (number: [qnco]), (words: []), (different words: []), (standard language sample: [lang]), (longer-term effects: [phpr]), (thr: [aapp,bacs,phsu]), (individuals: [humn]), (asd: [cgab]), (warrants: []), (thorough evaluation: [hlca]), (effects: []), (control: [sbst]), (clinical trial registration information: trial: [resa]), (therapeutic horseback riding: [dora]), (children: [aggp]), (adolescents: [aggp]), (autism spectrum disorder; http://clinicaltrials.gov; nct02301195: [mobd]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(diagnosis, 'Diagnosis')(hyperactivity, 'Overactivity')(hyperactivity, 'Overactivity')(hyperactivity behaviors, 'Overactivity')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 4585313
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (oxytocin: [aapp,horm,phsu]), (vasopressin: [aapp,horm,phsu]), (pituitary neuropeptides: [bpoc]), (social processes: [phpr]), (mammals: [mamm]), (interest: [menp]), (molecules: [sbst]), (receptors: [aapp,rcpt]), (potential precipitants: []), (and/or treatments: [topp]), (social deficits: []), (neurodevelopmental disorders: [mobd]), (autism spectrum disorder: [mobd]), (numerous behavioral-genetic studies: [inbe]), (association: [menp]), (peptides: [aapp]), (individual social abilities;: [socb]), (explanatory model: []), (hormonal activity: [moft]), (receptor level: [phsu]), (complex human behavior: [inbe]), (following review: []), (known associations: [menp]), (systems: []), (social neurocircuits: []), (brain: [bpoc]), (macro- level trajectory: [phsu]), (current literature: [inpr,mnob]), (synthesis: [biof]), (secretion: [biof]), (structure: []), ( function: [phsf]), (distribution: []), (respective receptors: [aapp,rcpt]), (first surveyed: [qnco]), (next: []), (current models: [npop]), (mechanism: []), (action: [acty]), (microcircuitry: []), (other neurotransmitter systems: [bacs]), (evidence: []), (acute effects: []), (exogenous administration: [topp]), (brain activity: [phsf]), (model: []), (local neuromodulatory effects: []), (brainstem: [bpoc]), (basal: []), (regions: []), (social neurocircuits proves: []), (however: []), (findings: [clna]), (animal models;: [anim]), (research: [resa]), (relevance: []), (mechanisms: []), (human behavior: [inbe]), (treatment: [topp]), (neuropsychiatric disorders: [dsyn]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(social deficits, 'Social Competence')(autism spectrum disorder, 'Autism Phenotype')(individual social abilities, 'Ability to Converse in Social Settings')(complex human behavior, 'Executive Function')(treatment of social deficits, 'Social Competence')

PMCID: 2958801
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (multi-round: [qnco]), ( two-party exchange game: [dora]), (healthy subject: [popg]), (subject: [humn]), (dsm-iv: []), (manual-iv) disorder: [inpr,mnob]), (bayesian clustering approach: [resa]), (behavior: [inbe]), (goal: []), (style: []), (play: [dora]), (healthy subject (the proposer): [popg]), (dsm-diagnosed partner: [popg]), (responder): []), (approach: []), (dynamics: [npop]), (healthy proposer: []), (biosensor: [medd,resd]), (cognitive features: []), (psychopathology group: [popg]), (other side: []), (interaction: []), (large cohort: [popg]), (subjects (n: [aapp,imft]), (significant clustering: [resa]), (proposers' behavior: [inbe]), (range: [qnco]), (dsm-iv disorders: [dsyn]), (autism spectrum disorder: [mobd]), ( borderline personality disorder: [mobd]), ( attention deficit hyperactivity disorder: [mobd]), (major depressive disorder: [mobd]), (further validate: []), (computer agent: [chvf]), (human subject: [humn]), (proposer role (the biosensor): [socb]), (show: [anim]), (dsm-defined disorders: [dsyn]), (results: [fndg]), (developed social sensitivities: [fndg]), (two-party social exchange: [clna]), (important psychopathologies: []), (interpersonal behavioral probe: [inbe]), (diagnostic criteria: []), 
ASD Terms: (cognitive features, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(attention deficit hyperactivity disorder, 'Overactivity')(major depressive disorder, 'Depressive Disorder')(developed social sensitivities, 'Ability to Converse in Social Settings')(two-party social exchange, 'Reciprocal Social Interaction')

PMCID: 5351212
SFARI Genes: IL-6, IL-6, 
Non SFARI Genes: 
Named Entities: (prenatal exposure: [fndg]), (infection: [dsyn]), (environmental risk factor: []), (neuropsychiatric disorders: [dsyn]), (developmental origins: [gngm]), (autism: [mobd]), (schizophrenia: [mobd]), (experimental work: []), (animals: [anim]), (link: []), (maternal immune activation (mia): [acty]), (interactions: []), (cytokine-associated inflammatory events: [aapp,imft]), (oxidative stress: [comd]), (other pathophysiological processes: [phpr]), (hypoferremia: []), (zinc deficiency: [dsyn]), (maternal administration: [topp]), (viral mimic polyriboinosinic-polyribocytidylic acid (poly(i:c)): [nnon,phsu]), (mice produces: [mamm]), (several behavioral phenotypes: [bhvr]), (adult offspring: [famg]), (relevance: []), (spectrum disorder (asd): [cgab]), (other neurodevelopmental disorders: [mobd]), (here: []), (phenotypes: [orga]), (juveniles: [aggp]), (addition: []), (known immunomodulatory: []), (neuroprotective effects: []), (vitamin d: [orch,phsu,vita]), (co-administration: [hlca]), (mia-induced asd-related behaviors: [cgab]), (active form: []), (dihydroxy vitamin d3 (1: [orch,vita]), (25ohd): []), (poly(i:c): [nnon,phsu]), ((i): [inch]), (social interaction: [fndg]), (behavior: [inbe]), ( emotional learning: [menp]), (memory: [menp]), (anxiety-like behavior: [mobd]), (levels: []), (pro-inflammatory cytokines il-1: [aapp,imft]), ( il-6: [aapp,imft]), (tnf-: [aapp,bacs]), (maternal plasma: [bdsu]), (fetal brains: [emst]), (adult: [aggp]), (mia: [gngm]), ( juveniles: [aggp]), (similar deficits: []), (social approach behavior: [inbe]), (juvenile mia: [gngm]), (digging: [neop]), (impaired acquisition: [acty]), (expression: [topp]), (tone-cued fear conditioning: [menp]), (importantly: []), (study reveals: [resa]), (prenatal administration: [topp]), (abolishes: []), (behavioral deficits: [inbe]), (poly(i:c)-treated juveniles: [nnon,phsu]), (however: []), (effect: []), (pro-inflammatory cytokine levels: [aapp,bacs]), (dams: [gngm]), (anti-inflammatory actions: [phsu]), (critical mechanism: []), (preventive actions: []), (asd animal model: [cgab]), (work: []), (possibility: []), (early dietary supplementation: [topp]), (new avenues: []), (successful attenuation: [acty]), (prevention: [resa]), (neurodevelopmental disorders: [mobd]), (maternal inflammation: [patf]), (pregnancy: [orgf]), (electronic supplementary material: []), (online version: []), (article: []), ((doi:10.1186/s13229-017-0125-0) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (prenatal exposure, 'Exposures')(autism, 'Autism Phenotype')(schizophrenia, 'Schizophrenia and Disorders with Psychotic Features')(adult offspring, 'Perinatal History')(other neurodevelopmental disorders, 'Learning Disorders')(vitamin d, 'Dietary Supplements')(vitamin d, 'Dietary Supplements')(vitamin d, 'Dietary Supplements')(dihydroxy vitamin d3, 'Dietary Supplements')(social interaction, 'Reciprocal Social Interaction')(memory, 'Working Memory')(social approach behavior, 'Reciprocal Social Interaction')(behavioral deficits in poly-treated juveniles, 'Personal Traits')(behavioral deficits, 'Personal Traits')(vitamin d, 'Dietary Supplements')(vitamin d, 'Dietary Supplements')(vitamin d, 'Dietary Supplements')(dietary supplementation, 'Dietary Supplements')(neurodevelopmental disorders, 'Learning Disorders')(early dietary supplementation, 'Dietary Supplements')

PMCID: 4872425
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (attention deficit hyperactivity disorder (adhd) continue: [mobd]), (prevalence: [qnco]), (>10%: [fndg]), (today's: [antb,orch]), (methods: []), (diagnosis: [fndg]), (subjective: []), ( cumbersome: []), (time intensive: [menp]), (gaps: []), (year: []), (initial suspicion: [menp]), (valuable time: []), (treatments: [topp]), (behavioral interventions: [topp]), (disorders: [dsyn]), (assess risk: [acty]), (these: []), (other: []), ( developmental disorders: [mobd]), (process: [phpr]), (families access: [famg]), (much-needed therapies: [topp]), (forward feature selection: [genf]), (10-fold cross-validation: [resa]), (machine: []), (models: []), (complete 65-item social responsiveness scale score sheets: [qnco]), (individuals: [humn]), (asd (n=2775): [cgab]), (adhd: [mobd]), (behaviors: [inbe]), (tool: []), (asd: [cgab]), (high accuracy (area: [qnco]), (curve=0.965): [fndg]), (results: [fndg]), (hypotheses: []), (machine learning: [mcha]), (autism: [mobd]), (high accuracy: [qnco]), (distinction: []), (small number: [qnco]), (findings: [clna]), (promise: []), (use: []), (administered: []), ( caregiver-directed resource: []), (preliminary risk evaluation: [hlca]), (pre-clinical screening: [diap]), (triage: [topp]), 
ASD Terms: (diagnosis, 'Diagnosis')(autism spectrum disorder, 'Autism Phenotype')(attention deficit hyperactivity disorder continue, 'Overactivity')(initial suspicion, 'Suspicious of Others')(diagnosis, 'Diagnosis')(attention deficit hyperactivity disorder, 'Overactivity')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(attention deficit hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(autism, 'Autism Phenotype')

PMCID: 5004296
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (much research: [resa]), (deficit: [dsyn]), (emotional reactivity: [fndg]), (others: [fndg]), (people: [popg]), (scant attention: [menp]), (own reactions: []), (features: []), (environment (objects: []), ( events: [evnt]), ( practices: [menp]), ( etc.): []), (present study: [qnco]), (preliminary analysis: [resa]), (ones own emotional reactions: [fndg]), (emotional reactions: [fndg]), (world: [popg]), (process: [phpr]), (term: [orgf]), (social-emotional calibration: [qnco]), (autism: [mobd]), (novel eye-tracking pupillometry paradigm: [bpoc]), (preschoolers: [aggp]), (preschoolers videos: [aggp]), (actor: []), (box: [qnco]), (object inside: []), (fear: [menp]), (happiness: [menp]), (threatening stimulus: [phpr]), (actors emotional expressions: [inbe]), (childrens: []), (pupil diameter: [fndg]), (emotional reactivity): [fndg]), (identical image: []), (scene: []), (difference: [qnco]), (index: [qnco]), (groups: [popg]), (box after: [qnco]), (scene (as indexed: []), (increase: []), (pupil size): [clna]), (reaction: []), (object: []), (duration: [phsu]), (emotional expressions;: [inbe]), (pupil dilation findings: [sosy]), (differences: [qnco]), (visual attention: [menp]), (happy condition: [dsyn]), (severe autism symptoms: [mobd]), (measurement: []), (physiological reactivity: []), ( findings: [clna]), (children: [aggp]), (calibration: [qnco]), (positive emotions: [menp]), (important: []), (study: [resa]), (possible mechanism: []), (individuals: [humn]), (idiosyncratic reactions: [fndg]), (environment: []), (harmonious participation: [fndg]), (cultural practices: [socb]), (infancy: []), (lifespan: [grpa]), (research: [resa]), (mediators: [orch,phsu]), (developmental sequence: [nusq]), (tendency: []), (feelings: [menp]), 
ASD Terms: (emotional reactions, 'Emotional Outbursts')(ones own emotional reactions, 'Emotional Outbursts')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(visual attention, 'Visual Thinking')(severe autism symptoms, 'Complaints and Indications')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(infancy, 'Perinatal History')

PMCID: 4706592
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (degree: [qnco]), (report bias: [bird]), (autistic traits: [mobd]), (parents: []), (preschoolers: [aggp]), (social communication questionnaire: [socb]), (autism-spectrum quotient: [qnco]), (acceptable agreement: [socb]), (mother: [famg]), (reports: [hlca]), (childrens mean scores: [qnco]), (interrater reliability: [qnco]), (rank-order correlations: [acty]), (evidence: []), (parent-offspring autistic traits: [mobd]), (however: []), ( adult: [aggp]), (autistic ratings: [mobd]), (biased: spouse-ratings: [famg]), (self-ratings: []), ( correlations: []), (same person: [grup]), (resemblance: []), (spouses separate self-reports: [resa]), (multiple informants: [grup]), (procedural and/or: [topp]), (statistical remedies: []), 
ASD Terms: (social communication questionnaire, 'Reciprocal Social Interaction')

PMCID: 3629229
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (efficient approach: []), (atypical brains: [bpoc]), (macroscopic neural dynamics: [npop]), (magnetoencephalograms: []), (approach: []), (fact: [gngm]), (spontaneous brain activity: [phsf]), (stochastic dynamics: [npop]), (multivariate ornstein-uhlenbeck process (moup): [phpr]), (data: [euka]), (moup: []), (functional connectivity matrix: [phsu]), (drift operator: [humn]), (traces: [qnco]), (background stochastic activity (noise): [phpr]), (brain: [bpoc]), (method: [lbpr]), (functional connectivity: []), (background noise: [phpr]), (juvenile patients: [podg]), (aspergers: []), (form: []), (autism spectrum disorder (asd): [mobd]), (age-matched juvenile control: [sbst]), ((n =: [aapp,imft]), (analysis reveals: [resa]), (significant alterations: [qnco]), (functional brain connectivity: [bpoc]), (asd patients: [cgab]), (dominant connectivity change: [qnco]), (asd: [cgab]), (shows: [anim]), (functional excitation: [acty]), (frontal areas: []), (parasagittal axis: [bpoc]), (wide areas: []), (areas: []), (correlated noise form: [phpr]), (patches: [bodm]), (analysis: [resa]), (spatial complexity reveals: [chvs]), (asd subjects: [cgab]), (detailed physiological mechanisms: []), (alterations: []), (macroscopic brain recordings: [bpoc]), (occipital-frontal excitation: [acty]), (changes: [qnco]), (white matter density: [tisu]), (previous studies: [lbpr]), (venture: []), (long-range spatial correlations: [qnco]), (specificity (or: [qnco]), (promiscuity): [fndg]), (thalamo-cortical projections: [bpoc]), (calculations: [acty]), (other algorithms: []), (comparable level: [phsu]), (accuracy: []), (results: [fndg]), (promising potential: []), (efficient biomarker: [clna]), (altered brain dynamics: [bpoc]), (cognitive phenotype: [orga]), 
ASD Terms: (background noise in juvenile patients, 'Medical History')(autism spectrum disorder, 'Autism Phenotype')(aspergers, 'Asperger Syndrome')(background noise in asd patients, 'Medical History')(background noise in asd patients, 'Medical History')(cognitive phenotype, 'Cognitive Ability')

PMCID: 4510834
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (econometric choice task: [inbe]), (implicit reward value: [menp]), (non-social stimuli: [phpr]), (interests: [menp]), (children: [aggp]), (adolescents: [aggp]), ((n =: [aapp,imft]), ((n: [aapp,imft]), (autism spectrum disorder (asd): [mobd]), (mixed effects: [fndg]), (logistic regression analyses: [resa]), (groups: [popg]), (valuation: []), (images: []), (interests: control children: [aggp]), (cash payouts: []), (asd: [cgab]), (cash payout: []), (social images: []), (non-social images: []), (results: [fndg]), (motivational accounts: [menp]), (reward value: [menp]), (asd (dichter: [cgab]), (adolphs: []), 
ASD Terms: (restricted interests, 'Restricted Range of Interests')(autism spectrum disorder, 'Autism Phenotype')(restricted interests, 'Restricted Range of Interests')

PMCID: 5900388
SFARI Genes: met, met, 
Non SFARI Genes: 
Named Entities: (background:: []), (paper: []), (literature: [inpr,mnob]), (factors: []), (stress: [fndg]), (resilience: []), (parents: []), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (south east asia (sea) region: []), (methods:: []), (extensive search: [acty]), (articles: []), (multiple online databases: [qnco]), (proquest: []), ( pudmed: []), ( embase: []), ( cinahl: []), ( web: []), (science: []), (google scholar): []), (papers: []), (inclusion criteria: []), (sea region: []), ( specific: []), (asd only: [cgab]), (peer-reviewed journal: [hlca]), (full text: []), (english): [lang]), (studies: [lbpr]), (following countries: brunei: []), (indonesia: [fish]), (malaysia: []), (philippines: []), (singapore: [fish]), (thailand: []), (n =: [aapp,imft]), (vietnam: []), (none: []), (cambodia: []), ( east timor: []), ( laos: []), (myanmar: []), (results:: [fndg]), (main factors: []), (stress: social support: [socb]), ( severity: []), (autism: [mobd]), (symptoms: [sosy]), ( financial difficulty: [fndg]), ( parents' perception: [menp]), (asd: [cgab]), ( parents' anxiety: [menp]), (worries: [fndg]), (child's future: [aggp]), (religious beliefs: []), (source: [fndg]), (coping strategy/resilience mechanism: [inbe]), (conclusion:: []), (findings: [clna]), (support services: []), (western countries: []), (cultural differences: []), (limitations: []), (current review: [npop]), (limited number: [qnco]), (search: [acty]), (need: []), (research: [resa]), ( coping: [inbe]), (identified stress: [fndg]), (resilience factors: [inbe]), (sociocultural markers: []), (clinicians: []), ( psychologists: []), (other professionals: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(parents' perception, 'Cognitive Ability')(parents' anxiety, 'Anxiety Disorders')

PMCID: 3792367
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (impairments: [patf]), (social cognition: [socb]), (key symptom: [clna]), (autism spectrum disorder (asd): [mobd]), (people: [popg]), (autism: [mobd]), (great difficulty: [fndg]), (beliefs: []), (desires: [menp]), (other people: [popg]), (recent years literature: [inpr,mnob]), (link: []), (abilities: [orga]), (use: []), (social skills: [socb]), (visual perspective taking (vpt): []), (flavell (1977): []), (levels: []), (perspective taking: vpt level: [phsu]), (ability: [orga]), (different line: [sbst]), (sight: [orgf]), (whereas vpt level: [phsu]), (same item: []), (different points: [qnco]), (space: []), (different things: []), (far: []), ( literature: [inpr,mnob]), (level: [phsu]), (vpt: []), (studies: [lbpr]), (vpt levels: []), (focus: []), (methods: []), (review: []), (evaluation: [hlca]), (findings: [clna]), (recommendations: []), (future research: [resa]), (clearer insight: [menp]), (perspective taking: []), 
ASD Terms: (social cognition, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(autism, 'Autism Phenotype')(social skills, 'Ability to Converse in Social Settings')(visual perspective taking, 'Visual Thinking')(visual perspective, 'Visual Thinking')(whereas visual perspective, 'Visual Thinking')(visual perspective taking, 'Visual Thinking')(autism, 'Autism Phenotype')(visual perspective taking levels, 'Visual Thinking')(visual perspective taking, 'Visual Thinking')

PMCID: 4633620
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (macroscopic: []), (structural networks: []), (human brain: [humn]), (rich-club architecture: [orgt]), (inter-connected central regions: [acty]), (connected peripheral regions: []), (recent studies: [lbpr]), (disruption: []), (efficient organisation: [orgt]), (several psychiatric disorders: [mobd]), (however: []), (attention: [menp]), (network: [popg]), (age-associated changes: [aggp]), (rich-club organisation: [orgt]), (human adolescence: [humn]), (here: []), (diffusion tensor: [npop]), (dataset: []), (adolescence: []), ( brains: [bpoc]), ((td) individuals: [humn]), (increases: [qnco]), (inferred network functionality: [popg]), (individuals: [humn]), (autism spectrum disorders: [mobd]), (not: []), (differences: [qnco]), (td: []), (asd groups: [cgab]), (functional properties: []), (moreover: []), (typical age-related changes: [aggp]), (progressive involvement: []), (right anterior insula: [bpoc]), (contrast: [irda]), (asd individuals: [cgab]), (typical increases: [qnco]), (grey matter volume: [tisu]), (relative anatomical immaturity: [qnco]), (severity: []), (asd: [cgab]), (social symptoms: [sosy]), (results: [fndg]), (evidence: []), (bases: [inch]), (efficient brain networks: [bpoc]), (complex cognitive functions: [menp]), (adult: [aggp]), (human brains: [humn]), (furthermore: []), (findings: [clna]), (immature: []), (neurodevelopmental disorders: [mobd]), 
ASD Terms: (several psychiatric disorders, 'Mental Disorders')(autism spectrum disorders, 'Autism Phenotype')(complex cognitive functions, 'Cognitive Ability')(neurodevelopmental disorders, 'Learning Disorders')

PMCID: 5816822
SFARI Genes: OXTr, AVPR1a, AVPR1b, OXTr, AVPR1a, AVPR1b, OXTr, OXTr, 
Non SFARI Genes: 
Named Entities: (oxytocin (oxt): [aapp,horm,phsu]), (arginine-vasopressin (avp) play: [aapp,horm,phsu]), (key regulatory part: [qnco]), (affiliative behaviors;: [inbe]), (aspects: [qnco]), (autism spectrum disorder (asd): [mobd]), (furthermore: []), ( variants: []), (adjacent oxytocin-vasopressin gene regions: [aapp,horm,phsu]), (asd diagnosis: [cgab]), (endophenotypes: []), (review: []), (common oxtr: [gngm]), (polymorphisms (snps): [nusq]), ( avpr1a microsatellites: [bacs,nnon]), (avpr1b polymorphisms: [rcpt]), (relation: [socb]), (development: [orgf]), (autism: [mobd]), (genes: [gngm]), (genome-wide association: [menp]), (evidence: []), (hypothesis: []), (receptors: [aapp,rcpt]), (polymorphisms: [genf]), (regulation: [biof]), (social behavior: [socb]), (physiological pathways: [moft]), (etiology: []), (asd: [cgab]), (specific focus: []), (variants: []), (issues: [fndg]), (suggestions: []), (inconsistencies: []), (present literature: [inpr,mnob]), (translational implications: [genf]), (future directions: []), (forward-looking perspective: [orga]), (scientific community: []), (significant progress: [qnco]), (understanding: [menp]), (research: [resa]), (ontology: []), (disorder: [dsyn]), (information: []), (differences: [qnco]), (male: [orga]), (female sexes: [orga]), (wider view: []), (current state: [clna]), (knowledge: []), (oxtr: [gngm]), (avpr mechanisms: [aapp,rcpt]), (functioning: []), (future research: [resa]), (identification: [menp]), (further risk factors: [qnco]), (new strategies: [menp]), (early interventions: [hlca]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(asd diagnosis, 'Diagnosis')(autism, 'Autism Phenotype')(social behavior, 'Reciprocal Social Interaction')(specific focus on variants, 'Attention and Focus')

PMCID: 5807481
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (low-level support: [phsu]), (adults: [aggp]), (autism spectrum disorder (hfasd): [mobd]), (good quality health: []), (social care: [hlca]), (research: [resa]), (area: []), (semi-structured interview data: [euka]), (paper: []), (efficacy: [resa]), (intervention: [hlca]), (hfasd: []), (funded support: [qnco]), (number: [qnco]), (perceived positive outcomes: [menp]), (families: [famg]), (service providers: []), (city: [clna]), (increased access: [qnco]), (volunteering: []), ( support: []), (information: []), (health: []), (wellbeing: []), (day-to-day: []), (lifes difficulties: [fndg]), (service users: [humn]), (barriers: []), (further support: []), (beneficial outcomes: []), (line: [sbst]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism spectrum, 'Autism Phenotype')

PMCID: 3734372
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abnormalities: [cgab]), (frontostriatal circuitry: []), (core deficits: [bdsu]), (autism spectrum disorder (asd);: [mobd]), (social interaction: [fndg]), (communication difficulties: [socb]), (restricted interests: [menp]), (repetitive behaviors: [fndg]), (few studies: [lbpr]), (connectivity: []), (circuitry: []), (asd: [cgab]), (previous study: [resa]), (structural connectivity: []), (same population: [popg]), (present study: [qnco]), (first exploration: [topp]), (structural frontostriatal connectivity: []), (twenty-eight right-handed caucasian male asd (17.28: [cgab]), (years): []), (right-handed male: [orga]), ( age: [orga]), (iq: []), (controls (17.15: [sbst]), (part: [qnco]), (study: [resa]), (state: []), (functional connectivity: []), (participants: [popg]), (tractography: []), (control participants: [popg]), (subjects: [humn]), (excessive motion: [npop]), (poor data quality: [grpa]), (functional connectivity analysis: [hlca]), (frontal cortex: [bpoc]), (striatum: [bpoc]), (regions: []), (significant group differences: [popg]), (asd group: [cgab]), ([anterior cingulate cortex (acc): [bpoc]), ( middle: []), (frontal gyrus (mfg): [bpoc]), ( paracingulate gyrus (pcg): []), (orbitofrontal cortex (ofc)]: [blor]), (striatum [nucleus: [bpoc]), ((nacc): []), (caudate]: []), (acc: [gngm]), (caudate: []), (deactivation: []), (social rewards: [menp]), (same participants: [popg]), (greater connectivity: [qnco]), (right mfg: []), (bilateral pcg: [aapp,bacs]), (nacc: []), (right ofc: [dsyn]), (communicative deficits: [socb]), (tracts: [bpoc]), (subject: [humn]), (group: [popg]), (results: [fndg]), (increased corticostriatal functional connectivity: [qnco]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(restricted interests, 'Restricted Range of Interests')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 4786616
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (mixed-methods study: [fndg]), (gender differences: [orga]), (social motivation: [menp]), (friendship experiences: [socb]), (adolescent boys: [aggp]), (girls: [aggp]), (autism: [mobd]), (special education settings: [edac]), (autistic girls: [mobd]), (similar social motivation: [menp]), (friendship quality: [socb]), (non-autistic girls: [mobd]), (autistic boys: [mobd]), (different friendships: [socb]), (motivation: [menp]), (social contact: [socb]), (semi-structured interviews: [resa]), (adolescents: [aggp]), (findings: [clna]), (exception:: []), (high levels: [qnco]), (relational aggression: [mobd]), (friendships: [socb]), (autism spectrum: [mobd]), (identifying: []), (conflict: [inbe]), (social lives: [socb]), 
ASD Terms: (autism, 'Autism Phenotype')(relational aggression, 'Aggressive Behavior')(autism spectrum, 'Autism Phenotype')

PMCID: 4537433
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (deficits: []), (social cognition: [socb]), ( communication: [socb]), (executive function: [menp]), (studies: [lbpr]), (asd: [cgab]), (functional organization: [orgt]), (brain networks: [bpoc]), (information: []), (here: []), (aspect: [qnco]), (cognitive control: [sbst]), (network-level disturbances: [popg]), (information processing: [menp]), (magnetoencephalography: [diap]), (children: [aggp]), (controls: [sbst]), (set-shifting task: [menp]), (mental flexibility: [menp]), (multiscale entropy (mse): [phpr]), (rate: [qnco]), (set: [menp]), (sources: [fndg]), (brain: [bpoc]), (multivariate: []), (partial least-squares analysis: [qnco]), (slow time scales: [bpoc]), (control children: [aggp]), (disrupted temporal organization: [orgt]), (networks: []), (moreover: []), (reaction times: []), (improvement: []), (performance: [inbe]), ( suggesting: []), (data demonstrate: [euka]), (coordination: [phsf]), (temporal organization: [orgt]), (large-scale neural assemblies: [acty]), (cognitive control tasks: [sbst]), (function deficits: [phsf]), (group: [popg]), 
ASD Terms: (social cognition, 'Cognitive Ability')(autism spectrum disorder, 'Autism Phenotype')(executive function, 'Executive Function')(cognitive control, 'Cognitive Ability')(information processing, 'Ability to Convey Information')(mental flexibility, 'Mental Flexibility')(cognitive control tasks, 'Cognitive Ability')(coordination, 'Motor Skills')(executive function deficits, 'Executive Function')

PMCID: 5600083
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract typical adults: [aggp]), (reward probabilities: [qnco]), (trials: [resa]), (volatility: [npop]), (environment: []), (information: []), (learning rate (behrens: [menp]), (stable environment: []), (account: [clna]), (outcomes: []), (many trials: [resa]), ( whereas: []), (volatile environment: [lbpr]), ( recent experience: [menp]), (distant experience: [menp]), (accounts: [clna]), (autism: [mobd]), (autistic individuals: [mobd]), (atypical updating: [fndg]), (behaviour: [inbe]), (response: [fndg]), (statistics: []), (reward environment: [menp]), (hypothesis: []), (appropriate version: []), (behrens: []), (al: [lbpr]), ((2007) task: []), (able children: [orga]), (years: []), (age: [orga]), (children: [aggp]), (typical adults: [aggp]), (participants: [popg]), (blue pirate chest: [blor]), (randomly: []), (value: [qnco]), (points: [qnco]), (combined total: [qnco]), (trial: [resa]), (reward: [menp]), (stimulus only: [phpr]), (stable condition: [fndg]), (ratio: [qnco]), (blue: [fndg]), (green response: [fndg]), (volatile condition: [dsyn]), (learning rate: [menp]), (participant: [popg]), (delta rule model: [qnco]), (rate: [qnco]), (conditions: [dsyn]), (groups: [popg]), (effect: []), (group: [popg]), (interaction: []), (condition: [dsyn]), (thus: []), (autistic children: [podg]), (decisions: [menp]), (similar extent: []), (adults: [aggp]), (results: [fndg]), (uniform differences: [qnco]), (weighting: [orga]), (prediction error: []), 
ASD Terms: (autism, 'Autism Phenotype')(autism, 'Autism Phenotype')

PMCID: 4564562
SFARI Genes: 
Non SFARI Genes: ms, 
Named Entities: (memory: [menp]), ((wm) impairments: [patf]), (profound behavioural manifestations: [inbe]), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (however: []), (previous behavioural results: [inbe]), (few functional magnetic resonance: [npop]), ((fmri) results: [diap]), (adults: [aggp]), (adolescents: [aggp]), (asd: [cgab]), (precise temporal dynamics: [npop]), (wm-related brain activity: [phsf]), (magnetoencephalography (meg): [diap]), (controls: [sbst]), (n-back wm task: [blor]), (different load levels: [acty]), (behavioural results: [inbe]), ((td): []), (between-group comparison: [popg]), (functional brain activity: [phsf]), (atypical wm-related brain processes: [bpoc]), (td children: [aggp]), (atypical responses: [orga]), (asd group: [cgab]), (ms post stimulus: [aapp,enzy]), (high- (2-back) memory load conditions: [menp]), (1-back condition: [dsyn]), ( children: [aggp]), (wm-related activations: [acty]), (right hippocampus: [bpoc]), (cingulate gyrus: [bpoc]), (activation: [acty]), (left dorso-lateral prefrontal cortex: [bpoc]), (insulae: [bpoc]), (2-back condition: [dsyn]), (activity: [acty]), (left insula: [bpoc]), (midcingulate gyrus: []), (left precuneus: [bpoc]), (addition: []), (anterior cingulate cortex: [bpoc]), (symptom severity: [fndg]), (thus: []), (meg study: [horm,orch,phsu]), (precise timing: []), (sources: [fndg]), (atypical wm-related activity: [acty]), (parietal regions: [bpoc]), (potential impacts: [gngm]), (such atypicalities: []), (social deficits: []), (autism: [mobd]), (discussed: [socb]), 
ASD Terms: (memory impairments, 'Working Memory')(autism spectrum disorder, 'Autism Phenotype')(memory task, 'Working Memory')(n-back working memory task, 'Working Memory')(high-) memory load conditions, 'Working Memory')(autism, 'Autism Phenotype')(social deficits, 'Social Competence')

PMCID: 5660713
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (recent research: [resa]), (autism spectrum disorders: [mobd]), (individuals: [humn]), (autism: [mobd]), (basic deficit: [fndg]), (others: [fndg]), (difficulty: [fndg]), (communicative deficits: [socb]), (here: []), (synchronization: []), (open-ended joint improvisation (ji) paradigm: [bsoj]), (mirror game (mg): [dora]), (mg: [elii,phsu]), (players: []), (turns: [fndg]), (leading: []), ( following: []), (motion: [npop]), (handles: []), (parallel tracks: [resa]), (motion tracks: [npop]), (spatial resolution: [qnco]), (series: [qnco]), (previous studies: [lbpr]), (mg attain moments: [elii,phsu]), (co-confident (cc) motion: [npop]), (typical kinematic pattern: []), (leader: []), (reactive follower: []), (moments players: []), (coupled unit: [qnco]), (high levels: [qnco]), (connectedness: []), (participants: [popg]), (asd: [cgab]), (cc: [celc]), (mg performance: [inbe]), (motor: []), (social skills: [socb]), (asd (n: [cgab]), (cc moments: [celc]), (expert improviser: []), (performance: [inbe]), (several ways: [qnco]), ((td) participants: [popg]), (specifically: []), ( asd participants: [cgab]), (rates: [qnco]), (td participants: [popg]), (following rounds: []), (duration: [phsu]), (cc segments: [celc]), (rounds: []), (participants motor skills: [orgf]), (mg console: [elii,phsu]), (variability: []), (group differences: [popg]), (asd participants alexithymia: [cgab]), (other social skills: [socb]), (subjective reports: [hlca]), (game: [dora]), (emotional factors: [menp]), (attention: [menp]), ( motivation: [menp]), (reward-processing: [menp]), (experiment: [resa]), (together: []), (results: [fndg]), (asd participants: [cgab]), (moments: []), (high motor synchronization: [qnco]), (open-ended task: []), (future studies: [lbpr]), (ways: []), (skills: [inbe]), (clinical settings: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(autism, 'Autism Phenotype')(social skills, 'Ability to Converse in Social Settings')(other social skills, 'Ability to Converse in Social Settings')

PMCID: 3665223
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (diagnostic: [fndg]), (statistical manual: [inpr,mnob]), (mental disorders: [mobd]), (edition: []), ((dsm-iv): []), ( autistic characteristics: [mobd]), (social interaction: [fndg]), (communication: [socb]), (qualitative impairments: [patf]), (however: []), (difference: [qnco]), (autistics: [mobd]), (nonautistics: []), (draft: [anim]), (5th edition: [fndg]), ((dsm-5 draft): [anim]), (word qualitative: []), (draft text: [anim]), (relation: [socb]), (social demands: [topp]), (individual limited capacities: [qnco]), (symptom manifestation (criterion c): [clna]), (proposed levels: []), (support requirement: []), (mere observable outcomes: []), (social vulnerability: []), (boundary: []), (level: [phsu]), (nonautistic condition: [dsyn]), (individual capacities: [qnco]), (addition: []), (introduction: [hlca]), (single category (autism spectrum disorder (asd)): [fndg]), (entire case: [qnco]), (dsm-5 draft: [anim]), (conviction: []), (asd: [cgab]), (normal behavioral range: [qnco]), (concise review: [bodm,orch]), (explanation: []), (implicit paradigm shift: [phpr]), (importantly: []), (conditional role: [socb]), (symptom manifestation: [clna]), (unique liability-probability model: [qnco]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(mental disorders, 'Mental Disorders')(conditional role of social demands, 'Social Competence')

PMCID: 6393688
SFARI Genes: 
Non SFARI Genes: PI4KA, PI4KA, 
Named Entities: (abstract chromosome: [celc]), (genomic rearrangements: [gngm]), (involve deletions: [genf]), (duplications: []), (low copy repeats lcr22a: [nnon]), (atypical: [fndg]), (deletions: [genf]), (valuable opportunity: []), (dosage effects: [qnco]), (subset: []), (genes: [gngm]), (genomic disorder region: [dsyn]), (thirteen individuals: [humn]), (families: [famg]), (atypical nested duplications: [fndg]), (region: []), (lcr22b: []), (lcr22d: []), (clinical data: []), (patients: [podg]), (study: [resa]), (atypical duplication cases: [qnco]), (cases: [qnco]), (typical duplications: []), (lcr22a: []), (further: []), (nested region: []), (candidates: []), (human brain tissues: [tisu]), (size: []), (incomplete penetrance: [fndg]), (variable clinical expressivity: [fndg]), (nested atypical duplications: [fndg]), (possible risk factor: [qnco]), (neurodevelopmental phenotypes: [orga]), (autism spectrum disorder (asd): [mobd]), ( speech: [orgf]), (language delay: [fndg]), (behavioral abnormalities: [mobd]), (addition: []), (genes (znf74: [gngm]), ( klhl22: [gngm]), ( med15: [orch,phsu]), ( pi4ka: [gngm]), ( serpind1: [gngm]), ( crkl: [aapp,bacs]), ( aifm3: [gngm]), ( slc7a4: [gngm]), (bcrp2): []), (enriched expression: [topp]), (nervous system: [bdsy]), (unique spatiotemporal patterns: []), (adult brain tissues: [aggp]), (interestingly: []), (brain: [bpoc]), (gene: [gngm]), (subjects: [humn]), (findings: [clna]), (variable expressivity: [fndg]), (pi4ka: [gngm]), (brain development: [ortf]), (disorder: [dsyn]), (further work: []), (basis: [phsu]), (variable neurodevelopmental phenotypes: [fndg]), (presence: [qnco]), (second disorder: [dsyn]), (genotypephenotype data: [euka]), (implications: []), (genetic counseling: [topp]), 
ASD Terms: (neurodevelopmental phenotypes, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(speech, 'Language Ability')(language delay, 'Language Ability')(behavioral abnormalities, 'Personal Traits')(variable neurodevelopmental phenotypes, 'Learning Disorders')

PMCID: 6220821
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (spectrum hypothesis states: [qnco]), (diagnosed individuals: [humn]), (individuals: [humn]), (general population exhibit: [popg]), (certain amount: [qnco]), (autistic traits: [mobd]), (idea: []), (studies: [lbpr]), (few electrophysiological studies: [diap]), (particular: []), (spontaneous restingstate studies: [lbpr]), (order: [acty]), (autism spectrum: [mobd]), (present study: [qnco]), (level: [phsu]), (young adults: [aggp]), (exhibit: []), (spontaneous restingstate gamma: [npop]), (measure: [qnco]), (social functioning impairments: [socb]), (influence: []), (age: [orga]), (gender: [orga]), (regression: [menp]), (gamma activity: [npop]), (selfreported autistic traits: [mobd]), (model: []), (only age: [orga]), (significance: [qnco]), (student population: [popg]), (however: []), (relationship: []), (low (3050 hz): [qnco]), (high (5070 hz) gamma power: [npop]), (models: []), (eyes: [bpoc]), (low gamma asymmetry: [npop]), (high gamma asymmetry: [npop]), (findings: [clna]), (gamma asymmetry: [npop]), (little additional variance: [qnco]), (addition: []), ( exploratory correlation analyses: [inpr,resa]), (other power: [hcpp]), (spectra (delta: [qnco]), ( theta: [gngm]), ( alpha: []), (beta): [plnt]), (hand: [bpoc]), (other hand: [bpoc]), (spontaneous restingstate brain electrophysiology: [bpoc]), (general population: [popg]), 
ASD Terms: (autism, 'Autism Phenotype')(autism spectrum, 'Autism Phenotype')(social functioning impairments, 'Ability to Converse in Social Settings')

PMCID: 2525446
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (repetitive behaviour: [fndg]), (response monitoring: [resa]), (consequences: []), (behaviour: [inbe]), (adjustments: [topp]), (outcomes: []), (deficiencies: [dsyn]), (function: [phsf]), (abnormalities: [cgab]), (anterior cingulate cortex (acc): [bpoc]), (factors: []), (autistic disorders: [mobd]), (acc structure: [cgab]), (asd: [cgab]), (acc activation: [cgab]), (erroneous antisaccades: []), (rapid presentation: []), (event-related functional mri: [diap]), (control: [sbst]), (asd participants: [cgab]), (product: [qnco]), (coordinated activity: [acty]), (acc networks: [cgab]), (microstructural integrity: [inbe]), (white matter (wm): [tisu]), (brain region: [blor]), (diffusion tensor: [npop]), ((dti) measures: [diap]), (fractional anisotropy (fa): [npop]), (adult asd participants: [cgab]), (fa: [gngm]), (relation: [socb]), (autism diagnostic: [mobd]), (interview-revised ratings: [acty]), (asd participants: (i): [cgab]), (antisaccade errors: []), (correct trials; (ii): [resa]), (reduced discrimination: [socb]), (error: []), (correct responses: [orga]), (rostral acc (racc): [cgab]), (activation: [acty]), (correct trials: [resa]), ((iv): []), (reduced fa: []), (wm: []), (acc: [gngm]), (finally: []), (asd (v): [cgab]), (racc wm: []), (ratings: [acty]), (findings: [clna]), (structural abnormalities: [fndg]), (racc activity: [acty]), (errors: []), (affective appraisal: []), (hyperactive racc response: [mobd]), (trials: [resa]), (misleading affective signal: [phpr]), (something: []), (repetitive attempts: [evnt]), (correction: []), (possible consequence: []), (reduced affective discrimination: [socb]), (reinforcement: [menp]), (responses: [orga]), (furthermore: []), ( dysconnection: []), (regions: []), (behavioural control: [topp]), (on-line modulations: [sbst]), (response speed: []), (performance (i.e: [inbe]), (speed-accuracy trade-off): [qnco]), (error likelihood: [qnco]), (functional abnormalities: [cgab]), (acc compromise response monitoring: [cgab]), (mechanisms: []), (clinical significance: [fndg]), (abnormal response monitoring: [resa]), (fruitful avenue: []), (further research: [resa]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(repetitive behaviour, 'Restricted and Repetitive Behavior')(autistic disorders, 'Autistic Disorder')(repetitive behaviour, 'Restricted and Repetitive Behavior')(coordinated activity, 'Motor Skills')(autism diagnostic, 'Autism Phenotype')(repetitive behaviour, 'Restricted and Repetitive Behavior')(hyperactive ranterior cingulate cortex response, 'Overactivity')

PMCID: 4204613
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (term autism spectrum disorder (asd): [orgf]), (range: [qnco]), (conditions: [dsyn]), (impairments: [patf]), (social interactions: [fndg]), ( communication: [socb]), (repetitive behaviors: [fndg]), (autism: [mobd]), (spectrum disorder: [dsyn]), (symptoms: [sosy]), (autonomic nervous system (ans) dysfunction: [fndg]), (objective: []), (study: [resa]), (effect: []), (sessions: [evnt]), (low frequency (lf): []), (repetitive transcranial magnetic stimulation (rtms): [topp]), (autonomic function: [fndg]), (children: [aggp]), (asd: [cgab]), (electrocardiogram (ecg): [fndg]), (electrodermal activity: [acty]), (rtms session: [evnt]), (autonomic measures: [bdsy]), (interest: [menp]), (r-r cardiointervals: [clna]), (ekg: [fndg]), ((r-r): [clna]), ( time: []), (frequency domain measures: [qnco]), (heart rate variability (hrv): [clna]), (skin conductance level (scl): [ortf]), (heart rate variability measures: [clna]), (r-r: [clna]), (intervals: []), ( standard deviation: [qnco]), (cardiac intervals: [bpoc]), (pnn50 (percentage: [qnco]), (cardiointervals: []), (interval): []), ( power: [hcpp]), (high frequency (hf): []), (lf components: [gngm]), (hrv spectrum: [qnco]), ( lf/hf ratio: [aapp,enzy]), (course: []), (weekly inhibitory lf rtms: [acty]), (dorsolateral prefrontal cortex (dlpfc): [bpoc]), (autonomic balance: [bdsy]), (frontal inhibition: [acty]), (limbic activity: [acty]), (overall heart rate (hr): [clna]), (hrv (in: []), (form: []), (increased hf power): [aapp,enzy]), (lf power: [hcpp]), (decreased lf/hf ratio): [aapp,enzy]), (scl: [gngm]), (behavioral evaluations: [hlca]), (tms: [gngm]), (decreased irritability: [fndg]), ( hyperactivity: [mobd]), ( stereotype behavior: [mobd]), (compulsive behavior ratings: [mobd]), (significant increase: [qnco]), (cardiac interval variability: [bpoc]), (decrease: [qnco]), (tonic scl: [phsu]), (results: [fndg]), (lf rtms: [gngm]), (asd results: [cgab]), (increased cardiac vagal control: [bpoc]), (reduced sympathetic arousal: [menp]), 
ASD Terms: (social interactions, 'Reciprocal Social Interaction')(term autism spectrum disorder, 'Autism Phenotype')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(autism, 'Autism Phenotype')(autonomic nervous system dysfunction, 'Nervous System Diseases')(compulsive behavior ratings, 'Obsessive-Compulsive Disorder')(hyperactivity, 'Overactivity')(stereotype behavior, 'Stereotyped, Restricted, and Repetitive Behavior')

PMCID: 6172273
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (machine: []), (methods: []), (subgroup: [virs]), (persons: [popg]), (autism spectrum disorder (asd): [mobd]), (vitamin b6 responsiveness: [orch,phsu,vita]), (phenotype variables: [orga]), (data: [euka]), (intervention study: []), (signs: [fndg]), (biomarkers: [clna]), (candidates: []), (vitamin b6 responsiveness indicators: [orch,phsu,vita]), (second: [qnco]), (hypothesis: []), (variables: []), (combinations: [phsu]), (finally: []), (results: [fndg]), (cluster analyses: [resa]), (different algorithms: []), ( affinity propagation: [orgf]), (k-medoids: [qnco]), (significant variables: [qnco]), (combination: [fndg]), (hypersensitivity: [patf]), (glutamine level: [aapp,bacs,phsu]), (priori variable: []), (pervasive developmental disorders autism society japan rating scale (pars) scores: [aapp,enzy]), (affinity propagation analysis: [lbpr]), (good classification: []), (potential vitamin: [orch,phsu,vita]), (b6-responsive persons: [popg]), (asd: [cgab]), (k-medoids analysis: [resa]), (knowledge: []), (first study: [qnco]), (specific treatment responsiveness: [topp]), (variables ability: [orga]), (small sample size: [qnco]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(vitamin b6 responsiveness, 'Dietary Supplements')(vitamin b6 responsiveness indicators, 'Dietary Supplements')(vitamin b6 responsiveness, 'Dietary Supplements')(pervasive developmental disorders autism society japan rating scale scores, 'Autism Phenotype')(potential vitamin, 'Dietary Supplements')

PMCID: 6195789
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract lay summary: individuals: [humn]), (autism display variation: [mobd]), (many traits: [gngm]), (interest: [menp]), (ability: [orga]), (social interaction: [fndg]), (resistance: [menp]), (variation: []), (spectrum: [qnco]), (range: [qnco]), (values: []), (axis: [bpoc]), (extent: []), (such variation: []), (incorrect inferences: [menp]), (term: [orgf]), (developmental disability: [mobd]), (communicative skills: [orga]), (repetitive behaviors: [fndg]), (restricted interests: [menp]), (autism spectrum disorder. spectrum: [mobd]), (: []), (single dimension: [fndg]), (people: [popg]), (autism: [mobd]), (autistic.: [mobd]), (fact: [gngm]), (multiple traits: [gngm]), (part: [qnco]), (evolutionary mechanisms: [genf]), (rise: []), (alleles: [gngm]), (accurate clinical descriptor: []), (autism-related disorders: [mobd]), 
ASD Terms: (autism display variation, 'Autism Phenotype')(social interaction, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(developmental disability, 'Learning Disorders')(communicative skills, 'Reciprocal Social Interaction')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(restricted interests, 'Restricted Range of Interests')(autism spectrum disorder. spectrum, 'Autism Phenotype')

PMCID: 3536992
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (few evidence-based social interventions: [hlca]), (young adults: [aggp]), (high-functioning autism: [mobd]), (encounter: [bhvr]), (significant challenges: [hlca]), (transition: [acty]), (adulthood: []), (current study: [resa]), (feasibility: []), (virtual reality social cognition training intervention: [hlca]), (social skills: [socb]), ( social cognition: [socb]), (social functioning: [socb]), (sessions: [evnt]), (weeks: []), (significant increases: [qnco]), (social cognitive measures: [qnco]), (theory: []), (mind: [menp]), (emotion recognition: [menp]), (real life: []), (occupational functioning: []), (post-training: []), (findings: [clna]), (virtual reality platform: [mcha]), (promising tool: []), ( cognition: [menp]), (functioning: []), (autism: [mobd]), 
ASD Terms: (high-functioning autism, 'Autism Phenotype')(virtual reality social cognition training intervention, 'Cognitive Ability')(social skills, 'Ability to Converse in Social Settings')(social cognition, 'Cognitive Ability')(social functioning, 'Ability to Converse in Social Settings')(social cognitive measures, 'Cognitive Ability')(emotion recognition, 'Empathy')(occupational functioning, 'Job Performance')(autism, 'Autism Phenotype')(cognition, 'Cognitive Ability')

PMCID: 5357270
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (relationships: []), (autism quotient (aq): [mobd]), ((sq): [qnco]), (over-selectivity: [genf]), (complex social skills: [socb]), (eighty participants: [popg]), (simultaneous discrimination task (ab+cd): [socb]), (extinction: [menp]), (degree: [qnco]), (elements: [elii]), (reinforced (ab) compound: [chem]), (aq: []), (eq scorers: [qnco]), (relationship: []), (sq: [qnco]), (results: [fndg]), (high aq scorers: [qnco]), (individuals: [humn]), (asd: [cgab]), (cognitive task: []), (empathy: [inbe]), 
ASD Terms: (autism quotient, 'Autism Phenotype')(complex social skills, 'Ability to Converse in Social Settings')(complex social skills, 'Ability to Converse in Social Settings')(empathy, 'Empathy')(high autism, 'Autism Phenotype')(cognitive task, 'Cognitive Ability')

PMCID: 4345535
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorders: [mobd]), (social impairments: [patf]), (behaviors: [inbe]), (children: [aggp]), (years: []), (substantial recent focus: []), (asd: [cgab]), (research: [resa]), (biological pathology and: [patf]), (effective treatment: []), (hypothesis: []), (neurobiological underpinnings: []), (observation: [hlca]), (phenotypic expression: [orga]), (underlying etiology: []), (neurodevelopmental basis: [phsu]), (marker (biomarker): [clna]), (prognostic purposes: []), (stratification: [resa]), (response indices: [lbpr]), (pharmaceutical development: [orgf]), (review: []), (current state: [clna]), (field: [irda]), (meg-related biomarkers: [horm,orch,phsu]), (several potential biomarkers: [clna]), ((middle latency delays: []), (mismatch negativity: [fndg]), (gamma-band oscillatory activity): [npop]), (relation: [socb]), (core domains: [bdsu]), (dysfunction (e.g.: [dsyn]), ( language impairment): [mobd]), (putative biological underpinnings: []), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(social impairments, 'Social Competence')(been substantial recent focus on asd, 'Attention and Focus')(neurodevelopmental basis, 'Learning Disorders')

PMCID: 5506186
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (behavioral studies: [inbe]), (individuals: [humn]), (autism spectrum disorder (asd): [mobd]), (ability: [orga]), (mind: [menp]), (eyes: [bpoc]), (impairment: [patf]), (social malfunctioning: [patf]), (structural neural correlates: []), (issue: [fndg]), (eyes test: [bpoc]), (version (eyes test): [bpoc]), (structural magnetic resonance images: [npop]), (adults: [aggp]), (high-functioning asd (n =: [cgab]), (age-: [orga]), ( sex-: [orgf]), (intelligence: [menp]), ((td): []), ((n =: [aapp,imft]), (behavioral level: [inbe]), (eyes test scores: [bpoc]), (asd group: [cgab]), (control group: [grup]), (neural level: [phsu]), (interaction: []), (group: [popg]), (eyes test score: [bpoc]), (left temporoparietal junction (tpj): []), (positive association: [menp]), (gray matter volume: [tisu]), (region: []), (finding: [sosy]), (failure: [inbe]), (appropriate structural neural representations: [acty]), (tpj: []), (impaired ability: [orga]), (asd: [cgab]), (neural findings: [clna]), (support: []), (theories: []), (impairments: [patf]), (others mental states: [fndg]), (core symptoms: [sosy]), (atypical features: [fndg]), (social brain network: [popg]), (underlie such impairments: [patf]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(core symptoms of asd, 'Complaints and Indications')

PMCID: 5483849
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (childhood-onset neurodevelopmental disorder: [mobd]), (prevalence: [qnco]), (children: [aggp]), (people: [popg]), (united states: []), (current asd interventions: [cgab]), (in-person behavioral therapies: [topp]), (interventions: [hlca]), (fundamental deficits: []), (asd: [cgab]), (deficits: []), (social communication: [socb]), (presence: [qnco]), (stereotypies: [mobd]), (other autism-related behaviors: [mobd]), (current: [npop]), (therapeutic approaches: [topp]), (quantitative data measures: [qnco]), (symptomatology: []), ( severity: []), (condition trajectory: [dsyn]), (current situation: [npop]), (brain power system: [bpoc]), (digital behavioral aid: [inbe]), (quantitative data gathering: [euka]), (reporting features: [hlca]), (bps: [dsyn]), (smartglasses: []), (personalized coaching experiences: [menp]), (family: [famg]), (gamified augmented-reality applications: [qnco]), (utilizing artificial intelligence: []), (applications: [hlca]), (adults: [aggp]), (emotion recognition: [menp]), ( face: [blor]), (gaze: [fndg]), ( eye contact: [socb]), (behavioral self-regulation: [inbe]), (preliminary case: []), (report: [hlca]), ( part: [qnco]), (set: [menp]), (upcoming research reports: [resa]), (feasibility: []), (boys: [aggp]), (years: []), (coaching intervention: [hlca]), (fun: []), (males: [orga]), (system: []), (technical problems: [phpr]), (intervention: [hlca]), ( caregivers: []), (improved non-verbal communication: [menp]), (social engagement: [fndg]), (decreased symptoms: [sosy]), (aberrant behavior checklist: [inbe]), (24-h post-intervention: [elii]), (specifically: []), (cases: [qnco]), (improvements: []), (irritability: [fndg]), ( lethargy: [sosy]), ( stereotypy: [mobd]), ( hyperactivity/non-compliance: [fndg]), (speech: [orgf]), (augmented reality: [qnco]), (important future role: [socb]), (therapeutic needs: [topp]), (quantitative data: [euka]), (such sensor-rich systems: []), (digital phenotyping: [lbpr]), (refinement: []), (social communication constructs: [socb]), (research domain criteria: [resa]), (evidence: []), ( usability: []), (tolerability: [resa]), (such specialized smartglasses: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(childhood-onset neurodevelopmental disorder, 'Learning Disorders')(social communication, 'Reciprocal Social Interaction')(emotion recognition, 'Empathy')(eye contact, 'Eye Contact')(eye contact, 'Eye Contact')(social engagement, 'Engaging in Social Conversation')(demonstrated decreased symptoms of asd, 'Complaints and Indications')(inappropriate speech, 'Language Ability')(social communication constructs, 'Reciprocal Social Interaction')

PMCID: 4345542
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (review: []), (literature: [inpr,mnob]), (gender-related concerns: [socb]), (autism spectrum disorders: [mobd]), (attention: [menp]), (critical shortcomings: []), (current understanding: [menp]), (potential clinical implications: []), (authors: []), (gender identity disorder (gid): [mobd]), (dysphoria (gd): [mobd]), (individuals: [humn]), (asd: [cgab]), (range: [qnco]), (potential explanations: []), (however: []), (capacity: [qnco]), (conclusions: []), (conceptual challenges: [hlca]), (gender identity: [menp]), (discourses: []), (gender: [orga]), (component: []), (identity formation: [biof]), (prominence: []), (equal rights: []), (regard: []), (treatment: [topp]), (gender dysphoria: [mobd]), (clinicians: []), (aspect: [qnco]), (identity: [menp]), (social frame: [nusq]), (exploration: [topp]), (gender roles: [socb]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')

PMCID: 5442708
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (abstract: []), (advances: []), (early diagnosis: [diap]), (behavioral therapies: [topp]), (effective treatments: []), (children: [aggp]), (autism spectrum disorder (asd): [mobd]), (umbilical cord: [emst]), (cell therapies: [topp]), (potential: []), (asd symptoms: [cgab]), (inflammatory processes: [phpr]), (brain: [bpoc]), (phase i: []), (trial: [resa]), (safety: [hcpp]), (feasibility: []), (single intravenous infusion: [fndg]), (autologous umbilical cord blood: [tisu]), (sensitivity: [patf]), (several asd assessment tools: [cgab]), (suitable endpoints: []), (future trials: [resa]), (twentyfive children: [aggp]), (median age: [orga]), (years: []), (confirmed diagnosis: [fndg]), (asd: [cgab]), (autologous umbilical cord blood unit: [tisu]), (battery: [inpo]), (functional tests: []), (blood infusion (baseline): [bdsu]), (months later: []), (assessment: [acty]), (adverse events: [patf]), (period: []), (treatment: [topp]), (significant improvements: [qnco]), (children's behavior: [inbe]), (parentreport measures: [qnco]), (social communication skills: [socb]), (autism symptoms: [mobd]), (clinician ratings: [acty]), (overall autism symptom severity: [mobd]), (degree: [qnco]), (improvement: []), (standardized measures: [qnco]), (expressive vocabulary: [topp]), (objective eyetracking measures: [qnco]), (children's attention: [menp]), (social stimuli: [phpr]), (measures: [qnco]), (useful endpoints: []), (future studies: [lbpr]), (behavioral improvements: [inbe]), (months: []), (infusion: [topp]), (baseline: [bodm]), (nonverbal intelligence quotients: [orga]), (data: [euka]), (basis: [phsu]), (efficacy: [resa]), (umbilical cord blood infusions: [tisu]), (stem cells translational medicine: [resa]), 
ASD Terms: (early diagnosis, 'Diagnosis')(autism spectrum disorder, 'Autism Phenotype')(asd symptoms, 'Complaints and Indications')(diagnosis, 'Diagnosis')(confirmed diagnosis, 'Diagnosis')(social communication skills, 'Reciprocal Social Interaction')(overall autism symptom severity, 'Complaints and Indications')(autism symptoms, 'Complaints and Indications')(nonverbal intelligence quotients, 'IQ')

PMCID: 4736958
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (subclinical variants: []), (social-communicative challenges: [socb]), (rigidity: [sosy]), (autism spectrum disorder (asd): [mobd]), (autism phenotype (bap): [mobd]), (bap: [gngm]), ((as specific: []), (subset: []), (relatives: [famg]), (individuals: [humn]), (asd): [cgab]), ((as: []), (general population): [popg]), (current study: [resa]), (compatibility: [evnt]), (approaches: []), (associations: [menp]), (autism symptoms: [mobd]), (social-communicative skills: [socb]), (young school-age children: [aggp]), (asd: [cgab]), ( children: [aggp]), (sibling: [famg]), (children: [aggp]), (reduced theory: []), (mind (tom): [gngm]), (adaptive skills: [inbe]), (cognitive empathy: [inbe]), (language skills: [menp]), (full sample: [sbst]), (reduced tom: [gngm]), (core aspect: [qnco]), (current sample regardless: [npop]), ((in terms: [orgf]), (siblings: [famg]), (atypical developmental): [orgf]), (entire sample): [sbst]), (early language skills: [menp]), (school-age tom: [mnob,orgt]), (findings: [clna]), (dimensional approaches: [qnco]), ( highlight: []), (tom: [gngm]), (school-age bap: [mnob,orgt]), (narrative-based approaches: [socb]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(autism phenotype, 'Autism Phenotype')(autism symptoms, 'Complaints and Indications')(adaptive skills, 'Adaptive Life Skills')(cognitive empathy, 'Cognitive Ability')(language skills, 'Development or Regression of Language Skills')(early language skills, 'Development or Regression of Language Skills')(school-age broader autism phenotype, 'Autism Phenotype')

PMCID: 4192352
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (few recent studies: [lbpr]), (quality: []), (life: []), (adults: [aggp]), (autism spectrum disorder (asd): [mobd]), (individuals: [humn]), (asd: [cgab]), (own quality: []), (primary purpose: [topp]), (study: [resa]), (life scores: [clna]), (non-asd control group: [cgab]), (taiwanese health population reference group: [popg]), (asd (m age: [cgab]), (sd: [gngm]), (intellectual disabilities: [mobd]), (comparison sample: [sbst]), (age: [orga]), (sex: [orgf]), (participants: [popg]), (validated measure: [qnco]), (taiwanese version: [popg]), (world health organization quality: [hcro]), (life-bref (whoqol-bref): []), (independent t-tests: [lbpr]), (differences: [qnco]), (groups: [popg]), (environment domain: []), (physical health: [orga]), (psychological health domains: [menp]), (life score: [clna]), (social relationship domain: []), (domains: []), (additionally: []), ( adults: [aggp]), (psychological health: [menp]), (social relationship domains: []), (comorbid: []), (self-rated health status: [acty]), (happiness: [menp]), (preliminary findings: [clna]), (supportive social contexts: [hcpp]), (interventions: [hlca]), (findings: [clna]), ( social relationship: []), (treatment programs: [topp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(intellectual disabilities, 'Learning Disorders')(comorbid, 'Comorbidities')

PMCID: 4734207
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disorder: [mobd]), (deficits: []), (social interaction: [fndg]), ( difficulties: [fndg]), (language: [lang]), (behaviors: [inbe]), (etiology: []), (asd: [cgab]), (immune dysfunction: [dsyn]), (abnormalities: [cgab]), (synaptogenesis: [ortf]), (disease phenotype: [dsyn]), (however: []), (understanding: [menp]), (processes: [phpr]), (non-inflammatory roles: [socb]), (microglia become: [cell]), (normal neurodevelopment: [ortf]), (dysfunction: [dsyn]), (disparate findings: [clna]), (aberrant synaptogenesis: [ortf]), (review: []), (research: [resa]), (importance: []), (microglia: [cell]), (development: [orgf]), (normal neural networks: [fndg]), ( review: []), (recent studies: [lbpr]), (abnormal microglia: [cell]), (autism: [mobd]), (relationship: []), (other neurodevelopmental disorders: [mobd]), (cellular level: [phsu]), 
ASD Terms: (social interaction, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(autism, 'Autism Phenotype')(autism, 'Autism Phenotype')(other neurodevelopmental disorders, 'Learning Disorders')

PMCID: 4893072
SFARI Genes: CD38, CD38, CD38, CD38, 
Non SFARI Genes: TRPM2, 
Named Entities: (oxytocin (ot): [aapp,horm,phsu]), (brain: [bpoc]), (cell soma: [celc]), ( axons: [celc]), (dendrites: [celc]), (neurosecretory cells: [cell]), (hypothalamus: [bpoc]), (ot: [gngm]), (receptors: [aapp,rcpt]), ( form inositol-1: [orch,phsu,vita]), (4: [fndg]), (5-trisphosphate: [qnco]), (intracellular free calcium (ca2+) concentrations: [celc]), (self: []), (neighboring neurons: [cell]), (further ot release: i.e.: [hlca]), ( autocrine: [ortf]), (paracrine systems: [phsf]), (ot-induced ot release: [hlca]), (cd38-dependent cyclic adp-ribose (cadpr): [bacs,nnon]), (autoregulation: [biof]), (ca2+ mobilization: [topp]), (ryanodine receptors: [aapp,rcpt]), (intracellular ca2+ pools: [celc]), (ca2+: [elii,phsu]), (cadpr: [bacs,nnon]), (addition: []), (heat stimulation: [npop]), (hyperthermia enhance [ca2+]i increases: [inch]), (ca2+ influx: [elii,phsu]), (trpm2 cation channels: [chvs]), (trpm2 molecules act: [topp]), (ca2+ signal amplifiers: [elii,phsu]), (thus: []), ( ot release: [hlca]), (coupling: []), (molecules: [sbst]), (critical roles: [socb]), (labor: [orgf]), (milk ejection: [ortf]), (reproductive females: [orgf]), (social behavior: [socb]), (daily life: []), (genders: [orga]), (cd38 knockout mice: [mamm]), (reduction: [npop]), ([ca2+]i elevation: [inch]), (subsequent ot secretion: [biof]), (evidence: []), (associations: [menp]), (cd38: [gngm]), (psychiatric disorder: [mobd]), (subjects: [humn]), (autism spectrum disorder: [mobd]), 
ASD Terms: (social behavior, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(psychiatric disorder, 'Mental Disorders')

PMCID: 4407191
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (cheng: []), ( rolls: []), (al: [lbpr]), (examine whole-brain voxel-based resting-state functional connectivity: [bpoc]), (people: [popg]), (autism: [mobd]), (connectivity: []), (regions: []), (facial expression processing: [fndg]), (theory: []), (mind: [menp]), ((middle temporal gyrus): [bpoc]), ( emotion: [menp]), ((ventromedial prefrontal cortex): [bpoc]), (representation: [acty]), (self (precuneus: [bpoc]), (related posterior cingulate areas): [bpoc]), 
ASD Terms: (autism, 'Autism Phenotype')(facial expression processing, 'Integrated Verbal and NonVerbal Communication')

PMCID: 5921983
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, SHANK3, 
Non SFARI Genes: 
Named Entities: (phelan-mcdermid syndrome (pms): [dsyn]), (neurodevelopmental disorder: [mobd]), (neurological features: [clna]), (cases: [qnco]), (deletions: [genf]), (shank3 haploinsufficiency: [comd]), (many other genes: [gngm]), (number: [qnco]), (point mutations: [comd]), (shank3: [gngm]), (recent years: []), (large-scale sequencing studies: [mbrt]), (systematic studies: [lbpr]), (phenotype: [orga]), (individuals: [humn]), (such mutations: [genf]), (genetic data: [euka]), (mutations: [genf]), (patients: [podg]), (pathogenic: [fndg]), (likely pathogenic shank3 variants: [fndg]), (phenotypic information: [orga]), (shank3 mutations: [genf]), (cohort: [popg]), (protein;: [aapp,bacs]), (majority: [socb]), (inheritance: [qnco]), (substantial allelic heterogeneity: []), (variants: []), (recurrent (p.leu1142valfs*153: [aapp,imft]), ( p.ala1227glyfs*69: [qnco]), ( p.arg1255leufs*25: [aapp,imft]), (c.2265+1g>a): []), (hotspots: [nusq]), (intellectual disability: [mobd]), (autism spectrum disorder: [mobd]), (prevalent (73%): [qnco]), (severe speech deficits: [fndg]), (common: [qnco]), (contrast: [irda]), (single words: [fndg]), (phrase speech: [orgf]), (other common findings: [clna]), (reports: [hlca]), (hypotonia: [fndg]), ( motor skill: [orgf]), (regression: [menp]), ( seizures: [sosy]), ( brain: [bpoc]), (abnormalities: [cgab]), ( mild dysmorphic features: [fndg]), (feeding: [acty]), (gastrointestinal problems: []), (haploinsufficiency: [comd]), (broad range: [qnco]), (features: []), (pms: [gngm]), (findings: [clna]), (phenotypic spectrum: [orga]), (shank3 point mutations: [comd]), (that: []), (general: [hlca]), ( speech impairment: [dsyn]), (motor deficits: [fndg]), (case: []), ( renal abnormalities: [cgab]), (loss: [qnco]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s13229-018-0205-9) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(neurological features, 'Neurologic Indications')(intellectual disability, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(severe speech deficits, 'Idiosyncratic and Routinized Speech')(phrase speech, 'Language Ability')(speech impairment, 'Language Ability')(speech impairment, 'Idiosyncratic and Routinized Speech')(motor deficits, 'Motor Skills')

PMCID: 5283828
SFARI Genes: SHANK3, SHANK3, SHANK3, SHANK3, 
Non SFARI Genes: 
Named Entities: (mutations: [genf]), (synaptic gene shank3 lead: [gngm]), (neurodevelopmental disorder: [mobd]), (phelan-mcdermid syndrome (pms): [dsyn]), (pms: [gngm]), (common monogenic: [qnco]), (penetrant cause: []), (autism spectrum disorder (asd): [mobd]), (intellectual disability (id): [mobd]), (presents: [qnco]), (attention deficits: [mobd]), (neurobiology: []), (pharmacological treatments: [topp]), (core symptoms: [sosy]), (here: []), (production: []), (characterization: [acty]), (shank3-deficient rat model: [mamm]), (genetic alteration: [genf]), (human shank3 mutation: [humn]), (shank3-deficient rats: [mamm]), (impaired long-term social recognition memory: [menp]), (attention: [menp]), (reduced synaptic plasticity: [ortf]), (hippocampal-medial prefrontal cortex pathway: [bpoc]), (deficits: []), (oxytocin treatment: [aapp,horm,phsu]), (effect: []), (oxytocin: [aapp,horm,phsu]), (non-social attention deficits: [mobd]), (novel finding: [sosy]), (results: [fndg]), (oxytocinergic contribution: [acty]), (subtype: []), (asd: [cgab]), (id: [lbpr]), (individualized therapeutic approach: [topp]), (doi: http://dx.doi.org/10.7554/elife.18904.001: [fndg]), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(intellectual disability, 'Learning Disorders')(impaired long-term social recognition memory, 'Social Competence')

PMCID: 5516334
SFARI Genes: 
Non SFARI Genes: PC, 
Named Entities: (autism: [mobd]), (neurodevelopmental disorder: [mobd]), (developmental: [orgf]), ( behavioral: [inbe]), (sensory abnormalities: [cgab]), (researchers: []), (last years: []), (immunological alteration: []), (inflammation: [patf]), (hot subject: [npop]), (autism field: [mobd]), (work: []), (alteration: []), (phospholipids: [bacs,orch]), (ps: [gngm]), (pc): [dsyn]), (change: [qnco]), (cpla2 concentration: [menp]), (main phospholipid hydrolytic enzyme: [npop]), (autistic patients: [mobd]), (correlation: []), (biomarkers: [clna]), (severity: []), (childhood autism rating scale (cars): [mobd]), ( social responsiveness scale (srs): [acty]), (short sensory profile (ssp): [qnco]), ( pc): [dsyn]), (cpla2: [gngm]), (biochemical parameters: [fndg]), (plasma: [bdsu]), (saudi: []), (autistic male patients: [mobd]), (mild-moderate: []), (social responsiveness scale (srs): [acty]), (gender-matched control samples: [orga]), (data demonstrate: [euka]), (levels: []), (pe: [bacs,orch]), ( ps: [gngm]), (pc: [gngm]), (significant increase: [qnco]), (association: [menp]), (impaired phospholipid concentration: [bacs,orch]), (impaired sensory processing: [ortf]), (impaired phospholipid level: [bacs,orch]), (roles: [socb]), (etiology: []), (characteristic analysis: [resa]), (predictiveness diagrams: []), (measured parameters: [fndg]), (predictive biomarkers: [clna]), (clinical symptoms: [sosy]), (significant guidance: [hlca]), (future therapeutic strategy: [menp]), (re-establish physiological homeostasis: [biof]), 
ASD Terms: (autism, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(sensory abnormalities, 'Reaction to Sensory Stimuli')(autism field, 'Autism Phenotype')(autism, 'Autism Phenotype')(childhood autism rating scale, 'Autism Phenotype')(impaired sensory processing, 'Reaction to Sensory Stimuli')(autism, 'Autism Phenotype')

PMCID: 3466125
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (patients: [podg]), (autism spectrum disorders: [mobd]), (exhibit core: [bdsu]), (autistic symptoms: [mobd]), (social impairments: [patf]), (early childhood: []), (secondary disabilities: [neop]), (irritability: [fndg]), (aggressive behavior: [mobd]), (core symptoms: [sosy]), (however: []), (radical treatments: [topp]), (oxytocin: [aapp,horm,phsu]), (important roles: [socb]), (multiple social behaviors: [socb]), (social recognition: [menp]), (effective treatments: []), (asds: [cgab]), (case presentation: []), (case: []), (16-year-old girl: [aggp]), (autistic disorder: [mobd]), (long-term administration: [hlca]), (oxytocin nasal spray: [aapp,horm,phsu]), (month: []), (girls social interactions: [fndg]), (social communication: [socb]), (adverse effects: [patf]), (marked decreases: [qnco]), (aberrant behavior checklist scores: [inbe]), (targeted treatment: [topp]), (female: [orga]), (long-term nasal oxytocin spray: [aapp,horm,phsu]), (treatment: [topp]), 
ASD Terms: (autism spectrum disorders, 'Autism Phenotype')(including social impairments from early childhood, 'Social Competence')(core autistic symptoms, 'Complaints and Indications')(social impairments, 'Social Competence')(aggressive behavior, 'Aggressive Behavior')(radical treatments of social impairments, 'Social Competence')(multiple social behaviors, 'Reciprocal Social Interaction')(effective treatments of social impairments, 'Social Competence')(autism spectrum disorders, 'Autism Phenotype')(autistic disorder, 'Autistic Disorder')(autistic symptoms, 'Complaints and Indications')(girls social interactions, 'Reciprocal Social Interaction')(social communication, 'Reciprocal Social Interaction')(targeted treatment of social impairments, 'Social Competence')(autistic disorder, 'Autistic Disorder')(treatment of social impairments, 'Social Competence')(autism spectrum disorders, 'Autism Phenotype')

PMCID: 6091196
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (prader-willi syndrome (pws): [cgab]), (angelman: []), ((as): []), (neurodevelopmental disorders: [mobd]), (abnormal expression: [topp]), (imprinted genes: [gngm]), (15q11-13 region: []), (dysregulation: []), (genes: [gngm]), (region: []), (susceptibility factor: [clna]), (autism spectrum disorder (asd): [mobd]), (disorders: [dsyn]), (study: [resa]), (symptoms: [sosy]), (asd: [cgab]), (pws: [cgab]), (individuals: [humn]), (years: []), (objective assessment: [acty]), (participants: [popg]), (autism diagnostic observation schedule-2nd edition (ados-2): [hlca]), (age-appropriate intellectual functioning assessment: [hlca]), (genetic diagnosis: [fndg]), (dna methylation analysis: [mbrt]), (microarray testing: []), (copy number changes: [qnco]), (social affect: [menp]), (severity: []), (ados-2: [aapp,enzy]), (= .0055: []), (.0015: []), ( respectively): []), (groups: [popg]), (css: [cgab,dsyn]), (repetitive: []), (behaviour domain: []), (pws cases: [cgab]), (as: []), (mental health issues: [fndg]), (adolescents: [aggp]), (adults: [aggp]), (electronic supplementary material: []), (online version: []), (article: []), ((10.1186/s11689-018-9242-0) contains: [acty]), (supplementary material: []), (users: [humn]), 
ASD Terms: (prader-willi syndrome, 'Prader-Willi Syndrome')(neurodevelopmental disorders, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')(autism diagnostic observation schedule-2nd edition, 'Autism Phenotype')(age-appropriate intellectual functioning assessment, 'Mental Retardation')(genetic diagnosis, 'Diagnosis')(prader-willi syndrome, 'Prader-Willi Syndrome')(prader-willi syndrome cases, 'Prader-Willi Syndrome')(prader-willi syndrome, 'Prader-Willi Syndrome')(mental health issues, 'Mental Retardation')

PMCID: 4120673
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (current paper: [npop]), (notion: []), (affordances offers: []), (alternative: []), (theory: []), (mind: [menp]), ((tom) approaches: [gngm]), (social engagement: [fndg]), (autism spectrum disorder (asd) specifically: [mobd]), (affordances: []), (possibilities: []), (action: [acty]), (environment: []), (contrast: [irda]), (tom: [gngm]), (concept: []), (complementarity: [aapp,imft]), (person: [grup]), (dualism: []), (behavior: [inbe]), (line: [sbst]), (gibsonian idea: []), (child: [aggp]), (others: [fndg]), (herself: []), (order: [acty]), (individuals: [humn]), (asd: [cgab]), (same affordances: []), (other people: [popg]), (difficulties: [fndg]), (others affordances: [fndg]), (disruption: []), (interpersonal behaviors: [inbe]), (methods: []), (interaction: []), (account: [clna]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(social engagement, 'Engaging in Social Conversation')(autism spectrum disorder specifically, 'Autism Phenotype')

PMCID: 6173230
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (introduction autism: [mobd]), (disorder (asd): [cgab]), (impairments: [patf]), (social communication: [socb]), (core symptoms: [sosy]), (deficits: []), (behaviours: [inbe]), (limited visual attention: [menp]), (sensitivity: [patf]), (eye gaze cues: [bpoc]), (intervention game: [dora]), (serious game mechanics: [npop]), (adolescents: [aggp]), (asd: [cgab]), (individuals: [humn]), (eyes: [bpoc]), (shifts: [phpr]), (gaze specifically: [fndg]), (information: []), (external world: [popg]), (game: [dora]), (understanding: [menp]), (gaze cues: [fndg]), (attention: [menp]), (methods: []), (analysis: [resa]), (social: []), (autism (saga) trial: [resa]), (preliminary: []), (trial: [resa]), (waitlist control condition: [topp]), ((1018 years): []), (full-scale iq: [acty]), (minimum second grade reading level: [dora]), (parents: []), (intervention: [hlca]), (control condition): [topp]), (baseline assessments: [bodm]), (intervention participants: [popg]), (computer game: []), (home: []), (computer: []), (~30: [fndg]), (times: [qnco]), (week: []), (families: [famg]), (lab: [gngm]), (baseline: [bodm]), (months: []), (randomisation: [resa]), (measures: [qnco]), (primary outcomes: [topp]), (eye: [bpoc]), (social visual attention: [menp]), (secondary outcomes: [neop]), (questionnaires: []), (social skills: [socb]), (autism-like behaviours: [mobd]), (analyses: [resa]), (feasibility: []), ( safety: [hcpp]), (preliminary effectiveness: []), (ethics: []), (dissemination saga: [aapp,enzy]), (institutional review board: []), (pennsylvania state university (00005097): [mnob,orgt]), (findings: [clna]), (scientific conferences: [hcpp]), (peer-reviewed journals: [hlca]), (participants: [popg]), (newsletter: [inpr,mnob]), (control condition: [topp]), (full data: [euka]), (trial registration number nct02968225: [resa]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(introduction autism spectrum disorder, 'Autism Phenotype')(limited visual attention, 'Visual Thinking')(autism trial, 'Autism Phenotype')(social visual attention, 'Visual Thinking')(social skills, 'Ability to Converse in Social Settings')(autism, 'Autism Phenotype')

PMCID: 5329757
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (objective children: [aggp]), (autism: [mobd]), (on-task behavior problems: [mobd]), (class: []), (study: [resa]), (effect: []), (alternative classroom-seating devices: []), (regular classroom chairs: []), ( therapy balls: [topp]), (air cushions: [inch,phsu]), (students classroom behavior: [inbe]), (materials: [sbst]), (students: [popg]), (a1-b-a2-c multiple treatments: [topp]), (mashhads tabasom school: [mnob,orgt]), ( mashhad: []), ( iran: []), (students behaviors: [inbe]), (phases:: [euka]), (common chairs: [qnco]), (phase a: []), ( air-sit: [inch,phsu]), (phase b: []), (chairs: []), (phase c. sitting times: [qnco]), (on-task behaviors: [inbe]), (momentary time: []), (different phases: [euka]), (important changes: [qnco]), (wk: []), (gilliam autism rating scale-second edition test: [mobd]), (communication skills: [orga]), (before: []), (research: [resa]), (significant increases: [qnco]), (in-seat behaviors: [inbe]), (therapy balls: [topp]), (significant effects: [qnco]), (in-seat/on-task behaviors: [inbe]), (results: [fndg]), (significant decrease: [qnco]), (stereotyped movement: [orgf]), (increase: []), (communication: [socb]), (social skills: [socb]), (teachers: []), (use: []), (balls: []), (air-cushioned chairs: [inch,phsu]), (therapy ball chairs: [topp]), (in-seat behavior: [inbe]), (behavior: [inbe]), (autism spectrum disorder: [mobd]), 
ASD Terms: (autism, 'Autism Phenotype')(on-task behavior problems in class, 'Personal Traits')(on-task behavior problems, 'Personal Traits')(autism, 'Autism Phenotype')(gilliam autism rating scale-second edition test, 'Autism Phenotype')(communication skills, 'Reciprocal Social Interaction')(stereotyped movement, 'Stereotyped, Restricted, and Repetitive Behavior')(social skills, 'Ability to Converse in Social Settings')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 6209889
SFARI Genes: 
Non SFARI Genes: impact, 
Named Entities: (background: students: [popg]), (autism spectrum disorder (asd): [mobd]), (prominent social communication deficits: [socb]), ( symptoms: [sosy]), (attention-deficit/hyperactivity disorder: [mobd]), (chronic irritability: [fndg]), (challenges: [hlca]), (academic progress: [fndg]), (educational: []), ( behavioral: [inbe]), (medical interventions: [hlca]), (assistive smartglasses technology: []), (individuals: [humn]), (technology: []), (ecologically-valid school settings: []), (study: [resa]), (feasibility: []), (efficacy: [resa]), (empowered brain: [bpoc]), (computerized smartglasses intervention: [hlca]), (socio-emotional behavioral aid: [inbe]), (students: [popg]), (asd: [cgab]), (methods:: []), (two-part six-week study: [resa]), (school children: [aggp]), (public elementary school: [mnob,orgt]), (initial three-week feasibility stage: [qnco]), (three-week controlled longitudinal efficacy stage: [fndg]), (stages: [clna]), (use: []), (twice-daily socio-emotional intervention: [menp]), (smartglasses: []), (educators: []), (pre-intervention: []), (post-intervention aberrant behavioral checklist (abc) ratings: [inbe]), (start: []), (feasibility stage: [clna]), (efficacy stage: [clna]), (primary outcome measures: [qnco]), (improvements: []), (abc subscales: [dsyn]), (irritability: [fndg]), ( hyperactivity: [mobd]), (social withdrawal: [fndg]), (results: students: [popg]), (efficacy stages: [resa]), (baseline period: [bodm]), (control periods: [sbst]), ( respectively: []), (participants: [popg]), (controlled efficacy stage: [clna]), (decreased abc subscale scores: [dsyn]), (hyperactivity: [mobd]), (intervention: [hlca]), (exposure-response improvement: [fndg]), (other assistive technologies: []), (substantial number: [qnco]), (asd demonstrate chronic: [cgab]), (behavioral challenges: [inbe]), (evidence: []), (smartglasses-based socio-emotional aid: [menp]), (autism: [mobd]), (symptoms: [sosy]), ( irritability: [fndg]), (improvement: []), (part: [qnco]), (longitudinal school-based intervention: [mnob,orgt]), (further studies: [lbpr]), (samples: [sbst]), (incorporation: []), (trial methodology: [resa]), (impact: [gngm]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(prominent social communication deficits, 'Reciprocal Social Interaction')(attention-deficit/hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(medical interventions, 'Medications')(hyperactivity, 'Overactivity')(hyperactivity, 'Overactivity')(hyperactivity, 'Overactivity')(hyperactivity, 'Overactivity')(autism, 'Autism Phenotype')(hyperactivity, 'Overactivity')

PMCID: 3570064
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (characteristics: []), (autism spectrum disorder (asd): [mobd]), (difficulty: [fndg]), (language: [lang]), (communication.1 children: [aggp]), (asd's onset: [cgab]), (speaking: [dora]), (many children: [aggp]), (asd: [cgab]), (grammatical complexity: [chvs]), ((td) peers.6: [popg]), (8: []), (12: []), (23 however: [qnco]), ( children: [aggp]), (significant social deficit: [dsyn]), (researchers: []), (clinicians: []), (extent: []), (deficits: []), (social interaction account: [fndg]), (language production.5: [lang]), (14: []), (19: []), (25 standardized assessments: [hlca]), (children: [aggp]), (comprehension component;: [menp]), (many such comprehension tasks: [menp]), (aspect: [qnco]), ((e.g.: []), ( vocabulary): []), (5: [qnco]), (significant motor component (e.g.: [qnco]), (act-out): [topp]), ( and/or require children: [aggp]), (number: [qnco]), (alternatives: []), (behaviors: [inbe]), (asd.7: [cgab]), (13: []), (16: []), (method: [lbpr]), (language comprehension: [menp]), ((9-36 months): [fndg]), (autism.2: [mobd]), (4: [fndg]), (9: []), (11: []), (22: []), ( portable intermodal preferential looking: [orga]), ((p-ipl): [aapp,imft]), ( projects: []), (side-by-side video images: []), (portable screen: [hlca]), (video images: []), ('baseline' (nondirecting) audio: [bodm]), ('test' linguistic audio: [lbpr]), (children's eye movements: [ortf]), (video: []), (coded: []), (linguistic audio: [inpr,mnob]), (to: []), (linguistic audio.2: [inpr,mnob]), (18: []), (26: []), (paradigm: [resa]), (components: []), ((projector: []), ( camcorder: []), ( digitizer): []), (portability: []), (easy setup: [acty]), (children's homes: []), (crucial point: [qnco]), (young children: [aggp]), (new (e.g.: []), ( laboratory) settings: [mnob,orgt]), (videos: []), (wide range: [qnco]), (specific components: []), (linguistic knowledge: []), (subject-verb-object word: [humn]), (tense/aspect suffixes: [qnco]), (verbs; videos: []), (principles: []), (word learning: [menp]), (noun bias: [bird]), (shape bias: [bird]), (syntactic bootstrapping.10: [fndg]), (17: []), (21: []), (24 videos: []), (characters: [menp]), (speech: [orgf]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(difficulty with language, 'Language Ability')(asd's onset, 'Onset of Symptoms')(social interaction account, 'Reciprocal Social Interaction')(deficits in language production.5, 'Language Ability')(significant social deficit, 'Social Competence')(language comprehension, 'Development or Regression of Language Skills')(speech, 'Language Ability')

PMCID: 3511407
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (rise: []), (prevalence: [qnco]), (diagnosed cases: [qnco]), (autism spectrum disorder (asd): [mobd]), (several studies: [lbpr]), (recent years: []), (asd prevalence: [qnco]), (awareness: [menp]), (diagnostic criteria: []), (role: [socb]), (environmental factors: []), (cause: []), (cases: [qnco]), (asd: [cgab]), (study: [resa]), (families: [famg]), (multiple affected children: [aggp]), (clues: []), (asd etiology: [cgab]), (majority: [socb]), (research: [resa]), (multiplex families: [famg]), (genetic anomalies: [fndg]), (disorder: [dsyn]), (symptom severity: [fndg]), (asd birth order: [qnco]), (evidence: []), (cognitive measures: [qnco]), (behavior: [inbe]), (second affected siblings: [famg]), (multiplex autism families: [famg]), (autism genetic resource exchange dataset: [mobd]), (measures: [qnco]), (nonverbal iq: [fndg]), (ravens colored progressive matrices: [bird]), (verbal iq: []), (peabody picture vocabulary test: []), (autism severity: [mobd]), (social responsiveness scale (srs): [acty]), (instrument: []), (quantitative measure: [qnco]), (autism: [mobd]), (results: [fndg]), (females: [orga]), (males: [orga]), (affected siblings: [famg]), (compared: [acty]), ( significant declines: [qnco]), (verbal iq scores: [clna]), (observed: []), (addition: []), ( srs results: [fndg]), (significant increase: [qnco]), (overall decline: []), (function: [phsf]), (iq data: [euka]), (age: [orga]), (sex: [orgf]), (siblings: [famg]), (surprisingly: []), (srs scores: [clna]), (age difference: [aggp]), (years: []), (dosage effect: [qnco]), (unknown epigenetic: []), ( environmental: []), (and/or immunological factors: [imft]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(cognitive measures, 'Cognitive Ability')(multiplex autism families, 'Autism Phenotype')(autism genetic resource exchange dataset, 'Autism Phenotype')(autism, 'Autism Phenotype')(autism severity, 'Autism Phenotype')(autism severity, 'Autism Phenotype')

PMCID: 6325071
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (set: [menp]), (childhood: []), (neurodevelopmental disorders: [mobd]), (impairments: [patf]), (social communication: [socb]), (restricted: []), ( repetitive: []), (patterns: []), (behavior: [inbe]), (here: []), (whole-genome sequencing (wgs) data: [euka]), (monozygotic twins: [famg]), (asd: [cgab]), (multiple patient-specific genetic variations: [npop]), (list: []), (asd risk genes: [cgab]), (results: [fndg]), (dvmt: []), ((discordant variation: []), (monozygotic twin): [famg]), (twin pairs: [famg]), (snps: [nusq]), (indels: [genf]), (cnvs: [nusq]), (total: [qnco]), (genes: [gngm]), (types: []), (variations: []), (gene ontology (go) enrichment analysis: [resa]), (biological processes: [biof]), (majority: [socb]), (neurodevelopmental processes: [phpr]), (addition: []), ( functional network analysis: [popg]), (strong functional relevance: []), (conclusion: []), (first time: [qnco]), (comprehensive scan: [diap]), (genomic differences: [gngm]), (researchers: []), (in-depth directions: [gngm]), (effective strategies: [menp]), (clinical treatment: [topp]), (individuals: [humn]), 
ASD Terms: (neurodevelopmental disorders, 'Learning Disorders')(stereotyped patterns of behavior, 'Stereotyped, Restricted, and Repetitive Behavior')(autism spectrum disorder, 'Autism Phenotype')(social communication, 'Reciprocal Social Interaction')(neurodevelopmental processes, 'Learning Disorders')

PMCID: 6002613
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (progress: []), (understanding: [menp]), (autism spectrum disorder (asd): [mobd]), (systematic differences: [fndg]), (canonical neural computations: [acty]), (sensory cortex: [bpoc]), (clinical symptoms: [sosy]), (diverse sensory: []), ( cognitive: []), (social domains: []), (key proposal: []), (asd: [cgab]), (reduced divisive normalisation: [resa]), (sensory responses: [orga]), (bridge: []), (molecular evidence: []), (ratio: [qnco]), (cortical excitation: [bpoc]), (inhibition: [acty]), (functional characteristics: []), (sensory coding: []), (perception: [menp]), (behaviour: [inbe]), (hypothesis: []), (context: [fndg]), (gaze processing: [acty]), (other people's direction: [popg]), (gaze): [fndg]), (domain: []), (direct relevance: []), (core: [bdsu]), (diagnostic features: [fndg]), (divisive normalisation: [resa]), (specific predictions: []), (psychophysical effects: []), (sensory adaptation: [ortf]), (direction: []), (test: [lbpr]), (predictions: []), (adults: [aggp]), (evidence: []), (results: [fndg]), (important theoretical implications: []), (types: []), (divisive computations: [acty]), (condition: [dsyn]), (distal control: [sbst]), (cortical gain): [bpoc]), (strong testament: []), (typical sensory coding: []), (gaze direction: [fndg]), (atypical responses: [orga]), (gaze: [fndg]), (hallmark feature: []), (diagnosis: [fndg]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(cognitive, 'Cognitive Ability')(cognitive, 'Cognitive Ability')(sensory responses, 'Reaction to Sensory Stimuli')(perception, 'Cognitive Ability')(sensory adaptation, 'Adaptive Life Skills')(diagnosis, 'Diagnosis')

PMCID: 4445747
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism: [mobd]), (spectrum conditions: [dsyn]), (affect ~1%: [menp]), (population: [popg]), (deficits: []), (social communication: [socb]), (oxytocin: [aapp,horm,phsu]), (social-communicative function: [socb]), (neural underpinnings: []), (first evidence: [qnco]), (intranasal: []), (oxytocin administration: [aapp,horm,phsu]), (core problem: [fndg]), (individuals: [humn]), (eye contact: [socb]), (real-world social settings: [hcpp]), (randomized double-blind: [resa]), ( placebo-controlled: [resa]), ( within-subjects design: [acty]), (intranasal administration: [topp]), (iu: [nnon]), (oxytocin affects: [aapp,horm,phsu]), (behavior: [inbe]), (adult males: [aggp]), (controls: [sbst]), (real-time interaction: []), (researcher: []), (interactive paradigm: [resa]), (limitations: []), (computer-based stimuli: [phpr]), (eye movements: [ortf]), (eye tracking: [bpoc]), (objective measurement: []), (patterns: []), (measure: [qnco]), (autism group: [mobd]), (time: []), (eye region: [blor]), (face: [gngm]), (gaze: [fndg]), (eyes: [bpoc]), (control groups: [grup]), (mean eye-fixation difference: [dsyn]), (second=0.082;: [qnco]), (ci:0.0250.14: [lbpr]), ( p=0.006): [fndg]), ( oxytocin: [aapp,horm,phsu]), (effect: []), (fixation duration: [phsu]), (impaired levels: []), (baseline: [bodm]), (d=0.86): [aapp,imft]), (findings: [clna]), (potential benefits: [qnco]), (evidence: []), (therapeutic effect: [clna]), (key aspect: [qnco]), 
ASD Terms: (social communication, 'Reciprocal Social Interaction')(autism, 'Autism Phenotype')(eye contact, 'Eye Contact')(autism spectrum conditions, 'Autism Phenotype')(eye tracking, 'Eye Contact')(eye contact, 'Eye Contact')(social communication, 'Reciprocal Social Interaction')

PMCID: 5063479
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (study: [resa]), (percentages: [qnco]), (attention deficit: [mobd]), (hyperactivity disorder (adhd): [mobd]), (autism spectrum disorder (asd): [mobd]), (taiwanese aboriginal preschool children: [aggp]), (child development level: [orgf]), (groups: [popg]), (teachers: []), (questionnaires: []), (adhd: [mobd]), ( asd: [cgab]), (development level: [phsu]), (72-month-old children: []), (kindergartens: [fndg]), (taiwan: []), (questionnaire results: [fndg]), (nonaboriginal children: [aggp]), (child psychiatrist: [aggp]), (aboriginal preschool children: [aggp]), (adhd and/or asd: [cgab]), (aboriginal group: [popg]), (nonaboriginal group: [popg]), (children: [aggp]), (asd: [cgab]), (aboriginal children: [aggp]), (developmental delays: [mobd]), (situation comprehension: [menp]), (personalsocial development (p=0.012: [qnco]), (respectively): []), (typical percentages: [qnco]), (literature: [inpr,mnob]), (relative strengths: [qnco]), (personalsocial skills: [inbe]), (further studies: [lbpr]), (learning styles: [fndg]), (effective screening: [diap]), (intervention strategies: [topp]), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(hyperactivity disorder and/or asd, 'Attention Deficit Disorder with Hyperactivity')(had developmental delays for situation comprehension, 'Learning Disorders')(developmental delays, 'Learning Disorders')

PMCID: 6287693
SFARI Genes: CACNA1D, Cav1.3, CACNA1D, Cav1.3, CACNA1D, CACNA1D, CACNA1D, CACNA1D, CACNA1D, CACNA1D, Cav1.3, Cav1.3, Cav1.3, Cav1.3, Cav1.3, Cav1.3, CACNA1D, CACNA1D, 
Non SFARI Genes: 
Named Entities: (abstract recently: []), (others: [fndg]), (gain-of-function mutations: [phsf]), (cacna1d: [gngm]), (gene: [gngm]), (1-subunit: [aapp]), (voltage-gated cav1.3 ca2+-channels: [elii,phsu]), (somatic mutations: [comd]), (aldosterone: [horm,orch,phsu]), (adenomas (apas) underlie treatment-resistant hypertension: [neop]), ( germline cacna1d mutations: [genf]), (neurodevelopmental disorder: [mobd]), (wide symptomatic spectrum: [qnco]), (autism spectrum disorder: [mobd]), (number: [qnco]), (missense mutations: [genf]), (pathogenic potential: [fndg]), (silico: []), (functional studies: [lbpr]), (contribution: [acty]), (risk: []), (functional characterization: [acty]), (cacna1d apa mutations f747l: [genf]), (m1354i: []), (whole-cell patch-clamp electrophysiology: [celf]), (recombinant expression: [topp]), (tsa-201 cells: [cell]), (alternative splicing: [genf]), (cav1.3: [gngm]), (aberrant gating: []), (apa mutation r990h: [genf]), (mutations: [genf]), (autism spectrum disorder (a479g: [mobd]), (g407r): []), (splice-variant dependent gating changes: [qnco]), (particular interest: [menp]), (germline mutations: [genf]), (relative expression: [topp]), (cav1.3 splice variants differs: [gngm]), (different tissues: [tisu]), (brain regions: [blor]), (result: [fndg]), (tissue-specific phenotypes: [orga]), (data: [euka]), (complex gain-of-function phenotype: [phsf]), (apa mutation f747l: [genf]), (pathogenic role: [socb]), (r990h: []), ( a749g: []), (g407r: []), (channel function: [phsf]), (cav1.3 splice variants: [gngm]), (rare non-pathogenic variant: [fndg]), (further proof: [qnco]), (pathogenicity: [orga]), (new findings: [fndg]), (allow classification: [socb]), (pathogenic cacna1d mutations: [genf]), (categories: []), (prototypical functional changes: [topp]), 
ASD Terms: (neurodevelopmental disorder, 'Learning Disorders')(autism spectrum disorder, 'Autism Phenotype')

PMCID: 6342986
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism spectrum disorder (asd): [mobd]), (neurodevelopmental disorder: [mobd]), (impairments: [patf]), (social interactions: [fndg]), (communication: [socb]), (interests: [menp]), (repetitive behaviors: [fndg]), (several studies: [lbpr]), (high prevalence: [qnco]), (gastrointestinal (gi) symptoms: [sosy]), (autistic individuals: [mobd]), (cumulative evidence reveals: []), (gut microbiota: [orgm]), (metabolites: [bacs]), (fatty acids: [orch]), ( scfas): []), (important role: [socb]), (gi disorders: [dsyn]), (pathogenesis: [patf]), (asd: [cgab]), (however: []), (composition: [clna]), (association: [menp]), (fecal scfas: [bdsu]), (gi symptoms: [sosy]), (autistic children: [podg]), (present study: [qnco]), (rrna gene: [gngm]), (relationship: []), (gut microbiome: [orgm]), (neurotypical individuals: [humn]), (results: [fndg]), (compositions: [clna]), (scfas: []), (asd individuals: [cgab]), (levels: []), (fecal acetic acid: [irda,orch,phsu]), (butyrate: [orch]), (level: [phsu]), (fecal valeric acid: [bacs,orch]), (asd subjects: [cgab]), (decreased abundances: [qnco]), (key butyrate-producing taxa (ruminococcaceae: [orch]), ( eubacterium: [bact]), ( lachnospiraceae: [bact]), (erysipelotrichaceae): [bact]), (increased abundance: [qnco]), (valeric acid: [bacs,orch]), (bacteria: [bact]), (constipation: [sosy]), (only gi disorder: [dsyn]), (asd children: [cgab]), (fusobacterium: [bact]), ( barnesiella: [bact]), ( coprobacter: [bact]), (valeric acid-associated bacteria (actinomycetaceae): [bact]), (reduced butyrate-producing taxa: [orch]), (constipated autistic subjects: [mobd]), (autism: [mobd]), (butyrate-producing bacteria: [orch]), (promising strategy: [menp]), (search: [acty]), (alternatives: []), (treatment: [topp]), (autism spectrum disorder: [mobd]), 
ASD Terms: (social interactions, 'Reciprocal Social Interaction')(autism spectrum disorder, 'Autism Phenotype')(neurodevelopmental disorder, 'Learning Disorders')(repetitive behaviors, 'Stereotyped, Restricted, and Repetitive Behavior')(gastrointestinal disorders, 'Gastrointestinal Diseases')(gastrointestinal symptoms of autistic children, 'Complaints and Indications')(bacteria, 'Bacterial Infections')(only gastrointestinal disorder, 'Gastrointestinal Diseases')(valeric acid-associated bacteria, 'Bacterial Infections')(autism, 'Autism Phenotype')(autism spectrum disorder, 'Autism Phenotype')(butyrate-producing bacteria, 'Bacterial Infections')

PMCID: 4989357
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (children: [aggp]), (autism spectrum disorder (asd) show: [mobd]), (impairment: [patf]), (social functioning: [socb]), (poor adaptation: [orgf]), (contexts: [fndg]), (regulatory processes: [biof]), (oxytocin (ot): [aapp,horm,phsu]), (cortisol: [horm,orch,phsu]), (key neuromodulators: [bacs]), (behavioral responses: [inbe]), (synergistic effect: []), (neuropathological profile: [lbpr]), (asd: [cgab]), (however: []), (investigated together: []), (purpose: []), (pilot study: [resa]), (relationship: []), (ot: [gngm]), (baseline: [bodm]), (physiological stress (hydrocortisone challenge) conditions: [horm,orch,phsu]), (arginine vasopressin (avp): [aapp,horm,phsu]), (double-blind: [resa]), ( placebo-controlled: [resa]), ( randomly assigned: []), ( crossover design: [resa]), (years: []), (asd (n: [cgab]), (typical development (td: [orgf]), ( n: [aapp,imft]), (low dose: [qnco]), (hydrocortisone: [horm,orch,phsu]), (placebo: [topp]), (liquid suspension: [bodm]), (analysis: [resa]), (variance (anova): [qnco]), (within-subject factor condition (hydrocortisone/placebo): [dsyn]), (time (pre: [mamm]), (post): []), (between-subject factor group (asd: [cgab]), (td): []), (pearson correlations: []), (hormone levels: [lbtr]), (clinical profile: [lbpr]), (significant time  condition  group interaction f (1.23): [inch,phsu]), (p: [gngm]), (rise: []), (experimental condition (hydrocortisone): [horm,orch,phsu]), (drop: [qnco]), (placebo condition: [dsyn]), (td group: [popg]), (asd group: [cgab]), (group: [popg]), (avp: [gngm]), (social profiles: [lbpr]), (td: []), (inverse relationship: []), (observed: []), (physiological challenge: [hlca]), (stress-buffering role: [socb]), (cortisol administration: [horm,orch,phsu]), (contrast: [irda]), ( ot: [hlca]), (stress buffer: [irda,phsu]), (conditions: [dsyn]), (physiological stress: [patf]), (social ability: [socb]), (diminished moderating effect: [qnco]), (contributory role: [socb]), (heightened stress: []), (results: [fndg]), (understanding: [menp]), (complexity: [chvs]), (effects: []), (social behavior: [socb]), (functional interplay: []), (differential regulation ot: [hlca]), (stress modulation: [fndg]), 
ASD Terms: (autism spectrum disorder show, 'Autism Phenotype')(social functioning, 'Social Competence')(poor adaptation, 'Adaptive Life Skills')(social ability of children, 'Ability to Converse in Social Settings')(social ability, 'Ability to Converse in Social Settings')(social behavior, 'Reciprocal Social Interaction')

PMCID: 2727364
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (autism-spectrum quotient (aq): [qnco]), (autism spectrum disorder (asd): [mobd]), (attention deficit: [mobd]), (hyperactivity disorder (adhd): [mobd]), (comorbid substance use disorder (sud): [fndg]), (anovas: []), (mean aq (sub)scores: [qnco]), (adults: [aggp]), (asd: [cgab]), (adhd: [mobd]), (receiver: []), (characteristic (roc) computations: [qnco]), (discriminant power: [hcpp]), (sud status: []), (general: [hlca]), (aq (sub)scores: [qnco]), (social skills: [socb]), (subscale patients: [podg]), (comorbid sud: []), (sud: []), (cut-off score: [clna]), (correct classifications: []), (clinical use: []), (aq: []), 
ASD Terms: (autism spectrum disorder, 'Autism Phenotype')(hyperactivity disorder, 'Attention Deficit Disorder with Hyperactivity')(comorbid substance use disorder, 'Comorbidities')(social skills, 'Ability to Converse in Social Settings')

PMCID: 4993848
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (impairments: [patf]), (statistical learning: [menp]), (common deficit: [dsyn]), (individuals: [humn]), (specific language impairment (sli): [dsyn]), (autism spectrum disorder (asd): [mobd]), (meta-analysis: [resa]), (sli (14: [aapp,bacs]), (comparisons): [acty]), (asd (13: [cgab]), (hypothesis: []), (effect sizes: []), (function: [phsf]), (diagnosis: [fndg]), (multiple statistical learning tasks: [menp]), ((serial reaction time: []), ( contextual cueing: []), ( artificial grammar learning: [menp]), ( speech stream: [npop]), ( observational learning: [menp]), (probabilistic classification): []), (sli: [gngm]), (deficits: []), (age-matched controls: [orga]), (contrast: [irda]), ( statistical learning: [menp]), (asd: [cgab]), (task modality: [diap]), (participant age: [orga]), (findings: [clna]), (debates: [acty]), (social-communicative difficulties: [socb]), (children: [aggp]), (distinct underlying mechanisms: []), (line: [sbst]), (procedural deficit hypothesis (ullman: [dsyn]), (pierpont: []), (syntactic difficulties: [mobd]), (impaired statistical learning fails: [menp]), (social-pragmatic difficulties: [fndg]), 
ASD Terms: (impairments in statistical learning, 'Learning Disorders')(specific language impairment, 'Language Ability')(autism spectrum disorder, 'Autism Phenotype')(specific language impairment, 'Language Ability')(diagnosis, 'Diagnosis')(specific language impairment, 'Language Ability')(impaired statistical learning, 'Learning Disorders')(impaired statistical learning fails, 'Learning Disorders')

PMCID: 4283728
SFARI Genes: 
Non SFARI Genes: 
Named Entities: (peer relations: [socb]), (vulnerable area: []), (children: [aggp]), (specific language: [lang]), (impairment (sli): [aapp,bacs]), (developmental trajectories: [orgf]), (individuals: [humn]), (peer problems: [fndg]), (9-year period: []), (years: []), (age): [orga]), (history: [orga]), (sli: [gngm]), (discrete factor growth modelling: [orgf]), (multinomial: []), (logistic regression analysis: [resa]), (factors: []), (group membership: [popg]), (distinct developmental trajectories: [orgf]), (identified: low-level/no problems: [fndg]), (participants): [popg]), ( childhood-limited problems: [fndg]), (childhood-onset persistent problems: [fndg]), (adolescent-onset problems: [qnco]), (risk: []), (poor trajectories: [grpa]), (pragmatic language difficulties: [fndg]), (prosocial behaviour: [inbe]), (factor: []), (trajectory group membership: [popg]), (prosocial children: [aggp]), (pragmatic language skills: [menp]), (levels: []), (emotional problems: [mobd]), (difficulty: [fndg]), (analysis: [resa]), (understanding: [menp]), (social development: [socb]), (sizeable minority: [popg]), (present sample: [sbst]), (positive relations: [socb]), (childhood: []), (adolescence: []), (others: [fndg]), (early difficulties: [fndg]), (low levels: [qnco]), (problems: []), (majority: [socb]), ( however: []), (childhood-onset persistent: [fndg]), 
ASD Terms: (specific language impairment, 'Language Ability')(specific language impairment, 'Language Ability')(children with pragmatic language difficulties, 'Language Ability')(pragmatic language difficulties, 'Language Ability')(pragmatic language skills, 'Development or Regression of Language Skills')(understanding of social development, 'Ability to Converse in Social Settings')(social development, 'Ability to Converse in Social Settings')

PMCID: 5876144
SFARI Genes: SHANK3, SHANK3, Grin2a, Grin2a, Shank3, SHANK3, Shank3, SHANK3, 
Non SFARI Genes: 
Named Entities: (haploinsufficiency: [comd]), (shank3 gene: [gngm]), (spectrum disorder (asd): [cgab]), (asd-associated genes: [cgab]), (chromatin remodelers: [aapp]), (here: []), (brief treatment: [topp]), (romidepsin: [aapp,antb]), (potent class: []), (deacetylase (hdac) inhibitor: [aapp,enzy]), (social deficits: []), (shank3-deficient mice: [mamm]), (~3 weeks: []), (hdac2 transcription: [aapp,enzy]), (mice: [mamm]), (knockdown: []), (hdac2: [gngm]), (prefrontal cortex: [bpoc]), (nuclear localization: [biof]), (shank3-binding protein: [aapp,bacs]), (adhesion: [patf]), (transcription: [genf]), (hdac2 upregulation: [aapp,enzy]), (downstream: []), (molecular level: [phsu]), ( romidepsin treatment: [aapp,antb]), (expression: [topp]), (histone acetylation: [moft]), (grin2a: [gngm]), (actin regulatory genes: [gngm]), (nmdar function: [aapp,rcpt]), (actin filaments: [celc]), (together: []), (findings: [clna]), (epigenetic mechanism: [genf]), (shank3 deficiency: [dsyn]), (potential therapeutic strategies: [menp]), (asd patients: [cgab]), (shank3 mutations: [genf]), 
ASD Terms: (alleviated social deficits in shank3-deficient mice, 'Social Competence')(social deficits, 'Social Competence')
